TSTP Solution File: MED011+1 by Crossbow---0.1
View Problem
- Process Solution
%------------------------------------------------------------------------------
% File : Crossbow---0.1
% Problem : MED011+1 : TPTP v8.1.0. Released v4.0.0.
% Transfm : none
% Format : tptp:raw
% Command : do_Crossbow---0.1 %s
% Computer : n007.cluster.edu
% Model : x86_64 x86_64
% CPU : Intel(R) Xeon(R) CPU E5-2620 v4 2.10GHz
% Memory : 8042.1875MB
% OS : Linux 3.10.0-693.el7.x86_64
% CPULimit : 300s
% WCLimit : 600s
% DateTime : Sun Jul 17 16:51:48 EDT 2022
% Result : Satisfiable 42.05s 41.91s
% Output : FiniteModel 42.10s
% Verified :
% SZS Type : -
% Comments :
%------------------------------------------------------------------------------
%----WARNING: Could not form TPTP format derivation
%------------------------------------------------------------------------------
%----ORIGINAL SYSTEM OUTPUT
% 0.11/0.12 % Problem : MED011+1 : TPTP v8.1.0. Released v4.0.0.
% 0.11/0.12 % Command : do_Crossbow---0.1 %s
% 0.12/0.33 % Computer : n007.cluster.edu
% 0.12/0.33 % Model : x86_64 x86_64
% 0.12/0.33 % CPU : Intel(R) Xeon(R) CPU E5-2620 v4 @ 2.10GHz
% 0.12/0.33 % Memory : 8042.1875MB
% 0.12/0.33 % OS : Linux 3.10.0-693.el7.x86_64
% 0.12/0.33 % CPULimit : 300
% 0.12/0.33 % WCLimit : 600
% 0.12/0.33 % DateTime : Tue Jul 5 01:38:42 EDT 2022
% 0.12/0.34 % CPUTime :
% 0.12/0.34 /export/starexec/sandbox2/solver/bin
% 0.12/0.34 crossbow.opt
% 0.12/0.34 do_Crossbow---0.1
% 0.12/0.34 eprover
% 0.12/0.34 runsolver
% 0.12/0.34 starexec_run_Crossbow---0.1
% 42.05/41.91 % SZS status Satisfiable for theBenchmark.p
% 42.05/41.91 % SZS output start FiniteModel for theBenchmark.p
% 42.05/41.91 % domain size: 1
% 42.05/41.91 fof(interp, fi_domain, ![X] : X = 0).
% 42.05/41.91 fof(interp, fi_functors, ' note category: do not confuse with CELL CULTURE TECHNIQUES %28%Cat E%29%; not for bact or other micro-organisms; almost always NIM with no subheadings; check HUMANS or ANIMALS; do not routinely add tissue or organ; TUMOR CELLS, CULTURED is available%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' /abnorm = HEART SEPTAL DEFECTS or its specifics; heart septal dis: coord IM with CARDIOMYOPATHIES %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' /adv eff permitted; do not use /util %28%except by MeSH definition%29% /vet; don%27%t forget also HUMANS %26% FEMALE %26% PREGNANCY%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' /antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASE-2 is available%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' /antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASE-3 is available%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' /biosyn /defic /physiol permitted; urso- refers to its first isol from URSIDAE %28%Latin ursus%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' /microbiol /parasitol /virol permitted; don%27%t forget BOMBYX exists; TN 111 for eff of insecticides%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' 1,2-Benzphenanthrenes. POLYCYCLIC COMPOUNDS obtained from coal tar.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' A genus of HEPADNAVIRIDAE causing hepatitis in humans, woodchucks %28% HEPATITIS B VIRUS, WOODCHUCK%29% and ground squirrels. hepatitis b virus is the type species.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' A pair of anal glands or sacs, located on either side of the ANUS, that produce and store a dark, foul-smelling fluid in carnivorous animals such as MEPHITIDAE and DOGS. The expelled fluid is used as a defensive repellent %28%in skunks%29% or a material to mark territory %28%in dogs%29%.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' CLATHRIN ASSEMBLY PROTEINS see ADAPTOR PROTEINS, VESICULAR TRANSPORT is available%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' GEN or unspecified but usually male; when male, check tags HUMANS %26% MALE; when unspecified, check HUMANS but no sex tag; for female, CIRCUMCISION, FEMALE is available%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' GEN or unspecified; prefer specific hydrocarbon groups or specific hydrocarbons; POLYCYCLIC COMPOUNDS %28%D4%29% %26% CYCLOPARAFFINS %28%D2%29% are also available%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' GEN or unspecified; prefer specifics; consider also ENDOCRINE GLANDS /surg or /surg with specific endocrine glands; also ENDOCRINE SYSTEM DISEASES /surg or /surg with specific endocrine dis; DF: ENDOCRINE SURG PROCEDURES%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' GEN: prefer specifics; relation to parasites: Manual 22.12-.20; parasitic dis not in MeSH: Manual 22.17, 22.18; parasitic dis of heart = PARASITIC DISEASES or specific parasitic dis %28%IM%29% + CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES; DF: PARASITIC DIS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' PREGNANCY, UNPLANNED is also available; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN UNWANTED%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' Peptide initiation factors from eukaryotic organisms. Over twelve factors are involved in PEPTIDE CHAIN INITIATION, TRANSLATIONAL in eukaryotic cells. Many of these factors play a role in controlling the rate of MRNA TRANSLATION.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' Peptide initiation factors from prokaryotic organisms. Only three factors are needed for translation initiation in prokaryotic organisms, which occurs by a far simpler process than in PEPTIDE CHAIN INITIATION, TRANSLATIONAL of eukaryotic organisms.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' Use of HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' a model for DIABETES MELLITUS, TYPE 2 not DIABETES MELLITUS, EXPERIMENTAL; NIM when exper animal; check tag RATS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' a resp distress syndrome; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; check tags HUMANS %26% INFANT, NEWBORN%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' also known as PPHN; check the tags HUMANS %26% INFANT, NEWBORN; DF: PFC SYNDROME%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' breast cyst fluid = FIBROCYSTIC BREAST DISEASE %28%IM%29% + EXUDATES AND TRANSUDATES with pertinent qualif %28%NIM%29%; DF: EXUDATES%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' breast cyst fluid: coord NIM with FIBROCYSTIC BREAST DISEASE %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check also tags HUMANS %26% ADOLESCENCE; DF: ADOLESCENT HEALTH SERV%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check also tags HUMANS %26% CHILD; DF: ICU PEDIATRIC ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check also tags HUMANS %26% INFANT, NEWBORN ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check also tags HUMANS %26% INFANT, NEWBORN; DF: ICU NEONATAL%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check tags HUMANS %26% MALE ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check tags HUMANS or ANIMALS; differentiate from CLONING, MOLECULAR and CLONE CELLS; DF: CLONING%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' check the tags HUMANS %26% INFANT, NEWBORN ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' coord IM with organ/dis precoord %28%IM%29%; sarcoidosis of heart: coord IM with CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' deposition of calcium salts in tissues; most texts will say %22%calcification%22%; coord IM with organ/diseases term %28%IM%29%; for calcinosis of the heart, coord IM with CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' do not confuse X ref KANGAROO RATS with rat kangaroos %28% = MACROPODIDAE%29%; NIM when exper animal: no qualif; when IM, qualif permitted; do not check tag RATS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' do not confuse with PORPHYRIAS, HEPATIC or PORPHYRIA, ERYTHROPOIETIC%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' do not confuse with PROTEIN BIOSYNTHESIS %28%RNA-directed formation of peptides%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; check the tags HUMANS %26% MALE%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' do not use /util except by MeSH definition; don%27%t forget also check tags HUMANS or ANIMALS %26% FEMALE %26% PREGNANCY%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' does not include maternal care services: index under MATERNAL HEALTH SERVICES; check also tags HUMANS and FEMALE; DF: WOMENS HEALTH SERV%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' don%27%t forget also check tags HUMANS %26% FEMALE %26% PREGNANCY%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' don%27%t forget also check tags HUMANS %26% FEMALE %26% PREGNANCY; for abortifacients in crim abort see note on ABORTION, INDUCED%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN TRIMESTER FIRST%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' human only; check tags HUMANS %26% FEMALE %26% PREGNANCY; DF: PREGN TRIMESTER SECOND%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' human only; for animal, see note at BREAST NEOPLASMS; coordinate IM with histological type of neoplasm %28%IM%29%; check tags HUMANS %26% MALE%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' in females; don%27%t forget also check tags HUMANS + FEMALE; corresponding age-related osteoporosis in men goes under OSTEOPOROSIS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' prefer SPOUSE ABUSE for battering of wives; check tags HUMANS %26% FEMALE%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' preimplant refers to ovum implant; check tags HUMANS or ANIMALS %26% FEMALE %26% PREGNANCY%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' the human is biting, not being bitten; don%27%t forget to check tag HUMANS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, ' usually dis of function: differentiate from CARDIOMYOPATHIES, dis of myocardial tissue %28%see note there%29%; cyanotic heart dis is probably HEART DEFECTS, CONGENITAL %26% not CYANOSIS unless especially discussed; parasitic dis of the heart: coord PARASITIC DISEASES or specific parasitic dis %28%IM%29% with CARDIOMYOPATHIES %28%IM%29%, not HEART DISEASES; heart dis, unspecified or specific, with rheumatic fever is probably RHEUMATIC HEART DISEASE: see note there%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%Decayed, missing and filled teeth,%22% a routinely used statistical concept in dentistry.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%IUDs that release contraceptive agents%22%; coord IM with specific contraceptive agent %28%IM%29%; pregn despite use: see note on INTRAUTERINE DEVICES; DF: IUD MEDICATED%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%Philadelphia%22% refers to the Philadelphia chromosome; do not use /blood supply /chem /second /secret /ultrastruct; DF: LEUKEMIA PHILA NEG%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%Philadelphia%22% refers to the Philadelphia chromosome; do not use /blood supply /chem /second /secret /ultrastruct; DF: LEUKEMIA PHILA POS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%Southern%22% %28%developed by E.M. Southern%29% is capitalized in titles %26% translations; DF: SOUTHERN BLOT%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%The business or profession of the commercial production and issuance of literature%22% %28%Webster%27%s 3d%29%. It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%V%22% in alphaV is the letter not the roman numeral ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a branch of dentistry dealing with dis of the oral %26% paraoral struct %26% the oral management of system dis%22%; SPEC: SPEC qualif; X ref STOMATOLOGY: seen most often in foreign lit: translate as %22%oral medicine%22%; %22%stomatol dis%22% = MOUTH DISEASES%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a cpd that on admin must undergo chem conversion by metab processes before becoming the pharmacologically active drug for which it is a prodrug%22%; D25-26 qualif; coord IM with specific drug %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a family of RNA viruses, mainly arboviruses%22%; infection = TOGAVIRIDAE INFECTIONS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a family of SERine Proteinase INhibitors%22%, thus the source of the name%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a fluorescent analog of ATP%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a form of phagocyte bactericidal dysfunct%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a major constituent of pulmonary surfactants%22%; /biosyn /physiol permitted; DF: DPPC%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a non-allergic contact dermatitis caused by prolonged exposure to irritants%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%a willingness to reveal information about oneself to others%22%; no qualif%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%abnormal appearance of histiocytes in the blood%22% %28%usually in tissue%29%; GEN or unspecified only; prefer specifics; do not confuse with HISTIOCYTOSIS X see HISTIOCYTOSIS, LANGERHANS-CELL%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%abnormally low intraocular pressure%22%: do not confuse with OCULAR HYPERTENSION%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%abstinence from alcohol%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%accidentally acquired infect in laboratory%22%; IM; coord with specific infection %28%IM%29% + lab animal %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%alveolar%22% has nothing to do with pulm alveoli: it refers to sac-like pathol of musc affected; /blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%alveolar%22% has nothing to do with pulm alveoli: it refers to sac-like pathol of soft part; /blood /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%amputation or separation at a joint%22%; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%an alternative to endotracheal intubation%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%an infect caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression%22%; coord IM with specific name of opportunistic infect %28%IM%29% + specific infect to which it is opportunistic %28%IM%29%, using /compl for all 3%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%an unusual amino acid...found in proteins of cooked foods%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%ancient%22% refers to a far-past date or period; GEN or unspecified ancient countries or empires; prefer specifics; use historical tags%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%any purulent skin dis%22% but do not make diagnoses: use term of text%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%aphakic eye%22% probably goes here unless truly congen %28% = APHAKIA /congen%29%; do not coord with CATARACT EXTRACTION unless particularly discussed; PSEUDOPHAKIA is available for the postcataract eye with an intraocular lens%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%ascending tubules%22% = ASCENDING LIMB OF LOOP OF HENLE ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%axillary lymph nodes%22% = LYMPH NODES %28%IM%29% + AXILLA %28%NIM, no qualif%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%beliefs %26% values shared by all members of the organization%22%; NIM; coord with specific organization %28%IM%29%; no qualif%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%biol systems as affected by time%22%; DF: CHRONOBIOL ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%biol treatment of ment disord%22%; GEN or unspecified; prefer specifics; DF: PSYCHIATRIC SOMATIC THER%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%board, room %26% other personal assist serv%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%borderline%22% is a psychiatric diag: follow text ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%brain-isolated%22%, %22%enc%C3%%A9%phale isol%C3%%A9%%22%, %22%pithed%22%, %22%spinal%22% as in %22%spinal cat%22%, %22%cerveau isol%C3%%A9%%22% go here%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%capitation%22% refers to %22%a fixed per capita amt without regard to no. or nature of serv provided%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%caring for individuals in the community, rather than in an institutional environment%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%cast syndrome%22% %28%duodenal compression caused by wearing a body cast%29% = SUPERIOR MESENTERIC ARTERY SYNDROME if confirmed by text but do not index under CASTS, SURGICAL /adv eff unless particularly discussed%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%caused by ingestion of mycotoxins %28%toxins of fungal origin%29%%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%cellulite%22% in Amer or Eng lit is indexed under OBESITY %28%IM%29% + ADIPOSE TISSUE %28%IM%29%, in French lit %22%cellulite%22% can be %22%cellulite%22% or CELLULITIS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%coded listing of physician or other professional services using units that indicate the relative value of the various services they perform%22%; no qualif; DF: RELAT VALUE SCALES%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%colony-forming cells which give rise to neoplasms%22%; A 11 qualif%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%colorless ... precursors that may be transformed ... into colored cpds; used in biochem assays %26% ... as indicators%22%; D25-26 qualif; DF: CHROMOGENIC CPDS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%confused flour beetle%22%; /microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%considered both a protozoon %26% an alga%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%considered both a protozoon %26% an alga%22% %28%green%29%; in freshwater %26% damp soil%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%considered both a protozoon %26% an alga%22%; in stagnant water%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%consult via remote telecommun%22%; usually diag %26% ther but not restricted to med%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%culture media free of serum proteins%22%; NIM; D25-26 qualif with caution%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%cyst-%22% refers to the bladder, not to %22%cyst%22%; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%deliv of health serv via remote telecommun%22%; note specifics; DF: TELEMED%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%dependency%22% is not restricted to substance dependence: can apply to family or workplace; DF: CODEPENDENCY%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%derived by a process of manufacture from any portion of carcasses of any animal%22% %28%e.g., sausage, scrapple%29% but for canned meat see note on MEAT; coord IM with animal source %28%NIM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%descending tubules%22% = DESCENDING LIMB OF LOOP OF HENLE ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%diffuse%22% need not be used by author: note X ref ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%dissolution of a vertebra%22%; do not confuse with SPONDYLOLISTHESIS, displacemt of 1 vertebra over another; IM; coord with specific vertebra %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%disturbance in the prooxidant-antioxidant balance in favor of the former%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation%22%; GEN %26% unspecified: prefer specifics; do not confuse with CARDIOPULMONARY BYPASS or ASSISTED CIRCULATION; do not use /util except by MeSH definition; DF: EXTRACORPOREAL CIRC%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%electronic transm of radiol images%22%; DF: TELERADIOL ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%endocrine cells%22% of Russian literature probably goes here%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%essential to meet the health needs of a population%22%; IM GEN; for specific drug as essential, coord IM with drug %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%eustachian%22% is not capitalized in titles or translations%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%evolution at the molec level of DNA seq and proteins%22%; DF: EVOLUTION MOL%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%exercise%22% is not %22%exercise therapy%22%: use EXERCISE; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%exertion of a strong influence or control over others%22%; no qualif; DF: POWER%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%external decompression applied to the lower body%22%; used in physiol research %26% ther%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%fodder converted into succulent feed for livestock%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%food products manufactured from fish %28%e.g., FISH FLOUR, fish meal%29%%22% but for canned fish coord FISHES %28%IM%29% or specific fish %28%IM%29% + FOOD PRESERVATION %28%IM%29%; coord IM with fish source %28%NIM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%food products manufactured from poultry%22% but for canned poultry meat coord POULTRY or specific poultry %28%IM%29% + FOOD PRESERVATION; coord IM with poultry source %28%NIM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%forward displacemt of 1 vertebra over another%22%; do not confuse with SPONDYLOLYSIS, dissolution of a vertebra; IM; coord with specific vertebra %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%generalized%22% as opposed to %22%focal%22% or partial %28% = EPILEPSIES, PARTIAL%29%; prefer specific indentions; note X ref EPILEPSY, TONIC: do not confuse with EPILEPSY, TONIC-CLONIC%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%glomerulonephritis associated with systemic lupus erythematosus%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%hairy%22% refers to flagellated appearance of the lymphoreticular cells; since the dis is chronic, do not coord with CHRONIC DISEASE; do not use /blood supply /chem /second /secret /ultrastruct; consider also LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%have a functional defect as the result of one or more amino acid substitutions in the amino acid seq of normal fibrinogen%22%; DF: FIBRINOGENS ABNORM%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs %26% taboos%22%; specify ethnic group %28%IM%29% + geog; DF: HEALTH SERV INDIGENOUS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%hearing aid%22% is correct translation for %22%proth%C3%%A8%se auditive%22%, not %22%auditory prosthesis%22% unless you mean COCHLEAR IMPLANT%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%historical%22% refers to the more remote or recent past or to a term with historic significance aside from its location; all historical %26% century check tags apply%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%human or animal tissue used as temporary wound covering%22%; do not specify source unless especially discussed %26% do not coord with TRANSPLANTATION, HETEROLOGOUS; note X refs below; DF: BIOL DRESSINGS%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%immunologically competent cells%22% = B-LYMPHOCYTES or T-LYMPHOCYTES but do not add IMMUNOCOMPETENCE%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%in the home or institution intermittently in order to provide temporary relief to the family home care giver%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%inability to practice medicine with reasonable skill %26% safety to patient%22%; the causes may include alcohol %26% drug abuse, ment disord, phys disability, senility; coord IM with specific impairment %28%IM%29% + specialty if pertinent %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%increased rate of gene expression%22%; DF: TRANS ACTIVATION%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%increased salivary flow%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%induce antibody formation in people not responsive to polysaccharide alone%22%; semisynthetic vaccines; coord NIM with specific vaccine %28%IM%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%inflamm of tissues around a joint%22% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%instructional%22% %26% %22%often in schools%22%: differentiate from EXERCISE %28%see MeSH definition there%29%, from GYMNASTICS %28%see note there%29% %26% from EXERCISE THERAPY %28%prescribed exercise %26% physical activity%29%; DF: PHYS ED or PHYSICAL EDUC or PHYSICAL EDUCATION%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%inter- or intracellular transfer of information through a signal pathway%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%interfacility or intrahospital transfer%22%: read MeSH definition %26% do not confuse with TRANSPORTATION OF PATIENTS %28% = bed to bed or outside hosp or elsewhere%29%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%intervention%22% refers to a modification of the research design, not surg or pharmacol intervention: read MeSH definition; IM GEN only; coord NIM with specific study %28%IM%29%; no qualif%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%large increase in oxygen uptake by neutrophils %26% most types of tissue macrophages%22%%A% ' = 0).
% 42.05/41.91 fof(interp, fi_functors, '%22%lipid-laden macrophages%22%; A 11 qualif ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%lombo-sciatique%22% in French texts is indexed here %28%IM%29% + SCIATICA %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%mandibulofacial dysostosis with congen eyelid dermoids%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%marine fish %26% shellfish used as food%22%; coord IM with specific fish or shellfish %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%medical ergonomics%22%: index here but do not coord with MEDICINE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%minimal change glomerular disease%22% = NEPHROSIS, LIPOID ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%minimal lesion glomerulonephritis%22% = GLOMERULOSCLEROSIS, FOCAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%morbilli virus%22% sometimes refers to the MEASLES VIRUS %26% sometimes to the genus Morbillivirus: check text; infection = MEASLES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%morbilli virus%22% sometimes refers to the genus Morbillivirus %26% sometimes to MEASLES VIRUS: check text; infection = MORBILLIVIRUS INFECTIONS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%myasthenia%22% unqualified in foreign titles is more often MYASTHENIA GRAVIS than MUSCLE WEAKNESS but check text; congen consider MYASTHENIC SYNDROMES, CONGENITAL or specifics%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%neck dissection%22% in cancer is probably LYMPH NODE EXCISION %28%IM%29% + NECK %28%NIM%29% if unspecified or RADICAL NECK DISSECTION if specified%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%necrosis or disintegration of skeletal muscle often followed by myoglobinuria%22%: do not index under MYOGLOBINURIA unless this is particularly discussed %26% then probably NIM%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%non-med support services%22% in the home; DF: HOMEMAKER SERV%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%normal cellular genes homologous to viral oncogenes%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%normal flora of the intestinal tract%22%; usually non-pathogenic%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%northern%22% is not capitalized in titles or translations; DF: NORTHERN BLOT%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%nose%22% unspecified as NASAL BONE or NASAL CAVITY; /abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /secret = NASAL MUCOSA /secret; /surg: consider also RHINOPLASTY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%numerous types of clay%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%oncogene%22% used by author may refer to ONCOGENES or PROTO-ONCOGENES; do not confuse with ONCOGENES see CARCINOGENS; Manual 24.4.4.3; do not confuse with GENES, NEOPLASM%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%one chromosome of a pair is missing%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%one drug is not of suitable composition to be combined or mixed with another%22%: do not confuse with DRUG INTERACTIONS, %22%the action of one drug on the metab, effect or tox of another%22%; IM when general; NIM when with specific drug; no qualif%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%one of the hallmarks of Alzheimer disease%22%; A 11 qualif except /cytol; /genet permitted%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%opening %26% closing of ion channels%22% after various types of stimulation; DF: GATING%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%operated by private groups or corporations for a profit%22%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%painful oral symptoms assoc with a burning sensation%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%palliative %26% supportive care to the dying patient %26% his family%22%; specify geog%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%partial or total removal, ablation or destruction of the cerebral cortex; may be chemical%22%; usually exper; coord IM or NIM with specific part of brain with probably /physiol %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%passage of blood from one fetus to another via an arteriovenous communication or other shunt%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES; do not coord with DISEASES IN TWINS; TN 186: differentiate among various %22%transfusion%22% concepts%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%passage of viable bact from the gastrointest tract to extra-intest sites%22%; coord IM with specific bact /physiol %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%patient involvement in the decision-making process in matters pertaining to health%22%; do not confuse with PATIENT COMPLIANCE %28%see note there%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%pelvic%22% in X ref refers to pelvic floor ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%peritoneal cells%22% = probably PERITONEAL CAVITY /cytol or ASCITIC FLUID /pathol if pertinent; note PERITONEAL FLUID see ASCITIC FLUID; /inj is probably PERITONEUM /inj%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%persistent flexure or contracture of a joint%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%pervasive%22% is a psychiatric diag: follow text; check also tag CHILD or specific%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%photo-%22% refers to natural or artificial light; no qualif%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%placebo%22% is not restricted to drugs; IM GEN only; coord NIM with disease %28%IM%29%; no qualif; DF: PLACEBO EFF%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%pneumoconiosis assoc with rheum arthritis%22%; do not coord with OCCUPATIONAL DISEASES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%postpartum amenorrhea%22% is indexed under AMENORRHEA %28%IM%29% + PUERPERIUM %28%IM%29% %26% not LACTATION unless lactation is particularly discussed%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%precise %26% detailed plans for the study of a med or biomed problem%22% or %22%plans for a regimen of ther%22%; IM GEN only; do not use for cancer polychemother protocols %28% = ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS%29%; DF: CLIN PROTOCOLS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%predeciduous teeth present at birth%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%predisposition to abnormal hemostasis%22%; do not use /congen %26% do not coord with INFANT, NEWBORN, DISEASES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%prepared by recombinant DNA technol%22%; /drug eff permitted; in titles %26% translations spell with hyphens: %22%granulocyte-macrophage colony-stimulating%22%; DF: GMCSF RECOMBINANT%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%presence of co-existing or additional diseases%22% in epidemiol studies: do not confuse with /compl; IM GEN only; coord NIM with both diseases /epidemiol %28%IM%29%, not /compl; specify geog if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%preservation of cells, tissue, organs or embryos by freezing%22%; cryopreserv of organs or tissue: coord IM with specific organ or tissue heading %28%IM with no qualif%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%promotion %26% maintenance of physical %26% mental health in the work environment%22%: do not confuse with OCCUPATIONAL MEDICINE %28%the specialty%29% or OCCUPATIONAL HEALTH SERVICES; note X ref OCCUPATIONAL SAFETY which is GEN only: do not use as coord for safety in an industrial milieu %28% = SAFETY + specific indust or occup heading%29%; DF: OCCUP HEALTH%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%proteins prepared by recombinant DNA technology%22%; IM; GEN only; prefer specifics; for synthesis of these proteins, coord IM with /biosyn + specific protein /biosyn %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%radiogr by air, oxygen or some other gas as the contrast medium%22%: nothing to do with LUNG /radiogr; do not use /util except by MeSH definition; DF: PNEUMORADIOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%rapidly decreasing response to a drug or physiol active agent after admin of a few doses%22%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%recognition of professional or technical competence%22% through various measures: see MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%reducing%22% refers to oxidation-reduction, not body weight or obesity; D25-26 qualif%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%removal of eyeball leaving eye musc %26% remaining orbital contents intact%22%: do not confuse with EYE EVISCERATION %28%%22%removal of inner contents of eye, leaving sclera intact%22%%29%; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%removal of the contents of the orbit%22% %28%see MeSH definition%29%: do not confuse with EYE EVISCERATION, %22%removal of the inner contents of the eye, leaving the sclera intact%22%; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%removal of the inner contents of the eye, leaving the sclera intact%22%: do not confuse with EYE ENUCLEATION %28%%22%removal of eyeball leaving eye musc %26% remaining orbital contents intact%22%%29% or ORBIT EVISCERATION %28%%22%removal of contents of orbit, including eyeball, blood vessels, muscles, fat, nerve supply %26% periosteum%22%%29%; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%respiratory allergy%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%retrocochlear%22% refers to the vestibulocochlear nerve, not the cochlea; GEN or unspecified; prefer specifics; DF: RETROCOCHLEAR DIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%rostral part of the frontal lobe%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%salts %26% esters of glutamic acid%22%, an amino acid; /agon = EXCITATORY AMINO ACID AGONISTS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%scompenso di cuore%22% is %22%heart decompensation%22% in Italian; do not confuse with CARDIOMYOPATHY, CONGESTIVE; heart failure that is not congestive is CARDIAC OUTPUT, LOW%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%seasonal%22% refers usually to winter; DF: SAD ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%smallest known agents of infect dis%22%; read MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%smallest peptide fragment of gastrin%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%spasm of the larynx%22%: note X ref ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%stimulators%22% or %22%inducers%22% = INTERFERON INDUCERS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%the business %26% managerial aspects of pharmacy in its broadest sense%22%; SPEC; SPEC qualif; DF: PHARM ADMIN%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%the embryo in the early stage following the blastula%22%; A 11 qualif%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%the hypothetical acid of carbon dioxide %26% water%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%the infective system of a virus%22%; read MeSH definition for component parts%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%the study of animal behavior%22%; do not confuse with ETHNOLOGY; SPEC: SPEC qualif; DF: ETHOL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%the study of the theory, philosophy %26% doctrine of death%22%; do not confuse with DEATH, the physiol concept; DF: THANATOL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%therapy using oral or topical photosensitizing agents with subsequent exposure to light%22%; IM; coord with disease /drug ther %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%to restore volume %26% composition of body fluids...with respect to water-electrolyte balance%22%; for other nourishment use PARENTERAL FEEDING or specifics; do not use /util except by MeSH definition; coord IM with dis /ther %28%IM%29%, not dis /diet ther; do not specify route of admin unless particularly significant %28%%26% then only NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%tokolysis%22%: translate as %22%tocolysis%22% %26% index as TOCOLYSIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%total no. of calories taken in daily%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%total of nursing care activities%22%; do not confuse with NURSING %28%the profession%29%, NURSING CARE %28%the patient%29%, NURSING SERVICES; DF: NURS PROCESS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%transducing of light energy to afferent nerve impulses%22% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%transfer of patients %26% their med records from onehealth care institution to another%22%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%transm %26% interpret of tissue specimens via remote telecommun%22%; DF: TELEPATHOL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%tuberc of the mouth, tongue %26% salivary glands%22%; IM; coord IM with specific mouth, tongue or salivary gland heading %28%IM%29% or mouth, tongue or salivary dis heading %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%upkeep of property or equipment%22%; NIM ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%use of ultrasound to increase percutaneous adsorption of drugs%22%; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%used for drainage of air or fluid from the pleural space%22%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%vaginal bleeding%22% is probably UTERINE HEMORRHAGE but check text; inflammation = VAGINITIS or specifics; surg: consider COLPOTOMY; %22%vaginal opening%22% %28%assessing SEXUAL MATURATION by repeated daily inspection of laboratory animals%29%: index SEXUAL MATURATION + VAGINA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%vaginal bleeding%22% usually refers to uterine bleeding through the vagina %26% goes here but check text for bleeding from vaginal injuries, vaginal diseases, vaginal tumors, etc %28%index under proper VAGINA term%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%ventriculo-%22% refers to the heart, not the cerebral ventricles; NIM; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: RADIONUCLIDE VENTRICULOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%ventriculo-%22% refers to the heart, not the cerebral ventricles; used for the right or left ventricle but is preferred for right: for the left ventricle GATED BLOOD-POOL IMAGING is preferred; /drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: VENTRICULOGR FIRST PASS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%viruses containing 2 or more pieces of nucleic acid from different parents%22%: see MeSH definition; coord IM with specific parent viruses %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%western%22% is not capitalized in titles or translations ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%western%22% is not capitalized in titles or translations; DF: WESTERN BLOT%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%22%yusho poisoning%22%: see note on RICE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%%28%2-Hexahydro-1%28%2H%29%-azocinyl%29%ethyl%29%guanidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%+%29%-Catechin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%+%29%-Cyanidanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%+-%29%-1-%28%3-Chlorophenyl%29%-2-%28%%28%1,1-dimethylethyl%29%amino%29%-1-propanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%+-%29%-17-Methylmorphinan-3-ol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%1 beta,2 alpha,11 beta,12 alpha,15 beta%28%S%29%%29%-11,20-Epoxy-1,2,11,12-tetrahydroxy-15-%28%2-hydroxy-2-methyl-1-oxobutoxy%29%picras-3-en-16-one. A quassinoid %28%Simaroubolide%29% from Simaruba glauca, a tropical shrub. It has been used as an antiamebic agent and is found to be cytotoxic. It may be of use in cancer chemotherapy.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%1,1-Dimethylethyl%29%-4-methoxyphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%1-hydroxyethylene%29%diphosphonic acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%1-hydroxyethylene%29%diphosphonic acid, Tetrapotassium Salt' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%11 alpha,13E,15S%29%-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid %28%PGE%28%1%29%%29%; %28%5Z,11 alpha,13E,15S%29%-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid %28%PGE%28%2%29%%29%; and %28%5Z,11 alpha,13E,15S,17Z%29%-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid %28%PGE%28%3%29%%29%. Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%131%29%I-MAA' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%13E,15S%29%-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid %28%PGA%28%1%29%%29%; %28%5Z,13E,15S%29%-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid %28%PGA%28%2%29%%29%; %28%5Z,13E,15S,17Z%29%-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid %28%PGA%28%3%29%%29%. A group of naturally occurring secondary prostaglandins derived from PGE; PGA%28%1%29% and PGA%28%2%29% as well as their 19-hydroxy derivatives are found in many organs and tissues.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%15S%29%-Hydroxy-11 alpha, 9 alpha-%28%epoxymethano%29%prosta-5Z, 13E-dienoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%15S%29%hydroxy-9alpha,11alpha-%28%epoxymethano%29%prosta-5,13-dienoic acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2%27%-5%27%%29%An Polymerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2-%28%4-%28%%28%4-Chlorophenyl%29%phenylmethyl%29%-1-piperazinyl%29%ethoxy%29%acetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2-Mercaptoethyl%29%Trimethylammonium Butyrate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2-Mercaptoethyl%29%trimethylammonium Acetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2-Mercaptoethyl%29%trimethylammonium. A reagent for the determination of cholinesterases; acts also as a highly selective nerve stain.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%24R%29%-24,25-Dihydroxyvitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%25R%29%-Spirost-5-en-3-beta-ol. A steroid sapogenin which is isolated from various plants. Can be converted to ecdysone, pregnenolone, and progesterone. Synonym: nitogenin.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2S-%28%2 alpha,3 beta%28%1E,3E,5Z,8Z%29%%29%%29%-3-%28%1,3,5,8-Tetradecatetraenyl%29%oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%2S-%28%2 alpha,3 beta,4 beta%29%%29%-2-Carboxy-4-%28%1-methylethenyl%29%-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%3 beta, 17 alpha%29%-19-Norpregn-4-en-20-yne-3,17 diol Diacetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%3 beta,5Z,7E%29%-9,10-Secocholesta-5,7,10%28%19%29%-trien-3-ol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%3-Mercapto-2-benzylpropionyl%29%glycine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%4-%28%Trifluoromethoxy%29%phenyl%29%hydrazonopropanedinitrile' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%4-%28%m-Chlorophenylcarbamoyloxy%29%-2-butynyl%29%trimethylammonium Chloride' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%4-Hydroxy-3-iodo-5-nitrophenyl%29%acetyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%4-Hydroxy-5-iodo-3-nitrophenyl%29%acetyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%5-HT%29%2B Receptors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%5Z%29%-%28%15S%29%-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD%28%P%29%+ delta%28%13%29%-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%5beta%29%-3,7,12-Trioxocholan-24-oic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%6 alpha%29%-17-%28%Acetoxy%29%-6-methylpregn-4-ene-3,20-dione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%6 alpha%29%-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%75%29%; use LOIASIS to search LOAIASIS 1975-88; search FILARIASIS 1967-74%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%8-Arginine%29%Oxytocin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%9 alpha,11 alpha,13E,15S%29%-9,11,15-Trihydroxyprost-13-en-1-oic acid %28%PGF%28%1 alpha%29%%29%; %28%5Z,9 alpha,11,alpha,13E,15S%29%-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid %28%PGF%28%2 alpha%29%%29%; %28%5Z,9 alpha,11 alpha,13E,15S,17Z%29%-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid %28%PGF%28%3 alpha%29%%29%. A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Acyl-Carrier-Protein%29% Acetyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Acyl-Carrier-Protein%29% Malonyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Acyl-Carrier-Protein%29% S-Acetyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Acyl-Carrier-Protein%29% S-Malonyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%But%29%%28%2%29% cAMP' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%GTP cyclohydrolase I%29% or GTP 7,8-8,9-dihydrolase %28%pyrophosphate-forming%29% %28%GTP cyclohydrolase II%29%. An enzyme group that hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. EC 3.5.4.16 %28%GTP cyclohydrolase I%29% and EC 3.5.4.25 %28%GTP cyclohydrolase II%29%.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Methyl-ONN-azoxy%29%methanol Acetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Methyl-ONN-azoxy%29%methyl beta-D-Glucopyranoside' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Pyruvate dehydrogenase %28%lipoamide%29%%29%-phosphate phosphohydrolase. A mitochondrial enzyme that catalyzes the hydrolytic removal of a phosphate on a specific seryl hydroxyl group of pyruvate dehydrogenase, reactivating the enzyme complex. EC 3.1.3.43.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%R%29%-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%R%29%-3-Hydroxy-alpha-%28%%28%methylamino%29%methyl%29%benzenemethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%R*,S*%29%-%28%+-%29%-8-Hydroxy-5-%28%1-hydroxy-2-%28%%28%1-methylethyl%29%amino%29%butyl%29%-2%28%1H%29%-quinolinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%S%29%-1-%28%%28%1,1-Dimethylethyl%29%amino%29%-3-%28%%28%4-%28%4-morpholinyl%29%-1,2,5-thiadazol-3-yl%29%oxy%29%-2-propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%S%29%-1-%28%3-Mercapto-2-methyl-1-oxopropyl%29%-L-proline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%S%29%-3-Bromo-N-%28%%28%1-ethyl-2-pyrrolidinyl%29%methyl%29%-2,6-dimethoxybenzamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%S-%28%E%29%%29%-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7%28%8H%29%-dione. One of a group of compounds known under the general designation of resorcylic acid lactones. Cis, trans, dextro and levo forms have been isolated from the fungus Gibberella zeae %28%formerly Fusarium graminearum%29%. They have estrogenic activity, cause toxicity in livestock as feed contaminant, and have been used as anabolic or estrogen substitutes.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Sar%28%1%29%,Ala%28%8%29%%29%ANGII' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Sar1,Val5,Ala8%29%Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%T-4%29%-Osmium oxide %28%OsO4%29%. A highly toxic and volatile oxide of osmium used in industry as an oxidizing agent. It is also used as a histological fixative and stain and as a synovectomy agent in arthritic joints. Its vapor can cause eye, skin, and lung damage.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%Z%29%-9-Octadecenoic acid 1,2,3-propanetriyl ester. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%all-Z%29%-5,8,11,14-Eicosatetraenoic acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%alpha-Bromoisovaleryl%29%urea' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%beta 1-%28%2-Deoxyribopyranosyl%29%%29%thymidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%endo,syn%29%-%28%+-%29%-3-%28%3-Hydroxy-1-oxo-2-phenylpropoxy%29%-8-methyl-8-%28%1-methylethyl%29%-8-azoniabicyclo%28%3.2.1%29%octane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%m-Phenoxybenzyl%29%-cis,trans-3-%28%2,2-dichlorovinyl%29%-2,2-dimethylcyclopropanecarboxylate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%28%pPNET%29% Peripheral Primitive Neuroectodermal Tumors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '%60%2004; see KNOWLEDGE ATTITUDES PRACTICE 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '-cidal or -static; consider also SCHISTOSOMA /drug eff %26% SCHISTOSOMIASIS /drug ther or pertinent specifics%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '-static or -cidal; consider also MYCOBACTERIUM LEPRAE /drug eff %26% LEPROSY /drug ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/DEFIC: consider also ALPHA-MANNOSIDOSIS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm permitted for congen deform but acquired deform = EAR DEFORMITIES, ACQUIRED %28%IM%29% + EAR CARTILAGES %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; /surg: consider also RHINOPLASTY; fractures: coord NASAL BONE /inj %28%IM%29% + SKULL FRACTURES %28%IM%29%; neopl: coord IM + NOSE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm permitted for congen deform but acquired deform = NOSE DEFORMITIES, ACQUIRED; neopl: coord IM + NOSE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; inflammation = RHINITIS; /secret = NASAL MUCOSA /secret%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm permitted for congenital deformities but acquired deformities = EAR DEFORMITIES, ACQUIRED; inflammation = OTITIS EXTERNA; ear acupuncture or auriculoacupuncture or otoacupuncture %28%acupuncture therapy with ear as pressure point%29% goes here %28%IM%29% + ACUPUNCTURE THERAPY %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm: BILIARY ATRESIA is also available; /radiogr permitted but CHOLECYSTOGRAPHY for gallbladder x-ray %26% CHOLANGIOGRAPHY for bile duct x-ray are available; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS; empyema = EMPYEMA, GALLBLADDER see CHOLECYSTITIS or EMPYEMA %28%IM%29% + BILIARY TRACT DISEASES %28%IM%29% if not of gallbladder; inflammation = CHOLECYSTITIS or CHOLANGITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm: BILIARY ATRESIA is also available; inflammation = CHOLANGITIS; calculi = BILIARY CALCULI see GALLSTONES but consider also CHOLELITHIASIS %28%IM%29% + BILE DUCT DISEASES %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnorm: CYSTIC ADENOMATOID MALFORMATION OF LUNG, CONGENITAL is available; /blood supply: consider also PULMONARY CIRCULATION; /surg: consider also PNEUMONECTOMY but PULMONARY SURGICAL PROCEDURES is also available; /transpl = LUNG TRANSPLANTATION or HEART-LUNG TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS unless particularly discussed; inflammation = PNEUMONIA; collapse of lung = ATELECTASIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/abnormalities was TONGUE ABNORMALITIES 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/admin: various administration procedures are available, as CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CHEMOEMBOLIZATION, THERAPEUTIC and INFUSIONS, INTRA-ARTERIAL; for combined anticancer agents, ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS is available; Manual 24.4.2.1+%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff /psychol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff = probably FOOD HYPERSENSITIVITY or FOOD POISONING; /rad eff = probably FOOD IRRADIATION or FOOD CONTAMINATION, RADIOACTIVE; Manual 31.5-31.12; food consumption = FOOD or EATING or FOOD SUPPLY; food for animals = ANIMAL FEED; refeeding after starvation goes here; microbes found in food: consider FOOD MICROBIOLOGY %28%IM%29% + specific microbe %28%IM%29%; parasites found in food: consider FOOD PARASITOLOGY %28%IM%29% + specific parasite %28%IM%29%; differentiation from DIET %26% NUTRITION: see note under NUTRITION %26% Manual 31.5%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff permitted but consider also SUNBURN %26% SUNSTROKE; using sunlight therapeutically = HELIOTHERAPY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff permitted but consider also ULTRASONOGRAPHY /adv eff %26% ULTRASONIC THERAPY /adv eff; ultrasonic or sonographic imaging of organs is organ /ultrasonogr%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff permitted but do not confuse adv eff of the suture with the adv eff of the material of which suture is made or the adv eff of the suture method%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff permitted but do not use for COAL MINING + PNEUMOCONIOSIS or ANTHRACOSILICOSIS unless particularly discussed as coal%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff permitted but more likely is FLUORIDES /adv eff or specific fluoride terms /adv eff; = %22%fluoridation of water supply%22% so do not also coord with WATER SUPPLY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff permitted; rotation of a body part on its axis is TORSION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was BARBITURATE TOXICOLOGY 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was CHLORPROMAZINE TOXICOLOGY 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was CORTISONE TOXICOLOGY 1963-65; /ther use was CORTISONE, THERAPEUTIC 1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was HYDROCORTISONE TOXICOLOGY 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was ISONIAZID TOXICOLOGY 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was PREDNISONE TOXICOLOGY 1963-65; /ther use was PREDNISONE, THERAPEUTIC 1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff-pois-tox was STREPTOMYCIN TOXICOLOGY 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: consider also EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem /ind; /ther use: coord with specific disease /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /defic = SODIUM /defic but consider also HYPONATREMIA; for intake of table salt index under SODIUM CHLORIDE, DIETARY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; /defic permitted; low- or high-fiber diet: use /admin%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; high-protein diet: use /admin; EGG PROTEINS; MILK PROTEINS; %26% VEGETABLE PROTEINS and specifics are also available; for dietary plant proteins see note on PLANT PROTEINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific dis /diet ther; low-carbohydrate diet: use /admin%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coord with disease /etiol, not /chem ind; /ther use: coord with specific disease /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adv eff: coordinate with disease /etiol, not /chem ind; /ther use: coord with disease /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were BARBITURATE TOXICOLOGY 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were CHLORPROMAZINE TOXICOLOGY 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were CORTISONE TOXICOLOGY 1963-65; /therapeutic use was CORTISONE, THERAPEUTIC 1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were HYDROCORTISONE TOXICOLOGY 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were ISONIAZID TOXICOLOGY 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were PREDNISONE TOXICOLOGY 1963-65; /therapeutic use was PREDNISONE, THERAPEUTIC 1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/adverse effects /poisoning /toxicity were STREPTOMYCIN TOXICOLOGY 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/agon = EXCITATORY AMINO ACID AGONISTS; /antag = EXCITATORY AMINO ACID ANTAGONISTS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/anal /chem permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/analogs = AMMONIUM COMPOUNDS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/analogs = MORPHINE DERIVATIVES ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/analogs = SULFIDES or SULFHYDRYL COMPOUNDS or specifics ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/analogs: consider also CURARE-LIKE AGENTS see NEUROMUSCULAR NONDEPOLARIZING AGENTS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/anat: CEPHALOPELVIC PROPORTION see PELVIMETRY is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag - consider also POTASSIUM HYDROGEN ATPASE /antag ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = CHOLINESTERASE INHIBITORS %28%IM%29% + BUTYRYLCHOLINESTERASE %28%NIM with no qualif%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = CHOLINESTERASE INHIBITORS %28%IM%29% + PSEUDOCHOLINESTERASE %28%NIM with no qualif%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; coord IM with specific cholinergic agent %28%IM%29%; DF: RECEPT CHOLINERGIC%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = PHOSPHORIC DIESTER HYDROLASE INHIBITORS %28%see PHOSPHODIESTERASE INHIBITORS%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = SEROTONIN ANTAGONISTS but consider also SEROTONIN UPTAKE INHIBITORS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag = probably HEPARIN ANTAGONISTS; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASE-1 is available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag is permitted but TISSUE INHIBITOR OF METALLOPROTEINASES is available; check MeSH for specific matrix metalloproteinases%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider KALLIKREIN-TRYPSIN INACTIVATOR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTISTREPTOLYSIN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; DF: AFB1 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; DF: AFM1 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coord IM with source of dermotoxin %28%IM or NIM%29%; do not use for dermatoxicity of various chemicals %26% drugs %28% = SKIN /drug eff or skin dis heading /chem ind + Cat D term /adv eff-pois-tox%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coord IM with specific bacterium %28%IM or NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coord IM with specific bacterium %28%IM with no qualif%29% but do not coord with BACTERIAL TOXINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coordinate IM with source of ciguatoxin%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coordinate IM with source of cytotoxin %28%IM or NIM%29%; cytotoxins are biological matter: do not confuse with antineoplastic agents called %22%cytotoxic drugs%22%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coordinate IM with specific source %28%IM with no qualifiers%29%; does not include venoms of sea snakes %28% = SEA SNAKE VENOMS%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coordinate IM with toxin or venom heading which is the source of the neurotoxin %28%IM or NIM%29%; do not use for neurotoxicity of various chemicals %26% drugs %28% = NERVOUS SYSTEM /drug eff or specific nervous system term /drug eff or nervous system disease heading /chem ind + Category D term /adv eff-pois-tox%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS; coordinate with source only if particularly discussed%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTITOXINS;/biosyn permitted if by fungus%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; /enzymol permitted%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific amphibian %28%IM or NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; /enzymol permitted; coord IM with specific arachnid or insect %28%IM or NIM%29% but note available specifics: ANT VENOMS; BEE VENOMS; SCORPION VENOMS; SPIDER VENOMS %26% WASP VENOMS %26% their indentions%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; /enzymol permitted; coordinate IM with specific mollusk %28%IM or NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; /enzymol permitted; includes adder venoms %26% viperotoxin; TN 241: common %26% scientific names of various viperids; note PIT VIPER VENOMS see CROTALID VENOMS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; /enzymol permitted; note that BUNGAROTOXINS; COBRA NEUROTOXINS; COBRA VENOMS %26% other specifics are available; TN 241: common %26% scientific names of various elapids%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also ANTIVENINS; coordinate with specific Cnidaria source%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also BOTULINUM ANTITOXIN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also CHOLINESTERASE REACTIVATORS; DF: ORGANOPHOSPHORUS CPDS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also COMPLEMENT C1 INACTIVATOR PROTEINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also DIPHTHERIA ANTITOXIN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted but consider also TETANUS ANTITOXIN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag permitted: not same as ANTITHROMBINS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag: consider COMPLEMENT C3B INACTIVATOR PROTEINS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag: consider also ALPHA 1-ANTICHYMOTRYPSIN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag: consider also ANTITOXINS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag: consider also PLASMINOGEN INACTIVATORS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag: coord IM with specific inhibitor %28%IM%29% + REVERSE TRANSCRIPTASE INHIBITORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antag: coord with CARBONIC ANHYDRASE INHIBITORS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/antagonists %26% inhibitors was ANTIHISTAMINICS 1963-76 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /defic /physiol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /defic /physiol permitted; POLYLYSINE is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /rad eff /ultrastruct permitted; DF: CL CHANNELS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /rad eff /ultrastruct permitted; DF: NA CHANNELS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /ultrastruct permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /ultrastruct permitted; /defic: consider also ABETALIPOPROTEINEMIA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X refs%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /ultrastruct permitted; do not use /analogs%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol /ultrastruct permitted; note X ref: do not index under ENCEPHALOMYELITIS, ALLERGIC unless the disease is discussed; DF: ENCEPH BASIC PROTEINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol permitted; TUBULIN is available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol permitted; do not use /analogs%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /drug eff /physiol permitted; for contractile proteins in muscle, index only under MUSCLE PROTEINS or specifics %26% not also under CONTRACTILE PROTEINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol /blood permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted if by living organism; DF: PG ANTAG%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted only with endogenous proteinase inhib; DF: CYSTEINE PROTEINASE INHIB%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; %22%tritiated thymidine%22% as a research technique is probably NIM if indexed at all%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; /admin: consider also INSULIN INFUSION SYSTEMS; /blood: consider also HYPERINSULINEMIA %28%excessively high blood insulin levels%29% but do not confuse with HYPERINSULINISM %28%excessive secretion of insulin by pancreas%29%; /immunology: consider also INSULIN ANTIBODIES; /ther use: if by INSULIN INFUSION SYSTEMS use INSULIN INFUSION SYSTEMS %26% not also INSULIN /ther use; precursor = PROINSULIN%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PG ENDOPEROXIDES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS E, SYNTHETIC: DF: PGE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; /chem syn permitted: do not convert to PROSTAGLANDINS F, SYNTHETIC; DF: PGF%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; /defic: consider also HYPOALDOSTERONISM; PSEUDOHYPOALDOSTERONISM is also available; consider also RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM see RENIN-ANGIOTENSIN SYSTEM %26% do not index under ALDOSTERONE unless particularly discussed%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; /urine = METMYOGLOBIN /urine %28%IM%29% + MYOGLOBINURIA %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; CHONDROITIN SULFATE B see DERMATAN SULFATE is available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: APPNHP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: BETA TG ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: BILE ACIDS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: CABP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: CYCL GMP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: CYCL IMP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: NMN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: PDGF ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: PGD2 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: PHRIH ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: PPGPP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: PPPGPP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: THYMIC FACTOR CIRC ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; DF: note short X ref ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; cAMP receptor protein, cyclic AMP receptor protein: index under RECEPTORS, CYCLIC AMP; DF: CYCL AMP%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; do not confuse X ref CERULEIN with CERULENIN%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; do not confuse X ref THYMINS with THYMINE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; do not confuse with MYOCARDIAL DEPRESSANTS %28%see ANTI-ARRHYTHMIA AGENTS%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; do not use /analogs; also called LIF; DF: LMIF%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC %28%IM%29%; /chem syn permitted: do not convert to PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; DF: PGG%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDINS, SYNTHETIC %28%IM%29%; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC: DF: PGB%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; for analogs, coord NIM with PROSTAGLANDINS, SYNTHETIC %28%IM%29%; /chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGD%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; spell in titles %26% translations with lowercase b: cytochrome b; do not confuse with CYTOCHROMES B%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; thymine deoxyriboside, thymine deoxyribonucleoside = THYMIDINE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn /physiol permitted; uracil deoxyriboside, uracil deoxyribonucleoside = DEOXYURIDINE; uracil riboside, uracil ribonucleoside = URIDINE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn if permitted by plant; do not confuse with the dye muscarine%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted for micro-organisms ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted if by fungus ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted if by living matter ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted if by organism ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted if by plant ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted if by toads, mushrooms, etc. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn permitted; DF: AMAIG ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/biosyn/physiol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood = BLOOD GLUCOSE but consider also HYPERGLYCEMIA %26% HYPOGLYCEMIA; /defic: consider also HYPOGLYCEMIA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood = DEOXYGLUCOSE /blood %28%NIM%29% + BLOOD GLUCOSE %28%IM%29%; do not use /defic /physiol%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood = SGPT /blood %28%not just SGPT%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with BILE DUCT NEOPLASMS %28%IM%29% + BILE DUCTS, INTRAHEPATIC %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%; osteoblastoclastoma: coord IM with OSTEOBLASTOMA %28%IM%29% + organ/neopl coords %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with BREAST NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with CEREBELLAR NEOPLASMS %28%IM%29% or other precoord brain/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with LIVER NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS %28%IM%29%, not BRONCHIAL NEOPLASMS; do not confuse X ref CARCINOMA, BRONCHIAL with BRONCHIAL NEOPLASMS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with LUNG NEOPLASMS %28%IM%29%; DF: ADENOMATOSIS PULM%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS %28%IM%29% or TESTICULAR NEOPLASMS %28%IM%29% %26% appropriate check tags%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with OVARIAN NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with PERITONEAL NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with PROSTATIC NEOPLASMS %28%IM%29%; DF: PROSTATIC INTRAEPITHELIAL NEOPL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with SEBACEOUS GLAND NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS %28%IM%29% in male or OVARIAN NEOPLASMS %28%IM%29% if in female%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with TESTICULAR NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with THYROID NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with UTERINE CERVICAL NEOPLASMS %28%IM%29%; DF: CIN%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%; CHOROID NEOPLASMS %26% IRIS NEOPLASMS are also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with histol type of neopl %28%IM%29%; note X ref EPULIS, CONGENITAL: do not confuse with EPULIS see GINGIVAL DISEASES; index EPULIS, CONGENITAL under GINGIVAL NEOPLASMS /congen%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl heading %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; MELANOMA, EXPERIMENTAL is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; SARCOMA, EXPERIMENTAL is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; consider also MALIGNANT CARCINOID SYNDROME or CARCINOID HEART DISEASE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; myxosarcoma of breast = PHYLLODES TUMOR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term but probably LUNG NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably COLONIC NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably SKIN NEOPLASMS %28%IM%29%; X ref RODENT ULCER: do not coord with ULCER%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with probably UTERINE NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific FEMUR HEAD or FEMUR NECK %28%NIM%29% as merely locational + histol type of neopl %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific histol type of neopl %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in brain %28%IM%29% + histol type of neopl %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; coord IM with specific site in heart %28%NIM%29% + histol type of neopl %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct permitted; organ/neopl %26% histol coords not necessary%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /second /secret /ultrastruct; coord IM with probably TESTICULAR NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; /drug ther: consider also ANTINEOPLASTIC AGENTS, HORMONAL; coord IM with precoord organ/neopl term %28%IM%29% + histol type %28%IM%29% + specific hormone %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with ADRENAL GLAND NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with BILE DUCTS, INTRAHEPATIC %28%IM%29% + BILE DUCT NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%; do not confuse with OSTEOMA, GIANT OSTEOID see OSTEOBLASTOMA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with BONE NEOPLASMS %28%IM%29% or specific precoord bone/neopl term %28%IM%29% or specific bone %28%IM%29% + BONE NEOPLASMS %28%IM%29%; osteoblastoclastoma = OSTEOBLASTOMA %28%IM%29% + GIANT CELL TUMOR OF BONE %28%IM%29% + precoord organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with PITUITARY NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with SALIVARY GLAND NEOPLASMS %28%IM%29% or specific salivary gland neopl precoord %28%IM%29%; if of a minor salivary gland, coord IM with SALIVARY GLAND NEOPLASMS %28%IM%29% + SALIVARY GLANDS, MINOR %28%IM%29%; for X ref SYRINGOMA, CHONDROID, coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if permitted%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with SKIN NEOPLASMS %28%IM%29% + site %28%IM or NIM%29% if relevant; BASAL CELL NEVUS SYNDROME %26% DYSPLASTIC NEVUS SYNDROME are also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with SWEAT GLAND NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord genital/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; %22%laryngeal papilloma%22% = PAPILLOMA %28%IM%29% + LARYNGEAL NEOPLASMS %28%IM%29%; %22%choroid plexus papilloma%22% = GLIOMA %28%IM%29% + CHOROID PLEXUS NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%; French %22%odontome%22% %28%a form of developmental anomaly%29%: index under TOOTH ABNORMALITIES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem /secret /ultrastruct permitted; coord IM with probably OVARIAN NEOPLASMS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply /chem/ second /secret /ultrastruct permitted; coord IM with precoord organ/neopl term %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply = RETINAL VESSELS or RETINAL ARTERY or RETINAL VEIN; inflammation = RETINITIS or CHORIORETINITIS; neopl: majority will be RETINOBLASTOMA %28%see note there%29%, otherwise retinal neopl goes under RETINAL NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; retinal dystrophy: index under RETINAL DEGENERATION or MACULAR DEGENERATION relying on text %26% refs; pigment epithelium of retina: coord RETINA with PIGMENT EPITHELIUM OF EYE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply: ESOPHAGEAL AND GASTRIC VARICES is available: see note there; /surg: consider also ESOPHAGECTOMY; ESOPHAGOPLASTY; or ESOPHAGOSTOMY; inflammation = ESOPHAGITIS; hemorrhage = ESOPHAGEAL DISEASES %28%IM%29% + GASTROINTESTINAL HEMORRHAGE %28%NIM%29%; rupture: index under ESOPHAGUS /inj %28%IM%29% + RUPTURE %28%NIM%29% or ESOPHAGEAL DISEASES %28%IM%29% + RUPTURE, SPONTANEOUS %28%NIM%29%; peristalsis of the esophagus = ESOPHAGUS /physiol %28%IM%29% + PERISTALSIS %28%NIM%29%; esophageal intubation = ESOPHAGUS %28%IM%29% + INTUBATION %28%IM%29%; esophageal obturator airway = ESOPHAGUS %28%IM%29% + INTUBATION /instrum %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply: consider PLACENTAL CIRCULATION; /surg: consider HYSTERECTOMY or HYSTEROTOMY; inflammation = ENDOMETRITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply: consider also LIVER CIRCULATION; /cytol: consider also KUPFFER CELLS; /surg: consider also HEPATECTOMY %26% LIVER TRANSPLANTATION; inflammation = HEPATITIS %26% its specifics; specialty is HEPATOLOGY see GASTROENTEROLOGY; be careful: do not confuse %22%hepatic%22% with %22%intrahepatic%22%: %22%intrahepatic%22% may refer to BILE DUCTS, INTRAHEPATIC %26% its dis, not LIVER%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply: consider also TIBIAL ARTERIES; /inj: consider also TIBIAL FRACTURES; avoid TIBIA /metab, TIBIA /chem, etc. when BONE AND BONES /metab, etc. is meant; tibia vara: index under TIBIA %28%IM%29% + BONE DISEASES, DEVELOPMENTAL %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood supply: gastric varix or varices = ESOPHAGEAL AND GASTRIC VARICES %26% see note there; perforation = STOMACH /inj, not STOMACH RUPTURE; gastric secretion = GASTRIC JUICE /secret or GASTRIC MUCOSA /secret, not STOMACH /secret; stomach secretes GASTRIN; HYDROCHLORIC ACID, GASTRIC %28%see GASTRIC ACID%29%; INTRINSIC FACTOR %26% PEPSINOGENS; /surg: consider also GASTRECTOMY; GASTROENTEROSTOMY %26% GASTROSTOMY; inflammation = GASTRITIS; Heidenhain pouch: index STOMACH /physiol; gastric hyperacidity: index under GASTRIC ACID /secret; mucosal prolapse = GASTRIC MUCOSA %28%IM%29% + STOMACH DISEASES %28%NIM%29% + PROLAPSE; many parts of STOMACH are available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood was BLOOD ACID PHOSPHATASE 1963-67 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood was BLOOD ALKALINE PHOSPHATASE 1963-67 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood was BLOOD CHOLESTEROL 1963-67 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood was BLOOD LIPIDS 1963-67; /metabolism was LIPID METABOLISM 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood was BLOOD PHOSPHATES 1963-67; PHOSPHATES, INORGANIC was see under PHOSPHATES 1974-76%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood: consider also GALACTOSEMIAS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood: consider also HYPERPROLACTINEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood: consider also HYPERTHYROXINEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood: consider also HYPERTRIGLYCERIDEMIA %26% the hypertriglyceridemias in HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE IV %26% HYPERLIPOPROTEINEMIA TYPE V%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/blood: consider also TYROSINEMIAS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind permitted but do not confuse with ABORTION, INDUCED; check the tags HUMANS %26% FEMALE %26% PREGNANCY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind permitted but not for testing of contraceptives%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind permitted: coord IM with drug /adv eff-pois-tox %28%IM%29%; coord IM with other cause %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind: EMETICS is also available; /drug ther: ANTIEMETICS is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind: consider also EMETICS; /drug ther: consider also ANTIEMETICS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind: consider also HALLUCINOGENS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem ind: coord with DRUG HYPERSENSITIVITY or specifics ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem syn permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem syn permitted: do not convert to PROSTAGLANDINS A, SYNTHETIC; DF: PGA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/chem syn permitted: do not convert to PROSTAGLANDINS, SYNTHETIC; DF: PGX%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/congen permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/congen permitted: do not coord with TOXOPLASMOSIS, CONGENITAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytol = BONE MARROW CELLS; /transpl = BONE MARROW TRANSPLANTATION: do not coord with TRANSPLANTATION, HOMOLOGOUS; inflammation = OSTEOMYELITIS; fibrosis = MYELOFIBROSIS; do not confuse words containing %22%myel-%22% for spinal cord with %22%myel-%22% for bone marrow%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytol: consider also LUTEAL CELLS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytol: consider also OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; /embryol: consider also OSTEOGENESIS; /surg: consider also OSTEOTOMY or ARTHRODESIS or FRACTURE FIXATION %26% its specifics; osteosynthesis not one of the preceding terms goes under BONE AND BONES /surg; differentiate from SKELETON which is almost never used: restrict SKELETON to bone arrangement as a whole %26% not for %22%skeletal%22% which usually means %22%bone%22% %28% = BONE AND BONES%29%; %22%disappearing bone%22% = OSTEOLYSIS, ESSENTIAL; inflammation = OSTEITIS; necrosis = OSTEONECROSIS; %22%bone minerals%22% = BONE AND BONES %28%IM%29% + MINERALS %28%IM%29% or specific mineral %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytol: consider also THECA CELLS; GRANULOSA CELLS; for follicular development use /physiol, not /growth%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytol: consider also specific CHROMAFFIN SYSTEM cell indentions%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytol: consider also specific cell types available in MeSH; for X ref INTESTINAL EPITHELIUM, do not routinely coordinate with EPITHELIUM unless it is specifically discussed%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/cytology was LIVER CYTOLOGY 1964-65; /enzymology was LIVER ENZYMOLOGY 1964-65; /physiology was LIVER FUNCTION 1964-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic /physiol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = AGAMMAGLOBULINEMIA or DYSGAMMAGLOBULINEMIA; index under IMMUNIZATION, PASSIVE for therapy with gamma-globulins in general or unspecified; anti-gamma globulin antibodies = ANTI-ANTIBODIES %28%IM%29% + GAMMA-GLOBULINS %28%IM%29%; gammopathies: coordinate GAMMA-GLOBULINS %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA, follow text%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = ASCORBIC ACID DEFICIENCY or SCURVY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = CHRISTMAS DISEASE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = FACTOR X DEFICIENCY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = FACTOR XI DEFICIENCY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = FACTOR XII DEFICIENCY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = IMMUNOGLOBULIN D / defic + DYSGAMMAGLOBULINEMIA %28%IM%29%; gammopathy: coordinate IMMUNOGLOBULIN D %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = IMMUNOGLOBULIN E / defic + DYSGAMMAGLOBULINEMIA %28%IM%29%; gammopathy: coordinate IMMUNOGLOBULIN E %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = IMMUNOGLOBULIN M / defic + DYSGAMMAGLOBULINEMIA %28%IM%29%; gammopathy: coordinate IMMUNOGLOBULIN M %28%IM%29% with PARAPROTEINEMIAS %28%IM%29% but consider also HYPERGAMMAGLOBULINEMIA %28%IM%29%, follow text;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic = VITAMIN D DEFICIENCY or RICKETS; /ther use: coordinate disease with /drug ther, not /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic permitted but consider also PORPHYRIA CUTANEA TARDA and HEPATOERYTHROPOIETIC PORPHYRIA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic permitted: TN 222; prostate-specific acid phosphatase %28%PROSTATE + ACID PHOSPHATASE%29%: do not confuse with PROSTATE-SPECIFIC ANTIGEN, a serine proteinase%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider CARBAMOYL-PHOSPHATE SYNTHETASE I DEFICIENCY DISEASE; DF: AMMONIA CP SYNTHASE or CP SYNTHASE I%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider GALACTOSEMIAS; DF: note short X ref ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; DF: RECEPT LEUKOCYTE ADHESION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also ALBINISM ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also ARGININOSUCCINIC ACID /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also BETA-MANNOSIDOSIS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also CITRULLINEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also CRIGLER-NAJJAR SYNDROME %26% coord with BILIRUBIN /metab %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also CYSTATHIONINE /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also FRUCTOSE INTOLERANCE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also FUCOSIDOSIS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also GALACTOSEMIAS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also GAUCHER DISEASE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also GLYCOGEN STORAGE DISEASE TYPE II; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also GLYCOGEN STORAGE DISEASE TYPE III ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HISTIDINEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HOMOCYSTINURIA or HYPERHOMOCYSTEINEMIA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HOMOCYSTINURIA; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPERARGININEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPERLYSINEMIAS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPOBETALIPOPROTEINEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPOGONADISM %26% other gonadal disord in Cat C19%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPOGONADISM %26% other gonadal disorders in Cat C19; for antagonists consider ANTIESTROGENS or ESTROGEN ANTAGONISTS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPOPARATHYROIDISM; see SCR for organism-specific terms%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also HYPOPHOSPHATASIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also LACTOSE INTOLERANCE and GANGLIOSIDOSIS GM1%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also LESCH-NYHAN SYNDROME or GOUT; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also LEUKODYSTROPHY, GLOBOID CELL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also LEUKODYSTROPHY, METACHROMATIC ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also LIPID METABOLISM, INBORN ERRORS %26% CHOLESTEROL ESTER STORAGE DISEASE %26% WOLMAN DISEASE; LIPOPROTEIN LIPASE is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also LIPOPROTEIN LIPASE DEFICIENCY, FAMILIAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also METHEMOGLOBINEMIA ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also METHYLMALONIC ACID /urine %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also MONOIODOTYROSINE /metab %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29% + CONGENITAL HYPOTHYROIDISM%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also MUCOPOLYSACCHARIDOSIS I ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also NIEMANN-PICK DISEASE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also OROTIC ACID /urine %28%IM%29% + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also OROTIC ACID /urine %28%IM%29% + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS %28%IM%29%; DF: OMP DECARBOXYLASE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also PELLAGRA; /ther use: coordinate disease with /drug ther, not /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also SEVERE COMBINED IMMUNODEFICIENCY or SCID%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also SUCROSE /metab %28%IM%29% + CARBOHYDRATE METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also TYROSINE /blood %28%IM%29% + AMINO ACID METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also TYROSINEMIAS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/defic: consider also XANTHINES /urine %28%IM%29% + PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/diag use = probably TUBERCULIN TEST ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/diag: consider also SYPHILIS SERODIAGNOSIS; note terms for specific types of syphilis%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /biosyn /physiol /ultrastruct permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; coord disease with /diag, not /radiogr since this is not a radiogr technique; DF: FLUORESCEIN ANGIOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; /instrum: STETHOSCOPES is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: BALLISTOCARDIOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CEREBRAL VENTRICULOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CINEANGIOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: CORONARY ANGIOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: DS ANGIOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER COLOR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOCARDIOGR DOPPLER PULSED%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ECHOENCEPHALOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: HEART CATH%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: PNEUMOENCEPHALOGR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER COLOR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER DUPLEX%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER PULSED%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: ULTRASONOGR DOPPLER TRANSCRANIAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: VECTORCARDIOGR or VECTOR ECG%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad eff permitted; do not use /util except by MeSH definition; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /rad effects permitted; do not use /util except by MeSH definition; DF: ECG AMBULATORY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function with the virus; IM; coord with specific protein %28%IM%29% + specific virus %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function within the archaeon; coord IM with specific protein %28%IM%29% + specific archaeon %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function within the bacterium; coord IM with specific protein %28%IM%29% + specific bacterium %28%IM%29%; BACTERIAL OUTER MEMBRANE PROTEINS is also available; DF: BACT PROTEINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function within the fungus; coord IM with specific protein %28%IM%29% + specific fungus %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function within the helminth; coord IM with specific protein %28%IM%29% + specific helminth %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function within the insect; coord IM with specific protein %28%IM%29% + specific insect %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; /physiol permitted for function within the protozoon; coord IM with specific protein %28%IM%29% + specific protozoon %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: ABPP ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: HPV PROBES ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: STAPH PROTEIN A ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: TRYPSIN INHIB BOWMAN%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: TRYPSIN INHIB KAZAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: TRYPSIN INHIB KUNITZ%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: VSG TRYPAN ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; DF: note short X refs ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; HLA-A, -B, -C, -D, -DR, %26% -Dw probes go here; DF: HLA PROBES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; in titles %26% translations use SP1 %28%the figure one%29%, not SPl %28%the letter l%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff /ultrastruct permitted; not for c-fos 39 %28% = C-FOS-ASSOCIATED PROTEIN P39 see PROTO-ONCOGENE PROTEINS C-JUN%29%; DF: note short X refs%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff permitted; DF: GCSF ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff permitted; DF: GMCSF ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff permitted; DF: HCGF ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff permitted; DF: note short X ref ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff permitted; coord IM with colonized cell %28%IM or NIM%29% if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also APPETITE DEPRESSANTS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also BRONCHOCONSTRICTOR AGENTS or BRONCHODILATOR AGENTS; inflammation = BRONCHITIS but note BRONCHIOLITIS is also available; dilatation = BRONCHIECTASIS; bronchial tuberc or tuberc bronchitis: index under TUBERCULOSIS, PULMONARY %26% not also under BRONCHI or BRONCHITIS unless particularly discussed%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also DIURETICS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also NEUROMUSCULAR BLOCKING AGENTS or NEUROMUSCULAR DEPOLARIZING AGENTS; neuromusc transm = NEUROMUSCULAR JUNCTION /physiol + NEURAL TRANSMISSION; dis = NEUROMUSCULAR JUNCTION DISEASES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also PARASYMPATHOMIMETICS %26% PARASYMPATHOLYTICS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also SYMPATHOLYTICS %26% SYMPATHOMIMETICS; /surg: probably SYMPATHECTOMY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug eff: consider also VASOCONSTRICTOR AGENTS %26% VASODILATOR AGENTS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug ther: consider FILARICIDES ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug ther: consider also ANTIFOAMING AGENTS; see note on %22%intestinal gases%22% under GASES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug ther: consider also ANTIPRURITICS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug ther: consider also ANTITUSSIVE AGENTS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug ther: consider also CARIOSTATIC AGENTS; /etiol: consider also CARIOGENIC AGENTS %26% DIET, CARIOGENIC; /epidemiol: consider also DMF INDEX; DF: DENT CARIES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/drug ther: consider also COCCIDIOSTATS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/econ /legis permitted; coord IM with specific drug or chemical %28%IM%29%; CRACK COCAINE is available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/econ /physiol /psychol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/econ permitted but consider many specific economics terms available; do not confuse with PHYSICIAN%27%S PRACTICE PATTERNS: see note there%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, DENTAL or its specifics; DF: STUDENTS DENT%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, DENTAL or specific ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, DENTAL or specific; Manual 34.11.3 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, MEDICAL or its specifics; DF: STUDENTS MED%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, MEDICAL or its specifics; Manual 34.1l.2%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, MEDICAL or its specifics; Manual 35.2.3; in biographies: Manual 32.16.7; when not to use: Manual 34.11.1; %22%role of physician in ...%22% = PHYSICIAN%27%S ROLE: see note there%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, NURSING or its specifics; DF: STUDENTS NURS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, PHARMACY or its specifics; DF: STUDENTS PHARM%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = EDUCATION, PREMEDICAL; DF: STUDENTS PREMED ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ = HEALTH OCCUPATIONS /educ; DF: STUDENTS HEALTH OCCUP%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ permitted: coord with specific type of educ ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ: coord IM %28%no qualif with ANESTHESIOLOGY /educ %28%NIM%29%%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/educ: coord IM %28%no qualif%29% with ANESTHESIOLOGY /educ %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/education %28% = PATIENT EDUCATION as of 1980%29% was used for indexing 1966-79; OUTPATIENTS was see AMBULATORY CARE 1978-79%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/education was used for indexing 1966-79; was in Cat G %26% M 1963-67%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/embryol: consider also AMELOGENESIS; DF: DENT ENAMEL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/embryol: consider also DENTINOGENESIS; reparative dentin = DENTIN, SECONDARY; dentin bridge = DENTIN, SECONDARY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/embryol: consider also ODONTOGENESIS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/embryol: consider also TOOTH GERM %26% ODONTOGENESIS; /ph permitted but consider DENTAL PHYSIOLOGY for function of dentition as a whole; tooth size %26% dimension = TOOTH /anat %28%IM%29% + ODONTOMETRY %28%NIM%29%; permanent tooth = TOOTH, deciduous tooth = TOOTH, DECIDUOUS; tooth pain = TOOTHACHE; tooth avulsion or luxation = TOOTH AVULSION; tooth socket: index under ALVEOLAR PROCESS; tooth sensitivity = DENTIN SENSITIVITY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/enzymol: consider also PANCREATIN for %22%pancreatic enzymes%22% particularly in ther; /surg: consider also PANCREATECTOMY; note that ISLETS OF LANGERHANS TRANSPLANTATION is also available; inflammation = PANCREATITIS; pancreatic A, B, C cells: index under ISLETS OF LANGERHANS; D cells = SOMATOSTATIN-SECRETING CELLS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/enzymology was BRAIN ENZYMOLOGY 1964-65; /physiology was BRAIN PHYSIOLOGY 1965; BRAIN ELECTROPHYSIOLOGY was heading 1964-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ethnol /psychol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ethnol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/genet permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/genet permitted but do not confuse with OPTIC ATROPHIES, HEREDITARY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/genet:consider also CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/growth: consider also MAXILLOFACIAL DEVELOPMENT; /innerv: consider also MANDIBULAR NERVE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/immunol: consider also IMMUNE RNA MANIPULATION see IMMUNOTHERAPY, ACTIVE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj is probably HIP DISLOCATION or HIP FRACTURES, otherwise coord IM with HIP INJURIES %28%IM%29%; differentiate from HIP%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj permitted: do not convert to KNEE INJURIES ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj permitted: do not coord with THORACIC INJURIES but note RIB FRACTURES is available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: consider also SPLENIC RUPTURE but traumatic spleen perforation is indexed under SPLEEN /inj; accessory spleen: index under SPLEEN /abnorm%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; DF: TRACK%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15+; includes body building if restricted to weight lifting, otherwise index under EXERCISE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15+; note X ref RUGBY; does not include non-North American %22%football%22% %28% = SOCCER%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.15.1; includes non-North American %22%football%22%; does not include rugby %28%RUGBY see FOOTBALL%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; Manual 30.31+; dancing as therapy = DANCE THERAPY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; a systematic set of exercises; differentiate from PHYSICAL EDUCATION AND TRAINING: instruction in hygiene as well as systematic exerc usually in formal setting; %22%corrective gymnastics%22% is probably EXERCISE THERAPY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; /physiol permitted; does not include water-skiing %28%index under SPORTS%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific inj %28%IM%29%; Manual 30.15.1 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord IM with specific injury %28%IM%29%; Manual 30.15.1; do not confuse X ref SQUASH %28%SPORT%29% with SQUASH PLANT see CUCURBITA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: coord with specific injury %28%IM%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/inj: pressure-induced injuries = EAR, INNER / inj %28%IM%29% + BAROTRAUMA %28%IM%29%, noise-induced injuries = HEARING LOSS, NOISE-INDUCED; inflammation = LABYRINTHITIS; neoplasms = LABYRINTH DISEASES %28%IM%29% + EAR NEOPLASMS %28%IM%29% + histological type of neoplasm %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/injuries: TN 115; upper jaw = MAXILLA; lower jaw = MANDIBLE; French %22%maxillaires%22% usually means jaws not necessarily maxilla%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/innerv = probably OCULOMOTOR NERVE but consider also ABDUCENS NERVE %26% TROCHLEAR NERVE; paralysis = OCULOMOTOR PARALYSIS see OPHTHALMOPLEGIA; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum is probably DUODENOSCOPES ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum permitted but consider also KIDNEY, ARTIFICIAL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum permitted if not KIDNEY, ARTIFICIAL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum: STETHOSCOPES is also available ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum: consider also DEFIBRILLATORS or DEFIBRILLATORS, IMPLANTABLE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum: consider also SURGICAL STAPLERS; coord IM with staple material %28%IM or NIM%29% if pertinent; do not use /util except by MeSH definition; DF: SURG STAPLING%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/instrum: consider also VENTILATORS, MECHANICAL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/legis = LEGISLATION, HOSPITAL or HOSPITALS %28%IM%29% + JURISPRUDENCE %28%IM%29%; note specific hosp depts %26% specific types of hosp available; hosp admission, discharge %26% readmiss are available as PATIENT ADMISSION; PATIENT DISCHARGE %26% PATIENT READMISSION %28%see notes under each%29%; specify geog: Manual 36.19%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/legis: consider also FAMILY PLANNING POLICY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metab consider also GLYCOGENOLYSIS or GLYCOGEN STORAGE DISEASE and specifics%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metab is probably TRICARBOXYLIC ACID CYCLE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metab: consider also CITRIC ACID CYCLE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metab: consider also PENTOSE PHOSPHATE PATHWAY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was AMINO ACID METABOLISM 1965; /metabolism was AMINO ACID METABOLISM see under PROTEIN METABOLISM 1963-64%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was CALCIUM METABOLISM 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was CARBOHYDRATE METABOLISM 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was FAT METABOLISM see under LIPID METABOLISM 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was FATTY ACID METABOLISM 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was FATTY ACID METABOLISM 1965; SODIUM MORRHUATE was see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was GLUCOSE METABOLISM 1965; GLUCOSE INJECTION was heading 1963-66%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was IRON METABOLISM 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was MINERAL METABOLISM 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was PHOSPHOLIPID METABOLISM 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was PHOSPHORUS METABOLISM 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/metabolism was PROTEIN METABOLISM 1963-65; PROTEIN METABOLISM DISORDERS was heading 1963-64%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/methods: consider also RESEARCH or its specifics/methods or METHODS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; DF: HELIX ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; NIM when merely research organism in genetic studies; DF: D MELANOGASTER%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; bite: coord IM with ARACHNIDISM %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; do not use /drug eff for insecticides: TN 111; note X ref MUSCA DOMESTICA but other Musca species %26% genera of family Muscidae go under MUSCIDAE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; infection = MITE INFESTATIONS; for miticides %28%chemicals killing or controlling mites%29% index under INSECTICIDES even though mites are not insects; mite vectors = ARACHNID VECTORS %28%IM%29% + MITES %28%IM%29%; mite control: coord IM with TICK CONTROL %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; scorpion sting: coord NIM with ARACHNIDISM %28%IM%29%; several genera: Androctonus, Buthus, Centruoides, Leiurus, Nebo, Tityus%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; spider bites = ARACHNIDISM; several venomous genera: Latrodectus %28%BLACK WIDOW SPIDER%29%, Loxosceles %28%brown recluse%29%, Tarantula%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiol /parasitol /virol permitted; wasp stings: coord IM with INSECT BITES AND STINGS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiology was INTESTINAL MICROORGANISMS 1963-67 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/microbiology was MOUTH MICROORGANISMS 1965-67 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/organ = PERSONNEL ADMINISTRATION, HOSPITAL but consider also other terms under ADMINISTRATIVE PERSONNEL %26% ALLIED HEALTH PERSONNEL, etc.; %22%orderlies%22% %26% %22%ward attendants%22% unspecified go here except for PSYCHIATRIC AIDES %28%see note there%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/parasitol: often coord with PARASITE EGG COUNT; consider also DEFECATION; CONSTIPATION; DIARRHEA; FECAL IMPACTION %26% FECAL INCONTINENCE; fecalith: index FECAL IMPACTION; fecal blood: index under OCCULT BLOOD %26% not also here%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/pathogen permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/pathol is more likely than %22%diseases of the tunica intima%22%; coord IM with specific blood vessel %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/pathol is more likely than %22%diseases of the tunica media%22%; coord IM with specific blood vessel %28%IM%29%; /growth: coord with MUSCLE DEVELOPMENT; /embryol: coord with MUSCLE DEVELOPMENT if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/physiol /psychol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/physiol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/physiol permitted for micro-organisms only ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/physiol: consider also HEMATOPOIESIS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/poisoning %28% = CADMIUM POISONING as of 1977%29% was used for indexing 1966-76%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/poisoning was used for indexing 1966-76 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/prev = COMMUNICABLE DISEASE CONTROL for GEN only; do not confuse X ref INFECTIOUS DISEASES with INFECTION: see note there%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/prev: consider also HEMOSTASIS, SURGICAL; for vol of blood lost, coord IM with BLOOD VOLUME %28%NIM%29%; DF: BLOOD LOSS SURG%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/prev: consider also SUNSCREENING AGENTS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/prevention %26% control was INFECTION/prevention %26% control 1966-91%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if catatonic aspect is less relevant %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if hebephrenic aspect is less relevant %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted but consider SCHIZOPHRENIC PSYCHOLOGY %28%IM%29% if paranoid aspect is less relevant %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted but do not confuse with PLAY THERAPY; includes games; DF: PLAY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted; coord IM with drug /admin %28%IM%29%; INFUSION PUMPS, IMPLANTABLE is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol permitted; does not include %22%celibacy%22%: CELIBACY see SEXUAL ABSTINENCE; %22%unwed parent%22% = PARENTS %28%IM%29% + ILLEGITIMACY %28%IM%29%; SINGLE PARENT is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/psychol: consider also PSYCHOLOGY, EDUCATIONAL; as persons: Manual 30.7.3; as children: Manual 34.16; relation to EDUCATION: Manual 34.16; /educ = EDUCATION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiogr permitted but PORTOGRAPHY is more likely ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiogr permitted but consider MYELOGRAPHY; /surg: probably CORDOTOMY; inflammation = MYELITIS; coord IM with specific vertebrae %28%NIM%29% to locate site on spinal cord; do not confuse words containing %22%myel-%22% for spinal cord with %22%myel-%22% for bone marrow%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiogr permitted: not necessarily LYMPHOGRAPHY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiogr permitted: not necessarily LYMPHOGRAPHY; /surg: probably LYMPH NODE EXCISION or specifics; GIANT LYMPH NODE HYPERPLASIA is also available; %22%axillary lymph nodes%22% = LYMPH NODES %28%IM%29% + AXILLA %28%NIM, no qualif%29%; %22%cervical lymph nodes%22% = LYMPH NODES %28%IM%29% + NECK %28%NIM, no qualif%29%; inflammation = LYMPHADENITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiogr: consider also PORTOGRAPHY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiogr: coord with CEREBRAL VENTRICULOGRAPHY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/radiography was CEREBRAL ANGIOGRAPHY 1975-94 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret = probably /physiol or NEUROSECRETION ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret or histamine liberation = HISTAMINE RELEASE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret permitted but consider GASTRIC JUICE /secret if pertinent; mucosal neoplasms: coordinate IM with STOMACH NEOPLASMS %28%IM%29% + histological type of neoplasm %28%IM%29%; mucosal prolapse: = GASTRIC MUCOSA %28%IM%29% + STOMACH DISEASES %28%NIM%29% + PROLAPSE %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret permitted but consider GASTRIC MUCOSA /secret if pertinent, and not STOMACH /secret; GASTRIC ACID is also available; absence of gastric HCl = ACHLORHYDRIA; hyperacidity: index under GASTRIC ACID /secret%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret permitted but consider PANCREAS /secret if pertinent%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret: consider also LACTATION ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret: consider also SWEAT or SWEATING ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret: see also SWEAT or SWEATING: TN 181 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/secret: see also SWEAT or SWEATING; inflammation = HIDRADENITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg = PULPECTOMY or PULPOTOMY; inflammation = PULPITIS; DF: DENT PULP%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg = THORACIC SURGERY, the specialty %28%Cat G2%29% or THORACIC SURGICAL PROCEDURES %28%Cat E4%29%; %22%intrathoracic%22% could be THORAX or HEART or LUNG or RIBS: check text; chest pain = CHEST PAIN%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg = probably ADRENALECTOMY; hypothalamo-pituitary-adrenal axis: coord HYPOTHALAMO-HYPOPHYSEAL SYSTEM + PITUITARY-ADRENAL SYSTEM; hyperplasia = ADRENAL GLANDS /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%; congenital adrenal hyperplasia %28%CAH%29% = ADRENAL HYPERPLASIA, CONGENITAL%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg = probably GANGLIONECTOMY; includes cervical, mesenteric %26% celiac ganglia but SUPERIOR CERVICAL GANGLION is available; STELLATE GANGLION is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: VENTRICULOCISTERNOSTOMY see VENTRICULOSTOMY is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider GLOSSECTOMY; /transpl permitted for tongue grafts as in palate surg; inflammation = GLOSSITIS; tongue thrust: index under TONGUE HABITS; painful or sore tongue = GLOSSALGIA; scrotal tongue = TONGUE, FISSURED%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider TYMPANOPLASTY; inflammation = OTITIS MEDIA; inj caused by pressure = EAR, MIDDLE /inj %28%IM%29% + BAROTRAUMA %28%IM%29%; middle ear effusions = OTITIS MEDIA%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also BARIATRIC SURGERY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also CHOLECYSTECTOMY %26% CHOLECYSTOSTOMY; calculi = GALLSTONES but consider also CHOLECYSTOLITHIASIS; inflammation = CHOLECYSTITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also CORONARY ARTERY BYPASS; inflammation = AORTITIS but note also AORTITIS, SYPHILITIC see SYPHILIS, CARDIOVASCULAR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also ORAL SURGICAL PROCEDURES; inflammation = STOMATITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also PARATHYROIDECTOMY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also PNEUMONOLYSIS; inflammation = PLEURISY; PLEURAL CAVITY is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also RHIZOTOMY; DORSAL ROOT GANGLIA is see GANGLIA, SPINAL; inflammation = RADICULITIS %28%single root%29% or POLYRADICULITIS %28%several roots%29% or POLYRADICULONEURITIS %28%nerve roots %26% peripheral nerves%29%; do not use vertebra headings to locate area of spinal nerves; nerve root compression: coord IM with NERVE COMPRESSION SYNDROMES %28%IM%29%, not SPINAL CORD COMPRESSION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also SCLERAL BUCKLING; X ref RETINAL PIGMENT EPITHELIAL DETACHMENT: do not coord with PIGMENT EPITHELIUM OF EYE unless particularly discussed%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also TRACHEOSTOMY %26% TRACHEOTOMY; inflammation = TRACHEITIS; tracheal cyst = TRACHEAL CYST see MEDIASTINAL CYST%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also VASECTOMY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also VESTIBULOPLASTY; mucositis: coordinate NIM with STOMATITIS %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: consider also VITRECTOMY; VITREOUS DETACHMENT is available; opacities, muscae volitantes %26% other dis are indexed VITREOUS BODY %28%IM%29% and EYE DISEASES %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: do not confuse with the specialty COLORECTAL SURGERY; rectal bleeding: RECTUM %28%NIM%29% + HEMORRHAGE, GASTROINTESTINAL %28%IM%29% for bleeding through the rectum; hemorrhaging rectum is RECTAL DISEASES %28%IM%29% + HEMORRHAGE, GASTROINTESTINAL %28%IM%29%; inflammation = PROCTITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: prefer GINGIVOPLASTY or GINGIVECTOMY; inflammation = GINGIVITIS; peripheral giant cell granuloma = GINGIVAL DISEASES %28%IM%29% + GRANULOMA, GIANT CELL %28%IM%29%, central giant cell granuloma = JAW DISEASES %28%IM%29% + GRANULOMA, GIANT CELL %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: probably APPENDECTOMY; diseases: coord IM with CECAL DISEASES %28%IM%29%; inflammation = APPENDICITIS; %22%ruptured%22% or %22%perforated%22% appendix: see note under APPENDICITIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: probably CEREBRAL DECORTICATION ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: probably THYROIDECTOMY; inflammation = THYROIDITIS; nodule = THYROID NODULE; /abnorm: consider also THYROID DYSGENESIS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surg: probably TONSILLECTOMY; inflammation = TONSILLITIS %28%note -LL-%29%; lingual tonsils = TONSIL %28%IM%29% + TONGUE %28%NIM%29%; pharyngeal tonsil = ADENOIDS; enlarged tonsils = TONSIL /pathol %28%IM%29% + HYPERPLASIA %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surgery %28% = THORACIC SURGERY as of 1980%29% was used for indexing 1966-79%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/surgery was used for indexing 1966-79 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther = treatment of FEVER: differentiate from FEVER THERAPY see HYPERTHERMIA, INDUCED %28% = high body temp induced to treat dis%29%; /chem ind: consider also HYPERTHERMIA, INDUCED or PYROGENS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther use: coordinate disease with /drug ther, not /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther use: coordinate disease with /drug ther, not /diet ther; deficiency: coordinate BIOTIN /defic %28%IM%29% with VITAMIN B DEFICIENCY %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther use: coordinate with disease /drug ther, not /diet ther%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther use; coordinate IM with disease /drug ther %28%IM%29% + specific chemical /ther use %28%IM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther: consider also LANGUAGE THERAPY; do not confuse with SPEECH DISORDERS: read differentiation of LANGUAGE %26% SPEECH under LANGUAGE; do not confuse with LANGUAGE DEVELOPMENT DISORDERS: see note there%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/ther: consider also SPEECH THERAPY; do not confuse with LANGUAGE DISORDERS: read differentiation of SPEECH %26% LANGUAGE under SPEECH%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/therapeutic use was ASCORBIC ACID, THERAPEUTIC 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/therapeutic use was HEPARIN, THERAPEUTIC 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/therapeutic use was PREDNISOLONE, THERAPEUTIC 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/tox permitted but consider also CARBON TETRACHLORIDE POISONING; DF: CCL4%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transpl: consider also CORD BLOOD STEM CELL TRANSPLANTATION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transpl: do not routinely coordinate with ISLETS OF LANGERHANS TRANSPLANTATION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transpl: if from pancreas, coordinate with ISLETS OF LANGERHANS TRANSPLANTATION%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was BLOOD VESSEL TRANSPLANTATION 1963-65%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was BONE TRANSPLANTATION 1963-65; was BONE AND BONES/transplantation 1966-89%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was CORNEAL TRANSPLANTATION 1963-65; was CORNEA/transplantation 1966-89%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was KIDNEY TRANSPLANTATION 1963-65; was KIDNEY/transplantation 1966-89%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was MUSCLE TRANSPLANTATION 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was SKIN TRANSPLANTATION 1963-65; was SKIN/transplantation 1966-89%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/transplantation was TENDON TRANSPLANTATION 1963-65 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine permitted but consider also AMINOACIDURIA, RENAL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: HYPEROXALURIA %26% HYPEROXALURIA, PRIMARY are also available; CALCIUM OXALATE is also available%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: consider also HOMOCYSTINURIA; do not confuse with HOMOCYSTEINE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBC ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: coord IM with HEMOGLOBINURIA %28%IM%29%; DF: HBH ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: coord IM with HEMOGLOBINURIA %28%IM%29%; do not confuse with HEMOGLOBINOPATHIES: use term in the text%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: coord IM with HEMOGLOBINURIA %28%IM%29%; hemoglobin S disease = ANEMIA, SICKLE CELL; DF: HBS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/urine: coord NIM with HEMOGLOBINURIA %28%IM%29%; DF: HBA2 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/vet = TOXOPLASMOSIS, ANIMAL /congen ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/vet permitted only if discussed as %22%septic%22% abortion: do not use automatically for animal abortion in brucellosis, vibriosis, trichomoniasis, etc; check the tags FEMALE %26% PREGNANCY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '/vet: coord with MUSCULAR DYSTROPHY, ANIMAL ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '0 beta Hydroxyethylrutoside' = 0).
% 42.05/41.92 fof(interp, fi_functors, '0 in P0 is the digit, not the letter O; /biosyn /drug eff /physiol /ultrastruct permitted; DF: note short X ref%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '0-beta-Hydroxyethylrutoside' = 0).
% 42.05/41.92 fof(interp, fi_functors, '027, FK' = 0).
% 42.05/41.92 fof(interp, fi_functors, '0791, MK' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 %28%4-Amino-6,7-dimethoxy-2-quinazolinyl%29%-4-%28%%28%2,3-dihydro-1,4-benzodioxin-2-yl%29%carbonyl%29%piperazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 AGP Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Acylglycerol 3 Phosphate O Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Acylglycerol Phosphate Acyltransferase 2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Acylglycerophosphate Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Acylglycerophosphocholine Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Acylglycerophosphocholine O Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Alkyl 2 Acylphosphatidates' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Alkyl 2 acetyl sn glycerophosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Alkyl 2 acetylglycerophosphocholine Esterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Amino 4 guanidinobutane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Aminoadamantane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Aminocyclopentanecarboxylic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Aminonaphthalene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Asparagine 5 valine Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Butanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Butylbiguanide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Carboxyglutamic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Chloro 2,4 Dinitrobenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Chromosome, Ph' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Chromosomes, Ph' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Dehydrotestolactone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Deoxymannojirimycin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Deoxynojirimycin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Deoxynojirimycin Hydrochloride' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Determinant, SSEA' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Dodecanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Fluoro 2,4 dinitrobenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Heptanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Hydroxyethane 1,1 Diphosphonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Hydroxyethylidene 1,1 Bisphosphonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Methyl 2 mercaptoimidazole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Methyl 3 isobutylxanthine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Methyl 4 phenylpyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Methyl 4 phenylpyridinium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Methyl 4 phenylpyridinium Chloride' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Methyl 4 phenylpyridinium Ion' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 N Imino Sugars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Naphthylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Naphthylisothiocyanate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Octanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Oxacephalosporin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Palmitylglycerol 3 Phosphate Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Phosphatidylinositol 3 Kinase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Phosphatidylinositol 4 Kinase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Phosphatidylinositol Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Protein, Fraction' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Pyrroline 5 Carboxylate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Sar 8 Ala Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Sar 8 Ile Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Sarcosine 8 Alanine Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 Sarcosine 8 Isoleucine Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 alpha, 25 dihydroxy 20 epi Vitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 alpha, 25-dihydroxy-20-epi-Vitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 alpha,25 Dihydroxycholecalciferol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 alpha,25 Dihydroxyvitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 alpha,25-Dihydroxycholecalciferol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 alpha,25-Dihydroxyvitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1 beta D Arabinofuranosyl Uracil' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Caspase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, EF' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Gap Phase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Heterovitamin B' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Kallikrein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Schwangerschaftsprotein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Thrombospondin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1, Trypsinogen' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1 Dimethyl 4 phenylpiperazine Iodide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1 hydroxyethylenediphosphonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1%27%-Bis%28%phenylmethyl%29%4,4%27%-bipyridinium dichloride. Oxidation-reduction indicator.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1,1-Trichloropropene-2,3-oxide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1,1-Trifluoro-2-Chloro-2-Bromoethane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1-Dimethyl-4-phenylpiperazine Iodide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,1-hydroxyethylenediphosphonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Benzo Pyrones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Benzopyrones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Cyclic Inositol Phosphate Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Cyclic Inositolphosphate Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Diacylglycerol Kinase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dibromoethane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dihexadecyl sn Glycerophosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dimethyl hydrazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dimethylhydrazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dimyristoyl glycero 3 phosphorylcholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dipalmitoyl Glycerophosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Dipalmitoylphosphatidylcholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Ditetradecanoyl glycero 3 phosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Ditetradecyl glycero 3 phosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Ethanediol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2 Propanediol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2,3,4-Tetrahydro-9-acridinamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2,3,4-Tetrahydroaminoacridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2,3,4-Tetrahydroisoquinolines' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2,3-Trihydroxybenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2,3-Trihydroxypropane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2,5,6-Dianhydrogalactitol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-BENZOPYRONES is available; pyran-2-ones: index PYRONES + LACTONES%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Benzo-Pyrones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Benzopyrones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Cyclic Inositolphosphate Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Cyclic-Inositol-Phosphate Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Diacylglycerol Kinase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dibromoethane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dihexadecyl-sn-Glycerophosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dihydro-3,6-pyridazinedione. A herbicide and plant growth regulator; also used to control suckering of tobacco. Its residue in food and tobacco is highly toxic, causing CNS disturbances and liver damage.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dihydro-6-Ethoxy-2,2,4-Trimethylquinoline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dimethyl-hydrazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dimethylhydrazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dimyristoyl-glycero-3-phosphorylcholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dioxygenase, Catechol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dioxygenase, Homogentisate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dioxygenase, Pyrocatechol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dipalmitoyl-Glycerophosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Dipalmitoylphosphatidylcholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Ditetradecanoyl-glycero-3-phosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Ditetradecyl-glycero-3-phosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Epoxy-3,3,3-Trichloropropane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Ethanediol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Oxygenase, Catechol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,2-Propanediol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxycholecalciferol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxycholecalciferol Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxycholecalciferol Receptors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxyvitamin D 3 Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxyvitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxyvitamin D3 Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 Dihydroxyvitamin D3 Receptors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25 dihydroxy 20 epi Vitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25%28%OH%29%2-20epi-D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxycholecalciferol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxycholecalciferol Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxycholecalciferol Receptors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxyvitamin D 3 Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxyvitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxyvitamin D3 Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-Dihydroxyvitamin D3 Receptors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,25-dihydroxy-20-epi-Vitamin D3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Dihydroxy 2 Propanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Dimethylxanthine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Dioxaindans' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Dioxindans' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Diphenyl 2 Propen 1 One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Diphenyl propanediones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Diphenyl propenones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Diphenylpropanediones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Diphenylpropenones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Oxazolidin 2 one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Oxazolidine 2 one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 Oxazolium 5 Oxides' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3 beta Glucanase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3,5-Benzenetriol. A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3,7-Trimethylxanthine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Bis%28%2-Chloroethyl%29%-1-Nitrosourea' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Dihydro-4-methyl-5-%28%4-%28%methylthio%29%benzoyl%29%-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Dihydroxy-2-Propanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Dimethyl-5-aminoadamantane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Dimethylxanthine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Dioxaindans' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Dioxindans' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Diphenyl-2-Propen-1-One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Diphenyl-propanediones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Diphenyl-propenones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Diphenylpropenones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Oxazolidin-2-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Oxazolidine-2-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-Oxazolium-5-Oxides' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-beta-Glucanase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,3-beta-Glucosidase, Glucan' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 Benzopyrones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 Butanediamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 Butanolide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 Diaminobutane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 Imino Sugars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 alpha Glucan Branching Enzyme' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 beta D Glucan Cellobiohydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 beta D Glucan Glucohydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4 beta D Xylanohydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4,5-IP3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4,5-InsP3' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Benzopyrones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Butanediamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Butanolide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Diaminobutane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Diethylene dioxides. Industrial solvents. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, dioxane itself may %22%reasonably be anticipated to be a carcinogen.%22% %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p354%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylic acid diethyl ester.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-Imino Sugars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-alpha-D-Glucan-1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase/dextrin 6 alpha-D-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase %28%EC 2.4.1.25%29% and amylo-1,6-glucosidase %28%EC 3.2.1.33%29% activities. As a transferase it transfers a segment of a 1,4-alpha-D-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-D-glucan. As a glucosidase it catalyzes the endohydrolysis of 1,6-alpha-D-glucoside linkages at points of branching in chains of 1,4-linked alpha-D-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-alpha-Glucan Branching Enzyme' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-alpha-Glucosidase, Exo' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-alpha-Glucosidase, Glucan' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-beta-Cellobiosidase, Cellulose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-beta-D-Glucan Cellobiohydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-beta-D-Glucan Glucohydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-beta-D-Xylanohydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-beta-Glucosidase, Glucan' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4-dihydro-2,3-dihydroxy-7-nitro-6-quinoxalinecarbonitrile' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,4:3,6-Dianhydro D-glucitol. Chemically inert osmotic diuretic used mainly to treat hydrocephalus; also used in glaucoma.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5 Biphosphate Carboxylase Oxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5 Diphenylcarbazide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5 Imino Sugars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5 Pentanediamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5-Biphosphate Carboxylase-Oxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5-Dimethyl-1,5-Diazaundecamethylene Polymethobromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5-Diphenylcarbazide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5-Imino Sugars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,5-Pentanediamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,6 Diphenylhexatriene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,6-Bisphosphate Aldolase, Fructose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,6-Diphenyl-1,3,5-hexatriene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,6-Diphenylhexatriene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,7-Dihydro-6H-purine-6-thione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,8 Dihydroxy 9 anthrone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,8,9-Anthracenetriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,8-Dihydroxy-9%28%10H%29%-anthracenone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,8-Dihydroxy-9-anthrone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1,N-6-Ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%%28%Methylethyl%29%amino%29%-3-%28%2-propylphenoxy%29%-2-propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%1-Phenylcyclohexyl%29%piperidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%2,5-Dimethoxy-4-Methylphenyl%29%-2-Aminopropane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%2-Tetrahydrofuryl%29%-5-fluorouracil' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%4-Acetoxy-2,3,5-Trimethylphenoxy%29%-3-Isopropylamino-2-Propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%5-Isoquinolinesulfonyl%29%-2-Methylpiperazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%5-Isoquinolinylsulfonyl%29%-2-Methylpiperazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%Diphenylmethyl%29%-4-%28%3-phenyl-2-propenyl%29%piperazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%N-Methylglycine%29%-8-L-Isoleucine-Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%Tetrahydro-2-furanyl%29%-5-fluorouracil' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-%28%o-Allylphenoxy%29%-3-%28%isopropylamino%29%-2-propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-24-ACTH' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-24-Corticotropin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-39 ACTH' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-AGP-Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Acylglycerol-3-Phosphate O-Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Acylglycerophosphate Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Acylglycerophosphocholine Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Acylglycerophosphocholine O-Acyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Acylhydrolase, Phosphatidate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Alkyl-2-acetyl-sn-glycerophosphocholine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Alkyl-2-acetylglycerophosphocholine Esterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Amino-3,5-dimethyladamantane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Amino-4-guanidinobutane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Aminoadamantane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Aminocyclopentanecarboxylic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Aminonaphthalene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Antichymotrypsin, alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Antiproteinase, alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Asparagine-5-valine Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-BUTANOL and TERT-BUTYL ALCOHOL also available ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Butanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Butyl-N-%28%2,6-dimethylphenyl%29%-2-piperidinecarboxamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Butylbiguanide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Carboxyglutamic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Carboxyglutamic Acid %28%1978-1981%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Carboxyvinyltransferase, 3-Phosphoshikimate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Carboxyvinyltransferase, aroA 3-Phosphoshikimate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Chloro-2,4,6-trinitrobenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Chloro-2,4-Dinitrobenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Deamino-8-D-arginine Vasopressin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Dehydrotestolactone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Deoxy-1-%28%methylamino%29%-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Deoxynojirimycin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Desamino-8-arginine Vasopressin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Diphosphate Synthetase, 5-Phospho-alpha-D-Ribose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Dodecanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Ethyl-3-%28%3-Dimethylaminopropyl%29%Carbodiimide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Fluoro-2,4-dinitrobenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Glycoproteins, Pregnancy-Specific beta' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Heptanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Hydroxyethane-1,1-Diphosphonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Hydroxyethylene Diphosphonate, Disodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Hydroxyethylidene-1,1-Bisphosphonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Isochromen-1-ones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-2-mercaptoimidazole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-3-isobutylxanthine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/poisoning %28%1990-1999%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-4-phenylpyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-4-phenylpyridinium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-4-phenylpyridinium Ion' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Methyl-N-%28%endo-9-Methyl-9-Azabicyclo%28%3.3.1%29%non-3-yl%29%-1H-Indazole-3-Carboxamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-N-Imino Sugars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Naphthyl-N-methylcarbamate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Naphthylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Naphthylamine/analogs %26% derivatives %28%1983-1998%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Naphthylisothiocyanate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-OCTANOL is also available ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Octanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Phosphate Receptor, Sphingosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Phosphatidylinositol 3-Kinase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Phosphatidylinositol 4-Kinase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Phosphatidylinositol Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Phosphohydrolase, D-Fructose-1,6-Bisphosphate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Plasminogen, Glutamic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Propanol %28%1975-1997%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Pyrroline-5-Carboxylate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Ring Heterocyclic Compounds' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Ring Heterocyclic Cpds' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Sar-8-Ala Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Sar-8-Ala-angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Sar-8-Ile Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Sarcosine-8-Alanine Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Sarcosine-8-Isoleucine Angiotensin II' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Sodium Sulfonate, 2,3-Dimercaptopropane' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-Thio-beta-D-galactopyranoside, Isopropyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-alkyl-2-Acetylglycerol Cholinephosphotransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-alpha-Hydroxylase, 25-Hydroxyergocalciferol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-alpha-Hydroxylase, 25-Hydroxyvitamin D' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-beta-D-Arabinofuranosyl Uracil' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1-hydroxylase, 25-Hydroxyvitamin D2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz%28%b,f%29%azepine-5-propanamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '10-carbon saturated monocarboxylic acids. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '100, NSP' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1000, PEG' = 0).
% 42.05/41.92 fof(interp, fi_functors, '101-508, Public Law' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1021, S' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1026, NSC' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1050, Agria' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Decorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Dehydroprostaglandin F2 alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Dehydroprostaglandin F2alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Deoxycortisol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Desoxycortisol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Desoxycortisone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Epicortisol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Hydroxycorticosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 Protein, Syntaxin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 alpha,9 alpha Epoxymethano PGH2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 alpha,9 alpha-Epoxymethano PGH2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta Hydroxysteroid Dehydrogenase Type 2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta-HSD2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta-Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta-Hydroxysteroid Dehydrogenase Type 1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 beta-Hydroxysteroid Dehydrogenase Type 2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11 cis Retinal' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11- to 14-membered macrocyclic lactones with a fused isoindolone. Members with INDOLES attached at the C10 position are called chaetoglobosins. They are produced by various fungi. Some members interact with ACTIN and inhibit CYTOKINESIS.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Decorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Dehydroprostaglandin F2 alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Dehydroprostaglandin F2alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Deoxycortisol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Desoxycortisol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Desoxycortisone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Epicortisol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Hydroxycorticosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Oxidoreductase, Corticosteroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Oxoreductase, Cortisone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-Reductase, Corticosteroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-beta-Hydroxysteroid Dehydrogenase Type 1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-beta-Hydroxysteroid Dehydrogenase Type 2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11-beta-Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '110-kDa Heat Shock Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11B Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11B-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta HSD1 Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta Hydroxysteroid Dehydrogenase Type 1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta Hydroxysteroid Dehydrogenase Type 2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-HSD1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-HSD1 Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-HSD2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-HSD2 Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-Hydroxysteroid Dehydrogenase Type 1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '11beta-Hydroxysteroid Dehydrogenase Type 2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 Lipoxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 Methoxyibogamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 Myristoyl 13 acetylphorbol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 O Tetradecanoyl Phorbol 13 Acetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 S Hydroxyeicosatetraenoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 alpha Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12 alpha-Hydroxylase, Sterol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12,13-Dibutyrate, Phorbol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Carbon saturated monocarboxylic acids. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-HETE' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Hydroxy-5,8,10,14-eicosatetraenoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Lipoxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Lipoxygenase, Arachidonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Lipoxygenase, Arachidonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Methoxyibogamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-Myristoyl-13-acetylphorbol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-O-Tetradecanoyl Phorbol 13-Acetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-S-Hydroxyeicosatetraenoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12-alpha-Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '120a Antigen, CD' = 0).
% 42.05/41.92 fof(interp, fi_functors, '120b Antigen, CD' = 0).
% 42.05/41.92 fof(interp, fi_functors, '123, Rhodamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '123I Labeled 3-Iodobenzylguanidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '123I-Labeled Idoxuridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1254, Aroclor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '125I Labeled 3-Iodobenzylguanidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '125I-Labeled Idoxuridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12937, SC' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12alpha Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12alpha-Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '12beta-Isomer Deoxycholic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13 cis Retinoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13 or more nucleotides ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13 or more units; GEN; prefer specifics ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-15-Ketoprostaglandin Reductase, delta' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-Acetate, 12-O-Tetradecanoyl Phorbol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-Reductase, 15-Ketoprostaglandin delta' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-Reductase, 15-Oxoprostaglandin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-cis-Isomer Fenretinide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '13-cis-Retinoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '131I-Labeled Idoxuridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '139481, LY' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein, beta Isoform' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein, epsilon Isoform' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein, eta Isoform' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein, gamma Isoform' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein, tau Isoform' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Protein, zeta Isoform' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 Proteins' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 beta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 epsilon Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 eta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 gamma Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 tau Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3 zeta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3beta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3epsilon Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3eta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3gamma Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3tau Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14 3 3zeta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 Protein, Brain' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 Proteins' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 beta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 epsilon Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 eta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 gamma Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 tau Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3 zeta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3beta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3epsilon Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3eta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3gamma Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3tau Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-3-3zeta Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14-carbon saturated monocarboxylic acids. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '14C-Labeled Mupirocin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 Ketoprostaglandin delta 13 Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 Ketosteryl Oleate Hydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 Lipoxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 Methylprostaglandin E2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 Methylprostaglandin F2alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 Oxoprostaglandin 13 Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 alpha Hydroxy Estriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 alpha Hydroxyestriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15 alpha-Hydroxyestriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15%28%S%29%-15-Methyl PGF2alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15,15%27%-Dioxygenase, beta-Carotene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15,15%27%-Monooxygenase, beta-Carotene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Hydroxy-11 alpha,9 alpha-%28%epoxymethano%29%prosta-5,13-dienoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Ketoprostaglandin delta 13-Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Lipoxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Lipoxygenase, Arachidonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Lipoxygenase, Arachidonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Methylprostaglandin E2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Methylprostaglandin F2alpha' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-Oxoprostaglandin 13-Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15-alpha-Hydroxy-Estriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '156758, LY' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15th Cent. Histories %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15th Cent. History %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15th Cent. History of Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15th Cent. Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15th Century Histories' = 0).
% 42.05/41.92 fof(interp, fi_functors, '15th Century History' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16 Epiestriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16 Hydroxyestradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16 alpha Hydroxy Estradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16 alpha Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16 alpha,17-Dihydroxypregn-4-ene-3,20-dione. Progestational dihydroxy derivative of PROGESTERONE. Its acetonide possesses anti-inflammatory properties.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16 alpha-Carbonitrile, Pregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16,16 Dimethyl PGE2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16,16 Dimethylprostaglandin E2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16,16-Dimethyl-PGE2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16,16-Dimethylprostaglandin E2' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16,17 Epiestriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16-Hydroxyestradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16-alpha Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16-alpha-Hydroxy-Estradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16-alpha-Hydroxylase, Steroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1601- History, Modern' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16S Ribosomal RNA' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16alpha-Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16th Cent. Histories %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16th Cent. History %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16th Cent. History of Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16th Cent. Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16th Century Histories' = 0).
% 42.05/41.92 fof(interp, fi_functors, '16th Century History' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Desoxymethasone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Epiestriol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Epimethyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Hydroxycorticosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Ketosteroid Reductases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Ketosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 Oxosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Ethynyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Hydroxy 6 alpha Methylprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Hydroxylase Cytochrome P 450' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Hydroxyprogesterone Aldolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha Testosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Dehydrogenase, Estradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Ethynyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxy-6 alpha-Methylprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxylase Cytochrome P-450' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxylase, Steroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxypregn-4-en-20-yn-3-one. A synthetic steroid hormone with progestational effects.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 alpha-Monooxygenase, Steroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Acetoxy 9 fluoro 11 beta hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Estradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Estradiol Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Hydroxy 17 methyl 4 androsten 3 one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Hydroxy 4 Androsten 3 one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Hydroxy 5 beta Androstan 3 One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Hydroxy 8 alpha 4 Androsten 3 one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Hydroxysteroid UDP Glucuronosyltransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta Oestradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta, 20 alpha Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Dehydrogenase, Estradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Estradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Estradiol Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. A synthetic steroid with anabolic and androgenic activities.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Hydroxy-17 alpha-methylestra-4,9,11-trien-3-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Hydroxy-17-methyl-4-androsten-3-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Hydroxy-4-androsten-3-ones. Testosterone derivatives formed by the substitution of one or more hydroxyl groups in any position.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17 beta-Oestradiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17, Interleukin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17,20 Desmolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17,20 Lyase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17,20-Desmolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17,20-Lyase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17,21-Dimethyl-19-nor-4,9-pregnadiene-3,20-dione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-%28%Cyclobutylmethyl%29%morphinan-3,14-diol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Acetate, Medroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Desoxymethasone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Epimethyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxy-Estr-4-Ene-3-One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxycorticosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxycorticosteroids %28%1974%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxylase, Steroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxypregnenolone, %28%3beta,13alpha%29%-Isomer' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxypregnenolone, %28%3beta,17alpha%29%-Isomer' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxyprogesterone, %28%17 alpha%29%-Isomer' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Ketosteroid Reductases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Ketosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Ketosteroids %28%1969-1974%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Monooxygenase, Steroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Oxosteroids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-Valerate, Betamethasone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-alpha-Hydroxylase, Steroid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-alpha-Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-alpha-Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-alpha-Testosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-beta-Hydroxy-4-Androsten-3-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-beta-Hydroxy-8 alpha-4-Androsten-3-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17-beta-Hydroxyestra-4,9,11-trien-3-one. An anabolic steroid used mainly as a growth substance in animals.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17alpha Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17alpha Methyl Testosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17alpha Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17alpha-Hydroxypregnenolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17alpha-Methyl-Testosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17alpha-Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta Hydroxy 17 methyl 4 androsten 3 one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta Hydroxy 19 Nor 4 Androsten 3 One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta Hydroxy 5alpha Androstan 3 One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta-Hydroxy-17-methyl-4-androsten-3-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta-Hydroxy-19-Nor-4-Androsten-3-One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta-Hydroxy-5alpha-Androstan-3-One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17beta-Methyltestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17th Cent. Histories %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17th Cent. History %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17th Cent. History of Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17th Cent. Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17th Century Histories' = 0).
% 42.05/41.92 fof(interp, fi_functors, '17th Century History' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18 Hydrocorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18 Hydroxy 11 Deoxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18 Hydroxy 11 Desoxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18 Hydroxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18 Hydroxydesoxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18, Concentrat VO' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18-Hydrocorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18-Hydroxy-11-Deoxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18-Hydroxy-11-Desoxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18-Hydroxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18-Hydroxydesoxycorticosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1861-1865 conflict between the Union %28%Northern states%29% and the 11 Southern states that seceded and were organized as the Confederate States of America.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18F Fluorodeoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18F-FDG' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18FDG' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18S Ribosomal RNA' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18alpha Carbenoxolone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18th Cent. History %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18th Cent. History of Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18th Cent. Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18th Century Histories' = 0).
% 42.05/41.92 fof(interp, fi_functors, '18th Century History' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19 Iodocholesterol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19 Norandrostanes' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19 Norandrostenes' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing%27%s syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19-Iodocholesterol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19-Norandrostanes' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19-Norandrostenes' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19-Nortestosterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1914-1918 World War' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1939-1945 World War' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19438, MDL' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1950-1953 Korean War' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1961-1975 Vietnamese Conflict' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1961-1975 Vietnamese Conflicts' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963 for M PHASE use MITOSIS 1991-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; /therapeutic use was ESTROGENS, THERAPEUTIC 1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; ANTHOCYANIN was indexed under ANTHOCYANINS ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; DIOXYGEN was indexed under OXYGEN %28%NM%29% 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; PACHYCARPINE was indexed under SPARTEINE 1973-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; PRORENIN was listed under ENZYME PRECUSORS %26% RENIN 1977-2003; PREPRORENIN was listed under ENZYME PRECUSORS %26% RENIN 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; SUSTANON was indexed under TESTOSTERONE/AA 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; TENSIDES was indexed under SURFACE ACTIVE AGENTS 1973-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for AGROBACTERIUM see AGROBACTERIUM 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for ANIMAL VIRUSES %26% ZOOPHAGINAE use VERTEBRATE VIRUSES 1975-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for ANTHOCYANIN use ANTHOCYANINS %28%NM%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for APHASIA, ACQUIRED see APHASIA, ACQUIRED 1991-1995, see APHASIA 1980-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL see GLIOMA 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for ASTROCYTOMA, SUBEPENDYMAL GIANT CELL use GLIOMA 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for AUDITORY NERVE see ACOUSTIC NERVE 1979-1999; for ACOUSTIC NERVE see VESTIBULOCOCHLEAR NERVE 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for AUDITORY NERVE use VESTIBULOCOCHLEAR NERVE 1979-1999; for ACOUSTIC NERVE use VESTIBULOCOCHLEAR NERVE 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for AUTOKINETIC EFFECT see AUTOKINETIC EFFECT 1991-1996, see ILLUSIONS 1968-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for BIRTH CONTROL see FAMILY PLANNING 1968-1974, see BIRTH CONTROL 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for BIRTH CONTROL use FAMILY PLANNING 1968-1974, use BIRTH CONTROL 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for BREAKTHROUGH BLEEDING %26% SPOTTING see UTERINE HEMORRHAGE 1980-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for BREAKTHROUGH BLEEDING %26% SPOTTING use UTERINE HEMORRHAGE 1980-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for CEREBRUM see BRAIN 1975-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for CEREBRUM use BRAIN 1975-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for COLEPTERA see COLEPTERA 1975-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for DIOXYGEN use OXYGEN %28%NM%29% 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for EPENDYMOMA, MYXOPAPILLARY see GLIOMA 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for EPENDYMOMA, MYXOPAPILLARY use GLIOMA 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for EPERYTHROZOON see EPERYTHROZOON 1966-2003; for HAEMOBARTONELLA see ANAPLASMATACEAE 1997-2003, see HAEMOBARTONELLA 1980-1996; for PLEUROPNEUMONIA-LIKE ORGANISMS see PLEUROPNEUMONIA-LIKE ORGANISMS 1963-1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for GENERAL PARALYSIS %26% PARALYSIS, GENERAL use PARESIS 1963-93%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for HAEMOBARTONELLA use ANAPLASMATACEAE 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for HEMIPARESIS see HEMIPLEGIA 1974-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for HEMIPARESIS use HEMIPLEGIA 1974-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for HYPERINSULINEMIA see HYPERINSULINEMIA 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for HYPOTHALAMUS, INFUNDIBULAR see HYPOTHALAMUS, MIDDLE 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for HYPOTHALAMUS, INFUNDIBULAR use HYPOTHALAMUS, MIDDLE 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for M PHASE see MITOSIS 1991-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for MORTALITY, PREMATURE see INFANT MORTALITY 1995-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for MORTALITY, PREMATURE use INFANT MORTALITY 1995-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for MYOCLONIC JERKING see EPILEPSY, MYOCLONIC 1992-1999; for MYOCLONIC JERKING, MASSIVE see SPASMS, INFANTILE 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for MYOCLONIC JERKING use EPILEPSY, MYOCLONIC 1992-1999; for MYOCLONIC JERKING, MASSIVE use SPASMS, INFANTILE 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for NATURAL PRODUCTS also use BIOLOGICAL FACTORS 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for NATURAL PRODUCTS see BIOLOGICAL FACTORS 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for PACHYCARPINE use SPARTEINE%28%NM%29% 1973-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for PRORENIN use RENIN %28%NM%29% 1977-2003, for PREPRORENIN use RENIN %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for RESPIRATORY CIRCULATION see RESPIRATORY CIRCULATION 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for RESPIRATORY CIRCULATION use PULMONARY CIRCULATION 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for SECULARISM see RELIGION 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for SECULARISM use RELIGION 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for SIMMONDS%27% DISEASE %26% SHEEHAN%27%S SYNDROME see SIMMONDS%27% DISEASE 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for SIMMONDS%27% DISEASE %26% SHEEHAN%27%S SYNDROME use SIMMONDS%27% DISEASE 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for SURGICAL PROCEDURES, ENDOSCOPIC and ENDOSCOPIC SURGICAL PROCEDURES see SURGICAL PROCEDURES, ENDOSCOPIC 1998-1999, see SURGERY, ENDOSCOPIC 1996-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for SUSTANON use TESTOSTERONE %28%NM%29% 1976-2003; /therapeutic use was TESTOSTERONE, THERAPEUTIC 1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for TONOMETRY see TONOMETRY 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for TONOMETRY use TONOMETRY 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for X-BEARING SPERM see X CHROMOSOME 1980-2005; for Y-BEARING SPERM see Y CHROMOSOME 1980-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for X-BEARING SPERM use X CHROMOSOME 1980-2005; for Y-BEARING SPERM use Y CHROMOSOME 1980-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; for ZOOPHAGINAE see VERTEBRATE VIRUSES 1975-1991; for ANIMAL VIRUSES see ANIMAL VIRUSES 1963-1965, see VERTEBRATE VIRUSES 1975-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; see ANKLE INJURIES to search ANKLE/injuries 1966-91; for TARSUS see TARSUS 1988-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1963; use ANKLE INJURIES to search ANKLE/injuries 1966-91%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1964 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1964%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1964-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1964-07-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1964; see HEPATO-LENTICULAR DEGENERATION 1963 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; %28%1963%29%; for CISTRON use GENES, STRUCTURAL 1980-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; HAND-SHOULDER SYNDROME was see REFLEX SYMPATHETIC DYSTROPHY 1992-95; SHOULDER-HAND SYNDROME %26% SUDECK%27%S ATROPHY were headings 1963-95; OSTEOPOROSIS, POST-TRAUMATIC was see SUDECK%27%S ATROPHY 1992-95%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; PROTEIN METABOLISM DISORDERS was heading 1963-1964 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; for ACEPHEN see MECLOFENOXATE 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; for ACEPHEN use MECLOFENOXATE 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; for CRANIOMETRY see CRANIOMETRY 1966-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; for ERGONOVINE MALEATE use ERGONOVINE %28%NM%29% 1979-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; see ADAMANTINOMA 1963-1964 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; see CHROMOSOMES 1963-1964; for CISTRON see GENES, STRUCTURAL 1980-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; see ERGOLINES 1969-1974; ERGONIVINE MALEATE was indexed under ERGONOVINE 1979-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; see THYROXIN 1963-1964; for LEVOTHYROXINE see LEVOTHYROXINE 1991-2001, see THYROXINE 1966-1990, see LEVOTHYROXINE 1963-1965%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1965; use THYROXIN 1963-1964; for LEVOTHYROXINE use LEVOTHYROXINE 1991-2001, use THYROXINE 1966-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966 %28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966%28%1963%29%; for ALEXIA use DYSLEXIA, ACQUIRED 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966%28%2003%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for CAROTENE see CAROTENE 1966-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for FEMALES use WOMEN 1978-2005 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for GENERAL PARALYSIS %26% PARALYSIS, GENERAL see PARESIS 1963-93%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for ICTERUS GRAVIS NEONATORUM see ERYTHROBLASTOSIS FETAL 1975-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for ICTERUS GRAVIS NEONATORUM use ERYTHROBLASTOSIS FETAL 1975-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for LANGAT VIRUS see LANGAT VIRUS 1991-1993, see FLAVIVIRUSES 1981-1990, see ARBOVIRUSES 1975-1980; for LOUPING ILL VIRUS see LOUPING ILL VIRUS 1991-1993, see ENCEPHALITIS VIRUSES, TICK-BORNE 1967-1990, see ARBOVIRUS 1965-1966, see ARBOVIRUSES 1963-1964; for POWASSAN VIRUS see POWASSAN VIRUS 1991-1993, see ENCEPHALITIS VIRUSES, TICK-BORNE 1975-1990; for KYASANUR FOREST DISEASE VIRUS see FLAVIVIRUSES 1986-1993, see FLAVIVIRUSES 1981-1985, see ARBOVIRUSES 1975-80%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for MALES use MEN 1979-2005 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for METHLERGOMETRINE MALEATE use METHYLERGONOVINE %28%NM%29% 1966-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for METHLERGOMETRINE MALEATE was indexed under METHYLERGONOVINE %28%NM%29% 1966-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for PARALYSIS, SPASTIC see MUSCLE SPASTICITY 1966-78, see PARALYSIS, SPASTICITY 1963-78%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for PROTEINASES see ENDOPEPTIDASES 1979-2004; for PROTEASES see ENDOPEPTIDASES 1987-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for PROTEINASES use ENDOPEPTIDASES 1979-2000; for PROTEASES use ENDOPEPTIDASES 1987-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; for articles that were case reports 1967-1975, that contained case reports 1966%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; restricted to comparison of drugs or technics only 1966-1973%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1966; see READING 1963-1965; for ALEXIA see DYSLEXIA, ACQUIRED 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967%28%1964%29%; for HYPOKINESIA, EXPERIMENTAL use HYPOKINESIA 2000-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967%28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967%28%1965%29%; for GENOME MAPPING use HUMAN GENOME PROJECT 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967: see POPULATION %26% VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE %26% AGE-SPECIFIC FERTILITY RATE see MATERNAL AGE 1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967: use POPULATION %26% VITAL STATISTICS 1963-1966; for AGE-SPECIFIC BIRTH RATE %26% AGE-SPECIFIC FERTILITY RATE use MATERNAL AGE 1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967; for GENOME MAPPING see HUMAN GENOME PROJECT 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967; for HEMERALOPIA see HEMERALOPIA 1963-1989 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967; for HYPOKINESIA, EXPERIMENTAL see HYPOKINESIA 2000-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1967; see MENTAL DEFICIENCY 1963-1966; see IDIOCY 1963-1984; see MENTAL RETARDATION, PSYCHOSOCIAL 1969-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; SPANDEX was indexed under POLYURETHANES 1975-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for CHROMOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001; for AUTOSOME ABNORMALITIES see CHROMOSOME ABNORMALITIES 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for CHROMOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001; for AUTOSOME ABNORMALITIES use CHROMOSOME ABERRATIONS 1963-2001 or CHROMOSOME DISORDERS 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for ENCEPHALITIS, CENTRAL EUROPEAN see ENCEPHALITIS, TICK-BORNE 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for EPERYTHROZOONOSIS see EPERYTHROZOONOSIS 1991-2003, see ANAPLASMATACEAE INFECTIONS 1977-1990, see BARTONELLA INFECTIONS 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for EPERYTHROZOONOSIS use ANAPLASMATACEAE INFECTIONS 1977-1990, use BARTONELLA INFECTIONS 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for GENETIC EQUILIBRIUM see GENETICS, POPULATION 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for GENETIC EQUILIBRIUM use GENETICS, POPULATION 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; for SPANDEX use POLYURETHANES %28%NM%29% 1975-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; see ACARIASIS 1963-1967 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; see FISH 1963-1967 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1968; see SEX CHROMOSOME ABNORMALITIES 1968-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1969 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1969%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1969%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1969%28%1967%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1969-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1969; see DEAF-MUTISM %26% SPEECH DISORDERS 1963-68 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1970%28%1964%29%; for FACTOR XIII TRANSAMIDASE see TRANSGLUTAMINASES %28%1990-2001%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1970-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1970; for FACTOR XIII TRANSAMIDASE use PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE %28%1990-2001%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1971 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1971-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1971; AMYOTONIA CONGENITA was heading 1963-96 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1971; AMYOTONIA CONGENITA was heading 1963-96; for MYATONIA CONGENITA %26% OPPENHEIM%27%S DISEASE see AMYOTONIA CONGENITA 1963-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1971; SCLERODERMA was heading 1963-70 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972 %28%1969%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972%28%1969%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972; see GASTROINTESTINAL SYSTEM 1963-1971 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1972; see VOICE 1963-1971 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973 %28%1965%29%; for KUNJIN VIRUS use ENCEPHALITIS VIRUSES, JAPANESE 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973 %28%1971%29%; for OCKELBO VIRUS use ALPHAVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973%28%1971%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973%28%1971%29%; for HEXOAMINIDASE use BETA-N-ACETYLHEXOSAMINIDASE 1987-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973%28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973%28%1972%29%; for PHYTOMITOGENS use PLANT LECTINS 1978-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973; 3%27%-5%27%-EXONUCLEASE use EXODEOXYRIBONUCLEASE V %26% 5%27%-3%27%-EXONUCLEASE were indexed under EXODEORIBONUCLEASES 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973; for 3%27%-5%27%-EXONUCLEASE use EXODEOXYRIBONUCLEASE V %26% 5%27%-3%27%-EXONUCLEASE %28%NM%29% 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973; for GALACTOSAMINIDASE see GALACTOAMINIDASE 1973-2004; for GLUCOSAMINIDASE see GLUCOSAMINIDASE 1973-2004; for HEXOAMINIDASE see BETA-N-ACETYLHEXOSAMINIDASE 1987-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973; for KUNJIN VIRUS see ENCEPHALITIS VIRUSES, JAPANESE 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973; for OCKLEBO VIRUS see ALPHAVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1973; for PHYTOMITOGENS see PLANT LECTINS 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974 %28%1972%29%; for B FIBERS use AUTONOMIC FIBERS, PREGANGLIONIC 1976-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974%28%1963%29%; for ANGIOTENSIN II, ILE%28%5%29%- use ANGIOTENSIN II %28%NM%29% 1974-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974%28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-10-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-11-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-11-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-11-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-11-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-12-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974-12-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974; for B FIBERS see AUTONOMIC FIBERS, PREGANGLIONIC 1976-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974; for KLEBSIELLA RHINOSCLEROMATIS see KLEBSIELLA RHINOSCLEROMATIS 1972-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 %28%HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973%29%; ANGIOTENSIN II, ILE%28%5%29%- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1974; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for LEUKODYSTROPHIES see CEREBRAL SCLEROSIS, DIFFUSE 1963-1973; for KRABBE DISEASE see KRABBE%27%S DISEASE 1974-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-02-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-02-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-03-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-07-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-07-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-07-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-07-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-07-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-08-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1975-09-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-04-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-04-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-04-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-04-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-04-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-05-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-05-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-05-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976-06-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; for ERYTHROCYTE AGGREGATION, INTRAVASCULAR see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1964-2003; for INTRAVASCULAR AGGLUTINATION see ERYTHROCYTE AGGREGATION, INTRAVASCULAR 1976-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; for SALMONELLA PARATYPHI see SALMONELLA PARATYPHI 1963-1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; for SALMONELLA PARATYPHI use SALMONELLA PARATYPHI 1963-1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; see ACHROMOBACTER 1963-1975 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; see THIORHODACEAE 1975 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; use LEPTOSPIRA ICTEROHAEMORRHAGIAE 1963-1975 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1976; was NON MESH before 1976; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977 %28%1969%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977%28%1975%29%; for ERGOT ALKALOIDS, HYDROGENATED use ERGOLOID MESYLATES 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-03-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-03-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-03-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-03-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-04-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-04-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-04-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-04-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-04-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-06-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-06-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-11-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-11-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-11-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977-12-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; for APC VIRUS %28%Adenoidal-Pharyngeal-Conjunctival virus%29% see ADENOVIRUSES 1975-1976, see ADENOVIRUS 1963-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; for KIENBOCK DISEASE, see OSTEOCHONDRITIS 1963-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; for KIENBOCK DISEASE, use OSTEOCHONDRITIS 1963-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; see ALEXIA 1963-1976 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; see CARRIER PROTEINS %26% TRANSFERASES 1975-1976 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; see CHOLESTENES 1975-1977, see INVERTEBRATE HORMONES 1972-1974, see CHOLESTANES 1969-1971%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; see ERGOT ALKALOIDS HYDROGENATED 1975-1976; for ERGOT ALKALOIDS, HYDROGENATED see ERGOLOID MESYLATES 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; see HYPSARRHYTHMIA 1963-76 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; use CARRIER PROTEINS %26% TRANSFERASES 1975-1976 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1977; was NON MESH before 1977 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978 CERM' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-01-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-01-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-01-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-01-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-02-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-03-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-04-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-04-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-05-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-06-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-07-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-10-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-10-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-11-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-11-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-11-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-11-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-11-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-12-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978-CERM' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978; for ANGIOTENSIN see ANGIOTENSIN II 1978-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978; for ANGIOTENSIN use ANGIOTENSIN II 1978-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978; for SAINT PIERRE AND MIQUELON use CANADA 1996-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978; see DISACCHARIDASES 1975-1977, see FUCOSIDASE 1975-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978; see MENINGITIS, MENINGOCOCCIC 1963-1977 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1978CERM' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979 %28%1974%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979%28%1967%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-01-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-01-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-01-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-02-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-02-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-02-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-02-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-02-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-03-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-03-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-03-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-03-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-03-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-03-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-04-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979-06-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; for PITRESSIN see VASOPRESSINS %28%1981-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; for CONVULSIVE SEIZURES %26% SEIZURES, CONVULSIVE see CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE see EPILEPSY, PARTIAL 1992-1999; for CONVULSIONS see CONVULSIONS 1963-2004; for CONVULSION, NON-EPILEPTIC see CONVULSIONS 2000-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; for CONVULSIVE SEIZURES %26% SEIZURES, CONVULSIVE use CONVULSIONS 1998-1999; for JACKSONIAN SEIZURE use EPILEPSY, PARTIAL 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME see SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST see SPINA BIFIDA OCCULTA 1991-1999, see NEURAL TUBE DEFECTS 1979-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; for DIASTEMATOMYELIA and TETHERED CORD SYNDROME use SPINA BIFIDA OCCULTA 1991-1999; for NEURENTERIC CYST use SPINA BIFIDA OCCULTA 1991-1999, use NEURAL TUBE DEFECTS 1979-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; for PITRESSIN use VASOPRESSINS %28%1981-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; see AMAUROTIC FAMILIAL IDIOCY 1963-1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; see PARKINSONISM 1967-1978, see PARALYSIS AGITANS 1963-1966%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; see PARKINSONISM, POSTENCEPHALITIC 1967-1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; see PREGNANCY TOXEMIAS 1963-1978; for PREGNANCY TOXEMIAS see PREGNANCY TOXEMIAS 1963-2004; for EDEMA-PROTEINURIA-HYPERTENSION GESTOSIS see GESTOSIS, EPH 1989-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; see TUBERCULOSIS VACCINES 1974-1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; use AMAUROTIC FAMILIAL IDIOCY 1963-1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1979; was OCULOMOTOR PARALYSIS 1963-1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-03-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-03-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-03-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-04-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-04-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-04-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-04-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-04-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-05-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980-12-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980; for IMMUNOGLOBULINS, SURFACE see IMMUNOGLOBULINS, SURFACE 1975-2005; for MEMBRANE-BOUND IMMUNOGLOBULINS see IMMUNOGLOBULINS, SURFACE 1975-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980; see NERVE GROWTH FACTOR 1972-1979; NEUROTROPHIC PROTEIN was indexed under NERVE TISSUE PROTEINS 1978-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1980; use NERVE GROWTH FACTOR 1966-1979; for NEUROTROPHIC PROTEIN use NERVE GROWTH FACTORS %28%NM%29% 1978-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981 %28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981%28%1963%29%; for BRAIN CONTUSION use BRAIN CONCUSSION 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981%28%1963-1967%29%; use LATEX RUBBER 1968-1980; for CAOUTCHOUC use LATEX 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-02-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-02-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-02-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-02-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-03-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-03-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-03-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-04-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981-05-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; FROEHLICH%27%S SYNDROME was heading 1963-1984 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; see BRAIN INJURIES 1981-1999, see BRAIN INJURIES, ACUTE 1973-1980, see BRAIN INJURY, ACUTE 1963-1972; for BRAIN CONTUSION see BRAIN CONCUSSION 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; see DEMENTIA, SENILE 1979-91; see PSYCHOSES, SENILE 1963-78; see PSYCHOSES, PRESENILE 1963-72; see PICK DISEASE OF BRAIN 1981-91; see PICK%27%S DISEASE OF BRAIN 1966-80; for DEMENTIA, PRESENILE see DEMENTIA 1967-97; for DEMENTIA, SENILE see DEMENTIA 1966-97%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; see IRIDOVIRUSES 1978-80; for GOLDFISH VIRUSES see GOLDFISH VIRUS 1-LIKE VIRUSES 1997-2001, see IRIDOVIRIDAE 1994-96, see IRIDOVIRUSES 1978-80%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; see LATEX RUBBER 1968-1980, see RUBBER 1963-1967; LATEX PARTICLES was heading 1968-1980; for CAOUTCHOUC see LATEX 1980-1999; for LATICES see LATEX 1981-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; was AUTONOMIC SYSTEM DISEASES %28%NON MESH%29% before 1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1981; was NON MESH before 1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-04-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982; see MUSCLE DYSTONIA 1979-1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982; see RODENTS 1963-1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1982; use RODENTS 1963-1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983%28%1979%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-02-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-02-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-02-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-03-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-03-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-03-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-03-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-04-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-04-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-04-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-04-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-05-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983; PLATELET AGGREGATING FACTOR was indexed under PLATLET ACTIVATING FACTOR 2002-2005 %26% BLOOD COAGULATION FACTORS 1979-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1983; see SCALENUS ANTICUS SYNDROME 1963-1982 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984%28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-02-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-04-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-06-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-06-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984-06-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984; see ANGIOTENSIN II 1978-83; 1-SARCOSINE-8-ALANINE ANGIOTENSIN II was indexed under ANGIOTENSIN II 1975-77%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984; see HEPATIC COMA 1975-83; HEPATIC COMA was heading 1963-83%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1984; use HEPATIC COMA 1975-83 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985%28%1975%29%; was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL PROLIFERATIVE PHASE use MENSTRUAL CYCLE 1985-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985%28%1975%29%; was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE use MENSTRUAL CYCLE 1985-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-02-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-03-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-03-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-03-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-03-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-03-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-04-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-04-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-05-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985; was MENSTRUATION, FOLLICULAR PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL PROLIFERATIVE PHASE see MENSTRUAL CYCLE 1985-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1985; was MENSTRUATION, LUTEAL PHASE see under MENSTRUATION 1975-1984; for MENSTRUAL SECRETORY PHASE see MENSTRUAL CYCLE 1985-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986%28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986%28%1980%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986%28%1985%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-03-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-03-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-03-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-03-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-03-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-04-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-05-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-05-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-06-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986-07-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986; see 5,8,11,14,17-EICOSAPENTAENOIC ACID 1986-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986; see BASAL GANGLIA DISEASES 1985 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986; see LANGUAGE DISORDERS 1980-1985 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1986; see PHENYLACETATES 1977-1985; for DICLOFENAC SODIUM see 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987 %28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987%28%1979%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-01-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-02-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-02-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-03-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-04-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-07-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987-09-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; for MECTIZAN see IVERMECTIN 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; for MECTIZAN use IVERMECTIN %28%NM%29% 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; for MOSQUITO FISH see FISHES 1975-86 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR see RECEPTORS, THYROID HORMONE 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; for RECEPTORS, LONG ACTING THYROID STIMULATOR use RECEPTORS, THYROID HORMONE 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; see ANTIBODIES, HETEROTYPIC 1964-1986; FORSSMAN ANTIBODY was indexed under ANTIBODIES, HETEROPHILE 1985-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; see CORONARY DISEASE 1974-1987; for CORONARY ARTERY DISEASE see CORONARY DISEASE 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; see NEUROLOGIC MANIFESTATIONS 1982-86, see MOVEMENT DISORDERS 1979-81%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1987; use CORONARY DISEASE 1974-1987; for CORONARY ARTERY DISEASE use CORONARY DISEASE 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988%28%1968%29%; for HOCK see HINDLIMB 1975-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-03-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-03-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-03-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-03-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-04-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-07-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988-07-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; see HINDLIMB 1968-87; for HOCK see HINDLIMB 1997-2001, see HOCK 1991-1996, see HINDLIMB 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; NMR TOMOGRAPHY %26% TOMOGRAPHY, NMR %26% TOMOGRAPHY, PROTON SPIN were see NUCLEAR MAGNETIC RESONANCE 1985-1987; for CHEMICAL SHIFT IMAGING see NUCLEAR MAGNETIC RESONANCE 1995-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; for MITOGENIC FACTORS, LYMPHOCYTE see INTERLEUKIN-2 1990-2001, INTERLEUKIN 2 1987-1989, LYMPHOKINES 1978-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; for MITOGENIC FACTORS, LYMPHOCYTE use INTERLEUKIN-2 1983-2001, LYMPHOKINES 1978-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; for NMR TOMOGRAPHY %26% TOMOGRAPHY, NMR %26% TOMOGRAPHY, PROTON SPIN use MAGNETIC RESONANCE SPECTROSCOPY 1985-1987; for CHEMICAL SHIFT IMAGING use MAGNETIC RESONANCE SPECTROSCOPY 1995-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; see HTLV-III 1987; for AIDS VIRUS see HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1988; use HTLV-III 1987; for AIDS VIRUS use HIV-1 1990-2004; for HUMAN T-CELL LEUKEMIA VIRUS TYPE III see HIV 1987-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989%28%1975%29%; use GLYCOGENOSIS 1975-1988 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-03-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-03-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-04-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-05-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-05-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-05-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-07-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-08-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-09-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-09-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989-10-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; for ESCITALOPRAM use CITALOPRAM %28%NM%29% 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; for ESCITALOPRAM was indexed under CITALOPRAM 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; for both publication type %26% main heading 1989-1990; publication type only 1991 forward%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; see GILLES DE LA TOURETTE%27%S DISEASE 1966-88 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; see GLYCOGENOSIS 1975-88 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; see HTLV INFECTIONS 1987-88; for LEUKEMIA, ADULT T-CELL %26% T-CELL LEUKEMIA, ADULT see HTLV INFECTIONS 1987-88%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; see LEUKEMIA, LYMPHOBLASTIC 1974-88; for ALL, ADULT see LEUKEMIA, LYMPHOCYTIC, ACUTE 1989-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; use HTLV INFECTIONS 1987-1988 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1989; use LEUKEMIA, LYMPHOBLASTIC 1974-88; for ALL, ADULT use LEUKEMIA, LYMPHOCYTIC, ACUTE 1989-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990 %28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990%28%1987%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990%28%1987%29%; see RECOMBINANT PROTEINS 1987-1989; for CHIMERIC PROTEINS, RECOMBINANT see CHIMERIC PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990, 1974-1977; for TUMOR NECROSIS FACTOR-BETA %26% TNF-BETA use TUMOR NECROSIS FACTOR 1988-1989; for LYMPHOCYTOTOXINS use LYMPHOTOXINS 1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-01-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-02-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-02-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-02-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-03-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-03-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-03-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-04-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-04-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-06-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-07-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-07-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-08-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990-11-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; LYMPHOTOXIN-ALPHA was indexed under LYMPHOTOXIN see LYMPHOTOXINS 1978-1989; see LYMPHOTOXIN 1974-1977; for TUMOR NECROSIS FACTOR-BETA %26% TNF-BETA see TUMOR NECROSIS FACTOR 1988-1989; for LYMPHOCYTOTOXINS see LYMPHOTOXINS 1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; N-3 POLYUNSATURATED FATTY ACID was indexed under FATTY ACIDS, UNSATURATED 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; for ACUPUNCTURE ANESTHESIA see ACUPUNCTURE ANESTHESIA 1990-2001; see ACUPUNCTURE 1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; for ACUPUNCTURE ANESTHESIA use ACUPUNCTURE ANESTHESIA 1991-2001; use ACUPUNCTURE 1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; for n-3 POLYUNSATURATED FATTY ACID use PIKASOL %28%NM%29% 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; see T LYMPHOCYTES 1973-1989 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1990; was PERIODICAL INDEXES as both main heading %26% publication type 1990; publication type only from 1991 forward%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991 %28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1963%29%; for RECTOCOLITIS, HEMORRHAGIC %26% RECTOCOLITIS, ULCERATIVE use COLITIS, ULCERATIVE 1979-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1964%29%; for SPINA BIFIDA use SPINA BIFIDA OCCULTA 1978-1990, use SPINAL DYSRAPHISM 1966-1970%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1965%29%; was see under UVEITIS 1965-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1970%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1971%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1971%29%; see MYELITIS 1971-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1971%29%; was see under NEURALGIA 1971-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1972%29%; for RHINENCEPHALON use LIMBIC SYSTEM 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1972%29%; use TROPANES 1972-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1974%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; for 18-HYDROXY-11-DEOXYCORTICOSTERONE use 18-HYDROXYDESOXYCORTICOSTERONE %28%NM%29% 2003-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; for 18ALPHA-CARBENOXOLONE use CARBENOXOLONE %28%NM%29% 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; for GENDER use SEX 1991-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; for MARLEX use PLASTIPORE %28%NM%29% 1978-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; use MACROMOLECULAR SUBSTANCES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; use SALMONIDAE 1968-1974 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; was see under DEMYELINATING DISEASES 1979-1990; was see under MULTIPLE SCLEROSIS 1963-1978 %28%Prov 1963-1966%29% ; DEVIC DISEASE was DEVIC%27%S DISEASE 1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1975%29%; was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1976%29%; for TRANSLAGEN use CHONDROITIN SULFATE %28%NM%29% 1991-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1976%29%; see QUINOLINIUM COMPOUNDS 1976-1990; for DECHALINIUM %26% DEQUALONUM see DEQUALINIUM 1976-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1976%29%; was see under AMNESIA 1976-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1976%29%; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1977%29%; use KETONES 1977-1990; for HEXAN-2-ONE use HEXANONES 2002-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1978%29%; use ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN use ANTIBIOTICS 1975-1977; NOURSEOTHRICIN was %28%NM%29% 1975-1993; for RACEMOMYCINS use RACEMOMYCIN %28%NM%29% 2000-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1978%29%; use CARNITINE 1978-1990; for MEDOSAN use ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL %28%NM%29% 1988-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1979%29%; was see under GASTROINTESTINAL HORMONES 1979-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1980%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1980%29%; use APHASIA 1975-1979 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1981%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1983%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1985%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1986%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1986%29%1963 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1987%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1987%29%; use COMPUTER SYSTEMS 1987-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%1989%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991%28%77%29%; use ARTHRITIS 1977-90; use ARTHRITIS, RHEUMATOID 1975-76%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991, 1963-1983; see MENINGOCOCCAL INFECTIONS 1984-1990, see WATERHOUSE-FRIDERICHSEN SYNDROME 1963-1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991, 1963-1983; use MENINGOCOCCAL INFECTIONS 1984-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991, 1963-1985; see PLANTS, MEDICINAL 1986-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-01-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-02-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-02-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-02-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-02-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-04-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-04-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-06-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-07-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-07-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-07-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-07-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-07-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-07-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-08-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-08-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-08-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991-11-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; for RESTING PHASE see INTERPHASE %28%1997-2004%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; for RESTING PHASE use INTERPHASE %28%1997-2004%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; for UNIDENTIFIED READING FRAME and UNASSIGNED READING FRAMES see READING FRAMES 1991-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; for UNIDENTIFIED READING FRAME and UNASSIGNED READING FRAMES use READING FRAMES 1991-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see ANTIBIOTICS, AMINOGLYCOSIDE 1978-1990; was STREPTOTHRICIN see ANTIBIOTICS 1975-77; NOURSEOTHRICIN was indexed under STREPTOTHRICINS 1975-1993; RACEMOMYCINS was indexed under RACEMOMYCIN %28%NM%29% 2000-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see APHASIA 1980-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see ARTERIAL OCCLUSIVE DISEASES 1978-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see ARTHRITIS 1977-90; see ARTHRITIS, RHEUMATOID 1975-76%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see AUTONOMIC NERVOUS SYSTEM DISEASES 1981-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see BASAL GANGLIA DISEASES 1979-1990, see BRAIN DISEASES 1975-78%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see BASAL GANGLIA DISEASES 1985-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see BRAIN DISEASES, METABOLIC 1985-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see CARNITINE 1978-1990; MEDOSAN was indexed under ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1988-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see CENTRAL NERVOUS SYSTEM 1972-90; for RHINENCEPHALON see LIMBIC SYSTEM 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see CEREBRAL SCLEROSIS, DIFFUSE 1983-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see CHONDROITIN 1976-90; TRANSLAGEN was indexed under CHONDROITIN SULFATES, COLLAGEN %26% HEPARIN 1991-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see COCCIDIA 1985-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see COLITIS 1963-1990; for RECTOCOLITIS, HEMORRHAGIC %26% RECTOCOLITIS, ULCERATIVE see COLITIS, ULCERATIVE 1979-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see COMPUTER SYSTEMS 1987-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see DESOXYCORTICOSTERONE 1975-1990; 18-HYDROXY-11-DEOXYCORTICOSTERONE was indexed under 18-HYDROXYCORTICOSTERONE 2003-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see ENCEPHALITIS, EPIDEMIC 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see ENCEPHALOMALACIA 1987-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see GLYCYRRHETINIC ACID 1979-1990, see TRITERPENES 1975-1978; for 18ALPHA-CARBENOXOLONE was indexed under CARBENOXOLONE %28%NM%29% 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see HYDRO-LYASES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see HYDROCEPHALUS 1970-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see HYDROCEPHALUS 1971-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see HYPERESTHESIA 1975-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see HYPOLIPOPROTEINEMIA 1980-1990, see HYPOLIPOPROTEINEMIAS 1978-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see IDENTIFICATION %28%PSYCHOLOGY%29% 1976-1990; for GENDER see SEX 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see KETONES 1977-90; HEXAN-2-ONE was indexed under HEXANONES 2002-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MACROMOLECULAR SYSTEMS 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MALARIA 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1991-1999, see ENVIRONMENTAL EXPOSURE 1975-1990; for MAXIMUM ALLOWABLE CONCENTRATION see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MEDLARS-MEDLINE INFORMATION SYSTEM 1978-1990; for INDEX MEDICUS see MEDLINE 1979-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MENINGITIS 1972-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MENINGITIS 1977-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see MYELITIS 1971-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see PITUITARY NEOPLASMS 1978-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see PLANTS, TOXIC 1986-1990, see FRANGULA 1963-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see PLASTICS 1975-1990; MARLEX was indexed under POLYETHYLENES %26% POLYPROPYLENES 1983-1999 %26% POLYMERS 1978-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see POLYCYSTIC KIDNEY 1991-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see POLYSACCHARIDES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see PRENATAL DIAGNOSIS 1977-1990; for AMNIOSCOPY see AMNIOSCOPY 1971-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see PROJECTIVE TECHNICS 1963-1990; for ROSENZWEIG PICTURE-FRUSTRATION STUDY see ROSENZWEIG PICTURE-FRUSTRATION STUDY 1991-1999; see PROJECTIVE TECHNICS 1975-1980; for PICTURE FRUSTRATION STUDY see ROSENZWEIG PICTURE-FRUSTRATION STUDY 1979-1991; see PROJECTIVE TECHNIQUES 1975-1999; for SZONDI TEST see SZONDI TEST 1991-1999; see PROJECTIVE TECHNIQUES 1975-1900%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see PSITTACINES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see QUINOLINIUM COMPOUNDS 1976-90; for DECHALINIUM %26% DEQUALONUM see DEQUALINIUM 1976-1993; DYNEXAN-MHP was indexed under DEQUALINIUM, POLYETHYLENES %26% SESQUITERPENES 1977-2000 and under POLYMERS %26% QUINOLINIUM COMPOUNDS 1974-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see REFLEX 1990, see REFLEX, ABNORMAL 1975-1989 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see RENAL TUBULAR TRANSPORT, INBORN ERRORS 1977-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see SALMONIDAE 1968-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see SOMATOMEDINS 1986-1990; SOMATOMEDIN A was indexed under INSULIN-LIKE GROWTH FACTOR II 1980-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see STATUS DYSRAPHICUS 1964-90 ; for SPINA BIFIDA see SPINA BIFIDA OCCULTA 1978-1990, see SPINAL DYSRAPHISM 1966-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see TASTE DISORDERS 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see TOGAVIRUS INFECTIONS 1981-1990, see ARBOVIRUS INFECTIONS 1966-80%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see TROPANES 1972-1990; BENZATROPINE METHANESULFONATE was indexed under BENZOTROPINE 1977-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see VASCULAR HEADACHE 1978-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see VIRGINIAMYCINS 1974-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; see under APHASIA 1980-1990, see APHASIA 1975-1979 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; use MEDLARS 1978-1990; for INDEX MEDICUS use MEDLINE 1979-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was Citation Type HISTORICAL ARTICLE 1966-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS see NEURAL TUBE DEFECTS 1979-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was SPINA BIFIDA 1978-1990; for DERMAL SINUS use NEURAL TUBE DEFECTS 1979-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was citation type MONOGRAPH 1976-1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was see under AMNESIA 1976-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was see under DEMYELINATING DISEASES 1979-1990; was see under MULTIPLE SCLEROSIS 1967-1978; DEVIC DISEASE was DEVIC%27%S DISEASE 1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was see under ENCEPHALOMYELITIS, EQUINE 1976-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was see under NEURALGIA 1971-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was see under THORACIC OUTLET SYNDROME 1983-90; was see under SCALENUS ANTICUS SYNDROME 1963-82%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was see under UVEITIS 1965-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1991; was under GASTROINTESTINAL HORMONES 1979-1990; see ENTEROGLUCAGON 1991-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992 %28%1974%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992 %28%1979%29%; for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004; for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992 %28%1981%29%; for CEBUELLA use CALLITRICHIDAE 1981-2005 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992%28%1966%29%; for NEUROFIBROMATOSIS, PERIPHERAL, NF1 use NEUROFIBROMATOSIS 1989-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992%28%1974%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992%28%1975%29%; for CYTOCHROME P-450 OXIDASE use NADPH-FERRIHEMOPROTEIN REDUCTASE %28%NM%29% 1983-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992%28%1976%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992, see NATRIURETIC PEPTIDES, ATRIAL 1986-1991; ATRIAL NATRIURETIC FACTOR %28%99-126%29% was indexed under ATRIAL NATRIURETIC FACTOR 1987-2003; ATRIAL NATRIURETIC FACTOR %28%1-28%29% was indexed under ATRIAL NATRIURETIC FACTOR 1992-2003; CARDIONATRIN IV was indexed under ATRIAL NATRIURETIC FACTOR 1986-2003; ATRIOPEPTIGEN was indexed under MUSCLE PROTEINS 1985-2003; ATRIAL NATRIURETIC FACTOR PRECURSORS was indexed under ATRIAL NATRIURETIC FACTOR 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992, use NATRIURETIC PEPTIDES, ATRIAL 1986-1991; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIAL NATRIURETIC FACTOR %28%99-126%29% 1987-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIAL NATRIURETIC FACTOR %28%1-28%29% 1992-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for CARDIONATRIN IV 1986-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIOPEPTIGEN 1985-2003; use ATRIAL NATRIURETIC FACTOR %28%NM%29% for ATRIAL NATRIURETIC FACTOR PRECURSORS 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-03-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-03-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-04-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-05-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-06-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-06-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-10-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-12-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992-12-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; for ENDOGLUCOSAMINIDASE F use GLUCOSAMINIDASE 1987-2004, for ENDOGLUCOSAMINIDASE H use GLUCOSAMINIDASE 1983-2004; for ENDOGLYCOSIDASE D use GLUCOSAMINIDASE 1980-2004; ENDO-BETA-ACETYLGLUCOSAMINIDASE was indexed under ACETYLGLUCOSAMINIDASE 1986-1991 %26% under GLYCOSIDE HYDROLASES 1979-1985; ENDOGLYCOSIDASE F was indexed under GLYCOSIDE HYDROLASES 1983-1991; ENDOHEXOSAMINIDASE H was indexed under HEXOSAMINIDASES 1982-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; LEVONORGESTREL was indexed under NORGESTREL 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; TAU %28%NM%29% was indexed under MICROTUBULE-ASSOCIATED PROTEINS 1985-91 %26% under PROTEINS 1977-84%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; for DUGBE VIRUS see NAIROBI SHEEP DISEASE VIRUSES 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see CALLITHRICIDAE 1981-1991; for CEBUELLA see CALLITRICHIDAE 1981-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see EPILEPSY, GRAND MAL 1963-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT see EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR see EPILEPSY, TEMPORAL LOBE 1964-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see GANGLIOSIDOSIS 1976-91 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see KIDNEY, POLYCYCSTIC, AUTOSOMAL RECESSIVE 1992-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see KIDNEY, POLYCYSTIC, AUTOSOMAL DOMINANT 1992-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see MYXOBACTERALES 1974-1991; for POLYANGIACEAE see POLYANGIACEAE 1975-1981; for POLYANGIUM see POLYANGIUM 1963-1981; for SLIME BACTERIA see MYXOBACTERALES 1974-1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see NADPH CYTOCHROME C REDUCTASE 1980-1991 %26% CYTOCHROME REDUCTASES 1975-1979; CYTOCHROME P-450 OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1997-2000 %26% OXIDOREDUCTASES 1983-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see NEUROFIBROMATOSIS 1966-91; for NEUROFIBROMATOSIS, PERIPHERAL, NF1 see NEUROFIBROMATOSIS 1989-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see SARCOSPORIDIOSIS 1963-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; see SPHINGOLIPIDOSIS 1974-91 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; use EPILEPSY, TEMPORAL LOBE 1977-1991; for EPILEPSY, PSYCHIC EQUIVALENT use EPILEPSY, TEMPORAL LOBE 1975-1991; for EPILEPSY, PSYCHOMOTOR use EPILEPSY, TEMPORAL LOBE 1964-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; use LEVONORGESTREL %28%NM%29% 1980-1991; for D-NORGESTREL use NORGESTREL 1978-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; use SYNAPSINS %28%NM%29% 1981-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; use TAU %28%NM%29% 1977-91 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; was EPILEPSY, GENERALIZED %28%NON MESH%29% 1977-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; was EPILEPSY, PETIT MAL 1963-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1992; was EPILEPSY, TRAUMATIC 1963-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993, 1971-1977; use PERITONEOSCOPY 1978-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993, 1973-1977; for SURGICAL PROCEDURES, LAPAROSCOPIC and LAPAROSCOPIC SURGICAL PROCEDURES see SURGICAL PROCEDURES, LAPROSCOPIC 1998-1999, see SURGERY, LAPAROSCOPIC 1993-1997; for PERITONEOSCOPY see PERITONEOSCOPY 1963-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-02-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-02-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-03-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-04-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-04-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-05-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-06-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-07-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-08-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-08-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-08-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-08-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-09-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-11-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-11-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-11-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993-12-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; ANNEXIN IV were indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTIN IV was indexed under CALCIUM-BINDING PROTEINS 1982-1992; ANNEXIN A4 was indexed under ANNEXIN IV 2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; ANNEXIN XI was indexed under CALCIUM-BINDING PROTEINS 1992; ANNEXIN IX %26% ANNEXIN X were indexed under CALCIUM-BINDING PROTEINS 1990-1992; VASCULAR ANTICOAGULANT %28%ENDOGENOUS%29% was indexed under PEPTIDES 1988-1992; PLACENTAL ANTICOAGULANT PROTEINS was indexed under PREGNANCY PROTEINS 1987-1992; LIPOCORTINS was indexed under CALCIUM-BINDING PROTEINS 1985-1992; CALPACTIN %26% CALCIMEDINS were indexed under CALCIUM-BINDING PROTEINS 1984-1992; CALELECTRIN was indexed under CALCIUM-BINDING PROTEINS 1982-1992; CHROMOBINDINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1986-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% was indexed under METHACRYLATES 1987-1992; PANVIA OPAQUE was indexed under DENTIN-BONDING AGENTS 1992-2000 %26% under ADHESIVES 1992; RETROPLAST was indexed under POLYMETHACRYLIC ACIDS 1992; SILUX was indexed under COMPOSITE RESINS 1984-1992; ADAPTIC was indexed under POLYMETHACRYLIC ACIDS 1981-1992; CONCISE was indexed under ACRYLIC RESINS 1981-1992; CONCISE WHITE SEALANT was indexed under COMPOSITE RESINS 1981-1992; BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% HOMOPOLYMER was indexed under POLYMETHACRYLIC ACIDS 1984-1992, METHACRYLATES 1975-1983, EPOXY RESINS 1979-1982 %26% RESINS, SYNTHETIC 1979-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; CDC28 PROTEIN KINASE %28%now CDC28 PROTEIN KINASE, S CEREVISIAE%29% was indexed under PROTEIN KINASES 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; FIBRONECTIN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-1992 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; TRIPTORELIN was indexed under GONADORELIN/analogs %26% derivatives 1978-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; for BACTERIOPHAGE T2 see MYOVIRIDAE 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; for BACTERIOPHAGE T2 use MYOVIRIDAE 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT see HEPATIC ENCEPHALOPATHY 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; for FULMINATING HEPATIC FAILURE; HEPATIC FAILURE, FULMINANT; and LIVER FAILURE, FULMINANT use HEPATIC ENCEPHALOPATHY 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; for PHAGE FD, FD PHAGE, BACTERIOPHAGE FD, %26% COLIPHAGE FD see INOVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; for PHAGE FD, FD PHAGE, BACTERIOPHAGE FD, %26% COLIPHAGE FD use INOVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; see BACKACHE 1987-1992; for LUMBAGO see BACKACHE 1963-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; use BACKACHE 1987-1992; for LUMBAGO use BACKACHE 1963-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1975-1992; for PANVIA OPAQUE use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1992-2000; for RETROPLAST use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1992; for SILUX use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1984-1992; for ADAPTIC, CONCISE %26% CONCISE WHITE SEALANT use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1981-1992; BIS%28%PHENOL A-GLYCIDYL METHACRYLATE%29%, HOMOPOLYMER use BIS%28%PHENOL A-GLYCYDYL METHACRYLATE%29% %28%NM%29% 1975-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; use FIBRONECTIN RECEPTOR %28%NM%29% 1981-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; use TRIPTORELIN %28%NM%29% 1980-1992; for LHRH, TRP%28%6%29%- use TRIPTORELIN %28%NM%29% 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1993; was SENSATION DISORDERS %28%NON MESH%29% 1967-92 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994 %28%1963%29%; for GERM CELL TUMOR use GERMINOMA 1994-2005 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994 %28%1975%29%; use NAD NUCLEOSIDASE 1977-1993; for NAD%28%P%29% NUCLEOSIDASE use NAD+ NUCLEOSIDASE %28%NM%29% 1973-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994%28%1975%29%; use CHOLINEPHOSPHOTRANSFERASE 1975-93; for 1-ALKYL-2-ACETOGLYCEROL CHOLINEPHOSPHOTRANSFERASE use DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE %28%NM%29% 1987-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE use PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994%28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994%28%1980%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994%28%1992%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994,1963-1977 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994,1963-1977; see POLYMYXIN 1994-2003; see POLYMYXINS 1978-93; see POLYMYXIN 1963-77%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-01-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-02-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-02-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-03-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-03-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-04-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-04-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-04-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-04-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-04-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-05-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-05-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-05-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-05-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-06-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-07-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-07-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-07-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-07-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-09-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-10-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-10-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-11-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994-12-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; ANTIPORTERS was indexed under CARRIER PROTEINS 1980-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; GELSOLIN was indexed under CALCIUM-BINDING PROTEINS and MICROFILAMENT PROTEINS 1980-1993; SERUM ACTIN IHIBITORY PROTEIN was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1986-1987%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-1993; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; PROTEIN KINASE G was indexed under PROTEIN KINASES 1999-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; THROMBIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993; TRAP PEPTIDE was indexed under PROTEINS 2000-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for ARRHENOBLASTOMA see ARRHENOBLASTOMA 1966-1994, see ANDROBLASTOMA 1994-2004; for ANDROBLASTOMA see ANDROBLASTOMA 1994-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for ARRHENOBLASTOMA use ARRHENOBLASTOMA 1966-1994, use ANDROBLASTOMA 1994-2004; for ANDROBLASTOMA use ANDROBLASTOMA 1994-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for CHANGUINOLA VIRUS see REOVIRIDAE 1976-1993; for CHENUDA VIRUS see KEMEROVO VIRUS 1994-2001, see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS see KEMEROVO VIRUS 1994-2001, see KEMEROVO GROUP VIRUSES 1979-1993, REOVIRIDAE 1981-1990, see REOVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for CHANGUINOLA VIRUS use REOVIRIDAE 1976-1993; for CHENUDA VIRUS see REOVIRIDAE 1976-1993; for KEMEROVO VIRUS, REOVIRIDAE 1981-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for CYSTOVIRUS see BACTERIOPHAGE PHI 6 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for CYSTOVIRUS use BACTERIOPHAGE PHI 6 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for INDIGENT CARE see MEDICAL INDIGENCY 1968-1999, see INDIGENT CARE 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for INDIGENT CARE use MEDICAL INDIGENCY 1968-1999, use INDIGENT CARE 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for NORIT see CARBON 1982-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for NORIT use CARBON 1982-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for PHAGE MU 2 see RNA PHAGES 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for PHAGE MU 2 use RNA PHAGES 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; for PROTEIN KINASE G use CYCLIC GMP-DEPENDENT PROTEIN KINASES %28%NM%29% 1999-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see ADENOVIRUSES, AVIAN 1990-93, see ADENOVIRIDAE 1981-1990, see ADENOVIRUSES 1977-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see CALICIVIRIDAE 1993; for SAN MIGUEL SEA LION VIRUSES use CALICIVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see CHOLINEPHOSPHOTRANSFERASE 1975-93; 1-ALKYL-2-ACETYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE was indexed under DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE 1994-1999; for PHOSPHORYLCHOLINE-GLYCERIDE TRANSFERASE see PHOSPHORYLCHOLINE GLYCERIDE TRANSFERASE 1976-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see FOOT-AND-MOUTH DISEASE VIRUS 1963-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see ION PUMP 1992-1993; for ION PUMP see BIOLOGICAL TRANSPORT, ACTIVE 1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see NAD NUCLEOSIDASE 1975-1993; NAD%28%P%29% NUCLEOSIDASE was indexed under N-GLYCOSYL HYDROLASES 1982-2002, NAD 1973-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see NEOPLASMS, EMBRYONAL AND MIXED 1963-1993; for GERM CELL TUMOR see GERMINOMA 1994-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see PARVOVIRIDAE 1992-1993; for LATENT RAT VIRUS see LATENT RAT VIRUS 1991-2001, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980; for PARVOVIRUS, RACCOON see PARVIRUSES, FELINE 1994-2001; for MINK ENTERITIS VIRUS see PARVOVIRUS, FELINE 1994-2001; for INFECTIOUS ENTERITIS VIRUS OF MINK see PARVOVIRUS, FELINE 1994-2001, see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see PERIPHERAL NERVE DISEASES 1963-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see TECHNETIUM TC 99M PERTECHNETATE 1985-1993; TECHNETIUM TC 99M O%28%4%29% was indexed under TECHNETIUM COMPOUNDS 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; see THECA CELL TUMOR 1981-93; for LUTEINOMA see THECA CELL TUMOR 1981-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; use ANTIPORTERS %28%NM%29% 1980-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; use CALICIVIRIDAE 1993; for SAN MIGUEL SEA LION VIRUSES use CALICIVIRIDAE 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; use PARVOVIRIDAE 1992-1993; for LATENT RAT VIRUS use LATENT RAT VIRUS 1975-1993; for PARVOVIRUS, RACCOON use PARVIRUSES, FELINE 1994-2001; for MINK ENTERITIS VIRUS use PARVOVIRUS, FELINE 1994-2001; for INFECTIOUS ENTERITIS VIRUS OF MINK use PARVOVIRUS, FELINE 1976-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; use TECHNETIUM TC 99M PERTECHNETATE 1985-1993; for TECHNETIUM TC 99M O%28%4%29% use TECHNETIUM TC 99M O%28%4%29% %28%NM%29% 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; use THECOMA 1981-93; for LUTEINOMA use THECOMA 1981-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; use THROMBIN RECEPTOR %28%NM%29% 1981-1993; for TRAP PEPTIDE use RECEPTORS, THROMBIN %28%NM%29% 2000-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1994; was SUPEROXIDE 1975-1993 %28%see under OXYGEN 1975-1983%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995 %28%1977%29%; for NEUROPATHIA EPIDEMICA use HANTAVIRUS INFECTIONS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995%28%1984%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995, 1963-1985; use TREES 1986-1994; for JUNIPERUS OXYCEDRUS use JUNIPERUS OXYCEDRUS %28%NM%29% 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-01-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-02-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-02-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-02-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-02-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-03-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-03-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-03-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-03-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-03-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-05-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-06-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-07-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995-07-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; VEGETATIVE STATE was see COMA 1980-1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; for HYPOKINESIA use IMMOBILIZATION 1992-1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; for KINESIA use IMMOBILIZATION 1992-1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; for SELECTION FOR TREATMENT see HEALTH CARE RATIONING 1991-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; for SELECTION FOR TREATMENT use HEALTH CARE RATIONING 1991-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; see COELENTERATA 1963-1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; see HEMORRHAGIC FEVER, EPIDEMIC 1977-1994, see HEMORRHAGIC FEVERS, VIRAL 1966-1976; for NEUROPATHIA EPIDEMICA see HANTAVIRUS INFECTIONS 1994-2001; for EPIDEMIC HEMORRHAGIC FEVER see EPIDEMIC HEMORRHAGIC FEVER 1963-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; see SUBDURAL EMPYEMA 1984-94; for EMPYEMA, SUBDURAL see SUBDURAL EMPYEMA 1984-94%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; see TREES 1986-1994, see JUNIPERUS 1963-1985; JUNIPERUS OXYCEDRUS was indexed under ALLERGENS 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; was ENCEPHALITIS, POST-VACCINAL 1963-94 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1995; was see CLINICAL TRIALS 1980-1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996%28%1987%29%; use INTEGRIN ALPHAIIBBETA3 %28%NM%29% 1992-1995 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-02-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-03-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-03-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-06-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996-09-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; CD36 ANTIGEN was indexed under ANTIGENS, CD 1990-1995 %26% ANTIGENS, DIFFERENTIATION 1989-1991; CD36 ANTIGEN %28%COLLAGEN TYPE I RECEPTOR, THROMBSPONDIN RECEPTOR%29% was indexed under ANTIGENS, CD36 2004; ORGANIC ANION TRANSPORTERS 1996-2004 %26% under MEMBRANE GLYCOPROTEINS 1996-2004; SCAVENGER RECEPTORS, CLASS B, TYPE I was indexed under RECEPTORS, IMMUNOLOGIC 2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; CD59 ANTIGEN was indexed under ANTIGENS, CD 1990-1995; MEMBRANE GLYCOPROTEINS 1989-1995; %26% ANTIGENS, DIFFERENTIATION 1989-1991; MEMBRANE ATTACK COMPLEX INHIBITION FACTOR %28%now ANTIGENS, CD59%29% was indexed under PROTEINS 1992-1997 %26% BLOOD PROTEINS 1990-1991; PROTECTIN was indexed under ION CHANNELS 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; FAS ANTIGEN %28%now ANTIGENS, CD95%29% was indexed under ANTIGENS, SURFACE 1989-1995; FAS RECEPTOR was indexed under RECEPTORS, TUMOR NECROSIS FACTOR 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; for MYOSIN HEAVY CHAIN see MYOSINS 1982-1995 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; for MYOSIN HEAVY CHAIN use MYOSINS 1982-1995 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; for MYOSIN LIGHT CHAIN see MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS see MYOSINS 1990-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; for MYOSIN LIGHT CHAIN use MYOSINS 1982-1995; for MYOSIN ALKALI LIGHT CHAINS use MYOSINS 1990-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; see BLOODLETTING 1987-1995; VENESECTION see BLOODLETTING 1987-1995; VENIPUNCTURE see BLOODLETTING 1989-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; see FMN 1966-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; see GAMMA GLOBULINS 1975-1995, see GAMMA GLOBULIN 1963-1974; /deficiency see GAMMA GLOBULIN DEFICIENCY see AGAMMAGLOBULINEMIA 1963-1967%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; see PLATELET MEMBRANE GLYCOPROTEINS 1987-95; INTEGRIN ALPHAIIBBETA3 was indexed under INTEGRINS 1992-95%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; use ANTIGENS, CD95 %28%NM%29% 1989-1995; for FAS RECEPTOR use ANTIGENS, CD95 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; use BLOODLETTING 1987-1995; VENESECTION use BLOODLETTING 1987-1995; VENIPUNCTURE use BLOODLETTING 1989-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1996; use CD59 ANTIGEN %28%NM%29% 1989-1995, for PROTECTIN use CATIONIC PROTEIN, URATE-CALCIUM OXALATE STONE %28%NM%29% 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997 %28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997%28%1985%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997%28%1994%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-01-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-06-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-06-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-06-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-06-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-06-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-07-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997-09-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; NAD%28%P%29%H OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 2000-2005; NADPH OXIDASE was indexed under NADH, NADPH OXIDOREDUCTASES 1979-1996, NADP 1972-1980 %26% OXIDOREDUCTASES 1972-1978;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; CURRENT BIOG-OBIT was Publication Type 1991-1996, was Citation Type 1966-1990; HISTORICAL BIOGRAPHY was Publication Type 1991-1996, was Citation Type 1966-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; see ARGININE CARBOXYPEPTIDASE 1991-1996, see CARBOXYPEPTIDASES 1975-1990; for KININASE I see CARBOXYPEPTIDASES 1975-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; see ENDOTHELINS 1991-1996; BIG ENDOTHELIN 3 was indexed under ENDOTHELINS %26% PROTEIN PRECURSORS 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; see G-PROTEINS 1985-1996; for G-PROTEINS see G-PROTEINS 1992-1999; for GUANINE NUCLEOTIDE REGULATORY PROTEINS see G-PROTEINS 1992-1996; for GTP-REGULATORY PROTEINS see G-PROTEINS 1985-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; see GEMINIVIRUS 1994-96 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; see ORTHOMYXOVIRUSES TYPE A 1977-1996; for ORTHOMYXOVIRUS TYPE A, HUMAN see INFLUENZA A VIRUS, HUMAN 1997-2005; for MYXOVIRUS INFLUENZAE-A HOMINIS see INFLUENZA A VIRUS 1974-2005; for ORTHOMYXOVIRUS TYPE A, AVIAN see INFLUENZA A VIRUS, AVIAN 1997-2005; for ORTHOMYXOVIRUS TYPE A, PORCINE see INFLUENZA A VIRUS, PORCINE 1995-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; see SEX BEHAVIOR 1978-1996 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; use ENDOTHELINS 1991-1996; for BIG ENDOTHELIN 3 use ENDOTHELIN-3 %28%NM%29% 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; use SEX BEHAVIOR 1978-1996 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1997; was ENCEPHALOMYELITIS, NECROTIZING HEMORRHAGIC 1991-1996 %28%see under ENCEPHALOMYELITIS 1972-1990%29%; HURST DISEASE was HURST%27%S DISEASE 1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998 %28%1967%29%; for ANIMAL ORGANS use ANIMALS 1986-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998 %28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998 %28%1986%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998%28%1963%29%; for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998%28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998%28%1985%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998%28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998%28%1994%29%; use CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE %28%NM%29% 1990-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-10' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-11' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-06-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-07-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998-09-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; 15-HYDROXY-11 ALPHA,9 ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID was indexed under PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1978-97 %26% THROMBOXANE A2/analogs %26% derivatives 1983-97; %28%15S%29%HYDROXY-9ALPHA,11ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID and 9,11-EPOXYMETHANO-PGH2 were indexed under PROSTAGLANDINS H 1993-2003 %26% PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; CHROMIUM ADENOSINE TRIPHOSPHATE was indexed under ADENOSINE TRIPHSOPHATE 1974-1997 and CHROMIUM 1974-1982; MANGANESE ATP was indexed under ADENOSINE TRIPHOSPHATE 1981-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; DATABASES was see INFORMATION SYSTEMS 1994-1996; for DATABANKS see DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; DATABASES was see INFORMATION SYSTEMS 1994-1996; for DATABANKS use DATABASES, FACTUAL 1991-2001; DATA BANKS was see INFORMATION SYSTEMS 1982-90%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; MIOCHOL %28%now ACETYLCHOLINE%29% was indexed under ACETYLCHOLINE %26% MANNITOL 1981-97; CHLOROACETYLCHOLINE was indexed under ACETYLCHOLINE 1975-2000 %26% under CHLORINE 1974-1975; BROMOACETYLCHOLINE was indexed under ACETYLCHOLINE/analogs %26% derivatives 1974-2000 %26% ACETYLCHOLINE 1969-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; NUCLEAR LOCALIZATION SIGNAL PEPTIDE was indexed under NUCLEAR PROTEINS 1990-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%ATP%29% was indexed under PHOSPHOENOLPYRUVATE CARBOXYKINASES 1994-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; PROTO-ONCOGENE PROTEIN MIL %28%now PROTO-ONCOGENE PROTEINS C-RAF%29% was indexed under PROTEIN-SERINE-THEONINE KINASES 1993-1997 %26% PROTO-ONCOGENE PROTEINS 1986-1997; CRAF1 KINASE was indexed under PROTO-ONCOGENE PROTEINS C-RAF 1993-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; TISSUE INHIBITOR OF METALLOPROTEINASE 2 was indexed under PROTEINS 1990-97 %26% NEOPLASM PROTEINS 1989-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; TISSUE INHIBITOR OF METALLOPROTEINASE 3 was indexed under PROTEINS 1995-97 %26% NEOPLASM PROTEINS 1992-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for ANIMAL ORGANS see ANIMAL 1986-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for CHROMIUM ADENOSINE TRIPHOSPHATE use ADENOSINE TRIPHOSPHATE %28%NM%29% 1974-1997; for MANGANESE ATP use ADENOSINE TRIPHOSPHATE %28%NM%29% 1981-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for DORONICUM see ARNICA 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for DORONICUM use ARNICA 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for HEMIC SYSTEM see BLOOD 1995-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for IMMUNOMODULATORS see ADJUVANTS, IMMUNOLOGIC 1980-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for IMMUNOMODULATORS use ADJUVANTS, IMMUNOLOGIC 1980-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for MELONS see CUCUMIS 2002-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for MELONS use CUCUMIS 2002-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for METHANOBACTERIA see METHANOGENS 1979-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for MIOCHOL use ACETYLCHOLINE %28%NM%29% 1981-1997; for CHLOROACETYLCHOLINE use ACETYLCHOLINE %28%NM%29% 1969-2000; for BROMOACETYLCHOLINE use ACETYLCHOLINE %28%NM%29% 1969-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for NEUROTRANSMITTERS see NEUROTRANSMITTERS 1968-2005; NEUROTRANSMITTERS was NEUROREGULATORS 1980-94, was NEUROHUMORS 1968-79, NEUROREGULATORS 1977-94%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; for NUCLEAR LOCALIZATION SIGNAL PEPTIDE use NUCLEAR LOCALIZATION SIGNAL %28%NM%29% 1990-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see ALZHEIMER%27%S DISEASE 1984-1997, see DEMENTIA, PRESENILE 1967-1983, see PSYCHOSES, PRESENILE 1963-1966; for DEMENTIA PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE, SENILE see DEMENTIA 1981-1999; for DEMENTIA, SENILE see DEMENTIA 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997 %26% PROTEIN KINASES 1990-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see CHIMPANZEE TROGLODYTES 1981-1997 %26% CHIMPANZEES 1972-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see CO-DEPENDENCY %28%PSYCHOLOGY%29% 1992-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see COMMUNICATIVE DISORDERS 1985-97 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see PROTEIN P16; CDK4-ASSOCIATED PROTEIN P16 was indexed under CARRIER PROTEINS 1994-1997; P16%28%INK4A%29% was indexed under CARRIER PROTEINS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see QUANTITATIVE TRAIT 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see REYE%27%S SYNDROME 1977-97 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see TISSUE INHIBITOR OF METALLOPROTEINASE-2 %28%NM%29% 1989-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see TISSUE INHIBITOR OF METALLOPROTEINASE-3 %28%NM%29% 1992-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; see Tic 1966-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use 15-HYDROXY-11 ALPHA,9 ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID %28%NM%29% 1977-1997; for %28%15S%29%HYDROXY-9ALPHA,11ALPHA-%28%EPOXYMETHANO%29%PROSTA-5,13-DIENOIC ACID and 9,11-EPOXYMETHANO-PGH2 use PROSTAGLANDIN H2 %28%NM%29% 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use PHOSPHOENOLPYRUVATE CARBOXYKINASE %28%ATP%29% %28%NM%29% 1994-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use explode ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use explode 1970-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use explode 1970-97 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use explode 1971-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1998; use explode 1995-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999 %28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999%28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999, use BRAIN NATRIURETIC PEPTIDE %28%NM%29% 1988-1998; use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% for NATRIURETIC PEPTIDE TYPE-B 1994-2003; use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% for NESIRITIDE 2003; for VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE use NATRIURETIC PEPTIDE, BRAIN %28%NM%29% 1994-2003.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-04' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-11-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-16' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999-12-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; BRAIN NATRIURETIC PEPTIDE was indexed under NERVE TISSUE PROTEINS 1988-1998; NATRIURETIC PEPTIDE TYPE-B was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003; NESIRITIDE was indexed under NATRIURETIC HORMONE 2003; VENTRICULAR NATRIURETIC PEPTIDE, B-TYPE was indexed under ATRIAL NATRIURETIC FACTOR 1994-2003.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; MEETING REPORT %28%PT%29% was Publication Type 1995-1998; CONGRESS %28%PT%29% was Publication Type 1991-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; for PIROMONAS see NEOCALLIMASTICALES 1999-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; for PIROMONAS use NEOCALLIMASTICALES 1999-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; see AUTISM INFANTILE 1981-1998; see AUTISM, EARLY INFANTILE 1971-1980; see SCHIZOPHRENIA, CHILDHOOD 1968-1970; AUTISM was heading 1966-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; see DTPA 1966-1998; for PENTETIC ACID see DTPA 1966-1998; CALCIUM TRISODIUM PENTETATE was indexed under ORGANOMETALLIC COMPOUNDS and GLYCINE 1998-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; see GLYCERALDEHYDEPHOSPHATE DEHYDROGENASE 1965-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; see PEDICULOSIS 1966-1998; for LICE INFESTATIONS see PEDICULOSIS 1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; see PHOTOTROPHIC BACTERIA or specifics %26% CHROMATOPHORES 1966-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; see PROPERDIN FACTOR D 1991-1998, see COMPLEMENT ACTIVATING ENZYMES 1978-1990; ADIPSIN was indexed under SERINE ENDOPEPTIDASES 1987-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; use INFORMED CONSENT for SPOUSAL CONSENT 1979-1998 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; was Abstract %28%Publication Type%29% 1991-1998 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1999; was Legal Brief %28%Publication Type%29% 1991-1998 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19S Gamma Globulin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19th Cent. Histories %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19th Cent. History %28%Medicine%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19th Cent. History of Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19th Cent. Medicine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19th Century Histories' = 0).
% 42.05/41.92 fof(interp, fi_functors, '19th Century History' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Bromazepam' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Felodipine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Flunitrazepam' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Flutamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Gemfibrozil' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Moclobemide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Molsidomine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Nitrendipine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Brand of Roxithromycin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Pharma, Nitren' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Receptor, 5-Hydroxytryptamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Receptor, Serotonin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1A Receptors, 5-Hydroxytryptamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1B Receptor, 5-Hydroxytryptamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1B Receptor, Serotonin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1B Receptors, 5-Hydroxytryptamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1Dbeta Receptor, Serotonin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1Dbeta Receptors, Serotonin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1H-2-Benzopyran-1-ones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1H-Indol-3-ol Hydrogen Sulfate Ester' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1st World War' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1st World Wars' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1st cranial nerve = OLFACTORY NERVE, 2d = OPTIC NERVE, 3d = OCULOMOTOR NERVE, 4th = TROCHLEAR NERVE, 5th = TRIGEMINAL NERVE, 6th = ABDUCENS NERVE, 7th = FACIAL NERVE, 8th = VESTIBULOCOCHLEAR NERVE, 9th = GLOSSOPHARYNGEAL NERVE, 10th = VAGUS NERVE, 11th = ACCESSORY NERVE, 12th = HYPOGLOSSAL NERVE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1st phase = PROPHASE, 2d phase = METAPHASE, 3d phase = ANAPHASE, final phase = TELOPHASE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '1st planet from sun with no moons; no qualif ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 2EtN 2MePhAcN' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 5 DOM' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 5A Synthetase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 AMS Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetamido 2 D galactopyranose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetamido 2 Deoxy D Galactose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetamido 2 Deoxy D Glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetamido 2 Deoxygalactose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetamido 2 Deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetamidofluorene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetohydroxy 3 Ketoacid Isomeroreductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetolactate Mutase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Acetylaminofluorene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Ala 4 MePhe 5 Gly Enkephalin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Alanyl Leucine Enkephalin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 2 Deoxy D Glucose 6 Phosphate Ketol Isomerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 2 Deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 5 phosphonopentanoate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 5 phosphonopentanoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 5 phosphonovalerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 5 phosphonovaleric Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino 6 trifluoromethoxybenzothiazole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Amino N Ribosylacetamide 5%27% Phosphate Transformylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoadipate 2 Oxoglutarate Aminotransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoadipate Aminotransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoadipate Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoadipate Transaminase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoadipic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethanethiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylisothiuronium Bromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylisothiuronium Diacetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylisothiuronium Dihydrochloride' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylisothiuronium Dihydroiodide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylisothiuronium Diperchlorate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylisothiuronium Monohydrobromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminoethylphosphonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminohexanedioic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminomuconic 6 Semialdehyde Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminonaphthalene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Aminopurine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Bromo alpha ergocryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Bromo alpha ergokryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Bromoergocryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Bromoergocryptine Mesylate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Bromoergocryptine Methanesulfonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Bromoergokryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Butenoic Acids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chlorethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chloro 1 phenylethanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chloroacetophenone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chloroadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chlorobenzylidene Malonitrile' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chlorobenzylidenemalonitrile' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Chloroethyl Alcohol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Cyanobutylacrylate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 D Doppler Echocardiography' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 D Echocardiography' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 D Gel Electrophoresis' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 D Polyacrylamide Gel Electrophoresis' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Dehydro 3 Deoxyphosphoheptonate Aldolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Deoxy D glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Deoxyribose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Desoxy D glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Ethyl 2 Phenylmalonamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Fluorenylacetamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Fluoro 2 deoxy D glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Fluoro 2 deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Hexanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Hydroxy 5 nitrobenzyl Bromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Hydroxybenzoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Hydroxyethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Hydroxyphenethylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Inhibitors, Cyclooxygenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Isopropyl 4 Pentenamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Isopropylmalate Synthase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Keto 4 Hydroxyglutarate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Mercaptoethanesulfonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Mercaptoethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Mercaptoimidazoline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Mercaptopropionylglycine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Methyl 4 chlorophenoxyacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Methyl 5 nitroimidazole 1 ethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Naphthylamide, Benzoylarginine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Naphthylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Neurofibromatoses, Type' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Neurofibromatosis, Type' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Nicotinamidethyl Nitrate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Nicotinamidoethyl Nitrate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Oxazolidone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Oxo Acid Carboxy Lyase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Oxoglutarate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Oxoglutarate Dehydrogenase Complex' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Oxoisocaproate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Oxoisovalerate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 PAM Compounds' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenethylhydrazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenyl 1,3 indandione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenyl 3 Hydroxy Benzopyran 4 Ones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenyl Benzopyran 4 Ones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenyl Benzopyrans' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenyl Chromenes' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenylethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phenylethanolamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Phospho D Glycerate Hydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Propenal' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Propylpentanoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Thiol L histidine betaine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Thiol propionamido acetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 Thiolpropionamidoacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 alpha-Cyano-17 beta-hydroxy-4,4%27%,17 alpha-trimethylandrost-5-ene-3-one. An androstenolone-nitrile compound with steroidogenesis-blocking activity.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 amino 4 mercaptobutyric acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 hydroxy 1,2 diphenylethanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 or more neopl, histologically different, at same or different sites occurring simultaneously: do not confuse with NEOPLASMS, SECOND PRIMARY %28%a neopl following an earlier neopl but not its metastasis%29%; coord with each specific histol type %28%IM%29% %26% each precoord organ/neopl term %28%IM%29%; do not use /compl with specific multiple neopl terms to show multiplicity; differentiate from NEOPLASM METASTASIS %26% NEOPLASM RECURRENCE, LOCAL: Manual 24.4.1.5, 24.4.1.6; MULTIPLE ENDOCRINE NEOPLASIA %26% its specifics are also available; DF: NEOPL MULTIPLE PRIMARY%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2 oxazolidinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27% CMP' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27% Deoxycoformycin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27% Deoxythymidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27% P ADPR Cyclase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27% Phospho adenosine Diphosphate Ribose Cyclase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Cyclic Nucleotide Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Cyclic Nucleotide Phosphodiesterases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Didehydro 3%27% deoxythymidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Dideoxy 3%27% thiacytidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Dideoxyadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Dideoxycytidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Dideoxyinosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27% Dideoxynucleosides' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Cyclic Nucleotide Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Cyclic Nucleotide Phosphodiesterases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Cyclic-Nucleotide Phosphodiesterases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Didehydro-2%27%,3%27%-dideoxythmidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Didehydro-3%27%-deoxythymidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Dideoxy-3%27%-thiacytidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Dideoxyadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Dideoxycytidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,3%27%-Dideoxyinosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,4%27%,5%27%,7%27%-Tetraiodofluorescein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,5%27% Oligoadenylate Polymerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,5%27% Oligoadenylate Synthetase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,5%27%-Oligo%28%A%29% Polymerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,5%27%-Oligo%28%A%29% Synthetase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,5%27%-Oligoadenylate Polymerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%,5%27%-Oligoadenylate Synthetase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%-Deoxy-2-chloroadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%-Deoxycoformycin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2%27%-Phospho-adenosine Diphosphate Ribose Cyclase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2, C-EBP-Related Protein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2, Complement Receptor' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2, Complement Receptors' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2, Gap Phase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2, Kallikrein' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2, Neurofibromatosis Type' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2 Bipyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2 Bipyridyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2 Dipyridyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2%27% Bipyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2%27% Dipyridyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2%27% Dithiobisethanamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2%27%-Bipyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2%27%-Dipyridyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2%27%-Dithiobisethanamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2,2-Trifluoroethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2,6,6-Tetramethyl-4-oxopiperidine-1-oxyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2-Bipyridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2-Bipyridyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2-Dihydroxy-1H-indene-1,3-%28%2H%29%-dione. Reagent toxic to skin and mucus membranes. It is used in chemical assay for peptide bonds, i.e., protein determinations and has radiosensitizing properties.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,2-Dipyridyl' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Bisphosphoglycerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Butanedione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Cyclic Nucleotide Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Cyclic Nucleotide Phosphodiesterases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Diaminopropiophenone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Diketogulonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dimercapto 1 propanesulfonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dimercaptopropane 1 Sodium Sulfonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dimercaptopropane 1 sulfonate Sodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dimercaptopropanesulfonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dimercaptopropanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dimercaptosuccinic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dioxoindoline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Diphosphoglycerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Diphosphoglyceric Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3 Dithiopropan 1 o1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3,5,6-Tetrachloro-1,4-benzoquinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3,5-Tris%28%ethyleneimine%29%benzoquinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3,7,8-Tetrachlorodibenzo-p-dioxin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Bisphosphate, Glycerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Bisphosphoglycerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Butanedione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Cyclic Nucleotide Phosphodiesterase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Cyclic Nucleotide Phosphodiesterases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-DPG' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Diaminopropiophenone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Diketogulonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercapto-1-propanesulfonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptopropane 1-Sodium Sulfonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptopropane Sulfonate, Sodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptopropane-1-sulfonate Sodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptopropanesulfonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptopropanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptopropanol, Cadmium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dimercaptosuccinic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dioxoindoline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dioxygenase, 3-Sulfocatechol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dioxygenase, Catechol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dioxygenase, Tryptophan' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Diphosphoglycerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dithiopropan-1-o1' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Dithiopropanesulfate, Sodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,3-Epoxy-4-oxo-7,10-dodecadienoylamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4 Dichlorophenoxyacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4 Dinitrophenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4 Toluenediisocyanate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4,5-T' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4,5-Trichlorophenoxyacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4,6-Triethylimino-1,3,5-Triazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4,6-Trinitro-1-chlorobenzene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4-D' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4-DNP' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4-Dichlorophenoxyacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4-Diisocyanate, Toluene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4-Dinitrophenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,4-Toluenediisocyanate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Diamino 7 ethoxyacridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Diaminopentanoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Dibromo 3 methyl 6 isopropyl p benzoquinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Dihydroxybenzenesulfonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Dihydroxybenzenesulfonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Dihydroxybenzoic Acids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Dimethoxy 4 Methylamphetamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Furandiones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Oligoadenylate Polymerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5 Oligoadenylate Synthetase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5,9-Trimethyl-7H-furo%28%3,2-g%29%benzopyran-7-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5-Diamino-7-ethoxyacridine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5-Diaminopentanoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5-Dibromo-3-methyl-6-isopropyl-p-benzoquinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5-Dihydroxybenzoic Acids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5-Dimethoxy-4-Methylamphetamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,5-Furandiones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Di t butyl 4 methylphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Di tert butyl p cresol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Dichlorobenzenoneindophenol Dye' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Dichlorobenzylideneaminoguanidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Dichloroindophenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Dichlorophenolindophenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6 Diisopropylphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6,8-Trihydroxypurine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Bis%28%1,1-dimethylethyl%29%-4-methylphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Bis%28%1-methylethyl%29%phenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Di-t-butyl-4-methylphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Di-tert-butyl-p-cresol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Dichlorobenzenoneindophenol Dye' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Dichlorobenzylideneaminoguanidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Dichloroindophenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Dichloroindophenol, Sodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Dichlorophenolindophenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Diisopropylphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,6-Pyridinedimethanol-bis-%28%N-methylcarbamate%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,7,9-Tricarboxy-1H-Pyrrolo-%28%2,3-f%29%Quinoline-4,5-Dione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2,7,9-Tricarboxypyrroloquinoline Quinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%%28%Cyclohexylhydroxyphenylacetyl%29%oxy%29%-N,N-diethyl-N-methylethanaminium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%%28%Diethoxyphosphinyl%29%thio%29%-N,N,N,-trimethylethanaminium iodide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%1-Piperazinyl%29%quinoline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%2,2-Dicyclohexylethyl%29%piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%2-%28%1-%28%4-Chlorophenyl%29%-1-phenylethoxy%29%ethyl%29%-1-methylpyrrolidine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%2-%28%4-%28%%28%4-Chlorophenyl%29%phenylmethyl%29%-1-piperazinyl%29%ethoxy%29%ethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%2-Chlorophenyl%29%-2-%28%methylamino%29%cyclohexanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%3-Benzoylphenyl%29%propionic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%4%27%-Thiazolyl%29%Benzimidazole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%4-Amino-4-carboxybutyl%29%-1-%28%5-amino-5-carboxypentyl%29%-3,5-bis%28%3-amino-3-carboxypropyl%29%pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%4-Chlorophenoxy%29%-2-methylpropionic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%Acetyloxy%29%-N,N,N-trimethyl-1-propanaminium Chloride' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%Acetyloxy%29%-N,N,N-trimethylethanaminium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%Acetyloxy%29%benzoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%Diethylamino%29%-N-%28%2,6-Dimethylphenyl%29%Acetamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%Ethylamino%29%-2-%28%2-thienyl%29%cyclohexanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-%28%Ethylpropylamino%29%-2%27%,6%27%-butyroxylidide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative %28%NIACIN%29% is active as a vitamin.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-12 amino acids %28%includes DIPEPTIDES, tripeptides, tetrapeptides, pentapeptides, etc.%29%; GEN; prefer specifics; conformation: coord OLIGOPEPTIDES or specific peptide %28%IM%29% + PROTEIN CONFORMATION %28%NIM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-12 nucleotides ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-2EtN-2MePhAcN' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-3-yr program in hosp school of nurs; DF: EDUC NURS DIPLOMA PROGRAMS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-5A Synthetase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-AAF' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-AMS Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-APV' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamido-2-D-galactopyranose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamido-2-Deoxy-D-Galactose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamido-2-Deoxy-D-Glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamido-2-Deoxygalactose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamido-2-Deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamido-2-deoxy-beta-D-glucoside acetamidodeoxygluco-hydrolase. Catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as mucolipidosis and various inflammatory disorders of muscle and connective tissue.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetamidofluorene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetohydroxy-3-Ketoacid Isomeroreductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetolactate Mutase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetylaminofluorene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Acetylhydrolase, PAF' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Ala-4-MePhe-5-Gly-Enkephalin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Alanyl-Leucine Enkephalin' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-1,5-dihydro-4,6-pteridinedione. Pigment first discovered in butterfly wings and widely distributed in plants and animals.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-2-Deoxy-D-Glucose-6-Phosphate Ketol-Isomerase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-2-Deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-4-%28%ethylthio%29%butyric acid. An antimetabolite and methionine antagonist that interferes with amino acid incorporation into proteins and with cellular ATP utilization. It also produces liver neoplasms.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-4-Pentenoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-5-phosphonopentanoate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-5-phosphonopentanoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-5-phosphonovalerate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-5-phosphonovaleric Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-6-%28%1,2,3-trihydroxypropyl%29%-4%28%3H%29%-pteridinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-6-%28%1,2-dihydroxypropyl%29%-4%28%1H%29%-pteridinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-6-trifluoromethoxybenzothiazole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Amino-N-Ribosylacetamide 5%27%-Phosphate Transformylase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoadipate Aminotransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoadipate Reductase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoadipate Transaminase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoadipate-2-Oxoglutarate Aminotransferase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoadipic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethanethiol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Bromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Diacetate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Dihydrochloride' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Dihydroiodide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Diperchlorate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Monohydrobromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Phosphate %28%1:1%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylisothiuronium Sulfate %28%1:1%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminoethylphosphonic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminohexanedioic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminomuconic 6-Semialdehyde Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminonaphthalene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Aminopurine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Bromo-alpha-ergocryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Bromo-alpha-ergokryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Bromoergocryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Bromoergocryptine Methanesulfonate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Bromoergokryptine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Butenoic Acids' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Butyl-4-chloro-1-%28%%28%2%27%-%28%1H-etrazol-5-yl%29% %28%1,1%27%-biphenyl%29%-4-yl%29%methyl%29%-1H-imidazole-5-methanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chlorethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloro-1-phenylethanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloro-11-%28%1-piperazinyl%29%dibenz%28%b,f%29%%28%1,4%29%oxazepine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloro-11-%28%4-methyl-1-piperazinyl%29%-dibenz%28%b,f%29%%28%1,4%29%oxazepine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloro-2%27%-deoxyadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloroacetophenone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloroadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloroadenosine/analogs %26% derivatives %28%1986-1992%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chlorobenzylidene Malonitrile' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chlorobenzylidenemalonitrile' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chlorodeoxyadenosine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Chloroethyl Alcohol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Cyanobutylacrylate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-D Doppler Echocardiography' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-D Echocardiography' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-D Gel Electrophoresis' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-D Immunoelectrophoresis' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-D Polyacrylamide Gel Electrophoresis' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Dehydro-3-Deoxyphosphoheptonate Aldolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Dehydrogenase, L-Iditol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Deoxy-2-%28%%28%methylnitrosoamino%29%carbonyl%29%amino-D-glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Deoxy-D-glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Deoxyribose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Desoxy-D-glucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Diethylaminopropiophenone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Diphenylmethoxy-N,N-dimethylethylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Ethyl-2-Phenylmalonamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Fluorenylacetamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Fluoro-2-deoxyglucose' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Fluoro-alpha-methyl-%28%1,1%27%-biphenyl%29%-4-acetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hexanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxy-2%27%,4,4%27%-trichlorodiphenyl Ether' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxy-5-nitrobenzyl Bromide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxy-Anisole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxy-N,N,N-trimethylethanaminium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxyanisole' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxybenzoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxyethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxylase, Imipramine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Hydroxyphenethylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Isopropyl-4-Pentenamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Isopropylmalate Synthase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Keto-4-Hydroxyglutarate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-ME' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Mercaptoethanesulphonate, Sodium' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Mercaptoethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Mercaptoimidazoline' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Mercaptopropionylglycine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methoxy-Phenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methoxyphenol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methyl-1,4-naphthalenedione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methyl-1,4-naphthoquinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methyl-4-chlorophenoxyacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methyl-5-nitroimidazole-1-ethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methylacetoacetyl CoA Thiolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Methylnaphthoquinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Microglobulin, beta' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Naphthylamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Nicotinamidethyl Nitrate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Nicotinamidoethyl Nitrate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins.%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxazolidone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxidoreductase, 3-Phosphoglycerate-NAD+' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxo Acid Carboxy-Lyase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoglutarate 6-Aminotransferase, Lysine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoglutarate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoglutarate Dehydrogenase Complex' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoglutarate Dioxygenase gamma-Butyrobetaine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoglutarate Dioxygenase, Lysine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoisocaproate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoisovalerate Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoisovalerate Dehydrogenase %28%Acylating%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Oxoisovalerate Dehydrogenase %28%Lipoamide%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-PAM Compounds' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenethylhydrazine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-1,3-indandione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-2-Ene-Benzopyran-4-One Compounds' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-3-Hydroxy-Benzopyran-4-Ones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-4-%28%ethoxymethylene%29%oxazol-5-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-Benzopyran-4-Ones' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-Benzopyrans' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenyl-Chromenes' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenylacetamides' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenylethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phenylethanolamine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Phospho-D-Glycerate Hydrolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Propanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Propenal' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Propenoic acid, 2-methyl-, %28%1-methylethylidene%29%bis%28%4,1-phenyleneoxy%28%2-hydroxy-3,1-propanediyl%29%%29% ester, homopolymer' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Propylpentanoic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Pyrrolidone-N-Acetamide' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Ring Heterocyclic Compounds' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Substituted benzimidazole first introduced in 1962. It is active against a variety of nematodes and is the drug of choice for strongyloidiasis. It has CNS side effects and hepatototoxic potential. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p919%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Thiol-L-histidine-betaine' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Thiol-propionamido-acetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Thiolpropionamidoacetic Acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-Transferrin, beta' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-amino-4-mercaptobutyric acid' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5%28%2H,4H%29%-dione' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-dimensional separation %26% anal of nucleotides ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-hydroxy-1,2-diphenylethanone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-oxazolidinone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-propylvalerate, 2-propylvaleric acid = VALPROATE ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-t-Butylamino-1-%28%4-hydroxy-3-hydroxy-3-hydroxymethyl%29%phenylethanol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2-yr community or junior college program; DF: EDUC NURS ASSOCIATE%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 Hydroxyecdysone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 Methylcholanthrene' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha Dihydroprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha HSD' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha Hydroxy 4 Pregnen 3 One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha-Dihydroprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha-Hydroxy-4-Pregnen-3-One' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha-Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 alpha-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 beta Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20 epi 1alpha,25 dihydroxycholecaliferol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20, Lannate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20, Polysorbate' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20, Tween' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20,22 Desmolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20,22-Desmolase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20,25 Diazacholesterol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20,25-Diazacholesterol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-Hydroxyecdysone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-Hydroxysteroid Dehydrogenases %28%1978-2003%29%' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-alpha-Dihydroprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-alpha-HSD' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-alpha-Hydroxyprogesterone' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-alpha-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-alpha-hydroxy- Pregn-4-en-3-one' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-beta-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.92 fof(interp, fi_functors, '20-carbon saturated monocarboxylic acids. ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000 %28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000 %28%1991%29%; see WALLENBERG%27%S SYNDROME 1991-1999, see CEREBRAL EMBOLISM AND THROMBOSIS 1964-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1963%29%; for UROKINASE-TYPE PLASMINOGEN ACTIVATOR use URINARY PLASMINOGEN ACTIVATOR %28%NM%29% 1984-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1964%29%; use HEADACHE 1975-1977 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1966%29%; for EPILEPSY, ABDOMINAL use EPILEPSY, TEMPORAL LOBE 1975-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1966%29%; for FRIEDREICH%27%S DISEASE use MYOCLONUS 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1966%29%; see AMYGDALOID BODY 1966-1996; for AMYGDALA see AMYGDALOID BODY 1979-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1966%29%; use explode 1971-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1967%29%; use TELECOMMUNICATIONS 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1969%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1970%29%; use CEREBELLAR ATAXIA 1970-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1971%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1974%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1975%29%; for PLASMOCOAGULASE use BATROXOBIN %28%NM%29% 1979-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1975%29%; use VESTIBULAR NUCLEI 1967-1974 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1977%29%; for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, INSULIN %28%NM%29% 1983-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1979%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1980%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1982%29%; use PEPTIDES 1977-1981; for UROGASTRONE use GASTROINTESTINAL HORMONES 1963-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1983%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1986%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1987%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1987%29%; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE use RECEPTOR, EPIDERMAL GROWTH FACTOR 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1988%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1989%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1989%29%; use NEUROPATHY, HEREDITARY SENSORY 1979-1988 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1989%29%; use PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1990%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1991%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1991%29%; use SLOW VIRUS DISEASES 1988-1990; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE was GERSTMANN-STRAUSSLER-SCHEINDER DISEASE see GERSTMANN-STRAUSSLER SYNDROME 1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1992%29% was EPILEPSY, MYOCLONUS 1977-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1992%29%; for MITOMYCIN use MITOMYCIN %28%NM%29% 1981-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1992%29%; see MITOMYCIN C 1992-1999; MITOMYCIN C was indexed under MITOMYCINS 1981-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1993%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1993%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1993%29%; use RECEPTOR, IGF TYPE 2 %28%NM%29% 1981-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1994%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1994%29%; see NEUROECTODERMAL TUMOR, PERIPHERAL 1994-1999; NEUROEPITHELIOMA was heading 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1995%29%; use RECEPTOR, ERBB-2 %28%NM%29% 1985-1994 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1996%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1996%29%; use PROTO-ONCOGENE PROTEIN c-KIT %28%NM%29% 1989-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1997%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1997%29%; use explode 1970-97 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1998%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000%28%1998%29%; use explode 1970-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000, Polyethylene Glycol' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-01-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-01-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-01-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-03-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-04-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-06-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-07-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-07-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-08-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000-08-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000: for STROKE and APOPLEXY use CEREBROVASCULAR DISORDERS 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000: see FACIAL PARALYSIS 1997-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; 1997-1999 was TECHNOLOGY, MEDICAL LABORATORY ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ACARBOSE was indexed under TRISACCHARIDES 1980-1999, CYCLOHEXANOLS 1979-1981, %26% POLYSACCHARIDES 1978-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ADP RIBOSYLATION FACTOR 1 %28%now ADP-RIBOSYLATION FACTOR 1%29% was indexed under G-PROTEINS 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ANGIOGENSIS FACTOR INHIBITORS was indexed under PROTEINS 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ARF PROTEIN COFACTOR %28%now ADP-RIBOSYLATION FACTORS%29% was indexed under G-PROTEINS 1984-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; BIOMEDICAL TECHNOLOGY use TECHNOLOGY, MEDICAL %28%1991-1999%29%; HEALTH CARE TECHNOLOGY %26% HEALTH TECHNOLOGY use TECHNOLOGY, MEDICAL %28%1998-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; BIOMEDICAL TECHNOLOGY was see TECHNOLOGY, MEDICAL %28%1991-1999%29%; HEALTH CARE TECHNOLOGY %26% HEALTH TECHNOLOGY see TECHNOLOGY, MEDICAL %28%1998-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; CALCIUM CHANNEL %28%T-TYPE%29% was indexed under CALCIUM CHANNELS 1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; CDC25 PROTEIN %28%now CDC25 PHOSPHATASE%29% was indexed under CELL CYCLE PROTEINS 1995-1999 %26% PHOSPHOPROTEIN PHOSPHATASES 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; CHAMOMILE was indexed under FLAVONES 1989-1999 %26% OILS, VOLATILE 1981-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; CILIARY NEUROTROPHIC FACTOR RECEPTOR %28%now RECEPTOR, CILIARY NEUROTROPHIC FACTOR%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1997-1999, RECEPTORS, GROWTH FACTOR 1993-1994, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; CILIARY NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; COATOMER PROTEIN %26% COATOMER SUBUNIT EPSILON-COP were indexed under MEMBRANE PROTEINS 1994-1999; RET1 PROTEIN %26% ZETA-COP were indexed under MEMBRANE PROTEINS 1995-1999; DELTA-COP PROTEIN %26% HEP-COP PROTEIN were indexed under MEMBRANE PROTEINS 1996-1999; BETA-COP was indexed under MEMBRANE PROTEINS 1991-1999; ARCN1 PROTEIN was indexed under PROTEINS 1995-1999; P102 PROTEIN %28%GOLGI%29% was indexed under MEMBRANE PROTEINS 1993-1999;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; CONUS GEOGRAPHUS TOXIN %28%now OMEGA-CONOTOXIN GVIA%29% was indexed under PEPTIDES 1994-1999 %26% MOLLUSK VENOMS 1984-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; COPI PROTEIN %28%now COAT PROTEIN PROTEIN COMPLEX I%29% was indexed under MEMBRANE PROTEINS 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; DIHYDROPYRIDINE RECEPTOR %28%now L-TYPE CALCIUM CHANNELS%29% was indexed under CALCIUM CHANNELS %26% MUSCLE PROTEINS 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; DIPEPTIDYL PEPTIDASE I was indexed under DIPEPTIDYL PEPTIDASES 1984-1999; CATHEPSINS 1981-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ELONGATION FACTOR 1 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999; ELONGATION FACTOR 1GAMMA was indexed under PEPTIDE ELONGATION FACTORS 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ELONGATION FACTOR 2 was indexed under PEPTIDE ELONGATION FACTORS 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ENKEPHALIN, ALA%28%2%29%-MEPHE%28%4%29%-GLY%28%5%29%- was indexed under ENKEPHALINS 1981-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ENKEPHALIN, PEN%28%2,5%29%- %28%now ENKEPHALIN, D-PENICILLAMINE %28%2,5%29%-%29% was indexed under ENKEPHALINS 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; EXOPROTEASES %28%now EXOPEPTIDASES%29% was indexed under PEPTIDE HYDROLASES 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; Elongation Factor G was indexed under PEPTIDE ELONGATION FACTORS 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; FK 027 %28%now CEFIXIME%29% was indexed under CEFOTAXIME/*analogs %26% derivatives 1986-1999 %26% CEPHALOSPORINS 1984-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; G25K PROTEIN %28%now CDC42 GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GELATINASE A was indexed under GELATINASES %26% METALLOPROTEINASES 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GELATINASE B was indexed under COLLAGENASES 1989-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GLIAL MATURATION FACTOR %28%now GLIA MATURATION FACTOR%29% was indexed under NERVE TISSUE PROTEINS 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GLUCURONIC ACID was indexed under GLUCURONATES 1981-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GRF2 PROTEIN, MAMMALIAN was indexed under PROTEINS 1995-1999; C3G PROTEIN was indexed under PROTEINS 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GTPASE-ACTIVATING PROTEIN %28%now GTPase-ACTIVATING PROTEINS%29% was indexed under PROTEINS 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; GUANINE-NUCLEOTIDE-RELEASING FACTOR was indexed under PROTEINS 1978-1999; GDP-GTP EXCHANGE PROTEIN was indexed under G-PROTEINS 1994-1999; GDP DISSOCIATION FACTOR was indexed under G-PROTEINS 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; KAVA was indexed under PLANT EXTRACTS 1981-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; KETOROLAC TROMETHAMINE was indexed under TOLMETIN/analogs %26% derivatives %26% TROMETHAMINE 1986-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; KETOROLAC was indexed under TOLMETIN/analogs %26% derivatives 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; LY 139481 %28%now RALOXIFENE%29% was indexed under PIPERIDINES 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MANNOSE-6-PHOSPHATE RECEPTOR %28%now RECEPTOR, IGF TYPE 2%29% was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MAP KINASE KINASE KINASE %28%now MAP KINASE KINASE KINASES%29% was indexed under PROTEIN-SERINE-THREONINE KINASES %28%1992-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MAP KINASE KINASE and MAPKK %28%now MITOGEN-ACTIVATED KINASE KINASES%29% were indexed under PROTEIN KINASES 1992-1999; MAP-ERK KINASE %28%now MITOGEN-ACTIVATED KINASE KINASES%29% was indexed under PROTEIN-TYROSINE KINASE 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MATRILYSIN was indexed under METALLOPROTEINASES 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MEDETOMIDINE %28%now DEXMEDETOMIDINE%29% was indexed under IMIDAZOLES 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MEDETOMIDINE was indexed under IMIDAZOLES 1986-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MIBEFRADIL was indexed under BENZIMIDAZOLES %26% TETRAHYDRONAPHTHALENS 1989-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; MOCLOBEMIDE was indexed under BENZAMIDES 1982-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; N-CHIMAERIN %28%now CHIMERIN 1%29% was indexed under NERVE TISSUE PROTEINS 1990-1999; ALPHA1-CHIMAERIN was indexed under PROTEINS 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; NERVE GROWTH FACTOR RECEPTOR P75 %28%now RECEPTOR, NERVE GROWTH FACTOR%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1994-1999; P75 NEUROTROPHIN RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; NEUREGULIN-1 was indexed under GLYCOPROTEINS 1993-1999; GLIAL GROWTH FACTOR was indexed under NERVE TISSUE PROTEINS 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; NEURONAL DIFFERENTIATION FACTOR, CHOLINERGIC %28%now NEUREGULINS%29% was indexed under GLYCOPROTEINS 1986-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; NEUROTROPHIN 3 was indexed under NERVE GROWTH FACTORS 1990-1999; for NERVE GROWTH FACTOR 2 see NERVE GROWTH FACTORS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; NEUTROPHIL COLLAGENASE was indexed under COLLAGENASES 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; OB PROTEIN %28%now LEPTIN%29% was indexed under PROTEINS 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; OMEGA-AGATOXIN IVA was indexed under SPIDER VENOMS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ONCOGENE PROTEIN REL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 %26% RETROVIRIDAE PROTEINS 1988-1989%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ONCOGENE PROTEINS MYB was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999 %26% RETROVIRIDAE PROTEINS 1986-1989%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ONCOGENE PROTEINS SIS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1999; RETROVIRIDAE PROTEINS 1986-1989; %26% VIRAL PROTEINS 1983-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; P-TYPE VDCC was indexed under CALCIUM CHANNELS 1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; P120-GAP PROTEIN was indexed under PROTEINS 1994-1999; P100-GAP PROTEIN was indexed under PROTEINS 1995-1999; P120RASGAP %26% P125 GAP were indexed under PROTEINS 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; P21 %28%RHO%29%PROTEIN %28%now RHO GTP-BINDING PROTEINS%29% was indexed under PROTEINS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PERINDOPRIL was indexed under INDOLES 1985-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PLATELET-DERIVED GROWTH FACTOR ALPHA RECEPTOR %28%now RECEPTOR, PDGF ALPHA%29% was indexed under RECEPTORS, PLATELET-DERIVED GROWTH FACTOR 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR %28%now RECEPTOR PDGF BETA%29% was indexed under RECEPTORS, PLATELET-DERIVED GROWTH FACTOR 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; POLYTHENE was indexed under POLYETHYLENES %26% POLYPROPYLENES 1983-1999 %26% POLYMERS 1978-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PROTO-ONCOGENE PROTEIN C-REL was indexed under PROTO-ONCOGENE PROTEINS 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PROTO-ONCOGENE PROTEIN ERBB-3 %28%now RECEPTOR, ERBB-3%29% was indexed under EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1993-1999 %26% PROTO-ONCOGENE PROTEINS 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PROTO-ONCOGENE PROTEIN MYB was indexed under PROTO-ONCOGENE PROTEINS 1986-1990 %26% TRANS-ACTIVATORS 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PROTO-ONCOGENE PROTEIN SIS was indexed under PROTO-ONCOGENE PROTEINS 1987-1999 %26% PLATELET-DERIVED GROWTH FACTOR 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; PROTO-ONCOGENE PROTEIN TRK %28%now RECEPTOR, TYPE 1 NEUROTROPHIC TYROSINE KINASE%29% was indexed under PROTO-ONCOGENE PROTEINS 1990-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999 %26% RECEPTORS, NERVE GROWTH FACTOR 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; Q-TYPE VDCC was indexed under CALCIUM CHANNELS 1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAB1A PROTEIN was indexed under G-PROTEINS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAB2 PROTEIN %28%now RAB2 GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAB3 PROTEIN %28%now RAB3 GTP-BINDING PROTEINS%29% was indexd under G-PROTEINS %28%1990-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAB3A PROTEIN was indexed under G-PROTEINS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAB4 PROTEIN %28%now RAB4 GTP-BINDING PROTEINS%29% was indexed under G-PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAB5 PROTEIN %28%now RAB5 GTP-BINDING PROTEINS%29% was indexed under G-PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAC PROTEINS was indexed under G-Proteins 1991-1999 %26% Proteins 1989-1990; RAC G PROTEIN was indexed under GTP PHOSPHOHYDROLASE 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAC1 GENE PRODUCT was indexed under G-PROTEINS 1991-1999 %26% PROTEINS 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RACLOPRIDE was indexed under SALICYLAMIDES 1987-1999 %26% BENZAMIDES 1985-1986%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAL PROTEIN %26% RAL A PROTEIN were indexed under G-PROTEINS 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR was indexed under G-PROTEINS 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAN PROTEIN %28%now RAN GTP-BINDING PROTEIN%29% was indexed under NUCLEAR PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAP1A PROTEIN, K-REV-1 PROTEIN %26% SMG P21A were indexed under G-PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR was indexed under PROTEINS 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAS-GAP was indexed under PROTEINS 1995-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAS-GRF1 was indexed under CELL CYCLE PROTEINS 1996-1999 %26% under PROTEINS 1992-1995; RAS-GRF was indexed under PROTEINS 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RAS-RELATED RAP PROTEINS %28%now RAP GTP-BINDING PROTEINS%29% was indexed under G-PROTEINS 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RGS PROTEIN %28%G-PROTEIN SIGNALING%29% was indexed under PROTEINS 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RHOA P21 PROTEIN %28%now RHOA GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS %28%1991-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RHOB P20 PROTEIN %28%now RHOB GTP-BINDING PROTEIN%29% was indexed under G-PROTEINS 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RIBONUCLEOPROTEINS, SMALL, U1 was heading 1993-1999; U1-RNP was indexed under RIBONUCLEOPROTEINS 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RIBONUCLEOPROTEINS, SMALL, U2 was heading 1993-1999; SNRNP-U2 was indexed under RIBONUCLEOPROTEINS 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RIBONUCLEOPROTEINS, SMALL, U4-U6 was heading 1993-1999; U4 RNP %26% U6 RNP were indexed under RIBONUCLEPROTEINS 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; RIBONUCLEOPROTEINS, SMALL, U5 was heading 1993-1999; U5 SNRNP was indexed under RIBONUCLEOPROTEINS 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; ROLIPRAM was indexed under PYRROLIDINONES 1983-1999 %26% CYCLOPENTANES 1979-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; SELENIOUS ACID was indexed under SELENIUM COMPOUNDS 1994-1999, SELENIUM 1974-1993, %26% OXIDES 1974-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; SMALL CYTOPLASMIC RNA was indexed under RNA %28%NM%29% 1984-1999; for 7S RNA see RNA, SMALL NUCLEAR 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; SON OF SEVENLESS PROTEIN was indexed under MEMBRANE PROTEINS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; SOS PROTEIN was indexed under MEMBRANE PROTEINS 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; SOS1 PROTEIN was indexed under REPRESSOR PROTEINS 1993-1999; MSOS1 PROTEIN was indexed under PROTEINS 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; TEA TREE OIL was indexed under OILS, VOLATILE %26% PLANT OILS 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; TISSUE KALLIKREIN was indexed under KALLIKREIN 1983-1999 %26% PEPTIDE PEPTIDOHYDROLASES 1982-1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; TRKB%28%GP145%29% PROTEIN was indexed under RECEPTORS, NERVE GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, and under MEMBRANE GLYCOPROTEINS, PROTEIN-TYROSINE KINASE %26% RECEPTORS, GROWTH FACTOR 1990-1999; BDNF RECEPTOR was indexed under RECEPTORS, NERVE GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; TRKC PROTEIN %28%now RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE%29% was indexed under RECEPTORS, NERVE GROWTH FACTOR 1995-1999, RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999, RECEPTORS, GROWTH FACTOR 1993-1994, MEMBRANE GLYCOPROTEINS 1991-1993 %26% PROTEIN-TYROSINE KINASE 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; U1 SNRNP was U1-RNP %28%SY%29% to SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; U2 SNRNP was SNRNP-U2 %28%SY%29% to SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; U4 SNRNP was U4 RNP %28%SY%29% to SMALL NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1982-92; U6 SNRNP was U6 RNP %28%SY%29% to SMALL NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; U5 SNRNP was SY to SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; VIGABATRIN was indexed under GABA/analogs %26% derivatives 1994-1999, AMINOCAPROIC ACIDS 1981-1994, %26% GABA/analogs 1979-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for BELL%27%S PALSY see Facial Paralysis 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for BELL%27%S PALSY use Facial Paralysis 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CENTRAL CORE DISEASE %26% SHY-MAGEE SYNDROME see NEMALINE MYOPATHY 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CENTRAL CORE DISEASE %26% SHY-MAGEE SYNDROME use NEMALINE MYOPATHY 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CEREBRAL EMBOLISM see CEREBRAL EMBOLISM AND THROMBOSIS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CEREBRAL EMBOLISM use INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CEREBRAL THROMBOSIS see INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CEREBRAL THROMBOSIS use INTRACRANIAL EMBOLISM AND THROMBOSIS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CEREBRAL VASOSPASM see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CEREBRAL VASOSPASM use CEREBRAL ISCHEMIA, TRANSIENT 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CERVICO-BRACHIAL NEURALGIA see CERVICO-BRACHIAL NEURALGIA 1965-1999; for BRACHIAL NEURALGIA; NEURALGIC AMYOTROPHY; PARSONAGE-TURNER SYNDROME; %26% SHOULDER-GIRDLE NEUROPATHY see CERVICO-BRACHIAL NEURALGIA 1988-1999; for BRACHIAL NEURALGIA see CERVICO-BRACHIAL NEURALGIA 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CERVICO-BRACHIAL NEURALGIA use BRACHIAL PLEXUS NEURITIS 1965-1999; for BRACHIAL NEURALGIA; NEURALGIC AMYOTROPHY; PARSONAGE-TURNER SYNDROME; %26% SHOULDER-GIRDLE NEUROPATHY use BRACHIAL PLEXUS NEURITIS 1989-1999; for BRACHIAL NEURALGIA use CERVICO-BRACHIAL NEURALGIA 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for COATOMER PROTEIN %26% COATOMER SUBUNIT EPSILON-COP use COATOMER PROTEIN %28%NM%29% 1994-1999; for ACRN1 PROTEIN, %26% RET1 PROTEIN use COATOMER PROTEIN %28%NM%29% 1995-1999; for BETA-COP use COATOMER PROTEIN %28%NM%29% 1991-1999; for P102 PROTEIN %28%GOLGI%29% use COATOMER PROTEIN %28%NM%29% 1993-1999; for ZETA-COP use RHOB GTP-BINDING PROTEIN %28%NM%29% 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CUBITAL TUNNEL SYNDROME see ULNAR NERVE COMPRESSION SYNDROME 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CUBITAL TUNNEL SYNDROME use ULNAR NERVE COMPRESSION SYNDROMES 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CULDOSCOPE see CULDOSCOPY 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for CULDOSCOPE use CULDOSCOPY 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ECTOTHIORHODOSPIRA VACUOLATA see ECTOTHIORHODOSPIRA 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ECTOTHIORHODOSPIRA VACUOLATA use ECTOTHIORHODOSPIRA 2000-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ELASTOMERS see RUBBER 1981-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ELASTOMERS use RUBBER 1981-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ELONGATION FACTOR 1 use PEPTIDE ELONGATION FACTOR 1 %28%NM%29% 1980-1999; for ELONGATION FACTOR 1GAMMA use PEPTIDE ELONGATION FACTOR 1 %28%NM%29% 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ELONGATION FACTOR 2 use PEPTIDE ELONGATION FACTOR 2 %28%NM%29% 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ELONGATION FACTOR G use PEPTIDE ELONGATION FACTOR G %28%NM%29% 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES see CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for EXTRACELLULAR SIGNAL-REGULATED KINASES use CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for GRANA see CHLOROPLASTS 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for GRANA use CHLOROPLASTS 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for GTP PHOSPHOHYDROLASE use GTP PHOSPHOHYDROLASES 1975-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for GUANOSINE TRIPHOSPHATE PHOSPHOHYDROLASES, GTP PHOSPHOHYDROLASE AND GUANOSINETRIPHOSPHATASES see GTP PHOSPHOHYDROLASE %28%1975-1999%29%; for GTPASE see GTP PHOSPHOHYDROLASE %28%1977-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for Hypericum %26% St. Johns Wort see THEALES 1999; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for Hypericum %26% St. Johns Wort use THEALES 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for INSULIN RECEPTOR PROTEIN-TYROSINE KINASE see INSULIN RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999; INSULIN-DEPENDENT PROTEIN TYROSINE KINASE was indexed under PROTEIN-TYROSINE KINASE 1986-1993 %26% PROTEIN KINASES 1983-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ISAACS%27% SYNDROME see FASCICULATION 1995-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for ISAACS%27% SYNDROME use FASCICULATION 1995-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for KAMPO %26% KAMPO use MEDICINE, CHINESE TRADITIONAL 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for KAMPO %26% KANPO use MEDICINE, CHINESE TRADITIONAL 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for LUNDBORG-UNVERRICHT SYNDROME see EPILEPSY, MYOCLONIC 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for LUNDBORG-UNVERRICHT SYNDROME use EPILEPSY, MYOCLONIC 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for LYMPHOMA, LYMPHOCYTIC, DIFFUSE, INTERMEDIATE; LYMPHOCYTIC LYMPHOMA, DIFFUSE, POORLY-DIFFERENTIATED; LYMPHOMA, CENTROCYTIC SMALL-CELL; LYMPHOMA, LYMPHOCYTIC, DIFFUSE, POORLY-DIFFERENTIATED; %26% LYMPHOMA, SMALL-CELL, CENTROCYTIC see LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for LYMPHOMA, LYMPHOCYTIC, DIFFUSE, INTERMEDIATE; LYMPHOCYTIC LYMPHOMA, DIFFUSE, POORLY-DIFFERENTIATED; LYMPHOMA, CENTROCYTIC SMALL-CELL; LYMPHOMA, LYMPHOCYTIC, DIFFUSE, POORLY-DIFFERENTIATED; %26% LYMPHOMA, SMALL-CELL, CENTROCYTIC use LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for MAP-ERK KINASE use MEK1 PROTEIN %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for MINAMATA DISEASE see MERCURY POISONING 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for MINAMATA DISEASE use MERCURY POISONING 1977-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for MUSCULAR DYSTROPHY, SCAPULOPERONEAL see MUSCULAR DYSTROPHIES 2000-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for MUSCULAR DYSTROPHY, SCAPULOPERONEAL use MUSCULAR DYSTROPHIES 2000-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for P-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNEL %28%P-Q TYPE%29% %28%NM%29% 1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for P120-GAP PROTEIN use GTPASE ACTIVATING PROTEINS %28%NM%29% 1994-1999; for P100-GAP PROTEIN use GTPASE ACTIVATING PROTEINS %28%NM%29% 1995-1999; for P120RASGAP %26% P125 GAP use GTPASE ACTIVATING PROTEINS %28%NM%29% 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PANCREASE see PANCREATIN 1989-1999; PANCRELIPSASE was indexed under LIPASE %26% PANCREATIC EXTRACTS 1980-1999 %26% PANCREATIN 1970-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PANCREASE use PANCREATIN 1989-1999; use PANCRELIPASE %28%NM%29% 1970-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PARKINSONISM see PARKINSON DISEASE 1978-1999; for PARKINSONIAN SYNDROME see PARKINSON DISEASE, SECONDARY 1974-1999: for RAMSAY HUNT PARALYSIS SYNDROME see PARKINSON DISEASE 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PARKINSONISM use PARKINSON DISEASE 1978-1999; for PARKINSONIAN SYNDROME use PARKINSON DISEASE, SECONDARY 1974-1999; for RAMSAY HUNT PARALYSIS SYNDROME use PARKINSON DISEASE 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PICKS DISEASE OF BRAIN see DEMENTIA 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PICKS DISEASE OF BRAIN use DEMENTIA 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for POLYTHENE use PLASTIPORE %28%NM%29% 1978-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PROCTOSCOPE see PROCTOSCOPY 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PROCTOSCOPE use PROCTOSCOPY 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR see PARALYSIS 1985-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PSEUDOBULBAR PARALYSIS and PARALYSIS, PSEUDOBULBAR use PARALYSIS 1985-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for PYRIDOXINE DEFICIENCY see PYRIDOXINE DEFICIENCY 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for Q-TYPE VDCC use VOLTAGE-DEPENDENT CALCIUM CHANNELS %28%P-Q TYPE%29% %28%NM%29% 1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAB1A PROTEIN use RAB1 GTP-BINDING PROTEINS %28%NM%29% 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAB3A PROTEIN see RAB3 GTP-BINDING PROTEINS %28%NM%29% 1992-1999;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAC PROTEINS use RAC GTP-BINDING PROTEINS %28%NM%29% 1989-1999; for RAC G PROTEIN use RAC GTP-BINDING PROTEINS %28%NM%29% 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAC1 GENE PRODUCT use RAC GTP-BINDING PROTEINS %28%NM%29% 1989-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR use RAL-GUANINE NUCLEOTIDE EXCHANGE FACTOR 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAP1A PROTEIN, K-REV-1 PROTEIN %26% SMG P21A use RAP GTP-BINDING PROTEINS %28%NM%29% 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR use RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RAS-GAP use RAS GTPASE-ACTIVATING PROTEINS %28%NM%29% 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RECEPTOR PROTEIN-TYROSINE KINASE see RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for RGS PROTEIN %28%G-PROTEIN SIGNALING%29% use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for SMALL CYTOPLASMIC RNA use RNA, SMALL CYTOPLASMIC %28%NM%29% 1984-1999; for 7S RNA use RNA, SMALL NUCLEAR 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for SOS PROTEIN use SON OF SEVENLESS PROTEINS 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for STROKE and APOPLEXY see CEREBROVASCULAR DISORDERS 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for SUPRASELLAR CYST see CRANIOPHARYNGIOMA 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for SUPRASELLAR CYST use CRANIOPHARYNGIOMA 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for TRKB%28%GP145%29% PROTEIN use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1990-1999; for BDNF RECEPTOR use RECEPTOR, TYPE 2 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1995-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 see RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%1993-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for U7 SNRNP, U7 SMALL NUCLEAR RIBONUCLEARPROTEINS and SMALL NUCLEAR RIBONUCLEARPROTEINS, U7 use RIBONUCLEOPROTEINS, SMALL NUCLEAR %28%1993-1999%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for XENORHABDUS LUMINESCENS see XENORHABDUS 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; for XENORHABDUS LUMINESCENS use XENORHABDUS 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ACOUSTIC NERVE 1963-1999; for VESTIBULOCOCHLEAR NERVE see ACOUSTIC NERVE 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ACOUSTIC NERVE DISEASES 1980-1999, use PERIPHERAL NERVE DISEASES 1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ADIE%27%S SYNDROME 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS see ALCOHOL AMNESTIC DISORDER 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ALTHESIN 1980-2000 %26% PREGNANEDIONES 1975-79 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ANDROGEN-BINDING PROTEINS 1986-1999, see CARRIER PROTEINS 1980-85%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ANOSMIA 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see APRAXIA 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ARNOLD-CHIARI DEFORMITY 1963-1999; for ARNOLD-CHIARI MALFORMATION see ARNOLD-CHIARI DEFORMITY 1963-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ASPARTIC PROTEINASES 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CALLUS 1973-1999, see FRACTURES 1963-1972 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBELLAR DYSSYNERGIA 1991-1999; see CEREBELLAR ATAXIA 1970-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ANEURYSM 1969-1999; for CEREBRAL ANEURYSM see CEREBRAL ANEURYSM 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ANOXIA 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ARTERIOSCLEROSIS 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1973-1999; for INTRACRANIAL ARTERIOVENOUS MALFORMATIONS see CEREBRAL ARTERIOVENOUS MALFORMATIONS 1974-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ARTERY DISEASES 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL EMBOLISM AND THROMBOSIS 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ISCHEMIA 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL ISCHEMIA, TRANSIENT 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL SCLEROSIS, DIFFUSE 1963-1999; for ENCEPHALITIS PERIAXIALIS see ENCEPHALITIS PERIAXIALIS 1963-1999; for BALO%27%S DISEASE, ENCEPHALITIS PERIAXIALIS DIFFUSA, MYELINOCLASTIC DIFFUSE SCLEROSIS, %26% SCHILDER%27%S DISEASE see ENCEPHALITIS PERIAXIALIS 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBRAL SCLEROSIS, DIFFUSE 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBROSPINAL OTORRHEA 1988-1999; for CEREBROSPINAL FLUID OTORRHEA see CEREBROSPINAL OTORRHEA 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CEREBROSPINAL RHINORRHEA 1966-1999; for CEREBROSPINAL FLUID RHINORRHEA see CEREBROSPINAL RHINORRHEA 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CHARCOT-MARIE DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-1990, see MUSCULAR ATROPHY 1966-1987; for CHARCOT-MARIE-TOOTH DISEASE see CHARCOT-MARIE DISEASE 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CHORDATA 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see COGNITIVE SYMPTOMS 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CONVULSIONS, FEBRILE 1982-1999, see CONVULSIONS 1977-1981; for SEIZURES, FEBRILE see CONVULSIONS, FEBRILE 1982-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see CYSTEINE PROTEINASES 1988-1999; for CYSTEINE ENDOPEPTIDASES see CYSTEINE PROTEINASES 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see DATAPHONE 1991-1999; see TELECOMMUNICATIONS 1998-1999; see TELEPHONE 1975-1990; see COMPUTERS 1967-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see DE LANGE%27%S SYNDROME 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see DEITER%27%S NUCLEUS 1991-1999, see VESTIBULAR NUCLEI 1967-90%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see DENDRITIC CELLS 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see DOUBLE BIND THEORY 1991-1999; see PSYCHOLOGICAL THEORY 1972-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see DUANE%27%S SYNDROME 1991-1999, see OPHTHALMOPLEGIA 1979-1990, see OCULOMOTOR PARALYSIS 1966-1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see EMBRYO RESORPTION 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ENCEPHALITIS, EPIDEMIC 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ENDOSCOPES 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ENDOSCOPY 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see EPIDERMAL GROWTH FACTOR-UROGASTRONE 1982-1999, see PEPTIDES 1977-1981; for UROGASTRONE see GASTROINTESTINAL HORMONES 1963-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see EPILEPSY, MYOCLONIC 1992-1999; see EPILEPSY, MYOCLONUS 1977-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see EPILEPSY, PARTIAL 1966-1999, see EPILEPSY, FOCAL 1977-1991; for EPILEPSY, ABDOMINAL see EPILEPSY, TEMPORAL LOBE, 1975-1999; for EPILEPSY, PARTIAL see EPILEPSY, FOCAL 1977-1991; for EPILEPSY, FOCAL see JACKSONIAN SEIZURE 1970-1976; for JACKSONIAN SEIZURE see JACKSONIAN SEIZURE 1963-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ESTHESIONEUROBLASTOMA 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ESTROGEN ANTAGONISTS 1978-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see Epilepsy, Myoclonic 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see FASCICULATION 1985-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see FICIN 1990-1999; see CYSTEINE PROTEINASES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see FOURNIER%27%S GANGRENE 1996-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see FRIEDREICH%27%S ATAXIA 1966-1999; for FRIEDREICH%27%S DISEASE see MYOCLONUS 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GALACTOSEMIA 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GANGLIOSIDOSIS G%28%M1%29% 1992-1999; for GANGLIOSIDOSIS GM1 see GANGLIOSIDOSIS G%28%M1%29% 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GAUCHER%27%S DISEASE 1966-1999; for GAUCHER DISEASE see GAUCHER%27%S DISEASE 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GERSTMANN-STRAUSSLER SYNDROME 1991-1999; see SLOW VIRUS DISEASES 1988-1990; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE was GERSTMANN-STRAUSSLER-SCHEINDER DISEASE see GERSTMANN-STRAUSSLER SYNDROME 1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GILBERT%27%S DISEASE 1991-1999, see HYPERBILIRUBINEMIA, HEREDITARY 1975-90%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GLIOMA 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GLUCURONATES 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GRAFT VS TUMOR EFFECT 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see GTP PHOSPHOHYDROLASE 1975-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see Gerstmann%27%s Syndrome 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HEAD INJURIES 1966-1999; for CRANIOCEREBRAL INJURIES see BRAIN INJURIES 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HEART HYPERTROPHY 1993-1999; see HEART ENLARGEMENT 1963-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HIGH PRESSURE NERVOUS SYNDROME 1991-1999; see CENTRAL NERVOUS SYSTEM DISEASES 1986-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HORNER%27%S SYNDROME 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HUNTINGTON%27%S DISEASE 1993-1999; for HUNTINGTON DISEASE see HUNTINGTON%27%S DISEASE 1993-1999, see HUNTINGTON CHOREA 1977-1992, see CHOREA, HEREDITARY 1963-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HYPERSOMNIA 1991-1999, see SLEEP DISORDERS 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see HYPOTHALAMIC AREA, ANTERIOR 1983-1999; for ANTERIOR HYPOTHALAMIC NUCLEUS see HYPOTHALAMIC AREA, ANTERIOR 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see I KAPPA B 2000-2005, I KAPPA B PROTEINS was indexed under PROTO-ONCOGENE PROTEINS 1993-1998 %26% DNA-BINDING PROTEINS 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see IDITOL DEHYDROGENASE 1991-1999, see SUGAR ALCOHOL DEHYDROGENASES 1978-90, see ALCOHOL OXIDOREDUCTASES 1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see INJURIES, POISONINGS, AND OCCUPATIONAL DISEASES 1974-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see INSOMNIA 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see INTERFERON ALFA, RECOMBINANT 1989-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see KALLIKREIN 1963-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see KINKY HAIR SYNDROME 1991-1999; see BRAIN DISEASES, METABOLIC 1977-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see LAURENCE-MOON-BIEDL SYNDROME 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see LENTINUS 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999; for TLV see MAXIMUM PERMISSIBLE EXPOSURE LEVEL 1976-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MENSTRUATION DISORDERS 1963-1999; for HYPOMENORRHEA, POLYMENORRHEA %26% MENSTRUATION, RETROGRADE see MENSTRUATION DISORDERS 1975-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see METALLOPROTEINASES 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MICROBODIES 1976-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MICROSCOPY, ATOMIC FORCE 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MULTIPLE SYSTEM ATROPHY 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR DYSTROPHY, BECKER %26% BECKER MUSCULAR DYSTROPHY see MUSCULAR DYSTROPHIES 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MUSCULAR DYSTROPHY 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see MYOTONIA ATROPHICA 1966-1999; for MYOTONIC DYSTROPHY see MYOTONIC ATROPHICA 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NEMALINE MYOPATHY 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NERVE GROWTH FACTORS 1980-1999, see NERVE GROWTH FACTOR 1966-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NERVOUS SYSTEM ABNORMALITIES 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NEUROECTODERMAL TUMOR, PRIMITIVE 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NEUROFIBROMATOSIS 1993-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1988-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NEUROPATHIES, HEREDITARY SENSORY AND AUTONOMIC 1989-1999; see NEUROPATHY, HEREDITARY SENSORY 1979-1988%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NIEMANN-PICK DISEASE 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see NYSTAGMUS 1966-1999; for NYSTAGMUS see NYSTAGMUS, PATHOLOGIC 2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see OCULOMOTOR NERVE PARALYSIS 1990-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see OLIVOPONTOCEREBELLAR ATROPHY 1991-1999, see SPINOCEREBELLAR DEGENERATION 1987-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ONCOGENES 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see OPHTHALMOPLEGIA 1981-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see OPTIC ATROPHY, HEREDITARY 1991-1999, see NEUROPATHIES, HEREDITARY MOTOR AND SENSORY 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see OXYTOCINASE 1991-1999; see AMINOPEPTIDASES 1973-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see P42 MAP KINASE 2000-2004, see P42%28%MAPK%29% KINASE 1998-1999; P42%28%MAPK%29% KINASE was indexed under CALMODULIN-DEPENDENT PROTEIN KINASES 1994-1997, PROTEIN-TYROSINE KINASE 1992-1997, PROTEIN-SERINE-THREONINE KINASES 1993-1995 %26% PROTEIN KINASES 1992; ERK2 BRAIN KINASE PK40 was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-1999; ERK2 was indexed under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1998-1999, CALMODULIN-DEPENDENT KINASES 1994-1997, PROTEIN-SERINE-THREONINE KINASES 1992-1993 %26% PROTEIN KINASES 1992; ERK2 MBP-KINASE was indexed under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1998-1999 %26% CALMODULIN-DEPENDENT KINASES 1994-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PANCREATOPEPTIDASE 1965-1999; for PANCREATIC ELASTASE see PANCREATOPEPTIDASE 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PARALYSIS, BULBAR 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PARALYSIS, FAMILIAL PERIODIC 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE %26% LEWY BODY DISEASE, DIFFUSE see PARKINSON DISEASE 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PARKINSON DISEASE, SYMPTOMATIC 1979-1999, see PARKINSONISM, SYMPTOMATIC 1973-1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PEPTIDE PEPTIDOHYDROLASES 1963-1999; for ENDOPEPTIDASES see PEPTIDE PEPTIDOHYDROLASES 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PERIODIC DISEASE 1966-1999; for FAMILIAL MEDITERRANEAN FEVER see PERIODIC DISEASE 1966-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PERIPHERAL NERVE NEOPLASMS 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PHENYLKETONURIA 1974-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see POLYNEURITIS 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see POLYRADICULONEURITIS 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PONS 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL see PROSTATECTOMY 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PROTEIN CONFORMATION %28%1993-1999%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PROTEINS 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PROTO-ONCOGENE PROTEINS C-ERBB-2 1995-1999; for PROTO-ONCOGENE PROTEIN ERBB-2 see EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1994, PROTO-ONCOGENE PROTEINS 1986-1994, %26% PHOSPHOPROTEINS 1985;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PROTO-ONCOGENE PROTEINS C-KIT 1999-1996; PROTO-ONCOGENE PROTEIN KIT %28%now PROTO-ONCOGENE PROTEIN C-KIT%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1995; RECEPTORS, COLONY-STIMULATING FACTOR 1991-1995; %26% PROTO-ONCOGENE PROTEINS 1989-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PTEROYL POLYGLUTAMATE HYDROLASE 1991-1999; for GAMMA-GLUTAMYL HYDROLASE see PTEROYL POLYGLUTAMATE HYDROLASE 1987-1999; see CYSTEINE PROTEINASES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PUPILLARY FUNCTIONS, ABNORMAL 1990-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PYRUVATE CARBOXYLASE DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY 1991-1999; see PYRUVATE METABOLISM, INBORN ERRORS 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see RADICULITIS 1971-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see RECEPTOR, INSULIN-LIKE-GROWTH FACTOR I 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see RECEPTORS, EPIDERMAL GROWTH FACTOR-UROGASTRONE 1978-1999; for EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE see EPIDERMAL GROWTH FACTOR RECEPTOR PROTEIN-TYROSINE KINASE 1994-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see RECRUITMENT LOUDNESS 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see REPTILASE 1991-1999; see SERINE PROTEINASES 1975-1990; for BATROXOBIN see REPTILASE 1982-199; PLASMOCOAGULASE was indexed under COAGULASE 1979-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see RHIZOBIUM MELILOTI 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see Restless Legs 1973-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SERINE PROTEINASES 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SINGLE PARENT %28%1989-1999%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SINUS THROMBOSIS 1964-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SLEEP DISORDERS 1981-1999; for SLEEP TERROR DISORDER see SLEEP DISORDERS 1981-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SPINOCEREBELLAR DEGENERATION 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SPINOCEREBELLAR DEGENERATION 1989-1999, see SPINOCEREBELLAR DEGENERATIONS 1987-1988%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see STIFF-MAN SYNDROME 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SUBSTANTIA INNOMINATA 1984-1999; for NUCLEUS BASALIS OF MEYNERT %26% NUCLEUS BASALIS MAGONCELLULARIS see SUBSTANTIA INNOMINATA 1984-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see SYMPTOMS AND GENERAL PATHOLOGY 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ULNAR NERVE COMPRESSION SYNDROME 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see UROKINASE 1984-1999, see PEPTIDE PEPTIDOHYDROLASES 1975-1983, see FIBRINOLYTIC AGENTS 1966-1974, see STREPTODORNASE AND STREPTOKINASE 1963-1965, UROKINASE-TYPE PLASMINOGEN ACTIVATOR was indexed under PLASMINOGEN ACTIVATORS %26% UROKINASE 1984-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see VASCULAR HEADACHE 1978-1999; see HEADACHE 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see VISION, SUBNORMAL 1990-1999, see VISION, LOW 1989; for VISION, LOW see VISION, SUBNORMAL 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see WERDNIG-HOFFMAN DISEASE 1991-1999, see MUSCULAR ATROPHY, SPINAL 1988-90%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see WERNICKE%27%S ENCEPHALOPATHY 1970-1999, see VITAMIN B DEFICIENCY 1963-1969%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ZENKER%27%s DIVERTICULUM 1992-1999; see ZENKER%27%s DIVERTICULUM 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; see ZINGIBERALES 1998-1999, see SPICES 1993-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use DENDRITIC CELLS 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ACARBOSE %28%NM%29% 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ADP-RIBOSYLATION FACTOR 1 %28%NM%29% 1993-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ADP-RIBOSYLATION FACTORS %28%NM%29% 1984-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ALCOHOL AMNESTIC DISORDER 1963-1999; for KORSAKOFF PSYCHOSIS use ALCOHOL AMNESTIC DISORDER 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CALCIUM CHANNELS, T-TYPE %28%NM%29% 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CDC25 PHOSPHATASE %28%NM%29% 1995-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CDC42 GTP-BINDING PROTEIN %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CEFIXIME %28%NM%29% 1984-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CEREBRAL SCLEROSIS, DIFFUSE 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CHIMERIN 1 %28%NM%29% 1990-1999; for ALPHA1-CHIMAERIN use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use CILIARY NEUROTROPHIC FACTOR %28%NM%29% 1980-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use COATOMER PROTEIN %28%NM%29% 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use DEXMEDETOMIDINE %28%NM%29% 1990-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use DIPEPTIDYL PEPTIDASE I %28%NM%29% 1984-1999; use CATHEPSINS 1981-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ENDOSCOPES 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ENDOSCOPY 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ENKEPHALIN, ALA%28%2%29%-MEPHE%28%4%29%-GLY%28%5%29%- %28%NM%29% 1981-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ENKEPHALIN, D-PENICILLAMINE %28%2,5%29%- %28%NM%29% 1983-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ESTROGEN ANTAGONISTS 1978-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use EXOPEPTIDASES %28%NM%29% 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use Epilepsy, Myoclonic 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use FACIAL PARALYSIS 1997-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use FASCICULATION 1985-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GELATINASE A %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GELATINASE B %28%NM%29% 1989-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GLIAL MATURATION FACTOR %28%NM%29% 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GLIOMA 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GLUCURONATES 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GLUCURONIC ACID %28%NM%29% 1981-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GRAFT VS TUMOR EFFECT 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GTPASE-ACTIVATING PROTEINS %28%NM%29% 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1978-1999; for GDP-GTP EXCHANGE PROTEIN use RAB3 GTP-BINDING PROTEINS %28%NM%29% 1994-1999; for GDP DISSOCIATION FACTOR use RAP GTP-BINDING PROTEINS %28%NM%29% 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1997-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use INTERFERON TYPE I, RECOMBINANT 1989-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use INTERSTITIAL COLLAGENASE %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use KETOROLAC %28%NM%29% 1983-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use KETOROLAC TROMETHAMINE %28%NM%29% 1986-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use L-TYPE CALCIUM CHANNELS %28%NM%29% 1993-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use LENTINUS 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use LEPTIN %28%NM%29% 1995-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MAP KINASE KINASE KINASE %28%1992-1999%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MATRILYSIN %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999; for TLV use MAXIMUM ALLOWABLE CONCENTRATION 1976-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MEDETOMIDINE %28%NM%29% 1986-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MIBEFRADIL 1989-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MICROBODIES 1976-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MICROSCOPY, ATOMIC FORCE 1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MOCLOBEMIDE %28%NM%29% 1982-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MULTIPLE SYSTEM ATROPHY 1998-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use MUSCULAR DYSTROPHIES 1980-1999; for MUSCULAR DYSTROPHY, BECKER %26% BECKER MUSCULAR DYSTROPHY use MUSCULAR DYSTROPHIES 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use NERVE GROWTH FACTORS 1966-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use NEUREGULIN-1 %28%NM%29% 1993-1999; for GLIAL GROWTH FACTOR use GLIA MATURATION FACTOR %28%NM%29% 1980-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use NEUREGULINS %28%NM%29% 1986-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use NEUROTROPHIN 3 %28%NM%29% 1990-1999; for NERVE GROWTH FACTOR 2 use NERVE GROWTH FACTORS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use NEUTROPHIL COLLAGENASE %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use OMEGA-AGATOXIN IVA %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use OMEGA-CONOTOXIN GVIA %28%NM%29% 1984-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ONCOGENE PROTEINS V-MYB %28%NM%29% 1986-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ONCOGENE PROTEINS V-REL %28%NM%29% 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ONCOGENE PROTEINS V-SIS %28%NM%29% 1983-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ONCOGENES 1985-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ONCOGENES 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use OPHTHALMOPLEGIA 1981-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PARKINSON DISEASE 1992-1999; for DIFFUSE LEWY BODY DISEASE %26% LEWY BODY DISEASE, DIFFUSE use PARKINSON DISEASE 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PERINDOPRIL %28%NM%29% 1985-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use POLYRADICULONEUROPATHY 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PONS 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PROSTATECTOMY 1999; for PROSTATECTOMY, TRANSURETHRAL use PROSTATECTOMY 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PROTEIN CONFORMATION %28%1993-1999%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PROTEINS 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PROTO-ONCOGENE PROTEINS C-MYB %28%NM%29% 1986-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PROTO-ONCOGENE PROTEINS C-REL %28%NM%29% 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use PROTO-ONCOGENE PROTEINS C-SIS %28%NM%29% 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAB2 GTP-BINDING PROTEIN %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAB3 GTP-BINDING PROTEIN %28%NM%29% 1990-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAB4 GTP-BINDING PROTEINS %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAB5 GTP-BINDING PROTEINS %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RACLOPRIDE 1985-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAL GTP-BINDING PROTEINS %28%NM%29% 1993-1999; for RAL A PROTEIN use RAL GTP-BINDING PROTEINS %28%NM%29% 1993-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RALOXIFENE %28%NM%29% 1983-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAN GTP-BINDING PROTEIN %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAP GTP-BINDING PROTEINS %28%NM%29% 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RAS-GRF1 %28%NM%29% 1992-1999; for RAS-GRF use RAS-GRF1 %28%NM%29% 1995-1999;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RECEPTOR, CILIARY NEUROTROPHIC FACTOR %28%NM%29% 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RECEPTOR, ERBB-3 %28%NM%29% 1990-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RECEPTOR, PDGF ALPHA %28%NM%29% 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RECEPTOR, PDGF BETA %28%NM%29% 1994-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RECEPTOR, TYPE 1 NEUROTROPHIC TYROSINE KINASE%28%NM%29% 1990-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RECEPTOR, TYPE 3 NEUROTROPHIC TYROSINE KINASE %28%NM%29% 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RHO GTP-BINDING PROTEINS %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RHOA GTP-BINDING PROTEIN %28%NM%29% 1991-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use RHOB GTP-BINDING PROTEIN %28%NM%29% 1988-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ROLIPRAM %28%NM%29% 1979-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SELENIOUS ACID %28%NM%29% 1974-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SINGLE PARENT %28%1989-1999%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SLEEP DISORDERS 1981-1999; for SLEEP TERROR DISORDER use SLEEP DISORDERS 1981-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SON OF SEVENLESS PROTEINS %28%NM%29% 1992-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SOS1 PROTEIN %28%NM%29% 1992-1999; for MSOS1 PROTEIN use GUANINE NUCLEOTIDE EXCHANGE FACTORS %28%NM%29% 1996-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SPINOCEREBELLAR DEGENERATION 1987-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use SUBSTANTIA INNOMINATA 1984-1999; for NUCLEUS BASALIS OF MEYNERT %26% NUCLEUS BASALIS MAGNOCELLULARIS use SUBSTANTIA INNOMINATA 1984-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use TEA TREE OIL %28%NM%29% 1993-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use TISSUE KALLIKREIN %28%NM%29% 1983-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use VIGABATRIN 1977-1999 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; use ZINGIBERALES 1998-1999, use SPICES 1993-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000; was RECEPTORS, MACROPHAGE COLONY-STIMULATING FACTOR 1993-1999; was RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR 1991-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000A' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000B' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2000C' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001 %28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001 %28%1989%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001 %28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1966%29%; for TRIACYLGLYCEROL use TRIGLYCERIDES %28%NM%29% 1976-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1967%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1967%29%; for S-%28%2-AMINOETHYL%29%ISOTHIOTHIOUREA use ISOTHIUREA, %28%BETA-AMINOETHYL%29% %28%NM%29% 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1968%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1969%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1972%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1973%29%; for %28%1-HYDROXYETHLENE%29%DIPHOSPHONIC ACID use ETIDRONAT DISODIUM %28%NM%29% 1987-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1975%29%; use AMINOBUTYRIC ACIDS 1966-1974 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1976%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1980%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1984%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1986%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1991%29%; for FIBROBLAST GROWTH FACTOR-2 use FIBROBLAST GROWTH FACTOR 2 %28%NM%29% 1995; for PROSTATROPIN use FIBROBLAST GROWTH FACTOR 2 %28%NM%29% 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1994%29%; for GASTROSPIRILLUM SUIS use GASTROSPIRILLUM 1993-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1994%29%; use DIDS %28%NM%29% 1977-93 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1994%29%; use TRANSFECTION 1988-93 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001%28%1995%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001, 1965-1971%28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-02-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-03-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-05-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-07-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-07-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-05' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-08-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-09-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-11-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-12-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-12-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001-12-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CHLAMYDIA PSITTACI 1976-2000, see MIYAGAWANELLA 1963-75%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; 1,3-OXAZOLIDINE-2-ONE %28%now OXAZOLIDIONES%29% was indexed under OXAZOLES 1995-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; ADRENERGIC BETA-3 RECEPTOR now RECEPTORS, ADRENERGIC, BETA-3 was indexed under RECEPTORS, ADRENERGIC, BETA 1977-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; ANTIFREEZE GLYCOPROTEINS %28%now ANTIFREEZE PROTEINS%29% was indexed under GLYCOPROTEINS 1983-2000 %26% PEPTIDES 1980-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; ANTIFREEZE GLYCOPROTEINS, TYPE IV was indexed under GLYCOPROTEINS 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; C-EBP BETA %28%now CCAAT-ENHANCER-BINDING PROTEIN-BETA%29% was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1994-2000; LIVER-ENRICHED INHIBITING PROTEIN was indexed under REPRESSOR PROTEINS 1995-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; C-EBP NUCLEAR PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1989-2000; CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1988-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; C-EBPALPHA use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1996-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; C-EBPALPHA was indexed under NUCLEAR PROTEINS %26% DNA-BINDING PROTEINS 1996-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; CCAAT-BINDING FACTOR was indexed under DNA-BINDING PROTEINS 1988-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; CD40L was indexed under MEMBRANE GLYCOPROTEINS 1992-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; DEFENSINS was indexed under PROTEINS %28%1999-2000%29% %26% BLOOD PROTEINS %28%1985-1998%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE was indexed under DIPHTHERIA-TETANUS-PERTUSSIS VACCINE 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; DT VACCINE %28%now DIPHTHERIA-TETANUS VACCINE%29% was indexed under DIPHTHERIA TOXOID %26% TETANUS TOXOID 1983-2000; VACCINES, COMBINED 1994-2000; and DRUG COMBINATIONS 1983-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; Deoxyribozyme %28%now DNA, CATALYTIC%29% was indexed under DNA, SINGLE-STRANDED 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; ESCHERICHIA COLI VACCINE was indexed under BACTERIAL VACCINES 1983-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; EUCHROMATIN was indexed under CHROMATIN 1981-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; FIBROBLAST GROWTH FACTOR-2 was indexed under FIBROBLAST GROWTH FACTOR, BASIC 1996-2001 %26% under FIBROBLAST GROWTH FACTOR 1995; PROSTATROPIN was indexed under NERVE TISSUE PROTEINS 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; FK 506 BINDING PROTEIN %28%now TACROLIMUS BINDING PROTEINS%29% was indexed under IMMUNOPHILINS 1999-2000 %26% under CARRIER PROTEINS, DNA-BINDING PROTEINS, %26% HEAT SHOCK PROTEINS 1991-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; FK 506 BINDING PROTEIN %28%now TACROLIMUS BINDING PROTEINS%29% was indexed under IMMUNOPHILINS 1999-2000 %26% under HEAT-SHOCK PROTEINS, DNA-BINDING PROTEINS, %26% CARRIER PROTEINS 1991-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; Hepatitis A Vaccine was indexed under VIRAL HEPATITIS VACCINES 1992-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; INTERLEUKIN 8 RECEPTOR was indexed under RECEPTORS, INTERLEUKIN 1994-2000, ANTIGENS, CD 1989-2000, %26% RECEPTORS, IMMUNOLOGIC 1989-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; INTERLEUKIN-8 RECEPTOR TYPE B was indexed under RECEPTORS, CHEMOKINE 1998-2000 %26% RECEPTORS, INTERLEUKIN 1994-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; MEASLES, MUMPS, RUBELLA VACCINE was indexed under MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE, %26% VACCINES, COMBINED 1986-2000 and under DRUG COMBINATIONS 1986-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; MENINGOCOCCAL VACCINE was indexed under BACTERIAL VACCINES 1983-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; MICROBICIDAL CATIONIC PROTEINS %28%now ANTIMICROBIAL CATIONIC PEPTIDES%29% was indexed under PROTEINS 1981-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; PNEUMOVAX %28%now PNEUMOCOCCAL VACCINES%29% was indexed under BACTERIAL VACCINES 1983-2000 %26% POLYSACCHARIDES, BACTERIAL 1978-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; PSUEDORABIES VACCINE was indexed under VIRAL VACCINES 1992-2000 %26% VACCINES, ATTENUATED 1992-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; SHIGA TOXIN was indexed under BACTERIAL TOXINS 1980-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; SHIGA-LIKE TOXIN 1 was indexed under BACTERIAL TOXINS 1984-2000; SHIGA TOXIN 1 %26% STX1 PROTEIN was indexed under BACTERIAL TOXINS 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; SHIGA-LIKE TOXIN II was indexed under BACTERIAL TOXINS 1988-2000; SHIGA TOXIN 2 %26% STX2 PROTEIN was indexed under BACTERIAL TOXINS 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; TRIACYLGLYCEROL was indexed under TRIGLYCERIDES 1976-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN %26% VERO TOXIN were indexed under BACTERIAL TOXINS 1980-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for AEROBACTER AEROGENES see KLEBSIELLA PNEUMONIAE 1992-2000, ENTEROBACTER 1976-1991, %26% AEROBACTER AEROGENES 1963-1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for AEROBACTER AEROGENES use KLEBSIELLA PNEUMONIAE 1992-2000 %26% ENTEROBACTER 1963-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for BESNOITIA see EIMERIINA 1992-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for BESNOITIA use EIMERIIDA 1992-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for C-EBP NUCLEAR PROTEIN use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1989-2000; for CCAAT SEQUENCE-SPECIFIC DNA-BINDING PROTEINS use CCAAT-ENHANCER BINDING PROTEINS 1988-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for COMPLEMENTARITY DETERMINING REGION and HYPERVARIABLE REGION see IMMUNOGLOBULIN VARIABLE REGION 1988-2000; COMPLEMENTARITY-DETERMINING REGION 3 was indexed under COMPLEMENTARITY DETERMINING REGIONS 1998-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for COMPLEMENTARITY DETERMINING REGION and HYPERVARIABLE REGION use IMMUNOGLOBULIN VARIABLE REGION 1988-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for HEAT PRODUCTION see BODY TEMPERATURE REGULATION 1975-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for HEAT PRODUCTION use BODY TEMPERATURE REGULATION 1975-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for MONOSPORIUM APIOSPERMUM see PSEUDALLESCHERIA 1986-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for NUCLEAR ENVELOPE see NUCLEAR MEMBRANE 1977-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for TUMOR XENOGRAFT ASSAY see SUBRENAL CAPSULE ASSAY %28%1988-2000%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for TUMOR XENOGRAFT ASSAY use SUBRENAL CAPSULE ASSAY %28%1988-2000%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for UTEROPLACENTAL CIRCULATION see UTEROPLACENTAL CIRCULATION 1995-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; for VERO CYTOTOXIN, VERO CELL CYTOTOXIN, VERO TOXIN %26% VERO TOXIN use SHIGA-LIKE TOXIN I %28%NM%29% 1980-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see AET 1967-2000; for S-%28%2-AMINOETHYL%29%ISOTHIOTHIOUREA see ISOTHIUREA, %28%BETA-AMINOETHYL%29% 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see AORTIC VALVE STENOSIS 1980-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see AORTIC VALVE STENOSIS 1986-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see APROCARB 1972-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see BERBINES 1969-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CENTROSOME 1993-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CHLOROFLUOROCARBONS, METHANE 1984-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CHOLERA VACCINE 1965-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CHROMOSOMES, HUMAN, 21-22 1968-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see COMPOUND 48-80 1963-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CONTRACEPTION, IMMUNOLOGIC %28%1996-2000%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see CYTOPLASMIC GRANULES 1980-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see DIDS 1981-2000; 4,4%27%-DISOTHIOCYANOSTILBEN-2,2%27%-DISULFONIC ACID was indexed under SITS/analogs %26% derivatives 1981-1993 %26% STILBENES 1977-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see DIVERTICULOSIS, COLONIC 1963-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see DMPP 1991-2000 %26% PIPERAZINES 1972-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see DOM 1991-2000 %26% AMPHETAMINES 1973-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see EPN 1991-2000 %26% INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see ERGOTAMINE DERIVATIVES 1978-2001, see ERGOTAMINE 1975-1977, see ERGOLINES 1969-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see ETIDRONATE DISODIUM 1993-2000, see SODIUM ETIDRONATE 1977-1991, see DIPHOSPHONATES 1973-1976; %28%1-HYDROXYETHYLENE%29%DIPHOSPHONIC ACID was indexed under DIPHOSPHONATES 1987-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see FIBROBLAST GROWTH FACTOR 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see FREONS 1977-2000, see HYDROCARBONS, HALOGENATED 1973-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see GABA 1979-2001, see AMINOBUTYRIC ACIDS 1975-1978, see AMINOBUTYRIC ACID 1963-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see GASTROSPIRILLUM HOMINUS 1993-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see GENE TRANSFER 1994-2000; see TRANSFECTION 1988-93%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see GLASGOW COMA SCALE 1990-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see GLOBIN 1972-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see HAEMOSPORINA 1992-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see HEMODIALYSIS 1967-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see HTLV-I 1989-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see MCPA 1991-2000 %26% GLYCOLATES 1975-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see MEMORY 1998-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see NBD CHLORIDE 1991-2000 %26% OXADIAZOLES 1976-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see NUCLEAR MEMBRANE 1977-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see PALATE 1998-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see PEPTIDYLPROLYL ISOMERASE 1998-2000, was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see POLYOMAVIRUS MACACAE 1994-2001, see SV40 VIRUS 1965-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see PREGNANCY IN DIABETICS 1965-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see RABIES VACCINE 1963-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see SHIVERING 1977-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see SITS 1991-2000 %26% STILBENES 1980-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see SLEEP DISORDERS, CIRCADIAN RHYTHM 2000; for CHRONOBIOLOGY DISORDERS see SLEEP DISORDERS, CIRCADIAN RHYTHM 2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see STAINING 1996-2000, see STAINS AND STAINING 1963-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see Signal Peptides 1986-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see TYPHOID 1963-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see VARICELLOVIRUS 1994-2000; for EQUINE RHINOPNEUMONITIS VIRUS see HERPESVIRUS 1, EQUID 1994-2000, EQUINE RHINOPNEUMONITIS VIRUS 1991-1993, HERPESVIRIDAE 1981-1990, %26% HERPESVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; see VIOLENCE 1981-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use ANTIFREEZE PROTEINS %28%NM%29% 1980-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use ANTIFREEZE PROTEINS %28%NM%29% 1997-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use ANTIMICROBIAL CATIONIC PEPTIDES %28%NM%29% to search MICROBICIDAL CATIONIC PROTEINS 1981-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use AORTIC VALVE STENOSIS 1980-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use AORTIC VALVE STENOSIS 1986-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1988-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CCAAT-ENHANCER-BINDING PROTEINS %28%NM%29% 1994-2000; for LIVER-ENRICHED INHIBITING PROTEIN use CCAAT-ENHANCER-BINDING PROTEIN-BETA %28%NM%29% 1995-2000;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CD40 LIGAND %28%NM%29% to search CD40L 1992-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CENTROSOME 1993-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CHLAMYDIA PNEUMONIAE 1992-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CHLOROFLUOROCARBONS, METHANE 1984-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CONTRACEPTION, IMMUNOLOGIC %28%1996-2000%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use CYTOPLASMIC GRANULES 1980-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use DEFENSINS %28%NM%29% to search DEFENSINS 1985-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use DIPHTHERIA-TETANUS VACCINE %28%NM%29% to search DT VACCINE 1983-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES %28%NM%29% to search DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINE 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use DNA, CATALYTIC %28%NM%29% 1997-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use ESCHERICHIA COLI VACCINES %28%NM%29% to search ESCHERICHIA COLI VACCINE 1983-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use EUCHROMATIN %28%NM%29% 1981-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use GLASGOW COMA SCALE 1990-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use HEPATITIS A VACCINES %28%NM%29% to search HEPATITIS A VACCINE 1992-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use HOSPITAL-PHYSICIAN JOINT VENTURES 1996-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use MEASLES-MUMPS-RUBELLA VACCINE %28%NM%29% to search MEASLES, MUMPS, RUBELLA VACCINE 1986-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use MEMORY 1998-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use MENINGOCOCCAL VACCINES %28%NM%29% to search MENINGOCOCCAL VACCINE 1983-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use NUCLEAR ENVELOPE 1977-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use OXAZOLIDINONES %28%NM%29% 1995-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use PALATE 1998-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use PEPTIDYLPROLYL ISOMERASE 1998-2000 %26% PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use PNEUMOCOCCAL VACCINES %28%NM%29% to search PNEUMOVAX 1978-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use PSEUDORABIES VACCINES %28%NM%29% to search PSEUDORABIES VACCINE 1992-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use RECEPTORS, ADRENERGIC, BETA-3 %28%NM%29% 1977-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use RECEPTORS, INTERLEUKIN-8A %28%NM%29% to search INTERLEUKIN 8 RECEPTOR 1989-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use RECEPTORS, INTERLEUKIN-8B %28%NM%29% to search INTERLEUKIN-8 RECEPTOR TYPE B 1994-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use SHIGA TOXINS %28%NM%29% 1980-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use SHIGA-LIKE TOXIN I %28%NM%29% 1984-2000; for SHIGA TOXIN 1 %26% STX1 PROTEIN use SHIGA TOXIN %28%NM%29% 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use SHIGA-LIKE TOXIN II %28%NM%29% 1988-2000; for SHIGA TOXIN 2 %26% STX2 PROTEIN use SHIGA TOXIN %28%NM%29% 1997-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use SHIVERING 1977-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use SLEEP DISORDERS, CIRCADIAN RHYTHM 2000; for CHRONOBIOLOGY DISORDERS use SLEEP DISORDERS, CIRCADIAN RHYTHM 2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use TACROLIMUS BINDING PROTEINS %28%NM%29% 1991-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use VARICELLOVIRUS 1994-2000; for EQUINE RHINOPNEUMONITIS VIRUS use HERPESVIRUS 1, EQUID 1994-2000, EQUINE RHINOPNEUMONITIS VIRUS 1973-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001; use VIOLENCE 1981-2000 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2001A' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1963%29%; for CILARY DYSKINESIA, PRIMARY use CILIARY MOTILITY DISORDERS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1963%29%; for MOUSE ELBERFELD VIRUS use ENCEPHALOMYOCARDITIS VIRUS 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1966%29%; was MOUSE LEUKEMIA VIRUSES 1966-93; for GRAFFI VIRUS use GRAFFI VIRUS 1991, use MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI%27%S CHLOROLEUKEMIC STRAIN use GRAFFI VIRUS 1975-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1974%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1977%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1978%29%; was SIMIAN SARCOMA VIRUSES 1978-93 %28%see under BUNYAVIRIDAE 1989-90, see under RETROVIRIDAE 1981-88, see under LEUKOVIRUSES 1978-80%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1979%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1980%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1984%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1985%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1987%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1989%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1989%29%; was STLV-I 1989-93 %28%see under SIMIAN RETROVIRUSES 1989-90%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1990%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1991%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1994%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1994%29%; for HTLV VIRUSES use HTLV VIRUSES 1989-1993, use HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES %26% LEUKEMIA VIRUSES, HUMAN T-CELL use HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, use HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES %26% T-CELL LEUKEMIA VIRUSES, HUMAN use HTLV VIRUSES 1989-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%1997%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002 %28%2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1963%29%; for BONNEVIE-ULLRICH SYNDROME use SEX CHROMOSOME ABNORMALITIES 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1966%29%; for BETA-HYDROXYTYROSINE use DIHYDOXYPHENYLALANINE %28%NM%29% 1989-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1968%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1969%29%; for LACTIC DEHYDROGENASE VIRUSES use LACTATE DEHYDROGENASE VIRUS 1977-1993, use RILEY VIRUS 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1971%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1971%29%; use ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1984-1988; for ACTOMYOSIN ATPASE use ADENOSINETRIPHOSPHATASE 1985-1988%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1975%29%; use IMIDAZOLES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1975%29%; use VIRGINIAMYCIN 1981-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1975%29%; was see under ANEMIA, APLASTIC 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1975%29%; was see under CYPRINODONTIFORMES 1987-90; was see under FISHES 1975-86%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1976%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1982%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1983%29%; for F%28%1%29%F%28%0%29%-ATPASE use PROTON-TRANSLOCATING ATPASES %28%NM%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1984%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1984%29%; for AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER %26% AE1 GENE PRODUCT use CHLORIDE-BICARBONATE ANTIPORTERS %28%NM%29% 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1985%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1986%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1991%29%; for FIBROBLAST GROWTH FACTOR-1 use FIBROBLAST GROWTH FACTOR 1%28%NM%29% 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1993%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1994%29%; for THEILER%27%S VIRUS use ENCEPHALOMYELITIS, MURINE 1992-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1995%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1996%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1997%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%1998%29%; use 3,4-DICHLORO-N-METHYL-N-%28%2-%28%1-PYRROLIDINYL%29%-CYCLOHEXYL%29%-BENZENEACETAMIDE, %28%TRANS%29%-ISOMER %28%NM%29% 1982-97%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%2000%29%; use CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE %28%NM%29% 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002%28%2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1963-1985; see POLYGONACEAE 1998-2001, see PLANTS, MEDICINAL 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1963-1985; use POLYGONACEAE 1998-2001, use PLANTS, MEDICINAL 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1963-1991; see PLANTS, TOXIC 1986-1990; for MANDRAKE, EUROPEAN see PLANTS, TOXIC 1997-2001; see MANDRAGORA 1986-96%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1963-1993; see APHTHOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1963-1993; use APHTHOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1963-1996; use PLANTS, TOXIC 1997-2001; for MANDRAKE, EUROPEAN use PLANTS, TOXIC 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1971-1991; use DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCRYPTINE MESYLATE use ERGOLOID MESYLATES 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1975-1991; use DIHYDROERGOTOXINE 1992-2001, for DIHYDROERGOCRISTINE MESYLATE use ERGOLOID MESYLATES 1977-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1975-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1977-1991; use DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCORNINE MESYLATE use ERGOLOID MESYLATES 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1977-1993; see HEPATOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1977-1993; use HEPATOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1981-1993; use VIRGINIAMYCIN 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002, 1983-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-01-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-06-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-07-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-07-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-07-12' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-07-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-07-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-07-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-08-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-08-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-09-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-09-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-10-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-10-23' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-10-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-10-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-10-31' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-11-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002-11-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002: see CALIFORNIA GROUP VIRUSES 1991-2001, see BUNYAVIRIDAE 1981-1990, see ENCEPHALITIS VIRUSES 1977-1980; for CALIFORNIA VIRUS see ARBOVIRUSES 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002: see PEANUTS 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; HEYMAN%27%S NEPHRITIS ANTIGEN GP330 was indexed under MEMBRANE GLYCOPROTEINS 1989-2001 %26% ANTIGENS, SURFACE 1986-1988; ANTIGEN GP330, NEPHRITIS was indexed under MEMBRANE GLYCOPROTEINS 1989-2001%26% ANTIGENS, SURFACE 1988; RENAL GLYCOPROTEIN GP330 was indexed under MEMBRANE GLYCOPROTEINS 1991-2001; GP330 ANTIGEN was indexed under MEMBRANE GLYCOPROTEINS 1991-2001; LPR-2 was indexed under MEMBRANE GLYCOPROTEINS 1996-2001; LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEINS 2 was indexed under MEMBRANE GLYCOPROTEINS 1994-2001; MEGALIN was indexed under MEMBRANE GLYCOPROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; NA+-INDEPENDENT NEUTRAL AMINO ACID TRANSPORTER was indexed under CARRIER PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CARP 1991-2001, see CYPRINIDAE 1975-90 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DIHYDROERGOTOXINE 1975-2001, for DIHYDROERGOCRISTINE MESYLATE see ERGOLOID MESYLATES 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HAGFISH 1991-2001, see CYCLOSTOMES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VIRGINIAMYCIN 1991-2001, see VIRGINIAMYCINS 1981-1990 , see MIKAMYCINS 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use 6-PHOSPHOFRUCTOKINASE 1993-2001, use PHOSPHOFRUCTOKINASE 1965-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HYDROXYMETHYLGLUTARYL COA REDUCTASES %28%NM%29% 1981-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; %28%1983%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; 2002; see VITAMIN D-BINDING PROTEIN 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; 4F2 ANTIGEN, HEAVY CHAIN was indexed under CARRIER PROTEINS %26% ANTIGENS, CD 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; 6-PHOSPHOFRUCTO-2-KINASE was indexed under PHOSPHOTRANSFERASES %28%NM%29% 1993-2001, under PHOSPHOTRANSFERASES, ATP %28%NM%29% 1981-1993; FRUCTOSE-2,6-BISPHOSPATASE was indexed under PHOSPHORIC MONOESTER HYDROLASES %28%NM%29% 1983-2001; 6-PHOSPHOFRUCTO-2-KINASE-FRUCTOSE-2,6-BISPHOSPHATASE was indexed under FRUCTOSE-BISPHOSPHATASE %28%NM%29% 1990-2001, under MULTIENZYME COMPLEXES %28%NM%29% 1990-2001, under PHOSPHOFRUCTOKINASE-1 %28%NM%29% 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ACTIVIN RECEPTOR TYPE I was indexed under RECEPTORS, GROWTH FACTOR 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ACTIVIN RECEPTOR TYPE II was indexed under RECEPTORS, GROWTH FACTORS 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ACTIVIN RECEPTORS was indexed under RECEPTORS, GROWTH FACTOR%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ACTIVIN was indexed under INHIBIN 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; AGAMOUS PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ALPHA-2-MACROGLOBULIN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1981-2000; APOLIPOPROTEIN E RECEPTOR was indexed under RECEPTORS, LIPOPROTEIN 1994-2001 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; AMINO ACID PERMEASE was indexed under PERMEASES 1981-2001; AMINO ACID TRANSPORTER was indexed under CARRIER PROTEINS 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; AMINO ACID TRANSPORTER A was indexed under CARRIER PROTEINS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ANDROGEN-DEPENDENT EPIDIDYMAL SECRETORY PROTEIN was indexed under METALLOPROTEINS 1987-2001, TESTICULAR HORMONES 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ANIMALS, TRANSGENIC was heading 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ANION TRANSPORT PROTEINS was indexed under CARRIER PROTEINS 1983-2001 %26% MEMBRANE PROTEINS 1980-1982; for ANION PUMP %26% ANION PUMPS use ION PUMPS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ANTIGEN 4F2 %28%now ANTIGENS, CD98%29% was indexed under CARRIER PROTEINS 1996-2001, under ANTIGENS CD 1996-2001, %26% under ANTIGENS, SURFACE 1989-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ATP SYNTHETASE COMPLEX was indexed under MULTIENZYME COMPLEXES 1980-2001, PHOSPHOTRANSFERASES %28%PHOSPHATE GROUP ACCEPTOR%29% 1994-2001, PHOSPHOTRANSFERASES, ATP 1977-1993, PHOSPHOTRANSFERASES 1972-1976 %26% ATP 1972-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ATRC1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1992-2001; CAT-1 TRANSPORTER was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; BCRA2 PROTEIN was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; CARBOXYPEPTIDASE U %28%NM%29% was indexed under CARBOXYPEPTIDASES 1994-2001; for ARGININE CARBOXYPEPTIDASE see LYSINE CARBOXYPEPTIDASE 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; CAT-2 GENE PRODUCT was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; CATIONIC AMINO ACID TRANSPORTER, MAMMALIAN %28%now AMINO ACID TRANSPORT SYTEMS, BASIC%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; CDC42 PROTEIN, FUNGAL %28%now CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE%29% was indexed under CELL CYCLE PROTEINS %26% G-PROTEINS 1996-1999 %26% FUNGAL PROTEINS 1991-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; CELLULAR APOPTOSIS SUSCEPTABILITY PROTEIN was indexed under PROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; CHLORIDE-BICARBONATE EXCHANGER %28%now CHLORIDE-BICARBONATE ANTIPORTERS%29% was indexed under ANTIPORTERS 1994-2001 %26% under CARRIER PROTEINS 1984-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; DEFICIENS PROTEIN was indexed under HOMEODOMAIN PROTEINS 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; DEFICIENS-AGAMOUS-LIKE PROTEINS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; DIAZEPAM BINDING INHIBITOR was indexed under CARRIER PROTEINS 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; DICARBOXYLATE TRANSPORT PROTEIN %28%now DICARBOXYLIC ACID TRANSPORTERS%29% was indexed under CARRIER PROTEINS 1981-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; DNA TOPOISOMERASE IV was indexed under TYPE II DNA TOPOISOMERASE 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ECDYSTEROIDS was indexed under STEROIDS 1992-2001and INVERTEBRATE HORMONES 1976-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ELEUTHEROCOCC %28%now ELEUTHEROCOCCUS%29% was indexed under PLANT EXTRACTS 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; EXCITATORY AMINO ACID TRANSPORTER 2 was indexed under RECEPTORS, NEUROTRANSMITTER 1995-2001; GLUTAMATE TRANSPORTER was indexed under ABC TRANSPORTERS 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; F2-ISOPROSTANE %28%now F2-ISOPROSTANES%29% was indexed under DINOPROST 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; FIBROBLAST GROWTH FACTOR-1 was indexed under FIBROBLAST GROWTH FACTOR ACIDIC 2001, FIBROBLAST GROWTH FACTOR 2000-2001 %26% under FIBROBLAST GROWTH FACTOR, BASIC 1998-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; GLUTAMATE TRANSLOCASE was indexed under ABC TRANSPORTERS 1996-2001, under GLYCOPROTEINS 1979-1995 %26% under GLUTAMATES/me 1979-1989; GLUTAMATE TRANSPORTER was indexed under ABC TRANSPORTERS 1996-2001, under GLYCOPROTEINS 1989-1995 %26% under GLUTAMATES/me 1989; GLUTAMATE TRANSPORT GLYCOPROTEIN was indexed under ABC TRANSPORTERS 1996-2001 %26% under GLYCOPROTEINS 1990-1995; GLUTAMATE-ASPARTATE TRANSPORTER%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; H+-PI SYMPORTER was indexed under CARRIER PROTEINS 1991-2001; PROTON-PHOSPHATE SYMPORTER was indexed under CARRIER PROTEINS 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; HEPARIN-BINDING PROTEIN 44, 39-KDA RECEPTOR-ASSOCIATED PROTEIN %26% 39KDA-RAP were indexed under CARRIER PROTEINS %26% GLYCOPROTEINS 1992-2001; ALPHA2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN %26% ALPHA2-MRAP were indexed under CARRIER PROTEINS %26% GLYCOPROTEINS 1994-2001; LDL RECEPTOR-ASSOCIATED PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1997-2001; LPRAP1 GENE PRODUCT was indexed under RECEPTORS, IMMUNOLOGIC 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; HMG I-C PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS 1993-2001, under TRANSCRIPTION FACTORS 1993-2001; HMGI-C PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; HMG I-TYPE PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; HMGY PROTEIN was indexed under HIGH MOBILITY GROUP PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; IMPORTIN %28%now KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS 1995-2001; TRANSPORTIN %28%now KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; INWARD RECTIFIER POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2003-2005, POTASSIUM CHANNELS 1999-2002, %26% MEMBRANE PROTEINS 1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; KARYOPHERIN ALPHA %28%now ALPHA KARYOPHERINS%29% was indexed under NUCLEAR PROTEINS 1994-2001; IMPORTIN-ALPHA was indexed under NUCLEAR PROTEINS 1995-2001; NLS-BINDING PROTEIN, NLSBP %26% NUCLEAR LOCALIZATION SIGNAL-BINDING PROTEIN were indexed under NUCLEAR PROTEINS %26% PHOSPHOPROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; KARYOPHERIN BETA %26% IMPORTIN-BETA were indexed under NUCLEAR PROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; LARGE NEUTRAL AMINO ACID TRANSPORTER %28%LNAA%29% was indexed under CARRIER PROTEINS 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 was indexed under CARRIER PROTEINS 1999-2001; OATP2 %26% OATP2 PROTEIN were indexed under CARRIER PROTEINS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; MANIPULATION, CHIROPRACTIC see CHIROPRACTIC 1992-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; MCM1 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2001 %26% FUNGAL PROTEINS 1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; MEMBRANE PROTEIN E16 was indexed under MEMBRANE PROTEINS 1995-2001; LAT1 PROTEIN was indexed under CARRIER PROTEINS 1999-2001; SCL7A5 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; MIRAA was indexed under PLANT EXTRACTS 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; MONOCARBOXYLIC ACID TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2001; ERYTHROCYTE LACTATE TRANSPORTER was indexed under CARRIER PROTEINS 1995-2001; LACTATE TRANSLOCASE %26% LACTATE TRANSPORTER were indexed under CARRIER PROTEINS 1991-2001; MONOCARBOXYLATE TRANSLOCATOR %26% MITOCHONDRIAL MONOCARBOXYLATE TRANSLOCATOR were indexed under CARRIER PROTEINS 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN was indexed under ABC TRANSPORTERS 1994-2001; MOAT PROTEIN %26% MULTISPECIFIC ORGANIC ANION TRANSPORTER were indexed under CARRIER PROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; NEPHRITIS ANTIGEN, HEYMAN now HEYMANN NEPHRITIS ANTIGENIC COMPLEX was indexed under MEMBRANE GLYCOPROTEINS 1989-2001 %26% under ANTIGENS, SURFACE 1986-1988%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; OAT1 PROTEIN, P-AMINOHIPPURATE TRANSPORTER %26% RENAL PAN TRANSPORTER were indexed under CARRIER PROTEINS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; OCT1 PROTEIN now ORGANIC CATION TRANSPORTER 1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ONCOGENE PROTEIN MIL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2001 and RETROVIRIDAE PROTEINS 1986-1989%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; ORGANISMS, TRANSGENIC was heading 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PERMETHRIN was indexed under PYRETHRINS 1978-2001 %26% PYRETHRUM 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PEROXYNITRITE was indexed under NITRATES 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PHOSPHATE TRANSPORT PROTEINS %26% PHOSPHATE TRANSPORTER were indexed under CARRIER PROTEINS 1991-2001; INORGANIC PHOSPHATE TRANSPORTER was indexed under CARRIER PROTEINS 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PHOSPHATE-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PIC 1 PROTEIN %28%now SUMO-1 PROTEIN%29% was indexed under UBIQUITIN 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PLANTS, TRANSGENIC as heading 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; POLYUBIQUITIN was indexed under UBIQUITIN %26% BIOPOLYMERS 1994-2001, and under POLYMERS 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; POTASSIUM-HYDROGEN ANTIPORTER %28%now POTASSIUM-HYDROGEN ANTIPORTERS%29% was indexed under ANTIPORTERS 1994-2001 %26% under CARRIER PROTEINS %28%1982-1993%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PROTEIN-D-ASPARTATE METHYLTRANSFERASE %28%now PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE%29% was indexed under PROTEIN METHYLTRANSFERASES 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29% was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; S-NITROSO-N-ACETYLPENICILLAMINE was indexed under PENICILLAMINE 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; S-NITROSOGLUTATHIONE was indexed under NITROSO COMPOUNDS 1980-2001, GLUTATHIONE 1980-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SAMBUCUS NIGRA was indexed under SAMBUCUS RIBOSOME-INACTIVATING PROTEIN %28%NM%29% 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SCHWANNOMIN PROTEIN was indexed under MEMBRANE PROTEINS 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SEMINAL PLASMA PROTEINS was indexed under PROTEINS 1979-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SEMINAL VESICLE CLOTTING PROTEIN was indexed under PROTEINS 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SERUM RESPONSE ELEMENT was indexed under DNA-BINDING PROTEINS and NUCLEAR PROTEINS 1988-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SERUM RESPONSE FACTOR was indexed under NUCLEAR PROTEINS 1988-2001 %26% DNA-BINDING PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SINGLET OXYGEN was indexed under OXYGEN 1974-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SODIUM BICARBONATE SYMPORT %28%now SODIUM-BICARBONATE SYMPORTERS%29% was indexed under CARRIER PROTEINS 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; SODIUM, POTASSIUM, CHLORIDE-COTRANSPORTER was indexed under CARRIER PROTEINS 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; TRIPTERYGIUM was indexed under DRUGS, CHINESE HERBAL 1985-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; TUMOR SUPPRESSOR PROTEIN P14ARF was indexed under P14ARF PROTEIN 2002-2005, %26% under PROTEINS 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; WT1 PROTEIN was indexed as DNA-BINDING PROTEINS and TRANSCRIPTION FACTORS 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for 4F2 ANTIGEN, HEAVY CHAIN use ANTIGENS, CD98 %28%NM%29% 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for 6-PHOSPHOFRUCTO-2-KINASE use PHOSPHOTRANSFERASES %28%NM%29% 1993-2001, use PHOSPHOTRANSFERASES, ATP %28%NM%29% 1981-1993; for FRUCTOSE-2,6-BISPHOSPATASE use PHOSPHORIC MONOESTER HYDROLASES %28%NM%29% 1983-2001; for 6-PHOSPHOFRUCTO-2-KINASE-FRUCTOSE-2,6-BISPHOSPHATASE use FRUCTOSE-BISPHOSPHATASE %28%NM%29% 1990-2001, use MULTIENZYME COMPLEXES %28%NM%29% 1990-2001, use PHOSPHOFRUCTOKINASE-1 %28%NM%29% 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for AFRICAN SWINE FEVER-LIKE VIRUSES see AFRICAN SWINE FEVER-LIKE VIRUSES 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ALPHA-2-MACROGLOBULIN RECEPTOR %26% APOLIPOPROTEIN E RECEPTOR use LDL-RECEPTOR RELATED PROTEIN 1 %28%NM%29% 1981-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for AMINO ACID PERMEASE use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1981-2001; for AMINO ACID TRANSPORTER use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for AMINO ACID TRANSPORTER A use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for APPLE see Rosales 1988-2001, see FRUIT 1963-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for APPLE use Rosales 1998-2001, use FRUIT 1963-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for APRICOT see ROSALES 1998-2001, see FRUIT 1963-1997;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for APRICOT use ROSALES 1998-2001, use FRUIT 1963-1997;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ATRC1 use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1992-2001; for CAT-1 TRANSPORTER use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for BANANA see ZINGIBERALES 1998-2001; see FRUIT 1983-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for BANANA use ZINGIBERALES 1998-2001; use FRUIT 1983-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for BIOLOGICAL PUMP %26% METABOLIC PUMP see BIOLOGICAL TRANSPORT ACTIVE 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for BIOLOGICAL PUMP %26% METABOLIC PUMP use BIOLOGICAL TRANSPORT ACTIVE 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for BIOLON see POLYMETHYL METHACRYLATE 1977-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for BIOLON use POLYMETHYL METHACRYLATE 1977-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CAMELLIA %26% THEA see Theales 1999-2001, see TEA 1986-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CAMELLIA %26% THEA use Theales 1999-2001, use TEA 1986-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CARDAMON see ZINGIBERALES 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CARDAMON use ZINGIBERALES 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CASTOR OIL PLANT see EUPHORBIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CASTOR OIL PLANT use EUPHORBIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CAT2 GENE PRODUCT use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CATION PUMPS %26% CATION PUMP see ION PUMPS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CATION PUMPS %26% CATION PUMP use ION PUMPS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CELERY see APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CELERY use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL see CEREBRAL AMYLOID ANGIOPATHY 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CEREBRAL AMYLOID ANGIOPATHY, FAMILIAL use CEREBRAL AMYLOID ANGIOPATHY 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CHLOROPLAST COUPLING FACTOR see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, ADENOSINE TRIPHOSPHATASE F1 1984-92 ADENOSINE TRIPHOSPHATASE F1 1983 %26% CHLOROPLAST COUPLING FACTOR 1978-1983; for CF1 ATPASE, COUPLING FACTOR 0 %26% COUPLING FACTOR 1 see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, ADENOSINE TRIPHOSPHATASE F1 1984-92 %26% ADENOSINE TRIPHOSPHATASE F1 1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CHLOROPLAST COUPLING FACTOR use PROTON TRANSLOCATING ATPASES 1978-2001; for CF1 ATPASE, COUPLING FACTOR 0 %26% COUPLING FACTOR 1 use PROTON TRANSLOCATING ATPASES 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CICUTA MAJOR %26% CICUTA VIROSA see HEMLOCK 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CICUTA MAJOR %26% CICUTA VIROSA use HEMLOCK 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CONIUM MACULATUM see HEMLOCK 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CONIUM MACULATUM use HEMLOCK 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for COXSACKIE A24 VARIANT VIRUS see COXSACKIEVIRUSES A 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for COXSACKIE A24 VARIANT VIRUS use ENTEROVIRUS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for COXSACKIE A9 VIRUS see ENTEROVIRUSES 1979-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for COXSACKIEVIRUSES B see COXSACKIEVIRUSES B 1994-2001, see COXSACKIE B VIRUSES 1979-1993; for PLEURODYNIA VIRUS see COXSACKIE VIRUSES 1963-1978; for ECHOVIRUSES see ECHOVIRUSES 1966-2001; for COXSACKIE A9 VIRUS see COXSACKIEVIRUSES A 1979-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CUMIN see APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for CUMIN use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for DEFICIENS-AGAMOUS-LIKE PROTEINS use MADS DOMAIN PROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for DILL PLANT see APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for DILL PLANT use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for DNA DATABANKS see DATABASES, FACTUAL 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for DNA DATABANKS use DATABASES, FACTUAL 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for E COLI COUPLING FACTOR see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, H%28%+%29%-TRANSPORTING ATPASE 1984-1992 %26% ADENOSINE TRIPHOSPHATASE F1 1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for E COLI COUPLING FACTOR use PROTON TRANSLOCATING ATPASES 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ECHINOPANAX see GINSENG 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ECHINOPANAX use GINSENG 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ECONOMIC VALUE OF LIFE %26% LIFE VALUATION, ECONOMIC see ECONOMIC VALUE OF LIFE 1991-2001; see ECONOMICS 1983-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ENTEROVIRUS-70 see ENTEROVIRUS 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ENTEROVIRUS-70 use ENTEROVIRUS 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for FOWL ADENOVIRUS 1 see AVIADENOVIRUS 1994-2001; for CELO VIRUS see AVIADENOVIRUS 1978-2001, see ADENOVIRUSES 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for FOWL ADENOVIRUS 1 use AVIADENOVIRUS 1994-2001; for CELO VIRUS use AVIADENOVIRUS 1978-2001, use ADENOVIRUSES 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GLUTAMATE TRANSLOCASE use AMINO ACID TRANSPORT SYSTEM X-AG %28%NM%29% 1979-2001; for GLUTAMATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG 1989-2001; for GLUTAMATE TRANSPORT GLYCOPROTEIN use AMINO ACID TRANSPORT SYSTEM X-AG 1990-2001; for GLUTAMATE-ASPARTATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG %28%NM%29% 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GOOSEFOOT see CHENOPODIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GOOSEFOOT use CHENOPODIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GRAPES see Rosales 1988-2001, see FRUIT 1983-1997, see GRAPES 1963-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GRAPES use Rosales 1998-2001, use FRUIT 1983-1997, use GRAPES 1963-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GYMNOTID see ELECTRIC FISH 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for GYMNOTID use ELECTRIC FISH 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for H+-PI SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001; for PROTON-PHOSPHATE SYMPORTER use PHOSPHATE-BINDING PROTEINS 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HEPARIN-BINDING PROTEIN 44, 39-KDA RECEPTOR-ASSOCIATED PROTEIN %26% 39KDA-RAP use LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN %28%NM%29% 1992-2001; for ALPHA2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN %26% ALPHA2-MRAP use LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN %28%NM%29% 1994-2001; for LDL RECEPTOR-ASSOCIATED PROTEIN use HEYMANN NEPHRITIS ANTIGEN COMPLEX %28%NM%29% 1997-2001; for LPRAP1 GENE PRODUCT use LDL-RECEPTOR RELATED PROTEIN 1 %28%NM%29% 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HEREDITARY DISEASES see HEREDITARY DISEASES 1968-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HEYMAN%27%S NEPHRITIS ANTIGEN GP330 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1984-2001; for ANTIGEN GP330, NEPHRITIS use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1988-2001; for RENAL GLYCOPROTEIN GP330 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1991-2001; for GP330 ANTIGEN use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1991-2001; for LPR-2 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1996-2001; for LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEINS 2 use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1994-2001; for MEGALIN use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 1 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG1 use HIGH MOBILITY GROUP PROTEINS 1992-2001; AMPHOTERIN was indexed under HIGH MOBILITY GROUP PROTEINS 1991-2001 %26% CARRIER PROTEINS 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 1 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG1 use HIGH MOBILITY GROUP PROTEINS 1992-2001; for AMPHOTERIN use HMGB1 PROTEIN %28%NM%29% 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 14 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 14 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 17 %26% HMG 17 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 17 %26% HMG 17 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 2 PROTEIN use HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG 2 %26% HMG2 use HIGH MOBILITY GROUP PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG 2 PROTEIN see HIGH MOBILITY GROUP PROTEINS 1985-2001; for HMG 2 %26% HMG2 see HIGH MOBILITY GROUP PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG I-C PROTEIN use HMGA1A PROTEIN %28%NM%29% 1993-2001; for HMGI-C PROTEIN use HMGA2 PROTEIN %28%NM%29% 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMG I-TYPE PROTEIN use HMGA1A PROTEIN %28%NM%29% 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for HMGY PROTEIN use HMGA1B PROTEIN %28%NM%29% 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for INSTITUTIONAL REVIEW BOARD see PROFESSIONAL STAFF COMMITTEES 1982-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for INSTITUTIONAL REVIEW BOARD use PROFESSIONAL STAFF COMMITTEES 1982-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for LANTHANIDES see METALS, RARE EARTH 1976-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for LANTHANIDES use METALS, RARE EARTH 1976-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for LARGE NEUTRAL AMINO ACID TRANSPORTER %28%LNAA%29% use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for LIVER-SPECIFIC ORGANIC ANION TRANSPORTER, LST-1 use ANION TRANSPORT PROTEINS %28%NM%29% 1999-2001; for OATP2 %26% OATP2 PROTEIN use ANION TRANSPORT PROTEINS %28%NM%29% 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MANDRAKE, AMERICAN see Podophyllum 1985-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MANDRAKE, AMERICAN use Podophyllum 1985-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MARBURG VIRUS see MARBURG VIRUS 1991-2001, see RHABDOVIRIDAE 1981-1990, see RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MARBURG VIRUS use MARBURG-LIKE VIRUSES 1991-2001, use RHABDOVIRIDAE 1981-1990, use RHABDOVIRUSES 1978-1980, see RNA VIRUSES 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MEMBRANE PROTEIN E16 use LARGE NEUTRAL AMINO ACID-TRANSPORTER 1 %28%NM%29% 1995-2001; for LAT1 PROTEIN use AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1999-2001; for SLC7A5 use BASIC AMINO ACID TRANSPORT SYSTEMS %28%NM%29% 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MIRAA use MIRAA %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MOLECULAR DIAGNOSTIC TESTING see CYTOGENETIC ANALYSIS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MOLECULAR DIAGNOSTIC TESTING use CYTOGENETIC ANALYSIS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MONOCARBOXYLIC ACID TRANSPORT PROTEIN use ANION TRANSPORT PROTEINS %28%NM%29% 1997-2001; for ERYTHROCYTE LACTATE TRANSPORTER use MONOCARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1995-2001; for LACTATE TRANSLOCASE %26% LACTATE TRANSPORTER use MONOCARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1991-2001; for MONOCARBOXYLATE TRANSLOCATOR %26% MITOCHONDRIAL MONOCARBOXYLATE TRANSLOCATOR use MONOCARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MORAL COMPLICITY see MORALS 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MORAL COMPLICITY use MORALS 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN B use MYOSINS 1982-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN IA %26% MYOSIN IB see MYOSIN 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN IA %26% MYOSIN IB use MYOSINS 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN II see MYOSIN 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN II use MYOSINS 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN V1 %26% MYOSIN V3 use MYOSINS 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for MYOSIN-V P190 use CHICKEN BRAIN MYOSIN-V P190 %28%NM%29% 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for NA+-INDEPENDENT NEUTRAL AMINO ACID TRANSPORTER use AMINO ACID TRANSPORT SYSTEMS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for NAZISM see POLITICAL SYSTEMS 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for NAZISM use POLITICAL SYSTEMS 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for OAT1 PROTEIN, P-AMINOHIPPURATE TRANSPORTER %26% RENAL PAN TRANSPORTER use ANION TRANSPORT PROTEINS 2000-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for OKRA see MALVACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for OKRA use MALVACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ONCOGENE PROTEIN MIL use ONCOGENE PROTEINS V-RAF %28%NM%29% 1986-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PARSLEY see APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PARSLEY use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PARSNIPS see APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PARSNIPS use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT see PATIENT ADVOCACY 1978-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PEROXYNITRITE use PEROXYNITROUS ACID %28%NM%29% 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PHOSPHATE TRANSPORT PROTEINS %26% PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS %28%NM%29% 1991-2001; for INORGANIC PHOSPHATE TRANSPORTER use PHOSPHATE BINDING PROTEINS %28%NM%29% 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PHOTOGRAPHY, INTRAORAL see PHOTOGRAPHY, INTRAORAL %28%2000-2001%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PUMPKINS %26% SQUASHES see CUCURBITACEAE 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for PUMPKINS %26% SQUASHES use CUCURBITACEAE 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RAPESEED see BRASSICA 1977-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RAPESEED use BRASSICA 1977-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for REAVEN SYNDROME X see INSULIN RESISTANCE 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for REAVEN SYNDROME X use INSULIN RESISTANCE 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for REOVIRUS 1 %26% REOVIRUS 2 see ORTHOREOVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for REOVIRUS 1 %26% REOVIRUS 2 use ORTHOREOVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RETROVIRUSES TYPE D see RETROVIRUSES TYPE D 1999-2001, see RETROVIRUSES, TYPE D 1994-1998, see ONCOVIRUSES, TYPE D 1991-1993; for FIBROBLAST VIRUS, HUMAN, PERMANENT see RETROVIRUSES TYPE D 1994-2001, see FIBROBLAST VIRUS, HUMAN, PERMANENT 1991-1993; for RETROVIRUSES TYPE B, MAMMALIAN see RETROVIRUSES TYPE D MAMMALIAN 1994-2001, see ONCOVIRUSES TYPE B, MAMMALIAN 1994-1996, see MAMMARY CANCER VIRUS 1991-1993; for TYPE B ONCOVIRUSES MAMMALIAN see MAMMARY CANCER VIRUS 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RHINOTRACHEITIS VIRUS, TURKEY see PNEUMOVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RHINOTRACHEITIS VIRUS, TURKEY use PNEUMOVIRUS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RUBBER TREE see EUPHORBIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for RUBBER TREE use EUPHORBIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SAFFRON see Liliaceae 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SAFFRON use Liliaceae 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SCHWANNOMIN PROTEIN use NEUROFIBROMIN 2 %28%NM%29% 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SELF DETERMINATION see FREEDOM 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SELF DETERMINATION use FREEDOM 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SEMINAL VESICLE CLOTTING PROTEIN use SEMINAL VESICAL SECRETORY PROTEINS %28%NM%29% 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SPURGE see EUPHORBIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for SPURGE use EUPHORBIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for STICKLEBACKS see FISHES 1975-2001; for MULLETS see PERCIFORMES 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for STICKLEBACKS use FISHES 1975-2001; for MULLETS use PERCIFORMES 1987-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for TRIPTERYGIUM WILFORDII use TRIPTERYGIUM %28%NM%29% 1985-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for TURNIP %26% RUTABAGA see BRASSICA 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for TURNIP %26% RUTABAGA use BRASSICA 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for WITHDRAWING CARE see EUTHANASIA, PASSIVE 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for WITHDRAWING CARE use EUTHANASIA, PASSIVE 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for WT1 PROTEIN use WT1 PROTEINS %28%NM%29% 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ZETA-CAROTENE see CAROTENE 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; for ZETA-CAROTENE use CAROTENOIDS 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; hydroxymethylglutaryl-CoA-reductase %28%NADP%29% now HYDROXYMETHYLGLUTARYL-COA-REDUCTASES, NADP-DEPENDENT was indexed under HYDROXYMETHYLGLUTARYL COA REDUCTASES 1981-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see 6-PHOSPHOFRUCTOKINASE 1993-2001, see PHOSPHOFRUCTOKINASE 1965-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see 6-PHOSPHOFRUCTOKINASE 1993-2001, use PHOSPHOFRUCTOKINASE 1965-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ABC TRANSPORTERS 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ABELSON LEUKEMIA VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1980-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see AKR VIRUS 1991-2001, see MOUSE LEUKEMIA VIRUSES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ALFALFA 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ALTERNATIVE MEDICINE %28%1986-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ALTRUISM 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see AMARANTH 1991-2001, see AZO COMPOUNDS 1975-1990; for C.I. ACID RED 27, C.I. 16185, %26% FD%26%C RED NO. 2 see AMARANTH 1975-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see AMYLOID NEUROPATHIES 1994-2001; for FAMILIAL AMYLOID POLYNEUROPATHIES see AMYLOID NEUROPATHIES 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ANTINEOPLASTIC AGENTS, COMBINED %28%1984-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ASPARTATE TRANSAMINASE 1998-2002, see ASPARTATE AMINOTRANSFERASE 1963-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ASPARTIC ACID 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ASTERACEAE 1998-2001, see HERBS 1995-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Allium 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BACTERIOCHLOROPHYLLS 1991-2001; see CHLOROPHYLL 1983-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BACTERIOPHAGE LAMBDA 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BACTERIORHODOPSIN 1977-2001, see CAROTENOIDS 1976-1986%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BACULOVIRIDAE 1997-2001; for GRANULOSIS VIRUSES see BACULOVIRIDAE 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BAND 3 PROTEIN 1984-2000; AE1 ANION EXCHANGER, AE1 CHLORIDE-BICARBONATE EXCHANGER, AE1 Cl- HCO3- EXCHANGER %26% AE1 GENE PRODUCT were indexed under ANTIPORTERS 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BIOETHICS 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BORRELIA BURGDORFERI 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see BUNYAMWERA VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-80%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Baths, Finnish %28%1963-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CARBONATE DEHYDRATASE 1992-2001, see CARBONIC ANHYDRASE 1963-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CARBONIC DEHYDATASE 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991; for CA I HIROSHIMA-1, CARBONIC ANHYDRASE B see CARBONIC DEHYDRATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B see CARBONIC DEHYDRATASE 1992-2001 %26% CARBONIC ANHYDRASE 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991; for CARBONIC ANHYDRASE C see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1984-1991; for CARBONIC ANHYDRASE ISOENZYME C see CARBONIC DEHYDATASE 1992-2001 %26% CARBONIC ANHYDRASE 1983-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CATFISH 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CH%27%I 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHENOPODIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHROMOSOMAL ABNORMALITIES 1978-1995 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHROMOSOMES, BACTERIAL ARTIFICIAL 2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHROMOSOMES, HUMAN ARTIFICIAL 2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHROMOSOMES, HUMAN, 6-12 1968-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHROMOSOMES, MAMMALIAN ARTIFICIAL 2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CHROMOSOMES, YEAST ARTIFICIAL 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CINNAMON 1991-2001, see CONDIMENTS 1975-1990; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN %28%1992-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN see COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I see PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN %26% PRO ALPHA 2 COLLAGEN see PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN see PROCOLLAGEN 1988-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1985-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE II see PROCOLLAGEN 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III see PROCOLLAGEN 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV see PROCOLLAGEN 1982-2001; for 7S COLLAGEN see COLLAGEN 1982-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1990-2001; for PROCOLLAGEN TYPE V see PROCOLLAGEN 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see COLLAGEN 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CORONARY DISEASE 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CUCUMBERS 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see CUCURBITACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Cannabis 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DIARRHEA VIRUS, BOVINE VIRAL 1994-2001, see BOVINE DIARRHEA VIRUS 1991-1993, see PESTIVIRUSES 1981-1990, see RNA VIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DIHYDROERGOTOXINE 1991-2001; for DIHYDROERGOCRYPTINE MESYLATE see ERGOLOID MESYLATES 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DIHYDROERGOTOXINE 1992-2001; for DIHYDROERGOCORNINE MESYLATE see ERGOLOID MESYLATES 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DNA TOPOISOMERASE %28%ATP-HYDROLYSING%29% 1994-2001, see DNA GYRASE 1980-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% 1994-2001, see DNA GYRASE 1980-1993; GYRA PROTEIN was indexed under DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1992-2001; GYRB PROTEIN was indexed under DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DNA TOPOISOMERASE 1994-2001, see DNA UNTWISTING PROTEINS 1978-1993; for DNA NICKING-CLOSING PROTEIN see DNA NICKING-CLOSING PROTEINS 1978-1993; for DNA RELAXING ENZYME see DNA RELAXING ENZYMES 1978-1993; for DNA UNTWISTING ENZYME see DNA UNTWISTING ENZYMES 1978-1993; for OMEGA PROTEIN see OMEGA PROTEINS 1978-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see DOPA 1966-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Down-Regulation %28%Physiology%29% 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ECHOVIRUS 6 1991-2001, see ECHOVIRUSES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ECHOVIRUS 9 1991-2001, see ECHOVIRUSES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ELECTRIC CONDUCTIVITY 1968-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ENCEPHALOMYELITIS VIRUS, MURINE 1991-2001, see ENTEROVIRUSES 1975-1990, see ENTEROVIRUS 1967-1974, see POLIOVIRUS 1963-1966; for MOUSE ELBERFELD VIRUS see ENCEPHALOMYOCARDITIS VIRUS 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ESTRUS 1975-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ETHICS 1979-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ETHICS 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ETHICS 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ETHICS, MEDICAL 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FABACEAE 1986-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FAD 1963-2001; for FLAVIN-ADENINE DINUCLEOTIDE see FAD 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FANCONI ANEMIA 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FANCONI%27%S ANEMIA 1991-2001; was see under ANEMIA, APLASTIC 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FLA 63 1991-2001 %26% IMIDAZOLES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FRIEND VIRUS 1966-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see FSH 1963-2001; for FOLLICLE STIMULATING HORMONE see FSH 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GASTROENTERITIS VIRUS, MURINE 1994-2001, see HEPATITIS VIRUS, MOUSE 1966-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GASTROENTERITIS VIRUS, PORCINE TRANSMISSIBLE 1994-2001, see GASTROENTERITIS VIRUS OF SWINE 1991-1993, see CORONAVIRIDAE 1981-1990, see CORONAVIRUSES 1975-1980; for TRANSMISSIBLE GASTROENTERITIS VIRUS, SWINE see GASTROENTERITIS VIRUS OF SWINE 1976-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GENE ENGINEERING 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GENES, SUPPRESSOR, TUMOR 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE %28%NADP+%29% %28%PHOSPHORYLATING%29% was indexed under GLYCERALDEHYDEPHOSPHATE DEHYDROGENASE 1991-1998 %26% ALDEHYDE OXIDOREDUCTASES 1991-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see GRASSES 1963-2001; for GRAMINEAE see GRAMINEA 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1993-2001, H%28%+%29%-TRANSPORTING ATPASE 1984-92, ADENOSINE TRIPHOSPHATASE F1 1983; for ATPASE, F0 see ATPASE F%28%0%29% 1984-1992; for ATPASE, F1 see ATPASE F1 1983-1992; for F1F0 ATPASE COMPLEX see H%28%+%29%-TRANSPORTING ATP SYNTHASE 1984-1993; F%28%1%29%F%28%0%29% ATPASE was indexed under ADENOSINE TRIPHOSPHATASE 1979-1985 %26% H%28%+%29%-TRANSPORTING ATP SYNTHASE 1986-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HAMAMELIDAE 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HANTAVIRUS 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HANTAVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HANTAVIRUS 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HARVEY SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1984-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HEPATITIS AGENTS, GB 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HEPATITIS C-LIKE VIRUSES 1997-2001, see HEPATITIS C VIRUSES 1994-1996, see HEPATITIS C VIRUS 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HERPESVIRUS SAIMIRINE 1994-2001, see HERPESVIRUS SAIMIRI 1980-1993, see HERPESVIRUSES 1975-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HERPESVIRUS, KAPOSI SARCOMA-ASSOCIATED 1998-2001, see HERPESVIRUS, KAPOSI%27%S SARCOMA-ASSOCIATED 1997; KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS was KAPOSI%27%S SARCOMA-ASSOCIATED HERPESVIRUS 1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HOG CHOLERA 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HOG CHOLERA VIRUS 1979-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HTLV-BLV INFECTIONS 1995-2001, see HTLV INFECTIONS 1987-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HTLV-BLV VIRUSES 1994-2001; for HTLV VIRUSES see HTLV VIRUSES 1989-1993, see HUMAN T-CELL LEUKEMIA VIRUS 1984-1988; for HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUSES %26% LEUKEMIA VIRUSES, HUMAN T-CELL see HUMAN T-CELL LEUKEMIA VIRUS 1985-1988, see HTLV VIRUSES 1989-1993; for HUMAN T-CELL LEUKEMIA VIRUSES %26% T-CELL LEUKEMIA VIRUSES, HUMAN see HTLV VIRUSES 1989-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see HTLV-II 1989-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see INDIGO CARMINE 1976-2001, see INDOLES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see INDIVIDUALITY 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see INFECTIOUS BRONCHITIS VIRUS, AVIAN 1994-2001, see AVIAN INFECTIOUS BRONCHITIS VIRUS 1991-1993, see CORONAVIRIDAE 1981-1990, see CORONAVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see INFECTIOUS PERITONITIS VIRUS, FELINE 1994-2001, see FELINE INFECTIOUS PERITONITIS VIRUS 1992-1993; for INFECTIOUS PERITONITIS VIRUS, FELINE see FELINE INFECTIOUS PERITONITIS VIRUS 1992-93%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see INHIBIN 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see INOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see IgA 1973-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see IgA, Secretory 1984-2001, see IGA 1976-1983 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see IgD 1973-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see IgE 1973-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see IgG 1973-2001; for GAMMA GLOBULIN, 7S see GAMMA GLOBULIN, 7S 1965-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see IgM 1973-2001; for GAMMA GLOBULIN, 19S see GAMMA GLOBULIN, 19S 1965-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see JAAGSIEKTE SHEEP RETROVIRUS 2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see KARTAGENER%27%S SYNDROME 1990-2001; see KARTAGENER TRIAD 1963-1989; for CILARY DYSKINESIA, PRIMARY see CILIARY MOTILITY DISORDERS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see KILLIFISH 1991-2001, see CYPRINODONTIFORMES 1987-1990, was see FISHES 1975-1986%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see KIRSTEN SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1980-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LACTATE DEHYDROGENASE VIRUS 1977-2001, see RNA VIRUSES 1969-1976; for RILEY VIRUS see RNA VIRUSES 1969-1976, see VERTEBRATE VIRUSES, UNCLASSIFIED 1967-1968; for LACTIC DEHYDROGENASE VIRUSES see LACTATE DEHYDROGENASE VIRUS 1977-1993, was see RILEY VIRUS 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LAMIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LATEX ALLERGY 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LAURACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LAURACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LCM-LASSA COMPLEX VIRUSES 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LEGUMES 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LEUKEMIA VIRUSES, MURINE 1994-2001, see MOUSE LEUKEMIA VIRUSES 1966-1993; for GRAFFI VIRUS see GRAFFI VIRUS 1991, see MOUSE LEUKEMIA VIRUSES 1975-1990; for GRAFFI%27%S CHLOROLEUKEMIC STRAIN see GRAFFI VIRUS 1975-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LINKAGE%28%GENETICS%29% 2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LONG QT SYNDROME 1986-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see LUNG DISEASES, OBSTRUCTIVE 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Liliaceae 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MALVACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MAMMARY TUMOR VIRUSES, MOUSE 1994-2001, see MAMMARY CANCER VIRUS 1966-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MANIPULATION, ORTHOPEDIC 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MARTIAL ARTS 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MEDICINE, HERBAL 1981-2001, see HERBALISM 1963-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MENTAL HEALING 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see METALS, ACTINIDE 1994-2001, see METALS, ACTINOID 1976-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see METHERGOLINE 1991-2001, see ERGOLINES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MISTLETOE 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MITOCHONDRIAL MYOPATHIES 2000-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MOLONEY LEUKEMIA VIRUS 1985-2001, see MOLONEY VIRUS 1966-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MOLONEY SARCOMA VIRUS 1991-2001, see MOUSE SARCOMA VIRUSES 1985-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see MYOSIN 1973-2001, see MUSCLE PROTEINS 1969-1972; see ADENOSINE TRIPHOSPHATASE 1963-1968; for MYOSIN ATPASE see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-1992, see ADENOSINE TRIPHOSPHATASE 1984-1988; for ADENOSINE TRIPHOSPHATASE, MYOSIN %26% MYOSIN ADENOSINETRIPHOSPHATASE see MYOSIN ATPASE 1993-2001; for ACTOMYOSIN ADENOSINETRIPHOSPHATASE %26% ADENOSINETRIPHOSPHATASE, ACTOMYOSIN see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-92; for ACTOMYOSIN ATPASE see MYOSIN ATPASE 1993-2001, see ADENOSINE TRIPHOSPHATASE, MYOSIN 1989-1992, see ADENOSINE TRIPHOSPHATASE 1985-1988%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see NEONATAL DISEASES AND ABNORMALTIES 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see OPTIC ATROPHIES, HEREDITARY 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see OPTIC ATROPHIES, HEREDITARY 2000-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ORBIVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ORTHOREOVIRUS 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PAPAVER 1998-2001, see PLANTS, MEDICINAL 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PARAMYXOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 1 1977-1996, see SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996; for INFLUENZA D VIRUS see PARAMYXOVIRUS 1997-2001, use PARAINFLUENZA VIRUS I, HUMAN 1976-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PARAMYXOVIRUS 1997-2001, see PARAINFLUENZA VIRUS TYPE 3 1976-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PARAMYXOVIRUS INFECTIONS 1977-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PARVOVIRUS FELINE 1994-2001, see FELINE INFECTIOUS ENTERITIS VIRUS 1991-1993, see PARVOVIRIDAE 1981-1990, see PARVOVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PHYSICAL THERAPY 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PNEUMOCYSTIS CARINII 1974-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PNEUMOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PODOVIRIDAE 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see POLIOVIRUSES, HUMAN 1-3 1994-2001; for BRUNHILDE VIRUS see POLIOVIRUS 1976-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see POLITICAL SYSTEMS 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see POLYOMAVIRUS HOMINIS 1 1994-2001, see BK VIRUS 1991-1993, see POLYOMAVIRUSES 1978-1990, see POLYOMA VIRUS 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see POLYOMAVIRUS HOMINIS 2 1994-2001, see JC VIRUS 1983-93%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1986-2002; for TRANSGLUTAMINASES see TRANSGLUTAMINASES 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PROTON PUMP 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see PYRIDOXINE 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Papaver 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Physical Sciences 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see REITER%27%S DISEASE 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RELIGION 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RETICULOENDOTHELIOSIS VIRUS, AVIAN 1994-2001, see AVIAN RETICULOENDOTHELIOSIS VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RETICULOENDOTHELIOSIS VIRUSES 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996, see AVIAN LEUKOSIS-SARCOMA VIRUSES 1966-1993; for RETROVIRUSES TYPE C, AVIAN see RETROVIRUSES TYPE C, AVIAN 1997-2001, see RETROVIRUSES, ALV-RELATED 1994-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RETROVIRUSES TYPE C, MAMMALIAN 1994-2001; for TUMOR VIRUSES, MURINE see TUMOR VIRUSES, MURINE 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RINDERPEST 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RUBIACEAE 1999-2001; see IPECAC 1977-1998; for URAGOGA see RUBIACEAE 1999-2001, see IPECAC 1977-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see RUBULAVIRUS 1997-2001, see PARAINFLUENZA VIRUSES 1994-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Rosales 1988-2001, see PLANTS, MEDICINAL 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Rosales 1998-2001, see SPICES 1993-1997; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Rosales 1998-2001; see PLANTS, MEDICINAL 1986-1997; for HAWTHORN see ROSALES 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SARCOMA VIRUS, FELINE 1994-2001, see FELINE FIBROSARCOMA VIRUS 1991-1993, see RETROVIRIDAE 1981-1990, see LEUKOVIRUSES 1978-1980, see LEUKEMOGENIC VIRUSES 1975-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SARCOMA VIRUSES, SIMIAN 1994-2001, see SIMIAN SARCOMA VIRUSES 1991-1993, see BUNYAVIRIDAE 1989-1990, see RETROVIRIDAE 1981-1988, see LEUKOVIRUSES 1978-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SENNA 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SIMBU VIRUS GROUP 1991-2001, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SOCIAL RESPONSIBILITY 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SOCIAL VALUES 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SOY PROTEINS %28%1997-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SPICES 1993-2001; for WHITE PEPPER see SPICES 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SPICES 1993-2001; see CONDIMENTS 1963-82; see HALLUCINOGENS 1975-77%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see STLV 1994-2001, see STLV-I 1991-1993, see SIMIAN RETROVIRUSES 1989-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see SWINE INFERTILITY AND RESPIRATORY SYNDROME VIRUS 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Solanaceae 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TACARIBE COMPLEX VIRUSES 1994-2001, see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1991-1993, see ARENAVIRIDAE 1981-1990, see ARENAVIRUSES 1978-1980, see RNA VIRUSES 1977, see ARBOVIRUSES 1975-1976, see ARBOVIRUS 1973-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TARSAL JOINT 1965-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TEA 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TESTICULAR FEMINIZATION %28%1970-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see THEILER MURINE ENCEPHALOMYELITIS VIRUS 1999-2001, see THEILER%27%S MURINE ENCEPHALOMYELITIS VIRUS 1997-1998, see POLIOVIRUSES, MURINE 1994-1996; for THEILER%27%S VIRUS see ENCEPHALOMYELITIS VIRUS, MURINE 1992-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see THOGOTO-LIKE VIRUSES 1997-2001, see ORTHOMYXOVIRUSES TYPE D 1994-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TOBACCO MOSAIC VIRUS SATELLITE 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TOXICODENDRON 1993-2001, see RHUS 1963-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING see TRUTH DISCLOSURE 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see TURNER%27%S SYNDROME 1963-2001; for BONNEVIE-ULLRICH SYNDROME see SEX CHROMOSOME ABNORMALITIES 1997-2001, see BONNEVIE-ULLRICH SYNDROME 1963-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Theales 1989-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Theales 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see U-50488 1998-2001; U-50488 %28%now 3,4-DICHLORO-N-METHYL-N-%28%2-%28%1-PYRROLIDINYL%29%-CYCLOHEXYL%29%-BENZENEACETAMIDE, %28%TRANS%29%-ISOMER%29% was indexed under PYRROLIDINES 1982-97%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see UBIQUITIN 1987-2001, see HIGH MOBILITY GROUP PROTEINS 1985-1986; for HIGH MOBILITY PROTEIN 20 %26% HMG-20 see UBIQUITIN 1985-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see UBIQUITINS %28%1985-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see UNITED STATES HEALTH CARE FINANCING ADMINISTRATION 1992-2001; see UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES 1982-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see UUKUNIEMI GROUP VIRUSES 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see Up-Regulation %28%Physiology%29% 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VIRGINIAMYCIN 1991-2001; for PRISTINAMYCIN IA see VIRGINIAMYCIN 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VIRGINIAMYCIN 1991-2001; for STAPHYLOMYCIN M1, PRISTAMYCIN IIA %26% VIRGINIAMYCIN FACTOR M1 see VIRGINIAMYCIN 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VIRGINIAMYCIN 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VIRGINIAMYCIN 1994-2001, see PRISTINAMYCINS 1981-1993; for RP7293 and RP 7293 see VIRGINIAMYCIN 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VIRGINIAMYCIN 1994-2001, see STREPTOGRAMINS 1981-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VITAMIN E 1966-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see VITAMIN K 1965-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see XANTHOPHYLL 1966-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; see ZINGIBERALES 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ACTIVIN RECEPTORS %28%NM%29% 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ACTIVIN RECEPTORS, TYPE I %28%NM%29% 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ACTIVIN RECEPTORS, TYPE II %28%NM%29% 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ACTIVINS %28%NM%29% 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ADENOMATOUS POLYPOSIS COLI PROTEIN %28%NM%29% 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use AGAMOUS PROTEIN %28%NM%29% 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ALPHA KARYOPHERINS %28%NM%29% 1994-2001; for IMPORTIN-ALPHA use KARYOPHERINS 1995-2001; for NLS-BINDING PROTEIN, NLSBP %26% NUCLEAR LOCALIZATION SIGNAL-BINDING PROTEIN use NOPP140 %28%NM%29% 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ALTRUISM 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use AMINO ACID TRANSPORT SYSTEMS, BASIC %28%NM%29% 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use AMYLOID NEUROPATHIES 1994-2001; for FAMILIAL AMYLOID POLYNEUROPATHIES use AMYLOID NEUROPATHIES 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ANION TRANSPORT PROTEINS %28%NM%29% 1980-2001; for ANION PUMP %26% ANION PUMPS use ION PUMPS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ANTIGENS, CD98 %28%NM%29% 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ASPARTIC ACID 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ASTERACEAE 1998-2001, use HERBS 1995-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ATP SYNTHETASE COMPLEXES %28%NM%29% 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Allium 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use BACTERIOCHLOROPHYLLS 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use BACTERIOPHAGE LAMBDA 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use BACULOVIRIDAE 1997-2001; for GRANULOSIS VIRUSES use BACULOVIRIDAE 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use BETA KARYOPHERINS %28%NM%29% 1995-2001; for IMPORTIN-BETA use KARYOPHERINS %28%NM%29% 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use BIOETHICS 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use BRCA2 PROTEIN %28%NM%29% 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Baths, Finnish %28%1963-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CARBONIC ANHYDRASES 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CARBONIC ANHYDRASES 1983-2001; for CA I HIROSHIMA-1 %26% CARBONIC ANHYDRASE B use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE ISOENZYME B use CARBONIC ANHYDRASES 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CARBONIC ANHYDRASES 1983-2001; for CARBONIC ANHYDRASE C use CARBONIC ANHYDRASES 1984-2001; for CARBONIC ANHYDRASE ISOENZYME C use CARBONIC ANHDYRASES 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CARBONIC ANHYDRASES 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CARBOXYPEPTIDASE U %28%NM%29% 1994-2001 and LYSINE CARBOXYPEPTIDASE 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CELLULAR APOPTOSIS SUSCEPTABILITY PROTEIN %28%NM%29% 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CHENOPODIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CHLORIDE-BICARBONATE ANTIPORTERS %28%NM%29% 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN %28%1992-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1966-2001; for ALPHA-2 TYPE 1 COLLAGEN use COLLAGEN 1987-2001; for PROCOLLAGEN TYPE I use PROCOLLAGEN 1986-2001; for TYPE I PROCOLLAGEN %26% PRO ALPHA 2 COLLAGEN use PROCOLLAGEN 1982-2001; for PRO ALPHA 1 COLLAGEN use PROCOLLAGEN 1988-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1985-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE II use PROCOLLAGEN 1982-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III use PROCOLLAGEN 1990-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE IV use PROCOLLAGEN 1982-2001; for 7S COLLAGEN use COLLAGEN 1982-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE V use PROCOLLAGEN 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use COLLAGEN 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CORONARY DISEASE 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use CUCURBITACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Cannabis 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DEFICIENS PROTEIN %28%NM%29% 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DIAZEPAM BINDING INHIBITOR %28%NM%29% 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DICARBOXYLIC ACID TRANSPORTERS %28%NM%29% 1981-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DNA TOPOISOMERASE %28%ATP-HYDROLYSING%29% 1994-2001, use DNA GYRASE 1980-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% 1994-2001, use DNA GYRASE 1980-1993; for GYRA PROTEIN use DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1992-2001; GYRB PROTEIN use DNA TOPOISOMERASE %28%ATP-HYDROLYZING%29% %28%NM%29% 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DNA TOPOISOMERASE 1994-2001, use DNA UNTWISTING PROTEINS 1978-1993; for DNA NICKING-CLOSING PROTEIN use DNA NICKING-CLOSING PROTEINS 1978-1993; for DNA RELAXING ENZYME use DNA RELAXING ENZYMES 1978-1993; for DNA UNTWISTING ENZYME use DNA UNTWISTING ENZYMES 1978-1993; for OMEGA PROTEIN use OMEGA PROTEINS 1978-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use DNA TOPOISOMERASE IV %28%NM%29% 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ECDYSTEROIDS %28%NM%29% 1976-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ELECTRIC CONDUCTIVITY 1968-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ELEUTHEROCOCC %28%NM%29% 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use EPIDIDYMAL SECRETORY PROTEINS %28%NM%29% 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ESTRUS 1975-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ETHICS 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ETHICS 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ETHICS 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ETHICS, MEDICAL 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use EXCITATORY AMINO ACID TRANSPORTER 2 %28%NM%29% 1995-2001; for GLUT-1 GLUTAMATE TRANSPORTER use AMINO ACID TRANSPORT SYSTEM X-AG %28%NM%29% 1996-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use F2-ISOPROSTANES %28%NM%29% 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use FABACEAE 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use FABACEAE 1986-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use FANCONI ANEMIA 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use GENE ENGINEERING 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES 1999-2001; use GLYCERALDEHYDEPHOSPHATE DEHYDROGENASES %28%NM%29% 1991-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HAMAMELIDAE 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HANTAVIRUS 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HANTAVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HANTAVIRUS 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HEPATITIS AGENTS, GB 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use HEYMANN NEPHRITIS ANTIGENIC COMPLEX %28%NM%29% 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use INDIVIDUALITY 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use INOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use KARYOPHERINS %28%NM%29% 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use LAMIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use LAURACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use LAURACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use LINKAGE%28%GENETICS%29% 2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use LONG QT SYNDROME 1986-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use LUNG DISEASES, OBSTRUCTIVE 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Liliaceae 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MALVACEAE 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MANIPULATION, ORTHOPEDIC 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MARTIAL ARTS 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MCM1 PROTEIN %28%NM%29% 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MENTAL HEALING 1983-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MISTLETOE 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MITOCHONDRIAL MYOPATHIES 2000-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS %28%NM%29% 1994-2001; for MOAT PROTEIN %26% MULTISPECIFIC ORGANIC ANION TRANSPORTER use ANION TRANSPORT PROTEINS 1995-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use OPTIC ATROPHIES, HEREDITARY 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use OPTIC ATROPHIES, HEREDITARY 2000-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ORBIVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ORGANIC CATION TRANSPORTER 1 %28%NM%29% 1995-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ORTHOREOVIRUS 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use OXYGEN %28%NM%29% 1974-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PAPAVER 1998-2001, use PLANTS, MEDICINAL 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PARVOVIRUS FELINE 1976-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PATIENT ADVOCACY 1978-2001; for RIGHT TO TREATMENT use PATIENT ADVOCACY 1978-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PERCHES 1987-2001; for TILAPIA NILOTICA use TILAPIA 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PHOSPHATE-BINDING PROTEINS %28%NM%29% 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PNEUMOVIRUS 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PODOVIRIDAE 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use POLITICAL SYSTEMS 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use POLYUBIQUITIN %28%NM%29% 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use POTASSIUM-HYDROGEN ANTIPORTERS 1982-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE %28%NM%29% 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PYMETHRIN %28%NM%29% 1975-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PYRIDOXINE 1963-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%NM%29% 1983-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Papaver 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use RELIGION 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 1 1977-1996, use SENDAI VIRUS 1964-1976; for SHIPPING FEVER VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996; for INFLUENZA D VIRUS use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS I, HUMAN 1976-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use RESPIROVIRUS 1997-2001, use PARAINFLUENZA VIRUS TYPE 3 1976-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use RINDERPEST 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use RUBIACEAE 1999-2001; use IPECAC 1977-1998; for URAGOGA use RUBIACEAE 1999-2001, use IPECAC 1977-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use RUBULAVIRUS 1997-2001, use PARAINFLUENZA VIRUSES 1994-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Rosales 1998-2001, use PLANTS, MEDICINAL 1986-1997; for HAWTHORN use ROSALES 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Rosales 1998-2001, use SPICES 1993-1997; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use S-NITROSO-N-ACETYLPENICILLAMINE %28%NM%29% 1984-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use S-NITROSOGLUTATHIONE %28%NM%29% 1980-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SAMBUCUS RIBOSOME-INACTIVATING PROTEIN %28%NM%29% 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SEMINAL PLASMA PROTEINS %28%NM%29% 1979-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SERUM RESPONSE FACTOR %28%NM%29% 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SOCIAL RESPONSIBILITY 1978-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SOCIAL VALUES 1987-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SODIUM-BICARBONATE SYMPORTERS %28%NM%29% 1986-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SODIUM-POTASSIUM-CHLORIDE COTRANSPORTERS 1984-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SPICES 1993-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SPICES 1993-2001; for WHITE PEPPER use SPICES 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use SUMO-1 PROTEIN %28%NM%29% 1996-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Solanaceae 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use TEA 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use TOXICODENDRON 1993-2001, use RHUS 1963-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use TRANSGLUTAMINASE 1990-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use TRUTH DISCLOSURE 1978-2001; for WHISTLEBLOWING use TRUTH DISCLOSURE 1997-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use Theales 1999-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use UBIQUITINS %28%1985-2001%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use VIRGINIAMYCIN 1991-2001; for PRISTINAMYCIN IA use VIRGINIAMYCIN 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use VIRGINIAMYCIN 1991-2001; for STAPHYLOMYCIN M1, PRISTAMYCIN IIA %26% VIRGINIAMYCIN FACTOR M1 use VIRGINIAMYCIN 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use VIRGINIAMYCIN 1994-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use VIRGINIAMYCIN 1994-2001; for RP7293 and RP 7293 use VIRGINIAMYCIN 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use VITAMIN E 1966-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use VITAMIN K 1965-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use ZINGIBERALES 1997-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; use explode 1971-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002; was VITAMIN D-BINDING PROTEIN 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002;see FANCONI ANEMIA 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2002A' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1966%29%; use MEMORY 1966-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1968%29%; see ICSH 1963-1967 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1968%29%; use ICSH 1963-1967 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1969%29%; for BLAST TRANSFORMATION use BLAST CRISIS 1987-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1975%29%; for 25-HYDROXYVITAMIN D2 1-HYDROXYLASE use STEROID HYDROXYLASES %28%NM%29% 1976-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1976%29%; use CORPUS LUTEUM 1975 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1977%29%; see NAD+ ADP-RIBOSYLTRANSFERASE 1992-2002, see POLY ADP RIBOSE POLYMERASE 1977-1991, see NAD NUCLEOSIDASE 1975-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1977%29%; use NAD NUCLEOSIDASE 1975-1976 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1979%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1985%29%; for OVUM IMPLANTATION use NIDATION 1965-1984 %28%Prov 1965-1966%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1986%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1989%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1991%29%; for OVUM IMPLANTATION, DELAYED use OVUM IMPLANTATION 1985-1990, NIDATION 1975-1984; for NIDATION, DELAYED use OVUM IMPLANTATION, DELAYED 1985-1990, NIDATION 1975-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1991%29%; use INTEGRIN ALPHAXBETA2 %28%NM%29% 1985-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1997%29%; for SEROSTIM use SOMATOTROPINS, RECOMBINANT %28%NM%29% 1996-2002; use NORDITROPIN %28%NM%29% 1992-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%1998%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 %28%2002%29%; use RAUWOLFIA 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003 see PERTUSSIS TOXINS 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1974%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1976%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1986%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1990%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1993%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1995%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1997%29%; for STIMULATORY GTP-BINDING PROTEIN, ALPHA SUBUNIT use G-PROTEIN, GS FAMILY %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1998%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%1998%29%; use RIBOSOMAL PROTEIN S6 KINASES %28%NM%29% 1985-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%2000%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%2000%29%; use EUKARYOTIC INITIATION FACTOR-2B %28%NM%29% 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003%28%2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1963-1981 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1965-1978; see BCG VACCINE 1965-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1965-1978; use BCG VACCINE 1965-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1975 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1975-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1975-1991; see HEMORRHAGIC BACTEREMIA 1992-2002, see HEMORRHAGIC SEPTICEMIA 1990-1991, see PASTEURELLA INFECTIONS 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1975; see SALMONELLA HIRSCHFELDII 1991-2002, see SALMONELLA 1976-1990, see SALMONELLA PARATYPHI 1966-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003, 1975; see SALMONELLA SCHOTTMUELLERI 1991-2002, see SALMONELLA 1976-1990, see SALMONELLA PARATYPHI 1966-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-03-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-03-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-04-17' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-07-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-07-14' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-07-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-07-24' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-07-25' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-07-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003-10-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003: DYNAMIN-2 was indexed under GTP PHOSPHOHYDROLASES 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003: see NEUROKININ K %28%1989-2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MASTOCYTOMA BENIGN see MASTOCYTOSIS 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see Health Behavior 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; 1963-1985; see RHAMNUS 1991-2002, see PLANTS, TOXIC 1986-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; 1963-1990; use RHAMNUS 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; A5 ANTIGEN %28%now NEUROPILIN-1%29% was indexed under NERVE TISSUE PROTEINS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ADAPTOR PROTEIN COMPLEX 1%28%AP-1%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1998-2001; GOLGI ADAPTOR PROTEIN 1 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ADP-RIBOSYL CYCLASE was indexed under ANTIGENS, DIFFERENTIATION 1988-2002, NUCLEOSIDASES 1988-1997, and NAD+ NUCLEOSIDASES 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ALPHA-ADAPTINS %28%now ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ALPHA4 INTEGRIN %28%now INTEGRIN ALPHA4%29% was indexed under ANTIGENS, CD 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; AP-2 PROTEIN COMPLEX, AP-2 ADAPTOR %28%CLATHRIN-COATED VESICLES%29%, HA-2 ADAPTORS, HYDROXYAPATITE 2 ADAPTORS were indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1994-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; AP-4 PROTEIN COMPLEX was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002 and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; AP3 ADAPTOR COMPLEX was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ASIALOGLYCOPROTEIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1980-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; AUXILIN was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; BETA-ADAPTINS %28%now ADAPTOR PROTEIN COMPLEX BETA SUBUNITS%29% was indexed under MEMBRANE PROTEINS 1995-2002, PROTEINS 1990-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; BRAIN-SPECIFIC KINASE %26% CEK7 PROTEIN %28%now RECEPTOR, EPHA5%29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHA5 PROTEIN %28%now RECEPTOR, EPHA5 %29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; C-TYPE LECTIN %28%now LECTINS, C-TYPE%29% was indexed under LECTINS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; C-TYPE PROTEIN HNRNP %26% HNRNP C PROTEIN was indexed under RIBONUCLEOPROTEINS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CALGRANULIN A was indexed under CALCIUM-BINDING BINDING PROTEINS 1989-2002; MRP-8 PROTEIN %28%now CALGRANULIN A%29% was indexed under ANTIGENS, DIFFERENTIATION %26% CALCIUM-BINDING PROTEINS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CALGRANULIN B was indexed under CALCIUM-BINDING PROTEINS 1989-2002; MRP-14 PROTEIN was indexed under ANTIGENS, DIFFERENTIATION %26% NEURONAL PROTEIN S100 1999-2002, CALCIUM-BINDING PROTEINS 1989-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CALNEXIN was indexed under CALCIUM-BINDING PROTEINS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CALRETICULIN was indexed under CALCIUM-BINDING PROTEINS 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CBP80 PROTEIN was indexed under RNA-BINDING PROTEINS 1994-2002; CAF20 PROTEIN was indexed under RNA-BINDING PROTEINS 1997-2002; CBP20 PROTEIN was indexed under RNA-BINDING PROTEINS 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CEK10 PROTEIN %28%now RECEPTOR, EPHB3%29% was indexed under PROTEIN-TYROSINE KINASE 1993-2002, EPHB3 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE KINASES 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CEK4 RECEPTOR PROTEIN-TYROSINE KINASE %28%now RECEPTOR, EPHA3 %29% were indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002, EPHA3 PROTEIN was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CLATHERIN HEAVY CHAIN was indexed under CLATHRIN 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CLEAVAGE AND POLYADENYLATION FACTOR %28%now MRNA CLEAVAGE AND POLYADENYLATION FACTORS%29% was indexed under RNA-BINDING PROTEINS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR was indexed under RNA-BINDING PROTEINS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CLEAVAGE STIMULATION FACTOR was indexed under RNA-BINDING PROTEINS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; COLLAGEN RECEPTOR was indexed under INTEGRINS 1983-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; COLLAPSIN %28%now SEMAPHORIN 3A%29% was indexed under GLYCOPROTEINS 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; COLLECTIN %28%now COLLECTINS%29% was indexed under CARRIER PROTEINS 1980-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; CYCLIC ADP-RIBOSE %28%NM%29% was indexed under ADENOSINE DIPHOSPHATE RIBOSE 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; DC-STRETCH-BINDING PROTEIN %28%now HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K%29% was indexed under DNA-BINDING PROTEINS 1994-2002; HNRNP K was indexed under RIBONUCLEOPROTEINS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; DELTA-ADAPTIN %28%now ADAPTOR PROTEIN COMPLEX DELTA SUBUNITS%29% was indexed under MEMBRANE PROTEINS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; DYNAMIN %28%now DYNAMINS%29% was indexed under GTP PHOSPHOHYDROLASES 1 1994-2002 %26% CA%28%2+%29% MG%28%2+%29%-ATPASE 1989-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; DYNAMIN I %26% DYNAMIN-1 were indexed under GTP PHOSPHOHYDROLASES 1994-2002 %26% CA%28%2+%29% MG%28%2+%29%-ATPASE 1989-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; DYNAMIN III was indexed under GTP PHOSPHOHYDROLASES 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EEK PROTEIN %28%now RECEPTOR, EPHA8 %29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1991-2002; EPHA8 PROTEIN %28%now RECEPTOR, EPHA8%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2002-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EHK-2 PROTEIN %28%now RECEPTOR, EPHA6%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002, EPHA6 PROTEIN was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EIF-3 %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1990-2002; EUKARYOTIC INITIATION FACTOR 3 P110 %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 2000-2002; EUKARYOTIC INITIATION FACTOR 3, SUBUNIT 4 %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1999-2002; INT-6 PROTEIN %28%now EUKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EIF-4A %28%now EUKARYOTIC INITIATION FACTOR-4A%29% was indexed under PEPTIDE INITIATION FACTORS 1980-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EIF-4E %28%now EUKARYOTIC INITIATION FACTOR-4E%29% was indexed under PEPTIDE INITIATION FACTORS 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EIF-4F %28%now EUKARYOTIC INITIATION FACTOR-4F%29% was indexed under PEPTIDE INITIATION FACTORS 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EIF-4G %28%now EUKARYOTIC INITIATION FACTOR-4G%29% was indexed under PEPTIDE INITIATION FACTORS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EIF-5 %28%now EUKARYOTIC INITIATION FACTOR-5%29% was indexed under PEPTIDE INITIATION FACTORS 1982-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ENDOTHELIUM SECRETED PROTEIN B61 %28%now Ephrin-A1%29% was indexed under PROTEINS 1990-2002,%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPH LIGAND FAMILY 2 PROTEIN, MAMMALIAN %28%now EPHRIN-B2%29% was indexed under MEMBRANE PROTEINS 1995-2002; LERK-5 PROTEIN %28%now EPHRIN-B2%29% was indexed under MEMBRANE PROTEINS 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHA1 PROTEIN %28%now RECEPTOR, EPHA1%29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHA2 PROTEIN %28%now RECEPTOR, EPHA2%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002 %26% MEMBRANE PROTEINS 1990-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHA4 RECEPTOR TYROSINE KINASE %28%now RECEPTOR, EPHA4%29% was indexed under FETAL PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002; CEK8 PROTEIN %28%now RECEPTOR, EPHA4%29% was indexed under NEUROPEPTIDES %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHB1 RECEPTOR, ELK PROTEIN EPHT2 PROTEIN %26% NEURONALLY EXPRESSED EPH-TYROSINE KINASE were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHB2-TYROSINE KINASE %28%now RECEPTOR, EPHB2%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1995-2002, PROTEIN-TYROSINE KINASE 1992-1994, DRT PROTEIN %28%now RECEPTOR, EPHB2%29% was indexed under PROTEIN-TYROSINE KINASE 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHRIN B RECEPTORS %28%now RECEPTORS, EPH FAMILY%29% was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002, EPH RECEPTOR TYROSINE KINASE was indexed under RECEPTOR PROTEIN TYROSINE KINASES 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHRIN-A5 was indexed under MEMBRANE PROTEINS %28%1998-2002%29%; REPUSLSIVE AXONAL GUIDANCE PROTEIN was indexed under TRANSCRIPTION FACTORS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHRIN-B1 was indexed under MEMBRANE PROTEINS 1998-2002, PROTEINS 1994-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EPHRIN-B3 was indexed under MEMBRANE PROTEINS 1998-2002; LERK-8 PROTEIN %28%now EPHRIN-B3%29% was indexed under MEMBRANE PROTEINS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEIN was indexed under CARRIER PROTEINS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2001, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2002, CARRIER PROTEINS 1998-2001 %26% MEMBRANE PROTEINS 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; EWS PROTEIN was indexed under RIBONUCLEOPROTEINS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; FERRITIN REPRESSOR PROTEIN was indexed under IRON-SULFUR PROTEINS %26% RNA-BINDING PROTEINS 1991-2002, IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN %26% IRP1 PROTEIN were indexed under IRON-SULFUR PROTEINS %26% RNA-BINDING PROTEINS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; FLT4 PROTEIN %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-2002, RECEPTORS, CELL SURFACE 1994-2000 %26% RECEPTORS, GROWTH FACTOR 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT was indexed under FOLLICLE STIMULATING HORMONE 2002; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT was indexed under FSH 1963-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; FUS PROTEIN %26% HNRNP P2 were indexed under RIBONUCLEOPROTEINS 1996-2002; TLS PROTEIN was indexed under 1993-2002 RIBONUCLEOPROTEINS%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GALACTOLIPIDS was indexed under GLYCOLIPIDS 1976-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GALAPTINS %28%now GALECTINS%29% was indexed under HEMAGGLUTININS 1978-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GALECTIN 1 was indexed under HEMAGLUTININS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GALECTIN 2 was indexed under HEMAGGLUTININS 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GAMMA-ADAPTIN %28%now ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS%29% was indexed under MEMBRANE PROTEINS 1995-2002, PROTEINS 1991-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GASTRODIA ELATA EXTRACT was indexed under DRUGS, CHINESE HERBAL 2002-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GINSENOSIDES was indexed under SAPONINS 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GLYCOGEN SYNTEHASE KINASE 3 was indexed under CA%28%2+%29%-CALMODULIN PROTEIN KINASE 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; GURMAR was indexed under PLANT EXTRACTS 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HEPATITIS A ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1985-2002, ANTIBODIES, VIRAL 1981-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HEPATITIS A ANTIGENS was indexed under ANTIGENS, VIRAL 1985-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HEPATITIS D ANTIGENS %28%now HEPATITUS DELTA ANTIGENS%29% was indexed under HEPATITIS ANTIGENS 1996-2002, ANTIGENS, VIRAL 1988-1996 %26% HEPATITIS B ANTIGENS 1981-1987%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HEPATOMA TRANSMEMBRANE KINASE %28%now RECEPTOR, EPHB4%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2002; EPHB4 RECEPTOR was indexed under RECEPTOR PROTEIN TYROSINE-KINASE 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS was indexed under RIBONUCLEOPROTEINS 1980-2002; INFORMATIN was indexed under RIBONUCLEOPROTEINS 1978-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HFQ GENE PRODUCT %26% HOST FACTOR 1 were indexed under CARRIER PROTEINS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HNRNP A2-B1 was indexed under DNA-BINDING PROTEINS 1993-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HNRNP F was indexed under RIBONUCLEOPROTEINS 1994-2002; HNRNP H was indexed under RIBONUCLEOPROTEINS 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HNRNP L was indexed under RIBONUCLEOPROTEINS 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HNRNP M was indexed under NUCLEOPROTEINS 2000-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HNRNP U PROTEIN was indexed under RIBONUCLEOPROTEINS 1992-2002, GRIP120 %26% SCAFFOLD ATTACHMENT FACTOR A %28%SAF-A%29% were indexed under RIBONUCLEOPROTEINS 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; HYBRIDIZATION was heading 1966-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; IMMUNOCONGLUTININS was indexed under IMMUNGLOBULINS 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRATION HOST FACTOR was indexed under BACTERIAL PROTEINS 1985-2002; HOST FACTOR was indexed under CARRIER PROTEINS 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA1 was indexed under ANTIGENS, CD 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA1BETA1 was indexed under INTEGRINS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA2 was indexed under ANTIGENS, CD 1996-2002 %26% under INTEGRINS 1993-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA2BETA1 was indexed under INTEGRINS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA3 was indexed under INTEGRINS %26% ANTIGENS CD 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA3BETA1 was indexed under INTEGRINS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA4BETA1 was indexed under INTEGRINS %26% RECEPTORS, LYMPHOCYTE HOMING 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA5 was indexed under ANTIGENS, CD 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA5BETA1 was indexed under INTEGRINS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA6 was indexed under ANTIGENS, CD 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHA6BETA4 was indexed under INTEGRINS; %26% ANTIGENS, SURFACE 1988-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN ALPHAV was indexed under ANTIGENS, CD 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN BETA3 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1989, INTEGRINS 1990-1995, PLATELET MEMBRANE GLYCOPROTEINS %26% ANTIGENS, CD 1996-2002; for PLATELET MEMBRANE GLYCPROTEIN IIIA see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INTEGRIN BETA4 was indexed under ANTIGENS, CD 1996-2002 %26% INTEGRINS 1994-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INULA RACEMOSA was indexed under INULIN 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; INVERSION STIMULATION FACTOR were indexed under CARRIER PROTEINS 1994-2002;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; IRIDOIDGLUCOSIDES was indexed under GLUCOSIDES 1975-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; IRON REGULATORY FACTOR now IRON-REGULATORY PROTEINS was indexed under RNA-BINDING PROTEINS %26% IRON-SULFUR PROTEINS 1991-2002, CARRIER PROTEINS 1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; IRON REGULATORY PROTEIN 2, IRE-BP2 %26% IRP-2 RNA-BINDING PROTEIN were indexed under RNA-BINDING PROTEINS %26% IRON-SULFUR PROTEINS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; IRON-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ISOLECTIN was indexed under LECTINS 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; KUTAJA was indexed under ALKALOIDS 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; L1 ANTIGEN %28%now LEUKOCYTE L1 ANTIGEN COMPLEX%29% was indexed under MEMBRANE GLYCOPROTEINS 1984-2002, NEURAL CELL ADHESION MOLECULES 1996-2002, CELL ADHESION MOLECULES, NEURONAL 1992-1995 %26% ANTIGENS, SURFACE 1984-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LACTOSE-BINDING AGGLUTINATION FACTOR was indexed under HEMAGGLUTININS 1984-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LAMIN A was indexed under NUCLEAR PROTEINS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LAMIN B was indexed under NUCLEAR PROTEINS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LAMINS was indexed under Nuclear Proteins 1988-2002, NUCLEOPROTEINS 1980-1987%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LERK-3 PROTEIN %28%now EPHRIN-A3%29% was indexed under MEMBRANE PROTEINS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LERK-4 PROTEIN %28%now EPHRIN-A4%29% was indexed under MEMBRANE PROTEINS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LERK-6 PROTEIN %28%now EPHRIN-A2%29% was indexed under TRANSCRIPTION FACTORS 1998-2002; EPH LIGAND FAMILY 1 PROTEIN, MAMMALIAN %28%now EPHRIN-A2%29% was indexed under TRANSCRIPTION FACTORS 1998-2002, PROTEINS 1994-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; LUTEINIZING HORMONE, BETA SUBUNIT was indexed under LH 1983-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; MAC-2 ANTIGEN %28%now GALECTIN 3 %29% was indexed under ANTIGENS, DIFFERENTIATION 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN %26% MANNAN-BINDING LECTIN were indexed under CARRIER PROTEINS 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; MANNOSE-SPECIFIC LECTIN %28%now MANNOSE-BINDING LECTINS%29% was indexed under LECTINS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; MEP PROTEIN %28%now RECEPTOR, EPHB6%29% was indexed under MEMBRANE PROTEINS 1996-2002, EPHB6 RECEPTOR was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; MICRORNAS was indexed under RNA, UNTRANSLATED and RNA, ANTISENSE 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; N-ACETYLGLUCOSAMIN RECEPTORS was indexed under RECEPTORS, IMMUNOLOGIC %26% RECEPTORS, THRYOID HORMONE 1988-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; NERVE GROWTH FACTOR-INDUCIBLE LARGE EXTERNAL GLYCOPROTEIN %28%now NEURAL CELL ADHESION MOLECULE L1%29% was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 %26% GLYCOPROTEINS 1983-1987; NEURAL CELL ADHESION MOLECULE L1; F11 GLYCOPROTEIN; CELL ADHESION MOLECULE L1; CAML1 GENE PRODUCT; CELL SURFACE GLYCOPROTEIN L1; L1 CELL ADHESION MOLECULE; L1 CAM %26% NEURAL ADHESION MOLECULE L1 were indexed under MEMBRANE GLYCOPROTEINS 1992-2002, NEURAL CELL ADHESION MOLECULES 1996-2002, CELL ADHESION MOLECULES, NEURONAL 1992-1995 %26% ANTIGENS, SURFACE 1984-1991; CALL PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1999-2002 %26% NEURAL CELL ADHESION MOLECULES 1999-2002; NILE PROTEIN was indexed under MEMBRANE GLYCOPROTEINS 1992-2002 %26% NEURAL CELL ADHESION MOLECULES 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; NEUROPILIN was indexed under NERVE TISSUE PROTEINS 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; NPN-2 PROTEIN was indexed under NERVE TISSUE PROTEINS 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; NUCLEAR ANTIGENS was indexed under NUCLEAR PROTEINS 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; NUCLEOSIDE TRANSPORTER %28%now NUCLEOSIDE TRANSPORT PROTEINS%29% was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1983-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; O-ACETYL-ADP-RIBOSE was indexed under ADENOSINE DIPHOSPHATE RIBOSE 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; P70 POLY%28%A%29% BINDING PROTEIN was indexed under RNA-BINDING PROTEINS 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PAB II was indexed under RNA-BINDING PROTEINS 1995-2002; PABP2 GENE PRODUCT %26% PABP2 PROTEIN were indexed under RNA-BINDING PROTEINS 1999-2002; PABP2 was indexed under RNA-BINDING PROTEINS 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PEPPERMINT was indexed under PLANT EXTRACTS 1973-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PEPTIDE INITIATION FACTOR 3 %28%now PROKARYOTIC INITIATION FACTOR-3%29% was indexed under PEPTIDE INITIATION FACTORS 1979-2002; TIF IF3 %26% TRANSLATION INITIATION FACTOR 3 were indexed under PEPTIDE INITIATION FACTORS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PILIN %28%now FIMBRIAE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1977-2002; PROPILIN %28%now FIMBRIAE PROTEINS%29% was indexed under BACTERIAL OUTER MEMBRANE PROTEINS %26% PROTEIN PRECURSORS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; POLY%28%A%29%-BINDING PROTEINS was indexed under RNA-BINDING PROTEINS 1994-2002 %26% under CARRIER PROTEINS 1982-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; POLYPYRIMIDINE TRACT-BINDING PROTEIN was indexed under RIBONUCLEOPROTEINS %26% RNA-BINDING PROTEINS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PROGESTERONE 16 ALPHA-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1977-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PROKARYOTIC INITIATION FACTOR-2 was indexed under PEPTIDE INTIATION FACTORS 1990-2002; TRANSLATIONAL INITIATION FACTOR 2 was indexed under PEPTIDE INITIATION FACTORS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PROTEIN-PROLINE KINASE %28%now PROLINE-DIRECTED PROTEIN KINASES%29% was indexed under PROTEIN-SERINE-THREONINE KINASES 1994-2002 %26% under PROTEIN KINASES 1990-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PROTO-ONCOGENE PROTEIN FLT %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1%29% was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASE 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PULMONARY SURFACTANT ASSOCIATED PROTEIN SP-B %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEIN B%29% was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PULMONARY SURFACTANT ASSOCIATED-PROTEIN SP-C %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEIN C%29% was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; PULMONARY SURFACTANT-ASSOCIATED PROTEIN %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEINS%29% was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RECEPTOR TYROSINE KINASE CEK11 %26% EPHA7 PROTEIN %28%now RECEPTOR, EPHA7%29% were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1997-2002, MDK1 %28%RTK%29% %26% MDK1 GENE PRODUCT were indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RECEPTOR TYROSINE KINASE CEK9 %28%now RECEPTOR, EPHB5 %29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RHATANY was indexed under TANNINS 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RIBOSOMAL PROTEIN S6 was indexed under RIBOSOMAL PROTEINS 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RNA CAP-BINDING PROTEINS was indexed under RNA-BINDING PROTEINS 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RNA, SMALL INTERFERING was indexed under RNA, UNTRANSLATED 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; RNA-INDUCED SILENCING COMPLEX was indexed under RIBONUCLEOPROTEINS 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; SEMA 1 %26% SEMAPHORIN-1 was indexed under CELL ADHESION MOLECULES, NEURONAL 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; SURFACTANT PROTEIN A %26% SP-A PROTEIN was indexed under PROTEOLIPIDS %26% PULMONARY SURFACTANTS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; SURFACTANT PROTEIN D %28%now PULMONARY SURFACTANT-ASSOCIATED PROTEIN D%29% was indexed under GLYCOPROTEINS %28%1990-2002%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TATA-BOX BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TBP-RELATED FACTOR %28%now TATA-BOX BINDING PROTEIN-LIKE PROTEINS%29% was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TBP1 PROTEIN %28%now TRANSFERRIN-BINDING PROTEIN A%29% was indexed under CARRIER PROTEINS 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TELOMERE-BINDING PROTEINS was indexed under DNA-BINDING PROTEINS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TEMPLATES was heading 1968-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; THYROTROPIN, BETA SUBUNIT was indexed under THYROTROPIN 1983-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSCRIPTION FACTOR TFIIA was indexed under TRANSCRIPTION FACTORS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSCRIPTION FACTOR TFIIB was indexed under TRANSCRIPTION FACTORS 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSCRIPTION FACTOR TFIID was indexed under TRANSCRIPTION FACTORS, TFII 1998-2002, TRANSCRIPTION FACTORS 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSCRIPTION FACTOR TFIIIA was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1984-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSCRIPTION FACTOR TFIIIB was indexed under TRANSCRIPTION FACTORS 1987-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSFERRIN-BINDING PROTEIN B was indexed under CARRIER PROTEINS 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRANSFERRIN-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRF1 PROTEIN was indexed under DNA-BINDING PROTEINS 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; TRF2 PROTEIN %28%now TELOMERIC REPEAT BINDING PROTEIN 2%29% was indexed under DNA-BINDING PROTEINS 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; VASCULAR ENDOTHELIAL CELL GROWTH FACTOR RECEPTOR %28%now RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR%29% was indexed under RECEPTORS, GROWTH FACTOR 1993-2002, RECEPTORS PROTEIN-TYROSINE KINASES 1994-2002, PROTEIN-TYROSINE KINASE 1993 %26% RECEPTORS, MITOGEN 1991-1992; ENDOTHELIAL GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, MITOGEN %26% RECEPTORS, GROWTH FACTOR 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; VEGFR-2 was indexed under RECEPTORS, PROTEIN-TYROSINE KINASES 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; ZOAPATLE was indexed under OXEPINS 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ACONITE see ACONITE 1963-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ACTINOMYCETES see ACTINOMYCETALES 1997-2002, see ACTINOMYCETES 1963-1966%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ACTINOMYCETES use ACTINOMYCETALES 1997-2002 %26% 1963-1966%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ADAPTOR PROTEIN COMPLEX 1%28%AP-1%29% use CLATHRIN ADAPTOR PROTEINS %28%NM%29% 1998-2002, for GOLGI ADAPTOR PROTEIN 1 use CLATHRIN ADAPTOR PROTEIN ALPHA SUBUNITS 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ALPHA A-CRYSTALLIN see CRYSTALLINS 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ALPHA A-CRYSTALLIN use CRYSTALLINS 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ALPHA B-CRYSTALLIN see CRYSTALLINS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ALPHA B-CRYSTALLIN use CRYSTALLINS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ALPHA-CRYSTALLIN see CRYSTALLINS 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ALPHA-CRYSTALLIN use CRYSTALLINS 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ANTIGENS CD11B %26% CD11B ANTIGEN see MACROPHAGE-1 ANTIGEN 1995-2002; for M01 ANTIGEN %26% MO1 GLYCOPROTEIN see MACROPHAGE-1 ANTIGEN 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ANTIGENS CD11B %26% CD11B ANTIGEN use MACROPHAGE-1 ANTIGEN 1995-2002; for M01 ANTIGEN %26% MO1 GLYCOPROTEIN use MACROPHAGE-1 ANTIGEN 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ANTIGENS, CD11A see LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 195-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ANTIGENS, CD11A use LYPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for AP-2 PROTEIN COMPLEX, AP-2 ADAPTOR %28%CLATHRIN-COATED VESICLES%29%, HA-2 ADAPTORS %26% HYDROXYAPATITE 2 ADAPTORS use CLATHRIN ADAPTOR PROTEINS %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for AP-4 PROTEIN COMPLEX use ADAPTOR PROTEINS 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for AP3 ADAPTOR COMPLEX use CLATHRIN ADAPTOR PROTEINS %28%NM%29% 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for AUXILIN use ADAPTOR PROTEINS %28%NM%29% 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for BETA-CRYSTALLIN BASIC PRINCIPAL POLYPEPTIDE see CRYSTALLINS 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for BETA-CRYSTALLIN BASIC PRINCIPAL POLYPEPTIDE use CRYSTALLINS 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for BETA-CRYSTALLIN see CRYSTALLINS 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for BETA-CRYSTALLIN use CRYSTALLINS 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for C FIBERS see NERVE FIBERS 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for C FIBERS use NERVE FIBERS 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for C-TYPE PROTEIN HNRNP %26% HNRNP C PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CBP80 PROTEIN use RNA CAP-BINDING PROTEINS 1994-2002; for CAF20 PROTEIN use RNA CAP-BINDING PROTEINS 1997-2002; for CBP20 PROTEIN use RNA CAP-BINDING PROTEINS 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CD11C ANTIGEN %26% ANTIGENS, CD11C see COMPLEMENT 4-BINDING PROTEIN 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CD11C ANTIGEN %26% ANTIGENS, CD11C use INTEGRIN ALPHAXBETA2 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CHAMAEMELUM NOBILE see CHAMOMILE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CHAMAEMELUM NOBILE use CHAMOMILE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR use MRNA CLEAVAGE AND POLYADENYLATION FACTORS %28%NM%29% 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CLEAVAGE STIMULATION FACTOR use MRNA CLEAVAGE AND POLYADENYLATION FACTORS %28%NM%29% 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for COMPENSATION see ECONOMICS 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for COMPENSATION use ECONOMICS 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CORALS see CNIDARIA 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for CORALS use CNIDARIA 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for DELTA-CRYSTALLIN see CRYSTALLINS 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for DELTA-CRYSTALLIN use CRYSTALLINS 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for DYNAMIN I %26% DYNAMIN-1 use DYNAMINS %28%NM%29% 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for DYNAMIN III use DYNAMINS %28%NM%29% 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for DYNAMIN-2 use DYNAMINS %28%NM%29% 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for EASTERN ORTHODOX ETHICS use CHRISTIANITY 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for EPSILON-CRYSTALLIN see CRYSTALLIN 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for EPSILON-CRYSTALLIN use CRYSTALLIN 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for EWS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for FERRITIN REPRESSOR PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1991-2002, for IRE-BP1, IRON REGULATORY PROTEIN 1, IRP-1 PROTEIN %26% IRP1 PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for FETAL LIVER KINASE-1, KDR TYROSINE KINASE, FLK-1 RECEPTOR TYROSINE KINASE %26% FLK-1 PROTEIN use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1993-2002; for VEGFR-2 use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for FUS PROTEIN %26% HNRNP P2 use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1996-2002; for TLS PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1993-2002;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for GAMMA-CRYSTALLIN see CRYSTALLINS 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for GAMMA-CRYSTALLIN use CRYSTALLINS 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for GIFTS, FINANCIAL see FUND RAISING 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for GIFTS, FINANCIAL use FUND RAISING 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for GINSENOSIDES use GINSENOSIDES %28%NM%29% 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for GURMAR use GURMAR %28%NM%29% 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for HFQ GENE PRODUCT %26% HOST FACTOR 1 use INTEGRATION HOST FACTORS %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for HNRNP A2-B1 use TELOMERE-BINDING PROTEINS %28%NM%29% 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for HNRNP F use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1994-2002; for HNRNP H use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for HNRNP L use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for HNRNP M use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for HNRNP U PROTEIN use HETEROGENEOUS-NUCLEAR RIBONUCLEAR PROTEINS 1992-2002, for GRIP120 %26% SCAFFOLD ATTACHMENT FACTOR A %28%SAF-A%29% use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for IF-1 use EUKARYOTIC INITIATION FACTOR-1 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for IF-1see EIF-1 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ILEALANAL POUCHES %26% ILEAL RESERVOIRS %26% J-POUCH %26% KOCH POUCH %26% W-POUCH see PROCTOCOLECTOMY, RESTORATIVE 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ILEALANAL POUCHES %26% ILEAL RESERVOIRS %26% J-POUCH %26% KOCH POUCH %26% W-POUCH use PROCTOCOLECTOMY, RESTORATIVE 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for INTERMETATARSAL JOINT see TARSAL JOINTS 1965-2005; for FOOT JOINT see TARSAL JOINTS 1975-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for INTERMETATARSAL JOINT use TARSAL JOINTS 1965-2005; for FOOT JOINT use TARSAL JOINTS 1975-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for INULA RACEMOSA use INULA %28%NM%29% 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for INVERSION STIMULATION FACTOR use INTEGRATION HOST FACTOR %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for IRIDOIDGLUCOSIDES use IRIDOIDS %28%NM%29% 1975-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for IRON REGULATORY PROTEIN 2, IRE-BP2 %26% IRP-2 RNA-BINDING PROTEIN use IRON-REGULATORY PROTEINS %28%NM%29% 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ISOLECTIN use LECTINS %28%NM%29% 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ITALIAN MILLET see PANICUM 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ITALIAN MILLET use PANICUM 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for KUTAJA use KUTAJA %28%NM%29% 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for LAMIN A use LAMINS %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for LAMIN B use LAMINS %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MANNOSE-BINDING LECTIN, MANNAN-BINDING PROTEIN %26% MANNAN-BINDING LECTIN use COLLECTINS 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MASTOCYTOMA BENIGN use MASTOCYTOSIS 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MASTOCYTOSIS, BULLOUS see URTICARIA PIGMENTOSA 1987-2002; for MASTOCYTOSIS, DIFFUSE CUTANEOUS see URTICARIA PIGMENTOSA 1987-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MASTOCYTOSIS, BULLOUS use URTICARIA PIGMENTOSA 1987-2002; for MASTOCYTOSIS, DIFFUSE CUTANEOUS use URTICARIA PIGMENTOSA 1987-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MATRICARIA CHAMOMILLA see CHAMOMILE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MATRICARIA CHAMOMILLA use CHAMOMILE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MATRICARIA PERFORATA see CHAMOMILE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MATRICARIA PERFORATA use CHAMOMILE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MORMONS see CHRISTIANITY 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for MORMONS use CHRISTIANITY 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NAD+ ADP-RIBOSYLTRANSFERASE use POLY%28%ADP-RIBOSE%29% POLYMERASES 1988-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NARRATIVE ETHICS see ETHICS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NARRATIVE ETHICS use ETHICS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NEUROPILIN use NEUROPILIN-1 %28%NM%29% 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NPN-2 PROTEIN use NEUROPILIN-1 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NUX-VOMICA see STRYCHNINE 1979-2001, see NUX VOMICA 1963-1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for NUX-VOMICA use STRYCHNINE 1979-2001, use NUX VOMICA 1963-1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for OMEGA-CRYSTALLIN see CRYSTALLINS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for OMEGA-CRYSTALLIN use CRYSTALLINS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for P70 POLY%28%A%29% BINDING PROTEIN use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for PAB II use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1995-2002; for PABP2 GENE PRODUCT %26% PABP2 PROTEIN use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1999-2002; for PABP2 use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for PEPPERMINT use MENTHA PIPERITA %28%NM%29% 1973-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for RADICAL NECK DISSECTION see RADICAL NECK DISSECTION 1965-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for RADICAL NECK DISSECTION use RADICAL NECK DISSECTION 1965-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for RECEPTOR, EPHB1, ELK PROTEIN EPHT2 PROTEIN %26% NEURONALLY EXPRESSED EPH-TYROSINE KINASE use RECEPTORS, EPH FAMILY 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for RHATANY use KRAMERIACEAE 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for SEMA 1 %26% SEMAPHORIN-1 use SEMAPHORIN 1A, GRASSHOPPER %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for SURFACTANT PROTEIN A %26% SP-A PROTEIN use PULMONARY SURFACTANT-ASSOCIATED PROTEINS %28%NM%29% 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for Siphonostomatoida see Siphonostomatotoida 2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for TAU-CRYSTALLIN see CRYSTALLINS 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for TAU-CRYSTALLIN use CRYSTALLINS 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for TRF1 PROTEIN use TELOMERE-BINDING PROTEINS %28%NM%29% 1997-2002;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for VLA-2 use COLLAGEN RECEPTORS %28%NM%29% 1991-2002; for PLATELET MEMBRANE GLYCOPROTEIN HETERODIMER IA-IIA use COLLAGEN RECEPTORS %28%NM%29% 1992-2000; for INTEGRIN ALPHA2BETA1 %26% CD49B-CD29 use COLLAGEN RECEPTORS %28%NM%29% 1994-2002; for ALPHA2BETA1INTEGRIN use COLLAGEN RECEPTORS %28%NM%29% 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for VOLUNTARY EUTHANASIA see EUTHANASIA 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for VOLUNTARY EUTHANASIA use EUTHANASIA 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ZETA-CRYSTALLIN see CRYSTALLINS 1989-2002; ZETA-CRYSTALLIN-NADPH OXIDOREDUCTASE was indexed under CRYSTALLINS %26% NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ZETA-CRYSTALLIN use CRYSTALLINS 1989-2002; for ZETA-CRYSTALLIN-NADPH OXIDOREDUCTASE use ZETA-CRYSTALLINS %28%NM%29% 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; for ZOAPATLE use MONTANOA %28%NM%29% 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HYPERPLASIA 2002, see DECIDUA 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see 25-HYDROXYCHOLECALCIFEROL 1-HYDROXYLASE 1991-2002, see STEROID HYDROXYLASES 1975-1990; 25-HYDROXYVITAMIN D2 1-HYDROXYLASE was indexed under STEROID HYDROXYLASES 1976-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ABDOMINAL MUSCLES 1966-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1991-2002 %26% NUCLEOTIDYLTRANSFERASES 1976-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADENINE NUCLEOTIDE TRANSLOCASE 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADNEXITIS 1963-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADNEXITIS 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADOLESCENCE 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ADVANCE DIRECTIVES 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS see ANIMAL 1978-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ANISE 2001-2002, see APIACEAE 1988-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ARM 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ARTEMISIA 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BARLEY 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BARNACLES 1972-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BASIL 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BEHAVIOR 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BEHCET%27%S SYNDROME 1963-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BELLADONA 1991-2003, see PLANTS, TOXIC 1986-1990, see BELLADONA 1963-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BLASTOCYST 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see BRAIN INJURY, CHRONIC 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CA%28%2+%29%-CALMODULIN-DEPENDENT PROTEIN KINASE 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CAPSID 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CARRIER PROTEINS 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CARROTS 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CASSAVA 1991-2002, see PLANTS, EDIBLE 1986-1990, see CASSAVA 1963-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CHOLESTEROL 7 ALPHA-MONOOXYGENASE 1997-2002, see CHOLESTEROL-7-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CHOLESTEROL MONOOXYGENASE 1997-2002, see CHOLESTEROL DESMOLASE 1988-1996, see OXIDOREDUCTASES 1975-1987%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CHRISTIANITY 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CHRISTIANITY 1978-2002; for SEVENTH-DAY ADVENTISTS see CHRISTIANITY 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CIGUATOXIN 1991-2002, see MARINE TOXINS 1978-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CIGUATOXINS 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COFFEE 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COGNITION 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COMPLEMENT 4-BINDING PROTEIN 2002, see ANTIGEN P150,95 1991-2001; INTEGRIN APHAXBETA2 was indexed under MEMBRANE GLYCOPROTEINS 1988-2002 %26% GLYCOPROTEINS 1985-1987%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COMPUTER COMMUNICATION NETWORKS 1996-2002; see OFFICE AUTOMATION 1987-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CORN 1966-2002, see GRAIN 1963-1965 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CORPUS LUTEUM REGRESSION 1976-2002; see CORPUS LUTEUM 1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COTTON 1963-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COUNSELING 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see COWDRIA 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CRABS 1972-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CRAYFISH 1972-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CRUCIFERAE 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CRUSTACEA 1990-2002; for EUPHAUSIA %26% NYCTIPHANES see CRUSTACEA 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see CYTOCHROME P-450 CYP11B2 1977-2002; for STEROID 18-HYDROXYLASE see CYTOCHROME P-450 1984-1996, see STEROID 11-HYDROXYLASE 1994-1996, see STEROID HYDROXYLASES 1979-1993, %26% see DESOXYCORTICOSTERONE 1979-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DATURA STRAMONIUM 1974-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DEAFNESS 2000-2002; for HYPOACUSIS see HEARING LOSS, PARTIAL 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DEAFNESS, SUDDEN 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DECISION MAKING 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DISCLOSURE 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DISCLOSURE 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DNA-DIRECTED RNA POLYMERASE 1998-2002, see RNA POLYMERASES 1977-1997, see RNA POLYMERASE 1973-1976%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see DRACUNCULUS 1963-2002; for DRACUNCULUS MEDINENSIS see DRACUNCULUS 1963-1985; for GUINEA WORM see DRACUNCULUS MEDINENSIS 1979-1985, see DRACUNCULUS 1968-1978; for MEDINA WORM see DRACUNCULUS MEDINENSIS 1979-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ECONOMICS 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see EIF-1 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see EIF-2 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see EIF-2B 2000-2002; EIF-2B was indexed under PROTEINS 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ETHICAL ANALYSIS 2002; see ETHICS 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ETHICAL REVIEW 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ETHICS 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ETHICS, PROFESSIONAL 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see FAMILY 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see FETAL DEVELOPMENT 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see FETUS 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see FEVERFEW 2000-2002, see SESQUITERPENES 1986-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see FRACTIONATION 1991-2002; see CHEMISTRY, ANALYTICAL 1967-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see G-PROTEIN, STIMULATORY GS 1997-2003; STIMULATORY GTP-BINDNG PROTEIN, ALPHA SUBUNIT was indexed under G-PROTEIN, STIMULATORY GS 1997-2003 %26% under G-PROTEINS 1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GENE FREQUENCY 1975-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GENETIC COUNSELING 2002, see REPRODUCTION TECHNIQUES 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GENETICS %28%1974-2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GENETICS, BEHAVIORAL 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GENETICS, POPULATION 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GENTIAN 2002, see RAUWOLFIA 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GONADOTROPINS, CHORIONIC %28%1964-2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see GYMNOSPERMS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HALOBACTERIUM SALINARIUM 1998-2002; for HALOBACTERIUM HALOBIUM see HALOBACTERIA HALOBIUM 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HISTONE DEACETYLASE 1991-2002; see AMIDOHYDROLASES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HTLV-BLV ANTIBODIES 1995-2002, see HTLV ANTIBODIES 1989-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HTLV-BLV ANTIGENS 1995-2002, see HTLV ANTIGENS 1989-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HUMAN EXPERIMENTATION 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see HYDRA 1997-2000, see CNIDARIA 2001-2002; for PHYSALIA %26% PORTUGESE MAN-OF-WAR see JELLYFISH 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see INCONTINENCE PADS 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see INFANT CARE 1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see INFORMATION SERVICES 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see INFORMED CONSENT 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see INTERPERSONAL RELATIONS 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see INTERPROFESSIONAL RELATIONS 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see JURISPRUDENCE 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see JURISPRUDENCE 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LABOR 1966-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LAWSONIA 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LECTINS 1979-2002, PLANT AGGLUTININS 1963-1978 %26% PHYTOMITOGENS 1972-1978%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LEG 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LEUKOPOIESIS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LIFE 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LOBSTERS 1972-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see LYMPHOCYTE TRANSFORMATION 1972-2002; for BLAST TRANSFORMATION see BLAST CRISIS 1987-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see MILLET 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see MOTIVATION 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see MUSCULAR DYSTROPHIES 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see MUSTARD 1985-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see Marketing of Health Services 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see NAD%28%P%29%%28%+%29%-ARGININE ADP-RIBOSYLTRANSFERASE 1992-2002, see NAD-ARGININE ADP-RIBOSYLTRANSFERASE 1989-1991; for NAD+ ADP-RIBOSYLTRANSFERASE see NAD+ ADP-RIBOSYLTRANSFERASE 1992-2002, see POLY ADP RIBOSE POLYMERASE 1988-1991; for MONO-ADP-RIBOSYLTRANSFERASE and NAD-ARGININE ADP-RIBOSYLTRANSFERASE and NADP-ARGININE ADP-RIBOSYLTRANSFERASE see NAD%28%P%29%%28%+%29%-ARGININE ADP-RIBOSYLTRANSFERASE 1992-2002, see NAD-ARGININE ADP-RIBOSYLTRANSFERASE 1989-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see NERVE TISSUE PROTEIN S 100 1984-2002, see NERVE TISSUE PROTEINS 1975-1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see NUCLEOSIDASES 1966-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see NUTRITION 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see OATS 1994-2002, see CEREALS 1985-1994; see GRAIN 1963-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see OCIMUM BASILICUM 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see ORGAN PROCUREMENT 2002; see TISSUE DONORS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see OSTEOLYSIS, ESSENTIAL 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see OVUM IMPLANTATION 1985-2002; for OVUM IMPLANTATION see NIDATION 1967-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see OVUM IMPLANTATION, DELAYED 1991-2002, see OVUM IMPLANTATION 1985-1990, see NIDATION 1975-1984; for NIDATION, DELAYED see OVUM IMPLANTATION 1985-1990, see NIDATION 1975-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PASTEURELLA HAEMOLYTICA 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PATIENT RIGHTS 2002, see PATIENT ADVOCACY 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PERTUSSIS TOXINS 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR see PERTUSSIS TOXINS 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PERTUSSIS TOXINS 1986-2002; CYCLOLYSIN was indexed under BACTERIAL PROTEINS and PROTEIN PRECURSORS 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PHILOSOPHY 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PLANTS 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PRION DISEASES 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PYRETHRUM 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see PYRETHRUM 1992-2002, see PLANTS 1986-1990, see PYRETHRUM 1963-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RECALL 1991-2002, see MEMORY 1966-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RECEPTORS, FIBRONECTIN 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RECEPTORS, THYROID HORMONE 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RECEPTORS, VITRONECTIN 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RELIGIOUS PHILOSOPHIES 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RESEARCH 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RESEARCH 1996-2002; for FETAL TISSUE RESEARCH see RESEARCH 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RESINS 1963-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RHAMNUS 1985-2002; for Tullidora see RHAMNUS 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RIBOSOMAL PROTEIN S6 KINASE 1998-2002; RIBOSOMAL PROTEIN S6 KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-1997 %26% PROTEIN KINASES 1985-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see RYE 1991-2002, see CEREALS 1985-1990, see GRAIN 1963-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see SETARIA 1993-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see SOCIAL CONTROL, FORMAL 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see SOCIETIES, SCIENTIFIC 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see SOMATOTROPIN 1966-2002; for GROWTH HORMONE, RECOMBINANT see SOMATOTROPINS, RECOMBINANT 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see SOMATROPIN 1997-2002; SEROSTIM was indexed under SOMATOTROPINS, RECOMBINANT 1996-2002; NORDITROPIN was indexed under SOMATOTROPIN %26% RECOMBINANT PROTEINS 1992-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see STE see STEROID 21-MONOOXYGENASE 1997-2002, see STEROID 21-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1978-1990; for STEROID 21-MONOOXYGENASE see STEROID 21-HYDROXYLASE 1978-1996; CYTOCHROME P-450 C21 was indexed under STEROID 21-HYDROXYLASE 2004 %26% under CYTOCHROME P-450 ENZYME SYSTEM 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see STEROID 11 BETA-MONOOXYGENASE 1997-2002, see STEROID 11-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1990, see STEROID-11-HYDROXYLASE 1978-1989%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see STEROID 12-MONOOXYGENASE 1997-2002, see STEROID 12-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1978-1990; for STEROID 12-MONOOXYGENASE see STEROID 12-HYDROXYLASE 1978-1996%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see STEROID 17 ALPHA-MONOOXYGENASE 1997-2002, see STEROID 17-HYDROXYLASE 1991-1996, see STEROID HYDROXYLASES 1990; for STEROID-17-HYDROXYLASE see STEROID HYDROXYLASES 1978-1989; for 17,20-LYASE see 17 ALPHA-HYDROXYPROGESTERONE ALDOLASE 1996-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see STRAMONIUM 1963-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see THIRD-PARTY CONSENT 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see TOMATOES 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see UROLOGY 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see VEGETARIANISM 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see WEIL%27%S DISEASE 1963-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; see under MARKETING OF HEALTH SERVICES 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, COLLAGEN %28%NM%29% 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ABDOMINAL MUSCLES 1966-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS %28%NM%29% 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADAPTOR PROTEIN COMPLEX BETA SUBUNITS %28%NM%29% 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADAPTOR PROTEIN COMPLEX DELTA SUBUNITS %28%NM%29% 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADAPTOR PROTEIN COMPLEX GAMMA SUBUNITS %28%NM%29% 1991-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADNEXITIS 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADOLESCENCE 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ADVANCE DIRECTIVES 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use AMIDOHYDROLASES 1975-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ANIMAL WELFARE 1987-2002; for ANIMAL EXPERIMENTS use ANIMALS 1978-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use APIACEAE 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ARM 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ARTEMISIA 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ASIALOGLYCOPROTEIN RECEPTOR %28%NM%29% 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use BEHAVIOR 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use BLASTOCYST 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use BRAIN INJURY, CHRONIC 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CALGRANULIN A %28%NM%29% 1998-2002; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CALGRANULIN B %28%NM%29% 1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CALNEXIN %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CALRETICULIN %28%NM%29% 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CAPSID 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CARRIER PROTEINS 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CD38 ANTIGEN %28%NM%29% 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CHRISTIANITY 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CHRISTIANITY 1978-2002; for SEVENTH-DAY ADVENTISTS use CHRISTIANITY 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CIGUATOXIN 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CLATHRIN HEAVY CHAINS %28%NM%29% 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use COFFEE 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use COGNITION 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use COLLECTINS %28%NM%29% 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use COMPUTER COMMUNICATION NETWORKS 1996-2002; use OFFICE AUTOMATION 1987-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use COUNSELING 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CRUSTACEA 1990-2002; for EUPHAUSIA %26% NYCTIPHANES use CRUSTACEA 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use CYCLIC ADP-RIBOSE %28%NM%29%1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use DEAFNESS 2000-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use DECISION MAKING 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use DISCLOSURE 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use DISCLOSURE 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use DYNAMINS %28%NM%29% 1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ECONOMICS 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-A1 %28%NM%29% 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-A2 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-A3 %28%NM%29% 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-A4 %28%NM%29% 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-A5 %28%NM%29% 1998-2002; for REPUSLSIVE AXONAL GUIDANCE PROTEIN use EPHRIN-A4 %28%NM%29% 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-B1 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-B2 %28%NM%29% 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EPHRIN-B3 %28%NM%29% 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS %28%NM%29% 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 %28%NM%29% 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2 %28%NM%29% 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ETHICAL ANALYSIS 2002; use ETHICS 1992-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ETHICAL REVIEW 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ETHICS 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ETHICS, PROFESSIONAL 1991-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EUKARYOTIC INITIATION FACTOR-3 %28%NM%29% 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EUKARYOTIC INITIATION FACTOR-4E %28%NM%29% 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EUKARYOTIC INITIATION FACTOR-4F %28%NM%29% 1983-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EUKARYOTIC INITIATION FACTOR-4G %28%NM%29% 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EUKARYOTIC INITIATION FACTOR-5 %28%NM%29% 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use EUKARYOTIC INITIATION FACTOR-F4A %28%NM%29% 1980-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use FAMILY 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use FETAL DEVELOPMENT 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use FETUS 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use FIMBRIAE PROTEINS %28%NM%29% 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use FOLLICLE STIMULATING HORMONE, BETA SUBUNIT %28%NM%29% 1983-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use FOLLISTATIN %28%NM%29% 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GALACTOLIPIDS %28%NM%29% 1976-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GALECTIN 1 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GALECTIN 2 %28%NM%29% 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GALECTIN 3 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GALECTIN 4 %28%NM%29% 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GALECTINS %28%NM%29% 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GENE FREQUENCY 1975-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GENETIC COUNSELING 2002, use REPRODUCTION TECHNIQUES 1999-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GENETICS %28%1974-2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GENETICS, BEHAVIORAL 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GENETICS, POPULATION 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GLYCOGEN SYNTHASE KINASE 3 %28%NM%29% 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GONADOTROPINS, CHORIONIC %28%1964-2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use GYMNOSPERMS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HEMATOPOIETIC STEM CELL TRANSPLANTATION 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HEPATITIS A ANTIBODIES %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HEPATITIS A ANTIGENS %28%NM%29% 1985-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HEPATITIS DELTA ANTIGENS %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K %28%NM%29% 1994-2002; for HNRNP K use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1980-2002; for INFORMATIN use HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS %28%NM%29% 1980-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HUMAN EXPERIMENTATION 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HYDRA 1997-2000, use CNIDARIA 2001-2002; for PHYSALIA %26% PORTUGESE MAN-OF-WAR use CNIDARIA 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use HYPERPLASIA 2002, use DECIDUA 1998-2001 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use Health Behavior 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use IMMUNOCONGLUTININS %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INCONTINENCE PADS 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INFANT CARE 1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INFORMATION SERVICES 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INFORMED CONSENT 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRATION HOST FACTORS %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA1 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA1BETA1 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA2 %28%NM%29% 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA3 %28%NM%29% 1995-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA3BETA1 %28%NM%29% 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA4 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA4BETA1 %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA5 %28%NM%29% 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA6 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA6BETA1 %28%NM%29% 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHA6BETA4 %28%NM%29% 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN ALPHAV %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN BETA3 %28%NM%29% 1989-2002; for PLATELET MEMBRANE GLYCPROTEIN IIIA use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTEGRIN BETA4 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTERPERSONAL RELATIONS 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use INTERPROFESSIONAL RELATIONS 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use IRON-BINDING PROTEINS %28%NM%29% 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use IRON-BINDING PROTEINS %28%NM%29% 1986-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use IRON-REGULATORY PROTEINS %28%NM%29% 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use JURISPRUDENCE 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use JURISPRUDENCE 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LAMINS %28%NM%29% 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LECTINS 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LECTINS, C-TYPE %28%NM%29% 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LEG 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LEUKOCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LEUKOPOIESIS 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LIFE 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use LUTEINIZING HORMONE, BETA SUBUNIT %28%NM%29% 1983-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MANNOSE-BINDING LECTINS %28%NM%29% 1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MARKETING OF HEALTH SERVICES 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MICRORNAS %28%NM%29% 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MITOCHONDRIAL ADP, ATP TRANSLOCASES 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MOTIVATION 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MRNA CLEAVAGE AND POLYADENYLATION FACTORS %28%NM%29% 1992-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MUSCULAR DYSTROPHIES 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use MUSTARD 1985-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use Marketing of Health Services 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use NEURAL CELL ADHESION MOLECULE L1 %28%NM%29% 1983-2002; for NEURAL CELL ADHESION MOLECULE L1; F11 GLYCOPROTEIN; CELL ADHESION MOLECULE L1; CAML1 GENE PRODUCT; CELL SURFACE GLYCOPROTEIN L1; L1 CELL ADHESION MOLECULE; L1 CAM %26% NEURAL ADHESION MOLECULE L1 use LEUKOCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1992-2002; for CALL PROTEIN use LEUKOCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1999-2002; for NILE PROTEIN use LEUCKCYTE L1 ANTIGEN COMPLEX %28%NM%29% 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use NEUROPILIN-1 %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use NUCLEAR ANTIGENS %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use NUCLEOSIDE TRANSPORT PROTEINS %28%NM%29% 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use NUTRITION 1979-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use O-ACETYL-ADP-RIBOSE %28%NM%29% 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use OCIMUM BASILICUM 1998-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use ORGAN PROCUREMENT 2002; use TISSUE DONORS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use OSTEOLYSIS, ESSENTIAL 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PATIENT RIGHTS 2002, use PATIENT ADVOCACY 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PHILOSOPHY 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX 1996-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use POLY%28%A%29%-BINDING PROTEINS %28%NM%29% 1982-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use POLYPYRIMIDINE TRACT-BINDING PROTEIN %28%NM%29% 1991-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PRION DISEASES 1993-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PROGESTERONE 16 ALPHA-HYDROXYLASE %28%NM%29% 1977-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PROKARYOTIC INITIATION FACTOR-2 %28%NM%29% 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PROKARYOTIC INITIATION FACTOR-3 %28%NM%29% 1979-2002; for TIF IF3 %26% TRANSLATION INITIATION FACTOR 3 use EUKARYOTIC INITIATION FACTOR-3 %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PROLINE-DIRECTED PROTEIN KINASES %28%NM%29% 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN B %28%NM%29% 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN C %28%NM%29% 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEIN D %28%NM%29% 1990-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PULMONARY SURFACTANT-ASSOCIATED PROTEINS %28%NM%29% 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use PYRETHRUM 1977-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA1 %28%NM%29% 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA2 %28%NM%29% 1990-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA3 %28%NM%29% 1999-2002, for EPHA3 PROTEIN use RECEPTOR, EPHA5 %28%NM%29% 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA4 %28%NM%29% 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA5 %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA6 %28%NM%29% 1994-2002, for EPHA6 PROTEIN use EPHA7 RECEPTOR 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA7 %28%NM%29% 1997-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHA8 %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHB2 %28%NM%29% 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHB3 %28%NM%29% 1993-2002; for EPHB3 RECEPTOR use RECEPTORS, EPH FAMILY %28%NM%29% 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHB4 %28%NM%29% 1994-2002; for EPHB4 RECPTOR use RECEPTORS, EPH FAMILY 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHB5 %28%NM%29% 1996-2002, for EPHB5 RECEPTOR use EPHB2 RECEPTOR %28%NM%29% 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTOR, EPHB6 %28%NM%29% 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, EPH FAMILY %28%NM%29% 1999-2002, for EPH RECEPTOR TYROSINE KINASE use EPHA1 RECEPTOR %28%NM%29% 1999-2002;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, FIBRONECTIN 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, N-ACETYLGLUCOSAMINE %28%NM%29% 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, THYROID HORMONE 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, THYROID HORMONE 1994-2002; THYROID HORMONE RECEPTOR BETA was indexed under RECEPTORS, THYROID HORMONE 2002-2005%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1991-2002; for ENDOTHELIAL GROWTH FACTOR RECEPTOR use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RECEPTORS, VITRONECTIN 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RELIGIOUS PHILOSOPHIES 2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RESEARCH 1996-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RESEARCH 1996-2002; for FETAL TISSUE RESEARCH use RESEARCH 1995-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RHAMNUS 1985-2002; for Tullidora use RHAMNUS 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RIBOSOMAL PROTEIN S6 %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RNA CAP-BINDING PROTEINS %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RNA, SMALL INTERFERING %28%NM%29% 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use RNA-INDUCED SILENCING COMPLEX %28%NM%29% 2001-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use SEMAPHORIN 3A %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use SOCIAL CONTROL, FORMAL 1978-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use SOCIETIES, SCIENTIFIC 1980-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TATA-BOX BINDING PROTEIN %28%NM%29% 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TATA-BOX BINDING PROTEIN-LIKE PROTEINS %28%NM%29% 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TELOMERE-BINDING PROTEINS %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TELOMERIC REPEAT BINDING PROTEIN 2 %28%NM%29% 1998-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use THIRD-PARTY CONSENT 1999-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use THYROTROPIN, BETA SUBUNIT %28%NM%29% 1983-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TRANSCRIPTION FACTOR TFIIA %28%NM%29% 1989-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TRANSCRIPTION FACTOR TFIIB %28%NM%29% 1991-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TRANSCRIPTION FACTOR TFIID %28%NM%29% 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TRANSCRIPTION FACTOR TFIIIA %28%NM%29% 1984-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use TRANSCRIPTION FACTOR TFIIIB %28%NM%29% 1987-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use UROLOGY 1992-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 %28%NM%29% 1990-2002; for FLK-1 RECEPTOR TYROSINE KINASE use RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1993-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3 %28%NM%29% 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for PERTUSSIGEN, ISLET-ACTIVATING PROTEIN, IAP PERTUSSIS TOXIN, and HISTAMINE-SENSITIZING FACTOR use VIRULENCE FACTORS, BORDETELLA 1986-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; use VIRULENCE FACTORS, BORDETELLA 1986-2002; for CYCLOLYSIN use ADENYLATE CYCLASE TOXIN %28%NM%29% 1989-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003; was indexed under FOLLISTATIN %28%NM%29% 1988-2002 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003A' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003B' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003C' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2003D' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1964%29%; for 17-HYDROXYPREGNENOLONE use HYDROXYPREGNENOLONE %28%NM%29% 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1965%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1966%29%; for UDDER see UDDER 1968-1978 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1968%29%; for FAMILY PLANNING PROGRAMS use HEALTH PLANNING 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1971%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1972%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1973%29%; for CENESTIN use ESTROGENS, CONJUGATED %28%NM%29% 1999-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1974%29%; was check tag only %28%not a descriptor%29% 1974-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1975%29%; for NATURAL FAMILY PLANNING use FAMILY PLANNING 1988-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1976%29%; use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1985%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1990%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1991%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1992%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1993%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1994%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1996%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1996%29%; use LIPODYSTROPHY, INTESTINAL 1963-1995 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1997%29%; use 17-HYDROXYPROGESTERONE %28%NM%29% 1982-1996, use HYDROXYPROGESTERONES 1975-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%1998%29%; use TRINUCLEOTIDE REPEAT EXPANSION 1998-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%2000%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%2002%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004 %28%2002%29%; for SMALL ROUND-STRUCTURED VIRUSES use NORWALK VIRUS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1963%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1963%29%; for SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE use CYTOCHROME C OXIDASE %28%NM%29% 1988-2001; for CYTOCHROME OXIDASE SUBUNIT III use CYTOCHROME C OXIDASE %28%NM%29% 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1963%29%; see BLACKS 1976-2003; see NEGROES 1963-75 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1963-1981%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1964%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1966%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1966%29%; see EQUILIBRIUM 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1966%29%; was MIDDLE AGE 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1966%29%; was see under RESPIRATION 1966-1990 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1968%29%; see RACIAL STOCKS 1968-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1968%29%; use RACIAL STOCKS 1968-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1973%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1975%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1975%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1978%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1983%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1984%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1985%29%; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1990%29%; for APOCYTOCHROME B5 use CYTOCHROMES B %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1991%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1993%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1994%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1994%29%; for CORE I PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE %26% CORE II PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE use ELECTRON TRANSPORT COMPLEX III %28%NM%29% 1991-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1994%29%; use CYTOCHROME A %28%NM%29% 1979-1993 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1996%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1996%29%; see SPHEROIDS 1996-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1997%29%; for GUANINE NUCLEOTIDE-BINDING PROTEIN GO use GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO %28%NM%29% 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1997%29%; use ENDOTHELINS 1991-96; for BIG ENDOTHELIN use ENDOTHELIN-1 %28%NM%29% 1990-2003; for PREPROENDOLTHELIN use ENDOTHELINS-1 %28%NM%29% 1989-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1997%29%; use INTEGRASE %28%NM%29% 1974-1996 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1998%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1998%29%; see TRINUCLEOTIDE REPEAT EXPANSION 1999-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1998%29%; use TRANSPOSASE %28%NM%29% 1981-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1999%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%1999%29%; for NEUROPHILIN use VASCULAR ENDOTHELIAL GROWTH FACTOR %28%NM%29% 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%2000%29%; for ANGIOGENESIS FACTOR INHIBITORS use ANGIOGENESIS INHIBITORS %28%NM%29% 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%2002%29%; use ROSALES 1998-2001, use SPICES 1993-1997 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004%28%2003%29% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-1975; use ALCALIGENES 1976-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-1992 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-1992; use PRASTERONE 1993-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-1993; see CARCINOMA, INFILTRATING DUCT 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-1993; use CARCINOMA, INFILTRATING DUCT 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-2000; see DIVERTICULUM, COLON 2001-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1963-2000; use DIVERTICULUM, COLON 2001-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1966-1999; see CHORDATA, NON-VERTEBRATE 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1966-1999; use CHORDATA, NON-VERTEBRATE 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1974-1992; use RHEOLOGY 1993-2003, use BLOOD FLOW VELOCITY 1963-1971%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1975-1991; use BACTERIA 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004, 1975-1991; use BRUCELLA 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-01-01' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-07' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-08' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-09' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-13' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-21' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-22' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-26' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-27' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-28' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-29' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-07-30' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-08-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-08-03' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-08-06' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-09-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-10-20' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-11-15' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-11-18' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-11-19' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004-12-02' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; UBIQUITIN-CONJUGATING ENZYME E2 %28% UBIQUITIN-CONJUGATING ENZYMES%29% was indexed under LIGASES %28%1990-2003%29%; HHR6 PROTEIN was indexed under LIGASES 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR A %28%NM%29% 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 1-ALKYL-2-ACETYLGLYCEROLPHOSPHOCHOLINE ESTERASE was indexed under PHOSPHOLIPASES A 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 1-PHOSPHATYDYLINOSITOL-GLYCAN-SPECIFIC PHOSPHOLIPASE C %28%now PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE%29% was indexed under PHOSPHOLIPASE C 1998-2003; under PHOSPHORIC DIESTER HYDROLASES 1976-1997 %26% under PHOSPHATIDYLINOSITOLS 1977-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 11 BETA-HSD2 was indexed under HYDROXYSTEROID DEHYDROGENASES 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 was indexed under HYDROXYSTEROID DEHYDROGENASES 1999-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 11BETA-HYDROXYSTEROID DEHYDROGENASE was indexed under HYDROXYSTEROID DEHYDROGENASES 1978-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 2-OXOISOVALERATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%now 3-METHYL-2-OXBUTANOATE DEHYDROGENASE %28%LIPOAMIDE%29%%29% was indexed under KETONE OXIDOREDUCTASES %26% MULTIENZYME COMPLEXES 1982-2003, under AMINO ACIDS, BRANCH-CHAIN 1979-1981, under KETO ACIDS 1973-1981, under CARBOXY-LYASES 1974-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE was indexed under 20-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1982-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 3,20-ALLOPREGNANEDIONE was indexed under PREGNANEDIONES %28%NM%29% 1971-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE %28%B-SPECIFIC%29% was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1979-2003; 5 ALPHA-DIHYDROPROGESTERONE 3 ALPHA-HYDROSTEROID OXIDOREDUCTASE was indexed under 3-HYDROXYSTEROID DEHYDROGENASES 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE %28%FADH2%29% was indexed under OXIDOREDUCTASES 1987-2003, under ALCOHOL OXIDOREDUCTASES 1974-1986, under TETRAHYDROFOLATES 1974-1982 %26% under FOLIC ACIDS 1970-1973%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; 5-METHYLCYTOSINE was indexed under CYTOSINE/AA 1976-2003, under CYTOSINE 1970-1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ACYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1982-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ACYL-COA OXIDASE was indexed under OXIDOREDUCTASES 1982-2003, under ACYL COENZYME A 1980-1981 %26% under PEROXIDASES 1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ADENOSINE A2B RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ADENOSINE A3 RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ADENOSYLHOMOCYSTEINASE was indexed under HYDROLASES 1976-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ADENSOSINE A%28%2A%29% RECEPTOR was indexed under RECEPTORS, PURINERGIC P1 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ALDEHYDE OXIDASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ALPHA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ANGIOPOIETIN-1 was indexed under MEMBRANE GLYCOPROTEINS 1997-2003 %26% ANGIOGENESIS FACTOR 2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ANGIOPOIETIN-2 was indexed under PROTEINS 1999-2002 %26% ANGIOGENESIS FACTOR 2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ANGIOSTATINS was indexed under PEPTIDE FRAGMENTS %26% PLASMINOGEN 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ANGIOTENSIN II TYPE 1 RECEPTOR %28%now RECEPTOR, ANGIOTENSIN, TYPE 1%29% was indexed under RECEPTORS, ANGIOTENSIN 1996-2003; ANGIOTENSIN II TYPE 1A RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1995-2003; ANGIOTENSIN II TYPE 1B RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ANGIOTENSIN II TYPE 2 RECEPTOR %28%now RECEPTOR, ANGIOTENSIN, TYPE 2%29% was indexed under RECEPTORS, ANGIOTENSIN 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ANTENNA POLYPEPTIDE, BACTERIAL was indexed under BACTERIAL PROTEINS %26% PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1992-2003; for CHLOROPHYLL AB-PROTEINS; CHLOROPHYL A-PROTEINS; CHLOROPHYLL AC-PROTEINS %26% LIGHT-HARVESTING CHLOROPHYLL PROTEIN see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003; PHYCOBILIPROTEINS was indexed under PROTEINS 1978-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ARYLDIALKYLPHOSPHATASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; BETA-FRUCTOFURANOSIDASE was indexed under GLYCOSIDE HYDROLASES 1983-2003, under SUCRASE 1979-1982, %26% under FRUCTOSE 1979-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; BETA-MANNOSIDASE was indexed under MANNOSIDASES 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; BIOTINIDASE was indexed under AMIDOHYDROLASES 1983 - 2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; BRADKININ B1 RECEPTOR %28%now RECEPTOR, BRADYKININ B1%29% was indexed under RECEPTORS, BRADYKININ 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; BRANDYKININ B2 RECEPTOR %26% BRADYKININ TYPE 2 RECEPTOR %28%now RECEPTOR, BRADYKININ B2%29% were indexed under RECEPTORS, BRADYKININ 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; BUTYL-CAO DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1980-2003; under OXIDOREDUCTASES 1974-1978; under BUTYRATES 1974-1980 %26% under COENZYME A 1974-1978; SHORT-CHAIN ACETYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CALCIUM-SENSING RECEPTOR %28%now RECEPTORS, CALCIUM-SENSING%29% was indexed under RECEPTORS, CELL SURFACE; for CALCIUM RECEPTORS use CALCIUM-BINDING PROTEINS 1982-2003; for RECEPTORS, CALCIUM use CALCIUM-BINDING PROTEINS 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CANNABINOID RECEPTORS was indexed under RECEPTORS, DRUG 1988-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CARBOXYLESTERASE was indexed under CARBOXYLIC ACID ESTERASES 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CARBOXYPEPTIDASE B was indexed under CARBOXYPEPTIDASES 1974-2003; PROCARBOXYPEPTIDASE B was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECURSORS 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CARBOXYPEPTIDASE C was indexed under CARBOXYPEPTIDASES 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CARBOXYPEPTIDASES A was indexed under CARBOXYPEPTIDASES 1974-2003; PROCARBOXYPEPTIDASE A was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECUSORS 1981-2003; PROCARBOXYPEPTIDASE A1 was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECUSORS 1998-2003; PROCARBOXYPEPTIDASE A2 was indexed under CARBOXYPEPTIDASES %26% ENZYME PRECUSORS 1998-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CARBOXYPETIDASE H was indexed under CARBOXYPEPTIDASES 1982-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CB1 RECEPTOR %28%now RECEPTOR, CANNABINOID, CB1%29% was indexed under RECEPTORS, DRUG 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CB2 RECEPTOR %28%now RECEPTOR, CANNABINOID, CB2%29% was indexed under RECEPTORS, DRUG 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CCK-A RECEPTOR %28%now RECEPTOR, CHOLECTCYSTOKININ A%29% was indexed under RECEPTORS, CHOLECYSTOKININ 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CCK-B RECEPTOR %28%now RECEPTOR, CHOLECYSTOKININ B%29% was indexed under RECEPTORS, CHOLECYSTOKININ 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CDC2-RELATED KINASE was indexed under CYCLIN-DEPENDENT KINASES 2000-2004; CDC2+-CDC28-RELATED PROTEIN KINASE was indexed under CDC28 PROTEIN KINASE 2003; PROTEIN-SERINE-THREONINE KINASES 1992-2002 %26% PROTEIN KINASES 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CHEMOTACTIC PEPTIDE RECEPTOR %28%now RECEPTORS, FORMYL PEPTIDE%29% was indexed under RECEPTORS, IMMUNOLOGIC %26% RECEPTORS, PEPTIDE 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CHOLESTENONE 5 ALPHA-REDUCTASE was indexed under OXIDOREDUCTASES 1983-2003 %26% under CHOLESTENONES 1970-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; COLLAGEN TYPE XVIII %26% COLLAGEN XVIII were indexed under COLLAGEN %26% PEPTIDE FRAGMENTS 1997-2002; COLLAGEN ALPHA1%28%XVIII%29% was indexed under COLLAGEN 1994-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; COMPLEMENT 5A RECEPTOR %28%now RECEPTOR, ANAPHYLATOXIN C5A%29% was indexed under RECEPTORS, COMPLEMENT %26% ANTIGENS, CD 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CORRINOID was indexed under PORPHYRINS 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROME B%28%5%29%REDUCTASE was indexed under CYTOCHROME REDUCTASES 1975-2003 %26% under OXIDOREDUCTASES 1973-1974; for METHEMOGLOBIN REDUCTASE see METHEMOGLOBIN REDUCTASE 1991-2003, see NADH, NADPH OXIDOREDUCTASES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROME B6 was indexed under CYTOCHROME B 1984-2003; APOCYTOCHROME B6 was indexed under APOPROTEINS %26% CYTOCHROME B 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROME B6F was indexed under CYTOCHROME B 1984-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROME C6 was indexed under CYTOCHROMES 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROME F was indexed under CYTOCHROMES 1979-2003; APOCYTOCHROME F was indexed under APOPROTEINS %26% CYTOCHROMES 1987-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROMES A1 was indexed under CYTOCHROME A 1994-2003 %26% under CYTOCHROMES 1980-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOCHROMES C2 was indexed under CYTOCHROME C 1979-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; CYTOSINE DEAMINASE was indexed under NUCLEOSIDE DEAMINASES 1983- 2003 %26% CYTOSINE 1978-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; DEOXYRIBONUCLEASE IV %28%PHAGE T4-INDUCED%29% was indexed under ENDODEOXYRIBONUCLEASES 1987-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; DEOXYRIBONUCLEASE was indexed under ENDODEOXYRIBONUCLEASES 1983-2003, under ENDONUCLEASES %26% DEOXYRIBONUCLEASE 1976-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; DIHYDROURACIL DEHYDROGENASE %28%NADP%29% was indexed under OXIDOREDUCTASES 1983-2003; %26% under URACIL 1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; DNA GLYCOSIDASES was indexed under N-GLYCOSIDE HYDROLASES 1982-2003, under GLYCOSIDE HYDROLASES %26% DNA 1978-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE was indexed under CARBON-OXYGEN LYASES 1996-2003, DEOXYRIBONUCLEASES 1978-1982, ENDODEOXYRIBONUCLEASES 1983-1995, ENDONUCLEASES 1978-1982 %26% LYASES 1978-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; DNA-FORMAIDOPYRIMIDINE GLYCOSYLASE was indexed under N-GLYCOSYL HYDROLASES 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ELECTRON-TRANSFERRING FLAVOPROTEINS was indexed under FLAVOPROTEINS 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDO-1,3%28%4%29%-BETA-D-GLUCANASE was indexed under GLYCOSIDE HYDROLASES 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDO-1,4 BETA XYLANASES was indexed under XYLOSIDASES 1995-2003, under GLYCOSIDE HYDROLASES 1980-1994 %26% under XYLANS 1977-1980, XYLANASE B was indexed under XYLOSIDASES 1995-2003 %26% under GLYCOSIDE HYDROLASES 1990-1994, XYLANASE C was indexed under XYLOSIDASES 1995-2003 %26% under GLYCOSIDE HYDROLASES 1992-1994, XYLANASE D was indexed under XYLOSIDASES %26% BETA-GLUCOSIDASE 1995-2003, under GLYCOSIDE HYDROLASES 1993-1994%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDOCRINE-GLAND-DERIVED ENDOTHELIAL GROWTH FACTOR %28%now VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED%29% was indexed under ANGIOGENESIS FACTOR %26% GASTROINTESTINAL HORMONES %28%2003%29%, under MITOGENS 2001-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDOOCANNABINOIDS was indexed under FATTY ACIDS 2002-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDOSTATINS was indexed under COLLAGEN and PEPTIDE FRAGMENTS 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDOTHELIN A RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; ENDOTHELIN B RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1993-2003; ENDOTHELIN B-2 RECEPTOR was indexed under RECEPTORS, ENDOTHELIN 1998-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; EXO-1,4-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; EXO-CELLOBIOHYDROLASE %28%now CELLULOSE 1,4-BETA-CELLOBIOSIDASE%29% was indexed under CELLULASE 1974-2003; EXOGLUCANASE II was indexed under BETA-GLUCOSIDASE 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; EXODEOXYRIBONUCLEASE V was indexed under EXODEOXYRIBONUCLEASES 1983-2003 %26% under EXONUCLEASES 1980-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; FIBROBLAST GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-1992; HEPARIN-BINDING GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, MITOGEN %26% RECEPTORS, GROWTH FACTOR 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; FLAP ENDONUCLEASES was indexed under ENDODEOYRIBONUCLEASES 1994-2003; FEN1 PROTEIN was indexed under EXODEOXYRIBNUCLEASES 1997-2003; RTH-1 NUCLEASE was indexed under EXODEOXYRIBNUCLEASES 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; FLAVONOLS was indexed under FLAVONES 1977-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; FURIN was indexed under SUBTILISINS 1993-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; G ALPHA Q PROTEIN %28%now GTP-BINDING PROTEIN ALPHA SUBUNITS GQ-G11%29% was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003; GTP-BINDING PROTEINS 1999-2000%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; G ALPHA12 PROTEIN was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003; G13 PROTEIN was indexed under DNA-BINDING PROTEINS 1996-2003; G%28%13%29% PROTEIN was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 %26% GTP-BINDING PROTEINS 1998-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GALANIN RECEPTOR was indexed under RECEPTORS, NEUROPEPTIDE 1999-2003 %26% RECEPTORS, GASTROINTESTINAL HORMONE 1987-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GALANIN-1 RECEPTOR %28%now RECEPTOR, GALANIN, TYPE 1%29% was indexed under RECEPTORS, NEUROPEPTIDE 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GALANIN-2 RECEPTOR %28%now RECEPTOR, GALANIN, TYPE 2%29% was indexed under RECEPTORS, NEUROPEPTIDE 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GALANIN-LIKE PROTEIN %28%now GALANIN-LIKE PEPTIDE%29% was indexed under NERVE TISSUE PROTEINS 2000-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GLUCAN 1,3-BETA-GLUCOSIDASE was indexed under BETA-GLUCOSIDASE 1979-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GLUCOSE 1-DEHYDROGENASE was indexed under GLUCOSE DEHYDROGENASES 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GLUTAMATE CARBOXYPEPTIDASE II was indexed under CARBOXYPEPTIDASES 1999-2003 %26% under DIPEPTIDASES 1988-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; GLUTAMYL AMINOPEPTIDASE was indexed under AMINOPEPTIDASES 1981-2003 %26% ASPARTIC ACID 1978-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; HOLLIDAY JUNCTION RESOLVASES was indexed under ENDONUCLEASES 1989-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; INORGANIC PYROPHOSPHATASE was indexed under PYROPHOSPHATASES 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; L-LACTATE DEHYDROGENASE %28%CYTOCHROME%29% was indexed under LACTATE DEHYDROGENASE 1981-2003 %26% under CYTOCHROMES 1974-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; LACCASE was indexed under OXIDOREDUCTASES 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; LACTASE was indexed under BETA-GALACTOSIDASE 1990-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; LAURIC ACID HYDROLASE %28%now ALKANE 1-MONOXYGENASE%29% was indexed under CYTOCHROME P-450 ENZYME SYSTEM %26% MIXED FUNCTION OXYGENASES 1982-2003, under LAURIC ACIDS 1979-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; LONG-CHAIN-ACYL-COA DEHYDROGENASE was indexed under FATTY ACID DESATURASES 1988-2003; for DECONOYL COA DEHYDROGENASE see FATTY ACID DESATURASES 1990-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; M5 MUSCARINIC RECEPTOR was indexed under RECEPTORS, MUSCARINIC 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MEL%28%1A%29%-MELATONIN RECEPTOR was indexed under RECEPTORS, CELL SURFACE %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELANOCORTIN RECEPTOR %28%now RECEPTORS, MELANOCORTIN%29% was indexed under RECEPTORS, CORTICOTROPIN 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELANOCORTIN RECEPTOR 2 was indexed under RECEPTORS, CORTICOTROPIN 1994-2003 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELANOCORTIN RECEPTOR 3 was indexed under RECEPTORS, CORTICOTROPIN 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELANOCORTIN RECEPTOR 4 was indexed under RECEPTORS, CORTICOTROPIN 1995-2003; RECEPTORS, PEPTIDE 1994-2002 %26% RECEPTORS, CELL SURFACE 1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELANOCORTIN-1 RECEPTOR %28%now RECEPTOR, MELANOCORTIN%29%%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELATONIN 1B RECEPTOR was indexed under RECEPTORS, CELL SURFACE %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MELATONIN RECEPTORS was indexed under RECEPTOR, CELL SURFACE %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1984-2003; RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1986; %26% RECEPTORS, NEUROHUMOR 1987-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; METHENYLTETRAHYDRODROFOLATE CYCLOHYDROLASE was indexed under AMINOHYDROLASES 1983-2003, under TETRAHYDROFOLATES 1974-1982, under HYDROLASES 1974-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; METHOXATIN %28%now PQQ COFACTOR%29% was indexed under QUINOLONES 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; METHYLENE-THF-REDUCTASE %28%NADPH%29% was indexed under AMINE OXIDOREDUCTASES 1986-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MUSCARINIC RECEPTOR M1 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MUSCARINIC RECEPTOR M2 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MUSCARINIC RECEPTOR M3 was indexed under RECEPTORS, MUSCARINIC 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MUSCARINIC RECEPTOR M4 was indexed under RECEPTORS, MUSCARINIC 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; MYOSIN-LIGHT CHAIN PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASE 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; NADH DEHYDROGENASE %28%UBIQUINONE%29% was indexed under NADH, NADPH OXIDOREDUCTASES 1992-2003; for NADH DEHYDROGENASE use NADH DEHYDROGENASE 1990-2003; for UBIQUINONE REDUCTASE see NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; NEUROPHILIN was indexed under LYMPHOKINES 1974-2003; ENDOTHELIAL GROWTH FACTORS 1991-2003 %26% INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; NUCLEOSIDE-TRIPHOSPHATASE was indexed under ACID ANHYDRIDE HYDROLASES 1994-2003, PHOSPHATASES 1973-1993, %26% NUCLEOTIDES 1973-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; OLIGOCLONAL IMMUNOGLOBULINS was indexed under IMMUNOGLOBULINS 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; P19%28%SKP1%29%PROTEIN and P45%28%SKP%29%PROTEIN were indexed under CELL CYCLE PROTEINS 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PARATHYROID HORMONE-RELATED PROTEIN was indexed under PEPTIDE HORMONES 2003; PROTEINS 1987-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PC1 PROHORMONE CONVERTASE, NEUROENDOCRINE CONVERTASE PC1, PC3 ENDOPROTEASE %26% PROHORMONE CONVERTASE 1 were indexed under ASPARTIC ENDOPEPTIDASES 1991-2003; PC1 ENDOPROTEASE %26% PC3 PROHORMONE CONVERTASE were indexed under ASPARTIC ENDOPEPTIDASES 1993-2003; PROPROTEIN CONVERTASE SPC3 was indexed under ASPARTIC ENDOPEPTIDASES 2001-2003; PROINSULIN CONVERTASE 1 was indexed under ASPARTIC ENDOPEPTIDASES 2002-2003;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PC2 PROTEIN %28%now PROPROTEIN CONVERTASE 2%29% was indexed under SUBTILISINS 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PC5 PROPROTEIN CONVERTASE %28%now PREPROTEIN CONVERTASE 5%29% was indexed under SERINE ENDOPEPTIDASES 1993-1997 %26% SUBTILISINS 1998-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PEPTIDE-N4-%28%N-ACETYL-BETA-GLUCOSAMINYL%29% ASPARAGINE AMIDASE was indexed under AMIDOHYDROLASES 1983-2003 %26% GLYCOPEPTIDES 1979-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PHOSPHODIESTERASE I was indexed under PHOSPHORIC DIESTER HYDROLASES 1981-2003, under NUCLEOTIDES 1978-1980%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PHOSPHOTRIESTERASE was indexed under ESTERASES 1994-2003; PHOSPHORIC MONOESTER HYRDOLASES 1990-1993; PHOSPHOMONOESTERASES 1982-1989%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PHYCOBILISOMES was indexed under PROTEINS 1978-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B was indexed under PROTEIN-SERINE-THREONINE KINASES 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROANTHOCYANIDINS was indexed under ANTHOCYANIDINS 1977-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROPIONYL-COA CARBOXYLASE was indexed under CARBOXY-LYASES 1983-2003 %26% under PROPIONATES 1975-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROPROTEIN COVERTASES was indexed under SUBSTILISINS 2002-2003; PRO-OPIOMELANOCORTIN CONVERTING ENZYME was indexed under ASPARTIC ENDOPEPTIDASES 1994-2003, under PEPTIDE PEPTIDOHYDROLASES 1982-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROSTACYCLIN RECEPTOR %28%now RECEPTORS, EPOPROSTENOL%29% was indexed under RECEPTORS, PROSTAGLANDIN 1981-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROSTAGLANDIN H2 was indexed under PROSTAGLANDINS H 1993-2003 %26% PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROTEASE-ACTIVATED RECEPTOR-1 %28%now RECEPTOR, PROTIENASE-ACTIVATED%29% was indexed under RECEPTORS, THROMBIN 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PROTEINASE ACTIVATED RECEPTOR 2 %28%now RECEPTOR, PAR-2%29% was indexed under RECEPTORS, THROMBIN 1994-2003; TRYPSIN RECEPTOR %28%now RECEPTOR, PAR-2%29% was indexed under RECEPTORS, CELL SURFACE 1986-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; PTH-2 RECEPTOR %28%now RECEPTOR, PARATHYROID HORMONE, TYPE 2%29% was indexed under RECEPTORS, PARATHYROID HORMONE 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; RECEPTOR, SEROTONIN 1A %28%now RECEPTOR, SEROTONIN, 5-HT1A%29% was indexed under RECEPTORS, SEROTONIN 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003; RESOLVASE was indexed under TRANSPOSASES 1997-2003, under DNA NUCLEOTIDYLTRANSFERASES 1992-1997 %26% under NUCLEOTIDYLTRANSFERASES 1981-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; RIBONUCLEASE III was indexed under ENDORIBONUCLEASES 1983-2003, under ENDONUCLEASE %26% RIBONUCLEASE 1979-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; RIBONUCLEASE P was indexed under ENDORIBONUCLEASES 1983-2003, under RNA, CATALYTIC 1991-2003, under ENDONUCLEASES 1981-1982, %26% under RIBONUCLEASES 1979-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SCF UBIQUITIN LIGASE %28%now SKP CULLIN F-BOX LIGASES%29% was indexed under PEPTIDE SYNTHASES 1999-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 1B RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT1B%29% was indexed under RECEPTORS, SEROTONIN 1993-2003; SEROTONIN 1D BETA RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT1B%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 1D RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT1D%29% was indexed under RECEPTORS, SEROTONIN 1996-2003; SEROTONIN 1DALPHA RECEPTOR was indexed under RECEPTORS, SEROTONIN 1997-2003;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 2A RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT2A%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 2B RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HT2B%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 2C RECEPTOR %28%now RECEPTOR, SEROTONIN, 5-HTC%29% was indexed under RECEPTORS, SEROTONIN 1994-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 3 RECEPTOR %28%now RECEPTORS, SEROTONIN, 5-HT3%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 4 RECEPTOR %28%now RECEPTORS, SEROTININ, 5HT4%29% was indexed under RECEPTORS, SEROTONIN 1995-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SEROTONIN 5-HT1 RECEPTOR %28%now RECEPTORS, SEROTONIN, 5-HT1%29% was indexed under RECEPTORS, SEROTONIN 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; STERYL-SULFATASE was indexed under ARYLSULFATASES 1976-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; SUCCINATE DEHYDROGENASE %28%UBIQUINONE%29% was indexed under MULTIENZYME COMPLEXES, OXIDOREDUCTASES %26% SUCCINATE DEHYDROGENASE 1972-2003; for SUCCINATE-Q OXIDOREDUCTASE see SUCCINATE DEHYDROGENASE 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; TETRAPYRROLES was indexed under PYRROLES 1978-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; THYMIDINE DNA GLYCOSYLASE was indexed under ENDODEOXYRIBONUCLEASES 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; TIE RECEPTOR TYROSINE KINASES %28%now RECEPTORS, TIE%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2003; under RECEPTORS, CELL SURFACE %26% PROTEIN-TYROSINE KINASE 1992-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; TIE-1 RECEPTOR TYROSINE KINASE %26% TIE1 TYROSINE KINASE were indexed under RECEPTORS, CELL SURFACE %26% RECEPTOR PROTEIN-TYROSINE KINASES 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; TIE-2 RECEPTOR TYROSINE KINASE %28%now RECEPTOR TIE-2%29% was indexed under RECEPTOR PROTEIN-TYROSINE KINASES 1994-2004 %26% under PROTEIN-TYROSINE KINASE 1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; TRANSPOSASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1996-1997 %26% NUCLEOTIDYLTRANSFERASES 1981-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; UBIQUITIN THIOLESTERASE was indexed under THIOLESTER HYDROLASES 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; UBIQUITIN-ACTIVATING ENZYME was indexed under LIGASES 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; UBIQUITIN-PROTEIN LIGASE was indexed under LIGASES 1983-2003; E3 UBIQUITIN LIGASE was indexed under LIGASES 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; VASCULAR ENDOTHELIAL GROWTH FACTOR B was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; VASCULAR ENDOTHELIAL GROWTH FACTOR C was indexed under ENDOTHELIAL GROWTH FACTORS 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; VASCULAR ENDOTHELIAL GROWTH FACTOR D was indexed under ENDOTHELIAL GROWTH FACTORS 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; VASCULAR ENDOTHELIAL GROWTH FACTOR was indexed under ENDOTHELIAL GROWTH FACTORS 2000-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; VDJ RECOMBINASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1986-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; XYLAN ENDO-1,3-BETA-XYLOSIDASE was indexed under XYLOSIDASES 1995-2003, under GYCOSIDE HYDROLASES 1975-1994, under XYLANS 1979-1982 %26% under XYLOSE 1975-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for 11 BETA-HSD2 use 11 BETA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for 3,20-ALLOPREGNANEDIONE use PREGNANEDIONES %28%NM%29% 1971-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for ABORIGINES, AUSTRALIAN see OCEANIC ANCESTRY GROUP 2006-; see ABORIGINES 1991-2003; for AUSTRALOID RACE see AUSTRALOID RACE 1978-2003, see AUSTRALIAN RACE 1963-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for ANDROGENS, SYNTHETIC see ANDROGENS, SYNTHETIC 1975-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for ANTENNA POLYPEPTIDE, BACTERIAL use LIGHT-HARVESTING PROTEIN COMPLEXES %28%NM%29% 1992-2003; for CHLOROPHYLL AB-PROTEINS; CHLOROPHYL A-PROTEINS; CHLOROPHYLL AC-PROTEINS %26% LIGHT-HARVESTING CHLOROPHYLL PROTEIN use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003; for PHYCOBILIPROTEINS use LIGHT-HARVESTING PROTEIN COMPLEXES %28%NM%29% 1980-2003 %26% PROTEINS 1978-1979%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BALLISTICS, WOUND see WOUNDS, GUNSHOT 1987-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BALLISTICS, WOUND use WOUNDS, GUNSHOT 1987-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BARRIER METHODS see CONTRACEPTION 1988-2003; for VAGINAL BARRIER METHODS see CONTRACEPTION 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BARRIER METHODS use CONTRACEPTION 1988-2003; for VAGINAL BARRIER METHODS use CONTRACEPTION 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BEGGIATOACEAE see BEGGIATOACEAE 1976-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BETA-GLUCOSIDASES see BETA-GLUCOSIDASE 1991-2003; for LAMINARINASE use GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 1974-2003; EXO-CELLULASE was indexed under CELLULASE 1991-2003; EXOCELLULASE was indexed under CELLULASE 2001-2003; AVICELASE was indexed under CELLULASE 1996-2003; AVICELASE II was indexed under CELLULASE 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BETA-GLUCOSIDASES use BETA-GLUCOSIDASE 1992-2003; for LAMINARINASE use GLUCAN ENDO-1,3-BETA-GLUCOSIDASE 1980-2003; for EXO-CELLULASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1991-2003; for EXOCELLULASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 2001-2003; for AVICELASE use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1996-2003; for AVICELASE II use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BUTTERMILK and KEFIR see MILK 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for BUTTERMILK and KEFIR use MILK 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CDC2-RELATED KINASE use CDC2-CDC28 KINASES %28%NM%29% 2000-2004; for CDC2+-CDC28-RELATED PROTEIN KINASE use CDC2-CDC28 KINASES %28%NM%29% 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CHLOROFLEXACEAE see GREEN SULFUR BACTERIA 1997-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CHLOROFLEXACEAE use CHLOROBI 1997-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CYTCHROME C6 use CYTOCHROMES F %28%NM%29% 1991-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CYTOCHROME A3 see CYTOCHROME-C OXIDASE 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CYTOCHROME A3 use MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV 1981-2004%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CYTOCHROME B6 use CYTOCHROME B6F COMPLEX %28%NM%29% 1984-2003; for APOPCYTOCHROME B6 use CYTOCHROMES B6 %28%NM%29% 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CYTOPHAGACEAE see CYTOPHAGACEAE 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for CYTOPHAGALES use CYTOPHAGALES 1976-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for ESTROGENS, SYNTHETIC see ESTROGENS, SYNTHETIC 1975-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for FERTILITY CONTROL, POSTCOITAL see CONTRACEPTIVES, POSTCOITAL 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for FERTILITY CONTROL, POSTCOITAL use CONTRACEPTIVES, POSTCOITAL 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for FLAVOBACTERIUM MENINGOSEPTICUM see FLAVOBACTERIUM 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for FLAVOBACTERIUM MENINGOSEPTICUM use FLAVOBACTERIUM 1992-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for FLAVONOLS use FLAVONOLS %28%NM%29% 1977-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for LYMPHATIC VESSELS, LYMPHATIC CAPILLARIES, LYMPHATIC VENULES %26% VENULES, POSTCAPILLARY see LYMPHATIC SYSTEM 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for LYMPHATIC VESSELS, LYMPHATIC CAPILLARIES, LYMPHATIC VENULES %26% VENULES, POSTCAPILLARY use LYMPHATIC SYSTEM 1997-2002%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for MEL%28%1A%29%-MELATONIN RECEPTOR use MELATONIN RECEPTORS %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for MELATONIN 1B RECEPTOR use RECEPTORS, MELATONIN %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for MUSCI see BRYOPSIDA 1996-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for MUSCI use BRYOPSIDA 1996-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for NADH DEHYDROGENASE %28%UBIQUINONE%29% use ELECTRON TRANSPORT COMPLEX I %28%NM%29% 1992-2003; for NADH DEHYDROGENASE COMPLEX 1 use NADH DEHYDROGENASE 1989-2003; for UBIQUINONE REDUCTASE use NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% 1992-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for NATRIURETIC HORMONES see NATRIURETIC HORMONES 1986-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for NITROBACTERACEAE see NITROBACTERACEAE 1975-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PARATHYROID HORMONE RECEPTOR see RECEPTORS, PARATHYROID HORMONE 1994-2003; PARATHYROID HORMONE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-1993; PARATHYROID HORMONE-LIKE PEPTIDE RECEPTOR was indexed under RECEPTORS PARATHYROID HORMONE 1994-2003 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1991-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PARATHYROID HORMONE RECEPTOR use RECEPTORS, PARATHYROID HORMONE 1994-2003 %26% RECEPTORS, PARATHYROID HORMONE %28%NM%29% 1980-1993; for PARATHYROID HORMONE-LIKE PEPTIDE RECEPTOR use RECEPTOR, PARATHYROID HORMONE, TYPE 1 %28%NM%29% 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PC1 PROHORMONE CONVERTASE, NEUROENDOCRINE CONVERTASE PC1, PC3 ENDOPROTEASE, PROHORMONE CONVERTASE 1 use PROPROTEIN CONVERTASE %28%NM%29% 1991-2003; for PC1 ENDOPROTEASE %26% PC3 PROHORMONE CONVERTASE use PROPROTEIN CONVERTASE %28%NM%29% 1993-2003; for PROPROTEIN CONVERTASE SPC3 use PROPROTEIN CONVERTASE %28%NM%29% 2001-2003; for PROINSULIN CONVERTASE 1 use PROPROTEIN CONVERTASE %28%NM%29% 2002-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PHOSPHOTRIESTERASE use ARYLDIALKYLPHOSPHATASE %28%NM%29% 1980 - 2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PHOTOSYNTHETIC REACTION CENTER, BACTERIAL see PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1991-2003; for PHOTOSYNTHETIC REACTION CENTER, PLANT see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PHOTOSYSTEM I REACTION CENTER see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PHOTOSYSTEM I REACTION CENTER use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PHOTOSYSTEM II REACTION CENTER see PHOTOSYNTHETIC REACTION CENTER, PLANT 1991-2003; WATER-SPLITTING ENZYMES OF PHOTOSYTHESIS was indexed under OXIDOREDUCTASES 1983-2003 %26% under CHLOROPHYLL %26% WATER 1972-1982; PHOTOSYSTEM II REACTION CENTER COMPLEX D2 PROTEIN was indexed under PHOTOSYNTHETIC REACTION CENTER, PLANT 1992-2003; D1 PHOTOSYSTEM II PROTEIN, PLANT was indexed under PHOTOSYNTHETIC REACTION CENTER, PLANT 1995-2003, under PHOTOSYNTHETIC REACTION CENTER, BACTERIAL 1994-2001, under PLANT PROTEINS %26% BACTERIAL PROTEINS 1989-1994 %26% under FUNGAL PROTEINS 1990-1991%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PHOTOSYSTEM II REACTION CENTER use PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003; for WATER-SPLITTING ENZYME OF PHOTOSYNTHESIS use PHOTOSYSTEM II PROTEIN COMPLEX %28%NM%29% 1980-2003; for PHOTOSYSTEM II REACTION CENTER COMPLEX D2 PROTEIN use PHOTOSYSTEM II PROTEIN COMPLEX %28%NM%29% 1992-2003; for D1 PHOTOSYSTEM II PROTEIN, PLANT use PHOTOSYSTEM II PROTEIN COMPLEX %28%NM%29% 1989-2003;%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED ALPHA-PLASMA PROTEIN 1991-2003, see PREGNANCY PROTEINS 1980-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PROGESTATIONAL HORMONES, SYNTHETIC see PROGESTATIONAL HORMONES, SYNTHETIC 1975-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PROMYELOCYTES see GRANULOCYTES 1985-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PROMYELOCYTES use GRANULOCYTES 1985-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PYRODICTIUM see DESULFUROCOCCACEAE 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for PYRODICTIUM use DESULFUROCOCCACEAE 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for SPHAGNUM see BRYOPSIDA 1996-2003; see PLANTS 1986-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for SPHAGNUM use BRYOPSIDA 1996-2003, use PLANTS 1986-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for THERMOFILUM see THERMOPROTEALES 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for THERMOFILUM use THERMOPROTEALES 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for THROMBOXANE A2 RECEPTOR see RECEPTORS, THROMBOXANE 1994-2003; PROSTAGLANDIN H2 RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for THROMBOXANE A2 RECEPTOR use RECEPTORS, THROMBOXANE 1994-2003; for PROSTAGLANDIN H2 RECEPTOR use RECEPTORS, TROMBOXANE A2, PROSTAGLANDIN H2 %28%NM%29% 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; for TIE-1 RECEPTOR TYROSINE KINASE %26% TIE1 TYROSINE KINASE use RECEPTOR, TIE-1 %28%NM%29% 1993-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see NITRIC OXIDE 1990-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see 17-HYDROXYPROGESTERONE 1997-2003; 17-HYDROXYPROGESTERONE was indexed under HYDROXYPROGESTERONES 1982-1996, under HYDROXYPROGESTERONES 1975-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see 3T3 CELLS 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ACID ETCHING, DENTAL 1977-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see AGROBACTERIUM TUMEFACIENS 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ALCALIGENES 1976-2003, see ACROMOBACTER 1963-1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ALGAE 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ALGAE, GREEN 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ALGAE, GREEN 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ALPHA PROTEOBACTERIA 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ANIMALS 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ANTIBIOTICS 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ASPIRATION 1991-2003; was see under RESPIRATION 1966-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see Acetobacteraceae 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see BACTERIA 1992-2003, see SPIRILLACEAE 1975-1991 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see BETA PROTEOBACTERIA 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see BREAST 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see BRUCELLA 1992-2003, see GRAM-POSITIVE AEROBIC BACTERIA 1976-1991, see BRUCELLACEAE 1975%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see BRUNNER%27%S GLANDS 1991-2003, see DUODENUM 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CARCINOMA, INFILTRATING DUCT 1994-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CAROLI%27%S DISEASE 1993-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CELIAC DISEASE 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CHEMICAL ACTIONS 1999-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CHEMORECEPTORS 1991-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CHOLELITHIASIS 1975-2003; for COMMON BILE DUCT CALCULI see COMMON BILE DUCT CALCULI 1963-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CHOLESTASIS 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CHROMOSOME FRAGILITY 1982-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CITROBACTER FREUNDII 2001-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CLOVE 2002-2004, see ROSALES 1988-2001, see SPICES 1993-1997%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see COLICIN FACTORS 1991-2003, see PLASMIDS 1978-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see COLONIC DISEASES, FUNCTIONAL 1979-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see COMAMONAS ACIDOVORANS 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see COMMON BILE DUCT CALCULI 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME A 1994-2003, see CYTOCHROMES 1979-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME B 1983-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME B GROUP 1983-2003; APOCYTOCHROME B was indexed under APOPROTEINS %26% CYTOCHROME B 1983-2003 %26% under CYTOCHROMES 1979-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME B5 1990-2003; APOCYTOCHROME B5 was indexed under CYTOCROME B %26% APOPROTEINS 1983-2003, under CYTOCHROMES 1979-1982%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME C 1973-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME C 1973-2003; APOCYTOCHROME C was indexed under CYTOCHROME C %26% APOPROTEINS 1983-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME C 1982-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME C1 1994-2003, see CYTOCHROME C-1 1991-1992, see CYTOCHROME C 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME D 1994-2003, see CYTOCHROMES 1979-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCHROME-C OXIDASE 1994-2003, see CYTOCHROME C OXIDASE 1992-1993, see CYTOCHROME OXIDASE 1963-1991; for CYTOCHROME C OXIDASE see CYTOCHROME OXIDASE 1984-1991; SIGNAL PEPTIDE P25-SUBUNIT IV CYTOCHROME OXIDASE was indexed under CYTOCHROME C OXIDASE 1988-2001; CYTOCHROME OXIDASE SUBUNIT III was indexed under CYTOCHROME C OXIDASE 1998-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see CYTOCROME A GROUP 1994-2004; CYTOCHROME A was indexed under CYTOCHROMES 1979-1993%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DIGESTIVE SYSTEM 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DIGESTIVE TRACT CONTENTS 1999-2003; see GASTROINTESTINAL CONTENTS 1985-1998%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DIHYDROPROGESTERONE 1991-2003, see PROGESTERONE 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DISSENT AND DISPUTES 2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DIVERTICULUM, ESOPHAGEAL 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DIVERTICULUM, STOMACH 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DNA 1985-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DNA 1986-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see DNA LIGASES 1978-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ECOSYSTEM 1996-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ECTOTHIORHODOSPIRA HALOPHILA 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ENDOTHELINS 1991-1996; BIG ENDOTHELIN was indexed under ENDTHELINS %26% PROTEIN PRECUSORS 1991-2003; under PEPTIDES 1990; PREPROENDOTHELIN was indexed under ENDOTHELINS %26% PROTEIN PRECUSORS 1989-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ENVIRONMENTAL POLLUTANTS, NOXAE, AND PESTICIDES 1998-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see EPOPROSTENOL 1991-2003, see PROSTGLANDINS X 1984-1990, see PROSTAGLANDINS 1979-1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ERWINIA CAROTOVORA 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ERWINIA CHRYSANTHEMI 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ESTROGENS, CONJUGATED 1994-2003, see ESTROGENIC SUBSTANCES, CONJUGATED 1973-1993; CENESTIN was indexed under ESTROGENS, CONJUGATED 1999-2002; PRESOMEN was indexed under ESTROGENIC SUBSTANCES, CONJUGATED 1987-1998; for PREMARIN see PREMARIN 1991-1993, see ESTROGENIC SUBSTANCES, CONJUGATED 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was indexed under ETHERS, CYCLIC 1976-1992%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see EUGENOL 1983-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see EXCIPIENTS 1983-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see EXTRACELLULAR SPACE 1975-2003, see BODY FLUIDS 1963-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see FAMILY PLANNING 1968-2003; for FAMILY PLANNING PROGRAMS see HEALTH PLANNING 1980-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see FATTY ACID DESATURASES 1977-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see FECES, IMPACTED 1964-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see FLAVONES 1963-2003; for BIOFLAVONOIDS see BIOFLAVONOIDS 1963-2003; QUERCETIN was under BIOFLAVONOIDS 1963-1974%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON see FOLLICLE STIMULATING HORMONE 1985-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see G-PROTEIN, INHBITORY GI 1997-2003; GUANINE NUCLEOTIDE-BINDING PROTEIN GO was indexed under HETEROTRIMERIC GTP-BINDING PROTEINS 2000-2003 %26% GTP-BINDING PROTEINS 1991-1999%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see GALANTHAMINE 1999-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see GREEN SULFUR BACTERIA 1997-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see GUAIACOL GLYCERYL ETHER 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see HEART ATRIUM 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see HEART VENTRICLE 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see HEMODYNAMICS 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see HYDROXYPREGNENOLONE 1972-2003; 17-HYDROXYPREGNENOLONE was indexed under HYDROXYPREGNENOLONE %28%NM%29% 1981-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see INTEGRASE 1997-2003; INTEGRASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1974-96, DNA UNWINDING PROTEINS 1974-87, VIRAL PROTEINS 1980-87, %26% COLIPHAGES/enzymology 1974-80%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see INTESTINAL OBSTRUCTION 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME see CHURG-STRAUSS SYNDROME 1992-1995%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see LACTATE DEHYDROGENASE 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see LIPOAMIDE DEHYDROGENASE 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MAMMARY NEOPLASMS 1990-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MANNOSIDOSIS 1984-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MECKEL%27%S DIVERTICULUM 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MERCAPTOPROPIONYLGLYCINE 1989-2003 %26% see AMINO ACIDS, SULFUR 1975-1988%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see METALLOENDOPEPTIDASES 1988-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1989-2003; 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE %28%NADH%29% was indexed under OXIDOREDUCTASES 1999-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1991-2003; see OXIDOREDUCTASES 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MILK 1998-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MOSSES 1996-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see MUSTARD 1991-2003, see BRASSICA 1986-1990, see MUSTARD 1963-1985%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see Mongoloid Race 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see N-SUBSTITUTED GLYCINE 2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see NEUROFIBROMATOSIS 1 2002 -2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see NORWALK-LIKE VIRUSES 2002-2003; for SMALL ROUND-STRUCTURED VIRUSES see NORWALK VIRUS 1992-2001%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see NUTRITION DISORDERS 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ODD%27%S SPHINCTER 1991-2003, see VATER%27%S AMPULLA 1975-1990%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PARAGANGLIA, NONCHROMAFFIN 1994-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PARAMYXOVIRINAE 1994-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PARAMYXOVIRINAE 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PARAMYXOVIRUSES, AVIAN 1994-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PARATHYROID HORMONES 1982-2003, see PARATHYROID HORMONE 1963-1981%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PHARMACOGENETICS 2003; for TOXICOGENOMICS see PHARMACOGENETICS 2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PNEUMOCYSTIS CARINII 1974-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PNEUMOCYSTIS CARINII INFECTIONS 1992-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PNEUMONIA, PNEUMOCYSTIS CARINII 1985-2003, see PNEUMONIA, INTERSTITIAL PLASMA CELL 1963-1984%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PREGNANCY ZONE PROTEINS 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PROGESTATIONAL HORMONES 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PROTEIN P34CDC2 1991-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see PSEUDOMONAS 2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see REC A PROTEIN 1984-2003, see REC A PROTEIN %28%NM%29% 1966-1983%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RECEPTORS, PURINERGIC P1 1994-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RECEPTORS, SEROTONIN 1989-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RESPIRATORY DISTRESS SYNDROME 1965-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RETICULOCYTE COUNT 1994-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RHODOMICROBIUM VANNIELII 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RHUBARB 1991-2003, see PLANTS, MEDICINAL 1978-1990, see RHUBARB 1963-1977%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RHYTHM METHOD 1975-2003; for NATURAL FAMILY PLANNING see FAMILY PLANNING 1988-2003%A% ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see RNA, CATALYTIC 1991-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see ROSALES 2003-2004 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SAPPORO-LIKE VIRUSES 2002-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SCLERODERMA, CIRCUMSCRIBED 1971-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SCLERODERMA, SYSTEMIC 1975-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SEAWEED 2000-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SEX 1991-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SEX BEHAVIOR 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SEX BEHAVIOR 1980-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SEX HORMONES 1963-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SIGMOID 1966-2003 ' = 0).
% 42.05/41.92 fof(interp, fi_functors, '2004; see SPECTROPHOTOMETRY, ATOMIC ABSORPTION 1972-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see STANOLONE 1963-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see STERILIZATION, SEXUAL 1963-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see SYNOVIAL CYST 1969-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see TESTOSTERONE 1977-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see THERMOPROTEACEAE 1998-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see THIOBACILLUS THIOOXIDANS 1991-2003, see THIOBACILLUS 1972-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see TONOMETRY 1966-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see UBIQUINOL-CYTOCHROME-C REDUCTASE 1994-2003, see UBIQUINOL-CYTOCHROME C REDUCTASE 1987-1993; CORE I PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE %26% CORE II PROTEIN, UBIQUINOL-CYTOCHROME C REDUCTASE were indexed under NUCLEAR PROTEINS 1991-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see USES OF CHEMICALS AND DRUGS 1999-2003 and SPECIALTY CHEMICALS AND PRODUCTS 1975-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see VALSALVA%27%S MANEUVER 1963-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see VATER%27%S AMPULLA 1963-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see VISCEROPTOSIS 1966-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see WHIPPLE%27%S DISEASE 1996-2003, see LIPODYSTROPHY, INTESTINAL 1963-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see WHITES 1978-2003; see CAUCASOID RACE 1978-2003; see CAUCASIA RACE 1963-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see delta Proteobacteria 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; see episilon Proteobacteria 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 1-ALKYL-2-ACETYLGLYCEROLPHOSPHOCHOLINE ESTERASE %28%NM%29% 1983-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 11-BETA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1978-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 %28%NM%29% 1999-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 20-ALPHA-HYDROXYSTEROID DEHYDROGENASES %28%NM%29% 1982-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE %28%B-SPECIFIC%29% %28%NM%29% 1979-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 3-METHYL-2-OXBUTANOATE DEHYDROGENASE %28%LIPOAMIDE%29% %28%NM%29% 1973-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 3T3 CELLS 1992-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE %28%FADH2%29% %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use 5-METHYLCYTOSINE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ACID ETCHING, DENTAL 1977-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ACYL-COA DEHYDROGENASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ACYL-COA OXIDASE %28%NM%29% 1979-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ADENOSYLHOMOCYSTEINASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ALDEHYDE OXIDASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ALGAE 1998-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ALGAE, GREEN 1998-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ALGAE, GREEN 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ALKENE 1-MONOOXYGENASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ALPHA-MANNOSIDASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ANGIOPOIETIN-1 %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ANGIOPOIETIN-2 %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ANGIOSTATINS %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ARYLDIALKYLPHOSPHATASE %28%NM%29% 1980 - 2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use Acetobacteraceae 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use BETA-FRUCTOFURANOSIDASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use BETA-MANNOSIDASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use BIOTINIDASE %28%NM%29% 1983 - 2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use BREAST 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use BUTYRYL-COA DEHYDROGENASE %28%NM%29% 1980-2003, for SHORT-CHAIN ACETYL-COA DEHYDROGENASE use ACYL-COA DEHYDROGENASE %28%NM%29% 1981-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CARBOXYLESTERASE %28%NM%29% 1981 - 2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CARBOXYPEPTIDASE B %28%NM%29% 1980-2003; for PROCARBOXYPEPTIDASE B use CARBOXYPEPTIDASE B %28%NM%29% 1985-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CARBOXYPEPTIDASE C %28%NM%29% 1995-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CARBOXYPEPTIDASE H %28%NM%29% 1982-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CARBOXYPEPTIDASES A %28%NM%29% 1980-2003, for PROCARBOXYPEPTIDASE A use CARBOXYPEPTIDASE A %28%NM%29% 1981-2003; for PROCARBOXYPEPTIDASE A1 use CARBOXYPEPTIDASES A 1998-2003; for PROCARBOXYPEPTIDASES A2 use CARBOXYPEPTIDASES A %28%NM%29% 1998-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CELIAC DISEASE 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CELLULOSE 1,4-BETA-CELLOBIOSIDASE %28%NM%29% 1974-2003; for EXOGLUCANASE II use GLUCAN 1,3-BETA-GLUCOSIDASE %28%NM%29% 1992-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CHEMORECEPTORS 1991-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CHLOROBI 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CHOLELITHIASIS 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CHOLESTASIS 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CHOLESTENONE 5 ALPHA-REDUCTASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CHROMOSOME FRAGILITY 1982-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CITROBACTER FREUNDII 2001-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use COLLAGEN TYPE XVIII %28%NM%29% 1994-2002 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use COLONIC DISEASES, FUNCTIONAL 1979-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use COMMON BILE DUCT CALCULI 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CORRINOIDS %28%NM%29% 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROME A GROUP 1994-2004, use CYTOCHROME A %28%NM%29% 1979-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROME B GROUP 1983-2003; for APOCYTOCHROME B use CYTOCHROMES B %28%NM%29% 1980-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROME B%28%5%29% REDUCTASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROME B6F COMPLEX %28%NM%29% 1984-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROME C GROUP 1973-2003; for APOPCYTOCHROME C use CYTOCHROMES C %28%NM%29% 1983-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROME C GROUP 1982-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROMES A1 %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROMES C2 %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOCHROMES F %28%NM%29% 1980-2003; for APOCYTOCHROME F use CYTOCHROMES F %28%NM%29% 1987-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use CYTOSINE DEAMINASE %28%NM%29% 1983 - 2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DEOXYRIBONUCLEASE %28%PYRIMIDINE DIMER%29% %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DEOXYRIBONUCLEASE IV %28%PHAGE T4-INDUCED%29% %28%NM%29% 1987-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DIGESTIVE SYSTEM 1998-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DIHYDROURACIL DEHYDROGENASE %28%NADP%29% %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DISSENT AND DISPUTES 2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DIVERTICULUM, ESOPHAGEAL 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DIVERTICULUM, STOMACH 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DNA 1985-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DNA 1986-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DNA GLYCOSIDASES %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DNA LIGASES 1978-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE %28%NM%29% 1981-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ECOSYSTEM 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ELECTRON TRANSPORT COMPLEX II %28%NM%29% 1980-2003; for SUCCINATE-Q OXIDOREDUCTASE use SUCCINATE DEHYDROGENASE 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ELECTRON-TRANSFERRING FLAVOPROTEINS %28%NM%29% 1983-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ENDO-1,4-BETA XYLANASES %28%NM%29% 1980-2003; for XYLANASE B use ENDO-1,4-BETA XYLANASES %28%NM%29% 1990-2003; for XYLANASE C use ENDO-1,4-BETA XYLANASES %28%NM%29% 1992-2003; for XYLANASE D use ENDO-1,4-BETA XYLANASES %28%NM%29% 1993-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ENDOCANNABINOIDS %28%NM%29% 2002-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ENDOSTATINS %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use EPOPROSTENOL 1979-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ETHERS, CYCLIC 1993-2003; CROWN COMPOUNDS was NM 1976-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use EUGENOL 1983-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use EXCIPIENTS 1983-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use EXO-1,4-BETA-GLUCOSIDASE %28%NM%29% 1981-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use EXODEOXYRIBONUCLEASE V %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use EXTRACELLULAR SPACE 1975-2003, use BODY FLUIDS 1963-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use FATTY ACID DESATURASES 1977-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use FIBROBLAST GROWTH FACTOR RECEPTOR %28%NM%29% 1985-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use FLAP ENDONUCLEASES %28%NM%29% 1994-2003; for FEN1 PROTEIN use EXODEOXYRIBONUCLEASE V 1997-2003; for RTH-1 NUCLEASE use EXODEOXYRIBONUCLEASE V 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use FOLLICLE STIMULATING HORMONE 1987-2003; for ANTHROGON use FOLLICLE STIMULATING HORMONE 1985-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use FURIN %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GALANIN-LIKE PEPTIDE %28%NM%29% 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GAMMA PROTEOBACTERIA 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GLUCAN 1,3-BETA-GLUCOSIDASE %28%NM%29% 1979-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GLUCOSE 1-DEHYDROGENASE %28%NM%29% 1983-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GLUTAMATE CARBOXYPEPTIDASE II %28%NM%29% 1988-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GLUTAMYL AMINPEPTIDASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GTP-BINDING PROTEIN ALPHA SUBUNITS GQ-G11%28%NM%29% 1999-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use GTP-BINDING PROTEIN, G12-13 ALPHA SUBUNITS %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use HETEROTRIMERIC GTP-BINDING PROTEINS 2001-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use HOLLIDAY JUNCTION RESOLVASES %28%NM%29% 1989-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use INORGANIC PYROPHOSPHATASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use INTESTINAL OBSTRUCTION 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use INTESTINAL POLYPS 1996-2003; for CRONKHITE-CANADA SYNDROME use CHURG-STRAUSS SYNDROME 1992-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use L-LACTATE DEHYDROGENASE %28%CYTOCHROME%29% %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use LACCASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use LACTASE %28%NM%29% 1990-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use LONG-CHAIN-ACYL-COA DEHYDROGENASE %28%NM%29% 1988-2003; for DECONOYL COA DEHYDROGENASE use LONG-CHAIN-ACYL-COA DEHYDROGENASE 1990-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use MANNOSIDOSIS, ALPHA B, LYSOSOMAL 1984-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use METALLOENDOPEPTIDASES 1988-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP%29% 1989-2003; for 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE %28%NADH%29% use METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NAD+%29% %28%NM%29% 1999-2003;%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use METHYLENETETRAHYDROFOLATE REDUCTASE %28%NADPH2%29% %28%NM%29% 1986-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use METHYLMALONYL-COA DECARBOXYLASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use MILK 1998-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use MYOSIN-LIGHT-CHAIN PHOSPHATASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use NEUROFIBROMATOSIS 1 2002 -2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use NITRIC OXIDE 1990-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use NUCLEOSIDE-TRIPHOSPHATASE %28%NM%29% 1973-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use NUTRITION DISORDERS 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use OLIGOCLONAL BANDS %28%NM%29% 1981-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PARAGANGLIA, NONCHROMAFFIN 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PARAMYXOVIRINAE 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PARAMYXOVIRINAE 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PARATHYROID HORMONE-RELATED PROTEIN %28%NM%29% 1987-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PEPTIDE-N4-%28%N-ACETYL-BETA-GLUCOSAMINYL%29% ASPARAGINE AMIDASE %28%NM%29% 1979 - 2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PHARMACOGENETICS 2003; for TOXICOGENOMICS use PHARMACOGENETICS 2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PHOSPHODIESTERASE I %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PHOSPHOTIDYLINOSITOL DIACYLGLYCEROL-LYASE %28%NM%29% 1980-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PHYCOBILISOMES %28%NM%29% 1980-2003; use PROTEINS 1978-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PNEUMOCYSTIS 1974-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PQQ COFACTOR %28%NM%29% 1981-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PREPROTEIN CONVERTASE 5 %28%NM%29% 1993-2003; for PC6 ENDOPROTEASE use PREPROTEIN CONVERTASE 5 %28%NM%29% 1993-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PROANTHOCYANIDIN %28%NM%29% 1977-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PROPROTEIN CONVERTASE 2 %28%NM%29% 1991-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PROPROTEIN CONVERTASES %28%NM%29% 2002-2003; for PRO-OPIOMELANOCORTIN CONVERTING ENZYME use PROPROTEIN CONVERTASES %28%NM%29% 1982-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PROSTAGLANDIN H2 %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use PSEUDOMONAS 2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RAYNAUD%27%S DISEASE 1966-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR SEROTONIN 5 HT1 SUBCLASS %28%NM%29% 1993-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR TIE-2 %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ADENOSINE A2A %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ADENOSINE A3 %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ADENSINE A2B %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ANAPHYLATOXIN C5A %28%NM%29% 1985-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ANGIOTENSIN, TYPE 1%28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ANGIOTENSIN, TYPE 2 %28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, BRADYKININ B1 %28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, BRADYKININ B2 %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, CHOLECYSTOKININ A %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, CHOLECYSTOKININ B %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ENDOTHELIN A %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, ENDOTHELIN B %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, GALANIN, TYPE 1 %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, GALANIN, TYPE 2 %28%NM%29% 1997-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MELANOCORTIN, TYPE 1 %28%NM%29% 1999-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MELANOCORTIN, TYPE 2 %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MELANOCORTIN, TYPE 4 %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MELANOCORTIN, TYPE, 3 %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MUSCARINIC M1%28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MUSCARINIC M2 %28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MUSCARINIC M3 %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MUSCARINIC M4 %28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, MUSCARINIC M5 %28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, PAR-2 %28%NM%29% 1994-2003; for TRYPSIN RECEPTOR use RECEPTOR, PAR-2 %28%NM%29% 1986-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, PARATHYROID HORMONE, TYPE 2 %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, PROTEINASE-ACTIVATED 1 %28%NM%29% 1997-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, SEROTONIN, 5-HT1B %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, SEROTONIN, 5-HT1D %28%NM%29% 1996-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, SEROTONIN, 5-HT2A %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, SEROTONIN, 5-HT2B %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTOR, SEROTONIN, 5-HT2C %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, CALCIUM-SENSING %28%NM%29% 1994-2003; for CALCIUM RECEPTORS see CALCIUM-BINDING PROTEINS 1982-2003; for RECEPTORS, CALCIUM see CALCIUM-BINDING PROTEINS 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, CANNABINOID %28%NM%29% 1988-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, CANNABINOID %28%NM%29% 1995-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, EPOPROSTENOL %28%NM%29% 1981-2002 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, FORMYL PEPTIDE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, GALANIN %28%NM%29% 1999-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, MELANOCORTIN %28%NM%29% 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, MELATONIN %28%NM%29% 1981-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, PURINERGIC P1 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, SEROTININ, 5HT4 %28%NM%29% 1995-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, SEROTONIN 1989-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, SEROTONIN, 5-HT1 %28%NM%29% 1993-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, SEROTONIN, 5-HT3 %28%NM%29% 1995-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECEPTORS, TIE %28%NM%29% 1999-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RECOMBINASES %28%NM%29% 1986-2003; for RESOLVASE use RECOMBINASES %28%NM%29% 1981-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RETICULOCYTE COUNT 1994-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RHEOLOGY 1993-2003, use FLOWMETERS 1974-1982, use BLOOD FLOW VELOCITY 1963-1971%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RIBONUCLEASE III %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RIBONUCLEASE P %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use RNA, CATALYTIC 1991-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use ROSALES 2003-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use S-PHASE KINASE ASSOCIATED PROTEINS %28%NM%29% 1983-2003; for P19%28%SKP1%29%PROTEIN and P45%28%SKP%29% PROTEIN use S-PHASE KINASE ASSOCIATED PROTEINS %28%NM%29% 1995-2003; for P45%28%SKP%29% use UBIQUITIN-PROTEIN LIGASES %28%NM%29% 1999-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use SCLERODERMA, SYSTEMIC 1975-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use SEAWEED 2000-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use SEX 1991-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use SEX BEHAVIOR 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use SKP CULLIN F-BOX LIGASES %28%NM%29% 1999-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use STERYL-SULFATASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use SYNOVIAL CYST 1969-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use TESTOSTERONE 1977-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use TETRAPYRROLES %28%NM%29% 1978-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use THERMOPROTEACEAE 1998-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use THYMINE DNA GLYCOSYLASE %28%NM%29% 1991-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use TONOMETRY 1966-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use UBIQUITIN THIOLESTERASE %28%NM%29% 1983-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use UBIQUITIN-ACTIVATING ENZYMES %28%NM%29% 1983-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use UBIQUITIN-CONJUGATING ENZYMES %28%NM%29% 1990-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use UBIQUITIN-PROTEIN LIGASE %28%NM%29% 1983-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR B %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR C %28%NM%29% 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR D %28%NM%29% 1997-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED %28%NM%29% 2001-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use VDJ RECOMBINASES %28%NM%29% 1986-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004; use XYLAN ENDO-1,3-BETA-XYLOSIDASE %28%NM%29% 1980-2003 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004A' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2004B' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1963%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1964%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1965%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1966%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1966%29%; was check tag only %28%not a descriptor%29% 1966-2004; for HOMO SAPIENS use HOMINIDAE 1989-2004; for MAN %28%TAXONOMY%29% use HOMINIDAE 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1968%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1971%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1972%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1973%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1974%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1975%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1975%29%; for PANDAS, GREATER use CARNIVORA 1997 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1978%29%; ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1979%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1980%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1981%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1982%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1983%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1984%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1985%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1986%29%; use LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA use EGG PROTEINS 1990-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1987%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1992%29%; for APEU VIRUS use APEU VIRUS 1991, use BUNYAVIRIDAE 1981-1990, use ARBOVIRUSES 1975-1980; for CATU VIRUS %26% GUAMA VIRUS use GUAMA GROUP VIRUSES 1975-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1993%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1994%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1994%29%; for CONN%27%S DISEASE use HYPERALDOSTERONISM 1985-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1994%29%; for GYNANDROBLASTOMA use NEOPLASMS, GONADAL TISSUE 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1996%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1998%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1999%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%1999%29%; use POLYPORACEAE 1986-98 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%2000%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%2003%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%2003%29%; use TWINS 1978-2002 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005 %28%2004%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1963%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1965%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1968%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1968%29%; see POLYMORPHISM %28%GENETICS%29% 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1969%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1971%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1972%29%; use LIGASES 1966-1971 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1973%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1973%29%; see TRANSLATION, GENETIC 1973-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1974%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1974%29%; POLYCYCLIC COMPOUNDS was heading 1966-1995; POLYCYCLIC HYDROCARBONS was heading 1966-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1975%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1977%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1978%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1979%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1980%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1981%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1983%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1984%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1986%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1987%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1988%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1989%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1990%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1991%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1991%29%; ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1992%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1993%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1993%29% for ANNEXIN II %26% CALPACTIN I use ANNEXINS 1984-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1993%29%; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; %26% INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE use ANNEXIN A3 1980-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1993%29%; for ANNEXIN IV use ANNEXINS 1987-1992 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1993%29%; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE use MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1993%29%; for LIPOCORTIN I use ANNEXINS %28%NM%29% 1985-1992, for ANNEXIN I %26% CALPACTIN II use ANNEXINS %28%NM%29% 1984-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1994%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1994%29%; see SYNDROME X 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1995%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1996%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1997%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1998%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1998%29%; see FLUDEOXYGLUCOSE F 18 1998-2004; FLUDEOXYGLUCOSE F 18 was indexed under DEOXYGLUCOSE/analogs %26% derivatives 1978-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%1999%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2000%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2000%29%; use GANGLIOSIDOSES GM2 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2001%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2002%29%; for PP90%28%RSK%29% %26% PP90%28%RSK%29% use RIBOSOMAL PROTEIN S6 KINASES 1998-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2002%29%; use FABACEAE 1978-2001 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2003%29%; for P70 S6 KINASE %26% P70S6K use RIBOSOMAL PROTEIN S6 KINASES 1998-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005%28%2004%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005, 1963-1992 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005, 1963-1992; see ACNE ROSACEA 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005, 1963-2003; see FLAVONOIDS 2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005, 1963-2003; use FLAVONOIDS 2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005, 1985-2002; see EMBRYONIC AND FETAL DEVELOPMENT 2003-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005, 1985-2002; use EMBRYONIC AND FETAL DEVELOPMENT 2003-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-01-01' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-03-04' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-04-04' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-05-18' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-06-20' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-06-30' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-01' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-05' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-06' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-07' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-08' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-11' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-12' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-13' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-14' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-15' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-18' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-19' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-20' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-21' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-22' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-25' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-27' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-28' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-29' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-07-30' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-08-01' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-08-02' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-08-03' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-08-15' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-08-31' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-09-28' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-09-30' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-10-11' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-10-27' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-10-31' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-11-09' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-11-10' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-11-14' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005-11-18' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005: MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1996-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for ELECTRICAL STIMULATION OF THE BRAIN see ELECTRIC STIMULATION 1997-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RIBOSOMAL PROTEIN S6 KINASES, 70 KD 2003-2004; for P70 S6 KINASE %26% P70S6K see RIBOSOMAL PROTEIN S6 KINASES 1998-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; 14-3-3 PROTEINS was indexed under TYROSINE 3-MONOOXYGENASE 2000-2004, under PROTEINS 1995-1999, %26% under NERVE TISSUE PROTEINS 1981-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ADHALIN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1993-2004; DELTA-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1996-2004; EPSILON-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1998-2004; GAMMA-SARCOGLYCAN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE GLYCOPROTEINS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ALPHA-N-ACETYL-D-GALATOSAMINIDASE was indexed under GALATOSAMINIDASE 1982-2004 %26% ACETYLGALACTOSAMINE 1978-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ANNEXIN III was indexed under CALCIUM-BINDING PROTEINS 1991-1992; ANNEXIN A3 was indexed under ANNEXIN III 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ANNEXIN V was indexed under CALCIUM-BINDING PROTEINS and PREGNANCY PROTEINS 1984-1992; ANNEXIN A5 was indexed under ANNEXINS 2003-2004 %26% under ANNEXIN V 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ANNEXIN VI was indexed under CALCIUM-BINDING PROTEINS 1990-1992; CALPHOBINDIN II was indexed under PREGNANCY PROTEINS 1987-1992; CALCIUM AND PHOSPHOLIPID-BINDING PROTEIN P68 was indexed under BINDING PROTEINS %26% CALCIUM 1979-1980; CALCIUM-BINDING PROTEINS 1981-2004 %26% ANNEXIN VI 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ANSAMYCINS was indexed under ANTI-BACTERIAL AGENTS 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; APIGENIN was indexed under FLAVONOIDS 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ARYLALKYLAMINE-N-ACETYLTRANSFERASE was indexed under ARYLAMINE N-ACETYLTRANSFERASE 1986-2004; for SEROTONIN ACETYLTRANSFERASE see ARYLAMINE N-ACETYLTRANSFERASE 1980-2004, for SEROTONIN N-ACETYLTRANSFERASE see ARYLAMINE N-ACETYLTRANSFERASE 1982-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ATP-DEPENDENT ENDOPROTEASE TI %28%now ENDOPEPTIDASE CLP%29% was indexed under SERINE ENDOPEPTIDASES %26% ADENOSINETRIPHOSPHATASE 1988-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ATP-DEPENDENT PROTEASE was indexed under SERINE ENDOPEPTIDASES and HEAT-SHOCK PROTEINS 1989-2004 %26% under PEPTIDE PEPTIDOHYDROLASES 1981-1988%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; BETA-N-ACETYL-GALACTOAMINIDASE was indexed under GALACTOSAMINIDASE 1982-2004, under ACETYLGALACTOSAMINE 1978-1981, %26% under ACETAMIDES %26% ACETIC ACIDS 1973-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CASEIN KINASE I was indexed under PROTEIN KINASES 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CASEIN KINASE IALPHA was indexed under PROTEIN KINASES 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CASEIN KINASE IALPHA was indxed under PROTEIN KINASES 1993-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CASEIN KINASE IEPSILON was indexed under PROTEIN KINASES 1993-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CASEIN KINASE II was indexed under PROTEIN-SERINE-THREONINE KINASES 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CASEIN KINSES was indexed under PROTEIN KINASES 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; CHITOSAN was indexed under CHITIN 2001-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; DYSTROGLYCANS was indexed under CYTOSKELETAL PROTEINS and MEMBRANE GLYCOPROTEINS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; EOSINOPHIL BASIC PROTEIN was indexed under BLOOD PROTEINS %26% RIBONUCLEASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; EOSINOPHIL CATIONIC PROTEIN was indexed under BLOOD PROTEINS %26% RIBONUCLEASES 1979-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; EOSINOPHIL GRANULE PROTEINS was indexed under BLOOD PROTEINS %26% RIBONUCLEASES 1979-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; EOSINOPHIL PEROXIDASE was indexed under PEROXIDES 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; EOSINOPHIL-DERIVED NEUROTOXIN was indexed under RIBONUCLEASES 1989-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ESTROGEN RECEPTOR ALPHA was indexed under RECEPTORS, ESTROGEN 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; ESTROGEN RECEPTOR BETA was indexed under RECEPTORS, ESTROGEN 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; G%28%M2%29% ACTIVATOR PROTEIN was indexed under PROTEINS 1983-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; GREEN FLUORESCENT PROTEIN %28%now GREEN FLUORESCENT PROTEINS%29% was indexed under LUMINESCENT PROTEINS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; HYDROCOLLOID DRESSING was indexed under COLLOIDS 1988-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; JNK MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1995-1999 %26% under PROTEIN-SERINE-THREONINE KINASES 1993-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; LUTEOLIN was indexed under FLAVONOIDS 1981-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE 1 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1992-2004 %26% under PROTEIN-TYROSINE KINASE 1992-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE 2 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES %26% PROTEIN-TYROSINE KINASE 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1993-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES %26% PROTEIN-TYROSINE KINASE 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE 4 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES %26% PROTEIN-TYROSINE KINASE 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-1999; JNK-ACTIVATING PROTEIN KINASE was indexed under JNK MITOGEN-ACTIVATED PROTEIN KINASES 2004-2005; under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 2000-2005, %26% under PROTEIN KINASES 1995-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE 6 was indexed under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE KINASE 2 was indexed under MAP KINASE KINASE KINASES 1999-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASES 1999-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE KINASE 4 was indexed under MAP KINASE KINASE KINASES 2000-2004, %26% under PROTEIN-SERINE-THREONINE KINASES %26% PROTEIN KINASES 1997-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MAP KINASE KINASE KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASE KINASES 2000-2004 %26% under PROTEIN KINASES 1997-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MIL-RAF PROTEIN KINASES %26% MIL-RAF PROTEINS was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-97 %26% PROTO-ONCOGENE PROTEINS 1986-97%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 10 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under PROTEIN-SERINE-THREONINE KINASES 1995-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 11, STRESS-ACTIVATED PROTEIN KINASE 2, SAPK2 %26% SAP KINASE-2 were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 12 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 %26% under MITOGEN-ACTIVATED PROTEIN KINASES 1996-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 13 was indexed under MITOGEN-ACTIVATED KINASES 2000-2004; under PROTEIN KINASES 1997-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 14 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2002-2004; CSAID-BINDING PROTEIN %26% KINASE CSBP were indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004; MXI2 PROTEIN was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 3 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004 %26% under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 6 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000 %26% under PROTEIN KINASES 1991-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 7 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 1999-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 8 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE 9 was indexed under MITOGEN-ACITVATED PROTEIN KINASES 2001-2004; under PROTEIN KINASES 1994-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE KINASE 5 was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2000-2004, %26% under PROTEIN-TYROSINE KINASE %26% PROTEIN-SERINE-THREONINE KINASES 1995-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 1 was indexed under MAP KINASE KINASE KINASES 2004 %26% under PROTEIN-SERINE-THREONINE KINASES 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; P38 MITOGEN-ACTIVATED PROTEIN KINASES was indexed under MITOGEN-ACTIVATED PROTEIN KINASES 2001-2004 %26% under CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASE 1994-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PENICILLIN-BINDING PROTEINS was indexed under HEXOSYLTRANSFERASES 1999-2004, under BACTERIAL PROTEINS, MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; CARRIER PROTEINS, %26% PEPTIDYLTRANSFERASE 1978-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PEPTIDOGLYCAN GLYCOSYLTRANSFERASE was indexed under HEXOSYLTRANSFERASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN was indexed under CARRIER PROTEINS 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PHOSPHATIDYLINOSITOL TRANSFER PROTEINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1979-2004; PHOSPHATIDYLCHOLINE EXCHANGE PROTEIN was indexed CARRIER PROTEINS 1978-2004; PHOSPHOLIPID EXCHANGE PROTEINS was indexed under PHOSPHOLIPID TRANSFER PROTEINS 2005, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1979-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PHYTOESTROGENS was indexed under ISOFLAVONES 2004 and ESTROGENS, NON-STEROIDAL 1978-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; POLYKETIDE SYNTHASE was indexed under MULTIENZYME COMPLEXES 1989-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PPAR ALPHA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PPAR BETA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PPAR DELTA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PPAR GAMMA was indexed under TRANSCRIPTION FACTORS %26% RECEPTORS, CYTOPLASMIC AND NUCLEAR 1994-2004, and under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PROTEASE LA was indexed under SERINE ENDOPEPTIDASES and HEAT-SHOCK PROTEINS 1989-2004 %26% under PEPTIDE PEPTIDOHYDROLASES 1981-1988%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PROTEASOME ENDOPEPTIDASE COMPLEX was indexed under CYSTEINE ENDOPEPTIDASES %26% MULTIENZYME COMPLEXES 1986-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PROTO-ONCOGENE PROTEIN A-RAF was indexed under PROTO-ONCOGENE PROTEINS C-RAF 2001-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; PROTO-ONCOGENE PROTEIN B-RAF was indexed under PROTO-OCOGENES C-RAF 2001-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; RECEPTORS, LYSOPHOSPHATIDIC ACID was indexed under RECEPTORS, CELL SURFACE 1992-2003 %26% under RECEPTORS, G-PROTEIN-COUPLED 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; RECEPTORS, LYSOPHOSPHOLIPID was indexed under RECEPTORS, G-PROTEIN-COUPLED 2004 %26% under RECEPTORS, CELL SURFACE 1996-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; RECEPTORS, LYSOSPHINGOLIPID was indexed under RECEPTORS, CELL SURFACE 1996-2003 %26% under RECEPTORS, G-PROTEIN-COUPLED 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; SAPOSIN A was indexed under GLYCOPROTEINS 1989-2004; SAPOSIN B was indexed under GLYCOPROTEINS 1993-2004 %26% PROTEINS 1981-1992; SAPOSIN D was indexed under GLYCOPROTEINS 1988-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; SERICINS was indexed under PEPTIDES, CYCLIC 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; SERINE-TYPE D-ALA-D-ALA CARBOXYPEPTIDASE was indexed under CARBOXYPEPTIDASES 1993-2003; for D-ALANYL-D-ALANINE-CLEAVING TRANSPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1984-2004; for D-D CARBOXYPEPTIDASE see MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; SILK was indexed under INSECT PROTEINS 1998-2004 %26% PROTEINS 1975-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; SPHINGOLIPID ACTIVATOR PROTEINS was indexed under GLYCOPROTEINS 1977-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TNF RECEPTOR-ASSOCIATED FACTOR 1 was indexed under PROTEINS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TNF RECEPTOR-ASSOCIATED FACTOR 2 was indexed under PROTEINS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TNF RECEPTOR-ASSOCIATED FACTOR 3 was indexed under PROTEINS 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TNF RECEPTOR-ASSOCIATED FACTOR 5 was indexed under PROTEINS 1999-2004, under CARRIER PROTEINS 1996-1998%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TNF RECEPTOR-ASSOCIATED FACTOR 6 was indexed under PROTEINS 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TRAF-INTERACTING PROTEIN was indexed under RECEPTORS, TUMOR NECROSIS FACTOR; TRADD PROTEIN was indexed under PROTEINS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TUMOR NECROSIS FACTOR RECEPTOR II %28%now RECEPTORS, TUMOR NECROSIS FACTOR II%29% was indexed under ANTIGENS, CD 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; TUMOR NECROSIS FACTOR RECEPTOR TYPE I %28%now RECEPTORS, TUMOR NECROSIS FACTOR TYPE I%29% was indexed under ANTIGENS, CD %26% TUMOR NECROSIS FACTOR RECEPTORS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; UTROPHIN was indexed under CYTOSKELETAL PROTEINS %26% MEMBRANE PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for 1,2-CYCLIC INOSITOLPHOSPHATE PHOSPHODIESTERASE; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE; %26% INOSITOL 1,2-CYCLIC PHOSPHATE 2-PHOSPHOHYDROLASE see ANNEXIN A3 1980-2004; 1,2-CYCLIC-INOSITOL-PHOSPHATE PHOSPHODIESTERASE was indexed under PHOSPHODIESTERASES 1973-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for ANSAMYCINS use LACTAMS, MACROCYCLIC 1974-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for ELECTRICAL STIMULATION OF THE BRAIN use ELECTRIC STIMULATION 1997-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for EXTRACELLULAR SIGNAL-REGULATED KINASES use MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for HISTORY OF MEDICINE, 21ST CENT. see HISTORY OF MEDICINE, 21ST CENT. 2001-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for HISTORY OF MEDICINE, EARLY MODERN see HISTORY OF MEDICINE, EARLY MODERN 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for HOMO SAPIENS see HOMINIDAE 1989-2004; for MAN %28%TAXONOMY%29% see HOMINIDAE 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for INAPPROPRIATE ACTH SECRETION SYNDROME see HYPERPITUITARISM 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for INAPPROPRIATE ACTH SECRETION SYNDROME use HYPERPITUITARISM 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for KARYOKINESIS see MITOSIS 1981-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for KARYOKINESIS use MITOSIS 1981-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for KIWI BIRD see RATITES 2002-2004; for RATITES see RATITES 1999-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for PHOTOKERATECTOMY see KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LlASER 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for PHOTOKERATECTOMY use KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LlASER 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for THYME, see THYME 2002-2004, see LAMIACEAE 1998-2001, see HERBS 1983-1997, see THYME 1963-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for YOHIMBANS see YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS see RAUWOLFIA ALKALOIDS 1975-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; for YOHIMBANS use YOHIMBANS 1969-2004; for RAUWOLFIA ALKALOIDS use RAUWOLFIA ALKALOIDS 1975-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN-1 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 was indexed under CARRIER PROTEINS 1992-95%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ADAPTOR PROTEINS 2002-2004; CLATHRIN ASSEMBLY PROTEINS was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 2001-2002, and under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1987-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ADDISON%27%S DISEASE 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ADENOMA, ADRENAL CORTICAL 1994-2004; for CONN%27%S DISEASE use HYPERALDOSTERONISM 1985-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ADRENAL GLAND HYPERFUNCTION 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ADRENAL GLAND HYPOFUNCTION 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ADRENAL HYPERPLASIA, CONGENITAL 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see AMINO ACYL-TRNA LIGASES 1998-2004, see AMINO ACYL T RNA SYNTHETASES 1972-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see AMYLOID PROTEIN SAA 1987-2004; see AMYLOID 1979-1986; for AMYLOID PROTEIN AA see AMYLOID PROTEIN AA 1988-2004; AMYLOID PROTEIN AA PRECURSOR was indexed under AMYLOID PROTEIN AA %26% APOLIPOPROTEINS 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ANATOMY, CROSS-SECTIONAL 1997-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ANNEXIN I 1993-2004; LIPOCORTIN 1 was indexed under CALCIUM-BINDING PROTEINS 1985-1992, ANNEXIN I %26% CALPACTIN II were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A1 was indexed under ANNEXIN I 2004; RENOCORTIN was indexed under GLYCOPROTEINS 1986-2004 %26% under PROTEINS 1983-1985; CHROMOBINDIN 9 was indexed under CARRIER PROTEINS %26% MEMBRANE PROTEINS 1986-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ANNEXIN VII 1993-2004; SYNEXIN was indexed under PROTEINS 1978-1992; ANNEXIN A7 was indexed under ANNEXIN VIII 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see APHYLLPHORALES 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see AY-9944 1991-2004; see CYCLOHEXANES 1975-1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BARTTER%27%S DISEASE 1991-2004, see HYPERALDOSTERONISM 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BEARS 1991-2004, see CARNIVORA 1975-1990; for PANDAS, GREATER see CARNIVORA 1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BEETLES 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BENZANTHRACENES 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BODY CONSTITUTION 1984-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BODY CONSTITUTION 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BUNYAVIRUS 1992-2004; for APEU VIRUS see APEU VIRUS 1991, see BUNYAVIRIDAE 1981-1990, see ARBOVIRUSES 1975-1980; for CATU VIRUS %26% GUAMA VIRUS see GUAMA GROUP VIRUSES 1975-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BW 284 C 51 1991-2004; see ANILINE COMPOUNDS 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see BW-775C 1996-2004; see BW 755C 1990; see BW-755C 1990-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CAMPYLOBACTER HYOINTESTINAL 2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CARCINOMA, ADRENAL CORTICAL 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CARDIOMYOPATHY, CONGESTIVE 1986-2004, see HEART FAILURE, CONGESTIVE 1984-1985%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CARNIVORA 1990-2004; for NYCTEREUTES see CARNIVORA 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CARNIVORA 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CARNIVORA 1998-2004; for CIVET CATS see CARNIVORA 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CARNIVORA 1998-2004; for PANDAS, LESSER see CARNIVORA 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CELL CULTURE 1996-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CELL DIVISION 1985-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CELL SIZE 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CHEETAHS 1991-2004, see CARNIVORA 1975-1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CHEMILUMINESCENCE 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CHYLOPERITONEUM 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CLIMACTERIC 2002-2004, see PREMENOPAUSE 1995-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see COCULTURE 1996-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CRAMBE 2003-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CROSSING OVER %28%GENETICS%29% 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see CROWN ETHERS 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DDD 1965-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DDE 1973-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DEMENTIA, MULTI-INFARCT 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DIABETES MELLITUS, TYPE I 2004, see DIABETES MELLITUS, INSULIN-DEPENDENT 1984-2003, see DIABETES MELLITUS, JUVENILE 1966-1983%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DIABETES MELLITUS, TYPE I 2004, see DIABETES MELLITUS, NON-INSULIN-DEPENDENT 1984-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DISEASE MODELS, AUTOIMMUNE, NERVOUS SYSTEM 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see DOGFISH 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see EGG PROTEINS 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see EMBRYO AND FETAL DEVELOPMENT 2003-2004, see FETAL DEVELOPMENT 1985-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see EMBRYONIC AND FETAL DEVELOPMENT 1985-2004; for POSTIMPLANTATION EMBRYO DEVELOPMENT see POSTIMPLANTATION PHASE 1985-2004, see POSTNIDATION PHASE 1980-1984, see PREGNANCY TRIMESTER, FIRST 1976-1979, see PREGNANCY, FIRST TRIMESTER 1975; for PREIMPLANTATION EMBRYO DEVELOPMENT see PREIMPLANTATION PHASE 1985-2004, see PRENIDATION PHASE 1980-1984, see PREGNANCY TRIMESTER, FIRST 1976-1979, see PREGNANCY, FIRST TRIMESTER 1975; for POSTNIDATION EMBRYO DEVELOPMENT, ANIMAL %26% PRENIDATION EMBRYO DEVELOPMENT, ANIMAL see PREGNANCY, ANIMAL 1975-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see EMUS 1999 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE 2000-2004, see ENCEPHALOMYELITIS, ALLERGIC 1964-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ENDOCRINE DISEASES 1965-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see FETAL DISEASES 1993-2004, see FETUS 1986-1992 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see FIBROCYSTIC DISEASE OF BREAST 1984-2004, see BREAST DISEASES 1980-1983%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see FIBROCYSTIC DISEASE OF BREAST 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see FIBROIN 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see GANGLIOSIDOSES GM2 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see GUIDED TISSUE REGENERATION 1992-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HEARING DISORDERS 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HEMATOMA, EPIDURAL 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HEMATOMA, SUBDURAL %28%2000-2004%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HEMATOMA, SUBDURAL 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HERNIA, VENTRAL 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HIRUDIN 1963-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, 15TH CENT. 1995-2004; for HISTORY OF MEDICINE 15 CENT. see HISTORY OF MEDICINE 15TH CENT. 1964-2004, see HISTORY OF MEDICINE, XV CENT. 1963%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, 16TH CENT. 1995-2004; for HISTORY OF MEDICINE 16 CENT. see HISTORY OF MEDICINE 16TH CENT. 1964-2004, see HISTORY OF MEDICINE, XVI CENT. 1963%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, 17TH CENT. 1995-2004; for HISTORY OF MEDICINE 17 CENT. see HISTORY OF MEDICINE 17TH CENT. 1964-2004, see HISTORY OF MEDICINE, XVII CENT. 1963%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, 18TH CENT. 1995-2004; for HISTORY OF MEDICINE 18 CENT. see HISTORY OF MEDICINE 18TH CENT. 1964-2004, see HISTORY OF MEDICINE, XVIII CENT. 1963%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, 19TH CENT. 1995-2004; for HISTORY OF MEDICINE 19 CENT. see HISTORY OF MEDICINE 19TH CENT. 1964-2004, see HISTORY OF MEDICINE, XIX CENT. 1963%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, 20TH CENT. 1995-2004; for HISTORY OF MEDICINE 20 CENT. see HISTORY OF MEDICINE 20TH CENT. 1964-2004, see HISTORY OF MEDICINE, XX CENT. 1963%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, ANCIENT 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, MEDIEVAL 1995-2004; for HISTORY OF MEDICINE, MEDIEVAL see HISTORY OF MEDICINE, MEDIEVAL 1966-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HISTORY OF MEDICINE, MODERN 1966-2004; for MEDICINE, MODERN %26% MODERN HISTORY see HISTORY OF MEDICINE, MODERN 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see HUMIC ACIDS 1963-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see IMMUNOLOGIC DISEASES 1971-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INFANT MORTALITY 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INFLUENZA VACCINE 1963-2004; TRIVALENT LIVE INFLUENZA VACCINE was indexed under INFLUENZA VACCINES 2003-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEIN 4 1996-2005; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4 was indexed under CARRIER PROTEINS 1991-95%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INSULIN-LIKE GROWTH-FACTOR-BINDING-PROTEIN-5 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-5 was indexed under CARRIER PROTEINS 1991-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INSULIN-LIKE-GROWTH-FACTOR-BINDING PROTEIN 6 1996-2004; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6 was indexed under CARRIER PROTEINS 1992-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see INVERSION %28%GENETICS%29% 1978-2004, see CHROMOSOME ABERRATIONS 1969-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see KANGAROOS 1991-2004, see MARSUPIALIA 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see KANGAROOS 2001-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see KEARNS SYNDROME 1991-2004, see OPHTHALMOPLEGIA 1983-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LABOR, PREMATURE 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LACTAMS 1996-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LEECHES 2002-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LEIOMYOMA 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LENTILS 2001-2004; see FABACEAE 1978-2001 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LENTINUS 1999-2004, see POLYPORACEAE 1986-98 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LIVER DISEASES 1997-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LUCIFERASE 1963-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see LUMINESCENCE 1963-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MACROMOLECULAR SYSTEMS 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MENSTRUATION 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY see MICROSCOPY, ELECTRON 2003-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MITOGEN-ACTIVATED PROTEIN KINASES 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MOLE RATS 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MONGOOSES 1998-2004, see MONGOOSE 1991-1997, see CARNIVORA 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MUSCULAR DYSTROPHIES 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MYASTHENIA GRAVIS, EXPERIMENTAL AUTOIMMUNE 2000-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see MYOCARDIAL DISEASES 1979-2004; MYOCARDIAL DISEASES, PRIMARY %26% MYOCARDIAL DISEASES, SECONDARY were headings 1966-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see McN-A-343 1991-2004; see AMMONIUM COMPOUNDS 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1973-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see NEURITIS, EXPERIMENTAL ALLERGIC 1982-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see OPOSSUMS 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see OPOSSUMS 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ORGAN CULTURE 1972-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ORGAN PROCUREMENT 1987-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see ORGAN WEIGHT 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see OSTRICHES 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see OWLS 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PANCREAS 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PANCREATIC DISEASES 1983-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PANCREATIC INSUFFICIENCY 1981-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PAPIO 1975-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PARROTS 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PEPTIDE CHAIN ELONGATION 1973-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PEPTIDE CHAIN INITIATION 1973-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PEPTIDE CHAIN TERMINATION 1973-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PEPTIDE SYNTHESIS 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PEPTIDYLTRANSFERASE 1998-2004, see PEPTIDYL TRANSFERASES 1991-1997, see ACYLTRANSFERASES 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PIGEONS 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PLACENTA INSUFFICIENCY 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PORPHYRIA 1963-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PORPHYRIA, ERYTHROHEPATIC 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PORPHYRIA, HEPATIC 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PRECIPITIN TESTS 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PREGNANCY 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN 1990-2004; see PREGNANCY PROTEINS 1980-1990; for PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN see PREGNANCY-ASSOCIATED BETA-PLASMA PROTEIN 1996-2003, see PREGNANCY-ASSOCIATED BETA PLASMA PROTEIN 1991-1995, see PREGNANCY PROTEINS 1980-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PRENATAL EXPOSURE DELAYED EFFECTS 1992-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PSITTACINES 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see PUERPERIUM 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RAPTORS 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RHEAS 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RIBOSOMAL PROTEIN S6 KINASES, 90KD 2003-2004; MAP-KINASE-ACTIVATED KINASE 1 %28%now RIBOSOMAL PROTEIN S6 KINASES, 90KDa%29% was indexed under RIBOSOMAL PROTEIN S6 KINASE 1993-2002; for PP90%28%RSK%29% %26% PP90%28%RSK%29% see RIBOSOMAL PROTEIN S6 KINASE 1998-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RO 21 1724 1991-2004;see IMIDAZOLES 1975-1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RO 4-1284 1991-2004; see QUINOLIZINES 1988-1990; see QUINOLIZINES 1975-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RODENTIA 1982-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RODENTIA 1982-2004; for COENDOU %26% HYSTRIX see RODENTIA 1982-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see RODENTIA 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SAFE SEX 2001-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SC-19220 1991-2005; see DIBENZOXAZEPINES 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SCH-2330 1990-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SEALS 1975-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SEALS 1978-2004, see PINNIPEDIA 1968-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SEALS 1990-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SEX CORD-STROMAL TUMOR 1994-2004; for GYNANDROBLASTOMA see NEOPLASMS, GONADAL TISSUE 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SEX MATURATION 1975-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SK%26%F-38393 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SKUNKS 1991-2004, see CARNIVORA 1975-1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SONGBIRDS 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SPINACH 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SQ-19506 1991-2004; see NITROFURANS 1975-1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see STOMACH DILATATION 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see SYMPATHOLYTICS 1963-1965, see DIBENAMINE 1966-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TISSUE CULTURE 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TISSUE HARVESTING 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TOMOGRAPHY, EMISSION-COMPUTED 1979-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TP53 PROTEIN 1991-2005; TP53 PROTEIN was indexed under NERVE TISSUE PROTEINS %26% NEOPLASM PROTEINS 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TRANSCRIPTION, GENETIC 1988-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TRANSLOCATION %28%GENETICS%29% 1978-2005; see CHROMOSOME ABERRATIONS 1968-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TUBERCULOSIS, PERITONEAL 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TUMOR NECROSIS FACTOR 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see TWINNING 2003-2004; see TWINS 1978-2002 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see UROPORPHYRINOGEN-III SYNTHASE 1998-2004, see UROPORPHYRINOGEN III SYNTHASE 1991-1997, see HYDRO-LYASES 1985-1990, see ISOMERASES 1975-1984%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see VITELLOGENIN 1986-2004; see LIPOPROTEINS 1975-1985; for YOLK PROTEIN 2, DROSOPHILA see EGG PROTEINS 1990-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; see WALRUS 1991-2004, see PINNIPEDIA 1975-1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use ADRENAL HYPERPLASIA, CONGENITAL 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use ANATOMY, CROSS-SECTIONAL 1997-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use ANNEXIN II 1993-2004; ANNEXIN II %26% CALPACTIN I were indexed under CALCIUM-BINDING PROTEINS 1984-1992, ANNEXIN A2 was indexed under ANNEXIN II 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use BANDAGES, HYDROCOLLOID %28%NM%29% 1988-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use BEETLES 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use BODY CONSTITUTION 1984-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use BODY CONSTITUTION 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CARNIVORA 1990-2004; for NYCTEREUTES use CARNIVORA 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CARNIVORA 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CARNIVORA 1998-2004; for CIVET CATS use CARNIVORA 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CARNIVORA 1998; for PANDAS, LESSER use CARNIVORA 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CELL DIVISION 1985-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CELL SIZE 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CLIMACTERIC 2002-2004, use PREMENOPAUSE 1995-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use CROWN ETHERS 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use DEMENTIA, MULTI-INFARCT 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use DOGFISH 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use EGG PROTEINS 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use EMBRYONIC AND FETAL DEVELOPMENT 1985-2004; for POSTIMPLANTATION EMBRYO DEVELOPMENT %26% PREIMPLANTATION EMBRYO DEVELOPMENT use EMBRYONIC AND FETAL DEVELOPMENT 1976-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use FETAL DISEASES 1993-2004, use FETUS 1986-1992 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use FIBROCYSTIC BREAST DISEASE 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use HEARING DISORDERS 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use HEMATOMA, SUBDURAL %28%2000-2004%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use HEMATOMA, SUBDURAL 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use HERNIA, VENTRAL 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use INFANT MORTALITY 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use LABOR, PREMATURE 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use LACTAMS 1996-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use LEECHES 2002-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use LEIOMYOMA 1994-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use LIVER DISEASES 1997-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use MACROMOLECULAR SUBSTANCES 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use MACROPODIDAE 2001-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use MENSTRUATION 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use MICROSCOPY, ELECTRON 1991-2004; for ELECTRON DIFFRACTION MICROSCOPY use MICROSCOPY, ELECTRON 2003-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use MOLE RATS 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use MUSCULAR DYSTROPHIES 2000-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use OPOSSUMS 1968-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use OPOSSUMS 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PANCREAS 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PANCREATIC DISEASES 1983-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PAPIO 1975-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PAPIO 1992-2004; for DRILL and MANDRILL use PAPIO 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PARROTS 1995-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PATTERN RECOGNITION 1973-2004, see AUTOMATIC DATA PROCESSING 1968-1972%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PEPTIDOGLYCAN GLYCOSYLTRANSFERASE %28%NM%29% 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PLACENTA INSUFFICIENCY 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PORPHYRIA, ERYTHROHEPATIC 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PORPHYRIA, HEPATIC 1993-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PRECIPITIN TESTS 1989-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PREGNANCY 1980-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1991-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PRENATAL EXPOSURE DELAYED EFFECTS 1992-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use PROTEASOME ENDOPEPTIDASE COMPLEX %28%NM%29% 1986-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use RAPTORS 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use RODENTIA 1982-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use RODENTIA 1982-2004; for COENDOU %26% HYSTRIX use RODENTIA 1982-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use RODENTIA 1998-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use SAFE SEX 2001-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use SEALS, EARLESS 1980-2004, use PINNIPEDIA 1968-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use SEALS, EARLESS 1990-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use SILK %28%NM%29% 1980 -2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use SILKWORMS 1963-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use SONGBIRDS 1999-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use TISSUE CULTURE 1966-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use TOMOGRAPHY, EMISSION-COMPUTED 1979-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; use TRANSCRIPTION, GENETIC 1988-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; was SUPPORT, U.S. Gov%27%t P.H.S 1981-2004; was UNITED STATES GOV%27%T SUPPORTED, P.H.S. 1979-1980; UNITED STATES GOV%27%T SUPPORTED, N.I.H. %26% UNITED STATES GOV%27%T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-1977 %28%UNITED STATES was U.S. 1977; GOV%27%T was GOVERNMENT 1975-1976%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005; was SUPPORT, U.S. Gov%27%t, Non-P.H.S. 1981-2004; was UNITED STATES GOV%27%T SUPPORTED %28%used for U.S. gov%27%t agencies other than P.H.S.%29% 1979-1980; UNITED STATES GOV%27%T SUPPORTED, N.I.H. %26% UNITED STATES GOV%27%T SUPPORTED, NON-N.I.H. were headings 1978, were headings having slightly different forms 1975-77 %28%UNITED STATES was U.S. 1977; GOV%27%T WAS GOVERNMENT 1975-1976%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005A' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005B' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005C' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2005D' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1963%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1963%29%; for HEMICRANIA see MIGRAINE 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1963%29%; for HEMICRANIA use MIGRAINE 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1964%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1965%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1966%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1970%29%; see PICKWICK SYNDROME 1964-1969 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1970%29%; use PICKWICK SYNDROME 1964-1969 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1972%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1973%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1974%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1975%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1975%29%; see CALLITHRICIDAE 1981-1991 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1976%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1977%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1978%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1979%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1980%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1981%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1982%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1985%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1986%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1987%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1987%29%; use GOITER, EXOPHTHALMIC 1963-1986 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1988%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1989%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1989%29%; for CVFBB use COMPLEMENT FACTOR B 1985-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1990%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1991%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1991%29%; for NEOTOMA, SIGMODON, and RATS, COTTON use ARVICOLINAE 1982-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1991%29%; for VOLES %26% MICROTUS use RODENTS 1975-1981 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1992%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1992%29%; use MICROSPORIDA 1991-2000 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1993%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1994%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1995%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1996%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1998%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1998%29%; for PANCREATIC DELTA CELLS use ISLETS OF LANGERHANS 1991-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%1999%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%2000%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%2000%29%; for COMPLICATED MIGRAINE use MIGRAINE 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%2001%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%2002%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%2004%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 %28%2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 CAVEOLIN 3 was indexed under CAVEOLINS 2005, %26% under MEMBRANE PROTEINS 2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE RECEPTOR TYPE I was indexed under RECEPTORS, CELL SURFACE 2005, %26% under RECEPTORS, PITUITARY HORMONE 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006 PROTO-ONCOGENE PROTEIN C-MAF was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1963%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1963%29%; for STAINS use STAINS AND STAINING 1991-1995 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1963%29%; see DYES 1963-2005; for STAINS see STAINS AND STAINING 1991-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1964%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1966%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1969%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1970%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1973%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1974%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1975%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1975%29%; for KINETIN use KINETINS %28%NM%29% 1974-2005; use PLANT GROWTH REGULATORS 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1976%29%; use OXIDOREDUCTASES, N-DEMETHYLATING, %26% SARCOSINE 1976-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1977%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1978%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1979%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use AMINO ACID OXIDOREDUCTASES %26% ALANINE 1972-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use CERAMIDES 1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use DNA 1976-1979 %26% DEOXYURACIL NUCLEOTIDES 1978-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use GUANOSINE MONOPHOSPHATE 1976-1979 %26% GUANINE NUCLEOTIDES 1976-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use HISTONES 1973-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use RHODOPSIN 1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29% use TRANSAMINASES 1978-1979, %26% KETOGLUTARIC ACIDS 1978-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ANTHRANILIC ACID 1974-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; GLYCINE 1974-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; KYNURENINE 1973-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use NUCLEOSIDE-PHOSPHATE KINASE 1979, %26% NUCLEOTIDES %26% PHOSPHOTRANSFERASES, ATP 1974-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use NUCLEOTIDYLTRANSFERASES 1976-1979, GLUCOSEPHOSPHATES 1972-1975, ADENINE NUCLEOTIDES 1970-1972, %26% ATP 1972-1975%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACETYLTRANSFERASES %26% ACETYL COENZYME A 1973-1979, SERINE 1970-1979, %26% ACYLTRANSFERASES 1970-1973%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACETYLTRANSFERASES 1970-1979, CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1979, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1979, %26% ACYLTRANSFERASES %26% PROTEINS 1970-1973%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACETYLTRANSFERASES 1973-1979, %26% GLYCERIDES 1973-1975%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACETYLTRANSFERASES 1977-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACETYLTRANSFERASES, ACETYL COENZYME A %26% GLUTAMATES 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACYLTRANSFERASES %26% CARRIER PROTEINS 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACYLTRANSFERASES 1971-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACYLTRANSFERASES 1973-1979, use COENZYME A %26% PHOSPHOLIPIDS 1973-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ACYLTRANSFERASES 1979, GLYCINE 1974-1979, FORMIC ACIDS 1974-1979, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1979, %26% TRANSFERASES 1974-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ALANINE TRANSAMINASE 1974-1979, %26% TRANSAMINASES 1977-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ALCOHOL OXIDOREDUCTASES %26% GLUCONATES 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ALDEHYDE OXIDOREDUCTASES 1978-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ALDEHYDE OXIDOREDUCTASES 1979, %26% OXIDOREDUCTASES %26% ALDEHYDES 1972-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ALDEHYDE OXIDREDUCTASES 1977-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ALKYL AND ARYL TRANSFERASES ALKYL, PHOSPHOENOLPYRUVATE %26% SHIKIMIC ACID 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use AMINO ACIDS, BRANCHED-CHAIN 1979, %26% KETO ACIDS %26% VALERATES 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use BENZOATES 1977-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use CEPHALINS 1971-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use CHOLINE 1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use CINNAMATES 1974-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use CYSTEINE 1973-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use DICARBOXYLIC ACIDS 1970-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use DIOXYGENASES 1975-1979 %26% CATECHOL 1973-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use ETHERS, CYCLIC 1970-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, FORMIC ACIDS %26% IMINES 1975-1976%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use GLYCERIC ACIDS 1974-1980 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use HOMOCYSTEINE 1974-1980 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use INOSITOL 1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use KETOGLUTARIC ACID 1973-1974, BETAINE 1972-1979, BUTYRATES 1974-1979, %26% AMINOBUTYRIC ACID 1970-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use KETONE OXIDOREDUCTASES 1975-1979, FERREDOXINS 1972-1979, ACETYL COENZYME A 1974-1978, PYRUVATES 1970-1979, %26% COENZYME A %26% CARBOXY-LYASES 1970-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use METHYLTRANSFERASES 1980-2005, S-ADENOSYLMETHIONINE 1973-1977, GUANIDINES 1973-1980, %26% ACETIC ACIDS 1973-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use OXYGENASES 1969-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use PHOSPHOINOSITIDES 1970-1977, TRANSFERASES 1970-1972, %26% TRANSFERASES %28%OTHER SUBSTITUTED PHOSPHATE GROUPS%29% 1970-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use PYROPHOSPHORIC ACIDS 1970-1979, ALLYL CPDS 1975-1979, %26% TERPENES 1970-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use PYRUVATE DEHYDROGENASE COMPLEX, ACETYLTRANSFERASES %26% under LIPOIC ACID 1968-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use SIALIC ACIDS %26% MUCOPROTEINS 1976-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use TRANSAMINASES %26% TRYPTOPHAN 1975-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use TRANSAMINASES 1973-1979, %26% KETOGLUTARIC ACID 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use TRANSAMINASES 1974-1979, %26% KETOGLUTARIC ACID 1974-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1980%29%; use VALERATES 1970-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1981%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1982%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1983%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1984%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1984%29%; for SODIUM-CHLORIDE COTRANSPORTER use SYMPORTERS %28%NM%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1984%29%; use CERVIX NEOPLASMS 1977-1983 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1985%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1986%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1987%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1988%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1989%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1990%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1990%29%; CYTOSKELETAL PROTEINS 1977-1979 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1990%29%; use HEAT-SHOCK PROTEINS 1990-1994 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1991%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1992%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1992%29%; ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1992%29%; was THYROTROPIN-RELEASING HORMONE 1991; was THYROTROPIN RELEASING HORMONE 1974-90; was THYROTROPIN RELEASING FACTOR 1968-73%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1993%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1994%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1994%29%; see TEDELPARIN 1994-2005, see HEPARIN, LOW-MOLECULAR-WEIGHT 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1994%29%; use HEAT-SHOCK PROTEINS 1990-1994 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1994%29%; use HEPARIN, LOW-MOLECULAR-WEIGHT 1992-1993 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1995%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1996%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1997%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1998%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%1999%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%2000%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%2001%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%2003%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%2004%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006%28%2993%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1963-1964; see AMELOBLASTOMA 1965-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1963-1964; use AMELOBLASTOMA 1965-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1966-1993; see VIRUSES 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1966-1993; use VIRUSES 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1968-1993; use HISTIOCYTOMA, BENIGN FIBROUS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1969-1992; see GROWTH INHIBITORS 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1969-1992; use GROWTH INHIBITORS 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1985-1994; see T-LYMPHOCYTES 1995-2005; for SUPPRESSOR CELLS, see T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, 1985-1994; use T-LYMPHOCYTES 1995-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006, see D CELLS 1998-2005; for PANCREATIC DELTA CELLS see ISLETS OF LANGERHANS 1991-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006-01-01' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for COUGH HEADACHE; HEADACHE, THUNDERCLAP; and STABBING HEADACHE see HEADACHE 2000-2005; for BENIGN EXERTIONAL HEADACHE and HYPNIC HEADACHE SYNDROME see HEADACHE DISORDERS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for COUGH HEADACHE; HEADACHE, THUNDERCLAP; and STABBING HEADACHE use HEADACHE 2000-2005; for BENIGN EXERTIONAL HEADACHE and HYPNIC HEADACHE SYNDROME use HEADACHE DISORDERS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CALLIMICONINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MONKEYS 1975-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; %28%ACYL-CARRIER PROTEIN%29% MALONYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, %26% under CARRIER PROTEINS 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; %28%ACYL-CARRIER-PROTEIN%29% S-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1970-2005, under CARRIER PROTEINS 1973-1978, ACYL CARRIER PROTEIN 1978-1982, ACYLTRANSFERASES 1970-1973, ACETYL COENZYME A 1978-1982, %26% under ACYLTRANSFERASES %26% PROTEINS 1970-1973%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1973-2005, %26% under COENZYME A %26% PHOSPHOLIPIDS 1973-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE was indexed under AMINE OXIDOREDUCTASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 2-AMINOADIPATE TRANSAMINASE was indexed under TRANSAMINASES 1983-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 2-OXOISOVALERATE DEHYDROGENASE %28%ACYLATING%29% was indexed under KETONE OXIDOREDUCTASES 1983-2005, under AMINO ACIDS, BRANCHED-CHAIN 1979-1982, under KETO ACIDS 1973-1982, %26% VALERATES 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, %26% under ANTHRANILIC ACID 1974-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 3-ISOPROPYLMALATE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1981-2005, %26% under DICARBOXYLIC ACIDS 1970-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES ALKYL 1973-2005, %26% under PHOSPHOENOLPYRUVATE %26% SHIKIMIC ACID 1973-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIN CAPPING PROTEINS was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1981-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIN DEPOLYMERIZING FACTORS was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1981-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIN-RELATED PROTEIN 2 was indexed under CYTOSKELETAL PROTEINS 2005, %26% under ACTINS 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIN-RELATED PROTEIN 3 was indexed under CYTOSKELETAL PROTEINS 2003-2005, %26% under ACTINS 1998-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIVATING TRANSCRIPTION FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIVATING TRANSCRIPTION FACTOR 2 was indexed under DNA-BINDING PROTEIN, CYCLIC-AMP RESPONSIVE %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIVATING TRANSCRIPTION FACTOR 3 was indexed under TRANSCRIPTION FACTORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIVATING TRANSCRIPTION FACTOR 4 was indexed under TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ACTIVATING TRANSCRIPTION FACTOR 6 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ADIPONECTIN was indexed under INTRACELULAR SIGNALING PEPTIDES AND PROTEINS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ALANINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1972-2005, %26% under ALANINE 1972-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ALPHA CATENIN was indexed under CYTOSKELETAL PROTEINS 1994-2000; %26% under CADHERINS 1991-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ALPHA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AMINO-ACID N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, %26% under ACETYL COENZYME A %26% GLUTAMATES 1973-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AMINOMETHYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1983-2005, under TRANSFERASES 1975-1997, CARBOXY-LYASES 1973-1974, under GLYCINE 1975-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AMINOMUCONATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHUDE OXIDREDUCTASES 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTENNAPEDIA HOMEODOMAIN PROTEIN was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005, under HOMEODOMAIN PROTEINS 1997-2005, %26% under DNA-BINDING PROTEINS 1990-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS CD107B was indexed under ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1986-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD146 was indexed under CD ANTIGENS %26% NEURAL CELL ADHESION MOLECULES 2005, %26% under MEMBRANE GLYCOPROTEINS 1990-2004, %26% under NEOPLASM PROTEINS 1993-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD147 was indexed under ANTIGENS, CD 2005, under ANTIGENS, SURFACE %26% BLOOD PROTEINS 1990-2004, under MEMBRANE GLYCOPROTEINS 1993-2004, %26% under GLYCOPROTEINS 1990-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD164 was indexed under CD ANTIGENS %26% NEURAL CELL ADHESION MOLECULES 2005, %26% under MEMBRANE GLYCOPROTEINS 1990-2004, %26% under NEOPLASM PROTEINS 1993-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD22 was indexed under ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE, under ANTIGENS, CD, under CELL ADHESION MOLECULES %26% under LECTINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD24 was indexed under ANTIGENS, CD %26% MEMBRANE GLYCOPROTEINS 1992-2005, %26% under ANTIGENS, DIFFERENTIATION 1990-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD38 was indexed under ANTIGENS, CD %26% ADP-RIBOSYL CYCLASE 2003-2005, %26% under NAD+ NUCLEOSIDASE 1998-2002, %26% under ANTIGENS, DIFFERENTIATION 1988-2002, %26% under NUCLEOSIDASES 1988-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD43 was indexed under SIALOGLYCOPROTEINS %26% ANTIGENS, CD 1984-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD46 was indexed under MEMBRANE GLYCOPROTEINS 1988-2005, %26% under ANTIGENS, CD 1992-2005, %26% under ANTIGENS, DIFFERENTIATION 1990-1991, %26% under MEMBRANE PROTEINS 1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD47 was indexed under ANTIGENS, CD 2005, %26% under CARRIER PROTEINS 1993-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD79 was indexed under RECEPTORS, ANTIGEN, B-CELL %26% ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1990-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD86 was indexed under MEMBRANE GLYCOPROTEINS %26% ANTIGENS, CD 1996-2005, %26% under B-CELL ACTIVATION ANTIGEN 1993-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ANTIGENS, CD94 was indexed under ANTIGENS, CD %26% LECTINS, C-TYPE 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1995-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; APOPTOSIS INDUCING FACTOR was indexed under FLAVOPROTEINS %26% MEMBRANE PROTEINS 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AQUAPORIN 1 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1994-1998, %26% under MEMBRANE PROTEINS 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AQUAPORIN 2 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1995-1998, %26% under MEMBRANE PROTEINS 1993-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AQUAPORIN 3 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1995-1998, %26% under MEMBRANE PROTEINS 1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AQUAPORIN 4 was indexed under AQUAPORINS 1999-2005, %26% under ION CHANNELS 1995-1998%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AQUAPORIN 5 was indexed under AQUAPORINS %26% MEMBRANE PROTEINS 1999-2005, %26% under ION CHANNELS 1996-1998%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; AQUAPORIN 6 was indexed under AQUAPORINS 2004-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ARAC TRANSCRIPTION REGULATOR was indexed under DNA-BINDING PROTEINS, REPRESSOR PROTEINS, %26% TRANSCRIPTION FACTORS 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ARMADILLO PROTEINS was indexed under TRANS-ACTIVATORS %26% DROSOPHILA PROTEINS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %26% RECEPTORS, ARYL HYDROCARBON 1995-2005, %26% under PROTEINS 1991-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; B-CELL-SPECIFIC ACTIVATOR PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2002-2005, %26% under NUCLEAR PROTEINS 1992-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BAD PROTEIN was indexed under CARRIER PROTEINS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BAK PROTEIN was indexed under MEMBRANE PROTEINS 1994-2005, %26% under PROTO-ONCOGENE PROTEINS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BCL-X PROTEIN was indexed under PROTO-ONCOGENE PROTEINS 1993-2004, %26% under PROTO-ONCOGENE PROTEINS C-BCL-2 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BCL2-ASSOCIATED X-PROTEIN was indexed under PROTO-ONCOGENE PROTEINS C-BCL-2 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BENZALDEHYDE DEHYDROGENASE %28%NADP+%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BENZOATE 4-MONOOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1982-2005, %26% under BENZOATES 1977-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETA CATENIN was indexed under CYTOSKELETAL PROTEINS %26% TRANS-ACTIVATORS 1993-2005, %26% under CADHERINS 1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETA-ADRENERGIC RECEPTOR KINASE was indexed PROTEIN KINASES 1987-1993, %26% CYCLIC AMP-DEPENDENT PROTEIN KINASES 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETA-ALANINE-PYRUVATE TRANSAMINASE was indexed under TRANSAMINASES 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETA-CAROTENE 15,15%27%-MONOOXYGENASE was indexed under OXYGENASES 1969-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETAINE-ALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1979-2005, %26% under NAD, OXIDOREDUCTASES %26% ALDEHYDES 1972-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1980-2005, %26% under BETAINE %26% HOMOCYSTEINE 1980-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BETALAINS was under AMMONIUM COMPOUNDS 1982-2005, BETALAIN PIGMENTS was under PIGMENTS 1982-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BID PROTEIN was indexed under CARRIER PROTEINS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BONE MORPHOGENETIC PROTEIN RECEPTORS was indexed under RECEPTORS, GROWTH FACTOR 2004-2005, %26% under RECEPTORS, CELL SURFACE 1994-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I was indexed under PROTEIN-SERINE-THREONINE KINASES %26% RECEPTORS, GROWTH FACTOR 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II was indexed under PROTEIN-SERINE-THREONINE KINASES 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; BUTYRATE RESPONSE FACTOR 1 was indexed under DNA-BINDING PROTEINS 2001-2005, %26% under IMMEDIATE-EARLY PROTEINS 1991-2005, %26% under PROTEINS 1998-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CAPSAICIN RECEPTORS was indexed under RECEPTRS, DRUG 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CAPZ PROTEIN was indexed under MICROFILAMENT PROTEINS %26% MUSCLE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CATACHOLAMINE TRANSPORT PROTEIN was indexed under MEMBRANE TRANSPORT PROTEINS 2004 %26% CARRIER PROTEINS 1980-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CATECHOL 1,2-DIOXYGENASE was indexed under DIOXYGENASES 1975-2005, %26% under CATECHOL 1973-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CATECHOL 2,3,-DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, under CATECHOLS 1975-1980, %26% under CATECHOL 1973-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CAVEOLIN 1 was indexed under CAVEOLINS 2001-2005, %26% under MEMBRANE PROTEINS 1992-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CAVEOLIN 2 was indexed under CAVEOLINS 2001-2005, %26% under MEMBRANE PROTEINS 1997-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CCAAT-ENHANCER-BINDING PROTEIN-DELTA was indexed under TRANSCRIPTION FACTORS 1991-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2001-2005, under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1991-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CD107A ANTIGEN was indexed under ANTIGENS, CD 1986-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CDP-DIACYLGLYCEROL-INOSITOL 3-PHOSPHATIDYLTRANSFERASE was indexed under TRANSFERASES %28%OTHER SUBSTITUTED PHOSPHATE GROUPS%29% 1970-2005, under PHOSPHOINOSITIDES 1970-1977, %26% under TRANSFERASES 1970-1972%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CELLUBREVIN %28%now VESICLE-ASSOCIATED MEMBRANE PROTEIN 3%29% was indexed under MEMBRANE PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CENTROMERE PROTEIN B was indexed under AUTOANTIGENS %26% CHROMOSOMAL PROTEINS, NON-HISTONE %26% DNA-BINDING PROTEINS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR I was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTOR II was indexed under DNA-BINDING PROTEINS %26% RECEPTORS, STEROID %26% TRANSCRIPTION FACTORS 1991-2005, %26% under REPRESSOR PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CHICKEN OVALBUMIN UPSTREAM PROMOTER-TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% RECEPTORS, STEROID %26% TRANSCRIPTION FACTORS 1991-2005, %26% under REPRESSOR PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CHOLINE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1982-2005, %26% under CHOLINE 1979-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CLUSTERIN was indexed under GLYCOPROTEINS %26% MOLECULAR CHAPERONES 1981-2005, %26% under SALIVARY PROTEINS 1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; COFILIN 1 was indexed under MICROFILAMENT PROTEINS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; COFILIN 2 was indexed under MICROFILAMENT PROTEINS 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; COMPLEMENT C2A was indexed under COMPLEMENT 2 1986-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; COMPLEMENT C2B was indexed under COMPLEMENT 2 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; COMPLEMENT C5B was indexed under COMPLEMENT 5 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CORE BINDING FACTOR BETA %26% CBFB PROTEIN were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CORE-BINDING FACTOR was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CORTACTIN was indexed under MICROFILAMENT PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CRATINE KINASE, MM FORM was indexed under CREATINE KINASE 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CREATINE KINASE, BB FORM was indexed under CREATINE KINASE 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CREATINE KINASE, MB FORM was indexed under CREATINE KINASE 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CREATINE KINASE, MITOCHONDRIAL FORM was indexed under CREATINE KINASE 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CREB-BINDING PROTEIN was indexed under TRANS-ACTIVATORS %26% NUCLEAR PROTEINS 1999-2005, %26% under TRANSCRIPTION FACTORS 1994-1998%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CRK-ASSOCIATED SUBSTRATE was indexed under PROTEINS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN A was indexed under DNA-BINDING PROTEIN, CYCLIC-AMP RESPONSIVE %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIC AMP RESPONSE ELEMENT MODULATOR was indexed under DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE 2 was indexed under CDC2-CDC28 KINASES 2004-2005, %26% under CYCLIN-DEPENDENT KINASES 1991-2003, %26% under PROTEIN KINASES 1991-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE 4 was indexed under CYCLIN-DEPENDENT KINASES %26% PROTO-ONCOGENE PROTEINS 2005, CELL CYCLE PROTEINS 1992-2004, PROTEIN SERINE THREONINE KINASES 1995, %26% under PROTEIN KINASES 1992-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE 5 was indexed under CYCLIN-DEPENDENT KINASES 2000-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-1999, %26% under PROTEIN KINASES 1993-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE 6 was indexed under CYCLIN-DEPENDENT KINASES 2003-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 1995-2002, %26% under PROTEIN KINASES 1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE INHIBITOR P 18 was indexed under TUMOR SUPPRESSOR PROTEINS %26% CELL CYCLE PROTEINS 2002-2005, %26% under CARRIER PROTEINS 1994-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE INHIBITOR P15 was indexed under TUMOR SUPPRESSOR PROTEINS %26% CELL CYCLE PROTEINS 2004-2005, under PROTEIN P16 2002-2004, %26% under CARRIER PROTEINS 1994-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE INHIBITOR P19 was indexed under CARRIER PROTEINS 1995-2001, under PROTEIN P16 2002-2004, %26% under CELL CYCLE PROTEINS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE INHIBITOR P21 was indexed under CYCLINS 1993-2005, %26% under CELL CYCLE PROTEINS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE INHIBITOR P27 was indexed under CELL CYCLE PROTEINS %26% TUMOR SUPPRESSOR PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLIN-DEPENDENT KINASE INHIBITOR P57 was indexed under NUCLEAR PROTEINS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLOOXYGENASE 1 was indexed under ISOENZYMES, %26% PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYCLOOXYGENASE 2 was indexed under ISOENZYMES, under PEROXIDASES %26% PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYSTEINE DIOXYGENASE was indexed under DIOXYGENASES 1981-2005, %26% under CYSTEINE 1973-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYTOCHROME P-450 CYP3A was indexed under ARYL HYDROCARBON HYDROXYLASES %26% OXIDOREDUCTASES, N-DEMETHYLATING 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; CYTOKINE RECEPTOR GP130 was indexed under ANTIGENS, CD %26% MEMBRANES GLYCOPROTEINS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; D-ALANINE TRANSAMINASE was indexed under ALANINE TRANSAMINASE 1974-2005, %26% under TRANSAMINASES 1977-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; D-ASPARTATE OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1975-2005 %26% under ASPARTIC ACID 1975-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; D-XYLULOSE REDUCTASE was indexed under SUGAR ALCOHOL DEHYDROGENASES 1981-2005, ALCOHOL OXIDOREDUCTASES 1975-1980, XYLULOSE 1976-1980, %26% KETOSES %26% PENTOSES 1975-1976%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DELAYED RECTIFIER POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESMOCOLLINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESMOGLEIN 1 was indexed under CADHERINS 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESMOGLEIN 2 was indexed under CYTOSKELETAL PROTEINS %28%2001-2005%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESMOGLEIN 3 was indexed under CYTOSKELETAL PROTEINS %28%2005%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESMOGLEINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESMOPLAKINS was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DESTRIN was indexed under MICROFILAMENT PROTEINS 1988-2005, %26% under MUSCLE PROTEINS %26% PROTEINS 1981-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DIACYLGLYCEROL O-ACYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, %26% GLYCERIDES 1973-1975%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DIHYDRODIPICOLINATE REDUCTASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1982-2003, and under PICOLINIC ACIDS 1974-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1968-2005, under ACETYLTRANSFERASES 1968-1973, under LIPOIC ACID 1968-1982; PYRUVATE DEHYDROGENASE COMPLEX E2 was indexed under PYRUVATE DEHYDROGENASE COMPLEX 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DIHYDROURACIL DEHYDROGENASE %28%NAD+%29% was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, OXIDOREDUCTASES 1983-2003, %26% URACIL 1970-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DIMETHYLGLYCINE DEHYDROGENASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1979-2005 %26% under METHYLGLYCINE 1979-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DNA-ACTIVATED PROTEIN KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES %26% DNA-BINDING PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DNA-BINDING PROTEINS 1997-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN was indexed under NERVE TISSUE PROTEINS %26% PHOSPHOPROTEINS 1984-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; DOPAMINE TRANSPORTER PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, CARRIER PROTEINS 1993-2004, NERVE TISSUE PROTEINS; MEMBRANE GLYOPROTEINS %26% MEMBRANE PROTEINS 1987-2004; DOPAMINE UPTAKE COMPLEX was indexed under MEMBRANE PROTEINS %26% NERVE TISSUE PROTEINS 1993-2004, DOPAMINE/metab 1991-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E1A-ASSOCIATED P300 PROTEIN was indexed under NUCLEAR PROTEINS %26% TRANS-ACTIVATORS 1999-2005 %26% under TRANSCRIPTION FACTORS 1994-1998%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F TRANSCRIPTION FACTORS was indexed under CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F3 transcription factor, E2F Transcription Factor 3 Protein, %26% Transcription Factor E2F-3 were indexed under CELL CYCLE PROTEINS, DNA-BINDING PROTEINS, %26% TRANSCRIPTION FACTORS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F4 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F5 TRANSCRIPTION FACTOR, E2F Transcription Factor 5 Protein, %26% TRANSCRIPTION FACTOR E2F-5 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F6 TRANSCRIPTION FACTOR, E2F TRANSCRIPTION FACTOR 6 PROTEIN, %26% TRANSCRIPTION FACTOR E2F-6 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; E2F7 TRANSCRIPTION FACTOR; E2F TRANSCRIPTION FACTOR 7 PROTEIN; %26% TRANSCRIPTION FACTOR E2F-7 were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTIONS FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; EARLY GROWTH RESPONSE PROTEIN 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %26% IMMEDIATE-EARLY PROTEINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; EARLY GROWTH RESPONSE PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; EARLY GROWTH RESPONSE PROTEIN 3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ENDOGENOUS SUBSTRATE PP120, FOCAL ADHESION-ASSOCIATED, PROTEIN-TYROSINE KINASE PP125FAK, %26% P125FAK PROTEIN were indexed under PROTEIN-TYROSINE KINASE 2001-2005, %26% under CELL ADHESION MOLECULES 1990-2000, %26% MEMBRANE GLYCOPROTEINS 1987-1992, MEMBRANE PROTEINS 1986-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ENDOTHELIAL CONSTITUTIVE NITRIC OXIDE SYNTHASE was indexed UNDER NITRIC-OXIDE SYNTHASE 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ENOYL-%28%ACYL-CARRIER-PROTEIN%29% REDUCTASE %28%NADPH%29% was indexed under OXIDOREDUCTASES 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ENOYL-%5B%ACYL-CARRIER-PROTEIN%5D% REDUCTASE %28%NADH%29% was indexed under OXIDOREDUCTASES 1984-2005, under ACYL CARRIER PROTEIN 1978-1983, under CARRIER PROTEINS 1972-1979, and under PROTEINS 1970-1972%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ERYTHROID-SPECIFIC DNA-BINDING FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ETHER-A-GO-GO POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ETS-DOMAIN PROTEIN ELK was indexed under DNA-BINDING PROTEINS 1995-2005 %26% FUNGAL PROTEINS 1992-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ETS-DOMAIN PROTEIN ELK-1 was indexed under PROTO-ONCOGENE PROTEINS, TRANSCRIPTION FACTORS, DNA-BINDING PROTEINS 1995-2005, under RETROVIRIDAE PROTEINS 1989, %26% under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; EXCITATORY AMINO ACID TRANSPORTER 3 was indexed under AMINO ACID TRANSPORT SYSTEM X-AG %26% SYMPORTERS 2003-2005 %26% under CARRIER PROTEINS 1984-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; EXCITATORY AMINO ACID TRANSPORTER 4 was indexed under SYMPORTERS %26% AMINO ACID TRANSPORT SYSTEM X-AG %28%2005%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; EXCITATORY AMINO ACID TRANSPORTER 5 was indexed under SYMPORTERS %26% AMINO ACID TRANSPORT SYSTEM X-AG %28%2005%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% CELL CYCLE PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN was indexed under NUCLEAR PROTEINS 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA COMPLEMENTATION GROUP E PROTEIN was indexed under NUCLEAR PROTEINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN was indexed under RNA-BINDING PROTEINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN was indexed under DNA-BINDING PROTEINS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN was indexed under LIGASES 2003-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FANCONI ANEMIA PROTEINS was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% CELL CYCLE PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FARNESYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FATTY ACID TRANSPORT PROTEINS was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE PROTEINS %26% CARRIER PROTEINS 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FATTY ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FERREDOXIN SULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FERREDOXIN-NITRITE REDUCTASE was indexed under NITRITE REDUCTASES 1980-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FERROSOFERRIC OXIDE was indexed under OXIDES 1991-2005 and IRON 1981-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 10 was indexed under FIBROBLAST GROWTH FACTORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 3 was indexed under FIBROBLAST GROWTH FACTORS 2005, %26% under PROTO-ONCOGENE PROTEINS 1989-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 4 was indexed under FIBROBLAST GROWTH FACTORS %26% PROTO-ONCOGENE PROTEINS 1991-2005, %26% under GROWTH SUBSTANCES 1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 5 was indexed under FIBROBLAST GROWTH FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 6 was indexed under FIBROBLAST GROWTH FACTORS %26% PROTO-ONCOGENE PROTEINS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 7 was indexed under FIBROBLAST GROWTH FACTORS 2002-2005, %26% under GROWTH SUBSTANCES 1989-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 8 was indexed under FIBROBLAST GROWTH FACTORS 1999-2005, %26% under GROWTH SUBSTANCES 1992-1998, %26% under NEOPLASM PROTEINS 1992-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR 9 was indexed under FIBROBLAST GROWTH FACTORS 2002-2005, %26% under GROWTH SUBSTANCES 1996-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR RECEPTOR 1 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASES 1994-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR RECEPTOR 2 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASE 2004-2005, %26% under PROTEIN-TYROSINE KINASE 1999-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR RECEPTOR 3 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR %26% RECEPTOR PROTEIN-TYROSINE KINASES 1993-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR RECEPTOR 4 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR 1993-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FIBROBLAST GROWTH FACTOR RECEPTOR 5 was indexed under RECEPTORS, FIBROBLAST GROWTH FACTOR 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FMS-LIKE TYROSINE KINASE 3 was indexed under PROTO-ONCOGENE PROTEINS 1999-2005, %26% under RECEPTOR PROTEIN-TYROSINE KINASES 2005, %26% under PROTEIN-TYROSINE KINASE %26% RECEPTORS, CELL SURFACE 1999-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FOCAL ADHESION KINASE 2 was indexed under PROTEIN-TYROSINE KINASE 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FOCAL ADHESION KINASE was indexed under under PROTEIN-TYROSINE KINASE 2001-2005, CELL ADHESION MOLECULES 1990-2000, MEMBRANE GLYCOPROTEINS 1987-1992, %26% MEMBRANE PROTEINS 1986-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FORKHEAD TRANSCRIPTION FACTORS was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FOS-RELATED ANTIGEN-2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FRAGILE X MENTAL RETARDATION PROTEIN was indexed under NERVE TISSUE PROTEINS %26% RNA-BINDING PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FRIZZLED RECEPTOR was indexed under PROTEINS 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; FUSHI TARAZU TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2005, %26% under POTASSIUM CHANNELS 1995-2004, %26% under MEMBRANE PROTEINS 1993-1994; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 1, G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 2, G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 3, %26% G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNEL 4 were indexed under POTASSIUM CHANNELS, INWARDLY RECTIFYING 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; G-BOX BINDING FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005, %26% under REPRESSOR PROTEINS 1992-2004, %26% under PLANT PROTEINS 1992-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GABA TRANSPORTERS was indexed under MEMBRANE TRANSPORT PROTEINS 2002-2005, CARRIER PROTEINS %26% under MEMBRANE PROTEINS 1979-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GAMMA CATENIN was indexed under CYTOSKELETAL PROTEINS 1990-2005, %26% under MEMBRANE GLYCOPROTEINS 1988-1989, %26% under MEMBRANE PROTEINS 1983-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GAMMA-BUTYROBETAINE DIOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1980-2005, KETOGLUTARIC ACID 1973-1974, BETAINE 1972-1980, BUTYRATES 1974-1979, %26% AMINOBUTYRIC ACID 1970-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GAMMA-SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GANGLIOSIDE GALACTOSYLTRANSFERASE was indexed under GALACTOSYLTRANSFERASES 1981-2005, CERAMIDES 1975-1980, HEXOSYLTRANSFERASES 1973-1976, %26% under GALACTOSE 1973-1975 %26% UDP SUGARS 1973-1975%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GATA1 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GATA2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GATA3 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GATA4 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GATA5 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GATA6 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GERANYLGERANYL-DIPHOSPHATE GERANYLGERANYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1991-2005, %26% under OXIDOREDUCTASES 1991-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GERANYLGERANYLTRANSFERASE was indexed under ALKYL AND ARYL TRANSFERASES 1997-2005, under PYROPHOSPHORIC ACIDS 1970-1979, under ALLYL CPDS 1975-1979, %26% under TERPENES 1970-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE GROWTH FACTORS 2003-2005, %26% under NERVE TISSUE PROTEINS 1993-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLIAL CELL-LINE DERIVED NEUROTROPHIC FACTOR RECEPTORS was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSAMINE 6-PHOSPHATE N-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1977-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSE TRANSPORTER TYPE 1 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSE TRANSPORTER TYPE 2 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 2003-2005, %26% under MEMBRANE TRANSPORT PROTEINS 1992-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSE TRANSPORTER TYPE 3 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS %26% NERVE TISSUE PROTEINS 2005, %26% under MEMBRANE PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSE TRANSPORTER TYPE 4 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS %26% MUSCLE PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSE TRANSPORTER TYPE 5 was indexed under MONOSACCHARIDE TRANSPORT PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUCOSE-1-PHOSPHATE ADENYLYLTRANSFERASE was indexed under NUCLEOTIDYLTRANSFERASES 1976-2005, under GLUCOSEPHOSPHATES 1972-1975, under ADENINE NUCLEOTIDES 1970-1972, %26% under ATP 1972-1975%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUTAMATE FORMIMIDOYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1980-2005, FORMIMINOGLUTAMIC ACID 1977-1980, TRANSFERASES 1975-1997, GLUTAMATES 1975-1977, %26% under FORMIC ACIDS %26% IMINES 1975-1976%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUTAMATE SYNTHASE %28%NADH%29% was indexed under AMINO ACID OXIDOREDUCTASES 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUTAMATE-5-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1978-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUTARYL-COA DEHYDROGENASE was indexed under ACYL COENZYME A 1973-1979; under GLUTARATES 1973-1982; and under COENZYME A 1973-1979; under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLUTATHIONE S-TRANSFERASE PI was indexed under GLUTATHIONE TRANSFERASE %26% ISOENZYMES 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCEROL-3-PHOSPHATE DEHYDROGENASE %28%NAD+%29% was indexed under GLYCEROLPHOSPHATE DEHYDROGENASE 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCINE DECARBOXYLASE COMPLEX was indexed under AMINO ACID OXIDOREDUCTASES 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCINE DEHYDROGENASE %28%DECARBOXYLATING%29% was indexed under AMINO ACID OXIDOREDUCTASES 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1977-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2005 %26% under GLYCINE 1974-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCINE TRANSAMINASES was indexed under TRANSAMINASES 1974-2005, %26% under KETOGLUTARIC ACID 1974-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCINE TRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEMS, NEUTRAL 2002-2005 %26% under CARRIER PROTEINS 1987-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GLYCOLALDEHYDE DEHYDROGENASE was indexd under ALDEHYDE OXIDREDUCTASES 1978-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GMP REDUCTASE was indexed under as NADH, NADPH OXIDOREDUCTASES 1983-2004, GUANOSINE MONOPHOSPHATE 1976-1982, %26% GUANINE NUCLEOTIDES 1976-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GOOSECOID PROTEIN was indexed under REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005, %26% under HOMEODOMAIN PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN 10 was indexed under PROTEINS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN-2 was indexed under ADAPTOR PROTEINS, SIGNAL TRANSDUCING 2005, %26% under PROTEINS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GROWTH FACTOR RECEPTOR-BOUND PROTEIN-7 was indexed under PROTEINS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2 was indexed under PROTO-ONCOGENE PROTEINS 1995-2005, %26% under GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO 2000-2005, %26% under GTP-BINDING PROTEINS 1994-1999, %26% under ONCOGENE PROTEINS 1993-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GUANIDINOACETATE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1978-2005, S-ADENOSYLMETHIONINE 1973-1977, GUANIDINES 1973-1982, %26% ACETIC ACIDS 1973-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; GUANYLATE CYCLASE-ACTIVATING PROTEINS was indexed under CALCIUM-BINDING PROTEINS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; H-PROTEIN, GLYCINE DECARBOXYLASE SYSTEM was indexed under AMINO ACID OXIDOREDUCTASES 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEAT-SHOCK PROTEIN 47 was indexed under HEAT-SHOCK PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEAT-SHOCK PROTEINS 110 was indexed under HEAT-SHOCK PROTEINS 70 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEAT-SHOCK PROTEINS 20 was indexed under HEAT-SHOCK PROTEINS %26% PHOSPHOPROTEINS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEAT-SHOCK PROTEINS 30 was indexed under HEAT-SHOCK PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEAT-SHOCK PROTEINS 40 was indexed under HEAT-SHOCK PROTEINS 1986-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEME OXYGENASE-1 was indexed under HEME OXYGENASE %28%DECYCLIZING%29% 1997-200%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 1-BETA was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 3-BETA was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 3-GAMMA was indexed under DNA-BINDING PROTINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 4 was indexed under DNA-BINDING PROTEINS, PHOSPHOPROTEINS %26% TRANSCRIPTION FACTORS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HEPATOCYTE NUCLEAR FACTOR 6 was indexed under TRANS-ACTIVATORS %26% HOMEODOMAIN PROTEINS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HIPPOCALCIN was indexed under CALCIUM-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HISTONE ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1981-2005, HISTONES 1973-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HOMOCYSTEINE S-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2004 %26% HOMOCYSTEINE 1974-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HOMOGENTISATE 1,2-DIOXYGENASE was indexed under DIOXYGENASES 1969-2005, OXYGENASES 1983-2004, %26% under HOMOGENTISIC ACID 1973-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HOMOSERINE O-SUCCINYLTRANSFERASE was indexed under ACYLTRANSFERASES 1971-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HOST CELL FACTOR C1 was indexed under TRANSCRIPTION FACTORS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HSC70 PROTEIN, was indexed under HEAT SHOCK PROTEINS 70 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HSP72 PROTEIN was indexed under HEAT SHOCK PROTEINS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS was indexed under NERVE TISSUE PROTEINS %26% RNA-BINDING PROTEINS 1991-2005; ELAV PROTEIN was indexed under RIBONUCLEOPROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HYDROXYPYRUVATE DEHYDROGENASE was indexed under ALCOHOL OXIDOREDUCTASES 1980-2005 %26% under GLYCERIC ACIDS 1974-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HYPOXIA-INDUCIBLE FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT was indexed under TRANSCRIPTION FACTORS 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; HYROGENSULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1995-2005; for DESULFOVIRIDINS and BISULFITE REDUCTASES see SULFITE REDUCTASES 1978-2005; for SIROHAEM SULFITE REDUCTASE see SULFITE REDUCTASES 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; I-KAPPA B KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; IKAROS TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INDUCIBLE NITRIC OXIDE SYNTHASE was indexed under NITRIC-OXIDE SYNTHASE 1998-2005; NITRIC OXIDE SYNTHASE II was indexed under NITRIC-OXIDE SYNTHASE 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INHIBITOR OF APOPTOSIS PROTEINS was indexed under PROTEINS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INHIBITOR OF DIFFERENTIATION PROTEIN 1 was indexed under REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005, %26% under DNA-BINDING PROTEINS 1990-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INHIBITOR OF DIFFERENTIATION PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INOSITOL OXYGENASE was indexed under OXYGENASES 1983-2005 %26% under INOSITOL 1979-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INTERFERON REGULATORY FACTOR was indexed under DNA-BINDING PROTEINS 1990-2005; PHOSPHOPROTEINS 1990-2005; %26% PROTEINS 1989%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INTERFERON REGULATORY FACTOR-2 was indexed under DNA-BINDING PROTEINS; REPRESSOR PROTEINS; %26% TRANSCRIPTION FACTORS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INTERFERON REGULATORY FACTOR-3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INTERFERON-STIMULATED GENE FACTOR 3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2005, %26% under POTASSIUM CHANNELS 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ISGF ALPHA SUBUNIT %26% ISGF-ALPHA PROTEIN were indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ISOVALERYL-COA DEHYDROGENASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1983-2003, under ACYL COENZYME A 1980-1982, COENZYME A 1973-1980, and under VALERATES 1973-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KANGAI-1 PROTEIN was indexed under MEMBRANE GLYCOPROTEINS %26% PROTO-ONCOGENE PROTEINS 1993-2005, %26% under ANTIGENS, CD 2005, %26% under SURFACE ANTIGENS 1993-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KCNQ POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005 %26% under POTASSIUM CHANNELS 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KCNQ1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KCNQ2 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KCNQ3 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1998-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KETOL-ACID REDUCTOISOMERASE was indexed under ALCOHOL OXODOREDUCTASES 1983-2000, %26% under VALERATES 1970-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KRUPPEL-LIKE TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005, %26% under JUVENILE HORMONES 1989-1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV CHANNEL-INTERACTING PROTEIN 1 %26% KV CHANNEL-INTERACTING PROTEIN 2 were indexed under CALCIUM-BINDING PROTEINS 2000-2005; KV CHANNEL-INTERACTING PROTEIN 3 was indexed under CALCIUM-BINDING PROTEINS %26% REPRESSOR PROTEINS 1998-2005; KV CHANNEL-INTERACTING PROTEIN 4 was indexed under POTASSIUM-CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV1.1 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV1.2 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV1.3 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV1.4 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV1.5 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1995-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KV1.6 POTASSIUM CHANNEL was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; KYNURENINE 3-MONOOXYGENASE was indexed under MIXED FUNCTION OXYGENASES 1981-2005, %26% under KYNURENINE 1973-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; L-AMINO ACID OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1974-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; L-AMINOADIPATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASE 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; L-GULONOLACTONE OXIDASE was indexed under SUGAR ALCOHOL DEHYDROGENASES 1980-2005, ALCOHOL OXIDOREDUCTASES %26% GLUCONATES 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL BETA SUBUNITS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM ACTIVATED 2002-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under MEMBRANE PROTEINS 1993-1995, under POTASSIUM CHANNELS 1995-2002, %26% under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2002-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LEUCINE DEHYDROGENASE was indexed under AMINO ACID OXIDOREDUCTASES 1970-2005 %26% LEUCINE 1970-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LEUCINE TRANSAMINASE was indexed under TRANSAMINASES 1973-2005 %26% under KETOGLUTARIC ACID 1973-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LEUCINE-RESPONSIVE REGULATORY PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1991-2005, %26% under BACTERIAL PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LINOLEOYL-COA DESATURASE was indexed under FATTY ACID DESATURASES 1981-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LITHOSTATHINE was indexed under CALCIUM-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LYMPHOID ENHANCER-BINDING FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2005, %26% under NUCLEAR PROTEINS 1991-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LYSINE 6-AMINOTRANSFERASE was indexed under TRANSAMINASES 1978-2005, %26% under KETOGLUTARIC ACIDS 1978-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS was indexed under ANTIGENS, CD 2003-2005, %26% under MEMBRANE GLYCOPROTEINS 1986-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MAFK PROTEIN was indexed under NUCLEAR PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MALATE DEHYDROGENASE %28%NADP+%29% was indexed under MALATE DEHYDROGENASE 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MALONATE-SEMIALDEHYDE DEHYDROGENASE %28%ACETYLATING%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES was indexed under SERINE ENDOPEPTIDASES 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MD-2 PROTEIN was indexed under CARRIER PROTEINS %26% ANTIGENS, SURFACE 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; METHYL-CPG-BINDING PROTEIN 2 was indexed under CHROMOSOMAL PROTEINS, NON-HISTONE %26% DNA-BINDING PROTEINS %26% REPRESSOR PROTEINS 2005, %26% under TRANSCRIPTION FACTORS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE %28%ACYLATING%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MSX1 TRANSCRIPTION FACTOR was indexed under TRANSCRIPTION FACTORS 1993-2005, %26% under HOMEODOMAIN PROTEINS 2005, %26% under REPRESSOR PROTEINS 1993-2004 %26% DNA-BINDING PROTEINS 1993-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MUNC18 PROTEINS was indexed under NERVE TISSUE PROTEINS %26% VESICULAR TRANSPORT PROTEINS 2005, %26% under MEMBRANE PROTEINS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MUTS DNA MISMATCH-BINDING PROTEIN was indexed under ADENOSINETRIPHOSPHATASE %26% DNA-BINDING PROTEINS 1991-2005, %26% under BACTERIAL PROTEINS 2005, %26% under ESCHERIA COLI PROTEINS 2002-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MUTS HOMOLOG 2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MYELOID-LYMPHOID LEUKEMIA PROTEIN was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; MYOGENIC REGULATORY FACTOR 5 was indexed under DNA-BINDING PROTEINS %26% MUSCLE PROTEINS 1989-2005, TRANS-ACTIVATORS 2005, %26% under TRANSCRIPTION FACTORS 1989-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; N-ACYLSPHINGOSINE GALACTOSYLTRANSFERASE was indexed under GALACTOSYLTRANSFERASES 1980-2005, %26% under CERAMIDES 1979-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NADPH-SULFITE REDUCTASE was indexed under SULFITE REDUCTASES 1983-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEUROCALCIN was indexed under RECEPTORS, CALCIUM-SENSING 2004-2005, under NERVE TISSUE PROTEINS 1992-2005, %26% under CALCIUM-BINDING PROTEINS 1992-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEUROENDOCRINE SECRETORY PROTEIN 7B2 was indexed under NERVE TISSUE PROTEINS %26% PITUITARY HORMONES 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEUROGRANIN was indexed under CALMODULIN-BINDING PROTEINS %26% NERVE TISSUE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEURONAL APOPTOSIS-INHIBITORY PROTEIN was indexed under NERVE TISSUE PROTEINS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEURONAL CONSTITUTIVE NITRIC OXIDE SYNTHASE was indexed under NITRIC-OXIDE SYNTHASE 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEURONAL WISKOTT-ALDRICH SYNDROME PROTEIN was indexed under NERVE TISSUE PROTEINS 1998-2005, %26% under PROTEINS 1996-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NEURTURIN was indexed under NERVE GROWTH FACTORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NF-E2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NF-E2-RELATED FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005, %26% under TRANSCRIPTION FACTORS 1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NF-E2-RELATED FACTOR 2 was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NF-KAPPA B P50 SUBUNIT was indexed under NF-KAPPA B %26% PROTEIN PRECURSORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NF-KAPPAB P52 SUBUNIT was indexed under NF-KAPPA B 1994-2005, %26% under TRANSCRIPTION FACTORS 1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NFATC TRANSCRIPTION FACTORS was indexed under DNA-BINDING PROTEIN, NUCLEAR PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NFI TRANSCRIPTION FACTORS was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1986-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NICOTINAMIDE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1983-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NITRATE REDUCTASE %28%NAD%28%P%29%H%29% was indexed under NITRATE REDUCTASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NITRATE REDUCTASE %28%NADH%29% was indexed under NITRATE REDUCTASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NITRATE REDUCTASE %28%NADPH%29% was indexed under NITRATE REDUCTASES 1984-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NITRATE REDUCTASE was indexed under NITRATE REDUCTASES 1985-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NITRITE REDUCTASE %28%NAD%28%P%29%H%29% was indexed under NITRITE REDUCTASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NITROGEN REGULATORY PROTEINS was indexed under BACTERIAL PROTEINS %26% DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %26% TRANS-ACTIVATORS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NOREPINEPHRINE TRANSPORTER PROTEIN was indexed under SYMPORTERS 2005 %26% under CARRIER PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NUCLEAR FACTOR 45 PROTEIN was indexed under TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; %26% DNA-BINDING PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NUCLEAR FACTOR 90 PROTEINS were indexed under DNA-BINDING PROTEINS, NUCLEAR PROTEINS, %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NUCLEAR RECEPTOR COACTIVATOR 2 was indexed under TRANSCRIPTION FACTORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NUCLEAR RESPIRATORY FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NUCLEAR RESPIRATORY FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005, %26% under TRANSCRIPTION FACTORS 1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; NUCLEOSIDE-PHOSPHATE KINASE 1979-2005, %26% under NUCLEOTIDES %26% PHOSPHOTRANSFERASES, ATP 1974-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; OLFACTORY MARKER PROTEIN was indexed under NERVE TISSUE PROTEINS 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ONCOGENE PROTEIN V-AKT was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, %26% under RETROVIRIDAE PROTEINS 1987-1989%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ONCOGENE PROTEIN V-CBL was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-2005, %26% under RETROVIRIDAE PROTEINS 1989%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ONCOGENE PROTEIN V-CRK was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ONCOGENE PROTEIN V-MAF was indexed under DNA-BINDING PROTEINS %26% ONCOGENE PROTEINS, VIRAL %26% VIRAL PROTEINS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ORIGIN RECOGNTION COMPLEX was indexed under DNA-BINDING PROTEINS 1997-2005, %26% under REPRESSOR PROTEINS 1993-1996, %26% under FUNGAL PROTEINS 1993-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; OTX TRANSCRIPTION FACTORS was indexed under HOMEODOMAIN PROTEINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; P300/CBP PROTEINS was indexed under NUCLEAR PROTEINS %26% TRANS-ACTIVATORS 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PACAP RECEPTORS was indexed under RECEPTORS, CELL SURFACE 2005, RECEPTORS, PITUITARY HORMONE 1990-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1990-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PAX2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PAX7 TRANSCRIPTION FACTOR was indexed under HOMEODOMAIN PROTEINS 2001-2005, %26% under MUSCLE PROTEINS %26% NERVE TISSUE PROTEINS 1993-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PAX9 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PAXILLIN was indexed under CYTOSKELETAL PROTEINS %26% PHOSPHOPROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHOSPHATIDYL-N-METHYLETHANOLAMINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1980-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1981-2005, %26% under CEPHALINS 1971-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHOSPHOGLYCERATE DEHYDROGENASE was indexed under CARBOHYDRATE DEHYSDROGENASES 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHOSPHOLIPASE C GAMMA was indexed under PHOSPHOLIPASE C 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1980-1997, FORMIC ACIDS 1974-1980, AMINOIMIDAZOLE CARBOXAMIDE 1979-1980, IMIDAZOLES 1974-1979, PENTOSEPHOSPHATES 1974-1979, TRANSFERASES 1974-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE was indexed under HYDROXYMETHYL AND FORMYL TRANSFERASES 1998-2005, ACYLTRANSFERASES 1979-1997, GLYCINE 1974-1980, FORMIC ACIDS 1974-1982, GLYCINE 1980-1982, PENTOSEPHOSPHATES 1974-1975, RIBOSEMONOPHOSPHATES 1975-1980, %26% under TRANSFERASES 1974-1978%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHYTOCHROME A was indexed under PHYTOCHROME 1994-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PHYTOCHROME B was indexed under PHOTORECEPTORS %26% PHYTOCHROME %26% TRANSCRIPTION FACTORS 1991-2005, %26% under PLANT PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE was indexed under NERVE GROWTH FACTORS %26% NEUROPEPTIDES %26% NEUROTRANSMITTERS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PLAKOPHILINS was indexed under PROTEINS 1995-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PLASTOQUINOL-PLASTOCYANIN REDUCTASE was indexed under OXIDOREDUCTASES 1981-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PLECTIN was indexed under INTERMEDIATE FILAMENT PROTEINS 1992-2005, %26% under PROTEINS 1982-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; POLYOMAVIRUS ENHANCER A BINDING PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1987-2005, %26% under NEOPLASM PROTEINS 1997-2005; RUNT DOMAIN FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2000-2005, %26% under NEOPLASM PROTEINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROFILINS was indexed under MICROFILAMENT PROTEINS %26% CONTRACTILE PROTEINS 2005, %26% under CYTOSKELETAL PROTEINS 1977-2004, %26% under PROTEINS 1977-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTEIN INHIBITORS OF ACTIVATED STAT was indexed under PROTEINS 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTEIN KINASE C ALPHA was indexed under PROTEIN KINASE C 2004-2006, %26% under ISOENZYMES 1999-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTEIN KINASE C EPSILON was indexed under PROTEIN KINASE C 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTEIN KINASE C-DELTA was indexed under PROTEIN KINASE C 2004-2006, %26% under ISOENZYMES 1993-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-BCL-6 was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-BCR was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-CRK was indexed under PROTO-ONCOGENE PROTEINS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-FES was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1986-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-FLI-1 was indexed under DNA-BINDING PROTEINS %26% PROTO-ONCOGENE PROTEINS %26% TRANS-ACTIVATORS 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-FYN was indexed under SRC-FAMILY KINASES %26% PROTO-ONCOGENE PROTEINS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-HCK was indexed under PROTEIN-TYROSINE KINASE %26% PROTO-ONCOGENE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-MET was indexed under RECEPTOR PROTEIN-TYROSINE KINASE 1994-1997 %26% PROTO-ONCOGENE PROTEINS 1989-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-PIM-1 was indexed under PROTO-ONCOGENE PROTEINS 1988-2005, %26% under PROTEIN-SERINE-THREONINE KINASES 1989-2005, %26% under PROTEIN-TYROSINE KINASE 1988%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-RET was indexed under PROTO-ONCOGENE PROTEINS %26% RECEPTOR PROTEIN-TYROSINE KINASES 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-VAV was indexed under PROTO-ONCOGENE PROTEINS %26% CELL CYCLE PROTEINS 2004-2005, %26% under ONCOGENE PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEIN C-YES was indexed under SCR-FAMILY KINASES 2005, %26% under PROTO-ONCOGENE PROTEINS 1987-2005, %26% under PROTEIN-TYROSINE KINASE 1987-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEINS C-AKT was indexed under PROTEIN-SERINE-THREONINE KINASES %26% PROTO-ONCOGENE PROTEINS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEINS C-CBL was indexed under UBIQUITIN-PROTEIN LIGASES 2005, %26% under LIGASES %26% PROTO-ONCOGENE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEINS C-ETS was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1986-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEINS C-ETS-1 was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1986-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEINS C-MDM2 was indexed under PROTO-ONCOGENE PROTEINS 2005, %26% under NUCLEAR PROTEINS 1991-2005, %26% under NEOPLASM PROTEINS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTO-ONCOGENE PROTEINS ETS-2 was indexed under PROTO-ONCOGENE PROTEINS %26% TRANS-ACTIVATORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PROTOPORPHYRINOGEN OXIDASE was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, under OXIDOREDUCTASES 1993-2003, under PORPHYRINS 1975-1976, and under PROTOPORPHYRINS 1975-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PTEN PROTEIN was indexed under PROTEIN-TYROSINE-PHOSPHATASES 1997-1998, under TUMOR SUPPRESSOR PROTEINS 1997-2005, %26% under PHOSPHORIC MONOESTER HYDROLASES 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; PYRUVATE SYNTHASE was indexed under KETONE OXIDOREDUCTASES 1975-2005, under FERREDOXINS 1972-1979, under ACETYL COENZYME A 1974-1978, under PYRUVATES 1970-1982, %26% under COENZYME A %26% CARBOXY-LYASES 1970-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RAD51 RECOMBINASE was indexed under DNA-BINDING PROTEINS 1996-2005, %26% under FUNGAL PROTEINS 1992-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RAD52 PROTEIN was indexed under DNA-BINDING PROTEINS 1993-2005, %26% under FUNGAL PROTEINS 1993-1998%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTOR, NOTCH1 was indexed under TRANSCRIPTION FACTORS 1991-2005, under RECEPTORS, CELL SURFACE 2004-2005, %26% under MEMBRANE PROTEINS 1991-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTOR, NOTCH2 was indexed under RECEPTORS, CELL SURFACE 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, DOPAMINE D3 was indexed under RECEPTORS, DOPAMINE D2 1997-2005, %26% under RECEPTORS, DOPAMINE 1987-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, DOPAMINE D4 was indexed under RECEPTORS, DOPAMINE D2 2005, %26% under RECEPTORS, DOPAMINE 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, DOPAMINE D5 was indexed under RECEPTORS DOPAMINE 1997-2005, %26% under RECEPTORS, DOPAMINE 1991-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, MATING FACTOR was indexed under TRANSCRIPTION FACTORS 1986-2005, %26% under RECEPTORS, PEPTIDE 1994-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, NOTCH was indexed under MEMBRANE PROTEINS 1990-2005, %26% under INSECT HORMONES 1990-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, OXIDIZED LDL was indexd under RECEPTORS, LDL 1997-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECEPTORS, SCAVENGER was indexed under RECEPTORS, IMMUNOLOGIC 1985-2005, %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-1984%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RECOVERIN was indexed under CALCIUM-BINDING PROTEINS, EYE PROTEINS %26% LIPOPROTEINS 1987-2005, %26% under ANTIGENS, NEOPLASM 1987-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; REPLICATION FACTOR A was indexed under DNA-BINDING PROTEINS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; REPLICATION FACTOR C was indexed under DNA-BINDING PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RESISTIN was indexed under HORMONES, ECTOPIC 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RETINAL DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1977-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RETINOBLASTOMA-LIKE PROTEIN P107 was indexed under NUCLEAR PROTEINS 1995-2005 %26% under PROTEINS 1991-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RETINOBLASTOMA-LIKE PROTEIN P130 was indexed under PROTEIN 2004-2005, under ADAPTOR PROTEINS 2004, under PHOSPHOPROTEINS 1996-2004, %26% under PROTEINS 1994-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RETINOL O-FATTY-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1982-2005, %26% under PALMITATES %26% VITAMIN A 1977-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RHODOPSIN KINASE was indexed under EYE PROTEINS %26% PROTEIN KINASES 1983-2005, %26% under RHODOPSIN 1979-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RNA POLYMERASE SIGMA 54 was indexed under DNA-BINDING PROTEINS %26% DNA-DIRECTED RNA POLYMERASES 1991-2005, %26% under SIGMA FACTOR 2005, %26% under BACTERIAL PROTEINS %26% TRANSCRIPTION FACTORS 1991-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RUNX1 PROTEIN was indexed under DNA-BINDING PROTEINS 1996-2005, NEOPLASM PROTEINS 1993-1996, PROTO-ONCOGENE PROTEINS 1996-2005, %26% TRANSCRIPTION FACTORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RUNX2 PROTEIN was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; RUNX3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SARCOSINE DEHYDROGENASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1976-2004, %26% under SARCOSINE 1976-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SARCOSINE OXIDASE was indexed under OXIDOREDUCTASES, N-DEMETHYLATING 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SCAVENGER RECEPTORS, CLASS A was indexed under RECEPTORS, IMMUNOLOGIC 2005; SCAVENGER RECEPTORS, CLASS A, TYPE I-II was indexed under RECEPTORS, IMMUNOLOGIC 2005, %26% under ANTIGENS, CD36 2001-2005; MACROPHAGE TYPE-II CLASS-A SCAVENGER RECEPTOR %26% MACROPHAGE TYPE-I CLASS-A SCAVENGER RECEPTOR were indexed under RECEPTORS, IMMUNOLOGIC 1994-2005 %26% under RECEPTORS, ENDOGENOUS SUBSTANCES 1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SCAVENGER RECEPTORS, CLASS B was indexed under RECEPTORS, IMMUNOLOGIC 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SCAVENGER RECEPTORS, CLASS C was indexed under RECEPTORS, IMMUNOLOGIC 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SCAVENGER RECEPTORS, CLASS D was indexed under RECEPTORS, IMMUNOLOGIC 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SCAVENGER RECEPTORS, CLASS E was indexed under RECEPTORS, IMMUNOLOGIC 2005; SCAVENGER RECEPTORS, CLASS E, TYPE I %26% SR-EI PROTEINS were indexed under RECEPTORS, LDL 2005; LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 was indexed under RECEPTORS, LDL 2000-2005;%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SCAVENGER RECEPTORS, CLASS F was indexed under RECEPTORS, IMMUNOLOGIC 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SELENIUM-BINDING PROTEINS was indexed as CARRIER PROTEINS 1983-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SELENOPROTEIN P was indexed under PROTEINS 1989-2005, %26% under SELENIUM 1982-1992, %26% under CARRIER PROTEINS 1982-1988%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SELENOPROTEIN R was indexed under PROTEINS 2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SELENOPROTEIN W was indexed under PROTEINS 2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SELENOPROTEINS was indexed under PROTEINS 1989-2005, %26% under SELENIUM 1982-1992, %26% under CARRIER PROTEINS 1982-1988%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SERINE C-PALMITOYLTRANSFERASE was indexed under ACYLTRANSFERASES 1984-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SERINE O-ACETYLTRANSFERASE was indexed under ACETYLTRANSFERASES 1973-2005, under ACETYL COENZYME A 1973-1980, under SERINE 1970-1980, %26% under ACYLTRANSFERASES 1970-1973%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SEROTONIN TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005, MEMBRANE GLYCOPROTEINS, NERVE TISSUE PROTEINS %26% MEMBRANE TRANSPORT PROTEINS 1992-2005, CARRIER PROTEINS 1992-2004; SEROTONECTIN was indexed under CARRIER PROTEINS 1983-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SEX-DETERMINING REGION Y PROTEIN was indexed under DNA-BINDING PROTEINS %26% NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SHAB POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SHAKER POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SHAL POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004, %26% under INSECT HORMONES 1990-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SHAW POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, VOLTAGE-GATED 2005, %26% under POTASSIUM CHANNELS 1994-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SIALOMUCINS was indexed under MUCINS 1982-2005, under SIALIC ACIDS, %26% under MUCOPROTEINS 1976-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD PROTEINS was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD4 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1997-2005, %26% under PROTEINS 1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD5 PROTEIN was indexed under DNA-BINDING PROTEINS %26% PHOSPHOPROTEINS %26% TRANS-ACTIVATORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD6 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMAD7 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS was indexed under POTASSIUM CHANNELS, CALCIUM-ACTIVATED 2004, %26% under POTASSIUM CHANNELS 1996-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SNAP RECEPTOR %28%now SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1995-2003 and VESICULAR TRANSPORT PROTEINS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-GLUCOSE TRANSPORTER 1 was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, %26% under MONOSACCHARIDE TRANSPORT PROTEINS 1996-2005, %26% under MEMBRANE PROTEINS 1993-1996, %26% under CARRIER PROTEINS 1993-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-GLUTAMATE COTRANSPORTER was indexed under AMINO ACID TRANSPORT SYSTEM X-AG %26% SYMPORTERS 2003-2005, CARRIER PROTEINS 1984-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I was indexed under SYMPORTERS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIa was indexed under SYMPORTERS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIb was indexed under SYMPORTERS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIc was indexed under SYMPORTERS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SODIUM-PHOSPHATE COTRANSPROTER PROTEINS was indexed under SYMPORTERS 2002-2005 %26% under CARRIER PROTEINS 1987-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SP2 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SP3 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SP4 TRANSCRIPTION FACTOR was indexed under TRANSCRIPTION FACTORS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SPHINGOSINE N-ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SQUALENE MONOOXYGENASE was indexed under OXYGENASES 1981-2005 %26% ETHERS, CYCLIC 1970-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STAT1 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STAT2 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STAT3 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANSACTIVATORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STAT4 PROTEIN was indexed under DNA-BINDING PROTEINS %26% TRANS-ACTIVATORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STAT5 PROTEIN was indexed under DNA-BINDING PROTEINS; MILK PROTEINS; %26% TRANS-ACTIVATORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STAT6 PROTEIN was indexed under TRANS-ACTIVATORS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STATHMIN was indexed under MICROTUBULE PROTEINS %26% PHOSPHOPROTEINS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STEROL REGULATORY ELEMENT BINDING PROTEIN 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005, %26% under CCAAT-ENHANCER-BINDING PROTEINS 2001-2005, %26% under NUCLEAR PROTEINS 1999-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; STEROL REGULATORY ELEMENT BINDING PROTEIN 2 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE %28%NADP+%29% was indexed under ALDEHYDE OXIDOREDUCTASES 1974-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE was indexed under ALDEHYDE OXIDOREDUCTASES 1977-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SUCCINYLDIAMINOPIMELATE TRANSAMINASE was indexed under TRANSAMINASES 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SULFITE DEHYDROGENASE was indexed as CYTOCHROME REDUCTASES 1981-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25 was indexed under MEMBRANE PROTEINS and NERVE TISSUE PROTEINS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNAPTOTAGMIN I was indexed under CALCIUM-BINDING PROTEINS, MEMRANE GLYCOPROTEINS, %26% NERVE TISSUE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNAPTOTAGMIN II was indexed under NERVE TISSUE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNAPTOTAGMIN was indexed under CALCIUM-BINDING PROTEINS, MEMBRANE GLYCOPROTEINS %26% NERVE TISSUE PROTEINS 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNTAXIN %28%now QA-SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1995-2005 and PROTEINS 1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNTAXIN 1 was indexed under ANTIGENS, SURFACE and NERVE TISSUE PROTEINS 1993-2005, and MEMBRANE PROTEINS 1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNTAXIN 16 was indexed under MEMBRANE PROTEINS and VESICULAR TRANSPORT PROTEINS 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; SYNUCLEIN was indexed under NERVE TISSUE PROTEINS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; T CELL FACTOR 1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1995-2005, %26% under NUCLEAR PROTEINS 1991-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 1 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2003-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 10 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 2 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 3 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 4 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 5 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 6 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 7 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 8 was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR 9 was indexed under RECEPTORS, CELL SURFACE %26% DNA-BINDING PROTEINS 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TOLL-LIKE RECEPTOR was indexed under MEMBRANE GLYCOPROTEINS %26% RECEPTORS, CELL SURFACE 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANS-CINNAMATE 4-MONOOXYGENASE was indexed under CYTOCHROME P-450 ENZYME SYSTEM %26% MIXED FUNCTION OXYGENASES 1983-2005, %26% UNDER CINNAMATES 1974-1982%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR AP-2 was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR BRM-3A was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR BRN-3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR BRN-3B was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS %28%1992-2005%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR BRN-3C was indexed under TRANSCRIPTION FACTORS %26% DNA-BINDING PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR CHOP was indexed under TRANSCRIPTION FACTORS 1995-2005, under CCAAT-ENHANCER BINDING PROTEINS 2001-2005, under DNA-BINDING PROTEINS 1993-2000, %26% under PROTEINS 1992-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR DP1 was indexed under CELL CYCLE PROTEINS %26% TRANSCRIPTION FACTORS 1997-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR OCT-1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005, NUCLEAR PROTEINS 1986-1989, %26% NUCLEOPROTEINS 1986-1987%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR OCT-3 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR OCT-6 was indexed under TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR PIT-1 was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1989-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR POU was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1992-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR RELA was indexed under NF-KAPPA B 1993-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR RELB was indexed under PROTO-ONCOGENE PROTEINS %26% TRANSCRIPTION FACTORS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRANSCRIPTION FACTOR TFIIH was indexed under TRANSCRIPTION FACTORS, TFII 2003-2005, %26% under TRANSCRIPTION FACTORS 1992-2002%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRISTETRAPROLIN was indexed under DNA-BINDING PROTEINS 2001-2005, %26% under IMMEDIATE-EARLY PROTEINS 1991-2005, %26% under PROTEINS 1998-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TROPOMODULIN was indexed under MICROFILAMENT PROTEINS %26% CARRIER PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRP CHANNEL was indexed under CALCIUM CHANNELS 1995-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TRYPTOPHAN TRANSAMINASES was indexed under TRANSAMINASES 1975-2005, %26% under TRYPTOPHAN 1975-1980; TRYPTOPHAN AMINOTRANSFERASE was indexed under TRANSAMINASES 1976-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TWIST TRANSCRIPTION FACTOR was indexed under NUCLEAR PROTEINS %26% TRANSCRIPTION FACTORS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TYPE II NA-PI COTRANSPORTER PROTEIN was indexed under SYMPORTERS 2002-2005, %26% under CARRIER PROTEINS 1987-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; TYPE III NA-DEPENDENT PHOSPHATE COTRANSPORTER; PIT1 SODIUM-DEPENDENT PHOSPHATE SYMPORTER; NPT1 PROTEIN; AMPHOTERIC VIRUS RECEPTOR GLVR-2; AMPHOTROPIC MULV RECEPTOR; AMPHOTROPIC MURINE LEUKEMIA VIRUS RECEPTOR; GLVR-2 RECEPTOR; %26% RAM-1 RECEPTOR were indexed under SYMPORTERS 2001-2005 %26% under CARRIER PROTEINS 1987-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; UPSTREAM STIMULATORY FACTORS was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; URACIL-DNA GLYCOSIDASE was indexd under DNA Glycosylases 1981-2005, under DEOXYURACIL NUCLEOTIDES 1978-1980, %26% under DNA 1976-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VALINE DEHYDROGENASE %28%NADP+%29% was indexed under AMINO ACID OXIDOREDUCTASES 1989-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VASOACTIVE INTESTINAL PEPTIDE 1 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VASOACTIVE INTESTINAL PEPTIDE 2 RECEPTOR was indexed under RECEPTORS, CELL SURFACE 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN %28%now R-SNARE PROTEINS%29% was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN 1 was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICLE-ASSOCIATED MEMBRANE PROTEIN 2 was indexed under MEMBRANE PROTEINS 1996-2005 and NERVE TISSUE PROTEINS 1988-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICULAR ACETYLCHOLINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE GLYCOPROTEINS 1997-2005, under NEUROPEPTIDES 1997-2005, %26% under GLYCOPROTEINS 1992-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICULAR AMINE TRANSPORTER was indexed under MEMBRANE TRANSPORT PROTEINS 2005; MEMBRANE GLYCORPOTEINS %26% NEUROPEPTIDES 1997-2005, %26% under GLYCOPROTEINS 1992-1996%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICULAR GLUTAMATE TRANSPORTER 1 was indexed under MEMBRANE TRANSPORT PROTEINS 2005, under VESICULAR TRANSPORT PROTEINS 2004-2005, %26% under CARRIER PROTEINS 2001-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VESICULAR GLUTAMATE TRANSPORTER 2 was indexed under MEMBRANE TRANSPORT PROTEINS 2005, under VESICULAR TRANSPORT PROTEINS 2004-2005, under CARRIER PROTEINS 2001-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VOLTAGE-DEPENDENT ANION CHANNEL 1 was indexed under MEMBRANE PROTEIN 1985-1999, %26% under PORINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VOLTAGE-DEPENDENT ANION CHANNEL 2 was indexed under MEMBRANE PROTEINS 1985-1999, %26% under PORINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VOLTAGE-DEPENDENT ANION CHANNELS was indexed under MEMBRANE PROTEINS 1985-1999, %26% under PORINS 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN was indexed under TUMOR SUPPRESSOR PROTEINS 2002-2005, under UBIQUITIN-PROTEIN LIGASES 2004-2005, under LIGASES 2002-3003, under PROTEINS 1995-2001, %26% under NUCLEAR PROTEINS 1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; WAVE PROTEINS was indexed under MICROFILAMENT PROTEINS 1999-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; WISKOTT-ALDRICH SYNDROME PROTEIN was indexed under PROTEINS 1994-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; WNT PROTEINS was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005, %26% under PROTO-ONCOGENE PROTEINS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; WNT1 PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005; %26% under PROTO-ONCOGENE PROTEINS 1987-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; WNT2 PROTEIN was indexed under INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS 2005 %26% under PROTO-ONCOGENE PROTEINS 2004-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN was indexed under PROTEINS 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; XERODERMA PIGMENTOSUM GROUP A PROTEIN was indexed under DNA-BINDING PROTEINS 1990-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; XERODERMA PIGMENTOSUM GROUP D PROTEIN was indexed under DNA HELICASES %26% DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1993-2005, %26% under PROTEINS 1992%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; Y-BOX-BINDING PROTEIN 1 was indexed under TRANSCRIPTION FACTORS 1984-2005, under CCAAT-ENHANCER-BINDING PROTEINS 2005, %26% under DNA-BINDING PROTEINS 1986-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; YY1 TRANSCRIPTION FACTOR was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; ZAP-70 KINASE was indexed under PROTEIN-TYROSINE KINASE 1992-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for ACOMYS, APODEMUS, BANDICOTA, MASTOMYS, PRAOMYS, and RATS, BANDICOTT see MURIDAE 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for ACOMYS, APODEMUS, BANDICOTA, MASTOMYS, PRAOMYS, and RATS, BANDICOTT use MURIDAE 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for CANCER GENES see ONCOGENES 1985-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for CANCER GENES use ONCOGENES 1985-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for COMPLEMENT 3 CONVERTASE see COMPLEMENT 3 CONVERTASE 1991-2005, see COMPLEMENT ACTIVATING ENZYMES 1978-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for CRICETUS see HAMSTERS 1966-1981 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for CUTTLEFISH see MOLLUSCA 1995-2005; for SQUID see SQUID 1973-2005;%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for CUTTLEFISH use MOLLUSCA 1995-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for GLUCOSE TRANSPORT PROTEINS, FACILITATIVE see MONOSACCHARIDE TRANSPORT PROTEINS 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for INFLUENZA VIRUS, EQUINE see INFLUENZA A VIRUS 1980-2005, see INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for INFLUENZA VIRUS, EQUINE use INFLUENZA A VIRUS 1980-2005, use INFECTIOUS ARTERITIS VIRUS OF HORSES 1975-1979%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for MITOCHONDRIAL INHERITANCE see EXTRACHROMOSOMAL INHERITANCE 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for MITOCHONDRIAL INHERITANCE use EXTRACHROMOSOMAL INHERITANCE 2001-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for MONKEYS, NEW WORLD see CEBIDAE 1981-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for MONKEYS, NEW WORLD use CEBIDAE 1981-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for MUSSELS see MUSSELS 1972-2005; for CLAMS see CLAMS 1972-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for OCTOPODA see OCTOPUS 1973-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for P21%28%RAS%29% see ONCOGENE PROTEIN P21%28%RAS%29% 1990 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for SULFITE REDUCTASES see SULFITE REDUCTASES 1980-2005; for SULFITE OXIDASES see SULFITE OXIDASES 1980-2005; for SULFITE DEHYDROGENASES see SULFITE OXIDASES 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for SULPHITE OXIDASE see SULFITE OXIDASES 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for TENDINITIS see TENDINITIS 1965-2005, see TENDONITIS 1963-1964%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; for THIAZIDE DIURETICS use THIAZIDE DIURETICS 1976-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ACHROMOBACTER XYLOSOXIDANS 2004-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see AMELOBLASTOMA 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see AMINE OXIDOREDUCTASES 1975-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see AMMONIUM COMPOUNDS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ANTINEOPLASTIC AGENTS 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ARTERIOSCLEROSIS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ARTERIOSCLEROSIS 2001-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ARTIFICIAL INTELLIGENCE %28%1987-2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ATTACHMENT SITES %28%MICROBIOLOGY%29% 1991-2006, see LYSOGENY 1980-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see AUTOPHAGOCYTOSIS 1991-2005, PHAGOCYTOSIS 1979-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see BARLEY 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see BONES OF UPPER EXTREMITY 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see BULIMIA 1987-2005, use HYPERPHAGIA 1981-1986 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CALLITRICHINAE 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CALLITRICHINAE 1992-2005, see CALLITHRICIDAE 1981-1991, see MARMOSETS 1975-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CARTILAGE 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CDK9 PROTEIN KINASE 2004-2005, CDK9 KINASE %28%now CYCLIN-DEPENDENT KINASE 9%29% was indexed under CYCLIN-DEPENDENT KINASES 2000-2003, under PROTEIN KINASES 1994-1999%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CERVICITIS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CERVIX DISEASES 1966-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CERVIX DYSPLASIA 1984-2005, see CERVIX NEOPLASMS 1977-1983%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CERVIX EROSION 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CERVIX INCOMPETENCE 1973-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CERVIX NEOPLASMS %28%1963-2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMMON MIGRAINE 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 1 1978-2005, see COMPLEMENT 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 1 INACTIVATORS 1978-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 1Q 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 1R 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 1S 1990-2005; for COMPLEMENT 1 ESTERASE see COMPLEMENT ACTIVATING ENZYMES 1978-1989%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 2 1978-2005, see COMPLEMENT 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C3 PRECURSOR was indexed under COMPLEMENT 3 1982-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3 NEPHRITIC FACTOR 1991-2005, see COMPLEMENT INACTIVATORS 1978-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3A 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3B 1978-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3B INACTIVATORS 1978-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3C 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 3D 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 4 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C4, PRECURSOR was indexed under COMPLEMENT 4 1980-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 4A 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 4B 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 5 1978-2005, see COMPLEMENT 1975-1977; COMPLEMENT C5, PRECURSOR was indexed under COMPLEMENT 5 1991-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 5A 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 5A, DES-ARGININE 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 6 1978-2005, see COMPLEMENT 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 7 1978-2005, see COMPLEMENT 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 8 1978-2005; see COMPLEMENT 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT 9 1978-2005, see COMPLEMENT 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see COMPLEMENT INACTIVATORS 1978-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CRETINISM 1966-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see CYCLOOXYGENASE INHIBITORS 2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see Charadriformes 2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DECUBITUS ULCER 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DENYS-DRASH SYNDROME 2002-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DERMATOFIBROMA 1994-2005, see HISTIOCYTOMA 1968-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DESCEMENT%27%S MEMBRANE 1964-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DOLPHINS 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DOSAGE COMPENSATION %28%GENETICS%29% 1982-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see DWARFISM 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ENDOCRINE CELLS OF GUT 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see EXONS 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see FETAL ANOXIA 1975-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see FLAVIN MONONUCLEOTIDE REDUCTASE 2003-2005; FLAVIN MONONUCLEOTIDE REDUCTASE%28%now FMN REDUCTASE%29% was indexed under NADH, NADPH OXIDOREDUCTASES 1981-2002 %26% under FMN 1975-1980%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see FREEMARTINISM 1975-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see G CELLS 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GENE FUSION 1998-2005; see CLONING, MOLECULAR 1988-1997%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GENES, IMMUNOGLOBULIN 1987-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GENES, IMMUNOGLOBULIN 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GENES, REGULATOR 1991-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GENES, STRUCTURAL 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GLYCERIDES %28%1963-2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GRAVES%27% DISEASE 1987-2005, see GOITER, EXOPHTHALMIC 1963-1986%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see GRAVES%27% DISEASE 1997-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HAY FEVER 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HEADACHE 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HEADACHE DISORDERS 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HEAT SHOCK PROTEINS 70 1995-2005, see HEAT-SHOCK PROTEINS 1990-1994; MITOCHONDRIAL HEAT SHOCK PROTEIN 70 was indexed under HEAT SHOCK PROTEINS 70 1996-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HEAT-SHOCK PROTEINS 90 1995-2005, see HEAT-SHOCK PROTEINS 1990-1994%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HERPES GESTATIONIS 1991-2005, see SKIN DISEASES, VESICULOBULLOUS 1976-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HESPEROMYINAE 1991-2005; for NEOTOMA, SIGMODON, and RATS, COTTON see CRICETIDAE 1982-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HISTIOCYTOMA, FIBROUS 1994-2005; for DERMATOFIBROMA see DERMATOFIBROMA 1994-2005, see ANGIOMA SCLEROSING 1963-1993%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HISTIOCYTOSIS, NON-LANGERHANS CELL 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HYPERLIPIDEMIA 1995-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HYPOGONADISM 1984-2005; see INFANTILISM 1963-1983%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see HYPOTHERMIA, INDUCED 1984-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULIN CONSTANT REGION 1988-2005, see IMMUNOGLOBULINS 1979-1987; for CONSTANT REGION IG see IMMUNOGLOBULIN CONSTANT REGION 1979-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULIN INV ALLOTYPES 1987-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, ALPHA-CHAIN 1992-2005, see IMMUNOGLOBULINS, ALPHA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, DELTA-CHAIN 1992-2005, see IMMUNOGLOBULINS, DELTA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, EPSILON-CHAIN 1992-2005, see IMMUNOGLOBULINS, EPSILON CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, FC 1987-2005, see IMMUNOGLOBULIN FRAGMENTS 1984-1986, see IMMUNOGLOBULINS, FC 1973-1983%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, GAMMA-CHAIN 1992-2005, see IMMUNOGLOBULINS, GAMMA CHAIN 1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, HEAVY-CHAIN 1992-2005, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1991, see IMMUNOGLOBULIN FRAGMENTS 1973-1975%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, J-CHAIN 1992-2005, see IMMUNOGLOBULINS, J CHAIN 1974-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, KAPPA-CHAIN 1992-2005, see IMMUNOGLOBULINS, KAPPA CHAIN 1986-1991, see IMMUNOGLOBULINS, LIGHT CHAIN 1975-1985, see IMMUNOGLOBULIN FRAGMENTS 1973-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, LAMBDA-CHAIN 1992-2005, see IMMUNOGLOBULINS, LAMBDA CHAIN 1986-1991, see IMMUNOGLOBULINS, LIGHT CHAIN 1975-1985, see IMMUNOGLOBULIN FRAGMENTS 1973-1974%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, LIGHT-CHAIN 1992-2005, see IMMUNOGLOBULINS, LIGHT CHAIN 1976-1991%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see IMMUNOGLOBULINS, MU-CHAIN 1992-2005, see IMMUNOGLOBULINS, MU CHAIN 1987-1991, see IMMUNOGLOBULINS, HEAVY CHAIN 1976-1986%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see INFLUENZA 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see INFLUENZA, AVIAN 2005, see FOWL PLAGUE 1970-2004, see MYXOVIRUS INFECTIONS 1963-1969%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ISLETS OF LANGERHANS 1980-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see JAUNDICE, NEONATAL 1976-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see KIDNEY FAILURE 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see KIDNEY FAILURE, ACUTE 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see KIDNEY FAILURE, CHRONIC 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see KIDNEY, SPONGE 1965-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see KINETINS 1991-2005, see PLANT GROWTH REGULATORS 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see KRAUROSIS VULVAE 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see LABOR COMPLICATIONS 1964-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see LABOR COOMPLICATIONS 1992-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see LABOR, PREMATURE 1964-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see LABYRINTH 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see LUMINESCENCE, PHYSICAL 2005-2006; for CHEMILUMENCENCE see CHEMILUMINESCENCE, PHYSICAL 2005-2006%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see LYMPHANGIOMYOMATOSIS 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MECONIUM ASPIRATION 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MEIGS%27% SYNDROME 1964-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MENOTROPINS 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see METHONIUM COMPOUNDS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MICROSPORA 1992-2005, see MICROSPORIDA 1991-2000%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MICROTINAE 1991-2005, see CRICETIDAE 1982-1990; for VOLES %26% MICROTUS see RODENTS 1975-1981%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MIGRAINE 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MONOSACCHARIDE TRANSPORT PROTEINS 1986-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MSH 1968-2005, INTERMEDIN 1963-67 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see MUSSELS 1979-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see NEPHROBLASTOMA 1994-2005, WILMS%27% TUMOR 1991-1993, see NEPHROBLASTOMA 1963-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see NERVE SHEATH TUMORS 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see NITRIC-OXIDE SYNTHASE 1996-2005, NITRIC OXIDE SYNTHASE was indexed under AMINO ACID OXIDOREDUCTASES 1990-1995%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ONCOGENE PROTEINS, FUSION 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see OPSONINS 1965-2004 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see ORNITHOSIS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see OXIDOREDUCTASES 1975-1990; FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE was indexed under OXIDOREDUCTASES %26% SQUALENE SYNTHETASE 1998-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see OYSTERS 1972-2006 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PENTOSEPHOSPHATE PATHWAY 1985-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PERFUSION, REGIONAL 1978-2005, see ISOLATION PERFUSION 1964-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PHYSICAL THERAPY TECHNIQUES 2002-2005, see PHYSICAL THERAPY 1963-2001%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PIGMENTS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PLACENTA PRAEVIA 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see POIKILODERMA CONGENITALE 1991-2005, see SKIN DISEASES 1964-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PORPOISES 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see POTATOES 1986-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see POWER SOURCES 1977-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PREGNANCY OUTCOME 2004-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PREGNANCY OUTCOME 2004-2005, see FETAL DEATH 1963-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1978-2005, see PROSTAGLANDIN SYNTHASE 1978-1991, see under HYDROXYLASES 1975-1977%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PROTIRELIN 1992-2006, was THYROTROPIN-RELEASING HORMONE 1991; was THYROTROPIN RELEASING HORMONE 1974-90; was THYROTROPIN RELEASING FACTOR 1968-73%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29% 1991-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see RALSTONIA 2002-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see RALSTONIA EUTROPHA 1999-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see SEMILUNAR BONE 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see SEX DISORDERS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see SIV 1989-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see SPHAERIALES 1991-2005, see ASCOMYCETES 1975-1990%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see TENSION HEADACHE 1995-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see THYROIDITIS, AUTOIMMUNE 1975-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see TOOTH MOVEMENT 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see TOXINS 1966-2005, see TOXINS AND ANTITOXINS 1963-1965%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see TRANSCRIPTION FACTOR, SP1 1991-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see TRANSFUSION-ASSOCIATED VIRUS 2001-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see TRYPTOPHAN OXYGENASE 1990-2005; INDOLAMINE-2,3-DIOXYGENASE was indexed under DIOXYGENASES 2005 and OXYGENASES 1990-2004%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see VASCULAR HEADACHES 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see WHALES 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; see WHALES 1998-2005; for Blue Whale, Bryde%27%s Whale, and Sei Whale see WHALES 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use AMELOBLASTOMA 1994-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use ANTINEOPLASTIC AGENTS 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use ARTERIOSCLEROSIS 1963-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use ARTERIOSCLEROSIS 2001-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use ARTIFICIAL INTELLIGENCE %28%1987-2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use BIVALVIA 1979-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use BONES OF UPPER EXTREMITY 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use BULIMIA 1987-2005, use HYPERPHAGIA 1981-1986 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use CALLITRICHIDAE 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use CARTILAGE 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use CLASSIC MIGRAINE 2000-2005; for COMPLICATED MIGRAINE see MIGRAINE 2000-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use DENYS-DRASH SYNDROME 2002-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use DOLPHINS 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use DOSAGE COMPENSATION, GENETIC 1982-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use DWARFISM 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use FREEMARTINISM 1975-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use GENES, IMMUNOGLOBULIN 1987-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use GENES, IMMUNOGLOBULIN 1988-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use GENES, REGULATOR 1991-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use GLYCERIDES %28%1963-2005%29% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use GRAVES DISEASE 1997-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use HEADACHE 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use HEADACHE DISORDERS 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use HISTIOCYTOSIS, NON-LANGERHANS CELL 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use HYPERLIPIDEMIA 1995-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use HYPOGONADISM 1984-2005; use INFANTILISM 1963-1983%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use HYPOTHERMIA, INDUCED 1984-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use ISLETS OF LANGERHANS 1980-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use JAUNDICE, NEONATAL 1976-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use KIDNEY FAILURE 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use KIDNEY FAILURE, ACUTE 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use KIDNEY FAILURE, CHRONIC 1993-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use LABOR COOMPLICATIONS 1992-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use MENOTROPINS 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use ONCOGENE PROTEINS, FUSION 1990-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use PORPOISES 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use PREGNANCY OUTCOME 2004-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use PREGNANCY OUTCOME 2004-2005, use FETAL DEATH 1963-2003%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use RALSTONIA 2002-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use THYROIDITIS, AUTOIMMUNE 1975-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use TOOTH MOVEMENT 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use VASCULAR HEADACHES 2000-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use WHALES 1998-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; use WHALES 1998-2005; for Blue Whale, Bryde%27%s Whale, and Sei Whale use WHALES 1998-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; was IMMUNOGLOBULINS, FAB 1973-2005 ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006; was indexed under COMPLEMENT 3B 1989-2005; for CVFBB see COMPLEMENT FACTOR B 1985-2005%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006A' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006B' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006C' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006D' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006E' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006F' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006G' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2006H' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20S Proteasome' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20alpha Hydroxypregn 4 Ene 3 One' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20alpha-Hydroxypregn-4-Ene-3-One' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20th Cent. Histories %28%Medicine%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20th Cent. History %28%Medicine%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20th Cent. History of Medicine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20th Cent. Medicine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20th Century Histories' = 0).
% 42.05/41.93 fof(interp, fi_functors, '20th Century History' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21 Hydroxy 4 pregnene 3,20 dione' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21 Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21 Hydroxyprogesterone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21-Hydroxy-4-pregnene-3,20-dione' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21-Hydroxypregn-4-ene-3,20-dione. Mineralocorticoid. Desoxycorticosterone acetate %28%DOCA%29% is used as replacement therapy in Addison%27%s Disease.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21-Hydroxyprogesterone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Cent. Histories %28%Medicine%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Cent. History %28%Medicine%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Cent. History of Medicine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Cent. Medicine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Cent. Medicines' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Century Histories' = 0).
% 42.05/41.93 fof(interp, fi_functors, '21st Century History' = 0).
% 42.05/41.93 fof(interp, fi_functors, '23-C-EBP Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '23S Ribosomal RNA' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24 Dehydrocholesterol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24,25 Dihydroxycholecalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24,25 Dihydroxyvitamin D 3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24,25 Dihydroxyvitamin D3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24,25-Dihydroxycholecalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24,25-Dihydroxyvitamin D 3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24,25-Dihydroxyvitamin D3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24-Dehydrocholesterol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '245382, NSC' = 0).
% 42.05/41.93 fof(interp, fi_functors, '24R,25-Dihydroxycholecalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 HCC Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxycalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxycholecalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxycholecalciferol 1 Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxycholecalciferol Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyergocalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyergocalciferol 1 alpha Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D 1 alpha Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D 2' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D 3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D2' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D2 1 hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25 Hydroxyvitamin D3 1 alpha Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-75 Percent, FEF' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-75 Percents, FEF' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-HCC-Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxycalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxycholecalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxycholecalciferol 1-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxycholecalciferol-1-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxycholecalciferol-Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyergocalciferol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyergocalciferol 1-alpha-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D 1-alpha-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D 2' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D 3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D%28%3%29% 1 alpha-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D-Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D2' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D2 1-hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D3' = 0).
% 42.05/41.93 fof(interp, fi_functors, '25-Hydroxyvitamin D3 1-alpha-Hydroxylase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2502, Bayer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '27E10 Antigen' = 0).
% 42.05/41.93 fof(interp, fi_functors, '28 kDa Protein, Adipocyte' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2821, Bay G' = 0).
% 42.05/41.93 fof(interp, fi_functors, '28S Ribosomal RNA' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2A Receptor, Serotonin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2A Receptors, Serotonin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2B Receptor, 5-Hydroxytryptamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2B Receptor, Serotonin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2B Receptors, Serotonin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2B, Protein Phosphatase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2C Receptor, Serotonin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2D Gel Electrophoresis' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2D Immunoelectrophoresis' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2D PAGE' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2H-1-Benzopyran-3,5,7-triol, 2-%28%3,4-dihydroxyphenyl%29%-3,4-dihydro-, %28%2R-cis%29%-' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2H-Benzo%28%a%29%quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2H4 Antigens' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2alpha%27%, Casein Kinase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2d cranial nerve; neopl = OPTIC NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%; atrophy = OPTIC ATROPHY; neuritis = OPTIC NEURITIS; optic nerve head = OPTIC DISK%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2d planet from sun with no moons; no qualif ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2nd World War' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2nd World Wars' = 0).
% 42.05/41.93 fof(interp, fi_functors, '2s, Neurofibromatosis Type' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Aminopropionic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Aminopropylene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Benzylchroman 4 Ones' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Benzylidene 4 Chromanones' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Beta Hydroxysteroid Sulfate Sulfatase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Beta-Hydroxysteroid Sulfate Sulfatase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Caffeoylquinic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Chloro 1,2 propanediol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Chloromercuri 2 methoxypropylurea' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Chloropropanediol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 D Echocardiography' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 D Homologs, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 D Homology, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 D Image' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 D Imaging' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Deazauridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Deoxyarabinoheptulosonate 7 Phosphate Synthetase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Dimensional Homologs, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Dimensional Homology, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Enol Pyruvoylshikimate 5 Phosphate Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Enolpyruvylshikimate 5 Phosphate Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Fucosyl N acetyl lactosamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Fucosyllactosamine Determinant' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 HAA Oxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy 3 methylglutaric Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy 3 methylglutaryl CoA Reductase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy 3 methylglutaryl coenzyme A reductase, NADP dependent' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy 3 methylpentanedioic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy DL tyrosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy L tyrosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxy N methylmorphinan' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxyacyl CoA Dehydrogenases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxyacyl CoA Hydrolyases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxyacyl Dehydratases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxyanthranilate 3,4 Dioxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxyanthranilic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxyanthranilic Acid Oxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxybutyrate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxybutyrate Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxybutyric Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxydiazepam' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxymethylpyridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxypregnan 20 one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Iodobenzylguanidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Iodobenzylguanidine, 123I Labeled' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Iodobenzylguanidine, 125I Labeled' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Isobutyl 1 methylxanthine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Isoleucyl Vasopressin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Isopropylmalate Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Keto 5 alpha Steroid delta 4 Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Keto ACP Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Keto Erythromycins' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Ketosteroid Isomerases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Mercaptopropanoic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Mercaptopropionic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Methoxy 4 Hydroxyphenylacetic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Methoxy 4 hydroxyphenylethanol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Methoxynoradrenaline' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Methylcholanthrene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Methylindole' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Nitro 10' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Nitro 4 Hydroxyphenylarsonic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 O Methyl D Glucose' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 O Methylglucose' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Oxoacyl %28%Acyl Carrier Protein%29% Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Oxoacyl Synthetase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Oxosteroid Isomerases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Phosphoglyceraldehyde' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Phosphoglycerate Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Phosphoglycerate NAD+ 2 Oxidoreductase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Phosphoshikimate 1 Carboxyvinyltransferase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Pyridinecarboxamide' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Pyridinecarboxylic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Selenylalanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Sulfoalanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 Sulfocatechol 2,3 Dioxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha Hydroxy 5 alpha Androstan 17 One' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha Hydroxy 5 alpha pregnan 20 one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha Hydroxy 5 beta Androstan 17 One' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha Hydroxy 5 beta pregnan 20 one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha Hydroxysteroid Oxidoreductase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha, 5 beta Tetrahydroprogesterone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha, 5 beta-Tetrahydroprogesterone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha,7 beta Dihydroxy 5 beta cholan 24 oic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha-Hydroxy-5 alpha-pregnan-20-one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha-Hydroxy-5 beta-pregnan-20-one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha-Hydroxysteroid Dehydrogenase %28%B-Specific%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 alpha-Hydroxysteroid Oxidoreductase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 beta Hydroxy delta 5 Steroid Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 beta Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 beta,12 beta,14-Trihydroxy-5 beta-card-20%28%22%29%-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 beta,14-Dihydroxy-5 beta-card-20%28%22%29%enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20%28%22%29%-enolide. The aglycone cardioactive agent isolated from Strophanthus Kombe, S. gratus and other species; it is a very toxic material formerly used as digitalis. Synonyms: Apocymarin; Corchorin; Cynotoxin; Corchorgenin.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 beta-Hydroxy-delta-5-Steroid Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3 hydroxy 4 keto Flavonoids' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% 5%27% Exonuclease' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% 5%27% Exonucleases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Amino 3%27% deoxy N,N dimethyladenosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Azido 2%27%,3%27% Dideoxythymidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Azido 3%27% deoxythymidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% CMP' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% End Processing, RNA' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Flanking Region' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Flanking Regions' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Flanking Sequence' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Flanking Sequences' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Methyl 4 dimethylaminoazobenzene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Polyadenylation Signal' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Polyadenylation Signals' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Splice Site' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Splice Sites' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% UTR' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% UTRs' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Untranslated Region' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% Untranslated Regions' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27% orf Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,4%27% Dideoxykanamycin B' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,4%27%,5,7-Tetrahydroxy-Flavone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,4%27%,5,7-Tetrahydroxyflavone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,4%27%-Dideoxykanamycin B' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27% Cyclic AMP 5%27% Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27% Cyclic AMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27% Cyclic GMP 5%27% Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27% Cyclic GMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27% Cyclic Nucleotide Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27% Nucleotide Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic AMP 5%27%-Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic AMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic GMP 5%27%-Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic GMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic Nucleotide Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic-AMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic-GMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Cyclic-Nucleotide Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Monophosphate, Adenosine Cyclic' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Monophosphate, Guanosine Cyclic' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%,5%27%-Nucleotide Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-5%27%-Exonuclease' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Amino-3%27%-deoxy-N,N-dimethyladenosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Azido-2%27%,3%27%-Dideoxythymidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Azido-3%27%-deoxythymidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Diphosphate 5%27%-Diphosphate, Guanosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Diphosphate 5%27%-Triphosphate, Guanosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Diphosphate, Guanosine 5%27%-Diphosphate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Methyl-4-dimethylaminoazobenzene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Phosphoadenosine-5%27%-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%-Phosphotransferase, Amikacin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%UTR' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3%27%UTRs' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3, IGF-Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3, Synaptobrevin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,20 Allopregnanedione' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,20-Allopregnanedione' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,20-Allopregnanedione, %28%5alpha%29%-Isomer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3 Diaminobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3 Dichlorobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27% Diaminobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27% Dichlorobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27% Diethylthiadicarbocyanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27% Dimethoxybenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%,4%27%,5,7-Flavanpentol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%,5%27%-Triiodothyronine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%-Diaminobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%-Dichloro-4,4%27%-Diaminodiphenylmethane' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%-Dichlorobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%-Diethylthiadicarbocyanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3%27%-Dimethoxybenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3,5 Triiodothyronine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3,5-Triiodothyronine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3-Diaminobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,3-Dichlorobenzidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Benzopyrene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Benzpyrene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Dihydroxynorephedrine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Dihydroxyphenethylamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Dihydroxyphenylacetic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Dihydroxyphenylalanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Dihydroxyphenylserine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 Methylenedioxyamphetamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4 threo DOPS' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4,5-Trihydroxybenzoic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4,5-Trimethoxyphenethylamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Benzopyrene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Benzpyrene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%-cyclohexyl%29%-benzeneacetamide, %28%trans%29%-Isomer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%cyclohexyl%29%-benzeneacetamide Mesylate, %28%trans%29%-%28%+%29%-Isomer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%cyclohexyl%29%-benzeneacetamide Mesylate, %28%trans%29%-%28%+-%29%-Isomer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydro-2,5,7,8-tetramethyl-2-%28%4,8,12-trimethyltridecyl%29%-2H-1-benzopyran-6-ol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydro-2,5,8-trimethyl-2-%28%4,8,12- trimethyltridecyl%29%-2H-1-benzopyran-6-ol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydro-2,7,8-trimethyl-2-%28%4,8,12- trimethyltridecyl%29%-2H-1-benzopyran-6-ol.' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydroxynorephedrine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydroxyphenethylamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydroxyphenylacetic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dihydroxyphenylalanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Dioxygenase, 3-Hydroxyanthranilate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Methylenedioxyamphetamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-Methylenedioxyamphetamine/analogs %26% derivatives %28%1984-1994%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,4-threo-DOPS' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5 Cyclic AMP 5 Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5 Cyclic AMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5 Cyclic GMP 5 Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5 Cyclic GMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5,3%27%,5%27%-Tetraiodothyronine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Cyclic AMP 5-Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Cyclic AMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Cyclic GMP 5-Nucleotidohydrolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Cyclic GMP Phosphodiesterase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Dicarbethoxy-1,4-Dihydrocollidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Dichloro-2,6-dimethyl-4-pyridinol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,5-Diethoxycarbonyl-1,4-Dihydro-2,4,6-Trimethylpyridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,6-Bis%28%dimethylamino%29%acridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,6-Diamino-10-methylacridinium chloride mixt. with 3,6-acridinediamine. Fluorescent dye used as a local antiseptic and also as a biological stain. It intercalates into nucleic acids thereby inhibiting bacterial and viral replication.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao %28%the cacao bean%29% and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9%29%%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3,7-dimethyl-9-%28%2,6,6-trimethyl-1-cyclohexen-1-yl%29%-2,4,6,8-nonatetraen-1-ol, %28%all-E%29%-Isomer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%%28%4-Amino-2-methyl-5-pyrimidinyl%29%methyl%29%-4-methyl-5-%28%4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl%29%thiazolium hydroxide, inner salt, P,P%27%,P%27%%27%-trioxide. The triphosphate ester of thiamine. In Leigh%27%s disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%%28%4-Amino-2-methyl-5-pyrimidinyl%29%methyl%29%-5-%28%2- hydroxyethyl%29%-4-methylthiazolium chloride.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%2-%28%4-%28%4-Fluorobenzoyl%29%piperidinol%29%ethyl%29%-2,4%28%1H,3H%29%-quinazolinedione' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%2-%28%Dimethylamino%29%ethyl%29%-N-methyl-1H-indole-5-methanesulfonamide' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%2-Aminoethyl%29%-1H-indol-5-ol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%2-Aminoethyl%29%-1H-indole-5,7-diol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%2-Aminoethyl%29%indole-5,6-diol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%3,4-Dichlorophenyl%29%-1,1-dimethylurea' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%3-Dimethylaminopropyl%29%-1-Ethylcarbodiimide' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%Carboxymethylthio%29%alanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-%28%p-Fluorophenyl%29%-alanine. ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Amino-1,1,3-propanetricarboxylic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Amino-1,2,4-triazole' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Aminopropanenitrile. Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Aminopropionic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Aminopropylene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Benzylchroman-4-Ones' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Benzylidene-4-Chromanones' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Caffeoylquinic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5%27%phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Chloro-1,2-propanediol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Chloro-4-%28%3-chloro-2-nitrophenyl%29%pyrrole. Antifungal antibiotic isolated from Pseudomonas pyrrocinia. It is effective mainly against Trichophyton, Microsporium, Epidermophyton, and Penicillium.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Chloromercuri-2-methoxypropylurea' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Chloropropanediol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Echocardiographies' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Echocardiography' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Homolog, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Homologies, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Homologs, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Homology, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Images' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Imaging' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-D Imagings' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Deazauridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Deoxyarabinoheptulosonate-7-Phosphate Synthetase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Dimensional Homolog, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Dimensional Homologies, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Dimensional Homology, Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Enol-Pyruvoylshikimate-5-Phosphate Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Enolpyruvylshikimate 5-Phosphate Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Ethyl-2-%28%5-%28%3-ethyl-2-benzothiazolinylidene%29%-1,3- pentadienyl%29%benzothiazolium. A benzothiazole that was formerly used as an antinematodal agent and is currently used as a fluorescent dye.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-HAA Oxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-3-methylglutaric Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-3-methylglutaryl CoA Reductase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-3-methylglutaryl CoA-Reductase, NAD-Dependent' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-3-methylglutaryl-coenzyme A reductase, NADP-dependent' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-3-methylpentanedioic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-4-oxo-1%28%4H%29%-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-DL-tyrosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxy-L-tyrosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxyacyl CoA Dehydrogenases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxyacyl CoA Hydrolyases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxyacyl Dehydratases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxyanthranilate 3,4-Dioxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxyanthranilic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxyanthranilic Acid Oxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxybutyrate Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxybutyric Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxydiazepam' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxykinase, Phosphoinositide' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxylase, Kynurenine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxymethylpyridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxypregnan-20-one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxysteroid Dehydrogenases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Hydroxysteroid Dehydrogenases %28%1979-2003%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Iodobenzylguanidine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Isobutyl-1-methylxanthine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Isoleucyl Vasopressin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Isopropylmalate Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Keto Erythromycins' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Keto-5-alpha-Steroid delta-4-Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Keto-ACP Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Keto-Erythromycins' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Ketoacyl CoA Thiolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Ketosteroid Isomerases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Ketothiolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Kinase, 1-Phosphatidylinositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Kinase, PI' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Kinase, Phosphatidylinositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Kinase, PtdIns' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Kinase, Vps34 Phosphatidylinositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson%27%s disease.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Mercaptopropanoic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Mercaptopropionic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Methoxy-4-Hydroxyphenylacetic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Methoxy-4-hydroxyphenylethanol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Methoxynoradrenaline' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Methyl-2-Oxobutanoate Dehydrogenase %28%Lipoamide%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Methylcholanthrene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Methylindole' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Monooxygenase, Kynurenine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Monooxygenase, Tyrosine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Nitro-4-Hydroxyphenylarsonic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-O-Methyl-D-Glucose' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-O-Methylglucose' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-O-hemisuccinate, Glycyrrhetinic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Oxoacyl %28%Acyl Carrier Protein%29% Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Oxoacyl CoA Thiolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Oxoacyl Synthetase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Oxoacyl-%28%Acyl-Carrier-Protein%29% Synthase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Oxoacyl-Coenzyme A Thiolase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Oxosteroid Isomerases' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phenoxybenzyl-%28%+-%29%-cis,trans-2,2-dichlorovinyl-2,2-dimethyl-cyclopropylcarboxylic acid, ester' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phenoxybenzyl-cis,trans-%28%1RS%29%-3-%28%2,2-dichlorovinyl%29%-2,2-dimethylcyclopropanecarboxylate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphate Acyltransferase, 1-Palmitylglycerol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphate, Dihydroxyacetone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphatidyltransferase, CDP-1,2-Diacyl-sn-Glycerol-Myoinositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphatidyltransferase, CDP-Diacylglycerol-Inositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphatidyltransferase, CDP-Diacylglycerol-Myo-Inositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphatidyltransferase, CDPdiacylglycerol-Inositol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphocholine, Glycerol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphoglyceraldehyde' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphoglycerate Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphoglycerate-NAD+ 2-Oxidoreductase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphoshikimate 1-Carboxyvinyltransferase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Phosphoshikimate 1-Carboxyvinyltransferase, aroA' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Pyridinecarboxamide' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Pyridinecarboxylic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-%28%2-%28%trifluoromethyl%29%phenyl%29%-, Methyl ester' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Ring Heterocyclic Compounds' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Selenylalanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Sulfoalanine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-Sulfocatechol 2,3-Dioxygenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-alpha-Hydroxy-5-alpha-Androstan-17-One' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-alpha-Hydroxy-5-beta-Androstan-17-One' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-alpha-Hydroxysteroid Dehydrogenase %28%B-Specific%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. It is possibly active also as a sulfhydryl reagent.%A% ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-beta-Hydroxysteroid Dehydrogenase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-carbon saturated monocarboxylic acids. ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-hydroxy-4-keto-Flavonoids' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3-hydroxy-N-%28%2-methyl-1-oxo-2-propenyl%29%-' = 0).
% 42.05/41.93 fof(interp, fi_functors, '300, Macrogol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '300, Polyethylene Glycol' = 0).
% 42.05/41.93 fof(interp, fi_functors, '300, Visotrast' = 0).
% 42.05/41.93 fof(interp, fi_functors, '32-kDa, Calelectrin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '32.644 BA, CIBA' = 0).
% 42.05/41.93 fof(interp, fi_functors, '33258, Hoechst' = 0).
% 42.05/41.93 fof(interp, fi_functors, '343, McNeil A' = 0).
% 42.05/41.93 fof(interp, fi_functors, '35 Antigens, CD' = 0).
% 42.05/41.93 fof(interp, fi_functors, '35S-Labeled Cysteamine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '36, Propagrin' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3625, Bayer' = 0).
% 42.05/41.93 fof(interp, fi_functors, '39 kDa RAP' = 0).
% 42.05/41.93 fof(interp, fi_functors, '39 kDa Receptor Associated Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '39-kDa Heparin-Binding Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '39-kDa Receptor-Associated Protein' = 0).
% 42.05/41.93 fof(interp, fi_functors, '39-kDa-RAP' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3D Echocardiographies' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3D Echocardiography' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3D Imaging, Computer-Generated' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3D Imagings, Computer-Generated' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3D QSAR' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3D-QSARs' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3F12 Kinase, p49' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3H-Labeled Idoxuridine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Amfepramone Hydrochloride' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Beclomethasone Dipropionate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Benzydamine Hydrochloride' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Betacarotene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Bromhexine Hydrochloride' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Calcium Gluconate Monohydrate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Flecainide Acetate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Mepivacaine Hydrochloride' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3M Brand of Nefopam Hydrochloride' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3Nitro10' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cell' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cell, BALB' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cell, BALB-c' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cell, NIH' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cells' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cells %28%1991-2003%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cells, BALB' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cells, BALB-c' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cells, NIH' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Cells, Swiss' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 L1 Cells' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3 Swiss Albino' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3-L1 Cell' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3-L1 Cells' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3T3-Swiss Albino' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3TC' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3alpha-Hydroxysteroid Dehydrogenase %28%B-specific%29%' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3beta Hydroxy 5alpha pregnan 20 one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3beta-Hydroxy-5alpha-pregnan-20-one' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3beta-Isomer Deoxycholic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '3d planet from sun with 1 moon; no qualif; DF: EARTH ' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Acetamido 4%27% isothiocyanatostilbene 2,2%27% disulfonic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Allyl 1,2 methylenedioxybenzene' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Amino 1 Hydroxybutylidene 1,1 Biphosphonate' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Amino 1,5 Dimethyl 2 Phenyl 3H Pyrazolone' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Amino-5-chloro-N-%28%2-%28%diethylamino%29%ethyl%29%-2-methoxybenzamide' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminoantipyrine' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminobenzenearsonic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminobenzoic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminobenzoic Acid Ethyl Ester' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminobutanoic Acid' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminobutyrate Transaminase' = 0).
% 42.05/41.93 fof(interp, fi_functors, '4 Aminobutyric Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Aminohippuric Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Aminophenazone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Aminopyridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Aminopyridine Sustained Release' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Aminosalicylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Androstene 3,17 dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Butyrolactone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Carboxyglutamic Protein, Bone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Chloro 7 nitrobenzofurazan' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Chloromercuribenzenesulfonate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Chloromercuribenzoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 D Echocardiography' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Demethoxydaunorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Desmethoxydaunorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Dimethylaminoazobenzene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Ene 3 Oxosteroid 5alpha Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Ene 5 alpha Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Ene Steroid 5 alpha Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Epitetracycline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Ethoxymethylene 2 phenyloxazolone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Fluorophenylalanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Homosulfanilamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxy 3 Methoxymandelic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxy 3 Methoxyphenylacetic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxy 3 methoxybenzoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxy 3 methoxyphenylethylene Glycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxy 3 methoxyphenylethyleneglycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxy 3 methoxyphenylglycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyaflatoxin B1' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyaminoquinoline 1 oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyaminoquinoline N oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxybenzoate 3 Monooxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxybenzoic Acids' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxybutyrate Sodium' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxybutyric Acid Lactone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxycephalexin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxycoumarins' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyphenylretinamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Hydroxyproline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Methyl 2,6 ditertbutylphenol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Nitrophenol 2 Hydroxylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Nitrophenol UDP Glucuronosyltransferase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Nitrophenyl Phosphatase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Nitrophenylphosphatase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Nitroquinoline 1 oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Nitroquinoline N oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 O beta D Glucopyranosyl D glucopyranose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Pyridoxic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Pyridoxinic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Pyridoxylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Quinolones' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Sphingenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4 Thiouridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27% Epi Adriamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27% Epi DXR' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27% Epi Doxorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27% Epiadriamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27% Epidoxorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%%27%%27% O Methyldigoxin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%%27%%27%-O-Methyldigoxin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%,4%27%%27%%27%-Sulfonylbis%28%acetanilide%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%-Epi-Adriamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%-Epi-DXR' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%-Epi-Doxorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%-Epiadriamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%27%-Epidoxorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4%28%1-Naphthylvinyl%29%pyridine hydrochloride. Cholinesterase inhibitor. Synonym: YuB 25.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4, Cardiotoxin VII' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4, Cholecystokinin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4, Vitamin B' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27% Diacetyldiaminodiphenylsulfone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27% Diaminophenyl Sulfone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27% Diazoaminobenzamidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-%28%2,3 Dimethyl-1,4-butanediyl%29%bis%28%1,2-benzenediol%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-%28%Diethylideneethylene%29%diphenol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-Diacetyldiaminodiphenylsulfone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-Diaminophenyl Sulfone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-Diazoaminobenzamidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-Diisothiocyano-2,2%27%-Stilbene Disulfonic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-Diisothiocyanostilbene-2,2%27%-Disulfonic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4%27%-Methylenebis%28%2-chloroaniline%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5 Dehydrogentamicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5%27%,8-Trimethylpsoralen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5-Biphosphate, Phosphatidylinositol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5-Dehydrogentamicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5-Dihydro-1-%28%3-%28%trifluoromethyl%29%phenyl%29%-1H-pyrazol-3-amine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5-Dihydro-4,5-Dioxo-1-H-Pyrrolo%28%2,3-f%29%Quinoline-2,7,9-Tricarboxylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,5-Diphosphate, Phosphatidylinositol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4,9-Dihydro-4-%28%1-methyl-4-piperidylidene%29%-10H-benzo%28%4,5%29%-cyclohepta%28%1,2-b%29%thiophen-10-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%%28%%28%2-Amino-3,5-dibromophenyl%29%methyl%29%amino%29%cyclohexanol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%%28%4-%28%Acetyloxy%29%phenyl%29%cyclohexylidenemethyl%29%phenol Acetate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%1-Hydroxy-2-%28%%28%1-methylethyl%29%amino%29%ethyl%29%-1,2-benzenediol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%1-Hydroxy-2-%28%methylamino%29%ethyl%29%-1,2-benzenediol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-%28%%28%Cyclohexylimidocarbonyl%29%amino%29%ethyl%29%-4-methylmorpholinium' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Hydrochloride, %28%R*,R*%29%-%28%+,-%29%-Isomer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Hydrochloride, %28%R*,S*%29%-%28%+-%29%-Isomer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Tartrate, %28%R*,R*%29%, %28%R*,R*%29%-Isomer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol Tartrate, %28%R*,S*%29%, %28%R*,R*%29%-Isomer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol, %28%R*,R*%29%-Isomer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Amino-1-hydroxypropyl%29%-1,2-benzenediol, %28%R*,S*%29%-Isomer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Aminoethyl%29%-1,2-benzenediol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%2-Aminoethyl%29%phenol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%3-Butoxy-4-methoxybenzyl%29%-2-imidazolidinone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%4-Amino-4-carboxybutyl%29%-1-%28%5-amino-5-carboxypentyl%29%-3,5-bis%28%3-amino-3-carboxypropyl%29%pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%8-Chloro-5,6-dihydro-11H-benzo%28%5,6%29%cyclohepta%28%1,2-b%29%pyridin-11-ylidene%29%-1-piperidinecarboxylic Acid Ethyl Ester' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%Aminobutyl%29%guanidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%Bis%28%2-chloroethyl%29%amino%29%benzenebutanoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%28%Bis%28%2-chloroethyl%29%amino%29%phenylalanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-%5B%4-%28%Dimethylamino%29%-N-methyl-L-phenylalanine%5D%virginiamycin S1' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Acetamido-4%27%-isothiocyanatostilbene-2,2%27%-disulfonic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Allyl-1,2-methylenedioxybenzene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Allyl-1,2-methylenedioxybenzenes' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Amino-1,5-Dimethyl-2-Phenyl-3H-Pyrazolone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Amino-5-cyano-7-%28%D-ribofuranosyl%29%-7H- pyrrolo%28%2,3-d%29%pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo%28%2,3-d%29%pyrimidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminoantipyrine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminobenzenearsonic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminobenzoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminobenzoic Acid Ethyl Ester' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminobutanoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminobutyrate Transaminase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminobutyric Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminohippuric Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminophenazone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminopyridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Aminosalicylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Androstene-3,17-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Butyrolactone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Carbon monounsaturated monocarboxylic acids with the unsaturation in the 2 position.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Carboxyglutamic Protein, Bone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Chloro-7-nitrobenzofurazan' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Chloromercuribenzenesulfonate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Chloromercuribenzoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-D Echocardiographies' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-D Echocardiography' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Demethoxydaunorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Desmethoxydaunorubicin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Dimethylaminoazobenzene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Dioxygenase, Proline,2-Oxoglutarate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Ene Steroid 5 alpha-Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Ene-3-Oxosteroid-5alpha-Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Ene-5-alpha-Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Epimer Chlortetracycline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Epimerase, UDP-Galactose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Epimerase, UDP-Glucose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Epimerase, UDPgalactose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Epimerase, UDPglucose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Ethoxymethylene-2-phenyloxazolone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-HPR' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Homosulfanilamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-1-%28%beta-D-Ribopentofuranosyl%29%-2-Pyridone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-1-%28%beta-D-ribofuranosyl%29%-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-%28%3-oxo-1-phenylbutyl%29%-2H-1-benzopyran-2-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-Methoxymandelic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-Methoxyphenylacetic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-methoxybenzoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-methoxyphenylethylene Glycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-methoxyphenylethyleneglycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-3-methoxyphenylglycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxy-4H-furo%28%3,2-c%29%pyran-2%28%6H%29%-one. A mycotoxin produced by several species of Aspergillus and Penicillium. It is found in unfermented apple and grape juice and field crops. It has antibiotic properties and has been shown to be carcinogenic and mutagenic and causes chromosome damage in biological systems.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxyaflatoxin B1' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxyaminoquinoline-1-oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxyaminoquinoline-N-oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxybenzoate-3-Monooxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxybutyrate Sodium' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxybutyric Acid Lactone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxycephalexin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxycoumarins' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Benzoate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Cinnamate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Debrisoquine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Phenylalanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Procollagen Prolyl' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Prolyl' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxylase, Trans-Cinnamic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxyphenylpyruvate Dioxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Hydroxyphenylretinamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Imidazoleacrylic acid. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Methoxy-2-%28%5-methoxy-3-methylpyrazol-1-yl%29%-6-methylpyrimidine. A pyrimidinyl pyrazole with antipyretic, analgesic, and anti-inflammatory activity.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Methoxy-5-%28%%28%5-methyl-4-pentyl-2H-pyrrol-2-ylidene%29%methyl%29%- 2,2%27%-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Methyl derivative of LOMUSTINE; %28%CCNU%29%. An antineoplastic agent which functions as an alkylating agent.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Methyl-2,6-ditertbutylphenol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Methyl-2-thiouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Monooxygenase CYP73, Trans-Cinnamate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Monooxygenase, Benzoate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Monooxygenase, Debrisoquine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Monooxygenase, Phenylalanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Monooxygenase, Trans-Cinnamate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Nitrophenol-2-Hydroxylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Nitrophenyl Phosphatase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Nitrophenylphosphatase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Nitroquinoline-1-oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Nitroquinoline-N-oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-O-beta-D-Glucopyranosyl-D-glucopyranose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Octopamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Pyridoxic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Pyridoxinic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Pyridoxylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Quinolones' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Reductase, delta' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Sphingenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Sulfatase, N-Acetylgalactosamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Thiouridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-Trimethylaminobutyrate, 2-Oxoglutarate Oxygen Oxidoreductase %28%3-Hydroxylating%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-carbon acids, salts, and derivatives of BUTYRIC ACID.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4-yr program leading to BS; DF: EDUC NURS BACCALAUREATE ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4.5 Preactin, Band' = 0).
% 42.08/41.93 fof(interp, fi_functors, '40, Kenalog' = 0).
% 42.08/41.93 fof(interp, fi_functors, '40,40 Protein, SP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '40-C-EBP Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '400, Polyethylene Glycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '400, Visotrast' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4000, Polyethylene Glycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '43 kDa Dystrophin Associated Glycoprotein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '43, Connexin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '43-kDa Dystrophin-Associated Glycoprotein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '447-G, Glucanase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '45S RNP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4885, SU' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4898, Asta C' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4B, Sepharose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4B, Sepharose C1' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4B4 Antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4D Echocardiographies' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4D Echocardiography' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2 Antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2 Antigen, Heavy Chain' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2 Antigen, Human' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2 Antigen, Light Chains' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2 Heavy Chain' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2 Light Chains' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2-antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4F2HC Subunit' = 0).
% 42.08/41.93 fof(interp, fi_functors, '4th planet from sun with 2 moons; no qualif ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Aminolaevulinate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Aminolevulinate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Aminolevulinate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Aminosalicylate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Aminosalicylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Androstane 3,17 diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Androsten 3 beta hydroxy 17 one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Androsten 3 ol 17 one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Androstene 3,17 diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Androstene 3beta 17beta Diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Azacytidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Bromo 2%27% Deoxycytidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Bromo 2%27% deoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Bromodeoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Bromouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Butyl 2 pyridinedicarboxylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Chloro 7 iodo 8 quinolinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Ene 3 beta hydroxysteroid Dehydrogenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Enol Pyruvyl Shikimate 3 Phosphate Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Enolpyruvyl Shikimic Acid 3 Phosphate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Enolpyruvylshikimate 3 Phosphate Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Enolpyruvylshikimic Acid 3 Phosphate Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Ethyl 3 Methyl 5 Phenylhydantoin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 FU Lederle' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 FU medac' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Fluoro 2%27% Deoxyuridine 5%27% Monophosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Fluoro 2%27% deoxyuridine Phosphorylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Fluorodeoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Fluorouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Fluorouracil biosyn' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Formyltetrahydrofolate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Formyltetrahydropteroylglutamate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT 2 Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT Antagonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT Containing Enterochromaffin Cells' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT Uptake Inhibitors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1 Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1 Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1 Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1D Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT1Dbeta Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT2 Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT2 Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT2A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT2B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT2C Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT3 Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT3 Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT3 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT3A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT3B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT4 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT4L Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HT4S Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HTPase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 HU Hexal' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxy 3 Indoleacetic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxy N,N dimethyltryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxyindolamine Acetic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 1A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 1A Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 1B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 1B Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 2B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 3 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine 4 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Antagonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Plasma Membrane Transport Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Type 2C Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Type 2C Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine Uptake Inhibitors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptamine1D Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptophan' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytryptophan Decarboxylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Hydroxytrytamine Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Imino Pyranoses' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Iodo 2%27% deoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Iodo 4 hydroxy 3 nitrophenacetyl' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Iododeoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Isothiocyanatofluorescein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 L Isoleucine Angiotensin II' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Leucine 2 Alanine Enkephalin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Leucine Enkephalin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Lipoxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methionine Enkephalin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methoxy N,N Dimethyltryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methoxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methylcytosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methylcytosine Monohydrochloride' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methylphenazinium Methyl Sulfate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Methyluracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Oxo L prolyl L histidyl L prolinamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Oxoprolinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Oxoprolyl Peptidase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Phospho alpha D Ribose 1 Diphosphate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Phosphononorvaline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Pregnen 3 beta ol 20 one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 S Cysteinyldopa' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Trifluoromethyl 2%27% deoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 Valine Angiotensin II Amide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Androstan 3 alpha ol 17 one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Androstane 3 alpha,17 beta diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Androstane 3 beta,17 alpha diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Androstane 3 beta,17 beta diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Androstane 3alpha,17 beta diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Cholestan 3 alpha ol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Cholestan 3 beta ol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha DHT' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Dihydroprogesterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Dihydroprogesterone 3 alpha Hydroxysteroid Oxidoreductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Dihydrotestosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Pregnane 3,20 dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Pregnanedione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha Reductase, Testosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-3 alpha-Hydroxysteroid Dehydrogenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Androstan-3 alpha-ol-17-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Androstane-3alpha,17 beta-diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Cholestan-3 beta-ol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Dihydroprogesterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Dihydrotestosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Pregnane-3,20-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 alpha-Reductase, Cholestenone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta Androstane 3 alpha,17 beta diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta Androsterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta Cholestan 3 beta ol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta Dihydroprogesterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta Dihydrotestosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta Pregnane 3,20 dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta-Cholestan-3 alpha-ol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5 beta-Pregnane-3,20-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% 3%27% Exonuclease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% 3%27% Exonucleases' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% AMP Deaminase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% AMP Nucleotidase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Capped RNA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Deiodinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Exonuclease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Flanking Region' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Flanking Regions' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Flanking Sequence' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Flanking Sequences' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Guanylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Hydroxylpolynucleotide Kinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% N Ethylcarboxamidoadenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Nucleotidase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Nucleotidase Phosphoribolase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Nucleotidephosphodiesterase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Phosphoribosylglycinamide Transformylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Splice Site' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Splice Sites' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% TOP Messenger RNA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% TOP Sequence' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% TOP Sequences' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% UTR' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% UTRs' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Untranslated Region' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% Untranslated Regions' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27% mRNA Cap Structure' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-3%27%-Exonuclease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-AMP Deaminase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-AMP Nucleotidase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Deiodinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Deiodinase, Iodothyronine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Deiodinase, Reverse Triiodothyronine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Deiodinase, Tetraiodothyronine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Deiodinase, Thyroxine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Diphosphate 3%27%-Diphosphate, Guanosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Diphosphate, Guanosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Diphosphate, Guanosine 3%27%-Diphosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Diphosphocholine, Cytidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Diphosphoribose, Adenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Exonuclease' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-GMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Guanylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Hydroxyl Kinase, Polynucleotide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Hydroxyl-Kinase, Polynucleotide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Hydroxylkinase, DNA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Hydroxylpolynucleotide Kinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Monodeiodinase, Thyroxine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Monophosphate Oxidoreductase, Guanosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Monophosphate Reductase, Guanosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Monophosphate, Guanosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Monophosphate, Riboflavin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Monophosphate, Uridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-N-Ethylcarboxamidoadenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Nucleotidase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Nucleotidase Phosphoribolase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Nucleotidephosphodiesterase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic AMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Phosphate Reductase, Guanosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Phosphate Transformylase, 2-Amino-N-Ribosylacetamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Phosphate, Riboflavin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Phosphoribosylglycinamide Transformylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Phosphosulfate, Adenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Pyrophosphate, Adenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-S-%28%3-Amino-3-carboxypropyl%29%-5%27%-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Triphosphate, Guanosine 3%27%-Diphosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%, 3%27% or 5%27% position.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%UTR' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5%27%UTRs' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5, Glycogenosis' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5, Proprotein Convertase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10 MTHF Cyclohydrolase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10 Methenyltetrahydrofolate Cyclohydrolase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10 Methylenetetrahydrofolate:NAD Oxidoreductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-MTHF Cyclohydrolase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methenyltetrahydrofolate 5-Hydrolase %28%Decyclizing%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methenyltetrahydrofolate Cyclohydrolase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methylenetetrahydrofolate Reductase %28%FADH%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methylenetetrahydrofolate Reductase %28%FADH2%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methylenetetrahydrofolate Reductase %28%NADPH%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methylenetetrahydrofolate Reductase, NADH-Dependent' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methylenetetrahydrofolate-Reductase %28%NADH%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,10-Methylenetetrahydrofolate:NAD Oxidoreductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,12 HETE' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,12 diHETE' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,12-HETE' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,5%27%-Nitrilodibarbituric acid ammonium derivative. Used as an indicator for complexometric titrations.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,5-Dimethyl-2,4-oxazolidinedione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,5-Dimethyloxazolidine-2,4-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,5-Diphenylhydantoin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6 Benzoflavone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6 Dichloro 1 beta ribofuranosylbenzimidazole' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6 Dihydroxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6-Benzoflavone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6-Dichloro-1-beta-ribofuranosylbenzimidazole' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,6-Dihydroxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7 Dichloro 2 methyl 8 quinolinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7 Dihydroxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7 Dihydroxytryptamine Creatine Sulfate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7,3%27%,4%27%-tetrahydroxy-flavone, one of the FLAVONES. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7,4%27%-trihydroxy-flavone, one of the FLAVONES. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7-Dichloro-2-methyl-8-quinolinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,7-Dihydroxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,8,11,14 Eicosatetraynoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,8,11,14,17-Eicosapentaenoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,8,11,14,17-Icosapentaenoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5,8,11,14-Eicosatetraynoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-%28%3,3-Dimethyl-1-triazeno%29%imidazole-4-carboxamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-%28%Bis%28%2-chloroethyl%29%amino%29%-2,4-%28%1H,3H%29%pyrimidinedione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-%28%Dimethylamino%29%-9-methyl-2-propyl-1H-pyrazolo%28%1,2-a%29%%28%1,2,4%29%benzotriazine-1,3%28%2H%29%-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Amidotransferase, Phosphoribosyldiphosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Amino-%28%3,4%27%-bipyridine%29%-6%28%1H%29%-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Amino-3-%28%%28%5-nitro-2-furyl%29%vinyl%29%-1,2,4-oxadiazole' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Aminolevulinate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Aminolevulinate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Aminosalicylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Androstane-3,17-diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Androstane-3,17-diol/analogs %26% derivatives %28%1980-1992%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Androsten-3-beta-hydroxy-17-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Androstene-3,17-diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Androstene-3beta-17beta-Diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Azacytidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Bromo-2%27%-Deoxycytidine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Bromo-2%27%-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Bromo-2%27%-deoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Bromo-2,4%28%1H,3H%29%-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside %28%BROMODEOXYURIDINE%29% is used to treat neoplasms.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Bromodeoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Bromouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Butyl-2-pyridinedicarboxylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Chloro-7-iodo-8-quinolinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-DP-3 alpha-HSO' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Dioxygenase Procollagen-Lysine, 2-Oxoglutarate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Ene-3 beta-hydroxysteroid Dehydrogenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Enol-Pyruvyl Shikimate-3-Phosphate Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Enolpyruvyl Shikimic Acid 3-Phosphate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Enolpyruvylshikimate-3-Phosphate Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Enolpyruvylshikimic Acid-3-Phosphate Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Ethyl-3-Methyl-5-Phenylhydantoin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-FU' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-FUdR' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Fluoro-1-%28%tetrahydro-2-furanyl%29%-2,4-pyrimidinedione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Fluoro-2%27%-Deoxyuridine-5%27%-Monophosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Fluoro-2%27%-deoxyuridylate. An inhibitor of thymidylate synthetase. Formed from 5-fluorouracil or 5-fluorodeoxyuridine.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Fluorocytosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Fluorodeoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Fluorouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Formiminotransferase, Formimino-L-Glutamate Tetrahydrofolate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Formyltetrahydrofolate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HIAA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT Antagonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT Uptake Inhibitors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT%28%1A%29% Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT%28%1B%29% Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT%28%1D%29% Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT%28%1Dbeta%29% Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT%28%2A%29% Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT%28%2C%29% Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT-2 Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT-Containing Enterochromaffin Cell' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT-Containing Enterochromaffin Cells' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1 Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1 Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1 Receptors Serotonin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1 Serotonin Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1A Serotonin Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1D Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1Dalpha Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1Dbeta Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT1a Receptor Serotonin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT2 Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT2 Receptors, Serotonin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT2 Serotonin Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT2A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT2B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT2C Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT3 Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT3 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT3A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT3B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT4 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT4L Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HT4S Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HTP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-HTPase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxy-3-Indoleacetic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxy-N,N-dimethyltryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxy-indole-3-ethanol. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxyindolamine Acetic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxymethyl-6-methyl- 2,4-%28%1H,3H%29%-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine 1A Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine 1A Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine 1B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine 1B Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine 2B Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Agonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Antagonists' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Plasma Membrane Transport Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Type 2C Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Type 2C Receptors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine Uptake Inhibitors' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine-3 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine-4 Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptamine1D Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptophan' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytryptophan Decarboxylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Hydroxytrytamine Agonist' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Imino-Pyranoses' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Iodo-2%27%-deoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Iodo-4-hydroxy-3-nitrophenacetyl' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Iododeoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Isopropoxycarbonylamino-2-%28%4-thiazoyl%29%benzimidazole' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Isothiocyanatofluorescein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Ketoproline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-L-Isoleucine Angiotensin II' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Leucine Enkephalin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Leucine-2-Alanine Enkephalin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Lipoxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Lipoxygenase, Arachidonate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Lipoxygenase, Arachidonic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methionine Enkephalin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methoxy-N,N-Dimethyltryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methoxytryptamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methylcytosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methylphenazinium Methyl Sulfate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Methyluracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Nucleotidohydrolase, 3,5-Cyclic AMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Nucleotidohydrolase, 3,5-Cyclic GMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Oxo-L-prolyl-L-histidyl-L-prolinamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Oxoprolinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Oxoproline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Oxoprolyl-Peptidase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Oxopyrrolidine-2-Carboxylic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Phosphate Synthase, 3-Enolpyruvylshikimate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Phospho-alpha-D-Ribose 1-Diphosphate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Phosphononorvaline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Pregnen-3-beta-ol-20-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-S-Cysteinyldopa' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Semialdehyde Dehydrogenase, Glutamate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Trifluoromethyl-2%27%-deoxyuridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-Valine-Angiotensin II Amide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-alpha-DHT' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-alpha-Dihydroprogesterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-alpha-Pregnane-3,20-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-alpha-Pregnanedione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-alpha-Reductase, Testosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-beta-Androsterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-beta-Pregnane-3,17,20-triol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5-carbon straight-chain or branched-chain ketones. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5.8S Ribosomal RNA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '50 kDa Dystrophin Associated glycoprotein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '50, Gesaguard' = 0).
% 42.08/41.93 fof(interp, fi_functors, '50, Hypaque' = 0).
% 42.08/41.93 fof(interp, fi_functors, '50, Inhibitory Concentration' = 0).
% 42.08/41.93 fof(interp, fi_functors, '50-kDa Dystrophin-Associated glycoprotein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '500 kDa HD1 Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '500-kDa HD1 Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5097, Bay b' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5097, FB b' = 0).
% 42.08/41.93 fof(interp, fi_functors, '53 32C' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5332C' = 0).
% 42.08/41.93 fof(interp, fi_functors, '538, ABT' = 0).
% 42.08/41.93 fof(interp, fi_functors, '54, Sigma Factor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '54, Tavan SP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '545, Celite' = 0).
% 42.08/41.93 fof(interp, fi_functors, '55 kDa High Affinity Calcium Binding Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '55-kDa Glycoproteins originally defined as differentiation antigens on T-lymphocytes, but also found on other cells including monocytes/macrophages. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MHC %28%Major Histocompatibility Complex%29% Class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as HIV receptors, binding directly to the envelope protein gp120 on HIV.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '55-kDa High-Affinity Calcium Binding Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '560, Celite' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5Alpha Reductase, Steroid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5FU' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5HT Transporter' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5S Gene Specific Transcription Factor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5S Gene-Specific Transcription Factor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5S RNA Gene Transcription Factor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5S Ribosomal RNA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5a, Complement Component' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha Androstane 3beta,17alpha diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha DHP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha Pregnane 3,20 dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha-Androstane-3beta,17alpha-diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha-DHP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha-Isomer Deoxycholic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5alpha-Pregnane-3,20-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5beta DHP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5beta-DHP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5beta-Pregnane-3alpha,17alpha,20alpha-triol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p Syndrome' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p Deletion Syndrome' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p Deletion Syndromes' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p- Syndrome' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p- Syndrome, Chromosome' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p- Syndromes' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5p- Syndromes, Chromosome' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5s, Glycogenosis' = 0).
% 42.08/41.93 fof(interp, fi_functors, '5th planet from sun with 16 moons; no qualif ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Aminocaproic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Aminohexanoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Aminonicotinamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Azauridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Carboxycellulose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Cyano 2,3 dihydroxy 7 nitroquinoxaline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Cyano 7 nitroquinoxaline 2,3 dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Dehydro 9 beta 10 alpha progesterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Deoxyerythronolide B Synthase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Diazo 5 oxo L norleucine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Furfuryladenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Furfurylaminopurine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Hydroxydopamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Iodomethylnorcholesterol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Keto PGF1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Ketoprostaglandin F1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Mercaptopurine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Mercaptopurine Monohydrate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Mercaptopurine Riboside' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Methylcompactin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Methylmercaptopurine Riboside' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Methylprednisolone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Methylthiopurine Riboside' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Oxo PGF1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Oxoprostaglandin F1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Phosphofructokinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Phosphogluconate Dehydrogenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Phytase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Propyl 2 Thiouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Receptor, Interleukin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Thioguanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Thiohypoxanthine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 Thiopurine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6 alpha Methyl 17alpha hydroxyprogesterone Acetate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6,17-Dimethylpregna-4,6-diene-3,20-dione. A synthetic progestational hormone with actions similar to those of progesterone. It is used in the treatment of menstrual irregularities and has also been employed in the treatment of prostatic hypertrophy and endometrial carcinoma.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6,7 Dihydropteridine Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6,7-Dihydropteridine Reductase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-%28%2-%28%4-%28%Bis%28%4-fluorophenyl%29%methylene%29%-1-piperidinyl%29%ethyl%29%-7-methyl-5H-thiazolo%28%3,2-a%29%pyrimidin-5-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-%28%4-Hydroxyphenylazo%29%uracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-%28%5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo%28%4,5-g%29%isoquinolin-5-yl%29%furo%28%3,4-e%29%1,3-benzodioxol-8%28%6H%29%one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-%28%Dimethylamino%29%-4,4-Diphenyl-3-Heptanol Acetate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-%28%Methylthio%29%-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Aminocaproic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Aminohexanoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Aminonicotinamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Aminotransferase, Lysine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Aminotransferase, Lysine 2-Oxoglutarate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Azauridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Cyano-7-nitroquinoxaline-2,3-dione' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-D-Tryptophan-Luteinizing Hormone-Releasing Factor %28%Pig%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Dehydro-9 beta-10 alpha-progesterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Diazo-5-oxo-L-norleucine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Furfuryladenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Furfurylaminopurine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Hydroxydopamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Iodomethylnorcholesterol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Keto-PGF1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Ketoprostaglandin F1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Mercaptopurine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Mercaptopurine Riboside' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Methylcompactin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Methylmercaptopurine Riboside' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Methylprednisolone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Methylthiopurine Riboside' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-O-Methylerythromycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-OHDA' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Oxidase, Protein-Lysine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Oxo-PGF1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Oxoprostaglandin F1 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-PF-2-K-Fru-2,6-P%28%2%29%ase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphate Hydrolase, Sucrose' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphate N-Acetyltransferase, Glucosamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphate Synthetase, Glucosamine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructo 2-kinase-fructose 2,6-bisphosphatase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructo-1-kinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructo-2-kinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructokinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructokinase %28%1977-2001%29%' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructokinase, Liver Type' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructokinase, Muscle Type' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphofructokinase, Platelet Type' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phosphogluconate Dehydrogenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Phytase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Propyl-2-Thiouracil' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Semialdehyde Dehydrogenase, 2-Aminomuconic' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Thioguanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Thiohypoxanthine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Thiopurine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-Transaminase, L-Lysine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6-carbon straight-chain or branched ketones. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '60, Tween' = 0).
% 42.08/41.93 fof(interp, fi_functors, '600, Carbowax' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6000, PEG' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6000, Polyethylene Glycol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6029 M' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6029M' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6059 S' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6059S' = 0).
% 42.08/41.93 fof(interp, fi_functors, '60B8 A Antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '60B8 B Antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '60B8-A Antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '60B8-B Antigen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; AVIAN PARAMYXOVIRUS 1 was AVIAN PARAMYXOVIRUS TYPE 1 1994-96; PARAMYXOVIRUS 1, AVIAN was PARAMYXOVIRUS TYPE 1, AVIAN 1994-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; BUTYRATE and N-BUTYRATE were indexed under BUTYRIC ACIDS 1981-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; CALABASH CURARE was see TOXIFERINE 1966-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; CATATOXIC STEROIDS was heading 1974-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; DENTAL ONLAYS %26% ONLAYS were see DENTURE, OVERLAY 1991-92; ONLAYS was see INLAYS 1984-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; EMBRYO, PLANT was EMBRYOS, PLANT see SEEDS 1986-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; KAPOSI DISEASE was KAPOSI%27%S DISEASE 1963-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; OVOCYCLIN was indexed under ESTRADIOL/analogs %26% derivatives 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1973-77 %28%Prov 1973-74%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; POLYHEDROSIS VIRUSES was heading 1978-90; was see under INSECT VIRUSES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; RABBIT POX VIRUS was heading 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%; RABBIT PLAGUE VIRUS was see RABBIT POX VIRUS 1975-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; SODIUM IODOACETATE was indexed under IODOACETATES 1988-98; IODOACETATE was indexed under IODOACETATES 1980-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; TYRAMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1980-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; for BUTYRATE and N-BUTYRATE use BUTYRATES %28%NM%29% 1981-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; for OVOCYCLIN use ESTRADIOL DIPROPIONATE %28%NM%29% 1980-98; /therapeutic use was ESTRADIOL, THERAPEUTIC 1965%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; for SODIUM IODOACETATE use IODOACETATES %28%NM%29% 1988-98; for IODOACETATE use IODOACETATES %28%NM%29% 1980-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '63; for TYRAMINE OXIDASE use MONOAMINE OXIDASE %28%NM%29% 1980-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64716, Compound' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; GASTRIC MUCOSA PROLAPSE was heading 1963-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; PICK%27%S DISEASE OF HEART was see under PERICARDITIS 1963%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; was DECARBOXYLASES 1963; CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; was ETHIONIAMIDE 1963 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; was in Cat C only 1964-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; was see under RADIOMETRY 1963 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '64; was see under YEASTS 1963 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29%; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29%; FLUDROXYCORTID was see FLURANDRENOLONE 1977-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29%; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29%; was see under HEART BLOCK 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29%; was see under PALATE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%63%29%; was see under STROPHANTHIN %28%now STROPHANTHINS%29% 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; ANAVAR was see OXANDROLONE 1965-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; CHROMATIN, NERVE was see NISSL BODIES 1973-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; KIMMELSTIEL-WILSON SYNDROME was heading 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; MRNA, NON-POLYADENYLATED was NON-POLYADENYLATED MRNA %28%NM%29% 1981-94; MRNA, POLYADENYLATED was POLYADENYLATED MRNA %28%NM%29% 1980-94; POLY%28%A%29%+ RNA was SY to POLY%28%A%29% RNA %28%NM%29% 1980-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; PROTOPLASM was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; was in Cat C only 1964-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; was see under AMINO ACIDS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; was see under BEHAVIOR 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; was see under EMOTIONS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65%28%64%29%; was see under MOTIVATION %26% REINFORCEMENT LEARNING 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; /injuries was ANKLE JOINT/injuries 1965-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; AMBESTIGMINUM was see AMBENONIUM CHLORIDE 1977-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; ANAVAR was see OXANDROLONE 1965-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; BARRE-LIEOU SYNDROME was heading 1967-96 %28%see under SPINAL OSTEOPHYTOSIS 1967-71%29%; POSTERIOR CERVICAL SYMPATHETIC SYNDROME was see BARRE-LIEOU SYNDROME 1975-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; BONE MARROW CELLS was heading 1965-77; /transplantation was BONE MARROW TRANSPLANTATION 1964-65, was BONE MARROW/transplantation 1966-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE %26% CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83, were Prov 1971-74; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 %28%PHOSPHORUS POISONS, ORGANIC deleted 1965%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; CHOLINESTERASE INHIBITORS, IRREVERSIBLE %26% CHOLINESTERASE INHIBITORS, REVERSIBLE were see under CHOLINESTERASE INHIBITORS 1975-83; CHOLINESTERASE INHIBITORS, ORGANIC was see PHOSPHORUS POISONS, ORGANIC 1963-64 %28%PHOSPHORUS POISONS, ORGANIC deleted 1965%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; CHRIST-SIEMENS SYNDROME was see ECTODERMAL DYSPLASIA 1987-92; CHRIST-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1968-86; CHRIS-SIEMENS-WEECH SYNDROME was see ECTODERMAL DYSPLASIA 1965-67; ECTODERMAL DEFECT, CONGENITAL was heading 1963-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; CHROMATIN, NERVE was see NISSL BODIES 1973-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74; was heading 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; CROWN AND BRIDGEWORK was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; DENTAL HYGIENE was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; DEXTRO PROPOXYPHENE was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; FLUDROXYCORTID was see FLURANDRENOLONE 1977-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; FUSIDIN was see FUSIDIC ACID 1965-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; GLOSSODYNIA was see under GLOSSALGIA 1965-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; GRANULOMA GANGRAENESCENS %26% LETHAL MIDLINE GRANULOMA were see under WEGENER%27%S GRANULOMATOSIS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; HYPERTROPHY AND HYPERPLASIA was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; KIMMELSTIEL-WILSON SYNDROME was heading 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; LE CELLS was heading 1963-95 %28%Prov 1963-64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; LE CELLS was heading 1965-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; LIGNAC-FANCONI SYNDROME was LIGNAC-FANCONI DISEASE see under METABOLIC DISEASES 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; MALABSORPTION SYNDROME was see SPRUE 1963-64; MALABSORPTION SYNDROME, CHILDHOOD was see CELIAC DISEASE 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; MATERIA ALBA was heading 1965-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; METHYSERGIDE DERIVATIVES was see under METHYSERGIDE 1975-77; was see under ERGOLINES 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; MOLAR, FOURTH was see under TOOTH, SUPERNUMERARY 1965-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; NON-POLYADENYLATED MRNA was indexed under RNA, MESSENGER 1981-94; POLYADENYLATED MRNA %26% POLY%28%A%29% RNA were indexed under POLY A %26% RNA, MESSENGER 1980-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; OSSIFICATION, PHYSIOLOGIC was heading 1965-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; PERICEMENTITIS was see under PERIODONTITIS 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; PHOSPHOLINE IODIDE was see ECHOTHIOPHATE IODIDE 1975-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; PROTOPLASM was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; PYRIDOSTIGMINE was see under PARASYMPATHOMIMETICS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; RICKETS, VITAMIN D-RESISTANT was heading 1972-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; SHOULDER ARTHROSES was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; TRANSPLANTATION, ALLOGENEIC was see under TRANSPLANTATION, HOMOLOGOUS 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; TRIANISOESTROL was see CHLOROTRIANISENE 1978-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; included total %26% partial edentulous state 1965-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; see ACETOPHENETIDIN 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was ACETYLSALICYLIC ACID 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was AMINOACIDURIA 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was ANEMIA, ERYTHROBLASTIC 1963-64; ANEMIA, TARGET-CELL was see THALASSEMIA 1965-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was ARBORVIRUS INFECTIONS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was BLOOD DISEASES see under HEMATOLOGY 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was CALCIFICATION 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was COLITIS, MUCOUS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was COLITIS, MUCOUS 1963-64; COLITIS, MUCOUS was see under COLONIC DISEASES, FUNCTIONAL 1965-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was CONDITIONED LEARNING 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was DENTAL HIGH SPEED EQUIPMENT 1965-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was ETHYL AMINOBENZOATE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was EXTINCTION LEARNING 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was GENERALIZATION LEARNING 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was HARELIP 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was JAWS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was LEVORPHAN see under MORPHINE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was LIPS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was NORTESTOSTERONE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was PANNICULITIS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was PERIODONTAL DISEASE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was PHOSPHINIC ACID 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was PLASMOCYTOMA 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was POLYPI 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was REINFORCEMENT LEARNING 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was STOMATOLOGY 1963-64; MOUTH MICROORGANISMS was heading 1965-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was TAPEWORM INFECTION 1963-64; CENURIASIS was heading 1968-81; DIPYLIDIASIS %26% RAILLIETINIASIS were headings 1968-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1978-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was TAPEWORMS 1963-64; RAILLIETINA was see under CESTODA 1965-85, was see under TAPEWORMS 1963-64; SPIROMETRA was heading 1979-85, was indexed under CESTODA 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was TEETH 1963-64; /transplantation was TOOTH TRANSPLANTATION 1965%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was TEETH EXTRACTION 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was TEETH, DECIDUOUS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was in Cat C only 1965-74; MATERIA ALBA was heading 1965-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was in Cat E only 1972-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under AMINO ACIDS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under BEHAVIOR 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under DERMATOLOGY 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under EMOTIONS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under ENDODONTICS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under HEART BLOCK 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under HEXOKINASE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under MASTICATION 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under MOTIVATION %26% REINFORCEMENT LEARNING 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under NARCOTIC ANTAGONISTS 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under OPHTHALMOLOGY 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under PALATE 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under POLYPI %28%now POLYPS%29% 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '65; was see under STROPHANTHIN %28%now STROPHANTHINS%29% 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29%; was see under ANGIOGRAPHY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29%; was see under COENZYMES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29%; was see under LIPIDS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29%; was see under PHENOLS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29%; was see under PHOSPHOLIPIDS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%63%29%; was see under TUMOR VIRUSES %28%now see ONCOGENIC VIRUSES%29% 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; BEHAVIOR MODIFICATION was see under BEHAVIOR THERAPY 1974-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; COMPUTERS, DIGITAL was heading 1964-77 %28%Prov 1964-65%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85 %28%Prov 1969-74%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was in Cat E %26% G 1973-79, was in Cat G only 1968-72, was in Cat E only 1964-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was see under AQUEOUS HUMOR 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was see under DIURETICS, MERCURIAL 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was see under HYPERTRICHOSIS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was see under NUCLEOSIDES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%64%29%; was see under VITAMIN B COMPLEX 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66%28%65%29%; was see under HUMAN ENGINEERING 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6640, Antibiotic' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; ACTINOMYCIN was heading 1963-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; ANEMIA, SPLENIC was heading 1963-83, was see under HYPERSPLENISM 1982-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; BAGASSOSIS was see under PNEUMOCONIOSIS 1969-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; COMPUTERS, DIGITAL was heading 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; DIHYDROFOLATE DEHYDROGENASE was heading 1966-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; DIURNAL RHYTHM was see under CIRCADIAN RHYTHM 1975-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; DUODENAL INTUBATION was heading 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE 1966-74, was heading 1965%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; EDUCATION, DENTAL, POSTGRADUATE was see under EDUCATION, DENTAL, CONTINUING %26% EDUCATION, DENTAL, GRADUATE 1966-74; was heading 1965%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE 1966-74, was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; EDUCATION, MEDICAL, POSTGRADUATE was see under EDUCATION, MEDICAL, CONTINUING %26% EDUCATION, MEDICAL, GRADUATE 1966-74; was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; FINGERPRINTS was see under DERMATOGLYPHICS 1966-78, was heading 1963-65; PLANTAR PRINTS was see under DERMATOGLYPHICS 1966-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; GRADUATE RECORDS EXAMINATION was see under EDUCATIONAL MEASUREMENT 1966-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; HEMOPERICARDIUM was see under PERICARDIAL EFFUSION 1969-83, was in Cat A %26% C 1969-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; HIPPURAN was see under IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; INDEXES see REFERENCE BOOKS 1996-98 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; INDEXES see REFERENCE BOOKS 1996-98; INDEX see REFERENCE BOOKS 1984-98%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; LARYNGEAL PERICHONDRITIS was heading 1963-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; METHOXYDIMETHYLTRYPTAMINES was see under SEROTONIN 1980-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; MOUSEPOX VIRUS was MOUSE POX VIRUS 1975-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; NASOPHARYNGITIS was see under PHARYNGITIS 1965-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; ORAL CHARACTER was heading 1975-96 %28%see under PSYCHOANALYTIC THEORY 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; PSYCHIC ENERGIZERS was see ANTIDEPRESSIVE AGENTS 1963-94; THYMOLEPTICS was see TRANQUILIZING AGENTS 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; RADIO-HIPPURAN was see under IUDOHIPPURIC ACID 1966-77; HIPPURAN was see IODOHIPPURIC ACID 1975-77, was see under IODOHIPPURIC ACID 1966-74, was see under CONTRAST MEDIA 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; RNA RODENT VIRUSES was heading 1975-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; STUDENT LOANS was see under TRAINING SUPPORT 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; TOXINS AND ANTITOXINS was heading 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; for ORMOND DISEASE see ORMOND%27%S DISEASE 1966-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was ALLERGY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was DENTAL PULP OBTURATION 1965 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was DISTEMPER VIRUS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was DRUG ALLERGY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was ENAMEL HYPOPLASIA 1965 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was FOOD ALLERGY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was HEMATO-ENCEPHALIC BARRIER 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was MIDWIVES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was NURSING, HOME 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was PERSANTIN 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was PETROLATUM, LIQUID 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was RESPIRATORY ALLERGY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was RESPIRATORY DISEASES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was SEGONTIN 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was TUBERCULIN REACTION 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was TUMOR VIRUSES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was in Cat A %26% C 1966-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was in Cat D only 1966-82, was PETROLATUM LIQUID in Cat D only 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under ANGIOGRAPHY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under AQUEOUS HUMOR 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under ARBOVIRUS 1965, was see under ARBORVIRUSES 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under BIBLIOGRAPHY 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under COENZYMES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under DIURETICS, MERCURIAL 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under ENERGY METABOLISM %26% TISSUE METABOLISM 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under ENERGY METABOLISM 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under EXERTION 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under GERIATRICS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under HUMAN ENGINEERING 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under HYDROLASES 1963-65; STAPHYLOCOAGULASE was see under HYDROLASES 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under HYPERTRICHOSIS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under LIPIDS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under NUCLEOSIDES 1963-65; ARABINOFURANOSYLURACIL was see under PYRIMIDINE NUCLEOSIDES 1976-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under PHENOLS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under PHOSPHOLIPIDS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under TUMOR VIRUSES %28%now see ONCOGENIC VIRUSES%29% 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under VETERINARY MEDICINE %26% ZOONOSES 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '66; was see under VITAMIN B COMPLEX 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%63%29%; PHOCOMELIA was see under ECTROMELIA 1967-78, was heading 1963-66; SIRENOMELIA was see under ECTROMELIA 1967-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%64%29%; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%64%29%; was see PANCREATIC EXTRACTS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%65%29%; FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%65%29%; was see under ENDOPEPTIDASES 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67,63-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; ANTISEPTICS %26% ANTISEPTICS, HALOGEN %26% ANTISEPTICS, MERCURIAL %26% ANTISEPTICS, QUATERNARY AMMONIUM were headings 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; AORTIC REGURGITATION was REGURGITATION, AORTIC VALVE 1963-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; AORTIC VALVE DISEASES was heading 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; ASCHOFF BODIES was see under RHEUMATIC NODULE 1967-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; CAPILLARY RESISTANCE was heading 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; CYTOCHEMISTRY was heading 1966; HISTOCHEMISTRY was heading 1964-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; DIGESTANTS was heading 1967-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; FRUSEMIDE was FRUSEMID see FUROSEMIDE 1977-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; GLIOTOXINS was GLIOTOXIN see under ANTIBIOTICS 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; MIRROR WRITING was see under HANDWRITING 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; MIYAGAWANELLA INFECTIONS was see CHLAMYDIA INFECTIONS 1977-91; was heading 1967-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; PHOCOMELIA was heading 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; THROMBOCYTOPATHY was see under BLOOD PLATELET DISORDERS 1967-85, was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was ACTINOMYCETES 1963-66; CORYNEBACTERIACEAE was heading 1975-91 %28%see under CORYNEFORM GROUP 1976-90%29%; CORYNEFORM GROUP was heading 1976-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was ACUTE RENAL FAILURE 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was ANEMIA, SIDEROBLASTIC REFRACTORY 1963-66 %28%Prov 1966%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was AORTIC STENOSIS 1963-66; AORTIC VALVE DISEASES was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was BEAUTY 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was CONTRACEPTIVES 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was DOMINANCE 1965-66 %28%Prov%29%; MIRROR WRITING was see under HANDWRITING 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was EDUCATION OF MENTALLY DEFECTIVE 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was FIBROUS DYSPLASIA 1963-66 %28%Prov%29%; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was FISTULA, ARTERIOVENOUS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was HOME CARE SERVICE 1966 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was HYPHEMIA 1966 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was INSECTICIDES RESISTANCE 1964-66 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was LACTOGLOBULIN see under GLOBULINS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was LACTOGLOBULIN see under GLOBULINS 1963-66 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was MENTAL HYGIENE 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was MENTAL HYGIENE SERVICES 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was MIRACIL 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was MITRAL INSUFFICIENCY 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was MITRAL STENOSIS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was MOXA 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was NECROSIS, RENAL CORTICAL 1964-66 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was OSTEITIS FIBROSA 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was PANCREATIC CYSTIC FIBROSIS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was PITYRIASIS RUBRA see under DERMATITIS EXFOLIATIVA 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was PULMONARY STENOSIS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was PYELONEPHRITIS, ACUTE NECROTIZING 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was SKELETAL AGE MEASUREMENT 1965-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was SOLUTIONS, OPHTHALMIC 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was TRICHINELLOIDEA 1963-66; TRICHINELLOIDEA was see TRICHUROIDEA 1967-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was TRICUSPID INSUFFICIENCY 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was TRICUSPID STENOSIS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was see ANTISEPTICS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was see PANCREATIC EXTRACTS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was see under HEART, MECHANICAL 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was see under HOOKWORMS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '67; was see under PEPTIDE PEPTIDOHYDROLASES 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%64%29%; CLOMIFENE was CLOMIFEN 1978-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%64%29%; ELECTROCONVULSIVE SHOCK was heading 1966-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%64%29%; was in Cat J only 1964-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%66%29%; EDWARDS PERSONAL PREFERENCE SCHEDULE was heading 1975-96 %28%see under PERSONALITY INVENTORY 1975-90%29%; MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%66%29%; OSLER-RENDU DISEASE was see under ANGIOMATOSIS 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%66%29%; was in Cat G only 1966-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; AGE-SEX DISTRIBUTION was see AGE FACTORS 1990-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; AIR BLADDER was heading 1968-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; ALLELISM TEST was heading 1968-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; ANAL STAGE was heading 1975-96 %28%see under PSYCHOSEXUAL DEVELOPMENT 1975-90%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1968-74; PHALLIC STAGE was heading 1975-96 %28%see under PSYCHOSEXUAL DEVELOPMENT 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; AS IF PERSONALITY was see under PERSONALITY DISORDERS 1975-78; IMPULSE-RIDDEN PERSONALITY %26% INADEQUATE PERSONALITY were see under PERSONALITY DISORDERS 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; AZIRIDINES was heading 1966-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; CARIBOU was heading 1975-94 %28%see under REINDEER 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; CHLORETHIAZOLE was see CHLORMETHAZOLE 1975-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; CLOMIFENE was CLOMIFEN 1978-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; COMMUNITY PHARMACIES was see under PHARMACIES 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; CORPUS LUTEUM CYST was heading 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; CREATINE AND CREATININE was heading 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; DAY DREAMS was see under FANTASY 1968-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; DIOXANES was heading 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; DRUG REGULATIONS was see LEGISLATION, DRUG 1990-92; DRUG RECALL was see LEGISLATION, DRUG 1985-92; NARCOTIC TRADE was heading 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; DUE PROCESS see JURISPRUDENCE 1977-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; EASTER ISLAND was see CHILE 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; EDWARDS PERSONAL PREFERENCE SCHEDULE was heading 1975-96 %28%see under PERSONALITY INVENTORY 1975-90%29%; MYERS-BRIGGS TYPE INDICATOR was see under PERSONALITY INVENTORY 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; ELECTROCONVULSIVE SHOCK was heading 1966-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; FACULTY, PHARMACY was heading 1968-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; FEDERAL AID see FINANCIAL SUPPORT 1994-2000 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; FLIGHT REACTION was see under ESCAPE REACTION 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78; FOOD, DRUG AND COSMETIC ACT was see under LEGISLATION, DRUG 1968-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; GONDERIASIS was see THEILERIASIS 1975-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; GONDERIASIS was see THEILERIASIS 1975-91; CORRIDOR DISEASE was see under THEILERIASIS 1968-78; EAST COAST FEVER was see under THEILERIASIS 1968-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; HEMOGLOBINURIA, BACILLARY was heading 1968-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; HOMESICKNESS was see under ANXIETY, SEPARATION 1975-78, was see under EMOTIONS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; HOMESICKNESS was see under EMOTIONS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; HOSPITAL PLANNING AND CONSTRUCTION was heading 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; INFANT HEALTH SERVICES was see under CHILD HEALTH SERVICES 1968-78; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; MODELS was heading 1966-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; MUSTARD GAS was heading 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; NATURAL SELECTION was indexed under EVOLUTION 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; OSLER-RENDU DISEASE was see under ANGIOMATOSIS 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; POPULATION EXPLOSION was see under POPULATION GROWTH 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; PREENING was see under GROOMING 1975-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; PROPYLIODONE was see under CONTRAST MEDIA 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; PROXEMICS was heading 1975-96 %28%see under SPATIAL BEHAVIOR 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; PYROPHOSPHORIC ACIDS was heading 1968-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; SELF CARE %28%REHABILITATION%29% was SELF CARE see ACTIVITIES OF DAILY LIVING 1979-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; SELF was heading 1965-68, was see under PERSONALITY 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; WELL CHILD CONFERENCE was see under CHILD HEALTH SERVICES 1968-78, was see CHILD HEALTH SERVICES 1979-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ADMINISTRATIVE MANAGEMENT 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was AMYLOID SUBSTANCE 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was AMYLOID SUBSTANCE 1963-67 %28%Cat C heading only 1966-67, Cat A heading only 1963-64%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ANEMIA, CONGENITAL HEMOLYTIC 1965-67, was ANEMIA, CONGENITAL HEMOLYTIC see SPHEROCYTOSIS, HEREDITARY 1963-64; ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC was heading 1968-81, was ANEMIA, CONGENITAL NON-SPHEROCYTIC HEMOLYTIC 1965-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ANEMIA, IDIOPATHIC ACQUIRED HEMOLYTIC 1965-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ARGENTAFFINOMA 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ARSPHENAMINES 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was BEHAVIOR, EXPLORATORY 1965-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was BEHAVIOR, EXPLORATORY 1965-67; CURIOSITY was see under EXPLORATORY BEHAVIOR 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was BETHANECHOL 1964-67 %28%Prov%29%; URECHOLINE was URECHOLINE CHLORIDE see under BETHANECHOL COMPOUNDS 1968-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was DERMATOLYSIS 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ENTEROTOXIN 1964-67 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was ETHICS, PHARMACEUTICAL 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was FARNESYL COMPOUNDS 1965-67 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was HEALTH PROFESSIONS 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was IDENTIFICATION see under DEFENSE MECHANISMS 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was INDIGENT CARE 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was LEVOMEPROMAZINE 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was MASS SCREENING TECHNICS 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was METHYLTYROSINE 1965-67 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was MYONEURAL JUNCTION 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was NERVE CONDUCTION 1965-67; WEDENSKY INHIBITION was heading 1977-96 %28%see under NEURAL CONDUCTION 1977-90%29%, was VVEDENSKII%27%S INHIBITION see under NEURAL CONDUCTION 1965-76 %28%Prov 1965-74%29%; VVEDENSKII%27%S INHIBITION was see WEDENSKY INHIBITION 1990-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was NERVE CONDUCTION 1965-67; WEDENSKY INHIBITION was heading 1977-96 %28%see under NEURAL CONDUCTION 1977-90%29%, was VVEDENSKII%27%S INHIBITION see under NEURAL CONDUCTION 1975-76; VVEDENSKII%27%S INHIBITION was see WEDENSKY INHIBITION 1990-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was NUCLEOTIDYL TRANSFERASES 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was OCCUPATIONS AND PROFESSIONS 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was OLD AGE HOMES 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was OLIGODENDROMA 1963-67; OLIGODENDROMA was see OLIGODENDROGLIOMA 1968-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was PHENYLETHYLAMINES 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was PLEURAL EFFUSIONS 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was PYRIDINONES 1966-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was PYRROLIDONES 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was SULFURIC ACID 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was UMBILICAL VEIN 1964-67 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was in Cat A %26% C 1968-83, was PLEURAL EFFUSIONS in Cat A %26% C 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was in Cat A 1968-83; PERITONEAL EFFUSION was PERITONEAL FLUID see under ASCITIC FLUID 1968-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was see under CELL DIVISION 1963-67; KARYOKINESIS was see under CELL DIVISION 1963-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was see under CYANIDES 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was see under GLYCINE 1963-67; METHYLGLYCINE was heading 1963-95 %28%see under GLYCINE 1963-67%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was see under HOOKWORM INFECTION 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was see under MOVEMENT 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '68; was see under RECEPTORS, NEURAL 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%64%29%; SUBLIMINAL PERCEPTION was see under SUBLIMINAL STIMULATION 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%65%29%; was see under MOTIVATION 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%67%29%; SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69%28%68%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; BENZOMORPHAN was see under BRIDGED COMPOUNDS 1966-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; DIETARY HABITS was see under FOOD HABITS 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; FEEDING PATTERNS was see under FEEDING BEHAVIOR 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; GESTALT LAW OF CLOSURE was see under PERCEPTUAL CLOSURE 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; IMMEDIATE RECALL was see under MEMORY, SHORT-TERM 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; KATZ ADJUSTMENT SCALES was heading 1975-96 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; WITTENBORN SCALES was heading 1979-91 %28%see under PSYCHIATRIC STATUS RATING SCALES 1979-90%29%, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1975-91 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; FACTOR CONSTRUCT RATING SCALES was see under PSYCHIATRIC STATUS RATING SCALES 1973-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; KATZ ADJUSTMENT SCALES was heading 1975-96 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%; WITTENBORN SCALES was heading 1991, was see under PSYCHIATRIC STATUS RATING SCALES 1979-90, was WITTENBORN SCALE see under PSYCHIATRIC STATUS RATING SCALES 1969-78; LORR%27%S INPATIENT MULTIDIMENSIONAL PSYCHIATRIC RATING SCALE was heading 1991, see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; PRISONER%27%S DILEMMA was see under GAME THEORY 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; ROLE CONCEPT was see under PSYCHOLOGY, SOCIAL 1966-68%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; ROLE CONCEPT was see under ROLE 1969-78, was see under PSYCHOLOGY, SOCIAL 1966-68%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; SELF PERCEPTION was see under SELF CONCEPT 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; SITUATIONAL THERAPY was see SOCIOENVIRONMENTAL THERAPY 1979-91, was see under SOCIOENVIRONMENTAL THERAPY 1973-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; TYLOCREBRINE was heading 1972-84 %28%Prov 1972%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; TYLOCREBRINE was heading 1973-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was DOMINANCE, SOCIAL 1968 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was HABIT 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was HYPERKINESIA see under MOVEMENT DISORDERS 1963-68%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was ISOLATION, SOCIAL 1968 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was JURISPRUDENCE, PSYCHIATRIC 1967-68; CRIMINAL INVESTIGATION was see under FORENSIC DENTISTRY %26% FORENSIC MEDICINE 1965-74, was heading 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was SUBCONSCIOUS 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was see under ACTING OUT 1968, was see under PROJECTIVE TECHNIQUES 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was see under AZOLES 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was see under MOTIVATION 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was see under NORTROPANES 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '69; was see under NORTROPANES 1963-68; HOMATROPINE was see under BELLADONNA 1963-68%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6PF2K' = 0).
% 42.08/41.93 fof(interp, fi_functors, '6th planet from sun with 12 moons; no qualif ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Alkoxycoumarin O Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Benzyloxyresorufin O Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Chloro 4 nitrobenzofurazan' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Chloro 7 deoxylincomycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Deazaadenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Ethoxycoumarin Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Ethoxycoumarin Hydroxylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Ethoxycoumarin Monooxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Ethoxycoumarin O De Ethylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Ethoxycoumarin O Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Ethoxycoumarin O Deethylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Hydroxycoumarin UDP Glucuronyltransferase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Hydroxycoumarins' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Pentylresorufin O Depentylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 Propoxycoumarin O Depropylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 epi Taxol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7 states on the southeast Arabian peninsula ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,12 Dimethylbenzanthracene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,12-Dimethylbenzanthracene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,12-Dimethylbenzanthracene. Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,8 Dihydroneopterintriphosphate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,8,8a,9a-Tetrahydrobenzo%28%10,11%29%chryseno %28%3,4-b%29%oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,8-BaP-9,10-Diol Epoxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,8-Dihydro-7,8-dihydroxybenzo%28%a%29%pyrene 9,10-oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,8-Dihydroneopterintriphosphate Synthetase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7,8-Dihydroxy-9,10-Epoxy-7,8,9,10-Tetrahydrobenzo%28%a%29%pyrene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Alkoxycoumarin O-Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Benzyloxyresorufin O-Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Chloro-4-nitrobenzofurazan' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Chloro-7-deoxylincomycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Deazaadenosine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxycoumarin Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxycoumarin Hydroxylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxycoumarin Monooxygenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxycoumarin O-De-Ethylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxycoumarin O-Dealkylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxycoumarin O-Deethylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Ethoxyresorufin O-Deethylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Hydroxycoumarins' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Hydroxycoumarins. Substances present in many plants, especially umbelliferae. Umbelliferones are used in sunscreen preparations and may be mutagenic. Their derivatives are used in liver therapy, as reagents, plant growth factors, sunscreens, insecticides, parasiticides, choleretics, spasmolytics, etc.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-O-Methylnogarol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-OMEN' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Pentylresorufin O-Depentylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-Propoxycoumarin O-Depropylase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-carbon saturated monocarboxylic acids. ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7-con-O-Methylnogarol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70 kDa Heat Shock Cognate Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70 kDa Heat-Shock Cognate Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70 kDa Zeta Associated Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70 kDa Zeta-Associated Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%66%29%; was see under IMMUNITY /radiation effects 1967-69%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%68%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%68%29%; ANTIBODY DEFICIENCY SYNDROME was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%68%29%; ATROCITIES was heading 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%68%29%; LYMPHATISM was heading 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%68%29%; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70%28%69%29%; was see under DUMPING SYNDROME 1963-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70143, Bayer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; ADIPOCERE, ALGOR MORTIS, CRUOR, LIVOR MORTIS %26% MUMMIFICATION were see under POSTMORTEM CHANGES 1970-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; ATROCITIES was heading 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; DENTAL PULP MUMMIFICATION was heading 1965-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; FILTERS was see under FILTRATION 1970-74, was heading 1963-69%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; HYPERTELORISM was see under CRANIOFACIAL DYSOSTOSIS 1963-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; LEPTOCURARES was see NEUROMUSCULAR DEPOLARIZING AGENTS 1970-92; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; LYMPHATISM was heading 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; LYMPHOCYTOTOXINS was see LYMPHOTOXINS 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; NEUROHEMAL ORGAN was see under NEUROSECRETORY SYSTEMS 1970-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was CORIOLIS EFFECT 1964-69 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was ECTHYMA CONTAGIOSUM see under POXVIRUS INFECTIONS 1963-69%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was SERUM GLOBULIN 1963-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was TOOTHBRUSHES 1963-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was see under DEATH 1963-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was see under DUMPING SYNDROME 1963-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70; was see under IMMUNITY /radiation effects 1967-69 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70Z Cbl Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '70Z-Cbl, Oncogene Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71%28%70%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71%28%70%29%; was CYCLAMATE see under SWEETENING AGENTS 1963-70; was in Cat D %26% J 1973-82, was in Cat D only 1963-72; CYCLAMIC ACID was %28%NM%29% 1982-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71%28%70%29%; was see under SWEETENING AGENTS 1963-70 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71782, RMI' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; EDUCATION, NURSING, DEGREE PROGRAMS was heading 1967-70%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; HEALTH CARE was heading 1997 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; NEUROTENDINOUS SPINDLES was heading 1975-96 %28%see under MECHANORECEPTORS 1977-90, see under RECEPTORS, NEURAL 1975-76%29%, was see under RECEPTORS, NEURAL 1972-74, was see under NERVE ENDINGS 1963-71; GOLGI TENDON ORGANS was see NEUROTENDINOUS SPINDLES 1994-96; KRAUSE%27%S END BULBS %26% RUFFINI%27%S CORPUSCLES were see THERMORECEPTORS 1979-93; were see under THERMORECEPTORS 1975-78; were see under RECEPTORS, NEURAL 1972-74; were see under NERVE ENDINGS 1963-71%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; VAN BOGAERT%27%S LEUKOENCEPHALITIS was see under SUBACUTE SCLEROSING PANENCEPHALITIS 1971-78; was see under CEREBRAL SCLEROSIS, DIFFUSE 1963-70%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; for PHOTORECEPTORS, RETINAL %26% RETINAL PHOTORECEPTORS see RODS AND CONES 1994-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; was CYCLAMATE see under SWEETENING AGENTS 1963-70; CYCLAMIC ACID was indexed under CYCLAMATES 1982-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; was EAR, EXTERNAL, DEFORMITY 1963-70 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; was HAND DEFORMITIES 1963-70 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; was see under ABORTION, CRIMINAL %26% ABORTION, THERAPEUTIC 1963-70, was see under ABORTION, LEGAL 1964-70; EMBRYOTOMY was heading 1963-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '71; was see under SWEETENING AGENTS 1963-70 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72 kDa Gelatinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72 kDa Type IV Collagenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%64%29%; was see under PODOPHYLLUM 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%65%29%; SEBACEOUS CYST was heading 1963-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%67%29%; was see under ANTIGENS 1968-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%68%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%69%29%; ENCOUNTER GROUPS was heading 1975-96 %28%see under SENSITIVITY TRAINING GROUPS 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%69%29%; was see under VENTRICULOGRAPHY 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%70%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%70%29%; IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE %26% IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%71%29%; METHYLPARABEN was heading 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%71%29%; THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%71%29%; was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72%28%71%29%; was see under LIPIDS 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72-KDA TYPE IV COLLAGENASE see GELATINASE A and 92-KDA TYPE IV COLLAGENASE see GELATINASE B are available%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72-kDa Gelatinase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72-kDa Type IV Collagenase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; AUSTRALORBIS GLABRATUS was see under BIOMPHALARIA 1972-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; DIO-9 was see under ANTIBIOTICS 1975-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; ENCOUNTER GROUPS was heading 1975-96 %28%see under SENSITIVITY TRAINING GROUPS 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; FIBROMA, SHOPE was heading 1968-81; PAPILLOMA, SHOPE was heading 1963-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; FUNGICIDES was included in ANTIFUNGAL AGENTS 1967-71, was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; HOMOGENATES was Prov 1964-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; IMMUNE SERUM GLOBULIN was heading 1965; GLOBULINS, IMMUNE %26% IMMUNE GLOBULINS were see IMMUNOGLOBULINS, INTRAVENOUS 1992-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; LEG LENGTHENING was heading 1964-71 %28%Prov 1964-66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; LEG LENGTHENING was heading 1967-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; LOCUSTS was see under GRASSHOPPERS 1972-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; METHYLPARABEN was heading 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; SEBACEOUS CYST was heading 1963-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was %28%NM%29% 1988-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; SILASTICS was see SILICONE ELASTOMERS 1975-93; SILASTIC was indexed under SILICONES 1988-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; SODIUM TETRADECYL SULFATE was SODIUM TETRADECYL SULFATES see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; TARSUS OSSEUS was see TARSUS 1988-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; THYMIDINE PHOSPHATES was see under NUCLEOTIDES 1963-71%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; for DICTYOPTERA see ORTHOPTERA 1986-98, see DICTYOPTERA 1975-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; for DICTYOPTERA use ORTHOPTERA 1975-98 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was ACIDS, TRICARBOXYLIC 1971 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was CEMENT, DENTAL see under DENTAL MATERIALS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was DENTAL OFFICE 1970-71 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was ELECTROGALVANISM 1965-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was RICKETS, RENAL 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was RNA, SOLUBLE 1965-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under ANTIGENS 1968-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under CYTOLOGY 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under LIPIDS 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under NUCLEOSIDES 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under OPISTHORCHIS 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under PODOPHYLLUM 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHURIS 1974-78, was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under TRICHUROIDEA 1967-71, was see under TRICHINELLOIDEA 1963-66; TRICHOCEPHALUS was see under TRICHUROIDEA 1967-73, was see under TRICHINELLOIDEA 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '72; was see under VENTRICULOGRAPHY 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%63%29%; METHYLPHENOBARBITOL was see MEPHOBARBITOL 1973-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%64%29%; was see under HYPOPROTHROMBINEMIAS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%64%29%; was see under PIPERIDINES 1969-72; was see under PIPERIDINES %26% ANESTHETICS 1968; was see under ANESTHETICS 1967%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%65%29%; was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%66%29%; REFLEX, CONDITIONED was heading 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%67%29%; was in Cat H %26% J 1967-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%68%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%68%29%; was see under THYROID ANTAGONISTS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%69%29%; CELL NUMBER was heading 1978-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%70%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; APE, BARBARY was BARBARY APES see under MACACA 1973-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; MORNING AFTER PILL was see under CONTRACEPTIVES, POSTCOITAL 1973-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, %26% RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; REPRESSION-SENSITIZATION SCALES was heading 1975-96 %28%see under REPRESSION-SENSITIZATION 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; only radioactive substances 1971-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; was see under AMINO ACIDS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; was see under MUSCLE PROTEINS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; was see under NUCLEOSIDES 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%71%29%; was see under PROTEINS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%72%29%; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73%28%72%29%; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; METHYLPHENOBARBITOL was see MEPHOBARBITOL 1973-94 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; ADENYLIC ACID was ADENYLIC ACIDS see under ADENINE NUCLEOTIDES 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; CELL NUMBER was heading 1978-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; CYTOCHROME P-450 OXYGENASE was NM 1977-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; CYTOCHROME P-450 OXYGENASE was indexed under CYTOCHROME P-450 %26% OXYGENASES 1977-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; DENTAL HYGIENE was heading 1963-64, was see DENTAL PROPHYLAXIS 1991%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; DIPHOSPHATIDYL GLYCEROLS was see PHOSPHATIDYL GLYCEROLS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; EPIPODOPHYLLOTOXIN was see under PODOPHYLLOTOXIN 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; HYDRAMYCIN was NM 1991-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; HYDRAMYCIN was indexed under ANTHRAQUINONES 1991-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; IMMUNOGLOBULINS, FC %26% IMMUNOGLOBULINS, FD were headings 1973-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; INTERNAL MAMMARY ARTERY IMPLANTATION was heading 1975-94 %28%see under MYOCARDIAL REVASCULARIZATION 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; LEGG-PERTHES DISEASE was see under OSTEOCHONDRITIS 1963-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; METHAZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; RECEPTORS, NOREPINEPHRINE was heading 1993; NORADRENALINE RECEPTORS, NOREPINEPHRINE RECEPTORS, %26% RECEPTORS, NORADRENALINE were see RECEPTORS, NOREPINEPHRINE 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; REPRESSION-SENSITIZATION SCALES was heading 1975-96 %28%see under REPRESSION-SENSITIZATION 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; SOCIAL BREAKDOWN was heading 1975-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; TRIMETHOBENZAMIDE was heading 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; VACCINE THERAPY was heading 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; only radioactive substances 1973-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was ANISOLE 1971-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was BACTERIAL ANTIGENS 1971-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was BIRTH INJURY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was BLAST INJURY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was CI-581 1969-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was CINEFLUOROGRAPHY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was DNA NUCLEOTIDYLTRANSFERASE 1968-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was ELECTRIC INJURY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was FIBRIN FILM AND FOAM 1963-72 %28%Prov%29% see under HEMOSTATICS%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was FIBRIN FILM AND FOAM see under HEMOSTATICS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was FOODS, FORTIFIED 1970-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was HOOKWORM INFECTION 1963-72; BUNOSTOMIASIS was heading 1968-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was INFANT FOODS 1970-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was MODELS, BIOLOGIC 1968-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was MODELS, PSYCHOLOGIC 1968-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was PYROPHOSPHATASE 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was RADIATION INJURY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was RADIATION INJURY, EXPERIMENTAL 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was RADIOAUTOGRAPHY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was REFLEX, CONDITIONED 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was RIBONUCLEOSIDES, DEOXY 1971-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was RIBONUCLEOTIDES, DEOXY 1971-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was RIFOMYCIN 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was SCHIFF BASE 1971-72 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was STRESS, PSYCHOLOGIC 1969-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was TENDON INJURY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was TRANSDUCER 1966-72 %28%Prov 1966-67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was TRANSDUCER 1968-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was VINCENT%27%S INFECTION 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was VINCENT%27%S INFECTIONS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was WHIPLASH INJURY 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was in Cat D only 1973-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was in Cat E only 1973-79; was QUESTIONNAIRE 1967-72 %28%Prov in Cat E only%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see ALUMINUM SILICATES 1963-72; MONTMORILLONITE was MONTMORRILLONITE 1977-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under ALBUMINS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under AMINO ACIDS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under FLUOROCARBON POLYMERS 1966-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under HERMAPHRODITISM 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under HOOKWORMS 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under HYPOPROTHROMBINEMIAS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under MUSCLE PROTEINS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under NICOTINIC ACID 1969-72, was see under PARASYMPATHOMIMETICS 1963-68; ARECHOLIN was see ARECOLINE 1981-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under NUCLEOSIDES 1963-71 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under PEPTIDES 1963-72; EULER-GADDUM SUBSTANCE P was see SUBSTANCE P 1973-92; HYPOTHALAMIC SUBSTANCE P was see SUBSTANCE P 1977-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under PIPERIDINES 1969-72; was see under PIPERIDINES %26% ANESTHETICS 1968; was see under ANESTHETICS 1967.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under PROTEINS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '73; was see under THYROID ANTAGONISTS 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%63%29%; was see under SYMPATHOMIMETICS 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%68%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%70%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%71%29%%28%66-67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%71%29%; was in Cat H only 1971-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%71%29%; was see under AIR POLLUTION 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%71%29%; was see under AIR POLLUTION 1969-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; LATEX PARTICLES was heading 1968-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; PHENSUXIMIDE was heading l963-84 %28%Prov l963-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; VERY-LOW-DENSITY LIPOPROTEINS was VERY LOW DENSITY LIPOPROTEINS 1972-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; was see under LIMBIC SYSTEM 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%72%29%; was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74%28%73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74,63-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74,66-67; was THYROCALCITONIN 1968-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74,66-67; was THYROCALCITONIN 1968-73 %26% 1964-65 %28%Prov 1964-65%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '740, Chlorophyll' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; /diagnostic use was IODINE ISOTOPES, DIAGNOSTIC 1963-76; /therapeutic use was IODINE ISOTOPES, THERAPEUTIC 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; ACTINOMYCES ASTEROIDES was see NOCARDIA ASTEROIDES 1974-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; CLOPENTHIXOL was see under TRANQUILIZING AGENTS 1967-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; CONTINUITY OF PATIENT CARE was see under COMPREHENSIVE HEALTH CARE 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; DEHYDROCHOLESTEROL was see under VITAMIN D3 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; DEOXYGLUCOSE was see under GLUCOSE 1973-74, was see under HEXOSES 1967-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; DIAMINOPIMELIC ACID was see under PIMELIC ACIDS 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; DRUG ADULTERATION was heading 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; KETOPROFEN was see under BENZOPHENONES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; LATEX PARTICLES was heading 1968-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; LENTICULAR NUCLEUS was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; MEDICAL MISSIONS was heading 1966-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; PHENSUXIMIDE was heading 1973-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; PHYTOL was see under TERPENES 1968-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; SIGN LANGUAGE was heading 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; TELESCOPIC PROSTHESIS was see DENTURE, OVERLAY 1974-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; TRITONS was heading 1975-82, was see under AMMONIUM COMPOUNDS 1975-78, was see under SURFACE-ACTIVE AGENTS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; VERY-LOW-DENSITY LIPOPROTEINS was VERY LOW DENSITY LIPOPROTEINS 1974-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; WARDS, HOSPITAL was see under HOSPITAL UNITS 1974-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; see ASCOMYCETES 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was AMINOACID OXIDOREDUCTASES 1964-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was ANDROSTENOL 1963-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was ETHYL ETHER 1965-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was FLUORESCENCE SPECTROPHOTOMETRY %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was FREY%27%S SYNDROME 1965-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was GAMMA SPECTROMETRY %28%Prov 1969-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was GRANULOMA, REPARATIVE GIANT CELL 1965-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was HYDROXYSTEROID DEHYDROGENASE 1965-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was INHIBITION, NEURAL 1972-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was MASS SPECTRUM ANALYSIS 1971-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was METHYL ETHER 1972-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was SCATTERING 1971-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was SUBLINGUAL REGION 1972-73 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was in Cat E %26% G 1974-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under AIR POLLUTION 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under AIR POLLUTION 1969-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under HELMINTHS 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under HEMOSTATICS 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under HEMOSTATICS 1963-73, was TOLUIDINE BLUE O 1972-73 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under LIMBIC SYSTEM 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under RADIOISOTOPES 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under SYMPATHOMIMETICS 1963-73 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '74; was see under VITAMIN D 1967-73, was see under VITAMIN D 2 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75%28%71%29%; BARYONS was heading 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75%28%73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75%28%73%29%63-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75,63-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75,64-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; AZOMONAS was heading 1976-81; AZOMONAS AGILIS was see under AZOMONAS 1976-81, was AZOTOBACTER AGILIS see under AZOTOBACTER 1975, was AZOTOBACTER AGILIS 1972-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; BARYONS was heading 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; FERTILITY AGENTS, FEMALE, HORMONAL %26% FERTILITY AGENTS, FEMALE, SYNTHETIC were headings 1975-91 %28%see under FERTILITY AGENTS, FEMALE 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; FERTILITY AGENTS, FEMALE, HORMONAL %26% FERTILITY AGENTS, FEMALE, SYNTHETIC were headings 1991, were see under FERTILITY AGENTS, FEMALE 1975-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; FERTILITY AGENTS, MALE, HORMONAL %26% FERTILITY AGENTS, MALE, SYNTHETIC were headings 1975-91 %28%see under FERTILITY AGENTS, MALE 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; FERTILITY AGENTS, MALE, HORMONAL %26% FERTILITY AGENTS, MALE, SYNTHETIC were headings 1991, were see under FERTILITY AGENTS, MALE 1975-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; GUANINE PHOSPHORIBOSYLTRANSFERASE was GUANINE PHOSPHORIBOSYLTRANSFERASE %28%NM%29% 1978-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; GUANINE PHOSPHORIBOSYLTRANSFERASE was indexed under PENTOSYLTRANSFERASES 1978-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; PROTOVERATRINE A was see under CEVANES 1975-79; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1963-68; CRYPTENAMINE %28%now see PROTOVERATRINES%29% was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; SID was see SUDDEN INFANT DEATH 1993 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; SPERM MATURATION BLOCKING AGENTS was heading 1975-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; VANILLIC ACID was see under BENZOATES 1968-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; for HYOSCYAMINE see BELLADONNA 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; for HYOSCYAMINE use BELLADONNA 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; see ASCOMYCETES 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ADIPIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AFLATOXIN 1965-74 %28%Prov 1965-66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AFLATOXIN 1967-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ALPHA GLOBULIN 1964-74 %28%Prov 1964%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ALPHA GLOBULIN 1965-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AMINOBENZOIC ACID 1965-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AMINOBENZOIC ACID 1965-74; ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AMINOBUTYRIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AMINOCAPROIC ACID 1963-74 %28%Prov 1963%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was AMINOCAPROIC ACID 1964-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ANTHRANILIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ARACHIDONIC ACID 1967-74, was ARACHIDONIC ACID see under FATTY ACIDS, ESSENTIAL 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ARBOVIRUS 1965-74, was ARBORVIRUSES 1963-64; CAPIM GROUP VIRUSES was see under ARBOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was BACTERIOPHAGE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was BETA GLOBULIN 1963-74 %28%Prov 1963-64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was BETA GLOBULIN 1965-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CATECHOL 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CHOLIC ACID 1973-74 %28%Prov 1973%29%, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CHOLIC ACID 1974, was CHOLIC ACID see under BILE ACIDS AND SALTS 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CHOLINESTERASE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOHEXANE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOHEXANOL 1972-74 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOHEXANOL 1974 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOHEXYLAMINE 1971-74 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOHEXYLAMINE 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOPENTANE 1966-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was CYCLOPROPANE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was DEFECTIVE VIRUS 1967-74 %28%Prov 1967-72%29%; INCOMPLETE VIRUSES was INCOMPLETE VIRUS 1975-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was DEFECTIVE VIRUS 1973-74; INCOMPLETE VIRUSES was INCOMPLETE VIRUS 1975-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ETHYLENE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ETHYLENE GLYCOL see under GLYCOLS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was FORMAMIDE 1964-74 %28%Prov 1964-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was FORMAMIDE 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was GALACTOSIDASE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was GLUCOSIDASE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HELPER VIRUS 1967-74 %28%Prov 1967-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HELPER VIRUS 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HEMOGLOBIN 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HYDROXAMIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HYDROXYAPATITE 1964-74 %28%Prov 1964-66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HYDROXYAPATITE 1967-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HYDROXYCHOLECALCIFEROL 1972-74 %28%Prov 1972%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was HYDROXYCHOLECALCIFEROL 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was INDOLEACETIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was ISONICOTINIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was KETOGLUTARIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was LEVULINIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was LINOLEIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was LINOLENIC ACID 1973-74, was LINOLENIC ACID see under FATTY ACIDS, ESSENTIAL 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was MANDELIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was NICOTINIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was OLEIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was OLEIC ACID 1963-74; RICINOLEIC ACIDS was see under FATTY ACIDS, UNSATURATED 1975-87, was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PALMITIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PENICILLIN 1963-74; /adv eff-pois-tox was PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PENICILLIN 1963-74; /adverse effects /poisoning /toxicity were PENICILLIN TOXICOLOGY 1963-65; HETACILLIN was heading 1974-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PHENYLHYDRAZINE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PHENYLPYRUVIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PHTHALIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was PIMELIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was RESORCINOL 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was SALICYLIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was STEARIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was STROPHANTHIN 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was SULFANILAMIDE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was UNDECYLENIC ACID 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was XYLENE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see ANALEPTICS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see DOPA 1972-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under AMINOHYDROLASES 1974, was NUCLEOSIDE AND NUCLEOTIDE DEAMINASES see AMINOHYDROLASES 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under ANDROSTENES 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under ANDROSTENOLS 1974; was see under ANDROSTENES 1973%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under ANTIDEPRESSIVE AGENTS %26% TRANQUILIZING AGENTS 1974%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under CHILD, GIFTED %26% MENTAL RETARDATION 1969-74; was see under MENTAL RETARDATION %28%but EXCEPTIONAL CHILD was see under CHILD, GIFTED%29% 1968; was see under MENTAL RETARDATION 1967; was see under MENTAL DEFICIENCY 1966%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under CHOLANES 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under CHOLESTENES 1974 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under CURARE-LIKE AGENTS %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under EFFICIENCY 1970-73, was see under EFFICIENCY %26% TASK PERFORMANCE AND ANALYSIS 1974%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under ESTRANES 1973-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under GASTROINTESTINAL AGENTS 1969-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under HEMOSTATICS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under LICE 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under NEURAMINIC ACIDS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under NORPREGNANES 1974 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under PASTEURELLA 1972-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under PERSONALITY 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under PHARMACEUTIC AIDS 1969-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under PLANT PROTEINS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '75; was see under SANITARY ENGINEERING 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%64%29%; was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%66%29%; was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%67%29%; was see under PLANTS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%68%29%; was in Cat C %26% E 1968-75 %28%Prov 1968-74%29%, was see under PHYSIOLOGY 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%68%29%; was in Cat C %26% E 1968-75 %28%Prov 1968-74%29%; was see under PATHOLOGY 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%69%29%; was see under BIOCHEMISTRY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%69%29%; was see under MITOCHONDRIA 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%71%29%; was see under CYTOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%71%29%; was see under TOXICOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%73%29%; was see under CELLS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%73%29%; was see under PHAGOCYTOSIS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under ABORTION 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under ANIMALS, NEWBORN 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under CLOTHING 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under CORPUS LUTEUM 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under ESTRUS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under OVUM 1974-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under PIGMENTATION 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under PLACENTA 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under PLATELET ADHESIVENESS 1974-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under PORPHYRINS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under SPERMATOZOA 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under TESTIS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under TONGUE 1975; was see under TONGUE/abnormalities 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76%28%75%29%; was see under VENOMS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; ACHROMATIACEAE was heading 1975-96; ACHROMATIUM, LEPTOTHRIX, %26% SPHAEROTILUS were headings 1963-96; ACHROMOBACTERIACEAE was heading 1975-91 %28%was see under GRAM-NEGATIVE AEROBIC BACTERIA 1976-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; ALDONOLACTONASE, CHOLESTEROL ESTERASE, DEHYDROASCORBATASE, MONOACYLGLYCEROL LIPASES %26% NAPHTHOL AS D ESTERASE were see under ESTERASES 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; CORYNEBACTERIUM ACNES %26% CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1972-75 %28%Provs 1972-74%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; CORYNEBACTERIUM ACNES %26% CORYNEBACTERIUM PARVUM were see under CORYNEBACTERIUM 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; GAFFKYA was see under MICROCOCCACEAE 1976-78, was heading 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; MAEDI was see PULMONARY ADENOMATOSIS, OVINE 1968-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; NECK NEOPLASMS was heading 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; THIOBACTERIACEAE was heading 1975-91 %28%see under GRAM-NEGATIVE CHEMOLITHOTROPHIC BACTERIA 1976-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; TRACHOMA VIRUS was see CHLAMYDIA TRACHOMATIS 1976-91, was see CHLAMYDIA 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ABO FACTORS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ANHIDROSIS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ANTINEOPLASTICS, PHYTOGENIC 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ANTIPARKINSON DRUGS 1972-75 %28%Prov 1972%29%; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ANTIPARKINSON DRUGS 1973-75; was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ANTITHROMBIN 1964-75 %28%Prov 1964-66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ANTITHROMBIN 1967-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was ATHIORHODACEAE 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was BUTYRIBACTERIUM 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was DIPLOCOCCUS PNEUMONIAE 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was FOOD SERVICE %28%NON MESH%29% before 1976 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was GEL FILTRATION 1966-75; CHROMATOGRAPHY, GEL was see under GEL FILTRATION 1966-75; CHROMATOGRAPHY, EXCLUSION was see under CHROMATOGRAPHY, GEL 1976, was see under GEL FILTRATION 1973-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was LIBRARY TECHNICAL PROCESSES %28%NON MESH%29% before 1976%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was MARRIAGE THERAPY 1973-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was MICROCOCCUS DENITRIFICANS 1972-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was MICROCOCCUS PYOGENES see under STAPHYLOCOCCUS 1963-75; MICROCOCCUS PYOGENES was see STAPHYLOCOCCUS AUREUS 1976-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was MOHAMMEDANISM 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was MYCOPLASMA LAIDLAWII 1972-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was MYOCARDIAL DEPRESSANTS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was NEGROES 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was NON MESH 1975, was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was NON MESH 1975, was see under PSYCHOLOGICAL TESTS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was NON MESH before 1976 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was NURSE PRACTITIONER 1973-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was PASTEURELLA PESTIS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was PASTEURELLA TULARENSIS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was PREGNANCY, FIRST TRIMESTER 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was PREGNANCY, SECOND TRIMESTER 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was PREGNANCY, THIRD TRIMESTER 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was PULMONARY ADENOMATOSIS, BOVINE 1968-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was RH FACTORS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was SALMONELLA TYPHOSA 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was SPHAEROPHORUS NECROPHORUS see under SPHAEROPHORUS 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was VIBRIO COMMA 1972-75 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was VIBRIO COMMA 1974-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was WHEEL CHAIRS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was included in CONSTRICTION 1968-75 %28%Prov 1968-74, Cat C %26% E heading 1968-75%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was included in CONSTRICTION see under PHYSIOLOGY 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was included in DILATATION 1968-75 %28%Prov 1968-74, Cat C %26% E heading 1968-75%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was included in DILATATION see under PATHOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was indexed under HEMOSTASIS 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was indexed under HEMOSTASIS 1963-75 %28%Cat E heading%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under ABORTION 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under ACHROMOBACTER 1974-75; HERELLEA was HERELLA see ACINETOBACTER 1976-91; MIMA was MIMAE see ACINETOBACTER 1976-91; MIMAE was heading 1963-75; COLLOIDES was see ACINETOBACTER 1976-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under ANIMALS, NEWBORN 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under ANTHELMINTICS 1975; NEMATOCIDES was heading 1974-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under ANTIDIABETICS 1968-74; ANTIDIABETICS was heading 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under BELLADONNA 1975-76, was see under TROPANES 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under BIOCHEMISTRY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under CELLS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under CLOTHING 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under CORPUS LUTEUM 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under CYTOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under ESTRUS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under GLOBULINS 1963-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under MITOCHONDRIA 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under OVUM 1974-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PATHOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PHAGOCYTOSIS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PHYSIOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PIGMENTATION 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PLACENTA 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PLANTS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PLATELET ADHESIVENESS 1974-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PORPHYRINS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under PSYCHOLOGICAL TESTS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under RICKETTSIA 1975; BASOPHILIC VIRUSES was see CHLAMYDIACEAE 1975-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under SCHIZOMYCETES 1975, was see under BACTERIA 1966-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under SPERMATOZOA 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under SWEATING 1963-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under TESTIS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under TONGUE 1975; was see under TONGUE/abnormalities 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under TOXICOLOGY 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '76; was see under VENOMS 1975 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%69-71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%71%29%; was see under CANNABIS 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%73%29%; was see under METHYLPREDNISOLONE 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was HEMOGLOBIN S 1973-74 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under BLASTOMYCOSIS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under CARDANOLIDES 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under COMMUNITY HEALTH SERVICES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under COMPREHENSIVE HEALTH CARE 1970-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under EXTRACORPOREAL CIRCULATION 1967-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under FLUOROCARBON POLYMERS 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under INVERTEBRATE HORMONES 1967-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under MUCOPOLYSACCHARIDES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under NITROSOGUANIDINES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under STATE MEDICINE 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under STEROIDS 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%75%29%; was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77%28%76%29%; was see under CHROMATOGRAPHY, GAS 1976 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77,63-65 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77,63-67; was PITUITARY GLAND IRRADIATION 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77,63-67; was THYROID GLAND FUNCTION TESTS 1968-76; PROTEIN-BOUND IODINE TEST was heading 1963-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77,66-67; was PITUITARY GLAND FUNCTION TESTS 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; HAEMOBARTONELLOSIS was heading 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; HEMORRHAGIC FEVER, ARGENTINIAN %26% HEMORRHAGIC FEVER, BOLIVIAN were see under EPIDEMIC HEMORRHAGIC FEVER 1975-76; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; HEPATITIS B ANTIGEN was see AUSTRALIA ANTIGEN 1974-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; HEPATITIS, VIRAL, NON-A, NON-B was heading 1980-91 %28%see under HEPATITIS, VIRAL, HUMAN 1980-90%29%, was see HEPATITIS C 1992-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; HYMECROMONE %26% SCOPOLETIN were see under COUMARINS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; NEORICKETTSIOSIS HELMINTHOECA was heading 1971-81; RICKETTSIALPOX was heading 1963-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; PENTACHLOROPHENOL was see under PHENOLS 1971-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; PHENPROCOUMON was see under COUMARINS 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; RECEPTORS, CORTICOSTEROID was see RECEPTORS, GLUCOCORTICOID 1984-93; CORTICOSTEROID RECEPTORS was see RECEPTORS, GLUCOCORTICOID 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966; CHEYNE-STOKES RESPIRATION was see under RESPIRATION 1966-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; SEX STEROID-BINDING PROTEIN was SEX-STEROID-BINDING PROTEIN %28%NM%29% 1981-91; ESTRADIOL-BINDING GLOBULIN %26% TESTOSTERONE-BINDING GLOBULIN were see SEX HORMONE-BINDING GLOBULIN 1977-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; SEX-STEROID-BINDING PROTEIN was indexed under CARRIER PROTEINS 1981-91; ESTRADIOL-BINDING GLOBULIN %26% TESTOSTERONE-BINDING GLOBULIN were see SEX HORMONE-BINDING GLOBULIN 1977-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; TOSYLLYSINE CHLOROMETHYL KETONE was see under LYSINE 1975-76; TOSYLPHENYLALANYL CHLOROMETHYL KETONE was see under PHENYLALANINE 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; see PHOSPHOLIPIDS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was ABDUCENT NERVE 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was ACTINOMYCETE INFECTIONS 1972-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was ALPORT%27%S SYNDROME 1964-76 %28%Prov 1964-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was ALPORT%27%S SYNDROME 1970-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was AMINOHIPPURIC ACID 1965-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was AMINOSALICYLIC ACID 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW was APPROPRIATENESS REVIEW %28%HEALTH CARE%29% see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1969-77 %28%Prov 1969-71%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was AREAWIDE PLANNING see under HEALTH AND WELFARE PLANNING 1968-76; ANNUAL IMPLEMENTATION PLANS was see under REGIONAL HEALTH PLANNING 1981-85, was see under STATE HEALTH PLANS 1980; APPROPRIATENESS REVIEW was APPROPRIATENESS REVIEW %28%HEALTH CARE%29% see under REGIONAL HEALTH PLANNING 1980-85; COMPREHENSIVE HEALTH PLANNING was heading 1972-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was BENZIDINE see under AMINOBIPHENYL COMPOUNDS 1975-76, was BENZIDINE see under BIPHENYL COMPOUNDS 1966-74; 3,3%27%-DIAMINOBENZIDINE %26% DIANISIDINE were see under AMINOBIPHENYL COMPOUNDS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was CADMIUM/poisoning 1966-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was CEYLON 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was CRYING CAT SYNDROME 1964-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was DERMATOMYCOSIS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was DEXTRO AMPHETAMINE 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was ENDODONTIC ENDOSSEOUS IMPLANTATION 1971-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was HEPATITIS VIRUS, HOMOLOGOUS SERUM 1966-76; DANE PARTICLE was see HEPATITIS B ANTIGENS 1977-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was HEPATITIS, HOMOLOGOUS SERUM 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was HEPATITIS, INFECTIOUS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was LATRINES 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was LIP READING 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was LYSOLECITHIN 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was MEDICAL RECORDS LIBRARIANS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was METEOROLOGY see under WEATHER 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was MIMAE INFECTIONS 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was MODELS, NEUROLOGIC 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was NEURAL INTERCONNECTIONS see under NERVOUS SYSTEM 1975-76, was NEURAL INTERCONNECTIONS 1969-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was NON MESH before 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was NON MESH before 1977; RESPIRATORY DISEASES was a heading 1963-65 superseded by RESPIRATORY TRACT DISEASES in 1966%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was NURSE ANESTHETIST see under NURSES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was NURSE MIDWIFE see under NURSES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was PHOSPHATIDYL CHOLINE see under LECITHINS 1963-76; LECITHINS was heading 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was PHOSPHATIDYL ETHANOLAMINE see under CEPHALINS 1963-76; CEPHALINS was heading 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was PHOSPHATIDYL GLYCEROL see under PHOSPHOLIPIDS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was PHOSPHATIDYL INOSITOL see under PHOSPHOINOSITIDES 1963-76; PHOSPHOINOSITIDES was heading 1963-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was PHOSPHATIDYL SERINE see under CEPHALINS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was RADIOISOTOPE SCANNING 1964-76; was RADIOISOTOPE SCANNING see under RADIOMETRY 1963%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was RECEPTORS, NEURAL 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was RESPIRATORY SYNCYTIAL VIRUS 1964-76 %28%Prov 1964-65%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was RESPIRATORY SYNCYTIAL VIRUS 1966-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was SHOCK, TOXIC 1963-76; SHOCK, ENDOTOXIC was heading 1968-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was SPHAEROPHORUS INFECTIONS 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was TYPHUS 1963-76; BRILL%27%S DISEASE was heading 1975-96 %28%see under TYPHUS, EPIDEMIC LOUSE-BORNE 1977-90, see under TYPHUS 1975-76%29%, was see under TYPHUS 1963-74; BRILL-ZINSSER DISEASE was see BRILL%27%S DISEASE 1992-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was TYPHUS, MURINE 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see ANTIHISTAMINICS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under BLASTOMYCOSIS 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under CANNABIS 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under CARDANOLIDES 1968-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under CHROMATOGRAPHY, GAS 1976 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under COMMUNITY HEALTH SERVICES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under COMPREHENSIVE HEALTH CARE 1970-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under EXTRACORPOREAL CIRCULATION 1967-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under FLUOROCARBON POLYMERS 1975-76; PERFLUOROBUTYL TETRAHYDROFURAN was see under FURANS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under HISTOLOGICAL TECHNIQUES 1974 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under INVERTEBRATE HORMONES 1967-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under METHYLPREDNISOLONE 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under MUCOPOLYSACCHARIDES 1969-76; MUCOPOLYSACCHARIDES was heading 1963-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under MUCOPOLYSACCHARIDES 1975-76; PROTEOCHONDROITIN SULFATES was see under MUCOPOLYSACCHARIDES 1976%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under NITROSOGUANIDINES 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under PARASYMPATHOMIMETICS 1963-68 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under SALIVARY GLAND DISEASES 1965-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under STATE MEDICINE 1963-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under STEROIDS 1975-76 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '77; was see under STROPHANTHINS 1975-76, was see under CARDANOLIDES 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%64%29%; was see under PLANT PROTEINS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%69%29%; was see under SANITARY ENGINEERING 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%71%29%; was see under BIOCHEMISTRY 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%71%29%; was see under NUCLEIC ACIDS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%72%29%; was see under HOSPITALS, SPECIAL 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%72%29%; was see under SEPTUM PELLUCIDUM 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%73%29%; was see under CATTLE DISEASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%73%29%; was see under COENZYME A 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%73%29%; was see under HYDRO-LYASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%73%29%; was see under HYDROXYLASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%63-67; was see under ADRENAL GLANDS 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%63-67; was see under PITUITARY GLAND 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under ATROPINE 1975-77, was see under TROPANES 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under CHROMATOPHORES 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under CHROMOSOME ABERRATIONS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under DISACCHARIDASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under DRUG RESISTANCE, MICROBIAL 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under ERGOTAMINE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under EVOLUTION 1967-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under FETAL MEMBRANES 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under GRAAFIAN FOLLICLE 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under HEALTH FACILITY SIZE 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under HYDRO-LYASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under INTRAUTERINE DEVICES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under IODOBENZOATES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under MOSAICISM 1967-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under NAPHTHALENEACETIC ACIDS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under NOSE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under OPTIC NERVE 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under PUBLIC ASSISTANCE 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under SNAILS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under STILBENES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under TRANSFORMATION, GENETIC 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%75%29%; was see under TRYPTAMINES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%76%29%; was see under CHOLESTEROL 1976-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%76%29%; was see under STREPTOCOCCUS 1976-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%77%29%; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%77%29%; was see under INFANT, LOW BIRTH WEIGHT 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78%28%Aug 77%29%; was see under PEPTIDES Aug-Dec 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78,63-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78,63-67; was see under ADRENAL GLANDS 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78,63-67; was see under PITUITARY GLAND 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78,64-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; ALDOSE REDUCTASE was see under ALCOHOL OXIDOREDUCTASES 1976-77; IDITOL DEHYDROGENASE was see under ALCOHOL OXIDOREDUCTASES 1977%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; ALLOXAN DIABETES was heading 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; ALUMINUM HYDROXIDE GEL was heading 1972-77 %28%Prov 1972%29%; ALUMINUM GELS was see under ANTACIDS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; ALUMINUM HYDROXIDE GEL was heading 1973-77; ALUMINUM GELS was see under ANTACIDS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; ANALGESICS AND ANTIPYRETICS was heading 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77, was Prov 1966-74; INSIGNIA AND DECORATIONS was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; CADUCEUS was see under HISTORY OF MEDICINE 1975-77; INSIGNIA AND DECORATIONS was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; CERASTES VENOM was %28%NM%29% 1986-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; CERASTES VENOM was indexed under VIPER VENOMS 1986-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; DEOXYCYTIDINE MONOPHOSPHATE was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; FLUORODEOXYURIDYLATE was see under URACIL NUCLEOTIDES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; FRUCTURONATE REDUCTASE, PHOSPHOGLYCERATE DEHYDROGENASE, TAGATURONATE REDUCTASE %26% URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE were see under ALCOHOL OXIDOREDUCTASES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; MONITORING SYSTEMS was heading 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; TESTOSTERONE DEHYDROGENASES was heading 1978-93 %28%see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; see ADRIAMYCIN 1973-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; see ASPERGILLUS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; see PHENYLPROPIONATES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was ALLIED DENTAL PERSONNEL %28%NON MESH%29% before 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was AMYLASE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was ARVIN see under ENDOPEPTIDASES 1975-77; ARVIN was see ANCROD 1978-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was ARVIN see under PEPTIDE PEPTIDOHYDROLASES 1975-77; ARVIN was see ANCROD 1978-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was BOTULINUM TOXIN 1969-77 %28%Prov 1969-71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was BOTULINUM TOXIN 1972-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was BRITISH HONDURAS 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was BUTADIENE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was DIPHENYLHYDANTOIN 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was DISCRIMINATION 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was DRUG CONTAINERS AND CLOSURES 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was ECHO VIRUS INFECTIONS 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was EPIDEMIC HEMORRHAGIC FEVER 1963-76; several specifics became headings %26% x-refs as of 1977%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was EXTROVERSION %28%PSYCHOLOGY%29% 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was GASTRIN 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was GELFOAM 1964-77 %28%Prov 1964-72%29%, was GELFOAM see under HEMOSTATICS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was GELFOAM 1973-77, was GELFOAM see under HEMOSTATICS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was GENTAMICIN 1963-77 %28%Prov 1963-65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was GENTAMICIN 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL CENTRAL SUPPLY 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL DENTAL SERVICE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL DENTAL STAFF 1971-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL EMERGENCY SERVICE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL EQUIPMENT AND SUPPLIES 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL FOOD SERVICE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL HOUSEKEEPING 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL MATERIALS MANAGEMENT see under HOSPITAL ADMINISTRATION 1976-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL MEDICAL STAFF 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL MEDICATION SYSTEMS 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL NURSERIES 1972-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL NURSING SERVICE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL NURSING STAFF 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL OUTPATIENT CLINICS 1968-77, was HOSPITAL OUTPATIENT SERVICES 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL PERSONNEL 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL PERSONNEL ADMINISTRATION 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL PHARMACY SERVICE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL PSYCHIATRIC DEPARTMENTS 1966-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL PURCHASING 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL READMISSION 1970-77 %28%Prov 1970-71%29%; HOSPITAL READMISSIONS was see PATIENT READMISSION 1997%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HOSPITAL READMISSION 1972-77; HOSPITAL READMISSIONS was see PATIENT READMISSION 1997%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HYDROXYCHOLESTEROL see under CHOLESTEROL 1973-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was HYDROXYPROGESTERONE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was INDWELLING CATHETER see under URINARY CATHETERIZATION 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was INHALATION THERAPY 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was JUGULAR VEIN 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was LEUKOCIDIN 1965-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was LIMULUS see under ARTHROPODS 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was LIVER CIRRHOSIS, OBSTRUCTIVE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was MARCHIAFAVA-MICHELI SYNDROME 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was MELANIN 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was METHYLHYDRAZINE see under HYDRAZINES 1967-77; DIMETHYLHYDRAZINES was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77; MONOMETHYLHYDRAZINE was METHYLHYDRAZINE see under HYDRAZINES 1966-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was NON MESH before 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was NOSE DEFORMITIES 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was NURSE CLINICIAN see NURSE PRACTITIONERS 1976-77, see NURSE PRACTITIONER 1973-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was PLAY 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was PRESCRIPTIONS 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was SINO-ATRIAL NODE 1964-77 %28%Prov 1964-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was SINO-ATRIAL NODE 1970-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was SOCIAL SERVICE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was SOCIAL SERVICE, PSYCHIATRIC 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was SOUTH PACIFIC ISLANDS 1967-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was STREPTOLYSIN 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was TRANSPORT OF WOUNDED AND SICK 1964-77, was TRANSPORT OF WOUNDED 1963%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was YOMESAN 1963-77 %28%Prov 1963-72%29%; YOMESAN was see NICLOSAMIDE 1978-96; CLONITRALIDE was %28%NM%29% 1975-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was YOMESAN 1973-77; YOMESAN was see NICLOSAMIDE 1978-96; CLONITRALIDE was indexed under NICLOSAMIDE/analogs %26% derivatives 1983-96 %26% ETHANOLAMINES 1975-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was in Cat D %26% J 1978-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was indexed under GENERAL PRACTICE 1969-77; GENERAL PRACTICE was heading 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was indexed under PEPTIDES Aug-Dec 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see PORTUGAL 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see VITELLINE MEMBRANE 1973-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under ALCOHOL OXIDOREDUCTASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under ARBOVIRUS INFECTIONS 1977, was see under EPIDEMIC HEMORRHAGIC FEVER 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under ARBOVIRUS INFECTIONS 1977; EPIDEMIC HEMORRHAGIC FEVER was heading 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under ATROPINE 1975-77, was see under TROPANES 1969-74; N-ISOPROPYLATROPINE was see under ATROPINE 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under BIOCHEMISTRY 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under CATTLE DISEASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under CHOLESTEROL 1976-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under CHROMATOPHORES 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under CHROMOSOME ABERRATIONS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under COENZYME A 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under CONJUGATION, GENETIC 1975-77; SEX FACTOR, BACTERIAL was SEX FACTORS, BACTERIAL see under PLASMIDS 1978-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under DISACCHARIDASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under DRUG RESISTANCE, MICROBIAL 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under ERGOTAMINE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under EVOLUTION 1967-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under EXTRACHROMOSOMAL INHERITANCE 1975-77; EPISOMES was see under EXTRACHROMOSOMAL INHERITANCE 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under FETAL MEMBRANES 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under GENERAL PRACTICE 1975-77, was see GENERAL PRACTICE 1969-74; GENERAL PRACTICE was heading 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under GRAAFIAN FOLLICLE 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under GRAAFIAN FOLLICLE 1975-77; OVARIAN INTERSTITIAL CELLS was see under OVARY 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under HEALTH FACILITY SIZE 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under HEARING 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under HOSPITALS, SPECIAL 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under HYDRO-LYASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under HYDROXYLASES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1970-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under INFANT, LOW BIRTH WEIGHT 1977 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under INOSITOL 1963-77; PHYTIN was see under INOSITOL 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under INTRAUTERINE DEVICES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under IODOBENZOATES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under MORPHINE 1975-77, was see under MORPHINANS 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under MOSAICISM 1967-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under NAPHTHALENEACETIC ACIDS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under NOSE 1963-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under NUCLEIC ACIDS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under OPTIC NERVE 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1972-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under PLANT PROTEINS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under PUBLIC ASSISTANCE 1968-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under SANITARY ENGINEERING 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under SCOPOLAMINE 1975-77, was see under TROPANES 1969-74; BUTYLSCOPOLAMMONIUM BROMIDE was see under SCOPOLAMINE 1976-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under SEPTUM PELLUCIDUM 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under SNAILS 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under SPINA BIFIDA 1963-77; MYELOCELE was see under SPINA BIFIDA 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under STILBENES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under STREPTOCOCCUS 1976-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under TRANSFORMATION, GENETIC 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '78; was see under TRYPTAMINES 1975-77 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%73%29%; was see under CEPHALOMETRY 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%73%29%; was see under DIGITALIS GLYCOSIDES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%73%29%; was see under KIDNEY 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%73%29%; was see under PLANT VIRUSES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%73%29%; was see under PSYCHOANALYTIC THERAPY 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%63-67; was see under ADRENAL GLAND DISEASES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under ANTIBIOTICS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1967-74 %28%Prov 1967-72%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under CESTODA 1965-78; was see under TAPEWORMS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under DECISION MAKING 1974-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under ELECTROOCULOGRAPHY 1973-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under ENTEROBACTERIACEAE 1976-78; was see under ESCHERICHIA 1974-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under EPIDEMIOLOGIC METHODS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under GAMBLING 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under HOOKWORMS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under INTELLIGENCE TESTS 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under INTENSIVE CARE UNITS 1966-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under INTRAUTERINE DEVICES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under LEUKOCYTES 1968-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under NEUROGLIA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under RETINAL DEGENERATION 1970-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under REWARD 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under SELF CONCEPT 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under SOCIAL BEHAVIOR 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under SPOROZOA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%75%29%; was see under UTERINE DISEASES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%76%29%; was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%76%29%; was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%77%29%; was see under HEMOGLOBINS 1977-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79%28%78%29%; was see under RESPIRATORY TRACT INFECTIONS 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79,63-65; was ZOOGLEA 1972-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79,63-67; was see under ADRENAL GLAND DISEASES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79,63-67; was see under ADRENAL GLAND NEOPLASMS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; AEQUORIN was see under PROTEINS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; FICUSIN %26% TRIOXSALEN were see under COUMARINS 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; FOOD AND DRUG LAWS was see under LEGISLATION, DRUG 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; METHAPYRILENE was see under PYRIDINES 1975-78, was see under ANTIHISTAMINICS 1963-74; PHENAZOPYRIDINE %26% PYRILAMINE were see under PYRIDINES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; OLEANOLIC ACID was see under TRITERPENES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; PHENETIDINE was see under ANILINE COMPOUNDS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; see MYXOMYCETES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; see PHYCOMYCETES 1963-78; for PHYCOMYCES see PHYCOMYCETES 1975-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; see PROCAINE AMIDE 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; use FUNGI 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ACCIDENTS, INDUSTRIAL 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ACETANILIDE 1968-78, was ACETANILID 1963-67 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ACOUSTIC TRAUMA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ANENCEPHALUS 1964-78 %28%Prov 1964-65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ANENCEPHALUS 1966-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY %26% PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was CANTHARIDES 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was CATHEPSIN 1963-78 %28%Prov 1963-64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was CATHEPSIN 1965-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was COLONY STIMULATING FACTOR see under GLYCOPROTEINS 1976-78; was COLONY-STIMULATING FACTOR 1979-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was COXSACKIE VIRUS INFECTIONS 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was DEMYELINATION 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was DEXTRAN 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was DISGERMINOMA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was DNA RESTRICTION ENZYME 1978, was DNA RESTRICTION ENZYME see under ENDONUCLEASES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ENOXOLONE see under TRITERPENES 1977-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ENOXOLONE see under TRITERPENES 1977-78; CARBENOXOLONE was see under TRITERPENES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was EXTENDED CARE FACILITIES 1968-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was EXTRAPYRAMIDAL DISORDERS 1972-78 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was EXTRAPYRAMIDAL DISORDERS 1974-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was FILM BADGE 1971-78 %28%Prov 1971-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was FILM BADGE 1974-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was FLUORESCENCE ANGIOGRAPHY 1973-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was FLUORESCENCE ANGIOGRAPHY 1973-78; FUNDUS FLUORESCENCE PHOTOGRAPHY was see under FLUORESCENCE ANGIOGRAPHY 1973-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was GARDONA 1972-78 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was GARDONA 1974-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was GOAL see under MOTIVATION 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was GYNECOLOGIC DISEASES 1965-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was GYNECOLOGIC NEOPLASMS 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was HEALTH AND WELFARE PLANNING 1968-78; NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 was heading 1982-95; HEALTH PLANNING AND RESOURCES DEVELOPMENT AMENDMENTS OF 1979, PL96-79; HEALTH PLANNING ACT 93-641; PUBLIC LAW 93-641; %26% PL93-641 were see NATIONAL HEALTH PLANNING AND RESOURCES DEVELOPMENT ACT OF 1974 1982-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was HEPARIN CO-FACTOR see under ALPHA GLOBULINS 1975-78, was HEPARIN CO-FACTOR 1963-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was INDUSTRIAL MEDICINE 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was INDUSTRIAL NURSING 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was KNOWLEDGE OF RESULTS 1965-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was LYSINE VASOPRESSIN see under VASOPRESSIN 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was LYSINE VASOPRESSIN see under VASOPRESSIN 1975-78; FELYPRESSIN was PHELYPRESSIN see under VASOPRESSIN 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was MUCIN 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was MUSCAT %26% OMAN 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was MYOCARDIAL INFARCT 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was NEIGHBORHOOD HEALTH CENTERS see under COMMUNITY HEALTH SERVICES 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was NEUROLEPTOANALGESIA 1966-78 %28%Prov 1966-67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was NEUROLEPTOANALGESIA 1968-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was NON MESH before 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ON LINE SYSTEMS 1971-78 %28%Prov 1971-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was ON LINE SYSTEMS 1974-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was OROFACIODIGITAL SYNDROME see under ABNORMALITIES, MULTIPLE 1975-78; was OROFACIODIGITAL SYNDROME 1964-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was OXYHEMOGLOBIN 1977-78, was OXYHEMOGLOBIN see under HEMOGLOBINS 1975-76, was OXYHEMOGLOBIN 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was PEMOLINE COMPOUNDS 1966-78 %28%Prov 1966-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was PEMOLINE COMPOUNDS 1970-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was PICOLINE 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was PSYCHOLOGY, PASTORAL 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was RUMANIA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SCHOLARSHIPS AND FELLOWSHIPS 1963-65; FELLOWSHIPS %26% SCHOLARSHIPS were see under TRAINING SUPPORT 1966-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SCHOOL HEALTH 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SCINTILLATION COUNTERS 1973-78; was SCINTILLATION COUNTER see under RADIOMETRY 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SELF ASSESSMENT see under SELF CONCEPT 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SOCIAL CLUBS see under ORGANIZATIONS 1975-78, was SOCIAL CLUBS 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SOLANUM ALKALOIDS 1977-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was SPIROCHETE INFECTIONS 1972-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was THRESHOLD %28%NON MESH%29% before 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was THYRONINE 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was TRINIDAD 1966-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was VASOPRESSIN 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was VITELLINE DUCTS 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was in Cat C %26% F 1979-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was in Cat G %26% J 1979-82, was ACCIDENTS, INDUSTRIAL in Cat G %26% J 1967-78 %26% Cat G %26% I 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was indexed under PLANT AGGLUTININS 1968-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see COMMUNITY MENTAL HEALTH SERVICES 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see PLASMAPHERESIS 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under ANNELIDA 1969-78; EARTHWORMS was heading 1972-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under ANTIBIOTICS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under ASSOCIATED VIRUSES 1975-78, was SATELLITE VIRUS see under ASSOCIATED VIRUS 1974; ASSOCIATED VIRUSES was heading 1975-78, was ASSOCIATED VIRUS 1973-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under CEPHALOMETRY 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under CESTODA 1965-78, was see under TAPEWORMS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under CESTODA 1965-78; was see under TAPEWORMS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under CORPUS STRIATUM 1974-78; was see under GANGLIA, BASAL 1963-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under DECISION MAKING 1974-78; CAREER CHOICE was see under DECISION MAKING 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under DIGITALIS GLYCOSIDES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under ELECTROOCULOGRAPHY 1973-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under ENTEROBACTERIACEAE 1976-78; was see under ESCHERICHIA 1974-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under EPIDEMIOLOGIC METHODS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under GAMBLING 1969-78; GAMBLING was heading 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under HEMOGLOBINS 1977-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under HOOKWORM INFECTIONS 1973-78, was see under HOOKWORM INFECTION 1967-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under HOOKWORMS 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under INTELLIGENCE TESTS 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under INTENSIVE CARE UNITS 1966-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under INTRAUTERINE DEVICES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under KIDNEY 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under LEUKOCYTES 1968-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under NEUROGLIA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under NITRILES 1976-78; LAETRILE was see AMYGDALIN 1979-95, see under NITRILES 1975-78;%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under PLANT VIRUSES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under PSYCHOANALYTIC THERAPY 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under RESPIRATORY TRACT INFECTIONS 1978 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under RETINAL DEGENERATION 1970-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under REWARD 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under SELF CONCEPT 1969-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under SHOULDER JOINT 1965-78, was see under SHOULDER 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under SOCIAL BEHAVIOR 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under SPOROZOA 1963-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '79; was see under UTERINE DISEASES 1975-78 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7B2, Neuroendocrine Chaperone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7B2, Neuroendocrine Peptide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7B2, Neuroendocrine Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7B2, Pituitary Protein' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7S Gamma Globulin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7th cranial nerve; neopl: coord FACIAL NERVE DISEASES %28%IM%29% + CRANIAL NERVE NEOPLASMS %28%IM%29% + histol type of neopl %28%IM%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '7th planet from sun with 5 moons; no qualif ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Aminonaphthalene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Azaguanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Br Cyclic AMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Bromo Cyclic AMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Bromo Cyclic Adenosine Monophosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Bromo Cyclic Adenosine Monophosphate, Monosodium Salt' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Bromo Cyclic Adenosine Monophosphate, Sodium Salt' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Bromo cAMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Bromoadenosine 3%27%,5%27% Cyclic Monophosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Hydroxyquinoline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Hydroxyquinoline Sulfate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Isotestosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 MOP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Methoxypsoralen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Methyl N Vanillyl 6 Nonenamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Oxyquinoline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8 Quinolinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8,11,14 Eicosatrienoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8,11,14-Eicosatrienoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Aminonaphthalene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Azaguanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Br Cyclic AMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Bromo Cyclic AMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Bromo Cyclic Adenosine Monophosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Bromo-cAMP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Bromoadenosine 3%27%,5%27%-Cyclic Monophosphate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Formylhydrolase, GTP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Hydroxy-2-%28%di-n-propylamino%29%tetralin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Hydroxyquinoline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Hydroxyquinoline Sulfate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom%28%s%29%. They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis, and have also been used as antiseborrheics. The compounds are mostly used topically, but have been used also as animal feed additives. They may cause optic and other neuropathies and are most frequently administered in combination with other agents.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Methoxypsoralen' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Methyl-N-Vanillyl-6-Nonenamide' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-OH-DPAT' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Oxyquinoline' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8-Quinolinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%72%29%; was see under DENTAL MATERIALS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%73%29%; was see under STATISTICS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under AMINOBUTYRIC ACIDS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under AMPICILLIN 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under BIGUANIDES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under BIOTRANSFORMATION 1970-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under CEPHALOSPORINS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under CRESOLS 1973-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under DNA 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under GLYCOPROTEINS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under HYDANTOINS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under ISOQUINOLINES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under METHANESULFONATES 1975-79; ETHYLMESYLATE %26% MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under METHANESULFONATES 1975-79; MESILATE, METHYL %26% METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under METHYL ETHERS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under NITROSAMINES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under PREGNADIENEDIOLS 1975-79; FLUORMETHYLDEHYDROCORTICOSTERONE was see FLUOCORTOLONE 1975-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under PREGNANCY 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under TRANSPLANTATION, HOMOLOGOUS 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%75%29%; was see under VITAMIN A 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%77%29%; was see under MECHANORECEPTORS 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%77%29%; was see under RECEPTORS, DRUG 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%78%29%; was see under ANTIBIOTICS 1978-79; was X 537A see under ANTIBIOTICS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%78%29%; was see under SOCIOLOGY 1978-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%79%29%; was see under COSTS AND COST ANALYSIS 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%79%29%; was see under HEALTH RESOURCES 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80%28%Aug 77%29%; was see under HOSPITALS, SPECIAL Aug 77-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80, Polysorbate' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80, Tween' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8000, PEG' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; ACRIFLAVINE was see under ACRIDINES 1963-81; NITRACRINE was see under ACRIDINES 1975-80; TACRINE was see under ACRIDINES 1975-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT %26% CALCIUM-DEPENDENT REGULATOR were see under CARRIER PROTEINS 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; CHILD SPACING was see BIRTH INTERVALS 1979-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; DIMETHYL ADIPIMIDATE was see under IMIDES 1978-79; DIMETHYL SUBERIMIDATE was see under IMIDES 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; EATON AGENT was see MYCOPLASMA 1967-91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; HYPERLIPOPROTEINEMIA was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; IMMUNOLOGY was heading 1963-79; RADIATION IMMUNOLOGY was heading 1964-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; PEPTIDES, CHEMOTACTIC was see CHEMOTACTIC FACTORS 1984-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; PLASTER OF PARIS was heading 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; QUALITY ASSURANCE PROGRAM was see QUALITY OF HEALTH CARE 1978-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; RHINITIS, ALLERGIC was see HAY FEVER 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; SYMPATHETIC GANGLIA was see GANGLIA, AUTONOMIC 1975-79, was see under GANGLIA, AUTONOMIC 1963-74; CELIAC GANGLIA was see CELIAC PLEXUS 1975-79, was see under CELIAC PLEXUS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; VASOMOTOR RHINITIS was see HAY FEVER 1973-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; for articles that were clinical trials 1980-90; CLINICAL RESEARCH was check tag 1965-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; see PRESSURE 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; see TRIAZENES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was ADRENOGENITAL SYNDROME 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was ALKYL MERCURY COMPOUNDS 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was BLOOD SUGAR 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was BONE CYST 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was CHLORIMIPRAMINE see under DIBENZAZEPINES 1968-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DAHOMEY 1966-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DAUNOMYCIN 1964-79 %28%Prov 1964-65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DAUNOMYCIN 1966-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DESENSITIZATION 1963-79 %28%Prov 1963-64%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DESENSITIZATION 1965-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DIAPHRAGMATIC HERNIA 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DIAPHRAGMATIC HERNIA, TRAUMATIC 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was DIET, SALT-FREE 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was EMERGENCY HEALTH SERVICES 1968-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was ENTERITIS, REGIONAL 1965-79, was ILEITIS, REGIONAL 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was ETHYL MERCURY COMPOUNDS 1972-79 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was ETHYL MERCURY COMPOUNDS 1974-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was FEMORAL HERNIA 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1973-78 %28%Prov 1973-74%29%; was FOODS, ARTIFICIAL 1972 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was FOOD, ARTIFICIAL 1979; was FOOD, ARTIFICIAL see under FOOD 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was FUTUROLOGY 1971-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was GENES, SUPPRESSOR 1968-79 %28%Prov 1968-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was GENES, SUPPRESSOR 1970-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was GENETICS, HUMAN 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was GRANULOMA, PERIAPICAL 1965-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HAIR FOLLICLE DISEASES %28%NON MESH%29% before 1980; HAIR FOLLICLE DISEASES was see HAIR DISEASES 1993-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HEMATOPORPHYRIN 1965-79 %28%Prov 1965-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HEMATOPORPHYRIN 1974-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HEPATIC DUCT 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HYPERCHOLESTEREMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HYPERLIPEMIA 1963-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79; HYPERCHOLESTEREMIA, ESSENTIAL FAMILIAL was see under HYPERLIPEMIA, ESSENTIAL FAMILIAL 1963-74; HYPERLIPOPROTEINEMIA, FAMILIAL was see HYPERLIPEMIA, ESSENTIAL FAMILIAL 1974-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was HYPOLIPOPROTEINEMIAS 1978-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was IMMUNE SERUMS 1963-79; IMMUNE SERUM GLOBULIN was heading 1965%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was INGUINAL HERNIA 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was MAINTENANCE, HOSPITAL 1978-79; was HOSPITAL MAINTENANCE 1963-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was MALAGASY REPUBLIC 1964-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was METHYL MERCURY COMPOUNDS 1972-79 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was METHYL MERCURY COMPOUNDS 1974-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was METHYLDOPAHYDRAZINE see under HYDRAZINES 1975-79; was METHYLDOPAHYDRAZINE 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was NON MESH before 1980 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was NORMAL VALUES 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was NYLON 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was NYLON in Cat D %26% J 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was ODONTOGENIC TUMOR 1963-79; NEOPLASMS, DENTAL TISSUE was heading 1963-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was OTORHINOLARYNGOLOGY 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was OXEDRINE 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PASSIVE TRANSFER 1970-79 %28%Prov 1970-72%29%; IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PASSIVE TRANSFER 1973-79; IMMUNOTHERAPY, PASSIVE was see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90; IMMUNE SERUM GLOBULIN THERAPY was see IMMUNIZATION, PASSIVE 1983-91; SEROTHERAPY was heading 1963-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PATIENTS/education 1966-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PHENYL MERCURY COMPOUNDS 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PHENYL MERCURY COMPOUNDS 1977-79; CHLOROMERCURIPHENYLSULFONATE was see under ORGANOMETALLIC COMPOUNDS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PHOSPHOLIPASE 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PHOSPHOLIPASE 1963-79; LECITHINASES was LECITHINASE see under PHOSPHOLIPASE 1963-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PHOTOSENSITIZATION 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PLACENTA DISORDERS 1969-79 %28%Prov 1969-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PLACENTA DISORDERS 1973-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PRIVILEGED COMMUNICATION 1975-79; was PRIVILEGED COMMUNICATION see under JURISPRUDENCE 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PROTEIN KINASE 1973-79 %28%Prov 1973%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PROTEIN KINASE 1974-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PSYCHIATRY, COMMUNITY 1971-79 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PSYCHIATRY, COMMUNITY 1973-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was PSYCHIATRY, MILITARY 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was REGRESSION 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was SPORT MEDICINE 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was THORAX /surgery 1966-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was THORAX /surgery 1966-79 %26% SURGERY, THORACIC %28%NON MESH%29% before 1980%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was TOMOGRAPHY, COMPUTERIZED AXIAL 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-79; PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was TOMOGRAPHY, RADIOGRAPHIC 1973-79; LAMINAGRAPHY, X-RAY was see TOMOGRAPHY, X-RAY 1980-96, was LAMINAGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1975-96; PLANIGRAPHY, X-RAY %26% STRATIGRAPHY, X-RAY were see TOMOGRAPHY, X-RAY 1980-96, were PLANIGRAPHY, RADIOGRAPHIC %26% STRATIGRAPHY, RADIOGRAPHIC see TOMOGRAPHY, RADIOGRAPHIC 1973-79; RADIOGRAPHY, BODY-SECTION was see TOMOGRAPHY, X-RAY 1973-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was TRYPTOPHAN SYNTHETASE 1972-79 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was TRYPTOPHAN SYNTHETASE 1974-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was UMBILICAL HERNIA 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was VENTRAL HERNIA 1963-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was VOICE PRODUCTION, ALARYNGEAL 1968-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was included in MOUTH, EDENTULOUS 1965-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was indexed under ANTIBIOTICS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see HOSPITALS, UNIVERSITY 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see HYPERLIPEMIA 1975-79; HYPERLIPEMIA, ESSENTIAL FAMILIAL was heading 1963-79 %28%see note under HYPERLIPIDEMIA for former cross refs to it%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see SPACE FLIGHT 1975-79; AVIATION MEDICINE was heading 1963-79; AVIATION DENTISTRY was heading 1965-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see SYSTEMS ANALYSIS 1976-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see TURNER%27%S SYNDROME 1967-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under AMINOBUTYRIC ACIDS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under AMPICILLIN 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under BENZODIAZEPINE TRANQUILIZERS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under BIGUANIDES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under BIOTRANSFORMATION 1970-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under BLASTOCYST 1975-79, was see under GERM LAYERS 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under BRIDGED COMPOUNDS 1975-79; DIAMANTANE was see ADAMANTANE 1975-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under CEPHALOSPORINS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under COSTS AND COST ANALYSIS 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under CRESOLS 1973-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under DENTAL MATERIALS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under DNA 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under GLYCOPROTEINS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under HEALTH RESOURCES 1979 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under HOSPITALS, SPECIAL 1978-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under HYDANTOINS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under ISOQUINOLINES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under MECHANORECEPTORS 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under METHANESULFONATES 1975-79; ETHYLMESYLATE %26% MESILATE, ETHYL were see ETHYL METHANESULFONATE 1981-93; ETHYL MESILATE was see ETHYL METHANESULFONATE 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under METHANESULFONATES 1975-79; MESILATE, METHYL %26% METHYLMESYLATE were see METHYL METHANESULFONATE 1981-93; METHYL MESILATE was see METHYL METHANESULFONATE 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under METHYL ETHERS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under NITROSAMINES 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under PREGNADIENEDIOLS 1975-79; FLUORMETHYLDEHYDROCORTICOSTERONE was see FLUOCORTOLONE 1975-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under PREGNANCY 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under RECEPTORS, DRUG 1977-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under SOCIOLOGY 1978-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under STATISTICS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under TRANSPLANTATION, HOMOLOGOUS 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under VEHICLES 1975-79, was see under PHARMACEUTIC AIDS 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '80; was see under VITAMIN A 1975-79 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%73%29%; was see under BEHAVIOR 1975-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%75%29%; was see under ACRYLIC RESINS 1975-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%75%29%; was see under AGGLUTININS 1975-80, was see under ANTIBODIES 1968-74, was see ANTIBODIES 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%75%29%; was see under BABOONS 1973-80; BABOONS was heading 1971-80 %28%Prov 1971-72%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%75%29%; was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%77%29%; was see under INFORMATION SERVICES 1977-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%78%29%; was see under CELL CYCLE 1978-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%78%29%; was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81%28%Aug 77%29%; was see under HEALTH SERVICES Aug 1977-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81, 63-74; FLIES was heading 1975-80; was see under DIPTERA 1963-74; MIDGES %28%either MIDGES, BITING see CERATOPOGONIDAE or MIDGES, NONBITING see CHIRONOMIDAE as of 1981%29% was see under DIPTERA 1975-80; CERATOPOGONIDAE was see CULICOIDES 1975-80; CULICOIDES %28%see CERATOPOGONIDAE as of 1981%29% was heading 1963-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81, Tween' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; DEPRESSION, NEUROTIC was DEPRESSIVE NEUROSES see DEPRESSION, REACTIVE 1979-80, see under DEPRESSION, REACTIVE 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; DEPRESSION, REACTIVE, PSYCHOTIC was see under PSYCHOSES 1977-80; AFFECTIVE DISTURBANCES was heading 1969-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; FROGS %26% TOADS were headings 1964-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; HYDROCHLORIC ACID, GASTRIC was see GASTRIC JUICE 1969-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; KLEPTOMANIA was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; NYCTICEBUS was NYCETIBUS 1981-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; VOLKMANN CONTRACTURE was heading VOLKMANN%27%S CONTRACTURE 1963-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; see PSYCHOSES, MANIC-DEPRESSIVE 1963-80; see MANIC DISORDER 1984-97; for MANIC DISORDER see AFFECTIVE DISORDERS, PSYCHOTIC 1981-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was 2-BROMOERGOCRYPTINE 1978-80, was 2-BROMOERGOCRYPTINE see under ERGOTOXINE 1977, was 2-BROMOERGOCRYPTINE see under ERGOLINES 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was ADENOVIRUSES 1975-80, was ADENOVIRUS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was AFFECTIVE DISTURBANCES 1969-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was ANTISOCIAL PERSONALITY 1976-80, was ANTISOCIAL PERSONALITY see under SOCIOPATHIC PERSONALITY 1969-75; SOCIOPATHIC PERSONALITY was heading 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was ANTISOCIAL PERSONALITY 1976-80, was SOCIOPATHIC PERSONALITY 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was ARENAVIRUSES 1978-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was AUTONOMIC DYSFUNCTION 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was BUFO 1972-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was CARCINOMA, EPIDERMOID 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was CHROMATOGRAPHY, HIGH SPEED LIQUID 1976-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was CONVERSION REACTION 1969-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was CONVERSION REACTION 1969-80; GLOBUS HYSTERICUS was see under CONVERSION REACTION 1974-80; ASTASIA-ABASIA was see under CONVERSION REACTION 1970-78; HYSTERIA, CONVERSION was see under CONVERSION REACTION 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was CORONAVIRUSES 1974-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DEPRESSION, REACTIVE 1966-80 %28%Prov 1966-68%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DEPRESSION, REACTIVE 1969-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DIATHESIS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DIBROMODULCITOL 1974-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DISSOCIATIVE REACTION 1968-80; DISSOCIATION was see under DISSOCIATIVE REACTION 1969-78; FUGUE was see under DISSOCIATIVE REACTION 1968-78, was heading 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DISSOCIATIVE REACTION 1968-80; FUGUE was heading 1963-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DRUG WITHDRAWAL SYMPTOMS 1964-80 %28%Prov 1964-66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was DRUG WITHDRAWAL SYMPTOMS 1967-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was EPOXIDE HYDRATASES 1975-80 %28%see under HYDRO-LYASES 1975-77%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was EXCHANGE TRANSFUSION 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was FOLIE A DEUX 1968-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was GALAGOS 1978-80, was GALAGOS see under MONKEYS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was GORILLAS 1975-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was HEPATITIS B SURFACE ANTIGEN 1977-80; AUSTRALIA ANTIGEN was see HEPATITIS B ANTIGENS 1977, was heading 1973-76, was see HEPATITIS VIRUS, HOMOLOGOUS SERUM 1971-72; HEPATITIS ASSOCIATED ANTIGEN was see AUSTRALIA ANTIGEN 1973-75, was see under HEPATITIS VIRUS, HOMOLOGOUS SERUM 1970-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was HEROIN ADDICTION 1973-80 %28%Prov 1973%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was HEROIN ADDICTION 1974-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was HERPESVIRUSES 1975-80, was HERPESVIRUS 1963-74; THYMIC GROUP VIRUSES was see MOUSE LEUKEMIA VIRUSES 1975-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was HYSTERICAL PERSONALITY 1969-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was KITASAMYCINS see under ANTIBIOTICS 1976-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was KORSAKOFF%27%S SYNDROME 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES %26% RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-3, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, %26% was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90 %28%Prov 1972-73%29%; C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES %26% TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was LEUKOVIRUSES 1978-80; was LEUKEMOGENIC VIRUSES 1966-77; RETROVIRUSES, MLV-RELATED was heading 1994-96; ONCOVIRINAE was heading 1992-93, was see RETROVIRIDAE 1991; MURINE LEUKEMIA VIRUS-RELATED RETROVIRUSES %26% RETROVIRUSES, MURINE LEUKEMIA VIRUS-RELATED were see RETROVIRUSES, MLV-RELATED 1994-96; ONCOVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91; RNA TUMOR VIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1978-91; ONCORNAVIRUSES was see ONCOVIRINAE 1992-93, was see RETROVIRIDAE 1981-91, was see LEUKOVIRUSES 1978-80, %26% was see ONCOGENIC VIRUSES 1975-77; ONCOVIRUSES, TYPE C was heading 1991-93, was C-TYPE VIRUSES 1974-90; C-TYPE VIRUSES was see ONCOVIRUSES, TYPE C 1991-93; LEUKOVIRUSES was see ONCOVIRUSES, TYPE C 1991-93, was see ONCOGENIC VIRUSES 1975-77, was heading 1978-90, was see RETROVIRIDAE 1981-90; TYPE C ONCOVIRUSES %26% TYPE C ONCORNAVIRUSES were see ONCOVIRUSES, TYPE C 1991-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was LIGHT/therapeutic use 1966-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was LIGHT/therapeutic use 1966-80; HELIOTHERAPY was see under PHYSICAL THERAPY 1975-85 %26% SUNLIGHT 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MEDICINE, HINDU 1964-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MEDICINE, PRIMITIVE 1963-80; FOLK MEDICINE was see under FOLKLORE 1968-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MONILIASIS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MONILIASIS, CUTANEOUS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MONILIASIS, ORAL 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MONILIASIS, VULVOVAGINAL 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was MORPHINE ADDICTION 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was NEUROSES 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was NEUROSES, ANXIETY 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was NEUROSES, POST-TRAUMATIC 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was NEWTS see under SALAMANDERS 1972-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was OLIVOMYCIN 1965-80 %28%Prov 1965-71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was OLIVOMYCIN 1972-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was ORTHOMYXOVIRUSES 1977-80; was INFLUENZA VIRUSES 1963-76; was MYXOVIRUSES 1975-76; was MYXOVIRUS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PARAMYXOVIRUSES 1971-80 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PARAMYXOVIRUSES 1973-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PARANOIA 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PARVOVIRUSES 1974-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PHOBIAS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PHOBIAS 1963-80; PHOBIC NEUROSES was see under PHOBIAS 1969-80; CLAUSTROPHOBIA was see under PHOBIAS 1968-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PICORNAVIRUSES 1975-80, was PICORNAVIRUS 1964-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was POLYVINYLPYRROLIDONE 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PORTACAVAL ANASTOMOSIS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PORTACAVAL ANASTOMOSIS 1963-80; ECK FISTULA was see under PORTACAVAL ANASTOMOSIS 1974-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was POXVIRUSES 1975-80, was POXVIRUS 1963-74 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PSYCHOSES 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PSYCHOSES, INVOLUTIONAL 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PSYCHOSES, INVOLUTIONAL 1963-80; MELANCHOLIA, INVOLUTIONAL was see under PSYCHOSES, INVOLUTIONAL 1963-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was PSYCHOSES, TOXIC 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was RANA 1972-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was REOVIRUSES 1975-80, was REOVIRUS 1964-74 %28%Prov 1964-65%29%; RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was REOVIRUSES 1975-80, was REOVIRUS 1966-74; RESPIRATORY ENTERIC ORPHAN VIRUSES was RESPIRATORY ENTERIC ORPHAN VIRUS 1976-92; CYTOPLASMIC POLYHEDROSIS VIRUSES was see POLYHEDROSIS VIRUSES 1975-90; REOVIRUS was see REOVIRIDAE 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was RHABDOVIRUSES 1978-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SALAMANDERS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SCHIZOID PERSONALITY 1972-80 %28%Prov 1972%29%, was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SCHIZOID PERSONALITY 1973-80, was SCHIZOID PERSONALITY see under PERSONALITY DISORDERS 1969-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SCHIZOPHRENIA, HEBEPHRENIC 1972-80 %28%Prov 1972%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SCHIZOPHRENIA, HEBEPHRENIC 1973-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SCHIZOPHRENIA, LATENT 1972-80 %28%Prov 1972%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SCHIZOPHRENIA, LATENT 1973-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SEX DEVIATION 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SHOCK THERAPY 1963-80; SHOCK THERAPY, INSULIN was heading 1963-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SHOCK THERAPY, ELECTRIC 1963-80; ELECTROCONVULSIVE SHOCK was heading 1966-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was SURINAM 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was TOGAVIRUSES see ARBOVIRUSES 1978-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was TREE SHREWS see under PROSIMIANS 1975-80, see under PRIMATES 1972-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was TRIETHYLENE MELAMINE 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was TRUCIAL STATES 1975-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was TURBIDIMETRY see under PHOTOMETRY 1975-80; was TURBIDIMETRY see under DENSITOMETRY 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was UMBILICAL CYST 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was VETERANS AFFAIRS 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was ZIMBABWE RHODESIA 1980, was RHODESIA 1967-79, was RHODESIA-NYASALAND 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see ACTIVITIES OF DAILY LIVING 1979-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see CULICOIDES 1975-80; CULICOIDES was heading 1963-80; MIDGES was see under DIPTERA 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see PLASMA SUBSTITUTES 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under ACRYLIC RESINS 1975-80; POLYHYDROXYETHYL METHACRYLATE was see under ACRYLIC RESINS 1978-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under AGGLUTININS 1975-80, was indexed under ANTIBODIES 1963-74.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under BABOONS 1973-80; BABOONS was heading 1973-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under BEHAVIOR 1975-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under CELL CYCLE 1978-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under CELL CYCLE 1978-80, was see MITOSIS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under HEALTH SERVICES 1977-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under INFORMATION SERVICES 1977-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1964-80 %28%Prov 1964-71%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under METHANTHELINE 1963-67; PROPANTHELINE BROMIDE was heading 1972-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81; was see under POLYETHYLENE GLYCOLS 1975-80; TWEENS was see under SURFACE-ACTIVE AGENTS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '81;STIGMATIZATION was see CHRISTIANITY 1982-1996 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82 %28%Aug 77%29%; was see under INSURANCE, HEALTH Aug 77-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82%28%77%29%; was see under CELLULOSE 1977-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; FASCIOLOPSIS was heading 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; FLOW MICROFLUORIMETRY was see FLUOROIMMUNOASSAY 1989-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; HAIRLESS MICE was see MICE, NUDE 1975-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; HETEROPHYES was see under TREMATODA 1963-81; METAGONIMUS was heading 1963-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; LOEFFLER SYNDROME was heading LOEFFLER%27%S SYNDROME 1963-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; NEAR EAST was see ASIA, WESTERN 1994-95 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; PHYSICAL EXAMINATION, PREADMISSION was see under PHYSICAL EXAMINATION Aug 77-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; PRENATAL INFLUENCES was heading 1963-72 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; RATS, ZUCKER was see under RATS 1981 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; TRIGEMINAL CAUDAL NUCLEUS was see under TRIGEMINAL NUCLEI 1980-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was ACTIN 1971-81 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was ACTIN 1973-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was ADRENAL CORTICAL REST TUMOR 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was ATOMIC ENERGY %28%Cat H heading only%29% 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was ATOMIC ENERGY 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was ATOMIC WARFARE 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was AUTONOMIC DRUGS 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was BABESIASIS 1968-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICIVIRIDAE 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was CALICIVIRUSES 1979-81; CALICIVIRUSES was see CALICVIRIDAE 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was CASEIN 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was CEREBRAL CORTEX DECORTICATION 1965-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was CHINCHILLAS 1968-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was CHROMIUM-COBALT ALLOYS 1965-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was FUELS %28%Cat J heading only%29% 1966-81 %28%Prov 1966-67%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was FUELS 1968-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was GANGLIA, BASAL 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was GANGLIA, BASAL 1963-81; CLAUSTRUM was see under GANGLIA, BASAL 1963-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was GERBILS 1968-81; PSAMMOMYS was see CRICETIDAE 1982-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was HEPATITIS, CANINE INFECTIOUS 1971-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was HL-A ANTIGENS 1978-81; was HL-A see under HISTOCOMPATIBILITY ANTIGENS 1974-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was HYDROXYDOPAMINE 1973-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was INDUSTRIAL DENTISTRY 1965-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was INFORMATION RETRIEVAL SYSTEMS 1966-81; EMERGENCY CARE INFORMATION SYSTEMS was see EMERGENCY MEDICAL SERVICE COMMUNICATION SYSTEMS 1987-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was MEGLUMINE IOTHALAMATE 1978-81, was MEGLUMINE IOTHALAMATE see under IOTHALAMIC ACID 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was MITOMYCIN 1963-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was OLIGOMYCIN 1963-81 %28%Prov 1963-65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was OLIGOMYCIN 1966-81; RUTAMYCIN was see under ANTIBIOTICS, ANTIFUNGAL 1975-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was REFLEX, TENDON 1965-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was REIMPLANTATION 1965-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was RUSSIAN FEDERATION %28%ASIA%29% 1967-81; RUSSIAN FEDERATION was heading 1966; RUSSIA was heading 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was SOMATOMEDIN 1973-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was SOMATOMEDIN 1973-81, was SULFATION FACTOR 1971-72 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was indexed under RODENTS or SQUIRRELS 1975-80; MARMOTA was MARMOTS see under RODENTS 1975-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was SQUIRRELS 1968-81; CHIPMUNKS was see under RODENTS 1975-81; GROUND SQUIRRELS was see SQUIRRELS 1981, was see under CHIPMUNKS 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was TERATOID TUMOR 1963-81; TERATOMA, CYSTIC %26% TERATOMA, MATURE were see DERMOID CYST 1985-93; DYSEMBRYOMA was heading 1963-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was TOOTH REIMPLANTATION 1965-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES 1981, was UNITED STATES DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 1976-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was UNITED STATES NATIONAL INSTITUTES OF HEALTH 1966-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1965-81 %28%Prov 1965%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was UNITED STATES NATIONAL LIBRARY OF MEDICINE 1966-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was indexed under INSURANCE, HEALTH Aug 77-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '82; was see under CELLULOSE 1977-81 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%73%29%; was see under HYDROXYCHOLECALCIFEROLS 1975-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%75%29%; was see under CHOICE BEHAVIOR 1981-82 %26% DECISION MAKING 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%75%29%; was see under FORENSIC PSYCHIATRY 1975-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%75%29%; was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%75%29%; was see under HYPOTHALAMUS 1975-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%75%29%; was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%79%29%; was see under GLYCOPEPTIDES 1979-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83%28%Aug 77%29%; was see under ENDORPHINS Aug 1977-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; INTERFERON-GAMMA was INTERFERON, GAMMA 1983-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; NYSTAGMUS, BARANY was NYSTAGMUS, BARANY%27%S 1993-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; SACCULE %26% UTRICLE were see under LABYRINTH 1966-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; SACCULE %26% UTRICLE were see under LABYRINTH 1966-82; MACULAE, ACOUSTIC was see under LABYRINTH 1979-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was ACETYLAMINOFLUORENE 1980-82; was ACETYLAMINOFLUORENE see under FLUORENES 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was AMBULATORY CARE FACILITIES, NON-HOSPITAL 1980-82; was HEALTH CENTERS 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was AMINOISOBUTYRIC ACID 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was CALCIUM ANTAGONISTS, EXOGENOUS 1982 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was CLEFT PALATE PROSTHESIS 1966-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was DEOXYRIBONUCLEASE 1966-82, was DESOXYRIBONUCLEASE 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was FISH LIVER OILS 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was HIRSCHSPRUNG%27%S DISEASE see MEGACOLON 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was HYPOTHALAMUS, MEDIAL see under HYPOTHALAMUS 1975-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was IMMUNITY, PASSIVE 1966-82 %28%Prov 1966%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was IMMUNITY, PASSIVE 1967-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was INTERFERON 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was METHYLMETHACRYLATE 1972-82 %28%Prov 1972%29%, was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was METHYLMETHACRYLATE 1973-82, was METHYLMETHACRYLATE see under ACRYLIC RESINS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was PARAVENTRICULAR NUCLEUS see under HYPOTHALAMUS 1975-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was RIBONUCLEASE 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was SARCOMA 180, CROCKER 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was STERILITY 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was STERILITY, FEMALE 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was STERILITY, MALE 1963-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see NICOTINIC ACIDS 1975-82 %26% NICOTINIC ACID 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under CHOICE BEHAVIOR 1981-82 %26% DECISION MAKING 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was heading 1964-82 %28%Prov 1964-71%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under CURARIFORM ANTAGONISTS 1963-69; EDROPHONIUM CHLORIDE was heading 1972-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under ENDORPHINS Aug 1977-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under FORENSIC PSYCHIATRY 1975-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under GLYCOPEPTIDES 1979-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under HYDROXYCHOLECALCIFEROLS 1975-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under HYPOTHALAMO-HYPOPHYSEAL SYSTEM 1974-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under HYPOTHALAMUS 1975-82 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '83; was see under MORTUARY CUSTOMS 1963-82; MORTUARY CUSTOMS was heading 1963-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%68%29%; was see under NUTRITION 1975-83, was Prov 1968-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%72%29%; was see under PYRIDINES 1972-83 %28%Prov 1972-74%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%73%29%; was see under ORGANOIDS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%73%29%; was see under PIPERIDINES 1975-83, was Prov 1973-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was ANATOMIC MODELS see under MODELS, STRUCTURAL 1968-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under AGGRESSION 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under AIR POLLUTANTS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under ANTIBIOTICS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under BLOOD PROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under CARBOXY-LYASES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under CEPHALOSPORINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under CHILD BEHAVIOR DISORDERS 1968-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under ERYTHROCYTES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under IMIDAZOLES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ %28%with LEUCOKININ a see ref to it%29% was see under GAMMA GLOBULINS 1975-83; LEUKOKININ %26% LEUCOKININ were see TUFTSIN 1984-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under METALLOPROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under MUSCLE PROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under OVUM 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under PEROXIDASES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under POLYSACCHARIDES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under PYRIDINES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under SERUM ALBUMIN 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under TISSUE PRESERVATION 1969-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under UTERUS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%75%29%; was see under VIRAL PROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%76%29%; was see under BLOOD COAGULATION FACTORS 1976-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%76%29%; was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1972-75 %28%Prov 1972-73%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%76%29%; was see under NUCLEOPROTEINS 1976-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; for DNA POLYMERASE ALPHA use DNA POLYMERASE II 1982-97%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; for DNA POLYMERASE EPSILON use DNA POLYMERASE II %28%NM%29% 1994-97%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under BINDING SITES, ANTIBODY 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under ERYTHROCYTES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under FLUORIDES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under GASTROINTESTINAL HORMONES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under LIPOPOLYSACCHARIDES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under LYMPHATIC DISEASES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under PEPTIDES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under PROPANOLAMINES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under RECEPTORS, ADRENERGIC 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under RECEPTORS, CHOLINERGIC 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%77%29%; was see under RNA POLYMERASES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under AMYLASES 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under ANTIBODIES, VIRAL 1978-83; was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77, was ANTI-AUSTRALIA ANTIGEN 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under CELL MEMBRANE 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under CEPHALOSPORINS 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under GUANIDINES 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under PROSTAGLANDINS 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%78%29%; was see under SEX CHROMOSOMES 1968-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%79%29%63; was see under BETA-LACTAMASES 1979-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%79%29%; was see under HYPERTENSION, RENAL 1979-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%80%29%; was RO 10-9359 see under TRETINOIN 1980-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84%28%81%29%; was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84,63-78; was see under BETA-LACTAMASES 1979-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84,73-75 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8440, EMBAY' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; DNA HELIX DESTABILIZING PROTEINS was see DNA UNWINDING PROTEINS 1980-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; MYOGLOBINURIA was heading 1965-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; RETINAL TEARS was see RETINAL DETACHMENT 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; RETINALDEHYDE was see under VITAMIN A 1968-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; see DNA POLYMERASES 1977-83; DNA POLYMERASE EPSILON was indexed under DNA POLYMERASES 1994-97%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; see DNA POLYMERASES 1977-83; for DNA POLYMERASE ALPHA see DNA POLYMERASE II 1982-97%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; see FATTY ACIDS, UNSATURATED 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was ANATOMIC MODELS see under MODELS, STRUCTURAL 1963-83; MOULAGES was see under MEDICAL ILLUSTRATION 1963-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was AURICULAR FIBRILLATION 1963-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was AURICULAR FLUTTER 1963-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1964-80 %28%Prov 1964-67%29% see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was BENZALKONIUM 1981-83, was BENZALKONIUM CHLORIDE 1968-80, was BENZALKONIUM CHLORIDE see under ANTI-INFECTIVE AGENTS, LOCAL 1967, was BENZALKONIUM CHLORIDE see under ANTISEPTICS, QUATERNARY AMMONIUM 1964-66, was BENZALKONIUM see under ANTISEPTICS, QUATERNARY AMMONIUM 1963%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was CALCIUM-DEPENDENT REGULATOR see under CALCIUM-BINDING PROTEINS 1980-83; was CALCIUM-DEPENDENT REGULATOR see under CARRIER PROTEINS 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1964-83 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was CRYOGENIC SURGERY 1963-83; CRYOTHERAPY was heading 1967-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was ESOPHAGEAL REFLUX 1964-83 %28%Prov 1964-65%29%; REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was ESOPHAGEAL REFLUX 1966-83; REGURGITATION, GASTRIC was see ESOPHAGEAL REFLUX 1979-83, was heading 1967-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was FETAL GLOBULINS 1970-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was FEVER THERAPY 1963-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was GLUTAMYL TRANSPEPTIDASE 1972-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was HOMOLOGOUS WASTING DISEASE 1964-83 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was HOMOLOGOUS WASTING DISEASE 1967-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1969-80 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was HYPERKINETIC SYNDROME 1981-83; was MINIMAL BRAIN DYSFUNCTION 1973-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was IPROVERATRIL 1964-83 %28%Prov 1964-71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was IPROVERATRIL 1972-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was MEDICINE, ORIENTAL 1966-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was MOLECULAR MODELS see under MODELS, STRUCTURAL 1969-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was NON MESH before 1984 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was TRYPANOSOMA BRUCEI 1972-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was TRYPANOSOMA GAMBIENSE 1972-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was UNITED STATES HEALTH RESOURCES ADMINISTRATION 1980-83; was see under UNITED STATES PUBLIC HEALTH SERVICE 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under AGGRESSION 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under AIR POLLUTANTS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under AMYLASES 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under ANTIBIOTICS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under ANTIBODIES, VIRAL 1978-83, was ANTI-AUSTRALIA ANTIGEN see under ANTIBODIES, VIRAL 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under BENZODIAZEPINE TRANQUILIZERS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under BINDING SITES, ANTIBODY 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under BLOOD COAGULATION FACTORS 1976-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under BLOOD PROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CAMPYLOBACTER 1976-83; was VIBRIO FETUS 1974-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CARBOXY-LYASES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CELL MEMBRANE 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CEPHALOSPORINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CEPHALOSPORINS 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CHILD BEHAVIOR DISORDERS 1968-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under CORONARY VASOSPASM 1982-83, was see under ANGINA PECTORIS 1977-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1981-83; was PLATINUM DIAMMINODICHLORIDE see under DIAMMONIUM CHLOROPLATINUM COMPOUNDS 1974-80; DIAMMONIUM CHLOROPLATINUM COMPOUNDS was heading 1974-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under ERYTHROCYTES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under ERYTHROCYTES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under FLUORIDES 1977-83; ACIDULATED PHOSPHATE FLUORIDE was see under FLUORIDES 1977-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under GASTROINTESTINAL HORMONES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under GENTAMICINS 1978-83, was see under ANTIBIOTICS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under GUANIDINES 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under HYPERTENSION, RENAL 1979-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under IMIDAZOLES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under IMMUNOGLOBULINS, FD 1975-83; LEUKOKININ %28%with LEUCOKININ a see ref to it%29% was see under GAMMA GLOBULINS 1975-83; LEUKOKININ %26% LEUCOKININ were see TUFTSIN 1984-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under LIPOPOLYSACCHARIDES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under LYMPHATIC DISEASES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under MEMBRANE PROTEINS 1978-83, was see under BLOOD PROTEINS 1977%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under METALLOPROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under MUSCLE PROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under NITROSOUREA COMPOUNDS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under NUCLEOPROTEINS 1976-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under NUTRITION 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under ORGANOIDS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under OVUM 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PEPTIDES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PEROXIDASES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PIPERIDINES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under POLYSACCHARIDES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PROPANOLAMINES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PROPANOLAMINES 1978-83; was ICI 66082 see under PROPANOLAMINES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PROSTAGLANDINS 1978-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under PYRIDINES 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under RECEPTORS, ADRENERGIC 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under RECEPTORS, CHOLINERGIC 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under RNA POLYMERASES 1977-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under SERUM ALBUMIN 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under SEX CHROMOSOMES 1968-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under THYMUS HORMONES 1977-83, was see under THYMUS EXTRACTS 1975-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under TISSUE PRESERVATION 1970-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under UTERUS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '84; was see under VIRAL PROTEINS 1975-83 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%72%29%; was see under LYMPHOID TISSUE 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%75%29%; was see under BENZANTHRACENES 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%75%29%; was see under FERTILIZATION 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%75%29%; was see under LABOR PRESENTATION 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%75%29%; was see under PLACENTA 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%75%29%; was see under SPERMATOZOA 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%76%29%; was see under MUSCLE PROTEINS 1976-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%78%29%; was see under BRAIN STEM 1978-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%79%29%; was see under MITOCHONDRIA 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%79%29%; was see under ORGANOIDS 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%79%29%; was see under RESPIRATORY SOUNDS 1980-84 %26% MOUTH BREATHING 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%79%29%; was see under TRIIODOTHYRONINE 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%80%29%; was see under CROSSING OVER %28%GENETICS%29% 1980-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85%28%82%29%; was see under PARAPROTEINEMIAS 1982-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85, Tween' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; APOLIPOPROTEIN B was see APOLIPOPROTEINS B 1985-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; APOLIPOPROTEIN C was see APOLIPOPROTEINS C 1985-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; APOLIPOPROTEIN E was see APOLIPOPROTEINS E 1985-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; CATHODE RAYS was see under RADIATION, IONIZING 1976-84, was see under RADIATION 1963-75%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; DYSCHONDRODYSPLASIAS was heading DYSCHONDROPLASIA 1963-84; SPONDYLOEPIPHYSEAL DYSPLASIA was see MUCOPOLYSACCHARIDOSIS 4 1980-84, was see ECCENTROOSTEOCHONDRODYSPLASIA 1968-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; LIPOPROTEINS, LDL RECEPTORS was see RECEPTORS, LDL 1985-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; MEMORY FOR DESIGNS TEST was heading 1973-84; APHASIA TESTS was see under LANGUAGE TESTS 1979-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; STREPTODORNASE was see DEOXYRIBONUCLEASES 1966-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; STREPTORDORNASE was see DEOXYRIBONUCLEASES 1966-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; for rRNA PROMOTER see rRNA OPERON 1990-98; for PROMOTER %28%GENETICS%29% see OPERON 1980-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; for rRNA PROMOTER use rRNA OPERON 1990-98; for PROMOTER %28%GENETICS%29% use OPERON 1980-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was ACHALASIA OF ESOPHAGUS see CARDIOSPASM 1974-84; was ACHALASIA see under CARDIOSPASM 1963-73; CARDIOSPASM was heading 1963-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was ALDRICH SYNDROME 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was ARACHNODACTYLY 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1964-84 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was CHONDRODYSTROPHIA CALCIFICANS CONGENITA 1967-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was CLEIDOCRANIAL DYSOSTOSIS 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was ENTEROCOLITIS, ACUTE 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was ESOPHAGEAL VARICES 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was EXTRAVASATION OF CONTRAST MEDIA 1981-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was FILES AND FILING 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84; GFA-PROTEIN was %28%NM%29% 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was GLIAL INTERMEDIATE FILAMENT PROTEINS see INTERMEDIATE FILAMENT PROTEINS 1983-84; GFA-PROTEIN was indexed under NERVE TISSUE PROTEINS 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was HEPATITIS B CORE ANTIGEN 1977-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was HEPATOMA, EXPERIMENTAL 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was HYPOPROCONVERTINEMIA 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was KREBS CYCLE 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was LYME ARTHRITIS see ARTHRITIS, INFECTIOUS l979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was MECILLINAM see under PENICILLANIC ACIDS 1978-84; AMDINOCILLIN PIVOXIL was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was MERCAPTOPURINE 1963-84; ARABINOSYL-6-MERCAPTOPURINE was heading 1975-91 %28%see under 6-MERCAPTOPURINE 1975-90%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was MERCAPTOPURINE 1963-84; ARABINOSYL-6-MERCAPTOPURINE was heading 1991, was see under 6-MERCAPTOPURINE 1975-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE 1984; CHEMOTACTIC PEPTIDE was see N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE 1984-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was NON MESH before 1985 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was NON MESH before 1985; MEMORY FOR DESIGNS TEST was heading 1971-84 %28%Prov 1971-72%29%; APHASIA TESTS was see under LANGUAGE TESTS 1979-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was STEIN-LEVENTHAL SYNDROME 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was THROMBOPENIA 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see SANDFLIES 1975-84; was SANDFLIES see PHLEBOTOMUS 1963-72%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see TOOTH CALCIFICATION 1975-84; was see under TOOTH CALCIFICATION 1969-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under BENZANTHRACENES 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under BRAIN STEM 1978-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under CARBOXYLIC ESTER HYDROLASES 1976-84, was see under ESTERASES 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under CROSSING OVER %28%GENETICS%29% 1980-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under FERTILIZATION 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under LABOR PRESENTATION 1963-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under LYMPHOID TISSUE 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under MITOCHONDRIA 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under MUSCLE PROTEINS 1976-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under ORGANOIDS 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under PARAPROTEINEMIAS 1982-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under PLACENTA 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under RESPIRATORY SOUNDS 1980-84 %26% MOUTH BREATHING 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under SPERMATOZOA 1975-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '85; was see under TRIIODOTHYRONINE 1979-84 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%72%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-85, was Prov 1972-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%72%29%; was see under PYRAZINES 1975-85, was Prov 1972-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%72%29%; was see under PYRIMIDINES 1975-85, was Prov 1972-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%73%29%; was see under FRACTURES 1975-85, was Prov 1973-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%73%29%; was see under PHENYLACETATES 1975-85, was Prov 1973-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; for MUSHROOMS use BASIDIOMYCOTA 1963-98; for AGARICACEAE use BASIDIOMYCOTA 1966-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under ANTIBIOTICS 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under BENZIMIDAZOLES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under CONTRACEPTIVES, ORAL 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under CYCLOPHOSPHAMIDE 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under DISABILITY EVALUATION 1966-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under ETHANOLAMINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under FILARIOIDEA 1969-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under GUANIDINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under INDOLES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under METHYLTRANSFERASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under NITROSAMINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under OLIGOSACCHARIDES 1966-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under OXIDOREDUCTASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under PEPTIDE PEPTIDOHYDROLASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under PEPTIDES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under PHORBOLS 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under PIPERAZINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%75%29%; was see under PROPANOLAMINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%76%29%; was see under BLOOD COAGULATION FACTORS 1976-85; FACTOR VIII RELATED ANTIGEN, previously in the Supplementary Chemical File, was mapped to both FACTOR VIII %26% ANTIGENS 1977-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%76%29%; was see under CATECHOLAMINES 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%76%29%; was see under CONTRACEPTIVES, ORAL 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%76%29%; was see under NALOXONE 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%76%29%; was see under OLIGONUCLEOTIDES 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%76%29%; was see under PEROXIDASES 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under ASSISTED CIRCULATION 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under GANGLIOSIDES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under GASTROINTESTINAL HORMONES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under IMIDAZOLES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under IMMUNOENZYME TECHNIQUES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under QUINAZOLINES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%77%29%; was see under RECEPTORS, STEROID 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%78%29%; was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%78%29%; was see under ISOQUINOLINES 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%78%29%; was see under PYRROLIDINES 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%78%29%; was see under THROMBOXANES 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%79%29%; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%79%29%; was see under CARDIAC OUTPUT 1979-85; was see CARDIAC OUTPUT 1974-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%79%29%; was see under GENTAMICINS 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%79%29%; was see under NITROIMIDAZOLES 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%79%29%; was see under OXAZOLES 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%79%29%; was see under SURGERY, OPERATIVE 1979-85, was in Cat E %26% H 1979-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%80%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%80%29%; was see under AUDIOMETRY 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%80%29%; was see under ENDOPEPTIDASES 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%80%29%; was see under PHOSPHOLIPASES 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%80%29%; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%81%29%; was see under VAGOTOMY 1981-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%81%29%; was see under VASCULAR SURGERY 1981-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%82%29%; was see under PERITONEAL DIALYSIS 1982-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%84%29%; was see under STEM CELLS 1984-85; EC CELLS was see TUMOR STEM CELLS 1986-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86%28%Mar 81%29%; was see under PHOTOCHEMOTHERAPY 1981-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; CALCIUM PHOSPHOLIPID-DEPENDENT PROTEIN KINASE was CALCIUM-PHOSPHOLIPID DEPENDENT PROTEIN KINASE 1986-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; GNATHOSTOMA %26% THELAZIA were see under SPIRUROIDEA 1963-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; LEISHMANIA TROPICA MINOR was LEISHMANIA MINOR see LEISHMANIA TROPICA 1986-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; MINK ENCEPHALOPATHY VIRUS was heading 1991-92, was see under VERTEBRATE VIRUSES, UNCLASSIFIED %28%now VIRUSES, UNCLASSIFIED%29% 1975-90; TRANSMISSIBLE ENCEPHALOPATHY VIRUS OF MINK was see MINK ENCEPHALOPATHY VIRUS 1975-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; OPERATOR %28%GENETICS%29% was see OPERON 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; PLATELETPHERESIS was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; SKID ROW ALCOHOLICS was heading 1975-95 %28%see under ALCOHOLISM 1975%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; VASOPROSTAN %28%now ALPROSTADIL%29% was indexed under VASODILATOR AGENTS 1995-97%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; for MUSHROOMS see BASIDOMYCETES 1986-98, see MUSHROOMS 1963-85; for CORTINARIUS see CORTINARIUS 1991-96, see AGARICALES 1986-90; for AGARICACEAE see AGARICACEAE 1975-85, see MUSHROOMS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; see CEPHALOSPORIUM 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; see ISOQUINOLINES 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; see PIPERAZINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; see VASOPROSTAN %28%NM%29% 1995-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was ACANTHOCHEILONEMA 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was ANGIOSARCOMA 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was ASCAROIDEA 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was CYTOPLASMIC FILAMENTS 1980-85; was MICROFILAMENTS see under CYTOPLASM 1977-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was DINOFLAGELLATES 1979-85, was DINOFLAGELLATES see under MASTIGOPHORA 1969-78; RED TIDE was heading 1979-85, was see under MASTIGOPHORA 1974-78; GONYAULAX, GYMNODINIUM %26% PERIDINIUM were see RED TIDE 1979-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was ENBUCRYLATE 1980-85; was BUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was HEMORRHAGIC THROMBOCYTHEMIA 1963-85 %28%Prov 1963-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was HEMORRHAGIC THROMBOCYTHEMIA 1967-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was HOOKWORMS 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1966-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was IRIDOCYCLITIS 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was MOUTH AND TEETH %28%NON MESH%29% 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was NON MESH before 1986 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was OTITIS MEDIA, SEROUS see under OTITIS MEDIA 1979-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was PREMENSTRUAL TENSION 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was PROFESSIONAL STANDARDS REVIEW ORGANIZATIONS 1974-85, was PSRO 1973 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was PURPURA, THROMBOPENIC 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was PURPURA, THROMBOTIC THROMBOPENIC 1965-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was SOY BEANS 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was SOY BEANS 1963-85; was in Cat J only 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was SPLENOPORTOGRAPHY 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was UPPER VOLTA 1963-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see ANEMIA, APLASTIC 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see CHROMOSOMES, HUMAN, 21-22 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see ONCOGENES 1983-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ANTIBIOTICS 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ARGIPRESSIN 1979-85; was DEAMINO ARGININE VASOPRESSIN see under VASOPRESSIN 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ASSISTED CIRCULATION 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under AUDIOMETRY 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under BENZIMIDAZOLES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under BENZODIAZEPINE TRANQUILIZERS 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under BLOOD COAGULATION FACTORS 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under CARDIAC OUTPUT 1979-85; was see CARDIAC OUTPUT 1974-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under CATECHOLAMINES 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under CONTRACEPTIVES, ORAL 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under CONTRACEPTIVES, ORAL 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under CYCLOPHOSPHAMIDE 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under DISABILITY EVALUATION 1966-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ETHANOLAMINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ETHANOLAMINES 1978-85; was AH 5158 see under ETHANOLAMINES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under FILARIOIDEA 1969-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under FRACTURES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under GANGLIOSIDES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under GASTROINTESTINAL HORMONES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under GENTAMICINS 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under GUANIDINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under IMIDAZOLES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under IMMUNOENZYME TECHNIQUES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under INDOLES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ISOQUINOLINES 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under METHYLTRANSFERASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under NADH, NADPH OXIDOREDUCTASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under NALOXONE 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under NITROIMIDAZOLES 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under NITROSAMINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under NITROSOUREA COMPOUNDS 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under OLIGONUCLEOTIDES 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under OLIGOSACCHARIDES 1966-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under OXAZOLES 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under OXIDOREDUCTASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PEPTIDE PEPTIDOHYDROLASES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PEPTIDE PEPTIDOHYDROLASES 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PEPTIDES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PERITONEAL DIALYSIS 1982-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PEROXIDASES 1976-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PHENYLACETATES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PHORBOLS 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PHOSPHOLIPASES 1980-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PHOTOCHEMOTHERAPY 1981-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PIPERAZINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PROLINE 1980-85; SQ 14225 was see CAPTOPRIL 1980-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PROPANOLAMINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PYRAZINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PYRIMIDINES 1975-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under PYRROLIDINES 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under QUINAZOLINES 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under RECEPTORS, STEROID 1977-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under STEM CELLS 1984-85; EC CELLS was see TUMOR STEM CELLS 1986-96%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under SURGERY, OPERATIVE 1979-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under THROMBOXANES 1978-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under VAGOTOMY 1981-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '86; was see under VASCULAR SURGERY 1981-85 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%72%29%; was see under CYTOSINE 1972-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%73%29%; was see under ANTIGENS 1973-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%73%29%; was see under HEMOGLOBINS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%73%29%; was see under INDICATORS AND REAGENTS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%73%29%; was see under OVALBUMIN 1969-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under ANGIOTENSINS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under ANISOLES 1973-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under ANTHRACENES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under BENZODIAZEPINONES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under BENZOFURANS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under BONE RESORPTION 1966-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under BUTYROPHENONES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under DIBENZAZEPINES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under FURANS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under KANAMYCIN 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under METHYL ETHERS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under MYCOBACTERIUM 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under NITROBENZENES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under PHORBOLS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under PROPYLAMINES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under PTERIDINES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%75%29%; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%76%29%; was see under AMINES 1976-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%76%29%; was see under SULFATASES 1976-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%77%29%; was see under BENZOPYRANS 1977-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%77%29%; was see under DRUGS 1977-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%77%29%; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%77%29%; was see under RECEPTORS, HISTAMINE 1977-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%78%29%; was see under ANGIOTENSINS 1978-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%78%29%; was see under ANIMALS 1978-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%78%29%; was see under GLUCOSIDASES 1978-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under ANIMALS 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under CALCIUM-BINDING PROTEINS 1980-86, was see under CARRIER PROTEINS 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under GLUCOSAMINE 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under GLUTAMATES 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under MORPHINANS 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%79%29%; was see under TRANSFERASES 1979-86; was SIALYLTRANSFERASE see under TRANSFERASES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%80%29%; was see under BETA GLOBULINS 1980-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%80%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%80%29%; was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%81%29%; was see under HEPATITIS B ANTIGENS 1981-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%81%29%; was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%82%29%; was see under DIATRIZOATE 1982-86; was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%83%29%; was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMIMG, COMPUTER see under COMPUTERS 1966-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%83%29%; was see under INFORMATION SYSTEMS 1983-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%84%29%; was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87%28%86%29%; was see under REIMBURSEMENT MECHANISMS 1986; was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; ANALGESICS, ANTI-INFLAMMATORY was heading 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, %26% THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE %26% RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; CAFFEINE RECEPTORS, METHYLXANTHINE RECEPTORS, %26% THEOPHYLLINE RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, CAFFEINE %26% RECEPTORS, THEOPHYLLINE were see RECEPTORS, PURINERGIC 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; CENTENARIANS, NONAGENARIANS, %26% OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, %26% OCTOGENARIAN 1987-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; CENTENERIANS, NONAGENARIANS, %26% OCTOGENARIANS were CENTENARIAN, NONAGENARIAN, %26% OCTOGENARIAN 1987-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; CHORIONIC GONADOTROPIN RECEPTORS was see RECEPTORS, GONADOTROPIN 1986-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; FOLLITROPIN RECEPTORS was see RECEPTORS, FSH 1987-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; INTERVENING SEQUENCES %26% INTRONS were see BASE SEQUENCE 1981-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; IOXAGLATE MEGLUMINE was IOXAGLATE, MEGLUMINE 1987-93; IOXAGLATE SODIUM was IOXAGLATE, SODIUM 1987-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; NIMODIPINE was indexed under NICOTINIC ACIDS 1981-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; POLISHES was see OILS 1978-86; was see under OILS 1966-77 %28%Prov 1966-74%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; POLISHES was see OILS 1978-86; was see under OILS 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; PROTO-ONCOGENE PROTEIN ERBA was %28%NM%29% 1987-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; PROTO-ONCOGENE PROTEIN ERBA was indexed under PROTO-ONCOGENE PROTEINS 1987-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; SESAME OIL was heading 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; SIGNAL INTERPRETATION, COMPUTER-ASSISTED was see DIAGNOSIS, COMPUTER-ASSISTED 1986-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; VENO-OCCLUSIVE DISEASE OF LIVER was see HEPATIC VENO-OCCLUSIVE DISEASE 1987-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; use NIMODIPINE %28%NM%29% 1981-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was ANEURYSM, MYCOTIC 1964-86 %28%Prov 1964-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was ANEURYSM, MYCOTIC 1970-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was COMPUTER PROGRAMS see under COMPUTERS 1983-86, was PROGRAMS, COMPUTER see COMPUTERS 1979-82, was PROGRAMMING, COMPUTER see under COMPUTERS 1966-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was COTTONSEED 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was DIPALMITOYL PHOSPHATIDYLCHOLINE see PULMONARY SURFACTANT 1977-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was DRUG ADMINISTRATION %28%NON MESH%29% before 1987 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was INJECTIONS, INTRATHECAL 1963-86 %28%Prov 1963-65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was INJECTIONS, INTRATHECAL 1966-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was INTESTINAL PSEUDO-OBSTRUCTION, IDIOPATHIC see under INTESTINAL OBSTRUCTION 1981-86; PARALYTIC ILEUS was see under INTESTINAL OBSTRUCTION 1975-86, was Prov 1971-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was LINSEED 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was OSTEOPATHY 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was PULMONARY SURFACTANT 1971-86 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was PULMONARY SURFACTANT 1973-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was RETROLENTAL FIBROPLASIA 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was SEMILUNAR CARTILAGES 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was THYROIDITIS, LYMPHOMATOUS 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was VENEREAL DISEASES 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see ANTIGENS, IMMUNE RESPONSE 1981-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see AUTOMATION 1963-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see BASE SEQUENCE 1980-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see HYPERPHAGIA 1981-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see HYPERTHYROIDISM 1974-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see INFUSIONS, PARENTERAL 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see TRANSPOSITION OF GREAT VESSELS 1984-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see URTICARIA PIGMENTOSA 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under AMINES 1976-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANGIOTENSINS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANGIOTENSINS 1978-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANIMALS 1978-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANIMALS 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANISOLES 1973-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANTHRACENES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under ANTIGENS 1973-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BENZAZEPINES 1979-86; was CRD 401 see under BENZAZEPINES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BENZODIAZEPINONES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BENZOFURANS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BENZOPYRANS 1977-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BETA GLOBULINS 1980-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BONE RESORPTION 1966-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under BUTYROPHENONES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under CALCIUM-BINDING PROTEINS 1980-86, was see under CARRIER PROTEINS 1979%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under CYTOSINE 1972-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under DIATRIZOATE 1982-86; was MEGLUMINE DIATRIZOATE see under DIATRIZOATE 1975-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under DIBENZAZEPINES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under DRUGS 1977-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under FURANS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under GLUCOSAMINE 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under GLUCOSIDASES 1978-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under GLUTAMATES 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under HEMOGLOBINS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under HEPATITIS B ANTIGENS 1981-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under INDICATORS AND REAGENTS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under INFORMATION SYSTEMS 1983-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under IRON 1975-86; FERRIC AND FERROUS COMPOUNDS was see under IRON 1964-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under KANAMYCIN 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under METHYL ETHERS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under MORPHINANS 1979-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under MYCOBACTERIUM 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under NITROBENZENES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1980-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under NURSING PROCESS 1980-86, was NURSING DIAGNOSIS see under NURSING CARE 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under OVALBUMIN 1969-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under PHORBOLS 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under PODOPHYLLOTOXIN 1981-86; was VP 16-213 see under PODOPHYLLOTOXIN 1976-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under PROPYLAMINES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under PTERIDINES 1975-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under RECEPTORS, ENDOGENOUS SUBSTANCES 1977-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under RECEPTORS, HISTAMINE 1977-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under REIMBURSEMENT MECHANISMS 1986; was REIMBURSEMENT, PROSPECTIVE see under REIMBURSEMENT MECHANISMS 1979-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under RICKETTSIACEAE INFECTIONS 1977-86; was see under RICKETTSIAL DISEASES 1965-76; was see under ROCKY MOUNTAIN SPOTTED FEVER 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under SULFATASES 1976-86 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under TRANSFERASES 1979-86; was SIALYLTRANSFERASE see under TRANSFERASES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '87; was see under VERAPAMIL 1984-86; was D 600 see under IPROVERATRIL 1975-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%75%29%; was see under ADRENOCORTICOTROPIC HORMONE 1987; was see under CORTICOTROPIN 1974-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%75%29%; was see under FLUOROSCOPY 1975-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%75%29%; was see under MYOCARDIAL REVASCULARIZATION 1975-87%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%75%29%; was see under PHOTOGRAPHY 1975-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%75%29%; was see under PROBABILITY 1973-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%81%29%; was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%84%29%; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88%28%85%29%; was see under GENES, REGULATOR 1985-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88,63-66; was see TRACHEOTOMY 1967-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; 64-66 %28%Prov%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; ANGIOTENSIN I-CONVERTING ENZYME INHIBITOR was see TEPROTIDE 1991-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; ANTI-HIV POSITIVITY was ANTI-HIV POSITIVE 1988-93; HIV ANTIBODY POSITIVITY was HIV ANTIBODY POSITIVE 1988-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; DIFFERENTIATION ANTIGENS, HAIRY CELL LEUKEMIA was see ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-91; LEU ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; MONACOLIN K was indexed under NAPHTHALENES 1981-98 %26% ANTIBIOTICS 1980%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; MONOUNSATURATED FATTY ACIDS was see FATTY ACIDS, MONOUNSATURATED 1988-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; for MONACOLIN K use LOVASTATIN %28%NM%29% 1980-98 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; for both the publication type %26% the main heading 1988-90; main heading only 1991 forward%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was AMINO ACYL T RNA 1978-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under ADRENOCORTICOTROPIC HORMONE 1987; was see under CORTICOTROPIN 1974-86%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under FLUOROSCOPY 1975-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under GENES, REGULATOR 1985-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under MEDICINE, ORIENTAL TRADITIONAL 1984-87; was MEDICINE, CHINESE see under MEDICINE, ORIENTAL 1981-83; was CHINESE MEDICINE see under MEDICINE, ORIENTAL 1967-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under MYOCARDIAL REVASCULARIZATION 1975-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under PHOTOGRAPHY 1975-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under PORTASYSTEMIC SHUNT, SURGICAL 1981-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '88; was see under PROBABILITY 1973-87 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%75%29%; was GLYCOGENOSIS 5 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%75%29%; was see under ADRENAL GLANDS 1969-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%75%29%; was see under ASCARIASIS 1967-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%75%29%; was see under DITERPENES 1975-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%75%29%; was see under ORGANOIDS 1977-88; was see under CELLULAR INCLUSIONS 1974-76; was see under CYTOPLASM 1966-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%75%29%; was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%76%29%; was GLYCOGEN DEBRANCHING ENZYME see under GLUCOSYLTRANSFERASES 1976-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%76%29%; was see under KALLIKREINS 1976-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%77%29%; was see under RADIOIMMUNOASSAY 1977-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%77%29%; was see under RECEPTORS, HISTAMINE 1977-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%79%29%; was see under DNA NUCLEOTIDYLTRANSFERASES 1979-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%80%29%; was see under ADIPOSE TISSUE 1980-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%80%29%; was see under COMPUTERS 1980-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%81%29%; was see under APPETITE DISORDERS 1981-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%81%29%; was see under ESOPHAGEAL DISEASES 1981-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%82%29%; was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%83%29%; was see under EVALUATION STUDIES 1983-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%84%29%; was see under CONTACT LENSES, HYDROPHILIC 1984-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%85%29%; was see under RECEPTORS, ESTROGEN 1985-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%86%29%; was see under DIAGNOSTIC RELATED GROUPS 1986-88; was SEVERITY OF ILLNESS CLASSIFICATION see CASE MIX 1984-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%87%29%; was see under HLA-ANTIGENS 1987-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%87%29%; was see under HLA-D ANTIGENS 1987-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%88%29%; was see under DRUGS 1988 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89%28%88%29%; was see under HEALTH SERVICES 1988 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; BURKITT LEUKEMIA was BURKITT%27%S LEUKEMIA 1989-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; CARCINOMA, TRABECULAR was see CARCINOMA, MERKEL CELL 1992-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; CUTANEOUS LEPROSY %26% NODULAR LEPROSY were see LEPROSY, LEPROMATOUS 1989-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; ENUCLEATION, EYE was see EYE ENUCLEATION 1989-92 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; ERYTHROLEUKEMIA was heading 1973-88 %28%Prov 1968-72%29%; ERYTHREMIC MYELOSIS was heading 1963-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; ERYTHROLEUKEMIA was heading 1973-88; ERYTHREMIC MYELOSIS was heading 1963-83%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; ESCULIN was see under BIOFLAVONOIDS 1966-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; FRUCTOSE INTOLERANCE was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; INCIDENCE STUDIES was heading 1989 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, %26% LEU-M4 ANTIGENS were see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; LEUKEMIA, MYELOCYTIC was heading 1963-88; LEUKEMIA, GRANULOCYTIC was see LEUKEMIA, MYELOCYTIC 1974-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; LEUKEMIA, MYELOCYTIC, CHRONIC %26% LEUKEMIA, MYELOGENOUS, CHRONIC were see LEUKEMIA, MYELOCYTIC 1974-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; LEUKEMIA, MYELOMONOCYTIC was see LEUKEMIA, MYELOCYTIC 1981-88; LEUKEMIA, NAEGELI-TYPE was see LEUKEMIA, MYELOCYTIC 1975-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; MAIC, MYCOBACTERIUM AVIUM-INTRACELLULARE %26% MYCOBACTERIUM INTRACELLULARE were see MYCOBACTERIUM AVIUM 1987-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; PHYSALAEMIN was see under KININS 1977-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 %28%was CALCIUM CHANNEL BLOCKER RECEPTOR %28%NM%29% 1983-92%29%; CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS %26% RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; RECEPTORS, CALCIUM CHANNEL BLOCKER was heading 1993 %28%was CALCIUM CHANNEL BLOCKER RECEPTOR %28%NM%29% 1983-92, was indexed under RECEPTORS, NICOTINIC 1983-92%29%; CALCIUM CHANNEL ANTAGONIST RECEPTORS, CALCIUM CHANNEL BLOCKER RECEPTORS %26% RECEPTORS, CALCIUM CHANNEL ANTAGONIST were see RECEPTORS, CALCIUM CHANNEL BLOCKER 1993%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; SIALOLITHIASIS was see SALIVARY DUCT CALCULI 1966-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; VENTILATORS, MECHANICAL, WEANING %26% VENTILATORS, PULMONARY, WEANING were see VENTILATOR WEANING 1989-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was ABSCESS, PERITONSILLAR 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was NM 1987-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was ANTIGENS, IMMUNE RESPONSE 1981-88; I-A-ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS CLASS II 1987-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was APPETITE DISORDERS 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was CHORDOTOMY 1966-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was DOPPLER ECHOCARDIOGRAPHY see ECHOCARDIOGRAPHY 1985-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was FIBROSITIS 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was GENETIC INTERVENTION 1973-88; was in Cat E %26% G 1973-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was GENETIC MARKER 1980-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was GLUCOSEPHOSPHATASE DEFICIENCY 1964-88 %28%Prov 1964%29%; VON GIERKE%27%S DISEASE was see GLYCOGENOSIS 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was GLYCOGEN DEBRANCHING ENZYME see under GLUCOSYLTRANSFERASES 1976-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was GLYCOGENOSIS 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was GLYCOGENOSIS 5 see under GLYCOGENOSIS 1975-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was LEUKEMIA, MEGAKARYOBLASTIC 1987-88; LEUKEMIA, MEGAKARYOCYTIC was see THROMBOCYTHEMIA, HEMORRHAGIC 1967-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was LEUKEMIA, MONOBLASTIC 1967-88; LEUKEMIA, SCHILLING-TYPE was see LEUKEMIA, MONOCYTIC 1975-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was LEUKEMIA, MYELOBLASTIC 1967-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was MOUTH AND TOOTH DISEASES %28%NON MESH%29% 1975-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was Non-MeSH before 1989 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was RESPIRATORS 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was SARCOMA, OSTEOGENIC 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was SMOKE INHALATION see BURNS, INHALATION 1963-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was heading 1963-64 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see BODY WEIGHT 1966-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see LEUKEMIA, LYMPHOCYTIC 1974-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see LEUKEMIA, MONOCYTIC 1974-88; LEUKEMIA, MONOCYTIC was heading 1963-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see LEUKEMIA, MYELOCYTIC 1981-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see ZOLLINGER-ELLISON SYNDROME 1982-88; was see ISLET CELL TUMOR 1981%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under ADIPOSE TISSUE 1980-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under ADRENAL GLANDS 1969-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under APPETITE DISORDERS 1981-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under ASCARIASIS 1967-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under COMPUTERS 1980-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under CONTACT LENSES, HYDROPHILIC 1984-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under DIAGNOSTIC RELATED GROUPS 1986-88; was SEVERITY OF ILLNESS CLASSIFICATION see CASE MIX 1984-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under DITERPENES 1975-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under DNA NUCLEOTIDYLTRANSFERASES 1979-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under DRUGS 1988 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under ESOPHAGEAL DISEASES 1981-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under EVALUATION STUDIES 1983-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under EXERTION %26% SPORTS 1963-74; EXERCISE, ISOMETRIC was see under EXERTION 1977-83, was see ISOMETRIC CONTRACTION 1984-88; EXERCISE, PHYSICAL was see EXERTION 1976-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under HEALTH SERVICES 1988 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under HLA-D ANTIGENS 1987-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under KALLIKREIN 1976-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under ORGANIZATION AND ADMINISTRATION 1982-88%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under ORGANOIDS 1977-88; was see under CELLULAR INCLUSIONS 1974-76; was see under CYTOPLASM 1966-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under RADIOGRAPHIC IMAGE ENHANCEMENT 1982-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under RADIOIMMUNOASAY 1977-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under RECEPTORS, ESTROGEN 1985-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under RECEPTORS, HISTAMINE 1977-88 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '89; was see under RECORDS 1979-88; was see under MEDICAL RECORDS 1963-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8GS, Alcian Blue' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8GX, Alcian Blue' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8MOP' = 0).
% 42.08/41.93 fof(interp, fi_functors, '8th planet from sun with 2 moons; no qualif ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 11 2001 Attack' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Aminoacridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Dimethylaminomethyl 10 hydroxycamptothecin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Fluoro 17 Hydroxycortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Fluorocortisol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Fluorohydrocortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Octadecenoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 Oxoxanthene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 alpha Fludrohydrocortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 alpha Fluoro 17 Hydroxycorticosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 alpha Fluorohydrocortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 alpha-Fluoro-17-Hydroxycorticosterone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 alpha-Fluorohydrocortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 beta Arabinofuranosyladenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 beta D Arabinofuranosyladenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 cis Halorhodopsin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 ene Tetrahydrocannabinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9 trans,12 trans Octadecadienoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,10 Epoxypalmitic Acid Hydrase' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,10-Dimethyl-1,2-benzanthracene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,10-Secoergosta-5,7,10%28%19%29%,22-tetraene-3 beta,25-diol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,10-Secoergosta-5,7,10%28%19%29%,22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3.%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,11 epoxymethano PGH2' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,11-epoxymethano-PGH2' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,12 Octadecadienoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,12-Octadecadienoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,3%27%%27% Di O Acetylmidecamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,3%27%%27% Diacetylmidecamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,3%27%%27%-Di-O-Acetylmidecamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9,3%27%%27%-Diacetylmidecamycin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-%28%%28%2-Hydroxyethoxy%29%methyl%29%guanine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-%28%5-O-Phosphono-beta-D-arabinofuranosyl%29%-9H-purin-6-amine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-11-2001 Attack' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-11-2001 Attacks' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Amino-1,2,3,4-Tetrahydroacridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Aminoacridine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Dimethylaminomethyl-10-hydroxycamptothecin' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano%28%3,2-g%29%quinoline-2,8-dicarboxylic acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Fluoro-17-Hydroxycortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Fluorocortisol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Fluorohydrocortisone' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Octadecenoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-Oxoxanthene' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-beta-Arabinofuranosyladenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-beta-D-Arabinofuranosyladenine' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-cis-Retinoic Acid Receptor' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-ene-Tetrahydrocannabinol' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9-trans,12-trans-Octadecadienoic Acid' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%66%29%; was PIMARICIN 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%72%29%; was RHODOPSEUDOMONAS SPHEROIDES 1972-89 %28%see under RHODOPSEUDOMONAS 1972-73%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%66-67; was see under AZIRINES 1975-89; was heading 1966-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was HAEMOPHILUS VAGINALIS see under HAEMOPHILUS 1975-89; CORYNEBACTERIUM VAGINALE was see GARDNERELLA VAGINALIS 1983-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was MEDIAN FOREBRAIN BUNDLE see under NEURAL PATHWAYS 1975-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under AMIDINES 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under DEATH 1974-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under EPIDEMIOLOGIC METHODS 1975-89; PREVALENCE STUDIES was heading 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under GLUCOSE 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under HEALTH SURVEYS 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under NEUROGLIA 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under PHENYLPROPIONATES 1978-89; was see under BENZOPHENONES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under POLYSACCHARIDES 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under POXVIRUS INFECTIONS 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under RETICULOENDOTHELIOSIS 1966-75; was HISTIOCYTOSIS X 1975-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under SODIUM CHLORIDE 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%75%29%; was see under TOE JOINT 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%76%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%76%29%; was see under EMERGENCY MEDICAL SERVICES 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%76%29%; was see under PYRROLES 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%76%29%; was see under RUNNING 1980-89; was see under SPORTS 1976-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%76%29%; was see under SPORTS 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%77%29%; was P-AMINOBENZOIC ACID see under AMINOBENZOIC ACIDS 1977-89; was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76; was PARA-AMINOBENZOIC ACID 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%77%29%; was see under FINGER JOINT 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%77%29%; was see under PEPTIDES 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%77%29%; was see under SPORTS 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under EUTHANASIA 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under HEALTH FACILITY ADMINISTRATORS 1978-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under PHENYLPROPIONATES 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under SUGAR PHOSPHATES 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%78%29%; was see under URACIL NUCLEOTIDES 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%79%29%; was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%79%29%; was see under HEALTH 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%79%29%; was see under INDENES 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%79%29%; was see under RIBONUCLEOSIDES 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%80%29%; was see under FINANCIAL MANAGEMENT 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%80%29%; was see under HEALTH 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%80%29%; was see under SALICYLIC ACIDS 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%80%29%; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%81%29%; was see under PERSONALITY DISORDERS 1981-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%82%29%; was see under ORGANIZATIONS 1982-89; was NATIONAL ACADEMY OF SCIENCES see under ORGANIZATIONS 1980-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%83%29%; was see under SPORTS 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%83%29%; was see under STRABISMUS 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%83%29%; was see under STRESS, PSYCHOLOGICAL 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%84%29%; was see under GOVERNMENT 1984-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%86%29%; was see under ASSISTED CIRCULATION 1986-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%86%29%; was see under MOTHERS 1986-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%87%29%; was see under ADMINISTRATION, TOPICAL 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%87%29%; was see under SPORTS 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%88%29%; was see under DELIVERY OF HEALTH CARE 1988-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90%28%Aug 77%29%; was in Cat E %26% H Aug 77-79; was see under RESEARCH DESIGN 1977-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '9015, Bayer' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; B-CELL GROWTH FACTOR was see INTERLEUKIN-4 1990-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; BENECKEA was see under VIBRIONACEAE 1978-89, was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; BENECKEA was see under VIBRIONACEAE l978-89, was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; BONE LOSS, PERIMENOPAUSAL; BONE LOSS, POSTMENOPAUSAL; PERIMENOPAUSAL BONE LOSS; %26% POSTMENOPAUSAL BONE LOSS were see OSTEOPOROSIS 1987-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; CD73 ANTIGENS was CD73 ANTIGEN 1992-93 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; CLUSTERING was see SPACE-TIME CLUSTERING 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; CO-VIDARABINE %28%now PENTOSTATIN%29% was indexed under VIDARABINE/*analogs %26% derivatives 1976-97%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; CORRESPONDENCE was see WRITING 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; DENTAL PROSTHESIS, SURGICAL was see DENTAL IMPLANTATION 1975-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; EPSTEIN-BARR VIRUS TRANS-ACTING FACTOR was see TRANSACTIVATORS 1990-92; LOR PROTEINS %26% PX PROTEINS were see TRANS-ACTIVATORS 1990%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; GLA-PROTEIN was see OSTEOCACLIN 1990-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; GLA-PROTEIN was see OSTEOCALCIN 1990-96 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; LIFE TABLE METHODS was see ACTUARIAL ANALYSIS 1979-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; LINEAR REGRESSION was see REGRESSION ANALYSIS 1990-93%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; MEROMYOSINS was heading 1971-90 %28%Prov 1971-73%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; MEROMYOSINS was heading 1974-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; MYELOID ANTIGEN EXPRESSION was heading 1994 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; N CADHERIN was NM 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; N CADHERIN was indexed under CADHERINS 1994-95; LIVER CELL ADHESION MOLECULES was see CELL ADHESION MOLECULES 1990-95%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; PROSTHESIS, PENILE was see PENILE PROSTHESIS 1990 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; T-LYMPHOTROPIC VIRUS TYPE III INFECTION, HUMAN was HUMAN T-LYMPHOTROPIC VIRUS TYPE III INFECTION see ACQUIRED IMMUNODEFICIENCY SYNDROME 1989; HIV INFECTION was see ACQUIRED IMMUNODEFICIENCY SYNDROME 1988-89; HTLV-III INFECTION %26% HTLV-III-LAV INFECTION were see ACQUIRED IMMUNODEFICIENCY SYNDROME 1987-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; for CO-VIDARABINE use PENTOSTATIN 1982-97 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; see PROPIONATES 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; use ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE to search CD4 ANTIGENS 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; use RHEUMATIC DISEASES to search RHEUMATISM 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTI-ANTIBODIES 1966-89 %28%Prov 1966%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTI-ANTIBODIES 1967-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTIBODY-TOXIN CONJUGATES 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTIGENS, DIFFERENTIATION, B LYMPHOCYTE 1988-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTIGENS, DIFFERENTIATION, T LYMPHOCYTE 1988-89; T8 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTIGENS, HETEROGENETIC 1972-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTIGENS, HETEROGENETIC 1972-89 %28%Prov 1966-71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTINUCLEAR FACTORS 1966-89 %28%Prov 1966-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ANTINUCLEAR FACTORS 1970-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was AORTOCORONARY BYPASS 1973-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was AORTOCORONARY BYPASS 1973-89 %28%Prov 1972%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was B LYMPHOCYTES 1973-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was BIAS see RESEARCH 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was BONE AND BONES/transplantation 1966-89; was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was BONE MARROW/transplantation 1966-89; was heading 1964-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CANNABIS ABUSE 1981-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CD4 ANTIGENS see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CEREBELLOPONTILE ANGLE 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CITROVORUM FACTOR 1964-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was COLOR BLINDNESS 1963-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CORNEA/transplantation 1966-89; was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CORNEAL DYSTROPHIES 1963-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was CORTICOTROPIN RELEASING HORMONE 1974-89; was CORTICOTROPIN RELEASING FACTOR 1968-73%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was DEOXYADENOSINE 1971-89 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was DEOXYADENOSINE 1973-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ELECTROANALGESIA see under ELECTROTHERAPY 1984-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ELECTROANALGESIA see under ELECTROTHERAPY l984-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ELECTROTHERAPY 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ENV GENE see GENES, VIRAL 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ERGOCALCIFEROL 1967-89; was VITAMIN D 2 1963-66 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was ETHYLENE DIBROMIDES see under HYDROCARBONS, BROMINATED 1977-89; was ETHYLENE DIBROMIDE see under HYDROCARBONS, BROMINATED 1975-76; ETHYLENE DIBROMIDES was see under HYDROCARBONS, BROMINATED 1977-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was EXOSTOSES, MULTIPLE 1968-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was GAG GENE see GENES, VIRAL 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was GIEDION-LANGER SYNDROME see EXOSTOSES, MULTIPLE 1968-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was GOUTY ARTHRITIS 1989 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HAEMOPHILUS VAGINALIS see under HAEMOPHILUS 1975-89; CORYNEBACTERIUM VAGINALE was see GARDNERELLA VAGINALIS 1983-91%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HEART/transplantation 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HEMORRHAGE, GASTROINTESTINAL 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HEMORRHAGE, ORAL 1967-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HEMORRHAGE, POSTPARTUM 1963-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HERPES ZOSTER, OCULAR 1963-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HYDROXYTRYPTOPHAN 1963-89 %28%Prov 1963-65%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was HYDROXYTRYPTOPHAN 1965-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was INTERLEUKIN 1 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was INTERLEUKIN 2 1987-89; was MITOGENIC FACTORS, LYMPHOCYTE 1983-86; was MITOGENIC FACTOR see under LYMPHOKINES 1978-82%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was INTERLEUKIN 3 1987-89; GROWTH FACTOR, MAST-CELL was see INTERLEUKIN-3 1987-94%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was KALLIKREIN-TRYPSIN INACTIVATOR 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was KIDNEY/transplantation 1966-89; was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was KITASAMYCINS see under ANTIBIOTICS 1976-80; was see LEUCOMYCINS 1981-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was LENS DISLOCATION AND SUBLUXATION 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was LIVER/transplantation 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was LUNG/transplantation 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was MEDIAN FOREBRAIN BUNDLE see under NEURAL PATHWAYS 1975-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was MID ATLANTIC REGION 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was NEW HEBRIDES 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was NIGHT BLINDNESS see NYCTALOPIA 1963-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was NON MESH 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was NON MESH before 1990 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was OPHTHALMIA 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was P-AMINOBENZOIC ACID see under AMINOBENZOIC ACIDS 1977-89; was PARA-AMINOBENZOIC ACID see under AMINOBENZOIC ACID 1965-76; was PARA-AMINOBENZOIC ACID 1963-64%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was PANCREAS/transplantation 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was PIMARICIN 1973-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was POL GENE see GENES, VIRAL 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was RECEPTORS, INTERLEUKIN 2 1989; CD25 ANTIGENS was CD25 ANTIGEN see RECEPTORS, INTERLEUKIN-2 1989-92%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was RHEUMATISM 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was RHODOPSEUDOMONAS SPHEROIDES 1972-89 %28%see under RHODOPSEUDOMONAS 1972-73%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was SEMILUNAR GANGLION see under TRIGEMINAL NERVE 1963-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY %26% SPECT see TOMOGRAPHY, EMISSION-COMPUTED 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was SKIN/transplantation 1966-89; was heading 1963-65%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was STERNOCOSTOCLAVICULAR HYPEROSTOSIS 1989 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was T LYMPHOCYTES, CYTOTOXIC 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was TOMOGRAPHY, EMISSION COMPUTED 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was TRIACETYLOLEANDOMYCIN 1964-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was VENTRICULOGRAPHY 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was VENTRICULOGRAPHY, CEREBRAL 1977-89; was VENTRICULOGRAPHY 1963-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was VESTIBULAR APPARATUS 1963-89; ENDOLYMPHATIC DUCT was see under LABYRINTH 1979-89; ENDOLYMPHATIC SAC was see under LABYRINTH 1979-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-89; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH %28%U.S%29% 1982-87%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see CONSENSUS DEVELOPMENT CONFERENCES 1988-89; was NIH CONSENSUS DEVELOPMENT see NATIONAL INSTITUTES OF HEALTH %28%U.S.%29% 1982-87; for both the publication type %26% the main heading 1988-90; main heading only 1991 forward%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see ENDOSCOPY 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see INCIDENCE STUDIES 1989 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see LEUCOMYCINS 1981-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see LEUCOMYCINS 1981-89; was heading 1963-80 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1964-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see LEUCOMYCINS 1981-89; was see under ANTIBIOTICS 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see MEDICINE 1986-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see MUSHROOM POISONING 1985-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see POISONING 1981-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see PREVALENCE STUDIES 1989 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see PROBABILITY 1979-89; was see under PROBABILITY 1969-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see RADIONUCLIDE IMAGING 1985-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see REFRACTIVE ERRORS 1984-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see UVEITIS, ANTERIOR 1985-89; was heading 1963-85%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under ADMINISTRATION, TOPICAL 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under AMIDINES 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under ASSISTED CIRCULATION 1986-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under DEATH 1974-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under DELIVERY OF HEALTH CARE 1988-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under EMERGENCY MEDICAL SERVICES 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under EPIDEMIOLOGIC METHODS 1975-89; PREVALENCE STUDIES was heading 1989%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under EUTHANASIA 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under FINANCIAL MANAGEMENT 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under FINANCIAL MANAGEMENT 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under GLUCOSE 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under GOVERNMENT 1984-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under HEALTH 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under HEALTH 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under HEALTH FACILITY ADMINISTRATORS 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under HEALTH SURVEYS 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under INDENES 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under MOTHERS 1986-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under NEUROGLIA 1966-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under ORGANIZATIONS 1982-89; was NATIONAL ACADEMY OF SCIENCES see under ORGANIZATIONS 1980-81%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under ORGANOPHOSPHORUS COMPOUNDS 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under PEPTIDES 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under PERSONALITY DISORDERS 1981-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under PHENYLPROPIONATES 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under PHENYLPROPIONATES 1978-89; was see under BENZOPHENONES 1975-77%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under PHOBIC DISORDERS 1981-89; was see under PHOBIAS 1968-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under POLYSACCHARIDES 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under POXVIRUS INFECTIONS 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under PYRROLES 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under RESEARCH DESIGN 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under RETICULOENDOTHELIOSIS 1965-75; was HISTIOCYTOSIS X 1975-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under RIBONUCLEOSIDES 1979-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under RUNNING 1980-89; was see under SPORTS 1976-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SALICYLIC ACIDS 1980-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SODIUM CHLORIDE 1975-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SPORTS 1976-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SPORTS 1977-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SPORTS 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SPORTS 1987-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under STRABISMUS 1980-89; was see STRABISMUS 1975-79%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under STRABISMUS 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under STRESS, PSYCHOLOGICAL 1983-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under SUGAR PHOSPHATES 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90; was see under URACIL NUCLEOTIDES 1978-89 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '90;66-67; was see under AZIRINES 1975-89; was heading 1966-67%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under ETHANOLAMINES 1963-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under GUANIDINES 1963-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963-66%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under RADIATION INJURIES 1963-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under SULFATHIAZOLES 1963-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under THIADIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%63%29%; was see under TYMPANIC MEMBRANE 1963-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was DIHYDROCHOLESTEROL see under CHOLESTEROL/analogs %26% derivatives 1975-90, see under CHOLESTEROL 1973-74, see under CHOLESTANES 1969-72, %26% see under STEROLS 1964-68 %28%Prov%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was RADIOISOTOPE DILUTION TECHNIC 1964-90 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was SUBTRACTION TECHNIC 1964-90 %28%Prov 1964-72%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under ALKALOIDS 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under ANENCEPHALY 1979-90; was see under ANENCEPHALUS 1967-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under ANIMAL FEED 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under BLOOD VESSELS 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under CLOACA 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under DIHYDROMORPHINONE 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under FOOD PRESERVATION 1964-90 %28%Prov 1964-67%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under HYPOGLYCEMIA 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under INDOLES 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under LUNG DISEASES 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under MOTOR NEURONS 1964-90 %28%Prov 1964-72%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under NERVOUS SYSTEM 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under OSTEOSCLEROSIS 1970-90; was see under BONE DISEASES 1967-69%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under OXAZOLES 1975-90; see under ANTICONVULSANTS 1963-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under PHYSICS 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under PUBLISHING 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under PYRROLIDINES 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%64%29%; was see under SKULL 1964-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was CENTROPHENOXINE see under GLYCOLATES 1975-90 %26% see under ACETIC ACIDS 1965-74 %28%Prov 1965-67%29%; MECLOFENOXATE was see CENTROPHENOXINE 1977-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under AZO COMPOUNDS 1965-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under CALCIUM METABOLISM DISORDERS 1965-90%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under CRANIOFACIAL DYSOSTOSIS 1985-90; was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under ETHERS 1975-90; was see under ALKYLATING AGENTS 1967-74%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under EYELID DISEASES 1965-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under HEART DISEASES 1965-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under HYDROXYQUINOLINES 1965-90 %28%Prov 1965-74%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%65%29%; was see under OSTEOLYSIS 1987-90; was see under BONE RESORPTION 1980-86; was see under BONE DISEASES 1965-79 %28%Prov 1965-66%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under ABNORMALITIES, MULTIPLE 1975-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under ADAPTATION, PHYSIOLOGICAL 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under BENZOXAZOLES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under ELECTRONICS 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under IMIDAZOLES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under MYCOSES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under PHENANTHRENES 1981-90; was see under PYRANS 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under PHENETHYLAMINES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under PIPERIDINES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under PYRIDINES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under PYRROLIDINES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under REOVIRUS INFECTIONS 1977-90; was see under ARBOVIRUS INFECTIONS 1966-76 %28%Prov 1966-74%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under SEALED CABIN ECOLOGY 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under THIOCARBAMATES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%66%29%; was see under TRIGLYCERIDES 1966-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29%; was SKIN WINDOW TECHNIC 1967-90 %28%Prov 1967-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29%; was see under HOSPITALS 1967-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29%; was see under PYRIDINES 1967-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29%; was see under SCIENCE 1967-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29%; was see under SUBCELLULAR FRACTIONS 1967-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%67%29%; was see under TIME 1967-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%68%29%; was see under CARBOXYLIC ACIDS 1968-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%68%29%; was see under ELASTICITY 1968-90 %28%Prov 1968-69%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%68%29%; was see under HYBRIDIZATION 1968-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%68%29%; was see under MOUTH DISEASES 1968-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%68%29%; was see under SHEEP DISEASES 1968-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%69%29%; was DIAGNOSIS, COMPUTER ASSISTED 1969-90 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%69%29%; was HEMOLYTIC PLAQUE TECHNIC 1969-90 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%69%29%; was see under CLOSTRIDIUM INFECTIONS 1969-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%69%29%; was see under EQUIPMENT AND SUPPLIES 1969-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%69%29%; was see under SKIN DISEASES 1969-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%70%29%; was see under REFLEX 1970-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%70%29%; was see under SPECTRUM ANALYSIS 1970-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was BONDING, DENTAL 1971-90 %28%Prov 1971%29% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under ALGAE 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under ANESTHETICS 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under BROMINE 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under CHEMISTRY, ORGANIC 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under CHEMISTRY, PHYSICAL 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under DISEASE 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under ELECTROPHYSIOLOGY 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under FLAVIVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A% ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under HETEROCYCLIC COMPOUNDS 1971-90 ' = 0).
% 42.08/41.93 fof(interp, fi_functors, '91%28%71%29%; was see under INK BLOT TESTS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under IODINE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under MANDIBULAR NERVE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under MECHANORECEPTORS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under METABOLISM 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under MOUTH DISEASES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under NEUROPSYCHOLOGICAL TESTS 1985-90; was see under PSYCHOLOGICAL TESTS 1971-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under NEUTRONS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was Prov 1971-74; was in Cat H only 1971-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under PICOLINIC ACIDS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under PIPERIDINES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under PLANKTON 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under PYRAZOLES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under PYRIDINIUM COMPOUNDS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under REFLEX 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under SPINAL NERVES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%71%29%; was see under THIAZINES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was BUNOLOL 1972-90 %28%Prov 1972%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was FOREIGN BODY REACTION 1972-90 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was GINGIVAL EXUDATE see under GINGIVITIS 1972-90 %28%Prov 1972-74%29%; was in Cat A %26% C 1972-83, was in Cat C 1984-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1972-90 %28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ABNORMALITIES, MULTIPLE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ALGAE, GREEN 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under AMINOCAPROIC ACIDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under AMMONIUM COMPOUNDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ANILIDES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under BENZAMIDES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under BENZOATES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under BITES AND STINGS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under CATTLE DISEASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under CORYNEBACTERIUM 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under CRESOLS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under DENTAL CEMENTS 1982-90; was see under ACRYLIC RESINS 1977-81; was see under ACRYLATES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under DISASTERS 1972-90; FLOODS was see under DISASTERS 1963-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under DISEASE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ELECTROENCEPHALOGRAPHY 1972-90 %28%Prov 1972-74%29%; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1972-83 %28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under FASCIA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under HERBICIDES, CARBAMATE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under HERBICIDES, TRIAZINE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under HERBICIDES, UREA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under INDOLES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under INSECTICIDES, CARBAMATE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under INSECTICIDES, ORGANOCHLORINE 1972-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under LEVORPHANOL 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under LYASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under MENINGES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under MORPHINANS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under MOUTH DISEASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under MUCOPOLYSACCHARIDES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under NEURAL CONDUCTION 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under NEURAL CONDUCTION 1977-90; was see under NEURAL TRANSMISSION 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under NORPREGNATRIENES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1972-79%28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under ORIENTATION 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under PARTNERSHIP PRACTICE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under PHYTOSTEROLS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under PRECIPITATION 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under PREGNADIENES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under PYRIDINES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under PYRIDINIUM COMPOUNDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under RATS, INBRED STRAINS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under REFLEX 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under SHIGELLA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under STOMATITIS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under STREPTOMYCES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under THIOCARBAMATES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under TOLUIDINES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under TRANSFERASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under TRIAZOLES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under TUBERCULOSIS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under URIDINE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%72%29%; was see under WATER 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%63-65; was see under RICKETTSIACEAE 1973-90 %28%Prov 1973-75%29%; was heading 1963-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; see SOCIAL ISOLATION 1973-90; HOMESICKNESS see ANXIETY, SEPARATION 1975-78; see EMOTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under ACETAMIDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under ACETIC ACIDS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under AEROSOLS 1973-90; was in Cat D %26% J 1973-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under ALDEHYDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under ANTHELMINTICS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under AZOLES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under CARBAMATES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under CARBODIIMIDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under CHEMISTRY, ORGANIC 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under CORTISONE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under DIAMINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under DISACCHARIDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under FATTY ACIDS, MONOUNSATURATED 1973-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under FERREDOXINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under GLYCOLATES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under HEMOGLOBINS, ABNORMAL 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under HOME CARE SERVICES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under HYDANTOINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under HYDROCORTISONE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under HYDROPHID VENOMS 1978-90; was see under SNAKE VENOMS 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under INSECTS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under ISOQUINOLINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under KETONE OXIDOREDUCTASES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under KIDNEY TUBULES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under LACTOGLOBULINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under LIGASES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under NERVE TISSUE PROTEINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PHENOLS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PIPERAZINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PREGNANCY 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PRESSURE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PROPANOLAMINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PROPIONATES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PSYCHOTHERAPY 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under PYRROLIDINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under SERINE ENDOPEPTIDASES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under SPIRO COMPOUNDS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under TETRACYCLINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under TICKS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under TRICARBOXYLIC ACIDS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%73%29%; was see under VACCINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%63-67%29%; was see under ERYTHROCYTES, ABNORMAL 1963-90 %28%Prov 1963-67%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%64-66%29%; was see under COLITIS, ULCERATIVE 1964-90 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%64-66%29%; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90; was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1964-88 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%64-67%29%; was see under SPINAL CORD 1964-90 %28%Prov 1964-67%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%64-72%29%; was see under MALIGNANT CARCINOID SYNDROME 1964-90 %28%Prov 1964-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%65-67%29%; was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1965-79 %28%Prov 1965-67%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%%28%68-69%29%; was see under CELLULOSE/analogs %26% derivatives 1975-90; was see under CELLULOSE 1968-74 %28%Prov 1968-69%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-64; was see under SILICA 1965-90; was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-65; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-66; was see under STERILIZATION 1967-90; was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-66; was see under VOLUNTARY HEALTH AGENCIES 1967-90; was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-67; was see under DIOXINS 1968-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-67; was see under INDENES 1975-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63-67; was see under TRICHOSTRONGYLOIDIASIS 1968-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%63; was see under ESTHETICS 1967-90; was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%66-73; was see under ANGIOTENSIN II/analogs %26% derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%72%28%66-71%29%; was see under ANTIBODIES 1975-90; was see under IGE 1966-71, 1973-74 %28%Prov 1966-71%29%; was heading 1972%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; BARANY TEST was BARANY%27%S TEST 1993-97 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; for GLIOSTATIN use THYMIDINE PHOSPHORYLASE %28%NM%29% 1992-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; for PERIPLANETA AMERICANA use COCKROACHES 1995-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; see HYDANTOINS 1975-90; for PHENANTION use PHENYTOIN 1978-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; use BASIDIOMYCOTA 1963-74 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; use FUNGI 1972-74 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was A 23187 1975-90 %28%see under ANTIBIOTICS 1975-83%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs %26% derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974, was heading 1964-73 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was METHYLNOREPINEPHRINE see under NOREPINEPHRINE/analogs %26% derivatives 1975-90, see under NORMETANEPHRINE 1971-74, %26% see NORMETANEPHRINE 1966-70%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was O-CHLOROBENZYLIDENE MALONITRILE see under NITRILES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was POST AND CORE TECHNIC see under CROWNS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was TOYOMICIN see under CHROMOMYCINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 17-HYDROXYCORTICOSTEROIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 17-KETOSTEROIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 2-ACETYLAMINOFLUORENE/analogs %26% derivatives 1980-90; was see under FLUORENES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under 4-HYDROXYCOUMARINS 1977-90; was see under COUMARINS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ABORTIFACIENT AGENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ABORTION, INDUCED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ABREACTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACANTHOCEPHALA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACCELERATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACCIDENT PREVENTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACETANILIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACETIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACETONITRILES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACETYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACIDOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACONITE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACRIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACRYLATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACTIVATION ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ACYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ADENINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ADENINE NUCLEOTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ADENOSINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ADENOSINE TRIPHOSPHATE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ADNEXA UTERI 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AGGRESSION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AGRANULOCYTOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AIR POLLUTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALCOHOL OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALCOHOL, ETHYL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALDEHYDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALKALOIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALKANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALKYL SULFONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALLOYS 1968-90; was see under METALS 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALOPECIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALPHAVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMEBIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMIDOHYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINE OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under LYSINE 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under PHENYLALANINE 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINO ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINO ACIDS, DIAMINO 1980-90; was see under PIMELIC ACIDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINO ACIDS, SULFUR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINO ALCOHOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOACRIDINES 1984-90; was see under ACRIDINES 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOHYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOPHENOLS 1979-90; was see under ANILINE COMPOUNDS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78; was see under ANTIHISTAMINICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOPYRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMINOTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMMONIA-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMMONIUM COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMOEBA 1977-90; was see under SARCODINA 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMPHETAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMPICILLIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AMPUTATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANDROSTENEDIOLS 1975-90; was see under ANABOLIC STEROIDS 1964-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANDROSTENOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANEMIA, MACROCYTIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANEMIA, SICKLE CELL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANESTHESIA, EPIDURAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANGER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANGIOMATOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANILIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANILINE COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIDUM 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANOXIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTHRACENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTHRANILIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTHRAQUINONES 1975-90; was see under CATHARTICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1981-90; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, ANTIFUNGAL 1990-90; was see under POLYENES 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, MACROLIDE 1990-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTIGENS, FUNGAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANTISEPSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ANURIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under APOPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under APPETITIVE BEHAVIOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under APPOINTMENTS AND SCHEDULES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ARGININE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was %28%NM%29% 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ARSENIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ARSENICALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ART 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ARTIODACTYLA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ASCORBIC ACID 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ATMOSPHERIC PRESSURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ATTITUDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AVIAN LEUKOSIS VIRUSES 1975-90; was see under AVIAN LEUKOSIS VIRUS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AZEPINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AZETINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AZIRINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AZO COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under AZO COMPOUNDS 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BACTERIAL PROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BARBITURATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BASIDIOMYCETES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BEHAVIOR THERAPY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZENESULFONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76; 3,3%27%-DIMETHOXYBENZIDINE was %28%NM%29% 1982-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZIMIDAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZOATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZODIAZEPINONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZOFURANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZOPYRANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BENZYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BEVERAGES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BIGUANIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BINDING SITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BIOFLAVONOIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BLOOD COAGULATION FACTORS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BODY FLUIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BONE DISEASES, DEVELOPMENTAL 1985-90; was see under CRANIOFACIAL DYSOSTOSIS 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BORON COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BREAST 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BREEDING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BRIDGED COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BUFANOLIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BUNYAVIRIDAE 1981-90; was see under ARBOVIRUSES 1975-80; was see under ARBOVIRUS 1965-74; was see under ARBORVIRUSES 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BUTANONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BUTYRATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under BUTYROPHENONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CALORIMETRY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CAPROATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CAPRYLATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBANILIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBODIIMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBON 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBOXY-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARCINOMA, SCIRRHOUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARICATURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CARNIVORA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CATECHOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CATHARTICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CAUSTICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CELL DIFFERENTIATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CELLULOSE 1976-90; was see under HEMOSTATICS 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CEPHALOSPORINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CETACEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CEVANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHEMISTRY, ANALYTICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHEMISTRY, PHYSICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHILD ABUSE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHILD WELFARE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHLOROBENZENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHLOROHYDRINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHLOROPHYLL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHOLESTANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHOLESTENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHOLINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHOLINESTERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHOLINESTERASES 1975-90; was see under CHOLINESTERASE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHROMAFFIN SYSTEM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHROMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHROMATOGRAPHY, GAS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CHROMATOGRAPHY, GEL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CINNAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CIRCADIAN RHYTHM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CLIMATE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CLOXACILLIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COAL 1975-90; was in Cat J only 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COCHLEA 1990; was see under LABYRINTH 1960-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COELENTERATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COGNITION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COGNITION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COLLOIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COMPULSIVE BEHAVIOR 1975-90; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CONTRACEPTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CONTRACEPTIVES, POSTCOITAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CORNEAL DYSTROPHIES, HEREDITARY 1990; was see under CORNEAL DYSTROPHIES 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CORPUS LUTEUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CORTICOSTERONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CORYNEBACTERIUM INFECTIONS 1977-90; was see under NOCARDIA INFECTIONS 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COSTS AND COST ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COUMARINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under COXSACKIEVIRUS INFECTIONS 1979-90; was see under COXSACKIE VIRUS INFECTIONS 1970-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CRESOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CULTURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYCLIC N-OXIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYCLOHEPTANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYCLOHEXANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYCLOHEXANOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYCLOSTOMES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under CYPRINIDAE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DECANOIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DEFENSE MECHANISMS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DEGLUTITION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DENTAL HEALTH SURVEYS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DENTIFRICES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DEOXYCYTIDINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DEOXYURACIL NUCLEOTIDES 1978-90; was see under URACIL NUCLEOTIDES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DERMATOLOGIC AGENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DEXTRANS 1979-90; was see under DEXTRAN 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIATHERMY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIBENZAZEPINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIBENZOCYCLOHEPTENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIBENZOXAZEPINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIHYDROPYRIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DILATATION AND CURETTAGE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIMETHYLAMINOAZOBENZENE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIOXINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIOXOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIPEPTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DISASTERS 1968-90; was see under DISASTERS %26% INDIGENT CARE 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DITERPENES 1975-90; was see under TERPENES 1968-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DITHIOTHREITOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIURETICS, MERCURIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIURETICS, SULFAMYL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DIURETICS, THIAZIDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under DOPAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EAR OSSICLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EATING DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EDENTATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EDUCATIONAL MEASUREMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EGG PROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EICOSANOIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ELECTROENCEPHALOGRAPHY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ELECTROMAGNETICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ELECTROPHORESIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ENTEROVIRUS INFECTIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ENTEROVIRUSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EPINEPHRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ERGOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ERYTHROMYCIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ESTRENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ESTRIOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ESTRUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ETHERS, CYCLIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ETHICS, MEDICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EXOCRINE GLANDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EXTRACTION, OBSTETRICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EYE MOVEMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EYELID DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under EYELIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FACIAL EXPRESSION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FACIAL NERVE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FAMILY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FATTY ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FATTY ACIDS 1975-90; was see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FATTY ACIDS, MONOUNSATURATED 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FATTY ACIDS, MONOUNSATURATED 1988-90; was see under FATTY ACIDS, UNSATURATED 1975-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FATTY ACIDS, UNSATURATED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FEAR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FEES, PHARMACEUTICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FEMUR HEAD NECROSIS 1979-90; was see under OSTEOCHONDRITIS 1963-78; COXA PLANA was see under OSTEOCHONDRITIS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FENFLURAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FERRICYANIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FERRITIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FETAL MEMBRANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FILARIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FILARIOIDEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FISH PRODUCTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FISHES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FLAVONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FLAVONES 1975-90; was see under BIOFLAVONOIDS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FLUOCINOLONE ACETONIDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FLUORENES 1975-90; AMYXIN was AMYXIN %28%NM%29% 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FLUOROACETATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FOLLICULITIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FORCED EXPIRATORY FLOW RATES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FORELIMB 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FORM PERCEPTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FORMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FORMIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FROSTBITE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under FURANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GALACTOSAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GALACTOSIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GALLIC ACID 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GAME THEORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GANGLIOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GASTROINTESTINAL MOTILITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GENETIC ENGINEERING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GINGIVITIS 1979-90; was see under PERIODONTITIS 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUCOSAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUCOSAMINIDASE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUCOSIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUTAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUTAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLUTARATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLYCERIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLYCOLATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLYCOPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLYCOSIDE HYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLYCOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GUANIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under GUILT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HAMSTERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART AUSCULTATION in Cat E 1972-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART BLOCK 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART CONDUCTION SYSTEM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART DEFECTS, CONGENITAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART FAILURE, CONGESTIVE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART SEPTAL DEFECTS, ATRIAL 1964-90; was see under HEART DEFECTS, CONGENITAL 1963%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEART SEPTAL DEFECTS, ATRIAL 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEME 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEMEPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEPTACHLOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEPTANOIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEPTOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HERBICIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HEXOSYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HINDLIMB 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HOMOCYSTEINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HORNS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HOSPITAL ADMINISTRATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HOSPITALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HOSPITALS, SPECIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDANTOINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDRO-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROCARBONS, CHLORINATED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROGEN-ION CONCENTRATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROXAMIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROXYBENZOIC ACIDS 1975-90; was see under BENZOATES 1968-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROXYBUTYRATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROXYLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYDROXYQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYMENOPTERA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYPERBILIRUBINEMIA, HEREDITARY 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYPOPROTHROMBINEMIAS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYPOTHALAMUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under HYSTERECTOMY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ILLUSIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IMIDAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INDENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INDENES 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INDOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INDOPHENOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INFANT, NEWBORN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INHIBITION %28%PSYCHOLOGY%29% 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INOSINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSECTICIDES, CARBAMATE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSECTICIDES, ORGANOCHLORINE 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSECTIVORA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSEMINATION, ARTIFICIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSURANCE, HEALTH 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSURANCE, HOSPITALIZATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under INSURANCE, PHYSICIAN SERVICES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IODINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IODOACETATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IODOBENZENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IODOBENZOATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IODOPYRIDONES 1975-90; was see under CONTRAST MEDIA 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ION EXCHANGE RESINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ISOMERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ISONICOTINIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ISONIPECOTIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ISOQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under JOINTS 1979-90; was see under RIBS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under JUVENILE HORMONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KERATOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 %28%which became KERATODERMA, PALMOPLANTAR 1993%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KETOACID-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KETONE OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KETONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KIDNEY FAILURE, ACUTE 1975-90; LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KIDNEY PELVIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LABOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LABYRINTHINE FLUIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LACRIMAL APPARATUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LACTATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LACTATION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LACTONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LANATOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LANGUAGE DEVELOPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LARYNGEAL NERVES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LARYNGITIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LAURIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LEARNING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LEPIDOPTERA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LEUCINE AMINOPEPTIDASE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LIPOIDOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LITERATURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LIZARDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LUNG VOLUME MEASUREMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under LYMPHEDEMA 1975-90; was see FILARIASIS %26% LYMPHEDEMA 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MACACA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MACULA LUTEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MALONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MALPRACTICE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MAMMALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MAMMALS 1975-90; was see under RABBITS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MANDELIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MANNITOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MEDICAL HISTORY TAKING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MEDICAL RECORDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MEDICAL SECRETARIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MENOPAUSE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MENSTRUATION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under METALLOPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under METHADONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under METHANE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under METHIONINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under METHYLCELLULOSE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under METHYLGLYCOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MICROTOMY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MITE INFESTATIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MITOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MODELS, ANATOMIC 1984-90; was see under MODELS, STRUCTURAL 1971-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MONOAMINE OXIDASE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MONOTREMATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MONOTREMATA 1975-90; DUCKMOLE was see PLATYPUS 9175-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MORALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MORPHINANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MORPHINANS 1975-90; DEXTRODROMORAN %26% D-DROMORAN were see DEXTRORPHAN 1977-94; DESTRORPHANOLUM was see DEXTRORPHAN 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MORTUARY PRACTICE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MUCOPOLYSACCHARIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MUSCULAR DYSTROPHY, ANIMAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MYCOBACTERIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MYCOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MYIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under MYRISTIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NADH, NADPH OXIDOREDUCTASES 1975-90; was NITRITE REDUCTASE 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NAPHTHALENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NEMATODA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NERVE DEGENERATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NERVE DEGENERATION 1975-90; NISSL DEGENERATION was see NERVE DEGENERATION 1997, was heading 1975-96 %28%see under NERVE DEGENERATION 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NEUROMUSCULAR JUNCTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NICOTINIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITRILES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITRITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROBENZENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROBENZOATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROFURANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROIMIDAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROPHENOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROSAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NITROSOUREA COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NORPREGNATRIENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NORPREGNENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NUCLEOSIDE DEAMINASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NUCLEOTIDE DEAMINASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under NUTRITION SURVEYS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OBSESSIVE-COMPULSIVE DISORDER 1981-90; was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; was in Cat F only 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OLEIC ACIDS 1988-90, was see under FATTY ACIDS, UNSATURATED 1975-87; was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OLIGOMYCINS 1982-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OLIGOPEPTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OLIGOSACCHARIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ONIUM COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH %26% PROGRAMMED INSTRUCTION 1966-68%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OPERATIONS RESEARCH 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORAL HEMORRHAGE 1990; was see under HEMORRHAGE, ORAL 1967-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90; was see under PHOSPHORIC ACIDS 1968-71; PHOSPHATES, ORGANIC was see ORGANOPHOSPHORUS COMPOUNDS 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORIENTATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ORTHOPEDIC EQUIPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90; was see under BONE DISEASES, DEVELOPMENTAL 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OVULATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OVUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXADIAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXAZOCINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXIDOREDUCTASES, N-DEMETHYLATING 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXIMES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under OXYGENASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PAINT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PALEONTOLOGY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PALMITIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PARABIOSIS 1975-90; was in Cat G only 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PARAGANGLIOMA, NONCHROMAFFIN 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PARATHION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PENICILLINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PENTOSEPHOSPHATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PENTOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PENTOSYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PEPTIDE HYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PEPTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PERIODONTIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PEROXIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PERSONALITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PERSONALITY ASSESSMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PERSONALITY DEVELOPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PERSONALITY INVENTORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PERSONNEL MANAGEMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PETROLEUM 1975-90; was in Cat J only 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHARMACEUTIC AIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENETHYLAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENOLPHTHALEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLACETATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLALANINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLBUTAZONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLENEDIAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLPROPANOLAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLPROPIONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHENYLTHIOUREA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHEROMONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHIMOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHLORETIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHOSPHODIESTERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHOSPHOPROTEIN PHOSPHATASES 1979-90; was see under PHOSPHOMONOESTERASES 1975-78; PR-ENZYME was see PHOSPHORYLASE PHOSPHATASE 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHOSPHOTRANSFERASES, ATP 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHTHALIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHYSICIANS%27% ASSISTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PHYSICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PICOLINIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PIGMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PIPERAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PIPERIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PLANT GROWTH REGULATORS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PLANT PROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYETHYLENE GLYCOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYETHYLENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYMERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYNUCLEOTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYSACCHARIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POLYVINYLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PORPHYRINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PRECIPITATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PREGNADIENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PREGNANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PRISONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROBABILITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROPIONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROPIOPHENONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROPYLAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROTAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROTEIN-LOSING ENTEROPATHIES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PROTOZOAN INFECTIONS 1990; was see under AMEBIASIS 1967-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSITTACINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78; TRIOXISALENUM was see TRIOXSALEN 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSYCHOANALYTIC THEORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSYCHODRAMA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSYCHOLOGICAL THEORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PUBLIC ASSISTANCE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PUBLIC HEALTH DENTISTRY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PURINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PUROMYCIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRANTEL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRIDAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRIDAZINES 1975-90; was see under HETEROCYCLIC COMPOUNDS 1966-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRIDINIUM COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRIDONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRIMIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYROPHOSPHATASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRROLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under PYRROLIDINONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under QUAIL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under QUINACRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under QUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under QUINONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under QUINOXALINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RADIOISOTOPES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RADIOTHERAPY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RADIUS FRACTURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under REFLEX, MONOSYNAPTIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under REFUSE DISPOSAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under REOVIRIDAE 1981-90; was see under REOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under REPRODUCTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under REPTILES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RESORCINOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RESPIRATORY AIRFLOW 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RETINAL PIGMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RIBONUCLEOTIDE REDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RICINUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RNA, MESSENGER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RNA, TRANSFER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ROSACEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ROSANILINE DYES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RUTHENIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under RUTIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SALICYLAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SALIVARY GLAND DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SAPOGENINS 1979-90; was see under TRITERPENES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SAPONINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SARCOIDOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SATIATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SCAPULA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SELENIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEMICARBAZIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEMICONDUCTORS 1975-90; was in Cat H %26% J 1975-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SERINE ENDOPEPTIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SESQUITERPENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEWAGE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEX BEHAVIOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SEX BEHAVIOR, ANIMAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SHARKS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE RENAL FAILURE 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SIALIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SILICA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SILICON 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SILICON 1975-90; HYDROSILICONS, SILICANS %26% SILICOHYDRIDES were see SILANES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SILICONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SKIN TESTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SOIL POLLUTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SORBITOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPECTRUM ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPEECH DISORDERS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPERMATOZOA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPHINGOSINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPIDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPIRO COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SPONDYLOLISTHESIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STANOLONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STARCH 1979-90; was see under POLYSACCHARIDES 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STEARIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STERNUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STEROIDS, HETEROCYCLIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STRESS 1975-90; was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under STROPHANTHINS 1975-90; TSIMARIN was see CYMARINE 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SUCCINIMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SUGAR ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SUGGESTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFANILAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFATASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFHYDRYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFONAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFONIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFONYLUREA COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 %28%see under SULFURIC ACIDS 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SULFURTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SURFACE-ACTIVE AGENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SWEAT GLANDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under SYPHILIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TAENIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TASK PERFORMANCE AND ANALYSIS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TERPHENYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TESTIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TESTOSTERONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TETRAZOLIUM SALTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THEOPHYLLINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOCARBAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOGLYCOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOPHENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOSEMICARBAZONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOSULFATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOUREA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THIOXANTHENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THORACIC ARTERIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THORACIC NERVES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THYMOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under THYROID HORMONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TICK TOXICOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TISSUE BANKS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TISSUE EXTRACTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TONGUE DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH ABNORMALITIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH FRACTURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH GERM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH MIGRATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH PERMEABILITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOOTH, DECIDUOUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TREMATODE INFECTIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRIALKYLTIN COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRIAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRIAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRICHOSTRONGYLOIDEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRICHOSTRONGYLOIDIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRIOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRYPANOSOMIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TRYPSIN INHIBITORS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TUBERCULOSIS, CARDIOVASCULAR 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TUBERCULOSIS, CUTANEOUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TURBELLARIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under TWINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ULNA FRACTURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under URACIL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under UREA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under URETHANE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under URIDINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under URIDINE DIPHOSPHATE SUGARS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under UROCHORDATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under URONIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under UTERINE RUPTURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VAGUS NERVE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VALERATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VERATRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VETERINARY MEDICINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VINYL COMPOUNDS 1975-90; was in Cat D %26% J 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VISION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under VOLUNTARY HEALTH AGENCIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under WATER POLLUTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under WEATHER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under XANTHENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%75%29%; was see under ZINC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ACETANILIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ADENOSINE TRIPHOSPHATE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ALKALOIDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AMINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AMINO ACID ISOMERASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AMINO ACIDS, DICARBOXYLIC 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AMINO ALCOHOLS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AMMONIUM COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ANTHRAQUINONES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ANTIMONY 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ARGININE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AZO COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU %26% T-1824 were see EVANS BLUE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under BARBITURATES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under BERBINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under BETAMETHASONE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under BILIRUBIN 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under BLOOD GROUPS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under BRETYLIUM COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CARBOXY-LYASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CHEMISTRY, ORGANIC 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CHLOROFORM 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CHOLINE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CHONDROITINASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CINNAMATES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CODEINE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CONTRACEPTIVES, ORAL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under CYCLOHEXANECARBOXYLIC ACIDS 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DAPSONE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DEXAMETHASONE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DIBENZOTHIEPINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DIMERCAPROL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under DIURETICS, SULFAMYL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under FETAL DEATH 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under GLUCOSYLTRANSFERASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under HIP DISLOCATION, CONGENITAL 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under HYDRALAZINE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under HYDROCARBONS, CHLORINATED 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under IMMUNOELECTROPHORESIS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under MORPHINANS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under MULTIENZYME COMPLEXES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under MUSCLE PROTEINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under NAPHTHALENES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under NICOTINAMIDE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under NITROFURANS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under NITROGEN MUSTARD COMPOUNDS 1976-90; LYMPHOCHIN %26% LYMPHOQUIN were see ANILINE MUSTARD 1976-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under NITROPHENOLS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under ORGANOMETALLIC COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under OXAZOLES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under OXIDOREDUCTASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PARAPROTEINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PENICILLIN G 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PENTOSYLTRANSFERASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PEROXIDASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PEROXIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PHENANTHRENES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PHENOTHIAZINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PHENYL ETHERS 1976-90; IRGASAN DP 300 was see TRICLOSAN 1976-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PHOSPHOTRANSFERASES, ATP 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PIPERAZINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PIPERIDINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under POLYDEOXYRIBONUCLEOTIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under POLYRIBONUCLEOTIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PORPHYRINOGENS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PROTEINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PROTEOGLYCANS 1977-90; was see under MUCOPOLYSACCHARIDES 1976%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under PYRAZOLES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under QUINOLINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under QUINONES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under QUINOXALINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under REFLEX 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under SUGAR ACIDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under SULFATASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under TASTE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under TETRAHYDROFOLATES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under THIADIAZOLES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under THIOUREA 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under TRIAZINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under URANIUM 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%76%29%; was see under URIDINE/analogs %26% derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; for DNA POLYMERASE DELTA use DNA POLYMERASE III %28%NM%29% 1980-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was DEMETHYLDIAZEPAM see under DIAZEPAM 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was DIMILIN see under JUVENILE HORMONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was FTORAFUR 1986-90 %26% FTORAFUR see under FLUOROURACIL 1977-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ALDEHYDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ALKALOIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ALPHA GLOBULINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMINE OXIDOREDUCTASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMINOBENZOIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMINOCAPROIC ACIDS 1977-90; EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMINOSALICYLIC ACIDS 1977-90; was PARA-AMINOSALICYLIC ACID see under AMINOSALICYLIC ACID 1963-76; PAS was see under AMINOSALICYLIC ACID 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AMPHETAMINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ANGIOTENSIN II 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ANISOLES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ANTIGEN-ANTIBODY COMPLEX 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ASPARTIC ACID 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AZEPINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under AZO COMPOUNDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BENZHYDRYL COMPOUNDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BENZIDINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BENZIMIDAZOLES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BENZOATES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BETAMETHASONE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BLOOD CELLS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BONDING, DENTAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under BROMHEXINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under CALORIMETRY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under CANNABINOIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under CARBOXY-LYASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under CHEMISTRY, ANALYTICAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under CHOLINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under CYCLOPROPANES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under DIABETIC COMA 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under DIGOXIN 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under DIURETICS, SULFAMYL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under DOPA 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ELASTIN 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under EMPHYSEMA 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ESTRONE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under FERREDOXINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under FLAVONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under FLAVOPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under FLUORIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under GANGLIOSIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under GLOMERULONEPHRITIS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76; was METHOXYHYDROXYPHENYL GLYCOL 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under GLYCOSIDE HYDROLASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under GUANIDINES 1977-90; CONGOCIDINE was %28%NM%29% 1973-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under HEMEPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under HEMOGLOBINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under HEMOGLOBINS, ABNORMAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under HISTOCYTOCHEMISTRY 1979-90; was see under STAINS AND STAINING 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under HOSPITALS, SPECIAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under HYDROCARBONS, CHLORINATED 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under IMIDAZOLES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under IMMUNOLOGIC TECHNIQUES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ISONIPECOTIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under KETOACID-LYASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under LABOR 1977-90; was LABOR, FIRST STAGE see under LABOR 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under LABOR 1977-90; was LABOR, SECOND STAGE see under LABOR 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under LABOR 1977-90; was LABOR, THIRD STAGE see under LABOR 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under LACTONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under LYASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MACROPHAGES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MAGNESIUM 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MAMMOGRAPHY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under METALLOPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MORPHOLINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MUSCLE CONTRACTION 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MUSCLE PROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under MYCOBACTERIUM INFECTIONS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under NECROSIS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under NEUROSECRETORY SYSTEMS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under NICOTINIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under NITROBENZENES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under OXAZINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PENTOSYLTRANSFERASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PHTHALIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PIPERIDINES 1975-90; was see under SYMPATHOLYTICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under POLYDEOXYRIBONUCLEOTIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PROTEIN METHYLTRANSFERASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PSYCHOTHERAPY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PYRIDAZINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PYRIDINIUM COMPOUNDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under PYROPHOSPHATES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under RADIOIMMUNOASSAY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under RNA POLYMERASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SALICYLAMIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SESQUITERPENES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SIALOGLYCOPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SORBITOL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SULFADIAZINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under SURFACE-ACTIVE AGENTS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under TACHYKININS 1989-90; was see under KININS 1977-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under TESTOSTERONE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under THIOCARBAMATES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under THIOCYANATES 1977-90; was ALPHA-NAPHTHYLISOTHIOCYANATE %28%see under THIOCYANATES 1976%29%; ANIT was see 1-NAPHTHYLISOTHIOCYANATE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under THYMUS HORMONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under TISSUE EXTRACTS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under TRANSCRIPTION FACTORS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%77%29%; was see under VITAMINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%63; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77; was in Cat B %26% D 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was EXO-1,4-ALPHA-GLUCOSIDASE 1978-90; was EXO-1,4-ALPHA-GLUCOSIDASE see under GLUCOSIDASES 1978-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was PROSTAGLANDINS X 1978-90 %28%see under PROSTAGLANDINS 1978-83%29%; PROSTACYCLIN was PROSTACYCLINS 1978-93; PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ACCOUNTING 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ACETIC ACIDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ACYL COENZYME A 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ALUMINUM 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under AMPICILLIN 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under AMYLASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ARTERIAL OCCLUSIVE DISEASES 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ARTERIES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ARTHROPOD VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ATMOSPHERIC PRESSURE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under BACTERIAL TOXINS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under BANDAGES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under BEE VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under BODY FLUIDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CARBENICILLIN 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CARBOHYDRATE DEHYDROGENASES 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CARNITINE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CELLS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CEPHALOSPORINS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CHENODEOXYCHOLIC ACID 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CHOLESTEROL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CHROMAFFIN SYSTEM 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CHROMOSOMES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under COBRA VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CROTALID VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CULTURE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CYTOSINE NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under CYTOSINE NUCLEOTIDES 1978-90; was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under DAIRY PRODUCTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under DEOXYCHOLIC ACID 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under DIBENZOCYCLOHEPTENES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under DIHYDROXYTRYPTAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ECHINODERMATA 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ETHANOLAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ETHYLENEDIAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under FINANCIAL MANAGEMENT 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under GENETICS, POPULATION 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under GLYCOSIDE HYDROLASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under GUANINE NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under GUANOSINE CYCLIC MONOPHOSPHATE 1980-90; was see under GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under GUANOSINE TRIPHOSPHATE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HAMSTERS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HEXOSEDIPHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HEXOSEPHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HOSPITAL BED CAPACITY 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HOSPITALS, PUBLIC 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HUMAN RIGHTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under HYPOLIPOPROTEINEMIA 1980-90; was see under HYPOLIPOPROTEINEMIAS 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under IMIDAZOLES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under INOSINE NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under INOSINE NUCLEOTIDES 1978-90; was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under IODOBENZOATES 1978-90; was TRIIODOBENZOIC ACID see under IODOBENZOATES 1972-77 %28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under JURISPRUDENCE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under LITHOCHOLIC ACID 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under LUNG VOLUME MEASUREMENTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under MEAT 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under MEPERIDINE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under METHYLHYDRAZINES 1978-90; was METHYLHYDRAZINE see under HYDRAZINES 1966-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under MORPHINE DERIVATIVES 1978-90; CODETHYLINE was see ETHYLMORPHINE 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under MULTIENZYME COMPLEXES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under NAPHTHALENES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under NITROFURANS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PAPAVERINE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PHENETHYLAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PLANTS, MEDICINAL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 %28%Cat B %26% D heading%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PLASMIDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under POLYISOPRENYL PHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under POLYMETHACRYLIC ACIDS 1981-90; was see under ACRYLIC RESINS 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under POLYMYXINS 1978-90; was AEROSPORIN see under POLYMYXIN 1971-77, see POLYMYXIN 1963-70; AEROSPORIN was see POLYMYXIN B 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under POLYSACCHARIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under PROSTAGLANDINS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under QUINOLINES 1978-90; QUIPAZINE MALEATE was NM 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under RESEARCH DESIGN 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under ROLE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SALMONELLA 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SEPTAL NUCLEI 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SEX CHROMOSOME ABNORMALITIES 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SOCIAL BEHAVIOR 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under STERILIZATION, SEXUAL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SUGAR ALCOHOLS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SUGAR PHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SULFHYDRYL COMPOUNDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under SYNOVITIS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under TERPENES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under TETRACYCLINES 1978-90; was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1963-77 %28%Prov 1963-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under THIOLESTER HYDROLASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under THYMINE NUCLEOTIDES 1978-90; was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, see under NUCLEOTIDES 1963-71%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under URACIL NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under VEINS 1975-90; was see under VEINS 1964-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under VIOLENCE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under WASTE PRODUCTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%78%29%; was see under WEIGHTS AND MEASURES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%68; was see under RISK-TAKING 1979-90; was heading 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was GOLD THIOGLUCOSE see under GOLD 1979-90; was AUROTHIOGLUCOSE see under GOLD 1973-78 %28%Prov 1973-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING %28%IPPB%29% see under POSITIVE PRESSURE RESPIRATION 1969-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was INTERMITTENT POSITIVE PRESSURE VENTILATION see under POSITIVE PRESSURE RESPIRATION 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ACETANILIDES 1979-90; was DIAMPHENETHIDE see under ACETANILIDE 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ACETIC ACIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ADENOSINE MONOPHOSPHATE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ALLIED HEALTH PERSONNEL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under AMIDOHYDROLASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ARABINONUCLEOTIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ARSENICALS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ASTHMA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BACTERIOCINS 1979-90; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BACTERIOCINS 1979-90; was PYOCIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BENZANTHRACENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under BUTADIENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CARBAMATES 1979-90; was THIOPHANATE-METHYL see under CARBAMATES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CARBOXY-LYASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CEREBROSIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CHEMISTRY, ORGANIC 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CHOLESTEROL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under COCHLEA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under COMMUNICATION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under COMPLEMENT ACTIVATION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under COSTS AND COST ANALYSIS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CRESOLS 1979-90; was TRITOLYL PHOSPHATE see under CRESOLS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CURRICULUM 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under CYANIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-90; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DENTIFRICES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DEXAMETHASONE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DIBENZAZEPINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DIBENZOTHIEPINS 1979-90; was PROTHIADENE see under DIBENZOTHIEPINS 1968-78; PROTHIADENE was see DOTHIEPIN 1979-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DIGOXIN 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under DISACCHARIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under EAR, EXTERNAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under EDUCATION, CONTINUING 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under EDUCATIONAL MEASUREMENT 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under EGO 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under EMBRYO 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ERGOLINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ESTRENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ETHNIC GROUPS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under FAMILY 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under FLAVONES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under FLUORESCEINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under FOLIC ACID 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under FURANS 1979-90; was CITRACONIC ANHYDRIDE see under FURANS 1977-78 %26% see under MALEATES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under GASTRINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under GLUCONATES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under GLYCOSPHINGOLIPIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HEALTH FACILITIES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HEARING LOSS, PARTIAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HEARING LOSS, SENSORINEURAL 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HEMEPROTEINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HEMOGLOBIN A 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HEXOSYLTRANSFERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HISTOCYTOCHEMISTRY 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HOSPITALS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1973-78 %28%Prov 1973-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under INFANT CARE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under IODIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ISOQUINOLINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under KIDNEY TUBULES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LABYRINTH DISEASES 1979-90; was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LARYNGEAL CARTILAGES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LARYNGEAL DISEASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LARYNX 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LYASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1965-78 %28%Prov 1965-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under LYSINE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MALOCCLUSION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MANDIBULOFACIAL DYSOSTOSIS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MEMORY 1979-90; was RETENTION see under MEMORY 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MICE, NEUROLOGIC MUTANTS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MORPHINANS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MORPHINE DERIVATIVES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MOTOR NEURONS 1979-90; was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MUSCLES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under MYOCARDIAL CONTRACTION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NADH, NADPH OXIDOREDUCTASES 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NICOTINIC ACIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NITRITES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NITROSAMINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NOISE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NUCLEOTIDYLTRANSFERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under NURSING HOMES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ORGAN OF CORTI 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under OSMIUM 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under OTITIS MEDIA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PEPTIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PERIODONTITIS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PERSONALITY 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PERSONALITY DISORDERS 1979-90; was PARANOID PERSONALITY see under PARANOIA 1969-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PERSONNEL MANAGEMENT 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHENANTHRIDINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHENOTHIAZINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHENYLPROPIONATES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHOSPHOMONOESTERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHOSPHOTRANSFERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHOSPHOTRANSFERASES, ATP 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PHTHALIC ACIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PIPERAZINES 1979-90; was ICRF 159 see under PIPERAZINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under POLYMERS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under POLYSACCHARIDES, BACTERIAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PREGNENEDIONES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PROFESSIONAL PRACTICE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PROPANOLAMINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PROPIOPHENONES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PYRIDINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PYRIMIDINES 1979-90; was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PYRROLIDINES 1979-90; was CI 628 see under PYRROLIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under PYRROLIDINES 1979-90; was MECLASTINE see under PYRROLIDINES 1973-78 %28%Prov 1973-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under REACTION TIME 1979-90; was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78; was REFRACTORY PERIOD, PSYCHOLOGIC 1972-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under REIMBURSEMENT MECHANISMS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under RESINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under RIBONUCLEOSIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SALIVARY GLANDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SAPOGENINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SPEECH DISCRIMINATION TESTS 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SPEECH PRODUCTION MEASUREMENT 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SPINAL CANAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SUCCINATES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SUGAR ALCOHOLS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under SUTURES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under THEOPHYLLINE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under THIAMINE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under THIOGLYCOSIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under THIOPHENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under THIOUREA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under THYRONINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under TRANSCRIPTION FACTORS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under VASOPRESSINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under VINCA ALKALOIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under VOICE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under WEIGHTS AND MEASURES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%79%29%; was see under WUCHERERIA 1979-90; was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%63; was see under AROMATIC AMINO ACID DECARBOXYLASES 1980-90; was heading 1963-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was DELPHI TECHNIC see under QUESTIONNAIRES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was ETHYLMERCURY CHLORIDE see under ETHYLMERCURY COMPOUNDS 1980-90; was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1972-79 %28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was LEUKOCYTE MIGRATION INHIBITORY FACTORS see under LYMPHOKINES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was METHYLPREDNISOLONE SUCCINATE see under METHYLPREDNISOLONE/analogs %26% derivatives 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ADAMANTANE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AJMALINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ALDEHYDE OXIDOREDUCTASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ALDEHYDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ALPRENOLOL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AMINE OXIDOREDUCTASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AMINOACRIDINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ANGIOTENSIN II 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ANTIPYRINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AUDIOMETRY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AUDITORY PERCEPTION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AZEPINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under AZO COMPOUNDS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under BACTERIOCINS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under BENZAMIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under BLOOD COAGULATION TESTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under BUFFERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CARCINOMA, BASAL CELL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CEPHALEXIN 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CEPHALOSPORINS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CHEMOTACTIC FACTORS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CHLORAMBUCIL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CHOLESTEROL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CLEAVAGE STAGE, OVUM 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CLOFIBRATE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under COLCHICINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under COMMUNICATION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under COMPUTERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CONSERVATION OF NATURAL RESOURCES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under CYTOCHROME REDUCTASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DECOMPRESSION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DENTAL CEMENTS 1980-90; ASPA CEMENT %26% SILICOPOLYACRYLATE CEMENT were see GLASS IONOMER CEMENTS 1980-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DEOXYCHOLIC ACID 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DEXTRINS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under DUODENAL OBSTRUCTION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under ECONOMICS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under EMERGENCY MEDICAL SERVICES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under EVOKED POTENTIALS, AUDITORY 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under FINANCIAL MANAGEMENT 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under FLUOCORTOLONE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under FLUORIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GLYCERALDEHYDE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GLYCINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GLYCOLATES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GONADAL DYSGENESIS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GROUP PRACTICE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under GUANOSINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HAIR CELLS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HEALTH FACILITIES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HEALTH PLANNING 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HEALTH PLANNING ORGANIZATIONS 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HEALTH PLANNING ORGANIZATIONS 1980-90; STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HEARING TESTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HERNIA 1980-90; was OBTURATOR HERNIA see under HERNIA 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HOSPITAL BED CAPACITY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HYDROCARBONS, CHLORINATED 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under HYPERLIPOPROTEINEMIA 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under IMMUNITY, CELLULAR 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under LARYNGEAL CARTILAGES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under LEUKEMIA, EXPERIMENTAL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under LYMPHOPROLIFERATIVE DISORDERS 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under MASTICATORY MUSCLES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under NADH, NADPH OXIDOREDUCTASES 1980-90; was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under OLIGOPEPTIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PATIENTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PATIENTS 1980-90; was see AMBULATORY CARE 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PERCEPTUAL DISORDERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PERIODONTITIS 1980-90; was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PHENETHYLAMINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PHOSPHOLIPASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PLATELET FUNCTION TESTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under POLYENES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under POLYSACCHARIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under POLYTETRAFLUOROETHYLENE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under POVERTY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PROPANOLAMINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PROPIONATES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE %26% 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST %26% 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PYRAZOLES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under PYRIDAZINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under QUINUCLIDINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under REHABILITATION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under RNA CAPS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under SEAWEED 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under SERINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under SOCIETIES, NURSING 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under SPEECH 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under SURGERY, OPERATIVE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under THEOPHYLLINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under THORACIC INJURIES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under THREONINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under THYMUS HORMONES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under TRANSDUCERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under TRIGEMINAL NUCLEUS, SPINAL 1982-90; was see under TRIGEMINAL NUCLEI 1980-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under URACIL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%80%29%; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%63; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%72; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under AFFECTIVE DISORDERS 1981-90; was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under AMBYSTOMA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under BILIARY TRACT DISEASES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under BLEOMYCINS 1981-90; was PHLEOMYCIN see under ANTIBIOTICS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under BOOKS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CALLITHRICIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CANDIDIASIS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CEBIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under CERCOPITHECUS 1981-90; CERCOPITHECUS PYGERYTHRUS %26% CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under DWARFISM 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under FATTY ALCOHOLS 1981-90; was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under GASTRITIS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under HISTIDINE/analogs %26% derivatives 1981-90; was METHYLHISTIDINE see under HISTIDINE 1972-80 %28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under LINKAGE %28%GENETICS%29% 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under LIVER DISEASES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under MACACA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under MALABSORPTION SYNDROMES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under METASTRONGYLOIDEA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under NECTURUS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under NITROIMIDAZOLES 1981-90; was RO 7-0207 see under NITROIMIDAZOLES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was %28%NM%29% 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PANCREATIC CYST 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80 %26% see under COMPULSIVE BEHAVIOR 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 %26% see under PICOLINE/analogs %26% derivatives 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under POLYENES 1981-90; was METHYL PARTRICIN see under POLYENES 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PONGIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under RANIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under RATS, MUTANT STRAINS 1982-90; was see under RATS 1981%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under RODS AND CONES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under SALAMANDRIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under SALIVARY GLAND DISEASES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under SALIVARY GLAND NEOPLASMS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under SKULL 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under TUPAIIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%81%29%; was see under VIOMYCINS 1981-90; was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%73%28%66 only%29%; was see under ANTIGENS, HETEROPHILE 1983-90; was heading 1973-81; was see under HAPTENS 1965-72 %28%Prov 1966%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%73; was see under MITOMYCINS 1982-90; was heading 1973-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ADMINISTRATIVE PERSONNEL 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under CYTOPHAGACEAE 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under DISEASE 1982-90; was REMISSION see under DISEASE 1975-81; was REMISSION 1971-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ECONOMICS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ENERGY-GENERATING RESOURCES 1982-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1982-90; was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under FINANCIAL MANAGEMENT 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under GOVERNMENT AGENCIES 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under HEALTH FACILITY PLANNING 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under HOSPITAL DEPARTMENTS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under HOSPITAL UNITS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under HOSPITALS, SPECIAL 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under HYPOPHYSECTOMY 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under INTENSIVE CARE UNITS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ISLET CELL TUMOR 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under NEPHRITIS, INTERSTITIAL 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under OPERATING ROOMS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under ORTHODONTIC APPLIANCES 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under PERSONNEL MANAGEMENT 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under POLITICS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under PSYCHOTIC DISORDERS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under RATS, MUTANT STRAINS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under TISSUE BANKS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1982-90; was UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-81; was NATIONAL INSTITUTE OF MENTAL HEALTH see under ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77; was NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%82%29%; was see under UNITED STATES PUBLIC HEALTH SERVICE 1982-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%63; was DIIODOHYDROXYQUIN 1963-91 %28%see under HYDROXYQUINOLINES 1983-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%63; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under BIOLOGICAL PRODUCTS 1983-90; was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under CORNEA 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under DELIVERY 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under DENTAL HEALTH SURVEYS 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under HEALTH EDUCATION 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under HEART SEPTAL DEFECTS 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under HEART VALVE DISEASES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under HYPOTHALAMUS, MIDDLE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under INDOLES 1983-90; was OXYPHENISATIN see under INDOLES 1975-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under JOINT DISEASES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under LENS, CRYSTALLINE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under OBJECT ATTACHMENT 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under ORGANIZATION AND ADMINISTRATION 1983-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under PERSONNEL MANAGEMENT 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under PROFESSIONAL PRACTICE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under RATS, MUTANT STRAINS 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under RECEPTOSOMES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under RETINA 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under SACCULE AND UTRICLE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under SALIVARY GLAND DISEASES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under SEX CHROMOSOME ABNORMALITIES 1983-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under SKULL FRACTURES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under SOCIAL ENVIRONMENT 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%83%29%; was see under WORK 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%63; was see under CALCINOSIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%63; was see under HEART DEFECTS, CONGENITAL 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%63; was see under PNEUMOCONIOSIS 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%63; was see under PNEUMONIA, ASPIRATION 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%63; was see under SARCOMA, EXPERIMENTAL 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%63; was see under TUBERCULOSIS, PLEURAL 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%65%28%63%29%; was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83; was Prov 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under ANEMIA, SICKLE CELL 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under ANGINA PECTORIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under BASAL GANGLIA 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1984-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under COLONY-FORMING UNITS ASSAY 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under DAUNORUBICIN/analogs %26% derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 %26% see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under DENTAL OCCLUSION 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under EYE MOVEMENTS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1984-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under GRANULOMA 1984-90; PSEUDOTUMOR, INFLAMMATORY was see FIBROMA 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under HEART DEFECTS, CONGENITAL 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under HOSPITAL ADMINISTRATION 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under HOSPITAL DEPARTMENTS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under INSURANCE, HEALTH 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under LARYNGITIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under MOUTHWASHES 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under MUSCLE CONTRACTION 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under MUSCLE CONTRACTION 1984-90; was EXERCISE, ISOMETRIC see under EXERTION 1977-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under MYOFIBRILS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under PARANASAL SINUS NEOPLASMS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under PERSONNEL MANAGEMENT 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under PYRIMIDINES 1984-90; was TRAPYMIN see under PYRIMIDINES 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under TRYPTAMINES 1989-90; was see under SEROTONIN 1984-88; was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under VIDEO RECORDING 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%84%29%; was see under WOMEN 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%63; was see under PENICILLIN G 1985-90; was heading 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%74%28%67%29%; was see under ELECTROPHORESIS, POLYACRYLAMIDE GEL 1985-91; was heading 1974-84; was ELECTROPHORESIS, DISK 1967-73 %28%Prov 1967-69%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under AFFECT 1988-90; was see under EMOTIONS 1985-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under ASTHMA 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under AXIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under CHROMOSOME ABERRATIONS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under CHROMOSOME DELETION 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under DRUG INDUSTRY 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under ECTODERMAL DYSPLASIA 1987-90, was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; GOLTZ-GORLIN SYNDROME was see FOCAL DERMAL HYPOPLASIA 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under ELECTROLYSIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under EYE MOVEMENTS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under FOLLICULAR PHASE 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under GENES, REGULATOR 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under GINGIVAL DISEASES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under KANAMYCIN 1985-90; was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 %26% see under BRIDGED COMPOUNDS 1966-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under NEUROPSYCHOLOGICAL TESTS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under OSTEOCHONDRITIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER%27%S DISEASE was see DYSCHONDROPLASIA 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under PERSONNEL MANAGEMENT 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under PHARYNGEAL NEOPLASMS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under RATS, INBRED STRAINS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under SHEEP DISEASES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under SYNDACTYLIA 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%85%29%; was see under TAXES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under NUTS 1986-90; was heading 1963-85; was in Cat J only 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under PLANTS, EDIBLE 1986-90; CHOCOLATE %26% COCOA were see under CACAO 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under SARCOMA 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under TREES 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under TREES 1986-90; was heading 1963-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%63; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%79; was see under CESTODA 1986-90; was heading 1979-85; was see SPARGANUM 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; for EMMONSIA use MITOSPORIC FUNGI 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under AGARICALES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under ARRHYTHMIA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under ASPERGILLUS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under BASE SEQUENCE 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under BLOOD PLATELET DISORDERS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85; was see under CYTOPLASM 1977-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under EQUIPMENT FAILURE 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 %26% see under NEMATODE INFECTIONS 1967-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under FINANCIAL MANAGEMENT 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under GRASSES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under HEALTH PLANNING ORGANIZATIONS 1986-90; was see HEALTH PLANNING ORGANIZATIONS 1984-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under HELIGMOSOMATOIDEA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under HOSPITAL ADMINISTRATION 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under HOSPITALS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under HYPERGAMMAGLOBULINEMIA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under INSURANCE, HEALTH 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under KERATOCONJUNCTIVITIS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under LEISHMANIA 1986-90; LEISHMANIA PERUVIANA was see LEISHMANIA BRAZILIENSIS 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under MEIOSIS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under MOUSE LEUKEMIA VIRUSES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under NORPREGNADIENES 1986-90; was R 5020 see under NORPREGNADIENES 1979-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under ORTHOPEDIC FIXATION DEVICES 1986-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under ORTHOPTERA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under PERSONNEL MANAGEMENT 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under PHOTOCHEMOTHERAPY 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under PLASMODIUM 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under POSTOPERATIVE PERIOD 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under PRE-EXCITATION SYNDROMES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under RATS, INBRED STRAINS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under SALIVARY GLAND NEOPLASMS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under SOMATOMEDINS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under STAPHYLOCOCCAL SKIN INFECTIONS 1986-90; RITTER%27%S DISEASE was see DERMATITIS EXFOLIATIVA 1968-85, was heading 1966-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under STRONGYLOIDEA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%86%29%; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%%28%75-79%29%; was see under NURSING ASSESSMENT 1987-90; was see NURSING ASSESSMENT 1980-86; was see under NURSING CARE 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%66%28%64%29%; was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86; was Prov 1964-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%66; was see under PLANT OILS 1987-90; was heading 1966-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%73%28%71%29%; was see under ELECTROPHORESIS 1987-90; was heading 1971-86 %28%Prov 1971-73%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%73%28%72%29%; was see under ELECTROPHORESIS 1987-90; was heading 1972-86 %28%Prov 1972%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under ACCIDENTS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under ANESTHESIA, INHALATION 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under ARACHIDONATE LIPOXYGENASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under ARTIFICIAL INTELLIGENCE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under CATECHOLS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under CATFISH 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under COMPUTER SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under COMPUTERS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under CYPRINODONTIFORMES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under DENTAL CARIES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under DNA REPAIR 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under ELECTRIC FISH 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under FILARIASIS 1988-90; was see under LYMPHEDEMA 1987%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under FLATFISHES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under HEART DEFECTS, CONGENITAL 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under HEART RUPTURE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under HOSPITAL INFORMATION SYSTEMS 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under HYPEROXALURIA 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under IMAGE INTERPRETATION, COMPUTER-ASSISTED 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under INFORMATION SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under INTESTINAL PSEUDO-OBSTRUCTION 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under KIDNEY DISEASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under LIPOMATOSIS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under MATHEMATICAL COMPUTING 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under NEVUS, PIGMENTED 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under OXIDOREDUCTASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under PERCIFORMES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under PIGMENTATION DISORDERS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under PLANT OILS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under PROSPECTIVE PAYMENT SYSTEM 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under RADIOTHERAPY, COMPUTER-ASSISTED 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under RATS, MUTANT STRAINS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under RHEOLOGY 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under RUBELLA 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under SOFTWARE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under SYNOVIAL CYST 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under THERAPY, COMPUTER-ASSISTED 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under THYROIDITIS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under TRACHEAL DISEASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under VACCINES 1989-90; was see under ANTIGENS 1987-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%87%29%; was see under YERSINIA INFECTIONS 1987-90; was PSEUDOTUBERCULOSIS, YERSINIA 1977-86; was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was see under PASTEURELLA 1963; PSEUDOTUBERCULOSIS INFECTIONS, YERSINIA was see YERSINIA PSEUDOTUBERCULOSIS INFECTIONS 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under BASE SEQUENCE 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under CEREBROSPINAL FLUID SHUNTS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under CHILD WELFARE 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under ENDOTHELIUM 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under ENTEROSTOMY 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under GENES 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under GENES, REGULATOR 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under GLYCOSIDES 1988-90; was NITROPHENYLGALACTOSIDE see under GLYCOSIDES 1975-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under HOSPITAL ADMINISTRATION 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under LYMPHATIC DISEASES 1988-90; was see under LYMPHANGIOMA 1966-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under MICROBIOLOGICAL TECHNIQUES 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under NORPREGNATRIENES 1988-90; was R 2323 see under NORPREGNATRIENES 1979-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under OPERON 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under OWNERSHIP 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under PERSONNEL MANAGEMENT 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under RNA, RIBOSOMAL 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%88%29%; was see under SALIVARY PROTEINS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under ACCREDITATION 1989-90; was JOINT COMMISSION ON ACCREDITATION OF HOSPITALS see under ACCREDITATION 1979-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under DIALYSIS SOLUTIONS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under DNA PROBES 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under ELECTRIC INJURIES 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 3 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 4 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 6 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 7 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 8 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under INSURANCE 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under INTERFERON ALFA, RECOMBINANT 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under MOLECULAR PROBE TECHNIQUES 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under NURSING RESEARCH 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under ORGANIZATION AND ADMINISTRATION 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under PANNICULITIS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under PUBLIC RELATIONS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under REIMBURSEMENT MECHANISMS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under SEROTONIN 1989-90; was METHOXYTRYPTAMINE see under TRYPTAMINES 1966-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%89%29%; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1973-88 %28%Prov 1973-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%70; was see under POXVIRUS INFECTIONS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under BIAS %28%EPIDEMIOLOGY%29% 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under ENTEROVIRUSES 1990; was DUCK HEPATITIS VIRUS 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under FOREIGN BODY REACTION 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under GENE AMPLIFICATION 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under GENES, VIRAL 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under GIANT CELLS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under IMMUNOLOGIC TESTS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under OPTIC NERVE DISEASES 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under POXVIRUS INFECTIONS 1990; was see VACCINIA 1974-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under PROBABILITY 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under REGRESSION ANALYSIS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under SKIN TESTS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under SPINAL OSTEOPHYTOSIS 1990; was DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS see under SPINAL OSTEOPHYTOSIS 1985-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under STATISTICS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under TRANS-ACTIVATORS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under TRAUMA SEVERITY INDICES 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%90%29%; was see under VIRAL REGULATORY PROTEINS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under CERTIFICATION 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under CRIME 1977-90; KICKBACKS was see CRIME 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under ECONOMICS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under ELECTRICITY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under ETHICS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under FEES AND CHARGES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under FIRES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under FOOD SERVICES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HEALTH FACILITIES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HEALTH SERVICES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HOSPITAL ADMINISTRATION 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HOSPITAL DEPARTMENTS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HOSPITAL UNITS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HOSPITAL VOLUNTEERS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HOSPITALS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under HOSPITALS, SPECIAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under INSURANCE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under LICENSURE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under MEDICAL AUDIT 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under MEDICAL STAFF, HOSPITAL 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under OFFICE MANAGEMENT 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under PERSONNEL MANAGEMENT 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under PUBLIC RELATIONS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under REGIONAL HEALTH PLANNING 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under SOCIETIES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91%28%Aug 77%29%; was see under UTILIZATION REVIEW 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-64; was see under CHROMIUM ALLOYS 1982-90; was see under CHROMIUM-COBALT ALLOYS 1965-81; was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-64; was see under ETHYL ETHERS 1974-90; was see under ETHYL ETHER 1965-73; was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-64; was see under SILICA 1965-90; was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-65; was see under RICKETTSIACEAE 1975-90; was heading 1963-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-66; was see under ESTHETICS 1967-90; was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-66; was see under STERILIZATION 1967-90; was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-67; was see under DIOXINS 1968-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-67; was see under INDENES 1975-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-67; was see under MUSTARD COMPOUNDS 1968-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-67; was see under PITUITARY-ADRENAL FUNCTION TESTS 1975-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-67; was see under TRICHOSTRONGYLOIDIASIS 1968-90; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-77; was see under PLANTS, MEDICINAL 1978-90; was heading 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-79; was see under AROMATIC AMINO ACID DECARBOXYLASES 1980-90; was heading 1963-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-80; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-82; was see under HYDROXYQUINOLINES 1983-90; was heading 1963-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-83; was see under CALCINOSIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-83; was see under PNEUMOCONIOSIS 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-83; was see under SARCOMA, EXPERIMENTAL 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-83; was see under TUBERCULOSIS, PLEURAL 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under HYPERTHERMIA, INDUCED 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under NUTS 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under PLANTS, EDIBLE 1986-90; CHOCOLATE %26% COCOA were see under CACAO 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under PLANTS, EDIBLE 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under PLANTS, TOXIC 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under SARCOMA 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under TREES 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,63-85; was see under VASCULAR RESISTANCE 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,65-83; was see under RHABDOMYOLYSIS 1984-90; was heading 1965-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,66-73; was see under ANGIOTENSIN II/analogs %26% derivatives 1975-90; was see under ANGIOTENSIN II 1974; was heading 1966-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,66-86; was see under INJECTIONS, SUBCUTANEOUS 1987-90; was heading 1966-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,68; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1982-90; was heading 1968-81; was ANEMIA, CONGENITAL NONSPHEROCYTIC HEMOLYTIC 1965-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,70; was see under POXVIRUS INFECTIONS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,72-80; was see under COMPARTMENT SYNDROMES 1981-90; was heading 1972-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,72; was see under ANTIBODIES 1975-90; was see under IGE 1973-74; was heading 1972%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,73-81; was see under ANTIGENS, HETEROPHILE 1983-90; was heading 1973-81; was see under HAPTENS 1965, 1967-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,73-86; was see under ELECTROPHORESIS 1987-90; was heading 1973-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,74-84; was see under ELECTROPHORESIS, POLYACRYLAMIDE GEL 1985-91; was heading 1974-84; was ELECTROPHORESIS, DISK 1970-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91,79-85; was see under CESTODA 1986-90; was heading 1979-85; was see SPARGANUM 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '910, Polygalactin' = 0).
% 42.08/41.94 fof(interp, fi_functors, '910, Polyglactin' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; 99MTC-DTPA was see TECHNETIUM TC 99M PENTETATE 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGEN were see RECEPTORS, LYMPHOCYTE HOMING 1991-93;ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; ANTIGENS, CD44, CD44 ANTIGENS %26% PgP-1 ANTIGENSwere see RECEPTORS, LYMPHOCYTE HOMING 1991-93; ANTIGENS, CD44 was ANTIGEN, CD44 see RECEPTORS, LYMPHOCYTE HOMING 1991-92; CD44 ANTIGENS was CD44 ANTIGEN see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; BACTEROIDES CORRODENS %28%with EIKENELLA CORRODENS as see ref to it%29% was see under BACTEROIDES 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; BIOLOGICAL SCIENCES was see BIOLOGY 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; BRACHIOCEPHALIC TRUNK was see INNOMINATE ARTERY 1963-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; DATABASES was see INFORMATION SYSTEMS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; DENTAL SEDATION was see CONSCIOUS SEDATION 1991-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; DIAGNOSIS-RELATED GROUP OUTLIERS was DIAGNOSTIC RELATED GROUP OUTLIERS 1991%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; HERLITZ DISEASE was HERLITZ%27%S DISEASE 1991-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; HISTAMINE-PRODUCING CELL-STIMULATING FACTOR was HISTAMINE-PRODUCING CELL STIMULATING FACTOR see INTERLEUKIN-3 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; HISTONE H1 KINASE, M-PHASE-SPECIFIC was HISTONE H1 KINASE, M PHASE-SPECIFIC 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; HTLV-I TRANS-ACTIVATOR PROTEIN, TRANS-ACTIVATOR PROTEIN P40%28%X%29%, %26% TAX PROTEIN were see TRANS-ACTIVATORS 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; IMMUNOBLASTOMA %26% SARCOMA, IMMUNOBLASTIC were see LYMPHOMA 1981-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; INNOMINATE VEIN was heading 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; INTEGRIN ALPHA%28%M%29%BETA%28%2%29% was NM 1994-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; INTEGRIN ALPHA%28%M%29%BETA%28%2%29% was indexed under INTEGRINS 1994-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; LOR PROTEINS %26% PX PROTEINS were see TRANS-ACTIVATORS 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; LYMPHOSARCOMA was see LYMPHOMA, NON-HODGKIN%27%S 1987-90; was heading 1963-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; NORSYNEPHRINE was heading 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; PATIENT NON-COMPLIANCE was see PATIENT COMPLIANCE 1982-90 %26% was see PATIENT DROPOUTS 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; POLARIZATION FLUOROIMMUNOASSAY was see FLUOROIMMUNOASSAY 1989-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; SKIN DISEASES, BULLOUS was heading 1976-90 %26% was NON MESH before 1976; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; SKIN DISEASES, BULLOUS was heading 1976-90; ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see ASCOMYCETES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see ASPERGILLUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see BASIDIOMYCETES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see BASIDIOMYCETES 1986-90, see AGARICACEAE 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see CHONDROITIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see COCKROACHES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see CRYPTOCOCCUS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see DIPTERA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see DNA POLYMERASES 1977-90, DNA POLYMERASE DELTA was indexed under DNA POLYMERASES 1980-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see ENDOMYCETALES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85; for HANSENULA see HANSENULA 1991-98, see ENDOMYCETALES 1986-90, see ASCOMYCETES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYDANTOINS 1975-90; for PHENANTION use PHENYTOIN 1978-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYPHOMYCETES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYPHOMYCETES 1986-90, see DEUTEROMYCETES 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYPHOMYCETES 1986-90, see MONILIALES 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYPHOMYCETES 1986-90, see PHYCOMYCETES 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYPHOMYCETES 1986-90; for EMMONSIA see MONILIALES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see HYPOCREALES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see LEVULINIC ACIDS 1975-90; see LEVULINIC ACID 1973-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1972-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see MASTIGOMYCOTINA 1986-90, see PHYCOMYCETES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see MUCORALES 1986-90, see PHYCOMYCETES 1975-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see NEUROSPORA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see NITRILES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see PENICILLIUM 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see PENTOSYLTRANSFERASES 1975-90; GLIOSTATIN was indexed under NERVE TISSUE PROTEINS 1992-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see PHENTERMINE 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see PROTECTIVE DEVICES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see PROTECTIVE DEVICES 1975-90; for GAS MASKS see MASKS 1968-74, see GAS MASKS 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see PYRROLIDINONES 1972-90; MAGNESIUM PIDOLATE was indexed under PYRROLIDONECARBOXYLIC ACID/analogs %26% derivatives 1995-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see THEOBROMINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see THIAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see TRIATOMIDAE 1979-90, see TRIATOMINAE 1973-78; for TRIATOMIDAE see TRIATOMINAE 1991-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see VESTIBULAR FUNCTION TESTS 1975-90; BARANY TEST was BARANY%27%S TEST 1993-97%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; see ZYGOMYCOTINA 1986-90, see ZYGOMYCETES 1979-85, see PHYCOMYCETES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; use CHYTRIDIOMYCOTA 1986-90, use FUNGI 1963-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was A 23187 1975-90 %28%see under ANTIBIOTICS 1975-83%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ABUTMENTS, DENTAL 1970-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ALPHA-DIFLUOROMETHYLORNITHINE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ALPHASONE see under ALGESTONE ACETOPHENIDE/analogs %26% derivatives 1975-90; was ALPHASONE see under ALGESTONE ACETOPHENIDE 1974; DIHYDROXYPROGESTERONE was see ALGESTONE ACETOPHENIDE 1975-76, was see under ALGESTONE ACETOPHENIDE 1974%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ANTIBIOTIC X 5108 see under ANTIBIOTICS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BACTERIAL TYPING TECHNICS 1989-90; BIOTYPING was see BACTERIAL TYPING TECHNICS 1989-90 %26% BACTERIAL TYPING TECHNIQUES 1991; BACTERIOCIN TYPING was see BACTERIOPHAGE TYPING 1986-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BACTERIOLOGICAL TECHNICS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BCR-ABL FUSION PROTEINS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BETA 2 MICROGLOBULIN 1984-90; was see under BETA GLOBULINS 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BIOLOGICAL SCIENCES %28%NON MESH%29% 1975-90; BIOLOGICAL SCIENCES was see BIOLOGY 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BONDING, DENTAL 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BRAIN/transplantation 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was BUNOLOL 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was CENTROPHENOXINE see under GLYCOLATES 1975-90 %26% see under ACETIC ACIDS 1968-74; MECLOFENOXATE was see CENTROPHENOXINE 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was CHLOROACETOPHENONE 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was COMPUTER ASSISTED INSTRUCTION 1974-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was CYTOLOGICAL TECHNICS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was Citation Type REVIEW 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DECALCIFICATION TECHNIC 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DECISION SUPPORT TECHNICS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DELPHI TECHNIC see under QUESTIONNAIRES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DEMETHYLDIAZEPAM see under DIAZEPAM 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL CASTING TECHNIC 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL HIGH SPEED TECHNIC 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL IMPRESSION TECHNIC 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL PROSTHESIS 1963-90; DENTURES was see DENTAL PROSTHESIS 1984-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL PROSTHESIS DESIGN 1970-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL PROSTHESIS REPAIR 1972-90 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL PROSTHESIS REPAIR 1974-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DENTAL PROSTHESIS RETENTION 1985-90, was DENTURE RETENTION 1965-84; DENTURE RETENTION was see DENTAL PROSTHESIS RETENTION 1985-90; DENTURE STABILITY was heading 1965-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DIAGNOSIS, COMPUTER ASSISTED 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DIHYDROCHOLESTEROL see under CHOLESTEROL/analogs %26% derivatives 1975-90, see under CHOLESTEROL 1973-74, see under CHOLESTANES 1969-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DIIODOHYDROXYQUIN 1963-91 %28%see under HYDROXYQUINOLINES 1983-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DIMILIN see under JUVENILE HORMONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was DYE DILUTION TECHNIC 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ENTEROCHELIN 1975-92; ENTEROCHELIN was see under SERINE 1975-92; ENTEROBACTIN was see ENTEROCHELIN 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ETHYLMERCURY CHLORIDE see under ETHYLMERCURY COMPOUNDS 1980-90; was ETHYL MERCURY CHLORIDE see under ETHYL MERCURY COMPOUNDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was EXO-1,4-ALPHA-GLUCOSIDASE 1978-90; was EXO-1,4-ALPHA-GLUCOSIDASE see under GLUCOSIDASES 1978-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was FLUMAZEPIL 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was FLUORESCENT ANTIBODY TECHNIC 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was FOREIGN BODY MIGRATION see under FOREIGN BODIES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was FOREIGN BODY REACTION 1974-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was FTORAFUR 1986-90 %26% FTORAFUR see under FLUOROURACIL 1977-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was GAG-ONC FUSION PROTEINS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was GAG-POL FUSION PROTEINS see under GENE PRODUCTS, GAG 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was GENETIC TECHNICS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was GINGIVAL EXUDATE see under GINGIVITIS 1975-90; was in Cat A %26% C 1972-83, was in Cat C 1984-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was GLUCOSE CLAMP TECHNIC 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was GOLD THIOGLUCOSE see under GOLD 1979-90; was AUROTHIOGLUCOSE see under GOLD 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 %28%PROV 1966%29%; MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, %26% HEALTH INSURANCE FOR AGED, TITLE 18 1975-78 1966-78 %28%Prov 1966%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, was HEALTH INSURANCE FOR AGED, TITLE 18 1966-78 %28%PROV 1966%29%; MEDICARE was see HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1979-90, %26% HEALTH INSURANCE FOR AGED, TITLE 18 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HEMOLYTIC PLAQUE TECHNIC 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HEMOSTATIC TECHNICS 1976-90; was indexed under HEMOSTASIS 1963-75 %28%Cat E heading%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HEMOSTATIC TECHNICS 1976-90; was indexed under HEMOSTASIS 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HISTOLOGICAL TECHNICS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HYDRAMNIOS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was HYPEROSTOSIS, CORTICAL CONGENITAL 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was IMMUNOENZYME TECHNICS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1971-82 %28%Prov 1971-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was IMMUNOLOGIC TECHNICS 1973-90; ANTIBODY DISSOCIATION was heading 1973-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was IMMUNOSORBENT TECHNICS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was INDICATOR DILUTION TECHNICS 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-93 %28%see under RNA VIRUSES 1981-90%29%; was INFECTIOUS ARTERITIS VIRUS OF HORSES see under RNA VIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was INTERMITTENT POSITIVE PRESSURE BREATHING see under POSITIVE PRESSURE RESPIRATION 1979-90; was INTERMITTENT POSITIVE PRESSURE BREATHING %28%IPPB%29% see under POSITIVE PRESSURE RESPIRATION 1969-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was INTERMITTENT POSITIVE PRESSURE VENTILATION see under POSITIVE PRESSURE RESPIRATION 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ISLANDS OF LANGERHANS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ISLANDS OF LANGERHANS/transplantation 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was JAKOB-CREUTZFELDT SYNDROME 1981-90; was CREUTZFELDT-JAKOB DISEASE 1969-80 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was JAKOB-CREUTZFELDT SYNDROME 1981-90; was CREUTZFELDT-JAKOB DISEASE 1973-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LEUKOCYTE MIGRATION INHIBITORY FACTORS see under LYMPHOKINES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LH-FSH RELEASING HORMONE 1974-90; GONADOTROPIN- RELEASING HORMONE was see PITUITARY HORMONE RELEASING HORMONES 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LIPOIC ACID 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LYMPHOMA, GIANT FOLLICULAR 1963-90; BRILL-SYMMERS DISEASE was see LYMPHOMA, GIANT FOLLICULAR 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LYMPHOMA, HISTIOCYTIC 1987-90; SARCOMA, RETICULUM CELL was see LYMPHOMA, HISTIOCYTIC 1987-90, was heading 1963-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LYMPHOMA, LYMPHOCYTIC 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was LYMPHOMA, MIXED 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was MACROPHAGE MIGRATION INHIBITORY FACTORS 1980-90; was MIGRATION INHIBITORY FACTOR 1974-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was MEDICAL ASSISTANCE, TITLE 19 1971-90; MEDICAID was see MEDICAL ASSISTANCE, TITLE 19 1975-90, was see under MEDICAL ASSISTANCE 1969-70; DENTAL MEDICAID PROGRAM was see under MEDICAL ASSISTANCE, TITLE 19 1979-85, was DENTICAID see under MEDICAL ASSISTANCE, TITLE 19 1974-78, was DENTICAID see under MEDICAL ASSISTANCE 1969-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was METHYLNOREPINEPHRINE see under NOREPINEPHRINE/analogs %26% derivatives 1975-90, see under NORMETANEPHRINE 1971-74, %26% see NORMETANEPHRINE 1966-70%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was METHYLPREDNISOLONE SUCCINATE see under METHYLPREDNISOLONE/analogs %26% derivatives 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was MICROBIOLOGICAL TECHNICS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was MICROSCOPY, PHASE CONTRAST 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was MOLECULAR PROBE TECHNICS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was MYC GENES see ONCOGENES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was O-CHLOROBENZYLIDENE MALONITRILE see under NITRILES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was OBIDOXIME see under OXIMES 1978-90; was TOXOGONIN see under OXIMES 1972-77 %28%Prov 1972-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was OBIDOXIME see under OXIMES 1978-90; was TOXOGONIN see under OXIMES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ONCOGENE PROTEIN PP60%28%SRC%29% 1990; PP60%28%SRC%29% was see ONCOGENE PROTEIN PP60%28%SRC%29% 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PALATAL EXPANSION TECHNIC 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PEPSIN 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PERICARDIAL WINDOW TECHNICS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PITUITARY HORMONE RELEASING HORMONES 1974-90; was PITUITARY HORMONE RELEASING FACTORS 1968-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PLANNING TECHNICS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was POSITIVE PRESSURE RESPIRATION 1979-90; was heading 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was POST AND CORE TECHNIC see under CROWNS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PROSTAGLANDINS X 1978-90 %28%see under PROSTAGLANDINS 1978-83%29%; PROSTACYCLIN was PROSTACYCLINS 1978-93; PROSTAGLANDIN I2 was PROSTAGLANDINS I2 1982-93; PROSTAGLANDIN X was PROSTAGLANDINS X 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was PROTO-ONCOGENE PROTEINS, CELLULAR 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was RADIOISOTOPE DILUTION TECHNIC 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was RAS GENES 1988-90; was RAS GENES see ONCOGENES 1985-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was RELAXATION TECHNICS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was RENNIN 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was REPRODUCTION TECHNICS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was REPRODUCTION TECHNICS 1988-90; was non-MeSH before 1988%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was S PERIOD see INTERPHASE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SCALING, DENTAL see under DENTAL PROPHYLAXIS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SENSITIVITY AND SPECIFICITY %28%EPIDEMIOLOGY%29% 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SHIPPING FEVER see under PASTEURELLA INFECTIONS 1963-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SKIN WINDOW TECHNIC 1970-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SOCIOMETRIC TECHNICS 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SOMATOTROPIN RELEASING HORMONE 1974-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SPEECH PATHOLOGY 1980-90; was included in SPEECH THERAPY 1964-79 %28%Prov 1964-65%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SPEECH PATHOLOGY 1980-90; was included in SPEECH THERAPY 1966-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SRC GENES see ONCOGENES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was STEREOTAXIC TECHNICS 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SUBTRACTION TECHNIC 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was SUTURE TECHNICS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was TOYOMICIN see under CHROMOMYCINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ULTRASONIC DIAGNOSIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was ULTRASONIC DIAGNOSIS 1985-90; was DIAGNOSIS, ULTRASONIC %28%NON MESH%29% 1974-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was UNITED STATES VETERANS ADMINISTRATION 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was VALPROATE 1979-90; was DIPROPYL ACETATE see under VALERATES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was WHOLE BODY IRRADIATION 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see BONE RESORPTION 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see CAMPYLOBACTER FETUS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see COMPUTER SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see DENTAL OCCLUSION, CENTRIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see ENVIRONMENTAL EXPOSURE 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see HEALTH OCCUPATIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see ICHTHYOSIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see INFORMATION SYSTEMS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see MENINGOMYELOCELE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see RESIDENTIAL FACILITIES 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see RIGHT TO DIE 1987-90; was see WILLS 1977-86 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see SIV 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see SUPPRESSION, GENETIC 1980-90; was heading 1968-79 %28%Prov 1968-69%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see SUPPRESSION, GENETIC 1980-90; was heading 1970-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see TACHYCARDIA 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-ALPHA was see TRANSFORMING GROWTH FACTORS 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see TRANSFORMING GROWTH FACTORS 1989-90; TGF-BETA was see TRANSFORMING GROWTH FACTORS 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 17-HYDROXYCORTICOSTEROIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 17-HYDROXYSTEROID DEHYDROGENASES 1978-90; was ESTRADIOL DEHYDROGENASE see under HYDROXYSTEROID DEHYDROGENASES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 17-KETOSTEROIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 2-ACETYLAMINOFLUORENE 1980-90; was see under FLUORENES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 2-ACETYLAMINOFLUORENE/analogs %26% derivatives 1980-90; was see under FLUORENES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 20-HYDROXYSTEROID DEHYDROGENASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 3-HYDROXYSTEROID DEHYDROGENASES 1978-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under 4-HYDROXYCOUMARINS 1977-90; was see under COUMARINS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ABNORMALITIES, MULTIPLE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ABNORMALITIES, MULTIPLE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ABORTIFACIENT AGENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ABORTION, INDUCED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ABREACTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACANTHOCEPHALA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACCELERATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACCIDENT PREVENTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACCIDENTS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACCOUNTING 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACCREDITATION 1989-90; was JOINT COMMISSION ON ACCREDITATION OF HOSPITALS see under ACCREDITATION 1979-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETAMIDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETANILIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETANILIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETANILIDES 1979-90; was DIAMPHENETHIDE see under ACETANILIDE 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETIC ACIDS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETIC ACIDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETIC ACIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETONITRILES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACETYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACIDOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACONITE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACRIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACRYLATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACTIVATION ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACYL COENZYME A 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ACYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADAMANTANE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADAPTATION, PHYSIOLOGICAL 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENINE NUCLEOTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENOSINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENOSINE MONOPHOSPHATE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENOSINE TRIPHOSPHATE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENOSINE TRIPHOSPHATE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENOVIRIDAE 1981-90; was see under ADENOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADENOVIRUS INFECTIONS 1977-90; PHARYNGO-CONJUNCTIVAL FEVER was see under ADENOVIRUS INFECTIONS 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADMINISTRATIVE PERSONNEL 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ADNEXA UTERI 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AEROSOLS 1973-90; was in Cat D %26% J 1973-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AFFECT 1988-90; was see under EMOTIONS 1985-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AFFECTIVE DISORDERS 1981-90; was CYCLOTHYMIC PERSONALITY see under PERSONALITY DISORDERS 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AGARICALES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AGARICALES 1986-90; was see under AGARICACEAE 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AGGRESSION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AGRANULOCYTOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AIR MOVEMENTS 1974-90; was see under WEATHER 1969-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AIR POLLUTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AJMALINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALCOHOL OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALCOHOL, ETHYL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALDEHYDE OXIDOREDUCTASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALDEHYDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALDEHYDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALDEHYDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALDEHYDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALGAE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALGAE, GREEN 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALKALOIDS 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALKALOIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALKALOIDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALKALOIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALKANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALKYL SULFONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALLIED HEALTH PERSONNEL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALLOYS 1968-90; was see under METALS 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALOPECIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALPHA GLOBULINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALPHAVIRUSES 1981-90; was see under ARBOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALPHAVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALPRENOLOL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALUMINUM 1975-90; ALUMINUM AMMONIUM SULFATE %26% ALUMINUM POTASSIUM SULFATE were see ALUM COMPOUNDS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALUMINUM 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ALVEOLITIS, EXTRINSIC ALLERGIC 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMANTADINE 1984-90; was D 145 see under AMANTADINE 1976-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMBYSTOMA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMDINOCILLIN 1985-90; was PIVMECILLINAM see under PENICILLANIC ACIDS 1978-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMEBIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMIDOHYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMIDOHYDROLASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINE OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINE OXIDOREDUCTASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINE OXIDOREDUCTASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under LYSINE 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACID CHLOROMETHYL KETONES 1977-90; was see under PHENYLALANINE 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACID ISOMERASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACIDS, DIAMINO 1980-90; was see under PIMELIC ACIDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACIDS, DICARBOXYLIC 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ACIDS, SULFUR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ALCOHOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINO ALCOHOLS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOACRIDINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOACRIDINES 1982-90; was see under ACRIDINES 1963-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOACRIDINES 1984-90; was see under ACRIDINES 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOACRIDINES 1985-90; was C 283 see under AMINOACRIDINES 1981-84; was C 283 see under ACRIDINES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOBENZOIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOCAPROIC ACIDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOCAPROIC ACIDS 1977-90; EPSILON-AMINOCAPROIC ACID was see AMINOCAPROIC ACIDS 1975-76, was see AMINOCAPROIC ACID 1964-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOHIPPURIC ACIDS 1977-90; was PARA-AMINOHIPPURIC ACID see under AMINOHIPPURIC ACID 1965-76; was PARA-AMINOHIPPURIC ACID 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOHYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOPHENOLS 1979-90; was see under ANILINE COMPOUNDS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOPYRIDINES 1979-90; was see under PYRIDINES 1975-78; was see under ANTIHISTAMINICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOPYRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOSALICYLIC ACIDS 1977-90; was PARA-AMINOSALICYLIC ACID see under AMINOSALICYLIC ACID 1963-76; PAS was see under AMINOSALICYCLIC ACID 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMINOTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMMONIA-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMMONIUM COMPOUNDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMMONIUM COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMMONIUM COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMMONIUM COMPOUNDS 1981-90; was BENZETHONIUM CHLORIDE see under AMMONIUM COMPOUNDS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMOEBA 1977-90; was see under SARCODINA 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMPHETAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMPHETAMINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMPICILLIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMPICILLIN 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMPUTATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AMYLASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANDROSTENEDIOLS 1975-90; was see under ANABOLIC STEROIDS 1964-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANDROSTENOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANEMIA, HEMOLYTIC, CONGENITAL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANEMIA, MACROCYTIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANEMIA, SICKLE CELL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANEMIA, SICKLE CELL 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANENCEPHALY 1979-90; was see under ANENCEPHALUS 1967-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANESTHESIA, EPIDURAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANESTHESIA, INHALATION 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANESTHETICS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANGER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANGINA PECTORIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANGIOMATOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANGIOMATOSIS 1975-90; DIMITRI DISEASE was see STURGE-WEBER SYNDROME 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANGIOTENSIN II 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANGIOTENSIN II 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANILIDES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANILIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANILINE COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANILINE COMPOUNDS 1975-90; PYOCTANIUM AUREUM was see BENZOPHENONEIUM 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANIMAL FEED 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANISOLES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANOXIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTHELMINTICS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTHRACENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTHRANILIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTHRAQUINONES 1975-90; was see under CATHARTICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTHRAQUINONES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, AMINOGLYCOSIDE 1981-90; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, ANTIFUNGAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, ANTIFUNGAL 1990-90; was see under POLYENES 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, MACROLIDE 1990-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIBIOTICS, MACROLIDE 1990; was see under ANTIBIOTICS, ANTIFUNGAL 1975-89; LEVORIN was see under ANTIBIOTICS, ANTIFUNGAL 1978-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIGEN-ANTIBODY COMPLEX 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIGENS, FUNGAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIGENS, FUNGAL 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIMONY 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTIPYRINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANTISEPSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ANURIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under APOPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under APPETITIVE BEHAVIOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under APPOINTMENTS AND SCHEDULES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARABINONUCLEOTIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARACHIDONATE LIPOXYGENASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARENAVIRIDAE 1981-90; was see under ARENAVIRUSES 1978-80; was see under RNA VIRUSES 1972-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARGININE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARGININE 1975-90; N-BENZOYLARGINYL-4-NITROANILIDE was indexed under BENZOYLARGININE NITROANILIDE 1993 %26% ARGININE/*analogs %26% derivatives 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARGININE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARGININE 1977-90; was BENZOYLARGININE BETA NAPHTHYLAMIDE see under ARGININE 1976%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARRHYTHMIA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARSENIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARSENICALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARSENICALS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ART 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARTERIAL OCCLUSIVE DISEASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARTERIES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARTHROPOD VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARTIFICIAL INTELLIGENCE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARTIODACTYLA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ARYL HYDROCARBON HYDROXYLASES 1977-90; was see under HYDROXYLASES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ASCOMYCETES 1986-90; MONOSPORIUM was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ASCORBIC ACID 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ASPARTIC ACID 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ASPERGILLUS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ASTHMA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ASTHMA 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ATMOSPHERIC PRESSURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ATMOSPHERIC PRESSURE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ATTITUDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AUDIOMETRY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AUDITORY PERCEPTION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AVIAN LEUKOSIS VIRUSES 1975-90; was see under AVIAN LEUKOSIS VIRUS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AXIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZEPINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZEPINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZEPINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZETINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZIRINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1976-90; ACID BLACK 1, NAPHTHOL BLUE BLACK, %26% C.I. ACID BLACK 1 were see AMIDO BLACK 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1976-90; AZOVAN BLUE, AZOVANUM CAERULEUM, DIAZOBLEU %26% T-1824 were see EVANS BLUE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZO COMPOUNDS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under AZOLES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BACTERIAL PROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BACTERIAL TOXINS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BACTERIOCINS 1979-80; was MEGACIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BACTERIOCINS 1979-90; was PYOCIN see under BACTERIOCINS 1968-78, see under ANTIBIOTICS 1966-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BACTERIOCINS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BANDAGES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BARBITURATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BARBITURATES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BASAL GANGLIA 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BASE SEQUENCE 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BASE SEQUENCE 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BASIDIOMYCETES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BEE VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BEE VENOMS 1978-90; was see under VENOMS 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BEHAVIOR THERAPY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BEHAVIOR, ANIMAL 1979-90; was ELIMINATIVE BEHAVIOR see under BEHAVIOR, ANIMAL 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZAMIDES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZAMIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZANTHRACENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZENESULFONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZENESULFONATES 1983-90; was SULFANILIC ACID see under BENZENESULFONATES 1975-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZHYDRYL COMPOUNDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZIDINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZIDINES 1977-90; was see under AMINOBIPHENYL COMPOUNDS 1975-76; 3,3%27%-DIMETHOXYBENZIDINE was indexed under DIANISIDINE 1982-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZIMIDAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZIMIDAZOLES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZOATES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZOATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZOATES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZODIAZEPINE TRANQUILIZERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZODIAZEPINE TRANQUILIZERS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZODIAZEPINE TRANQUILIZERS 1980-90; was D 40TA see under BENZODIAZEPINE TRANQUILIZERS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZODIAZEPINONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZOFURANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZOPYRANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZOXAZOLES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BENZYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BERBINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BETA-LACTAMASES 1979-90; was see under AMIDOHYDROLASES 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BETAMETHASONE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BETAMETHASONE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BEVERAGES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BIAS %28%EPIDEMIOLOGY%29% 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BIGUANIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BILE DUCTS, INTRAHEPATIC 1981-90; was see BILE DUCTS, INTRAHEPATIC 1980%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BILIARY TRACT DISEASES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BILIRUBIN 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BINDING SITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BIOFLAVONOIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BIOLOGICAL PRODUCTS 1983-90; was STREPTOCOCCAL PREPARATION OK-432 see under BIOLOGICAL PRODUCTS 1978-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BITES AND STINGS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLEOMYCINS 1981-90; was PHLEOMYCIN see under ANTIBIOTICS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD CELLS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD COAGULATION FACTORS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD COAGULATION TESTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD COMPONENT REMOVAL 1986-90; was see under CELL SEPARATION 1981-85; was see under BLOOD TRANSFUSION 1979-80; was see PLASMAPHERESIS 1978%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD GROUPS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD PLATELET DISORDERS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BLOOD VESSELS 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BODY FLUIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BODY FLUIDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BONDING, DENTAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BONE DISEASES, DEVELOPMENTAL 1985-90; was see under CRANIOFACIAL DYSOSTOSIS 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BOOKS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BORON COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BREAST 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BREEDING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BRETYLIUM COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BRIDGED COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BROMHEXINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BROMINE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUFANOLIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUFFERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUNYAVIRIDAE 1981-90; was see under ARBOVIRUSES 1975-80; was see under ARBOVIRUS 1965-74; was see under ARBORVIRUSES 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUTADIENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUTANONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUTYRATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under BUTYROPHENONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CALCIUM METABOLISM DISORDERS 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CALLITHRICIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CALORIMETRY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CALORIMETRY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CANDIDIASIS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CANNABINOIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CANNABINOIDS 1977-90; was see under CANNABIS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CAPROATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CAPRYLATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBAMATES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBAMATES 1979-90; was THIOPHANATE-METHYL see under CARBAMATES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBANILIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBENICILLIN 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBODIIMIDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBODIIMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOHYDRATE DEHYDROGENASES 1978-90; was see under ALCOHOL OXIDOREDUCTASES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBON 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBONATES 1975-90; was see under CARBON DIOXIDE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOXY-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOXY-LYASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOXY-LYASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOXY-LYASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOXYLIC ACIDS 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARBOXYLIC ESTER HYDROLASES 1976-90; was see under ESTERASES 1975%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARCINOMA, BASAL CELL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARCINOMA, SCIRRHOUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARCINOMA, SQUAMOUS CELL 1981-90; was see under CARCINOMA, EPIDERMOID 1969-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARDIOMYOPATHY, HYPERTROPHIC 1986-90; was see under IDIOPATHIC HYPERTROPHIC SUBVALVULAR STENOSIS 1967-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARICATURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARNITINE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CARNIVORA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CATECHOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CATECHOLS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CATFISH 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CATHARTICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CATTLE DISEASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CAUSTICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEBIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEBIDAE 1981-90; was HOWLER MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEBIDAE 1981-90; was NIGHT MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEBIDAE 1981-90; was SQUIRREL MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CELL DIFFERENTIATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CELLS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CELLULOSE 1976-90; was see under HEMOSTATICS 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CELLULOSE/analogs %26% derivatives 1975-90; was see under CELLULOSE 1970-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1984-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CENTRIFUGATION, DENSITY GRADIENT 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEPHALEXIN 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEPHALOSPORINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEPHALOSPORINS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEPHALOSPORINS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CERCOPITHECIDAE 1981-90; was PATAS MONKEYS see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CERCOPITHECIDAE 1981-90; was see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CERCOPITHECUS 1981-90; CERCOPITHECUS PYGERYTHRUS %26% CERCOPITHECUS SABEUS were see under CERCOPITHECUS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEREBROSIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEREBROSPINAL FLUID SHUNTS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CERTIFICATION Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CESTODA 1987-90; was MESOCESTROIDES see under CESTODA 1986%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CETACEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CEVANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, ANALYTICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, ANALYTICAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, ORGANIC 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, ORGANIC 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, ORGANIC 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, ORGANIC 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, PHYSICAL 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMISTRY, PHYSICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHEMOTACTIC FACTORS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHENODEOXYCHOLIC ACID 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHILD ABUSE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHILD WELFARE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHILD WELFARE 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHLORAMBUCIL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHLOROBENZENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHLOROFORM 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHLOROHYDRINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHLOROPHENOLS 1977-90; was see under PHENOLS 1971-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHLOROPHYLL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTADIENOLS 1978-90; DEHYDROCHOLESTEROL was see under VITAMIN D 3 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTEROL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTEROL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTEROL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLESTEROL 1989-90; was see under STEROLS 1979-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLINE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLINESTERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHOLINESTERASES 1975-90; was see under CHOLINESTERASE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHONDROITINASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMAFFIN SYSTEM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMAFFIN SYSTEM 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMATOGRAPHY, GAS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMATOGRAPHY, GEL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMOSOME ABERRATIONS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMOSOME DELETION 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CHROMOSOMES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CINNAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CINNAMATES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CIRCADIAN RHYTHM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CLEAVAGE STAGE, OVUM 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CLIMATE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CLOACA 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CLOFIBRATE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CLOSTRIDIUM INFECTIONS 1969-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CLOXACILLIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COAL 1975-90; was in Cat J only 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COBRA VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COCHLEA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COCHLEA 1979-90; was DUCTUS COCHLEARIS see under LABYRINTH 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COCHLEA 1990; was see under LABYRINTH 1960-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CODEINE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COELENTERATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COGNITION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COGNITION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COLCHICINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COLITIS, ULCERATIVE 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COLLOIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COLONY-FORMING UNITS ASSAY 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMMUNICATION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMMUNICATION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMMUNITY MENTAL HEALTH CENTERS 1979-90; was see under COMMUNITY MENTAL HEALTH SERVICES 1967-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMMUNITY PSYCHIATRY 1980-90; was see under PSYCHIATRY, COMMUNITY 1973-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMPLEMENT ACTIVATION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMPULSIVE BEHAVIOR 1975-90; OBSESSION was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMPUTER SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMPUTERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COMPUTERS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CONSERVATION OF NATURAL RESOURCES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CONTRACEPTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CONTRACEPTIVES, ORAL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CONTRACEPTIVES, POSTCOITAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORNEA 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORNEAL DYSTROPHIES, HEREDITARY 1990; was see under CORNEAL DYSTROPHIES 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORNEAL OPACITY 1990; was see under EYE DISEASES 1964-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORONARY DISEASE 1987-90; was THROMBOSIS, CORONARY see CORONARY DISEASE 1974-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORPUS LUTEUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORTICOSTERONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORTISONE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORYNEBACTERIUM 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CORYNEBACTERIUM INFECTIONS 1977-90; was see under NOCARDIA INFECTIONS 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COSTS AND COST ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COSTS AND COST ANALYSIS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COUMARINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COUMARINS 1989-90; was see under BIOFLAVONOIDS 1966-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under COXSACKIEVIRUS INFECTIONS 1979-90; was see under COXSACKIE VIRUS INFECTIONS 1970-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CRANIOFACIAL DYSOSTOSIS 1985-90; was see under MANDIBULOFACIAL DYSOSTOSIS 1965-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CRESOLS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CRESOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CRESOLS 1979-90; was TRITOLYL PHOSPHATE see under CRESOLS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CRIME Aug 1977-90; KICKBACKS was see CRIME 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CROTALID VENOMS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CULTURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CULTURE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CURRICULUM 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYANIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYANOACRYLATES 1980-90; was ISOBUTYLCYANOACRYLATE see under CYANOACRYLATES 1972-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLIC N-OXIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOHEPTANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOHEXANECARBOXYLIC ACIDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOHEXANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOHEXANOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOPROPANES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYCLOSTOMES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYPRINIDAE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYPRINIDAE 1987-90; BRACHYDANIO was see ZEBRAFISH 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYPRINODONTIFORMES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYSTEINE 1980-90; was CARBOXYMETHYLCYSTEINE see under CYSTEINE 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYTOCHROME REDUCTASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYTOPHAGACEAE 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYTOSINE NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYTOSINE NUCLEOTIDES 1978-90; was CYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under CYTOSKELETON 1986-90; was see CYTOPLASMIC FILAMENTS 1980-85; was see under CYTOPLASM 1977-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DAIRY PRODUCTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DAPSONE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DAUNORUBICIN/analogs %26% derivatives 1984-90; was CARMINOMYCIN see under DAUNORUBICIN 1980-83 %26% see under ANTIBIOTICS, ANTINEOPLASTIC 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DECANOIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DECOMPRESSION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEFENSE MECHANISMS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEGLUTITION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DELIVERY 1981-90; was VERSION see under DELIVERY 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DELIVERY 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL AUXILIARIES 1980-90; was see DENTAL AUXILIARIES 1979%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL CARIES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL CEMENTS 1980-90; ASPA CEMENT %26% SILICOPOLYACRYLATE CEMENT were see GLASS IONOMER CEMENTS 1980-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL CEMENTS 1982-90; was see under ACRYLIC RESINS 1977-81; was see under ACRYLATES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL EQUIPMENT 1977-90; was ARTICULATORS, DENTAL see under DENTAL EQUIPMENT 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL HEALTH SURVEYS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL HEALTH SURVEYS 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL IMPLANTATION, ENDOSSEOUS 1979-80; ENDOSSEOUS BLADE IMPLANTS was see under DENTAL IMPLANTATION 1974%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL INSTRUMENTS 1980-90; was MATRIX BAND see under DENTAL MATERIALS 1969-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTAL OCCLUSION 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTIFRICES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DENTIFRICES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEOXY SUGARS 1975-90; was see under GLUCOSE 1973-74; was see under HEXOSES 1967-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEOXYCHOLIC ACID 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEOXYCHOLIC ACID 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEOXYCYTIDINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEOXYCYTOSINE NUCLEOTIDES 1978-90; was DEOXYCYTIDYLIC ACIDS see under CYTOSINE NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEOXYURACIL NUCLEOTIDES 1978-90; was see under URACIL NUCLEOTIDES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DERMATOLOGIC AGENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEXAMETHASONE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEXAMETHASONE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEXTRANS 1979-90; was see under DEXTRAN 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DEXTRINS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIABETIC COMA 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIALYSIS SOLUTIONS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIAMINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIATHERMY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZAZEPINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZAZEPINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZOCYCLOHEPTENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZOCYCLOHEPTENES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZOTHIEPINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZOTHIEPINS 1979-90; was PROTHIADENE see under DIBENZOTHIEPINS 1968-78; PROTHIADENE was see DOTHIEPIN 1979-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIBENZOXAZEPINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIGITOXIN 1980-90; was ACETYLDIGITOXIN see under DIGITOXIN 1966-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIGOXIN 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIGOXIN 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIHYDROMORPHINONE 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIHYDROPYRIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIHYDROXYDIHYDROBENZOPYRENES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIHYDROXYTRYPTAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DILATATION AND CURETTAGE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIMERCAPROL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIMETHYLAMINOAZOBENZENE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIOXINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIOXOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIPEPTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISACCHARIDES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISACCHARIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISASTERS 1968-90; was see under DISASTERS %26% INDIGENT CARE 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISASTERS 1972-90; FLOODS was see under DISASTERS 1963-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISEASE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISEASE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISEASE 1982-90; was REMISSION see under DISEASE 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DISPLACEMENT %28%PSYCHOLOGY%29% 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DITERPENES 1975-90; was see under TERPENES 1968-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DITHIOTHREITOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIURETICS, MERCURIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIURETICS, SULFAMYL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIURETICS, SULFAMYL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIURETICS, SULFAMYL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DIURETICS, THIAZIDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DNA PROBES 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DNA REPAIR 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DOPA 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DOPAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DRUG INDUSTRY 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DUODENAL OBSTRUCTION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under DWARFISM 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EAR OSSICLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EAR, EXTERNAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EATING DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ECHINODERMATA 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ECONOMICS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ECONOMICS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ECONOMICS Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ECTODERMAL DYSPLASIA 1987-90, was see under ECTODERMAL DEFECT, CONGENITAL 1985-86; GOLTZ-GORLIN SYNDROME was see FOCAL DERMAL HYPOPLASIA 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EDENTATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EDUCATION, CONTINUING 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EDUCATION, MEDICAL, UNDERGRADUATE 1983-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EDUCATIONAL MEASUREMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EDUCATIONAL MEASUREMENT 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EGG PROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EGO 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EICOSANOIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELASTICITY 1970-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELASTIN 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTRIC FISH 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTRIC INJURIES 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTRICITY Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTROENCEPHALOGRAPHY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTROENCEPHALOGRAPHY 1975-90; CORTICAL DESYNCHRONIZATION was see under ELECTROENCEPHALOGRAPHY 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTROLYSIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTROMAGNETICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTRONICS 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTROPHORESIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELECTROPHYSIOLOGY 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ELEMENTARY PARTICLES 1985-90, was see ELEMENTARY PARTICLES 1975-84; MUONS was see ELEMENTARY PARTICLES 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EMBRYO 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EMERGENCY MEDICAL SERVICES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EMERGENCY MEDICAL SERVICES 1980-90; was see under EMERGENCY HEALTH SERVICES 1976-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EMPHYSEMA 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENDOTHELIUM 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENERGY-GENERATING RESOURCES 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENTEROBACTERIACEAE 1975-90; was see under PROTEUS 1975-89; PROTEUS INCONSTANS was see PROVIDENCIA 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENTEROBACTERIACEAE 1978-90; was AEROBACTER see under ENTEROBACTERIACEAE 1976-77; was AEROBACTER 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENTEROSTOMY 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENTEROVIRUS INFECTIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENTEROVIRUSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ENTEROVIRUSES 1990; was DUCK HEPATITIS VIRUS 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EPINEPHRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EQUIPMENT AND SUPPLIES 1969-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EQUIPMENT FAILURE 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERGOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERGOLINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERYSIPELOTHRIX INFECTIONS 1968-90; was see under ERYSIPELOID 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERYTHROCYTES, ABNORMAL 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERYTHROCYTES, ABNORMAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERYTHROCYTES, ABNORMAL 1975-90; was see under ERYTHROCYTES 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ERYTHROMYCIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ESTRENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ESTRENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ESTRIOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ESTRONE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ESTRUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHANOLAMINES 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHANOLAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHERS 1975-90; was see under ALKYLATING AGENTS 1967-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHERS, CYCLIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHICS Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHICS, MEDICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHNIC GROUPS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHYLENEDIAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ETHYLMERCURY COMPOUNDS 1980-90; was see under ETHYL MERCURY COMPOUNDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EVOKED POTENTIALS, AUDITORY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EXOCRINE GLANDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EXTRACTION, OBSTETRICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYE HEMORRHAGE 1987-90; was CHOROIDAL HEMORRHAGE 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYE MOVEMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYE MOVEMENTS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYE MOVEMENTS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYELID DISEASES 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYELID DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under EYELIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FACIAL EXPRESSION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FACIAL NERVE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FACILITY DESIGN AND CONSTRUCTION 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FACILITY DESIGN AND CONSTRUCTION 1982-90; was LOCATION DIRECTORIES see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FACILITY DESIGN AND CONSTRUCTION 1984-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FACILITY DESIGN AND CONSTRUCTION Aug 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FAMILY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FAMILY 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FASCIA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ACIDS 1975-90; was see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ACIDS, MONOUNSATURATED 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ACIDS, MONOUNSATURATED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ACIDS, MONOUNSATURATED 1988-90; was see under FATTY ACIDS, UNSATURATED 1975-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ACIDS, UNSATURATED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FATTY ALCOHOLS 1981-90; was SODIUM TETRADECYL SULFATES see under FATTY ALCOHOLS 1975-80, see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FEAR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FEES AND CHARGES Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FEES, PHARMACEUTICAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FEMUR HEAD NECROSIS 1979-90; was see under OSTEOCHRONDRITIS 1963-78; COXA PLANA was see under OSTEOCHRONDRITIS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FENFLURAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FERREDOXINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FERREDOXINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FERRICYANIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FERRITIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FETAL DEATH 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FETAL MEMBRANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FIBROUS DYSPLASIA OF BONE 1967-90; ALBRIGHT%27%S DISEASE %26% JAFFE-LICHTENSTEIN DISEASE were see under OSTEITIS FIBROSA 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FILARIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FILARIASIS 1986-90; was ACANTHOCHEILONEMIASIS see under FILARIASIS 1975-85 %26% see under NEMATODE INFECTIONS 1967-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FILARIASIS 1988-90; was see under LYMPHEDEMA 1987%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FILARIASIS 1989-90; was LOAIASIS see under FILARIASIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FILARIOIDEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FINANCIAL MANAGEMENT 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FINANCIAL MANAGEMENT 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FINANCIAL MANAGEMENT 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FINANCIAL MANAGEMENT 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FIRES Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FISH OILS 1983-90; was see under FISH LIVER OILS 1963-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FISH PRODUCTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FISHES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLATFISHES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLAVIVIRUSES 1981-90; was see under ENCEPHALITIS VIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLAVONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLAVONES 1975-90; was see under BIOFLAVONOIDS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLAVONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLAVONES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLAVOPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUOCINOLONE ACETONIDE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUOCORTOLONE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUORENES 1975-90; AMYXIN was indexed under TILORONE/analogs %26% derivatives 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUORESCEINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUORESCENT ANTIBODY TECHNIQUE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUORIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUORIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FLUOROACETATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOLIC ACID 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOLLICULAR PHASE 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOLLICULITIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOOD PRESERVATION 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOOD SERVICES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOOD SERVICES Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FORCED EXPIRATORY FLOW RATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FOREIGN BODY REACTION 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FORELIMB 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FORENSIC PSYCHIATRY 1985-90; was MCNAUGHTON RULE see under FORENSIC PSYCHIATRY 1969-84; was MCNAUGHTON RULE see under JURISPRUDENCE, PSYCHIATRIC 1968%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FORM PERCEPTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FORMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FORMIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FROSTBITE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FRUCTOSE METABOLISM, INBORN ERRORS 1989-90; was see under CARBOHYDRATE METABOLISM, INBORN ERRORS 1967-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FURANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FURANS 1977-90; was GAMMA BUTYROLACTONE see under FURANS 1976%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FURANS 1979-90; was CITRACONIC ANHYDRIDE see under FURANS 1977-78 %26% see under MALEATES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under FURANS 1979-90; was MALEIC ANHYDRIDE see under FURANS 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GALACTOSAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GALACTOSIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GALLIC ACID 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GAME THEORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GANGLIOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GANGLIOSIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GASTRINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GASTRITIS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GASTROINTESTINAL MOTILITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENE AMPLIFICATION 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENES 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENES, REGULATOR 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENES, REGULATOR 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENES, VIRAL 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENETIC ENGINEERING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GENETICS, POPULATION 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GIANT CELLS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GINGIVAL DISEASES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GINGIVITIS 1979-90; was see under PERIODONTITIS 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLOMERULONEPHRITIS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUCONATES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUCOSAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUCOSAMINIDASE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUCOSIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUCOSYLTRANSFERASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUCOSYLTRANSFERASES 1979-90; was see under HEXOSYLTRANSFERASES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUTAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUTAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLUTARATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCERALDEHYDE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCERIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOGEN PHOSPHORYLASE 1979-90; was see GLYCOGEN PHOSPHORYLASE 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 3 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 4 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 6 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 7 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOGEN STORAGE DISEASE 1989-90; was GLYCOGENOSIS 8 see under GLYCOGENOSIS 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOLATES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOLATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOLATES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOLIPIDS 1980-90; was CORD FACTOR see under GLYCOLIPIDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOLS 1977-90; was METHOXYHYDROXYPHENYL GLYCOL see under GLYCOLS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOPROTEINS 1976-90; was see under BLOOD PLATELETS 1975%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSIDE HYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSIDE HYDROLASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSIDE HYDROLASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSIDES 1976-90; was see under UVA URSI 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSIDES 1988-90; was NITROPHENYLGALACTOSIDE see under GLYCOSIDES 1975-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GLYCOSPHINGOLIPIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GONADAL DYSGENESIS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GOVERNING BOARD 1980-90; was see GOVERNING BOARD 1968-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GOVERNMENT AGENCIES 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GRANULOMA 1984-90; PSEUDOTUMOR, INFLAMMATORY was see FIBROMA 1990-1991%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GRASSES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GROUP PRACTICE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANIDINES 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANIDINES 1977-90; CONGOCIDINE was indexed under PYRROLES 1983-93, GUANIDINES 1973-83 %26% AMIDINES 1973-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANINE NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANOSINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANOSINE CYCLIC MONOPHOSPHATE 1980-90; was see under GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUANOSINE TRIPHOSPHATE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under GUILT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HAIR CELLS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HAIR PREPARATIONS 1980-90; was see under COSMETICS 1979%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HAMSTERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HAMSTERS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH EDUCATION 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH FACILITIES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH FACILITIES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH FACILITIES 1983-90; was HOSPITAL CLOSURE see under HOSPITAL ADMINISTRATION Aug 1977-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH FACILITIES Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH FACILITY PLANNING 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH INSURANCE FOR AGED AND DISABLED, TITLE 18 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH PLANNING 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH PLANNING ORGANIZATIONS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH PLANNING ORGANIZATIONS 1980-90; STATE HEALTH PLANNING AGENCIES, UNITED STATES was see HEALTH SYSTEMS AGENCIES 1979%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH PLANNING ORGANIZATIONS 1986-90; was see HEALTH PLANNING ORGANIZATIONS 1984-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH SERVICES Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEALTH SERVICES RESEARCH 1980-90; was see under HEALTH PLANNING 1979; was see under HEALTH AND WELFARE PLANNING Aug 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEARING LOSS, PARTIAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEARING LOSS, SENSORINEURAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEARING LOSS, SENSORINEURAL 1979-90; was see under DEAFNESS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEARING TESTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART AUSCULTATION 1963-90; was in Cat E 1963-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART AUSCULTATION in Cat E 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART BLOCK 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART CONDUCTION SYSTEM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART DEFECTS, CONGENITAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART DEFECTS, CONGENITAL 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART DEFECTS, CONGENITAL 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART DEFECTS, CONGENITAL 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART DISEASES 1965-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART FAILURE, CONGESTIVE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART RUPTURE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART SEPTAL DEFECTS 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART SEPTAL DEFECTS, ATRIAL 1964-90; was see under HEART DEFECTS, CONGENITAL 1963%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART SEPTAL DEFECTS, ATRIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEART VALVE DISEASES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HELIGMOSOMATOIDEA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEME 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMEPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMEPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMEPROTEINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMOGLOBIN A 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMOGLOBINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMOGLOBINS, ABNORMAL 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEMOGLOBINS, ABNORMAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEPTACHLOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEPTANOIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEPTOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HERBICIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HERBICIDES, CARBAMATE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HERBICIDES, TRIAZINE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HERBICIDES, UREA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HERNIA 1980-90; was OBTURATOR HERNIA see under HERNIA 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HERNIA, DIAPHRAGMATIC 1980-90; was HIATAL HERNIA see under DIAPHRAGMATIC HERNIA 1963-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HETEROCYCLIC COMPOUNDS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEXOSEDIPHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEXOSEPHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEXOSYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HEXOSYLTRANSFERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HINDLIMB 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HIP DISLOCATION, CONGENITAL 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HISTIDINE/analogs %26% derivatives 1981-90; was METHYLHISTIDINE see under HISTIDINE 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HISTOCYTOCHEMISTRY 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HISTOCYTOCHEMISTRY 1979-90; was see under STAINS AND STAINING 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOME CARE SERVICES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOMOCYSTEINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HORNS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL ADMINISTRATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL ADMINISTRATION 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL ADMINISTRATION 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL ADMINISTRATION 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL ADMINISTRATION Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL BED CAPACITY 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL BED CAPACITY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, 200 TO 499 see under HOSPITAL BED CAPACITY 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL BED CAPACITY 1980-90; was HOSPITAL BED CAPACITY, UNDER 200 see under HOSPITAL BED CAPACITY 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL DEPARTMENTS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL DEPARTMENTS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL DEPARTMENTS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL DEPARTMENTS Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL INFORMATION SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL UNITS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL UNITS Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITAL VOLUNTEERS Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS, PUBLIC 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS, SPECIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS, SPECIAL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS, SPECIAL 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS, SPECIAL Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HOSPITALS, TEACHING 1978-90; was UNIVERSITY HOSPITALS see under HOSPITALS, TEACHING 1968-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HUMAN RIGHTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYBRIDIZATION 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDANTOINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDANTOINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDRALAZINE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDRAZINES 1979-90; was SERYLTRIHYDROXY BENZYLHYDRAZINE see under HYDRAZINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDRAZINES 1980-90; was BINAZINE see under HYDRAZINES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDRO-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROCARBONS, CHLORINATED 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROCARBONS, CHLORINATED 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROCARBONS, CHLORINATED 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROCARBONS, CHLORINATED 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROCORTISONE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROGEN-ION CONCENTRATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROPHID VENOMS 1978-90; was see under SNAKE VENOMS 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROXAMIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROXYBENZOIC ACIDS 1975-90; was see under BENZOATES 1968-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROXYBUTYRATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROXYLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYDROXYQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYMENOPTERA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPERBILIRUBINEMIA, HEREDITARY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPERGAMMAGLOBULINEMIA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPERLIPOPROTEINEMIA 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPEROXALURIA 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPHOMYCETES 1986-90; was see under MONILIALES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPOGLYCEMIA 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPOLIPOPROTEINEMIA 1980-90; was see under HYPOLIPOPROTEINEMIAS 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPOPHYSECTOMY 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPOPROTHROMBINEMIAS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPOTHALAMUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYPOTHALAMUS, MIDDLE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under HYSTERECTOMY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ILLUSIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMAGE INTERPRETATION, COMPUTER-ASSISTED 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDAZOLES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDAZOLES 1975-90; was see under VASOCONSTRICTOR AGENTS, NASAL 1967-74; was see under SYMPATHOMIMETICS 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDAZOLES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDAZOLES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMIDOESTERS 1980-90; was see under IMIDES 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMMUNITY, CELLULAR 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMMUNOELECTROPHORESIS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMMUNOGLOBULIN FRAGMENTS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMMUNOLOGIC DEFICIENCY SYNDROMES 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMMUNOLOGIC TECHNIQUES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMMUNOLOGIC TESTS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IMPULSE CONTROL DISORDERS 1981-90; was see under COMPULSIVE BEHAVIOR 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDENES 1975-90; was see under INDICATORS AND REAGENTS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDOLES 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDOLES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDOLES 1983-90; was OXYPHENISATIN see under INDOLES 1975-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INDOPHENOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INFANT CARE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INFANT, NEWBORN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INFORMATION SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INHIBITION %28%PSYCHOLOGY%29% 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INK BLOT TESTS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INOSINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INOSINE NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INOSINE NUCLEOTIDES 1978-90; was INOSINIC ACIDS see under INOSINE NUCLEOTIDES 1974-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, CARBAMATE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, CARBAMATE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOCHLORINE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOCHLORINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOPHOSPHATE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOPHOSPHATE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOPHOSPHATE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1979-90, was IMIDAN see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-78; IMIDAN was see PHOSMET 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTIVORA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSECTS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSEMINATION, ARTIFICIAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE, HEALTH 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE, HEALTH 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE, HEALTH 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE, HOSPITALIZATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INSURANCE, PHYSICIAN SERVICES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INTELLIGENCE TESTS 1979-90; was BINET TESTS see under INTELLIGENCE TESTS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INTENSIVE CARE UNITS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INTERFERON ALFA, RECOMBINANT 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under INTESTINAL PSEUDO-OBSTRUCTION 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODINE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODOACETATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODOBENZENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODOBENZOATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODOBENZOATES 1978-90; was TRIIODOBENZOIC ACID see under IODOBENZOATES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IODOPYRIDONES 1975-90; was see under CONTRAST MEDIA 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ION EXCHANGE RESINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under IRIDOVIRIDAE 1981-90; was see under IRIDOVIRUSES 1978-80; was see under DNA VIRUSES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISLET CELL TUMOR 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1979-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISLET CELL TUMOR 1982-90; was see ISLET CELL TUMOR 1981%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISOMERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISONICOTINIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISONIPECOTIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISONIPECOTIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISOQUINOLINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISOQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ISOQUINOLINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under JOINT DISEASES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under JOINTS 1979-90; was see under RIBS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under JURISPRUDENCE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under JUVENILE HORMONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KANAMYCIN 1985-90; was DIDEOXYKANAMYCIN B see under KANAMYCIN 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KERATOCONJUNCTIVITIS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KERATOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KERATOSIS PALMARIS ET PLANTARIS 1975-90 %28%which became KERATODERMA, PALMOPLANTAR 1993%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KETOACID-LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KETOACID-LYASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KETONE OXIDOREDUCTASES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KETONE OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KETONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KIDNEY DISEASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KIDNEY FAILURE, ACUTE 1975-90; LOWER NEPHRON NEPHROSIS was see under KIDNEY FAILURE, ACUTE 1971-78, was see KIDNEY FAILURE, ACUTE 1967-70, was see ACUTE RENAL FAILURE 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KIDNEY PELVIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KIDNEY TUBULES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KIDNEY TUBULES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under KINESICS 1968-90; was see under COMMUNICATION 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LABOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LABOR 1977-90; was LABOR, FIRST STAGE see under LABOR 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LABOR 1977-90; was LABOR, SECOND STAGE see under LABOR 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LABOR 1977-90; was LABOR, THIRD STAGE see under LABOR 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LABYRINTH DISEASES 1979-90; was OTITIS INTERNA see under LABYRINTH DISEASES 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LABYRINTHINE FLUIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LACRIMAL APPARATUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LACTATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LACTATION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LACTOGLOBULINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LACTONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LACTONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LANATOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LANGUAGE DEVELOPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNGEAL CARTILAGES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNGEAL CARTILAGES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNGEAL DISEASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNGEAL NERVES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNGITIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNGITIS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LARYNX 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LAURIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEARNING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEISHMANIA 1986-90; LEISHMANIA PERUVIANA was see LEISHMANIA BRAZILIENSIS 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEMURIDAE 1981-90; was LEMURS see under PROSIMIANS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LENS, CRYSTALLINE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEPIDOPTERA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEUCINE AMINOPEPTIDASE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEUKEMIA, EXPERIMENTAL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LEVORPHANOL 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LICENSURE Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LIGASES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LINKAGE %28%GENETICS%29% 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LIPOIDOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LIPOMATOSIS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LITERATURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LITHOCHOLIC ACID 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LIVER DISEASES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LIZARDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LUMINESCENT PROTEINS 1979-90; was see under PROTEINS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LUNG DISEASES 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LUNG VOLUME MEASUREMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LUNG VOLUME MEASUREMENTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYMPHATIC DISEASES 1988-90; was see under LYMPHANGIOMA 1966-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYMPHEDEMA 1975-90; was see FILARIASIS %26% LYMPHEDEMA 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYMPHOPROLIFERATIVE DISORDERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYPRESSIN 1979-90; was PHELYPRESSIN see under VASOPRESSIN 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under LYSINE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MACACA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MACACA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MACACA 1981-90; was CYNOMOLGUS MONKEYS see under MACACA 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MACACA 1981-90; was RHESUS MONKEYS see under MACACA 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MACROPHAGES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MACULA LUTEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MAGNESIUM 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MALABSORPTION SYNDROMES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MALIGNANT CARCINOID SYNDROME 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MALOCCLUSION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MALONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MALPRACTICE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MAMMALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MAMMALS 1975-90; was see under RABBITS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MAMMOGRAPHY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANAGED CARE PROGRAMS 1990; was see under INSURANCE, HEALTH 1985-89; was see INSURANCE, HEALTH 1984%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANAGEMENT INFORMATION SYSTEMS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANDELIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANDIBULAR NERVE 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANDIBULOFACIAL DYSOSTOSIS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANNITOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MANUAL COMMUNICATION 1974-90; was heading 1963-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MASTICATORY MUSCLES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MASTIGOMYCOTINA 1986-90; was see under PHYCOMYCETES 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MATERIALS MANAGEMENT, HOSPITAL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MATHEMATICAL COMPUTING 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEAT 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MECHANORECEPTORS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MECHANORECEPTORS 1972-90; was see under NERVE ENDINGS 1963-71%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEDICAL AUDIT Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEDICAL HISTORY TAKING 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEDICAL RECORDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEDICAL RECORDS 1975-90; was MEDICAL RECORDS, PROBLEM ORIENTED 1975-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEDICAL SECRETARIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEDICAL STAFF, HOSPITAL Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEIOSIS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MELPHALAN 1981-90; was see under NITROGEN MUSTARD COMPOUNDS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEMORY 1979-90; was RETENTION see under MEMORY 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MENINGES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MENOPAUSE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MENSTRUATION DISORDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MEPERIDINE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METABOLISM 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METALLOPROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METALLOPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METASTRONGYLOIDEA 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHADONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHANE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHIONINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHYL ETHERS 1979-90; was DICHLOROMETHYL ETHER see under METHYL ETHERS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHYLCELLULOSE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHYLGLYCOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHYLHYDRAZINES 1978-90; was 1,2 DIMETHYLHYDRAZINE see under HYDRAZINES 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under METHYLHYDRAZINES 1978-90; was METHYLHYDRAZINE see under HYDRAZINES 1966-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MICE, NEUROLOGIC MUTANTS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MICROBIOLOGICAL TECHNIQUES 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MICROTOMY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MITE INFESTATIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MITOMYCINS 1982-90; was heading 1973-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MITOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MODELS, ANATOMIC 1984-90; was see under MODELS, STRUCTURAL 1971-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOLECULAR PROBE TECHNIQUES 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MONOAMINE OXIDASE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MONOTREMATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MONOTREMATA 1975-95; DUCKMOLE was see PLATYPUS 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORALS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINANS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINANS 1975-90; DEXTRODROMORAN %26% D-DROMORAN were see DEXTRORPHAN 1977-94; DESTRORPHANOLUM was see DEXTRORPHAN 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINANS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINANS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINANS 1985-90; was BENZOMORPHAN see under MORPHINANS 1973-84 %26% see under BRIDGED COMPOUNDS 1966-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINE DERIVATIVES 1978-90; CODETHYLINE was see ETHYLMORPHINE 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHINE DERIVATIVES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORPHOLINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MORTUARY PRACTICE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOTOR NEURONS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOTOR NEURONS 1979-90; was MOTOR NEURONS, GAMMA EFFERENT see under MOTOR NEURONS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOUSE LEUKEMIA VIRUSES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOUTH DISEASES 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOUTH DISEASES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOUTH DISEASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MOUTHWASHES 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUCOPOLYSACCHARIDES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUCOPOLYSACCHARIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MULTIENZYME COMPLEXES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MULTIENZYME COMPLEXES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCLE CONTRACTION 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCLE CONTRACTION 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCLE CONTRACTION 1984-90; was EXERCISE, ISOMETRIC see under EXERTION 1977-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCLE PROTEINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCLE PROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCLES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MUSCULAR DYSTROPHY, ANIMAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYCOBACTERIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYCOBACTERIUM INFECTIONS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYCOPLASMA INFECTIONS/veterinary 1979-90; was see under ANIMAL DISEASES 1978; was see under MYCOPLASMA INFECTIONS 1968-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYCOSES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYCOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYOCARDIAL CONTRACTION 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYOFIBRILS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under MYRISTIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NADH, NADPH OXIDOREDUCTASES 1975-90; was NITRITE REDUCTASE 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NADH, NADPH OXIDOREDUCTASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NADH, NADPH OXIDOREDUCTASES 1980-90; was OLD YELLOW ENZYME see under NADH, NADPH OXIDOREDUCTASES 1975-79, see under OXIDOREDUCTASES 1967-74; NADP DIAPHORASE was see under LIPOAMIDE DEHYDROGENASE 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NAPHTHALENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NAPHTHALENES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NAPHTHALENES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NASOPHARYNGEAL DISEASES 1990; was see under PHARYNGITIS 1965-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NECROSIS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NECTURUS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEMATODA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEMATODE INFECTIONS 1979-90; was see under ASCARIASIS 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEOPLASMS, MULTIPLE PRIMARY 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEOPLASTIC ENDOCRINE-LIKE SYNDROMES 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEPHRITIS, INTERSTITIAL 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NERVE DEGENERATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NERVE DEGENERATION 1975-90; NISSL DEGENERATION was see NERVE DEGENERATION 1997, was heading 1975-96 %28%see under NERVE DEGENERATION 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NERVE TISSUE PROTEINS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NERVOUS SYSTEM 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEURAL CONDUCTION 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEURAL CONDUCTION 1977-90; was see under NEURAL TRANSMISSION 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEUROMUSCULAR JUNCTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEUROPSYCHOLOGICAL TESTS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEUROPSYCHOLOGICAL TESTS 1985-90; was see under PSYCHOLOGICAL TESTS 1971-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEUROSECRETORY SYSTEMS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEUTRONS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NEVUS, PIGMENTED 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NICOTINAMIDE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NICOTINIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NICOTINIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NICOTINIC ACIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NICOTINIC ACIDS 1980-90; was SQ 20009 see under NICOTINIC ACIDS 1976-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITRILES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITRITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITRITES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROBENZENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROBENZENES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROBENZOATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROFURANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROFURANS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROFURANS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROGEN MUSTARD COMPOUNDS 1976-90; LYMPHOCHIN %26% LYMPHOQUIN were see ANILINE MUSTARD 1976-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROGEN MUSTARD COMPOUNDS 1980-90; was ESTRAMUSTINPHOSPHATE see under NITROGEN MUSTARD COMPOUNDS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROIMIDAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROIMIDAZOLES 1981-90; was RO 7-0207 see under NITROIMIDAZOLES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROPHENOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROPHENOLS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROQUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROSAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROSAMINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NITROSOUREA COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NOISE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NORPREGNADIENES 1986-90; was R 5020 see under NORPREGNADIENES 1979-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NORPREGNATRIENES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NORPREGNATRIENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NORPREGNATRIENES 1988-90; was R 2323 see under NORPREGNATRIENES 1979-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NORPREGNENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NUCLEAR ENERGY 1982-90; was see under ATOMIC ENERGY 1975-81; was in Cat H only 1971-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NUCLEOSIDE DEAMINASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NUCLEOSIDE DIPHOSPHATE SUGARS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NUCLEOTIDE DEAMINASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NUCLEOTIDYLTRANSFERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NURSING ASSESSMENT 1987-90; was see NURSING ASSESSMENT 1980-86; was see under NURSING CARE 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NURSING HOMES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NURSING RESEARCH 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under NUTRITION SURVEYS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OBJECT ATTACHMENT 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OBSESSIVE-COMPULSIVE DISORDER 1981-90; was see under NEUROSES, OBSESSIVE-COMPULSIVE 1963-80; was in Cat F only 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ODONTOGENIC TUMORS 1980-90; was see under ODONTOGENIC TUMOR 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OFFICE MANAGEMENT Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OLEIC ACIDS 1988-90, was see under FATTY ACIDS, UNSATURATED 1975-87; was RICINOLEIC ACID see under FATTY ACIDS 1963-74; SODIUM RICINOLEATE was see under FATTY ACIDS, UNSATURATED 1975-80, was see under SCLEROSING SOLUTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OLIGOMYCINS 1982-90; was see under ANTIBIOTICS, ANTIFUNGAL 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OLIGOPEPTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OLIGOPEPTIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OLIGOPEPTIDES 1981-90, was SQ 20881 see under OLIGOPEPTIDES 1975-80; SQ 20881 was see TEPROTIDE 1981-93; NONAPEPTIDE CONVERTING-ENZYME INHIBITOR was indexed under OLIGOPEPTIDES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OLIGOSACCHARIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ONIUM COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OPERATING ROOMS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OPERATIONS RESEARCH 1969-90; was see under OPERATIONS RESEARCH %26% PROGRAMMED INSTRUCTION 1966-68%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OPERATIONS RESEARCH 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OPERON 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OPTIC NERVE DISEASES 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORAL HEMORRHAGE 1990; was see under HEMORRHAGE, ORAL 1967-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGAN OF CORTI 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANIZATION AND ADMINISTRATION 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANIZATION AND ADMINISTRATION 1982-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANIZATION AND ADMINISTRATION 1983-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANIZATION AND ADMINISTRATION 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANIZATION AND ADMINISTRATION Aug 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANOMETALLIC COMPOUNDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANOPHOSPHORUS COMPOUNDS 1972-90; was see under PHOSPHORIC ACIDS 1968-71; PHOSPHATES, ORGANIC was see ORGANOPHOSPHORUS COMPOUNDS 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANOPHOSPHORUS COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANOPHOSPHORUS COMPOUNDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORIENTATION 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORIENTATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORTHODONTIC APPLIANCES 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORTHODONTIC APPLIANCES, REMOVABLE 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORTHOPEDIC EQUIPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORTHOPEDIC FIXATION DEVICES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ORTHOPTERA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSMIUM 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSTEOCHONDRITIS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSTEOCHONDRODYSPLASIAS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSTEOCHONDRODYSPLASIAS 1985-90; OLLIER%27%S DISEASE was see DYSCHONDROPLASIA 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSTEOCHONDRODYSPLASIAS 1985-90; was see under BONE DISEASES, DEVELOPMENTAL 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSTEOLYSIS 1987-90; was see under BONE RESORPTION 1980-86; was see under BONE DISEASES 1967-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OSTEOSCLEROSIS 1970-90; was see under BONE DISEASES 1967-69%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OTITIS MEDIA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OVULATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OVUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OWNERSHIP 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXADIAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXAZINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXAZOCINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXAZOLES 1975-90; see under ANTICONVULSANTS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXAZOLES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXIDOREDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXIDOREDUCTASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXIDOREDUCTASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXIDOREDUCTASES, N-DEMETHYLATING 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXIMES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under OXYGENASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PAINT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PALEONTOLOGY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PALMITIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PANCREATIC CYST 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PANNICULITIS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PAPAVERINE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARABIOSIS 1975-90; was in Cat G only 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARAGANGLIA, NONCHROMAFFIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARAGANGLIOMA, NONCHROMAFFIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARANASAL SINUS NEOPLASMS 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARAPHILIAS 1981-90; was see under SEX DEVIATION 1969-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARAPROTEINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARATHION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PARTNERSHIP PRACTICE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PATIENTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PATIENTS 1980-90; was see AMBULATORY CARE 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENICILLIN G 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENICILLIN G 1985-90; was heading 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENICILLINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENTOSEPHOSPHATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENTOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENTOSYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENTOSYLTRANSFERASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PENTOSYLTRANSFERASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PEPTIDE HYDROLASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PEPTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PEPTIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERCEPTUAL DISORDERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERCIFORMES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERIODONTAL PROSTHESIS 1980-90; was SPLINTS, PERIODONTAL see under PERIODONTAL PROSTHESIS 1966-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERIODONTITIS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERIODONTITIS 1980-90; was ABSCESS, PERIODONTAL see under PERIODONTITIS 1965-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERIODONTIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PEROXIDASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PEROXIDASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PEROXIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY ASSESSMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY DEVELOPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY DISORDERS 1979-90; was PARANOID PERSONALITY see under PARANOIA 1969-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY DISORDERS 1981-90; was OBSESSIVE-COMPULSIVE PERSONALITY see under PERSONALITY DISORDERS 1975-80 %26% see under COMPULSIVE BEHAVIOR 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-AGGRESSIVE PERSONALITY see under PERSONALITY DISORDERS 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY DISORDERS 1981-90; was PASSIVE-DEPENDENT PERSONALITY see under PERSONALITY DISORDERS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONALITY INVENTORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PERSONNEL MANAGEMENT Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PETROLEUM 1975-90; was in Cat J only 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHAGOCYTE BACTERICIDAL DYSFUNCTION 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHARMACEUTIC AIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHARYNGEAL NEOPLASMS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENANTHRENES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENANTHRENES 1981-90; was see under PYRANS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENANTHRIDINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENETHYLAMINES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENETHYLAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENETHYLAMINES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENETHYLAMINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENETHYLAMINES 1984-90; was DEPRENYL see under PHENETHYLAMINES 1979-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENOLPHTHALEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENOLS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENOTHIAZINE TRANQUILIZERS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENOTHIAZINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENOTHIAZINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYL ETHERS 1976-90; IRGASAN DP 300 was see TRICLOSAN 1976-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLACETATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLACETATES 1975-90; DOPACETIC ACID was see 3,4-DIHYDROXYPHENYLACETIC ACID 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLALANINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLBUTAZONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLENEDIAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLMERCURY COMPOUNDS 1980-90; was see under PHENYL MERCURY COMPOUNDS 1977-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLPROPANOLAMINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLPROPIONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLPROPIONATES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHENYLTHIOUREA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHEROMONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHIMOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHLORETIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHATASES 1976-90; ATP-DIPHOSPHATASE was ATP DIPHOSPHATASE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHODIESTERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOLIPASES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOMONOESTERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOPROTEIN PHOSPHATASES 1979-90; was see under PHOSPHOMONOESTERASES 1975-78; PR-ENZYME was see PHOSPHORYLASE PHOSPHATASE 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOTRANSFERASES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOTRANSFERASES, ATP 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOTRANSFERASES, ATP 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOSPHOTRANSFERASES, ATP 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOTOCHEMOTHERAPY 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHOTOTHERAPY 1986-90; was see under PHYSICAL THERAPY 1975-85; was see under SUNLIGHT 1966-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHTHALIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHTHALIC ACIDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHTHALIC ACIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHYSICIANS%27% ASSISTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHYSICS 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHYSICS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PHYTOSTEROLS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PICOLINES 1981-90; was AMPROL see under PICOLINES 1979-80 %26% see under PICOLINE/analogs %26% derivatives 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PICOLINIC ACIDS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PICOLINIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIGMENTATION DISORDERS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIGMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERAZINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERAZINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERAZINES 1979-90; was ICRF 159 see under PIPERAZINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERIDINES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERIDINES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERIDINES 1975-90; was see under SYMPATHOLYTICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PIPERIDINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLACENTA DISEASES 1980-90; was see under PLACENTA DISORDERS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANKTON 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANT GROWTH REGULATORS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANT OILS 1975-90; was see under FATTY ACIDS, ESSENTIAL 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANT OILS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANT OILS 1987-90; was heading 1966-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANT PROTEINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANTS, MEDICINAL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANTS, MEDICINAL 1978-90; was see PSYLLIUM 1963-77 %28%Cat B %26% D heading%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANTS, MEDICINAL 1986-90; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLANTS, TOXIC 1986-90; was heading 1963-85; was in Cat B %26% D 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLASMIDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLASMODIUM 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLATELET FUNCTION TESTS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PLETHYSMOGRAPHY, IMPEDANCE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PNEUMONIA, ASPIRATION 1984-90; was heading 1963-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PODOPHYLLOTOXIN 1981-90; was VM 26 see under PODOPHYLLOTOXIN 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLITICS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYCHLOROBIPHENYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYDEOXYRIBONUCLEOTIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYDEOXYRIBONUCLEOTIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYENES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYENES 1981-90; was METHYL PARTRICIN see under POLYENES 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYETHYLENE GLYCOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYETHYLENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYISOPRENYL PHOSPHATE SUGARS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYISOPRENYL PHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYMERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYMERS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYMETHACRYLIC ACIDS 1981-90; was see under ACRYLIC RESINS 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYMYXINS 1978-90; was AEROSPORIN see under POLYMYXIN 1971-77, see POLYMYXIN 1963-70; AEROSPORIN was see POLYMYXIN B 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYNUCLEOTIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYPHOSPHATES 1978-90; was see under PHOSPHATES 1977%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYRIBONUCLEOTIDES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYSACCHARIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYSACCHARIDES 1975-90; was XYLAN see under CELLULOSE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYSACCHARIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYSACCHARIDES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYSACCHARIDES, BACTERIAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYTETRAFLUOROETHYLENE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POLYVINYLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PONGIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PONGIDAE 1981-90; was GIBBONS see under APES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PORPHYRINOGENS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PORPHYRINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POSTOPERATIVE PERIOD 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POVERTY 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POVIDONE 1981-90; was see under POLYVINYLPYRROLIDONE 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POXVIRIDAE 1981-90; was see under POXVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under POXVIRUS INFECTIONS 1990; was see VACCINIA 1974-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PRE-EXCITATION SYNDROMES 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PRECIPITATION 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PRECIPITATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PREGNADIENES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PREGNADIENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PREGNADIENETRIOLS 1975-90; PREDNACINOLONE was PREDNACINOLON 1975-94; HYDROXYPREDNISOLONACETONIDE was see DESONIDE 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PREGNANCY 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PREGNANES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PREGNENEDIONES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PRESSURE 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PRIMARY HEALTH CARE 1979-90; was see under COMPREHENSIVE HEALTH CARE 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PRISONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROBABILITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROBABILITY 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROFESSIONAL PRACTICE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROFESSIONAL PRACTICE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPANOLAMINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPANOLAMINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPANOLAMINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPIONATES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPIONATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPIONATES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPIOPHENONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPIOPHENONES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROPYLAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSPECTIVE PAYMENT SYSTEM 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSTAGLANDIN ENDOPEROXIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSTAGLANDINS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; 15-METHYLPROSTAGLANDIN E2 METHYL ESTER %26% METHYLDINOPROSTONE were see ARBAPROSTIL 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE %26% 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSTAGLANDINS F, SYNTHETIC 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROSTAGLANDINS F, SYNTHETIC 1980-90; METHYLDINOPROST %26% 15-METHYLPROSTAGLANDIN F2ALPHA METHYL ESTER were see CARBOPROST 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROTAMINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROTEIN METHYLTRANSFERASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROTEIN-LOSING ENTEROPATHIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROTEINS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROTEOGLYCANS 1977-90; was see under MUCOPOLYSACCHARIDES 1976%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PROTOZOAN INFECTIONS 1990; was see under AMEBIASIS 1967-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSITTACINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSORALENS 1979-90; was see under COUMARINS 1975-78; TRIOXISALENUM was see TRIOXSALEN 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHIATRIC STATUS RATING SCALES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOANALYTIC THEORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHODRAMA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOLOGICAL THEORY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOSES, ALCOHOLIC 1981-90; was DELIRIUM TREMENS see under PSYCHOSES, ALCOHOLIC 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOSEXUAL DEVELOPMENT 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOTHERAPY 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOTHERAPY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PSYCHOTIC DISORDERS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PUBLIC ASSISTANCE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PUBLIC HEALTH DENTISTRY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PUBLIC RELATIONS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PUBLIC RELATIONS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PUBLISHING 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PURINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PUROMYCIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRANS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRANS 1980-90; was AUROVERTIN see under ANTIBIOTICS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRANTEL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRAZOLES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRAZOLES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRAZOLES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDAZINES 1975-90; was see under HETEROCYCLIC COMPOUNDS 1966-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDAZINES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDAZINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINES 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINES 1977-90; was ALPHA,ALPHA-DIPYRIDYL see under PYRIDINES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINIUM COMPOUNDS 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINIUM COMPOUNDS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINIUM COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDINIUM COMPOUNDS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIDONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIMIDINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIMIDINES 1979-90; was THIAMINE TETRAHYDROFURFURYL DISULFIDE see under PYRIMIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIMIDINES 1984-90; was TRAPYMIN see under PYRIMIDINES 1975-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRIMIDINES 1985-90; was RA 233 see under PYRIMIDINES 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYROPHOSPHATASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYROPHOSPHATES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINES 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINES 1975-90; FLAGECIDIN was see ANISOMYCIN 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINES 1979-90; was CI 628 see under PYRROLIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINES 1979-90; was MECLASTINE see under PYRROLIDINES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under PYRROLIDINONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUAIL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUAIL 1975-90; BOBWHITE was BOB-WHITE 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINACRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINOLINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINOLINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINOLINES 1978-90; QUIPAZINE MALEATE was indexed under QUIPAZINE/analogs %26% derivatives 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINONES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINOXALINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINOXALINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under QUINUCLIDINES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIATION INJURIES 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1963-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1965-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIATION, IONIZING 1976-90; was see under RADIATION 1975%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIOIMMUNOASSAY 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIOISOTOPES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIOTHERAPY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIOTHERAPY, COMPUTER-ASSISTED 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RADIUS FRACTURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RANIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, INBRED STRAINS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, INBRED STRAINS 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, INBRED STRAINS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, MUTANT STRAINS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, MUTANT STRAINS 1982-90; was see under RATS 1981%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, MUTANT STRAINS 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RATS, MUTANT STRAINS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REACTION TIME 1979-90; was REFRACTORY PERIOD, PSYCHOLOGIC see under REACTION TIME 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RECEPTOSOMES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REFLEX 1970-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REFLEX 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REFLEX 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REFLEX 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REFLEX, MONOSYNAPTIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REFUSE DISPOSAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REGIONAL HEALTH PLANNING 1981-90; was see under STATE HEALTH PLANS 1980%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REGIONAL HEALTH PLANNING Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REGRESSION ANALYSIS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REHABILITATION 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REIMBURSEMENT MECHANISMS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REIMBURSEMENT MECHANISMS 1989-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REOVIRIDAE 1981-90; was see under REOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REOVIRUS INFECTIONS 1977-90; was see under ARBOVIRUS INFECTIONS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REPRODUCTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under REPTILES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RESEARCH DESIGN 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RESINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RESORCINOLS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RESPIRATION DISORDERS 1977-90; was see under RESPIRATION 1966-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RESPIRATORY AIRFLOW 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RETINA 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RETINAL PIGMENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RETINOIDS 1984-90; was see under VITAMIN A 1968-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RHEOLOGY 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RIBONUCLEOSIDES 1978-90; was VIRAZOLE see under RIBONUCLEOSIDES 1975-77; VIRAZOLE was see RIBAVIRIN 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RIBONUCLEOSIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RIBONUCLEOTIDE REDUCTASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RICINUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RISK-TAKING 1979-90; was heading 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA CAPS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA NUCLEOTIDYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA POLYMERASES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA, MESSENGER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA, RIBOSOMAL 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA, TRANSFER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RNA, TRANSFER, AMINO ACID-SPECIFIC 1988-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RODENTIA 1982-90; was KANGAROO RATS see under RODENTS 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RODS AND CONES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ROLE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ROSACEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ROSANILINE DYES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RUBELLA 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RUTHENIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under RUTIN 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SACCULE AND UTRICLE 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALAMANDRIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALICYLAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALICYLAMIDES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY GLAND DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY GLAND DISEASES 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY GLAND DISEASES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY GLAND NEOPLASMS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY GLAND NEOPLASMS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY GLANDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALIVARY PROTEINS 1988-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SALMONELLA 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SAPOGENINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SAPOGENINS 1979-90; was see under TRITERPENES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SAPONINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SARCOIDOSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SATIATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SCAPULA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SCHOOLS, HEALTH OCCUPATIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SCIENCE 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SCIURIDAE 1982-90; was MARMOTS see under RODENTS 1975-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SCOPOLAMINE DERIVATIVES 1978-90; was see under SCOPOLAMINE 1976-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEALED CABIN ECOLOGY 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEAWEED 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SELENIUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEMICARBAZIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEMICONDUCTORS 1975-90; was in Cat H %26% J 1975-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEPTAL NUCLEI 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SERINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SERINE PROTEINASES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SERINE PROTEINASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEROTONIN 1975-90; was see under HALLUCINOGENS 1966-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEROTONIN 1989-90; was METHOXYTRYPTAMINE see under TRYPTAMINES 1966-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SESQUITERPENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SESQUITERPENES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SESQUITERPENES 1981-90; was EPOXYTRICHOTHECENES see under SESQUITERPENES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEWAGE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEX BEHAVIOR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEX BEHAVIOR 1975-90; CELIBACY was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEX BEHAVIOR, ANIMAL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEX CHROMOSOME ABNORMALITIES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SEX CHROMOSOME ABNORMALITIES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SHARKS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SHEEP DISEASES 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SHEEP DISEASES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SHIGELLA 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SHOCK, TRAUMATIC 1979-90; was see under KIDNEY FAILURE, ACUTE 1967-78; was see under ACUTE KIDNEY FAILURE 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SIALIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SIALOGLYCOPROTEINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SILICA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SILICON 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SILICON 1975-90; HYDROSILICONS, SILICANS %26% SILICOHYDRIDES were see SILANES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SILICONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKIN DISEASES 1969-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKIN DISEASES, VESICULOBULLOUS 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKIN TESTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKIN TESTS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKULL 1964-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKULL 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SKULL FRACTURES 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOCIAL BEHAVIOR 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOCIAL DOMINANCE 1969-90; was see under DOMINANCE, SOCIAL 1968%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOCIAL ENVIRONMENT 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOCIAL ISOLATION 1973-90; for HOMESICKNESS see ANXIETY, SEPARATION 1975-97; see EMOTIONS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOCIETIES Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOCIETIES, NURSING 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SODIUM FLUORIDE 1984-90; was see under FLUORIDES 1977-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOFTWARE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOIL POLLUTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SOMATOMEDINS 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SORBITOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SORBITOL 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPATIAL BEHAVIOR 1974-90; BODY BUFFER ZONE was see under SPATIAL BEHAVIOR 1974-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPECTRUM ANALYSIS 1970-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPECTRUM ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPEECH 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPEECH DISCRIMINATION TESTS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPEECH DISORDERS 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPEECH PRODUCTION MEASUREMENT 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPEECH, ALARYNGEAL 1979-90; was see under VOICE PRODUCTION, ALARYNGEAL 1968-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPERMATOZOA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPHINGOSINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPIDERS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPINAL CANAL 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPINAL CORD 1968-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPINAL NERVES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPINAL OSTEOPHYTOSIS 1990; was DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS see under SPINAL OSTEOPHYTOSIS 1985-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPIRO COMPOUNDS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPIRO COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SPONDYLOLISTHESIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STANOLONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STAPHYLOCOCCAL SKIN INFECTIONS 1986-90; RITTER%27%S DISEASE was see DERMATITIS EXFOLIATIVA 1968-85, was heading 1966-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STARCH 1979-90; was see under POLYSACCHARIDES 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STATISTICS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STATISTICS 1990-90; was see under PROBABILITY 1968-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STEARIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STERILIZATION, SEXUAL 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STERNUM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STEROIDS, HETEROCYCLIC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STOMATITIS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STREPTOMYCES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STRESS 1975-90; was see under STRESS %26% ADAPTATION, PHYSIOLOGICAL 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STRESS DISORDERS, POST-TRAUMATIC 1981-90; was NEUROSES, WAR 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STRONGYLOIDEA 1986-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under STROPHANTHINS 1975-90; TSIMARIN was see CYMARINE 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUBCELLULAR FRACTIONS 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUCCINATES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUCCINIMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGAR ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGAR ACIDS 1975-90; was MURAMIC ACID 1973-74 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGAR ACIDS 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGAR ALCOHOLS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGAR ALCOHOLS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGAR PHOSPHATES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUGGESTION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFADIAZINE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFANILAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFATASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFATASES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFATHIAZOLES 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFHYDRYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFHYDRYL COMPOUNDS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFITES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFONAMIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFONIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFONYLUREA COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFURIC ACIDS 1975-90; SULFATES, ORGANIC was see SULFURIC ACIDS 1977-93; THIOSULFURIC ACID ESTERS was heading 1975-93 %28%see under SULFURIC ACIDS 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SULFURTRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SURFACE-ACTIVE AGENTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SURFACE-ACTIVE AGENTS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SURFACE-ACTIVE AGENTS 1981-90; was heading 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SURGERY, OPERATIVE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SURGERY, OPERATIVE 1982-90; REVISION ARTHROPLASTY was see REOPERATION 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SURGERY, ORAL, PREPROSTHETIC 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SUTURES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SWEAT GLANDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SYNDACTYLIA 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SYNOVIAL CYST 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SYNOVITIS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under SYPHILIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TACHYCARDIA, SUPRAVENTRICULAR 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TACHYKININS 1989-90; was see under KININS 1977-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TAENIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TASK PERFORMANCE AND ANALYSIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TASTE 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TAXES 1985-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TERPENES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TERPHENYL COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TESTIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TESTOSTERONE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TESTOSTERONE 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TETRACYCLINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TETRACYCLINES 1978-90; was TETRACYCLINE-L-METHYLENE LYSINE see under TETRACYCLINE 1975-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TETRAHYDROFOLATES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TETRAZOLIUM SALTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THELAZIOIDEA 1986-90; was see under SPIRUROIDEA 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THEOPHYLLINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THEOPHYLLINE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THEOPHYLLINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THERAPY, COMPUTER-ASSISTED 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIADIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIADIAZOLES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIAMINE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIAZINES 1971-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIAZOLES 1975-90; was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOCARBAMATES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOCARBAMATES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOCARBAMATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOCARBAMATES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOCYANATES 1977-90; was ALPHA-NAPHTHYLISOTHIOCYANATE %28%see under THIOCYANATES 1976%29%; ANIT was see 1-NAPHTHYLISOTHIOCYANATE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOGLYCOSIDES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOGLYCOSIDES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOLESTER HYDROLASES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOPHENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOPHENES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOSEMICARBAZONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOSULFATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOUREA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOUREA 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOUREA 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOXANTHENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THIOXANTHENES 1975-90; was see under TRANQUILIZING AGENTS 1967-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THORACIC ARTERIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THORACIC INJURIES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THORACIC NERVES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THREONINE 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYMINE NUCLEOTIDES 1978-90; was THYMIDYLIC ACIDS see under THYMINE NUCLEOTIDES 1972-77, see under NUCLEOTIDES 1963-71%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYMOL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYMUS HORMONES 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYMUS HORMONES 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYROID HORMONES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYROIDITIS 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under THYRONINES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TICK TOXICOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TICKS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TIME 1967-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TISSUE BANKS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TISSUE BANKS 1982-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TISSUE EXTRACTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TISSUE EXTRACTS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOBACCO 1986-90; was SNUFF see under TOBACCO 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOLUIDINES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TONGUE DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH ABNORMALITIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH DISEASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH FRACTURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH GERM 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH MIGRATION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH PERMEABILITY 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOOTH, DECIDUOUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TOXIFERINE 1975-90; ALLOFERIN was see ALCURONIUM 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRACHEAL DISEASES 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRANS-ACTIVATORS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRANSCRIPTION FACTORS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRANSCRIPTION FACTORS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRANSDUCERS 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRANSFERASES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRANSFERASES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRAUMA SEVERITY INDICES 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TREMATODE INFECTIONS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIALKYLTIN COMPOUNDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIATOMIDAE 1979-90; was see under TRIATOMINAE 1973-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIAZINES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIAZINES 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIAZOLES 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIAZOLES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRICARBOXYLIC ACIDS 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRICHOSTRONGYLOIDEA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRICHOSTRONGYLOIDEA 1986-90; was see under METASTRONGYLOIDEA 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRICHOSTRONGYLOIDIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRICHUROIDEA 1967-90, was see under TRICHINELLOIDEA 1963-66; HEPATICOLA HEPATICA was see under TRICHUROIDEA 1967-78, was see under TRICHINELLOIDEA 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIGEMINAL NUCLEUS, SPINAL 1982-90; was see under TRIGEMINAL NUCLEI 1980-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIGLYCERIDES 1966-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRIOSES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRYPANOSOMIASIS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRYPSIN INHIBITORS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRYPTAMINES 1989-90; was DIMETHYLTRYPTAMINE 1975-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TRYPTAMINES 1989-90; was see under SEROTONIN 1984-88; was METHOXYDIMETHYLTRYPTAMINE see under SEROTONIN 1980-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TUBERCULOSIS 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TUBERCULOSIS, CARDIOVASCULAR 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TUBERCULOSIS, CUTANEOUS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TUPAIIDAE 1981-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TURBELLARIA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TWINS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under TYMPANIC MEMBRANE 1963-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ULNA FRACTURES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ULTRASONICS 1974-90; was see under VIBRATION 1969-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UMBELLIFERONES 1977-90; was see under COUMARINS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1982-90; was UNITED STATES NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-81; was NATIONAL INSTITUTE OF MENTAL HEALTH see under UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UNITED STATES HEALTH RESOURCES AND SERVICES ADMINISTRATION 1980-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UNITED STATES PUBLIC HEALTH SERVICE 1982-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URACIL 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URACIL 1980-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URACIL NUCLEOTIDES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URACIL NUCLEOTIDES 1978-90; was URIDYLIC ACIDS see under URACIL NUCLEOTIDES 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URANIUM 1976-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UREA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URETHANE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URIDINE 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URIDINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URIDINE DIPHOSPHATE SUGARS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URIDINE/analogs %26% derivatives 1978-90; was see under PYRIMIDINE NUCLEOSIDES 1976-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UROCHORDATA 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under URONIC ACIDS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UTERINE RUPTURE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under UTILIZATION REVIEW Aug 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VACCINES 1973-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VACCINES 1989-90; was see under ANTIGENS 1987-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VAGUS NERVE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VALERATES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VASOPRESSINS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VEINS 1975-90; was see under VEINS 1964-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VERATRINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VERATRUM ALKALOIDS 1981-90; PROTOVERATRINE A was see under CEVANES 1975-79, was Prov 1966-74; PROTOVERATRINE A DERIVATIVES was see under CEVANES 1969-77; PROTOVERATRINE was see under VERATRUM 1966-68; CRYPTENAMINE was see under VERATRUM ALKALOIDS 1975-79, was see under VERATRUM 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VERTEBRATE VIRUSES, UNCLASSIFIED 1981-90; was see under ENCEPHALITIS VIRUSES 1977-80; was see under ARBOVIRUSES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VESTIBULE 1990-90; was see under VESTIBULAR APPARATUS 1979-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VESTIBULE 1990; was see under LABYRINTH 1979-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VETERINARY MEDICINE 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VIDEO RECORDING 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VINCA ALKALOIDS 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VINYL COMPOUNDS 1975-90; was in Cat D %26% J 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VIOLENCE 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VIOMYCINS 1981-90; was TUBERACTINOMYCIN-N see under ANTIBIOTICS, ANTITUBERCULAR 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VIRAL REGULATORY PROTEINS 1990 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VISION 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VITAMINS 1977-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VOICE 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VOLUNTARY HEALTH AGENCIES 1967-90; was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under VOLUNTARY HEALTH AGENCIES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WASTE PRODUCTS 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WATER 1972-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WATER POLLUTANTS 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WEATHER 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WEIGHTS AND MEASURES 1978-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WEIGHTS AND MEASURES 1979-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WOMEN 1984-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WORK 1983-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under WUCHERERIA 1979-90; was FILARIA BANCROFTI see under WUCHERERIA 1963-78; FILARIA SANGUINIS HOMINIS was see under WUCHERERIA 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under XANTHENES 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under XANTHENES 1975-90; TETRAETHYLRHODAMINE was see RHODAMINES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under YERSINIA INFECTIONS 1987-90; was PSEUDOTUBERCULOSIS, YERSINIA 1977-86; was PSEUDOTUBERCULOSIS, PASTEURELLA see under PASTEURELLA INFECTIONS 1964-76, was see under PASTEURELLA 1963; TUBERCULOSIS INFECTIONS, YERSINIA was see YERSINIA PSEUDOTUBERCULOSIS INFECTIONS 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '91; was see under ZINC 1975-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92 kDa Gelatinase' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92 kDa Type IV Collagenase' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92%28%63%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92%28%63%29%; was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92%28%64%29%; was OXYPHENONIUM BROMIDE 1964-91 %28%see under AMMONIUM COMPOUNDS 1964-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92%28%72%29%; was STREPTOCOCCUS LACTIS 1972-91 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92%28%75%29%; was FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91 %28%see under GALACTOSYLTRANSFERASES 1979-90, see under HEXOSYLTRANSFERASES 1975-78%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92%28%82%29%; for CYCLOSPORIN A see CYCLOSPORINS 1982-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92-kDa Gelatinase' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92-kDa Type IV Collagenase' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92: was LACTOSE SYNTHETASE 1972-91 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; 5-LIPOXYGENASE INHIBITORS was see LIPOXYGENASE INHIBITORS 1992-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; 6-HYDROXYDOPAMINE was indexed under HYDROXYDOPAMINES 1982-91 %26% under HYDROXYDOPAMINE 1981%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; AFLATOXIN B1 was indexed under AFLATOXINS 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; AFLATOXIN M1 was indexed under AFLATOXINS 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; AMYLOID BETA-PROTEIN PRECURSOR was indexed under AMYLOID BETA-PROTEIN 1990-91 and AMYLOID %26% PROTEIN PRECURSORS 1988-91; AMYLOID A4 PROTEIN PRECURSOR was indexed under AMYLOID BETA-PROTEIN PRECURSOR 1993-94, AMYLOID BETA-PROTEIN 1991-92, PROTEIN PRECURSORS 1987-92, %26% AMYLOID 1987-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; APHIDICOLIN was indexed under DITERPENES 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; APOLIPOPROTEIN A-I was indexed under APOLIPOPROTEINS A 1985-91, under APOLIPOPROTEINS 1979-84 %26% under APOPROTEINS 1974-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; APOLIPOPROTEIN A-II was indexed under APOLIPOPROTEINS A 1985-91 %26% under APOLIPOPROTEINS 1978-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; ARACHIDONIC ACID was indexed under ARACHIDONIC ACIDS 1981-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; ASTEMIZOLE was indexed under BENZIMIDAZOLES 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; AZOFERREDOXIN %28%NM%29% was indexed under FERREDOXINS 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; BUPROPION was indexed under PROPIOPHENONES 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CANCER CARE UNITS was see HOSPITAL UNITS 1986-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CANTHAXANTHIN was indexed under CAROTENE/analogs %26% derivatives 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CD4 IMMUNOADHESIN %28%NM%29% was indexed under IGG %26% ANTIGENS, CD %26% ANTIBODIES, ANTI-IDIOTYPIC 1990-91 and under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989.%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CD8 ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CHEIROGALEUS; LEMUR, DWARF; LEMUR, MOUSE and MICROCEBUS were see LEMURIDAE 1981-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CHILOMASTIX was see MASTIGOPHORA 1986-91, was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CILIATA was heading 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; CORYNEBACTERIUM EQUI was see RHODOCOCCUS 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; COST SHARING INSURANCE was see DEDUCTIBLES AND COINSURANCE 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; DOUROUCOULI was see AOTUS TRIVIRGATUS 1981-91; MONKEY, NIGHT was see AOTUS TRIVIRGATUS 1981-91, was NIGHT MONKEYS see under MONKEYS 1975-80; MONKEY, OWL was see AOTUS TRIVIRGATUS 1981-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; ENCAINIDE was indexed under ANILIDES 1979-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; ENPROSTIL was indexed under PROSTAGLANDINS E, SYNTHETIC 1985-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; FLEROXACIN was indexed under QUINOLINES 1986 %26% under CIPROFLOXACIN/analogs %26% derivatives 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; FLUORESCEIN-5-ISOTHIOCYANATE was indexed under FLUORESCEINS %26% THIOCYANATES 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; FLUVOXAMINE was indexed under OXIMES 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; GABEXATE was indexed under GUANIDINES 1976-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; GLOBULIN-N was NM 1986-91; VENOGLOBULIN was NM 1983-91; GAMMONATIV %26% INTRAGLOBIN were NM 1982-91; SANDOGLOBULIN %26% MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% were NM 1981-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; GLOBULIN-N was indexed under IGG, IGA, %26% DRUG COMBINATIONS 1986-91; VENOGLOBULIN was indexed under GAMMA GLOBULINS, FIBRINOLYSIN, %26% DRUG COMBINATIONS 1983-91; INTRAGLOBIN was indexed under IGG/analogs 1982-91; GAMMONATIV was indexed under IGG 1982-90; MODIFIED IMMUNE GLOBULIN %28%ANTI-ECHOVIRUS ANTIBODY%29% was indexed under IMMUNOGLOBULINS %26% ANTIBODIES, VIRAL 1981-90; SANDOGLOBULIN was indexed under IGG 1981-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; HERPES SIMPLEX, OCULAR was see KERATITIS, DENDRITIC 1963-91; OCULAR HERPES SIMPLEX was see KERATITIS, DENDRITIC 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; HIV MAJOR CORE PROTEIN P24 was indexed under GENE PRODUCTS, GAG %26% VIRAL CORE PROTEINS 1990-91 %26% under RETROVIRIDAE PROTEINS 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; INTERLEUKIN 9 %28%NM%29% was indexed under INTERLEUKINS 1990-91 %26% under GROWTH SUBSTANCES 1989-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; INTERLEUKIN-10 %28%NM%29% was indexed under INTERLEUKINS 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; KETOSIS, DIABETIC was heading 1975-91 %28%see under ACIDOSIS, DIABETIC 1975-90%29%; ACIDOSIS, DIABETIC was heading 1966-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; KINESIN was indexed under ADENOSINE TRIPHOSPHATASE 1985-91 %26% under NERVE TISSUE PROTEINS 1985-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; LEUPROLIDE was indexed under PEPTIDES 1975-76 %26% GONADORELIN/analogs %26% derivatives 1977-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; LITHIUM CARBONATE was indexed under LITHIUM 1969-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; LUPUS COAGULATION INHIBITOR was indexed under BLOOD COAGULATION FACTORS/immunology 1986-91 %26% BLOOD COAGULATION FACTORS/antagonists %26% inhibitors 1978-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; MISOPROSTOL was indexed under ALPROSTADIL/analogs %26% derivatives 1986-91, under PROSTAGLANDINS E, SYNTHETIC 1979-85 %26% under PROSTAGLANDINS, SYNTHETIC 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; MLS ANTIGENS was indexed under ANTIGENS, SURFACE 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; MONOCLONAL ANTIBODY OKT3 was MONOCLONAL ANTIBODY OKT3, ORTHOCLONE %28%NM%29% 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; MONOCLONAL ANTIBODY OKT3 was indexed under ANTIBODIES, MONOCLONAL 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; MONOCROTALINE was indexed under PYRROLIZIDINE ALKALOIDS 1973-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; MUCOPOLYSACCHARIDOSIS 2 and HUNTER%27%S SYNDROME were see LIPOCHONDRODYSTROPHY 1976-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% was indexed under OXIDOREDUCTASES 1973, under NADH, NADPH OXIDOREDUCTASES 1974-79 %26% under QUINONE REDUCTASES 1980-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; NEUROFIBROMATOSIS, CENTRAL, NF2 was NEUROFIBROMATOSIS, CENTRAL, NF-2 see NEUROMA, ACOUSTIC 1989-91; NEUROMA, ACOUSTIC, BILATERAL was see NEUROMA, ACOUSTIC 1989-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; NEUROFILAMENT PROTEINS was indexed under INTERMEDIATE FILAMENT PROTEINS 1982-91 %26% NERVE TISSUE PROTEINS 1977-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; NIZATIDINE was indexed under THIAZOLES 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; ONCOGENE PROTEIN FOS %28%NM%29% was indexed under ONCOGENE PROTEINS, VIRAL 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; ONCOGENE PROTEIN JUN %28%NM%29% was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-91 %26% under RETROVIRIDAE PROTEINS 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PATIENT OUTCOME ASSESSMENT was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; POLYDIOXANONE was indexed under POLYESTERS 1979-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PRAVASTATIN was indexed under NAPHTHALENES %26% HEPTANOIC ACIDS 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PROSTAGLANDIN SYNTHESIS ANTAGONISTS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1987-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PROTEIN-TYROSINE PHOSPHATASE was indexed under PHOSPHOPROTEIN PHOSPHATASES 1985-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PROTO-ONCOGENE PROTEIN FOS %28%NM%29% was indexed under PROTO-ONCOGENE PROTEINS 1985-91; FOS B PROTEIN %28%NM%29% was indexed under NUCLEAR PROTEINS 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PROTO-ONCOGENE PROTEIN JUN %28%NM%29% was indexed under DNA-BINDING PROTEINS %26% TRANSCRIPTION FACTORS 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; PSEUDOMONIC ACID was indexed under ANTIBIOTICS 1977-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; RIOPROSTIL was indexed under PROSTAGLANDINS E 1985-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; RITANSERIN was indexed under PIPERIDINES 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; RNA-BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; STILL%27%S DISEASE was see ARTHRITIS, JUVENILE RHEUMATOID 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; SUCTORIA was see CILIATA 1985-91, was heading 1963-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; SWAINSONINE was indexed under ALKALOIDS 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; SYNAPTOPHYSIN was indexed under MEMBRANE PROTEINS 1985-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; T-CELL RECEPTORS ALPHA-CHAIN %26% T-CELL RECEPTORS BETA-CHAIN were indexed under RECEPTORS, ANTIGEN, T-CELL 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; T-CELL RECEPTORS ALPHA-CHAIN was ANTIGEN T CELL RECEPTOR, ALPHA CHAIN %28%NM%29% 1986-91; T-CELL RECEPTORS BETA-CHAIN was ANTIGEN T CELL RECEPTOR, BETA CHAIN %28%NM%29% 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; T-CELL RECEPTORS DELTA CHAIN was ANTIGEN T CELL RECEPTOR, DELTA CHAIN %28%NM%29% 1988-91; T-CELL RECEPTORS GAMMA CHAIN was ANTIGEN T CELL RECEPTOR, GAMMA CHAIN %28%NM%29% 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; T-CELL RECEPTORS DELTA CHAIN was indexed under RECEPTORS, ANTIGEN, T-CELL 1988-91; T-CELL RECEPTORS GAMMA CHAIN was indexed under RECEPTORS, ANTIGEN, T-CELL 1987-91 %26% under PEPTIDE FRAGMENTS 1986-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TALIN was indexed under CYTOSKELETAL PROTEINS 1987-91, under MUSCLE PROTEINS 1984-86 %26% under CONTRACTILE PROTEINS 1982-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TARSIIDAE %26% TARSIUS were see PROSIMII 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TECHNETIUM TC 99M PYROPHOSPHATE was indexed under TECHNETIUM 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TERFENADINE was indexed under BENZHYDRYL COMPOUNDS 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; THEROPITHECUS GELADA was heading 1981-96 %28%see under CERCOPITHECIDAE 1981-90%29%; was GELADA see under MONKEYS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TOCAINIDE was indexed under LIDOCAINE 1974 %26% under LIDOCAINE/analogs and derivatives 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TRIMETREXATE was indexed under QUINAZOLINES 1979-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; TUMOR AUTOCRINE MOTILITY FACTOR was indexed under NEOPLASM PROTEINS 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; VINCULIN was indexed under CYTOSKELETAL PROTEINS 1990-91 %26% under MUSCLE PROTEINS 1980-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; WERLHOF%27%S DISEASE was see PURPURA, THROMBOCYTOPENIC 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; for CYCLOSPORIN A use CYCLOSPORINS 1982-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; see EDTA 1966-91, see EDATHAMIL 1963-65 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was 2-MERCAPTOETHANESULFONATE 1977-91 %28%see under MERCAPTOETHANOL 1977-90%29%; MESNA was see 2-MERCAPTOETHANESULFONATE 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was 3-AMINOPROPIONIC ACID 1979-91 %28%see under ALANINE 1979-90%29%; BETA-ALANINE was see 3-AMINOPROPIONIC ACID 1979-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was 6-HYDROXYDOPAMINE %28%NM%29% 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was 8-HYDROXYQUINOLINE 1975-91 %28%see under HYDROXYQUINOLINES 1975-90%29%; OXYQUINOLINE was see 8-HYDROXYQUINOLINE 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ACUTE PHASE REACTION 1987-91 %28%see under INFLAMMATION 1987-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was AFLATOXIN %28%NM%29% 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was AFLATOXIN B1 %28%NM%29% 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ALDOSE REDUCTASE 1976-91 %28%see under SUGAR ALCOHOL DEHYDROGENASES 1978-90, see under ALCOHOL OXIDOREDUCTASES 1976-77%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ALGAE, BLUE-GREEN 1970-91; CYANOBACTERIA was see ALGAE, BLUE-GREEN 1978-91; CYANOPHYTA was see ALGAE, BLUE-GREEN 1970-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was AMYLOID BETA PROTEIN PRECURSOR %28%NM%29% 1988-91; AMYLOID A4 PROTEIN PRECURSOR was NM 1987-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ANKLE/injuries 1966-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ANTHROPOIDEA 1981-91; was ANTHROPOIDS see under PRIMATES 1963-80; MONKEYS was heading 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was APHIDICOLIN %28%NM%29% 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was APOLIPOPROTEIN A-I %28%NM%29% 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was APOLIPOPROTEIN A-II %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ARACHIDONIC ACID %28%NM%29% 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ASTEMIZOLE %28%NM%29% 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ATP-GUANOSINE PHOSPHATE PYROPHOSPHOTRANSFERASE 1980-91 %28%see under PHOSPHOTRANSFERASES, ATP 1980-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was AZOFERREDOXIN %28%NM%29% 1985-91; AZOFERREDOXIN was see under FERREDOXINS 1977-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was BETA-GALACTOSIDASES 1978-91 %28%see under GALACTOSIDASES 1978-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was BETA-GLUCOSIDASES 1978-91 %28%see under GLUCOSIDASES 1978-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was BRANHAMELLA CATARRHALIS 1988-91; MORAXELLA %28%BRANHAMELLA%29% CATARRHALIS was see BRANHAMELLA CATARRHALIS 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was BUNYAVIRUS INFECTIONS 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was BUPROPION %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was BUSERELIN ACETATE 1984-91; BUSERELIN was see BUSERELIN ACETATE 1984-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was CANTHAXANTHIN %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was CD4 IMMUNOADHESIN %28%NM%29% 1989-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was CD8 ANTIGEN %28%NM%29% 1988-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was CONGO VIRUS 1975-91 %28%see under BUNYAVIRIDAE 1981-90, see under ARBOVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DEMETHYLCHLORTETRACYCLINE 1963-91; DEMECLOCYCLINE was see DEMETHYLCHLORTETRACYCLINE 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DIAGNOSTIC RELATED GROUPS 1986-91; was CASE MIX see under COSTS AND COST ANALYSIS 1982-85; DIAGNOSTIC RELATED GROUPS was see CASE MIX 1982-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DIDEOXYINOSINE 1990-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DIMETHYLAMINOAZOBENZENE 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DIPHENOL OXIDASES 1968-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DISODIUM CROMOGLYCATE 1971-91 %28%Prov 1971-72%29%; CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DISODIUM CROMOGLYCATE 1973-91; CROMOLYN SODIUM was see DISODIUM CROMOGLYCATE 1973-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was DIVERTICULOSIS 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was EGTA 1975-91 %28%see under ETHYLENE GLYCOLS 1975-86%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ENCAINIDE %28%NM%29% 1979-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ENDOCRINE GLAND NEOPLASMS %28%NON MESH%29% 1971-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ENPROSTIL %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1964-79 %28%Prov 1964-65%29%; ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ENTERAL FEEDING 1980-91, was TUBE FEEDING 1966-79; ENTERAL NUTRITION was see ENTERAL FEEDING 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ERGOT ALKALOIDS, HYDROGENATED 1963-91; ERGOLOID MESYLATE was see DIHYDROERGOTOXINE 1984-91; HYDERGINE was see DIHYDROERGOTOXINE 1977-91, see under ERGOT ALKALOIDS, HYDROGENATED 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ESOPHAGEAL DIVERTICULA 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was EXPENDITURES, HEALTH 1968-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was FLECAINIDE ACETATE 1991; was FLECAINIDE 1987-90 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was FLEROXACIN %28%NM%29% 1986-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was FLUORESCEIN-5-ISOTHIOCYANATE %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was FLUVOXAMINE %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was FUCOSYL GALACTOSE ACETYLGALACTOSAMINYLTRANSFERASE 1975-91 %28%see under GALACTOSYLTRANSFERASES 1979-90, see under HEXOSYLTRANSFERASES 1975-78%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GABEXATE %28%NM%29% 1976-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GEL DIFFUSION TESTS 1966-91; was see GEL DIFFUSION TESTS 1975-91; was see under PRECIPITIN TESTS 1963-65%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GENES, IMMUNE RESPONSE 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLIBENCLAMIDE 1971-91 %28%Prov 1971-72%29%; GLYBURIDE was see GLIBENCLAMIDE 1973-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLIBENCLAMIDE 1973-91; GLYBURIDE was see GLIBENCLAMIDE 1973-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLUTARALDEHYDE 1973-91 %28%see under ALDEHYDES 1973-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLYCERYL TRINITRATE 1963-91; NITROGLYCERIN was see GLYCERYL TRINITRATE 1963-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLYCOGEN SYNTHETASE 1972-91 %28%Prov 1972-73%29%; GLYCOGEN SYNTHASE was see GLYCOGEN SYNTHETASE 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLYCOGEN SYNTHETASE 1974-91; GLYCOGEN SYNTHASE was see GLYCOGEN SYNTHETASE 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GLYCOGEN SYNTHETASE PHOSPHATASE 1975-91 %28%see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GOLD THIOMALATE 1973-91 %28%Prov 1973%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GOLD THIOMALATE 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS %28%NON MESH%29% 1976-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GRAM-POSITIVE COCCI %28%NON MESH%29% 1976-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GUANYLORIBONUCLEASE 1975-91 %28%see under ENDORIBONUCLEASES 1984-90 %26% see under RIBONUCLEASES 1975-83%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was GUANYLORIBONUCLEASE 1975-91 %28%was see under ENDORIBONUCLEASES 1984-90 %26% see under RIBONUCLEASES 1975-83%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%; was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, %26% see under ARBOVIRUSES 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%; was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, see under ARBORVIRUSES 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HEPATITIS, VIRAL, NON-A, NON-B 1980-91 %28%see under HEPATITIS, VIRAL, HUMAN 1980-90%29%; HEPATITIS C was see HEPATITIS, VIRAL, NON-A, NON-B 1985-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HEXAMETHYLMELAMINE 1975-91 %28%see under TRIAZINES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was SY to AMINE OXIDASE %28%NM%29% 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HISTAMINASE 1963-91; COPPER AMINE OXIDASE was indexed under AMINE OXIDOREDUCTASES 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HIV MAJOR CORE PROTEIN P24 %28%NM%29% 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was HOME PARENTERAL NUTRITION 1991 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INDEPENDENT PRACTICE ASSOCIATION 1988-91 %28%see under PRIVATE PRACTICE 1988-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INFECTION/prevention %26% control 1966-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INSURANCE, LONG TERM CARE 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INTERFERON GAMMA, RECOMBINANT 1989-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INTERFERON, ALPHA see INTERFERON TYPE I 1983-91; INTERFERON, LYMPHOBLAST %26% INTERFERON, LEUKOCYTE were see INTERFERON TYPE I 1983-91; INTERFERON ALFA-N1 was see INTERFERON TYPE I 1989-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INTERFERON, BETA see INTERFERON TYPE I 1983-91; INTERFERON, FIBROBLAST was see INTERFERON TYPE I 1983-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INTERLEUKIN 9 %28%NM%29% 1989-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INTERLEUKIN-10 %28%NM%29% 1990-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was INTRACISTERNAL A-PARTICLE GENES 1986-91 %28%see under PROTO-ONCOGENES 1986-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was KINESIN %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LACTOSE SYNTHETASE 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LEUKEMIA, MAST CELL 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LEUPROLIDE %28%NM%29% 1975-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LIPOCHONDRODYSTROPHY 1966-91; MUCOPOLYSACCHARIDOSIS 5 was heading 1991, was see under MUCOPOLYSACCHARIDOSIS 1975-90; MUCOPOLYSACCHARIDOSIS 1 was see LIPOCHONDRODYSTROPHY 1976-91; HURLER%27%S DISEASE was see LIPOCHONDRODYSTROPHY 1975-91; SCHEIE%27%S SYNDROME was see MUCOPOLYSACCHARIDOSIS 5 1975-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LIPOCHONDRODYSTROPHY 1966-91; MUCOPOLYSACCHARIDOSIS 5 was heading 1991, was see under MUCOPOLYSACCHARIDOSIS 1975-90; MUCOPOLYSACCHARIDOSIS 1 was see LIPOCHONDRODYSTROPHY 1976-91; HURLER%27%S DISEASE was see LIPOCHONDRODYSTROPHY 1975-91; SCHEIE%27%S SYNDROME was see MUCOPOLYSACCHARIDOSIS 5 1975-91;%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LIPOXYGENASES 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LITHIUM CARBONATE %28%NM%29% 1969-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LONG TERM CARE 1968-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LUPUS COAGULATION INHIBITOR %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was LYSINE HYDROXYLASE 1977-91 %28%see under HYDROXYLASES 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MAMMILLARY BODIES 1971-91; was MAMMILLARY BODIES see under HYPOTHALAMUS 1963-70%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was METHYLOMONADACEAE 1976-91, was METHANOMONADACEAE 1975%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MISOPROSTOL %28%NM%29% 1977-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MLS ANTIGENS %28%NM%29% 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MOLLICUTES %28%NON MESH%29% 1976-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MONOCROTALINE %28%NM%29% 1973-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MSH RELEASING HORMONE 1975-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MUCOPOLYSACCHARIDOSIS 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MUCOPOLYSACCHARIDOSIS 3 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MUCOPOLYSACCHARIDOSIS 4 1980-91, was ECCENTROOSTEOCHONDRODYSPLASIA 1963-79; MORQUIO%27%S DISEASE was MORQUIO DISEASE see MUCOPOLYSACCHARIDOSIS 4 1980-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MUCOPOLYSACCHARIDOSIS 6 1991; was see under MUCOPOLYSACCHARIDOSIS 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was MUSCULOSKELETAL DISEASES %28%NON MESH%29% 1967-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was N-ACETYLLACTOSAMINE SYNTHETASE 1975-91 %28%see under LACTOSE SYNTHASE 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29% %28%NM%29% 1973-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was NEUROFILAMENT PROTEINS %28%NM%29% 1977-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was NIZATIDINE %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was NON MESH 1966-91; was see HEALTH MANPOWER 1989-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was NOSEMA CUNICULI 1982-91 %28%see under SPOROZOA 1982-90%29%; ENCEPHALITOZOON CUNICULI was see NOSEMA CUNICULI 1982-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ONCOGENE PROTEIN FOS %28%NM%29% 1990-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was ONCOGENE PROTEIN JUN %28%NM%29% 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was OSSIFICATION, PATHOLOGIC 1965-91; OSSIFICATION was heading 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was OXYPHENONIUM BROMIDE 1964-91 %28%see under AMMONIUM COMPOUNDS 1964-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PAPPATACI FEVER 1966-91; PHLEBOTOMUS FEVER was see PAPPATACI FEVER 1977-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PARATYPHOID FEVERS 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PARENTERAL FEEDING 1966-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PARENTERAL HYPERALIMENTATION 1975-91 %28%see under PARENTERAL FEEDING 1975-85%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1964-84 %28%Prov 1964-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PENICILLIN, PHENOXYMETHYL 1963-91; PENICILLIN V was see PENICILLIN, PHENOXYMETHYL 1963-91; PROPICILLIN was heading 1973-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PHLORETIN GLUCOSIDASE 1978-91 %28%see under GLUCOSIDASES 1978-90%29%; PHLORETIN-GLUCOSIDASE was PHLORETIN GLUCOSIDASE 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was POLYCHLOROBIPHENYL COMPOUNDS 1971-91 %28%Prov 1971-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was POLYCHLOROBIPHENYL COMPOUNDS 1973-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was POLYDIOXANONE %28%NM%29% 1979-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PRAVASTATIN %28%NM%29% 1986-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PRE-EXCITATION, MAHAIM TYPE 1986-91 %28%see under PRE-EXCITATION SYNDROMES 1986-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROLACTIN RELEASING HORMONE 1975-91; was see under PITUITARY HORMONE RELEASING HORMONES 1974; was PROLACTIN RELEASING FACTOR see under PITUITARY HORMONE RELEASING FACTORS 1968-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROSIMII 1981-91; was PROSIMIANS 1975-80 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROTEIN-CALORIE MALNUTRITION 1972-91 %28%Prov 1972-73%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROTEIN-CALORIE MALNUTRITION 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROTEIN-TYROSINE PHOSPHATASE %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROTO-ONCOGENE PROTEIN FOS %28%NM%29% 1985-91; FOS B PROTEIN was FOS B PROTEIN %28%NM%29% 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PROTO-ONCOGENE PROTEIN JUN %28%NM%29% 1988-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PSEUDOMONIC ACID %28%NM%29% 1977-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was PURINE NUCLEOSIDE PHOSPHORYLASES 1975-91 %28%see under PENTOSYLTRANSFERASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was RED CELL APLASIA, PURE 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was REPUBLIC OF GUINEA see AFRICA, WESTERN 1988-91; was see GUINEA-BISSAU 1980-82; was heading 1966-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was RIOPROSTIL %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was RITANSERIN %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was RNA-BINDING PROTEINS %28%NM%29% 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SARCOMA, MAST CELL 1968-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SARCOSPORIDIA 1963-91; SARCOCYSTIS was see SARCOSPORIDIA 1979-91, was see under SARCOSPORIDIA 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SCHIZOPHYLLAN 1976-91 %28%see under MUCOPOLYSACCHARIDES 1976-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SEVIN 1971-91 %28%Prov 1971-73%29%; CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SEVIN 1974-91; CARBARYL was see SEVIN 1976-91; SEVIN was see CARBARYL 1991-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SODIUM GOLD THIOSULFATE 1975-91 %28%see under GOLD 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was STOMACH DIVERTICULA 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was STREPTOCOCCUS FAECALIS 1963-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was STREPTOCOCCUS LACTIS 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SWAINSONINE %28%NM%29% 1981-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was SYNAPTOPHYSIN %28%NM%29% 1985-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TALIN %28%NM%29% 1984-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TECHNETIUM TC 99M PYROPHOSPHATE %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TERFENADINE %28%NM%29% 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was THIO-TEPA 1963-91; THIOTEPA was see THIO-TEPA 1977-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was THYROXINE-BINDING PROTEIN 1965-91 %28%Prov 1965%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was THYROXINE-BINDING PROTEIN 1966-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TOCAINIDE %28%NM%29% 1974-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TRIFLUOROTHYMIDINE 1975-91 %28%see under THYMIDINE 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TRIMETREXATE %28%NM%29% 1979-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TRYPANOSOMATIDAE 1986-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TRYPANOSOMIASIS, SOUTH AMERICAN 1966-91; CHAGAS DISEASE was see TRYPANOSOMIASIS, SOUTH AMERICAN 1981-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TUMOR AUTOCRINE MOTILITY FACTOR %28%NM%29% 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TYROSINASE 1977-91 %28%see under DIPHENOL OXIDASES 1977-90%29%; TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 %26% see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1973-91 %28%see under DIPHENOL OXIDASES 1968-90 %28%Prov 1973-74%29%%29%, was see under TYROSINE DECARBOXYLASE 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was TYROSINASE 1977-91 %28%see under DIPHENOL OXIDASES 1977-90%29%; TYROSINASE was see DIPHENOL OXIDASES 1975-76, see under DIPHENOL OXIDASES 1968-74 %26% see TYROSINE DECARBOXYLASE 1963-67; DOPA OXIDASE was heading 1991, was see under DIPHENOL OXIDASES 1968-72 %26% 1975-90, was see under TYROSINE DECARBOXYLASE 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was UDP GLUCURONOSYLTRANSFERASE 1973-91 %28%see under HEXOSYLTRANSFERASES 1975-76, Prov 1973-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was UDP GLUCURONOSYLTRANSFERASE 1975-91 %28%see under HEXOSYLTRANSFERASES 1975-76%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was VERTEBRATE VIRUSES, UNCLASSIFIED 1966-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was VINCULIN %28%NM%29% 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was WHOLE BODY COUNTING 1979-91; was WHOLE BODY COUNTERS 1973-78; was WHOLE BODY COUNTER 1971-72 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was XANTHOMA, JUVENILE 1963-91 %28%Prov 1963-66%29%; XANTHOGRANULOMA, JUVENILE was see XANTHOMA, JUVENILE 1979-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was XANTHOMA, JUVENILE 1967-91; XANTHOGRANULOMA, JUVENILE was see XANTHOMA, JUVENILE 1979-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was heading 1992-93; was see HEPARIN, LOW MOLECULAR WEIGHT 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see AFRICA, CENTRAL 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see CELL SURVIVAL 1977-91; CELL SENESCENCE %26% SENESCENCE, CELLULAR were see CELL SURVIVAL 1991%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see CELL SURVIVAL 1978-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see CONSUMER SATISFACTION 1982-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see CRITICAL CARE 1980-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see EMPYEMA 1984-91; PYOTHORAX was see EMPYEMA 1984-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see GENES, VIRAL 1978-91; VIRAL GENOME was see GENES, VIRAL 1978-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see GENOMIC LIBRARY 1990-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see HEALTH MANPOWER 1989-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see HISPANIC AMERICANS 1978-91; CHICANOS was see HISPANIC AMERICANS 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see HOSPITALS, PRIVATE 1991 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see LEISHMANIASIS 1979-91; ORIENTAL SORE was see LEISHMANIASIS 1979-91, was see under LEISHMANIASIS 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see OUTCOME AND PROCESS ASSESSMENT %28%HEALTH CARE%29% 1979-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see PRONATION 1988-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see PROTOZOA 1989-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see RESUSCITATION 1978-91; MOUTH-TO-MOUTH RESUSCITATION was see RESUSCITATION 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see SEPTICEMIA 1975-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see SUPINATION 1988-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '92; was see TRYPANOSOMA BRUCEI BRUCEI 1987-91; TRYPANOSOMA RHODESIENSE was see TRYPANOSOMA BRUCEI BRUCEI 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93%28%71%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93%28%75%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93%28%75%29%; was ENTEROCHELIN 1975-92; ENTEROCHELIN was see under SERINE 1975-90; ENTEROBACTIN was see ENTEROCHELIN 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93,63-85; was see NEMATODA 1986-92; RHABDITIS %26% TURBATRIX were see NEMATODA 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '933, Forneau' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93: was MEDROXYPROGESTERONE 17-ACETATE %28%NM%29% 1973-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; 7-O-METHYLNOGAROL was indexed under NOGALAMYCIN/analogs %26% derivatives 1979-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; 8-HYDROXY-2-%28%DI-N-PROPYLAMINO%29%TETRALIN was indexed under TETRAHYDRONAPHTHALENES 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ABLATION, TRANSVENOUS ELECTRIC and CATHETER ABLATION, ELECTRIC were see ELECTROCOAGULATION 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ACITRETIN was indexed under TRETINOIN/analogs %26% derivatives 1977-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was NM 1979-92; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1989-92; MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOSINE TRIPHOSPHATASE, MAGNESIUM was heading 1986-92; CALCIUM MAGNESIUM ATPASE was indexed under ADENOSINE TRIPHOSPHATASE, CALCIUM %26% ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92, ADENOSINE TRIPHOSPHATASE 1981-92, %26% MAGNESIUM 1979-80; MAGNESIUM ADENOSINE TRIPHOSPHATASE was see ADENOSINE TRIPHOSPHATASE 1989-92; MAGNESIUM ATPASE %26% ATPASE, MAGNESIUM were see ADENOSINE TRIPHOSPHATASE, MAGNESIUM 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E1A PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E1A PROTEIN DOMAIN 3 was NM 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E1A PROTEIN was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 %26% ANTIGENS, VIRAL, TUMOR 1985; ADENOVIRUS E1A PROTEIN DOMAIN 3 was indexed under ONCOGENE PROTEINS, VIRAL %26% TRANSCRIPTION FACTORS 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E1B PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E1B PROTEIN was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 %26% ANTIGENS, VIRAL, TUMOR 1985%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E2A PROTEIN %26% ADENOVIRUS E2F PR0TEIN were SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E2A 72K PROTEIN was ADENOVIRUS 72K PROTEIN %28%NM%29% 1984-92; ADENOVIRUS E2A DNA-BINDING PROTEIN was ADENOVIRUS DNA-BINDING PROTEIN %28%SY%29% to ADENOVIRUS 72K PROTEIN %28%NM%29% 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E2A PROTEIN %26% ADENOVIRUS E2F PROTEIN were indexed under ONCOGENE PROTEINS, VIRAL 1985-92; ADENOVIRUS 72K PROTEIN %26% ADENOVIRUS DNA-BINDING PROTEIN were indexed under VIRAL PROTEINS %26% DNA-BINDING PROTEINS 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E3 PROTEINS was indexed under ONCOGENE PROTEINS, VIRAL 1985-92; ADENOVIRUS E3 19K PROTEIN was indexed under VIRAL PROTEINS 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E4 PROTEIN %26% ADENOVIRUS E4F were indexed under ONCOGENIC PROTEINS, VIRAL 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS E4 PROTEIN was SY to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E4F PROTEIN was ADENOVIRUS E4F %28%SY%29% to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS was indexed under ONCOGENE PROTEINS, VIRAL 1985-92 %26% ANTIGENS, VIRAL, TUMOR 1985%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ALBUMIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-92 %26% RECEPTORS, HORMONE 1981-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ALDOSTERONE RECEPTOR was indexed under RECEPTORS, GLUCOCORTICOID 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; AMINO ACID RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; AMLODIPINE was indexed under NIFEDIPINE/analogs %26% derivatives 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ANKYRIN was indexed under BLOOD PROTEINS %26% MEMBRANE PROTEINS 1979-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ATRIAL NATRIURETIC FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1984-92 %26% MUSCLE PROTEINS 1984-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; BISOPROLOL was indexed under PROPANOLAMINES 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CD45 ANTIGEN was indexed under ANTIGENS, CD 1989-92 and HISTOCOMPATIBILITY ANTIGENS %26% ANTIGENS, DIFFERENTIATION 1984-92; RT7 ANTIGEN was indexed under HISTOCOMPATIBILITY ANTIGENS 1983-92; B220 ANTIGEN was indexed under ANTIGENS, SURFACE 1990-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CELIPROLOL was indexed under PROPANOLAMINES 1982-92 %26% under UREA/analogs %26% derivatives 1978-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CELL WALL SKELETON was indexed under MYCOLIC ACIDS %26% MUCOPROTEINS 1976-92 %26% POLYSACCHARIDES %26% PEPTIDES 1974-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CETIRIZINE was indexed under HYDROXYZINE/analogs %26% derivatives 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CGS 16949A was indexed under IMIDAZOLES %26% NITRILES 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CILAZAPRIL was indexed under PYRIDAZINES 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CLARITHROMYCIN was indexed under ERYTHROMYCIN/analogs %26% derivatives 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; COLLAGENASE was see CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1966-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; COMPLEMENT 3B RECEPTOR was indexed under RECEPTORS, COMPLEMENT 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; COMPLEMENT FACTOR H was indexed under COMPLEMENT 3B INACTIVATORS 1980-92 %26% under BETA GLOBULINS and GLYCOPROTEINS 1978-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; COMPLEMENT FACTOR I was indexed under SERINE PROTEINASES 1988-92 %26% under PEPTIDE PEPTIDOHYDROLASES 1983-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN was indexed under DNA-BINDING PROTEINS 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; CYPROTERONE ACETATE was indexed under CYPROTERONE/analogs %26% derivatives 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DEOXYNOJIRIMYCIN was indexed under GLUCOSAMINE/analogs %26% derivatives 1981-92; 1,5-DEOXY-1,5-IMINO-D-MANNITOL was indexed under MANNITOL/analogs %26% derivatives 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DERMATITIS, CONTACT, PHOTOSENSITIVE; DERMATITIS, PHOTOCONTACT; %26% PHOTOALLERGY were see PHOTOSENSITIVITY DISORDERS 1979-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DIHEMATOPORPHYRIN ETHER was indexed under HEMATOPORPHYRINS 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DIMAPRIT was indexed under APT 1980-92, APT/analogs %26% derivatives 1979-80 %26% THIOUREA/analogs %26% derivatives 1977-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DIOCTOPHYMA RENALE INFECTIONS was heading 1968-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DIOCTOPHYMA was see NEMATODA 1986-92; was heading 1963-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DOPAMINE-D1 RECEPTOR was indexed under RECEPTORS, DOPAMINE 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DOPAMINE-D2 RECEPTOR was indexed under RECEPTORS, DOPAMINE 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DRUG EVALUATION, FDA PHASE I was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE I was EVALUATION STUDIES, DRUG, FDA PHASE I see DRUG EVALUATION 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DRUG EVALUATION, FDA PHASE II was see DRUG EVALUATION 1980-92; EVALUATION STUDIES, FDA PHASE II was EVALUATION STUDIES, DRUG, FDA PHASE II see DRUG EVALUATION 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DRUG EVALUATION, FDA PHASE III was see CLINICAL TRIALS 1980-92; EVALUATION STUDIES, FDA PHASE III was see CLINICAL TRIALS 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; DRUG EVALUATION, FDA PHASE IV was see CLINICAL TRIALS 1981-92; EVALUATION STUDIES, FDA PHASE IV was see CLINICAL TRIALS 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ENDOTHELIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1988-92; ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS %26% RECEPTORS, ENDOTHELIUM DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; EPSTEIN-BARR VIRUS RECEPTOR was indexed under RECEPTORS, VIRUS 1981-98; COMPLEMENT 3D RECEPTOR was indexed under RECEPTORS, COMPLEMENT %26% ANTIGENS 1981-92 %26% DIFFERENTIATION, B-LYMPHOCYTE 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ERYTHROPOIETIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ETANIDAZOLE was indexed under NITROIMIDAZOLES 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ETODOLAC was indexed under INDOLEACETIC ACIDS 1989-92 %26% 1976-79 %26% ACETIC ACIDS 1976-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; FENRETINIDE was indexed under TRETINOIN/analogs %26% derivatives 1979-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; FOSCARNET was SY to PHOSPHONOFORMIC ACID %28%NM%29% 1983-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; FOSCARNET was indexed under PHOSPHONOACETIC ACID 1981-92 %26% under ORGANOPHOSPHORUS COMPOUNDS and FORMATES 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; FOSENOPRIL was indexed under PROLINE/analogs %26% derivatives 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; GLUTAMATE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1980-92, RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84 %26% RECEPTORS, DRUG 1980-81; EXCITATORY AMINO ACID RECEPTORS %26% RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; GLYCOSYL-PHOSPHATIDYLINOSITOL was indexed under GLYCOLIPIDS %26% PHOSPHATIDYLINOSITOLS 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; GUIDE RNA was indexed under RNA 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; HABRONEMIASIS was heading 1968-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; HEART DISEASE, ISCHEMIC %26% ISCHEMIC HEART DISEASE were see CORONARY DISEASE 1969-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; HEMATOPORPHYRIN D was indexed under HEMATOPORPHYRINS 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; HEPATITIS B VACCINE was indexed under VIRAL HEPATITIS VACCINES 1985-92 %26% VIRAL VACCINES 1982-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; HEPATOCYTE GROWTH FACTOR was indexed under GROWTH SUBSTANCES 1992 and under BLOOD PROTEINS 1984-91; SCATTER FACTOR was indexed under CYTOKINES 1992 and under PROTEINS 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; HISTAMINE H1 RECEPTOR AGONISTS %26% HISTAMINE H2 RECEPTOR AGONISTS were see HISTAMINE AGONISTS 1993-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ICI 118630 was indexed under BUSERELIN/analogs %26% derivatives 1984-92 %26% GONADORELIN/analogs %26% derivatives 1979-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; IMMUNOGLOBULIN E RECEPTOR was indexed under RECEPTORS, FC 1981-92, ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-92 %26% RECEPTORS, IMMUNOLOGIC 1981-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; IMMUNOGLOBULIN G RECEPTOR was indexed under ANTIGENS, DIFFERENTIATION 1988-92, RECEPTORS, FC 1981-92 %26% RECEPTORS, IMMUNOLOGIC 1981-87; CD32 ANTIGEN was indexed under ANTIGENS, CD 1990-92 %26% ANTIGENS, DIFFERENTIATION 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; IMPROMIDINE was indexed under GUANIDINES 1979-82 %26% 1989-92, %26% IMIDAZOLES 1979-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; INSULIN-LIKE GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-92 %26% RECEPTORS, INSULIN 1980-89; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; INTERFERON RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-92, RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84 %26% RECEPTORS, DRUG 1980-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; INTERLEUKIN 1 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-92; CD121A was CD121WA 1996-1999%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; INTERLEUKIN-11 was indexed under INTERLEUKINS 1990-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ISOASPARTIC ACID was %28%NM%29% 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ISOASPARTIC ACID was indexed under ASPARTIC ACID 1990-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ISRADIPINE was indexed under DIHYDROPYRIDINES 1991-92, PYRIDINES 1987-91, %26% OXADIAZOLES 1983-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; LAMININ RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1984-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1983-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; LIPOPROTEIN LP%28%A%29% was indexed under LIPOPROTEINS 1977-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; LORATADINE was indexed under CYPROHEPTADINE/analogs %26% derivatives 1976-92 %26% PIPERIDINES 1984-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; MDL 17043 was indexed under IMIDAZOLES 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; MEDROXYPROGESTERONE 17-ACETATE was indexed under MEDROXYPROGESTERONE/analogs %26% derivatives 1978-1992, HYDROXYPROGESTERONES 1976-78, %26% MEDROXYPROGESTERONE 1973-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; NAFARELIN was indexed under GONADORELIN/analogs %26% derivatives 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; NEONATAL NURSING %26% PERINATAL NURSING were see MATERNAL-CHILD NURSING 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; NERVE GROWTH FACTORS RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; NEUROPEPTIDE Y RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1985-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; NS PROTEINS was indexed under VIRAL CORE PROTEINS %26% CAPSID 1988-92, %26% VIRAL PROTEINS 1980-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ONCOGENE PROTEIN P37%28%MOS%29% was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-92; ONCOGENE PROTEIN MOS was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1989-92 %26% under RETROVIRIDAE PROTEINS 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; ONDANSETRON was indexed under IMIDAZOLES 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; OPSIN was indexed under EYE PROTEINS 1973-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PAI-1 was see PLASMINOGEN INACTIVATORS 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PAI-2 was see PLASMINOGEN INACTIVATORS 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PAROXETINE was indexed under PIPERIDINES 1982-92 %26% DIOXOLANES 1978-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY was see ANGIOPLASTY, LASER 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PHENCYCLIDINE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1983-92 %26% RECEPTORS, DRUG 1981-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PHOTOTOXICITY was see PHOTOSENSITIVITY DISORDERS 1979-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PIPECURIUM was indexed under PIPERAZINES %26% ANDROSTANES 1980-92 %26% STEROIDS 1979-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PLATELET-DERIVED GROWTH FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was indexed under PROTEIN KINASES 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PROCATEROL was indexed under ETHANOLAMINES 1981-92 %26% AMINO ALCOHOLS %26% HYDROXYQUINOLINES 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PROSTATE CANCER SPECIFIC ANTIGENS was indexed under ANTIGENS, NEOPLASM 1982-92; SEMENOGELASE was indexed under PROSTATE-SPECIFIC ANTIGEN 1988-95 %26% PEPTIDE PEPTIDOHYDROLASE 1976-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PROTEIN S, VITAMIN K-DEPENDENT was indexed under GLYCOPROTEINS 1980-92, %26% VITAMIN K 1979-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; PROTO-ONCOGENE PROTEIN C-MOS %28%NM%29% was indexed under PROTO-ONCOGENE PROTEINS 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; QUINOLINIC ACID was indexed under QUINOLINIC ACIDS 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; RAMIPRIL was indexed under BICYCLO COMPOUNDS 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; REMOXIPRIDE was indexed under BENZAMIDES 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SELENOCYSTEINE was indexed under CYSTEINE/analogs %26% derivatives 1977-92, ORGANOSELENIUM COMPOUNDS 1991-92, %26% SELENIUM 1977-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SERINE KINASE was indexed under PROTEIN KINASES 1985-92; PROTEIN-THREONINE KINASE was indexed under PROTEIN KINASES 1983-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SIDEROCHROMES was indexed under IRON CHELATES 1981-92, HYDROXAMIC ACIDS 1972-81, PEPTIDES 1972-78 %26% CATECHOLS 1972-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SIGMA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SMALL RIBONUCLEOPROTEINS was indexed under RIBONUCLEOPROTEINS 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SOMATOSTATIN RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE was indexed under SOMATOTROPIN-RELEASING HORMONE/analogs %26% derivatives %26% PEPTIDE FRAGMENTS 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; STEPHANURUS DENTATUS INFECTION was heading 1975-92 %28%see under NEMATODE INFECTIONS 1975-90%29%; SYNGAMIASIS was heading 1968-92, was SYNGAMOSIS 1967%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; SULFENTANIL was indexed under FENTANYL/analogs %26% derivatives 1979-92 %26% ANILIDES %26% PIPERIDINES 1977-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; T3 ANTIGEN COMPLEX was indexed under RECEPTORS, ANTIGEN, T-CELL 1990-92 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92 %26% ANTIGENS, SURFACE 1983-87 %26% ANTIGENS 1983-84; T3 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; TECHNETIUM TC 99M HEXAKIS%28%2-METHOXY-2-METHYLPROPYLISONITRILE%29% was indexed under ORGANOTECHNETIUM COMPOUNDS 1989-92 and ORGANOMETALLIC COMPOUNDS %26% TECHNETIUM 1987-92; TECHNETIUM TC 99M 2-METHOXY-2-METHYLPROPYLISONITRILE was indexed under NITRILES %28%1987-93%29%, ORGANOMETALLIC COMPOUNDS %28%1987-89%29%, ORGANOTECHNETIUM COMPOUNDS %28%1990-93%29%, %26% TECHNETIUM TC 99M SESTAMIMBI %28%1994-98%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; TECHNETIUM TC 99M MERTIATIDE was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-92, OLIGOPEPTIDES %26% TECHNETIUM 1986-92, %26% ORGANOMETALLIC COMPOUNDS 1986-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; TEICOMYCINS was indexed under GLYCOPEPTIDES 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; THROMBOXANE RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; TOREMIFENE was indexed under TAMOXIFEN/analogs %26% derivatives 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; UK 33274 was indexed under PRAZOSIN/analogs %26% derivatives 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; VASOPRESSIN RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1984-92 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; VIRAL TAIL PROTEINS was indexed under VIRAL PROTEINS 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; WAS TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE %26% UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; XAMOTEROL was indexed under PROPANOLAMINES 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; see ABSCISSINS 1991-92, see CYCLOHEXANECARBOXYLIC ACID 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; see P-CHLOROPHENYLALANINE 1973-92; for FENCLONINE see P-CHLOROPHENYLALANINE 1978-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; use AFRICA, EASTERN to search COMOROS 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; use DENTAL CARE FOR DISABLED to search DENTAL CARE FOR HANDICAPPED 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; use INTERLEUKIN 1 RECEPTOR %28%NM%29% 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; use RECEPTORS, COMPLEMENT 3D %28%NM%29% 1981-92; for EPSTEIN-BARR VIRUS RECEPTOR use RECEPTORS, COMPLEMENT 3D %28%NM%29% 1981-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was 7-O-METHYLNOGAROL %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was 8-HYDROXY-2-%28%DI-N-PROPYLAMINO%29%TETRALIN %28%NM%29% 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ABDOMINAL WALL 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ABDOMINAL WALL 1966-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ACITRETIN %28%NM%29% 1977-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ACNE 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ACTINOSPECTACIN 1965-92 %28%Prov 1965-72%29%; SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ACTINOSPECTACIN 1973-92; SPECTINOMYCIN was see ACTINOSPECTACIN 1978-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ADENOSINE TRIPHOSPHATASE 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ADENOSINE TRIPHOSPHATASE, CALCIUM 1979-92; CALCIUM PUMP was heading 1992-93; CALCIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, CALCIUM 1992; CALCIUM ADENOSINETRIPHOSPHATASE was CALCIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, CALCIUM 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ADENOVIRUS E3 PROTEINS %28%SY%29% to ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92; ADENOVIRUS E3 19K PROTEIN was ADENOVIRUS TYPE 2 E3-19K PROTEIN %28%NM%29% 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ADENOVIRUS EARLY REGION TRANSFORMING PROTEINS %28%NM%29% 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ALBUMIN RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ALDOSTERONE RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ALOPECIA MUCINOSA 1965-92 %28%see under ALOPECIA 1965-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was AMINO ACID RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was AMLODIPINE %28%NM%29% 1986-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ANGIOPLASTY, TRANSLUMINAL 1982-92; ANGIOPLASTY, BALLOON was see ANGIOPLASTY, TRANSLUMINAL 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ANKYRIN %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ARTHUS PHENOMENON 1966-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ARTHUS PHENOMENON 1966-92 %28%Prov 63-65%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ATRIAL NATRIURETIC FACTOR RECEPTOR %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was AZERBAIJAN S.S.R. 1982-92; was heading 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was BACKACHE 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was BISOPROLOL %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was BISPHOSPHOGLYCEROMUTASE 1975-92 %28%see under PHOSPHOTRANSFERASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was BISPHOSPHOGLYCEROMUTASE 1975-92 %28%see under PHOSPHOTRANSFERASES%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was BURMA 1968-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was BYELORUSSIAN S.S.R. 1982-92; was BELORUSSIA 1963-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CD45 ANTIGEN %28%NM%29% 1984-92; RT7 ANTIGEN was RT7 %28%SY%29% to HISTOCOMPATIBILITY ANTIGENS RT %28%NM%29%; B220 ANTIGEN was NM 1990-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CELIPROLOL %28%NM%29% 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CELL WALL SKELETON %28%NM%29% 1974-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CETIRIZINE %28%NM%29% 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CGS 16949A %28%NM%29% 1988-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CILAZAPRIL %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CLARITHROMYCIN %28%NM%29% 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was COMMUNICATION AIDS FOR HANDICAPPED 1980-92 %28%see under SELF-HELP DEVICES 1980-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was COMPLEMENT 3B RECEPTOR %28%NM%29% 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was COMPLEMENT FACTOR H %28%NM%29% 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS %26% PACHYCURARES were see CURARE-LIKE AGENTS 1970-92; CURARIFORM DRUGS was see MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CURARE-LIKE AGENTS 1970-92; MUSCLE RELAXANTS, POLARIZING was see NEUROMUSCULAR NONDEPOLARIZING AGENTS 1989-94; NEUROMUSCULAR NONDEPOLARIZING AGENTS %26% PACHYCURARES were see CURARE-LIKE AGENTS 1975-92; CURARIFORM DRUGS was see under MUSCLE RELAXANTS 1963-69; MUSCLE RELAXANTS was see under CURARE-LIKE AGENTS %26% MUSCLE RELAXANTS, CENTRAL %26% NEUROMUSCULAR DEPOLARIZING AGENTS 1970-74, was heading 1963-69; CURARIFORM ANTAGONISTS was heading 1963-69%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN %28%NM%29% 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CYCLIN 1991-2 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was CYPROTERONE ACETATE %28%NM%29% 1980-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DENTAL CARE FOR HANDICAPPED 1980-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DEOXYNOJIRIMYCIN %28%NM%29% 1981-92; 1,5-DIDEOXY-1,5-IMINO-D-MANNITOL was NM 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DERMATITIS EXFOLIATIVA 1963-92; ERYTHRODERMA was heading 1963-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DERMATITIS MEDICAMENTOSA 1963-92; DRUG ERUPTIONS was see DERMATITIS MEDICAMENTOSA 1975-92, was see under DERMATITIS MEDICAMENTOSA 1971-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DESOGESTREL %28%NM%29% 1977-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DICHLOROMETHYLENE DIPHOSPHONATE 1977-92 %28%see under DIPHOSPHONATES 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DICTYOCAULUS INFECTION 1982-92; was DICTYOCAULIASIS 1968-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DIHEMATOPORPHYRIN ETHER %28%NM%29% 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DIMAPRIT %28%NM%29% 1977-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DOPAMINE-D1 RECEPTOR %28%NM%29% 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DOPAMINE-D2 RECEPTOR %28%NM%29% 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DOWN%27%S SYNDROME 1975-92 %26% 1963-64; was MONGOLISM 1965-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DRACUNCULOSIS 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was DYNEIN 1977-92 %28%see under ADENOSINE TRIPHOSPHATASE 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ENDOTHELIN RECEPTOR %28%NM%29% 1988-92; ENDOTHELIN DERIVED VASOCONSTRICTOR FACTORS RECEPTORS %26% RECEPTORS, ENDOTHELIUM-DERIVED VASOCONSTRICTOR FACTORS were see RECEPTORS, ENDOTHELIN 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ERYTHROPOIETIN RECEPTOR %28%NM%29% 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ETANIDAZOLE %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ETODOLAC %28%NM%29% 1976-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FACTOR I, C 3B INACTIVATOR %28%NM%29% 1983-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FENRETINIDE %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FIBRINOLYSIN 1963-92; PLASMIN was see FIBRINOLYSIN 1963-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FLUORODEOXYURIDINE 1963-92; FLOXURIDINE was see FLUORODEOXYURIDINE 1976-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FOSENOPRIL %28%NM%29% 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FUNCTIONAL ORTHODONIC APPLIANCES see ACTIVATOR APPLIANCES 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was FUNCTIONAL ORTHODONTIC APPLIANCES see ACTIVATOR APPLIANCES 1975-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GENE PRODUCT, RAP 1991-92; GENE PRODUCTS, VPR %26% RAP PROTEIN %26% HIV RAP GENE PRODUCT were see GENE PRODUCTS, RAP 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GENE PRODUCTS, RAP 1991-92; GENE PRODUCTS, VPR %26% RAP PROTEIN %26% HIV RAP GENE PRODUCT were see GENE PRODUCTS, RAP 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GENES, RAP 1991-92; GENES, VPR was see GENES, RAP 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GEORGIAN S.S.R. 1982-92; was GEORGIAN SSR 1967-81; was GEORGIA SSR 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GLUTAMATE RECEPTOR %28%NM%29% 1980-92; EXCITATORY AMINO ACID RECEPTORS %26% RECEPTORS, EXCITATORY AMINO ACID were see RECEPTORS, AMINO ACID 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GLYCOSYL-PHOSPHATIDYLINOSITOL %28%NM%29% 1988-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was GUIDE RNA %28%NM%29% 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was HELPER CELLS 1983-92; was see T-LYMPHOCYTES 1979-82; was see LYMPHOCYTE COOPERATION 1978%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was HEMATOPORPHYRIN D %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was HEPATITIS B VACCINE %28%NM%29% 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was HEPATOCYTE GROWTH FACTOR %28%NM%29% 1984-92 and SCATTER FACTOR %28%NM%29% 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 see TRANS-ACTIVATORS 1991-92; ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 was indexed under HERPES SIMPLEX VIRUS PROTEIN VMW65 1993-96 %26% VIRAL PROTEINS 1987-92; HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 was indexed under VIRAL PROTEINS 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was HERPES SIMPLEX VIRUS TRANSCRIPTIONAL ACTIVATOR VMW65 see TRANS-ACTIVATORS 1991-92; was also ALPHA-TRANS INDUCING FACTOR, HERPES SIMPLEX VIRUS 1 %28%NM%29% 1987-96; HERPES SIMPLEX VIRUS PROTEIN VP16 was HERPES SIMPLEX VIRUS TYPE 2 PROTEIN VP16 %28%NM%29% 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ICI 118630 %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was IMMUNE COMPLEX DISEASE 1972-92 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was IMMUNE COMPLEX DISEASE 1974-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was IMMUNOGLOBULIN E RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was IMMUNOGLOBULIN G RECEPTOR %28%NM%29% 1981-92; CD32 ANTIGEN was NM 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was IMPROMIDINE %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was INFORMATION SCIENCE %28%NON MESH%29% 1974-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was INSULIN-LIKE GROWTH FACTOR RECEPTOR %28%NM%29% 1980-92; INSULIN-LIKE GROWTH FACTORS RECEPTORS was see RECEPTORS, SOMATOMEDIN 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was INTERFERON RECEPTOR %28%NM%29% 1980-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was INTERLEUKIN 11 %28%NM%29% 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was IODOCHLORHYDROXYQUIN 1963-92 %28%see under HYDROXYQUINOLINES 1983-90%29%; CLIOQUINOL was see IODOCHLORHYDROXYQUIN 1976-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ISRADIPINE %28%NM%29% 1983-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was KAZAKH S.S.R. 1982-92; was heading 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was KERATOSIS PALMARIS ET PLANTARIS 1974-92; KERATODERMA, PALMOPLANTAR was see KERATOSIS PALMARIS ET PLANTARIS 1990-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was KIRGHIZ S.S.R. 1982-92; was KIRGHIZIA 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was LAMININ RECEPTOR %28%NM%29% 1983-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was LEUKOCYTE CULTURE TEST, MIXED 1973-92; LYMPHOCYTE CULTURE TEST, MIXED was see LEUKOCYTE CULTURE TEST, MIXED 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was LIPOPROTEIN LP%28%A%29% %28%NM%29% 1977-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was LORATADINE %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was MDL 17043 %28%NM%29% 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was MITHRAMYCIN 1971-92 %28%Prov 1971-72%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was MITHRAMYCIN 1973-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was MOLDAVIAN S.S.R. 1982-92; was MOLDAVIA 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was N-ISOPROPYLATROPINE 1975-92 %28%see under ATROPINE DERIVATIVES 1978-90 %26% see under ATROPINE 1975-77%29%; IPRATROPIUM BROMIDE was see N-ISOPROPYLATROPINE 1976-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was N-ISOPROPYLATROPINE 1975-92 %28%see under ATROPINE DERIVATIVES 1978-90, see under ATROPINE 1975-77%29%; IPRATROPIUM BROMIDE was see N-ISOPROPYLATROPINE 1976-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NAFARELIN %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NEOCARZINOSTATIN 1975-92 %28%see under ANTIBIOTICS, ANTINEOPLASTIC 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NERVE GROWTH FACTORS RECEPTOR %28%NM%29% 1980-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NEUROMUSCULAR SPINDLES 1965-92; was see under NERVE ENDINGS 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NEUROPEPTIDE Y RECEPTOR %28%NM%29% 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NICOTINAMIDE 1963-92; NIACINAMIDE was see NICOTINAMIDE 1963-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was NS PROTEINS %28%NM%29% 1980-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was OCCUPATIONAL DERMATITIS 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ONCOGENE PRODUCTS 1990-92; ONCOGENE PROTEINS was see ONCOGENE PRODUCTS 1990-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ONCOGENE PROTEIN P37%28%MOS%29% %28%NM%29% 1989-92 and ONCOGENE PROTEIN MOS %28%NM%29% 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ONDANSETRON %28%NM%29% 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was OPSIN %28%NM%29% 1973-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PAROXETINE %28%NM%29% 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PEDODONTICS 1965-92; was PEDODONTIA 1963-64 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PHAGE LAMBDA 1980-92; BACTERIOPHAGE LAMBDA was see PHAGE LAMBDA 1980-92, was see COLIPHAGES 1975-79; LAMBDA PHAGE was see COLIPHAGES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PHAGE MU 1990-92; BACTERIOPHAGE MU was see PHAGE MU 1990-92, was see PHAGE MU 1 1980-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PHAGE PHI X 174 1980-92; PHI X 174 was see BACTERIOPHAGE PHI X 174 1980-93; BACTERIOPHAGE PHI X 174 was see PHAGE PHI X 174 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PHENCYCLIDINE RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PIPECURIUM %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PLATELET-DERIVED GROWTH FACTOR RECEPTOR %28%NM%29% 1982-92; PLATELET DERIVED GROWTH FACTOR RECEPTOR-KINASE was NM 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was POISON IVY DERMATITIS 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was POLYETHYLENE TEREPHTHALATE 1973-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was POMPHOLYX 1963-92; ECZEMA, DYSHIDROTIC was see POMPHOLYX 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was POST-ANESTHESIA NURSING 1992 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PROCATEROL %28%NM%29% 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PROSTATE CANCER SPECIFIC ANTIGENS %28%NM%29% 1982-92; SEMENOGELASE was NM 1976-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PROTEIN S, VITAMIN K-DEPENDENT %28%NM%29% 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was PROTO-ONCOGENE PROTEIN C-MOS %28%NM%29% 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was QUINOLINIC ACID %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RAMIPRIL %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; G-CSF RECEPTORS was G-CSF RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTORS was see RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR 1993-96, was GRANULOCYTE-COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE COLONY-STIMULATING FACTOR 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTORS was GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92; GM-CSF RECEPTORS was GM-CSF RECEPTOR see RECEPTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RECEPTOR, N-METHYL-D-ASPARTATE 1991-92; N-METHYL-D-ASPARTATE RECEPTORS was N-METHYL-D-ASPARTATE RECEPTOR see RECEPTOR, N-METHYL-D-ASPARTATE 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was REMOXIPRIDE %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1966-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RHUS 1963-92; TOXICODENDRON was see RHUS 1986-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was RUSSIAN S.F.S.R. 1982-92, was RUSSIAN FEDERATION %28%EUROPE%29% 1967-81, was RUSSIAN FEDERATION 1966; RUSSIA was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SEBORRHEA 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SELENOCYSTEINE %28%NM%29% 1977-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SERINE KINASE %28%NM%29% 1985-92 %26% PROTEIN-THREONINE KINASE %28%NM%29% 1983-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SIDEROCHROMES %28%NM%29% 1972-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SIGMA RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SMALL RIBONUCLEOPROTEINS %28%NM%29% 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SOMATOSTATIN RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SOMATOTROPIN RELEASING HORMONE%28%1-29%29%AMIDE %28%NM%29% 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SPECIFIC PATHOGEN FREE 1975-92 %28%see under GERM-FREE LIFE 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was STAPHYLOCOCCAL PHAGES 66-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was STREPTOZOTOCIN 1972-92 %28%Prov 1972%29%; STREPTOZOCIN was see STREPTOZOTOCIN 1977-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was STREPTOZOTOCIN 1973-92; STREPTOZOCIN was see STREPTOZOTOCIN 1977-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was SULFENTANIL %28%NM%29% 1977-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was T3 ANTIGEN COMPLEX %28%NM%29% 1983-92; T3 ANTIGENS was see ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TADZHIK S.S.R. 1982-92; was TADZHIKISTAN 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TECHNETIUM TC 99M HEXAKIS%28%2-METHOXY-2-METHYLPROPYLISONITRILE%29% 1987-92; for TECHNETIUM TC 99M 2-METHOXY-2-METHYLPROPYLISONITRILE use TECHNETIUM TC 99M SESTAMIBI %28%NM%29% 1987-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TECHNETIUM TC 99M MERCAPTOACETYLGLYCYL-GLYCYL-GLYCINE %28%NM%29% 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TEICHOMYCINS %28%NM%29% 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was THROMBOXANE RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was THYMOXAMINE 1972-92 %28%Prov 1972%29%; MOXISYLYTE was see THYMOXAMINE 1976-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was THYMOXAMINE 1972-92; MOXISYLYTE was see THYMOXAMINE 1976-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TINEA UNGUIUM 1963-92; ONYCHOMYCOSIS was see TINEA UNGUIUM 1963-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TOREMIFENE %28%NM%29% 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92; NEUROTRANSMITTER UPTAKE INHIBITORS, INHIBITORS OF NEUROTRANSMITTER UPTAKE %26% UPTAKE INHIBITORS, NEUROTRANSMITTER were see TRANSMITTER UPTAKE INHIBITORS, NEURONAL 1985-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was TURKMEN S.S.R. l982-92; was heading 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was UK 33274 %28%NM%29% 1980-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was UZBEK S.S.R. 1982-92; was heading 1963-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was VASOPRESSIN RECEPTOR %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was VIRAL TAIL PROTEINS %28%NM%29% 1981-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was WORKMEN%27%S COMPENSATION 1963-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was XAMOTEROL %28%NM%29% 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was ZIMELIDINE 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was heading 1963-90; was see DENTURES 1991-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was heading 1966-90; was see DENTURE RETENTION 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was heading 1970-90, was see DENTURE DESIGN 1991-92; PROSTHESIS DESIGN, DENTAL was see DENTURE DESIGN 1992%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was heading 1972-90 %28%Prov 1972-73%29%; was see DENTURE REPAIR 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was heading 1974-90; was see DENTURE REPAIR 1991-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was indexed under NORPREGNENES 1979-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see AFRICA, EASTERN 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see ANIMAL WELFARE 1986-92; SPECIESISM was see ANIMAL WELFARE 1987-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see BASE SEQUENCE 1988-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see CHROMOSOME DELETION 1984-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see CONDIMENTS 1984-92; was see under CONDIMENTS 1963-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see CONTRACEPTIVE DEVICES, MALE 1988-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see HAMSTERS 1982-92; DJUNGARIAN was see HAMSTERS 1982-92; DJUNGARIAN HAMSTERS was DJUNGARIAN HAMSTER see HAMSTERS 1984-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92; ERYTHRODERMA ICHTHYOSIFORME, BULLOUS was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92, was see SKIN DISEASES, BULLOUS 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92; ERYTHRODERMA ICHTHYOSIFORME, NONBULLOUS was see ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL 1991-92, was see ICHTHYOSIS 1979-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see INDIAN OCEAN ISLANDS 1987-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see LIGHT COAGULATION 1992; was heading 1968-85 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see MARRIAGE 1990-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see NECATOR 1979-92; HOOKWORM, NEW WORLD was see NECATOR 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see NEMATODA 1989-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see NEMATODE INFECTIONS 1989-92; was see under ASCARIASIS 1968-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see OXYURIASIS 1975-92; was see under OXYURIASIS 1967-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see PARENTAL LEAVE 1992 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see PARTICLE ACCELERATORS 1978-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see PARTICLE ACCELERATORS 1978-92; SYNCHROCYCLOTRONS was see PARTICLE ACCELERATORS 1978-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see RATS, INBRED STRAINS 1982-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see TELECOMMUNICATIONS 1985-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see TEMPOROMANDIBULAR JOINT SYNDROME 1991-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see THALASSEMIA 1988-92; ANEMIA, ERYTHROBLASTIC was see THALASSEMIA 1965-92, was heading 1963-64; ANEMIA, COOLEY%27%S was see THALASSEMIA 1963-92; ANEMIA, MEDITERRANEAN was see THALASSEMIA 1965-92; HEMOGLOBIN F DISEASE %26% THALASSEMIA MAJOR were see THALASSEMIA 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see THALASSEMIA 1988-92; HEMOGLOBIN H DISEASE was see THALASSEMIA 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '93; was see TYLENCHOIDEA 1986-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94, 63-81 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94, 64-74; was RHINOVIRUSES 1975-93; COMMON COLD VIRUS was see under RHINOVIRUSES 1975-78, was see under RHINOVIRUS 1964-74, was heading 1963%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94, 67-74; was CHOLECALCIFEROLS 1975-93, was CHOLECALCIFEROL 1967-74, was VITAMIN D 3 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94, 78-80; was ROTAVIRUSES 1981-93 %28%see under REOVIRIDAE 1981-82%29%; was see under RNA VIRUSES 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94,63-74; was ENTEROVIRUSES 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94,63-80; was VIOMYCINS 1981-93; was VIOMYCIN 1963-80 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94,63-86; was ADRENOCORTICOTROPIC HORMONE 1987-93; /adv eff-pois-tox was CORTICOTROPIN TOXICOLOGY 1963-65; /ther use was CORTICOTROPIN, THERAPEUTIC 1965%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94,63-86; was ADRENOCORTICOTROPIC HORMONE 1987-93; /adverse effects /poisoning /toxicity were CORTICOTROPIN TOXICOLOGY 1963-65; /therapeutic use was CORTICOTROPIN, THERAPEUTIC 1965%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94,73-74%28%71-72%29%; was PENICILLANIC ACIDS 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94,73-74; was PENICILLANIC ACIDS 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '946, HOE-BAY' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR was indexed under RECEPTORS, STEROID 1980-93; VITAMIN D3 RECEPTOR was indexed under RECEPTORS, STEROID 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ADENOSINE RECEPTORS was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ADENOSINE RECEPTORS, was see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADENOSINE was see RECEPTORS, PURINERGIC 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ADP RECEPTORS %26% ATP RECEPTORS were see RECEPTORS, PURINERGIC 1987-93; RECEPTORS, ADP %26% RECEPTORS, ATP were see RECEPTORS, PURINERGIC 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; AGRIN was indexed under NERVE TISSUE PROTEINS 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID was indexed under IBOTENIC ACID/analogs %26% derivatives 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ALPHA-LINOLENIC ACID was indexed under LINOLENIC ACIDS 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; AMOSITE was indexed under ASBESTOS 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; AMPA RECEPTOR was indexed under RECEPTORS, GLUTAMATE 1993, RECEPTORS, SYNAPTIC 1990-92, %26% RECEPTORS, DRUG 1981-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; AMPHIBOLES was indexed under SILICA 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ARYL HYDROCARBON RECEPTOR was indexed under RECEPTORS, DRUG 1981-93; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR was indexed under RECEPTORS, DRUG 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; AZITHROMYCIN was indexed under ERYTHROMYCIN/*analogs %26% derivatives 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BACLOFEN RECEPTOR was indexed under RECEPTORS, GABA-BENZODIAZEPINE 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BACLOFEN RECEPTORS was BACLOFEN RECEPTOR %28%NM%29% 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BIRD POX VIRUS %26% POXVIRUS AVIUM were see FOWL POX VIRUS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BIRNAVIRUS INFECTIONS was see BIRNAVIRIDAE INFECTIONS 1994-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BIRNAVIRUS was heading 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BOMBESIN RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1987-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCE 1982-86; NEUROMEDIN B RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BRACONID VIRUSES was see BACULOVIRIDAE 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; BROME MOSAIC VIRUSES was see BROMOVIRUS 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CALCITONIN GENE-RELATED PEPTIDE RECEPTOR was SY to CALCITONIN RECEPTOR %28%NM%29% 1986-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CALCITONIN GENE-RELATED PEPTIDE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CALCITONIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CATECHOLAMINE RECEPTOR was indexed under RECEPTORS, ADRENERGIC 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CD27 ANTIGEN was indexed under ANTIGENS, CD %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1989-93; T-CELL ACTIVATION ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CD28 ANTIGEN was indexed under ANTIGENS, CD 1990-93 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1986-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CD30 ANTIGENS was CD30 ANTIGEN %28%NM%29% 1983-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CHLORIDE CHANNELS was indexed under MEMBRANE PROTEINS 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CHRYSOTILE was %28%NM%29% 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CHRYSOTILE was indexed under ASBESTOS 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; COMPLEMENTARY DNA was see DNA 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; COMPLEMENTARY RNA was indexed under RNA 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CONNEXIN 43 was %28%SY%29% to GAP JUNCTION PROTEIN 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CONNEXIN 43 was indexed under MEMBRANE PROTEINS 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CORTICOTROPIN RECEPTOR was indexed under RECEPTORS, PITUITARY HORMONE 1987-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CORTICOTROPIN RELEASING HORMONE RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1986-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1983-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; COWPEA MOSAIC VIRUSES was see COMOVIRUS 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CROCIDOLITE was indexed under ASBESTOS 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; CUCUMBER MOSAIC VIRUSES was see CUCUMOVIRUS 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; DAPTOMYCIN was indexed under PEPTIDES %26% ANTIBIOTICS 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; DENERVATION, AUTONOMIC was see SYMPATHECTOMY 1989-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; DESMOID was see FIBROMA 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; DEUTERIUM OXIDE was indexed under DEUTERIUM %26% WATER 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; DIAMOND was indexed under CARBON 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ESOX was see SALMONIDAE 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; FELINE CALICIVIRUSES was see CALICIVIRIDAE 1978-92; FELINE CALICIVIRUS was see under CALICIVIRUSES 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; FINASTERIDE was indexed under ANDROSTENES %26% AZASTEROIDS 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GABA RECEPTORS %26% RECEPTORS, GAMMA-AMINOBUTYRIC ACID were see RECEPTORS, GABA-BENZODIAZEPINE 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GAMMA-LINOLENIC ACID was indexed under LINOLENIC ACIDS 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GAP JUNCTION PROTEIN was %28%NM%29% 1982-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GAP JUNCTION PROTEIN was indexed under MEMBRANE PROTEINS 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GELATINASE was indexed under PEPTIDE PEPTIDOHYDROLASES 1993, PEPSIN A 1975-92, GELATIN 1973-81 %26% PEPTIDE HYDROLASES 1973-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GLUCAGON RECEPTOR was indexed under RECEPTORS, GASTROINTESTINAL HORMONE 1986-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1981-86, %26% GLUCAGON 1980-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GLUTAMATE DEHYDROGENASE %28%NADP+%29% was indexed under GLUTAMATE DEHYDROGENASE 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GLYCINE RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GRANISETRON was indexed under INDAZOLES 1988-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; GYNANDROBLASTOMA was heading 1963-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; HISTAMINE H3 RECEPTOR was indexed under RECEPTORS, HISTAMINE 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; HYDROBROMIC ACID was indexed under ACIDS 1983-93 %26% BROMIDES 1974-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; HYDROXYAPATITE was indexed under HYDROXYAPATITES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; HYDROXYL RADICAL was indexed under HYDROXIDES 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; INFECTIOUS HUMAN WART VIRUS was see PAPILLOMAVIRUSES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ISOCYANATES was see CYANATES 1993 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ITRACONAZOLE was indexed under KETOCONAZOLE/*analogs %26% derivatives 1984-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; KAINIC ACID RECEPTOR was indexed under RECEPTORS, GLUTAMATE 1993, RECEPTORS, SYNAPTIC 1985-92, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; KINETOPLAST DNA was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MAXICIRCLES was indexed under DNA, CIRCULAR 1987-93; KINETOPLAST DNA MINICIRCLES was indexed under DNA, CIRCULAR 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; KININ RECEPTORS was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1980-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; KRINGLES was indexed under PEPTIDE FRAGMENTS 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LEIOMYOBLASTOMA was see LEIOMYOMA 1992-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LEUKOTRIENE A was indexed under LEUKOTRIENES 1989-93 %26% ARACHIDONIC ACIDS 1980-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LEUKOTRIENE B4 RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1985-93, RECEPTORS, ENDOGENOUS SUBSTANCES 1982-84 %26% RECEPTORS, HORMONE 1982%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LEUKOTRIENE E was indexed under SRS-A/*ANALOGS %26% DERIVATIVES 1983-93 %26% ARACHIDONIC ACIDS 1980-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LIGNANS was indexed under LIGNIN 1990-93 %26% PLANT EXTRACTS 1979-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LIPOPROTEIN RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LISINOPRIL was indexed under ENALAPRIL/analogs %26% derivatives 1986-92 %26% DIPEPTIDES 1981-85, 93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; LITHIUM CHLORIDE was indexed under LITHIUM %26% CHLORIDES 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; MARMOSET VIRUS was heading 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS %26% HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; MARMOSET VIRUS was heading 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; HERPESVIRUS HOMINIS was heading 1963-93; HERPES-T VIRUS %26% HERPESVIRUS PLATYRHINAE were see MARMOSET VIRUS 1975-93; FEVER BLISTER VIRUS was see HERPESVIRUS HOMINIS 1976-93; HERPES SIMPLEX VIRUS was see HERPESVIRUS HOMINIS 1963-93;%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; MINERALOCORTICOID RECEPTOR was indexed under RECEPTORS, STEROID 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; MORBILLI VIRUS was see MEASLES VIRUS 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; MYOD FACTOR was indexed under MUSCLE PROTEINS 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; MYOGENIN was indexed under MUSCLE PROTEINS 1989-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; NEDOCROMIL was indexed under QUINOLINONES 1989-93 %26% QUINOLINES 1984-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; NEUROMEDIN K RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; NEUROTENSIN RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUSBSTANCES 1980-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; NIH OFFICE OF SCIENTIFIC INTEGRITY was heading 1991-93; NATIONAL INSTITUTES OF HEALTH OFFICE OF SCIENTIFIC INTEGRITY %26% OFFICE OF SCIENTIFIC INTEGRITY %28%U.S.%29% were see NIH OFFICE OF SCIENTIFIC INTEGRITY 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; NITRIC ACID was indexed under NITRATES 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; OCTOXYNOL was indexed under POLYETHYLENE GLYCOLS 1983-94 %26% 1974-79, TRITONS 1979-82 %26% PHENYL ETHERS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ODONTOGENESIS IMPERFECTA was heading 1965-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ODORANT RECEPTOR was indexed under CARRIER PROTEINS 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ODORANT RECEPTORS was ODORANT RECEPTOR %28%SY%29% to ODORANT-BINDING PROTEIN %28%NM%29% 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; OXYTOCIN RECEPTOR was indexed under RECEPTORS, ANGIOTENSIN 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES %28%1981-84%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PARAINFLUENZA was heading 1994-96; was PARA-INFLUENZA 1963-93 %28%see under MYXOVIRUS INFECTIONS %28%now ORTHOMYXOVIRUS INFECTIONS%29% 1963-69%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PARATHYROID HORMONE RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PEPLEOMYCIN was indexed under BLEOMYCINS 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PHOSPHINOUS ACIDS %26% PHOSPHONOUS ACIDS were headings 1968-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; POLYPHOSPHOINOSITIDES was indexed under PHOSPHOINOSITIDES 1983-93 %26% POLYMERS 1978-82; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PORINS %26% PHOE PROTEIN were indexed under BACTERIAL OUTER MEMBRANE PROTEINS 1985-93 %26% MEMBRANE PROTEINS 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PROSTAGLANDINS E RECEPTOR was %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PROSTAGLANDINS E RECEPTOR was indexed under RECEPTORS, PROSTAGLANDIN 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; PROTEIN C INHIBITOR was indexed under PLASMINOGEN INACTIVATORS 1992-93 %26% BLOOD PROTEINS 1981-92; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; RABBIT HEMORRHAGIC DISEASE VIRUS was see CALICIVIRIDAE 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; RADON DAUGHTERS was indexed under RADON 1993 %26% BISMUTH, LEAD %26% POLONIUM 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; RECEPTORS, THROMBIN was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; RETINOIC ACID-BINDING PROTEINS was indexed under CARRIER PROTEINS 1979-93 and under PROTEINS %26% PROTEIN BINDING 1976-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; RHO%28%D%29% IMMUNE GLOBULIN was indexed under IMMUNOGLOBULINS 1973-93, ANTI-ANTIBODIES 1980-83, %26% GAMMA GLOBULINS 1978-83%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; RIFABUTINE was indexed under RIFAMYCINS 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SALMO GAIRDNERI was see TROUT 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SIGNAL RECOGNITION PARTICLE was indexed under RIBONUCLEOPROTEINS 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SODIUM BICARBONATE was indexed under BICARBONATES %26% SODIUM 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SODIUM SELENITE was indexed under SELENIUM 1992-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SODIUM-HYDROGEN ANTIPORTER was indexed under CARRIER PROTEINS 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SRS-A RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1990-93, RECEPTORS, PROSTAGLANDIN 1984-89, %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1983-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; STAVUDINE was indexed under DIDEOXYNUCLEOSIDES 1988-93 %26% THYMIDINE/*ANALOGS %26% DERIVATIVES 1987-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SUBSTANCE K RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1984-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SUBSTANCE P RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1981-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SULFUROUS ACIDS was heading 1968-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SUMATRIPTAN was indexed under INDOLES %26% SULFONAMIDES 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; SWINEPOX VIRUS was see POXVIRIDAE 1986-93; see under POXVIRIDAE 1981-85; see under POXVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; TACHYKININ RECEPTOR was indexed under RECEPTORS, SYNAPTIC 1985-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1984%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; THROMBOMODULIN was SY to THROMBIN RECEPTOR %28%NM%29% 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; THYROTROPIN RELEASING HORMONE RECEPTOR was indexed under RECEPTORS, NEUROHUMOR 1987-93 %26% RECEPTORS, ENDOGENOUS SUSBSTANCES 1981-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; TOBACCO RINGSPOT VIRUSES was see NEPOVIRUS 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; TOMATO BUSHY STUNT VIRUSES was see TOMBUSVIRUS 1994-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; TRANSFORMING GROWTH FACTOR RECEPTOR, BETA 1986-93 was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1986-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; TUMOR NECROSIS FACTOR RECEPTOR was indexed under RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; VASOACTIVE INTESTINAL PEPTIDE RECEPTOR was indexed under RECEPTORS, GASTROINTESTINAL HORMONE 1987-93 %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1980-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; WIDOWERS %26% WIDOWS were WIDOWER %26% WIDOW see SINGLE PERSON 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; ZEOLITES was indexed under ALUMINUM SILICATES 1981-93 %26% SODIUM HYDROXIDE 1972-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was 1,25-DIHYDROXYCHOLECALCIFEROL RECEPTOR %28%NM%29% 1980-93; VITAMIN D3 RECEPTOR was %28%NM%29% 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 1985-93; was 2%27%,3%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE see under PHOSPHODIESTERASES 1975-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was 3%27%,5%27%-CYCLIC AMP PHOSPHODIESTERASE 1975-93 %28%see under PHOSPHODIESTERASES 1975-77%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was 3%27%,5%27%-CYCLIC GMP PHOSPHODIESTERASE 1978-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was 4-NITROPHENYL PHOSPHATASE 1992-93; was NITROPHENYL PHOSPHATASE 1975-91 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ADENO-ASSOCIATED VIRUSES 1979-93; was ADENO-ASSOCIATED VIRUSES see SATELLITE VIRUSES 1975-78; DEPENDOVIRUS was see PARVOVIRIDAE 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ADENOMA, BASOPHILIC 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ADENOMA, EOSINOPHILIC 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1968-77 %28%Prov 1968-71%29%; CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ADENOSINE CYCLIC MONOPHOSPHATE 1980-93, was ADENOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was ADENOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1972-77; CYCLIC AMP was see ADENOSINE CYCLIC MONOPHOSPHATE 1976-93; ADENOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see ADENOSINE CYCLIC MONOPHOSPHATE 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ADENOVIRUS INFECTIONS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AFTER CARE 1968-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AGRIN %28%NM%29% 1988-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ALKYL SULFONATES 1973-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID %28%NM%29% 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ALPHA-GALACTOSIDASES 1978-93 %28%see under GALACTOSIDASES 1978-90%29%; MELIBIASES was see ALPHA-GALACTOSIDASE 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ALPHA-GALACTOSIDASES 1978-93 %28%see under GALACTOSIDASES 1978-90%29%; MELIBIASES was see ALPHA-GALACTOSIDASES 1978-93; MELIBIASE was see GALACTOSIDASES 1975-78, was see GALACTOSIDASE 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ALPHA-LINOLENIC ACID %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ALPHAVIRUSES 1981-93; ALPHAVIRUSES was see ARBOVIRUSES 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AMOSITE %28%NM%29% 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AMPA RECEPTOR %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AMPHIBOLES %28%NM%29% 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ANTIMONY SODIUM GLUCONATES 1991-93 %28%see under GLUCONATES 1977-90%29%; SODIUM STIBOGLUCONATE was STIBOGLUCONATE SODIUM 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ARENAVIRUS INFECTIONS 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ARYL HYDROCARBON RECEPTOR %28%NM%29% 1981-93; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN RECEPTOR was %28%NM%29% 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ARYL SULFONATES 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AVIAN ENCEPHALOMYELITIS VIRUS 1975-93 %28%see under ENTEROVIRUSES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AVIAN INFECTIOUS LARYNGOTRACHEITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AVIAN LEUKOSIS VIRUSES 1975-93, was AVIAN LEUKOSIS VIRUS 1963-74; LEUKEMIA VIRUS, AVIAN was see AVIAN LEUKOSIS VIRUSES 1978-93; LEUKEMIA VIRUS, AVIAN %26% LYMPHOMATOSIS VIRUS, AVIAN were see under AVIAN LEUKOSIS VIRUSES 1975-77, were see under AVIAN LEUKOSIS VIRUS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AVIAN SARCOMA 1983-93; was ROUS SARCOMA 1963-82 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AVIAN SARCOMA VIRUSES 1983-93, was ROUS SARCOMA VIRUS 1963-82; CHICKEN SARCOMA VIRUS B77 was heading 1975-93 %28%see under AVIAN SARCOMA VIRUSES 1983-90, see under ROUS SARCOMA VIRUS 1975-82%29%; AVIAN SARCOMA VIRUS B77 was see CHICKEN SARCOMA VIRUS B77 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was AZITHROMYCIN %28%NM%29% 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BACTEROIDES GINGIVALIS 1992-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BLUE TONGUE 1968-93 %28%Prov 1968-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BLUE TONGUE 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BLUE TONGUE VIRUS 1975-93 %28%see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BOMBESIN RECEPTOR %28%NM%29% 1982-93; NEUROMEDIN B RECEPTOR was %28%NM%29% 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BOVINE IMMUNODEFICIENCY-LIKE VIRUS 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BOVINE LEUKEMIA VIRUS 1977-93 %28%see under RETROVIRIDAE 1981-90, see under LEUKOVIRUSES 1978-80, see under LEUKEMOGENIC VIRUSES 1977%29%; was CATTLE LEUKEMIA VIRUS see under LEUKEMOGENIC VIRUSES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BOVINE PAPILLOMATOSIS VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was BOVINE ULCERATIVE MAMMILLITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; ALLERTON VIRUS INFECTIONS was indexed under LUMPY SKIN DISEASE 1970-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CALCITONIN RECEPTOR %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CALICIVIRUS INFECTIONS 1993 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%; CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CANINE TRACHEOBRONCHITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-90%29%; CANINE HERPESVIRUS was see CANINE TRACHEOBRONCHITIS VIRUS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CARCINOMA, BRONCHIOLAR 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CARCINOMA, DUCTAL 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CARCINOMA, MUCINOUS 1981-93; CARCINOMA, COLLOID was heading 1963-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CARCINOMA, NON-SMALL CELL LUNG 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CARCINOMA, SCIRRHOUS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CATABOLITE GENE ACTIVATOR PROTEINS 1988-93; CYCLIC AMP RECEPTOR PROTEIN was see CATABOLITE GENE ACTIVATOR PROTEIN 1990-93; CATABOLITE GENE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLITE ACTIVATOR PROTEIN was see RECEPTORS, CYCLIC AMP 1987; CATABOLIC GENE ACTIVATORS was see RECEPTORS, CYCLIC AMP 1977-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CATECHOL ESTROGENS 1982-93; ESTROGENS, CATECHOL was see CATECHOL ESTROGENS 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CATECHOLAMINE RECEPTOR %28%NM%29% 1982-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CD27 ANTIGEN %28%NM%29% 1989-93; T-CELL ACTIVATION ANTIGEN was T CELL ACTIVATION ANTIGEN %28%NM%29% 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CD28 ANTIGEN %28%NM%29% 1986-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CELLULAR INCLUSIONS 1970-93 %28%Prov 1970-71%29%; INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CELLULAR INCLUSIONS 1972-93; INCLUSION BODIES was see CELLULAR INCLUSIONS 1972-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1983-93, was CENTER FOR DISEASE CONTROL 1982, was UNITED STATES CENTER FOR DISEASE CONTROL 1978-81; UNITED STATES CENTERS FOR DISEASE CONTROL was see CENTERS FOR DISEASE CONTROL %28%U.S.%29% 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CHLORIDE CHANNELS %28%NM%29% 1988-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CHLOROMERCURIPHENYLSULFONATE %28%see under PHENYLMERCURY COMPOUNDS 1977-90, see under ORGANOMETALLIC COMPOUNDS 1975-76%29%; CHLOROMERCURIBENZENESULFONATE was see CHLOROMERCURIPHENYLSULFONATE 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CHOLANGIOMA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CHORIOADENOMA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CLOSTRIDIUM HISTOLYTICUM COLLAGENASE 1991-93; was CLOSTRIDIOPEPTIDASE A 1963-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was COLUMBIA-SK VIRUSES see ENCEPHALOMYOCARDITIS VIRUSES 1979-93; was see under ENCEPHALOMYOCARDITIS VIRUSES 1965-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was COMPLEMENTARY RNA %28%NM%29% 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CORONAVIRUS INFECTIONS 1977-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CORTICOTROPIN RECEPTOR %28%NM%29% 1981-93; CORTICOTROPIN RECEPTORS %26% ACTH RECEPTORS were SYs 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CORTICOTROPIN RELEASING HORMONE RECEPTOR %28%NM%29% 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CROCIDOLITE %28%NM%29% 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYCLIC AMP-DEPENDENT PROTEIN KINASE see PROTEIN KINASES 1984-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYLINDROMA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYSTOSARCOMA PHYLLODES 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYTIDINE CYCLIC MONOPHOSPHATE 1980-93 %28%see under CYTOSINE NUCLEOTIDES 1980-90%29%; CYCLIC CMP %26% CYTIDINE CYCLIC-2%27%,3%27%-MONOPHOSPHATE were see CYTIDINE CYCLIC MONOPHOSPHATE 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYTOCHROME PEROXIDASE 1976-93 %28%see under PEROXIDASES 1976-90%29%; CYTOCHROME C PEROXIDASE was see CYTOCHROME PEROXIDASE 1976-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYTOMEGALIC INCLUSION DISEASE 1963-93; CYTOMEGALOVIRUS INFECTIONS was see CYTOMEGALIC INCLUSION DISEASE 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was CYTOMEGALOVIRUSES 1966-93; SALIVARY GLAND VIRUSES was see under CYTOMEGALOVIRUSES 1966-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DAPTOMYCIN %28%NM%29% 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DEUTERIUM OXIDE %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIAMOND %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIARRHEOGENIC TUMOR 1982-93 %28%see under ISLET CELL TUMOR 1982-90%29%; VIPOMA was see DIARRHEOGENIC TUMOR 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIBUTYRYL CYCLIC AMP 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIDEOXYCYTIDINE 1990-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIETHYLDITHIOCARBAMATE 1973-93 %28%see under THIOCARBAMATES 1973-86%29%; DITIOCARB was see DIETHYLDITHIOCARBAMATE 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIHYDRO-OROTATE OXIDASE 1977-93 %28%see under OXIDOREDUCTASES 1977-90%29%; DIHYDRO-OROTATE DEHYDROGENASE %26% OROTATE REDUCTASE were see DIHYDRO-OROTATE OXIDASE 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DIMERCAPTOSUCCINIC ACID 1979-93 %28%see under SULFHYDRYL COMPOUNDS 1979-90%29%; SUCCIMER was see DIMERCAPTOSUCCINIC ACID 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DNA UNWINDING PROTEINS 1978-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was DRUG TREATMENT CENTERS 1991-93; SUBSTANCE ABUSE TREATMENT CENTERS was see DRUG TREATMENT CENTERS 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ELECTRON SPIN RESONANCE 1966-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ELECTRON SPIN RESONANCE 1966-93 %28%Prov 1964-66%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ENCEPHALITIS, JAPANESE B 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ENCEPHALOMYOCARDITIS VIRUSES 1965-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ENOXAPARIN 1992-93, was HEPARIN, LOW MOLECULAR WEIGHT 1988-91; HEPARIN, LOW MOLECULAR WEIGHT was see ENOXAPARIN 1992-93; LOW-MOLECULAR-WEIGHT HEPARIN was LOW MOLECULAR WEIGHT HEPARIN 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ENTERITIS VIRUS, TURKEY 1975-93 %28%see under CORONAVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ENTERITIS VIRUS, TURKEY 1991-93 %28%see under CORONAVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was EOSIN 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT%27%S LYMPHOMA VIRUS 1969-77 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was EPSTEIN-BARR VIRUS 1978-93; was BURKITT%27%S LYMPHOMA VIRUS 1973-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was EQUINE COITAL EXANTHEMA VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was EQUINE INFECTIOUS ANEMIA VIRUS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was EQUINE RHINOPNEUMONITIS VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ETHIODIZED OILS 1978-93, was ETHIODOL 1964-77 %28%Prov 1964-72%29%; ETHIODOL was see ETHIODIZED OILS 1978-93; ETHIODIZED POPPY SEED OIL was %28%NM%29% 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ETHIODIZED OILS 1978-93, was ETHIODOL 1973-77; ETHIODOL was see ETHIODIZED OILS 1978-93; ETHIODIZED POPPY SEED OIL was indexed under ETHIODIZED OILS 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ETHIOFOS 1985-93 %28%see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1985-90%29%; was WR 2721 see under ORGANOTHIOPHOSPHORUS COMPOUNDS 1977-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FELINE IMMUNODEFICIENCY VIRUS 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FELINE LEUKEMIA VIRUS 1973-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FINASTERIDE %28%NM%29% 1988-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FLAVIVIRUSES 1981-93, was see ARBOVIRUSES 1978-80; ARBOVIRUS GROUP B was ARBOVIRUSES GROUP B see FLAVIVIRUSES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FOWL POX 1970-93; BIRDPOX was BIRD POX see FOWL POX 1970-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FOWL POX VIRUS 1975-93 %28%see under POXVIRIDAE 1981-89, see under POXVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was FRUCTOSE-1,6-DIPHOSPHATASE 1989-93; was HEXOSEDIPHOSPHATASE 1965-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GAMMA-LINOLENIC ACID %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GASES, RARE 1976-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GASES, RARE 1976-93; was RARE GASES %28%NON MESH%29% 1971-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GELATINASE %28%NM%29% 1973-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GLIOBLASTOMA MULTIFORME 1963-93; GLIOBLASTOMA was see ASTROCYTOMA 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GLOMANGIOMA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GLUCAGON RECEPTOR %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GLUCOSEPHOSPHATASE 1965-93; was GLUCOSE PHOSPHATASES 1964%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GLUTAMATE DEHYDROGENASE %28%NADP+%29% %28%NM%29% 1982-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GLYCINE RECEPTOR %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GRANISETRON %28%NM%29% 1988-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1971-77 %28%Prov 1971%29%; CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GUANOSINE CYCLIC MONOPHOSPHATE 1980-93, was GUANOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE 1978-79, was GUANOSINE CYCLIC 3%27%,5%27% MONOPHOSPHATE 1972-77; CYCLIC GMP was see GUANOSINE CYCLIC MONOPHOSPHATE 1975-93; GUANOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see GUANOSINE CYCLIC MONOPHOSPHATE 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GUANOSINE MONOPHOSPHATE 1978-93 %28%see under GUANINE NUCLEOTIDES 1978-90%29%; was GUANYLIC ACIDS see under GUANINE NUCEOTIDES 1963-77; GUANYLIC ACID was see GUANOSINE MONOPHOSPHATE 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GUANOSINE MONOPHOSPHATE 1978-93 %28%see under GUANINE NUCLEOTIDES 1978-90%29%; was GUANYLIC ACIDS see under GUANINE NUCEOTIDES 1963-77; GUANYLIC ACID was see GUANOSINE MONOPOSPHATE 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was GUANYL CYCLASE 1973-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE 1993; POTASSIUM HYDROGEN ATPASE was indexed under ADENOSINE TRIPHOSPHATASE 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was H%28%+%29%-K%28%+%29%-TRANSPORTING ATPASE 1993; was POTASSIUM HYDROGEN ATPASE %28%NM%29% 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HEPATITIS A VIRUS 1977-93; was HEPATITIS VIRUS, INFECTIOUS 1966-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HEPATITIS VIRUS, INFECTIOUS CANINE 1966-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HEPATOMA 1963-93; CARCINOMA, HEPATOCELLULAR was see HEPATOMA 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HERPESVIRUS INFECTIONS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HERPESVIRUS SIMIAE 1991-93; was HERPESVIRUS SIMIAN B see under HERPESVIRIDAE 1981-90 %26% see under HERPESVIRUSES 1971-80 %28%Prov 1971-74%29%; HERPESVIRUS SIMIAN B was see HERPESVIRUS SIMIAE 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HERPESVIRUS SIMIAE 1991-93; was HERPESVIRUS SIMIAN B see under HERPESVIRIDAE 1981-90 %26% see under HERPESVIRUSES 1975-80; HERPESVIRUS SIMIAN B was see HERPESVIRUS SIMIAE 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HERPESVIRUS-6, HUMAN 1990-93; HUMAN HERPESVIRUS-6 was see HERPESVIRUS-6, HUMAN 1990-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HERPESVIRUS-7, HUMAN 1991-93; HUMAN HERPESVIRUS-7 was see HERPESVIRUS-7, HUMAN 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HIDRADENOMA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HISTAMINE H3 RECEPTOR %28%NM%29% 1983-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HISTIDINOLPHOSPHATASE 1975-93 %28%see under PHOSPHOMONOESTERASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HISTONE KINASE 1975-93 %28%see under PROTEIN KINASES 1980-90, see under PROTEIN KINASE 1975-79%29%; PROTAMINE KINASE was %28%NM%29% 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HISTONE KINASE 1975-93 %28%see under PROTEIN KINASES 1980-90, see under PROTEIN KINASE 1975-79%29%; PROTAMINE KINASE was indexed under PROTEIN KINASES 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HYDROBROMIC ACID %28%NM%29% 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HYDROCYANIC ACID 1963-93; HYDROGEN CYANIDE was see HYDROCYANIC ACID 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HYDROXYAPATITE %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HYDROXYL RADICAL %28%NM%29% 1978-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HYPOCHLOROUS ACIDS 1975-93 %28%see under ACIDS 1975-76%29%; HYPOCHLOROUS ACID was %28%NM%29% 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was HYPOCHLOROUS ACIDS 1975-93 %28%see under ACIDS 1975-76%29%; HYPOCHLOROUS ACID was indexed under HYPOCHLOROUS ACIDS 1982-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was INFECTIOUS ARTERITIS VIRUS, EQUINE 1981-93 %28%see under RNA VIRUSES 1981-90%29%; was INFECTIOUS ARTERITIS VIRUS OF HORSES see under RNA VIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS 1966-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was INFECTIOUS BURSAL AGENT 1975-93 %28%see under REOVIRIDAE 1981-90, see under REOVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was INOSINE CYCLIC MONOPHOSPHATE 1980-93 %28%see under INOSINE NUCLEOTIDES 1980-90%29%, was INOSINE CYCLIC-3%27%,5%27%-MONOPHOSPHATE see under INOSINE NUCLEOTIDES 1975-79; CYCLIC IMP was see INOSINE CYCLIC MONOPHOSPHATE 1975-93; INOSINE CYCLIC 2%27%,3%27%-MONOPHOSPHATE was see INOSINE CYCLIC MONOPHOSPHATE 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was INTEGRATED ACADEMIC INFORMATION MANAGEMENT SYSTEMS 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 %28%see under IODIZED OILS 1975-90%29%; IODOLIPOL was %28%NM%29% 1967-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was IODIZED OILS 1963-93; OIL, IODIZED was OILS, IODIZED 1963-93; LIPIODOL was heading 1975-93 %28%see under IODIZED OILS 1975-90%29%; IODOLIPOL was indexed under IODIZED OILS 1967-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ISLET CELL TUMOR 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ITRACONAZOLE %28%NM%29% 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was IVORY COAST 1971-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KAINIC ACID RECEPTOR %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KINETOPLAST DNA %28%NM%29% 1987-93; KINETOPLAST DNA MAXICIRCLES was NM 1987-93; KINETOPLAST DNA MINICIRCLES was NM 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KININ RECEPTOR %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KININASE II 1973-93 %28%Prov 1973%29%; TONIN was see KININASE II 1984-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KININASE II 1974-93; TONIN was see KININASE II 1984-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KLIPPEL-TRENAUNAY DISEASE 1975-93 %28%see under ANGIOMATOSIS 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KRINGLES %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was KRUKENBERG%27%S TUMOR 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEISHMANIA BRAZILIENSIS GUYANENSIS see LEISHMANIA BRAZILIENSIS 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEISHMANIA DONOVANI INFANTUM see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA INFANTUM see LEISHMANIA DONOVANI 1986-91; LEISHMANIA DONOVANI CHAGASI was see LEISHMANIA DONOVANI 1992-93, was LEISHMANIA CHAGASI see LEISHMANIA DONOVANI 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEISHMANIA ENRIETTI see LEISHMANIA MEXICANA 1986-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEISHMANIA TROPICA MAJOR see LEISHMANIA TROPICA 1992-93; was LEISHMANIA MAJOR see LEISHMANIA TROPICA 1986-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LENTIVIRINAE 1991-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEOPARD FROG CARCINOMA VIRUS 1975-93 %28%see under HERPESVIRIDAE 1981-90, see under HERPESVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEUKOTRIENE A %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEUKOTRIENE B4 RECEPTOR %28%NM%29% 1982-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEUKOTRIENE E %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LEUKOTRIENES B 1983-93; LEUKOTRIENE B4 was see LEUKOTRIENES B 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LIGNANS %28%NM%29% 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LIPOPROTEIN RECEPTOR %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LISINOPRIL %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LITHIUM CHLORIDE %28%NM%29% 1977-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was LUNG DISEASE, INTERSTITIAL see PULMONARY FIBROSIS 1985-93; PNEUMONITIS, INTERSTITIAL was see PULMONARY FIBROSIS 1985-93; PNEUMONIA, INTERSTITIAL was see under PULMONARY FIBROSIS 1963-74, was see PULMONARY FIBROSIS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MAREK%27%S DISEASE VIRUS 1975-93; MAREK%27%S DISEASE HERPESVIRUS 1 was MAREK%27%S DISEASE VIRUS see HERPESVIRUS 2, GALLID 1994-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MENGO VIRUS 1973-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MENSTRUATION INDUCING AGENTS 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MENTAL HEALTH ASSOCIATION 1975-93 %28%see under VOLUNTARY HEALTH AGENCIES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was METHANESULFONATES 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MINERALOCORTICOID RECEPTOR %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MIXED SALIVARY GLAND TUMOR 1963-93; SYRINGOMA, CHONDROID was see HIDRADENOMA %28%now ADENOMA, SWEAT GLAND%29% 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MOUSE SARCOMA VIRUSES 1980-93; was MOUSE SARCOMA VIRUS see under MOUSE TUMOR VIRUSES 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MURRAY VALLEY ENCEPHALITIS VIRUS see FLAVIVIRUSES 1981-93, see ENCEPHALITIS VIRUSES 1977-80, see ARBOVIRUSES 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MYELOPEROXIDASE 1975-93 %28%see under PEROXIDASES 1975-85%29%; GUAIACOL PEROXIDASE %26% HYDROPEROXIDASE II were see MYELOPEROXIDASE 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MYOD FACTOR %28%NM%29% 1989-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MYOEPITHELIAL TUMOR 1963-93; MYOEPITHELIOMA was see MYOEPITHELIAL TUMOR 1984-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was MYOGENIN %28%NM%29% 1989-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NA%28%+%29% K%28%+%29%-TRANSPORTING ATPASE 1993; was ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1979-92; SODIUM-POTASSIUM PUMP was heading 1992-93; POTASSIUM PUMP %26% SODIUM PUMP were see SODIUM-POTASSIUM PUMP 1992-93; SODIUM POTASSIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, SODIUM POTSSIUM 1992; SODIUM, POTASSIUM ADENOSINE TRIPHOSPHATASE was SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NA%28%+%29% K%28%+%29%-TRANSPORTING ATPASE 1993; was ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1979-92; SODIUM-POTASSIUM PUMP was heading 1992-93; POTASSIUM PUMP %26% SODIUM PUMP were see SODIUM-POTASSIUM PUMP 1992-93; SODIUM, POTASSIUM PUMP PROTEIN was see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1992; SODIUM, POTASSIUM ADENOSINETRIPHOSPHATASE was SODIUM, POTASSIUM ADENOSINE TRIPHOSPHATASE see ADENOSINE TRIPHOSPHATASE, SODIUM, POTASSIUM 1989-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEDOCROMIL %28%NM%29% 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEOPLASMS, GLANDULAR EPITHELIAL 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEOPLASMS, NERVOUS TISSUE 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION 1969-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEURAL TRANSMISSION 1969-93, was NEUROHUMORAL TRANSMISSION 1968; NERVE TRANSMISSION was see NEURAL TRANSMISSION%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEUROMEDIN K RECEPTOR %28%NM%29% 1987-93; NK-3 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NEUROTENSIN RECEPTOR %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NITRIC ACID %28%NM%29% 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NON MESH 1971-93; SULFUROUS ACIDS was heading 1968-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NONOXYNOLS 1993; NONOXYNOLS was indexed under POLYETHYLENE GLYCOLS 1974-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NONOXYNOLS 1993; was NONOXYNOLS %28%NM%29% 1974-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NORWALK AGENT 1982-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NUCLEOSIDE DIPHOSPHATE KINASES 1977-93 %28%see under PHOSPHOTRANSFERASES, ATP 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was NUCLEOSIDE MONOPHOSPHATE KINASES 1977-93 %28%see under PHOSPHOTRANSFERASES, ATP 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was OCTOXYNOL %28%NM%29% 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ORTHOMYXOVIRUS INFECTIONS 1977-93; was MYXOVIRUS INFECTIONS 1963-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was OXYTOCIN RECEPTOR %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PAGET%27%S DISEASE OF BREAST 1975-93 %28%see under CARCINOMA, DUCTAL 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PAGET%27%S DISEASE, EXTRA-MAMMARY 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PAPILLOMAVIRUSES 1978-93; was PAPILLOMA VIRUSES 1975-77; was PAPILLOMA VIRUS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PARAGANGLIOMA, NONCHROMAFFIN 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PARATHYROID HORMONE RECEPTOR %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PARAVACCINIA VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%; PSEUDO-COWPOX VIRUS was see PARAVACCINIA VIRUS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PARVOVIRUS INFECTIONS 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PEPLEOMYCIN %28%NM%29% 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was NM 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PERCHLORIC ACIDS 1963-93; PERCHLORIC ACID was indexed under PERCHLORIC ACIDS 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was NM 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PERIODIC ACIDS 1963-93; PERIODIC ACID was indexed under PERIODIC ACIDS 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PESTIVIRUSES 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHLOXINE B 1979-93 %28%see under FLUORESCEINS 1979-90%29%; ACID RED 92 was see PHLOXINE B 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHOSPHODIESTERASES 1972-93 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHOSPHODIESTERASES 1974-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHOSPHOGLYCEROMUTASE 1975-93 %28%see under PHOSPHOTRANSFERASES 1975-90%29%; PHOSPHOGLYCERATE PHOSPHOMUTASE was %28%NM%29% 1973-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHOSPHOGLYCEROMUTASE 1975-93 %28%see under PHOSPHOTRANSFERASES 1975-90%29%; PHOSPHOGLYCERATE PHOSPHOMUTASE was indexed under ISOMERASES 1983-93, GLYCERIC ACIDS 1973-82 %26% ORGANOPHOSPHORUS COMPOUNDS 1973-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHOSPHOMONOESTERASES 1975-93; PHOSPHORIC MONOESTER HYDROLASES was see PHOSPHOMONOESTERASES 1975-93; PHOSPHATASES was heading 1963-93; PHOSPHOHYDROLASES was see PHOSPHATASES 1963-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHOSPHOPROTEIN PHOSPHATASES 1978-93; PHOSPHOPROTEIN PHOSPHOHYDROLASE was PHOSPHOPROTEIN PHOSPHOHYDROLASES 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PHYTASE 1966-93; INOSITOLHEXAPHOSPHATE PHOSPHOHYDROLASE was see PHYTASE 1966-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PICORNAVIRUS INFECTIONS 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PICORNAVIRUS INFECTIONS 1980-93; was PICORNAVIRUS INFECTIONS %28%NON MESH%29% before 1980%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POLIOVIRUS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POLYANETHOL SULFONATE 1977-93 %28%see under BENZENESULFONATES 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POLYBROMOBIPHENYL COMPOUNDS 1977-93 %28%see under BIPHENYL COMPOUNDS 1977-83%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POLYOMAVIRUSES 1978-93; was POLYOMA VIRUS 1963-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POLYPHOSPHOINOSITIDES %28%NM%29% 1978-93; PHOSPHATIDYLINOSITOL PHOSPHATES was see PHOSPHOINOSITIDES 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POLYPOSIS SYNDROME, FAMILIAL 1987-93; ADENOMATOUS POLYPOSIS COLI, FAMILIAL was see POLYPOSIS SYNDROME, FAMILIAL 1993%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PORINS %28%NM%29% 1977-93; PHOE PROTEIN was SY to PORINS %28%NM%29% 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was POXVIRUS INFECTIONS 1963-93; MILKER%27%S NODES was heading 1975-96 %28%see under POXVIRUS INFECTIONS 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PROLINE HYDROXYLASE 1972-93 %28%Prov 1972-73%29%; PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE was PROLINE,2-OXOGLUTARATE DIOXYGENASE see PROLINE HYDROXYLASE 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PROLINE HYDROXYLASE 1974-93; PROLINE,2-OXOGLUTARATE 4-DIOXYGENASE was PROLINE,2-OXOGLUTARATE DIOXYGENASE see PROLINE HYDROXYLASE 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PROSTAGLANDIN-13,14-REDUCTASE 1978-93 %28%see under OXIDOREDUCTASES 1978-90%29%; DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE was %28%NM%29% 1976-93; PROSTAGLANDIN DELTA 13 REDUCTASE was %28%NM%29% 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PROSTAGLANDIN-13,14-REDUCTASE 1978-93 %28%see under OXIDOREDUCTASES 1978-90%29%; DELTA 13-15-KETOPROSTAGLANDIN REDUCTASE was indexed under PROSTAGLANDIN-13,14-REDUCTASE 1981-93 and OXIDOREDUCTASES %26% PROSTAGLANDINS 1976-80; PROSTAGLANDIN DELTA 13 REDUCTASE was indexed under OXIDOREDUCTASES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PROTEIN C INHIBITOR %28%NM%29% 1981-93; PAI-3 was see PLASMINOGEN INACTIVATORS 1990-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PSEUDORABIES VIRUS 1963-93 %28%see under HERPESVIRUSES 1975-79, see under HERPESVIRUS 1963-74%29%; HERPESVIRUS SUIS was see PSEUDORABIES VIRUS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PYROPHOSPHATES 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PYRUVATE DEHYDROGENASE PHOSPHATASE 1975-93 %28%see under PHOSPHOPROTEIN PHOSPHATASES 1979-90, see under PHOSPHOMONOESTERASES 1975-78%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was PYRUVATE, PHOSPHATE DIKINASE 1975-93 %28%see under PHOSPHOTRANSFERASES, ATP 1975-90%29%; PHOSPHOENOLPYRUVATE SYNTHETASE was see PYRUVATE, PHOSPHATE DIKINASE 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was QUINOLINONES 1989-93; QUINOLONES was see QUINOLINONES 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RADON DAUGHTERS %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, DELTA 1993; DELTA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, DELTA 1993; was DELTA RECEPTOR %28%NM%29% 1982-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, ENDOGENOUS SUBSTANCES 1983-93; was RECEPTORS, HORMONE 1973-82; CELL RECEPTORS %26% RECEPTORS, BIOLOGIC were see RECEPTORS, ENDOGENOUS SUBSTANCES 1985-93; HORMONE RECEPTORS was see RECEPTORS, ENDOGENOUS SUBSTANCES 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, ENDORPHIN 1980-93; was RECEPTORS, NARCOTIC 1977-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, GABA-BENZODIAZEPINE 1985-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, GONADORELIN 1992-93; was RECEPTORS, GONADOLIBERIN 1987-91; FOLIBERIN RECEPTORS was see RECEPTORS, GONADOLIBERIN 1987-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, KAPPA 1993; KAPPA RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, KAPPA 1993; was KAPPA RECEPTOR %28%NM%29% 1980-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, MU 1993; MU RECEPTOR was indexed under RECEPTORS, ENDORPHIN 1981-92; MORPHINE RECEPTORS %26% RECEPTORS, MORPHINE were see RECEPTORS, OPIOID 1977-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RECEPTORS, MU 1993; was MU RECEPTOR %28%NM%29% 1981-92; MORPHINE RECEPTORS %26% RECEPTORS, MORPHINE were see RECEPTORS, OPIOID 1977-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was REOVIRUS INFECTIONS 1968-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RETINOIC ACID-BINDING PROTEINS %28%NM%29% 1976-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RETROVIRUS INFECTIONS 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RHO%28%D%29% IMMUNE GLOBULIN %28%NM%29% 1973-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RIBONUCLEASE H 1992-93; ENDORIBONUCLEASE H was indexed under ENDORIBONUCLEASES 1983-91 and under ENDONUCLEASES %26% RIBONUCLEASES 1973-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RIBONUCLEASE H 1992-93; was ENDORIBONUCLEASE H %28%NM%29% 1973-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RIBOSEPHOSPHATE PYROPHOSPHOKINASE 1975-93 %28%see under PHOSPHOTRANSFERASES, ATP 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was RIFABUTINE %28%NM%29% 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SHOPE FIBROMA VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SIGNAL RECOGNITION PARTICLE %28%NM%29% 1985-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SILICA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SIMIAN RETROVIRUSES 1989-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SMALLPOX VIRUS 1963-93; VARIOLA VIRUS was see SMALLPOX VIRUS 1975-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SODIUM BICARBONATE %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SODIUM SELENITE %28%NM%29% 1992-93; was SY to SELENIOUS ACID %28%NM%29% 1980-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SODIUM-HYDROGEN ANTIPORTER %28%NM%29% 1980-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SPERMATOGENESIS BLOCKING AGENTS 1975-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SPUMAVIRINAE 1991-93; FOAMY VIRUS was see under RETROVIRIDAE 1981-90, was see under LEUKOVIRUSES 1978-80, %26% was see under LEUKEMOGENIC VIRUSES 1975-77.%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SRS-A RECEPTOR %28%NM%29% 1983-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was STAVUDINE %28%NM%29% 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SUBSTANCE K 1989-93; NEUROKININ A was see SUBSTANCE K 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SUBSTANCE K RECEPTOR %28%NM%29% 1984-93; NK-2 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SUBSTANCE P RECEPTOR %28%NM%29% 1981-93; NK-1 RECEPTOR %26% NEUROKININ-1 RECEPTOR were SY to SUBSTANCE K RECEPTOR 1986-93; NK-1 RECEPTOR SITE was SY to TACHYKININ RECEPTOR 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SUMATRIPTAN %28%NM%29% 1988-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SYNDACTYLIA 1967-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was SYNOVIOMA 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TACHYKININ RECEPTOR %28%NM%29% 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was THECA CELL TUMOR 1963-93; THECOMA was see THECA CELL TUMOR 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was THIAMINE PYROPHOSPHOKINASE 1979-93 %28%see under PHOSPHOTRANSFERASES, ATP 1979-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was THIAMINE TRIPHOSPHATASE 1979-93 %28%see under PHOSPHATASES 1979-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was THYROTROPIN RELEASING HORMONE RECEPTOR %28%NM%29% 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TOGAVIRUS INFECTIONS 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TOLUENE DIISOCYANATE 1975-93 %28%see under CYANATES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TOROVIRIDAE 1992-93; TOROVIRUSES was see TOROVIRIDAE 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TRANSFORMING GROWTH FACTOR RECEPTOR, BETA %28%NM%29% 1986-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TRI-ALLATE 1975-93 %28%see under THIOCARBAMATES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TROPHOBLASTIC TUMOR 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TUMOR NECROSIS FACTOR RECEPTOR %28%NM%29% 1985-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was TYROCIDINES 1975-93 %28%see under TYROTHRICIN 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-93; was ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77, was UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was UNITED STATES ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1978-93; was ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION 1975-77; was UNITED STATES HEALTH SER AND MENTAL HEALTH AD 1973-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was VARICELLA-ZOSTER VIRUS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was VASOACTIVE INTESTINAL PEPTIDE RECEPTOR %28%NM%29% 1980-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was VESICULAR STOMATITIS VIRUS 1963-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was VISNA VIRUS 1991-93; was VISNA-MAEDI VIRUSES 1975-90 %28%see under RNA VIRUSES 1975-77%29%; VISNA-MAEDI VIRUS was see VISNA VIRUS 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was YABA VIRUS 1964-93 %28%see under POXVIRIDAE 1990, Prov 1964-65%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was YABA VIRUS 1966-93 %28%see under POXVIRIDAE 1990%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was ZEOLITE %28%NM%29% 1972-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was heading 1977-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was heading 1992-93; was see HEPARIN, LOW-MOLECULAR-WEIGHT 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see BLOOD COMPONENT TRANSFUSION 1992-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see CALIFORNIA GROUP VIRUSES 1976-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see CARCINOMA, OAT CELL 1982-93; CARCINOMA, OAT CELL was heading 1972-93 %28%Prov 1972-73%29%; SMALL CELL LUNG CANCER was see CARCINOMA, OAT CELL 1991-93; CARCINOMA, RESERVE CELL was see CARCINOMA, OAT CELL 1976-93; RESERVE CELL CARCINOMA was see CARCINOMA, OAT CELL 1974-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see CARCINOMA, OAT CELL 1982-93; CARCINOMA, OAT CELL was heading 1974-93; SMALL CELL LUNG CANCER was see CARCINOMA, OAT CELL 1991-93; CARCINOMA, RESERVE CELL was see CARCINOMA, OAT CELL 1976-93; RESERVE CELL CARCINOMA was see CARCINOMA, OAT CELL 1974-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see CRYOSURGERY 1984-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see DYSGERMINOMA 1979-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see ECOLOGY 1993 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see EXOSTOSES, MULTIPLE HEREDITARY 1990-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see HANTAVIRUS 1992-93, was see HEMORRHAGIC FEVER VIRUS, EPIDEMIC 1987-91; HEMORRHAGIC FEVER RENAL SYNDROME VIRUS was HEMORRHAGIC FEVER WITH RENAL SYNDROME VIRUS see HANTAVIRUS 1987-94; HFRS VIRUS was see HANTAVIRUS 1987-94; HEMORRHAGIC FEVER VIRUS, EPIDEMIC was see HANTAVIRUS 1992-94, was heading 1977-91 %28%see under RNA VIRUSES 1978-86, see under ARBOVIRUSES 1977%29%, was EPIDEMIC HEMORRHAGIC FEVER VIRUS see under ARBOVIRUSES 1975-76, see under ARBOVIRUS 1965-74, %26% see under ARBOVIRUSES 1963-64; HEMORRHAGIC FEVER VIRUS, KOREAN was see HANTAVIRUS 1977-94; HEMORRHAGIC NEPHROSO-NEPHRITIS VIRUS was see HANTAVIRUS 1976-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1975-93; HEMORRHAGIC FEVER VIRUS, ARGENTINIAN was see HEMORRHAGIC FEVER VIRUSES, AMERICAN 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see HIV SEROPOSITIVITY 1988-93; HTLV-III SERONEGATIVITY was see HIV SEROPOSITIVITY 1988-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see MESONEPHROMA 1979-93; YOLK SAC TUMOR was see MESONEPHROMA 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see OSTEOMA, OSTEOID 1985-93; GIANT OSTEOID OSTEOMA was see OSTEOMA, OSTEOID 1985-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see PARVOVIRIDAE 1992-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see RADIATION 1985-1993 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1970-93 %28%was SYNAPTIC RECEPTORS 1970-90 %28%Prov 1970-72%29%; NEUROTRANSMITTER RECEPTORS %26% SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, %26% NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see RECEPTORS, SYNAPTIC 1984-93; RECEPTORS, NEUROHUMOR was heading 1987-93; RECEPTORS, SYNAPTIC was heading 1973-93 %28%was SYNAPTIC RECEPTORS 1973-90%29%; NEUROTRANSMITTER RECEPTORS %26% SYNAPTIC RECEPTORS were see RECEPTORS, SYNAPTIC 1991-93; NEUROHUMOR RECEPTORS, NEUROMEDIATOR RECEPTORS, NEUROMODULATOR RECEPTORS, %26% NEUROREGULATOR RECEPTORS were see RECEPTORS, NEUROHUMOR 1987-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see RUBELLA VIRUS 1981-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see SALMON 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see SPINOCEREBELLAR DEGENERATION 1987-93 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see SRS-A 1983-93; LEUKOTRIENE C1 %26% LEUKOTRIENES C were see SRS-A 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '94; was see SRS-A 1983-93; LEUKOTRIENES D was see SRS-A 1983-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95%28%63%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95: was 5-OXOPROLYL-PEPTIDASE 1991-94; was PYROGLUTAMATE AMINOPEPTIDASE see under AMINOPEPTIDASES 1975-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1969-94 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95: was ADRENERGIC BETA RECEPTOR BLOCKADERS 1973-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95: was ASPARAGINE SYNTHETASE 1975-94 %28%see under LIGASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ADHESIN, E COLI was indexed under ANTIGENS, BACTERIAL 1982-94, BACTERIAL OUTER MEMBRANE PROTEINS 1985-94, %26% BACTERIAL PROTEINS 1982-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ADRENERGIC-BLOCKING AGENTS was see SYMPATHOLYTICS 1978-94; ANTIADRENERGIC AGENTS was see SYMPATHOLYTICS 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ALPHA-ENDORPHIN was indexed under ENDORPHINS 1980-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ANTIMUSCARINIC AGENTS was see PARASYMPATHOLYTICS 1969-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ANTIPYRETICS was see ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL 1990-94; was see ANALGESICS, ANTI-INFAMMATORY 1978-89; was see ANALGESICS AND ANTIPYRETICS 1975-77; was see under ANALGESICS AND ANTIPYRETICS 1963-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ARNICA was indexed under PLANT EXTRACTS 1985-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; BETHANECHOL was indexed under BETHANECHOL COMPOUNDS 1981-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CD11 ANTIGENS was indexed under ANTIGENS, CD 1990-94 %26% ANTIGENS, DIFFERENTIATION 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CD13 ANTIGEN was indexed under ANTIGENS, CD 1991-94, ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94, %26% ANTIGENS, DIFFERENTIATION 1988; ALANINE AMINOPEPIDASE was indexed under AMINOPEPTIDASES 1981-94 %26% ALANINE 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CD18 ANTIGEN was indexed under ANTIGENS, CD 1990-94; RECEPTORS, LEUKOCYTE-ADHESION 1989-91; MEMBRANE GLYCOPROTEINS 1986-89; %26% MEMBRANE PROTEINS 1986-87; INTEGRIN BETA2 was indexed under INTEGRINS 1994-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CD26 ANTIGEN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1990-94; DIPEPTIDYL PEPTIDASE IV was indexed under DIPEPTIDYL PEPTIDASES 1980-94; ADENOSINE DEAMINASE-BINDING PROTEINS was indexed under CARRIER PROTEINS 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CHAPERONIN 10 was SY to GROES STRESS PROTEIN %28%NM%29% 1989-94; HEAT-SHOCK PROTEINS 10 was HEAT-SHOCK PROTEIN 10 %28%NM%29% 1993-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CHAPERONIN 10 was indexed under HEAT-SHOCK PROTEINS 1989-94; HEAT-SHOCK PROTEIN 10 was indexed under HEAT-SHOCK PROTEINS 1993-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CHAPERONIN 60 was indexed under BACTERIAL PROTEINS %26% HEAT-SHOCK PROTEINS 1989-94; HEAT-SHOCK PROTEIN 60 was indexed under HEAT-SHOCK PROTEINS 1993-94; HSP60 PROTEIN was indexed under HEAT-SHOCK PROTEINS 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CHAPERONIN FAMILY was indexed under PROTEINS 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; CHOLINERGIC-BLOCKING AGENTS was see PARASYMPATHOLYTICS 1963-94; CHOLINOLYTICS %26% ANTICHOLINERGIC AGENTS were see PARASYMPATHOLYTICS 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; DOPAMINE AGONISTS %26% DOPAMINE RECEPTOR AGONISTS were see DOPAMINERGIC AGENTS 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; FEE FOR SERVICE, MEDICAL was see FEES, MEDICAL 1982-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; FENOLDOPAM was indexed under SK%26%F-38393/analogs %26% derivatives 1989-94 %26% BENZAZEPINES 1982-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; FG 9065 was indexed under QUINOXALINES 1988-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; GAMMA-ENDORPHIN was indexed under ENDORPHINS 1980-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; GLUTAMIC ACID was indexed under GLUTAMATES 1981-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; GROEL STRESS PROTEIN was indexed under BACTERIAL PROTEINS %26% HEAT-SHOCK PROTEINS 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; GROES STRESS PROTEIN was indexed under BACTERIAL PROTEINS %26% HEAT-SHOCK PROTEINS 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; HEXAMETHONIUM was indexed under HEXAMETHONIUM COMPOUNDS 1980-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; HOME HEALTH AGENCIES was see HOME CARE SERVICES 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; INTERCELLULAR ADHESION MOLECULE 1 was indexed under CELL ADHESION MOLECULES 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; INTERLEUKIN 12 was indexed under INTERLEUKINS 1991-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; INTERLEUKIN 13 was indexed under INTERLEUKINS 1993-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; IRON DEFICIENCY ANEMIA was see ANEMIA, HYPOCHROMIC 1970-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; MACEDONIA %28%YUGOSLAVIA%29% was see YUGOSLAVIA 1994 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; MEA I, MEN I, %26% WERMER SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; MEA II, MEN II, %26% SIPPLE SYNDROME were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; MEA III %26% MEN III were see NEOPLASMS, MULTIPLE ENDOCRINE 1983-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE was indexed under 3,4-METHYLENEDIOXYAMPHETAMINE/analogs %26% derivatives 1984-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ONCOGENE PROTEIN ERBA was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-94 %26% RETROVIRIDAE PROTEINS 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; ONCOGENE PROTEINS ERBB was indexed under RETROVIRIDAE PROTEINS, ONCOGENIC 1990-94 %26% VIRAL PROTEINS 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES, ENDOGENOUS was see ENDORPHINS 1980-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; OPIOID PEPTIDES was see ENDORPHINS 1982-94; OPIATES, ENDOGENOUS was see ENDORPHINS 1980-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; OVERALL AND GORHAM BRIEF PSYCHIATRIC RATING SCALE was heading 1975-94 %28%see under PSYCHIATRIC STATUS RATING SCALES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; PROLIFERATING CELL NUCLEAR ANTIGEN was indexed under NUCLEAR PROTEINS 1988-94 %26% NUCLEOPROTEINS 1983-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SCRAPIE AGENT was see PRIONS 1992-94, was heading 1987-91, was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85; SCRAPIE PRP was NM 1988-94; SCRAPIE VIRUS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91, was see SCRAPIE PRION 1986, was heading 1966-85; RIDA VIRUS was see SCRAPIE AGENT 1976-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SCRAPIE AGENT was see PRIONS 1992-94, was heading 1987-91, was SCRAPIE PRION 1986, was SCRAPIE VIRUS 1966-85; SCRAPIE PRP was indexed under PRIONS 1992-94 %26% VIRAL PROTEINS 1989-91; SCRAPIE VIRUS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91, was see SCRAPIE PRION 1986, was heading 1966-85; RIDA VIRUS was see SCRAPIE AGENT 1976-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SCRAPIE AMYLOID PRECURSOR PROTEIN was NM 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SCRAPIE AMYLOID PRECURSOR PROTEIN was indexed under PRIONS %26% PROTEIN PRECURSORS 1992-94 and under VIRAL PROTEINS 1989-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SCRAPIE-ASSOCIATED FIBRILS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91; SCRAPIE PRP 27-30 PROTEIN was NM 1985-94; SCRAPIE ASSOCIATED FIBRIL-PROTEIN was NM 1984-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SCRAPIE-ASSOCIATED FIBRILS was see PRIONS 1992-94, was see SCRAPIE AGENT 1987-91; SCRAPIE PRP 27-30 PROTEIN was indexed under PRIONS 1992-94 %26% VIRAL PROTEINS 1985-91; SCRAPIE ASSOCIATED FIBRIL-PROTEIN was indexed under NERVE TISSUE PROTEINS 1984-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SEALED CABIN ECOLOGY was heading 1963-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SEROTONIN NEURON AGENTS %28%NON MESH%29% was heading 1995 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; SKELETAL MUSCLE RELAXANTS was see MUSCLE RELAXANTS, CENTRAL 1977-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; T11 ERYTHROCYTE-BINDING GLYCOPROTEIN was indexed under ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE %26% RECEPTORS, IMMUNOLOGIC 1989-94, ANTIGENS, DIFFERENTIATION 1988, %26% CARRIER PROTEINS 1985-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; THY-1 ANTIGEN was indexed under MEMBRANE GLYCOPROTEINS 1983-94, ANTIGENS, SURFACE 1981-94, MEMBRANE PROTEINS 1979-82, %26% ANTIGENS 1979-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; THYROID-STIMULATING IMMUNOGLOBULIN was indexed under AUTOANTIBODIES 1977-94 %26% IGG 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; TOCODYNAMOMETRY %26% TOCOGRAPHY were see CARDIOTOCOGRAPHY 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; see SALICYLAZOSULFAPYRIDINE 1963-94; for SULFASALAZINE see SALICYLAZOSULFAPYRIDINE 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; use CRYPTORCHIDISM to search CRYPTORCHISM 1966-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was 2-CHLORODEOXYADENOSINE 1993-94; 2-CHLORO-2%27%-DEOXYADENOSINE was indexed under 2-CHLOROADENOSINE/analogs %26% derivatives %26% DEOXYADENOSINES 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was 2-CHLORODEOXYADENOSINE 1993-94; was 2-CHLORO-2%27%-DEOXYADENOSINE %28%NM%29% 1986-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ACETYL COENZYME A SYNTHETASE 1991-94; was see under COENZYME A SYNTHETASES 1976-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADHESIN, E COLI %28%NM%29% 1982-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1969-94 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC ALPHA RECEPTOR AGONISTS 1973-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1969-94 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC ALPHA RECEPTOR BLOCKADERS 1973-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC BETA RECEPTOR AGONISTS 1969-94 %28%Prov 1969-72%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC BETA RECEPTOR AGONISTS 1973-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ADRENERGIC RECEPTOR AGONISTS 1975-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ALPHA-ENDORPHIN %28%NM%29% 1980-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ANALEPTICS 1963-94; CENTRAL NERVOUS SYSTEM STIMULANTS was see ANALEPTICS 1985-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ANALGESICS, ADDICTIVE 1975-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ANTI-RHEUMATIC AGENTS see ANTI-INFLAMMATORY AGENTS 1987-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ARNICA %28%NM%29% 1985-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ASPARAGINE SYNTHETASE 1975-94 %28%see under LIGASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was BACTEROIDES MELANINOGENICUS 1976-94 %28%see under BACTEROIDES 1976-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was BETHANECHOL %28%NM%29% 1981-94; was heading 1964-67 %28%Prov%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was CD11 ANTIGENS %28%NM%29% 1988-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was CD13 ANTIGEN %28%NM%29% 1988-94 %26% ALANINE AMINOPEPTIDASE %28%NM%29% 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was CD18 ANTIGEN %28%NM%29% 1986-94; INTEGRIN BETA2 was NM 1994-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was CD26 ANTIGEN %28%NM%29% 1990-94, DIPEPTIDYL PEPTIDASE IV %28%NM%29% 1980-94, %26% ADENOSINE DEAMINASE-BINDING PROTEINS %28%NM%29% 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was CHAPERONIN FAMILY %28%NM%29% 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was COELENTERATE VENOMS 1978-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was CRYPTORCHISM 1963-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was D-AMINO ACID OXIDASE 1974-94, was D-AMINOACID OXIDASE 1963-73 %28%Prov 1963-65%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was D-AMINO ACID OXIDASE 1974-94, was D-AMINOACID OXIDASE 1966-73%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was DESENSITIZATION %28%PSYCHOLOGY%29% 1975-94 %28%see under BEHAVIOR THERAPY 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was DIHYDRO-OROTASE 1977-94 %28%see under AMIDOHYDROLASES 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was DOPAMINERGIC AGENTS 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was DOPAMINERGIC AGENTS 1989-94; DOPAMINE NEURON AGENTS %28%NON MESH%29% was heading 1995%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was DYNORPHIN 1985-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ECHOCARDIOGRAPHY, DOPPLER COLOR see ECHOCARDIOGRAPHY, DOPPLER 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ECHOCARDIOGRAPHY, PULSED DOPPLER see ECHOCARDIOGRAPHY, DOPPLER 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ETHYLPHENYLEPHRINE 1976-94 %28%see under PHENYLEPHRINE 1976-90%29%; ETHYLNORMETAOXEDRIN %26% ETILEFRIN were see ETHYLPHENYLEPHRINE 1976-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was FATIGUE, MENTAL 1963-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was FENOLDOPAM %28%NM%29% 1982-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was FG 9065 %28%NM%29% 1988-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was FOOT/injuries 1966-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GAMMA-ENDORPHIN %28%NM%29% 1980-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GANGLIONIC BLOCKADERS 1970-94; was GANGLIONIC-BLOCKING AGENTS 1963-69%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GENES, HOMEO BOX 1987-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GLAPHENINE 1975-94 %28%see under ANTHRANILIC ACIDS 1975-90%29%; GLAFENINE was see GLAPHENINE 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GLUTAMIC ACID %28%NM%29% 1981-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GLUTAMINE SYNTHETASE 1972-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GROEL STRESS PROTEIN %28%NM%29% 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was GROES STRESS PROTEIN %28%NM%29% 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was HEMATOPOIETIC STEM CELLS/transplantation 1971-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was HEMATOPOIETIC STEM CELLS/transplantation 1972-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was HEXAMETHONIUM %28%NM%29% 1980-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was HISTAMINE H1 RECEPTOR BLOCKADERS 1977-94; was ANTIHISTAMINICS 1963-76; ANTIHISTAMINICS, CLASSICAL was ANTIHISTAMINICS see HISTAMINE H1 RECEPTOR BLOCKADERS 1977-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was HISTAMINE H2 RECEPTOR BLOCKADERS 1977-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was INTERCELLULAR ADHESION MOLECULE 1 %28%NM%29% 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was INTERLEUKIN 12 %28%NM%29% 1991-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was INTERLEUKIN 13 %28%NM%29% 1993-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was LYSYL OXIDASE 1975-94 %28%see under AMINO ACID OXIDOREDUCTASES 1975-90%29%; PROTEIN-LYSINE 6-OXIDASE was NM 1985-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was LYSYL OXIDASE 1975-94 %28%see under AMINO ACID OXIDOREDUCTASES 1975-90%29%; PROTEIN-LYSINE 6-OXIDASE was indexed under AMINO ACID OXIDOREDUCTASES 1986-92 %26% LYSYL OXIDASE 1993-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was MACULAE, ACOUSTIC 1979-94 %28%see under SACCULE AND UTRICLE 1983-90, see under LABYRINTH 1979-82%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was MOSQUITOES 1963-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE %28%NM%29% 1984-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82 %28%Prov 1964%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was NEOPLASMS, MULTIPLE ENDOCRINE 1983-94; was ADENOMATOSIS, FAMILIAL ENDOCRINE 1965-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was NON MESH 1974-94; SKELETAL MUSCLE RELAXANTS was see MUSCLE RELAXANTS, CENTRAL 1977-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ONCOGENE PROTEIN ERBA %28%NM%29% 1987-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ONCOGENE PROTEINS ERBB %28%NM%29% 1987-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PANCREATODUODENECTOMY 1992-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PERIARTERITIS NODOSA 1963-94; POLYARTERITIS NODOSA was see PERIARTERITIS NODOSA 1968-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PHYSICIANS%27% ASSISTANTS 1971-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PILI, BACTERIAL 1980-94; FIMBRIAE, BACTERIAL was see PILI, BACTERIAL 1980-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PORPHYRIA, CUTANEA TARDA 1993-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PROLIFERATING CELL NUCLEAR ANTIGEN %28%NM%29% 1983-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PULSELESS DISEASE 1993-94, was TAKAYASU SYNDROME 1963-92 %28%see under AORTIC ARCH SYNDROMES 1965-90, see under AORTIC DISEASES 1963-64%29%; TAKAYASU ARTERITIS was see PULSELESS DISEASE 1993-94, was see TAKAYASU SYNDROME 1987-92; PULSELESS DISEASE was see AORTIC ARCH SYNDROMES 1965-92, was see under AORTIC DISEASES 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was PULSELESS DISEASE 1993-94; was TAKAYASU SYNDROME 1963-92 %28%see under AORTIC ARCH SYNDROMES 1965-90, see under AORTIC DISEASES 1963-64%29%; TAKAYASU ARTERITIS was see PULSELESS DISEASE 1993-94, was see TAKAYASU SYNDROME 1987-92; PULSELESS DISEASE was see AORTIC ARCH SYNDROMES 1965-92, was see under AORTIC DISEASES 1963-64%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was RECEPTOSOMES 1983-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was RESTRICTION FRAGMENT LENGTH POLYMORPHISMS 1987-94 %28%see under POLYMORPHISM %28%GENETICS%29% 1987-89%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was SLOW-REACTING SUBSTANCES 1967-94 %28%Prov 1967-73%29%; AUTACOIDS was see SLOW-REACTING SUBSTANCES 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was SLOW-REACTING SUBSTANCES 1974-94; AUTACOIDS was see SLOW-REACTING SUBSTANCES 1978-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was SOLDERING, DENTAL 1973-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; LEU-M1 ANTIGENS was see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; CD 15 ANTIGEN was indexed under ANTIGENS, CD %26% ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1992-94 %26% ANTIGENS, DIFFERENTIATION 1987-91; LEWIS X HAPTEN was indexed under GANGLIOSIDES 1987-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was STAGE-SPECIFIC EMBRYONIC ANTIGEN-1 1991-94; LEU-M1 ANTIGENS was see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94; CD15 ANTIGENS was CD15 ANTIGEN %28%NM%29% 1987-94; LEWIS X HAPTEN was NM 1987-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was STEARYL-COA DESATURASE 1975-94 %28%see under FATTY ACID DESATURASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was STREPTOVARICINS 1973-94; was STREPTOVARICIN 1963-72%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was SY to GROEL STRESS PROTEIN %28%NM%29% 1989-94; HEAT-SHOCK PROTEINS 60 was HEAT-SHOCK PROTEIN 60 %28%NM%29% 1993-94; HSP60 FAMILY was HSP60 PROTEIN %28%SY%29% to MITOCHONDRIAL ASSEMBLY FACTOR HSP60 %28%NM%29% 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was T11 ERYTHROCYTE-BINDING GLYCOPROTEIN %28%NM%29% 1985-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was T4 LYMPHOCYTES 1989-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TAXOL 1993-94; TAXOL A was indexed under ALKALOIDS 1982-92 %26% TERPENES 1977-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TAXOL 1993-94; was TAXOL A %28%NM%29% 1977-92 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was THY-1 ANTIGEN %28%NM%29% 1979-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was THYROID-STIMULATING IMMUNOGLOBULIN %28%NM%29% 1977-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TOOTH/injuries 1966-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TRANQUILIZING AGENTS, MAJOR 1975-94; ANTIPSYCHOTIC AGENTS was see TRANQUILIZING AGENTS, MAJOR 1975-94; NEUROLEPTICS was see TRANQUILIZING AGENTS 1975-78, was see under TRANQUILIZING AGENTS 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TRANQUILIZING AGENTS, MINOR 1975-94; ANTI-ANXIETY AGENTS was see TRANQUILIZING AGENTS, MINOR 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TRANSCRIPTION FACTOR, AP-1 see PROTO-ONCOGENE PROTEINS C-JUN 1992-94; AP-1 ENHANCER-BINDING PROTEIN was see PROTO-ONCOGENE PROTEINS C-JUN 1992-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TRIMEPRANOL 1979-94 %28%see under PROPANOLAMINES 1979-90%29%; METIPRANOLOL was see TRIMEPRANOL 1986-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TYROSINE AMINOTRANSFERASE 1964-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TYROSINE AMINOTRANSFERASE 1964-94 %28%Prov 1964-68%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TYROSINE HYDROXYLASE 1971-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was TYROSINE HYDROXYLASE 1971-94 %28%Prov 1971-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was ULTRASONOGRAPHY, TRANSCRANIAL DOPPLER 1994 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was UROCANASE 1972-94, see under HYDRO-LYASES 1972-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was VECURONIUM 1987-94; VECURONIUM BROMIDE was see VECURONIUM 1987-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was VOLCANIC ERUPTIONS see NATURAL DISASTERS 1982-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1990-94; EPISIALIN was indexed under MEMBRANE GLYCOPROTEINS 1988-96, MUCINS 1981-96, MEMBRANE PROTEINS 1982-87, %26% GLYCOPROTEINS 1981-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1990-94; was also EPISIALIN %28%NM%29% 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see BACTERIORHODOPSIN 1976-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see CHINA 1975-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see CLINICAL TRIALS 1980-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see ECOLOGY 1982-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see ECONOMICS 1994; ECONOMIC MODELS was see ECONOMICS 1994%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see ENERGY TRANSFER 1992-94; LET was see ENERGY TRANSFER 1968-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see LEGUMES 1978-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see PARASYMPATHOMIMETICS 1975-94; NICOTINIC AGENTS was see GANGLIONIC STIMULANTS 1978-94; CHOLINOMIMETICS was see PARASYMPATHOMIMETICS 1974-94; MUSCARINIC AGENTS was see PARASYMPATHOMIMETICS 1969-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see PLANT POISONING 1979-94; was see under PLANT POISONING 1968-78; was heading 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see POLITICAL SYSTEMS 1990-94 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see SYMPATHOMIMETICS 1977-94; ADRENERGIC NEURON AGENTS was heading 1995; ADRENERGIC NEUROHUMOR DEPLETERS, ADRENERGIC RELEASE INHIBITORS, ADRENERGIC SYNTHESIS INHIBITORS, %26% SYMPATHETIC TRANSMITTER RELEASERS were see ADRENERGIC NEURON AGENTS 1995; SYMPATHETIC TRANSMITTER RELEASERS was see SYMPATHOMIMETICS 1976-94; ADRENOLYTICS was see SYMPATHOLYTICS 1975-94; ADRENOMIMETICS was see SYMPATHOMIMETICS 1975-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '95; was see under HOMOSEXUALITY 1976-80; LESBIANISM was see HOMOSEXUALITY 1981-94, was see HOMOSEXUALITY, FEMALE 1976-80, %26% was see under HOMOSEXUALITY 1968-75%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96791, Lilly' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; B CELL ANTIGEN CD19 was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95; %26% ANTIGENS, SURFACE 1987-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD1 ANTIGENS was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION 1988-91; %26% T-LYMPHYCYTES 1988%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD14 MONOCYTE DIFFERENTIATION ANTIGEN was indexed under ANTIGENS, CD 1990-95; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-95; %26% ANTIGENS, DIFFERENTIATION 1988; LIPOGLYCAN RECEPTOR was indexed under RECEPTORS, IMMUNOLOGIC 1983-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD20 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD34 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD40 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1989-95; CDW40 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD5 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CD7 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR was indexed under MEMBRANE PROTEINS 1989-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; DECAY-ACCELERATING FACTOR was indexed under ANTIGENS, CD 1990-95; MEMBRANE GLYCOPROTEINS 1988-95; MEMBRANE PROTEINS 1985-92; %26% BLOOD PROTEINS 1985-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; DENTISTRY FOR CHILDREN was see PEDIATRIC DENTISTRY 1995%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; ENDODEOXYRIBONUCLEASE HPAII was indexed under DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC 1989-95 %26% DNA RESTRICTION ENZYMES 1980-88%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 was indexed under CELL ADHESION MOLECULES 1989-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; FOLCH-PI PROTEOLIPID PROTEIN was indexed under MYELIN PROTEINS 1979-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; GALANIN was indexed under PEPTIDES 1984-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; HCG-BETA was indexed under GONADOTROPINS, CHORIONIC %26% PEPTIDE FRAGMENTS 1977-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; HEPATITIS C VIRUS ANTIBODIES was indexed under HEPATITIS ANTIBODIES 1992-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; HEPATITIS NON-A, NON-B ANTIGEN was indexed under ANTIGENS, VIRAL 1984-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; HNK-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95; ANTIGENS DIFFERENTIATION, T-LYMPHOCYTE 1989-95; %26% ANTIGENS, DIFFERENTIATION 1989-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; HYALURONIC ACID BINDING PROTEIN was indexed under CARRIER PROTEINS 1980-95; RECEPTORS, LYPHOCYTE HOMING 1991-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 was indexed under CARRIER PROTEINS 1991-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 was SY to INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS 1980-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS was indexed under CARRIER PROTEINS 1980-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; INTEGRIN BETA1 was indexed under INTEGRINS 1991-95; CD29 ANTIGEN was indexed under ANTIGENS, CD %26% INTEGRINS 1990-95; %26% ANTIGENS, DIFFERENTIATION 1990-91; CDW29 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; LEUKOCYTE ADHESION MOLECULE, LAM-1 was indexed under CELL ADHESION MOLECULES 1989-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 was indexed under ANTIGENS, CD 1990-95; ANTIGENS DIFFERENTIATION 1990-91; MEMBRANE GLYCOPROTEINS 1988-95; %26% ANTIGENS, SURFACE 1988-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; MAST CELL GROWTH FACTOR was indexed under HEMATOPOIETIC CELL GROWTH FACTORS 1990-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; MERKEL%27%S RECEPTOR was see MECHANORECEPTORS 1994-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR was indexed under CHEMOTACTIC FACTORS 1991-95 %26% GLYCOPROTEINS 1988-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; MYELIN P2 PROTEINS was indexed under ENCEPHALITOGENIC BASIC PROTEINS 1982-95 %26% MYELIN PROTEINS 1980-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; NKH-1 ANTIGEN was indexed under ANTIGENS, CD 1990-95 %26% ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; O ANTIGEN, BACTERIAL was indexed under POLYSACCHARIDES, BACTERIAL 1993-95 %26% ANTIGENS, BACTERIAL 1981-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PARASITICIDES was heading 1963-66 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PHOSPHOTYROSINE was indexed under TYROSINE/analogs %26% derivatives 1980-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PLATELET ALPHA-GRANULE MEMBRANE PROTEIN was indexed under PLATELET MEMBRANE GLYCOPROTEINS 1986-95 %26% MEMBRANE PROTEINS 1985-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PLATELET MEMBRANE GLYCOPROTEIN IB was see PLATELET MEMBRANE GLYCOPROTEINS 1987-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PLEURAL GLYCOPROTEINS was indexed under MYELIN PROTEINS 1982-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; POLYNUCLEAR AROMATIC HYDROCARBONS was see POLYCYCLIC HYDROCARBONS 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PRIVACY ACT was see CIVIL RIGHTS 1980-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; PROTEIN ZERO, PERIPHERAL NERVE MYELIN was indexed under MYELIN PROTEINS 1981-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; QUINQUESTRIATUS TOXIN was indexed under SCORPION VENOMS 1984-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; RANTES PROTEIN, T-CELL was indexed under LYMPHOKINES 1988-95; RANTES PROTEIN, MURINE was indexed under LYMPHOKINES 1992-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; RISPERIDONE was indexed under ISOXAZOLES %26% PIPERIDINES 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; TENASCIN was indexed under CELL ADHESION MOLECULES, NEURONAL %26% EXTRACELLULAR MATRIX PROTEINS 1990-95; PROTEINS %26% GLYCOPROTEINS 1986-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; VASCULAR CELL ADHESION MOLECULE %26% INDUCIBLE CELL ADHESION MOLECULE 110 were indexed under CELL ADHESION MOLECULES 1990-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; VITRONECTIN RECEPTOR was indexed under INTEGRINS %26% RECEPTORS, CYTOADHESIN 1990-95; RECEPTORS, IMMUNOLOGIC 1987-92; %26% RECEPTORS, ENDOGENOUS SUBSTANCES 1985-86%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; VITRONECTIN was indexed under GLYCOPROTEINS 1978-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE was indexed under HORSERADISH PEROXIDASE 1986-95, WHEAT GERM AGGLUTININS 1987-95, %26% LECTINS 1986%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was 3-HYDROXY-3-METHYLGLUTARIC ACID 1980-95 %28%see under GLUTARATES 1980-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ABATE 1972-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1972-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ACETYLPROCAINAMIDE 1980-95 %28%see under PROCAINAMIDE 1980-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ALPHA FETOPROTEINS 1975-95 %28%see under FETAL GLOBULINS 1975-76%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ALPHA MACROGLOBULINS 1976-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AMERICA 1975-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ANALGESIA, CONGENITAL 1964-95 %28%Prov 1964-72%29%; PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ANALGESIA, CONGENITAL 1973-95; PAIN INSENSITIVITY, CONGENITAL was see ANALGESIA, CONGENITAL 1973-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ANTIGENIC DETERMINANTS 1970-95 %28%as Prov 1970-71%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ANTIGENIC DETERMINANTS 1972-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ARABINOFURANOSYLADENINE MONOPHOSPHATE 1979-95 %28%see under ARABINONUCLEOTIDES 1979-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AUDIO-VISUAL AIDS 1963-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AUTOMOBILE EXHAUST 1963-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AUTOMOBILE EXHAUST 1963-95; was in Cat G only 1968-74, was in Cat G %26% J 1963-67%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AXOPLASMIC FLOW 1972-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AXOPLASMIC FLOW 1972-95 %28%Prov 1969-71%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AZACYTIDINE 1972-95 %28%Prov 1972-73%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was AZACYTIDINE 1974-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was B CELL ANTIGEN CD19 %28%NM%29% 1987-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was B-CELL ACTIVATION ANTIGEN 1994-95; B7-1 PROTEIN was indexed under B-CELL ACTIVATION ANTIGEN 1994-95; B CELL ACTIVATION ANTIGEN B7 was indexed under ANTIGENS, SURFACE 1991-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was B-CELL ACTIVATION ANTIGEN 1994-95; was B CELL ACTIVATION ANTIGEN B7 %28%NM%29% 1991-93; B7-1 COSTIMULATORY MOLECULE was B7-1 PROTEIN %28%NM%29% 1994-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was BENZENE HEXACHLORIDE 1963-95; LINDANE was see BENZENE HEXACHLORIDE 1963-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was BISHYDROXYCOUMARIN 1963-95; DICUMAROL was see BISHYDROXYCOUMARIN 1963-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1972-80 %28%Prov 1972-73%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was BLEOMYCINS 1981-95, was BLEOMYCIN 1974-80 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was BUTIROSINS 1975-95 %28%see under ANTIBIOTICS, AMINOGLYCOSIDE 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CAPREOMYCIN 1972-95 %28%Prov 1972-73%29%; CAPROMYCIN was see CAPREOMYCIN 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CAPREOMYCIN 1974-95; CAPROMYCIN was see CAPREOMYCIN 1978-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD1 ANTIGENS %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD14 MONOCYTE DIFFERENTIATION ANTIGEN %28%NM%29% 1988-95 %26% LIPOGLYCAN RECEPTOR %28%NM%29% 1983-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD20 ANTIGEN %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD34 ANTIGEN %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD40 ANTIGEN %28%NM%29% 1989-95 %26% CDW40 ANTIGEN %28%NM%29% 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD5 ANTIGEN %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CD7 ANTIGEN %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CHILD DEVELOPMENT DISORDERS 1981-95; was CHILD DEVELOPMENT DEVIATIONS 1968-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CHLORMADINONE 1964-1995 %28%Prov 1964-65%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CHLORMADINONE 1966-1995 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CRONOLONE 1965-95 %28%see under PREGNENEDIONES 1965-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CYCLOCYTIDINE 1977-95 %28%see under CYTARABINE 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR %28%NM%29% 1989-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DECAY-ACCELERATING FACTOR %28%NM%29% 1985-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DIHYDROMORPHINONE 1963-95; DIHYDROMORPHINONE DERIVATIVES was see under DIHYDROMORPHINONE 1975-77, was see under MORPHINANS 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DIHYDROSTREPTOMYCIN 1963-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DIOCTYL SULFOSUCCINATES 1978-95 %28%see under SUCCINATES 1978-90%29%; DIOCTYL SULFOSUCCINIC ACID was NM 1968-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DIOCTYL SULFOSUCCINATES 1978-95 %28%see under SUCCINATES 1978-90%29%; DIOCTYL SULFOSUCCINIC ACID was indexed under DIOCTYL SULFOSUCCINATES 1978-95; ALCOHOLS, OCTYL 1973-78; ALKYL SULFONATES 1974-76; %26% SUCCINATES 1968-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DURSBAN 1971-95 %28%Prov 1971-74%29%; CHLORPYRIFOS was see DURSBAN 1971-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was DYFONATE 1973-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1973-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ENCEPHALITOGENIC BASIC PROTEINS 1973-95 %28%Prov 1974%29%; MYELIN BASIC PROTEINS was see ENCEPHALITOGENIC BASIC PROTEINS 1979-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ENCEPHALITOGENIC BASIC PROTEINS 1974-95; MYELIN BASIC PROTEINS was see ENCEPHALITOGENIC BASIC PROTEINS 1979-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ENDODEOXYRIBONUCLEASE HPAII %28%NM%29% 1980-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 %28%NM%29% 1989-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was EXTRASYSTOLE 1963-95; PREMATURE BEATS was PREMATURE BEAT 1985-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was FK-506 1992-95, was FK 506 %28%NM%29% 1987-91 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was FK-506 1992-95; FK-506 was indexed under ANTIBIOTICS, MACROLIDE 1989-91 %26% PYRIDINES 1987-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was FOLCH-PI PROTEOLIPID PROTEIN %28%NM%29% 1979-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was FORMAMIDASE 1964-95 %28%see under AMIDOHYDROLASES 1964-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was GALANIN %28%NM%29% 1984-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was GLIOTOXINS 1981-95 %28%see under MYCOTOXINS 1981-90%29%; was GLIOTOXIN see under ANTIBIOTICS 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was GRAMICIDINS 1963-95 %28%see under TYROTHRICIN 1963-73%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HCG-BETA %28%NM%29% 1977-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HEPARANOID 1963-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HEPATITIS C VIRUS ANTIBODIES %28%NM%29% 1992-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HEPATITIS NON-A, NON-B ANTIGEN %28%NM%29% 1984-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HISTAMINE LIBERATION 1963-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HNK-1 ANTIGEN %28%NM%29% 1989-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HYALIN SUBSTANCE 1965-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HYALURONIC ACID BINDING PROTEIN %28%NM%29% 1980-95; CD44 ANTIGENS was see RECEPTORS, LYMPHOCYTE HOMING 1992-93; CD44 ANTIGEN was see RECEPTORS, LYMPHOCYTE HOMING 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was HYDROXYETHYL STARCH 1975-95 %28%see under STARCH 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was INSULIN LIKE GROWTH FACTOR-BINDING PROTEIN-2 %28%NM%29% 1991-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was INTEGRIN BETA1 %28%NM%29% 1991-95, CD29 ANTIGEN %28%NM%29% 1990-95, %26% CDW29 ANTIGEN %28%NM%29% 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ISOPRINOSINE 1976-95 %28%see under INOSINE 1976-90%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was KEPONE 1977-95 %28%see under INSECTICIDES, ORGANOCHLORINE 1977-90%29%; CHLORDECONE was see KEPONE 1977-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was LEUKOCYTE ADHESION MOLECULE, LAM-1 %28%NM%29% 1989-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was LIPOTROPIC FACTORS 1963-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 %28%NM%29% 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was MAST CELL GROWTH FACTOR %28%NM%29% 1990-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was MERBROMINE 1975-95 %28%see under FLUORESCEINS 1975-90%29%; MERCURESCEINE was see MERBROMINE 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was MIDODRIN 1975-95 %28%see under ETHANOLAMINES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR %28%NM%29% 1989-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was MYELIN P2 PROTEINS %28%NM%29% 1980-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NEOVASCULARIZATION 1980-95; ANGIOGENESIS, PATHOLOGIC was ANGIOGENESIS 1980-85; was in Cat G 1980-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NEURON-GLIA ADHESION MOLECULES see CELL ADHESION MOLECULES, NEURONAL 1990-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NKH-1 ANTIGEN %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NON MESH 1967-95; PARASITICIDES was heading 1963-66%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NON MESH 1974-95; POLYNUCLEAR AROMATIC HYDROCARBONS was see POLYCYCLIC HYDROCARBONS 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was NON MESH 1975-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was O ANTIGEN, BACTERIAL %28%NM%29% 1981-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PALLIATIVE TREATMENT 1964-95 %28%Prov 1964-65%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PALLIATIVE TREATMENT 1966-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PHENETHYL ALCOHOL 1975-95 %28%see under ALCOHOL, ETHYL 1975-90%29%; PHENYLETHYL ALCOHOL was see PHENETHYL ALCOHOL 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PHOSPHOTYROSINE %28%NM%29% 1980-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PHOSVEL 1975-95 %28%see under INSECTICIDES, ORGANOTHIOPHOSPHATE 1975-90%29%; LEPTOPHOS was see PHOSVEL 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PLATELET ALPHA-GRANULE MEMBRANE PROTEIN %28%NM%29% 1985-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PLEURAL GLYCOPROTEINS %28%NM%29% 1982-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PROTEIN ZERO, PERIPHERAL NERVE MYELIN %28%NM%29% 1981-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PSEUDOMONAS CEPACIA 1992-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was PSEUDOMONAS PSEUDOMALLEI 1992-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was QUINQUESTRIATUS TOXIN %28%NM%29% 1984-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was RANTES PROTEIN, T-CELL %28%NM%29% 1988-95; RANTES PROTEIN, MURINE was NM 1992-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was REFSUM%27%S DISEASE 1991-95; was REFSUM%27%S SYNDROME 1964-90 %28%Prov 1964-66%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was REFSUM%27%S DISEASE 1991-95; was REFSUM%27%S SYNDROME 1967-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was REVERSE TRANSCRIPTASE 1972-95 %28%Prov 1972%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was REVERSE TRANSCRIPTASE 1973-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was RIBOSOMAL FRAMESHIFT see FRAMESHIFT MUTATION 1991-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was RISPERIDONE %28%NM%29% 1988-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ROCHALIMAEA HENSELAE 1995 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was ROCHALIMAEA QUINTANA 1995 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was SURGICAL NURSING 1968-95; PERIOPERATIVE NURSING was see OPERATING ROOM NURSING 1988-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was SYMBOLISM %28%PSYCHOLOGY%29% 1979-95; was heading 1963-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was TENASCIN %28%NM%29% 1986-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was TEPA 1972-95 %28%see under AZIRINES 1972-90%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was THIACETAZONE 1963-95 %28%Prov 1963-67%29%; THIOACETAZON was see THIACETAZONE 1977-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was THIACETAZONE 1968-95; THIOACETAZON was see THIACETAZONE 1977-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was THYROID ANTAGONISTS 1963-95; GOITROGENS was heading 1963-66; ANTITHYROID DRUGS was see THYROID ANTAGONISTS 1975-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was VASCULAR CELL ADHESION MOLECULE %28%NM%29% %26% INDUCIBLE CELL ADHESION MOLECULE 110 %28%NM%29% 1990-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was VASOCONSTRICTOR AGENTS, NASAL 1967-95; NASAL DECONGESTANTS was see VASOCONSTRICTOR AGENTS, NASAL 1967-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was VITRONECTIN %28%NM%29% 1978-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was VITRONECTIN RECEPTOR %28%NM%29% 1985-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was WHEAT GERM AGGLUTININ-HORSERADISH PEROXIDASE CONJUGATE %28%NM%29% 1986-95%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see AIR POLLUTION, INDOOR 1992-95, was see ENVIRONMENTAL EXPOSURE 1990-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see ETHIOPIA 1975-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see HELIX-LOOP-HELIX MOTIFS 1994-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see INTERCELLULAR JUNCTIONS 1995 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see MICRONESIA 1995; was PAULAU see MICRONESIA 1994%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see PLAY AND PLAYTHINGS 1984-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see SOLAR SYSTEM 1995 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see TRACE ELEMENTS 1994-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see WESTERN SAMOA 1976-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see WESTERN SAMOA 1994-95 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '96; was see under FACIAL EXPRESSION 1963-73 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97%28%75%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97%28%87%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97%28%95%29%; for SIMPLE REPETITIVE SEQUENCE use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97,75-93; was ALEUTIAN MINK DISEASE PARVOVIRUS 1994-96; was see under PARVOVIRIDAE 1986-90, see under VERTEBRATE VIRUSES, UNCLASSIFIED 1975-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97: was BUTHIONINE SULFOXIMINE %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97: was CALORIC INTAKE 1977-96 %28%see under DIET 1977-83%29% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; 1-%28%5-ISOQUINOLINESULFONYL%29%-2-METHYLPIPERAZINE was indexed under ISOQUINOLINES %26% PIPERAZINES 1985-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID was indexed under HYDROXYEICOSATETRAENOIC ACIDS 1985-96, ARACHIDONIC ACIDS 1975-84, HYDROXY ACIDS 1976-80, %26% FATTY ALCOHOLS 1975-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; 2,4-DINITROPHENOL was indexed under DINITROPHENOLS 1980-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; 3-O-METHYLGLUCOSE was indexed under METHYLGLUCOSIDES 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ABT 538 was indexed under THIAZOLES %26% VALINE/analogs %26% derivatives 1996 %26% HIV PROTEASE INHIBITORS 1995%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ACETIC ACID GLACIAL was indexed under ACETIC ACIDS 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ALENDRONATE was indexed under DIPHOSPHONATES 1987-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ANTIGEN KI67 was indexed under NEOPLASM PROTEINS 1994-96, NUCLEAR PROTEINS 1992-96 %26% ANTIGENS, SURFACE 1988-91%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; BCRA1 PROTEIN was indexed under NEOPLASM PROTEINS %26% TRANSCRIPTION FACTORS 1994-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; BETA-CAROTENE was indexed under CAROTENE 1980-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; BETA-NAPHTHOFLAVONE was indexed under BENZOFLAVONES 1981-96, NAPHTHALENES 1973-80, %26% FLAVONES 1973-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; BONE MORPHOGENETIC PROTEIN was indexed under PROTEINS 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; BRAIN-DERIVED NEUROTROPHIC FACTOR was indexed under NERVE TISSUE PROTEINS 1986-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; BUTHIONINE SULFOXIMINE was indexed under METHIONINE SULFOXIMINE 1979-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; C-ANCA was indexed under AUTOANTIBODIES 1991-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CADMIUM CHLORIDE was indexed under CADMIUM %26% CHLORIDES 1980-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CALCIUM CITRATE was SY to CITRIC ACID %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CALCIUM CITRATE was indexed under CITRATES 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CAMPHOR-5-MONOOXYGENASE was indexed under CYTOCHROME P-450 %26% HYDROXYLASES 1973-96, %26% CAMPHOR 1973-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CD31 ANTIGEN was indexed under CELL ADHESION MOLECULES 1995-96, ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1990-96, %26% MEMBRANE GLYCOPROTEINS 1990-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CENSUS was see DEMOGRAPHY 1990-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; CITRIC ACID was indexed under CITRATES 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; COPPER SULFATE was indexed under COPPER 1969-96 %26% SULFATES 1969-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; DEBRISOQUINE 4-HYDROXYLASE was indexed under CYTOCHROME P-450 %26% HYDROXYLASES 1982-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; DEHYDROEPIANDROSTERONE SULFATE was indexed under PRASTERONE/analogs %26% derivatives 1978-96 %26% SULFURIC ACIDS 1978-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; DENTAL ATTRITION was see TOOTH ABRASION 1976-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; DIMETHYLNITROSAMINE N-DEMETHYLASE was indexed under CYTOCHROME P-450 %26% OXIDOREDUCTASES, N-DEMETHYLATING 1975-96, NITROSAMINES 1972-76, %26% OXIDOREDUCTASES 1972-74; 4-NITROPHENOL-2-HYDROXYLASE was indexed under CYTOCHROME P-450 %26% HYDROXYLASES 1984-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; DISINTEGRINS was indexed under PEPTIDES 1992-96 %26% VENOMS 1992-94%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; EBV-ASSOCIATED NUCLEAR ANTIGEN was indexed under ANTIGENS, VIRAL 1979-96 and DNA-BINDING PROTEINS 1993-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ENDOPEPTIDASE K was indexed under SERINE PROTEINASES 1988-96 %26% PEPTIDE PEPTIDOHYDROLASES 1979-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ETHOXYRESORUFIN O-DEETHYLASE was indexed under CYTOCHROME P-450 1982-96, OXIDOREDUCTASES 1980-96, %26% OXAZINES 1979-81%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; FAT SUBSTITUTES was indexed under DIETARY PROTEINS 1994-96 %26% PROTEINS 1990-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; FILGRASTIM was indexed under GRANULOCYTE COLONY-STIMULATING FACTOR 1994-96, RECOMBINANT PROTEINS 1992-96, %26% COLONY-STIMULATING FACTORS 1992-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; FRUCTOSAMINE was indexed under HEXOSAMINES 1983-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; GLUCOSE-6-PHOSPHATE was indexed under GLUCOSEPHOSPHATES 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; GLYCOCALYX was indexed under GLYCOPROTEINS %26% POLYSACCHARIDES 1976-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; GUERNSEY ISLAND was see CHANNEL ISLANDS 1975-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS was indexed under HEMAGGLUTININS, VIRAL 1983-96 %26% GLYCOPROTEINS 1980-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; HIV ENVELOPE PROTEIN GP160 was indexed under GENE PRODUCTS, ENV %26% PROTEIN PRECURSORS 1990-96 and RETROVIRIDAE PROTEINS %26% VIRAL ENVELOPE PROTEINS 1988-89%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; HIV INTEGRASE was SY to INTEGRASE %28%NM%29% 1993-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; HIV INTEGRASE was indexed under DNA NUCLEOTIDYLTRANSFERASES 1993-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; HIV-1 REVERSE TRANSCRIPTASE was indexed under RNA-DIRECTED DNA POLYMERASE 1992-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; HYPOXANTHINE was indexed under HYPOXANTHINES 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; IDAZOXAN was indexed under DIOXANES %26% IMIDAZOLES 1982-96 and DIOXINS 1982-84%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; INDINAVIR was indexed under PYRIDINES 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; INTERLEUKIN 15 was indexed under INTERLEUKINS 1994-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; INTERLEUKIN-14 was indexed under INTERLEUKINS 1995-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; LACTIC ACID was indexed under LACTATES 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; LAMIVUDINE was indexed under ZALCITABINE/analogs %26% derivatives 1993-96 and CYTOSINE/analogs %26% derivatives 1991-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; LEUKOCYTE ELASTASE was indexed under PANCREATOPEPTIDASE 1988-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; LYMPHOCYTE CHEMOATTRACTANT FACTOR was indexed under LYMPHOKINES 1987-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; LYMPHOCYTOMA was see LYMPHOMA, SMALL LYMPHOCYTIC 1991-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; MACROPHAGE INFLAMMATORY PROTEIN 1 was indexed under MONOKINES %26% CYTOKINES 1991-96 and PROTEINS 1990%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; N%28%G%29%-NITROARGININE METHYL ESTER was indexed under ARGININE/analogs %26% derivatives 1990-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; N-ACETYLNEURAMINIC ACID was indexed under SIALIC ACIDS 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; NITROARGININE was indexed under ARGININE/analogs %26% derivatives 1990-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; NON-HEME IRON PROTEINS was indexed under METALLOPROTEINS 1983-96 %26% IRON 1978-82%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; OCCLUSAL EQUILIBRATION was see DENTAL OCCLUSION, BALANCED 1975-96; was see under DENTAL OCCLUSION, BALANCED 1969-74%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; OKADAIC ACID was indexed under ETHERS, CYCLIC 1982-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; OLEIC ACID was indexed under OLEIC ACIDS 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; OMEGA-N-METHYLARGININE was indexed under ARGININE/analogs %26% derivatives 1979-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PALMITIC ACID was indexed under PALMITIC ACIDS 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PARATHYROID HORMONE PEPTIDE %28%1-34%29% was indexed under PARATHYROID HORMONES %26% PEPTIDE FRAGMENTS 1978-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PENTOXYRESORUFIN O-DEALKYLASE was indexed under CYTOCHROME P-450 %26% OXIDOREDUCTASES 1985-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PHENACETIN O-DEALKYLASE was indexed under OXIDOREDUCTASES 1980-96, CYTOCHROME P-450 1976-96, %26% PHENACETIN 1976-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE was indexed under PHOSPHATIDYLINOSITOL PHOSPHATES 1994-96 %26% PHOSPHOINOSITIDES 1981-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; POTASSIUM ACETATE was SY to ACETIC ACID GLACIAL %28%NM%29% 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; POTASSIUM ACETATE was indexed under ACETIC ACIDS 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; POTASSIUM CITRATE was SY to CITRIC ACID %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; POTASSIUM CITRATE was indexed under CITRATES 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PROTO-ONCOGENE PROTEIN BCL-2 was indexed under PROTO-ONCOGENE PROTEINS 1989-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; PYRUVIC ACID was indexed under PYRUVATES 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; QUINPIROLE was indexed under ERGOLINES 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; S ANTIGEN, RETINAL was indexed under ANTIGENS %26% EYE PROTEINS 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; SAQUINAVIR was indexed under ISOQUINOLINES %26% QUINOLINES 1993-96 and HIV PROTEASE/antagonists %26% inhibitors 1990-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; SATELLITE RNA was indexed under RNA 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; SODIUM ACETATE was SY to ACETIC ACID GLACIAL %28%NM%29% 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; SODIUM ACETATE was indexed under ACETIC ACIDS 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; SODIUM LACTATE was SY to LACTIC ACID %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; STAUROSPORINE was indexed under ALKALOIDS 1977-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; STEDIRIL was indexed under NORGESTREL %26% ETHINYL ESTRADIOL 1972-96, CONTRACEPTIVES, ORAL, COMBINED 1976-82, %26% CONTRACEPTIVES, ORAL 1972-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; STROMELYSIN 1 was indexed under METALLOPROTEINASES 1988-96 %26% PEPTIDE PEPTIDOHYDROLASES 1985-87%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; THAPSIGARGIN was indexed under TERPENES 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; TISSUE POLYPEPTIDE ANTIGEN was indexed under PEPTIDES 1978-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; TROPONIN C was indexed under TROPONIN 1980-96 %26% MUSCLE PROTEINS 1975-79%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; TROPONIN I was indexed under TROPONIN 1979-96 %26% MUSCLE PROTEINS 1975-78%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; VARICELLA VACCINE was indexed under VIRAL VACCINES 1985-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; VIRAL N PROTEIN was indexed under VIRAL CORE PROTEINS 1986-96, CAPSID 1983-96, and VIRAL PROTEINS 1983-85%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ZINC ACETATE was SY to ACETIC ACID GLACIAL %28%NM%29% 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ZINC ACETATE was indexed under ACETIC ACIDS 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; ZINC SULFATE was indexed under ZINC COMPOUNDS 1994-96, SULFATES 1979-96, %26% ZINC 1979-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; see LYMPHOMA, NON-HODGKIN%27%S 1987-97 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; see PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE %28%NM%29% 1981-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; see REOVIRUS TYPE 3 1991-96, see REOVIRIDAE 1981-90, see REOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; see VARIABLE NUMBER OF TANDEM REPEATS 1995-96; for SIMPLE REPETITIVE SEQUENCE see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was 1-%28%5-ISOQUINOLINESULFONYL%29%-2-METHYLPIPERAZINE %28%NM%29% 1985-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was 12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID %28%NM%29% 1975-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was 2,4-DINITROPHENOL %28%NM%29% 1980-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was 3,4-DIHYDROXYPHENYLSERINE 1975-96 %28%see under SERINE 1975-90%29%; DOPS was see DIHYDROXYPHENYLSERINE 1975-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was 3-O-METHYLGLUCOSE %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ABT 538 %28%NM%29% 1995-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ACETIC ACID GLACIAL %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ADOPTIVE CELL TRANSFER see IMMUNOTHERAPY, ADOPTIVE 1991-96, was see IMMUNIZATION, PASSIVE 1983-90%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ALENDRONATE %28%NM%29% 1987-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ANTIGEN KI67 %28%NM%29% 1988-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ASTROVIRUSES 1979-96 %28%see under VERTEBRATE VIRUSES, UNCLASSIFIED 1979-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was BETA-CAROTENE %28%NM%29% 1980-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was BETA-NAPHTHOFLAVONE %28%NM%29% 1973-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was BONE MORPHOGENETIC PROTEIN %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was BRAIN-DERIVED NEUROTROPHIC FACTOR 1986-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was BRCA1 PROTEIN %28%NM%29% 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was C-ANCA %28%NM%29% 1991-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was CADMIUM CHLORIDE %28%NM%29% 1980-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was CAMPHOR-5-MONOOXYGENASE %28%NM%29% 1973-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was CARBOXYPEPTIDASE TRANSPEPTIDASE 1975-96 %28%see under CARBOXYPEPTIDASES 1975-86%29%; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE was see CARBOXYPEPTIDASE TRANSPEPTIDASE 1979-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was CD31 ANTIGEN %28%NM%29% 1990-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was CHONDROITINSULFATASE 1976-96 %28%see under CHONDROITINASES 1976-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was CITRIC ACID %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was COPPER SULFATE %28%NM%29% 1969-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DEBRISOQUINE 4-HYDROXYLASE %28%NM%29% 1982-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DEHYDROEPIANDROSTERONE SULFATE %28%NM%29% 1978-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DENTAL PULP GANGRENE 1965-96; DENTAL PULP AUTOLYSIS was heading 1965-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DEOXYCYTIDYLATE DEAMINASE 1976-96 %28%see under NUCLEOTIDE DEAMINASES 1976-90%29%; DCMP DEAMINASE was see DEOXYCYTIDYLATE DEAMINASE 1976-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DIMETHYLALLYLTRANSFERASE 1979-96 %28%see under TRANSFERASES 1979-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DIMETHYLNITROSAMIME N-DEMETHYLASE %28%NM%29% 1972-96 %26% was 4-NITROPHENOL-2-HYDROXYLASE %28%NM%29% 1984-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DISINTEGRINS %28%NM%29% 1992-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was DNA PHOTOLYASE 1975-96 %28%see under LYASES 1975-90%29%; DEOXYRIBODIPYRIMIDINE PHOTOLYASE was see DNA PHOTOLYASE 1975-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was EBV-ASSOCIATED NUCLEAR ANTIGEN %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ENDO-1,3-BETA-GLUCANASE 1975-96 %28%see under GLYCOSIDE HYDROLASES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ENDOPEPTIDASE K %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ENOYL COA HYDRATASES 1978-96 %28%see under HYDRO-LYASES 1978-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ETHOXYRESORUFIN O-DEETHYLASE %28%NM%29% 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FAT SUBSTITUTES %28%NM%29% 1990-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FELINE INFECTIOUS ENTERITIS 1970-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FENESTRATION 1963-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FENESTRATION 1966-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FIBROMATOSIS GINGIVAE 1965-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FILGRASTIM %28%NM%29% 1992-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was FRUCTOSAMINE %28%NM%29% 1983-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was GENES, REITERATED 1987-96; MULTIGENE FAMILY was see GENES, REITERATED 1987-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was GLUCOSE-6-PHOSPHATE %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was GLYCOCALYX %28%NM%29% 1976-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS %28%NM%29% 1980-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was HEPATITIS VIRUS, WOODCHUCK 1994-96; HEPATITIS B VIRUS, WOODCHUCK was see HEPATITIS VIRUS, WOODCHUCK 1994-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was HIV ENVELOPE PROTEIN GP160 %28%NM%29% 1988-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was HIV-1 REVERSE TRANSCRIPTASE %28%NM%29% 1992-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was HYPOXANTHINE %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was IDAZOXAN %28%NM%29% 1982-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was IMMUNODEFICIENCY VIRUSES, PRIMATE 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was INDINAVIR %28%NM%29% 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was INSULINASE 1963-96 %28%see under PEPTIDE HYDROLASES 1975-90, see under ENDOPEPTIDASES 1963-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was INSULINASE 1963-96 %28%see under PEPTIDE HYDROLASES 1975-90, see under PEPTIDE PEPTIDOHYDROLASES 1963-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was INTERLEUKIN 15 %28%NM%29% 1994-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was INTERLEUKIN-14 %28%NM%29% 1995-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was LACTIC ACID %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was LAMIVUDINE %28%NM%29% 1991-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was LEUKOCYTE ELASTASE %28%NM%29% 1988-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was LYMPHOCYTE CHEMOATTRACTANT FACTOR %28%NM%29% 1987-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MACROPHAGE INFLAMMATORY PROTEIN 1 %28%NM%29% 1990-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MEDICAL DIRECTORS 1978-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MELENGESTROL 1973-96 %28%see under PREGNADIENES 1973-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS %28%NM%29% 1983-92%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MEMBRANE METALLO-ENDOPEPTIDASE 1989-96; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGENS was indexed under ANTIGENS, NEOPLASM %26% ANTIGENS, DIFFERENTIATION 1983-92; for CALLA ANTIGEN see CALLA 1993-2002%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MINUTE VIRUS OF MICE 1975-96 %28%see under PARVOVIRIDAE 1981-90, see under PARVOVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MONKEYPOXVIRUS 1994-96; was MONKEY POX VIRUS 1975-93 %28%see under POXVIRIDAE 1981-90, see under POXVIRUSES 1975-80%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was MOTTLED ENAMEL 1965-96; FLUOROSIS, DENTAL was see MOTTLED ENAMEL 1987-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was N%28%G%29%-NITROARGININE METHYL ESTER %28%NM%29% 1990-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was N-ACETYLNEURAMINIC ACID %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was NITROARGININE %28%NM%29% 1990-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was NON MESH 1987-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was NON-HEME IRON PROTEINS %28%NM%29% 1978-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was NUCLEAR POLYHEDROSIS VIRUS 1994-96, was NUCLEAR POLYHEDROSIS VIRUSES see BACULOVIRIDAE 1991-93, was see POLYHEDROSIS VIRUSES 1975-90; POLYHEDROSIS VIRUSES was heading 1978-90, was see under INSECT VIRUSES 1973-77 %28%Prov 1973-74%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was NUCLEAR POLYHEDROSIS VIRUS 1994-96, was NUCLEAR POLYHEDROSIS VIRUSES see BACULOVIRIDAE 1991-93, was see POLYHEDROSIS VIRUSES 1975-90; POLYHEDROSIS VIRUSES was heading 1978-90, was see under INSECT VIRUSES 1973-77%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was OKADAIC ACID %28%NM%29% 1982-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was OLEIC ACID %28%NM%29% 1981-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was OMEGA-N-METHYLARGININE 1979-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ORTHOMYXOVIRUSES TYPE B 1985-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was ORTHOMYXOVIRUSES TYPE C 1986-96 %28%see under ORTHOMYXOVIRIDAE 1986-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PALMITIC ACID %28%NM%29% 1981-96; HEXADECANOIC ACID was see PALMITIC ACIDS 1975-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PAPILLOMAVIRUS SYLVILAGI 1994-96; was SHOPE PAPILLOMA VIRUS 1975-93 %28%see under PAPILLOMAVIRUSES 1978-90, see under PAPILLOMA VIRUSES 1975-77%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PARAINFLUENZA VIRUS TYPE 1 1994-96, was PARA-INFLUENZA VIRUS TYPE 1 1977-93, was SENDAI VIRUS 1964-76%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PARAINFLUENZA VIRUS TYPE 2 1994-96, was PARA-INFLUENZA VIRUS TYPE 2 1977-93 %28%see under PARA-INFLUENZA VIRUSES 1977-90%29%; was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see under PARA-INFLUENZA VIRUSES 1975-76; ACUTE LARYNGOTRACHEOBRONCHITIS VIRUS was ACUTE LARYNGOTRACHEO-BRONCHITIS VIRUS see PARAINFLUENZA VIRUS TYPE 2 1977-93%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PARAINFLUENZA VIRUS TYPE 3 1994-96, was PARA-INFLUENZA VIRUS TYPE 3 1975-93 %28%see under PARA-INFLUENZA VIRUSES 1975-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PARATHYROID HORMONE PEPTIDE %28%1-34%29% %28%NM%29% 1978-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PENTOXYRESORUFIN O-DEALKYLASE %28%NM%29% 1985-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PERIODONTOSIS 1984-96 %28%see under PERIODONTAL DISEASES 1984-90%29%, was see PERIODONTAL DISEASES 1966-83; PERIODONTITIS, JUVENILE was see PERIODONTOSIS 1984-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PHENACETIN O-DEALKYLASE %28%NM%29% 1976-96 ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PILONIDAL CYST 1963-96; PILONIDAL SINUS was see PILONIDAL CYST 1978-96%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PROCOLLAGEN PEPTIDASE 1977-96 %28%see under ENDOPEPTIDASES 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PROCOLLAGEN PEPTIDASE 1977-96 %28%see under PEPTIDE PEPTIDOHYDROLASES 1977-90%29%%A% ' = 0).
% 42.08/41.94 fof(interp, fi_functors, '97; was PROPYLAMINE TRANSFERASE 1975-96 %28%see under TRANSFERASES 1975-90%29%; SPERMIDINE SYNTHASE was see PROPYLAMINE TRANSFERASE 1975-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was PROTO-ONCOGENE PROTEIN BCL-2 %28%NM%29% 1989-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was PYRUVIC ACID %28%NM%29% 1981-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was QUINPIROLE %28%NM%29% 1981-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was REPETITION STRAIN INJURY 1988-96; CUMULATIVE TRAUMA DISORDERS was see REPETITION STRAIN INJURY 1996%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was RESPIRATORY AIRFLOW 1971-96 %28%Prov 1971%29%; VENTILATION TESTS was see RESPIRATORY FUNCTION TESTS 1990-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was RESPIRATORY AIRFLOW 1972-96; VENTILATION TESTS was see RESPIRATORY FUNCTION TESTS 1990-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was S ANTIGEN, RETINAL %28%NM%29% 1981-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was SAQUINAVIR %28%NM%29% 1990-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was SATELLLITE RNA %28%NM%29% 1981-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was STAUROSPORINE %28%NM%29% 1977-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was STEDIRIL %28%NM%29% 1972-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was STEREOISOMERS 1974-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was STEREOISOMERS 1974-96 %28%Prov 1968-73%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was STROMELYSIN 1 %28%NM%29% 1985-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TEMPOROMANDIBULAR JOINT DISEASES 1982-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TEMPOROMANDIBULAR JOINT SYNDROME 1973-96, was COSTEN%27%S SYNDROME 1966-72; COSTEN%27%S SYNDROME was see TEMPOROMANDIBULAR JOINT SYNDROME 1973-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was THAPSIGARGIN %28%NM%29% 1979-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TISSUE POLYPEPTIDE ANTIGEN %28%NM%29% 1978-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TOOTH LUXATION 1970-96; TOOTH AVULSION was see TOOTH LUXATION 1984-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TOOTH MOVEMENT, MINOR 1973-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TROPONIN C %28%NM%29% 1975-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was TROPONIN I %28%NM%29% 1975-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was VARICELLA VACCINE %28%NM%29% 1985-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was VIRAL N PROTEIN %28%NM%29% 1983-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was ZINC SULFATE %28%NM%29% 1979-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was see DENTISTRY 1980-96; STOMATOLOGY was see DENTISTRY 1989-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was see DEPRESSIVE DISORDER 1981-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was see ENDOTHELINS 1991-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was see HEMOSIDEROSIS 1996 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was see TOOTH ROOT 1975-96; was see under TOOTH ROOT 1969-74%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '97; was see WOMEN%27%S RIGHTS 1994-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%63%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%63%29% for NON PSYCHOTIC BRAIN SYNDROME use MENTAL DISORDERS 1969-74%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%64%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%65%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%65%29%; see GLUCOSEPHOSPHATE ISOMERASE 1965-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%66%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%67%29%; for SERINE DEAMINASE use HYDRO-LYASES 1963-71 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%68%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%68%29%; for DNA POLYMERASE use DNA NUCLEOTIDYLTRANSFERASES 1968-76%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%71%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%72%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%72%29%; use NUCLEOTIDYLTRANSFERASES 1968-72, use NUCLEOTIDYL TRANSFERASES 1963-67%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%73%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%73%29%; see PEPTIDE SYNTHETASES 1973-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%74%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%75%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%75%29%; for UDPGALACTOSE 4-EPIMERASE use GALACTOSE EPIMERASE %28%NM%29% 1977-98; for UDP-GALACTOSE 4-EPIPMERASE use GALACTOSE EPIMERASE %28%NM%29% 1977-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%75%29%; see ACETYL-COA ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%75%29%; see ISOLEUCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%75%29%; see NUCLEOTIDYLTRANSFERASES 1975-90 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%75%29%; was 5-ANDROSTANE-3,17-DIOL 1975-97; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%76%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%77%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%77%29%; for DNA LIGASES use POLYNUCLEOTIDE SYNTHETASES 1973-76%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%78%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%79%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%80%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%80%29%; see ARYLAMINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1980-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%81%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%81%29%; ARCHAEA was see ARCHAEOBACTERIA 1995-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%86%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%86%29%; see METHYLTRANSFERASES 1975-85, see THYMIDYLATE SYNTHETASE 1985-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%87%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%88%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%88%29%; was DIAGNOSIS, RADIOISOTOPE %28%NON MESH%29% 1974-87 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%89%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%89%29%; see CHLORAMPHENICOL ACETYLTRANSFERASE 1989-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%91%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%94%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%96%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98%28%97%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98, 65-77 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98, 65-77; use explode 1978-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98, 66-91; see ANIMAL VIRUSES 1963-65 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98, 66-91; use ANIMAL VIRUSES 1963-65; use pre-explosion ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98, 72-77 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 1,2-DIMETHYLHYDRAZINE was indexed under DIMETHYLHYDRAZINES 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 1-OCTANOL was indexed under ALCOHOLS, OCTYL 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 1-PHOSPHATIDYLINOSITOL 3-KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97 %26% PHOSPHOTRANSFERASES, ATP 1988-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 1-PHOSPHATIDYLINOSITOL 4-KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97, PHOSPHATIDYLINOSITOLS 1980-82, PHOSPHOTRANSFERASES, ATP 1974-93, %26% PHOSPHOINOSITIDES 1974-75%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 2,3-DIPHOSPHOGLYCERATE was indexed under DIPHOSPHOGLYCERIC ACIDS 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 3-IODOBENZYLGUANIDINE was indexed under IODOBENZENES 1983-97 %26% GUANIDINES 1980-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; 65-77, use explode 1978-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; ADENOSINE-5%27%-%28%N-ETHYLCARBOXAMIDE%29% was indexed under ADENOSINE/analogs %26% derivatives 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; ALPHA-METHYLTYROSINE was indexed under METHYLTYROSINES 1979-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; AMPHOCIL %28%now AMPHOTERICIN B%29% was indexed under AMPHOTERICIN B/*analogs %26% derivatives %26% CHOLESTEROL ESTERS 1992-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; B CELL-ACTIVATING FACTOR RECEPTOR %28%now RECEPTORS, INTERLEUKIN-4%29% was indexed under RECEPTORS, INTERLEUKIN 1994-97, ANTIGENS, CD 1990-97, %26% RECEPTORS, MITOGEN 1986-94%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; BENZYL ALCOHOL was indexed under BENZYL ALCOHOLS 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; BRL 25000 %28%now AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION%29% was indexed under ANTIBIOTICS, COMBINED 1989-97 AMOXICILLIN %26% CLAVULANIC ACIDS 1981-97, DRUG COMBINATIONS 1981-88, %26% LACTAMS 1981-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; BUDESONIDE was indexed under PREGNENEDIONES 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; CALCINEURIN was indexed under PHOSPHOPROTEIN PHOSPHATASE 1988-97 %26% CALMODULIN-BINDING PROTEINS 1986-97; CALCINEURIN B %28%now CALCINEURIN%29% was indexed under CALCIUM-BINDING PROTEINS 1994-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; CALCIUM-RYANODINE RECEPTOR COMPLEX %28%now RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL%29% was indexed under CALCIUM CHANNELS 1988-97, MUSCLE PROTEINS 1993-97, %26% RECEPTORS, CHOLINERGIC 1985-92%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; CC CHEMOKINE RECEPTOR 5 %28%now RECEPTORS, CCR5%29% was indexed under RECEPTORS, HIV 1997 %26% RECEPTORS, CYTOKINE 1996-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; CHOLINE-PHOSPHATE CYTIDYLTRANSFERASE was indexed under CYTOSINE NUCLEOTIDES %26% CHOLINE 1975-77, CYTIDINE DIPHOSPHATE CHOLINE 1977-81 %26% NUCLEOTIDYLTRANSFERASES 1975-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; CLAVULANIC ACID was indexed under CLAVULANIC ACIDS 1978-97 %26% LACTAMS 1976-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; COLLAGENASE INHIBITOR %28%now TISSUE INHIBITOR OF METALLOPROTEINASES%29% was indexed under GLYCOPROTEINS 1989-97 %26% ENZYME INHIBITORS 1980-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; COLLAGENASE INHIBITOR %28%now TISSUE-INHIBITOR OF METALLOPROTEINASE-1%29% was indexed under GLYCOPROTEINS 1990-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; CROMAKALIM was indexed under BENZOPYRANS %26% PYRROLES 1986-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; DELAVIRDINE was indexed under PIPERAZINES %26% INDOLES 1993-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; DIACYLGLYCEROL KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97, PHOSPHOTRANSFERASES, ATP 1975-93, DIGLYCERIDES 1975-80, and GLYCERIDES %26% PHOSPHOTRANSFERASES 1973-74%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; DIETARY SUPPLEMENTATION was see FOOD, FORTIFIED 1995-97; FOOD, SUPPLEMENTED was see FOOD, FORTIFIED 1975-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; DNA PRIMASE was indexed under RNA NUCLEOTIDYLTRANSFERASES 1978-97 %26% DNA 1978-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; EIF-2 KINASE was indexed under PROTEIN-SERINE-THREONINE KINASES 1993-97 %26% PROTEIN KINASES 1980-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; ETHANOLAMINE was indexed under ETHANOLAMINES 1973-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; ETHYLENE GLYCOL was indexed under ETHYLENE GLYCOLS 1982-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; FMRFAMIDE was indexed under NEUROPEPTIDES 1987-97, NERVE TISSUE PROTEINS 1986-87, %26% OLIGOPEPTIDES 1978-86%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; FUSIN %28%now RECEPTORS, CXCR4%29% was indexed under RECEPTORS, HIV 1997 %26% MEMBRANE PROTEINS 1996-97; LESTR RECEPTOR %28%now RECEPTORS, CXCR4%29% was indexed under RECEPTORS, IMMUNOLOGIC 1994-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; GADOLINIUM DTPA was indexed under DTPA/analogs %26% derivatives 1994-97, ORGANOMETALLIC COMPOUNDS 1987-97, and DTPA 1987-93; GADOPENTETATE DIMEGLUMINE %28%now GADOLINIUM DTPA%29% was indexed under DTPA/analogs %26% derivatives 1994-97, ORGANOMETALLIC COMPOUNDS 1987-97, MEGLUMINE 1987-97, DRUG COMBINATIONS 1987-97, %26% DTPA 1987-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; GASTRIN RELEASING PEPTIDE was indexed under PEPTIDES 1978-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; GENISTEIN was indexed under ISOFLAVONES 1976-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; GLUTATHIONE DISULFATE was indexed under GLUTATHIONE/analogs %26% derivatives %28%80-97%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; GLYCYRRHIZIC ACID was indexed under GLYCYRRHETINIC ACID 1979-97, GLYCYRRHIZA 1976-79, GLUCOSIDURONATES 1976-79, %26% ENOXOLONE 1977-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; GUANIDINE was indexed under GUANIDINES 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; HALOBACTERIUM MARISMORTUI was see HALOBACTERIUM 1992-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; HEPARAN SULFATE PROTEOGLYCAN was indexed under PROTEOGLYCANS 1982-97, HEPARITIN SULFATE 1982-97, %26% PROTEOCHONDROITIN SULFATES 1982-92%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; HEPARIN LYASE was indexed under POLYSACCHARIDE-LYASES 1975-97, HEPARIN 1973-82 %26% LYASES 1973-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; HYDROXYLAMINE was indexed under HYDROXYLAMINES 1976-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; IMPLANTS, ARTIFICIAL was heading 1981-97; PROSTHESIS was heading 1963-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; INTERLEUKIN 6 RECEPTOR %28%now RECEPTORS, INTERLEUKIN-6%29% was indexed under RECEPTORS, INTERLEUKIN 1994-97, ANTIGENS, CD 1989-97, %26% RECEPTORS, IMMUNOLOGIC 1988-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; KANAMYCIN KINASE was indexed under PHOSPHOTRANSFERASES %28%ALCOHOL GROUP ACCEPTOR%29% 1994-97, PHOSPHOTRANSFERASES, ATP 1976-93 %26% KANAMYCIN 1976-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; LINOLEIC ACID was indexed under LINOLEIC ACIDS 1981-97 %26% FATTY ACIDS, UNSATURATED 1981-83%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; LOSARTAN was indexed under IMIDAZOLES 1990-97, TETRAZOLES 1990-97, %26% BIPHENYL COMPOUNDS 1990-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56%28%LCK%29% was indexed under SRC-FAMILY KINASES 1996-97 %26% PROTEIN-TYROSINE KINASE 1988-95%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; MESALAMINE was indexed under AMINOSALICYLIC ACIDS 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; METHYLMETHACRYLATE %28%now POLYMETHYL METHACRYLATE%29% was indexed under METHYLMETHACRYLATES 1974-97 and POLYMERS 1974-80; for POLYMETHYLMETHACRYLATE see METHYLMETHACRYLATES 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; MYRISTIC ACID was indexed under MYRISTIC ACIDS 1982-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; N-BUTYL ALCOHOL %28%now 1-BUTANOL%29% was indexed under ALCOHOLS, BUTYL 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; N-HEPTANOL was indexed under ALCOHOLS 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; N-METHYLSCOPOLAMINE was indexed under SCOPOLAMINE DERIVATIVES 1972-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; NELFINAVIR MESYLATE %28%now NELFINAVIR%29% was indexed under ISOQUINOLINES 1997; AG 1343 %28%now NELFINAVIR%29% was indexed under ISOQUINOLINES %26% SULFONIC ACIDS 1995-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; NEOPTERIN was indexed under BIOPTERIN/analogs %26% derivatives 1977-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; NERVE GROWTH CONE MEMBRANE PROTEIN GAP-43 %28%now GAP-43 PROTEIN%29% was indexed under NERVE TISSUE PROTEINS 1986-97, MEMBRANE GLYCOPROTEINS 1988-97, CALMODULIN-BINDING PROTEINS 1986-92, %26% MEMBRANE PROTEINS 1986-89.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; O%28%6%29%-METHYLGUANINE-DNA METHYLTRANSFERASE was indexed under METHYLTRANSFERASES 1978-97 %26% DNA %28%CYTOSINE-5-%29%-METHYLTRANSFERASE 1978-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; ORGAN TRANSPLANTS was see ORGAN TRANSPLANTATION 1991-97, was see TRANSPLANTATION 1990%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PEANUT AGGLUTININ was indexed under LECTINS 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PEPTIDE YY was indexed under PEPTIDES 1982-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PEPTIDYLPROLYL ISOMERASE was indexed under CARRIER PROTEINS %26% AMINO ACID ISOMERASES 1984-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PHENOL was indexed under PHENOLS 1969-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PRAD1 PROTEIN %28%now CYCLIN D1%29% was indexed under CYCLINS %26% ONCOGENE PROTEINS 1991-97; PROTO-ONCOGENE PROTEIN BCL-1 %28%now CYCLIN D1%29% was indexed under PROTO-ONCOGENE PROTEINS 1990-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PROPYLENE GLYCOL was indexed under PROPANEDIOLS 1972-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; PROTEIN DISULFIDE-ISOMERASE was indexed under ISOMERASES 1977-97, DISULFIDES 1974-82, %26% PROTEINS 1974-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; RILUZOLE was indexed under THIAZOLES 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; SIMVASTATIN was indexed under LOVASTATIN/analogs %26% derivatives 1988-97 %26% NAPHTHALENES 1986-87%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; SODIUM AZIDE was indexed under AZIDES 1977-97 %26% NITROGEN 1975-76%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; SODIUM-CALCIUM CARRIER %28%now SODIUM-CALCIUM EXCHANGER%29% was indexed under CARRIER PROTEINS 1980-97; CALCIUM-SODIUM ANTIPORTER was indexed under ANTIPORTERS 1993-97, CARRIER PROTEINS %26% MEMBRANE PROTEINS 1980-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; STREPTAVIDIN was indexed under BACTERIAL PROTEINS 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; SUCCINIC ACID was indexed under SUCCINATES 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TAQ POLYMERASE was indexed under DNA POLYMERASES 1989-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TECHNETIUM TC 99M DIETHYL IDA %28%now TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID%29% was indexed under IMINO ACIDS 1977-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, ORGANOMETALLIC COMPOUNDS 1977-89, LIDOCAINE/analogs %26% derivatives 1979-80, %26% ACETANILIDES 1977-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID was indexed under SUCCIMER 1980-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, SULFHYDRYL COMPOUNDS 1977-89, ORGANOMETALLIC COMOUNDS 1977-89, %26% SUCCINATES 1977-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TECHNETIUM TC 99M DISOFENIN was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-97, IMINO ACIDS 1980-97, %26% ORGANOMETALLIC COMPOUNDS 1980-89%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TECHNETIUM TC 99M EXAMETAZINE was indexed under ORGANOTECHNETIUM COMPOUNDS 1990-97, OXIMES 1985-97, %26% ORGANOMETALLIC COMPOUNDS 1985-89%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TECHNETIUM TC 99M LIDOFENIN was indexed under IMINO ACIDS 1977-97, ORGANOTECHNETIUM COMPOUNDS 1990-97, ORGANOMETALLIC COMPOUNDS 1977-89, ACETANILIDE/analogs %26% derivatives 1978-89, %26% LIDOCAINE/analogs %26% derivatives 1978-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TERT-BUTYL ALCOHOL was indexed under ALCOHOLS, BUTYL 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TETRAETHYLAMMONIUM was indexed under TETRAETHYLAMMONIUM COMPOUNDS 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; THROMBOSPONDIN 1 was indexed under MEMBRANE GLYCOPROTEINS 1993-97%26% PLATELET MEMBRANE GLYCOPROTEINS 1991-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; THROMBOSPONDIN was indexed under MEMBRANE GLYCOPROTEINS 1989-97, PLATELET MEMBRANE GLYCOPROTEINS 1992-93, %26% GLYCOPROTEINS 1981-89%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; TOPOTECAN was indexed under CAMPTOTHECIN/analogs %26% derivatives 1991-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; XANTHINE was indexed under XANTHINES 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; for 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE use 1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE %28%NM%29% 1982-97, see ACYLTRANSFERASES 1976-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; for AMPHOCIL use AMPHOTERICIN B %28%NM%29% 1992-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; for FAMILY RELATIONSHIP see FAMILY 1978-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; for HEAD BANGING %26% BODY ROCKING see STEREOTYPED BEHAVIOR 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; for HEAD BANGING %26% BODY ROCKING use STEREOTYPED BEHAVIOR 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see 3-OXOACYL %28%ACYL CARRIER PROTEIN%29% SYNTHASE 1991-97; see ACYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ACETYLSEROTONIN METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ACYLNEURAMINATE CYTIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ADENYL CYCLASE 1972-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ADENYLOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1979-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AFFECTIVE DISORDERS 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AFRICAN HORSESICKNESS VIRUS 1991-97, see REOVIRIDAE 1981-90, see REOVIRUSES 1975-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AFRICAN HORSESICKNESS 1970-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALANINE AMINOTRANSFERASE 1966-97; for GLUTAMIC-PYRUVIC TRANSMINASE see ALANINE 1963%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALANYL T RNA SYNTHETASE 1991-97; see AMINOACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOL, ETHYL 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOL, METHYL 1966-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOL, PROPYL 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOLS, AMYL 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOLS, BUTYL 1972-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOLS, HEXYL 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALCOHOLS, OCTYL 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ALTEPLASE 1992-97; see PLASMINOGEN ACTIVATOR, TISSUE-TYPE 1986-91%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AMBULATORY SURGERY 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AMINOBUTYRATE AMINOTRANSFERASE 1984-97, see AMINOTRANSFERASES 1975-83%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AMINOLEVULINIC ACID DEHYDRATASE 1978-97, see HYDRO-LYASES 1973-77%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AMINOLEVULINIC ACID SYNTHETASE 1972-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AMINOTRANSFERASES 1963-97; for TRANSAMINASES see AMINOTRANSFERASES 1974-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ARCHAEOBACTERIA 1992-97, see ARCHAEBACTERIA 1991, see BACTERIA 1981-90; ARCHAEA was see ARCHAEOBACTERIA 1995-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ARGININOSUCCINATE SYNTHETASE 1991-97; see LIGASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ARGINYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see AROMATIC AMINO ACID DECARBOXYLASES 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ASPARTYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ATP CITRATE LYASE 1977-97; see KETOACID-LYASES 1973-76%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see BILIARY TRACT SURGERY 1988-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see BURKITT%27%S LYMPHOMA 1968-97; for BURKITT TUMOR see BURKITT%27%S TUMOR 1968-97; for LYMPHOMA, BURKITT see LYMPHOMA, BURKITT%27%S 1968-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see BUTANEDIOLS 1975-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CALCINEURIN %28%NM%29% 1987-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CARBAMYL PHOSPHATE SYNTHASE %28%AMMONIA%29% 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CARBAMYL PHOSPHATE SYNTHASE %28%GLUTAMINE%29% 1989-97; see LIGASES 1981-88; see PHOSPHOTRANSFERASES, ATP 1975-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CARNITINE ACETYLTRANSFERASE 1991-97; see ACETYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CARNITINE PALMITOYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CATECHOL METHYLTRANSFERASE 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CDP DIACYLGLYCEROL-SERINE O-PHOSPHATIDYLTRANSFERASE 1994-97, PHOSPHATIDYLSERINE SYNTHETASE 1991-93, %26% PHOSPHOTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CEREMONIAL 1968-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CHOLESTEROL ACYLTRANSFERASE 1985-97; see ACYLTRANSFERASES 1976-84%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CHOLINE ACETYLTRANSFERASE 1978-97; see ACETYLTRANSFERASES 1975-77%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CHONDROITIN LYASES 1975-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CHONDROITINASES 1976-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CITRATE SYNTHASE 1991-97, see KETOACID-LYASES 1973-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see COCHLEAR IMPLANT 1987-97, see AUDITORY PROSTHESIS 1980-86%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see COENZYME A SYNTHETASES 1973-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CYCLINS 1993-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see CYCLINS 1993-97; CDC13 PROTEIN %28%now CYCLIN B%29% was indexed under CYCLINS 1993-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DECOMPRESSION 1981-97, see ATMOSPHERIC PRESSURE 1975-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DELTA AGENT 1986-97; for HEPATITIS DELTA VIRUS see DELTA AGENT 1997%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DELTA INFECTION 1986-97; for HEPATITIS D see DELTA INFECTION 1986-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DEPERSONALIZATION DISORDER 1963-80; see DEPERSONALIZATION 1963-80%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DIAGNOSIS, LABORATORY 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DIAGNOSIS, RADIOISOTOPE 1988-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DIAGNOSIS, SURGICAL 1966-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DISABLED 1993-97; see HANDICAPPED 1963-92 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DNA MODIFICATION METHYLASES %28%ADENINE-SPECIFIC%29% 1989-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DNA MODIFICATION METHYLASES %28%CYTOSINE-SPECIFIC%29% 1989-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DNA POLYMERASE I 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DNA POLYMERASES 1977-97, for DNA POLYMERASE see DNA NUCLEOTIDYLTRANSFERASES 1973-76, see DNA NUCLEOTIDYLTRANSFERASE 1968-72%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DOLPHINS 1968-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DRUGS 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see DULCITOL 1991-97, see SUGAR ALCOHOLS 1972-90; for GALACTITOL see DULCITOL 1978-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see EUROPEAN ECONOMIC COMMUNITY 1976-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see FIBRINOPEPTIDES A 1991-97; see FIBRINOGEN 1976-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see FIBRINOPEPTIDES B 1991-97; see FIBRINOGEN 1976-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see FLUORESCEIN %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see FLUORESCEINS 1969-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see FORMYLTETRAHYDROFOLATE SYNTHETASE 1991-97; see LIGASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see FRUCTOSEDIPHOSPHATE ALDOLASE 1974-97, see ALDOLASE 1963-73%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GALACTOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GAMMA-GLUTAMYL-CYSTEINE SYNTHETASE 1991-97; see PEPTIDE SYNTHETASES 1977-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLUCOSAMINEPHOSPHATE ISOMERASE %28%GLUTAMINE-FORMING%29% 1991-97; see AMINOTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLUCOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLUTAMYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLUTATHIONE SYNTHETASE 1991-97; see PEPTIDE SYNTHETASES 1977-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLYCERIN 1963-97; for GLYCEROL see GLYCERIN 1976-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLYCEROLPHOSPHATE ACYLTRANSFERASE 1991-97; see ACYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLYCOGEN PHOSPHORYLASE 1971-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLYCOPROTEIN 4-BETA-GALACTOSYLTRANSFERASE 1992-97; see GLYCOPROTEIN BETA-GALACTOSYLTRANSFERASE 1991; see GALACTOSYLTRANSFERASES 1976-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLYCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GLYCYRRHIZIC ACID %28%NM%29% 1976-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see GOODPASTURE%27%S SYNDROME 1966-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HEART, MECHANICAL 1963-97, for HEART-LUNG MACHINE see HEART, MECHANICAL 1967-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HEXOSEPHOSPHATE URIDYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HIP PROSTHESIS 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HISTAMINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HISTIDASE 1991-97, see AMMONIA-LYASES 1973-90 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HISTIDYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASE 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HISTONE-LYSINE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1977-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HMG-COA REDUCTASE INHIBITORS 1997; for HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS see HMG-COA REDUCTASE INHIBITORS 1997%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HODGKIN%27%S DISEASE 1966-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HOME RANGE 1968-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see HYALURONIDASE 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see INOSITOL-1-PHOSPHATE SYNTHASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; for MYO-INOSITOL-1-PHOSPHATE SYNTHASE see INOSITOL-1-PHOSPHATE SYNTHASE 1975-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see INTRAOPERATIVE MONITORING 1991-97, for MONITORING, INTRAOPERATIVE see INTRAOPERATIVE MONITORING 1991-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see IRON CHELATES 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see JOINT PROSTHESIS 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see JOURNALISM 1994-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see KETOACID-LYASES 1973-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see KININOGENS 1989-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL see KNEE PROSTHESIS 1992-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see L CELLS 1966-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LACTOYL GLUTATHIONE LYASE 1991-97, see LYASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LAURYL ALCOHOL 1991-97; see FATTY ALCOHOLS 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LECITHIN ACYLTRANSFERASE 1978-97; see ACYLTRANSFERASES 1975-77%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LEUCYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LYING 1966-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LYSOLECITHIN ACYLTRANSFERASE 1991-97; 1-ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE was indexed under ACYLTRANSFERASES 1982-97, see ACYLTRANSFERASES 1976-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see LYSYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see MANNOSEPHOSPHATE ISOMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1978-90; for MANNOSE-6-PHOSPHATE ISOMERASE see MANNOSEPHOSPHATE ISOMERASE 1978-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see METHIONYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see METHYLTRANSFERASES 1975-85 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see MULTIPLE-PERSONALITY DISORDER 1979-97; for MULTIPLE PERSONALITIES see DUAL PERSONALITY 1968-78; DUAL PERSONALITY was heading 1968-78%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see NARCOTIC DEPENDENCE 1981-97, see NARCOTIC ADDICTION 1980%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see NMN ADENYLYLTRANSFERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1979-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ORGANIC MENTAL DISORDERS 1981-97; see MENTAL DISORDERS 1969-80; see PSYCHOSES, ORGANIC 1996-80; see PSYCHOSES, TRAUMATIC 1963-78; see ORGANIC MENTAL DISORDERS, PSYCHOTIC%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ORGANIC MENTAL DISORDERS, SUBSTANCE-INDUCED 1981-97; see SUBSTANCE ABUSE 1981-97; see DRUG ABUSE 1968-80; see DRUG ADDICTION 1963-75%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see ORNITHINE AMINOTRANSFERASE 1991-97; see AMINOTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see OSSICULAR REPLACEMENT PROSTHESIS 1987-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see PHENYLALANYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-1990%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see PHOSPHO-2-KETO-3-DEOXYHEPTONATE ALDOLASE 1995-97, see PHOSPHO-2-KETO-3-DEOXY-HEPTONATE ALDOLASE 1991-94, see ALDEHYDE-LYASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see PHOSPHOENOLPYRUVATE CARBOXYKINASES 1975-97, see PHOSPHOENOLPYRUVATE CARBOXYKINASE 1973-74%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see POLY A POLYMERASE 1991-97; see NUCLEOTIDYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see POLYDEOXYRIBONUCLEOTIDE SYNTHETASES 1991-97, see POLYNUCLEOTIDE SYNTHETASES 1978-90; for DNA LIGASES see POLYNUCLEOTIDE SYNTHETASES 1974-77, %26% see DNA LIGASE 1973-76%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see POLYNUCLEOTIDE HYDROXYLKINASE 1991-97; see PHOSPHOTRANSFERASES, ATP 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see POLYNUCLEOTIDE PHOSPHORYLASE 1973-97, NUCLEOTIDYLTRANSFERASES 1968-72, %26% NUCLEOTIDYL TRANSFERASES 1963-67%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see POLYNUCLEOTIDE SYNTHETASES 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see POLYRIBONUCLEOTIDE SYNTHETASE 1991-97; see POLYNUCLEOTIDE SYNTHETASES 1978-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see PORPHOBILINOGEN DEAMINASE 1991-97, see AMMONIA-LYASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see PROPANEDIOLS 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see PROTEIN-ARGININE METHYLTRANSFERASE 1991-97; see PROTEIN METHYLTRANSFERASES 1977-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see RACEMASES 1991-97, see EPIMERASES 1991-97, see ISOMERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see RADIOVISIOGRAPHY, DENTAL 1997 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see RIBULOSEBIPHOSPHATE CARBOXYLASE 1984-97, see CARBOXY-LYASES 1975-83%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see RNA, TRANSFER, METHYLTRANSFERASES 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see RUNAWAY REACTION 1969-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see S-ADENOSYLMETHIONINE DECARBOXYLASE 1991-97, see CARBOXY-LYASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SERINE DEHYDRATASE 1972-97; for SERINE DEAMINASE see HYDRO-LYASES 1963-71%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SERINE HYDROXYMETHYLTRANSFERASE 1991-97, see TRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SERODIAGNOSIS 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SERYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SEX DETERMINATION 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SEXUALITY 1997; see SEX BEHAVIOR 1990-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see STARCH %28%BACTERIAL GLYCOGEN%29% SYNTHASE 1991-97; see GLUCOSYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SUCCINYL COENZYME A SYNTHETASES 1991-97; see COENZYME A SYNTHETASES 1976-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SULFHYDRASES 1991-97, see LYASES 1975-90 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SURGERY, ELECTIVE 1994-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SURGERY, MINIMALLY INVASIVE 1996-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SURGERY, MINOR 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see SURGERY, OPERATIVE 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TECHNETIUM TC 99M EXAMETAZIME %28%NM%29% 1985-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TETRAHYDROPTEROYLGLUTAMATE METHYLTRANSFERASE 1991-97; see METHYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see THORACIC RADIOGRAPHY 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see THREONYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see THROMBOSPONDIN %28%NM%29% 1991-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see THROMBOSPONDINS %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see THROMBOXANE SYNTHETASE 1986-97; see OXIDOREDUCTASES 1978-85%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TISSUE INHIBITOR OF METALLOPROTEINASES %28%NM%29% 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TISSUE-INHIBITOR OF METALLOPROTEINASE-1 %28%NM%29% 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TRIOSEPHOSPHATE ISOMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TRYPTOPHANYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see TYROSYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see URIDINE DIPHOSPHATE GLUCOSE EPIMERASE 1991-97, see CARBOHYDRATE ISOMERASES 1975-90; UDPGALACTOSE 4-EPIMERASE %26% UPD-GALACTOSE 4-EPIMERASE were indexed under CARBOHYDRATE ISOMERASES 1977-96, GALACTOSE 1977-82, and UDPGLUCOSE 4-EPIMERASE 1977-98,%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; see VALYL T RNA SYNTHETASE 1991-97; see AMINO ACYL T RNA SYNTHETASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 1,2-DIMETHYLHYDRAZINE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 1-BUTANOL %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 1-OCTANOL %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 1-PHOSPHATIDYLINOSITOL 3-KINASE %28%NM%29% 1988-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 1-PHOSPHATIDYLINOSITOL 4-KINASE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 2,3-DIPHOSPHOGLYCERATE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use 3-IODOBENZYLGUANIDINE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use ACETYL COA ACYLTRANSFERASE 1991-97, ACYLTRANSFERASES 1975-90%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use ADENOSINE-5%27%-%28%N-ETHYLCARBOXAMIDE%29% %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use ALPHA-METHYLTYROSINE %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION %28%NM%29% 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use BENZYL ALCOHOL %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use BUDESONIDE %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE %28%NM%29% 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CHONDROITIN LYASES 1975-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CLAVULANIC ACID %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CROMAKALIM %28%NM%29% 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CYCLIN D1 %28%NM%29% 1990-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CYCLINS %26% CYCLIN B %28%NM%29% 1993-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use CYCLINS 1993-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use DECOMPRESSION 1981-97, use ATMOSPHERIC PRESSURE 1975-80; use DECOMPRESSION 1964-74%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use DELAVIRDINE %28%NM%29% 1993-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use DIACYLGLYCEROL KINASE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use DNA POLYMERASE I 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use DNA PRIMASE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use DOLPHINS 1968-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use EIF-2 KINASE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use ETHANOLAMINE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use ETHYLENE GLYCOL %28%NM%29% 1982-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use FMRFAMIDE %28%NM%29% 1978-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use GADOLINIUM DTPA %28%NM%29% 1987-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use GAP-43 PROTEIN %28%NM%29% 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use GASTRIN-RELEASING PEPTIDE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use GENISTEIN %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use GLUTATHIONE DISULFIDE %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use GUANIDINE %28%NM%29% 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use HEPARAN SULFATE PROTEOGLYCAN %28%NM%29% 1982-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use HEPARIN LYASE %28%NM%29% 1973-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use HEPTANOL %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use HIP PROSTHESIS 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use HYDROXYLAMINE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use JOINT PROSTHESIS 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use KANAMYCIN KINASE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use KININOGENS 1989-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use KNEE PROSTHESIS 1980-97; for KNEE REPLACEMENT, TOTAL use KNEE PROSTHESIS 1992-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use LINOLEIC ACID %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use LOSARTAN %28%NM%29% 1990-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56%28%LCK%29% %28%NM%29% 1988-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use MESALAMINE %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use METHYLMETHACRYLATE %28%NM%29% 1977-97; for POLYMETHYLMETHACRYLATE use METHYLMETHACRYLATES 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use MYRISTIC ACID %28%NM%29% 1982-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use N-METHYLSCOPOLAMINE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use NELFINAVIR %28%NM%29% 1995-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use NEOPTERIN %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use O%28%6%29%-METHYLGUANINE-DNA METHYLTRANSFERASE %28%NM%29% 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use PEANUT AGGLUTININ %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use PEPTIDE YY %28%NM%29% 1982-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use PEPTIDYLPROLYL ISOMERASE %28%NM%29% 1984-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use PHENOL %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use PROPYLENE GLYCOL %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use PROTEIN DISULFIDE-ISOMERASE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RECEPTORS, CCR5 %28%NM%29% 1996-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RECEPTORS, CXCR4 %28%NM%29% 1994-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RECEPTORS, INTERLEUKIN-4 %28%NM%29% 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RECEPTORS, INTERLEUKIN-6 %28%NM%29% 1988-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RILUZOLE %28%NM%29% 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RUNAWAY REACTION 1969-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL %28%NM%29% 1985-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use SEXUALITY 1997; use SEX BEHAVIOR 1990-96 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use SIMVASTATIN %28%NM%29% 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use SODIUM AZIDE %28%NM%29% 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use SODIUM-CALCIUM EXCHANGER %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use STREPTAVIDIN %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use SUCCINIC ACID %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TAQ POLYMERASE %28%NM%29% 1989-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID %28%NM%29% 1977-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID %28%NM%29% 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TECHNETIUM TC 99M DISOFENIN %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TECHNETIUM TC 99M LIDOFENIN %28%NM%29% 1977-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TERT-BUTYL ALCOHOL %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TETRAETHYLAMMONIUM %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use TOPOTECAN %28%NM%29% 1991-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use XANTHINE %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1967-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1968-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1970-74 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1970-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1971-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1972-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1974-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1975-79 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1975-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1975-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1976-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1978-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1978-97; for FAMILY RELATIONSHIP use FAMILY 1978-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1982-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1985-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1988-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1989-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1990-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1991-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1992-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1993-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1994-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use explode 1995-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use pre-explosion ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use pre-explosion 1970-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; use pre-explosion 1975-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was 5-ANDROSTANE-3,17-DIOL 1975-97; 91; see ANDROSTANOLS 1980-90; was ANDROSTANEDIOL see ANDROSTANES 1975-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was COLON AND RECTAL SURGERY %28%SPECIALTY%29% 1980-97; was PROCTOLOGY 1963-79%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was EDENTATA 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was GASTRIC BUBBLE 1990-97; GASTRIC BALLOON was see GASTRIC BUBBLE 1990-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was HEART SURGERY 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was HEME OXYGENASE 1980-97 %28%see under HYDROXYLASES 1980-90%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was HEPATITIS, CHRONIC ACTIVE 1983-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was KAPOSI%27%S VARICELLIFORM ERUPTION 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was KEROSINE 1982-97 %28%see under PETROLEUM 1982-90%29%; was KEROSENE see under PETROLEUM 1963-81 %28%Prov 1963-74%29%; was Cat J heading only 1975-81, Cat D %26% H heading 1968-74, Cat D heading only 1963-67%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was KEROSINE 1982-97 %28%see under PETROLEUM 1982-90%29%; was KEROSENE see under PETROLEUM 1975-81; was Cat J heading only 1975-81%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was PNEUMONIA, LOBAR 1963-97; PNEUMONIA, PNEUMOCOCCAL was see PNEUMONIA, LOBAR 1978-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was Physical Sciences 1998-2001 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was SARCOMA, KAPOSI%27%S 1963-97; KAPOSI SARCOMA was KAPOSI%27%S SARCOMA 1963-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was SURGERY, ORAL, PREPROSTHETIC 1980-97; PREPROSTHETIC ORAL SURGICAL PROCEDURES was PREPROSTHETIC ORAL SURGERY 1980-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was VASCULAR SURGERY 1963-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was WERNER%27%S SYNDROME 1964-97 %28%Prov 1964-67%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was WERNER%27%S SYNDROME 1967-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was see ALLIUM 1986-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was see CARDIOMYOPLASTY 1995-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was see DENGUE 1997; DENGUE SHOCK SYNDROME was see DENGUE 1997; HEMORRHAGIC FEVER, DENGUE was see DENGUE 1977-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was see LENSES, INTRAOCULAR 1979-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was see NUCLEOCAPSID 1997 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98; was see UTERINE DISEASES 1993-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '98;%28%68%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%63%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%63%29%; for EREMOTHECIUM use ASCOMYCOTA 1963-74 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%65%29%; for PEPTIDASE S use LEUCYL AMINOPEPTIDASE %28%NM%29% 1979-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%66%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%71%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%72%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%73%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%75%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%78%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%79%29%; use FUNGI 1971-78 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%80%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%81%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%86%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%89%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%90%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%95%29%; for MOBILE DISPERSED GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1982-98; for TY1 TRANSPOSON use DNA TRANSPOSABLE ELEMENTS 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99%28%98%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99, 63-85; use MITOSPORIC FUNGI 1963-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '990, MK' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; 3-HYDROXYBUTYRIC ACID was indexed under HYDROXYBUTYRATES 1966-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; 4-CHLOROMERCURIBENZOIC ACID %28%now P-CHLOROMERCURIBENZOIC ACID%29% was indexed under CHLOROMERCURIBENZOATES 1980-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; 63-97; use MAMMALS 1998; use SIRENIA 1963-67 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; ACRYLAMIDE was indexed under ACRYLAMIDES 1982-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; AROCLOR 1254 was indexed under AROCLORS 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; ASSESSMENT OF HEALTH CARE NEEDS %26% DETERMINATION OF HEALTH CARE NEEDS see HEALTH SERVICES NEEDS AND DEMAND 1980-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; ASSESSMENT OF HEALTH CARE NEEDS %26% DETERMINATION OF HEALTH CARE NEEDS use HEALTH SERVICES NEEDS AND DEMAND 1980-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; BENZOATE %26% POTASSIUM BENZOATE were indexed under BENZOATES 1980-98;%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; BENZOIC ACID was indexed under BENZOATES 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; BREFELDIN A was indexed under CYCLOPENTANES 1974-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; BUTYRIC ACID was indexed under BUTYRIC ACIDS 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; C-TYPE NATRIURETIC PEPTIDE was indexed under PROTEINS 1995-98 %26% NERVE TISSUE PROTEINS 1990-94%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; CATHEPSIN E %26% ERYTHROCYTE MEMBRANE ASPARTIC PROTEINASE were indexed under CATHEPSINS 1980-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; CD6 LIGAND was indexed under GLYCOPROTEINS 1995-98; KG-CAM was indexed under CELL ADHESION MOLECULES, NEURON-GLIA 1996-98 %26% CELL ADHESION MOLECULES 1994-95; NEUROLIN was indexed under CELL ADHESION MOLECULES, NEURONAL 1992-98; all are now ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; CHOLATE was indexed under CHOLIC ACIDS 1983-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; CHOLIC ACID was indexed under CHOLIC ACIDS 1983-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; CISAPRIDE was indexed under PIPERIDINES 1984-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; DEVAZEPIDE was indexed under BENZODIAZEPINONES 1986-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; HYDROGEL was indexed under POLYETHYLENE GLYCOLS 1981-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; INTERFERON-GAMMA INDUCING FACTOR %28%now INTERLEUKIN-18%29% was indexed under CYTOKINES 1995-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; INTERLEUKIN 17 was indexed under INTERLEUKINS 1996-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; INTERLEUKIN 1BETA CONVERTING ENZYME %28%now CASPASE 1%29% was indexed under CYSTEINE PROTEINASES 1995-98 %26% METALLOPROTEINASES 1989-94%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; INTERLEUKIN 7 RECEPTOR %28%now RECEPTORS, INTERLEUKIN-7%29% was indexed under RECEPTORS, INTERLEUKIN 1994-98, ANTIGENS, CD 1991-98, %26% RECEPTORS, IMMUNOLOGIC 1990-93%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; IODOACETIC ACID was indexed under IODOACETATES 1980-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; IODOCYANOPINDOLOL was indexed under PINDOLOL/analogs %26% derivatives 1981-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; IOFETAMINE was indexed under AMPHETAMINES 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; JOURNALISM was heading 1994-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; METHYLMETHACRYLATE was indexed under METHYLMETHACRYLATES 1974-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; MILRINONE was indexed under PYRIDONES 1983-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; NICORANDIL was indexed under NIACINAMIDE 1983-98 %26% NITRATES 1978-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; OXALACETIC ACID %28%now OXALOACETIC ACIDS%29% was indexed under OXALOACETATES 1981-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; OXALIC ACID was indexed under OXALATES 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; OXALOACETATE was indexed under OXALOACETATES 1982-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; P-GLYCOPROTEIN was indexed under P-GLYCOPROTEIN 1995-98, CARRIER PROTEINS %26% MEMBRANE GLYCOPROTEINS 1980-94, GLYCOPROTEINS 1980-87, and MEMBRANE PROTEINS 1980-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; PHENOLPHTHALEIN was indexed under PHENOLPHTHALEINS 1983-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; PINACIDIL was indexed under GUANIDINES 1983-98 %26% PYRIDINES 1980-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN %28%now MEROZOITE SURFACE PROTEIN 1%29% was indexed under PROTOZOAN PROTEINS 1990-98 and ANTIGENS, PROTOZOAN 1987-89%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; RAPAMYCIN %28%now SIROLIMUS%29% was indexed under POLYENES 1976-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; RHODAMINE 123 was indexed under RHODAMINES 1982-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; RNA HELICASE was indexed under RNA NUCLEOTIDYLTRANSFERASES 1992-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; SALICYLIC ACID was indexed under SALICYLIC ACIDS 1981-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; SERTRALINE was indexed under 1-NAPHTHYLAMINE/analogs %26% derivatives 1983-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; SODIUM BENZOATE was indexed under BENZOATES 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; SODIUM CHOLATE was indexed under CHOLIC ACIDS 1983-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; STYRENE was indexed under STYRENES 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; TERT-BUTYLHYDROPEROXIDE was indexed under PEROXIDES 1976-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; TROPONIN T was indexed under TROPONIN 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for AQUEOUS SHUNTS see MOLTENO IMPLANTS 1995-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for AQUEOUS SHUNTS use MOLTENO IMPLANTS 1995-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for ARTHRODERMA use ASCOMYCOTA 1975-98; for NANNIZZIA use MICROSPORUM 1975-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for ARYLSULFATASE B see CHONDRO-4-SULFATASE 1975-98; N-ACETYLGALACTOSAMINE-4-SULFATE SULFATASE %28%now N-ACETYLGALACTOSAMINE-4-SULFATASE%29% was indexed under SULFATASES 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for ARYLSULFATASE B use CHONDRO-4-SULFATASE 1975-98; use N-ACETYLGALACTOSAMINE-4-SULFATASE %28%NM%29% 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for BENZOATE %26% POTASSIUM BENZOATE use BENZOIC ACID %28%NM%29% 1980-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for CHOLATE use CHOLIC ACIDS %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for CORRESPONDENCE COURSES see EDUCATION 1978-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for DELTA ELEMENTS see DNA INSERTION ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT %26% R REPETITIVE SEQUENCE see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for DELTA ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1988-98; for INVERTED TERMINAL REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1988-98; for LONG TERMINAL REPEAT, TERMINAL REPEAT %26% R REPETITIVE SEQUENCE use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for DUGONGS %26% SEA COWS see MAMMALS 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for DUGONGS %26% SEA COWS use MAMMALS 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for GINKGOPHYTA see GYMNOSPERMS 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for GINKGOPHYTA use GYMNOSPERMS 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for MANATEES see MAMMALS 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for MANATEES use MAMMALS 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for MANTIDS %26% PRAYING MANTIS see ORTHOPTERA 1986-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for MANTIDS %26% PRAYING MANTIS use ORTHOPTERA 1986-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for MOBILE GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1986-98; for SELFISH DNA see DNA %28%1983-2003%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for MOBILE GENETIC ELEMENTS use DNA TRANSPOSABLE ELEMENTS 1986-98; for SELFISH DNA use DNA %28%1983-2003%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for PEPSINOGEN see PEPSINOGEN 1972-98; UROPEPSINOGEN was indexed under PEPSINOGEN 1978-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for PEPSINOGEN use PEPSINOGENS 1972-98; for UROPEPSINOGEN use PEPSINOGEN A %28%NM%29% 1978-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for PHOSPHOGLYCERIDES see GLYCEROPHOSPHATES 1977-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for PHOSPHOGLYCERIDES use GLYCEROPHOSPHATES 1977-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for PHYSICAL MAPPING %28%GENETICS%29% see RESTRICTION MAPPING 1997-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for PHYSICAL MAPPING %28%GENETICS%29% use RESTRICTION MAPPING 1997-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for POLOXAMERS see POLOXALENE 1974-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for POLOXAMERS use POLOXALENE 1974-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for RNA HELICASE use RNA HELICASES 1989-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for SODIUM BENZOATE use BENZOIC ACID %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for SULFHYDRYL COMPOUND ANTAGONISTS see SULFHYDRYL COMPOUNDS ANTAGONISTS 1978-98; for SULFHYDRYL COMPOUND INHIBITORS see SULFHYDRYL COMPOUNDS INHIBITORS 1978-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for TANDEM REPEAT see REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; for TANDEM REPEAT use REPETITIVE SEQUENCE, NUCLEIC ACID 1990-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see ABORTION 1966-98; for ABORTION, SPONTANEOUS see ABORTION 1992-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see ANESTHESIA ADJUVANTS 1963-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see ASCOMYCETES 1963-98; for COCHLIOBOLUS %26% SCLEROTINA see ASCOMYCETES 1975-85%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see BASE COMPOSITION 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see BASIDIOMYCETES 1963-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see BIOSENSORS 1989-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see CHRISTMAS DISEASE 1966-98; for HEMOPHILIA B see CHRISTMAS DISEASE 1974-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see COENZYMES 1996-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see COMPUTER COMMUNICATION NETWORKS 1996-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see CUSHING%27%S SYNDROME 1966-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see DERMATOPHYTES 1963-98; for ARTHRODERMA see ASCOMYCOTA 1975-98; for NANNIZZIA see MICROSPORUM 1975-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see DEUTEROMYCETES 1973-98; for HYPHOMYCETES see HYPHOMYCETES 1986-98, see MONILIALES 1963-85; for MADURELLA %26% GLIOCLADIUM see HYPHOMYCETES 1986-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see DIACETYLMORPHINE 1978-98; for HEROIN see DIACETYLMORPHINE 1963-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see DNA INSERTION ELEMENTS 1980-98; for INSERTION SEQUENCE ELEMENTS see INSERTION SEQUENCE ELEMENTS 1980%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see DNA SEQUENCE, UNSTABLE 1998 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see ENDOMYCETALES 1986-98, see ASCOMYCETES 1963-85; for ENDOMYCOPSIS see ASCOMYCETES 1975-85; for EREMOTHECIUM see ASCOMYCETES 1963-85%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see FABRY%27%S DISEASE 1992-98; see ANGIOKERATOMA CORPORIS DIFFUSUM 1973-91; for FABRY%27%S DISEASE see ANGIOKERATOMA CORPORIS DIFFUSUM 1974-91%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see GRAAFIAN FOLLICLE 1966-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see HEMOPHILIA 1966-98; for HEMOPHILIA A see HEMOPHILIA 1993-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see HEMORRHAGIC DIATHESIS 1963-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see HYPHOMYCETES 1986-98, see MADURELLA 1963-85 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see HYPHOMYCETES 1986-98, see MONILIALES 1975-85 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see IPECAC %28%SYRUP%29% 1995-98; see IPECAC 1963-94 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see JOURNALISM, MEDICAL 1994-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see LEUCINE AMINOPEPTIDASE 1965-98; PEPTIDASE S was indexed under AMINOPEPTIDASES 1979-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see MAMMALS 1998; see SIRENIA 1963-67 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see MASTIGOMYCOTINA 1986-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see MUCORMYCOSIS 1989-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see MULTIGENE FAMILY 1987-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see MYCOBACTERIUM, ATYPICAL 1977-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see MYXOMYCOTA 1986-98, see MYXOMYCETES 1963-85 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see OLIGONUCLEOTIDES, ANTISENSE 1991-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see P-GLYCOPROTEIN 1995-98; P-GLYCOPROTEIN was indexed under CARRIER PROTEINS %26% MEMBRANE GLYCOPROTEINS 1980-94, GLYCOPROTEINS 1980-87, and MEMBRANE PROTEINS 1980-82%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see PHOTORECEPTORS 1997-98; for RODS AND CONES see PHOTORECEPTORS 1997-98, see RODS AND CONES 1966-96%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see PROPERDIN FACTOR B 1991-98, see ENZYME PRECURSORS 1978-90; for COMPLEMENT FACTOR B see PROPERDIN FACTOR B 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see Pepsinogen 1972-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE see REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see RETROTRANSPOSONS 1995-98; for MOBILE DISPERSED GENETIC ELEMENTS see DNA INSERTION ELEMENTS 1982-98; for TY1 TRANSPOSON see DNA INSERTION ELEMENTS 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see RICKETTSIA TSUTSUGAMUSHI 1966-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see SEROEPIDEMIOLOGIC METHODS 1990-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see SEXUAL DYSFUNCTIONS 1998; see PSYCHOSEXUAL DISORDERS was heading 1981-98; for FRIGIDITY see FRIGIDITY 1966-97; for PSYCHOSEXUAL DISORDERS see PSYCHOSEXUAL DISORDERS 1981-97%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see SPOROTRICHUM 1963-98; for SPOROTHRIX see SPOROTRICHUM 1974-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see SULFATIDES 1971-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see THROMBOPHLEBITIS 1963-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see TRIATOMINAE 1979-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see WALDENSTROM%27%S MACROGLOBULINEMIA 1992-98, was WALDENSTROM%27%S MACROGLOBULINEMIA see MACROGLOBULINEMIA 1963-91%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see ZYGOMYCOTINA 1986-98, see ZYGOMYCETES 1979-85, see PHYCOMYCETES 1971-78%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see rRNA OPERON 1988-98; for rRNA GENES see rRNA OPERON 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; see von Willebrand%27%s Disease 1968-98, see HEMORRHAGIC DIATHESIS 1967, see THROMBOCYTOPATHY 1963-66%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use 3-HYDROXYBUTYRIC ACID %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use ACRYLAMIDE %28%NM%29% 1982-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE %28%NM%29% 1990-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use AROCLOR 1254 %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use BASE COMPOSITION 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use BENZOIC ACID %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use BREFELDIN A %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use BUTYRIC ACID %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use C-TYPE NATRIURETIC PEPTIDE %28%NM%29% 1990-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use CASPASE 1 %28%NM%29% 1989-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use CATHEPSIN E %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use CHOLIC ACID %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use CISAPRIDE %28%NM%29% 1984-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use COENZYMES 1996-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use COMPUTER COMMUNICATION NETWORKS 1996-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use DEVAZEPIDE %28%NM%29% 1986-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use ENTEROCOLITIS, PSEUDOMEMBRANOUS 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use HYDROGEL %28%NM%29% 1981-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use INTERLEUKIN-17 %28%NM%29% 1996-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use INTERLEUKIN-18 %28%NM%29% 1995-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use IODOACETIC ACID %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use IODOCYANOPINDOLOL %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use IOFETAMINE %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use METHYLMETHACRYLATE %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use MILRINONE %28%NM%29% 1983-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use MITOSPORIC FUNGI 1975-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use MUCORMYCOSIS 1989-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use MULTIGENE FAMILY 1987-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use NICORANDIL %28%NM%29% 1978-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use OXALIC ACID %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use OXALOACETIC ACID %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use OXALOACETIC ACIDS %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use P-CHLOROMERCURIBENZOIC ACID %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use P-GLYCOPROTEIN 1995-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use PEPSINOGENS 1987-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use PHENOLPHTHALEIN %28%NM%29% 1983-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use PHOTORECEPTORS 1997-98; for RODS AND CONES use PHOTORECEPTORS 1966-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use PINACIDIL %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use PLASMODIUM FALCIPARUM MEROZOITE PRECURSOR SURFACE COAT PROTEIN %28%NM%29% 1987-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use RECEPTORS, INTERLEUKIN-7 %28%NM%29% 1990-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98; for ALU REPETITIVE SEQUENCE, ALU FAMILY, and ALU-LIKE REPETITIVE SEQUENCE use REPETITIVE SEQUENCES, NUCLEIC ACID 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use RHODAMINE 123 %28%NM%29% 1982-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use SALICYLIC ACID %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use SERTRALINE %28%NM%29% 1983-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use SIROLIMUS %28%NM%29% 1980-97 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use SODIUM CHOLATE %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use STYRENE %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use TERT-BUTYLHYDROPEROXIDE %28%NM%29% 1980-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use THROMBOPHLEBITIS 1963-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use TRIATOMINAE 1979-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use TROPONIN T %28%NM%29% 1981-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; use rRNA OPERON 1988-98; for rRNA GENES use rRNA OPERON 1988-98%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; was MUNICIPAL GOVERNMENT 1966-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; was OLIGONUCLEOTIDES, ANTISENSE 1991-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; was TERMINOLOGY see NOMENCLATURE 1966-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99; was WESTERN SAMOA 1975-98 ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99Tc Pertechnetate' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99Tc Succimer' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99Tc-Succimer' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99TcmO4' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m Mercaptoacetylglycyl-glycyl-glycine, Technetium' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m Mertiatide, Tc' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m Tc Diethyl IDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m Tc Dimercaptosuccinic Acid' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m Tc Disofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m Tc Lidofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m, Technetium' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-DTPA, Tc' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Pertechnetate, Tc' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Tc-Diethyl IDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Tc-Dimercaptosuccinic Acid' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Tc-Disofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Tc-HMPAO' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Tc-HSA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99m-Tc-Lidofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Albures' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc DISIDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc DMSA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Diethyl IDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Diethyliminodiacetic Acid' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Dimercaptosuccinate' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Dimercaptosuccinic Acid' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Disofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc EHIDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc HIDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Hexamibi' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Human Serum Albumin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Lidofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc MAG3' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Mercaptoacetyltriglycine' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Methylene Diphosphonate' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Pyrophosphate' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc Sestamibi' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-DISIDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-DMSA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Diethyl IDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Diethyliminodiacetic Acid' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Dimercaptosuccinic Acid' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Disofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-EHIDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-HIDA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-HMPAO' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-HSA' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Hexamibi' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Lidofenin' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-MAG3' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-MDP' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Mercaptoacetyltriglycine' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Methylene Diphosphonate' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Pyrophosphate' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTc-Sestamibi' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTcAlbures' = 0).
% 42.08/41.95 fof(interp, fi_functors, '99mTcO4' = 0).
% 42.08/41.95 fof(interp, fi_functors, '9alpha,11beta PGF2' = 0).
% 42.08/41.95 fof(interp, fi_functors, '9alpha,11beta-PGF2' = 0).
% 42.08/41.95 fof(interp, fi_functors, '9th %28%farthest%29% planet from sun with 1 moon; no qualif ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= %22%bacterial virus%22%; GEN or unspecified: prefer specific available phages; for other phages, coord IM with specific bacterium /virol %28%NIM; IM only when identity of bacterium is particularly significant%29%; policy: Manual 22.24.3%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= %22%neural tracts%22%; coord NIM with origin %28%IM%29% + termination %28%IM%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= %22%trophoblastic disease%22%; coord IM with UTERINE NEOPLASMS %28%IM%29%; check the tags FEMALE %26% PREGNANCY if needed%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= Algeria, Egypt, Libya, Morocco, Tunisia collectively: prefer specifics; titles often refer to the Maghreb or Maghrib, the Arabic name for Algeria, Morocco, Tunisia %26% sometimes Libya collectively: check text for possible specificity, otherwise index under AFRICA, NORTHERN%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= Dimethyl diChloro Vinyl phOSphate; TN 111 for eff on insects%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= ENGLAND; SCOTLAND %26% WALES strictly speaking; UNITED KINGDOM = GREAT BRITAIN + NORTHERN IRELAND, strictly speaking; available also are CHANNEL ISLANDS %28%see there for available X refs%29% %26% HEBRIDES%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= ESTONIA; LATVIA %26% LITHUANIA collectively ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= H3; naturally radioactive ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= HExaMethylPhosphorAmide ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= LANGUAGE as it comes out of the mouth; VERBAL BEHAVIOR is how it comes out; PHONETICS is the sounds making up SPEECH; AMERICAN SPEECH-LANGUAGE-HEARING ASSOCIATION is also available%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= M. tuberc. bovis; infection = TUBERCULOSIS, BOVINE if in cattle, TUBERCULOSIS /vet %28%IM%29% + MYCOBACTERIUM BOVIS %28%IM%29% if in other animals; DF: MYCOBACT BOVIS or short X ref%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= Outer Mongolia; INNER MONGOLIA is see CHINA ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= Siam ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= abnorm of size %26% shape; do not equate with ERYTHROCYTES /pathol; do not confuse with ERYTHROCYTE DEFORMABILITY which is the %22%ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature%22%; A 11 qualif; coord with disease /blood, not /compl%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= availability of HEALTH PERSONNEL: do not confuse with the HEALTH PERSONNEL themselves, the persons in the field of health care %26% delivery; GEN only: prefer /manpower with specific headings; when GEN %26% IM, /educ = HEALTH OCCUPATIONS /educ or HEALTH PERSONNEL /educ; DF: HEALTH MAN%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= benzals; DF: BENZYLIDENE CPDS ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= care prescribed by MD or generated by person himself %26% includes care for self, family or friends; differentiate from SELF MEDICATION %28%medication not prescribed by MD%29% and SELF ADMINISTRATION %28%admin of medication prescribed by MD or self admin of substances by exper animals%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= color of iris, not the color of the eye as in disease ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= defic of myocard blood supply; may lead to MYOCARDIAL INFARCTION%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= deformities acquired from inj or dis; congenital deformities = NOSE /abnorm %26% do not coord with INFANT, NEWBORN, DISEASES%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= degree of spread of neopl %28%do not confuse with %22%grading%22% which = degree of malignancy%29%; staging is given in roman numerals, grading in arabic; Manual 24.4.1.12+; usually NIM with no qualif + neopl terms /pathol %28%IM%29%; IM as technique %26% general only %26% when IM, qualif permitted; relation to /pathol %26% differentiation from classification: TN 214; DF: NEOPL STAGING%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= fetus + newborn inf: differentiate from NEONATOLOGY, the newborn inf only; SPEC: SPEC qualif; DF: PERINATOL%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= herniation or prolapse; coord IM with specific vertebrae %28%IM%29%; ther by chemonucleolysis = INTERVERTEBRAL DISK CHEMOLYSIS: see note there%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= histochem or cytochem or both; NIM usually with no qualif; SPEC qualif when IM; histochem of disease is disease /metab; Manual 26.11+%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= inflammation of kidney + its pelvis ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= iron%28%II%29% or Fe%28%II%29%, as FeO, FeCl2; iron%28%III%29% or Fe%28%III%29% = FERRIC COMPOUNDS; DF: FERROUS CPDS%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= iron%28%III%29% or Fe%28%III%29%, as Fe2O3, FeCl3; iron%28%II%29% or Fe%28%II%29% = FERROUS COMPOUNDS; hematinics; DF: FERRIC CPDS%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= kidney pelvis inflammation ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= lung collapse, any part of the lung ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= movement as associated with behavior: differentiate from MOVEMENT, a physiol process; animal running in exercise wheel goes here %28%unless better under EXERTION%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= perop or postop control of bleeding; do not use /util except by MeSH%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= pois by mushroom toxins; TN 133: relation to food pois from canned mushrooms%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= professional care by a professional; DF: DENT CARE CHRONIC ILL%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= professional care by a professional; ORAL HYGIENE = personal care by the subject himself; do not confuse with DENTISTRY: DENTISTRY is the dentist %26% the profession, DENTAL CARE is the patient %26% the care given him; GEN only: do not confuse with TOOTH DISEASES; DF: DENT CARE%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= professional care by a professional; disability can refer to emotional, mental or physical dis; DF: DENT CARE DISABLED%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= professional care by a professional; do not confuse with GERIATRIC DENTISTRY, the specialty; check tag AGED; DF: DENT CARE AGED%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= professional care by a professional; do not confuse with PEDIATRIC DENTISTRY, the specialty; check tag CHILD; DF: DENT CARE CHILDREN%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= pyridinamines %26% pyridylamines ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= relief without cure; coord IM with disease /ther or /surg or /drug ther or other specific qualif %28%IM%29%; consider also PAIN /ther%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= science of LANGUAGE %26% SPEECH; do not confuse with LANGUAGE %28%what is spoken%29%, SEMANTICS %28%hist or psychol study of language %26% meaning changes%29%, NOMENCLATURE %28%names of things %26% etymology, the origin or words%29%, PHONETICS %28%how words are sounded%29%, LITERATURE %28%literary works%29%, PHILOLOGY %28%study of literature or language as used in literature%29% or VOCABULARY %28%a person%27%s stock of words%29%; grammar, syntax, accent go here; SPEC: SPEC qualif%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= scrofula in hist articles only: differentiate from SCROFULA see TUBERCULOSIS, LYMPH NODE which is restricted to scrofula in modern clin med%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= state; NEW YORK CITY is also available ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= the Federal district; city is Washington, D.C. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, '= the writing of histories; no qualif; DF: HISTORIOGR ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family in the order Rhodobacterales, class ALPHAPROTEOBACTERIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glutamate plasma membrane transporter protein found in ASTROCYTES and in the LIVER.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A species in the genus LAGOVIRUS which causes hemorrhagic disease, including hemorrhagic septicemia, in rabbits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A %26% H Brand of Beclomethasone Dipropionate' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 1.5-kDa small ubiquitin-related modifier protein that can covalently bind via an isopeptide link to a number of cellular proteins. It may play a role in intracellular protein transport and a number of other cellular processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 10.8-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN B and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin A is found in many cell types including GRANULOCYTES; KERATINOCYTES; and myelomonocytes, and has been shown to act as a chemotactic substance for NEUTROPHILS. Because it is present in acute inflammation but absent in chronic inflammation, it is a useful biological marker for a number of pathological conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 105-kDa serum glycoprotein with significant homology to the other late complement components, C7-C9. It is a polypeptide chain cross-linked by 32 disulfide bonds. C6 is the next complement component to bind to the membrane-bound COMPLEMENT C5B in the assembly of MEMBRANE ATTACK COMPLEX. It is encoded by gene C6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol /transpl; /genet permitted ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol /transpl; /genet permitted; /physiol: consider also SYNAPTIC TRANSMISSION %28%see note there%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet /isol permitted ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet /permitted; coord IM with specific archaeon /genet %28%IM%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; DF: COATED PITS%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; ENDOPLASMIC RETICULUM, SMOOTH is also available%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; coord IM with specific bact /genet %28%IM%29%; DF: CHROMOSOMES BACT%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; coord IM with specific fungus /genet %28%IM%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; coord IM with specific precoord mitochondria term %28%IM or NIM%29% if pertinent%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; coord with organ /metab %28%IM%29% but not also organ /ultrastruct for metab studies, coord with organ /ultrastruct %28%IM%29% for morphol studies: TN 126; mitochondria of vasc or smooth musc tissue goes under MITOCHONDRIA, MUSCLE %26% do not coord with MUSCLE, SMOOTH or MUSCLE, SMOOTH, VASCULAR unless particularly discussed %26% then probably only NIM%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; do not confuse with NERVE FIBERS%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; for bacteria, coord IM with specific bacterium %28%IM%29%; for viruses, INCLUSION BODIES, VIRAL is available: see note there%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; for skeletal %26% smooth musc mitochondria; for vasc %26% smooth musc mitochondria see note on MITOCHONDRIA%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif except /cytol; /genet permitted; smooth endoplasmic reticulum in muscle = SARCOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM, ROUGH is also available%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif with discretion ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; decrease in number = LYMPHOPENIA; excess number = LYMPHOCYTOSIS; LYMPHOCYTE COUNT is also available; LYMPHOCYTE CULTURE TEST, MIXED is also available%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; /transpl = HEMATOPOIETIC STEM CELL TRANSPLANTATION%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; DF: AKM ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; ENDODERMAL SINUS TUMOR is also available: see note there%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; a subpopulation of regulatory T-lymphocytes; subpopulations: coord IM with T-LYMPHOCYTE SUBSETS %28%IM%29%; count: coord IM with LYMPHOCYTE COUNT %28%NIM%29%; DF: note short X ref%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; coord IM with specific T-lymphocyte %28%IM%29% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; coord IM with specific lymphocyte %28%IM%29% but note that B-LYMPHOCYTE SUBSETS %26% T-LYMPHOCYTE SUBSETS are available%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; cutaneous cells: do not confuse with ISLETS OF LANGERHANS %28%pancreas%29% nor with GIANT CELLS, LANGHANS %28%macrophages%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; decrease in no. = NEUTROPENIA; neutrophil chemotaxis: coord NIM with CHEMOTAXIS, LEUKOCYTE %28%IM%29%; note X ref LE CELLS: do not coord with LUPUS ERYTHEMATOSUS, SYSTEMIC unless disease is particularly discussed %28%see note there%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; decrease in no. of platelets = THROMBOCYTOPENIA, increase = THROMBOCYTOSIS; platelet factors %26% defic: TN 228%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; not for micro-organisms ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%; DF: TIL%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 11 qualif; subpopulations: coord IM with LYMPHOCYTE SUBSETS %28%IM%29%; DF: note short X ref%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 110-kDa extracellular signal-regulated MAP kinase that is activated in response to cellular stress and by GROWTH FACTOR RECEPTOR-mediated pathways.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 12-KDa tacrolimus binding protein that is found associated with and may modulate the function of calcium release channels. It is a peptidyl-prolyl cis/trans isomerase which is inhibited by both tacrolimus %28%commonly called FK506%29% and SIROLIMUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 12-kDa cysteine-rich polypeptide hormone secreted by FAT CELLS in the ADIPOSE TISSUE. It is the founding member of the resistin-like molecule %28%RELM%29% hormone family. Resistin suppresses the ability of INSULIN to stimulate cellular GLUCOSE uptake.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 120-kDa RAS GTPase-activating protein that binds to tyrosine phosphoproteins through its SH2 domains. The 100-kDa RNA-splicing variant %28%p100 GAP protein%29% is expressed in placenta.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 13-amino acid peptide derived from the ANTERIOR PITUITARY GLAND in man and from the pars intermedia in lower vertebrates. Its amino acid sequence is identical to the first 13 amino acids of ACTH. It influences the formation of deposition of MELANIN in the body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 13.2-kDa member of the S-100 family of calcium-binding proteins that can form homo- or heterocomplexes with CALGRANULIN A and a variety of other proteins. The calgranulin A/B heterodimer is known as LEUKOCYTE L1 ANTIGEN COMPLEX. Calgranulin B is expressed at high concentrations in GRANULOCYTES during early monocyte differentiation, and serum calgranulin B levels are elevated in many inflammatory disorders such as CYSTIC FIBROSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 145-kDa guanine nucleotide exchange factor that is specific for rap1 and ras GTP-BINDING PROTEINS. It associates with SH3 domains of the crk family of signaling proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 15 kD %22%joining%22% peptide that forms one of the linkages between monomers of IMMUNOGLOBULIN A or IMMUNOGLOBULIN M in the formation of polymeric immunoglobulins. There is one J chain per one IgA dimer or one IgM pentamer. It is also involved in binding the polymeric immunoglobulins to POLYMERIC IMMUNOGLOBULIN RECEPTOR which is necessary for their transcytosis to the lumen. It is distinguished from the IMMUNOGLOBULIN JOINING REGION which is part of the IMMUNOGLOBULIN VARIABLE REGION of the immunoglobulin light and heavy chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 150 kDa neurotoxic protein produced by CLOSTRIDIUM BOTULINUM. When consumed in contaminated food it can cause paralysis and death. In its purified form, it has been used in the treatment of BLEPHAROSPASM and STRABISMUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 150-kDa MAP kinase kinase kinase that may play a role in the induction of APOPTOSIS. It has specificity for MAP KINASE KINASE 3; MAP KINASE KINASE 4; and MAP KINASE KINASE 6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 150-kDa serum glycoprotein composed of three subunits with each encoded by a different gene %28%C8A; C8B; and C8G%29%. This heterotrimer contains a disulfide-linked C8alpha-C8gamma heterodimer and a noncovalently associated C8beta chain. C8 is the next component to bind the C5-7 complex forming C5b-8 that binds COMPLEMENT C9 and acts as a catalyst in the polymerization of C9.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 16-kDa peptide hormone secreted from white adipocytes and implicated in the regulation of food intake and energy balance. Leptin provides the key afferent signal from fat cells in the feedback system that controls body fat stores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 17-KDa cytoplasmic PEPTIDYLPROLYL ISOMERASE involved in immunoregulation. It is a member of the cyclophilin family of proteins that binds to CYCLOSPORINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 17-kDa single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. It binds to HEPARIN, which potentiates its biological activity and protects it from proteolysis. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages, and also has chemotactic and mitogenic activities. It was originally named acidic fibroblast growth factor based upon its chemical properties and to distinguish it from basic fibroblast growth factor %28%FIBROBLAST GROWTH FACTOR 2%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 170-kDa transmembrane glycoprotein from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS. It serves as an ATP-dependent efflux pump for a variety of chemicals, including many ANTINEOPLASTIC AGENTS. Overexpression of this glycoprotein is associated with multidrug resistance %28%see DRUG RESISTANCE, MULTIPLE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 180-kDa MAP kinase kinase kinase with specificity for MAP KINASE KINASE 4 and MAP KINASE KINASE 6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 %28%fms-like tyrosine kinase receptor-1%29%. A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 19-kDa cationic peptide found in EOSINOPHIL granules. Eosinophil-derived neurotoxin is a RIBONUCLEASE and may play a role as an endogenous antiviral agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 191-amino acid polypeptide hormone secreted by the human adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%, also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 195-kDa MAP kinase kinase kinase with broad specificity for MAP KINASE KINASES. It is found localized in the CYTOSKELETON and can activate a variety of MAP kinase-dependent pathways.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 1974 Federal act which preempts states%27% rights with regard to workers%27% pension benefits and employee benefits. It does not affect the benefits and rights of employees whose employer is self-insured. %28%From Slee %26% Slee, Health Care Reform Terms, 1993%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 1:1 molar complex of heme or hematin and albumin formed after the dissociation of methemoglobin into heme or hematin and globin in plasma. This complex, which imparts a coffee-brown color to plasma, occurs in hemolytic and hemorrhagic disorders. Its presence in plasma is used as a test to differentiate between hemorrhagic and edematous pancreatitis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 20-carbon branched chain fatty acid. In phytanic acid storage disease %28%REFSUM DISEASE%29% this lipid may comprise as much as 30%25% of the total fatty acids of the plasma. This is due to a phytanic acid alpha-hydroxylase deficiency.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 20-carbon dibenz%28%de,kl%29%anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E%28%2%29% and F%28%2a%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 20-carbon-chain fatty acid, unsaturated at positions 8, 11, and 14. It differs from arachidonic acid, 5,8,11,14-eicosatetraenoic acid, only at position 5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 206-amino-acid fragment in the alpha chain %28%672-1663%29% of C3b. It is generated when C3b is inactivated %28%iC3b%29% and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c %28%749-954%29%, and C3dg %28%955-1303%29% in the presence COMPLEMENT FACTOR H.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. %28%N Eng J Med 1995;333%28%6%29%:356-63%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 21-amino acid peptide produced predominantly within the kidney and intestine, with smaller amounts produced in the myocardium, placenta, and uterus, but the cells of origin are not clear. Endothelin-2 has no unique physiologic functions, as compared with endothelin-1. %28%N Eng J Med 1995;333%28%6%29%:356-63%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 21-amino acid peptide that circulates in the plasma, but its source is not known. Endothelin-3 has been found in high concentrations in the brain and may regulate important functions in neurons and astrocytes, such as proliferation and development. It also is found throughout the gastrointestinal tract and in the lung and kidney. %28%N Eng J Med 1995;333%28%6%29%:356-63%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 21-carbon steroid that is converted from PREGNENOLONE by STEROID 17-ALPHA-HYDROXYLASE. It is an intermediate in the delta-5 pathway of biosynthesis of GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 23-kDa HMG-box protein that binds to and distorts the minor grove of DNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 23-kDa regulatory protein important for virion infectivity in HIV. The protein is found in the cytoplasm of HIV-infected cells and is not absolutely required for virion formation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 23187' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 235-kDa cytoplasmic protein that is also found in platelets. It has been localized to regions of cell-substrate adhesion. It binds to INTEGRINS; VINCULIN; and ACTINS and appears to participate in generating a transmembrane connection between the extracellular matrix and the cytoskeleton.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 24-kDa HMGB protein that binds to and distorts the minor grove of DNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 25-kDa peptidase produced by Staphylococcus simulans which cleaves a glycine-glcyine bond unique to an inter-peptide cross-bridge of the STAPHYLOCOCCUS AUREUS cell wall. EC 3.4.24.75.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 272' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 29-amino acid peptide that is found in both the central and peripheral nervous systems. It inhibits glucose-induced insulin release, hippocampal acetylcholine release, hippocampal glutamate %28%but not GAMMA-AMINOBUTYRIC ACID%29% release, and it lowers spinal excitability and firing of locus coeruleus neurons. It stimulates food %28%fat%29% intake and growth hormone release upon hypothalamic or i.c.v. injection. %28%Crit Rev Neurobiol 1993;7%28%3-4%29%:229-74%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 3-hydroxysteroid dehydrogenase which catalyzes the reversible reduction of the active androgen, DIHYDROTESTOSTERONE to 5 ALPHA-ANDROSTANE-3 ALPHA,17 BETA-DIOL. It also has activity towards other 3-alpha-hydroxysteroids and on 9-, 11- and 15- hydroxyprostaglandins. The enzyme is B-specific in reference to the orientation of reduced NAD or NADPH.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 301' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 302-amino-acid fragment in the alpha chain %28%672-1663%29% of C3b. It is generated when C3b is inactivated %28%iC3b%29% and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c, and C3dg %28%955-1303%29% in the presence COMPLEMENT FACTOR H. Serum proteases further degrade C3dg into C3d %28%1002-1303%29% and C3g %28%955-1001%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 31-amino acid peptide which connects the A and B chains of proinsulin. The exact composition of the peptide is species dependent. In beta cells proinsulin is enzymatically converted to insulin with the liberation of the C-peptide. An immunoassay has been developed for assessing pancreatic beta cell secretory function in diabetic patients in whom circulating insulin antibodies and exogenous insulin interfere with insulin immunoassay.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 33-kDa protein identical to adenovirus E1A-associated protein p60. Cyclin A regulates p33cdk2 and p34cdc2, and is necessary for progression through the S phase of the cell cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 34-amino acid polypeptide antibiotic produced by Streptococcus lactis. It has been used as a food preservative in canned fruits and vegetables, and cheese.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 343, McNeil' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 36-amino acid peptide produced by the L cells of the distal small intestine and colon. Peptide YY inhibits gastric and pancreatic secretion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 36-amino acid polypeptide secreted by the PANCREAS that has physiological regulatory functions. Plasma pancreatic polypeptide increases after ingestion of food, with age, and in disease states. A lack of pancreatic polypeptide in the ISLETS OF LANGERHANS has been associated with the OBESITY in rats and mice.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 37-amino acid residue peptide isolated from the scorpion Leiurus quinquestriatus hebraeus. It is a neurotoxin that inhibits calcium activated potassium channels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 38-kDa integral membrane glycoprotein of the presynaptic vesicles in neuron and neuroendocrine cells. It is expressed by a variety of normal and neoplastic neuroendocrine cells and is therefore used as an immunocytochemical marker for neuroendocrine differentiation in various tumors. In ALZHEIMER DISEASE and other dementing disorders, there is an important synapse loss due in part to a decrease of synaptophysin in the presynaptic vesicles.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 38-kDa mitogen-activated protein kinase found expressed at high levels in LUNG; KIDNEY; TESTIS; PANCREAS; and SMALL INTESTINE. It may play a role in regulating functions such as CELL DIFFERENTIATION and APOPTOSIS of EPITHELIAL CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 38-kDa mitogen-activated protein kinase found primarily in SKELETAL MUSCLE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 38-kDa mitogen-activated protein kinase that is abundantly expressed in a broad variety of cell types. It is involved in the regulation of cellular stress responses as well as the control of proliferation and survival of many cell types. The kinase activity of the enzyme is inhibited by the pyridinyl-imidazole compound SB 203580.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 38-kDa mitogen-activated protein kinase that is expressed in a broad variety of cell types. It may play a role in regulating cell proliferation and TRANSCRIPTION FACTOR AP-1 dependent transcription.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1445%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 4-aminoquinoquinoline compound with anti-inflammatory properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 4-hydroxylated metabolite of AFLATOXIN B1, one of the MYCOTOXINS from ASPERGILLUS tainted food. It is associated with LIVER damage and cancer resulting from its P450 activation to the epoxide which alkylates DNA. Toxicity depends on the balance of liver enzymes that activate it %28%CYTOCHROME P-450%29% and others that detoxify it %28%GLUTATHIONE S TRANSFERASE%29% %28%Pharmac Ther 50.443 1991%29%. Primates %26% rat are sensitive while mouse and hamster are tolerant %28%Canc Res 29.236 1969%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 4-kDa protein, 39-43 amino acids long, expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with Alzheimer%27%s disease and in aged individuals with trisomy 21 %28%DOWN SYNDROME%29%. The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 41304' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 43-kDa peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes %28%the alpha-1 gene%29%. It was first isolated from mammalian heart, but is widespread in the body including the brain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 43818' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 44 kDa mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 44-kDa extracellular signal-regulated MAP kinase that may play a role the initiation and regulation of MEIOSIS; MITOSIS; and postmitotic functions in differentiated cells. It phosphorylates a number of TRANSCRIPTION FACTORS; and MICROTUBULE-ASSOCIATED PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 48-Kd protein of the outer segment of the retinal rods and a component of the phototransduction cascade. Arrestin quenches G-protein activation by binding to phosphorylated photolyzed rhodopsin. Arrestin causes experimental autoimmune uveitis when injected into laboratory animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 5-carbon keto sugar. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 50-kDa protein that complexes with cdk2 in the late G1 phase of the cell cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation %28%COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE%29%. It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE %28%C3bBb%29% and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 56268' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 58-kDa protein that is regulated post-transcriptionally and post-translationally in the cell cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. EPIDERMAL GROWTH FACTOR exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and epithelial cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 60-kDa extracellular protein of Streptomyces avidinii with four high-affinity biotin binding sites. Unlike AVIDIN, streptavidin has a near neutral isoelectric point and is free of carbohydrate side chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 63-kDa serum glycoprotein encoded by gene C9. Monomeric C9 %28%mC9%29% binds the C5b-8 complex to form C5b-9 which catalyzes the polymerization of C9 forming C5b-p9 %28%MEMBRANE ATTACK COMPLEX%29% and transmembrane channels leading to lysis of the target cell. Patients with C9 deficiency suffer from recurrent bacterial infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 66-kDa peroxidase found in EOSINOPHIL granules. Eosinophil peroxidase is a cationic protein with a pI of 10.8 and is comprised of a heavy chain subunit and a light chain subunit. It possesses cytotoxic activity towards BACTERIA and other organisms, which is attributed to its peroxidase activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 7-carbon keto sugar having the mannose configuration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 70-kDa MAP kinase kinase kinase with specificity for MAP KINASE KINASE 5. It is activated during the cellular response to GROWTH FACTORS, oxidative stress, and hyperosmotic conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 70-kDa MAPK kinase kinase with specificity for MAP KINASE KINASE 5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 700-kDa cytosolic protein complex consisting of seven equimolar subunits %28%alpha, beta, beta%27%, gamma, delta, epsilon and zeta%29%. COATOMER PROTEIN and ADP-RIBOSYLATION FACTOR 1 are principle components of COAT PROTEIN COMPLEX I and are involved in vesicle transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 74, 33' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 77-kDa subcomponent of complement C1, encoded by gene C1S, is a SERINE PROTEASE existing as a proenzyme %28%homodimer%29% in the intact complement C1 complex. Upon the binding of COMPLEMENT C1Q to antibodies, the activated COMPLEMENT C1R cleaves C1s into two chains, A %28%heavy%29% and B %28%light, the serine protease%29%, linked by disulfide bonds yielding the active C1s. The activated C1s, in turn, cleaves COMPLEMENT C2 and COMPLEMENT C4 to form C4b2a %28%CLASSICAL C3 CONVERTASE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 80-kDa subcomponent of complement C1, existing as a SERINE PROTEASE proenzyme in the intact complement C1 complex. When COMPLEMENT C1Q is bound to antibodies, the changed tertiary structure causes autolytic activation of complement C1r which is cleaved into two chains, A %28%heavy%29% and B %28%light, the serine protease%29%, connected by disulfide bonds. The activated C1r serine protease, in turn, activates COMPLEMENT C1S proenzyme by cleaving the Arg426-Ile427 bond. No fragment is released when either C1r or C1s is cleaved.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2%27% position and an alpha-isobutyl sidechain at 5%27%alpha position of the molecule.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2%27% position of the molecule.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 9,10alpha-dihydro derivative of ERGOTAMINE that contains isopropyl sidechains at the 2%27% and 5%27% positions of the molecule.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 90-kDa protein produced by macrophages that severs ACTIN filaments and forms a cap on the newly exposed filament end. Gelsolin is activated by CALCIUM ions and participates in the assembly and disassembly of actin, thereby increasing the motility of some CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 93-kDa serum glycoprotein encoded by C7 gene. It is a polypeptide chain with 28 disulfide bridges. In the formation of MEMBRANE ATTACK COMPLEX; C7 is the next component to bind the C5b-6 complex forming a trimolecular complex C5b-7 which is lipophilic, resembles an integral membrane protein, and serves as an anchor for the late complement components, C8 and C9.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A 97-kDa extracellular signal-regulated MAP kinase. Mitogen-activated protein kinase 6 levels increase during cellular differentiation, while in proliferating cells the enzyme is degraded rapidly via the PROTEASOME ENDOPEPTIDASE COMPLEX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A B Family hnRNP Proteins' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A B-cell lymphoma presumably representing a tumor of interfollicular B-lymphocytes that may be functional. Those that are secrete identical immunoglobulin molecules.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR that is synthesized as a membrane-bound protein in the ENDOPLASMIC RETICULUM. In response to endoplasmic reticulum stress it translocates to the GOLGI APPARATUS. It is activated by PROTEASES and then moves to the CELL NUCLEUS to regulate GENETIC TRANSCRIPTION of GENES involved in the unfolded protein response.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A BETARETROVIRUS that causes pulmonary adenomatosis in sheep %28%PULMONARY ADENOMATOSIS, OVINE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A BRAIN-specific substrate for PROTEIN KINASE C that binds CALMODULIN and is involved in regulation of CALCIUM SIGNALING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A BROWN ALGAE closely related to FUCUS. It is found attached to rocks and boulders on the middle shore, primarily in the North Atlantic basin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Ba C 50,005' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A British colony in the Atlantic Islands, comprising two principal islands, East Falkland and West Falkland. Its capital is Stanley. Discovered in 1592, it was not occupied until the French settled there briefly in 1764. Later the English settled there but were expelled by the Spanish in 1770. The Falklands were claimed by Argentina but were occupied in 1833 by the British who, after an April 1982 invasion by Argentina, regained them in June. The islands were named by British Captain John Strong in 1690 for the fifth Viscount Falkland who financed Strong%27%s expedition. The Spanish name for the islands, Malvinas, is from the French Malouins, inhabitants of St. Malo who attempted to colonize the islands in 1764. %28%From Webster%27%s New Geographical Dictionary, 1988, p389 %26% Room, Brewer%27%s Dictionary of Names, 1992, p182%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A British colony in the western North Atlantic Ocean about 640 miles east southeast of Cape Hatteras, North Carolina. It comprises a group of about 300 islands of which only about 20 are inhabited. It is called also the Bermuda Islands or the Bermudas. It was named for the Spanish explorer Juan Bermudez who visited the islands in 1515. %28%From Webster%27%s New Geographical Dictionary, 1988, p140 %26% Room, Brewer%27%s Dictionary of Names, 1992, p61%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A C-type lectin that associates with NKG2 proteins to form receptors for HLA-E antigen on NATURAL KILLER CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A C-type lectin that is a cell surface receptor for ASIALOGLYCOPROTEINS. It is found primarily in the LIVER where it mediates the endocytosis of serum glycoproteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A C19 norditerpenoid alkaloid %28%DITERPENES%29% from the root of ACONITUM plants. It activates voltage-gated SODIUM CHANNELS. It has been used to induce ARRHYTHMIA in experimental animals and it has antiinflammatory and antineuralgic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CALCIUM-dependent adhesion molecule of DESMOSOMES that also plays a role in embryonic STEM CELL proliferation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CALCIUM-dependent endopeptidase that has specificity for cleavage at ARGININE that is near paired basic residues. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN; PRORENIN; proenkephalins; prodynorphin; prosomatostatin; and PROINSULIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CALCIUM-dependent, constitutively-expressed form of nitric acid synthase found primarily in ENDOTHELIAL CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CALCIUM-dependent, constitutively-expressed form of nitric acid synthase found primarily in NERVE TISSUE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CCAAT-enhancer binding protein that is induced by DNA DAMAGE and growth arrest. It serves as a dominant negative inhibitor of other CCAAT-enhancer binding proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CCAAT-enhancer-binding protein found in LIVER; ADIPOSE TISSUE; INTESTINES; LUNG; ADRENAL GLANDS; PLACENTA; OVARY and peripheral blood mononuclear cells %28%LEUKOCYTES, MONONUCLEAR%29%. Experiments with knock-out mice have demonstrated that CCAAT-enhancer binding protein-alpha is essential for the functioning and differentiation of HEPATOCYTES and ADIPOCYTES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CCAAT-enhancer-binding protein found in LIVER; INTESTINES; LUNG and ADIPOSE TISSUE. It is an important mediator of INTERLEUKIN-6 signaling.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CD antigen that contains a conserved I domain which is involved in ligand binding. When combined with CD18 the two subunits form MACROPHAGE-1 ANTIGEN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CD antigen that plays a role in T-lymphocyte proliferation and interleukin 2 production. It is a co-stimulatory ligand for the CD28 ANTIGEN on T-LYMPHOCYTES and initiates T-cell activation and immune response.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CD98 antigen light chain that when heterodimerized with CD98 antigen heavy chain %28%ANTIGENS, CD98 HEAVY CHAIN%29% forms a protein that mediates sodium-independent L-type amino acid transport.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CELL LINE derived from the kidney of the African green %28%vervet%29% monkey, %28%CERCOPITHECUS AETHIOPS%29% used primarily in virus replication studies and plaque assays.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CENTRAL NERVOUS SYSTEM STIMULANT. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1229%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CHROMATOGRAPHY method using supercritical fluid, usually carbon dioxide under very high pressure %28%around 73 atmospheres or 1070 psi at room temperature%29% as the mobile phase. Other solvents are sometimes added as modifiers. This is used both for analytical %28%SFC%29% and extraction %28%SFE%29% purposes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A COUP transcription factor that plays a role as a negative regulator of GENETIC TRANSCRIPTION that competes with other hormone receptors for the common response element AGGTCA. It can also stimulate transcription of genes involved in the METABOLISM of GLUCOSE and CHOLESTEROL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A COUP transcription factor that was originally identified as a homodimer that binds to a direct repeat regulatory element in the chicken albumin PROMOTOR. It is a transcription factor that plays an important role in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Chain, Ricin' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Chain, beta-Crystallin' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DIVERTICULUM at the upper end of the ESOPHAGUS through the cricopharyngeal muscle at the junction of the PHARYNX and the esophagus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA alkylating agent that has been shown to be a potent carcinogen and is widely used to induce colon tumors in experimental animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA amplification technique based upon the ligation of OLIGONUCLEOTIDE PROBES. The probes are designed to exactly match two adjacent sequences of a specific target DNA. The chain reaction is repeated in three steps in the presence of excess probe: %28%1%29% heat denaturation of double-stranded DNA, %28%2%29% annealing of probes to target DNA, and %28%3%29% joining of the probes by thermostable DNA ligase. After the reaction is repeated for 20-30 cycles the production of ligated probe is measured.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA helicase that is a component of TRANSCRIPTION FACTOR TFIIH. It plays an essential role in NUCLEOTIDE EXCISION REPAIR, and mutations in this protein are associated with XERODERMA PIGMENTOSUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA repair enzyme that catalyses the excision of ribose residues at apurinic and apyrimidinic DNA sites that can result from the action of DNA GLYCOSYLASES. The enzyme catalyzes a beta-elimination reaction in which the C-O-P bond 3%27% to the apurinic or apyrimidinic site in DNA is broken, leaving a 3%27%-terminal unsaturated sugar and a product with a terminal 5%27%-phosphate. This enzyme was previously listed under EC 3.1.25.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA repair enzyme that catalyzes DNA synthesis during base excision DNA repair. EC 2.7.7.7.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA repair enzyme that is an N-glycosyl hydrolase with specificity for DNA-containing ring-opened N%28%7%29%-methylguanine residues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA sequence that is found in the promoter region of many growth-related genes. The regulatory transcription factor SERUM RESPONSE FACTOR binds to and regulates the activity of genes containing this element.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA sequence that is found in the promoter region of vitamin D regulated genes. Vitamin D receptor %28%RECEPTOR, CALCITRIOL%29% binds to and regulates the activity of genes containing this element.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-binding protein that consists of 5 polypeptides and plays an essential role in DNA REPLICATION in eukaryotes. It binds DNA PRIMER-template junctions and recruits PROLIFERATING CELL NUCLEAR ANTIGEN and DNA POLYMERASES to the site of DNA synthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-binding protein that interacts with a 17-base pair sequence known as the CENP-B box motif. The protein is localized constitutively to the CENTROMERE and plays an important role in its maintenance.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-binding protein that mediates DNA REPAIR of double strand break, and GENETIC RECOMBINATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-binding protein that represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms but may be present in higher organisms. Use also for a more complex form of DNA polymerase III designated as DNA polymerase III* or pol III* which is 15 times more active biologically than DNA polymerase I in the synthesis of DNA. This polymerase has both 3%27%-5%27% and 5%27%-3%27% exonuclease activities, is inhibited by sulfhydryl reagents, and has the same template-primer dependence as pol II. EC 2.7.7.7.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. It may be present in higher organisms and has an intrinsic molecular activity only 5%25% of that of DNA Polymerase I. This polymerase has 3%27%-5%27% exonuclease activity, is effective only on duplex DNA with gaps or single-strand ends of less than 100 nucleotides as template, and is inhibited by sulfhydryl reagents. EC 2.7.7.7.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-dependent DNA polymerase characterized in prokaryotes and may be present in higher organisms. It has both 3%27%-5%27% and 5%27%-3%27% exonuclease activity, but cannot use native double-stranded DNA as template-primer. It is not inhibited by sulfhydryl reagents and is active in both DNA synthesis and repair. EC 2.7.7.7.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. EC 2.7.7.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin. EC 2.7.7.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A DNA-directed RNA polymerase found in BACTERIA. It is a holoenzyme that consists of multiple subunits including sigma factor 54.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Dehydrogenase, Isovaleryl-Coenzyme' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Disintegrin and Metalloprotease Proteins' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FENFLURAMINE analog that inhibits serotonin uptake and may provoke release of serotonin. It is used as an appetite depressant and an experimental tool in animal studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FERREDOXIN-dependent oxidoreductase that is primarily found in PLANTS where it plays an important role in the assimilation of SULFUR atoms for the production of CYSTEINE and METHIONINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FLAVOPROTEIN enzyme for AMMONIA assimilation in BACTERIA, microorganisms and PLANTS. It catalyzes the oxidation of 2 molecules of L-GLUTAMATE to generate L-GLUTAMINE and 2-oxoglutarate in the presence of NAD+.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FLAVOPROTEIN enzyme that catalyzes the oxidation of THIOREDOXIN to thioredoxin disulfide in the presence of NADP+. It was formerly listed as EC 1.6.4.5%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FLAVOPROTEIN enzyme that catalyzes the oxidative demethylation of DIMETHYLGLYCINE to SARCOSINE and FORMALDEHYDE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FLAVOPROTEIN oxidoreductase that occurs both as a soluble enzyme and a membrane-bound enzyme due to ALTERNATIVE SPLICING of a single mRNA. The soluble form is present mainly in ERYTHROCYTES and is involved in the reduction of METHEMOGLOBIN. The membrane-bound form of the enzyme is found primarily in the ENDOPLASMIC RETICULUM and outer mitochondrial membrane, where it participates in the desaturation of FATTY ACIDS; CHOLESTEROL biosynthesis and drug metabolism. A deficiency in the enzyme can result in METHEMOGLOBINEMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A FLAVOPROTEIN, this enzyme catalyzes the oxidation of SARCOSINE to GLYCINE; FORMALDEHYDE; and HYDROGEN PEROXIDE %28%H2O2%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Factor Receptor' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fanconi anemia complementation group protein that interacts with FANCC PROTEIN and FANCD2 PROTEIN. It promotes the accumulation of FANCC protein in the CELL NUCLEUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fanconi anemia complementation group protein that is the most commonly mutated protein in FANCONI ANEMIA. It undergoes PHOSPHORYLATION by PROTEIN KINASE B and forms a complex with FANCC PROTEIN in the CELL NUCLEUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fanconi anemia complementation group protein that regulates the activities of CYTOCHROME P450 REDUCTASE and GLUTATHIONE S-TRANSFERASE. It is found predominately in the CYTOPLASM, but moves to the CELL NUCLEUS in response to FANCE PROTEIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fanconi anemia complementation group protein that undergoes PHOSPHORYLATION by CDC2 PROTEIN KINASE during MITOSIS. It forms a complex with other FANCONI ANEMIA PROTEINS and helps protect CELLS from DNA DAMAGE by genotoxic agents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fanconi anemia complementation group protein that undergoes mono-ubiquitination by FANCL PROTEIN in response to DNA DAMAGE. Also, in response to IONIZING RADIATION it can undergo PHOSPHORYLATION by ATAXIA TELANGIECTASIA MUTATED PROTEIN. Modified FANCD2 interacts with BRCA2 PROTEIN in a stable complex with CHROMATIN, and it is involved in DNA REPAIR by homologous RECOMBINATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fanconi anemia complementation group protein. It is an essential component of a nuclear core complex that protects the GENOME against CHROMOSOMAL INSTABILITY. It interacts directly with FANCG PROTEIN and helps stabilize a complex with FANCA PROTEIN and FANCC PROTEIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Fiber' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai %28%born%29% + ana %28%kin%29%, implying a united and interrelated race of people. %28%From Webster%27%s New Geographical Dictionary, 1988, p418 %26% Room, Brewer%27%s Dictionary of Names, 1992, p195%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A G-protein-coupled receptor that signals an increase in intracellular calcium in response to the potent ANAPHYLATOXIN peptide COMPLEMENT C5A.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist at GABA-B receptors %28%RECEPTORS, GABA-B%29%. It is used in the treatment of spasticity, especially that due to spinal cord damage. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; %28%MEN 1%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GATA transcription factor that is expressed in the MYOCARDIUM of developing heart and has been implicated in the differentiation of CARDIAC MYOCYTES. GATA4 is activated by PHOSPHORYLATION and regulates transcription of cardiac-specific genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GATA transcription factor that is expressed predominately in SMOOTH MUSCLE CELLS and is involved in the CELL DIFFERENTIATION of CARDIAC MYOCYTES. In the developing heart, GATA5 becomes restricted to the ENDOCARDIUM and regulates transcription of genes such as cardiac TROPONIN C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GATA transcription factor that is expressed predominately in SMOOTH MUSCLE CELLS and regulates vascular smooth muscle CELL DIFFERENTIATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GATA transcription factor that is found predominately in LYMPHOID CELL precursors and has been implicated in the CELL DIFFERENTIATION of HELPER T-CELLS. Haploinsufficiency of GATA3 is associated with HYPOPARATHYROIDISM; SENSORINEURAL HEARING LOSS; and renal anomalies syndrome.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GATA transcription factor that is specifically expressed in hematopoietic lineages and plays an important role in the CELL DIFFERENTIATION of ERYTHROID CELLS and MEGAKARYOCYTES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GLUTATHIONE dimer formed by a disulfide bond between the cysteine sulfhydryl side chains during the course of being oxidized.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in developing tectum. It has been shown to mediate the bundling of cortical axons and repel the axonal growth of retinal ganglia axons. It is found in a variety of adult tissues of BRAIN; HEART; and KIDNEY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in variety of adult tissue such as KIDNEY; LUNG; COLON and OVARY. During embryonic development, ephrin-A4 is expressed in the HIPPOCAMPUS and CEREBRAL CORTEX. It binds preferentially to ephA receptors %28%EPH FAMILY RECEPTORS%29% with the exception of the EPHA1 RECEPTOR.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin with a high affinity for the EPHA3 RECEPTOR; EPHA5 RECEPTOR; EPHA6 RECEPTOR; EPHA7 RECEPTOR; and EPHA8 RECEPTOR. It is found primarily in NERVE TISSUE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR-containing ephrin with a high affinity for the EPHA3 RECEPTOR. Early in embryogenesis it is expressed at high levels in the MESENCEPHALON; SOMITES; branchial arches, and LIMB BUD.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GTP-BINDING PROTEIN involved in regulating a signal transduction pathway that controls assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GTPase activating protein that is specific for RAC GTP-BINDING PROTEINS. It is expressed primarily in the brain and may be involved in signal transduction. The alternatively spliced form of CHIMERIN 1 %28%alpha-2 Chimerin%29% contains an additional src homology domain and is expressed in both the brain and testes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Gene' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Gene Product' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Genes' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A HEPARIN binding fibroblast growth factor that may play a role in LIMB BUD development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A HERNIA due to an imperfect closure or weakness of the umbilical ring. It appears as a skin-covered protrusion at the UMBILICUS during crying, coughing, or straining. The hernia generally consists of OMENTUM or SMALL INTESTINE. The vast majority of umbilical hernias are congenital but can be acquired due to severe abdominal distention.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Hydratase, trans-2-Enoyl-Coenzyme' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A LDL-receptor related protein involved in clearance of chylomicron remnants and of activated ALPHA-MACROGLOBULINS from plasma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A LEUCINE and DNA-binding protein that is found primarily in BACTERIA and ARCHAEA. It regulates GENETIC TRANSCRIPTION involved in METABOLISM of AMINO ACIDS in response to the increased concentration of LEUCINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A LIPOIC ACID-containing protein that plays the pivotal role in the transfer of methylamine groups and reducing equivalents between the three enzymatic components of the glycine decarboxylase complex.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A LIVER mitochondrial matrix flavoenzyme that catalyzes the oxidation of SARCOSINE to GLYCINE and FORMALDEHYDE. Mutation in the enzyme causes sarcosinemia, a rare autosomal metabolic defect characterized by elevated levels of SARCOSINE in BLOOD and URINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Ligases, Co' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Ligases, Coenzyme' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A MADS domain-containing transcription factor that binds to the SERUM RESPONSE ELEMENT in the promoter-enhancer region of many genes. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A MANNOSE/GLUCOSE binding lectin isolated from the jack bean %28%Canavalia ensiformis%29%. It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A MEPERIDINE congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A MOLYBDENUM requiring enzyme that catalyzes the terminal reaction in the oxidative degradation of SULFUR AMINO ACIDS with the formation of a sulfate. A deficiency of sulfite oxidase results in sulfocysteinuria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A N-hydroxylated derivative of 2-ACETYLAMINOFLUORENE that has demonstrated carcinogenic action.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A NAD-dependent oxidoreductase that catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5,10-methenyl-tetrahdyrofolate. It has been found in a variety of microorganisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A NADPH-dependent oxidase that reduces hydrogen sulfite to HYDROGEN SULFIDE. It is found in many microoganisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Netherlands overseas territory in the Lesser Antilles in the West Indies. It includes the islands of Aruba, Bonaire, Curacao, Saba, St. Eustatius, and the southern part of St. Martin. Its capital is Willemstad. Its former names are Curacao, Netherlands West Indies, and Dutch West Indies. Its colonial status was abolished by the Netherlands government in 1954 but it is considered an integral part of the Dutch realm. There is no positive evidence for the name Antilles. %28%From Random House Unabridged Dictionary, 2d ed, 1993 %26% Webster%27%s New Geographical Dictionary, 1988, p823%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A P450 oxidoreductase that catalyzes the hydroxylation of the terminal carbon of linear hydrocarbons such as OCTANE and FATTY ACIDS in the omega position. The enzyme may also play a role in the oxidation of a variety of structurally unrelated compounds such as XENOBIOTICS, and STEROIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PDGF receptor that binds specifically to both PDGF-A chains and PDGF-B chains. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PDGF receptor that binds specifically to the PDGF-B chain. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PEPTIC ULCER located in the DUODENUM. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PEPTIDE of 22 amino acids, derived mainly from cells of VASCULAR ENDOTHELIUM. It is also found in the BRAIN, major endocrine glands, and other tissues. It shares structural homology with ATRIAL NATRIURETIC FACTOR. It has vasorelaxant activity thus is important in the regulation of vascular tone and blood flow. Several high molecular weight forms containing the 22 amino acids have been identified.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PERTUSSIS TOXIN-sensitive GTP-binding protein alpha subunit. It couples with a variety of CELL SURFACE RECEPTORS, has been implicated in INTERLEUKIN-12 production, and may play a role in INFLAMMATORY BOWEL DISEASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A POSTPARTUM condition consists of persistent lactation %28%GALACTORRHEA%29% and AMENORRHEA in patients not BREAST FEEDING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A POU domain factor that activates GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS; alpha internexin; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; and BCL-2 PROTO-ONCOGENE PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A POU domain factor that activates neuronal cell GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS, alpha internexin, and SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. Mutations in the Brn-3c gene have been associated with DEAFNESS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A POU domain factor that regulates expression of GROWTH HORMONE; PROLACTIN; and THYROTROPIN-BETA in the ANTERIOR PITUITARY GLAND.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A POU domain factor that represses GENETIC TRANSCRIPTION of GENES encoding NEUROFILAMENT PROTEINS, alpha internexin, and SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PREDNISOLONE derivative with similar anti-inflammatory action.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PROFILIN binding domain protein that is part of the Arp2-3 complex. It is related in sequence and structure to ACTIN and binds ATP.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PROTEIN O-METHYLTRANSFERASE that recognizes and catalyzes the methyl esterification of ISOASPARTIC ACID and D-ASPARTIC ACID residues in peptides and proteins. It initiates the repair of proteins damaged by the spontaneous decomposition of normal L-aspartic acid and L-asparagine residues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PROTEIN-SERINE-THREONINE KINASE that is found in PHOTORECEPTORS. It mediates light-dependent PHOSPHORYLATION of RHODOPSIN and plays an important role in PHOTOTRANSDUCTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60%28%V-SRC%29%. They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src %28%v-src%29% genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transamination of branched-chain AMINO ACIDS to 2-OXOGLUTARATE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the reversible transfer of an amino group between D-Alanine and ALPHA-KETOGLUTARATE to form PYRUVATE and D-GLUTAMATE, respectively. It plays a role in the synthesis of the bacterial CELL WALL. This enzyme was formerly classified as EC 2.6.1.10.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer amino group from L-TRYPTOPHAN to 2-OXOGLUTARATE in order to generate indolepyruvate and L-GLUTAMATE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer amino group from N-succinyl-L-2,6-diaminoheptanedioate to 2-OXOLGLUTARATE in order to generate N-succinyl-2-L-amino-6-oxoheptanedioate and L-GLUTAMATE, respectively.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of GLYCINE onto 2-OXOGLUTARATE to generate GLYOXYLATE and L-GLUTAMATE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-2-aminoadipate onto 2-OXOGLUTARATE to generate 2-oxoadipate and L-GLUTAMATE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of amino group of L-LYSINE onto 2-OXOGLUTARATE to generate 2-aminoadipate 6-semialdehyde and L-GLUTAMATE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE containing enzyme that catalyzes the transfer of an amino group from L-ALANINE to 3-oxopropanoate to generate PYRUVATE and BETA-ALANINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE dependent enzyme that catalyzes the decarboxylation of GLYCINE with the transfer of an aminomethyl group to the LIPOIC ACID moiety of the GLYCINE DECARBOXYLASE COMPLEX H-PROTEIN. Defects in P-protein are the cause of non-ketotic hyperglycinemia. It is one of four subunits of the glycine decarboxylase complex.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL PHOSPHATE-containing enzyme that catalyzes the transfer of a formyl group from L-GLUTAMATE to N-formimidoyl-L-glutamate and TETRAHYDROFOLATE. This enzyme may also catalyze formyl transfer from 5-formyltetrahydrofolate to L-GLUTAMATE. This enzyme was formerly categorized as EC 2.1.2.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A PYRIDOXAL-phosphate containing enzyme that catalyzes the dehydration and deamination of L-serine to form pyruvate. This enzyme was formerly listed as EC 4.2.1.13.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Polymerase, Poly' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Portuguese colony on the island of Macao and adjacent islands off the southeast coast of China.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A RHO GTP-BINDING PROTEIN involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A RNA-binding protein that binds to polypyriminidine rich regions in the INTRONS of messenger RNAs. Polypyrimidine tract-binding protein may be involved in regulating the ALTERNATIVE SPLICING of mRNAs since its presence on an intronic RNA region that is upstream of an EXON inhibits the splicing of the exon into the final mRNA product.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A RNA-binding protein that is found predominately in the CYTOPLASM. It helps regulate GENETIC TRANSLATION in NEURONS and is absent or under-expressed in FRAGILE X SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A RNA-binding protein that stimulates the cleavage of the 3%27% end of MRNA near the POLYADENYLATION site. It is a heterotrimer of 55-, 64- and 77-kDa subunits and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3%27% cleavage and polyadenylation reaction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Rec A recombinase found in eukaryotes. Rad51 is involved in DNA REPAIR of double-strand breaks.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Receptor, Cholecystokinin' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Receptors, Neurokinin' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A SH2 DOMAIN-containing protein that mediates SIGNAL TRANSDUCTION pathways from multiple CELL SURFACE RECEPTORS, including the EPHB1 RECEPTOR. It interacts with FOCAL ADHESION KINASE and is involved in CELL MIGRATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A SKELETAL MUSCLE-specific transcription factor that contains a basic HELIX-LOOP-HELIX MOTIF. It plays an essential role in MUSCLE DEVELOPMENT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A SOMATOSTATIN-secreting tumor derived from the pancreatic delta cells %28%SOMATOSTATIN-SECRETING CELLS%29%. It is also found in the INTESTINE. Somatostatinomas are associated with DIABETES MELLITUS; CHOLELITHIASIS; STEATORRHEA; and HYPOCHLORHYDRIA. The majority of somatostatinomas have the potential for METASTASIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A SYNOVIAL CYST located in the back of the knee, in the popliteal space arising from the semimembranous bursa or the knee joint.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Subunit beta-Crystallin' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Synthetases, Coenzyme' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A T-cell factor that plays an essential role in EMBRYONIC DEVELOPMENT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine %28%T4%29%. Most T3 is derived from peripheral monodeiodination of T4 at the 5%27% position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TCF transcription factor that was originally identified as a DNA-binding protein that interacts with the ENHANCERS of T-CELL RECEPTOR ALPHA GENES. It is a plays a role in T-LYMPHOCYTE development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TETRACYCLINE analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than TETRACYCLINE, it maintains effective blood levels for longer periods of time.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES rimosus and used in a wide variety of clinical conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TETRACYCLINE with a 7-chloro substitution. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TEXTILE fiber obtained from the pappus %28%outside the SEEDS%29% of cotton plant %28%GOSSYPIUM%29%. Inhalation of cotton fiber dust over a prolonged period can result in BYSSINOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TIE receptor found predominantly on ENDOTHELIAL CELLS. It is considered essential for vascular development and can form a heterodimer with the TIE-2 RECEPTOR. The TIE-1 receptor may play a role in regulating BLOOD VESSEL stability and maturation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A TIE receptor tyrosine kinase that is found almost exclusively on ENDOTHELIAL CELLS. It is required for both normal embryonic vascular development %28%NEOVASCULARIZATION, PHYSIOLOGIC%29% and tumor angiogenesis %28%NEOVASCULARIZATION, PATHOLOGIC%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Transferases, Coenzyme' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Type Potassium Channel Modulatory Protein 1' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Type Potassium Channel Modulatory Protein 2' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Type Potassium Channel Modulatory Protein 3' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Type Potassium Channel Modulatory Protein 4' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Type Potassium Channel Modulatory Proteins' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A United States organization of distinguished scientists and engineers established for the purpose of investigating and reporting upon any subject of art or science as requested by any department of government. The National Research Council organized by NAS serves as the principal operating agency to stimulate and support research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A V Node' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A VITAMIN D that can be regarded as a reduction product of vitamin D2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC FINGER MOTIF containing immediate early protein that is closely related to TRISTETRAPROLIN. It interacts with and helps destabilize VASCULAR ENDOTHELIAL GROWTH FACTOR mRNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC FINGER MOTIF containing transcription factor that was originally identified as one of the IMMEDIATE-EARLY PROTEINS. It shuttles between the CYTOPLASM and the CELL NUCLEUS and is involved in destabilization of mRNAs for TUMOR NECROSIS FACTOR-ALPHA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC FINGER MOTIF protein that recognizes and interacts with damaged DNA. It is a DNA-binding protein that plays an essential role in NUCLEOTIDE EXCISION REPAIR. Mutations in this protein are associated with the most severe form of XERODERMA PIGMENTOSUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC metalloenzyme that catalyzes the transfer of a methyl group from BETAINE to HOMOCYSTEINE to produce dimethylglycine and METHIONINE, respectively. This enzyme is a member of a family of ZINC-dependent METHYLTRANSFERASES that use THIOLS or selenols as methyl acceptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC-containing exopeptidase primarily found in SECRETORY VESICLES of endocrine and neuroendocrine cells. It catalyzes the cleavage of C-terminal ARGININE or LYSINE residues from polypeptides and is active in processing precursors of PEPTIDE HORMONES and other bioactive peptides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC-dependent carboxypeptidase primary found in the DIGESTIVE SYSTEM. The enzyme catalyzes the preferential cleavage of a C-terminal peptidyl-L-lysine or arginine. It was formerly classified as EC 3.4.2.2 and EC 3.4.12.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ZINC-dependent membrane-bound aminopeptidase that catalyzes the N-terminal peptide cleavage of GLUTAMATE %28%and to a lesser extent ASPARTATE%29%. The enzyme appears to play a role in the catabolic pathway of the RENIN-ANGIOTENSIN SYSTEM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A alphalipoprotein Neuropathy' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. %28%From AMA Drug Evaluations Annual, 1994, p2290%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Gyrase binds to DNA as a heterotetramer consisting two A and two B subunits. In the presence of ATP, gyrase is able to convert relaxed circular DNA duplex into a superhelix. In the absence of ATP, supercoiled DNA is relaxed by DNA gyrase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Topoisomerase IV binds to DNA as a heterotetramer consisting 2 parC and 2 parE subunits. Topoisomerase IV is a decatenating enzyme that resolves interlinked daughter chromosomes following DNA replication.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterial genus of the order ACTINOMYCETALES. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterial protein from Pseudomonas, Bordetella, or Alcaligenes which operates as an electron transfer unit associated with the cytochrome chain. The protein has a molecular weight of approximately 16,000, contains a single copper atom, is intensively blue, and has a fluorescence emission band centered at 308nm.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bactericidal and fungicidal antiseptic. It is used as a 0.1%25% mouthwash for local infections and oral hygiene. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p797%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacteriocin produced by a plasmid that can occur in several bacterial strains. It is a basic protein of molecular weight 56,000 and exists in a complex with its immunity protein which protects the host bacterium from its effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacteriophage genus of the family LEVIVIRIDAE, whose viruses contain the longer version of the genome and have no separate cell lysis gene.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacteriophage genus of the family LEVIVIRIDAE, whose viruses contain the short version of the genome and have a separate gene for cell lysis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p208%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterium which causes mastitis in cattle and occasionally in man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bacterium which is one of the etiologic agents of bacillary dysentery %28%DYSENTERY, BACILLARY%29% and sometimes of infantile gastroenteritis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration. It is also used for hypnosis and for the control of convulsive states. It has been used in neurosurgical patients to reduce increased intracranial pressure. It does not produce any excitation but has poor analgesic and muscle relaxant properties. Small doses have been shown to be anti-analgesic and lower the pain threshold. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p920%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p919%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbiturate that is effective as a hypnotic and sedative.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbiturate that is metabolized to PHENOBARBITAL. It has been used for similar purposes, especially in EPILEPSY, but there is no evidence mephobarbital offers any advantage over PHENOBARBITAL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbiturate with hypnotic and sedative properties %28%but not antianxiety%29%. Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p565%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory GAMMA-AMINOBUTYRIC ACID subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basement membrane in the cochlea that supports the HAIR CELLS of the ORGAN OF CORTI, consisting keratin-like fibrils. It stretches from the SPIRAL LAMINA to the basilar crest. The movement of fluid in the cochlea, induced by sound, causes displacement of the basilar membrane and subsequent stimulation of the attached hair cells which transform the mechanical signal into neural activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic aluminum complex of sulfated sucrose. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation %28%as factor IV%29% and in many enzymatic processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic helix-loop-helix leucine zipper transcription factor that regulates the CELL DIFFERENTIATION and development of a variety of cell types including MELANOCYTES; OSTEOCLASTS; and RETINAL PIGMENT EPITHELIUM. Mutations in MITF protein have been associated with OSTEOPETROSIS and WAARDENBURG%27%S SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic helix-loop-helix transcription factor that plays a role in APOPTOSIS. It is composed of two subunits: ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR and HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic helix-loop-helix transcription factor that was originally identified in DROSOPHILA as essential for proper gastrulation and MESODERM formation. It plays an important role in EMBRYONIC DEVELOPMENT and CELL DIFFERENTIATION of MUSCLE CELLS, and is found in a wide variety of organisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic leucine zipper transcription factor that is highly homologous to ACTIVATING TRANSCRIPTION FACTOR 2. It binds the consensus site TGACGTCA of the cyclic AMP response element in partnership with either PROTO-ONCOGENE PROTEINS C-JUN or activating transcription factor 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic polypeptide isolated from Streptomyces netropsis. It is cytotoxic and its strong, specific binding to A-T areas of DNA is useful to genetics research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic-leucine zipper transcription factor that is closely related to C-FOS PROTEINS. It forms heterodimeric complexes with C-JUN PROTEINS to regulate GENE transcription.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic-leucine zipper transcription factor that is involved in regulating inflammatory responses, MORPHOGENESIS, and HEME biosynthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic-leucine zipper transcription factor that regulates GLOBIN gene expression and is related to TRANSCRIPTION FACTOR AP-1. NF-E2 consists of a small MAF protein subunit and a tissue-restricted 45 kDa subunit.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom %28%A. campestris%29% and the commercial mushroom %28%A. bisporus%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. %28%From DSM-IV%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A behavioral response manifested by leaving home in order to escape from threatening situations. Children or adolescents leaving home without permission is usually implied.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign brain tumor composed of neural elements which most often arise from the SEPTUM PELLUCIDUM and the walls of the lateral ventricles. Immunohistochemistry and electron microscopy evaluations may reveal expression of neuron specific enolase and synaptophysin and cells containing microtubuli, neurosecretory granules, and presynaptic vesicles. %28%From Acta Med Port 1994 Feb;7%28%2%29%:113-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign compound nevus occurring most often in children before puberty, composed of spindle and epithelioid cells located mainly in the dermis, sometimes in association with large atypical cells and multinucleate cells, and having a close histopathological resemblance to malignant melanoma. The tumor presents as a smooth to slightly scaly, round to oval, raised, firm papule or nodule, ranging in color from pink-tan to purplish red, often with surface telangiectasia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign condition of the tongue characterized by hypertrophy of the filiform papillae that give the dorsum of the tongue a furry appearance. The color of the elongated papillae varies from yellowish white to brown or black, depending upon staining by substances such as tobacco, food, or drugs. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign epithelial tumor of the LIVER. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign epithelial tumor with a glandular organization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign familial disorder, transmitted as an autosomal dominant trait. It is characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign myxoma of cutaneous nerve sheath origin. Theke is from the Greek theke, sheath. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm composed of a mixture of adipose tissue and blood vessels. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm derived from epithelial cells of sweat glands. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone %28%true chondroma or enchondroma%29% or may develop on the surface of a cartilage %28%ecchondroma or ecchondrosis%29%. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm of alveolar pneumocytes or ontogenetically primitive counterparts thereof. Morphological patterns that have been described include: solid, hemorrhagic, papillary, and sclerotic. Most lesions display a combination of two or three morphological patterns. Despite the implication by its name %28%HEMANGIOMA%29% of a vascular neoplasm, pulmonary sclerosing hemangioma is considered by most authorities to be an epithelial tumor. %28%Histopathology 2003;43%28%3%29%:239-43; Arch Pathol Lab Med. 2001;125%28%10%29%: 1335-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm of muscle %28%usually smooth muscle%29% with glandular elements. It occurs most frequently in the uterus and uterine ligaments. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm of muscular tissue. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm of the ADRENAL CORTEX. It is characterized by a well-defined nodular lesion, usually less than 2.5 cm. Most adrenocortical adenomas are nonfunctional. The functional ones are yellow and contain LIPIDS. Depending on the cell type or cortical zone involved, they may produce ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm of the ovary. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign neoplasm that usually arises from the sympathetic trunk in the mediastinum. Histologic features include spindle cell proliferation %28%resembling a neurofibroma%29% and the presence of large ganglion cells. The tumor may present clinically with HORNER SYNDROME or diarrhea due to ectopic production of vasoactive intestinal peptide. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p966%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign pituitary-region neoplasm that originates from Rathke%27%s pouch. The two major histologic and clinical subtypes are adamantinous %28%or classical%29% craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. %28%From Joynt, Clinical Neurology, 1998, Ch14, p50%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor composed of bone tissue or a hard tumor of bonelike structure developing on a bone %28%homoplastic osteoma%29% or on other structures %28%heteroplastic osteoma%29%. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor composed of fat cells. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 5th ed, p1747%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor consisting of vascular and smooth muscle elements.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements %28%angiolipoleiomyoma%29% in association with tuberous sclerosis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1354%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of fibrous or fully developed connective tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of the anterior pituitary in which the cells do not stain with acidic or basic dyes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of the intrahepatic bile ducts. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of the nervous system that may occur sporadically or in association with HIPPEL-LINDAU DISEASE. It accounts for approximately 2%25% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor of the sweat glands which is usually multiple and results from malformation of sweat ducts. It is uncommon and more common in females than in males. It is most likely to appear at adolescence, and further lesions may develop during adult life. It does not appear to be hereditary. %28%Rook et al., Textbook of Dermatology, 4th ed, pp2407-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor representing a congenital malformation of the lymphatic system and made up of newly formed lymph-containing vascular spaces and channels. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor that consists chiefly of fibrous CONNECTIVE TISSUE, with variable numbers of MUSCLE CELLS forming portions of the neoplasm %28%From Stedman%27%s, 27th ed%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor, made up of an overgrowth of BLOOD VESSELS. It is extremely common, occurring mostly in infancy and childhood. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. About 75%25% are present at birth, and about 60%25% occur in the head and neck area. %28%from Stedman, 25th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1355%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, autosomally recessive inherited hyperbilirubinemia characterized by the presence of a dark pigment in the centrilobular region of the liver cells. There is a functional defect in biliary excretion of bilirubin, cholephilic dyes, and porphyrins. Affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. The liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, inflammatory, variably ulcerated, occasionally bilateral, self-healing lesion of the minor salivary glands that is often confused clinically and histologically with carcinoma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, painful, tumor of bone characterized by the formation of osteoid tissue, primitive bone and calcified tissue. It occurs frequently in the spine of young persons. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, rapidly growing, deeply pigmented tumor of the jaw and occasionally of other sites, consisting of an infiltrating mass of cells arranged in an alveolar pattern, and occurring almost exclusively in infants. Its source of origin is in dispute, the various theories giving rise to its several names. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, relatively slow-growing, central bone tumor, usually of the jaws %28%especially the mandible%29% which is composed of fibrous connective tissue within which bone is formed. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzamide-sulfonamide-indole. It is called a thiazide-like diuretic but structure is different enough %28%lacking the thiazo-ring%29% so it is not clear that the mechanism is comparable.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects of GALLAMINE TRIETHIODIDE and TUBOCURARINE and has been studied as a treatment for ALZHEIMER DISEASE and other central nervous system disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzene-sulfonamide-furan. It is used as a diuretic that affects the concentrating ability of the KIDNEY, increases SODIUM CHLORIDE excretion, but may not spare POTASSIUM. It inhibits CARBONIC ANHYDRASES and may increase the blood URIC ACID level.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p38%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzimidazoyl-substituted tetraline that selectively binds and inhibits CALCIUM CHANNELS, T-TYPE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine derivative used as an anticonvulsant and hypnotic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine derivative used mainly as a hypnotic. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine that is used in the treatment of ANXIETY DISORDERS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p589%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than DIAZEPAM or NITRAZEPAM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzodioxane alpha-adrenergic blocking agent with considerable stimulatory action. It has been used to diagnose PHEOCHROMOCYTOMA and as an antihypertensive agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzofuran derivative used as a protein reagent since the terminal N-NBD-protein conjugate possesses interesting fluorescence and spectral properties. It has also been used as a covalent inhibitor of both beef heart mitochondrial ATPase and bacterial ATPase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzothaizole which is oxidized by LUCIFERASES, FIREFLY to cause emission of light %28%LUMINESCENCE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-2 selective adrenergic antagonist. It is used primarily in animal and tissue experiments to characterize beta-2 receptor involvement and identify beta-2 receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic agonist used in the treatment of asthma and bronchospasms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-carboline alkaloid isolated from seeds of PEGANUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beta-lactamase preferentially cleaving penicillins. %28%Dorland, 28th ed%29% EC 3.5.2.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beverage made from ground COFFEA beans %28%SEEDS%29% infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A beverage prepared from SOYBEANS. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bibliographic database that includes MEDLINE as its primary subset. It is produced by the National Center for Biotechnology Information %28%NCBI%29%, part of the NATIONAL LIBRARY OF MEDICINE. PubMed, which is searchable through NLM%27%s Web site, also includes access to additional citations to selected life sciences journals not in MEDLINE, and links to other resources such as the full-text of articles at participating publishers%27% Web sites, NCBI%27%s molecular biology databases, and PubMed Central.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliography of publications about a country %28%whether written by its nationals or not%29% and those written in the language of the country as well as those published in it. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bicyclic monoterpene ketone found widely in plant %28%primarily the camphor tree, Cinnamomum camphora%29%. Natural camphor is used topically as a skin antipruritic and as an anti-infective agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE %28%cADPR%29% from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biguanide compound which has little antimalarial activity until metabolized in the body to the active antimalarial agent cycloguanil. The usefulness of proguanil is limited by the rapid development of drug resistance by the malarial parasite. The hydrochloride is used for the casual prophylaxis of falciparum malaria, to suppress other forms of malaria, and to reduce transmission of infection %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p405%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p289%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p290%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile pigment that is a degradation product of HEME. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. It is a cholagogue and choleretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A binding partner for several RECEPTOR PROTEIN-TYROSINE KINASES, including INSULIN RECEPTOR and INSULIN-LIKE GROWTH FACTOR RECEPTOR. It contains a C-terminal SH2 DOMAIN and mediates various SIGNAL TRANSDUCTION pathways.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families %28%RECEPTORS, SEROTONIN%29% explain the broad physiological actions and distribution of this biochemical mediator.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biocompatible polymer used as a surgical suture material.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biocompatible, hydrophilic, inert gel that is permeable to tissue fluids. It is used as an embedding medium for microscopy, as a coating for implants and prostheses, for contact lenses, as microspheres in adsorption research, etc.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bioflavonoid that strengthens vascular walls. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biography which includes a list of the writings of the subject person.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biologically active 5-alpha-reduced metabolite of plasma PROGESTERONE. It is the immediate precursor of 5-alpha-pregnan-3-alpha-ol-20-one %28%ALLOPREGNANOLONE%29%, a neuroactive steroid that binds with GABA%28%A%29% RECEPTOR.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. %28%From Dictionary of Prostaglandins and Related Compounds, 1990%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biologically active tridecapeptide isolated from the hypothalamus. It has been shown to induce hypotension in the rat, to stimulate contraction of guinea pig ileum and rat uterus, and to cause relaxation of rat duodenum. There is also evidence that it acts as both a peripheral and a central nervous system neurotransmitter.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biosensing technique in which biomolecules capable of binding to specific analytes or ligands are first immobilized on one side of a metallic film. Light is then focused on the opposite side of the film to excite the surface plasmons, that is, the oscillations of free electrons propagating along the film%27%s surface. The refractive index of light reflecting off this surface is measured. When the immobilized biomolecules are bound by their ligands, an alteration in surface plasmons on the opposite side of the film is created which is directly proportional to the change in bound, or adsorbed, mass. Binding is measured by changes in the refractive index. The technique is used to study biomolecular interactions, such as antigen-antibody binding.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A biotin-dependent enzyme belonging to the ligase family that catalyzes the addition of CARBON DIOXIDE to pyruvate. It is occurs in both plants and animals. Deficiency of this enzyme causes severe psychomotor retardation and ACIDOSIS, LACTIC in infants. EC 6.4.1.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A birth defect due to malformation of the URETHRA in which the urethral opening is above its normal location. In the male, the malformed urethra generally opens on the top or the side of the PENIS, but the urethra can also be open the entire length of the penis. In the female, the malformed urethral opening is often between the CLITORIS and the labia, or in the ABDOMEN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A birth defect due to malformation of the URETHRA in which the urethral opening is below its normal location. In the male, the malformed urethra generally opens on the ventral surface of the PENIS or on the PERINEUM. In the female, the malformed urethral opening is in the VAGINA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A birth defect in which the urinary BLADDER is malformed and exposed, inside out, and protruded through the ABDOMINAL WALL. It is caused by closure defects involving the top front surface of the bladder, as well as the lower abdominal wall; SKIN; MUSCLES; and the pubic bone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blocking of nerve conduction to a specific area by an injection of an anesthetic agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blood group consisting mainly of the antigens Fy%28%a%29% and Fy%28%b%29%, determined by allelic genes, the frequency of which varies profoundly in different human groups; amorphic genes are common.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blood group related both to the ABO and P systems that includes several different antigens found in most people on erythrocytes, in milk, and in saliva. The antibodies react only at low temperatures.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blood group related to the ABO, Lewis and I systems. At least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blood plasma glycoprotein that mediates cell adhesion and interacts with proteins of the complement, coagulation, and fibrinolytic cascade. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blood protein %28%NSILA%29% which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10%25% of the activity is found in the supernatant %28%NSILA-S%29% and the remaining activity in the precipitate %28%NSILA-P%29%. The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blood-filled VAGINA that is obstructed. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blue-green biliprotein widely distributed in the plant kingdom.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A blue-red, extremely painful vascular neoplasm involving a glomeriform arteriovenous anastomosis %28%glomus body%29%, which may be found anywhere in the skin, most often in the distal portion of the fingers and toes, especially beneath the nail. It is composed of specialized pericytes %28%sometimes termed glomus cells%29%, usually in single encapsulated nodular masses which may be several millimeters in diameter %28%From Stedman, 27th ed%29%. CHEMODECTOMA, a tumor of NEURAL CREST origin, is also sometimes called a glomus tumor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bluish-gray to gray-brown benign, melanocytic nevus found usually in the LUMBOSACRAL REGION of dark-skinned people, especially those of East Asian ancestry. It is usually congenital or appears shortly after birth, and disappears in childhood.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A board-certified specialty of VETERINARY MEDICINE, requiring at least four years of special education, training, and practice of veterinary surgery after graduation from veterinary school. In the written, oral, and practical examinations candidates may choose either large or small animal surgery. %28%From AVMA Directory, 43d ed, p278%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A body of stories, the origins of which may be unknown or forgotten, that serve to explain practices, beliefs, institutions or natural phenomena. Mythology includes legends and folk tales. It may refer to classical mythology or to a body of modern thought and modern life. %28%From Webster%27%s 1st ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A body of water covering approximately one-fifth of the total ocean area of the earth, extending amidst Africa in the west, Australia in the east, Asia in the north, and Antarctica in the south. Including the Red Sea and the Persian Gulf, it constitutes the third largest ocean after the ATLANTIC OCEAN and the PACIFIC OCEAN. %28%New Encyclopaedia Britannica Micropaedia, 15th ed, 1990, p289%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bone fixation technique using an external fixator %28%FIXATORS, EXTERNAL%29% for lengthening limbs, correcting pseudarthroses and other deformities, and assisting the healing of otherwise hopeless traumatic or pathological fractures and infections, such as chronic osteomyelitis. The method was devised by the Russian orthopedic surgeon Gavriil Abramovich Ilizarov %28%1921-1992%29%. %28%From Bull Hosp Jt Dis 1992 Summer;52%28%1%29%:1%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bony outgrowth on the lower surface of the CALCANEUS. Though often presenting along with plantar fasciitis %28%FASCIITIS, PLANTAR%29%, they are not considered causally related.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bony proliferation and articular degeneration of the first METATARSOPHALANGEAL JOINT that is characterized by pain and a progressive decrease in the dorsiflexion range of motion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bony prominence situated on the upper surface of the body of the sphenoid bone. It houses the PITUITARY GLAND.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A botanical insecticide that is an inhibitor of mitochondrial electron transport.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of applied ethics that studies the value implications of practices and developments in life sciences, medicine, and health care.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of computer or library science relating to the storage, locating, searching, and selecting, upon demand, relevant data on a given subject.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. %28%Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of engineering concerned with the design, construction, and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism %28%BIOTRANSFORMATION%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of law that defines criminal offenses, regulates the apprehension, charging and trial of suspected persons, and fixes the penalties and modes of treatment applicable to convicted offenders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of medicine concerned with an individual%27%s resuscitation, transportation and care from the point of injury or beginning of illness through the hospital or other emergency treatment facility.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of medicine concerned with the role of socio-environmental factors in the occurrence, prevention and treatment of disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period beginning with puberty until the cessation of somatic growth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of medicine which deals with sexually transmitted disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of psychology in which there is collaboration between psychologists and physicians in the management of medical problems. It differs from clinical psychology, which is concerned with the diagnosis and treatment of behavior disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of psychology which investigates the correlation between experience or behavior and the basic neurophysiological processes. The term neuropsychology stresses the dominant role of the nervous system. It is a more narrowly defined field than physiological psychology or psychophysiology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of the external carotid artery which distributes to the deep structures of the face %28%internal maxillary%29% and to the side of the face and nose %28%external maxillary%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of the facial %28%7th cranial%29% nerve which passes through the middle ear and continues through the petrotympanic fissure. The chorda tympani nerve carries taste sensation from the anterior two-thirds of the tongue and conveys parasympathetic efferents to the salivary glands.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of the tibial nerve which supplies sensory innervation to parts of the lower leg and foot.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branch of the trigeminal %28%5th cranial%29% nerve. The mandibular nerve carries motor fibers to the muscles of mastication and sensory fibers to the teeth and gingivae, the face in the region of the mandible, and parts of the dura.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. %28%From Hosp Pharm 1995 Jul;30%28%7%29%:596%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of chemical actions and uses that result in the prevention, treatment, cure or diagnosis of disease. Included here are drugs and chemicals that act by altering normal body functions, such as the REPRODUCTIVE CONTROL AGENTS and ANESTHETICS. Effects of chemicals on the environment are also included.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of chemical actions with harmful or deadly effect on living organisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of disorders characterized by impairment of blood flow in the arteries and veins which supply the brain. These include CEREBRAL INFARCTION; BRAIN ISCHEMIA; HYPOXIA, BRAIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and VASCULITIS, CENTRAL NERVOUS SYSTEM. In common usage, the term cerebrovascular disorders is not limited to conditions that affect the cerebrum, but refers to vascular disorders of the entire brain including the DIENCEPHALON; BRAIN STEM; and CEREBELLUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of enzymes that are involved in the process of GENETIC RECOMBINATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of membrane transport proteins that specifically transport FREE FATTY ACIDS across cellular membranes. They play an important role in LIPID METABOLISM in CELLS that utilize free fatty acids as an energy source.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of nuclear proteins that are components of or participate in the formation of the NUCLEAR MATRIX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of oxidoreductases that either reduce double bonds or oxidize single bonds between OXYGEN and CARBON in organic compounds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of proteins involved in the formation, transport and dissolution of TRANSPORT VESICLES. They play a role in the intracellular transport of molecules contained within membrane vesicles. Vesicular transport proteins are distinguished from MEMBRANE TRANSPORT PROTEINS, which move molecules across membranes, by the mode in which the molecules are transported.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad category of sleep disorders characterized by either hypersomnolence or insomnia. The three major subcategories include intrinsic %28%i.e., arising from within the body%29% %28%SLEEP DISORDERS, INTRINSIC%29%, extrinsic %28%secondary to environmental conditions or various pathologic conditions%29%, and disturbances of circadian rhythm. %28%From Thorpy, Sleep Disorders Medicine, 1994, p187%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad class of proteins involved in the transport of nucleobases, NUCLEOSIDES; NUCLEOTIDES; and NUCLEIC ACIDS; across membranes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad class of substances encompassing all those that do not include carbon and its derivatives as their principal elements. However, carbides, carbonates, cyanides, cyanates, and carbon disulfide are included in this class.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad family of synthetic organosiloxane polymers containing a repeating silicon-oxygen backbone with organic side groups attached via carbon-silicon bonds. Depending on their structure, they are classified as liquids, gels, and elastomers. %28%From Merck Index, 12th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad group of eukaryotic six-transmembrane cation channels that are classified by sequence homology because their functional involvement with SENSATION is varied. They have only weak voltage sensitivity and ion selectivity. They are named after a DROSOPHILA mutant that displayed transient receptor potentials in response to light. A 25-amino-acid motif containing a TRP box %28%EWKFAR%29% just C-terminal to S6 is found in TRPC, TRPV and TRPM subgroups. ANKYRIN repeats are found in TRPC, TRPV %26% TRPN subgroups. Some are functionally associated with TYROSINE KINASE or PHOSPHOLIPASE C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad spectrum antimycotic with some action against Gram positive bacteria. It is used topically in dermatomycoses also orally and parenterally.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum 6-fluoronaphthyridinone antibacterial agent %28%FLUOROQUINOLONES%29% structurally related to NALIDIXIC ACID.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum antimicrobial carboxyfluoroquinoline. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum excitatory amino acid antagonist used as a research tool.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum semisynthetic antibiotic related to TETRACYCLINE but excreted more slowly and maintaining effective blood levels for a more extended period.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broad-spectrum spectrum antineoplastic antibiotic isolated from Streptomyces refuineus var. thermotolerans. It has low toxicity, some activity against Trichomonas and Endamoeba, and inhibits RNA and DNA synthesis. It binds irreversibly to DNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A broadly distributed protein that binds directly to ACTIVINS. It functions as an activin antagonist, inhibits FOLLICLE STIMULATING HORMONE secretion, regulates CELL DIFFERENTIATION, and plays an important role in embryogenesis. Follistatin is a single glycosylated polypeptide chain of approximately 37-kDa and is not a member of the inhibin family %28%INHIBINS%29%. Follistatin also binds and neutralizes many members of the TRANSFORMING GROWTH FACTOR BETA family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A brominating agent that replaces hydrogen atoms in benzylic or allylic positions. It is used in the oxidation of secondary alcohols to ketones and in controlled low-energy brominations. %28%From Miall%27%s Dictionary of Chemistry, 5th ed; Hawley%27%s Condensed Chemical Dictionary, 12th ed,%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A building block of penicillin, devoid of significant antibacterial activity. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A butterlike product made of refined vegetable oils, sometimes blended with animal fats, and emulsified usually with water or milk. It is used as a butter substitute. %28%From Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A butyrophenone used in the treatment of PSYCHOSES. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A butyrophenone with general properties similar to those of HALOPERIDOL. It has been used in the treatment of aberrant sexual behavior. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p567%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p593%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p621%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A butyryl-beta-alanine that can also be viewed as pantoic acid complexed with BETA ALANINE. It is incorporated into COENZYME A and protects cells against peroxidative damage by increasing the level of GLUTATHIONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29% %28%Merck Index, 11th ed%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 43 and 48 KD exist due to multiple ALTERNATIVE SPLICING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A c-jun amino-terminal kinase that is activated by environmental stress and pro-inflammatory cytokines. Several isoforms of the protein with molecular sizes of 48 and 54 KD exist due to multiple ALTERNATIVE SPLICING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A c-jun amino-terminal kinase that is found predominantly within NEURONS of the BRAIN, suggesting a role in stress-induced neuronal APOPTOSIS. Several isoforms of the protein with molecular sizes of 47 kDa and 52 kDa exist due to multiple ALTERNATIVE SPLICING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cadmium halide in the form of colorless crystals, soluble in water, methanol, and ethanol. It is used in photography, in dyeing, and calico printing, and as a solution to precipitate sulfides. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcification of the posterior longitudinal ligament of the spinal column, usually at the level of the cervical spine. It is often associated with anterior ankylosing hyperostosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcium channel blocker that is a class IV anti-arrhythmia agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. It exists in various forms and states of hydration. Plaster of Paris is a mixture of powdered and heat-treated gypsum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcium- and calmodulin-binding protein present in highest concentrations in the central nervous system. Calcineurin is composed of two subunits. A catalytic subunit, calcineurin A, and a regulatory subunit, calcineurin B, with molecular weights of about 60 kDa and 19 kDa, respectively. Calcineurin has been shown to dephosphorylate a number of phosphoproteins including histones, myosin light chain, and the regulatory subunit of cAMP-dependent protein kinase. It is involved in the regulation of signal transduction and is the target of an important class of immunophilin-immunosuppressive drug complexes in T-lymphocytes that act by inhibiting T-cell activation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 3.6.1.5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calicivirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A calmodulin-dependent enzyme that catalyzes the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins. %28%From Enzyme Nomenclature, 1992, p277%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cancer of the lung, so-called because it arises from the epithelium of the bronchial tree. It is not a histologic designation despite the name.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results %28%SEER%29% Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. %28%From National Cancer Institute, NIH Publication No. 91-3074, October 1990%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbamate derivative used as an alcohol deterrent. It is a relatively nontoxic substance when administered alone, but markedly alters the intermediary metabolism of alcohol. When alcohol is ingested after administration of disulfiram, blood acetaldehyde concentrations are increased, followed by flushing, systemic vasodilation, respiratory difficulties, nausea, hypotension, and other symptoms %28%acetaldehyde syndrome%29%. It acts by inhibiting aldehyde dehydrogenase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbamate insecticide and parasiticide. It is a potent anticholinesterase agent belonging to the carbamate group of reversible cholinesterase inhibitors. It has a particularly low toxicity from dermal absorption and is used for control of head lice in some countries.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbamate insecticide with anticholinesterase activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbamate insecticide. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbamate that is used as an herbicide and as a plant growth regulator.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures %28%which may be exacerbated%29%. It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p603%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbodiimide that is used as a chemical intermediate and coupling agent in peptide synthesis. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbon-nitrogen ligase that catalyzes the formation of 10-formyltetrahydrofolate from formate and TETRAHYDROFOLATE in the presence of ATP. In higher eukaryotes the enzyme also contains METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP+%29% and METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbon-nitrogen ligase. During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP; IMP; and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carbonic anhydrase isoenzyme found in MITOCHONDRIA where it provides bicarbonate ions that are components in the urea cycle and in GLUCONEOGENESIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carboxy-lyase that catalyzes the decarboxylation of %28%S%29%-2-Methyl-3-oxopropanoyl-CoA to propanoyl-CoA. In microorganisms the reaction can be coupled to the vectorial transport of SODIUM ions across the cytoplasmic membrane.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalyzes transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA %28%From Enzyme Nomenclature, 1992%29% EC 6.4.1.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carboxypeptidase that catalyzes the release of a C-terminal amino acid with a broad specificity. It also plays a role in the LYSOSOMES by protecting BETA-GALACTOSIDASE and NEURAMINIDASE from degradation. It was formerly classified as EC 3.4.12.1 and EC 3.4.21.13.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carboxypeptidase that is specific for proteins that contain two ALANINE residues on their C-terminal. Enzymes in this class play an important role in bacterial CELL WALL biosynthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinogen that is often used in experimental cancer studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinogenic mycotoxin produced in high yields by strains of the common molds, Aspergillus versicolor, A. nidulans, and an unidentified species of Bipolaris. It causes necrosis of the liver and kidney and has an inhibitory effect on orotic acid incorporation into nuclear RNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinoma arising from MERKEL CELLS located in the basal layer of the epidermis and occurring most commonly as a primary neuroendocrine carcinoma of the skin. Merkel cells are tactile cells of neuroectodermal origin and histologically show neurosecretory granules. The skin of the head and neck are a common site of Merkel cell carcinoma, occurring generally in elderly patients. %28%Holland et al., Cancer Medicine, 3d ed, p1245%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%25%-7%25% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%25%-10%25% of all thyroid malignancies. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. %28%From Cancer Chemother Rep 2 1972 Nov;%28%3%29%1:325%29% It is also called 3LL and LLC and is used as a transplantable malignancy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carcinoma thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardiac arrhythmia caused by the interaction of two foci independently initiating cardiac impulses at different rates. Generally one of the foci is the sinoatrial node %28%the normal pacemaker%29% and the ectopic focus is usually in the ventricle, but can occur in the sinus and AV nodes, atrium and ventricle, and AV junction. Each focus - and thus each rhythm - is protected from the influence of the other.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardiac depressant used in arrhythmias. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p665%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA%28%+%29%-K%28%+%29%-EXCHANGING ATPASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardioselective beta-1-adrenergic antagonist that may act as a partial agonist at some adrenergic sites.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardioselective beta-1-adrenergic blocker. It is effective in the management of hypertension and angina pectoris.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardioselective beta-adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardiotonic glycoside isolated from Scilla maritima var. alba %28%Squill%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p666%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carotenoid alcohol widespread in nature. It is present in egg yolk, algae, and petals of yellow flowers, among other sources.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in %22%dark%22% reactions to return to the native trans-configuration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carotenoid produced in most carotenogenic organisms. It is one of several sequentially synthesized molecules that are precursors to BETA CAROTENE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carotenoid that is a precursor of VITAMIN A. It is administered to reduce the severity of photosensitivity reactions in patients with erythropoietic protoporphyria %28%PORPHYRIA, ERYTHROPOIETIC%29%. %28%From Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Engewood, CO, 1995.%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carpal bone adjacent to the TRAPEZOID BONE. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carpal bone located between the CAPITATE BONE and the TRIQUETRUM BONE. The hamate has a prominent process that projects anteriorly.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carpal bone which is located between the LUNATE BONE and HAMATE BONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carpal bone which is located between the TRAPEZIUM BONE and the CAPITATE BONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carpal bone with a rounded head located between the TRAPEZOID BONE and the HAMATE BONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A carrier or inert medium used as a solvent %28%or diluent%29% in which the medicinally active agent is formulated and or administered. %28%Dictionary of Pharmacy, 1986%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A casein kinase I isoenzyme that plays a regulatory role in a variety of cellular functions including vesicular transport, CHROMOSOME SEGREGATION; CYTOKINESIS, developmental processes, and the CIRCADIAN RHYTHM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A casein kinase I isoenzyme that plays a role in intracellular signaling pathways including the CELL CYCLE, membrane trafficking, and RNA processing. In DROSOPHILA casein kinase Ialpha has been in regulation of Hedghog and Wingless signaling pathways. Multiple isoforms of casein kinase Ialpha exist and are due ALTERNATIVE SPLICING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A casein kinase I isoenzyme with specificity for proteins involved the regulation of the CIRCADIAN RHYTHM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A casein kinase that was originally described as a monomeric enzyme with a molecular weight of 30-40 kD. Several ISOENZYMES of casein kinase I have been found which are encoded by separate genes. Many of the casein kinase I isoenzymes have been shown to play distinctive roles in intracellular SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A catarrhal disorder of the upper respiratory tract, which may be viral, a mixed infection, or an allergic reaction. It is marked by acute coryza, slight rise in temperature, chilly sensations, and general indisposition. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A catatoxic steroid and microsomal enzyme inducer having significant effects on the induction of cytochrome P450. It has also demonstrated the potential for protective capability against acetaminophen-induced liver damage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A catenin that binds F-ACTIN and links the CYTOSKELETON with BETA CATENIN and GAMMA CATENIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cattle disease of uncertain cause, probably an allergic reaction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A caveolin that is expressed exclusively in MUSCLE CELLS and is sufficient to form CAVEOLAE in SARCOLEMMA. Mutations in caveolin 3 are associated with multiple muscle diseases including DISTAL MYOPATHY and LIMB-GIRDLE MUSCULAR DYSTROPHY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell adhesion molecule of the immunoglobulin superfamily that is expressed in ENDOTHELIAL CELLS and is involved in INTERCELLULAR JUNCTIONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell adhesion protein that was originally identified as a heat stable antigen in mice. It is involved in METASTASIS and is highly expressed in many NEOPLASMS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell line derived from cultured tumor cells. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell line established in 1962 from disaggregated Swiss albino mouse embryos. This fibroblast cell line is extremely popular in research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell surface protein-tyrosine kinase receptor that is found to be overexpressed in a significant number of adenocarcinomas. It has extensive homology to and can heterodimerize with the EGF receptor %28%RECEPTOR, EPIDERMAL GROWTH FACTOR%29%, the erbB-3 receptor %28%RECEPTOR, ERBB-3%29% and the erbB-4 receptor. Activation of the erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB receptor family members.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell surface protein-tyrosine kinase receptor that is specific for NEUREGULINS. It has extensive homology to and can heterodimerize with the EGF Receptor %28%RECEPTOR, EPIDERMAL GROWTH FACTOR%29% and the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%. Overexpression of the erbB-3 receptor is associated with tumorigenesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell surface receptor for INSULIN. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precusor protein. The receptor contains an intrinsic tyrosine kinase domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the LIVER; MUSCLE; and ADIPOSE TISSUE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF related peptides including TRANSFORMING GROWTH FACTOR ALPHA, amphiregulin, and heparin-binding EGF-like growth factor. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell surface receptor mediating cell adhesion to the EXTRACELLULAR MATRIX and to other cells via binding to LAMININ. It is involved in cell migration, embryonic development, leukocyte activation and tumor cell invasiveness. Integrin alpha6beta1 is the major laminin receptor on PLATELETS; LEUKOCYTES; and many EPITHELIAL CELLS, and ligand binding may activate a number of signal transduction pathways. Alternative splicing of the cytoplasmic domain of the alpha6 subunit %28%INTEGRIN ALPHA6%29% results in the formation of A and B isoforms of the heterodimer, which are expressed in a tissue-specific manner.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell wall-degrading enzyme found in microorganisms and higher plants. It catalyzes the random hydrolysis of 1,4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. EC 3.2.1.15.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p462%29% This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell-separation technique where magnetizable microspheres or beads are first coated with monoclonal antibody, allowed to search and bind to target cells, and are then selectively removed when passed through a magnetic field. Among other applications, the technique is commonly used to remove tumor cells from the marrow %28%BONE MARROW PURGING%29% of patients who are to undergo autologous bone marrow transplantation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a %22%starburst%22% appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cellular transcriptional coactivator that was originally identified by its requirement for the stable assembly IMMEDIATE-EARLY PROTEINS of the HERPES SIMPLEX VIRUS. It is a nuclear protein that is a transcriptional coactivator for a number of transcription factors including VP16 PROTEIN; GA-BINDING PROTEIN; EARLY GROWTH RESPONSE PROTEIN 2; and E2F4 TRANSCRIPTION FACTOR. It also interacts with and stabilizes HERPES SIMPLEX VIRUS PROTEIN VMW65 and helps regulate GENETIC TRANSCRIPTION of IMMEDIATE-EARLY GENES in HERPES SIMPLEX VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cellulose derivative which is a Beta-%28%1-%3E%4%29%-D-glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in cosmetics and pharmaceuticals and as a stabilizer for reagents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cellulose of varied carboxyl content retaining the fibrous structure. It is used as a local hemostatic and as a matrix for normal blood coagulation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A center in the HEALTH RESOURCES ADMINISTRATION Division of Planning Methods and Technology which provides access to current information on health planning and resources development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A center in the PUBLIC HEALTH SERVICE which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A center in the PUBLIC HEALTH SERVICE which is primarily concerned with the collection, analysis, and dissemination of health statistics on vital events and health activities to reflect the health status of people, health needs, and health resources.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A central respiratory stimulant with a brief duration of action. %28%From Martindale, The Extra Pharmocopoeia, 30th ed, p1225%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting antihypertensive agent. The drug lowers both systolic and diastolic blood pressure by activating the central nervous system alpha-2 adrenoreceptors, which results in reduced sympathetic outflow leading to reduced vascular tone. Its adverse reactions include dry mouth, sedation, and constipation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. %28%From Martindale, The Extra Pharmacopoea, 30th ed, p1202%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting muscarinic antagonist. Benactyzine has been used in the treatment of depression and is used in research to investigate the role of cholinergic systems on behavior.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1211%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1206%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting muscle relaxant with a short duration of action.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting muscle relaxant. Its mode of action is unknown. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1203%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1202%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cephalorsporin antibiotic. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cephalosporin antibiotic. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chain of islands, cays, and reefs in the West Indies, lying southeast of Florida and north of Cuba. It is an independent state, called also the Commonwealth of the Bahamas or the Bahama Islands. The name likely represents the local name Guanahani, itself of uncertain origin. %28%From Webster%27%s New Geographical Dictionary, 1988, p106 %26% Room, Brewer%27%s Dictionary of Names, 1992, p45%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change in cardiovascular function resulting in a reduction in BLOOD VOLUME, and reflex DIURESIS. It occurs frequently after actual or simulated WEIGHTLESSNESS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change in electrical resistance of the skin, occurring in emotion and in certain other conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change in the CERVIX UTERI with respect to its readiness to relax. The cervix normally becomes softer, more flexible, more distensible, and shorter in the final weeks of PREGNANCY. These cervical changes can also be chemically induced %28%LABOR, INDUCED%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change in, or manipulation of, gravitational force. This may be a natural or artificial effect.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change of a substance from one form or state to another.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A change or shift in personnel due to reorganization, resignation, or discharge.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A channel containing perilymph passing through the temporal bone, connecting the scala tympani of the cochlea to the subarachnoid space.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chaperonin 10 heat-shock protein isolated from Escherichia coli.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chaperonin 60 heat-shock protein isolated from Escherichia coli.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A characteristic showing quantitative inheritance such as SKIN PIGMENTATION in humans. %28%From A Dictionary of Genetics, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chelating agent %28%CHELATING AGENTS%29% that sequesters a variety of polyvalent cations. It is used in pharmaceutical manufacturing and as a food additive.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chelating agent used as an antidote to heavy metal poisoning.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemical by-product that results from burning or incinerating chlorinated industrial chemicals and other hydrocarbons. This compound is considered an environmental toxin, and may pose reproductive, as well as, other health risks for animals and humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs %28%Lehninger, Principles of Biochemistry, 1982, p471%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemical reagent that reacts with and modifies chemically the tryptophan portion of protein molecules. Used for %27%active site%27% enzyme studies and other protein studies. Sometimes referred to as Koshland%27%s reagent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemical that acts as a dopamine beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemically diverse group of substances produced by various tissues in the body that cause slow contraction of smooth muscle; they have other intense but varied pharmacologic activities.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. %28%From Gilman, et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p414%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemistry-based technology in which sets of reactions, for solution or solid-phase synthesis, are used to create molecular libraries for analysis of compounds on a large scale.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemokine that is a chemoattractant for eosinophils, monocytes, and lymphocytes. It is a potent and selective eosinophil chemotaxin that is stored in and released from platelets and activated T-cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemokine that is a chemoattractant for human MONOCYTES and may also cause cellular activation of specific functions related to host defense. It is produced by LEUKOCYTES of both monocyte and lymphocyte lineage and by FIBROBLASTS during tissue injury.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemokine that is chemotactic for neutrophils and monocytes, stimulates macrophages, and may play a role in regulating hematopoiesis. Its two variants, MIP-1alpha and MIP-1beta, are 60%25% homologous to each other.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemosterilant agent that is anticipated to be a carcinogen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p970%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A child between 1 and 23 months of age. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A child between the ages of 2 and 5. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A child or adolescent who is deserted by parents or parent substitutes without regard for its future care.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A child or adolescent who, when compared to others of the same age or experience, exhibits capability of high performance in intellectual, creative, or artistic areas, possesses an unusual capacity for leadership or excels in specific academic fields. %28%From PL 100-297, Sec. 4103, Definitions%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A child who is receiving long-term in-patient services or who resides in an institutional setting.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A child whose needs, abilities, or other characteristics vary so much from the average in mental, physical, or social areas that a greater than usual level of services is needed to facilitate the child%27%s maximum potential development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A childhood disorder predominately affecting boys and similar to autism %28%AUTISTIC DISORDER%29%. It is characterized by severe, sustained, clinically significant impairment of social interaction, and restricted repetitive and stereotyped patterns of behavior. In contrast to autism, there are no clinically significant delays in language or cognitive development. %28%From DSM-IV%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A childhood seizure disorder characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. %28%Menkes, Textbook of Child Neurology, 5th ed, p736%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. %28%Hum Genet 1994;93%28%4%29%:364-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated anilide that is used as an herbicide. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated bisphenol antiseptic with a bacteriostatic action against Gram-positive organisms, but much less effective against Gram-negative organisms. It is mainly used in soaps and creams and is an ingredient of various preparations used for skin disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p797%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated epoxy compound used as an industrial solvent. It is a strong skin irritant and carcinogen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated hydrocarbon used as an industrial solvent and cooling liquid in electrical transformers. It is a potential carcinogen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated organic herbicide. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chlorinated propanediol compound that has shown anti-fertility activity in males and has been used as a chemosterilant in rodents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholesterol derivative found in human feces, gallstones, eggs, and other biological matter.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer%27%s disease and other central nervous system disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor that is used as a systemic insecticide, an acaricide, and nematocide. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor that is used as an insecticide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor that is used as an organothiophosphorus insecticide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chromatographic technique that utilizes the ability of biological molecules to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chromogenic substrate that permits direct measurement of peptide hydrolase activity, e.g., papain and trypsin, by colorimetry. The substrate liberates p-nitroaniline as a chromogenic product.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chromosomal disorder characterized by MENTAL RETARDATION, broad thumbs, webbing of fingers and toes, beaked nose, short upper lip, pouting lower lip, agenesis of corpus callosum, large foramen magnum, keloid formation, pulmonary stenosis, vertebral anomalies, chest wall anomalies, sleep apnea, and megacolon. The disease has an autosomal dominant pattern of inheritance and is associated with deletions of the short arm of chromosome 16 %28%16p13.3%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe MENTAL RETARDATION. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. %28%Menkes, Textbook of Child Neurology, 5th ed, p213%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chromosome instability syndrome resulting from a defective response to DNA double-strand breaks. In addition to characteristic FACIES and MICROCEPHALY, patients have a range of findings including RADIOSENSITIVITY, immunodeficiency, increased cancer risk, and growth retardation. Causative mutations occur in the NBS1 gene, located on human chromosome 8q21. NBS1 codes for nibrin, the key regulator protein of the R/M/N %28%RAD50/MRE11/NBS1%29% protein complex which senses and mediates cellular response to DNA DAMAGE caused by IONIZING RADIATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic cerebral vasculopathy primarily occurring in childhood and characterized by slowly progressive carotid artery narrowing and occlusion at the base of the brain. An extensive network of anastomoses forms between branches of the carotid arteries, resulting in a characteristic angiographic appearance. The condition may be idiopathic %28%classic moyamoya disease%29% or occur in association with ANEMIA, SICKLE CELL; DOWN SYNDROME; CRANIOCEREBRAL TRAUMA; RADIOTHERAPY induced arterial injury; NEUROFIBROMATOSIS; and other diseases. Clinical manifestations include hemiparesis, headache, seizures, and delayed mental development. In older individuals, this disease may present as SUBARACHNOID HEMORRHAGE. %28%From Adams et al., Principles of Neurology, 6th ed, p831; Clin Neurol Neurosurg 1997 Oct;99 Suppl 2:S36-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean %28%or infantile%29%, and African.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones %28%blackheads%29%, closed comedones %28%whiteheads%29%, and pustular nodules. The cause is unknown, but heredity and age are predisposing factors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic endemic form of hypoplasia of the dental enamel caused by drinking water with a high fluorine content during the time of tooth formation, and characterized by defective calcification that gives a white chalky appearance to the enamel, which gradually undergoes brown discoloration. %28%Jablonski%27%s Dictionary of Dentistry, 1992, p286%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic form of cutaneous lupus erythematosus %28%LUPUS ERYTHEMATOSUS, CUTANEOUS%29% in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic form of rhinitis marked by wasting of the mucous membrane and the glands. It is usually associated with crusting and foul-smelling discharges.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic infection of the conjunctiva and cornea caused by CHLAMYDIA TRACHOMATIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic inflammatory disease characterized by shiny, flat-topped, usually flesh-colored micropapules no larger than the head of a pin. Lesions are localized in the early stages, found chiefly on the lower abdomen, penis, and inner surface of the thighs. Distribution may become generalized as the disease progresses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic inflammatory disease of the skin of unknown etiology. It is characterized by moderate erythema, dry, moist, or greasy scaling, and yellow crusted patches on various areas, especially the scalp. On the scalp, it generally appears first as small patches of scales, progressing to involve the entire scalp with exfoliation of excessive amounts of dry scales %28%dandruff%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin %28%IgE%29%, with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic lung disease characterized by dyspnea, productive cough, chest pain, weakness, weight loss, and hemoptysis, and by the filling of the distal alveoli with a bland, eosinophilic, proteinaceous material that prevents ventilation of affected areas. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation %28%VENTILATION, MECHANICAL%29% in certain premature infants %28%INFANT, PREMATURE%29% or newborn infants with respiratory distress syndrome %28%RESPIRATORY DISTRESS SYNDROME, NEWBORN%29%. Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS. Severity of this disease and lung injuries depend on the duration of oxygen supplementation, positive pressure requirement, GESTATIONAL AGE, and BIRTH WEIGHT of the infant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic malabsorption syndrome, occurring mainly in residents of or visitors to the tropics or subtropics. The failed INTESTINAL ABSORPTION of nutrients from the SMALL INTESTINE results in MALNUTRITION and ANEMIA that is due to FOLIC ACID deficiency.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic malignant T-cell lymphoma of the skin. In the late stages the lymph nodes and viscera are affected.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature %28%hard skin%29%, and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic neoplasm-like inflammatory reaction, usually affecting the orbital tissues of both eyes, also known as orbital myositis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic skin disease characterized by small follicular papules, disseminated reddish-brown scaly patches, and often, palmoplantar hyperkeratosis. The papules are about the size of a pin and topped by a horny plug.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident. Hormonal mechanisms are expected in its pathogenesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic systemic infection by a gram-positive bacterium, Tropheryma whippelii, mainly affecting the SMALL INTESTINE but also the JOINTS; CARDIOVASCULAR SYSTEM; and the CENTRAL NERVOUS SYSTEM. The disease is characterized by fat deposits in the INTESTINAL MUCOSA and LYMPH NODES, malabsorption, DIARRHEA with fatty stools, MALNUTRITION, and ARTHRITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic, atrophic skin disease characterized by white, angular, flat, well-defined, indurated papules with an erythematous halo and follicular, black, keratotic plugs. It is the most common cause of VULVAR LICHEN SCLEROSUS in females and balanitis xerotica obliterans in males. It is called also white spot disease and Csillag%27%s disease. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic, benign, and usually painless inflammatory swelling of the lacrimal and salivary glands. It is considered by some to include the glandular enlargement associated with other diseases, such as Sjogren%27%s syndrome, sarcoidosis, lupus erythematosus, etc.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic, clinically mild, infectious pneumonia of PIGS caused by MYCOPLASMA HYOPNEUMONIAE. Ninety percent of swine herds worldwide are infected with this economically costly disease that primarily affects animals aged two to six months old. The disease can be associated with porcine respiratory disease complex. PASTEURELLA MULTOCIDA is often found as a secondary infection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A chronobiologic disorder resulting from rapid travel across a number of time zones, characterized by insomnia or hypersomnolence, fatigue, behavioral symptoms, headaches, and gastrointestinal disturbances. %28%From Cooper, Sleep, 1994, pp593-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cinnamate derivative of the shikamate pathway found in CLOVE OIL and other PLANTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cinnamon-colored strain of Long-Evans rats which carries a mutation causing fulminant hepatitis and jaundice, with an associated gross accumulation of copper in the liver. This strain is a model for Wilson%27%s Disease %28%see HEPATOLENTICULAR DEGENERATION%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circular structural unit of bone tissue. It consists of a central hole, the Haversian canal through which blood vessels run, surrounded by concentric rings, called lamellae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circumscribed collection of fluid, especially a collection of fluid in the tunica vaginalis of the testicle or along the spermatic cord. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear %28%see EAR, MIDDLE%29%; HEART %28%see also ENDOCARDITIS, BACTERIAL%29%, and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. %28%Adams et al., Principles of Neurology, 6th ed, pp712-6%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circumscribed stable malformation of the skin and occasionally of the oral mucosa, which is not due to external causes and therefore presumed to be of hereditary origin. The excess %28%or deficiency%29% of tissue may involve epidermal, connective tissue, adnexal, nervous, or vascular elements. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A circumstance where a substance or organism takes fire and burns without an exogenous source. Spontaneous human combustion differs from preternatural human combustibility in that in the latter, some spark or trivial flame sets the fire and the body tissues, which have a greatly enhanced inflammability, continue to undergo incineration without any external heat source or combustible materials. %28%Bergman NA. Spontaneous human combustion: its role in literature and science. Pharos 1988;Fall;51%28%4%29%:18-21%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class I anti-arrhythmic agent %28%one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent%29% with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum CNIDARIA which alternates between polyp and medusa forms during their life cycle. There are over 2700 species in five orders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum CNIDARIA, comprised mostly of corals and anemones. All members occur only as polyps; the medusa stage is completely absent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum MOLLUSCA comprised of SNAILS and slugs. The former have coiled external shells and the latter usually lack shells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum MOLLUSCA comprised of SQUID; CUTTLEFISH; OCTOPUS; and NAUTILUS. These marine animals are the most highly organized of all the mollusks.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum MOLLUSCA comprised of flattened, elongated marine mollusks, commonly called chitons. They are unique in that they possess seven or eight separate shell plates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum MOLLUSCA comprised of mussels; clams; OYSTERS; COCKLES; and SCALLOPS. They are characterized by a bilaterally symmetrical hinged shell and a muscular foot used for burrowing and anchoring.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum PROTEOBACTERIA comprised mostly of two major phenotypes: purple non-sulfur bacteria and aerobic bacteriochlorophyll-containing bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class in the phylum PROTEOBACTERIA comprised of chemoheterotrophs and chemoautotrophs which derive nutrients from decomposition of organic material.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of Arthropoda that includes SPIDERS; TICKS; MITES; and SCORPIONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of BRYOPHYTA which is best known for Sphagnum forming PEAT bogs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of C-type lectins that target the carbohydrate structures found on invading pathogens. Binding of collectins to microorganisms results in their agglutination and enhanced clearance. Collectins form trimers that may assemble into larger oligomers. Each collectin polypeptide chain consists of four regions: a relatively short N-terminal region, a collagen-like region, an alpha-helical coiled-coil region, and carbohydrate-binding region.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of Echinodermata characterized by long, slender bodies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of G-protein-coupled receptors that are specific for CANNABINOIDS such as those derived from CANNABIS. They also bind a structurally distinct class of endogenous factors referred to as ENDOCANNABINOIDS. The receptor class may play a role in modulating the release of signaling molecules such as NEUROTRANSMITTERS and CYTOKINES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of G-protein-coupled receptors that react to varying extracellular CALCIUM levels. Calcium-sensing receptors in the PARATHYROID GLANDS play an important role in the maintenance of calcium HOMEOSTASIS by regulating the release of PARATHYROID HORMONE. They differ from INTRACELLULAR CALCIUM-SENSING PROTEINS which sense intracellular calcium levels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of MOLECULAR CHAPERONES found in both prokaryotes and in several compartments of eukaryotic cells. These proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of MOLECULAR CHAPERONES whose members act in the mechanism of SIGNAL TRANSDUCTION by STEROID RECEPTORS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of RAS GUANINE NUCLEOTIDE EXCHANGE FACTORS that are genetically related to the Son of Sevenless gene from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of acids containing a ring structure in which at least one atom other than CARBON is incorporated.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of ameboid protozoa that forms either filiform subpseudopodia or lobopodia. Characteristics include the absence of sorocarps, sporangia, or similar fruiting bodies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of amino acids characterized by a closed ring structure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of animal lectins that bind specifically to beta-galactoside in a calcium-independent manner. Members of this class are distiguished from other lectins by the presence of a conserved carbohydrate recognition domain. The majority of proteins in this class bind to sugar molecules in a sulfhydryl-dependent manner and are often referred to as S-type lectins, however this property is not required for membership in this class.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of animal lectins that bind to carbohydrate in a calcium-dependent manner. They share a common carbohydrate-binding domain that is structurally distinct from other classes of lectins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of annelid worms with few setae per segment. It includes the earthworms such as Lumbricus and Eisenia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of asbestos that includes silicates of magnesium, iron, calcium, and sodium. The fibers are generally brittle and cannot be spun, but are more resistant to chemicals and heat than ASBESTOS, SERPENTINE. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of carbohydrates that contains five carbon atoms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of carrier proteins that bind to TRANSFERRIN. Many strains of pathogenic bacteria utilize transferrin-binding proteins to acquire their supply of iron from serum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface leukotriene receptors with a preference for leukotriene B4. Leukotriene B4 receptor activation influences chemotaxis, chemokinesis, adherence, enzyme release, oxidative bursts, and degranulation in polymorphonuclear leukocytes. There are at least two subtypes of these receptors. Some actions are mediated through the inositol phosphate and diacylglycerol second messenger systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface receptors for purines that prefer ATP or ADP over adenosine. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. Subtypes have been proposed, usually designated P2 x, y, z, and t. P2x receptors may mediate fast synaptic transmission by ATP. The ADP-preferring P2t receptors in platelets stimulate aggregation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface receptors for tachykinins that prefers neurokinin A; %28%NKA, substance K, neurokinin alpha, neuromedin L%29%, neuropeptide K; %28%NPK%29%; or neuropeptide gamma over other tachykinins. Neurokinin-2 %28%NK-2%29% receptors have been cloned and are similar to other G-protein coupled receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface receptors for tachykinins that prefers neurokinin B %28%neurokinin beta, neuromedin K%29% over other tachykinins. Neurokinin-3 %28%NK-3%29% receptors have been cloned and are members of the G-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface receptors for tachykinins with a preference for substance P. Neurokinin-1 %28%NK-1%29% receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known %28%although they can react to certain endogenous steroids%29%. Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cell surface receptors that prefers ADENOSINE to other endogenous purines. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types %28%A1 and A2, or Ri and Ra%29%. The methylxanthines, e.g., CAFFEINE, bind to these receptors, but also have other unrelated effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cellular membrane receptors that either have an intrinsic guanylate cyclase activity or are closely coupled to specific guanylate cyclases within the cell.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cellular receptors that have an intrinsic PROTEIN-TYROSINE KINASE activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of chemicals that contain an anthracene ring with a naphthalene ring attached to it.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of ciliate protozoa characterized by a well-developed, conspicuous adoral zone of numerous buccal or peristomial organelles, often extending out onto the body surface.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of ciliate protozoa. Characteristics include the presence of a well developed oral apparatus and oral cilia being clearly distinct from somatic cilia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of ciliate protozoa. Prominent cytopharyngeal apparatus is characteristic of this class as is only a slight distinction between oral and somatic cilia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of closely related heterogeneous-nuclear ribonucleoproteins of approximately 34-40 kDa in size. Although they are generally found in the nucleoplasm, they also shuttle between the nucleus and the cytoplasm. Members of this class have been found to have a role in mRNA transport, telomere biogenesis and RNA SPLICING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of compounds composed of repeating 5-carbon units of HEMITERPENES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of compounds named after and generally derived from C20 fatty acids %28%EICOSANOIC ACIDS%29% that includes PROSTAGLANDINS; LEUKOTRIENES; THROMBOXANES, and HYDROXYEICOSATETRAENOIC ACIDS. They have hormone-like effects mediated by specialized receptors %28%RECEPTORS, EICOSANOID%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of crystallins that provides refractive power and translucency to the lens %28%LENS, CRYSTALLINE%29% in VERTEBRATES. Beta-crystallins are similar in structure to GAMMA-CRYSTALLINS in that they both contain Greek key motifs. Beta-crystallins exist as oligomers formed from acidic %28%BETA-CRYSTALLIN A CHAIN%29% and basic %28%BETA-CRYSTALLIN B CHAIN%29% subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of cyclic prostaglandins that contain the 6,9-epoxy bond. Endogenous members of this family are biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of dibenzylbutane derivatives which occurs in higher plants and in fluids %28%bile, serum, urine, etc.%29% in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of dicarboxylic acids with the general structure of butanedioic acid %28%succinic acid%29%. They are used in perfumery and as a chemical intermediate in medicine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine %28%without aura%29% and classic migraine %28%with aura or neurological symptoms%29%. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into %22%specific%22% agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and %22%nonspecific%22% agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. %28%From Gilman AG, et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p252%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. %28%From AMA, Drug Evaluations Annual, 1994, p2026%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes involved in the hydrolysis of the N-glycosidic bond of nitrogen-linked sugars.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze geometric or structural changes within a molecule to form a single product. The reactions do not involve a net change in the concentrations of compounds other than the substrate and the product.%28%from Dorland, 28th ed%29% EC 5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze oxidation-reduction reactions of amino acids. EC 1.4.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze the cleavage of C-C, C-O, and C-N, and other bonds by other means than by hydrolysis or oxidation. %28%Enzyme Nomenclature, 1992%29% EC 4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze the formation of a bond between two substrate molecules, coupled with the hydrolysis of a pyrophosphate bond in ATP or a similar energy donor. %28%Dorland, 28th ed%29% EC 6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze the hydrolysis of one of the three ester bonds in a phosphotriester-containing compound.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyzes the ATP-dependent formation of a thioester bond between itself and UBIQUITIN. It then transfers the activated ubiquitin to one of the UBIQUITIN-PROTEIN LIGASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.24.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that catalyzes the phosphorylation of fructose in the presence of ATP. EC 2.7.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that form a thioester bond to UBIQUITIN with the assistance of UBIQUITIN-ACTIVATING ENZYMES. They transfer ubiquitin to the LYSINE of a substrate protein with the assistance of UBIQUITIN-PROTEIN LIGASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that inactivate aminocyclitol-aminoglycoside antibiotics %28%AMINOGLYCOSIDES%29% by regiospecific PHOSPHORYLATION of the 3%27% and/or 5%27% hydroxyl.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that transfers nucleotidyl residues. EC 2.7.7.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that transfers phosphate groups and has a carboxyl group as an acceptor. EC 2.7.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of enzymes that transfers substituted phosphate groups. EC 2.7.8.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of fibrous proteins or scleroproteins important both as structural proteins and as keys to the study of protein conformation. The family represents the principal constituent of epidermis, hair, nails, horny tissues, and the organic matrix of tooth enamel. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms an alpha-helix, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of free-living freshwater flatworms of North America.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of genetic disorders resulting in mental retardation that is associated either with mutations of GENES located on the X CHROMOSOME or aberrations in the structure of the X chromosome %28%SEX CHROMOSOME ABERRATIONS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of glucosyltransferases that catalyzes the degradation of storage polysaccharides, such as glucose polymers, by phosphorolysis in animals %28%GLYCOGEN PHOSPHORYLASE%29% and in plants %28%STARCH PHOSPHORYLASE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of gram-negative bacteria consisting of cells bounded by a plasma membrane. Its organisms differ from other bacteria in that they are devoid of cell walls. It contains a single order, MYCOPLASMATALES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H2 receptors act via G-proteins to stimulate adenylate cyclase. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. %28%From Biochem Soc Trans 1992 Feb;20%28%1%29%:122-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of hospitals that includes profit or not-for-profit hospitals that are controlled by a legal entity other than a government agency. %28%Hospital Administration Terminology, AHA, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of immunoglobulin bearing mu chains %28%IMMUNOGLOBULIN MU-CHAINS%29%. IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally being called a macroglobulin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of inorganic or organic compounds that contain the borohydride %28%BH4-%29% anion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions %28%as well as to monovalent cations%29% are important in excitotoxicity and neuronal plasticity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of iron-sulfur proteins that contains one iron coordinated to the sulfur atom of four cysteine residues. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of ketodicarboxylic acids derived from oxalic acid. Oxaloacetic acid is an intermediate in the citric acid cycle and is converted to ASPARTIC ACID by a transamination reaction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of large neuroglial %28%macroglial%29% cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes %28%from %22%star%22% cells%29% are irregularly shaped with many long processes, including those with %22%end feet%22% which form the glial %28%limiting%29% membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and %22%reactive astrocytes%22% %28%along with MICROGLIA%29% respond to injury.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of large neuroglial %28%macroglial%29% cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal %28%not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA%29% according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of lipoproteins frequently divided into HDL2 and HDL3 and the minor variant HDL1. HDL promote transport of cholesterol from extrahepatic tissue to the liver for excretion in the bile. Synthesized by the liver as discoid %22%nascent HDL%22% particles lacking a lipid core, they accumulate a core of cholesterol esters during reverse cholesterol transport and transfer them to the liver directly or indirectly via other lipoproteins. HDL also shuttle apolipoproteins C-II and E to and from triglyceride-rich lipoproteins during catabolism of the lipoproteins. Serum HDL cholesterol has been negatively correlated with premature coronary heart disease. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of lipoproteins responsible for transport of cholesterol to extrahepatic tissues. They are formed in the circulation when very-low-density lipoproteins are degraded first to intermediate-density lipoproteins and then to LDL by the gain and loss of specific apolipoproteins and the loss of most of their triglycerides. LDL are taken up and catabolized by both the liver and extrahepatic tissues by specific receptor-mediated endocytosis. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of lipoproteins that carry dietary cholesterol and triglycerides from the small intestines to the tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of lipoproteins that transport triglycerides from the intestine and liver to adipose and muscle tissues. Synthesized by the liver, they contain primarily triglycerides in their lipid cores, with some cholesterol esters. As their triglycerides are cleaved by endothelial lipoprotein lipase and transferred to hepatic tissues, the VLDL %28%very-low-density lipoprotein%29% particles lose most of their apolipoprotein C and become intermediate-density lipoproteins. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of lymphocytes characterized by the lack of surface markers specific for either T or B lymphocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of marine annelids including sandworms, tube worms, clamworms, and fire worms. It includes also the genus Myxicola infundibulum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of membrane lipids that have a polar head and two nonpolar tails. They are composed of one molecule of the long-chain amino alcohol sphingosine %28%4-sphingenine%29% or one of its derivatives, one molecule of a long-chain acid, a polar head alcohol and sometimes phosphoric acid in diester linkage at the polar head group. %28%Lehninger et al, Principles of Biochemistry, 2nd ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of minute animals of the phylum Aschelminthes. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of monomeric, low molecular weight %28%20-25 kDa%29% GTP-binding proteins that regulate a variety of intracellular processes. The GTP bound form of the protein is active and limited by its inherent GTPase activity, which is controlled by an array of GTPase activators, GDP dissociation inhibitors, and guanine nucleotide exchange factors. This enzyme was formerly listed as EC 3.6.1.47%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured. Such rupture is supposed to be under metabolic %28%hormonal%29% control. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of multicomponent structures found in all cells, in mitochondria, and chloroplasts. They have roles both in the genetic translation of transcripts and in the manufacture and secretion of the proteins. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of natural contraceptive methods in which SEXUAL ABSTINENCE is practiced a few days before and after the estimated day of ovulation, during the fertile phase. Methods for determining the fertile period or OVULATION DETECTION are based on various physiological indicators, such as circulating hormones, changes in cervical mucus %28%CERVIX MUCUS%29%, and the basal body temperature.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of natural cyclic peptide antibiotics produced by certain subspecies of STREPTOMYCES. They include two structurally unrelated components, STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B, which generally act synergistically to inhibit bacterial growth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the myelinated nerve fibers are completely encased in a MYELIN SHEATH. They are fibers of relatively large and varied diameters. Their NEURAL CONDUCTION rates are faster than those of the unmyelinated nerve fibers %28%NERVE FIBERS, UNMYELINATED%29%. Myelinated nerve fibers are present in somatic and autonomic nerves.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of nerve fibers as defined by their structure, specifically the nerve sheath arrangement. The AXONS of the unmyelinated nerve fibers are small. The axons to SCHWANN CELLS ratio is greater in the unmyelinated nerve fibers than that in the myelinated fiber %28%NERVE FIBERS, MYELINATED%29% which is 1:1. Usually several axons are surrounded by a single Schwann cell in the unmyelinated nerve fibers. Therefore, each unmyelinated fiber is not completely covered by the MYELIN SHEATH formed by the Schwann cell. Unmyelinated nerve fibers conduct impulses at low velocities. They represent the majority of peripheral sensory and autonomic fibers. They are also found in the spinal cord and brain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of non-sedating drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early %28%first generation%29% antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of nucleotide translocases found abundantly in mitochondria that function as integral components of the inner mitochondrial membrane. They facilitate the exchange of ADP and ATP between the cytosol and the mitochondria, thereby linking the subcellular compartments of ATP production to those of ATP utilization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors %28%RECEPTORS, OPIOID, KAPPA%29% and have been shown to play a role as central nervous system transmitters.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds containing a ring structure made up of more than one kind of atom, usually carbon plus another atom. The ring structure can be aromatic or nonaromatic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds containing four or more ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds containing three ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds containing two ring structures, one of which is made up of more than one kind of atom, usually carbon plus another atom. The heterocycle may be either aromatic or nonaromatic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds that contains a naphthalene moiety linked to a sulfonic acid salt or ester.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds which contain an anilino %28%phenylamino%29% group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of organic compounds which contain two rings that share a pair of bridgehead carbon atoms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of oxidized LDL receptors that contain LECTIN-like extracellular domains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of parasitic FUNGI. Characteristics include spores that are spherical, oval, or tubular in shape and sporoplasm which is uninuclear or binuclear.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of parasitic and saprophytic microorganisms whose origins can be traced near the animal-fungal divergence. Members of the class are typically pathogens of FISHES, but there are exceptions. There are two recognized orders: Icthyophonida and Dermocystida.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of phosphotransferases that catalyzes the transfer of diphosphate-containing groups. EC 2.7.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of plant growth hormone isolated from cultures of Gibberella fujikuroi, a fungus causing Bakanae disease in rice. There are many different members of the family as well as mixtures of multiple members; all are diterpenoid acids based on the gibberellane skeleton.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of plants within the Bryophyta comprising the mosses, which are found in both damp %28%including freshwater%29% and drier situations. Mosses possess erect or prostrate leafless stems, which give rise to leafless stalks bearing capsules. Spores formed in the capsules are released and grow to produce new plants. %28%Concise Dictionary of Biology, 1990%29%. Many small plants bearing the name moss are in fact not mosses. The %22%moss%22% found on the north side of trees is actually a green alga %28%ALGAE, GREEN%29%. Irish moss is really a red alga %28%ALGAE, RED%29%. Beard lichen %28%beard moss%29%, Iceland moss, oak moss, and reindeer moss are actually LICHENS. Spanish moss is a common name for both LICHENS and an air plant of the pineapple family %28%BROMELIACEAE%29%. Club moss is an evergreen herb of the family LYCOPODIACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of porins that allow the passage of WATER and other small molecules across CELL MEMBRANES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of protein-serine-threonine kinases that was originally found as one of the three types of kinases that phosphorylate GLYCOGEN SYNTHASE. Glycogen synthase kinases along with CA%28%2+%29%-CALMODULIN DEPENDENT PROTEIN KINASES and CYCLIC AMP-DEPENDENT PROTEIN KINASES regulate glycogen synthase activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of proteins involved in the transport of molecules via TRANSPORT VESICLES. They perform functions such as binding to the cell membrane, capturing cargo molecules and promoting the assembly of CLATHRIN. The majority of adaptor proteins exist as multi-subunit complexes, however monomeric varieties have also been found.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of proteins related in structure and function to TATA-BOX BINDING PROTEIN that can take the place of TATA-BOX BINDING PROTEIN in the transcription initiation complex. They are found in most multicellular organisms and may be involved in tissue-specific promoter regulation. They bind to DNA and interact with TATA-BINDING PROTEIN ASSOCIATED FACTORS, however they may lack specificity for the TATA-BOX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of proteins that were originally identified by their ability to bind the DNA sequence CCAAT. The typical CCAAT-enhancer binding protein forms dimers and consists of an activation domain, a DNA-binding basic region, and a leucine-rich dimerization domain %28%LEUCINE ZIPPERS%29%. CCAAT-BINDING FACTOR is structurally distinct type of CCAAT-enhancer binding protein consisting of a trimer of three different subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of protozoa comprising myxamoebae having filiform subpseudopodia. Aerial fruiting bodies are produced and the presence of a stalk tube in the fruiting body is observed in some species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of protozoa consisting of animal-like flagellates. Its organisms are heterotrophic and have one-to-many flagella. This class includes one superorder, Parabasalidea, and six orders: Choanoflagellida, KINETOPLASTIDA, Proteromonadida, Retortamonadida, DIPLOMONADIDA, and Oxymonadida.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of protozoa consisting of plantlike flagellates. Its organisms are free-living and have one or two flagella.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of receptors that are activated by the action of PROTEINASES. The most notable examples are the THROMBIN RECEPTORS. The receptors contain cryptic ligands that are exposed upon the selective proteolysis of specific N-terminal cleavage sites.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of saturated compounds consisting of two rings only, having two or more atoms in common, containing at least one hetero atom, and that take the name of an open chain hydrocarbon containing the same total number of atoms. %28%From Riguady et al., Nomenclature of Organic Chemistry, 1979, p31%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of scavenger receptors that are specific for oxidized LOW-DENSITY LIPOPROTEINS and apoptotic cells. They are expressed almost exclusively in INTRACELLULAR MEMBRANES of MACROPHAGES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of sequence-related MOLECULAR CHAPERONES found in bacteria, mitochondria, and plastids. Chaperonins are abundant constitutive proteins that increase in amount after stresses such as heat shock, bacterial infection of macrophages, and an increase in the cellular content of unfolded proteins. Bacterial chaperonins are major immunogens in human bacterial infections because of their accumulation during the stress of infection. Two members of this class of chaperones are CHAPERONIN 10 and CHAPERONIN 60.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of sodium-independent nucleoside transporters that mediate the facilitative transport of NUCLEOSIDES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of sphingolipids found largely in the brain and other nervous tissue. They contain phosphocholine or phosphoethanolamine as their polar head group so therefore are the only sphingolipids classified as PHOSPHOLIPIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of statistical procedures for estimating the survival function %28%function of time, starting with a population 100%25% well at a given time and providing the percentage of the population still well at later times%29%. The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of structurally related proteins of 12-20 kDa in size. They covalently modify specific proteins in a manner analogous to UBIQUITIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of thiocarbamate derivatives whose salts possess fungicidal activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; %28%RNA, RIBOSOMAL%29% with PEPTIDE ELONGATION FACTORS. They include SHIGA TOXIN which is produced by SHIGELLA DYSENTERIAE and a variety of shiga-like toxins that are produced by pathologic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of traumatic stress disorders that is characterized by the significant dissociative states seen immediately after overwhelming trauma. By definition it cannot last longer than 1 month, if it persists, a diagnosis of post-traumatic stress disorder %28%STRESS DISORDERS, POST-TRAUMATIC%29% is more appropriate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures. Many species are parasites.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A class of weak acids with the general formula R-CONHOH.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A classification of B-lymphocytes based on structurally or functionally different populations of cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A classification of lymphocytes based on structurally or functionally different populations of cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clathrin adaptor protein complex primarily involved in clathrin-related transport at the TRANS-GOLGI NETWORK.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clear or white discharge from the VAGINA, consisting mainly of MUCUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clear, homogenous, structureless, eosinophilic substance occurring in pathological degeneration of tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A climate which is typical of equatorial and tropical regions, i.e., one with continually high temperatures with considerable precipitation, at least during part of the year. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical condition characterized by fever and profuse sweating and associated with high mortality. It occurred in epidemic form five times in the fifteenth and sixteenth centuries in England, first in 1485 and last in 1551, specially during the summer and early autumn, attacking the relatively affluent adult male population. The etiology was unknown.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical manifestation consisting of alterations in an individual%27%s weight from his or her norm.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical manifestation consisting of an unnatural paleness of the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical syndrome characterized by palpitation, SHORTNESS OF BREATH, labored breathing, subjective complaints of effort and discomfort, all following slight EXERTION. Other symptoms may be DIZZINESS, tremulousness, SWEATING, and INSOMNIA. Neurocirculatory asthenia is most typically seen as a form of anxiety disorder.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the electrocardiogram, but with preserved exercise capacity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical syndrome with acute abdominal pain that is severe, localized, and rapid onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical syndrome with intermittent abdominal pain characterized by sudden onset and cessation. It is usually associated with obstruction of the INTESTINES; of the CYSTIC DUCT; or of the URINARY TRACT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinical triad consisting of potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. It results from mutations in the KCNJ2 gene which codes for the INWARD RECTIFIER POTASSIUM CHANNELS subfamily J, member 2 %28%KCNJ2 protein, human.%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic %28%i.e., occurring secondary to known disease processes such as infections, hypoxic-ischemic injuries, trauma, etc.%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM %28%i.e., VERTEBROBASILAR INSUFFICIENCY%29% resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. %28%From J Cardiovasc Surg 1994;35%28%1%29%:11-4; Acta Neurol Scand 1994;90%28%3%29%:174-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A closely related group of toxic substances elaborated by various strains of Streptomyces. They are 26-membered macrolides with lactone moieties and double bonds and inhibit various ATPases, causing uncoupling of phosphorylation from mitochondrial respiration. Used as tools in cytochemistry. Some specific oligomycins are RUTAMYCIN, peliomycin, and botrycidin %28%formerly venturicidin X%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic %28%THROMBOSIS%29% state. %28%from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coccidiostat for poultry. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A codon that directs initiation of protein translation %28%TRANSLATION, GENETIC%29% by stimulating the binding of initiator tRNA %28%RNA, TRANSFER, MET%29%. In prokaryotes, the codons AUG or GUG can act as initiators while in eukaryotes, AUG is the only initiator codon.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A codon that has been converted to the same sequence as a stop codon %28%CODON, TERMINATOR%29% by a nonsense mutation. It is different from a stop codon in that it occurs abnormally and causes premature termination of protein translation resulting in the production of truncated proteins which may be non-functional.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coenzyme composed of ribosylnicotinamide 5%27%-diphosphate coupled to adenosine 5%27%-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized %28%NAD+%29% and reduced %28%NADH%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cognitive disorder characterized by an impaired ability to comprehend written and printed words or phrases despite intact vision. This condition may be developmental or acquired. Developmental dyslexia is marked by reading achievement that falls substantially below that expected given the individual%27%s chronological age, measured intelligence, and age-appropriate education. The disturbance in reading significantly interferes with academic achievement or with activities of daily living that require reading skills. %28%From DSM-IV%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cognitive process involving the formation of ideas generalized from the knowledge of qualities, aspects, and relations of objects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cold infusion of tar in water, formerly regarded as a cure-all. %28%Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine %28%HYPOTHALAMIC HORMONES%29% regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collection of cloned peptides, or chemically synthesized peptides, frequently consisting of all possible combinations of amino acids making up an n-amino acid peptide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collection of fluid and gas within the pleural cavity. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat. They include total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collection of single-stranded RNA viruses scattered across the Bunyaviridae, Flaviviridae, and Togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collection of watery fluid in the pleural cavity. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective expression for all behavior patterns acquired and socially transmitted through symbols. Culture includes customs, traditions, and language.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective name for a group of closely related lipids that contain substitutions on the 2H-1-benzopyran-6-ol nucleus and a long hydrocarbon chain of isoprenoid units. They are antioxidants by virtue of the phenolic hydrogen. Tocopherols react with the most reactive form of oxygen and protect unsaturated fatty acids from oxidation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for a group of around nine geometric and positional isomers of LINOLEIC ACID in which the trans/cis double bonds are conjugated, where double bonds alternate with single bonds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for diseases characterized by the formation, development, or presence of a thrombus %28%THROMBOSIS%29% and the blocking of a vessel by the thrombus brought to its site by the blood current %28%EMBOLISM%29%. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for diseases of the skin and its appendages and of connective tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for muscle and ligament injuries without dislocation or fracture. A sprain is a joint injury in which some of the fibers of a supporting ligament are ruptured but the continuity of the ligament remains intact. A strain is an overstretching or overexertion of some part of the musculature.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for nutritional disorders %28%result of poor assimilation or utilization of food%29% and metabolic disorders %28%result of poor metabolism or inherited enzyme abnormality%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for the various types of nevi and melanomas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A collective term for urinary tract diseases in male and female and diseases of the male genitalia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colloidal system of semisolid hydrocarbons obtained from PETROLEUM. It is used as an ointment base, topical protectant, and lubricant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colloidal, hydrated aluminum silicate that swells 12 times its dry size when added to water.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorimetric reagent for iron, manganese, titanium, molybdenum, and complexes of zirconium. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless and flammable gas at room temperature and pressure. Ethylene oxide is a bactericidal, fungicidal, and sporicidal disinfectant. It is effective against most micro-organisms, including viruses. It is used as a fumigant for foodstuffs and textiles and as an agent for the gaseous sterilization of heat-labile pharmaceutical and surgical materials. %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p794%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless compound formed in the intestines by the reduction of bilirubin. Some is excreted in the feces where it is oxidized to urobilin. Some is reabsorbed and re-excreted in the bile as bilirubin. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless inorganic compound %28%HONH2%29% used in organic synthesis and as a reducing agent, due to its ability to donate nitric oxide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless liquid with a fragrant odor. It is used as an intermediate, solvent and in cosmetics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless liquid with a sharp burning taste and slight odor. It is used as a local anesthetic and to reduce pain associated with LIDOCAINE injection. Also, it is used in the manufacture of other benzyl compounds, as a pharmaceutic aid, and in perfumery and flavoring.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless or slightly yellow crystalline compound obtained from nutgalls. It is used in photography, pharmaceuticals, and as an analytical reagent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless to white crystalline compound with a camphoraceous odor and taste. It is a widely used preservative in various pharmaceutical solutions, especially injectables. Also, it is an active ingredient in certain oral sedatives and topical anesthetics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, odorless, highly water soluble vinyl monomer formed from the hydration of acrylonitrile. It is primarily used in research laboratories for electrophoresis, chromatography, and electron microscopy and in the sewage and wastewater treatment industries.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, odorless, viscous dihydroxy alcohol. It has a sweet taste, but is poisonous if ingested. Ethylene glycol is the most important glycol commercially available and is manufactured on a large scale in the United States. It is used as an antifreeze and coolant, in hydraulic fluids, and in the manufacture of low-freezing dynamites and resins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticizers. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, syrupy, strongly acidic liquid that can form detergents with oleic acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A colorless, toxic liquid with a strong aromatic odor. It is used to make rubbers, polymers and copolymers, and polystyrene plastics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combination of atrial septal defect and mitral stenosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combination of congenital cardiac defects consisting of pulmonary stenosis, interventricular septal defects, dextroposition of the aorta so that it overrides the interventricular septum and receives venous as well as arterial blood, and right ventricular hypertrophy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse %28%such as pain, water-retention, anxiety, cravings, and depression%29% and they diminish markedly 2 or 3 days after the initiation of menses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combination of pulmonary hemorrhage and glomerulonephritis. It is known also as the lung purpura glomerulonephritis complex. It is considered by some to be a form of hypersensitivity reaction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combination of rheumatoid arthritis, splenomegaly, leukopenia, pigmented spots on lower extremities, and other evidence of hypersplenism %28%anemia and thrombocytopenia%29%. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combination of the debris index and the dental calculus index to determine the status of oral hygiene.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine %28%DIPHTHERIA-TETANUS-PERTUSSIS VACCINE%29% when PERTUSSIS VACCINE is contraindicated.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A commercially important species of SALMON in the family SALMONIDAE, order SALMONIFORMES, which occurs in the North Atlantic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A commission created by the Consolidated Omnibus Reconciliation Act of 1985, enacted in 1986, and given the mandate to advise Congress on Medicare-physician payment. The commission members are appointed by the U.S. Office of Technology Assessment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue %28%adenosis%29%. The fibrocystic breast has a dense irregular lumpy bumpy consistency.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions, and is caused by Pityrosporon orbiculare. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common condition characterized by transient partial or total paralysis of skeletal muscles and areflexia that occurs upon awakening from sleep or less often while falling asleep. Stimuli such as touch or sound may terminate the episode, which usually has a duration of seconds to minutes. This condition may occur in normal subjects or be associated with NARCOLEPSY; CATAPLEXY; and hypnagogic HALLUCINATIONS. The pathophysiology of this condition is closely related to the normal hypotonia that occur during REM sleep. %28%From Adv Neurol 1995;67:245-271%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common congenital midline defect of fusion of the vertebral arch without protrusion of the spinal cord or meninges. The lesion is also covered by skin. L5 and S1 are the most common vertebrae involved. The condition may be associated with an overlying area of hyperpigmented skin, a dermal sinus, or an abnormal patch of hair. The majority of individuals with this malformation are asymptomatic although there is an increased incidence of tethered cord syndrome and lumbar SPONDYLOSIS. %28%From Joynt, Clinical Neurology, 1992, Ch55, p34%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes %28%GRAVES OPHTHALMOPATHY%29% and the skin %28%Graves dermopathy%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis %28%ENTEROCOLITIS, PSEUDOMEMBRANOUS%29% in patients receiving antibiotic therapy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common inhabitant of the vagina and cervix and a potential human pathogen, causing infections of the male and female reproductive tracts. It has also been associated with respiratory disease and pharyngitis. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common name for fish of the family Percidae, belonging to the suborder Percoidei, order PERCIFORMES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10%28%1%29%:43-51%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation %28%trigger points%29%. Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome %28%FATIGUE SYNDROME, CHRONIC%29%. Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. %28%From Adams et al., Principles of Neurology, 6th ed, p1494-95%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common parasite of humans in the moist tropics and subtropics. These organisms attach to villi in the small intestine and suck blood causing diarrhea, anorexia, and anemia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like %28%or vice-like%29% PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and STRESS. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common spice from fruit of PIPER NIGRUM. Black pepper is picked unripe and heaped for a few days to ferment. White Pepper is the ripe fruit dehulled by maceration in water. PIPERINE is a key component used medicinally to increase gastrointestinal assimilation of other supplements and drugs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common, acute infection usually caused by the Epstein-Barr virus %28%HERPESVIRUS 4, HUMAN%29%. There is an increase in mononuclear white blood cells and other atypical lymphocytes, generalized lymphadenopathy, splenomegaly, and occasionally hepatomegaly with hepatitis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A common, benign, usually self-limited viral infection of the skin and occasionally the conjunctivae by a poxvirus %28%MOLLUSCUM CONTAGIOSUM VIRUS%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A commonly occurring abnormal hemoglobin in which lysine replaces a glutamic acid residue at the sixth position of the beta chains. It results in reduced plasticity of erythrocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A commonly used prosthesis that results in a strong, permanent restoration. It consists of an electrolytically etched cast-metal retainer that is cemented %28%bonded%29%, using resins, to adjacent teeth whose enamel was previously acid-treated %28%acid-etched%29%. This type of bridgework is sometimes referred to as a Maryland bridge.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A commonly used x-ray contrast medium. As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A competitive inhibitor of nitric oxide synthetase. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A competitive nine-member team sport including softball.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A competitive team sport played on a rectangular court having a raised basket at each end.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A competitive team sport played on a rectangular field. This is the American or Canadian version of the game and also includes the form known as rugby. It does not include non-North American football %28%= SOCCER%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complete denture constructed for replacement of natural teeth immediately after their removal. It does not fit the mouth perfectly and is intended only for functional and cosmetic purposes during the healing process after total extraction. It is to be replaced by the fitted permanent denture.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complete denture replacing all the natural mandibular teeth and associated structures. It is completely supported by the oral tissue and underlying mandibular bone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complete denture replacing all the natural maxillary teeth and associated maxillary structures. It is completely supported by the oral tissue and underlying maxillary bone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complete separation or tear in the wall of the UTERUS with or without expulsion of the FETUS. It may be due to injuries, multiple pregnancies, large fetus, previous scarring, or obstruction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex body of social, cultural, and religious beliefs and practices evolved in and largely confined to the Indian subcontinent and marked by a caste system, an outlook tending to view all forms and theories as aspects of one eternal being and truth, and the practice of the way of works, the way of knowledge, or the way of devotion as a means of release from the round of rebirths. %28%From Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex group of fibers arising from the basal olfactory regions, the periamygdaloid region, and the septal nuclei, and passing to the lateral hypothalamus. Some fibers continue into the tegmentum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex involuntary response to an unexpected strong stimulus usually auditory in nature.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors %28%HEMATOPORPHYRIN PHOTORADIATION%29%. A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex neoplasm composed of a mixture of gonadal elements, such as large primordial GERM CELLS, immature SERTOLI CELLS or GRANULOSA CELLS of the sex cord, and gonadal stromal cells. Gonadoblastomas are most often associated with abnormal chromosomal karyotype, GONADAL DYSGENESIS, and the presence of a Y CHROMOSOME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex network of nerve fibers in the pelvic region. The hypogastric plexus distributes sympathetic fibers from the lumbar paravertebral ganglia and the aortic plexus, parasympathetic fibers from the pelvic nerve, and visceral afferents. The bilateral pelvic plexus is in its lateral extent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex network of nerve fibers including sympathetic and parasympathetic efferents and visceral afferents. The celiac plexus is the largest of the autonomic plexuses and is located in the abdomen surrounding the celiac and superior mesenteric arteries.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of ansamycin antibiotics consisting of streptovaricins A, B, C, D, E, F, G, J, and K of which streptovaricin C is the major component. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of antibiotic substances produced by Streptomyces tenebrarius.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of antigenic proteins obtained from the brush border of kidney tubules. It contains two principal components LDL-RECEPTOR RELATED PROTEIN 2 and LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN. The name of this complex is derived from researcher, Dr. Walter Heymann, who developed an experimental model of membranous glomerulonephritis %28%GLOMERULONEPHRITIS%29% by injecting this antigenic complex into rats to induce an autoimmune response.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of cells consisting of juxtaglomerular cells, extraglomerular mesangium lacis cells, the macula densa of the distal convoluted tubule, and granular epithelial peripolar cells. Juxtaglomerular cells are modified smooth muscle cells found in the walls of afferent glomerular arterioles and sometimes the efferent arterioles. Extraglomerular mesangium lacis cells are located in the angle between the afferent and efferent glomerular arterioles. Granular epithelial peripolar cells are located at the angle of reflection of the parietal to visceral angle of the renal corpuscle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. %28%From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed, p1140%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of enzymes and PROTON PUMPS located on the inner membrane of the MITOCHONDRIA and in bacterial membranes. The protein complex provides energy in the form of an electrochemical gradient, which may be used by either MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES or BACTERIAL PROTON-TRANSLOCATING ATPASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. %28%Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1292%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid %28%DTPA see PENTETIC ACID%29%, that is given to enhance the image in cranial and spinal MRIs. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of polyene antibiotics obtained from Streptomyces filipinensis. Filipin III alters membrane function by interfering with membrane sterols, inhibits mitochondrial respiration, and is proposed as an antifungal agent. Filipins I, II, and IV are less important.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of proteins that forms a receptor for TRANSFERRIN in BACTERIA. Many pathogenic bacteria utilize the transferrin-binding complex to acquire their supply of iron from serum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of seven proteins including ARP2 PROTEIN and ARP3 PROTEIN that plays an essential role in maintenance and assembly of the CYTOSKELETON. Arp2-3 complex binds WASP PROTEIN and existing ACTIN FILAMENTS, and it nucleates the formation of new branch point filaments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of several closely related glycosidic antibiotics from Streptomyces griseus. The major component, CHROMOMYCIN A3, is used as a fluorescent stain of DNA where it attaches and inhibits RNA synthesis. It is also used as an antineoplastic agent, especially for solid tumors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2, and C1%28%subA%29%, obtained from Micromonospora purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit protein synthesis %28%GENETIC TRANSLATION%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch %28%HYPERESTHESIA%29% in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor %28%i.e., sympathetic innervation to sweat glands%29%, vasomotor, and trophic skin changes may also occur. %28%Adams et al., Principles of Neurology, 6th ed, p1359%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. %28%From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26%28%6%29%:788-93%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of HEART DISEASES. Defective cardiac filling and/or impaired contraction and emptying, resulting in the heart%27%s inability to pump a sufficient amount of blood to meet the needs of the body tissues or to be able to do so only with an elevated filling pressure. %28%from Braunwald, Heart Disease, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of OBSTETRIC LABOR in which the corpus of the UTERUS is forced completely or partially through the UTERINE CERVIX. This can occur during the late stages of labor and is associated with IMMEDIATE POSTPARTUM HEMORRHAGE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of a localized area of pneumonia or when a neoplasm becomes necrotic and contains purulent material that cannot drain easily from the area because of partial or complete bronchial obstruction. %28%Harrison%27%s Principles of Internal Medicine, 12th ed, p1068%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of gastrojejunostomy %28%BILLROTH II PROCEDURE%29%, a reconstructive GASTROENTEROSTOMY. It is caused by acute %28%complete%29% or chronic %28%intermittent%29% obstruction of the afferent jejunal loop due to HERNIA, intussusception, kinking, VOLVULUS, etc. It is characterized by PAIN and VOMITING of BILE-stained fluid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A complication of multiple rib fractures, rib and sternum fractures, or thoracic surgery. A portion of the chest wall becomes isolated from the thoracic cage and exhibits paradoxical respiration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of NEOMYCIN that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p100 precursor protein and is important for maturation of B-LYMPHOCYTES and adaptive HUMORAL IMMUNITY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p105 precursor protein and is capable of forming dimeric complexes with itself or with TRANSCRIPTION FACTOR RELA. It regulates expression of GENES involved in immune and inflammatory responses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of PHOSPHATIDYLCHOLINES %28%lecithins%29%, in which the two hydroxy groups of GLYCEROL are esterified with fatty acids. %28%From Stedman, 26th ed%29% It counteracts the effects of urea on enzymes and other macromolecules.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of eukaryotic initiation factor 4F that as an RNA helicase involved in unwinding the secondary structure of the 5%27% UNTRANSLATED REGION of MRNA. The unwinding facilitates the binding of the 40S ribosomal subunit.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of eukaryotic initiation factor-4F that is involved in multiple protein interactions at the site of translation initiation. Thus it may serve a role in bringing together various initiation factors at the site of translation initiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolized and excreted from the body. This protein modulates the activation of lecithin-cholesterol acyltransferase in the presence of apolipoprotein A-I.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the Arp2-3 complex that is related in sequence and structure to ACTIN and that binds ATP. It is expressed at higher levels than ARP2 PROTEIN and does not contain a PROFILIN binding domain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the B-cell antigen receptor that is involved in B-cell antigen receptor heavy chain transport to the PLASMA MEMBRANE. It is expressed almost exclusively in B-LYMPHOCYTES and serves as a useful marker for B-cell NEOPLASMS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the CLASSICAL COMPLEMENT PATHWAY. C2 is cleaved by activated COMPLEMENT C1S into COMPLEMENT C2B and COMPLEMENT C2A. C2a, the COOH-terminal fragment containing a SERINE PROTEASE, combines with COMPLEMENT C4B to form C4b2a %28%CLASSICAL PATHWAY C3 CONVERTASE%29% and subsequent C4b2a3b %28%CLASSICAL PATHWAY C5 CONVERTASE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the CYTOCHROME B6F COMPLEX, this enzyme catalyzes the oxidation of plastoquinol-1 to PLASTOQUINONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the Department of Health and Human Services to oversee and direct the Medicare and Medicaid programs and related Federal medical care quality control staffs. Name was changed effective June 14, 2001.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the NATIONAL INSTITUTES OF HEALTH concerned with research, overall planning, promoting, and administering mental health programs and research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A component of the PUBLIC HEALTH SERVICE that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A composite substructure of the mesencephalic tectum comprised of the SUPERIOR COLLICULUS and INFERIOR COLLICULUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A composition in prose or verse presenting in dialogue or pantomime a story involving various characters, usually intended to be acted on a stage and to be regarded as a form of entertainment. %28%From Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis %28%transcription%29%, with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. %28%From AMA Drug Evaluations Annual, 1993, p2015%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive %28%I-131%29% form as an diagnostic aid, particularly for thyroid function tests.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound given in the treatment of conditions associated with zinc deficiency such as acrodermatitis enteropathica. Externally, zinc sulfate is used as an astringent in lotions and eye drops. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics. %28%From Dorland%27%s, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound originally developed as an anticoagulant, but possessing anticomplement action and lowering the bactericidal action of blood. It is used in vitro to inhibit blood coagulation and as a diagnostic reagent to encourage the growth of pathogens in the blood. It is also used to stabilize colloidal solutions such as milk and gelatin. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound suggested to be both a nootropic and a neuroprotective agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound that contains a reduced PURINE ring system but is not biosynthetically related to the purine alkaloids. It is a poison found in certain edible mollusks at certain times; elaborated by GONYAULAX and consumed by mollusks, fishes, etc. without ill effects. It is neurotoxic and causes RESPIRATORY PARALYSIS and other effects in MAMMALS, known as paralytic SHELLFISH poisoning.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound that inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. This compound has been classified as a loop or high ceiling diuretic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound that, along with its isomer, Cleland%27%s reagent %28%DITHIOTHREITOL%29%, is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound tubular gland, located around the eyes and nasal passages in marine animals and birds, the physiology of which figures in water-electrolyte balance. The Pekin duck serves as a common research animal in salt gland studies. A rectal gland or rectal salt gland in the dogfish shark is attached at the junction of the intestine and cloaca and aids the kidneys in removing excess salts from the blood. %28%Storer, Usinger, Stebbins %26% Nybakken: General Zoology, 6th ed, p658%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound used as a topical insect repellent that may cause irritation to eyes and mucous membranes, but not to the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound used to treat histomoniasis in poultry. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A compulsion to set fires. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A computer architecture, implementable in either hardware or software, modeled after biological neural networks. Like the biological system in which the processing capability is a result of the interconnection strengths between arrays of nonlinear processing nodes, computerized neural networks, often called perceptrons or multilayer connectionist models, consist of neuron-like units. A homogeneous group of units makes up a layer. These networks are good at pattern recognition. They are adaptive, performing tasks by example, and thus are better for decision-making than are linear learning machines or cluster analysis. They do not require explicit programming.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A computer based method of simulating or analyzing the behavior of structures or components.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A computerized biomedical bibliographic storage and retrieval system operated by the NATIONAL LIBRARY OF MEDICINE. MEDLARS stands for Medical Literature Analysis and Retrieval System, which was first introduced in 1964 and evolved into an online system in 1971 called MEDLINE %28%MEDLARS Online%29%. As other online databases were developed, MEDLARS became the name of the entire NLM information system while MEDLINE became the name of the premier database. MEDLARS was used to produce the former printed Cumulated Index Medicus, and the printed monthly Index Medicus, until that publication ceased in December 2004.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A concept that stands for or suggests something else by reason of its relationship, association, convention, or resemblance. The symbolism may be mental or a visible sign or representation. %28%From Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A concept, developed in 1983 under the aegis of and supported by the National Library of Medicine under the name of Integrated Academic Information Management Systems, to provide professionals in academic health sciences centers and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In August 1992 the name was changed from Integrated Academic Information Management Systems to Integrated Advanced Information Management Systems to reflect use beyond the academic milieu.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condensation product of riboflavin and adenosine diphosphate. The coenzyme of various aerobic dehydrogenases, e.g., D-amino acid oxidase and L-amino acid oxidase. %28%Lehninger, Principles of Biochemistry, 1982, p972%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the thoracic outlet and caused by a complete or incomplete anomalous cervical rib or fascial band connecting the tip of a cervical rib with the first thoracic rib. Clinical manifestations may include pain in the neck and shoulder which radiates into the upper extremity, PARESIS or PARALYSIS of brachial plexus innervated muscles; sensory loss; PARESTHESIAS; ISCHEMIA; and EDEMA. %28%Adams et al., Principles of Neurology, 6th ed, p214%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea %28%SLEEP APNEA, OBSTRUCTIVE%29% by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration. This condition may be idiopathic %28%primary%29% or associated with lower brain stem lesions; chronic obstructive pulmonary disease %28%LUNG DISEASES, OBSTRUCTIVE%29%; HEART FAILURE, CONGESTIVE; medication effect; and other conditions. Sleep maintenance is impaired, resulting in daytime hypersomnolence. Primary central sleep apnea is frequently associated with obstructive sleep apnea. When both forms are present the condition is referred to as mixed sleep apnea %28%see SLEEP APNEA SYNDROMES%29%. %28%Adams et al., Principles of Neurology, 6th ed, p395; Neurol Clin 1996;14%28%3%29%:611-28%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by a deficiency of PARATHYROID HORMONE %28%or PTH%29%. It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1 %28%DIGEORGE SYNDROME%29%; CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by deficiency of VITAMIN D, especially in infancy and childhood, with disturbance of normal ossification. The disease is marked by bending and distortion of the bones under muscular action, by the formation of nodular enlargements on the ends and sides of the bones, by delayed closure of the fontanels, pain in the muscles, and sweating of the head. Vitamin D and sunlight together with an adequate diet are curative, provided that the parathyroid glands are functioning properly. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by degenerative arthritis %28%see OSTEOARTHRITIS%29% of the METATARSOPHALANGEAL JOINT of the great toe and characterized by pain and limited dorsiflexion, but relatively unrestricted plantar flexion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by inhalation of MECONIUM into the LUNG of FETUS or NEWBORN, usually due to vigorous respiratory movements during difficult PARTURITION or respiratory system abnormalities. Meconium aspirate may block small airways leading to difficulties in PULMONARY GAS EXCHANGE and ASPIRATION PNEUMONIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by overwhelming BACTERIAL INFECTIONS or SEPTICEMIA, leading to HEMORRHAGE and NECROSIS of the ADRENAL GLAND. It is characterized by rapidly developing ADRENAL INSUFFICIENCY; HYPOTENSION; and widespread cutaneous PURPURA. This syndrome may occur at any age but is more common in children.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by prolonged exposure to excess levels of cortisol %28%HYDROCORTISONE%29% or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw %28%PROGNATHISM%29%; hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. %28%From Joynt, Clinical Neurology, 1992, Ch36, pp79-80%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia %28%PARKINSON DISEASE, SECONDARY%29%. MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. %28%Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36%28%2%29%:250-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by a broad range of progressive disorders ranging from TENOSYNOVITIS to tendon rupture with or without hindfoot collapse to a fixed, rigid, FLATFOOT deformity. Pathologic changes can involve associated tendons, ligaments, joint structures of the ANKLE, hindfoot, and midfoot. Posterior tibial tendon dysfunction is the most common cause of acquired flatfoot deformity in adults.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by a dry, waxy type of swelling %28%EDEMA%29% with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by a series of interrelated digital symptoms and joint changes of the lesser digits and METATARSOPHALANGEAL JOINTS of the FOOT. The syndrome can include some or all of the following conditions: hammer toe, claw toe, mallet toe, overlapping fifth toe, curly toe, EXOSTOSIS, HYPEROSTOSIS, interdigital heloma, or contracted toe.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by abnormal posturing of the limbs that is associated with injury to the brainstem. This may occur as a clinical manifestation or induced experimentally in animals. The extensor reflexes are exaggerated leading to rigid extension of the limbs accompanied by hyperreflexia and opisthotonus. This condition is usually caused by lesions which occur in the region of the brainstem that lies between the red nuclei and the vestibular nuclei. In contrast, decorticate rigidity is characterized by flexion of the elbows and wrists with extension of the legs and feet. The causative lesion for this condition is located above the red nuclei and usually consists of diffuse cerebral damage. %28%From Adams et al., Principles of Neurology, 6th ed, p358%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by an abnormally elevated concentration of ketone bodies in the body tissues and fluids. It is a complication of diabetes mellitus and starvation. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by focal DYSTONIA that progresses to involuntary spasmodic contractions of the muscles of the legs, trunk, arms, and face. The hands are often spared, however, sustained axial and limb contractions may lead to a state where the body is grossly contorted. Onset is usually in the first or second decade. Familial patterns of inheritance, primarily autosomal dominant with incomplete penetrance, have been identified. %28%Adams et al., Principles of Neurology, 6th ed, p1078%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed %28%waxy flexibility%29%. Catalepsy may be associated with PSYCHOTIC DISORDERS %28%e.g., SCHIZOPHRENIA, CATATONIC%29%, nervous system drug toxicity, and other conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders %28%see BRAIN DISEASES, METABOLIC%29%; and other conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by mucosal tears at the ESOPHAGOGASTRIC JUNCTION, sometimes with HEMATEMESIS. Typically it is caused by forceful bouts of retching or VOMITING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by multiple formations of myofibromas %28%LEIOMYOMA%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by neck stiffness, headache, and other symptoms suggestive of meningeal irritation, but without actual inflammation of the meninges %28%MENINGITIS%29%. Spinal fluid pressure may be elevated but spinal fluid is normal. %28%DeJong, The Neurologic Examination, 4th ed, p673%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs in tennis players as well as housewives, artisans, and violinists.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY %28%involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT%29%; or lesions of the CAUDA EQUINA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. There is no consensus on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by persistent spasms %28%SPASM%29% involving multiple muscles, primarily in the lower limbs and trunk. The illness tends to occur in the fourth to sixth decade of life, presenting with intermittent spasms that become continuous. Minor sensory stimuli, such as noise and light touch, precipitate severe spasms. Spasms do not occur during sleep and only rarely involve cranial muscles. Respiration may become impaired in advanced cases. %28%Adams et al., Principles of Neurology, 6th ed, p1492; Neurology 1998 Jul;51%28%1%29%:85-93%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma %28%CYSTADENOCARCINOMA, MUCINOUS%29%, which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by precipitation of calcium phosphate in the tubules of the kidney, with resultant renal insufficiency. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness %28%microsomnias%29% that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement %28%REM%29% sleep, which normally follows stage III or IV sleep. %28%From Neurology 1998 Feb;50%28%2 Suppl 1%29%:S2-S7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by resonant barking cough, hoarseness and persistant stridor and caused by allergy, foreign body, infection, or neoplasm. It occurs chiefly in infants and children.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by shortness of the neck resulting from reduction in the number of vertebrae or the fusion of multiple hemivertebrae into one osseous mass. The hairline is low and the motion of the neck is limited. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by somnolence or coma in the presence of an acute infection with PLASMODIUM FALCIPARUM %28%and rarely other Plasmodium species%29%. Initial clinical manifestations include HEADACHES; SEIZURES; and alterations of mentation followed by a rapid progression to COMA. Pathologic features include cerebral capillaries filled with parasitized erythrocytes and multiple small foci of cortical and subcortical necrosis. %28%From Adams et al., Principles of Neurology, 6th ed, p136%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia %28%ANEMIA, HEMOLYTIC%29%, general edema %28%HYDROPS FETALIS%29%, and SEVERE JAUNDICE IN NEWBORN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the formation of CALCULI and concretions in the hollow organs or ducts of the body. They occur most often in the gallbladder, kidney, and lower urinary tract.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the presence of abnormal or abnormal quantities of cryoglobulins in the blood. They are precipitated into the microvasculature on exposure to cold and cause restricted blood flow in exposed areas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the presence of endotoxins in the blood. If endotoxemia is the result of gram-negative rod-shaped bacteria, shock may occur.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the presence of multiple gas-filled cysts in the intestinal wall, the submucosa and/or subserosa of the INTESTINE. The majority of the cysts are found in the JEJUNUM and the ILEUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the presence of rudimentary THYROID tissue at the base of the TONGUE. It is due to failed embryonic development and migration of thyroid tissue to its normal location. The lingual thyroid usually cannot maintain adequate hormone production thereby resulting in HYPOTHYROIDISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function %28%CARDIOMYOPATHY, RESTRICTIVE%29%. It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies %28%HEART DEFECTS,CONGENITAL;%29% INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium %28%MYOCARDIUM%29%, seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles %28%CARDIOMYOPATHY, RESTRICTIVE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by transient weakness or paralysis of somatic musculature triggered by an emotional stimulus or physical exertion. Cataplexy is frequently associated with NARCOLEPSY. During a cataplectic attack, there is a marked reduction in muscle tone similar to the normal physiologic hypotonia that accompanies rapid eye movement sleep %28%SLEEP, REM%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p396%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized by underdevelopment of the left cardiac chambers, atresia or stenosis of the aorta or mitral valve or both, and hypoplasia of the aorta. These anomalies are a common cause of heart failure in early infancy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome %28%at gene loci FRAXA or FRAXE%29% and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. MENTAL RETARDATION occurs in nearly all males and roughly 50%25% of females with the full mutation of FRAXA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p226%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition due to a deficiency of one or more essential vitamins. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition due to a dietary deficiency of ascorbic acid %28%vitamin C%29%, characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow%27%s milk exclusively during their first year. It develops also commonly in chronic alcoholism. %28%Cecil Textbook of Medicine, 19th ed, p1177%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing polyuria and decreased maximal urinary concentrating ability with secondary polydipsia. %28%Merck Manual, 16th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition due to deficiency of ASCORBIC ACID %28%vitamin C%29% in the diet and marked by weakness, anemia, spongy gums, a tendency to mucocutaneous hemorrhages and a brawny induration of the muscles of the calves and legs. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in pregnant women with elevated systolic %28%%3E%140 mm Hg%29% and diastolic %28%%3E%90 mm Hg%29% blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10%25% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which albumin level in blood %28%SERUM ALBUMIN%29% is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine %28%ALBUMINURIA%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which an infant or child%27%s weight gain and growth are far below usual levels for age.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which certain opposing teeth fail to establish occlusal contact when the jaws are closed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which one of a pair of legs fails to grow as long as the other, which could result from injury or surgery.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which one or more of the arches of the foot have flattened out.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the HEAD of the FETUS is larger than the mother%27%s PELVIS through which the fetal head must pass during a vaginal delivery.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the death of adipose tissue results in neutral fats being split into fatty acids and glycerol.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the left ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the left ventricular wall.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the right ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the right ventricular wall.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which the ventricles of the heart exhibit a decreased functionality.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which there is a change of one adult cell type to another similar adult cell type.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which there is a derivation of pleasure from inflicting pain, discomfort or humiliation on another person or persons. The sexual significance of sadistic wishes or behavior may be conscious or unconscious.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which total serum protein level is below the normal range. Hypoproteinemia can be caused by protein malabsorption in the gastrointestinal tract, EDEMA, or PROTEINURIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition in which two closely related persons, usually in the same family, share the same delusions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition marked by abnormal protrusion of the mandible. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition marked by progressive CEREBELLAR ATAXIA combined with MYOCLONUS usually presenting in the third decade of life or later. Additional clinical features may include generalized and focal SEIZURES, spasticity, and DYSKINESIAS. Autosomal recessive and autosomal dominant patterns of inheritance have been reported. Pathologically, the dentate nucleus and brachium conjunctivum of the CEREBELLUM are atrophic, with variable involvement of the spinal cord, cerebellar cortex, and basal ganglia. %28%From Joynt, Clinical Neurology, 1991, Ch37, pp60-1%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury %28%see OPTIC NERVE DISEASES%29% and visual loss %28%see BLINDNESS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition marked by recurrent seizures that occur during the first 4-6 weeks of life despite an otherwise benign neonatal course. Autosomal dominant familial and sporadic forms have been identified. Seizures generally consist of brief episodes of tonic posturing and other movements, apnea, eye deviations, and blood pressure fluctuations. These tend to remit after the 6th week of life. The risk of developing epilepsy at an older age is moderately increased in the familial form of this disorder. %28%Neurologia 1996 Feb;11%28%2%29%:51-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition marked by softening of the bones %28%due to impaired mineralization, with excess accumulation of osteoid%29%, with pain, tenderness, muscular weakness, anorexia, and loss of weight, resulting from deficiency of vitamin D and calcium. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition marked by the presence of multiple osteochondromas. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition occurring in FETUS or NEWBORN due to in utero ETHANOL exposure when mother consumed alcohol during PREGNANCY. It is characterized by a cluster of irreversible BIRTH DEFECTS including abnormalities in physical, mental, and behavior development %28%such as FETAL GROWTH RETARDATION; MENTAL RETARDATION; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS%29% with varied degree of severity in an individual.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition occurring in the female offspring of dizygotic twins %28%TWIN, DIZYGOTIC%29% in a mixed-sex pregnancy, usually in CATTLE. Freemartinism can occur in other mammals. When placental fusion between the male and the female FETUSES permits the exchange of fetal cells and fetal hormones, TESTICULAR HORMONES from the male fetus can androgenize the female fetus producing a sterile XX/XY chimeric %22%female%22%%28%CHIMERISM%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition occurring in untreated or partially treated females with PHENYLKETONURIA when they become pregnant. This may result in damages to the FETUS, including MICROCEPHALY; MENTAL RETARDATION; congenital heart disease; FETAL GROWTH RETARDATION; and CRANIOFACIAL ABNORMALITIES. %28%From Am J Med Genet 1997 Mar 3;69%28%1%29%:89-95%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of abnormally elevated output of PARATHYROID HORMONE %28%or PTH%29% triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria %28%AMNIOTIC FLUID INDEX%29%. It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of an inequality of refractive power of the two eyes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of chronic gastroenteritis in adult pigs and fatal gastroenteritis in piglets caused by a CORONAVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of decreased oxygen content at the cellular level.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of morphologic change in which there is accumulation of lipids in the large foam cells of tissues. It is the cutaneous manifestation of lipidosis in which plasma fatty acids and lipoproteins are quantitatively changed. The xanthomatous eruptions have several different distinct morphologies dependent upon the specific form taken by the disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of sexual ambiguity in which the individual %28%pseudohermaphrodite%29% possesses gonadal tissue of one SEX but exhibits external PHENOTYPE of the opposite sex. Female pseudohermaphroditism is an individual with XX karyotype, normal development of OVARIES and internal reproductive tract, but with ambiguous or virilized external GENITALIA. Male pseudohermaphroditism is characterized by the presence of a Y CHROMOSOME and TESTES, but the genital tract and external genitalia are ambiguous or completely female.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of the bladder occurring predominantly in women, with an inflammatory lesion, usually in the vertex, and involving the entire thickness of the wall, appearing as a small patch of brownish red mucosa, surrounded by a network of radiating vessels. The lesions, known as Fenwick-Hunner or Hunner ulcers, may heal superficially, and are notoriously difficult to detect. Typically, there is urinary frequency and pain on bladder filling and at the end of micturition. It is also called chronic interstitial cystitis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. %28%Andrews%27% Diseases of the Skin, 8th ed, p27%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of the mucous membrane characterized by erythematous papular lesions. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition or physical state produced by the ingestion, injection or inhalation of, or exposure to a deleterious agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline %28%included in the B vitamin complex%29% and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. %28%From Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein %28%or amino acids%29%, vitamins, and minerals. It also includes an inadequacy of calories. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition produced by exposure to the sun, and marked by convulsions, coma, and a high temperature of the skin. It is distinguished from HEAT STROKE which is caused by excessive heat, natural or artificial, and is marked by dry skin, vertigo, headache, thirst, nausea and muscular cramps. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition produced by the presence of toxins or other harmful substances in the BLOOD.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition produced in man by the prolonged migration of animal nematode larvae in extraintestinal tissues other than skin; characterized by persistent hypereosinophilia, hepatomegaly, and frequently pneumonitis, commonly caused by Toxocara canis and Toxocara cati.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition resulting from congenital malformations involving the brain. The syndrome of septo-optic dysplasia combines hypoplasia or agenesis of the SEPTUM PELLUCIDUM and the OPTIC NERVE. The extent of the abnormalities can vary. Septo-optic dysplasia is often associated with abnormalities of the hypothalamic and other diencephalic structures, and HYPOPITUITARISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition resulting from the excessive retention of water with sodium depletion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition seen primarily in childhood, most often resulting from chronic exposure to MERCURY COMPOUNDS which may result in encephalopathy and POLYNEUROPATHY. Clinical features include pain, swelling and pinkish discoloration of the fingers and toes, weakness in the extremities, extreme irritability, HYPERESTHESIA, and alterations in level of consciousness. %28%From Menkes, Textbook of Child Neurology, 5th ed, p603%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition sometimes occurring after tooth extraction, particularly after traumatic extraction, resulting in a dry appearance of the exposed bone in the socket, due to disintegration or loss of the blood clot. It is basically a focal osteomyelitis without suppuration and is accompanied by severe pain %28%alveolalgia%29% and foul odor. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine %28%INTESTINE, SMALL%29% and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition that is characterized by chronic fatty DIARRHEA, a result of abnormal DIGESTION and/or INTESTINAL ABSORPTION of FATS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition when the SELLA TURCICA is not filled with pituitary tissue. The pituitary gland is either compressed, atrophied, or removed. There are two types: %28%1%29% primary empty sella is due a defect in the sella diaphragm leading to arachnoid herniation into the sellar space; %28%2%29% secondary empty sella is associated with the removal or treatment of PITUITARY NEOPLASMS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition where damage to the peripheral nervous system %28%including the peripheral elements of the autonomic nervous system%29% is associated with chronic ingestion of alcoholic beverages. The disorder may be caused by a direct effect of alcohol, an associated nutritional deficiency, or a combination of factors. Clinical manifestations include variable degrees of weakness; ATROPHY; PARESTHESIAS; pain; loss of reflexes; sensory loss; diaphoresis; and postural hypotension. %28%From Arch Neurol 1995;52%28%1%29%:45-51; Adams et al., Principles of Neurology, 6th ed, p1146%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition where seizures occur in association with ethanol abuse %28%ALCOHOLISM%29% without other identifiable causes. Seizures usually occur within the first 6-48 hours after the cessation of alcohol intake, but may occur during periods of alcohol intoxication. Single generalized tonic-clonic motor seizures are the most common subtype, however, STATUS EPILEPTICUS may occur. %28%Adams et al., Principles of Neurology, 6th ed, p1174%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition where the stomach wall becomes thickened, rubbery and loses its ability to distend. The stomach assumes a %22%leather bottle%22% shape. It is most often seen in adenocarcinoma of the stomach. The term is often used synonymously with diffuse adenocarcinoma of the stomach.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition with abnormally elevated level of AMYLASES in the serum. Hyperamylasemia due to PANCREATITIS or other causes may be differentiated by identifying the amylase isoenzymes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition with congenital and acquired forms causing recurrent ulcers in the fingers and toes. The congenital form exhibits autosomal dominant inheritance; the acquired form is found in workers who handle VINYL CHLORIDE. When acro-osteolysis is accompanied by generalized OSTEOPOROSIS and skull deformations, it is called HAJDU-CHENEY SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux %28%ESOPHAGITIS, REFLUX%29%. Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett%27%s columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A condition with trapped gas or air in the PERITONEAL CAVITY, usually secondary to perforation of the internal organs such as the LUNG and the GASTROINTESTINAL TRACT, or to recent surgery. Pneumoperitoneum may be purposely introduced to aid radiological examination.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conditioned chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, seborrhea, hyperhidrosis, periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. It is believed to be inherited as an autosomal dominant trait. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cone-shaped structure in plants made up of a mass of meristematic cells that covers and protects the tip of a growing root. It is the putative site of gravity sensing in plant roots.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conflict occurring from 1954 through 1975 within the Republic of Vietnam. It involved neighboring nations and the United States and other members of the Southeast Asia Treaty Organization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital abnormality characterized by the elevation of the DIAPHRAGM dome. It is the result of a thinned diaphragmatic muscle and injured PHRENIC NERVE, allowing the intra-abdominal viscera to push the diaphragm upward against the LUNG.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital abnormality characterized by the outpouching or sac formation in the ILEUM. It is a remnant of the embryonic YOLK SAC in which the VITELLINE DUCT failed to close.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital abnormality characterized by the persistence of the anal membrane, resulting in a thin membrane covering the normal ANAL CANAL. Imperforation is not always complete and is treated by surgery in infancy. This defect is often associated with NEURAL TUBE DEFECTS; MENTAL RETARDATION; and DOWN SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital abnormality in which there is only a rudimentary iris. This is due to the failure of the optic cup to grow. Aniridia also occurs in a hereditary form, usually autosomal dominant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital abnormality of the central nervous system marked by failure of the midline structures of the cerebellum to develop, dilation of the fourth ventricle, and upward displacement of the transverse sinuses, tentorium, and torcula. Clinical features include occipital bossing, progressive head enlargement, bulging of anterior fontanelle, papilledema, ataxia, gait disturbances, nystagmus, and intellectual compromise. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp294-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anatomic malformation of a bile duct, including cystic dilatation of the extrahepatic bile duct or the large intrahepatic bile duct. Classification is based on the site and type of dilatation. Type I is most common.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anomaly characterized by clusters of dilated hypertrophic veins surrounded by normal nervous system tissue. The blood vessels have thin walls composed of a single layer of fibromuscular tissue lined by epithelium. These lesions may occur in the brain, but are more frequent in the spinal cord and spinal meninges. The incidence of hemorrhage is relatively low, but when it occurs it may be associated with venous infarctions of the nervous system. %28%From Davis et al., Textbook of Neuropathology, 2nd ed, pp628-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anomaly characterized by the presence in the atrium of a perforated muscular membrane which separates the atrium into upper and lower chambers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anomaly in which there is abnormal communication between the ascending aorta and pulmonary artery just above the semilunar valves.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anomaly of the hand or foot, marked by the presence of supernumerary digits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anomaly of the hand or foot, marked by the webbing between adjacent fingers or toes. Syndactylies are classified as complete or incomplete by the degree of joining. Syndactylies can also be simple or complex. Simple syndactyly indicates joining of only skin or soft tissue; complex syndactyly marks joining of bony elements.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital anomaly resulting from the failure of the aorticopulmonary system to develop and divide the truncus arteriosus into the aorta and the pulmonary trunk.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially ADP, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein IIb-IIIa complex %28%PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital cardiomyopathy in which transmural infiltration of adipose tissue results in weakness and aneurysmal bulging of the infundibulum, apex, and posterior basilar region of the right ventricle and leads to ventricular tachycardia arising in the right ventricle. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital cardiovascular malformation in which the aorta arises entirely from the right ventricle and the pulmonary artery from the left ventricle, so that the venous return from the peripheral circulation is recirculated by the right ventricle via the aorta to the systemic circulation without being oxygenated in the lungs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital condition where the greater portions of the cerebral hemispheres and CORPUS STRIATUM are replaced by CSF and glial tissue. The meninges and the skull are well formed, which is consistent with earlier normal embryogenesis of the telencephalon. Bilateral occlusions of the internal carotid arteries in utero is a potential mechanism. Clinical features include intact brainstem reflexes without evidence of higher cortical activity. %28%Menkes, Textbook of Child Neurology, 5th ed, p307%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital defect in which the mouth is unusually small. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital defect with major fissure in the ABDOMINAL WALL lateral to, but not at, the UMBILICUS. This results in the extrusion of VISCERA. Unlike OMPHALOCELE, herniated structures in gastroschisis are not covered by a sac or PERITONEUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital or acquired condition in which the SPLEEN is not in its normal anatomical position but moves about in the ABDOMEN. This is due to laxity or absence of suspensory ligaments which normally provide peritoneal attachments to keep the SPLEEN in a fixed position. Clinical symptoms include ABDOMINAL PAIN, splenic TORSION and ISCHEMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital or acquired condition of insufficient production of ALDOSTERONE by the ADRENAL CORTEX leading to diminished aldosterone-mediated synthesis of Na%28%+%29%-K%28%+%29%-EXCHANGING ATPASE in renal tubular cells. Clinical symptoms include HYPERKALEMIA, sodium-wasting, HYPOTENSION, and sometimes metabolic ACIDOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital or acquired protrusion of the meninges, unaccompanied by neural tissue, through a bony defect in the skull or vertebral column.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital reproductive abnormality in white female offspring %28%heifers%29% in certain breeds of CATTLE, such as Belgian Blue and Shorthorn. The white color is inherited as a recessive trait which is associated with defects in the female reproductive tract %28%Muellerian system%29%. These heifers are usually sterile.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A congenital syndrome characterized by a port-wine nevus covering portions of the face and cranium %28%in the distribution of the ophthalmic division of the TRIGEMINAL NERVE%29% and angiomas of the meninges and choroid. Clinical manifestations include the onset of focal SEIZURES, progressive hemiparesis, GLAUCOMA, hemianopsia, and cognitive deficits in the first decade of life. By age two years, skull radiographs reveal %22%tramline calcifications%22% of the margins of the occipital and parietal lobes. Pathologically cortical neurons are replaced by glial tissue that undergoes calcification. %28%From Adams et al., Principles of Neurology, 6th ed, pp1018-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conical fibro-serous sac surrounding the HEART and the roots of the great vessels %28%AORTA; VENAE CAVAE; PULMONARY ARTERY%29%. The pericardium consists of two layers or sacs, the outer fibrous pericardium and the inner serous pericardium %28%or epicardium%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conserved A-T rich sequence which is contained in promoters for RNA polymerase II. The segment is seven base pairs long and the nucleotides most commonly found are TATAAAA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A conserved class of proteins that control APOPTOSIS in both VERTEBRATES and INVERTEBRATES. IAP proteins interact with and inhibit CASPASES, and they function as ANTI-APOPTOTIC PROTEINS. The protein class is defined by an approximately 80-amino acid motif called the baculoviral inhibitor of apoptosis repeat.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A constellation of responses that occur when an organism is exposed to excessive heat and other environmental stresses. Responses include synthesis of some proteins, repression of other proteins, and expression of new proteins. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A constituent organization of the DEPARTMENT OF HEALTH AND HUMAN SERVICES concerned with protecting and improving the health of the nation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A constitutively expressed subfamily of the HSP70 heat-shock proteins. They preferentially bind and release hydrophobic peptides by an ATP-dependent process and are involved in post-translational PROTEIN TRANSLOCATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A constitutively expressed subtype of bradykinin receptor that may play a role in the acute phase of the inflammatory and pain response. It has high specificity for intact forms of BRADYKININ and KALLIDIN. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A constitutively-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contact herbicide used also to produce desiccation and defoliation. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contagious cutaneous inflammation caused by the bite of the mite SARCOPTES SCABIEI. It is characterized by pruritic papular eruptions and burrows and affects primarily the axillae, elbows, wrists, and genitalia, although it can spread to cover the entire body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contagious disease caused by canine adenovirus %28%ADENOVIRUSES, CANINE%29% infecting the LIVER, the EYE, the KIDNEY, and other organs in dogs, other canids, and bears. Symptoms include FEVER; EDEMA; VOMITING; and DIARRHEA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contagious disease of horses that can be transmitted to humans. It is caused by BURKHOLDERIA MALLEI and characterized by ulceration of the respiratory mucosa and an eruption of nodules on the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contagious, neoplastic, pulmonary disease of sheep characterized by hyperplasia and hypertrophy of pneumocytes and epithelial cells of the lung. It is caused by OVINE PULMONARY ADENOCARCINOMA VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contiguous gene syndrome associated with a heterozygous microdeletion in the chromosomal region 7q11.23, encompassing the ELASTIN gene. Clinical manifestations include supravalvular aortic stenosis %28%AORTIC STENOSIS, SUPRAVALVULAR%29%, MENTAL RETARDATION, elfin facies, impaired visuospatial constructive abilities, and transient hypercalcemia in infancy. The condition affects both sexes, with onset at birth or in early infancy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A continuous cell line of high contact-inhibition established from NIH Swiss mouse embryo cultures. The cells are useful for DNA transfection and transformation studies. %28%From ATCC %5B%Internet%5D%. Virginia: American Type Culture Collection; c2002 %5B%cited 2002 Sept 26%5D%. Available from http://www.atcc.org/%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A continuous cell line that is a substrain of SWISS 3T3 CELLS developed though clonal isolation. The mouse fibroblast cells undergo an adipose-like conversion as they move to a confluent and contact-inhibited state.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A continuous circle of peptide bonds, typically of 2-3 dozen AMINO ACIDS, so there is no free N- or C-terminus. They are further characterized by six conserved CYSTEINE residues that form CYSTINE KNOT MOTIFS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A continuous protein fiber consisting primarily of FIBROINS. It is synthesized by a variety of INSECTS and ARACHNIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contraceptive method whereby coitus is purposely interrupted in order to prevent EJACULATION of SEMEN into the VAGINA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine %28%IOTHALAMATE MEGLUMINE%29% salts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A convolution on the inferior surface of each cerebral hemisphere, lying between the hippocampal and collateral sulci. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coordinated effort of researchers to map %28%CHROMOSOME MAPPING%29% and sequence %28%SEQUENCE ANALYSIS, DNA%29% the human GENOME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A copolymer of polyethylene and polypropylene ether glycol. It is a non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A copper protein that catalyzes the formation of 2 moles of 3-phosphoglycerate from ribulose 1,5-biphosphate in the presence of carbon dioxide. It utilizes oxygen instead of carbon dioxide to form 2-phosphoglycollate and 3-phosphoglycerate. EC 4.1.1.39.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A copper-containing oxidoreductase enzyme that catalyzes the oxidation of 4-benzenediol to 4-benzosemiquinone. It also has activity towards a variety of O-quinols and P-quinols. It primarily found in FUNGI and is involved in LIGNIN degradation, pigment biosynthesis and detoxification of lignin-derived products.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coronary vasodilator agent. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A corps of the armed services concerned with animal medicine, the chief interest of which is the care of government-owned working dogs %28%as in the military police units%29%, working horses %28%as in state funerals%29%, and working military dolphins %28%as in undersea exploration and other activities%29%. In the United States Army Veterinary Corps animal medicine overlaps and interconnects with biomedical research using laboratory research animals. A related activity is laboratory animal care. The Corps provides limited care for privately owned animals of military personnel through non-appropriated funds. Military service veterinarians in the United States Army must be graduates of accredited veterinary schools and must have a state license. %28%Telephone communication with Lt. Col. William Inskeep II, U.S. Army Veterinary Corps, October 4, 1994%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p733%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in analytical chemistry for the determination of nitric acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coumarin that is used as an anticoagulant. It has actions similar to those of WARFARIN. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p226%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p233%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A count of SPERM in the ejaculum, expressed as number per milliliter.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country consisting of the eastern half of the island of New Guinea and adjacent islands, including New Britain, New Ireland, the Admiralty Islands, and New Hanover in the Bismarck Archipelago; Bougainville and Buka in the northern Solomon Islands; the D%27%Entrecasteaux and Trobriand Islands; Woodlark %28%Murua%29% Island; and the Louisiade Archipelago. It became independent on September 16, 1975. Formerly, the southern part was the Australian Territory of Papua, and the northern part was the UN Trust Territory of New Guinea, administered by Australia. They were administratively merged in 1949 and named Papua and New Guinea, and renamed Papua New Guinea in 1971.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. It includes the eastern half of the island of Timor, the Oecussi %28%Ambeno%29% region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco. On May 20, 2002, East Timor was internationally recognized as an independent state. This followed its declared independence from Portugal on November 20, 1975 and a period of armed conflict with Indonesia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country in northern Africa between MOROCCO and LIBYA. Its capital is Algiers. It was known to the Romans as Numidia. From 430 A.D. until 1942 it was successively in the hands of the Vandals, the Eastern Roman Empire, the Arabs, the Ottoman Empire, and the French, and gained independence in 1962. The country took its name from its capital, from the Arabic al %28%the%29% + jaza%27%ir %28%islands%29%, with reference to four islands lying off the coast at Algiers but joined to the mainland by 1525. %28%From Webster%27%s New Geographical Dictionary, 1988, p31 %26% Room, Brewer%27%s Dictionary of Names, 1992, p14%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country in northern Africa. Its capital is Tripoli. The general geographical area has been known since ancient times to the Phoenicians, Greeks, and Romans. Although the name is ancient and appeared in Egyptian hieroglyphics as early as 2000 B.C., the meaning is not known. %28%From Webster%27%s New Geographical Dictionary, 1988, p668%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country in western Africa, east of MAURITANIA and north of SUDAN. Its capital is Bamako. Its earlier names give a clue to its African and overseas connections: 1904-1920 it was known as Upper Senegal-Niger; prior to 1958, as French Sudan; 1958-1960 as the Sudanese Republic and 1959-1960 it joined Senegal in the Mali Federation. It became an independent republic in 1960 but the government is at present in transition. Mali was the name of a former empire, extinct from the 17th century. It may be derived from Malinke, an indigenous people of this region or from a Mandingo word meaning hippopotamus. %28%From Webster%27%s New Geographical Dictionary, p717 %26% Room, Brewer%27%s Dictionary of Names, 1992, p329%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country of central Asia, nominally an autonomous region within Communist China. It first came under Chinese control during the Manchu dynasty in 1720 and was generally closed to foreigners until late in the nineteenth century. Tibetans are an ancient race of Mongolian type and their ruler is the Dalai Lama. Buddhism was introduced in the seventh century A.D. and most Tibetans are Buddhists. %28%From Webster%27%s New Geographical Dictionary, 1988%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country of eastern Africa, west of the Red Sea. In ancient times, it formed a part of many kingdoms at different periods. Its capital is Asmara. Under Italian rule from 1869 to 1890 and under the British as a protectorate until 1952, it was federated with Ethiopia in 1952 and was made one of its provinces in 1962. In 1991 Eritrea was established as a de facto independent state and became fully independent in 1993. The name Eritrea alludes to its location near the Red Sea since it comes from the Greek erythros, red. %28%From Webster%27%s New Geographical Dictionary, p376 %26% Information Section, Embassy of Eritrea, Washington, D.C., 1995; from Room, Brewer%27%s Dictionary of Names, 1992, p174%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A country of eastern Europe, formerly the province of Bosnia in Yugoslavia, uniting with the province of Herzegovina to form the Republic of Bosnia and Herzegovina in 1946. It was created 7 April 1992 as a result of the division of Yugoslavia and recognized by the United States as an independent state. Bosnia takes is name from the river Bosna, in turn from the Indoeuropean root bhog, %22%current%22%; Herzegovina is from the Serbian herceg %28%duke%29% + -ov %28%the possessive%29% + -ina %28%country or territory%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A course of study offered by an educational institution.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A course or method of action selected, usually by a government, from among alternatives to guide and determine present and future decisions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A course or method of action selected, usually by a government, to guide and determine present and future decisions on population control by limiting the number of children or controlling fertility, notably through family planning and contraception within the nuclear family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A course or method of action selected, usually by an organization, institution, university, society, etc., from among alternatives to guide and determine present and future decisions and positions on matters of public interest or social concern. It does not include internal policy relating to organization and administration within the corporate body, for which ORGANIZATION AND ADMINISTRATION is available.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A covalently linked dimeric nonessential amino acid formed by the oxidation of CYSTEINE. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A creeping annual plant species of the CUCURBITACEAE family. It has a rough succulent, trailing stem and hairy leaves with three to five pointed lobes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes %28%T-LYMPHOCYTES, CYTOTOXIC%29% and suppressor T-lymphocytes %28%T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cross-shaped DNA structure that can be observed under the electron microscope. It is formed by the incomplete exchange of strands between two double-stranded helices.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A crystalline compound used as a laboratory reagent in place of HYDROGEN SULFIDE. It is a potent hepatocarcinogen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A culture-specific acute delusional syndrome occurring mostly in the Malay people and Southern Chinese. The syndrome is characterized by the individual%27%s sudden experience of depersonalization depicted by the belief that his penis is shrinking into his abdomen and that he will die when this occurs. Although generally classified as a culture-specific syndrome, koro may be no more than a variant of castration anxiety %28%ANXIETY, CASTRATION%29% as it has been described in non-Asian patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cultured line of C3H mouse FIBROBLASTS that do not adhere to one another and do not express CADHERINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A curare alkaloid that is a very potent competitive nicotinic antagonist at the neuromuscular junction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A curved elevation of gray matter extending the entire length of the floor of the temporal horn of the lateral ventricle %28%Dorland, 28th ed%29%. The hippocampus, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular %28%National Rosacea Society%27%s Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyanogenic glycoside found in the seeds of Rosaceae. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic nonadecapeptide antibiotic that can act as an ionophore and is produced by strains of Trichoderma viride. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic nucleotide formed from CYTIDINE TRIPHOSPHATE by the action of cytidylate cyclase. It is a potential cyclic nucleotide intracellular mediator of signal transductions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic peptide consisting of three residues of delta-N-hydroxy-delta-N-acetylornithine. It acts as an iron transport agent in Ustilago sphaerogena.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic polypeptide antibiotic isolated from culture filtrates of Bacillus subtilis that acts as an antifungal agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. %28%From Martindale, The Extra Pharmacopoeia, 30th ed%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclic-AMP protein kinase that mediates agonist-dependent PHOSPHORYLATION and desensitization of G-PROTEIN-COUPLED RECEPTORS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclin-dependent kinase inhibitor that coordinates the activation of CYCLIN and CYCLIN-DEPENDENT KINASES during the CELL CYCLE. It interacts with active CYCLIN D complexed to CYCLIN-DEPENDENT KINASE 4 in proliferating cells, while in arrested cells it binds and inhibits CYCLIN E complexed to CYCLIN-DEPENDENT KINASE 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclin-dependent kinase inhibitor that mediates TUMOR SUPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered ring. %28%From Merck Index, 11th ed%29% Valinomycin is a potassium selective ionophore and is commonly used as a tool in biochemical studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors %28%RECEPTORS, N-METHYL-D-ASPARTATE%29% and may interact with sigma receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclohexylamido analog of PENICILLANIC ACID. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent %28%NSAID%29% that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyst %28%CYSTS%29% near the OVARY, derived from anomalies of the FALLOPIAN TUBES or the BROAD LIGAMENT. The paramesonephric type consists of ciliated cells similar to the oviduct epithelium. The mesonephric type consisted of an epithelium with minimally surface structures. They can be found on the thin oviduct %28%paratubal cysts%29% or near its fimbriated end %28%hydatid of Morgagni%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cysteine endopeptidase isolated from papaya latex. Preferential cleavage at glutamic and aspartic acid residues. EC 3.4.22.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cysteine-type peptidase that is CHLORINE dependent and functions maximally at acidic pHs. At neutral pH, it polymerizes esters, aryl- and dipeptide amides. EC 3.4.14.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cystic distention of the epididymis or the rete testis containing spermatozoa. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cystic form of sweat gland adenoma %28%ADENOMA, SWEAT GLAND%29%. It is produced by the cystic proliferation of apocrine secretory glands. It is not uncommon, occurring in adult life in no particular age group, with males and females equally affected. The commonest site is around the eye, particularly lateral to the outer canthus. It is cured by surgical removal. %28%Stedman, 25th ed; Rook et al., Textbook of Dermatology, 4th ed, p2410%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma %28%CYSTADENOMA, MUCINOUS%29%. It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. %28%Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytochrome P-450 monooxygenase that can be induced by polycyclic aromatic xenobiotics in the liver of human and several animal species. This enzyme is of significant clinical interest due to the large number of drug interactions associated with its induction and its metabolism of THEOPHYLLINE. Caffeine is considered to be a model substrate for this enzyme. CYP1A2 activity can also be increased by environmental factors such as cigarette smoking, charbroiled meat, cruciferous vegetables, and a number of drugs including phenytoin, phenobarbital, and omeprazole.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytochrome P-450 monooxygenase that is involved in an NADPH-dependent electron transport pathway by oxidizing a variety of structurally unrelated compounds, including STEROIDS; FATTY ACIDS; and XENOBIOTICS. This enzyme has clinical significance due to its ability to metabolize a diverse array of clinically important drugs such as CYCLOSPORINE; VERAPAMIL; and MIDAZOLAM. This enzyme also catalyzes the N-demethylation of ERYTHROMYCIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytochrome P450 enzyme that catalyzes the hydroxylation of many drugs and environmental chemicals, such as DEBRISOQUINE; ADRENERGIC RECEPTOR ANTAGONISTS; and TRICYCLIC ANTIDEPRESSANTS. This enzyme is deficient in up to 10 percent of the Caucasian population.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytochrome form of lactate dehydrogenase found in the MITOCHONDRIA. It catalyzes the oxidation of L-lactate to PYRUVATE with transfer of electrons to CYTOCHROME C. The enzyme utilizes FMN and PROTOHEME IX as cofactors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytochrome oxidase inhibitor which is a nitridizing agent and an inhibitor of terminal oxidation. %28%From Merck Index, 12th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytokine receptor that mediates SIGNAL TRANSDUCTION PATHWAYS for a diverse group of ligands including: INTERLEUKIN 6; INTERLEUKIN 11; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; and CILIARY NEUROTROPHIC FACTOR. The gp130 receptor acts through the formation of oligomeric complexes of itself with a variety of receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytokine that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. IL-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytologic technique for measuring the functional capacity of stem cells by assaying their activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytoplasmic serine threonine kinase involved in regulating CELL DIFFERENTIATION and CELLULAR PROLIFERATION. Overexpression of this enzyme has been shown to promote PHOSPHORYLATION of BCL-2 PROTO-ONCOGENE PROTEINS and chemoresistance in human acute leukemia cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytoskeletal linker protein with a molecular weight of greater than 500 kDa. It binds INTERMEDIATE FILAMENTS; MICROTUBULES; and MICROFILAMENTS and plays a central role in the organization and stability of the CYTOSKELETON. Plectin is phosphorylated by CALMODULIN KINASE; PROTEIN KINASE A; and PROTEIN KINASE C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytoskeletal protein associated with cell-cell and cell-matrix interactions. The amino acid sequence of human vinculin has been determined. The protein consists of 1066 amino acid residues and its gene has been assigned to chromosome 10.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytosolic carbonic anhydrase isoenzyme found widely distributed in cells of almost all tissues. Deficiencies of carbonic anhydrase II produce a syndrome characterized by OSTEOPETROSIS, renal tubular acidosis %28%ACIDOSIS, RENAL TUBULAR%29% and cerebral calcification. EC 4.2.1.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytosolic carbonic anhydrase isoenzyme primarily expressed in ERYTHROCYTES, vascular endothelial cells, and the gastrointestinal mucosa. EC 4.2.1.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytosolic carbonic anhydrase isoenzyme primarily expressed in skeletal muscle %28%MUSCLES, SKELETAL%29%. EC 4.2.1.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytosolic ribonucleoprotein complex that acts to induce elongation arrest of nascent presecretory and membrane proteins until the ribosome becomes associated with the rough endoplasmic reticulum. It consists of a 7S RNA and at least six polypeptide subunits %28%relative molecular masses 9, 14, 19, 54, 68, and 72K%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytostatic triazole derivative which is not to be confused with guanazolo, the generic name for 8-azaguanine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytotoxic member of the CYTOCHALASINS. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytotoxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A daidzein derivative occurring naturally in forage crops which has some estrogenic activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dangerous life-threatening hypermetabolic condition characterized by high FEVER and dysfunction of the cardiovascular, the nervous, and the gastrointestinal systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dark-gray, metallic element of widespread distribution but occurring in small amounts; atomic number, 22; atomic weight, 47.90; symbol, Ti; specific gravity, 4.5; used for fixation of fractures. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A darkly stained mat-like EXTRACELLULAR MATRIX %28%ECM%29% that separates cell layers, such as EPITHELIUM from ENDOTHELIUM or a layer of CONNECTIVE TISSUE. The ECM layer that supports an overlying EPITHELIUM or ENDOTHELIUM is called basal lamina. Basement membrane %28%BM%29% can be formed by the fusion of either two adjacent basal laminae or a basal lamina with an adjacent reticular lamina of connective tissue. BM, composed mainly of TYPE IV COLLAGEN; glycoprotein LAMININ; and PROTEOGLYCAN, provides barriers as well as channels between interacting cell layers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A databank established by the Health Care Quality Improvement Act of 1986 authorizing the Department of Health and Human Services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians%27% malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dead body, usually a human body. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deaminated metabolite of LEVODOPA. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A decapeptide bradykinin homolog cleaved from kininogen by kallikreins. It is a smooth-muscle stimulant and hypotensive agent that acts by vasodilatation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A decapeptide hormone released by the hypothalamus. It stimulates the synthesis and secretion of both FOLLICLE STIMULATING HORMONE and luteinizing hormone %28%LH%29% from the pituitary gland.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A decrease in the number of GRANULOCYTES; %28%BASOPHILS; EOSINOPHILS; and NEUTROPHILS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A decrease in the number of blood platelets. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A decrease in the number of neutrophilic leukocytes in the blood. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deep type of gyrate erythema that follows a bite by an ixodid tick; it is a stage-1 manifestation of LYME DISEASE. The site of the bite is characterized by a red papule that expands peripherally as a nonscaling, palpable band that clears centrally. This condition is often associated with systemic symptoms such as chills, fever, headache, malaise, nausea, vomiting, fatigue, backache, and stiff neck.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A defective variant of MEASLES VIRUS that has been isolated from the brain tissue of patients with subacute sclerosing panencephalitis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A defense mechanism operating unconsciously, in which the individual attempts to justify or make consciously tolerable, by plausible means, feelings, behavior, and motives that would otherwise be intolerable.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A defense mechanism through which unacceptable impulses and instinctive urges are diverted into personally and socially acceptable channels; e.g., aggression may be diverted through sports activities.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A defense mechanism, operating unconsciously, whereby that which is emotionally unacceptable in the self is rejected and attributed %28%projected%29% to others.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deficiency in the activities of biotin-dependent enzymes %28%propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE%29% due to one of two defects in BIOTIN metabolism. The neonatal form is due to HOLOCARBOXYLASE SYNTHETASE DEFICIENCY. The late-onset form is due to BIOTINIDASE DEFICIENCY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor %28%FSF%29% that prevents blood clot formation and results in a clinical hemorrhagic diathesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deficiency of blood coagulation factor IX inherited as an X-linked disorder. %28%Also known as Christmas Disease, after the first patient studied in detail, not the holy day.%29% Historical and clinical features resemble those in classic hemophilia %28%HEMOPHILIA A%29%, but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. %28%From Cecil Textbook of Medicine, 19th ed, p1008%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deficiency of blood coagulation factor V %28%known as proaccelerin or accelerator globulin or labile factor%29% leading to a rare hemorrhagic tendency known as Owren%27%s disease or parahemophilia. It varies greatly in severity. Factor V deficiency is an autosomal recessive trait. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deficiency of blood coagulation factor XI %28%known as plasma thromboplastin antecedent or PTA or antihemophilic factor C%29% resulting in a systemic blood-clotting defect called hemophilia C or Rosenthal%27%s syndrome, that may resemble classical hemophilia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deficiency or absence of fibrinogen %28%coagulation factor I%29% in the blood. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deformed foot in which the foot is plantarflexed, inverted and adducted.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deformity of the SKULL that is not due to bone fusion %28%SYNOSTOSIS%29%, such as CRANIOSYNOSTOSES, and is characterized by an asymmetric skull and face. It is observed with increased frequencies in INFANTS after the adoption of supine sleeping recommendations to prevent SUDDEN INFANT DEATH SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degeneration of the ARTICULAR CARTILAGE of the PATELLA, caused by a decrease in sulfated MUCOPOLYSACCHARIDES in the ground substance. When accompanied by pain, it is sometimes considered part of or confused with PATELLOFEMORAL PAIN SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. %28%From Adams et al., Principles of Neurology, 6th ed, pp1049-57%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS %28%supranuclear ophthalmoplegia%29%; DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. %28%From Adams et al., Principles of Neurology, 6th ed, pp1076-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. %28%From Adams et al., Principles of Neurology, 6th ed, pp1089-94%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degradation product of ethylenebis%28%dithiocarbamate%29% fungicides. It has been found to be carcinogenic and to cause THYROID hyperplasia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A degraded form of GINKGOLIDES that have three LACTONES and a unique tert-butyl group which are found in GINKGO plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed hypersensitivity involving the reaction between sunlight or other radiant energy source and a chemical substance to which the individual has been previously exposed and sensitized. It manifests as a papulovesicular, eczematous, or exudative dermatitis occurring chiefly on the light-exposed areas of the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed rectifier subtype of shaker potassium channels that conducts a delayed rectifier current. It contributes to ACTION POTENTIAL repolarization of MYOCYTES in HEART ATRIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed rectifier subtype of shaker potassium channels that has been described in NEURONS and ASTROCYTES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed rectifier subtype of shaker potassium channels that is commonly mutated in human episodic ATAXIA and MYOKYMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed rectifier subtype of shaker potassium channels that is selectively inhibited by a variety of SCORPION VENOMS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed rectifier subtype of shaker potassium channels that is the predominant VOLTAGE-GATED POTASSIUM CHANNEL of T-LYMPHOCYTES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delayed response interval occurring when two stimuli are presented in close succession.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A delta-selective opioid %28%ANALGESICS, OPIOID%29%. It can cause transient depression of mean arterial blood pressure and heart rate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A demographic parameter indicating a person%27%s status with respect to marriage, divorce, widowhood, singleness, etc.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A demyelinating condition affecting the PONS and characterized clinically by an acute progressive QUADRIPLEGIA; DYSARTHRIA; DYSPHAGIA; and alterations of consciousness. Pathologic features include prominent demyelination in the central PONS with sparing of axons and neurons. This condition is usually associated with systemic disorders such as HYPONATREMIA; chronic ALCOHOLISM; LIVER FAILURE; severe BURNS; malignant NEOPLASMS; hemorrhagic PANCREATITIS; HEMODIALYSIS; and SEPSIS. The rapid medical correction of hyponatremia has been cited as a cause of this condition. %28%From Adams et al., Principles of Neurology, 6th ed, pp1125-6%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dense intricate feltwork of interwoven fine glial processes, fibrils, synaptic terminals, axons, and dendrites interspersed among the nerve cells in the gray matter of the central nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with pathology of the oral cavity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with the histology, physiology, and pathology of the tissues that support, attach, and surround the teeth, and of the treatment and prevention of disease affecting these tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with the maintenance of the dental pulp in a state of health and the treatment of the pulp cavity %28%pulp chamber and pulp canal%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with the prevention and correction of dental and oral anomalies %28%malocclusion%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with the prevention of disease and the maintenance of oral health through promoting organized dental health programs at a community, state, or federal level.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing teeth and structures by artificial devices or prostheses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dentifrice in paste form; usually contains binder, humectant, an abrasive, a detergent, flavoring agent and often caries preventives, anti-infective agents or other medicaments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A denture replacing all natural teeth and associated structures in both the maxilla and mandible.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A denture replacing one or more %28%but not all%29% natural teeth. It is supported and retained by underlying tissue and some or all of the remaining teeth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines %28%adenine and guanine%29% and pyrimidines %28%thymine and cytosine%29%, forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines %28%adenine to thymine and guanine to cytosine%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A department of the United States Government concerned with improving and maintaining farm income and developing and expanding markets for agricultural products. It also helps landowners in protecting the soil, water, forest, and other natural resources. It carries out rural development and conservation programs. Through inspection and grading services it safeguards and insures standards of quality in food supply and production.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A department of the United States government concerned with administering those agencies and offices having programs pertaining to health and human services.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A departure from the normal gait in animals. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A depolarizing neuromuscular-blocking agent, that causes persistent nicotinic activation resulting in spastic paralysis of susceptible nematodes. It is a drug of second-choice after benzimidazoles for treatment of ascariasis, hookworm, and pinworm infections, being effective after a single dose. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p920%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of 7-aminocephalosporanic acid. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of CHLORAL HYDRATE that was used as a sedative but has been replaced by safer and more effective drugs. Its most common use is as a general anesthetic in animal experiments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%, which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL-cholesterol %28%LIPOPROTEINS, LDL CHOLESTEROL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of PROCAINE with less CNS action. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of STARCH used as a plasma substitute in the treatment of hemorrhage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of acetic acid which increases the activity of pyruvate dehydrogenase and rate of lipogenesis. It is used in organic synthesis, pharmaceuticals, and medicine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of acetic acid, N%28%CH2COOH%29%3. It is a complexing %28%sequestering%29% agent that forms stable complexes with Zn2+. %28%From Miall%27%s Dictionary of Chemistry, 5th ed.%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of benzodiazepine that acts on the cholecystokinin A %28%CCKA%29% receptor to antagonize CCK-8%27%s %28%SINCALIDE%29% physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of complement C5a, generated when the carboxy-terminal ARGININE is removed by CARBOXYPEPTIDASE B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability %28%CHEMOATTRACTANTS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A designation for publications of research resulting from extramural research funded by the National Institutes of Health.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A designation for publications of research resulting from intramural research at the National Institutes of Health.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS FOLIACEUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A desmosomal cadherin that is an autoantigen in the acquired skin disorder PEMPHIGUS VULGARIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of dental care.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of nursing care.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A developmental anomaly in which the lower sternum is posteriorly dislocated and concavely deformed, resulting in a funnel-shaped thorax.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A developmental anomaly that usually becomes apparent in the neonatal period with progressive respiratory distress. This malformation is a focal pulmonary dysplasia characterized by a multicystic mass of terminal bronchiolar structures. CCAM is classified into 3 separate types %28%I, II, III%29% depending on cyst size.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A developmental defect in which a TESTIS or both TESTES failed to descend from high in the ABDOMEN to the bottom of the SCROTUM. Testicular descent is essential to normal SPERMATOGENESIS which requires temperature lower than the BODY TEMPERATURE. Cryptorchidism can be subclassified by the location of the maldescended testis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary %28%external%29% or permanent %28%internal or internal-external%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A device that substitutes for a heart valve. It may be composed of biological material %28%BIOPROSTHESIS%29% and/or synthetic material.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A device, activated electronically or by expired pulmonary air, which simulates laryngeal activity and enables a laryngectomized person to speak. Examples of the pneumatic mechanical device are the Tokyo and Van Hunen artificial larynges. Electronic devices include the Western Electric electrolarynx, Tait oral vibrator, Cooper-Rand electrolarynx and the Ticchioni pipe.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A di-tert-butyl PHENOL with antioxidant properties. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diagnostic aid as a radiopaque medium in cholecystography.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diagnostic procedure used to determine whether LYMPHATIC METASTASIS has occurred. The sentinel lymph node is the first lymph node to receive drainage from a neoplasm.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diagnostic radiopaque that usually occurs as the sodium salt.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diagnostic technique that incorporates the measurement of molecular diffusion %28%such as water or metabolites%29% for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient %28%ADC%29% with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diagnostic test in which vitamin B12 is tagged with radioactive cobalt, taken orally, and gastrointestinal absorption is determined via measurement of the amount of radioactivity in a 24-hour urine collection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H%28%1%29%- and H%28%2%29%-receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE %28%ddI%29% by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dideoxynucleoside compound in which the 3%27%-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diet that contains limited amounts of CARBOHYDRATES. This is in distinction to a regular DIET.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diet that contains limited amounts of fat with less than 30%25% of calories from all fats and less than 10%25% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIA. %28%From Bondy et al, Metabolic Control and Disease, 8th ed, pp468-70; Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diet typical of the Mediterranean region characterized by a pattern high in fruits and vegetables, cereals and bread, potatoes, poultry, beans, nuts, olive oil and fish while low in red meat and dairy and moderate in alcohol consumption.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-colored tongue that may show fissures, corneal vascularization, dyssebacia, and anemia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diffuse or multifocal peripheral neuropathy related to the remote effects of a neoplasm, most often carcinoma or lymphoma. Pathologically, there are inflammatory changes in peripheral nerves. The most common clinical presentation is a symmetric distal mixed sensorimotor polyneuropathy. %28%Adams et al., Principles of Neurology, 6th ed, p1334%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. It is used primarily as a research tool.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dilation of the duodenal papilla that is the opening of the juncture of the COMMON BILE DUCT and the MAIN PANCREATIC DUCT, also known as the hepatopancreatic ampulla.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dimension of auditory sensation varying with cycles per second of the sound stimulus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dimeric sesquiterpene found in cottonseed %28%GOSSYPIUM%29%. The %28%-%29% isomer is active as a male contraceptive %28%CONTRACEPTIVE AGENTS, MALE%29% whereas toxic symptoms are associated with the %28%+%29% isomer.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diminution of the skeletal muscle tone marked by a diminished resistance to passive stretching.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dinoflagellate with a life cycle that includes numerous flagellated, amoeboid, and encysted stages. Both the flagellated and amoeboid forms produce toxins which cause open wounds on fish. Pfiesteria piscicida feeds on tissue sloughed from these wounds, as well as on bacteria and algae. It is found in Atlantic estuaries of the United States.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is a LIVER-specific enzyme that is the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dioxygenase with specificity for the oxidation of the indoleamine ring of TRYPTOPHAN. It is an extrahepatic enzyme that plays a role in metabolism as the first and rate limiting enzyme in the kynurenine pathway of TRYPTOPHAN catabolism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diphenyl ether derivative used in cosmetics and toilet soaps as an antiseptic. It has some bacteriostatic and fungistatic action.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. %28%From AMA Drug Evaluations Annual, 1994, p403%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diphenylmethane stimulant laxative used for the treatment of constipation and for bowel evacuation. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p871%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diphenylpropylamine with intense narcotic analgesic activity of long duration. It is a derivative of MEPERIDINE with similar activity and usage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dipolar ionic buffer. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1251%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct communication system, usually telephone, established for instant contact. It is designed to provide special information and assistance through trained personnel and is used for counseling, referrals, and emergencies such as poisonings and threatened suicides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct form of psychotherapy based on the interpretation of situations %28%cognitive structure of experiences%29% that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct-acting oxidative stress-inducing agent used to examine the effects of oxidant stress on Ca%28%2+%29%-dependent signal transduction in vascular endothelial cells. It is also used as a catalyst in polymerization reactions and to introduce peroxy groups into organic molecules.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct-acting peripheral vasodilator that causes flushing and may decrease blood pressure. It is used in vasospasm and threatened gangrene.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct-acting smooth muscle relaxant used to dilate blood vessels. It may cause gastrointestinal distress and tachycardia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A direct-acting vasodilator that is used as an antihypertensive agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A directed change in translational READING FRAMES that allows the production of a single protein from two or more OVERLAPPING GENES. The process is programmed by the nucleotide sequence of the MRNA and is sometimes also affected by the secondary or tertiary mRNA structure. It has been described mainly in VIRUSES %28%especially RETROVIRUSES%29%; RETROTRANSPOSONS; and bacterial insertion elements but also in some cellular genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc. The interview may be conducted by a social worker or psychologist.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disaccharide consisting of one galactose and one glucose moiety in an alpha %28%1-6%29% glycosidic linkage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disaccharide consisting of two glucose units in an alpha %28%1-6%29% glycosidic linkage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disaccharide consisting of two glucose units in beta %28%1-4%29% glycosidic linkage. Obtained from the partial hydrolysis of cellulose.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding %28%phonetics%29% and decoding %28%psychoacoustics%29% as they relate states of messages to states of communicators.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A discipline concerned with the prevention of mental illness and the promotion of mental health.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A discipline or occupation concerned with the study of INSECTS, including the biology and the control of insects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease caused by a deficiency of thiamine %28%vitamin B1%29% and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white %28%polished%29% rice is the staple food, as in Japan, China, the Philippines, India, and other countries of southeast Asia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous %28%Old and New World%29% %28%LEISHMANIASIS, CUTANEOUS%29%, diffuse cutaneous %28%LEISHMANIASIS, DIFFUSE CUTANEOUS%29%, mucocutaneous %28%LEISHMANIASIS, MUCOCUTANEOUS%29%, and visceral %28%LEISHMANIASIS, VISCERAL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS %28%including respiratory paralysis%29%, blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes %28%e.g., food-borne, infant, wound, and others%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p1208%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease caused by various fungi %28%Madurella mycetomi%29% or actinomycetes %28%Nocardia brasiliensis%29%. It usually affects the foot, hand, and legs with tissues becoming necrosed and swollen after infection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by bony deposits or the ossification of muscle tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by deficiency or low levels of plasma lecithin cholesterol acyl transferase. Clinical manifestations include corneal opacity, anemia, and proteinuria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by pulmonary infiltrations of eosinophils and blood eosinophilia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by suppurative and granulomatous lesions in the respiratory tract, upper alimentary tract, skin, kidneys, joints, and other tissues. Actinobacillus lignieresii infects cattle and sheep while A. equuli infects horses and pigs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath %28%DYSPNEA%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease characterized by thrombocytopenia, hemolytic anemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease due to infection with TRICHINELLA SPIRALIS. It is caused by eating undercooked meat, usually pork.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the tsetse fly. Involvement of the central nervous system produces %22%African sleeping sickness.%22% Nagana is a rapidly fatal trypanosomiasis of horses and other animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. %22%Organizing%22% refers to unresolved pneumonia %28%in which the alveolar exudate persists and eventually undergoes fibrosis%29% in which fibrous tissue forms in the alveoli. %28%From Segen, Dictionary of Modern Medicine, 1992; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease in which the low density lipoprotein %28%beta-lipoprotein%29% concentrations are far below normal.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease in which the metabolic products of phenylalanine and tyrosine accumulate, resulting in the deposition of HOMOGENTISIC ACID %28%a brown-black pigment%29% in the connective tissue. It occurs in ALKAPTONURIA, but has also been observed in connection with exposure to certain chemicals %28%e.g., phenol, trinitrophenol, benzene derivatives%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of bone marked by thinning of the cortex and replacement of bone marrow by gritty fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. Only one bone may be involved %28%FIBROUS DYSPLASIA, MONOSTOTIC%29% or several %28%FIBROUS DYSPLASIA, POLYOSTOTIC%29%. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of cats and mink characterized by a marked inflammation of adipose tissue and the deposition of %22%ceroid%22% pigment in the interstices of the adipose cells. It is believed to be caused by feeding diets containing too much unsaturated fatty acid and too little vitamin E. %28%Merck Veterinary Manual, 5th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of elderly men characterized by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of herbivorous mammals, particularly cattle and sheep, caused by stomach worms of the genus OSTERTAGIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of horses and donkeys caused by Trypanosoma equiperdum. The disease occurs in Africa, the Americas, and Asia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, pneumonia, and bacteremia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of infants due to group 2 phage type 17 staphylococci that produce an epidermolytic exotoxin. Superficial fine vesicles and bullae form and rupture easily, resulting in loss of large sheets of epidermis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease, which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10%25% develop acute illness such as MYOCARDITIS %28%mostly in children%29%. The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects %28%HEART BLOCK%29% and CARDIOMEGALY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol %28%HYDROCORTISONE%29% by the ADRENAL GLANDS resulting in CUSHING SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the glomerulus manifested clinically by proteinuria, and sometimes by other features of the nephrotic syndrome. It is histologically characterized by deposits in the glomerular capillary wall between the epithelial cell and the basement membrane and a thickening of the membrane. Also characteristic are outward projections of the membrane between the epithelial deposits in the form of %22%spikes%22%. There is some agreement that the deposits are antigen-antibody complexes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the horny parts and of the adjacent soft structures of the feet of cattle, swine, and sheep. It is usually caused by Corynebacterium pyogenes or Bacteroides nodosus %28%see DICHELOBACTER NODOSUS%29%. It is also known as interdigital necrobacillosis. %28%From Black%27%s Veterinary Dictionary, 18th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the inner ear characterized by vertigo, tinnitus, and fluctuating hearing loss often accompanied by fullness in the affected ear. ENDOLYMPHATIC HYDROPS %28%swelling of the endolymph-containing structures%29% is the main pathologic finding.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary %28%idiopathic%29% or secondary to mycosis fungoides or reticulosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. %28%Arnold, Odom, and James, Andrew%27%s Diseases of the Skin, 8th ed, p319%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of unknown etiology in which there are plaques or strands of dense fibrous tissue causing induration of the corpora cavernosa of the penis. The condition produces a painful deformity and is sometimes seen in cases of DUPUYTREN%27%S CONTRACTURE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease of young infants characterized by soft tissue swellings over the affected bones, fever, and irritability, and marked by periods of remission and exacerbation. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease or state in which death is possible or imminent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of ANTIDIURETIC HORMONE %28%also known as ADH or VASOPRESSIN%29% secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease that results from a congenital defect in ELECTRON TRANSPORT COMPLEX IV. Defects in ELECTRON TRANSPORT COMPLEX IV can be caused by mutations in the SURF1, SCO2, COX10, or SCO1 genes. ELECTRON TRANSPORT COMPLEX IV deficiency caused by mutation in SURF1 manifests itself as LEIGH DISEASE; that caused by mutation in SCO2 as fatal infantile cardioencephalomyopathy; that caused by mutation in COX10 as tubulopathy and leukodystrophy; and that caused by mutation in SCO1 as early-onset hepatic failure and neurologic disorder. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM%23%220110, May 17, 2001%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to hemolytic anemia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder affecting newborn infants %28%usually premature%29% characterized pathologically by the development of a hyaline-like membrane lining the terminal respiratory passages. Extensive atelectasis is attributed to the lack of surfactant. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. %28%DSM-IV%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. %28%From Adams et al., Principles of Neurology, 6th ed, pp411-2%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by a reduction in oxygen supply %28%HYPOXIA%29% combined with reduced blood flow %28%ISCHEMIA%29% to the brain. This condition may result from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep. Complying with an irresistible urge to move the affected limbs brings temporary relief. Sleep may become disrupted, resulting in excessive daytime hypersomnolence. This condition may be associated with UREMIA; DIABETES MELLITUS; and rheumatoid arthritis. Restless Legs Syndrome differs from NOCTURNAL MYOCLONUS SYNDROME in that in the latter condition the individual does not report adverse sensory stimuli and it is primarily a sleep-associated movement disorder. %28%Adams et al., Principles of Neurology, 6th ed, p387; Schweiz Rundsch Med Prax 1997 Apr 30;86%28%18%29%:732-736%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by episodes of respiratory distress, usually occurring after several hours of sleep in a reclining position. It is most commonly caused by pulmonary edema resulting from congestive heart failure. The episodes may be accompanied by coughing, a feeling of suffocation, a cold sweat, and tachycardia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by episodes of vigorous and often violent motor activity during REM sleep %28%SLEEP, REM%29%. The affected individual may inflict self injury or harm others, and is difficult to awaken from this condition. Episodes are usually followed by a vivid recollection of a dream that is consistent with the aggressive behavior. This condition primarily affects adult males. %28%From Adams et al., Principles of Neurology, 6th ed, p393%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by grinding and clenching of the teeth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by incomplete arousals from sleep associated with behavior suggesting extreme fright. This condition primarily affects children and young adults and the individual generally has no recall of the event. Episodes tend to occur during stage III or IV. SOMNAMBULISM is frequently associated with this condition. %28%Adams et al., Principles of Neurology, 6th ed, p391%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by muscle twitches, cramps, and carpopedal spasm, and when severe, laryngospasm and seizures. This condition is associated with unstable depolarization of axonal membranes, primarily in the peripheral nervous system. Tetany usually results from HYPOCALCEMIA or reduced serum levels of MAGNESIUM that may be associated with HYPERVENTILATION; HYPOPARATHYROIDISM; RICKETS; UREMIA; or other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1490%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac ARRHYTHMIA and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. %28%From Adams et al., Principles of Neurology, 6th ed, p395%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: %28%1%29% clinical features of the seizure episodes %28%e.g., motor seizure%29%, %28%2%29% etiology %28%e.g., post-traumatic%29%, %28%3%29% anatomic site of seizure origin %28%e.g., frontal lobe seizure%29%, %28%4%29% tendency to spread to other structures in the brain, and %28%5%29% temporal patterns %28%e.g., nocturnal epilepsy%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p313%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by recurrent focal onset seizures which have sensory %28%i.e., olfactory, visual, tactile, gustatory, or auditory%29% manifestations. Partial seizures that feature alterations of consciousness are referred to as complex partial seizures %28%EPILEPSY, COMPLEX PARTIAL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by recurrent localized paroxysmal discharges of cerebral neurons that give rise to seizures that have motor manifestations. The majority of partial motor seizures originate in the FRONTAL LOBE %28%see also EPILEPSY, FRONTAL LOBE%29%. Motor seizures may manifest as tonic or clonic movements involving the face, one limb or one side of the body. A variety of more complex patterns of movement, including abnormal posturing of extremities, may also occur.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by recurrent partial seizures marked by impairment of cognition. During the seizure the individual may experience a wide variety of psychic phenomenon including formed hallucinations, illusions, deja vu, intense emotional feelings, confusion, and spatial disorientation. Focal motor activity, sensory alterations and AUTOMATISM may also occur. Complex partial seizures often originate from foci in one or both temporal lobes. The etiology may be idiopathic %28%cryptogenic partial complex epilepsy%29% or occur as a secondary manifestation of a focal cortical lesion %28%symptomatic partial complex epilepsy%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp317-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form %28%thalassemia minor%29%, which is asymptomatic, while in the homozygous form %28%thalassemia major, Cooley%27%s anemia, Mediterranean anemia, erythroblastic anemia%29%, which can result in severe complications and even death, hemoglobin A synthesis is absent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels. The activation of the clotting mechanism may arise from any of a number of disorders. In the late stages, it is marked by profuse hemorrhaging. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by the onset of myoclonus in adolescence, a marked increase in the incidence of absence seizures %28%see EPILEPSY, ABSENCE%29%, and generalized major motor seizures %28%see EPILEPSY, TONIC-CLONIC%29%. The myoclonic episodes tend to occur shortly after awakening. Seizures tend to be aggravated by sleep deprivation and alcohol consumption. Hereditary and sporadic forms have been identified. %28%From Adams et al., Principles of Neurology, 6th ed, p323%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder characterized by the presence of ANEMIA, abnormally large red blood cells %28%megalocytes or macrocytes%29%, and MEGALOBLASTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder consisting of the accumulation of abnormal localized, or tumor-like fat in the tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary. Full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron. Acquired hemochromatosis may be the result of blood transfusions, excessive dietary iron, or secondary to other disease. Idiopathic or genetic hemochromatosis is an autosomal recessive disorder of metabolism associated with a gene tightly linked to the A locus of the HLA complex on chromosome 6. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder genetically distinct from the other inherited hyperlipidemias characterized by the type II or type IV lipoprotein pattern %28%the pattern may change from time to time and the lipid level may be normal at one time and abnormal at another time%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder in which fantasies about or the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of amino acid transport characterized by the childhood %28%or rarely adult%29% onset of photosensitive dermatitis and intermittent neurologic symptoms. Ataxia, personality changes, migraine headaches, and photophobia may occur periodically. The disorder results from impaired sodium-dependent transport of neutral amino acids across the brush border membrane of the small intestine and renal tubular epithelium. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp59-60%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries %28%CORONARY ARTERIOSCLEROSIS%29%, to obstruction by a thrombus %28%CORONARY THROMBOSIS%29%, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle %28%MYOCARDIAL INFARCTION%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of cognition characterized by the tetrad of finger agnosia, dysgraphia, dyscalculia, and right-left disorientation. The syndrome may be developmental or acquired. Acquired Gerstmann syndrome is associated with lesions in the dominant %28%usually left%29% PARIETAL LOBE which involve the angular gyrus or subjacent white matter. %28%From Adams et al., Principles of Neurology, 6th ed, p457%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N-%28%amino-%29% terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable %28%V%29% and constant %28%C%29% region genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of lipid metabolism inherited as an autosomal recessive trait characterized by the near absence of APOLIPOPROTEINS B and apoB-containing lipoproteins in plasma. Microsomal triglyceride transfer protein is deficient or absent in enterocytes. Clinical and laboratory findings include acanthocytosis, hypocholesterolemia, peripheral neuropathy, posterior column degeneration, ataxia, and steatorrhea. Intellectual abilities may also be impaired. %28%Menkes, Textbook of Child Neurology, 5th ed, p118; Curr Opin Lipidol 1994 Apr;5%28%2%29%:81-6%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. %28%Adams et al., Principles of Neurology, 6th ed, p1459%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves %28%i.e., transient neonatal myasthenia gravis%29% although this disorder may rarely continue beyond the neonatal period %28%i.e., persistent neonatal myasthenia gravis%29%. %28%From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48%28%1%29%:50-4%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of neutrophils characterized by the presence of abnormal or absent chemotactic responses and hyperimmunoglobulinemia E. It is transmitted as an autosomal recessive trait and most cases reported have been in girls.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of the buccal mucosa resembling early leukoplakia, characterized by the presence of filmy opalescence of the mucosa in the early stages to a whitish gray cast with a coarsely wrinkled surface in the later stages, associated with intracellular edema of the spinous or malpighian layer. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder of the skin, the oral mucosa, and the gingiva, that usually presents as a solitary polypoid capillary hemangioma often resulting from trauma. It is manifested as an inflammatory response with similar characteristics to those of a granuloma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disseminated vesicular-pustular eruption caused by the herpes simplex virus %28%HERPESVIRUS HOMINIS%29%, the VACCINIA VIRUS, or Varicella zoster %28%HERPESVIRUS 3, HUMAN%29%. It is usually superimposed on a preexisting, inactive or active, atopic dermatitis %28%DERMATITIS, ATOPIC%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A distention of the pelvis and calices of the kidney with urine, as a result of obstruction of the ureter, with accompanying atrophy of the parenchyma of the organ. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A distinct and virulent form of DENGUE characterized by thrombocytopenia and hemoconcentration %28%grades I and II%29% and distinguished by a positive tourniquet test. When accompanied by circulatory failure and shock %28%grades III and IV%29%, it is called dengue shock syndrome. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A distinct subnuclear domain enriched in splicesomal snRNPs %28%RIBONUCLEOPROTEINS, SMALL NUCLEAR%29% and p80-coilin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A distinct vascular lesion in the PYLORIC ANTRUM that is characterized by tortuous dilated blood vessels %28%ectasia%29% radiating outward from the PYLORUS. The vessel pattern resembles the stripes on the surface of a watermelon. This lesion causes both acute and chronic GASTROINTESTINAL HEMORRHAGE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A distribution function used to describe the occurrence of rare events or to describe the sampling distribution of isolated counts in a continuum of time or space.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual%27%s age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. %28%From DSM-IV, 1994%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products %28%Sies, Oxidative Stress, 1991, pxv-xvi%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disturbance of lipid metabolism with abnormal deposit of lipids in the cells. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A disulfide opioid pentapeptide that selectively binds to the DELTA OPIOID RECEPTOR. It possesses antinociceptive activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dithiobiurea compound with anti-gonadotropic activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dithiocarbamate chemical, used commercially in the rubber processing industry and as a fungicide. In vivo studies indicate that it inactivates the enzyme glutathione reductase. It has mutagenic activity and may induce chromosomal aberrations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A divalent calcium ionophore that is widely used as a tool to investigate the role of intracellular calcium in cellular processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverse class of enzymes that interact with UBIQUITIN-CONJUGATING ENZYMES and ubiquitination-specific protein substrates. Each member of this enzyme group has its own distinct specificity for a substrate and ubiquitin-conjugating enzyme. Ubiquitin-protein ligases exist as both monomeric proteins multiprotein complexes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverse genus of minute freshwater CRUSTACEA, of the suborder CLADOCERA. They are a major food source for both young and adult freshwater fish.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. %28%Adv Pharmacol 1995;34:361-81%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological %28%acute%29% or cutaneous %28%skin lesions%29%. Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyse MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A diverticulum from the fourth pharyngeal pouch of an embryo, regarded by some as a rudimentary fifth pharyngeal pouch and by others as a lateral thyroid primordium. The ultimobranchial bodies of lower vertebrates contain large amounts of calcitonin. In mammals the bodies fuse with the thyroid gland and are thought to develop into the parafollicular cells. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division %28%some say phylum or class%29% of the ALGAE, characterized by biflagellated cells and found in both freshwater and marine environments. Pigmentation varies but only one CHLOROPLAST is present. Unique structures include a nucleomorph and ejectosomes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division of GYMNOSPERMS which look like palm trees %28%ARECACEAE%29% but are more closely related to PINUS. They have large cones and large pinnate leaves and are sometimes called cycads, a term which may also refer more narrowly to cycadales or CYCAS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division of organisms that exist vegetatively as complex mobile plasmodia, reproduce by means of spores, and have complex life cycles. They are now classed as protozoa but formerly were considered fungi.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs pertaining to veterans. The Department of Veterans Affairs %28%VA%29% was established March 15, 1989 as a Cabinet-level position.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs relative to the provision of opportunities for economic advancement.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division of the UNITED STATES PUBLIC HEALTH SERVICE that is responsible for the public health and the provision of medical services to native American Indian populations in the United States, primarily those residing on reservation lands.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A division of the plant kingdom. Bryophyta contains the subdivision, Musci, which contains the classes: Andreaeopsida, BRYOPSIDA, and SPHAGNOPSIDA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dominantly inherited muscle disease that begins in early childhood and is characterized by severe myotonia %28%delayed relaxation of a muscle%29% after forceful voluntary contractions. Muscular hypertrophy is common and myotonia may impair ambulation and other movements. Myotonia typically becomes less severe with repetitive voluntary contractions of the affected muscles. Generalized myotonia %28%of Becker%29% is an autosomal recessive variant of myotonia congenita that may feature more severe myotonia and muscle wasting. %28%From Adams et al., Principles of Neurology, 6th ed, pp1476-7; Joynt, Clinical Neurology, 1997, Ch53, p18%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dominantly-inherited ATAXIA first described in people of Azorean and Portuguese descent, and subsequently identified in Brazil, Japan, China, and Australia. This disorder is classified as one of the SPINOCEREBELLAR ATAXIAS %28%Type 3%29% and has been associated with a mutation of the MJD1 gene on chromosome 14. Clinical features include progressive ataxia, DYSARTHRIA, postural instability, nystagmus, eyelid retraction, and facial FASCICULATIONS. DYSTONIA is prominent in younger patients %28%referred to as Type I Machado-Joseph Disease%29%. Type II features ataxia and ocular signs; Type III features MUSCULAR ATROPHY and a sensorimotor neuropathy; and Type IV features extrapyramidal signs combined with a sensorimotor neuropathy. %28%From Clin Neurosci 1995;3%28%1%29%:17-22; Ann Neurol 1998 Mar;43%28%3%29%:288-96%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine D1 receptor antagonist that has no effect or only very limited effect on dopamine D2 receptors. The compound has tranquilizing effects, inhibits conditioned avoidance response, impairs memory acquisition, produces dose-dependent catalepsy, blocks central serotonin receptors, and reduces the lethal effects of cocaine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine D2 antagonist that is used as an antiemetic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine D2/D3 receptor agonist. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. %28%From AMA Drug Evaluations Annual, 1994, p457%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopamine-beta-hydroxylase inhibitor. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dosage compensation process occurring at an early embryonic stage in mammalian development whereby, at random, one X CHROMOSOME of the pair is repressed in the somatic cells of females.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A double-stranded polyribonucleotide comprising polyadenylic and polyuridylic acids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A double-walled epithelial capsule that is the bulbous closed proximal end of the kidney tubular system. It surrounds the cluster of convoluted capillaries of KIDNEY GLOMERULUS and is continuous with the convoluted PROXIMAL KIDNEY TUBULE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A doubly unsaturated fatty acid, occurring widely in plant glycosides. It is an essential fatty acid in mammalian nutrition and is used in the biosynthesis of prostaglandins and cell membranes. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drive stemming from a physiological need for WATER. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drop in blood pressure upon standing or after standing motionless in a static position.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug combination that contains DIPHENHYDRAMINE and THEOPHYLLINE. It is used for treating vertigo, motion sickness, and nausea associated with pregnancy. It is not effective in the treatment of nausea associated with cancer chemotherapy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It%27%s most common use is in bronchial asthma, but it has been investigated for several other applications.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug composed of DIMETHYLAMINOETHANOL and parachlorphenoxyacetic acid %28%PCPA%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug formerly used as an antipsychotic but now used primarily in the treatment of various movement disorders including tardive dyskinesia. Tetrabenazine blocks uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug formerly used in the treatment of angina pectoris but superseded by less hazardous drugs. Prenylamine depletes myocardial catecholamine stores and has some calcium channel blocking activity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1406%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p21%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE. Because of the risk of serious adverse effects its use is justified only in serious situations where no alternative is available or suitable. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p13%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter%27%s syndrome %28%investigational indication%29%. Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. %28%From AMA Drug Evaluations Annual, 1994, p1822%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1408%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that is derived from opium, which contains from 0.3-1.5%25% thebaine depending on its origin. It produces strychnine-like convulsions rather than narcosis. It may be habit-forming and is a controlled substance %28%opiate%29% listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.12 %28%1985%29%. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid %28%see MESALAMINE%29% released in the colon. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p907%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1310%29% It may also be an antagonist at 5HT-2 serotonin receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug used in the treatment of angina pectoris, heart failure, conduction defects, and myocardial infarction. It is a partial agonist at beta adrenergic receptors and acts as a coronary vasodilator and cardiotonic agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p993%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug used to reduce hemorrhage in diabetic retinopathy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug with analgesic, anti-inflammatory, and antipyretic properties but, owing to the risk of agranulocytosis, whose use is discouraged. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug-metabolizing enzyme found in the hepatic, placental and intestinal microsomes that metabolizes 7-alkoxycoumarin to 7-hydroxycoumarin. The enzyme is cytochrome P-450- dependent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug-metabolizing enzyme of the hepatic microsomal oxidase system which catalyzes the oxidation of the N-methyl group of ethylmorphine with the formation of formaldehyde.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug-metabolizing, cytochrome P-448 %28%P-450%29% enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. EC 1.14.14.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A drugless system of therapy, making use of physical forces such as air, light, water, heat, massage, etc. Treatments are often diet- and nutrition-oriented with attention given to the patient%27%s personal history and lifestyle. %28%From Cassileth, Alternative Medicine Handbook, 1998, p329%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dry artificial sterile sponge of fibrin prepared by clotting with thrombin a foam or solution of fibrinogen. It is used in conjunction with thrombin as a hemostatic in surgery at sites where bleeding cannot be controlled by more common methods. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p648%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dsRNA-activated cAMP-independent protein serine/threonine kinase that is induced by interferon. In the presence of dsRNA and ATP, the kinase autophosphorylates on several serine and threonine residues. The phosphorylated enzyme catalyzes the phosphorylation of the alpha subunit of EUKARYOTIC INITIATION FACTOR-2, leading to the inhibition of protein synthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dye obtained from the heartwood of logwood %28%Haematoxylon campechianum Linn., Leguminosae%29% used as a stain in microscopy and in the manufacture of ink.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dye that has been used as an industrial dye, a laboratory indicator, and a biological stain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dye used as a reagent in the determination of vitamin C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dye used to stain proteins in electrophoretic techniques. It is used interchangeably with its acid form.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt %28%aluminon%29% is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dynamic actin-rich extension of the surface of an animal cell used for locomotion or prehension of food.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN A.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN G.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A dyskinesia characterized by an inability to maintain the fingers, toes, tongue, or other body parts in a stable position, resulting in continuous slow, sinusoidal, and flowing involuntary movements. This condition is frequently accompanied by CHOREA, where it is referred to as choreoathetosis. Athetosis may occur as a manifestation of BASAL GANGLIA DISEASES or DRUG TOXICITY. %28%From Adams et al., Principles of Neurology, 6th ed, p76%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A enzyme complex that catalyzes the oxidative DECARBOXYLATION and DEAMINATION of GLYCINE into CARBON DIOXIDE; AMMONIA; NADH; and N5N10-methylenetetrahydrofolate. It is composed of four different component protein components referred to as H, P, L, and T.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A enzyme that catalyzes the transfer of acetyl groups from ACETYL CoA to acyl-carrier protein to form COENZYME A and acetyl-acyl-carrier protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A eukaryotic initiation factor that binds to 40S ribosomal subunits. Although initially considered a %22%non-essential%22% factor for eukaryotic transcription initiation, eukaryotic initiation factor-1 is now thought to play an important role in localizing RIBOSOMES at the initiation codon of MRNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A eukaryotic initiation factor that interacts with the 40S initiation complex and promotes the hydrolysis of the bound GTP. The hydrolysis of GTP causes the release of EUKARYOTIC INITIATION FACTOR-2 and EUKARYOTIC INITIATION FACTOR-3 from the 40S subunit and the subsequent joining of the 60S ribosomal subunit to the 40S complex to form the functional 80S initiation complex%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A extremely rare bone tumor characterized by abundant collagen formation and a fibrous stroma, without evidence of mitosis or pleomorphism. It appears on x-rays as an osteolytic lesion with well-defined margins and must be differentiated from primary fibrosarcoma of bone. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1441%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fabricated tooth substituting for a natural tooth in a prosthesis. It is usually made of porcelain or plastic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A facial expression which may denote feelings of pleasure, affection, amusement, etc.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A factor identified in the brain that influences the growth and differentiation of NEURONS and NEUROGLIA. Glia maturation factor beta is the 17-kDa polypeptide product of the GMFB gene and is the principal component of GLIA MATURATION FACTOR.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 %28%TGF-beta1.2%29% or of TGF-beta2 and 3 %28%TGF-beta2.3%29% have been isolated. The TGF-beta proteins are synthesized as precursor proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one%27%s associates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial condition marked by the deposition of AMYLOID in the walls of small blood vessels in the cerebral cortex and meninges and characterized clinically by cerebral ischemia %28%see BRAIN ISCHEMIA%29%; CEREBRAL INFARCTION; and CEREBRAL HEMORRHAGE..%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial congenital hemolytic anemia characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial disease occurring in the course of latent diabetes, marked by yellowish nodules on the skin and mucosae, keratotic lesions on the extremities, and hoarseness due to faulty lipid metabolism. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial disorder characterized by ANEMIA with multinuclear ERYTHROBLASTS, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors %28%ERYTHROID PROGENITOR CELLS%29%. Type II is the most common of the 3 types; it is often referred to as HEMPAS, based on the Hereditary Erythroblast Multinuclearity with Positive Acidified Serum test.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial disorder characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in VLDL. It is considered to be an autosomal dominant trait.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial disorder characterized by increased plasma concentration of cholesterol carried in low density lipoproteins %28%LDL%29% and by a deficiency in a cell surface receptor which regulates LDL degradation and cholesterol synthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. %28%From Adams et al., Principles of Neurology, 6th ed, pp1060-4%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial form of PSEUDOHERMAPHRODITISM transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor %28%RECEPTORS, ANDROGEN%29% gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A familial, cerebral arteriopathy mapped to chromosome 19q12, and characterized by the presence of granular deposits in small CEREBRAL ARTERIES producing ischemic STROKE; PSEUDOBULBAR PALSY; and multiple subcortical infarcts %28%CEREBRAL INFARCTION%29%. CADASIL is an acronym for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. CADASIL differs from BINSWANGER DISEASE by the presence of MIGRAINE WITH AURA and usually by the lack of history of arterial HYPERTENSION. %28%From Bradley et al, Neurology in Clinical Practice, 2000, p1146%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family %28%Aphididae%29% of small insects, in the suborder Sternorrhyncha, that suck the juices of plants. Important genera include Schizaphis and Myzus. The latter is known to carry more than 100 virus diseases between plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family composed of spouses and their children. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family in the order Chromatiales, class GAMMAPROTEOBACTERIA. These are haloalkaliphilic, phototrophic bacteria that deposit elemental sulfur outside their cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family in the order MONONEGAVIRALES comprising one genus Bornavirus. This family has a unique form of mRNA processing: replication and transcription takes place in the nucleus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family in the order Rhizobiales, class ALPHAPROTEOBACTERIA comprised of many genera of budding or appendaged bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of 3,3-bis%28%p-hydroxyphenyl%29%phthalides. They are used as CATHARTICS, indicators, and COLORING AGENTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of 3,6-di%28%substituted-amino%29%-9-benzoate derivatives of xanthene that are used as dyes and as indicators for various metals; also used as fluorescent tracers in histochemistry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents %28%CYTOSINE; THYMINE; and URACIL%29% and form the basic structure of the barbiturates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by complex contractile tails.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by long, non-contractile tails.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of CELL SURFACE RECEPTORS that bind BONE MORPHOGENETIC PROTEINS. They are PROTEIN-SERINE-THREONINE KINASES that mediate SIGNAL TRANSDUCTION PATHWAYS through SMAD PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of CRUSTACEA, order DECAPODA, comprising the palaemonid shrimp. Genera include Macrobrachium, Palaemon, and Palaemonetes. Palaemonidae osmoregulate by means of gills.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of CRUSTACEA, order DECAPODA, comprising the pandalid shrimp. They are protandic hermaphrodites and can breed in both male and female stages. Many species are commercially harvested in the Pacific Northwest.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of CRUSTACEA, order DECAPODA, comprising the penaeid shrimp. Species of the genus Penaeus are the most important commercial shrimp throughout the world.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA binding proteins that regulate expression of a variety of GENES during CELL DIFFERENTIATION and APOPTOSIS. Family members contain a highly conserved carboxy-terminal basic HELIX-TURN-HELIX MOTIF involved in dimerization and sequence-specific DNA binding.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA invertebrate viruses with one genus: Whispovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA plant viruses that infect eukaryotic algae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA repair enzymes that recognize damaged nucleotide bases and remove them by hydrolyzing the N-glycosidic bond that attaches them to the sugar backbone of the DNA molecule. The process called BASE EXCISION REPAIR can be completed by a DNA-%28%APURINIC OR APYRIMIDINIC SITE%29% LYASE which excises the remaining RIBOSE sugar from the DNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA-binding proteins that are primarily expressed in T-LYMPHOCYTES. They interact with BETA CATENIN and serve as transcriptional activators and repressors in a variety of developmental processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA-binding proteins that contain three ZINC FINGERS at their carboxy termini. They are transcription factors that have specificity for GC boxes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of DNA-binding transcription factors that contain a basic HELIX-LOOP-HELIX MOTIF.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ESOCIFORMES comprising the mudminnows. There are three genera: Dallia, Novumbra, and Umbra, with much disagreement about their taxonomic interrelations. The Umbridae are freshwater fish inhabiting parts of the Northern Hemisphere.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of F-box domain proteins that contain sequences that are homologous to the beta subunit of transducin %28%BETA-TRANSDUCIN%29%. They play an important role in the protein degradation pathway by becoming components of SKP CULLIN F-BOX PROTEIN LIGASES, which selectively act on a subset of proteins including beta-catenin and IkappaBbeta.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of G-protein-coupled receptors that are specific for GALANIN and galanin peptides. They are generally considered to be coupled to the GI, INHIBITORY G-PROTEIN to meditate the neurological effects of galanin. Several subtypes of galanin receptors occur with differing specificities for the full length galanin, galanin peptide fragments, and galanin-like peptide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of G-protein-coupled receptors that are specific for and mediate the effects of MELATONIN. Activation of melatonin receptors has been associated with decreased intracellular CYCLIC AMP and increased hydrolysis of PHOSPHOINOSITIDES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of G-protein-coupled receptors that bind to specific LYSOPHOSPHOLIPIDS such as lysophosphatidic acid and lysosphinglipids such as sphingosine-1-phosphate. They play an important role in the formation and function of the CARDIOVASCULAR SYSTEM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of G-protein-coupled receptors that have specificity for MELANOCYTE-STIMULATING HORMONES and CORTICOTROPIN. There are several subtypes of melanocortin receptors, each having a distinct ligand specificity profile and tissue localization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of G-protein-coupled receptors that share significant homology with GLUCAGON RECEPTORS. They bind PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE with high affinity and trigger intracellular changes that influence the behavior of CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of G-protein-coupled receptors that was originally identified by its ability to bind N-formyl peptides such as N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE. Since N-formyl peptides are found in MITOCHONDRIA and BACTERIA, this class of receptors is believed to play a role in mediating cellular responses to cellular damage and bacterial invasion. However, non-formylated peptide ligands have also been found for this receptor class.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of GLYCOSYLPHOSPHATIDYLINOSITOL-anchored cell surface receptors that are specific for GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTORS. They form a multi-component receptor complex with PROTO-ONCOGENE PROTEIN C-RET and regulate a variety of intracellular SIGNAL TRANSDUCTION PATHWAYS in conjunction with c-ret protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of GTPASE-ACTIVATING PROTEINS that are specific for RAC GTP-BINDING PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of GUANINE NUCLEOTIDE EXCHANGE FACTORS that are specific for RAS PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of HIGH MOBILITY GROUP PROTEINS that bind to NUCLEOSOMES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of MEMBRANE TRANSPORT PROTEINS that require ATP hydrolysis for the transport of substrates across membranes. The protein family derives its name from the ATP-binding domain found on the protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of MONOMERIC GTP-BINDING PROTEINS that are related to RAS PROTEINS.This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of Maf Transcription Factors that lack activation domains. Small Maf proteins function as transcriptional repressors or form heterodimeric complexes to serve as transcriptional coactivators. Small Maf proteins include MafF, MafG, and MafK.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of New World monkeys in the infraorder PLATYRRHINI, consisting of nine subfamilies: ALOUATTINAE; AOTINAE; Atelinae; Callicebinae; CALLIMICONINAE; CALLITRICHINAE; CEBINAE; Pithecinae; and SAIMIRINAE. They inhabit the forests of South and Central America, comprising the largest family of South American monkeys.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of North American freshwater CATFISHES. It consists of four genera %28%Ameiurus, Ictalurus, Noturus, Pylodictis,%29% comprising several species, two of which are eyeless.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of POTASSIUM and SODIUM-dependent acidic amino acid transporters that demonstrate a high affinity for GLUTAMIC ACID and ASPARTIC ACID. Several variants of this system are found in neuronal tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of POU domain factors that bind the octamer motif ATTTGCAT in PROMOTER and ENHANCER regions to regulate GENE EXPRESSION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of Primates of the suborder Strepsirhini containing six genera. The family is distributed in parts of Africa, India, Asia, and the Philippines. The six genera are: Arctocebus %28%golden potto%29%, GALAGO %28%bush babies%29%, Loris %28%slender loris%29%, Nycticebus %28%slow loris%29%, and Perodicticus %28%potto%29%. Lorises and pottos are relatively common except for Arctocebus, the golden potto. All are arboreal and nocturnal.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA plant viruses infecting dicotyledons. Transmission is mainly by mechanical inoculation and through propagative plant material. All species elicit formation of multivesicular inclusion bodies. There are at least eight genera: Aureusvirus, Avenavirus, CARMOVIRUS, Dianthovirus, Machlomovirus, Necrovirus, Panicovirus, and TOMBUSVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA plant viruses with a wide host range in crops and horticultural species. All viruses are readily transmitted by mechanical means and some by insects and pollen. The genera include: ALFAMOVIRUS; BROMOVIRUS; CUCUMOVIRUS; ILARVIRUS; and OLEAVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA plant viruses with flexuous, filamentous particles and consisting of three genera: POTYVIRUS, Rymovirus, and Bymovirus. A fourth genus, Ipomovirus, is possible. All members of the family form cytoplasmic cylindrical inclusion bodies during infection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses infecting a broad range of animals. Most individual species are restricted to their natural hosts. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped %28%chalice%29% indentions. Transmission is by contaminated food, water, fomites, and occasionally aerosolization of secretions. Genera include LAGOVIRUS; NORWALK-LIKE VIRUSES; SAPPORO-LIKE VIRUSES; and VESIVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses infecting insects and fish. There are two genera: Alphanodavirus and Betanodavirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses naturally infecting rodents and consisting of one genus %28%ARENAVIRUS%29% with two groups: Old World Arenaviruses %28%ARENAVIRUSES, OLD WORLD%29% and New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%. Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses that infect fungi and protozoa. There are three genera: TOTIVIRUS; GIARDIAVIRUS; and LEISHMANIAVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses with one genus: ASTROVIRUS. They cause gastroenteritis in humans and also infect other vertebrates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses, mainly arboviruses, consisting of two genera: ALPHAVIRUS %28%group A arboviruses%29%, and RUBIVIRUS. Virions are spherical, 60-70 nm in diameter, with a lipoprotein envelope tightly applied to the icosahedral nucleocapsid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA viruses, many of which cause disease in humans and domestic animals. There are three genera FLAVIVIRUS; PESTIVIRUS; and HEPACIVIRUS, as well as several unassigned species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of RNA-binding proteins that are homologues of ELAV protein, Drosophila. They were initially identified in humans as the targets of autoantibodies in patients with PARANEOPLASTIC ENCEPHALOMYELITIS. They are thought to regulate GENE EXPRESSION at the post-transcriptional level.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of SERINE ENDOPEPTIDASES isolated from Bacillus subtilis. EC 3.4.21.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of SULFOLOBALES consisting of aerobic or facultatively anaerobic chemolithotrophic cocci, usually occurring singly. They grow best at a pH of about 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of THERMOPROTEALES consisting of anaerobic, thermoacidophilic thin rods found in solfataric hot springs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of THERMOPROTEALES consisting of variable length rigid rods without septa. They grow either chemolithoautotrophically or by sulfur respiration. The four genera are: PYROBACULUM, THERMOPROTEUS, Caldivirga, and Thermocladium. %28%From Bergey%27%s Manual of Systematic Bacteriology, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of Urodela consisting of 15 living genera and about 42 species and occurring in North America, Europe, Asia, and North Africa.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of VERTEBRATE homeodomain proteins that share homology with orthodenticle protein, Drosophila. They regulate GENETIC TRANSCRIPTION and play an important role in EMBRYONIC DEVELOPMENT of the BRAIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of aerobic gram-negative rods that are nitrogen fixers. They are highly viscous, and appear as a semitransparent slime in giant colonies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of alicyclic hydrocarbons containing an amine group with the general formula R-C6H10NH2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of anadromous fish comprising SALMON; TROUT; whitefish; and graylings. They are the most important food and game fishes. Their habitat is the northern Atlantic and Pacific, both marine and inland, and the Great Lakes. %28%Nelson: Fishes of the World, 1976, p97%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of anaerobic METHANOCOCCALES whose organisms are motile by means of flagella. These methanogens use carbon dioxide as an electron acceptor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of anaerobic METHANOMICROBIALES whose cells are coccoid to straight or slightly curved rods. There are six genera.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of anaerobic METHANOSARCINALES whose cells are mesophilic or thermophilic and appear as irregular spheroid bodies or sheathed rods. These methanogens are found in any anaerobic environment including aquatic sediments, anaerobic sewage digesters and gastrointestinal tracts. There are four genera: METHANOSARCINA, Methanolobus, Methanothrix, and Methanococcoides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of anaerobic THERMOCOCCALES found in hot environments. There are two genera: PYROCOCCUS and THERMOCOCCUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of anaerobic, coccoid to rod-shaped METHANOBACTERIALES. Cell membranes are composed mainly of polyisoprenoid hydrocarbons ether-linked to glycerol. Its organisms are found in anaerobic habitats throughout nature.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of archaea, in the order DESULFUROCOCCALES consisting of anaerobic coccoid to disc-shaped cells. They grow either chemolithoautotrophically or by FERMENTATION. Three genera are recognized: Pyrodictium, Hyperthermus, and Pyrolobus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of archaea, in the order DESULFUROCOCCALES, consisting of anaerobic cocci which utilize peptides, proteins or carbohydrates facultatively by sulfur respiration or fermentation. There are eight genera: AEROPYRUM, Desulfurococcus, Ignicoccus, Staphylothermus, Stetteria, Sulfophoboccus, Thermodiscus, and Thermosphaera. %28%From Bergey%27%s Manual of Systematic Bacteriology, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ark shell mollusks, in the class BIVALVIA. They have soft bodies with platelike GILLS enclosed within two shells hinged together.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ascomycetous fungi, order Onygenales, characterized by smooth ascospores. The two genera in the family are Arthroderma and Ctenomyces. Several well-known anamorphic forms are parasitic upon the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria comprised of endosymbionts of PROTOZOA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria consisting of flexible helical cells exhibiting a right-handed conformation. It consists of a single genus, LEPTOSPIRA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria in the order Sphingobacteriales, class Sphingobacteria. They are gram-negative rods, mostly saprophytic in terrestrial and aquatic habitats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria in the order Sphingobacteriales, class Sphingobacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria including numerous parasitic and pathogenic forms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria which inhabit RED BLOOD CELLS and cause several animal diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteria which produce endospores. They are mostly saprophytes from soil, but a few are insect or animal parasites or pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteriophages containing one genus %28%Cystovirus%29% with one member %28%BACTERIOPHAGE PHI 6%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteriophages that infects enterobacteria, CAULOBACTER, and PSEUDOMONAS. The genome consists of linear, positive-sense single-stranded RNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bacteriophages which are characterized by short, non-contractile tails.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of basic helix-loop-helix transcription factors that control expression of a variety of GENES involved in CELL CYCLE regulation. E2F transcription factors typically form heterodimeric complexes with TRANSCRIPTION FACTOR DP1 or transcription factor DP2, and they have N-terminal DNA binding and dimerization domains. E2F transcription factors can act as mediators of transcriptional repression or transcriptional activation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of basidiomycetous fungi, order POLYPORALES, living in decaying plant matter and timber.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bisegmented, double-stranded RNA viruses causing infection in fish, mollusks, fowl, and Drosophila. There are three genera: AQUABIRNAVIRUS; AVIBIRNAVIRUS; and ENTOMOBIRNAVIRUS. Horizontal and vertical transmission occurs for all viruses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of biting midges, in the order DIPTERA. It includes the genus Culicoides which transmits filarial parasites pathogenic to man and other primates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bivalve MOLLUSKS with heart-shaped shells, commonly known as cockles. Unlike most BIVALVES, cockles are hermaphroditic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of blood flukes of the class Trematoda which is found in animals and man. It Includes the genera Heterobilharzia, Schistosomatium, Schistosoma, Ornithobilharzia, Bilharziella, Trichobilharzia, Pseudobilharzia, and Austrobilharzia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of bullet-shaped viruses of the order MONONEGAVIRALES, infecting vertebrates, arthropods, protozoa, and plants. Genera include VESICULOVIRUS; LYSSAVIRUS; EPHEMEROVIRUS; NOVIRHABDOVIRUS; Cytorhabdovirus; and Nucleorhabdovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of cell cycle-dependent kinases that are related in structure to CDC28 PROTEIN KINASE; S CEREVISIAE; and the CDC2 PROTEIN KINASE found in mammalian species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of cellular proteins that mediate the correct assembly or disassembly of other polypeptides, and in some cases their assembly into oligomeric structures, but which are not components of those final structures. It is believed that chaperone proteins assist polypeptides to self-assemble by inhibiting alternative assembly pathways that produce nonfunctional structures. Some classes of molecular chaperones are the nucleoplasmins, the CHAPERONINS, the HEAT-SHOCK PROTEINS 70, and the HSP90 HEAT-SHOCK PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular Ig-like domains which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of closely related nerve growth factors that promote NEURON survival. They bind to GDNF RECEPTORS and stimulate SIGNAL TRANSDUCTION through PROTO-ONCOGENE PROTEIN C-RET.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of closely-related serine-threonine kinases that were originally identified as the cellular homologs of the retrovirus-derived V-RAF KINASES. They are MAP kinase kinase kinases that play important roles in SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that includes the genera ACTINOBACILLUS; HAEMOPHILUS; MANNHEIMIA; and PASTEURELLA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of colorless sulfur bacteria in the order Thiotrichales, class GAMMAPROTEOBACTERIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of compounds containing an oxo group with the general structure of 1,5-pentanedioic acid. %28%From Lehninger, Principles of Biochemistry, 1982, p442%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of conserved cell surface receptors that contain EPIDERMAL GROWTH FACTOR repeats in their extracellular domain and ANKYRIN repeats in their cytoplasmic domains. The cytoplasmic domain of notch receptors is released upon ligand binding and translocates to the CELL NUCLEUS where it acts as transcription factor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of cytoskeletal proteins that play essential roles in CELL ADHESION at ADHERENS JUNCTIONS by linking CADHERINS to the ACTIN FILAMENTS of the CYTOSKELETON.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of delayed rectifier voltage-gated potassium channels that share homology with their founding member, KCNQ1 PROTEIN. KCNQ potassium channels have been implicated in a variety of diseases including LONG QT SYNDROME; DEAFNESS; and EPILEPSY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of diphenylenemethane derivatives. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of double-stranded DNA viruses containing one genus Asfivirus. It is the source of AFRICAN SWINE FEVER.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of double-stranded DNA viruses infecting mammals %28%including humans%29%, birds and insects. There are two subfamilies: CHORDOPOXVIRINAE, poxviruses of vertebrates, and ENTOMOPOXVIRINAE, poxviruses of insects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of double-stranded RNA-binding proteins that are related to NFATC TRANSCRIPTION FACTORS. In addition to binding to RNA, nuclear factor 90 proteins form heterodimeric complexes that regulate GENETIC TRANSCRIPTION and may play a role in T-CELL activation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. EC 2.7.1.37.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enzymes that catalyze the exonucleolytic cleavage of DNA. It includes members of the class EC 3.1.11 that produce 5%27%-phosphomonoesters as cleavage products.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of enzymes that catalyze the stereoselective, regioselective, or chemoselective syn-dehydrogenation reactions. They function by a mechanism that is linked directly to reduction of molecular OXYGEN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of extremely halophilic archaea found in environments with high salt concentrations, such as salt lakes, evaporated brines, or salted fish. Halobacteriaceae are either obligate aerobes or facultative anaerobes and are divided into six genera: HALOARCULA; HALOBACTERIUM; HALOCOCCUS; HALOFERAX; NATRONOBACTERIUM; and NATRONOCOCCUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of extremely venomous snakes, comprising coral snakes, cobras, mambas, kraits, and sea snakes. They are widely distributed, being found in the southern United States, South America, Africa, southern Asia, Australia, and the Pacific Islands. The elapids include three subfamilies: Elapinae, Hydrophiinae, and Lauticaudinae. Like the viperids, they have venom fangs in the front part of the upper jaw. The mambas of Africa are the most dangerous of all snakes by virtue of their size, speed, and highly toxic venom. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p329-33%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flattened, translucent flukes %28%TREMATODA%29% occurring in the gut, gallbladder, bile ducts, liver or pancreatic ducts of amphibians, reptiles, birds, and mammals. %28%Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p188%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flightless, running BIRDS, in the order Casuariiformes. The emu is the only surviving member of the family. They naturally inhabit forests, open plains, and grasslands in Australia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flowering plants in the order Caryophyllales, with about 60 genera and more than 800 species of plants, with a few shrubs, trees, and vines. The leaves usually have nonindented edges.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flowering plants in the order Magnoliales. Many of the species are tropical and have fragrant wood and leaves.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flukes %28%TREMATODA%29% characterized by a collar of spines at their anterior end. The body is elongated and is covered with spines, and the two suckers are usually close together. %28%Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p183%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flukes %28%TREMATODA%29% usually under 10 mm in length, some being only 1 or 2 mm long. In general they are thick, spinous, or scaly flukes having an oval outline and living in various organs and sinuses of birds and mammals. The genus with the greatest interest is PARAGONIMUS. %28%From Noble et al., Parasitology: the Biology of Animal Parasites, 6th ed, p191%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flukes of the class Trematoda found in the intestinal tract and liver of animals and man. Some of the genera are Homalagaster, Gastrodiscus, Paramphistomum, Watsonius, Nilocotyle, Gigantocotyle, Gastrothylax, Macropotrema, Ceylonocotyle, Zygocotyle, Cotylophoron, and Calicophoron.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of freshwater fish comprising the minnows or CARPS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of freshwater fish of the order ESOCIFORMES, comprising the pikes, inhabiting the waters of the Northern Hemisphere. There is one genus, Esox, with five species: northern pike, grass pickerel, chain pickerel, muskellunge, and Amur pike.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of freshwater mussels in the class BIVALVIA. They differ from ZEBRA MUSSELS in that they are larger and posses a larval stage called glochidia, which requires attachment to the GILLS or fins of particular species of FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage. EC 3.2.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of glycoprotein cofactors that are required for the efficient catabolization of SPHINGOLIPIDS by specific acid hydrolases such as GLUCOSYLCERAMIDASE; GALACTOCEREBROSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; and CEREBROSIDE-SULFATASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of glycosidases that hydrolyse crystalline CELLULOSE into soluble sugar molecules. Within this family there are a variety of enzyme subtypes with differing substrate specificities that must work together to bring about complete cellulose hydrolysis. They are found in structures called CELLULOSOMES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram negative, aerobic, non-sporeforming, rod-shaped bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative aerobic bacteria consisting of ellipsoidal to rod-shaped cells that occur singly, in pairs, or in chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative aerobic bacteria in the class BETA PROTEOBACTERIA, encompassing the acidovorans rRNA complex. Some species are pathogenic for PLANTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the class BETAPROTEOBACTERIA. There are at least eight genera.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Burkholderiales, class BETAPROTEOBACTERIA. It is comprised of a single genus RALSTONIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Hydrogenophilales, class BETAPROTEOBACTERIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Legionellales. It includes genera COXIELLA and Rickettsiella.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Methylophilales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Nitrosomonadales, class BETAPROTEOBACTERIA. It contains a single genus Gallionella.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Nitrosomonadales. It formerly included the genera CAMPYLOBACTER and SPIRILLUM, then was abandoned, and is now reinstated as a family with a single genus SPIRILLUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Oceanospirillales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Rhizobiales. Genera include METHYLOBACTERIUM, Protomonas, and Roseomonas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria in the order Rhodocyclales, class BETAPROTEOBACTERIA. It includes many genera previously assigned to the family PSEUDOMONADACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria which are saprophytes, symbionts, or plant pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria whose members predominate in the bacterial flora of PLANKTON; FISHES; and SEAWATER. Some members are important pathogens for humans and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria, in the order Clostridiales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria, in the order Thiotrichales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative bacteria, in the order Xanthomonadales, pathogenic to plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative coccoid to rod-shaped bacteria in the order Rhizobiales. They are obligate parasites chiefly of warm-blooded VERTEBRATES. Many are pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative facultatively anaerobic bacteria, ubiquitous in fresh and brackish water, and associated with GASTROINTESTINAL DISEASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative methanotrophs in the order Rhizobiales, distantly related to the nitrogen-fixing and phototrophic bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative nitrifying bacteria, in the order Nitrosomonadales, class BETAPROTEOBACTERIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, aerobic bacteria in the order Pseudomonadales. Some strains are parasites of the mucosal membranes of animals and humans; others are found in association with food products or in the environment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, aerobic bacteria that do not form endospores or microcysts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, aerobic bacteria utilizing only one-carbon organic compounds and isolated from in soil and water.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, aerobic, non-spore forming rods or cocci. Well known genera include ACHROMOBACTER; ALCALIGENES; and BORDETELLA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, asporogenous rods or ovoid cells, aerobic or facultative anaerobic chemoorganotrophs. They are commonly isolated from SOIL, activated sludge, or marine environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, coccoid microorganisms, in the order CHLAMYDIALES, pathogenic for vertebrates. Genera include CHLAMYDIA and CHLAMYDOPHILA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, helical bacteria in the order Entomoplasmatales, that require STEROLS for growth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, moderately halophilic bacteria in the order Oceanospirillales. Members of the family have been isolated from temperate and Antarctic saline lakes, solar salt facilities, saline soils, and marine environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, mostly aerobic bacteria, in the order Cardiobacteriales. There are three genera: CARDIOBACTERIUM; DICHELOBACTER; and Suttonella.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, non-motile bacteria from human and animal sources. One saprophytic species is known.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, nonhelical, arthropod-associated bacteria in the order Entomoplasmatales. It is comprised of two genera: Entomoplasma and Mesoplasma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, parasitic bacteria including several important pathogens of man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-negative, rod-shaped bacteria isolated from the RUMEN of SHEEP and CATTLE and from human FECES. They are chemoorganotrophic and strictly anaerobic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-positive bacteria found in dairy products or in the intestinal tracts of animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-positive bacteria found in soil and dairy products and as parasites on animals and man. Several are important pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-positive bacteria found regularly in the mouth and intestinal tract of man and other animals, in food and dairy products, and in fermenting vegetable juices. A few species are highly pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of gram-positive, saprophytic bacteria occurring in soil and aquatic environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of hardbacked TICKS, in the subclass ACARI. Genera include DERMACENTOR and IXODES among others.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of heat-shock proteins that contain a 70 amino-acid consensus sequence known as the J domain. The J domain of HSP40 heat shock proteins interacts with HSP70 HEAT-SHOCK PROTEINS. HSP40 heat-shock proteins play a role in regulating the ADENOSINETRIPHOSPHATASE activity of HSP70 heat-shock proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus %28%HEPATITIS B VIRUS, DUCK%29%, heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus %28%HEPATITIS B VIRUS, WOODCHUCK%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of herbivorous leaping MAMMALS of Australia, New Guinea, and adjacent islands. Members include kangaroos, wallabies, quokkas, and wallaroos.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of heterotrimeric GTP-binding protein alpha subunits that activate ADENYLATE CYCLASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of heterotrimeric GTP-binding protein alpha subunits that activate PHOSPHOLIPASE C dependent signaling pathways. The Gq-G11 part of the name is also spelled Gq/G11.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of heterotrimeric GTP-binding protein alpha subunits that were originally identified by their ability to inhibit ADENYLATE CYCLASE. Members of this family can couple to beta and gamma G-protein subunits that activate POTASSIUM CHANNELS. The Gi-Go part of the name is also spelled Gi/Go.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of hexahydropyridines. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of high molecular weight GTP phosphohydrolases that play a direct role in vesicle transport. They associate with microtubule bundles %28%MICROTUBULES%29% and are believed to produce mechanical force via a process linked to GTP hydrolysis. This enzyme was formerly listed as EC 3.6.1.50.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of high molecular weight Maf transcription factors that contain distinct activation domains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif %28%EF-HAND MOTIFS%29% found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100%25% saturated ammonium sulfate solution.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of highly conserved and widely expressed sodium-phosphate cotransporter proteins. They are electrogenic sodium-dependent transporters of phosphate that were originally identified as retroviral receptors in HUMANS and have been described in yeast and many other organisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of histone acetyltransferases that is structurally-related to CREB-BINDING PROTEIN and to E1A-ASSOCIATED P300 PROTEIN. They function as transcriptional coactivators by bridging between DNA-binding TRANSCRIPTION FACTORS and the basal transcription machinery. They also modify transcription factors and CHROMATIN through ACETYLATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of homologous proteins of low MOLECULAR WEIGHT that are predominately expressed in the BRAIN and that have been implicated in a variety of human diseases. They were originally isolated from CHOLINERGIC FIBERS of TORPEDO.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of hoofed MAMMALS consisting of HORSES, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of icosahedral, lipid-containing, non-enveloped bacteriophages containing one genus %28%Corticovirus%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of icosahedral, non-enveloped, RNA plant viruses comprised of three genera: TYMOVIRUS, Marafivirus and Maculavirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of immunophilin proteins that bind to the immunosuppressive drugs TACROLIMUS %28%also known as FK506%29% and SIROLIMUS. EC 5.2.1.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of inhibitory proteins which bind to the REL PROTO-ONCOGENE PROTEINS and modulate their activity. In the CYTOPLASM, I-kappa B proteins bind to the transcription factor NF-KAPPA B. Cell stimulation causes its dissociation and translocation of active NF-kappa B to the nucleus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of insect viruses causing disease in lepidopterous larvae, most commonly from species of the owlet moth family Noctuidae. There is one genus: Ascovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of insect viruses isolated from endoparasitic hymenopteran insects belonging to the families Ichneumonidae and Braconidae. The two genera are Ichnovirus and Bracovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of insects, in the order Dictyoptera %28%COCKROACHES%29%, including genera Blattella, Parcoblatta, and Symploce.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of intestinal flukes of the class Trematoda which occurs in animals and man. Some of the genera are Heterophyes, Metagonimus, Cryptocotyle, Stellantchasmus, and Euryhelmis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of intracellular CYSTEINE ENDOPEPTIDASES. They play a key role in inflammation and mammalian APOPTOSIS. They are specific for aspartic acid at the P1 position. They are divided into two classes based on the lengths of their N-terminal prodomains. Caspases-1,-2,-4,-5,-8, and -10 have long prodomains and -3,-6,-7,-9 have short prodomains. EC 3.4.22.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of intracellular calcium-sensing proteins found predominately in NEURONS and PHOTORECEPTORS. They contain EF HAND MOTIFS and undergo conformational changes upon calcium-binding. Neuronal calcium-sensor proteins interact with other regulatory proteins to mediate physiological responses to a change in intracellular calcium concentration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of inwardly-rectifying potassium channels that are activated by PERTUSSIS TOXIN sensitive G-PROTEIN-COUPLED RECEPTORS. GIRK potassium channels are primarily activated by the complex of GTP-BINDING PROTEIN BETA SUBUNITS and GTP-BINDING PROTEIN GAMMA SUBUNITS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of isomeric, colorless aromatic hydrocarbon liquids, that contain the general formula C6H4%28%CH3%29%2. They are produced by the destructive distillation of coal or by the catalytic reforming of petroleum naphthenic fractions. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of lanceolate liver flukes of the class Trematoda which occurs in animals and man. There are several genera including Amphimerus, Cyclorchis, Delphinicola, Metorchis, Parametorchis, Phocitrema, Clonorchis, and Opisthorchis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of large adaptin protein complex subunits of approximately 90-130 kDa in size.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of large adaptin protein subunits of approximately 100 kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of large adaptin protein subunits of approximately 130-kDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of large adaptin protein subunits of approximately 90 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of large icosahedral DNA viruses infecting insects and poikilothermic vertebrates. Genera include IRIDOVIRUS; RANAVIRUS; Chloriridovirus, and Lymphocystivirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of large terrestrial carnivores possessing long legs, coarse guard hairs and a busy tail. It is comprised of hyenas and aardwolves.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of lemon-shaped DNA viruses infecting ARCHAEA and containing one genus: Fusellovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of light chains that bind to the CD98 heavy chain %28%ANTIGENS, CD98 HEAVY CHAIN%29% to form a heterodimer. They convey functional specificity to the protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of lipid-containing bacteriophages with double capsids which infect both gram-negative and gram-positive bacteria. It has one genus, Tectivirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of lipoprotein particles varying in density and size depending on the protein-lipid ratio and the protein composition. These particles consist of apolipoprotein B-100 covalently linked to apolipoprotein-a by one or two disulfide bonds. There is a correlation between high plasma levels of this lipoprotein and increased risk for atherosclerotic cardiovascular disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of long-tailed terrestrial omnivores including RACCOONS, lesser panda, ringtails, and coatimundis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of low MOLECULAR WEIGHT actin-binding proteins found throughout eukaryotes. They remodel the actin CYTOSKELETON by severing ACTIN FILAMENTS and increasing the rate of monomer dissociation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of low molecular weight heat-shock proteins that can serve as MOLECULAR CHAPERONES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of low molecular weight proteins that bind ACTIN and control actin polymerization. They are found in eukaryotes and are ubiquitously expressed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of low-molecular weight, non-histone proteins found in chromatin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of mainly aromatic evergreen plants in the order Laurales. The laurel family includes 2,200 species in 45 genera and from these are derived medicinal extracts, essential oils, camphor and other products.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of mammalian POU domain factors that are expressed predominately in NEURONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of marine CRUSTACEA, in the order DECAPODA, comprising the clawless lobsters. They are found in tropical and subtropical waters and characterized by short spines along the length of the tail and body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of marine MUSSELS in the class BIVALVIA. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of marine mollusks in the class BIVALVIA, commonly known as oysters. They have a rough irregular shell closed by a single adductor muscle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of marine, gram-negative PROTEOBACTERIA including the genera ALTEROMONAS; Colwellia; Idiomarina; Marinobacter; MORITELLA; PSEUDOALTEROMONAS; and SHEWANELLA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of marsupials in the order Diprotodontia, native to Australia and possessing vestigial tails. There is a single living genus and species: Phascolarctos cinereus, the koala.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of medium adaptin protein subunits of approximately 45 KDa in size. They have been primarily found as components of ADAPTOR PROTEIN COMPLEX 3 and ADAPTOR PROTEIN COMPLEX 4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of membrane-anchored glycoproteins that contain a disintegrin and metalloprotease domain. They are responsible for the proteolytic cleavage of many transmembrane proteins and the release of their extracellular domain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of membrane-associated proteins responsible for the attachment of the cytoskeleton. Erythrocyte-related isoforms of ankyrin attach the SPECTRIN cytoskeleton to a transmembrane protein %28%ANION EXCHANGE PROTEIN 1, ERYTHROCYTE%29% in the erythrocyte plasma membrane. Brain-related isoforms of ankyrin also exist.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of microfilament proteins whose name derives from the fact that mutations in members of this protein family have been associated with WISKOTT-ALDRICH SYNDROME. They are involved in ACTIN polymerization and contain a polyproline-rich region that binds to PROFILIN, and a verprolin homology domain that binds G-ACTIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of monopartite RNA plant viruses resembling picornaviruses and containing two genera: SEQUIVIRUS and WAIKAVIRUS. Transmission is by aphids or leafhoppers and requires a helper protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of monosaccharide transport proteins characterized by 12 membrane spanning helices. They facilitate passive diffusion of GLUCOSE across the CELL MEMBRANE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of muscle-specific transcription factors which bind to DNA in control regions and thus regulate myogenesis. All members of this family contain a conserved helix-loop-helix motif which is homologous to the myc family proteins. These factors are only found in skeletal muscle. Members include the myoD protein %28%MYOD PROTEIN%29%; MYOGENIN; myf-5, and myf-6 %28%also called MRF4 or herculin%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of neuronal calcium-sensor proteins that interact with and regulate potassium channels, type A.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of neurotransmitter transporter proteins that are INTEGRAL MEMBRANE PROTEINS of the LIPID BILAYER of SECRETORY VESICLES. They are ANTIPORTERS that exchange vesicular PROTONS for cytoplasmic NEUROTRANSMITTER and play an essential role in regulating neurotransmission.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of neurotransmitter transporter proteins that facilitate NEUROTRANSMITTER reuptake into PRESYNAPTIC TERMINALS. They may play a role in regulating the intensity and duration of neurotransmission.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of new world monkeys in the infraorder PLATYRRHINI, comprising the HOWLER MONKEYS, spider monkeys, and wooley monkeys.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of nocturnal rodents, similar in appearance to SQUIRRELS, but smaller. There are 28 species, half of which are found in Africa.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of non-enveloped RNA plant viruses, transmitted by biological vectors and experimentally by mechanical inoculation. There are three genera: COMOVIRUS; FABAVIRUS; and NEPOVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of non-enveloped viruses infecting mammals %28%MASTADENOVIRUS%29% and birds %28%AVIADENOVIRUS%29% or both %28%ATADENOVIRUS%29%. Infections may be asymptomatic or result in a variety of diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of non-fibrillar collagens that interact with FIBRILLAR COLLAGENS. They contain short triple helical domains interrupted by short non-helical domains and do not form into collagen fibrils.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of non-receptor, PROLINE-rich protein-tyrosine kinases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of nonbiting midges, in the order DIPTERA. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of nonmetallic, generally electronegative, elements that form group 17 %28%formerly group VIIa%29% of the periodic table.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of organic anion transporters that specifically transport DICARBOXYLIC ACIDS such as alpha-ketoglutaric acid across cellular membranes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of parasitic PROTOZOA in the order EIMERIIDA. CRYPTOSPORIDIUM is the most important genus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of parasitic PROTOZOA in the order EIMERIIDAE. They form tissue-cysts in their intermediate hosts, ultimately leading to pathogenesis in the final hosts that includes various mammals %28%including humans%29% and birds. The most important genera include NEOSPORA; SARCOCYSTIS; and TOXOPLASMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of peptides originally found as factors that stimulate the phosphorylation of the erbB-2 receptor %28%RECEPTORS, ERBB-2%29%. Multiple variant forms of NEUREGULINS occur due to alternative splicing of their mRNAs. The NEUREGULINS include products from the three known genes %28%NGR1; NGR2 and NGR3%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of peptidyl-prolyl cis-trans isomerases that bind to CYCLOSPORINS and regulate the IMMUNE SYSTEM. EC 5.2.1.-%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of pheromone receptors that were initially discovered in SACCHAROMYCES CEREVISIAE as proteins necessary for fungal conjugation. Each mating factor receptor is expressed in HAPLOID CELLS of a single mating type.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of phototrophic bacteria, in the order Rhodospirillales, isolated from stagnant water and mud.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of phototrophic purple sulfur bacteria that deposit globules of elemental sulfur inside their cells. They are found in diverse aquatic environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of plant viruses containing the largest single-stranded RNA genomes. Infections typically involve yellowing and necrosis, particularly affecting the phloem.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of plant viruses where the virions possess an unusual morphology consisting of a pair of isometric particles. Transmission occurs via leafhoppers or whitefly. Some viruses cause economically important diseases in cultivated plants. There are three genera: Mastrevirus, Curtovirus, and Begomovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of plasma membrane neurotransmitter transporter proteins that couple the uptake of GLUTAMATE with the import of SODIUM ions and PROTONS and the export of POTASSIUM ions. In the CENTRAL NERVOUS SYSTEM they regulate neurotransmission through synaptic reuptake of the excitatory neurotransmitter glutamate. Outside the central nervous system they function as signal mediators and regulators of glutamate metabolism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of plasma membrane neurotransmitter transporter proteins that regulates that extracellular levels of the inhibitory neurotransmitter GAMMA-AMINOBUTYRIC ACID. They differ from GABA RECEPTORS, which signal cellular responses to GAMMA-AMINOBUTYRIC ACID. They control GABA reuptake into PRESYNAPTIC TERMINALS in the CENTRAL NERVOUS SYSTEM through high-affinity sodium-dependent transport.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of polypeptides purified from snake venoms, which contain the arginine-glycine-aspartic acid %28%RGD%29% sequence. The RGD tripeptide binds to integrin receptors and thus competitively inhibits normal integrin-ligand interactions. Disintegrins thus block adhesive functions and act as platelet aggregation inhibitors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of possums and cuscuses found in Australia, Tasmania, New Guinea and other islands.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of protein serine/threonine kinases which act as intracellular signalling intermediates. Ribosomal protein S6 kinases are activated through phosphorylation in response to a variety of HORMONES and INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS. Phosphorylation of RIBOSOMAL PROTEIN S6 by enzymes in this class results in increased expression of 5%27% TOP MRNAS. Although specific for RIBOSOMAL PROTEIN S6 members of this class of kinases can act on a number of substrates within the cell. The immunosuppressant SIROLIMUS inhibits the activation of ribosomal protein S6 kinases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteinase-activated receptors that are specific for THROMBIN. They are found primarily on PLATELETS and on ENDOTHELIAL CELLS. Activation of thrombin receptors occurs through the proteolytic action of THROMBIN, which cleaves the N-terminal peptide from the receptor to reveal a new N-terminal peptide that is a cryptic ligand for the receptor. The receptors signal through HETEROTRIMERIC GTP-BINDING PROTEINS. Small synthetic peptides that contain the unmasked N-terminal peptide sequence can also activate the receptor in the absence of proteolytic activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins involved in NUCLEOCYTOPLASMIC TRANSPORT. Karyopherins are heteromeric molecules composed two major types of components, ALPHA KARYOPHERINS and BETA KARYOPHERINS, that function together to transport molecules through the NUCLEAR PORE COMPLEX. Several other proteins such as RAN GTP BINDING PROTEIN and CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN bind to karyopherins and participate in the transport process.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins involved in intracellular membrane trafficking. They interact with SYNTAXINS and play important roles in vesicular docking and fusion during EXOCYTOSIS. Their name derives from the fact that they are related to Unc-18 protein, C elegans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins involved in the transport of monocarboxylic acids such as LACTIC ACID and PYRUVIC ACID across cellular membranes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins involved in the transport of organic cations. They play an important role in the elimination of a variety of endogenous substances, xenobiotics, and their metabolites from the body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that are involved in the translocation of signals from TGF-BETA RECEPTORS; BONE MORPHOGENETIC PROTEIN RECEPTORS; and other surface receptors to the CELL NUCLEUS. They were originally identified as a class of proteins that are related to the mothers against decapentaplegic protein, Drosophila and sma proteins from CAENORHABDITIS ELEGANS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that are structurally-related to Ubiquitin. Ubiquitins and ubiquitin-like proteins participate in diverse cellular functions, such as protein degradation and HEAT-SHOCK RESPONSE, by conjugation to other proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that contain several 42-amino acid repeat domains and are homologous to the Drosophila armadillo protein. They bind to other proteins through their armadillo domains and play a variety of roles in the CELL including SIGNAL TRANSDUCTION, regulation of DESMOSOME assembly, and CELL ADHESION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that mediate axonal guidance. Semaphorins act as repulsive cues for neuronal GROWTH CONES and bind to receptors on their filopodia. At least 20 different molecules have been described and divided into eight classes based on domain organization and species of origin. Classes 1 and 2 are invertebrate, classes 3-7 are vertebrate, and class V are viral. Semaphorins may be secreted %28%classes 2, 3, and V%29%, transmembrane %28%classes 1, 4, 5, and 6%29%, or membrane-anchored %28%class 7%29%. All semaphorins possess a common 500-amino acid extracellular domain which is critical for receptor binding and specificity, and is also found in plexins and scatter factor receptors. Their C termini are class-specific and may contain additional sequence motifs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that play a role as cofactors in the process of CLATHRIN recycling in cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that promote unwinding of RNA during splicing and translation. EC 2.7.7.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that share sequence similarity with the low density lipoprotein receptor %28%RECEPTORS, LDL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that share the F-BOX MOTIF and are involved in protein-protein interactions. They play an important role in process of protein ubiquition by associating with a variety of substrates and then associating into SCF UBIQUITIN LIGASE complexes. They are held in the ubiquitin-ligase complex via binding to SKP DOMAIN PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of proteins that were originally identified by their ability to cause NECROSIS of NEOPLASMS. Their necrotic effect on cells is mediated through TUMOR NECROSIS FACTOR RECEPTORS which induce APOPTOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of rat kangaroos found in and around Australia. Genera include Potorous and Bettongia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of recombinases initially identified in BACTERIA. They catalyze the ATP-driven exchange of DNA strands in GENETIC RECOMBINATION. The product of the reaction consists of a duplex and a displaced single-stranded loop, which has the shape of the letter D and is therefore called a D-loop structure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of related proteins that associate with cytoskeletal elements and junctional complexes at INTERCELLULAR JUNCTIONS. Plakins share a common plakin domain or a plakin repeat domain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of related, adhesive glycoproteins which are synthesized, secreted, and incorporated into the extracellular matrix of a variety of cells, including alpha granules of platelets following thrombin activation and endothelial cells. They interact with a number of BLOOD COAGULATION FACTORS and anticoagulant factors. Five distinct forms have been identified, thrombospondin 1, -2, -3, -4, and cartilage oligomeric matrix protein %28%COMP%29%. They are involved in cell adhesion, platelet aggregation, cell proliferation, angiogenesis, tumor metastasis, vascular smooth muscle growth, and tissue repair.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ribonucleoproteins that were originally found as proteins bound to nascent RNA transcripts in the form of ribonucleoprotein particles. Although considered ribonucleoproteins they are primarily classified by their protein component. They are involved in a variety of processes such as packaging of RNA and RNA TRANSPORT within the nucleus. A subset of heterogeneous-nuclear ribonucleoproteins are involved in additional functions such as nucleocytoplasmic transport %28%ACTIVE TRANSPORT, CELL NUCLEUS%29% of RNA and mRNA stability in the CYTOPLASM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ribosomal protein S6 kinases that are considered the major physiological kinases for RIBOSOMAL PROTEIN S6. Unlike RIBOSOMAL PROTEIN S6 KINASES, 90KDa the proteins in this family are sensitive to the inhibitory effects of RAPAMYCIN and contain a single kinase domain. They are referred to as 70kDa proteins, however ALTERNATIVE SPLICING of mRNAs for proteins in this class also results in 85kDa variants being formed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ribosomal protein S6 kinases that are structurally distinguished from RIBOSOMAL PROTEIN KINASES, 70-kDa by their apparent molecular size and the fact they contain two functional kinase domains. Although considered RIBOSOMAL PROTEIN S6 KINASES members of this family are activated via the MAP KINASE SIGNALING SYSTEM and have been shown to act on a diverse array of substrates that are involved in cellular regulation such as RIBOSOMAL PROTEIN S6 and CAMP RESPONSE ELEMENT-BINDING PROTEIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of rod-shaped or filamentous bacteriophages consisting of single-stranded DNA. There are two genera: INOVIRUS and PLECTROVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of rod-shaped viruses, in the order NIDOVIRALES. It includes one genus: Okavirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of scavenger receptors that are predominately localized to CAVEOLAE of the PLASMA MEMBRANE and bind HIGH DENSITY LIPOPROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of scavenger receptors that mediate the influx of LIPIDS into MACROPHAGES and are involved in FOAM CELL formation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of scavenger receptors with broad polyanionic ligand binding properties that are expressed in embryonic insect MACROPHAGES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of sea snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp331-3; Moore: Poisonous Snakes of the World, 1980, p159%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of secreted proteins %28%TIMP-1; TIMP-2; and TIMP-3%29% that play a crucial role in regulating the activity of the secreted METALLOENDOPEPTIDASES; %28%COLLAGENASES; stromelysins; GELATINASES%29%. Of the three characterized, only TIMP-1 and TIMP-2 appear to have related primary structures and inhibitory properties. They influence the activation of the prometalloproteinase and act to modulate proteolysis of extracellular matrix, notably during tissue remodeling and inflammatory processes. On certain cell types, they can exhibit growth factor-like activity, and they can inhibit the tumorigenic and metastatic phenotype in cancer cells. %28%Pharmacol Ther 1993;59:329-41%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of sequence-related proteins similar to HMGB1 PROTEIN that contains specific HMG-BOX DOMAINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES, and some serpins occur in plants where their function is not known.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of seven-pass transmembrane cell-surface receptors. They contain an extracellular cysteine-rich domain and are receptors for WNT PROTEINS. Frizzled receptors often couple with HETEROTRIMERIC G PROTEINS and regulate multiple SIGNAL TRANSDUCTION PATHWAYS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of shrimp in the class CRUSTACEA, order DECAPODA, containing a single genus, Crangon, with multiple species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of signal transducing adaptor proteins that control the METABOLISM of NITROGEN. They are primarily found in prokaryotes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of smad proteins that undergo PHOSPHORYLATION by CELL SURFACE RECEPTORS in response to TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; or BONE MORPHOGENETIC PROTEIN signaling.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are six genera: APHTHOVIRUS; CARDIOVIRUS; ENTEROVIRUS; HEPATOVIRUS; PARECHOVIRUS; and RHINOVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small adaptin protein complex subunits of approximately 19 KDa in size.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small gram-negative bacteria whose organisms are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small, gram-negative organisms, often parasitic in humans and other animals, causing diseases that may be transmitted by invertebrate vectors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small, non-enveloped DNA viruses infecting MAMMALS. There is one genus: PAPILLOMAVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of small, non-enveloped DNA viruses, infecting mainly MAMMALS, and containing a single genus: POLYOMAVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of snakes comprising the boas, anacondas, and pythons. They occupy a variety of habitats through the tropics and subtropics and are arboreal, aquatic or fossorial %28%burrowing%29%. Some are oviparous, others ovoviviparous. Contrary to popular opinion, they do not crush the bones of their victims: their coils exert enough pressure to stop a prey%27%s breathing, thus suffocating it. There are five subfamilies: Boinae, Bolyerinae, Erycinae, Pythoninae, and Tropidophiinae. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p315-320%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of snakes comprising three subfamilies: Azemiopinae %28%the mountain viper, the sole member of this subfamily%29%, Viperinae %28%true vipers%29%, and Crotalinae %28%pit vipers%29%. They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood %28%hemotoxic%29% as compared to the venom of elapids which act on the nervous system %28%neurotoxic%29%. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, pp333-36%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE. Glycine plasma membrane transport proteins are different than%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of sodium-phosphate cotransporter proteins that also transport organic ANIONS. They are low affinity phosphate transporters.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of sodium-phosphate cotransporter proteins with eight transmembrane domains. They are present primarily in the KIDNEY and SMALL INTESTINE and are responsible for renal and small intestinal epithelial transport of phosphate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of softbacked TICKS, in the subclass ACARI. Genera include ARGAS and ORNITHODOROS among others.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of soil bacteria. It also includes some parasitic forms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. %28%Int J Gynaecol Obstet 1992;39%28%1%29%:3-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of spherical viruses, of the order MONONEGAVIRALES, somewhat larger than the orthomyxoviruses, and containing single-stranded RNA. Subfamilies include PARAMYXOVIRINAE and PNEUMOVIRINAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of spiral bacteria of the order SPIROCHAETALES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of spiro%28%isobenzofuran-1%28%3H%29%,9%27%-%28%9H%29%xanthen%29%-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of stalked bacteria that reproduces by budding. There are four genera: CAULOBACTER, Asticcacaulis, Brevundimonas, and Phenylobacterium.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of sterols commonly found in plants and plant oils. Alpha-, beta-, and gamma-isomers have been characterized.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally related collagens that form the characteristic collagen fibril bundles seen in CONNECTIVE TISSUE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally related neurotoxic peptides from mollusk venom that inhibit voltage-activated entry of calcium into the presynaptic membrane. They selectively inhibit N-, P-, and Q-type calcium channels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally related proteins that are constitutively expressed and that negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. PIAS proteins inhibit the activity of SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally related proteins that are induced by CYTOKINES and negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. SOCS proteins contain a central SH2 DOMAIN and a C-terminal region of homology known as the SOCS box.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally related proteins that were originally discovered for their role in cell-cycle regulation in CAENORHABDITIS ELEGANS. They play important roles in regulation of the CELL CYCLE and as components of UBIQUITIN-PROTEIN LIGASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally-related angiogenic proteins of approximately 70 kDa in size. They have high specificity for members of the TIE RECEPTOR FAMILY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally-related proteins that were originally identified by their ability to complex with cyclin proteins %28%CYCLINS%29%. They share a common domain that binds specifically to F-BOX MOTIFS. They take part in SKP CULLIN F-BOX PROTEIN LIGASES, where they can bind to a variety of F-BOX PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally-related short-chain collagens that do not form large fibril bundles.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of structurally-related tyrosine kinase receptors that are expressed predominantly in ENDOTHELIAL CELLS and are essential for development of BLOOD VESSELS %28%NEOVASCULARIZATION, PHYSIOLOGIC%29%. The name derives from the fact that they are tyrosine kinases that contain Ig and EGF domains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of symporters that facilitate sodium-dependent membrane transport of phosphate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsin I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of synthetic protein tyrosine kinase inhibitors. They selectively inhibit receptor autophosphorylation and are used to study receptor function.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of terrestrial carnivores with long snouts and non-retractable claws. Members include COYOTES; DOGS; FOXES; JACKALS; RACCOON DOGS; and WOLVES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of terrestrial carnivores with long, slender bodies, long tails, and anal scent glands. They include badgers, weasels, martens, FERRETS; MINKS; wolverines, polecats, and OTTERS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order Anura, distinguished by the lack of a tongue. It includes four living genera of aquatic %22%toads%22%. Two of the most familiar pipids are the popularly called Surinam %22%toad%22% %28%Pipa pipa%29% and XENOPUS LAEVIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order DIPTERA that comprises the mosquitoes. The larval stages are aquatic, and the adults can be recognized by the characteristic wing venation, the scales along the wing veins, and the long proboscis. Many species are of particular medical importance.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order DIPTERA that includes the TSETSE FLIES. These flies occur only in Africa.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus %28%HOUSEFLIES%29%, Musca autumnalis %28%face fly%29%, Stomoxys calcitrans %28%stable fly%29%, Haematobia irritans %28%horn fly%29% and Fannia spp.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order DIPTERA. These flies are generally found around decaying vegetation and fruit. Several species, because of their short life span, giant salivary gland chromosomes, and ease of culturing, have been used extensively in studies of heredity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order PRIMATES that consists of four genera: CALLITHRIX %28%marmosets%29%, CALLIMICO %28%Goeldi%27%s monkey%29%, LEONTOPITHECUS %28%lion tamarins%29%, and SAGUINUS %28%long-tusked tamarins%29%. The members of this family inhabit the tropical forests of South and Central America.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order PRIMATES, suborder Strepsirhini %28%PROSIMII%29%, containing five genera. All inhabitants of Madagascar, the genera are: Allocebus, Cheirogaleus %28%dwarf lemurs%29%, Microcebus %28%mouse lemurs%29%, Mirza, and Phaner.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order PRIMATES, suborder Strepsirhini %28%PROSIMII%29%, containing four genera which inhabit Madagascar and the Comoro Island. Most of the lemurs prefer wooded areas. The four genera are Hapalemur, LEMUR, Lepilemur, and Varecia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order Rodentia containing 250 genera including the two genera Mus %28%MICE%29% and Rattus %28%RATS%29%, from which the laboratory inbred strains are developed. The fifteen subfamilies are SIGMODONTINAE %28%New World mice and rats%29%, CRICETINAE, Spalacinae, Myospalacinae, Lophiomyinae, ARVICOLINAE, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, GERBILLINAE, Dendromurinae, Cricetomyinae, MURINAE %28%Old World mice and rats%29%, and Hydromyinae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the order Rodentia which contains 49 genera. Some of the more common genera are MARMOTA, which includes the marmot and woodchuck; Sciurus, the gray squirrel, S. carolinensis, and the fox squirrel, S. niger; Tamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels, except the scaly-tailed Anomaluridae, also belong to this family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of the suborder HAPLORHINI comprising only one genus, HYLOBATES %28%also called Nomascus or Symphalangus%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors characterized by the presence of a bipartite DNA-binding domain known as the POU domain. The POU domain contains two subdomains, a POU-specific domain and a POU-homeodomain. The POU domain was originally identified as a region of approximately 150 amino acids shared between the Pit-1, Oct-1, Oct-2, and Unc-86 transcription factors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors characterized by the presence of highly conserved calcineurin- and DNA-binding domains. NFAT proteins are activated in the CYTOPLASM by the calcium-dependent phosphatase CALCINEURIN. They transduce calcium signals to the nucleus where they can interact with TRANSCRIPTION FACTOR AP-1 or NF-KAPPA B and initiate GENETIC TRANSCRIPTION of GENES involved in CELL DIFFERENTIATION and development. NFAT proteins stimulate T-CELL activation through the induction of IMMEDIATE-EARLY GENES such as INTERLEUKIN-2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors containing SH2 DOMAINS that are involved in CYTOKINE-mediated SIGNAL TRANSDUCTION. STAT transcription factors are recruited to the cytoplasmic region of CELL SURFACE RECEPTORS and are activated via PHOSPHORYLATION. Once activated they dimerize and translocate into the CELL NUCLEUS where they influence GENE expression. They play a role in regulating CELL GROWTH PROCESSES and CELL DIFFERENTIATION. STAT transcription factors are inhibited by SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS and PROTEIN INHIBITORS OF ACTIVATED STAT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors found primarily in PLANTS that bind to the G-box DNA sequence CACGTG or to a consensus sequence CANNTG.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that are induced by GROWTH FACTORS and contain a highly conserved DNA-binding domain composed of three ZINC FINGER MOTIFS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that bind to the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. Family members contain a highly conserved DNA-binding domain known as the runt domain. They can act as both activators and repressors of expression of GENES involved in CELL DIFFERENTIATION and CELL CYCLE progression.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that contain a single cut domain and a divergent homeodomain. They regulate gene networks by controlling the expression of other transcription factors and they play an important role in CELL DIFFERENTIATION and METABOLISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that contain regions rich in basic residues, LEUCINE ZIPPER domains, and HELIX-LOOP-HELIX MOTIFS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that contain two ZINC FINGER MOTIFS and bind to the DNA sequence %28%A/T%29%GATA%28%A/G%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that control EMBRYONIC DEVELOPMENT within a variety of cell lineages. They are characterized by a highly conserved paired DNA-binding domain that was first identified in DROSOPHILA segmentation genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that control expression of a variety of nuclear GENES encoding proteins that function in the RESPIRATORY CHAIN of the MITOCHONDRIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that share a unique DNA-binding domain. The name derives from viral oncogene-derived protein ONCOGENE PROTEIN V-ETS of the AVIAN ERYTHROBLASTOSIS VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transcription factors that share an N-terminal HELIX-TURN-HELIX MOTIF and bind INTERFERON-inducible PROMOTERS to control GENE expression. IRF proteins bind specific DNA sequences such as interferon-stimulated response elements, interferon regulatory elements, and the interferon consensus sequence.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transforming proteins isolated from retroviruses such as MOUSE SARCOMA VIRUSES. They are viral-derived members of the raf-kinase family of serine-theonine kinases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transmembrane dystrophin-associated proteins that plays a role in the membrane association of the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX. Mutations abolishing the expression of sarcoglycans result in LIMB-GIRDLE MUSCULAR DYSTROPHY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of transmembrane glycoproteins %28%MEMBRANE GLYCOPROTEINS%29% consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors%28%RECEPTORS, CYTOADHESIN%29%, the leukocyte adhesion receptors %28%RECEPTORS, LEUKOCYTE ADHESION%29%, and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit %28%INTEGRIN BETA CHAINS%29% combined with one or more distinct alpha-subunits %28%INTEGRIN ALPHA CHAINS%29%. These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants %28%ANTIDEPRESSIVE AGENTS, TRICYCLIC%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of trypsin-like SERINE ENDOPEPTIDASES that are expressed in a variety of cell types including human prostate epithelial cells. They are formed from tissue prokallikrein by action with TRYPSIN. They are highly similar to PROSTATE-SPECIFIC ANTIGEN. EC 3.4.21.35.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of ubiquitously expressed MONOMERIC GTP-BINDING PROTEINS that are involved in intracellular signal transduction. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of unenveloped RNA viruses with cubic symmetry. The eight genera include ORTHOREOVIRUS; ORBIVIRUS; COLTIVIRUS; ROTAVIRUS; Aquareovirus, Cypovirus, Phytoreovirus, Fijivirus, and Oryzavirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of very small DNA viruses containing a single molecule of single-stranded DNA and consisting of two subfamilies: PARVOVIRINAE and DENSOVIRINAE. They infect both vertebrates and invertebrates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of very small viruses containing circular, single-stranded DNA and possessing no envelope. The modes of transmission are not known.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of vesicular neurotransmitter transporter proteins that sequester the inhibitory neurotransmitters GLYCINE; GAMMA-AMINOBUTYRIC ACID; and possibly GAMMA-HYDROXYBUTYRATE into SECRETORY VESICLES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of vesicular transport proteins characterized by an N-terminal transmembrane region and two C-terminal calcium-binding domains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera: ORTHOBUNYAVIRUS; HANTAVIRUS; NAIROVIRUS; PHLEBOVIRUS; and TOSPOVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of viruses, of the order MONONEGAVIRALES, containing filamentous virions. Although they resemble RHABDOVIRIDAE in possessing helical nucleocapsids, Filoviridae differ in the length and degree of branching in their virions. There are two genera: EBOLA-LIKE VIRUSES and MARBURG-LIKE VIRUSES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of viruses, of the order NIDOVIRALES, containing spherical virions. In contrast to CORONAVIRIDAE, no protruding spikes are obvious on the surface.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of voltage-gated eukaryotic porins that form aqueous channels. They play an essential role in mitochondrial CELL MEMBRANE PERMEABILITY, are often regulated by BCL-2 PROTO-ONCOGENE PROTEINS, and have been implicated in APOPTOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of winged insects of the suborder HETEROPTERA, called assassin bugs, because most prey on other insects. However one subfamily, TRIATOMINAE, attacks humans and other vertebrates and transmits Chagas disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of wingless, blood-sucking insects of the suborder HETEROPTERA, including the bedbugs and related forms. Cimex %28%BEDBUGS%29%, Heamatosiphon, and Oeciacus are medically important genera. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of zinc finger transcription factors that share homology with Kruppel protein, Drosophila. They contain a highly conserved seven amino acid spacer sequence in between their ZINC FINGER MOTIFS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A family of zinc-dependent metalloendopeptidases that are involved in the degradation of EXTRACELLULAR MATRIX components. EC 3.4.24.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fast inactivating subtype of shaker potassium channels that contains two inactivation domains at its N terminus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. %28%From AMA Drug Evaluations Annual, 1993, p1619%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fatty acid that is found in plants and involved in the formation of prostaglandins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fatty acid with anticonvulsant properties used in the treatment of epilepsy. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of voltage dependent sodium channels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A febrile disease caused by STREPTOCOCCUS PNEUMONIAE. This condition is characterized by inflammation of one or more lobes of the lungs and symptoms include chills, fever, rapid breathing, and cough.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A febrile disease occurring as a delayed sequela of infections with group A hemolytic streptococci and characterized by multiple focal inflammatory lesions of the connective tissue structures, especially of the heart, blood vessels, and joints %28%polyarthritis%29%, and by the presence of Aschoff bodies in the myocardium and skin. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A febrile illness associated with pericardial and sometimes pleuropulmonary reaction that often follows extensive pericardiotomy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A febrile illness characterized by chills, aches, vomiting, leukopenia, and sometimes encephalitis. It is caused by the COLORADO TICK FEVER VIRUS, a reovirus transmitted by the tick Dermacentor andersoni.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A federal area located between Maryland and Virginia on the Potomac river; it is coextensive with Washington, D.C., which is the capital of the United States.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A federally administered division of Canada. Its capital is Yellowknife. The former northern and eastern-most parts of the Territory comprise the new territory of Nunavut, effective April 1, 1999.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A federation of seven states on the southeast portion of the Arabian peninsula: Abu Dhabi, Ajman, Dubai, Fujairah, Ras al-Khaimah, Sharjah and Umm al-Qaiwain. In 1820 a treaty of peace was concluded between Great Britain and native rulers. During the 19th century the rulers agreed to suppression of the slave trade and restriction of foreign relations to Great Britain. The Trucial Council was established in 1952 and defense treaties with Great Britain terminated. In 1971 an independent six-member federation was formed, with Ras al-Khaimah joining the federation in 1972. %28%From Webster%27%s New Geographical Dictionary, 1988, p1250%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ferredoxin-containing enzyme that catalyzes the COENZYME A-dependent oxidative decarboxylation of PYRUVATE to acetyl-COENZYME A and CARBON DIOXIDE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ferroin compound that forms a stable magenta-colored solution with the ferrous ion. The complex has an absorption peak at 562 nm and is used as a reagent and indicator for iron.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fetal blood vessel connecting the pulmonary artery with the descending aorta.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fetus or infant with such pronounced developmental anomalies as to be grotesque and usually nonviable. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p986%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibril-associated collagen found in many tissues bearing high tensile stress, such as TENDONS and LIGAMENTS. It is comprised of a trimer of three identical alpha1%28%XII%29% chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibril-associated collagen usually found crosslinked to the surface of COLLAGEN TYPE II fibrils. It is a heterotrimer containing alpha1%28%IX%29%, alpha2%28%IX%29% and alpha3%28%IX%29% subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrillar collagen consisting of three identical alpha1%28%III%29% chains that is widely distributed in many tissues containing COLLAGEN TYPE I. It is particularly abundant in BLOOD VESSELS and may play a role in tissues with elastic characteristics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrillar collagen found predominantly in CARTILAGE and vitreous humor. It consists of three identical alpha1%28%II%29% chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrillar collagen found primarily in interstitial CARTILAGE. Collagen type XI is heterotrimer containing alpha1%28%XI%29%, alpha2%28%XI%29% and alpha3%28%XI%29% subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrillar collagen found widely distributed as a minor component in tissues that contain COLLAGEN TYPE I and COLLAGEN TYPE III. It is a heterotrimeric molecule composed of alpha1%28%V%29%, alpha2%28%V%29% and alpha3%28%V%29% subunits. Several forms of collagen type V exist depending upon the composition of the subunits that form the trimer.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrin-stabilizing plasma enzyme %28%TRANSGLUTAMINASES%29% that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer %28%clot%29% which culminates the coagulation cascade.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. EC 3.4.99.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibro-osseous hereditary disease of the jaws. The swollen jaws and raised eyes give a cherubic appearance; multiple radiolucencies are evident upon radiographic examination.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor receptor that is found in two isoforms. One receptor isoform is found in the MESENCHYME and is activated by FIBROBLAST GROWTH FACTOR 2. A second isoform of fibroblast growth factor receptor 2 is found mainly in EPITHELIAL CELLS and is activated by FIBROBLAST GROWTH FACTOR 7 and FIBROBLAST GROWTH FACTOR 10. Mutation of the gene for fibroblast growth factor receptor 2 can result in APERT SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor receptor that is mainly expressed in LUNG; KIDNEY; PANCREAS; and SPLEEN. It also plays an important role in SKELETAL MUSCLE development and can contribute to NEOPLASTIC CELL TRANSFORMATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor receptor that regulates CHONDROCYTE growth and CELL DIFFERENTIATION. Mutations in the gene for fibroblast growth factor receptor 3 have been associated with ACHONDROPLASIA; THANATOPHORIC DYSPLASIA and NEOPLASTIC CELL TRANSFORMATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor receptor with specificity for FIBROBLAST GROWTH FACTORS; HEPARAN SULFATE PROTEOGLYCAN; and NEURONAL CELL ADHESION MOLECULES. Several variants of the receptor exist due to multiple ALTERNATIVE SPLICING of its mRNA. Fibroblast growth factor receptor 1 is a tyrosine kinase that transmits signals through the MAP KINASE SIGNALING SYSTEM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that is a MITOGEN for KERATINOCYTES. It activates FIBROBLAST GROWTH FACTOR RECEPTOR 2B and is involved in LUNG and limb development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that is a specific mitogen for EPITHELIAL CELLS. It binds a complex of HEPARAN SULFATE and FIBROBLAST GROWTH FACTOR RECEPTOR 2B.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that is expressed primarily during development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that may play a role in regulation of HAIR FOLLICLE phenotype. Spontaneous mutation of the gene for this protein results in a strain of MICE with abnormally long hair, referred to as angora mice..%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that preferentially activates FIBROBLAST GROWTH FACTOR RECEPTOR 4. It was initially identified as an androgen-induced growth factor and plays a role in regulating growth of human BREAST NEOPLASMS and PROSTATIC NEOPLASMS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that was initially identified based on its sequence similarity to FIBROBLAST GROWTH FACTOR 4. It is found in MYOBLASTS and plays an important role in MUSCLE DEVELOPMENT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibroblast growth factor that was originally identified as a mitogen for GLIAL CELLS. It is expressed primarily in NEURONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibromatosis of the palmar fascia characterized by thickening and contracture of the fibrous bands on the palmar surfaces of the hand and fingers. It arises most commonly in men between the ages of 30 and 50.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibromuscular band that attaches to the UTERUS and then passes along the BROAD LIGAMENT, out through the INGUINAL RING, and into the labium majus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrosarcoma of the skin, beginning most often as an indurated nodule that grows slowly and hence is often ignored until it grows large. Dermatofibrosarcomas show an extremely aggressive tendency to invade local surrounding tissue. They do not metastasize, however, even after multiple recurrences. About 50%25% will recur after simple incision; hence wide excision should be resorted to. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1356%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fibrous degeneration, cyst formation, and the presence of fibrous nodules in bone, usually due to HYPERPARATHYROIDISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A field of biology concerned with the development of techniques for the collection and manipulation of biological data, and the use of such data to make biological discoveries or predictions. This field encompasses all computational methods and theories applicable to MOLECULAR BIOLOGY and areas of computer-based techniques for solving biological problems including manipulation of models and datasets.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A field of chemistry which pertains to chemical compounds or ions that do not contain the element carbon %28%with the exception of carbon dioxide and compounds containing a carbonate radical, e.g., calcium carbonate%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A field of chemistry which pertains to the study of inorganic compounds or ions in biological systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A field of medicine concerned with developing and using strategies aimed at repair or replacement of damaged, diseased, or metabolically deficient organs, tissues, and cells via TISSUE ENGINEERING; CELL TRANSPLANTATION; and ARTIFICIAL ORGANS and BIOARTIFICIAL ORGANS and tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A figure representing the number of years, based on known statistics, to which any person of a given age may reasonably expect to live.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A filarial nematode parasite of mammalian blood with the vector being a tick or small fly.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A filarial parasite primarily of dogs but occurring also in foxes, wolves, and humans. The parasite is transmitted by mosquitoes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A filarial worm of Southeast Asia, producing filariasis and elephantiasis in various mammals including man. It was formerly included in the genus WUCHERERIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A film base coated with an emulsion designed for use with x-rays.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A film or video wholly or partially created by photographing drawings, sculptures, or other inanimate things in sequence to create the illusion of motion. Animations are also generated by computers. %28%From Moving Image Materials: Genre Terms, 1988%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A first generation selective estrogen receptor modulator %28%SERM%29%. Like TAMOXIFEN, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fistula between a salivary duct or gland and the cutaneous surface of the oral cavity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fistula between the maxillary sinus and the oral cavity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A five-carbon sugar alcohol derived from XYLOSE by reduction of the carbonyl group. It is as sweet as sucrose and used as a noncariogenic sweetener.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fixed-ratio combination of amoxicillin trihydrate %28%see AMOXICILLIN%29%, an aminopenicillin, and potassium clavulanate %28%see CLAVULANIC ACID%29%, a beta-lactamase inhibitor, used to treat a broad-spectrum of bacterial infections, especially resistant strains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavanone glycoside found in CITRUS fruit peels. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavonol glycoside found in many plants, including BUCKWHEAT; TOBACCO; FORSYTHIA; HYDRANGEA; VIOLA, etc. It has been used therapeutically to decrease capillary fragility.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein amine oxidoreductase that catalyzes the reversible conversion of 5-METHYLTETRAHYDROFOLATE to 5,10-METHYLENETETRAHYDROFOLATE. This enzyme was formerly classified as EC 1.1.1.171.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein and iron sulfur-containing oxidoreductase complex that catalyzes the conversion of UBIQUINONE to ubiquinol. In MITOCHONDRIA the complex also couples its reaction to the transport of PROTONS across the internal mitochondrial membrane. The NADH DEHYDROGENASE component of the complex can be isolated and is listed as EC 1.6.99.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein and iron sulfur-containing oxidoreductase that catalyzes the oxidation of NADH to NAD. In eukaryotes the enzyme can be found as a component of mitochondrial electron transport complex I. Under experimental conditions the enzyme can use CYTOCHROME C GROUP as the reducing cofactor. The enzyme was formerly listed as EC 1.6.2.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein containing oxidoreductase that catalyzes the dehdyrogenation of SUCCINATE to FUMARATE. In most eukaryotic organisms this enzyme is a component of mitochondrial electron transport complex II.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein containing oxidoreductase that catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD+. The enzyme is a component of several MULTIENZYME COMPLEXES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein enzyme that catalyzes the formation of acetolactate from 2 moles of PYRUVATE in the biosynthesis of VALINE and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of ISOLEUCINE. This enzyme was formerly listed as EC 4.1.3.18.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein enzyme that catalyzes the univalent reduction of OXYGEN using NADPH as an electron donor to create SUPEROXIDE ANION. The enzyme is dependent on a variety of CYTOCHROMES. Defects in the production of superoxide ions by enzymes such as NADPH oxidase result in GRANULOMATOUS DISEASE, CHRONIC.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein enzyme that is responsible for the catabolism of LYSINE; HYDROXYLYSINE; and TRYPTOPHAN. It catalyzes the oxidation of GLUTARYL-CoA to crotonoyl-CoA using FAD as a cofactor. Glutaric aciduria type I is an inborn error of metabolism due to the deficiency of glutaryl-CoA dehydrogenase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein oxidase complex that contains iron-sulfur centers. It catalyzes the oxidation of SUCCINATE to FUMARATE and couples the reaction to the reduction of UBIQUINONE to ubiquinol.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein oxidoreductase that has specificity for long-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein oxidoreductase that has specificity for medium-chain fatty acids. It forms a complex with ELECTRON TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein oxidoreductase that has specificity for short-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. EC 1.6.2.4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein that catalyzes the synthesis of protocatechuic acid from 4-hydroxybenzoate in the presence of molecular oxygen. EC 1.14.13.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein that functions as a powerful antioxidant in the MITOCHONDRIA and promotes APOPTOSIS when released from the mitochondria. In mammalian cells AIF is released in response to pro-apoptotic protein members of the bcl-2 protein family. It translocates to the CELL NUCLEUS and binds DNA to stimulate CASPASE-independent CHROMATIN condensation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein that reversibly catalyzes the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine. EC 1.6.99.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. %28%J Biotechnol 1996;50%28%2-3%29%:107-13%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A flour made of pulverized, dried fish or fish parts. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluid occurring in minute amounts in the gingival crevice, believed by some authorities to be an inflammatory exudate and by others to cleanse material from the crevice, containing sticky plasma proteins which improve adhesions of the epithelial attachment, have antimicrobial properties, and exert antibody activity. %28%From Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluid-filled VAGINA that is obstructed. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluid-filled closed cavity or sac that is lined by an EPITHELIUM and found in the BREAST. It may appear as a single large cyst in one breast, multifocal, or bilateral in FIBROCYSTIC BREAST DISEASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluorescent calcium chelating agent which is used to study intracellular calcium in many tissues. The fluorescent and chelating properties of Fura-2 aid in the quantitation of endothelial cell injury, in monitoring ATP-dependent calcium uptake by membrane vesicles, and in the determination of the relationship between cytoplasmic free calcium and oxidase activation in rat neutrophils.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluorescent compound that emits light only in specific configurations in certain lipid media. It is used as a tool in the study of membrane lipids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluorescent probe with low toxicity which is a potent substrate for P-glycoprotein and the bacterial multidrug efflux transporter. It is used to assess mitochondrial bioenergetics in living cells and to measure the efflux activity of P-glycoprotein in both normal and malignant cells. %28%Leukemia 1997;11%28%7%29%:1124-30%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fluorinated cytosine analog that is used as an antifungal agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fold of the mucous membrane of the CONJUNCTIVA in many animals. At rest, it is hidden in the medial canthus. It can extend to cover part or all of the cornea to help clean the CORNEA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A folic acid derivative used as a rodenticide that has been shown to be teratogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A followup operation to examine the outcome of the previous surgery and other treatments, such as chemotherapy or radiation therapy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A forkhead transcription factor that is an essential activator of GLUCAGON gene expression.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A forkhead transcription factor that regulates expression of metabolic GENES and is involved in EMBRYONIC DEVELOPMENT. Mutations in HNF-3beta have been associated with PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of systemic mastocytosis %28%MASTOCYTOSIS, SYSTEMIC%29% characterized by the presence of large numbers of tissue MAST CELLS in the peripheral blood without skin lesions. It is a high-grade LEUKEMIA disease with bone marrow smear of %3E%20%25% MAST CELLS, multi-organ failure and a short survival.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of ACTINOMYCOSIS characterized by slow-growing inflammatory lesions of the lymph nodes that drain the mouth %28%lumpy jaw%29%, reddening of the overlying skin, and intraperitoneal abscesses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of AMELOGENESIS IMPERFECTA characterized by incomplete formation of the dental enamel and transmitted as an X-linked or autosomal dominant trait. It is also associated with vitamin A, C, or D deficiency, infectious disease, prematurity, birth injury, Rh incompatibility, trauma, or local infection. Small grooves, pits, and fissures are seen in mild cases, deep horizontal rows of pits in severe cases, or absence of enamel in extreme cases. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of APRAXIA characterized by an acquired inability to carry out a complex motor activity despite the ability to mentally formulate the action. This condition has been attributed to a disruption of connections between the dominant parietal cortex and supplementary and premotor cortical regions in both hemispheres. %28%From Adams et al., Principles of Neurology, 6th ed, p57%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases %28%ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS%29% causing interstitial fibrosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, contractile dysfunction of the left or both HEART VENTRICLES, and congestive heart failure %28%HEART FAILURE, CONGESTIVE%29% symptoms. Risk factors include ETHANOL and TOBACCO abuse, PREGNANCY; HYPERTENSION; INFECTION; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy %28%HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR%29%, frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; %28%FAMILIAL HYPERTROPHIC CARDIOMYOPATHY%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of GENE LIBRARY containing the complete DNA sequences present in the genome of a given organism. It contrasts with a cDNA library which contains only sequences utilized in protein coding %28%lacking introns%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of GM2 gangliosidosis resulting from a lack of G%28%M2%29% ACTIVATOR PROTEIN function, usually due to genetic mutations. The AB variant designation refers to the elevated levels of HEXOSAMINIDASE A and HEXOSAMINIDASE B proteins that occur in tissues that lack of G%28%M2%29% ACTIVATOR PROTEIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of IODINE deficiency disorders characterized by an enlargement of the THYROID GLAND in a significantly large fraction of a POPULATION GROUP. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the DIET contains insufficient amount of iodine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of LEPROSY in which there are clinical manifestations of both principal types %28%lepromatous and tuberculoid%29%. The disease may shift toward one of these two polar or principal forms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of PERITONITIS seen in patients with TUBERCULOSIS, characterized by lesion either as a miliary form or as a pelvic mass on the peritoneal surfaces. Most patients have ASCITES, abdominal swelling, ABDOMINAL PAIN, and other systemic symptoms such as FEVER; WEIGHT LOSS; and ANEMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. %28%From Holland et al., Cancer Medicine, 3d ed, p2188%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. %22%Alveolar%22% refers to its microscopic appearance simulating the cells of the respiratory alveolus. %28%Holland et al., Cancer Medicine, 3d ed, p2188%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of SILICON DIOXIDE composed of skeletons of prehistoric aquatic plants which is used for its ABSORPTION quality, taking up 1.5-4 times its weight in water. The microscopic sharp edges are useful for insect control but can also be an inhalation hazard. It has been used in baked goods and animal feed. Kieselguhr is German for flint + earthy sediment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of acupuncture with electrical impulses passing through the needles to stimulate NERVE TISSUE. It can be used for ANALGESIA; ANESTHESIA; PHYSICAL REHABILITATION; and treatment for diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of acute kidney disease characterized by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual etiologic agents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer %28%neuroleptic%29% and a narcotic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of arboviral encephalitis %28%primarily affecting equines%29% endemic to eastern regions of North America. The causative organism %28%ENCEPHALOMYELITIS VIRUS, EASTERN EQUINE%29% may be transmitted to humans via the bite of AEDES mosquitoes. Clinical manifestations include the acute onset of fever, HEADACHE, altered mentation, and SEIZURES followed by coma. The condition is fatal in up to 50%25% of cases. Recovery may be marked by residual neurologic deficits and EPILEPSY. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp9-10%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of arboviral encephalitis %28%which primarily affects horses%29% endemic to western and central regions of NORTH AMERICA. The causative organism %28%ENCEPHALOMYELITIS VIRUS, WESTERN EQUINE%29% may be transferred to humans via the bite of mosquitoes %28%CULEX tarsalis and others%29%. Clinical manifestations include headache and influenza-like symptoms followed by alterations in mentation, SEIZURES, and COMA. DEATH occurs in a minority of cases. Survivors may recover fully or be left with residual neurologic dysfunction, including PARKINSONISM, POSTENCEPHALITIC. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp8-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of arboviral encephalitis endemic to Central America and the northern latitudes of South America. The causative organism %28%ENCEPHALITIS VIRUS, VENEZUELAN EQUINE%29% is transmitted to humans and horses via the bite of several mosquito species. Human viral infection may be asymptomatic or remain restricted to a mild influenza-like illness. Encephalitis, usually not severe, occurs in a small percentage of cases and may rarely feature SEIZURES and COMA. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp9-10%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of bacterial meningitis caused by MYCOBACTERIUM TUBERCULOSIS or rarely MYCOBACTERIUM BOVIS. The organism seeds the meninges and forms microtuberculomas which subsequently rupture. The clinical course tends to be subacute, with progressions occurring over a period of several days or longer. Headache and meningeal irritation may be followed by SEIZURES, cranial neuropathies, focal neurologic deficits, somnolence, and eventually COMA. The illness may occur in immunocompetent individuals or as an OPPORTUNISTIC INFECTION in the ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunodeficiency syndromes. %28%From Adams et al., Principles of Neurology, 6th ed, pp717-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of behavior which leads to self-assertion; it may arise from innate drives and/or a response to frustration; may be manifested by destructive and attacking behavior, by covert attitudes of hostility and obstructionism, or by healthy self-expressive drive to mastery. %28%Dorland 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of bronchial disorder associated with airway obstruction, marked by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of compensated hydrocephalus characterized clinically by a slowly progressive gait disorder %28%see GAIT DISORDERS, NEUROLOGIC%29%, progressive intellectual decline, and URINARY INCONTINENCE. Spinal fluid pressure tends to be in the high normal range. This condition may result from processes which interfere with the absorption of CSF including SUBARACHNOID HEMORRHAGE, chronic MENINGITIS, and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, pp631-3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of congenital ichthyosis inherited as an autosomal dominant trait and characterized by erythroderma and severe hyperkeratosis. It is manifested at birth by blisters followed by the appearance of thickened, horny, verruciform scales over the entire body, but accentuated in flexural areas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of creatine kinase found in the BRAIN. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of creatine kinase found in the MITOCHONDRIA. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of cutaneous T-cell lymphoma manifested by generalized exfoliative erythroderma, intense pruritus, peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear cells in the skin, lymph nodes, and peripheral blood %28%Sezary cells%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of cutaneous tuberculosis. It is seen predominantly in women and typically involves the nasal, buccal, and conjunctival mucosa.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of discrimination in the workplace which violates the Civil Rights Act of 1964. Sexual harassment takes two forms: quid pro quo, where the employee must submit to sexual advances in exchange for job benefits or be penalized for refusing; or a hostile environment, where the atmosphere of the workplace is offensive and affects the employee%27%s well-being. Offensive sexual conduct may include unwelcome advances, comments, touching, questions about marital status and sex practices, etc. Both men and women may be aggressors or victims. %28%Slee and Slee, Health Care Terms, 2d ed, p.404%29%. While civil rights legislation deals with sexual harassment in the workplace, the behavior is not restricted to this; it may take place outside the work environment: in schools and colleges, athletics, and other social milieus and activities.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of dwarfism caused by complete or partial GROWTH HORMONE deficiency, resulting from either the lack of GROWTH HORMONE-RELEASING FACTOR from the HYPOTHALAMUS or from the mutations in the growth hormone gene %28%GH1%29% in the PITUITARY GLAND. It is also known as Type I pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of HUMAN GROWTH HORMONE during development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of encephalopathy with fatty infiltration of the LIVER, characterized by brain EDEMA and VOMITING that may rapidly progress to SEIZURES; COMA; and DEATH. It is caused by a generalized loss of mitochondrial function leading to disturbances in fatty acid and CARNITINE metabolism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. %28%From Bennington, Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of fluorescent antibody technique utilizing a fluorochrome conjugated to an antibody, which is added directly to a tissue or cell suspension for the detection of a specific antigen. %28%Bennington, Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of gangliosidosis characterized by accumulation of G%28%M1%29% GANGLIOSIDE and oligosaccharides in lysosomes caused by an absence or severe deficiency of the enzyme BETA-GALACTOSIDASE %28%type A1%29%. The three phenotypes of this disorder are infantile %28%generalized%29%, juvenile, and adult. The infantile form is characterized by skeletal abnormalities, hypotonia, poor psychomotor development, hirsutism, hepatosplenomegaly, and facial abnormalities. The juvenile form features hyperacusis, seizures, and psychomotor retardation. The adult form features progressive intellectual deterioration, involuntary movements, ataxia, and spasticity. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp96-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of gram-negative meningitis that tends to occur in neonates, in association with anatomical abnormalities %28%which feature communication between the meninges and cutaneous structures%29% or as OPPORTUNISTIC INFECTIONS in association with IMMUNOLOGIC DEFICIENCY SYNDROMES. In premature neonates the clinical presentation may be limited to ANOREXIA; VOMITING; lethargy; or respiratory distress. Full-term infants may have as additional features FEVER; SEIZURES; and bulging of the anterior fontanelle. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp398-400%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of group psychotherapy. It involves treatment of more than one member of the family simultaneously in the same session.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of heart block in which one ventricle is excited before the other because of absence of conduction in one of the branches of the bundle of His.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. %28%Dictionary of Visual Science, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of interactive entertainment in which the player controls electronically generated images that appear on a video display screen. This includes video games played in the home on special machines or home computers, and those played in arcades. %28%McGraw Hill Encyclopedia of Science %26% Technology, 7th ed, v19, p223%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of intestinal obstruction caused by the PROLAPSE of a part of the intestine into the adjoining intestinal lumen. There are four types: colic, involving segments of the LARGE INTESTINE; enteric, involving only the SMALL INTESTINE; ileocecal, in which the ILEOCECAL VALVE prolapses into the CECUM, drawing the ILEUM along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the COLON.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of leukemia that occurs without elevated levels of leukocytes within the blood. Lesions containing abnormal leukocytes can be found within tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of lung disease %28%pneumoconiosis%29% caused by inhaling fibers of asbestos and marked by interstitial fibrosis of the lung varying in extent from minor involvement of the basal areas to extensive scarring. It is associated with pleural mesothelioma and bronchogenic carcinoma. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute %28%= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions%29%, subacute, and chronic %28%= LUPUS ERYTHEMATOSUS, DISCOID%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of lymphoma in which relatively large stem cells with large nuclei, pale, scanty cytoplasm, and indistinct borders are predominant. The cells are undifferentiated, i.e., show no morphologic evidence of maturation toward lymphocytes or histiocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility %28%INFERTILITY, MALE%29%. Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns %28% 46,XY/47,XXY; 47,XXY/48,XXXY, etc.%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp1-3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma %28%CARCINOMA, MEDULLARY%29% of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 %28%Locus: 10q11.2%29%, also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene %28%GENES, TUMOR SUPPRESSOR%29% on CHROMOSOME 11 %28%Locus: 11q13%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. %28%From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance %28%a %22%free interval%22%%29% followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. %28%From Adams et al., Principles of Neurology, 6th ed, p54%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of necrotizing vasculitis involving small- and medium-sized arteries. The signs and symptoms result from infarction and scarring of the affected organ system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of nontransient HYPOGLYCEMIA, unique to infancy, due to autosomal recessive mutations of the sulfonylurea receptor gene on CHROMOSOME 11. Defects in the sulfonylurea receptors %28%ATP-BINDING CASSETTE TRANSPORTERS%29% on the PANCREATIC BETA CELLS prevent negative feedback of GLUCOSE-regulated INSULIN release thus resulting in HYPERINSULINEMIA. Clinical phenotype includes SEIZURES; COMA; and often large BIRTH WEIGHT for GESTATIONAL AGE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of ocular misalignment characterized by an excessive convergence of the visual axes, resulting in a %22%cross-eye%22% appearance. An example of this condition occurs when paralysis of the lateral rectus muscle causes an abnormal inward deviation of one eye on attempted gaze.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of ocular misalignment where the visual axes diverge inappropriately. For example, medial rectus muscle weakness may produce this condition as the affected eye will deviate laterally upon attempted forward gaze. An exotropia occurs due to the relatively unopposed force exerted on the eye by the lateral rectus muscle, which pulls the eye in an outward direction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of osteogenic sarcoma of relatively low malignancy, probably arising from the periosteum and initially involving cortical bone and adjacent connective tissue. It occurs in middle-aged as well as young adults and most commonly affects the lower part of the femoral shaft. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of osteosclerosis or hyperostosis extending in a linear track through one of the long bones of an extremity, and consisting of proliferated ivory-like new bone. %22%Melo-%22% is from the Greek, limb and %22%-rheostosis%22% refers to streaks %28%rheo- from the Greek, flow%29%, in the bones. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of panniculitis characterized by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of paralytic poliomyelitis affecting neurons of the MEDULLA OBLONGATA of the brain stem. Clinical features include impaired respiration, HYPERTENSION, alterations of vasomotor control, and dysphagia. Weakness and atrophy of the limbs and trunk due to spinal cord involvement is usually associated. %28%From Adams et al., Principles of Neurology, 6th ed, p765%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of pigmented nevus showing intense melanocytic activity around the dermo-epidermal junction. Large numbers of spindle-shaped melanocytes proliferate downward toward the dermis and usually a large amount of pigment is present. It was first described in 1976 and the bulk of patients reported have been young females with the lesions presenting on the thighs. %28%From Rook et al., Textbook of Dermatology, 4th ed, 1992, p185%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of pre-excitation characterized by a normal PR interval and a long QRS interval with a delta wave.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of pre-excitation characterized by a short PR interval associated with a normal QRS complex.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of psychotherapy involving the husband and wife and directed to improving the marital relationship.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of rhinitis brought about by changes in vascular tone and permeability. The etiology is obscure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of spinal dysraphism associated with a protruding cyst made up of either meninges %28%i.e., a MENINGOCELE%29% or meninges in combination with spinal cord tissue %28%i.e., a MENINGOMYELOCELE%29%. These lesions are frequently associated with spinal cord dysfunction, HYDROCEPHALUS, and SYRINGOMYELIA. %28%From Davis et al., Textbook of Neuropathology, 2nd ed, pp224-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of stimulus sensitive myoclonic epilepsy inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid %28%Lafora%29% bodies are found in neurons, liver, skin, bone, and muscle %28%From Menkes, Textbook of Childhood Neurology, 5th ed, pp111-110%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of supportive psychotherapy in which the patient is given carefully selected material to read.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of therapy consisting in the local or general use of cold. The selective destruction of tissue by extreme cold or freezing is CRYOSURGERY. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of therapy in which two or more patients participate under the guidance of one or more psychotherapists for the purpose of treating emotional disturbances, social maladjustments, and psychotic states.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus %28%HERPESVIRUS 4, HUMAN%29% has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form of violent crowd behavior which expresses the emotional release of resentments and prejudices, usually relevant to grievances toward the social system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form species of spore-producing CYANOBACTERIA, in the family Nostocaceae, order Nostocales. It is an important source of fixed NITROGEN in nutrient-depleted soils. When wet, it appears as a jelly-like mass.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of CYANOBACTERIA in the order Chroococcales. Many species are planktonic and possess gas vacuoles.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of CYANOBACTERIA in the order Nostocales, characterized by thin trichomes, cylindrical akinetes, and terminal heterocysts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of CYANOBACTERIA in the order Nostocales. Trichomes composed of spherical or ovoid vegetative cells along with heterocysts and akinetes. The species form symbiotic associations with a wide range of eukaryotes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of CYANOBACTERIA in the order Oscillatoriales. They are non-heterocystous but may carry out NITROGEN FIXATION under microaerobic conditions. Some smaller members have undergone transfer to the form-genus Leptolyngbya.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of filamentous CYANOBACTERIA in the order Nostocales. Its members can be planktonic or benthic and the trichomes are composed of disc-shaped vegetative cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of planktonic CYANOBACTERIA in the order Nostocales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of spherical to rod-shaped CYANOBACTERIA in the order Chroococcales. They contain THYLAKOIDS and are found in a wide range of habitats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of unicellular CYANOBACTERIA in the order Chroococcales. None of the strains fix NITROGEN, there are no gas vacuoles, and sheath layers are never produced.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-genus of unicellular coccoid to rod-shaped CYANOBACTERIA, in the order Chroococcales. Three different clusters of strains from diverse habitats are included.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A form-species of nitrogen-fixing CYANOBACTERIA, in the family Nostocaceae, order Nostocales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A formal financial agreement made between one or more physicians and a hospital to provide ambulatory alternative services to those patients who do not require hospitalization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A formal process of examination of patient care or research proposals for conformity with ethical standards. The review is usually conducted by an organized clinical or research ethics committee %28%CLINICAL ETHICS COMMITTEES or RESEARCH ETHICS COMMITTEES%29%, sometimes by a subset of such a committee, an ad hoc group, or an individual ethicist %28%ETHICISTS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A former branch of knowledge embracing the study, description, and classification of natural objects %28%as animals, plants, and minerals%29% and thus including the modern sciences of zoology, botany, and mineralogy insofar as they existed at that time. In the 17th, 18th, and 19th centuries it was much used for the generalized pursuit of certain areas of science. %28%Webster, 3d ed; from Dr. James H. Cassedy, NLM History of Medicine Division%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A formulation for presenting an antigen to induce specific immunologic responses. It consists of an assembly of antigens in multimeric form. The assembly is attached to a matrix with a built-in adjuvant, saponin. ISCOMs induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A foul-smelling accumulation of SEBUM and desquaminated epidermal cells, especially the cheesy substance found under the foreskin of the penis and at the base of the labia minor near the clitoris.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A foul-smelling diamine formed by bacterial decarboxylation of lysine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A four-carbon sugar that is found in algae, fungi, and lichens. It is twice as sweet as sucrose and can be used as a coronary vasodilator.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A four-year program in nursing education in a college or university leading to a B.S.N. %28%Bachelor of Science in Nursing%29%. Graduates are eligible for state examination for licensure as RN %28%Registered Nurse%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p166%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fracture in which the bone is splintered or crushed. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fracture in which union fails to occur, the ends of the bone becoming rounded and eburnated, and a false joint occurs. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A free-floating DNA virus genus, unattached to any family, comprising several species of hepatitis-related viruses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A free-living soil amoeba pathogenic to humans and animals. It occurs also in water and sewage. The most commonly found species in man is NAEGLERIA FOWLERI which is the pathogen for primary amebic meningoencephalitis in primates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A freshwater fish used as an experimental organism and for food. This genus of the family Cichlidae %28%CICHLIDS%29% inhabits Central and South America %28%one species extends north into Texas%29%, West Indies, Africa, Madagascar, Syria, and coastal India.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A front limb of a quadruped. %28%The Random House College Dictionary, 1980%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A frozen dairy food made from cream or butterfat, milk, sugar, and flavorings. Frozen custard and French-type ice creams also contain eggs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fulminant and often fatal demyelinating disease of the brain which primarily affects young adults and children. Clinical features include the rapid onset of weakness, SEIZURES, and COMA. It may follow a viral illness or MYCOPLASMA PNEUMONIAE infections but in most instances there is no precipitating event. Pathologic examination reveals marked perivascular demyelination and necrosis of white matter with microhemorrhages. %28%Adams et al., Principles of Neurology, 6th ed, pp924-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. %28%From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10%28%1%29%:13-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fulminating group A streptococcal infection beginning with severe or extensive cellulitis that spreads to involve the superficial and deep fascia, producing thrombosis of the subcutaneous vessels and gangrene of the underlying tissues. A cutaneous lesion usually serves as a portal of entry for the infection, but sometimes no such lesion is found. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A functional system which includes the organisms of a natural community together with their environment. %28%McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal genus in the family Trichocomaceae, order EUROTIALES, characterized by loose hyphal fruiting bodies containing spherical asci. Anamorphs include PENICILLIUM and PAECILOMYCES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal genus which grows in the epidermis and is the cause of TINEA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal infection of the nail plate, usually caused by a species of Epidermophyton, Microsporum, or Trichophyton, and producing opaque, white, thickened, friable, and brittle nails. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal infection that may appear in two forms: 1, a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2, chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%, which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal metabolite that blocks cytoplasmic cleavage by blocking formation of contractile microfilament structures resulting in multinucleated cell formation, reversible inhibition of cell movement, and the induction of cellular extrusion. Additional reported effects include the inhibition of actin polymerization, DNA synthesis, sperm motility, glucose transport, thyroid secretion, and growth hormone release.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal metabolite which is a macrocyclic lactone exhibiting a wide range of antibiotic activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fungistatic compound that is widely used as a food preservative. It is conjugated to GLYCINE in the liver and excreted as hippuric acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX %28%laryngopharynx%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A furanyl adenine found in PLANTS and FUNGI. It has plant growth regulation effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A galanin receptor subtype with broad specificity for full length GALANIN, galanin peptide fragments and GALANIN-LIKE PEPTIDE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A galanin receptor subtype with high affinity for GALANIN-LIKE PEPTIDE and low affinity for full length GALANIN and galanin peptide fragments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A galectin found abundantly in smooth muscle %28%MUSCLE, SMOOTH%29% and SKELETAL MUSCLE and many other tissues. It occurs as a homodimer with two 14-kDa subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A galectin found in the small and large intestine and the stomach. It occurs as a homodimer with two 36-kDa subunits and is localized to sites of cell adhesion where it may play role in assembly of ADHERENS JUNCTIONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A galectin found preferentially expressed in the gastrointestinal tract. The protein occurs as a homodimer with two 14-kDa subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A game in which a round inflated ball is advanced by kicking or propelling with any part of the body except the hands or arms. The object of the game is to place the ball in opposite goals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A game in which two parties of players provided with curved or hooked sticks seek to drive a ball or puck through opposite goals. This applies to either ice hockey or field hockey.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A game played by two or four players with rackets and an elastic ball on a level court divided by a low net.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A game whose object is to sink a ball into each of 9 or 18 successive holes on a golf course using as few strokes as possible.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gamma Globin' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gamma-emitting radionuclide imaging agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and myocardial imaging. It has also been used to label leukocytes in the investigation of inflammatory bowel diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ganglioside present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G%28%M3%29%:UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G%28%M2%29% ganglioside from G%28%M3%29% ganglioside and is the cause of an anabolic sphingolipidosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gas that condenses under slight pressure. Because of its low boiling point ethyl chloride sprayed on skin produces an intense cold by evaporation. Cold blocks nerve conduction. Ethyl chloride has been used in surgery but is primarily used to relieve local pain in sports medicine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gas that has been used as an aerosol propellant and is the starting material for polyvinyl resins. Toxicity studies have shown various adverse effects, particularly the occurrence of liver neoplasms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gastrointestinal peptide hormone of about 43-amino acids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gelatinous membrane overlying the acoustic maculae of SACCULE AND UTRICLE. It contains minute crystalline particles %28%otoliths%29% of CALCIUM CARBONATE and protein on its outer surface. In response to head movement, the otoliths shift causing distortion of the vestibular hair cells which transduce nerve signals to the BRAIN for interpretation of equilibrium.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gene interaction whereby the expression of one gene interfers with or masks the expression of a different gene or genes. Genes whose expression interfers with or masks the effects of other genes are said to be epistatic to the effected genes. Genes whose expression is effected %28%blocked or masked%29% are hypostatic to the interfering genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gene product of the p16 tumor suppressor gene %28%GENES, P16%29%. It antagonizes the function of MDM2 PROTEIN %28%which regulates P53 TUMOR SUPPRESSOR PROTEIN by targeting it for degradation%29%. p14ARF is produced from the beta mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced alpha transcript, is CYCLIN-DEPENDENT KINASE INHIBITOR P16. Both p16 gene products have tumor suppressor functions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gene silencing phenomenon whereby specific dsRNAs %28%RNA, DOUBLE-STRANDED%29% trigger the degradation of homologous mRNA %28%RNA, MESSENGER%29%. The specific dsRNAs are processed into SMALL INTERFERING RNA %28%siRNA%29% which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX %28%RISC%29%. DNA METHYLATION may also be triggered during this process.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general class of integral membrane proteins that transport ions across a membrane against an electrochemical gradient.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general class of ortho-dihydroxyphenylalkylamines derived from tyrosine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general concept referring to the organization and administration of nursing activities.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general name for small, wingless, parasitic insects, previously of the order Phthiraptera. Though exact taxonomy is still controversial, they can be grouped in the orders ANOPLURA %28%sucking lice%29%, MALLOPHAGA %28%biting lice%29%, and Rhynchophthirina %28%elephant-lice%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term collectively applied to tumors associated with the APUD CELLS series, irrespective of their specific identification.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term covering bibliographical and bibliothecal classifications. It mostly refers to library CLASSIFICATION for arrangement of books and documents on the shelves. %28%Harrod%27%s Librarians%27% Glossary, 7th ed, p85%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term describing various dermatophytoses. Specific types include TINEA CAPITIS %28%ringworm of the scalp%29%, TINEA FAVOSA %28%of scalp and skin%29%, TINEA PEDIS %28%athlete%27%s foot%29%, and tinea unguium %28%see ONYCHOMYCOSIS, ringworm of the nails%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term encompassing three types of excision of the external female genitalia - Sunna, clitoridectomy, and infibulation. It is associated with severe health risks and has been declared illegal in many places, but continues to be widely practiced in a number of countries, particularly in Africa.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for MYCOBACTERIUM infections of any part of the UROGENITAL SYSTEM in either the male or the female.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for a malignant neoplasm derived from muscular tissue. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for a number of unrelated organic substances that occur in many foods in small amounts and that are necessary in trace amounts for the normal metabolic functioning of the body. They may be water-soluble or fat-soluble. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for diseases produced by viruses. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for single-celled rounded fungi that reproduce by budding. Brewers%27% and bakers%27% yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for the complete loss of the ability to hear from both ears.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for the complete or partial loss of the ability to hear from one or both ears.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term for various neoplastic diseases of the lymphoid tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term indicating inflammation of the BRAIN and SPINAL CORD, often used to indicate an infectious process, but also applicable to a variety of autoimmune and toxic-metabolic conditions. There is significant overlap regarding the usage of this term and ENCEPHALITIS in the literature.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. %28%From Adams et al., Principles of Neurology, 6th ed, p45%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term referring to a mild to moderate degree of muscular weakness, occasionally used as a synonym for PARALYSIS %28%severe or complete loss of motor function%29%. In the older literature, paresis often referred specifically to paretic neurosyphilis %28%see NEUROSYPHILIS%29%. %22%General paresis%22% and %22%general paralysis%22% may still carry that connotation. Bilateral lower extremity paresis is referred to as PARAPARESIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general term referring to the learning of some particular response.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general transcription factor that is involved in basal GENETIC TRANSCRIPTION and NUCLEOTIDE EXCISION REPAIR. It consists of nine subunits including ATP-dependent DNA HELICASE; CYCLIN H; and XERODERMA PIGMENTOSUM GROUP D PROTEIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A general transcription factor that plays a major role in the activation of eukaryotic genes transcribed by RNA POLYMERASES. It binds specifically to the TATA BOX promoter element, which lies close to the position of transcription initiation in RNA transcribed by RNA POLYMERASE II. Although considered a principal component of TRANSCRIPTION FACTOR TFIID it also takes part in general transcription factor complexes involved in RNA POLYMERASE I and RNA POLYMERASE III transcription.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness %28%post-ictal state%29% which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic %28%caused by an identified disease process%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p329%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic expression for any tachycardia that originates above the BUNDLE OF HIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic grouping for dihydric alcohols with the hydroxy groups %28%-OH%29% located on different carbon atoms. They are viscous liquids with high boiling points for their molecular weights.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic name for film produced from wood pulp by the viscose process. It is a thin, transparent sheeting of regenerated cellulose, moisture-proof and sometimes dyed, and used chiefly as food wrapping or as bags for dialysis. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic term for a variety of compounds that contain silicon, oxygen, and magnesium, and may contain hydrogen. Examples include TALC and some kinds of ASBESTOS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic term for all substances having the properties of natural, reclaimed, vulcanized, or synthetic rubber, in that they stretch under tension, have a high tensile strength, retract rapidly, and recover their original dimensions fully.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic term for any circumscribed mass of foreign %28%e.g., lead or viruses%29% or metabolically inactive materials %28%e.g., ceroid or Mallory bodies%29%, within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids %28%lipochromes%29%, and fatty acids. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. %28%From Goodman and Gilman%27%s The Pharmacologic Basis of Therapeutics, 8th ed, p588%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic disorder with autosomal recessive inheritance, characterized by multiple CYSTS in both KIDNEYS and associated LIVER lesions. Serious manifestations are usually present at BIRTH with high PERINATAL MORTALITY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin %28%NEUROPHYSINS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or aquaporin-2 %28%AQUAPORINS%29%; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetic skin disease characterized by hypoplasia of the dermis, herniations of fat, and hand anomalies. It is found exclusively in females and transmitted as an X-linked dominant trait.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked %28%GENETIC DISEASES, X-LINKED%29%, an autosomal dominant, or an autosomal recessive trait.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically related form of PSEUDOHYPOPARATHYROIDISM characterized by the same features except for the abnormal response to parathyroid hormone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in calcium-dependent EXOCYTOSIS. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in recycling of proteins such as cell surface receptors from early endosomes to the cell surface. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in transport from the cell membrane to early endosomes. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically related subfamily of RAB GTP-BINDING PROTEINS involved in vesicle transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS and through early Golgi compartments. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genetically related subfamily of RAP GTP-BINDING PROTEINS that share homology with RAS PROTEINS. They bind to Ras effectors but do not activate them, therefore they may antagonize the effects of RAS PROTEINS. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genodermatosis occurring mostly in females and characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eyes, teeth, central nervous system, and skin appendages.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a %22%comet with tail%22% formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus %28%and common name%29% in the AGAVACEAE family. It is known for SAPONINS in the root that are used in SOAPS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus %28%formerly part of Rhus genus%29% of shrubs, vines, or trees that yields a highly allergenic oleoresin which causes a severe contact dermatitis %28%DERMATITIS, TOXICODENDRON%29%. The most toxic species are Toxicodendron vernix %28%poison sumac%29%, T. diversilobum %28%poison oak%29%, and T. radicans %28%poison ivy%29%. T. vernicifera yields a useful varnish from which certain enzymes %28%laccases%29% are obtained.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus comprised of nine species of small PARROTS from Africa. They are noted for showing affection for their mates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus comprised of spinner, spotted, and striped DOLPHINS, in the family Delphinidae. Schools of Stenella, that may number in the thousands, often associate with schools of TUNA, and are thus vulnerable to accidental harvesting.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family ACETOBACTERACEAE comprised of acetate-oxidizing bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family ACETOBACTERACEAE consisting of chemoorganotrophic, straight rods with rounded ends. They are aerobic and acidophilic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family BROMOVIRIDAE containing one species: Olive latent virus 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family Blattidae containing several species, the most common being P. americana, the American cockroach.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family CALICIVIRIDAE, associated with epidemic GASTROENTERITIS in humans. The type species, NORWALK VIRUS, contains multiple strains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family CALLITRICHIDAE consisting of 12 species and found in Panama as well as South America. Species seen most frequently in the literature are S. oedipus %28%cotton-top marmoset%29%, S. nigricollis, and S. fusicollis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family CALLITRICHIDAE, comprising a single species with the common name Goeldi%27%s monkey.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family CIRCOVIRIDAE comprising the single species CHICKEN ANEMIA VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family ENTOMOPLASMATACEAE, order Entomoplasmatales. It is pathogenic to GOATS, causing caprine pleuropneumonia %28%PLEUROPNEUMONIA, CONTAGIOUS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family FELIDAE comprising felines with long legs, ear tufts, and a short tail.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family FELIDAE comprising one species, Puma concolor. It is a large, long-tailed, feline of uniform color. The names puma, cougar, and mountain lion are used interchangeably for this species. There are more than 20 subspecies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family FILOVIRIDAE consisting of one species %28%Marburg virus%29% with several strains. The genus shows no antigenic cross-reactivity with EBOLA-LIKE VIRUSES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family FILOVIRIDAE consisting of several distinct species of Ebola virus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease %28%HEMORRHAGIC FEVER, EBOLA%29% in humans, usually with high mortality.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, associated with malignancy in birds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family Monascaceae, order EUROTIALES. One species, Monascus purpureus, has multiple uses in traditional Chinese medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family ORTHOMYXOVIRIDAE causing influenza and other diseases in humans and animals. It contains many strains as well as antigenic subtypes of the integral membrane proteins hemagglutinin %28%HEMAGGLUTININS%29% and NEURAMINIDASE. The type species is INFLUENZA A VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family ORTHOMYXOVIRIDAE containing one species: Infectious salmon anemia virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family PICORNAVIRIDAE containing one species: Human parechovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family PSITTACIDAE containing three species of PARAKEETS: the Derbyan, the Alexandrine, and the rose-ringed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma %28%LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED%29%, and bovine leukemia %28%ENZOOTIC BOVINE LEUKOSIS%29%. The type species is LEUKEMIA VIRUS, BOVINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family RETROVIRIDAE infecting fish. Species include Walleye dermal sarcoma virus, Walleye epidermal hyperplasia virus 1, and Walleye epidermal hyperplasia virus 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family RHABDOVIRIDAE, infecting numerous species of fish with broad geographic distribution. The type species is INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family ROSACEAE of shrubs and small trees native to the North Temperate Zone. It is best known for a traditional medication for the heart.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family TOMBUSVIRIDAE mostly found in temperate regions. Some species infecting legumes %28%FABACEAE%29% are reported from tropical areas. Most viruses are soil-borne, but some are transmitted by the fungus Olpidium radicale and others by beetles. Carnation mottle virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family Trichocomaceae, order EUROTIALES. The anamorph is ASPERGILLUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the family of EARLESS SEALS %28%Phocidae%29% and collectively the most abundant PINNIPEDS in the Northern Hemisphere.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the mint family %28%LAMIACEAE%29%. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the order Dermocystidium, class MESOMYCETOZOEA. It causes RHINOSPORIDIOSIS in MAMMALS and BIRDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE, causing disease in domestic fowl. There are many species, the most well-known being avian paramyxovirus 1 %28%NEWCASTLE DISEASE VIRUS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus in the subfamily PARAMYXOVIRINAE, family PARAMYXOVIRIDAE. It contains species that infect and cause potentially fatal disease in a number of host species, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus known for fibers obtained from their leaves: sisal from A. sisalana, henequen from A. fourcroyoides and A. cantala, or Manila-Maguey fiber from A. cantala. Some species provide a sap that is fermented to an intoxicating drink, called pulque in Mexico. Some contain agavesides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes found in the digestive tract of herbivorous animals. They cause incidental infections in humans from the following species: Trichostrongylus colubriformis, T. orientalis, T. axei, and T. probolurus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ADENOVIRIDAE comprising species including viruses of frogs %28%FROGS AND TOADS%29% and TURKEYS. The type species is Frog adenovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ADENOVIRIDAE that comprises viruses of several species of MAMMALS and BIRDS. The type species is Ovine adenovirus D.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ADENOVIRIDAE that infects MAMMALS including humans and causes a wide range of diseases. The type species is Human adenovirus C %28%see ADENOVIRUSES, HUMAN%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ADENOVIRIDAE that infects birds. The type species is FOWL ADENOVIRUS A.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family CHARACEAE. They are found in shallow to deep waters of soft water or acid lakes and bogs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family CHARACEAE. They have a strong garlic-like odor and are an important food source for waterfowl.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family Lagenidiaceae. One species %28%L. giganteum%29% parasitizes the larval stage of MOSQUITOES and is used in its biological control %28%PEST CONTROL, BIOLOGICAL%29%; it also causes disease in freshwater FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family Peronosporaceae. Most species are obligatory parasites and many are plant pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family Saprolegniaceae. It causes root rot in plants and is also a pathogen of FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family Saprolegniaceae. It is a parasite and pathogen of freshwater FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ALGAE in the family Saprolegniaceae. They are pathogens of FISHES and INSECTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of Australian trees of the Myrtaceae family that yields gums, oils, and resins which are used as flavoring agents, astringents, and aromatics, and formerly to treat diarrhea, asthma, bronchitis, and respiratory tract infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of BIRDS in the family Phasianidae, order GALLIFORMES, containing the common European and other Old World QUAIL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of BROWN ALGAE in the family Fucaceae. It is found in temperate, marine intertidal areas along rocky coasts and is a source of ALGINATES. Some species of Fucus are referred to as KELP.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of BROWN ALGAE in the family Laminariaceae. Dried pencil-like pieces may be inserted in the cervix where they swell as they absorb moisture, serving as osmotic dilators.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of BROWN ALGAE in the family Lessoniaceae, and one of the major forms of KELP. The species Macrocystis pyrifera, also known as giant kelp, is the largest of the marine algae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of BROWN ALGAE, in the family Alariaceae, native to Japan, Korea, and China. The edible SEAWEED Undaria pinnatifida is also called wakame.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of CALLITRICHIDAE occurring in forests of Brazil and Bolivia and containing seventeen species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of CHLAMYDOPHILA infecting primarily birds. It contains eight known serovars, some of which infect more than one type of host, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of CRUSTACEA of the order ANOSTRACA, found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of CYANOBACTERIA consisting of trichomes that are untapered with conspicuous constrictions at cross-walls. A firm individual sheath is absent, but a soft covering is often present. Many species are known worldwide as major components of freshwater PLANKTON and also of many saline lakes. The species ANABAENA FLOS-AQUAE is responsible for acute poisonings of various animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of DNA plant viruses with bacilliform morphology. Transmission in clonally-propagated plants is by vegetative propagation of infected plant materials. Transmission in nature is by mealybugs, seeds, pollen, and leafhoppers %28%rice tungro bacilliform%29%. The type species is Commelina yellow mottle virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of Eurasian herbaceous plants, the poppies %28%family PAPAVERACEAE of the dicotyledon class Magnoliopsida%29%, that yield OPIUM from the latex of the unripe seed pods.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of European newts in the Salamandridae family. The two species of this genus are Salamandra salamandra %28%European %22%fire%22% salamander%29% and Salamandra atra %28%European alpine salamander%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the only member and type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FLAVIVIRIDAE containing several subgroups and many species. Most are arboviruses transmitted by mosquitoes or ticks. The type species is YELLOW FEVER VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FLAVIVIRIDAE, also known as mucosal disease virus group, which is not arthropod-borne. Transmission is by direct and indirect contact, and by transplacental and congenital transmission. Species include BORDER DISEASE VIRUS, bovine viral diarrhea virus %28%DIARRHEA VIRUS, BOVINE VIRAL%29%, and CLASSICAL SWINE FEVER VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FUNGI in the family Glugeidae, parasitic on FISHES. The PARASITES cause the formation of large cysts causing hypertrophy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FUNGI originally considered a member of the class SPOROZOEA but now recognized as part of the class MICROSPOREA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FUNGI, in the family Amblyosporidae, which is a parasite of MOSQUITOES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FUNGI, in the family Glugeidae, a parasite of ATLANTIC SALMON and other FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FUNGI, in the family Magnaporthaceae of uncertain position %28%incertae sedis%29%. It is best known for its species, M. grisea, which is one of the most popular experimental organisms of all fungal plant pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of FUNGI, in the family Thelohaniidae, a parasite of red imported fire ants, MOSQUITOES, and other organisms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of GOLDEN-BROWN ALGAE in the family Ochromonadaceae, found mostly in freshwater. They bear two unequal FLAGELLA and are heterotrophic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of GRAM-NEGATIVE AEROBIC BACTERIA of marine origin. Many species were formerly classified under ALTEROMONAS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of GREEN ALGAE in the family Scenedesmaceae. It forms colonies of usually four or eight cylindrical cells that are widely distributed in freshwater and SOIL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of GREEN ALGAE in the family Ulvaceae. Commonly know as sea lettuces, they grow attached to rocks and KELP in marine and estuarine waters.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of GREEN ALGAE in the family Volvocaceae. They form spherical colonies of hundreds or thousands of bi-flagellated cells in a semi-transparent gelatinous ball.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of HALOBACTERIACEAE distinguished from other genera in the family by the presence of specific derivatives of TGD-2 polar lipids. Haloarcula are found in neutral saline environments such as salt lakes, marine salterns, and saline soils.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of HALOBACTERIACEAE whose growth requires a high concentration of salt. Binary fission is by constriction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of HEPADNAVIRIDAE infecting birds but rarely causing clinical problems. Transmission is predominantly vertical. HEPATITIS B VIRUS, DUCK is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of IRIDOVIRIDAE comprising small iridescent insect viruses. The infected larvae and purified virus pellets exhibit a blue to purple iridescence.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of IRIDOVIRIDAE which infects amphibians. It is non-pathogenic for its natural host, Rana pipiens, but is lethal for tadpoles and Fowler toads. Frog virus 3 is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of Old World monkeys found in Africa although some species have been introduced into the West Indies. This genus is composed of at least twenty species: C. AETHIOPS, C. ascanius, C. campbelli, C. cephus, C. denti, C. diana, C. dryas, C. erythrogaster, C. erythrotis, C. hamlyni, C. lhoesti, C. mitis, C. mona, C. neglectus, C. nictitans, C. petaurista, C. pogonias, C. preussi, C. salongo, and C. wolfi.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of Old World monkeys of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, that inhabits the mountainous regions of Ethiopia. The genus consists of only one species, Theropithecus gelada.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of Old World monkeys, subfamily COLOBINAE, family CERCOPITHECIDAE, that inhabits the forests of Africa. It consists of eight species: C. angolensis %28%Angolan colobus%29%, C. badius or C. rufomitratus %28%Red or Bay colobus%29%, C. guereza %28%Guereza or Eastern black-and-white colobus%29%, C. kirkii %28%Kirk%27%s colobus%29%, C. polykomos %28%King colobus or Western black-and-white colobus%29%, C. satanas %28%Black colobus%29%, and C. verus %28%Olive colobus%29%. Some authors recognize Procolobus as a separate genus and then the olive colobus is recognized as the species P. verus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PARVOVIRIDAE, subfamily DENSOVIRINAE, comprising helper-independent viruses containing only two species. Junonia coenia densovirus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. HEPATITIS A VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PICORNAVIRIDAE inhabiting primarily the respiratory tract of mammalian hosts. It includes over 100 human serotypes associated with the COMMON COLD.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PLANT VIRUSES, in the family Caulimoviridae, that are transmitted by APHIDS in a semipersistent manner. Aphid-borne transmission of some caulimoviruses requires certain virus-coded proteins termed transmission factors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PORPOISES, in the family Phocoenidae, comprised of several species. They frequent coastal waters, bays, estuaries, and the mouths of large rivers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of POXVIRIDAE, subfamily CHORDOPOXVIRINAE, infecting humans. Transmission is by direct contact among children, by sexual contact among young adults, or by fomites. MOLLUSCUM CONTAGIOSUM VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PROCHLOROPHYTES containing unicellular, spherical bacteria without a mucilaginous sheath. They are found almost exclusively as extracellular symbionts of colonial ASCIDIANS on subtropical or tropical marine shores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PROCHLOROPHYTES occurring in unbranched chains of indefinite length and containing both chlorophylls a and b.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PSEUDOMONADACEAE whose cells produce a yellow pigment %28%Gr. xanthos - yellow%29%. It is pathogenic to plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of PSYCHODIDAE which functions as the vector of a number of pathogenic organisms, including LEISHMANIA DONOVANI; LEISHMANIA TROPICA; Bartonella bacilliformis, and the Pappataci fever virus %28%SANDFLY FEVER NAPLES VIRUS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of QUAIL, in the family Odontophoridae, comprised of at least four different species of bobwhites.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RED ALGAE in the family Bangiaceae. It is the most widely consumed SEAWEED in the world and especially in Asia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RED ALGAE in the family Gracilariaceae. It is a highly commercial SEAWEED and a source of AGAR.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RED ALGAE in the family Porphyridiaceae. A single stellate CHLOROPLAST is present in each cell which has no CELL WALL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RED ALGAE in the family Rhodomelaceae. Some species are a rich source of chlorine-and bromine-containing metabolites which show significant antibacterial activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RED ALGAE, in the family Gigartinaceae. The species Chondrus crispus is a source of CARRAGEENAN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RED ALGAE, in the family Plocamiaceae, found in temperate marine environments worldwide. Polyhalogenated monoterpenes of potential medicinal use have been isolated from its species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of REOVIRIDAE infecting Ixodidae ticks and transmitted by them to humans, deer, and small animals. The type species is COLORADO TICK FEVER VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of REOVIRIDAE infecting a wide range of arthropods and vertebrates including humans. It comprises at least twelve serological subgroups. Transmission is by vectors such as midges, mosquitoes, sandflies, and ticks.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of REOVIRIDAE, causing acute gastroenteritis in BIRDS and MAMMALS, including humans. Transmission is horizontal and by environmental contamination. Seven species %28%Rotaviruses A thru G%29% are recognized.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RETROVIRIDAE comprising endogenous sequences in mammals, related RETICULOENDOTHELIOSIS VIRUSES, AVIAN, and a reptilian virus. Many species contain oncogenes and cause leukemias and sarcomas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RHODOCYCLACEAE occurring as rod-shaped cells embedded in a gelatinous matrix. It includes Z. filipendula.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA fungi viruses in the family TOTIVIRIDAE. Some of the viruses contain additional satellite RNA or defective RNA. Transmission occurs during cell division, sporogenesis and cell fusion. The type species is Saccharomyces cerevisiae virus L-A.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA plant viruses as yet unassigned to any family. Plant hosts are all in the family Poaceae. Each species is transmitted by a particular species of planthopper. The type species is Rice stripe virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA plant viruses, with unassigned family, containing slightly flexuous filaments, often transmitted by aphids in a non-persistent manner. Carnation latent virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA protozoan viruses of the family TOTIVIRIDAE. It infects many isolates of the flagellated protozoan human parasite G. lamblia, but does not seem to be associated with the virulence of the parasite. The type species is Giardia lamblia virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA protozoan viruses of the family TOTIVIRIDAE. Several different strains of Leishmania are infected by a variety of viral species. The type species is Leishmania RNA virus 1-1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA viruses in the family BIRNAVIRIDAE infecting birds. It is transmitted horizontally with no known vectors. The type species is INFECTIOUS BURSAL DISEASE VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA viruses in the family BIRNAVIRIDAE infecting fish, mollusks, and crustaceans. It is transmitted both vertically and horizontally with no known vectors. The natural hosts are salmonids and the type species is INFECTIOUS PANCREATIC NECROSIS VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of RNA viruses of the family BIRNAVIRIDAE infecting fruitflies. Transmission is horizontal and there are no known vectors. Drosophila melanogaster is the natural host and the type species is Drosophila X virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SEA URCHINS in the family Arbaciidae. They have only one spheridium %28%stalked body%29% per ambulacral area %28%contains tube feet%29%; most sea urchins have several spheridia per area.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SEA URCHINS in the family Echinidae found primarily on the western coasts of Ireland.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SEA URCHINS in the family Echinometridae. They are closely related to and some say indistinguishable from the genus Heliocidaris.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SEA URCHINS in the family Strongylocentrotidae with a hemicyclic apical disk and short spines.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SEA URCHINS in the family Strongylocentrotidae. They possess more than three pore pairs per ambulacral plate. The species STRONGYLOCENTROTUS PURPURATUS is commonly used for research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SEA URCHINS in the family Toxopneustidae possessing trigeminate ambulacral plating.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SHARKS in the family SQUALIDAE, comprised of many different species. They travel in large groups and are bottom dwellers that feed mostly on bony fishes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Axinellidae, comprised of a choanosomal skeleton differentiated in the axial and extra-axial region. The type species is Axinella polypoides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Callyspongiidae comprised of a regular ectosomal reticulate skeleton.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Chalinidae characterized by unispicular secondary lines in the choanosomal skeleton.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Crambeidae characterized by desmoid spicules. The type species is Crambe crambe.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Dysideidae, in which all skeletal fibers are filled with detritus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Petrosiidae, characterized by an ectosomal skeleton consisting only of an isotropic reticulation of single spicules or spicule tracts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Petrosiidae, characterized by an ectosomal triangular or polygonal reticulation of spicule tracts or single spicules.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SPONGES in the family Plakinidae, with the skeleton formed by small diactine %28%and some triactine%29% needle-like terminations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of SQUID in the family Loliginidae, superorder DECAPODIFORMES, with a spindle-shaped body. They are well-studied, common inshore squids of the Atlantic and eastern Pacific Oceans, but their various species are taxonomically unresolved.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of STARFISH in the family Asteriidae. One species, Asterias rubens, is the most common in the north-east Atlantic region.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of STARFISH in the family Asterinidae. They externally hold developing embryos %28%EMBRYO, NON-MAMMALIAN%29% among the spines below the oral surface.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of TICKS, in the family IXODIDAE, widespread in Africa. Members of the genus include many important vectors of animal and human pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of TOGAVIRIDAE, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the SINDBIS VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of VIBRIONACEAE, made up of short, slightly curved, motile, gram-negative rods. Various species produce cholera and other gastrointestinal disorders as well as abortion in sheep and cattle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of WHALES in the family Balaenopteridae, consisting of five species: Blue Whale, Bryde%27%s Whale, FIN WHALE, Sei Whale, and MINKE WHALE. They are distinguished by a relatively slender body, a compressed tail stock, and a pointed snout.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of achlorophyllic algae in the family Chlorellaceae, and closely related to CHLORELLA. It is found in decayed matter; WATER; SEWAGE; and SOIL; and produces cutaneous and disseminated infections in various VERTEBRATES including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aerobic or facultatively anerobic BACTERIA, in the family Cellulomonadaceae. It is found in the SOIL and capable of hydrolyzing CELLULOSE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aerobic, chemolithotrophic, coccoid ARCHAEA whose organisms are thermoacidophilic. Its cells are highly irregular in shape, often lobed, but occasionally spherical. It has worldwide distribution with organisms isolated from hot acidic soils and water. Sulfur is used as an energy source.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aerobic, gram-negative bacteria in the family FLAVOBACTERIACEAE. Many of its species were formerly in the genus FLAVOBACTERIUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aerobic, gram-negative, motile, slightly curved, rod-shaped bacteria. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aerobic, helical spirochetes, some species of which are pathogenic, others free-living or saprophytic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ameboid protozoa characterized by the presence of beaded chromatin on the inner surface of the nuclear membrane. Its organisms are parasitic in invertebrates and vertebrates, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ameboid protozoa found in the intestines of vertebrates and invertebrates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ameboid protozoa. Characteristics include a vesicular nucleus and the formation of several lodopodia, one of which is dominant at a given time. Reproduction occurs asexually by binary fission.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic bacteria in the family PEPTOCOCCACEAE, widely distributed in SOIL and the RUMEN of animals. Stains gram-negative but cell well is gram-positive type.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic coccoid METHANOCOCCACEAE whose organisms are motile by means of polar tufts of flagella. These methanogens are found in salt marshes, marine and estuarine sediments, and the intestinal tract of animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic, chemolithotropic coccoid ARCHAEA, in the family DESULFUROCOCCACEAE. They live in marine environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic, gram-negative bacteria in the family Fusobacteriaceae. Some species cause BACTEREMIA and some intra-amniotic infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic, gram-positive bacteria in the family Peptococcaceae, that reductively dechlorinates CHLOROPHENOLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic, irregular spheroid-shaped METHANOSARCINALES whose organisms are nonmotile. Endospores are not formed. These archaea derive energy via formation of methane from acetate, methanol, mono-, di-, and trimethylamine, and possibly, carbon monoxide. Organisms are isolated from freshwater and marine environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anaerobic, rod-shaped METHANOBACTERIACEAE. Its organisms are nonmotile and use ammonia as the sole source of nitrogen. These methanogens are found in aquatic sediments, soil, sewage, and the gastrointestinal tract of animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of anoxygenic, photosynthetic, nonmotile, spherical to slightly ovoid bacterial cells occurring singly, or in aggregates of two or four, and usually surrounded with slime. It is found in stagnant water, mud of ponds, estuaries, and microbial mats of salt marshes. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aquatic fungi of the family Blastocladiaceae, order Blastocladiales, used in the study of zoospore formation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aquatic newts belonging to the family Salamandridae and sometimes referred to as %22%spiny%22% tritons. There are two species P. waltlii and P. poireti. P. waltlii is commonly used in the laboratory. Since this genus adapts to aquarium living, it is easy to maintain in laboratories.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of aquatic newts in the Salamandridae family. During breeding season many Triturus males have a dorsal crest which also serves as an accessory respiratory organ. One of the common Triturus species is Triturus cristatus %28%crested newt%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycete FUNGI in the order SORDARIALES, which is found on SOIL and herbivore dung %28%FECES%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi %28%ASCOMYCOTA%29%, family Clavicipitaceae, order HYPOCREALES, that grows by infecting insect larvae or mature insects with spores that germinate often before the cocoon is formed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi of the family Chaetomiaceae, order SORDARIALES. Many members are cellulolytic and some mycotoxic. They occur naturally on paper and cotton fabric.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi of the family Hypocreaceae, order Hypocreales including several pathogens of grains and cereals. It is also the source of plant growth regulators such as gibberellin and gibberellic acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi of the family Saccharomycetaceae, order SACCHAROMYCETALES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi of the family Schizosaccharomycetaceae, order Schizosaccharomycetales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi, family Clavicipitaceae, order Hypocreales, parasitic on various grasses %28%POACEAE%29%. The sclerotia contain several toxic alkaloids. Claviceps purpurea on rye causes ergotism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous fungi, family Sordariaceae, order SORDARIALES, comprising bread molds. They are capable of converting tryptophan to nicotinic acid and are used extensively in genetic and enzyme research. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ascomycetous yeast in the family Dipodascaceae, order SACCHAROMYCETALES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of asporogenous bacteria isolated from soil that displays a distinctive rod-coccus growth cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria capable of developing within other bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria causing GRANULOMA INGUINALE and other granulomatous lesions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria comprised of a heterogenous group of gram-negative small rods and coccoid forms associated with arthropods. %28%From Bergey%27%s Manual of Systematic Bacteriology, vol 1, 1984%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria found in the human genital and urinary tract. It is considered to be a major cause of bacterial vaginosis %28%VAGINOSIS, BACTERIAL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage. Its species are parasitic on cold-blooded and warm-blooded animals, including man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteriophages of the family INOVIRIDAE. Organisms of this genus infect Acholeplasma and Spiroplasma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bacteriophages of the family MICROVIRIDAE. The genome consists of isometric single-stranded DNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of basidiomycetous fungi, family POLYPORACEAE, order POLYPORALES, that grows on logs or tree stumps in shelflike layers. The species P. ostreatus, the oyster mushroom, is a choice edible species and is the most frequently encountered member of the genus in eastern North America. %28%Alexopoulos et al., Introductory Mycology, 4th ed, p531%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of basidiomycetous smut fungi comprising the loose smuts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of beetles which infests grain products. Its larva is called mealworm.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of bioluminescent marine invertebrates in the family Renillidae, order Pennatulacea, class ANTHOZOA. It contains Renilla LUCIFERASE which oxidizes coelenterazine resulting in LUMINESCENCE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of blind, subterranean MOLE RATS, in the subfamily Spalacidae, family MURIDAE, used as a animal model in neurophysiology. There are at least five different species described, all found in the Ukraine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of brush-tailed possums found chiefly in Australia and New Zealand. Secretions from their ANAL GLAND function both in defense and demarcating territory.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of chemoorganotrophic, gram negative rods, in the family ALCALIGENACEAE. They are pathogenic parasites of HORSES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ciliate protozoa commonly used in genetic, cytological, and other research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ciliate protozoa having a dorsoventrally flattened body with widely spaced rows of short bristle-like cilia on the dorsal surface.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ciliate protozoa having a unique cursorial type of locomotion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ciliate protozoa that is often large enough to be seen by the naked eye. Paramecia are commonly used in genetic, cytological, and other research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of coccidian parasites in the family EIMERIIDAE. Cyclospora cayetanensis is pathogenic in humans, probably transmitted via the fecal-oral route, and causes nausea and diarrhea.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of coccidian parasites of the family CRYPTOSPORIDIIDAE, found in the intestinal epithelium of many vertebrates including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of coccidian protozoa that comprise the malaria parasites of mammals. Four species infect humans %28%although occasional infections with primate malarias may occur%29%. These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of coccoid, extremely halophilic HALOBACTERIACEAE which grows in alkaline conditions. They are nonmotile and strictly aerobic and are found in soda lakes, alkaline salterns, and soda soils.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of cone-nosed bugs of the subfamily TRIATOMINAE. Its species are vectors of TRYPANOSOMA CRUZI.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of cone-shaped marine snails in the family Conidae, class GASTROPODA. It comprises more than 600 species, many containing unique venoms %28%CONUS VENOMS%29% with which they immobilize their prey.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of cuttlefish in the family Sepiidae. They live in tropical, subtropical and temperate waters in most oceans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of deer, Rangifer, that inhabits the northern parts of Europe, Asia, and America. Caribou is the North American name; reindeer, the European. They are often domesticated and used, especially in Lapland, for drawing sleds and as a source of food. Rangifer is the only genus of the deer family in which both sexes are antlered. Most caribou inhabit arctic tundra and surrounding arboreal coniferous forests and most have seasonal shifts in migration. They are hunted extensively for their meat, skin, antlers, and other parts. %28%From Webster, 3d ed; Walker%27%s Mammals of the World, 5th ed, p1397%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of destructive parasitic algae in the family Pythiaceae, order Peronosporales, affecting numerous fruit, vegetable, and other crops. Differentiation of zoospores usually takes place in the sporangium and no vesicle is formed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of destructive root-parasitic algae in the family Pythiaceae, order Peronosporales, commonly found in cultivated soils all over the world. Differentiation of zoospores takes place in a vesicle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of dextrally coiled freshwater snails that includes some species of importance as intermediate hosts of parasitic flukes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of diurnal rats in the family Octodonidae, found in South America. The species Octodon degus is frequently used for research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of extremely halophilic HALOBACTERIACEAE which are chemoheterotropic and strictly aerobic. They are found in neutral saline environments such as salt lakes %28%especially the Dead Sea%29% and marine salterns.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of extremely halophilic HALOBACTERIACEAE with coccoid cells occurring singly or as pairs, tetrads, or irregular clusters. They are found in neutral salt lakes, marine salterns, saline soils and seawater.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of extremely thermophilic heterotrophic archaea, in the family THERMOCOCCACEAE, occurring in heated sea flows. They are anerobic chemoorganotropic sulfidogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of extremely thermophilic, sulfate-reducing archaea, in the family Archaeoglobaceae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of facultatively anaerobic coccoid ARCHAEA, in the family SULFOLOBACEAE. Cells are highly irregular in shape and thermoacidophilic. Lithotrophic growth occurs aerobically via sulfur oxidation in some species. Distribution includes solfataric springs and fields, mudholes, and geothermically heated acidic marine environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of facultatively anaerobic heterotrophic archaea, in the order THERMOPLASMALES, isolated from self-heating coal refuse piles and acid hot springs. They are thermophilic and can grow both with and without sulfur.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of facultatively or obligately anaerobic marine phototrophic bacteria, in the family RHODOBACTERACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of filamentous bacteriophages of the family INOVIRIDAE. Organisms of this genus infect enterobacteria, PSEUDOMONAS; VIBRIO; and XANTHOMONAS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of filarial nematodes. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fish, in the family GYMNOTIFORMES, capable of producing an electric shock that immobilizes fish and other prey. The species Electrophorus electricus is also known as the electric eel, though it is not a true eel.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of flagellate intestinal protozoa parasitic in various vertebrates, including humans. Characteristics include the presence of four pairs of flagella arising from a complicated system of axonemes and cysts that are ellipsoidal to ovoidal in shape.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of flagellate protozoans found in the blood and lymph of vertebrates and invertebrates, both hosts being required to complete the life cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of flagellate protozoans possessing three long anterior flagella.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fleshy shelf basidiomycetous fungi, family Schizophyllaceae, order POLYPORALES, growing on woody substrata. It is pathogenic in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of flexible, spiral rods found in hydrogen sulfide-containing mud, sewage, and polluted water. None of the species properly referred to in this genus are pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of free-living amoebae found in fresh water. The cysts usually pass harmlessly through the intestinal tract of man and may thus be found in feces. Occasionally, these organisms cause respiratory tract infections or generalized fatal meningoencephalitis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of freshwater clams, in the family Corbiculidae, class BIVALVIA. It originated in Asia but was introduced in North America and is now found throughout the United States.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of freshwater mussel in the family MYTILIDAE, class BIVALVIA. It is found in tropical and warm temperate coastal waters. Most species have green in their shells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of freshwater mussels in the family UNIONIDAE, class BIVALVIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi in the family Ancylistaceae, order ENTOMOPHTHORALES, characterized by the presence of small nuclei with a prominent central nucleolus in interphase. They are commonly found in the soil but also infect termites, aphids, and sometimes, though rarely, mammals including humans. %28%Alexopoulos et al, Introductory Mycology, 4th ed, pp159-60%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi in the family Corticiaceae, order Stereales, that degrades lignin. The white-rot fungus Phanerochaete chrysosporium is a frequently used species in research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi in the family Entomophthoraceae, order Entomorphthorales. They are primarily parasites of insects and spiders, but have been found to cause mycotic infections of the nose in man and horses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi in the family Ganodermataceae, order POLYPORALES, containing a dimitic hyphal system. It causes a white rot, and is a wood decomposer. Ganoderma lucidum %28%REISHI%29% is used in traditional Chinese medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES, containing uniflagellate zoospores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi in the family Neocallimasticaceae, order NEOCALLIMASTICALES. They contain polyflagellate zoospores and grow on a range of simple and complex carbohydrates in the rumen of sheep and cattle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungi of the family Tricholomataceae, order AGARICALES. The commonly known SHIITAKE MUSHROOMS are Lentinula edodes %28%also seen as Lentinus edodes%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of fungus in the family Hypocreaceae, order HYPOCREALES. Anamorphs include TRICHODERMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gliding bacteria that are common inhabitants on tree bark and decomposing vegetation. The cells are slender rods with tapering ends.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative aerobic bacteria that occurs free-living in the soil or associated with the roots of cereal crops or grasses %28%POACEAE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria characteristically appearing in chains of several segmenting organisms. It occurs in man and arthropod vectors and is found only in the Andes region of South America. This genus is the etiologic agent of human bartonellosis. The genus Rochalimaea, once considered a separate genus, has recently been combined with the genus Bartonella as a result of high levels of relatedness in 16S rRNA sequence data and DNA hybridization data.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria existing symbiotically with nematodes of the family Heterorhabditidae %28%see RHABDITOIDEA%29%. These nematodes infect a variety of soil-dwelling insects. Upon entering an insect host, the nematode releases Photorhabdus from its intestinal tract and the bacterium establishes a lethal septicemia in the insect.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, found in the RUMEN of SHEEP and CATTLE, and also in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from spoiled BEER and pitching yeast.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the family ACIDAMINOCOCCACEAE, isolated from the INTESTINES of PIGS and humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the family ENTEROBACTERIACEAE consisting of species that profusely produce pectinolytic enzymes in plant pathogenesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the family Eubacteriaceae. Species are homoacetogenic, having the ability to use CARBON DIOXIDE as an electron sink, and to reduce it producing acetate as a typical fermentation product.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the family OXALOBACTERACEAE, comprised of vibrioid or sometimes helical cells. They are chemoorganotrophic nitrogen fixers and are found free-living in the soil or in association with the roots of members of the GRAMINEAE. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria in the genus ACTINOBACILLUS, which is pathogenic for HORSES and PIGS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria isolated from individuals in LONG-TERM CARE facilities and HOSPITALS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria which are obligately intracellular endosymbionts of APHIDS. The bacteria are found within specialized cells in the aphid body cavity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative bacteria widely distributed in fresh water as well as marine and hypersaline habitats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative gliding bacteria found in SOIL; HUMUS; and FRESHWATER and marine habitats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative organisms including saprophytic and parasitic or pathogenic species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative rod-shaped bacteria in the class GAMMAPROTEOBACTERIA. They are obligately acidophilic and aerobic, using reduced sulfur compounds to support autotrophic growth.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative rods which form exospores and are obligate methanotrophs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic bacteria in the family MORAXELLACEAE, associated with processed MEAT; FISH PRODUCTS; and POULTRY PRODUCTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic bacteria occurring as rods %28%subgenus Moraxella%29% or cocci %28%subgenus Branhamella%29%. Its organisms are parasitic on the mucous membranes of humans and other warm-blooded animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic bacteria whose cells are minute coccobacilli. It consists of both parasitic and pathogenic species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic bacteria, in the family XANTHOMONADACEAE. It is found in the xylem of plant tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic or microaerophilic, colorless filaments. It is nonfruiting, motile by gliding, and found in freshwater sediments and cow dung. One species %28%V. stercoraria%29% is considered morphologically to be a streptobacillus. That species is strictly aerobic and produces a homodimeric bacterial hemoglobin, especially under oxygen-limited growth conditions. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, facultatively methylotrophic rods occurring singly or occasionally in rosettes. Members of this genus are usually motile and are isolated from soil, dust, fresh water, lake sediments, leaf surfaces, rice, air, and hospital environments. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, motile, rod-shaped bacteria formerly classified as part of the genus XANTHOMONAS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, nonsporeforming rods which usually contain granules of poly-beta-hydroxybutyrate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod- or vibroid-shaped or fusiform bacteria that commonly produce a stalk. They are found in fresh water and soil and divide by binary transverse fission.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria characterized by an outer membrane that contains glycosphingolipids but lacks lipopolysaccharide. They have the ability to degrade a broad range of substituted aromatic compounds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria found in wet soil containing decaying organic material and in water. Cells tend to be pleomorphic if grown on media containing succinate or coccoid if grown in the presence of an alcohol as the sole carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria often surrounded by a protein microcapsular layer and slime layer. The natural cycle of its organisms generally involves a vertebrate and an invertebrate host. Species of the genus are the etiological agents of human diseases, such as typhus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria that produce nodules on the roots of leguminous plants. Members of this genus are common soil inhabitants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria usually containing granules of poly-beta-hydroxybutyrate. They characteristically invade the root hairs of leguminous plants and act as intracellular symbionts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria whose organisms are part of the normal flora of the mucous membranes of the upper respiratory tract. Some species are pathogenic for man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in SOIL and WATER. Its organisms are also found in raw meats, MILK and other FOOD, hospital environments, and human clinical specimens. Some species are pathogenic in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria, in the family RALSTONIACEAE, that are mobile by means of peritrichous FLAGELLA. Species in this genus were formerly in the genus RALSTONIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, rod-shaped bacteria. Organisms in this genus had originally been classified as members of the PSEUDOMONAS genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Pseudomonas species, and hence, this new genus was created.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, spherical cells usually occurring in pairs. The resting stage is considered a cyst. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerobic, straight, curved, or branched rods which are motile by a single polar flagellum. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, aerotolerant, spiral-shaped bacteria isolated from water and associated with diarrhea in humans and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic bacteria in the family Desulfovibrionaceae. It was originally recovered from infections in patients with gangrenous and PERFORATED APPENDICITIS. It is also associated with ABSCESS; BACTEREMIA; and BILIARY TRACT sepsis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic bacteria in the family Fibrobacteraceae, isolated from the human GASTROINTESTINAL TRACT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic bacteria in the family Thermoanaerobacteriaceae. They are thermophilic and saccharolytic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, helical bacteria, various species of which produce RELAPSING FEVER in humans and other animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, metal-reducing bacteria in the family Geobacteraceae. They have the ability to oxidize a variety of organic compounds, including AROMATIC HYDROCARBONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, nonsporeforming bacteria in the family Desulfuromonadaceae. It is found in anoxic marine sediments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods or coccobacilli. Organisms in this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings indicated the need to separate them from other Bacteroides species, and hence, this new genus was created.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods. Organisms of this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings in 1990 indicated the need to separate them from other Bacteroides species, and hence, this new genus was established.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, rod-shaped bacteria capable of reducing sulfur compounds to hydrogen sulfide. Organisms are isolated from anaerobic mud of fresh and salt water, animal intestines, manure, and feces.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, rod-shaped bacteria isolated from the bovine RUMEN, the human gingival sulcus, and dental PULPITIS infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are found in the human vagina, particularly in association with Gardnerella vaginalis in cases of bacterial vaginosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, chemolithoautotrophic bacteria in the family CHROMATIACEAE. Several of its species were reclassified to this genus from THIOBACILLUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, chemoorganotrophic bacteria in the family Flexibacteraceae. In some species there is a cyclic change in cell morphology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, chemoorganotrophic bacteria in the family Sphingobacteriaceae. They lack FLAGELLA but some species exhibit gliding motility.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, chemoorganotrophic bacteria, in the family FLAVOBACTERIACEAE. It is pathogenic in BIRDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, curved and spiral-shaped bacteria found in stagnant, freshwater environments. These organisms are motile by bipolar tufts of flagella having a long wavelength and about one helical turn. Some species of Spirillum cause a form of RAT-BITE FEVER.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, curved or straight rod-shaped bacteria, in the family ALTEROMONADACEAE. They are chemo-organotrophic, halophilic, and associated with cold marine habitats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, ellipsoidal or rod-shaped bacteria whose major source of energy and reducing power is from the oxidation of ammonia to nitrite. Its species occur in soils, oceans, lakes, rivers, and sewage disposal systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic bacteria in the family CARDIOBACTERIACEAE. It is found in the nasal flora of humans and causes ENDOCARDITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic bacteria in the family ENTEROBACTERIACEAE. It is found in FOOD; SOIL; and SEWAGE; and is an opportunistic pathogen of humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic bacteria including species which are often associated with grasses %28%POACEAE%29% and which fix nitrogen as well as species which anaerobically degrade toluene and other mono-aromatic hydrocarbons.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic rod- to coccobacillus-shaped bacteria that occurs in a broad spectrum of habitats.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic rod-shaped cells which are motile by peritrichous flagella. Late in the growth cycle, spheroplasts or coccoid bodies occur, resulting from disintegration of the cell wall. The natural habitat is the intestinal lumen of certain nematodes. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic rods. It is a saprophytic, marine organism which is often isolated from spoiling fish.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria occurring in soil and water. Its organisms are generally nonpathogenic, but some species do cause infections of mammals, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are common in the marine environment and on the surfaces and in the intestinal contents of marine animals. Some species are bioluminescent and are found as symbionts in specialized luminous organs of fish.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery %28%DYSENTERY, BACILLARY%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that is not known to be pathogenic for man, animals, or plants. Its organisms are spoilers for beers and ciders and in sweet English ciders they are the causative agents of a secondary fermentation known as %22%cider sickness.%22% The species Z. mobilis is used for experiments in molecular genetic studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in fish and other aquatic animals and in a variety of mammals, including man. Its organisms probably do not belong to the normal intestinal flora of man and can cause diarrhea.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the human mouth and intestine. Organisms of this genus can be opportunistic pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment %28%soil, water, and plant surfaces%29% or as an opportunistic human pathogen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that require SERUM; ASCITIC FLUID; or BLOOD for growth. Its organisms inhabit the THROAT; and NASOPHARYNX of wild and laboratory rats and cause one form of RAT-BITE FEVER in man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, small, rod-shaped bacteria occurring in fresh water.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. Most strains produce a yellow pigment. This organism is isolated from plant surfaces, seeds, soil, and water, as well as from animals and human wounds, blood, and urine. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, facultatively anaerobic, straight rods which are motile by peritrichous flagella. These organisms are chemoorganotrophic and have both a respiratory and fermentative type of metabolism. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, helical bacteria, in the family SPIROPLASMATACEAE, order Entomoplasmatales, causing disease in PLANTS. It has been isolated from TICKS; INSECTS; and PLANTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, nonmotile bacteria which are common parasitic inhabitants of the urogenital tracts of humans, cattle, dogs, and monkeys.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, obligate intracellular bacteria causing a proliferative enteritis in animals, especially pigs, deer, horses, and rabbits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, ovoid to rod-shaped bacteria that is phototrophic. All species use ammonia as a nitrogen source. Some strains are found only in sulfide-containing freshwater habitats exposed to light while others may occur in marine, estuarine, and freshwater environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, oxidase-positive, nonfermentative rods which are motile by means of a single flagellum. Afipia felis and BARTONELLA HENSELAE are causative agents of CAT-SCRATCH DISEASE. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped bacteria able to anaerobically oxidize and degrade toluene.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped bacteria in the family ENTEROBACTERIACEAE. They exist only as primary endosymbionts of five species of TSETSE FLIES, found in specialized organelles called mycetomes. The bacteria supply crucial B vitamins %28%VITAMIN B COMPLEX%29% which the flies require for fertility.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped bacteria that derives energy from the oxidation of one or more reduced sulfur compounds. Many former species have been reclassified to other classes of PROTEOBACTERIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped bacteria that is widely distributed in TICKS and various mammals throughout the world. Infection with this genus is particularly prevalent in CATTLE, SHEEP, and GOATS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped bacteria that oxidizes nitrites to nitrates. Its organisms occur in aerobic environments where organic matter is being mineralized, including soil, fresh water, and sea water.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped or pleomorphic bacteria which are halotolerant. Members of this genus are capable of growth in sodium chloride concentrations of up to 20%25% or more. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped to ellipsoidal bacteria occurring singly or in pairs and found in flowers, soil, honey bees, fruits, cider, beer, wine, and vinegar. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped, obligate aerobes which are motile by peritrichous flagella on solid medium and one lateral flagellum in liquid medium. Under microaerobic conditions Azorhizobium fixes nitrogen. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, rod-shaped, phototrophic bacteria found in aquatic environments. Internal photosynthetic membranes are present as lamellae underlying the cytoplasmic membrane.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, sheathed, rod-shaped bacteria in the family COMAMONADACEAE. They are closely related to LEPTOTHRIX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, sheathed, rod-shaped bacteria in the family COMAMONADACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, spiral bacteria that possesses internal photosynthetic membranes. Its organisms divide by binary fission, are motile by means of polar flagella, and are found in aquatic environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, spiral-shaped bacteria in the family SUCCINIVIBRIONACEAE. It has been isolated from the THROAT and COLON of beagle dogs and from human FECES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the GASTRIC MUCOSA of MAMMALS, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the intestinal tract of mammals, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, straight or curved rods which are motile by means of a single, polar flagellum. Members of this genus are found in coastal waters and the open ocean. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, straight or slightly curved rods which are motile by polar flagella and which accumulate poly-beta-hydroxybutyrate within the cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, strictly aerobic chemoorganotrophic bacteria, in the family COMAMONADACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-negative, strictly aerobic, non-spore forming rods. Soil and water are regarded as the natural habitat. They are sometimes isolated from a hospital environment and humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive BACTERIA in the family Gordoniaceae, isolated from soil and from sputa of patients with chest disorders. It is also used for biotransformation of natural products.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive aerobic cocci found in the soil, that is highly resistant to radiation, especially ionizing radiation %28%RADIATION, IONIZING%29%. Deinococcus radiodurans is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive bacteria in the family Lachnospiraceae that inhabits the RUMEN; LARGE INTESTINE; and CECUM of MAMMALS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive bacteria that forms a branched mycelium. It commonly occurs as a saprophytic form in soil and aquatic environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive bacteria whose spores are round to oval and covered by a sheath.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for man and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, anaerobic bacteria in the family Thermoanaerobacteriaceae. Cultures consist of rods interspersed with coccoid cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, anaerobic bacteria whose organisms divide in three perpendicular planes and occur in packets of eight or more cells. It has been isolated from soil, grains, and clinical specimens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, anaerobic, cocci to short rod-shaped ARCHAEA, in the family METHANOBACTERIACEAE, order METHANOBACTERIALES. They are found in the GASTROINTESTINAL TRACT or other anoxic environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of humans. Its organisms are opportunistic pathogens causing bacteremias and soft tissue infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, coccoid bacteria mainly isolated from milk and milk products. These bacteria are also found in plants and nonsterile frozen and dry foods. Previously thought to be a member of the genus STREPTOCOCCUS %28%group N%29%, it is now recognized as a separate genus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. No endospores are produced. Its organisms are found in fermenting plant products and are nonpathogenic to plants and animals, including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, facultatively anaerobic, rod-shaped bacteria that has a tendency to form long filaments. Its organisms are widely distributed in nature and are found in MAMMALS; BIRDS; and FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. The genus Eubacterium should not be confused with EUBACTERIA, one of the three domains of life.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, rod-shaped bacteria whose cells occur singly, in pairs or short chains, in V or Y configurations, or in clumps resembling letters of the Chinese alphabet. Its organisms are found in cheese and dairy products as well as on human skin and can occasionally cause soft tissue infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of green algae found in the Mediterranean and other warm seas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of green nonsulfur bacteria in the family Chloroflexaceae. They are photosynthetic, thermophilic, filamentous gliding bacteria found in hot springs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of hamsters characterized by small size, very short tail, and short, broad feet with hairy soles.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of hard-shelled clams in the family Veneridae, class BIVALVIA, commonly called quahogs. They are found just below the surface in the subtidal or lower intertidal coastal waters.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of intestinal flukes of the family Echinostomatidae which consists of many species. They occur in man and other vertebrates. The intermediate hosts are frequently mollusks.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of intestinal nematode parasites belonging to the superfamily HELIGMOSOMATOIDEA, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of intestinal nematode worms which includes the pinworm or threadworm Enterobius vermicularis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of intestinal parasite worms which includes one of the most important hookworms of man, NECATOR AMERICANUS. The only other known species, N. suillus, has been recovered from pigs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of intestinal parasitic nematodes occurring in animals and man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of large OPOSSUMS in the family Didelphidae, found in the Americas. The species Didelphis virginiana is prominent in North America.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of large SEA CUCUMBERS in the family Holothuriidae possessing thick body walls, a warty body surface, and microscopic ossicles.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of large SEA CUCUMBERS possessing the primitive radial configuration of podia in all five ambulacral areas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of large marine sea slugs in the family Tritoniidae found in the northern Pacific Ocean. They are used in neurological research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of large tapeworms. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of large, brightly colored SPONGES in the family Agelasidae, possessing a skeleton of spongin fibers with a core of large spicules %28%megascleres%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivatives, CARBENOXOLONE for example. Licorice toxicity is manifested as hypokalemia, low blood potassium. Licorice is used as flavoring and aromatic in pharmaceuticals and as candy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of leguminous shrubs or trees, mainly tropical, yielding certain alkaloids, lectins, and other useful compounds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of lichens containing usnic acid and mucilage. Usnea barbata has been used as an herbal medicine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of livebearing cyprinodont fish comprising the guppy and molly. Some species are virtually all female and depend on sperm from other species to stimulate egg development. Poecilia is used in carcinogenicity studies as well as neurologic and physiologic research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of long-legged, swift-moving felines %28%FELIDAE%29% from Africa %28%and formerly Asia%29% about the size of a small leopard.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of lung flukes of the family Troglotrematidae infecting humans and animals. This genus consists of several species one of which is PARAGONIMUS WESTERMANI, a common lung fluke in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of marine mussels in the family MYTILIDAE, class BIVALVIA. The species MYTILUS EDULIS is the highly edible common mussel.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of marine planktonic CYANOBACTERIA in the order PROCHLOROPHYTES. They lack PHYCOBILISOMES and contain divinyl CHLOROPHYLL, a and b.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of marine sea slugs in the family Glaucidae, superorder GASTROPODA, found on the Pacific coast of North America. They are used in behavioral and neurological laboratory studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of massive or globular SPONGES in the family Geodiidae, with large spicules at or near the surface.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of microaerophilic, gram-negative bacteria that forms crystals of the mineral magnetite.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of microorganisms of the order SPIROCHAETALES, many of which are pathogenic and parasitic for man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of minute bacteria in the family ACHOLEPLASMATACEAE that inhabit phloem sieve elements of infected PLANTS and cause symptoms such as yellowing, phyllody, and witches%27% brooms. Organisms lack a CELL WALL and thus are similar to MYCOPLASMA in animals. They are transmitted by over 100 species of INSECTS especially leafhoppers, planthoppers, and PSYLLIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of minute protozoa that are characterized by the preponderance of binucleate over uninucleate forms, the presence of several distinct granules in the karyosome, and the lack of a cystic stage. It is parasitic in the large intestine of humans and certain monkeys.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mitosporic Phyllachoraceae fungi which contains at least 40 species of plant parasites. They have teleomorphs in the genus Glomerella %28%see PHYLLACHORALES%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mitosporic fungi containing about 100 species and eleven different teleomorphs in the family Trichocomaceae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mollusks in the family ARCIDAE, class BIVALVIA. It is used in the study of HEMOGLOBINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mosquitoes %28%CULICIDAE%29% commonly found in tropical regions. Species of this genus are vectors for St. Louis encephalitis %28%ENCEPHALITIS, ST. LOUIS%29% as well as many other diseases of man and domestic and wild animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mosquitoes %28%CULICIDAE%29% frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mosquitoes %28%CULICIDAE%29% that are known vectors of MALARIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mosquitoes in the family CULICIDAE. A large number of the species are found in the neotropical part of the Americas.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of mussels in the family Dreissenidae, class BIVALVIA. They are found in both fresh and brackish water and are not native to North America. Accidentally introduced into the Great Lakes in 1986, they now proliferate widely throughout the United States.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematode intestinal parasites that consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs, but all have been known to occur in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematode parasites which inhabit the body cavity, serous membranes, and connective tissues of vertebrates. The parasitic species in humans is Dracunculus medinensis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematode worms comprising the whipworms. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematode worms. A. galli and A. lineata are important intestinal parasites of domestic fowl.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematodes found mainly in mice. Its organisms are used in biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematodes of the superfamily ASCARIDOIDEA whose species usually inhabit the intestine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematodes of the superfamily ASCARIDOIDEA. Its organisms are found in the stomachs of marine animals and birds. Human infection occurs by ingestion of raw fish that contain larvae.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of nematodes of the superfamily STRONGYLOIDEA, parasitic in the intestines of animals. The adults are usually free in the intestinal lumen; the larvae encyst in the wall.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of newts of the Salamandridae family found in North America in areas east of the 100th meridian. A common species is NOTOPHTHALMUS VIRIDESCENS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of obligately aerobic marine phototrophic and chemoorganotrophic bacteria, in the family RHODOBACTERACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of obligately aerobic, thermophilic, gram-negative bacteria in the family Crenotrichaceae. They were isolated from submarine alkaline HOT SPRINGS in Iceland.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of obligately anaerobic ARCHAEA, in the family THERMOPROTEACEAE. They are found in acidic hot springs and water holes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of onygenacetous mitosporic fungi whose perfect state is Ajellomyces %28%see ONYGENALES%29%. The species Blastomyces dermatitidis %28%perfect state Ajellomyces dermatitidis%29% causes blastomycosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of organisms considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold %26% Wynne, Introduction to the Algae, 2d ed, p84%29%. It consists of solitary biflagellated organisms common in fresh water and damp soil.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of owlet moths of the family Noctuidae. These insects are used in molecular biology studies during all stages of their life cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of oysters in the family OSTREIDAE, class BIVALVIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of oysters in the family OSTREIDAE, which includes the edible true oyster, Ostrea edulis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic FUNGI in the family Enterocytozoonidae, which infects humans. Enterocytozoon bieneusi has been found in the intestines of patients with AIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic FUNGI in the family Nosematidae that infects humans. Vittaforma corneae has been isolated from AIDS patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic FUNGI in the family Nosematidae. Some species are pathogenic for invertebrates of economic importance while others are being researched for possible roles in controlling pest INSECTS. They are also pathogenic in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic FUNGI in the family Pleistophoridae that infects humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic flagellate protozoans distinguished by the presence of four anterior flagella, an undulating membrane, and a trailing flagellum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses %28%POACEAE%29% they eat. Infestation of man is accidental.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes found in the peritoneal cavity of wild or domestic cattle or equines.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes found throughout the rain-forest areas of the Sudan and the basin of the Congo. L. loa inhabits the subcutaneous tissues, which it traverses freely.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes occurring in the stomach of ruminants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes that causes TRICHINOSIS in man and carnivores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes that occurs in mammals including man. Infection in humans is either by larvae penetrating the skin or by ingestion of uncooked fish.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes whose organisms are distributed in Central and South America. Characteristics include a smooth cuticle and an enlarged anterior end.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic nematodes widely distributed as intestinal parasites of mammals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of parasitic protozoans found in the digestive tract of invertebrates, especially insects. Organisms of this genus have an amastigote and choanomastigote stage in their life cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of pearl oysters in the family Pteriidae, class BIVALVIA. Both cultured and natural pearls are obtained from species in the genus. They are distinct from the distantly related, edible true oysters of the family OSTREIDAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of perennial herbs used topically and internally. It contains echinacoside, GLYCOSIDES; INULIN; isobutyl amides, resin, and SESQUITERPENES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of phototrophic, obligately anaerobic bacteria in the family Chlorobiaceae. They are found in hydrogen sulfide-containing mud and water environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses in the family BUNYAVIRIDAE. Tomato spotted wilt virus is the type species. Transmission occurs by at least nine species of thrips.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses in the family CLOSTEROVIRIDAE containing highly flexuous filaments. Some members are important pathogens of crop plants. Natural vectors include APHIDS, whiteflies, and mealybugs. The type species is Beet yellows virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses in the family CLOSTEROVIRIDAE. Transmission is by whiteflies. Lettuce infectious yellows virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by APHIDS but depends on the presence of a helper protein encoded by the Anthriscus yellow virus, a WAIKAVIRUS. The type species is Parsnip yellow fleck virus %28%parsnip serotype%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses in the family SEQUIVIRIDAE. Transmission is by leafhoppers or APHIDS and depends on a self-encoded helper protein. The type species is Rice tungro spherical virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses in which the virion is a rigid filament. Transmission is by mechanical inoculation or seed. The type species is TOBACCO MOSAIC VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses of the family BROMOVIRIDAE, which infect cucurbits and solanaceous plants. Transmission occurs via aphids in a non-persistent manner, and also via seeds. The type species Cucumber mosaic virus, a CUCUMOVIRUS, should not be confused with Cucumber green mottle mosaic virus, a TOBAMOVIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses of the family COMOVIRIDAE in which the bipartite genome is encapsidated in separate icosahedral particles. Mosaic and mottle symptoms are characteristic, and transmission is exclusively by leaf-feeding beetles. Cowpea mosaic virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses that cause mosaic and ringspot symptoms. Transmission occurs mechanically.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses that infects ANGIOSPERMS. Transmission occurs mechanically and through soil, with one species transmitted via a fungal vector. The type species is Tomato bushy stunt virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses that infects both monocotyledonous and dicotyledonous plants. Its organisms are persistently transmitted by aphids, and weeds may provide reservoirs of infection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of plant viruses, in the family TYMOVIRIDAE, possessing a narrow host range that includes CRUCIFERAE. Transmission occurs by BEETLES and mechanical inoculation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of poisonous American herbs, family BERBERIDACEAE. The roots yield PODOPHYLLOTOXIN and other pharmacologically important agents. The plant was formerly used as a cholagogue and cathartic. It is different from the European mandrake, MANDRAGORA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of poisonous snakes of the VIPERIDAE family. About 50 species are known and all are found in tropical America and southern South America. Bothrops atrox is the fer-de-lance and B. jararaca is the jararaca. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. There are six recognized species, all inhabiting Africa except the Asiatic %28%Indian%29% cobra, Naja naja. Some species %22%spit%22% their venom into the eyes of their %22%enemies%22%. So-called spitting cobras show a high degree of accuracy in aiming for the eyes. The ringhals, the most highly specialized of the spitting cobras, is limited to southern Africa. Its spray destroys eye tissue and can cause blindness; its bite can cause death. %28%Moore: Poisonous Snakes of the World, 1980, p80%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. They comprise the kraits. Twelve species are recognized and all inhabit southeast Asia. They are considered extremely dangerous. %28%Moore: Poisonous Snakes of the World, 1980, p120%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of poisonous, liliaceous plants. The roots %28%corms%29% of Colchicum autumnale, the fall crocus or meadow saffron, yield COLCHICINE, which is used as a biochemical tool and to treat gout. Other members of this genus yield saffron dye, flavoring agents, and aromatics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of polyhedral plant viruses of the family COMOVIRIDAE causing ringspots and spotting on leaves or sometimes symptomless infection. Transmission occurs by seeds, soil nematodes, or experimentally by mechanical inoculation. Tobacco ringspot virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of potentially oncogenic viruses of the family POLYOMAVIRIDAE. These viruses are normally present in their natural hosts as latent infections. The virus is oncogenic in hosts different from the species of origin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of primitive ALGAE in the family Cyanophoraceae, class Glaucocystophyceae. They contain pigmented prokaryotic endosymbionts called cyanelles, which have characteristics of both CYANOBACTERIA and CHLOROPLASTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of primitive fish in the family Petromyzontidae. The sole species is Petromyzon marinus, known as the sea lamprey. The adult form feeds parasitically on other fish species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoa found in reptiles, birds, and mammals, including humans. This heteroxenous parasite produces muscle cysts in intermediate hosts such as domestic herbivores %28%cattle, sheep, pigs%29% and rodents. Final hosts are predators such as dogs, cats, and man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoa of the suborder BLASTOCYSTINA. It was first classified as a yeast but further studies have shown it to be a protozoan.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoa parasitic in the digestive tract of vertebrate or invertebrate hosts. Asexual multiplication is accomplished by transverse binary fission. Its organisms are ovoidal in shape and have a ciliated covering over the entire body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoa, formerly also considered a fungus. Characteristics include the presence of violet to brown spores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoa, formerly also considered a fungus. Its natural habitat is decaying forest leaves, where it feeds on bacteria. D. discoideum is the best-known species and is widely used in biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoan parasites found in the intestines of birds, amphibians, reptiles, and mammals, including man. The oocysts produce two sporocysts, each with four sporozoites. Many species are parasitic in wild and domestic animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoan parasites of the subclass COCCIDIA. Its species are parasitic in dogs, cattle, goats, and sheep, among others. N. caninum, a species that mainly infects dogs, is intracellular in neural and other cells of the body, multiplies by endodyogeny, has no parasitophorous vacuole, and has numerous rhoptries. It is known to cause lesions in many tissues, especially the brain and spinal cord as well as abortion in the expectant mother.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of protozoan parasites of the subclass COCCIDIA. Various species are parasitic in the epithelial cells of the liver and intestines of man and other animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of pufferfish commonly used for research. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of question mark-shaped bacteria spirochetes which is found in fresh water that is contaminated by animal urine. It causes LEPTOSPIROSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of rod-shaped, almost rectangular ARCHAEA, in the family THERMOPROTEACEAE. Organisms are facultatively aerobic or strictly anaerobic, grow on various organic substrates, and are found in continental solfataras.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of rod-shaped, extremely halophilic HALOBACTERIACEAE which grows in alkaline conditions. They are strictly aerobic and some strains are motile. Natronobacterium is found in soda lakes, alkaline salterns, and soda soils.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of rod-shaped, oval, or bean-shaped bacteria found in soil and fresh water. Polar prosthecae are present and cells reproduce by budding at the tips of the prosthecae. Cells of this genus are aerobic and grow best with one-carbon compounds. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of roundworms of the phylum Acanthocephala, parasitic in rats, mice, hamsters, dogs and cats. Occasional infection in man produces inflammation and ulceration of the intestinal mucosa.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of rubiaceous South American trees that yields the toxic CINCHONA ALKALOIDS from their bark; QUININE; QUINIDINE; chinconine, cinchonidine and others are used to treat malaria and cardiac arrhythmias.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of ruminants in the family Bovidae. The common name chamois usually refers to the species Rupicapra rupicapra. Rupicapra pyrenaica, found in the Pyrenees, is more properly referred to as the Pyrenean chamois.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of scallops in the family PECTINIDAE, class BIVALVIA. The shell is usually radially ribbed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of shallow-cupped SPONGES with a broad base in the family Theonellidae. They are characterized by ectosomal spicules dominated by phyllotriaenes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of short, aerobic, gram-negative rods which are obligate methylotrophs, growing on one-carbon compounds other than methane. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of short-tailed OPOSSUMS in the family Didelphidae found in South American, chiefly Brazil. They are opossums least well-adapted to arboreal life.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of side-gilled sea slugs in the family Pleurobranchidae, superorder GASTROPODA. They are opportunistic voracious feeders but prefer the sea anemone.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of silkworm MOTHS in the family Bombycidae of the order LEPIDOPTERA. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree %28%on which it feeds%29%. A native of Asia, it is sometimes reared in this country. It has long been raised for its SILK and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental GENETICS. %28%From Borror et al., An Introduction to the Study of Insects, 4th ed, p519%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small beetles of the family Tenebrionidae; T. confusum is the %22%confused flour beetle%22%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small tapeworms of birds and mammals. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small, circular RNA viruses in the family ASTROVIRIDAE. They cause gastroenteritis and are found in the stools of several vertebrates including humans. Transmission is by the fecal-oral route. There are at least eight human serotypes and the type species is Human astrovirus 1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small, shell-less, marine mollusks in the family Clione, superorder GASTROPODA. These pteropod %28%possessing a foot developed into wing-like organ for swimming%29% sea slugs feed exclusively on another pteropod mollusk, Limacina.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small, straight gram-negative rods which are facultatively anaerobic, chemoorganotrophic, and usually motile by peritrichous flagella. Members of this genus are usually found in the intestines of cold-blooded animals and in fresh water. They are pathogenic for eels, CATFISHES, and other animals and are rare opportunistic pathogens for humans. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of snakes of the family VIPERIDAE, one of the pit vipers, so-called from the pit hollowing out the maxillary bone, opening between the eye and the nostril. They are distinctively American serpents. Most of the 25 recognized species are found in the southwestern United States and northern Mexico. Several species are found as far north as Canada and east of the Mississippi, including southern Appalachia. They are named for the jointed rattle %28%Greek krotalon%29% at the tip of their tail. %28%Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980, p335%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of snakes of the family VIPERIDAE. About 30 species are currently recognized, found in southeast Asia and adjacent island chains. The Okinawa habu frequently enters dwellings in search of rats and mice; the Chinese habu is often found in suburban and agricultural areas. They are quite irritable. %28%Moore: Poisonous Snakes of the World, 1980, p136%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of snakes of the family VIPERIDAE. It is distributed in West Pakistan, most of India, Burma, Ceylon, Thailand, southeast China, Taiwan, and a few islands of Indonesia. It hisses loudly when disturbed and strikes with great force and speed. Very prolific, it gives birth to 20-60 young. This viper is the leading cause of snakebite in India and Burma. %28%Moore: Poisonous Snakes of the World, 1980, p127%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of soft-shell clams in the family Myidae, class BIVALVIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of softbacked TICKS in the family ARGASIDAE. Most infect birds or bats but a few parasitize terrestrial mammals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of softbacked TICKS, in the family ARGASIDAE, serving as the vector of BORRELIA, causing RELAPSING FEVER, and of the AFRICAN SWINE FEVER VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of sphinx or hawk moths of the family Sphingidae. These insects are used in molecular biology studies during all stages of their life cycle.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of spiral bacteria of the family SPIROCHAETACEAE. This genus contains two species, SERPULINA HYODYSENTERIAE and Serpulina innocens, which were formerly classified as Treponema hyodysenteriae and Treponema innocens, respectively. When researchers determined that T. hyodysenteriae and T. innocens did not belong to the genus Treponema, the new genus was named Serpula. Within a short time, however, it was discovered that Serpula was already the name of a fungal genus and thus, Serpula was changed to Serpulina.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of straight or slightly curved gram-negative rods occurring singly or in pairs and isolated from sludge, mud, and river and pond water. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of straight, gram-negative bacterial rods which are facultatively anaerobic and motile by peritrichous flagella. This genus is found in human and animal feces, soil, water, and dairy products. It is an opportunistic pathogen in humans. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of strictly anaerobic ultrathermophilic archaea, in the family THERMOCOCCACEAE, occurring in heated seawaters. They exhibit heterotrophic growth at an optimum temperature of 100 degrees C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of strictly anaerobic, nonsporeforming gram-negative bacteria in the family Fusobacteriaceae. Species in this genus are popularly used in biochemical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of surf clams in the family Mactridae, class BIVALVIA. They are often used in EMBRYOLOGY research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tall, erect American herbs of the Compositae. The seeds yield oil and are used as food and animal feed; the roots of Helianthus tuberosum %28%Jerusalem artichoke%29% are edible.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tapeworm, containing several species, found as adults in birds and mammals. The larvae or cysticercoid stage develop in invertebrates. Human infection has been reported and is probably acquired from eating inadequately cooked meat of animals infected with the second larval stage known as the tetrahythridium.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tapeworms of the family Diphyllobothriidae, which are parasites of fish-eating cats, dogs, and birds. Infection in man is caused by eating undercooked fish. The larval form is called SPARGANUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the Ambystomatidae family. The best known species of this genus are the axolotl forms AMBYSTOMA MEXICANUM and Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the LAMIACEAE family. It is known for its mild calming effect and for the way cats are attracted to the aroma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the MYXOCOCCALES having vegetative cells which are straight rods with tapered ends and myxospores which are short and somewhat crooked. Fruiting bodies consist of spherical, ovoid, or club-shaped sporangioles on stalks. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the Torpedinidae family consisting of several species. Members of this family have powerful electric organs and are commonly called electric rays.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family ARTERIVIRIDAE, in the order NIDOVIRALES. The type species is ARTERITIS VIRUS, EQUINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BACULOVIRIDAE, subfamily Eubaculovirinae, characterized by ovicylindrical occlusion bodies. The type species is Cydia pomonella granulovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BACULOVIRIDAE, subfamily Eubaculovirinae, characterized by the formation of crystalline, polyhedral occlusion bodies in the host cell nucleus. The type species is Autographa californica nucleopolyhedrovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BROMOVIRIDAE which infects mainly woody plants. Species are divided into ten subgroups. Tobacco streak virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BROMOVIRIDAE with a wide host range. Transmission is by aphids and the type species is ALFALFA MOSAIC VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BRUCELLACEAE comprising obligately aerobic gram-negative rods with parallel sides and rounded ends.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BUNYAVIRIDAE causing HANTAVIRUS INFECTIONS, first identified during the Korean war. Infection is found primarily in rodents and humans. Transmission does not appear to involve arthropods. HANTAAN VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BUNYAVIRIDAE comprising many viruses, most of which are transmitted by Phlebotomus flies and cause PHLEBOTOMUS FEVER. The type species is RIFT VALLEY FEVER VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BUNYAVIRIDAE containing over 150 viruses, most of which are transmitted by mosquitoes or flies. They are arranged in groups defined by serological criteria, each now named for the original reference species %28%previously called serogroups%29%. Many species have multiple serotypes or strains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family BUNYAVIRIDAE named after NAIROBI SHEEP DISEASE, an acute, hemorrhagic, tick-borne, gastroenteritis affecting sheep and goats. The type species is Dugbe virus. Some viruses in this genus are capable of causing severe and fatal disease in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Bovidae having two species: B. bison and B. bonasus. This concept is differentiated from BUFFALOES, which refers to Bubalus arnee and Syncerus caffer.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CALICIVIRIDAE associated with worldwide sporadic outbreaks of GASTROENTERITIS in humans. The first recorded outbreak was in human infants in Sapporo, Japan in 1977. The genus is comprised of a single species, Sapporo virus, containing multiple strains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CALICIVIRIDAE comprised of species infecting a wide range of organisms. Most members of this genus can be readily propagated in cell culture %28%as opposed to other genera of Caliciviridae%29%. The type species is VESICULAR EXANTHEMA OF SWINE VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CALICIVIRIDAE, associated with infections in rabbits and hares, responsible for epidemics with high mortality. RABBIT HEMORRHAGIC DISEASE VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CEBIDAE consisting of four species: S. boliviensis, S. orstedii %28%red-backed squirrel monkey%29%, S. sciureus %28%common squirrel monkey%29%, and S. ustus. They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CEBIDAE, subfamily CEBINAE, consisting of four species which are divided into two groups, the tufted and untufted. C. apella has tufts of hair over the eyes and sides of the head. The remaining species are without tufts - C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South America.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CHLAMYDIACEAE comprising gram-negative non CHLAMYDIA TRACHOMATIS-like species infecting vertebrates. Chlamydophila do not produce detectable quantities of glycogen. The type species is CHLAMYDOPHILA PSITTACI.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CIRCOVIRIDAE that infects SWINE; PSITTACINES; and non-psittacine BIRDS. Species include Beak and feather disease virus causing a fatal disease in psittacine birds, and Porcine circovirus causing postweaning multisystemic wasting syndrome in pigs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family COMOVIRIDAE with a wide host range among dicotyledons and some monocotyledons. They are transmitted nonpersistently by aphids. The type species is broad bean wilt virus 1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CORONAVIRIDAE characterized by enveloped, peplomer-bearing particles containing an elongated tubular nucleocapsid with helical symmetry. Toroviruses have been found in association with enteric infections in horses %28%Berne virus%29%, cattle %28%Breda virus%29%, swine, and humans. Transmission probably takes place via the fecal-oral route.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of vertebrates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Chinchillidae which consists of three species: C. brevicaudata, C. lanigera, and C. villidera. They are used extensively in biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, with a single species: HERPESVIRUS 1, GALLID.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE. Its species include those causing CHICKENPOX and HERPES ZOSTER in humans %28%HERPESVIRUS 3, HUMAN%29%, as well as several animal viruses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, causing infection involving several organs in mice and rats. Murid herpesvirus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, whose viruses have been isolated from lymphocytes. HERPESVIRUS 6, HUMAN is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans and new world primates. The type species human herpesvirus 4 %28%HERPESVIRUS 4, HUMAN%29% is better known as the Epstein-Barr virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting New World primates and other species. HERPESVIRUS 2, SAIMIRIINE is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family HYLOBATIDAE consisting of six species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees. Some authors refer to Symphalangus and Nomascus as Hylobates. The six genera include: H. concolor %28%crested or black gibbon%29%, H. hoolock %28%Hoolock gibbon%29%, H. klossii %28%Kloss%27%s gibbon; dwarf siamang%29%, H. lar %28%common gibbon%29%, H. pileatus %28%pileated gibbon%29%, and H. syndactylus %28%siamang%29%. H. lar is also known as H. agilis %28%lar gibbon%29%, H. moloch %28%agile gibbon%29%, and H. muelleri %28%silvery gibbon%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They are found in arid or desert habitats and travel by hopping on their hind limbs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Lemuridae consisting of five species: L. catta %28%ring-tailed lemur%29%, L. fulvus, L. macaco %28%acoumba or black lemur%29%, L. mongoz %28%mongoose lemur%29%, and L. variegatus %28%white lemur%29%. Most members of this genus occur in forested areas on Madagascar and the Comoro Islands.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Lorisidae having four species which inhabit the forests and bush regions of Africa south of the Sahara and some nearby islands. The four species are G. alleni, G. crassicaudatus, G. demidovii, and G. senegalensis. There is another genus, Euoticus, containing two species which some authors have included in the Galago genus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family ORTHOMYXOVIRIDAE comprising tick-borne viruses occasionally infecting humans. Dhori and Thogoto viruses were formerly thought to be members of BUNYAVIRIDAE. Thogoto virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to types A and B but less common, more stable, more homogeneous, and lacking the neuraminidase protein. They have not been associated with epidemics but may cause mild influenza. Influenza C virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family ORTHOMYXOVIRUS causing HUMAN INFLUENZA and other diseases primarily in humans. In contrast to INFLUENZAVIRUS A, no distinct antigenic subtypes of hemagglutinin %28%HEMAGGLUTINS%29% and NEURAMINIDASE are recognized.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where all the species have hemagglutinin and neuraminidase activities but lack a C protein. MUMPS VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where all the virions have both HEMAGGLUTININ and NEURAMINIDASE activities and encode a non-structural C protein. SENDAI VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARAMYXOVIRIDAE %28%subfamily PARAMYXOVIRINAE%29% where the virions of most members have hemagglutinin but not neuraminidase activity. All members produce both cytoplasmic and intranuclear inclusion bodies. MEASLES VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARAMYXOVIRIDAE %28%subfamily PNEUMOVIRINAE%29% where the human and bovine virions have neither hemagglutinin nor neuraminidase activity. RESPIRATORY SYNCYTIAL VIRUS, HUMAN is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, and containing the type species PARVOVIRUS B19, HUMAN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, infecting a variety of vertebrates including humans. Parvoviruses are responsible for a number of important diseases but also can be non-pathogenic in certain hosts. The type species is MICE MINUTE VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. The type species is Adeno-associated virus 2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PICORNAVIRIDAE causing encephalitis and myocarditis in rodents. ENCEPHALOMYOCARDITIS VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated %22%human enterovirus%22%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, causing tumors in primates. The type species is YABA MONKEY TUMOR VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising bird poxviruses. The type species is FOWLPOX VIRUS. Transmission is mechanical by arthropods.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising poxviruses infecting sheep, goats, and cattle. Transmission is usually mechanical by arthropods, but also includes contact, airborne routes, and non-living reservoirs %28%fomites%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, consisting of ether-sensitive viruses of leporids and squirrels. They commonly cause tumors and are usually transmitted mechanically by arthropods. MYXOMA VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, containing one species, swinepox virus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, which infect ungulates and may infect humans. ORF VIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family REOVIRIDAE infecting vertebrates only. Transmission is horizontal and infected species include humans, birds, cattle, monkeys, sheep, swine, baboons, and bats. MAMMALIAN ORTHOREOVIRUS is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames %28%ORFs%29% between the pol and env genes and in the 3%27% env region. Five serogroups are recognized, reflecting the mammalian hosts with which they are associated. HIV-1 is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family RETROVIRIDAE consisting of viruses with either type B or type D morphology. This includes a few exogenous, vertically transmitted and endogenous viruses of mice %28%type B%29% and some primate and sheep viruses %28%type D%29%. MAMMARY TUMOR VIRUS, MOUSE is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family RETROVIRIDAE with type C morphology, that causes malignant and other diseases in wild birds and domestic fowl.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family RHABDOVIRIDAE that includes RABIES VIRUS and other rabies-like viruses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family RHABDOVIRIDAE that infects a wide range of vertebrates and invertebrates. The type species is VESICULAR STOMATITIS-INDIANA VIRUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family RHABDOVIRIDAE which primarily infect cattle. EPHEMERAL FEVER VIRUS, BOVINE is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family SALMONIDAE %28%salmons and trouts%29%. They are named for their hooked %28%onco%29% nose %28%rhynchus%29%. They are usually anadromous and occasionally inhabit freshwater. They can be found in North Pacific coastal areas from Japan to California and adjacent parts of the Arctic Ocean. Salmon and trout are popular game and food fish. Various species figure heavily in genetic, metabolism, and hormone research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the family TOGAVIRIDAE containing only one recognized species, RUBELLA VIRUS. Transmission is primarily by aerosolization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the order Sirenia characterized by a notched tail, the presence of nasal bones and a long nasal cavity, and large columnar teeth lacking enamel. Dugongs inhabit the coastal waters of the Indian Ocean, Red Sea, and the Malay Archipelago. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the order Sirenia comprising what are commonly called manatees. The distinguishing characteristics include a tail that is not notched, a short nasal cavity, the absence of nasal bones, and enamel-covered teeth. Members of this genus are found in marine bays and/or sluggish rivers, usually in turbid water. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the plant family Liliaceae %28%sometimes classified as Alliaceae%29% in the order Liliales. Many produce pungent, often bacteriostatic and physiologically active compounds and are used as food, condiment, and medicament, the latter in traditional medicine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily ALOUATTINAE, family CEBIDAE, composed of six species. They are A. belzebul %28%black and red howler%29%, A. caraya %28%black howler%29%, A. fusca %28%brown howler%29%, A. palliata %28%mantled howler%29%, A. seniculus %28%red howler%29%, and A. villosa %28%also known as A. pigra; Guatemalan howler%29%. They inhabit the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily CERCOPITHECINAE inhabiting the African forests. They are also known as mangabeys.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, comprising two species: the drill %28%M. leucophaeus%29% and the mandrill %28%M. sphinx%29%. They are usually found in thick rainforest and have a gentle disposition despite their ferocious reputation. Some authors consider Mandrillus a subgenus of PAPIO.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS %28%chacma baboon%29%, PAPIO CYNOCEPHALUS %28%yellow baboon%29%, PAPIO PAPIO %28%western baboon%29%, PAPIO ANUBIS %28%or olive baboon%29%, and PAPIO HAMADRYAS %28%hamadryas baboon%29%. Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily PNEUMOVIRINAE, containing two members: Turkey rhinotracheitis virus and a human Metapneumovirus. Virions lack HEMAGGLUTININ and NEURAMINIDASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily SIGMODONTINAE consisting of 49 species. Two of these are widely used in medical research. They are P. leucopus, or the white-footed mouse, and P. maniculatus, or the deer mouse.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily TRIATOMINAE. Rhodnius prolixus is a vector for TRYPANOSOMA CRUZI.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of the subfamily TRIATOMINAE. Several species are vectors of TRYPANOSOMA CRUZI.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of thin-shelled freshwater mussels in the family UNIONIDAE, class BIVALVIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tick-borne protozoa parasitic in the lymphocytes, erythrocytes, and endothelial cells of mammals. Its organisms multiply asexually and then invade erythrocytes, where they undergo no further reproduction until ingested by a transmitting tick.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tick-borne protozoan parasites that infests the red blood cells of mammals, including humans. There are many recognized species, and the distribution is world-wide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of toxic herbaceous Eurasian plants of the SCROPHULARIACEAE which yield cardiotonic DIGITALIS GLYCOSIDES. The most useful species are Digitalis lanata and D. purpurea.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of toxic marine GREEN ALGAE found throughout tropical and subtropical seas. One species, Caulerpa taxifolia, is highly invasive and produces the poison caulerpenyne, deadly to marine organisms though not humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tree shrews of the family TUPAIIDAE which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus inhabit rain forests and secondary growth areas in southeast Asia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of trees in the VERBENACEAE %28%sometimes classified in the LAMIACEAE%29% family containing assorted flavonoids with possible analgesic and antineoplastic properties. The fruit of these trees is used in herbal preparations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of trematode liver flukes of the family Dicrocoeliidae which includes the species dendriticum and hospes. It occurs in the biliary passages or liver of many vertebrates including man. The intermediate hosts are mainly mollusks but occasionally ants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of trematode liver flukes of the family Opisthorchidae. It consists of the following species: O. felineus, O. noverca %28%Amphimerus noverca%29%, and O. viverrini. The intermediate hosts are snails, fish, and amphibia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species, C. hepatica and C. philippinensis, produce often fatal infections in man.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of tripartite plant viruses in the family BROMOVIRIDAE. Transmission is by beetles. Brome mosaic virus is the type species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of velvety smooth SPONGES in the family Suberitidae, characterized by the ectosomal and choanosomal skeletons dominated by tylostyles %28%pin-like spicules with a pinched bulbous end%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. %28%Goin, Goin, and Zug, Introduction to Herpetology, 3d ed, p336; Moore, Poisonous Snakes of the World, 1980, p75%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of very large, epibenthic SEA CUCUMBERS in the family Stichopodidae, commercially harvested in Southeast Asia for food.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of very small TAPEWORMS, in the family Taeniidae. The adult form is found in various CARNIVORA but not humans. The larval form is seen in humans under certain epidemiologic circumstances.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of vibrioid or rod-shaped cells which are motile by polar flagella. Internal photosynthetic membranes are present as lamellar stacks and contain bacteriochlorophyll a or b and carotenoids. Growth occurs photoautotrophically under anaerobic conditions. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; vulvovaginal candidiasis %28%CANDIDIASIS, VULVOVAGINAL%29%, and thrush %28%see CANDIDIASIS, ORAL%29%. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi in the family Mucoraceae, order MUCORALES, forming mycelia having a metallic sheen. It has been used for research on phototropism.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi of the family Cunninghamellaceae, order MUCORALES. Some species cause systemic infections in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi of the family Mortierellaceae, order MUCORALES. Its species are abundant in soil and can cause rare infections in humans and animals. Mortierella alpinais is used for production of arachidonic acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES, a common saprophyte and facultative parasite of mature fruits and vegetables. It may cause cerebral mycoses in diabetes and cutaneous infection in severely burned patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi of the family Mucoraceae, order Mucorales. It is primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus, Muntiacus, of the deer family %28%Cervidae%29% comprising six species living in China, Tibet, Nepal, India, the Malay Peninsula, and neighboring island countries. They are usually found in forests and areas of dense vegetation, usually not far from water. They emit a deep barklike sound which gives them the name %22%barking deer.%22% If they sense a predator they will %22%bark%22% for an hour or more. They are hunted for their meat and skins; they thrive in captivity and are found in many zoos. The Indian muntjac is believed to have the lowest chromosome number in mammals and cell lines derived from them figure widely in chromosome and DNA studies. %28%From Walker%27%s Mammals of the World, 5th ed., p1366%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus, commonly called budgerigars, in the family PSITTACIDAE. In the United States they are considered one of the five species of PARAKEETS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A genus, in the family HYPHOMICROBIACEAE, comprised of ovoid-shaped bacteria with polar growth and a characteristic vegetative growth cycle. Cells grow preferably photoheterotrophically under anaerobic conditions in the light, but will also grow under microaerobic or aerobic conditions in the dark. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A geographic area defined and served by a health program or institution.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A geographic area of east and southeast Asia encompassing CHINA; HONG KONG; JAPAN; KOREA; MACAO; MONGOLIA; and TAIWAN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A geographic location which has insufficient health resources %28%manpower and/or facilities%29% to meet the medical needs of the resident population.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A geographical area of the United States comprising the District of Columbia, Delaware, Maryland, New Jersey, New York, and Pennsylvania.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A geographical area of the United States with no definite boundaries but comprising northeastern Alabama, northwestern Georgia, northwestern South Carolina, western North Carolina, eastern Kentucky, eastern Tennessee, western Virginia, West Virginia, western Maryland, southwestern Pennsylvania, southern Ohio, and southern New York.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gland in males that surrounds the neck of the BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glandular epithelial cell or a unicellular gland. Goblet cells secrete MUCUS. They are scattered in the epithelial linings of many organs, especially the SMALL INTESTINE and the RESPIRATORY TRACT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glial cell line-derived neurotrophic factor ligand that is specific for the GFRA2 RECEPTOR. Neurturin is essential for the development of specific postganglionic parasympathetic NEURONS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glial type glutamate plasma membrane transporter protein found predominately in ASTROCYTES. It is also expressed in HEART and SKELETAL MUSCLE and in the PLACENTA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p732%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p732%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p724%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p739%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid used topically in the treatment of DERMATITIS; ECZEMA; or PSORIASIS. It may cause skin irritation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid with anti-inflammatory activity used topically for various skin disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p737%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucose dehydrogenase that catalyzes the oxidation of beta-D-glucose to form D-glucono-1,5-lactone, using NAD as well as NADP as a coenzyme.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucose transport facilitator that is expressed primarily in PANCREATIC BETA CELLS; LIVER; and KIDNEYS. It may function as a GLUCOSE sensor to regulate INSULIN release and glucose HOMEOSTASIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glucose transport protein found in mature MUSCLE CELLS and ADIPOCYTES. It promotes transport of glucose from the BLOOD into target TISSUES. The inactive form of the protein is localized in CYTOPLASMIC VESICLES. In response to INSULIN, it is translocated to the PLASMA MEMBRANE where it facilitates glucose uptake.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glutamate antagonist %28%RECEPTORS, GLUTAMATE%29% used as an anticonvulsant %28%ANTICONVULSANTS%29% and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glutamate plasma membrane transporter protein that is primarily expressed in cerebellar PURKINJE CELLS on postsynaptic DENDRITIC SPINES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glutamate plasma membrane transporter protein that is primarily expressed in the RETINA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glutathione transferase that catalyzes the conjugation of electrophilic substrates to GLUTATHIONE. This enzyme has been shown to provide cellular protection against redox-mediated damage by FREE RADICALS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycine-rich, heat-labile serum glycoprotein that contains a component of the ALTERNATIVE COMPLEMENT C3 CONVERTASE %28%C3bBb%29%. Bb, a serine protease, is generated when factor B is cleaved by COMPLEMENT FACTOR D into Ba and Bb.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycogen synthase kinase that was originally described as a key enzyme involved in glycogen metabolism. It regulates a diverse array of functions such as CELL DIVISION, microtubule function and APOPTOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycolipid, cross-species antigen that induces production of antisheep hemolysin. It is present on the tissue cells of many species but absent in humans. It is found in many infectious agents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein albumin from hen%27%s egg white with strong iron-binding affinity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5%27%-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein hormone secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%. Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones %28%TSH; LUTEINIZING HORMONE and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein migrating as alpha 1-globulin, molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein secreted by the cells of the gastric glands that is required for the absorption of VITAMIN B 12. Deficiency of intrinsic factor results in ANEMIA, PERNICIOUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in GAUCHER DISEASE. EC 3.2.1.45.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoside hydrolase found primarily in PLANTS and YEASTS. It has specificity for beta-D-fructofuranosides such as SUCROSE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoside obtained from Digitalis purpurea; the aglycone is digitogenin which is bound to five sugars. Digitonin solubilizes lipids, especially in membranes and is used as a tool in cellular biochemistry, and reagent for precipitating cholesterol. It has no cardiac effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycoside of a kaurene type diterpene that is found in some plants including Atractylis gummifera %28%ATRACTYLIS%29%; COFFEE; XANTHIUM, and CALLILEPIS. Toxicity is due to inhibition of ADENINE NUCLEOTIDE TRANSLOCASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A glycosphingolipid that accumulates due to a deficiency of hexosaminidase A or B %28%BETA-N-ACETYLHEXOSAMINIDASE%29%, or GM2 activator protein, resulting in GANGLIOSIDOSES, heredity metabolic disorders that include TAY-SACHS DISEASE and SANDHOFF DISEASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gonadal stimulant and inducer of ovulation. It is used in the treatment of infertility and amenorrhea, but is thought to be less effective than CLOMIPHENE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gonadal stromal neoplasm composed only of THECA CELLS, occurring mostly in the postmenopausal OVARY. It is filled with lipid-containing spindle cells and produces ESTROGENS that can lead to ENDOMETRIAL HYPERPLASIA; UTERINE HEMORRHAGE; or other malignancies in postmenopausal women and sexual precocity in girls. When tumors containing theca cells also contain FIBROBLASTS, they are identified as thecoma-fibroma tumors with less active hormone production.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the three pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity %28%CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-negative gliding bacterium isolated from the oral cavity. It is a pathogen often causing PERIODONTITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-negative, facultatively chemoautotrophic bacterium, formerly called Ralstonia eutropha, found in water and soil.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-negative, obligate anaerobe of the family Cardiobacteriaceae. It has polar fimbriae and is the causative agent of ovine FOOT ROT. It is the lone species in the genus Dichelobacter.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-negative, rod-shaped to coccoid bacterium. It is the etiologic agent of SCRUB TYPHUS in humans and is transmitted by mites from rodent reservoirs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-positive organism found in dental plaque, in blood, on heart valves in subacute endocarditis, and infrequently in saliva and throat specimens. L-forms are associated with recurrent aphthous stomatitis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A granulomatous disease affecting the nose and nasopharynx, usually ascribed to KLEBSIELLA RHINOSCLEROMATIS. It occurs in Egypt, eastern Europe, and Central and South America.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A graphic device used in decision analysis, series of decision options are represented as branches %28%hierarchical%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A gray substance found in the GASTROINTESTINAL TRACT of the SPERM WHALE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A groin hernia occurring inferior to the inguinal ligament and medial to the FEMORAL VEIN and FEMORAL ARTERY. The femoral hernia sac has a small neck but may enlarge considerably when it enters the subcutaneous tissue of the thigh. It is caused by defects in the ABDOMINAL WALL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group comprised of several species of aquatic carnivores in different genera, in the family Otariidae. In comparison to FUR SEALS, they have shorter, less dense hair.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group comprised of several species of eared seals found in two genera, in the family Otariidae. In comparison to SEA LIONS, they have an especially dense wooly undercoat.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 1,2-benzenediols that contain the general formula R-C6H5O2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 13 or more ribonucleotides in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 16-carbon fatty acids that contain no double bonds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 16-member MACROLIDES which stabilize MICROTUBULES in a manner similar to PACLITAXEL. They were originally found in the myxobacterium Sorangium cellulosum, now renamed to Polyangium %28%MYXOCOCCALES%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 3-hydroxy-4-keto-FLAVONOIDS. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 4-keto-FLAVONOIDS. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 6-alkyl SALICYLIC ACIDS that are found in ANACARDIUM and known for causing CONTACT DERMATITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of 7 proteins produced from a single gene by alternate splicing found in central and peripheral nervous system myelin. The major basic protein %28%MBP%29% has long been of interest because it is the antigen, that, when injected into an animal, elicits a cellular immune response that produces the CNS autoimmune disease called experimental allergic encephalomyelitis %28%ENCEPHALOMYELITIS, ALLERGIC%29%. In the peripheral nervous system, myelin basic protein 18.5-kDa is often referred to as the P1 protein. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p130, 133%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of ALGAE, formerly considered FUNGI, whose exact taxonomic level is unsettled. Many consider Oomycetes %28%Oomycota%29% a phylum in the kingdom Stramenopila, or alternatively, as Pseudofungi in the phylum Heterokonta of the kingdom Chromista. They are morphologically similar to fungi but have no close phylogenetic relationship to them. Oomycetes are found in both fresh and salt water as well as in terrestrial environments. %28%Alexopoulos et al., Introductory Mycology, 4th ed, pp683-4%29%. They produce flagellated, actively motile spores %28%zoospores%29% that are pathogenic to many crop plants and FISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of ALKALOIDS, characterized by a nitrogen-containing necine, occurring mainly in plants of the BORAGINACEAE; COMPOSITAE; and LEGUMINOSAE plant families. They can be activated in the liver by hydrolysis of the ester and desaturation of the necine base to reactive electrophilic pyrrolic CYTOTOXINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of ALPHAVIRUS INFECTIONS which affect horses and man, transmitted via the bites of mosquitoes. Disorders in this category are endemic to regions of South America and North America. In humans, clinical manifestations vary with the type of infection, and range from a mild influenza-like syndrome to a fulminant encephalitis. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp8-10%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of AROMATIC HYDROCARBONS that have three rings joined as a triad around a single carbon atom so all three are conjoined, in contrast to a linear arrangement %28%ANTHRACENES%29% or angular arrangement %28%PHENANTHRENES%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of CORTICOSTEROIDS primarily associated with the water and electrolyte balance. This is accomplished through the effect on ION TRANSPORT in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by PLASMA VOLUME, serum potassium, and ANGIOTENSIN II.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of CORTICOSTEROIDS that affect carbohydrate metabolism %28%GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR%29%, inhibit CORTICOTROPIN secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of D-related human leukocyte antigens that are polymorphic glycoproteins found on lymphoid cells. They consist of alpha and beta chains and their inheritance differs from that of the DQ and DP antigens; their presence seems to be associated with certain skin diseases like pemphigus vulgaris, dermatitis herpetiformis, and type I diabetes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of DITERPENES cyclized into 2-rings with a side-chain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of DITERPENES cyclized into 3-ring PHENANTHRENES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of DITERPENES cyclized into four rings. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of FLAVONOIDS characterized with a 4-ketone. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of FLAVONOIDS derived from FLAVONOLS, which lack the ketone oxygen at the 4-position. They are glycosylated versions of cyanidin, pelargonidin or delphinidin. The conjugated bonds result in blue, red, and purple colors in flowers of plants.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of FLAVONOLS based on kaempferol. They are derived from naringenin and can be hydroxylated to QUERCETIN or reduced to leucopelargonidin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of GLYCOLIPIDS in which the sugar group is GALACTOSE. They are distinguished from GLYCOSPHINGOLIPIDS in lacking nitrogen. They constitute the majority of MEMBRANE LIPIDS in PLANTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of INTEGRINS that includes the platelet outer membrane glycoprotein GPIIb-IIIa %28%PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX%29% and the vitronectin receptor %28%RECEPTORS, VITRONECTIN%29%. They play a major role in cell adhesion and serve as receptors for fibronectin, von Willebrand factor, and vitronectin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of Indian Ocean Islands, east of Tanzania. Their capital is Victoria. They were first claimed by the French in 1744 but taken by the English in 1794 and made a dependency of MAURITIUS in 1810. They became a crown colony in 1903 and a republic within the Commonwealth in 1976. They were named for the French finance minister, Jean Moreau de Sechelles, but respelled by the English in 1794. %28%From Webster%27%s New Geographical Dictionary, 1988, p1102 %26% Room, Brewer%27%s Dictionary of Names, 1992, p496%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of Indian Ocean Islands, the islands of Great Comoro, Anjouan, Mayotte, and Moheli, lying between northeast Mozambique and northwest Madagascar. The capital is Moroni. In 1914 they became a colony attached to Madagascar administratively and were made a French overseas territory in 1947. Except for Mayotte which remained French, Comoros became an independent republic in 1975. Comoros represents the Arabic qamar, moon, said by some scholars to be linked with the mystical Mountains of the Moon said to be somewhere in equatorial Africa. %28%From Webster%27%s New Geographical Dictionary, 1988, p283 %26% Room, Brewer%27%s Dictionary of Names, 1992, p122%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of LEUKOTRIENES; %28%LTC4; LTD4; and LTE4%29% that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a %22%slow-reacting substance of ANAPHYLAXIS%22% released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of MYCOTOXINS found in CORN contaminated with FUSARIUM fungus. They are chains of about 20 carbons with acidic ester, acetylamino and sometimes other substituents. They inhibit ceramide synthetase conversion of SPHINGOLIPIDS to CERAMIDES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of PROTEOBACTERIA represented by morphologically diverse, anaerobic sulfidogens. Some members of this group are considered bacterial predators, having bacteriolytic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of SESQUITERPENES and their analogs that contain a peroxide group %28%PEROXIDES%29% within an oxepin ring %28%OXEPINS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of TETRAHYDRONAPHTHALENES containing a keto oxygen.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of XANTHENES that contain a 9-keto OXYGEN. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of abnormal hemoglobins in which amino acid substitutions take place in either the alpha or beta chains but near the heme iron. This results in facilitated oxidation of the hemoglobin to yield excess methemoglobin which leads to cyanosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of abnormal hemoglobins with similar electrophoretic characteristics. They have faster electrophoretic mobility and different amino acid substitutions in either the alpha or beta chains than normal adult hemoglobin. Some of the variants produce hematologic abnormalities, others result in no clinical disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. %28%Dorland, 27th ed.%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, KALLIKREINS, papain and the cathepsins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of adenine ribonucleotides in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of alicyclic hydrocarbons with the general formula R-C5H9.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of alicyclic hydrocarbons with the general formula R-C6H11.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of amides with the general formula of R-CONH2. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of amylolytic enzymes that cleave starch, glycogen, and related alpha-1,4-glucans. %28%Stedman, 25th ed%29% EC 3.2.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of anaerobic coccoid bacteria that show up as pink %28%negative%29% when treated by the gram-staining method.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of anaerobic, rod-shaped bacteria that show up as pink %28%negative%29% when treated by the Gram-staining method.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of antibiotic aminoglycosides differing only in the number of repeating residues in the peptide side chain. They are produced by Streptomyces and Actinomyces and may have broad spectrum antimicrobial and some antiviral properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. %28%Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1065%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of antigens consisting principally of Jk%28%a%29% and Jk%28%b%29%, determined by allelic genes. Amorphs are encountered. Antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive DNA or RNA sequences are used in MOLECULAR GENETICS to detect the presence of a complementary sequence by NUCLEIC ACID HYBRIDIZATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE %28%i.e., atypical phenylketonuria%29%. Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. %28%From Adams et al., Principles of Neurology, 6th ed, p952%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of autosomal-dominant inherited diseases in which COLON CANCER arises in discrete adenomas. Unlike FAMILIAL POLYPOSIS COLI with hundreds of polyps, hereditary nonpolyposis colorectal neoplasms occur much later, in the fourth and fifth decades. HNPCC has been associated with germline mutations in mismatch repair %28%MMR%29% genes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. EC 4.2.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round %22%blue cells%22%, granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small %28%%22%oat%22%%29% cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of carrier proteins which bind with VITAMIN B12 in the BLOOD and aid in its transport. Transcobalamin I migrates electrophoretically as a beta-globulin, while transcobalamins II and III migrate as alpha-globulins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cell-surface receptors for oxidatively modified LOW-DENSITY LIPOPROTEINS. The group includes certain SCAVENGER RECEPTORS that contribute to the pathogenesis of ATHEROSCLEROSIS by uptake of oxidized LDL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cells at the base of a leaf in certain plants that, by rapidly losing water, brings about changes in the position of the leaves. %28%Concise Dictionary of Biology, 1990%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cells that includes FIBROBLASTS, cartilage cells, ADIPOCYTES, smooth muscle cells, and bone cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of closely related heterogeneous-nuclear ribonucleoproteins of approximately 41-43 kDa in size found in the cell nucleus. Members of this class have been implicated in a variety of processes including splicing, polyadenylation, and nuclear retention of RNA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of closely-related 72-74-kDa heterogeneous-nuclear ribonucleoproteins that are involved in RNA SPLICING events.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of closely-related heterogeneous-nuclear ribonucleoproteins that are involved in pre-mRNA splicing.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cognitive disorders characterized by the inability to perform previously learned skills that cannot be attributed to deficits of motor or sensory function. The two major subtypes of this condition are ideomotor %28%see APRAXIA, IDEOMOTOR%29% and ideational apraxia, which refers to loss of the ability to mentally formulate the processes involved with performing an action. For example, dressing apraxia may result from an inability to mentally formulate the act of placing clothes on the body. Apraxias are generally associated with lesions of the dominant PARIETAL LOBE and supramarginal gyrus. %28%From Adams et al., Principles of Neurology, 6th ed, pp56-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds consisting in part of two rings sharing one carbon atom in common.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds consisting of two aromatic rings separated by seven carbons %28%HEPTANES%29% and having various substituents. The best known member is CURCUMIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds forming the nucleus of the estrogenic steroid family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds having the general formula CH2=C%28%CN%29%-COOR; it polymerizes on contact with moisture; used as tissue adhesive; higher homologs have hemostatic and antibacterial properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of aminohexanoic acids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of beta-methylacetylcholine %28%methacholine%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of octadecanoic acid which is one of the most abundant fatty acids found in animal lipids. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of phenylpyruvic acid which has the general formula C6H5CH2COCOOH, and is a metabolite of phenylalanine. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are derivatives of the amino acid 2-amino-2-methylpropanoic acid.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are methyl derivatives of the amino acid TYROSINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are monomethyl derivatives of pyridines. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that are structurally related to methoxybenzene and contain the general formula R-C7H70.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic %28%nascent%29% oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that contain the general formula R-OCH3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that contain the structure SO2NH2. Members of this group, also known as sulfa drugs, are derivatives of sulfanilamide, which competitively inhibit folic acid synthesis in microorganisms, and are bacteriostatic. They have been largely supplanted by more effective and less toxic antibiotics. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds that has the general structure of a dicarboxylic acid-substituted benzene ring. The ortho-isomer is used in dye manufacture. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds which can be described as benzo-pyrano-furano-benzenes which can be formed from ISOFLAVONES by internal coupling of the B ring to the 4-ketone position. Members include medicarpin, phaseolin, and pisatin which are found in FABACEAE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule%28%s%29%. The nucleotide can contain any number of phosphates.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds with an 8-carbon ring. They may be saturated or unsaturated.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds with the general formula M10%28%PO4%29%6%28%OH%29%2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds with the heterocyclic ring structure of benzo%28%c%29%pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of compounds with three aromatic rings joined in linear arrangement.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of condensed ring hydrocarbons. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of conditions due to overexposure to or overexertion in excess environmental temperature. It includes heat cramps, which are non-emergent and treated by salt replacement; HEAT EXHAUSTION, which is more serious, treated with fluid and salt replacement; and HEAT STROKE, a condition most commonly affecting extremes of age, especially the elderly, accompanied by convulsions, delusions, or coma and treated with cooling the body and replacement of fluids and salts. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of congenital malformations involving the brainstem, cerebellum, upper spinal cord, and surrounding bony structures. Type II is the most common, and features compression of the medulla and cerebellar tonsils into the upper cervical spinal canal and an associated MENINGOMYELOCELE. Type I features similar, but less severe malformations and is without an associated meningomyelocele. Type III has the features of type II with an additional herniation of the entire cerebellum through the bony defect involving the foramen magnum, forming an ENCEPHALOCELE. Type IV is a form a cerebellar hypoplasia. Clinical manifestations of types I-III include TORTICOLLIS; opisthotonus; HEADACHE; VERTIGO; VOCAL CORD PARALYSIS; APNEA; NYSTAGMUS, CONGENITAL; swallowing difficulties; and ATAXIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p261; Davis, Textbook of Neuropathology, 2nd ed, pp236-46%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of corticosteroids bearing a hydroxy group at the 11-position.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of corticosteroids carrying hydroxy groups, usually in the 11- or 17-positions. They comprise the bulk of the corticosteroids used systemically. As they are relatively insoluble in water, salts of various esterified forms are often used for injections or solutions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of crystallins that have been found in the lens %28%LENS, CRYSTALLINE%29% of DUCKS and CROCODILES. They are inactivated forms of the B chain subunit of lactate dehydrogenase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of crystallins that have been found in the lens %28%LENS, CRYSTALLINE%29% of certain species of VERTEBRATES including GUINEA PIGS; CAMELS; and LLAMAS. They are inactivated forms of NAD%28%P%29%H DEHYDROGENASE %28%QUINONE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. %28%Enzyme Nomenclature, 1992, p539%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of cytosine ribonucleotides in which the phosphate residues of each cytosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of degraded TRITERPENES in which the four terminal carbons of the C17 side chain have been removed, and the remaining portion often forming C17 furans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of degraded TRITERPENES which have lost ten carbons %28%8 from the side chain, C17, and one from C4%29% so have C20 skeletons which could be misinterpreted as DITERPENES. They especially occur in plants of the SIMAROUBACEAE family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of deoxyribonucleotides %28%up to 12%29% in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of dermatoses with distinct morphologic features. The primary lesion is most commonly a papule, usually erythematous, with a variable degree of scaling on the surface. Plaques form through the coalescing of primary lesions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of desmosomal cadherins with cytoplasmic tails that are divergent from those of classical CADHERINS. Their intracytoplasmic domains bind PLAKOGLOBIN; PLAKOPHILINS; and DESMOPLAKINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of desmosomal cadherins with cytoplasmic tails that resemble those of classical CADHERINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of dicarboxylic acids that are structurally related to hexanedioic acid %28%adipic acid%29%. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of dipyridinium chloride derivatives that are used as oxidation-reduction indicators. The general formula is 1,1%27%-di-R-4,4%27%-bipyridinium chloride, where R = methyl, ethyl, benzyl or, betaine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features %28%DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY%29% or their etiological/pathological factors %28%CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of diseases marked by autosomal recessive inheritance and accumulation of sphingomyelin in cells of the RETICULOENDOTHELIAL SYSTEM. They are divided into 5 subtypes: A-E. Type A %28%classic infantile form%29% is caused by a deficiency of SPHINGOMYELIN PHOSPHODIESTERASE and presents at age 6-12 months with progressive hepatosplenomegaly and neurologic deterioration. Type B %28%non-neuronopathic form%29% presents in childhood with hepatosplenomegaly and pulmonary infiltrates. Type C %28%chronic neuronopathic form%29% is caused by defective intracellular cholesterol transport and is divided into severe infantile, late infantile, juvenile, and neonatal hepatitis forms. Type D %28%Nova Scotian Variant%29% is phenotypically similar to type C. Type E is an adult non-neuronopathic form. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp101-4%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, p49%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders caused by the defective salt reabsorption in the ascending LOOP OF HENLE. It is characterized by severe salt-wasting, HYPOKALEMIA, hypercalciuria, metabolic ALKALOSIS, and hyper-reninemic HYPERALDOSTERONISM without HYPERTENSION. There are several subtypes resulting from mutations of autosomal recessive genes for SODIUM-POTASSIUM-CHLORIDE COTRANSPORTERS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 %28%generalized neurofibromatosis%29% accounts for approximately 95%25% of cases, although multiple additional subtypes %28%e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.%29% have been described. %28%From Neurochirurgie 1998 Nov;44%28%4%29%:267-72%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders characterized by ectodermal-based malformations and neoplastic growths in the skin, nervous system, and other organs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. %28%American Psychiatric Glossary, 1988%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders characterized by swelling, basophilia, and distortion of collagen bundles in the dermis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. %28%From Dorland, 28th ed %26% Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders marked by progressive degeneration of motor neurons in the spinal cord resulting in weakness and muscular atrophy, usually without evidence of injury to the corticospinal tracts. Diseases in this category include Werdnig-Hoffmann disease and later onset SPINAL MUSCULAR ATROPHIES OF CHILDHOOD, most of which are hereditary. %28%Adams et al., Principles of Neurology, 6th ed, p1089%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism %28%see PARKINSON DISEASE%29%, secondary parkinsonism %28%see PARKINSON DISEASE, SECONDARY%29% and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features mental retardation, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia features mental retardation and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE. %28%Menkes, Textbook of Child Neurology, 5th ed, pp42-3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of dominantly and independently inherited antigens associated with the ABO blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype Le%28%b%29% is the result of the interaction of the Le gene Le%28%a%29% with the genes for the ABO blood groups.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of dominantly inherited, predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. %28%From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57%28%6%29%:531-43%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of elements that include SCANDIUM; YTTRIUM; and the LANTHANOID SERIES ELEMENTS. Historically, the rare earth metals got their name from the fact that they were never found in their pure elemental form, but as an oxide. In addition they were very difficult to purify. They are not truly rare and comprise about 25%25% of the metals in the earth%27%s crust.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of elongate elasmobranchs. Sharks are mostly marine fish, with certain species large and voracious.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymatic disorders affecting the nervous system and to a variable degree the skeletal system, lymphoreticular system, and other organs. The conditions are marked by an abnormal accumulation of catabolic material within lysosomes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes catalyzing the endonucleolytic cleavage of DNA. They include members of EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- %28%DNA RESTRICTION ENZYMES%29%, EC 3.1.24.- %28%DNA RESTRICTION ENZYMES%29%, and EC 3.1.25.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes removing the serine- or threonine-bound phosphate groups from a wide range of phosphoproteins, including a number of enzymes which have been phosphorylated under the action of a kinase. %28%Enzyme Nomenclature, 1992%29% EC 3.1.3.16.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that are dependent on cyclic AMP and catalyze the phosphorylation of serine or threonine residues on proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that are dependent on cyclic GMP and catalyzes the phosphorylation of serine or threonine residues of proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze an intramolecular transfer of a phosphate group. It has been shown in some cases that the enzyme has a functional phosphate group, which can act as the donor. These were previously listed under PHOSPHOTRANSFERASES %28%EC 2.7.-%29%. %28%From Enzyme Nomenclature, 1992%29% EC 5.4.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze the hydrolysis of alpha- or beta-xylosidic linkages. EC 3.2.1.8 catalyzes the endo-hydrolysis of 1,4-beta-D-xylosidic linkages; EC 3.2.1.32 catalyzes the endo-hydrolysis of 1,3-beta-D-xylosidic linkages; EC 3.2.1.37 catalyzes the exo-hydrolysis of 1,4-beta-D-linkages from the non-reducing termini of xylans; and EC 3.2.1.72 catalyzes the exo-hydrolysis of 1,3-beta-D-linkages from the non-reducing termini of xylans. Other xylosidases have been identified that catalyze the hydrolysis of alpha-xylosidic bonds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. %28%Enzyme Nomenclature, 1992%29% EC 3.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze the hydrolysis of various sulfate bonds of chondroitin sulfate. EC 3.1.6.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze the reduction of 1-pyrroline carboxylate to proline in the presence of NAD%28%P%29%H. Includes both the 2-oxidoreductase %28%EC 1.5.1.1%29% and the 5-oxidoreductase %28%EC 1.5.1.2%29%. The former also reduces 1-piperidine-2-carboxylate to pipecolate and the latter also reduces 1-pyrroline-3-hydroxy-5-carboxylate to hydroxyproline.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze the reversible reduction-oxidation reaction of 20-hydroxysteroids, such as from a 20-ketosteroid to a 20-alpha-hydroxysteroid %28%EC 1.1.1.149%29% or to a 20-beta-hydroxysteroid %28%EC 1.1.1.53%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyze the transfer of carboxyl- or carbamoyl- groups. EC 2.1.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. %28%Enzyme Nomenclature, 1992%29% EC 2.7.1.2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS GM1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyzes the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyzes the transfer of a phosphate group onto a nitrogenous group acceptor. EC 2.7.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that catalyzes the transfer of a phosphate group onto a phosphate group acceptor. EC 2.7.4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that oxidize diverse nitrogenous substances to yield nitrite. %28%Enzyme Nomenclature, 1992%29% EC 1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes that transfers two phosphate groups from a donor such as ATP to two different acceptors. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.9.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes which catalyze the hydrolysis of ATP coupled with another function such as transporting Ca%28%2+%29% across a membrane. These enzymes may be dependent on Ca%28%2+%29%, Mg%28%2+%29%, anions, H+, or DNA. EC 3.6.1.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes with the general formula CMP-N-acetylneuraminate:acceptor N-acetylneuraminyl transferase. They catalyze the transfer of N-acetylneuraminic acid from CMP-N-acetylneuraminic acid to an acceptor, which is usually the terminal sugar residue of an oligosaccharide, a glycoprotein, or a glycolipid. EC 2.4.99.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of eukaryotic high-molecular mass heat-shock proteins that represent a subfamily of HSP70 HEAT-SHOCK PROTEINS. Hsp110 proteins prevent protein aggregation and can maintain denatured proteins in folding-competent states.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of four British islands and several islets in the English Channel off the coast of France. They are known to have been occupied prehistorically. They were a part of Normandy in 933 but were united to the British crown at the time of the Norman Conquest in 1066. Guernsey and Jersey originated noted breeds of cattle. %28%From Webster%27%s New Geographical Dictionary, 1988, p242%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of four homologous sphingolipid activator proteins that are formed from proteolytic cleavage of a common protein precursor molecule referred to as prosaposin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of functionally related glycoproteins responsible for the calcium-dependent cell-to-cell adhesion mechanism. They are divided into subclasses E-, P-, and N-cadherins, which are distinct in immunological specificity and tissue distribution. They promote cell adhesion via a homophilic mechanism. These compounds play a role in the construction of tissues and of the whole animal body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. %28%From Proc Natl Acad Sci USA 1998 Nov 10;95%28%23%29%:13363-83%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. %28%From King %26% Stansfield, Dictionary of Genetics, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of glycine amides of aminobenzoic acids. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of gram-negative bacteria consisting of rod- and coccus-shaped cells. They are both aerobic %28%able to grow under an air atmosphere%29% and microaerophilic %28%grow better in low concentrations of oxygen%29% under nitrogen-fixing conditions but, when supplied with a source of fixed nitrogen, they grow as aerobes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of gram-negative, anaerobic bacteria that is able to oxidize acetate completely to carbon dioxide using elemental sulfur as the electron acceptor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of guanine ribonucleotides in which the phosphate residues of each guanine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of healing methods which emphasize mind-body interactions with intended benefits that include relaxation and emotional well being.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of highly cellular primitive round cell neoplasms which occur extracranially in soft tissue and bone and are derived from embryonal neural crest cells. These tumors occur primarily in children and adolescents and share a number of characteristics with Ewing%27%s Sarcoma %28%SARCOMA, EWING%27%S%29%. They may arise from the chest wall, skin, orbit, kidney, and other structures and tend to be locally invasive or metastasize, although relatively benign forms may occur. Characteristic histologic features include a tendency to form Homer-Wright rosettes and to stain positively with neuron-specific enolase and vimentin. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2113; J Clin Oncol 1998 Mar;16%28%3%29%:1150-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. EC 3.1.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of hydroxycorticosteroids bearing a hydroxy group at the 17-position. Urinary excretion of these compounds is used as an index of adrenal function. They are used systemically in the free alcohol form, but with esterification of the hydroxy groups, topical effectiveness is increased.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of indole-indoline dimers which are ALKALOIDS obtained from the VINCA genus of plants. They inhibit polymerization of TUBULIN into MICROTUBULES thus blocking spindle formation and arresting cells in METAPHASE. They are some of the most useful ANTINEOPLASTIC AGENTS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited and sporadic disorders which share progressive ataxia in combination with atrophy of the CEREBELLUM; PONS; and inferior olivary nuclei. Additional clinical features may include MUSCLE RIGIDITY; NYSTAGMUS, PATHOLOGIC; RETINAL DEGENERATION; MUSCLE SPASTICITY; DEMENTIA; URINARY INCONTINENCE; and OPHTHALMOPLEGIA. The familial form has an earlier onset %28%second decade%29% and may feature spinal cord atrophy. The sporadic form tends to present in the fifth or sixth decade, and is considered a clinical subtype of MULTIPLE SYSTEM ATROPHY. %28%From Adams et al., Principles of Neurology, 6th ed, p1085%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited conditions characterized initially by HEMATURIA and slowly progressing to RENAL INSUFFICIENCY. The most common form is the Alport syndrome %28%hereditary nephritis with HEARING LOSS%29% which is caused by mutations in genes for TYPE IV COLLAGEN and defective GLOMERULAR BASEMENT MEMBRANE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited congenital myopathic conditions characterized clinically by weakness, hypotonia, and prominent hypoplasia of proximal muscles including the face. Muscle biopsy reveals large numbers of rod-shaped structures beneath the muscle fiber plasma membrane. This disorder is genetically heterogeneous and may occasionally present in adults. %28%Adams et al., Principles of Neurology, 6th ed, p1453%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. %28%J Neurol Neurosurg Psychiatry 1998 Jan;64%28%1%29%:61-6; Curr Opin Neurol 1997 Aug;10%28%4%29%:313-8%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and clinically by loss of sensation and autonomic dysfunction. There are five subtypes. Type I features autosomal dominant inheritance and distal sensory involvement. Type II is characterized by autosomal inheritance and distal and proximal sensory loss. Type III is DYSAUTONOMIA, FAMILIAL. Type IV features insensitivity to pain, heat intolerance, and mental deficiency. Type V is characterized by a selective loss of pain with intact light touch and vibratory sensation. %28%From Joynt, Clinical Neurology, 1995, Ch51, pp142-4%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol %28%HYDROCORTISONE%29% and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. The most common defect is in STEROID 21-HYDROXYLASE. Other defects occur in STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; or 3-beta-hydroxysteroid dehydrogenase %28%3-HYDROXYSTEROID DEHYDROGENASES%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited enzyme deficiencies which feature elevations of GALACTOSE in the blood. This condition may be associated with deficiencies of GALACTOKINASE; UDPGLUCOSE-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; or UDPGLUCOSE 4-EPIMERASE. The classic form is caused by UDPglucose-Hexose-1-Phosphate Uridylyltransferase deficiency, and presents in infancy with FAILURE TO THRIVE; VOMITING; and INTRACRANIAL HYPERTENSION. Affected individuals also may develop MENTAL RETARDATION; JAUNDICE; hepatosplenomegaly; ovarian failure %28%OVARIAN FAILURE, PREMATURE%29%; and cataracts. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp61-3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. Mental retardation and skeletal changes, most notably dysostosis multiplex, occur frequently. %28%From Joynt, Clinical Neurology, 1992, Ch56, pp36-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited metabolic disorders characterized by an excessive intra-lysosomal deposition of glycosphingolipids and phosphosphingolipids in the CENTRAL NERVOUS SYSTEM and, to a variable degree, in visceral structures. Clinical features vary with the specific subtype of the disease, but common features include progressive deterioration in psychomotor and visual function. %28%From Arch Neurol 1998 Aug;55%28%8%29%:1055-6; Menkes, Textbook of Child Neurology, 5th ed, p89%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inherited metabolic disorders which have in common elevations of serum LYSINE levels. Enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the SACCHAROPINE DEHYDROGENASES have been associated with hyperlysinemia. Clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. %28%From Menkes, Textbook of Child Neurology, 5th ed, p56%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of inosine ribonucleotides in which the phosphate residues of each inosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of interrelated trophoblastic diseases arising from pregnancy. They are commonly associated with hyperplasia of trophoblasts %28%TROPHOBLAST%29% and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole %28%HYDATIDIFORM MOLE, INVASIVE%29%, placental-site trophoblastic tumor %28%TROPHOBLASTIC TUMOR, PLACENTAL SITE%29%, and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of invertebrate chordates %28%CHORDATA, NONVERTEBRATE%29% in the subphylum Craniota. They include the single order Myxiniformes, which comprise various HAGFISHES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands in Melanesia constituting a French overseas territory. The group includes New Caledonia %28%the main island%29%, Ile des Pins, Loyalty Island, and several other islet groups. The capital is Noumea. It was discovered by Captain Cook in 1774 and visited by various navigators, explorers, and traders from 1792 to 1840. Occupied by the French in 1853, it was set up as a penal colony 1864-94. In 1946 it was made a French overseas territory. It was named by Captain Cook with the 5th and 6th century A.D. Latin name for Scotland, Caledonia. %28%From Webster%27%s New Geographical Dictionary, 1988, p830 %26% Room, Brewer%27%s Dictionary of Names, 1992, p375%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands in Polynesia, in the north central Pacific Ocean, comprising eight major and 114 minor islands, largely volcanic and coral. Its capital is Honolulu. It was first reached by Polynesians about 500 A.D. It was discovered and named the Sandwich Islands in 1778 by Captain Cook. The islands were united under the rule of King Kamehameha 1795-1819 and requested annexation to the United States in 1893 when a provisional government was set up. Hawaii was established as a territory in 1900 and admitted as a state in 1959. The name is from the Polynesian Owhyhii, place of the gods, with reference to the two volcanoes Mauna Kea and Mauna Loa, regarded as the abode of the gods. %28%From Webster%27%s New Geographical Dictionary, 1988, p493 %26% Room, Brewer%27%s Dictionary of Names, 1992, p2330%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands in the Atlantic Ocean west of Scotland, comprising the Outer Hebrides and the Inner Hebrides. They were the scene of frequent incursions of Scandinavian settlers from the 6th century A.D. They were ceded to Scotland by Norway in the 13th century. The origin of the name is uncertain. It is suggested that it is the result of a miscopying of the Roman name Ebudae or Hebudae with ri for u. %28%From Webster%27%s New Geographical Dictionary, 1988, p496 %26% Room, Brewer%27%s Dictionary of Names, 1992, p235%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands in the Lesser Antilles in the West Indies, the three main islands being St. Croix, St. Thomas, and St. John. The capital is Charlotte Amalie. The Virgin Islands were discovered by Columbus in 1493. Before 1917 the U.S. Virgin Islands were held by the Danish and called the Danish West Indies but the name was changed when the United States acquired them by purchase. Virgin refers to the fact that Columbus made his discovery on St. Ursula%27%s day - virgins being her legendary companions - or to the resemblance of the chain of islands to a procession of nuns or virgins. %28%From Webster%27%s New Geographical Dictionary, 1988, p1305 %26% Room, Brewer%27%s Dictionary of Names, 1992, p577%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands in the southwest Pacific. Its capital is Wellington. It was discovered by the Dutch explorer Abel Tasman in 1642 and circumnavigated by Cook in 1769. Colonized in 1840 by the New Zealand Company, it became a British crown colony in 1840 until 1907 when colonial status was terminated. New Zealand is a partly anglicized form of the original Dutch name Nieuw Zeeland, new sea land, possibly with reference to the Dutch province of Zeeland. %28%From Webster%27%s New Geographical Dictionary, 1988, p842 %26% Room, Brewer%27%s Dictionary of Names, 1992, p378%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands in the southwest central Pacific, divided into AMERICAN SAMOA and the INDEPENDENT STATE OF SAMOA %28%Western Samoa%29%. First European contact was made in 1722 by Jacob Roggeveen, a Dutchman. In 1768 they were named Navigators Islands by Louis de Bougainville. The present name may derive from that of a local chieftain or from a local word meaning place of the moa, a now-extinct island bird. %28%From Webster%27%s New Geographical Dictionary, 1988, p1061 %26% Room, Brewer%27%s Dictionary of Names, 1992, p481%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islands of SAMOA, in the southwest central Pacific. Its capital is Pago Pago. The islands were ruled by native chiefs until about 1869. An object of American interest beginning in 1839, Pago Pago and trading and extraterritorial rights were granted to the United States in 1878. The United States, Germany, and England administered the islands jointly 1889-99, but in 1899 they were granted to the United States by treaty. The Department of the Interior has administered American Samoa since 1951. %28%From Webster%27%s New Geographical Dictionary, 1988, p44%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of islet cells %28%10-35%25%%29% which secrete PANCREATIC POLYPEPTIDE, a hormone that regulates APPETITE and FOOD INTAKE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of lymphocyte surface antigens differentially located on subpopulations of mouse lymphocytes. This localization has been useful in distinguishing different functional subpopulations of lymphocytes. For example, cytotoxic T-cells bear primarily Lyt-23 on their surface and not Lyt-1, whereas helper cells bear Lyt-1 and not Lyt-23.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES and SEZARY SYNDROME are the best characterized of these disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of lysosomal proteinases or endopeptidases found in aqueous extracts of a variety of animal tissue. They function optimally within an acidic pH range.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of macrocyclic compounds formed by chain extension of multiple PROPIONATES and cyclized into a large %28%typically 12, 14, 16%29% membered lactone. They are often glycosylated. Many of them are ANTIBIOTICS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma %28%LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC%29%, this group%27%s unique features warrant separate treatment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially %28%i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL%29%. This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of membrane transport proteins that transport biogenic amine derivatives of catechol across the PLASMA MEMBRANE. Catecholamine plasma membrane transporter proteins regulate neural transmission as well as catecholamine metabolism and recycling.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of mental disorders associated with organic brain damage and caused by poisoning from alcohol.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of metabolic diseases due to deficiency of one of a number of LIVER enzymes in the biosynthetic pathway of HEME. They are characterized by the accumulation and increased excretion of PORPHYRINS or its precursors. Clinical features include neurological symptoms %28%PORPHYRIA, ACUTE INTERMITTENT%29%, cutaneous lesions due to photosensitivity %28%PORPHYRIA CUTANEA TARDA%29%, or both %28%HEREDITARY COPROPORPHYRIA%29%. Hepatic porphyrias can be hereditary or acquired as a result of toxicity to the hepatic tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of metabolic disorders primarily of infancy characterized by the subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, dysphagia, and lactic acidosis. Pathological features include spongy degeneration of the neuropile of the basal ganglia, thalamus, brain stem, and spinal cord. Patterns of inheritance include X-linked recessive, autosomal recessive, and mitochondrial. Leigh disease has been associated with mutations in genes for the PYRUVATE DEHYDROGENASE COMPLEX; CYTOCHROME-C OXIDASE; ATP synthase subunit 6; and subunits of mitochondrial complex I. %28%From Menkes, Textbook of Child Neurology, 5th ed, p850%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of metabolites derived from THYROXINE and TRIIODOTHYRONINE via the peripheral enzymatic removal of iodines from the thyroxine nucleus. Thyronine is the thyroxine nucleus devoid of its four iodine atoms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of methane-based halogenated hydrocarbons containing one or more fluorine and chlorine atoms.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of muscle diseases associated with abnormal mitochondria function.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects %28%e.g., histamine, serotonin, epinephrine, tyramine%29%. Those derived from aromatic amino acids, and also their synthetic analogs %28%e.g., amphetamine%29%, are of use in pharmacology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of nerve cells in the substantia innominata that has wide projections to the neocortex and is rich in acetylcholine and choline acetyltransferase. In Parkinson and Alzheimer diseases the nucleus undergoes degeneration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of nine islands and several islets belonging to Portugal in the north Atlantic Ocean off the coast of Portugal. The islands are named after the acores, the Portuguese for goshawks, living there in abundance. %28%Webster%27%s New Geographical Dictionary, 1988, p102 %26% Room, Brewer%27%s Dictionary of Names, 1992, p42%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of nitrogen mustard compounds which are substituted with a phosphoramide group or its derivatives. They are usually cytotoxic and used as antineoplastic agents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of often fatal inherited diseases marked by the accumulation of GANGLIOSIDES in LYSOSOMES secondary to enzymatic deficiency states. Gangliosidoses include TAY-SACHS DISEASE; GANGLIOSIDOSIS GM1; GANGLIOSIDOSES GM2; and SANDHOFF DISEASE; which share the infantile or childhood onset of CENTRAL NERVOUS SYSTEM deterioration. %28%Menkes, Textbook of Child Neurology, 5th ed, pp89-97%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of organic sulfur-containing nitrites, alkyl thionitrites. S-Nitrosothiols include compounds such as S-NITROSO-N-ACETYLPENICILLAMINE and S-NITROSOGLUTATHIONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands %28%LIVER; BILIARY TRACT; PANCREAS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. %28%Enzyme Nomenclature, 1992, p100%29% EC 1.6.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of people who meet in an unstructured setting to learn about themselves, interpersonal relationships, and group processes and about larger social systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of peptide antibiotics from BACILLUS brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D are linear. Gramicidin is one of the two principal components of TYROTHRICIN which is used topically for gram-positive organisms. It is toxic to blood, liver, kidneys, meninges, and the olfactory apparatus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of pharmacologic activities, effects on living systems and the environment, and modes of employment of drugs and chemicals. They are broken into actions, which describe their effects, and uses, which describe how they are employed.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of phenotypically similar but genotypically distinct species %28%genomovars%29% in the genus BURKHOLDERIA. They are found in water, soil, and the rhizosphere of crop plants. They can act as opportunistic human pathogens and as plant growth promoting and biocontrol agents.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of phenyl benzopyrans named for having structures like FLAVONES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of phosphate minerals that includes ten mineral species and has the general formula X5%28%YO4%29%3Z, where X is usually calcium or lead, Y is phosphorus or arsenic, and Z is chlorine, fluorine, or OH-. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of plant cells that are capable of dividing infinitely and whose main function is the production of new growth at the growing tip of a root or stem. %28%From Concise Dictionary of Biology, 1990%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols %28%STEROLS%29%, and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of protein-serine-threonine kinases that was originally identified as being responsible for the PHOSPHORYLATION of CASEINS. They are ubiquitous enzymes that have a preference for acidic proteins. Casein kinases play a role in SIGNAL TRANSDUCTION by phosphorylating a variety of regulatory cytoplasmic and regulatory nuclear proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of proteins possessing only the iron-sulfur complex as the prosthetic group. These proteins participate in all major pathways of electron transport: photosynthesis, respiration, hydroxylation and bacterial hydrogen and nitrogen fixation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of proteins that associate with DYSTROPHIN at the CELL MEMBRANE to form the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of proteins that covalently attach to selenium or SELENIUM-containing compounds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of proteins that includes thyroxine-binding globulin, a glycoprotein that serves as the major and specific carrier of thyroxine in plasma, accounting for 70-75%25% of the bound thyroxine; thyroxine-binding prealbumin, an albumin that serves as the secondary carrier, accounting for between 20 and 25%25% of the bound thyroxine; and serum albumin, which accounts for the remaining bound thyroxine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of proteobacteria consisting of chemoorganotrophs usually associated with the DIGESTIVE SYSTEM of humans and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of recessively inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I %28%Werdnig-Hoffman disease%29%, type II %28%intermediate form%29%, and type III %28%Kugelberg-Welander disease%29%. Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. %28%J Med Genet 1996 Apr:33%28%4%29%:281-3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin %28%M-component%29% and/or an abnormal immunoglobulin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of related enzymes responsible for the endohydrolysis of the di-N-acetylchitobiosyl unit in high-mannose-content glycopeptides and GLYCOPROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of related mycotoxins produced by the pasture fungus Pithomyces chartarum %28%formerly Sporidesmium bakeri%29%; causes liver damage and facial eczema in cattle and sheep.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of related plant alkaloids that contain the BERBERINE heterocyclic ring structure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of religious bodies tracing their origin to Joseph Smith in 1830 and accepting the Book of Mormon as divine revelation. %28%from Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of replication-defective viruses, in the genus GAMMARETROVIRUS, which are capable of transforming cells, but which replicate and produce tumors only in the presence of Murine leukemia viruses %28%LEUKEMIA VIRUS, MURINE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of ribonucleotides %28%up to 12%29% in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of rods or cocci whose taxonomic affinities are uncertain. They form endospores, thick-walled bodies formed within the vegetative cells of certain bacteria, able to withstand adverse environmental conditions for prolonged periods.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. %28%From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of slow opening and closing voltage-gated potassium channels. Because of their delayed activation kinetics they play an important role in controlling ACTION POTENTIAL duration.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of slowly progressive inherited disorders affecting motor and sensory peripheral nerves. Subtypes include HMSNs I-VII. HMSN I and II both refer to CHARCOT-MARIE-TOOTH DISEASE. HMSN III refers to hypertrophic neuropathy of infancy. HMSN IV refers to REFSUM DISEASE. HMSN V refers to a condition marked by a hereditary motor and sensory neuropathy associated with spastic paraplegia %28%see SPASTIC PARAPLEGIA, HEREDITARY%29%. HMSN VI refers to HMSN associated with an inherited optic atrophy %28%OPTIC ATROPHIES, HEREDITARY%29%, and HMSN VII refers to HMSN associated with retinitis pigmentosa. %28%From Adams et al., Principles of Neurology, 6th ed, p1343%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of small, soluble proteins secreted by the hypothalamus. They serve as binding proteins for oxytocin and vasopressin during their transport to the posterior pituitary. They are secreted with the hormones but have no known functions other than serving as a carrier.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of structurally related scavenger receptors expressed predominately by ENDOTHELIAL CELLS. They-contain repeats of EPIDERMAL GROWTH FACTOR-like cysteine-rich motifs in their extracellular domains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of substances similar to VITAMIN K 1 which contains a ring of 2-methyl-1,4-naphthoquinione and an isoprenoid side chain of varying number of isoprene units. In vitamin K 2, each isoprene unit contains a double bond. They are produced by bacteria including the normal intestinal flora.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of symptoms that are two- to three-fold more common in those who work in large, energy-efficient buildings, associated with an increased frequency of headaches, lethargy, and dry skin. Clinical manifestations include hypersensitivity pneumonitis %28%ALVEOLITIS, EXTRINSIC ALLERGIC%29%; allergic rhinitis %28%RHINITIS, ALLERGIC, PERENNIAL%29%; ASTHMA; infections, skin eruptions, and mucous membrane irritation syndromes. Current usage tends to be less restrictive with regard to the type of building and delineation of complaints. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of techniques developed to apply scientific methods and tools to solve the problems of DECISION MAKING in complex organizations and systems. Operations research searches for optimal solutions in situations of conflicting GOALS and makes use of mathematical models from which solutions for actual problems may be derived. %28%From Psychiatric Dictionary, 6th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of telomere associated proteins that interact with TRF1 PROTEIN, contain ANKYRIN REPEATS and have poly%28%ADP-ribose%29% polymerase activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of tetraterpenes, with four terpene units joined head-to-tail. Biologically active members of this class are used clinically in the treatment of severe cystic ACNE; PSORIASIS; and other disorders of keratinization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of the D-related HLA antigens %28%human%29% found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of the proteobacteria comprised of facultatively anaerobic and fermentative gram-negative bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of thermoplastic or thermosetting polymers containing polyisocyanate. They are used as ELASTOMERS, as coatings, as fibers and as foams.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of three different alpha chains %28%CD11a, CD11b, CD11c%29% that are associated with an invariant CD18 beta chain %28%ANTIGENS, CD18%29%. The three resulting leukocyte-adhesion molecules %28%RECEPTORS, LEUKOCYTE ADHESION%29% are LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; and ANTIGEN, P150,95.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of thymine nucleotides in which the phosphate residues of each thymine nucleotide act as bridges in forming diester linkages between the deoxyribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of tick-borne diseases of mammals including ZOONOSES in humans. They are caused by PROTOZOANS of the genus BABESIA, which parasitize erythrocytes, producing hemolysis. In the U.S., the organism%27%s natural host is mice and transmission is by the deer tick IXODES SCAPULARIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of transcription factors that were originally described as being specific to ERYTHROID CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of transfer RNAs which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of transmissible viral diseases of chickens and turkeys. Liver tumors are found in most forms, but tumors can be found elsewhere.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Permitted is any degree of hydrogenation, any substituents and any H-isomer.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of unicellular flagellates of ancient eukaryotic lineage with unclear taxonomy. Classification differs depending on what characteristics are used. Some authorities consider them to be an order of PROTOZOA. For others, they are classed as ALGAE due to the presence of CHLOROPLASTS in some genera. However, the origin of the chloroplasts is in dispute and they are missing from many of the genera. Euglenida lack a CELL WALL but are covered by a proteinaceous flexible coat, the pellicle, that allows the cell to change shape.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of uridine ribonucleotides in which the phosphate residues of each uridine ribonucleotide act as bridges in forming diester linkages between the ribose moieties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of viruses in the genus GAMMARETROVIRUS comprising a few isolates from birds, with no known corresponding endogenous relatives.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of viruses in the genus PESTIVIRUS, causing diarrhea, fever, oral ulcerations, hemorrhagic syndrome, and various necrotic lesions among cattle and other domestic animals. The two species %28%genotypes%29%, BVDV-1 and BVDV-2 , exhibit antigenic and pathological differences. The historical designation, BVDV, consisted of both %28%then unrecognized%29% genotypes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A group of water-soluble vitamins, some of which are COENZYMES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. %28%Merck Index, 12th ed%29% MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A guanine nucleotide exchange factor from DROSOPHILA. Sevenless refers to genetic mutations in DROSOPHILA that cause loss of the R7 photoreceptor which is required to see UV light.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A guanine nucleotide exchange factor that acts to restore EUKARYOTIC INITIATION FACTOR-2 to its GTP bound form.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A guanine nucleotide exchange factor that is expressed primarily in neuronal tissue and may be specific for the Ha-ras homolog of the RAS PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A guanine nucleotide exchange factor that stimulates the dissociation of GDP from RAL GTP-BINDING PROTEINS. It also has GDP exchange activity towards other MONOMERIC GTP-BINDING PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hair-containing cyst or sinus, occurring chiefly in the coccygeal region.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors %28%RECEPTORS, N-METHYL-D-ASPARTATE%29%. As a drug of abuse, it is known as PCP and Angel Dust.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A halogen with the atomic symbol Br, atomic number 36, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hapten that generates suppressor cells capable of down-regulating the efferent phase of trinitrophenol-specific contact hypersensitivity. %28%Arthritis Rheum 1991 Feb;34%28%2%29%:180%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hard thin translucent layer of calcified substance which envelops and protects the dentin of the crown of the tooth. It is the hardest substance in the body and is almost entirely composed of calcium salts. Under the microscope, it is composed of thin rods %28%enamel prisms%29% held together by cementing substance, and surrounded by an enamel sheath. %28%From Jablonski, Dictionary of Dentistry, 1992, p286%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hardy grain crop, rye, grown in northern climates. It is the most frequent host to ergot %28%CLAVICEPS%29%, the toxic fungus. Its hybrid with TRITICUM is TRITICALE, another grain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A health care system which combines physicians, hospitals, and other medical services with a health plan to provide the complete spectrum of medical care for its customers. In a fully integrated system, the three key elements - physicians, hospital, and health plan membership - are in balance in terms of matching medical resources with the needs of purchasers and patients. %28%Coddington et al., Integrated Health Care: Reorganizing the Physician, Hospital and Health Plan Relationship, 1994, p7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A health professional%27%s obligation to breach patient CONFIDENTIALITY to warn third parties of the danger of their being assaulted or of contracting a serious infection.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heat stable DNA-DIRECTED DNA POLYMERASE from the bacteria Thermus aquaticus. It is widely used for the amplification of genes through the process of POLYMERASE CHAIN REACTION. EC 2.7.7.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heavy, soft, bluish white metal, atomic number 81, atomic weight 204.37, symbol Tl. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hematopoietic growth factor and the ligand of the cell surface c-kit protein %28%PROTO-ONCOGENE PROTEINS C-KIT%29%. It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hematopoietic growth factor which promotes proliferation and maturation of neutrophil granulocytes. Clinically it is effective in decreasing the incidence of febrile neutropenia in patients with non-myeloid malignancies receiving myelosuppressive therapy or in reducing the duration of neutropenia and neutropenia-related clinical sequelae in patients with non-myeloid malignancies undergoing myeloblastive chemotherapy followed by BMT. It has also been used in AIDS patients with CMV retinitis being treated with GANCICLOVIR. %28%Gelman CR, Rumack BH %26% Hess AJ %28%eds%29%: DRUGDEX%28%R%29% System. MICROMEDEX, Inc., Englewood, Colorado %28%Edition expires 11/30/95%29%%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemeprotein which catalyzes the oxidation of ferrocytochrome c to ferricytochrome c in the presence of hydrogen peroxide. EC 1.11.1.5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemoflagellate subspecies of parasitic protozoa that causes Gambian or West African sleeping sickness in humans. The vector host is usually the tsetse fly %28%Glossina%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemoflagellate subspecies of parasitic protozoa that causes Rhodesian sleeping sickness in humans. It is carried by Glossina pallidipes, G. morsitans and occasionally other species of game-attacking tsetse flies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies %28%Glossina%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemoglobin-like oxygen-binding hemeprotein present in the nitrogen-fixing root nodules of leguminous plants. The red pigment has a molecular weight approximately 1/4 that of hemoglobin and has been suggested to act as an oxido-reduction catalyst in symbiotic nitrogen fixation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemorrhage into the wall of the carotid artery, separating the intima from the media and leading to aneurysm formation. This process may occlude the carotid artery and result in thromboembolic complications, including CEREBRAL INFARCTION. Dissections may occur spontaneously or follow CRANIOCEREBRAL TRAUMA; NECK INJURIES; and rarely severe bouts of coughing. %28%Adams et al., Principles of Neurology, 6th ed, p830%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hemostatic disorder characterized by a poor anticoagulant response to activated protein C %28%APC%29%. The activated form of Factor V %28%Factor Va%29% is more slowly degraded by activated protein C. Factor V Leiden mutation %28%R506Q%29% is the most common cause of APC resistance.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hepatic GLYCOGEN STORAGE DISEASE in which there is an apparent deficiency of hepatic phosphorylase %28%GLYCOGEN PHOSPHORYLASE, LIVER FORM%29% activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hepatocyte nuclear factor that is closely related to HEPATOCYTE NUCLEAR FACTOR 1-ALPHA but is only weakly expressed in the LIVER. Mutations in hepatocyte nuclear factor 1-beta are associated with renal CYSTS and MATURITY-ONSET DIABETES MELLITUS type 5.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heptapeptide formed by the enzymatic hydrolysis of ANGIOTENSIN II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20%25% of the pressor activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD %28%first letter of each word%29% and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary condition clinically resembling HYPOPARATHYROIDISM, but caused by failure of response to rather than deficiency of parathyroid hormones. It is characterized by hypocalcemia and hyperphosphatemia, and is commonly associated with short stature, obesity, short metacarpals, and ectopic calcification. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary disease caused by autosomal dominant mutations involving CHROMOSOME 19. It is characterized by the presence of INTESTINAL POLYPS, consistently in the JEJUNUM, and mucocutaneous pigmentation with MELANIN spots of the lips, buccal MUCOSA, and digits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary disease characterized by childhood onset HYPERTENSION, hypokalemic alkalosis, and low RENIN and ALDOSTERONE secretion. It results from a defect in the activity of the 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 enzyme which results in inadequate conversion of CORTISOL to CORTISONE. The build up of unprocessed cortisol to levels that stimulate MINERALOCORTICOID RECEPTORS creates the appearance of having excessive MINERALOCORTICOIDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary disorder occurring in two forms: the complete form %28%Franceschetti%27%s syndrome%29% is characterized by antimongoloid slant of the palpebral fissures, coloboma of the lower lid, micrognathia and hypoplasia of the zygomatic arches, and microtia. It is transmitted as an autosomal trait. The incomplete form %28%Treacher Collins syndrome%29% is characterized by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary disorder of connective tissue characterized by tall stature, elongated extremities, subluxation of the lens, dilatation of the ascending aorta, and %22%pigeon breast.%22% It is inherited as an autosomal dominant trait.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs %28%and occasionally involving the arms%29%. Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy %28%HMSN%29% types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. %28%Adams et al., Principles of Neurology, 6th ed, p1343%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heritable disorder of faulty keratinization characterized by the proliferation of abnormal clones of KERATINOCYTES and lesions showing varying atrophic patches surrounded by an elevated, keratotic border. These keratotic lesions can progress to overt cutaneous neoplasm. Several clinical variants are recognized, including porokeratosis of Mibelli, linear porokeratosis, disseminated superficial actinic porokeratosis, palmoplantar porokeratosis, and punctate porokeratosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hernia caused by weakness of the anterior ABDOMINAL WALL due to midline defects, previous incisions, or increased intra-abdominal pressure. Ventral hernias include UMBILICAL HERNIA, incisional, epigastric, and spigelian hernias.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hernial protrusion of part of the rectum into the vagina. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A herpesvirus infection of CATTLE characterized by INFLAMMATION and NECROSIS of the mucous membranes of the upper RESPIRATORY TRACT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A herpesvirus infection of cattle characterized by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterodimeric complex of STAT1 PROTEIN and STAT2 PROTEIN that interacts with ISGF3GAMMA and is a subunit of the ISGF3 COMPLEX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterodimeric cytokine that stimulates the production of interferon gamma from T-cells and natural killer cells, and also induces differentiation of Th1 helper cells. It is an initiator of cell-mediated immunity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterodimeric protein complex of RNA cap-binding proteins, which binds with high affinity to the 5%27% MRNA CAP STRUCTURE in the CELL NUCLEUS. The complex contains two subunits, one of 80-kDa molecular weight and another of 20-kDa molecular weight.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterodimeric protein that is a cell surface antigen associated with lymphocyte activation. The initial characterization of this protein revealed one identifiable heavy chain %28%ANTIGENS, CD98 HEAVY CHAIN%29% and an indeterminate smaller light chain. It is now known that a variety of light chain subunits %28%ANTIGENS, CD98 LIGHT CHAINS%29% can dimerize with the heavy chain. Depending upon its light chain composition a diverse array of functions can be found for this protein. Functions include: type L amino acid transport, type y+L amino acid transport and regulation of cellular fusion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous family of water-soluble structural proteins found in cells of the vertebrate lens. The presence of these proteins accounts for the transparency of the lens. The family is composed of four major groups, alpha, beta, gamma, and delta, and several minor groups, which are classed on the basis of size, charge, immunological properties, and vertebrate source. Alpha, beta, and delta crystallins occur in avian and reptilian lenses, while alpha, beta, and gamma crystallins occur in all other lenses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form %28%CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC%29%, an autosomal dominant form %28%Conradi-Hunermann syndrome%29%, and a milder X-linked form. Metabolic defects associated with impaired peroxisomes are present only in the rhizomelic form.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of diseases characterized by the early onset of hypotonia, developmental delay of motor skills, non-progressive weakness. Each of these disorders is associated with a specific histologic muscle fiber abnormality.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the NEUROMUSCULAR JUNCTION. This includes presynaptic, synaptic, and postsynaptic disorders %28%that are not of autoimmune origin%29%. The majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor %28%RECEPTORS, NICOTINIC%29% on the postsynaptic surface of the junction. %28%From Arch Neurol 1999 Feb;56%28%2%29%:163-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of disorders that includes sporadic and familial forms, characterized clinically by cerebral ischemia %28%see BRAIN ISCHEMIA%29%; CEREBRAL INFARCTION; and CEREBRAL HEMORRHAGE. Pathologically the condition is marked by the deposition of AMYLOID in the walls of small blood vessels in the cerebral cortex and meninges. The sporadic form is associated with lobar cerebral hemorrhage in the elderly and ALZHEIMER DISEASE. %28%From Neuropathol Appl Neurobiol 1996 Jun;22%28%3%29%:216-227; Adams et al., Principles of Neurology, 6th ed, p852%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of disorders with common symptoms of apparent HYPOALDOSTERONISM despite the elevated levels of ALDOSTERONE and RENIN. Other clinical symptoms include HYPERKALEMIA with %28%Type I%29% or without %28%Type II%29% sodium wasting. Pseudohypoaldosteronism can be the result of defective MINERALOCORTICOID RECEPTORS or defects in the epithelial SODIUM CHANNEL. It can also be acquired after KIDNEY TRANSPLANTATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of eosinophils in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. It is often referred to as idiopathic.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p358%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of genetic disorders characterized by progressive MUSCULAR ATROPHY and MUSCLE WEAKNESS beginning in the hands, the legs, or the feet. Most are adult-onset autosomal dominant forms. Others are autosomal recessive.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of hereditary and acquired disorders in which the KIDNEY contains one or more CYSTS unilaterally or bilaterally %28%KIDNEY, CYSTIC%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis %28%MENINGITIS, ASEPTIC%29%, a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia %28%PLEURODYNIA, EPIDEMIC%29% and a serious MYOCARDITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of inherited COLLAGEN DISEASES. The most common manifestations of Ehlers-Danlos Syndrome are hyperextensible skin and joints, skin fragility and reduced wound healing capability.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional PEROXISOMES. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include ZELLWEGER SYNDROME; infantile Refsum disease; rhizomelic chondrodysplasia %28%CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC%29%; hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and ADRENOLEUKODYSTROPHY %28%X-linked%29%. Neurologic dysfunction is a prominent feature of most peroxisomal disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of intermediate-grade lymphomas of mixed cellular composition. Although they have not been extensively studied, it appears that they are predominantly B-cell diseases.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. %22%Interstitial%22% refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. %28%Dorland, 27th ed; Wyngarden, Cecil Textbook of Medicine, 19th ed, p396%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity %28%see MUSCLE SPASTICITY%29% in all limbs. Spastic diplegia %28%Little disease%29% is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. %28%From Dev Med Child Neurol 1998 Aug;40%28%8%29%:520-7%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of primarily familial disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis %28%see MUCOLIPIDOSES%29%, and UNVERRICHT-LUNDBORG SYNDROME.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to PLASMIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells %28%sarcomatoid%29%, or mixed cell-type carcinoma.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous mixture of glycoproteins responsible for the gel structure of egg white. It has trypsin-inhibiting activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous-nuclear ribonucleoprotein found associated with the NUCLEAR MATRIX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous-nuclear ribonucleoprotein found in the CELL NUCLEUS and the CYTOPLASM. Heterogeneous-nuclear ribonucleoprotein K has been implicated in the regulation of gene expression at nearly all levels: GENETIC TRANSCRIPTION; mRNA processing %28%RNA PROCESSING, POST-TRANSCRIPTIONAL%29%, mRNA transport, mRNA stability, and translation %28%TRANSLATION, GENETIC%29%. The hnRNP protein has a strong affinity for polypyrimidine-rich RNA and for single-stranded polypyrimidine-rich DNA. Multiple hnRNP K protein isoforms exist due to alternative splicing and display different nucleic-acid-binding properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogeneous-nuclear ribonucleoprotein that has specificity for AU-rich elements found in the 3%27%-region of mRNA and may play a role in RNA stability. Several isoforms of hnRNP D protein have been found to occur due to alternative mRNA splicing %28%RNA SPLICING%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of degenerative syndromes marked by progressive cerebellar dysfunction either in isolation or combined with other neurologic manifestations. Sporadic and inherited subtypes occur. Inheritance patterns include autosomal dominant, autosomal recessive, and X-linked.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset %28%usually in the first or second decade of life%29%, distribution of affected muscles, severity, and course. %28%From Adams et al., Principles of Neurology, 6th ed, pp984-5%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of disorders characterized by the abnormal increase of MAST CELLS in only the skin %28%MASTOCYTOSIS, CUTANEOUS%29%, in extracutaneous tissues involving multiple organs %28%MASTOCYTOSIS, SYSTEMIC%29%, or in solid tumors %28%MASTOCYTOMAS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of inherited disorders characterized by recurring attacks of rapidly progressive flaccid paralysis or myotonia. These conditions have in common a mutation of the gene encoding the alpha subunit of the sodium channel in skeletal muscle. They are frequently associated with fluctuations in serum potassium levels. Periodic paralysis may also occur as a non-familial process secondary to THYROTOXICOSIS and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1481%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of inherited muscular dystrophy that can be autosomal dominant or autosomal recessive. There are many forms %28%called LGMDs%29% involving genes encoding muscle membrane proteins such as the sarcoglycan %28%SARCOGLYCANS%29% complex that interacts with DYSTROPHIN. The disease is characterized by progressing wasting and weakness of the proximal muscles of arms and legs around the HIPS and SHOULDERS %28%the pelvic and shoulder girdles%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of inherited muscular dystrophy without the involvement of nervous system. The disease is characterized by MUSCULAR ATROPHY; MUSCLE WEAKNESS; CONTRACTURE of the elbows; ACHILLES TENDON; and posterior cervical muscles; with or without cardiac features. There are several INHERITANCE PATTERNS including X-linked %28%X CHROMOSOME%29%, autosomal dominant, and autosomal recessive gene mutations.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous group of transient or low voltage activated type CALCIUM CHANNELS. They are found in cardiac myocyte membranes, the sinoatrial node, Purkinje cells of the heart and the central nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterogenous-nuclear ribonucleoprotein found associated with most nascent transcripts, most notably those of the landmark giant loops of amphibian lampbrush chromosomes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterotetrameric transcription factor composed of two distinct proteins. Its name refers to the fact it binds to DNA sequences rich in GUANINE and ADENINE. GA-binding protein integrates a variety of SIGNAL TRANSDUCTION PATHWAYS and regulates expression of GENES involved in CELL CYCLE control, PROTEIN BIOSYNTHESIS, and cellular METABOLISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterotrimeric DNA-binding protein that binds to CCAAT motifs in the promoters of eukaryotic genes. It is composed of three subunits: A, B and C.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A heterotrimeric GTP-binding protein that mediates the light activation signal from photolyzed rhodopsin to cyclic GMP phosphodiesterase and is pivotal in the visual excitation process. Activation of rhodopsin on the outer membrane of rod and cone cells causes GTP to bind to transducin followed by dissociation of the alpha subunit-GTP complex from the beta/gamma subunits of transducin. The alpha subunit-GTP complex activates the cyclic GMP phosphodiesterase which catalyzes the hydrolysis of cyclic GMP to 5%27%-GMP. This leads to closure of the sodium and calcium channels and therefore hyperpolarization of the rod cells. EC 3.6.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hexosaminidase with specificity for terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-alpha-D-galactosaminides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed %26% Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hexose transporter that mediates FRUCTOSE transport in SKELETAL MUSCLE and ADIPOCYTES and is responsible for luminal uptake of dietary fructose in the SMALL INTESTINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hexosiminidase that specifically hydrolyzes terminal non-reducing N-acetyl-D-galactosamine residues in N-acetyl-beta-D-galactosaminides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hexosyltransferase involved in the transfer of disaccharide molecules to the peptidoglycan structure of the CELL WALL SKELETON. It plays an important role in the genesis of the bacterial CELL WALL.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high mobility group protein encoded by the Y CHROMOSOME. It functions as a transcription factor and is essential for development of the TESTES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high molecular weight %28%220-250 kDa%29% water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins, and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-affinity, low capacity system y+ amino acid transporter found ubiquitously. It has specificity for the transport of ARGININE; LYSINE; and ORNITHINE. It may also act as an ecotropic leukemia retroviral receptor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-affinity, low capacity system y+ amino acid transporter with strong similarity to CATIONIC AMINO ACID TRANSPORTER 1. The two isoforms of the protein, CAT-2A and CAT-2B, exist due to alternative mRNA splicing. The transporter has specificity for the transport of ARGININE; LYSINE; and ORNITHINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-grade malignant lymphoma composed of a diffuse, relatively uniform proliferation of cells with round or convoluted nuclei and scanty cytoplasm. The cells are cytologically similar to the lymphoblasts seen in acute lymphocytic leukemia, and in some cases, the disease may evolve into a leukemic phase morphologically indistinguishable from acute T-lymphocytic leukemia %28%LEUKEMIA, T-CELL, ACUTE%29%. Lymphoblastic lymphoma represents approximately one-third of the cases of non-Hodgkin%27%s lymphomas in children and 5%25% of the cases in adults. It is more prevalent in males.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-grade malignant lymphoma that includes both Burkitt tumor %28%BURKITT LYMPHOMA%29% and other lymphomas previously designated undifferentiated non-Burkitt type. Nuclei in Burkitt tumor are round to ovoid and uniform in size. The non-Burkitt type exhibits greater nuclear variation and less evidence of cellular maturation with a correspondingly lesser degree of differentiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in von Willebrand%27%s disease is due to the deficiency of this factor.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-molecular-weight polymeric elastomer derived from the milk juice %28%LATEX%29% of HEVEA brasiliensis and other trees and plants. It is a substance that can be stretched at room temperature to at least twice its original length and after releasing the stress, retractrapidly, and recover its original dimensions fully. Synthetic rubber is made from many different chemicals, including STYRENE; ACRYLONITRILE; ethylene; propylene; and isoprene.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-molecular-weight protein %28%approximately 22,500%29% containing 198 amino acid residues. It is a strong inhibitor of trypsin and human plasmin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A high-molecular-weight proteoglycan-platelet factor complex which is released from blood platelets by thrombin. It acts as a mediator in the heparin-neutralizing capacity of the blood and plays a role in platelet aggregation. At high ionic strength %28%I=0.75%29%, the complex dissociates into the active component %28%molecular weight 29,000%29% and the proteoglycan carrier %28%chondroitin 4-sulfate, molecular weight 350,000%29%. The molecule exists in the form of a dimer consisting of 8 moles of platelet factor 4 and 2 moles of proteoglycan.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly abundant DNA binding protein whose expression is strongly correlated with the growth phase of bacteria. The protein plays a role in regulating DNA topology and activation of RIBOSOMAL RNA transcription. It was originally identified as a factor required for inversion stimulation by the Hin recombinase of SALMONELLA and Gin site-specific recombinase of BACTERIOPHAGE MU.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase %28%EC 5.4.2.1%29%. %28%From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors %28%RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly branched glucan in starch. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly caustic substance that is used to neutralize acids and make sodium salts. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly chlorinated polycyclic hydrocarbon insecticide whose large number of chlorine atoms makes it resistant to degradation. It has been shown to be toxic to mammals and causes abnormal cellular changes in laboratory animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly conserved 76-amino acid peptide universally found in eukaryotic cells that functions as a marker for intracellular PROTEIN TRANSPORT and degradation. Ubiquitin becomes activated through a series of complicated steps and forms an isopeptide bond to lysine residues of specific proteins within the cell. These %22%ubiquitinated%22% proteins can be recognized and degraded by proteosomes or be transported to specific compartments within the cell.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly conserved heterodimeric glycoprotein that is differentially expressed during many severe physiological disturbance states such as CANCER; APOPTOSIS; and various NEUROLOGICAL DISORDERS. Clusterin is ubiquitously expressed and appears to function as a secreted MOLECULAR CHAPERONE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly contagious DNA virus infection of the cat family and of mink, characterized by fever, enteritis and bone marrow changes. It is also called feline ataxia, feline agranulocytosis, feline infectious enteritis, cat fever, cat plague, show fever.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly contagious disease characterized by subconjunctival hemorrhage, sudden swelling of the eyelids and congestion, redness, and pain in the eye. Epidemic conjunctivitis caused by Enterovirus 70 %28%EV-70%29% was first described in Africa in 1969. It is caused also by Coxsackievirus A24 variant %28%CA24v%29%. Epidemics by this organism have appeared most frequently in Asia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the reticuloendothelial system. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly contagious infectious disease caused by the varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29%. It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly effective inhibitor of gastric acid secretion used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits the H%28%+%29%-K%28%+%29%-ATPase %28%H%28%+%29%-K%28%+%29%-EXCHANGING ATPASE%29% in the proton pump of GASTRIC PARIETAL CELLS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly fatal contagious disease of goats and sheep caused by PESTE-DES-PETITS-RUMINANTS VIRUS. The disease may be acute or subacute and is characterized by stomatitis, conjunctivitis, diarrhea, and pneumonia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLA-LIKE VIRUSES, first occurring in the Sudan and adjacent northwestern %28%what was then%29% Zaire. The natural reservoir and mode of transmission of the virus are unknown, but secondary infection is by direct contact with infected blood and other body secretions. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA. It is also used as an intracellular pH indicator.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly malignant CHORIOCARCINOMA derived from the non-placental origin such as the totipotent cells in the TESTIS, the OVARY, and the PINEAL GLAND. It produces high levels of CHORIONIC GONADOTROPIN and can metastasize widely through the bloodstream to the lungs, brain, liver, bone, and other viscera by the time of diagnosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases %28%NEOPLASM METASTASIS%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20%25% of all testicular tumors. %28%From Dorland, 27th ed %26% Holland et al., Cancer Medicine, 3d ed, p1595%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly miniaturized version of ELECTROPHORESIS performed in a microfluidic device.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly neurotoxic polypeptide from the venom of the honey bee %28%Apis mellifera%29%. It consists of 18 amino acids with two disulfide bridges and causes hyperexcitability resulting in convulsions and respiratory paralysis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly poisonous compound that is an inhibitor of many metabolic processes and is used as a test reagent for the function of chemoreceptors. It is also used in many industrial processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly poisonous organochlorine insecticide. The EPA has cancelled registrations of pesticides containing this compound with the exception of its use through subsurface ground insertion for termite control and the dipping of roots or tops of non-food plants. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during cryopreservation. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly potent and specific histamine H2 receptor agonist. It has been used diagnostically as a gastric secretion indicator.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution %28%formalin%29% is considered a hazardous compound, and its vapor toxic. %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly selective and specific beta antagonist that is used to characterize beta-adrenoceptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly toxic cholinesterase inhibitor that is used as an acaricide and as an insecticide.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly toxic compound used as a fungicide for treating seeds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly toxic compound used as a gasoline additive. It causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly toxic gas that has been used as a chemical warfare agent. It is an insidious poison as it is not irritating immediately, even when fatal concentrations are inhaled. %28%From The Merck Index, 11th ed, p7304%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly toxic saponin occurring in HOLOTHUROIDEA. This marine toxin is an anionic surfactant, hemolyzing ERYTHROCYTES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly toxic, colorless, nonflammable gas. It is used as a pharmaceutical aid and antioxidant. It is also an environmental air pollutant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly vascular ovoid body of chemoreceptive tissue lying adjacent to the TYMPANIC CAVITY. It is derived from NEURAL CREST tissue and is considered part of the diffuse neuroendocrine system. It is the site of a rare neoplasm called a GLOMUS TYMPANICUM TUMOR.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly vascularized extra-embryonic membrane, formed by the fusion of the CHORION and the ALLANTOIS. It is mostly found in BIRDS and REPTILES. It serves as a model for studying tumor or cell biology, such as angiogenesis and TISSUE TRANSPLANTATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion %28%CHORIONIC VILLI%29% derived from TROPHOBLASTS and a maternal portion %28%DECIDUA%29% derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones %28%PLACENTAL HORMONES%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly volatile inhalation anesthetic used mainly in short surgical procedures where light anesthesia with good analgesia is required. It is also used as an industrial solvent. Prolonged exposure to high concentrations of the vapor can lead to cardiotoxicity and neurological impairment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A highly-sensitive %28%in the picomolar range, which is 10,000-fold more sensitive than conventional electrophoresis%29% and efficient technique that allows separation of proteins, nucleic acids, and carbohydrates. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hinge joint connecting the FOREARM to the ARM. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p935%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies %28%including skin eruptions%29% both parenterally and locally. It is a common ingredient of cold remedies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H2 agonist used clinically to test gastric secretory function.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H2 receptor antagonist that is used as an anti-ulcer agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in Meniere%27%s disease and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histamine congener, it competitively inhibits histamine binding to H2 receptors. Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrin output. It also blocks the activity of cytochrome P-450.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histidine decarboxylase inhibitor. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A histochemical technique for staining carbohydrates. It is based on PERIODIC ACID oxidation of a substance containing adjacent hydroxyl groups. The resulting aldehydes react with Schiff reagent to form a colored product.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A historical and cultural entity dispersed across a wide geographical area under the administrative, intellectual, social, and cultural domination of the Arab empire. The Arab world, under the impetus of Islam, by the eighth century A.D., extended from Arabia in the Middle East to all of northern Africa, southern Spain, Sardinia, and Sicily. Close contact was maintained with Greek and Jewish culture. While the principal service of the Arabs to medicine was the preservation of Greek culture, the Arabs themselves were the originators of algebra, chemistry, geology, and many of the refinements of civilization. %28%From A. Castiglioni, A History of Medicine, 2d ed, p260; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, p126%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A historical and cultural entity dispersed across a wide geographical area under the influence of Greek civilization, culture, and science. The Greek Empire extended from the Greek mainland and the Aegean islands from the 16th century B.C., to the Indus Valley in the 4th century under Alexander the Great, and to southern Italy and Sicily. Greek medicine began with Homeric and Aesculapian medicine and continued unbroken to Hippocrates %28%480-355 B.C.%29%. The classic period of Greek medicine was 460-136 B.C. and the Graeco-Roman period, 156 B.C.-576 A.D. %28%From A. Castiglioni, A History of Medicine, 2d ed; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A historical and cultural entity dispersed across a wide geographical area under the political domination and influence of ancient Rome, bringing to the conquered people the Roman civilization and culture from 753 B.C. to the beginning of the imperial rule under Augustus in 27 B.C. The early city built on seven hills grew to conquer Sicily, Sardinia, Carthage, Gaul, Spain, Britain, Greece, Asia Minor, etc., and extended ultimately from Mesopotamia to the Atlantic. Roman medicine was almost entirely in Greek hands, but Rome, with its superior water system, remains a model of sanitation and hygiene. %28%From A. Castiglioni, A History of Medicine, 2d ed pp196-99; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, pp107-120%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A historical and cultural entity dispersed across the wide geographical area of Europe, as opposed to the East, Asia, and Africa. The term was used by scholars through the late medieval period. Thereafter, with the impact of colonialism and the transmission of cultures, Western World was sometimes expanded to include the Americas. %28%Dr. James H. Cassedy, NLM History of Medicine Division%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hole or break through the wall of the UTERUS, usually made by the placement of an instrument or INTRAUTERINE DEVICES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hollow part of the alveolar process of the MAXILLA or MANDIBLE where each tooth fits and is attached via the periodontal ligament.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A homeodomain protein that interacts with TATA-BOX BINDING PROTEIN. It represses GENETIC TRANSCRIPTION of target GENES and plays a critical role in ODONTOGENESIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A homolog of ALPHA-SYNUCLEIN that plays a role in neurofilament network integrity. It is overexpressed in a variety of human NEOPLASMS and may be involved in modulating AXON architecture during EMBRYONIC DEVELOPMENT and in the adult. Gamma-Synuclein may also activate SIGNAL TRANSDUCTION PATHWAYS associated with ETS-DOMAIN PROTEIN ELK-1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A homolog of ERGONOVINE containing one more CH2 group. %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A homologous family of proteins that includes the NAD-dependent protein deacetylases which deacetylate proteins by catalyzing the formation of O-acetyl-ADP-ribose from the ADP-RIBOSE moiety %28%of NAD%29% and the acetyl group that is being removed from the protein. Sir2p, from Saccharomyces cerevisiae, is the founding member and the family includes other homologs %28%HSTs - homologs of Sir Two%29%. Some HISTONE DEACETYLASES %28%the Sir2-like HDACs%29% belong to this family of proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A homologous group of endogenous cysteine proteinase inhibitors. Four distinct families are recognized within the cystatin superfamily: cystatin B or stefins; cystatin C or post-gamma-globulin; egg-white or chicken cystatin; and kininogen cystatin. The cystatins inhibit most Cysteine Endopeptidases of the papain type, and other peptidases which have a sulfhydryl group at the active site.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A household that includes children and is headed by one adult.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A housing and health care alternative combining independence with personal care. It provides a combination of housing, personalized supportive services and health care designed to meet the needs, both scheduled and unscheduled, of those who need help with activities of daily living. %28%www.alfa.org%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A huge subclass of mostly marine CRUSTACEA, containing over 14,000 species. The 10 orders comprise both planktonic and benthic organisms, and include both free-living and parasitic forms. Planktonic copepods form the principle link between PHYTOPLANKTON and the higher trophic levels of the marine food chains.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A human and animal pathogen causing mesenteric lymphadenitis, diarrhea, and bacteremia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A human cell line established from a diffuse histiocytic lymphoma %28%HISTIOCYTIC LYMPHOMA, DIFFUSE%29% and displaying many monocytic characteristics. It serves as an in vitro model for MONOCYTE and MACROPHAGE differentiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A human infant born before 37 weeks of GESTATION. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A humoral factor that stimulates the production of thrombocytes %28%BLOOD PLATELETS%29%. Thrombopoietin stimulates the proliferation of bone marrow MEGAKARYOCYTES and their release of blood platelets. The process is called THROMBOPOIESIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hybrid separation technique combining both chromatographic and electrophoretic separation principles. While the method was invented to separate neutral species, it can also be applied to charged molecules such as small peptides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hydrocarbon used as an industrial solvent. It has been used as an aerosal propellent, as a refrigerant and as a local anesthetic. %28%From Martindale, The Extra Pharmacopoeia, 31st ed, p1403%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hydrogen-carrying protein that participates in a variety of biochemical reactions including ribonucleotide reduction. Thioredoxin is oxidized from a dithiol to a disulfide during ribonucleotide reduction. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hydrolase enzyme that converts L-asparagine and water to L-aspartate and NH3. EC 3.5.1.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hydroxylated derivative of the amino acid LYSINE that is present in certain collagens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hydroxylated metabolite of ESTRADIOL or ESTRONE that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During PREGNANCY, large amount of estriol is produced by the PLACENTA. Isomers with inversion of the hydroxyl group or groups are called epiestriol.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypermotility disorder of the ESOPHAGUS that is characterized by spastic non-peristaltic responses to SWALLOWING; CHEST PAIN; and DYSPHAGIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypnotic and sedative with anticonvulsant effects. However, because of the hazards associated with its administration, its tendency to react with plastic, and the risks associated with its deterioration, it has largely been superseded by other agents. It is still occasionally used to control status epilepticus resistant to conventional treatment. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p608-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypnotic and sedative. Its use has been largely superseded by other drugs.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypotensive agent with some anti-arrhythmic effects. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A infiltrating %28%invasive%29% breast cancer, relatively uncommon, accounting for only 5%25%-10%25% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1205%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kappa opioid receptor agonist. The compound has analgesic action and shows positive inotropic effects on the electrically stimulated left atrium. It also affects various types of behavior in mammals such as locomotion, rearing, and grooming.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ketone oxidoreductase that catalyzes the overall conversion of alpha-keto acids to ACYL-CoA and CO2. The enzyme requires THIAMINE DIPHOSPHATE as a cofactor. Defects in genes that code for subunits of the enzyme are a cause of MAPLE SYRUP URINE DISEASE. The enzyme was formerly classified as EC 1.2.4.3.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A key enzyme in SPHINGOLIPIDS biosynthesis, this enzyme catalyzes the pyridoxal-5%27%-phosphate-dependent condensation of L-SERINE and PALMITOYL COENZYME A to 3-dehydro-D-sphinganine. The enzyme consists of two different subunits.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A key enzyme in the glyoxylate cycle. It catalyzes the conversion of isocitrate to succinate and glyoxylate. EC 4.1.3.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid %28%citrates%29% can be used as anticoagulants due to their calcium chelating ability.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A key regulator of CELL CYCLE progression. It partners with CYCLIN E to regulate entry into S PHASE and also interacts with CYCLIN A to phosphorylate RETINOBLASTOMA PROTEIN. Its activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P27 and CYCLIN-DEPENDENT KINASE INHIBITOR P21.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom in northern Africa, west of ALGERIA. Its capital is Rabat. It was known to the Romans as Mauretania, part of the Carthaginian empire %28%not to be confused with the modern MAURITANIA, a country of western Africa%29%. Morocco was invaded by the Muslims in the 7th century A.D. It engaged in hostilities with England, France, and Spain from 1662 to 1911. The country gained independence in 1956. The name is from the Arabic marukus, the name of the former capital Marrakech, from a Berber word meaning fortified. The Arabic name for Morocco is al-magrib al-aasa, the far west. %28%From Webster%27%s New Geographical Dictionary, 1988, p708, 792 %26% Room, Brewer%27%s Dictionary of Names, 1992, p362%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom in southern Africa, an enclave lying within the republic of SOUTH AFRICA. Its capital is Maseru. It was mostly uninhabited before 1800. In the early 19th century it had many disputes with the Boers. First receiving British protection in 1843, it was annexed in 1868 and made part of Cape Colony in 1871. It became a British colony in 1884 and gained independence in 1966. Sotho is the name of the indigenous people, probably meaning black. The plural is Basotho which gave the former name Basutoland. %28%From Webster%27%s New Geographical Dictionary, 1988, p664 %26% Room, Brewer%27%s Dictionary of Names, 1992, p304%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom in southern Africa, west of MOZAMBIQUE. Its capital is Mbabane. The area was settled by the Swazi branch of the Zulu nation in the early 1880%27%s, with its independence guaranteed by the British and Transvaal governments in 1881 and 1884. With limited self-government introduced in 1962, it became independent in 1968. Swazi is the Zulu name for the people who call themselves Swati, from Mswati, the name of a 16th century king, from a word meaning stick or rod. %28%From Webster%27%s New Geographical Dictionary, 1988, p1170 %26% Room, Brewer%27%s Dictionary of Names, 1992, p527%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom in the domain ARCHAEA comprised of thermoacidophilic, sulfur-dependent organisms. The two orders are SULFOLOBALES and THERMOPROTEALES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom in the domain ARCHAEA, comprising thermophilic organisms from the hot spring Obsidian Pool %28%Yellowstone National Park%29% that are among the most primitive of all life forms. They have undergone comparatively little evolutionary change since the last common ancestor of all extant life. %28%From ASM News, 1996; 62%28%9%29%:468-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom in the eastern Himalayas on the northeast border of India, bounded on the north by Tibet, on the east by Assam, on the south by Assam and West Bengal, and on the west by Sikkim and Tibet. From 1720 to 1970 it was under Chinese or Indian domination. In 1971 it became a member of the United Nations. The name comes from the Sanskrit bhota, the name for Tibet, + anta, end, with reference to its location at the southern extremity of Tibet. %28%From Webster%27%s New Geographical Dictionary, 1988, p144 %26% Room, Brewer%27%s Dictionary of Names, 1992, p64%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A kingdom of hyperthermophilic ARCHAEA found in diverse environments.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lack of HYDROCHLORIC ACID in GASTRIC JUICE despite stimulation of gastric secretion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lactogenic hormone secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lactose-fermenting bacterium causing dysentery. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A language dysfunction characterized by the inability to name people and objects that are correctly perceived. The individual is able to describe the object in question, but cannot provide the name. This condition is associated with lesions of the dominant hemisphere involving the language areas, in particular the TEMPORAL LOBE. %28%From Adams et al., Principles of Neurology, 6th ed, p484%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large collection of DNA fragments cloned %28%CLONING, MOLECULAR%29% from a given organism, tissue, organ, or cell type. It may contain complete genomic sequences %28%GENOMIC LIBRARY%29% or complementary DNA sequences, the latter being formed from messenger RNA and lacking intron sequences.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of MONOMERIC GTP-BINDING PROTEINS that are involved in regulation of actin organization, gene expression and cell cycle progression. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of MONOMERIC GTP-BINDING PROTEINS that play a key role in cellular secretory and endocytic pathways. EC 3.6.1.-.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of cell surface receptors that bind conserved molecular structures present in pathogens. They play important roles in host defense by mediating cellular responses to pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of evolutionarily conserved proteins that function as negative regulators of HETEROTRIMERIC GTP-BINDING PROTEINS. RGS PROTEINS act by increasing the GTPase activity of the G alpha subunit of a heterotrimeric GTP-binding protein, causing it to revert to its inactive %28%GDP-bound%29% form.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of fruit flies in the order DIPTERA, comprising over 4,500 species in about 100 genera. They have patterned wings and brightly colored bodies and are found predominantly in the tropical latitudes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of lytic bacteriophages infecting enterobacteria; SPIROPLASMA; BDELLOVIBRIO; and CHLAMYDIA. It contains four genera: MICROVIRUS; Spiromicrovirus; Bdellomicrovirus; and Chlamydiamicrovirus.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of mollusks in the class BIVALVIA, known commonly as scallops. They possess flat, almost circular shells and are found in all seas from shallow water to great depths.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29%. Food grains %28%CEREALS%29% come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of parasitic PROTOZOA in the order EIMERIIDA. They cause COCCIDIOSIS in a number of vertebrates including humans.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of receptor protein-tyrosine kinases that are structurally-related. The name of this family of proteins derives from original protein Eph %28%now called the EPHA1 RECEPTOR%29%, which was named after the cell line it was first discovered in: Erythropoietin-Producing human Hepatocellular carcinoma cell line. Members of this family have been implicated in regulation of cell-cell interactions involved in nervous system patterning and development.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large family of signal-transducing adaptor proteins present in wide variety of eukaryotes. They are PHOSPHOSERINE and PHOSPHOTHREONINE binding proteins involved in important cellular processes including SIGNAL TRANSDUCTION; CELL-CYCLE control; APOPTOSIS; and cellular stress responses. 14-3-3 proteins function by interacting with other signal-transducing proteins and effecting changes in their enzymatic activity and subcellular localization. The name 14-3-3 derives from numerical designations used in the original fractionation patterns of the proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large genus of plant viruses of the family POTYVIRIDAE which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. The type species is potato virus Y.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of aerobic bacteria which show up as pink %28%negative%29% when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of anaerobic bacteria which show up as pink %28%negative%29% when treated by the Gram-staining method.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of bacteria including those which oxidize ammonia or nitrite, metabolize sulfur and sulfur compounds, or deposit iron and/or manganese oxides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of cytochrome P-450 %28%heme-thiolate%29% monooxygenases that complex with NAD%28%P%29%H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of facultatively anaerobic, rod-shaped bacteria that show up as pink %28%negative%29% when treated by the gram-staining method.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of membrane transport proteins that shuttle MONOSACCHARIDES across CELL MEMBRANES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of nuclei lying between the internal medullary lamina and the internal capsule. It includes the ventral anterior, ventral lateral, and ventral posterior nuclei.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of proteins that control APOPTOSIS. This family of proteins includes many ONCOGENE PROTEINS as well as a wide variety of classes of INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS such as CASPASES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of rod-shaped bacteria that retains the crystal violet stain when treated by Gram%27%s method.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large group of structurally diverse cell surface receptors that mediate endocytic uptake of modified LIPOPROTEINS. Scavenger receptors are expressed by MYELOID CELLS and some ENDOTHELIAL CELLS, and were originally characterized based on their ability to bind acetylated LOW-DENSITY LIPOPROTEINS. They can also bind a variety of other polyanionic ligand. Certain scavenger receptors can internalize micro-organisms as well as apoptotic cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large heterogeneous group of mostly alpha-hemolytic streptococci. They colonize the respiratory tract at birth and generally have a low degree of pathogenicity. This group of species includes STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUIS; STREPTOCOCCUS SOBRINUS; and the STREPTOCOCCUS MILLERI GROUP. The latter are often beta-hemolytic and commonly produce invasive pyogenic infections including brain and abdominal abscesses.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large increase in oxygen uptake by neutrophils and most types of tissue macrophages through activation of an NADPH-cytochrome b-dependent oxidase that reduces oxygen to a superoxide. Individuals with an inherited defect in which the oxidase that reduces oxygen to superoxide is decreased or absent %28%GRANULOMATOUS DISEASE, CHRONIC%29% often die as a result of recurrent bacterial infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large maf protein that regulates HINDBRAIN development, contributes to CELL DIFFERENTIATION of MONOCYTES, and interacts with ETS-1 TRANSCRIPTION FACTOR.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large multisubunit protein complex found in the THYLAKOID MEMBRANE. It uses light energy derived from LIGHT-HARVESTING PROTEIN COMPLEXES to catalyze the splitting of WATER into DIOXYGEN and of reducing equivalents of HYDROGEN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large multisubunit protein complex that is found in the THYLAKOID MEMBRANE. It uses light energy derived from LIGHT-HARVESTING PROTEIN COMPLEXES to drive electron transfer reactions that result in either the reduction of NADP to NADPH or the transport of PROTONS across the membrane.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large or important municipality of a country, usually a major metropolitan center.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large order of insects characterized by having the mouth parts adapted to piercing or sucking. It is comprised of four suborders: HETEROPTERA, Auchenorrhyncha, Sternorrhyncha, and Coleorrhyncha.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large order of insects comprising the butterflies and moths.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of %22%daisy%22% refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. They have a milky sap and a female flower consisting of a single pistil, surrounded by numerous male flowers of one stamen each. Euphorbia hirta is rarely called milkweed but that name is normally used for ASCLEPIAS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large stout-bodied, sometimes anadromous, TROUT found in still and flowing waters of the Pacific coast from southern California to Alaska. It has a greenish back, a whitish belly, and pink, red, or lavender stripes on the sides, with usually a sprinkling of black dots. It is highly regarded as a sport and food fish. Its former name was Salmo gairdneri. The sea-run rainbow trouts are often called steelheads. Redband trouts refer to interior populations of rainbows.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large subphylum of mostly marine ARTHROPODS containing over 42,000 species. They include familiar arthropods such as lobsters %28%NEPHROPIDAE%29%, crabs %28%BRACHYURA%29%, shrimp %28%PENAEIDAE%29%, and barnacles %28%THORACICA%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large superfamily of transcription factors that contain a region rich in BASIC AMINO ACID residues followed by a LEUCINE ZIPPER domain.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large vessel supplying the whole length of the small intestine except the superior part of the duodenum. It also supplies the cecum and the ascending part of the colon and about half the transverse part of the colon. It arises from the anterior surface of the aorta below the celiac artery at the level of the first lumbar vertebra.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large, nuclear protein, encoded by the BRCA2 gene %28%GENE, BRCA2%29%. Mutations in this gene predispose humans to breast and ovarian cancer. The BRCA2 protein is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. %28%from Genes Dev. 2000;14%28%11%29%:1400-6%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large, subclass of arachnids comprising the MITES and TICKS, including parasites of plants, animals, and humans, as well as several important disease vectors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A large-cell, non-Hodgkin%27%s, malignant lymphoma with pleomorphic appearance and reactivity with the monoclonal antibody Ki-1. The lymphoma is most often found in the skin and lymph nodes and expresses the Ki-1 %28%CD30%29% antigen %28%ANTIGENS, CD30%29% on its surface. It is often mistaken for metastatic carcinoma and malignant histiocytosis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A late 20th-century philosophical approach or style of cultural analysis that seeks to reveal the cultural or social construction of concepts conventionally assumed to be natural or universal. %28%from E.R. DuBose, The Illusion of Trust: Toward a Medical Theological Ethics in the Postmodern Age, Kluwer, 1995%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A late-appearing component of the event-related potential. P stands for positive voltage potential and 300 represents 300 millisecond poststimulus. Its amplitude increases with unpredictable, unlikely, or highly significant stimuli and thereby constitutes an index of mental activity. %28%From Campbell, Psychiatric Dictionary, 6th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lattice of fibrils which covers the entire inner surface of the nuclear envelope and interlinks nuclear pores %28%NUCLEAR PORE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lavender, acid-resistant asbestos. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A laxative that undergoes enterohepatic circulation. It may cause jaundice.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A layer of acellular matrix that lies beneath the CORNEAL EPITHELIUM and above the CORNEAL STROMA. It consists of randomly arranged COLLAGEN fibers in a condensed bed of intercellular substance. It provides stability and strength to the cornea.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A layer of epithelium that lines the heart, blood vessels %28%ENDOTHELIUM, VASCULAR%29%, lymph vessels %28%ENDOTHELIUM, LYMPHATIC%29%, and the serous cavities of the body.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A layer of highly vascular pigmented granular cells on the outer wall of the cochlear duct.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A layer of the cornea. It is the basal lamina of the CORNEAL ENDOTHELIUM %28%from which it is secreted%29% separating it from the CORNEAL STROMA. It is a homogeneous structure composed of fine collagenous filaments, and slowly increases in thickness with age.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A layer of the peritoneum which attaches the abdominal viscera to the ABDOMINAL WALL and conveys their blood vessels and nerves.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A layer of vascularized connective tissue underneath the EPIDERMIS. The surface of the dermis contains innervated papillae. Embedded in or beneath the dermis are SWEAT GLANDS; HAIR FOLLICLES; and SEBACEOUS GLANDS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A learning situation involving more than one alternative from which a selection is made in order to attain a specific goal.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lectin and cell adhesion molecule found in B-LYMPHOCYTES. It interacts with SIALIC ACIDS and mediates signaling from B-CELL ANTIGEN RECEPTORS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lectin found in ENDOPLASMIC RETICULUM membranes that binds to specific N-linked OLIGOSACCHARIDES found on newly synthesized proteins. It may play role in PROTEIN FOLDING or retention and degradation of misfolded proteins in the endoplasmic reticulum.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A left-handed double helix of DNA. Its name derives from its narrow zigzag structure that is the least twisted and thinnest form of DNA. Z-DNA forming regions within the GENOME may play an important role in GENE EXPRESSION REGULATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A legal concept for individuals who are designated to act on behalf of persons who are considered incapable of acting in their own behalf, e.g., minors and persons found to be not mentally competent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A legal concept that an accused is not criminally responsible if, at the time of committing the act, the person was laboring under such a defect of reason from disease of the mind as not to know the nature and quality of the act done or if the act was known, to not have known that what was done was wrong. %28%From Black%27%s Law Dictionary, 6th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A legal requirement that designated types of information acquired by professionals or institutions in the course of their work be reported to appropriate authorities.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A leucine-sensitive amino acid transport system with high affinity for basic amino acids%28% AMINO ACIDS, BASIC%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A leukomaine %28%animal alkaloid%29% formed in brain and liver from dopamine and L-dopa; it may be implicated in psychiatric problems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by excessive LIPOLYSIS, oxidation of FATTY ACIDS, production of KETONE BODIES, a sweet smell to the breath %28%KETOSIS;%29% DEHYDRATION; and depressed consciousness leading to COMA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A light microscopic technique in which only a small spot is illuminated and observed at a time. An image is constructed through point-by-point scanning of the field in this manner. Light sources may be conventional or laser, and fluorescence or transmitted observations are possible.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A light, silvery, metallic element. It has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. Its salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation. It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. Deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A light-activated enzyme that catalyzes the oxidation of %28%S%29%-malate to OXALOACETATE. It is involved in PYRUVATE metabolism and CARBON fixation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other biogenic amines, and neuropeptides.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lignan %28%LIGNANS%29% found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A linear polysaccharide of beta-1-%3E%4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 %28%VITAMIN K 1%29% derived from plants, VITAMIN K 2 %28%menaquinone%29% from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 %28%menadione%29%. Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipid phosphatase that acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipid storage disease, inherited as an autosomal recessive trait, characterized by xanthomas of the tendons, the white matter of the brain, and the lungs, and by spasticity, ataxia, pyramidal paresis, mental retardation, dementia, early cataracts, and atherosclerosis. It is associated with elevated plasma and tissue levels of cholestanol and defective bile synthesis, with the deposition of cholestanol in the central nervous system and myelin of peripheral nerves. The lesions contain cholesterol and dehydrocholesterol. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipid-regulating agent that lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipid-soluble benzoquinone which is involved in electron transport in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipopeptide antibiotic that inhibits gram-positive bacteria.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipoprotein with pronounced electronegative surface charge found in association with platelet membrane and platelet granules. In the sequence of blood coagulation reactions, it is required for activation of factor VIII and for the conversion of prothrombin to thrombin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A liposarcoma containing myxomatous tissue. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lipoxygenase metabolite of ARACHIDONIC ACID. It is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumor cell metastatic potential through activation of protein kinase C. %28%J Pharmacol Exp Ther 1995; 274%28%3%29%:1545-51; J Natl Cancer Inst 1994; 86%28%15%29%:1145-51%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A list of works, documents or other publications, usually with some relationship between them, e.g., by a given author, on a given subject, or published in a given place, and differing from a catalog in that its contents are restricted to holdings of a single collection, library, or group of libraries. %28%The ALA Glossary of Library and Information Science, 1983%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A list of works, documents, and other publications on medical subjects and topics of interest to the field of medicine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A listing of established professional service charges, for specified dental and medical procedures.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A live VACCINIA VIRUS vaccine of calf lymph or chick embryo origin, used for immunization against smallpox. It is now recommended only for laboratory workers exposed to smallpox virus. Certain countries continue to vaccinate those in the military service. Complications that result from smallpox vaccination include vaccinia, secondary bacterial infections, and encephalomyelitis. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A live, attenuated varicella virus vaccine used for immunization against chickenpox. It is recommended for children between the ages of 12 months and 13 years.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A liver microsomal cytochrome P-450 monooxygenase capable of biotransforming xenobiotics such as polycyclic hydrocarbons and halogenated aromatic hydrocarbons into carcinogenic or mutagenic compounds. They have been found in mammals and fish. This enzyme, encoded by CYP1A1 gene, can be measured by using ethoxyresorufin as a substrate for the ethoxyresorufin O-deethylase activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A liver microsomal cytochrome P450 enzyme that catalyzes the 12-alpha-hydroxylation of a broad spectrum of sterols in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP8B1gene, converts 7-alpha-hydroxy-4-cholesten-3-one to 7-alpha-12-alpha-dihydroxy-4-cholesten-3-one and is required in the synthesis of BILE ACIDS from cholesterol.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A liver microsomal cytochrome P450 enzyme that catalyzes the 16-alpha-hydroxylation of a broad spectrum of steroids, fatty acids, and xenobiotics in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme is encoded by a number of genes from several CYP2 subfamilies.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A liverwort plant genus of the family Marchantiaceae, order Marchantiales, subclass MARCHANTIAE. Members contain brassinosteroids and DITERPENES.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1006%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic of the ester type that has a rapid onset of action and a longer duration of action than procaine hydrochloride. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1017%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1016%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity %28%primarily blood disorders%29% and potential carcinogenicity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. %28%From AMA Drug Evaluations, 1994, p168%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic that is similar pharmacologically to LIDOCAINE. Currently, it is used most often for infiltration anesthesia in dentistry. %28%From AMA Drug Evaluations Annual, 1992, p165%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A local anesthetic with rapid onset and long action, similar to BUPIVACAINE.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A localization-related %28%focal%29% form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures %28%see EPILEPSY, COMPLEX PARTIAL%29% originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic %28%i.e., related to an identified disease process or lesion%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p321%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A localization-related %28%focal%29% form of epilepsy characterized by seizures which arise in the frontal lobe. A variety of clinical syndromes exist depending on the exact location of the seizure focus. Simple or complex motor movements may occur, and most commonly involve the face and upper extremities. Seizures in the anterior frontal regions may be associated with head and eye turning, typically away from the side of origin of the seizure. Frontal lobe seizures may be idiopathic %28%cryptogenic%29% or caused by an identifiable disease process such as traumatic injuries, neoplasms, or other macroscopic or microscopic lesions of the frontal lobes %28%symptomatic frontal lobe seizures%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp318-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A localized arrested tooth development which appears to involve most commonly the anterior teeth, usually on one side of the midline, most often the maxillary central and lateral incisors. Roentgenographically, the teeth have a ghostlike appearance. Calcification and bits of prismatic enamel may be found in the pulp and the enamel is thin and absent in part. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A localized defect in the visual field bordered by an area of normal vision. This occurs with a variety of EYE DISEASES %28%e.g., RETINAL DISEASES and GLAUCOMA%29%; OPTIC NERVE DISEASES, and other conditions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A localized proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumors or galls usually form in response to the action of a pathogen or a pest. %28%Holliday, P., A Dictionary of Plant Pathology, 1989, p330%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A locally aggressive, osteolytic neoplasm of the long bones, probably of epithelial origin and most often involving the TIBIA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long flat muscle that extends along the whole length of both sides of the abdomen. It flexes the vertebral column, particularly the lumbar portion; it also tenses the anterior abdominal wall and assists in compressing the abdominal contents. It is frequently the site of hematomas. In reconstructive surgery it is often used for the creation of myocutaneous flaps. %28%From Gray%27%s Anatomy, 30th American ed, p491%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting GONADORELIN analog agonist. It has been used in the treatment of prostatic cancer, ovarian cancer, precocious puberty, endometriosis, and to induce ovulation for in vitro fertilization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting dopamine agonist which is effective in the treatment of Parkinson%27%s disease and hyperprolactinemia. It has also been observed to have antihypertensive effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting injectable antipsychotic agent used for chronic schizophrenia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting potent progestogen structurally related to PROGESTERONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1185%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-acting, non-sedative antihistaminic used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria. The drug is well tolerated and has no anticholinergic side effects.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents %28%including the antipsychotics and anti-anxiety agents%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A loss of mucous substance of the mouth showing local excavation of the surface, resulting from the sloughing of inflammatory necrotic tissue. It is the result of a variety of causes, e.g., denture irritation, aphthous stomatitis %28%STOMATITIS, APHTHOUS%29%; NOMA; necrotizing gingivitis %28%GINGIVITIS, NECROTIZING ULCERATIVE%29%; TOOTHBRUSHING; and various irritants. %28%From Jablonski, Dictionary of Dentistry, 1992, p842%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A love or pursuit of wisdom. A search for the underlying causes and principles of reality. %28%Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low affinity receptor that binds NERVE GROWTH FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; and neurotrophin 4.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental hemorrhagic pancreatitis, severe ischemia, and postoligemic shock.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-affinity 11 beta-hydroxysteroid dehydrogenase found in a variety of tissues, most notably in LIVER; LUNG; ADIPOSE TISSUE; vascular tissue; OVARY; and the CENTRAL NERVOUS SYSTEM. The enzyme acts reversibly and can use either NAD or NADP as cofactors.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-grade malignant lymphoma of follicular pattern in which there is no clear preponderance of one cell type %28%small or large%29% over another. The large cells, cleaved or noncleaved, are often 2-3 times larger in diameter than normal lymphocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-grade malignant lymphoma of predominantly follicular pattern. Follicles are of relatively uniform size and shape and the cells are usually somewhat larger than normal lymphocytes. Nuclei are irregular with prominent indentations and cytoplasm can rarely be identified. Cells exhibiting these characteristics are often called centrocytes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-grade malignant lymphoma that may, in some cases, be considered histologically identical to chronic lymphocytic leukemia %28%CLL; LEUKEMIA, LYMPHOCYTIC, CHRONIC%29%. It is diffuse in pattern, representing the neoplastic proliferation of well-differentiated B-lymphocytes. In patients with immunoglobulin gammopathies, the lymphocytes may exhibit plasmacytoid characteristics.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-molecular-weight %28%16,000%29% iron-free flavoprotein containing one molecule of flavin mononucleotide %28%FMN%29% and isolated from bacteria grown on an iron-deficient medium. It can replace ferredoxin in all the electron-transfer functions in which the latter is known to serve in bacterial cells.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-molecular-weight %28%approx. 10 kD%29% protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-molecular-weight protein %28%minimum molecular weight 8000%29% which has the ability to inhibit trypsin as well as chymotrypsin at independent binding sites. It is characterized by a high cystine content and the absence of glycine.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A low-osmolar, ionic contrast medium used in various radiographic procedures.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lung disease caused by exposure to metallic beryllium or its soluble salts.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lymphoid neoplastic disease in cattle caused by the bovine leukemia virus. Enzootic bovine leukosis may take the form of lymphosarcoma, malignant lymphoma, or leukemia but the presence of malignant cells in the blood is not a consistent finding.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lyophilized preparation of a low-virulence strain %28%SU%29% of Streptococcus pyogenes %28%S. hemolyticus%29%, inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A lysosomal cysteine proteinase which hydrolyzes proteins, with a specificity resembling that of papain. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in demyelination, emphysema, rheumatoid arthritis, and neoplastic infiltration. EC 3.4.22.1.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic of the oligomycin group, obtained from Streptomyces rutgersensis. It is used in cytochemistry as a tool to inhibit various ATPases and to uncouple oxidative phosphorylation from electron transport and also clinically as an antifungal agent.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic that has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic that is similar to ERYTHROMYCIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide antibiotic, produced by Streptomyces erythreus. This compound is an ester of erythromycin base and succinic acid. It acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide isolated from cultures of Streptomyces lucensis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macromolecular complex of proteins that includes DYSTROPHIN and DYSTROPHIN-ASSOCIATED PROTEINS. It plays a structural role in the linking the CYTOSKELETON to the EXTRACELLULAR MATRIX.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A macular lesion on the side of the FACE, involving the CONJUNCTIVA and EYELIDS, as well as the adjacent facial skin, SCLERA; OCULOMOTOR MUSCLES; and PERIOSTEUM. Histological features vary from those of a MONGOLIAN SPOT to those of a BLUE NEVUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone %28%DHEA%29% can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated %28%DEHYDROEPIANDROSTERONE SULFATE%29% before secretion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major adhesion-associated heterodimer molecule expressed by MONOCYTES; GRANULOCYTES; NK CELLS; and some LYMPHOCYTES. The alpha subunit is the CD11c ANTIGEN %28%also called Leu-M5%29%, a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 antigen %28%ANTIGENS, CD18%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major affective disorder marked by severe mood swings %28%manic or major depressive episodes%29% and a tendency to remission and recurrence.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever %28%PERIODIC DISEASE%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major alkaloid of Vinca minor L., Apocynaceae. It has been used therapeutically as a vasodilator and antihypertensive agent, particularly in cerebrovascular disorders.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major class of calcium activated potassium channels whose members are voltage-dependent. MaxiK channels are activated by either membrane depolarization or an increase in intracellular Ca%28%2+%29%. They are key regulators of calcium and electrical signaling in a variety of tissues.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major class of calcium-activated potassium channels that are found primarily in excitable CELLS. They play important roles in the transmission of ACTION POTENTIALS and generate a long-lasting hyperpolarization known as the slow afterhyperpolarization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major class of calcium-activated potassium channels that were originally discovered in ERYTHROCYTES. They are found primarily in non-excitable CELLS and set up electrical gradients for PASSIVE ION TRANSPORT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major cytochrome P-450 enzyme which is inducible by PHENOBARBITAL in both the LIVER and SMALL INTESTINE. It is active in the metabolism of compounds like pentoxyresorufin, TESTOSTERONE, and ANDROSTENEDIONE. This enzyme, encoded by CYP2B1 gene, also mediates the activation of CYCLOPHOSPHAMIDE and IFOSFAMIDE to MUTAGENS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major deviation from normal patterns of behavior. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major glucose transporter found in NEURONS. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major gonadotropin secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major gonadotropin secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones %28%TSH, LH and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major gonadotropin secreted by the human adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones %28%TSH, LH, and FSH%29%, but the beta subunit is unique and confers its biological specificity.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major group of polyphyletic organisms of extremely varied morphology and physiology, mostly photosynthetic, but distinguished from plants by their complex form of sexual reproduction. They are freshwater and marine, terrestrial and subterranean; some are neustonic %28%living at the interface of water and the atmosphere%29%. They live in various protozoa and within other plants. They live also in soil and on soil surfaces, on long-persistent snows, and in Antarctic rocks. Thermophilic algae inhabit hot springs. %28%From Webster, 3d ed; from Bold %26% Wynne, Introduction to the Algae, 2d ed, pp1-6%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major group of unsaturated cyclic hydrocarbons containing two or more rings. The vast number of compounds of this important group, derived chiefly from petroleum and coal tar, are rather highly reactive and chemically versatile. The name is due to the strong and not unpleasant odor characteristic of most substances of this nature. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed, p96%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major nerve of the upper extremity. In humans the fibers of the radial nerve originate in the lower cervical and upper thoracic spinal cord %28%usually C5 to T1%29%, travel via the posterior cord of the brachial plexus, and supply motor innervation to extensor muscles of the arm and cutaneous sensory fibers to extensor regions of the arm and hand.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major nerve of the upper extremity. In humans, the fibers of the median nerve originate in the lower cervical and upper thoracic spinal cord %28%usually C6 to T1%29%, travel via the brachial plexus, and supply sensory and motor innervation to parts of the forearm and hand.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major nerve of the upper extremity. In humans, the fibers of the ulnar nerve originate in the lower cervical and upper thoracic spinal cord %28%usually C7 to T1%29%, travel via the medial cord of the brachial plexus, and supply sensory and motor innervation to parts of the hand and forearm.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major nerve of the upper extremity. The fibers of the musculocutaneous nerve originate in the lower cervical spinal cord %28%usually C5 to C7%29%, travel via the lateral cord of the brachial plexus, and supply sensory and motor innervation to the upper arm, elbow, and forearm.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major orthodox system of Hindu philosophy based on Sankhya %28%metaphysical dualism%29% but differing from it in being theistic and characterized by the teaching of raja-yoga as a practical method of liberating the self. It includes a system of exercises for attaining bodily or mental control and well-being with liberation of the self and union with the universal spirit. %28%From Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malabsorption condition resulting from greater than 10%25% reduction in the secretion of pancreatic digestive enzymes %28%LIPASE; PROTEASES; and AMYLASE%29% by the EXOCRINE PANCREAS into the DUODENUM. This condition is often associated with CYSTIC FIBROSIS and with chronic PANCREATITIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malabsorption syndrome that is precipitated by the ingestion of GLUTEN-containing foods, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malformation of the nervous system caused by failure of the anterior neuropore to close. Infants are born with intact spinal cords, cerebellums, and brainstems, but lack formation of neural structures above this level. The skull is only partially formed but the eyes are usually normal. This condition may be associated with folate deficiency. Affected infants are only capable of primitive %28%brain stem%29% reflexes and usually do not survive for more than two weeks. %28%From Menkes, Textbook of Child Neurology, 5th ed, p247%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 %28%formerly, mild dysplasia%29% to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. %28%From Hughes, Obstetric-Gynecologic Terminology, 1972, p185%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. %28%Hughes, Obstetric-Gynecologic Terminology, 1972, p184%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue, and the presence of large, usually multinucleate, cells %28%REED-STERNBERG CELLS%29% of unknown origin.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant epithelial tumor of glandular tissue, especially the salivary glands, characterized by acini with mucus-producing cells and by the presence of malignant squamous elements. Most mucoepidermoid tumors are low-grade lesions readily cured by adequate excision. They may appear in any age group. They grow slowly. If high-grade, they behave aggressively, widely infiltrating the salivary gland and producing lymph node and distant metastases. %28%Dorland, 27th ed; from DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p575%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant epithelial tumor with a glandular organization.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant kidney tumor, caused by the uncontrolled multiplication of renal stem %28%blastemal%29%, stromal %28%STROMAL CELLS%29%, and epithelial %28%EPITHELIAL CELLS%29% elements. However, not all three are present in every case. Several genes or chromosomal areas have been associated with Wilms tumor which is usually found in childhood as a firm lump in a child%27%s side or ABDOMEN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts %28%TROPHOBLASTS%29%. It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental %28%fetal%29% origin or non-placental origin %28%CHORIOCARCINOMA, NON-GESTATIONAL%29%.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic %28%characterized by sheaths of monotonous spindle cells%29% and the biphasic %28%characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells%29%. These sarcomas occur most commonly in the second and fourth decades of life. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1363%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm arising simultaneously or consecutively in mesodermal tissue and glandular epithelium of the same part. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. %28%Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm derived from transitional epithelium, occurring chiefly in the urinary bladder, ureters or renal pelves %28%especially if well differentiated%29%, frequently papillary. Transitional cell carcinomas are graded 1 to 3 or 4 according to the degree of anaplasia, grade 1 appearing histologically benign but being liable to recurrence. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for %22%cancer.%22% %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic %28%ANAPLASIA%29% masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism %28%CUSHING SYNDROME%29%; HYPERALDOSTERONISM; and/or VIRILISM.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm of the germinal tissue of the GONADS; MEDIASTINUM; or pineal region. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. %28%Stedman, 265th ed; from DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp1642-3%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells %28%i.e., blast forms%29% with little or virtually no stroma. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood %28%see NEUROECTODERMAL TUMOR, PRIMITIVE%29%. The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant olfactory neuroblastoma arising from the olfactory epithelium of the superior nasal cavity and cribriform plate. It is uncommon %28%3%25% of nasal tumors%29% and rarely is associated with the production of excess hormones %28%e.g., SIADH, Cushing Syndrome%29%. It has a high propensity for multiple local recurrences and bony metastases. %28%From Holland et al., Cancer Medicine, 3rd ed, p1245; J Laryngol Otol 1998 Jul;112%28%7%29%:628-33%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16%25% of all germ cell tumors but are rare before the age of 10, although nearly 50%25% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1646%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid %28%pagetoid%29%. More than 95%25% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85%25% are found on the head and neck area and the remaining 15%25% on the trunk and limbs. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1471%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar %28%RHABDOMYOSARCOMA, ALVEOLAR%29%, mainly in adolescents and young adults; embryonal %28%RHABDOMYOSARCOMA, EMBRYONAL%29%, predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp1647-9%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose %28%Latin racemosus, full of clusters%29% refers, as does acinar %28%Latin acinus, grape%29%, to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13%25% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16%25% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. %28%Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p575%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor arising from the intrahepatic bile duct epithelium. It is composed of ducts lined by cuboidal or columnar cells that do not contain bile, with abundant stroma. %28%From Holland et al., Cancer Medicine, 3d ed, p1455; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex %28%leukokoria%29%; NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. %28%From Rook et al., Textbook of Dermatology, 4th ed, pp2403-4%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor composed of more than one type of neoplastic tissue. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid %28%LIPOSARCOMA, MYXOID%29%, round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor of plasma cells usually arising in the bone marrow; characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria, and anemia.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. There are conspicuous foci of necrosis in association with irregular masses of small, regular, rounded or ovoid cells with very scanty cytoplasm. The tumor occurs usually before the age of 20, about twice as frequently in males as in females. %28%From Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor of the kidney characterized by spindled myofibroblastic cells arranged in sheets or bundles with a tendency to infiltrate into the adjoining normal kidney and through the capsule into the perirenal tissues. %28%From Holland et al., Cancer Medicine, 3d ed, p2208%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor of the skin appendages, which include the hair, nails, sebaceous glands, sweat glands, and the mammary glands. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malignant tumor that arises from small cutaneous nerves, is locally aggressive, and has a potential for metastasis. Characteristic histopathologic features include proliferating atypical spindle cells with slender wavy and pointed nuclei, hypocellular areas, and areas featuring organized whorls of fibroblastic proliferation. The most common primary sites are the extremities, retroperitoneum, and trunk. These tumors tend to present in childhood, often in association with NEUROFIBROMATOSIS 1. %28%From DeVita et al., Cancer: Principles %26% Practice of Oncology, 5th ed, p1662; Mayo Clin Proc 1990 Feb;65%28%2%29%:164-72%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A malpresentation of the FETUS at near term or during OBSTETRIC LABOR with the fetal cephalic pole in the fundus of the UTERUS. There are three types of breech: the complete breech with flexed hips and knees; the incomplete breech with one or both hips partially or fully extended; the frank breech with flexed hips and extended knees.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mammalian fetus expelled by INDUCED ABORTION or SPONTANEOUS ABORTION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mammalian homolog of the DROSOPHILA SON OF SEVENLESS PROTEIN. It is a guanine nucleotide exchange factor for RAS PROTEINS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ A with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BLADDER and UTERUS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mammalian order which consists of 29 families and many genera.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mammalian pancreatic extract composed of enzymes with protease, amylase and lipase activities. It is used as a digestant in pancreatic malfunction.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A man-made compound previously used to control termites and other insects. Even though production of heptachlor was phased out of use in the United States during the late 1980%27%s it remains in soil and hazardous waste sites. It is clearly toxic to animals and humans but, the International Agency for Research on Cancer %28%IARC%29% has determined that heptachlor is not classifiable as to its carcinogenicity to humans. %28%From ATSDR Public Heath Statement, April 1989%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A manifestation of congestive heart failure caused by increased venous and capillary pressures and often associated with the retention of sodium by the kidneys. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A manifestation of sarcoidosis marked by chronic inflammation of the parotid gland and the uvea.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A manifestation of severe ROSACEA resulting in significant enlargement of the NOSE and occurring primarily in men. It is caused by hypertrophy of the SEBACEOUS GLANDS and surrounding CONNECTIVE TISSUE. The nose is reddened and marked with TELANGIECTASIS.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mass of histologically normal tissue present in an abnormal location.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mass of organic or inorganic solid fragmented material, or the solid fragment itself, that comes from the weathering of rock and is carried by, suspended in, or dropped by air, water, or ice. It refers also to a mass that is accumulated by any other natural agent and that forms in layers on the earth%27%s surface, such as sand, gravel, silt, mud, fill, or loess. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1689%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mass spectrometric technique that is used for the analysis of a wide range of biomolecules, such as glycoalkaloids, glycoproteins, polysaccharides, and peptides. Positive and negative fast atom bombardment spectra are recorded on a mass spectrometer fitted with an atom gun with xenon as the customary beam. The mass spectra obtained contain molecular weight recognition as well as sequence information.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free %28%gas phase%29% matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mass-spectrometric technique that is used for microscopic chemical analysis. A beam of primary ions with an energy of 5-20 kiloelectronvolts %28%keV%29% bombards a small spot on the surface of the sample under ultra-high vacuum conditions. Positive and negative secondary ions sputtered from the surface are analyzed in a mass spectrometer in regards to their mass-to-charge ratio. Digital imaging can be generated from the secondary ion beams and their intensity can be measured. Ionic images can be correlated with images from light or other microscopy providing useful tools in the study of molecular and drug actions.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A massive slaughter, especially the systematic mass extermination of European Jews in Nazi concentration camps prior to and during World War II.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A masticatory muscle whose action is closing the jaws. ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A material used for cementation of inlays, crowns, bridges, and orthodontic appliances and occasionally as a temporary restoration. It is prepared by mixing zinc oxide and magnesium oxide powders with a liquid consisting principally of phosphoric acid, water, and buffers. %28%From Bouchers%27% Clinical Dental Terminology, 3d ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A material used in the manufacture of azo dyes that is toxic to skin and carcinogenic in several species.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A maternally linked genetic disorder that presents in mid-life as acute or subacute central vision loss leading to central scotoma and blindness. The disease has been associated with missense mutations in the mtDNA, in genes for Complex I, III, and IV polypeptides, that can act autonomously or in association with each other to cause the disease. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/, MIM%23%535000 %28%April 17, 2001%29%%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mature haploid female germ cell extruded from the OVARY at OVULATION.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A measure of inpatient health facility use based upon the average number or proportion of beds occupied for a given period of time.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of %22%avidity,%22% which refers to the strength of the antigen-antibody bond after formation of reversible complexes.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. %28%BIOETHICS Thesaurus, 1994%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mechanism of communication among life processes to coordinate development, reproduction, and homeostasis. In humans, feedback loops are especially important for communication between organs that are spatially separated. Virtually all hormones from the nervous and endocrine systems are under feedback control: by peripheral hormones, cations, metabolites, osmolarity or extracellular fluid volume.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A mechanism of information stimulus and response that may control subsequent behavior, cognition, perception, or performance. %28%From APA Thesaurus of Psychological Index Terms, 8th ed.%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical device used to ensure the proper amount of medication is delivered for inhalation. Usually, it is a small aerosol canister placed in a plastic holder. When the canister is pressed, a calibrated amount of drug is released.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty concerned with the use of physical agents, mechanical apparatus, and manipulation in rehabilitating physically diseased or injured patients.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical specialty primarily concerned with prevention of disease %28%PRIMARY PREVENTION%29% and the promotion and preservation of health in the individual.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical-surgical specialty concerned with management and care of women during pregnancy, parturition, and the puerperium.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intrafallopian transfer of zygotes. %28%From Infertility and Reproductive Medicine Clinics of North America, Foreword 1990; Journal of Reproduction and Fertility, Notice to Contributors, Jan 1979%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A medical-surgical specialty concerned with the physiology and disorders primarily of the female genital tract, as well as female endocrinology and reproductive physiology.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH and CORTICOTROPIN.%A% ' = 0).
% 42.08/41.95 fof(interp, fi_functors, 'A melanocortin receptor subtype found primarily in BRAIN. It shows specificity for ALPHA-MSH; BETA-MSH; GAMMA-MSH and CORTICOTROPIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A melanocortin receptor subtype found primarily in MELANOCYTES. It shows specificity for ALPHA-MSH and CORTICOTROPIN. Loss of function mutations of the type 1 melanocortin receptor account for the majority of red hair and fair skin recessive traits in human.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A melanocortin receptor subtype found primarily in the ADRENAL CORTEX. It shows specificity for CORTICOTROPIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A melatonin receptor subtype primarily found expressed in the BRAIN and RETINA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A melatonin receptor subtype that is primarily found in the HYPOTHALAMUS and in the KIDNEY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the AGARICALES known for edible MUSHROOMS. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the Bcl-2 protein family that reversibly binds MEMBRANES. It is a pro-apoptotic protein that is activated by caspase cleavage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the C-EBP protein family of transcription factors. It plays a key role in G0 PHASE mammary EPITHELIAL CELL growth arrest, and it is involved in transcriptional regulation of INTERLEUKIN 1; INTERLEUKIN 6; and TUMOR NECROSIS FACTOR-ALPHA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the MATRIX METALLOPROTEINASES that cleaves triple-helical collagens types I, II, and III. EC 3.4.24.34.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the P450 superfamily, this enzyme catalyzes the first oxidative step of the phenylpropanoid pathway in higher PLANTS by transforming trans-cinnamate into p-coumarate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS from SACCHAROMYCES CEREVISIAE. It is involved in morphological events related to the cell cycle. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS. It is associated with a diverse array of cellular functions including cytoskeletal changes, filopodia formation and transport through the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the S-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis. It is a complex of a light chain %28%CALGRANULIN A%29% and a heavy chain %28%CALGRANULIN B%29%. L1 binds calcium through an EF-hand motif, and has been shown to possess antimicrobial activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the VITAMIN B COMPLEX. It used to be a common sunscreening agent until found to also be a sensitizer. The potassium salt is used therapeutically in fibrotic skin disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the Wiskott-Aldrich syndrome protein family that is found at high levels in NERVE CELLS. It interacts with GRB2 ADAPTOR PROTEIN and with CDC42 PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the actin depolymerizing factors. Its depolymerizing activity is independent of HYDROGEN-ION CONCENTRATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the alkali metals. It has an atomic symbol Cs, atomic number 50, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the annexin family that is a substrate for a tyrosine kinase, ONCOGENE PROTEIN PP60%28%V-SRC%29%. Annexin A2 occurs as a 36-KDa monomer and in a 90-KDa complex containing two subunits of annexin A2 and two subunits of S100 FAMILY PROTEIN P11. The monomeric form of annexin A2 was formerly referred to as calpactin I heavy chain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the bcl-2 protein family that plays a role in the regulation of APOPTOSIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING of the BCL2L1 mRNA and are referred to as Bcl-XS and Bcl-XL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the c-ets family of transcription factors that is preferentially expressed in cells of hematopoietic lineages and vascular endothelial cells. It was originally identified as a protein that provides a retroviral integration site for integration of FRIEND MURINE LEUKEMIA VIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the caspase family that is highly specific for interleukin-1beta %28%INTERLEUKIN-1%29%. It plays a role in inflammation and mammalian APOPTOSIS. Interleukin-1beta converting enzyme is frequently abbreviated ICE. EC 3.4.22.36%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the cofilin family of proteins that is expressed in MUSCLE CELLS. It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a 21-kDa nonglycosylated protein found in tissue fluid and is secreted as a complex with progelatinase A by human fibroblast and uncomplexed from alveolar macrophages. An overexpression of TIMP-2 has been shown to inhibit invasive and metastatic activity of tumor cells and decrease tumor growth in vivo.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the family of tissue inhibitor of metalloproteinases. Mutations of the gene for TIMP3 protein causes Sorsby fundus dystrophy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the immunoglobulin superfamily of neuronal cell adhesion molecules that is required for proper nervous system development. Neural cell adhesion molecule L1 consists of six Ig domains, five fibronectin domains, a transmembrane region and an intracellular domain. Two splicing variants are known: a neuronal form that contains a four-amino acid RSLE sequence in the cytoplasmic domain, and a non-neuronal form that lacks the RSLE sequence. Mutations in the L1 gene result in L1 disease. Neural cell adhesion molecule L1 is predominantly expressed during development in neurons and Schwann cells; involved in cell adhesion, neuronal migration, axonal growth and pathfinding, and myelination.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the metalloproteinase family of enzymes that is principally responsible for cleaving fibrillar collagen. It can degrade interstitial collagens, types I, II and III. EC 3.4.24.7.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the nerve growth factor family of trophic factors. In the brain BDNF has a trophic action on retinal, cholinergic, and dopaminergic neurons, and in the peripheral nervous system it acts on both motor and sensory neurons. %28%From Kendrew, The Encyclopedia of Molecular Biology, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the p300-CBP transcription factor family that was initially identified as a binding partner for CAMP RESPONSE ELEMENT-BINDING PROTEIN. Mutations in CREB-binding protein are associated with RUBINSTEIN-TAYBI SYNDROME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the p300-CBP transcription factors that was originally identified as a binding partner for ADENOVIRUS E1A PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and able to inhibit activated protein C, thrombin, kallikrein, and other SERINE ENDOPEPTIDASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the serpin superfamily found in human plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the ternary complex family of ets-related transcription factors that is regulated by MITOGEN-ACTIVATED PROTEIN KINASES including JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; and P38 MITOGEN-ACTIVATED PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the ternary complex family of ets-related transcription factors that is regulated by MITOGEN-ACTIVATED PROTEIN KINASES such as EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; and P38 MITOGEN-ACTIVATED PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the tumor necrosis factor receptor superfamily found on mature B-LYMPHOCYTES and some EPITHELIAL CELLS, and lymphoid DENDRITIC CELLS. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the tumor necrosis factor receptor superfamily found on most T-LYMPHOCYTES. Activation of T-cells by the receptor increases CD27 surface expression and T cell expansion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. They normally present in a small number of cells in the LYMPH NODES and TONSILS in vivo, but also capable of being induced in a wide range of cells in vitro. CD30 antigens are clinically useful as tumor markers for Ki-1 lymphoma %28%LYMPHOMA, LARGE-CELL, KI-1%29% and some cases of LYMPHOMATOID PAPULOSIS; MYCOSIS FUNGOIDES; and HODGKIN%27%S DISEASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the vesicle associated membrane protein family. It has a broad tissue distribution and is involved in MEMBRANE FUSION events of the endocytic pathways.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the vesicle-associated membrane protein family involved in the MEMBRANE FUSION of TRANSPORT VESICLES to their target membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses %28%POACEAE%29%. Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane on the vitreal surface of the retina resulting from the proliferation of one or more of three retinal elements: %28%1%29% fibrous astrocytes; %28%2%29% fibrocytes; and %28%3%29% retinal pigment epithelial cells. Localized epiretinal membranes may occur at the posterior pole of the eye without clinical signs or may cause marked loss of vision as a result of covering, distorting, or detaching the fovea centralis. Epiretinal membranes may cause vascular leakage and secondary retinal edema. In younger individuals some membranes appear to be developmental in origin and occur in otherwise normal eyes. The majority occur in association with retinal holes, ocular concussions, retinal inflammation, or after ocular surgery. %28%Newell, Ophthalmology: Principles and Concepts, 7th ed, p291%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane protein found in the rough endoplasm reticulum %28%ENDOPLASMIC RETICULUM, ROUGH%29% that binds to LDL-RECEPTOR RELATED PROTEINS. It may function to prevent ligand binding of receptors during protein processing events within endosomal compartments.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane protein homologous to the ERM %28%Ezrin-Radixin-Moesin%29% family of cytoskeleton-associated proteins which regulate physical properties of membranes. Alterations in neurofibromin 2 are the cause of NEUROFIBROMATOSIS 2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane, attached to the bony SPIRAL LAMINA, overlying and coupling with the HAIR CELLS of the ORGAN OF CORTI in the inner ear. It is a glycoprotein-rich keratin-like layer containing fibrils embedded in a dense amorphous substance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane-bound carbonic anhydrase found in lung capillaries and kidney.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane-bound flavoenzyme that catalyzes the oxygen-dependent aromatization of PROTOPORPHYRINOGEN IX %28%Protogen%29% to protoporphyrin IX %28%Proto IX%29%. It is the last enzyme of the common branch of the HEME and CHLOROPHYLL pathways in plants, and is the molecular target of diphenyl ether-type herbicides. VARIEGATE PORPHYRIA is an autosomal dominant disorder associated with deficiency of protoporphyrinogen oxidase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A membrane-bound or cytosolic enzyme that catalyzes the synthesis of CYCLIC ADP-RIBOSE %28%cADPR%29% from nicotinamide adenine dinucleotide %28%NAD%29%. This enzyme generally catalyzes the hydrolysis of cADPR to ADP-RIBOSE, as well, and sometimes the synthesis of cyclic ADP-ribose 2%27% phosphate %28%2%27%-P-cADPR%29% from NADP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mental disorder associated with chronic ethanol abuse %28%ALCOHOLISM%29% and nutritional deficiencies characterized by short term memory loss, confabulations, and disturbances of attention. %28%Adams et al., Principles of Neurology, 6th ed, p1139%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mental disorder characterized by chronic fatigue and concomitant physiologic symptoms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mercurial compound that has been used as a diuretic but is now superseded by more potent and less toxic drugs. The radiolabeled form has been used as a diagnostic and research tool.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite in the principal biochemical pathway of lysine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor, N-METHYL-D-ASPARTATE; %28%NMDA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of 17-ALPHA-HYDROXYPROTESTERONE, normally produced in small quantities by the GONADS and the ADRENAL GLANDS, found in URINE. An elevated urinary pregnanetriol is associated with CONGENITAL ADRENAL HYPERPLASIA with a deficiency of STEROID 21-HYDROXYLASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of AMINOPYRINE with analgesic and anti-inflammatory properties. It is used as a reagent for biochemical reactions producing peroxides or phenols. Ampyrone stimulates LIVER MICROSOMES and is also used to measure extracellular water.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of ESTRIOL with a 15-alpha-hydroxyl group. Estetrol can be converted from estriol sulfate or DEHYDROEPIANDROSTERONE SULFATE by the fetal-placental unit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of TESTOSTERONE or ANDROSTENEDIONE with a 3-alpha-hydroxyl group and without the double bond. The 3-beta hydroxyl isomer is epiandrosterone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of THYROXINE, formed by the peripheral enzymatic monodeiodination of T4 at the 5 position of the inner ring of the iodothyronine nucleus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of primidone. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It has the atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue %28%hemoglobin%29% and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element that has the atomic symbol Bi, atomic number 83 and atomic weight 208.98.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element that has the atomic symbol Sb, atomic number 51, and atomic weight 121.75. It is used as a metal alloy and as medicinal and poisonous salts. It is toxic and an irritant to the skin and the mucous membranes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.94. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element with the atomic symbol V, atomic number 23, and atomic weight 50.94. It is used in the manufacture of vanadium steel. Prolonged exposure can lead to chronic intoxication caused by absorption usually via the lungs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallic element, atomic number 49, atomic weight 114.82, symbol In. It is named from its blue line in the spectrum. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallocarboxypeptidase that is predominantly expressed as a membrane-bound enzyme. It catalyzes the hydrolysis of an unsubstituted, C-terminal glutamyl residue, typically from PTEROYLPOLYGLUTAMIC ACIDS. It was formerly classified as EC 3.4.19.8.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallocarboxypeptidase that removes C-terminal basic amino acid from peptides and proteins, with preference shown for lysine over arginine. It is a plasma zinc enzyme that inactivates bradykinin and anaphylatoxins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metallocarboxypeptidase that removes C-terminal lysine and arginine from biologically active peptides and proteins thereby regulating their activity. It is a zinc enzyme with no preference shown for lysine over arginine. Pro-carboxypeptidase U in human plasma is activated by thrombin or plasmin during clotting to form the unstable carboxypeptidase U.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metalloflavoprotein enzyme involved the metabolism of VITAMIN A, this enzyme catalyzes the oxidation of RETINAL to RETINOIC ACID, using both NAD+ and FAD coenzymes. It also acts on both the 11-trans- and 13-cis-forms of RETINAL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms %28%or 2 classes%29% have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method %28%first developed by E.M. Southern%29% for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for determining points of contact between interacting proteins or binding sites of proteins to nucleic acids. Protein footprinting utilizes a protein cutting reagent or protease. Protein cleavage is inhibited where the proteins, or nucleic acids and protein, contact each other. After completion of the cutting reaction, the remaining peptide fragments are analyzed by electrophoresis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for determining the sequence specificity of DNA-binding proteins. DNA footprinting utilizes a DNA damaging agent %28%either a chemical reagent or a nuclease%29% which cleaves DNA at every base pair. DNA cleavage is inhibited where the ligand binds to DNA. %28%from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for diagnosing a disease in one organism by inoculating the putative causative organism in a second animal of a different species. It has been used for the detection of parasites %28%Trypanosoma cruzi and Trichinella spiralis%29% when peripheral blood smears are negative. %28%Segen, Current Med Talk, 1995%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for diagnosis of fetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for extinguishing anxiety by a saturation exposure to the feared stimulus situation or its substitute.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for ordering genetic loci along CHROMOSOMES. The method involves fusing irradiated donor cells with host cells from another species. Following cell fusion, fragments of DNA from the irradiated cells become integrated into the chromosomes of the host cells. Molecular probing of DNA obtained from the fused cells is used to determine if two or more genetic loci are located within the same fragment of donor cell DNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method in which either the observer%28%s%29% or the subject%28%s%29% is kept ignorant of the group to which the subjects are assigned.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of ETHICAL ANALYSIS that emphasizes practical problem solving through examining individual cases that are considered to be representative; sometimes used to denote specious argument or rationalization. Differentiate from casuistics, which is the recording and study of cases and disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of analyzing the variation in utilization of health care in small geographic or demographic areas. It often studies, for example, the usage rates for a given service or procedure in several small areas, documenting the variation among the areas. By comparing high- and low-use areas, the analysis attempts to determine whether there is a pattern to such use and to identify variables that are associated with and contribute to the variation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of chemical analysis based on the detection of characteristic radionuclides following a nuclear bombardment. It is also known as radioactivity analysis. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of comparing the cost of a program with its expected benefits in dollars %28%or other currency%29%. The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of data collection and a qualitative research tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of delineating blood vessels by subtracting a tissue background image from an image of tissue plus intravascular contrast material that attenuates the X-ray photons. The background image is determined from a digitized image taken a few moments before injection of the contrast material. The resulting angiogram is a high-contrast image of the vessel. This subtraction technique allows extraction of a high-intensity signal from the superimposed background information. The image is thus the result of the differential absorption of X-rays by different tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of detecting gene mutation by mixing PCR-amplified mutant and wild-type DNA followed by denaturation and reannealing. The resultant products are resolved by gel electrophoresis, with single base substitutions detectable under optimal electrophoretic conditions and gel formulations. Large base pair mismatches may also be analyzed by using electron microscopy to visualize heteroduplex regions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of examining and setting levels of payments. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of gel filtration chromatography using agarose, the non-ionic component of agar, for the separation of compounds with molecular weights up to several million.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of generating a large library of randomized nucleotides and selecting NUCLEOTIDE APTAMERS by iterative rounds of in vitro selection. A modified procedure substitutes AMINO ACIDS in place of NUCLEOTIDES to make PEPTIDE APTAMERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of lowering core BODY TEMPERATURE by filling the STOMACH with chilled fluids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of mechanical ventilation in which pressure is maintained to increase the volume of gas remaining in the lungs at the end of expiration, thus reducing the shunting of blood through the lungs and improving gas exchange.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of non-invasive, continuous measurement of microcirculation. The technique is based on the values of the Doppler effect of low-power laser light scattered randomly by static structures and moving tissue particulates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy x-rays.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of recording heart motion and internal structures by combining ultrasonic imaging with exercise testing %28%EXERCISE TEST%29% or pharmacologic stress.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of separation of two or more substances by repeated distribution between two immiscible liquid phases that move past each other in opposite directions. It is a form of liquid-liquid chromatography. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of speech used after laryngectomy, with sound produced by vibration of the column of air in the esophagus against the contracting cricopharyngeal sphincter. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method of three-dimensional morphometry in which contour maps are produced from the overlapping interference fringes created when an object is illuminated by beams of coherent light issuing from two different point sources.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method that is derived from western blotting %28%BLOTTING, WESTERN%29% and is used to detect protein-protein interactions. The blotted proteins are probed with a non-antibody protein which can then be tagged with a labeled antibody.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method that is used to detect DNA-protein interactions. Proteins are separated by electrophoresis and blotted onto a nitrocellulose membrane similar to Western blotting %28%BLOTTING, WESTERN%29% but the proteins are identified when they bind labeled DNA PROBES %28%as with Southern blotting %28%BLOTTING, SOUTHERN%29%%29% instead of antibodies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method used to study the lateral movement of MEMBRANE PROTEINS and LIPIDS. A small area of a cell membrane is bleached by laser light and the amount of time necessary for unbleached fluorescent marker-tagged proteins to diffuse back into the bleached site is a measurement of the cell membrane%27%s fluidity. The diffusion coefficient of a protein or lipid in the membrane can be calculated from the data. %28%From Segen, Current Med Talk, 1995%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A method, developed by Dr. Virginia Apgar, to evaluate a newborn%27%s adjustment to extrauterine life. Five items - heart rate, respiratory effort, muscle tone, reflex irritability, and color - are evaluated 60 seconds after birth and again five minutes later on a scale from 0-2, 0 being the lowest, 2 being normal. The five numbers are added for the Apgar score. A score of 0-3 represents severe distress, 4-7 indicates moderate distress, and a score of 7-10 predicts an absence of difficulty in adjusting to extrauterine life.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3%27%,5%27%-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLATE CYCLASE and cyclic AMP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methyl-directed mismatch DNA REPAIR protein that has weak ATPASE activity. MutS was originally described in ESCHERICHIA COLI.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methylated nucleotide base found in eukaryotic DNA. In ANIMALS, the DNA METHYLATION of CYTOSINE to form 5-methylcytosine is found primarily in the palindromic sequence CpG. In PLANTS, the methylated sequence is CpNpGp, where N can be any base.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methylpentose whose L- isomer is found naturally in many plant glycosides and some gram-negative bacterial lipopolysaccharides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methylsulfonyl analog of CHLORAMPHENICOL. It is an antibiotic and immunosuppressive agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methyltransferase that catalyzes the reaction of S-adenosyl-L-methionine and phenylethanolamine to yield S-adenosyl-L-homocysteine and N-methylphenylethanolamine. It can act on various phenylethanolamines and converts norepinephrine into epinephrine. %28%From Enzyme Nomenclature, 1992%29% EC 2.1.1.28.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine%27%s most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microcomputer-based software package providing a user-friendly interface to the MEDLARS system of the National Library of Medicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microfilament protein that interacts with F-ACTIN and regulates cortical actin assembly and organization. It is also an SH3 DOMAIN containing phosphoprotein, and it mediates tyrosine PHOSPHORYLATION based SIGNAL TRANSDUCTION by PROTO-ONCOGENE PROTEIN PP60%28%C-SRC%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microscopically inflammatory, usually reversible, patchy hair loss occurring in sharply defined areas and usually involving the beard or scalp. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microsomal cytochrome P450 enzyme that catalyzes the 17-alpha-hydroxylation of progesterone or pregnenolone and subsequent cleavage of the residual two carbons at C17 in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP17 gene, generates precursors for glucocorticoid, androgen, and estrogen synthesis. Defects in CYP17 gene cause congenital adrenal hyperplasia %28%ADRENAL HYPERPLASIA, CONGENITAL%29% and abnormal sexual differentiation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from sperm flagella, cilia, and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to colchicine, vincristine, and vinblastine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microtubule-associated mechanical adenosine triphosphatase, that uses the energy of ATP hydrolysis to move organelles along microtubules toward the plus end of the microtubule. The protein is found in squid axoplasm, optic lobes, and in bovine brain. Bovine kinesin is a heterotetramer composed of two heavy %28%120 kDa%29% and two light %28%62 kDa%29% chains. EC 3.6.1.-.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A microtubule-disrupting pre-emergence herbicide. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mild, eruptive skin disease of milk cows caused by COWPOX VIRUS, with lesions occurring principally on the udder and teats. Human infection may occur while milking an infected animal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mild, highly infectious viral disease of children, characterized by vesicular lesions in the mouth and on the hands and feet. It is caused by coxsackieviruses A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A milky, product excreted from the latex canals of a variety of plant species that contain cauotchouc. Latex is composed of 25-35%25% caoutchouc, 60-75%25% water, 2%25% protein, 2%25% resin, 1.5%25% sugar %26% 1%25% ash. RUBBER is made by the removal of water from latex.%28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29% However, the term latex has been broadened in scope to include RUBBER and other synthetic polymers. Latexes are used as inert vehicles to carry antibodies or antigens in LATEX FIXATION TESTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mismatch between donor and recipient blood. Antibodies present in the recipient%27%s serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. %28%From Saunders Dictionary %26% Encyclopedia of Laboratory Medicine and Technology, 1984%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial cytochrome P450 enzyme that catalyzes the 1-alpha-hydroxylation of 25-hydroxyvitamin D3 %28%also known as 25-hydroxycholecalciferol%29% in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP27B1 gene, converts 25-hydroxyvitamin D3 to 1-alpha,25-dihydroxyvitamin D3 which is the active form of VITAMIN D in regulating bone growth and calcium metabolism. This enzyme is also active on plant 25-hydroxyvitamin D2 %28%ergocalciferol%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial cytochrome P450 enzyme that catalyzes the 11-beta-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11B1 gene, is important in the synthesis of CORTICOSTERONE and HYDROCORTISONE. Defects in CYP11B1 cause congenital adrenal hyperplasia %28%ADRENAL HYPERPLASIA, CONGENITAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial cytochrome P450 enzyme that catalyzes the 18-hydroxylation of steroids in the presence of molecular oxygen and NADPH-specific flavoprotein. This enzyme, encoded by CYP11B2 gene, is important in the conversion of CORTICOSTERONE to 18-hydroxycorticosterone and the subsequent conversion to ALDOSTERONE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial cytochrome P450 enzyme that catalyzes the side-chain cleavage of C27 cholesterol to C21 pregnenolone in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP11A1 gene, catalyzes the breakage between C20 and C22 which is the initial and rate-limiting step in the biosynthesis of various gonadal and adrenal steroid hormones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. %28%From Joynt, Clinical Neurology, 1992, Ch56, p117%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial disorder featuring the triad of chronic progressive EXTERNAL OPHTHALMOPLEGIA, cardiomyopathy %28%CARDIOMYOPATHIES%29% with conduction block %28%HEART BLOCK%29%, and RETINITIS PIGMENTOSA. Disease onset is in the first or second decade. Elevated CSF protein, sensorineural deafness, seizures, and pyramidal signs may also be present. Ragged-red fibers are found on muscle biopsy. %28%Adams et al., Principles of Neurology, 6th ed, p984%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial encephalomyopathy characterized clinically by a mixed seizure disorder, myoclonus, progressive ataxia, spasticity, and a mild myopathy. Dysarthria, optic atrophy, growth retardation, deafness, and dementia may also occur. This condition tends to present in childhood and to be transmitted via maternal lineage. Muscle biopsies reveal ragged-red fibers and respiratory chain enzymatic defects. %28%From Adams et al., Principles of Neurology, 6th ed, p986%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial flavoprotein, this enzyme catalyzes the oxidation of 3-methylbutanoyl-CoA to 3-methylbut-2-enoyl-CoA using FAD as a cofactor. Defects in the enzyme, is associated with isovaleric acidemia %28%IVA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial matrix enzyme that catalyzes the synthesis of L-GLUTAMATE to N-acetyl-L-glutamate in the presence of ACETYL-COA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitochondrial myopathy characterized by slowly progressive paralysis of the levator palpebrae, orbicularis oculi, and extraocular muscles. Ragged-red fibers and atrophy are found on muscle biopsy. Familial and sporadic forms may occur. Disease onset is usually in the first or second decade of life, and the illness slowly progresses until usually all ocular motility is lost. %28%From Adams et al., Principles of Neurology, 6th ed, p1422%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase kinase with specificity for JNK MITOGEN-ACTIVATED PROTEIN KINASES. It takes part in a SIGNAL TRANSDUCTION pathway that is activated in response to CYTOKINES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase kinase with specificity for JNK MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES and the RETINOID X RECEPTORS. It takes part in a SIGNAL TRANSDUCTION pathway that is activated in response to cellular stress.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 7.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase kinase with specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase kinase with specificity for a subset of P38 MITOGEN-ACTIVATED PROTEIN KINASES that includes MITOGEN-ACTIVATED PROTEIN KINASE 12; MITOGEN-ACTIVATED PROTEIN KINASE 13; and MITOGEN-ACTIVATED PROTEIN KINASE 14.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitogen-activated protein kinase subfamily that regulates a variety of cellular processes including CELL GROWTH PROCESSES; CELL DIFFERENTIATION; APOPTOSIS; and cellular responses to INFLAMMATION. The P38 MAP kinases are regulated by CYTOKINE RECEPTORS and can be activated in response to bacterial pathogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Ceratobasidiaceae fungal genus that is an important plant pathogen affecting potatoes and other plants. There are numerous teleomorphs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Hypocreales fungal genus, various species of which are important parasitic pathogens of plants and a variety of vertebrates. Teleomorphs include GIBBERELLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Leotiales fungal genus of plant pathogens. It has teleomorphs in the genus Botryotina.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Loculoascomycetes fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. Its teleomorph is Lewia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Loculoascomycetes fungal genus including some economically important plant parasites. Teleomorphs include Mycosphaerella and Venturia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Onygenaceae fungal genus which causes adiaspiromycosis, a pulmonary mycosis of man and rodents. One of its teleomorphs is Ajellomyces.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Onygenales fungal genus causing HISTOPLASMOSIS in humans and animals. Its single species is Histoplasma capsulatum which has two varieties: H. capsulatum var. capsulatum and H. capsulatum var. duboisii. Its teleomorph is AJELLOMYCES capsulatus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Ophiostomataceae fungal genus, whose species Sporothrix schenckii is a well-known animal pathogen. The conidia of this soil fungus may be inhaled causing a primary lung infection, or may infect independently via skin punctures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Oxygenales fungal genus causing various diseases of the skin and hair. The species Microsporum canis produces TINEA CAPITIS and tinea corporis, which usually are acquired from domestic cats and dogs. Teleomorphs includes Arthroderma %28%Nannizzia%29%. %28%Alexopoulos et al., Introductory Mycology, 4th edition, p305%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Saccharomycetales fungal genus, various species of which have been isolated from pulmonary lesions. Teleomorphs include Dipodascus and Galactomyces.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Tremellales fungal genus whose species usually have a capsule and do not form pseudomycellium. Teleomorphs include Filobasidiella and Fidobasidium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic Trichocomaceae fungal genus that develops fruiting organs resembling a broom. When identified, teleomorphs include Eupenicillium and TALAROMYCES. Several species %28%but especially PENICILLIUM CHRYSOGENUM%29% are sources of the antibiotic penicillin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus and an anamorphic form of Arthroderma. Various species attack the skin, nails, and hair.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus causing opportunistic infections, endocarditis, fungemia, and white PIEDRA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus commonly isolated from soil. Some species are the cause of wilt diseases in many different plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus frequently found in soil and on wood. It is sometimes used for controlling pathogenic fungi. Its teleomorph is HYPOCREA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus including both saprophytes and plant parasites.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. Its teleomorph is Byssochlamys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus occurring in soil or decaying plant matter. It is structurally similar to Penicillium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus previously called Monosporium. Teleomorphs include PSEUDALLESCHERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus that causes MADUROMYCOSIS %28%mycetoma%29% in humans. Madurella grisea and M. mycetomatis are the etiological agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur %28%Pityrosporum orbiculare%29% causes TINEA VERSICOLOR.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus. P. brasiliensis %28%previously Blastomyces brasiliensis%29% is the etiologic agent of PARACOCCIDIOIDOMYCOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal genus. Phialophora verrucosa is a cause of chromomycosis %28%CHROMOBLASTOMYCOSIS%29%. Ophiobolus is the teleomorph of Phialophora.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mitosporic fungal species used in the production of penicillin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed condition of anthracosis and silicosis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75%25% are malignant. %28%Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed tumor of odontogenic origin, in which both the epithelial and mesenchymal cells exhibit complete differentiation, resulting in the formation of tooth structures. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed-function oxygenase that catalyzes the hydroxylation of a prolyl-glycyl-containing-peptide, usually in protocollagen, to a hydroxyprolylglycyl-containing-peptide. The enzyme utilizes molecular oxygen with a concomitant oxidative decarboxylation of 2-oxoglutarate to succinate. EC 1.14.11.2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixed-function oxygenase that catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of dimethicone and SILICA GEL used as an antiflatulent. Dimethicone is used as an ointment base ingredient and skin protectant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum. It consists primarily of silybin and its isomers, silicristin and silidianin. Silymarin displays antioxidant and membrane stabilizing activity. It protects various tissues and organs against chemical injury, and shows potential as an antihepatoxic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of isomeric tritolyl phosphates. Used in the sterilization of certain surgical instruments and in many industrial processes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions for use in restorative or prosthetic dentistry.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of mostly avermectin H2B1a %28%RN 71827-03-7%29% with some avermectin H2B1b %28%RN 70209-81-3%29%, which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of polychlorinated biphenyls that induces hepatic microsomal UDP-glucuronyl transferase activity towards thyroxine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of polymyxins B1 and B2, obtained from Bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of several closely related glycosidic antibiotics obtained from Actinomyces %28%or Streptomyces%29% olivoreticuli. They are used as fluorescent dyes that bind to DNA and prevent both RNA and protein synthesis and are also used as antineoplastic agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of several dental waxes, usually containing paraffin wax, ceresin, beeswax, resins, and other natural and synthetic waxes. It is used for making patterns to determine the shape of the metallic framework and other parts of removable partial dentures. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p868%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of six synthetic oligopeptides, each containing MELPHALAN. It is used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions but, is toxic to bone marrow, gastrointestinal system and vasculature.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of smoke and fog polluting the atmosphere. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of solid hydrocarbons obtained from petroleum. It has a wide range of uses including as a stiffening agent in ointments, as a lubricant, and as a topical anti-inflammatory. It is also commonly used as an embedding material in histology.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of the enzymes %28%streptokinase and streptodornase%29% produced by hemolytic streptococci. It is used topically on surface lesions and by instillation in closed body cavities to remove clotted blood or fibrinous or purulent accumulations. It is also used as a skin test antigen in evaluating generalized cell-mediated immunodeficiency. %28%Dorland, 27th ed%29% EC 3.-.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of the mesylates %28%methane sulfonates%29% of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The methanesulfonate salts of this mixture of alkaloids are called ERGOLOID MESYLATES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mode of communication concerned with inducing or urging the adoption of certain beliefs, theories, or lines of action by others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A moderate-growing, photochromogenic species found in aquariums, diseased fish, and swimming pools. It is the cause of cutaneous lesions and granulomas %28%swimming pool granuloma%29% in humans. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A moderately firm, benign, encapsulated tumor resulting from proliferation of SCHWANN CELLS and FIBROBLASTS that includes portions of nerve fibers. The tumors usually develop along peripheral or cranial nerves and are a central feature of NEUROFIBROMATOSIS 1, where they may occur intracranially or involve spinal roots. Pathologic features include fusiform enlargement of the involved nerve. Microscopic examination reveals a disorganized and loose cellular pattern with elongated nuclei intermixed with fibrous strands. %28%From Adams et al., Principles of Neurology, 6th ed, p1016%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A moderately lipophilic beta blocker %28%ADRENERGIC BETA-ANTAGONISTS%29%. It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. %28%From Martindale, The Extra Pharmocopoeia, 30th ed, p638%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. It may undergo transformation into a neuroblastoma. It arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. Cervical ganglioneuroblastomas may be associated with HORNER SYNDROME and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A modification of the freeze-drying method in which the ice within the frozen tissue is replaced by alcohol or other solvent at a very low temperature.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A modified Greco-Arabic medical system flourishing today as unani medicine. It was the product of Arab physicians and scholars captivated by Greek philosophy, science, and medicine. It is practiced today in India and Pakistan, largely as a type of herbal medicine. %28%From Magner, A History of Medicine, 1992, p136%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A modified form of insulin that contains protamine and zinc. Isophane insulin is an intermediate-acting INSULIN with time of onset of 2 hours and duration of 24 hours.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A molecular probe technique that utilizes branched DNA %28%bDNA%29% as a means to amplify the hybridization signal. One end of the bDNA molecule is designed to bind a specific target, while the other end of the bDNA molecule contains many branches of DNA that are designed to bind a probe used for signal detection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A molluscan neuroactive peptide which induces a fast excitatory depolarizing response due to direct activation of amiloride-sensitive SODIUM CHANNELS. %28%From Nature 1995; 378%28%6558%29%: 730-3%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monoamine oxidase inhibitor with antihypertensive properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monocot family within the order Liliales. This family is divided by some botanists into other families such as Convallariaceae, Hyacinthaceae and Amaryllidaceae. Amaryllidaceae, which have inferior ovaries, includes CRINUM; GALANTHUS; LYCORIS; and NARCISSUS and are known for AMARYLLIDACEAE ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monocot plant family of the Liliopsida class. It is classified by some in the Liliales order and some in the Asparagales order.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monomeric GTP-binding protein involved in nucleocytoplasmic transport of proteins into the nucleus and RNA into the cytoplasm. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mononuclear Fe%28%II%29%-dependent oxygenase, this enzyme catalyzes the conversion of homogentisate to 4-maleylacetoacetate, the third step in the pathway for the catabolism of TYROSINE. Deficiency in the enzyme causes ALKAPTONURIA, an autosomal recessive disorder, characterized by homogentisic aciduria, OCHRONOSIS and ARTHRITIS. This enzyme was formerly characterized as EC 1.13.1.5 and EC 1.99.2.5.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mononuclear phagocyte colony-stimulating factor %28%M-CSF%29% synthesized by mesenchymal cells. The compound stimulates the survival, proliferation, and differentiation of hematopoietic cells of the monocyte-macrophage series. M-CSF is a disulfide-bonded glycoprotein dimer with a MW of 70 kDa. It binds to a specific high affinity receptor %28%RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monooxygenase that catalyzes the conversion of BETA-CAROTENE into two molecules of RETINAL. It was formerly characterized as EC 1.13.11.21 and EC 1.18.3.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monosynaptic reflex elicited by stimulating a nerve, particularly the tibial nerve, with an electric shock.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A moon-shaped carpal bone which is located between the SCAPHOID BONE and TRIQUETRUM BONE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A morbid condition of ANOXIA caused by the reduced available oxygen at high altitudes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mosquito-borne encephalitis caused by the Japanese B encephalitis virus %28%ENCEPHALITIS VIRUS, JAPANESE%29% occurring throughout Eastern Asia and Australia. The majority of infections occur in children and are subclinical or have features limited to transient fever and gastrointestinal symptoms. Inflammation of the brain, spinal cord, and meninges may occur and lead to transient or permanent neurologic deficits %28%including a POLIOMYELITIS-like presentation%29%; SEIZURES; COMA; and death. %28%From Adams et al., Principles of Neurology, 6th ed, p751; Lancet 1998 Apr 11;351%28%9109%29%:1094-7%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mosquito-borne species of the PHLEBOVIRUS genus found in eastern, central, and southern Africa, producing massive hepatitis, abortion, and death in sheep, goats, cattle, and other animals. It also has caused disease in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. %28%From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352%28%9130%29%:767-71%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A motility disorder characterized by biliary COLIC, absence of GALLSTONES, and an abnormal GALLBLADDER ejection fraction. It is caused by gallbladder dyskinesia and/or SPHINCTER OF ODDI DYSFUNCTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER %28%near the CARDIA%29% fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus %28%megaesophagus%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A motor neuron disease marked by progressive weakness of the muscles innervated by cranial nerves of the lower brain stem. Clinical manifestations include dysarthria, dysphagia, facial weakness, tongue weakness, and fasciculations of the tongue and facial muscles. The adult form of the disease is marked initially by bulbar weakness which progresses to involve motor neurons throughout the neuroaxis. Eventually this condition may become indistinguishable from AMYOTROPHIC LATERAL SCLEROSIS. Fazio-Londe syndrome is an inherited form of this illness which occurs in children and young adults. %28%Adams et al., Principles of Neurology, 6th ed, p1091; Brain 1992 Dec;115%28%Pt 6%29%:1889-1900%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mouse substrain that is genetically predisposed to the development of systemic lupus erythematosus-like syndrome, which has been found to be clinically similar to the human disease. It has been determined that this mouse strain carries a mutation in the fas gene. Also, the MRL/lpr is a useful model to study behavioral and cognitive deficits found in autoimmune diseases and the efficacy of immunosuppressive agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p744%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mucopolysaccharide constituent of chondrin. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mucoprotein found in the cell wall of various types of bacteria. It has adjuvant and antitumor activities and has been used to augment the production of lymphokine-activated killer %28%LAK%29% cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mucosal tumor of the urinary bladder or nasal cavity in which proliferating epithelium is invaginated beneath the surface and is more smoothly rounded than in other papillomas. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multi-domain mitochondrial membrane protein and member of the bcl-2 Protein family. Bak protein interacts with TUMOR SUPPRESSOR PROTEIN P53 and promotes APOPTOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multi-functional catenin that is highly homologous to BETA CATENIN. Gamma catenin binds CADHERINS and helps link their cytoplasmic tails to ACTIN in the CYTOSKELETON via ALPHA CATENIN. It is also found in DESMOSOMES where it mediates the link between DESMOSOMAL CADHERINS and DESMOPLAKIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multi-functional neuropeptide that serves as a NEUROTRANSMITTER, and a VASODILATOR. PACAP can stimulate secretion of GROWTH HORMONE; ACTH; CATECHOLAMINES; and INSULIN; and it interacts with PACAP RECEPTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi%27%s sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04%25% of kidney transplant patients. There is also a high incidence in AIDS patients. %28%From Dorland, 27th ed %26% Holland et al., Cancer Medicine, 3d ed, pp2105-7%29% HHV-8 is the suspected cause.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multicomponent, ribonucleoprotein complex that cleaves specific mRNAs %28%RNA, MESSENGER%29% which are targeted for degradation by homologous dsRNAs %28%RNA, DOUBLE-STRANDED%29% during the process of RNA INTERFERENCE. It includes siRNA %28%RNA, SMALL INTERFERING%29% that is generated from the specific dsRNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multienzyme complex responsible for the formation of ACETYL COENZYME A from pyruvate. The enzyme components are PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29%; dihydrolipoamide acetyltransferase; and LIPOAMIDE DEHYDROGENASE. Pyruvate dehydrogenase complex is subject to three types of control: inhibited by acetyl-CoA and NADH; influenced by the energy state of the cell; and inhibited when a specific serine residue in the pyruvate decarboxylase is phoshorylated by ATP. PYRUVATE DEHYDROGENASE %28%LIPOAMIDE%29%-PHOSPHATASE catalyzes reactivation of the complex. %28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities %28%most commonly including PULMONARY VALVE STENOSIS%29%, and some degree of MENTAL RETARDATION. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. However, Noonan syndrome occurs in both males and females with a normal sex chromosome constitution %28%46,XX and 46,XY%29%. NS1 is due to mutations at chromosome location 12q24.1, in PTPN11, a gene encoding the non-receptor type 11 PROTEIN TYROSINE PHOSPHATASE. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras %28%RAS PROTEINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifactorial disease of CATTLE resulting from complex interactions between environmental factors, host factors, and pathogens. The environmental factors act as stressors adversely affecting the IMMUNE SYSTEM and other host defenses and enhancing transmission of infecting agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional CDC2 kinase-related kinase that plays roles in transcriptional elongation, CELL DIFFERENTIATION and APOPTOSIS. It is a component of POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional galactin initially discovered as a macrophage antigen that binds to IMMUNOGLOBULIN E, and as 29-35-kDa lectin that binds LAMININ. It is involved in a variety of biological events including interactions with galactose-containing glycoconjugates, cell proliferation, CELL DIFFERENTIATION, and APOPTOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional heterogeneous-nuclear ribonucleoprotein that may play a role in homologous DNA pairing and recombination. The N-terminal portion of protein is a potent transcriptional activator, while the C terminus is required for RNA binding. The name FUS refers to the fact that genetic recombination events result in fusion oncogene proteins %28%ONCOGENE PROTEINS, FUSION%29% that contain the N-terminal region of this protein. These fusion proteins have been found in myxoid liposarcoma %28%LIPOSARCOMA, MYXOID%29% and acute myeloid leukemia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its RNA binding ability and its aconitate hydrolase activity are dependent upon availability of IRON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional iron-sulfur protein that is both an iron regulatory protein and cytoplasmic form of aconitate hydratase. It binds to iron regulatory elements found on mRNAs involved in iron metabolism and regulates their translation. Its rate of degradation is increased in the presence of IRON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional protein that is found primarily within membrane-bound organelles. In the ENDOPLASMIC RETICULUM it binds to specific N-linked oligosaccharides found on newly-synthesized proteins and functions as a MOLECULAR CHAPERONE that may play a role in PROTEIN FOLDING or retention and degradation of misfolded proteins. In addition calreticulin is a major storage form for CALCIUM and functions as a calcium-signaling molecule that can regulate intracellular calcium HOMEOSTASIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional pyridoxal phosphate enzyme. In the final step in the biosynthesis of cysteine it catalyzes the cleavage of cystathionine to yield cysteine, ammonia, and 2-ketobutyrate. EC 4.4.1.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multifunctional pyridoxal phosphate enzyme. In the second stage of cysteine biosynthesis it catalyzes the reaction of homocysteine with serine to form cystathionine with the elimination of water. Deficiency of this enzyme leads to HYPERHOMOCYSTEINEMIA and HOMOCYSTINURIA. EC 4.2.1.22.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multilineage cell growth factor secreted by lymphocytes, epithelial cells, and astrocytes which stimulates clonal proliferation and differentiation of various types of blood and tissue cells. Also called multi-CSF, it is considered one of the hematopoietic colony stimulating factors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multimeric complex that functions as a ligand-dependent transcription factor. ISGF3 is assembled in the CYTOPLASM and translocated to the CELL NUCLEUS in response to INTERFERON signaling. It consists of ISGF3-GAMMA and ISGF3-ALPHA, and it regulates expression of many interferon-responsive GENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerize in order to bind to the AP-1 recognition site, also known as the TPA-responsive element %28%TRE%29%. AP-1 controls both basal and inducible transcription of several genes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multiribosomal structure representing a linear array of RIBOSOMES held together by messenger RNA; %28%RNA, MESSENGER%29%; They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro. %28%From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multistage process that includes DNA cloning, physical mapping, subcloning, sequencing, and information analysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multistage process that includes RNA cloning, physical mapping, subcloning, sequencing, and information analysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multistage process that includes the determination of a sequence %28%protein, carbohydrate, etc.%29%, its fragmentation and analysis, and the interpretation of the resulting sequence information.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multisubunit enzyme complex containing CYTOCHROME A GROUP; CYTOCHROME A3; two copper atoms; and 13 different protein subunits. It is the terminal oxidase complex of the RESPIRATORY CHAIN and collects electrons that are transferred from the reduced CYTOCHROME C GROUP and donates them to molecular OXYGEN, which is then reduced to water. The redox reaction is simultaneously coupled to the transport of PROTONS across the inner mitochondrial membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multisubunit enzyme complex that contains CYTOCHROME B GROUP; CYTOCHROME C1; and iron-sulfur centers. It catalyzes the oxidation of ubiquinol to UBIQUINONE, and transfers the electrons to CYTOCHROME C. In MITOCHONDRIA the redox reaction is coupled to the transport of PROTONS across the inner mitochondrial membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multisubunit eukaryotic initiation factor that contains at least 8 distinct polypeptides. It plays a role in recycling of ribosomal subunits to the site of transcription initiation by promoting the dissociation of non-translating ribosomal subunits. It also is involved in promoting the binding of a ternary complex of EUKARYOTIC INITIATION FACTOR-2; GTP; and INITIATOR TRNA to the 40S ribosomal subunit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multisystem disease chiefly affecting males, characterized by necrotizing granulomatous vasculitis involving the upper and lower respiratory tracts, glomerulonephritis, and variable degrees of systemic, small vessel vasculitis, which is generally considered to represent an aberrant hypersensitivity reaction to an unknown antigen. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A multisystemic disorder characterized by a sensorimotor polyneuropathy %28%POLYNEUROPATHIES%29%, organomegaly, endocrinopathy, monoclonal gammopathy, and pigmentary skin changes. Other clinical features which may be present include EDEMA; CACHEXIA; microangiopathic glomerulopathy; pulmonary hypertension %28%HYPERTENSION, PULMONARY%29%; cutaneous necrosis; THROMBOCYTOSIS; and POLYCYTHEMIA. This disorder is frequently associated with osteosclerotic myeloma. %28%From Adams et al., Principles of Neurology, 6th ed, p1335; Rev Med Interne 1997;18%28%7%29%:553-62%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the %28%-%29%-enantimorph of dexetimide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mushroom, Ganoderma lucidum, of the POLYPORALES order of basidiomycetous fungi. It has long been used in traditional Chinese medicine in various forms. Contains STEROLS; COUMARINS; MANNITOL; POLYSACCHARIDES; and triterpenoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mutant strain of TRANSMISSIBLE GASTROENTERITIS VIRUS causing mild or subclinical respiratory infections in young SWINE. It may also play a role in post-weaning porcine respiratory disease complex, especially when combined with other respiratory agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. %28%From A Dictionary of Genetics, King %26% Stansfield, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused by Paracoccidioides brasiliensis. It is also called paracoccidioidal granuloma. Superficial resemblance of P. brasiliensis to Blastomyces brasiliensis %28%BLASTOMYCES%29% may cause misdiagnosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A mycotoxin with antibiotic and carcinogenic activity produced by various strains of PENICILLIUM and ASPERGILLUS. It has been found in tobacco, sausages, and corn.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It has a structure that is similar to members of the Ig superfamily that participate in cell adhesion. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p132%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. %28%From Siegel et al., Basic Neurochemistry, 4th ed, p122%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites %28%liver and spleen%29%. In time myelofibrosis occurs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myodegeneration most frequent in calves and lambs whose dams have been fed during gestation or longer on feeds, especially legumes %28%FABACEAE%29%, grown in certain areas where selenium is either deficient or unavailable in the soil. It has been recorded in many countries. It has been produced experimentally in several species of animals on low-selenium intake. A similar myopathy occurs naturally in goats, deer, foals, and dogs but proof of the etiology is lacking. %28%Merck Veterinary Manual, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myogenic regulatory factor that controls myogenesis. Myogenin is induced during differentiation of every skeletal muscle cell line that has been investigated, in contrast to the other myogenic regulatory factors that only appear in certain cell types.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A name for several highly contagious viral diseases of animals, especially canine distemper. In dogs, it is caused by the canine distemper virus %28%DISTEMPER VIRUS, CANINE%29%. It is characterized by a diphasic fever, leukopenia, gastrointestinal and respiratory inflammation and sometimes, neurologic complications. In cats it is known as FELINE PANLEUKOPENIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A name originally applied to a group of skin diseases characterized by the formation of fine, branny scales, but now used only with a modifier. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naphthalene derivative with carcinogenic action. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic and antitussive. It is metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as an indicator of liver function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic morphinan used as a sedative in veterinary practice.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic proposed for severe pain. It may be habituating.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic similar to MEPERIDINE; it exists in four stereoisomers, two of which, the beta %28%isopromedol%29% and the gamma %28%trimeperidine%29% are active.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic structurally related to METHADONE. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic that may be habit-forming. It is a controlled substance %28%opium derivative%29% listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 %28%1987%29%. Sale is forbidden in the United States by Federal statute. %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic antagonist with analgesic properties. It is used for the control of moderate to severe pain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narrow cleft inferior to the corpus callosum, within the diencephalon, between the paired thalami. Its floor is formed by the HYPOTHALAMUS, its anterior wall by the lamina terminalis, and its roof by EPENDYMA. It communicates with the FOURTH VENTRICLE by the CEREBRAL AQUEDUCT, and with the LATERAL VENTRICLES by the interventricular foramina.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narrow strip of cell groups on the dorsomedial surface of the thalamus. It includes the lateral dorsal nucleus, lateral posterior nucleus, and the PULVINAR.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narrowing of the aorta in the region above the aortic valve.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A narrowing of the aorta in the region below the aortic valve.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural high-viscosity mucopolysaccharide with alternating beta %28%1-3%29% glucuronide and beta %28%1-4%29% glucosaminidic bonds. It is found in the umbilical cord, in vitreous humor, in synovial fluid, in pathologic joints, in group A and C hemolytic streptococci, and in Wharton%27%s jelly. A high urinary level is found in PROGERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural product that has been considered as a growth factor for some insects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural tocopherol with less antioxidant activity than ALPHA-TOCOPHEROL. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. As in BETA-TOCOPHEROL, it also has three methyl groups on the 6-chromanol nucleus but at different sites.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural tocopherol with less antioxidant activity than alpha-tocopherol. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. As in GAMMA-TOCOPHEROL, it also has three methyl groups on the 6-chromanol nucleus but at different sites.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A natural, adoptive, or substitute parent of a dependent child, who lives with only one parent. The single parent may live with or visit the child. The concept includes the never-married, as well as the divorced and widowed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1341%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring dipeptide neuropeptide found in muscles.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring furocoumarin, found in PSORALEA. After photoactivation with UV radiation, it binds DNA via single and double-stranded cross-linking.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite HYDROCORTISONE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p726%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A %28%see CHONDROITIN SULFATES%29% by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. %28%from Merck, 12th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring lipid pigment with histochemical characteristics similar to lipofuscin. It accumulates in various tissues in certain experimental and pathological conditions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring metabolite of HISTIDINE that has antioxidant properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring opium alkaloid that is a centrally acting antitussive agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring phenolic acid which is a carcinogenic inhibitor. It has also been shown to prevent paraquat-induced oxidative stress in rats. %28%From J Chromatogr A 1996;741%28%2%29%:223-31; Biosci Biotechnol Biochem 1996;60%28%5%29%:765-68%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring product of plants obtained following reduction of GALACTOSE. It appears as a white crystalline powder with a slight sweet taste. It may form in excess in the lens of the eye in GALACTOSEMIAS, a deficiency of GALACTOKINASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A necessary enzyme in the metabolism of galactose. It reversibly catalyzes the conversion of UDPglucose to UDPgalactose. NAD+ is an essential component for enzymatic activity. EC 5.1.3.2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that blocks activation of CYCLIN-DEPENDENT KINASE INHIBITOR P16 and is de-regulated in a variety of NEOPLASMS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A negative regulator of BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS. It plays a role in regulating IMMUNOGLOBULIN E expression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A negative regulator of beta-catenin signaling which is mutant in ADENOMATOUS POLYPOSIS COLI and GARDNER SYNDROME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. It contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A negative regulator of the CELL CYCLE that undergoes PHOSPHORYLATION by CYCLIN-DEPENDENT KINASES. RBL2 contains a conserved pocket region that binds E2F4 TRANSCRIPTION FACTOR and E2F5 TRANSCRIPTION FACTOR. RBL2 also interacts with viral ONCOPROTEINS such as POLYOMAVIRUS TUMOR ANTIGENS; ADENOVIRUS E1A PROTEINS; and PAPILLOMAVIRUS E7 PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes %28%GENE EXPRESSION REGULATION%29%, mRNAs %28%RNA, MESSENGER%29%, and proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep, and horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nematocide in humans and animals. It acts by interfering with the carbohydrate metabolism and associated energy production of the parasite.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplasm composed entirely of GRANULOSA CELLS, occurring mostly in the OVARY. In the adult form, it may contain some THECA CELLS. This tumor often produces ESTRADIOL and INHIBIN. The excess estrogen exposure can lead to other malignancies in women and PRECOCIOUS PUBERTY in girls. In rare cases, granulosa cell tumors have been identified in the TESTES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplasm composed of squamous or epidermal cells. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplasm containing HISTIOCYTES. Important forms include BENIGN FIBROUS HISTIOCYTOMA; and MALIGNANT FIBROUS HISTIOCYTOMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy %28%between benign hemangiomas and conventional angiosarcomas%29%. They affect men and women about equally and rarely develop in childhood. %28%From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin%27%s disease %28%previously termed granulomatous thymoma%29%, should not be regarded as thymoma. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. %28%From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterized by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplastic disease of cats frequently associated with feline leukemia virus infection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of %22%hairy%22% or %22%flagellated%22% cells in the blood and bone marrow.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neotenic aquatic species of mudpuppy %28%Necturus%29% occurring from Manitoba to Louisiana and Texas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nerve originating in the lumbar spinal cord %28%L2 to L4%29% and traveling through the lumbar plexus to the lower extremity. The obturator nerve provides motor innervation to the adductor muscles of the thigh and cutaneous sensory innervation of the inner thigh.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nerve originating in the lumbar spinal cord %28%usually L2 to L4%29% and traveling through the lumbar plexus to provide motor innervation to extensors of the thigh and sensory innervation to parts of the thigh, lower leg, and foot, and to the hip and knee joints.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nerve which originates in the lumbar and sacral spinal cord %28%L4 to S3%29% and supplies motor and sensory innervation to the lower extremity. The sciatic nerve, which is the main continuation of the sacral plexus, is the largest nerve in the body. It has two major branches, the TIBIAL NERVE and the PERONEAL NERVE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nervous tissue specific protein which is highly expressed in NEURONS during development and NERVE REGENERATION. It has been implicated in neurite outgrowth, long-term potentiation, SIGNAL TRANSDUCTION, and NEUROTRANSMITTER release. %28%From Neurotoxicology 1994;15%28%1%29%:41-7%29% It is also a substrate of PROTEIN KINASE C.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A network of cross-linked hydrophilic macromolecules used in biomedical applications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A network of membrane compartments, located at the cytoplasmic side of the GOLGI APPARATUS, where proteins and lipids are sorted for transport to various locations in the cell or cell membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A network of nerve fibers originating in the upper four cervical spinal cord segments. The cervical plexus distributes cutaneous nerves to parts of the neck, shoulders, and back of the head, and motor fibers to muscles of the cervical spinal column, infrahyoid muscles, and the diaphragm.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A network of tubules and sacs in the cytoplasm of skeletal muscles that assist with muscle contraction and relaxation by releasing and storing calcium ions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland %28%usually called a chromaffinoma or pheochromocytoma%29%. It is more common in women than in men. %28%Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurobehavioral syndrome associated with bilateral medial temporal lobe dysfunction. Clinical manifestations include oral exploratory behavior; tactile exploratory behavior; hypersexuality; BULIMIA; MEMORY DISORDERS; placidity; and an inability to recognize objects or faces. This disorder may result from a variety of conditions, including CRANIOCEREBRAL TRAUMA; infections; ALZHEIMER DISEASE; PICK DISEASE OF THE BRAIN; and CEREBROVASCULAR DISORDERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. %28%From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. %28%From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332%28%14%29%:934-40%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuromuscular blocker and active ingredient in CURARE; plant based alkaloid of Menispermaceae.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuronal and epithelial type glutamate plasma membrane transporter protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuronal calcium sensor protein that is expressed as several isoforms and can interact with ACTIN; TUBULIN; and CLATHRIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuronal calcium-sensor protein that is found in ROD PHOTORECEPTORS and CONE PHOTORECEPTORS. It interacts with RHODOPSIN KINASE in a Ca2+ dependent manner and plays an important role in PHOTOTRANSDUCTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuronal calcium-sensor protein that was initially found in the NEURONS of the HIPPOCAMPUS. It interacts with NEURONAL APOPTOSIS-INHIBITORY PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuronal cell membrane protein that combines with SNAP-25 and SYNAPTOBREVIN 2 to form a SNARE complex that leads to EXOCYTOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuropeptide of about 41 amino acids released by the HYPOTHALAMUS that stimulates the release of CORTICOTROPIN by the ANTERIOR PITUITARY GLAND.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuropeptide that is highly homologous to GALANIN. It is produced by proteolytic processing of a larger protein that is unrelated to prepro-galanin and preferentially binds to GALANIN-2 RECEPTOR.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuropeptide toxin from the venom of the funnel web spider, Agelenopsis aperta. It inhibits CALCIUM CHANNELS, P-TYPE by altering the voltage-dependent gating so that very large depolarizations are needed for channel opening. It also inhibits CALCIUM CHANNELS, Q-TYPE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism %28%active or passive refusal to follow commands%29%, mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses %28%e.g., SCHIZOPHRENIA; MOOD DISORDERS%29% or organic disorders %28%NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.%29%. %28%From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or a general medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. %28%From DSM-IV, 1994; Neurol Clin 1997 May;15%28%2%29%:357-79%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurosurgical procedure that removes or disconnects the epileptogenic CEREBRAL CORTEX of a hemisphere. Hemispherectomy is usually performed for patients with intractable unilateral EPILEPSY due to malformations of cortical development or brain lesions. Depending on the epileptogenic area in the hemisphere, cortical removal can be total or partial.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurosurgical procedure that removes the anterior TEMPORAL LOBE including the medial temporal structures of CEREBRAL CORTEX; AMYGDALA; HIPPOCAMPUS; and the adjacent PARAHIPPOCAMPAL GYRUS. This procedure is generally used for the treatment of intractable temporal epilepsy %28%EPILEPSY, TEMPORAL LOBE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotoxic isoxazole %28%similar to KAINIC ACID and MUSCIMOL%29% found in AMANITA mushrooms. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotoxic peptide, which is a cleavage product %28%VIa%29% of the omega-Conotoxin precursor protein contained in venom from the marine snail, CONUS geographus. It is an antagonist of CALCIUM CHANNELS, N-TYPE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotrophic factor involved in regulating the survival of visceral and proprioceptive sensory neurons. It is closely homologous to nerve growth factor beta and BRAIN-DERIVED NEUROTROPHIC FACTOR.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotrophic factor that promotes the survival of various neuronal cell types and may play an important role in the injury response in the nervous system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurotropic agent which reduces permeability of blood-brain barrier to phosphate. It has no vitamin B6 activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A neurovascular syndrome associated with compression of the BRACHIAL PLEXUS; SUBCLAVIAN ARTERY; and SUBCLAVIAN VEIN at the superior thoracic outlet. This may result from a variety of anomalies such as a cervical rib %28%CERVICAL RIB SYNDROME%29%, anomalous fascial bands, and abnormalities of the origin or insertion of the anterior or medial scalene muscles. Clinical features may include pain in the shoulder and neck region which radiates into the arm, PARESIS or PARALYSIS of brachial plexus innervated muscles, PARESTHESIA, loss of sensation, reduction of arterial pulses in the affected extremity, ISCHEMIA, and EDEMA. %28%Adams et al., Principles of Neurology, 6th ed, pp214-5%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nevus containing melanin. The term is usually restricted to nevocytic nevi %28%round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper%29% or moles, but may be applied to other pigmented nevi. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nevus in which nests of melanocytes are found in the dermis, but not at the epidermal-dermal junction. Benign pigmented nevi in adults are most commonly intradermal. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A new pattern of perceptual or ideational material derived from past experience.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nicotinic antagonist most commonly used as an experimental tool. It has been used as a ganglionic blocker in the treatment of hypertension but has largely been supplanted for that purpose by more specific drugs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p514%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin%27%s disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%. %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985, p133%29%, this substance may reasonably be anticipated to be a carcinogen %28%Merck, 11th ed%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nitrovinyl furan used as a schistosomicidal agent and proposed for trypanosomiasis, especially Chagas disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noble gas with the atomic symbol Xe, atomic number 54, and atomic weight 131.30. It is found in the earth%27%s atmosphere and has been used as an anesthetic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion %28%EXOCRINE PANCREAS%29% is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-DNA binding transcription factor that is a subunit of core binding factor. It forms heterodimeric complexes with CORE BINDING FACTOR ALPHA SUBUNITS, and regulates GENETIC TRANSCRIPTION of a variety of GENES involved primarily in CELL DIFFERENTIATION and CELL CYCLE progression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-depolarizing skeletal muscle relaxant similar to TUBOCURARINE. It is used as an anesthesia adjuvant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-electrogenic sodium-dependent phosphate transporter. It is found primarily in apical membranes of PROXIMAL RENAL TUBULES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES, PYRIMIDINES, and other amino acids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. %28%From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen found as a ubiquitously expressed membrane- associated protein. Type XIII collagen contains both collagenous and non-collagenous domains along with a transmembrane domain within its N-terminal region.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen found in BASEMENT MEMBRANE. The C-terminal end of the alpha1 chain of collagen type XVIII contains the ENDOSTATIN peptide, which can be released by proteolytic cleavage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen found in the structure of BASEMENT MEMBRANE. Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. The predominant form of the protein is comprised of two alpha1%28%IV%29% subunits and one alpha2%28%IV%29% subunit, however, at least six different alpha subunits can be incorporated into the heterotrimer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen found primarily in terminally differentiated hypertrophic CHONDROCYTES. It is a homotrimer of three identical alpha1%28%X%29% subunits.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen involved in anchoring the epidermal BASEMENT MEMBRANE to underlying tissue. It is a homotrimer comprised of C-terminal and N-terminal globular domains connected by a central triple-helical region.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen originally found in DESCEMET MEMBRANE. It is expressed in endothelial cell layers and in tissues undergoing active remodeling. It is heterotrimer comprised of alpha1%28%VIII%29% and alpha2%28%VIII%29% chains.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. The alpha subunits of collagen type VI assemble into antiparallel, overlapping dimers which then align to form tetramers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-heme IRON enzyme that catalyzes the conversion of MYOINOSITOL to D-glucuronic acid. The reaction is the first committed step in MYOINOSITOL catabolic pathway. This enzyme was formerly characterized as EC 1.13.1.11 and 1.99.2.6.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-heme iron protein consisting of eight apparently identical subunits each containing 2 iron atoms. It binds one molecule of oxygen per pair of iron atoms and functions as a respiratory protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE along with molybdoferredoxin and is active in nitrogen fixation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE, which is active in nitrogen fixation, and consists of two subunits with molecular weights of 59.5 kDa and 50.7 kDa, respectively.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-hereditary KIDNEY disorder characterized by the abnormally dilated %28%ECTASIA%29% medullary and inner papillary portions of the collecting ducts. These collecting ducts usually contain CYSTS or DIVERTICULA filled with jelly-like material or small calculi %28%KIDNEY STONES%29% leading to infections or obstruction. It should be distinguished from congenital or hereditary POLYCYSTIC KIDNEY DISEASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-hydrolyzable analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It binds tightly to G-protein in the presence of Mg2+. The nucleotide is a potent stimulator of adenylate cyclase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-hydrolyzed muscarinic agonist used as a research tool.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-imidazole blocker of those histamine receptors that mediate gastric secretion %28%H2 receptors%29%. It is used to treat gastrointestinal ulcers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-invasive imaging method that uses computed tomographic data combined with specialized imaging software to examine the colon.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-invasive technique using ultrasound for the measurement of cerebrovascular hemodynamics, particularly cerebral blood flow velocity and cerebral collateral flow. With a high-intensity, low-frequency pulse probe, the intracranial arteries may be studied transtemporally, transorbitally, or from below the foramen magnum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-medical term defined by the lay public as a food that has little or no preservatives, which has not undergone major processing, enrichment or refinement and which may be grown without pesticides. Health foods have been attributed with the ability to prevent the development of diseases, slow the aging process, and prolong life. %28%from Segen, The Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-metabolizable galactose analog that induces expression of the LAC OPERON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. %28%J Neurochem 1993;60%28%4%29%:1498-504%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-neoplastic cyst of the MEIBOMIAN GLANDS of the eyelid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-neoplastic disease of unknown etiology beginning with inflammation, ulceration, and perforation of nose and palate and progressing to gradual destruction of midline facial structures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva %28%giant cell epulis%29%; central refers to the jaw.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-neoplastic keratinizing mass with stratified squamous epithelium, frequently occurring in the meninges, central nervous system, bones of the skull, and most commonly in the middle ear and mastoid region.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-pathogenic species of LACTOCOCCUS found in DAIRY PRODUCTS and responsible for the souring of MILK and the production of LACTIC ACID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-penetrating amino reagent %28%commonly called SITS%29% which acts as an inhibitor of anion transport in erythrocytes and other cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-peptide, kappa-opioid receptor agonist which has also been found to stimulate the release of adrenocorticotropin %28%CORTICOTROPIN%29% via the release of hypothalamic arginine vasopressin %28%ARGIPRESSIN%29% and CORTICOTROPIN-RELEASING HORMONE. %28%From J Pharmacol Exp Ther 1997;280%28%1%29%:416-21%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-prostaglandin synthase inhibitor. It was utilized extensively in a wide variety of analgesic mixtures, but its causal role in analgesic-abuse nephropathy led to its withdrawal from the market. %28%From Smith and Reynard, Textbook of Pharmacology,1991, p431%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-receptor protein tyrosine kinase that is localized to FOCAL ADHESIONS and is a central component of integrin-mediated SIGNAL TRANSDUCTION PATHWAYS. Focal adhesion kinase 1 interacts with PAXILLIN and undergoes PHOSPHORYLATION in response to adhesion of cell surface integrins to the EXTRACELLULAR MATRIX. Phosphorylated p125FAK protein binds to a variety of SH2 DOMAIN and SH3 DOMAIN containing proteins and helps regulate CELL ADHESION and CELL MIGRATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-receptor protein-tyrosine kinase that is expressed primarily in the BRAIN; OSTEOBLASTS; and LYMPHOID CELLS. In the CENTRAL NERVOUS SYSTEM focal adhesion kinase 2 modulates ION CHANNEL function and MITOGEN-ACTIVATED PROTEIN KINASES activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens %28%PB95-109781, 1994%29% this substance may reasonably be anticipated to be a carcinogen. %28%From Merck Index, 12th ed%29% It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-fertility agent with anti-hormonal properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory agent %28%ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL%29% similar in mode of action to INDOMETHACIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory agent %28%NSAID%29% that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory agent %28%NSAID%29% with antipyretic and analgesic actions. It is primarily available as the sodium salt.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. %28%From AMA Drug Evaluations Annual, 1992, p120%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. %28%From AMA, Drug Evaluations Annual, 1994, p2000%29% It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p27%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal estrogen analog. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal estrogen antagonist %28%as the 1:1 citrate%29% most commonly used as a research tool in animal studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-steroidal estrogen antagonist. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-template-directed DNA polymerase normally found in vertebrate thymus and bone marrow. It catalyzes the elongation of oligo- or polydeoxynucleotide chains and is widely used as a tool in the differential diagnosis of acute leukemias in man. EC 2.7.7.31.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-tuberculous mycobacterium causing cervical lymphadenitis in children. It very rarely causes pulmonary disease, and is believed to be non-pathogenic in animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonapeptide posterior pituitary hormone that causes UTERINE CONTRACTIONS and stimulates MILK EJECTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonchromaffin paraganglion located in the wall of the jugular bulb. The most common tumors of the middle ear arise from this tissue. %28%Lockard, Desk Reference for Neuroscience, 1992, p114%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noncompetitive antagonist at GABA-A receptors and thus a convulsant. Picrotoxin blocks the GAMMA-AMINOBUTYRIC ACID-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. %28%From AMA Drug Evaluations Annual, 1994, p178%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonfluorescent reagent for the detection of primary amines, peptides and proteins. The reaction products are highly fluorescent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nongenetic defect due to malformation of the KIDNEY which appears as a bunch of grapes with multiple renal cysts but lacking the normal renal bean shape, and the collection drainage system. This condition can be detected in-utero with ULTRASONOGRAPHY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noninvasive %28%noninfiltrating%29% carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noninvasive diagnostic technique that enables an experienced clinician to perform direct microscopic examination of the surface and architecture of pigmented SKIN lesions. The four major dermoscopic criteria are ABCD: asymmetry %28%A%29%, borders %28%B%29%, colors %28%C%29%, and different structural components %28%D%29% providing a semiquantitative scoring system for each lesion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noninvasive method for quantitating bone mineral content. It is used especially in the diagnosis of osteoporosis and also in measuring bone mineralization in infants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A noninvasive technique that uses the differential absorption properties of hemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional hemodynamics and blood flow. Near-infrared light %28%NIR%29% can propagate through tissues and at particular wavelengths is differentially absorbed by oxygenated vs. deoxygenated forms of hemoglobin and myoglobin. Illumination of intact tissue with NIR allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonionic polyoxyethylene-polyoxypropylene block co-polymer with the general formula HO%28%C2H4O%29%a%28%-C3H6O%29%b%28%C2H4O%29%aH. It is available in different grades which vary from liquids to solids. It is used as an emulsifying agent, solubilizing agent, surfactant, and wetting agent for antibiotics. Poloxamer is also used in ointment and suppository bases and as a tablet binder or coater. %28%Martindale The Extra Pharmacopoeia, 31st ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight 12.011. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as flouride %28%FLUORIDES%29% to prevent dental caries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonmuscle isoform of myosin type II found predominantly in neuronal tissue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonmuscle isoform of myosin type II found predominantly in platelets, lymphocytes, neutrophils and brush border enterocytes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonreassuring fetal status %28%NRFS%29% indicating that the FETUS is compromised %28%American College of Obstetricians and Gynecologists 1988%29%. It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonreducing disaccharide composed of GLUCOSE and FRUCTOSE linked via their anomeric carbons. It is obtained commercially from SUGARCANE, sugar beet %28%BETA VULGARIS%29%, and other plants and used extensively as a food and a sweetener.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonselective beta-blocker used as an antihypertensive and an antianginal agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonspecific term referring both to the pathologic finding of swelling of distal portions of axons in the brain and to disorders which feature this finding. Neuroaxonal dystrophy is seen in various genetic diseases, vitamin deficiencies, and aging. Infantile neuroaxonal dystrophy is an autosomal recessive disease characterized by arrested psychomotor development at 6 months to 2 years of age, ataxia, brain stem dysfunction, and quadriparesis. Juvenile and adult forms also occur. Pathologic findings include brain atrophy and widespread accumulation of axonal spheroids throughout the neuroaxis, peripheral nerves, and dental pulp. %28%From Davis %26% Robertson, Textbook of Neuropathology, 2nd ed, p927%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness %28%often defined as greater than 6 hours in duration%29% may be referred to as post-traumatic coma %28%COMA, POST-HEAD INJURY%29%. %28%From Rowland, Merritt%27%s Textbook of Neurology, 9th ed, p418%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of PREGNANCY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nonsteroidal anti-inflammatory agent with potent analgesic and antiarthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ankylosing SPONDYLITIS; and in the alleviation of postoperative pain %28%PAIN, POSTOPERATIVE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans. %28%J Nucl Med 1977;18%28%10%29%:997-1004%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nontoxic radiopharmaceutical that is used in the clinical evaluation of hepatobiliary disorders in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A norepinephrine derivative used as a vasoconstrictor agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A normal developing tooth which has not yet perforated the oral mucosa or one that fails to erupt in the normal sequence or time interval expected for the type of tooth in a given gender, age, or population group.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A normal intermediate in the fermentation %28%oxidation, metabolism%29% of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A normally saprophytic mitosporic Chaetothyriales fungal genus. Infections in humans include phaeohyphomycosis, peritonitis, and chromoblastomycosis. Exophiala jeanselmei %28%previously Phialophora jeanselmei%29% is an etiological agent of maduromycosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A north temperate species of tapeworm %28%CESTODA%29% whose adult form infects FOXES and wild RODENTS. The larval form can infect humans producing HEPATIC HYDATID CYSTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A notch receptor that interacts with a variety of ligands and regulates SIGNAL TRANSDUCTION PATHWAYS for multiple cellular processes. It is widely expressed during EMBRYOGENESIS and is essential for EMBRYONIC DEVELOPMENT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A notch receptor that plays an important role in CELL DIFFERENTIATION in a variety of cell types. It is the preferentially expressed notch receptor in mature B-LYMPHOCYTES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A novel diuretic with uricosuric action. It has been proposed as an antihypertensive agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U1 snRNP along with other small nuclear ribonucleoproteins %28%U2, U4-U6, and U5%29% assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U1 snRNA forms base pairs with conserved sequence motifs at the 5%27%-splice site and recognizes both the 5%27%- and 3%27%-splice sites and may have a fundamental role in aligning the two sites for the splicing reaction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U2 snRNP along with other small nuclear ribonucleoproteins %28%U1, U4-U6, and U5%29% assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U2 snRNA forms base pairs with conserved sequence motifs at the branch point, which associates with a heat- and RNAase-sensitive factor in an early step of splicing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U4-U6 snRNP along with the U5 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form mature SPLICEOSOMES. There is also evidence for the existence of individual U4 or U6 snRNPs in addition to their organization as a U4-U6 snRNP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U5 snRNP along with U4-U6 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form SPLICEOSOMES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear transcription factor. Heterodimerization with PPAR ALPHA is important to metabolism of LIPIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear transcription factor. Heterodimerization with PPAR-GAMMA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR ALPHA is important in regulation of GLUCOSE metabolism and CELL GROWTH PROCESSES. It is a target of THIAZOLIDINEDIONES for control of DIABETES MELLITUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear transcription factor. Heterodimerization with RETINOID X RECEPTOR GAMMA is important to metabolism of LIPIDS. It is the target of FIBRATES to control HYPERLIPIDEMIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nuclear transcription factor. It is activated by PROSTACYCLIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleic acid sequence that contains an above average number of ADENINE and THYMINE bases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleic acid sequence that contains an above average number of GUANINE and CYTOSINE bases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleocytoplasmic transport protein that binds to ALPHA KARYOPHERINS and RAN GTP BINDING PROTEIN inside the CELL NUCLEUS and participates in their export into CYTOPLASM. It is also associated with the regulation of APOPTOSIS and microtubule assembly.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside consisting of the base guanine and the sugar deoxyribose.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside diphosphate sugar which can be converted to the deoxy sugar GDPfucose, which provides fucose for lipopolysaccharides of bacterial cell walls. Also acts as mannose donor for glycolipid synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside diphosphate sugar which is formed from UDP-N-acetylglucosamine and phosphoenolpyruvate. It serves as the building block upon which peptidoglycan is formed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside diphosphate sugar which serves as a source of N-acetylgalactosamine for glycoproteins, sulfatides and cerebrosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleus located in the middle hypothalamus in the most ventral part of the third ventricle near the entrance of the infundibular recess. Its small cells are in close contact with the ependyma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nucleus of the middle hypothalamus, the largest cell group of the tuberal region with small-to-medium size cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A number of ligaments on either side of, and serving as a radius of movement of, a joint having a hingelike movement. They occur at the elbow, knee, wrist, metacarpo- and metatarsophalangeal, proximal interphalangeal, and distal interphalangeal joints of the hands and feet. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A number of syndromes with defective gonadal developments such as streak gonads and dysgenetic testes. The spectrum of gonadal and sexual abnormalities is reflected in their varied sex chromosome %28%SEX CHROMOSOMES%29% constitution as shown by the karyotypes of 45,X monosomy %28%TURNER SYNDROME%29%; 46,XX %28%GONADAL DYSGENESIS, 46XX%29%; 46,XY %28%GONADAL DYSGENESIS, 46,XY%29%; and sex chromosome MOSAICISM; %28%GONADAL DYSGENESIS, MIXED%29%. Their phenotypes range from female, through ambiguous, to male. This concept includes gonadal agenesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A numerical rating scale for classifying the periodontal status of a person or population with a single figure which takes into consideration prevalence as well as severity of the condition. It is based upon probe measurement of periodontal pockets and on gingival tissue status.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A numerical system of measuring the rate of BLOOD GLUCOSE generation by a particular food item as compared to a reference item, such as glucose = 100. Foods with higher glycemic index numbers create greater blood sugar swings. These numbers do not correspond to calories or amounts of food intake but rather, depend on the rates of digestion and absorption of these food items.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nursing specialty created to answer the need for developing a global perspective in the practice of nursing in a world of interdependent nations and people. The focus of this nursing discipline is on the integration of international and transcultural content into the training. Courses include study in the area of cultural differences, nursing in other countries, and international health issues and organizations, as an example.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. %28%Merck Manual, 16th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. %28%From Cecil Textbook of Medicine, 19th ed, p1171%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea %28%XEROPHTHALMIA%29%. Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. %28%From Cecil Textbook of Medicine, 19th ed, p1179%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. %28%From Cecil Textbook of Medicine, 19th ed, p848%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of VITAMIN B 6 in the diet, characterized by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhea, anemia, and seizures. Deficiency can be caused by certain medications, such as isoniazid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. %28%From Cecil Textbook of Medicine, 19th ed, p1406%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. %28%Cecil Textbook of Medicine, 19th ed, p1181%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage %28%HEMORRHAGIC DISORDERS%29%. Such bleeding episodes may be particularly severe in newborn infants. %28%From Cecil Textbook of Medicine, 19th ed, p1182%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. %28%Harrison%27%s Principles of Internal Medicine, 12th ed, p1936%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality %28%i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization%29%. %28%From Merck Manual, 16th ed; Harrison%27%s Principles of Internal Medicine, 12th ed, p406%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritional reservoir of fatty tissue found mainly in insects and amphibians.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A nutritious food consisting primarily of the curd or the semisolid substance formed when milk coagulates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A once-popular mercury containing topical antiseptic. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A one-carbon group transferase that transfers lipoamide-linked methylamine groups to tetrahydrofolate %28%TETRAHYDROFOLATES%29% to form methylenetetrahydrofolate and AMMONIA. It is one of four components of the glycine decarboxylase complex.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A onecut transcription factor that regulates expression of GENES involved in EMBRYONIC DEVELOPMENT of the PANCREAS and LIVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A organochlorophosphate cholinesterase inhibitor that is used as an insecticide for the control of flies and roaches. It is also used in anthelmintic compositions for animals. %28%From Merck, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A organothiophosphorus cholinesterase inhibitor that is used as an anthelmintic, insecticide, and as a nematocide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pH sensitive dye that has been used as an indicator in many laboratory reactions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A painful linear ulcer at the margin of the anus. It appears as a crack or slit in the mucous membrane of the anus and is very painful and difficult to heal. %28%Dorland, 27th ed %26% Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pair of highly specialized muscular canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM collection, and the site for the final maturation of gametes and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three histologic layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pair of nuclei and associated gray matter in the interpeduncular space rostral to the posterior perforated substance in the posterior hypothalamus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pair of ophthalmic lenses in a frame or mounting which is supported by the nose and ears. The purpose is to aid or improve vision. It does not include goggles or nonprescription sun glasses for which EYE PROTECTIVE DEVICES is available.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paired box transcription factor that is essential for ORGANOGENESIS of the CENTRAL NERVOUS SYSTEM and KIDNEY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paired box transcription factor that is involved in EMBRYONIC DEVELOPMENT of the CENTRAL NERVOUS SYSTEM and SKELETAL MUSCLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paired box transcription factor that is involved in ODONTOGENESIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pancreatic peptide hormone of about 29 amino acids secreted by PANCREATIC ALPHA CELLS. It has an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p1511%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pancreatic trypsin inhibitor common to all mammals. It is secreted with the zymogens into the pancreatic juice. It is a protein composed of 56 amino acid residues and is different in amino acid composition and physiological activity from the Kunitz bovine pancreatic trypsin inhibitor %28%APROTININ%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A papular eruption of unknown etiology that progresses to residual papular erythema and scaling usually confined to the area of the mouth, and almost exclusively occurring in young women. It may also be localized or extend to involve the eyelids and adjacent glabella area of the forehead %28%periocular dermatitis%29%. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. %28%From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp1603-4%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paralytic condition of the legs caused by ingestion of lathyrogens, especially beta-aminopropionitrile, found in the seeds of plants of the genus Lathyrus %28%see FABACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paraneoplastic syndrome marked by degeneration of neurons in the medial temporal lobe. Clinical features include behavioral changes, HALLUCINATIONS, loss of short term memory, anosmia, AGEUSIA, and DEMENTIA. Circulating anti-neuronal antibodies %28%anti-Hu; also called ANNA 1%29% and small cell lung carcinomas are frequently associated with this condition. %28%From Pathologe 1997 Sep;18%28%5%29%:406-10; J Int Neuropsychol Soc 1996 Sep;2%28%5%29%:460-6; Brain 1997 Jun;120%28%Pt 6%29%:923-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate PROTOZOA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasite of carnivorous mammals that causes TRICHINOSIS. It is especially common in rats and in swine fed uncooked garbage. Human infection is initiated by the consumption of raw or insufficiently cooked pork or other meat containing the encysted larvae.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania leishmania that has been found as a natural infection of the Brazilian guinea pig. Its host-tissue relationship is, in general, comparable to that of L. braziliensis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes cutaneous leishmaniasis %28%LEISHMANIASIS, CUTANEOUS%29% of the Old World. Transmission is by Phlebotomus sandflies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis %28%LEISHMANIASIS, VISCERAL%29%. Human infections are confined almost entirely to children. This parasite is commonly seen in dogs, other Canidae, and porcupines with humans considered only an accidental host. Transmission is by Phlebotomus sandflies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis %28%LEISHMANIASIS, VISCERAL%29%. The sandfly genera Phlebotomus and Lutzomyia are the vectors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous %28%LEISHMANIASIS, CUTANEOUS%29% and diffuse cutaneous leishmaniasis %28%LEISHMANIASIS, DIFFUSE CUTANEOUS%29% and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis %28%LEISHMANIASIS, CUTANEOUS%29% in the New World. The sandfly, Lutzomyia, appears to be the vector.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis %28%LEISHMANIASIS, CUTANEOUS%29% of the Old World.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals and causes mucocutaneous leishmaniasis %28%LEISHMANIASIS, MUCOCUTANEOUS%29%. Transmission is by Lutzomyia sandflies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous %28%LEISHMANIASIS, CUTANEOUS%29%, diffuse cutaneous %28%LEISHMANIASIS, DIFFUSE CUTANEOUS%29%, and mucocutaneous leishmaniasis %28%LEISHMANIASIS, MUCOCUTANEOUS%29% depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly %28%Tabanus%29% or the deerfly or mango fly %28%Chrysops%29%. The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasomnia characterized by a partial arousal that occurs during stage IV of non-REM sleep. Affected individuals exhibit semipurposeful behaviors such as ambulation and are difficult to fully awaken. Children are primarily affected, with a peak age range of 4-6 years.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasomnia characterized by paroxysmal episodes of choreoathetotic, ballistic, dystonic movements, and semipurposeful activity. The episodes occur during non-rapid eye movement sleep and typically recur several times per night. %28%Neurology 1992 Jul;42%28%7 Suppl 6%29%:61-67; Adams et al., Principles of Neurology, 6th ed, p391%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parathyroid hormone receptor subtype found in the BRAIN and the PANCREAS. It is a G-protein-coupled receptor with a ligand specificity that varies between homologs from different species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parathyroid hormone receptor subtype that recognizes both PARATHYROID HORMONE and PARATHYROID HORMONE-RELATED PROTEIN. It is a G-protein-coupled receptor that is expressed at high levels in BONE and in KIDNEY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A paravertebral sympathetic ganglion formed by the fusion of the inferior cervical and first thoracic ganglia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A parliamentary democracy with a constitutional monarch in southeast Asia, consisting of 11 states %28%West Malaysia%29% on the Malay Peninsula and two states %28%East Malaysia%29% on the island of BORNEO. It is also called the Federation of Malaysia. Its capital is Kuala Lumpur. Before 1963 it was the Union of Malaya. It reorganized in 1948 as the Federation of Malaya, becoming independent from British Malaya in 1957 and becoming Malaysia in 1963 as a federation of Malaya, Sabah, Sarawak, and Singapore %28%which seceded in 1965%29%. The form Malay- probably derives from the Tamil malay, mountain, with reference to its geography. %28%From Webster%27%s New Geographical Dictionary, 1988, p715 %26% Room, Brewer%27%s Dictionary of Names, 1992, p329%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A part of the embryo in a seed plant. The number of cotyledons is an important feature in classifying plants. In seeds without an endosperm, they store food which is used in germination. In some plants, they emerge above the soil surface and become the first photosynthetic leaves. %28%From Concise Dictionary of Biology, 1990%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the Shy-Drager syndrome.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partial denture attached to prepared natural teeth, roots, or implants by cementation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partial denture constructed before the teeth it replaces are removed. It is then inserted immediately after the removal of the natural teeth for functional and cosmetic reasons during the healing process. It is to be replaced later by the fitted partial denture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partial denture designed and constructed to be removed readily from the mouth.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partial denture intended for short-term use in a temporary or emergency situation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A particular category of body build, determined on the basis of certain physical characteristics. The three basic body types are ectomorph %28%thin physique%29%, endomorph %28%rounded physique%29%, and mesomorph %28%athletic physique%29%. The typology was devised by the American psychologist William Herbert Sheldon %28%1899-1977%29%. Somatotypes have been related to personality in early studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A particular kind of learning characterized by occurrence in very early life, rapidity of acquisition, and relative insusceptibility to forgetting or extinction. Imprinted behavior includes most %28%or all%29% behavior commonly called instinctive, but imprinting is used purely descriptively.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A partnership, corporation, association, or other legal entity that enters into an arrangement for the provision of services with persons who are licensed to practice medicine, osteopathy, and dentistry, and with other care personnel. Under an IPA arrangement, licensed professional persons provide services through the entity in accordance with a mutually accepted compensation arrangement, while retaining their private practices. Services under the IPA are marketed through a prepaid health plan. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathologic condition resulting from accumulation of acid or depletion of the alkaline reserve %28%bicarbonate%29% content of the blood and body tissues, and characterized by an increase in hydrogen ion concentration %28%decrease in pH%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal BONY CALLUS leading to existence of the %22%false joint%22% that gives the condition its name. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathologic process consisting in proliferation of blood vessels in abnormal tissues or in abnormal positions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathologic process consisting in the formation of pus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological accumulation of air in tissues or organs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition characterized by the presence of a number of COLONIC DIVERTICULA in the COLON. Its pathogenesis is multifactorial, including colon aging, motor dysfunction, increases in intraluminal pressure, and lack of dietary fibers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition characterized by the presence of a number of ESOPHAGEAL DIVERTICULA in the ESOPHAGUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition characterized by the presence of a number of GASTRIC DIVERTICULA in the STOMACH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition manifested as a pouch or sac opening from a tubular or saccular organ.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition that can suddenly affect the hemodynamic equilibrium, usually manifested by failure to perfuse or oxygenate vital organs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological condition that removes acid or adds base to the body fluids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological process consisting of the formation of new blood vessels in the CHOROID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological process resulting from the reaction of the body to external forces and abnormal conditions that tend to disturb the organism%27%s homeostasis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pathway of fibers originating in the lateral part of the entorhinal area, perforating the subiculum of the hippocampus, and running into the stratum moleculare of the hippocampus, where these fibers synapse with others that go to the dentate gyrus. It is also called the perforating fasciculus. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that binds DOUBLE-STRANDED RNA. It mediates cellular responses to certain viral pathogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that binds FLAGELLIN. It mediates cellular responses to certain bacterial pathogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that binds several forms of imidazo-quinoline including the antiviral compound Imiquimod.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that binds unmethylated CPG CLUSTERS. It mediates cellular responses to bacterial pathogens by distinguishing between self and bacterial DNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that forms heterodimers with TLR2 RECEPTOR. The complex interacts with a variety of ligands including LIPOPROTEINS from MYCOPLASMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that forms heterodimers with TOLL-LIKE RECEPTOR 2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that forms heterodimers with other TOLL-LIKE RECEPTORS. It interacts with multiple ligands including PEPTIDOGLYCAN, bacterial LIPOPROTEINS, lipoarabinomannan, and a variety of PORINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that is expressed in LUNG and in B-LYMPHOCYTES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pattern recognition receptor that recognizes GUANOSINE and URIDINE-rich single-stranded RNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pea-shaped carpal bone that actually sits in the tendon of the flexor carpi ulnaris muscle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pelvic hernia through the obturator foramen, a large aperture in the hip bone normally covered by a membrane. Obturator hernia can lead to intestinal incarceration and INTESTINAL OBSTRUCTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pentose active in biological systems usually in its D-form.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide consisting of amino acid sequence 61-91 of the endogenous pituitary hormone BETA-LIPOTROPIN. The first four amino acids show a common tetrapeptide sequence with METHIONINE- and LEUCINE ENKEPHALIN. The compound shows opiate-like activity. Injection of beta-endorphin induces a profound analgesia of the whole body for several hours. This action is reversed after administration of naloxone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide extracted from the posterior salivary glands of certain small octopi %28%Eledone spp., Mollusca%29%, or obtained by synthesis. Its actions resemble those of SUBSTANCE P; it is a potent vasodilator and increases capillary permeability. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1364%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide factor originally identified by its ability to stimulate the phosphorylation the erbB-2 receptor %28%RECEPTOR, ERBB-2%29%. It is a ligand for the erbB-3 receptor %28%RECEPTOR, ERBB-3%29% and the erbB-4 receptor. Variant forms of NEUREGULIN-1 occur through alternative splicing of its mRNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide hormone of about 11 amino acids derived from PRO-OPIOMELANOCORTIN that has natriuretic activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide hormone of about 22 amino acids. It is derived from PRO-OPIOMELANOCORTIN and has natriuretic activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide hormone of about 27 amino acids from the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. %28%USAN and the USP Dictionary of Drug Names, 1994, p597%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide hormone which originates in the HYPOTHALAMUS and stimulates secretion of MELANOCYTE-STIMULATING HORMONES in the PITUITARY GLAND.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide initiation factor that binds specifically to the 5%27% MRNA CAP STRUCTURE of MRNA in the CYTOPLASM. It is a component of the trimeric complex EIF4F.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide processed from proglucagon in the GI TRACT that acts at glucagon-like peptide-1 receptor and is degraded by DIPEPTIDYL-PEPTIDASE IV. It stimulates INSULIN secretion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide that is a homopolymer of glutamic acid. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide which is a homopolymer of lysine. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine %28%or digestive%29% enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptidohydrolytic enzyme that is formed from PREKALLIKREIN by FACTOR XIIA. It activates FACTOR XII; FACTOR VII; and PLASMINOGEN. It is selective for both ARGININE and to a lesser extent LYSINE bonds. EC 3.4.21.34.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. It is a Cl%28%-%29%-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. It may also have endopeptidase activity on some substrates. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.15.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A perceptual phenomenon used by Gestalt psychologists to demonstrate that events in one part of the perceptual field may affect perception in another part.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A performance measure for rating the ability of a person to perform usual activities, evaluating a patient%27%s progress after a therapeutic procedure, and determining a patient%27%s suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A performance test based on forced MOTOR ACTIVITY on a rotating rod, usually by a rodent. Parameters include the riding time %28%seconds%29% or endurance. Test is used to evaluate balance and coordination of the subjects, particular in experimental animal models for neurological disorders and drug effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction %28%FERTILITY%29%, development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peripheral vasodilator that was formerly used in the management of peripheral and cerebral vascular disorders. It is hepatotoxic and fatalities have occurred. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1312%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peritoneal mesothelioma affecting mainly young females and producing cysts of variable size and number lined by a single layer of benign mesothelial cells. The disease follows a benign course and is compatible with a normal life expectancy, requiring occasionally partial excision or decompression for relief of pain or other symptoms. Malignant potential is exceptional. %28%From Holland et al., Cancer Medicine, 3d ed, p1345%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peroxide derivative that has been used topically for burns and as a dermatologic agent in the treatment of acne and poison ivy. It is used also as a bleach in the food industry.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A peroxisome proliferator that is used experimentally to promote liver tumors. It has been used as an antihyperlipoproteinemic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A persistent activity-dependent decrease in synaptic efficacy between NEURONS. It typically occurs following repeated low-frequency afferent stimulation, but it can be induced by other methods. Long-term depression appears to play a role in MEMORY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A persistent attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. %28%Adams et al., Principles of Neurology, 6th ed, p77%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. %28%From Rook et al., Textbook of Dermatology, 4th ed, pp2428-9%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A persistent skin infection marked by the presence of furuncles, often chronic and recurrent. In humans, the causative agent is various species of STAPHYLOCOCCUS. In salmonid fish %28%SALMONIDS%29%, the pathogen is AEROMONAS SALMONICIDA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person 13 to 18 years of age. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person 80 years of age and older. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person authorized to decide or act for another person, for example, a person having durable power of attorney.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person having attained full growth or maturity. Adults are of 19 through 44 years of age.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person who has not attained the age at which full civil rights are accorded.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person%27%s concept of self as being male and masculine or female and feminine, or ambivalent, based in part on physical characteristics, parental responses, and psychological and social pressures. It is the internal experience of gender role.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A person%27%s view of himself. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality assessment technique in which the subject or observer indicates the degree to which a standardized set of descriptive statements actually describes the subject. The term reflects %22%sorting%22% procedures occasionally used with this technique.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality dimension characterized by the manipulation of others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder characterized by a pervasive and excessive need to be taken care of that leads to submissive and clinging behavior and fears of separation, beginning by early adulthood and present in a variety of contexts. %28%From DSM-IV, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder characterized by an emotionally constricted manner that is unduly conventional, serious, formal, and stingy, by preoccupation with trivial details, rules, order, organization, schedules, and lists, by stubborn insistence on having things one%27%s own way without regard for the effects on others, by excessive devotion to work and productivity to the detriment of interpersonal relationships, and by indecisiveness due to fear of making mistakes. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder characterized by an indirect resistance to demands for adequate social and occupational performance; anger and opposition to authority and the expectations of others that is expressed covertly by obstructionism, procrastination, stubbornness, dawdling, forgetfulness, and intentional inefficiency. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder characterized by overly reactive and intensely expressed or overly dramatic behavior, proneness to exaggeration, emotional excitability, and disturbances in interpersonal relationships.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder characterized by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity, and mistrust.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder in which there are oddities of thought %28%magical thinking, paranoid ideation, suspiciousness%29%, perception %28%illusions, depersonalization%29%, speech %28%digressive, vague, overelaborate%29%, and behavior %28%inappropriate affect in social interactions, frequently social isolation%29% that are not severe enough to characterize schizophrenia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder manifested by a profound defect in the ability to form social relationships, no desire for social involvement, and an indifference to praise or criticism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. %28%DSM-IV%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. %28%From DSM-IV, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A personality trait rendering the individual acceptable in social or interpersonal relations. It is related to social acceptance, social approval, popularity, social status, leadership qualities, or any quality making him a socially desirable companion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pharmaceutical preparation containing a mixture of esterified estrogens derived from estrogen sulfates, principally from ESTRONE sulfate. Esterified estrogen content should be 75-85%25% of the estrone sulfate and 6-15%25% of the EQUILIN sulfate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate %28%52-62%25%%29% and equilin sulfate %28%22-30%25%%29% with a total of the two between 80-88%25%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phase of the ESTROUS CYCLE that precedes ESTRUS. During proestrus, the Graafian follicles undergo maturation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phase of the ESTROUS CYCLES that follows METESTRUS. Diestrus is a period of sexual quiescence separating phases of ESTRUS in polyestrous animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenolphthalein that is used as a diagnostic aid in hepatic function determination.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenomenon in which symptoms of a disease are fabricated by an individual other than the patient causing unnecessary, and often painful, physical examinations and treatments. This syndrome is considered a form of CHILD ABUSE, since another individual, usually a parent, is the source of the fabrication of symptoms and presents the child for medical care.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenomenon in which there is a relatively profound alteration in brain function resulting from repeated electrical or chemical stimulation and culminating in the appearance of electrographic and behavioral convulsions whenever the stimulus is re-applied. It is used as an experimental model for epilepsy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenomenon manifested by an agent or substance adhering to or being adsorbed on the surface of a red blood cell, as tuberculin can be adsorbed on red blood cells under certain conditions. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenomenon that is observed when a small subgroup of a larger POPULATION establishes itself as a separate and isolated entity. The subgroup%27%s GENE POOL carries only a fraction of the genetic diversity of the parental population resulting in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than CHLORPROMAZINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p618%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p612%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine antipsychotic with actions and uses similar to those of CHLORPROMAZINE. Extrapyramidal symptoms may be more common than other side effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine antipsychotic with effects similar to CHLORPROMAZINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine derivative that is used as an antipruritic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine that has been used as a hemostatic, a biological stain, and a dye for wool and silk. Tolonium chloride has also been used as a diagnostic aid for oral and gastric neoplasms and in the identification of the parathyroid gland in thyroid surgery.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine that is used in the treatment of PSYCHOSES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine used as an antipsychotic agent and as an antiemetic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenothiazine with pharmacological activity similar to that of both CHLORPROMAZINE and PROMETHAZINE. It has the histamine-antagonist properties of the antihistamines together with CENTRAL NERVOUS SYSTEM effects resembling those of chlorpromazine. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p604%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenotypic outcome %28%physical characteristic or disease predisposition%29% that is determined by more than one gene. Polygenic refers to those determined by many genes, while oligogenic refers to those determined by a few genes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide, and bacteriocide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME %28%a drug of choice%29% and occasionally as adjunctive therapy in MENTAL RETARDATION and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. %28%From AMA Drug Evaluations Annual, 1994, p279%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A philosophically coherent set of propositions %28%for example, utilitarianism%29% which attempts to provide general norms for the guidance and evaluation of moral conduct. %28%from Beauchamp and Childress, Principles of Biomedical Ethics, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A philosophy based upon spiritual intuition that is believed to transcend ordinary sensory experiences or understanding.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A philosophy of nursing practice that takes into account total patient care, considering the physical, emotional, social, economic, and spiritual needs of patients, their response to their illnesses, and the effect of illness on patients%27% abilities to meet self-care needs. %28%From Mosby%27%s Medical, Nursing, %26% Allied Health Dictionary, 4th ed, p745%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phorbol ester found in CROTON OIL which, in addition to being a potent skin tumor promoter, is also an effective activator of calcium-activated, phospholipid-dependent protein kinase %28%protein kinase C%29%. Due to its activation of this enzyme, phorbol 12,13-dibutyrate profoundly affects many different biological systems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. %28%From AMA Drug Evaluations Annual, 1994, p752%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphodiesterase inhibitor which inhibits platelet aggregation. Formerly used as an antineoplastic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphodiesterase inhibitor with antidepressant properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphoinositide present in all eukaryotic cells, particularly in the plasma membrane. It is the major substrate for receptor-stimulated phosphoinositidase C, with the consequent formation of inositol 1,4,5-triphosphate and diacylglycerol, and probably also for receptor-stimulated inositol phospholipid 3-kinase. %28%Kendrew, The Encyclopedia of Molecular Biology, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phospholipase C that is activated in response to growth factor stimulation and TYROSINE phosphorylation. Isoforms of this enzyme are critical for the generation of CALCIUM signals in HEMATOPOIETIC SYSTEMS in response to the stimulation of immune receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phospholipid-interacting antimalarial drug %28%ANTIMALARIALS%29%. It is very effective against PLASMODIUM FALCIPARUM with very few side effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphoprotein phosphatase that is specific for MYOSIN LIGHT CHAINS. It is composed of three subunits, which include a catalytic subunit, a myosin binding subunit, and a third subunit of unknown function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphoprotein that was initially identified as a major target of DOPAMINE activated ADENYLYL CYCLASE in the CORPUS STRIATUM. It regulates the activities of PROTEIN PHOSPHATASE-1 and PROTEIN KINASE A, and it is a key mediator of the biochemical, electrophysiological, transcriptional, and behavioral effects of DOPAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphoric diester hydrolase that removes 5%27%-nucleotides from the 3%27%-hydroxy termini of 3%27%-hydroxy-terminated OLIGONUCLEOTIDES. It has low activity towards POLYNUCLEOTIDES and the presence of 3%27%-phosphate terminus on the substrate may inhibit hydrolysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphoric diester hydrolase with specificity for the cleavage of GLYCEROL from 1-%28%sn-glycero-3-phospho%29%-1D-myo-inositol. It also has specificity for hydrolysis of the cyclic phosphate bond in inositol 1,2-cyclic phosphate%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphorus-oxygen lyase found primarily in BACTERIA. The enzyme catalyzes the cleavage of a phosphoester linkage in 1-phosphatidyl-1D-myo-inositol to form 1D-myo-inositol 1,2-cyclic phosphate and diacylglycerol. The enzyme was formerly classified as a phosphoric diester hydrolase %28%EC 3.1.4.10%29% and is often referred to as a PHOSPHOLIPASE C. However it is now known that a cyclic phosphate is the final product of this enzyme and that water does not enter into the reaction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phosphorylating glyceraldehyde-3-phosphate dehydrogenase found in the CHLOROPLASTS of higher plants. This enzyme exists as an A2B2 heterotetramer and transfers hydrogen to NADP. It plays an important role in catalyzing the reductive step of the Calvin cycle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A photoactivable URIDINE analog that is used as an affinity label.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A photoelectric method of recording an X-ray image on a coated metal plate, using low-energy photon beams, long exposure time and dry chemical developers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, this substance may reasonably be anticipated to be a carcinogen %28%Merck Index, 9th ed%29%. Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A photoprotein isolated from the bioluminescent jellyfish Aequorea. It emits visible light by an intramolecular reaction when a trace amount of calcium ion is added. The light-emitting moiety in the bioluminescence reaction is believed to be 2-amino-3-benzyl-5-%28%p-hydroxyphenyl%29%pyrazine %28%AF-350%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A photoreceptor protein found in retinal rods. It is a complex formed by the binding of RETINALDEHYDE, the oxidized form of retinol, to the protein OPSIN and undergoes a series of complex reactions in response to visible light resulting in the transmission of nerve impulses to the brain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium, such as the aqueous humor, and is used therapeutically as a diagnostic aid in corneal injuries and corneal trauma. It has been approved by FDA for use in externally applied drugs and cosmetics. %28%From Merck Index, 12th ed; American Medical Association Drug Evaluations; 1995, p2275%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of ARCHAEA comprising at least seven classes: Methanobacteria, Methanococci, Halobacteria %28%extreme halophiles%29%, Archaeoglobi %28%sulfate-reducing species%29%, Methanopyri, and the thermophiles: Thermoplasmata, and Thermococci.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus. It includes three classes: Cestoda, Turbellaria, and Trematoda.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of anaerobic, gram-negative bacteria with a chemoorganotrophic heterotrophic metabolism. They are resident flora of the OROPHARYNX.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of anoxygenic, phototrophic, CHLOROBI including the family Chlorobiaceae. They occur in aquatic sediments, sulfur springs, and hot springs and utilize reduced sulfur compounds instead of oxygen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of bacteria comprised of three classes: Bacteroides, Flavobacteria, and Sphingobacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of bacteria consisting of the purple bacteria and their relatives which form a branch of the eubacterial tree. This group of predominantly gram-negative bacteria is classified based on homology of equivalent nucleotide sequences of 16S ribosomal RNA or by hybridization of ribosomal RNA or DNA with 16S and 23S ribosomal RNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of fungi comprising minute intracellular PARASITES with FUNGAL SPORES of unicellular origin. It has two classes: Rudimicrosporea and MICROSPOREA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of fungi that produce their sexual spores %28%basidiospores%29% on the outside of the basidium. It includes forms commonly known as mushrooms, boletes, puffballs, earthstars, stinkhorns, bird%27%s-nest fungi, jelly fungi, bracket or shelf fungi, and rust and smut fungi.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of fungi that was formerly considered a subdivision of Phycomycetes. They are the only fungi that produce motile cells at some stage in their life cycle. Most are saprobes but they also contain examples of plant, animal and fungal pathogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of fungi which have cross-walls or septa in the mycelium. The perfect state is characterized by the formation of a saclike cell %28%ascus%29% containing ascospores. Most pathogenic fungi with a known perfect state belong to this phylum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of fungi, formerly included in the Phycomycetes, usually saprophytic or parasitic, especially for insects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids %28%POLYCHAETA%29%, freshwater annelids, earthworms %28%OLIGOCHAETA%29%, and LEECHES. Only the leeches are of medical interest. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of oxygenic photosynthetic bacteria comprised of unicellular to multicellular bacteria possessing CHLOROPHYLL a and carrying out oxygenic PHOTOSYNTHESIS. Cyanobacteria are the only known organisms capable of fixing both CARBON DIOXIDE %28%in the presence of light%29% and NITROGEN. Cell morphology can include nitrogen-fixing heterocysts and/or resting cells called akinetes. Formerly called blue-green algae, cyanobacteria were traditionally treated as ALGAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of protozoa characterized by the presence of cilia at some time during the life cycle. It comprises three classes: KINETOFRAGMINOPHOREA; OLIGOHYMENOPHOREA; and POLYMENOPHOREA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of protozoa with a single-type nucleus and locomotion by flagella, pseudopodia, or both types of locomotor organelles. It comprises the subphyla MASTIGOPHORA, Opalinata, and SARCODINA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of protozoans in the alveloate clade %28%some authorities prefer to call it an order%29%. They are small endoparasites of marine invertebrates. Spores are structurally complex but without polar filaments or tubes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of radially symmetrical invertebrates characterized by possession of stinging cells called nematocysts. It includes the classes ANTHOZOA; CUBOZOA; HYDROZOA, and SCYPHOZOA. Members carry CNIDARIAN VENOMS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of small sessile aquatic animals living as small tufted colonies. Some appear like hydroids or corals, but their internal structure is more advanced. Most bryozoans are matlike, forming thin encrustations on rocks, shells, or kelp. %28%Storer %26% Stebbins, General Zoology, 6th ed, p443%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of the kingdom Metazoa. Mollusca have soft, unsegmented bodies with an anterior head, a dorsal visceral mass, and a ventral foot. Most are encased in a protective calcareous shell. It includes the classes GASTROPODA; BIVALVIA; CEPHALOPODA; Aplacophora; Scaphopoda; Polyplacophora; and Monoplacophora.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A phylum of the most familiar marine invertebrates. Its class Stelleroidea contains two subclasses, the Asteroidea %28%the STARFISH or sea stars%29% and the Ophiuroidea %28%the brittle stars, also called basket stars and serpent stars%29%. There are 1500 described species of STARFISH found throughout the world. The second class, Echinoidea, contains about 950 species of SEA URCHINS, heart urchins, and sand dollars. A third class, Holothuroidea, comprises about 900 echinoderms known as SEA CUCUMBERS. Echinoderms are used extensively in biological research. %28%From Barnes, Invertebrate Zoology, 5th ed, pp773-826%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A physical examination in which the qualified health care worker inserts a lubricated, gloved finger of one hand into the RECTUM and may use the other hand to press on the lower ABDOMEN or pelvic area to palpate for abnormalities in the lower rectum, and nearby organs or tissues. The method is commonly used to check the lower rectum, the PROSTATE gland in men, and the UTERUS and OVARIES in women.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A physical phenomenon involving electric charges and their effects when at rest and when in motion. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A physiologically active metabolite of VITAMIN D. The compound is involved in the regulation of calcium metabolism, alkaline phosphatase activity, and enhances the calcemic effect of CALCITRIOL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A physiologically inactive constituent of Cannabis sativa L.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A picolinic acid derivative that is used as a herbicide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A picornavirus infection producing symptoms similar to poliomyelitis in pigs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pinkish-yellow portion of the midbrain situated in the rostral mesencephalic tegmentum. It receives a large projection from the contralateral half of the CEREBELLUM via the superior cerebellar peduncle and a projection from the ipsilateral MOTOR CORTEX.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A piperazine derivative with histamine H1-receptor and calcium-channel blocking activity and considerable antiemetic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent %28%NEUROMUSCULAR NONDEPOLARIZING AGENTS%29%. It is used as a muscle relaxant during ANESTHESIA and surgical procedures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A piperidine botanical insecticide. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppresive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pituitary adenoma which secretes ADRENOCORTICOTROPIN, leading to CUSHING DISEASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pituitary adenylate cyclase-activating peptide receptor subtype found in LYMPHOCYTES. It binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE and regulates immune responses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pituitary adenylate cyclase-activating peptide receptor subtype that is found in the HYPOTHALAMUS; BRAIN STEM; PITUITARY GLAND; ADRENAL GLAND; PANCREAS; and TESTES and has a high affinity only for PACAP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pituitary adenylate cyclase-activating polypeptide receptor subtype that binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE. It is found predominately in the BRAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pituitary tumor that secretes GROWTH HORMONE. In humans, excess HUMAN GROWTH HORMONE leads to ACROMEGALY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A placenta that fails to be expelled after BIRTH of the FETUS. A PLACENTA is retained when the UTERUS fails to contract after the delivery of its content, or when the placenta is abnormally attached to the MYOMETRIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plague-like disease of rodents, transmissible to man. It is caused by FRANCISELLA TULARENSIS and is characterized by fever, chills, headache, backache, and weakness.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant division of GYMNOSPERMS consisting of cone-bearing trees and shrubs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant division of seed plants containing only a few members.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant division that includes hornworts, named for the horn-like appearance of the spore-producing plant %28%sporophyte%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant division. They are simple plants that lack vascular tissue and possess rudimentary rootlike organs %28%rhizoids%29%. Like MOSSES, liverworts have alternation of generations between haploid gamete-bearing forms %28%gametophytes%29% and diploid spore-bearing forms %28%sporophytes%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family in the order Linales. These plants have simple leaves and regular flowers housing a compound ovary. Stamens are usually fused by their filaments.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers. Fagara species have been reclassified, most to ZANTHOXYLUM, some to Melicope or GLEDITSIA. The common name of stinkwood used for Zieria is also used for OCOTEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Arales, subclass Arecidae, class Liliopsida %28%monocot%29%. Many members contain OXALIC ACID and calcium oxalate %28%OXALATES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Arales, subclass Arecidae, class Liliopsida %28%monocot%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Aristolochiales subclass Magnoliidae class Magnoliopsida. They are mostly tropical woody vines and a few temperate-zone species. The flowers are 3-parted; some species lack petals while others are large and foul smelling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Bromeliales, subclass Zingiberidae, class Liliopsida %28%monocotyledons%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Campanulales, subclass Asteridae, class Magnoliopsida%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida that are mostly herbs and shrubs growing in warm arid regions. Several produce GLUCOSINOLATES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. It is a small family of herbs and shrubs. Some produce GLUCOSINOLATES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Capparales, subclass Dilleniidae, class Magnoliopsida. They are mostly herbaceous plants with peppery-flavored leaves, due to gluconapin %28%GLUCOSINOLATES%29% and its hydrolysis product butenylisotrhiocyanate. The family includes many plants of economic importance that have been extensively altered and domesticated by humans. Flowers have 4 petals. Podlike fruits contain a number of seeds. Cress is a general term used for many in the Brassicacea family. Rockcress is usually ARABIS; Bittercress is usually CARDAMINE; Yellowcress is usually RORIPPA; Pennycress is usually THLASPI; Watercress refers to NASTURTIUM; or RORIPPA or TROPAEOLUM; Gardencress refers to LEPIDIUM; Indiancress refers to TROPAEOLUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. Some members contain triterpenoid saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. There are no true petals; each flower has two to six sepals. They produce betacyanin and betaxanthin pigments and lack anthocyanins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida, a small family growing in the tropics. Members contain piperidine alkaloids and GLUCOSINOLATES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida. The Hippocratea genus contains friedelanes, triterpenoid quinone, and hippocrateine I.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Celastrales, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29% that are often somewhat succulent. The leaves are alternate, simple, parallel-veined, and usually with a closed sheathing base. The flowers are often in cymes and have 3 petals and 3 sepals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Commelinales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida that is a loose grouping of woody ornamentals: 11 of its 14 genera have been placed in single families by some authorities. Some botanists combine members of NYSSACEAE into this family.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida, consisting of slow-growing evergreen trees common in tropical forests of south India and Burma. Members contain tetrahydroisoquinoline-monoterpene and iridoid glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Cornales, subclass Rosidae, class Magnoliopsida. Some botanical classifications do not recognize this family and place the members in CORNACEAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Cycadales, class Cycadopsida, division CYCADOPHYTA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Dilleniales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. It is sometimes called the teasel family.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida. Members of this family are sometimes classified in CAPRIFOLIACEAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Dipsacales, subclass Asteridae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida that are tropical trees which have elongate latex cells. Several members bear sweet edible fruits and produce triterpenoid saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Ericales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Eucommiales, subclass Hamamelidae, class Magnoliopsida %28%some botanists have classified this in the order Hamamelidales or Urticales%29%. Eucomia is an elmlike tree of central and eastern China. Leaves are alternate; deciduous flowers are solitary and unisexual and lack petals and sepals. The male flowers have 6 to 10 stamens and female flowers have one ovary of two carpels, one of which aborts during development so the fruit %28%a dry, winged structure%29% contains only one seed. The latex is a source of RUBBER. Tochu tea is an aqueous extract of Eucommia ulmoides leaves and a popular beverage in Japan. %28%Mutat Res 1997 Jan 15;388%28%1%29%:7-20%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Euphorbiales, subclass Rosidae, class Magnoliopsida. Leaves are alternate, simple, and leathery. Fruits are one- or two-seeded capsules or drupes %28%stony-pitted fleshy fruits%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Fagales subclass Hamamelidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Fagales, subclass Hamamelidae, class Magnoliopsida. They have simple, serrate, alternate leaves. Male flowers are borne in long, pendulous catkins; the female in shorter, pendulous or erect catkins. The fruit is usually a small nut or a short-winged samara.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida. They have leaflike appendages at the base of the leafstalks, have terminal flower clusters. Petals have four or five overlapping lobes and the fruit is a capsule containing winged or wingless seeds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Gentianales, subclass Asteridae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Geraniales %28%or Ericales in APG system%29%, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Geraniales, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Hamamelidales, subclass Hamamelidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Hydrocharitales, subclass ALISMATIDAE, class Liliopsida %28%monocotyledons%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Hydropteridales, class Filicopsida, division PTERIDOPHYTA. They are aquatic ferns with quatrifoliate leaves resembling four leaf clover, creeping rhizome, and bean shaped sporocarps.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Illiciales, subclass Magnoliidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Lamiales, subclass Asteridae, class Magnoliopsida. The leaves are opposite or whorled. The flowers are aggregated in spikes, clusters, or racemes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida. Members contain cytotoxic furofuran LIGNANS and isoquinoline ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Laurales, subclass Magnoliidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Lecythidales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Liliales %28%or by some as Dioscoreales or Burmanniales%29%, subclass Liliidae, class Liliopsida %28%monocotyledons%29%. They are perennial saprophytic plants obtaining their carbon from FUNGI.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledon%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%. Most species are perennials, native primarily to tropical America. They have creeping rootstocks, fibrous roots, and leaves in clusters at the base of the plant or borne on branched stems. The fruit is a capsule containing many seeds, or a one-seeded winged structure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Liliales, subclass Liliidae, class Liliopsida. Members of the family have narrow, lance-shaped, sometimes fleshy or toothed leaves that are clustered at the base of each plant. Most species have large flower clusters containing many flowers. The fruit is a capsule or berry.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Linales, subclass Rosidae, class Magnoliopsida best known for the coca plant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals %28%sepals and petals that are not distinctly different%29% and many spirally arranged stamens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. The wood lacks water-conducting cells but has acrid sap. The leaves are gland-dotted, leathery, and smooth-margined. The flowers are small, in clusters, with two to six sepals, petals in two or more series, several stamens, and one to several carpels.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida of tropical trees.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida. The leaves of Sterculiaceae are alternate and simple or palmately compound. Flowers have three to five sepals and five or no petals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Malvales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Myricales, subclass Hamamelidae, class Magnoliopsida. They are trees and shrubs having aromatic leaves that often have yellow glandular dots on the surface. Single-seeded fruits are often covered with waxy granules, bumps, or layers. The flowers are small, greenish, and inconspicuous.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida composed of tropical plants with parallel-nerved leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida that is a small family with a single genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mainly trees and shrubs. Many members contain mucilage and COUMARINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Myrtales, subclass Rosidae, class Magnoliopsida. They are mostly trees and shrubs growing in warm areas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Najadales, subclass ALISMATIDAE, class Liliopsida %28%monocotyledons%29%. This is a group of perennial aquatic herbs with basal leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Najadales, subclass Alismatidae, class Liliopsida %28%monocotyledons%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Nepenthales, subclass Dilleniidae, class Magnoliopsida, notable for leaves with sticky gland-tipped hairs that entrap insects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Nymphaeales, subclass Magnoliidae, class Magnoliopsida. They are aquatic plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Orchidales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%. All orchids have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Pandanales, subclass Arecidae, class Liliopsida %28%monocotyledons%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Pinales, class Pinopsida, division Coniferophyta %28%conifers%29%. They are mainly resinous, aromatic evergreen trees.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Pinales, class Pinopsida, division Coniferophyta, known for the various conifers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Piperales, subclass Magnoliidae class Magnoliopsida. Members contain sauristolactam, and aristololactam BII.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Plumbaginales, subclass Caryophyllidae, class Magnoliopsida of shrubs and herbs. Some members contain anthocyanins and naphthaquinones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Polygalales, subclass Rosidae class, Magnoliopsida that are mostly shrubs and small trees. Many of the members contain indole alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Polygalales, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Polypodiales, class Filicopsida, division Pteridophyta %28%FERNS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Primulales, subclass Dilleniidae, class Magnoliopsida. The flowers have both stamens and pistil, and the fruits are capsules.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Primulales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Proteales, subclass Rosidae class Magnoliopsida. Cluster roots, bottlebrush-like clusters of rootlets which form in response to poor soil, are common in this family.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida that are tropical plants. The flowers are usually bisexual and have 5 sepals and petals; 5 or 10 stamens; and 1, 4, or usually 5 separate, one-chambered, female ovule-bearing structures %28%carpels%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida. They are deciduous woody shrubs with alternate leaves. The flowers are in terminal racemes with 5 petals and 5 stamens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order ROSALES, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. Members are mostly vines and shrubs and they contain isoquinoline alkaloids, some of which have been used as arrow poisons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Rhamnales, subclass Rosidae class Magnoliopsida. The plants have a characteristic silvery or rusty-colored sheen, caused by tiny distinctive scales. Flowers have a tubular structure of four sepals. Root nodules host the Frankia %28%ACTINOMYCETES%29% nitrogen-fixing symbionts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Rhamnales, subclass Rosidae, class Magnoliopsida, best known for the VITIS genus, the source of grapes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Rhizophorales, subclass Rosidae, class Magnoliopsida, that includes mangrove trees.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Salicales, subclass Dilleniidae, class Magnoliopsida. The leaves are alternate and simple. Staminate %28%male%29% flowers consist of from one to many stamens. Pistillate %28%female%29% flowers consist of a one-chambered ovary with several to many ovules %28%potential silky seeds%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are parasites that form connections %28%haustoria%29% to their hosts to obtain water and nutrients. The one-seeded fruit may be surrounded by a brightly colored nut-like structure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Santalales, subclass Rosidae, class Magnoliopsida. They are root parasites lacking CHLOROPHYLL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida which is a small family of small trees and shrubs growing in arid and warm regions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. They are resinous trees and shrubs with alternate leaves composed of many leaflets.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are alternate and compound. Most have small flowers, bitter bark, and fleshy fruits that are sometimes winged. Members contain QUASSINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida. Leaves are opposite and usually toothed or lobed. The fruit, a samara %28%a winged nutlet%29%, splits into two %28%rarely three%29% winged, one-seeded parts. This family is widely distributed in the Northern Hemisphere.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Sapindales, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Scrophulariales subclass Asteridae, class Magnoliopsida. The leaves are usually opposite and the flowers usually have four sepals, four petals, two stamens, and two fused carpels that form a single superior ovary.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida. It is characterized by simple leaves in opposite pairs, cystoliths %28%enlarged cells containing crystals of calcium carbonate%29%, and bilaterally symmetrical and bisexual flowers that are usually crowded together. The common name for Ruellia of wild petunia is easily confused with PETUNIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida. The family is characterized by oppositely paired, usually compound leaves and bell- or funnel-shaped, bisexual flowers having a five-lobed calyx and corolla.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Scrophulariales, subclass Asteridae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Selaginellales, class Lycopodiopsida, division Lycopodiophyta, subkingdom Tracheobionta. Members contain bilobetin. The rarely used common name of resurrection plant is mainly used with CRATEROSTIGMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Solanales, subclass Asteridae. Among the most important are POTATOES; TOMATOES; CAPSICUM %28%green and red peppers%29%; TOBACCO; and BELLADONNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida that have evergreen, alternate leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida, best known for CAMELLIA SINENSIS, which is the source of Oriental TEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Taxales, class Pinopsida, division CONIFEROPHYTA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Theales, subclass Dilleniidae, class Magnoliopsida. It is best known for Kiwi fruit %28%ACTINIDIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Typhales, subclass Commelinidae, class Liliopsida %28%monocotyledons%29% that contains a single genus, Typha, that grows worldwide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. It is most notable for the members, Cannabis and Hops.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida. Members are trees and shrubs of temperate regions that have watery sap and alternate leaves which are lopsided at the base. The flowers lack petals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Urticales, subclass Hamamelidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Violales %28%by some in Begoniales%29%, subclass Dilleniidae, class Magnoliopsida. Members are found throughout tropical and warm temperate habitats. Most are perennial herbs with monoecious flowers %28%both sexes on the same plant%29%. Fruits are usually capsules containing many tiny seeds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Violales, subclass Dilleniidae class Magnoliopsida. Members contain naphthylisoquinolines which inhibit PLASMODIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida that are herbaceous or woody vines, shrubs, and trees, mostly of warm regions. Many have tendrils in leaf axils. Leaves are alternate. Flowers have 3-5 sepals, petals and stamens. Nearly all species have seeds that bear a fleshy appendage called an aril.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. Bixa contains bixin. Cochlospermum contains arjunolic acid and gum kondagogu %28%POLYSACCHARIDES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida. The common name of rock rose is used with several plants of this family.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Violales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida best known for banana %28%MUSA%29%. The slender false trunk, formed by leaf sheaths of the spirally arranged leaves, may rise to 15 meters %28%50 feet%29%. There is a crown of large leaves at the top.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida. Some species in this genus are called bird-of-paradise which is also a common name for CAESALPINIA and Heliconia %28%HELICONIACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order ZINGIBERALES, subclass Zingiberidae, class Liliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric %28%CURCUMA%29%, and cardamom %28%ELETTARIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant family of the subclass ALISMATIDAE, class Liliopsida %28%monocotyledons%29% of aquatic plants. The flower parts are in threes with 3 green sepals and 3 white or yellow petals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus best known for edible underground tubers. Yam may also refer to a moist variety of sweet potato, IPOMOEA BATATAS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the ANACARDIACEAE family known for the Pistachio nuts and for gum Mastic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the ASTERACEAE family. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the CANNABACEAE family. Best known for the buds of Humulus lupulus L. used in BEER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the CHENOPODIACEAE family. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. Laurus nobilis L. leaves are known for use in SPICES, having a similar flavor as UMBELLULARIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. Lindera benzoin is a source of a balsamic resin called benzoin which is up to 1/3 BENZOIC ACID. This should not be confused with the chemical BENZOIN or the plant STYRAX BENZOIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. The tree, Persea americana Mill., is known for the Avocado fruit, the food of commerce.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. The bark of the trees is used in FOLK MEDICINE and FLAVORING AGENTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. The common name of stinkwood is also used for Zieria %28%RUTACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. The tree bark has been used medicinally.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the LAURACEAE family. The tree, Umbellularia californica %28%Hook. %26% Arn.%29% Nutt., is known for aromatic leaves used in SPICES having a similar flavor to LAURUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ACANTHACEAE. Adhatoda vasica Nees is a source of vasicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family APIACEAE %28%Umbelliferae%29% that is used in SPICES and is a source of anethole.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is best known as an adaptogen and a substitute for ginseng.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It includes Aralia californica S. Watson, Aralia nudicaulis L., and Aralia racemosa L.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ARALIACEAE, order Apiales, subclass Rosidae. It is the source of cirensenosides %28%triterpenoid saponins%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ARECACEAE, order Arecales, subclass Arecidae. The fruit or the extract %28%Permixon%29% is used for PROSTATIC HYPERPLASIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family BERBERIDACEAE. Oregon Grape was discovered in North America and classified by Pursh as a BERBERIS but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Now botanists insist on Berberis while horticulturists stay with this genus. It is a source of BERBERINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family BERBERIDACEAE. The common names of Barberry or Oregon Grape are also used for MAHONIA. The similar-named Bayberry is the unrelated MYRICA. Oregon Grape was classified by Pursh as a Berberis but Nuttall claimed it is different enough to call it a new genus, MAHONIA. Botanists insist on this name while horticulturists stay with Mahonia. They are shrubs with yellow wood and usually three-branched spines at the base of leafstalks. Flowers are yellow, six-petaled and fruit is a berry with one to several seeds. Members contain BERBERINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family Boraginaceae, order Lamiales, subclass Asteridae. This is the True Heliotrope that should not be confused with an unrelated plant sometimes called Garden Heliotrope %28%VALERIAN%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family CAPRIFOLIACEAE best known for elderberries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family CAPRIFOLIACEAE. The common name derives from its traditional use for menstrual cramps. It is a source of viburnine, valerianic acid, vibsanin, and ursolic acid. Note that true cranberry is VACCINIUM MACROCARPON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family CONVOLVULACEAE best known for morning glories %28%a common name also used with CONVOLVULUS%29% and sweet potato.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family FABACEAE known for LATHYRISM poisoning.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family FABACEAE which is the source of edible beans and the lectin PHYTOHEMAGGLUTININS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family FABACEAE, subfamily Papilionaceae, order Fabales, subclass Rosidae. Many of the species are associated with poisoning of grazing animals. Some of the species are used medicinally.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family LILIACEAE %28%sometimes classified as Amaryllidaceae%29%. Galanthus nivalis L. is the source of GALANTHAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family LILIACEAE %28%sometimes placed in Asparagaceae%29% that contains ECDYSTEROIDS and is an ingredient of Siotone. The shoots are used as a vegetable and the roots are used in FOLK MEDICINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family LILIACEAE generally growing in temperate areas. The word lily is also used in the common names of many plants of other genera that resemble true lilies. True lilies are erect perennial plants with leafy stems, scaly bulbs, usually narrow leaves, and solitary or clustered flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family MYRTACEAE, order Myrtales, subclass Rosidae. It is best known for allspice from the dried berry of Pimenta diocia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family MYRTACEAE, order Myrtales, subclass Rosidae. It is best known for cloves, which is the flower bud that is the source of an oil rich in EUGENOL. The botanical name has varied: Syzygium aromaticum %28%L.%29% Merr. %26% L. M. Perry = Eugenia caryophyllata Thunb. = Caryophyllus aromaticus L. The Eugenia-Syzygium name is discussed in Amer. J. Bot 59:423 1972.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PAPAVERACEAE, order Papaverales, subclass Magnoliidae.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. It is the source of cedarwood oil. Cedar ordinarily refers to this but also forms part of the name of plants in other genera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are coniferous evergreen trees and should not be confused with hemlock plants %28%CICUTA and CONIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are coniferous evergreen trees with long, flat, spirally arranged needles that grow directly from the branch.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen trees mainly in temperate climates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves is jointed near the stem on a separate woody base.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. Balm of Gilead is a common name more often referring to POPULUS and sometimes to COMMIPHORA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ROSACEAE and order Rosales. This should not be confused with the genus RHODIOLA which is sometimes called roseroot.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of edible fruits such as apricot, plum, peach, cherry, and almond.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of the edible fruit %28%apple%29% and is cultivated in temperate climates worldwide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family THEACEAE, order THEALES best known for CAMELLIA SINENSIS which is the source of Oriental TEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family VISCACEAE, order Santalales, subclass Rosidae, class Magnoliopsida. Species of this genus contain cytotoxic LECTINS. The common name of MISTLETOE is used for many species of this and the LORANTHACEAE families.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family VISCACEAE, order Santalales, subclass Rosidae. Members contain phoratoxin and oleanane TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus in the family VITACEAE, order Rhamnales, subclass Rosidae. It is a woody vine cultivated worldwide. It is best known for grapes, the edible fruit and used to make WINE and raisins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of subsucculent annual or perennial plants in the family BALSAMINACEAE, order Geraniales.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the APOCYNACEAE or dogbane family. Alkaloids from plants in this genus have been used as tranquilizers and antihypertensive agents. RESERPINE is derived from R. serpentina.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the DIOSCOREACEAE plant family. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the FABACEAE family known for the seeds used as food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the LAMIACEAE family that contains marrubiin %28%a labdane diterpene%29%. It is known as a traditional medicinal for sore throat.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the LAMIACEAE family. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the LAMIACEAE family. It is known as a spice and medicinal plant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ACANTHACEAE. Members contain andrographolide and other DITERPENES and androechin, a CHALCONE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ACERACEAE, best known for trees with palmately lobed leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ACORACEAE, order Arales, subclass Arecidae most notable for Acorus calamus L. root which contains asarone and has been used in traditional medicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family AIZOACEAE. It is a native of Africa and widely planted for erosion control to stabilize soil along roadsides and beaches.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ALISMATACEAE that grows in salty marshes and is used for phytoremediation of oil spills. The unisexual flowers have 3 sepals and 3 petals. Members contain trifoliones %28%DITERPENES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ALISMATACEAE. The flowers have 3 green sepals, 3 yellow and white petals, 6 stamens, and several pistils. Members contain TRITERPENES and SESQUITERPENES. Alisma is a component of tokishakuyakusan. Some species in this genus are called water plantain which is also a common name for other ALISMATACEAE plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family AMARANTHACEAE, order Caryophyllales, which has been used in traditional medicine %28%MEDICINE, CHINESE TRADITIONAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family AMARANTHACEAE. Young leaves are used as vegetables in Asia. Members contain betacyanins, celogentins, betaxanthin, and celosian.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANACARDIACEAE best known for the edible fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANACARDIACEAE that is the source of anacarcin forte. The nut milk extract is cytotoxic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANACARDIACEAE. This is the source of the familiar cashew nuts, which are heat treated to remove the irritant toxin. Cashew nut shell liquid %28%frequently abbreviated as CNSL%29% is a major source of alkenyl phenolic compounds, especially ANACARDIC ACIDS, cardol, and cardanol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain acetogenins and benzoquinazoline and other alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANNONACEAE. It has edible fruit and seeds which contain asitrocin, asitrilobins, and other tetrahydrofuran acetogenins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANNONACEAE. Members contain 8-oxopolyalthiaine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANNONACEAE. Members contain aporphines, acetogenins and rollinone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANNONACEAE. Members contain asarone, isoguattouregidine %28%an isoquinoline alkaloid%29%, norlaureline, puterine, noraporphine alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ANNONACEAE. Members contain uvarigrin, uvarigrandin, chamuvaritin and other acetogenins and benzylisoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE that is a source of coniine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE that is sometimes called Hemlock Water Dropwort but should not be confused with HEMLOCK. It contains enanthotoxin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE that is the source of bupleurum root and of bupleurotoxin and is an ingredient of sho-saiko-to.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE used for flavoring food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE used in SPICES. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. It contains pungent oils and resins. It is used to flavor curries, as a carminative, and as cat and dog repellent. The occasionally used common name of %27%giant fennel%27% should not be confused with true fennel %28%FOENICULUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. It is a source of cicutoxin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. Members contain COUMARINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. Members contain SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. Members contain osthol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. The leaves are the source of cilantro and the seeds are the source of coriander, both of which are used in SPICES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. The roots are used as food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APIACEAE. The seed is used in SPICES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE that contains OUABAIN cardiac glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE that contains bisindole alkaloids and IBOGAINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. Vinca rosea has been changed to CATHARANTHUS roseus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. It contains ellipticine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. It is a very poisonous plant that contains cardioactive agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. It is rarely called Milkweed, but should not be confused with true Milkweed %28%ASCLEPIAS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. Members contain echitovenidine, echitamine, venenatine %28%an indole alkaloid%29%, and anti-inflammatory triterpenoids%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. Members contain holarrhenine %28%a steroidal alkaloid%29% and TRICHOTHECENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. Members contain thevetin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. Members contain voacangine and other INDOLES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family APOCYNACEAE. Species of this genus contain YOHIMBINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family AQUIFOLIACEAE. The common name of %27%holly%27% usually refers to this genus but may sometimes refer to similar looking plants of the MAHONIA or QUERCUS genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE that contains pinellian %28%an acidic polysaccharide%29%. The plant is an ingredient of some traditional Asian medicinal mixtures including sho-saiko-to, saiko-keishi-to, and banxia houpu decoction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE that may be confused with other ARACEAE having similar common names.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. The common names of %27%Coco Yam%27% %28%Cocoyam%29% or %27%Elephant%27%s Ear%27% may be confused with COLOCASIA and other ARACEAE or with common yam %28%DIOSCOREA%29%. It contains LECTINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. As a houseplant it sometimes poisons children and animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. Calla Lily %28%Callalily%29% also refers to the ZANTEDESCHIA. There is no relationship with CALLA ANTIGEN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. It has a stemless, tuberous root.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. Members contain acrid calcium oxalate and LECTINS. Polynesians prepare the root into poi. Common names of Taro and Coco Yam %28%Cocoyam%29% may be confused with other ARACEAE; XANTHOSOMA; or with common yam %28%DIOSCOREA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. Members contain beta-glucosidases and trypsin inhibitors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. Members contain konjac glucomannan %28%MANNANS%29% and SEROTONIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. The common name of Calla Lily or Callalily also refers to the Calla genus %28%CALLA PLANT%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARACEAE. The name derived from ar %28%fire in Arabic%29% due to the irritating sap. Flower is a spathe.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARALIACEAE. Ciwujia extract, which is prepared from plants of this genus, contains ciwujianosides and is used to enhance PHYSICAL ENDURANCE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARALIACEAE. Members contain hederin %28%olean-12-ene%29% type TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARALIACEAE. Members contain triterpene saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARECACEAE that should not be confused with ACORUS CALAMUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARECACEAE. It is a tropical palm tree that yields a large, edible hard-shelled fruit from which oil and fiber are also obtained.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARECACEAE. Members contain ARECOLINE and CATECHIN. The leaves and nuts have been used as masticatories, stimulants, and astringents in traditional medicine. The common name of betel is also used for PIPER BETLE. The common name of catechu is sometimes used for ACACIA CATECHU.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARISTOLOCHIACEAE which was used medicinally by North American Indians. The common name of %27%snakeroot%27% is also used for many other plants, including SANICULA; or ARISTOLOCHIA; or Polygala.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ARISTOLOCHIACEAE. Species of this genus have been used in traditional medicine but they contain aristolochic acid which is associated with nephropathy. These are sometimes called %27%snakeroot%27% but that name is also used with a number of other plants such as POLYGALA; SANICULA; ASARUM; ARISTOLOCHIA; AGERATINA; and others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. It is a source of PREGNANES. It is sometimes an adulterant of commercial sarsaparilla.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. It is a source of periplocosides %28%pregnane steroid glycosides%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. Members contain phenanthro-indolizidine alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. Members contain pregnane glycosides %28%marsdekoiside %26% marstomentosides, maryal%29% and hainaneosides %28%SAPONINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. Members contain steroidal glycosides and cytotoxic phenanthroindolizidine N-oxide alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. Members contain the alkaloids quindoline, CSA-3, cryptolepine, and neocryptolepine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. The downy akund floss fiber from the seeds is used like kapok.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASCLEPIADACEAE. This is the true milkweed; APOCYNUM %26% EUPHORBIA hirta are rarely called milkweed. Asclepias asthmatica has been changed to TYLOPHORA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE known for allergenic pollen %28%ALLERGENS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that causes vermeersiekte poisoning of sheep in South Africa. Members contain dihydrogriesenin and ivalin %28%sesquiterpene lactones%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that contains PYRROLIZIDINE ALKALOIDS. Yellow vein disease of Ageratum is caused by a viral DNA complex of a begomovirus %28%GEMINIVIRIDAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that contains antifungal plant defensin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that contains phenyl propanoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that has long been used in folk medicine for treating wounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that is similar to CONYZA. Members contain SESQUITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that is similar to MATRICARIA but this has tiny chaffy bract scales between each pair of florets. Members contain sesquiterpene lactones. Other plants with similar common names include FERULA; FOENICULUM; MATRICARIA; CHAMAEMELUM and TRIPLEUROSPERMUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that is the primary plant source of KHELLIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that is used for experiments in molecular genetic studies in plant physiology and development.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE that is used in folk medicine as CHAMOMILE. Other plants with similar common names include MATRICARIA; TRIPLEUROSPERMUM and ANTHEMIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE with a name that is similar to CYNARA SCOLYMUS. Members contain taraxasteryl acetate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE with strong-smelling foliage. It is a source of SANTONIN and other cytotoxic TERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE, order Asterales, subclass Asteridae. It is a source of costus root oil and should not be confused with the genus COSTUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Flower buds contain farfaratin %28%SESQUITERPENES%29% and bisabolene epoxide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. It is easily confused with related plants with similar common names of Chamomile and Mayweed %28%MATRICARIA; CHAMAEMELUM; and ANTHEMIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Sesquiterpene lactone glucosides %28%SESQUITERPENES%29% have been found in it.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The POLLEN is one cause of HAYFEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. This plant should not be confused with microtubule asters %28%MICROTUBULES%29% nor with aster yellows phytoplasma %28%mycoplasma-like organisms%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Arctiin %28%LIGNANS%29% is in the seed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. ECDYSONE has been found in seeds of some members.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. INULIN and SESQUITERPENES have been found in it.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Ingestion has been associated with MILK SICKNESS. The common name of thoroughwort is also used for other plants including CHROMOLAENA; Hebeclinium, and Koanophyllon.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. M. chamomilla appears similar to Anthemis but this flower disk is conical and hollow and lacks chaffy bract scales and the odor is weaker. The common name of %27%manzanilla%27% is confused with other meanings of the word. %27%Matricaria chamomilla sensu%27% is classified by some as Tripleurospermum perforata. Other plants with similar common names include CHAMAEMELUM; TRIPLEUROSPERMUM and ANTHEMIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Many of the member species have been reclassified to other genera such as Machaeranthera, Isocoma, Ericameria, etc. Ingestion of the plant has been associated with MILK SICKNESS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain 5-methyl-8-hydroxycoumarin. The common name of centaury is more often used for CENTAURIUM%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE which inhibits ADENINE NUCLEOTIDE TRANSLOCASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain ATRACTYLOSIDE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain CAROTENOIDS, essential oils %28%OILS, VOLATILE%29%, flavonoids, mucilage, SAPONINS, and STEROLS. The plants are used both topically and internally. The common name of Marigold is also used for TAGETES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain CHALCONE, helichrysetin, arenarin, and flamin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain INULIN, alantol, helenin, alantic acid, and acrid resin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain SESQUITERPENES. The common name of sweet coltsfoot is similar to the common name for TUSSILAGO.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain TERPENES and achyrofuran, a prenylated dibenzofuran %28%BENZOFURANS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain a pseudoguaiane sesquiterpene. San-fang-feng is the root of E. grijisii used in DRUGS, CHINESE HERBAL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain alkenynes, daucosterol, friedelinol, conyzasaponins and other TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain arctiin and onopordopicrin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain bidensyneosides %28%polyacetylene glucosides%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain chicoric and chlorogenic acids and germacrane- and eudesmane-type SESQUITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain cnicin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain eudesmane and elemane SESQUITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain galegine %28%GUANIDINES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain germacrane and sesquiterpene LACTONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain hinesol and atractylon. Atractylodes rhizome is Byaku-jutsu. A. lancea rhizome is So-jutsu.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain pectolinarin %28%a flavonoid glycoside%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain scandenolide %28%a sesquiterpene lactone%29% and germacranolides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain sesquiterpene lactones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain stevioside and other sweet diterpene glycosides. The leaf is used for sweetening %28%SWEETENING AGENTS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain triterpenoid sapogenins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain wedelolactone and wedeloside.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Members contain wedelolactone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Oil from the seed %28%SAFFLOWER OIL%29% is an important food oil of commerce.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Other plants called broom include CYTISUS; SPARTIUM; and BROMUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Some Rudbeckia species have been reclassified to ECHINACEA; RATIBIDA; or HELIANTHUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Some species of the CHRYSANTHEMUM and the old Pyrethrum genera have been reclassified to this genus. The common name of tansy usually refers to this but also forms part of the common name of other plants such as Tansy Ragwort %28%SENECIO%29% and Tansyaster %28%HAPLOPAPPUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. Steroidal activity has been observed in animals. Members of this genus contain sesquiterpene lactones such as tomentosin, OXEPINS such as zoapatanol, and kaurene type DITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The common name of cudweed is also used for other plants including Evax, Hesperevax, Pseudognaphalium, and Omalotheca. The common name of everlasting is also used for other plants including Anaphalis, Antennaria, HELICHRYSUM, Gamochaeta, and Pseudognaphalium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The common name of marigold is also used for CALENDULA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The common name of snakeroot is also used for POLYGALA; SANICULA; ARISTOLOCHIA and others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The common name of thoroughwort is also used for other plants including EUPATORIUM; CHROMOLAENA, Hebeclinium and Koanophyllon. Eupolin is the aqueous extract of the leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The common names of daisy or marguerite are easily confused with other plants. Some species in this genus have been reclassified to TANACETUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The dried flower heads of Arnica montana are used externally as a counterirritant and tincture for sprains and bruises, either as crude extract or in homeopathic dilution %28%HOMEOPATHY%29%. Arnica contains volatile oils %28%OILS, VOLATILE%29%, arnicin, arnisterol, FLAVONOIDS; TANNINS; and resin. The common name of Wolf%27%s Bane is similar to the common name for ACONITUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The name %22%prickly burweed%22% is sometimes used but causes confusion with AMSINCKIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ASTERACEAE. The root and shoots have been used for food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Aloeaceae, order Liliales %28%or Asphodelaceae, Asparagales in APG system%29% which is used medicinally. It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin %28%EMODIN%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Anacardiaceae, order Sapindales, subclass Rosidae. It is a source of gallotannin %28%TANNIC ACID%29% and of somewhat edible fruit. Do not confuse with TOXICODENDRON which used to be part of this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Apiaceae. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Apiaceae. Commonly called snakeroot but that name is used for many other plants such as ASARUM; ARISTOLOCHIA; and Polygala.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Apiaceae. The seeds are used as flavoring.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Apocynaceae. It is the source of VINCA ALKALOIDS, used in leukemia chemotherapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Apocynaceae. Species of this genus contain 9-methoxyellipticine %28%ELLIPTICINES%29% which is the basis of one of the classes of ANTINEOPLASTIC AGENTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BALANOPHORACEAE. Members contain stigmastanes and ursanes %28%TRITERPENES%29% and lignan glucopyranosides %28%LIGNANS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BERBERIDACEAE %28%sometimes classified as Leonticaceae%29%, most notably Caulophyllum thalictroides %28%L.%29% Michx.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BERBERIDACEAE which is used in DRUGS, CHINESE HERBAL. Members contain flavonol glycosides including epimedins, icariin and noricariin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BETULACEAE known for the edible nuts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BETULACEAE that is distinguished from birch %28%BETULA%29% by its usually stalked winter buds and by cones that remain on the branches after the small, winged nutlets are released.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BETULACEAE. The tree has smooth, resinous, varicolored or white bark, marked by horizontal pores %28%lenticels%29%, which usually peels horizontally in thin sheets.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BIGNONIACEAE that is a source of lapachol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BOMBACACEAE that is used for FOOD and MEDICINE, TRADITIONAL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used for floatation, stuffing, and insulation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BOMBACACEAE. The fine silky hairs covering the seeds have been used like kapok %28%CEIBA%29% for floatation, stuffing, and insulation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BORAGINACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BORAGINACEAE. Members contain GAMMA-LINOLENIC ACID and PYRROLIZIDINE ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BORAGINACEAE. Members contain PYRROLIZIDINE ALKALOIDS. The common name of burweed is also used for Triumfetta %28%TILIACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BORAGINACEAE. Members contain TRITERPENES and naphthoxirene.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BORAGINACEAE. Members contain lithospermans and lithospermic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE growing in Peru mountains. It is the source of maca root.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE known for its peppery red root.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE known for the root used in hot SPICES and is the source of HORSERADISH PEROXIDASE which is widely used in laboratories.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE that contains ARABIDOPSIS PROTEINS and MADS DOMAIN PROTEINS. The species A. thaliana is used for experiments in classical plant genetics as well as molecular genetic studies in plant physiology, biochemistry, and development.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE that includes several marshy plants. The common name of watercress is also used for NASTURTIUM %26% TROPAEOLUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE that is an ingredient of the preparation PC-SPES that is used to treat PROSTATIC HYPERPLASIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE that is grown in rock gardens. T. arvense is grown for its large, round ornamental seed pods. The common name of pennycress usually refers to this genus but may also refer to the genus Microthlaspi.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE that is low-growing in damp meadows of the Northern Hemisphere and has pinnately divided leaves and small white to rose flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE used for its hot peppery root.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE. Member species are ornamentals grown for their numerous small white, yellow, pink, or purplish flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE. Members contain crambin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE. Members contain glucobrassicin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE. Nasturtium is also used as a common name for TROPAEOLUM. The common name of watercress is also used for RORIPPA %26% TROPAEOLUM. This is the most popular of the edible cresses, is a hardy creeping perennial plant, native to Europe but extensively naturalized elsewhere in moist places.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE. Some members contain CARDIAC GLYCOSIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BRASSICACEAE. The common name of white mustard sometimes refers to other plants %28%MUSTARD PLANT%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BROMELIACEAE known for the edible fruit that is the source of BROMELAINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BROMELIACEAE. Members contain 3-methoxy-5-hydroxyflavonols.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BROMELIACEAE. Members contain karatasin and balansain %28%ENDOPEPTIDASES%29% and BROMELAINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BURSERACEAE used medicinally since ancient times. It is a source of salai guggal %28%the gum resin%29% and boswellic acid %28%ursane type TRITERPENES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BURSERACEAE which is a source of gugulipid and guggulu extract. Balm of Gilead is a common name more often referring to POPULUS and sometimes to ABIES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BURSERACEAE. Members contain a PODOPHYLLOTOXIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BUXACEAE that should not be confused with common spurge %28%EUPHORBIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family BUXACEAE. Members contain steroidal alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CACTACEAE. Species with cylindrical joints are called Cholla; flat jointed ones are Prickly-pear.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAMPANULACEAE that contains platycodin and other triterpenoid SAPONINS. It is a constituent of kikyo-to %28%MEDICINE, KAMPO%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAMPANULACEAE used medicinally and is a source of LOBELINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAMPANULACEAE. The common name of bellflower may sometimes be confused with other plants in the family that have similar appearance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAPPARACEAE that contains cleogynol and 15alpha-acetoxycleomblynol %28%dammaranes%29% and 1-epibrachyacarpone %28%a triterpene%29%, and ISOTHIOCYANATES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAPPARACEAE that contains mabinlin, a sweet protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAPRIFOLIACEAE. Members contain iridoid glucosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CAPRIFOLIACEAE. The common name of %22%snowberry%22% is also used for GAULTHERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE that contains ALLANTOIN and a ribosome-inactivating protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE. Members contain dianthins, which are ribosome inactivating proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE. The common name %22%Campion%22% is also used with SILENE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE. The common name %22%Soapwort%22% is also used with SAPONARIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE. The common name of campion is also used with LYCHNIS. The common name of %27%pink%27% can be confused with other plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CARYOPHYLLACEAE. The common name of sandwort is used with other plants. Do not confuse with Arenaria bird or with other genera which use arenaria as the species name such as Mya arenaria %28%softshell clam%29% or Meloidogyne arenaria, or Ammophila arenaria %28%marram grass%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CECROPIACEAE. Hypotensive and hypoglycemic effects have been observed in animals after ingesting members of this genus. There is no relation to cecropia moth %28%Hyalophora cecropia%29% see MOTHS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CELASTRACEAE that contains insecticidal sesquiterpenoids and celastrus oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CELASTRACEAE that is a source of triterpenoids and diterpene epoxides such as triptolide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CELASTRACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CELASTRACEAE. The leafy stems of khat are chewed by some individuals for stimulating effect. Members contain %28%%28%+%29%-norpseudoephedrine%29%, cathionine, cathedulin, cathinine %26% cathidine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CELASTRACEAE. Members contain friedelane-type TRITERPENES and SESQUITERPENES, EUDESMANE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CHENOPODIACEAE. The extract may be called lochein. Tumbleweed may occasionally refer to AMARANTHUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CISTACEAE. The common name of rock rose is also sometimes used with the closely related Helianthemum genus %28%CISTACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CLUSIACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CLUSIACEAE. It is the source of the mangosteen fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CLUSIACEAE. Members contain benzophenones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CLUSIACEAE. Members contain costatolide, calanolides and 4-phenylfuranocoumarins %28%PSORALENS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CLUSIACEAE. Members contain xanthones and BENZOPHENONES. The common name of Mamey is also used with POUTERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family COMBRETACEAE. Members contain arjunin, an ellagitannin %28%TANNINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family COMBRETACEAE. Triterpenes and combretastatin have been identified in members of this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family COMMELINACEAE of perennial herbs with blue flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family COMMELINACEAE that is used in genotoxic bioassays.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CONVOLVULACEAE. Members contain bonaspectins %28%tetrahydrofuran-type sesqui-lignans%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CONVOLVULACEAE. Members contain calystegine and calystegins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CONVOLVULACEAE. The common name of morning glory also refers to IPOMOEA. The common name of bindweed also refers to IPOMOEA; CALYSTEGIA; or POLYGONUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CORNACEAE. It is widely cultivated for the attractive flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CRASSULACEAE. Members contain bryophyllins %28%also called bryotoxins%29% which are bufadienolides %28%BUFANOLIDES%29% that have insecticidal activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CRASSULACEAE. Members contain rhodioloside. This roseroot is unrelated to the familiar rose %28%ROSA%29%. Some species in this genus are called stonecrop which is also a common name for SEDUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CRASSULACEAE. Some species in this genus are called stonecrop which is also a common name for RHODIOLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CRUCIFERAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE known for the edible fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE known for the fruit which is the source of the luffa sponge and the seeds which contain luffin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE that is the source of bryodin 1 %28%a ribosome-inactivating protein%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae best known for cucumber %28%CUCUMIS SATIVUS%29% and cantaloupe %28%CUCUMIS MELO%29%. Watermelon is a different genus, CITRULLUS. Bitter melon may refer to MOMORDICA or this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE, order Violales, subclass Dilleniidae, which includes pumpkin, gourd and squash.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE. It is a source of momordin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUCURBITACEAE. It is a source of gypenosides and triterpenoid SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUPRESSACEAE which should not be confused with other cedar and cypress trees of THUJA or CUPRESSUS genera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUPRESSACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUPRESSACEAE. Cypress ordinarily refers to this but also forms part of the name of plants in other genera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUPRESSACEAE. The species are slow growing coniferous evergreen trees or shrubs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CUPRESSACEAE. The common name of %27%Cedar%27% makes this easily confused with other trees using that name including cedrus, JUNIPERUS; and CHAMAECYPARIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CYPERACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CYPERACEAE. SESQUITERPENES are found in some of the species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family CYPERACEAE. The seed contains oligostilbenes %28%STILBENES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Caricaceae, order Violales, subclass Dilleniidae, class Magnoliopsida. It is the source of edible fruit and PAPAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Cephalotaxaceae, order Pinales, class Pinopsida, division CONIFEROPHYTA. Members contain homoharringtonine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Costaceae %28%sometimes classified in Zingiberaceae%29%, order Zingiberales, subclass Zingiberidae, class Liliopsida %28%monocotyledons%29%. It is a source of SAPONINS and furostanol glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Cruciferae. It contains many species and cultivars used as food including cabbage, cauliflower, broccoli, Brussel sprouts, kale, collard greens, MUSTARD PLANT; %28%B. alba, B. junica, and B. nigra%29%, turnips %28%BRASSICA NAPUS%29% and rapeseed %28%BRASSICA RAPA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Cuscutaceae. It is a threadlike climbing parasitic plant that is used in DRUGS, CHINESE HERBAL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Cycadaceae, order Cycadales, class Cycadopsida, division CYCADOPHYTA of palm-like trees. It is a source of CYCASIN, the beta-D-glucoside of methylazoxymethanol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family DENNSTAEDTIACEAE. Members contain ptaquiloside, braxin A1, and braxin B. The name is similar to brake fern %28%PTERIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family DRYOPTERIDACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family DRYOPTERIDACEAE. Members contain aspidin and filicic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Droseraceae, order Nepenthales, subclass Dilleniidae, class Magnoliopsida, that contains naphthoquinone glucosides. The name sundew is rarely used for PYROLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EBENACEAE, order Ebenales, subclass Dilleniidae, class Magnoliopsida best known for the edible fruit and the antibacterial activity and compounds of the wood.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ELAEAGNACEAE. Linoleic %28%18:2n-6%29% and alpha-linolenic acids %28%18:3n-3%29% comprised about 70%25% of seed oil fatty acids. This is unrelated to %27%artificial sea buckthorn oil%27%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ERICACEAE known for species with edible fruits.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ERICACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ERICACEAE. The common name of %22%wintergreen%22% is also used for PYROLA and %22%snowberry%22% is also used for SYMPHORICARPOS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE that contains bukittinggine and PHORBOL ESTERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE that contains gelonin, a ribosome-inactivating protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE that is perennial with conspicuous, almost palmate leaves like those of RICINUS but more deeply parted into five to nine lobes. It is a source of a starch after removal of the cyanogenic glucosides. The common name of Arrowroot is also used with Maranta %28%MARANTACEAE%29%. The common name of yuca is also used for YUCCA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE that is the source of tung oil and a phorbol diester %28%PHORBOL ESTERS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. Commercial natural RUBBER is mainly obtained from Hevea brasiliensis but also from some other plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. The seed of Ricinus communis L. is the CASTOR BEAN which is the source of CASTOR OIL; RICIN; and other lectins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE. Bahupatra %28%MEDICINE, AYURVEDIC%29% is prepared from this.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE. Members contain fredelin type TRITERPENES, mallorepine %28%a cyano-pyridone%29%, and hydrolyzable TANNINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE. Members contain jatrophone and other diterpenes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE. The common name of dragon%27%s blood is also used for DRACAENA and Daemonorops %28%ARECACEAE%29%. Croton tiglium is the source of CROTON OIL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family EUPHORBIACEAE. The trees contain hippomanin A %28%TANNINS%29% and the latex is a skin irritant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE %28%sometimes classified as Papilionaceae%29%. Members contain LECTINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE a common weed of the southeast US. There has been folk use for alcoholism and liver protection. It contains puerarin, kakkalide, daidzein %28%isoflavonoids%29%, and kudzusaponins %28%oleanene-type triterpene glycosides%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE known for its sour fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE known for the edible beans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE named after the drooping clusters of flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains LECTINS and raffinose oligosaccharides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains LECTINS. Many members have been reclassified into other genera of the FABACEAE family.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains butrin and isobutrin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains castanospermines, swainsonine, and triterpenoid saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains crotalarin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains galegine %28%GUANIDINES%29%. Most of the other species have been reclassified to TEPHROSIA; a few to ASTRAGALUS PLANT; and INDIGOFERA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains gleditsiosides %28%triterpenoid SAPONINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains julibroside %28%triterpenoid saponins%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains kukulkanin, a CHALCONE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains linarin %28%acaciin%29% and LECTINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains tephrorin, tephrosone, and C-prenylflavonoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that contains ternatins %28%anthocyanins%29% and preternatins, antifungal proteins, stigmast-4-ene-3,6-dione, and clitoriacetal %28%ROTENONE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is a source of PHYSOSTIGMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is a source of SPARTEINE, lupanine and other lupin alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is a source of SPARTEINE. Do not confuse with Broom or Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Brome %28%BROMUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is a source of aromatic resinous balsams %28%Balsam of Tolu and Balsam of Peru%29% used in perfumery and as a constituent in cough syrups and lozenge.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is a source of prosopis gum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is a source of psoralen %28%FICUSIN%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is sometimes called broom because of the shape of the plant. Members produce SPARTEINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is the source of guar gum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is the source of mucuna gum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is used for food in NIGERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE that is widely used as ground cover and forage and known for the edible beans, VICIA FABA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. It contains a hemagglutinin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. It is distinct from Sweet Clover %28%MELILOTUS%29%, from Bush Clover %28%LESPEDEZA%29%, and from Red Clover %28%TRIFOLIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus %28%SENNA PLANT%29% and some to CHAMAECRISTA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. The common name of %22%Bird-Of-Paradise%22% is also used for other plants such as Heliconia %28%HELICONIACEAE%29% and Strelitzia %28%STRELITZIACEAE%29% and some birds. The common name of %22%Cat%27%s-Claw%22% is more often used with UNCARIA. The common name of %22%Pernambuco%22% also refers to a state in Brazil. Furanoditerpenoid lactones and caesalpin are produced by members of this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Canavalia ensiformis is the source of CONCANAVALIN A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. It is the source of an herbal tea that is commonly consumed in South Africa. Members contain aspalathin and other polyphenols %28%PHENOLS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain ABRIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain COUMARINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain Griffonia simplicifolia agglutin-I and griffonin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain ISOFLAVONES, some of which show molluscicidal and schistosomicidal activity. Some species of Pongamia have been reclassified to this genus and some to DERRIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain STILBENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain SWAINSONINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain isoacteoside, luteolin, indole-3-carboxylic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain molluscicidal triterpene glycosides %28%TRITERPENES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain piperidine alkaloids %28%PIPERIDINES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members contain wistarin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Members of this genus can cause CONTACT DERMATITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. SENNA EXTRACT is obtained from members of this genus. Members contain ANTHRAQUINONES and have been an ingredient in laxatives %28%CATHARTICS%29%. Many species of the CASSIA genus have been reclassified into this genus. This bush should not be confused with the Cassia tree %28%CINNAMOMUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Some Pachyrhizus have been reclassified to PUERARIA. Do not confuse with yam %28%IPOMOEA; or DIOSCOREA%29% or African yam bean %28%SPHENOSTYLIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. Some species were reclassified from CASSIA and Senna.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. The common name of broom may be confused with Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29% or Brome %28%BROMUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. The common name of indigo also refers to Baptisia or Amorpha genera %28%FABACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. The gums and tanning agents obtained from Acacia are called GUM ARABIC. The common name of catechu is more often used for Areca catechu %28%ARECA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. The root is a source of rotenoids %28%ROTENONE%29% and flavonoids. Some species of Pongamia have been reclassified to this genus and some to MILLETTIA. Some species of Deguelia have been reclassified to this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FABACEAE. This genus was formerly known as Tetragonolobus. The common name of lotus is also used for NYMPHAEA and NELUMBO.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FAGACEAE that is a source of TANNINS. Do not confuse with Holly %28%ILEX%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FAGACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FLACOURTIACEAE that is the source of RYANODINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FLACOURTIACEAE. Members contain casearins which are clerodane type DITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FUMARIACEAE %28%classified by some in PAPAVERACEAE%29% that contains isoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family FUMARIACEAE that contains fumariline and other isoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GENTIANACEAE that contains nitiol %28%a C25 sesterterpenoid%29% %26% nitidasin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GENTIANACEAE. It is a source of swertiapuniside and iridoid glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GENTIANACEAE. Members contain secoiridoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GENTIANACEAE. Triterpene lactones and other compounds have been isolated from species of this genus. The common name of century plant has also been used for the AGAVE genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GERANIACEAE. Geranium is also used as a common name for PELARGONIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GERANIACEAE. The common name of geranium is also used for the GERANIUM genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family GROSSULARIACEAE. GAMMA-LINOLENIC ACID is obtained from the black currant oil of the seeds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Gnetaceae, order Gnetales class Gnetopsida, division GNETOPHYTA. Members contain STILBENES and benzylisoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family HAMAMELIDACEAE. The sap is a source of storax, which should not be confused with the similar named STYRAX genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family HIPPOCASTANACEAE %28%or SAPINDACEAE by some%29% that contains antimicrobial protein 1 and escin. A. hippocastanum is used in folk medicine for treating chronic venous insufficiency.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family HYDRANGEACEAE. Members contain hydrangenol, thunberginols, hydramacrosides A and B, and secoiridoid glucosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family HYDROPHYLLACEAE that has a characteristic strong smell.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Hamamelidaceae, order Hamamelidales. It is known for the astringent %28%ASTRINGENTS%29% extract of leaves and bark used in over the counter preparations. This should not be confused with the similar named Hamelia genus %28%RUBIACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family IRIDACEAE that contains IRIP, a type-1 ribosome-inactivating protein, and iridals %28%TRITERPENES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Illiciaceae, order Illiciales, subclass Magnoliidae, class Magnoliopsida. They have evergreen, aromatic leaves and bisexual flowers. The female portion of the flower consists of 7 to 15 carpels.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family JUGLANDACEAE that bears edible nuts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family JUGLANDACEAE that provides the familiar walnut.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Jubulaceae, subclass JUNGERMANNIAE. Members contain eudesmane-type sesquiterpene lactones and cause CONTACT DERMATITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE best known for the thyme spice added to foods.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE having characteristic flavor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains 5-methoxydehydropodophyllotoxin %28%a PODOPHYLLOTOXIN%29% and other LIGNANS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains cyasterone, ajugasterone, 20-hydroxyecdysone, 8-acetylharpagide %28%an iridoid glycoside%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains eudesmane sesquiterpenes and antimicrobial abietane diterpenoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains isoscutellarein-7-O-%28%allosyl%28%1-2%29%glucoside%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains leonurine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains macrocalin B. R. japonica is an ingredient of PC-SPES, a treatment for prostate cancer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains phenylpropanoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains phlorigidosides, iridoid glucosides and megastigmane glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains pimarane-type diterpenes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains pulegone. Do not confuse with %27%American false pennyroyal%27% %28%HEDEOMA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains rosmarinic acid and isopimarane diterpenoids and has been used in folk medicine for HYPERTHYROIDISM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that contains tilianin, agastanol, and agastaquinone %28%a cytotoxic diterpenoid quinone%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that has a characteristic odor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that is a source of perilla alcohol and the oil is rich in alpha-linolenic acid %28%alpha-18:3%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that is an ingredient of Banxia Houpu %28%DRUGS, CHINESE HERBAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that is closely related to the European pennyroyal %28%MENTHA PULEGIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that is the source of a familiar food seasoning.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE that is the source of peppermint oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE used in folk medicine as a nervine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE used to flavor food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE which is the natural source of FORSKOLIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE. Members contain TRITERPENES. Heal all is another common name.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE. Members contain ent-kaurene type DITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE. Members contain teuscordonin. There have been reports of hepatoxicity by this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MELISSA. The common name of bergamot is also used for Citrus bergamia %28%CITRUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAMIACEAE. The common names of beebalm or lemonbalm are also used for MONARDA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAURACEAE. Members contain cryptofolione, caryachine, grandisin and other compounds. Some PEUMUS species have been reclassified as CRYPTOCARYA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LAURACEAE. Members contain laurotetanine and other APORPHINES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains CARDIAC GLYCOSIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains bufadienolides %28%BUFANOLIDES%29%. The common name of squill is also used for SCILLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains cholestane glycosides %28%CHOLESTANES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains curculin and cycloartane saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains spirostanol %26% furostanol SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains steroidal SAPONINS and should not be confused with Death Camas %28%ZIGADENUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that contains steroidal saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that is a short plant with a distinct whorl of 3 broad leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE that is fatally toxic to grazing animals. The name is similar to another plant called Camas %28%CAMASSIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE with roots that contain VERATRUM ALKALOIDS used as emetics, parasiticides, antihypertensives. It is the main ingredient of Boicil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Do not confuse with water hyacinth %28%EICHHORNIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain allergens, tuliposide A and tulipalin A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain anemarans %28%POLYSACCHARIDES%29%, hinokiresinol, mangiferin %28%a xanthone%29%, and timosaponin %28%a steroidal saponin%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain benzoquinones, steroidal saponin, and ribosome-inactivating proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain radiatine, vittatine, haemanthamine, lycorenine, dihydrolycorine, lycorine, lycoricidinol and lycoricidine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain ruscogenin. Do not confuse with the Liriope jellyfish %28%CNIDARIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain steroidal glycosides and provide an ingredient of shengmaisan %28%DRUGS, CHINESE HERBAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain steroidal saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain the cardiotonic PROSCILLARIDIN. The common name of squill is also used for URGINEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain tuliposides and tulipalins and have been associated with allergic contact dermatitis in florists.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members contain ungiminorine and LECTINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. Members of this genus produce imperialine, a steroidal alkaloid which acts at muscarinic receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. The cluster of flowers at the end of the stalk distinguishes this plant from %22%true%22% Solomon%27%s seal %28%POLYGONATUM%29%, which has flowers that grow along the stem.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. The common name of %22%dragon%27%s blood%22% is also used for CROTON and Daemonorops %28%ARECACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LILIACEAE. This should not be confused with Broom or Scotch Broom %28%CYTISUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29% or Brome %28%BROMUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LINACEAE that is cultivated for its fiber %28%manufactured into linen cloth%29%. It contains a trypsin inhibitor and the seed is the source of LINSEED OIL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LOGANIACEAE %28%classified by some botanists as Gelsemiaceae%29%. The sometimes used common name of trumpet flower is also used for DATURA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LOGANIACEAE %28%classified by some botanists as Strychnaceae%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYCOPODIACEAE. Members contain ALKALOIDS. Lycopodium oil is obtained from L. clavatum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYCOPODIACEAE. Members contain huperzine, one of the CHOLINESTERASE INHIBITORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYTHRACEAE that contains ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYTHRACEAE that is the source of henna and has cytotoxic activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYTHRACEAE. Members contain lagertannin and have hypoglycemic effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYTHRACEAE. Members contain lauric acid and cuphiin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family LYTHRACEAE. Members contain woodfordins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Lecythidaceae which is the source of edible Brazil nuts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Lecythidaceae. Members contain nasimalun A and B %28%neo-clerodane diterpenoids%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MAGNOLIACEAE. Members include hardwood trees of eastern North America with distinct large tuliplike flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALPIGHIACEAE which includes an Amazonian psychoactive plant that contains the beta-carboline harmine and N,N-dimethyltryptamine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALPIGHIACEAE. G. glauca is the source of %27%Galphimia glauca extract%27% and contains %27%galphimine B%27% and tetragalloylquinic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALVACEAE known for mucilaginous roots. The common names of hollyhock and mallow are also used for other genera of MALVACEAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALVACEAE, order Malvales, subclass Dilleniida. The common name of %27%Mallow%27% may sometimes get confused with other plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALVACEAE, order Malvales, subclass Dilleniidae best known for okra.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALVACEAE. It is the source of COTTON FIBER; COTTONSEED OIL, which is used for cooking, and GOSSYPOL. The economically important cotton crop is a major user of agricultural PESTICIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MALVACEAE. Members contain LIGNANS. H. cannabinus is a source of textile fiber %28%TEXTILES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MELIACEAE. Members contain azadirachtin A %28%a limonoid commonly referred to as azadirachtin%29% and other TRITERPENES. They have been used in PESTICIDES. The old name of Melia azadirachta is very similar to a related plant, MELIA AZEDARACH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MELIACEAE. Members contain cedrelanolide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MELIACEAE. Members contain lariciresinol, pregnanes, insecticidal rocaglamide derivatives and other compounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MELIACEAE. Members contain meliavolkinin, melianin C and limonoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members contain bisbenzylisoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members contain cycleanine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members contain dauricine and other ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members contain eletefine %28%a stephaoxocane alkaloid%29% and tropoloisoquinoline and protoberberine ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members contain sinococuline, coccuvine and other ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members contain sinomenine, caffeine, 1,7-dimethylxanthine, and other ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MENISPERMACEAE. Members have been used in AYURVEDIC MEDICINE. Hypoglycemic effect has been reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MONIMIACEAE. Members contain boldine ALKALOIDS. Some PEUMUS species have been reclassified as CRYPTOCARYA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MORACEAE that is widely planted for shade.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MORACEAE. It is the source of the familiar fig fruit and the latex from this tree contains FICAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MORACEAE. Members contain PYRROLIDINES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MORACEAE. Members contain maclurin, antifungal chalcones, and other compounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MORACEAE. Members have been used as an arrow poison.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MORACEAE. Puag-haad extract, from A. lakoocha, contains STILBENES and related 4-substituted RESORCINOLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYOPORACEAE. Members contain dehydrongaione, deisopropylngaione, dehydromyodesmone and other furanoid sesquiterpene essential oils. It is the source of Ngaio oil and ngaione.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYOPORACEAE. Members have been used in FOLK MEDICINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRICACEAE. Members contain myricanol. The common name of bayberry is similar to the name barberry which is used for BERBERIS and MAHONIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRSINACEAE. Members contain ardisiacrispins %28%oleanane triterpenoid saponins%29%, ardicrenin, and cyclamiretin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRSINACEAE. Members contain embelin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRTACEAE that bears an edible fruit and contains guavin B and quercetin glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRTACEAE that is cultivated for the edible fruit, which is different from the ordinary guava %28%PSIDIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRTACEAE. M. alternifolia foliage is a source of TEA TREE OIL. The common name of tea tree also refers to LEPTOSPERMUM or KUNZEA. M. vindifolia is a source of niaouli oil. M. cajuputi and M. leucadendra are sources of cajuput oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRTACEAE. Members contain PHYTOHEMAGGLUTININS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRTACEAE. The common name of tea tree is also used for MELALEUCA and KUNZEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family MYRTACEAE. The common name of tea tree more often refers to MELALEUCA or LEPTOSPERMUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Moringaceae, order Capparales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Musaceae, order Zingiberales, subclass Zingiberidae, class Liliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family NELUMBONACEAE. The common name of lotus is also for LOTUS and NYMPHAEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family NYCTAGINACEAE. Members contain Mirabilis antiviral protein %28%a ribosome-inactivating protein%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family NYMPHAEACEAE. Members contain sesquiterpene thioalkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family NYMPHAEACEAE. The common name of lotus is also used for LOTUS and NELUMBO.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family NYSSACEAE %28%or Cornaceae by some%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family NYSSACEAE %28%sometimes classified in the CORNACEAE family%29%. It is a source of CAMPTOTHECIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OLEACEAE. Members contain secoiridoid glucosides and this is the source of oil of jasmine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OLEACEAE. Members contain secoiridoid glucosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OLEACEAE. Members contain suspensaside.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OLEACEAE. Oleuropein has been identified in the stem bark.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OLEACEAE. Oleuropein, a phenolic secoiridoid glycoside, is found in the leaves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OLEACEAE. The olive fruit is the source of olive oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ONAGRACEAE. Members contain oenotheins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ONAGRACEAE. The common name of fireweed is also used with other plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ORCHIDACEAE that contains dihydroayapin %28%COUMARINS%29% and phenanthraquinones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ORCHIDACEAE that is the source of the familiar flavoring used in foods and medicines %28%FLAVORING AGENTS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ORCHIDACEAE which depends on the fungus Armillaria mellea to complete its life cycle. It is an ingredient of Zhenxuanyin %28%DRUGS, CHINESE HERBAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OROBANCHACEAE. Lacking chlorophyll, they are nonphotosynthetic parasitic plants. The common name is similar to Broom or Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29% or Brome %28%BROMUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family OROBANCHACEAE. Members contain phenylethanoid glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PAPAVERACEAE that contains benzo%5B%c%5D%phenanthridine alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PAPAVERACEAE that contains isoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PAPAVERACEAE. S. canadensis is the source of sanguinarine extract used in MOUTHWASHES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PEDALIACEAE that is the source of the edible seed and SESAME OIL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PEDALIACEAE. Members contain harpagoside and are the source of extract WS 1531.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PHYTOLACCACEAE, order Caryophyllales.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PIPERACEAE that includes species used for spicy and stimulating qualities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PIPERACEAE that is indigenous in the Indian Malay region and cultivated in Madagascar, and the West Indies. It contains chavibetol, chavicol and cadinene. The leaf is chewed as a stimulant, antiseptic and sialogogue. The common name of betel is also used for ARECA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PIPERACEAE. Members contain prenylated quinones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE originating from the savanna of eastern Africa. It is widely grown for livestock forage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that contains Hol l 1 and Hol l 5 allergens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that contains allergen Dac g I.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that contains the Phl p 4 allergen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that contains the Poa p Ia allergen and allergen C KBGP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that is considered a lawngrass by some and a weed by others. It contains allergen Cyn d 7.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that is grown mainly as a hay crop.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that is the source of wheat grain. A hybrid with rye %28%SECALE CEREALE%29% is called TRITICALE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that is used for forage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE that many people consider to be a weed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE which is a source of citronella oil and lemongrass oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE widely cultivated in the tropics for the sweet cane that is processed into sugar.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. Finger millet or raggee %28%E. coracana%29% is an important food grain in southern Asia and parts of Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. Folin is the water-soluble extract from Sasa albomarginata. Sasa kurinensis is an ingredient of Sho-ju-sen, a Japanese herbal medicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The RHIZOME contains SESQUITERPENES and is the source of vetiver oil used in PERFUME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The common name of bluestem is also used for other plants in this family. Andropogon nardus has been reclassified as CYMBOPOGON nardus and Andropogon zizanioides to VETIVERIA zizanioides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The common name of buffelgrass is also used for PENNISETUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The common name of fescue is also used with some other grasses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The common name of wheatgrass is also used for other plants in the family.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The common name of wildrye is used with some other grasses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The grain is used for FOOD and for ANIMAL FEED. This should not be confused with KAFFIR LIME or with KEFIR milk product.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The name is similar to Broom or Scotch Broom %28%CYTISUS%29% or Butcher%27%s Broom %28%RUSCUS%29% or Desert Broom %28%BACCHARIS%29% or Spanish Broom %28%SPARTIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The seed grain, barley, is widely used as food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The seed is one of the millets used in CEREALS and in feed for birds and livestock %28%ANIMAL FEED%29%. It contains diosgenin %28%SAPONINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The seed is one of the millets used in CEREALS. It contains vitexin. The common name of buffelgrass is also used for CENCHRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The seed is used in folk medicine %28%DRUGS, CHINESE HERBAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. The small pointed seeds are grown for hay in North America and western Europe and important as food in China and other Asian countries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POACEAE. Young shoots are eaten in Asian foods while the stiff mature stems are used for construction of many things. The common name of bamboo is also used for other genera of Poaceae including Phyllostachys, SASA, and Dendrocalamus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGALACEAE that contains onjisaponins, xanthones, pyrones, and benzophenones. The name is similar to other snakeroots such as ASARUM; SANICULA; ARISTOLOCHIA; AGERATINA; and others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGALACEAE that contains securiosides and indole alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGONACEAE that contains patientosides and other naphthalene glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGONACEAE that is an ingredient of Shou-Wu-Pian, a Chinese herbal preparation %28%DRUGS, CHINESE HERBAL%29%. The common name of black bindweed also refers to TAMUS or Fallopia %28%use POLYGONACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGONACEAE that is used as a cereal grain. Although the seeds are used as cereal, the plant is not one of the cereal grasses %28%POACEAE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGONACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYGONACEAE. Members contain chrysophanic acid, rhein, EMODIN, and other anthraquinones. The roots were formerly used as purgatives.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family POLYPODIACEAE. Members contain polypodoside.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PONTEDERIACEAE that is used as a biological filter for treating wastewater.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PORTULACACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PRIMULACEAE that contains anagallosides, which are molluscacidal triterpenoid saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PRIMULACEAE that contains triterpenoid saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PRIMULACEAE. It can cause CONTACT DERMATITIS. SAPONINS have been identified in the root.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PROTEACEAE that is the source of edible NUTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PTERIDACEAE. Members contain entkaurane DITERPENES. The name is similar to bracken fern %28%PTERIDIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family PYROLACEAE. The common name of wintergreen is more often used for GAULTHERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Paeoniaceae, order Dilleniales, subclass Dilleniidae, class Magnoliopsida. These perennial herbs are up to 2 m %28%6%27%%29% tall. Leaves are alternate and are divided into three lobes, each lobe being further divided into three smaller lobes. The large flowers are symmetrical, bisexual, have 5 sepals, 5 petals %28%sometimes 10%29%, and many stamens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Passifloraceae, order Violales, subclass Dilleniidae, class Magnoliopsida. They are vines with ornamental flowers and edible fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Plantaginaceae, order Plantaginales, subclass Asteridae, class Magnoliopsida. The small plants usually have a dense tuft of basal leaves and long, leafless stalks bearing a terminal spike of small flowers. The seeds, known as PSYLLIUM, swell in water and are used as laxatives. The leaves have been used medicinally.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Pteridaceae. Members contain TRITERPENES. Some species in this genus are called maidenhair fern which is also a common name occasionally used for Lygodium %28%FERNS%29% and POLYPODIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE that contains alpha-hederin, a triterpene saponin in the seeds, and is the source of black seed oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE that contains aquiledine, isoaquiledine and cycloartane-type glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE that contains griffonilide, lithospermoside, and magnoflorine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE that contains protoanemonin, anemonin, and ranunculin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE that contains triterpene saponins. The root of Anemone raddeana is the source of a Chinese folk medicine, zhu jie xian fu. The common name of liverwort is also used with other plants. This genus is unrelated to SEA ANEMONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE that contains triterpenoid saponins. Remifemin from C. racemosa is used to suppress LUTEINIZING HORMONE. It is reclassified by some to ACTAEA. The common name of black snakeroot is also used with ASARUM and SANICULA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Cycloartanes have been found in the rhizomes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain ACONITINE and other diterpenoid alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain BERBERINE and other isoquinoline ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain BERBERINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain SCOPOLETIN and SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain a number of diterpenoid alkaloids including: aconitans, hypaconitine, ACONITINE, jesaconitine, ignavine, napelline, and mesaconitine. The common name of Wolfbane is similar to the common name for ARNICA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain cardenolide oligoglycosides such as adoniside, adonisidum and alepposide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain cernuosides and other oleanane and hederagenin saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain hellebrin %28%BUFANOLIDES%29%. The extract is the basis of Biocil preparation used for rheumatism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids and triterpene glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. Members contain isoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RANUNCULACEAE. The name is similar to giant fennel %28%FERULA%29%, true fennel %28%FOENICULUM%29%, and dog fennel %28%ANTHEMIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RHAMNACEAE that contains tullidinol %28%toxin T-544%29% and peroxisomicine %28%toxin T-514%29%. It is sometimes called buckthorn but should not be confused with other plants called that.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RHAMNACEAE. Members contain antifungal jujubogenin saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RHAMNACEAE. Members contain nummularogenin %28%a spirostane%29% and is the source of an edible fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RHAMNACEAE. Root nodules host the Frankia %28%ACTINOMYCETES%29% nitrogen-fixing bacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RHAMNACEAE. Several species have been reclassified to the FRANGULA genus. It is often called buckthorn but should not be confused with other plants called that.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RHAMNACEAE. This genus is often called buckthorn but should not be confused with other plants called that such as HIPPOPHAE or KARWINSKIA. Some RHAMNUS species have been reclassified into this genus. F. purshiana bark is cascara sagrada %28%CASCARA%29%. Members contain emodine, frangulanin, frangulin, and anthraquinones such as EMODIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE known for the edible fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE that has been used in folk treatment of diabetes. Members contain agrimoniin %28%TANNINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE that is the source of an edible fruit. Members contain TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE widely cultivated as a prickly hedge with bright red berries. Members contain pyracrenic acid %28%a lupane triterpenoid%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Bark extract of P. africanum is an ingredient of folk remedies to treat PROSTATIC HYPERPLASIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain TANNINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain esculetin and QUERCETIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain procyanidins and TANNINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain prunioside, spiramine and other diterpene alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. Members contain sanguiin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ROSACEAE. The common names of chokeberry or chokecherry are also used for some species of PRUNUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE that has a name very similar to another plant genus, HAMAMELIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE with a name very similar to the element GALLIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE, order Rubiales, subclass Asteridae. Cephaelis ipecacuanha is the source of IPECAC.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. It is best known for the COFFEE beverage prepared from the beans %28%SEEDS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members contain anthraquinones and iridoids. H. diffusa is used in DRUGS, CHINESE HERBAL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members contain antimalarial %28%ANTIMALARIALS%29% and analgesic %28%ANALGESICS%29% indole alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members contain genepin, from which geniposide is obtained for use as a crosslinking agent in ADHESIVES, and 3-caffeoyl-4-sinapoylquinic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members contain iridoid glycosides and ANTHRAQUINONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members contain psychotridine and brachycerine %28%indole alkaloids%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members contain uncarine and other cytotoxic and hypotensive oxindole alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Members produce YOHIMBINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. Some species are used as an ingredient in Chinese and African traditional medicines. Members contain kalata B1, a macrocyclic peptide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUBIACEAE. The root is a source of red dyes %28%madder color and 1,2,4-trihydroxy-9,10-anthracenedione%29% and ANTHRAQUINONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE that is the natural source of PILOCARPINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE which is used in Chinese medicine %28%DRUGS, CHINESE HERBAL%29%. Evodiamine and other quinazoline alkaloids %28%QUINAZOLINES%29% are obtained from the fruit of E. ruticarpa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. The fruit is edible and the seed has cardiovascular activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. They bear the familiar citrus fruits including oranges, grapefruit, lemons, and limes. There are many hybrids which makes the nomenclature confusing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. Members contain BERBERINE, indolopyridoquinazoline and other ALKALOIDS and limonoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. Members contain eudesmane type SESQUITERPENES; COUMARINS, and obacunone %28%a limonoid%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. Members contain murrayanine, koenine, isomahanine, kwangsine, siamenol, murrayafoline A, murrayaquinone A and other cytotoxic carbazolequinones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. Members contain ponfolin, a coumarin %28%COUMARINS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. Members contain quinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family RUTACEAE. Most plants that are called Fagara are actually Zanthoxylum. Some members of Zanthoxylum are reclassified from ELEUTHEROCOCCUS, Melicope, and EVODIA. The twigs are used as dental brushing sticks %28%TOOTHBRUSHING%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SALICACEAE. Balm of Gilead is a common name used for P. candicans, or P. gileadensis, or P. jackii, and sometimes also used for ABIES BALSAMEA or for COMMIPHORA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SALICACEAE. Members contain salicin, which yields SALICYLIC ACID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SANTALACEAE which is the source of sandalwood oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SANTALACEAE. Members contain thionin toxin, which shouldn%27%t be confused with thionine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPINDACEAE that bears sweet fruits. Unusual fatty acids such as cyclopropanoic fatty acids have been identified in the seeds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPINDACEAE that contain SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPINDACEAE. Members contain hypoglycins and ackee oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPINDACEAE. The seed of P. cupana is the source of guarana powder which contains 4%25% CAFFEINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPOTACEAE that bears sweet fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPOTACEAE that is the source of mahua oil. Members contain oleanene triterpenoid saponins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPOTACEAE. Members contain triterpenes. Some species in this genus are called mamey which is also a common name for MAMMEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPOTACEAE. Latex from bark incisions is processed into GUTTA-PERCHA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPOTACEAE. Members contain miraculin %28%also spelled mieraculin%29%, a sweet protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAPOTACEAE. Members contain triterpenoid saponins. Latex from bark incisions is processed into gutta balata.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SAXIFRAGACEAE with dark green round or heart-shaped leaves and tiny flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCHISANDRACEAE that is used in folk medicine much like SCHISANDRA. Members contain kadsurenone and kadsurin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCHISANDRACEAE. Members contain schisandrins %28%Russian%29% which are also called gomisins %28%Japanese%29% or wuweizins %28%Chinese%29%. The compounds in this genus are very similar to those in the related KADSURA and medicinal usage is very similar. It is sometimes adulterated with KADSURA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE having a folk reputation for use with the eyes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE that is parasitic on the roots of other plants. Members contain the flavones, apigenin and luteolin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain 6-geranylflavanones and mimulone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain DEFICIENS PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain bacopaside, bacopasaponins and other dammarane type jujubogenins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain bis-sesquiterpene and iridoid glucosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain catapol, rehmannin and ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain iridoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain linarin %28%also called acaciin%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain mimengoside B, verbascoside, and phenylethanoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain phenylpropanoid and iridoid glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain phenylpropanoid glycosides and iridoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain scrosides %28%CINNAMATES%29% and phenylethanoid glycoside. P. kurrooa is the source of picroliv %28%a purified iridoid glycoside fraction from the roots having hepatoprotective, anti- inflammatory and antioxidant properties%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SCROPHULARIACEAE. Members contain thyrsiflorin and other scopadulane %28%labdane%29% type DITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SIMAROUBACEAE. Members contain ailantinols and other quassinoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SIMAROUBACEAE. Members contain bruceosides and bruceanols %28%quassinoids%29%. The astringent seeds have been used to treat dysentery in southeastern Asia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SIMAROUBACEAE. Members contain javanicins, picrasinoside and other quassinoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SIMAROUBACEAE. Members contain quassinoids. Quassia simarouba has been reclassified as SIMAROUBA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SIMAROUBACEAE. Members contain quassinoids. There is Malaysian folk use of these plants for male virility.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SIMAROUBACEAE. Members produce quassinoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SMILACACEAE. Members contain smiglasides %28%phenylpropanoid glycosides%29% and steroidal saponins. Commercially it is sometimes adulterated with HEMIDESMUS, which would affect experimental results.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE after which the compound SCOPOLAMINE got its name.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE that is a source of SCOPOLAMINE and other TROPANES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE which contain SOLANACEOUS ALKALOIDS including ATROPINE which is named after this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE which contains TROPANES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. The hot peppers yield CAPSAICIN, which activates vanilloid receptors. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain CEREBROSIDES and SCOPOLETIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for ATROPA BELLADONNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain TROPANES. The common name of trumpet flower is also sometimes used for GELSEMIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain physalin and withangulatin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain steroidal glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain steroidal saponins and cause CALCINOSIS in grazing livestock due to high levels of 1 ALPHA,25-DIHYDROXYVITAMIN D3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family SOLANACEAE. Members contain withanolides. Withania somnifera is the source of ashwagandha and aswal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family STERCULIACEAE. This is the source of the kola nut which contains CAFFEINE and is used in popular beverages.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family STERCULIACEAE. S. urens is the source of KARAYA GUM which is sometimes called Indian tragacanth, which is different from the true TRAGACANTH which comes from ASTRAGALUS GUMMIFER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family STYRACACEAE. Sap of these Asian trees are a source of a balsam %28%BALSAMS%29%. This styrax balsam is 3/4 coniferyl benzoate, 1/8 free BENZOIC ACID, along with benzyl cinnamate, vanillin, and TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TAXODIACEAE known for including some of the tallest trees.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TAXODIACEAE known for tall trees like the SEQUOIA redwoods.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TAXODIACEAE. Its POLLEN is one of the major ALLERGENS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TAXODIACEAE. Members contain DITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TAXODIACEAE. Members contain taxodione and taxodone, which are diterpenoid quinone methide tumor inhibitors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family THYMELAEACEAE. Members contain daphnoretin and wikstroelides and daphnane-type DITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family THYMELAEACEAE. They are evergreen shrubs much cultivated in garden borders and rock gardens in mild climates. Members contain mezerein, flavonoids, and COUMARINS such as daphnetin and daphnin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TILIACEAE. Members contain cycloartane saponins and CARDENOLIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TILIACEAE. Members contain lupeol and betulin TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TILIACEAE. Some species in this genus are called Limetree which is nearly the same as the common name for lime %28%CITRUS AURANTIIFOLIA%29%. Some people are allergic to the POLLEN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TILIACEAE. The common name of burweed is also used for AMSINCKIA. Triumfetta semitriloba is considered a noxious weed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family TROPAEOLACEAE. The common nasturtium is a plant that grows 2.4-3.6 m %28%8-12 feet%29% tall and has funnel-shaped flowers that are commonly yellow-orange with red spots or stripes and have a long spur that contains sweet nectar. Some species in this genus are called watercress which is also a common name for RORIPPA and NASTURTIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family Turneraceae, order Violales, subclass Dilleniidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ULMACEAE that is susceptible to Dutch elm disease which is caused by the ASCOMYCOTA fungus, Ophiostoma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ULMACEAE. Members contain PHENANTHRENES and COUMARINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family URTICACEAE which is the most common cause of pollinosis in Mediterranean countries. It is the source of %27%allergen Par o I%27% and of Pollinex used for DESENSITIZATION, IMMUNOLOGIC.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family URTICACEAE. Members contain cryptopleurine, beta-sitosterol, daucosterol and 19 alpha-hydroxyursolic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VALERIANACEAE, order Dipsacales, subclass Asteridae, class Magnoliopsida. It is best known for the sedative use and valepotriate content of the roots. It is sometimes called Garden Heliotrope but is unrelated to true Heliotrope %28%HELIOTROPIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VALERIANACEAE. It is sometimes called goosefoot cornsalad but should not be confused with true goosefoot %28%CHENOPODIUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VALERIANACEAE. Members contain ursolic acid and oleanolic acid glycosides, sulfapatrinosides %28%triterpenoid glycosides%29%, and patriscabrol %28%iridolactone%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VALERIANACEAE. Nardostachysin, nardostachin, nardosinone, valeranone, and patchoulene have been found in this genus. Nardostachys jatamansi is classified by some as Valeriana jatamansi.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VERBENACEAE. Inerminosides %28%iridoid glycosides%29%, colebroside A, STEROIDS, STEROLS, terpenoid glucosides, and abietane DITERPENES have been found in this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VERBENACEAE. Lippsidoquinone; TRITERPENES; SESQUITERPENES; and THYMOL have been found in this genus. Plant extracts have cytotoxic activity. It is sometimes called Mexican oregano but that confuses it with real oregano %28%ORIGANUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VERBENACEAE. Members contain NAPHTHOQUINONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VERBENACEAE. Members contain clerodane DITERPENES and callicarpone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VERBENACEAE. Members contain lantadene and other TRITERPENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VERBENACEAE. Members contain verbenachalcone %28%dimeric dihydrochalcone%29%, iridoids, and phenylethanoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VIOLACEAE. Some species in this genus are called bouncing bet which is a common name more often used with SAPONARIA OFFICINALIS. Members contain macrocyclic peptides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VITACEAE. Cissus rufescence gum is considered comparable to TRAGACANTH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family VITACEAE. Members contain momordin and SITOSTEROLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family WINTERACEAE. Members contain polygodial.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family WINTERACEAE. They have leathery, elliptic-shaped leaves; red-tinged shoots; and jasmine-scented, cream-colored, 8- to 12-petaled, 2.5-centimeter %28%1-inch%29% flowers in clusters.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZINGIBERACEAE that contains CURCUMIN and curcuminoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZINGIBERACEAE, order Zingiberales, subclass Zingiberidae. Elettaria cardamomum %28%L.%29% Maton is the source of Cardamom used in SPICES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZINGIBERACEAE. Members contain aculeatin D, beta-sitosterol, and STIGMASTEROL. Some members have been reclassified to ELETTARIA and other ZINGIBERACEAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZINGIBERACEAE. Members contain galangin, yakuchinone-A, and diarylheptanoids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZYGOPHYLLACEAE. Feruloyltyramine, balanitoside %28%a furostanol glycoside%29%, and cytostatic steroidal saponins have been found in this genus. B. aegyptiaca fruit water extract is traditionally used as an anthelmintic in the Sudan.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZYGOPHYLLACEAE. GUAIAC is obtained from G. officinale or G. sanctum. Some species in this genus are called lignum vitae which is also a common name for other trees.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZYGOPHYLLACEAE. Harmala and other ALKALOIDS, phenylpropanoids, and TRITERPENES have been found in plants of this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZYGOPHYLLACEAE. It is sometimes called chaparral but that is a generic word which is used with a number of other plants. Members contain NORDIHYDROGUAIARETIC ACID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZYGOPHYLLACEAE. Members contain SAPONINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the family ZYGOPHYLLACEAE. Members contain steroidal saponins. Ingestion by grazing animals causes PHOTOSENSITIVITY DISORDERS called geeldikkop %28%yellow thick head%29% in South Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus of the genus STRYCHNOS, family LOGANIACEAE that is the source of STRYCHNINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus, in the IRIDACEAE family, known as a source of Saffron.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus, in the family AMARANTHACEAE, best known as a source of high-protein grain crops and of Red Dye No. 2 %28%AMARANTH DYE%29%. Tumbleweed sometimes refers to Amaranthus but more often refers to SALSOLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant genus, of the family ONAGRACEAE, which is the subject of genetic studies. The floral aroma is attributed to benzenoid esters and benzylacetate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant homeotic protein involved in the development of stamens and carpels of Arabidopsis thaliana. It is a DNA-binding protein that contains the MADS-box domain. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant in the genus ALLIUM, similar to ONIONS. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant of the family APIACEAE which is the source of asiatic acid and asiaticoside. Centella asiatica %28%L.%29% Urb. = Hydrocotyle asiatica L. is known for effect on peripheral circulation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant of the genus PODOPHYLLUM, family BERBERIDACEAE %28%sometimes classified as Podophyllaceae%29% which is the source of PODOPHYLLIN and of PODOPHYLLOTOXIN that inhibits DNA TOPOISOMERASES, TYPE II. It is different from the European mandrake, MANDRAGORA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant order of the subclass Dilleniidae, class Magnoliopsida. It includes 18 families, approximately 175 genera, and 3,400 species. Its members are mostly tropical trees and shrubs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant photo regulatory protein that exists in two forms that are reversibly interconvertible by LIGHT. In response to light it moves to the CELL NUCLEUS and regulates transcription of target genes. Phytochrome B plays an important role in shade avoidance and mediates plant de-etiolation in red light.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species cultivated for the seed used as animal feed and as a source of canola cooking oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species in the CHENOPODIUM genus known for edible greens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species in the MYRISTICACEAE family. The seed is used as a spice and used for antimicrobial and psychoactive effects. Myristicin, SAFROLE, and methyleugenol are key components.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species in the PIPERACEAE plant family. It is a common spice on foods and is used medicinally to increase gastrointestinal assimilation of other supplements and drugs. PIPERINE is a key component. Black pepper is picked unripe and heaped for a few days to ferment. White Pepper is the ripe fruit dehulled by maceration in water.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species in the genus SAMBUCUS, known for the elderberry fruit. The plant is also a source of Sambucus nigra lectins and ribosome-inactivating protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the Astragalus genus which is source of Huang qi preparation used in TRADITIONAL CHINESE MEDICINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the Salvia genus known as a spice and medicinal plant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family ACTINIDIACEAE, order Theales.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family APIACEAE that is the source of dong quai.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family APIACEAE that is widely cultivated for the edible yellow-orange root. The plant has finely divided leaves and flat clusters of small white flowers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family APIACEAE. The stalks are a food source.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family AQUIFOLIACEAE known for ritual use by Amazonian Jivaro Indians.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family AQUIFOLIACEAE. An infusion of the leaves is commonly drunk in South America for stimulating effect in much the same manner as coffee is in other cultures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family AQUIFOLIACEAE. It has been used to induce vomiting in purification rites.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family Apiaceae that contains COUMARINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family BRASSICACEAE best known for the edible roots.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CARYOPHYLLACEAE. It is a source of SAPONINS. The common name %22%Soapwort%22% is also used with VACCARIA. The common name of %22%Bouncing Bet%22% is occasionally used with VIOLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CHENOPODIACEAE. It is a source of furonaphthoquinones. The common name of burning bush is also used with the unrelated EUONYMUS sieboldianus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CLUSIACEAE. It is a source of hydroxycitric acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CLUSIACEAE. The common name of %27%Bitter Kola%27% is sometimes also used to refer to COLA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CUCURBITACEAE that is a source of TRICHOSANTHIN %28%a ribosomal inhibitory protein%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CUCURBITACEAE, order Violales, subclass Dilleniidae known for the melon fruits with reticulated %28%net%29% surface including cantaloupes, honeydew, casaba, and Persian melons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family CUCURBITACEAE. It is a source of ribosome-inactivating proteins and triterpene glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family EUPHORBIACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family Ephedraceae, order Ephedrales, class Gnetopsida, division Gnetophyta. It is a source of EPHEDRINE and other alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family FABACEAE that yields edible seeds, the familiar peanuts, which contain protein, oil and lectins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family FABACEAE used to study GENETICS because it is DIPLOID, self fertile, has a small genome, and short generation time.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family FABACEAE widely cultivated for animal feed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family FABACEAE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family Moringaceae, order Capparales, subclass Dilleniidae. It is a source of niaziminin and hypotensive thiocarbamate glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains POKEWEED MITOGENS, triterpene glycosides, and antiviral protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family PHYTOLACCACEAE. The root has been used in traditional medicine and contains SAPONINS used to poison SNAILS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family POACEAE that is widely cultivated for its edible seeds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family POACEAE. It is a tall grass grown for its seed, corn, used as food and animal fodder.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family POLYGONACEAE. Itadori tea is prepared from the root of this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family SOLANACEAE, native of South America, widely cultivated for their edible, fleshy, usually red fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family VACCINIUM known for the sour fruit which is sometimes used for urinary tract infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family VACCINIUM. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the family VISCACEAE, order Santalales, subclass Rosidae. This is the traditional mistletoe of literature and Christmas. Members contain viscotoxin %28%5 kDa basic polypeptides related to thionins%29%, beta-galactoside- and N-acetyl-D-galactosamine-specific lectin II %28%60 kDa%29%, and polysaccharides. Mistletoe lectin I is a type 2 ribosome-inactivating protein. Commercial extracts include Plenosol, Eurixor, Helixor Isorel, Iscador, and NSC 635089 %28%ANTINEOPLASTIC AGENTS, PHYTOGENIC%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus ARTEMISIA, family ASTERACEAE that has been used in ABSINTHE. The oil contains neurotoxic 1-thujone and d-isothujone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus ARTEMISIA, family ASTERACEAE. It is the source of the antimalarial artemisinin %28%ANTIMALARIALS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus ATROPA, family SOLANACEAE that contains ATROPINE; SCOPOLAMINE; BELLADONNA ALKALOIDS and other SOLANACEOUS ALKALOIDS. Some species in this genus are called deadly nightshade which is also a common name for SOLANUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus CHRYSANTHEMUM, family ASTERACEAE. The flowers contain PYRETHRINS, cinerolones, and chrysanthemines which are powerful contact insecticides. Most in the old Pyrethrum genus are reclassified to TANACETUM; some to other ASTERACEAE genera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus CINNAMOMUM that contains CINNAMATES and has been used in traditional Chinese medicine %28%DRUGS, CHINESE HERBAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus CITRUS, family RUTACEAE that provides the familiar grapefruit. There is evidence that grapefruit juice inhibits CYTOCHROME P-450 isoform 3A4, resulting in delayed metabolism and higher blood levels of a variety of drugs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus CITRUS, family RUTACEAE that provides the familiar lime fruit. Its common name of lime is similar to the limetree %28%TILIA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus CITRUS, family RUTACEAE that provides the familiar orange fruit which is also a source of orange oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus CYNARA, family ASTERACEAE. The flower bud is the familiar artichoke eaten as a vegetable.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus Chenopodium known for toxicity to intestinal worms and other simple organisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus DATURA, family SOLANACEAE, that contains TROPANES and other SOLANACEOUS ALKALOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus GYMNEMA that contains gymnemic acid %28%triterpene SAPONINS%29% which affects blood sugar level and gurmarin protein. The common name of Gurmar should not be confused with Guar %28%CYAMOPSIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus IPOMOEA, family CONVOLVULACEAE. An abundance of spontaneous mutants makes it useful in study of PLANT DNA and GENETICS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus IPOMOEA, family CONVOLVULACEAE. Some cultivars are sweet and edible whereas bitter varieties are a source of SAPONINS. This sweet potato is sometimes referred to as a yam %28%DIOSCOREA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus LEPIDIUM, family BRASSICACEAE that is a fast-growing, often weedy native of western Asia. It is widely grown, especially in its curl-leaved form, and used as a garnish%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus MELIA, family MELIACEAE, which is toxic to insects. The name is very similar to Melia azadirachta %28%AZADIRACHTA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus OCIMUM, family LAMIACEAE. It is a condiment with carminative properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus PINUS that contains isocupressic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus PINUS which is the source of pinosylvin. It is sometimes called Scotch pine or Scots pine, which is also a common name for other species of this genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus PINUS which is the subject of genetic study.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus SCUTELLARIA, family LAMIACEAE, that contains skullcapflavone and is used in CHINESE HERBAL DRUGS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus SOLANUM, family SOLANACEAE that causes CALCINOSIS in grazing livestock due to high levels of 1a,25-dihydroxy vitamin D3 %28%CALCITRIOL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus SOLANUM, family SOLANACEAE that contains steroidal glycosides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus SOLANUM, family SOLANACEAE. The fruit is a large, egg-shaped berry, varying in color from dark purple to red, yellowish, or white. The leaves are large and ovate. The flowers are pendant, violet, and two inches across.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus SOLANUM, family SOLANACEAE. The starchy roots are used as food. SOLANINE is found in green parts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus STEPHANIA, family MENISPERMACEAE, that contains tetrandrine and bisbenzylisoquinoline alkaloids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus Urtica, family URTICACEAE. Roots have been used to treat PROSTATIC HYPERPLASIA. Leaves are edible after the stinging quality is eliminated by brief heating.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus VACCINIUM. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus VICIA, family FABACEAE. The edible beans are well known but they cause FAVISM in some individuals with GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY. This plant contains vicine, convicine, Vicia lectins, unknown seed protein, AAP2 transport protein, and Vicia faba DNA-binding protein 1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species of the genus VICIA, family FABACEAE. The seed is used for food and contains THIOCYANATES such as prunasin, cyanoalanine, cyanogen, and vicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species which is known as an Oriental traditional medicinal plant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant species, of the genus OENOTHERA, family ONAGRACEAE, that is the source of evening primrose oil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plant subclass of the class Liliopsida %28%monocotyledons%29% in the Chronquist classification system. This is equivalent to the Alismatales order in the APG classification system. It is a primitive group of more or less aquatic plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes; it was formerly called Antithrombin II %28%AT II%29% which has now been shown to be identical to AT III; ANTITHROMBIN III DEFICIENCY, hereditary or acquired, results in thromboembolism. It is a member of the serpin superfamily. Some authors use the term antithrombin to refer to antithrombin III.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma cell dyscrasia resembling leukemia with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an IMMUNOGLOBULIN M monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma membrane exchange glycoprotein transporter that functions in intracellular pH regulation, cell volume regulation, and cellular response to many different hormones and mitogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma protein that circulates in increased amounts during inflammation and after tissue damage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with PREKALLIKREIN. HMWK is split by plasma kallikrein to produce BRADYKININ. The complex is a cofactor in the activation of coagulation factor XII. The product of this reaction, XIIa, in turn activates prekallikrein to KALLIKREINS. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasma serine proteinase that cleaves the alpha-chains of C3b and C4b in the presence of the cofactors COMPLEMENT FACTOR H and C4-binding protein, respectively. It is a 66-kDa glycoprotein that converts C3b to inactivated C3b %28%iC3b%29% followed by the release of two fragments, C3c %28%150-kDa%29% and C3dg %28%41-kDa%29%. It was formerly called KAF, C3bINF, or enzyme 3b inactivator.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasmid whose presence in the cell, either extrachromosomal or integrated into the BACTERIAL CHROMOSOME, determines the %22%sex%22% of the bacterium, host chromosome mobilization, transfer via conjugation %28%CONJUGATION, GENETIC%29% of genetic material, and the formation of SEX PILI.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plastic operation on the esophagus. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plastic substance deposited by insects or obtained from plants. Waxes are esters of various fatty acids with higher, usually monohydric alcohols. The wax of pharmacy is principally yellow wax %28%beeswax%29%, the material of which honeycomb is made. It consists chiefly of cerotic acid and myricin and is used in making ointments, cerates, etc. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plastic surgical operation on the nose, either reconstructive, restorative, or cosmetic. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plasticizer used in most plastics and found in water, air, soil, plants and animals. It may have some adverse effects with long-term exposure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A plate of fibrous tissue that divides the temporomandibular joint into an upper and lower cavity. The disk is attached to the articular capsule and moves forward with the condyle in free opening and protrusion. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p92%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pleuropneumonia of cattle and goats caused by species of MYCOPLASMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A political and economic system characterized by individual rights, by private or corporate ownership of capital goods, and by prices, production, and the distribution of goods that are determined mainly by competition in a free market. %28%From Merriam-Webster%27%s Collegiate Dictionary, 10th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A political subdivision of eastern RUSSIA located within Europe. It consists of a plateau and mountainous area of the Southern Urals. %28%From Webster%27%s New Geographical Dictionary, 1997%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A poly%28%A%29% binding protein that has a variety of functions such as mRNA stabilization and protection of RNA from nuclease activity. Although poly%28%A%29% binding protein I is considered a major cytoplasmic RNA-binding protein it is also found in the CELL NUCLEUS and may be involved in transport of mRNP particles.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A poly%28%A%29% binding protein that is involved in promoting the extension of the poly A tails of MRNA. The protein requires a minimum of ten ADENOSINE nucleotides in order for binding to mRNA. Once bound it works in conjunction with CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR to stimulate the rate of poly A synthesis by POLY A POLYMERASE. Once poly-A tails reach around 250 nucleotides in length poly%28%A%29% binding protein II no longer stimulates POLYADENYLATION. Mutations within a GCG repeat region in the gene for poly%28%A%29% binding protein II have been shown to cause the disease MUSCULAR DYSTROPHY, OCULOPHARYNGEAL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. %28%From AMA Drug Evaluations Annual, 1992, p1643%29% It has also been shown to have potent antineoplastic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. %28%Proc Soc Exp Biol Med 1994 Dec:207%28%3%29%:302-308%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polychlorinated compound used for controlling a variety of insects. It is practically water-insoluble, but readily adheres to clay particles and persists in soil and water for several years. Its mode of action involves repetitive nerve-discharges positively correlated to increase in temperature. This compound is extremely toxic to most fish. %28%From Comp Biochem Physiol %28%C%29% 1993 Jul;105%28%3%29%:347-61%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polychlorinated pesticide that is resistant to destruction by light and oxidation. Its unusual stability has resulted in difficulties in residue removal from water, soil, and foodstuffs. This substance may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens %28%NTP-85-002, 1985%29%. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyester used for absorbable sutures %26% surgical mesh, especially in ophthalmic surgery. 2-Hydroxy-propanoic acid polymer with polymerized hydroxyacetic acid, which forms 3,6-dimethyl-1,4-dioxane-dione polymer with 1,4-dioxane-2,5-dione copolymer of molecular weight about 80,000 daltons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polygonal anastomosis at the base of the brain formed by the internal carotid %28%CAROTID ARTERY, INTERNAL%29%, proximal parts of the anterior, middle, and posterior cerebral arteries %28%ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; POSTERIOR CEREBRAL ARTERY%29%, the anterior communicating artery and the posterior communicating arteries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyhedral CARBON structure composed of around 60-80 carbon atoms in pentagon and hexagon configuration. They are named after Buckminster Fuller because of structural resemblance to geodesic domes. Fullerenes can be made in high temperature such as arc discharge in an inert atmosphere.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyhydric alcohol with about half the sweetness of sucrose. Sorbitol occurs naturally and is also produced synthetically from glucose. It was formerly used as a diuretic and may still be used as a laxative and in irrigating solutions for some surgical procedures. It is also used in many manufacturing processes, as a pharmaceutical aid, and in several research applications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polymer obtained by reacting polyacrylic acid with a special anion-leachable glass %28%alumino-silicate%29%. The resulting cement is more durable and tougher than others in that the materials comprising the polymer backbone do not leach out.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polymer prepared from polyvinyl acetates by replacement of the acetate groups with hydroxyl groups. It is used as a pharmaceutic aid and ophthalmic lubricant as well as in the manufacture of surface coatings artificial sponges, cosmetics, and other products.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polymeric mixture of polyesters of phosphoric acid and phloretin. It blocks some cellular responses to prostaglandins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polynucleotide formed from the ADP-RIBOSE moiety of nicotinamide-adenine dinucleotide %28%NAD%29% by POLY%28%ADP-RIBOSE%29% POLYMERASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide antibiotic mixture obtained from Bacillus brevis. It consists of a mixture of three tyrocidines %28%60%25%%29% and several gramicidins %28%20%25%%29% and is very toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. It is used topically.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide hormone %28%84 amino acid residues%29% secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide hormone produced in the HYPOTHALAMUS that inhibits the release of PROLACTIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide hormone produced in the HYPOTHALAMUS, and other tissues and organs. It inhibits the release of growth hormone %28%SOMATOTROPIN%29%, and also modulates important physiological functions of the kidney, pancreas, and gastrointestinal tract. Somatostatin receptors are widely expressed throughout the body. Somatostatin also acts as a neurotransmitter in the central and peripheral nervous systems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones %28%BONE AND BONES%29% and teeth %28%TOOTH%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypeptide that is secreted by the adenohypophysis %28%PITUITARY GLAND, ANTERIOR%29%. Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polypoid granulomatous projection into the lumen of the larynx.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyposis syndrome due to an autosomal dominant mutation of the APC genes %28%GENES, APC%29% on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood. The lifetime risk of colorectal cancer in these patients reaches 100 percent by age 60.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyspecific transporter for organic cations found primarily in the kidney. It mediates the coupled exchange of alpha-ketoglutarate with organic ions such as P-AMINOHIPPURIC ACID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polysymptomatic condition believed by clinical ecologists to result from immune dysregulation induced by common foods, allergens, and chemicals, resulting in various physical and mental disorders. The medical community has remained largely skeptical of the existence of this %22%disease%22%, given the plethora of symptoms attributed to environmental illness, the lack of reproducible laboratory abnormalities, and the use of unproven therapies to treat the condition. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A polyvinyl resin used extensively in the manufacture of plastics, including medical devices, tubing, and other packaging. It is also used as a rubber substitute.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A portion of the animal phylum Chordata comprised of the subphyla Cephalochordata, UROCHORDATA, and HYPEROTRETI, but not including the Vertebrata %28%VERTEBRATES%29%. It includes nonvertebrate animals having a NOTOCHORD during some developmental stage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A portion of the nucleus of ansa lenticularis located medial to the posterior limb of the internal capsule, along the course of the ansa lenticularis and the inferior thalamic peduncle or as a separate nucleus within the internal capsule adjacent to the medial GLOBUS PALLIDUS %28%NeuroNames, http://rprcsgi.rprc. washington.edu/neuronames/ %28%September 28, 1998%29%%29%. In non-primates, the entopeduncular nucleus is analogous to both the medial globus pallidus and the entopeduncular nucleus of human.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A positive inotropic cardiotonic %28%CARDIOTONIC AGENTS%29% with vasodilator properties, phosphodiesterase inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes %28%GENE EXPRESSION REGULATION%29%, mRNAs %28%RNA, MESSENGER%29%, and proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A positive-stranded RNA virus species in an unassigned genus, Hepatitis E-like Viruses, causing enterically-transmitted non-A, non-B hepatitis %28%HEPATITIS E%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A positively charged protein found in peripheral nervous system myelin. Sensitive immunological techniques have demonstrated that P2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis %28%NEURITIS, EXPERIMENTAL ALLERGIC%29%, the peripheral nervous system counterpart of experimental allergic encephalomyelitis. %28%From Siegel et al., Basic Neurochemistry, 5th ed, p133%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A post-translational modification of proteins by the attachment of an isoprenoid to the C-terminal cysteine residue. The isoprenoids used, farnesyl diphosphate or geranylgeranyl diphosphate, are derived from the same biochemical pathway that produces cholesterol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p827%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potassium-channel opener that produces direct peripheral vasodilatation of the arterioles. It reduces blood pressure and peripheral resistance and produces fluid retention. %28%Martindale The Extra Pharmacopoeia, 31st ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. %28%Martindale, The Extra Pharmacopoeia, 30th ed, p352%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potassium-selective ion channel blocker. %28%From J Gen Phys 1994;104%28%1%29%:173-90%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent HIV protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent and durable analog of naturally occurring gonadotropin-releasing hormone %28%GONADORELIN%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent and long acting analog of naturally occurring gonadotropin-releasing hormone %28%GONADORELIN%29%. Its action is similar to gonadorelin, which regulates the synthesis and release of pituitary gonadotropins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent androgenic metabolite of TESTOSTERONE. Dihydrotestosterone %28%DHT%29% is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to ESTRADIOL therefore DHT is considered a pure androgenic steroid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent antagonist of CALCIUM CHANNELS that is highly selective for vascular smooth muscle. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent direct-acting peripheral vasodilator %28%VASODILATOR AGENTS%29% that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p371%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent epoxide hydrase and aryl hydrocarbon hydroxylase inhibitor. It enhances the tumor-initiating ability of certain carcinogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent excitatory amino acid antagonist with a preference for non-NMDA iontropic receptors. It is used primarily as a research tool.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent eye, throat, and skin irritant. One of its uses is as a riot control agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent inhibitor of membrane metalloendopeptidase %28%ENKEPHALINASE%29%. Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent inhibitor of the high affinity uptake system for CHOLINE. It has less effect on the low affinity uptake system. Since choline is one of the components of ACETYLCHOLINE, treatment with hemicholinium can deplete acetylcholine from cholinergic terminals. Hemicholinium 3 is commonly used as a research tool in animal and in vitro experiments.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent local anesthetic of the ester type used for surface and spinal anesthesia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent mast cell degranulator. It is involved in histamine release.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent mutagen and carcinogen. It is a reduction product of 4-NITROQUINOLINE-1-OXIDE. It binds with nucleic acids and inactivates both bacteria and bacteriophage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent mycotoxin produced in feedstuffs by several species of the genus FUSARIUM. It elicits a severe inflammatory reaction in animals and has teratogenic effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1078%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent nitrofuran derivative tumor initiator. It causes bladder tumors in all animals studied and is mutagenic to many bacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent noncompetitive antagonist of the NMDA receptor %28%RECEPTORS, N-METHYL-D-ASPARTATE%29% used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent oxidant synthesized by the cell during its normal metabolism. Peroxynitrite is formed from the reaction of two free radicals, NITRIC OXIDE and the superoxide anion %28%SUPEROXIDES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent phosphodiesterase inhibitor proposed as an antipsychotic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent skin irritating sesquiterpene lactone isolated from the roots of Thapsia garganica L. %28%Apiaceae%29%. It also acts as a non-phorbol-ester-type tumor promoter which discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca%28%2+%29%-ATPase. %28%Biochem Pharmacol 1987;36%28%5%29%:621-6; Proc Natl Acad Sci USA 1991;88%28%16%29%:7096-100%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries, without any effects on heart rate, blood pressure or cardiac output.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV infection and AIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potentially fatal syndrome associated primarily with the use of neuroleptic agents %28%see ANTIPSYCHOTIC AGENTS%29% which are in turn associated with dopaminergic receptor blockade %28%see RECEPTORS, DOPAMINE%29% in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. %28%From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49%28%9%29%:1163-72%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potentially life-threatening condition in which the EMBRYO implants outside the cavity of the UTERUS. Most ectopic pregnancies %28%%3E%96%25%%29% occur in the FALLOPIAN TUBES, known as TUBAL PREGNANCY. They can be in other locations, such as UTERINE CERVIX; OVARY; and abdominal cavity %28%PREGNANCY, ABDOMINAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pouch or sac opening from the COLON. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powder preparation of dried thyroid glands after the removal of fat and connective tissue. It is a yellowish to buff-colored amorphous powder containing 0.17-0.23%25% of iodine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powder that dissolves in water, which is administered orally, and is used as a diuretic, expectorant, systemic alkalizer, and electrolyte replenisher.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powerful flexor of the thigh at the hip joint %28%psoas major%29% and a weak flexor of the trunk and lumbar spinal column %28%psoas minor%29%. Psoas is derived from the Greek %22%psoa%22%, the plural meaning %22%muscles of the loin%22%. It is a common site of infection manifesting as abscess %28%PSOAS ABSCESS%29%. The psoas muscles and their fibers are also used frequently in experiments in muscle physiology.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powerful herbicide used as a selective weed killer. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powerful synthetic, non-steroidal estrogen. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A poxvirus infection of cattle characterized by the appearance of nodules on all parts of the skin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses %28%cankers%29% in the upper digestive and respiratory tracts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A practice whereby tokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pre-emergence, selective herbicide for the control of wild oats in various crops.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pre-emergent herbicide. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A precision device used for attaching a fixed or removable partial denture to the crown of an abutment tooth or a restoration. One type is the intracoronal attachment and the other type is the extracoronal attachment. It consists of a female portion within the coronal portion of the crown of an abutment and a fitted male portion attached to the denture proper. %28%Jablonski, Dictionary of Dentistry, 1992, p85; from Boucher%27%s Clinical Dental Terminology, 4th ed, p264%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A preconceived judgment made without adequate evidence and not easily alterable by presentation of contrary evidence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A precursor of insulin, with a molecular weight of 8,000 to 10,000. It has minimum hormonal activity and is converted to insulin by removal of the connecting C peptide, leaving the two %28%A and B%29%-chain, active insulin molecule. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A precursor of noradrenaline that is used in the treatment of parkinsonism. The racemic form %28%DL-threo-3,4-dihydroxyphenylserine%29% has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson%27%s disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease. Administration of DL-threo-3,4-dihydroxyphenylserine has been claimed to result in an improvement in this phenomenon but controlled studies have failed to demonstrate improvement. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A precursor protein, MW 30,000, synthesized mainly in the anterior pituitary gland but also found in the hypothalamus, brain, and several peripheral tissues. It incorporates the amino acid sequences of ACTH and beta-lipotropin. These two hormones, in turn, contain the biologically active peptides MSH, corticotropin-like intermediate lobe peptide, alpha-lipotropin, endorphins, and methionine enkephalin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A precursor to the AMYLOID-BETA PROTEIN %28%beta/A4%29%. Alterations in the expression of the amyloid beta-protein precursor %28%ABPP%29% gene, located on chromosome 21, plays a role in the development of the neuropathology common to both ALZHEIMER DISEASE and DOWN SYNDROME. ABPP is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/A4 %28%695 amino acids%29% or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in ALZHEIMER DISEASE; DOWN SYNDROME and, to a limited extent, in normal aging.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prediction of the probable outcome of a disease based on a individual%27%s condition and the usual course of the disease as seen in similar situations.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A predominantly X-linked recessive syndrome characterized by a triad of reticular skin pigmentation, nail dystrophy and leukoplakia of mucous membranes. Oral and dental abnormalities may also be present. Complications are a predisposition to malignancy and bone marrow involvement with pancytopenia. %28%from Int J Paediatr Dent 2000 Dec;10%28%4%29%:328-34%29% The X-linked form is also known as Zinsser-Cole-Engman syndrome and involves the gene which encodes a highly conserved protein called dyskerin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pregnane found in the urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A premature contraction of the heart that is initiated somewhere other than the sinoatrial node.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prenatal ultrasonic measurement of the thickness or translucent area below the SKIN in the back of the fetal NECK, or nape of the neck, during the first 11-14 weeks of gestation %28%PREGNANCY TRIMESTER, FIRST%29%. Abnormal thickness or nuchal translucent measurements resulting from fluid collection, is associated with increased risks of CHROMOSOME ABNORMALITIES. %28%Nicolaides et al., 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prepaid health insurance plan for costs of physicians%27% services.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prepaid health insurance plan for hospital costs and related services. It usually excludes physicians%27% services %28%which are covered under BLUE SHIELD%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A preparation of hog pancreatic enzymes standardized for lipase content.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary headache disorder that is characterized by frequent short-lasting, unilateral, neuralgiform pain attacks in the ocular area, with CONJUNCTIVA fluid-filling and tearing. SUNCT syndrome is usually resistant to treatment.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary headache disorder that is characterized by severe, strictly unilateral PAIN which is orbital, supraorbital, temporal or in any combination of these sites, lasting 15-180 min. occurring 1 to 8 times a day. The attacks are associated with one or more of the following, all of which are ipsilateral: conjunctival injection, lacrimation, nasal congestion, rhinorrhea, facial SWEATING, eyelid EDEMA, and miosis. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary headache disorder that is similar to the CLUSTER HEADACHE with unilateral head pain, but differs by its multiple short severe attacks. It is usually seen in females, and may be responsive to non-steroidal-anti-inflammatory drugs %28%NSAIDS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary malignant neoplasm of the pancreatic ISLET CELLS. Usually it involves the non-INSULIN-producing cell types, the PANCREATIC ALPHA CELLS and the pancreatic delta cells %28%SOMATOSTATIN-SECRETING CELLS%29% in GLUCAGONOMA and SOMATOSTATINOMA, respectively.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. %28%Morse %26% Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A primitive form of digestive gland found in marine ARTHROPODS, that contains cells similar to those found in the mammalian liver %28%HEPATOCYTES%29%, and the PANCREAS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A principal or polar form of LEPROSY in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy %28%LEPROSY, LEPROMATOUS%29%, the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A principality in the Pyrenees between France and Spain. Its capital is also called Andorra. %28%From Webster%27%s New Geographical Dictionary, 1988, p50%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A principle that learning is facilitated when the learner receives immediate evaluation of learning performance. The concept also hypothesizes that learning is facilitated when the learner is promptly informed whether a response is correct, and, if incorrect, of the direction of error.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prion disease found exclusively among the Fore linguistic group natives of the highlands of NEW GUINEA. The illness is primarily restricted to adult females and children of both sexes. It is marked by the subacute onset of tremor and ataxia followed by motor weakness and incontinence. Death occurs within 3-6 months of disease onset. The condition is associated with ritual cannibalism, and has become rare since this practice has been discontinued. Pathologic features include a noninflammatory loss of neurons that is most prominent in the cerebellum, glial proliferation, and amyloid plaques. %28%From Adams et al., Principles of Neurology, 6th ed, p773%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pro-apoptotic protein and member of the Bcl-2 protein family that is regulated by PHOSPHORYLATION. Unphosphorylated Bad protein inhibits the activity of BCL-XL PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. The small incision allows the surgeon to use very few or even no stitches to close the tiny wound. There is usually no need for hospitalization and patients may resume most activities within days. %28%Cline, et al., Dictionary of Visual Science, 4th ed %26% In Focus 1993;1%28%1%29%:1%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure for smoothing of the roughened root surface or cementum of a tooth after subgingival curettage or scaling, as part of periodontal therapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure in which a laparoscope %28%LAPAROSCOPES%29% is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure in which fluid is withdrawn from a body cavity via a trocar and cannula, needle, or other hollow instrument.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure in which the therapist refrains from directing the client, but instead reflects back to the client what the latter has said, sometimes restating the client%27%s remark.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure in which total right atrial or total caval blood flow is channeled directly into the pulmonary artery or into a small right ventricle that serves only as a conduit. The principal congenital malformations for which this operation is useful are TRICUSPID ATRESIA and single ventricle with pulmonary stenosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure that modifies the refractive error of the lens by the transplantation of a donor cornea to the anterior surface of the patient%27%s cornea. The basic indication for epikeratophakia is the incapability of correcting refractive errors with conservative methods, such as glasses, contact lenses, or intraocular lenses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals %28%CARDIOPLEGIC SOLUTIONS%29% or cold temperature %28%such as chilled perfusate%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A procedure to treat myopia by cutting radial slits into the cornea to flatten it and thereby change its refractive properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process by which an individual unconsciously endeavors to pattern himself after another. This process is also important in the development of the personality, particularly the superego or conscience, which is modeled largely on the behavior of adult significant others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process in psychotherapy in which the patient is %22%desensitized%22% to emotionally painful, often forgotten %28%repressed%29% memories by recalling and reacting to them in the %22%safety%22% of the treatment setting.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen %28%METHOXSALEN%29% and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of GENETIC TRANSLATION whereby the formation of a peptide chain is started. It includes assembly of the RIBOSOME components, the MESSENGER RNA coding for the polypeptide to be made, INITIATOR TRNA, and PEPTIDE INITIATION FACTORS; and placement of the first amino acid in the peptide chain. The details and components of this process are unique for prokaryotic protein biosynthesis and eukaryotic protein biosynthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of GENETIC TRANSLATION whereby the last amino acid is added to a lengthening polypeptide. This termination is signaled from the MESSENGER RNA, by one of three termination codons %28%CODON, TERMINATOR%29% that immediately follows the last amino acid-specifying CODON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of GENETIC TRANSLATION, when an amino acid is transferred from its cognate TRANSFER RNA to the lengthening chain of PEPTIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of differentiation having for its goal the development of the individual personality.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of preserving animal hides by chemical treatment %28%using vegetable tannins, metallic sulfates, and sulfurized phenol compounds, or syntans%29% to make them immune to bacterial attack, and subsequent treatments with fats and greases to make them pliable. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1, the conversion of cytosine to uracil in mRNA; 2, the addition of variable number of guanines at pre-determined sites; and 3, the addition and deletion of uracils, templated by guide-RNAs %28%RNA, GUIDE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process that includes the determination of an amino acid sequence of a protein %28%or peptide, oligopeptide or peptide fragment%29% and the information analysis of the sequence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process whereby bile is delivered from the gallbladder into the duodenum. The emptying is caused by both contraction of the gallbladder and relaxation of the sphincter mechanism at the choledochal terminus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prodromal phase of infection with the human immunodeficiency virus %28%HIV%29%. Laboratory criteria separating AIDS-related complex %28%ARC%29% from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi%27%s sarcoma, signaling the transition to the full-blown AIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product formed from skin, white connective tissue, or bone COLLAGEN. It is used as a protein food adjuvant, plasma substitute, hemostatic, suspending agent in pharmaceutical preparations, and in the manufacturing of capsules and suppositories.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product from the iodination of tyrosine. In the biosynthesis of thyroid hormones %28%THYROXINE and TRIIODOTHYRONINE%29%, tyrosine is first iodized to monoiodotyrosine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product of COMPLEMENT ACTIVATION cascade, regardless of the pathways, that forms transmembrane channels causing disruption of the target CELL MEMBRANE and cell lysis. It is formed by the sequential assembly of terminal complement components %28%COMPLEMENT C5B; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; and COMPLEMENT C9%29% into the target membrane. The resultant C5b-8-poly-C9 is the %22%membrane attack complex%22% or MAC.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product of putrefaction. Poisonous. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product of the PLACENTA, and DECIDUA, secreted into the maternal circulation during PREGNANCY. It has been identified as an IGF binding protein %28%IGFBP%29%-4 protease that proteolyzes IGFBP-4 and thus increases IGF bioavailability. It is found also in human FIBROBLASTS, ovarian FOLLICULAR FLUID, and GRANULOSA CELLS. The enzyme is a heterotetramer of about 500-kDa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product of the lysis of plasminogen %28%profibrinolysin%29% by PLASMINOGEN activators. It is composed of two polypeptide chains, light %28%B%29% and heavy %28%A%29%, with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A product of the p16 tumor suppressor gene %28%GENES, P16%29%. It is also called INK4 or INK4A because it is the prototype member of the INK4 CYCLIN-DEPENDENT KINASE INHIBITORS. This protein is produced from the alpha mRNA transcript of the p16 gene. The other gene product, produced from the alternatively spliced beta transcript, is TUMOR SUPPRESSOR PROTEIN P14ARF. Both p16 gene products have tumor suppressor functions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A professional society in the United States whose membership is composed of hospitals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progesterone that has been used in ESTRUS SYNCHRONIZATION and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of ACNE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A programmed mutation process whereby changes are introduced to the nucleotide sequence of immunoglobulin gene DNA during development.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. %28%From Brain 1998 Jan;121%28%Pt 1%29%:115-26%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progressive neurodegenerative condition of the central and autonomic nervous systems characterized by atrophy of the preganglionic lateral horn neurons of the thoracic spinal cord, which differentiates this condition from other forms of idiopathic orthostatic hypotension %28%HYPOTENSION, ORTHOSTATIC%29%. This disease is generally considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Affected individuals present in the fifth or sixth decade with orthostasis and bladder dysfunction; and later develop FECAL INCONTINENCE; anhidrosis; ATAXIA; IMPOTENCE; and alterations of tone suggestive of basal ganglia dysfunction. %28%From Adams et al., Principles of Neurology, 6th ed, p536%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion %28%i.e. a tendency to fall backwards%29%, rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition %28%LEWY BODY DISEASE, DIFFUSE%29% characterized by dementia in combination with varying degrees of parkinsonism. %28%Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. It is classified according to degree of cell differentiation as acute or chronic, and according to predominant type of cell involved as myelogenous or lymphocytic. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A projective technique which focuses primarily on the dynamics of interpersonal relationships. It consists of a series of 31 pictures that depict various social situations and interpersonal relations. A subset is selected by the examiner and presented to the subject who is asked to tell a story about each picture. The stories are interpreted in terms of the subject%27%s relations to authority figures, to contemporaries of both sexes, and in terms of the compromises between external demands and the needs of the id, the ego, and the superego. %28%From Campbell, Psychiatric Dictionary, 1996%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject%27%s responses to inkblot prints are scored along with subjective interpretation by the test administrator.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prokaryotic ATP-dependent protease that plays a role in the degradation of many abnormal proteins. It is a tetramer of 87-kDa subunits, each of which contains a proteolytic site and a ATP-binding site.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prokaryotic initiation factor that plays a role in recycling of ribosomal subunits for a new round of translational initiation. It binds to 16S RIBOSOMAL RNA and stimulates the dissociation of vacant 70S ribosomes. It may also be involved in the preferential binding of initiator tRNA to the 30S initiation complex.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proline analog that acts as a stoichiometric replacement of proline. It causes the production of abnormal proteins with impaired biological activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proline-directed serine/threonine protein kinase which mediates signal transduction from the cell surface to the nucleus. Activation of the enzyme by phosphorylation leads to its translocation into the nucleus where it acts upon specific transcription factors. p40 MAPK and p41 MAPK are isoforms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition %28%see also EPILEPSIA PARTIALIS CONTINUA%29%. Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. %28%From N Engl J Med 1998 Apr 2;338%28%14%29%:970-6; Neurologia 1997 Dec;12 Suppl 6:25-30%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. %28%From Hay et al., American Type Culture Collection, 7th ed, pp127-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A property of microorganisms which enables one microorganism to kill, injure, or inhibit the growth of a different microorganism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proposed family of bacteria belonging to the alpha-2 subgroup of PROTEOBACTERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proprotein convertase with specificity for the proproteins of PROALBUMIN; COMPLEMENT 3C; and VON WILLEBRAND FACTOR. It has specificity for cleavage near paired ARGININE residues that are separated by two amino acids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. %28%From AMA Drug Evaluations Annual, 1994, p311%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension %28%HYPERTENSION, PULMONARY%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prosthesis or restoration placed for a limited period, from several days to several months, which is designed to seal the tooth and maintain its position until a permanent restoration %28%DENTAL RESTORATION, PERMANENT%29% will replace it. %28%From Jablonski, Dictionary of Dentistry, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prosthesis that gains its support, stability, and retention from a substructure that is implanted under the soft tissues of the basal seat of the device and is in contact with bone. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prosthetic appliance for the replacement of areas of the mandible missing or defective as a result of deformity, disease, injury, or surgery.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prosthetic appliance for the replacement of areas of the maxilla, mandible, and face, missing as a result of deformity, disease, injury, or surgery. When the prosthesis replaces portions of the mandible only, it is referred to as MANDIBULAR PROSTHESIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A prosthetic restoration that reproduces the entire surface anatomy of the visible natural crown of a tooth. It may be partial %28%covering three or more surfaces of a tooth%29% or complete %28%covering all surfaces%29%. It is made of gold or other metal, porcelain, or resin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein complex comprised of COATOMER PROTEIN and ADP RIBOSYLATION FACTOR 1. It is involved in transport of vesicles between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein complex that includes CYTOCHROME B6 and CYTOCHROME F. It is found in the THYLAKOID MEMBRANE and plays an important role in process of PHOTOSYNTHESIS by transferring electrons from PLASTOQUINONE to PLASTOCYANIN or CYTOCHROME C6. The transfer of electrons is coupled to the transport of PROTONS across the membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein component of the synaptic basal lamina. It has been shown to induce clustering of acetylcholine receptors on the surface of muscle fibers and other synaptic molecules in both synapse regeneration and development.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein cytokine secreted by tumor cells. It elicits increases in cell motility and phosphoinositide metabolism in the secreting cell via a pertussis toxin-sensitive G-protein signal transduction pathway. It is closely related to PHOSPHOHEXOSE ISOMERASE; NEUROLEUKIN; and maturation factor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein extract of human menopausal urine in which LUTEINIZING HORMONE has been partially or completely removed. Urofollitropin represents FOLLICLE STIMULATING HORMONE from the urine. In highly purified preparations, LH and other urinary proteins are removed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein extracted from boiled culture of tubercle bacilli %28%MYCOBACTERIUM TUBERCULOSIS%29%. It is used in the tuberculin skin test %28%TUBERCULIN TEST%29% for the diagnosis of tuberculosis infection in asymptomatic persons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein factor that regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein found in bacteria and eukaryotic mitochondria which delivers aminoacyl-tRNA%27%s to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP. EC 3.6.1.-.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein found in the thin filaments of muscle fibers. It inhibits contraction of the muscle unless its position is modified by TROPONIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein found most abundantly in the nervous system. Defects or deficiencies in this protein are associated with NEUROFIBROMATOSIS 1, Watson syndrome, and LEOPARD syndrome. Mutations in the gene %28%GENE, NEUROFIBROMATOSIS 1%29% affect two known functions: regulation of ras-GTPase and tumor suppression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein fraction of pregnant uterine fluid which can induce and regulate blastocystic development. Blastokinin is thought to be similar or identical to uteroglobin. Presence in uterine fluid regulated by progesterone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein hormone secreted by beta cells of the pancreas. Insulin plays a major role in the regulation of glucose metabolism, generally promoting the cellular utilization of glucose. It is also an important regulator of protein and lipid metabolism. Insulin is used as a drug to control insulin-dependent diabetes mellitus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein involved in transport between the ENDOPLASMIC RETICULUM and the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein kinase C subtype that was originally characterized as a CALCIUM-independent, serine-threonine kinase that is activated by PHORBOL ESTERS and DIACYLGLYCEROLS. It is targeted to specific cellular compartments in response to extracellular signals that activate G-PROTEIN-COUPLED RECEPTORS; TYROSINE KINASE RECEPTORS; and intracellular protein tyrosine kinase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein kinase encoded by the Saccharomyces cerevisiae CDC28 gene and required for progression from the G1 PHASE to the S PHASE in the CELL CYCLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein obtainable from corn. It has a molecular weight of about 40,000. It does not contain tryptophan or lysine. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein of the annexin family isolated from human PLACENTA and other tissues. It inhibits cytosolic PHOSPHOLIPASE A2, and displays anticoagulant activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein of the annexin family that catalyzes the conversion of 1-D-inositol 1,2-cyclic phosphate and water to 1-D-myo-inositol 1-phosphate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein phytotoxin from the seeds of Ricinus communis, the castor oil plant. It agglutinates cells, is proteolytic, and causes lethal inflammation and hemorrhage if taken internally.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein serine-threonine kinase that catalyzes the PHOSPHORYLATION of I KAPPA B PROTEINS. This enzyme also activates the transcription factor NF-KAPPA B and is composed of alpha and beta catalytic subunits, which are protein kinases and gamma, a regulatory subunit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein substance of wheat which is intermixed with the starchy endosperm of the grain. It causes the carbon dioxide produced during dough fermentation to be retained by the dough in a manner which provides the porous and spongy structure of bread. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein subunit that takes part in forming nuclear factor 90 protein complexes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. %28%From J Cell Biol 1994;126%28%4%29%:1089-97%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein that has been shown to function as a calcium-regulated transcription factor as well as a substrate for depolarization-activated CALCIUM-CALMODULIN DEPENDENT PROTEIN KINASES. This protein functions to integrate both calcium and cAMP signals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein that plays a fundamental role in the Vitamin D mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein tyrosine kinase that is required for T-CELL development and T-CELL ANTIGEN RECEPTOR function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA;-RNA POLYMERASE DNA at the termination of a gene.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein which is a subunit of RNA polymerase. It effects initiation of specific RNA chains from DNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein with a molecular weight of 40,000 isolated from bacterial flagella. At appropriate pH and salt concentration, three flagellin monomers can spontaneously reaggregate to form structures which appear identical to intact flagella.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by KALLIKREINS, it forms KALLIDIN. Kallidin, in turn, is converted into BRADYKININ. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-nucleic acid complex which forms part or all of a virion. It consists of a CAPSID plus enclosed nucleic acid. Depending on the virus, the nucleocapsid may correspond to a naked core or be surrounded by a membranous envelope.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-serine-threonine kinase that is activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. It plays a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-tyrosine kinase receptor that is closely related in structure to the INSULIN RECEPTOR. Although commonly referred to as the IGF-I receptor, it binds both IGF-I and IGF-II with high affinity. It is comprised of a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precusor protein. The beta subunit contains an intrinsic tyrosine kinase domain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-tyrosine kinase receptor that is specific for BRAIN-DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; neurotrophin 4 and neurotrophin 5. It is widely expressed in nervous tissue and plays a role in mediating the effects of neurotrophins on growth and differentiation of neuronal cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-tyrosine kinase receptor that is specific for NERVE GROWTH FACTOR; NEUROTROPHIN 3; neurotrophin 4, neurotrophin 5. It plays a crucial role in pain sensation and thermoregulation in humans. Gene mutations that cause loss of receptor function are associated with congenital insensitivity to pain with anhidrosis, while gene rearrangements that activate the protein-tyrosine kinase function are associated with tumorigenesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-tyrosine kinase receptor that is specific for NEUROTROPHIN 3. It is widely expressed in nervous tissue and may play a role in mediating the effects of NEUROTROPHIN 3 on the proliferation and differentiation of NEURONS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protein-tyrosine kinase receptor that is specific for STEM CELL FACTOR. This interaction is crucial for the development of hematopoietic, gonadal, and pigment stem cells. Genetic mutations that disrupt the expression of PROTO-ONCOGENE PROTEINS C-KIT are associated with PIEBALDISM, while overexpression or constitutive activation of the c-kit protein-tyrosine kinase is associated with tumorigenesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to PLASMIN. It has fibrin-binding activity and is immunologically different from URINARY PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. EC 3.4.21.68.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proteolytic enzyme obtained from Streptomyces griseus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proteolytic enzyme obtained from the venom of fer-de-lance %28%Bothrops atrox%29%. It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Hemocoagulase is a mixture containing batroxobin and factor X activator. EC 3.4.21.-.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proteolytic enzyme that converts plasminogen to plasmin where the preferential cleavage is between arginine and valine. It was isolated originally from human urine, but is found in most tissues of most vertebrates. EC 3.4.21.73.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proto-oncogene protein and member of the Wnt family of proteins. It is expressed in the caudal MIDBRAIN and is essential for proper development of the entire mid-/hindbrain region.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proto-oncogene protein and member of the Wnt family of proteins. It is frequently up-regulated in human GASTRIC CANCER and is a tumor marker %28%TUMOR MARKERS, BIOLOGICAL%29% of gastric and COLORECTAL CANCER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite causing tropical theileriasis in cattle. It is transmitted by ticks of the Hyalomma genus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite from Southeast Asia that causes monkey malaria. It is naturally acquired by man in Malaysia and can also be transmitted experimentally to humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite of rodents transmitted by the mosquito Anopheles stephensi.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite that causes avian malaria %28%MALARIA, AVIAN%29%, primarily in chickens, and is transmitted by the Aedes mosquito.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite that causes vivax malaria %28%MALARIA, VIVAX%29%. This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite that is the etiologic agent of East Coast fever %28%THEILERIASIS%29%. Transmission is by ticks of the Physicephalus and Hyalomma genera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria %28%MALARIA, VIVAX%29%. This species has been found to give rise to both natural and experimental human infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan parasite that occurs primarily in subtropical and temperate areas. It is the causal agent of quartan malaria. As the parasite grows it exhibits little ameboid activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protozoan, previously also considered a fungus. Characteristics include sporangia that are stalked and multilobed. It is widely used in biomedical research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A protrusion of abdominal structures through the retaining ABDOMINAL WALL. It involves two parts: an opening in the abdominal wall, and a hernia sac consisting of PERITONEUM and abdominal contents. Abdominal hernias include groin hernia %28%HERNIA, FEMORAL; HERNIA, INGUINAL%29% and VENTRAL HERNIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of Canada lying between the provinces of Manitoba and Quebec. Its capital is Toronto. It takes its name from Lake Ontario which is said to represent the Iroquois oniatariio, beautiful lake. %28%From Webster%27%s New Geographical Dictionary, 1988, p892 %26% Room, Brewer%27%s Dictionary of Names, 1992, p391%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of Canada on the Pacific coast. Its capital is Victoria. The name given in 1858 derives from the Columbia River which was named by the American captain Robert Gray for his ship Columbia which in turn was named for Columbus. %28%From Webster%27%s New Geographical Dictionary, 1988, p178 %26% Room, Brewer%27%s Dictionary of Names, 1992, p81-2%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of Canada, lying between the provinces of Alberta and Manitoba. Its capital is Regina. It is entirely a plains region with prairie in the south and wooded country with many lakes and swamps in the north. The name was taken from the Saskatchewan River from the Cree name Kisiskatchewani Sipi, meaning rapid-flowing river. %28%From Webster%27%s New Geographical Dictionary, 1988, p1083 %26% Room, Brewer%27%s Dictionary of Names, 1992, p486%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of Canada, lying between the provinces of Saskatchewan and Ontario. Its capital is Winnipeg. Taking its name from Lake Manitoba, itself named for one of its islands, the name derived from Algonquian Manitou, great spirit. %28%From Webster%27%s New Geographical Dictionary, 1988, p724 %26% Room, Brewer%27%s Dictionary of Names, 1992, p332%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. %28%From Webster%27%s New Geographical Dictionary, 1988, p871 %26% Room, Brewer%27%s Dictionary of Names, 1992, p384%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of eastern Canada, one of the Maritime Provinces with NOVA SCOTIA; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND. Its capital is Fredericton. It was named in honor of King George III, of the House of Hanover, also called Brunswick. %28%From Webster%27%s New Geographical Dictionary, 1988, p828 %26% Room, Brewer%27%s Dictionary of Names, 1992, p375%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of eastern Canada. Its capital is Quebec. The region belonged to France from 1627 to 1763 when it was lost to the British. The name is from the Algonquian quilibek meaning the place where waters narrow, referring to the gradually narrowing channel of the St. Lawrence or to the narrows of the river at Cape Diamond. %28%From Webster%27%s New Geographical Dictionary, 1988, p993 %26% Room, Brewer%27%s Dictionary of Names, 1992, p440%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A province of western Canada, lying between the provinces of British Columbia and Saskatchewan. Its capital is Edmonton. It was named in honor of Princess Louise Caroline Alberta, the fourth daughter of Queen Victoria. %28%From Webster%27%s New Geographical Dictionary, 1988, p26 %26% Room, Brewer%27%s Dictionary of Names, 1992, p12%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents %28%Dorland, 27th ed%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pseudotumor of the lung composed of inflammatory cells and showing complete maturity of fibroblastic components with a striking lack of mitosis. It is also called postinflammatory pseudotumor and pseudoneoplastic pneumonitis. %28%Surg Gynecol Obstet 1983 Jan;156%28%1%29%:89-96%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychedelic phenyl isopropylamine derivative, commonly called DOM, whose mood-altering effects and mechanism of action may be similar to those of LSD.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychoactive compound extracted from the resin of Cannabis sativa %28%marihuana, hashish%29%. The isomer delta-9-tetrahydrocannabinol %28%THC%29% is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. Dronabinol is a synthetic form of delta-9-THC.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychoanalytic term meaning self-love. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychoanalytic therapy wherein each social transaction is analyzed to determine the involved ego state %28%whether parent-like, child-like, or adult-like%29% as a basis for understanding behavior.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychologic theory developed by James B. Watson concerned with studying and measuring behaviors that are observable.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychological theory based on dimensions or categories used by a given person in describing or explaining the personality and behavior of others or of himself. The basic idea is that different people will use consistently different categories. The theory was formulated in the fifties by George Kelly. Two tests devised by him are the role construct repertory test and the repertory grid test. %28%From Stuart Sutherland, The International Dictionary of Psychology, 1989%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychotic disorder characterized by the patient%27%s belief that acquaintances or closely related persons have been replaced by doubles or imposters.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. %28%From Stedman, 26th ed%29% Neopterin also serves as a precursor in the biosynthesis of biopterin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pteridine that is used as a mild diuretic. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A publication issued at stated, more or less regular, intervals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECI. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pulmonary surfactant associated protein that plays a role in alveolar stability by lowering the surface tension at the air-liquid interface. It is a membrane-bound protein that constitutes 1-2%25% of the pulmonary surfactant mass. Pulmonary surfactant-associated protein C is one of the most hydrophobic peptides yet isolated and contains an alpha-helical domain with a central poly-valine segment that binds to phospholipid bilayers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pulmonary surfactant associated-protein that plays an essential role in alveolar stability by lowering the surface tension at the air-liquid interface. Inherited deficiency of pulmonary surfactant-associated protein B is one cause of RESPIRATORY DISTRESS SYNDROME, NEWBORN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pupillary abnormality characterized by a poor pupillary light reaction, reduced accommodation, iris sector palsies, an enhanced pupillary response to near effort that results in a prolonged, %22%tonic%22% constriction, and slow pupillary redilation. This condition is associated with injury to the postganglionic parasympathetic innervation to the pupil. %28%From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp492-500%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine base and a fundamental unit of ADENINE NUCLEOTIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine base found in most body tissues and fluids, certain plants, and some urinary calculi. It is an intermediate in the degradation of adenosine monophosphate to uric acid, being formed by oxidation of hypoxanthine. The methylated xanthine compounds caffeine, theobromine, and theophylline and their derivatives are used in medicine for their bronchodilator effects. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine or pyrimidine base bonded to DEOXYRIBOSE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A purine that is an isomer of ADENINE %28%6-aminopurine%29%. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrano-acridone alkaloid found in RUTACEAE plants. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with ASTHMA, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p705%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrazine that is used therapeutically as an antitubercular agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrazole diuretic with long duration and high capacity of action. It was proposed for kidney failure and hypertension but was withdrawn worldwide because of severe neurological effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. It has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p15%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrazolodiazepinone with pharmacological actions similar to ANTI-ANXIETY AGENTS. It is commonly used in combination with TILETAMINE to obtain immobilization and anesthesia in animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrethroid insecticide commonly used in the treatment of LICE INFESTATIONS and SCABIES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridine nucleotide that mobilizes CALCIUM. It is synthesized from nicotinamide adenine dinucleotide %28%NAD%29% by ADP RIBOSE CYCLASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal phosphate enzyme that catalyzes the formation of glutamate gamma-semialdehyde and an L-amino acid from L-ornithine and a 2-keto-acid. EC 2.6.1.13.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal phosphate enzyme that catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. It also catalyzes the reaction of glycine with acetaldehyde to form L-threonine. EC 2.1.2.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal-phosphate protein that catalyzes the conversion of L-tyrosine to tyramine and carbon dioxide. The bacterial enzyme also acts on 3-hydroxytyrosine and, more slowly, on 3-hydroxyphenylalanine. %28%From Enzyme Nomenclature, 1992%29% EC 4.1.1.25.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal-phosphate protein that catalyzes the deamination of THREONINE to 2-ketobutyrate and AMMONIA. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for ISOLEUCINE biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. This enzyme was formerly listed as EC 4.2.1.16.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal-phosphate protein that reversibly catalyzes the conversion of L-alanine to D-alanine. EC 5.1.1.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. EC 4.1.1.17.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine base that is a fundamental unit of nucleic acids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. The interference with folic acid metabolism may cause a depression of hematopoiesis. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p472%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine nucleoside formed in the body by the deamination of CYTARABINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrrolidinylmethyl TETRACYCLINE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quality-of-life scale developed in the United States in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviorally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like. It measures the patient%27%s perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups. %28%From Medical Care, vol.xix, no.8, August 1981, p.787-805%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quantitative method of combining the results of independent studies %28%usually drawn from the published literature%29% and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1112%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1116%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quiescent state of cells during G1 PHASE. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p604%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quinazoline-sulfonamide that is considered a thiazide-like diuretic which is long-acting so useful in chronic RENAL FAILURE. It also tends to lower BLOOD PRESSURE and increase POTASSIUM loss.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A quinone fungicide used for treatment of seeds and foliage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rac GTP-binding protein involved in regulating actin filaments at the plasma membrane. It controls the development of filopodia and lamellipodia in cells and thereby influences cellular motility and adhesion. It is also involved in activation of NADPH OXIDASE. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A racemic mixture with a 1:1 ratio of the r-isomer, levalbuterol, and s-albuterol. It is a short-acting beta2-adrenergic agonist with its main clinical use in ASTHMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiation-protective agent that interferes with sulfhydryl enzymes. It may also protect against carbon tetrachloride liver damage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiation-protective agent that oxidizes in air to form CYSTAMINE. It can be given intravenously or orally to treat radiation sickness. The bitartrate has been used for the oral treatment of nephropathic cystinosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radioactive actinide with atomic symbol Cm, atomic number 96, and atomic weight 247. Thirteen curium isotopes have been produced with mass numbers ranging from 238-250. Its valence can be +3 or +4. It is intensely radioactive and decays by alpha-emission.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiopaque medium. It is a mixture of its meglumine and sodium salts and is used to visualize the biliary tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiopharmaceutical used extensively in cholescintigraphy for the evaluation of hepatobiliary diseases. %28%From Int Jrnl Rad Appl Inst 1992;43%28%9%29%:1061-4%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical %28%typical%29%, the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells %28%seminoma cells%29%, each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A raf 1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A raf Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A raf Protein Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A raf kinase subclass expressed primarily in non-neuronal tissues such as SKELETAL MUSCLE. The A-raf kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rapid biochemical reaction involved in the formation of proteins. It begins even before a protein has been completely synthesized and proceeds through discrete intermediates %28%primary, secondary, and tertiary structures%29% before the final structure %28%quaternary structure%29% is developed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rapid onset form of SYSTEMIC SCLERODERMA with progressive widespread SKIN thickening over the arms, the legs and the trunk, resulting in stiffness and disability.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rapid, low-dose, digital imaging system using a small intraoral sensor instead of radiographic film, an intensifying screen, and a charge-coupled device. It presents the possibility of reduced patient exposure and minimal distortion, although resolution and latitude are inferior to standard dental radiography. A receiver is placed in the mouth, routing signals to a computer which images the signals on a screen or in print. It includes digitizing from x-ray film or any other detector. %28%From MEDLINE abstracts; personal communication from Dr. Charles Berthold, NIDR%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rapid-growing, nonphotochromogenic species of MYCOBACTERIUM originally isolated from human smegma and found also in soil and water. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rapid-growing, nonphotochromogenic species that is potentially pathogenic, producing lesions of lung, bone, or soft tissue following trauma. It has been found in soil and in injection sites of humans, cattle, and cold-blooded animals. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare PARAGANGLIOMA involving the GLOMUS TYMPANICUM, a collection of chemoreceptor tissue adjacent to the TYMPANIC CAVITY. It can cause TINNITUS and conductive hearing loss %28%HEARING LOSS, CONDUCTIVE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1456%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare and probably congenital condition characterized by great enlargement of the lumen of the trachea and the larger bronchi.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare and sometimes fatal disease characterized by recurring attacks of leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, or poisoning. It can lead to generalized edema and MULTIPLE ORGAN FAILURE. %28%Zikria, et al. %28%eds.%29%, Reperfusion Injuries and Clinical Capillary Leak Syndrome, pp. 470-72, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare autosomal dominant condition in which there is defective ossification of the cranial bones with large fontanels and delayed closing of the sutures, complete or partial absence of the clavicles, wide pubic symphysis, short middle phalanges of the fifth fingers, and dental and vertebral anomalies. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. Pathologic examination reveals neuronal atrophy in the globus pallidus and iron deposition in blood vessels and perivascular spaces. %28%From Adams et al., Principles of Neurology, 6th ed, p972; Davis %26% Robertson, Textbook of Neuropathology, 2nd ed, pp972-929%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 %28%EC 3.6.3.4%29%, also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare autosomal recessive disorder of the urea cycle. It is caused by a deficiency of the hepatic enzyme ARGINASE. Arginine is elevated in the blood and cerebrospinal fluid, and periodic hyperammonemia may occur. Disease onset is usually in infancy or early childhood. Clinical manifestations include seizures, microcephaly, progressive mental impairment, hypotonia, ataxia, spastic diplegia, and quadriparesis. %28%From Hum Genet 1993 Mar;91%28%1%29%:1-5; Menkes, Textbook of Child Neurology, 5th ed, p51%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare autosomal recessive disorder resulting from the absence of CATALASE activity. Though usually asymptomatic, a syndrome of oral ulcerations and gangrene may be present.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare autosomal recessive familial disorder of cholesterol metabolism, characterized by extremely low HDL-cholesterol, reduced total cholesterol, and increased triglyceride levels in serum. Clinical features include the onset before age 20 years of HEPATOMEGALY; SPLENOMEGALY; the deposition of cholesterol in each TONSIL %28%creating a yellow-orange appearance%29%; and RETINITIS PIGMENTOSA. A sensorimotor or distal sensory POLYNEUROPATHY occurs in approximately 50%25% of affected individuals. The condition is associated with decreased synthesis and increased catabolism of APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II, and a defect in cellular signaling and mobilization of lipids. %28%From Nat Genet 1998 Sep;20%28%1%29%:96-8; Adams et al., Principles of Neurology, 6th ed, pp1347-8; Menkes, Textbook of Child Neurology, 5th ed, p118%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase. It results in an accumulation of neutral lipids, particularly cholesterol esters, within cells %28%particularly leukocytes, fibroblasts, and liver cells%29%. It is an allelic variant of WOLMAN DISEASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. %28%From Holland et al., Cancer Medicine, 3d ed, p2210%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare central nervous system demyelinating condition affecting children and young adults. Pathologic findings include a large, sharply defined, asymmetric focus of myelin destruction that may involve an entire lobe or cerebral hemisphere. The clinical course tends to be progressive and includes dementia, cortical blindness, cortical deafness, spastic hemiplegia, and pseudobulbar palsy. Concentric sclerosis of Balo is differentiated from diffuse cerebral sclerosis of Schilder by the pathologic finding of alternating bands of destruction and preservation of myelin in concentric rings. Alpers%27% Syndrome refers to a heterogeneous group of diseases that feature progressive cerebral deterioration and liver disease. %28%From Adams et al., Principles of Neurology, 6th ed, p914; Dev Neurosci 1991;13%28%4-5%29%:267-73%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare condition characterized by recurrent hypersomnias associated with hyperphagia, occurring primarily in males in the second to third decade of life. Clinical features include mental confusion, excessive sleep requirements %28%approximately 18 hours per day%29%, restlessness, and in some cases hallucinations. Episodes have a duration of days to weeks, and may recur several times per year. This condition may resolve spontaneously over several years. %28%From Adams, et al., Principles of Neurology, 6th ed, p569%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare condition of sexual ambiguity in which the individual possesses gonadal tissues of both SEXES, tissues from the OVARY and the TESTIS. There can be a testis on one side and an ovary on the other %28%lateral%29%, or there may be combined ovarian and testicular tissue %28%ovotestes%29% on each side %28%bilateral%29%. Most common karyotype is 46,XX. Others include 46,XY and 45,X/XY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare condition usually affecting one extremity, characterized by hypertrophy of the bone and related soft tissues, large cutaneous hemangiomas, persistent nevus flammeus, and skin varices. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare congenital hypoplastic anemia that usually presents early in infancy. The disease is characterized by a moderate to severe macrocytic anemia, occasional neutropenia or thrombocytosis, a normocellular bone marrow with erythroid hypoplasia, and an increased risk of developing leukemia. %28%Curr Opin Hematol 2000 Mar;7%28%2%29%:85-94%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1478%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare disease, believed to be autosomal dominant, manifested by fatty deposits that press on nerves causing weakness and pain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare epidural hematoma in the spinal epidural space, usually due to a vascular malformation %28%CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS%29% or TRAUMA. Spontaneous spinal epidural hematoma is a neurologic emergency due to a rapidly evolving compressive MYELOPATHY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins. It is due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic %28%Pick%29% bodies. %28%From Brain Pathol 1998 Apr;8%28%2%29%:339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5%25% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t%28%11;14%29% translocation resulting in overexpression of the cyclin D1 gene %28%GENES, BCL-1%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare form of non-Langerhans-cell histiocytosis %28%HISTIOCYTOSIS, NON-LANGERHANS-CELL%29% with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare inherited disorder of myelin formation. Alexander disease is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of cytoplasmic inclusions called Rosenthal fibers. The fibers contain GLIAL FIBRILLARY ACIDIC PROTEIN in association with ALPHA-CRYSTALLIN B CHAIN. Rosenthal fibers are found predominantly in ASTROCYTES located in the subependymal, subpial, and periventricular areas of the BRAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare intra-abdominal tumor in the MESENTERY. Mesenteric cysts are usually benign and can be very large fluid-filled %28%2000 mL%29% lesions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare metal element with a blue-gray appearance and atomic symbol Ge, atomic number 32, and atomic weight 72.59.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare movement disorder developed during PREGNANCY, characterized by involuntary jerky motion %28%CHOREA%29% and inability to maintain stable position of body parts %28%ATHETOSIS%29%. RHEUMATIC FEVER and collagen vascular disorders are frequently associated with this disease. Chorea may vary from mild to severe and occurs in approximately 1 per 2,000 to 3,000 pregnancies. %28%From Md Med J 1997 Sep;46%28%8%29%:436-9%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demeylination that gives rise to a spongy appearance. Aspartoacylase deficiency leads to an accumulation of N-acetylaspartate in astrocytes. Inheritance may be autosomal recessive or the illness may occur sporadically. This illness occurs more frequently in individuals of Ashkenazic Jewish descent. The neonatal form features the onset of hypotonia and lethargy at birth, rapidly progressing to coma and death. The infantile form features developmental delay, DYSKINESIAS, hypotonia, spasticity, blindness, and megalencephaly. The juvenile form is characterized by ATAXIA; OPTIC ATROPHY; and DEMENTIA. %28%From Adams et al., Principles of Neurology, 6th ed, p944; Am J Med Genet 1988 Feb;29%28%2%29%:463-71%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare neuromuscular disorder with onset usually in late childhood or early adulthood, characterized by intermittent or continuous widespread involuntary muscle contractions; FASCICULATION; hyporeflexia; MUSCLE CRAMP; MUSCLE WEAKNESS; HYPERHIDROSIS; TACHYCARDIA; and MYOKYMIA. Involvement of pharyngeal or laryngeal muscles may interfere with speech and breathing. The continuous motor activity persists during sleep and general anesthesia %28%distinguishing this condition from STIFF-PERSON SYNDROME%29%. Familial and acquired %28%primarily autoimmune%29% forms have been reported. %28%From Ann NY Acad Sci 1998 May 13;841:482-496; Adams et al., Principles of Neurology, 6th ed, p1491%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare sometimes familial disorder of the renal tubule characterized by the inability to excrete urine of normal acidity. This leads to a hyperchloremic acidosis which is often associated with one or more secondary complications such as hypercalcinuria with nephrolithiasis and nephrocalcinosis, rickets, or osteomalacia and severe potassium depletion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare syndrome characterized by UROGENITAL ABNORMALITIES; GONADAL DYSGENESIS; PSEUDOHERMAPHRODITISM; and WILMS TUMOR. It is caused by a mutation in the Wilms tumor suppressor gene %28%GENES, WILMS TUMOR%29% on chromosome 11.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare teratoid tumor of the ovary composed almost entirely of thyroid tissue, with large follicles containing abundant colloid. Occasionally there are symptoms of hyperthyroidism. 5-10%25% of struma ovarii become malignant, the only absolute criterion for which is the presence of metastasis. %28%Dorland, 27th ed; Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD %28%potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM%29% have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. %28%From N Engl J Med, 1998 Dec 31;339%28%27%29%%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: %28%1%29% clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and %28%2%29% an embryonal tumor %28%called also ENDODERMAL SINUS TUMOR and yolk sac tumor%29%, occurring chiefly in children. The latter variety may also arise in the testis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenic purpura, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, X-linked mental retardation syndrome that results from mutations in the RIBOSOMAL PROTEIN S6 KINASE gene. Typical manifestations of the disease include an intelligence quotient of less than 50, facial anomalies, and other malformations.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, benign rheumatologic disorder or syndrome characterized by hyperostosis and soft tissue ossification between the clavicles and the anterior part of the upper ribs. It is often associated with the dermatologic disorder palmoplantar pustulosis, particularly in Japan. Careful diagnosis is required to distinguish it from psoriatic arthritis, OSTEITIS DEFORMANS, and other diseases. Spondylitis of pustulosis palmaris et plantaris is one of the possible causes; also, evidence suggests one origin may be bone infection. Bone imaging is especially useful for diagnosis. It was originally described by Sonozaki in 1974.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, metallic element designated by the symbol, Ga, atomic number 31, and atomic weight 69.72.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, progressive inherited disorder resulting from extensive basophilic degeneration of elastic tissue, usually presenting after puberty and involving the skin, eye, and cardiovascular system. Characteristic manifestations are small, circumscribed yellowish patches at sites of considerable movement of the skin, ANGIOID STREAKS in the retina, and a tendency towards hemorrhage and arterial insufficiency.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, slowly progressive disorder of myelin formation. Subtypes are referred to as classic, congenital, transitional, and adult forms of this disease. The classic form is X-chromosome linked, has its onset in infancy and is associated with a mutation of the proteolipid protein gene. Clinical manifestations include TREMOR, spasmus nutans, roving eye movements, ATAXIA, spasticity, and NYSTAGMUS, CONGENITAL. Death occurs by the third decade of life. The congenital form has similar characteristics but presents early in infancy and features rapid disease progression. Transitional and adult subtypes have a later onset and less severe symptomatology. Pathologic features include patchy areas of demyelination with preservation of perivascular islands %28%trigoid appearance%29%. %28%From Menkes, Textbook of Child Neurology, 5th ed, p190%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. %28%From Adams et al., Principles of Neurology, 6th ed, pp767-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rare, usually rapidly progressive disorder, characterized by abrupt onset, fever, weight loss, hepato-splenomegaly, pancytopenia, and lymphadenopathy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rather uncommon form of familial hyperlipemia characterized by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-VLDL and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal VLDL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reaction that introduces an aminoacyl group to a molecule. TRANSFER RNA AMINOACYLATION is the first step in GENETIC TRANSLATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ready-made or custom-made prosthesis of glass or plastic shaped and colored to resemble the anterior portion of a normal eye and used for cosmetic reasons. It is attached to the anterior portion of an orbital implant %28%ORBITAL IMPLANTS%29% which is placed in the socket of an enucleated or eviscerated eye. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH %28%thiol%29% groups and for reducing disulphides to dithiols.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reagent that forms fluorescent conjugation products with primary amines. It is used for the detection of many biogenic amines, peptides, and proteins in nanogram quantities in body fluids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reagent that is highly selective for the modification of arginyl residues. It is used to selectively inhibit various enzymes and acts as an energy transfer inhibitor in photophosphorylation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reagent that is used to neutralize peptide terminal amino groups.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reagent used for the determination of iron. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, p. 89%29% published in 1985, this compound %22%may reasonably be anticipated to be a carcinogen.%22% %28%Merck, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptive visual aphasia characterized by the loss of a previously possessed ability to comprehend the meaning or significance of handwritten words, despite intact vision. This condition may be associated with posterior cerebral artery infarction %28%INFARCTION, POSTERIOR CEREBRAL ARTERY%29% and other BRAIN DISEASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor for MACROPHAGE COLONY-STIMULATING FACTOR encoded by the c-fms proto-oncogene %28%GENES, FMS%29%. It contains an intrinsic protein-tyrosine kinase activity. When activated the receptor undergoes autophosphorylation, phosphorylation of down-stream signaling molecules and rapid down-regulation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor that is specific for IGF-II and mannose-6-phosphate. The receptor is a 250-kDa single chain polypeptide which is unrelated in structure to the type 1 IGF receptor %28%RECEPTOR, IGF TYPE 1%29% and does not have a tyrosine kinase domain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor tyrosine kinase that is involved in HEMATOPOIESIS. It is closely related to FMS PROTO-ONCOGENE PROTEIN and is commonly mutated in acute MYELOID LEUKEMIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. Activated Smad3 can bind directly to DNA, and it regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. It regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS and regulates BONE MORPHOGENETIC PROTEIN signaling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and is essential for PHYSIOLOGICAL ANGIOGENESIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A receptor-regulated smad protein that undergoes PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS. It regulates BONE MORPHOGENETIC PROTEIN signaling and plays an essential role in EMBRYONIC DEVELOPMENT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recessive X-linked defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recombinant alfa interferon consisting of 165 amino acid residues with arginine in position 23 and histidine in position 34. It is used extensively as an antiviral and antineoplastic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recombinant alfa interferon consisting of 165 amino acids with arginine at positions 23 and 34. It is used extensively as an antiviral and antineoplastic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recombinant alfa interferon consisting of 165 amino acids with lysine at position 23 and histidine at position 34. It is used extensively as an antiviral and antineoplastic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recurrent contact dermatitis caused by substances found in the work place.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p742%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A red fluorescein dye used as a histologic stain. It may be cytotoxic, mutagenic, and inhibit certain mitochondrial functions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A red yeast-like mitosporic fungal genus generally regarded as nonpathogenic. It is cultured from numerous sources in human patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reduction in brain oxygen supply. Severe hypoxia is referred to as anoxia, and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives. %28%From Adams et al., Principles of Neurology, 6th ed, pp1109-11%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reduction in the amount of air entering the pulmonary alveoli.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reference book containing a list of words - usually in alphabetical order - giving information about form, pronunciation, etymology, grammar, and meaning. A foreign-language dictionary is an alphabetical list of words of one language with their meaning and equivalents in another language.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A refined petroleum fraction used as a fuel as well as a solvent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reflex wherein impulses are conveyed from the cupulas of the SEMICIRCULAR CANALS and from the OTOLITHIC MEMBRANE of the SACCULE AND UTRICLE via the VESTIBULAR NUCLEI of the BRAIN STEM and the median longitudinal fasciculus to the OCULOMOTOR NERVE nuclei. It functions to maintain a stable retinal image during head rotation by generating appropriate compensatory EYE MOVEMENTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation %28%ACCOMMODATION, OCULAR%29% is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A region extending from the PONS %26% MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A region in the mesencephalon which is dorsomedial to the substantia nigra and ventral to the red nucleus. The mesocortical and mesolimbic dopaminergic systems originate here, including an important projection to the nucleus accumbens. Overactivity of the cells in this area has been suspected to contribute to the positive symptoms of schizophrenia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A region of DNA that is highly polymorphic and is prone to strand breaks, rearrangements or other MUTATIONS because of the nature of its sequence. These regions often harbor palindromic, or repetitive sequences %28%REPETITIVE SEQUENCES, NUCLEIC ACID%29%. Variability in stability of the DNA sequence is seen at CHROMOSOME FRAGILE SITES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A registration of any positional relationship of the mandible in reference to the maxillae. These records may be any of the many vertical, horizontal, or orientation relations. %28%Jablonski, Illustrated Dictionary of Dentistry%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A regressive change of teeth characterized by excessive development of secondary cementum on the tooth surface. It may occur on any part of the root, but the apical two-thirds are most commonly affected. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A regulatory region first identified in the human beta-globin locus but subsequently found in other loci. The region is believed to regulate GENETIC TRANSCRIPTION by opening and remodeling CHROMATIN structure. It may also have ENHANCER activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A regulatory sequence found in the 5%27% terminal regions of a variety of RNA species. The sequence starts with a CYTIDINE, which is followed by a stretch of 5 to 15 PYRIMIDINE NUCLEOTIDES. Messenger RNA that contains the 5%27% Terminal Oligo Pyrimidine tract is often referred to as 5%27% TOP mRNA. The sequence acts as a translational regulator and has been found in mRNAs for PEPTIDE ELONGATION FACTORS and RIBOSOMAL PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relational pattern in which a person attempts to derive a sense of purpose through relationships with others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families %28%i.e., familial tremor%29%. %28%Mov Disord 1988;13%28%1%29%:5-10%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively common sequela of blunt head injury, characterized by a global disruption of axons throughout the brain. Associated clinical features may include NEUROBEHAVIORAL MANIFESTATIONS; PERSISTENT VEGETATIVE STATE; DEMENTIA; and other disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively hard, translucent, restorative material used primarily in anterior teeth. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p50%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively rare smooth muscle tumor found most frequently in the wall of the gastrointestinal tract, especially in the stomach. It is similar to other smooth muscle tumors but may become very large and hemorrhage and exhibit small cystic areas. Simple excision is almost always curative. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1354%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the CAROTID BODY; GLOMUS JUGULARE; GLOMUS TYPANICUM;, and AORTIC BODIES. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. %28%From Stedman, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. %28%From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A religion discovered by Mary Baker Eddy in 1866 that was organized under the official name of the Church of Christ, Scientist, that derives its teachings from the Scriptures as understood by its adherents, and that includes a practice of spiritual healing based upon the teaching that cause and effect are mental, and that sin, sickness, and death will be destroyed by a full understanding of the divine principle of Jesus%27% teaching and healing. %28%Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. %28%From DSM-IV, 1994%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A replica technique in which cells are frozen to a very low temperature and cracked with a knife blade to expose the interior surfaces of the cells or cell membranes. The cracked cell surfaces are then freeze-dried to expose their constituents. The surfaces are now ready for shadowing to be viewed using an electron microscope. This method differs from freeze-fracturing in that no cryoprotectant is used and, thus, allows for the sublimation of water during the freeze-drying process to etch the surfaces.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A replication-defective mouse sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% first described by J.J. Harvey in 1964.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A replication-defective murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% capable of transforming mouse lymphoid cells and producing erythroid leukemia after superinfection with murine leukemia viruses %28%LEUKEMIA VIRUS, MURINE%29%. It has also been found to transform cultured human fibroblasts, rat liver epithelial cells, and rat adrenocortical cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A replication-defective murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29% isolated from a rhabdomyosarcoma by Moloney in 1966.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A replication-defective strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with FRIEND MURINE LEUKEMIA VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; or RAUSCHER VIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A representation, generally small in scale, to show the structure, construction, or appearance of something. %28%From Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic consisting of a group of about 100 islands and islets in the western Pacific Ocean. Its capital is Koror. Under Spain it was administered as a part of the Caroline Islands but was sold to Germany in 1899. Seized by Japan in 1914, it was taken by the Allies in World War II in 1944. In 1947 it became part of the U.S. Trust Territory of the Pacific Islands, became internally self-governing in 1980, obtained independent control over its foreign policy %28%except defense%29% in 1986, and achieved total independence October 1, 1994. %28%Webster%27%s New Geographical Dictionary, 1988, p915; telephone communication with Randy Flynn, Board on Geographic Names, 17 January 1995%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic consisting of an island group in Melanesia, in the southwest Pacific Ocean. Its capital is Port-Vila. It was called New Hebrides until 1980. It was discovered in 1606 by the Portuguese, forgotten for 160 years, then visited by Bougainville in 1768 and Captain Cook in 1774. It was under joint British and French administration from 1906 until it became independent in 1980 under the name of Vanuatu. The name is native, meaning our land. %28%From Webster%27%s New Geographical Dictionary, 1988, p833 %26% Room, Brewer%27%s Dictionary of Names, 1992, p570%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic consisting of an island group in Melanesia, in the southwest Pacific Ocean. Its capital is Suva. It was discovered by Abel Tasman in 1643 and was visited by Captain Cook in 1774. It was used by escaped convicts from Australia as early as 1804. It was annexed by Great Britain in 1874 but achieved independence in 1970. The name Fiji is of uncertain origin. In its present form it may represent that of Viti, the main island in the group. %28%From Webster%27%s New Geographical Dictionary, 1988, p396 %26% Room, Brewer%27%s Dictionary of Names, 1992, p186%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO. Its capital is Brazzaville. It became a territory of French Equatorial Africa in 1910, a French overseas territory in 1946, an autonomous republic within the French Community in 1958, and achieved independence in 1960. The country takes its name from the Congo River running through it: the Bantu name for the river means mountain, with reference to the local topography. %28%From Webster%27%s New Geographical Dictionary, 1988, p285 %26% Room, Brewer%27%s Dictionary of Names, 1992, p123%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC. Its capital is Yaounde. As the Cameroons, it existed from 1884 under German, British, French, and UN mandates until it achieved independence in 1960. It united with the former British trust territory of Southern Cameroons in 1961. Its name is from the river that runs through it, Rio dos Camaroes, river of prawns, so called by 16th century Portuguese explorers impressed by the abundance of prawns in its waters. %28%From Webster%27%s New Geographical Dictionary, 1988, p208 %26% Room, Brewer%27%s Dictionary of Names, 1992, p93%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in central Africa lying south of CHAD, west of SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. In 1906 it united with Chad to form the French colony of Ubangi-Shari-Chad and, through various changes in status, achieved independence in 1960. The earlier name Ubangi-Shari comes from the Bantu u %28%land or country%29% + bangi %28%rapid%29%, with reference to the current of the river and territory through which it flows, and Shari or Chari, a native word for river. %28%From Webster%27%s New Geographical Dictionary, 1988, p233 %26% Room, Brewer%27%s Dictionary of Names, 1992, p370, 562%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in central Africa, north of GABON and bounded on the west by the Atlantic Ocean. Its capital is Malabo. Equatorial Guinea was discovered by the Portuguese in 1491 and ceded to Spain in 1778. The country gained independence in 1968. Equatorial refers to its location near the equator in the broad region long known as Guinea %28%from the Tuareg aginaw, black people%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p375 %26% Room, Brewer%27%s Dictionary of Names, 1992, p173, 222%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in central Africa, south of the CENTRAL AFRICAN REPUBLIC and north of ANGOLA and ZAMBIA. Its name changes bespeak its history: 1885-1908 Congo Free State, 1908-60 Belgian Congo, 1960-71 Democratic Republic of the Congo, 1971-97 Zaire. It changed its name back to Democratic Republic of the Congo in 1997. The name Zaire is an alternate name for the Congo River from nzai, a Kikongo dialect form of nazdi, river. %28%From Room, Brewer%27%s Dictionary of Names, 1992, p608%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in central Africa, west of SUDAN. Its capital is N%27%Djamena, called Fort-Lamy before 1973. Explored in 1891 by the French, it became part of French Equatorial Africa in 1910 and, after many changes of status, became independent in 1960. The republic is named from Lake Chad, from the Arabic tsad, a local word meaning large expanse of water %28%or lake%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p239, 407 %26% Room, Brewer%27%s Dictionary of Names, 1992, p104%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in east and central Asia, known also as the People%27%s Republic of China. It is an ancient country, with a civilization existing as early as 3000 B.C. Until 1912 it was known as the Chinese Empire. It was one of the four Great Powers in World War II. By 1950 the Communist regime had gained control. China became a member of the United Nations in 1971. The name may be derived from the qin or Ts%27%in dynasty %28%221-206 B.C.%29% or the Sanskrit name cina or the central province of Shaanxi or Shensi %28%its capital is Shian%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p257 %26% Room, Brewer%27%s Dictionary of Names, 1992, p111%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa bounded by the Gulf of Aden and the Indian Ocean. Its capital is Mogadishu. In 1960 it was constituted as an independent republic by the union of British Somaliland with the Trust Territory of Somalia %28%formerly Italian Somaliland%29%, both flourishing in the 19th century. Many derivations are posed for its name taken from the indigenous people: from a Cushitic word meaning dark or black with reference to their skin; from soo mal, a local phrase meaning go and milk with reference to the hospitable people offering milk to guests; from the name of a tribal chieftain; or from the Arabic zamla, cattle, with reference to the many herds there. %28%From Webster%27%s New Geographical Dictionary, 1988, p1130 %26% Room, Brewer%27%s Dictionary of Names, 1992, p512%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa bounded on the north by RWANDA and on the south by TANZANIA. It was formerly called Urundi. Its capital is Bujumbura. With Ruanda it was part of the Belgian trust territory of Ruanda-Urundi from 1919 to 1962 when it was divided into two independent countries, Burundi and Rwanda. The name comes from the name of the people, the Barundi: Ba- is the prefix for the people, Bu- is the prefix for the country. %28%From Webster%27%s New Geographical Dictionary, 1988, p194, 1034; Room, Brewer%27%s Dictionary of Names, 1992, p86%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa, on the Gulf of Aden at the entrance to the Red Sea. Djibouti is also the name of its capital. It was formerly the French Territory of Afars and Issas and later French Somaliland, in French hands from 1862 to 1977 when it became independent. The republic was named from the capital, which is said to derive from an Afar word gabouri, plate, with reference to a plate woven from doum palm used in ceremonies. %28%From Webster%27%s New Geographical Dictionary, 1988, p10, 335 %26% Room, Brewer%27%s Dictionary of Names, 1992, p149%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa, south of EGYPT and west of ETHIOPIA. Its capital is Khartoum. It was under Egypt 1820-82, then jointly administered by Egypt and Great Britain after 1899 as the Anglo-Egyptian Sudan. It gained independence in 1956. The name is of Arabic origin, balad as-sudan: bal %28%land%29% + al %28%as%29% %28%the%29% + sudan %28%black%29%, the land of the blacks, the name given originally by Arabian travelers. %28%From Webster%27%s New Geographical Dictionary, 1988, p1161 %26% Room, Brewer%27%s Dictionary of Names, 1992, p524%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa, south of ETHIOPIA and east of SOMALIA. Its capital is Nairobi. The region was organized as the British East Africa Protectorate in 1895, became a British colony in 1920, became independent in 1963, and became a republic in 1964. It took its name from Mount Kenya which probably meant simply mountain. %28%From Webster%27%s New Geographical Dictionary, 1988, p601 %26% Room, Brewer%27%s Dictionary of Names, 1992, p282%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa, south of SUDAN and east of KENYA. Its capital is Kampala. In 1894 it was formally proclaimed a British protectorate but became independent in 1966. Its name is Swahili, u, land + Ganda, the name of its indigenous people, the land of the Ganda. The origin of their name is unknown. %28%From Webster%27%s New Geographical Dictionary, 1992, p1244 %26% Room, Brewer%27%s Dictionary of Names, 1992, p562%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa, south of UGANDA and east of DEMOCRATIC REPUBLIC OF THE CONGO. It was originally called Ruanda. Its capital is Kigali. Formerly part of the Belgian trust territory of Ruanda-Urundi %28%now RWANDA and BURUNDI%29%, it became independent in 1962. The country has taken the name of the people, the Rwanda, but its meaning is unknown. %28%From Webster%27%s New Geographical Dictionary, 1988, p1038 %26% Room, Brewer%27%s Dictionary of Names, 1992, p469%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam %28%House of Peace%29%. It was formed in 1964 by a merger of the countries of Tanganyika and Zanzibar. The country has been dominated successively by Arabs, Portugal, Oman, Zanzibar, Germany, and Britain. It became a British mandate in 1920 as Tanganyika and became independent in 1961. It united with Zanzibar in 1964 as Tanzania. Tanganyika was named for the lake of that name, kou tanganyika meaning to join, i.e., the place where waters met and Zanzibar, from Zeni or Zengj, the name of a local people, meaning black + the Arabic barr, coast or shore. %28%From Webster%27%s New Geographical Dictionary, 1988, p1186 %26% Room, Brewer%27%s Dictionary of Names, 1992, p533, 609%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in northern Africa between ALGERIA and LIBYA. Its capital is Tunis, which occupies the site of ancient Carthage. Tunisia became a French protectorate in 1881 but was reorganized in 1922. France recognized its independence in 1956. The country takes its name from the capital, which some authorities derive from the name of the Phoenician goddess Tanith, the meaning of which is uncertain. %28%Webster%27%s New Geographical Dictionary, 1988, p1235 %26% Room, Brewer%27%s Dictionary of Names, 1992, p558%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in northwest Africa. Its capital is Cairo. It was a very ancient kingdom which, by ca. 3000 B.C., was one of the early civilizations of the ancient world. It was the center of Hellenistic culture 330-323 B.C. and part of the Roman Empire from 30 B.C. until 640 A.D.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa east of ZAMBIA. Its capital is Lilongwe. It was formerly called Nyasaland. This region was visited by Livingstone in 1859. It became a British protectorate in 1891, part of the Federation of Rhodesia and Nyasaland in 1953, and independent in 1964. It takes its name from the Malavi people whose name means flames, possibly referring to the reflection of the rising sun on Lake Malawi. Its former name Nyasaland is from the Malawi word for lake. %28%Webster%27%s New Geographical Dictionary, 1988, p715 %26% Room, Brewer%27%s Dictionary of Names, 1992, p326, 386%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa, between NAMIBIA and ZAMBIA. It was formerly called Bechuanaland. Its capital is Gaborone. The Kalahari Desert is in the west and southwest. Botswana was organized as a British protectorate in 1885 and became independent in 1966. The name comes from bo, the prefix for abstract nouns + Tswana, the people themselves. Bechuana in its earlier name is the English corruption of Botswana. %28%From Webster%27%s New Geographical Dictionary, 1988, p185 %26% Room, Brewer%27%s Dictionary of Names, 1992, p74%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa, east of ZAMBIA and BOTSWANA and west of MOZAMBIQUE. Its capital is Harare. It was formerly called Rhodesia and Southern Rhodesia. The region was under the administration of the British South Africa Company from 1889 to 1923 when it became a self-governing British colony. Zimbabwe was a member of the Federation of Rhodesia and Nyasaland 1953-63. It was granted independence by the British in 1980 when it became Zimbabwe. The name is from that of a famous archaeological site whose name is the Bantu zimba we bahwe, %28%house of stones%29% from zimba, the plural of imba %28%house%29% + bahwe %28%stones%29%. It refers to ruins comprising an acropolis with huge walls of monoliths fitted without mortar. %28%From Webster%27%s New Geographical Dictionary, 1988, p1013, 1374 %26% Room, Brewer%27%s Dictionary of Names, 1992, p610%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa, south of ANGOLA and west of BOTSWANA. Its capital is Windhoek. It was a region not much visited before the middle of the 19th century although the Portuguese landed at one of its harbors in 1486. Namibia was annexed by Germany in 1885. As the former German colony of South West Africa, it was mandated to South Africa 1920-1966, and made a direct dependent of the United Nations 1966. Its name was changed from South West Africa to Namibia in 1968. The name is from Nama, the Hottentot people who inhabit it; its origin is unknown. %28%From Webster%27%s New Geographical Dictionary, 1988, p1144 %26% Room, Brewer%27%s Dictionary of Names, 1992, p369%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa, south of DEMOCRATIC REPUBLIC OF THE CONGO and TANZANIA, and north of ZIMBABWE. Its capital is Lusaka. It was formerly called Northern Rhodesia. Under the jurisdiction of the British South Africa Company 1889-1924, it became a British Protectorate in 1924, then part of the Federation of Rhodesia and Nyasaland 1953-63. It became an independent republic in 1964. The country takes its name from the Zambezi River flowing through it, the fourth longest on the continent. Za %28%river%29% also gave its name to Zaire. %28%From Webster%27%s New Geographical Dictionary, 1988, p1370 %26% Room, Brewers%27% Dictionary of Names, 1992, p608%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda. It was formerly a Portuguese overseas province called Portuguese West Africa, having been reached by Portuguese sailors in 1483, with Portuguese rule established in 1575. Its status was changed from colony to overseas province in 1951 and it received its independence in 1975. Angola is named for N%27%gola, a native ruler there in the 16th century. %28%From Webster%27%s New Geographical Dictionary, 1988, p51 %26% Room, Brewer%27%s Dictionary of Names, 1992, p23%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in southern Africa, the southernmost part of Africa. It has three capitals: Pretoria %28%administrative%29%, Cape Town %28%legislative%29%, and Bloemfontein %28%judicial%29%. The history is a fabric interwoven with hostile activity among the native tribes, particularly the Zulus, the Boers %28%Dutch settlers%29%, and the British. Officially the Republic of South Africa since 1960, it was called the Union of South Africa 1910-1960.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in the Greater Antilles in the West Indies. Its capital is Port-au-Prince. With the Dominican Republic it forms the island of Hispaniola - Haiti occupying the western third and the Dominican Republic, the eastern two thirds. Haiti belonged to France from 1697 until its rule was challenged by slave insurrections from 1791. It became a republic in 1820. It was virtually an American protectorate from 1915 to 1934. It adopted its present constitution in 1964 and amended it in 1971. The name may represent either of two Caribbean words, haiti, mountain land, or jhaiti, nest. %28%From Webster%27%s New Geographical Dictionary, 1988, p481 %26% Room, Brewer%27%s Dictionary of Names, 1992, p225%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in the Greater Antilles in the West Indies. Its capital is Santo Domingo. With Haiti, it forms the island of Hispaniola - the Dominican Republic occupying the eastern two thirds, and Haiti, the western third. It was created in 1844 after a revolt against the rule of President Boyer over the entire island of Hispaniola, itself visited by Columbus in 1492 and settled the next year. Except for a brief period of annexation to Spain %28%1861-65%29%, it has been independent, though closely associated with the United States. Its name comes from the Spanish Santo Domingo, Holy Sunday, with reference to its discovery on a Sunday. %28%From Webster%27%s New Geographical Dictionary, 1988, p338, 506 %26% Room, Brewer%27%s Dictionary of Names, 1992, p151%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in the north of South America, bordered on the west by GUYANA %28%British Guiana%29% and on the east by FRENCH GUIANA. Its capital is Paramaribo. It was formerly called Netherlands Guiana or Dutch Guiana or Surinam. Suriname was first settled by the English in 1651 but was ceded to the Dutch by treaty in 1667. It became an autonomous territory under the Dutch crown in 1954 and gained independence in 1975. The country was named for the Surinam River but the meaning of that name is uncertain. %28%From Webster%27%s New Geographical Dictionary, 1988, p1167 %26% Room, Brewer%27%s Dictionary of Names, 1992, p526%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in the north of South America, east of BRAZIL. Its capital is Georgetown. It was formerly called British Guiana and its history is allied with that of the region of Guiana which comprised British Guiana, FRENCH GUIANA, and Dutch Guiana %28%now SURINAME%29%. It was founded about 1620 by the Dutch and settled in the 18th century by many non-Dutch, mainly British, to whom it was ceded in 1814. Guyana gained independence in 1966 and became a republic in 1970. The name is probably of Indian origin meaning respectable, but some derive it from the Guarani guai %28%born%29% + ana %28%kin%29%, implying a united and interrelated race of people. %28%From Webster%27%s New Geographical Dictionary, 1988, p477 %26% Room, Brewer%27%s Dictionary of Names, 1992, p223%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in west equatorial Africa, south of CAMEROON and west of CONGO. Its capital is Libreville. It was the first part of French Equatorial Africa to be settled in 1841. Gabon achieved independence from France in 1960. Gabon was named for the Gabon River, whose estuary was discovered by the Portuguese in the late 15th century: gabao is the word for hood, probably with reference to its shape. %28%From Webster%27%s New Geographical Dictionary, 1988, p423 %26% Room, Brewer%27%s Dictionary of Names, 1992, p198%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, constituting an enclave within SENEGAL extending on both sides of the Gambia River. Its capital is Banjul, formerly Bathurst. The mouth of the river was discovered in 1455 by the Portuguese and the English ascended the river 1618-19. The British claim to the region was recognized by the Treaty of Versailles in 1783. Its status under the British and Sierra Leone changed several times from 1807 until 1965 when it became independent. The country is named for the river and is a Portuguese corruption of the native name Ba-Dimma, meaning river. %28%From Webster%27%s New Geographical Dictionary, 1988, p426 %26% Room, Brewer%27%s Dictionary of Names, 1992, p200%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, lying between GHANA on its west and BENIN on its east. Its capital is Lome. Togo was the eastern part of the German protectorate of Togoland from 1884 until it was captured by Anglo-French forces in 1914. It became an autonomous republic within the French Union in 1956, achieving independence in 1960. The country probably derives its name from Lake Togo, to %28%water%29% + go %28%edge or shore%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p1216 %26% Room, Brewer%27%s Dictionary of Names, 1992, p548%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, north of NIGERIA and west of CHAD. Its capital is Niamey. It was first explored by the Europeans in the late 18th century. It became part of the French sphere of influence in the latter part of the 19th century and was formally constituted as part of French West Africa in 1904. Nigeria gained independence in 1960. The country took its name from the river Niger flowing through it. The river%27%s name came from the Tuareg egereou n-igereouen, river of rivers, the second part of the name giving the modern European form Niger. %28%From Webster%27%s New Geographical Dictionary, 1988, p847 %26% Room, Brewer%27%s Dictionary of Names, 1992, p379%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south and east of MALI and west of NIGER. Its capital is Ouagadougou. It was formerly called Upper Volta until 1984. A French protectorate was established over the region 1895-97. It was part of Upper Senegal-Niger colony until 1919 when it became a separate colony. Burkina Faso remained under French jurisdiction with varied status until it became totally independent in 1960. Its name is native, meaning land of worthy men, from burkina %28%worthy%29% + faso %28%land, literally father village from fa %28%father%29% + so %28%village%29%%29%. %28%From Webster%27%s New Geographical Dictionary, 1988, p191, 1273 %26% Room, Brewer%27%s Dictionary of Names, 1992, p85%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. It was called the Gold Coast until 1957, from the gold discovered there by the Portuguese in the late 15th century. A center for slave trade, it was acquired by the British in the 19th century and became independent in 1957. Ghana took its name from a tribal leader that stands for king. %28%From Webster%27%s New Geographical Dictionary, 1988, p441 %26% Room, Brewer%27%s Dictionary of Names, 1992, p206%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of GUINEA and east of COTE D%27%IVOIRE. Its capital is Monrovia, named for the U.S. President James Monroe. Liberia was projected as a settlement of freed American slaves by the American Colonization Society in 1817 and hence named from the Latin liber, free. In 1847 it was established as the Free and Independent Republic of Liberia. Liberia is the only black African state never to have been subjected to colonial rule. %28%From Webster%27%s New Geographical Dictionary, 1988, p668 %26% Room, Brewer%27%s Dictionary of Names, 1992, p307%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of GUINEA and west of LIBERIA. Its capital is Freetown. Its coast was first visited by the Portuguese in 1462, later by English slave traders. In 1787 English philanthropists sponsored settlements on the coast for runaway and freed slaves. After a clash with the French in 1893 the region was acquired by treaty in 1895, proclaimed a protectorate in 1896, and achieved independence in 1961. The name is from the Spanish sierra %28%mountain chain%29% + leone %28%lion%29%, meaning Lion Mountains, which refers not to the roar of lions %28%they are not found in this part of Africa%29% but to the noise from claps of thunder from storm clouds constantly surrounding the mountains. %28%From Webster%27%s New Geographical Dictionary, 1988, p1114 %26% Room, Brewer%27%s Dictionary of Names, 1992, p504%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of MALI and BURKINA FASO. Its capital is Abidjan. It was formerly called Ivory Coast. From 1842 the French had a treaty with the native rulers. By 1889 a French protectorate was established and in 1893 it was made a colony. Cote d%27%Ivoire achieved self-government in 1958 and became an independent republic in 1960. It is named for the ivory first traded by the Portuguese there in the 16th century. %28%From Webster%27%s New Geographical Dictionary, 1988, p295, 560 %26% Room, Brewer%27%s Dictionary of Names, 1992, p264%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of NIGER and between TOGO and NIGERIA. Its capital is Porto-Novo. It was formerly called Dahomey. In the 17th century it was a kingdom in the southern area of Africa. Coastal footholds were established by the French who deposed the ruler by 1892. It was made a French colony in 1894 and gained independence in 1960. Benin comes from the name of the indigenous inhabitants, the Bini, now more closely linked with southern Nigeria %28%Benin City, a town there%29%. Bini may be related to the Arabic bani, sons. %28%From Webster%27%s New Geographical Dictionary, 1988, p136, 310 %26% Room, Brewer%27%s Dictionary of Names, 1992, p60%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Lagos. From the time it was visited in the 18th and 19th centuries by many European explorers, figuring in its administrative history were Great Britain, the native king, Sierra Leone, and the Gold Coast colony. Nigeria gained independence in 1960, becoming a republic in 1961. Nigeria derives its name from the Niger River which flows through it. %28%From Webster%27%s New Geographical Dictionary, 1988, p848 %26% Room, Brewer%27%s Dictionary of Names, 1992, p379%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of SENEGAL and MALI, east of GUINEA-BISSAU. Its capital is Conakry. Its coastal region was proclaimed a French protectorate in 1849, was established as a separate colony called French Guinea in 1893, and gained its independence in 1958. This Guinea gave its name to the coin originally made out of gold coming from there. Guinea is from a Tuareg word aginaw, meaning black people. %28%From Webster%27%s New Geographical Dictionary, 1988, p474 %26% Room, Brewer%27%s Dictionary of Names, 1992, p222%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, south of SENEGAL and west of GUINEA. Its capital is Bissau. It was discovered by the Portuguese in 1446. In the 17th and 18th centuries it was active in slave trading. Its boundaries were established by convention with France in 1886 and 1902-05 and in 1974 it gained its independence. As a Portuguese overseas province, the country was called Portuguese Guinea; it was named Guinea-Bissau in 1974. The name Guinea is from the Tuareg word Aginaw, meaning black people. Bissau is from the native name of the people there, the Bijuga, whose meaning is uncertain. %28%From Webster%27%s New Geographical Dictionary, 1988, p975 %26% Room, Brewer%27%s Dictionary of Names, 1992, p222%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, southwest of ALGERIA and west of MALI. Its capital is Nouakchott. Its coast was opened by the Portuguese in the 15th century. Although recognized as in the French sphere from 1817, it did not become a French colony until 1921. It gained independence in 1960. Mauritania takes its name from the Moors, either from the Greek mauros, dark, with reference to their skin or from the Punic mahurim or mauharin, western, with reference to the geographical area of North Africa that they occupied. It should not be confused with the ancient country of Mauretania in northern Africa, although both share a common derivation for their names. %28%From Webster%27%s New Geographical Dictionary, 1988, p742 %26% Room, Brewer%27%s Dictionary of Names, 1992, p361%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar. The first settlements were by the Portuguese in the 15th century and the French in the 17th century, with the coastal region becoming the object of much rivalry and conflict between the two until French possession was recognized in 1814. Senegal became independent in 1960. The nation was named for the Senegal River, its main river, which possibly derived its name from a local African word meaning navigable. %28%From Webster%27%s New Geographical Dictionary, 1988, p1097 %26% Room, Brewer%27%s Dictionary of Names, 1992, p493%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic of southeast Asia, northwest of Thailand, long familiar as Burma. Its capital is Yangon, formerly Rangoon. Inhabited by people of Mongolian stock and probably of Tibetan origin, by the 3d century A.D. it was settled by Hindus. The modern Burmese state was founded in the 18th century but was in conflict with the British during the 19th century. Made a crown colony of Great Britain in 1937, it was granted independence in 1947. In 1989 it became Myanmar. The name comes from myanma, meaning the strong, as applied to the Burmese people themselves. %28%From Webster%27%s New Geographical Dictionary, 1988, p192 %26% Room, Brewer%27%s Dictionary of Names, 1992, p367%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A republic stretching from the Indian Ocean east to New Guinea, comprising six main islands: Java, Sumatra, Bali, Kalimantan %28%the Indonesian portion of the island of Borneo%29%, Sulawesi %28%formerly known as the Celebes%29% and Irian Jaya %28%the western part of New Guinea%29%. Its capital is Djakarta. The ethnic groups living there are largely Chinese, Arab, Eurasian, Indian, and Pakistani; 85%25% of the peoples are of the Islamic faith.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A research and development program initiated by the NATIONAL LIBRARY OF MEDICINE to build knowledge sources for the purpose of aiding the development of systems that help health professionals retrieve and integrate biomedical information. The knowledge sources can be used to link disparate information systems to overcome retrieval problems caused by differences in terminology and the scattering of relevant information across many databases. The three knowledge sources are the Metathesaurus, the Semantic Network, and the Specialist Lexicon.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A residue of coal, left after dry %28%destructive%29% distillation, used as a fuel.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A respiratory disorder due to an acquired hypersensitivity to the dust of bird droppings.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A respiratory support system used to remove mucus and clear airway by oscillating pressure on the chest.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A response to a cue that is instrumental in avoiding a noxious experience.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A restoration designed to remain in service for not less than 20 to 30 years, usually made of gold casting, cohesive gold, or amalgam. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. %28%Newell, Ophthalmology: Principles and Concepts, 7th ed, p304%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A return to earlier, especially to infantile, patterns of thought or behavior, or stage of functioning, e.g., feelings of helplessness and dependency in a patient with a serious physical illness. %28%From APA, Thesaurus of Psychological Index Terms, 1994%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3%27% carbon of the pentose ring. It is used to treat HIV disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reversible inhibitor of monoamine oxidase type A; %28%RIMA%29%; %28%see MONOAMINE OXIDASE INHIBITORS%29% that has antidepressive properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rheumatic disease causing diffuse thickening of the mitral valve leaflets by fibrous tissue or calcific deposits. %28%Harrison%27%s Principles of Internal Medicine, 13th ed, p1052%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rheumatic syndrome of possibly allergic origin, usually affecting children and adolescents, and characterized by high fever, exanthema, arthralgia, leukocytosis, and increased sedimentation rate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms %28%particularly calf thymus%29% as well as retroviruses. EC 3.1.26.4.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ribosomal protein that may play a role in controlling cell growth and proliferation. It is a major substrate of RIBOSOMAL PROTEIN S6 KINASES and plays a role in regulating the translation %28%TRANSLATION, GENETIC%29% of RNAs that contain an RNA 5%27% TERMINAL OLIGOPYRIMIDINE SEQUENCE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A richly vascularized and innervated connective tissue of mesodermal origin, contained in the central cavity of a tooth and delimited by the dentin, and having formative, nutritive, sensory, and protective functions. %28%Jablonski, Dictionary of Dentistry, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rigorously mathematical analysis of energy relationships %28%heat, work, temperature, and equilibrium%29%. It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. %28%From Hawley%27%s Condensed Chemical Dictionary, 12th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ring of tissue extending from the scleral spur to the ora serrata of the retina. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A riot control agent which causes temporary irritation of the eyes and the mucosal surface of the respiratory tract. It is a more potent irritant than OMEGA-CHLOROACETOPHENONE, but less incapacitating.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rod-shaped bacterium surrounded by a sheath-like structure which protrudes balloon-like beyond the ends of the cell. It is thermophilic, with growth occurring at temperatures as high as 90 degrees C. It is isolated from geothermally heated marine sediments or hot springs. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rod-shaped to ellipsoidal, gram-negative bacterium which oxidizes ethanol to acetic acid and prefers sugar-enriched environments. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family Bifidobacteriaceae, order Bifidobacteriales, class ACTINOBACTERIA. It inhabits the intestines and feces of humans as well as the human vagina.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A round-to-oval mass of lymphoid tissue embedded in the lateral wall of the PHARYNX situated on each side of the fauces, between the anterior and posterior pillars of the soft palate %28%PALATE, SOFT%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sac formed by the dilatation of the wall of an artery, a vein, or the heart.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sac or recess formed by a fold of the peritoneum. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A saccharolytic species of gram-negative bacteria in the family Prevotellaceae. It ferments a wide range of CARBOHYDRATES in the RUMEN of animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A salt of lithium that has been used experimentally as an immunomodulator.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A salt produced by the reaction of zinc oxide with acetic acid and used as an astringent, styptic, and emetic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A salt-soluble precursor of elastin. Lysyl oxidase is instrumental in converting it to elastin in connective tissue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A saprophytic bacterium widely distributed in soil and dust and on plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma characterized by the presence of small cells, cells measuring 9-14 micrometers with a faint or indistinct rim of cytoplasm and an oval-to-elongated nucleus with relatively dense chromatin. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20%25% of patients. %28%Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma of young, often female, adults of the lower extremities and acral regions, intimately bound to tendons as circumscribed but unencapsulated melanin-bearing tumors of neuroectodermal origin. An ultrastructural finding simulates flattened and curved barrel staves, corresponding to the internal structures of premelanosomes. There is a 45-60%25% mortality in clear cell sarcoma. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sarcoma, usually a liposarcoma or malignant fibrous histiocytoma, with an abundant component of myxoid tissue resembling primitive mesenchyme containing connective tissue mucin. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A satellite RNA %28%not a satellite virus%29% which has several types. Different cucumoviruses can act as helper viruses for different types.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A saturated 12-carbon fatty alcohol obtained from coconut oil fatty acids. It has a floral odor and is used in detergents, lubricating oils, and pharmaceuticals. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. %28%From Hersen, M. and Bellack, A.S., Dictionary of Behavioral Assessment Techniques, p. 87%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scale that assesses the outcome of serious craniocerebral injuries, based on the level of regained social functioning.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scale that assesses the response to stimuli in patients with craniocerebral injuries. The parameters are eye opening, motor response, and verbal response.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scanning microscope-based, cytofluorimetry technique for making fluorescence measurements and topographic analysis on individual cells. Lasers are used to excite fluorochromes in labeled cellular specimens. Fluorescence is detected in multiple discrete wavelengths and the locational data is processed to quantitatively assess APOPTOSIS; PLOIDIES; cell proliferation; GENE EXPRESSION; PROTEIN TRANSPORT; and other cellular processes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scheme which provides reimbursement for the health services rendered, generally by an institution, and which provides added financial rewards if certain conditions are met. Such a scheme is intended to promote and reward increased efficiency and cost containment, with better care, or at least without adverse effect on the quality of the care rendered.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A school of thought and set of moral, ethical, and political teachings usually considered to be founded by Confucius in 6th-5th century B.C. China. %28%from Cambridge Dictionary of Philosophy, 1995%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A schwannoma that arises from the vestibular division of the vestibulocochlear nerve and tends to present in the fifth or sixth decade of life. Clinical manifestations include loss of hearing, headache, vertigo, facial pain, tinnitus, and facial weakness. Bilateral acoustic neuromas are associated with NEUROFIBROMATOSIS 2. %28%From Adams et al., Principles of Neurology, 6th ed, p673%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scientific or medical discipline concerning the study of male reproductive biology, diseases of the male genital organs, and male infertility. Major areas of interest include ENDOCRINOLOGY; SPERMATOGENESIS; semen analysis; FERTILIZATION; CONTRACEPTION; and CRYOPRESERVATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scientific tool based on ULTRASONOGRAPHY and used not only for the observation of microstructure in metalwork but also in living tissue. In biomedical application, the acoustic propagation speed in normal and abnormal tissues can be quantified to distinguish their tissue elasticity and other properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scleroprotein fibril consisting mostly of type III collagen. Reticulin fibrils are extremely thin, with a diameter of between 0.5 and 2 um. They are involved in maintaining the structural integrity in a variety of organs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A scraping, usually of the interior of a cavity or tract, for removal of new growth or other abnormal tissue, or to obtain material for tissue diagnosis. It is performed with a curet %28%curette%29%, a spoon-shaped instrument designed for that purpose. %28%From Stedman, 25th ed %26% Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sebaceous gland that, in some animals, acts as an accessory to the lacrimal gland. The harderian gland excretes fluid that facilitates movement of the third eyelid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A second generation selective estrogen receptor modulator %28%SERM%29% used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines %28%HISTAMINE H1 ANTAGONISTS%29% it lacks central nervous system depressing effects such as drowsiness.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p868%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A secondary headache disorder attributed to low CEREBROSPINAL FLUID pressure caused by SPINAL PUNCTURE, usually after dural or lumbar puncture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A secreted protein that associates with TOLL-LIKE RECEPTOR 4 and is essential for receptor recognition of LIPOPOLYSACCHARIDES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sedative and hypnotic that has been used in the short-term management of INSOMNIA. Its use has been superseded by other drugs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sedative and mild hypnotic with potentially toxic effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A segment of the COLON between the RECTUM and the descending colon.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A segment of the LOWER GASTROINTESTINAL TRACT that includes the CECUM; the COLON; and the RECTUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A segment of the immunoglobulin heavy chains, encoded by the IMMUNOGLOBULIN HEAVY CHAIN GENES in the J segment where, during the maturation of B-LYMPHOCYTES, the gene segment for the variable region upstream is joined to a constant region gene segment downstream. The exact position of joining of the two gene segments is variable and contributes to ANTIBODY DIVERSITY. It is distinguished from the IMMUNOGLOBULINS, J CHAIN; a separate polypeptide that serves as a linkage piece in polymeric IGA or IGM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective D1 dopamine receptor agonist used primarily as a research tool.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud%27%s syndrome, prostatic hypertrophy, and urinary retention.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective adrenergic beta-1-blocking agent with no stimulatory action. It%27%s binding to plasma albumin is weaker than alprenolol and it may be useful in angina pectoris, hypertension, or cardiac arrhythmias.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective alpha-1-adrenergic blocker that lowers serum CHOLESTEROL. It is also effective in the treatment of HYPERTENSION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin %28%5-HYDROXYTRYPTAMINE%29%. Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective beta-1-adrenergic partial agonist. Because it is a partial agonist it acts like an agonist when sympathetic activity is low and as an antagonist when sympathetic activity is high. It reduces myocardial ischemia and improves ventricular function in patients with mild to moderate heart failure. In patients with severe heart failure it has been shown to produce benefits in systolic and diastolic function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug is used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective inhibitor of RECEPTORS, ADRENERGIC ALPHA-2 that has analgesic and sedative properties. MEDETOMIDINE is the other racemic form.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective pre- and post-emergence herbicide. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective serotonin reuptake inhibitor. It is effective in the treatment of depression, obsessive-compulsive disorders, anxiety, panic disorders, and alcohol amnestic disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective serotonin uptake inhibitor that is used in the treatment of depression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective triazine herbicide. Inhalation hazard is low and there are no apparent skin manifestations or other toxicity in humans. Acutely poisoned sheep and cattle may show muscular spasms, fasciculations, stiff gait, increased respiratory rates, adrenal degeneration, and congestion of the lungs, liver, and kidneys. %28%From The Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson%27%s disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. %28%From AMA Drug Evaluations Annual, 1994, p385%29% The compound without isomeric designation is Deprenyl.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A selenium compound used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A self-governing state of the Windward Islands in the West Indies, comprising Saint Vincent and the northern islets of the Grenadines. Its capital is Kingstown. It is one of the original homes of the Carib Indians supposed to have been sighted by Columbus in 1498. It was in English hands from 1627 till held by the French 1779-83. Saint Vincent subsequently became a British possession and, with other nearby British territories, was administered by the Governor of the Windward Islands till 1959. It attained a measure of independence in 1969 but achieved full independence as Saint Vincent and the Grenadines in 1979. Saint Vincent was the 4th century Spanish martyr on whose feast day Columbus discovered the island. Grenadines is derived from the Spanish kingdom of Granada. %28%From Webster%27%s New Geographical Dictionary, 1988, p1054 %26% The Europa World Year Book 1993, p2441%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A self-governing territory formed from the central and eastern portions of the Northwest Territories. It was officially established April 1, 1999. The capital is Iqaluit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A self-learning technique, usually online, involving interaction of the student with programmed instructional materials.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A self-limited hemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin K-dependent blood coagulation factors II, VII, IX, and X. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A self-limiting bacterial infection of the regional lymph nodes caused by AFIPIA felis, a gram-negative bacterium recently identified by the Centers for Disease Control and Prevention and by BARTONELLA HENSELAE. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A self-reporting test consisting of items concerning fear and worry about taking tests and physiological activity, such as heart rate, sweating, etc., before, during, and after tests.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semi-synthetic aminoglycoside antibiotic that is used in the treatment of TUBERCULOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semi-synthetic antibiotic related to penicillin. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semi-synthetic cephalosporin antibiotic. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic ampicillin-derived acylureido penicillin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic analgesic used in the study of narcotic receptors. It has abuse potential.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic anthracycline with the amino sugar on the D ring. It displays broad-spectrum antineoplastic activity against a variety of tumors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p1160%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic antibiotic related to TETRACYCLINE. It is more readily absorbed than TETRACYCLINE and can be used in lower doses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic bile acid made from cholic acid. It is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic cephamycin antibiotic resistant to beta-lactamase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent cells from entering into the mitotic phase of the cell cycle, and lead to cell death. Teniposide acts primarily in the G2 and S phases of the cycle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sensory branch of the MANDIBULAR NERVE, which is part of the trigeminal %28%5th cranial%29% nerve. The lingual nerve carries general afferent fibers from the anterior two-thirds of the tongue, the floor of the mouth, and the mandibular gingivae.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sensory branch of the trigeminal %28%5th cranial%29% nerve. The ophthalmic nerve carries general afferents from the superficial division of the face including the eyeball, conjunctiva, upper eyelid, upper nose, nasal mucosa, and scalp.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sequence of amino acids in a polypeptide or of nucleotides in DNA or RNA that is similar across multiple species. A known set of conserved sequences is represented by a CONSENSUS SEQUENCE. AMINO ACID MOTIFS are often composed of conserved sequences.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sequence of successive nucleotide triplets that are read as CODONS specifying AMINO ACIDS and begin with an INITIATOR CODON and end with a stop codon %28%CODON, TERMINATOR%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sequence-related subfamily of ATP-BINDING CASSETTE TRANSPORTERS that actively transport organic substrates. Although considered organic anion transporters, a subset of proteins in this family have also been shown to convey drug resistance to neutral organic drugs. Their cellular function may have clinical significance for CHEMOTHERAPY in that they transport a variety of ANTINEOPLASTIC AGENTS. Overexpression of proteins in this class by NEOPLASMS is considered a possible mechanism in the development of multidrug resistance %28%DRUG RESISTANCE, MULTIPLE%29%. Although similar in function to P-GLYCOPROTEINS, the proteins in this class share little sequence homology to the p-glycoprotein family of proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sequence-specific DNA-binding protein that plays an essential role as a global regulator of yeast cell cycle control. It contains a MADS-box domain within the N-terminal 56 amino acids. It is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sequential pattern of amino acids occurring more than once in the same protein sequence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of 7 virulent phages which infect E. coli. The T-even phages T2, T4; %28%BACTERIOPHAGE T4%29%, and T6, and the phage T5 are called %22%autonomously virulent%22% because they cause cessation of all bacterial metabolism on infection. Phages T1, T3; %28%BACTERIOPHAGE T3%29%, and T7; %28%BACTERIOPHAGE T7%29% are called %22%dependent virulent%22% because they depend on continued bacterial metabolism during the lytic cycle. The T-even phages contain 5-hydroxymethylcytosine in place of ordinary cytosine in their DNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of oxidative reactions in the breakdown of acetyl units derived from GLUCOSE; FATTY ACIDS; or AMINO ACIDS by means of tricarboxylic acid intermediates. The end products are CARBON DIOXIDE, water, and energy in the form of phosphate bonds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of prostaglandin-like compounds that are produced by the attack of free-radical species on unsaturated fatty acids, especially ARACHIDONIC ACID, of cellular MEMBRANES. Once cleaved from the lipid membrane by the action of phospholipases they can circulate into various bodily fluids and eventually be excreted. Although these compounds resemble enzymatically synthesized prostaglandins their stereoisometric arrangement is usually different than the %22%naturally occurring%22% compounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of radioactive elements from ACTINIUM, atomic number 89, to and including LAWRENCIUM, atomic number 103.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of structurally-related alkaloids containing the ergotaman backbone structure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of structurally-related alkaloids that contain the ergoline backbone structure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of tests designed to assess neuropsychological function. The battery is used to diagnose specific cerebral dysfunction and also to determine lateralization.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine endopeptidase found primarily in the EXTRACELLULAR MATRIX. It has specificity for cleavage of a variety of substrates including PRORENIN, pro-membrane type-1 matrix metalloproteinase, and NEURAL CELL ADHESION MOLECULE L1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine endopeptidase isolated from Bacillus subtilis. It hydrolyzes proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. It also hydrolyzes peptide amides. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.21.62.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine endopeptidase that has specificity for cleavage at ARGININE. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN, proluteinizing-hormone-releasing hormone, proenkephalins, prodynorphin, and PROINSULIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine protease that cleaves multiple COMPLEMENT 3 into COMPLEMENT 3A %28%anaphylatoxin%29% and COMPLEMENT 3B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of COMPLEMENT 4B and COMPLEMENT 2A %28%C4b2a%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine protease that cleaves multiple COMPLEMENT 5 into COMPLEMENT 5A %28%anaphylatoxin%29% and COMPLEMENT 5B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of CLASSICAL PATHWAY C3 CONVERTASE %28%C4b2a%29% with an additional COMPLEMENT C3B, or C4b2a3b.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine protease that cleaves multiple COMPLEMENT C5 into COMPLEMENT C5A %28%anaphylatoxin%29% and COMPLEMENT C5B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. It is the complex of ALTERNATIVE PATHWAY C3 CONVERTASE %28%C3bBb%29% with an additional COMPLEMENT C3B, or C3bBb3b.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine protease that is the complex of COMPLEMENT C3B and COMPLEMENT FACTOR BB. It cleaves multiple COMPLEMENT C3 into COMPLEMENT C3A %28%anaphylatoxin%29% and COMPLEMENT C3B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation %28%DIC%29%, and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine-rich sticky protein secreted by MOTHS. Generally, the term refers to silkworm silk gum protein secreted in the middle section of silk gland cells of SILKWORMS, Bombyx mori. Sericin acts as a cement and coating for the two fibroin filaments in a silk strand and is readily soluble in mild alkaline solution.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine-threonine kinase that plays important roles in CELL DIFFERENTIATION; CELL MIGRATION; and CELL DEATH of NERVE CELLS. It is closely related to other CYCLIN-DEPENDENT KINASES but does not seem to participate in CELL CYCLE regulation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine-threonine protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases %28%also known as SAPK kinases%29% are a subfamily.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serine-threonine protein kinase that, when activated by DNA, phosphorylates several DNA-binding protein substrates including the TUMOR SUPPRESSOR PROTEIN P53 and a variety of TRANSCRIPTION FACTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serious complication of TYPE 2 DIABETES MELLITUS. It is characterized by extreme HYPERGLYCEMIA; DEHYDRATION; serum hyperosmolarity; and depressed consciousness leading to COMA in the absence of KETOSIS and ACIDOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin antagonist with limited antihistaminic, anticholinergic, and immunosuppressive activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor %28%5HT-3 selective%29% antagonist that has been used as an antiemetic for cancer chemotherapy patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor subtype found at high levels in the BASAL GANGLIA and the frontal cortex. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1D RECEPTOR. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug%27%s antimigraine effect.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor subtype found distributed through the CENTRAL NERVOUS SYSTEM where they are involved in neuroendocrine regulation of ACTH secretion. The fact that this serotonin receptor subtype is particularly sensitive to SEROTONIN AGONISTS such as BUSPIRONE suggests its role in the modulation of ANXIETY and DEPRESSION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor subtype found in the BRAIN; HEART; LUNGS; PLACENTA and DIGESTIVE SYSTEM organs. A number of functions have been attributed to the action of the 5-HT2B receptor including the development of cardiac myocytes %28%MYOCYTES, CARDIAC%29% and the contraction of SMOOTH MUSCLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor subtype found primarily in the CENTRAL NERVOUS SYSTEM and the CHOROID PLEXUS. This receptor subtype is believed to mediate the anorectic action of SEROTONIN, while selective antagonists of the 5-HT2C receptor appear to induce ANXIETY. Several isoforms of this receptor subtype exist, due to adenine deaminase editing of the receptor mRNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin receptor subtype that is localized to the CAUDATE NUCLEUS; PUTAMEN; the NUCLEUS ACCUMBENS; the HIPPOCAMPUS, and the RAPHE NUCLEI. It plays a role as a terminal autoreceptor that regulates the rate of SEROTONIN release from nerve endings. This serotonin receptor subtype is closely related to and has similar drug binding properties as the 5-HT1B RECEPTOR, but is expressed at low levels. It is particularly sensitive to the agonist SUMATRIPTAN and may be involved in mediating the drug%27%s antimigrane effect.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin uptake inhibitor that is effective in the treatment of depression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. %28%From AMA Drug Evaluations Annual, 1994, p309%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of ORTHOREOVIRUS, MAMMALIAN causing serious pathology in laboratory rodents, characterized by diarrhea, oily coat, jaundice, and multiple organ involvement.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of SALMONELLA ENTERICA which is an agent of PARATYPHOID FEVER in Asia, Africa, and southern Europe.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of SALMONELLA ENTERICA which is an agent of PARATYPHOID FEVER in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of Salmonella enterica which is an etiologic agent of gastroenteritis in man and other animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serotype of the species California encephalitis virus %28%ENCEPHALITIS VIRUS, CALIFORNIA%29%, in the genus ORTHOBUNYAVIRUS, causing human MENINGOENCEPHALITIS. This is the agent most responsible for California encephalitis %28%ENCEPHALITIS, CALIFORNIA%29%, the most prevalent mosquito-borne disease recognized in the United States.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serovar of the bacterial species LEPTOSPIRA INTERROGANS, characteristically associated with a severe zoonotic disease in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose frequent host is CATTLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose natural host is DOGS where disease is characterized by GASTROENTERITIS, and INTERSTITIAL NEPHRITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary host is RATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary host is the MOUSE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serovar of the bacterial species LEPTOSPIRA INTERROGANS, whose primary hosts include CATTLE and SWINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serum protein that regulates the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It binds as a cofactor to COMPLEMENT FACTOR I which then hydrolyzes the COMPLEMENT C4B in the CLASSICAL PATHWAY C3 CONVERTASE %28%C4bC2a%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A serum protein which is important in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. This enzyme cleaves the COMPLEMENT C3B-bound COMPLEMENT FACTOR B to form C3bBb which is ALTERNATIVE PATHWAY C3 CONVERTASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of ADHESINS and TOXINS, BIOLOGICAL produced by BORDETELLA organisms that determine the pathogenesis of BORDETELLA INFECTIONS, such as WHOOPING COUGH. They include filamentous hemagglutinin; FIMBRIAE PROTEINS; pertactin; PERTUSSIS TOXIN; ADENYLATE CYCLASE TOXIN; dermonecrotic toxin; tracheal cytotoxin; Bordetella LIPOPOLYSACCHARIDES; and tracheal colonization factor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of beliefs concerning the nature, cause, and purpose of the universe, especially when considered as the creation of a superhuman agency. It usually involves devotional and ritual observances and often a moral code for the conduct of human affairs. %28%Random House Collegiate Dictionary, rev. ed.%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of forebrain structures common to all mammals that is defined functionally and anatomically. It is implicated in the higher integration of visceral, olfactory, and somatic information as well as homeostatic responses including fundamental survival behaviors %28%feeding, mating, emotion%29%. For most authors, it includes the AMYGDALA; EPITHALAMUS; GYRUS CINGULI; hippocampal formation %28%see HIPPOCAMPUS%29%; HYPOTHALAMUS; PARAHIPPOCAMPAL GYRUS; SEPTAL NUCLEI; anterior nuclear group of thalamus, and portions of the basal ganglia. %28%Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p744; NeuroNames, http://rprcsgi.rprc.washington.edu/neuronames/index.html %28%September 2, 1998%29%%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of genes descended by duplication and variation from some ancestral gene. Such genes may be clustered together on the same chromosome or dispersed on different chromosomes. Examples of multigene families include those that encode the hemoglobins, immunoglobulins, histocompatibility antigens, actins, tubulins, keratins, collagens, heat shock proteins, salivary glue proteins, chorion proteins, cuticle proteins, yolk proteins, and phaseolins, as well as histones, ribosomal RNA, and transfer RNA genes. The latter three are examples of reiterated genes, where hundreds of identical genes are present in a tandem array. %28%King %26% Stanfield, A Dictionary of Genetics, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of models of how communication impacts and is impacted by subjective experience. Techniques are generated from these models by sequencing of various aspects of the models in order to change someone%27%s internal representations. Neurolinguistic programming is concerned with the patterns or programming created by the interactions among the brain, language, and the body, that produce both effective and ineffective behavior.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of nuclear proteins in SACCHAROMYCES CEREVISIAE that are required for the transcriptional repression of the silent mating type loci. They mediate the formation of silenced CHROMATIN and repress both transcription and recombination at other loci as well. They are comprised of 4 non-homologous, interacting proteins, Sir1p, Sir2p, Sir3p, and Sir4p. Sir2p, an NAD-dependent HISTONE DEACETYLASE, is the founding member of the family of SIRTUINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of opposing, nonequilibrium reactions catalyzed by different enzymes which act simultaneously, with at least one of the reactions driven by ATP hydrolysis. The results of the cycle are that ATP energy is depleted, heat is produced and no net substrate-to-product conversion is achieved. Examples of substrate cycling are cycling of gluconeogenesis and glycolysis pathways and cycling of the triglycerides and fatty acid pathways. Rates of substrate cycling may be increased many-fold in association with hypermetabolic states resulting from severe burns, cold exposure, hyperthyroidism, or acute exercise.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal %28%CODON, TERMINATOR%29%. Most codons are universal, but some organisms do not produce the transfer RNAs %28%RNA, TRANSFER%29% complementary to all codons. These codons are referred to as unassigned codons %28%CODONS, NONSENSE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A seven-membered aromatic ring compound. It is structurally related to a number of naturally occurring antifungal compounds %28%ANTIBIOTICS, ANTIFUNGAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases %28%over eighty percent%29%, while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, hallucinations, emotional disharmony, and regressive behavior.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe familial adult-onset hypertriglyceridemia different from that due to lipoprotein lipase deficiency.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe form of LEPTOSPIROSIS, usually caused by LEPTOSPIRA INTERROGANS SEROVAR ICTEROHAEMORRHAGIAE and occasionally other serovars. It is transmitted to humans by the rat and is characterized by hemorrhagic and renal symptoms with accompanying JAUNDICE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe form of acute INFLAMMATION of the PANCREAS characterized by one or more areas of NECROSIS in the pancreas with varying degree of involvement of the surrounding tissues or organ systems. Massive pancreatic necrosis may lead to DIABETES MELLITUS, and malabsorption.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe form of neonatal dwarfism with very short limbs. All cases have died at birth or later in the neonatal period.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe gangrenous process occurring predominantly in debilitated and malnourished children, especially in underdeveloped countries. It typically begins as a small vesicle or ulcer on the gingiva that rapidly becomes necrotic and spreads to produce extensive destruction of the buccal and labial mucosa and tissues of the face, which may result in severe disfigurement and even death. Various bacteria have been implicated in the etiology. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal failure, either acute %28%KIDNEY FAILURE, ACUTE%29% or chronic %28%KIDNEY FAILURE, CHRONIC%29%, requires HEMODIALYSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe stage of acute renal insufficiency, characterized by the sudden decrease in GLOMERULAR FILTRATION RATE to less than 15 ml per min, sometime to less than 1 to 2 ml per min. It is usually associated with OLIGURIA; EDEMA; and increase in BLOOD UREA NITROGEN and serum CREATININE concentrations.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe, often fatal disease in humans caused by the Crimean-Congo hemorrhagic fever virus %28%HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization %28%VIRILISM%29% in the females. In some cases, the Sertoli cells produce ESTROGENS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sex-linked recessive disorder of amino acid transport which affects the EYE; NERVOUS SYSTEM; and KIDNEY. Clinical manifestations include CATARACT; GLAUCOMA; developmental delay %28%which eventually leads to profound cognitive deficits%29%; myopathy; peripheral neuropathy; and hypotonia. There is an associated generalized aminoaciduria of the FANCONI SYNDROME type; renal tubular acidosis %28%ACIDOSIS, RENAL TUBULAR%29%; and hypophosphatemic RICKETS. This condition has been associated with deficient activity of the enzyme phosphatidylinositol 4,5-bisphosphate-5-phosphatase. %28%Menkes, Textbook of Child Neurology, 5th ed, p60; Am J Hum Genet 1997 Jun;60%28%6%29%:1384-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sex-specific cell surface antigen produced by the sex-determining gene of the Y chromosome in mammals. It causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sexual disorder occurring in a person 16 years or older and that is recurrent with intense sexually arousing fantasies, sexual urges, or behaviors involving sexual activity with a prepubescent child %28%generally age 13 or younger%29%. %28%from APA, DSM-IV, 1994%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A shaker subfamily of potassium channels that participate in transient outward potassium currents by activating at subthreshold MEMBRANE POTENTIALS, inactivating rapidly, and recovering from inactivation quickly.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A shaker subfamily that is prominently expressed in NEURONS and are necessary for high-frequency, repetitive firing of ACTION POTENTIALS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A shared service which combines the purchasing power of individual organizations or facilities in order to obtain lower prices for equipment and supplies. %28%From Health Care Terms, 2nd ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar %28%CICATRIX, HYPERTROPHIC%29% in that the former does not spread to surrounding tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sheath that is worn over the penis during sexual behavior in order to prevent pregnancy or spread of sexually transmitted disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, arsenic and certain arsenic compounds have been listed as known carcinogens. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A short thick vein formed by union of the superior mesenteric vein and the splenic vein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A short-acting barbiturate that is effective as a sedative and hypnotic %28%but not as an anti-anxiety%29% agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. %28%From AMA Drug Evaluations Annual, 1994, p236%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A short-acting opioid anesthetic and analgesic derivative of FENTANYL. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sialic acid-rich protein and an integral cell membrane mucin. It plays an important role in activation of T-LYMPHOCYTES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sialomucin protein that functions as a cell adhesion molecule. It is a negative regulator of certain types of HEMATOPOIETIC STEM CELLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducer and activator of transcription that mediates cellular responses to INTERFERONS. Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-12 in T-LYMPHOCYTES. Stat4 is an important signaling molecule for differentiation in TH1 CELLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-4. Stat6 has been shown to partner with NF-KAPPA B and CCAAT-ENHANCER-BINDING PROTEINS to regulate GENETIC TRANSCRIPTION of interleukin-4 responsive GENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducer and activator of transcription that mediates cellular responses to INTERLEUKIN-6 family members. STAT3 is constitutively activated in a variety of TUMORS and is a major downstream transducer for the CYTOKINE RECEPTOR GP130.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducer and activator of transcription that mediates cellular responses to TYPE I INTERFERONS. Stat2 protein is associated constitutively with INTERFERON REGULATORY FACTOR-9. After PHOSPHORYLATION Stat2 forms the IFN-STIMULATED GENE FACTOR 3 COMPLEX to regulate expression of target GENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing adaptor protein and tumor suppressor protein. It forms a complex with activated RECEPTOR-REGULATED SMAD PROTEINS. The complex then translocates to the CELL NUCLEUS and regulates GENETIC TRANSCRIPTION of target GENES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing adaptor protein that is encoded by the crk ONCOGENE from TYPE C AVIAN RETROVIRUSES. It contains SRC HOMOLOGY DOMAINS and is closely related to its cellular homolog, PROTO-ONCOGENE PROTEIN C-CRK.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing adaptor protein that links extracellular signals to the MAP KINASE SIGNALING SYSTEM. Grb2 associates with activated EPIDERMAL GROWTH FACTOR RECEPTOR and PLATELET-DERIVED GROWTH FACTOR RECEPTORS via its SH2 DOMAIN. It also binds to and translocates the SON OF SEVENLESS PROTEINS through its SH3 DOMAINS to activate PROTO-ONCOGENE PROTEIN P21%28%RAS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing tumor necrosis factor receptor associated factor that is involved in TNF RECEPTOR feedback regulation. It is similar in structure and appears to work in conjunction with TNF RECEPTOR-ASSOCIATED FACTOR 1 to inhibit APOPTOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing tumor necrosis factor receptor associated factor that is involved in TNF RECEPTOR feedback regulation. It is similar in structure and appears to work in conjunction with TNF RECEPTOR-ASSOCIATED FACTOR 2 to inhibit APOPTOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signaling and activation of MITOGEN-ACTIVATED PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing tumor necrosis factor receptor associated factor that is involved in regulation of NF-KAPPA B signalling and activation of JNK MITOGEN-ACTIVATED PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A signal transducing tumor necrosis factor receptor associated factor that mediates signaling from CD27 ANTIGENS; CD40 ANTIGENS; and the lymphotoxin beta-specific receptor. It is involved in regulation of NF-KAPPA B signalling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg %28%from hydrargyrum, liquid silver%29%, atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A simple tachycardia with origin in the sinus node with gradual onset and termination.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single SELENOCYSTEINE containing protein that binds reduced GLUTATHIONE and can act as an antioxidant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single citation covering several articles of various degrees of specificity or a single citation covering papers or abstracts presented at a meeting. A subject overall refers to a series of articles on a single subject; a congress overall refers to papers presented at a formal local, regional, national, or international gathering; a society overall refers to papers presented at an annual, semi-annual, monthly, weekly, or other meeting of a society, academy, institute, hospital, etc. The publication type may be used for a single citation with or without the additional indexing or cataloging of individual papers. The individual papers, however, are not labeled OVERALL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single layer of cells produced by cleavage of the fertilized ovum and forming the outer cells of the blastula.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single protein comprised of tandem repeats of the UBIQUITIN 78-amino acid sequence. It is a product of the polyubiquitin gene which contains multiple copies of the ubiquitin coding sequence. Proteolytic processing of ubiquitin C results in the formation of individual ubiquitin molecules. This protein is distinct from POLYUBIQUITIN, which is a protein formed through isopeptide linkage of multiple ubiquitin species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including chymotrypsin, kallikrein, plasmin, and trypsin. It is used in the treatment of hemorrhage associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with extracorporeal circulation. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene. It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor %28%FIBROBLAST GROWTH FACTOR 1%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single-pass transmembrane glycoproteins that mediate CALCIUM-dependent CELL ADHESION and are core components of DESMOSOMES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single-stranded DNA-binding protein that is found in EUKARYOTIC CELLS. It is required for DNA REPLICATION; DNA REPAIR; and GENETIC RECOMBINATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A single-stranded DNA-dependent RNA polymerase that functions to initiate, or prime, DNA synthesis by synthesizing oligoribonucleotide primers. EC 2.7.7.-.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A site located in the INTRONS at the 5%27% end of each constant region segment of a immunoglobulin heavy-chain gene where recombination %28%or rearrangement%29% occur during IMMUNOGLOBULIN CLASS SWITCHING. Ig switch regions are found on genes encoding all five classes %28%IMMUNOGLOBULIN ISOTYPES%29% of IMMUNOGLOBULIN HEAVY CHAINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A site on an enzyme which upon binding of a modulator, causes the protein to undergo a conformational change that may alter the catalytic or binding properties of the enzyme.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A situation in which an individual might benefit personally from official or professional actions. It includes a conflict between a person%27%s private interests and official responsibilities in a position of trust. The term is not restricted to government officials. The concept refers both to actual conflict of interest and the appearance or perception of conflict.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A situation in which the level of living of an individual, family, or group is below the standard of the community. It is often related to a specific income level.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A situation where one member %28%allele%29% of a gene pair is lost %28%LOSS OF HETEROZYGOSITY%29% or amplified.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic %22%bull%27%s-eye%22% lesions usually occurring on the dorsal aspect of the hands and forearms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A skin carcinoma that histologically exhibits both basal and squamous elements. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A skull fracture characterized by inward depression of a fragment or section of cranial bone, often compressing the underlying dura mater and brain. Depressed cranial fractures which feature open skin wounds that communicate with skull fragments are referred to as compound depressed skull fractures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sleep disorder characterized by grinding and clenching of the teeth and forceful lateral or protrusive jaw movements. Sleep bruxism may be associated with TOOTH INJURIES; TEMPOROMANDIBULAR JOINT DISORDERS; sleep disturbances; and other conditions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sleep disorder of central nervous system origin characterized by prolonged nocturnal sleep and periods of daytime drowsiness. Affected individuals experience difficulty with awakening in the morning and may have associated sleep drunkenness, automatic behaviors, and memory disturbances. This condition differs from narcolepsy in that daytime sleep periods are longer, there is no association with CATAPLEXY, and the multiple sleep latency onset test does not record sleep-onset rapid eye movement sleep. %28%From Chokroverty, Sleep Disorders Medicine, 1994, pp319-20; Psychiatry Clin Neurosci 1998 Apr:52%28%2%29%:125-129%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slightly acid milk food produced by fermentation due to the combined action of Lactobacillus acidophilus and Streptococcus thermophilus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slightly alkaline secretion of the endocervical glands. The consistency and amount are dependent on the physiological hormone changes in the menstrual cycle. It contains the glycoprotein mucin, amino acids, sugar, enzymes, and electrolytes, with a water content up to 90%25%. The mucus is a useful protection against the ascent of bacteria and sperm into the uterus. %28%From Dictionary of Obstetrics and Gynecology, 1988%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slow-growing, nonphotochromogenic species that causes chronic skin lesions in humans %28%Buruli ulcer%29%. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slow-growing, photochromogenic species that is the etiologic agent of a tuberculosis-like disease in humans and is frequently isolated from human pulmonary secretions or tubercles. The incidence of infection is sharply increased among immunocompromised individuals. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slow-growing, scotochromogenic species occurring usually harmlessly in human secretions but occasionally associated with chronic pulmonary disease. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, cardiac rate changes, and bronchial spasms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. %28%Adams et al., Principles of Neurology, 6th ed, p1337%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly progressive autosomal dominant disorder of keratinization characterized by pinkish-to-tan papules that coalesce to form plaques. These lesions become darker over time and commonly fuse, forming papillomatous and warty malodorous growths.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small Maf protein involved in differentiation of ERYTHROID CELLS. MafK was originally described as the small subunit of the NF-E2 Transcription Factor, but other small MAF PROTEINS also serve as NF-E2 subunits.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small bony canal linking the vestibule of the inner ear to the posterior part of the internal surface of the petrous temporal bone. It surrounds the endolymphatic duct.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small circumscribed mass in the THYROID GLAND that can be of neoplastic growth or non-neoplastic abnormality. It lacks a well-defined capsule or glandular architecture. Thyroid nodules are often benign but can be malignant. The growth of nodules can lead to a multinodular goiter %28%GOITER, NODULAR%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. %28%From AMA Drug Evaluations Annual, 1992, p1083%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small maf protein that forms dimers with NRF1 PROTEIN; NRF2 PROTEIN; and P45 NF-E2 PROTEIN. MafF complexes bind Maf recognition elements to regulate tissue-specific GENETIC TRANSCRIPTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small order of primarily marine fish containing 340 species. Most have a rotund or box-like shape. TETRODOTOXIN is found in their liver and ovaries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small plant family of the order Ebenales, subclass Dilleniidae, class Magnoliopsida. Members contain NAPHTHOQUINONES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small plant family of the order Liliales, subclass Liliidae, class Liliopsida %28%monocotyledons%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small plant family of the order Santalales, subclass Rosidae, class Magnoliopsida.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small protuberance at the dorsal, posterior corner of the wall of the third ventricle, adjacent to the dorsal thalamus and pineal body. It contains the habenular nuclei and is a major part of the epithalamus. %28%From Lockard, Desk Reference for Neuroscience, 2nd ed, p121%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small round or oval, mostly subcutaneous nodule made up chiefly of a mass of Aschoff bodies and seen in cases of rheumatic fever. It is differentiated from the RHEUMATOID NODULE which appears in rheumatoid arthritis, most frequently over bony prominences. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING SYNDROME. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small, circumscribed, benign tumor of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small, often impalpable benign papilloma arising in a lactiferous duct and frequently causing bleeding from the nipple. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small, oval, bony chamber of the labyrinth. The vestibule contains the utricle and saccule, organs which are part of the balancing apparatus of the ear.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small, rounded eminence on each side of the FOURTH VENTRICLE, which receives nerve fibers from the SOLITARY NUCLEUS; SPINAL CORD; and adjacent areas of the MEDULLA. The area postrema lies outside the BLOOD-BRAIN BARRIER and its functions include acting as an emetic chemoreceptor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A smooth, solid or cystic fibroepithelial %28%FIBROEPITHELIAL NEOPLASMS%29% tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A snow sport which uses skis to glide over the snow. It does not include water-skiing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A social group consisting of parents or parent substitutes and children.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A social science dealing with group relationships, patterns of collective behavior, and social organization.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. It is used in the prevention of dental caries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium salt of gold thiosulfate. It has uses like the ORGANOGOLD COMPOUNDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium-dependent neutral amino acid transporter that accounts for most of the sodium-dependent neutral amino acid uptake by mammalian cells. The preferred substrates for this transporter system include ALANINE; SERINE; and GLUTAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium-dependent phosphate transporter present primarily at apical sites of EPITHELIAL CELLS in the SMALL INTESTINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium-independent neutral amino acid transporter system with specificity for large amino acids. One of the functions of the transporter system is to supply large neutral amino acids to the brain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sodium-independent, basic amino acid transport system with a high-affinity for LYSINE; ARGININE; and ORNITHINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soft tissue infection of the throat with entry usually by the pharynx but sometimes as an extension of a lateral neck infection resulting from a neck injury. The major risk is upper airway obstruction caused by pharyngeal swelling. %28%Daniel R. Masys, from a written communication%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.19, symbol Pb. %28%Dorland, 28th%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soft, loose-fitting polyurethane sheath, closed at one end, with flexible rings at both ends. The device is inserted into the vagina by compressing the inner ring and pushing it in. Properly positioned, the ring at the closed end covers the cervix, and the sheath lines the walls of the vagina. The outer ring remains outside the vagina, covering the labia. %28%Med Lett Drugs Ther 1993 Dec 24;35%28%12%29%:123%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soil-dwelling actinomycete with a complex lifecycle involving mycelial growth and spore formation. It is involved in the production of a number of medically important ANTIBIOTICS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A solid form of carbon dioxide used as a refrigerant. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A solid tumor consisting of a dense infiltration of MAST CELLS. It is generally benign.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soluble cytochrome P-450 enzyme that catalyzes camphor monooxygenation in the presence of putidaredoxin, putidaredoxin reductase, and molecular oxygen. This enzyme, encoded by the CAMC gene also known as CYP101, has been crystallized from bacteria and the structure is well defined. Under anaerobic conditions, this enzyme reduces the polyhalogenated compounds bound at the camphor-binding site.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soluble factor produced by monocytes, macrophages, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. IL-1 consists of two distinct forms, IL-1 alpha and IL-1 beta which perform the same functions but are distinct proteins. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. The factor is distinct from INTERLEUKIN-2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A solution or compound that is introduced into the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A solution used for irrigating the mouth in xerostomia and as a substitute for saliva.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sometimes fatal ASFIVIRUS infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. It is transmitted between domestic swine by direct contact, ingestion of infected meat, or fomites, or mechanically by biting flies or soft ticks %28%genus Ornithodoros%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A somewhat heterogeneous class of enzymes that catalyze the transfer of alkyl or related groups %28%excluding methyl groups%29%. EC 2.5.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A source of inorganic fluoride which is used topically to prevent dental caries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A space in which the pressure is far below atmospheric pressure so that the remaining gases do not affect processes being carried on in the space.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A space which has limited openings for entry and exit combined with unfavorable natural ventilation such as caves, refrigerators, deep tunnels, pipelines, sewers, silos, tanks, vats, mines, deep trenches or pits, vaults, manholes, chimneys, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spasm of the diaphragm that causes a sudden inhalation followed by rapid closure of the glottis which produces a sound.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A special service provided by volunteers to accompany patients who need help in moving about the health facility.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized barrier, in the TESTIS, between the interstitial BLOOD compartment and the adluminal compartment of the SEMINIFEROUS TUBULES. The barrier is formed by layers of cells from the VASCULAR ENDOTHELIUM of the capillary BLOOD VESSELS, to the SEMINIFEROUS EPITHELIUM of the seminiferous tubules. TIGHT JUNCTIONS form between adjacent SERTOLI CELLS, as well as between the ENDOTHELIAL CELLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized part of the olfactory system located anteriorly in the nasal cavity within the nasal septum. Chemosensitive cells of the vomeronasal organ project via the vomeronasal nerve to the accessory olfactory bulb. The primary function of this organ appears to be in sensing pheromones which regulate reproductive and other social behaviors. While the structure has been thought absent in higher primate adults, data now suggests it may be present in adult humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized proteolytic enzyme secreted by intestinal cells. It converts TRYPSINOGEN into its active form TRYPSIN by removing the N-terminal peptide. EC 3.4.21.9.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized residential treatment program for behavior disorders including substance abuse. It may include therapeutically planned group living and learning situations including teaching of adaptive skills to help patient functioning in the community. %28%From Kahn, A. P. and Fawcett, J. Encyclopedia of Mental Health, 1993, p320.%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized structure that serves as an organ of the sense of smell as well as part of the respiratory system; the term includes both the external nose and the nasal cavity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialized transport barrier, in the EYE, formed by the retinal pigment EPITHELIUM, and the ENDOTHELIUM of the BLOOD VESSELS of the RETINA. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty concerned with the diagnosis and treatment of foot disorders and injuries and anatomic defects of the foot.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty concerned with the study of anesthetics and anesthesia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specialty which is concerned with the health and medical problems of man in AVIATION %28%aviation medicine%29% and SPACE FLIGHT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species ARTERIVIRUS, occurring in a number of transplantable mouse tumors. Infected mice have permanently elevated serum levels of lactate dehydrogenase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE family. Previously a large group of serotypes, most are now considered separate species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. A large number of serotypes or strains exist in many parts of the world. They are transmitted by mosquitoes and infect humans in some areas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the ORTHOBUNYAVIRUS genus of the family BUNYAVIRIDAE. Serotypes are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several serotypes infect humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the family DELTARETROVIRUS comprising strains of different host species but arising from the same geographic origin. They include HUMAN T-LYMPHOTROPIC VIRUS 1 and SIMIAN T-LYMPHOTROPIC VIRUS 1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the family DELTARETROVIRUS, comprising strains from different host species but arising from the same geographic origin. They include HUMAN T-LYMPHOTROPIC VIRUS 2 and SIMIAN T-LYMPHOTROPIC VIRUS 2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the family ENTEROVIRUS infecting cattle. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus ANABAENA containing gas vacuoles that gives buoyancy to the organism. It can form extensive blooms in FRESH WATER and is responsible for acute poisonings of various animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus ANABAENA whose trichomes are composed of cylindrical cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus Bornavirus, family BORNAVIRIDAE, causing a rare and usually fatal encephalitic disease in horses and other domestic animals and possibly deer. Its name derives from the city in Saxony where the condition was first described in 1894, but the disease occurs in Europe, N. Africa, and the Near East.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It contains hemagglutinin-esterase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus CORONAVIRUS causing the common cold and possibly nervous system infections in humans. It lacks hemagglutinin-esterase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus CORYNEBACTERIUM, family Corynebacteriaceae, which is used for industrial production of the amino acid LYSINE. It is closely related to Corynebacterium glutamicum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans %28%HEPATITIS A%29% and primates, respectively.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus MAREK%27%S DISEASE-LIKE VIRUSES, in the family HERPESVIRIDAE, infecting chickens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus MAREK%27%S DISEASE-LIKE VIRUSES, in the family HERPESVIRIDAE, infecting turkeys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus PHLEBOVIRUS causing PHLEBOTOMUS FEVER, an influenza-like illness. Related serotypes include Toscana virus and Tehran virus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus PHLEBOVIRUS of the family BUNYAVIRIDAE, infecting vertebrates and vectored by ticks. It has not been associated with human disease though antibodies have been isolated from human sera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting cattle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and %22%classical%22% Kaposi sarcoma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the genus ROSEOLOVIRUS, of the family HERPESVIRIDAE. It was isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species in the group RETICULOENDOTHELIOSIS VIRUSES, AVIAN of the genus GAMMARETROVIRUS that causes a chronic neoplastic and a more acute immunosuppressive disease in fowl.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ACTINOMYCES found in the oral cavity of man and hamsters. It has been isolated from actinomycotic lesions in swine, cats, and dogs and has been identified as a causative agent of animal diseases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALGAE in the genus EUGLENA, family Euglenaceae. It is a colorless heterotrophic flagellate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHARETROVIRUS causing anemia in fowl. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHARETROVIRUS causing progressive anemia and weakness in domestic and wild fowl.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHAVIRUS associated with epidemic EXANTHEMA and polyarthritis in Australia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHAVIRUS causing an acute dengue-like fever.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHAVIRUS causing encephalomyelitis in Equidae and humans. The virus ranges along the Atlantic seaboard of the United States and Canada and as far south as the Caribbean, Mexico, and parts of Central and South America. Infections in horses show a mortality of up to 90 percent and in humans as high as 80 percent in epidemics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHAVIRUS isolated in central, eastern, and southern Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines in the United States, southern Canada, and parts of South America.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ALPHAVIRUS that is the etiologic agent of encephalomyelitis in humans and equines. It is seen most commonly in parts of Central and South America.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ANABAENA that can form SPORES called akinetes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ARENAVIRUS, one of the New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%, causing a fatal infection in the cricetine rodent Oryzomys albigularis. Asymptomatic laboratory infection in humans has been reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ARENAVIRUS, part of the New World Arenaviruses %28%ARENAVIRUSES, NEW WORLD%29%, causing Argentinian hemorrhagic fever. The disease is characterized by congestion, edema, generalized lymphadenopathy and hemorrhagic necrosis and is sometimes fatal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ARENAVIRUS, part of the Old World Arenaviruses %28%ARENAVIRUSES, OLD WORLD%29%, and the etiologic agent of LASSA FEVER. LASSA VIRUS is a common infective agent in humans in West Africa. Its natural host is the multimammate mouse Mastomys natalensis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ARTERIVIRUS causing reproductive and respiratory disease in pigs. The European strain is called Lelystad virus. Airborne transmission is common.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of AVIBIRNAVIRUS causing severe inflammation of the bursa of Fabricius in chickens and other fowl. Transmission is thought to be through contaminated feed or water. Vaccines have been used with varying degrees of success.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of AVIPOXVIRUS, subfamily CHORDOPOXVIRINAE. Canarypox virus vectors are used in vaccine and immunotherapy research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of AZORHIZOBIUM which forms nodules on the roots of the tropical legume Sesbania rostrata. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of BETARETROVIRUS isolated from mammary carcinoma in rhesus monkeys. It appears to have evolved from a recombination between a murine B oncovirus and a primate C oncovirus related to the baboon endogenous virus. Several serologically distinct strains exist. MPMV induces simian AIDS %28%SAIDS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of BORDETELLA isolated from the respiratory tracts of TURKEYS and other BIRDS. It causes a highly contagious bordetellosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of BORDETELLA that is parasitic and pathogenic. It is found in the respiratory tract of domestic and wild mammalian animals and can be transmitted from animals to man. It is a common cause of bronchopneumonia in lower animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of BORDETELLA with similar morphology to BORDETELLA PERTUSSIS, but growth is more rapid. It is found only in the RESPIRATORY TRACT of humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of BURKHOLDERIA considered to be an opportunistic human pathogen. It has been associated with various types of infections of nosocomial origin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CAMPYLOBACTER comprised of three biovars based on their reaction to CATALASE and UREASE. They have been isolated from humans, CATTLE, and SHEEP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CAMPYLOBACTER isolated from DOGS; CATS; and humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CAMPYLOBACTER isolated from cases of human PERIODONTITIS. It is a microaerophile, capable of respiring with OXYGEN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CAMPYLOBACTER isolated from the INTESTINES of PIGS with proliferative ENTERITIS. It is also found in CATTLE and in CRICETINAE and can cause enteritis in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CAPRIPOXVIRUS causing a cattle disease occurring in Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CARDIOVIRUS which contains of three strains: Theiler%27%s murine encephalomyellitis virus, Vilyuisk human encephalomyelitis virus, and Rat encephalomyelitis virus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannas of Africa. The African green monkey %28%C. pygerythrus%29% is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CHLAMYDOPHILA that causes acute respiratory infection, especially atypical pneumonia, in humans, horses, and koalas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of COLTIVIRUS transmitted by the tick DERMACENTOR andersonii and causing fever, chills, aching head and limbs, and often vomiting. It occurs in the northwestern United States, except the Pacific Coast.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS causing a fatal disease to pigs under 3 weeks old.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS causing atypical respiratory disease %28%SEVERE ACUTE RESPIRATORY SYNDROME%29% in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS causing enteritis in turkeys and pullets.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS causing infections in chickens and possibly pheasants. Chicks up to four weeks old are the most severely affected.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS causing pneumonia in newborn rats but a clinically inapparent infection in adults. It is separate but antigenically related to MURINE HEPATITIS VIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS infecting cats of all ages and commonly found in catteries and zoos. Cats are often found carrying the virus but only a small proportion develop disease. Feline coronavirus and Feline infectious peritonitis virus %28%FIPV%29% are virtually the same virus in genetic and antigenetic terms, and are morphologically indistinguishable. Since they only differ in their disease potential %28%with FIPV causing a more serious illness%29%, they are considered biotypes of each other. %28%From Hoskins, JD. Update on Feline Coronavirus Disease. http://maxshouse.com.FIP%25%20Update.htm %28%April 3, 2001%29%%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS infecting dogs. Onset of symptoms is usually sudden and includes vomiting, diarrhea, and dehydration.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORONAVIRUS infecting neonatal calves, presenting as acute diarrhea, and frequently leading to death.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of CORYNEBACTERIUM isolated from abscesses of warm-blooded animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of DELTARETROVIRUS comprising one strain: Simian T-lymphotropic virus 3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of DNA virus, in the genus WHISPOVIRUS, infecting PENAEID SHRIMP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ECTOTHIORHODOSPIRA distinguished by its ability to utilize nitrate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of EDWARDSIELLA distinguished by its hydrogen sulfide production. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of EDWARDSIELLA distinguished by its nonmotility. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS associated with outbreaks of aseptic meningitis %28%MENINGITIS, ASEPTIC%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS infecting humans and consisting of 2 serotypes: Human enterovirus 68 and Human enterovirus 70.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS infecting humans and containing 10 serotypes, mostly coxsackieviruses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS infecting humans and containing 11 serotypes, all coxsackieviruses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS that has caused outbreaks of aseptic meningitis in children and adults.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes %28%strains%29% exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector %28%flies%29%. Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of European freshwater LEECHES used for BLOODLETTING in ancient times and also for LEECHING in modern times.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%, found in Australia and New Guinea. It causes a fulminating viremia resembling Japanese encephalitis %28%ENCEPHALITIS, JAPANESE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%, which is the etiologic agent of St. Louis encephalitis %28%ENCEPHALITIS, ST. LOUIS%29% in the United States, the Caribbean, and Central and South America.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%, which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of FLAVIVIRUS, one of the Japanese encephalitis virus group %28%ENCEPHALITIS VIRUSES, JAPANESE%29%. It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever %28%WEST NILE FEVER%29%. The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of GAMMARETROVIRUS causing leukemia in the gibbon ape. Natural transmission is by contact.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of GAMMARETROVIRUS causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas %28%see also SARCOMA VIRUSES, FELINE%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of GAMMARETROVIRUS producing tumors in primates. Originally isolated from a fibrosarcoma in a woolly monkey, WMSV is a replication-defective v-onc virus which carries the sis oncogene. In order to propagate, WMSV requires a replication-competent helper virus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HANTAVIRUS causing a less severe form of HEMORRHAGIC FEVER WITH RENAL SYNDROME in Asia %28%primarily Korea and Japan%29%. It is transmitted by rats, especially Rattus rattus and R. norvegicus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HANTAVIRUS causing nephropathia epidemica, a mild form of HEMORRHAGIC FEVER WITH RENAL SYNDROME. It is found in most of Europe and especially in Finland, along with its carrier rodent, the bank vole %28%Clethrionomys glareolus%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HANTAVIRUS which emerged in the Four Corners area of the United States in 1993. It causes a serious, often fatal pulmonary illness %28%HANTAVIRUS PULMONARY SYNDROME%29% in humans. Transmission is by inhaling aerosolized rodent secretions that contain virus particles, carried especially by deer mice %28%PEROMYSCUS maniculatus%29% and pinyon mice %28%P. truei%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HELICOBACTER commonly associated with STOMACH DISEASES in FERRETS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HELICOBACTER that colonizes in the STOMACH of laboratory MICE; CATS; and DOGS. It is associated with lymphoid follicular hyperplasia and mild GASTRITIS in CATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HELICOBACTER that colonizes the CECUM and COLON of several strains of MICE, and is associated with HEPATITIS and carcinogenesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HENIPAVIRUS first identified in Australia in 1994 in HORSES and transmitted to humans. The natural host appears to be fruit bats %28%PTEROPUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of HENIPAVIRUS, closely related to HENDRA VIRUS, which emerged in Peninsular Malaysia in 1998. It causes a severe febrile ENCEPHALITIS in humans and also encephalitis and RESPIRATORY TRACT DISEASES in pigs. Fruit bats %28%PTEROPUS%29% are the natural host.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of Halorhodospira distinguished by its ability to grow optimally in an environment of 15-20%25% salinity. It was formerly called Ectothiorhodospira halophila.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of LENTIVIRUS, subgenus equine lentiviruses %28%LENTIVIRUSES, EQUINE%29%, causing acute and chronic infection in horses. It is transmitted mechanically by biting flies, mosquitoes, and midges, and iatrogenically through unsterilized equipment. Chronic infection often consists of acute episodes with remissions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of LENTIVIRUS, subgenus feline lentiviruses %28%LENTIVIRUSES, FELINE%29% isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma %28%FIP-P%29%, Oma %28%FIP-O%29% and Puma lentivirus %28%PLV%29%. There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses %28%LENTIVIRUSES, OVINE-CAPRINE%29%, closely related to VISNA-MAEDI VIRUS and causing acute encephalomyelitis; chronic arthritis; PNEUMONIA; MASTITIS; and GLOMERULONEPHRITIS in goats. It is transmitted mainly in the colostrum and milk.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses %28%LENTIVIRUSES, OVINE-CAPRINE%29%, that can cause chronic pneumonia %28%maedi%29%, mastitis, arthritis, and encephalomyelitis %28%visna%29% in sheep. Maedi is a progressive pneumonia of sheep which is similar to but not the same as jaagsiekte %28%PULMONARY ADENOMATOSIS, OVINE%29%. Visna is a demyelinating leukoencephalomyelitis of sheep which is similar to but not the same as SCRAPIE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of LEPORIPOXVIRUS causing subcutaneous localized swellings in rabbits, usually on the feet.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of METHYLOBACTERIUM which can utilize acetate, ethanol, or methylamine as a sole carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of METHYLOCOCCUS which forms capsules and is capable of autotrophic carbon dioxide fixation. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of METHYLOPHILUS which is motile by single flagella. In addition to growth on methanol as a sole carbon source, growth also occurs on glucose. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of METHYLOSINUS which is capable of degrading trichloroethylene and other organic pollutants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MITOSPORIC FUNGI that is a major cause of SEPTICEMIA and disseminated CANDIDIASIS, especially in patients with LYMPHOMA; LEUKEMIA; and DIABETES MELLITUS. It is also found as part of the normal human mucocutaneous flora.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MOLLUSCIPOXVIRUS causing skin lesions in humans. It is transmitted by direct contact or from non-living reservoirs %28%fomites%29%, such as books or clothing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MORBILLIVIRUS causing a severe, often fatal enteritis and pneumonia %28%PESTE-DES-PETITS-RUMINANTS%29% in sheep and goats.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MORBILLIVIRUS causing cattle plague, a disease with high mortality. Sheep, goats, pigs, and other animals of the order Artiodactyla can also be infected.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MORBILLIVIRUS causing distemper in dogs, wolves, foxes, raccoons, and ferrets. Pinnipeds have also been known to contract Canine distemper virus from contact with domestic dogs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MORBILLIVIRUS causing distemper in seals. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of MORGANELLA formerly classified as a Proteus species. It is found in the feces of humans, dogs, other mammals, and reptiles. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of NAIROVIRUS of the family BUNYAVIRIDAE. It is primarily transmitted by ticks and causes a severe, often fatal disease in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of NAIROVIRUS, transmitted by the ixodid ticks and producing a lethal gastroenteritis in sheep and goats. Though a major veterinary pathogen, its effect on humans has not been firmly established.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORBIVIRUS causing a fatal disease in deer. It is transmitted by flies of the genus Culicoides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORBIVIRUS infecting cattle and sheep. It is transmitted by culicine mosquitoes and gnats %28%CULICOIDES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORBIVIRUS that causes disease in horses, mules, and donkeys. Via its principal vector CULICOIDES, it can also infect dogs, elephants, camels, cattle, sheep, goats, and, in special circumstances, humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORTHOPOXVIRUS causing an epidemic disease among captive primates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORTHOPOXVIRUS causing infections in humans. No infections have been reported since 1977 and the virus is now believed to be virtually extinct.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORTHOPOXVIRUS infecting mice and causing a disease that involves internal organs and produces characteristic skin lesions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORTHOPOXVIRUS that is the etiologic agent of COWPOX. It is closely related to but antigenically different from VACCINIA VIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORTHOREOVIRUS infecting birds, with outcomes ranging from inapparent to lethal depending on the virus strain and age of the host bird. This species does not infect mammals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ORTHOREOVIRUS infecting mammals %28%other than baboons%29%. There are three serotypes. In humans they are generally benign but may sometimes cause upper respiratory tract illness or enteritis in infants and children. REOVIRUS 3 is a very pathogenic virus in laboratory rodents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of Old World monkeys from the genera CERCOCEBUS that is important in AIDS research. They may be naturally or experimentally infected with the simian immunodeficiency virus. They inhabit African forests from Sierra Leone to the Congo Republic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PAPILLOMAVIRUS causing WARTS in humans. These benign, squamous EPITHELIAL NEOPLASMS can sometimes progress to malignancy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PAPILLOMAVIRUS producing large numbers of WARTS on calves. Connective tissue proliferation is an important component of the warts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PARAPOXVIRUS causing a pox-like disease on udders of cows that may spread to milkers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PARVOVIRUS causing reproductive failure in pigs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PARVOVIRUS chiefly affecting young cats in endemic areas, but all felines are susceptible.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PARVOVIRUS infecting cats with a highly contagious enteric disease. Host range variants include mink enteritis virus, canine parvovirus %28%PARVOVIRUS, CANINE%29%, and raccoon parvovirus. After infecting their new hosts, many of these viruses have further evolved and are now considered distinct species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PERCIFORMES commonly used in saline aquaculture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PESTIVIRUS causing a congenital sheep disease characterized by an abnormally hairy birth-coat, tremors, and poor growth.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PESTIVIRUS causing systemic infections %28%BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE%29% in cattle and some other cloven-hoofed animals. There are several strains and two biotypes: cytopathic %28%rare%29% and non-cytopathic. Infections range from clinically inapparent to severe, but do not correlate with biotypes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PESTIVIRUS causing systemic infections including BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE and BOVINE HEMORRHAGIC SYNDROME in cattle and some other cloven-hoofed animals. There are several strains and two biotypes: cytopathic %28%rare%29% and non-cytopathic. The severity of disease appears to be strain dependent. Cytopathogenic effects do not correlate with virulence as non-cytopathic BVDV-2 is associated only with Hemorrhagic Disease, Bovine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PLASMODIUM causing malaria in rodents. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PNEUMOCYSTIS infecting humans and causing PNEUMOCYSTIS PNEUMONIA. It also occasionally causes extrapulmonary disease in immunocompromised patients. Its former name was Pneumocystis carinii f. sp. hominis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of POLYOMAVIRUS apparently infecting over 90%25% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient%27%s initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RESPIROVIRUS also called hemadsorption virus 2 %28%HA2%29%, which causes laryngotracheitis in humans, especially children.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RESPIROVIRUS, subfamily PARAMYXOVIRINAE, most often seen in conjunction with a secondary infection of MANNHEIMIA HAEMOLYTICA resulting in pneumonic pasteurellosis %28%PASTEURELLOSIS, PNEUMONIC%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RHODOCOCCUS found in soil, herbivore dung, and in the intestinal tract of cows, horses, sheep, and pigs. It causes bronchopneumonia in foals and can be responsible for infection in humans compromised by immunosuppressive drug therapy, lymphoma, or AIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RUBULAVIRUS associated particularly with acute laryngotracheitis %28%CROUP%29% in children aged 6 months to 3 years.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RUBULAVIRUS causing endemic upper respiratory infections in children. It produces only a mild clinical disease and often goes undetected.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of RUBULAVIRUS originally isolated from cultured primary monkey cells. Its natural host is the DOG in which it causes kennel cough, but it can also infect humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of Ralstonia previously classed in the genera PSEUDOMONAS and BURKHOLDERIA. It is an important plant pathogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of SEA URCHINS in the family Strongylocentrotidae found on the Pacific coastline from Alaska to Mexico. This species serves as a major research model for molecular developmental biology and other fields.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of SHEWANELLA noted for its ability to reduce iron and manganese anaerobically.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of SIMPLEXVIRUS associated with genital infections %28%HERPES GENITALIS%29%. It is transmitted by sexual intercourse and close personal contact.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of SIMPLEXVIRUS causing mammillitis in cattle in Great Britain and South Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of SIMPLEXVIRUS that causes vesicular lesions of the mouth in monkeys. When the virus is transmitted to man it causes an acute encephalitis or encephalomyelitis, which is nearly always fatal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of STAPHYLOCOCCUS found on the skin of humans %28%and non-human primates%29%, often causing hospital-acquired infections %28%CROSS INFECTION%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of STAPHYLOCOCCUS similar to STAPHYLOCOCCUS HAEMOLYTICUS, but containing different esterases. The subspecies Staphylococcus hominis novobiosepticus is highly virulent and novobiocin resistant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of STENOTROPHOMONAS, formerly called Xanthomonas maltophilia, which reduces nitrate. It is a cause of hospital-acquired ocular and lung infections, especially in those patients with cystic fibrosis and those who are immunosuppressed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of STIGMATELLA usually isolated from rotting wood. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of STREPTOCOCCUS isolated from pigs. It is a pathogen of swine but rarely occurs in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of SWINE, in the family Suidae, comprising a number of subspecies including the domestic pig Sus scrofa domestica.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of THIOCAPSA which is facultatively aerobic and chemotrophic and which can utilize thiosulfate. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of Trypanosome hemoflagellates that is carried by tsetse flies and causes severe anemia in cattle. These parasites are also found in horses, sheep, goats, and camels.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS and the chief cause of rhinopneumonitis in horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS causing abortion and respiratory disease in horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS causing coital exanthema in horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS producing a respiratory infection %28%PSEUDORABIES%29% in swine, its natural host. It also produces an usually fatal ENCEPHALOMYELITIS in cattle, sheep, dogs, cats, foxes, and mink.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS that causes INFECTIOUS BOVINE RHINOTRACHEITIS and other associated syndromes in CATTLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS that causes a fatal MENINGOENCEPHALITIS in calves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of VARICELLOVIRUS virus that causes a disease in newborn puppies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of acetate-oxidizing bacteria, formerly known as Acetobacter xylinum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of aerobic, chemolithotrophic ARCHAEA consisting of coccoid cells that utilize sulfur as an energy source. The optimum temperature for growth is 70-75 degrees C. They are isolated from acidic fields.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of anaerobic bacteria, in the family Lachnospiraceae, found in RUMINANTS. It is considered both gram-positive and gram-negative.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of anaerobic, gram-positive, rod-shaped bacteria in the family Clostridiaceae that produces proteins with characteristic neurotoxicity. It is the etiologic agent of BOTULISM in humans, wild fowl, HORSES; and CATTLE. Seven subtypes %28%sometimes called antigenic types, or strains%29% exist, each producing a different botulinum toxin %28%BOTULINUM TOXINS%29%. The organism and its spores are widely distributed in nature.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of anaerobic, spiral bacteria that was formerly classified as Treponema hyodysenteriae %28%and for a short while, Serpula hyodysenteriae%29%. This organism is the agent of swine dysentery.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ascomycetous fungi of the family Sordariaceae, order SORDARIALES, much used in biochemical, genetic, and physiologic studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of baboon in the family CERCOPITHECIDAE found in southern Africa. They are dark colored and have a variable social structure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of baboon in the family CERCOPITHECIDAE found in southern equatorial and east Africa. They are smaller than PAPIO ANUBIS and have a thinner mane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of baboon in the family CERCOPITHECIDAE with a somewhat different social structure than PAPIO HAMADRYAS. They inhabit several areas in Africa south of the Sahara.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of baboon in the family CERCOPITHECIDAE, often used as an animal model for cognitive studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of baboon in the family CERCOPITHECIDAE, which has a well-studied trilevel social structure consisting of troops, bands, and clans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria found in the marine environment, sea foods, and the feces of patients with acute enteritis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria in the family SPIROCHAETACEAE, frequently isolated from periodontal pockets %28%PERIODONTAL POCKET%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria isolated from soil. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria that causes ANTHRAX in humans and animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria which is comprised of gram-negative rods which often approach a spherical shape. They are nonmotile and microaerophilic. They are considered parasites of horses and are pathogenic for mares. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ciliate protozoa used extensively in genetic research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ciliate protozoa used in genetic and cytological research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ciliate protozoa. It is used in biomedical research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of ciliated PROTOZOA possessing two micronuclei. It is one of the smallest PARAMECIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of coccidian protozoa that mainly infects domestic poultry.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of extremely thermophilic, sulfur-reducing archaea. It grows at a maximum temperature of 95 degrees C. in marine or deep-sea geothermal areas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of extremophilic bacteria in the family Thermotogaceae. Generally anaerobic but in the presence of OXYGEN, it can produce hydrogen gas as a byproduct of metabolism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of filamentous Pseudomonas phage in the genus INOVIRUS, family INOVIRIDAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of filamentous phage in the genus INOVIRUS, family INOVIRIDAE. They are specific for enterobacteria that contain an IncN plasmid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of fish in the cod family GADIDAE, known as the Atlantic cod. It is one of the most important commercial FISHES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of flagellate parasitic protozoa. It possesses a long undulating membrane that is bordered on its outer margin by a flagellum that becomes free posteriorly. This organism causes infections in cows that could lead to temporary infertility or abortion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of free-living soil amoebae in the family Acanthamoebidae. It can cause ENCEPHALITIS and KERATITIS in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of fruit fly much used in genetics because of the large size of its chromosomes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of fruit fly originating in sub-Saharan Africa but widely distributed worldwide. One of the most destructive fruit pests, its larvae feed and develop on many different fruits and some vegetables.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gliding bacteria found on soil as well as in surface fresh water and coastal seawater.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram negative, aerobic, denitrifying bacteria in the genus ACHROMOBACTER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria %28%currently incertae sedis%29% causing multisystem disease in CATTLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria and a common inhabitant of the NASAL CAVITY of both healthy and diseased PIGS. It is a common secondary invader in MYCOPLASMAL PNEUMONIA OF SWINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria and an nitrogen inoculum that displays a high intrinsic tolerance to acidity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria and causative agent of severe bovine ANAPLASMOSIS. It is the most pathogenic of the ANAPLASMA species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria and nitrogen innoculant of PHASEOLUS VULGARIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing CONJUNCTIVITIS and KERATOCONJUNCTIVITIS in SHEEP and GOATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing MASTITIS; ARTHRITIS; and RESPIRATORY TRACT DISEASES in CATTLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing PNEUMONIA, MYCOPLASMA in calves. Mycoplasma dispar also possibly plays a synergistic role with other BACTERIA and VIRUSES to cause other RESPIRATORY TRACT DISEASES in calves.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing chronic respiratory disease in POULTRY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing contagious agalactia of SHEEP and GOATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing lesions to AIR SACS and HOCK joints in TURKEYS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing mild ANAPLASMOSIS in CATTLE. It also can infect SHEEP and GOATS. It is transmitted by TICKS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria causing purulent POLYARTHRITIS in RATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria found in the human genitourinary tract %28%UROGENITAL SYSTEM%29%, oropharynx, and anal canal. Serovars 1, 3, 6, and 14 have been reclassed into a separate species UREAPLASMA parvum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria functioning as a nitrogen inoculum for dry beans, especially species in the genus PHASEOLUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria highly pathogenic to RATS and MICE. It is the primary cause of murine respiratory mycoplasmosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the family ANAPLASMATACEAE, that causes HEARTWATER DISEASE in ruminants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the family Prevotellaceae. It is the species most commonly isolated from endodontic infections %28%PULPITIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus ACTINOBACILLUS, which causes EPIDIDYMITIS in SHEEP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus ACTINOBACILLUS. It is mainly a pathogen of PIGS, but also can infect HORSES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus ANAPLASMA, family ANAPLASMATACEAE, formerly called Ehrlichia phagocytophila or Ehrlichia equi. This organism is tick-borne %28%IXODES%29% and causes disease in horses and sheep. In humans, it causes human granulocytic EHRLICHIOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus CITROBACTER, family ENTEROBACTERIACEAE. As an important pathogen of laboratory mice, it serves as a model for investigating epithelial hyperproliferation and tumor promotion. It was previously considered a strain of CITROBACTER FREUNDII.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus ENTEROBACTER, found in the environment and in foods. It has biochemical characteristics similar to ENTEROBACTER CLOACAE, but is yellow-pigmented.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus HAEMOPHILUS found, in the normal upper respiratory tract of SWINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus HAEMOPHILUS, causing respiratory tract disease in CHICKENS known as infectious coryza.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus HAEMOPHILUS, found in the normal flora of the human ORAL CAVITY and PHARYNX. It can cause SUBACUTE BACTERIAL ENDOCARDITIS; and BRAIN ABSCESS, among other conditions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus HAEMOPHILUS, ubiquitous in the human ORAL CAVITY and PHARYNX. It has low pathogenicity but is occasionally implicated in ENDOCARDITIS in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE, causing Sennetsu fever and found in the FAR EAST and SOUTHEAST ASIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus NEORICKETTSIA, family ANAPLASMATACEAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PASTEURELLA, found in the NASOPHARYNX of normal GUINEA PIGS; RATS; HAMSTERS; MICE; DOGS; and CATS. When associated with disease, it is usually a secondary invader. Occasional infections have been reported in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PORPHYROMONAS, family Porphyromonadaceae. It is a key pathogen in endodontic infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PSEUDOMONAS, containing multiple genomovars. It is distinguishable from other pseudomonad species by its ability to use MALTOSE and STARCH as sole carbon and energy sources. It can degrade ENVIRONMENTAL POLLUTANTS and has been used as a model organism to study denitrification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PSEUDOMONAS, which is found in SOIL and WATER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PSEUDOMONAS. All strains can utilize FRUCTOSE for energy. It is occasionally isolated from humans and some strains are pathogenic to WATERMELON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PSEUDOMONAS. It cannot utilize FRUCTOSE; GLUCOSE; or MALTOSE for energy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus PSEUDOMONAS. It is isolated from oil-water emulsions used as lubricants and cooling agents in the cutting and grinding of materials.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus SERRATIA found in plants and the DIGESTIVE TRACT of rodents. It is the most prevalent Serratia species in the natural environment.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus VIBRIO, isolated from SHELLFISH, as well as from human diarrheal stools and ear infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus VIBRIO, the causative agent of cold water vibriosis, a HEMORRHAGIC SEPTICEMIA of ATLANTIC SALMON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in the genus VIBRIO, which exhibits LUMINESCENCE. V. fischeri is found in a symbiotic relationship with the SQUID Euprymna scolopes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria in which man is the primary host and the human body louse, Pediculus humanus, the principal vector. It is the etiological agent of TRENCH FEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria infecting DOGS, the natural hosts, and causing canine BRUCELLOSIS. It can also cause a mild infection in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria isolated from MILK, cheese, and compressed yeast.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria isolated from the SYNOVIAL FLUID; LYMPH NODES; and MUCOUS MEMBRANE secretions in diseased SWINE. It causes nonsuppurative ARTHRITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria of the family ACETOBACTERACEAE found in FLOWERS and FRUIT. Cells are ellipsoidal to rod-shaped and straight or slightly curved.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria originally isolated from the LUNGS; TRACHEA; and NASAL CAVITY of SHEEP. It causes chronic interstitial pneumonia %28%PNEUMONIA, MYCOPLASMA%29% in both SHEEP and GOATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria originally isolated from urethral specimens of patients with non-gonoccocal URETHRITIS. In primates it exists in parasitic association with ciliated EPITHELIAL CELLS in the genital and respiratory tracts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria parasitic on HORSES and DONKEYS causing GLANDERS, which can be transmitted to humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria pathogenic to CATTLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria pathogenic to CHICKENS; TURKEYS, and guinea fowls. It causes disease in a wide variety of organs and tissues including JOINTS, tendon sheaths and the RESPIRATORY TRACT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria producing air sacculitis and skeletal abnormalities in TURKEYS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria producing mild to severe ANAPLASMOSIS in SHEEP and GOATS, and mild or inapparent infections in DEER and CATTLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria responsible for red mouth disease in rainbow trout %28%ONCORHYNCHUS MYKISS%29%. The bacteria is a natural component of fresh water ecosystems in the United States and Canada.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria strongly implicated in oral infection, PERIODONTAL DISEASES, eye and ear disorders, and SEPTIC ARTHRITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria that causes MYCOPLASMA PNEUMONIA OF SWINE. The organism damages the CILIA in the airways of the pig, and thus compromises one of the most effective mechanical barriers against invading pathogens. The resulting weakening of the IMMUNE SYSTEM can encourage secondary infections, leading to porcine respiratory disease complex.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria that causes rickettsialpox. The vector is a mouse mite and the reservoirs are mites and mice.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria that grows preferentially in the vacuoles of the host cell. It is the etiological agent of Q FEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria that is a common inhabitant of the human OROPHARYNX and also cell culture contaminant. It is usually non-pathogenic but it can cause infections in leukemic or immunosuppressed patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria that is the causative agent of human EHRLICHIOSIS. This organism was first discovered at Fort Chaffee, Arkansas, when blood samples from suspected human ehrlichiosis patients were studied.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis %28%ANGIOMATOSIS, BACILLARY%29%. This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria transmitted by the flea Ctenocephalides felis, and known to infect CATS, oppossums, and humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria, in the family Aeromonadaceae. It is strictly parasitic and often pathogenic causing FURUNCULOSIS in SALMONIDS and ulcer disease in GOLDFISH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria, in the genus ERWINIA, causing a necrotic disease of plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria, in the genus XANTHOMONAS, causing disease in TOMATO and pepper crops.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative bacteria, primarily infecting SWINE, but it can also infect humans, DOGS, and HARES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative enterobacteria found in WATER; SEWAGE; SOIL; and FOOD. It can be present in any clinical specimen as an opportunistic pathogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative hyperthermophilic ARCHAEA found in deep ocean hydrothermal vents. It is an obligate anaerobe and obligate chemoorganotroph.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative rod-shaped bacteria found ubiquitously and formerly called Comamonas acidovorans and Pseudomonas acidovorans. It is the type species of the genus DELFTIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative to gram-variable, nitrogen-fixing bacteria. They are free-living in SOIL or found in association with PLANT ROOTS. It is the type species of the genus AZOSPIRILLUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic BACTERIA commonly found in the NASOPHARYNX of infants and children, but rarely pathogenic. It is the only species to produce acid from LACTOSE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic BACTERIA consisting of short chains of rods. It has been isolated from the PHARYNX of healthy individuals and patients with ENDOCARDITIS. There are several recognized subspecies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic BACTERIA found in the human NASOPHARYNX; SALIVA; and SPUTUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic BACTERIA, found in the human NASOPHARYNX and in the normal flora of the respiratory tissues in DOLPHINS. It is occasionally pathogenic for humans and pathogenic for MICE. %28%Bergey%27%s Manual of Systemic Bacteriology, 1st edition, p295%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis %28%MENINGITIS, MENINGOCOCCAL%29%. It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria first isolated from soil in Vineland, New Jersey. Ammonium and nitrate are used as nitrogen sources by this bacterium. It is distinguished from other members of its genus by the ability to use rhamnose as a carbon source. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria found in soil and water. Although considered to be normally nonpathogenic, this bacterium is a causative agent of nosocomial infections, particularly in debilitated individuals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria found in the human NASOPHARYNX.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria in the genus LEGIONELLA, first isolated in Long Beach, California. Infection is associated with the use of potting SOIL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria in the genus PSEUDOMONAS. It has a characteristic strawberry color and is widely distributed in SOIL and WATER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria isolated from soil and the stems and roots of plants. It causes the formation of PLANT TUMORS in a wide variety of higher plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria isolated from soil and water as well as clinical specimens. Occasionally it is an opportunistic pathogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that acts as both a human and plant pathogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that causes MELIOIDOSIS. It has been isolated from soil and water in tropical regions, particularly Southeast Asia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that causes formation of root nodules on some, but not all, types of sweet clover, MEDICAGO SATIVA, and fenugreek.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that consist of slender vibroid cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is a fast-growing and soybean-nodulating innoculant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is found in soil and which causes formation of root nodules on some, but not all, types of field pea, lentil, kidney bean, and clover.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is most frequently isolated from bovine eyes in cases of infectious keratoconjunctivitis %28%KERATOCONJUNCTIVITIS, INFECTIOUS%29%, but also occurs in unaffected eyes and the nasal cavity of cattle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is pathogenic for plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES%27% DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is the etiologic agent of BOUTONNEUSE FEVER. It resembles RICKETTSIA RICKETTSII but is antigenically distinct and less virulent for animals and man. %28%From Bergey%27%s Manual of Systematic Bacteriology, vol 1%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice %28%TYPHUS, EPIDEMIC LOUSE-BORNE%29% as well as Brill%27%s disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic rods formerly called Pseudomonas testosteroni. It is differentiated from other Comamonas species by its ability to assimilate testosterone and to utilize phenylacetate or maleate as carbon sources.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens %28%wound, burn, and urinary tract infections%29%. It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic, rod-shaped bacteria found in hot springs of neutral to alkaline pH, as well as in hot-water heaters.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, aerobic, rod-shaped bacteria which is distinguished from other members of the genus KINGELLA by its beta hemolysis. It occurs normally in human mucous membranes of the upper respiratory tract, but can cause septic arthritis and endocarditis. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, rod-shaped bacteria isolated from soil, animal intestines and feces, and fresh and salt water.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, rod-shaped bacteria isolated from the gingival margin and sulcus and from infections of the upper respiratory tract and pleural cavity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium has been isolated from the mouth, urine, feces, and infections of the mouth, soft tissue, respiratory tract, urogenital tract, and intestinal tract. It is pathogenic, but usually in association with other kinds of organisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium is a common commensal in the gingival crevice and is often isolated from cases of gingivitis and other purulent lesions related to the mouth.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium produces a cell-bound, oxygen-sensitive collagenase and is isolated from the human mouth.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, sigmoid-shaped bacteria isolated from salt and freshwater in Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, anaerobic, spiral-shaped bacteria originally isolated from a saltwater pond in France. It contains a well-characterized metabolic pathway that enables it to survive transient contacts with OXYGEN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, coccoid, mostly chemolithoautotrophic bacteria, in the family RHODOBACTERACEAE. Some strains can grow anaerobically.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic bacteria. This organism shows remarkable pathobiologic properties: it adheres to cell surfaces, deeply penetrates into the cell, and strongly adsorbs human red blood cells and human CD4+ lymphocytes and monocytes. M. penetrans was first isolated from the urogenital tract of patients with AIDS and high frequencies of antibodies to it are seen in HIV-infected patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic coccobacillus-shaped bacteria that has been isolated from pneumonic lesions and blood. It produces pneumonia with accompanying fibrinous pleuritis in swine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic spherical or rod-shaped bacteria that associates with species of ACTINOMYCES in actinomycotic lesions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria %28%GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS%29% commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally commensal in the flora of CATTLE and SHEEP. But under conditions of physical or physiological STRESS, it can cause MASTITIS in sheep and SHIPPING FEVER or ENZOOTIC CALF PNEUMONIA in cattle. Its former name was Pasteurella haemolytica.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally found in the flora of the mouth and respiratory tract of animals and birds. It causes shipping fever %28%see PASTEURELLOSIS, PNEUMONIC%29%; HEMORRHAGIC BACTEREMIA; and intestinal disease in animals. In humans, disease usually arises from a wound infection following a bite or scratch from domesticated animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes rotting, particularly of storage tissues, of a wide variety of plants and causes a vascular disease in CARROTS; and POTATO plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes vascular wilts on a wide range of plant species. It was formerly named Erwinia chrysanthemi.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is extremely pathogenic and causes severe dysentery. Infection with this organism often leads to ulceration of the intestinal epithelium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that may be pathogenic for frogs, fish, and mammals, including man. In humans, cellulitis and diarrhea can result from infection with this organism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, fluorescent, phytopathogenic bacteria in the genus PSEUDOMONAS. It is differentiated into approximately 50 pathovars with different plant pathogenicities and host specificities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, halophilic bacteria, in the genus VIBRIO. It is considered part of normal marine flora and commonly associated with ear infections and superficial wounds exposed to contaminated water sources.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, obligately aerobic rods. Motility occurs by peritrichous flagella. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, rod-shaped bacteria belonging to the K serogroup of ESCHERICHIA COLI. It lives as a harmless inhabitant of the human LARGE INTESTINE and is widely used in medical and GENETIC RESEARCH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-negative, spiral-shaped bacteria found in the gastric mucosa that is associated with chronic antral gastritis. This bacterium was first discovered in samples removed at endoscopy from patients investigated for HELICOBACTER PYLORI colonization.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is commonly found in the oropharnyx flora and has a proclivity for abscess formation in the upper body and respiratory tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is commonly found in the oropharynx flora and has a proclivity for abscess formation, most characteristically in the CENTRAL NERVOUS SYSTEM and LIVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the STREPTOCOCCUS MILLERI GROUP. It is the most frequently seen isolate of that group, has a proclivity for abscess formation, and is most often isolated from the blood, gastrointestinal, and urogenital tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae isolated from infected CATTLE; SHEEP; and other animals. It causes blackleg in cattle and sheep and is transmitted through soil-borne spores.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae responsible for spoilage of some CHEESE via FERMENTATION of BUTYRIC ACID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae that ferments both CARBOHYDRATES and AMINO ACIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae, capable of solventogenesis, and isolated from SOIL, infected WOUNDS, fermenting OLIVES, and spoiled CANDY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae, causing BACTEREMIA in humans and ANIMALS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae, found in INTESTINES and SOIL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae, used for the industrial production of SOLVENTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae. It is a cellulolytic, mesophilic species isolated from decayed GRASS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae. It is distinctive for its ability to ferment ETHANOL to caproic acid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae. Its GLUTAMATE DEHYDROGENASE is commonly used in research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria in the family Clostridiaceae. Its glutamate mutase is commonly used in research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria isolated from MILK and cheese-starter cultures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria that is a common soil and water saprophyte.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, aerobic bacteria commonly found in soil and occasionally isolated from sputum. It causes postoperative wound infections as well as gluteal abscesses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, aerobic bacteria non-pathogenic for humans. It is the etiologic agent of Johne%27%s disease %28%see PARATUBERCULOSIS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, aerobic bacteria that causes granulomatous or ulcerating skin lesions in immunosuppressed persons. This organism owes its name to its requirement for growth of high levels of iron, conveniently supplied as blood, heme, or ferric ammonium citrate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, anaerobic bacteria in the family Clostridiaceae frequently used for the study of ENZYMES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types %28%gravis, intermedius, and mitis%29% were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, asporogenous bacteria that was originally isolated from necrotic areas in the kidney of a sheep. It may cause ulcerative lymphangitis, abscesses, and other chronic purulent infections in sheep, horses, and other warm-blooded animals. Human disease may form from contact with infected animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, cellulolytic bacteria in the family Clostridiaceae. It produces CELLULOSOMES which are involved in plant CELL WALL degradation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria commensal in the respiratory tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria commonly found in the alimentary tract of cows, sheep, and other ruminants. It occasionally is encountered in cases of human endocarditis. This species is nonhemolytic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria isolated from abscesses in submaxillary glands and mucopurulent discharges of the upper respiratory tract of horses. This organism belongs to Group C streptococci with regards to antigen response and is known to cause strangles. The subspecies S. zooepidemicus is also considered a pathogen of horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria isolated from the human tooth surface. Strains have been shown to be cariogenic in experimental animals and may be associated with human dental caries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria that is numerous in the mouth and throat. It is a common cause of endocarditis and is also implicated in dental plaque formation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped LACTIC ACID bacteria found naturally in the human intestinal flora and BREAST MILK.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped LACTIC ACID bacteria that is frequently used as starter culture in SILAGE fermentation, sourdough, and lactic-acid-fermented types of beer and wine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped bacteria associated with DENTAL CARIES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. This organism produces the fermented product, acidophilus milk.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped bacteria used in PROBIOTICS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing LACTIC ACID. It is important in the manufacture of fermented dairy products.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, spherical bacteria whose organisms occur in tetrads and in irregular clusters of tetrads. The primary habitat is mammalian skin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, strongly proteolytic bacteria in the family Clostridiaceae. It contains several forms of COLLAGENASE whose action can lead to GAS GANGRENE in humans and HORSES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of gram-positive, thermophilic, cellulolytic bacteria in the family Clostridaceae. It degrades and ferments CELLOBIOSE and CELLULOSE to ETHANOL in the CELLULOSOME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of green microalgae in the family Chlorellaceae. It is used as a model organism for PHOTOSYNTHESIS, and as a food supplement %28%DIETARY SUPPLEMENTS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of halophilic archaea distinguished by its production of acid from sugar. This species was previously called Halobacterium marismortui.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of halophilic archaea found in salt lakes. Some strains form a PURPLE MEMBRANE under anaerobic conditions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of halophilic archaea found in the Dead Sea. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of halophilic archaea found in the Mediterranean Sea. It produces bacteriocins active against a range of other halobacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of halophilic archaea whose organisms are nonmotile. Habitats include freshwater and marine mud, animal-waste lagoons, and the rumens of ungulates.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of halophilic bacteria in the genus VIBRIO, which lives in warm SEAWATER. It can cause infections in those who eat raw contaminated seafood or have open wounds exposed to seawater.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of hydatid tapeworm %28%class CESTODA%29% in the family Taeniidae, whose adult form infects the DIGESTIVE TRACT of DOGS, other canines, and CATS. The larval form infects SHEEP; PIGS; HORSES; and may infect humans, where it migrates to various organs and forms permanent HYDATID CYSTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of imperfect fungi from which the antibiotic fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of imperfect fungi from which the antibiotic nidulin is obtained. Its teleomorph is Emericella nidulans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of imperfect fungi which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin. It is also used in the production of the antibiotic flavicin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of intestinal nematode parasites which occur most commonly in mice. Infection is by ingesting larvae. This particular species is used extensively in immunological research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of lung fluke infecting humans and other animals, and found chiefly in Asia and the Far East.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of macaque monkey that mainly inhabits the forest of southern India. They are also called bonnet macaques or bonnet monkeys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of migratory Old World locusts, in the family ACRIDIDAE, that are important pests in Africa and Asia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of mite that causes SCABIES in humans and sarcoptic mange in other animals. Specific variants of S. scabiei exist for humans and animals, but many have the ability to cross species and cause disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of monogenetic, parasitic protozoa usually found in insects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of mosquito in the genus Anopheles and the principle vector of MALARIA in Africa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of motile, free-living, gram-negative bacteria that occur in the soil. They are aerobic or microaerophilic and are sometimes capable of nitrogen fixation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of mussel in the genus MYTILUS, family MYTILIDAE, class BIVALVIA, known as the common mussel. It has a bluish-black shell and is highly edible.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of nematode that is widely used in biological, biochemical, and genetic studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of newt in the Salamandridae family in which the larvae transform into terrestrial eft stage and later into an aquatic adult. They occur from Canada to southern United States. Viridescens refers to the greenish color often found in this species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of non-enveloped DNA virus in the genus ANELLOVIRUS, associated with BLOOD TRANSFUSIONS; and HEPATITIS. However, no etiological role has been found for TTV in hepatitis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic FUNGI. This intracellular parasite is found in the BRAIN; HEART; and KIDNEYS of several MAMMALS. Transmission is probably by ingestion of the spores %28%SPORES, FUNGAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode causing Malayan filariasis and having a distribution centering roughly on the Malay peninsula. The life cycle of B. malayi is similar to that of WUCHERERIA BANCROFTI, except that in most areas the principal mosquito vectors belong to the genus Mansonia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode found in man and other mammals. It has been reported from Malaya and East Pakistan and may produce symptoms of tropical eosinophilia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode found in rats. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode found in the intestine of dogs. Lesions in the brain, liver, eye, kidney, and lung are caused by migrating larvae. In humans, these larvae do not follow normal patterns and may produce visceral larva migrans %28%LARVA MIGRANS, VISCERAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode that is the largest found in the human intestine. Its distribution is worldwide, but it is more prevalent in areas of poor sanitation. Human infection with A. lumbricoides is acquired by swallowing fully embryonated eggs from contaminated soil.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode usually found in domestic pigs and a few other animals. Human infection can also occur, presumably as result of handling pig manure, and can lead to intestinal obstruction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematode widely distributed in tropical and subtropical countries. The females and their larvae inhabit the mucosa of the intestinal tract, where they cause ulceration and diarrhea.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematodes distributed throughout the Pacific islands that infests the lungs of domestic rats. Human infection, caused by consumption of raw slugs and land snails, results in eosinophilic meningitis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic nematodes widely distributed throughout central Africa and also found in northern South America, southern Mexico, and Guatemala. Its intermediate host and vector is the blackfly or buffalo gnat.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic protozoa causing ENTAMOEBIASIS and amebic dysentery %28%DYSENTERY, AMEBIC%29%. Characteristics include a single nucleus containing a small central karyosome and peripheral chromatin that is finely and regularly beaded.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic protozoa found in the intestines of humans and other primates. It was classified as a yeast in 1912. Over the years, questions arose about this designation. In 1967, many physiological and morphological B. hominis characteristics were reported that fit a protozoan classification. Since that time, other papers have corroborated this work and the organism is now recognized as a protozoan parasite of humans causing intestinal disease with potentially disabling symptoms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic protozoa having both an ameboid and flagellate stage in its life cycle. Infection with this pathogen produces primary amebic meningoencephalitis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic protozoa that attaches itself to the intestinal mucosa and feeds on mucous secretions. The organism is roughly pear-shaped and motility is somewhat erratic, with a slow oscillation about the long axis. Considered for many years to be non-pathogenic and often found in completely asymptomatic individuals, there is presently strong evidence for its pathogenic potential.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of protozoa infecting humans via the intermediate tick vector IXODES scapularis. The other hosts are the mouse PEROMYSCUS leucopus and meadow vole MICROTUS pennsylvanicus, which are fed on by the tick. Other primates can be experimentally infected with Babesia microti.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of protozoa that is a cause of bovine babesiosis. Ticks of the genera Boophilus, Rhipicephalus, and IXODES are the chief vectors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of protozoa that is the causal agent of falciparum malaria %28%MALARIA, FALCIPARUM%29%. It is most prevalent in the tropics and subtropics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of protozoan parasite causing MALARIA. It is the rarest of the four species of PLASMODIUM infecting humans, but is common in West African countries and neighboring areas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of rod-shaped, LACTIC ACID bacteria used in PROBIOTICS and SILAGE production.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of shark in the family SQUALIDAE, used for its oil %28%SQUALENE%29% and as fish meal. It also figures heavily in biological research, especially with reference to its RECTAL GLAND in studies of WATER-ELECTROLYTE BALANCE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of sheep, Ovis aries, descended from Near Eastern wild forms, especially mouflon.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of sheep, Ovis canadensis, characterized by massive brown horns. There are at least four subspecies and they are all endangered or threatened.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of strictly anaerobic, hyperthermophilic archaea which lives in geothermally-heated marine sediments. It exhibits heterotropic growth by fermentation or sulfur respiration.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of tapeworm %28%TAPEWORMS%29% infecting RATS and MICE but rarely causing disease in humans. Its life cycle involves RODENTS as the definitive host and BEETLES as the intermediate host.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of temperate bacteriophage in the genus P1-like Viruses, family MYOVIRIDAE which infects E. coli. It is the largest of the coliphages and consists of double-stranded DNA, terminally redundant, and circularly permuted.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of temperate bacteriophage in the genus P2-like Viruses, family MYOVIRIDAE, which infects E. coli. It consists of linear double-stranded DNA with 19-base sticky ends.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of temperate bacteriophage in the genus P22-like Viruses, family PODOVIRIDAE, that infects Salmonella species. The genome consists of double-stranded DNA, terminally redundant, and circularly permuted.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the Beta genus. Cultivars are used as a source of beets %28%root%29% or chard %28%leaves%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the CORONAVIRUS genus causing hepatitis in mice. Four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 %28%also known as MHV-JHM, which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the Chenopodium genus which is the source of edible seed called quinoa. It contains makisterone A and other STEROIDS, some having ECDYSTEROID activity on insects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the PESTIVIRUS genus causing exceedingly contagious and fatal hemorrhagic disease of swine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the family HERPESVIRIDAE, whose genus is so far unassigned. It is probably the causative agent of ADENOMA or ADENOCARCINOMA in the kidneys of certain frogs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the family Ranidae %28%true frogs%29%. The only anuran properly referred to by the common name %22%bullfrog%22%, it is the largest native anuran in North America.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the fungus Cryptococcus, which causes CRYPTOCOCCOSIS. Its teleomorph is Filobasidiella neoformans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus BRUCELLA which are pathogenic to SHEEP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Abortion and placentitis are frequently produced in the pregnant animal. Other mammals, including humans, may be infected.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including humans, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus ERYTHROCEBUS, subfamily CERCOPITHECINAE, family CERCOPITHECIDAE. It inhabits the flat open arid country of Africa. It is also known as the patas monkey or the red monkey.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus MYCOPLASMA, originally isolated infrequently from the lower genital tract of humans, and possessing uncertain pathogenicity. The incognitus strain of M. fermentans has been identified in necrotizing lesions of multiple organs from AIDS and non-AIDS patients dying of an acute influenza-like disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus PARVOVIRUS and a host range variant of feline parvovirus %28%PARVOVIRUS, FELINE%29%. It causes a highly infectious fulminating enteritis in dogs producing high mortality. It is distinct from minute virus of canines, another parvovirus which is sometimes also called canine parvovirus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus PNEUMOVIRUS causing pneumonia in mice.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus POTYVIRUS that affects many species of Prunus. It is transmitted by aphids and by infected rootstocks.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as %22%baker%27%s%22% or %22%brewer%27%s%22% yeast. The dried form is used as a dietary supplement.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus VESIVIRUS infecting cats. Transmission occurs via air and mechanical contact.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the subfamily AOTINAE, family CEBIDAE, inhabiting the forested regions of Central and South America %28%from Panama to the Amazon%29%. Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the true toads, Bufonidae, found in South America.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of the true toads, Bufonidae, widely distributed in the United States and Europe.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of thermoacidophilic ARCHAEA in the family Sulfolobaceae, found in volcanic areas where the temperature is about 80 degrees C and SULFUR is present.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of thermophilic CAMPYLOBACTER found in healthy seagulls and causing ENTERITIS in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of thermophilic, gram-positive bacteria found in MILK and milk products.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of tick %28%TICKS%29% in the family IXODIDAE, distributed throughout the world but abundant in southern Europe. It will feed on a wide variety of MAMMALS, but DOGS are its preferred host. It transmits a large number of diseases including BABESIOSIS; THEILERIASIS; EHRLICHIOSIS; and MEDITERRANEAN SPOTTED FEVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of toxic plants of the Compositae. The poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the Far East. The intermediate host is a snail. It occurs in man and other mammals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of virus %28%unassigned to a genus%29% in the family FLAVIVIRIDAE, that have been identified in at least six species of New World monkeys. They do not cause HEPATITIS in the host or other susceptible species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of virus %28%unassigned to a genus%29% in the family FLAVIVIRIDAE, that was recovered from a tamarin monkey, but may have been of human origin. It causes HEPATITIS in several species of New World monkeys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species of virus %28%unassigned to a genus%29% in the family FLAVIVIRIDAE. It is genetically heterogeneous, of human origin, and transmitted by blood or blood products. Despite its alternate name %28%Hepatitis G virus%29%, its pathogenicity remains controversial.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A species with unassigned genus in the family PODOVIRIDAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific complex of toxic proteins from the venom of Crotalus durissus terrificus %28%South American rattlesnake%29%. It can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme, and is specifically neurotoxic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian. Caerulein is similar in action and composition to CHOLECYSTOKININ. It stimulates gastric, biliary, and pancreatic secretion; and certain smooth muscle. It is used in paralytic ileus and as diagnostic aid in pancreatic malfunction.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. %28%Thromb Res 1992;67%28%4%29%:345-54 %26% Cancer Res 1993;53%28%2%29%:239-41%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific mannose-binding member of the collectin family of lectins. It binds to carbohydrate groups on invading pathogens and plays a key role in the MANNOSE-BINDING LECTIN COMPLEMENT PATHWAY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair GROUP C CHROMSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP B CHROMOSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP C CHROMOSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP C CHROMSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP D CHROMOSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP F CHROMOSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of GROUP G CHROMOSOMES of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific pair of human chromosomes in group A %28%CHROMOSOMES, HUMAN, 1-3%29% of the human chromosome classification.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific protein in egg albumin that interacts with BIOTIN to render it unavailable to mammals, thereby producing biotin deficiency.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils %28%PMN%29% stimulated with phorbol myristate acetate or synthetic diacylglycerol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific species of bacteria, part of the BORRELIA BURGDORFERI GROUP, whose common name is Lyme disease spirochete.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific streptogramin group A antibiotic produced by Streptomyces graminofaciens and other bacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific streptogramin group B antibiotic produced by Streptomyces graminofaciens and other bacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific subtype of muscarinic receptor found in a variety of locations including the SALIVARY GLANDS and the SUBSTANTIA NIGRA and VENTRAL TEGMENTAL AREA of the BRAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific subtype of muscarinic receptor found in the CORPUS STRIATUM and the LUNG. It has similar receptor binding specificities to MUSCARINIC RECEPTOR M1 and MUSCARINIC RECEPTOR M2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific subtype of muscarinic receptor found in the lower BRAIN, the HEART and in SMOOTH MUSCLE-containing organs. Although present in smooth muscle the M2 muscarinic receptor appears not to be involved in contractile responses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific subtype of muscarinic receptor that has a high affinity for the drug PIRENZEPINE. It is found in the peripheral GANGLIA where it signals a variety of physiological functions such as GASTRIC ACID secretion and BRONCHOCONSTRICTION. This subtype of muscarinic receptor is also found in neuronal tissues including the CEREBRAL CORTEX and HIPPOCAMPUS where it mediates the process of MEMORY and LEARNING.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specific type of health insurance which provides surgeons%27% fees for specified amounts according to the type of surgery listed in the policy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specificity protein transcription factor that is expressed primarily in the CENTRAL NERVOUS SYSTEM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specificity protein transcription factor that regulates expression of a variety of genes including VASCULAR ENDOTHELIAL GROWTH FACTOR and CYCLIN-DEPENDENT KINASE INHIBITOR P27.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A specified list of terms with a fixed and unalterable meaning, and from which a selection is made when CATALOGING; ABSTRACTING AND INDEXING; or searching BOOKS; JOURNALS; and other documents. The control is intended to avoid the scattering of related subjects under different headings %28%SUBJECT HEADINGS%29%. The list may be altered or extended only by the publisher or issuing agency. %28%From Harrod%27%s Librarians%27% Glossary, 7th ed, p163%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spectroscopic technique which uses the Mossbauer effect %28%inelastic scattering of gamma radiation resulting from interaction with heavy nuclei%29% to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus %28%ENDOMETRITIS%29%, the FALLOPIAN TUBES; %28%SALPINGITIS%29%; the ovaries %28%OOPHORITIS%29%, the supporting ligaments %28%PARAMETRITIS%29%, or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spherical RNA satellite virus which requires an obligatory helper TOBACCO MOSAIC VIRUS for replication.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. %28%see Int J Syst Bacteriol 1989 Oct;39%28%4%29%:297-405%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A spontaneous diminution or abatement of the symptoms of a disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sporadic neurodegenerative disease with onset in middle-age characterized clinically by Parkinsonian features %28%e.g., MUSCLE RIGIDITY; HYPOKINESIA; stooped posture%29% and HYPOTENSION. This condition is considered a clinical variant of MULTIPLE SYSTEM ATROPHY. Pathologic features include a prominent loss of neurons in the zona compacta of the SUBSTANTIA NIGRA and PUTAMEN. %28%From Adams et al., Principles of Neurology, 6th ed, p1075-6%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sport consisting of hand-to-hand combat between two unarmed contestants seeking to pin or press each other%27%s shoulders to the ground.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sport in which weights are lifted competitively or as an exercise.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sport involving mountain climbing techniques. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of VASOPRESSIN and activation of PHOSPHOLIPASE C. %28%From J Pharmacol Exp Ther 1983;224%28%1%29%: 108-117; Biochem J 1984;222%28%1%29%:103-110%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stable synthetic analog of methionine enkephalin %28%ENKEPHALIN, METHIONINE%29%. Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction %28%release of ADP and serotonin%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stack of flattened vesicles that functions in posttranslational processing and sorting of proteins, receiving them from the rough ENDOPLASMIC RETICULUM and directing them to secretory vesicles, LYSOSOMES, or the CELL MEMBRANE. The movement of proteins takes place by transfer vesicles that bud off from the rough endoplasmic reticulum or Golgi apparatus and fuse with the Golgi, lysosomes or cell membrane. %28%From Glick, Glossary of Biochemistry and Molecular Biology, 1990%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stage of development at which the ADRENAL GLANDS undergo maturation leading to the capability of producing increasing amounts of adrenal androgens, DEHYDROEPIANDROSTERONE and ANDROSTENEDIONE. Adrenarche usually begins at about 7 or 8 years of age before the signs of PUBERTY and continues throughout puberty.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A starch found in the tubers and roots of many plants. Since it is hydrolyzable to FRUCTOSE, it is classified as a fructosan. It has been used in physiologic investigation for determination of the rate of glomerular function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state arrived at through prolonged and strong contraction of a muscle. Studies in athletes during prolonged submaximal exercise have shown that muscle fatigue increases in almost direct proportion to the rate of muscle glycogen depletion. Muscle fatigue in short-term maximal exercise is associated with oxygen lack and an increased level of blood and muscle lactic acid, and an accompanying increase in hydrogen-ion concentration in the exercised muscle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state due to excess loss of carbon dioxide from the body. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in northeastern Australia. Its capital is Brisbane. Its coast was first visited by Captain Cook in 1770 and its first settlement %28%penal%29% was located on Moreton Bay in 1824. The name Cooksland was first proposed but honor to Queen Victoria prevailed. %28%From Webster%27%s New Geographical Dictionary, 1988, p996 %26% Room, Brewer%27%s Dictionary of Names, 1992, p441%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in south central Australia. Its capital is Adelaide. It was probably first visited by F. Thyssen in 1627. Later discoveries in 1802 and 1830 opened up the southern part. It became a British province in 1836 with this self-descriptive name and became a state in 1901. %28%From Webster%27%s New Geographical Dictionary, 1988, p1135%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in southeastern Australia, the southernmost state. Its capital is Melbourne. It was discovered in 1770 by Captain Cook and first settled by immigrants from Tasmania. In 1851 it was separated from New South Wales as a separate colony. Self-government was introduced in 1851; it became a state in 1901. It was named for Queen Victoria in 1851. %28%From Webster%27%s New Geographical Dictionary, 1988, p1295 %26% Room, Brewer%27%s Dictionary of Names, p574%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in southeastern Australia. Its capital is Sydney. It was discovered by Captain Cook in 1770 and first settled at Botany Bay by marines and convicts in 1788. It was named by Captain Cook who thought its coastline resembled that of South Wales. %28%From Webster%27%s New Geographical Dictionary, 1988, p840 %26% Room, Brewer%27%s Dictionary of Names, 1992, p377%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in western Australia. Its capital is Perth. It was first visited by the Dutch in 1616 but the English took possession in 1791 and permanent colonization began in 1829. It was a penal settlement 1850-1888, became part of the colonial government in 1886, and was granted self government in 1890. %28%From Webster%27%s New Geographical Dictionary, 1988, p1329%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in which attention is largely directed inward upon one%27%s self.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in which attention is largely directed outward from the self.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in which the environs of hospitals, laboratories, domestic and animal housing, work places, spacecraft, and other surroundings are under technological control with regard to air conditioning, heating, lighting, humidity, ventilation, and other ambient features. The concept includes control of atmospheric composition. %28%From Jane%27%s Aerospace Dictionary, 3d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state in which there is an enhanced potential for sensitivity and an efficient responsiveness to external stimuli.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of consciousness in which the individual eliminates environmental stimuli from awareness so that the mind can focus on a single thing, producing a state of relaxation and relief from stress. A wide variety of techniques are used to clear the mind of stressful outside interferences. It includes meditation therapy. %28%Mosby%27%s Medical, Nursing, and Allied Health Dictionary, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of elevated cardiac output. Conditions that lower peripheral vascular resistance, such as anemia, arteriovenous fistulas, thyrotoxicosis, and pregnancy, are among the most important factors augmenting the venous return and therefore elevating cardiac output. Increased cardiac output also occurs in muscular exercise, fever, and severe anoxia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of harmony between internal needs and external demands and the processes used in achieving this condition. %28%From APA Thesaurus of Psychological Index Terms, 8th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of increased receptivity to suggestion and direction, initially induced by the influence of another person.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of insufficient flesh on the body usually defined as having a body weight less than skeletal and physical standards. Depending on age, sex, and genetic background, a BODY MASS INDEX of less than 18.5 is considered as underweight.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of internal activity of an organism that is a necessary condition before a given stimulus will elicit a class of responses; e.g., a certain level of hunger %28%drive%29% must be present before food will elicit an eating response.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of intersex or sexual ambiguity, involving the GENOTYPE, the GONADS, the reproductive tract, and/or the external GENITALIA or PHENOTYPE. This concept covers TRUE HERMAPHRODITISM and PSEUDOHERMAPHRODITISM. True hermaphrodites are rare and they possess gonadal tissues of both SEXES, tissues from the OVARY and the TESTIS. Pseudohermaphrodites possess gonadal tissue of one sex but exhibit external phenotype of the opposite sex.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of prolonged irreversible cessation of all brain activity, including lower brain stem function with the complete absence of voluntary movements, responses to stimuli, brain stem reflexes, and spontaneous respirations. Reversible conditions which mimic this clinical state %28%e.g., sedative overdose, hypothermia, etc.%29% are excluded prior to making the determination of brain death. %28%From Adams et al., Principles of Neurology, 6th ed, pp348-9%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of sexual inactivity in female animals exhibiting no ESTROUS CYCLE. Causes of anestrus include pregnancy, presence of offspring, season, stress, and pathology.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular, or pericardial disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of the body being evenly balanced in POSTURE. The biomechanical responses of the MUSCULOSKELETAL SYSTEM during standing, walking, sitting, and other movements.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A state of well-being in which performance is optimal, often as a result of physical conditioning which may be prescribed for disease therapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. %28%From Winslade, Dictionary of Clinical Research, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A statistically significant excess of cases of a disease, occurring within a limited space-time continuum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A status with BODY WEIGHT that is above certain standard of acceptable or desirable weight. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat %28%ADIPOSE TISSUE%29%, hence overweight does not equal %22%over fat%22%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese %28%MORBID OBESITY%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stereotactic neurosurgery in which the usual rigid needles or probes are replaced with beams of ionizing radiation directed toward an intracranial target so as to achieve local tissue destruction. No skin incision or skull opening is required. It is performed with the %22%gamma knife%22%, a self-contained unit with 201 cobalt-60 sources or with an isocentric linear accelerator %28%linac%29%. %28%Goodman, M.L., Southern Medical Journal, vol. 83, May 1990, pp. 551-4%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sterile solution containing the by-products of growth products of Coccidioides immitis, injected intracutaneously as a test for coccidioidomycosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. Ecdysterone is the 20-hydroxylated ECDYSONE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A steroid hormone that regulates the processes of MOLTING or ecdysis in insects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A steroid of interest both because its biosynthesis in FUNGI is a target of ANTIFUNGAL AGENTS, notably AZOLES, and because when it is present in SKIN of animals, ULTRAVIOLET RAYS break a bond to result in ERGOCALCIFEROL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sterol regulatory element binding protein that regulates GENES involved in CHOLESTEROL synthesis and uptake.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sterol regulatory element binding protein that regulates expression of GENES involved in FATTY ACIDS metabolism and LIPOGENESIS. Two major isoforms of the protein exist due to ALTERNATIVE SPLICING.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sterol usually substituted with radioactive iodine. It is an adrenal cortex scanning agent with demonstrated high adrenal concentration and superior adrenal imaging.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, isolated from rodents and lagomorphs and occasionally causing febrile illness in man.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, that infects rodents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, usually causing an inapparent intestinal infection in mice. A small number of mice may show signs of flaccid paralysis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of HEPATITIS A VIRUS which causes hepatitis in humans. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and newborn hamsters. It is apparently transmitted to embryos in utero and to newborns through mother%27%s milk.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% associated with mouse tumors similar to those caused by the FRIEND MURINE LEUKEMIA VIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% isolated from radiation-induced lymphomas in C57BL mice. It is leukemogenic, thymotrophic, can be transmitted vertically, and replicates only in vivo.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% isolated from spontaneous leukemia in AKR strain mice.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% obtained from inbred mice with a high incidence of spontaneous lymphoid leukemia. Infection is passed by vertical transmission from one generation to another through the ovum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Murine leukemia virus %28%LEUKEMIA VIRUS, MURINE%29% producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia %28%LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED%29%, T-cell lymphoma %28%LYMPHOMA, T-CELL%29%, and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis %28%PARAPARESIS, TROPICAL SPASTIC%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 isolated from Congolese bonobos %28%PAN PANISCUS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2 that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-1. It is associated with T-cell hairy cell leukemia %28%LEUKEMIA, T-CELL, HTLV-II-ASSOCIATED%29%, a relatively benign disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of PRIMATE T-LYMPHOTROPIC VIRUS 2, closely related to the human HTLV-1 virus. The clinical, hematological, and histopathological characteristics of the disease in STLV-infected monkeys are very similar to those of human adult T-cell leukemia. Subgroups include the African green monkey subtype %28%STLV-I-AGM%29%, for which the nucleotide sequence is 95%25% homologous with that of HUMAN T-LYMPHOTROPIC VIRUS 1, and the Asian rhesus macaque subtype %28%STLV-I-MM%29%, for which the nucleotide sequence is 90%25% homologous with that of HUMAN T-LYMPHOTROPIC VIRUS 1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats %28%SHR%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Rattus norvegicus which is a model for spontaneous insulin-dependent diabetes mellitus %28%DIABETES MELLITUS, INSULIN-DEPENDENT%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of mice arising from a spontaneous MUTATION %28%mdx%29% in inbred C57BL mice. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein DYSTROPHIN, have high serum levels of muscle ENZYMES, and possess histological lesions similar to human MUSCULAR DYSTROPHY. The histological features, linkage, and map position of mdx make these mice a worthy animal model of DUCHENNE MUSCULAR DYSTROPHY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of mice bred specifically as high or low antibody responders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of mice widely studied as a model for cystic fibrosis. These mice are generated from embryonic stem cells in which the CFTR %28%cystic fibrosis transmembrane conductance regulator%29% gene is inactivated by gene targeting. As a result, all mice have one copy of this altered gene in all their tissues. Mice homozygous for the disrupted gene exhibit many features common to young cystic fibrosis patients, including failure to thrive, meconium ileus, and alteration of mucous and serous glands.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strain of the VIBRIO CHOLERAE bacteria belonging to serogroup non-O1, infecting humans and other PRIMATES. It is related to VIBRIO CHOLERAE O1, but causes a disease less severe than CHOLERA. Eating raw shellfish contaminated with the bacteria results in GASTROENTERITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strategy for purchasing health care in a manner which will obtain maximum value for the price for the purchasers of the health care and the recipients. The concept was developed primarily by Alain Enthoven of Stanford University and promulgated by the Jackson Hole Group. The strategy depends on sponsors for groups of the population to be insured. The sponsor, in some cases a health alliance, acts as an intermediary between the group and competing provider groups %28%accountable health plans%29%. The competition is price-based among annual premiums for a defined, standardized benefit package. %28%From Slee and Slee, Health Care Reform Terms, 1993%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stream of positive or negative electrons ejected with high energy from a disintegrating atomic nucleus; most biomedically used isotopes emit negative particles %28%electrons or negatrons, rather than positrons%29%. Cathode rays are low-energy negative electrons produced in cathode ray tubes, also called television tubes or oscilloscopes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strictly autotrophic species of bacteria that oxidizes sulfur and thiosulfate to sulfuric acid. It was formerly called Thiobacillus thiooxidans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A stricture of the ESOPHAGUS. Most are acquired but can be congenital.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strip of specialized ectoderm flanking each side of the embryonal neural plate, which after the closure of the neural tube, forms a column of isolated cells along the dorsal aspect of the neural tube. Most of the cranial and all of the spinal sensory ganglion cells arise by differentiation of neural crest cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong acid used as a protein precipitant in clinical chemistry and also as a caustic for removing warts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong emotional feeling of displeasure aroused by being interfered with, injured or threatened.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong ligament of the knee that originates from the anterolateral surface of the medial condyle of the femur, passes posteriorly and inferiorly between the condyles, and attaches to the posterior intercondylar area of the tibia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong ligament of the knee that originates from the posteromedial portion of the lateral condyle of the femur, passes anteriorly and inferiorly between the condyles, and attaches to the depression in front of the intercondylar eminence of the tibia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. %28%From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed%29% It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strong oxidizing agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium as Cl%28%-%29% anion. It exchanges chloride ions with bile salts, thus decreasing their concentration and that of cholesterol. It is used as a hypocholesteremic in diarrhea and biliary obstruction, and as an antipruritic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A structural protein which forms the arms on the microtubule doublets of cilia and flagella. In the presence of divalent cations, dynein catalyzes the hydrolysis of ATP. This hydrolysis plays an important functional role in the motility process. This enzyme was formerly listed as EC 3.6.1.33.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A structural subclass of streptogramins that includes molecules containing unsaturated macrocyclic lactones with approximate molecular weight of 500 KDa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A structural subclass of streptogramins. They are cyclic hexadepsipeptides with approximate molecular weight of 800 that contain a characteristic 3-hydroxy picolinoyl exocyclic component.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. %28%Horm Res 1997;48:155-63%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A structure, situated close to the intraventricular foramen, which induces drinking behavior after stimulation with angiotensin II.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sub-family of RHO GTP-BINDING PROTEINS that is involved in regulating the organization of cytoskeletal filaments. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sub-family of smad proteins that inhibit cell signaling by RECEPTOR-REGULATED SMAD PROTEINS. They form autoinhibitory feedback loops in the TGF-BETA signaling pathway and mediate signaling cross-talk with other signaling pathways%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sub-family of steroid receptor transcription factors with specificity for a variety of DNA sequences related to AGGTCA. They can heterodimerize with a variety of factors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; and VITAMIN D RECEPTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sub-subclass of ENDOPEPTIDASES that depend on an ASPARTIC ACID residue for their activity. EC 3.4.23.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sub-subclass of PEPTIDE HYDROLASES that act only near the ends of polypeptide chains. Exopeptidases are further divided into AMINOPEPTIDASES; EC 3.4.11; DIPEPTIDASES; EC 3.4.13; DIPEPTIDYL PEPTIDASES %26% tripeptidyl peptidases, EC 3.4.14; peptidyl-dipeptidases, EC 3.4.15; CARBOXYPEPTIDASES; EC 3.4.16 - EC 3.4.18, and omega peptidases, EC 3.4.19. EC 3.4.-.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash %28%or less often an exfoliative dermatitis%29% involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. %28%From Adams et al., Principles of Neurology, 6th ed, pp1405-6%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. %28%Adams et al., Principles of Neurology, 6th ed, p1239%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by anatomic alterations of the lungs, such as the enlargement of airspaces and destruction of alveolar walls.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic %28%more than 3 months in 2 consecutive years%29% productive cough. Infectious agents are a major cause of chronic bronchitis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subcategory of mucins that contain SIALIC ACID. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid %28%N-ACETYLNEURAMINIC ACID%29% residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. %28%From Oxford Dictionary of Biochemistry and Molecular Biology, 1997%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ADENOSINE RECEPTORS that are generally considered to be coupled to the GS, STIMULATORY G-PROTEIN which causes up regulation of CYCLIC AMP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ANTIFREEZE PROTEINS that are 3-5 kDa in size and contain a single alanine-rich amphipathic alpha-helix.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ANTIFREEZE PROTEINS that are globular, 6.5 kDa in size and contain compact beta-sheet structures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ANTIFREEZE PROTEINS that contain four amphipathic alpha-helices folded into an antiparallel helix bundle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ANTIFREEZE PROTEINS that have a cystine-rich globular structure of approximately 14 kD.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent %28%NIDDM%29%. It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of G-protein coupled SEROTONIN receptors that couple preferentially to GI-GO G-PROTEINS resulting in decreased intracellular CYCLIC AMP levels.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of G-protein coupled SEROTONIN receptors that couple preferentialy to the GQ-G11 G-PROTEINS resulting in increased intracellular levels of INOSITOL PHOSPHATES and free CALCIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of GLYCOSPHINGOLIPIDS containing large polar heads made up of several sugar units. One or more of their terminal sugar units are bound to a negatively charged molecule at pH 7. Members of this class include: GANGLIOSIDES, uronoglycosphingolipids, SULFOGLYCOSPHINGOLIPIDS, phosphoglycosphingolipids, and phosphonoglycosphingolipids.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of GLYCOSPHINGOLIPIDS containing one or more sugars within their head group connected directly to a ceramide moiety. They consist of monoglycosyl-, and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ORGANIC ANION TRANSPORTERS that do not rely directly or indirectly upon sodium ion gradients for the transport of organic ions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is driven either directly or indirectly by a gradient of sodium ions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ORGANIC ANION TRANSPORTERS whose transport of organic anions is linked directly to the hydrolysis of ATP. The subclass includes those ATP-BINDING CASSETTE TRANSPORTERS that transport organic ions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of adenosine A2 receptors found in LEUKOCYTES, the SPLEEN, the THYMUS and a variety of other tissues. It is generally considered to be a receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of adenosine A2 receptors found in the CECUM, the COLON, the BLADDER, and a variety of other tissues. It is generally considered to be a low affinity receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of alpha-adrenergic receptors %28%RECEPTORS, ADRENERGIC, ALPHA%29%. alpha-1 Adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of alpha-adrenergic receptors %28%RECEPTORS, ADRENERGIC, ALPHA%29%. alpha-2 Adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of anhydrides with the general structure of dihydrofurandione. They can be substituted on any carbon atom. They modify and inhibit proteins and enzymes and are used in the acylation of amino- and hydroxyl groups.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of beta-adrenergic receptors %28%RECEPTORS, ADRENERGIC, BETA%29%. beta-1 Adrenergic receptors are equally sensitive to epinephrine and norepinephrine and bind the agonist dobutamine and the antagonist metoprolol with high affinity. They are found in the heart, juxtaglomerular cells, and in the central and peripheral nervous systems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of beta-adrenergic receptors %28%RECEPTORS, ADRENERGIC, BETA%29%. beta-2 Adrenergic receptors are more sensitive to epinephrine than to norepinephrine and have a high affinity for the agonist terbutaline. They are widespread, with clinically important roles in skeletal muscle, liver, and vascular, bronchial, gastrointestinal, and genitourinary smooth muscle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of beta-adrenergic receptors %28%RECEPTORS, ADRENERGIC, BETA%29%. beta-3 Adrenergic receptors are the predominant beta-adrenergic receptor type expressed in white and brown ADIPOCYTES and are involved in modulating ENERGY METABOLISM and THERMOGENESIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of c-ets proto-oncogene proteins that were first described by their property of binding to DNA when associated with other regulatory proteins such as SERUM RESPONSE FACTOR. They contain an amino-terminal ets domain that binds to DNA along with centrally located SERUM RESPONSE FACTOR interacting domain, and carboxy-terminal map kinase activation domains. They play an important role in transcriptional regulation by INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of cannabinoid receptor found primarily on immune cells where it may play a role modulating release of CYTOKINES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of cartilaginous fish comprising the SHARKS; rays; skates %28%SKATES %28%FISH%29%;%29%, and sawfish. Elasmobranchs are typically predaceous, relying more on smell %28%the olfactory capsules are relatively large%29% than sight %28%the eyes are relatively small%29% for obtaining their food.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of clathrin assembly proteins that occur as monomers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of crystallins found in the lens %28%LENS, CRYSTALLINE%29% in BIRDS and REPTILES. They are inactive forms of the enzyme argininosuccinate lyase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of crystallins that found in the lens %28%LENS, CRYSTALLINE%29% of VERTEBRATES. Gamma-crystallins are similar in structure to BETA-CRYSTALLINS in that they both form into a Greek key-like structure. They are composed of monomeric subunits.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of crystallins that provides the majority of refractive power and translucency to the lens %28%LENS, CRYSTALLINE%29% in VERTEBRATES. Alpha-crystallins also act as molecular chaperones that bind to denatured proteins, keep them in solution and thereby maintain the translucency of the lens. The proteins exist as large oligomers that are formed from ALPHA-CRYSTALLIN A CHAIN and ALPHA-CRYSTALLIN B CHAIN subunits.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of developmentally regulated lamins having a neutral isoelectric point. They are found to disassociate from nuclear membranes during mitosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of eicosanoid receptors that have specificity for THROMBOXANE A2 and PROSTAGLANDIN H2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. %28%Dorland, 28th ed%29% EC 2.1.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor %28%generally an amino acid%29% to an acceptor %28%generally a 2-keto acid%29%. Most of these enzymes are pyridoxyl phosphate proteins. %28%Dorland, 28th ed%29% EC 2.6.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of enzymes which includes all dehydrogenases acting on carbon-carbon bonds. This enzyme group includes all the enzymes that introduce double bonds into substrates by direct dehydrogenation of carbon-carbon single bonds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ %28%subclass 1.1.1%29%, cytochrome %28%1.1.2%29%, oxygen %28%1.1.3%29%, quinone %28%1.1.5%29%, or another acceptor %28%1.1.99%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of heme a containing cytochromes have a reduced alpha-band absorption of 587-592 nm. They are primarily found in microorganisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of heme a containing cytochromes that have two imidazole nitrogens as axial ligands and an alpha-band absorption of 605 nm. They are found in a variety of microorganisms and in eucaryotes as a low-spin cytochrome component of MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of heme a containing cytochromes with an alpha-band absorption of 605 nm. They are found in a variety of microorganisms and in eukaryotes as a high-spin cytochrome component of MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of heteroxenous parasitic protozoa usually transmitted by ticks. Its organisms are rod-shaped or amoeboid with conoid, oocysts, spores, and pseudocysts absent. Locomotion is by body flexion, gliding, or, in sexual stages, by large axopodium-like organelles.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of lectins that are specific for CARBOHYDRATES that contain MANNOSE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of muscarinic receptor that mediates cholinergic-induced contraction in a variety of SMOOTH MUSCLES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of myosin found in ACANTHAMOEBA. It is a non-filamentous myosin containing a single 180-kDa myosin heavy chain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of myosin involved in organelle transport and membrane targeting. It is abundantly found in nervous tissue and neurosecretory cells. The heavy chains of myosin V contain unusually long neck domains that are believed to aid in translocating molecules over large distances.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of myosins found generally associated with actin-rich membrane structures such as filopodia. Members of the myosin type I family are ubiquitously expressed in eukaryotes. The heavy chains of myosin type I lack coiled-coil forming sequences in their tails and therefore do not dimerize.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of myosins originally found in the photoreceptor of DROSOPHILA. The heavy chains can occur as two alternatively spliced isoforms of 132 and 174 KDa. The amino terminal of myosin type III is highly unusual in that it contains a protein kinase domain which may be an important component of the visual process.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of nematodes characterized by numerous caudal papillae and an excretory system possessing lateral canals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of nematodes characterized by reduced or absent caudal papillae and an excretory system lacking lateral canals. Its organisms are usually infective to their final host.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of protein serine-threonine kinases that phosphorylate proteins on a SERINE or THREONINE residue that is immediately preceding a PROLINE residue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. Its organisms are found in both vertebrates and higher invertebrates and comprise two orders: EIMERIIDA and EUCOCCIDIIDA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of segmented worms comprising the tapeworms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of serotonin receptors that form cation channels and mediate signal transduction by depolarizing the cell membrane. The cation channels are formed from 5 receptor subunits. When stimulated the receptors and allow the selective passage of SODIUM; POTASSIUM; and CALCIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of symporters found in KIDNEY TUBULES, DISTAL that are the major pathway for salt resorption. Inhibition of these symporters by BENZOTHIADIAZINES is the basis of action of some DIURETICS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of symporters that specifically transport SODIUM CHLORIDE and POTASSIUM CHLORIDE across cellular membranes in a tightly coupled process.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of transferases that transfer chemical groups containing a single carbon. These include the METHYLTRANSFERASES, the HYDROXYMETHYL AND FORMYL TRANSFERASES, the CARBOXYL AND CARBAMOYL TRANSFERASES, and the AMIDINOTRANSFERASES. EC 2.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of ubiquitously-expressed lamins having an acidic isoelectric point. They are found to remain bound to nuclear membranes during mitosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subclass of winged helix DNA-binding proteins that share homology with their founding member fork head protein, Drosophila.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subcomponent of complement C1, composed of six copies of three polypeptide chains %28%A, B, and C%29%, each encoded by a separate gene %28%C1QA; C1QB; C1QC%29%. This complex is arranged in nine subunits %28%six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C%29%. C1q has binding sites for antibodies %28%the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M%29%. The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subdiscipline of genetics that studies RADIATION EFFECTS on the components and processes of biological inheritance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subdiscipline of genetics which deals with the cytological and molecular analysis of the CHROMOSOMES, and location of the GENES on chromosomes, and the movements of chromosomes during the CELL CYCLE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subdiscipline of genetics which deals with the genetic basis of the immune response %28%IMMUNITY%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subdiscipline of genetics which deals with the genetic mechanisms and processes of microorganisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subdiscipline of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of an individual or of any two parents or potential parents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily in the family MURIDAE, comprising the Old World MICE and RATS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of CEBIDAE inhabiting the forests of Central and South America. The genus ALOUATTA, or howler monkeys, belongs to this subfamily of New World monkeys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of CEBIDAE inhabiting the forests of Central and South America. This subfamily of New World monkeys consists of one genus, the SAIMIRI or squirrel monkeys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of DNA arthropod viruses, in the family PARVOVIRIDAE. The host range includes members of Dictyoptera, DIPTERA, LEPIDOPTERA, Odonata, and ORTHOPTERA. There are three genera: DENSOVIRUS, Iteravirus, and Brevidensovirus. Densovirus-like viruses also infect and multiply in crabs and shrimp.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of DNA vertebrate viruses, in the family PARVOVIRIDAE. There are three genera: PARVOVIRUS; ERYTHROVIRUS; and DEPENDOVIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLATE CYCLASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLATE CYCLASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of HELIX-TURN-HELIX DNA-binding proteins that contain a variable length loop adjacent to the HTH motif. The loop connects two anti-parallel strands and forms a wing when bound to DNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of HERPESVIRIDAE characterized by a relatively long replication cycle. Genera include: CYTOMEGALOVIRUS; MUROMEGALOVIRUS; and ROSEOLOVIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of HERPESVIRIDAE characterized by a short replication cycle. The genera include: SIMPLEXVIRUS; VARICELLOVIRUS; MAREK%27%S DISEASE-LIKE VIRUSES; and INFECTIOUS LARYNGOTRACHEITIS-LIKE VIRUSES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of HERPESVIRIDAE characterized by variable reproductive cycles. The genera include: LYMPHOCRYPTOVIRUS and RHADINOVIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of MURIDAE found nearly world-wide and consisting of about 20 genera. Voles, lemmings, and muskrats are members.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of New World monkeys in the family CEBIDAE. They inhabit the forests of South and Central America and comprise members of the genus CEBUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of PARAMYXOVIRIDAE containing two genera: PNEUMOVIRUS; and METAPNEUMOVIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of PARAMYXOVIRIDAE. Genera include RUBULAVIRUS; RESPIROVIRUS; MORBILLIVIRUS; HENIPAVIRUS; and AVULAVIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of POXVIRIDAE comprising poxviruses infecting insects including members of COLEOPTERA; DIPTERA; LEPIDOPTERA; and ORTHOPTERA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of Q-SNARE PROTEINS which occupy the same position as syntaxin 1A in the SNARE complex and which also are most similar to syntaxin 1A in their AMINO ACID SEQUENCE. This subfamily is also known as the syntaxins, although a few so called syntaxins are Qc-SNARES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the C-terminal SNARE domain of SNAP-25 and which also are most similar to the C-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of Q-SNARE PROTEINS which occupy the same position in the SNARE complex as the N-terminal SNARE domain of SNAP-25 and which also are most similar to the N-terminal region of SNAP-25 in their AMINO ACID SEQUENCE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of assassin bugs %28%REDUVIIDAE%29% that are obligate blood-suckers of vertebrates. Included are the genera TRIATOMA; RHODNIUS; and PANSTRONGYLUS, which are vectors of TRYPANOSOMA CRUZI, the agent of CHAGAS DISEASE in humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of lysophospholipid receptors with specificity for LYSOPHOSPHATIDIC ACIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of lysophospholipid receptors with specificity for LYSOSPHINGOLIPIDS such as sphingosine-1-phosphate and sphingosine phosphorylcholine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of motile, gram-negative bacteria found in SOIL and WATER and capable of fixing atmospheric nitrogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of nuclear receptors that regulate GENETIC TRANSCRIPTION of a diverse group of GENES involved in the synthesis of BLOOD COAGULATION FACTORS; and in GLUCOSE; CHOLESTEROL; and FATTY ACIDS metabolism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of shaker potassium channels that shares homology with its founding member, Shab protein, Drosophila. They regulate delayed rectifier currents in the NERVOUS SYSTEM of DROSOPHILA and in the SKELETAL MUSCLE and HEART of VERTEBRATES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of small heat-shock proteins found in a wide variety of organisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of small heat-shock proteins that are closely related to ALPHA B-CRYSTALLIN. Hsp20 heat-shock proteins can undergo PHOSPHORYLATION by CYCLIC GMP-DEPENDENT PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of the New World monkeys, CEBIDAE, inhabiting the forests of South and Central America. The Aotinae are also referred to as night monkeys or owl monkeys. There are two species occurring in this subfamily: Aotus azarae %28%Southern night monkeys%29% and AOTUS TRIVIRGATUS %28%Northern night monkeys%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of the Old World monkeys, CERCOPITHECIDAE, that inhabits the forests of Africa and Asia. The genera COLOBUS %28%Procolobus; colobus%29%, Nasalis %28%proboscis monkey%29%, Presbytis %28%Semnopithecus; leaf monkey%29%, Pygathrix %28%Rhinopithecus; snub-nosed monkey%29%, and Simias %28%pig-tailed langur%29% all belong to this subfamily.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of the Old World monkeys, CERCOPITHECIDAE. They inhabit the forests and savannas of Africa. This subfamily contains the following genera: CERCOCEBUS; CERCOPITHECUS; ERYTHROCEBUS; MACACA; PAPIO; and THEROPITHECUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of the family MURIDAE comprised of 69 genera. New World mice and rats are included in this subfamily.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of the family POXVIRIDAE, containing eight genera comprising all the vertebrate poxviruses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfamily of transmembrane proteins from the superfamily of ATP-BINDING CASSETTE TRANSPORTERS that are closely related in sequence to P-GLYCOPROTEIN. When overexpressed, they function as ATP-dependent efflux pumps able to extrude lipophilic drugs, especially ANTINEOPLASTIC AGENTS, from cells causing multidrug resistance %28%DRUG RESISTANCE, MULTIPLE%29%. Although P-Glycoproteins share functional similarities to MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS they are two distinct subclasses of ATP-BINDING CASSETTE TRANSPORTERS, and have little sequence homology.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subfield of acoustics dealing in the radio frequency range higher than SOUND waves %28%beyond 20 kilohertz%29%, but usually restricted to frequencies above 500,000 Hertz. Ultrasonic radiation is used therapeutically %28%DIATHERMY and ULTRASONIC THERAPY%29% to generate HEAT and to selectively destroy tissues. It is also used in diagnostics, for example, ULTRASONOGRAPHY; ECHOENCEPHALOGRAPHY; and ECHOCARDIOGRAPHY, to visually display echoes received from irradiated tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgenus of LENTIVIRUS comprising viruses that produce immunodeficiencies in primates, including humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cats.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cattle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in sheep and goats.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgenus of Salmonella containing several medically important serotypes. The habitat for the majority of strains is warm-blooded animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis. An important variant of the chronic form is LYMPHOMATOID PAPULOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of TRP cation channels named after melastatin protein. They have the TRP domain but lack ANKYRIN repeats. Enzyme domains in the C-terminus leads to them being called chanzymes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of TRP cation channels named after vanilloid receptor. They are very sensitive to TEMPERATURE and hot spicy food and CAPSAICIN. They have the TRP domain and ANKYRIN repeats. Selectivity for CALCIUM over SODIUM ranges from 3 to 100 fold.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of TRP cation channels that are widely expressed in various cell types. Defects are associated with POLYCYSTIC KIDNEY DISEASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of TRP cation channels that contain 3-4 ANKYRIN repeats and a conserved C-terminal domain. Members are highly expressed in the CENTRAL NERVOUS SYSTEM. Selectivity for calcium over sodium ranges from 0.5 to 10.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of aquaporins that transport WATER; GLYCEROL; and other small solutes across CELL MEMBRANES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of mitogen-activated protein kinases that activate TRANSCRIPTION FACTOR AP-1 via the phosphorylation of C-JUN PROTEINS. They are components of intracellular signaling pathways that regulate CELL PROLIFERATION; APOPTOSIS; and CELL DIFFERENTIATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by TICKS and there is an associated milk-borne transmission from viremic cattle, goats, and sheep.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subgroup of the genus FLAVIVIRUS which comprises a number of viral species that are the etiologic agents of human encephalitis in many different geographical regions. These include Japanese encephalitis virus %28%ENCEPHALITIS VIRUS, JAPANESE%29%, St. Louis encephalitis virus %28%ENCEPHALITIS VIRUS, ST. LOUIS%29%, Murray Valley encephalitis virus %28%ENCEPHALITIS VIRUS, MURRAY VALLEY%29%, and WEST NILE VIRUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subjective feeling that an experience which is occurring for the first time has been experienced before.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subkingdom consisting of unicellular organisms that are the simplest in the animal kingdom. Most are free living. They range in size from submicroscopic to macroscopic. Protozoa are divided into seven phyla: SARCOMASTIGOPHORA; Labyrinthomorpha, APICOMPLEXA; MICROSPORA; Ascetospora, Myxozoa, and CILIOPHORA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of CRUSTACEA, order Diplostraca, comprising the water fleas. They are benthic filter feeders that consume PHYTOPLANKTON. The body is laterally compressed and enclosed in a bivalved carapace, from which the head extends.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of FUNGI in the phylum MICROSPORIDIA, commonly lacking a pansporoblastic membrane. The sporoblast is usually dinucleate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of FUNGI in the phylum MICROSPORIDIA, possessing a pansporoblastic membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of HEMIPTERA, called true bugs, characterized by the possession of two pairs of wings. It includes the medically important families CIMICIDAE and REDUVIIDAE. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of PRIMATES consisting of six families: CEBIDAE %28%some New World monkeys%29%, ATELIDAE %28%some New World monkeys%29%, CERCOPITHECIDAE %28%Old World monkeys%29%, HYLOBATIDAE %28%gibbons and siamangs%29%, CALLITRICHIDAE %28%marmosets and tamarins%29%, and HOMINIDAE %28%humans and great apes%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of PRIMATES consisting of the following five families: CHEIROGALEIDAE; Daubentoniidae; Indriidae; LEMURIDAE; and LORISIDAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of ameboid protozoa characterized by a branched or unbranched cylindrical body and the absence of bidirectional cytoplasmic flow. Nuclear division is mesomitotic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of ameboid protozoa. Characteristics include subpseudopodia that are more or less finely tipped, occasionally filiform, commonly furcate hyaline, and produced from a broad hyaline lobe. Cysts are usually formed and nuclear division is mesomitotic or metamitotic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of ciliate protozoa characterized by non-reduction of the somatic ciliature.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of ciliate protozoa having a body that is commonly oval to elliptical in shape. Most species are free-living in widely diverse habitats.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of ciliate protozoa. Most organisms are free-living in fresh water and many species are used extensively for experimental studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of monoflagellate parasitic protozoa that lives in the blood and tissues of man and animals. Representative genera include: Blastocrithidia, Leptomonas, CRITHIDIA, Herpetomonas, LEISHMANIA, Phytomonas, and TRYPANOSOMA. Species of this suborder may exist in two or more morphologic stages formerly named after genera exemplifying these forms - amastigote %28%LEISHMANIA%29%, choanomastigote %28%CRITHIDIA%29%, promastigote %28%Leptomonas%29%, opisthomastigote %28%Herpetomonas%29%, epimastigote %28%Blastocrithidia%29%, and trypomastigote %28%TRYPANOSOMA%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of nematodes characterized by larvae lacking cephalic hooks and a tail that is generally long and pointed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of nematodes characterized by larvae possessing cephalic hooks and multinucleated esophageal glands.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of protozoa characterized by peniculi, which are often situated deep in the buccal cavity, and by fusiform trichocysts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of protozoa of the class LOBOSEA. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suborder of the order ARTIODACTYLA whose members have the distinguishing feature of a four-chambered stomach, including the capacious RUMEN. Horns or antlers are usually present, at least in males.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subphylum of chordates intermediate between the invertebrates and the true vertebrates. It includes the Ascidians.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subphylum of flagellate protozoa. It contains two classes: PHYTOMASTIGOPHOREA and ZOOMASTIGOPHORA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subphylum of protozoa characterized by the ability to alter their body shape. Its organisms acquire food by pseudopodia of various types, or by locomotive protoplasmic flow without the production of discrete pseudopodia. Flagella, when present, are usually restricted to developmental or other temporary stages.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subset of VIRIDANS STREPTOCOCCI, but the species in this group differ in their hemolytic pattern and diseases caused. These species are often beta-hemolytic and produce pyogenic infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subset of ubiquitin protein ligases that are formed by the association of a SKP DOMAIN PROTEIN, a CULLIN DOMAIN PROTEIN and a F-BOX DOMAIN PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of Pediatrics concerned with the newborn infant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the endocrine system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with the study of neoplasms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures %28%esophagus, liver, gallbladder, and pancreas%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of internal medicine concerned with the study of the respiratory system. It is especially concerned with diagnosis and treatment of diseases and defects of the lungs and bronchial tree.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of pathology applied to the solution of clinical problems, especially the use of laboratory methods in clinical diagnosis. %28%Dorland, 28th ed.%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subspecialty of psychiatry concerned with the mental health of the aged.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substance occurring in the urine of mammals and also in blood plasma as the normal metabolite of tryptophan. An increased urinary excretion of indican is seen in Hartnup disease from the bacterial degradation of unabsorbed tryptophan.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor %28%see RECEPTORS, DOPAMINE D2%29% antagonist.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. %28%Martindale The Extra Pharmacopoeia, 31st ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substituted carcinogenic nitrosamine. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substituted dihydroxybenzene that is used topically as an antiseptic for the treatment of minor skin infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of locations including the BRAIN and endocrine tissues. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of tissues including the BRAIN and DORSAL HORN NEURONS. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of G-protein-coupled SEROTONIN receptors that preferentially couple to GS STIMULATORY G-PROTEINS resulting in increased intracellular CYCLIC AMP. Several isoforms of the receptor exist due to ALTERNATIVE SPLICING of its mRNA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and for swine flu.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 2 and neuraminidase 2. The H2N2 subtype was responsible for the Asian flu pandemic of 1957.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 8. The H3N8 subtype has frequently been found in horses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic %28%POULTRY%29% and wild birds. It does not usually infect humans, but some cases have been reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 2. The H5N2 subtype has been found to be highly pathogenic in chickens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 7. The H7N7 subtype produced an epidemic in 2003 which was highly pathogenic among domestic birds %28%POULTRY%29%. Some infections in humans were reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 9 and neuraminidase 2. The H9N2 subtype usually infects domestic birds %28%POULTRY%29% but there have been some human infections reported.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show infiltration of LYMPHOCYTES in the superficial EPITHELIUM and the underlying connective tissue %28%lamina propria%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of MICROSCOPIC COLITIS, characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. Microscopic examination of biopsy samples taken from the COLON show larger-than-normal band of subepithelial COLLAGEN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of RETINOIC ACID RECEPTORS that are specific for 9-cis-retinoic acid which function as nuclear TRANSCRIPTION FACTORS that regulate multiple signalling pathways.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of bacterial transferrin-binding protein found in bacteria. It forms a cell surface receptor complex with TRANSFERRIN-BINDING PROTEIN B.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of bone morphogenetic protein receptors with low affinity for BONE MORPHOGENETIC PROTEINS. They are constitutively active PROTEIN-SERINE-THREONINE KINASES that can interact with and phosphorylate TYPE I BONE MORPHOGENETIC PROTEIN RECEPTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of bradykinin receptor that is induced in response to INFLAMMATION. It may play a role in chronic inflammation and has a high specificity for KININS lacking the C-terminal ARGININE such as des-Arg%28%10%29%-kallidin and des-Arg%28%9%29%-bradykinin. The receptor is coupled to G-PROTEIN, GQ-G11 ALPHA FAMILY and G-PROTEIN, GI-GO ALPHA FAMILY signaling proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of cholecystokinin receptor found primarily in the CENTRAL NERVOUS SYSTEM and the GASTRIC MUCOSA. It may play a role as a neuromodulator of dopaminergic neurotransmission the regulation of GASTRIC ACID secretion from GASTRIC PARIETAL CELLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of cholecystokinin receptor found primarily in the PANCREAS; STOMACH; INTESTINE; and GALLBLADDER. It plays a role in regulating digestive functions such as gallbladder contraction, pancreatic enzyme secretion and absorption in the GASTROINTESTINAL TRACT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of dopamine D1 receptors that has higher affinity for DOPAMINE and differentially couples to GTP-BINDING PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of dopamine D2 receptors that are highly expressed in the LIMBIC SYSTEM of the brain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of dopamine D2 receptors that has high affinity for the antipsychotic CLOZAPINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of dynamin found expressed exclusively in the testis, lung and brain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of dynamin found primarily in the NEURONS of the brain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of dynamin found ubiquitously expressed in a variety of tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of endothelin receptor found predominantly in the KIDNEY. It may play a role in reducing systemic ENDOTHELIN levels.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of endothelin receptor found predominantly in the VASCULAR SMOOTH MUSCLE. It has a high affinity for ENDOTHELIN-1 and ENDOTHELIN-2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of enteroendocrine cells found in the gastrointestinal MUCOSA, particularly in the glands of PYLORIC ANTRUM; DUODENUM; and ILEUM. These cells secrete mainly SEROTONIN and some neuropeptides. Their secretory granules stain readily with silver %28%argentaffin stain%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of epilepsy characterized by seizures that are consistently provoked by a certain specific stimulus. Auditory, visual, and somatosensory stimuli as well as the acts of writing, reading, eating, and decision making are examples of events or activities that may induce seizure activity in affected individuals. %28%From Neurol Clin 1994 Feb;12%28%1%29%:57-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of equilibrative nucleoside transporter proteins that is insensitive to inhibition by 4-nitrobenzylthioinosine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of equilibrative nucleoside transporter proteins that is sensitive to inhibition by 4-nitrobenzylthioinosine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of lymphocytic leukemia classified as acute or chronic depending on the degree of cell differentiation, not the duration of the disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms %28%aura%29% that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. %28%International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of mitochondrial ADP, ATP translocase found primarily in FIBROBLASTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of mitochondrial ADP, ATP translocase found primarily in heart muscle %28%MYOCARDIUM%29% and skeletal muscle %28%MUSCLE, SKELETAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subtype of mitochondrial ADP, ATP translocase found primarily in the LIVER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A subunit of NF-kappa B that is primarily responsible for its transactivation function. It contains a C-terminal transactivation domain and an N-terminal domain with homology to PROTO-ONCOGENE PROTEINS C-REL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sucrose polymer of high molecular weight. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sudden loss of pressure in a pressurized cabin, cockpit, or the like, so rapid as to be explosive. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sudden, nonconvulsive loss of neurologic function due to an ischemic or hemorrhagic intracranial vascular event. In general, cerebrovascular accidents are classified by anatomic location in the brain, vascular distribution, etiology, age of the affected individual, and hemorrhagic vs. nonhemorrhagic nature. %28%From Adams et al., Principles of Neurology, 6th ed, pp777-810%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sudden, temporary sensation of heat predominantly experienced by some women during MENOPAUSE. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sugar alcohol formed by the reduction of ribose. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfamoylbenzamide analog of CLOPAMIDE. It is diuretic and saluretic with antihypertensive activity. It is bound to PLASMA PROTEINS, thus has a delayed onset and prolonged action.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfamoylbenzamide piperidine. It is considered a thiazide-like diuretic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfamyl diuretic. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfanilamide antibacterial agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfanilamide antimicrobial agent that is used to treat enteric infections.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfanilamide that is used as an anti-infective agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfanilamide that is used as an antibacterial agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfated pentosyl polysaccharide with heparin-like properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfated plasma protein with the MW of approximately 66kDa that resembles ANTITHROMBIN III. The protein is an inhibitor of thrombin in plasma and is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfathiazole antibacterial agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfhydryl proteinase with cysteine at the active site from ficus latex. Preferential cleavage is at tyrosine and phenylalanine residues. EC 3.4.22.3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfhydryl reagent that is widely used in experimental biochemical studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfhydryl reagent which oxidizes sulfhydryl groups to the disulfide form. It is a radiation-sensitizing agent of anoxic bacterial and mammalian cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonamide that inhibits the enzyme carbonic anhydrase and is used as topical anti-infective, especially in burn therapy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonilamide anti-infective agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p277%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p277%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfotransferase that catalyzes the sulfation of a phenol in the presence of 3%27%-phosphoadenylylsulfate as sulfate donor to yield an aryl sulfate and adenosine 3%27%,5%27%-bisphosphate. A number of aromatic compounds can act as acceptors; however, organic hydroxylamines are not substrates. Sulfate conjugation by this enzyme is a major pathway for the biotransformation of phenolic and catechol drugs as well as neurotransmitters. EC 2.8.2.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulfuric acid dimer, formed by disulfide linkage. This compound has been used to prolong coagulation time and as an antidote in cyanide poisoning.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p290%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sultanate on the southeast coast of the Arabian peninsula. Its capital is Masqat. Before the 16th century it was ruled by independent emirs but was captured and controlled by the Portuguese 1508-1648. In 1741 it was recovered by a descendent of Yemen%27%s imam. After its decline in the 19th century, it became virtually a political and economic dependency within the British Government of India, retaining close ties with Great Britain by treaty from 1939 to 1970 when it achieved autonomy. The name was recorded by Pliny in the 1st century A.D. as Omana, said to be derived from the founder of the state, Oman ben Ibrahim al-Khalil. %28%From Webster%27%s New Geographical Dictionary, 1988, p890; Oman Embassy, Washington; Room, Brewer%27%s Dictionary of Names, 1992, p391%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of PROTEIN-SERINE-THREONINE KINASES that are activated by diverse stimuli via protein kinase cascades. They are the final components of the cascades, activated by phosphorylation by MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn are activated by mitogen-activated protein kinase kinase kinases %28%MAP KINASE KINASE KINASES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases %28%MIXED FUNCTION OXYGENASES%29%. In animals, these P-450 enzymes serve two major functions: %28%1%29% biosynthesis of steroids, fatty acids, and bile acids; %28%2%29% metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs %28%BIOTRANSFORMATION%29%. They are classified, according to their sequence similarities rather than functions, into CYP gene families %28%%3E%40%25% homology%29% and subfamilies %28%%3E%59%25% homology%29%. For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of intestinal nematode parasites containing one genus, STRONGYLOIDES, and several species. It is transmitted through fecal material onto the skin and occurs in animals and humans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematode parasitic hookworms consisting of four genera: ANCYLOSTOMA, NECATOR, Bunostomum, and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the order ENOPLIDA. Characteristics include a reduced alimentary tract and the presence of a trophosome. Its organisms can be present in the human intestine through ingestion of unwashed or contaminated raw vegetables.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the order ENOPLIDA. Characteristics include a well developed cylindrical esophagus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the order ENOPLIDA. Its organisms have a well developed intestine and rectum.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the order RHABDITIDA. Characteristics include an open tube stoma and an excretory system with lateral canals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the order STRONGYLIDA. Characteristics include a fluid-filled outer layer of cuticle and a reduced mouth and bursa.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the suborder CAMALLANINA. Its organisms possess a poorly developed buccal cavity and a rudimentary esophagus and intestine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes of the suborder SPIRURINA. Its organisms possess a filiform body and a mouth surrounded by papillae.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes whose members are free-living saprophytes or parasites of plants. Ova are sometimes found in human feces after ingestion of infected plants.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of nematodes. Most are intestinal parasites of ruminants and accidentally in humans. This superfamily includes seven genera: DICTYOCAULUS; HAEMONCHUS; Cooperia, OSTERTAGIA; Nematodirus, TRICHOSTRONGYLUS; and Hyostrongylus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of parasitic nematodes consisting of several genera. ENTEROBIUS, which occurs in humans, and Oxyuris, which occurs in horses, are two of the most common. Other genera are: Skrjabinema, Passalurus, Dermatoxys, and Probstmayria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of parasitic nematodes which includes three genera: Thelazia, Spirocerca, and GNATHOSTOMA. Only Thelazia and GNATHOSTOMA occasionally occur in man.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of parasitic nematodes which requires one or two intermediate arthropod hosts before finally being eaten by the final host. Its organisms occur rarely in man.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of parasitic nematodes which were formerly considered a part of TRICHOSTRONGYLOIDEA. It includes the following genera: Heligmosomum, NEMATOSPIROIDES, and NIPPOSTRONGYLUS. The hosts are rodents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of polymyarian nematode worms. An important characteristic of this group is the presence of three prominent lips around the mouth of the organism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of proteins that share a highly conserved MADS domain sequence motif. The term MADS refers to the first four members which were MCM1 PROTEIN; AGAMOUS PROTEIN; DEFICIENS PROTEIN; and SERUM RESPONSE FACTOR. Many MADS domain proteins have been found in species from all eukaryotic kingdoms. They play an important role in development, especially in plants where they have an important role in flower development.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of small proteins which are involved in the MEMBRANE FUSION events, intracellular protein trafficking and secretory processes. They share a homologous SNARE motif. The SNARE proteins are divided into subfamilies: QA-SNARES; QB-SNARES; QC-SNARES; and R-SNARES. The formation of a SNARE complex %28%composed of one each of the four different types SNARE domains %28%Qa, Qb, Qc, and R%29%%29% mediates MEMBRANE FUSION. Following membrane fusion SNARE complexes are dissociated by the NSFs %28%N-ETHYLMALEIMIDE-SENSITIVE FACTORS%29%, in conjunction with SOLUBLE NSF ATTACHMENT PROTEIN, i.e., SNAPs %28%no relation to SNAP 25.%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of strongyles or roundworms which are parasites in the intestinal tract of equines, pigs, rodents, and primates %28%including man%29%. It includes the genera Cyasthostomum, Ransomus, Globocephalus, OESOPHAGOSTOMUM, and STRONGYLUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superfamily of various freshwater CRUSTACEA, in the infraorder Astacidea, comprising the crayfish. Common genera include Astacus and Procambarus. Crayfish resemble lobsters, but are usually much smaller.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers %28%KERATITIS, DENDRITIC%29%. %28%Dictionary of Visual Science, 3d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superorder in the class CEPHALOPODA, consisting of the orders Octopoda %28%octopus%29% with over 200 species and Vampyromorpha with a single species. The latter is a phylogenetic relic but holds the key to the origins of Octopoda.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superorder of CEPHALOPODS comprised of squid, cuttlefish, and their relatives. Their distinguishing feature is the modification of their fourth pair of arms into tentacles, resulting in 10 limbs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superorder of large, mostly flightless birds, named for their distinctive PALATE morphology. It includes the orders Apterygiformes, Casuriiformes, Dinornithiformes, RHEIFORMES; STRUTHIONIFORMES and Tinamiformes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A superorder of marine CRUSTACEA, free swimming in the larval state, but permanently fixed as adults. There are some 800 described species, grouped in several genera, and comprising of two major orders of barnacles: stalked %28%Pedunculata%29% and sessile %28%Sessilia%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A supplemental health insurance policy sold by private insurance companies and designed to pay for health care costs and services that are not paid for either by Medicare alone or by a combination of Medicare and existing private health insurance benefits. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surface protein found on Plasmodium species which induces a T-cell response. The antigen is polymorphic, sharing amino acid sequence homology among PLASMODIUM FALCIPARUM; PLASMODIUM CHABAUDI; PLASMODIUM VIVAX; and PLASMODIUM YOELII.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface; used in foods and cosmetics; important in contrast media; also with contact lenses, dentures, and some prostheses. Synonyms: humectants; hydrating agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical device designed for retaining a hernia in a reduced state within the abdominal cavity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical operation for the relief of pressure in a body compartment or on a body part. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical procedure involving the excision of the COLON and RECTUM and the formation of an ILEOANAL RESERVOIR %28%pouch%29%. In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an OSTOMY by allowing for transanal defecation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical procedure to correct MYOPIA by CORNEAL STROMA subtraction. It involves the use of a microkeratome to make a lamellar dissection of the CORNEA creating a flap with intact CORNEAL EPITHELIUM. After the flap is lifted, the underlying midstroma is reshaped with an excimer laser and the flap is returned to its original position.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical procedure used in treatment of glaucoma in which an opening is created through which aqueous fluid may pass from the anterior chamber into a sac created beneath the conjunctiva, thus lowering the pressure within the eye. %28%Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs, and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the colon, rectum, and anal canal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty concerned with the study and treatment of disorders of the ear, nose, and throat.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty concerned with the treatment of diseases and disorders of the brain, spinal cord, and peripheral and sympathetic nervous system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical technique to correct REFRACTIVE ERRORS of the EYE, such as MYOPIA and ASTIGMATISM. In this method, the flap of CORNEAL EPITHELIUM is lifted then replaced after laser ablation of the subepithelial CORNEA. The hinged flap is created by epithelial marking and exposure of the marking to dilute alcohol.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A surgical technique used primarily in the treatment of skin neoplasms, especially basal cell or squamous cell carcinoma of the skin. This procedure is a microscopically controlled excision of cutaneous tumors either after fixation in vivo or after freezing the tissue. Serial examinations of fresh tissue specimens are most frequently done.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suspected industrial carcinogen %28%and listed as such by OSHA%29%. Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suspension of formalin-inactivated poliovirus grown in monkey kidney cell tissue culture and used to prevent POLIOMYELITIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis %28%WHOOPING COUGH%29%. It is generally used in a mixture with diphtheria and tetanus toxoids %28%DTP%29%. There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suspension of killed Yersinia pestis used for immunizing people in enzootic plague areas.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suspension of metallic gold particles. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A suspension of radioactive gold particles emitting negative beta particles and gamma irradiation. It was formerly used for liver scans and irradiation treatment of some metastatic malignancies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sustained and usually painful contraction of muscle fibers. This may occur as an isolated phenomenon or as a manifestation of an underlying disease process %28%e.g., UREMIA; HYPOTHYROIDISM; MOTOR NEURON DISEASE; etc.%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p1398%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sweet viscous liquid food, produced in the honey sacs of various bees from nectar collected from flowers. The nectar is ripened into honey by inversion of its sucrose sugar into fructose and glucose. It is somewhat acidic and has mild antiseptic properties, being sometimes used in the treatment of burns and lacerations.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A swelling on the trunk of the vertebrate embryo that becomes a limb. Limb bud cultures are used in developmental, organogenesis, morphogenesis, and cell differentiation studies. The limb bud of the chick embryo is most commonly used but mouse and rat limb buds are also used.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1223%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia. Although the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1248%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1222%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A symptom complex characterized by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A symptom complex of unknown etiology, that is characteristic of a particular abnormality.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A symptom complex resulting from ingestion of excessive amounts of vitamin A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A symptom, not a disease, of a twisted neck. In most instances, the head is tipped toward one side and the chin rotated toward the other. The involuntary muscle contractions in the neck region of patients with torticollis can be due to congenital defects, trauma, inflammation, tumors, and neurological or other factors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synaptic membrane protein involved in MEMBRANE FUSION of SYNAPTIC VESICLES with the presynaptic membranes. It is the prototype member of the R-SNARE PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome associated with damage to the spinal cord above the mid thoracic level %28%see SPINAL CORD INJURIES%29% characterized by a marked increase in the sympathetic response to minor stimuli such as bladder or rectal distention. Manifestations include HYPERTENSION; TACHYCARDIA %28%or reflex bradycardia%29%; FEVER; FLUSHING; and HYPERHIDROSIS. Extreme hypertension may be associated with a CEREBROVASCULAR ACCIDENT. %28%From Adams et al., Principles of Neurology, 6th ed, pp538 and 1232; J Spinal Cord Med 1997;20%28%3%29%:355-60%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome associated with defective sympathetic innervation to one side of the face, including the eye. Clinical features include MIOSIS; mild BLEPHAROPTOSIS; and hemifacial ANHIDROSIS %28%decreased sweating%29%%28%see HYPOHIDROSIS%29%. Lesions of the BRAIN STEM; cervical SPINAL CORD; first thoracic nerve root; apex of the LUNG; CAROTID ARTERY; CAVERNOUS SINUS; and apex of the ORBIT may cause this condition. %28%From Miller et al., Clinical Neuro-Ophthalmology, 4th ed, pp500-11%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome associated with inflammation of the BRACHIAL PLEXUS. Clinical features include severe pain in the shoulder region which may be accompanied by MUSCLE WEAKNESS and loss of sensation in the upper extremity. This condition may be associated with VIRUS DISEASES; IMMUNIZATION; SURGERY; heroin use %28%see HEROIN DEPENDENCE%29%; and other conditions. The term brachial neuralgia generally refers to pain associated with brachial plexus injury. %28%From Adams et al., Principles of Neurology, 6th ed, pp1355-6%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome associated with injury to the lateral half of the spinal cord. The condition is characterized by the following clinical features %28%which are found below the level of the lesion%29%: contralateral hemisensory anesthesia to pain and temperature, ipsilateral loss of propioception, and ipsilateral motor paralysis. Tactile sensation is generally spared. %28%From Adams et al., Principles of Neurology, 6th ed, p162%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome associated with traumatic injury to the cervical or upper thoracic regions of the spinal cord characterized by weakness in the arms with relative sparing of the legs and variable sensory loss. This condition is associated with ischemia, hemorrhage, or necrosis involving the central portions of the spinal cord. Corticospinal fibers destined for the legs are spared due to their more external location in the spinal cord. This clinical pattern may emerge during recovery from spinal shock. Deficits may be transient or permanent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome caused by obstruction of the terminal aorta. It usually occurs in males and is characterized by fatigue in the hips, thighs, or calves on exercising, absence of pulsation in the femoral arteries, impotence, and often pallor and coldness of the lower limbs. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by CHRONIC KIDNEY FAILURE and GONADAL DYSGENESIS in phenotypic females with karyotype of 46,XY or 46,XX. It is caused by donor splice-site mutations of Wilms tumor suppressor gene %28%GENES, WILMS TUMOR%29% on chromosome 11.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by DYSARTHRIA, dysphagia, dysphonia, impairment of voluntary movements of tongue and facial muscles, and emotional lability. This condition is caused by diseases that affect the motor fibers that travel from the cerebral cortex to the lower BRAIN STEM %28%i.e., corticobulbar tracts%29%; including MULTIPLE SCLEROSIS; MOTOR NEURON DISEASE; and CEREBROVASCULAR DISORDERS. %28%From Adams et al., Principles of Neurology, 6th ed, p489%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by Lentigines %28%LENTIGO%29%; Electrocardiographic conduction abnormalities; Ocular HYPERTELORISM; PULMONARY STENOSIS; Abnormal genitalia; Retardation of growth; and Deafness %28%HEARING LOSS, SENSORINEURAL%29%. It is caused by mutations of the PTPN11 gene which codes for non-receptor PROTEIN TYROSINE PHOSPHATASE, type 11. The clinical features of LEOPARD syndrome overlap those of NOONAN SYNDROME, also caused by mutations in PTPN11, as well as those of NEUROFIBROMATOSIS 1. The syndrome has also been associated with mutations in the NF1 gene %28%GENES, NEUROFIBROMATOSIS 1%29%. %28%J Med Genet 2002 Aug;39%28%8%29%:571-4%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by a TONIC PUPIL that occurs in combination with decreased lower extremity reflexes. The affected pupil will respond more briskly to accommodation than to light %28%light-near dissociation%29% and is supersensitive to dilute pilocarpine eye drops, which induce pupillary constriction. Pathologic features include degeneration of the ciliary ganglion and postganglionic parasympathetic fibers that innervate the pupillary constrictor muscle. %28%From Adams et al., Principles of Neurology, 6th ed, p279%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. %28%From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63%28%2%29%:59-67%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by a transient loss of the ability to form new memories. It primarily occurs in middle aged or elderly individuals, and episodes may last from minutes to hours. During the period of amnesia, immediate and recent memory abilities are impaired, but the level of consciousness and ability to perform other intellectual tasks are preserved. The condition is related to bilateral dysfunction of the medial portions of each TEMPORAL LOBE. Complete recovery normally occurs, and recurrences are unusual. %28%From Adams et al., Principles of Neurology, 6th ed, pp429-30%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by acute OPTIC NEURITIS in combination with acute MYELITIS, TRANSVERSE. Demyelinating and/or necrotizing lesions form in one or both optic nerves and in the spinal cord. The onset of optic neuritis and myelitis may be simultaneous or separated by several months. %28%J Neurol Neurosurg Psychiatry 1996 Apr;60%28%4%29%:382-387%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta %28%a strand of depigmented hair%29%, HEARING DISORDERS, and meningeal signs %28%neck stiffness and headache%29%. Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. %28%Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39%28%4%29%:265-292%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION %28%frequently progressing to COMA%29%; ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes %28%see REFLEX, BABINSKI%29%. ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. %28%From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum %26% Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by chronic, well-established DIARRHEA %28%greater than one month in duration%29% without an identified infectious cause after thorough evaluation, in an HIV-positive individual. It is thought to be due to direct or indirect effects of HIV on the enteric mucosa. HIV enteropathy is a diagnosis of exclusion and can be made only after other forms of diarrheal illness have been ruled out. %28%Harrison%27%s Principles of Internal Medicine, 13th ed, pp1607-8; Haubrich et al., Bockus Gastroenterology, 5th ed, p1155%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite %28%carbohydrate cravings%29%, increased duration of sleep, and weight gain. SAD %28%seasonal affective disorder%29% can be treated by daily exposure to bright artificial lights %28%PHOTOTHERAPY%29%, during the season of recurrence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by facial palsy in association with a herpetic eruption of the external auditory meatus. This may occasionally be associated with tinnitus, vertigo, deafness, severe otalgia, and inflammation of the pinna. The condition is caused by reactivation of a latent HERPESVIRUS 3, HUMAN infection which causes inflammation of the facial and vestibular nerves, and may occasionally involve additional cranial nerves. %28%From Adams et al., Principles of Neurology, 6th ed, p757%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by growth retardation, severe MENTAL RETARDATION, short stature, a low-pitched growling cry, brachycephaly, low-set ears, webbed neck, carp mouth, depressed nasal bridge, bushy eyebrows meeting at the midline, hirsutism, and malformations of the hands. The condition may occur sporadically or be associated with an autosomal dominant pattern of inheritance or duplication of the long arm of chromosome 3. %28%Menkes, Textbook of Child Neurology, 5th ed, p231%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by headache, neck stiffness, low grade fever, and CSF lymphocytic pleocytosis in the absence of an acute bacterial pathogen. Viral meningitis is the most frequent cause although MYCOPLASMA INFECTIONS; RICKETTSIA INFECTIONS; diagnostic or therapeutic procedures; NEOPLASTIC PROCESSES; septic perimeningeal foci; and other conditions may result in this syndrome. %28%From Adams et al., Principles of Neurology, 6th ed, p745%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by history of syncopal episodes and a long QT interval, sometimes leading to sudden death %28%DEATH, SUDDEN, CARDIAC%29% due to paroxysmal ventricular arrhythmia. A form associated with autosomal recessive inheritance and congenital deafness is called the JERVELL-LANGE NIELSEN SYNDROME. An autosomal dominant form without deafness is called the ROMANO-WARD SYNDROME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by indifference to PAIN despite the ability to distinguish noxious from nonnoxious stimuli. Absent corneal reflexes and MENTAL RETARDATION may be associated. Familial forms with autosomal recessive and autosomal dominant patterns of inheritance have been described. %28%Adams et al., Principles of Neurology, 6th ed, p1343%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by inflammation in the ILEUM, the CECUM, and the ASCENDING COLON. It is observed in cancer patients with CHEMOTHERAPY-induced NEUTROPENIA or in other immunocompromised individuals %28%IMMUNOCOMPROMISED HOST%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by marked limitation of abduction of the eye, variable limitation of adduction and retraction of the globe, and narrowing of the palpebral fissure on attempted adduction. The condition is caused by aberrant innervation of the lateral rectus by fibers of the oculomotor nerve. There are three subtypes: type 1 %28%associated with loss of abduction%29%, type 2 %28%associated with loss of adduction%29%, and type 3 %28%loss of abduction and adduction%29%. Two loci for Duane retraction syndrome have been located, one at chromosome 8q13 %28%DURS1%29% and another at chromosome 2q31%28%DURS2%29%. It is usually caused by congenital hypoplasia of the abducens nerve or nucleus, but may rarely represent an acquired syndrome. %28%Adams et al., Principles of Neurology, 6th ed, p271; Miller et al., Clinical Neuro-Ophthalmology, 4th ed, p691%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by multiple abnormalities, MENTAL RETARDATION, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms %28%SPASMS, INFANTILE%29%; easily provoked and prolonged paroxysms of laughter %28%hence %22%happy%22%%29%; jerky puppetlike movements %28%hence %22%puppet%22%%29%; continuous tongue protrusion; motor retardation; ATAXIA; MUSCLE HYPOTONIA; and a peculiar facies. It is associated with maternal deletions of chromosome 15q11-13 and other genetic abnormalities. %28%From Am J Med Genet 1998 Dec 4;80%28%4%29%:385-90; Hum Mol Genet 1999 Jan;8%28%1%29%:129-35%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I %28%classical; CSA%29% is early childhood onset in the second year of life; type II %28%congenital; CSB%29% is early onset at birth with severe symptoms; type III %28%xeroderma pigmentosum; XP%29% is late childhood onset with mild symptoms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. %28%From Ann NY Acad Sci 1995 May 25;753:68-80%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by orofacial DYSTONIA; including BLEPHAROSPASM; forceful jaw opening; lip retraction; platysma muscle spasm; and tongue protrusion. It primarily affects older adults, with an incidence peak in the seventh decade of life. %28%From Adams et al., Principles of Neurology, 6th ed, p108%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by outbreaks of late term abortions, high numbers of stillbirths and mummified or weak newborn piglets, and respiratory disease in young unweaned and weaned pigs. It is caused by PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS. %28%Radostits et al., Veterinary Medicine, 8th ed, p1048%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. %28%From Semin Neurol 1998;18%28%2%29%:237-42; Ann Intern Med 1994 Dec 15;121%28%12%29%: 953-9%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the trigeminal nerve. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. %28%Adams et al., Principles of Neurology, 6th ed, p187%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by recurring fever, rash, and arthralgias occurring days to weeks after a rat bite. The causative agents are either Streptobacillus moniliformis or Spirillum minus.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by retropatellar or peripatellar PAIN resulting from physical and biochemical changes in the patellofemoral joint. The pain is most prominent when ascending or descending stairs, squatting, or sitting with flexed knees. There is a lack of consensus on the etiology and treatment. The syndrome is often confused with %28%or accompanied by%29% CHONDROMALACIA PATELLAE, the latter describing a pathological condition of the CARTILAGE and not a syndrome.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by severe burning pain in an extremity accompanied by sudomotor, vasomotor, and trophic changes in bone without an associated specific nerve injury. This condition is most often precipitated by trauma to soft tissue or nerve complexes. The skin over the affected region is usually erythematous and demonstrates hypersensitivity to tactile stimuli and erythema. %28%Adams et al., Principles of Neurology, 6th ed, p1360; Pain 1995 Oct;63%28%1%29%:127-33%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. %28%Adams et al., Principles of Neurology, 6th ed, p1376%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation %28%HYPOXEMIA%29% in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension %28%HYPERTENSION, PORTAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome characterized by the onset of isolated language dysfunction in otherwise normal children %28%age of onset 4-7 years%29% and epileptiform discharges on ELECTROENCEPHALOGRAPHY. Seizures, including atypical absence %28%EPILEPSY, ABSENCE%29%, complex partial %28%EPILEPSY, COMPLEX PARTIAL%29%, and other types may occur. The electroencephalographic abnormalities and seizures tend to resolve by puberty. The language disorder may also resolve although some individuals are left with severe language dysfunction, including APHASIA and auditory AGNOSIA. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp749-50; J Child Neurol 1997 Nov;12%28%8%29%:489-495%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. %28%From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6%28%1%29%:187-204; Med Clin North Am 1999 Mar;83%28%2%29%:381-92%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with TEMPORAL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome inherited as an autosomal recessive trait and incompatible with life. The main features are narrow thorax, short ribs, scapular and pelvic dysplasia, and polydactyly.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of DYSPHAGIA with IRON-DEFICIENCY ANEMIA that is due to congenital anomalies in the ESOPHAGUS %28%such as cervical esophageal webs%29%. It is known as Patterson-Kelly syndrome in the United Kingdom.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count %28%THROMBOCYTOPENIA%29%. HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of congenital facial paralysis, frequently associated with abducens palsy and other congenital abnormalities including lingual palsy, clubfeet, brachial disorders, cognitive deficits, and pectoral muscle defects. Pathologic findings are variable and include brain stem nuclear aplasia, facial nerve aplasia, and facial muscle aplasia, consistent with a multifactorial etiology. %28%Adams et al., Principles of Neurology, 6th ed, p1020%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of cutaneous changes associated with sweat retention and extravasation of sweat at different levels in the skin. Miliaria rubra, or prickly heat, results from apocrine duct obstruction. The sweat then seeps into the epidermis, producing pruritic erythematous papulovesicles. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of defective gonadal development in phenotypic women with a karyotype of sex chromosome monosomy %28%45,X or 45,XO%29%, associated with the loss of a sex chromosome X or Y. Patients generally are of short stature with undifferentiated %28%streak%29% gonads, sexual infantilism %28%HYPOGONADISM%29%, webbing of the neck, cubitus valgus, elevated GONADOTROPINS and decreased ESTRADIOL level in blood. Studies of Turner Syndrome and its variants have contributed significantly to the understanding of SEX DIFFERENTIATION. NOONAN SYNDROME bears similarity to this disorder; however, it also occurs in males, has normal karyotype, and is inherited as an autosomal dominant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of life-threatening progressive pulmonary insufficiency in the absence of known pulmonary disease, usually following a systemic insult such as SURGERY or major TRAUMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the PATELLA and congenital nail dystrophy. It is a genetically determined autosomal dominant trait.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of multiple defects characterized primarily by umbilical hernia %28%HERNIA, UMBILICAL%29%; MACROGLOSSIA; and GIGANTISM; and secondarily by visceromegaly; HYPOGLYCEMIA; and ear abnormalities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant %28%INFANT, NEWBORN%29% without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction %28%reactive type%29%, hypertrophy of pulmonary arterial muscle %28%hypertrophic type%29%, or abnormally developed pulmonary arterioles %28%hypoplastic type%29%. The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus %28%DUCTUS ARTERIOSUS, PATENT%29% and at times a patent foramen ovale %28%FORAMEN OVALE, PATENT%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning %22%displaced child%22%. Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome related to increased atmospheric pressure and characterized by tremors, nausea, dizziness, decreased motor and mental performance, and SEIZURES. This condition may occur in those who dive deeply %28%c. 1000 ft%29% usually while breathing a mixture of oxygen and helium. The condition is associated with a neuroexcitatory effect of helium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome that is characterized by the triad of severe PEPTIC ULCER, hypersecretion of GASTRIC ACID, and GASTRIN-producing tumors of the PANCREAS or other tissue %28%GASTRINOMA%29%. This syndrome may be sporadic or be associated with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome which is characterized by symbrachydactyly and aplasia of the sternal head of pectoralis major.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor %28%INSULINOMA%29%; autoantibodies against insulin %28%INSULIN ANTIBODIES%29%; defective insulin receptor %28%INSULIN RESISTANCE%29%; or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud%27%s phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable %28%saline soluble%29% nuclear antigen and a %22%speckled%22% epidermal nuclear staining pattern on direct immunofluorescence.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic TETRACYCLINE derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria %28%MALARIA, FALCIPARUM%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. %28%J Biol Chem 1995;270%28%33%29%:1945-7%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic analog of the pituitary hormone, ARGIPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic analog of vasopressin with ornithine in position 8 of the cyclic nonapeptide. It is used as a local vasoconstrictor and hemostatic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic antifungal agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p887%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic estrogen that has been used as a hormonal antineoplastic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic fluorinated steroid that is used as a progestational hormone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic fluoroquinolone %28%FLUOROQUINOLONES%29% antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic fluoroquinolone %28%FLUOROQUINOLONES%29% with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic glucocorticoid with anti-inflammatory properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic hormone used for androgen replacement therapy and as an hormonal antineoplastic agent %28%ANTINEOPLASTIC AGENTS, HORMONAL%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic hormone with anabolic and androgenic properties and moderate progestational activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002%29%, this compound may reasonably be anticipated to be a carcinogen. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic hormone with anabolic and androgenic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic mineralocorticoid with anti-inflammatory activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic nonapeptide %28%Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro%29% which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of TUBOCURARINE, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. %28%From AMA Drug Evaluations Annual, 1992, p198%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, diethylstilbestrol has been listed as a known carcinogen. %28%Merck, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic polymer which agglutinates red blood cells. It is used as a heparin antagonist.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1995%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic polypeptide with adrenocorticotropic %28%CORTICOTROPIN%29% activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic pregnadiene compound with anti-aldosterone activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic pregnadiene derivative with anti-aldosterone activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or %28%+-%29%-form has about half the potency of the levo form %28%LEVONORGESTREL%29%. Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or %28%+-%29%-isomer %28%NORGESTREL%29%. It is used for contraception, control of menstrual disorders, and treatment of endometriosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestational hormone without significant estrogenic or androgenic properties. It was formerly used as the progestational component in oral sequential contraceptives.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid that has anabolic and androgenic properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1194%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid that has been used for its anabolic action.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid with anabolic and androgenic properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1188%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid with anabolic properties that are more pronounced than its androgenic effects. It has little progestational activity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1188%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid with estrogenic activity. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid with progestational activity. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic steroid with progestational and contraceptive activities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synthetic, non-steroidal estrogen structurally related to stilbestrol. It is used, usually as the cream, in the treatment of menopausal and postmenopausal symptoms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synuclein that is a major component of LEWY BODIES that plays a role in neurodegeneration and neuroprotection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A synuclein that is closely related to ALPHA-SYNUCLEIN. It may play a neuroprotective role against some of the toxic effects of aggregated ALPHA-SYNUCLEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system containing any combination of computers, computer terminals, printers, audio or visual display devices, or telephones interconnected by telecommunications equipment or cables: used to transmit or receive information. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system in which the functions of the man and the machine are interrelated and necessary for the operation of the system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of artificial or natural drains, generally used for the disposal of liquid wastes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization %28%From ICD-10, p1%29%. The Clinical Modifications, produced by the UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane %28%CELL MEMBRANE%29% or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced %28%ENDOPLASMIC RETICULUM, ROUGH%29%; otherwise it is said to be smooth-surfaced %28%ENDOPLASMIC RETICULUM, SMOOTH%29%. %28%King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of government in which means of production and distribution of goods are controlled by the state.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of government in which there is free and equal participation by the people in the political decision-making process.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of hand gestures used for communication by the deaf or by people speaking different languages.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of medicine which aims at discovering the exact nature of the relationship between the emotions and bodily function, affirming the principle that the mind and body are one.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of medicine, most popular in the 19th century, that advocates the use of indigenous plants in the treatment of specific signs and symptoms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of metabolic interactions by products produced in the distal nephron of the KIDNEY. These products include KALLIKREIN; KININS; KININASE I; KININASE II; and ENKEPHALINASE. This system participates in the control of renal functions. It interacts with the RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM to regulate BLOOD PRESSURE, generation of PROSTAGLANDINS, release of VASOPRESSINS, and WATER-ELECTROLYTE BALANCE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of neurons that has the specialized function to produce and secrete hormones, and that constitutes, in whole or in part, an endocrine organ or system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of organs and tissues that process and transport immune cells and LYMPH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of physical units in which the fundamental quantities are length, time, mass, electric current, temperature, luminous intensity, and amount of substance, and the corresponding units are the meter, second, kilogram, ampere, kelvin, candela, and mole. The system has been given official status and recommended for universal use by the General Conference on Weights and Measures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of record keeping in which a list of the patient%27%s problems is made and all history, physical findings, laboratory data, etc. pertinent to each problem are placed under that heading.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of therapeutics founded by Samuel Hahnemann %28%1755-1843%29%, based on the Law of Similars where %22%like cures like%22%. Diseases are treated by highly diluted substances that cause, in healthy persons, symptoms like those of the disease to be treated. The dilutions are repeated so many times that there is less than one molecule per dose and it is suggested that benefit is from the energetic life force of the original substance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of therapy and medicine based on the theory that the normal body is a vital mechanical organism whose structural and functional states are of equal importance and is capable of making its own remedies against infections and toxic conditions when there are favorable environmental circumstances and adequate nutrition.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of traditional medicine which is based on the beliefs and practices of the African peoples. It includes treatment by medicinal plants and other materia medica as well as by the ministrations of diviners, medicine men, witch doctors, and sorcerers.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of traditional medicine which is based on the beliefs and practices of the Tibetan culture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of traditional medicine which is based on the customs, beliefs and practices of the Oriental people.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system of vessels in which blood, after passing through one capillary bed, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system using beamed and reflected radio signals to and from an object in such a way that range, bearing, and other characteristics of the object may be determined.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A system which emphasizes that experience and behavior contain basic patterns and relationships which cannot be reduced to simpler components; that is, the whole is greater than the sum of its parts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systematic collection of factual data pertaining to dental or oral health and disease in a human population within a given geographic area.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels. The text may be cursive or in outline form but is generally a comprehensive guide to problems and approaches in any field of activity. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES is available.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic agricultural fungicide and seed treatment agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic agricultural fungicide used for control of certain fungal diseases of stone fruit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic autoimmune vasculitis occurring primarily in people over the age of 50. Pathologic features include a necrotizing panarteritis including granulomas and giant cells. There is a predilection for involvement of central nervous system blood vessels and the most frequent neurologic complication is an OPTIC NEUROPATHY, ISCHEMIC. Large blood vessels may become involved, including the aorta. Clinical manifestations may include myalgias, weight loss, headache, visual loss, necrosis of the skin or tongue, and chest discomfort. Superficial scalp arteries may become tender and enlarged. A related condition, juvenile temporal arteritis, tends to occur in the first or second decade of life. %28%From Adams et al., Principles of Neurology, 6th ed, p856%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic infection of various salmonid and a few nonsalmonid fishes caused by Viral hemorrhagic septicemia virus %28%see NOVIRHABDOVIRUS%29%,%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of livedo reticularis, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers %28%see also ANTIPHOSPHOLIPID SYNDROME%29%, cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media. %28%From Jablonski, Dictionary of Syndromes %26% Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54%28%1%29%:53-60%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic non-venereal infection of the tropics caused by Treponema pallidum subspecies pertenue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A systemic response to infection, defined as hypothermia or hyperthermia, tachycardia, tachypnea, a clinically evident focus of infection or positive blood cultures, one or more end organs with either dysfunction or inadequate perfusion, cerebral dysfunction, hypoxemia, increased plasma lactate or unexplained metabolic acidosis, and oliguria. It is one of the most common causes of adult respiratory distress syndrome %28%RESPIRATORY DISTRESS SYNDROME, ADULT%29%. %28%Segen, Dictionary of Modern Medicine, 1992%29% While usually related to infection, it can also be associated with noninfectious insults such as trauma, burns, pancreatitis. %28%JAMA 1995;273%28%2%29%:155-6%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tachycardia arising from the sinus node region and characterized by rates between 115 and 140 beats per minute. It is paroxysmal rather than constant.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tachycardia arising in the conduction tissues surrounding the atrioventricular node. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication. The rate may range from 140 to 250 beats per minute.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tachycardia characterized by rates between 150 and 250 beats per minute and a QRS complex of supraventricular origin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tachycardia originating in the atrial myocardium and characterized by rates between 135 and 175 beats per minute.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technetium diagnostic aid used in renal function determination.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. %28%From McGraw-Hill Encyclopedia of Science and Technology, 7th edition%29% Electron nuclear double resonance %28%ENDOR%29% spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications such as MAGNETIC RESONANCE IMAGING.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique encompassing morphometry, densitometry, neural networks, and expert systems that has numerous clinical and research applications and is particularly useful in anatomic pathology for the study of malignant lesions. The most common current application of image cytometry is for DNA analysis, followed by quantitation of immunohistochemical staining.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for analysis of the chemical composition of molecules. A substance is bombarded with monochromatic ELECTRONS. Some of the electrons passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The energy loss is element dependent. Analysis of the energy loss spectrum reveals the elemental composition of a specimen. ENERGY-FILTERED TRANSMISSION ELECTRON MICROSCOPY is a type of electron energy loss spectroscopy carried out in electron microscopes specially outfitted to analyze the spectrum of electron energy loss.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for detecting short-lived reactive FREE RADICALS in biological systems by providing a nitrone or nitrose compound for an addition reaction to occur which produces an ELECTRON SPIN RESONANCE SPECTROSCOPY-detectable aminoxyl radical. In spin trapping, the compound trapping the radical is called the spin trap and the addition product of the radical is identified as the spin adduct. %28%Free Rad Res Comm 1990;9%28%3-6%29%:163%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for growing plants in culture solutions rather than in soil. The roots are immersed in an aerated solution containing the correct proportions of essential mineral salts. %28%From Concise Dictionary of Biology, 1990%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for identifying specific DNA sequences that are bound, in vivo, to proteins of interest. It involves formaldehyde fixation of CHROMATIN to crosslink the DNA-BINDING PROTEINS to the DNA. After shearing the DNA into small fragments, specific DNA-protein complexes are isolated by immunoprecipitation with protein-specific ANTIBODIES. Then, the DNA isolated from the complex can be identified by PCR amplification and sequencing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for maintaining or growing CELLS in vitro. Cultures of dispersed cells derived directly from fresh TISSUES are called primary cell cultures. Cultures may also derive from established CELL LINE usually stored frozen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for maintaining or growing TISSUE in vitro, usually by DIFFUSION, perifusion, or PERFUSION. The tissue is cultured directly after removal from the host without being dispersed for cell culture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. %28%Freshney, Culture of Animal Cells, 3d ed, p1%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for the treatment of neoplasms in which an isotope is introduced into target cells followed by irradiation with thermal neutrons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique for visualizing CHROMOSOME ABERRATIONS using fluorescently labeled DNA probes which are hybridized to chromosomal DNA. Multiple fluorochromes may be attached to the probes. Upon hybridization, this produces a multicolored, or painted, effect with a unique color at each site of hybridization. This technique may also be used to identify cross-species homology by labeling probes from one species for hybridization with chromosomes from another species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique in assisted reproduction %28%REPRODUCTIVE TECHNIQUES, ASSISTED%29% consisting of hormonal stimulation of the ovaries, follicular aspiration of preovulatory oocytes, in-vitro fertilization, and intrafallopian transfer of zygotes at the pronuclear stage %28%before cleavage%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique in which electric pulses of intensity in kilovolts per centimeter and of microsecond-to-millisecond duration cause a temporary loss of the semipermeability of cell membranes, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA. Some applications of electroporation include introduction of plasmids or foreign DNA into living cells for transfection, fusion of cells to prepare hybridomas, and insertion of proteins into cell membranes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique in which tissue is rendered resistant to the deleterious effects of prolonged ischemia and reperfusion by prior exposure to brief, repeated periods of vascular occlusion. %28%Am J Physiol 1995 May;268%28%5 Pt 2%29%:H2063-7, Abstract%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique of closing incisions and wounds, or of joining and connecting tissues, in which staples are used as sutures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimized, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique of respiratory therapy, in either spontaneously breathing or mechanically ventilated patients, in which airway pressure is maintained above atmospheric pressure throughout the respiratory cycle by pressurization of the ventilatory circuit. %28%On-Line Medical Dictionary %5B%Internet%5D%. Newcastle upon Tyne%28%UK%29%: The University Dept. of Medical Oncology: The CancerWEB Project; c1997-2003 %5B%cited 2003 Apr 17%5D%. Available from: http://cancerweb.ncl.ac.uk/omd/%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique that came into use in the mid-1980%27%s for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis %28%usually agarose%29%, then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique that involves the use of electrical coils on the head to generate a brief magnetic field which reaches the CEREBRAL CORTEX. It is coupled with ELECTROMYOGRAPHY response detection to assess cortical excitability by the threshold required to induce MOTOR EVOKED POTENTIALS. This method is also used for BRAIN MAPPING, to study NEUROPHYSIOLOGY, and as a substitute for ELECTROCONVULSIVE THERAPY for treating DEPRESSION. Induction of SEIZURES limits its clinical usage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique that labels specific sequences in whole chromosomes by in situ DNA chain elongation or PCR %28%polymerase chain reaction%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique to arrest the flow of blood by lowering BODY TEMPERATURE to about 20 degrees Centigrade, usually achieved by infusing chilled perfusate. The technique provides a bloodless surgical field for complex surgeries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique used to separate particles according to their densities in a continuous density gradient. The sample is usually mixed with a solution of known gradient materials and subjected to centrifugation. Each particle sediments to the position at which the gradient density is equal to its own. The range of the density gradient is usually greater than that of the sample particles. It is used in purifying biological materials such as proteins, nucleic acids, organelles, and cell types.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique using a pneumatic, high-pressure stream of aluminum oxide to remove DENTAL ENAMEL; DENTIN; and restorative materials from teeth. In contrast to using DENTAL HIGH-SPEED EQUIPMENT, this method usually requires no dental anesthesia %28%ANESTHESIA, DENTAL%29% and reduces risks of tooth chipping and microfracturing. It is used primarily for routine DENTAL CAVITY PREPARATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an excimer laser which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty %28%ANGIOPLASTY, BALLOON, LASER-ASSISTED%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A technique with which an unknown region of a chromosome can be explored. It is generally used to isolate a locus of interest for which no probe is available but that is known to be linked to a gene which has been identified and cloned. A fragment containing a known gene is selected and used as a probe to identify other overlapping fragments which contain the same gene. The nucleotide sequences of these fragments can then be characterized. This process continues for the length of the chromosome.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A telecommunication system combining the transmission of a document scanned at a transmitter, its reconstruction at a receiving station, and its duplication there by a copier.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A temperate coliphage, in the genus Mu-like Viruses, family MYOVIRIDAE, composed of a linear, double-stranded molecule of DNA, which is able to insert itself randomly at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial operon at the site of insertion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A temperate inducible phage and type species of the genus lambda-like Viruses, in the family SIPHOVIRIDAE. Its natural host is E. coli K12. Its virion contains linear double-stranded DNA with single-stranded 12-base 5%27% sticky ends. The DNA circularizes on infection.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tentative species in the genus HEPATOVIRUS infecting primarily young chicks, but also found in turkeys, pheasants, and guinea fowl. It causes a fatal neuronal degeneration and is transmitted by mechanical contact.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tentative species in the genus lambda-like Viruses, family SIPHOVIRIDAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER %28%e.g., SEPSIS%29%. This condition occurs primarily in neonates %28%INFANT, NEWBORN%29%, but may rarely occur in adults. %28%Menkes, Textbook of Child Neurology, 5th ed, p613%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques %28%morphea%29%, bands %28%linear%29%, or nodules.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A term used to describe pregnancies that exceed the upper limit of a normal gestational period. In humans, a prolonged pregnancy is defined as one that extends beyond 42 weeks %28%294 days%29% after the first day of the last menstrual period %28%MENSTRUATION%29%, or birth with gestational age of 41 weeks or more.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A territory in north central Australia, east of the state of Queensland. Its capital is Darwin. Originally a part of New South Wales, it was annexed to South Australia in 1863, entered the Commonwealth as part of it in 190l, transferred to the Commonwealth in 1911, divided in 1927, but was reestablished in 1931. It was granted self government within the Commonwealth of Australia in 1978. %28%From Webster%27%s New Geographical Dictionary, 1988, p864%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A territory of Australia consisting of Canberra, the national capital and surrounding land. It lies geographically within NEW SOUTH WALES and was established by law in 1988.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A territory of northwest Canada, bounded on the north by the Arctic Ocean, on the south by British Columbia, and on the west by Alaska. Its capital is Whitehorse. It takes its name from the Yukon River, the Indian yu-kun-ah, meaning big river. %28%From Webster%27%s New Geographical Dictionary, 1988, p1367 %26% Room, Brewer%27%s Dictionary of Names, 1992, p608%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake %28%75 or 100 g%29% or intravenous infusion %28%0.5 g/kg%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A test to determine the lowest sound intensity level at which fifty percent or more of the spondaic test words %28%words of two syllables having equal stress%29% are repeated correctly.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A test used to determine whether or not complementation %28%compensation in the form of dominance%29% will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tetradecapeptide originally obtained from the skins of toads Bombina bombina and B. variegata. It is also an endogenous neurotransmitter in many animals including mammals. Bombesin affects vascular and other smooth muscle, gastric secretion, and renal circulation and function.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tetraiodofluorescein used as a red coloring in some foods %28%cherries, fish%29%, as a disclosure of DENTAL PLAQUE, and as a stain of some cell types. It has structural similarity to THYROXINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits %28%LDH-A, LDH-B and LDH-C%29% exist.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A theorem in probability theory named for Thomas Bayes %28%1702-1761%29%. In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihoods of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A theoretical psychoanalytical system centered around symbols of the unconscious with the unconscious material derived from two sources - the personal unconscious %28%repressed or forgotten experiences, thoughts and feelings%29% and the collective or objective unconscious %28%the universal inherited qualities which dispose individuals to behave in ways similar to their ancestors%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A theoretical representative nucleotide or amino acid sequence in which each nucleotide or amino acid is the one which occurs most frequently at that site in the different sequences which occur in nature. The phrase also refers to an actual sequence which approximates the theoretical consensus. A known CONSERVED SEQUENCE set is represented by a consensus sequence. Commonly observed supersecondary protein structures %28%AMINO ACID MOTIFS%29% are often formed by conserved sequences.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A theoretical technique utilizing a group of related constructs to describe or prescribe how individuals or groups of people choose a course of action when faced with several alternatives and a variable amount of knowledge about the determinants of the outcomes of those alternatives.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient%27%s condition. Salvage therapy is most often used for neoplastic diseases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thermogenic form of adipose tissue found in newborns of many species, including humans, and in hibernating mammals. The tissue is capable of rapid liberation of energy and seems to be important in the maintenance of body temperature immediately after birth and upon waking from hibernation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thermostable extracellular metalloendopeptidase containing four calcium ions. %28%Enzyme Nomenclature, 1992%29% 3.4.24.27.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thermotolerant, cyst-forming, anoxygenic photosynthetic species, in the genus RHODOSPIRILLUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiamine antagonist due to its inhibition of thiamine pyrophosphorylation. It is used to produce thiamine deficiency.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p812%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p822%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p826%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p810%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p825%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiazide diuretic with properties similar to those of HYDROCHLOROTHIAZIDE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p830%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thick mass of ICE formed over large regions of land, RIVERS, lakes, ponds, or SEAWATER.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thick-rooted perennial %28%Cichorium intybus%29% native to Europe but widely grown for its young leaves used as salad greens and for its roots, dried and ground-roasted, used to flavor or adulterate coffee. %28%From Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thin layer of cells forming the outer integument of seed plants and ferns. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thin lining of closed cavities of the body, consisting of a single layer of squamous epithelial cells %28%MESOTHELIUM%29% resting on a thin layer of CONNECTIVE TISSUE, and covered with secreted clear fluid from blood and lymph vessels. Major serous membranes in the body include PERICARDIUM; PERITONEUM; and PLEURA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thin membrane that lines the ventricles of the brain and the central canal of the SPINAL CORD.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thin protein film on the surface of DENTAL ENAMEL. It is widely believed to result from the selective adsorption of precursor proteins present in SALIVA onto tooth surfaces, and to reduce microbial adherence to the TEETH.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thin-walled, glandular stomach found in birds. It precedes the gizzard.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioester hydrolase which acts on esters formed between thiols such as DITHIOTHREITOL or GLUTATHIONE and the C-terminal glycine residue of UBIQUITIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioglucose derivative used as an antirheumatic and experimentally to produce obesity in animals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiol-containing amino acid formed by a demethylation of METHIONINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiol-containing non-essential amino acid that is oxidized to form CYSTINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiosemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens. Thiacetazone containing regimens are less effective than the short-course regimen recommended by the International Union Against Tuberculosis and are used in some developing countries to reduce drug costs. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p217%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiourea antithyroid agent that inhibits the synthesis of thyroid hormone. It is used in the treatment of hyperthyroidism.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thiourea antithyroid agent. Propythiouracil inhibits the synthesis of thyroxine and inhibits the peripheral conversion of throxine to tri-iodothyronine. It is used in the treatment of hyperthyroidism. %28%From Martindale, The Extra Pharmacopeoia, 30th ed, p534%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p595%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thioxanthine with effects similar to the phenothiazine antipsychotics.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased PHOSPHOLIPASE C and increased PHOSPHOLIPASE A2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thrombin-like enzyme from the venom of snakes of the viper/rattlesnake group. Species variants of the enzyme include ANCROD %28%Agkistrodon rhodostoma %28%Malayan pit viper%29%%29%; BATROXOBIN from Bothrops atrox; and crotalase from Crotalus adamanteus %28%Eastern diamondback rattlesnake%29%. EC 3.4.21.74.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thrombo-obliterative process of the great vessels stemming from the aortic arch, occurring generally in young women. Radial and carotid pulses are typically obliterated. Skin changes are due to the disturbed circulation. There may be loss of hair and atrophy of the skin and its appendages with underlying muscle atrophy. %28%Andrews%27% Diseases of the Skin, 8th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1271%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tick-borne disease characterized by FEVER; HEADACHE; myalgias; ANOREXIA; and occasionally RASH. It is caused by several bacterial species and can produce disease in DOGS; CATTLE; SHEEP; GOATS; HORSES; and humans. The primary species causing human disease are EHRLICHIA CHAFFEENSIS; ANAPLASMA PHAGOCYTOPHILUM; and Ehrlichia ewingii.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tick-borne septicemic disease of domestic and wild ruminants caused by EHRLICHIA RUMINANTIUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tissue adhesive that is applied as a monomer to moist tissue and polymerizes to form a bond. It is slowly biodegradable and used in all kinds of surgery, including dental.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tissue or organ remaining at physiological temperature during decreased BLOOD perfusion or in the absence of blood supply. During ORGAN TRANSPLANTATION it begins when the organ reaches physiological temperature before the completion of SURGICAL ANASTOMOSIS and ends with reestablishment of the BLOOD CIRCULATION through the tissue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tissue preparation technique that involves the injecting of plastic %28%acrylates%29% into blood vessels or other hollow viscera and treating the tissue with a caustic substance. This results in a negative copy or a solid replica of the enclosed space of the tissue that is ready for viewing under a scanning electron microscope.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tissue-specific subunit of NF-E2 transcription factor that interacts with small MAF PROTEINS to regulate gene expression. P45 NF-E2 protein is expressed primarily in MEGAKARYOCYTES; ERYTHROID CELLS; and MAST CELLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tooth from which the dental pulp has been removed or is necrotic. %28%Boucher, Clinical Dental Terminology, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tooth that is prevented from erupting by a physical barrier, usually other teeth. Impaction may also result from orientation of the tooth in an other than vertical position in the periodontal structures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tooth%27%s loss of minerals, such as calcium in hydroxyapatite from the tooth matrix, caused by acidic exposure. An example of the occurrence of demineralization is in the formation of dental caries.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial wounds, burns, ulcers, and skin infections. Nitrofurazone has also been administered orally in the treatment of trypanosomiasis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical anti-inflammatory glucocorticoid used in DERMATOSES, skin allergies, PSORIASIS, etc.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical dermatologic agent that is used in the treatment of acne vulgaris and several other skin diseases. The drug has teratogenic and other adverse effects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical glucocorticoid used in the treatment of ECZEMA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topical glucocorticoid used in various DERMATOSES. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It is also administered as the valerate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topically applied anti-infective agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A totalitarian system of government in which a single authoritarian party controls state-owned means of production with the professed aim of establishing a classless society.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tough transparent membrane surrounding the OVUM. It is penetrated by the sperm during FERTILIZATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tough, malleable, iron-based alloy containing up to, but no more than, two percent carbon and often other metals. It is used in medicine and dentistry in implants and instrumentation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxic alkaloid found in Amanita muscaria %28%fly fungus%29% and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxic compound, isolated from the Spanish fly or blistering beetle %28%Lytta %28%Cantharis%29% vesicatoria%29% and other insects. It is a potent and specific inhibitor of protein phosphatases 1 %28%PP1%29% and 2A %28%PP2A%29%. This compound can produce severe skin inflammation, and is extremely toxic if ingested orally.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxic dye, chemically related to trinitrophenol %28%picric acid%29%, used in biochemical studies of oxidative processes where it uncouples oxidative phosphorylation. It is also used as a metabolic stimulant. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for: hemagglutinating activity, %26% abrins a-d, the toxic principals each consisting of two peptide chains are held together by disulfide bonds.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxic thiol mercury salt formerly used as a diuretic. It inhibits various biochemical functions, especially in mitochondria, and is used to study those functions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxin produced by SHIGELLA DYSENTERIAE. It is the prototype of class of toxins that inhibit protein synthesis by blocking the interaction of ribosomal RNA; %28%RNA, RIBOSOMAL%29% with PEPTIDE ELONGATION FACTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It is closely related to SHIGA TOXIN produced by SHIGELLA DYSENTERIAE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A toxin produced by certain pathogenic strains of ESCHERICHIA COLI such as ESCHERICHIA COLI O157. It is shares 50-60%25% homology with SHIGA TOXIN and SHIGA-LIKE TOXIN I.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element that constitutes about 27.6%25% of the earth%27%s crust in the form of SILICON DIOXIDE. It does not occur free in nature. Silicon has the atomic symbol Si, atomic number 14, and atomic weight 28.09.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens %28%NTP85-002,1985%29%, chromium and some of its compounds have been listed as known carcinogens.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. %28%From AMA Drug Evaluations Annual 1992, p2035%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element with the atomic symbol B, atomic number 5, and atomic weight 10.81. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS %28%minor tranquilizers%29%, ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS %28%major tranquilizers%29%. These drugs act by different mechanisms and are used for different therapeutic purposes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A traditional term for all the activities which a physician or other health care professional normally performs to insure the coordination of the medical services required by a patient. It also, when used in connection with managed care, covers all the activities of evaluating the patient, planning treatment, referral, and follow-up so that care is continuous and comprehensive and payment for the care is obtained. %28%From Slee %26% Slee, Health Care Terms, 2nd ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trans-carotenoid pigment widely distributed in nature. The compound is used as an oral suntanning agent and as a food and drug coloring agent. Oral ingestion of the compound causes canthaxanthin retinopathy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor found in BACTERIA that positively and negatively regulates the expression of proteins required for the uptake and catabolism of L-ARABINOSE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that controls the expression of variety of proteins including CYTOCHROME C and 5-AMINOLEVULINATE SYNTHETASE. It plays an important role in maintenance of the RESPIRATORY CHAIN of MITOCHONDRIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that dimerizes with CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain and is involved in genetic regulation of skeletal development and CELL DIFFERENTIATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain. Runx1 is frequently mutated in human LEUKEMIAS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that dimerizes with the cofactor CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that is essential for CELL DIFFERENTIATION of B-LYMPHOCYTES. It functions both as a transcriptional activator and repressor to mediate B-cell commitment.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that partners with ligand bound GLUCOCORTICOID RECEPTORS and ESTROGEN RECEPTORS to stimulate GENETIC TRANSCRIPTION. It plays an important role in FERTILITY as well as in METABOLISM of LIPIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that plays a role as a key regulator of HEMATOPOIESIS. Aberrant Ikaros expression has been associated with LYMPHOBLASTIC LEUKEMIAS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that possesses DNA-binding and E2F-binding domains but lacks a transcriptional activation domain. It is a binding partner for E2F TRANSCRIPTION FACTORS and enhances the DNA binding and transactivation function of the DP-E2F complex.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that regulates the expression of a large set of hepatic proteins including SERUM ALBUMIN; beta-fibrinogen; and ALPHA 1-ANTITRYPSIN. It is composed of hetero- or homo-dimers of HEPATOCYTE NUCLEAR FACTOR 1-ALPHA and HEPATOCYTE NUCLEAR FACTOR 1-BETA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcription factor that takes part in the NF-kappa-B complex by interacting with NF-KAPPA B P50 SUBUNIT or NF-KAPPA B P52 SUBUNIT. It regulates GENETIC TRANSCRIPTION that is involved in immune and inflammatory responses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcriptional elongation factor complex that is comprised of a heterodimer of CYCLIN-DEPENDENT KINASE 9 and one of several CYCLINS including cyclin T1, T2 and K. It functions by phosphorylating the carboxy-terminal domain %28%CTD%29% of RNA POLYMERASE II, which results in more processive transcription complexes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transcriptional regulator in prokaryotes which, when activated by binding cyclic AMP, acts at several promoters. Cyclic AMP receptor protein was originally identified as a catabolite gene activator protein. It was subsequently shown to regulate several functions unrelated to catabolism, and to be both a negative and a positive regulator of transcription. Cell surface cyclic AMP receptors are not included %28%CYCLIC AMP RECEPTORS%29%, nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins, which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying alanine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying arginine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying cysteine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying glutamine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying histidine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying isoleucine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying leucine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying lysine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying methionine to sites on the ribosomes. During initiation of protein synthesis, tRNA%28%f%29%Met in prokaryotic cells and tRNA%28%i%29%Met in eukaryotic cells binds to the start codon %28%CODON, INITIATOR%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying serine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying tryptophan to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying tyrosine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transfer RNA which is specific for carrying valine to sites on the ribosomes in preparation for protein synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transferase that catalyzes the addition of aliphatic, aromatic, or heterocyclic FREE RADICALS as well as EPOXIDES and arene oxides to GLUTATHIONE. Addition takes place at the SULFUR. It also catalyzes the reduction of polyol nitrate by glutathione to polyol and nitrite.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transient absence of spontaneous respiration. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transient and intermittent type of arrhythmia with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with digitalis toxicity. Suppressive therapy is rarely necessary because the ventricular rate is generally less than 100 beats per minute.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transient dilatation of the lymphatic vessels. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transient increase in the number of leukocytes in a body fluid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transient loss of consciousness and postural tone caused by diminished blood flow to the brain %28%i.e., BRAIN ISCHEMIA%29%. Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. %28%From Adams et al., Principles of Neurology, 6th ed, pp367-9%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transient reddening of the face that may be due to fever, certain drugs, exertion, stress, or a disease process.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transition zone in the anterior part of the diencephalon interposed between the thalamus, hypothalamus, and tegmentum of the mesencephalon. Components of the subthalamus include the SUBTHALAMIC NUCLEUS, zona incerta, nucleus of field H, and the nucleus of ansa lenticularis. The latter contains the ENTOPEDUNCULAR NUCLEUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transitional diencephalic zone of the thalamus consisting of complex and varied cells lying caudal to the ventral posterolateral nucleus, medial to the rostal part of the pulvinar, and dorsal to the medial geniculate body. It contains the limitans, posterior, suprageniculate, and submedial nuclei.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmembrane domain containing ephrin that binds with high affinity to EPHB1 RECEPTOR; EPHB3 RECEPTOR; and EPHB4 RECEPTOR. Expression of ephrin-B2 occurs in a variety of adult tissues. During embryogenesis, high levels of ephrin-B2 is seen in the PROSENCEPHALON; RHOMBENCEPHALON; developing SOMITES; LIMB BUD; and bronchial arches.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmembrane domain containing ephrin that is specific for EPHB1 RECEPTOR; EPHB2 RECEPTOR and EPHB3 RECEPTOR. It is widely expressed in a variety of developing and adult tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmembrane domain containing ephrin. Although originally found to be specific for the EPHB3 RECEPTOR it has since been shown to bind a variety of EPH FAMILY RECEPTORS. During embryogenesis ephrin-B3 is expressed at high levels in the ventral neural tube. In adult tissues, it is found primarily in the BRAIN and HEART.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmembrane glycoprotein subunit that can dimerize with a variety of light chain subunits %28%ANTIGENS, CD98 LIGHT CHAINS%29%. This protein subunit serves a diverse array of functions including amino acid transport and cell fusion. Its function is altered depending which of the light chain subunits it interacts with.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmissible spongiform encephalopathy %28%prion disease%29% of DEER and elk characterized by chronic weight loss leading to death. It is thought to spread by direct contact between animals or through environmental contamination with the prion protein %28%PRIONS%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmissible spongiform encephalopathy of cattle associated with abnormal prion proteins in the brain. Affected animals develop excitability and salivation followed by ATAXIA. This disorder has been associated with consumption of SCRAPIE infected ruminant derived protein. This condition may be transmitted to humans, where it is referred to as variant or new variant CREUTZFELDT-JAKOB SYNDROME. %28%Vet Rec 1998 Jul 25;143%28%41%29%:101-5%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transmissible viral disease of birds caused by avian herpesvirus 2 %28%HERPESVIRUS 2, GALLID%29% and other MAREK%27%S DISEASE-LIKE VIRUSES. There is lymphoid cell infiltration or lymphomatous tumor formation in the peripheral nerves and gonads, but may also involve visceral organs, skin, muscle, and the eye.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor %28%VITREOUS BODY%29%. It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A treatment method in which patients are under direct observation when they take their medication or receive their treatment. This method is designed to reduce the risk of treatment interruption and to ensure patient compliance.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A treatment modality in endodontics concerned with the therapy of diseases of the dental pulp. For preparatory procedures, ROOT CANAL PREPARATION is available.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A treatment program based on manipulation of the patient%27%s environment by the medical staff. The patient does not participate in planning the treatment regimen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A treatment technique utilizing play as a medium for expression and communication between patient and therapist.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tree of the family Sterculiaceae %28%or Byttneriaceae%29%, usually Theobroma cacao, or its seeds, which after fermentation and roasting, yield cocoa and chocolate.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tree, Cinnamomum camphora %28%L.%29% J. Presl, known as the source of CAMPHOR.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tri-benzene-ammonium usually compounded with zinc chloride. It is used as a biological stain and for the dyeing and printing of textiles.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triad of nongonococcal urethritis followed by conjunctivitis and arthritis, of unknown etiology.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triangular double membrane separating the anterior horns of the lateral ventricles of the brain. It is situated in the median plane and bounded by the corpus callosum and the body and columns of the fornix.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triazine herbicide. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triazine used as a selective pre- and post-emergence herbicide. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. %28%From AMA Drug Evaluations Annual, 1994, p238%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tribe of gram-negative bacteria of the family RICKETTSIACEAE whose organisms are found in arthropods and are pathogenic for man and certain other vertebrate hosts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclic antidepressant that has actions and uses similar to those of AMITRIPTYLINE, but has only weak antimuscarinic and sedative effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p257%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclic antidepressant with actions similar to AMITRIPTYLINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclic antidepressant with some tranquilizing action.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA. It is used as a fluorescent dye and as an antineoplastic agent, especially in bone and testicular tumors. Plicamycin is also used to reduce hypercalcemia, especially that due to malignancies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricyclo bridged hydrocarbon. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triglyceride that is used as an antifungal agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trihydroxy bile salt that is used as a digestive aid in dietary supplements. It is used in culture media and in conjunction with PAPAIN and PANCREATIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trimeric peptide initiation factor complex that associates with the 5%27% MRNA CAP STRUCTURE of RNA and plays an essential role in MRNA TRANSLATION. It is composed of EUKAYROTIC INITIATION FACTOR-4A; EUKARYOTIC INITIATION FACTOR-4E; and EUKAYROTIC INITIATION FACTOR-4G.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tripeptide hormone that originates in the HYPOTHALAMUS and stimulates the secretion of THYROTROPIN from the PITUITARY GLAND. In humans, it also acts as a prolactin-releasing factor. It is also a neurotransmitter in the central nervous system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A triphosphate nucleotide analog which is the biologically active form of CYTARABINE. It inhibits nuclear DNA synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trisaccharide occurring in Australian manna %28%from Eucalyptus spp, Myrtaceae%29% and in cottonseed meal.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A true cyst of the PANCREAS, distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a lining of mucous EPITHELIUM. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of PANCREATIC DUCTS secondary to ductal obstruction. %28%From Bockus Gastroenterology, 4th ed, p4145%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They may be solid or cystic and are classified histologically as mature, immature, and malignant. %28%From Dorland, 27th ed %26% DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1642%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trypanosome found in the blood of adult rats and transmitted by the rat flea. It is generally non-pathogenic in adult rats but can cause lethal infection in suckling rats.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tube that transports URINE from the BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tube-like invagination of the EPIDERMIS from which the hair shaft develops and into which SEBACEOUS GLANDS open. The hair follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. %28%Stedman, 26th ed%29% Follicles of very long hairs extend into the subcutaneous layer of tissue under the SKIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tubulointerstitial disease of unknown etiology occurring in a limited geographic area including adjacent regions of Romania, Bulgaria, and Yugoslavia.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor composed of cells resembling those of the hair matrix, which undergo %27%mummification%27% and may calcify. It is a relatively uncommon tumor, which may occur at any age from infancy. The majority of patients are under 20, and females are affected more than males. The lesion is usually a solitary deep dermal or subcutaneous tumor 3-30 mm in diameter, situated in the head, neck, or upper extremity. %28%From Rook et al., Textbook of Dermatology, 4th ed, p2401%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1364%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor derived from branchial epithelium or branchial rests. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor derived from eccrine sweat duct epithelium which may be intra-epidermal %28%hidro-acanthoma simplex%29%, juxta-epidermal %28%eccrine poroma%29% or intradermal %28%dermal duct tumor%29%. They are comparatively uncommon. There is no indication that heredity or external agents cause these tumors. %28%Rook et al., Textbook of Dermatology, 4th ed, p2409%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor derived from mesothelial tissue %28%peritoneum, pleura, pericardium%29%. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor made up of nerve cells and nerve fibers. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor necrosis factor family member that is released by LYMPHOCYTES activated by ANTIGENS or T-cell MITOGENS. Lymphotoxin is antigenically distinct from TUMOR NECROSIS FACTOR-ALPHA, though they both share common receptors, biological activities, and significant amino acid sequence homology.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor necrosis factor receptor subtype that is constitutively expressed in most tissues. It is the key mediator of tumor necrosis factor signaling in the vast majority of cells. The activated receptor signals by associating with TNF RECEPTOR-ASSOCIATED FACTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor necrosis factor receptor subtype that is expressed primarily in IMMUNE SYSTEM cells. It has specificity for membrane-bound form of TUMOR NECROSIS FACTORS and mediates intracellular-signaling through TNF RECEPTOR ASSOCIATED FACTORS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21%25% of the malignant tumors of the parotid gland and 10%25% of the sublingual gland. They are the most common malignant tumor of the parotid. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. These tumors are thought to have %22%borderline%22% aggression, where one-third develop local recurrences, but only rarely metastasize. It is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to Kimura%27%s disease %28%see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA%29%. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor of undifferentiated %28%anaplastic%29% cells of large size. It is usually bronchogenic. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor suppressor gene %28%GENES, TUMOR SUPPRESSOR%29% located on human chromosome 13 at locus 13q12.3. Mutations in this gene predispose humans to breast and ovarian cancer. It encodes a large, nuclear protein that is an essential component of DNA repair pathways, suppressing the formation of gross chromosomal rearrangements. %28%from Genes Dev 2000;14%28%11%29%:1400-6%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor suppressor gene %28%GENES, TUMOR SUPPRESSOR%29% located on human chromosome 17 at locus 17q21. Mutations of this gene are associated with the formation of familial breast and ovarian cancer. It encodes a large, nuclear protein that is a component of DNA repair pathways.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor that secretes VASOACTIVE INTESTINAL PEPTIDE, a neuropeptide that causes VASODILATION; relaxation of smooth muscles; watery DIARRHEA; HYPOKALEMIA; and HYPOCHLORHYDRIA. Vipomas, derived from the pancreatic ISLET CELLS, generally are malignant and can secrete other hormones. In most cases, Vipomas are located in the PANCREAS but can be found in extrapancreatic sites.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. %28%Holland et al., Cancer Medicine, 3d ed, p1703%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumor-like mass resulting from the enlargement of a tuberculous lesion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tumorlike condition characterized by smooth muscle and endothelium proliferation of lymphatic vessels and lymph nodes in the mediastinum and retroperitoneum, also in the lung. It may be manifested by chylous pleural effusion and ascites.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A twisting in the intestine %28%INTESTINES%29% that can cause INTESTINAL OBSTRUCTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A twisting or rotation of a bodily part or member on its axis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A two-person sport in which the fists are skillfully used to attack and defend.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A two-year program in nursing education in a community or junior college leading to an A.D. %28%Associate Degree%29%. Graduates of this program are eligible for state examination for licensure as RN %28%Registered Nurse%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type I interferon with antiviral and antineoplastic activity produced by recombinant DNA technology. It can be a mixture of alpha and beta interferons.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type II interferon produced by recombinant DNA technology. It is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of CARTILAGE characterized by a homogenous amorphous matrix containing predominately TYPE II COLLAGEN and ground substance. Hyaline cartilage is found in ARTICULAR CARTILAGE; LARYNGEAL CARTILAGES; and the NASAL SEPTUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of CARTILAGE whose matrix contains ELASTIC FIBERS and elastic lamellae, in addition to the normal components of HYALINE CARTILAGE matrix. Elastic cartilage is found in the EXTERNAL EAR; EUSTACHIAN TUBE; EPIGLOTTIS; and LARYNX.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of CARTILAGE whose matrix contains large bundles of COLLAGEN TYPE I. Fibrocartilage is typically found in the INTERVERTEBRAL DISK; SYMPHYSIS PUBIS; TIBIAL MENISCI; and articular disks in synovial JOINTS. %28%From Ross et. al., Histology, 3rd ed., p132,136%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication %28%S PHASE%29% result in daughter cells with half the number of CHROMOSOMES as the parent cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of COUMARINS with added pyran ring%28%s%29%. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of FLUORESCENCE SPECTROSCOPY using two FLUORESCENT DYES with overlapping emission and absorption spectra, which is used to indicate proximity of labeled molecules. This technique is useful for studying interactions of molecules and PROTEIN FOLDING.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of HUMAN PAPILLOMAVIRUS causing recurrent respiratory PAPILLOMATOSIS; GENITAL WARTS; and other neoplasms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of HUMAN PAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of HUMAN PAPILLOMAVIRUS especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of HUMAN PAPILLOMAVIRUS usually associated with GENITAL WARTS; and LARYNGEAL NEOPLASMS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles %28%MUSCLE, SMOOTH%29% or the NERVOUS SYSTEM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of MAGNETIC RESONANCE IMAGING that uses only one nuclear spin excitation per image and therefore can obtain images in a fraction of a second rather than the minutes required in traditional MRI techniques. It is used in a variety of medical and scientific applications.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of MONOTERPENES, derived from geraniol. They have the general form of cyclopentanopyran, but in some cases, one of the rings is broken as in the case of secoiridoid. They are different from the similarly named iridals %28%TRITERPENES%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of TRANSMISSION ELECTRON MICROSCOPY in which the object is examined directly by an extremely narrow electron beam scanning the specimen point-by-point and using the reactions of the electrons that are transmitted through the specimen to create the image. It should not be confused with SCANNING ELECTRON MICROSCOPY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures ends in keloidal scarring. It manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. It is most often encountered in black or Asian men.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects %28%e.g., age-matched controls%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of asbestos that occurs in nature as the dihydrate of magnesium silicate. It exists in two forms: antigorite, a plated variety, and chrysotile, a fibrous variety. The latter makes up 95%25% of all asbestos products. %28%From Merck Index, 11th ed, p.893%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of chromosomal aberration which may result from spontaneous or induced breakage. ALKYLATING AGENTS and other chemical MUTAGENS, and various types of RADIATION have been found to cause chromosomal breakage. Breakage can result in translocation; CHROMOSOME INVERSION; or SEQUENCE DELETION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of climate characterized by insufficient moisture to support appreciable plant life. It is a climate of extreme aridity, usually of extreme heat, and of negligible rainfall. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of connective tissue neoplasm arising from intralobular stroma of the BREAST. It is characterized by the rapid enlargement of an asymmetric firm mobile mass. Histologically, its leaf-like stromal clefts are lined by EPITHELIAL CELLS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of crystallin that has been found in the lens %28%LENS, CRYSTALLINE%29% of certain species of MOLLUSCA such as SQUID and OCTOPUS. It is an inactivated form of aldehyde dehydrogenase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of crystallin that has been found in the lens %28%LENS, CRYSTALLINE%29% of certain species of VERTEBRATES. They are inactivated form of PHOSPHOPYRUVATE HYDRATASE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of defective gonadal development in patients with a wide spectrum of chromosomal mosaic variants. Their karyotypes are of partial sex chromosome monosomy resulting from an absence or an abnormal second sex chromosome %28%X or Y%29%. Karyotypes include 45,X/46,XX; 45,X/46,XX/47,XXX; 46,XXp-; 45,X/46,XY; 45,X/47,XYY; 46,XYpi; etc. The spectrum of phenotypes may range from phenotypic female through pseudohermaphrodite to phenotypic male, depending on the ratio in each gonad of 45,X primordial germ cells to those with normal 46,XX or 46,XY constitution.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of diabetes mellitus that is characterized by a paucity of adipose tissue %28%LIPODYSTROPHY%29% and severe INSULIN RESISTANCE. There are several forms involving any one of a number of genes encoding nuclear protein LAMIN TYPE A; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; or other proteins.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of ectopic pregnancy in which the EMBRYO implants in the ABDOMINAL CAVITY instead of in the ENDOMETRIUM of the UTERUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of endoplasmic reticulum %28%ER%29% where polyribosomes are present on the cytoplasmic surfaces of the ER membranes. This form of ER is prominent in cells specialized for protein secretion and its principal function is to segregate proteins destined for export or intracellular utilization.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of endoplasmic reticulum lacking associated ribosomes on the membrane surface. It exhibits a wide range of specialized metabolic functions including supplying enzymes for steroid synthesis, detoxification, and glycogen breakdown. In muscle cells, smooth endoplasmic reticulum is called SARCOPLASMIC RETICULUM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of extracellularly deposited substance composed of an amyloid protein and additional components including HEPARAN SULFATE PROTEOGLYCAN; LAMININ; COLLAGEN TYPE IV; SERUM AMYLOID P-COMPONENT; and APOLIPOPROTEINS E which together form characteristic amyloid fibrils. The core of amyloid fibrils is formed by the stacking of overlapping beta-pleated sheet domains of the amyloid protein. There are many different amyloid proteins that have been found forming the core of the fibrils in vivo. However, amyloid can be formed from any protein that exposes beta-pleated strand conformations during unfolding or refolding. A common characteristic of amyloid is the ability to bind such dyes as CONGO RED and thioflavine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of fibrous joint between bones of the head. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of fluent aphasia characterized by an impaired ability to repeat one and two word phrases, despite retained comprehension. This condition is associated with dominant hemisphere lesions involving the arcuate fasciculus %28%a white matter projection between Broca%27%s and Wernicke%27%s areas%29% and adjacent structures. Like patients with Wernicke aphasia %28%APHASIA, WERNICKE%29%, patients with conduction aphasia are fluent but commit paraphasic errors during attempts at written and oral forms of communication. %28%From Adams et al., Principles of Neurology, 6th ed, p482; Brain %26% Bannister, Clinical Neurology, 7th ed, p142; Kandel et al., Principles of Neural Science, 3d ed, p848%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo MRI sequence with retrospective ECG-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualized.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of ion exchange chromatography using diethylaminoethyl cellulose %28%DEAE-CELLULOSE%29% as a positively charged resin. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of irritant dermatitis localized to the area in contact with a diaper and occurring most often as a reaction to prolonged contact with urine, feces, or retained soap or detergent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. %28%From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of massage in which finger pressure on specific body sites is used to promote healing, relieve fatigue, etc. Although the anatomical locations are the same as the ACUPUNCTURE POINTS used in ACUPUNCTURE THERAPY %28%hence acu-%29%, no needle or other acupuncture technique is employed in acupressure. %28%From Random House Unabridged Dictionary, 2d ed%29%. Shiatsu is a modern outgrowth that focuses more on prevention than healing.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of mutation in which a number of NUCLEOTIDES not divisible by three is deleted from or inserted into a protein coding sequence, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of neurofibroma manifesting as a diffuse overgrowth of subcutaneous tissue, usually involving the face, scalp, neck, and chest but occasionally occurring in the abdomen or pelvis. The tumors tend to progress, and may extend along nerve roots to eventually involve the spinal roots and spinal cord. This process is almost always a manifestation of NEUROFIBROMATOSIS 1. %28%From Adams et al., Principles of Neurology, 6th ed, p1016; J Pediatr 1997 Nov;131%28%5%29%:678-82%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of oropharyngeal airway that provides an alternative to endotracheal intubation and standard mask anesthesia in certain patients. It is introduced into the hypopharynx to form a seal around the larynx thus permitting spontaneous or positive pressure ventilation without penetration of the larynx or esophagus. It is used in place of a facemask in routine anesthesia. The advantages over standard mask anesthesia are better airway control, minimal anesthetic gas leakage, a secure airway during patient transport to the recovery area, and minimal postoperative problems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of osteochondritis in which articular cartilage and associated bone becomes partially or totally detached to form joint loose bodies. Affects mainly the knee, ankle, and elbow joints.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of pancreatic cell representing about 5-20%25% of the islet cells. Alpha cells secrete GLUCAGON.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of pancreatic cell representing about 50-80%25% of the islet cells. Beta cells secrete INSULIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of panniculitis characterized histologically by the presence of granulomas, vasculitis, and necrosis. It is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. It is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. The nodules may progress to form indurations, ulcerations, and scars.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of pneumonia resulting from the aspiration of food, liquid, or gastric contents into the upper respiratory tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of porcelain used in dental restorations, either jacket crowns or inlays, artificial teeth, or metal-ceramic crowns. It is essentially a mixture of particles of feldspar and quartz, the feldspar melting first and providing a glass matrix for the quartz. Dental porcelain is produced by mixing ceramic powder %28%a mixture of quartz, kaolin, pigments, opacifiers, a suitable flux, and other substances%29% with distilled water. %28%From Jablonski%27%s Dictionary of Dentistry, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of refractive surgery of the CORNEA to correct MYOPIA and ASTIGMATISM. An excimer laser is used directly on the surface of the EYE to remove the CORNEAL EPITHELIUM in order to reshape the anterior curvature of the cornea.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of scanning probe microscopy in which a probe systematically rides across the surface of a sample being scanned in a raster pattern. The vertical position is recorded as a spring attached to the probe rises and falls in response to peaks and valleys on the surface. These deflections produce a topographic map of the sample.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of scanning probe microscopy in which a very sharp conducting needle is swept just a few angstroms above the surface of a sample. The tiny tunneling current that flows between the sample and the needle tip is measured, and from this are produced three-dimensional topographs. Due to the poor electron conductivity of most biological samples, thin metal coatings are deposited on the sample.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of schizophrenia characterized by abnormality of motor behavior which may involve particular forms of stupor, rigidity, excitement or inappropriate posture.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of schizophrenia characterized by frequent incoherence; marked loosening of associations, or grossly disorganized behavior and flat or grossly inappropriate affect that does not meet the criteria for the catatonic type; associated features include extreme social withdrawal, grimacing, mannerisms, mirror gazing, inappropriate giggling, and other odd behavior. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of shock that occurs as a result of a surgical procedure.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. %28%JAMA 1995;273%28%23%29%:1824-30%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tyrosine phosphatase required for progression of the cell cycle. It is required for p34%28%cdc2%29% kinase activation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tyrosine phosphoprotein that plays an essential role in CAVEOLAE formation. It binds CHOLESTEROL and is involved in LIPIDS transport, membrane traffic, and SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A tyrosine-specific protein kinase encoded by the v-src oncogene of Rous sarcoma virus. The transforming activity of pp60%28%v-src%29% depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60%28%v-src%29% to the plasma membrane which is accomplished by myristylation of its N-terminal glycine.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitin-protein ligase that mediates OXYGEN-dependent polyubiquitination of HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT. It is inactivated in VON HIPPEL-LINDAU SYNDROME.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous casein kinase that is comprised of two distinct catalytic subunits and dimeric regulatory subunit. Casein kinase II has been shown to phosphorylate a large number of substrates, many of which are proteins involved in the regulation of gene expression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous family of proteins that transport PHOSPHOLIPIDS such as PHOSPHATIDYLINOSITOL and PHOSPHATIDYLCHOLINE between membranes. They play an important role in phospholipid metabolism during vesicular transport and SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous hnRNP protein found in the CELL NUCLEUS and the CYTOPLASM. Translocations that result in the formation of fusion proteins containing parts of RNA-binding protein EWS may play a role in neoplastic processes such as Ewing Sarcoma %28%SARCOMA, EWING%27%S%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous membrane transport protein found in the plasma membrane of diverse cell types and tissues, and in nuclear, mitochondrial, and Golgi membranes. It is the major integral transmembrane protein of the erythrocyte plasma membrane, comprising 25%25% of the total membrane protein. It exists as a dimer and performs the important function of allowing the efficient transport of bicarbonate across erythrocyte cell membranes in exchange for chloride ion.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous phosphoprotein that serves as an intracellular substrate for a variety of SIGNAL TRANSDUCTION PATHWAYS. PHOSPHORYLATION of stathmin occurs during CELL CYCLE progression, and stathmin functions as a microtubule-destabilizing protein that promotes MICROTUBULE depolymerization during INTERPHASE and late MITOSIS. Stathmin is expressed at very high levels in a variety of human CANCERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous sodium salt that is commonly used to season food. It plays an important biological role in maintaining the osmotic tension of blood and tissues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous sodium-dependent neutral amino acid transporter. The preferred substrates for this transporter system include ALANINE; SERINE; and CYSTEINE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous target SNARE protein that interacts with SYNTAXIN and SYNAPTOBREVIN. It is a core component of the machinery for intracellular MEMBRANE FUSION. The sequence contains 2 SNARE domains, one is the prototype for the Qb-SNARES, and the other is the prototype for the Qc-SNARES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitous, cytoplasmic protein found in mature OLFACTORY RECEPTOR NEURONS of all VERTEBRATES. It is a modulator of the olfactory SIGNAL TRANSDUCTION PATHWAY.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed Sp transcription factor that binds to the consensus DNA sequence GGGCGGGAC.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed complement receptor that binds COMPLEMENT C3B and COMPLEMENT C4B and serves as a cofactor for their inactivation. CD46 also interacts with a wide variety of pathogens and mediates immune response.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed ets proto-oncogene protein that may play a role in regulation of CELL PROLIFERATION and CELL DIFFERENTIATION.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed family of heterotrimeric GTP-binding protein alpha subunits that signal through interactions with a variety of second messengers as GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; and HEAT SHOCK PROTEINS. The G12-G13 part of the name is also spelled G12/G13.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed glucose transporter that is important for constitutive, basal GLUCOSE transport. It is predominately expressed in ENDOTHELIAL CELLS and ERYTHROCYTES at the BLOOD-BRAIN BARRIER and is responsible for GLUCOSE entry into the BRAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed member of the syntaxin subfamily of SNARE proteins that localizes to the GOLGI APPARATUS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed octamer transcription factor that regulates GENETIC TRANSCRIPTION of SMALL NUCLEAR RNA; IMMUNOGLOBULIN GENES; and HISTONE H2B genes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed protein kinase that is involved in a variety of cellular SIGNAL PATHWAYS. Its activity is regulated by a variety of signaling protein tyrosine kinase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed raf kinase subclass that plays an important role in SIGNAL TRANSDUCTION. The c-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed sequence-specific transcriptional repressor that is normally the target of signaling by NOTCH PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the CELL CYCLE. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 2 in that it contains acidic N-terminal amino acid residues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed telomere-binding protein that is present at TELOMERES throughout the cell cycle. It is a suppressor of telomere elongation and may be involved in stabilization of telomere length. It is structurally different from TELOMERIC REPEAT BINDING PROTEIN 1 in that it contains basic N-terminal amino acid residues.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed zinc finger-containing protein that acts both as a repressor and activator of transcription. It interacts with key regulatory proteins such as TATA-BINDING PROTEIN; TFIIB; and ADENOVIRUS E1A PROTEINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously expressed, secreted protein with bone resorption and renal calcium reabsorption activities that are similar to PARATHYROID HORMONE. It does not circulate in appreciable amounts in normal subjects, but rather exerts its biological actions locally. Overexpression of parathyroid hormone-related protein by tumor cells results in humoral calcemia of malignancy.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ubiquitously found basic protein that binds to phosphatidylethanolamine and NUCLEOTIDES. It is an endogenous inhibitor of RAF KINASES and may play a role in regulating SIGNAL TRANSDUCTION. Phosphatidylethanolamine-binding protein is the precursor of hippocampal cholinergic neurostimulating peptide, which is cleaved from the N-terminal region of the protein.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS %28%moniliasis%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The hydrochloride is available as an aid to smoking cessation treatment.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A unifocal malignant tumor that consists of atypical pathological MAST CELLS without systemic involvement. It causes local destructive growth in organs other than in skin or bone marrow.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A union between adjacent bones or parts of a single bone formed by osseous material, such as ossified connecting cartilage or fibrous tissue. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A unique DNA sequence of a replicon at which DNA REPLICATION is initiated and proceeds bidirectionally or unidirectionally. It contains the sites where the first separation of the complementary strands occurs, a primer RNA is synthesized, and the switch from primer RNA to DNA synthesis takes place. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A unisexual reproduction without the fusion of a male and a female gamete %28%FERTILIZATION%29%. In parthenogenesis, an individual is formed from an unfertilized OVUM that did not complete MEIOSIS. Parthenogenesis occurs in nature and can be artificially induced.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A unit or standard of measurement. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. The disorder is caused by a reduction in the activity of hepatic mitochondrial CARBAMOYL-PHOSPHATE SYNTHASE %28%AMMONIA%29%. %28%Menkes, Textbook of Child Neurology, 5th ed, pp50-1%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A urea cycle enzyme that catalyzes the formation of orthophosphate and L-citrulline %28%CITRULLINE%29% from CARBAMOYL PHOSPHATE and L-ornithine %28%ORNITHINE%29%. Deficiency of this enzyme may be transmitted as an X-linked trait. EC 2.1.3.3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ureahydrolase that catalyzes the hydrolysis of arginine or canavanine to yield L-ORNITHINE and urea. Deficiency of this enzyme causes HYPERARGININEMIA. EC 3.5.3.1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A uricosuric and muscle relaxant. Zoxazolamine acts centrally as a muscle relaxant, but the mechanism of its action is not understood.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A urine test for formiminoglutamic acid, an intermediate metabolite in L-histidine catabolism in the conversion of L-histidine to L-glutamic acid. It may be an indicator of vitamin B12 or folic acid deficiency or liver disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually benign neoplasm that arises from the cuboidal epithelium of the choroid plexus and takes the form of an enlarged CHOROID PLEXUS, which may be associated with oversecretion of CSF. The tumor usually presents in the first decade of life with signs of increased intracranial pressure including HEADACHES; ATAXIA; DIPLOPIA; and alterations of mental status. In children it is most common in the lateral ventricles and in adults it tends to arise in the fourth ventricle. Malignant transformation to choroid plexus carcinomas may rarely occur. %28%Adams et al., Principles of Neurology, 6th ed, p667; DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2%25% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. %28%From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1846%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually benign tumor made up predominantly of myoepithelial cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5%25% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1298%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually four-wheeled automotive vehicle designed for passenger transportation and commonly propelled by an internal-combustion engine using a volatile fuel. %28%Webster, 1973%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract %28%and in the lungs and other sites%29%; approximately 90%25% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. %28%From Stedman, 25th ed %26% Holland et al., Cancer Medicine, 3d ed, p1182%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A uterine tumor derived from persistent gestational TROPHOBLASTS, most likely after a molar pregnancy %28%HYDATIDIFORM MOLE%29%. Invasive hyadatiform mole develops in about 15%25% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the MYOMETRIUM and erode uterine vessels causing hemorrhage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. %28%From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A value equal to the total volume flow divided by the cross-sectional area of the vascular bed.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A valve situated at the entrance to the pulmonary trunk from the right ventricle.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variable annual leguminous vine %28%Pisum sativum%29% that is cultivated for its rounded smooth or wrinkled edible protein-rich seeds, the seed of the pea, and the immature pods with their included seeds. %28%From Webster%27%s New Collegiate Dictionary, 1973%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variant of ADENOMATOUS POLYPOSIS COLI caused by mutation in the APC gene %28%GENES, APC%29% on CHROMOSOME 5. It is characterized by not only the presence of multiple colonic polyposis but also extracolonic ADENOMATOUS POLYPS in the UPPER GASTROINTESTINAL TRACT; the EYE; the SKIN; the SKULL; and the FACIAL BONES; as well as malignancy in organs other than the GI tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variant of acute cholecystitis with inflammation of the GALLBLADDER that is characterized by the pockets of gas in the gallbladder wall. It is due to secondary infection caused by gas-forming organisms, and has a high risk of perforation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variant of bullous erythema multiforme. It ranges from mild skin and mucous membrane lesions to a severe, sometimes fatal systemic disorder. Ocular symptoms include ulcerative conjunctivitis, keratitis, iritis, uveitis, and sometimes blindness. The cause of the disease is unknown.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variant of epilepsy characterized by continuous focal jerking of a body part over a period of hours, days, or even years without spreading to other body regions. Contractions may be aggravated by movement and are reduced, but not abolished during sleep. ELECTROENCEPHALOGRAPHY demonstrates epileptiform %28%spike and wave%29% discharges over the hemisphere opposite to the affected limb in most instances. The repetitive movements may originate from the CEREBRAL CORTEX or from subcortical structures %28%e.g., BRAIN STEM; BASAL GANGLIA%29%. This condition is associated with Russian Spring and Summer encephalitis %28%see ENCEPHALITIS, TICK BORNE%29%; Rasmussen syndrome %28%see ENCEPHALITIS%29%; MULTIPLE SCLEROSIS; DIABETES MELLITUS; BRAIN NEOPLASMS; and CEREBROVASCULAR DISORDERS. %28%From Brain, 1996 April;119%28%pt2%29%:393-407; Epilepsia 1993;34;Suppl 1:S29-S36; and Adams et al., Principles of Neurology, 6th ed, p319%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variant of the GUILLAIN-BARRE SYNDROME characterized by the acute onset of oculomotor dysfunction, ataxia, and loss of deep tendon reflexes with relative sparing of strength in the extremities and trunk. The ataxia is produced by peripheral sensory nerve dysfunction and not by cerebellar injury. Facial weakness and sensory loss may also occur. The process is mediated by autoantibodies directed against a component of myelin found in peripheral nerves. %28%Adams et al., Principles of Neurology, 6th ed, p1313; Neurology 1987 Sep;37%28%9%29%:1493-8%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30%25% treated with radiation become highly aggressive within six months. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A varicose condition of the veins of the pampiniform plexus, forming a swelling that feels like a %22%bag of worms,%22% appearing bluish through the skin of the scrotum, and accompanied by a constant pulling, dragging, or dull pain in the scrotum. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variety of TUBERCULOSIS affecting various birds, including chickens and ducks. It is caused by MYCOBACTERIUM AVIUM and characterized by tubercles consisting principally of epithelioid cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. %28%From Thoma%27%s Oral Pathology, 6th ed, pp577-600%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variety of devices used in conjunction with METERED DOSE INHALERS. Their purpose is to hold the released medication for inhalation and make it easy for the patients to inhale the metered dose of medication into their lungs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variety of sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck region of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. %28%From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1365%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variety of simple di- %28%DINUCLEOTIDE REPEATS%29%, tri- %28%TRINUCLEOTIDE REPEATS%29%, tetra-, and pentanucleotide tandem repeats %28%usually less than 100 bases long%29%. They are dispersed in the euchromatic arms of most chromosomes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A variety of surgical reconstructive procedures devised to restore gastrointestinal continuity, The two major classes of reconstruction are the Billroth I %28%gastroduodenostomy%29% and Billroth II %28%gastrojejunostomy%29% procedures.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular connective tissue formed on the surface of a healing wound, ulcer, or inflamed tissue. It consists of new capillaries and an infiltrate containing lymphoid cells, macrophages, and plasma cells.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular disease of the LIVER characterized by the occurrence of multiple blood-filled CYSTS or cavities. The cysts are lined with ENDOTHELIAL CELLS; the cavities lined with hepatic parenchymal cells %28%HEPATOCYTES%29%. Peliosis hepatis has been associated with use of anabolic steroids %28%ANABOLIC AGENTS%29% and certain drugs.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular endothelial cell growth factor receptor whose expression is restricted primarily to adult lymphatic endothelium. VEGFR-3 preferentially binds the vascular endothelial growth factor C and vascular endothelial growth factor D and may be involved in the control of lymphangiogenesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular endothelial growth factor expressed in a variety of tissues. It binds with high specificity to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 and NEUROPILIN-1.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR C in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR D in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular endothelial growth factor whose expression is found largely restricted to the GONADS; ADRENAL CORTEX; and PLACENTA. It has similar biological activity to VASCULAR ENDOTHELIAL GROWTH FACTOR-A.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular malformation composed of clusters of large, thin walled veins lacking intervening nervous tissue. They are most common in the BRAIN STEM but may also occur in the cerebral hemispheres, diencephalon, cerebellum, and spinal cord. The lesions have a tendency to rupture and cause a variety of clinical deficits %28%e.g., SEIZURES; hemiparesis%29% that depend upon the location of the hemorrhage. %28%From Adams et al., Principles of Neurology, 6th ed, pp851-2%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular malformation of developmental origin characterized pathologically by ectasia of superficial dermal capillaries, and clinically by persistent macular erythema. In the past, port wine stains have frequently been termed capillary hemangiomas, which they are not; unfortunately this confusing practice persists: HEMANGIOMA, CAPILLARY is neoplastic, a port-wine stain is non-neoplastic. Port-wine stains vary in color from fairly pale pink to deep red or purple and in size from a few millimeters to many centimeters in diameter. The face is the most frequently affected site and they are most often unilateral. %28%From Rook et al., Textbook of Dermatology, 5th ed, p483%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular tumor preponderantly composed of large dilated blood vessels, often containing large amounts of blood, occurring in the skin, subcutaneously, or both, and also in many viscera, particularly the liver, spleen, pancreas, and sometimes the brain. The typical superficial lesions are bright to dark red in color; deep lesions have a blue color. A cavernous hemangioma in the skin extends more deeply than a capillary hemangioma and is less likely to regress spontaneously. %28%Dorland, 27th ed; from Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vascular, horny neoplasm of the skin characterized by TELANGIECTASIS and secondary epithelial changes including acanthosis and hyperkeratosis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasculitis, local or systemic, caused by a two-stage reaction in which a first encounter with endotoxin produces intravascular fibrin thrombi whose clearance results in reticuloendothelial blockade which prevents the clearance of thrombi caused by a second encounter with endotoxin, %28%or a variety of polyanions, glycogen or antigen/antibody complexes%29% resulting in tissue necrosis and/or hemorrhage. In pregnancy gram-negative septicemia during delivery or abortion may serve as the first or provocative encounter.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of MIGRAINE DISORDERS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator that also has bronchodilatory action. It has been employed in the treatment of angina pectoris, in the treatment of asthma, and in conjunction with ultraviolet light A, has been tried in the treatment of vitiligo. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1024%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator that is administered by inhalation. It is also used recreationally due to its supposed ability to induce euphoria and act as an aphrodisiac.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator used in angina of effort or ischemic heart disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator with general properties similar to NITROGLYCERIN but with a more prolonged duration of action. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1025%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vasodilator with general properties similar to NITROGLYCERIN. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1020%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vegetative stage in the life cycle of sporozoan PROTOZOA. It is characteristic of members of the phyla APICOMPLEXA and MICROSPORIDIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vehicle equipped for transporting patients in need of emergency care.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A venomous New World spider with an hourglass-shaped red mark on the abdomen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A ventricular tachycardia characterized by periodic twisting of the points of the QRS complexes and rates between 200 and 250 beats per minute. It may be self-limited or may progress to ventricular fibrillation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A verbal or nonverbal means of communicating ideas or feelings.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. Recently, a strain from this serogroup, serotype H7 which produces Shiga-like toxins, has been linked to human disease outbreaks resulting from contamination of foods from bovine origin. This serogroup causes hemorrhagic and HEMOLYTIC-UREMIC SYNDROME and predominantly hemorrhagic diarrhea and GASTROENTERITIS in children.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A versatile x-ray contrast medium for diagnostic radiology. It can be administered by most routes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very complex, but reproducible mixture of at least 177 C10 polychloro derivatives, having an approximate overall empirical formula of C10-H10-Cl8. It is used as an insecticide and may reasonably be anticipated to be a carcinogen: Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very effective anticoccidial agent used in poultry. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents %28%antipsychotics and antianxiety agents%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very potent liver carcinogen. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very slow opening and closing voltage-gated potassium channel that is expressed in NEURONS and is closely related to KCNQ2 POTASSIUM CHANNEL. It is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very slow opening and closing voltage-gated potassium channel that is expressed in NEURONS and is commonly mutated in BENIGN FAMILIAL NEONATAL CONVULSIONS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very strong halogenated derivative of acetic acid. It is used in acid catalyzed reactions, especially those where an ester is cleaved in peptide synthesis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, thiotepa may reasonably be anticipated to be a carcinogen %28%Merck Index, 11th ed%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vesicant and necrotizing irritant destructive to mucous membranes. It was formerly used as a war gas. The hydrochloride is used as an antineoplastic in Hodgkin%27%s disease and lymphomas. It causes severe gastrointestinal and bone marrow damage.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vesicular glutamate transporter protein that is predominately expressed in TELENCEPHALON of the BRAIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vesicular glutamate transporter protein that is predominately expressed in the DIENCEPHALON and lower brainstem regions of the CENTRAL NERVOUS SYSTEM.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vesicular transport protein expressed predominately in NEURONS. Synaptotagmin helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vesicular transport protein that was originally characterized as an inositol polyphosphate binding protein. Synaptotagmin II helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the capillary bed. Not to be confused with surgical anastomosis, nor with arteriovenous fistula.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A villous structure of tangled masses of BLOOD VESSELS contained within the third, lateral, and fourth ventricles of the BRAIN. It regulates part of the production and composition of CEREBROSPINAL FLUID.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vine %28%Uncaria tomentosa%29% indigenous to the Amazon rainforest whose name is derived from its hook-like thorns. It contains oxindole alkaloids and glycosides and has many medicinal uses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vinyl polymer made from ethylene. It can be branched or linear. Branched or low-density polyethylene is tough and pliable but not to the same degree as linear polyethylene. Linear or high-density polyethylene has a greater hardness and tensile strength. Polyethylene is used in a variety of products, including implants and prostheses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A violation of the criminal law, i.e., a breach of the conduct code specifically sanctioned by the state, which through its administrative agencies prosecutes offenders and imposes and administers punishments. The concept includes unacceptable actions whether prosecuted or going unpunished.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral disease infecting PRIMATES and RODENTS. Its clinical presentation in humans is similar to SMALLPOX including FEVER; HEADACHE; COUGH; and a painful RASH. It is caused by MONKEYPOX VIRUS and is usually transmitted to humans through BITES or via contact with an animal%27%s BLOOD. Interhuman transmission is relatively low %28%significantly less than smallpox%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral disease of cloven-hoofed animals caused by MORBILLIVIRUS. It may be acute, subacute, or chronic with the major lesions characterized by inflammation and ulceration of the entire digestive tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral disorder characterized by high FEVER, dry COUGH, shortness of breath %28%DYSPNEA%29% or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral encephalitis caused by the St. Louis encephalitis virus %28%ENCEPHALITIS VIRUS, ST. LOUIS%29%, a FLAVIVIRUS. It is transmitted to humans and other vertebrates primarily by mosquitoes of the genus CULEX. The primary animal vectors are wild birds and the disorder is endemic to the midwestern and southeastern United States. Infections may be limited to an influenza-like illness or present as an ASEPTIC MENINGITIS or ENCEPHALITIS. Clinical manifestations of the encephalitic presentation may include SEIZURES, lethargy, MYOCLONUS, focal neurologic signs, COMA, and DEATH. %28%From Adams et al., Principles of Neurology, 6th ed, p750%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral infection of mice, causing edema and necrosis followed by limb loss.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral infection of the brain caused by serotypes of California encephalitis virus %28%ENCEPHALITIS VIRUS, CALIFORNIA%29% transmitted to humans by the mosquito AEDES triseriatus. The majority of cases are caused by the LA CROSSE VIRUS. This condition is endemic to the midwestern United States and primarily affects children between 5-10 years of age. Clinical manifestations include FEVER; VOMITING; HEADACHE; and abdominal pain followed by SEIZURES, altered mentation, and focal neurologic deficits. %28%From Joynt, Clinical Neurology, 1996, Ch26, p13%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viral oncoprotein originally isolated from a murine T CELL LYMPHOMA infected with the acutely transforming retrovirus AKT8. v-akt protein is the viral homologue of PROTO-ONCOGENE PROTEINS C-AKT.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A visual image which is recalled in accurate detail. It is a sort of projection of an image on a mental screen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A visual pigment protein found in the retinal rods. It combines with retinaldehyde to form RHODOPSIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vitamin antagonist which has teratogenic effects. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vitamin-like antioxidant. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vitreoretinal dystrophy characterized by splitting of the neuroretinal layers. It occurs in two forms: degenerative retinoschisis and X chromosome-linked juvenile retinoschisis.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A vocabulary database of universal identifiers for laboratory and clinical test results. Its purpose is to facilitate the exchange and pooling of results for clinical care, outcomes management, and research. It is produced by the Regenstrief Institute. %28%LOINC and RELMA %5B%Internet%5D%. Indianapolis: The Regenstrief Institute; c1995-2001 %5B%cited 2002 Apr 2%5D%. Available from http://www.regenstrief.org/loinc%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A voltage-gated potassium channel that is expressed primarily in the HEART.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A voluntary contract between two or more dentists who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A voluntary contract between two or more doctors who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A voluntary organization concerned with the prevention and treatment of cancer through education and research.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of Bacillus circulans. Two components %28%A and B%29% have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS %28%Carrageen%29%, and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble polypeptide %28%molecular weight approximately 8,000%29% extractable from the corpus luteum of pregnancy. It produces relaxation of the pubic symphysis and dilation of the uterine cervix in certain animal species. Its role in the human pregnant female is uncertain. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble radiographic contrast media for cholecystography and intravenous cholangiography.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. %28%Hawley%27%s Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A weight-carrying structure for navigation of the air that is supported either by its own buoyancy or by the dynamic action of the air against its surfaces. %28%Webster, 1973%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A well-circumscribed mass composed of tuberculous granulation tissue that may occur in the cerebral hemispheres, cerebellum, brain stem, or perimeningeal spaces. Multiple lesions are quite common. Management of intracranial manifestations vary with lesion site. Intracranial tuberculomas may be associated with SEIZURES, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. Spinal cord tuberculomas may be associated with localized or radicular pain, weakness, sensory loss, and incontinence. Tuberculomas may arise as OPPORTUNISTIC INFECTIONS, but also occur in immunocompetent individuals.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A well-differentiated, benign, hamartomatous proliferation of odontogenic epithelium, probably arising from the rests of Malassez.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A whiplike motility appendage present on the surface cells. Prokaryote flagella are composed of a protein called FLAGELLIN. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. %28%From King %26% Stansfield, A Dictionary of Genetics, 4th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide and used in organic syntheses. This should not be confused with benzoin gum from%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A white patch on a mucous membrane that will not rub off. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia %28%LEUKOPLAKIA, HAIRY%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A white powder prepared from lime that has many medical and industrial uses. It is in many dental formulations, especially for root canal filling.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A white threadlike worm which causes elephantiasis, lymphangitis, and chyluria by interfering with the lymphatic circulation. The microfilaria are found in the circulating blood and are carried by mosquitoes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A wide spectrum aliphatic organophosphate insecticide widely used for both domestic and commercial agricultural purposes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely cultivated plant, native to Asia, having succulent, edible leaves eaten as a vegetable. %28%From American Heritage Dictionary, 1982%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely distributed cell surface transmembrane glycoprotein that stimulates the synthesis of MATRIX METALLOPROTEINASES. It is found at high levels on the surface of malignant NEOPLASMS and may play a role as a mediator of malignant cell behavior.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely distributed genus of TICKS, in the family IXODIDAE, including a number that infest humans and other mammals. Several are vectors of diseases such as TULAREMIA; ROCKY MOUNTAIN SPOTTED FEVER; COLORADO TICK FEVER; and ANAPLASMOSIS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely distributed order of perching BIRDS, including more than half of all bird species.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely expressed transmembrane glycoprotein that functions as a METASTASIS suppressor protein. It is under-expressed in a variety of human NEOPLASMS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely occurring subclass of c type cytochromes which function as electron carriers in the electron transport chain in photosynthetic and denitrifying BACTERIA.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely used anti-inflammatory agent isolated from the licorice root. It is metabolized to glycyrrhetic acid, which inhibits 11 beta-hydroxysteroid dehydrogenase and other enzymes involved in the metabolism of corticosteroids. Therefore, glycyrrhizic acid, which is the main and sweet component of licorice, has been investigated for its ability to cause hypermineralocorticoidism with sodium retention and potassium loss, edema, increased blood pressure, as well as depression of the renin-angiotensin-aldosterone system.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely used industrial solvent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely used local anesthetic agent. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A widely used non-cardioselective beta-adrenergic antagonist. Propranolol is used in the treatment or prevention of many disorders including acute myocardial infarction, arrhythmias, angina pectoris, hypertension, hypertensive emergencies, hyperthyroidism, migraine, pheochromocytoma, menopause, and anxiety.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A willingness to reveal information about oneself to others.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A winged-helix transcription factor that regulates GENE expression in metabolic tissues. It plays a role in HOMEOSTASIS of GLUCOSE and controls expression of GLUT2 PROTEIN.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A work consisting of a list of books, articles, documents, publications, and other items, usually on a single subject or related subjects.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A work that consists of summary statements representing the majority and current agreement of physicians, scientists, and other professionals meeting to reach a consensus on a selected subject.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A worm-like blind tube extension from the CECUM. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A written account of a person%27%s life and the branch of literature concerned with the lives of people. %28%Harrod%27%s Librarians%27% Glossary, 7th ed%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A written agreement for the transfer of patients and their medical records from one health care institution to another.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A xanthine oxidase inhibitor. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A xanthine-related, putative nootropic drug. ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A xylosidase that catalyses the random hydrolysis of 1,3-beta-D-xylosidic linkages in 1,3-beta-D-xylans.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A yellow fat obtained from sheep%27%s wool. It is used as an emollient, cosmetic, and pharmaceutic aid.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A yellowish fossil resin, the gum of several species of coniferous trees, found in the alluvial deposits of northeastern Germany. It is used in molecular biology in the analysis of organic matter fossilized in amber.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A zinc containing enzyme of the hydrolase class that catalyzes the removal of the N-terminal amino acid from most L-peptides, particularly those with N-terminal leucine residues but not those with N-terminal lysine or arginine residues. This occurs in tissue cell cytosol, with high activity in the duodenum, liver, and kidney. EC 3.4.11.1%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A zinc-containing enzyme which oxidizes primary and secondary alcohols or hemiacetals in the presence of NAD. In alcoholic fermentation, it catalyzes the final step of reducing an aldehyde to an alcohol in the presence of NADH and hydrogen.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A zinc-containing stereo-specific methionine sulfoxide reductase.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A%28%1%29%-Acid Seromucoid' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Acid Lipase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Ara' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Calcineurin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Chymotrypsinogen' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Coenzyme' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Colipase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Concanavalin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Cyclophilin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Exfoliatin Toxin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Fibrinopeptide' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Fibrinopeptides' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Hemoglobin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Hemophilia' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Kallocryl' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Kenacort' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Lipid' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Lysophospholipase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Malonyl Coenzyme' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Palmitoyl Coenzyme' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Phospholipases' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Proscillaridin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Prostaglandins' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Protochlorophyllide' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, RNA Polymerase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Sebidin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Staphylococcal Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, Zymosan' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, alpha-Ara' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, alpha-Lactalbumin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, beta-Ara' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A, beta-Lactoglobulin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-B Family hnRNP Proteins' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-DNA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Factor Receptor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Form DNA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Glycidyl Methacrylate, Bisphenol' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Monacylglycerophosphateacyltransferase, Acyl Coenzyme' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Particle Element, Intracisternal' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Particle Elements, Intracisternal' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Particle Gene, Intracisternal' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Particle Genes, Intracisternal' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Transferases, Coenzyme' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Type Potassium Channel Modulatory Protein 1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Type Potassium Channel Modulatory Protein 2' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Type Potassium Channel Modulatory Protein 3' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Type Potassium Channel Modulatory Protein 4' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-Type Potassium Channel Modulatory Proteins' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-V Node' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-V Nodes' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-alphalipoprotein Neuropathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-alphalipoprotein Neuropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-raf Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-raf Protein Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-raf-1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A-sn-1,2-Diacylglycerol Acyltransferase, Palmitoyl-Coenzyme' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A.L. Labs Brand of Bacitracin Zinc Salt' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1 - ANATOMY-BODY REGIONS ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1 Receptor, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1 Receptors, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1, Lecithinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1, Lysophospholipase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1, Phospholipase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A10 - ANATOMY-TISSUES ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A11 - ANATOMY-CELLS ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A11 qualif except /cytol; /genet permitted; coord IM with specific virus %28%IM%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A12 - ANATOMY-FLUIDS AND SECRETIONS ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A13 - ANATOMY-ANIMAL STRUCTURES ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A14 - ANATOMY-STOMATOGNATHIC SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A15 - ANATOMY-HEMIC AND IMMUNE SYSTEMS ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A16 - ANATOMY-EMBRYONIC STRUCTURES ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A17 - ANATOMY-INTEGUMENTARY SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1PI' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1a-1 Hemoglobin, Glycosylated' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A1b Hemoglobin, Glycosylated' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2 - ANATOMY-MUSCULOSKELETAL SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2 Receptor, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2 Receptors, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2 Synthetase, Thromboxane' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2, Hemoglobin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2, Lecithinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2, Phospholipase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2, Thromboxane' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A23187' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A23187, Antibiotic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A24, Human coxsackievirus' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A272' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2A Receptor, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2A Receptors, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2B Receptor, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2B Receptors, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A2MRAP Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A3 - ANATOMY-DIGESTIVE SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A3 Receptor, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A3 Receptors, Adenosine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A301' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A4 - ANATOMY-RESPIRATORY SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A41304' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A43818' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A5 - ANATOMY-UROGENITAL SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A5 Antigen' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A56268' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A6 - ANATOMY-ENDOCRINE SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A7 - ANATOMY-CARDIOVASCULAR SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A8 - ANATOMY-NERVOUS SYSTEM ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A8 Protein, S100' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A9 - ANATOMY-SENSE ORGANS ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'A9 Antigen' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AA Spectrophotometries' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AA Spectrophotometry' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AADPR' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AAUAAA RNA Sequences' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AB Piperacillin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AB Variant Gangliosidosis GM2' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABC Transporters' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABC Transporters %28%1996-2001%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABH Blood Group' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABH Blood Groups' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABO Blood Group System' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABO Blood-Group System' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABO Blood-Group Systems' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABO Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABP %28%Alzheimer%27%s%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABT-538' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABT538' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ABaC50,005' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AC Globulin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AC Toxin, Bordetella' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACA Infarction' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACA Infarctions' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACACIA %26% EUCALYPTUS were headings 1963-85 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACANTHOLYSIS BULLOSA see EPIDERMOLYSIS BULLOSA is also available%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACE Inhibitors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACEL IMUNE' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACELIMUNE' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACETIC ACID ESTERS was heading 1975-96 %28%see under ACETIC ACIDS 1975-90%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACHYLIA GASTRICA was see under ACHLORHYDRIA 1963-78 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACI Rat' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACI Rat, Inbred' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACI Rats' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACI Rats, Inbred' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACNU' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACO1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACONITE %28%see ACONITUM%29% is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACP Reductase, NADH-Enoyl' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACRP30 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACRYLAMIDE is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACRYLAMIDES is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTAEA RACEMOSA see CIMICIFUGA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH %28%1-39%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH 1-24' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Endorphin Precursor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Hypersecretion, Pituitary' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Producing Pituitary Adenoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Receptor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Releasing Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Secreting Pituitary Adenoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Syndrome, Ectopic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH Syndromes, Ectopic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH beta Lipotropin Precursor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH, Synthetic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-Endorphin Precursor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-Producing Pituitary Adenoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-Producing Pituitary Adenomas' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-Releasing Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-Secreting Pituitary Adenoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-Secreting Pituitary Adenomas' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTH-beta-Lipotropin Precursor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTINON was see RADON 1978-93; THORON %28%ELEMENT%29% was %28%NM%29% 1974-93%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTINON was see RADON 1978-93; THORON %28%ELEMENT%29% was indexed under RADON 1983-93 %26% RADIOISOTOPES 1974-82%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTR2 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACTR3 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACUTE YELLOW ATROPHY was heading 1963-96 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACYL-COA DEHYDROGENASE and other specifics are also available%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACYL-COA DEHYDROGENASE is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACYL-COA DEHYDROGENASES and ACYL-COA DEHYDROGENASE, LONG-CHAIN are also available%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ACh Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AD beta Casein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AD beta-Casein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AD-AP, Amyloid' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADAM %28%A Disintegrin and Metalloprotease%29% Proteins' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADAM Proteins' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADCC' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADD1, Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADESP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADF Protein %28%Actin Depolymerizing Factor%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADF Proteins %28%Actin Depolymerizing Factors%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADH Syndrome, Inappropriate' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADL' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Glucose' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Glucose Pyrophosphorylase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Glucose Starch Glucosyltransferase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Glucose Synthase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Glucose Synthetase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Kinases' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Phosphocreatine Phosphotransferase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Phosphohydrolase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Receptor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribose' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribose Cyclase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribose Transferase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribose Transferases' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribose, Poly' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribosylation Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribosylation Factor 1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribosylation Factors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribosyltransferase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Ribosyltransferase, Nuclear' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Sugars' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP Translocase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP ribosyl Cyclase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP, Magnesium' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP,ATP Carrier' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP,ATP Carrier Protein, Liver Isoform T2' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP,ATP Translocator Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-ATP Carriers, Mitochondrial' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Glucose Pyrophosphorylase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Glucose Synthase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Glucose Synthetase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-RIBOSYLATION FACTOR 1 is involved in regulating intracellular transport by modulating the interaction of coat proteins with organelle membranes in the early secretory pathway. It is a component of COAT PROTEIN COMPLEX I. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribose' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribose, Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosylation Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosylation Factor 1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosylation Factors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase %28%Polymerizing%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, NAD' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, NAD+' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, NAD-Agmatine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, NAD-Arginine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, NADP-Arginine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, Nuclear' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-Ribosyltransferase, Nuclear NAD+' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-ribose Hydrolase, Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-ribose Transferases, Mono' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADP-ribosyl Cyclase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPG' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPG Synthetase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPGlucose Pyrophosphorylase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPKD' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPR Cyclase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPR Cyclase CD38' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPR Cyclase T10' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPRT' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPRT, Nuclear' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPRTs' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPribose' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPribose Transferase, Mono' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPribose Transferases, Mono' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADPribose, Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADR 529' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADR529' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ADRENERGIC FALSE TRANSMITTERS was heading 1973-81 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE Spectrophotometries' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE Spectrophotometry' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE1 Anion Exchanger' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE1 Chloride Bicarbonate Exchanger' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE1 Chloride-Bicarbonate Exchanger' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE1 Cl HCO3 Exchanger' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE1 Cl- HCO3- Exchanger' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AE1 Gene Product' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AEP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AER I beta Lactamase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AESCULUS, ARECA, CASTANEA, CHELIDONIUM, CHENOPODIUM, COCA, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, ERYTHRINA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, PAPAVER, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX, TAMARIND %26% VALERIAN were headings 1963-85; ADONIS, ASPIDIUM %26% OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85; ALOE %26% RHUBARB were headings 1963-77; PLANTAGO was see PSYLLIUM 1963-77%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AESCULUS, CASTANEA, CHELIDONIUM, CHENOPODIUM, COLCHICUM, COLOCYNTH, CRATAEGUS, CUBEB, ECHINACEA, GELSEMIUM, GENTIAN, HYDRASTIS, LITHOSPERMUM, MARRUBIUM, MYRICA, RAUWOLFIA, ROSA, SARSAPARILLA, SALIX %26% TAMARIND were headings 1963-85; ADONIS, ASPIDIUM %26% OLEANDER were see under PLANTS, MEDICINAL 1978-85 and headings 1963-77; AMMI was see under PLANTS, MEDICINAL 1977-85%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AET' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AF 1161' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AF 2' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AF Brand of Pipemidic Acid' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AF1161' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AF2' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AFGP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AFP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AG-1343' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AG1343' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGAMOUS 1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGAMOUS Protein, Arabidopsis' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGEPC' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGP EBP Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGP-EBP Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGR16 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AGS' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AH 19065' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AH 5158' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AH Receptor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AH Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AH19065' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AH5158' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHG CDC Tests' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHG-CDC Test' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHG-CDC Tests' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Bufexamac' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Demeclocycline Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Doxapram Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Ethambutol Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Lorazepam' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Minocycline Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Mitoxantrone Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Piperacillin Sodium' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHP Brand of Temazepam' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHR 1911' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AHR1911' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AI %28%Artificial Intelligence%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AI3 24916' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AI324916' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AICAR Formyltransferase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AICAR Transformylase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AICARTFase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AID' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AID TO THE BLIND %26% AID TO THE TOTALLY DISABLED were see under PUBLIC ASSISTANCE 1968-77%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Antibodies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Antigens' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Arteritis, Central Nervous System' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Associated Cerebral Aneurysmal Arteriopathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Associated Enteropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Associated Lymphoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Associated Nephropathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Associated Nephropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Dementia Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Drugs' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Encephalopathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Encephalopathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Enteropathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Enteropathies, Idiopathic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Enteropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Enteropathy, Idiopathic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Long Term Survivors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Long-Term Survivor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Nephropathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Nephropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Related Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Related Dementia Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Related Lymphoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Related Opportunistic Infections' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Seroconversion' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Seroconversions' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Serodiagnoses' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Serodiagnosis' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Serology' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Seropositivities' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Seropositivity' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Vaccines' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Vaccines, Simian' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Virus' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Virus Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Viruses' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS Wasting Syndrome' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS, Feline' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS, Murine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS, Simian' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Associated Enteropathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Associated Enteropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Associated Lymphoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Associated Lymphomas' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Associated Nephropathies' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Associated Nephropathy' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Related Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Related Dementia Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Related Lymphoma' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Related Lymphomas' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Related Opportunistic Infection' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDS-Related Opportunistic Infections' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDSs, Murine' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIDSs, Simian' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIF Apoptosis Regulatory Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIH' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIRSICKNESS, CARSICKNESS %26% SEASICKNESS were see under MOTION SICKNESS 1963-78%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIVR' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AIs %28%Artificial Intelligence%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AK Con' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AK Sulf' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKCon' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKE' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR Mice' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR Mice, Inbred' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR Mouse' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR Mouse, Inbred' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR Virus' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR Viruses' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKR murine leukemia virus' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKT1 Protein Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKT2 Protein Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AKT3 Protein Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL 1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Acetylcystein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Amantadin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Benzbromaron' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Domperidon' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Doxazosin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Doxepin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, NAC' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL, Nitrendipin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL-1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AL-1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALA Dehydrase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALA-Dehydrase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALASTRIM was heading 1975-96 %28%see under SMALLPOX 1975-90%29%; VARIOLA MINOR was see ALASTRIM 1979-96%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALCALIGENES EUTROPHA see WAUTERSIA EUTROPHA is available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALCAM' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALCOHOL WITHDRAWAL DELIRIUM is available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALD %28%Adrenoleukodystrophy%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALDs %28%Adrenoleukodystrophy%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALEXIA see DYSLEXIA is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALKALESCENS-DISPAR GROUP was heading 1975-96 %28%see under ESCHERICHIA 1975-90%29%; was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1963-73 %28%Prov 1963-67%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALKALESCENS-DISPAR GROUP was heading 1975-96 %28%see under ESCHERICHIA 1975-90%29%; was see under SHIGELLA 1974; was see under ENTEROBACTERIACEAE 1968-73%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALL, Childhood' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALLOXAN DIABETES indexed as DIABETES MELLITUS, EXPERIMENTAL %28%IM%29% + ALLOXAN %28%NIM%29% only if chem is particularly discussed%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALO 1401 02' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALO140102' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALPHA-HYPOPHAMINE was see OXYTOCIN 1977-93; ISOLEUCYL, LEUCYL VASOPRESSIN; VASOPRESSIN, ISOLEUCYL-LEUCYL; VASOTOCIN, LEUCYL, %26% 3-ISOLEUCINE,8-LEUCINE VASOPRESSIN were see OXYTOCIN 1983-93%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALPHA-LINOLENIC ACID is an omega-3 fatty acid ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALPHA-MANNOSIDASE and BETA-MANNOSIDASE are also available; /defic: consider also MANNOSIDASE DEFICIENCY DISEASES%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALS %28%Amyotrophic Lateral Sclerosis%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALV-Related Retrovirus' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ALV-Related Retroviruses' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM 0715' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM 715' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM 833' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM, Bisolvon' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM-715' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM0715' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AM833' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMANTADINE derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMARANTH PLANT see AMARANTHUS is also available; D25-26 qualif%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMAUROTIC FAMILIAL IDIOCY was heading 1963-84 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMBIDEXTERITY was see under LATERALITY 1975-85, was see LATERALITY 1966-74%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMCA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMCHA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMIF 72' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMIF72' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMINO ACIDS composed of GLYCINE substituted at the nitrogen rather than the usual carbon position, resulting in the loss of HYDROGEN BONDING donors. Polymers of these compounds are called PEPTOIDS.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMINO ALCOHOLS containing the ETHANOLAMINE; %28%-NH2CH2CHOH%29% group and its derivatives.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMINO ALCOHOLS containing the propanolamine %28%NH2CH2CHOHCH2%29% group and its derivatives.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMINOSALICYLIC ACIDS is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AML1A Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AML1B Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AML1C Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AML1D Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AML2 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AML3 Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMNESIA, GLOBAL see AMNESIA is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMODIACHIN was see AMODIAQUINE 1978-95 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP 5%27%-Nucleotidohydrolase, 3%27%,5%27%-Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP 5-Nucleotidohydrolase, 3,5-Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Aminase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Aminohydrolase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Deaminase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Kinase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Phosphatase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Phosphodiesterase, 3%27%,5%27%-Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Phosphodiesterase, 3,5-Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP Pyrophosphorylase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP, Br Cycl' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP, Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP, Dibutyryl Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP-PNP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP-PNP, Mg' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMP-Phosphodiesterase Activator, Cyclic' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMPA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMPA Receptor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMPA Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMPPNP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMSA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMSA P D' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMSA P-D' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AMSA PD' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AN448' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANAE' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANCA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANCYLOSTOMA AMERICANA was see NECATOR 1979-92; UNCINARIA AMERICANA was see NECATOR 1977-92%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANCYLOSTOMA DUODENALE was UNCINARIA DUODENALE 1979-92 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANDROPOGON NARDUS see CYMBOPOGON and ANDROPOGON ZIZANOIDES see VETIVERIA are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANEMIA, HEMOLYTIC, ACQUIRED was heading 1968-81, was ANEMIA, ACQUIRED HEMOLYTIC 1965-67; ANEMIA, CHEMICAL INDUCED HEMOLYTIC %26% ANEMIA, SECONDARY ACQUIRED HEMOLYTIC were headings 1965-67%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANEMIA, SPLENIC was heading 1963-81 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANESTHESIA achieved by lowering either BODY TEMPERATURE %28%core cooling%29% or SKIN TEMPERATURE %28%external cooling%29%.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANESTHESIA, INTRALIGAMENTAL, DENTAL was see ANESTHESIA, DENTAL 1984-92%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANESTHESIA, REFRIGERATION %26% HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1964-83 %28%Prov 1964-65%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANESTHESIA, REFRIGERATION %26% HIBERNATION, ARTIFICIAL were headings 1963-83; GASTRIC HYPOTHERMIA was heading 1966-83%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANF' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANF %28%1-126%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANF %28%1-28%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANF %28%99-126%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANF Precursors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANF Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANG-%28%1-8%29%Octapeptide' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. %28%Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes %26% Eponymic Diseases, 2d ed%29%. It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANIMALS whose GENOME has been altered by GENETIC ENGINEERING, or their offspring.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANION TRANSPORT PROTEINS is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANK Repeat' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANK Repeats' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANLL' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANOREXIA NERVOSA is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANOREXIA is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANOVA' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP %28%1-126%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP %28%1-28%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP 3624' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP Prohormone %28%99-126%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP Receptors' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP-%28%99-126%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANP3624' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANS %28%Autonomic Nervous System%29% Diseases' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANS Disease' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANS Diseases' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT 1 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT 2 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT 3 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT-1 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT-2 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT-3 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT1 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT2 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANT3 Transport Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANTIPERSPIRANTS was see ASTRINGENTS 1985-94 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANTISPASMODICS %26% SPASMOLYTICS were see MUSCLE RELAXANTS 1963-69%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ANUS, ARTIFICIAL was see COLOSTOMY 1975-97 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AOC Tetragastrin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AOC Tetrapeptide' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AOC-Tetragastrin' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AOC-Tetrapeptide' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AORTIC VALVE DISEASES was heading 1963-66 ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AORTITIS, SYPHILITIC was see under SYPHILIS, CARDIOVASCULAR 1963-83 %28%Prov 1963-74%29%%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 1 Enhancer Binding Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 2 Enhancer Binding Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 2 Protein Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 2 alpha Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 2 beta Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 2 gamma Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP 2delta Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP Endonuclease' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP Lyase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-1 Enhancer Binding Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-1 Enhancer-Binding Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 Adaptor %28%Clathrin-Coated Vesicles%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 Enhancer Binding Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 Protein Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 alpha Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 beta Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 epsilon Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2 gamma Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2, Activator Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2, Enhancer-Binding Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2, Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2alpha, Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2beta, Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2delta Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2epsilon, Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-2gamma, Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP-4 protein complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AP3 Adaptor Complex' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APACHE' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APAETP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APAP' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APC Gene' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APC Genes' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APC Resistance' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APC Virus' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APC Viruses' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APF-1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APO 1 Antigen' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APO-1 Antigen' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APOMORPHINE DERIVATIVES was see under APOMORPHINE 1969-77%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APOPTOSIS REGULATORY PROTEINS is also available ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APOPTOSIS triggered by loss of contact with the EXTRACELLULAR MATRIX.%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APRF Transcription Factor' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APRTase' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APRV Ventilation Mode' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APRV Ventilation Modes' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APS Brand of Allopurinol' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APS Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APS Brand of Diethylstilbestrol' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APS Brand of Heroin Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APS Brand of Mefenamic Acid' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APS Brand of Minocycline Hydrochloride' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APSAC' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APT %28%1980-1992%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APT 3%27% I and II' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APT-3%27%-I and II' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APT/analogs %26% derivatives %28%1979-1980%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APUD Cell' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APUD Cells' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'APUD Cells %28%1977-1997%29%' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQ 110' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQ110' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQL 208' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQL208' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP CHIP Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP-CHIP Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP2 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP3 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP4 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP5 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQP6 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'AQUILEGIA ADOXOIDES see SEMIAQUILEGIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ARC' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ARC 1' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ARCN1 Protein' = 0).
% 42.08/41.96 fof(interp, fi_functors, 'ARCUS SENILIS was see under EYE DISEASES 1964-89 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARDS, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARDSs, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARF 1 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARF Protein Cofactor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARF1 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARF1p' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARHA GTP Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARHA GTP-Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARHB GTP Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARHB GTP-Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARHB Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARMENIAN S.S.R. was heading 1982-92; was ARMENIAN SSR 1975-81%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AROCLORS is also available ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARPKD' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARROWROOT see MARANTACEAE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARSENIC COMPOUNDS was heading 1994-95 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ART Transferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ART Transferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTERENOL was see NOREPINEPHRINE 1974-93; LEVONOREPINEPHRINE was heading 1963-65%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant %28%ADJUVANTS, IMMUNOLOGIC%29% or COLLAGEN.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTHRITIS, ADJUVANT was ADJUVANT ARTHRITIS see under ARTHRITIS, RHEUMATOID 1975-76%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTHROPLASTY, REPLACEMENT, HIP %26% ARTHROPLASTY, REPLACEMENT, KNEE are also available; do not use /util except by MeSH definition; DF: ARTHROPLASTY REPLACE%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTIFICIAL GENE FUSION is also available ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ARTases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASCHELMINTHES was heading 1976-85 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASGP-R' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASGPH' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASK1 Protein Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC is also available%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL is also available%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASPICULARIASIS was see NEMATODE INFECTIONS 1986-92; was heading 1968-85%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASSIMILATION was see under ACCULTURATION 1968-82 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA D 7093' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Ademetionine Tosilate Disulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Ajmaline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Amiodarone Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Azapropazone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Baclofen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Dextromoramide Tartrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Estrogens, Conjugated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Mesna' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Mitoxantrone Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Nedocromil Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of Pimozide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of beta Acetyldigoxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTA Medica Brand of beta-Acetyldigoxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASTAD 7093' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ASYSTOLE was see under ARRHYTHMIA 1969-90 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT 2266' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hook' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hook 1a Protein, High Mobility Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hook 1b Protein, High Mobility Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hook 1c Protein, High Mobility Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hook Motif' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hook Motifs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Hooks' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Rich Region' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Rich Regions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Rich Sequence' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT Rich Sequences' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT-10' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT-Hook 1a Protein, High Mobility Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT-Hook 1b Protein, High Mobility Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT-Hook 1c Protein, High Mobility Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT-Hook Motif' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT-Hook Motifs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT1 Receptor, Angiotensin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT10' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT1a Receptor, Angiotensin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT1b Receptor, Angiotensin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT2 Receptor, Angiotensin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AT2266' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATF Transcription Factors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATF1 Transcription Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATF2 Transcription Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATF3 Transcription Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATF4 Transcription Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATF6 Transcription Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATGAMs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATHLETICS was see under SPORTS 1963-75 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATLL' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATLLs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATLV' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATLV Antibodies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATLV Antigens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP ADP Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP ADPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP AMP Phosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP AMP Transphosphorylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Binding Cassette Transporters' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Binding Cassette, Sub Family B Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Binding Cassette, Sub Family C Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Choline Transphosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Citrate %28%pro-3S%29%-Lyase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Citrate %28%pro-S%29%-Lyase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Citrate Lyase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Citrate Synthase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Creatine Phosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Citrate Lyase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent DNase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Endoprotease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Endoprotease Ti' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Organic Anion Transporters' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Phosphoenolpyruvate Carboxykinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Protease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Proteases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Proteolysis Factor 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Dependent Proton Translocase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Diphosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Diphosphohydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Guanosine Phosphate Pyrophosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Methionine S Adenosyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP MgCl2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP NMN Adenylyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Phosphoribosyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Phosphotransferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP RNA Adenylyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Requiring Protease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Sulfurylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Synthase, Chloroplast' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Synthase, Mitochondrial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Synthases, Chloroplast' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Synthases, Mitochondrial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Synthetase Complex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Synthetase Complexes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP Translocase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP%28%beta,gamma-NH%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP,ADP-Carrier' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-%28%2%27%-5%27%%29%oligo%28%A%29%adenylyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-%28%d%29%GMP Phosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-ADP Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-ADP Translocase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-ADPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-AMP Phosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-AMP Transphosphorylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Binding Cassette Transporters' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Binding Cassette, Sub-Family B Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Binding Cassette, Sub-Family B, Member 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Binding Cassette, Sub-Family C Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-D-Fructose-6-phosphate 2-phosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Citrate Lyase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent DNase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Endoprotease Ti' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Organic Anion Transporters' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Phosphoenolpyruvate Carboxykinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Protease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Proteases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Dependent Proteolysis Factor 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Diphosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Guanosine Phosphate Pyrophosphotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Methionine S-Adenosyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-MgCl2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-NMN Adenylyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-RNA Adenylyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP-Requiring Protease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes %28%L, R, M1, and M2%29%. Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPHPM' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase Complex, Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase Complexes, Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase Hydrogen, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase Sodium, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Actin Activated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Actin S1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Actin-Activated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Actin-S1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Actomyosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, CF1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Ca2+' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Ca2+-Mg2+' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Calcium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Calcium Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Chloroplast' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Dynein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, F%28%1%29%F%28%0%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, F0' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, F0F1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, F1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, H%28%+%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, H+' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, H+-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Hydrogen, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Mg2+-Dependent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Myosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, N-Ethylmaleimide-Sensitive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, NSF' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Potassium Hydrogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPase, Sodium, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPases that are members of the AAA protein superfamily %28%ATPase family Associated with various cellular Activities%29%. The NSFs functions, acting in conjunction with SOLUBLE NSF ATTACHMENT PROTEINS %28%i.e. SNAPs, which have no relation to SNAP 25%29%, are to dissociate SNARE complexes.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPases, Bacterial Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPases, Chloroplast' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPases, Chloroplast Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPases, Lysosomal Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATPases, Mitochondrial Proton-Translocating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATRC1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'ATRC2 Transporter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AUC' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AUROVERTINS was AUROVERTIN see under ANTIBIOTICS 1975-79 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM is available ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AUTOMOBILES, trucks, buses, or similar engine-driven conveyances. %28%From Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AV Node' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AV Nodes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AVIATION DENTISTRY was heading 1965-79 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AVM %28%Arteriovenous Malformation%29% Intracranial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AWD, Baclofen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AWD.pharma Brand of Cetirizine Dihydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AWD.pharma Brand of Digitoxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AWD.pharma Brand of Digoxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AWD.pharma Brand of Medazepam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AWS-FOC Laws' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 20694' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 22 989' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 22989' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 23,028' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 24,236' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 24236' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 25650' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY 9944' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY-24236' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY20694' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY23,028' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY24,236' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY24236' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY25650' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AY9944' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AYERZA%27%S SYNDROME was heading 1963-83 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZACYCLONOL was heading 1963-84 ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZACYCLOPROPANES, SATURATED see AZIRIDINES is available ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZACYCLOPROPANES, UNSATURATED see AZIRINES is available ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZT %28%Antiviral%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZT Antiviral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZT, Antiviral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZU, Amantadin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZU, Doxazosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZU, Doxepin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZU, Fenofibrat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AZU, Moclobemid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AacI Endonuclease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AaeI Endonuclease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aardvark' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aardwolve' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aardwolves' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ Brand of Amantadine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ Brand of Felodipine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ Brand of Fluconazole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ Brand of Nitrendipine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ Brand of Piracetam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ Brand of Procetofen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AbZ, Nitre' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abandoned Adolescent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abandoned Adolescents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abandoned Child' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abandoned Children' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abandonment, Patient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abattoir' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abattoirs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbot Brand of Levothyroxine Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbot Brand of Naphazoline Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott 38579' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott 48999' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott 50192' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Alprostadil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Bretylium Tosilate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Bupivacaine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Calcitriol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Desoximetasone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Enflurane' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Estazolam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Flurbiprofen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Gallopamil Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Levophed Bitartrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Mepivacaine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Methamphetamine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Naftidrofuryl Oxalate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Pemoline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Pipobroman' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Procaine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Procetofen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Propafenone Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Propofol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Proscillaridin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Silver Sulfadiazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Sodium Nitroprusside' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Thiopental Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Tranexamic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Trimethadione' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott Brand of Vancomycin Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott38579' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott48999' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbott50192' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbreviated Injury Scale' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbreviated Injury Scales' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbreviation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbreviations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbreviations %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abbreviations %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen %28%1964-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen %28%1966-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen %28%1967-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen Rectus Muscle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen Rectus Muscles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen, Acute' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomen/radiography %28%1967-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdomens, Acute' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Abscess' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Abscesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Adipose Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Aorta' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Aortas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Aortic Aneurysm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Aortic Aneurysms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Cavities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Cavity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Cramp' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Decompression' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Deliveries' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Delivery' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Epilepsies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Fat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Fats' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Fibromatoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Fibromatosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Hernia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Hernias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Injuries' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Injuries %28%1966-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Injury' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Migraines' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Muscle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Muscles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Muscles %28%1965-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Muscles %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Muscles/abnormalities %28%1966-1998%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Muscles/blood supply %28%1966-1995%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Neoplasm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Neoplasms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Pain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Pains' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Polyradiculopathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Polyradiculopathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Pregnancies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Pregnancy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Radiographies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Radiography' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Reflex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Subcutaneous Adipose Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Subcutaneous Fat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Subcutaneous Fats' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Typhus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Visceral Fat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Visceral Fats' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Wall' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Wall %28%1966-1969%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal Wall/AB %28%1966-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal artery that follows the curvature of the stomach. The right gasteroepiploic artery is frequently used in coronary artery bypass grafting, myocardial revascularization, and other vascular reconstruction.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abdominal symptoms after removal of the GALLBLADDER. The common postoperative symptoms are often the same as those present before the operation, such as COLIC, bloating, NAUSEA, and VOMITING. There is pain on palpation of the right upper quadrant and sometimes JAUNDICE. The term is often used, inaccurately, to describe such postoperative symptoms not due to gallbladder removal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve %28%1967-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve %28%1968-1980%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Injuries' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Injury' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Palsies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Palsy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Trauma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerve Traumas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Nerves' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Neuropathies, Traumatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducens Neuropathy, Traumatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducent Nerve' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abducent Nerves' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abello Brand of Aciclovir' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abello Brand of Naloxone Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abello Farmacia Brand of Mebendazole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abello, Naloxone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abelmoschus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abelson Leukemia Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abelson murine leukemia virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrant Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrant Tissues' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrant chromosomes with no ends, i.e., circular. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberration, Chromosomal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberration, Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberration, Cytogenetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberration, Sex Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrations, Chromosomal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrations, Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrations, Cytogenetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aberrations, Sex Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abetalipoproteinemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abetalipoproteinemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abietane Diterpenes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abietanes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abilities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abilities, Kidney Concentrating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abilities, Urine Concentrating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability of a microbe to survive under given conditions. This can also be related to a colony%27%s ability to replicate.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability of neoplasms to infiltrate and actively destroy surrounding tissue.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability to determine the specific location of a sound source.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability to make speech sounds that are recognizable. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability, Kidney Concentrating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ability, Urine Concentrating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Catheter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Electric Catheter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Electrical Catheter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Percutaneous Catheter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Radiofrequency Catheter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Transvenous Catheter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ablation, Transvenous Electrical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Erythrocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Erythrocytes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Fibrinogens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Hemoglobins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Karyotypes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Movement' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Movements' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Pupillary Function' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Pupillary Functions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Reflex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal Reflexes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal SEX DIFFERENTIATION caused by disorders of the GONADS or the ADRENAL GLANDS, such as CONGENITAL ADRENAL HYPERPLASIA and ADRENAL CORTEX NEOPLASMS. Due to abnormal steroid biosynthesis, clinical features include VIRILISM in females; FEMINIZATION in males; or precocious sexual development in children.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal accumulation of serous fluid in two or more fetal compartments, such as SKIN; PLEURA; PERICARDIUM; PLACENTA; PERITONEUM; AMNIOTIC FLUID. General fetal EDEMA may be of non-immunologic origin, or of immunologic origin as in the case of ERYTHROBLASTOSIS FETALIS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal anatomical or physiological conditions and objective or subjective manifestations of disease, not classified as disease or syndrome.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal behavioral or physiologic events that are associated with REM sleep, including REM SLEEP BEHAVIOR DISORDER.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal communication between two arteries that may result from injury or occur as a congenital abnormality.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal concretion or calcified deposit that forms around the teeth or dental prostheses.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal development of cartilage and bone. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal development of immature squamous EPITHELIAL CELLS of the UTERINE CERVIX, a term used to describe premalignant cytological changes in the cervical EPITHELIUM. These atypical cells do not penetrate the epithelial BASEMENT MEMBRANE.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal distention of the STOMACH due to accumulation of gastric contents that may reach 10 to 15 liters. Gastric dilatation may be the result of GASTRIC OUTLET OBSTRUCTION; ILEUS; GASTROPARESIS; or denervation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal enlargement or overgrowth of the gingivae brought about by enlargement of existing cells.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal fear or dread of visiting the dentist for preventive care or therapy and unwarranted anxiety over dental procedures.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal genetic constitution in males characterized by an extra Y chromosome.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal immunoglobulins synthesized by atypical cells of the RETICULOENDOTHELIAL SYSTEM. Paraproteins containing only light chains lead to Bence Jones paraproteinemia, while the presence of only atypical heavy chains leads to heavy chain disease. Most of the paraproteins show themselves as an M-component %28%monoclonal gammopathy%29% in electrophoresis. Diclonal and polyclonal paraproteins are much less frequently encountered.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal increase in eosinophils in the blood, tissues or organs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal increase in skeletal or smooth muscle tone. Skeletal muscle hypertonicity may be associated with PYRAMIDAL TRACT lesions or BASAL GANGLIA DISEASES.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal intracellular inclusions, composed of denatured hemoglobin, found on the membrane of red blood cells. They are seen in thalassemias, enzymopathies, hemoglobinopathies, and after splenectomy.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes %28%see MOVEMENT DISORDERS%29%. Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal isoform of prion proteins %28%PRIONS%29% resulting from a posttranslational modification of the cellular prion protein %28%PRPC PROTEINS%29%. PrPSc are disease-specific proteins seen in certain human and animal neurodegenerative diseases %28%PRION DISEASES%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents %28%see ANTIPSYCHOTIC AGENTS%29%. %28%Adams et al., Principles of Neurology, 6th ed, p1199%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal number or structure of chromosomes. Many chromosome aberrations, but not all, are the cause of CHROMOSOME DISORDERS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal number or structure of the SEX CHROMOSOMES. Many sex chromosome aberrations, but not all, are the cause of SEX CHROMOSOME DISORDERS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal passage between the ESOPHAGUS and the TRACHEA, acquired or congenital, often associated with ESOPHAGEAL ATRESIA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal passage communicating with the ESOPHAGUS. The most common type is TRACHEOESOPHAGEAL FISTULA between the esophagus and the TRACHEA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal passage communicating with the PANCREAS. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal passage communicating with the STOMACH. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal passage in any organ of the biliary tract or between biliary organs and other organs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal persistence of an open lumen in the ductus arteriosus after birth, the direction of flow being from the aorta to the pulmonary artery, resulting in recirculation of arterial blood through the lungs. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS %28%the zone of dilation%29% and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal protrusion of one or both of the leaflets of the mitral valve into the left atrium during systole. This may be accompanied by mitral regurgitation, systolic murmur, nonejection click, or cardiac arrhythmia.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal protrusion of one or more of the leaflets of the tricuspid valve into the right atrium during systole.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal sensitivity to light. This may occur as a manifestation of EYE DISEASES; MIGRAINE; SUBARACHNOID HEMORRHAGE; MENINGITIS; and other disorders. Photophobia may also occur in association with DEPRESSION and other MENTAL DISORDERS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal smallness of the head, usually associated with mental retardation. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal structures located chiefly in distal dendrites and, along with NEUROFIBRILLARY TANGLES and SENILE PLAQUES, constitute the three morphological hallmarks of ALZHEIMER DISEASE. Neuropil threads are made up of straight and paired helical filaments which consist of abnormally phosphorylated microtubule-associated tau proteins. It has been suggested that the threads have a major role in the cognitive impairment seen in Alzheimer disease.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments %28%neurofilaments and microtubules%29%. These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: %28%1%29% the intermediate filaments: medium- and high-molecular-weight neurofilaments; %28%2%29% the microtubule-associated proteins map-2 and tau; %28%3%29% actin; and %28%4%29% UBIQUITINS. As one of the hallmarks of ALZHEIMER DISEASE, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brain stem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of Alzheimer disease.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal swelling of the outer aspect of the fifth metatarsal head affecting the fifth METATARSOPHALANGEAL JOINT.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormal, tangled collections of dilated blood vessels that result from congenitally malformed vascular structures in which arterial afferents flow directly into venous efferents without the usual resistance of an intervening capillary bed. A common type is the congenital arteriovenous fistula %28%ARTERIOVENOUS FISTULA /congenital%29%. For arteriovenous malformations in the brain, INTRACRANIAL ARTERIOVENOUS MALFORMATIONS is available. %28%From Merck Manual, 15th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities in development of the GONADS, the genital tracts, and the external GENITALIA. Disorders of sexual differentiation are due to genetic defects or endocrine imbalance. Sex-determining genes %28%GENE, SRY%29% dictate the gonadal SEX whereas the fetal TESTICULAR HORMONES determine the somatic sex during SEX DIFFERENTIATION.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities in the serum levels of LIPIDS. Dyslipidemias are disorders of lipid and LIPOPROTEIN metabolism, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and normal to elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities of motor function that are associated with organic and non-organic cognitive disorders.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Autosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Cardiovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Chromosomal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Congenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Congenital, Nervous System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Craniofacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Cytogenetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Digestive System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Drug Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Drug-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Drug-Induced %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Eye' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Genitourinary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Heart' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Jaw' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Lymphatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Maxillofacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Mouth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1966-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1966-1996%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1966-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1967-1995%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1982%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1968-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1979-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Multiple %28%1981-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Musculoskeletal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Nervous System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Radiation Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Radiation-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Respiratory System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Sex Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Skin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Stomatognathic System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Teeth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Tooth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormalities, Urogenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Autosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Cardiovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Chromosomal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Congenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Craniofacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Cytogenetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Digestive System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Drug-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Eye' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Genitourinary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Heart' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Jaw' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Lymphatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Maxillofacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Mouth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Musculoskeletal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Nervous System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Radiation-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Respiratory System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Sex Chromosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Skin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Stomatognathic System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Teeth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Tooth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormality, Urogenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally diminished or absent perspiration. Both generalized and segmented %28%reduced or absent sweating in circumscribed locations%29% forms of the disease are usually associated with other underlying conditions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally elevated THYROXINE level in the BLOOD. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally high BLOOD GLUCOSE level, beyond the normal range %28%roughly 70 to 150 mg/100 ml of PLASMA%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally high level of calcium in the blood. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally high levels of cholesterol in the blood. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities %28%elevated T waves and depressed P waves, and eventually by atrial asystole%29%. In severe cases, weakness and flaccid paralysis may occur. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation %28%heat waves, infra-red%29%, ultrasound, or drugs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally increased convexity in the curvature of the thoracic spine as viewed from the side. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally infrequent menstruation. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally low BODY TEMPERATURE intentionally induced in warm-blooded animals by artificial means.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally low blood pressure seen in shock but not necessarily indicative of it. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally low intraocular pressure often related to chronic inflammation %28%uveitis%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities %28%depression of the T wave and elevation of the U wave%29%, by renal disease, and by gastrointestinal disorders. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abomasum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abomasums' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aborigine, Australian' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aborted Embryo' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aborted Embryos' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aborted Fetus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aborted Fetuses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Non Steroidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Non-Steroidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Non-Steroidal %28%1975-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Non-Steroidal %28%1977-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Nonsteroidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Steroidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacient Agents, Steroidal %28%1975-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacients' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortifacients, Steroid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion %28%Induced%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Applicant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Applicants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Center' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Failures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Histories' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion History' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Rates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Seeker' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Seeker, Refused' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Seeker, Repeated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Seekers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Survey' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Technic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Technics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion Technique' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion induced to save the life or health of a pregnant woman. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion performed because of possible fetal defects. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Clonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Criminal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Criminal %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Drug Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Eugenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Habitual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Habitual %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Illegal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Incomplete' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Induced %28%1970-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Induced %28%1984-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Legal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Legal %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Legal %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Missed' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Previous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Recurrent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Saline Solution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Septic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Soap Solution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Spontaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Spontaneous %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Therapeutic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Therapeutic %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Therapeutic %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Threatened' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortion, Veterinary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions %28%Induced%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Clonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Criminal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Drug-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Eugenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Habitual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Illegal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Incomplete' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Legal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Missed' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Previous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Recurrent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Rivanol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Saline-Solution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Selective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Septic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Soap-Solution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Spontaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Therapeutic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Threatened' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Tubal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abortions, Veterinary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'About an axis, the product of a force and the distance of its line of action from the axis. %28%NASA Thesaurus, 1994%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abrasion, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abrasion, Dental Air' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abrasion, Tooth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abrasions, Dental Air' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abreaction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abreactions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abrin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abruptio Placentae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abruption, Placental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abruptions, Placental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abrus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess %28%1966-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess %28%1968-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess %28%1977-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess of the PSOAS MUSCLES resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Amebic Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Amebic, Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Amoebic Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Amoebic Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Apical Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Apical Dentoalveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Brain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Cerebral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Child Brain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Cranial Epidural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Cranial Extradural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Epidural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Extradural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Hepatic, Amebic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Iliopsoas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Intra Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Intra-Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Intracranial Epidural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Intracranial Extradural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Liver, Amebic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Lung' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Multiple Brain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Periapical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Periodontal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Peritonsillar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Psoas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Pyogenic Brain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Pyogenic Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Pyogenic Iliopsoas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Pyogenic Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Retropharyngeal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Spinal Epidural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Spinal Extradural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Subdiaphragmatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess, Subphrenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscess/complications %28%1966-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Amebic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Amebic Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Amoebic Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Amoebic Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Apical Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Apical Dentoalveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Cerebral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Iliopsoas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Intra-Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Intracranial Extradural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Lung' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Multiple Brain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Periapical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Periodontal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Peritonsillar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Psoas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Pyogenic Hepatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Pyogenic Iliopsoas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Pyogenic Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Retropharyngeal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Subdiaphragmatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscesses, Subphrenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscisic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscissic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscissins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abscission-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsies, Childhood' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsies, Juvenile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsies, Myoclonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsy, Childhood' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsy, Juvenile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Epilepsy, Myoclonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Seizure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Seizure Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Seizure Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Seizure, Atonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Seizures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Seizures, Atonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence Status' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of Brain, Congenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of Cerebral Hemispheres, Congenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of Voice' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of a normal opening in the lumen of the female genital tract, from the FALLOPIAN TUBES to the VAGINA. This anomaly may be congenital or acquired due to injuries, diseases, or adhesions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of hair from areas where it is normally present.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of menstruation. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of teeth from a portion of the mandible and/or maxilla.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of the crystalline lens resulting from cataract extraction.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence of the orifice between the right atrium and ventricle, with the presence of an atrial defect through which all the systemic venous return reaches the left heart. As a result, there is left ventricular hypertrophy %28%HYPERTROPHY, LEFT VENTRICULAR%29% because the right ventricle is absent or not functional.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absence or reduced levels of prothrombin in the blood. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absent Reflex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absent or reduced sensitivity to cutaneous stimulation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absenteeism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absenteeism %28%1966-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absidia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absinthe' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbable Cellulose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbable Gelatin Sponge' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbable Gelatin Sponges' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbable Implant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbable Implants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbent Pad' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbent Pads' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbent pads designed to be worn as underpants or pants liners by adults.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbent pads designed to be worn by infants and very young children.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorbent pads used for URINARY INCONTINENCE and usually worn as underpants or pants liners by the ELDERLY.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometries, Dual-Photon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometries, Photon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometries, Single-Photon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Dual Energy Radiographic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Dual Energy X Ray' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Dual-Energy Radiographic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Dual-Energy X-Ray' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Dual-Photon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Photon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptiometry, Single-Photon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption %28%1972-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption Spectrophotometry, Atomic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption, Intestinal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption, Percutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorption, Skin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptions, Skin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstaining from all food. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstinence Syndrome, Neonatal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstinence Syndromes, Neonatal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstinence from alcohol. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstinence, Periodic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstinence, Postpartum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstinence, Sexual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstract standards or empirical variables in social life which are believed to be important and/or desirable.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstracting and Indexing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstracts %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abstracts %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abundant Src Homology Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse Drugs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse of children in a family, institutional, or other setting. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Aged' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Alcohol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Amphetamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Angel Dust' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Cannabis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Child' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Child Sexual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Cocaine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Elder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Hashish' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Heroin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Human Rights' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Marihuana' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Marijuana' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Morphine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Narcotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, PCP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Partner' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Phencyclidine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Sexual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Sports Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Spousal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Spouse' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Substance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, Wife' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuse, overuse, or misuse of a substance by its injection into a vein.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abused Woman' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abused Women' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuses, Child' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuses, Narcotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuses, Sexual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuses, Sports Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abuses, Substance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abutment, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Abutments, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ac Hly, Bordetella' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ac%C3%%A9%butolol ratiopharm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ac%C3%%A9%butololratiopharm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ac-Hly, Bordetella' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acacia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acacia %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acacia Gum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acacia, Gum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Disorder, Developmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Disorders, Developmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Dissertation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Dissertations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Dissertations %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Dissertations %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Medical Center' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academic Medical Centers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academies and Institutes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academies and Institutes %28%1970-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Academy and Institute' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acalculous Cholecystitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acalculous Gallbladder Inflammation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthamoeba' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthamoeba %28%1987-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthamoeba Keratitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthamoeba Keratitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthamoeba castellanii' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthocephala' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthocheilonema' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthocheilonema perstans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthocheilonemiases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthocytes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acantholyses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acantholysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acantholysis Bullosa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthoma, Degos' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthomas, Clear Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthomas, Pilar Sheath' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthopanax' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthopodina' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acanthosis Nigricans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acarbose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acari' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acariasis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acaridae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acatalasemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acatalasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acathisia, Drug Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acathisia, Drug-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acathisias, Drug-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AccEBI Endonuclease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerated Ambulation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerated Idioventricular Rhythm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerated Idioventricular Rhythms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceleration' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceleration %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceleration produced by the mutual attraction of two masses, and of magnitude inversely proportional to the square of the distance between the two centers of mass. It is also the force imparted by the earth, moon, or a planet to an object near its surface. %28%From NASA Thesaurus, 1988%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceleration, Coriolis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerator, Linear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerator, Particle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerators, Linear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelerators, Particle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accelographies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptability of Healthcare' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptability, Method' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptability, Program' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptance Process' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptance, Physician Assignment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptances, Physician Assignment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptor Characteristic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptor Site, Splice' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptor Sites, Splice' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptor, New' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acceptor, Repeat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Access Port, Vascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Access Ports, Vascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Access to Health Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Access to Information' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Access, Facility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accesses, Facility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessibility of Health Services' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessibility, Architectural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessibility, Health Services' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessibility, Program' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Bodies of Cajal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Cell, Immunologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Cells, Immunologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerve' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerve %28%1965-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerve Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerve Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerve, Spinal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerves' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Nerves, Spinal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Olfactory Bulbs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Pancreatic Ducts' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory Sex Organ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Insurance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Insurances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Prevention' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Prevention %28%1966-1969%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Prevention %28%1966-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Preventions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Proneness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident Pronenesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Acute Cerebrovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Aviation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Brain Vascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Cerebrovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Chernobyl Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Chornobyl Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Home' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Industrial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Nuclear Reactor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Occupational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Radiation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accident, Traffic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental Electrocution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental Electrocutions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental Fall' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental Falls' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental Hypothermia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental Hypothermias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental dispersal of radioactive materials from a radiation source. Accidents at nuclear reactors can involve large groups of the population from dispersion of radioactivity into the environment and through fallout or a few individuals with high injurious doses.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidental injuries caused by brief high-voltage electrical discharges during thunderstorms. Cardiopulmonary arrest, coma and other neurologic symptoms, myocardial necrosis, and dermal burns are common. Prompt treatment of the acute sequelae, including cardiopulmonary resuscitation, is indicated for survival.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidentally acquired infection in laboratory workers. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents %28%1967-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents %28%1986-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES %28%passenger cars, buses, and trucks%29%, BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES; RAILROADS nor snowmobiles.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Acute Cerebrovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Aviation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Brain Vascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Cerebrovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Chernobyl Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Chornobyl Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Home' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Nuclear Reactor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Occupational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Radiation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Traffic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accidents, Traffic %28%1966-1969%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acclimation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acclimatization' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accommodation, Ocular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accommodation, Ocular %28%1966-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accommodation, Ocular %28%1967-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accommodation, Ocular Distance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Account Books' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Account Books %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Account Books %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Account, Medical Savings' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accountability and responsibility to another, enforceable by civil or criminal sanctions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accountability, Social' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accountable Health Plan' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accountable Health Plans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accounting' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accounting %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accounting procedures for determining credit status and methods of obtaining payment.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accounting, Demographic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accountings' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accounts Payable and Receivable' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accounts, Medical Savings' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accreditation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accreditation %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accreditations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accreta, Placenta' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acculturation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acculturations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumbens, Nucleus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated %28%indirect%29% or the conjugated %28%direct%29% form. The condition may be self-limiting %28%PHYSIOLOGICAL NEONATAL JAUNDICE%29% or pathological with toxic levels of bilirubin.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation of a drug or chemical substance in various organs %28%including those not relevant to its pharmacologic or therapeutic action%29%. This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation of blood in the cranial epidural space due to rupture of the middle meningeal artery or rarely the meningeal vein, often associated with a temporal or parietal bone fracture. The hematoma tends to expand rapidly, compressing the dura and underlying brain. Clinical features include the acute or subacute onset of HEADACHE; VOMITING; alterations of mentation, and HEMIPARESIS. The natural history of the process is progression to COMA and eventually DEATH. %28%Adams et al., Principles of Neurology, 6th ed, p885%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation of purulent EXUDATES beneath the DIAPHRAGM, also known as upper abdominal abscess. It is usually associated with PERITONITIS or postoperative infections.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation of watery fluid in the cavity of a joint. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulation or retention of free fluid within the peritoneal cavity.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Accumulations of solid or liquid animal excreta usually from stables and barnyards with or without litter material. Its chief application is as a fertilizer. %28%From Webster%27%s 3d ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acebutolol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acebutolol Gepepharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acecainide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acecainide Monohydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acedapsone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acellular Vaccines' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acemidophen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acenaphthenes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acenocoumarin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acenocoumarol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acenocoumarol Alliance Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acenocoumarol Ciba-Geigy Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acenocoumarol Novartis Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acepromazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aceraceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetabularia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetabularias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetabulum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetabulums' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetaldehyde' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetals %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1971-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1973-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1973-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamides %28%1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetamidophenol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetaminophen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilide derivative used as a local anesthetic. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides %28%1970-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides %28%1973-1974%29%/analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides %28%1974%29% /analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides %28%1977-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetanilides/analogs %26% derivatives %28%1977-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate CoA Ligase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate Esterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate Esterase, alpha-Naphthyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate Free Biofiltration' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate Hydrochloride, Levomethadyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate Thiokinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, 6-alpha-Methyl-17alpha-hydroxyprogesterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Benzocaine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Buserelin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Carbamazepine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Chlorhexidine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Chlormadinon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Chlormadinone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Depo-Medroxyprogesterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Dequalinium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Desmopressin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Diethylaminoethyldiphenylpropyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Dipropyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Flecainide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Flugestone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Fluorogestone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Flurogestone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Gonadorelin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Hydrated Saralasin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Leuprolide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Levomethadyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Lysine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Mafenide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Medroxyprogesterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Megestrol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Melengestrol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Methadyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Methylazoxymethanol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Mitoxantrone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Oxyphenisatin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Paroxetine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Phenylmercuric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Phorbol Myristate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Teriparatide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Tetradecanoylphorbol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate, Zinc' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate-CoA Ligase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetate-Free Biofiltrations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetates %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetates %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetates %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetates %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetates, Germine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Apotex Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Chiesi Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Dioptic Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Grin Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide ICN Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Jumer Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Llorens Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Medphano Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Novopharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Orion Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetazolamide Wassermann Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetfenolisatin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acid Glacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acid, 5-Hydroxyindolamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acid, Glacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1968-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1968-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1968-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1973-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1976-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Acids %28%1981-1996%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic Anhydrides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic acid and its derivatives which may be formed by substitution reactions. Mono- and di-substituted, as well as halogenated compounds have been synthesized.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetic acid derivatives of the heterocyclic compound indole. %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoacetates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoacetates %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoacetyl CoA Thiolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacter %28%1997-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacter %28%2000-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacter liquefaciens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacter xylinum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacter xylinus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacteraceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacteraceae %28%1993-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacteraceae %28%1999-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobacterium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetobutolol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohexamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohexamide Lilly Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohexamide Salvat Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohydroxy Acid Isomeroreductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohydroxy Acid Reductoisomerase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohydroxy Acid Synthase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetohydroxy Acid Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoin Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetokinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetolactate Synthase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetolactate Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetominophen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetonchloroform' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetone %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetone %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetonide 21-Acetate, Fluocinolone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetonide, Fluocinolone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetonide, Fluortriamcinolone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetonide, Triamcinolone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetonitriles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetophenetidin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetophenide, Algestone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetophenide, Alphasone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetophenide, Dihydroxyprogesterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetophenones' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetopromazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetothiokinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoxyacetamidofluorene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoxyacetylaminofluorene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoxyfluorenylacetamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoxyphenylmercury' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetoxythymoxamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetrizoic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl 2 methylcholine Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Activating Enzyme' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Carnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA ACP Transacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Acylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Arylamine N Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA C Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA C Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Carboxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Deacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Dihydrolipoamide S Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Glutamate N Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Glutamate N-Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Hydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA Transacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl CoA-ACP Transacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A %28%1974-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Acyl Carrier Protein Transacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Carboxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Glutamate N Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Glutamate N-Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Hydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Coenzyme A-Acyl Carrier Protein Transacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Glyceryl Ether Phosphorylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Hapten, NIP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl Hydroperoxide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl L Carnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl LDL Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl LDL Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl beta methacholine Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl beta methylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-2-methylcholine Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Acylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Arylamine N-Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA C-Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA C-Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Carboxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Deacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Hydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA Transacylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-CoA-Dihydrolipoamide S-Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-LDL Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-LDL Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyl-beta-methacholine Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylanilines' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylase, Arylamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylase, Choline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylase, Glucosamine-6-Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylase, Histone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylases, Arylamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylated LDL Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of DAPSONE. It has antimicrobial and antimalarial action, but is mainly used as a depot leprostatic agent.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylbenzoyl aconine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylbenzoyl-aconine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylbenzoylaconine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcarnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Hydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine L Tartrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Picrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Receptor, Muscarinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Receptor, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Receptors, Muscarinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Receptors, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Transporter, Vesicular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine Transporters, Vesicular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholine/pharmacology %28%1967-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholinesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcholinesterase %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcystein, mentopin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Alcon Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Aluid Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Atid Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Azupharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Betapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Bioiberica Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Bouchara Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Centrafarm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Disphar Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Farmasan Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Fresenius Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine G%C3%%A9%n%C3%%A9%vrier Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine GNR-Pharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Guerbet Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Hermes Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Heumann Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Inpharzam Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Intra Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Klinge Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Krewel Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Lichtenstein Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Lindopharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Merck Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Oberlin Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Pfleger Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Pharbita Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Roberts Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Temmler Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Teva Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Thiemann Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Trommsdorff Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine UPSA Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Whitehall Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Zambon Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine Zyma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylcysteine ac-Pharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyldigitoxins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyldigoxins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyldiphenazonum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylformaldehyde' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylgalactosamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylgalactosamine %28%1978-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylgalactosamine, UDP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylgalactosaminyltransferase, Fucosyl Galactose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylglucosamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylglucosamine, UDP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylglucosaminidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylglucosaminidase %28%1986-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylglucosaminyltransferase, Chitin-UDP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylhydrolase II, PAF' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylhydrolase, PAF' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylmethadol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylmethylcarbinol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylmuramic Acid, UDP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylmuramyl Alanyl Isoglutamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylmuramyl-Alanyl-Isoglutamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylneuraminic Acid, CMP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylprocainamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylpromazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylsalicylic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylserotonin Methyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylserotonin N Methyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylserotonin N-Methyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylsulfanilamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetylthiocholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Acetyl-CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Amino Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Amino-Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Carnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Chloramphenicol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Choline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Dihydrolipoamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Dihydrolipoyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Dihydrolipoyllysine-Residue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Glucosamine-6-Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Glucosamine-Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Histone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Lipoate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Serine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferase, Serotonin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferases %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferases %28%1973-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferases %28%1973-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferases, Arylamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acetyltransferases, Histone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achalasia, Esophageal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achalasias, Esophageal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ache, Back' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ache, Low Back' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ache, Neck' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aches' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aches, Back' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aches, Low Back' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aches, Neck' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achievement' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achievement of full sexual capacity in animals and in humans.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achievement, Educational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achievements' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achievements, Educational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achillea' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achilleic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achilles Tendon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achilles Tendons' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achlorhydria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achlya' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acholeplasma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acholeplasma laidlawii' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acholeplasmataceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achondroplasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achondroplasias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achras zapotilla' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achromobacter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achromobacter cycloclastes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achromobacter denitrificans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achromobacter xylosoxidans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achylia Gastrica' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achyranthes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Achyrocline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aci Sanorania' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Abello Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Alcon Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Alphapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Amrad Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Azupharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Betapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Britisfarma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Clonmel Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Dermapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Fabrigen Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Fustery Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Gr%C3%%BC%nenthal Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Grin Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Hexal Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Isis Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Kendrick Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Lichtenstein Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Liomont Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Mann Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Menarini Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Niddapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Novag Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Novartis Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Pensa Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Pisa Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Rentschler Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Sanorania' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Sanorania Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Stada Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir TAD Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Ursapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Warner-Lambert Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Wellcome Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Wolff Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Yamanouchi Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir Zyma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir ct-Arzneimittel Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aciclovir-Sanorania' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid 3-O-hemisuccinate, Glycyrrhetinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid 4-Hydroxylase, Trans-Cinnamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Acetyltransferase, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Agents, gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Agonist, gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Agonists, gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Amide Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Amino Acid Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Ammonia Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Ammonium Purpurate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Anhydrase, Organophosphorus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Anhydride Hydrolases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Anhydride Hydrolases %28%1994-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Anhydrolase, Organophosphorus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Antagonists, Folic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Antagonists, gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Aspiration Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Base Balance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Base Equilibrium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Base Imbalance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Bisdimethylamide, Diazodicarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Carboxy-Lyase, 2-Oxo' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Carboxypeptidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Ceramidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Decarboxylase, Glutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Deficiencies, Folic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Deficiency, Folic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Dehydratase, Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Dehydratase, delta-Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Dehydrogenase, Alpha-Keto' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Dehydrogenase, D-Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Dehydrogenase, Inosinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Delta-6-Desaturase, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Denaturation, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Denaturations, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Diethylamide, Lysergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Esterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Esters, Acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Esters, Formic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Esters, Phosphonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Esters, Phosphoric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Esters, Thiophosphoric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Etching, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Etching, Dental %28%1977-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Etching, Dental %28%1982-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Glacial, Acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Heteroduplexes, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hybridization, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hybridizations, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hydrase, 9,10-Epoxypalmitic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hydrazide, Maleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hydrochloride, Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hydrolase, Organophosphorus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hydroperoxides, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Hydroxylase, Lauric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Invertase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Isomerases, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Isomeroreductase, Acetohydroxy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Maltase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Maltase Deficiency Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Modulators, gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Omega-Hydroxylase, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Omega-hydroxylase, Lauric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Oxidase, Homogentisic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Oxidase, L-Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Oxidase, L-Pipecolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Oxidase, dextro-Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Oxidoreductases, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Oxygenase, 3-Hydroxyanthranilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Phosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Phosphate Fluoride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Polyester, Glycolic-Lactic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Polymers, Methacrylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Precursors, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Probes, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Racemases, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Rain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Rains' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Receptor, Lysophosphatidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Receptors, Lysophosphatidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Reductase, Dihydrodipicolinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Reductase, Folic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Reductoisomerase, Acetohydroxy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Renaturation, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Renaturations, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Seromucoid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Synthase, Acetohydroxy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Synthase, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Synthetase, Acetohydroxy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Synthetase, Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Synthetase, delta-Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Test, Formiminoglutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Tests, Formiminoglutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Thiol Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Transport, Ribonucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Transporters, Monocarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Urate, Ammonium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid Urate, Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid alpha 1 Glycoprotein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid alpha 1-Glycoprotein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid beta Glucosidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid beta Glycerophosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid beta-Glucosidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 1-Aminocyclopentanecarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 12-S-Hydroxyeicosatetraenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2 Aminoadipic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2,3-Diketogulonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2-Aminoadipic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2-Aminoethylphosphonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2-Aminohexanedioic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2-Hydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2-Thiol-propionamido-acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 2-Thiolpropionamidoacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Caffeoylquinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Hydroxy-3-methylglutaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Hydroxy-3-methylpentanedioic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Hydroxyanthranilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Hydroxybutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Mercaptopropanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Mercaptopropionic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Methoxy-4-Hydroxyphenylacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Nitro-4-Hydroxyphenylarsonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 3-Pyridinecarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 4-Aminobenzenearsonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 4-Chloromercuribenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 4-Hydroxy-3-Methoxymandelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 4-Hydroxy-3-Methoxyphenylacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 4-Hydroxy-3-methoxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 5%27%-Guanylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 5-Butyl-2-pyridinedicarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 5-Hydroxy-3-Indoleacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 5-Hydroxyindolamine Acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 5alpha-Isomer Deoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 6-Aminocaproic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 6-Aminohexanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 9,12-Octadecadienoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 9-Octadecenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 99m-Tc-Dimercaptosuccinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 99mTc-Diethyliminodiacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, 99mTc-Dimercaptosuccinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Acetrizoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Acetylsalicylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Achilleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aconitic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Acontic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Adonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Amidotricoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Amidotrizoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminoacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminocaproic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminocyclopentanecarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminoethylphosphonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminooxoacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminooxyacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminopropylaminoethylthiophosphoric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aminosalicylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Apurinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Argininosuccinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Arsanilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ascorbic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aspartic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Atractylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aureolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aurin Tricarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Aurintricarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Azetidine-2-carboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Azetidinecarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Azolinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Benzoaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Benzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Bichloroacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Butanedioic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Butanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Butyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, CMP Acetylneuraminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, CMP-Sialic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Cacodylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Canrenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Capronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Carbolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Carbonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Carboxyglutaconic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Catechinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Catechuic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Cellulosic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chenique' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chenodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chlorogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chloromercuribenzene-p-sulphonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Choleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Cholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chorismic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Chrysotropic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Citric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Citridic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Citridinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Clodronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Cysteic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Cytidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, D-Glucaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dehydroascorbic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Delta-Aminolevulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Deoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Deoxycytidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Deoxyursocholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Desoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Diaminopimelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dichloroacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dichloromethanediphosphonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Diethylenetriamine Pentaacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Digenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dihomo-gamma-Linolenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dihomogammalinolenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dihydroxycholanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dimethylarsinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Dithionitrobenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Edetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Egtazic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ellagic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Equisetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Etacrynic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ethacrinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ethacrynic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ethylenediaminetetraacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ethylenedinitrilotetraacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Etodolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Excitatory Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Flufenamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Fluohydric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Fluorhydric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Folic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Folinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Formiminoglutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Fusaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Fusidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Gallic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Gallodesoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Gastric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Gastric Hydrochloric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Gelseminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glacial Acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glucaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glucosaccharic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycerol Teichoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycochenodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycyrrhetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycyrrhetinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycyrrhizic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glycyrrhizinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Glyoxalinylacrylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hexadecanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hexadienoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Homo-gamma Linolenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Homogentisic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Homovanillic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hyaluronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrobromic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrobromide Aspartic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrochloric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrochloride Aspartic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrochloride gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrocyanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydrofluoric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydroxamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydroxyethylsulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Hydroxyindoleacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ibotenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iduronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Inosinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iodoacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iodogorgoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iodohippuric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iodopanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ioglycamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iopanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iotalamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Iothalamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Isethionic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Isolithocholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Isonicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Kainic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ketoglutaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Kynurenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, L-Ascorbic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, L-Aspartic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, L-Gularic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Lactic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Lagodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Levo-Gularic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Lithocholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Lysergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Meclofenamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mefenamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mefenaminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mercapturic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mersalyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Methalamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Methoxyhydroxymandelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Methylmalonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mevalonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Monoiodoacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Muramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Muriatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mycolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Mycophenolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Myristic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, N-Acetylneuraminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, N-Methyl-D-aspartic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Nafenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Nalidixic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Niflumic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Nitric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Nitrilotriacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Nitrous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ocadaic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Okadaic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oleanolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Orotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Osmic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oxalamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oxalic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oxamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oxamidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Oxolinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Palmitic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Paraperiodic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Penicillanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Penicillic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Peracetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Perchloric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Periodic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Peroxyacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Peroxyethanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Peroxynitrous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phenylethylbarbituric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phosphatidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phosphinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phosphonacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phosphonoacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phosphotungstic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phytanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Phytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pimelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pipemidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Piperamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Piromidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Polyadenylic-Polyuridylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Polyanhydroglucuronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Propenylacrylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pseudomonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pteroylglutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pyrocitric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pyroglutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pyrrolidonecarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Pyruvic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Quinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Retinoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Rhetinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ribonucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Salicylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Selenious' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Shikimic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Sialic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Sorbic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Succinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tannic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Taurochenodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Taurodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Taurolithocholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tc-99m Dimercaptosuccinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Technetium-99m-Diisopropyliminodiacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Technetium-99m-Dimercaptosuccinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tenuazonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tetradecanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tetrahydroxyadipic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Thienylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Thymidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tienilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Tranexamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Trichloroacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Trifluoroacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Triiodobenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, UDP Acetylmuramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, UDP Glucuronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Undecylenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Uralenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Uric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Uridine Diphosphoglucuronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Uridylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Urocanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Urogranoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ursacholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Ursodeoxycholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Valproic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Vanillic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Vanillylmandelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Vanilmandelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, Vitamin A' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, all-trans-Retinoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, alpha-Aminoadipic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, alpha-Lipoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, beta-Hydroxybutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, beta-all-trans-Retinoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, cis-9-Octadecenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, epsilon-Aminocaproic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, gamma-Vinyl-gamma-Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, o-Hydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, ortho-Hydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, p-Aminophenylarsonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, p-Butoxyphenylacethydroxamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, p-Chloromercuribenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, p-Hydroxy-m-methoxy-benzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, tRNA-Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid, trans-Retinoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-3-Phosphate Synthase, 5-Enolpyruvylshikimic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Amide Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Amino-Acid Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Ammonia Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Base Balance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Base Equilibrium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Base Equilibrium %28%1966-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Base Imbalance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Base Imbalances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Specific tRNA, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Specific tRNA, Aspartic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Specific tRNA, Glutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acid-Thiol Ligases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidaminococcaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidaminococcus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidemia, Hyperpipecolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidemias, Hyperpipecolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidianus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Amino Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Amino Acid Transport Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Amino Acid Transport Systems' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Amino Acid Transporters' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Amino Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Dipeptidase, N-Acetylated-alpha-Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Fibroblast Growth Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic Glycosphingolipids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic protein found in SARCOPLASMIC RETICULUM that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary thymocytes, granulocytes, macrophages, erythrocytes, and fibroblasts. CD44 antigens are the principle cell surface receptors for hyaluronate and this interaction mediates binding of lymphocytes to high endothelial venules. %28%From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidic water usually pH 2.5 to 4.5, which poisons the ecosystem and adversely affects plants, fishes, and mammals. It is caused by industrial pollutants, mainly sulfur oxides and nitrogen oxides, emitted into the atmosphere and returning to earth in the form of acidic rain water.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidin Pepsin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AcidinPepsin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidiphilium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidithiobacillus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidithiobacillus thiooxidans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidity Determination, Gastric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidity Determinations, Gastric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidophil Adenoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidophil Adenomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidophilic Adenoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidophilic Adenomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidoses, Diabetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidoses, Renal Tubular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidoses, Respiratory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis %28%1966%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis %28%1985-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as diabetes mellitus, leukemia, or liver failure.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Diabetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Lactic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Lactic %28%1987-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Renal Tubular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Renal Tubular Type IV' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Renal Tubular, Type I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Renal Tubular, Type II' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidosis, Respiratory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids %28%1974-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids %28%1983-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids Activation, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids Activations, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids derived from monosaccharides by the oxidation of the terminal %28%-CH2OH%29% group farthest removed from the carbonyl group to a %28%-COOH%29% group. %28%From Stedmans, 26th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, 2,5-Dihydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, 2-Butenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, 4-Hydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Acetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Acyclic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Adipic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aldehydic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aliphatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Alkanesulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminobenzenesulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminobenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminocaproic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminohippuric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminoisobutyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Aminosalicylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Anacardic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Anilinesulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Anthranilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Arachidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Arachidonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Arylsulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Benzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Bile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Boric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Borinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Boronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Branched-Chain Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Brassidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Butanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Butyric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Caffeic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Capric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Carbocyclic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Carboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Cephalosporanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Cholalic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Cholic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Clavulanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Conjugated Linoleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Coumaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Crotonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Cyclic Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Cyclohexanecarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Cytidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Decanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Deoxycytidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Diamino Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Dibasic Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Dicarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Dicarboxylic Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Dihydrooleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Diphenylacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Diphosphoglyceric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Docosahexaenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Docosahexenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Docosenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Dodecanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Eicosanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Eicosatetraenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Erucic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Essential Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Essential Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Esterified Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Ethanedioic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Excitatory Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Formic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Formyltetrahydrofolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Free Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Gastric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Gastric Hydrochloric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Glucuronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Glutaminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Glyceric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Glycerol Teichoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Guanylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Heptanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Heterocyclic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hexanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hexouronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hexuronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Humic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hydroxamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hydroxy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hydroxycinnamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hydroxyeicosatetraenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hydroxymalonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Hypophosphorous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Imino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Indoleacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Indolylacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Inosinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Isonicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Isonipecotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Keto' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Ketoglutaric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Lauric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Levulinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Linoleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Lysophosphatidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Mandelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Monounsaturated Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Muramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Mycolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Myristic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, N-6 Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, N-Acetylneuraminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Naphthaleneacetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Neuraminic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Neutral Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Nipecotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Noncarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Nonesterified Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Octadecanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Octadecenoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Octanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Oleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Omega-3 Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Omega-6 Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Oxalic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Palmitic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Pentanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Peptide Nucleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Perchloric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Periodic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Peroxynitrous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phenylpyruvic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphatidic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphinous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphoamino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphonous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphoric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphorous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphorus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phosphorus Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Phthalic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Picolinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Pimelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Pipecolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polycytidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polyguanylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polyinosinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polymethacrylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polythymidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polyunsaturated Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Polyuridylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Propionic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Prostanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Pteroylpolyglutamic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Pyrophosphoric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Quinolinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Ricinoleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Salicylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Saturated Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Secondary Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sialic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Stearic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Succinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sugar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfanilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfur' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfur Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfuric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Sulfurous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Tannic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Teichoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Tetradecanoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Tetrahydrolinoleic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Thiosulfonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Thymidylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Trans Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Trans-Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Tricarboxylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Triiodobenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Undecylenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Unsaturated Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Uridylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, Uronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, o-Aminobenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, ortho-Aminobenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, para-Hydroxybenzoic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, salts, and derivatives of BENZOIC ACID. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, salts, and derivatives of OXALIC ACID. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acids, salts, and derivatives of clavulanic acid %28%C8H9O5N%29%. They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acidulated Phosphate Fluoride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinar Cell Carcinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinar Cell Carcinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter %28%1975-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter %28%1988-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter baumannii' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinetobacter calcoaceticus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acinonyx' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acitretin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acitretin Andreu Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acitretin Roche Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ackee' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aclacinomycin A' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aclarubicin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aclases, Diaphyseal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aclasis, Diaphyseal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne Keloid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne Keloidalis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne Keloids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne Rosacea' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne Vulgaris' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne Vulgaris %28%1966-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acne, Keloidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acneiform Eruption' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acneiform Eruptions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acocantherin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acolongifloroside K' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitase 1, Soluble' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitate Hydratase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconite %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aconitum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acontic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoraceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acorus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Evoked Brain Stem Potential' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Evoked Brain Stem Potentials' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Evoked Brainstem Potential' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Evoked Brainstem Potentials' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Impedance Test' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Impedance Tests' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Macula' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Maculae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Maculas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Microscopies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Microscopies, Scanning' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Microscopy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Microscopy, Scanning' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve %28%1966-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerve Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Nerves' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurilemmoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurilemmomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurilemoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurilemomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurofibromatoses, Bilateral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neurofibromatosis, Bilateral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neuroma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neuroma, Cerebellopontine Angle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neuroma, Familial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neuromas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Neuromas, Familial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Perceptual Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Perceptual Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Reflex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Rhinometry' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Schwannoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Schwannomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Stimulation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Stimulation %28%1972-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Stimulation %28%1984-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic Trauma %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustic, Speech' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics %28%1972-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics %28%1973-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics %28%1984-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics %28%1991-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acoustics, Speech' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acovil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Agraphias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Alexia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Aphasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Blindness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Childhoood Aphasia with Convulsive Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Color Blindness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Communication Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Deafness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Dysgraphia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Dysgraphias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Dyslexia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Ear Deformities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Ear Deformity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Encephaloceles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Epidermolysis Bullosa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Epileptic Aphasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Epileptic Aphasias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Facial Neuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Foot Deformities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Foot Deformity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Gerstmann%27%s Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Hand Deformities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Hand Deformity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Hemolytic Anemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Hemolytic Anemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Horner Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Hyperostosis Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Hyperostosis Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immune Deficiency Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immune Deficiency Syndrome Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immuno Deficiency Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immuno-Deficiency Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immuno-Deficiency Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome %28%1983-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome %28%1983-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome %28%1984-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome %28%1984-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome %28%1984-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome %28%1987-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndrome Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Immunodeficiency Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Joint Deformities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Joint Deformity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Language Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Meningoceles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Meningomyeloceles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Metabolic Diseases, Brain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Metabolic Encephalopathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Metabolic Encephalopathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Myelomeningocele' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Myelomeningoceles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Nose Deformities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Nose Deformity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Pellicle, Salivary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Polyneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Prosopagnosia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Prosopagnosias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Reading Disabilities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Reading Disability' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Stuttering' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Word Blindness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired Word Blindnesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired and hereditary conditions which feature CHOREA as a primary manifestation of the disease process.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias %28%e.g., dystonia musculorum deformans%29% and focal dystonias %28%e.g., writer%27%s cramp%29%. They are also classified by patterns of inheritance and by age of onset.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus %28%FIV%29% and in some cats infected with feline leukemia virus %28%FeLV%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired defect of cellular immunity that occurs in mice infected with mouse leukemia viruses %28%MuLV%29%. The syndrome shows striking similarities with human AIDS and is characterized by lymphadenopathy, profound immunosuppression, enhanced susceptibility to opportunistic infections, and B-cell lymphomas.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; %28%MPMV%29%, or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient%27%s own RED BLOOD CELLS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired or developmental cognitive disorders of AUDITORY PERCEPTION characterized by a reduced ability to perceive information contained in auditory stimuli despite intact auditory pathways. Affected individuals have difficulty with speech perception, sound localization, and comprehending the meaning of inflections of speech.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary %28%i.e., disorders intrinsic to the brain%29% and secondary %28%i.e., extracranial%29% metabolic conditions that adversely affect cerebral function.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired or learned food preferences. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired or learned responses which are regularly manifested.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired responses regularly manifested by tongue movement or positioning.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired, familial, and congenital disorders of skeletal muscle %28%MUSCLE, SKELETAL%29% and smooth muscle %28%MUSCLE, SMOOTH%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquired-Immune Deficiency Syndrome Dementia Complex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquisition of knowledge as a result of instruction in a formal course of study.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquisition, Health Facility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquisition, Knowledge %28%Computer%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquisition, organization, and preparation of library materials for use, including selection, weeding, cataloging, classification, and preservation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquisitions, Health Facility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acquisitions, Knowledge %28%Computer%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acraldehyde' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acranias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acremonium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridinamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridine Diamine, Tetramethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridine Orange' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridine Orange Base' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridine, Cain%27%s' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines %28%1968-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acridines which are substituted in any position by one or more amino groups or substituted amino groups.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acriflavine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acriflavine Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrinol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acro Osteolysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acro-Osteolysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acro-Osteolysis Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acro-Osteolysis Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrocephalosyndactylia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrocephalosyndactylias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodermatitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodermatitides, Infantile Papular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodermatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodermatitis, Infantile Papular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodynia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodynic Erythema' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrodysplasia V' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrolein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acromegaly' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acromioclavicular Joint' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acromioclavicular Joints' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acromion' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acromions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acronine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acronycin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acronycine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acronyms %28%Publication Type%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acroosteolysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acroosteolysis Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosomal proteinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosome Reaction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosome Reactions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosome/physiology %28%1975-1998%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrosomes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrospiroma, Eccrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrospiromas, Eccrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylaldehyde' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylamides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylamides %28%1971-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylamides %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylamides %28%1973-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylamides %28%1982-1998%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1968-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1968-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylates %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylic Aldehyde' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylic Resins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylic Resins %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylic Resins %28%1981-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylic acids or acrylates which are substituted in the C-2 position with a methyl group.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acrylonitrile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act of listening for sounds within the body. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act of listening for sounds within the heart. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act, Hill-Burton' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act, Privacy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act, Sherman Antitrust' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act, Tax Equity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act-2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Act2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actaea' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actaea racemosa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actihaemyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Activated ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Binding Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Capping Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Capping Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Depolymerizing Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Depolymerizing Factors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Depolymerizing Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Filament' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Filament Capping Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Filaments' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Related Protein 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Related Protein 2 3 Complex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin Related Protein 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin S1 ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin capping proteins are cytoskeletal proteins that bind to the ends of ACTIN FILAMENTS to regulate actin polymerization.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin-Activated ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin-Capping Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin-Related Protein 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin-Related Protein 2-3 Complex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin-Related Protein 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actin-S1 ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acting Out' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acting Out %28%1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actiniaria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Dermatitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Dermatitides, Chronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Dermatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Dermatitis, Chronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Ray' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Rays' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinic Reticuloid Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinide Metals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinidia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinidiaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinium. A trivalent radioactive element and the prototypical member of the actinide family. It has the atomic symbol Ac, atomic number 89, and atomic weight 227.0278. Its principal isotope is 227 and decays primarily by beta-emission.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacilloses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillosis %28%1968-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus %28%1966-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus %28%1966-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus %28%1971-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus %28%1974-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus %28%1985-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus actinomycetemcomitans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus equuli' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus pleuropneumoniae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus seminis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacillus suis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinobacteria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinoid Metals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinoid Series Elements' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinoids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomyces' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomyces %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomyces %28%1969-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomyces Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomyces Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomyces viscosus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetaceae %28%1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetaceae %28%1975-1983%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1967-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1967-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1971-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1974-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales %28%1980-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetales Infections %28%1984-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycete Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycete Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycetes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycin D' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycoses, Cervicofacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinomycosis, Cervicofacial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinospectacin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinotherapies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actinotherapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actins %28%1978-2000%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action Myoclonus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action Myoclonus Renal Failure Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action Potential' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action Potentials' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action Potentials %28%1967-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action Tremors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action, Community' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action, Court' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Action, Judicial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions which have a high risk of being harmful or injurious to oneself or others.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions, Chemical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions, Community' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions, Court' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions, Judicial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions, Pharmacologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actions, Toxic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Cell, Tumor-Derived' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Cells, Tumor-Derived' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Coagulation Time, Whole Blood' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor IX' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor V' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor VII' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor VIII' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor X' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor XI' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor XII' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Factor XIII' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Killer Monocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Killer Monocytes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Leukocyte Cell Adhesion Molecule' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Partial Thromboplastin Time' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Protein C Inhibitor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated Protein C Resistance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of FACTOR XIII, a transglutaminase, which stabilizes the formation of the fibrin polymer %28%clot%29% culminating the blood coagulation cascade.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor IX. This activation can take place via the intrinsic pathway by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor V. It is an essential cofactor for the activation of prothrombin catalyzed by factor Xa.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor VIII. The B-domain of factor VIII is proteolytically cleaved by thrombin to form factor VIIIa. Factor VIIIa exists as a non-covalent dimer in a metal-linked %28%probably calcium%29% complex and functions as a cofactor in the enzymatic activation of factor X by factor IXa. Factor VIIIa is similar in structure and generation to factor Va.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; %28%HIGH MOLECULAR WEIGHT KININOGEN%29%. Factor XIa then activates factor IX to factor IXa in the presence of calcium.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein %28%with cofactor HIGH MOLECULAR WEIGHT KININOGEN%29% cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments %28%Hageman-Factor fragments%29%. These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activated-Leukocyte Cell Adhesion Molecule' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Enzyme, Acetyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Enzymes, Complement' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Factor, Phosphodiesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Peptide, Neutrophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor 4' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor 6' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factor-3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating Transcription Factors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with EARLY PROMOTERS from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Analyses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Analyses, Neutron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Analysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Analysis, Neutron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Antigen, T-Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Antigens, VLA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Factor, Neutrophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation Peptide, Neutrophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation analysis in which the specimen is bombarded with neutrons. Identification is made by measuring the resulting radioisotopes. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Complement' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Enzyme' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Gene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Insertional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Lymphocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Macrophage' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Neutrophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Transcription' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Transcriptional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activation, Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Complement' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Enzyme' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Insertional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Macrophage' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Metabolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Neutrophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Transcription' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Transcriptional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activations, Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 Protein, 145 kDa Subunit' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 Protein, 36 kDa Subunit' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 Protein, 37 kDa Subunit' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 Protein, 38 kDa Subunit' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 Protein, 40 kDa Subunit' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator 1 p40' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Appliance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Appliances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Appliances %28%1975-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Orthodontic Appliance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Orthodontic Appliances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein AP 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein AP-2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein, Bovine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein, Calcium-Dependent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein, Catabolite' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein, GM2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein, Phosphodiesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Protein-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator Proteins, Catabolite' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, C3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, C3 Convertase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Catabolic Gene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Cyclic AMP-Phosphodiesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Function' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Harvold' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Phosphodiesterase Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Prekallikrein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, T-Plasminogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Tissue Plasminogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Tissue-Type Plasminogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, U-Plasminogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activator, Urinary Plasminogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators of Enzymes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, Calcium Channel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, Catabolic Gene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, Enzyme' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, Function' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, GTP Phosphohydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, GTPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activators, Small GTPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Agents, Surface' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Biologic Transport' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Biological Transport' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Euthanasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Immunities' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Immunity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Immunization' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Immunizations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Immunotherapies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Immunotherapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Learning' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Oxygen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Sites' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Transport' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active Transport, Cell Nucleus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active euthanasia of a patient at the patient%27%s request and/or with the patient%27%s consent.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor Like Kinase 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor Like Kinase 6' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor Like Kinases, Type I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor Like Kinases, Type II' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor like Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor like Kinases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor-Like Kinase 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor-Like Kinase 6' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor-Like Kinases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor-Like Kinases, Type I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptor-like Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptors Type II' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptors, Type I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin Receptors, Type II' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin-Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activin-beta Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activins %28%1994-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activins %28%2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities and functions of the musculoskeletal system, the nervous system, and the eye and their parts.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities associated with the physical burial of the dead. It excludes cultural practices such as funeral rites.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities at the molecular level of exogenous compounds affecting normal biochemical pathways, including the actions of PROTEINS; CELL SURFACE RECEPTORS; NEUROTRANSMITTERS; and inhibitors.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities by crew members conducted outside the pressurized hull of a spacecraft.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities concerned with governmental policies, functions, etc.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities designed to attract the attention or favors of another.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities devoted to freeing persons or animals from danger to life or well-being in accidents, fires, bombings, floods, earthquakes, other disasters and life-threatening conditions. While usually performed by team efforts, rescue work is not restricted to organized services.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities in which participants learn self-defense mainly through the use of hand-to-hand combat. Judo involves throwing an opponent to the ground while karate %28%which includes kung fu and tae kwon do%29% involves kicking and punching an opponent.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities of Daily Living' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities of Daily Living %28%1975-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities of Daily Living %28%1978-1980%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities or games, usually involving physical effort or skill. Reasons for engagement in sports include pleasure, competition, and/or financial reward.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities performed by humans. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities performed in the preparation of bibliographic records for CATALOGS. It is carried out according to a set of rules and contains information enabling the user to know what is available and where items can be found.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities which affect organs and systemic functions without regard to a particular disease.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Blood Bactericidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Clinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Daily Living' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Distributional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Educational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Financial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Higher Nervous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Leisure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Locomotor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Motor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Physical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Political' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Recruitment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Research' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Sexual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Solar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activities, Training' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity Cycle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity Cycles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity engaged in for pleasure. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity involved in transfer of goods from producer to consumer or in the exchange of services.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity which reduces feelings of tension. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Blood Bactericidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Cathepsin B-Like' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Clinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Daily Living' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Distributional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Educational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Extravehicular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Financial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Glomerular Procoagulant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Higher Nervous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Leisure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Locomotor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Motor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Nonsuppressible Insulin-Like' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Nonsuppressible Insulinlike' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Physical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Political' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Recruitment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Research' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Sexual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Activity, Solar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actomyosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actomyosin ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actomyosin Subfragment 1 ATPase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actual loss of a portion of the chromosome. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actuarial Analyses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actuarial Analysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Actuarial Analysis %28%1979-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acuities, Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acuity, Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupoint' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupoints' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupressure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture %28%1968-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture %28%1972-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture %28%1972-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Analgesia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Point' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Points' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Points %28%1990-1995%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Therapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Therapy %28%1989-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture Therapy/trends %28%1978-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture therapy by inserting needles in the ear. It is used to control pain and for treating various ailments.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture, Auricular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupuncture, Ear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupunctures, Auricular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acupunctures, Ear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Abdomen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Abdomens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Articular Rheumatism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Articular Rheumatisms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Autoimmune Neuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Autoimmune Neuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute B-Cell Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute B-Cell Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute B-Lymphocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute B-Lymphocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Basophilic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Basophilic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Brain Injuries' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Brain Injury' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Cerebrovascular Accident' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Cerebrovascular Accidents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Cholecystitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Confusional Migraines' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Coryza' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Disease %28%1968-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Disseminated Encephalomyelitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Disseminated Encephalomyelitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Eosinophilic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Eosinophilic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Erythroblastic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Erythroblastic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Febrile Neutrophilic Dermatosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Hemorrhagic Conjunctivitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Hemorrhagic Conjunctivitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Hemorrhagic Leukoencephalitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Hemorrhagic Leukoencephalitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Hepatic Failure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute INFLAMMATION in the INTESTINAL MUCOSA of the continent ileal reservoir %28%or pouch%29% in patients who have undergone ILEOSTOMY and restorative proctocolectomy %28%PROCTOCOLECTOMY, RESTORATIVE%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Idiopathic Facial Neuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Infectious Thyroiditides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Infectious Thyroiditis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Inflammatory Demyelinating Polyradiculoneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Inflammatory Facial Neuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Inflammatory Polyneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Inflammatory Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Inflammatory Polyradiculoneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Inflammatory Polyradiculoneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Intermittent Porphyria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Intermittent Porphyrias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Kidney Failure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Kidney Insufficiencies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Kidney Insufficiency' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Kidney Tubular Necrosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Laryngotracheo-Bronchitis Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Laryngotracheo-Bronchitis Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Laryngotracheobronchitis Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Laryngotracheobronchitis Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Liver Failure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lung Injuries' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lymphoblastic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lymphoblastic Leukemia Cells Antigen CD38' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lymphoblastic Leukemia Protein 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lymphoblastic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lymphocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Lymphocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Megakaryoblastic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Megakaryoblastic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Megakaryocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Megakaryocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Monoblastic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Monoblastic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Monocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Monocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myeloblastic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myeloblastic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myelocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myelocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myelogenous Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myelogenous Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myeloid Leukemia 1 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myeloid Leukemia 2 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myeloid Leukemia 3 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myeloid Leukemia Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myelomonocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Myelomonocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Necrotizing Encephalitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Necrotizing Encephalitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Necrotizing Encephalitis, Herpetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Necrotizing Pancreatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Necrotizing Pyelonephritides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Necrotizing Pyelonephritis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Neuronopathic Gaucher Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Nonlymphoblastic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Nonlymphoblastic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Nonlymphocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Nonlymphocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Nonsuppurative Periodontitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Nonsuppurative Periodontitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Onset Aura Migraine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Onset Vascular Dementia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Pain Services' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Peripheral Vestibulopathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase Glycoproteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase Reactants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase Reaction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase Response Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase State' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Phase alpha 1 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Physiology and Chronic Health Evaluation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Pityriasis Lichenoides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Poliomyelitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Poliomyelitis, Epidemic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Porphyria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Porphyrias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Post Traumatic Stress Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Promyelocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Promyelocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Relapsing Multiple Sclerosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Renal Failure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Renal Failures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Renal Insufficiencies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Renal Insufficiency' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Respiratory Distress Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Retinal Necroses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Retinal Necrosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Rheumatic Arthritides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Rheumatic Arthritis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Stress Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Stress Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Stroke' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Strokes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Subdural Hematoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Subdural Hematomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Suppurative Thyroiditides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Suppurative Thyroiditis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute T-Cell Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute T-Cell Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute T-Lymphocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute T-Lymphocytic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Toxicity Test' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Toxicity Tests' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Transverse Myelitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Vestibular Neuritides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Vestibular Neuritis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Yellow Atrophies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Yellow Atrophy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute Yellow Atrophy of Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute and chronic %28%see also BRAIN INJURIES, CHRONIC%29% injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute and chronic conditions characterized by external mechanical compression of the SPINAL CORD due to extramedullary neoplasm; EPIDURAL ABSCESS; SPINAL FRACTURES; bony deformities of the vertebral bodies; and other conditions. Clinical manifestations vary with the anatomic site of the lesion and may include localized pain, weakness, sensory loss, incontinence, and impotence.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute and chronic neurologic disorders associated with the various neurologic effects of ETHANOL. Primary sites of injury include the brain and peripheral nerves.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is NEISSERIA GONORRHOEAE. The baby%27%s eyes are contaminated during passage through the birth canal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute disease of cattle caused by the bovine viral diarrhea viruses %28%DIARRHEA VIRUSES, BOVINE VIRAL%29%. Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Severity of clinical disease varies and is strain dependent. Outbreaks are characterized by low morbidity and high mortality.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute hemorrhage or excessive fluid loss resulting in HYPOVOLEMIA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute inflammation of the GALLBLADDER wall. It is characterized by the presence of ABDOMINAL PAIN; FEVER; and LEUKOCYTOSIS. Gallstone obstruction of the CYSTIC DUCT is present in approximately 90%25% of the cases.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute inflammation of the intestine associated with infectious DIARRHEA of various etiologies, generally acquired by eating contaminated food containing TOXINS, BIOLOGICAL derived from BACTERIA; PROTOZOA; or other microorganisms. Dysentery is characterized initially by watery FECES then by bloody mucoid stools. It is often associated with ABDOMINAL PAIN; FEVER; and DEHYDRATION.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute inflammation of the walls of the smaller bronchial tubes, with varying amounts of pulmonary consolidation due to spread of the inflammation into peribronchiolar alveoli and the alveolar ducts. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute inflammatory disease of the THYROID GLAND due to infections by BACTERIA; FUNGI; PROTOZOA; or other microorganisms. Symptoms include tender swelling, FEVER, and often with LEUKOCYTOSIS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute kidney failure resulting from destruction of EPITHELIAL CELLS of the KIDNEY TUBULES. It is commonly attributed to exposure to toxic agents or renal ISCHEMIA following severe TRAUMA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute leukemia distinguished from acute lymphocytic leukemia %28%ALL%29% by the morphology of the marrow and blood leukemic cells. Cytoplasmic granules are usually present and the nucleus is usually large and irregular. ANLL is more common in adults than ALL and occurs at any age.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute leukemia in which lymphocytes are positive for the common acute lymphoblastic leukemia antigen %28%CALLA%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute or chronic INFLAMMATION of the PANCREAS due to excessive ALCOHOL DRINKING. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute or chronic inflammation of the arachnoid membrane of the meninges most often involving the spinal cord or base of the brain. This term generally refers to a persistent inflammatory process characterized by thickening of the ARACHNOID membrane and dural adhesions. Associated conditions include prior surgery, infections, trauma, SUBARACHNOID HEMORRHAGE, and chemical irritation. Clinical features vary with the site of inflammation, but include cranial neuropathies, radiculopathies, and myelopathies. %28%From Joynt, Clinical Neurology, 1997, Ch48, p25%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute or chronic inflammation of tissues surrounding the apical portion of a tooth, associated with the collection of pus, resulting from infection following pulp infection through a carious lesion or as a result of an injury causing pulp necrosis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute respiratory illness in humans caused by the Muerto Canyon virus whose primary rodent reservoir is the deer mouse Peromyscus maniculatus. First identified in the southwestern United States, this syndrome is characterized most commonly by fever, myalgias, headache, cough, and rapid respiratory failure.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute suppurative inflammation of the inner eye with necrosis of the sclera %28%and sometimes the cornea%29% and extension of the inflammation into the orbit. Pain may be severe and the globe may rupture. In endophthalmitis the globe does not rupture.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase Reactants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase Reaction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase Response' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase Response Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase State' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acute-Phase alpha 1-Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acuteness or clearness of vision, especially of form vision, which is dependent mainly on the sharpness of the retinal focus.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclic Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclic Hydrocarbons' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclic branched or unbranched hydrocarbons having two carbon-carbon double bonds.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclic hydrocarbons with one triple bond of the general formula Cn-H2n-2. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclo V' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acycloguanosine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclovir' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyclovir/analogs %26% derivatives %28%1982-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl ACP Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Carrier Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Carrier Protein %28%1978-1983%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Carrier Protein S Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Carrier Protein S Malonyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA 1 Acyl Syn Glycerol 3 Phosphate O Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA 1 Acylglycero 3 Phosphocholine O Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Cholesterol Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Dehydrogenase, Long Chain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Dehydrogenases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Lysolecithin Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Monoacylglycerophosphateacyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Oxidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Retinol Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Sn Glycerol 3 Phosphate O Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Synthetases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA Transferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA, Long-Chain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA-1-Acyl-Syn-Glycerol-3-Phosphate O-Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA-Monoacylglycerophosphateacyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl CoA-Retinol Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A %28%1973-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A %28%1980-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A %28%1980-1982%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A Diacyl glycerol Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A Monacylglycerophosphateacyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A Oxidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A Synthetases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Coenzyme A-Monacylglycerophosphateacyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl Malonyl ACP Condensing Enzyme' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl coenzyme A Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl tRNA, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl, tRNA-Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-ACP Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-Carrier Protein S-Acetyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-Carrier Protein S-Malonyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Dehydrogenase, Long-Chain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Dehydrogenase, Medium-Chain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Dehydrogenase, Short-Chain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Dehydrogenase, Very-Long-Chain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Dehydrogenases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Oxidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Oxidase, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA Sn-Glycerol-3-Phosphate-O-Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA-1-Acylglycero-3-Phosphocholine-O-Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA-Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA-Cholesterol Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-CoA-Transferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-Coenzyme A Diacyl-glycerol Acyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-Malonyl-ACP Condensing Enzyme' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-coenzyme A Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-tRNA Ligases, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyl-tRNA Synthetases, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylase, Acetyl-CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylase, Benzylpenicillin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylase, Cephalosporin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylase, Penicillin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylase, Penicillin G' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylase, Penicillin V' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylation, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylation, Transfer RNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylation, tRNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylations, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylations, Transfer RNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylations, tRNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylcarnitine Translocase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylcholesterol Lipase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylcholineacylhydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylglycerols' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylhydrolase, Oleoyl-CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylhydrolase, Sterol Ester' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acylneuraminate Cytidylyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase 1, Diglyceride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase Deficiencies, Lecithin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase Deficiency, Lecithin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase I, Carnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, 1-Acylglycerophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, 1-Acylglycerophosphocholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, 1-Palmitylglycerol 3-Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Acetyl CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Acyl CoA-Retinol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Acyl-CoA-Cholesterol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Cholesterol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Diacylglycerol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Diglyceride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Glycerolphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Glycerophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lecithin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lecithin Cholesterol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lysolecithin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lysolecithin-Lysolecithin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lysophosphatidylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lysophosphatidylcholine-Palmitoyl CoA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Lysophospholipid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Palmitoyl-CoA-sn-1,2-Diacylglycerol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Palmitoyl-Coenzyme A-sn-1,2-Diacylglycerol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Palmitylcarnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Phosophatidylcholine-Sterol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferase, Sphingosine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1966-1985%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1967-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1970-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1972-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1973-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases %28%1984-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acyl-CoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. EC 2.3.1.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Acyltransferases, Carnitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adam Stokes Attacks' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adam-Stokes Attacks' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantane' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantane/analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantinous Craniopharyngioma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantinous Craniopharyngiomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adamantylamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adams Brand of Amobarbital Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adams Brand of Amorbarbital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adams Stokes Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adams-Stokes Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adansonia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation Syndrome, General' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation Syndrome, Space' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation Syndromes, General' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation of the person to the social environment. Adjustment may take place by adapting the self to the environment or by changing the environment. %28%From Campbell, Psychiatric Dictionary, 1996%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation to a new environment or to a change in the old.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Biologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Biological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Dark' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Dental Marginal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Light' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Marginal %28%Dentistry%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Marginal, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Ocular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Ocular %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Physiologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Physiological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Psychologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Psychological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Psychological %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Psychological %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptation, Scotopic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptations, Dental Marginal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptations, Light' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptations, Marginal %28%Dentistry%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptations, Ocular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptations, Physiologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptations, Physiological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adapter Protein, CrkII' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptin, alpha' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptive Behavior' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptive Behaviors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Complex, AP3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex 1 %28%AP-1%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex 4' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex alpha Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex beta Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex delta Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex gamma Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex mu Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Complex sigma Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Protein Subunits' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Proteins %28%1995-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Proteins %28%1997-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Proteins, Cytoskeletal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Proteins, Signal Transducing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Proteins, Vesicular Transport' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Related Protein Complex 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Related Protein Complex 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Related Protein Complex 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor Related Protein Complex 4' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor-Related Protein Complex 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor-Related Protein Complex 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor-Related Protein Complex 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptor-Related Protein Complex 4' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptors, Clathrin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adaptors, Clathrin-Associated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adder, European' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adders, European' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Amphetamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Cocaine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Heroin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Morphine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Narcotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Neonatal Passive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Opiate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addiction, Substance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addictions, Neonatal Passive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addictive Analgesics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addictive Behavior' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addictive Behaviors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addison Anemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addison Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addison%27%s Anemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addison%27%s Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addisons Anemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addisons Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addition Enzyme, Terminal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addition of hydrogen to a compound, especially to an unsaturated fat or fatty acid. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addition of methyl groups to DNA. DNA methyltransferases %28%DNA methylases%29% perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Additive, Food' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Additives, Food' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addresses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addresses %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Addresses %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adducts, DNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ademetionine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ademetionine Europharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine %28%1971-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Arabinoside' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Arabinoside Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Deoxyribonucleosides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Dinucleotide, Dihydronicotinamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Carrier %28%Mitochondrial%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Carrier Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Translocase %28%1999-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Translocator 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Translocator 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Translocator 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Translocator, Fibroblast Isoform' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotide Translocator, Muscle Isoform' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Nucleotides %28%1972-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine Phosphoribosyltransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenine nucleotides which contain deoxyribose as the sugar moiety.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adeno-Associated Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma %28%1966-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma %28%1968-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma %28%1969-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma %28%1970-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma %28%1986-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma of the common hepatic duct bifurcation. These tumors are generally small, sharply localized, and seldom metastasizing. G. Klatskin%27%s original review of 13 cases was published in 1965. Once thought to be relatively uncommon, tumors of the bifurcation of the bile duct now appear to comprise more than one-half of all bile duct cancers. %28%From Holland et al., Cancer Medicine, 3d ed, p1457%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Bronchiolo Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Bronchiolo-Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Clear Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Follicular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Granular Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Mucinous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Mucinous %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Papillary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Renal Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Scirrhous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinoma, Sebaceous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Basal Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Bronchiolo-Alveolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Clear Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Endometrioid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Follicular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Granular Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Mucinous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Oxyphilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Papillary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Renal Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Scirrhous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Sebaceous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenocarcinomas, Tubular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenofibroma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenofibroma %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenofibromas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenohypophyseal Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenohypophyseal Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenohypophyseal Hormones' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenohypophyseal Hyposecretion' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenohypophyses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenohypophysis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoid Cystic Carcinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoid Cystic Carcinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoidectomies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoidectomy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenolymphoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenolymphoma %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenolymphomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1966-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1967-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1967-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1968-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma %28%1971-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Acidophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Acidophilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Adrenal Cortical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Adrenocortical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Basophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Basophilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Bile Duct' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Bile Duct %28%1967-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Bile Duct %28%1981-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Chromophobe' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Conn' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Corticotroph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Eosinophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Eosinophilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Hepatocellular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Islet Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Islet Cell %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Lactotroph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Liver Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Malignant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Oxyphilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Oxyphilic %28%1992-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Parathyroid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Pituitary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Pleomorphic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Pleomorphic %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Prolactin-Secreting, Pituitary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Somatotroph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Sweat Gland' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Sweat Gland %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Sweat Gland %28%1973-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Sweat Gland %28%1979-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Thyroid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, Villous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, alpha Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, alpha-Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, beta Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoma, beta-Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Acidophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Acidophilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Adrenal Cortical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Adrenocortical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Basal Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Basophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Basophilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Bile Duct' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Chromophobe' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Conn' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Corticotroph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Eosinophil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Eosinophilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Follicular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Hepatocellular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Islet Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Lactotroph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Liver Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Malignant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Microcystic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Monomorphic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Papillary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Parathyroid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Pituitary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Pleomorphic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Prostatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Somatotroph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Sweat Gland' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Trabecular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, Villous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, alpha-Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomas, beta-Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoid Tumor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoid Tumors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoses, Bovine Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoses, Familial Endocrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoses, Multiple Endocrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoses, Ovine Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoses, Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatoses, Pulmonary Ovine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Bovine Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Familial Endocrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Multiple Endocrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Ovine Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Pulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Pulmonary Ovine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Pulmonary, Bovine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatosis, Pulmonary, Ovine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyp' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyposis Coli' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyposis Coli Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyposis Coli, Familial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyposis of the Colon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyposis, Familial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomatous Polyps' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomyoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenomyomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenopathies, Multiple Endocrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenopathy, Multiple Endocrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenophorea' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenophorea Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenophorea Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosarcoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosarcomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoses, Microglandular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 2%27% Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 3%27% Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 3%27% phosphate 5%27% Phosphosulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27% Diphosphoribose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27% N ethyluronamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27% Phosphosulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27% Pyrophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27%-%28%beta,gamma-Imino%29%triphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27%-%28%trihydrogen diphosphate%29%. An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5%27%-position.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27%-Diphosphoribose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27%-Phosphosulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine 5%27%-Pyrophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A%28%2A%29% Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A%28%2B%29% Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A1 Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A1 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A2 Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A2 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A2A Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A2A Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A2B Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A2B Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A3 Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine A3 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Aminohydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic 3%27%,5%27% Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic 3%27%,5%27%-Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic 3,5 Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic Monophosphate %28%1968-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic Monophosphate %28%1968-1983%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic Monophosphate %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic Monophosphate Dependent Protein Kinases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic Monophosphate-Dependent Protein Kinases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Cyclic-3%27%,5%27%-Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Deaminase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Deaminase Binding Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Deaminase-Binding Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Glucose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Glucose Pyrophosphorylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Ribose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Ribose %28%1989-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Ribose Cyclase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Ribose, Cyclic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Ribose, O Acetyl ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Sugars' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphate Sugars %28%1975-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphoglucose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphoglucose Pyrophosphorylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphoribose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Diphosphoribosyltransferase, Nuclear' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Monophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Monophosphate %28%1971-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Monophosphate %28%1973-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Monophosphate %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Phosphates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Phosphosulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Pyrophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Pyrophosphateglucose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase %28%1966-1982%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase %28%1966-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase Complex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Calcium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Calcium, Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Dynein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Hydrogen, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Magnesium %28%1986-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Myosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphatase, Sodium, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate %28%1972-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate %28%1972-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate %28%1974-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate Dependent Proteolytic System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate-Dependent Proteolytic System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine Triphosphate/analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine, N6-Ethyl-carboxamido' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine-3%27%,5%27%-Monophosphate, Dibutyryl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine-3%27%-phosphate-5%27%-Phosphosulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine-5%27%-%28%N-ethylcarboxamide%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine-5%27%-N-ethyluronamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine-Diphosphate-Ribose, O-Acetyl-' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosine/analogs %26% derivatives %28%1980-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase %28%1980-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase %28%1981-1985%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase %28%1988-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase F1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase Sodium, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Actomyosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Calcium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Calcium Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Calcium, Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Dynein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Hydrogen, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Magnesium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Myosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosinetriphosphatase, Sodium, Potassium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosis of Breast' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosis, Microglandular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosquamous Carcinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosquamous Carcinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosylhomocysteinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosylhomocysteine, S' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosylmethionine Decarboxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenosyltransferase, Methionine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae %28%1966%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae %28%1966-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae %28%1983-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae %28%2002-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviridae Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus 1, Fowl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1 Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E19 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1A Associated Protein p60' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1A Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1A Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1A-Associated Protein p60' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1B Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E1B Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E2 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E2 Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E29 Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E2A Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E2F Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E3 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E3 Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E4 Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus E4 Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Early Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Early Region Transforming Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Infection' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Infection, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Infections' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Infections %28%1966-1985%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Infections, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Type 2 E3 19K Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus Type 2 E3-19K Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus, Avian' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus, Porcine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenovirus, Simian' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses, Avian' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses, Canine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses, Human' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses, Human %28%1983-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses, Porcine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenoviruses, Simian' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenyl Cyclase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenyl Imidodiphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase %28%1968-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase Haemolysin Bifunctional Protein, B. pertussis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase Hemolysin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase Toxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase-Haemolysin Bifunctional Protein, B. pertussis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Cyclase-Hemolysin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Deaminase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Kinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylate Phosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%-, 3%27%-, or 5%27%-position.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylimidodiphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylokinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylosuccinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylosuccinate Lyase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylosuccinate Synthase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylosuccinate Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylpyrophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyl Cyclase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyl Imidodiphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyl Sulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyldeoxyribonucleosides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylylimidodiphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, ATP-NMN' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, ATP-RNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, Glucose-1-Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, NMN' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, Nicotinamide Mononucleotide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, Nicotinamide-Nucleotide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, Polynucleotide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adenylyltransferase, Sulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhalin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhatoda' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence Reaction, Immune' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence Reactions, Immune' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence of cells to surfaces or to other cells. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence, Advance Directive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence, Directive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence, Guideline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherence, Institutional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherences, Directive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherens Junction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherens Junction, Cell-Matrix' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherens Junctions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherens Junctions, Cell-Matrix' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherens, Zonula' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adherent debris produced when cutting the enamel or dentin in cavity preparation. It is about 1 micron thick and its composition reflects the underlying dentin, although different quantities and qualities of smear layer can be produced by the various instrumentation techniques. Its function is presumed to be protective, as it lowers dentin permeability. However, it masks the underlying dentin and interferes with attempts to bond dental material to the dentin.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesin, Bacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesin, E coli' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesin, Escherichia coli' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesins, Bacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesins, Escherichia coli' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesins, Fimbrial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Inhibitor, Leukocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Molecules, Axon-Associated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Molecules, Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Molecules, Intercellular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Molecules, Leukocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Molecules, Neuron-Glia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Plaque' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion Plaques' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion, Bacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion, Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesion, Focal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesions, Bacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesions, Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesions, Cell-Matrix' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesions, Focal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive Capsulitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive Receptor Mac-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive Receptor, Mac-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive, Fibrin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive, Fibrin Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive, Fibrinogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesive, Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesiveness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesiveness %28%1969-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesiveness, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesivenesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesivenesses, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesives' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adhesives, Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adiadochokineses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adiantum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adie Pupil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adie Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adie%27%s Pupil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adie%27%s Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adies Pupil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipex P' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AdipexP' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipic Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipic Acids %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipic Acids %28%1969-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipic Acids %28%1970-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipimate, Dimethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipimidate, Dimethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipinamidate, Dimethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipiodon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Complement Related Protein 30 kDa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Complement-Related Protein 30-kDa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Cysteine Rich Secreted Protein FIZZ3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Cysteine-Rich Secreted Protein FIZZ3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Determination And Differentiation Factor 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Lipid Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Membrane Protein p88' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte Specific Fatty Acid Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte, C1q and Collagen Domain Containing Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocyte-Specific Fatty Acid-Binding Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipocytes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipogeneses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipogenesis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipogenesis Inhibitory Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adiponectin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Most Abundant Gene Transcript 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1965-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1966-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1966-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1967-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1967-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1968-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue %28%1975-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue Neoplasm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue Neoplasms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Abdominal Subcutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Brown' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Intra-Abdominal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Retroperitoneal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Subcutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue, Visceral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissue/surgery %28%1967-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissues' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipose Tissues, Brown' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adiposis Dolorosa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adiposity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipozin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adipsin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjunctive computer programs in providing drug treatment to patients.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjusted Life Year' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Disorders %28%1966-1980%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Factor, Discretionary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Factors, Discretionary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Scales, Katz' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment Sleep Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment and manipulation of the vertebral column. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment of the eyes under conditions of low light. The sensitivity of the eye to light is increased during dark adaptation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Case-Mix' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Chiropractic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Occlusal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Prosthesis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Psychological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Risk' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustment, Social' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Case-Mix' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Discretionary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Occlusal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Prosthesis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Psychological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Risk' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjustments, Social' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant Arthritis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant Chemotherapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant Drug Therapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant Radiotherapies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant Radiotherapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant, Freund' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant, Freund%27%s' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant, Immunologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant, Immunological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant, Pharmaceutic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvant, Pharmaceutical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Anesthesia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Anesthetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Immunologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Immunologic %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Immunologic %28%1985-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Immunological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Pharmaceutic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adjuvants, Pharmaceutical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adlay Seed Plant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration Research, Nursing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration Researchs, Nursing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration Route, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration Routes, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration Schedule, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration Schedules, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration and Organization' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration and functional structures for the purpose of collectively systematizing activities for a particular goal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of a soluble dosage form between the cheek and gingiva. It may involve direct application of a drug onto the buccal mucosa, as by painting or spraying.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of a soluble dosage form by placement under the tongue.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of an antigen to large populations in order to produce an immune response to that antigen.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of high doses of pharmaceuticals over short periods of time.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of nursing services for one or more clinical units.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of the total dose of radiation %28%RADIATION DOSAGE%29% in parts, at timed intervals.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration of vaccines to stimulate the host%27%s immune response. This includes any preparation intended for active immunological prophylaxis.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Anal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Bladder Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Buccal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Buccal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Cutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Cutaneous Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Dermal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Dermal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Health Services' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Hospital Personnel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Inhalation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Inhalation Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Intranasal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Intranasal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Intravaginal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Intravesical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Intravesical Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Library' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Oral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Oral %28%1971-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Oral Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Percutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Pharmacy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Public Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Rectal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Rectal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Respiratory Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Self' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Sublingual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Sublingual Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Topical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Topical %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Topical %28%1974-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Topical %28%1975-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Topical Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Transdermal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Vaginal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administration, Vaginal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Anal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Bladder Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Buccal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Buccal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Cutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Cutaneous Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Dermal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Dermal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Intranasal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Intranasal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Intravaginal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Intravesical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Intravesical Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Library' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Oral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Oral Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Percutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Pharmacy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Rectal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Rectal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Self' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Sublingual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Sublingual Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Topical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Topical Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Transcutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Transdermal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Vaginal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrations, Vaginal Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Coordination' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative District' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Efficiency' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Nursing Research' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Nursing Researchs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Personnel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Personnel %28%1968-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Technic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Technics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Technique' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative Techniques' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrative units of government responsible for policy making and management of governmental activities in the U.S. and abroad.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrator' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrator, Health Facility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrator, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrator, Medical Record' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrator, Nurse' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrator-selected management groups who are responsible for making decisions pertaining to the provision of integrated direction for various institutional functions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrators, Health Facility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrators, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrators, Medical Record' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Administrators, Nurse' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission Criteria, School' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission Test, College' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission Test, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission Test, Routine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission Tests, College' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission Tests, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission, Patient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admission, Voluntary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admissions Office, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admissions Offices, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admissions, Patient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admissions, Voluntary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admitting Department, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admitting Departments' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Admitting Departments, Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adnexa Uteri' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adnexal Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adnexal Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adnexal Diseases %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adnexal and Skin Appendage Neoplasms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adnexitis %28%1967-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AdoMet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence %28%1965-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence %28%1965-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence %28%1966-1982%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence %28%1970-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescence, Pregnancy in' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Behavior' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Behaviors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Development' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Health Service' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Health Services' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Medicine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Myoclonic Epilepsies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Myoclonic Epilepsy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Nutrition' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Nutritions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Pregnancies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Pregnancy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Psychiatry' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Psychology' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent Psychology %28%1967-1980%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent hospitalized for short term care. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent, Female' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent, Hospitalized' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent, Institutionalized' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescent, Male' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescents, Abandoned' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescents, Gifted' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescents, Hospitalized' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adolescents, Institutionalized' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adonic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adonis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adonitol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoption' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Cell Transfers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Cellular Immunotherapies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Cellular Immunotherapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Immunotherapies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Immunotherapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Transfer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoptive Transfers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adosterol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adoxaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cancers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex %28%1975-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Cancer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Cancers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Function Tests' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Hormones' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Hormones %28%1966%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Hormones %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Neoplasm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Neoplasms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortex Neoplasms %28%1970-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortical Adenoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortical Adenomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortical Carcinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortical Carcinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Cortical Rest Tumor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Fasciculata' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Cancer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Cancers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Diseases %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Hyperfunction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Hypofunction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Hypofunction %28%1966-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Hypofunction %28%1968-1982%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Neoplasm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Neoplasms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Neoplasms %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Gland Neoplasms %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Glands' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Glands %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Glands %28%1966-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Glands %28%1973-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Glomerulosa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Hyperplasia, Congenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Hyperplasia, Congenital %28%1964-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Hyperplasias, Congenital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Insufficiencies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Insufficiency' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Insufficiency, Primary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Medulla' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Medullas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Rest Tumor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Rest Tumors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenal Reticularis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenalectomies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenalectomy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenaline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenalitides, Meningococcal Hemorrhagic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenalitis, Meningococcal Hemorrhagic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenarche' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Antagonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Beta Receptor Blockaders %28%1969-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Beta Receptor Blockaders %28%1969-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Blockaders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Blocker' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Blockers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Blocking Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Drugs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Fiber' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Fibers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Neuron Drugs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor Blockaders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, alpha 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, alpha 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, alpha-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, alpha-2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, beta 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, beta 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, beta-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptor, beta-2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors, alpha-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors, alpha-2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors, beta 3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors, beta-1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors, beta-2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Receptors, beta-3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Reuptake Inhibitors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic Uptake Inhibitors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha 1 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha 2 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Agonists %28%1969-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Blockers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Receptor Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Receptor Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Receptor Blockaders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-1 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-2 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Blockers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Receptor Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Receptor Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Receptor Blockaders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic alpha-Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta 1 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta 2 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta 3 Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta 3 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Receptor Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Receptor Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Receptor Blockaders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-1 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-2 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-2 agonist used as bronchodilator for emphysema, bronchitis and asthma.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-3 Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-3 Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Antagonists %28%1969-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Blockers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Receptor Agonist' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Receptor Agonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Receptor Blockaders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic beta-agonist used to control premature labor.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergic-Blocking Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenergics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoceptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenochrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Adenoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Adenomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Cancers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Carcinoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Carcinomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Hyperfunction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Insufficiencies, Primary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocortical Insufficiency, Primary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotrophic Hormone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropic Hormone, Inappropriate Secretion' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenocorticotropin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenodoxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenodoxin Reductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenogenital Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenogenital Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoleukodystrophies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoleukodystrophies, Neonatal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoleukodystrophies, X-Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoleukodystrophy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoleukodystrophy, X-Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenolytic Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenolytic Drugs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenolytics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenomimetics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenomyeloneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrenoreceptor, beta3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adriablastin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adrianol, Ethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adriblastin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adriblastina' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adriblastine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adsorption' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adsorption %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adsorption %28%1977-1982%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adsorption %28%1983-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adsorption of substances from the gastrointestinal tract onto an orally administered sorbent medium like activated charcoal. This technique is used to eliminate toxic and some biologically active substances and serves to modify the lipid and amino acid spectrum of the intestinal contents.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adsorptions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Acute Lymphocytic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Children' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Craniopharyngioma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Craniopharyngiomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Daughter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Daughters' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Dentition' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Derived Stem Cell Transplantation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Diaper' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Diapers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Gangliosidosis GM1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Learning Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Medulloblastoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Medulloblastomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Neuroaxonal Dystrophies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Neurologic Saturnism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Night Terror' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Night Terrors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Offspring' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Oligodendroglioma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Oligodendrogliomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Onset Dystonias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Onset Idiopathic Focal Dystonias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Onset Idiopathic Torsion Dystonias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Onset Still Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Onset Still%27%s Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Pavor Nocturnus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Pelizaeus Merzbacher Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Pelizaeus-Merzbacher Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Polycystic Kidney Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Polycystic Kidney Disease Type 1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Polycystic Kidney Disease Type 2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Progeria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Respiratory Distress Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Reye Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Reye%27%s Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Sleep Bruxism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Sleep Bruxisms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Son' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Sons' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Spinal Muscular Atrophy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Stuttering' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Subependymal Astrocytoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Subependymal Astrocytomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult T Cell Leukemia Lymphoma Virus I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult T-Cell Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult T-Cell Leukemia-Lymphoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult T-Cell Leukemia-Lymphoma Virus I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult T-Cell Leukemia-Lymphomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult T-Cell Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Type Dermatomyositides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult Type Dermatomyositis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult, Frail Older' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult-Onset Diabetes Mellitus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult-Onset Dystonia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult-Onset Still Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult-Onset Still%27%s Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adult-Onset Stills Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adulteration, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adulteration, Food' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adulterations, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adulterations, Food' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adultery' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adults' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adults, Frail Older' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Care Planning' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Directive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Directive Adherence' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Directive Compliance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Directives' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Directives %28%1991-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Directives %28%1994-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advance Health Care Planning' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advanced Cardiac Life Support' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advanced Glycation End Products' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advanced Glycosylation End Products' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advancement, Mandibular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adventist, Seventh-Day' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adventists, Seventh-Day' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adventitial Tissues' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adventitious Tissue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adventitious Tissues' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adverse Drug Reaction Reporting Systems' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adverse of favorable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advertisements' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advertisements %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advertisements %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advertising' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advice and support given to individuals to help them understand and resolve their sexual adjustment problems. It excludes treatment for PSYCHOSEXUAL DISORDERS or PSYCHOSEXUAL DYSFUNCTION.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advisory Committee' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advisory Committees' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advisory Service' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advisory Services' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacies, Child' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacies, Consumer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacies, Public' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacy, Child' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacy, Consumer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacy, Patient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Advocacy, Public' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Adynamia Episodica Hereditaria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aedes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aedes aegypti densoviruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aegle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aequorin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aequorine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerial Parts, Plant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerial Plant Components' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AeroBec Forte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobacter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobacter aerogenes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobec' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobic Bacteria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobic Exercise' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobic Exercises' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobioses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobiosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerobiosis %28%1971-1983%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeromonadaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeromonas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeromonas %28%1966-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeromonas %28%1967-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeromonas hydrophila' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeromonas salmonicida' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerophagy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aeropyrum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosil 380' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosol Drug Therapy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosol Propellants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosol Therapy, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosols' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosols %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosols %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosols %28%1976-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosols %28%1979-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerosols, Fluorocarbon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerospace Medicine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerospace Medicine %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aerospace Medicine %28%1966-1969%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aescin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aesculin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aesculus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aesthesioneuroblastoma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aesthesioneuroblastomas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aesthetics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aesthetics, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aethimizole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affect' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affect %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affection; in psychiatry commonly refers to pleasure, particularly as it applies to gratifying experiences between individuals.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorder, Psychotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorder, Seasonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorders %28%1985-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorders, Psychotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Disorders, Seasonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Psychoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Psychosis, Bipolar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Symptom' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affective Symptoms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affects' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Loop Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Loop Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Neuron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Neurons' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Pathway' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Pathways' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Pathways %28%1976-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent Pupillary Defects' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferent, Visceral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afferents, Visceral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affiliation, Organizational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affiliations, Organizational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinities, Antibody' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Chromatographies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Chromatography' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Labeling Reagents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Labels' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Labels %28%1975-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Tagging, Isotope-Coded' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity Tagging, Isotopically-Coded' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinity, Antibody' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Affinotoxins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afghanistan' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afibrinogenemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afibrinogenemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afipia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aflatoxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aflatoxin B1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aflatoxin M1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aflatoxins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aflatoxins %28%1966-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aflatoxins %28%1969-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa South of the Sahara' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Central' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Central %28%1966-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Eastern' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Eastern %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Eastern %28%1983-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, French-Speaking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Northern' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Southern' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Southern %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Sub-Saharan' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Western' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Africa, Western %28%1966-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Americans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Continental Ancestry Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Green Monkey' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Horse Sickness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Horse Sicknesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Horsesickness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Horsesickness Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Horsesickness Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Horsesicknesses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Medicine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Medicine, Traditional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Prune' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Sleeping Sickness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Swine Fever' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Swine Fever Like Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Swine Fever Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Swine Fever-Like Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Traditional Medicine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Trypanosomiases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Trypanosomiasis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African Witch Doctors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'African horse sickness virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'After Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'After Hours Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'After Treatment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'After-Hours Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'After-Treatment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'After-Treatments' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aftercare' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aftereffect, Figural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aftereffects, Figural' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afterimage' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Afterimages' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ag Zn Superoxide Dismutase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ag, vWF' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ag-107; Ag-109 = SILVER %28%IM%29% + ISOTOPES %28%NIM%29%; Ag-102-106, 108, 110-117 = SILVER %28%IM%29% + RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agammaglobulinemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agammaglobulinemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agamous Like Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agamous Related Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agamous-Related Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aganglionosis, Rectosigmoid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aganglionosis, Total Colonic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agapornis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agar Dilution Counts' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agar Gel Electrophoresis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agaricales' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agaricales %28%1966-1985%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agaricales %28%1978-1998%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agaricus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agarin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agarose' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agarose Chromatographies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agarose Chromatography' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agarose Gel Electrophoresis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agastache' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agavaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agave' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Determination by Skeleton' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Determination by Teeth' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Distribution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Distributions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Factors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Factors %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Factors %28%1968-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Group' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Groups' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Measurement, Bone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Measurement, Skeletal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Measurements, Bone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Measurements, Skeletal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Related Maculopathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Related Maculopathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Related Memory Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Related Osteoporosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Specific Birth Rate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Specific Death Rate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age Specific Fertility Rate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age of Onset' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age of the biological father. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age, Fetal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age, Gestational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age, Marriage' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age, Maternal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age, Parental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age, Paternal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Related Bone Loss' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Related Bone Losses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Related Maculopathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Related Memory Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Related Osteoporoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Related Osteoporosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Specific Birth Rates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Specific Death Rates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Age-Specific Fertility Rates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged %28%1965-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged %28%1966-1983%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged %28%1977-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged Abuse' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged, 80 and over' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged, 80 and over %28%1987-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aged, Dentistry for' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agelas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies established under PL93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual State Health Plan and giving assistance to the Statewide Health Coordinating Council.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies of the FEDERAL GOVERNMENT of the United States.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies, Government' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies, Health Systems' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies, Home Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies, Home Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies, International' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agencies, Voluntary Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency for Health Care Policy and Research' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency, Government' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency, Health Systems' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency, Home Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency, Home Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency, International' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agency, Voluntary Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageneses, Enamel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agenesis, Enamel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agenesis, Thyroid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent 48 80' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent 48-80' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent 4880' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Cleansing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Combined Antineoplastic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Dermatologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Dermatological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Flavoring' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, GABAergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Glycinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Patient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agent, Sweetening' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents and factors that activate GTP phosphohydrolase activity.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents capable of exerting a harmful effect on the body.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents causing contraction of the pupil of the eye. Because the size of the pupil is under the antagonistic control of the sympathetic and parasympathetic systems, drugs affecting either system can cause miosis. Drugs that mimic or potentiate the parasympathetic input to the circular constrictor muscle and drugs that inhibit sympathetic input to the radial dilator muscle tend to contract the pupils. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents causing the narrowing of the lumen of a bronchus or bronchiole.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents counteracting or neutralizing the action of POISONS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents destructive to parasitic worms. They are used therapeutically in the treatment of HELMINTHIASIS in man and animal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents destructive to snails and other mollusks. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents. They must quickly kill and coagulate living tissue.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents inhibiting the effect of narcotics on the central nervous system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents of the law charged with the responsibility of maintaining law and order among the citizenry.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents or remedies that historically have produced stimulation or excited functional activity. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that act systemically to kill adult schistosomes.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that affect ION PUMPS; ION CHANNELS; ABC TRANSPORTERS; and other MEMBRANE TRANSPORT PROTEINS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that affect MITOSIS of CELLS. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that affect the function of FIBRIN in BLOOD COAGULATION. They used as COAGULANTS for HEMORRHAGE or ANTICOAGULANTS for THROMBOSIS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that aid or increase the action of the principle drug %28%DRUG SYNERGISM%29% or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug %28%PHARMACOKINETICS%29% in such a way as to enhance its effects.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anesthesia adjuvants. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general anesthesia, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are put on the SKIN to reduce SWEATING or prevent excess sweating %28%HYPERHIDROSIS%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are used to decrease appetite. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. %28%From AMA Drug Evaluations Annual, 1994, p475%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are used to treat bipolar disorders or mania associated with other affective disorders.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that arrest cells in MITOSIS, most notably TUBULIN MODULATORS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that cause an increase in the expansion of a bronchus or bronchial tubes.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in schizophrenia, senile dementia, transient psychosis following surgery or myocardial infarction, etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma. Mydriatics are used in eye diseases and to facilitate eye examination.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of MIGRAINE DISORDERS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus %28%NIDDM%29% to treat obesity.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that increase uric acid excretion by the kidney %28%URICOSURIC AGENTS%29%, decrease uric acid production %28%antihyperuricemics%29%, or alleviate the pain and inflammation of acute attacks of gout.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that induce or stimulate the PHYSIOLOGIC ANGIOGENESIS process. This is caused by a number of ANGIOGENIC PROTEINS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that induce various degrees of analgesia; depression of consciousness, circulation, and respiration; relaxation of skeletal muscle; reduction of reflex activity; and amnesia. There are two types of general anesthetics, inhalation and intravenous. With either type, the arterial concentration of drug required to induce anesthesia varies with the condition of the patient, the desired depth of anesthesia, and the concomitant use of other drugs. %28%From AMA Drug Evaluations Annual, 1994, p.173%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that inhibit PROTEIN KINASES. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that interact with TUBULIN to inhibit or promote polymerization.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that modulate the PHYSIOLOGIC ANGIOGENESIS process. This is accomplished by endogenous ANGIOGENIC PROTEINS and a variety of other chemicals and pharmaceutical agents.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that promote and/or ease defecation by accelerating the passage of feces through the large intestine, by influencing the consistency and amount of stool, and by facilitating the elimination of feces from the rectum. The terms laxative and cathartic reflect the typical intensity and latency of effect. A cathartic usually produces prompt fluid evacuation, while a laxative usually produces a soft formed stool over a protracted period; the same drug may act as a laxative or a cathartic depending on the dose administered or individual patient sensitivity. %28%From AMA Drug Evaluations Annual, 1994, p941%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that promote the excretion of urine through their effects on kidney function.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. They differ from antineoplastic agents in that they prevent neoplasms from forming. The anticarcinogenic substances can be divided into three categories. The first consists of compounds that prevent the formation of carcinogens from precursor substances. The second group consists of %22%blocking agents%22% which inhibit carcinogenesis by preventing carcinogenic agents from reaching or reacting with critical target sites in the tissues. The third group is the %22%suppressor agents%22% which act by suppression of expression of neoplasia in cells previously exposed to carcinogens that would otherwise cause neoplasms.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that remove, correct, repress, or mask undesirable ODORS. In personal hygiene, deodorants often contain astringent preparations that reduce SWEATING, referred to as ANTIPERSPIRANTS. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used in the treatment of Parkinson%27%s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. %28%From AMA, Drug Evaluations Annual, 1992, p1585%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to occlude dental enamel pits and fissures in the prevention of dental caries.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to prevent the formation of foam or to treat flatulence or bloat.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to treat RETROVIRIDAE INFECTIONS. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to treat cestode, trematode, or other flatworm infestations in man or animals.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to treat infections with bacteria of the genus TREPONEMA. This includes SYPHILIS %26% YAWS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to treat tapeworm infestations in man or animals.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents used to treat trichomonas infections. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents which affect CELL DIVISION and the MITOTIC SPINDLE APPARATUS resulting in the loss or gain of whole CHROMOSOMES, thereby inducing an ANEUPLOIDY.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents which lower the blood glucose level. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Abortifacient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Acetylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Adrenergic Neuron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Adrenergic-Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Adrenolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Alkylating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Amphiphilic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anabolic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Analeptic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Analgesic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Androgenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anesthetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Aneugenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Aneuploidy-Inducing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Angiogenesis Inducing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Angiogenesis Stimulating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Angiostatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti Inflammatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-AIDS' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Allergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Angiogenetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Anxiety' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Arrhythmia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Asthmatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Bacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Carcinogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Diuretic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Dyskinesia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-HIV' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Hypertensive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Infective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Inflammatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Microbial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Mutagenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Mycobacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Obesity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Retroviral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Rheumatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anti-Ulcer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiadrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiallergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiallergy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiangiogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiarrhythmia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiasthmatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antibacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticarcinogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticestodal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticholesteremic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticholinesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticoagulant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticoccidial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anticonvulsive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antidepressive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antidiabetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antidiarrheal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antidiuretic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiemetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiepileptic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antifibrillatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antifibrinolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antifoaming' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antifungal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antigout' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antihypertensive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiinfective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiinflammatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antileprotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antilipemic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimalarial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimanic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimicrobial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimitotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimuscarinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimutagenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antimycobacterial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antinematodal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antineoplastic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antineoplastic Hormonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antinociceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiobesity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiparasitic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiparkinson' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiparkinsonian' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiperistaltic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiplatelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiplatyhelmintic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiprotozoal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antipruritic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antipsychotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiretroviral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antirheumatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antischistosomal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiserotonergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antisickling' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antispasmodic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antispermatogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antisyphilitic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antithrombotic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antithyroid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antitreponemal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antitrichomonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antitubercular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antitussive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Antiviral' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Anxiolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Aspirin-Like' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Autonomic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Bacteriocidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Bronchial-Constricting' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Bronchial-Dilating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Bronchoconstrictor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Bronchodilator' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Broncholytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cardiovascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cariogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cariostatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Chelating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Chemical Warfare' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cholinergic-Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cleansing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Combined Antineoplastic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Complement Inactivating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Complement Inhibiting' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Contact-Sensitizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cryoprotective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Curare-Like' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Cytostatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Defoaming' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Dentin Bonding' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Dentin-Bonding' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Dermatologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Dermatological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Desickling' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Desquamating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Dopamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Dopaminergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, EAA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Emetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Emulsifying' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Estrogen Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Estrogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Excitatory Amino Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Female Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Female Fertility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Female Infertility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Fertility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Fibrinolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Fireproofing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Flavoring' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Fluorescence' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Fluorescent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Food Coloring' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, GABA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, GABAergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Ganglionic Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Ganglioplegic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Gastric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Gastrointestinal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Glutamate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Glutamatergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Glycine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Glycinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hair Coloring' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hallucinogenic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hematologic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hematological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hematopoietic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Histamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Histaminergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hypocholesteremic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hypoglycemic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Hypolipidemic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Immunosuppressive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Infertility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Intercalating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Iron Chelating' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Isoelectric Focusing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Keratolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Leprostatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Lipotropic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Local Anti-Infective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Local Antiinfective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Luminescent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Luteolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Major Tranquilizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Major Tranquillizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Male Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Male Fertility' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Menstruation-Inducing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Minor Tranquilizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Minor Tranquillizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Movement Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Mucolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Muscarinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Nasal Vasoconstrictor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Natriuretic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neuroleptic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neuromuscular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neuromuscular Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neuromuscular Depolarizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neuromuscular Nondepolarizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neuroprotective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Neurotransmitter' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Non-Steroidal Abortifacient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Non-Steroidal Anti-Inflammatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Non-Steroidal Anti-Rheumatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Non-Steroidal Antirheumatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Nonsteroidal Abortifacient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Nonsteroidal Anti-Inflammatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Nonsteroidal Antiinflammatory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Nootropic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Oxidizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Oxytocic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Parasympathetic-Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Parasympatholytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Parasympathomimetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Patient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Phosphorescent' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Photosensitizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Phytogenic Antineoplastic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Pickling' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Polyploidy-Inducing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Post-Coital Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Postcoital Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Postconception Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Protective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Psychedelic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Psychoactive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Psychotomimetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Radiation Protective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Radiation Sensitizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Radiation-Protective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Radiation-Sensitizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Radioprotective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Radiosensitizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Reducing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Renal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Reproductive Control' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Respiratory System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sclerosing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Second-Generation Antidepressive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sensory System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Serotonergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Serotonin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Skin-Peeling' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sperm Immobilizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sperm-Immobilizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Spermatocidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Spermatocidal Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Spermatogenesis Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Spermatogenesis-Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Spermicidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Spermicidal Contraceptive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Stabilizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Steroidal Abortifacient' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sunscreening' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Surface Active' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Surface-Active' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Suspending' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sweetening' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sympathetic-Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sympatholytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Sympathomimetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Thrombolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Tocolytic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Topical Anti-Infective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Topical Antiinfective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Tranquilizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Tranquillizing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Tricyclic Antidepressive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Trypanocidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Trypanosomicidal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Tuberculostatic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Uncoupling' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Uricosuric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Urinary Anti-Infective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Urinary Antiinfective' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Vasoconstrictor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Vasodilator' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Vasopressor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Weight-Loss' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, Wetting' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, alpha-Adrenergic Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, beta-Adrenergic Blocking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, gamma-Aminobutyric Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agents, usually topical, that relieve itching %28%pruritus%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageratina' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageratum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ages, Fetal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ages, Gestational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ages, Marriage' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ages, Maternal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ages, Parental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ages, Paternal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageusia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageusias, Hysterical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageusic Aphasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ageusic Aphasias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination Test' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination Test, Latex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination Tests' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination Tests, Latex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination of erythrocytes by a virus. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination of spermatozoa by antibodies or autoantibodies.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutination, Sperm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinations, Intravascular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinations, Sperm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinin Disease, Cold' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinin Diseases, Cold' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinin, Peanut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinins, Pertussis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agglutinins, Wheat Germ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregate Myopathies, Tubular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregate Myopathy, Tubular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregating Factor, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation Bias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation Inhibitors, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation, Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation, Data' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation, Erythrocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation, Intravascular Erythrocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregation, Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregations, Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregations, Erythrocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggregations, Intravascular Erythrocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggression' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggression %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggression %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggressions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggressive Fibromatoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggressive Fibromatosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggressive Systemic Mastocytoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging %28%1966-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging %28%1966-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Biological' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Cell' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Cellular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Demographic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Erythrocyte' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Premature' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aging, Skin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agit' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agitation, Psychomotor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agkistrodon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agkistrodon Serine Proteinase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agkistrodon rhodostoma Venom Protease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aglaia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agmatine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnogenic Myeloid Metaplasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnogenic Myeloid Metaplasias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia %28%1967-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia for Face' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia for Faces' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia for Tastes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Auditory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Body-Image' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Congenital Auditory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Developmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Facial Recognition' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Finger' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Ideational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Olfactory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Position' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Sensory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Somatosensory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Tactile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Time' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Topographical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Visual Verbal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosia, Visuospatial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Auditory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Body-Image' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Congenital Auditory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Developmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Facial Recognition' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Finger' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Ideational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Olfactory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Position' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Sensory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Somatosensory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Tactile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Time' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Topographical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Visual Verbal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agnosias, Visuospatial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, 5-HT' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, 5-HT1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, 5-HT2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, 5-HT3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, 5-Hydroxytrytamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Acetylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Adrenergic alpha-Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Adrenergic beta-Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Calcium Channel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Dopamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Dopamine Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Dopaminergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, EAA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, GABA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, GABA Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Glutamate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, H1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, H2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, H3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Histamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Histamine H1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Histamine H2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Histamine H3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Histaminergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Muscarinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Muscarinic Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Myeloablative' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Nicotinic Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Serotonergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Serotonin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, Serotonin Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, alpha-Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, alpha-Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, beta-Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, beta-Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonist, gamma-Aminobutyric Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonistic Behavior' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonistic Behaviors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, 5-HT' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, 5-HT1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, 5-HT2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, 5-HT3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, 5-Hydroxytryptamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Acetylcholine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Adrenergic alpha-Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Adrenergic beta-Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Calcium Channel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Dopamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Dopamine Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Dopaminergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, EAA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Excitatory Amino Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, GABA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, GABA Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Glutamate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, H1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, H2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, H3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Histamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Histamine H1' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Histamine H2' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Histamine H3' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Histaminergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Muscarinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Muscarinic Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Myeloablative' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Nicotinic Cholinergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Serotonergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Serotonin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Serotonin Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, Vasoactive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, alpha-Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, alpha-Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, beta-Adrenergic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, beta-Adrenergic Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agonists, gamma-Aminobutyric Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agoraphobia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agoraphobias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agouron Brand of Delavirdine Mesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agouron Brand of Nelfinavir Mesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agranular Endoplasmic Reticulum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agranulocytoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agranulocytoses, Feline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agranulocytosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agranulocytosis, Feline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphia, Acquired' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphia, Alexia Without' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphia, Constructional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphia, Developmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphia, Pure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphias, Acquired' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphias, Alexia Without' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphias, Constructional' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphias, Developmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agraphias, Pure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agreement, Transfer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agreements between two or more parties, especially those that are written and enforceable by law %28%American Heritage Dictionary of the English Language, 4th ed%29%. It is sometimes used to characterize the nature of the professional-patient relationship.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agreements, Transfer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrichemicals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Chemicals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Chemistries' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Chemistry' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Crop' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Crops' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Worker' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Worker Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Worker Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Worker%27%s Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Worker%27%s Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Workers Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Workers Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Workers%27% Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agricultural Workers%27% Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agriculture' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agriculture %28%1966-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrimonia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrimony' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrobacterium %28%1966-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrobacterium tumefaciens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrochemicals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agropyron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrostemma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Agrostis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aguettant Brand of Apomorphine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ah Receptor Nuclear Translocator Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AhR Nuclear Translocator' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid to Families with Dependent Children' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Audio-Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Audiovisual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Decision' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Federal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, First' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Foreign' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Hearing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Sensory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aid, Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Community Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Home Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Home Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Homemaker-Home Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Nurses%27%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Pharmacists%27%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aide, Psychiatric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Community Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Home Care' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Home Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Homemaker-Home Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Nurses%27%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Pharmacists%27%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aides, Psychiatric' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Audio-Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Audiovisual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Decision' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Federal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, First' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Hearing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Pharmaceutic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Pharmaceutical' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Sensory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aids, Visual' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ailanthus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ailmentary System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ainhum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Abrasion, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Abrasions, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Ambulance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Ambulances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Bag' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Bags' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Bladder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Bladders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Blood Barrier' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Conditioning' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Conditionings' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Embolism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Embolisms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Environmental Pollutants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Force Hospital' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Force Hospitals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Ionization' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Ionizations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Microbiology' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Movement' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Movements' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants %28%1972-1983%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants %28%1975-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Environmental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Environmental %28%1975-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Environmental %28%1975-1988%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Environmental %28%1982-1994%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Occupational' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Occupational %28%1975-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutants, Radioactive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution %28%1968-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution %28%1972-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution, Indoor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution, Indoor %28%1992-1995%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution, Radioactive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollution, Tobacco Smoke' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pollutions, Radioactive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pressure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Pressures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Radiographies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Radiography' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Revitalizations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Sac' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Sacs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Sickness' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air Swallowing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air pollutants found in the work area. They are usually produced by the specific nature of the occupation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air pollutants which affect environmental conditions. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air-Blood Barrier' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air-Blood Barriers' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air-Purifying Respirator' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air-Purifying Respirators' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones. They vary in size and form in different individuals and are lined by the ciliated mucous membranes of the nasal cavity.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airbag' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airbags' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aircraft' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aircraft %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aircraft %28%1966-1993%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aircrafts' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airflow Obstructions, Chronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airflow, Respiratory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airocele, Cranial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airoceles, Cranial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway Obstruction' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway Obstruction %28%1972-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway Obstructions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway Resistance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway Resistance %28%1980-1989%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway Resistances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airway, Laryngeal Mask' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Airways, Laryngeal Mask' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aizoaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline %28%1971-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline Forest Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline Giulini Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline Lacer Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline Protea Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline Servier Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajmaline Solvay Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajowan' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ajuga' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ak Tracin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ak Zol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AkZol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akathisia, Drug Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akathisia, Drug-Induced' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akee' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akinetic Autism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akinetic Epilepsies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akinetic Epilepsy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akinetic Mutism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akinetic Mutisms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akinetic Rigid Variant of Huntington Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akne Puren' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aknin Mino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akorn Brand of Bacitracin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akorn Brand of Levobunolol Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akorn Brand of Naphazoline Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akorn Brand of Sulfacetamide Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akrosin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt alpha Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt beta Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt gamma Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt, Proto-Oncogene Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt-alpha Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt-beta Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Akt-gamma Protein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Al-27; Al-23-26, 28-30 = ALUMINUM %28%IM%29% + RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ala Ala Carboxypeptidase, Serine Type' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ala Transfer RNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ala tRNA Ligase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ala%28%2%29%-MePhe%28%4%29%-Gly-ol%28%5%29% Enkephalin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ala-Ala Carboxypeptidase, Serine-Type' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ala-tRNA Ligase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alabama' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alacan Brand of Astemizole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alacan Brand of Capsaicin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alagille Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alagille Watson Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alagille-Watson Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alamethicin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alangiaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1973-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1974-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine %28%1975-1980%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine 2 Oxoglutarate Aminotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Aminopeptidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Aminotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Doms-Adrian Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Racemase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Specific tRNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine Transaminase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine tRNA Ligase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine, L Isomer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine, L-Isomer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine-2-Oxoglutarate Aminotransferase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine-Specific tRNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanine-tRNA Ligase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanyl Aminopeptidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanyl Isoglutamine, Acetylmuramyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanyl T RNA Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanyl tRNA Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alanyl-tRNA Synthetase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alarm Clock Headache' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alarm Clock Headaches' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alarm System, Equipment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alarm Systems, Equipment' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alaryngeal Speech' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alaryngeal Voice Production' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alaryngeal Voice Productions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alaska' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alastrim' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albania' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Armstrong Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Diba Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Fustery Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Hormona Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Liferpal Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Pfizer Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Sanicoopa Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albendazole Valdecasas Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albenza' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albers Schoenberg Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albers-Schoenberg Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alberta' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism %28%1966-1990%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. The classic type is X-linked %28%Nettleship-Falls%29%, but an autosomal recessive form also exists. Ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Cutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Ocular' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Oculocutaneous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Oculocutaneous %28%1990-2000%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Partial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Tyrosinase Negative' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Tyrosinase Positive' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albinism, Yellow Mutant' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albizia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albizzia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albright Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albrights Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin Colloid, Technetium-99m' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin Proximal Factor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin, 99mTc-Human Serum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin, Bovine Serum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin, Radio-Iodinated Serum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin, Radioiodinated Serum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumin, Serum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumins %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumins %28%1966-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albumins %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albuminuria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albuminurias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Albuterol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcala Brand of Levonorgestrel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcalase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcalase, Novo' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes %28%1965-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes %28%1971-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes %28%1972-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes %28%1995-1998%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes denitrificans subsp. xylosoxidans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes denitrificans subsp. xylosoxydans' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes eutropha' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcaligenes faecalis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcam protein, Zebrafish' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alchemies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alchemilla' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alchemy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcian Blue' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcian Blue 8GS' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcian Blue 8GX' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcinonide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcobon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Abuse, Nervous System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Amnestic Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Amnestic Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Amnestic Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Amnestic Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Consumption' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Dehydrogenase %28%NAD+%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Dehydrogenase, Yeast' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Dehydrogenases, Sugar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Deterrents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Drinking' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Amnestic Psychosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Amnestic Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Disorders, Nervous System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Dysmnesic Psychosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Dysmnesic Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Korsakoff Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Peripheral Neuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Persisting Amnestic Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Induced Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol NAD+ Oxidoreductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1966-1986%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1972-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1973-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1974-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases %28%1974-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Oxidoreductases, Sugar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Related Autonomic Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Related Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Related Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Associated Autonomic Hyperactivity' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Delirium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Induced Delirium Tremens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Induced Major Motor Seizure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Induced Seizure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Induced Status Epilepticus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Seizure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal Seizures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal-Induced Delirium Tremens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal-Induced Seizure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal-Induced Seizures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol Withdrawal-Induced Status Epilepticus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol oxidoreductases with substrate specificity for LACTIC ACID.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, 2-Chloroethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Absolute' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Benzyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Dodecyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl %28%1970-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Ethyl %28%1977-1981%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Grain' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Heptyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Hydroxymethoxyphenethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Isopropyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Lauryl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Methyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Methyl %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Methyl %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Methyl %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Methyl %28%1974%29% /analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Nicotinic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Nicotinyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Phenethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Phenylethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Polyvinyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Propyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Propyl %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Propyl %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Propyl %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Rubbing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Trifluoroethyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, Wood' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, n-Butyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, n-Dodecyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, n-Octyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, tert-Butyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol, tertiary-Butyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Amnestic Psychoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Amnestic Psychosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Amnestic Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Amnestic Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Disorders, Nervous System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Dysmnesic Psychoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Dysmnesic Psychosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Dysmnesic Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Dysmnesic Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Korsakoff Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Korsakoff Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Peripheral Neuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Peripheral Neuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Persisting Amnestic Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Polyneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Induced Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-NAD+ Oxidoreductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Related Autonomic Polyneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Related Autonomic Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Related Disorder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Related Disorders' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Related Polyneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohol-Related Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Axonal Neuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Beverage' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Beverages' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Beverages %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Cardiomyopathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Cirrhosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Fatty Liver' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Hepatic Cirrhosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Hepatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Hepatitis, Chronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Intoxication' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Intoxication, Chronic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Korsakoff Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Korsakoff Syndromes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Liver Cirrhosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Liver Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Liver Diseases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Neuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Neuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Pancreatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Polyneuritides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Polyneuritis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Polyneuropathies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Polyneuropathy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Psychoses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Seizure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic Seizures' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholic, Skid Row' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholics Anonymous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholics, Skid Row' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism %28%1966-1967%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism %28%1966-1985%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism %28%1966-1996%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism %28%1966-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcoholism/complications %28%1966-1999%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1966-1973%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1971-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols %28%1980-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols derived from the aryl radical %28%C6H5CH2-%29% and defined by C6H5CHOH. The concept includes derivatives with any substituents on the benzene ring.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Amino' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Amyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Amyl %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Benzyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Bile' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Butyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Butyl %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Butyl %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Fatty' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Hexyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Octyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Octyl %28%1973-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Octylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Pentyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Propyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcohols, Sugar' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand 1 of Naphazoline Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand 1 of Sulfacetamide Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand 2 of Naphazoline Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand 2 of Sulfacetamide Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Acetylcholine Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Acetylcysteine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Aciclovir' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Betaxolol Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Carbachol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Desonide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Fluorescein Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Fluorometholone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Povidone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon Brand of Scopolamine Hydrobromide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcon, Betaxolol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcuronium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alcuronium Dichloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldadiene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Dehydrogenase, Betaine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Dehydrogenase, Glycol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Dehydrogenase, Semiaspartate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Ketone Transferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Lyases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde NAD Oxidoreductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidase, Betaine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidoreductases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidoreductases %28%1973-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidoreductases %28%1978-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidoreductases %28%1980-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Oxidoreductases %28%1998-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde Reductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde, Acrylic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde, Allyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde, Ethylene' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde, Pyruvic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde, Vitamin A' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde, ortho-Phthalic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde-Ketone Transferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde-Lyases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde-Lyases %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehyde-NAD Oxidoreductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehydes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehydes %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehydes %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehydes %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehydes %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldehydic Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alder' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alder, Black' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldicarb' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alditols' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldo Brand of Beclomethasone Dipropionate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldo Brand of Silver Sulfadiazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldo Brand of Warfarin Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, 17 alpha-Hydroxyprogesterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, 2-Dehydro-3-Deoxyphosphoheptonate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Allothreonine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Fructose 1,6-Bisphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Fructose 1-Phosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Fructose Biphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Fructose-Bisphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Fructosediphosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Fructosemonophosphate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Hydroxyprogesterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Phospho-2-Keto-3-Deoxyheptonate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Serine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolase, Threonine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldolases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldose Ketose Isomerases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldose Reductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldose-Ketose Isomerases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone %28%1966-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone %28%1971-1987%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone Antagonists' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone Receptor' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone Receptors' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone Synthase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosterone Synthase Cytochrome P-450' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosteronism' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldosynthase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldrich Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldrin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aldrox' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alendronate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alendronate Monosodium Salt, Trihydrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleukemic Leukemia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleukemic Leukemias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleurites' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleutian Disease Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleutian Disease of Mink' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleutian Mink Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleutian Mink Disease Parvovirus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aleutian Mink Disease Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexander Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexander%27%s Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexanders Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexia Syndrome Without Agraphia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexia Without Agraphia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexia Without Agraphias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexia, Pure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexias, Pure' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alexithymias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfa, Colirio' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfadolone Mixture, Alfaxalone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfalfa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfalfa %28%1963-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfalfa mosaic virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfalfa mosaic viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfamovirus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfamoviruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfaxalone Alfadolone Mixture' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfenta' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfentanil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfentanyl' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfeprol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alfoscerate, Choline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alga' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1963-1998%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1964-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1965-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1965-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1965-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1965-1995%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1965-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1966-1969%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1966-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1966-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1967-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1969-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1975-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae %28%1989-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae of the division Chlorophyta, in which the green pigment of CHLOROPHYLL is not masked by other pigments. Green algae have over 7000 species and live in a variety of primarily aquatic habitats. Only about ten percent are marine species, most live in freshwater. They are more closely related to the green vascular land PLANTS than any other group of algae.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae of the division Rhodophyta, in which the red pigment %28%PHYCOERYTHRIN%29% predominates. However if this pigment is destroyed, the algae can appear purple, brown, green, or yellow. Two important substances found in the cell walls of red algae are AGAR and CARRAGEENAN. Red algae are thought to be closely related to the prokaryotic CYANOBACTERIA.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Blue Green' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Blue-Green' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Brown' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Brown %28%1974-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Brown %28%1993-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Golden Brown' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Golden-Brown' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1967-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1969-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1970-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1970-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1970-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1971-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1972-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Green %28%1973-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Red' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Red %28%1971-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Red %28%1973-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Red %28%1976-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algae, Red %28%1977-2003%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal Blooms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal DNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal Gene Products' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal Gene Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal Proteins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal RNA' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algal Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algarrobo' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Axcan Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Pharmacia Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Philopharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Roques Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Stiefel Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Whitehall Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeldrate Wyeth Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algeria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algestone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algestone Acetophenide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alginates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algodystrophies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algodystrophy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algorithm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Algorithms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ali esterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Ali-esterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'AliI Endonuclease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alicyclic Hydrocarbons' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alicyclic hydrocarbons in which three or more of the carbon atoms in each molecule are united in a ring structure and each of the ring carbon atoms is joined to two hydrogen atoms or alkyl groups. The simplest members are cyclopropane %28%C3H6%29%, cyclobutane %28%C4H8%29%, cyclohexane %28%C6H12%29%, and derivatives of these such as methylcyclohexane %28%C6H11CH3%29%. %28%From Sax, et al., Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alien' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alienation, Social' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alienations, Social' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alignment, Sequence' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alignments, Sequence' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alimemazine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alimemazine Italfarmaco Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alimentary System' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliphatic four carbon acids substituted in any position%28%s%29% with amino group%28%s%29%. They are found in most living things. The best known is GAMMA-AMINOBUTYRIC ACID.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alisma' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alismataceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alismatales' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alismatidae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Amantadine Sulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Benzbromarone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Betahistine Mesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Bromazepam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Cetirizine Dihydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Cinnarizine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Dihydroergotamine Mesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Doxazosin Mesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Etilefrine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Felodipine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Fluconazole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Fluvoxamine Maleate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Nitrazepam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Nitrendipine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Procetofen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Propafenone Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Terbutaline Sulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aliud Brand of Terfenadine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkadienes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkadienes %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkali' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkali Metals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkalies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Comet Assays' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Earth Metals' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Hematin D 575' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Phosphatase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Phosphatase %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Phosphodiesterase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Phosphodiesterase I' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Proteinase, Tritirachium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Single Cell Gel Electrophoresis Assay' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaline Single-Cell Gel Electrophoresis Assay' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkalis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloid isolated from seeds of Peganum harmala L., Zygophyllaceae. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but %28%as banisterine%29% was hailed as a cure for postencephalitic Parkinson disease in the 1920%27%s.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1965-2004%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1968%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1966-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1968-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1969-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1969-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1970-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1972-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1977-1996%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1980-1991%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids %28%1982-1992%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the Amaryllidaceae %28%LILIACEAE%29% plant family.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids extracted from various species of Cinchona. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids obtained from various plants, especially the deadly nightshade %28%Atropa belladonna%29%, variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids originally isolated from the ergot fungus Claviceps purpurea %28%Hypocreaceae%29%. They include compounds that are structurally related to ergoline %28%ERGOLINES%29% and ergotamine %28%ERGOTAMINES%29%. Many of the ergot alkaloids act as alpha-adrenergic antagonists.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids with powerful hypotensive effects isolated from American or European Hellebore %28%Veratrum viride Ait. Liliaceae and Veratrum album L. Liliaceae%29%. They increase cholinergic and decrease adrenergic tone with appropriate side effects and at higher doses depress respiration and produce cardiac arrhythmias; only the ester alkaloids have been used as hypotensive agents in specific instances. They have been generally replaced by drugs with fewer adverse effects.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Amaryllidaceae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Belladonna' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Berberine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Cephalotaxine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Cephalotaxus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Cevane' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Cinchona' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Clavine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Ergot' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Hydrogenated Ergot' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Indole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Monoterpenoid Indole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Pyrrolizidine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Rauvolfia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Rauwolfia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Salsoline' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Secologanin Indole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Secologanin Tryptamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Senecio' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Solanaceous' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Solanum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Terpenoid Indole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Veratrum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, Vinca' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc. Some act as cholinergic antagonists; most are very toxic; many are used medicinally.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaloses, Respiratory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkalosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkalosis %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkalosis, Respiratory' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkane 1 Hydroxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkane 1 Monooxygenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkane 1-Hydroxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkane 1-Monooxygenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkane Hydroxylase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanes %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanes %28%1966-1973%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanes %28%1966-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanes %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanesulfonates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkanesulfonic Acids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkaptonuria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes %28%1966%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes %28%1972-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkenes, Cyclic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkiron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl Estrogenic Steroids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl Mercury Compounds' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl Sulfonates' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl Sulfonates %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl Sulfonates %28%1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl Sulfonates %28%1974-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl and Aryl Transferases' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl and Aryl Transferases %28%1991-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl and Aryl Transferases %28%1992-2005%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylated Estrogenic Steroids' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Agents %28%1966-1971%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Agents %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Agents %28%1966-1995%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Agents, Antineoplastic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Antineoplastic Agents' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Antineoplastic Drugs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Antineoplastics' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating Drugs, Antineoplastic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating anti-neoplastic agent. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating antineoplastic agent used especially in bladder neoplasms. It is toxic to hair follicles, gastro-intestinal tract, and vasculature.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating antineoplastic agent used mainly for ovarian tumors. It is toxic to skin, gastrointestinal tract, bone marrow and kidneys.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylation %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylators' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylmercurials' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkylmercury Compounds' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkynes' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkynes %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alkynes %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All Terrain Vehicles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All Trans Retinol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All blood proteins except albumin %28% = SERUM ALBUMIN, which is not a globulin%29% and FIBRINOGEN %28%which is not in the serum%29%. The serum globulins are subdivided into ALPHA-GLOBULINS; BETA-GLOBULINS; and GAMMA-GLOBULINS on the basis of their electrophoretic mobilities. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All deaths reported in a given population. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All of Africa except Northern Africa %28%AFRICA, NORTHERN%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All of the continents and every country situated within, the UNITED STATES and each of the constituent states arranged by region, CANADA and each of its provinces, AUSTRALIA and each of its states, the major bodies of water and major islands on both hemispheres, and selected major cities. Although the geographic locations are not printed in INDEX MEDICUS as main headings, in indexing they are significant in epidemiologic studies and historical articles and for locating administrative units in education and the delivery of health care.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All of the processes involved in increasing in CELL NUMBER. These processes include more than CELL DIVISION which is part of the CELL CYCLE.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All organized methods of funding. ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All tumors in the GASTROINTESTINAL TRACT arising from mesenchymal cells %28%MESODERM%29% except those of smooth muscle cells %28%LEIOMYOMA%29% or SCHWANN CELLS %28%SCHWANNOMA%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All-Terrain Vehicle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All-Trans-Retinol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'All-purpose surfactant, wetting agent, and solubilizer used in the drug, cosmetics, and food industries. It has also been used in laxatives and as cerumenolytics. It is usually administered as either the calcium, potassium, or sodium salt.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allantoic Membrane' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allantoin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allantoin Campbell Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allantoin Sween Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allantois' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allata, Corpora' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allatum, Corpus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allegation, False' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allegations, False' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allegron' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allele' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allele Frequencies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allele Frequency' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allele, X-Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allele, Y-Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alleles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alleles %28%1968-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alleles %28%1968-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alleles, X Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alleles, Y Linked' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic Imbalance' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic Imbalances' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic Loss' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic Losses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic alloantigens often responsible for weak graft rejection in cases when %28%major%29% histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic variants of the gamma-immunoglobulin heavy chain %28%IMMUNOGLOBULIN GAMMA-CHAINS%29% encoded by ALLELES of IMMUNOGLOBULIN HEAVY CHAIN GENES.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic variants of the immunoglobulin light chains %28%IMMUNOGLOBULIN LIGHT CHAINS%29% or heavy chains %28%IMMUNOGLOBULIN HEAVY CHAINS%29% encoded by ALLELES of IMMUNOGLOBULIN GENES.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelic variants of the kappa light chains %28%IMMUNOGLOBULIN KAPPA-CHAINS%29% encoded by ALLELES of IMMUNOGLOBULIN LIGHT CHAIN GENES.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelism Test' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelism Tests' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelomorph' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allelomorphs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allen %26% Hanburys Brand of Acetylcysteine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allen %26% Hanburys Brand of Beclomethasone Dipropionate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allen %26% Hanburys Brand of Dequalinium Chloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand 1 of Fluorometholone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand 2 of Fluorometholone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand 3 of Fluorometholone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Alimemazine Tartrate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Botulinum A Toxin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Fluocinolone Acetonide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Fluorescein Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Fluorouracil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Flurbiprofen Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Levobunolol Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Naphazoline Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Nedocromil Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Povidone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Sulfacetamide Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergan Brand of Trifluridine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergen Bronchial Provocation Tests' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergen Challenge, Bronchial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergen Challenge, Endobronchial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergen Challenges, Bronchial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergen Challenges, Endobronchial' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergen Immunotherapies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens %28%1966-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens %28%1968-2002%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens Radioimmunosorbent Assay' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens Radioimmunosorbent Assays' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens, Dermatophagoides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens, Dermatophagoides farinae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens, Dermatophagoides pteronyssinus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergens, House Dust Mites' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Alveolitides, Extrinsic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Alveolitis, Extrinsic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Angiitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Angiitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Aspergilloses, Bronchopulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Aspergillosis, Bronchopulmonary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Bronchopulmonary Aspergilloses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Bronchopulmonary Aspergillosis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Conjunctivitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Conjunctivitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Contact Dermatitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Contact Dermatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Cutaneous Angiitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Cutaneous Angiitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Cutaneous Vasculitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Cutaneous Vasculitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Eczematous Dermatitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Eczematous Dermatitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Encephalomyelitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Encephalomyelitis, Experimental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Granulomatous Angiitides' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Granulomatous Angiitis' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Neuritis, Experimental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Purpura' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Reactions' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Rhinitides, Seasonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic Rhinitis, Seasonal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic reaction to eggs that is triggered by the immune system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic reaction to milk %28%usually cow%27%s milk%29% or milk products. MILK HYPERSENSITIVITY should be differentiated from LACTOSE INTOLERANCE, an intolerance to milk as a result of congenital deficiency of lactase.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic reaction to peanuts that is triggered by the immune system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic reaction to products containing processed natural rubber latex such as rubber gloves, condoms, catheters, dental dams, balloons, and sporting equipment. Both T-cell mediated %28%HYPERSENSITIVITY, DELAYED%29% and IgE antibody-mediated %28%HYPERSENSITIVITY, IMMEDIATE%29% allergic responses are possible. Delayed hypersensitivity results from exposure to antioxidants present in the rubber; immediate hypersensitivity results from exposure to a latex protein.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic reaction to tree nuts that is triggered by the immune system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic reaction to wheat that is triggered by the immune system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies %28%Specialty%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Egg' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Food' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Latex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Milk' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Nut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Peanut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Pollen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Rubber' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Rubber Latex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Tree Nut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergies, Wheat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy and Immunology' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy and Immunology %28%1966-1970%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Drug' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Egg' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Food' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Immunology' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Latex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Milk' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Nut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Peanut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Pollen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Rubber' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Rubber Latex' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Tree Nut' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allergy, Wheat' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allerton Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allescheria' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allethrin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allethrins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliance Brand of Acenocoumarol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliance Brand of Amantadine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliance Brand of Methysergide Maleate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliance Brand of Metyrapone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliance Brand of Phentolamine Mesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliance, Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alliances, Health' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allied Health Occupation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allied Health Occupations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allied Health Personnel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allied Health Personnel %28%1971-1977%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allied Health Personnel %28%1971-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allied health personnel who assist the professional nurse in routine duties.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alligator' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alligators and Crocodiles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium %28%1986-1997%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium %28%1998-2001%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium sativum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium sativum. One of the Liliaceae used as a spice and traditional remedy. It contains allicin, the pungent active ingredient, which may reduce blood cholesterol and inhibit platelet aggregation.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium schoenoprasum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allium tuberosum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allnortoxiferine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allo Uridine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allo-Uridine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloantibodies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloantigen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloantigens, Platelet' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allocation of Resources' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allocation, Cost' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allocation, Random' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allocation, Resource' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allocations, Cost' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allocations, Resource' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allogeneic Transplantation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allogeneic Transplantations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allograft Dressing' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allograft Dressings' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allografts' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allohexan' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allolevivirus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloleviviruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allophanamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allophanate Hydrolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopregnan 3 beta ol 20 one' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopregnan-3 beta-ol-20-one' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopregnanolone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol APS Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Alphapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Amrad Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Ashbourne Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Azupharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol BASF Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Bicther Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Boots Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Clonmel Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Dorsch Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Douglas Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Hennig Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Hexal Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Horner Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol ICN Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Jenapharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Merckle Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Merz Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Multipharma Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Nicholas Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Novopharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Pharmafarm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Pinewood Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Protea Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol R.A.N. Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Rima Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Roche Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Rosen Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Rougier Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol TAD Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Thiemann Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol Wellcome Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allopurinol gepepharm Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allosteric Regulation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allosteric Regulations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allosteric Site' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allosteric Sites' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allosteric enzymes that regulate glycolysis and gluconeogenesis. These enzymes catalyze phosphorylation of fructose-6-phosphate to either fructose-1,6-bisphosphate %28%PHOSPHOFRUCTOKINASE-1 reaction%29%, or to fructose-2,6-bisphosphate %28%PHOSPHOFRUCTOKINASE-2 reaction%29%.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allothreonine Aldolase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Gm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Ig' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Immunoglobulin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Immunoglobulin Gm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Immunoglobulin Inv' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Immunoglobulin Km' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Inv' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotype, Km' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Gm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Ig' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Immunoglobulin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Immunoglobulin Gm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Immunoglobulin Inv' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Immunoglobulin Km' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Inv' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypes, Km' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypic Antibodies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allotypic Antibody' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowable Concentration, Maximum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowable Concentrations, Maximum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowance, Family' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowance, Recommended Daily' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowance, Recommended Dietary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowances, Family' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowances, Recommended Daily' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowances, Recommended Dietary' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowing a woman to be in LABOR, OBSTETRIC long enough to determine if vaginal birth may be anticipated.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allowing to Die' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloxan' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloxanthine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloy, Cobalt-Chromium-Molybdenum' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloy, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloy, Metal Ceramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloy, Metallo-Ceramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloy, Metalloceramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys %28%1966-1972%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys that contain a high percentage of gold. They are used in restorative or prosthetic dentistry.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Chromium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Chromium-Cobalt' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Chromium-Nickel' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Cobalt-Chromium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Dental' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Gold' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Metal Ceramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Metallo-Ceramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Metalloceramic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Nickel-Chromium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alloys, Porcelain-Metal' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Alprostadil' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Betaxolol Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Carbachol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Disulfiram' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Ethamsylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Flucytosine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Flurazepam Monohydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Human Growth Hormone' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Levothyroxine Sodium' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Mesalamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Nitrazepam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Sulpiride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allphar Brand of Tranylcypromine Sulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Aldehyde' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds %28%1971-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds %28%1971-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds %28%1971-1978%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds %28%1972-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds %28%1973-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyl Compounds %28%1974-1975%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allylamine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allylestrenol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allylestrenol Organon Brand' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allylglycine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allylisopropylacetamide' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allylnormorphine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Allyloestrenol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almanac' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almanacs' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almanacs %28%PT%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almanacs %5B%Publication Type%5D%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Amlodipine Besilate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Bleomycin Sulfate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Carboplatin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Estrogens, Conjugated' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Nicardipine Hydrochloride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Nimodipine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Nitrendipine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Pipemidic Acid' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Piracetam' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Probucol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Ramipril' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Sulpiride' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almirall Brand of Tegafur' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almitrine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almitrine Bis%28%methanesulfonate%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almitrine Bismesylate' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system.%A% ' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almonds' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almshouse' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Almshouses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alnus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alobar Holoprosencephalies' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alocasia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Aloe' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alogia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alogias' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alonga Brand of Aciclovir' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alonga Brand of Aciclovir Sodium Salt' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alonga Brand of Astemizole' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alonga, Astemizol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alopecia' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alopecia Areata' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alopecia Mucinosa' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alopecia, Androgenetic' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alopecia, Male Pattern' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alouatta' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alouattas' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alouattinae' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpaca' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alper Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alper Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alper%27%s Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alper%27%s Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpers%27% Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpers%27% Syndrome' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Acetohydroxyacid Isomeroreductase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Amanitin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Amanitine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Aminoadipic Semialdehyde Deficiency Disease' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Amylase Bayer' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Brand of Propofol' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Chymotrypsinogen' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulins %28%1966-1969%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulins %28%1966-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulins %28%1966-1984%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulins %28%1968-1974%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Globulins %28%1974-1976%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Glycerophosphate Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Keto Acid Dehydrogenase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Macroglobulins %28%1976-1979%29%' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Neurotoxins' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Particle' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Particles' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Peroxidase' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Radiation' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Radiations' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Ray' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Rhythm' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Rhythm Electroencephalography' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Rhythm Encephalography' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Rhythms' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Solanine' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Stathmin' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Subunit, Go' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Virus' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha Viruses' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha%28%1%29%-Acid Glycoprotein' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha, Recombinant Interferon' = 0).
% 42.08/41.97 fof(interp, fi_functors, 'Alpha- or beta-acetyl derivatives of DIGOXIN or lanatoside C from Digitalis lanata. They are better absorbed and longer acting than digoxin and are used in congestive heart failure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpha-Acetohydroxyacid Isomeroreductase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpha-D-Mannopyranosyl Phosphate, Dolichyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpha-Globulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpha-Globulins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpha-Glycerophosphate Dehydrogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpha-Keto Acid Dehydrogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'AlphaAmylase Bayer' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphacetylmethadol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphaherpesvirinae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphaherpesvirinae %28%1994-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphamethyldopa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Aciclovir' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Allopurinol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Alprazolam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Amiloride Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Amiodarone Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Baclofen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Calcitriol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Danazol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Dicloxacillin Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Doxepin Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Felodipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Flecainide Acetate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Flutamide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Gemfibrozil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Gliclazide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Glipizide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Labetalol Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Methylcellulose' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Methyldopa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Minocycline Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Moclobemide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Quinine Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Spironolactone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Sulfasalazine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Sulindac' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharm Brand of Temazepam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphapharma Brand of Nitrazepam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphaprodine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphaproteobacteria' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphaproteobacteria %28%2000-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharetrovirus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Cephradine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Cetirizine Dihydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Cinnarizine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Dihydroergotamine Mesylate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Doxazosin Mesylate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Etilefrine Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Felodipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Flecainide Acetate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Fluconazole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Meclofenoxate Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Methocarbamol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Minocycline Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Moclobemide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Molsidomine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Naftidrofuryl Oxalate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Nimodipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Nitrazepam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Nitrendipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Pentaerythritol Tetranitrate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Piracetam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Propafenone Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Robenidine Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Roxithromycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Spironolactone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Terbutaline Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpharma Brand of Trimetazidine Dihydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphasone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphasone Acetophenide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphavirus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphavirus Infection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphavirus Infections' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphaviruses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alphoscerate, Choline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpine Lovage' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alpinia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alport Syndrome, X Linked' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alport%27%s Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Alphapharm Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Apotex Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Kenral Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Novopharm Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Nu-Pharm Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Orion Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Pharmacia Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Temmler Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolam Upjohn Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprazolan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprenolol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprenolol %28%1972-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprostadil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alprostadil/analogs %26% derivatives %28%1975-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alra Brand of Dimenhydrinate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Also called 4-hydroxy-3-iodo-5-nitrophenylacetate. A haptenic determinant that can be radiolabeled and used as salts and derivatives for investigations of immunogenic specificity studies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Also known as CD104 antigen, this protein is distinguished from other beta integrins by its relatively long cytoplasmic domain %28%approximately 1000 amino acids vs. approximately 50%29%. Five alternatively spliced isoforms have been described.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alstonia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alstroemeria' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altace' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Brand of Betahistine Mesylate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Brand of Disulfiram' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Brand of Gold Sodium Thiomalate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Brand of Thiopental Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Oranienburg Brand of Calcium Dobesilate Monohydrate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Oranienburg Brand of Dihydralazine Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altana Pharma Oranienburg Brand of Mebendazole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alteplase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alteplase Genentech Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alteplase Promeco Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alter Brand of Meprobamate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alter Brand of Nitrazepam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alter Brand of Spironolactone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alter, Doxazosina' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alteration, Appetite' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alterations in the mechanical integrity or structure of the blood vessels leading to bleeding disorders.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alterations or deviations from normal shape or size which result in a disfigurement of the foot.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alterations or deviations from normal shape or size which result in a disfigurement of the hand occurring at or before birth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alterations or deviations from normal shape or size which result in a disfigurement of the hand.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alterations, Appetite' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altered Level of Consciousness' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altered Taste' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternaria' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternate Splicing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternate Splicings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternating Nystagmus, Periodic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Complement Activation Pathway' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Complement Pathway' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Medicine %28%1985-1995%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Medicine %28%1990-1995%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Pathway C3 C5 Convertases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Pathway C3 Convertase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Pathway C3-C5 Convertases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Pathway C5 Convertase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative RNA Splicing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative RNA Splicings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Splicing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative Splicings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative health care delivery mechanisms, such as PREFERRED PROVIDER ORGANIZATIONS or other health insurance services or prepaid plans %28%other than HEALTH MAINTENANCE ORGANIZATIONS%29%, that meet Medicare qualifications for a risk-sharing contract. %28%From Facts on File Dictionary of Health Care Management, 1988%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative, Animal Testing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternative, Animal Use' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternatives to Animal Testing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternatives to the use of animals in research, testing, and education. The alternatives may include reduction in the number of animals used, replacement of animals with a non-animal model or with animals of a species lower phylogenetically, or refinement of methods to minimize pain and distress of animals used.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternatives, Animal Testing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alternatives, Animal Use' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alteromonadaceae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alteromonas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Althaea' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altidudinal Hemianopias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitude' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitude Sickness' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitude Sicknesses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitudes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitudinal Hemianopsia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitudinal Hemianopsias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitudinal Scotoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altitudinal Scotomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altosid PS 10' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altosid PS10' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine Bellon Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine Chiesi Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine Faulding Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine Lilly Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine Speywood Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altretamine Wassermann Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altruism' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altruism %28%1974-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Altruline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alu Element' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alu Elements' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alu Families' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alu Family' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alu Repetitive Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alu Repetitive Sequences' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluid Brand of Acetylcysteine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alum Compounds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alumina' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alumina, Hydrated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alumino 4 Aminosalicylic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum %28%1966-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum %28%1972-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Compounds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Hydroxide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum L Glutamate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Oxide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Salt Ibuprofen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Salt, Niacin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Silicates' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Silicates %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Silicates %28%1980-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum Sucrose Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alumroot' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolalgias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Abscess, Apical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Abscesses, Apical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Adenocarcinoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Adenocarcinomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Bone Loss' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Bone Losses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Carcinoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Carcinomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Echinococcis, Hepatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Echinococcoses, Hepatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Echinococcosis, Hepatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Hypoventilation, Central' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Hypoventilations, Central' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Lavage Fluids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Macrophage' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Macrophages' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Nerves, Inferior' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Nerves, Superior' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Osteitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Osteitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Periostitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Periostitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Process' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Process %28%1966-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Processes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Proteinoses, Pulmonary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Proteinosis, Pulmonary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Resorption' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Resorptions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Rhabdomyosarcoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Rhabdomyosarcomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Ridge Augmentation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolar Ridge Augmentations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolectomies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolectomy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveoli, Human Mammary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveoli, Pulmonary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolitides, Extrinsic Allergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolitides, Fibrosing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolitis Sicca Dolorosa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolitis, Extrinsic Allergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolocapillary Membrane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolocapillary Membranes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolodental Ligament' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolodental Ligaments' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolodental Membrane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolodental Membranes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveoloplasties' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveoloplasty' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveoloplasty %28%1966-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolus Dentali' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolus Dentalis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolus, Dental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolus, Human Mammary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alveolus, Pulmonary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alvit 55' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alvit55' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alza Brand of Amifostine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer Dementia, Presenile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer Disease %28%1979-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer Type Dementia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer Type Senile Dementia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer Vaccines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer beta Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer beta-Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Alzheimer%27%s Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amacrine Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amacrine Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amalgam, Dental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amalgams, Dental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amanita' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amanitins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amanta HCI AZU' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amanta Sulfate AZU' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'AmantaHCIAZU' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'AmantaSulfateAZU' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadin AZU' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadin neuraxpharm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadin ratiopharm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadine %28%1974%29%/analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadinneuraxpharm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amantadinratiopharm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaranth Dye' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaranth Dye %28%1988-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaranth Plant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaranthaceae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaranthus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaryllidaceae Alkaloids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amatine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amauroses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaurosis Fugax' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amaurotic Familial Idiocies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amazon Manatee' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amazon Manatees' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amazon Parrot' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amazon Parrots' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amazon River Dolphins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amazona' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambenonium Chloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amber' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amber Suppressor Gene' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amber Suppressor Genes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambergris' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambidexterities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambilhar' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopia, Anisometropic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopia, Stimulus Deprivation Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopia, Stimulus Deprivation-Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopias, Anisometropic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopias, Developmental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopias, Stimulus Deprivation-Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyopias, Suppression' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblyospora' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblystoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amblystomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambro Puren' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'AmbroPuren' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambrohexal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambrol%C3%%B6%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambrosia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambroxocompren' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambroxol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambroxol Marjan Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambroxol P%C3%%A4%dia Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulance, Air' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulance, Helicopter' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulances' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulances %28%1966-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulances, Air' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulances, Helicopter' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulation Disorder, Neurologic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulation Disorders, Neurologic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulation, Accelerated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulation, Dependent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulation, Early' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory 24 hour Esophageal pH Monitoring' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory 24-hour Esophageal pH Monitoring' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Blood Pressure Monitoring' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care %28%1966-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care %28%1978-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Facilities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Facilities, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Facilities, Non Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Facilities, Non-Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Facilities, Nonhospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Facility' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Care Information Systems' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Difficulty' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Electrocardiographic Monitoring' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Electrocardiography' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Electrocardiography Monitoring' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Health Center' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Health Centers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Monitoring' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Surgeries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Surgery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Surgical Procedure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambulatory Surgical Procedures' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambystoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambystoma %28%1972-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambystoma mexicanum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambystoma mexicanums' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambystomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ambystomatidae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amdinocillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amdinocillin Pivoxil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameba' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiases, Intestinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiasis %28%1966-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiasis %28%1975-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiasis, Hepatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebiasis, Intestinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Abscess' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Abscesses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Colitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Colitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Dysenteries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Dysentery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Liver Abscess' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebic Liver Abscesses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebicides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebicides %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebida' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amebomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amelanotic Melanoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amelanotic Melanomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblast' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblastic Fibro-odontoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblastic Fibro-odontomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblastoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblastoma %28%1965-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblastomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ameloblasts' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amelogeneses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amelogenesis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amelogenesis Imperfecta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amendment, Constitutional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amendments, Constitutional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amenorrhea' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amenorrhea, Postpartum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amentia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amentias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'America' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Amerind, Central' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Amerind, South' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Amerinds, Central' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Amerinds, South' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Buffalo' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Buffaloes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Cancer Societies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Cancer Society' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Civil War' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Civil Wars' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Cockroach' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Cockroaches' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Dental Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American False Pennyroyal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American False Pennyroyal = HEDEOMA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Heart Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Heart Associations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Hemorrhagic Fever' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Hemorrhagic Fever Virus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Hospital Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American House Dust Mite' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indian' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indian, Central' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indian, North' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indian, South' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indians, Central' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indians, North' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Indians, South' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Leishmaniasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Medical Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Mink' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Native Continental Ancestry Group' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Nurses Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Nurses%27% Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Nurses%27% Associations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Ostrich' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Ostriches' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Ostrichs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Pennyroyal, False' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Pharmaceutical Partners Brand 1 of Pentamidine Isethionate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Pharmaceutical Partners Brand 2 of Pentamidine Isethionate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Public Health Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Regent Brand of Bretylium Tosilate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Regent Brand of Iron-Dextran Complex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Revolution' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Revolution, 1775 1783' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Revolution, 1775-1783' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Revolutions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Samoa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Speech Language Hearing Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Speech-Language-Hearing Association' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Trypanosomiasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American War of Independence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American War, Spanish' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American Wars, Spanish' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Asian' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Chinese' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Hispanic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Japanese' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Korean' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Mexican' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'American, Native' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, African' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Asian' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Chinese' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Cuban' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Hispanic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Japanese' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Korean' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Mexican' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Native' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americans, Spanish' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Americium. A completely man-made radioactive actinide with atomic symbol Am, atomic number 95, and atomic weight 243. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amerind, Central American' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amerind, North American' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amerind, South American' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amerinds, Central American' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amerinds, North American' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amerinds, South American' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amet, S' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ametazole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amethocaine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amethopterin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ametropias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amfebutamone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amfepramon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amfepramone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amfetamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amgen Brand of Mitoxantrone Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidase, Cephalexin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidase, N-Acetylmuramoyl-L-alanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidase, Penicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidazine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidazophen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amide Synthases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amide, 5-Valine-Angiotensin II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amide, Angiotensin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amide, Procaine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1966-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides %28%1974-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amides of salicylic acid. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidine Lyases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidine-Lyases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidines %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidines %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidines %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidines %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidinopenicillanic acid derivative with broad spectrum antibacterial action. It is poorly absorbed if given orally and is used in urinary infections and typhus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidinotransferases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amido Black' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amido-beta-Lactam Hydrolase, Cephalosporin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Aspartylglucosamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Aspartylglycosamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Dihydro-Orotate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Mucopeptide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Nicotinamide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Penicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolase, Urea' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1979-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases %28%1983-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidohydrolases/deficiency %28%1983-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidophen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidophenazon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidophosphoribosyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidopyrine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidotransferase, Glutamine Ketoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidotransferase, Ketoglutarate Glutamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidotransferase, Phosphoribosyl Pyrophosphate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidotrezoate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidotrizoate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amidotrizoate, Meglumine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amifostine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amifostine Alza Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amifostine Essex Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amifostine Lilly Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amifostine Schering-Plough Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amikacin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amikacin 3%27% Phosphotransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amikacin 3%27%-Phosphotransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amiklin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amiksin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amiloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminacrine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminalon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminalone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminase, AMP' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminase, Fumaric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminase, Guanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amination' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase %28%Copper-Containing%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase %28%Flavin-Containing%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase, Clorgyline-Resistant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase, Copper' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase, Copper Containing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase, Copper-Containing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidase, Semicarbazide-Sensitive' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidoreductases %28%1975-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidoreductases %28%1975-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidoreductases %28%1986-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidoreductases, Primary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidoreductases, Secondary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Oxidoreductases, Secondary Amine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine Transporter, Vesicular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine oxidoreductases that use either NAD+ %28%EC 1.5.1.7%29% or NADP+ %28%EC 1.5.1.8%29% as an acceptor to form L-LYSINE or NAD+ %28%EC 1.5.1.9%29% or NADP+ %28%EC 1.5.1.10%29% as an acceptor to form L-GLUTAMATE. Deficiency of this enzyme causes HYPERLYSINEMIAS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amine, Biogenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1966-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1969-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1972-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines %28%1974-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amines, Biogenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Acetyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Agents, Excitatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Agonist, Excitatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Agonists, Excitatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Antagonists, Excitatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Chloromethyl Ketones' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Decarboxylases, Aromatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Isomerases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Isomerases %28%1970-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Isomerases %28%1984-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Isomerases %28%1985-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism Disorders, Inborn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Error' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors %28%1965-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors %28%1966-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors %28%1966-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors %28%1967-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Metabolism, Inborn Errors %28%1975-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Co Translational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Post Translational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Posttranslational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Pre Translational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Pre-Translational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Pretranslational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Modification, Translational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Motif' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Motifs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid N Acetyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Naphthylamidases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases %28%1966-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases %28%1970-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases %28%1975-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases %28%1977-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Oxidoreductases %28%1998-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Permease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Receptors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Repeat Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Repetitive Seq' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1966-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1966-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1966-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1966-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1966-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1967-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1971-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1975-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1975-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1977-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1980-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1980-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1981-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1981-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1985-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1987-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1989-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1989-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1989-1995%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1990-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence %28%1990-1996%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence Analyses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence Analysis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence Databases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence Determination' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence Determinations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequence Homology' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Sequences' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Specific Transfer RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Specific tRNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Substitution' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Substitutions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Disorder, Neutral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Disorders, Inborn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System A Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System ASC' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System ASC Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System L' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System L Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System X AG' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System X-AG' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System X-AG %28%1984-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System XAG' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System y Plus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System y+' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System y+L' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System y-Plus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport System yPlus L' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems, Acidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems, Anionic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems, Basic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems, Cationic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems, Neutral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transport Systems, Neutral %28%1987-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transporter' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transporter A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transporter ASC' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid Transporters' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid, Acidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid, Aromatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid, Basic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid, Excitatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid-Specific Transfer RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acid-Specific tRNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acidopathies, Congenital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acidopathies, Inborn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acidopathy, Congenital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acidopathy, Inborn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1965-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1966-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1968-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1969-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids Activation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids Activations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids Receptors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Acidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Aromatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Basic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Branched Chain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Branched Chain %28%1979-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Branched-Chain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Cyclic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Diamino' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Diamino %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Dibasic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Dicarboxylic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Dicarboxylic %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Dicarboxylic %28%1974-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Essential' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Excitatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Excitatory, Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Excitatory, Agonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Excitatory, Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Neutral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Peptides, and Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Phosphorus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Secondary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Sulfur' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids, Sulfur %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids/analysis %28%1966-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids/metabolism %28%1975-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids/metabolism %28%1976-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids/metabolism %28%1980-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acids/metabolism %28%1992-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl T RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl T RNA %28%1978-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl T RNA Synthetases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl T RNA Synthetases %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl T RNA Synthetases %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl T RNA Synthetases %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl tRNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl tRNA Ligases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl tRNA Synthetases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl-tRNA Ligases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acyl-tRNA Synthetases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acylation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acylation, tRNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Acylations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1966-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1969-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1972-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Alcohols %28%1978-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Coumarins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Sugars' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Sugars %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Sugars %28%1971-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Sugars %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino Sugars %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acid sequence in which two disulfide bonds %28%DISULFIDES%29% and their connecting backbone form a ring that is penetrated by a third disulfide bond. Members include CYCLOTIDES and agouti-related protein.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acid sequences found in transported proteins that selectively guide the distribution of the proteins to specific cellular compartments.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acid transporter systems capable of transporting acidic amino acids %28%AMINO ACIDS, ACIDIC%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acid transporter systems capable of transporting basic amino acids %28%AMINO ACIDS, BASIC%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acid transporter systems capable of transporting neutral amino acids %28%AMINO ACIDS, NEUTRAL%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids and chains of amino acids connected by peptide linkages.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids containing an aromatic side chain. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids that contain phosphorus as an integral part of the molecule.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids which have a branched carbon chain. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids with side chains that are negatively charged at physiological pH.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids with side chains that are positively charged at physiological pH.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino acids with uncharged R groups or side chains. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino-Acid Acetyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino-Acid N-Acetyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino-Coumarins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino-Terminal Kinase, c-jun' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino-oligopeptidase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amino-substituted glyoxylic acid derivative. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacetic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacetonitrile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoaciduria, Renal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacridine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacridine Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacridines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacridines %28%1980-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacyl Transfer RNA Synthetase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacyl tRNA Synthetase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacyl-tRNA Synthetase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacylation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacylation, Transfer RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacylation, tRNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacylations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacylations, Transfer RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacylations, tRNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoacyltransferases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoadipate Semialdehyde Dehydrogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoadipate-Semialdehyde Dehydrogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoadipic Acid, 2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoantipyrine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzenesulfonic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzenesulfonic acids. Organic acids that are used in the manufacture of dyes and organic chemicals and as reagents.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzoic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzoic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzoic Acids %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzoic Acids %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzyl Penicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobenzylpenicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobiphenyl Compounds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyrate Aminotransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acid %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acids %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acids %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acids %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acids %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminobutyric Acids %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Acids %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Acids %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Acids %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Acids %28%1981-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocaproic Lactam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocoumarins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocyclitol Phosphotransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocyclohexylpenicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminocyclopentanecarboxylic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoethanols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoethylisothiuronium Bromide Hydrobromide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoethylphosphonic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminofenazone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglutethimide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycoside 3%27% Phosphotransferase Type VIII' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycoside 3%27%-Phosphotransferase Type VIII' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycoside Phosphotransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycoside produced by Streptomyces hygroscopicus. It is used as an anthelmintic against swine infections by large roundworms, nodular worms, and whipworms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycosides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycosides %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoglycosides %28%1974-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohippuric Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohippuric Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohippuric Acids %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolase, AMP' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolase, Adenosine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolase, Cytidine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolase, Cytosine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolase, Deoxycytidylate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolase, Guanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydrolases %28%1983-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminohydroxybutane Bisphosphonate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoimidazole Carboxamide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoimidazolecarboxamide Ribonucleotide Transformylase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoisobutyric Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminolevulinate Hydro Lyase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminolevulinate Hydro-Lyase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminolevulinic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminolevulinic Acid Dehydratase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminolevulinic Acid Synthetase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminomethyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminomethyltransferase, Tetrahydrofolate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminomuconate Semialdehyde Dehydrogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminomuconate-Semialdehyde Dehydrogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminonucleoside, Puromycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminooxoacetic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminooxyacetic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase I, Dipeptidyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase M' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase N' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Aspartate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Aspartyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Cytosol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Glutamyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Leucine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Leucyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Methoxyleucine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Pyroglutamate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidase, Zinc-Manganese-Leucine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidases %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidases %28%1981-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopeptidases %28%1981-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophenazone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophenazone Berlin-Chemie Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophenetole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophenols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophenurobutane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophospholipid Flippase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophospholipid Translocase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophospholipid Translocator' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophospholipid Transporter' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminophylline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropanols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropionitrile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropyl Aminoethylthiophosphate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropylaminoethylthiophosphoric Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropyltransferase, Putrescine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopropyltransferase, Spermidine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopterin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopyridines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopyridines %28%1979-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopyridines %28%1979-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopyrine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopyrine N Demethylase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminopyrine N-Demethylase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoquinolines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminorex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminosalicylic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminosalicylic Acids %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminosalicylic Acids %28%1981-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminosidine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, 2-Aminoadipate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, 2-Aminoadipate-2-Oxoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Alanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Alanine-2-Oxoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Aminobutyrate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Aspartate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Cytoplasmic Aspartate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, D-Alanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, GABA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, GABA-alpha-Ketoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Glutamine-Fructose-6-P' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Glutamine-Fructose-6-Phosphate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Glycine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Glycine-2-Oxoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Hexosephosphate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, L-Aspartate-2-Oxoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, L-Ornithine-2-Oxo-Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, L-Ornithine-2-Oxoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, L-Tryptophan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Leucine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Lysine-epsilon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Mitochondrial Aspartate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Ornithine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Ornithine Ketoacid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Ornithine-2-Ketoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Succinyldiaminopimelate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Tryptophan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, Tyrosine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, alpha-Aminoadipate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, beta-Alanine Ketoglutarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferase, beta-Alanine Pyruvate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferases %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferases %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferases %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferases %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotransferases, Aspartate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminotriazole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoxafen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aminoxaphen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amiodarone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amipaque' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amithiozone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amitriptylin neuraxpharm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amitriptyline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amitriptylinneuraxpharm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amitrole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amixin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amizil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amla' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amlodipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amlodipine Maleate %28%1:1%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amlor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammi' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammoidin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammon Horn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammon%27%s Horn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia %28%1966-2000%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia Lyases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, Aspartate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, Ethanolamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, Histidine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, L-Serine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, Phenylalanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, Porphobilinogen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyase, Threonine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia-Lyases %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonia. A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammoniated Ruthenium Oxychloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Chloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1966-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1969-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1970-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1972-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds %28%1973-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds, Benzyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds, Phenylmethyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds, Quaternary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Compounds, Trimethyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Purpurate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Purpurate, Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Salt Ditiocarb' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Salt Sulfisoxazole' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Salt Tetraphenylborate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Salt, Niacin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammonium Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammons Horn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ammotherapy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia %28%1966-1968%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia %28%1966-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia %28%1966-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia %28%1967-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia Memory Loss' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia, Anterograde' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia, Post Ictal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia, Post-Ictal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia, Pre Ictal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia, Retrograde' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia, Transient Global' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia-Memory Loss' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesia-Memory Losses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Anterograde' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Dissociative' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Global' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Hysterical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Post-Ictal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Pre-Ictal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Retrograde' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Tactile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesias, Temporary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnesic Aphasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Disorder, Alcohol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Disorders, Alcohol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Psychoses, Alcohol-Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Psychosis, Alcohol Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Psychosis, Alcohol-Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic States' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Syndrome, Alcohol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Syndrome, Alcohol-Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Syndromes, Alcohol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnestic Syndromes, Alcohol-Induced' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniocenteses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniocentesis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniocentesis %28%1971-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnion %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnion %28%1966-1982%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnion %28%1966-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnionitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnioscope' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnioscopic Surgeries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnioscopic Surgery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnioscopic Surgical Procedure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amnioscopies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Band' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Band Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Fluid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Fluid %28%1966-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Fluid Embolism' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Fluid Embolisms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Fluid Indices' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Fluids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Membrane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Membrane Dressing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic Membranes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amniotic cavity fluid which is produced by the AMNION and fetal lungs and kidneys.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amobarbital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amobarbital, Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amodiachin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amodiaquin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amodiaquine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoeba' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoeba %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoeba %28%1966-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoeba %28%1974-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebiases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebiases, Intestinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebiasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebiasis, Hepatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebiasis, Intestinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Colitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Colitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Dysenteries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Dysentery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Hepatic Abscess' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Hepatic Abscesses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Liver Abscess' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebic Liver Abscesses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebicides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoebida' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amomum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amomum cardamomum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amorbarbital Miquel Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amorphophallus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amosite' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amosite Asbestos' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amount of stimulation required before the sensation of pain is experienced.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amounts charged to the patient as payer for dental services.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amounts charged to the patient as payer for health care services.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amounts charged to the patient as payer for medical services.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amounts charged to the patient or third-party payer for medication. It includes the pharmacist%27%s professional fee and cost of ingredients, containers, etc.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amox clav' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amox-clav' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxapine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxapine Cyanamid Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxapine Lederle Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxapine Wyeth Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxi Clavulanate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxi-Clavulanate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin %28%1981-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin Clariana Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin Clavulanic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin Potassium Clavulanate Combination' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin-Clavulanic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicillin-Potassium Clavulanate Combination' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxicilline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxycillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxycillin Clavulanic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxycillin, Clavulanate Potentiated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amoxycillin-Clavulanic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampelopsis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine %28%1966-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine %28%1973-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine Related Disorders' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine Sulfate %28%2:1%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine User' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamine-Related Disorders' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphetamines %28%1980-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibia %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibia %28%1966-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibian Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibian Venom' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibian Venoms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibians' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphibole Asbestos' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphipoda' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphipods' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphistomidae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphiuma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampholines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampholyte Mixtures' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampholytes, Carrier' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphoteric Virus Receptor GLVR 2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphoteric Virus Receptor GLVR-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphotericin B' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphoterin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphotropic MuLV Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amphotropic Murine Leukemia Virus Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin %28%1966-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin %28%1975-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin Pivaloyl Ester' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin Resistance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin Resistances' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampicillin, Phthalidyl' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technic, DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technic, RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technics, DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technics, Nucleic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technics, RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technique, DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Technique, RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Techniques, DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Techniques, Nucleic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification Techniques, RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplification, Gene' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplifier' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amplifiers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amprolium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampulla of Vater' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampulla, Hepatopancreatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampulla, Vater%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampullas, Hepatopancreatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation Stump' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation Stumps' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation of a lower limb through the sacroiliac joint.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation or separation at a joint. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputation, Traumatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputations, Intrauterine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputations, Traumatic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputee' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amputees' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ampyrone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrad Brand of Aciclovir' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrad Brand of Allopurinol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrad Brand of Amiloride Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrad Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrinon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrinone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amrinone LAW Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amsacrina' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amsacrine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amsacrine G%C3%%B6%decke Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amsinckia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amsonia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amstelodamensis, Typus Degenerativus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amukin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amur Pike' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdala' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdalase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdalin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdalo-Hippocampal Epilepsies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdaloid Bodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdaloid Body' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdaloid Body %28%1966-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amygdaloside' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyl Alcohols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyl Nitrite' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylases %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylases %28%1967-2002%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylobarbitone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloglucosidase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid %28%1966-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid %28%1988-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid A Precursor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid A Protein Related Serum Component' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid A Protein-Related Serum Component' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid A4 Protein Precursor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid AD AP' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid AD-AP' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Angiopathy, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Fibril Protein %28%Alzheimer%27%s%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Fibril Protein AA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Neuropathies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Neuropathies %28%1994-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Neuropathies, Familial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Neuropathies, Secondary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Neuropathy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Neuropathy, Familial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid P Component' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal %28%pentaxin%29% structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid P-Component, Serum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Plaque' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Plaques' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Polyneuropathies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Polyneuropathies, Familial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Polyneuropathy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Polyneuropathy, Familial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Polyneuropathy, Iowa Type' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Protein A4' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Protein AA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Protein AA Precursor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Protein Precursor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Protein SAA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Serum Protein SAA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid Substance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid beta Precursor Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid beta Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid beta Protein Precursor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid beta-Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid beta-Protein Precursor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloid-Related Serum Protein %28%SAA%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidoses, Familial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidoses, Hereditary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidoses, Portuguese Polyneuritic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis %28%1966-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis %28%1967-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis %28%1974-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis, Familial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis, Icelandic Type' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyloidosis, Portuguese Polyneuritic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylopectin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylopectinoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylopectinosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylophosphorylase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amylose' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyoplasia Congenita' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotonia Congenita' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophic Lateral Sclerosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophic Neuralgia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophic Neuralgias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophies, Diabetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophies, Neuralgic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophy, Diabetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyotrophy, Neuralgic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Amyxin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An 11-kDa AT-hook motif-containing %28%AT-HOOK MOTIFS%29% protein that binds to the minor grove of AT-rich regions of DNA. It is the full-length product of the alternatively-spliced HMGA1 gene and may function as an architectural chromatin binding protein that is involved in transcriptional regulation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An 11-kDa protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinemia, renal failure, or kidney transplants.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An 86-amino acid polypeptide, found in central and peripheral tissues, that displaces diazepam from the benzodiazepine recognition site on the gamma-aminobutyric acid receptor %28%RECEPTORS, GABA%29%. It also binds medium- and long-chain acyl-CoA esters and serves as an acyl-CoA transporter. This peptide regulates lipid metabolism.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ADP-ribosylating EXOTOXIN produced by CORYNEBACTERIUM DIPHTHERIAE that causes the signs and symptoms of DIPHTHERIA. It can be broken into two unequal domains: the smaller, catalytic A domain is the lethal moiety and contains mono ADPribose transferase which transfers ADP RIBOSE to PEPTIDE ELONGATION FACTOR 2 thereby inhibiting protein synthesis; and the larger B domain that is needed for entry into cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ANGIOTENSIN II analog which acts as a highly specific inhibitor of ANGIOTENSIN TYPE 1 RECEPTOR.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ASPARTIC ACID residue in polypeptide chains that is linked at the beta-carboxyl group instead of at the normal, alpha-carboxyl group, polypeptide linkage. It is a result of the spontaneous decomposition of aspartic acid or ASPARAGINE residues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An AT-hook motif-containing protein %28%AT-HOOK MOTIFS%29% that binds to the minor grove of AT-rich regions of DNA. It is a truncated form of HMGA1a protein that is produced by alternative-splicing of the HMGA1 gene. It may function as an architectural chromatin binding protein that is involved in transcriptional regulation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An AT-hook-containing %28%AT-HOOK MOTIFS%29% nuclear protein that is expressed predominantly in proliferating and undifferentiated mesenchymal cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An AT-hook-containing %28%AT-HOOK MOTIFS%29% nuclear protein that may be involved in retinoid-dependent transcriptional activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ATP-dependent enzyme that catalyzes the addition of ADP to alpha-D-glucose 1-phosphate to form ADP-glucose and diphosphate. The reaction is the rate-limiting reaction in prokaryotic GLYCOGEN and plant STARCH biosynthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ATP-dependent exodeoxyribonuclease that cleaves in either the 5%27%- to 3%27%- or the 3%27%- to 5%27%-direction to yield 5%27%-phosphooligonucleotides. It is primarily found in BACTERIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ATP-dependent protease found in prokaryotes, CHLOROPLASTS, and MITOCHONDRIA. It is a soluble multisubunit complex that plays a role in the degradation of many abnormal proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A and activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F1 is involved in DNA REPAIR and APOPTOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F3 regulates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that interacts directly with RETINOBLASTOMA PROTEIN and CYCLIN A. E2F2 activates GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F4 recruits chromatin remodeling factors indirectly to target gene PROMOTER REGIONS through RETINOBLASTOMA LIKE PROTEIN P130 and RETINOBLASTOMA LIKE PROTEIN P107.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F5 recruits chromatin remodeling factors indirectly to target gene promoters through RETINOBLASTOMA LIKE PROTEIN P130.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F6 recruits chromatin remodeling factors directly to target gene promoters and lacks the transactivation domain responsible for binding to the retinoblastoma family of tumor suppressors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E2F transcription factor that represses GENETIC TRANSCRIPTION required for CELL CYCLE entry and DNA synthesis. E2F7 has two separate DNA-binding domains and binds to DNA independently of a dimerization partner.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E3 UBIQUITIN LIGASE that interacts with and inhibits TUMOR SUPPRESSOR PROTEIN P53. Its ability to ubiquitinate p53 is regulated by TUMOR SUPPRESSOR PROTEIN P14ARF.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An E3 UBIQUITIN LIGASE that plays a key role in the DNA damage response pathway of FANCONI ANEMIA PROTEINS. It is associated with mono-ubiquitination of FANCD2 PROTEIN and the redistribution of FANCD2 to nuclear foci containing BRCA1 PROTEIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy %28%H%29% or A subunit and the B protomer which consists of 5 light %28%L%29% or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO%28%ADP-RIBOSE%29% TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer %28%lamina propria%29% of loose CONNECTIVE TISSUE, and an outer layer %28%muscularis mucosae%29% of smooth muscle cells that separates the mucosa from submucosa.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An Eph family receptor found abundantly in tissues of epithelial origin. It is expressed in a diverse array of tissues during embryonic development, suggesting that it may play a role in embryogenesis. In adult tissues high levels of the receptor are expressed in the LUNG; SKIN; SMALL INTESTINE and OVARY.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An Ephemerovirus infection of cattle caused by bovine ephemeral fever virus %28%EPHEMERAL FEVER VIRUS, BOVINE%29%. It is characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, tremor, and stiffness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An FAD-dependent oxidoreductase found primarily in BACTERIA. It is specific for the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This enzyme was formerly listed as EC 1.1.1.68 and 1.1.99.15.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An FAD-dependent peroxisomal flavoenzyme, this catalyzes the oxidative deamination of D-ASPARTATE to OXALOACETATE and AMMONIA using oxygen as electron acceptor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An HMG-box domain %28%HMG-BOX DOMAINS%29% found highly expressed in embryonic tissue and in placenta.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors %28%RECEPTORS, AMPA%29%. It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy %28%RADIOTHERAPY%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN REPEATS. Aberrant expression of this protein has been associated with TESTICULAR CANCER.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An INK4 cyclin-dependent kinase inhibitor containing five ANKYRIN-LIKE REPEATS. Aberrant expression of this protein has been associated with deregulated EPITHELIAL CELL growth, organ enlargement, and a variety of NEOPLASMS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An INK4 cyclin-dependent kinase inhibitor containing four ANKYRIN-LIKE REPEATS. INK4B is often inactivated by deletions, mutations, or hypermethylation in HEMATOLOGIC NEOPLASMS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An IRON-containing protein that uses siroheme and 4Fe-4S iron-sulfur centers as prosthetic groups. It catalyzes the six-electron oxidation of AMMONIA to nitrite.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An IgG autoantibody against the ALTERNATIVE COMPLEMENT C3 CONVERTASE %28%C3bBb%29%, found in serum of patients with MESANGIOCAPILLARY GLOMERULONEPHRITIS. The binding of this autoantibody to C3bBb stabilizes the enzyme thus reduces the actions of C3b inactivators %28%COMPLEMENT FACTOR H; COMPLEMENT FACTOR I%29%. This abnormally stabilized enzyme induces a continuous COMPLEMENT ACTIVATION and generation of C3b thereby promoting the assembly of MEMBRANE ATTACK COMPLEX and cytolysis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An LDL-RECEPTOR RELATED PROTEIN found in the neuroepithelium and in proximal tubular cells of the kidney. It is considered a multiligand receptor in that it binds to a variety of ligands with relatively high affinity and may function in mediating the uptake and lysosomal degradation of macromolecules such as: LIPOPROTEINS; ENDOPEPTIDASES; and PROTEASE INHIBITORS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. %28%From AMA, Drug Evaluations Annual, 1994, p311%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An MAO inhibitor that is used as an antidepressive agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. %28%From Dorland, 28th ed, p1518%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica %28%Apocynaceae%29% and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD+ dependent enzyme that catalyzes the oxidation 3-methyl-2-oxobutanoate to 2-methylpropanoyl-CoA. It plays a role in the degradation of VALINE; LEUCINE; and ISOLEUCINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD+ dependent enzyme that catalyzes the oxidation of 2-aminomuconate 6-semialdehyde to 2-aminomuconate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD+ dependent enzyme that catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate to 3-carboxy-4-methyl-2-oxopentanoate. It is involved in the biosynthesis of VALINE; LEUCINE; and ISOLEUCINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD+ dependent enzyme that catalyzes the oxidation of betain aldehyde to BETAINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD-dependent enzyme that catalyzes the oxidation of acyl-%5B%acyl-carrier protein%5D% to trans-2,3-dehydroacyl-%5B%acyl-carrier protein%5D%. It has a preference for acyl groups with a carbon chain length between 4 to 16.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD-dependent enzyme that catalyzes the oxidation of nitrite to nitrate. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM and is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. It was formerly classified as EC 1.6.6.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD-dependent enzyme that catalyzes the oxidation of sn-glycerol 3-phosphate to glycerone phosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD-dependent enzyme that catalyzes the reversible DEAMINATION of L-ALANINE to PYRUVATE and AMMONIA. The enzyme is needed for growth when ALANINE is the sole CARBON or NITROGEN source. It may also play a role in CELL WALL synthesis because L-ALANINE is an important constituent of the PEPTIDOGLYCAN layer.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NAD-dependent glyceraldehyde-3-phosphate dehydrogenase found in the cytosol of eucaryotes. It catalyses the dehydrogenation and phosphorylation of GLYCERALDEHYDE 3-PHOSPHATE to 3-phospho-D-glyceroyl phosphate, which is an important step in the GLYCOLYSIS pathway.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NADP+ dependent enzyme that catalyzes the oxidation of BENZALDEHYDE to BENZOIC ACID. It also plays a role in the degradation of TOLUENE and XYLENE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NADP+ dependent enzyme that catalyzes the oxidation of L-glutamate 5-semialdehyde to L-glutamyl 5-phosphate. It plays a role in the urea cycle and metabolism of amino groups.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NADP-dependent oxidoreductase that catalyses the conversion of 5,10-methyleneterahydrofolate to 5,10-methenyl-tetrahydrofolate. In higher eukaryotes a trifunctional enzyme exists with additional METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE and FORMATE-TETRAHYDROFOLATE LIGASE activity. The enzyme plays an important role in the synthesis of 5-methyltetrahydrofolate, the methyl donor for the VITAMIN B12-dependent remethylation of HOMOCYSTEINE to METHIONINE via METHIONINE SYNTHETASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NADP-dependent, non-phosphorylating aldehyde dehydrogenase that catalyzes the irreversible oxidation of GLYCERALDEHYDE 3-PHOSPHATE to 3-phosphoglycerate. It is found in the cytosol of a wide variety of organisms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NADPH-dependent enzyme that catalyzes the conversion of L-ARGININE and OXYGEN to produce CITRULLINE and NITRIC OXIDE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An NADPH-dependent flavin monooxygenase that plays a key role in the catabolism of TRYPTOPHAN by catalyzing the HYDROXYLATION of KYNURENINE to 3-hydroxykynurenine. It was formerly characterized as EC 1.14.1.2 and EC 1.99.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An OOCYTE-containing structure in the cortex of the OVARY. The oocyte is enclosed by a layer of GRANULOSA CELLS providing a nourishing microenvironment %28%FOLLICULAR FLUID%29%. The number and size of follicles vary depending on the age and reproductive state of the female. The growing follicles are divided into five stages: primary, secondary, tertiary, Graafian, and atretic. Follicular growth and steroidogenesis depend on the presence of GONADOTROPINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA POLYMERASE II specific transcription factor. It may play a role in transcriptional activation of gene expression by interacting with the TATA-BOX BINDING PROTEIN component of TRANSCRIPTION FACTOR TFIID.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA POLYMERASE II specific transcription factor. It plays a role in assembly of the pol II transcriptional preinitiation complex and has been implicated as a target of gene-specific transcriptional activators.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA-binding protein that recognizes the AAUAAA RNA SEQUENCE at the 3%27% end of MRNA. It contains four subunits of 30, 73, 100 and 160 kDa molecular size and combines with CLEAVAGE STIMULATION FACTOR to form a stable complex with mRNA that directs the 3%27% cleavage and polyadenylation reaction.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An RNA-containing enzyme that plays an essential role in tRNA processing by catalyzing the endonucleolytic cleavage of TRANSFER RNA precursors. It removes the extra 5%27%-nucleotides from tRNA precursors to generate mature tRNA molecules.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An X chromosome-linked abnormality characterized by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and MENTAL RETARDATION. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein %28%ATP-BINDING CASSETTE TRANSPORTERS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy %28%see MYOCARDIAL DISEASES%29%, and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease %28%usually adolescence%29% and a slowly progressive course. %28%Adams et al., Principles of Neurology, 6th ed, p1415%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abacterial form of arthritis developing after infection at a site distant from the affected joint or joints. The causative bacteria cannot be cultured from synovial specimens but bacterial antigens have been demonstrated in cells from the synovial fluid and membrane. It often follows Yersinia infection.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abdominal hernia with an external bulge in the GROIN region. It can be classified by the location of herniation. Indirect inguinal hernias occur through the internal inguinal ring. Direct inguinal hernias occur through defects in the ABDOMINAL WALL %28%transversalis fascia%29% in Hesselbach%27%s triangle. The former type is commonly seen in children and young adults; the latter in adults.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aberrant form of human CHROMOSOME 22 characterized by translocation of genetic material from chromosome 22, usually to the long arms of chromosome 9. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia %28%LEUKEMIA, MYELOID, CHRONIC%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal anatomical passage between the BLADDER and the VAGINA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal anatomical passage between the INTESTINE, and another segment of the intestine or other organs. External intestinal fistula is connected to the SKIN %28%enterocutaneous fistula%29%. Internal intestinal fistula can be connected to a number of organs, such as STOMACH %28%gastrocolic fistula%29%, the BILIARY TRACT %28%cholecystoduodenal fistula%29%, or the BLADDER of the URINARY TRACT %28%colovesical fistula%29%. Risk factors include inflammatory processes, cancer, radiation treatment, and surgical misadventures %28%MEDICAL ERRORS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal anatomical passage between the RECTUM and the VAGINA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal anatomical passage connecting the RECTUM to the outside, with an orifice at the site of drainage.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal anatomical passage that connects the VAGINA to other organs, such as the bladder %28%VESICOVAGINAL FISTULA%29% or the rectum %28%RECTOVAGINAL FISTULA%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal communication between an artery and a vein.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal congenital condition, associated with defects in the LAMIN TYPE A gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature greying; hair loss; hearing loss %28%DEAFNESS%29%; cataracts %28%CATARACT%29%; ARTHRITIS; OSTEOPOROSIS; DIABETES MELLITUS; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary HYALURONIC ACID; and accelerated ATHEROSCLEROSIS. Many affected individuals develop malignant tumors, especially SARCOMA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal elevation of body temperature, usually as a result of a pathologic process.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal hardening or increased density of bone tissue.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal hemoglobin composed of four beta chains. It is caused by the reduced synthesis of the alpha chain. This abnormality results in ALPHA-THALASSEMIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal increase in the amount of oxygen in the tissues and organs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal lipoprotein which is present in large amounts in individuals suffering from obstructive liver diseases. It exists as a bilayer vesicle of equimolar phospholipids and unesterified cholesterol containing small amounts of plasma proteins %28%mainly albumin%29% in its internal aqueous compartment together with some apolipoproteins adsorbed on its surface. Separates with LDL by ultracentrifugation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal opening or fissure between two adjacent teeth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage between two or more arteries, or between an artery and a vein.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage communicating between any components of the digestive system, or between any part of the digestive system and surrounding organ%28%s%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage in any organ of the urinary tract or between urinary organs and other organs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage in the bladder or between the bladder and any surrounding organ.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage in the oral cavity on the gingiva. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage or communication between a bronchus and another part of the body.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage or communication leading from an internal organ to the surface of the body.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal passage within the mouth communicating between two or more anatomical structures.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal reflex consisting of dorsiflexion of the great toe and abduction of the other toes in response to cutaneous stimulation of the plantar surface of the foot.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal response to a stimulus applied to the sensory components of the nervous system. This may take the form of increased, decreased, or absent reflexes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal structural condition of the human body, usually macroscopic, that is common to a variety of different diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormally decreased level of phosphates in the blood. The manifestations include hemolysis, lassitude, weakness, and convulsions. It may be found in hyperparathyroidism, rickets, osteomalacia, and several renal tubular abnormalities. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormally disproportionate increase in the sensation of loudness in response to auditory stimuli of normal volume. COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; FACIAL NERVE DISEASES; STAPES SURGERY; and other disorders may be associated with this condition.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormally low volume of blood circulating through the body. It may result in hypovolemic shock %28%see SHOCK%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abnormally rapid ventricular rhythm with wide QRS complexes, usually in excess of 150 per minute. It is generated within the ventricle, below the BUNDLE OF HIS, and is most commonly associated with atrioventricular dissociation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abscess in the peritonsillar tissue extending into the tonsil capsule, resulting from suppuration of the tonsil. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An absence from work permitted because of illness or the number of days per year for which an employer agrees to pay employees who are sick. %28%Webster%27%s New Collegiate Dictionary, 1981%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An absence of warmth or heat or a temperature notably below an accustomed norm.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An absence or deficiency in PROTEIN C which leads to impaired regulation of blood coagulation. It is associated with an increased risk of severe or premature thrombosis. %28%Stedman%27%s Med. Dict., 26th ed.%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An absence or reduced level of blood coagulation factor XII. It normally occurs in the absence of patient or family history of hemorrhagic disorders and is marked by prolonged clotting time.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An absorbable suture material used also as ligating clips, as pins for internal fixation of broken bones, and as ligament reinforcement for surgically managed ligament injuries. Its promising characteristics are elasticity, complete biodegradability, and lack of side effects such as infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abundant 43-kDa mitogen-activated protein kinase kinase subtype with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. In PLATELETS and T-LYMPHOCYTES it may play a role in the cellular degranulation process.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by phagocytic cells. Surfactant protein D contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens, resulting in their opsinization. It also stimulates MACROPHAGES to undergo PHAGOCYTOSIS of microorganisms. Surfactant protein A contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An accidental or deliberate dose of a medication or street drug that is in excess of what is normally used.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An accumulation of air or gas in the pleural space, which may occur spontaneously or as a result of trauma or a pathological process, or be introduced deliberately %28% = PNEUMOTHORAX, ARTIFICIAL%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An accumulation of endolymph in the inner ear resulting in deafness and tinnitus, and sometimes vertigo %28%MENIERE%27%S DISEASE%29%. Induced experimentally, it often serves as an animal model for Meniere%27%s disease. %28%From Dorland, 27th ed.%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acetyl ester of ADENOSINE DIPHOSPHATE RIBOSE formed during NAD-dependent deacetylation of proteins by SIRTUINS. The acetate group resides on the ribose ring where nicotinamide was cleaved from NAD during the reaction. Several isomers of O-acetyl-ADP-ribose have been isolated from the reaction.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acetyltransferase with specificity towards the amine group of aromatic alkylamines %28%arylalkylamines%29% such as SEROTONIN. This enzyme is also referred to as serotonin acetylase despite the fact that serotonin acetylation can also occur through the action of broad specificity acetyltransferases such as ARYLAMINE N-ACETYLTRANSFERASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acid dye used in testing for hydrochloric acid in gastric contents. It is also used histologically to test for AMYLOIDOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acid which is found in cinchona bark and elsewhere in plants. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acidic protein found in the NEUROENDOCRINE SYSTEM that functions as a molecular chaperone for PROPROTEIN CONVERTASE 2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acidifying agent that is used as an expectorant and a diuretic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. %28%Adams et al., Principles of Neurology, 6th ed, p1139%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus %28%HIV%29%, a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14%25% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation %28%wasting%29% and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and can result in deformities such as floppy ear and saddle nose. Loss of cartilage in the respiratory tract can lead to respiratory obstruction.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acquired disorder characterized by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses below those established in the general population to cause harmful effects. %28%Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med 1987;2%28%4%29%:655-61%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An act of employing sorcery %28%the use of power gained from the assistance or control of spirits%29%, especially with malevolent intent, and the exercise of supernatural powers and alleged intercourse with the devil or a familiar. %28%From Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An act which constitutes the termination of a given instinctive behavior pattern or sequence.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An actin capping protein that binds to the barbed-ends of ACTIN filaments. It is a heterodimer consisting of an alpha and a beta subunit. It regulates actin assembly by stabilizing actin oligomers for elongation. In SKELETAL MUSCLE, CapZ is localized to the Z-disk.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An actin capping protein that binds to the pointed-end of ACTIN. It functions in the presence of TROPOMYOSIN to inhibit microfilament elongation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An actinomycete from which the antibiotic CHLORTETRACYCLINE is obtained.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An actinomycete from which the antibiotic OLEANDOMYCIN is obtained.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An actinomycete from which the antibiotics STREPTOMYCIN, grisein, and CANDICIDIN are obtained.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An actinomycete used for production of commercial ANTIBIOTICS and as a host for gene cloning.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activating transcription factor that plays a key role in cellular responses to GENOTOXIC STRESS and OXIDATIVE STRESS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activating transcription factor that regulates expression of a variety of GENES including C-JUN GENES; CYCLIN A; CYCLIN D1; and ACTIVATING TRANSCRIPTION FACTOR 3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activating transcription factor that regulates expression of a variety of genes including C-JUN GENES and TRANSFORMING GROWTH FACTOR BETA2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activating transcription factor that regulates the expression of a variety of GENES involved in amino acid metabolism and transport. It also interacts with HTLV-I TRANS-ACTIVATOR PROTEIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An active blood parasite that is present in practically all domestic animals in Africa, the West Indies, and parts of Central and South America. In Africa, the insect vector is the tsetse fly. In other countries, infection is by mechanical means indicating that the parasites have been introduced to these countries and have been able to maintain themselves in spite of the lack of a suitable intermediate host. It is a cause of nagana, the severity of which depends on the species affected.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of EXERTION or endurance.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An activity in which the organism plunges into water. It includes scuba and bell diving. Diving as natural behavior of animals goes here, as well as diving in decompression experiments with humans or animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute %28%or rarely chronic%29% inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 %28%HERPESVIRUS 1, HUMAN%29% and less often by human herpesvirus 2 %28%HERPESVIRUS 2, HUMAN%29%. Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. %28%From Adams et al., Principles of Neurology, 6th ed, pp751-4%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute and chronic contagious disease of young pigs caused by Erysipelothrix insidiosa.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute brain syndrome which results from the excessive ingestion of ETHANOL or ALCOHOLIC BEVERAGES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute disease of young pigs that is usually associated with weaning. It is characterized clinically by paresis and subcutaneous edema.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus Hantavirus. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. Milder forms are caused by SEOUL VIRUS and transmitted by the rodents Rattus rattus and R. norvegicus, and the PUUMALA VIRUS with transmission by Clethrionomys galreolus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute febrile human disease caused by the LASSA VIRUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute febrile, contagious, viral disease of birds caused by an AVULAVIRUS called NEWCASTLE DISEASE VIRUS. It is characterized by respiratory and nervous symptoms in fowl and is transmissible to man causing a severe, but transient conjunctivitis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute generalized dermatitis of pigs which occurs from 5 to 35 days of age, characterized by sudden onset, with morbidity of 10 to 90%25% and mortality of 5 to 90%25%. The lesions are caused by Staphylococcus hyos but the bacterial agent is unable to penetrate the intact skin. Abrasions on the feet and legs or lacerations on the body frequently precede infection. In acute cases, a vesicular-type virus may be the predisposing factor. The causative organism is inhibited by most antibiotics. %28%Merck Veterinary Manual, 5th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infection caused by the RIFT VALLEY FEVER VIRUS, an RNA arthropod-borne virus, affecting domestic animals and humans. In animals, symptoms include HEPATITIS; abortion %28%ABORTION, VETERINARY%29%; and DEATH. In humans, symptoms range from those of a flu-like disease to hemorrhagic fever, ENCEPHALITIS, or BLINDNESS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin %28%cutaneous anthrax%29%, the lungs %28%inhalation anthrax%29%, or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infection characterized by recurrent episodes of PYREXIA alternating with asymptomatic intervals of apparent recovery. This condition is caused by SPIROCHETES of the genus BORRELIA. It is transmitted by the BITES of either the body louse %28%PEDICULUS humanus corporis%29%, for which humans are the reservoir, or by soft ticks of the genus ORNITHODOROS, for which rodents and other animals are the principal reservoirs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease caused by COXIELLA BURNETII. It is characterized by a sudden onset of FEVER; HEADACHE; malaise; and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals %28%ANIMALS, DOMESTIC%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease caused by ORIENTIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus %28%POLIOVIRUS%29%. Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. %28%From Adams et al., Principles of Neurology, 6th ed, pp764-5%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease of the central nervous system affecting almost all mammals, including humans. It is caused by a rhabdovirus and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, vampire bat, mongoose, skunk, wolf, raccoon, and fox. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious, eruptive, febrile disease caused by four antigenically related but distinct serotypes of the DENGUE VIRUS. It is transmitted by the bite of infected Aedes mosquitoes, especially A. aegypti. Classical dengue %28%dengue fever%29% is self-limiting and characterized by fever, myalgia, headache, and rash. DENGUE HEMORRHAGIC FEVER is a more virulent form of dengue virus infection and a separate clinical entity. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus %28%HERPESVIRUS 3, HUMAN%29% in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute infective gangrene involving the scrotum, penis, or perineum caused by gram-positive organisms, enteric bacilli, and anaerobes, usually resulting from local trauma, operative procedures, or urinary tract disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE %28%pseudomembranous enteritis%29% and the LARGE INTESTINE %28%pseudomembranous colitis%29%. It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. %28%From Adams et al., Principles of Neurology, 6th ed, pp1312-1314%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute inflammatory disease of the upper RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute neurological disorder characterized by the triad of ophthalmoplegia, ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. THIAMINE DEFICIENCY and chronic ALCOHOLISM are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to KORSAKOFF SYNDROME. %28%Adams et al., Principles of Neurology, 6th ed, pp1139-42; Davis %26% Robertson, Textbook of Neuropathology, 2nd ed, pp452-3%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute or chronic GINGIVITIS characterized by redness and swelling, NECROSIS extending from the interdental papillae along the gingival margins, PAIN; HEMORRHAGE, necrotic odor, and often a pseudomembrane. The condition may extend to the ORAL MUCOSA; TONGUE; PALATE; or PHARYNX. The etiology is somewhat unclear, but may involve a complex of FUSOBACTERIUM NUCLEATUM along with spirochetes BORRELIA or TREPONEMA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute or subacute blockage of the HEPATIC VEINS, usually extrahepatic and caused by blood clots %28%THROMBUS%29% or fibrous webs. Parenchymal FIBROSIS is uncommon.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal. %28%Adams et al., Principles of Neurology, 6th ed, p921%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity %28%e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis%29%. This condition may occasionally be fatal. It was formerly called delirium tremens. %28%From Adams et al., Principles of Neurology, 6th ed, p1175%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease %28%ANEMIA, SICKLE CELL%29%; skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits %28%notably DEAFNESS%29%; and COMA. %28%From Miller et al., Merritt%27%s Textbook of Neurology, 9th ed, p111%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute tick-borne arbovirus infection causing meningoencephalomyelitis of sheep.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, febrile, infectious disease generally occurring in epidemics. It is usually caused by coxsackieviruses B and sometimes by coxsackieviruses A; echoviruses; or other enteroviruses.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, highly contagious disease affecting swine of all ages and caused by the CLASSICAL SWINE FEVER VIRUS. It has a sudden onset with high morbidity and mortality.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, highly contagious virus disease of turkeys characterized by chilling, anorexia, decreased water intake, diarrhea, dehydration and weight loss. The infectious agent is a CORONAVIRUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, highly contagious, often fatal infectious disease caused by an orthopoxvirus characterized by a biphasic febrile course and distinctive progressive skin eruptions. Vaccination has succeeded in eradicating smallpox worldwide. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, often fatal disease caused by the ingestion of milk, milk products, or the flesh of cattle or sheep which have a disease known as trembles. It is marked by weakness, anorexia, vomiting, constipation, and sometimes muscular tremors. It is caused by poisoning by white snakeroot %28%Eupatorium rugosum%29% and the rayless goldenrod %28%Haplopappus heterophyllus%29%. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6; %28%HERPESVIRUS 6, HUMAN%29%. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, transmissible, infectious disease associated with high MORTALITY and MORBIDITY in young turkeys %28%poults%29%. It is characterized by DIARRHEA; ANOREXIA; growth depression, and immune dysfunction. The cause is unknown but astroviruses %28%ASTROVIRUS%29% and coronaviruses %28%CORONAVIRUS, TURKEY%29% have been isolated from diseased poults and are thought to cause the enteritis and increased susceptibility to bacterial infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acute, usually benign, infectious disease caused by the RUBELLA VIRUS and most often affecting children and nonimmune young adults, in which the virus enters the respiratory tract via droplet nuclei and spreads to the lymphatic system. %28%From Dorland, 27th edition%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acyclic state that resembles PREGNANCY in that there is no ovarian cycle, ESTROUS CYCLE, or MENSTRUAL CYCLE. Unlike pregnancy, there is no EMBRYO IMPLANTATION. Pseudopregnancy can be experimentally induced to form DECIDUOMA in the UTERUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; %28%TISSUE PLASMINOGEN ACTIVATOR%29%; 16 minutes for URINARY PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adaptor protein complex found primarily on perinuclear compartments.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adaptor protein complex involved in transport of molecules between the TRANS-GOLGI NETWORK and the endosomal-lysosomal system.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adaptor protein complex primarily involved in the formation of clathrin-related endocytotic vesicles %28%ENDOSOMES%29% at the CELL MEMBRANE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenine nucleotide containing one phosphate group which is esterified to both the 3%27%- and 5%27%-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. %28%From Holland et al., Cancer Medicine, 3d ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma producing mucin in significant amounts. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenocarcinoma with a hard %28%Greek skirrhos, hard%29% structure owing to the formation of dense connective tissue in the stroma. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue %28%fibroma%29% containing glandular %28%adeno-%29% structures. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adhesion-promoting leukocyte surface membrane heterodimer. The alpha subunit consists of the CD11b ANTIGEN and the beta subunit the CD18 ANTIGEN. The antigen, which is an integrin, functions both as a receptor for complement 3 and in cell-cell and cell-substrate adhesive interactions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adolescent who is receiving long-term in-patient services or who resides in an institutional setting.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenal microsomal cytochrome P450 enzyme that catalyzes the 21-hydroxylation of steroids in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP21 gene, converts progesterones to precursors of adrenal steroid hormones %28%CORTICOSTERONE; HYDROCORTISONE%29%. Defects in CYP21 cause congenital adrenal hyperplasia %28%ADRENAL HYPERPLASIA, CONGENITAL%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release of norepinephrine. It has been used primarily as a vasoconstrictor in the treatment of hypotension.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic agonist that appears to interact with beta-2 and some alpha adrenergic receptors. It has been used as a vasoconstrictor agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic alpha-agonist used as a sedative, analgesic, and muscle relaxant in veterinary medicine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic beta-agonist used as a bronchodilator agent in asthma therapy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic vasoconstrictor agent used as a decongestant.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. %28%From Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1437%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adult hemoglobin component normally present in hemolysates from human erythrocytes in concentrations of about 3%25%. The hemoglobin is composed of two alpha chains and two delta chains. The percentage of HbA2 varies in some hematologic disorders, but is about double in beta-thalassemia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An affective disorder characterized by periods of depression and hypomania. These may be separated by periods of normal mood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency in the executive branch which endeavors to abate and control pollution in the areas of air, water, solid waste, noise, radiation, and toxic substances.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency of the NATIONAL INSTITUTES OF HEALTH concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym SAMHSA. On 1 October 1992, the United States Alcohol, Drug Abuse, and Mental Health Administration %28%ADAMHA%29% became SAMHSA. %28%Telephone communication with SAMHSA 7 April 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency of the PUBLIC HEALTH SERVICE established in 1990 to %22%provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery...%22% It supersedes the National Center for Health Services Research. The United States Agency for Health Care Policy and Research was renamed Agency for Healthcare Research and Quality %28%AHRQ%29% under the Healthcare Research and Quality Act of 1999.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agent that causes the production of physical defects in the developing embryo.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agent thought to have disinfectant properties and used as an expectorant. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p747%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agent used as a substrate in assays for cholinesterases, especially to discriminate among enzyme types.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aggregation of cells in the middle hypothalamus dorsal to the ventromedial nucleus and bordering the third ventricle.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agonist of RECEPTORS, ADRENERGIC ALPHA-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of DEXMEDETOMIDINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agricultural fungicide and seed treatment agent. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An agricultural fungicide of the dithiocarbamate class. It has relatively low toxicity and there is little evidence of human injury from exposure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An airway obstruction due to the dust inhaled during the processing of cotton.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An albumin obtained from the white of eggs. It is a member of the serpin superfamily.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alcohol oxidoreductase which catalyzes the oxidation of L-iditol to L-sorbose in the presence of NAD. It also acts on D-glucitol to form D-fructose. It also acts on other closely related sugar alcohols to form the corresponding sugar. EC 1.1.1.14%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alcohol produced from mint oils or prepared synthetically.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alcoholic beverage usually made from malted cereal grain %28%as barley%29%, flavored with hops, and brewed by slow fermentation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aldehyde oxidoreductase expressed predominantly in the LIVER; LUNGS; and KIDNEY. It catalyzes the oxidation of a variety of organic aldehydes and N-heterocyclic compounds to CARBOXYLIC ACIDS, and also oxidizes QUINOLINE and PYRIDINE derivatives. The enzyme utilizes molybdenum cofactor and FAD as cofactors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase %28%GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE%29% causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid found in the root of Rauwolfia serpentina, among other plant sources. It is a class Ia antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid found in the seeds of STRYCHNOS NUX-VOMICA. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid isolated from Colchicum autumnale L. and used as an antineoplastic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid obtained from the betel nut %28%Areca catechu%29%, fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid that occurs in the extract of leaves of wild tomato plants. It has been found to inhibit the growth of various fungi and bacteria. It is used as a precipitating agent for steroids. %28%From The Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia %28%MYELOID LEUKEMIA, CHRONIC%29%, but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, busulfan is listed as a known carcinogen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating agent of value against both hematologic malignancies and solid tumors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating agent that forms DNA ADDUCTS at the C-8 position in GUANINE, resulting in single strand breaks. It has demonstrated carcinogenic action.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating carcinogen that produces gastrointestinal and probably lung and nervous system tumors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alkylating sulfhydryl reagent. Its actions are similar to those of iodoacetate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allergic contact dermatitis caused by exposure to plants of the genus Toxicodendron %28%formerly Rhus%29%. These include poison ivy, poison oak, and poison sumac, all plants that contain the substance urushiol, a potent skin sensitizing agent. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allosteric enzyme that regulates glycolysis and gluconeogenesis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-2,6-bisphosphate, an allosteric effector for the other 6-phosphofructokinase, PHOSPHOFRUCTOKINASE-1. Phosphofructokinase-2 is bifunctional: the dephosphorylated form is a kinase and the phosphorylated form is a phosphatase that breaks down fructose-2,6-bisphosphate to yield fructose-6-phosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. D-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. UTP, CTP, and ITP also are donors. In human phosphofructokinase-1, three types of subunits have been identified. They are PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE; PHOSPHOFRUCTOKINASE-1, LIVER TYPE; and PHOSPHOFRUCTOKINASE-1, C TYPE; found in platelets, brain, and other tissues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In human liver, the 6-phosphofructose-1-kinase exists as the homotetramer of L subunits.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In humans, PHOSPHOFRUCTOKINASE-1 in muscle exists as the homotetramer of M subunits. Defects in this muscle enzyme cause GLYCOGEN STORAGE DISEASE TYPE VII, also known as Tarui%27%s disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from ATP to fructose-6-phosphate to yield fructose-1,6-bisphosphate. In the humans, 6-phosphofructose-1-kinase isozyme C is found in platelets, brain, heart, kidney, colon and testis. This isozyme C can exist as the homotetramer of C subunits %28%P subunits%29%, or heterotetramer of C type and L type subunits.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alloy of 60%25% cobalt, 20%25% chromium, 5%25% molybdenum, and traces of other substances. It is used in dentures, certain surgical appliances, prostheses, implants, and instruments.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alloy used in restorative dentistry that contains mercury, silver, tin, copper, and possibly zinc.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An allylic compound that acts as a suicide inactivator of CYTOCHROME P450 by covalently binding to its heme moiety or surrounding protein.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha adrenergic antagonist. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha integrin with a molecular weight of 160-kDa that is found in a variety of cell types. It undergoes posttranslational cleavage into a heavy and a light chain that are connected by disulfide bonds. Integrin alphaV can combine with several different beta subunits to form heterodimers that generally bind to RGD sequence-containing extracellular matrix proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha%28%2%29%-adrenoceptor antagonist. It has been used experimentally to test the binding activity of other chemicals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-2 adrenergic agonist that crosses the blood-brain barrier. Clonidine acts centrally by reducing sympathetic tone, resulting in a fall in diastolic and systolic blood pressure and a reduction in heart rate. It also acts peripherally, and this peripheral activity may be responsible for the transient increase in blood pressure seen during rapid intravenous administration. %28%From Martindale, the Extra Pharmacopoeia, 30th ed, p350%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-2 selective adrenergic agonist used as an antihypertensive agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-adrenergic blocking agent that is used in Raynaud%27%s disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1312%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D%28%-%29% form is more potent than the L%28%+%29% form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component %28%Gc%29%. Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-globulin of which a fragment of 14 amino acids is converted by renin to angiotensin I, the inactive precursor of angiotensin II. It is a member of the serpin superfamily.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alpha-integrin subunit found on lymphocytes, granulocytes, macrophages and monocytes. It combines with the integrin beta2 subunit %28%CD18 ANTIGEN%29% to form LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alternative to amputation in patients with neoplasms, ischemia, fractures, and other limb-threatening conditions. Generally, sophisticated surgical procedures such as vascular surgery and reconstruction are used to salvage diseased limbs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An alternative to general anesthesia in patients for whom general anesthesia is refused or considered inadvisable. It involves the administering of an antianxiety drug %28%minor tranquilizer%29% and an analgesic or local anesthetic. This renders the patient free of anxiety and pain while allowing the patient to remain in verbal contact with the physician or dentist.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amidohydrolase that removes intact asparagine-linked oligosaccharide chains from glycoproteins. It requires the presence of more than two amino-acid residues in the substrate for activity. This enzyme was previously listed as EC 3.2.2.18.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid intermediate in the metabolism of choline.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid oxidoreductase that catalyzes the oxidative hydroxylation of L-VALINE to 3-methyl-2-oxobutanoate and AMMONIA in the presence of NADP.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid produced in the urea cycle by the splitting off of urea from arginine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid that inhibits phosphate-activated glutaminase and interferes with glutamine metabolism. It is an antineoplastic antibiotic produced by an unidentified species of Streptomyces from Peruvian soil. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid that occurs in endogenous proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors %28%RECEPTORS, NMDA%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol%27%s therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amino sugar formed when glucose non-enzymatically reacts with the N-terminal amino group of proteins. The fructose moiety is derived from glucose by the %22%classical%22% Amadori rearrangement.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10%25% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aminohydrolase that catalyzes the hydrolysis of 5,10-methenyltetrahydrofolate to 10-formyltetrahydrofolate. In most higher eucaryotic organisms this enzyme also includes METHYLENETETRAHYDROFOLATE DEHYDROGENASE %28%NADP%29% and FORMATE-TETRAHYDROFOLATE LIGASE activities.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aminopeptidase frequently used to test for LEUCYL AMINOPEPTIDASE activity. It also hydrolyzes naphthylamides of leucine. EC 3.4.11.-.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aminopurine factor in plant extracts that induces cell division. %28%Grant %26% Hackh%27%s Chemical Dict, 5th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. %28%From Martindale, The Extra Pharmacopeia, 30th ed, p404%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amorphous region of electron dense material in the cytoplasm from which the MICROTUBULES polymerization is nucleated. The pericentriolar region of the CENTROSOME which surrounds the CENTRIOLES is an example.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An amphetamine-like anorectic agent. It may cause pulmonary hypertension.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anabolic steroid with some progestational activity and little androgenic effect.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anadromous species of SALMON found in the streams of the Pacific coast from Sacramento north, and also common in Japan. It is used frequently in genetic and other medical research.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anadromous species of SALMON ranging from the Arctic and Pacific Oceans to Monterey Bay, California and inhabiting ocean and coastal streams. It is familiarly known as the coho or silver salmon. It is relatively small but its light-colored flesh is of good flavor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p29%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analgesic with mixed narcotic agonist-antagonist properties.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analog of DEOXYURIDINE that inhibits viral DNA synthesis. The drug is used as an antiviral agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analog of benzilylcholine mustard. It is an alkylating nitrogen mustard analog that binds specifically and irreversibly to cholinergic muscarinic receptors and is used as an affinity label to isolate and study the receptors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analytical technique for resolution of a chemical mixture into its component compounds. Compounds are separated on an adsorbent paper %28%stationary phase%29% by their varied degree of solubility/mobility in the eluting solvent %28%mobile phase%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An analytical transmission electron microscopy method using an electron microscope fitted with an energy filtering lens. The method is based on the principle that some of the ELECTRONS passing through the specimen will lose energy when they ionize inner shell electrons of the atoms in the specimen. The amount of energy loss is dependent upon the element. Analysis of the energy loss spectrum %28%ELECTRON ENERGY-LOSS SPECTROSCOPY%29% reveals the elemental composition of a specimen. It is used analytically and quantitatively to determine which, how much of, and where specific ELEMENTS are in a sample. For example, it is used for elemental mapping of PHOSPHORUS to trace the strands of NUCLEIC ACIDS in nucleoprotein complexes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. There are admixtures of small cell lung carcinoma with other types of lung cancer. Small cell carcinomas are distinguished by their distinctive biological features, response to chemotherapy and radiotherapy, and by their nearly universal tendency to develop overt or subclinical metastases, which frequently eliminates surgery in most patients. %28%From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anatomic alteration in the mitral valve apparatus and interventricular septum leading to obstruction of left ventricular outflow. %28%from Eur J Cardiothorac Surg 1998;14%28%3%29%:296-303%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anatomic severity scale based on the Abbreviated Injury Scale %28%AIS%29% and developed specifically to score multiple traumatic injuries. It has been used as a predictor of mortality.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anchoring junction of the cell to a non-cellular substrate, similar in morphology to halves of DESMOSOMES. They are composed of specialized areas of the plasma membrane where INTERMEDIATE FILAMENTS bind on the cytoplasmic face to the transmembrane linkers, INTEGRINS, via intracellular attachment proteins, while the extracellular domain of the integrins binds to EXTRACELLULAR MATRIX PROTEINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anchoring junction of the cell to a non-cellular substrate. It is composed of a specialized area of the plasma membrane where bundles of MICROFILAMENTS terminate and attach to the transmembrane linkers, INTEGRINS, which in turn attach through their extracellular domains to EXTRACELLULAR MATRIX PROTEINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ancient Greek medical theory that health and illness result from a balance or imbalance of body fluids or %22%humors%22%. The humors are blood, phlegm, yellow bile, and black bile.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ancient city, the site of modern Istanbul. From the 4th to 15th centuries the empire extended from southeastern Europe to western Asia, reaching its greatest extent under Justinian %28%527-565%29%. By about 1000 A.D. it comprised the southern Balkans, Greece, Asia Minor, and parts of southern Italy. The capture of Constantinople in 1453 marked the formal end of the Byzantine Empire. %28%From Webster%27%s New Geographical Dictionary, 1988%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ancient civilization, known as early as 2000 B.C. The Persian Empire was founded by Cyrus the Great %28%550-529 B.C.%29% and for 200 years, from 550 to 331 B.C., the Persians ruled the ancient world from India to Egypt. The territory west of India was called Persis by the Greeks who later called the entire empire Persia. In 331 B.C. the Persian wars against the Greeks ended disastrously under the counterattacks by Alexander the Great. The name Persia in modern times for the modern country was changed to Iran in 1935. %28%From Webster%27%s New Geographical Dictionary, 1988, p546 %26% Asimov, Words on the Map, 1962, p176%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ancient country in western Asia, by the twentieth century divided among the former USSR, Turkey, and Iran. It was attacked at various times from before the 7th century B.C. to 69 B.C. by Assyrians, Medes, Persians, the Greeks under Alexander, and the Romans. It changed hands frequently in wars between Neo-Persian and Roman Empires from the 3d to 7th centuries and later under Arabs, Seljuks, Byzantines, and Mongols. In the 19th century Armenian nationalism arose but suffered during Russo-Turkish hostilities. It became part of the Soviet Republic in 1921, with part remaining under Turkey. %28%Webster%27%s New Geographical Dictionary, 1988%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aneurysm in that part of the aorta continuing from the thoracic region and giving rise to the inferior phrenic, lumbar, median sacral, mesenteric, renal, and ovarian or testicular arteries.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aneurysm in the proximal portion of the descending aorta proceeding from the arch of the aorta and giving rise to the bronchial, esophageal, pericardiac, and mediastinal branches.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aneurysm in which the entire wall is injured and the blood is contained by the surrounding tissues, with eventual formation of a sac communicating with the artery or heart. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aneurysm of the common, internal, or external iliac arteries.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aneurysmal dilatation of a portion of the wall of the ventricle, usually the left, or, rarely, a saccular protrusion through it %28%false aneurysm of the heart%29%. It is usually consequent to myocardial infarction but other causes such as bacterial endocarditis or trauma have been described. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An angiocentric and angiodestructive lymphoreticular proliferative disorder primarily involving the lungs. Histologically it simulates malignant lymphoma and in some cases may progress to lymphoma.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An angiopoietin that is closely related to ANGIOPOIETIN-1. It binds to the TIE-2 RECEPTOR without receptor stimulation and antagonizes the effect of ANGIOPOIETIN-1. However its antagonistic effect may be limited to cell receptors that occur within the vasculature. Angiopoietin-2 may therefore play a role in down-regulation of BLOOD VESSEL branching and sprouting.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aniline dye used as a disinfectant and an antiseptic agent. It is weakly fluorescing and binds specifically to certain proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An animal%27%s cleaning and caring for the body surface. This includes preening, the cleaning and oiling of feathers with the bill or of hair with the tongue.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anionic compound that is used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. It also uncouples oxidative phosphorylation and forms complexes with biological materials, and is used in biological assays.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anionic form of oxaloacetic acid. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anionic, hydrophilic azo dye with an orange-yellow color used in fabrics, foods and cosmetics, and as a biological stain.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An annexin family member that plays a role in MEMBRANE FUSION and signaling via VOLTAGE-DEPENDENT CALCIUM CHANNELS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An annual legume or the seeds of this plant. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An annular transitional zone, approximately 1 mm wide, between the cornea and the bulbar conjunctiva and sclera. It is highly vascular and is involved in the metabolism of the cornea. It is ophthalmologically significant in that it appears on the outer surface of the eyeball as a slight furrow, marking the line between the clear cornea and the sclera. %28%Dictionary of Visual Science, 3d ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ansa macrolide isolated from the East African shrubs Maytenus serrata and M. buchananii. It has antineoplastic activity, probably due to its inhibition of DNA synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antagonist of histamine H1 receptors. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antagonist of histamine that appears to block both H2 and H3 histamine receptors. It has been used in the treatment of ulcers.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anterior pituitary hormone that stimulates the secretion of CORTICOSTEROIDS and induces growth of the ADRENAL CORTEX. It is a single-chain polypeptide of about 39 amino acids, the first 24 of which are identical in all species. This 24-amino acid segment is said to be responsible for the biological activity of the peptide while the remaining 15-amino acid segment is said to be necessary for any immunological specificity. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthelmintic used in most schistosome and many cestode infestations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. %28%From Martidale, The Extra Pharmacopoeia, 31st ed, p121%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthracenedione-derived antineoplastic agent. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthracycline produced by Streptomyces galilaeus. It has potent antineoplastic activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthracycline which is the 4%27%-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthranilic acid derivative with analgesic properties used for the relief of all types of pain.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p16%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-androgen that, in the form of its acetate %28%CYPROTERONE ACETATE%29%, also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-gas warfare agent that is effective against Lewisite %28%dichloro%28%2-chlorovinyl%29%arsine%29% and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p173%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory 9-fluoro-glucocorticoid. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory agent used in the treatment of rheumatoid arthritis. It also has uricosuric properties and has been used to treat gout.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to ASPIRIN, but causes less gastrointestinal bleeding.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting carbonic anhydrase.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory anthracene derivative used for the treatment of DERMATOSES, especially PSORIASIS. It may cause folliculitis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory glucocorticoid used in veterinary practice.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. It may cause water and salt retention.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiandrogen with about the same potency as cyproterone in rodent and canine species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na,K-activated myocardial adenosine triphosphatase. There is a resulting decrease in heart rate and in vascular resistance.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiarrhythmia agent used primarily for ventricular rhythm disturbances.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiarrhythmic agent which exerts a potential- and frequency-dependent block of sodium channels.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibacterial agent that has been used in veterinary practice for treating swine dysentery and enteritis and for promoting growth. However, its use has been prohibited in the UK following reports of carcinogenicity and mutagenicity. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p125%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibacterial growth promoter used in animal feeds. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic complex originally isolated from Streptomyces mitakaenis. It contains two principle ingredients: STREPTOGRAMIN A %28%mikamycin A%29% and STREPTOGRAMIN B %28%mikamycin B%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase %28%ATPase%29% activity. %28%From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic derived from penicillin similar to CARBENICILLIN in action.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p106%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic isolated from the fermentation broth of Fusidium coccineum. %28%From Merck Index, 11th ed%29% It acts by inhibiting translocation during protein synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic mixture of two components, A and B, obtained from Nocardia lurida %28%or the same substance produced by any other means%29%. It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic mixture originally isolated from Streptomyces loidensis. It contains a mixture of compounds belonging to STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic mixture produced by Bacillus brevis which may be separated into three components, tyrocidines A, B, and C. It is the major constituent %28%40-60 per cent%29% of tyrothricin, gramicidin accounting for the remaining 10-20 per cent active material. It is a topical antimicrobial agent, that is very toxic parenterally.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic produced by Pseudomonas cocovenenans. It is an inhibitor of MITOCHONDRIAL ADP, ATP TRANSLOCASES. Specifically, it blocks adenine nucleotide efflux from mitochondria by enhancing membrane binding.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic produced by Streptomyces fradiae. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by inhibiting the initiation and elongation processes during protein synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic purine ribonucleoside that readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic substance derived from Penicillium stoloniferum, and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites. %28%From Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 9th ed, p1301%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic substance produced by Streptomyces species. It inhibits mitochondrial respiration and may deplete cellular levels of ATP. Antimycin A1 has been used as a fungicide, insecticide, and miticide. %28%From Merck Index, 12th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticholesteremic agent that inhibits sterol biosynthesis in animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticoccidial agent mainly for poultry. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. %28%From AMA Drug Evaluations Annual, 1994, p378%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant effective in tonic-clonic epilepsy %28%EPILEPSY, TONIC-CLONIC%29%. It may cause blood dyscrasias.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant that is the active metabolite of TRIMETHADIONE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant that is used in a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiepileptic agent related to the barbiturates; it is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with PHENOBARBITAL. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p309%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antifungal antibiotic. Griseofulvin may be given by mouth in the treatment of tinea infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity %28%IMMUNITY, CELLULAR%29% and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antihelmintic that is active against most tapeworms. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p48%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antihistomonal agent with low toxicity. It also promotes growth and feed utilization in poultry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antihyperlipoproteinemic agent and uricosuric agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antilipemic agent and the biologically active metabolite of CLOFIBRATE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase %28%HYDROXYMETHYLGLUTARYL COA REDUCTASES%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antimitotic agent with immunosuppressive properties. Dexrazoxane, the %28%+%29%-enantiomorph of razoxane, provides cardioprotection against anthracycline toxicity. It appears to inhibit formation of a toxic iron-anthracycline complex.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent derived from BLEOMYCIN. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent that acts by alkylation. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent that is a derivative of progesterone and used to treat advanced breast cancer.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone %28%the MOPP protocol%29% in the treatment of Hodgkin%27%s disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic agent. It has significant activity against melanomas. %28%from Martindale, The Extra Pharmacopoeia, 31st ed, p564%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antineoplastic dispiropiperazine derivative. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antioxidant flavonoid, occurring especially in woody plants as both %28%+%29%-catechin and %28%-%29%-epicatechin %28%cis%29% forms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiphospholipid antibody found in association with systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC;%29%, ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. It does not interfere with hosts%27% development of acquired immunity to the majority of coccidial species. Monensin is a sodium and proton selective ionophore and is widely used as such in biochemical studies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl, and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antipsychotic agent used in schizophrenia. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antischistosomal agent that has become obsolete. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiseptic and disinfectant. It is active against a wide range of micro-organisms including some fungi and viruses, but is only slowly effective against spores. It has been used to disinfect skin and to relieve itching. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p801%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitoxin used for the treatment of TETANUS. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitrichomonal agent which is effective either topically or orally and whose urinary metabolites are also trichomonicidal.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitubercular agent often administered in association with ISONIAZID. The sodium salt of the drug is better tolerated than the free acid.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, p863%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antitumor isolate from the culture filtrate of the F-41 variant of Streptomyces carzinostaticus. It is a protein of known amino acid sequence with a molecular weight of approximately 11,500 and possessing a regulatory function on the metabolism of DNA. In this process, that is first an inhibition of DNA biosynthesis followed by the degradation of DNA, zinostatin functions in a manner analogous to that of the much higher molecular weight antibiotic MITOMYCIN. Zinostatin is also a potent cytostatic agent active against gram-positive organisms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiviral agent effective against pox viruses. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiviral derivative of THYMIDINE used mainly in the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to HERPES SIMPLEX virus. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p557%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to DIAZEPAM.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aphasia characterized by impairment of expressive language %28%speech, writing, signs%29% and relative preservation of receptive language abilities %28%i.e., comprehension%29%. This condition is caused by lesions of the motor association cortex in the frontal lobe %28%Broca%27%s area and adjacent cortical and white matter regions%29%. The deficits range from almost complete muteness to a reduction in the fluency and rate of speech. CEREBROVASCULAR ACCIDENTS %28%in particular INFARCTION, MIDDLE CEREBRAL ARTERY%29% are a relatively common cause of this condition. %28%From Adams et al., Principles of Neurology, 6th ed, pp478-9%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An apparently hereditary disorder of dentin formation, marked by a normal appearance of coronal dentin associated with pulpal obliteration, faulty root formation, and a tendency for peripheral lesions without obvious cause. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues. It does not include CROWNS; DENTAL ABUTMENTS; nor TOOTH, ARTIFICIAL.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An application that must be submitted to a regulatory agency %28%the FDA in the United States%29% before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. %28%From the %22%New Medicines in Development%22% Series produced by the Pharmaceutical Manufacturers Association and published irregularly.%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An appreciable lateral deviation in the normally straight vertical line of the spine. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An approach to ethics that focuses on theories of the importance of general principles such as respect for autonomy, beneficence/nonmaleficence, and justice.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An approach to health care financing with only one source of money for paying health care providers. The scope may be national %28%the Canadian System%29%, state-wide, or community-based. The payer may be a governmental unit or other entity such as an insurance company. The proposed advantages include administrative simplicity for patients and providers, and resulting significant savings in overhead costs. %28%From Slee and Slee, Health Care Reform Terms, 1993, p106%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An approach to nutrition based on whole cereal grains, beans, cooked vegetables and the Chinese YIN-YANG principle. It advocates a diet consisting of organic and locally grown foods, seasonal vegetables, complex carbohydrates, and fewer fats, sugars, and chemically processed foods.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine. Sometimes confused with Siberian ginseng %28%ELEUTHEROCOCCUS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arbovirus infection of sheep and goats transmitted by ticks. It is characterized by high fever and hemorrhagic gastroenteritis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An archipelago in Polynesia in the southwest Pacific Ocean, comprising about 150 islands. It is a kingdom whose capital is Nukualofa. It was discovered by the Dutch in 1616, visited by Tasman in 1643, and by Captain Cook in 1773 and 1777. The modern kingdom was established during the reign of King George Tupou I, 1845-93. It became a British protectorate in 1900 and gained independence in 1970. The name Tonga may be of local origin, meaning either island or holy. Its other name, Friendly Islands, was given by Captain Cook from the welcome given him by the natives. %28%From Webster%27%s New Geographical Dictionary, 1988, p1219 %26% Room, Brewer%27%s Dictionary of Names, 1992, p549%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An area approximately 1.5 millimeters in diameter within the macula lutea where the retina thins out greatly because of the oblique shifting of all layers except the pigment epithelium layer. It includes the sloping walls of the fovea %28%clivus%29% and contains a few rods in its periphery. In its center %28%foveola%29% are the cones most adapted to yield high visual acuity, each cone being connected to only one ganglion cell. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An area of recreation or hygiene for use by the public.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent %22%virus factories%22% in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. One example, Negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An armed conflict between Communist and non-Communist forces in Korea from June 25, 1950, to July 27, 1953. The parties included United Nations forces from 15 member nations under United States command against military from North Korea and the Peoples Republic of China.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aromatase inhibitor that produces a state of %22%medical%22% adrenalectomy by blocking the production of adrenal steroids. It also blocks the conversion of androgens to estrogens. Aminoglutethimide has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p454%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aromatic perennial plant species that has been used to treat migraines, arthritis, and as a febrifuge. It contains TANNINS, volatile oils %28%OILS, ESSENTIAL%29%, and sesquiterpene lactones, especially parthenolide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arrangement of wires distributing electricity. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An array of tests used to determine the toxicity of a substance to living systems. These include tests on clinical drugs, foods, and environmental pollutants.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arsenic derivative which has anticoccidial action and promotes growth in animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arsenical that has been used as a dermatologic agent and as an herbicide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arthropod subclass %28%Xiphosura%29% comprising the North American %28%Limulus%29% and Asiatic %28%Tachypleus%29% genera of horseshoe crabs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An article or book published after examination of published material on a subject. It may be comprehensive to various degrees and the time range of material scrutinized may be broad or narrow, but the reviews most often desired are reviews of the current literature. The textual material examined may be equally broad and can encompass, in medicine specifically, clinical material as well as experimental research or case reports. State-of-the-art reviews tend to address more current matters. A review of the literature must be differentiated from HISTORICAL ARTICLE %5B%PUBLICATION TYPE%5D% on the same subject, but a review of historical literature is also within the scope of this publication type.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An article or portion of an article giving an account of past events or circumstances significant in a field of study, a profession, a discovery, an invention, etc. The concept of history is very wide, ranging from the dawn of time to the present. This publication type is often checked in conjunction with BIOGRAPHY %5B%PUBLICATION TYPE%5D%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An articulation between the condyle of the mandible and the articular tubercle of the temporal bone.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An artifical implanted device, usually in the form of an inflatable silicone cuff, inserted in or around the bladder neck in the surgical treatment of urinary incontinence caused by sphincter weakness. Often it is placed around the bulbous urethra in adult males. The artificial urinary sphincter is considered an alternative to urinary diversion.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An artificial replacement for one or more natural teeth or part of a tooth, or associated structures, ranging from a portion of a tooth to a complete denture. The dental prosthesis is used for cosmetic or functional reasons, or both. DENTURES and specific types of dentures are also available. %28%From Boucher%27%s Clinical Dental Terminology, 4th ed, p244 %26% Jablonski, Dictionary of Dentistry, 1992, p643%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. A deficiency of this enzyme is responsible for the inherited lysosomal disease, Maroteaux-Lamy syndrome %28%MUCOPOLYSACCHARIDOSIS VI%29%. EC 3.1.6.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An arylsulfatase with high specificity towards sulfated steroids. Defects in this enzyme are the cause of ICHTHYOSIS, X-LINKED.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ascarid nematode found primarily in the small intestine of the larger Felidae as well as dogs and cats. It differs from TOXOCARA in that the larvae do not migrate through the lungs. It does occasionally produce visceral larva migrans %28%LARVA MIGRANS, VISCERAL%29% in man, although more rarely than does Toxocara.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ascomycetous yeast of the fungal family Saccharomycetaceae, order SACCHAROMYCETALES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspartate aminotransferase found in MITOCHONDRIA. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspartate aminotransferase found in the CYTOPLASM. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspartic endopeptidase of the hydrolase class that is similar to cathepsin D but has a slightly broader specificity. EC 3.4.23.34.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspect of cholinesterase %28%EC 3.1.1.8%29%. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspect of cholinesterases. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An aspect of protein kinase %28%EC 2.7.1.37%29% in which serine residues in protamines and histones are phosphorylated in the presence of ATP. EC 2.7.1.70.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An assertion that an action apparently unobjectionable in itself would set in motion a train of events leading ultimately to an undesirable outcome. %28%From Cambridge Dictionary of Philosophy, 1995%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility %28%INFERTILITY, MALE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An asymptomatic, autosomal dominant trait in which pea-sized sclerotic spots, prominent in the metaphyseal area, are accompanied by unique cutaneous lesions. These are yellowish papules or plaques with increased elastin content. %28%From Cecil Textbook of Medicine, 19th ed, pp1434-35%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An atom or group of atoms that have a positive or negative electric charge due to a gain %28%negative charge%29% or loss %28%positive charge%29% of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An auditory orientation mechanism involving the emission of high frequency sounds which are reflected back to the emitter %28%animal%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle, lower extremities, trunk, and shoulder girdle. There is relative sparing of extraocular and bulbar muscles. CARCINOMA, SMALL CELL of the lung is a frequently associated condition, although other malignancies and autoimmune diseases may be associated. Muscular weakness results from impaired impulse transmission at the NEUROMUSCULAR JUNCTION. Presynaptic calcium channel dysfunction leads to a reduced amount of acetylcholine being released in response to stimulation of the nerve. %28%From Adams et al., Principles of Neurology, 6th ed, pp 1471%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery %28%see MULTIPLE SCLEROSIS, RELAPSING-REMITTING%29%, but acute fulminating and chronic progressive forms %28%see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE%29% also occur. %28%Adams et al., Principles of Neurology, 6th ed, p903%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive %28%inflammation of the orbital connective tissue%29%, myopathic %28%swelling and dysfunction of the extraocular muscles%29%, and mixed congestive-myopathic ophthalmopathy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autonomic disorder characterized by excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to gustatory stimuli. The auriculotemporal syndrome features facial flushing or sweating limited to the distribution of the auriculotemporal nerve and may develop after trauma to the parotid gland, in association with PAROTID NEOPLASMS, or following their surgical removal. %28%From Ann Neurol 1997 Dec;42%28%6%29%:973-5%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal disorder of the peripheral and autonomic nervous systems limited to individuals of Ashkenazic Jewish descent. Clinical manifestations are present at birth and include diminished lacrimation, defective thermoregulation, orthostatic hypotension %28%HYPOTENSION, ORTHOSTATIC%29%, fixed pupils, excessive SWEATING, loss of pain and temperature sensation, and absent reflexes. Pathologic features include reduced numbers of small diameter peripheral nerve fibers and autonomic ganglion neurons. %28%From Adams et al., Principles of Neurology, 6th ed, p1348; Nat Genet 1993;4%28%2%29%:160-4%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant LONG QT SYNDROME, without deafness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant MUTATION involving CHROMOSOME 20. It is characterized by the almost normal LIVER that has few or no intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%. Other extrahepatic malformations include those in the heart, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. %28%Neuromuscul Disord 1997;7%28%1%29%:55-62; Adams et al., Principles of Neurology, 6th ed, p1420%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder associated with various neoplasms including central nervous system %28%most often cerebellar%29% and retinal HEMANGIOBLASTOMA, endolymphatic sac tumors, renal cell carcinoma %28%see CARCINOMA, RENAL CELL%29%, renal and pancreatic cysts, HEMANGIOMA of the spinal cord, and PHEOCHROMOCYTOMA. The most common presenting manifestations are neurologic deficits associated with intracranial hemangioblastomas which may HEMORRHAGE, causing ataxia, INTRACRANIAL HYPERTENSION, and other signs of neurologic dysfunction. %28%From Neurochirurgie 1998 Nov;44%28%4%29%:258-66%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 %28%15q11-q13%29% or by inheritance of both of the pair of chromosomes 15 from the mother %28%UNIPARENTAL DISOMY%29% which are imprinted %28%GENETIC IMPRINTING%29% and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. %28%Menkes, Textbook of Child Neurology, 5th ed, p229%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas %28%NEURILEMMOMA%29% of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene %28%GENES, NEUROFIBROMATOSIS 2%29% on chromosome 22 %28%22q12%29% and usually presents clinically in the first or second decade of life.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma %28%KERATODERMA, PALMOPLANTAR%29%, as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder characterized by acrocephaly, exophthalmos, hypertelorism, strabismus, parrot-beaked nose, and hypoplastic maxilla with relative mandibular prognathism. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein %28%PRIONS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to Mondini type cochlear defect and stapes fixation. %28%Jablonski%27%s Dictionary of Syndromes %26% Eponymic Diseases, 2d ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth, ranging from dusky blue to brownish. The dentin is poorly formed with an abnormally low mineral content; the pulp canal is obliterated, but the enamel is normal. The teeth usually wear down rapidly, leaving short, brown stumps. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C %28%also a vitamin K-dependent protein%29%, and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. %28%From Harrison%27%s Principles of Internal Medicine, 12th ed, p1511; Wintrobe%27%s Clinical Hematology, 9th ed, p1523%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder that is the most frequent form of short-limb dwarfism. Affected individuals exhibit short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and mid-face hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, and trident hand. %28%Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim, MIM%23%100800, April 20, 2001%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant disorder which is generally classified as a phacomatosis. Pathologically, the condition is characterized by glial cell tumors which arise in the cerebral hemispheres and retina. There is an increased incidence of benign rhabdomyomas of the heart and angiomyolipomas of kidney, liver, lungs, thyroid, and testes. Clinical manifestations include MENTAL RETARDATION; adenoma sebaceum of the face %28%actually angiofibromas%29%; EPILEPSY; SPASMS, INFANTILE; Shagreen patches on the trunk; and subungual fibromas. %28%From Adams et al., Principles of Neurology, 6th ed, p1011%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. %28%Adams et al., Principles of Neurology, 6th ed, p1483%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant familial disorder which presents in infancy or childhood and is characterized by episodes of weakness associated with hyperkalemia. During attacks, muscles of the lower extremities are initially affected, followed by the lower trunk and arms. Episodes last from 15-60 minutes and typically occur after a period of rest following exercise. A defect in skeletal muscle sodium channels has been identified as the cause of this condition. Normokalemic periodic paralysis is a closely related disorder marked by a lack of alterations in potassium levels during attacks of weakness. %28%Adams et al., Principles of Neurology, 6th ed, p1481%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant familial prion disease with a wide spectrum of clinical presentations including ATAXIA, spastic paraparesis, extrapyramidal signs, and DEMENTIA. Clinical onset is in the third to sixth decade of life and the mean duration of illness prior to death is five years. Several kindreds with variable clinical and pathologic features have been described. Pathologic features include cerebral prion protein amyloidosis, and spongiform or neurofibrillary degeneration. %28%From Brain Pathol 1998 Jul;8%28%3%29%:499-513; Brain Pathol 1995 Jan;5%28%1%29%:61-75%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY%28%A%29%-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant inherited disorder %28%with a high frequency of spontaneous mutations%29% that features developmental changes in the nervous system, muscles, bones, and skin, most notably in tissue derived from the embryonic NEURAL CREST. Multiple hyperpigmented skin lesions and subcutaneous tumors are the hallmark of this disease. Peripheral and central nervous system neoplasms occur frequently, especially OPTIC NERVE GLIOMA and NEUROFIBROSARCOMA. NF1 is caused by mutations which inactivate the NF1 gene %28%GENES, NEUROFIBROMATOSIS 1%29% on chromosome 17q. The incidence of learning disabilities is also elevated in this condition. %28%From Adams et al., Principles of Neurology, 6th ed, pp1014-18%29% There is overlap of clinical features with NOONAN SYNDROME in a syndrome called neurofibromatosis-Noonan syndrome. Both the PTPN11 and NF1 gene products are involved in the SIGNAL TRANSDUCTION pathway of Ras %28%RAS PROTEINS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant inherited partial epilepsy syndrome with onset between age 3 and 13 years. Seizures are characterized by PARESTHESIA and tonic or clonic activity of the lower face associated with drooling and dysarthria. The episodes tend to occur at night and may become secondarily generalized. In most cases, affected children are neurologically and developmentally normal. The electroencephalogram shows characteristic high-voltage sharp waves over the central temporal regions, which are more prominent during drowsiness and sleep. In general, seizures do not continue beyond mid-adolescence. %28%From Epilepsia 1998 39;Suppl 4:S32-S41%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant neuromuscular disorder which usually presents in early adulthood, characterized by progressive muscular atrophy %28%most frequently involving the hands, forearms, and face%29%, myotonia, frontal baldness, lenticular opacities, and testicular atrophy. Cardiac conduction abnormalities, diaphragmatic weakness, and mild mental retardation may also occur. Congenital myotonic dystrophy is a severe form of this disorder, characterized by neonatal MUSCLE HYPOTONIA, feeding difficulties, respiratory muscle weakness, and an increased incidence of MENTAL RETARDATION. %28%From Adams et al., Principles of Neurology, 6th ed, pp1423-5; Joynt, Clinical Neurology, 1997, Ch16, pp16-7%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant or X-linked disorder in which there is faulty development of the dental enamel owing to agenesis, hypoplasia, or hypocalcification of the enamel. It is marked by enamel that is very thin and friable and frequently stained in various shades of brown. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant porphyria that is due to a deficiency of COPROPORPHYRINOGEN OXIDASE in the LIVER, the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, 5-AMINOLEVULINATE and COPROPORPHYRINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant porphyria that is due to a deficiency of FERROCHELATASE %28%heme synthetase%29% in both the LIVER and the BONE MARROW, the last enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include mainly neurological symptoms, rarely cutaneous lesions, and elevated levels of protoporphyrin and COPROPORPHYRINS in the feces.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant porphyria that is due to a deficiency of protoporphyrinogen oxidase %28%EC 1.3.3.4%29% in the LIVER, the seventh enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features include both neurological symptoms and cutaneous lesions. Patients excrete increased levels of porphyrin precursors, COPROPORPHYRINS and protoporphyrinogen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal dominant vascular anomaly characterized by the presence of multiple small telangiectases of the skin, mucous membranes, gastrointestinal tract, and other organs, associated with recurrent episodes of bleeding from affected sites and gross or occult melena. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal inherited disease caused by deficiency of the enzymes hexosaminidase A %26% B %28%see BETA-N-ACETYLHEXOSAMINIDASE%29% which leads to an accumulation of GM2 ganglioside and sphingolipid globoside in neurons and other organs. Clinical manifestations resemble TAY-SACHS DISEASE, but the disease is not limited to Askenazi Jews and may feature hepatosplenomegaly. The infantile form presents in the first 4 months of life with psychomotor delay, hypotonia followed by spasticity, and cherry red spots in the macula. Rare juvenile and adult forms have been reported. %28%From Menkes, Textbook of Child Neurology, 5th ed, p92%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive characteristic or a coagulation disorder acquired in association with VITAMIN K DEFICIENCY. FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive condition characterized by hypogonadism; spinocerebellar degeneration; MENTAL RETARDATION; RETINITIS PIGMENTOSA; and OBESITY. This syndrome was previously referred to as Laurence-Moon-Biedl syndrome until BARDET-BIEDL SYNDROME was identified as a distinct entity. %28%From N Engl J Med. 1989 Oct 12;321%28%15%29%:1002-9%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive condition characterized by recurrent myoclonic and generalized seizures, ATAXIA, slowly progressive intellectual deterioration, dysarthria, and intention tremor. Myoclonic seizures are severe and continuous, and tend to be triggered by movement, stress, and sensory stimuli. The age of onset is between 8 and 13 years, and the condition is relatively frequent in the Baltic region, especially Finland. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp109-110%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive cutaneous porphyria that is due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in both the LIVER and the BONE MARROW. Similar to PORPHYRIA CUTANEA TARDA, this disorder is caused by defects in the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME, but is a homozygous enzyme deficiency with less than 10%25% of the normal enzyme activity. Cutaneous lesions are severe and mutilating.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disease, usually of childhood onset, characterized pathologically by degeneration of the spinocerebellar tracts, posterior columns, and to a lesser extent the corticospinal tracts. Clinical manifestations include GAIT ATAXIA, pes cavus, speech impairment, lateral curvature of spine, rhythmic head tremor, kyphoscoliosis, congestive heart failure %28%secondary to a cardiomyopathy%29%, and lower extremity weakness. Most forms of this condition are associated with a mutation in a gene on chromosome 9, at band q13, which codes for the mitochondrial protein frataxin. %28%From Adams et al., Principles of Neurology, 6th ed, p1081; N Engl J Med 1996 Oct 17;335%28%16%29%:1169-75%29% The severity of Friedreich ataxia associated with expansion of GAA repeats in the first intron of the frataxin gene correlates with the number of trinucleotide repeats. %28%From Durr et al, N Engl J Med 1996 Oct 17;335%28%16%29%:1169-75%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder caused by deficiency of the enzyme glucocerebrosidase %28%see GLUCOSYLCERAMIDASE%29% featuring the pathological storage of glycosylceramide in mononuclear PHAGOCYTES %28%Gaucher Cells%29%. The most common subtype is the non-neuronopathic form, a slowly progressive condition characterized by hepatosplenomegaly and skeletal deformities. The neuronopathic forms are divided into infantile and juvenile forms. The infantile form presents at 4-5 months of age with anemia, loss of cognitive gains, neck retraction, dysphagia, and hepatosplenomegaly. The juvenile form features a slowly progressive loss of intellect, hepatosplenomegaly, ATAXIA, myoclonic SEIZURES, and spasticity. The neuronopathic forms are characterized by neuronal loss with neuronophagia, and accumulation of glucocerebroside in neurons. %28%From Baillieres Clin Haematol 1997 Dec;10%28%4%29%:711-23; Menkes, Textbook of Child Neurology, 5th ed, p97%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder characterized by BRONCHIECTASIS; SINUSITIS; DEXTROCARDIA; and INFERTILITY. In vitro studies of tissues from these patients, have shown various patterns of abnormal ciliary beating. %28%Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/OMIM, MIM %23% 244400, April 24, 2001%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder characterized by RETINITIS PIGMENTOSA; POLYDACTYLY; OBESITY; MENTAL RETARDATION; hypogenitalism; renal dysplasia; and short stature. This syndrome has been distinguished as a separate entity from LAURENCE-MOON SYNDROME. %28%From J Med Genet 1997 Feb;34%28%2%29%:92-8%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder characterized by brachygnathia and cleft palate, often associated with glossoptosis, backward and upward displacement of the larynx, and angulation of the manubrium sterni. Cleft palate makes sucking and swallowing difficult, permitting easy access of fluids into the larynx. It may appear in several syndromes or as an isolated hypoplasia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder characterized by short stature, defective GROWTH HORMONE RECEPTOR, and failure to generate INSULIN-LIKE GROWTH FACTOR I by GROWTH HORMONE. Laron syndrome is not a form of primary pituitary dwarfism %28%GROWTH HORMONE DEFICIENCY DWARFISM%29% but the result of mutation of the human GHR gene on chromosome 5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder characterized by telangiectatic ERYTHEMA of the face, photosensitivity, DWARFISM and other abnormalities, and a predisposition toward developing cancer. The Bloom syndrome gene %28%BLM%29% encodes a RecQ-like DNA helicase.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder due to defects in PEROXISOME biogenesis which involves more than 13 genes encoding peroxin proteins of the peroxisomal membrane and matrix. Zellweger syndrome is typically seen in the neonatal period with features such as dysmorphic skull; MUSCLE HYPOTONIA; SENSORINEURAL HEARING LOSS; visual compromise; SEIZURES; progressive degeneration of the KIDNEYS and the LIVER. Zellweger-like syndrome refers to phenotypes resembling the neonatal Zellweger syndrome but seen in children or adults with apparently intact peroxisome biogenesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive disorder that causes premature aging in adults, characterized by sclerodermal skin changes, cataracts, subcutaneous calcification, muscular atrophy, a tendency to diabetes mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive familial disorder that usually presents in childhood with POLYNEUROPATHY, sensorineural DEAFNESS; ICHTHYOSIS; ATAXIA; RETINITIS PIGMENTOSA; and cardiomyopathy. CEREBROSPINAL FLUID PROTEINS and serum PHYTANIC ACID are generally elevated. This condition is associated with the impaired metabolism of phytanic acid in PEROXISOMES. %28%From Joynt, Clinical Neurology, 1991, Ch37, p58-9; Rev Med Interne 1996;17%28%5%29%:391-8%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive form of CHONDRODYSPLASIA PUNCTATA characterized by defective plasmalogen biosynthesis and impaired peroxisomes. Patients have shortened proximal limbs and severely disturbed endochondral bone formation. The metabolic defects associated with the impaired peroxisomes are present only in the rhizomelic form of chondrodysplasia punctata. %28%From Scriver et al, Metabolic Basis of Inherited Disease, 6th ed, p1497%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors %28%e.g., amino acids, lactate, ketones%29% and manifested as hypoglycemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase %28%EC 2.1.2.13%29% activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle %28%PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE%29% resulting in abnormal deposition of glycogen in muscle tissue. These patients have severe congenital muscular dystrophy and are exercise intolerant.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive inborn error of methionine metabolism usually caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and associated with elevations of homocysteine in plasma and urine. Clinical features include a tall, slender habitus, SCOLIOSIS, arachnodactyly, MUSCLE WEAKNESS, genu varis, thin blond hair, malar flush, lens dislocations, an increased incidence of MENTAL RETARDATION, and a tendency to develop fibrosis of arteries, frequently complicated by CEREBROVASCULAR ACCIDENTS and MYOCARDIAL INFARCTION. %28%From Adams et al., Principles of Neurology, 6th ed, p979%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive inherited disease characterized by episodic FEVER; severe ABDOMINAL PAIN; PLEURISY; ARTHRITIS; and a characteristic ankle RASH. Disease flare-ups tend to last 3 days, and individuals are asymptomatic between attacks. ORCHITIS; benign recurrent MENINGITIS; HEADACHE; and AMYLOID nephropathy may also occur. %28%From Medicine %28%Baltimore%29% 1998 Jul;77%28%4%29%:268-97%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. %28%Menkes, Textbook of Child Neurology, 5th ed, p688%29% The gene for this disorder %28%ATM%29% encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 %28%11q22-q23%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids %28%AMINO ACIDS, BRANCHED-CHAIN%29%. These metabolites accumulate in body fluids and render a %22%maple syrup%22% odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. %28%From Adams et al., Principles of Neurology, 6th ed, p936%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive inherited gangliosidosis characterized by the onset in the first 6 months of life of an exaggerated startle response, delay in psychomotor development, hypotonia %28%followed by spasticity%29%, visual loss, and a macular cherry red spot. Hexosaminidase A %28%see BETA-N-ACETYLHEXOSAMINIDASE%29% is deficient, leading to the accumulation of GM2 ganglioside in neurons of the central nervous system and retina. This condition is strongly associated with Askenazic Jewish ancestory. %28%Menkes, Textbook of Pediatric Neurology, 5th ed pp89-96%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive inherited sphingolipidosis caused by a deficiency of GALACTOSYLCERAMIDASE leading to an accumulation of PSYCHOSINE in LYSOSOMES of the BRAIN; PERIPHERAL NERVES; LIVER; KIDNEY; and LEUKOCYTES. In the nervous system there is prominent central and peripheral demyelination. The infantile form presents at age 4-6 months with psychomotor retardation, MUSCLE SPASTICITY, and tonic spasms induced by minor stimuli. Death occurs within two years. Later onset forms of this disease are characterized by a less fulminant course. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp195-7%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive lysosomal storage disease caused by a deficiency of ALPHA-L-FUCOSIDASE activity resulting in an accumulation of fucose containing SPHINGOLIPIDS; GLYCOPROTEINS, and mucopolysaccharides %28%GLYCOSAMINOGLYCANS%29% in lysosomes. The infantile form %28%type I%29% features psychomotor deterioration, MUSCLE SPASTICITY, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, SEIZURES, recurrent infections, and MACROGLOSSIA, with death occurring in the first decade of life. Juvenile fucosidosis %28%type II%29% is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type II survival may be through the fourth decade of life. %28%From Menkes, Textbook of Child Neurology, 5th ed, p87; Am J Med Genet 1991 Jan;38%28%1%29%:111-31%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive lysosomal storage disease caused by a deficiency of CEREBROSIDE-SULFATASE leading to an accumulation of cerebroside sulfate in the nervous system and other organs. Pathologic features include diffuse demyelination and metachromatically-staining granules within glial cells, macrophages, and free in tissue. Clinical subtypes include late infantile, juvenile, and adult forms. The late infantile form presents at 12-18 months of age with progressive psychomotor retardation, ATAXIA, spasticity, and OPTIC ATROPHY. The juvenile form has onset at 4-12 years and features behavioral alterations and ataxia followed by spasticity, DEMENTIA, and visual loss. The adult form presents in the second decade or later with psychiatric manifestations, gait difficulties, and less often as a peripheral neuropathy. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp192-5%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive metabolic disorder caused by absent or decreased PYRUVATE CARBOXYLASE activity, the enzyme that regulates gluconeogenesis, lipogenesis, and neurotransmitter synthesis. Clinical manifestations include lactic acidosis, seizures, respiratory distress, marked psychomotor delay, periodic HYPOGLYCEMIA, and hypotonia. The clinical course may be similar to LEIGH DISEASE. %28%From Am J Hum Genet 1998 Jun;62%28%6%29%:1312-9%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial GLYCINE cleavage system; an enzyme system with four components: P-, T-, H-, and L-proteins. Deficiency of the P-protein is the most prevalent form. Neonatal and juvenile presentations have been reported. Neonatal onset is more common and may be fatal. Clinical features include SEIZURES; hypotonia; APNEA; and COMA. When the illness presents in childhood there tends to be an associated progressive DEMENTIA accompanied by extrapyramidal signs. %28%Menkes, Textbook of Child Neurology, 5th ed, p46; Jpn J Hum Genet 1997 Mar;42%28%1%29%:13-22%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive metabolic disorder due to a deficiency in expression of GLYCOGEN BRANCHING ENZYME 1 %28%alpha-1,4-glucan-6-alpha-glucosyltransferase%29%, resulting in an accumulation of abnormal GLYCOGEN with long outer branches. Clinical features are MUSCLE HYPOTONIA and CIRRHOSIS. Death from liver disease usually occurs before age 2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase %28%one part of the glycogen debranching enzyme system%29%. The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive porphyria that is due to a deficiency of UROPORPHYRINOGEN III SYNTHASE in the BONE MARROW; also known as congenital erythropoietic porphyria. This disease is characterized by SPLENOMEGALY; ANEMIA; photosensitivity; cutaneous lesions; accumulation of hydroxymethylbilane; and increased excretion of UROPORPHYRINS and COPROPORPHYRINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive syndrome occurring principally in females, characterized by the presence of reticulated, atrophic, hyperpigmented, telangiectatic cutaneous plaques, often accompanied by juvenile cataracts, saddle nose, congenital bone defects, disturbances in the growth of HAIR; NAILS; and TEETH; and HYPOGONADISM.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive syndrome of abnormal cardioelectrophysiology, combining LONG QT SYNDROME with deafness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle %28%MUSCLE, SKELETAL%29%; HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy %28%CARDIOMYOPATHY, HYPERTROPHIC%29%. The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. %28%From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An autosomally-encoded 376-kDa cytoskeletal protein that is similar in structure and function to DYSTROPHIN. It is a ubiquitously-expressed protein that plays a role in anchoring the CYTOSKELETON to the PLASMA MEMBRANE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An axolotl found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An azo dye used in blood volume and cardiac output measurement by the dye dilution method. It is very soluble, strongly bound to plasma albumin, and disappears very slowly.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An azo dye with carcinogenic properties. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An azo that that is used in protozoal infections. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An early growth response transcription factor that controls the formation of the MYELIN SHEATH around peripheral AXONS by SCHWANN CELLS. Mutations in EGR2 transcription factor have been associated with HEREDITARY MOTOR AND SENSORY NEUROPATHIES such as CHARCOT-MARIE-TOOTH DISEASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An early growth response transcription factor that has been implicated in regulation of CELL PROLIFERATION and APOPTOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An early growth response transcription factor that is essential for the development of MUSCLE SPINDLES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An early non-mammalian embryo %28%EMBRYO, NONMAMMALIAN%29% that follows the MORULA stage. Blastula is usually a spherical structure containing a single layer of cells with a hollow cavity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eating disorder that is characterized by a cycle of binge eating %28%BULIMIA or bingeing%29% followed by inappropriate acts %28%purging%29% to avert weight gain. Purging methods often include self-induced VOMITING, use of LAXATIVES or DIURETICS, excessive exercise, and FASTING.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eating disorder that is characterized by the lack or loss of APPETITE, known as ANOREXIA. Other features include excess fear of becoming OVERWEIGHT; BODY IMAGE disturbance; significant WEIGHT LOSS; refusal to maintain minimal normal weight; and AMENORRHEA. This disorder occurs most frequently in adolescent females. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An edible species of the family Ranidae, occurring in Europe and used extensively in biomedical research. Commonly referred to as %22%edible frog%22%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An effect of excessive exposure to heat occurring commonly among workers in furnace rooms, foundries, etc., although it may occur from exposure to the sun%27%s heat %28%SUNSTROKE%29%. It is marked by subnormal temperature, with dizziness, headache, nausea, and sometimes delirium and/or collapse. It is distinguished from HEAT STROKE, in which the body temperature may be dangerously elevated. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, 1,2-dibromoethane may reasonably be anticipated to be a carcinogen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An effective trypanocidal agent. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An egg yolk phosphoglycoprotein which contains about 90%25% of the yolk protein phosphorus. It is synthesized in the liver of the hen and transferred to the developing oocyte, where it is bound to lipoproteins within the yolk granules.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eicosanoid, derived from the cyclooxygenase pathway of arachidonic acid metabolism. It is a stable and synthetic analog of EPOPROSTENOL, but with a longer half-life than the parent compound. Its actions are similar to prostacyclin. Iloprost produces vasodilation and inhibits platelet aggregation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrical current applied to the HEART to terminate a disturbance of its rhythm, ARRHYTHMIA. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrochemical technique for measuring the current that flows in solution as a function of an applied voltage. The observed polarographic wave, resulting from the electrochemical response, depends on the way voltage is applied %28%linear sweep or differential pulse%29% and the type of electrode used. Usually a mercury drop electrode is used.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrogenic ion exchange protein that maintains a steady level of calcium by removing an amount of calcium equal to that which enters the cells. It is widely distributed in most excitable membranes, including the brain and heart.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrogenic sodium-dependent phosphate transporter. It is present primarily in BRUSH BORDER membranes of PROXIMAL RENAL TUBULES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrolyte replenisher, as well as a urinary and systemic alkalizer, which can be administered orally or by intravenous infusion. Formerly, it was used as a diuretic and expectorant. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electron transport chain complex that catalyzes the transfer of electrons from SUCCINATE to CYTOCHROME C. It includes ELECTRON TRANSPORT COMPLEX II and ELECTRON TRANSPORT COMPLEX III.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrophoretic technique employed to assay for binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. The movement of the labeled compound through the electrophoretic medium will be retarded if it is bound by the other.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element of the alkaline earth family of metals. It has the atomic symbol Sr, atomic number 38, and atomic weight 87.62.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet %28%YAG%29% lasers.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element in the diet, a major component of the mineral phase of bone, and is abundant in all tissues, being involved in some form in almost all metabolic processes. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element that is a member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. With a valence of 1, it has a strong affinity for oxygen and other nonmetallic elements. Sodium provides the chief cation of the extracellular body fluids. Its salts are the most widely used in medicine. %28%From Dorland, 27th ed%29% Physiologically the sodium ion plays a major role in blood pressure regulation, maintenance of fluid volume, and electrolyte balance.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight 32.066. It is found in the amino acids cysteine and methionine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element that is in the alkali group of metals. It has an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte and it plays a significant role in the regulation of fluid volume and maintenance of the water-electrolyte balance.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to CADMIUM POISONING.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element with atomic symbol O, atomic number 8, and atomic weight 16. It is the most abundant element on earth and essential for respiration.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element with the atomic symbol N, atomic number 7, and atomic weight 14. Nitrogen exists as a diatomic gas and makes up about 78%25% of the earth%27%s atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An element with the atomic symbol Se, atomic number 34, and atomic weight 78.96. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An elevated scar, resembling a KELOID, but which does not spread into surrounding tissues. It is formed by enlargement and overgrowth of cicatricial tissue and regresses spontaneously.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of PAIN, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An embolism of lipid debris from an ulcerated atheromatous deposit, generally from a large artery to small arterial branches. It is usually small and rarely causes infarction. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An emotional attitude excited by realization of a shortcoming or impropriety.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An encephalomyelitis of horses, sheep and cattle caused by BORNA DISEASE VIRUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endocellulase with specificity for the hydrolysis of 1,3- or 1,4-linkages in beta-D-glucans. This enzyme specifically acts on sites where reducing glucose residues are substituted at the 3 position.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endocellulase with specificity for the hydrolysis of 1,3-beta-D-glucosidic linkages in 1,3-beta-D-glucans including laminarin, paramylon, and pachyman.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages in CELLULOSE, lichenin, and cereal beta-glucans.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endocrine state in men, characterized by a significant decline in the production of TESTOSTERONE; DEHYDROEPIANDROSTERONE; and other hormones such as HUMAN GROWTH HORMONE. Andropause symptoms are related to the lack of androgens including DEPRESSION, sexual dysfunction, and OSTEOPOROSIS. Andropause may also result from hormonal ablation therapy for malignant diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endogenous family of proteins belonging to the serpin superfamily that neutralizes the action of thrombin. Six naturally occurring antithrombins have been identified and are designated by Roman numerals I to VI. Of these, Antithrombin I %28%see FIBRIN%29% and ANTITHROMBIN III appear to be of major importance.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endogenous opioid peptide derived from the pro-opiomelanocortin precursor peptide. It differs from ALPHA-ENDORPHIN by one amino acid.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endogenous opioid peptide derived from the pro-opiomelanocortin precursor. It differs from GAMMA-ENDORPHIN by one amino acid.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endogenous serine protease inhibitor %28%SERPINS%29%. It is a 105-kDA plasma glycoprotein, encoded by C1NH gene and produced primarily by the liver and monocytes. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from hereditary ANGIONEUROTIC EDEMA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. %28%Reynolds JEF%28%Ed%29%: Martindale: The Extra Pharmacopoeia %28%electronic version%29%. Micromedex, Inc, Englewood, CO, 1996%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endopeptidase that is structurally similar to GELATINASE A. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V. EC 3.4.24.35.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An endoribonuclease that is specific for double-stranded RNA. It plays a role in POST-TRANSCRIPTIONAL RNA PROCESSING of pre-RIBOSOMAL RNA and a variety of other RNA structures that contain double-stranded regions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enduring attitude or sentiment toward persons or objects manifested by anger, aversion and desire for the misfortune of others.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enduring, learned predisposition to behave in a consistent way toward a given class of objects, or a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An energy dependent process following the crosslinking of B CELL ANTIGEN RECEPTORS by multivalent ligands %28%bivalent anti-antibodies, LECTINS or ANTIGENS%29%, on the B-cell surface. The crosslinked ligand-antigen receptor complexes collect in patches which flow to and aggregate at one pole of the cell to form a large mass - the cap. The caps may then be endocytosed or shed into the environment.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enkephalin analog that selectively binds to the MU OPIOID RECEPTOR. It is used as a model for drug permeability experiments.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enlarged THYROID GLAND containing multiple nodules %28%THYROID NODULE%29%, usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enlarged THYROID GLAND with at least 50%25% of the gland situated behind the STERNUM. It is an unusual presentation of an intrathoracic goiter. Substernal goiters frequently cause compression on the TRACHEA leading to deviation, narrowing, and respiratory symptoms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enlarged underground root or stem of some plants. It is usually rich in carbohydrates. Some, such as POTATOES, are important human FOOD. They may reproduce vegetatively from buds.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enterovirus infection of swine clinically indistinguishable from FOOT-AND-MOUTH DISEASE, vesicular stomatitis, and VESICULAR EXANTHEMA OF SWINE. It is caused by a strain of HUMAN ENTEROVIRUS B.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An environment simulating one or more parameters of the space environment, applied in testing space systems or components. Often, a closed chamber is used, capable of approximating the vacuum and normal environments of space. %28%From NASA Thesaurus, 1988%29% This also includes simulated EXTRAVEHICULAR ACTIVITY studies in atmosphere exposure chambers or water tanks.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme bound to the inner mitochondrial membrane that catalyzes the oxidation of CHOLINE to BETAINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme capable of hydrolyzing highly polymerized DNA by splitting phosphodiester linkages, preferentially adjacent to a pyrimidine nucleotide. This catalyzes endonucleolytic cleavage of DNA yielding 5%27%-phosphodi- and oligonucleotide end-products. The enzyme has a preference for double-stranded DNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme catalyzing the deamination of pyridoxaminephosphate to pyridoxal phosphate. It is a flavoprotein that also oxidizes pyridoxine-5-phosphate and pyridoxine. EC 1.4.3.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme catalyzing the endonucleolytic cleavage of RNA at the 3%27%-position of a guanylate residue. EC 3.1.27.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme catalyzing the formation of AMP from adenine and phosphoribosylpyrophosphate. It can act as a salvage enzyme for recycling of adenine into nucleic acids. EC 2.4.2.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme catalyzing the hydrolysis of penicillin to penicin and a carboxylic acid anion. EC 3.5.1.11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme catalyzing the oxidation of 2 moles of glutathione in the presence of hydrogen peroxide to yield oxidized glutathione and water. EC 1.11.1.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme catalyzing the transfer of a phosphate group from 3-phospho-D-glycerate in the presence of ATP to yield 3-phospho-D-glyceroyl phosphate and ADP. EC 2.7.2.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme complex consisting of aspartokinase, EC 2.7.2.4, and homoserine dehydrogenase, EC 1.1.1.3. The complex has been isolated from E. coli and consists of four identical subunits with a molecular weight of 85,000. The enzyme complex is involved in the biosynthesis of amino acids of the aspartate family.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme complex found in the brush border membranes of the small intestine. It is believed to be an enzyme complex with different catalytic sites. Its absence is manifested by an inherited disease called sucrase-isomaltase deficiency.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme derived from cow%27%s milk. It catalyzes the radioiodination of tyrosine and its derivatives and of peptides containing tyrosine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found in bacteria. It catalyzes the reduction of ferredoxin and other substances in the presence of molecular hydrogen and is involved in the electron transport of bacterial photosynthesis. EC 1.18.99.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found in the SARCOPLASMIC RETICULUM vesicle membrane. During the relaxation of SKELETAL MUSCLES and muscle rich in MITOCHONDRIA this enzyme catalyzes the active transport of CALCIUM into the sarcoplasmic reticulum vesicles from the sarcoplasm. It requires micromolar concentrations of Ca%28%2+%29% and utilizes MgATP as a substrate. %28%Prog Biophys Mol Biol 1988;52%28%1%29%:1%29%. This enzyme was formerly listed as EC 3.6.1.38.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found in the alpha-toxin of Clostridium welchii and other strains of clostridia and bacilli. It hydrolyzes glycerophosphatidates with the formation of 1,2-diacylglycerol and a phosphorylated nitrogenous base such as choline. EC 3.1.4.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found mostly in plant tissue. It hydrolyzes glycerophosphatidates with the formation of a phosphatidic acid and a nitrogenous base such as choline. This enzyme also catalyzes transphosphatidylation reactions. EC 3.1.4.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG%28%2%29% and PGH%28%2%29% %28%prostaglandin endoperoxides%29% to thromboxane A2. EC 5.3.99.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found primarily in BACTERIA and FUNGI that catalyzes the oxidation of AMMONIUM HYDROXIDE to nitrite. It is an iron-sulfur HEME; FLAVOPROTEIN containing SIROHEME and can utilize both NAD and NADP as cofactors. This enzyme was formerly classified as EC 1.6.6.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found primarily in SULFUR-REDUCING BACTERIA where it plays an important role in the anaerobic carbon oxidation pathway.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme found primarily in the LIVER that catalyzes the N-methylation of NICOTINAMIDE and other structurally related compounds.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme fraction from the venom of the Malayan pit viper, Agkistrodon rhodostoma. It catalyzes the hydrolysis of a number of amino acid esters and a limited proteolysis of fibrinogen. It is used clinically to produce controlled defibrination in patients requiring anticoagulant therapy. EC 3.4.21.-.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme from the sulfuric ester hydrolase class that breaks down one of the products of the chondroitin lyase II reaction. EC 3.1.6.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis. EC 3.1.3.48.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine %28%DOPA DECARBOXYLASE%29%, tryptophan, and hydroxytryptophan. EC 4.1.1.28.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme hydrolyzing terminal non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Hexosaminidase A cleaves GM2, GA2, globosides, and hexosamine oligosaccharides. Hexosaminidase B cleaves all the above substrates except GM2. Deficiency of Hexosaminidase A causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme in the tryptophan biosynthetic pathway. EC 4.1.1.48.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme involved in the MEVALONATE pathway, it catalyses the synthesis of FARNESYL DIPHOSPHATE from ISOPENTENYL DIPHOSPHATE and dimethylallyl diphosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme involved in the biosynthesis of isoleucine and valine. It converts 2-acetolactate into 3-hydroxy-2-oxo-isovalerate. Also acts on 2-hydroxy-2-acetobutyrate to form 2-hydroxy-2-oxo-3-methylvalerate. EC 5.4.99.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme involved in the metabolism of ASCORBIC ACID and aldarate. It catalyzes the oxidation of L-gulono-1,4-lactone to L-xylo-hex-3-ulonolactone.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme isolated from the gastric mucosa that catalyzes the hydrolysis of ATP coupled with the exchange of hydrogen and potassium ions across the cell wall. This enzyme was formerly listed as EC 3.6.1.36.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme localized predominantly within the plasma membrane of lymphocytes. It catalyzes the transfer of long-chain fatty acids, preferentially unsaturated fatty acids, to lysophosphatides with the formation of 1,2-diacylglycero-3-phosphocholine and CoA. EC 2.3.1.23.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-%28%acyl carrier protein%29% to another molecule of fatty acyl-%28%acyl carrier protein%29%, giving a beta-ketoacyl-%28%acyl carrier protein%29% with the release of carbon dioxide. EC 2.3.1.41.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the PHOSPHORYLASES family that catalyzes the degradation of starch, a mixture of unbranched AMYLOSE and branched AMYLOPECTIN compounds. This phosphorylase from plants is the counterpart of GLYCOGEN PHOSPHORYLASE in animals that catalyzes the reaction of inorganic phosphate on the terminal alpha-1,4-glycosidic bond at the non-reducing end of glucans resulting in the release of glucose-1-phosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. %28%From Dorland, 27th ed%29% EC 3.1.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. %28%Dorland, 27th ed%29% EC 3.1.1.34.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the isomerase class that catalyzes the eliminative cleavage of polysaccharides containing 1,4-linked D-glucuronate or L-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-D-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends. %28%From Enzyme Nomenclature, 1992%29% EC 4.2.2.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on %28%3S,4R%29%-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. %28%Enzyme Nomenclature, 1992%29% E.C. 4.1.2.13.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the lyase class that catalyzes the conversion of ATP and oxaloacetate to ADP, phosphoenolpyruvate, and carbon dioxide. The enzyme is found in some bacteria, yeast, and Trypanosoma, and is important for the photosynthetic assimilation of carbon dioxide in some plants. EC 4.1.1.49.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the lyase class that catalyzes the conversion of GTP and oxaloacetate to GDP, phosphoenolpyruvate, and carbon dioxide. This reaction is part of gluconeogenesis in the liver. The enzyme occurs in both the mitochondria and cytosol of mammalian liver. %28%From Dorland, 27th ed%29% EC 4.1.1.32.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the lyase class that catalyzes the dehydration of 2-phosphoglycerate to form phosphoenolpyruvate. %28%Dorland, 28th ed%29% EC 4.2.1.11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the lyase class that catalyzes the formation of CYCLIC AMP and pyrophosphate from ATP. EC 4.6.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives. Related enzymes in this class include the ARACHIDONATE LIPOXYGENASES; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONATE 12-LIPOXYGENASE; and ARACHIDONATE 15-LIPOXYGENASE. EC 1.13.11.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. %28%From Enzyme Nomenclature, 1992%29% EC 1.1.3.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid %28%tricarboxylic%29% cycle. %28%From Dorland, 27th ed%29% %28%The NADP+ enzyme is EC 1.1.1.42.%29% EC 1.1.1.41.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the formation of 2%27%-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. %28%From Dorland, 27th ed%29% EC 1.17.4.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the reaction 6-phospho-D-gluconate and NADP+ to yield D-ribulose 5-phosphate, carbon dioxide, and NADPH. The reaction is a step in the pentose phosphate pathway of glucose metabolism. %28%From Dorland, 27th ed%29% EC 1.1.1.43.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. %28%Dorland, 27th ed%29% EC 1.5.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 1.10.3.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the shikimate pathway of AROMATIC AMINO ACID biosynthesis, it generates 5-enolpyruvylshikimate 3-phosphate and ORTHOPHOSPHATE from PHOSPHOENOLPYRUVATE and SHIKIMATE-3-PHOSPHATE. The shikimate pathway is present in BACTERIA and PLANTS but not in MAMMALS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that catalyzes condensation of the succinyl group from succinyl coenzyme A with glycine to form delta-aminolevulinate. It is a pyridoxyal phosphate protein and the reaction occurs in mitochondria as the first step of the heme biosynthetic pathway. The enzyme is a key regulatory enzyme in heme biosynthesis. In liver feedback is inhibited by heme. EC 2.3.1.37.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate in the PENTOSE PHOSPHATE PATHWAY. %28%Dorland, 27th ed%29% EC 2.2.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. %28%From Dorland, 27th ed%29% EC 2.1.1.45.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that catalyzes the reaction RNA%28%n+1%29% and orthophosphate to yield RNA%28%n%29% and a nucleoside diphosphate, or the reverse reaction. ADP, IDP, GDP, UDP, and CDP can act as donors in the latter case. %28%From Dorland, 27th ed%29% EC 2.7.7.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that catalyzes the reaction sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to yield D-erythrose 4-phosphate and D-fructose phosphate in the PENTOSE PHOSPHATE PATHWAY. %28%Dorland, 27th ed%29% EC 2.2.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that catalyzes the transfer of galactose from UDPgalactose to glucose, forming lactose. The enzyme is a complex of the enzyme N-ACETYLLACTOSAMINE SYNTHASE and alpha-lactalbumin; the latter protein is present in lactating mammary gland cells where it alters the usual specificity of the former to make lactose synthesis the preferred reaction. %28%Dorland, 28th ed%29% EC 2.4.1.22.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the transferase class that uses ATP to catalyze the phosphorylation of diacylglycerol to a phosphatidate. EC 2.7.1.107.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease argininosuccinic acidemia in man. EC 4.3.2.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme oxidizing peptidyl-lysyl-peptide in the presence of water %26% molecular oxygen to yield peptidyl-allysyl-peptide plus ammonia %26% hydrogen peroxide. EC 1.4.3.13.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme present in nerve tissue. It catalyzes reversibly the formation of thiamine diphosphate and orthophosphate from thiamine triphosphate. EC 3.6.1.28.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy %28%ATP%29% it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell DNA. The enzyme catalyzes the methylation of DNA adenine in the presence of S-adenosyl-L-methionine to form DNA containing 6-methylaminopurine and S-adenosyl-L-homocysteine. EC 2.1.1.72.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme responsible for producing a species-characteristic methylation pattern on cytosine residues in a specific short base sequence in the host cell%27%s DNA. The enzyme catalyzes the methylation of DNA cytosine in the presence of S-adenosyl-L-methionine to form S-adenosyl-L-homocysteine and DNA containing 5-methylcytosine. EC 2.1.1.73.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma. EC 2.3.1.43.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme substrate which permits the measurement of peptide hydrolase activity, e.g. trypsin and thrombin. The enzymes liberate 2-naphthylamine, which is measured by colorimetric procedures.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme system that catalyzes the fixing of nitrogen in soil bacteria and blue-green algae %28%CYANOBACTERIA%29%. EC 1.18.6.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates alanine with its specific transfer RNA. EC 6.1.1.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates arginine with its specific transfer RNA. EC 6.1.1.19.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates aspartic acid with its specific transfer RNA. EC 6.1.1.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates glutamic acid with its specific transfer RNA. EC 6.1.1.17.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates glycine with its specific transfer RNA. EC 6.1.1.14.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates histidine with its specific transfer RNA. EC 6.1.1.21.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates isoleucine with its specific transfer RNA. EC 6.1.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates leucine with its specific transfer RNA. EC 6.1.1.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates lysine with its specific transfer RNA. EC 6.1.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates methionine with its specific transfer RNA. EC 6.1.1.10.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates phenylalanine with its specific transfer RNA. EC 6.1.1.20.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates serine with its specific transfer RNA. EC 6.1.1.11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates threonine with its specific transfer RNA. EC 6.1.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates tryptophan with its specific transfer RNA. EC 6.1.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates tyrosine with its specific transfer RNA. EC 6.1.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that activates valine with its specific transfer RNA. EC 6.1.1.9%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyses RNA-template-directed extension of the 3%27%- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. %28%Enzyme Nomenclature, 1992, p293%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyses the last step of the TRIACYLGLYCEROL synthesis reaction in which diacylglycerol is covalently joined to LONG-CHAIN ACYL COA to form triglyceride. It was formerly categorized as EC 2.3.1.124.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyses the reaction of D-glucosamine 6-phosphate with ACETYL-COA to form N-acetylglucosamine 6-phosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyses three sequential METHYLATION reactions for conversion of PHOSPHATIDYLETHANOLAMINE to PHOSPHATIDYLCHOLINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes endonucleolytic cleavage to 5-phosphomononucleotides and 5-phosphooligonucleotide end-products. It has a preference for single-stranded substrates but is active with either ribo- or deoxyribonucleic acids. %28%From Enzyme Nomenclature, 1992%29% EC 3.1.30.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes oxidation of sulfite to sulfate along with the reduction of FERROCYTOCHROME C to FERRICYTOCHROME C.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the conversion of D-glyceraldehyde 3-phosphate to dihydroxyacetone phosphate. A deficiency in humans causes nonspherocytic hemolytic disease %28%ANEMIA, HEMOLYTIC, CONGENITAL NONSPHEROCYTIC%29%. EC 5.3.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in GALACTOSEMIA. EC 2.7.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA. EC 4.2.1.17.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the hydrolysis of acetyl-CoA to yield CoA and acetate. The enzyme is involved in the oxidation of fatty acids. EC 3.1.2.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus %28%HERPESVIRUS HOMINIS%29%. EC 2.7.1.74.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the phosphorylation of pyridoxal in the presence of ATP with the formation of pyridoxal 5-phosphate and ADP. Pyridoxine, pyridoxamine and various derivatives can also act as acceptors. EC 2.7.1.35.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the transfer of a pyrophosphate group from ATP to the 3%27%-OH group of GDP or GTP with the formation of guanosine 3%27%-diphosphate 5%27%-diphosphate or guanosine 3%27%-diphosphate 5%27%-triphosphate and AMP. The enzyme, also called stringent factor, is located in the relA gene in stringent strains of bacteria. The above synthesis is induced by mRNA and uncharged tRNA which is bound to the aminoacyl-t-RNA binding site of the ribosome by a codon-specific association. EC 2.7.6.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to yield phosphatidylethanolamine %28%cephalin%29% and CMP. The enzyme is found in the endoplasmic reticulum. EC 2.7.8.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of NMN to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyzes the final reaction in the major pathway for the biosynthesis of NAD in mammals. EC 2.7.7.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the HYDROLYSIS of terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. The enzyme plays a role in the processing of newly formed N-glycans and in degradation of mature GLYCOPROTEINS. There are multiple isoforms of alpha-mannosidase, each having its own specific cellular location and pH optimum. Defects in the lysosomal form of the enzyme results in a buildup of mannoside intermediate metabolites and the disease ALPHA-MANNOSIDOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the HYDROLYSIS of the N-glycosidic bond between sugar phosphate backbone and URACIL residue during DNA synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the HYDROXYLATION of gamma-butyrobetaine to L-CARNITINE. It is the last enzyme in the biosynthetic pathway of L-CARNITINE and is dependent on alpha-ketoglutarate; IRON; ASCORBIC ACID; and OXYGEN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the METHYLATION of GLYCINE using S-ADENOSYLMETHIONINE to form SARCOSINE with the concomitant production of S-ADENOSYLHOMOCYSTEINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the METHYLATION of PHOSPHATIDYL-N-METHYLETHANOLAMINE to produce phosphatidyl-N-dimethylethanolamine. This enzyme can also methylate phosphatidyl-N-dimethylethanolamine to produce phosphatidyl-N-trimethylethanolamine %28%PHOSPHATIDYLCHOLINE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the acetyltransferase reaction using ACETYL CoA as an acetyl donor and dihydrolipoamide as acceptor to produce COENZYME A %28%CoA%29% and S-acetyldihydrolipoamide. It forms the %28%E2%29% subunit of the PYRUVATE DEHYDROGENASE COMPLEX.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the activation of sulfate ions by ATP to form adenosine-5%27%-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. EC 3.6.1.37.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the acyl group transfer of ACYL COA to 1-acyl-sn-glycerol 3-phosphate to generate 1,2-diacyl-sn-glycerol 3-phosphate. This enzyme has alpha, beta, gamma, delta and epsilon subunits.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the acyl group transfer of acyl COENZYME A to RETINOL to generate COENZYME A and a retinyl ester.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the acyltransferase of SPHINGOSINE to N-acylsphingosine using acyl-COENZYME A as donor and COENZYME A as acceptor. The enzyme is mainly localized in the MITOCHONDRIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the biosynthesis of cysteine in microorganisms and plants from O-acetyl-L-serine and hydrogen sulfide. This enzyme was formerly listed as EC 4.2.99.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. EC 1.11.1.10.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the cleavage of tyrosine to phenol, pyruvate, and ammonia. It is a pyridoxal phosphate protein. The enzyme also forms pyruvate from D-tyrosine, L-cysteine, S-methyl-L-cysteine, L-serine, and D-serine, although at a slower rate. EC 4.1.99.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the condensation of two molecules of GERANYLGERANYL DIPHOSPHATE to give prephytoene diphosphate. The prephytoene diphosphate molecule is a precursor for CAROTENOIDS and other tetraterpenes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of %28%S%29%-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of 2-phospho-D-glycerate to 3-phospho-D-glycerate. EC 5.4.2.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of 3-hydroxyanthranilate to 2-amino-3-carboxymuconate semialdehyde. It was formerly characterized as EC 1.13.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of 4,5-dihydro-4-oxo-5-imidazolepropanoate to urocanate and water. EC 4.2.1.49.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. EC 1.13.11.27.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or 6-mercaptopurine to the corresponding 5%27%-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of ATP and phosphorylase b to ADP and phosphorylase a. EC 2.7.1.38.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5%27%-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. %28%From Enzyme Nomenclature, 1992%29% EC 2.7.1.21.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of ATP into a series of %28%2%27%-5%27%%29% linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease %28%RNase L%29% which cleaves single-stranded RNA. Interferons can act as inducers of these reactions. EC 2.7.7.-.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. %28%From Enzyme Nomenclature, 1992%29% EC 6.3.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of D-fructose 1,6-bisphosphate and water to D-fructose 6-phosphate and orthophosphate. EC 3.1.3.11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of GTP to 3%27%,5%27%-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. %28%From Enzyme Nomenclature, 1992%29% EC 4.6.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-CYSTEINE to 3-sulfinoalanine %28%3-sulfino-L-alanine%29% in the CYSTEINE metabolism and TAURINE and hypotaurine metabolic pathways.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-SERINE to COENZYME A and O-acetyl-L-serine, using ACETYL-COA as a donor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-TYROSINE and 2-oxoglutarate to 4-hydroxyphenylpyruvate and L-GLUTAMATE. It is a pyridoxal-phosphate protein. L-PHENYLALANINE is hydroxylated to L-tyrosine. The mitochondrial enzyme may be identical with ASPARTATE AMINOTRANSFERASES %28%EC 2.6.1.1.%29%. Deficiency of this enzyme may cause type II Tyrosinemia %28%see TYROSINEMIAS%29%. EC 2.6.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. %28%From Enzyme Nomenclature, 1992%29% EC 2.6.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. %28%From Enzyme Nomenclature, 1992%29% EC 1.4.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-glutamate, H2O, and NADP+ to 2-oxoglutarate, NH3, and NADPH. %28%From Enzyme Nomenclature, 1992%29% EC 1.4.1.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-serine and 1-%28%indol-3-yl%29%glycerol 3-phosphate to L-tryptophan and glyceraldehyde 3-phosphate. It is a pyridoxal phosphate protein that also catalyzes the conversion of serine and indole into tryptophan and water and of indoleglycerol phosphate into indole and glyceraldehyde phosphate. %28%From Enzyme Nomenclature, 1992%29% EC 4.2.1.20.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-tryptophan and water to indole, pyruvate, and ammonia. It is a pyridoxal-phosphate protein, requiring K+. It also catalyzes 2,3-elimination and beta-replacement reactions of some indole-substituted tryptophan analogs of L-cysteine, L-serine, and other 3-substituted amino acids. %28%From Enzyme Nomenclature, 1992%29% EC 4.1.99.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of N%28%4%29%-%28%beta-N-acetyl-D-glucosaminyl%29%-L-asparagine and water to N-acetyl-beta-D-glucosaminylamine and L-aspartate. It acts only on asparagine oligosaccharides containing one amino acid, i.e. the asparagine has free alpha-amino and alpha-carboxyl groups. %28%From Enzyme Nomenclature, 1992%29% EC 3.5.1.26.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of N-formyl-L-kynurenine and water to formate and L-kynurenine. It also acts on other aromatic formylamines. %28%Enzyme Nomenclature, 1992%29% EC 3.5.1.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of UDP-galactose and N-acylsphingosine to D-galactosylceramide and UDP.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC 3.1.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of acetoin to diacetyl in the presence of NAD. EC 1.1.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of alpha D-glucose 1-phosphate to alpha D-glucose 6-phosphate. EC 5.4.2.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of alpha,alpha-trehalose and water to D-glucose. EC 3.2.1.28.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of aminoimidazole-4-carboxamide ribonucleotide to 5-formyl-aminoimidazole-4-carboxamide ribonucleotide in the PURINE de novo synthesis pathway. It requires the cofactor N%28%10%29%-FORMYLTETRAHYDROFOLATE as the formyl donor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. EC 4.3.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. %28%From Enzyme Nomenclature, 1992%29% EC 2.1.3.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of linear RNA to a circular form by the transfer of the 5%27%-phosphate to the 3%27%-hydroxyl terminus. It also catalyzes the covalent joining of two polyribonucleotides in phosphodiester linkage. EC 6.5.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA by transfer of the carbonyl group. It requires a cobamide coenzyme. A block in this enzymatic conversion leads to the metabolic disease, methylmalonic aciduria. EC 5.4.99.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of phosphatidylinositol %28%PHOSPHATIDYLINOSITOLS%29% to phosphatidylinositol 4-phosphate, the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, V%28%D%29%J recombination and cell cycle checkpoints. EC 2.7.1.137.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of phosphorylated, inactive glycogen synthase D to active dephosphoglycogen synthase I. EC 3.1.3.42.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of prephenate to p-hydroxyphenylpyruvate in the presence of NAD. In the enteric bacteria, this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of tyrosine. EC 1.3.1.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of prephenate to phenylpyruvate with the elimination of water and carbon dioxide. In the enteric bacteria this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of phenylalanine. EC 4.2.1.51.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the cyclization of hydroxymethylbilane to yield UROPORPHYRINOGEN III and water. It is the fourth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by UROS gene. Mutations of UROS gene result in CONGENITAL ERYTHROPOIETIC PORPHYRIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the deamination of L-phenylalanine to form trans-cinnamate and ammonia. It may also act on L-tyrosine. Since the enzyme deprives neoplastic tissue of phenylalanine, it has been used experimentally in the treatment of acute lymphoblastic leukemia. The enzyme is obtained from many plants. EC 4.3.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the deamination of ethanolamine to acetaldehyde. EC 4.3.1.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the deamination of guanine to form xanthine. EC 3.5.4.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the decarboxylation of S-adenosyl-L-methionine to yield 5%27%-deoxy-%28%5%27%-%29%,3-aminopropyl-%28%1%29%, methylsulfonium salt. It is one of the enzymes responsible for the synthesis of spermidine from putrescine. EC 4.1.1.50.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the decarboxylation of UROPORPHYRINOGEN III to coproporphyrinogen III by the conversion of four acetate groups to four methyl groups. It is the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME. Several forms of cutaneous PORPHYRIAS are results of this enzyme deficiency as in PORPHYRIA CUTANEA TARDA; and HEPATOERYTHROPOIETIC PORPHYRIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the degradation of GLYCOGEN in animals by releasing glucose-1-phosphate from the terminal alpha-1,4-glycosidic bond. This enzyme exists in two forms: an active phosphorylated form %28% PHOSPHORYLASE A%29% and an inactive un-phosphorylated form %28%PHOSPHORYLASE B%29%. Both a and b forms of phosphorylase exist as homodimers. In mammals, the major isozymes of glycogen phosphorylase are found in muscle, liver and brain tissue.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the dehydration of 1,2-propanediol to propionaldehyde. EC 4.2.1.28.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the dehydrogenation of inosine 5%27%-phosphate to xanthosine 5%27%-phosphate in the presence of NAD. EC 1.1.1.205.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the demethylation of L-homocysteine to L-METHIONINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the desaturation %28%aromatization%29% of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the eliminative degradation of polysaccharides containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups. %28%Enzyme Nomenclature, 1992%29% EC 4.2.2.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked D-glucose units. EC 3.2.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the endohydrolysis of 1,6-alpha-glucosidic linkages in isomaltose and dextrins produced from starch and glycogen by alpha-amylase. EC 3.2.1.10.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3%27%-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2%27%,3%27%-cyclic phosphate intermediates. EC 3.1.27.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the endonucleolytic cleavage to 3%27%-phosphomononucleotide and 3%27%-phospholigonucleotide end-products. It can cause hydrolysis of double- or single-stranded DNA or RNA. %28%From Enzyme Nomenclature, 1992%29% EC 3.1.31.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the first and rate-determining steps of peroxisomal beta-oxidation of fatty acids. It acts on COENZYME A derivatives of fatty acids with chain lengths from 8 to 18, using FLAVIN-ADENINE DINUCLEOTIDE as a cofactor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the first step in the biosynthetic pathway to LEUCINE, forming isopropyl malate from acetyl-CoA and alpha-ketoisovaleric acid. This enzyme was formerly listed as EC 4.1.3.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the first step of histidine catabolism, forming UROCANIC ACID and AMMONIA from HISTIDINE. Deficiency of this enzyme is associated with elevated levels of serum histidine. EC 4.3.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the first step of the pathway for histidine biosynthesis in Salmonella typhimurium. ATP reacts reversibly with 5-phosphoribosyl-1-pyrophosphate to yield N-1-%28%5%27%-phosphoribosyl%29%-ATP and pyrophosphate. EC 2.4.2.17.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of 2 molecules of glutamate from glutamine plus alpha-ketoglutarate in the presence of NADPH. EC 1.4.1.13.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of 7-phospho-2-keto-3-deoxy-D-arabinoheptonate from phosphoenolpyruvate and D-erythrose-4-phosphate. It is one of the first enzymes in the biosynthesis of tyrosine and phenylalanine. EC 4.1.12.15.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of CoA derivatives from ATP, acetate, and CoA to form AMP, pyrophosphate, and acetyl CoA. It acts also on propionates and acrylates. EC 6.2.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of N-5%27%-phosphoribosylanthranilic acid from anthranilate and phosphoribosylpyrophosphate, the first step in tryptophan synthesis in E. coli. It exists in a complex with ANTHRANILATE SYNTHASE in bacteria. EC 2.4.2.18.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of O-acetylcarnitine from acetyl-CoA plus carnitine. EC 2.3.1.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of PHOSPHATIDYLINOSITOL and CMP from CDP-DIACYLGLYCEROL and MYOINOSITOL.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of UDPglucose from UTP plus glucose 1-phosphate. EC 2.7.7.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of acetoacetyl-CoA from two molecules of ACETYL COA. Some enzymes called thiolase or thiolase-I have referred to this activity or to the activity of ACETYL-COA C-ACYLTRANSFERASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of anthranilate %28%o-aminobenzoate%29% and pyruvic acid from chorismate and glutamine. Anthranilate is the biosynthetic precursor of tryptophan and numerous secondary metabolites, including inducible plant defense compounds. EC 4.1.3.27.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. EC 6.3.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. This enzyme is important in the de novo biosynthesis of pyrimidines. EC 6.3.5.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. EC 2.5.1.15.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP and, in the case of the yeast enzyme, ITP and GTP can act as donors. It provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. EC 2.7.1.30.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of methionine by transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine. It requires a cobamide coenzyme. The enzyme can act on mono- or triglutamate derivatives. EC 2.1.1.13.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD. EC 5.5.1.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of oleoyl-CoA, A, and water from stearoyl-CoA, AH2, and oxygen where AH2 is an unspecified hydrogen donor. EC 1.14.99.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of phosphatidylserine and CMP from CDPdiglyceride plus serine. EC 2.7.8.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of phosphoribosyl pyrophosphate from ATP and ribose-5-phosphate. EC 2.7.6.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of riboflavin from two molecules of 6,7-dimethyl-8-ribityllumazine, utilizing a four-carbon fragment from one molecule which is transferred to the second molecule. EC 2.5.1.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the formation of thiamine pyrophosphate from ATP and thiamine. EC 2.7.6.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides so as to remove successive beta-maltose units from the non-reducing ends of the chains. EC 3.2.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of ATP and is activated by millimolar concentrations of either Ca%28%2+%29% or Mg%28%2+%29%. Unlike CA%28%2+%29%-TRANSPORTING ATPASE it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. %28%Prog Biophys Mol Biol 1988;52%28%1%29%:1%29%. A subgroup of EC 3.6.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of a ceramidetrihexoside to a ceramidedihexoside plus galactose. EC 3.2.1.47.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of adenosine to inosine with the elimination of ammonia. Since there are wide tissue and species variations in the enzyme, it has been used as a tool in the study of human and animal genetics and in medical diagnosis. EC 3.5.4.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of allophanic acid to two molecules of ammonia plus two molecules of %22%active carbon dioxide%22%. EC 3.5.1.54.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages %28%at a decreasing rate, respectively%29% of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. %28%From Enzyme Nomenclature, 1992%29% EC 3.2.1.18.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause FUCOSIDOSIS. EC 3.2.1.51.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of cerebroside 3-sulfate %28%sulfatide%29% to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy %28%LEUKODYSTROPHY, METACHROMATIC%29%. EC 3.1.6.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of cholesterol and some other sterol esters, to liberate cholesterol plus a fatty acid anion. EC 3.1.1.13.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of cyclic AMP to form adenosine 5%27%-phosphate. The enzyme is widely distributed in animal tissue and controls the level of intracellular cyclic AMP. Also acts on 3%27%,5%27%-cyclic IMP and 3%27%,5%27%-cyclic GMP. EC 3.1.4.17.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of cyclic GMP to yield guanosine-5%27%-phosphate. EC 3.1.4.35.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids EC 3.1.1.23.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of histidinol-phosphate to histidinol. One of the regulatory enzymes in histidine biosynthesis. EC 3.1.3.15.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of keratin, and of other proteins with subtilisin-like specificity. It hydrolyses peptide amides. Endopeptidase K is from the mold Tritirachium album Limber. %28%Enzyme Nomenclature, 1992%29% EC 3.4.21.64.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of nicotinamide adenine dinucleotide %28%NAD%29% to NICOTINAMIDE and ADENOSINE DIPHOSPHATE RIBOSE. Some are extracellular %28%ectoenzymes%29%.The enzyme from some sources also catalyses the hydrolysis of nicotinamide adenine dinucleotide phosphate %28%NADP%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of nicotinamide to nicotinate and ammonia. EC 3.5.1.19.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of nitrophenyl phosphates to nitrophenols. At acid pH it is probably ACID PHOSPHATASE %28%EC 3.1.3.2%29%; at alkaline pH it is probably ALKALINE PHOSPHATASE %28%EC 3.1.3.1%29%. EC 3.1.3.41.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of proteins, including elastin. It cleaves preferentially bonds at the carboxyl side of Ala and Val, with greater specificity for Ala. EC 3.4.21.37.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide %28%N-acylsphingosine%29% plus choline phosphate. A defect in this enzyme leads to NIEMANN-PICK DISEASE. EC 3.1.4.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4. EC 3.2.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids. EC 3.2.1.22.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolysis of terminal, non-reducing beta-D-mannose residues in beta-D-mannosides. The enzyme plays a role in the lysosomal degradation of the N-glycosylprotein glycans. Defects in the lysosomal form of the enzyme in humans result in a buildup of mannoside intermediate metabolites and the disease BETA-MANNOSIDOSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the hydroxylation of TRYPTOPHAN to 5-HYDROXYTRYPTOPHAN in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of SEROTONIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the interconversion of a ketone and hydroxy group at C-20 of cortisone and other 17,20,21-trihydroxy steroids. EC 1.1.1.53.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. EC 4.4.1.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the isomerization of proline residues within proteins. EC 5.2.1.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the methylation of arginine residues of proteins to yield N-mono- and N,N-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen. EC 2.1.1.23.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine. EC 2.1.1.43.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of L-2-aminoadipate 6-semialdehyde to L-2-aminoadipate %28%alpha-aminoadipic acid%29%. It is involved in the biosynthetic pathway of LYSINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of %28%R%29%-2,3-dihydroxy-3-methylbutanoate to %28%S%29%-2-hydroxy-2-methyl-3-oxobutanoate in the presence of NADP. It is involved in the biosynthesis of VALINE; LEUCINE; ISOLEUCINE; pentothenate and COENZYME A. This enzyme was formerly classified as EC 1.1.1.89.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of 1-pyrroline-5-carboxylate to L-GLUTAMATE in the presence of NAD. Defects in the enzyme are the cause of hyperprolinemia II.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of 2,3,4,5-tetrahydrodipicolinate to 2,3-dihydrodipicolinate using NAD%28%P%29%+ as a cofactor. It is found in BACTERIA and higher plants involved in the biosynthesis of DIAMINOPIMELIC ACID and LYSINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of 3-oxopropanoate %28%malonate semialdehyde%29% to acetyl COENZYME A. It plays a role in the metabolism of BETA-ALANINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of 3-phosphoglycerate to 3-phosphohydroxypyruvate. It takes part in the L-SERINE biosynthesis pathway.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of 5,6-dihydrouracil to URACIL using NAD as a cofactor. This enzyme also plays a role in the catabolism of the antimetabolite 5-FLUOROURACIL.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of BENZOATE to 4-HYDROXYBENZOATE. It requires IRON and tetrahydropteridine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of D-glycerate to hydroxypyruvate in the presence of NADP.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of GLYCOLALDEHYDE to GLYCOLATE, using NAD and NADP as COENZYMES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of UDPglucose to UDPglucuronate in the presence of NAD+. EC 1.1.1.22.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of acyl-%5B%acyl-carrier protein%5D% to trans-2,3-dehydroacyl-%5B%acyl-carrier protein%5D% in the fatty acid biosynthesis pathway. It has a preference for acyl derivatives with carbon chain length from 4 to 16.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate %28%12-HPETE%29% which is itself rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate %28%12-HETE%29%. The 12-hydroperoxides are preferentially formed in platelets. EC 1.13.11.31.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate %28%15-HPETE%29% which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate %28%15-HETE%29%. The 15-hydroperoxides are preferentially formed in neutrophils and lymphocytes. EC 1.13.11.33.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate %28%5-HPETE%29% which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate %28%5-HETE%29%. The 5-hydroperoxides are preferentially formed in leukocytes. EC 1.13.11.34.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of catechol to muconic acid with the use of Fe3+ as a cofactor. This enzyme was formerly characterized as EC 1.13.1.1 and EC 1.99.2.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of nitrite to nitrate in the presence of NADP+. It is a FLAVOPROTEIN that contains IRON and MOLYBDENUM. This enzyme was formerly classified as EC 1.6.6.3 and should not be confused with the enzyme NITRATE REDUCTASE %28%NAD%28%P%29%H%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of nitrite to nitrate. It is a cytochrome protein that contains IRON and MOLYBDENUM.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. It contains ferric ion. EC 1.13.11.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of succinate semialdehyde to SUCCINIC ACID. It plays a role in the metabolism of GLUTAMATE; TYROSINE; and butanoate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes. EC 1.1.1.204.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidative deamination of L-amino acids to KETO ACIDS with the generation of AMMONIA and HYDROGEN PEROXIDE. L-amino acid oxidase is widely distributed in and is thought to contribute to the toxicity of SNAKE VENOMS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. %28%From Goodman and Gilman%27%s, The Pharmacological Basis of Therapeutics, 8th ed, p415%29% EC 1.4.3.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen IX by the conversion of two propionate groups to two vinyl groups. It is the sixth enzyme in the 8-enzyme biosynthetic pathway of HEME, and is encoded by CPO gene. Mutations of CPO gene result in HEREDITARY COPROPORPHYRIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the phosphorylation of tyrosine residues in proteins with ATP or other nucleotides as phosphate donors. EC 2.7.1.112.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5%27%-phosphate and cytidine 5%27%-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. %28%From Enzyme Nomenclature, 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reaction of ATP, pyruvate, and orthophosphate to form AMP plus phosphoenolpyruvate plus pyrophosphate. EC 2.7.9.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reactivation by light of UV-irradiated DNA. It breaks two carbon-carbon bonds in pyrimidine dimers in DNA. EC 4.1.99.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the rearrangement of disulfide bonds within proteins during folding. It is a monomer identical to one of the subunits of PROCOLLAGEN-PROLINE DIOXYGENASE. %28%From Dorland, 28th ed%29% EC 5.3.4.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reduction of a 3 beta-hydroxy-delta%28%5%29%-steroid to 3-oxo-delta%28%4%29%-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. EC 1.1.1.145.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. EC 1.8.4.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. EC 1.1.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the release of a N-terminal pyroglutamyl group from a polypeptide provided the next residue is not proline. It is inhibited by thiol-blocking reagents and occurs in mammalian tissues, microorganisms, and plants. %28%From Enzyme Nomenclature, 1992%29% EC 3.4.19.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the replication of the RNA of coliphage Q beta. EC 2.7.7.-.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reversible hydration of cis-aconitate to yield citrate or isocitrate. It is one of the citric acid cycle enzymes. EC 4.2.1.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reversible hydration of fumaric acid to yield L-malic acid. It is one of the citric acid cycle enzymes. EC 4.2.1.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate, and is a part of the glycolytic and gluconeogenic pathways. Deficiency of the enzyme, an autosomal recessive trait, results in liver glycogenesis and hemolytic anemia. EC 5.3.1.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate, an important step in glycolysis. EC 5.3.1.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reversible oxidation of inosine 5%27%-phosphate %28%IMP%29% to guanosine 5%27%-phosphate %28%GMP%29% in the presence of AMMONIA and NADP+. This enzyme was formerly classified as EC 1.6.6.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the reversible oxidation of mannonate to fructuronate in the presence of NAD. Also reduces D-tagaturonate to D-altronate. EC 1.1.1.57.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the syn-dehydrogenation of linoleol-CoA gamma-linolenoyl-CoA. It was formerly characterized as EC 1.14.99.25.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of S-adenosylmethionine from methionine and ATP. EC 2.5.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. It is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. EC 2.7.7.10.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of acetylphosphate from acetyl-CoA and inorganic phosphate. Acetylphosphate serves as a high-energy phosphate compound. EC 2.3.1.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of fructose-6-phosphate plus glutamine from glutamate plus glucosamine-6-phosphate. EC 2.6.1.16.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of geranylgeranyl diphosphate from trans, trans-farnesyl diphosphate and isopentenyl diphosphate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of hydroxymethylglutaryl-CoA from acetyl-CoA and acetoacetyl-CoA. This is a key enzyme in steroid biosynthesis. This enzyme was formerly listed as EC 4.1.3.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. EC 2.7.8.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of polyadenylic acid from ATP. May be due to the action of RNA polymerase %28%EC 2.7.7.6%29% or polynucleotide adenylyltransferase %28%EC 2.7.7.19%29%. EC 2.7.7.19.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the synthesis of pyroglutamate from a gamma-glutamyl-amino acid, also releasing the free amino acid. The enzyme acts on derivatives of glutamate, 2-aminobutyrate, alanine and glycine. The enzyme has been proposed to have a role in a gamma-glutamyl cycle for amino acid transport into cells in the intestines. EC 2.3.2.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the tetrapolymerization of the monopyrrole PORPHOBILINOGEN into the hydroxymethylbilane preuroporphyrinogen %28%UROPORPHYRINOGENS%29% in several discrete steps. It is the third enzyme in the 8-enzyme biosynthetic pathway of HEME. In humans, deficiency in this enzyme encoded by HMBS %28%or PBGD%29% gene results in a form of neurological porphyria %28%PORPHYRIA, ACUTE INTERMITTENT%29%. This enzyme was formerly listed as EC 4.3.1.8%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of UMP from UDPglucose to galactose 1-phosphate, forming UDPgalactose and glucose 1-phosphate. Deficiency in this enzyme is the major cause of GALACTOSEMIA. EC 2.7.7.12.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of a formyl group from N10-formyltetrahydrofolate to N1-%28%5-phospho-D-ribosyl%29%glycinamide to yield N2-formyl-N1-%28%5-phospho-D-ribosyl%29%glycinamide and TETRAHYDROFOLATE. It plays a role in the de novo PURINE biosynthetic pathway.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine %28%MELATONIN%29%. EC 2.1.1.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to the 5-position of cytosine or to the 6-position in adenine in mammalian DNA. EC 2.1.1.37.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of a phosphate group to the 5%27%-terminal hydroxyl groups of DNA and RNA. EC 2.7.1.78.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of cytidylate %28%CMP%29% to choline phosphate to form CDPcholine. It is the rate-limiting enzyme in the choline pathway for the biosynthesis of phosphatidylcholine. Its activity is increased by glucocorticoids. EC 2.7.7.15.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-D-glucosyl-glycopeptide, during glycopeptide synthesis. EC 2.4.1.38.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of glucose from ADPglucose to glucose-containing polysaccharides in 1,4-alpha-linkages. EC 2.4.1.21.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of methyl groups from S-adenosylmethionine to free carboxyl groups of a protein molecule forming methyl esters. EC 2.1.1.-.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of phosphate from C-3 of 1,3-diphosphoglycerate to C-2 of 3-phosphoglycerate, forming 2,3-diphosphoglycerate. EC 5.4.2.4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. EC 2.4.2.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion. EC 2.8.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of the propylamine moiety from 5%27%-deoxy-5%27%-S-%28%3-methylthiopropylamine%29%sulfonium adenosine to putrescine in the biosynthesis of spermidine. The enzyme has a molecular weight of approximately 73,000 kDa and is composed of two subunits of equal size.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that catalyzes the transfer of the propylamine moiety from 5%27%-deoxy-5%27%-S-%28%3-methylthiopropylamine%29%sulfonium adenosine to spermidine in the biosynthesis of spermine. It has an acidic isoelectric point at pH 5.0. EC 2.5.1.22.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that converts ascorbic acid to dehydroascorbic acid. EC 1.10.3.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that converts brain gamma-aminobutyric acid %28%GAMMA-AMINOBUTYRIC ACID%29% into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC 2.6.1.19.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. EC 3.1.3.17.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that forms CMP-acylneuraminic acids, which donate the N-acylneuraminic acid residues to the terminal sugar residue of a ganglioside or glycoprotein. EC 2.7.7.43.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that hydrolyzes 1,6-alpha-glucosidic branch linkages in glycogen, amylopectin, and their beta-limit dextrins. It is distinguished from pullulanase %28%EC 3.2.1.41%29% by its inability to attack pullulan and by the feeble action of alpha-limit dextrins. It is distinguished from amylopectin 6-glucanohydrolase %28%EC 3.2.1.69%29% by its action on glycogen. With EC 3.2.1.69, it produces the activity called %22%debranching enzyme%22%. EC 3.2.1.68.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that hydrolyzes galactose from ceramide monohexosides. Deficiency of this enzyme may cause globoid cell leukodystrophy %28%LEUKODYSTROPHY, GLOBOID CELL%29%. EC 3.2.1.46.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that hydrolyzes iduronosidic linkages in desulfated dermatan. Deficiency of this enzyme produces Hurler%27%s syndrome. EC 3.2.1.76.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that hydrolyzes thiamine pyrophosphate to thiamine monophosphate plus inorganic phosphate. EC 3.6.1.-.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that in the course of pyrimidine biosynthesis, catalyzes the oxidation of dihydro-orotic acid to orotic acid utilizing oxygen as the electron acceptor. This enzyme is a flavoprotein which contains both FLAVIN-ADENINE DINUCLEOTIDE and FLAVIN MONONUCLEOTIDE as well as iron-sulfur centers. EC 1.3.3.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that is active in the first step of choline phosphoglyceride %28%lecithin%29% biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. EC 1.2.1.3. Before 1978, it was classified as EC 1.1.1.70.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. It is a copper protein. EC 1.1.3.9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and calmodulin. The 20-kDa light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that plays a role in the GLUTAMATE and butanoate metabolism pathways by catalyzing the oxidation of succinate semialdehyde to SUCCINATE using NAD+ as a coenzyme. Deficiency of this enzyme, causes 4-hydroxybutyricaciduria, a rare inborn error in the metabolism of the neurotransmitter 4-aminobutyric acid %28%GABA%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that plays a role in the PENTOSES and GLUCURONATES interconversion pathway by catalyzing the oxidation of XYLITOL to D-xylulose. This enzyme has been found to be specific for NAD+.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that plays a role in the VALINE; LEUCINE; and ISOLEUCINE catabolic pathways by catalyzing the oxidation of 2-methyl-3-oxopropanate to propanoyl-CoA using NAD+ as a coenzyme. Methylmalonate semialdehyde dehydrogenase deficiency is characterized by elevated BETA-ALANINE and 3-HYDROXYPROPIONIC ACID.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that removes THYMINE and URACIL bases mispaired with GUANINE through hydrolysis of their N-glycosidic bond. These mispaired nucleotides generally occur through the hydrolytic DEAMINATION of 5-METHYLCYTOSINE to thymine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter%27%s syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 3.1.6.13.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. EC 2.3.1.15.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that transfers methyl groups from O%28%6%29%-methylguanine, and other methylated moieties of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single-step reaction. EC 2.1.1.63.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that utilizes NADH or NADPH to reduce FLAVINS. It is involved in a number of biological processes that require reduced flavin for their functions such as bacterial bioluminescence. Formerly listed as EC 1.6.8.1%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5%27%-phosphoribosyl-4-%28%N-succinocarboxamide%29%-5-aminoimidazole to 5%27%-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that, in the course of pyrimidine biosynthesis, catalyzes ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme that, in the presence of ATP and COENZYME A, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and ORTHOPHOSPHATE. This reaction represents an important step in fatty acid biosynthesis. This enzyme was formerly listed as EC 4.1.3.8.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme the catalyzes the degradation of insulin, glucagon and other polypeptides. It is inhibited by bacitracin, chelating agents EDTA and 1,10-phenanthroline, and by thiol-blocking reagents such as N-ethylmaleimide, but not phosphoramidon. %28%Eur J Biochem 1994;223:1-5%29% EC 3.4.24.56.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes an endonucleolytic cleavage near PYRIMIDINE DIMERS to produce a 5%27%-phosphate product. The enzyme acts on the damaged DNA strand, from the 5%27% side of the damaged site.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the catabolism of S-ADENOSYLHOMOCYSTEINE to ADENOSINE and HOMOCYSTEINE. It may play a role in regulating the concentration of intracellular adenosylhomocysteine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the deamination of CYTOSINE resulting in the formation of URACIL. It can also act on 5-methylcytosine to form THYMIDINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the endonucleolytic cleavage of phosphodiester bonds at purinic or apyrimidinic sites %28%AP-sites%29% to produce 5%27%-Phosphooligonucleotide end products. The enzyme prefers single-stranded DNA %28%ssDNA%29% and was formerly classified as EC 3.1.4.30.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the hydrolysis of LACTOSE to D-GALACTOSE and D-GLUCOSE. Defects in the enzyme cause LACTOSE INTOLERANCE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the hydrolysis of an aryl-dialkyl phosphate to form dialkyl phosphate and an aryl alcohol. It can hydrolyze a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. It may also mediate an enzymatic protection of LOW DENSITY LIPOPROTEINS against oxidative modification and the consequent series of events leading to ATHEROMA formation. The enzyme was previously regarded to be identical with Arylesterase %28%EC 3.1.1.2%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the hydrolysis of diphosphate %28%DIPHOSPHATES%29% into inorganic phosphate. The hydrolysis of pyrophosphate is coupled to the transport of HYDROGEN IONS across a membrane.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the hydrolysis of nucleoside triphosphates to nucleoside diphosphates. It may also catalyze the hydrolysis of nucleotide triphosphates, diphosphates, thiamine diphosphates and FAD. The nucleoside triphosphate phosphohydrolases I and II are subtypes of the enzyme which are found mostly in viruses.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which catalyzes the release of BIOTIN from biocytin. In human, defects in the enzyme are the cause of the organic acidemia MULTIPLE CARBOXYLASE DEFICIENCY or BIOTINIDASE DEFICIENCY.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme which is secreted by the KIDNEY and is formed from prorenin in plasma and kidney. The enzyme cleaves the Leu-Leu bond in ANGIOTENSINOGEN to generate ANGIOTENSIN I. This enzyme was formerly listed as EC 3.4.99.19.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme with high affinity for carbon dioxide. It catalyzes irreversibly the formation of oxaloacetate from phosphoenolpyruvate and carbon dioxide. This fixation of carbon dioxide in several bacteria and some plants is the first step in the biosynthesis of glucose. EC 4.1.1.31.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme, involved in the early steps of purine nucleotide biosynthesis, that catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. EC 2.4.2.14.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; %28%GSH, a tripeptide that protects cells from many toxins%29%. It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An enzymes that catalyzes the reversible reduction-oxidation reaction of 20-alpha-hydroxysteroids, such as from PROGESTERONE to 20-ALPHA-DIHYDROPROGESTERONE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ependymal derivative located at the junction of the third ventricle and the cerebral aqueduct, secreting somatostatin.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found a variety of adult and embryonic tissues. Unlike the majority of proteins in this class there is little or no expression of EphB4 receptor in the BRAIN. It has been found at high levels in developing mammary glands and in invasive mammary tumors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found at high levels in adult THYMUS and RETINA. In embryonic tissues it is found in many developing organs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found exclusively in BRAIN. EphA8 receptors may play a role in the axonal guidance of a subset of tectal commissural NEURONS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found in a number of tissues including BRAIN; LUNG; KIDNEY; PANCREAS; INTESTINE; and HEART. During embryogenesis EphB3 receptor is expressed at high levels in the brain.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found in variety of tissues including BRAIN. During embryogenesis, EphA4 receptor exhibits a diverse spatial and temporal pattern of expression suggesting its role in multiple developmental processes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found primarily in BRAIN and THYMUS. The EphB6 receptor is unusual in that its tyrosine kinase domain shares little homology with other members of this class. The unusual tyrosine kinase domain of this receptor appears to result in its lack of tyrosine kinase activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found primarily in differentiated neuronal tissues. Several isoforms of EphA5 receptor occur due to multiple alternative RNA splicing. The protein is prominently expressed in the NEURONS of the LIMBIC SYSTEM during development and throughout adult life, suggesting its role in the plasticity of limbic structure and function.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found primarily in the nervous system. In the embryonic BRAIN EphB1 receptor expression occurs in the mantle layer and increases with the progression of embryogenesis. In adult brain it is found in the several regions including the CEREBELLUM; CEREBRAL CORTEX; and CAUDATE NUCLEUS; and PUTAMEN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found widely expressed in embryo tissues, including the NERVOUS SYSTEM. In the BRAIN high levels of EphA7 expression occurs in the anterior tectum, medulla, RHOMBENCEPHALON, and SUBCOMMISSURAL ORGAN. Several isoforms of the protein occur due to multiple alternative spicing of the EphA7 mRNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor found widely expressed in embryonic and adult tissues. High levels of EphB2 receptor are observed in growing AXONS and NERVE FIBERS. Several isoforms of the protein exist due to multiple alternative mRNA splicing.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor that is found in a variety of neuronal regions of the BRAIN. In contrast to the other proteins in this class, it is expressed at higher levels in adult tissues than in embryonic tissues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An eph family receptor that is found primarily in adult BRAIN and variety of tissues in the developing embryo tissues. During embryonic development high levels of EphA3 receptor expression is seen in the nervous system and coincides with neuronal cell migration, suggesting a role for this protein in axonal pathfinding.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ephrin that was originally identified as the product of an early response gene induced by TUMOR NECROSIS FACTORS. It is linked to the CELL MEMBRANE via a GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR and binds EPHA2 RECEPTOR with high affinity. During embryogenesis high levels of ephrin-A1 are expressed in LUNG, KIDNEY, SALIVARY GLANDS and INTESTINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic %28%idiopathic%29% and symptomatic %28%secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.%29%. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp744-8%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An epithelial neoplasm characterized by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid. %28%From Stedman, 25th ed %26% Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An epithelial outgrowth of the cloaca in birds similar to the thymus in mammals. It atrophies within 6 months after birth and remains as a fibrous remnant in adult birds. It is composed of lymphoid tissue and prior to involution, is the site of B-lymphocyte maturation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An epithelium-lined sac containing fluid; usually found at the apex of a pulp-involved tooth. The lateral type occurs less frequently along the side of the root.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An equimolar complex of 4,4%27%-Dinitrocarbanilide and 2-Hydroxy-4,6-dimethylpyrimidine. A coccidiostat for poultry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ergot alkaloid %28%ERGOT ALKALOIDS%29% with uterine and vascular smooth muscle contractile properties.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ergot derivative that acts as an agonist at dopamine D2 receptors %28%DOPAMINE AGONISTS%29%. It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors %28%SEROTONIN AGONISTS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An error-prone mechanism or set of functions for repairing damaged microbial DNA. SOS functions %28%a concept reputedly derived from the SOS of the international distress signal%29% are involved in DNA repair and mutagenesis, in cell division inhibition, in recovery of normal physiological conditions after DNA repair, and possibly in cell death when DNA damage is extensive.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential GATA transcription factor that is expressed primarily in HEMATOPOIETIC STEM CELLS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN %28%hence its use as an antidepressant and sleep aid%29%. It can be a precursor to NIACIN, albeit inefficiently, in mammals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential amino acid that is physiologically active in the L-form.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential amino acid that is required for the production of HISTAMINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential amino acid. It is often added to animal feed.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin %28%NOREPINEPHRINE%29%, and THYROXINE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of LEUCINE. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential branched-chain amino acid important for hemoglobin formation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An essential cofactor for the degradation of G%28%M2%29%GANGLIOSIDE by lysosomal BETA-N-ACETYLHEXOSAMINIDASE. Genetic mutations resulting in loss of G%28%M2%29% activator protein are one of the causes of TAY-SACHS DISEASE, AB VARIANT.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ester formed between the aldehydic carbon of RIBOSE and the terminal phosphate of ADENOSINE DIPHOSPHATE. It is produced by the hydrolysis of nicotinamide-adenine dinucleotide %28%NAD%29% by a variety of enzymes, some of which transfer an ADP-ribosyl group to target proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ester of AMPICILLIN which is readily hydrolysed on absorption to release ampicillin. It is well absorbed from the gastrointestinal tract resulting in a greater bioavailability of ampicillin than can be achieved with equivalent doses of ampicillin.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ester of TESTOSTERONE with a propionate substitution at the 17-beta position.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. It is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ester of phthalic acid. It appears as a light-colored, odorless liquid and is used as a plasticizer for many resins and elastomers.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An estrogen antagonist that has been used in the treatment of breast cancer.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An estrogenic steroid produced by HORSES. It has a total of four double bonds in the A- and B-ring. High concentration of euilin is found in the URINE of pregnant mares.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ethanol-inducible cytochrome P450 enzyme that metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Substrates include alcohol; NITROSAMINES; BENZENE; URETHANE; and other low molecular weight compounds. CYP2E1 has been used as an enzyme marker in the study of alcohol abuse.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ethical system which emphasizes human values and the personal worth of each individual, as well as concern for the dignity and freedom of humankind.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ethnic group with historical ties to the land of ISRAEL and the religion of JUDAISM.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ethylene compound with two hydroxy groups %28%-OH%29% located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ets proto-oncogene expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An evolutionarily conserved 9-KDa nuclear protein that binds NUCLEOSOMES and may be involved in the process of CHROMATIN unfolding.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An evolutionarily-conserved 10-kDa nuclear protein that binds NUCLEOSOMES and may be involved in the process of CHROMATIN unfolding.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An examination, review and verification of all financial accounts.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excess of GAMMA-GLOBULINS in the blood. It is seen frequently in chronic infectious diseases. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excess of LIPIDS in the BLOOD. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. %28%From Churchill%27%s Illustrated Medical Dictionary, 1989%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excessive stress reaction to one%27%s occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excited state of molecular oxygen generated photochemically or chemically. Singlet oxygen reacts with a variety of biological molecules such as NUCLEIC ACIDS; PROTEINS; and LIPIDS; causing oxidative damages.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An excretory duct of the embryonic kidney. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exfoliative disease of skin seen primarily in adults and characterized by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded. It results primarily from a toxic reaction to various drugs, but occasionally occurs as a result of infection, neoplastic conditions, or other exposure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exocellulase with specificity for 1,3-beta-D-glucasidic linkages. It catalyzes hydrolysis of beta-D-glucose units from the non-reducing ends of 1,3-beta-D-glucans, releasing GLUCOSE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exocellulase with specificity for a variety of beta-D-glycoside substrates. It catalyzes the hydrolysis of terminal non-reducing residues in beta-D-glucosides with release of GLUCOSE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exocellulase with specificity for the hydrolysis of 1,4-beta-glucosidic linkages of 1,4-beta-D-glucans resulting in successive removal of GLUCOSE units.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An exotic species of the family CYPRINIDAE, originally from Asia, that has been introduced in North America. They are used in embryological studies and to study the effects of certain chemicals on development.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An expectorant that also has some muscle relaxing action. It is used in many cough preparations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND%27%S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. %28%From Immunol Res 1998;17%28%1-2%29%:217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An experimental animal model for the demyelinating disease of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. %28%From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84%28%1%29%:40-52%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An experimental lymphocytic leukemia of mice. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An expression of the number of mitoses found in a stated number of cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extensive order of basidiomycetous fungi whose fruiting bodies are commonly call mushrooms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extensive order of highly specialized insects including bees, wasps, and ants.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extra tooth, erupted or unerupted, resembling or unlike the other teeth in the group to which it belongs. Its presence may cause malposition of adjacent teeth or prevent their eruption.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extra-embryonic membranous sac derived from the YOLK SAC of REPTILES; BIRDS; and MAMMALS. It lies between two other extra-embryonic membranes, the AMNION and the CHORION. The allantois serves to store urinary wastes and mediate exchange of gas and nutrients for the developing EMBRYO.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extracellular endopeptidase of vertebrate tissues similar to INTERSTITIAL COLLAGENASE. It digests proteoglycan, fibronectin, collagen types III, IV, V, and IX, and activates procollagenase. %28%Enzyme Nomenclature, 1992%29% EC 3.4.24.17.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extracellular endopeptidase which excises a block of peptides at the amino terminal, nonhelical region of the procollagen molecule with the formation of collagen. Absence or deficiency of the enzyme causes accumulation of procollagen which results in the inherited connective tissue disorder--dermatosparaxis. EC 3.4.24.14.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extracellular selenoprotein that contains most of the SELENIUM in PLASMA. Selenoprotein P functions as an antioxidant and appears to transport selenium from the LIVER to peripheral tissues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extract of absinthium and other bitter herbs, containing 60%25% alcohol. Prolonged ingestion causes nervousness, convulsions, trismus, amblyopia, optic neuritis, and mental deterioration. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extramedullary tumor of immature myeloid cells. Granulocytic sarcoma usually occurs with or follows the onset of acute myeloid leukemia %28%LEUKEMIA, MYELOCYTIC, ACUTE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extravasation of blood localized in an organ, space, or tissue.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extremely rare condition manifested as monoclonal IMMUNOGLOBULIN M dysproteinemia without features of lymphoproliferative disease, but with chronic urticaria, fever of unknown origin, disabling bone pain, hyperostosis, and increased erythrocyte sedimentation rate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An extremely variable eczematous skin disease that is presumed to be a response to prolonged vigorous scratching, rubbing, or pinching to relieve intense pruritus. It varies in intensity, severity, course, and morphologic expression in different individuals. Neurodermatitis is believed by some to be psychogenic. The circumscribed or localized form is often referred to as lichen simplex chronicus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An herbicide with irritant effects on the eye and the gastrointestinal system.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An herbicide with strong irritant properties. Use of this compound on rice fields, orchards, sugarcane, rangeland, and other noncrop sites was terminated by the EPA in 1985. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An high-affinity, NAD-dependent 11-beta-hydroxysteroid dehydrogenase that acts unidirectionally to catalyze the dehydrogenation of CORTISOL to CORTISONE. It is found predominantly in mineralocorticoid target tissues such as the KIDNEY; COLON; SWEAT GLANDS; and the PLACENTA. Absence of the enzyme leads to a fatal form of childhood hypertension termed, APPARENT MINERALOCORTICOID EXCESS SYNDROME.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An icosahedral RNA satellite virus which requires an obligatory Tobacco necrosis virus %28%see NECROVIRUS%29% for its replication.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic disorder characterized by the loss of filiform papillae leaving reddened areas of circinate macules bound by a white band. The lesions heal, then others erupt.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic syndrome characterized by one or more of the following; recurrent orofacial swelling, relapsing facial paralysis, and fissured tongue %28%lingua plicata%29%. The onset is usually in childhood and relapses are common. Cheilitis granulomatosa is a monosymptomatic variant of this condition. %28%Dermatol Clin 1996 Apr;14%28%2%29%:371-9; Magalini %26% Magalini, Dictionary of Medical Syndromes, 4th ed, p531%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic syndrome characterized by the formation of granulation tissue in the anterior cavernous sinus or superior orbital fissure, producing a painful ophthalmoplegia. %28%Adams et al., Principles of Neurology, 6th ed, p271%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or STRESS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries. Most commonly affected are the renal arteries; involvement of the axillary, iliac, basilar, carotid, hepatic and intracranial arteries have been reported.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear %28%EAR, INNER%29%; VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. %28%From Adams et al., Principles of Neurology, 6th ed, pp300-1%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An illusion of vision usually affecting spatial relations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imagined sequence of events or mental images, e.g., daydreams.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length %28%coherence%29% as the reference mirror, the detector observes interference fringes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imaging technique using compounds labelled with short-lived positron-emitting radionuclides %28%such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18%29% to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and BRAIN. SPECT is closely related to PET, but uses isotopes with longer half-lives and resolution is lower.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA %28%insufficient blood supply to the heart muscle%29% caused by a decreased capacity of the coronary vessels.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imbalanced nutritional status resulted from excessive intake of nutrients. Generally, overnutrition generates an energy imbalance between food consumption and energy expenditure leading to disorders such as OBESITY.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imbalanced nutritional status resulted from insufficient intake of nutrients to meet normal physiological requirement.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imidazole antifungal agent that is used topically and by intravenous infusion.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imidazole antithyroid agent. Carbimazole is metabolized to METHIMAZOLE, which is responsible for the antithyroid activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immature epithelial tumor of the JAW originating from the epithelial rests of Malassez or from other epithelial remnants of the ENAMEL from the developmental period. It is a slowly growing tumor, usually benign, but displays a marked propensity for invasive growth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunoenzyme test for the presence of drugs and other substances in urine and blood. The test uses enzyme linked antibodies that react only with the particular drug for which the sample is being tested.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunoglobulin which accounts for less than 1%25% of plasma immunoglobulin. It is found on the membrane of many circulating B LYMPHOCYTES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens %28%NTP 85-002, 1985%29%, this substance has been listed as a known carcinogen. %28%Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imperfect fungus causing smut or black mold of several fruits, vegetables, etc.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imperfect fungus present on most agricultural seeds and often responsible for the spoilage of seeds in bulk storage. It is also used in the production of fermented food or drink, especially in Japan.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imperfect fungus that produces ochratoxins and contaminates cereals and coffee beans.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An implant used to replace one or more of the ear ossicles. They are usually made of plastic, Gelfoam, ceramic, or stainless steel.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An important aggregate factor in epidemiological studies of women%27%s health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An important enzyme in the glyoxylic acid cycle which reversibly catalyzes the synthesis of L-malate from acetyl-CoA and glyoxylate. This enzyme was formerly listed as EC 4.1.3.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An important intermediate in lipid biosynthesis and in glycolysis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia %28%LEUKEMIA, PROMYELOCYTIC, ACUTE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An important soluble regulator of the alternative pathway of complement activation %28%COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE%29%. It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b %28%inactivated complement 3b%29% susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex %28%COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION %28%single or multiple%29%, and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. %28%From Gerontol Geriatr 1998 Feb;31%28%1%29%:36-44%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An impulse-conducting system composed of modified cardiac muscle and having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An in situ method for detecting areas of DNA which are nicked during apoptosis. Terminal deoxynucleotidyl transferase is used to add labeled dUTP, in a template-independent manner, to the 3 prime OH ends of either single- or double-stranded DNA. The terminal deoxynucleotidyl transferase nick end labeling, or TUNEL, assay labels apoptosis on a single-cell level, making it more sensitive than agarose gel electrophoresis for analysis of DNA fragmentation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IMMUNOGLOBULIN E antibodies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An in vitro test used in the diagnosis of allergies including drug hypersensitivity. The allergen is added to the patient%27%s white blood cells and the subsequent histamine release is measured.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inactive stage between the larval and adult stages in the life cycle of insects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inborn condition characterized by deficiencies of red cell precursors that sometimes also includes LEUKOPENIA and THROMBOCYTOPENIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inborn error of amino acid metabolism resulting from a defect in the enzyme homogentisate 1,2-dioxygenase and causing an accumulation of homogentisic acid in the urine. The condition is characterized by ochronosis in various tissues and arthritis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inborn error of metabolism marked by a defect in the lysosomal isoform of ALPHA-MANNOSIDASE activity that results in lysosomal accumulation of mannose-rich intermediate metabolites. Virtually all patients have psychomotor retardation, facial coarsening, and some degree of dysostosis multiplex. It is thought to be an autosomal recessive disorder.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inborn error of metabolism marked by a defect in the lysosomal isoform of BETA-MANNOSIDASE that results in lysosomal accumulation of mannose-rich intermediate metabolites containing 1,4-beta linkages. The human disease occurs through autosomal recessive inheritance and manifests itself with variety of symptoms that depend upon the type of gene mutation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inborn error of methionone metabolism which produces an excess of homocysteine in the blood. It is often caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and is a risk factor for coronary vascular disease.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inbred strain of Long-Evans rats that develops hyperglycemia, hyperinsulinemia, and mild obesity, mostly in males, that resembles non-insulin-dependent diabetes mellitus in humans. It was developed from outbred Long-Evans stock in 1983.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An incision in the uterus, performed through either the abdomen or the vagina.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An incision in the vagina. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An incision of the posterior vaginal wall and a portion of the pudenda which enlarges the vaginal introitus to facilitate delivery and prevent lacerations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration %28%stimulation of red bone marrow%29% and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increase in the total red cell mass of the blood. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increase number of repeats of a genomic, tandemly repeated DNA sequence from one generation to the next.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increased number of contiguous trinucleotide repeats in the DNA sequence from one generation to the next. The presence of these regions is associated with diseases such as FRAGILE X SYNDROME and MYOTONIC DYSTROPHY. Some CHROMOSOME FRAGILE SITES are composed of sequences where trinucleotide repeat expansion occurs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increased reactivity to specific antigens mediated not by antibodies but by cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increased sensation to painful stimuli that may follow damage to soft tissue containing NOCICEPTORS or injury to a peripheral nerve. Hyperalgesia can occur both at the site of tissue damage %28%primary hyperalgesia%29% and in the surrounding undamaged areas %28%secondary hyperalgesia%29%. %28%Kandel et al., Principles of Neural Science, 3d ed, p386%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increased tendency of the GENOME to acquire MUTATIONS when various processes involved in maintaining and replicating the genome are dysfunctional.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increased tendency to acquire CHROMOSOME ABERRATIONS when various processes involved in chromosome replication, repair, or segregation are dysfunctional.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus. It is an electrical event indicative of a state of readiness or expectancy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p234%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indentation of three fused benzene rings. A common bay region is the site on BENZO%28%A%29%PYRENE, an indirect carcinogen that is metabolically activated by the P-450 system at the 7,8-double bond, leading to a 7,8-oxide, which is rapidly converted to a 7,8-dihydrodiol and later epoxidated near the bay region at the 9,10-double bond. The resulting product, a diol-epoxide is a poor substrate for epoxide hydratase and is released from the mitochondria into the cell as a highly reactive electrophil, becoming an %27%ultimate%27% carcinogen, as it reacts with negative charges in DNA. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent Federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the Earth%27%s atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles. %28%From U.S. Government Manual, 1993%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent administrative agency concerned with maintaining competitive free enterprise by prohibiting unfair methods of competition and unfair deceptive acts or practices.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent federation of the Leeward Islands in the West Indies, consisting of Saint Christopher, Nevis, and Sombrero. Its capital is Basseterre. It was discovered by Columbus in 1493, settled by the British in 1625, the first of the Leeward Islands to be colonized by them. It was held jointly by the French and English 1628-1713, but returned to Great Britain by the Treaty of Utrecht in 1713. It was held by the French 1782-83. Under the British for the next 200 years, it gained its independence in 1983. %28%From Webster%27%s New Geographical Dictionary, 1988, p1045; Embassy, telephone 202-686-2636%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent state consisting of three islands in the Mediterranean Sea, south of Sicily. Its capital is Valetta. The major island is Malta, the two smaller islands are Comino and Gozo. It was a Phoenician and Carthaginian colony, captured by the Romans in 218 B.C. It was overrun by Saracens in 870, taken by the Normans in 1090, and subsequently held by the French and later the British who allotted them a dominion government in 1921. It became a crown colony in 1933, achieving independence in 1964. The name possibly comes from a pre-Indoeuropean root mel, high, referring to its rocks, but a more picturesque origin derives the name from the Greek melitta or melissa, honey, with reference to its early fame for its honey production. %28%From Webster%27%s New Geographical Dictionary, 1988, p719 %26% Room, Brewer%27%s Dictionary of Names, 1992, p330%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent state in eastern Africa, east of SUDAN and bounded on the north by the Red Sea. Its capital is Addis Ababa. It gained independence in 1941. In 1952 it became federated with ERITREA which became a separate nation in 1993. %28%Webster%27%s New Geographical Dictionary, 1997, p366%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent state in southern Africa, south of TANZANIA and east of ZAMBIA, on the Indian Ocean. Its capital is Maputo. It was formerly called Portuguese East Africa, the town of Mozambique having been a Portuguese trading fort early in the 16th century. Organized as a colony in 1907, it became an overseas province of Portugal in 1951 and became independent in 1975. The name is a Portuguese corruption of the Arabic musa malik: Musa %28%the name of an early African ruler%29% + malik %28%king%29%. %28%From Webster%27%s New Geographical Dictionary, 1992, p798 %26% Room, Brewer%27%s Dictionary of Names, 1992, p365%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent state in the Lesser Antilles in the West Indies, north of Venezuela, comprising the islands of Trinidad and Tobago. Its capital is Port of Spain. Both islands were discovered by Columbus in 1498. The Spanish, English, Dutch, and French figure in their history over four centuries. Trinidad and Tobago united in 1898 and were made part of the British colony of Trinidad and Tobago in 1899. The colony became an independent state in 1962. Trinidad was so named by Columbus either because he arrived on Trinity Sunday or because three mountain peaks suggested the Holy Trinity. Tobago was given the name by Columbus from the Haitian tambaku, pipe, from the natives%27% habit of smoking tobacco leaves. %28%Webster%27%s New Geographical Dictionary, 1988, p1228, 1216 %26% Room, Brewer%27%s Dictionary of Names, 1992, p555, 547%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent state in the West Indies. Its capital is Castries. It was probably discovered by Columbus in 1502 and first settled by the English in 1605. Contended for by the French and English in the 17th century, it was regarded as neutral in 1748 but changed hands many times in the wars of the 19th century. It became a self-governing state in association with Great Britain in 1967 and achieved independence in 1979. Columbus named it for the day on which he discovered it, the feast of St. Lucy, a Sicilian virgin martyr. %28%From Webster%27%s New Geographical Dictionary, 1988, p1051 %26% Room, Brewer%27%s Dictionary of Names, 1992, p477%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent state, an archipelago in the western Persian Gulf, northwest of Qatar. It comprises low-lying islands of Bahrain %28%the largest%29%, Muharraq, Sitra, and several islets. It has extensive oil fields. The name comes from the Arabic al-bahrayn, %22%the two seas%22%, with reference to its lying in the middle of a bay with its %22%two seas%22% east and west of it. %28%From Webster%27%s New Geographical Dictionary, 1988, p107 %26% Room, Brewer%27%s Dictionary of Names, 1992, p45%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An independent sultanate on the northeast coast of Borneo. Its chief products are oil and natural gas. Its name is Hindi, coming from the Sanskrit bhumi, land or region. It gave its name Brunei to Borneo. %28%From Webster%27%s New Geographical Dictionary, 1988, p183 %26% Room, Brewer%27%s Dictionary of Names, 1992, p82%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An index which scores the degree of dental plaque accumulation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indication of the contribution of a food to the nutrient content of the diet. This value depends on the quantity of a food which is digested and absorbed and the amounts of the essential nutrients %28%protein, fat, carbohydrate, minerals, vitamins%29% which it contains. This value can be affected by soil and growing conditions, handling and storage, and processing.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indicator and reagent. It has been used for several purposes including the determination of serum albumin concentrations%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indicator and reagent. It has been used in serum albumin determinations and as a pH indicator.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight %28%kg%29%/height squared %28%m2%29%. BMI correlates with body fat %28%ADIPOSE TISSUE%29%. Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 %28%underweight%29%; 18.5-24.9 %28%normal%29%; 25.0-29.9 %28%overweight%29%; 30.0 and above %28%obese%29%. %28%National Center for Health Statistics, Centers for Disease Control and Prevention%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indirect sympathomimetic. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine may be a neurotransmitter in some invertebrate nervous systems.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An individual having different alleles at one or more loci regarding a specific character.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An individual in which both alleles at a given locus are identical.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An individual that contains cell populations derived from different zygotes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An individual%27%s objective and insightful awareness of the feelings and behavior of another person. It should be distinguished from sympathy, which is usually nonobjective and noncritical. It includes caring, which is the demonstration of an awareness of and a concern for the good of others. %28%From Bioethics Thesaurus, 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of CLOZAPINE. %28%From AMA Drug Evaluations Annual, 1994, p283%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indolesulfonic acid that is used as a dye in renal function testing and as a reagent for the detection of nitrates and chlorates and in the testing of milk.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An indolocarbazole that is a potent PROTEIN KINASE C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. %28%Biochem Biophys Res Commun 1995;214%28%3%29%:1114-20%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An induced response to threatening stimuli characterized by complete loss of muscle strength.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An induced response to threatening stimuli characterized by the cessation of body movements, except for those that are involved with BREATHING, and the maintenance of an immobile POSTURE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An induced state of non-reactivity to grafted tissue from a donor organism that would ordinarily trigger a cell-mediated or humoral immune response.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An industrial fungicide with low mammalian toxicity, although it does possess an irritant capacity for skin and mucous membranes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An industrial solvent which causes nervous system degeneration. MBK is an acronym often used to refer to it.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infant born at or after 42 weeks of gestation. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infant during the first month after birth. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infant having a birth weight lower than expected for its gestational age.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infant having a birth weight of 2500 gm. %28%5.5 lb.%29% or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams %28%3.3 lb.%29% or less.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infant whose weight at birth is less than 1500 grams %28%3.3 lbs%29%, regardless of gestational age.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infantile syndrome characterized by a cat-like cry, failure to thrive, microcephaly, MENTAL RETARDATION, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia. It is caused by a deletion of the short arm of chromosome 5 %28%5p-%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infarction in the vascular distribution of the anterior cerebral artery which supplies the majority of the medial surface of the cerebral hemispheres, and provides branches %28%including Heubner%27%s artery%29% to the anterior limb of the internal capsule, head of the CAUDATE NUCLEUS, and anterior GLOBUS PALLIDUS. Clinical manifestations may include contralateral lower extremity weakness and sensory loss. Bilateral anterior cerebral artery infarctions are associated with abulia, PARAPLEGIA, and URINARY INCONTINENCE. %28%From Adams et al., Principles of Neurology, 6th ed, pp789-93%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection caused by Erysipelothrix rhusiopathiae that is almost wholly restricted to persons who in their occupation handle infected fish, shellfish, poultry, or meat. Three forms of this condition exist: a mild localized form manifested by local swelling and redness of the skin; a diffuse form that might present with fever; and a rare systemic form associated with endocarditis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection caused by the infestation of the larval form of tapeworms of the genus Echinococcus. The liver, lungs, and kidney are the most common areas of infestation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection occurring in PUERPERIUM, the period of 6-8 weeks after giving birth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection of cattle caused by MYCOBACTERIUM BOVIS. It is transmissible to man and other animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection of cutaneous and subcutaneous tissue that consists of a cluster of boils. Commonly, the causative agent is STAPHYLOCOCCUS AUREUS. Carbuncles produce fever, leukocytosis, extreme pain, and prostration.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection of the SMALL INTESTINE caused by the flagellated protozoan GIARDIA LAMBLIA. It is spread via contaminated food and water and by direct person-to-person contact.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infectious bacterial disease characterized by cutaneous vascular lesions. It is caused by BARTONELLA HENSELAE and is seen in AIDS patients and other immunocompromised hosts.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips. It is caused by a poxvirus and may be transmitted to man.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infectious disease caused by MYCOBACTERIUM PARATUBERCULOSIS. Characteristics include chronic debilitation and weight loss.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini %28%see IXODES%29% and pacificus ticks in the United States and Ixodes ricinis %28%see IXODES%29% in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infectious disease clinically similar to epidemic louse-borne typhus %28%TYPHUS, EPIDEMIC LOUSE-BORNE%29%, but caused by RICKETTSIA TYPHI, which is transmitted from rat to man by the rat flea, Xenopsylla cheopis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inflammatory condition of the kidney most commonly resulting in a grossly enlarged and nonfunctioning kidney associated with stones and infection.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inflammatory process involving the brain %28%ENCEPHALITIS%29% and meninges %28%MENINGITIS%29%, most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inflammatory process of the mucous membranes of the paranasal sinuses that occurs in three stages: acute, subacute, and chronic. Sinusitis results from any condition causing ostial obstruction or from pathophysiologic changes in the mucociliary transport mechanism.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inflammatory reaction involving the folds of the skin surrounding the fingernail. It is characterized by acute or chronic purulent, tender, and painful swellings of the tissues around the nail, caused by an abscess of the nail fold. The pathogenic yeast causing paronychia is most frequently Candida albicans. Saprophytic fungi may also be involved. The causative bacteria are usually Staphylococcus, Pseudomonas aeruginosa, or Streptococcus. %28%Andrews%27% Diseases of the Skin, 8th ed, p271%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a %22%saw-tooth%22% pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble %28%GEGB%29%, approved by the FDA in 1985, and the Ballobes Balloon.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infraclass of MAMMALS, also called Metatheria, where the young are born at an early stage of development and continue to develop in a pouch %28%marsupium%29%. In contrast to Eutheria %28%placentals%29%, marsupials have an incomplete PLACENTA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infraorder %28%or suborder%29% of small PRIMATES comprised of a single family and genus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infraorder of CRUSTACEA, in the order DECAPODA comprising the hermit crabs and characterized by a small fifth pair of legs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infraorder of PRIMATES comprised of the families CERCOPITHECIDAE %28%old world monkeys%29%; HYLOBATIDAE %28%siamangs and GIBBONS%29%; and HOMINIDAE %28%great apes and HUMANS%29%. With the exception of humans, they all live exclusively in Africa and Asia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infraorder of chiefly marine, largely carnivorous CRUSTACEA, in the order DECAPODA, including the genera Cancer, Uca, and Callinectes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An infraorder of new world monkeys, comprised of the families ATELIDAE; CALLITRICHIDAE; and CEBIDAE. They are found exclusively in the Americas.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. %28%From AMA Drug Evaluations Annual, 1994, p180%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited abnormality of renal tubular transport of dibasic amino acids leading to massive urinary excretion of cystine, lysine, arginine, and ornithine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited autosomal dominant trait characterized by abnormally elevated levels of total serum THYROXINE; %28%T4%29% in euthyroid patients with abnormal SERUM ALBUMIN that binds T4 with enhanced affinity. The serum levels of free T4, free T3, and TSH are normal. It is one of several T4 abnormalities produced by non-thyroid disorder. This condition is due to mutations of the ALB gene on CHROMOSOME 4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the PANCREAS and PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY. It is due to focal hyperplasia of pancreatic ISLET CELLS budding off from the ductal structures and forming new islets of Langerhans. Mutations in the islet cells involve the potassium channel gene KCNJ11 or the ATP-binding cassette transporter gene ABCC8, both on CHROMOSOME 11.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited autosomal recessive trait, characterized by peripheral resistance to THYROID HORMONES and the resulting elevation in serum levels of THYROXINE and TRIIODOTHYRONINE. This syndrome is caused by mutations of gene THRB encoding the THYROID HORMONE RECEPTORS BETA in target cells. HYPOTHYROIDISM in these patients is partly overcome by the increased thyroid hormone levels.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited congenital myopathic condition characterized by weakness and hypotonia in infancy and delayed motor development. Muscle biopsy reveals a condensation of myofibrils and myofibrillar material in the central portion of each muscle fiber. %28%Adams et al., Principles of Neurology, 6th ed, p1452%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited defect interfering with normal nuclear lobulation of neutrophils and eosinophils. The nuclei appear rodlike, spherical, or dumbbell-shaped and their structure is coarse and lumpy. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited degenerative disease characterized by neuronal cytoplasmic inclusions which stain positively for ceroid and lipofuscin. Affected individuals develop retinal degeneration, seizures, myoclonus, ataxia, rigidity, and progressive dementia. Clinically there are four subtypes, divided by age of onset of symptoms: infantile %28%Santavuori-Haltia type%29%, late infantile %28%Jansky-Bielschowsky type%29%, juvenile %28%Spielmeyer-Vogt type%29%, and adult %28%Kuf%27%s disease%29%. The late infantile and juvenile forms may both also be referred to as Batten Disease and Batten-Mayou Disease. %28%Adams et al., Principles of Neurology, 6th ed, p957%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited disorder of copper metabolism transmitted as an X-linked trait and characterized by the infantile onset of HYPOTHERMIA, feeding difficulties, hypotonia, SEIZURES, bony deformities, pili torti %28%twisted hair%29%, and severely impaired intellectual development. Defective copper transport across plasma and endoplasmic reticulum membranes results in copper being unavailable for the synthesis of several copper containing enzymes, including PROTEIN-LYSINE 6-OXIDASE; CERULOPLASMIN; and SUPEROXIDE DISMUTASE. Pathologic changes include defects in arterial elastin, neuronal loss, and gliosis. %28%From Menkes, Textbook of Child Neurology, 5th ed, p125%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis. %28%Menkes, Textbook of Child Neurology, 5th ed, pp127%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited metabolic disorder caused by deficient enzyme activity in the PYRUVATE DEHYDROGENASE COMPLEX, resulting in deficiency of acetyl CoA and reduced synthesis of acetylcholine. Two clinical forms are recognized: neonatal and juvenile. The neonatal form is a relatively common cause of lactic acidosis in the first weeks of life and may also feature an erythematous rash. The juvenile form presents with lactic acidosis, alopecia, intermittent ATAXIA; SEIZURES; and an erythematous rash. %28%From J Inherit Metab Dis 1996;19%28%4%29%:452-62%29% Autosomal recessive and X-linked forms are caused by mutations in the genes for the three different enzyme components of this multisubunit pyruvate dehydrogenase complex. One of the mutations at Xp22.2-p22.1 in the gene for the E1 alpha component of the complex leads to LEIGH DISEASE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. %28%From Menkes, Textbook of Child Neurology, 5th ed, p199%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as a sex-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. %28%Menkes, Textbook of Child Neurology, 5th ed, pp49-50%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of SERINE ENDOPEPTIDASES. Acts as an alkylating agent and is known to interfere with the translation process.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. %28%From Martindale The Extra Pharmacopoeia, 31st ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of anion conductance including band 3-mediated anion transport.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of apoptosis protein that is translated by a rare cap-independent mechanism. It blocks caspase-mediated cellular destruction by inhibiting CASPASE 3; CASPASE 7; and CASPASE 9.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of apoptosis protein that was initially identified during analysis of CHROMOSOME DELETIONS associated with SPINAL MUSCULAR ATROPHY. Naip contains a nucleotide binding oligomerization domain and a carboxy-terminal LEUCINE rich repeat.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of folate metabolism. It is used as a coccidiostat in poultry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of glutamate decarboxylase and an antagonist of GAMMA-AMINOBUTYRIC ACID. It is used to induce convulsions in experimental animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. %28%Neurochem Res 1995:200%28%4%29%:451-6%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of nucleotide metabolism. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of ornithine decarboxylase, the rate limiting enzyme of the polyamine biosynthetic pathway.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. %28%Martindale, The Extra Pharmacopoeia, 30th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitor of the last step of noradrenaline biosynthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitory Smad protein that negatively regulates the SIGNAL TRANSDUCTION PATHWAYS from BONE MORPHOGENETIC PROTEIN RECEPTORS. Smad6 inhibits PHOSPHORYLATION of SMAD2 PROTEIN and SMAD3 PROTEIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inhibitory smad protein that associates with TRANSFORMING GROWTH FACTOR BETA RECEPTORS and BONE MORPHOGENETIC PROTEIN RECEPTORS. It negatively regulates SIGNAL TRANSDUCTION PATHWAYS by inhibiting PHOSPHORYLATION of RECEPTOR-REGULATED SMAD PROTEINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inner coating, as of varnish or other protective substance, to cover the dental cavity wall. It is usually a resinous film-forming agent dissolved in a volatile solvent, or a suspension of calcium hydroxide in a solution of a synthetic resin. The lining seals the dentinal tubules and protects the pulp before a restoration is inserted. %28%Jablonski, Illustrated Dictionary of Dentistry, 1982%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inorganic dye used in microscopy for differential staining and as a diagnostic reagent. In research this compound is used to study changes in cytoplasmic concentrations of calcium. Ruthenium red inhibits calcium transport through membrane channels.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases, notably HYPOPHOSPHATASIA and pseudogout %28%CHONDROCALCINOSIS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An inosine nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insect chemosterilant and an antineoplastic agent. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insecticide and herbicide that has also been used as a wood preservative. Pentachlorphenol is a widespread environmental pollutant. Both chronic and acute pentachlorophenol poisoning are medical concerns. The range of its biological actions is still being actively explored, but it is clearly a potent enzyme inhibitor and has been used as such as an experimental tool.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insecticide synergist, especially for pyrethroids and ROTENONE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insecticide. Methoxychlor has estrogenic effects in mammals, among other effects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An insoluble support for an ANTIGEN or ANTIBODIES that is used in AFFINITY CHROMATOGRAPHY to adsorb the homologous antibody or antigen from a mixture. Many different substances are used, among them SEPHAROSE; GLUTARALDEHYDE; copolymers of ANHYDRIDES; polyacrylamides, etc.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An institute of the CENTERS FOR DISEASE CONTROL AND PREVENTION which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An institutional policy of granting authority to health personnel to perform procedures on patients or to remove organs from cadavers for transplantation unless an objection is registered by family members or by the patient prior to death. This also includes emergency care of minors without prior parental consent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An instrument for reproducing sounds especially articulate speech at a distance. %28%Webster, 3rd ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integration host factor that was originally identified as a bacterial protein required for the integration of bacteriophage Q beta %28%ALLOLEVIVIRUS%29%. Its cellular function may be to regulate mRNA stability and processing in that it binds tightly to poly%28%A%29% RNA and interferes with ribosome binding.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin alpha subunit of approximately 150-kDa molecular weight. It is expressed at high levels on monocytes and combines with CD18 ANTIGEN to form the cell surface receptor INTEGRIN ALPHAXBETA2. The subunit contains a conserved I domain which is characteristic of several of alpha integrins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin alpha subunit that binds COLLAGEN and LAMININ though its I domain. It combines with INTEGRIN BETA1 to form the heterodimer INTEGRIN ALPHA1BETA1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin alpha subunit that is unique in that it does not contain an I domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane as in other integrin alpha subunits.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin alpha subunit that occurs as alternatively spliced isoforms. The isoforms are differentially expressed in specific cell types and at specific developmental stages. Integrin alpha3 combines with INTEGRIN BETA1 to form INTEGRIN ALPHA3BETA1 which is a heterodimer found primarily in epithelial cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin alpha subunit that primarily associates with INTEGRIN BETA1 or INTEGRIN BETA4 to form laminin-binding heterodimers. Integrin alpha6 has two alternatively spliced isoforms: integrin alpha6A and integrin alpha6B, which differ in their cytoplasmic domains and are regulated in a tissue-specific and developmental stage-specific manner.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin alpha subunit that primarily combines with INTEGRIN BETA1 to form the INTEGRIN ALPHA2BETA1 heterodimer. It contains a domain which has homology to collagen-binding domains found in von Willebrand factor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin beta subunit of approximately 85-kDa in size which has been found in INTEGRIN ALPHAIIB-containing and INTEGRIN ALPHAV-containing heterodimers. Integrin beta3 occurs as three alternatively spliced isoforms, designated beta3A-C.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin found in FIBROBLASTS; PLATELETS; MONOCYTES, and LYMPHOCYTES. Integrin alpha5beta1 is the classical receptor for FIBRONECTIN, but it also functions as a receptor for LAMININ and several other EXTRACELLULAR MATRIX PROTEINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin found on fibroblasts, platelets, endothelial and epithelial cells, and lymphocytes where it functions as a receptor for COLLAGEN and LAMININ. Although originally referred to as the collagen receptor, it is one of several receptors for collagen. Ligand binding to integrin alpha2beta1 triggers a cascade of intracellular signaling, including activation of p38 MAP kinase.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin heterodimer widely expressed on cells of hematopoietic origin. CD11A ANTIGEN comprises the alpha chain and the CD18 antigen %28%ANTIGENS, CD18%29% the beta chain. Lymphocyte function-associated antigen-1 is a major receptor of T-CELLS; B-CELLS; and GRANULOCYTES. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by NATURAL KILLER CELLS and granulocytes. Intracellular adhesion molecule-1 has been defined as a ligand for lymphocyte function-associated antigen-1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An integrin that binds to a variety of plasma and extracellular matrix proteins containing the conserved RGD amino acid sequence and modulates cell adhesion. Integrin alphavbeta3 is highly expressed in OSTEOCLASTS where it may play role in BONE RESORPTION. It is also abundant in vascular smooth muscle and endothelial cells, and in some tumor cells, where it is involved in angiogenesis and cell migration. Although often referred to as the vitronectin receptor there is more than one receptor for vitronectin %28%RECEPTORS, VITRONECTIN%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interactive process whereby members of a community are concerned for the equality and rights of all.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interdisciplinary field in materials science, ENGINEERING, and BIOLOGY, studying the use of biological principles for synthesis or fabrication of BIOMIMETIC MATERIALS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interdisciplinary study dealing with the transmission of messages or signals, or the communication of information. Information theory does not directly deal with meaning or content, but with physical representations that have meaning or content. It overlaps considerably with communication theory and CYBERNETICS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interferon regulatory factor that binds upstream TRANSCRIPTIONAL REGULATORY ELEMENTS in the GENES for INTERFERON-ALPHA and INTERFERON-BETA. It functions as a transcriptional activator for the INTERFERON TYPE I genes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interferon regulatory factor that is expressed constitutively and undergoes POST-TRANSLATIONAL MODIFICATION following viral infection. PHOSPHORYLATION of IRF-3 causes the protein to be translocated from the CYTOPLASM to CELL NUCLEUS where it binds DNA, and activates transcription.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interferon regulatory factor that is induced by INTERFERONS as well as LMP-1 protein from EPSTEIN-BARR VIRUS. IRF-7 undergoes PHOSPHORYLATION prior to nuclear translocation and it activates GENETIC TRANSCRIPTION of multiple interferon GENES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interferon regulatory factor that recruits STAT1 PROTEIN and STAT2 PROTEIN heterodimers to interferon-stimulated response elements and functions as an immediate-early protein.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interferon regulatory factor that represses transcription of TYPE I INTERFERONS and activates transcription of HISTONE H4.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group %28%17-HYDROXYSTEROID DEHYDROGENASES%29%, is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group %28%3-HYDROXYSTEROID DEHYDROGENASES%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate in the pathway of coenzyme A formation in mammalian liver and some microorganisms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate in the synthesis of cholesterol. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate stage between polytheism and monotheism, which assumes a %22%Great Spirit%22%, with lesser deities subordinated. With the beginnings of shamanism there was the advent of the medicine man or witch doctor, who assumed a supervisory relation to disease and its cure. Formally, shamanism is a religion of Ural-Altaic peoples of Northern Asia and Europe, characterized by the belief that the unseen world of gods, demons, ancestral spirits is responsive only to shamans. The Indians of North and South America entertain religious practices similar to the Ural-Altaic shamanism. The word shaman comes from the Tungusic %28%Manchuria and Siberia%29% saman, meaning Buddhist monk. The shaman handles disease almost entirely by psychotherapeutic means; he frightens away the demons of disease by assuming a terrifying mien. %28%From Garrison, An Introduction to the History of Medicine, 4th ed, p22; from Webster, 3d ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermediate-grade malignant lymphoma in which the neoplastic cells %28%B-lymphocytes%29% exhibit variability in size, configuration, and degree of differentiation. The cells are irregular in shape and have distinct nuclei.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intermittent fever characterized by intervals of chills, fever, and splenomegaly each of which may last as long as 40 hours. It is caused by BARTONELLA QUINTANA and transmitted by the human louse.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An international agency providing various humanitarian services.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An international agreement of the World Medical Association which offers guidelines for conducting experiments using human subjects. It was adopted in 1962 and revised by the 18th World Medical Assembly at Helsinki, Finland in 1964. Subsequent revisions were made in 1975, 1983, 1989, and 1996. %28%From Encyclopedia of Bioethics, rev ed, 1995%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An international organization whose members include most of the sovereign nations of the world with headquarters in New York City. The primary objectives of the organization are to maintain peace and security and to achieve international cooperation in solving international economic, social, cultural, or humanitarian problems.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An international professional organization composed of one association per country for the purpose of improving and developing nursing%27%s contribution to the promotion of health and care of the sick.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An interval of care by a health care facility or provider for a specific medical problem or condition. It may be continuous or it may consist of a series of intervals marked by one or more brief separations from care, and can also identify the sequence of care %28%e.g., emergency, inpatient, outpatient%29%, thus serving as one measure of health care provided.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intervertebral disk in which the nucleus pulposus has protruded through surrounding fibrocartilage. This occurs most frequently in the lower lumbar region.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intra-extracellular electrolyte exchange agent with a variety of effects.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intracellular proteinase found in a variety of tissue. It has specificity similar to but narrower than that of pepsin A. The enzyme is involved in catabolism of cartilage and connective tissue. EC 3.4.23.5. %28%Formerly EC 3.4.4.23%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intracellular signaling system involving the MAP kinase cascades %28%three-membered protein kinase cascades%29%. Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; %28%MAPKKKs%29%. Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; %28%MAPKs%29%. The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK %28%extracellular signal-regulated kinase%29% pathway, the SAPK/JNK %28%stress-activated protein kinase/c-jun kinase%29% pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intracranial or rarely intraspinal suppurative process invading the space between the inner surface of the DURA MATER and the outer surface of the ARACHNOID. Bacteria and other pathogenic organisms may gain entrance to the subdural space from the FRONTAL SINUS; ETHMOID SINUS; middle ear %28%EAR, MIDDLE%29%; MASTOID; or as the result of CRANIOCEREBRAL TRAUMA or NEUROSURGICAL PROCEDURES. This condition may be associated with intracranial sinus thrombosis %28%SINUS THROMBOSIS, INTRACRANIAL%29%. Circumscribed collections of purulent material in the subdural space are referred to as subdural abscesses. %28%From Adams et al., Principles of Neurology, 6th ed, p709%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intraductal carcinoma of the breast extending to involve the nipple and areola, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells %28%Paget%27%s cells%29%. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intrauterine mass containing decidual cells %28%DECIDUA%29% or with structures resembling the PLACENTA. Deciduomas usually are induced experimentally.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. %28%From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p918%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An invariably benign, encapsulated, firm round mass at the bifurcation of the common carotid artery, with nests of large polyhedral cells in alveolar or organoid arrangement. It is usually asymptomatic but large masses may encroach upon the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies. %28%Dorland, 27th ed; DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, pp570-71%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An invasive %28%infiltrating%29% CARCINOMA of the mammary ductal system %28%MAMMARY GLANDS%29% in the human BREAST.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An involuntary contraction of a muscle or group of muscles. Spasms may involve skeletal muscle %28%MUSCLE, SKELETAL%29% or smooth muscle %28%MUSCLE, SMOOTH%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An involuntary deep INHALATION with the MOUTH open, often accompanied by the act of stretching.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An involuntary expression of merriment and pleasure; it includes the patterned motor responses as well as the inarticulate vocalization.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An involuntary movement accompanying a volitional movement. It often refers to facial movements that accompany FACIAL PARALYSIS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iodinated radiographic contrast medium used as acetrizoate sodium in HYSTEROSALPINGOGRAPHY.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iodine-containing compound used in pyelography as a radiopaque medium. If labeled with radioiodine, it can be used for studies of renal function.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ionic monomeric contrast medium that was formerly used for a variety of diagnostic procedures. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ionic monomeric contrast medium. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p706%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron chelating agent with properties like EDETATES. DTPA has also been used as a chelator for other metals, such as plutonium.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron-binding cyclic trimer of 2,3-dihydroxy-N-benzoyl-L-serine. It is produced by E COLI and other enteric bacteria.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron-binding protein in plasma and secretions %28%milk, mucus, bile%29%, secreted by leukocytes. It is an important component of GRANULOCYTES. It is bacteriostatic, working by depriving bacteria of iron essential for growth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron-containing protein complex that is formed by a combination of ferric iron with the protein APOFERRITIN.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. EC 1.1.3.22.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron-sulfur and MOLYBDENUM containing FLAVOPROTEIN that catalyzes the oxidation of nitrite to nitrate. This enzyme can use either NAD or NADP as cofactors. It is a key enzyme that is involved in the first step of nitrate assimilation in PLANTS; FUNGI; and BACTERIA. This enzyme was formerly classified as EC 1.6.6.2.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin, and cytochrome P-450.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An irrational reaction compounded of grief, loss of self-esteem, enmity against the rival and self criticism.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An irregularly shaped cavity in the rhombencephalon, between the medulla oblongata, the pons, and the isthmus in front, and the cerebellum behind. It is continuous with the central canal of the cord below and with the CEREBRAL AQUEDUCT above, and through its lateral and median apertures it communicates with the subarachnoid space.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An irregularly shaped venous space in the dura mater at either side of the sphenoid bone.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An irregularly shaped, musculocartilaginous tubular structure, lined with mucous membrane, located at the top of the trachea and below the root of the tongue and the hyoid bone. It is the essential sphincter guarding the entrance into the trachea and functioning secondarily as the organ of voice.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An irreversible cholinesterase inhibitor with actions similar to those of echothiophate. It is a powerful miotic used mainly in the treatment of glaucoma. Its vapor is highly toxic and it is recommended that only solutions in arachis oil be used therapeutically. %28%From Martindale, The Extra Pharmacopoeia, 29th ed, p1330%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island group and constitutional monarchy in the southwest central Pacific Ocean. The capital is Apia. The islands were jointly administered by England, the United States, and Germany 1889-99, with the chief islands of Savai%27%i and Upolu recognized as German until 1919. Western Samoa gained independence in 1962 and assumed its present formal name in 1997.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in Micronesia, east of the Philippines, the largest and southernmost of the Marianas. Its capital is Agana. It was discovered by Magellan in 1521 and occupied by Spain in 1565. They ceded it to the United States in 1898. It is an unincorporated territory of the United States, administered by the Department of the Interior since 1950. The derivation of the name Guam is in dispute. %28%From Webster%27%s New Geographical Dictionary, 1988, p471%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in Polynesia, in the south Pacific Ocean. It was discovered in 1767 by Philip Carteret, uninhabited until 1790 when settled by mutineers from the English ship, Bounty. The settlement was discovered in 1808; the population was removed temporarily to Tahiti in 1831 and to Norfolk Island %28%between New Caledonia and New Zealand%29% in 1856. Some later returned to Pitcairn and their descendents constitute the present population of this British colony. The island is named for the midshipman who first sighted it from the ship. %28%From Webster%27%s New Geographical Dictionary, 1988, p958 %26% Room, Brewer%27%s Dictionary of Names, 1992, p422%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Atlantic Ocean, off the east coast of Canada, constituting with Labrador on the mainland, a province of Canada. The name describing a land just discovered was recorded by John Cabot in 1497. %28%From Webster%27%s New Geographical Dictionary, 1988, p831 %26% Room, Brewer%27%s Dictionary of Names, 1992, p376%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Greater Antilles in the West Indies, south of Florida. With the adjacent islands it forms the Republic of Cuba. Its capital is Havana. It was discovered by Columbus on his first voyage in 1492 and conquered by Spain in 1511. It has a varied history under Spain, Great Britain, and the United States but has been independent since 1902. The name Cuba is said to be an Indian name of unknown origin but the language that gave the name is extinct, so the etymology is a conjecture. %28%From Webster%27%s New Geographical Dictionary, 1988, p302 %26% Room, Brewer%27%s Dictionary of Names, 1992, p132%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Greater Antilles in the West Indies. Its capital is Kingston. It was discovered in 1494 by Columbus and was a Spanish colony 1509-1655 until captured by the English. Its flourishing slave trade was abolished in the 19th century. It was a British colony 1655-1958 and a territory of the West Indies Federation 1958-62. It achieved full independence in 1962. The name is from the Arawak Xaymaca, rich in springs or land of springs. %28%From Webster%27%s New Geographical Dictionary, 1988, p564 %26% Room, Brewer%27%s Dictionary of Names, 1992, p267%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Greater Antilles in the West Indies. Its capital is San Juan. It is a self-governing commonwealth in union with the United States. It was discovered by Columbus in 1493 but no colonization was attempted until 1508. It belonged to Spain until ceded to the United States in 1898. It became a commonwealth with autonomy in internal affairs in 1952. Columbus named the island San Juan for St. John%27%s Day, the Monday he arrived, and the bay Puerto Rico, rich harbor. The island became Puerto Rico officially in 1932. %28%From Webster%27%s New Geographical Dictionary, 1988, p987 %26% Room, Brewer%27%s Dictionary of Names, 1992, p436%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Gulf of St. Lawrence constituting a province of Canada in the eastern part of the country. It is very irregular in shape with many deep inlets. Its capital is Charlottetown. Discovered by the French in 1534 and originally named Ile Saint-Jean, it was renamed in 1799 in honor of Prince Edward, fourth son of George III and future father of Queen Victoria. %28%From Webster%27%s New Geographical Dictionary, 1988, p981 %26% Room, Brewer%27%s Dictionary of Names, 1992, p433%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Lesser Antilles in the West Indies. It is chiefly of coral formation with no good harbors and only small streams. It was probably discovered by the Portuguese in the sixteenth century. The name was given by 16th-century Spanish explorers from barbados, the plural for %22%bearded%22%, with reference to the beard-like leaves or trails of moss on the trees that grew there in abundance. %28%From Webster%27%s New Geographical Dictionary, 1988, p116 %26% Room, Brewer%27%s Dictionary of Names, 1992, p49%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Lesser Antilles, one of the Leeward Islands. With Barbuda and Redonda, an uninhabited island, it constitutes the independent state of Antigua and Barbuda. Its capital is St. Johns. It was discovered by Columbus in 1493, settled by the English in 1632, occupied by the French in 1666, returned to the British in 1667, became self-governing in 1967 and independent in 1981. It was named by Columbus after the church of Santa Maria la Antigua %28%St. Mary the Ancient%29% in Seville. %28%From Webster%27%s New Geographical Dictionary, 1988, p56; Antigua and Barbuda Embassy %28%telephone 202-362-5122%29%; Room, Brewer%27%s Dictionary of Names, 1992, p24%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Lesser Antilles, one of the Windward Islands. Its capital is Fort-de-France. It was discovered by Columbus in 1502 and from its settlement in 1635 by the French it passed into and out of Dutch and British hands. It was made a French overseas department in 1946. One account of the name tells of native women on the shore calling %22%Madinina%22% as Columbus approached the island. The meaning was never discovered but was entered on early charts as Martinique, influenced by the name of St. Martin. %28%From Webster%27%s New Geographical Dictionary, 1988, p734 %26% Room, Brewer%27%s Dictionary of Names, 1992, p339%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island in the Malay Archipelago, east of Sumatra, north of Java, and west of Celebes. It is the third largest island in the world. Its name is a Portuguese alteration of BRUNEI, located on it. %28%From Webster%27%s New Geographical Dictionary, 1988, p163; Room, Brewer%27%s Dictionary of Names, 1992, p73%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island of the West Indies. Its capital is St. George%27%s. It was discovered in 1498 by Columbus who called it Concepcion. It was held at different times by the French and the British during the 18th century. The British suppressed a native uprising in 1795. It was an associate state of Great Britain 1967-74 but became an independent nation within the British Commonwealth in 1974. The original name referred to the Feast of the Immaculate Conception but it was later renamed for the Spanish kingdom of Granada. %28%From Webster%27%s New Geographical Dictionary, 1988, p467 %26% Room, Brewer%27%s Dictionary of Names, 1992, p219%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island republic in the eastern Mediterranean Sea. Its capital is Nicosia. It was colonized by the Phoenicians and ancient Greeks and ruled successively by the Assyrian, Persian, Ptolemaic, Roman, and Byzantine Empires. It was under various countries from the 12th to the 20th century but became independent in 1960. The name comes from the Greek Kupros, probably representing the Sumerian kabar or gabar, copper, famous in historic times for its copper mines. The cypress tree is also named after the island. %28%From Webster%27%s New Geographical Dictionary, 1988, p308 %26% Room, Brewer%27%s Dictionary of Names, 1992, p134%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island republic of the West Indies. Its capital is Roseau. It was discovered in 1493 by Columbus and held at different times by the French and the British in the 18th century. A member of the West Indies Federation, it achieved internal self-government in 1967 but became independent in 1978. It was named by Columbus who discovered it on Sunday, Domingo in Spanish, from the Latin Dominica dies, the Lord%27%s Day. %28%From Webster%27%s New Geographical Dictionary, 1988, p338 %26% Room, Brewer%27%s Dictionary of Names, 1992, p151%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An island south of Australia and the smallest state of the Commonwealth. Its capital is Hobart. It was discovered and named Van Diemen%27%s Island in 1642 by Abel Tasman, a Dutch navigator, in honor of the Dutch governor-general of the Dutch East Indian colonies. It was renamed for the discoverer in 1853. In 1803 it was taken over by Great Britain and was used as a penal colony. It was granted government in 1856 and federated as a state in 1901. %28%From Webster%27%s New Geographical Dictionary, 1988, p1190 %26% Room, Brewer%27%s Dictionary of Names, p535%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in brain tissue.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in liver tissue. Mutation of the gene coding this enzyme on chromosome 14 is the cause of GLYCOGEN STORAGE DISEASE TYPE VI.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoenzyme of GLYCOGEN PHOSPHORYLASE that catalyzes the degradation of GLYCOGEN in muscle. Mutation of the gene coding this enzyme is the cause of McArdle disease %28%GLYCOGEN STORAGE DISEASE TYPE V%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoenzyme of creatine kinase found in the CARDIAC MUSCLE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoenzyme of creatine kinase found in the MUSCLE. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II %28%DNA TOPOISOMERASES, TYPE II%29%; activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoform of DNA that occurs in an environment rich in SODIUM and POTASSIUM ions. It is a right-handed helix with 11 base pairs per turn, a pitch of 0.256 nm per base pair and a helical diameter of 2.3 nm.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoform of DNA that occurs under experimental conditions. It is a right-handed helix that is less compact than the B-form of DNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1379%29% Inositol phospholipids are important in signal transduction.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isomerase that catalyzes the conversion of chorismic acid to prephenic acid. EC 5.4.99.5.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p266%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An isothermal in-vitro nucleotide amplification process. The process involves the concomitant action of a RNA-DIRECTED DNA POLYMERASE, a ribonuclease %28%RIBONUCLEASES%29%, and DNA-DIRECTED RNA POLYMERASES to synthesize large quantities of sequence-specific RNA and DNA molecules.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An itching, autoimmune, bullous SKIN disease that occurs during the last two trimesters of PREGNANCY and PUERPERIUM. It also affects non-pregnant females with tissue of PLACENTA origin, such as CHORIOCARCINOMA; or HYDATIDIFORM MOLE. It exhibits antigenic and clinical similarity to bullous pemphigoid %28%PEMPHIGOID, BULLOUS%29%. This disease does not involve herpes viruses %28%old name, herpes gestationis%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An iterative questionnaire designed to measure consensus among individual responses. In the classic Delphi approach, there is no interaction between responder and interviewer.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oath, attributed to Hippocrates, that serves as an ethical guide for the medical profession.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An objective determination of the refractive state of the eye %28%NEARSIGHTEDNESS; FARSIGHTEDNESS; ASTIGMATISM%29%. By using a RETINOSCOPE, the amount of correction and the power of lens needed can be determined.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An obsolete concept, historically used for childhood mental disorders thought to be a form of schizophrenia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An occlusion resulting in overstrain and injury to teeth, periodontal tissue, or other oral structures.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An occupational discipline founded by D.D. Palmer in the 1890%27%s based on the relationship of the spine to health and disease. The spine is analyzed by X-rays and palpation, and vertebrae are adjusted manually to relieve pressures on the spinal cord. OSTEOPATHIC MEDICINE was originally similar but has become more like FAMILY PRACTICE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An octamer transcription factor expressed primarily in B-LYMPHOCYTES and the developing CENTRAL NERVOUS SYSTEM that regulates GENETIC TRANSCRIPTION of IMMUNOGLOBULIN GENES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An octamer transcription factor that is expressed primarily in totipotent embryonic STEM CELLS and GERM CELLS and is down-regulated during CELL DIFFERENTIATION.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An octamer transcription factor that plays an important role in the MYELIN SHEATH development by SCHWANN CELLS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An octameric enzyme belonging to the superfamily of amino acid dehydrogenases. Leucine dehydrogenase catalyzes the reversible oxidative deamination of L-LEUCINE, to 4-methyl-2-oxopentanoate %28%2-ketoisocaproate%29% and AMMONIA, with the corresponding reduction of the cofactor NAD+.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An octapeptide analog of angiotensin II %28%bovine%29% with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An octapeptide hormone present in the intestine and brain. When secreted from the gastric mucosa, it stimulates the release of bile from the gallbladder and digestive enzymes from the pancreas.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. %28%Dictionary of Visual Science, 4th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oculomandibulofacial syndrome principally characterized by dyscephaly %28%usually brachycephaly%29%, parrot nose, mandibular hypoplasia, proportionate nanism, hypotrichosis, bilateral congenital cataracts, and microphthalmia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An odontogenic fibroma in which cells have developed into cementoblasts and which consists largely of cementum.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An offensive, foul breath odor resulting from a variety of causes such as poor oral hygiene, dental or oral infections, or the ingestion of certain foods.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An office established to help Congress participate and plan for the consequences of uses of technology. It provided information on both the beneficial and adverse effects of technological applications. The Office of Technology Assessment closed on September 29, 1995.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An office in the Department of Labor responsible for developing and establishing occupational safety and health standards.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An office of the UNITED STATES PUBLIC HEALTH SERVICE organized in June 1992 to promote research integrity and investigate misconduct in research supported by the Public Health Service. It consolidates the Office of Scientific Integrity of the National Institutes of Health and the Office of Scientific Integrity Review in the Office of the Assistant Secretary for Health.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oil from flower buds of SYZYGIUM trees which contains large amounts of EUGENOL.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oil-resistant synthetic rubber made by the polymerization of chloroprene.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oily liquid extracted from the seeds of the safflower, Carthamus tinctorius. It is used as a dietary supplement in the management of HYPERCHOLESTEROLEMIA. It is used also in cooking, as a salad oil, and as a vehicle for medicines, paints, varnishes, etc. %28%Dorland, 28th ed %26% Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An old term that is no longer used in the scientific literature. Cholera morbus refers to acute GASTROENTERITIS occurring in summer or autumn; characterized by severe cramps, diarrhea, and vomiting.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oleanolic acid from GLYCYRRHIZA that has some antiallergic, antibacterial, and antiviral properties. It is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oligomer formed from the repetitive linking of the C-terminal glycine of one UBIQUITIN molecule via an isopeptide bond to a lysine residue on a second ubiquitin molecule. It is structurally distinct from UBIQUITIN C, which is a single protein containing a tandemly arrayed ubiquitin peptide sequence.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oligopeptide isolated from the skin of Physalaemus fuscumaculatus, a South American frog. It is a typical kinin, resembling SUBSTANCE P in structure and action and has been proposed as a sialagogue, antihypertensive, and vasodilator.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oligopeptide produced by various bacteria which acts as a protease inhibitor.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oligosaccharide antibiotic produced by various STREPTOMYCES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oncogene protein that was originally isolated from a spontaneous musculo-aponeurotic FIBROSARCOMA in CHICKEN and shown to be the transforming gene of the avian retrovirus AS42. It is a basic leucine zipper TRANSCRIPTION FACTOR and the founding member of the MAF TRANSCRIPTION FACTORS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oncoprotein from the Cas NS-1 murine retrovirus that induces pre- B-CELL LYMPHOMA and MYELOID LEUKEMIAS. v-cbl protein is a tyrosine-phosphorylated, truncated form of its cellular homologue, PROTO-ONCOGENE PROTEIN C-CBL.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opaque, milky-white fluid consisting mainly of emulsified fats that passes through the lacteals of the small intestines into the lymphatic system.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opening in the tympanic membrane usually caused by trauma. There are four general categories: compression injuries %28%the most common and usually the result of a blow to the ear%29%; instrumentation injuries %28%the second most common, usually inadvertent, caused often by cotton swabs or bobby-pins%29%; burn-slag injuries %28%frequently seen in industry, from hot metal from machines or welding%29%; and blast injuries %28%usually seen during war or as a result of terrorist bombing%29%. In the absence of infection, most traumatic tympanic membrane perforations heal spontaneously. Persistent perforation is usually a manifestation of tubotympanitis, an inflammation of the eustachian tube and tympanic cavity %28%middle ear%29%. %28%From Paparella, Shumrick, Gluckman, and Meyerhoff: Otolaryngology, vol. II, 3d ed, pp1363-65%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opening through the NUCLEAR ENVELOPE formed by the nuclear pore complex which transports nuclear proteins or RNA into or out of the CELL NUCLEUS and which, under some conditions, acts as an ion channel.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An operation in which carious material is removed from teeth and biomechanically correct forms are established in the teeth to receive and retain restorations. A constant requirement is provision for prevention of failure of the restoration through recurrence of decay or inadequate resistance to applied stresses. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p239-40%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An operation that uses stimulated latissimus dorsi muscle %28%SKELETAL MUSCLE VENTRICLE%29% to assist cardiac function. The latissimus dorsi muscle is mobilized from the chest wall and moved into the thorax through the bed of the resected 2nd or 3rd rib. The muscle is then wrapped around the left and right ventricles and stimulated to contract during cardiac systole by means of an implanted burst-stimulator. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An operation to remobilize the footplate of the stapes to relieve conductive hearing impairment caused by its immobilization through otosclerosis or middle ear disease. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1067%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic structurally related to METHADONE and used in the treatment of severe pain. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1070%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic used similarly to MORPHINE in the control of moderate to severe pain. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1097%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic with actions and uses similar to MORPHINE. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1095%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid analgesic with actions and uses similar to those of MORPHINE, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p1092%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. %28%From Martindale, The Extra Pharmacopoeia, 30th ed, p683%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya %28%seaweed%29% species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity %28%e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES%29%. The causative organism is JC Polyomavirus %28%JC VIRUS%29% which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp36-7%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An optical disk storage system for computers on which data can be read or from which data can be retrieved but not entered or modified. A CD-ROM unit is almost identical to the compact disk playback device for home use.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An optical disk storage system used on specialized players that combine the functions of computer and CD player in a self-contained box, designed to be connected to a television set and a home stereo for video and sound output. The player is controlled with a hand-held remote unit resembling a television remote control. %28%J Allied Health 1993 Winter;22%28%1%29%:131-8%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An optical isomer of quinine, extracted from the bark of the Cinchona tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular action potential, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral hypolipemic agent in dogs and rats. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An orally active synthetic progestational hormone used often in combinations as an oral contraceptive.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order comprising four families of eukaryotic viruses possessing linear, non-segmented, negative-strand RNA genomes. The families are BORNAVIRIDAE; FILOVIRIDAE; PARAMYXOVIRIDAE; and RHABDOVIRIDAE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order comprising three families of tailed bacteriophages: MYOVIRIDAE; PODOVIRIDAE; and SIPHOVIRIDAE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order comprising two families of eukaryotic viruses possessing linear, nonsegmented, positive sense RNA genomes. The families are CORONAVIRIDAE; ARTERIVIRIDAE; and RONIVIRIDAE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of BIRDS comprised of PIGEONS; DOVES; and an extinct family that includes dodos.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of BIRDS comprised of several families and more than 300 species. It includes COCKATOOS; PARROTS; PARAKEETS; macaws; and BUDGERIGARS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of BIRDS comprising the waterfowl, particularly DUCKS; GEESE; swans; and screamers.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of BIRDS including over 300 species that primarily inhabit coastal waters, beaches, and marshes. They are comprised of shorebirds, gulls, and terns.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of BIRDS with the common name owls characterized by strongly hooked beaks, sharp talons, large heads, forward facing eyes, and facial disks. While considered nocturnal RAPTORS, some owls do hunt by day.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of CRENARCHAEOTA comprised of irregular coccoid to disc-shaped, hyperthermophiles, and found in submarine hydrothermal systems and solfataric hot springs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of CRENARCHAEOTA comprised of rod, disc, or spherical shaped, nonseptate, anaerobic, extreme thermophiles and found in solfataric hot waters, mud holes, and superheated submarine environments.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of CRENARCHAEOTA consisting of aerobic or facultatively aerobic, chemolithotrophic cocci which are extreme thermoacidophiles. They lack peptidoglycan in their cell walls.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of CRUSTACEA comprised of shrimp-like organisms containing body trunks with at least 20 segments. The are commonly used as aquarium food.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of CRUSTACEA that are parasitic on freshwater fish.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of GRAM-NEGATIVE OXYGENIC PHOTOSYNTHETIC BACTERIA containing CHLOROPHYLL, a and b, but lacking PHYCOBILISOMES %28%light-harvesting antennae%29%. There are three genera: PROCHLORON; PROCHLOROCOCCUS; and PROCHLOROTHRIX. This order was thought to be the missing link between CYANOBACTERIA and plant CHLOROPLASTS, hence the name.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of MAMMALS, usually flesh eaters with appropriate dentition. Suborders include the terrestrial carnivores Fissipedia, and the aquatic carnivores PINNIPEDIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of New World mammals characterized by the absence of incisors and canines from among their teeth, and comprising the ARMADILLOS, the SLOTHS, and the anteaters. The order is distinguished from all others by what are known as xenarthrous vertebrae %28%xenos, strange; arthron, joint%29%: there are secondary, and sometimes even more, articulations between the vertebrae of the lumbar series. The order was formerly called Edentata. %28%From Random House Unabridged Dictionary, 2d ed; Walker%27%s Mammals of the World, 5th ed, vol. I, p515%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of aerobic, thermophilic archaea, in the kingdom EURYARCHAEOTA, characterized by the absence of a cell wall. Two genera have been described: THERMOPLASMA and Picrophilus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ameboid protozoa commonly having a monopodial cylindrically shaped body. Nuclear division is promitotic and most species have a temporary flagellate stage.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ameboid protozoa that is commonly uninucleate and possess mitochondria. Most organisms are nonpathogenic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. There are two families: METHANOSARCINACEAE and Methanosaetaceae.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of anaerobic methanogens in the kingdom EURYARCHAEOTA. They are pseudosarcina, coccoid or sheathed rod-shaped and catabolize methyl groups. The cell wall is composed of protein. The order includes one family, METHANOCOCCACEAE. %28%From Bergey%27%s Manual of Systemic Bacteriology, 1989%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of anaerobic, coccoid to rod-shaped methanogens, in the kingdom EURYARCHAEOTA. They are nonmotile, do not catabolize carbohydrates, proteinaceous material, or organic compounds other than formate or carbon monoxide, and are widely distributed in nature.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of anaerobic, highly specialized methanogens, in the kingdom EURYARCHAEOTA. Its organisms are nonmotile or motile, with cells occurring as coccoid bodies, pseudosarcina, or rods. Families include METHANOMICROBIACEAE, Methanocorpusculaceae, and Methanospirillaceae.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ascomycetous FUNGI which includes many economically important plant parasites as well as saprophytes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of basidiomycetous fungi; some species are parasitic on grasses %28%POACEAE%29% and maize.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of bottom fishes with short, small, spinous dorsal fins. It is comprised of one family %28%Batrachoididae%29% and about 70 species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ciliate protozoa in which the cytostome is usually situated at the base of an oral groove, the wall of which bears dense cilia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ciliate protozoa. Characteristics include a dorsoventrally flattened, highly mobile body with a unique cursorial type of locomotion.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ciliate protozoa. Characteristics include a ventral oral area and a well-defined buccal cavity. It comprises three suborders: TETRAHYMENINA, Ophryoglenina, and PENICULINA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of diurnal BIRDS of prey, including EAGLES; HAWKS; buzzards; vultures; and falcons.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of extremely halophilic archaea, in the kingdom EURYARCHAEOTA. They occur ubiquitously in nature where the salt concentration is high, and are chemoorganotrophic, using amino acids or carbohydrates as a carbon source.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of extremely thermophilic, sulfate-reducing archaea, in the kingdom EURYARCHAEOTA. The single family Archaeoglobaceae contains one genus ARCHAEOGLOBUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fish comprising salmons, trouts, whitefish, graylings, and other families. They are both marine and freshwater fish, found in all oceans and are quite numerous in the Northern Hemisphere. %28%From Nelson: Fishes of the World%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fish in the group SMEGMAMORPHA, comprising adrianichthyids, medakas %28%ORYZIAS%29%, needlefishes, halfbeaks, and flying fishes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fish including smelts, galaxiids, and salamanderfish.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fish including the families Gadidae %28%cods%29%, Macrouridae %28%grenadiers%29%, and hakes. The large Gadidae family includes cod, haddock, whiting, and pollock.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fish with 26 families and over 3,000 species. This order includes the families CYPRINIDAE %28%minnows and CARPS%29%, Cobitidae %28%loaches%29%, and Catostomidae %28%suckers%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fish with eight families and numerous species of both egg-laying and livebearing fish. Families include Cyprinodontidae %28%egg-laying KILLIFISHES%29%, FUNDULIDAE %28%topminnows%29%, Goodeidae %28%Mexican livebearers%29%, Jenynsiidae %28%jenynsiids%29%, Poeciliidae %28%livebearers%29%, Profundulidae %28%Middle American killifishes%29%, Aplocheilidae, and Rivulidae %28%rivulines%29%. In the family Poeciliidae, the guppy and molly belong to the genus POECILIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fishes native to North America and Northern Eurasia, consisting of two families: ESOCIDAE %28%pikes%29% and UMBRIDAE %28%mudminnows%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of flagellate protozoa. Characteristics include the presence of one or two flagella arising from a depression in the cell body and a single mitochondrion that extends the length of the body.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of flightless birds comprising the ostriches, which naturally inhabit open, low rainfall areas of Africa.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi comprising mostly insect pathogens, though some infect mammals including humans. Strict host specificity make these fungi a focus of many biological control studies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum ASCOMYCOTA characterized by stromatic perithecial forms in most species. Notable genera are Magnaporthe and Glomerella, the latter having the anamorph %28%mitosporic form%29% COLLETOTRICHUM.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum ASCOMYCOTA characterized by the presence of well defined peridia and cleistothecial asci. Notable anamorphs %28%mitosporic forms%29% of Eurotiales include PENICILLIUM and ASPERGILLUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum ASCOMYCOTA containing many medically important species. There are four families and mitosporic %28%anamorphic%29% forms are prominent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum ASCOMYCOTA that includes a number of species which are parasitic on higher plants, insects, or fungi. Other species are saprotrophic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum ASCOMYCOTA that includes many valuable experimental organisms. There are eight families and very few anamorphic forms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum Ascomycota that multiply by budding. They include the telomorphic ascomycetous yeasts which are found in a very wide range of habitats.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum BASIDIOMYCOTA having macroscopic basidiocarps. The members are characterized by their saprophytic activities as decomposers, particularly in the degradation of CELLULOSE and LIGNIN. A large number of species in the order have been used medicinally. %28%From Alexopoulos, Introductory Mycology, 4th ed, pp504-68%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of fungi in the phylum CHYTRIDIOMYCOTA comprising anaerobic chytrids that inhabit the RUMEN; and CECUM of herbivorous animals. Genera %28%all in the lone family Neocallimasticaceae%29% include NEOCALLIMASTIX, Orpinomyces, PIROMYCES, and Caecomyces.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of heavy-bodied, largely terrestrial BIRDS including pheasants, TURKEYS, grouse, QUAIL, and CHICKENS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of heavy-bodied, slow-moving, completely aquatic, herbivorous mammals. The body is fusiform, plump, and hairless, except for bristles on the snout. Hindlimbs are absent, the forelimbs are modified to flippers, and the tail is a horizontal fluke. %28%From Scott, Concise Encyclopedia Biology, 1996%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of heteroxenous protozoa in which the macrogamete and microgamont develop independently. A conoid is usually absent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of highly pleomorphic, gram-negative bacteria including both pathogenic and saprophytic species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of insect eating MAMMALS including MOLES; SHREWS; HEDGEHOGS and tenrecs.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of insects comprising the chewing lice or biting lice, many of which are parasitic on wild birds and domestic fowl and on wild and domestic mammals. Suborders include Amblycera and Ischnocera.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of insects comprising the sucking lice, which are blood-sucking ectoparasites of mammals. Recognized families include: Echinphthiriidae, Haematopinidae, and Pediculidae. The latter contains the medically important genera affecting humans: PEDICULUS and PHTHIRUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of insects comprising two suborders: Caelifera and Ensifera. They consist of GRASSHOPPERS, locusts, and crickets %28%GRYLLIDAE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of insects, comprising a single family %28%Mantidae%29%, restricted almost entirely to the tropics. Only one species, the praying mantis %28%Mantis religiosa%29%, is found in temperate habitats.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of insects, restricted mostly to the tropics, containing at least eight families. A few species occur in temperate regions of North America.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of large, long-necked, long-legged, flightless birds, found in South America. Known as rheas, they are sometimes called American ostriches, though they are in a separate order from true OSTRICHES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of mostly marine CRUSTACEA containing more than 5500 species in over 100 families. Like ISOPODA, the other large order in the superorder Peracarida, members are shrimp-like in appearance, have sessile compound eyes, and no carapace. But unlike Isopoda, they possess thoracic gills and their bodies are laterally compressed.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes consisting of many species which are plant parasites. Female worms lay eggs that hatch either in soil or in the host plant.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes of the subclass ADENOPHOREA. Its organisms commonly have a cylindrical esophagus. The superfamilies of this order are DIOCTOPHYMATOIDEA; MERMITHOIDEA; and TRICHUROIDEA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes of the subclass SECERNENTEA. Characteristics include an H-shaped excretory system with two subventral glands.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes of the subclass SECERNENTEA. Characteristics include ventral or caudoventral papillae and an esophagus divided into anterior muscular and posterior glandular parts.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by a single, ventral excretory gland and a relatively stout, short body.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by an annulated or smooth cuticle and the absence of caudal glands.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of nematodes of the subclass SECERNENTEA. Its organisms possess two or three pairs of dorsolateral caudal papillae.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of neotropical electric fish found chiefly in the waters of South America. They continually emit weak electric discharges, which they use in object location and communication. A most popular species of research interest is the electric eel, ELECTROPHORUS electricus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of obligately intracellular bacteria that have the chlamydia-like developmental cycle of replication. This is a two-stage cycle that includes a metabolically inactive infectious form, and a vegetative form that replicates by binary fission. Members of Chlamydiales are disseminated by aerosol or by contact. There are at least four recognized families: CHLAMYDIACEAE, Parachlamydiaceae, Simkaniaceae, and Waddliaceae.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of parasitic FUNGI found mostly in ARTHROPODS; FISHES; and in some VERTEBRATES including humans. It comprises two suborders: Pansporoblastina and APANSPOROBLASTINA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of parasitic PROTOZOA found in blood cells and epithelial cells of vertebrates and invertebrates. Life cycles involve both sexual and asexual phases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of parasitic PROTOZOA in the class COCCIDIA. Families include CRYPTOSPORIDIIDAE; EIMERIIDAE; and SARCOCYSTIDAE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of parasitic protozoa typically having four to six flagella. True cysts are known in very few species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of pelagic, shrimplike CRUSTACEA. Many consume ZOOPLANKTON and a few are predacious. Many antarctic species, such as Euphuasia superba, constitute the chief food of other animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of photosynthetic bacteria representing a physiological community of predominantly aquatic bacteria.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of plantlike, flagellate protozoa commonly found in freshwater habitats. Characteristics include the presence of a cellulose wall and two-to-four equal, smooth, apical flagella.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of protozoa characterized by a peridium and capillitium that are calcareous and a spore mass that is usually dark-colored.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of protozoa characterized by the presence of one or two karyomastigonts and either two-fold rotational or mirror symmetry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of protozoa characterized by their ability to aggregate to form a multicellular pseudoplasmodium, which gives rise to a multispored fruiting body. A stalk tube is present.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of protozoa comprising heteroxenous tick-borne blood parasites. Representative genera include BABESIA, Dactylosoma, and THEILERIA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of rod-shaped, gram-negative fruiting gliding bacteria found in SOIL; WATER; and HUMUS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of small mammals comprising two families, Ochotonidae %28%pikas%29% and Leporidae %28%RABBITS and HARES%29%. Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. Rabbits are born furless and with both eyes and ears closed. HARES are born fully haired with eyes and ears open. All are vegetarians. %28%From Nowak, Walker%27%s Mammals of the World, 5th ed, p539-41%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of strictly anaerobic, thermophilic archaea, in the kingdom EURYARCHAEOTA. Members exhibit heterotropic growth by sulfur respiration. There is a single family THERMOCOCCACEAE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of the ANGIOSPERMS, subclass Rosidae. Its members include some of the most known ornamental and edible plants of temperate zones including roses, apples, cherries, and peaches.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size %28%except in Sirenidae%29%, and a reduction in skull bones.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term %22%toad%22% is ambiguous and is properly applied only to the family Bufonidae.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, Sarcophagidae, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE; CHIRONOMIDAE; CULICIDAE; DROSOPHILIDAE; GLOSSINIDAE; MUSCIDAE; TEPHRITIDAE; and PSYCHODIDAE. The larval form of Diptera species are called maggots %28%see LARVA%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of the class MAMMALS that consists of one family, TUPAIIDAE %28%tree shrews%29%, 5 genera %28%one of which is TUPAIA%29%, and 16 species. Their recent distribution is from India to the Philippines, southern China to Java, Borneo, Sumatra, Bali, and other islands in those regions.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of wholly aquatic MAMMALS occurring in all the OCEANS and adjoining seas of the world, as well as in certain river systems. They feed generally on FISHES, cephalopods, and crustaceans. Most are gregarious and most have a relatively long period of parental care and maturation. Included are DOLPHINS; PORPOISES; and WHALES. %28%From Walker%27%s Mammals of the World, 5th ed, pp969-70%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organelle consisting of three components: %28%1%29% the astral microtubules, which form around each centrosome and extend to the periphery; %28%2%29% the polar microtubules which extend from one spindle pole to the equator; and %28%3%29% the kinetochore microtubules, which connect the centromeres of the various chromosomes to either centrosome.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. %28%From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organic anion transporter found in human liver. It is capable of transporting a variety organic anions and mediates sodium-independent uptake of bile in the liver.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organic cation transporter found in kidney. It is localized to the basal lateral membrane and is likely to be involved in the renal secretion of organic cations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organic mercurial used as a sulfhydryl reagent. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold %26% Wynne, Introduction to the Algae, 2d ed, p84%29%. Delicate, hairlike appendages arise from the flagellar surface in these organisms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold, Introduction to the Algae, 2d ed, p292%29%. Characteristics include a pellicle usually marked by spiral or longitudinal striations. Most are found in stagnant water.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism considered both a protozoon %28%Dorland, 27th ed%29% and an alga %28%Bold, Introduction to the Algae, 2d ed, p292%29%. It is a flagellate organism commonly found in stagnant water.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism originally isolated from sewage, manure, humus, and soil, but recently found as a parasite in mammals and birds.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism that, as a result of transplantation of donor tissue or cells, consists of two or more cell lines descended from at least two zygotes. This state may result in the induction of donor-specific TRANSPLANTATION TOLERANCE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient%27%s cells which would otherwise reject the donor cells.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organization of cells into an organ-like structure. Organoids can be generated in culture. They are also found in certain neoplasms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organization of insurers or reinsurers through which particular types of risk are shared or pooled. The risk of high loss by a particular insurance company is transferred to the group as a whole %28%the insurance pool%29% with premiums, losses, and expenses shared in agreed amounts.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organized and comprehensive program of health care that identifies and reduces a woman%27%s reproductive risks before conception through risk assessment, health promotion, and interventions. Preconception care programs may be designed to include the male partner in providing counseling and educational information in preparation for fatherhood, such as genetic counseling and testing, financial and family planning, etc. This concept is different from PRENATAL CARE, which occurs during pregnancy.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organized group of three or more full-time physicians rendering services for a fixed prepayment.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organized procedure carried out by a select committee of professionals in evaluating the performance of other professionals in meeting the standards of their specialty. Review by peers is used by editors in the evaluation of articles and other papers submitted for publication. Peer review is used also in the evaluation of grant applications. It is applied also in evaluating the quality of health care provided to patients.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine compound that was formerly used as an insecticide. Its manufacture and use has been discontinued in the United States. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine insecticide that has been used as a pediculicide and a scabicide. It has been shown to cause cancer.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine insecticide that is carcinogenic. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine insecticide that is slightly irritating to the skin. %28%From Merck Index, 11th ed, p482%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine insecticide whose use has been cancelled or suspended in the United States. It has been used to control locusts, tropical disease vectors, in termite control by direct soil injection, and non-food seed and plant treatment. %28%From HSDB%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine insecticide. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organochlorine pesticide, it is the ethylene metabolite of DDT.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphate cholinesterase inhibitor that is used as a pesticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphate cholinesterase inhibitor that is used as an insecticide. It has low mammalian toxicity. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphate cholinesterase inhibitor that is used as an insecticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphate insecticide that inhibits monoamine oxidase and acetylcholinesterase. It has been shown to be genotoxic.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphorus cholinesterase inhibitor that is used as an insecticide and an acaricide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphorus compound isolated from human and animal tissues.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphorus ester compound that produces potent and irreversible inhibition of cholinesterase. It is toxic to the nervous system and is a chemical warfare agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organophosphorus insecticide that inhibits acetylcholinesterase.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organoplatinum compound that possesses antineoplastic activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphate cholinesterase inhibitor that is used as an insecticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphate insecticide. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphorus cholinesterase inhibitor that is used as an insecticide and as a acaricide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphorus cholinesterase inhibitor that is used as an insecticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphorus cholinesterase inhibitor. It has been used as an acaricide and as an insecticide.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An organothiophosphorus insecticide that has been used to control pig mange.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An orthodontic method used for correcting narrow or collapsed maxillary arches and functional cross-bite. %28%From Jablonski%27%s Dictionary of Dentistry%29%,%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An outbred strain of rats developed in 1915 by crossing several Wistar Institute white females with a wild gray male. Inbred strains have been derived from this original outbred strain, including Long-Evans cinnamon rats %28%RATS, INBRED LEC%29% and Otsuka-Long-Evans-Tokushima Fatty rats %28%RATS, INBRED OLETF%29%, which are models for Wilson%27%s disease and non-insulin dependent diabetes mellitus, respectively.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oval area in the retina, 3 to 5 mm in diameter, usually located temporal to the posterior pole of the eye and slightly below the level of the optic disk. It is characterized by the presence of a yellow pigment diffusely permeating the inner layers, contains the fovea centralis in its center, and provides the best phototropic visual acuity. It is devoid of retinal blood vessels, except in its periphery, and receives nourishment from the choriocapillaris of the choroid. %28%From Cline et al., Dictionary of Visual Science, 4th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oval semitransparent membrane separating the external EAR CANAL from the tympanic cavity %28%EAR, MIDDLE%29%. It contains three layers: the skin of the external ear canal; the core of radially and circularly arranged collagen fibers; and the MUCOSA of the middle ear.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ovarian neoplasm composed of LUTEAL CELLS derived from luteinized GRANULOSA CELLS and THECA CELLS. Luteomas respond to GONADOTROPINS, and vary in their hormone production %28%PROGESTERONE; ESTROGENS; or ANDROGENS%29%. During PREGNANCY, a transient type of luteoma may develop due to an exaggerated LUTEINIZATION of the OVARY.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oversimplified perception or conception especially of persons, social groups, etc.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oviparous burrowing mammal of the order Monotremata native to Australia, Tasmania, and New Guinea. It has hair mingled with spines on the upper part of the body and is adapted for feeding on ants.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the optic chiasm.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidation product of HEPTACHLOR formed by many plants and animals, including humans, after exposure to HEPTACHLOR. It has been shown to remain in soil treated with HEPTACHLOR for over fifteen years and is toxic to animals and humans. %28%From ATSDR Public Heath Statement, April 1989%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidative decarboxylation process that converts GLUCOSE-6-PHOSPHATE to D-ribose-5-phosphate via 6-phosphogluconate. The pentose product is used in the biosynthesis of NUCLEIC ACIDS. The generated energy is stored in the form of NADPH. This pathway is prominent in tissues which are active in the synthesis of FATTY ACIDS and STEROIDS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidizing agent that is used in analytical chemistry for separation of potassium from sodium. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidoreductase involved in pyrimidine base degradation. It catalyzes the catabolism of THYMINE; URACIL and the chemotherapeutic drug, 5-FLUOROURACIL.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidoreductase that catalyzes the conversion of compounds that contain 5-alpha-cholestan-3-one into the cholest-4-en-3-one derivative. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidoreductase that catalyzes the conversion of hydrogen peroxide to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. EC 1.11.1.6.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidoreductase that catalyzes the oxidative DEAMINATION of GLYCINE to GLYOXYLATE and AMMONIA in the presence of NAD. In BACTERIA lacking transaminating pathways the enzyme can act in the reverse direction to synthesize glycine from glyoxylate and ammonia and NADH.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxidoreductase that catalyzes the reaction between superoxide anions and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. EC 1.15.1.1.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An oxyacid of chlorine %28%HClO%29% containing monovalent chlorine that acts as an oxidizing or reducing agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ulceration caused by prolonged pressure on the SKIN and TISSUES when one stay in one position for a long period of time, such as lying in bed. The bony areas of the body are the most frequently affected sites which become ischemic %28%ISCHEMIA%29% under sustained and constant pressure.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An ulcerative pyoderma usually caused by group A beta-hemolytic streptococcal infection at the site of minor trauma. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unbranched glucan in starch. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An uncommon variant of CHORIOCARCINOMA. It is composed almost entirely of mononuclear cytotrophoblasts %28%TROPHOBLASTS%29%. Because its secretion of hCG %28%CHORIONIC GONADOTROPIN%29% is low, a large tumor may develop before the hCG can be detected.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unctuous substance composed of sebum and desquamated epithelial cells, which covers the skin of the fetus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An undecenyl THIOUREA which may have topical anti-inflammatory activity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unnaturally deep or rough quality of voice. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. %28%Dorland, 27th ed; Stedman, 25th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unsaturated fatty acid that is the most widely distributed and abundant fatty acid in nature. It is used commercially in the preparation of oleates and lotions, and as a pharmaceutical solvent. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance %28%RCS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unstable triatomic form of oxygen, O3, that exists in the atmosphere in varying proportions. It is produced continuously in the outer layers of the atmosphere by the action of solar UV-radiation on the oxygen of the air.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An unusual and aggressive tumor of germ-cell origin that reproduces the extraembryonic structures of the early embryo. It is the most common malignant germ cell tumor found in children. It is characterized by a labyrinthine glandular pattern of flat epithelial cells and rounded papillary processes with a central capillary %28%Schiller-Duval body%29%. The tumor is rarely bilateral. Before the use of combination chemotherapy, the tumor was almost invariably fatal. %28%From DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1189%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabaena' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabaena %28%1991-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabaena %28%1992-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabaena cylindrica' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabaena flos-aquae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabaena variabilis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabasine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabolic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anabolic Steroids %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anacardiaceae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anacardic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anacardium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anacin 3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anacin3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anacondas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobic Bacteria' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobic Threshold' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobic Thresholds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobic hyperthermophilic species of ARCHAEA, isolated from hydrothermal fluid samples. It is obligately heterotrophic with coccoid cells that require TRYPTOPHAN for growth.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobioses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobiosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobiosis %28%1971-1983%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaerobiospirillum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anagallis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Atresia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Atresias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Canal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Cancers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Drug Administration' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Drug Administrations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Fissure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Gland' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Gland Neoplasm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Gland Neoplasms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Gland, Animal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Glands, Animal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Glands, Human' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Neoplasm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Neoplasms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Sac' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Sacs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Stages' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Ulcer' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anal Ulcers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analeptic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analeptic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analeptics %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analeptics %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analeptics %28%1966-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia %28%1966-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia %28%1966-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia %28%1972-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia %28%1975-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia Test' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia Tests' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia and Anesthesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia produced by the insertion of ACUPUNCTURE needles at certain ACUPUNCTURE POINTS on the body. This activates small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary/hypothalamus - to produce analgesia.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Acupuncture' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Congenital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Epidural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Obstetric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Obstetrical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Patient Controlled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesia, Patient-Controlled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesic Overuse Headaches' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesic Rebound Headaches' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics %28%1966-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Anti Inflammatory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Anti-Inflammatory %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Narcotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Narcotic %28%1975-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Non Narcotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Non-Narcotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Nonnarcotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Nonopioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analgesics, Opioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog Computer' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog Computers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog Digital Conversion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog Pain Scale' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog Pain Scales' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog or digital communications device in which the user has a wireless connection from a telephone to a nearby transmitter. It is termed cellular because the service area is divided into multiple %22%cells.%22% As the user moves from one cell area to another, the call is transferred to the local transmitter.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog-Digital Conversion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analog-Digital Conversions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs and derivatives of atropine. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of bephenium %28%N,N-dimethyl-N-%28%2-phenoxyethyl%29%benzenemethanaminium%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of mandelic acid %28%alpha-hydroxybenzeneacetic acid%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of morphine. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of prostaglandin A that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs or derivatives of scopolamine. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, Androgen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, Estrogen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, PG' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, Prostaglandin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, Prostaglandin A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, Prostaglandin E' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, Prostaglandin F' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogs, RNA Cap' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue Computer' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue Computers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue Digital Conversion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue Pain Scales' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue Scale, Visual' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue Scales, Visual' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue-Digital Conversion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogue-Digital Conversions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Androgen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Estrogen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Prostaglandin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Prostaglandin A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Prostaglandin E' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Prostaglandin Endoperoxide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, Prostaglandin F' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analogues, RNA Cap' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analphalipoproteinemia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analphalipoproteinemias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Activation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Actuarial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Area' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Bibliometric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Blood Chemical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Blood Gas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cell Array' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Claims' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cluster' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cohort' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Computer-Assisted Numerical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cost' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cost Benefit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cost-Benefit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cross Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cross-Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cyclic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Cytogenetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, DNA Mutational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, DNA Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Data' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Decision' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Demographic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Dental Stress' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Differential Thermal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Discriminant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Equipment Failure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Ethical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Event History' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Factor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Finite Element' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Flow Injection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Food' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Gel Shift' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Heteroduplex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Least-Squares' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Life Table' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Mass Spectrum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Matched-Pair' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Materials Failure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Microchip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Microfluidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Multiple Classification' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Multiregional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Multivariate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, NASBA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Neutron Activation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Peptide Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Period' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Policy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Principal Component' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Prosthesis Failure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Protein Array' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Protein Microarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Protein Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, RNA Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, ROC' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Radioimmunoprecipitation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Regression' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Restriction Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Signal Detection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Small-Area' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Small-Area Variation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Spectrum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Statistical Data' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Statistical Factor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Survival' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Systems' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Tissue Array' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Transactional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Transcript Expression' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyses, Variance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis based on the mathematical function first formulated by Jean-Baptiste-Joseph Fourier in 1807. The function, known as the Fourier transform, describes the sinusoidal pattern of any fluctuating pattern in the physical world in terms of its amplitude and its phase. It has broad applications in biomedicine, e.g., analysis of the x-ray crystallography data pivotal in identifying the double helical nature of DNA and in analysis of other molecules, including viruses, and the modified back-projection algorithm universally used in computerized tomography imaging, etc. %28%From Segen, The Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of Variance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of Variance %28%1968-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of the mass of an object through means of determining the wave length%28%s%29% at which electromagnetic energy is absorbed by that object.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis of word concepts by the association of polar adjectives, e.g., good-bad, with the concept, father. The adjectives are usually scaled in 7 steps. The subject%27%s placement of the concept on the adjectival scale indicates the connotative meaning of the concept.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Activation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Actuarial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Area' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Bayesian' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Best Practice' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Bibliometric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Blood Chemical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Blood Gas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cell Array' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Claims' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cluster' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Computer Assisted Numerical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Computer-Assisted Image' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Computer-Assisted Numerical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cost' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cost Benefit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cost-Benefit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cross Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cross-Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cyclic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Cytogenetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, DNA Mutational' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, DNA Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Data' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Decision' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Demographic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Dental Stress' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Differential Thermal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Discriminant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Equipment Failure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Ethical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Finite Element' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Flow Injection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Food' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Fourier' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Gel Shift' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Heteroduplex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Least Squares' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Least-Squares' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Life Table' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Mass Spectrum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Matched Pair' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Matched-Pair' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Materials Failure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Microarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Microchip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Microfluidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Multiple Classification' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Multiregional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Multivariate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, NASBA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Neutron Activation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Peptide Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Period' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Policy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Principal Component' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Prosthesis Failure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Protein Array' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Protein Microarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Protein Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, RNA Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, ROC' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Radioimmunoprecipitation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Raman Spectrum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Regression' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Restriction Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Sequence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Signal Detection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Small Area' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Small-Area' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Small-Area Variation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Spectrum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Statistical Data' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Statistical Factor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Survival' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Systems' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Tissue Array' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Transactional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Transcript Expression' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analysis, Variance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytic Chemistry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Chemistry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Device, Microarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Device, Microchip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Device, Nanoarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Device, Nanochip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Devices, Microarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Devices, Microchip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Devices, Nanoarray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Devices, Nanochip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Procedure, Microchip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Procedures, Microchip' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Technique, Microfluidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical Techniques, Microfluidic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analytical technique for studying substances present at enzyme concentrations in single cells, in situ, by measuring light absorption. Light from a tungsten strip lamp or xenon arc dispersed by a grating monochromator illuminates the optical system of a microscope. The absorbance of light is measured %28%in nanometers%29% by comparing the difference between the image of the sample and a reference image.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyzer, Neural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Analyzers, Neural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ananas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anankastic Personalities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anankastic Personality' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anantamul' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylactic Reaction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylactic Reactions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylactic Shock' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylactoid Purpura' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylatoxin C5a Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylatoxin Inactivator' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylatoxins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylatoxins %28%1977-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylatoxins %28%1980-1982%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylaxis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylaxis %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylaxis %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaphylaxis, Passive Cutaneous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma %28%1964-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma %28%1966-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma %28%1968-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma centrale' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma marginale' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma ovis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasma phagocytophilum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasmataceae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasmataceae Infection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasmataceae Infections' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasmoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasmosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplasmosis %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplastic Astrocytomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplastic Carcinoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplastic Carcinomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplastic Ependymomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anaplastic Oligodendrogliomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anapriline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomose, Arteriovenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomoses, Arteriovenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomoses, Cavopulmonary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomoses, Portacaval' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomoses, Roux-en-Y' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomoses, Surgical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis of splenic vein to renal vein to relieve portal hypertension.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Arteriovenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Cavopulmonary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Internal Mammary Coronary Artery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Internal Mammary-Coronary Artery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Portacaval' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Roux en Y' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Roux-en-Y' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastomosis, Surgical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastrepha ludens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anastrepha suspensa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomic Model' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomic Models' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomical Model' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomical Models' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomical Pathological Condition' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomical Pathological Conditions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomical and functional disorders affecting the foot.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomical areas of the body. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomies, Artistic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomies, Comparative' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomies, Regional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomies, Veterinary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Artistic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Comparative' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Cross Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Cross-Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Cross-Sectional %28%1991-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Regional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Sectional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anatomy, Veterinary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anbex Brand of Potassium Iodide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancestry Group, Oceanic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancestry Groups, Oceanic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchorage Procedure, Orthodontic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchorage Procedures, Orthodontic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchorage Technique, Orthodontic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchorage Techniques, Orthodontic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchored Genomic Island' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchored Polymerase Chain Reaction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchorin CII' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchoring points where the CYTOSKELETON of neighboring cells are connected to each other. They are composed of specialized areas of the plasma membrane where bundles of MICROFILAMENTS attach to the membrane through the transmembrane linkers, CADHERINS, which in turn attach through their extracellular domains to cadherins in the neighboring cell membranes. In sheets of cells, they form into adhesion belts %28%zonula adherens%29% that go all the way around a cell.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchors, GPI Membrane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anchors, Glycosylphosphatidylinositol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient Histories %28%Medicine%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient History' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient History %28%Medicine%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient History Medicine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient History Medicines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient History of Medicine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancient Lands' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancillary Information System' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancillary Service, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancillary Services, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancistrodon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancitabine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancotil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancrod' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancrod Berk Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancrod Knoll Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancylostoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancylostomatoidea' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancylostomatoidea %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancylostomatoidea %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancylostomiases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ancylostomiasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andersen Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andersen Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andersen%27%s Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andersens Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anderson Fabry Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anderson-Fabry Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andorra' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andreu Brand of Acitretin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andreu Brand of Bencyclane acefyllinate and fumarate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androblastoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androblastomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Analogs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Analogues' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Binding Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Induced Growth Factor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Insensitivity Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Insensitivity Syndrome, Complete' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Insensitivity Syndrome, Partial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen Receptors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Binding Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Dependent Epididymal Secretory Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Induced Growth Factor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Insensitivity Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Insensitivity Syndrome, Complete' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Insensitivity Syndrome, Partial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgen-Insensitivity Syndromes, Partial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgenic Compounds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens %28%1964-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens %28%1966-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens Receptors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens, Synthetic %28%1975-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androgens/antagonists %26% inhibitors %28%1968-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andrographis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Android 10' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Android 25' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Android 5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Android F' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andrology' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andromaco Brand of Buformin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andromaco Brand of Nimodipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andropause' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andropogon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andropogon nardus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Andropogon zizanioides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androst 5 ene 3 beta,17 beta Diol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androst 5 ene 3,17 diol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androst-5-ene-3 beta,17 beta-Diol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androst-5-ene-3,17-diol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstadienes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanazol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstane 3,17 diol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstane-3,17-diol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes %28%1968-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes %28%1968-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes %28%1968-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes %28%1973-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanes in which ring contractions have occurred or which are lacking carbon-18. Compounds with any degree of unsaturation are included. Androstanes which are lacking carbon-19 are ESTRANES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanolone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstanols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstatrienes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenediol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenediols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenediols %28%1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenedione' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenedione Aromatase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenes %28%1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenes %28%1988-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenolone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenols' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androstenols %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androsterone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Androsterone UDP Glucuronosyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anecdote' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anecdotes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anecdotes %28%PT%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anecdotes %5B%Publication Type%5D%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anellovirus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anelloviruses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemarrhena' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemarrhenae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia %28%1966-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia Neonatorum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. %28%Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume %28%MCV%29% and increased mean corpuscular hemoglobin %28%MCH%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia due to decreased life span of erythrocytes. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Acquired Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Addison' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Addison%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Addisons' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Aplastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Aplastic %28%1966-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Aplastic %28%1966-1985%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Aplastic %28%1970-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Aplastic %28%1974-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Autoimmune Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Congenital Dyserythropoietic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Congenital Dyserythropoietic, Type II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Congenital Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Congenital Hypoplastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Congenital Nonspherocytic Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Cooley' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Cooley%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Cooleys' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Diamond Blackfan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Diamond-Blackfan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Dyserythropoietic, Congenital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Equine Infectious' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Erythroblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Fanconi' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Fanconi%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic Congenital, Nonspherocytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic, Autoimmune' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic, Congenital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic, Congenital Nonspherocytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hemolytic, Hereditary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hereditary Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hypochromic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hypochromic %28%1966-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Hypoplastic, Congenital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Iron Deficiency' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Iron-Deficiency' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Leukoerythroblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Macrocytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Mediterranean' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Megaloblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Myelophthisic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Neonatal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Pernicious' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Refractory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Refractory, with Excess of Blasts' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Sickle Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Sickle Cell %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Sickle Cell %28%1966-1983%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia, Sideroblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemia/drug therapy %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Acquired Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Aplastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Autoimmune Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Congenital Dyserythropoietic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Congenital Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Congenital Hypoplastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Equine Infectious' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Erythroblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Fanconi' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Hereditary Hemolytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Hypochromic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Hypoplastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Iron Deficiency' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Iron-Deficiency' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Leukoerythroblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Macrocytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Megaloblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Microangiopathic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Myelophthisic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Neonatal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Refractory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Sickle Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Sideroblastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemias, Splenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anemone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephalia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephalias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephalies, Partial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephalus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephaly' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephaly %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephaly, Hemicranial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephaly, Incomplete' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anencephaly, Partial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anepia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anepias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anergies, Clonal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anergy, Clonal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia %28%1968-2005%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Adjuvants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Assistant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Department' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Department, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Departments' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Departments, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Recovery Period' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Recovery Periods' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia Resuscitation Department, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia and Analgesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia or specific %28%1966-1985%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Acupuncture' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Caudal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Closed Circuit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Closed-Circuit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Conduction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Conduction %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Dental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Dental %28%1973-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Electric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Epidural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Epidural %28%1966-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Epidural %28%1976-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Extradural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, General' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, General %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Gynecologic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Gynecological' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Inhalation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Inhalation %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Inhalation %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Inhalation %28%1972-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Insufflation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Intratracheal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Intravenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Local' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Obstetric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Obstetrical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Obstetrical %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Obstetrical %28%1976-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Peridural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Rebreathing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Rectal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Refrigeration' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Regional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Sacral Epidural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia, Spinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesia-Resuscitation Departments, Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Closed-Circuit' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Electric' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, General' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Intratracheal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Intravenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Rebreathing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Rectal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesias, Spinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesiology' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthesiology %28%1966-Jul 1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetic Adjuvants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetic Gas Scavenger' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetic Hypnoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetic Hypnosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1966-1969%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1966-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1966-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1968-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1970-1996%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics %28%1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Combined' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Conduction Blocking' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Conduction-Blocking' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Dissociative' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, General' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Inhalation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Intravenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Local' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Local %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetics, Local %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetist, Nurse' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anesthetists, Nurse' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anestrus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anethol Dithiolthione' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anethole Trithione' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anetholetrithione' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anetholtrithion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anetholtrithione' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anethum graveolens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anethum graveolens L. is a plant species of the family APIACEAE. It is one of the plant SPICES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneugenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneugens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploid Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidy %28%1968-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidy %28%1980-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidy %28%1989-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidy Inducing Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneuploidy-Inducing Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm %28%1966-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm of a coronary vessel. A coronary artery aneurysm is rarely congenital; it is usually due to atherosclerosis, inflammatory processes, or a coronary fistula. %28%From Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm of the aorta. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Abdominal Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Arteriovenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Berry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Cardiac' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Coronary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Dissecting' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, False' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Giant Intracranial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Heart' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Iliac' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Infected' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Intracranial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Intracranial Mycotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Ruptured' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Ruptured Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Saccular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysm, Thoracic Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysmal Bone Cyst' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysmal Bone Cysts' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysmal Subarachnoid Hemorrhage' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysmal Subarachnoid Hemorrhages' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Abdominal Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Arteriovenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Bacterial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Basilar Artery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Berry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Cardiac' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Coronary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Dissecting' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, False' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Giant Intracranial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Heart' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Iliac' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Infected' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Intracranial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Intracranial Mycotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Mycotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Ruptured' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Ruptured Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Saccular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aneurysms, Thoracic Aortic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anexate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angel Dust' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angel Dust Abuse' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angelica' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angelica archangelica' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angelica sinensis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angelman Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anger' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitides, Allergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitides, Allergic Cutaneous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitides, Allergic Granulomatous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitides, Hypersensitivity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitides, Leukocytoclastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Allergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Allergic Cutaneous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Allergic Granulomatous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Central Nervous System' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Granulomatous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Hypersensitivity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiitis, Leukocytoclastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris %28%1966-1983%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris %28%1977-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris with Normal Coronary Arteriogram' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris, Variant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Pectoris, Variant %28%1977-1983%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Syndrome X' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina Syndrome Xs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina X Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina X Syndromes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina at Rest' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Ludwig%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Microvascular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Preinfarction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Prinzmetal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Prinzmetal%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Unstable' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angina, Vincent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anginas, Preinfarction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anginas, Unstable' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anginas, Vincent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angio Conray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'AngioConray' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioblastic Meningiomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiocardiographies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiocardiographies, Equilibrium Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiocardiography' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiocardiography %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiocardiography, Equilibrium Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiodysplasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiodysplasia %28%1992-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiodysplasias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioedema' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioedemas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiofibroma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiofibromas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiofollicular Lymphoid Hyperplasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiofollicular Lymphoid Hyperplasias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Factor %28%1973-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Factor %28%1981-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Factor %28%2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Inducers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Inducing Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Inhibitors %28%2000-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Modulating Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Modulating Agents %28%1973-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Modulators' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Stimulating Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis Stimulators' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis, Corneal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis, Pathologic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis, Pathological' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis, Physiologic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenesis, Physiological' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenetic Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenetic Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenic Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenic Factor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenic Factor, Tumor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenic Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogenic Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiogranulomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Coronary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Equilibrium Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, First-Pass Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Gated Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, MRI' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Magnetic Resonance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Radioisotope' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiographies, Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography %28%1977-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography %28%1980-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography %28%1983-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Coronary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Digital Subtraction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Equilibrium Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, First-Pass Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Fluorescein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Fluorescence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Gated Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, MRI' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Magnetic Resonance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Radioisotope' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiography, Radionuclide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiohemophilia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiohemophilias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioid Streak' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioid Streaks' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioimmunoblastic Lymphadenopathies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioimmunoblastic Lymphadenopathy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiokeratoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiokeratoma %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiokeratoma Corporis Diffusum' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiokeratomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioleiomyoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioleiomyomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiolipoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiolipomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiolymphoid Hyperplasia with Eosinophilia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioma, Cavernous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioma, Sclerosing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioma, Venous, Central Nervous System' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomas, Cavernous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomas, Sclerosing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses, Bacillary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses, Bacillary Epithelioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses, Epithelioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses, Familial Cerebello-Retinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses, Familial Cerebelloretinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatoses, Meningo-Oculo-Facial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis %28%1989-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis Oculoorbital-Thalamic Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis, Bacillary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis, Bacillary Epithelioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis, Epithelioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis, Familial Cerebello-Retinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis, Familial Cerebelloretinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatosis, Meningo-Oculo-Facial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomatous Meningiomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomyolipoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomyolipomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomyoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomyomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomyxoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiomyxomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioneurotic Edema' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioneurotic Edemas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopathies, Diabetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopathies, Peripheral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopathy, Cerebral Amyloid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopathy, Congophilic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopathy, Diabetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopathy, Peripheral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties, Coronary Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties, Excimer Laser' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties, Laser' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties, Laser Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties, Laser-Assisted' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasties, Laser-Assisted Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Balloon %28%1982-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Balloon %28%1985-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Balloon %28%1986-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Balloon, Coronary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Balloon, Laser-Assisted' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Coronary Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Laser' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Laser %28%1991-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Laser Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Laser-Assisted' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Laser-Assisted Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Laser-Assisted, Balloon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Percutaneous Transluminal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Transluminal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Transluminal %28%1982-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Transluminal %28%1982-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Transluminal %28%1982-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Transluminal, Percutaneous Coronary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioplasty, Transluminal, Percutaneous Coronary %28%1989-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietin 1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietin 2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietin Receptor Tie 2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietin Receptor Tie-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietin-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietin-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiopoietins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiosarcoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiosarcomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscope' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopic Surgeries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopic Surgery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopic Surgical Procedure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopic, Surgery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopics, Surgery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopies, Microscopic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopy %28%1993-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopy, Microscopic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angioscopy/instrumentation %28%1993-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiosperms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostatic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostatic Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostatin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostatin %28%1994-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostatins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostrongylus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostrongylus %28%1981-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiostrongylus cantonensis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin AT1 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin AT1a Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin AT1b Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin AT2 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Amide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Converting Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Converting Enzyme Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Converting Enzyme Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Forming Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin I' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin I Converting Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin I Converting Enzyme Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin I-Converting Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin I-Converting Enzyme Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1966-1974%29%/analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1966-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II %28%1975-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Type 1 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Type 1 Receptor Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Type 1 Receptor Blockers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Type 1a Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Type 1b Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II Type 2 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, 1-Asparagine-5-valine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, 1-Sar-8-Ala' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, 1-Sar-8-Ile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, 1-Sarcosine-8-Alanine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, 1-Sarcosine-8-Isoleucine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, 5-L-Isoleucine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, Des-Asp' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, Isoleucine%28%5%29%-' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin II, Valine%28%5%29%-' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin III' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin III %28%1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin III Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Receptors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Receptors/antagonists %26% inhibitors %28%1984-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Type 1 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Type 1a Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Type 1b Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin Type 2 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin-%28%1-8%29% Octapeptide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin-Converting Enzyme Antagonists' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin-Converting Enzyme Inhibitors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensin-Forming Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensinamide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensinase A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensinogen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensinogenase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angiotensins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle Class I' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle Class II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle Class III' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle Classification' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle Closure Glaucoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle Closure Glaucomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle refers to Edward Hartley Angle, Amer orthodontist ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle, Cerebellopontile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle, Cerebellopontine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle-Closure Glaucoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angle-Closure Glaucomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angles Classification' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angles, Cerebellopontile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angles, Cerebellopontine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anglican' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anglicans' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angola' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Angor Pectoris' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anguilla' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anguillas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anguilliformes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anguilluliases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anguish' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhidrotic Ectodermal Dysplasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhidrotic Ectodermal Dysplasias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrase 4, Carbonic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrase B, Carbonic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrase, Muscle-Specific Carbonic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrase, OPA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrase, Organophosphorus Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrases, Carbonic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydride Hydrolases, Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydride polymers with a repeating structure of RC%28%=O%29%OC%28%=O%29%R. They readily hydrolyze in water making them useful for DELAYED-ACTION PREPARATIONS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydride, Carbonic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydride, Ethoxyformic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydride, Maleic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydride, Sulfurous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides %28%1974-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides %28%1985-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides, Acetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides, Citraconic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides, Maleic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides, Methylmaleic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides, Phthalic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrides, Succinic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydro-Ara-C' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydroglucochloral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrohydroxyprogesterone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrolase, Organophosphorus Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Amiloride Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Apomorphine Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Butirosin Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Calcium Chloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Calcium Sulfate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Ceftriaxone Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Enalaprilat Citrate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Imipenem' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Saralasin Acetate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Sodium Acetate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Spectinomycin Dihydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Sulfate of Lime' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous Tolmetin Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous, Bupivacaine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous, Enalaprilat' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous, Pinacidil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anhydrous, Potassium Citrate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1974-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilides %28%1977-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1970-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1973-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds %28%1974-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Compounds, Triphenylmethane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Hydroxylase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniline Mustard' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilinesulfonic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anilino Naphthalenesulfonates' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal %28%1967-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Behavior' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Behaviors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Care Assistant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Care Assistants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Care Committee' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Care Committees' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Care Technician' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Care Technicians' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Carpus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Communication' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Communications' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Disease Model' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Disease Models' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Diseases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Diseases %28%1966-1969%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Eliminative Behavior' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Eliminative Behaviors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Ethics Committee' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Euthanasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Experiment' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Experimental Use' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Experimental Uses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Experimentation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Feed' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Feeds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Flight' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Flights' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Gait Disorder' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Gait Disorders' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Helminthiases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Helminthiasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Hepatitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Hepatitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Hospital' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Hospitals' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Housing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Housings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Human Bonding' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Husbandries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Husbandry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Hypnosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Identification System' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Identification Systems' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Inbred Strain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Inbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Lameness' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Lamenesses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Leukemia Model' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Leukemia Models' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mammary Carcinoma' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mammary Carcinomas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mammary Gland' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mammary Glands' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mammary Neoplasm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mammary Neoplasms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mating Behavior' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mating Behaviors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Mercy Killing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Migration' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Migrations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Milk Fever' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Model' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Model, Experimental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Model, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Models' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Models, Experimental' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Models, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Muscular Dystrophies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Muscular Dystrophy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Nutrition' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Nutritions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Organ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Outbred Strain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Outbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Parasitic Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Parasitic Diseases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Physical Conditioning' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Physical Conditionings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Population Group' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Population Groups' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Pregnancies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Pregnancy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Protozoan Infection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Protozoan Infections' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Research' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Rights' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Salmonella Infection' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Salmonella Infections' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Science, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Sciences, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Sex Behavior' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Sex Behaviors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Strain, Inbred' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Strain, Outbred' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Strains, Inbred' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Strains, Outbred' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Structure' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Structures' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Tarsus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Technician' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Technicians' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Technologist, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Technologists, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Testing Alternative' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Testing Alternatives' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Testing Alternatives %28%1985-2000%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Toxoplasmoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Toxoplasmosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Use Alternative' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Use Alternatives' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Virus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Vocalization' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Vocalizations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Welfare' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Welfare %28%1978-2002%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Welfare %28%1986-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal Welfare %28%1986-2002%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal behavior associated with the nest; includes construction, effects of size and material; behavior of the adult during the nesting period and the effect of the nest on the behavior of the young.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal reproductive bodies, or the contents thereof, used as food. The concept is differentiated from OVUM, the anatomic or physiologic entity.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal searching behavior. The variable introductory phase of an instinctive behavior pattern or sequence, e.g., looking for food, or sequential courtship patterns prior to mating.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Axenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Coisogenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Congenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Domestic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Farm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, GMO' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Genetically Engineered' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Genetically Modified' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Inbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Newborn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Nondomestic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Outbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Poisonous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Suckling' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Transgenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Transgenic Founder' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Wild' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal, Zoo' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animal-Human Bondings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animalia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals %28%1963-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals %28%1966-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals Inbred Strain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals Inbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals Outbred Strain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals Outbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals considered to be wild or feral or not adapted for domestic use. It does not include wild animals in zoos for which ANIMALS, ZOO is available.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals grouped according to ecological, morphological or genetic populations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals having a vertebral column, members of the phylum Chordata, subphylum Craniata comprising mammals, birds, reptiles, amphibians, and fishes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals not contaminated by or associated with any foreign organisms.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals produced by the mating of littermates or siblings over multiple generations. The resultant strain of animals is virtually identical genotypically. Highly inbred animal lines allow the study of certain traits in a relatively pure form. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals that are generated from breeding two genetically dissimilar strains of the same species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals that have no spinal column. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals which have become adapted through breeding in captivity to a life intimately associated with man. They include animals domesticated by man to live and breed in a tame condition on farms or ranches %28%e.g., horses, cattle, sheep%29% and those raised or kept for pleasure and companionship %28%e.g., dogs, cats, horses%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Axenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Coisogenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Congenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Domestic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Farm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, GMO' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Genetically Engineered' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Genetically Modified' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Inbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Laboratory' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Laboratory %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Laboratory %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Newborn' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Newborn %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Outbred Strains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Poisonous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Suckling' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Transgenic Founder' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Wild' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals, Zoo' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animals/anatomy %26% histology %28%1966-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animate or inanimate sources which harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs should be distinguished from vectors and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animation %28%PT%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Animation %5B%Publication Type%5D%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Channels, Voltage-Dependent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Exchange Protein 1, Erythrocyte' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Exchange Resins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Exchanger, Erythrocyte' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Exchangers %28%Proteins%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Exchangers %28%Resins%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Gaps' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Pump' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Transport Protein, Erythrocyte' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Transport Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion Transporters, Organic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anion-Selective Channels Voltage-Dependent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anionic Amino Acid Transport Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anionic Amino Acid Transport Systems' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anionic Amino Acid Transporters' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anionic Neutrophil Activating Peptide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anionic Neutrophil-Activating Peptide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anions %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniridia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisakiases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisakiasis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisakis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anise %28%2001-2002%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anise, Star' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Aniseikonia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisocoria' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisoles' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisoles %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisoles %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisoles %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisoles %28%1974-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisometropia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisometropic Amblyopias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisomycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisotropies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisotropies, Fluorescence' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisotropy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisoylated Plasminogen-Streptokinase Activator Complex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anistreplase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anistreplase Madaus Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anistreplase Reusch Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anistreplase Roberts Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anistreplase, Monmouth Brand' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anisyldithiolthionine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Bones' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Injuries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Injury' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Joint' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Joint %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Joints' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Lateral Ligament' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle Lateral Ligaments' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankle/injuries %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankles' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyloses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyloses, Dentoalveolar' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyloses, Tooth' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosing Hyperostoses, Vertebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosing Hyperostosis, Vertebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosing Spondylitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosing Spondylitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosis %28%1966-1998%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosis, Dentoalveolar' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankylosis, Tooth' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyrin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyrin Like Repeats' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyrin Repeat' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyrin Repeats' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyrin-Like Repeat' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ankyrins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anlage Tumor, Retinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anlage Tumors, Retinal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annelida' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annelida %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annelids of the class Hirudinea. Some species, the bloodsuckers, may become temporarily parasitic upon animals, including man. Medicinal leeches %28%HIRUDO MEDICINALIS%29% have been used therapeutically for drawing blood since ancient times.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A3 %28%1980-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A4' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A6' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin A7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin I' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin II, P36' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin II, P90 Complex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin III' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin IV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin IX' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin V' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin VI' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin VII' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin VIII' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin X' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexin XI' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annexins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anniversaries and Special Events' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anniversary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anniversary Reactions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annona' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annonaceae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual Implementation Plan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual Report' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual Reports' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual Reports %28%PT%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual Reports %5B%Publication Type%5D%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual cereal grass of the family POACEAE and its edible starchy grain, rice, which is the staple food of roughly one-half of the world%27%s population.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annual statements reviewing the status of the administrative and operational functions and accomplishments of an institution or organization.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Annular Groove' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anochlesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anochlesias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anodes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anodonta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anodontia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anodynes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anogenital ulcers caused by Calymmatobacterium granulomatis as distinguished from lymphogranuloma inguinale %28%see LYMPHOGRANULOMA VENEREUM%29% caused by CHLAMYDIA TRACHOMATIS. Diagnosis is made by demonstration of typical intracellular Donovan bodies in crushed-tissue smears.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoikis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomalies, Coronary Vessel' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomalies, Nervous System' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomalies, Pupillary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomalous Cervical Rib Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomalous venous drainage of the right lung into the inferior vena cava, with hypoplasia of the right lung. The scimitar-shaped radiographic shadow of the anomalous vein gives the syndrome its name.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly of the tooth, found chiefly in upper lateral incisors. It is characterized by invagination of the enamel at the incisal edge.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly, Coronary Vessel' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly, Ebstein%27%s' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly, Nervous System' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly, Pelger-Huet' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly, Pupillary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomaly, Taussig-Bing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomia, Color' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomias, Color' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomic Aphasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomic Dysphasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomic Dysphasias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomie' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anomura' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anonym' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anonymous Testing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anonymous, Alcoholics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anonyms and Pseudonyms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anopheles' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anopheles %28%1965-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anopheles gambiae' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anophthalmia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anophthalmias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anophthalmos' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoplura' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorectics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexia %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexia Nervosa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexia Nervosas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexia/drug therapy %28%1975-1996%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anorexigenic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anostraca' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anovulation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anovulation %28%1975-1977%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anovulations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxemia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxemias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia %28%1968-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia %28%1971-1999%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia Ischemia, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia Ischemia, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia, Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia, Cellular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia, Fetal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia-Ischemias, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxia-Ischemias, Cerebral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxias, Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxias, Cellular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Brain Injuries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Brain Injury' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Encephalopathies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Encephalopathy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Injuries, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Injury, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Ischemic Brain Injury' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic Ischemic Encephalopathy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic-Ischemic Brain Injuries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic-Ischemic Brain Injury' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anoxic-Ischemic Encephalopathies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ansa Lenticularis Nucleus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ansamycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ansatipine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anseriformes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anserine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Answering Service' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Answering Services' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ant Venom' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ant Venoms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ant-Eater, Spiny' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Ant-Eaters, Spiny' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antacids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antacids %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antacids %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonism, Drug' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonism, Microbial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonisms, Drug' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonisms, Microbial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonist of urate oxidase. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonist, Adrenergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonist, Cholinergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonist, GABA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonist, Prostaglandin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, 5 HT' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, 5 Hydroxytryptamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, 5-HT' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, 5-Hydroxytryptamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Acetylcholine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Adrenergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Adrenergic Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Aldosterone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Androgen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Angiogenetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Angiogenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Angiotensin Converting Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Angiotensin-Converting Enzyme' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Blood Platelet' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Cholinergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Cysteine Proteinase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Dopamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Dopamine Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Dopaminergic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, EAA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Estradiol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Estrogen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Excitatory Amino Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Exogenous Calcium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Folic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, GABA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, GABA Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Glutamate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Glutamate Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Heparin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Histamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Histamine H1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Histamine H1 Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Histamine H2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Hormone' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Insulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Kininase II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Leukotriene' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Leukotriene Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Metal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Muscarinic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Narcotic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Nicotinic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Opioid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Organophosphate Insecticide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Organothiophosphate Insecticide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Platelet' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Prostaglandin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Prostaglandin Synthesis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Protease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Protein Synthesis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Serotonin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Sulfhydryl Compound' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Sulfhydryl Compounds' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Thyroid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, Vasoactive' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antagonists, gamma-Aminobutyric Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antarctic Regions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antarctic Regions %28%1991-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antazoline' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anteater, Spiny' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anteaters, Spiny' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antecedent, Plasma Thromboplastin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antelope' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antelopes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antelopine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antelopines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antemortem Diagnoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antenatal Diagnoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antenatal Diagnosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antennapedia Homeodomain Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antennapedia Protein' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antennapedia homeodomain protein is a homeobox protein involved in limb patterning in ARTHROPODS. Mutations in the gene for the antennapedia homeodomain protein are associated with the conversion of antenna to leg or leg to antenna DROSOPHILA.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antepartum CTG' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Aphasia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Aphasias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cerebral Arteries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cerebral Artery' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cerebral Artery Aneurysm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cerebral Artery Infarction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cerebral Artery Stroke' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cervical Pains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Chamber' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Chamber %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Chamber %28%1966-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Chamber Endothelium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Chambers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Circulation Infarction, Brain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Circulation Transient Ischemic Attack' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Commissure Nucleus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Communicating Artery Aneurysm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Compartment Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Compartment Syndrome %28%1972-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Compartment Syndromes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Corneal Epithelium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cranial Fossa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cruciate Ligament' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Cruciate Ligaments' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Eye Segment' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Eye Segments' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Fronto-Polar Epilepsies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Fronto-Polar Epilepsy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Horn Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Horn Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Horn Neuron' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Horn Neurons' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Hypothalamic Area' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Hypothalamic Areas' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Hypothalamic Nucleus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Hypothalamus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Knee Pain Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Longitudinal Ligaments' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Neck Pain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Neck Pains' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Nuclear Group' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Optic Neuritides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Optic Neuritis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Perforated Substances' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Pituitary Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Pituitary Gland' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Pituitary Glands' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Pituitary Hormones' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Pituitary Hyposecretion Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Spinal Artery Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Temporal Lobectomy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Thalamic Nuclei' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Tibial Arteries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Tibial Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Tibial Syndromes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Uveitides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior Uveitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterior midline brain, cranial, and facial malformations resulting from the failure of the embryonic prosencephalon to undergo segmentation and cleavage. Alobar prosencephaly is the most severe form and features anophthalmia; cyclopia; severe MENTAL RETARDATION; CLEFT LIP; CLEFT PALATE; SEIZURES; and microcephaly. Semilobar holoprosencepaly is characterized by hypotelorism, microphthalmia, coloboma, nasal malformations, and variable degrees of mental retardation. Lobar holoprosencephaly is associated with mild %28%or absent%29% facial malformations and intellectual abilities that range from mild mental retardation to normal. Holoprosencephaly is associated with CHROMOSOME ABNORMALITIES.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterodorsal Nucleus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterograde Amnesia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterograde Amnesias' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterograde Memory Loss' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anterograde Memory Losses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anteromedial Nucleus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anteroventral Nucleus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintic isolated from the dried unexpanded flower heads of Artemisia maritima and other species of Artemisia found principally in Russian and Chinese Turkestan and the Southern Ural region. %28%From Merck, 11th ed.%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintic used in grazing animals for fasciola and cestode infestations.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintic. It has been shown to be useful in fasciola infections in sheep.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintics %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintics %28%1966-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintics %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintics %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthelmintics %28%1966-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthemis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthemis nobilis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anther, Plant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocerotophyta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocidaris' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocyanidin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocyanidin Polymers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocyanidins %28%1977-2003%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocyanin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthocyanins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthozoa' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthozoa %28%2002-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracenediones' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracenes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracenes %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracenes %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracosilicoses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracosilicosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthracyclines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthralin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthramycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilate PR Transferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilate Phosphoribosyltransferase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilate Synthase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilate Synthetase' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilic Acids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilic Acids %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilic Acids %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranilic Acids %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranoids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthranol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthraquinones' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthraquinones %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthraquinones %28%1972-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthrax' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthrax Vaccines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropoidea %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropoidea %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropoidea %28%1966-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropoidea %28%1981-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropoids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropology' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropology %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropology, Cultural' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropology, Forensic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropology, Physical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropometry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropometry %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropometry %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthropometry %28%1966-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anthroposophy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti AIDS Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti AIDS Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Abortion Groups' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Adrenergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Allergic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Allergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Allergy Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Angiogenetic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Angiogenic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Anxiety Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Anxiety Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Arrhythmia Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Arrhythmia Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Arrhythmics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Asthmatic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Asthmatic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Asthmatics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Australia Antigens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti BaPDE' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Bacterial Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Cancer Drug Screens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Carcinogenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Carcinogenic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Cholinergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Cholinesterases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti D Immunoglobulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti DNA Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Diuretic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Dyskinesia Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti GBM Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Glomerular Basement Membrane Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti HAV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti HBAg' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti HCV Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti HIV Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti HIV Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti HIV Positivity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Hepatitis B Antigens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Hepatitis C Virus Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Human Globulin Complement Dependent Cytotoxicity Test' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Human Globulin Complement Dependent Cytotoxicity Tests' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Human Globulin Consumption Test' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Hypertensive Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Hypertensive Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Hypertensives' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Idiotype Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Infective Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Infective Agents, Local' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Infective Agents, Topical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Infective Agents, Urinary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Inflammatories' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Inflammatory Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Inflammatory Agents, Non Steroidal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Inflammatory Agents, Nonsteroidal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Malarials' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Microbial Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Mutagenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Mycobacterial Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Neutrophil Cytoplasmic Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Neutrophil Cytoplasmic Antibody' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Obesity Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Obesity Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Oncogenes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Phospholipid Antibody Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Phospholipid Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Rejection Therapy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Retroviral Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Rheumatic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Rheumatic Agents, Non Steroidal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Rheumatic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense Elements' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense Oligodeoxyribonucleotides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense Oligonucleotides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense Oligoribonucleotide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense Oligoribonucleotides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense Probes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Sense RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Shock Trousers' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Thymocyte Globulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Ulcer Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Ulcer Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Venins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Venoms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Worm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti Yo Associated Paraneoplastic Cerebellar Degeneration' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti emetics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti gamma Globulin Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-AIDS Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-AIDS Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Abortion Group' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Adrenergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Allergic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Allergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Allergy Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Angiogenetic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Angiogenic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Antibodies %28%1966-1969%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Anxiety Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Anxiety Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Apoptotic Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmia Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmia Agents %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmia Agents %28%1966-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmia Agents %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmia Agents %28%1976-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmia Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Arrhythmics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Asthmatic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Asthmatic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Asthmatics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Australia Antigens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-BaPDE' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Bacterial Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex %28%CD3/Ti%29%. This biochemically purified IMMUNOGLOBULIN G is obtained through the fusion of mouse myeloma cells to lymphocytes from immunized animals to produce hybridomas that secrete specific antibodies to the T3 %28%CD3%29% antigens of human T-lymphocytes. It is often used as an IMMUNOSUPPRESSIVE AGENTS in TRANSPLANTATION.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Cancer Drug Screen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Cancer Drug Screens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Carcinogenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Carcinogenic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Cholinergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Cholinesterases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-D-Immunoglobulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-DNA Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Diuretic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Dyskinesia Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-GBM Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-GBM Diseases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Glomerular Basement Membrane Disease' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HAV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HBAg' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HCV Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HIV Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HIV Agents %28%1998-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HIV Agents/therapeutic use %28%1997-2000%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HIV Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HIV Positivities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-HIV Positivity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Hepatitis B Antigens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Hepatitis C Virus Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Human Globulin Complement-Dependent Cytotoxicity Test' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Human Globulin Consumption Test' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Hypertensive Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Hypertensive Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Hypertensives' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Idiotype Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Idiotypic Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1966-1985%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1966-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1981-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1983-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents %28%1997-2000%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Local' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Local %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Local %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Quinolone %28%1987-2001%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Quinolone %28%1989-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Topical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Urinary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Urinary %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Urinary %28%1966-1985%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Urinary %28%1981-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Infective Agents, Urinary %28%1983-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatories' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Agents %28%1966-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Agents %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Agents, Non-Steroidal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Agents, Non-Steroidal %28%1987-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Agents, Nonsteroidal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Inflammatory Analgesics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Lewisite Agent, British' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Lewisite, British' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Malarials' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Microbial Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Mutagenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Neutrophil Cytoplasmic Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Neutrophil Cytoplasmic Antibody' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Obesity Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Obesity Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Oncogene' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Oncogenes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Phospholipid Antibody Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Phospholipid Syndrome' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Rejection Therapies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Rejection Therapy' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Retroviral Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Rheumatic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Rheumatic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense Elements' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense Oligodeoxyribonucleotides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense Oligonucleotides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense Oligoribonucleotide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense Oligoribonucleotides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense Probes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Sense RNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Shock Trousers, Military' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Thymocyte Globulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Thymocyte Globulins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Ulcer Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Ulcer Agents %28%1977-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Ulcer Agents %28%1977-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Ulcer Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Venins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Venoms' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-emetics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-gamma Globulin Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-inflammatory agents that are not steroids. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Certain NSAIDs also may inhibit lipoxygenase enzymes or phospholipase C or may modulate T-cell function. %28%AMA Drug Evaluations Annual, 1994, p 1814-5%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anti-inflammatory analgesic. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiactivator, Plasmin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiadrenergic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiadrenergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiaggregants, Blood Platelet' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiaggregants, Platelet' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiallergic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiallergic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiallergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiallergy Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiandrogens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiangiogenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiaris' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiarrhythmia Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiarrhythmia Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiarrhythmic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiasthmatic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiasthmatic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiasthmatics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial Drug Resistance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial against mainly gram negative organisms. It is used for urinary tract and intestinal infections.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial used topically in burn therapy. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibacterial, potentially toxic, used to treat certain skin diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibioses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic 10676' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic A23187' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic Associated Colitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic Premedication' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic Premedications' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic Prophylaxis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic analog of CLOXACILLIN. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic and mycotoxin from Aspergillus niveus and Penicillium citrinum.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic complex obtained from Streptomyces bambergiensis containing mainly Moenomycins A and C. They are used as feed additives and growth promoters for poultry, swine, and cattle.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C. It acts by inhibiting translation during protein synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic macrolide produced by Streptomyces antibioticus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic obtained from a Streptomyces variant considered as possibly effective against Streptococcus pyogenes infections. It may promote growth in poultry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic pigment produced by Pseudomonas aeruginosa. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex %28%GENTAMICINS%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic substance produced by Streptomyces garyphalus.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotic substance produced by various Streptomyces species. It is an inhibitor of enzymatic activities that involve glutamine and is used as an antineoplastic and immunosuppressive agent.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibioticos Brand of Benzathine Benzylpenicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibioticos Brand of Dicloxacillin Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibioticos Brand of Penicillin G Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1969%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1980%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1982%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1968-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1970-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1971-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1980-1982%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics %28%1987-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics inhibiting the growth of or killing fungi and used in the treatment of various fungal diseases.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal %28%1969-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antifungal %28%1973-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1967-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1967-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1967-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1967-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1967-1975%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1967-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1971-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1972-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1973-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antineoplastic %28%1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Antitubercular' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Carbapenem' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Cephalosporin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Cephamycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Combined %28%1989-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Lactam %28%1983-1985%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Lactam %28%1983-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Macrolide %28%1987-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Monobactam' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Penicillin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics, Thienamycin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibiotics/therapeutic use %28%1966-1995%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1966-1969%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1966-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1966-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1975-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1984-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1985-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1986-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies %28%1997-2004%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies directed against immunogen-coupled phosphorylated PEPTIDES corresponding to amino acids surrounding the PHOSPHORYLATION site. They are used to study proteins involved in SIGNAL TRANSDUCTION pathways. %28%From Methods Mol Biol 2000; 99:177-89%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher %28%H-D%29%, and Paul-Bunnell %28%P-B%29%. Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies from an ndividual that react with ISOANTIGENS of another individual of the same species.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies produced by clones of cells such as those isolated after hybridization of activated B LYMPHOCYTES with neoplastic cells. These hybrids are often referred to as HYBRIDOMAS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic HELMINTH ANTIGENS. The IMMUNOGLOBULIN E class of immunoglobulins is usually formed and released, but IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; and IMMUNOGLOBULIN A may also occur.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic PROTOZOAN ANTIGENS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies reactive with HIV ANTIGENS. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies reactive with the HTLV-I ANTIGENS. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies reactive with the HTLV-II ANTIGENS. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies specific to INSULIN. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies specific to STREPTOLYSINS which indicate STREPTOCOCCAL INFECTIONS.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies that can catalyze a wide variety of chemical reactions. They are characterized by high substrate specificity and share many mechanistic features with enzymes.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES %28%e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response%29%. Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. %28%Rosen et al., Dictionary of Immunology, 1989%29%%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies that react with self-antigens %28%AUTOANTIGENS%29% of the organism that produced them.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface %28%Australia%29% and core of the Dane particle and those to the %22%e%22% antigens.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies which react with the individual structural determinants %28%idiotopes%29% on the variable region of other antibodies.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, AIDS' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, ATLV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Allotypic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti DNA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti Idiotypic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti-Idiotype' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti-Idiotypic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti-Idiotypic %28%1980-1983%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti-Neutrophil Cytoplasmic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anti-gamma Globulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Anticardiolipin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antigamma Globulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antilymphocyte' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antineutrophil Cytoplasmic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antinuclear' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antiphospholipid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antiphosphopeptide Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Antiphosphopeptide-Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Archaeal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, BLV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Bacterial' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Bacterial %28%1974-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Bacterial %28%1984-1997%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Bifunctional' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Bispecific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Bispecific Monoclonal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Blocking' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Catalytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Deltaretrovirus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Enhancing' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Fluorescent Antinuclear' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Fungal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HIV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HIV Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HIV-Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV I' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV III' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV-BLV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV-I' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV-II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV-III' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, HTLV-III-LAV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Helminth' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Hepatitis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Hepatitis A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Hepatitis B' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Heterogenetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Heterologous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Heterophil' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Heterophile' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Heterotypic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Insulin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Intravenous' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, LAV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Lymphadenopathy Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Lymphadenopathy-Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Lymphocytotoxic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal %28%1981-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal %28%1982-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal %28%1982-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal %28%1982-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal %28%1986-1992%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal/diagnostic use %28%1980-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Monoclonal/therapeutic use %28%1984-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Neoplasm' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Neoplasm %28%1980-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Phospho Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Phospho-Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Phosphopeptide Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Phosphopeptide-Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Phosphorylation State-Specific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Plant Derived' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Plant-Derived' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Protozoan' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Recombinant Plant' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Thyroid-Stimulating' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Tumor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral %28%1973-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral %28%1981-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral %28%1982-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral %28%1983-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral %28%1983-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Viral %28%1986-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Xenogeneic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, Xenogenic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, especially IGE, that bind to tissue of the same species so that ANTIGENS induce release of HISTAMINE and other vasoactive agents. HYPERSENSITIVITY is the clinical manifestation.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Affinities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Affinity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Avidities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Binding Site' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Binding Sites' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Classes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Coated Bacteria Test, Urinary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Deficiency Syndromes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Dependent Cell Cytotoxicity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Dependent Enhancement' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Dissociations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Diversities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Diversity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Enzyme Technic, Unlabeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1966-1968%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1966-1969%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1966-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1966-1984%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1969-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Formation %28%1972-1973%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Positivities, HIV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Positivity, HIV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Producing Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Production' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Response' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Responses' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Secreting Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Specificities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Specificity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Specificity %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Specificity %28%1970-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Specificity %28%1970-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Syndrome, Anti-Phospholipid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Syndrome, Antiphospholipid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technic, Enzyme-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technic, Fluorescent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technic, Peroxidase-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technics, Enzyme-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technics, Fluorescent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technics, Peroxidase-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technique, Enzyme-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technique, Fluorescent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Technique, Peroxidase-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Techniques, Enzyme-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Techniques, Fluorescent' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Techniques, Peroxidase-Labeled' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Toxin Conjugates' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Toxin Hybrids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Transfer, Passive' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody Transfers, Passive' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Allotypic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Anti-Neutrophil Cytoplasmic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Anticardiolipin' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Antilymphocyte' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Antineutrophil Cytoplasmic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Antinuclear' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Antiphospholipid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Catalytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Forssman' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Lymphocytotoxic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Phosphospecific' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody, Thyroid Stimulating' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Coated Bacteria Test, Urinary' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Dependent Cell Cytotoxicities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Dependent Cell Cytotoxicity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Dependent Cell Cytoxicities' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Dependent Cell Cytoxicity' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Dependent Enhancement' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Dependent Enhancements' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Producing Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Producing Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Secreting Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Toxin Conjugates' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Toxin Conjugates, Monoclonal' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antibody-Toxin Hybrids' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticancer Drug Combination' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticancer Drug Combinations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticancer Drug Sensitivity Tests' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticarcinogenic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticarcinogenic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticarcinogens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticardiolipin Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticardiolipin Antibody' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticestodal Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremic Agents %28%1966-1968%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremic Agents %28%1966-1972%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremic Agents %28%1966-1979%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremic Agents %28%1966-1987%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholesteremics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholinergics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholinesterase Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholinesterase Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticholinesterases' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticipation, Genetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticipations, Genetic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticipatory Vomiting' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticoagulant Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticoagulant Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticoagulant, Lupus' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticoagulants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticoagulants %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticodon' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticodons' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsant Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsants %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsants %28%1966-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsants %28%1966-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsive Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Anticonvulsive Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressant Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressant Drugs, Tricyclic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressants, Atypical' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressants, Tricyclic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1966-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1966-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1968-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1977-1988%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1977-1994%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents %28%1979-1991%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents, Second Generation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents, Second-Generation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Agents, Tricyclic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Drugs, Second Generation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidepressive Drugs, Second-Generation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiabetic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiabetic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiarrheal Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiarrheal Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiarrheals' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiuretic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiuretic Hormone, Inappropriate Secretion' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidiuretic Hormones' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidotes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antidromic Potential' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiemetic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiemetic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiemetics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiemetics %28%1977-1981%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiepileptic Drugs' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiepileptics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiestrogen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antiestrogens' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifertility Vaccines' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifibrinolysins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifibrinolytic Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifibrinolytic hemostatic used in severe hemorrhage. ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifibrinolytics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifoaming Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifolates' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Glycopeptides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Peptides' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Proteins' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Proteins, Type I' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Proteins, Type II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Proteins, Type III' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifreeze Proteins, Type IV' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal Agents' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal Agents %28%1966%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal Agents %28%1966-1971%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal Antibiotics' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal Drug Resistance' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal antibiotic isolated from several species, including Acremonium %28%Cephalosporium%29%, Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function and is used as a biochemical tool.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antifungal metabolite from several fungi, mainly Trichoderma viride; inhibits protein synthesis by binding to ribosomes; proposed as antifungal and antineoplastic; used as tool in cellular biochemistry.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigamma Globulin Antibodies' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen 4F2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen 4F2, Heavy Chain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen 60B8 A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen 60B8-A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Antibody Complex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Antibody Complexes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Antibody Reactions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Chenodeoxycholic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Danazol' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Dextromoramide Tartrate' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Doxapram Hydrochloride' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Mefenamic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Mesalamine' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Ursodeoxycholic Acid' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Brand of Warfarin Sodium' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Bronchial Provocation Tests' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CA 125' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CA 15 3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CA 19 9' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CA-125' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CA-15-3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CA-19-9' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen CD94' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Family, Hermes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen GP 330, Nephritis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Ki 67' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Ki-67' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Ki67' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen L1, Myelomonocytic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Mimicries' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Mimicry' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Presentation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Presentations' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Presenting Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Processings' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptor' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptor, Mo1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptor, T-Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors, B Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors, B-Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors, T Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors, T-Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors, T-Cell, alpha-beta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Receptors, T-Cell, gamma-delta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen S 100' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen T Cell Receptor, alpha Chain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen T Cell Receptor, delta Chain' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen Variation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen p150,95' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen p40x, Transforming' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, 27E10' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, 4B4' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, 60B8-A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, 60B8-B' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, A5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, A9' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Australia' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, B-Cell Blast-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, B220' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, B7 1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, B7 2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, B7-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, B7-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Bacterial O' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ber-H2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA 125' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA 15-3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA 15.3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA 19-9' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA 19.9' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA-125' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA-15-3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CA-19-9' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD 120a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD 120b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD10' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD104' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD106' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD115' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD116' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD11a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD11b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD11c' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD120a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD120b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD13' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD135' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD140a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD140b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD146' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD147' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD154' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD164' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD19' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD20' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD21' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD22' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD23' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD24' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD26' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD27' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD28' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD29' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD30' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD31' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD34' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD35' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD36' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD4' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD40' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD41' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD42a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD42b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD42c' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD42d' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD43' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD44' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD45' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD46' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD47' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD49a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD49b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD49c' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD49d' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD49e' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD49f' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD51' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD54' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD56' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD57' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD58' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD61' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD62E' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD62L' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD62P' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD66e' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD73' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD79' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD79a' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD79b' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD8' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD82' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD86' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD88' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD90' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD94' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CD98' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CDw29' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, CDw40' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Carcinoembryonic' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Carcinoma Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Carcinoma-Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Cell Surface' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Class II' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Cystic Fibrosis' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, EG2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Epithelial Membrane' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Factor VIII-Related' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Forssman' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Gastrointestinal Cancer' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, H-Y' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-A1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-A2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-A3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-B27' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-B35' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-B7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-B8' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR4' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR6' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HLA-DR7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HNK-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HUPL-ml Surface' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, HY' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Hepatitis D' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Histocompatibility' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, I-A' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, IA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, IAP-50' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Igbeta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Jo-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ki-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ki-67' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, L1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Large T' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Le' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Leu-19' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Leu-7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Leu-8' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Leukocyte Common' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ly-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ly-5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ly-6' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Ly-7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Lyt 1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Lyt-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Lyt-1.2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Lyt-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Lyt-3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Lyt-3.2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, MIB-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Mac-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Macrophage-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Macrophage-2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Mel-14' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Mo1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, NKH-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, O' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, OKM5' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Proliferating Cell Nuclear' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, RT7' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Small T' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Surface' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, T' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, T-Cell Activation' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, T10' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, T3' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, TPA' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, TQ1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Tdt' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Thy-1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Thy-1.1' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Thy-1.2' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, Tissue Polypeptide' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, delta' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen, p150,95' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-1, Lymphocyte Function-Associated' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-4, Very Late' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Complex' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Complex %28%1970-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Complexes' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reaction' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions %28%1966-1967%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions %28%1966-1968%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions %28%1966-1970%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions %28%1966-1976%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions %28%1966-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Antibody Reactions %28%1968-1989%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Presenting Cell' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Presenting Cells' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Presenting Cells %28%1985-1986%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-Presenting Cells/immunology %28%1985-1993%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigen-type substances that produce immediate hypersensitivity %28%HYPERSENSITIVITY, IMMEDIATE%29%.%A% ' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigenic Determinants' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigenic Determinants %28%1966-1990%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigenic Determinants %28%1970-1974%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigenic Determinants %28%1970-1978%29%' = 0).
% 42.08/41.98 fof(interp, fi_functors, 'Antigenic Determinants %28%1970-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Determinants %28%1970-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Determinants %28%1972-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Determinants %28%1975-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Determinants %28%1982-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Determinants, Immunodominant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Mimicries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Modulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Modulations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Switching' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Variability' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic Variation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic characteristics and DNA fingerprint patterns identified from blood stains. Their primary value is in criminal cases.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic determinants recognized and bound by the B-cell receptor. Epitopes recognized by the B-cell receptor are located on the surface of the antigen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigenic determinants recognized and bound by the T-cell receptor. Epitopes recognized by the T-cell receptor are often located in the inner, unexposed side of the antigen, and become accessible to the T-cell receptors after proteolytic processing of the antigen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1966-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1971-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1977-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1979-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1979-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1981-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1983-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens %28%1992-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens associated with HUMAN T-LYMPHOTROPIC VIRUS 1.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens associated with HUMAN T-LYMPHOTROPIC VIRUS 2. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus %28%HIV%29%; also called HTLV-III-associated and lymphadenopathy-associated virus %28%LAV%29% antigens.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens associated with the DELTARETROVIRUS; HTLV-I ANTIGENS and HTLV-II ANTIGENS belong to this group.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens from any of the hepatitis viruses including surface, core, and other associated antigens.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens from the genus TRICHOPHYTON. Trichophytin has been used in studies of immunological responses to these dermatophytes.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens from the house dust mites %28%DERMATOPHAGOIDES%29%, mainly D. farinae and D. pteronyssinus. They are proteins, found in mite feces or mite extracts, that can cause ASTHMA and other allergic diseases such as perennial rhinitis %28%RHINITIS, ALLERGIC, PERENNIAL%29% and atopic dermatitis %28%DERMATITIS, ATOPIC%29%. More than 11 groups of Dermatophagoides ALLERGENS have been defined. Group I allergens, such as Der f I and Der p I from the above two species, are among the strongest mite immunogens in humans.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface %28%HEPATITIS B SURFACE ANTIGENS%29%, core %28%HEPATITIS B CORE ANTIGENS%29%, and other associated antigens, including the HEPATITIS B E ANTIGENS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens of the virions of HEPACIVIRUS, their surface, core, or other associated antigens.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens produced by various strains of HEPATITIS A VIRUS such as the human hepatitis A virus %28%HEPATITIS A VIRUS, HUMAN%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens produced by various strains of HEPATITIS D VIRUS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens stimulating the formation of, or combining with heterophile antibodies. They are cross-reacting antigens found in phylogenetically unrelated species.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens that exist in alternative %28%allelic%29% forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens which may directly stimulate B lymphocytes without the cooperation of T lymphocytes.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, 2H4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, AIDS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, ATLV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Anti-Australia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Anti-Hepatitis B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Archaeal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Autologous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, B-Cell Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, B-Lymphocyte Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, B-Lymphocyte Leu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, B220' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, BLV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Bacterial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Bacterial %28%1971-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Bacterial %28%1981-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Bacterial %28%1981-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Bacterial %28%1982-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Ber-H2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Blood Group' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1985-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1989-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1989-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1989-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1990-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1991-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1991-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1993-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1994-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1994-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1995-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1996-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD %28%1996-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD 16' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD 21' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD 23' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD 32' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD 35' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD 64' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD10' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD104' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD106' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD107a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD107b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD11' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD115' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD116' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD117' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD11a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD11b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD11c' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD120a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD120b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD122' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD124' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD126' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD127' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD13' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD130' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD135' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD14' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD140a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD140b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD142' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD143' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD146' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD147' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD15' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD154' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD164' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD166' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD18' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD19' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD20' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD21' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD22' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD23' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD24' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD26' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD27' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD28' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD29' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD3' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD30' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD31' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD32' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD34' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD35' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD36' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD38' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD40' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD41' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD42a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD42b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD42c' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD42d' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD43' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD44' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD45' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD45R' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD45R0' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD45RA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD45RB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD45RO' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD46' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD47' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD49a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD49b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD49c' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD49d' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD49e' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD49f' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD5' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD51' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD54' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD55' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD56' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD57' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD58' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD59' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD61' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD62E' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD62L' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD62P' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD64' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD66e' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD7' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD73' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD79' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD80' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD82' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD86' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD88' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD90' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD94' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD95' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD98' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD98 Heavy Chain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CD98 Light Chains' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CDw121a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CDw128a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CDw128b' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, CDw32' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Cancer-Associated Carbohydrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Carbohydrate, Tumor-Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Cell Surface' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Class I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Class II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Deltaretrovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Dermatophagoides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1984-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1988-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1988-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1988-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1988-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1988-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1989-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1989-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1989-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1990-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1991-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation %28%1999-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, B Lymphocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, B-Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, B-Lymphocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, B-Lymphocyte %28%1988-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, B-Lymphocyte %28%1988-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, Myelomonocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, Myelomonocytic %28%1989-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, Myelomonocytic %28%1989-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, Myelomonocytic %28%1990-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T Lymphocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1986-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1986-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1987-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1988-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1988-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1988-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1989-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1989-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Differentiation, T-Lymphocyte %28%1990-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Extractable Nuclear' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Fungal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Fungal %28%1973-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, H-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, H-D' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, H2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HIV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HIV Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HIV-Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HL-A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA D' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-BR' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-D' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-D-Related' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-DC' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-DP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-DQ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-DR' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-DS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-Dw' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-LB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-MB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-MT' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-PL' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HLA-SB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV-BLV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV-I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV-II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV-III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, HTLV-III-LAV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hanganutziu-Deicher' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Helminth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Helminth/immunology %28%1985-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hepatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hepatitis A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hepatitis B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hepatitis Be' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hepatitis D' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Hepatitis delta' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Heterogenetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Heterologous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Heterophil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Heterophile' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Histocompatibility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, House Dust Mites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Human Ia-Like' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Human Immune-Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Human Immune-Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Human Leukocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Human Platelet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Ia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Ia-Like' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Immune Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Immune Response %28%1981-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Immune Response %28%1981-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Immune-Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Immune-Response-Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Ki 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Ki-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, L-CA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, L3T4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, LAV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, LD' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Le' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leu-11' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leu-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leu-M5' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leukemia, Common Acute Lymphoblastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leukocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Leukocyte Common' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Ly' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Lymphadenopathy Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Lymphadenopathy-Associated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Marker' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Minor Lymphocyte Stimulatory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Minor Lymphocyte-Stimulating' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Mls' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Myelomonocytic Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Myelomonocytic, Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1973-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1973-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1973-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1973-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1975-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1977-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1982-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1984-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1985-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Neoplasm %28%1986-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Nuclear' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, O' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Paul-Bunnell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Plasma Cell, PC-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Platelet Specific' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Platelet-Specific' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Polyomavirus Transforming' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Polyomavirus Tumor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Protozoan' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Protozoan %28%1985-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Protozoan/immunology %28%1985-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, RT7' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, SD' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, SV40 T' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1978-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1979-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1979-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1979-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1979-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1979-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1981-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1983-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1984-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1984-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1985-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1986-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1987-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1988-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1988-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1988-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1989-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1991-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1992-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1993-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface %28%1995-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface/analysis %28%1979-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Surface/immunology %28%1979-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T Independent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T-Cell Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T-Cell T4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T-Cell T8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T-Independent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T-Lymphocyte Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T-Lymphocyte Leu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T200' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T3' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, T6' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, TI-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Thy 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Thy-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Thymus-Independent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Transplantation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Tumor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Tumor-Associated Carbohydrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Tumor-Associated, Carbohydrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Tumor-Associated, Carbohydrate %28%1988-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Tumor-Associated, Carbohydrate %28%1989-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, UCHL1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, VLA Activation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, VLA Differentiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1973-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1977-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1977-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1983-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1983-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1984-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1985-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1985-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral %28%1988-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral Neoplasm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral T' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral Tumor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral, Tumor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral, Tumor %28%1984-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral, Tumor %28%1984-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Viral, Tumor %28%1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Virus Transforming' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Xenogeneic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, Xenogenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, e' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, env' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens, gag' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigens/immunology %28%1981-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin Augmented Lymphocytotoxicity Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin Augmented Lymphocytotoxicity Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin Consumption Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin Consumption Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin-Augmented Lymphocytotoxicity Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulin-Augmented Lymphocytotoxicity Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiglobulins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigout Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigravity Suits' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigua' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antigua and Barbuda' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihemophilic Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiheparin Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihistamines, Classical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihistamines, Second Generation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihistaminics, Classical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihistaminics, H1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihistaminics, H2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihuman Globulin Consumption Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihyperlipemics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihyperlipidemics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Agents %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Agents %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Agents %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Agents %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Agents %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensive Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antihypertensives' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinfective Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinfective Agents, Local' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinfective Agents, Topical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinfective Agents, Urinary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinflammatories' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinflammatory Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinflammatory Agents, Non Steroidal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiinflammatory Agents, Nonsteroidal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antileprotic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic Agents %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic Agents %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic Agents %28%1976-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic agent that lowers cholesterol and triglycerides. It decreases low density lipoproteins and increases high density lipoproteins.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilipemics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphoblast Globulin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphocyte Antibody' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphocyte Globulins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphocyte Immunoglobulins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphocyte Serum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphocyte Serum %28%1968-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antilymphocyte Serums' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimalarial Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimalarial Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimalarials' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimalarials %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimanic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimanic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimanics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimetabolites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimetabolites %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimetabolites %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimetabolites that are useful in cancer chemotherapy.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimetabolites, Antineoplastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimicrobial Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimicrobial Cationic Peptides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimicrobial Drug Resistance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimicrobial Drug Resistances' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimicrobial against Gram negative and some Gram positive bacteria. It is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimitotic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimitotic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimitotics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony %28%1969-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony %28%1970-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony Gluconate Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony Potassium Tartrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony Sodium Gluconate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimony, Tartrated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimonyltartrate, Potassium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimuscarinic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimutagenic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimutagens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimycin A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antimycobacterial Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinatalist Policies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinematodal Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinematodal Agents %28%1974-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinematodal Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinematodal agent used mainly for livestock. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinematodal benzimidazole used in veterinary medicine.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinematodals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agent Resistance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agent, Combined' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1973%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1966-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1975-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1982-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1984-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents %28%1988-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents or specific %28%1966-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents, Alkylating' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents, Combined' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents, Combined/adverse effects/therapeutic use %28%1980-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents, Hormonal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents, Phytogenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Agents/therapeutic use %28%1984-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Alkylating Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Alkylating Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Antibiotics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Antimetabolites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Chemotherapy Protocol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Combined Chemotherapy Protocols' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Combined Chemotherapy Protocols %28%1983-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Combined Chemotherapy Regimens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Drug Combination' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Drug Combinations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Drug Resistance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Drugs, Alkylating' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Drugs, Hormonal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Hormonal Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Hormonal Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Protocol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic Protocols' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic agent that is also used as a veterinary anesthetic. It has also been used as an intermediate in organic synthesis. Urethane is suspected to be a carcinogen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. %28%From AMA Drug Evaluations Annual 1994, p2079%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastics, Alkylating' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastics, Botanical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastics, Hormonal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineoplastics, Phytogenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineutrophil Cytoplasmic Antibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antineutrophil Cytoplasmic Antibody' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinociceptive Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinociceptive Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinuclear Antibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinuclear Antibodies, Fluorescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinuclear Antibody' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinuclear Antibody Test, Fluorescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinuclear Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antinuclear Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiobesity Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiobesity Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antioncogene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antioncogenes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiorthostatic Hypokinesia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiorthostatic Hypokinesias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antioxidant; also a post-harvest dip to prevent scald on apples and pears.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antioxidants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antioxidants %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparasitic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparasitic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparasitics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparkinson Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparkinson Agents %28%1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparkinson Agents %28%1976-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparkinson Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparkinsonian Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiparkinsonians' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiperistaltic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiperistaltics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiperspirants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphlogistine Rub A 535 Capsaicin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphlogistine Rub A535 Capsaicin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphosphodiesterases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphospholipid Antibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphospholipid Antibody' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphospholipid Antibody Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphospholipid Antibody Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphospholipid Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphospholipid antibodies found in association with systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC;%29%, ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiphosphopeptide-Specific Antibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplasmin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplasmin, alpha-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplasmins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplatelet Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplatyhelmintic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplatyhelmintic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiplatyhelmintics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiport, Bicarbonate-Chloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporter, Calcium-Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporter, Potassium-Hydrogen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporter, Sodium-Calcium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporter, Sodium-Hydrogen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporter, Sodium-Proton' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporters' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporters %28%1993-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporters %28%1994-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporters, Chloride-Bicarbonate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiporters, Potassium-Hydrogen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotease, alpha 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiproteases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotozoal Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotozoal Agents %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotozoal Agents %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotozoal Agents %28%1969-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiprotozoal and antimicrobial agent used mainly in veterinary practice.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipruritic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipruritic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipruritics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipsychotic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipsychotic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipsychotics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipyrine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipyrine %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antipyrine %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirejection Therapies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirejection Therapy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiretroviral Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiretroviral Therapy, Highly Active' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirheumatic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirheumatic Agents, Non Steroidal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirheumatic Agents, Non-Steroidal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirheumatic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirheumatic Drugs, Disease Modifying' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antirrhinum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense Elements %28%Genetics%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense OligoDNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense OligoRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense Oligodeoxyribonucleotide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense Oligodeoxyribonucleotides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense Oligonucleotides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense Oligoribonucleotide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense Oligoribonucleotides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisense RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisepsis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiseptics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisera' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisera used to counteract poisoning by animal VENOMS, especially SNAKE VENOMS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiserotonergic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiserum given therapeutically in BOTULISM. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antishock Trousers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antishock Trousers, Military' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisickling Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisocial Personalities' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisocial Personality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisocial Personality Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisocial Personality Disorder %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisocial Personality Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antispasmodic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antispasmodic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antispermatogenic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antistreptolysin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antistrumin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisyphilitic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antisyphilitics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin 3 Deficiencies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin 3 Deficiency' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin Baxter Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin Bayer Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin Grifols Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin III Alpha' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin III Deficiencies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin III Deficiency' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin III/deficiency %28%1979-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin IIIAlpha' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin Pharmacia Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombin VI' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombins %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombins/deficiency %28%1971-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithrombotic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithymocyte Globulin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithymocyte Globulins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithymoglobulins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithyroid Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antithyroid Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitoxin, Botulinum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitoxin, Diphtheria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitoxin, Tetanus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitoxins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitoxins %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitoxins %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitreponemal Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitreponemal Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrichomonal Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrichomonal Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrichomonals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrust Act, Sherman' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrust Law' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrust Laws' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitrust Liabilities' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitubercular Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitubercular Agents %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitubercular Agents %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitubercular Antibiotics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitubercular Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitubercular agent similar in action and side effects to ETHIONAMIDE. It is used mostly in combination with other agents.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor Assay, Xenograft' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor Assays, Xenograft' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor Assays, Xenograft Model' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor Drug Screen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor Drug Screening Assays' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor Drug Screens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor alkaloid isolated from Vinca Rosea. %28%Merck, 11th ed.%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitumor alkaloid isolated from Vinca rosea. %28%Merck, 11th ed.%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitussive Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitussive Agents %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitussive Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antitussives' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antivenins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antivenoms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral AZT' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents %28%1985-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents %28%1988-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents %28%1990-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Agents %28%1994-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Drug Resistance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Drug Resistances' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antiviral, AZT' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antivirals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antler' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antlers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anto Brand of Dihydroergotamine Mesylate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anto Brand of Procetofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anton Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antral Fluid, Ovarian Follicle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antral Vascular Ectasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antral Vascular Ectasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antramycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrum of Highmore' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrum, Gastric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrum, Maxillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrum, Pyloric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrums, Gastric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrums, Maxillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Antrums, Pyloric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ants %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anturan' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anura' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anura %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anura %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anura %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anuras' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anuria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anurias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Cancer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Cancers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Neoplasm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Neoplasms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Neoplasms %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus Prolapses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anus, Imperforate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxieties' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxieties, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Disorder, Separation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Disorders %28%1978-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Neuroses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Scale, Manifest' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety Scales, Manifest' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety State, Neurotic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety due to fantasized injuries to or loss of the genitals.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety experienced by an individual upon separation from a person or object of particular significance to him.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety, Castration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety, Castration %28%1976-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiety, Separation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiolytic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anxiolytics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. %28%Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by the patient during the course of treatment.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any arthropod of the subclass ACARI except the TICKS. They are minute animals related to the spiders, usually having transparent or semitransparent bodies. They may be parasitic on humans and domestic animals, producing various irritations of the skin %28%MITE INFESTATIONS%29%. Many mite species are important to human and veterinary medicine as both parasite and vector. Mites also infest plants.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any aspect of the operations in the preparation, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any autoimmune animal disease model used in the study of MYASTHENIA GRAVIS. Injection with purified neuromuscular junction acetylcholine receptor %28%AChR%29% %28%see RECEPTORS, CHOLINERGIC%29% components results in a myasthenic syndrome that has acute and chronic phases. The motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-AChR antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. Passive transfer of AChR antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. %28%From Joynt, Clinical Neurology, 1997, Ch 54, p3%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any behavior associated with conflict between two individuals.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any behavior caused by or affecting another individual, usually of the same species.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any blood or formed element especially in invertebrates.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any change in the hue, color, or translucency of a tooth due to any cause. Restorative filling materials, drugs %28%both topical and systemic%29%, pulpal necrosis, or hemorrhage may be responsible. %28%Jablonski, Dictionary of Dentistry, 1992, p253%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any codon that signals the termination of genetic translation %28%TRANSLATION, GENETIC%29%. PEPTIDE TERMINATION FACTORS bind to the stop codon and trigger the hydrolysis of the aminoacyl bond connecting the completed polypeptide to the tRNA. Terminator codons do not specify amino acids.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol %28%see GLYCERIDES%29%, a sphingoid, a ceramide %28%CERAMIDES%29% %28%N-acylsphingoid%29% or a prenyl phosphate. %28%From IUPAC%27%s webpage%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside %28%glucose%29%, pentoside %28%pentose%29%, fructoside %28%fructose%29%, etc. Upon hydrolysis, a sugar and nonsugar component %28%aglycone%29% are formed. %28%From Dorland, 28th ed; From Miall%27%s Dictionary of Chemistry, 5th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells %28%i.e., %22%generative%22% cells ancestral to the gametes%29% are transmitted to progeny while those in somatic cells are not.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any deviation of results or inferences from the truth, or processes leading to such deviation. Bias can result from several sources: one-sided or systematic variations in measurement from the true value %28%systematic error%29%; flaws in study design; deviation of inferences, interpretations, or analyses based on flawed data or data collection; etc. There is no sense of prejudice or subjectivity implied in the assessment of bias under these conditions.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any device or element which converts an input signal into an output signal of a different form. Examples include the microphone, phonographic pickup, loudspeaker, barometer, photoelectric cell, automobile horn, doorbell, and underwater sound transducer. %28%McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any diagnostic evaluation using radioactive %28%unstable%29% isotopes. This diagnosis includes many nuclear medicine procedures as well as radioimmunoassay tests.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any discrete, presumably solitary, mass of neoplastic plasma cells either in bone marrow or various extramedullary sites.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any disease marked especially by progressive emaciation and weakness. %28%Dorland, 28th ed, p490%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any disorder marked by persistent obstruction of bronchial air flow.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any drug treatment modality designed to inhibit UTERINE CONTRACTION. It is used in pregnant women to arrest PREMATURE LABOR.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any enhancement of a motivated behavior in which individuals do the same thing with some degree of mutual stimulation and consequent coordination.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any fluid-filled closed cavity or sac %28%CYSTS%29% that is lined by an EPITHELIUM and found in the ESOPHAGUS region.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the fortified food. The supplementation of cereals with iron and vitamins is an example of fortified food. Fortified food includes also enriched food to which various nutrients have been added to compensate for those essential nutrients removed by refinement or processing. %28%From Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any form of psychotherapy designed to produce therapeutic change within a minimal amount of time, generally not more than 20 sessions.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any group of three or more full-time dentists, organized in a legally recognized entity for the provision of dental care, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any hindrance to the passage of air into and out of the lungs.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any hindrance to the passage of air into and out of the nose. The obstruction may be in the nasal vestibule, fossae, or other areas of the nasal cavity.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any horny growth such as a wart or callus. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any hydrocarbon deposit that may be used for fuel. Examples are petroleum, coal, and natural gas.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any infection acquired in the community, that is, contrasted with those acquired in a health care facility %28%CROSS INFECTION%29%. An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any infection which a patient contracts in a health-care institution.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any inflammation of the skin. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any materials used in providing care specifically in the hospital.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases %28%GLYCOSIDE HYDROLASES%29%, lipases, NUCLEOTIDASES, peptidases %28%PEPTIDE HYDROLASES%29%, and phosphatases %28%PHOSPHORIC MONOESTER HYDROLASES%29%. EC 3.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. EC 3.4.21.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any member of the more than 250,000 species of flowering plants. Angiosperms are often differentiated from GYMNOSPERMS by their production of seeds within a closed chamber %28%OVARY, PLANT%29%. The Angiosperms division is composed of two classes, the monocotyledons %28%Liliopsida%29% and dicotyledons %28%Magnoliopsida%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any method of artifical breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have RESPIRATORY INSUFFICIENCY to increase their intake of oxygen %28%O2 %29% and excretion of carbon dioxide %28%CO2 %29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any method of measuring the amount of work done by an organism, usually during EXERTION. Ergometry also includes measures of power. Some instruments used in these determinations include the hand crank and the bicycle ergometer.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any method used for determining the location of and relative distances between genes on a chromosome.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any negative tradition or behavior that is generally regarded as harmful to social welfare and forbidden within a cultural or social group.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1%25% of that in females.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any normal or abnormal coloring matter in PLANTS; ANIMALS or micro-organisms.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any observable response or action of a neonate or infant up through the age of 23 months.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any observable response or action of an adolescent. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a group of disorders leading to occlusion of the arteries arising from the aortic arch. Such occlusion may be caused by atherosclerosis, arterial embolism, syphilitic or tuberculous arteritis, etc. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a group of infections of fowl caused by protozoa of the genera PLASMODIUM, Leucocytozoon, and Haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin%27%s disease.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a group of plants formed by a mutual combination of an alga and a fungus.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a group of polysaccharides of the general formula %28%C6-H10-O5%29%n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve %28%carbohydrates%29% in plants.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of certain small mammals of the order Hyracoidea. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several BRASSICA species that are commonly called mustard. Brassica alba is white mustard, B. juncea is brown or Chinese mustard, and B. nigra is black, brown, or red mustard. The plant is grown both for mustard seed from which oil is extracted and for greens or animal feed. It was formerly used as an emetic, counter-irritant, and carminative. There is no relationship to MUSTARD COMPOUNDS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several Old World finches of the genus Serinus. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several South American shrubs of the Erythroxylon genus %28%and family%29% that yield COCAINE; the leaves are chewed with alum for CNS stimulation.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several bacterial diseases, usually caused by PASTEURELLA MULTOCIDA, marked by the presence of hemorrhagic areas in the subcutaneous tissues, serous membranes, muscles, lymph glands, and throughout the internal organs. The diseases primarily affect animals and rarely humans.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several burrowing rodents of the families MURIDAE and Bathyergidae, found in eastern Europe, Africa, and Asia. They have short limbs, small eyes with permanently closed lids, and no tail. Three genera SPALAX %28%Muridae%29%, Heterocephalus %28%Bathyergidae%29% and Cryptomys %28%Bathyergidae%29% are used frequently as experimental animals in biomedical research. %28%From Walker%27%s Mammals of the World, 6th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several carnivores in the family CANIDAE, that possess erect ears and long bushy tails and are smaller than WOLVES. They are classified in several genera and found on all continents except Antarctica.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several large carnivorous mammals of the family CANIDAE that usually hunt in packs.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several poisonous plants, commonly called poison hemlock, of the CICUTA or CONIUM genus. The hemlock tree %28%TSUGA%29% is completely unrelated being a coniferous tree of the pine family.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several processes in which undesirable impurities in water are removed or neutralized; for example, chlorination, filtration, primary treatment, ion exchange, and distillation. It includes treatment of waste water to provide potable and hygiene water in a controlled or closed environment as well as provision of public drinking water supplies. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the DNA in between gene-coding DNA, including untranslated regions, 5%27% and 3%27% flanking regions, INTRONS, non-functional pseudogenes, and non-functional repetitive sequences. This DNA may or may not encode regulatory functions.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the compounds derived from a group of glycols or polyhydroxy alcohols by chlorine substitution for part of the hydroxyl groups. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA%27%s have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3%27%-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. %28%Riger et al., Glossary of Genetics, 5th ed %26% Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the ducts which transport saliva. Salivary ducts include the parotid duct, the major and minor sublingual ducts, and the submandibular duct.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the eight frontal teeth %28%four maxillary and four mandibular%29% having a sharp incisal edge for cutting food and a single root, which occurs in man both as a deciduous and a permanent tooth. %28%Jablonski, Dictionary of Dentistry, 1992, p820%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the enzymatically catalyzed modifications of the individual AMINO ACIDS of PROTEINS, and enzymatic cleavage or crosslinking of peptide chains that occur pre-translationally %28%on the amino acid component of AMINO ACYL TRNA%29%, co-translationally %28%during the process of GENETIC TRANSLATION%29%, or after translation is completed %28%POST-TRANSLATIONAL PROTEIN PROCESSING%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the lipid-protein complexes in which lipids are transported in the blood. Lipoprotein particles consist of a spherical hydrophobic core of triglycerides or cholesteryl esters surrounded by an amphipathic monolayer of phospholipids, cholesterol, and apolipoproteins. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the monobasic inorganic or organic acids of sulfur with the general formula RSO%28%OH%29%. %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in archaea.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. These processes include gene activation and genetic induction.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the tubular vessels conveying the blood %28%arteries, arterioles, capillaries, venules, and veins%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the various plants of the genus Lactuca, especially L. sativa, cultivated for its edible leaves. %28%From American Heritage Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus %28%wart hogs%29%, and Sus, the latter containing the domestic pig %28%see SUS SCROFA%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any of various ruminant mammals of the order Bovidae. They include numerous species in Africa and the American pronghorn.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any operation on the cranium or incision into the cranium. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any operation on the spinal cord. %28%Stedman, 26th ed%29% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any part or derivative of any protozoan that elicits immunity; malaria %28%Plasmodium%29% and trypanosome antigens are presently the most frequently encountered.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any purulent skin disease %28%Dorland, 27th ed%29%. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any restorative and replacement device that is used as a therapeutic aid in the treatment of periodontal disease. It is an adjunct to other forms of periodontal therapy and does not cure periodontal disease by itself. %28%Boucher%27%s Clinical Dental Terminology, 3d ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any salt or ester of glycerophosphoric acid. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any situation where an animal or human is trained to respond differentially to two stimuli %28%e.g., approach and avoidance%29% under reward and punishment conditions and subsequently trained under reversed reward values %28%i.e., the approach which was previously rewarded is punished and vice versa%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any solid objects moving in interplanetary space that are smaller than a planet or asteroid but larger than a molecule. Meteorites are any meteoroid that has fallen to a planetary surface. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any spaces or cavities within a cell. They may function in digestion, storage, secretion, or excretion.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any suction exerted by the mouth; response of the mammalian infant to draw milk from the breast. Includes sucking on inanimate objects. Not to be used for thumb sucking, which is indexed under fingersucking.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any surgical procedure for treatment of glaucoma by means of puncture or reshaping of the trabecular meshwork. It includes goniotomy, trabeculectomy, and laser perforation.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any surgical procedure performed on the biliary tract. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any system of defining ownership of dentures or dental prostheses.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any system which allows payors to share some of the financial risk associated with a particular patient population with providers. Providers agree to adhere to fixed fee schedules in exchange for an increase in their payor base and a chance to benefit from cost containment measures. Common risk-sharing methods are prospective payment schedules %28%PROSPECTIVE PAYMENT SYSTEM%29%, capitation %28%CAPITATION FEES%29%, diagnosis-related fees %28%DIAGNOSIS-RELATED GROUPS%29%, and pre-negotiated fees.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any tests done on exhaled air. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms %28%i.e., bacteria, fungi, viruses%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any type of abortion, induced or spontaneous, that is associated with infection of the UTERUS and its appendages. It is characterized by FEVER, uterine tenderness, and foul discharge.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any type of variation in the appearance of energy output of the sun. %28%NASA Thesaurus, 1994%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any vaccine raised against any virus or viral derivative that causes hepatitis.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any variation from the normal rhythm or rate of the heart beat.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any violation of established legal or moral codes in respect to sexual behavior.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any visible result of a procedure which is caused by the procedure itself and not by the entity being analyzed. Common examples include histological structures introduced by tissue processing, radiographic images of structures that are not naturally present in living tissue, and products of chemical reactions that occur during analysis.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any waste product generated by a dental office, surgery, clinic, or laboratory including amalgams, saliva, and rinse water.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any woven or knit material of open texture used in surgery for the repair, reconstruction, or substitution of tissue. The mesh is usually a synthetic fabric made of various polymers. It is occasionally made of metal.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any-Willing-Provider-Law' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Any-Willing-Provider-Laws' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aonyx' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta, Abdominal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta, Ascending' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta, Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta, Thoracic/abnormalities %28%1966-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorta/abnormalities %28%1966-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortas, Abdominal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortas, Ascending' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysm %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysm %28%1966-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysm, Abdominal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysm, Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysms, Abdominal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysms, Ruptured' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Aneurysms, Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Arch Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Arch Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Bodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Body' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Coarctation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Coarctations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Diseases %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Glomus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Incompetence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Regurgitation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Rupture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Ruptures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Sinus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Stenoses, Subvalvular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Stenosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Stenosis, Subvalvular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Stenosis, Subvalvular %28%1986-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Stenosis, Supravalvular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Subvalvular Stenoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Subvalvular Stenosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Supravalvular Stenoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Supravalvular Stenosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve %28%1966-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Incompetence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Insufficiency' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Insufficiency %28%1967-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Prolapse' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Prolapses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Stenoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Stenosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Stenosis %28%1965-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Stenosis %28%1969-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valve Stenosis %28%1972-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortic Valves' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorticopulmonary Septal Defect' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorticopulmonary Septal Defects' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aorticum, Glomus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortitides, Giant Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortitides, Syphilitic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortitis Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortitis, Giant Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortocoronary Bypass' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortocoronary Bypasses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortographies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortography' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortopulmonary Septal Defect' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aortopulmonary Septal Defects' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aotinae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aotus trivirgatus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ap-2delta, Transcription Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apansporoblastina' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apatites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apazone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ape' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ape Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ape Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ape, Barbary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ape, Black' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apertognathia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aperture Syndrome, Thoracic Outlet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apes, Barbary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apes, Black' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apes, Celebes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apex Brand of Bromhexine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apex Cardiographies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apex, Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apgar Score' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphakia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphakia, Postcataract' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphakias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphakias, Postcataract' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphaniptera' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphanizomenon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphanomyces' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia %28%1966-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia %28%1982-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia Syndrome, Verbal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia Syndromes, Verbal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Acquired Epileptic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Amnesic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Anomic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Associative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Broca' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Conduction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Epileptic, Acquired' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Fluent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Frontocortical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Kussmaul' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Kussmaul%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Motor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Nominal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Nonfluent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Post Ictal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Post Traumatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Primary Progressive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Progressive Nonfluent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Psychosensory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Receptive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Sensory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Wernicke' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Wernicke %28%1980-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasia, Wernicke%27%s Fluent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Acquired Epileptic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Ageusic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Anterior' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Associative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Ataxic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Auditory Discriminatory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Broca' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Commisural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Conduction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Frontocortical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Functional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Global' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Graphomotor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Intellectual' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Jargon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Mixed' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Post-Ictal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Post-Traumatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Posterior' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Primary Progressive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Progressive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Progressive Nonfluent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Psychosensory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Semantic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Syntactical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasias, Wernicke' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasmidia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasmidia Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphasmidia Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphereses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apheresis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphidicolin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphididae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphids/microbiology %28%1993-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonia, Functional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonia, Nonorganic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonia, Spastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonias, Functional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonias, Nonorganic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphonias, Spastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphorism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphorisms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphorisms and Proverbs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphrodisiacs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthous Stomatitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthous Stomatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthous Ulcer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthous Ulcers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthovirus %28%1964-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphthoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphyllophorales' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aphyllophorales %28%1979-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apiaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apiaceae %28%1998-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Alveolar Abscess' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Alveolar Abscesses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Dentoalveolar Abscess' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Dentoalveolar Abscesses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Periodontal Cyst' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Periodontal Cysts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Periodontitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Periodontitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Periodontium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apical Periodontiums' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apices, Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apicoectomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apicoectomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apicomplexa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apicomplexa %28%1971-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apicomplexa %28%1992-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apigenin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apis Venoms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apium graveolens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplasia, Erythrocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplasia, Pure Red-Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplasias, Erythrocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplasias, Pure Red-Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplastic Anemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplastic Anemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aplysia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea Syndrome, Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea Syndromes, Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea, Central Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea, Obstructive Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea, Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apnea, Sleep, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apneas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apneas, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apneas, Central Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apneas, Obstructive Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apneas, Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A-I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A-II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo A2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo AI' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo AII' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Acebutolol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Acetazolamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Alpraz' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Amitriptyline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Baclofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Benztropine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Bisacodyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Bromazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Buspirone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Dimenhydrinate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Domperidone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Doxazosin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Doxepin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo E' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo E Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Feno Micro' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Fenofibrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Fluconazole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Flurazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Flurbiprofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Flutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Gemfibrozil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Labetalol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Levobunolol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Lorazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Mefenamic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Megestrol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Methyldopa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Minocycline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Misoprostol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Moclobemide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Nortriptyline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Pravastatin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Quinidine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Sertraline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Sulfinpyrazone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Sulin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Temazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Tolbutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Trazodone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo Triazo' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-Desmopressin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-Domperidone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-E' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apo-Fenofibrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoA-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoA-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoA-I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoA-II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoAI Regulatory Protein 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoAI Regulatory Protein-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoAcebutolol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoAcetazolamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoAlpraz' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoAmitriptyline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoBaclofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoBenztropine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoC' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoDesmopressin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoDomperidone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoDoxazosin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoDoxepin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoE' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoE Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoFlutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoGemfibrozil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoJ Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoLabetalol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoLevobunolol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoLorazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoMefenamic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApoMegestrol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoaminotransferase, Aspartate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apocard' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apocrine Gland' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apocrine Glands' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apocrine Miliaria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apocynaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apocynum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoenzymes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoferritin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apogepha Brand of Etilefrine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apogepha Brand of Flutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apogepha Brand of Nitrendipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apogepha, Doxazosin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apogepha, Nitrendipin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A-I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A-II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein A2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein AI' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein AI Regulatory Protein 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein AII' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein B Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein E Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoprotein J' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins %28%1977-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins A %28%1985-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apolipoproteins E' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apomorphin Teclapharm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'ApomorphinTeclapharm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apomorphine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apomorphine %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoplexy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoplexy, Cerebrovascular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoplexy, Pituitary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoprotein %28%B%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoprotein %28%C%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoprotein %28%E%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoproteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoproteins %28%1972-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoproteins %28%1987-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoproteins %28%1988-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoproteins A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis %28%1994-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis %28%1994-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis Inducing Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis Inducing Transgenes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis Proteins Inhibitor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis Regulatory Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis Signal Regulating Kinase 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis Signal-Regulating Kinase 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inducing Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inducing Factor, Mitochondrial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inducing Gene, Transgenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inducing Genes, Transgenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inducing Transgene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inducing Transgenes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoptosis-Inhibitory Protein, Neuronal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aporphines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apostichopus japonicus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Acebutolol Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Acetazolamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Alprazolam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Baclofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Beclomethasone Dipropionate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Benzatropine Mesilate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Bisacodyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Bromazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Buspirone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Butorphanol Tartrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Chlorpropamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Desipramine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Diflunisal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Dimenhydrinate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Dipyridamole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Doxazosin Mesylate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Doxepin Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Fluconazole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Flurazepam Monohydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Flurbiprofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Flutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Gemfibrozil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Labetalol Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Levobunolol Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Lorazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Mefenamic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Megestrol Acetate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Methyldopa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Minocycline Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Misoprostol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Moclobemide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Nortriptyline Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Pravastatin Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Prednisone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Primidone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Procainamide Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Procetofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Propafenone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Quinidine Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Sertraline Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Sulfinpyrazone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Sulindac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Temazepam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Tolbutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Trazodone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Triazolam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apotex Brand of Warfarin Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apothecon Brand of Amikacin Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apothecon Brand of Bendroflumethiazide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apothecon Brand of Cephapirin Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apothecon Brand of Procainamide Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apothecon Brand of Trazodone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoxin I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apoxin-I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appalachia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appalachian Region' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appalachian Type Familial Amyloid Polyneuropathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus Disease, Lacrimal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus Diseases, Lacrimal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus and Instruments' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus for removing exhaled or leaked anesthetic gases or other volatile agents, thus reducing the exposure of operating room personnel to such agents, as well as preventing the buildup of potentially explosive mixtures in operating rooms or laboratories.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus that provides mechanical circulatory support during open-heart surgery, by passing the heart to facilitate surgery on the organ. The basic function of the machine is to oxygenate the body%27%s venous supply of blood and then pump it back into the arterial system. The machine also provides intracardiac suction, filtration, and temperature control. Some of the more important components of these machines include pumps, oxygenators, temperature regulators, and filters. %28%UMDNS, 1999%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus used to support, align, prevent, or correct deformities or to improve the function of movable parts of the body.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Golgi' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Juxtaglomerular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Lacrimal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Mitotic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Mitotic Spindle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Vestibular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, Vestibulocochlear' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparatus, devices, or supplies intended for one-time or temporary use.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apparent Mineralocorticoid Excess Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage Carcinoma, Skin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage Carcinomas, Skin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage, Atrial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage, Atrium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage, Auricular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage, Heart Atrium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendage, Uterine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendages of the UTERUS which include the FALLOPIAN TUBES, the OVARY, and the supporting ligaments of the uterus %28%BROAD LIGAMENT; ROUND LIGAMENT%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendages, Atrial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendages, Atrium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendages, Auricular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendages, Heart Atrium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendages, Uterine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendectomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendectomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendiceal Neoplasm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendiceal Neoplasms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendices, Omental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendicitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendicitis, Perforated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendicitis, Ruptured' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendicular Ataxia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendicular Ataxias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendix' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendix Cancer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendix, Omental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appendix, Vermiform' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apperception Test, Thematic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apperception Tests, Thematic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Alteration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Depressants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Depressants %28%1982-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Depressing Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Disorders %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Disorders %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Regulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Regulations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Stimulants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Stimulating Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Suppressant Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite Suppressants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite-Depressing Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite-Stimulating Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetite-Suppressant Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetitive Behavior' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appetitive Behaviors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance Design, Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance Designs, Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Activator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Activator Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Andresen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Bimler' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Extraoral Traction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Functional Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Herbst' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliance, Removable Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances that close a cleft or fissure of the palate.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances, Activator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances, Activator Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances, Extraoral Traction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances, Functional Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances, Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appliances, Removable Orthodontic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applicant, Abortion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applicants, Abortion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of a ligature to tie a vessel or strangulate a part.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of a protective agent to an exposed pulp %28%direct capping%29% or the remaining thin layer of dentin over a nearly exposed pulp %28%indirect capping%29% in order to allow the pulp to recover and maintain its normal vitality and function.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of allergens to the nasal mucosa. Interpretation includes observation of nasal symptoms, rhinoscopy, and rhinomanometry. Nasal provocation tests are used in the diagnosis of nasal hypersensitivity, including RHINITIS, ALLERGIC, SEASONAL.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of computer programs designed to assist the physician in solving a diagnostic problem.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of heat to correct hypothermia, accidental or induced.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of laser techniques %28%LASERS%29% to reduce or reshape the CORNEA to correct REFRACTIVE ERRORS of the EYE, such as MYOPIA and ASTIGMATISM.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of marketing principles and techniques to maximize the use of health care resources.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of positive pressure to the inspiratory phase of spontaneous respiration.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of principles and practices of engineering science to biomedical research and health care.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of statistical procedures to analyze specific observed or assumed facts from a particular study.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from VISION TESTS, which are given to evaluate/measure individual visual performance not related to a specific population.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application, Employment' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application, Job' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Application, Medical Informatics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applications, Employment' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applications, Job' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applications, Medical Informatics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applied Kinesiology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applied Psychologies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applied Psychology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applies to movements of the forearm in turning the palm backward or downward or when applied to the foot, a combination of eversion and abduction movements in the tarsal and metatarsal joints, %28%turning the foot up and in toward the midline of the body%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Applies to the movements of the forearm in turning the palm forward or upward and when applied to the foot, a combination of adduction and inversion of the foot.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appointment' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appointment, Patient' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appointments and Schedules' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appointments, Patient' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apportionment, Cost' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apportionments, Cost' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appraisal of one%27%s own personal qualities or traits. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appraisal, Employee Performance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appraisal, Health Risk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appraisals, Employee Performance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appraisals, Health Risk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appropriateness Reviews' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Appropriateness, Program' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval Process, Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval Process, Drug' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval Processes, Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval Processes, Drug' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval, Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval, Drug' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval, New Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval, New Drug' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approval, Product' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approvals, Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approvals, Drug' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approvals, New Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approvals, New Drug' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approvals, Product' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Approximate, quantitative reasoning that is concerned with the linguistic ambiguity which exists in natural or synthetic language. At its core are variables such as good, bad, and young as well as modifiers such as more, less, and very. These ordinary terms represent fuzzy sets in a particular problem. Fuzzy logic plays a key role in many medical expert systems.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apr 79; TEST-TUBE FERTILIZATION was TEST TUBE BABIES see FERTILIZATION IN VITRO Apr-Dec 1979, was TEST TUBE BABIES see ECTOGENESIS 1978-Mar 79%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AprA Subtilisin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia of Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Bruns%27% Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Classic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Dressing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Facial Oral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Frontal Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Ideational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Ideokinetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Ideomotor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Limb Kinetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxia, Transcortical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias %28%1965-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias %28%1968-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Articulatory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Bruns%27% Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Classic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Developmental Verbal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Dressing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Facial-Oral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Frontal Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Gestural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Ideational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Ideokinetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Ideomotor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Limb Kinetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Motor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Oral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Transcortical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apraxias, Verbal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apresoline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apressin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apricot Tree' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apricots' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'April 25th -26th, 1986 nuclear power accident that occurred at Chernobyl in the former USSR %28%Ukraine%29% located 80 miles north of Kiev.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aprindine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aprosencephalies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aprosodias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aprosodic Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aprotinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptamer Technique, SELEX' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptamer Techniques, SELEX' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptamers, Nucleotide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptamers, Peptide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptin Duriles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptin-Duriles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AptinDuriles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptitude' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptitude Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptitude Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aptitudes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apudoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apudomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apurine Apyrimidine Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apurine-Apyrimidine Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apurinic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apurinic DNA Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apurinic Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Apyrase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquabirnavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquabirnaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaculture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquacultures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaglyceroporins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 1 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 1 forms a water-specific channel that is constitutively expressed at the PLASMA MEMBRANE of ERYTHROCYTES and KIDNEY TUBULES, PROXIMAL. It provides these cells with a high permeability to WATER. In humans polymorphisms of this protein result in the Colton blood group antigen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 2 is a water-specific channel protein that is expressed in KIDNEY COLLECTING DUCTS. The translocation of aquaporin 2 to the apical PLASMA MEMBRANE is regulated by VASOPRESSIN, and MUTATIONS in AQP2 have been implicated in a variety of kidney disorders including DIABETES INSIPIDUS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 3' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 3 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 3 is an aquaglyceroporin that is expressed in the KIDNEY COLLECTING DUCTS and is constitutively localized at the basolateral MEMBRANE.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 4 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 4 is the major water-selective channel in the CENTRAL NERVOUS SYSTEM of mammals.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 5' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 5 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 5 is a water-specific channel protein that is expressed primarily in alveolar, tracheal, and upper bronchial EPITHELIUM. It plays an important role in maintaining water HOMEOSTASIS in the LUNGS and may also regulate release of SALIVA and TEARS in the SALIVARY GLANDS and the LACRIMAL GLAND.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 6' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 6 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin 6 is an aquaglyceroporin that is found primarily in KIDNEY COLLECTING DUCTS. AQP6 protein functions as an anion-selective channel.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin CD' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin CHIP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin-5' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin-6' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin-CD' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporin-CHIP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporins, Multi-Functional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquaporins, Non-Specific' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquareoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquatic Reovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquatic Reoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquatic invertebrates belonging to the phylum MOLLUSCA or the subphylum CRUSTACEA, and used as food.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueduct of Sylvius' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueduct, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueduct, Cochlear' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueduct, Vestibular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueducts, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueducts, Cochlear' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueducts, Vestibular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Blood Barrier' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Flares' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Humor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Humor %28%1966-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Humor Shunt' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Humor Shunts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Humors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Shunt' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous Shunts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous-Blood Barrier' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aqueous-Blood Barriers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquiculture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquicultures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquifoliaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquilegia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aquilegia adoxoides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara AMP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara CTP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara U' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara-A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara-AMP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara-C Transcription Regulator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara-CTP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ara-U' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AraC Repressor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AraC Transcription Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AraC Transcription Regulator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AraC Transcriptional Regulator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arab' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arab Republic of Egypt' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arab World' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabic Medicine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabic, Gum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabidopsis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabidopsis AGAMOUS Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabidopsis Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranoside, Uracil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosyladenine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosyladenine Monophosphate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosylcytosine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosylcytosine Triphosphate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosylnucleosides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosylnucleotides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinofuranosyluracil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinonucleosides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinonucleotides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinose' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinose %28%1971-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinose %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinose %28%1972-1974%29%/analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinoside, Adenine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinoside, Cytosine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinoside, Uracil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinosyladenine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinosylcytosine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinosylcytosine Triphosphate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabinosyluracil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arabs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Araceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidic Acids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate 12 Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate 12-Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate 15 Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate 15-Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate 5 Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate 5-Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate Lipoxygenases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid 12 Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid 12-Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid 15 Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid 15-Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid 5 Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid 5-Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid Cyclooxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acid Lipoxygenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1967-1982%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1967-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1967-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1975-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1975-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1979-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1980-1982%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1980-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonic Acids %28%1994-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachidonoyl Diacylglycerol Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachis hypogaea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachis hypogaea %28%1966-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnid Vector' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnid Vectors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnid Venom' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnida' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnida %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnida %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnidism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnidism, Necrotic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnodactylies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Cyst' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Cyst, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Cysts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Cysts, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Diverticula' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Diverticulas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Membrane Inflammation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoid Membrane Inflammations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoiditides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoiditis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arachnoids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aracytidine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aralia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Araliaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Araneid Venom' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Araneid Venoms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arauridine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbacia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbaprostil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbitrarily Primed PCR Reaction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbitration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbor Vitae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Encephalitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Encephalitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Infections %28%1966-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Infections %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus Infections %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus, Group A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbovirus, Group B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1965-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1968-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1970-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1971-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses %28%1973-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses, Group A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arboviruses, Group B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbuscular Mycorrhizae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arbutin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch of the Aorta' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch, Aortic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch, Branchial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch, Pharyngeal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch, Visceral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arch, Zygomatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1980-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1983-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1985-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1988-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1989-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1989-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1990-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1991-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1991-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1992-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1996-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1996-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%1999-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea %28%2002-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea/genetics %28%1993-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaea/virology %28%1996-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Antibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Chromosome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Chromosomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Gene Expression Regulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Gene Products' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Gene Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Genes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Genome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Genomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Peptides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Topoisomerase 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Topoisomerases II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal enzymes of the DNA TOPOISOMERASES, TYPE I class that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These archaeal enzymes reduce the topological stress in the DNA structure by relaxing negatively, but not positively, supercoiled DNA.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeal enzymes of the DNA TOPOISOMERASES, TYPE II class that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaebacteria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeobacteria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeoglobales' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeoglobus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeoglobus fulgidus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archaeon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archebacteria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archenteron' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archenterons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archeology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arches, Branchial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arches, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arches, Pharyngeal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arches, Visceral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectural Accessibility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectural Barrier' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectural Barriers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectural Drawings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectural Drawings %28%PT%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectural Drawings %5B%Publication Type%5D%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architecture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architecture %28%1966%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architecture %28%1966-Jul 1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architecture, Computer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. The concept also includes architecture, design, and construction of specialized contained, controlled, or closed research environments including those of space labs and stations.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Architectures, Computer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archives' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archiving, Radiologic Picture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Archs, Pharyngeal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcidae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcobacter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arctic Fox' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arctic Regions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arctic Regions %28%2000-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arctium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arctostaphylos' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcuate Nucleus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcuate Scotoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcuate Scotomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcus Senilis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arcus, Corneal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ardern Brand of Podophyllotoxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ardeypharm Brand of Mebendazole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ardeypharm Brand of Tryptophan' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ardeytropin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ardisia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Analyses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Health Education Center' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Health Education Centers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Network, Local' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Networks, Local' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Postrema' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Postremas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Under Curve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area Under Curves' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area of Europe that includes ARMENIA,; AZERBAIJAN; and the Republic of GEORGIA.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area of the frontal lobe concerned with primary motor control. It lies anterior to the central sulcus.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area of the occipital lobe concerned with vision. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area of the parietal lobe concerned with receiving general sensations. It lies posterior to the central sulcus.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area of the temporal lobe concerned with hearing. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Anterior Hypothalamic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Body Surface' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Broca' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Catchment %28%Health%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Entorhinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Health Service' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Laminar Air-Flow' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Lateral Hypothalamic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Medically Underserved' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Physician Shortage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Poverty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Preoptic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Septal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Area, Wernicke' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas of increased density of the dinucleotide sequence cytosine--phosphate diester--guanine. They form stretches of DNA several hundred to several thousand base pairs long. In humans there are about 45,000 CpG islands, mostly found at the 5%27% ends of genes. They are unmethylated except for those on the inactive X chromosome and some associated with imprinted genes.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Anterior Hypothalamic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Body Surface' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Catchment %28%Health%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Entorhinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Health Service' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Lateral Hypothalamic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Medically Underserved' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Physician Shortage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Poverty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areas, Preoptic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areawide planning for health care institutions on the basis of projected consumer need.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. This does not include hospital design and construction or architectural plans.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areca' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arecaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arecaline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arechine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arecholin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arecholine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arecolin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arecoline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaria Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviridae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviridae %28%1978-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviridae %28%1979-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviridae Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviridae Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenavirus %28%1993-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenavirus Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenavirus Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviruses, New World' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arenaviruses, Old World' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Areu Brand of Sulpiride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arg Pro Pro Gly Phe Ser Pro Phe Arg' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arg Transfer RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arg tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arg-tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argasidae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argemone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentaffin Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentaffin Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentaffin System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentaffin Systems' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentaffinomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentina' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentine Toad' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentine Toads' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argentinian Hemorrhagic Fever' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginase Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginase Deficiency Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1971-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1971-1974%29% /analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1973-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine %28%1973-1974%29% /analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Carboxypeptidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Methylase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Methyltransferase, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Oxytocin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Specific tRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Vasopressin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Vasopressin, Deamino' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine Vasotocin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine derivative which is a substrate for many proteolytic enzymes. As a substrate for the esterase from the first component of complement, it inhibits the action of C%28%l%29% on C%28%4%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine, L Isomer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine, L-Isomer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine, L-NG-Monomethyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine-Specific tRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine-tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine/analogs %26% derivatives %28%1979-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginine/analogs %26% derivatives %28%1990-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinate Lyase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinate Synthase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinate Synthase Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinate Synthase/deficiency %28%1975-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinate Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinic Acid Synthase Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argininosuccinic Acid Synthetase Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginyl T RNA Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginyl tRNA Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arginyl-tRNA Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argipressin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argiprestocin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argiprestocine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argon. A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arguloida' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argyll-Robertson Pupil, Non-Syphilitic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argyria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Argyrias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arhinencephalies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aril, Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arils, Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arisaema' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aristolochia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aristolochiaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aristolochic Acids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arizona' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arizona Bacteria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ark Shells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arkansas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arkopharma Brand of Moxisylyte Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm %28%1963-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm %28%1966-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Bone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Bones' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Ergometry Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Injuries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Injury' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Motif Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Prostheses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm Prosthesis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm, Artificial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arm/blood supply %28%1966-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armadillo' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armadillo Domain Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armadillo Motif Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armadillo Protein Family' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armadillo Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armadillos' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armed Forces Personnel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armed conflict that resulted in separation of American colonies from Britain and established the United States of America.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armenia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armenian Hamster' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armenian Hamsters' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armenian S.S.R.' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armenian SSR' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armoracia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arms, Artificial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armstrong Brand of Albendazole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armstrong Brand of Amiodarone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armstrong Brand of Buspirone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armstrong Brand of Fluconazole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armstrong Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Armstrong%27%s Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Army Hospital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Army Hospitals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnica' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Deformity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Malformation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Malformation, Type I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Malformation, Type II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Malformation, Type III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Malformation, Type IV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold Chiari Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold-Chiari Deformity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold-Chiari Malformation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arnold-Chiari Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroclor 1254' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroclor-1254' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroclor1254' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroclors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroclors %28%1980-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroma Therapies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aroma Therapy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatase Inhibitors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatase, Androstenedione' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatase/antagonists %26% inhibitors %28%1975-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatherapies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatherapy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Amino Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Amino Acid Decarboxylases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Amino Acids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Hydrocarbons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Hydrocarbons, Polycyclic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Hydrocarbons, Polynuclear' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic L Amino Acid Decarboxylases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic Polycyclic Hydrocarbons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic diamine used in the plastics industry as curing agent for epoxy resins and urethane rubbers. It causes bladder, liver, lung, and other neoplasms.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic substances added to food before or after cooking to enhance its flavor. These are usually of vegetable origin.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aromatic-L-Amino-Acid Decarboxylases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aronia melanocarpa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousal %28%1968-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousal Disorder, Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousal Disorders, Sexual' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousal Disorders, Sleep' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousal, Confusional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arousals, Confusional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arp2 3 Complex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arp2 3 Protein Complex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arp2 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arp2-3 Complex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arp2-3 Protein Complex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arp3 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arranged Marriages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrangement, Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrangement, Living' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrangements negotiated between a third-party payer %28%often a self-insured company or union trust fund%29% and a group of health-care providers %28%hospitals and physicians%29% who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrangements, Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrangements, Living' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Analyses, Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Analyses, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Analyses, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Analysis, Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Analysis, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Analysis, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Assay, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array Assays, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array, DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array, Oligonucleotide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Array, cDNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrays, DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrays, Oligonucleotide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrays, Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrays, cDNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrest of cell locomotion or cell division when two cells come into contact.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrest, Cardiac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrest, Cardiopulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrest, Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrestin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrestins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhenoblastoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhenoblastomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia %28%1974-1982%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia %28%1975-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia %28%1981-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia, Sinus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmia, Sinus %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmias, Sinus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmogenic Right Ventricular Cardiomyopathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrhythmogenic Right Ventricular Dysplasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrow Brand of Fluvoxamine Maleate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrowhead' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrowroot' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrowroot, Brazilian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arrythmia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsanilate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsanilic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenates' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenazo III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Compounds' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Encephalopathies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Poisoning' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Poisoning, Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Poisoning, Organic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Poisonings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Poisonings, Inorganic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic Poisonings, Organic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic-Induced Polyneuropathies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenic-Induced Polyneuropathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenical Neurotoxicity Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenical Neurotoxicity Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals %28%1968-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals %28%1969-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals %28%1970-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals %28%1972-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenicals/poisoning %28%1966-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenilate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenobenzol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsenobenzol, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arsphenamine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Art' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Art Therapies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Art Therapies, Sensory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Art Therapy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Art, Language' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Art, Medicine in' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artefact' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artefacts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artegodan Brand of Amfepramone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artemisia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artemisia %28%1996-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artemisia absinthium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artemisia annua' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artemisinins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Brain Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Brain Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Brain Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Brain Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Bypass, EC-IC' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Bypass, Extracranial-Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Bypasses, EC-IC' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Bypasses, Extracranial-Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Catheterization, Peripheral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Catheterizations, Peripheral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Circle, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Dilatation, Transluminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Dilatations, Transluminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Disease, Brain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Disease, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Disease, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Disease, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Diseases, Brain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Diseases, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Diseases, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Diseases, External Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Diseases, Internal Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Diseases, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Disorder, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Disorders, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Fatty Streak' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Fatty Streaks' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Infusion, Intra' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Infusion, Regional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Infusions, Intra' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Infusions, Regional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Intimas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Line' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Lines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Medias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Obstructive Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Obstructive Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Occlusive Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Occlusive Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Occlusive Diseases %28%1972-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Occlusive Diseases %28%1973-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Occlusive Diseases %28%1973-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Occlusive Diseases/surgery %28%1973-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Stretch Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterial Stretch Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries %28%1966-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles and mammary gland.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles, mammary gland and the axillary aspect of the chest wall.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries which arise from the abdominal aorta and distribute to most of the intestines.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries which supply the dura mater. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Anterior Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Anterior Tibial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Axillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Brachial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Bronchial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Celiac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Central Retinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Ciliary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Common Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Epigastric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, External Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Femoral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Gastroepiploic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Hepatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Iliac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Inferior Mesenteric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Innominate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Internal Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Internal Mammary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Internal Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Mammary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Maxillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Meningeal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Mesenteric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Middle Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Ophthalmic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Popliteal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Posterior Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Posterior Tibial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Pulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Radial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Renal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Retinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Sinus Node' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Splenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Subclavian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Superior Mesenteric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Temporal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Tibial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Ulnar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Umbilical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries/surgery %28%1966-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteries/transplantation %28%1990-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterio Arterial Fistula' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterio-Arterial Fistula' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterio-Arterial Fistulas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriogenic Impotence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriographies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriohepatic Dysplasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriohepatic Dysplasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterioles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterioloscleroses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriolosclerosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriopathies, Traumatic Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriopathy, Traumatic Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterioscleroses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterioscleroses, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterioscleroses, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterioscleroses, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis %28%1965-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis %28%1966%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis %28%1966-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis %28%1999-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis Obliterans' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis in which proliferation of the intima leads to occlusion of the lumen of the arteries.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerosis, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerotic Dementias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerotic Encephalopathies, Subcortical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosclerotic Encephalopathy, Subcortical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosus, Ductus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosus, Patent Ductus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosus, Persistent Truncus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriosus, Truncus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Anastomose' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Anastomoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Anastomosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Aneurysm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Aneurysms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistula' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistula %28%1964-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistula %28%1966-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistula, Dural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistula/congenital %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistula/congenital %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistulas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Fistulas, Dural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Hemofiltration, Continuous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Hemofiltrations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Hemofiltrations, Continuous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Malformation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Malformation, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Malformation, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Malformations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Malformations %28%1976-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Malformations, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Shunt, Surgical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriovenous Shunts, Surgical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritides, Cranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritides, Giant Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritides, Juvenile Temporal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritides, Necrotizing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritides, Temporal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis Virus, Equine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis Viruses, Equine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Cranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Giant Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Giant Cell, Horton' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Giant Cell, Horton%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Granulomatous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Juvenile Temporal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Necrotizing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Postzoster' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Takayasu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Takayasu%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Takayasus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteritis, Temporal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriviridae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterivirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterivirus Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arterivirus Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arteriviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Aneurysm, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Aneurysms, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Bypass, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Bypasses, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Catheterization, Pulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Catheterizations, Pulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Disease, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Disease, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Disease, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Diseases, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Diseases, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Diseases, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Disorder, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Disorders, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Dissection, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Dissections, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Infarction, Heubner' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Infarction, Heubner%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Injuries, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Injury, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Insufficiencies, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Insufficiencies, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Insufficiency, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Insufficiency, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Ischemia, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Ischemia, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Ischemias, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Ischemias, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Narrowing, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Narrowings, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Plaque, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Plaques, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Spasm, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Spasms, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenoses, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenoses, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenoses, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenoses, Subclavian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenoses, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenosis, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenosis, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenosis, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenosis, Subclavian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Stenosis, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Trauma, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Traumas, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Vasospasm, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery Vasospasms, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery arising from the brachiocephalic trunk on the right side and from the arch of the aorta on the left side. It distributes to the neck, thoracic wall, spinal cord, brain, meninges, and upper limb.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery formed by the bifurcation of the BASILAR ARTERY. Branches of the posterior cerebral artery supply portions of the OCCIPITAL LOBE; PARIETAL LOBE; inferior temporal gyrus, brainstem, and CHOROID PLEXUS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery formed by the bifurcation of the internal carotid artery %28%CAROTID ARTERY, INTERNAL%29%. Branches of the anterior cerebral artery supply the CAUDATE NUCLEUS; INTERNAL CAPSULE; PUTAMEN; SEPTAL NUCLEI; GYRUS CINGULI; and surfaces of the FRONTAL LOBE and PARIETAL LOBE.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Anterior Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Anterior Tibial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Axillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Basilar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Brachial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Bronchial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Celiac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Central Retinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Ciliary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Common Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Epigastric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, External Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Femoral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Gastroepiploic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Hepatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Iliac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Inferior Mesenteric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Innominate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Internal Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Internal Mammary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Internal Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Mammary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Maxillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Meningeal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Mesenteric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Middle Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Ophthalmic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Popliteal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Posterior Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Posterior Tibial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Pulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Radial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Renal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Retinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Sinus Node' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Splenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Subclavian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Superior Mesenteric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Temporal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Thoracic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Tibial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Ulnar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Umbilical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artery, Vertebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthralgia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthralgias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritic Psoriasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Acute Rheumatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Bacterial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Collagen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Degenerative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Gouty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Infectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Juvenile Idiopathic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Post-Infectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Postinfectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Reactive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Septic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Suppurative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritides, Viral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis %28%1966-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis %28%1975-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis Encephalitis Virus, Caprine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis Encephalitis Viruses, Caprine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis of the spine, specifically involving the intervertebral articulations.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Acute Rheumatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Adjuvant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Collagen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Degenerative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Experimental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Gouty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Infectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Infectious %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Infectious %28%1979-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Juvenile Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Juvenile Idiopathic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Juvenile Rheumatoid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Juvenile Rheumatoid %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Lyme' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Post Infectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Post-Infectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Postinfectious' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Psoriatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Reactive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Rheumatic, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Rheumatoid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Rheumatoid %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Septic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Spinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, Suppurative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis-Encephalitis Virus, Caprine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthritis-Encephalitis Viruses, Caprine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrobacter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrocine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroderma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrodermataceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrodeses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrodesis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrographies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrography' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrogryposes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthrogryposis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthromyodysplasia, Congenital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthromyodysplasias, Congenital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropathies, Neurogenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropathy, Neurogenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties, Finger Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties, Hip Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties, Knee Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties, Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties, Replacement, Hip' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasties, Replacement, Knee' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Finger Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Hip Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Knee Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Replacement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Replacement, Finger' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Replacement, Hip' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroplasty, Replacement, Knee' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Borne Encephalitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Borne Viral Encephalitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Borne Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Vector' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Vectors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Vectors %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Venom' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod Venoms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-Borne Encephalitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-Borne Encephalitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-Borne Viral Encephalitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-Borne Viral Encephalitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-Borne Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-Borne Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE; BUNYAVIRIDAE; REOVIRIDAE; TOGAVIRIDAE; and FLAVIVIRIDAE. %28%From Dictionary of Microbiology and Molecular Biology, 2nd ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropods' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropods %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropods %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropods of the class ARACHNIDA, order Araneae. Except for mites and ticks, spiders constitute the largest order of arachnids, with approximately 37,000 species having been described. The majority of spiders are harmless, although some species can be regarded as moderately harmful since their bites can lead to quite severe local symptoms. %28%From Barnes, Invertebrate Zoology, 5th ed, p508; Smith, Insects and Other Arthropods of Medical Importance, 1973, pp424-430%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropods of the order Scorpiones, of which 1500 to 2000 species have been described. The most common live in tropical or subtropical areas. They are nocturnal and feed principally on insects and other arthropods. They are large arachnids but do not attack man spontaneously. They have a venomous sting. Their medical significance varies considerably and is dependent on their habits and venom potency rather than on their size. At most, the sting is equivalent to that of a hornet but certain species possess a highly toxic venom potentially fatal to humans. %28%From Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973, p417; Barnes, Invertebrate Zoology, 5th ed, p503%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscope' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopic Surgeries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopic Surgery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopic Surgical Procedure' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthroscopy/instrumentation %28%1982-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthus Phenomenon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arthus Reaction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articaine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artichoke, Jerusalem' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Article, Household' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articles of cloth, usually cotton or rayon and other synthetic or cotton-blend fabrics, used in households, hospitals, physicians%27% examining rooms, nursing homes, etc., for sheets, pillow cases, toweling, gowns, drapes, and the like.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food %28%e.g., head cheese, sausage, scrapple%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research %28%OMAR%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articles, Household' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Capsule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Capsules' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Cartilage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Cartilages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Disk, Temporomandibular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Disks, Temporomandibular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Ligament' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Ligaments' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Rheumatism, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articular Rheumatisms, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulatio talocruralis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Disorder, Developmental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Disorder, Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Disorders, Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Test, Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation Tests, Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulation, Unintelligible' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulationes intertarsales' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulationes intertarseae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulationes pedis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulations, Unintelligible' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulator, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulators, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulatory Apraxia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulatory Apraxias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulatory Dyspraxia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Articulatory Dyspraxias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artifact' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artifacts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. %28%Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Arms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Cardiac Pacemaker' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Cardiac Pacemakers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Cardiac Pacing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Cardiac Pacings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosome, Bacterial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosome, Human' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosome, Mammalian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosome, P1-Derived' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosome, Yeast' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes, Bacterial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes, Human' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes, Mammalian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes, P1 Bacteriophage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes, P1-Derived' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Chromosomes, Yeast' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Dental Stone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Endocrine Pancreas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Erythrocytes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Extremities' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Extremity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Eye' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Eyes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Fat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Fats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Gene Fusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Gene Fusion %28%1998-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Gene Fusions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Genes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Genitourinary Sphincter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Genitourinary Sphincters' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Gravity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Heart Ventricle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Heart Ventricles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Hearts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Hibernation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Implant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Implants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Insemination' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Insemination, Donor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Insemination, Husband' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Inseminations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Intelligence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Intelligence %28%1987-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Kidney' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Kidneys' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Larynges' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Larynx' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Leg' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Legs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Limb' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Limbs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Liver' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Livers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Membrane' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Membranes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Organ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Organs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Organs %28%1966%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Organs %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Organs %28%1972-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Organs %28%1973-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Pacemaker' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Pacemakers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Pancreas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Penis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Pneumoperitoneum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Pneumothorax' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Pneumothoraxs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Respiration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Respirations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Saliva' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Satellite' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Satellites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Skin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Skins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Sweetener' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Tears' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Teeth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Urinary Sphincter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Urinary Sphincters' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial Ventricles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial beta Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial beta Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial implanted lenses. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial introduction of SEMEN or SPERMATOZOA into the VAGINA to facilitate FERTILIZATION.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial openings between two cavities or canals, or between such and the surface of the body. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial organs that are composites of biomaterials and cells. The biomaterial can act as a membrane %28%container%29% as in BIOARTIFICIAL LIVER or a scaffold as in bioartificial skin.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial respiration %28%RESPIRATION, ARTIFICIAL%29% using an oxygenated fluid.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial substitutes for body parts and materials inserted into organisms during experimental studies.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificial, single or multilaminar vesicles %28%made from lecithins or other lipids%29% that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificially induced UTERINE CONTRACTION. Generally, LABOR, OBSTETRIC is induced with the intent to cause delivery of the fetus and termination of pregnancy.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis %28%RENAL DIALYSIS%29%, monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artiodactyla' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artiodactyla %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artiodactyla %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artiodactyla %28%1973-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artiodactylas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artistic Anatomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artistic Anatomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artocarpus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arts, Industrial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arts, Language' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arts, Martial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arts, Medicine in' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artu Brand of Cinnarizine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Artu Brand of Disulfiram' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arvicolinae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arvicoline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arvicolines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arvin IRC 50' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arvin IRC50' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arwin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl CYCLOPENTANES that are a reduced %28%protonated%29% form of INDENES.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Hydrocarbon Hydroxylases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Hydrocarbon Nuclear Translocator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Hydrocarbon Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Hydrocarbon Receptor Nuclear Translocator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Hydrocarbon Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Sulfonates' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Sulfonates %28%1974-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl Sulfotransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl dialkyl Phosphatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl hydrocarbon receptor nuclear translocator is a basic HELIX-LOOP-HELIX MOTIF containing protein that forms a complex with DIOXIN RECEPTOR. The complex binds xenobiotic regulatory elements and activates transcription of a variety of genes including UDP GLUCURONOSYLTRANSFERASE. AhR nuclear translocator is also a subunit of HYPOXIA-INDUCIBLE FACTOR 1.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryl-dialkyl Phosphatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylalkylamine N Acetyltransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylalkylamine N-Acetyltransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylalkylphosphatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamidases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine Acetylase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine Acetylases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine Acetyltransferases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine N Acetyltransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine N-Acetyltransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine N-Acetyltransferase %28%1986-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylamine N-Acetyltransferase, Acetyl-CoA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aryldialkylphosphatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylformamidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatase A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatase A Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatase B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatase C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatases %28%1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfatases %28%1997-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfate Sulfohydrolases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfonates' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfonic Acids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulfotransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulphatase C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arylsulphatases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arytenoid Cartilage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arytenoid Cartilages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arythmol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arzneimittelwerk Dresden Brand of Alprazolam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Arzneimittelwerk Dresden Brand of Aprotinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'As, Hemophilia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'As-75; As-69-81, except As-75 = ARSENIC %28%IM%29% + RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asa-foetida' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asafetida' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asarum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos %28%1969-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos %28%1974-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos %28%1975-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos %28%1979-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Amosite' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Amphibole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Amphibole group Minerals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Amphibole-group Minerals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Blue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Crocidolite' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, Serpentine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos, grunerite. A monoclinic amphibole form of asbestos having long fibers and a high iron content. It is used in insulation. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestos. Fibrous incombustible mineral composed of magnesium and calcium silicates with or without other elements. It is relatively inert chemically and used in thermal insulation and fireproofing. Inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asbestosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascariases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascariasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridiases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridiasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridida' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridida Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridida Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridoidea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaridoidea %28%1975-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaris' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaris %28%1966-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaris lumbricoides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaris suum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascaroidea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascending Aortas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascending Colon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asche Brand of Beclomethasone Dipropionate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aschelminthes %28%1975-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites %28%1975-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites Shunt, Peritoneovenous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites Shunts, Peritoneovenous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites Tumor, Ehrlich' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites, Chylous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascites, Gelatinous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascitic Fluid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascitic Fluid %28%1968-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascitic Fluids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asclepiadaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asclepias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asclepias asthmatica' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascocortonyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycetes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycetes %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycetes %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycetous fungi, family Microascaceae, order Microascales, commonly found in the soil. They are causative agents of mycetoma, maduromycosis, and other infections in humans.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota %28%1965-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota %28%1967-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota %28%1968-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota %28%1974-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota %28%1975-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascomycota %28%1990-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascophyllum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbate Oxidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbate, Ferrous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid %28%1969-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid %28%1973-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid %28%1974-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid Deficiencies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid Deficiency' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbic Acid, Monosodium Salt' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascorbino Dehydrogenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascotoxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ascoviridae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asendis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asepsis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aseptic Meningitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aseptic Necrosis of Bone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aseptic or avascular necrosis of the femoral head. The major types are idiopathic %28%primary%29%, as a complication of fractures or dislocations, and LEGG-PERTHES DISEASE.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asexual Reproduction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asexual Reproductions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asfarviridae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asfiviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ash Tree' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ash, Common' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ash, Mountain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ash, Volcanic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Allopurinol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Baclofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Cinnarizine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Dipyridamole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Lofepramine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Mefenamic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Minocycline Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Spironolactone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ashbourne Brand of Sulfasalazine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asia, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asia, Southeastern' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asia, Western' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asia, Western %28%1966-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialogangliosides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoglycoprotein Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoglycoprotein Receptor, Hepatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoglycoprotein Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoglycoproteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoorosomucoid Binding Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoorosomucoid Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoorosomucoid Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asialoorosomucoid-Binding Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asian American' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asian Americans' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asian Continental Ancestry Group' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asian includes Far East, Southeast Asia, %26% the Indian subcontinent; despite X refs specify NIM CHINA /ethnol, JAPAN /ethnol, KOREA/ethnol, or other Asiatic country with /ethnol when pertinent%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asiatic Cobra' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asiatic Cobras' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asiatic Race' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asiatic Races' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asimina' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Askenazy Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asn Transfer RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asp Transfer RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asp tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asp-tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspalathus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Bayer Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Bellon Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Christiaens Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Ispen Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Merck Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Sanfer Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase Speywood Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginase medac Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparaginate, Potassium Magnesium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine %28%1972-1973%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine Deaminase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine Specific tRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine Synthase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagine-Specific tRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asparagus Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartame' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartame Fuca Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartame Hermes Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartame Muro Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartame Prodes Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminopeptidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminotransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminotransferase, Cytoplasmic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminotransferase, Mitochondrial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminotransferases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminotransferases %28%1968-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Aminotransferases %28%1972-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Ammonia Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Ammonia Lyase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Ammonia-Lyase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Apoaminotransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Carbamoyltransferase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Semialdehyde Dehydrogenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Transaminase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate Transcarbamylase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate, K-Mg' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate, Magnesium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate, Potassium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate, Potassium Magnesium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate-Ammonia Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate-Semialdehyde Dehydrogenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartate-tRNA Ligase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1966-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1970-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1973-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1973-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1974-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1975-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1978-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid %28%1984-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid Specific tRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Acid-Specific tRNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Endopeptidases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Endopeptidases %28%1991-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Endopeptidases %28%1994-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Oxidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartic Proteinases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartoacylase Deficiency Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartoacylase Deficiency Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartokinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartokinase Homoserine Dehydrogenase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl Aminopeptidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl Proteases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl Proteinases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl T RNA Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl tRNA Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartyl-tRNA Synthetase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylglucosamine Amidohydrolase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylglucosaminidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylglucosylaminase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylglucosylamine Deaspartylase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylglycosamine Amidohydrolase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylphenylalanine Methyl Ester' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspartylphenylalanine, Methyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspect, Historical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspect, International' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspect, Legal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspect, Multinational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspects of health and disease related to travel. It includes the physiologic and psychologic beneficial or adverse effects of travel in general or with regard to specific diseases. It includes also emporiatrics, the specialty devoted to the medical aspects of travel. It excludes study tours.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspects, Historical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspects, International' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspects, Legal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspects, Multinational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asperger Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asperger Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asperger%27%s Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asperger%27%s Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergers Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergers Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergilloses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergilloses, Allergic Bronchopulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergilloses, Bronchopulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergilloses, Bronchopulmonary Allergic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis %28%1966-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis of the lung occurring in an individual with long-standing bronchial asthma. It is characterized by pulmonary infiltrates, eosinophilia, elevated serum IgE and immediate type skin reactivity to aspergillus antigen.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis, Allergic Bronchopulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis, Bronchopulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillosis, Bronchopulmonary Allergic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus Endonuclease S1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus Nuclease S1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus flavus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus fumigatus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus nidulans' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus niger' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus ochraceus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus oryzae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus oryzae Ribonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspergillus/enzymology %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asphyxia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asphyxia Neonatorum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asphyxia Neonatorum %28%1977-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asphyxias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiculariases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspidium filix-mas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspidosperma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration %28%1975-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration %28%Psychology%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Biopsies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Biopsies, Fine-Needle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Biopsy, Fine Needle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Lipectomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Lipolysis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Pneumonia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Pneumonias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration Syndrome, Meconium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration of the contents of the uterus with a vacuum curette.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration, Fine-Needle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration, Mechanical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration, Meconium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration, Respiratory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspiration, Vacuum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirations %28%Psychology%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirations, Fine-Needle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirations, Mechanical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirations, Respiratory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirations, Vacuum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirator, Uterine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirators, Uterine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirin Like Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aspirin Tolerance Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asps' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ass' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assassin Bugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Alkaline Comet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Bandshift Mobility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Biologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Biological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Branched DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, CH50' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Chemiluminescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Clonogenic Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Colony-Forming Units' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Comet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Direct Immunofluorescence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, End Point' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Endpoint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Enzyme-Linked Immunosorbent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Farr' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Gel Retardation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Hemolytic Titration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Immunofluorometric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Immunoradiometric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Indirect Immunofluorescence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Luminescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Micronucleus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Mobility Shift' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Nuclease Protection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Phosphorescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Plaque' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Protein Array' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Protein Microarray' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Radioimmunoprecipitation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Radioligand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Radioreceptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Rotarod' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Stem Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Subrenal Capsule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Supershift Mobility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Time-Resolved Immunofluorometric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Two-Hybrid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, Xenograft Antitumor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assay, bDNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Alkaline Comet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Bandshift Mobility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Biologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Biological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Branched DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, CH50' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Chemiluminescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Clonogenic Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Colony-Forming Units' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Comet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Direct Immunofluorescence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, End Point' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Endpoint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Enzyme-Linked Immunosorbent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Gel Retardation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Hemolytic Titration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Immunofluorometric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Immunoradiometric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Indirect Immunofluorescence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Luminescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Micronucleus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Mobility Shift' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Nuclease Protection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Phosphorescent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Plaque' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Protein Array' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Protein Microarray' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Radioimmunoprecipitation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Radioligand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Radioreceptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Stem Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Subrenal Capsule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Supershift Mobility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Time-Resolved Immunofluorometric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Two-Hybrid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, Xenograft Antitumor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assays, bDNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assemblies, Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assembly Proteins, Clathrin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assembly, Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assertiveness' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assertivenesses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment of Health Care Needs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment of Healthcare Needs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment of physiological capacities in relation to job requirements. It is usually done by measuring certain physiological %28%e.g., circulatory and respiratory%29% variables during a gradually increasing workload until specific limitations occur with respect to those variables.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment of psychological variables by the application of mathematical procedures.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Benefit-Risk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Biomedical Technology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Educational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Educational Needs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Geriatric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Healthcare Quality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Nursing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Nutrition' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Outcome %28%Health Care%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Outcomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Pain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Patient Outcome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Patient Outcomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Personality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Process' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Process %28%Health Care%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Risk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Risk-Benefit' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Self' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Self %28%Psychology%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessment, Technology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Benefit-Risk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Biomedical Technology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Educational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Geriatric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Healthcare Quality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Nursing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Nutrition' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Outcome %28%Health Care%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Outcomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Pain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Patient Outcome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Patient Outcomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Personality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Process' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Process %28%Health Care%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Risk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Risk-Benefit' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Self' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Self %28%Psychology%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assessments, Technology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assignment, Medicare' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assignments, Medicare' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory NAD%28%P%29%H Nitrate Reductase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory NADPH Nitrate Reductase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory NADPH-Nitrate Reductase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Nitrate Reductase, NADH Dependent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Nitrate Reductase, NADH-Dependent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Nitrate Reductase, NADPH Dependent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Nitrate Reductase, NADPH-Dependent' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Nitrite Reductase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Reduced Nicotinamide Adenine Dinucleotide Phosphate Nitrate Reductase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assimilatory Reduced Nicotinamide Adenine Dinucleotide Phosphate-Nitrate Reductase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistance Program, Employee %28%Health Care%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistance Programs, Employee %28%Health Care%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistance, Medical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistance, Old Age' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistance, Public' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistance, such as money, food, or shelter, given to the needy, aged, or victims of disaster. It is usually granted on a temporary basis. %28%From The American Heritage Dictionary, 2d college ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistances, Old Age' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Anesthesia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Animal Care' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Doctor%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Laboratory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Ophthalmic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Pediatric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Physician' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Physicians%27%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistant, Veterinary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants to a veterinarian, biological or biomedical researcher, or other scientist who are engaged in the care and management of animals, and who are trained in basic principles of animal life processes and routine laboratory and animal health care procedures. %28%Facts on File Dictionary of Health Care Management, 1988%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Anesthesia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Animal Care' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Doctor%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Laboratory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Ophthalmic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Pediatric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Physician' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Physicians%27%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistants, Veterinary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Circulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Circulation %28%1967-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Circulation %28%1967-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Circulation %28%1967-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Circulation %28%1967-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Death' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Deaths' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Living Facilities' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Living Facility' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Reproductive Technic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Reproductive Technics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Reproductive Technique' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Reproductive Techniques' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Reproductive Technologies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Reproductive Technology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Suicide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Suicides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assisted Ventilation, Liquid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistive Device' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistive Devices' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistive Technologies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assistive Technology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associate Nursing Education' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associate Nursing Educations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associated Antigens, HIV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associated Antigens, Lymphadenopathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associated Fibril-Protein, Scrapie' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associated Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associated Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associateship Practices, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association Learning' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association Learnings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association Test, Word' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association Tests, Word' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association with or participation in an act that is, or is perceived to be, criminal or immoral. One is complicitous when one promotes or unduly benefits from practices or institutions that are morally or legally suspect.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, American Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, American Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, American Hospital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, American Medical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, American Nurses%27%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, American Speech-Language-Hearing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, Free' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, Independent Practice' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, Individual Practice' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, Library' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Association, Mental Health' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, American Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, American Nurses%27%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, Free' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, Independent Practice' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, Individual Practice' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, Library' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associations, Mental Health' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associative Aphasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associative Aphasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associative Dysphasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Associative Dysphasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assurance, Healthcare Quality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Assurances, Healthcare Quality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astacoidea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astasia Abasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astasia longa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astatic Epilepsies, Myoclonic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astatic Epilepsy, Myoclonic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astatine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Alacan Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Alonga Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Byk Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Diba Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Elfar Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Esteve Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Fustery Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole ICN Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Janssen Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Lesvi Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole McNeil Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Medinsa Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Merck Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Senosiain Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Septa Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Smaller Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Urbion Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole Vita Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astemizole ratiopharm Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aster Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asteraceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asteraceae %28%2001-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asterias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asterina' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asteroid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asteroids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthenia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthenia, Neurocirculatory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthenias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthenias, Neurocirculatory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthenopia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma %28%1966-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma %28%1970-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed %28%i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma, Bronchial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma, Cardiac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma, Exercise Induced' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma, Exercise-Induced' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthma/drug therapy %28%1966-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmas, Bronchial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmas, Exercise-Induced' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmatic Crises' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmatic Crisis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmatic Shock' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmatic Shocks' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmaticus, Status' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asthmaweed' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astigmatism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astonin H' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astonin Merck' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astonin-H' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Alprenolol Benzoate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Alprenolol Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Alprostadil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Benzatropine Mesilate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Bupivacaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Cefotetan Disodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Chloroguanide Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Felodipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Mepivacaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Niacinamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Prilocaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Primidone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Propofol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Ramipril' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Ritodrine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Tocainide Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astra Brand of Viloxazine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Alprostadil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Bumetanide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Bupivacaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Cefotetan Disodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Chloroguanide Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Doxazosin Mesylate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Enflurane' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Felodipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Mepivacaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Prilocaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Primidone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Propofol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Ramipril' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Terbutaline Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Testosterone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Tocainide Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AstraZeneca Brand of Viloxazine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astragalus Bone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astragalus Bones' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astragalus Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astragalus gummifer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astragalus gummifer Labill. is the source of gum TRAGACANTH.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astragalus membranaceus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrapin Brand of Piperacillin Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astringents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroblastomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytic Glioma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytic Gliomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Adult Subependymal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Anaplastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Childhood Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Fibrillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Gemistocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Grade III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Grade IV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Juvenile Pilocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Pilocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytoma, Subependymal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Adult Subependymal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Anaplastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Childhood Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Fibrillary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Gemistocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Grade I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Grade II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Grade III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Grade IV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Juvenile Pilocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Pilocytic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Protoplasmic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrocytomas, Subependymal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroglia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroglias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroglioma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrogliomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astronauts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astronomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astronomy %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astronomy %28%1966-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroprotein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroviridae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroviridae Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astroviridae Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Astrovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asulfidine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymmetric Polyneuropathies, Diabetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymmetric Polyneuropathy, Diabetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymmetric Septal Hypertrophies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymmetric Septal Hypertrophy, Familial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymmetries, Facial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymmetry, Facial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asymptomatic Neurosyphilis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asystole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Asystoles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atadenovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atadenoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataractics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia %28%1966-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia %28%1972-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia Telangiectasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia Telangiectasia Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia of Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia with Lactic Acidosis, Type II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Cerebellar Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Dentate Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Dominantly-Inherited Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Enzootic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Feline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Freidreich%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich Familial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich Hereditary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich%27%s Familial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Friedreich%27%s Hereditary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Hereditary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Limb' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Locomotor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Presenile' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Sensory Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia, Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia-Telangiectasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxia/genetics %28%1965-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Appendicular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Cerebellar Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Dentate Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Dominantly-Inherited Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Enzootic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Feline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Friedreich' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Friedreich%27%s Hereditary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Limb' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Locomotor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Motor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Presenile' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Sensory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Sensory Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxias, Truncal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxic Aphasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxic Aphasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxic Paraplegia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxic Paraplegias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ataxy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atebrin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atelectases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atelectases, Congestive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atelectasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atelectasis of the right middle pulmonary lobe, with chronic pneumonitis. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ateles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atelidae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ateline herpesvirus 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atenolol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ateroid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athena Brand of Baclofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athena Brand of Pergolide Mesylate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies, Directional Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies, Percutaneous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies, Percutaneous Transluminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies, Rotational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomies, Transluminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy, Directional Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy, Percutaneous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy, Percutaneous Transluminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy, Rotational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherectomy, Transluminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroembolism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroembolisms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherogenic Diet' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherogenic Diets' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheromas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroscleroses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroscleroses, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroscleroses, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atheroscleroses, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerosis %28%1987-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerosis, Cerebral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerosis, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerosis, Intracranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerotic Disease, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherosclerotic Diseases, Carotid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atherothrombotic microembolism of the lower extremities due to recurrent cholesterol embolic %27%showers%27% with painful cyanotic discoloration of the toes and embolism to other sites that completely resolve between attacks. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation. %28%Segen, Dictionary of Modern Medicine, 1992%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetoid Cerebral Palsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetoid Movement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetoid Movements' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetosis %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athetotic Gait' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athlete Foot' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athlete%27%s Foot' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletes Foot' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Equipment' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Injuries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Injuries %28%1968-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Injuries %28%1968-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Injuries %28%1968-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Injuries %28%1968-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athletic Injury' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athymic Mice' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athymic Mouse' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athymic Rat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Athymic Rats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atid Brand of Acetylcysteine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atid, Acetylcystein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atid, Nitrendipin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atla' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Cod' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Islands' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Islands %28%1982-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Killifish' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Ocean' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Salmon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic Salmons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantic White Cedar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantis Brand of Bumetanide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantis Brand of Dicyclomine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantis Brand of Fluoxymesterone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto Axial Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto Axial Joints' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto Occipital Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto-Axial Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto-Axial Joints' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto-Occipital Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlanto-Occipital Joints' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantoaxial Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlantoaxial Joints' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlas %28%1966-1982%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlases %28%PT%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atlases %5B%Publication Type%5D%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atloido Occipital Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atloido-Occipital Joint' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atloido-Occipital Joints' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmosphere' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmosphere Exposure Chamber' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmosphere Exposure Chambers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmospheres' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmospheric Pressure' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmospheric Pressure %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmospheric Pressure %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmospheric Pressure %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atmospheric Pressures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Absorption Spectrophotometry' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Emission Spectrophotometry' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Energy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Force Microscopies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Force Microscopy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Medicine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Spectrophotometry' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic Warfare' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomic species differing in mass number but having the same atomic number. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atomizer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atonic Absence Seizure' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atonic Cerebral Palsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atonic Epilepsies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atonic Epilepsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atonic Neurogenic Bladder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atonic Neurogenic Bladders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atony, Uterine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Conjunctivitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Conjunctivitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Dermatitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Dermatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Eczema' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Hypersensitivities' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Hypersensitivity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Neurodermatitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atopic Neurodermatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atractylate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atractylic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atractylis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atractylodes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atractyloside' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atracurium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atracurium Besilate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atracurium Dibesylate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrazine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Anal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Biliary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Choanal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Esophageal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Follicular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Intestinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Pulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Pulmonary Valve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Tricuspid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresia, Tricuspid Valve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Anal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Choanal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Esophageal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Follicular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Pulmonary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Pulmonary Valve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Tricuspid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atresias, Tricuspid Valve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atretic Follicles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atria, Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Appendage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Appendages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Beat, Premature' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Beats, Premature' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Complex, Premature' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Complices, Premature' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Contraction, Premature' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Contractions, Premature' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Ectopic Beat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Ectopic Beats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Ectopic Tachycardia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Ectopic Tachycardias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Extrasystole' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Extrasystoles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Fibrillation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Fibrillations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Flutter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Flutters' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Function' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Function, Left' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Function, Right' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Functions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Functions, Left' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Functions, Right' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Myosin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Myosins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor %28%1-126%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor %28%1-28%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor %28%99-126%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor Prohormone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Factor Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Peptide %28%1-126%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Peptides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Peptides Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Natriuretic Peptides Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Premature Complex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Premature Complexes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Premature Complices' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Pronatriodilatin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Septal Defect' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Septal Defects' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Tachycardia, Ectopic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrial Tachycardias, Ectopic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrio Ventricular Node' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrio-Ventricular Node' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrio-Ventricular Nodes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptidase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptin %28%1-28%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptin %28%99-126%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptin 126' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptin Prohormone %28%1-126%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptin Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriopeptins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Blocks' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Bundle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Bundles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Nodal Reentry Tachycardia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Node' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Node %28%1975-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrioventricular Nodes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atriplex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrium Appendage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrium Appendage, Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrium Appendages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrium, Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrium, Left' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrium, Right' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atromid S' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropa belladonna' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropa mandragora' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Gastritides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Gastritis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Muscular Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Muscular Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Polychondritides, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Polychondritis, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Rhinitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophic Rhinitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Dentate Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Dentatorubral-Pallidoluysian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Disuse' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Facioscapulohumeral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Gyrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Hemifacial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Hereditary Optic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Lobar %28%Brain%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Multisystem' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Multisystemic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Muscle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Neurogenic Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Neurotrophic Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Peroneal Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Pigmentary Pallidal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Progressive Hemifacial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Spinobulbar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Spinobulbar Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Spinopontine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Striatonigral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, Sudek%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophies, X-Linked Bulbo-Spinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy %28%1970-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy of the optic disk which may be congenital or acquired. This condition indicates a deficiency in the number of nerve fibers which arise in the RETINA and converge to form the OPTIC DISK; OPTIC NERVE; OPTIC CHIASM; and optic tracts. GLAUCOMA; ISCHEMIA; inflammation, a chronic elevation of intracranial pressure, toxins, optic nerve compression, and inherited conditions %28%see OPTIC ATROPHIES, HEREDITARY%29% are relatively common causes of this condition.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Dentate Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Dentatorubral-Pallidoluysian' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Facioscapulohumeral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Familial Olivopontocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Gyrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Hemifacial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Hereditary Optic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Idiopathic Olivopontocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Inherited Olivopontocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Lobar %28%Brain%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Multiple System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Multisystem' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Multisystemic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Muscle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Muscular, Peroneal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Myelopathic Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Neurogenic Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Neurotrophic Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Nonfamilial Olivopontocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Olivo-Ponto-Cerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Olivopontocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Optic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Peroneal Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Pigmentary Pallidal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Pontoolivocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Progressive Hemifacial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Spinal Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Spinobulbar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Spinobulbar Muscular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Spinocerebellar' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Spinopontine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Striatonigral' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Sudek' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, Sudek%27%s' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atrophy, X-Linked Bulbo-Spinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine %28%1973-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine Chauvin Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine Derivatives' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atropine Winzer Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Att Attachment Site' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Att Attachment Sites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AttB Attachment Site' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AttB Attachment Sites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AttP Attachment Site' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AttP Attachment Sites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Denture, Precision' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Dentures, Precision' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Disorder, Reactive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Disorders, Reactive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Loss, Periodontal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Protein, NSF' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site %28%Microbiology%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, Att' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, AttB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, AttP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, Bacterial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, Microbiologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, Microbiological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Site, Phage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites %28%Microbiology%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, Att' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, AttB' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, AttP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, Bacterial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, Microbiologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, Microbiological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment Sites, Phage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment of orthodontic devices and materials to the MOUTH area for support and to provide a counterforce to orthodontic forces.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment of the child to the parent of the opposite sex, accompanied by envious and aggressive feelings toward the parent of the same sex.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment, Dental Slotted' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment, Denture Precision' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment, Epithelial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment, Intracoronal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment, Object' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachment, conscious or unconscious, of emotional feeling and significance to an idea, object or most commonly a person.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachments, Dental Slotted' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachments, Denture Precision' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachments, Epithelial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachments, Intracoronal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attachments, Object' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attack, 9-11-2001' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attack, Drop' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attack, Lightning' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attack, Panic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attack, Transient Ischemic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, 9-11-2001' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, Adam-Stokes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, Lightning' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, Panic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, Salaam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, Stokes-Adams' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attacks, Transient Ischemic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attempted Suicide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attendant, Psychiatric Ward' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attendants, Psychiatric Ward' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attending Physician, Hospital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention Deficit Disorder with Hyperactivity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention Deficit Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention Deficit Disorders with Hyperactivity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention Deficit Hyperactivity Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention Deficit Hyperactivity Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attention Deficit and Disruptive Behavior Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attentions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attenuated Vaccines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude %28%1966-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude of Health Personnel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude of Health Personnel %28%1968-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Computer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Computers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Death' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Health' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Health %28%1968-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Health %28%1969-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude to Health %28%1976-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude, Health' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitude, Staff' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitudes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitudes of personnel toward their patients, other professionals, toward the medical care system, etc.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitudes to Death' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitudes, Health' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attitudes, Staff' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attorney' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attorney Healthcare Power' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attorney Medical Power' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attorneys' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attractants, Sex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attribute, Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attributes, Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attrition, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Attrition, Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Antidepressants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Bacterial Forms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Cluster Headaches' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Endometrial Hyperplasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Inclusion Body Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Inclusion-Body Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Interstitial Pneumonia of Cattle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Mycobacteria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Mycobacterium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Mycobacterium Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Mycobacterium Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Neuralgia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Neuralgias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Pelizaeus Merzbacher Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Pelizaeus-Merzbacher Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Pelizaeus-Merzbacher Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Phenylketonuria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Phenylketonurias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Pneumonia, Primary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical Pneumonias, Primary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Atypical gamma immunoglobulins characterized by their irreversible heat denaturation at 56-degrees C. Pyroprecipitation is inhibited at pH below 3 and above 9. The presence of pyroglobulins in the serum is the cause of pyroglobulinemia. They are frequently present in multiple myeloma and the pyroglobulin precipitate binds complement, reacts with rheumatoid factor, produces passive cutaneous anaphylaxis, generalized passive anaphylaxis and passive Arthus-type phenomena.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Au-185-196, 198-201, 203; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Au-197 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Au-197; NIM ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audio Visual Aids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audio-Visual Aid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audio-Visual Aids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audio-Visual Aids %28%1966-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audioanalgesia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audioanalgesias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiogenic Epilepsies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiogenic Epilepsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiogenic Reflex Epilepsies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiogenic Reflex Epilepsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiology %28%1978-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometries, Electroencephalic Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometries, Evoked Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometries, Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry, Electroencephalic Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry, Evoked Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry, Pure Tone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry, Pure-Tone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiometry, Speech' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiotape' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiovisual Aid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audiovisual Aids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit Program, Medical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit Programs, Medical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Financial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Insurance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Management' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Medical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Nursing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audit, Operational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Agnosias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Agnosias, Congenital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brain Stem Evoked Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brain Stem Evoked Responses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brain Stem Implantation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brain Stem Implants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brain Stem Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brain Stem Responses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Evoked Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Evoked Responses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Implant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Implantation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Implantations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Implants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Brainstem Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Canal, External' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Canals, External' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Comprehension Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Comprehension Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Cortex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Cortex %28%1968-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Cortex Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Discriminatory Aphasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Discriminatory Aphasias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Disease, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Diseases, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Dysfunction, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Evoked Potential' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Evoked Potentials' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Evoked Response' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Evoked Responses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Fatigue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Fatigues' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Hallucination' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Hallucination, Verbal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Hallucinations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Hallucinations, Verbal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Hyperesthesias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Illusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Illusions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Inattentions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Localization' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Localizations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Nerves' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Ossicle' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Ossicles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Pathway' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Pathway Disorders, Central' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Pathways' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Pattern Recognition' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perception' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perception %28%1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perception %28%1967-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perception %28%1967-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perception %28%1967-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perception %28%1967-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perceptions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perceptual Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Perceptual Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Processing Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Processing Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Prostheses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Prosthesis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Seizure' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Seizures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Stimulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Threshold' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Threshold %28%1967-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Threshold %28%1968-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Threshold %28%1968-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Threshold %28%1968-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Thresholds' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Tube' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory Tubes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auditory and visual instructional materials. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Financial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Insurance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Management' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Medical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Nursing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Audits, Operational' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auerbach Plexus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auerbach%27%s Plexus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auerbachs Plexus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augen%C3%%B6%l, Atropin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augensalbe, Aristamid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augentropfen, Aristamid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augmentation, Alveolar Ridge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augmentation, Mandibular Ridge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augmentation, Maxillary Ridge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augmentations, Alveolar Ridge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augmentations, Mandibular Ridge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Augmentations, Maxillary Ridge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'August Rat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aujeszky Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aujeszky Disease Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aujeszky%27%s Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aujeszky%27%s Disease Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aujeszkys Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aujeszkys Disease Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aural Vertigo' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auramine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auranofin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auranofin Recordati Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auranofin Robapharm Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auranofin Rubio Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auranofin Yamanouchi Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auras' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aureolic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aureomycine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aureusviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Acupuncture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Acupunctures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Appendage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Appendages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Cancers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Fibrillation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Fibrillations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Flutter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Flutters' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Neoplasm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Neoplasms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auricular Syndrome of Ramsay Hunt' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auriculin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auriculo Ventricular Dissociation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auriculo-Ventricular Dissociations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurin Tricarboxylic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurintricarboxylic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurintricarboxylic Acid, Triammonium Salt' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurodox' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurorex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothioglucose' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothioglucose Nourypharma Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothioglucose Schering Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothioglucose Schering-Plough Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothioglucose Tosse Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothioglucose, beta D Isomer' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothiomalate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurothiosulfate, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurovertin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aurovertins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultation, Cardiac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultation, Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultation/instrumentation %28%1966-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultations, Cardiac' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auscultations, Heart' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australasia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australia %28%1966-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australia %28%1969-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australia %28%1990-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australia Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australia, New Zealand and neighboring islands in the South Pacific Ocean. %28%Random House Unabridged Dictionary, 2d ed.%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australian Aborigine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australian Aborigines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australian Capital Territory' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australian Race' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australian Wild Lime' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australian bat lyssaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australoid Race %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australoid Races' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australophocaena dioptrica' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Australorbis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Austria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autacoids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authoritarianism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authoritarianism %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authoritarianisms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authoritative treatises on drugs and preparations, their description, formulation, analytic composition, physical constants, main chemical properties used in identification, standards for strength, purity, and dosage, chemical tests for determining identity and purity, etc. They are usually published under governmental jurisdiction %28%e.g., USP, the United States Pharmacopoeia; BP, British Pharmacopoeia; P. Helv., the Swiss Pharmacopoeia%29%. They differ from FORMULARIES in that they are far more complete: formularies tend to be mere listings of formulas and prescriptions.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authoritative works containing lists of drugs and preparations, their description, formulation, analytic composition, main chemical properties, standards for strength, purity, and dosage, chemical tests for determining identity, etc. They have the status of a standard.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authorship' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Authorships' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism, Akinetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism, Early Infantile' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism, Infantile' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autisms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autistic Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autistic Disorder %28%1981-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auto PEEP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auto-PEEP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AutoPEEP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoanalyses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoanalysis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies %28%1969-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies %28%1983-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies %28%1984-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies %28%1991-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for WEGENER%27%S GRANULOMATOSIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA %28%cytoplasmic%29%, p-ANCA %28%perinuclear%29%, and atypical ANCA.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies directed against newly-formed EPITOPES created as the COMPLEMENT cascade is activated and the proteins involved change their conformations.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus %28%LUPUS ERYTHEMATOSUS, SYSTEMIC;%29%, ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren%27%s syndrome, scleroderma, polymyositis, and mixed connective tissue disease.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantibodies that bind to the thyroid-stimulating hormone %28%TSH%29% receptor %28%RECEPTORS, THYROTROPIN%29% on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES DISEASE.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoantigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autobiographies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autobiography' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autocrine Communication' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autocrine Communications' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autocrine Motility Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autocrine Signaling' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autocrine Signalings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoexperimentation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autogenic Training' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autogenic Trainings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autograft' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autografts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Demyelinating Diseases, CNS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Demyelinating Diseases, Central Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Demyelinating Diseases, Spinal Cord' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Demyelinating Disorders, CNS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diabete' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diabetes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Disease Models, Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Disease, Neurologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1966-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1967-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1968-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1969-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1973-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases %28%1988-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases of the Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases, Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Diseases, Neurologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Disorders of the Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Disorders, Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Encephalomyelitis, Experimental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Experimental Encephalomyelitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Experimental Myasthenia Gravis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Experimental Myositis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Hemolytic Anemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Hemolytic Anemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Hepatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Nervous System Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Neuritis, Experimental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Neuropathies, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Neuropathies, Experimental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Neuropathy, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Neuropathy, Experimental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyendocrinopathies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyendocrinopathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal-Dystrophy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyglandular Syndrome Type I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Polyglandular Syndrome Type II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Responses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Syndrome Type I, Polyglandular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Syndrome Type II, Polyglandular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Thrombocytopenias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Thrombocytopenic Purpura' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Thrombocytopenic Purpuras' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Thyroiditides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune Thyroiditis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis %28%CANDIDIASIS, CHRONIC MUCOCUTANEOUS%29%, while type II exhibits any combination of adrenal insufficiency %28%ADDISON%27%S DISEASE%29%, lymphocytic thyroiditis %28%THYROIDITIS, AUTOIMMUNE;%29%, HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmunities' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoimmunity' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autokinetic Effects' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autokinetic Illusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous Blood Transfusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous Blood Transfusions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous Fibrin Tissue Adhesive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous Transplantation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous Transplantations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autologous skeletal muscle that is wrapped around the heart and electrically stimulated in order to provide mechanical heart assistance. The latissimus dorsi muscle is commonly used to form this ventricle that functions to independently augment cardiac performance by pumping in series with the heart.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autolyses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autolyses, Dental Pulp' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autolysis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autolysis %28%1968-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autolysis, Dental Pulp' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated External Defibrillator' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated Medical Record System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated Medical Record Systems' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated Medical Records System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated Medical Records Systems' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated Pattern Recognition' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automated systems applied to the patient care process including diagnosis, therapy, and systems of communicating medical data within the health care setting.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic Data Processing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic Data Processing %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic Food Dispenser' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic Food Dispensers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic Information Processing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic or hand operated equipment used to control and extinguish fires.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatic, mechanical, and apparently undirected behavior which is outside of conscious control.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automation %28%1966%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automation %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automation %28%1966-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automation, Library' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automation, Office' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automations, Office' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automatism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobile' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobile Driver Examination' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobile Driver Examinations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobile Driving' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobile Drivings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobiles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobiles %28%1966-1969%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automobiles %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Automotive safety devices consisting of a bag designed to inflate upon collision and prevent passengers from pitching forward. %28%American Heritage Dictionary, 1982%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Agents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Agents %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Agents %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Denervation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Denervations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Drugs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysfunction, Paraneoplastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysfunction, Segmental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysfunctions, Paraneoplastic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysfunctions, Segmental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysreflexia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysreflexia, Spinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysreflexias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Dysreflexias, Spinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Failure, Progressive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Failure, Pure' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Failures, Progressive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Fiber, Postganglionic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Fiber, Preganglionic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Fibers, Postganglionic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Fibers, Postganglionic %28%1971-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Fibers, Preganglionic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Ganglia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Ganglion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Hyperreflexia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Hyperreflexias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nerve Block' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nerve Blocks' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System %28%1968-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System Diseases %28%1981-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous System Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Nervous Systems' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Neuropathies, Diabetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Neuropathy, Diabetic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Pathway' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Pathways' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Peripheral Nervous System Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Polyneuropathies, Alcohol-Related' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomic Polyneuropathy, Alcohol-Related' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomous Replications' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomy, Personal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autonomy, Professional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagic Cell Death' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagic Cell Deaths' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagic Programmed Cell Death' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagies, Cellular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagocytosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autophagy, Cellular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoprothrombin C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoprothrombin II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoprothrombin III' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autopsies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autopsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoradiography' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoreceptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoreceptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autoregulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Chromosome Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Emery Dreifuss Muscular Dystrophy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Hereditary Spastic Paraplegia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Juvenile Parkinsonism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Nemaline Myopathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Optic Atrophy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Polycystic Kidney' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Spastic Paraplegia Hereditary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Dominant Striatonigral Degeneration' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Recessive Emery Dreifuss Muscular Dystrophy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Recessive Nemaline Myopathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Recessive Polycystic Kidney' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Recessive Polycystic Kidney Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Recessive Spastic Paraplegia, Hereditary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal Recesssive Juvenile Parkinsonism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal dominant COLLAGEN DISEASES resulting from defective biosynthesis of COLLAGEN TYPE I and characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. There are four major types, I-IV.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal dominant disorder characterized by cone-shaped epiphyses in the hands and multiple cartilaginous exostoses. Mental retardation and abnormalities of chromosome 8 are often present. The exostoses in this syndrome appear identical to those of hereditary multiple exostoses %28%EXOSTOSES, HEREDITARY MULTIPLE%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. The most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. The underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest %28%neurocristopathy%29%. Piebaldism may be closely related to Waardenburg%27%s syndrome.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal recessive disorder characterized by multiple congenital anomalies including microcephaly, mental retardation, unusual facies, and genital abnormalities. The biochemical defect is a lack of 7-dehydrocholesterol-delta-7-reductase, resulting in abnormally high levels of 7-dehydrocholesterol and low levels of cholesterol.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal recessive hereditary disorders characterized by congenital SENSORINEURAL HEARING LOSS and RETINITIS PIGMENTOSA. Genetically and symptomatically heterogeneous, clinical classes include type I, type II, and type III. Their severity, age of onset of retinitis pigmentosa and the degree of vestibular dysfunction are variable.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosomal recessive neurodegenerative disorders caused by lysosomal membrane transport defects that result in accumulation of free sialic acid %28%N-ACETYLNEURAMINIC ACID%29% within the lysosomes. The two main clinical phenotypes, which are allelic variants of the SLC17A5 gene, are ISSD, a severe infantile form, or Salla disease, a slowly progressive adult form, named for the geographic area in Finland where the kindred first studied resided.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosome Abnormality' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosuggestion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autosuggestions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autotransfusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autotransfusions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autotransplant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autotransplants' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Autumn Crocus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxiliaries, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxiliaries, Hospital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxiliaries, Nursing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxiliary, Dental' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxiliary, Hospital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxiliary, Nursing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxilin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxilins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxilium Pharmaceuticals Inc. Brand of Testosterone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Auxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availabilities, Biologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availabilities, Biological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availabilities, Physiologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability Equivalencies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability of Health Services' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Biologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Biologic Nutritional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Biological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Biological Nutritional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Contraceptive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Nutritional' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Nutritional Biologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Nutritional Biological' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Availability, Physiologic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Available manpower, facilities, revenue, equipment, and supplies to produce requisite health care and services.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avascular Necrosis of Bone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avascular Necrosis of Femur Head' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avena sativa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avenaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Behring Brand of Desipramine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Behring Brand of Dicyclomine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Behring Brand of Nedocromil Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Bisacodyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Bromelains' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Buphenine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Bupivacaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Buserelin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Buserelin Acetate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Calcifediol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Cefotaxime Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Desipramine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Desoximetasone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Dicyclomine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Diethylcarbamazine Citrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Felodipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Gestrinone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Gold Sodium Thiomalate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Levothyroxine Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Mepivacaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Mepyramine Maleate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Molsidomine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Nedocromil Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Nicergoline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Niclosamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Nicorandil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Norepinephrine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Pentamidine Isethionate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Pheniramine Maleate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Pipemidic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Polygeline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Pravastatin Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Prednisone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Pristinamycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Probucol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Procaine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Promegestone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Pyrimethamine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Quinine Bisulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Ramipril' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Roxithromycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Spiramycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Teicoplanin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Tolbutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Trazodone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Ursodeoxycholic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Brand of Yohimbine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Cefotaxime Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Cetylpyridinium Chloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Levonorgestrel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Mepyramine Maleate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Nicorandil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Plasmin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Ramipril' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Teicoplanin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aventis Pharma Brand of Trazodone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Average Family Size' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Average Family Sizes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aversion Disorders, Sexual' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aversion Therapies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aversion Therapy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aversive Therapies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aversive Therapy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aves' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aviadenovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aviadenoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Adenovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Adenoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Bill' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Bills' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Crop' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Crops' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Encephalomyelitis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Encephalomyelitis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Erythroblastosis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Erythroblastosis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Flu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Hypersensitivity Pneumonitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Hypersensitivity Pneumonitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Infectious Bronchitis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Infectious Laryngotracheitis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Influenza' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Influenzas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukosis %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukosis Sarcoma Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukosis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukosis-Sarcoma Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Leukosis-Sarcoma Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Lymphomatosis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Lymphomatosis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Malaria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Malarias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Metapneumovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Myeloblastosis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Nephrosis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Nephrosis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Orthomyxovirus Type A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Paramyxovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Paramyxovirus 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Paramyxoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Reovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Reoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Reticuloendotheliosis Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Reticuloendotheliosis Virus Group' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Reticuloendotheliosis Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcoma Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcoma Virus B77' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcoma Virus Transforming Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcoma Virus-Transforming Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcoma Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Sarcomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Stomach' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Stomachs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Tuberculoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian Tuberculosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian encephalomyelitis-like virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian leukosis virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian myeloblastosis virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avian orthoreovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aviation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aviation Accident' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aviation Accidents' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avibirnavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avibirnaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avicennia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avicopharma Brand of Carbaril' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avidin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avidities, Antibody' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avidity, Antibody' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avihepadnavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avihepadnaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avipoxvirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avipoxvirus %28%1994-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avipoxviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avitaminoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avitaminosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avoidance Learning' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avoidance Learnings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avoidant Personality Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulavirus Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulavirus Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsed Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsion, Facial Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsion, Nerve Root' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsion, Optic Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsion, Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsions, Facial Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsions, Nerve Root' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsions, Optic Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Avulsions, Tooth' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Awakening, Early' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Award' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Awards and Prizes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Awareness' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Awareness of oneself in relation to time, place and person.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Awarenesses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axcan Brand 1 of Pancrelipase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axcan Brand 2 of Pancrelipase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axcan Brand of Algeldrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axcan Brand of Mesalamine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axcan Brand of Ursodeoxycholic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axenic Animal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axerophthal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axilla' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axillary Arteries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axillary Artery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axillary Vein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axillary Veins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axillas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axinella' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axis %28%1966-1982%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axis %28%1966-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axis, Dens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axolotl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axolotl, Mexican' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axolotls' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axolotls, Mexican' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axon Associated Adhesion Molecules' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axon Reaction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axon Reactions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axon Terminal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axon Terminals' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Injuries, Diffuse' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Injury, Diffuse' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Neuropathies, Alcoholic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Neuropathy, Alcoholic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Reaction' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Reactions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Transport' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axonal Transports' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axons %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axons %28%1966-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axons %28%1967-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axons %28%1968-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axons of certain cells in the dentate gyrus. They project to the polymorphic layer of the dentate gyrus and to the proximal dendrites of pyramidal cells of the hippocampus. These mossy fibers should not be confused with mossy fibers that are cerebellar afferents %28%see NERVE FIBERS%29%.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axoplasmic Flows' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axoplasmic Streaming' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axoplasmic Transport' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axoplasmic Transports' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axotomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Axotomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayahuasca' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayerza Arrilaga Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayerza%27%s Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayerza-Arrilaga Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayerzas Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ayurvedic Medicine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Az threonam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Az-threonam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aza Compounds' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aza Compounds %28%1972-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aza Oxa Crown Ethers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aza Thia Crown Compounds' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azacitidine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azaclorzine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azacosterol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azacyclopropanes, Saturated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azacyclopropanes, Unsaturated' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azacytidine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azadirachta' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azadose' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azaguanine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azaperone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azaperone Janssen Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azapropazone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azaserine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azasteroids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azasteroids %28%1988-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azathioprine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azauridine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1966-1973%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1968-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1973-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azepines %28%1991-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azerbaijan' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azerbaijan S.S.R.' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azerbaijan SSR' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azeserine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azetidine 2 carboxylic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azetidine-2-carboxylic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azetidinecarboxylic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azetidines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azetines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azetines %28%1974-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azide, Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azides %28%1977-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azidothymidine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azinphos Methyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azinphos-Methyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azinphosmethyl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aziridines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azirines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azirines %28%1968-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azirines %28%1971-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azithromycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azithromycin Pfizer Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azitrocin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azlocillin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azlocillin Bayer Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1968-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1969-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1969-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1970-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1971-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1972-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1973-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Compounds %28%1973-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Dine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Gesic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Natural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azo Standard' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AzoDine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AzoGesic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AzoNatural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'AzoStandard' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoarcus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azocines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azocines %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azocines %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoferredoxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoles %28%1966-1968%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoles %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azolinic Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoospermias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorean Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorean Disease %28%Machado Joseph%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorean Disease %28%Machado-Joseph%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorean Disease, Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorean Diseases %28%Machado-Joseph%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azores' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorhizobium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azorhizobium caulinodans' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azospirillum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azospirillum %28%1978-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azospirillum brasilense' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azospirillum lipoferum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azotemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azothioprine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azotobacter' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azotobacter %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azotobacter vinelandii' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azotobacteraceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azovan Blue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azoxymethane' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azthreonam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aztreonam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aztreonam Esteve Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Aztreonam Squibb Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azulenes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azulfadine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azulfidine EN tabs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azulfidine EN-tabs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Acetylcysteine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Aciclovir' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Allopurinol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Amantadine Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Amantadine Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Beclomethasone Dipropionate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Bezafibrate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Cetirizine Dihydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Felodipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Flutamide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Moclobemide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Molsidomine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Naftidrofuryl Oxalate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Nitrendipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Piracetam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Pirenzepine Dihydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Procetofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Propafenone Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Spironolactone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Terbutaline Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma Brand of Vancomycin Hydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azupharma, Dexamethason' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azure Stains' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azurin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azygos Vein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azygos Veins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Azythromycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 1, Heterovitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 12, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 15,000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 15000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 3, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 4, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 5, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 50 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B 663' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Antibodies, Hepatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Antigens, Anti-Hepatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Antigens, Hepatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Activating Factor Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Activation Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Antigen CD19' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Antigen Receptor Complex Associated Protein Beta Chain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Antigen Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Blast 2 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Differentiation Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Differentiation Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Differentiation Factor 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Epitope' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Epitopes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Growth Factor 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Growth Factor I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Growth Factor II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Growth Factor, High Molecular Weight' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Heavy Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Leukemia 2 Family Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Leukemia, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Light Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Lymphoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Lymphoma 6 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Mu Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Proliferating Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Specific Activator Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Specific Transcription Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Stimulating Factor 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Stimulatory Factor 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Stimulatory Factor 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Stimulatory Factor-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Stimulatory Factor-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell Subsets' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell kappa Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell kappa-Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell lambda Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell lambda-Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell, Pancreatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell-Activating Factor Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cell-Specific Transcription Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Cells, Pancreatic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Chain, Ricin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Chain, alpha-Crystallin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Chain, beta-Crystallin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Fiber' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B K Mole Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Kinase, I-kappa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Cell Adhesion Molecule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Differentiation Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Epitope' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Epitopes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Heavy Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Light Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Mu Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte Subsets' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte kappa Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocyte lambda Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes %28%1973-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes %28%1973-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes %28%1973-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes %28%1973-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes %28%1975-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes %28%1977-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytes/immunology %28%1977-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytic Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytic Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Lymphocytic Leukemia, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Oleosum, Solganal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Pertussis Restriction Enzyme I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Receptor, Cholecystokinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Receptor, Neuromedin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Receptors, Neurokinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Receptors, Neuromedin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Subunit alpha-Crystallin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B Vitamins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B and T Cell Acute Lymphoblastic Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B and T Cell Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B esterase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B raf Kinases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B virus, Hepatitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B%C3%%A9%fizal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B%C3%%A9%tamaze' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, 3%27%,4%27%-Dideoxykanamycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Acid Lipase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Arylsulfatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Batrachotoxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Calcineurin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Cathepsin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Colipase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Deferoxamine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Desferrioxamine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Exfoliative Toxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Fibrinopeptide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Fibrinopeptides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Haemophilia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Hemophilia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Hygromycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Lecithinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Mel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Parvalbumin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Phospholipase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Prostaglandins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, RNA Polymerase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Regadrin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Relaxin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, Transferrin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, alpha-Lactalbumin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B, beta-Lactoglobulin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B- and T-Cell Acute Lymphoblastic Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B- and T-Cell Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-11; B-10 = BORON %28%IM%29% + ISOTOPES %28%NIM%29%; B-8, 9, 12, 13 = BORON %28%IM%29% + RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-15000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-4, Leukotriene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-50 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-ALL' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Activation Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Antigen Receptor Complex Associated Protein Beta-Chain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Antigen Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Differentiation Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Differentiation Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Differentiation Factor-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Epitope' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Epitopes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Gene Rearrangements' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Growth Factor, High Molecular Weight' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Growth Factor-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Growth Factor-I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Growth Factor-II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Heavy Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Leukemia, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Leukemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Leukemias, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Leukemias, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Light Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Lymphocytic Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Lymphocytic Leukemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Lymphoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Lymphoma 6 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Lymphomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Proliferating Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Stimulating Factor-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Stimulatory Factor 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Stimulatory Factor 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Stimulatory Factor-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Stimulatory Factor-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Subset' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell Subsets' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cell-Specific Activator Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Crystallin, beta' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Form DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-K Mole Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Like Activity, Cathepsin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Like Proteinase, Cathepsin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Cell Adhesion Molecule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Differentiation Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Epitope' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Epitopes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Gene Rearrangements' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Heavy Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Leu Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Light Chain Gene Rearrangement' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Subset' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocyte Subsets' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes %28%1973-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes %28%1973-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes %28%1976-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes %28%1977-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes/classification %28%1980-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytes/immunology %28%1977-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytic Leukemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytic Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytic Leukemia, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytic Leukemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytic Leukemias, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphocytic Leukemias, Chronic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphotropic Virus, Human' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Lymphotropic Viruses, Human' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-Type Natriuretic Peptide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including Burkitt lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-esterase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-lymphocyte differentiation antigens ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-raf Kinases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-raf, Proto-Oncogene Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B-raf, Proto-Oncogene Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index here%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B. burgdorferi or B. burgdorferi group infection = LYME DISEASE; infection by other species = probably RELAPSING FEVER, but if not, index under BORRELIA INFECTIONS%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B1 - ORGANISMS-ANIMALS ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B1 Receptor, Bradykinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B1 Receptors, Bradykinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B1, Arylsulfatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B1, Cathepsin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B10 9359' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B109359' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B12 Coenzymes, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B12, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B15,000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B15000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B16 Melanoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B16 Melanomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B19 virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B19 viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B2 - ORGANISMS-ALGAE ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B2 Receptor, Bradykinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B2 Receptors, Bradykinin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B2, Arylsulfatase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B2, Thromboxane' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B220 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B3 - ORGANISMS-BACTERIA ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B3, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B4 - ORGANISMS-VIRUSES ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B5 - ORGANISMS-FUNGI ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B5 Reductase, NADH-Cytochrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B5, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B6 - ORGANISMS-PLANTS ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B6 Deficiencies, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B6 Deficiency, Vitamin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B61 Secreted Protein, Endothelium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B663' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7 - ORGANISMS-ARCHAEA ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7 1 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7 1 Costimulatory Molecule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7 2 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7-1 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7-1 Costimulatory Molecule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7-2 Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B7-2 Costimulatory Molecule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B70 Costimulatory Molecule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'B8 - ORGANISMS-MESOMYCETOZOEA ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BA, CIBA 32.644' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAC %28%Chromosome%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BACTERIAL INFECTIONS of the nervous system caused by HAEMOPHILUS organisms, and marked by prominent inflammation of the meninges. HAEMOPHILUS INFLUENZAE TYPE B is the most common causative organism. The condition primarily affects children under 6 years of age but may occur in adults. Clinical manifestations include fever; nuchal rigidity; PHOTOPHOBIA; SEIZURES; HEARING LOSS, SENSORINEURAL; COMA; and cerebrovascular thrombosis. The organism tends to enter the central nervous system following infections of adjacent structures, including the middle ear %28%see also OTITIS MEDIA%29%, sinuses, and pharynx. %28%From Menkes, Textbook of Child Neurology, 5th ed, pp396-7%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BACTERIAL WARFARE was see under BIOLOGICAL WARFARE 1963-78%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BACs %28%Chromosomes%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB 3T3 Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB 3T3 Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB C Mice' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB C Mice, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB C Mouse' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB C Mouse, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB c 3T3 Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB-3T3 Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB-3T3 Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB-c 3T3 Cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALB-c 3T3 Cells' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BALTIMORE is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAPN' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAPNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BASF Brand of Allopurinol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAY 946' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAY Va 1470' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAY-946' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BAYVa 1470' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB 10010' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB Creatine Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB K 8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB K8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB Rat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB Rat, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB Rats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB Rats, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB Wistar Rats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB-K 8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BB10010' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BBK 8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BBK8' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC 105' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC 2627' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC Brand of Felodipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC Brand of Moclobemide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC Brand of Nitrendipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC, Bromhexin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC105' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BC2627' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCAR1 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCG Vaccine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCG Vaccine %28%1966-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCG vaccination in prev of tuberc = BCG VACCINE %28%IM%29% + TUBERCULOSIS /prev %28%IM%29%; BCG ther of various diseases = BCG VACCINE /ther use %28%IM%29% + dis /drug ther %28%IM%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCG was see under MYCOBACTERIUM BOVIS 1975-79 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCGF-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCGF-II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCH 189' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCH189' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCKA Decarboxylase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BCNU' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BDNF' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BDNF Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BDS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BEER is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BEETLES in the family Curculionidae and the largest family in the order COLEOPTERA. They have a markedly convex shape and many are considered pests.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BEJEL was heading 1963-67, 75-96 %28%see under TREPONEMAL INFECTIONS 1975-90%29%; was see under TREPONEMAL INFECTIONS 1968-74%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BEK Fibroblast Growth Factor Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BEK Fibroblast Growth Factor Receptor Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BEK Protein Tyrosine Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BENZOIC ACID amides. ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BENZOIC ACID is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BENZOIC ACID substituted with an amino group. They can either be mono-, di-, or tri- substituted. Para-aminobenzoic acid %28%see 4-AMINOBENZOIC ACID%29% is considered a member of the vitamin b complex.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BENZOIC ACIDS is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BENZYL ALCOHOL also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BENZYL ALCOHOLS also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BESNOITIASIS was see PROTOZOAN INFECTIONS 1985-94, was heading 1968-84; EIMERIA INFECTIONS %26% ISOSPORA INFECTIONS were see COCCIDIOSIS 1975-91, were see under COCCIDIOSIS 1967-74%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BETA-ALANINE is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BFU E' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BFU-E' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BFU-Es' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BGPP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BH3 Interacting Domain Death Agonist Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BHA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BHLH Zip Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BHLH-Zip Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BHLHLZ Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BHM Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BHT' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BI RG 587' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BICARBONATE ION was %28%NM%29% 1981-93 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BICARBONATE ION was indexed under BICARBONATES 1981-93 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BILIRUBIN ENCEPHALOPATHY see KERNICTERUS is available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BIOMIMETIC MATERIALS is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BIRDS of the large family Psittacidae, widely distributed in tropical regions and having a distinctive stout, curved hooked bill. The family includes LOVEBIRDS; AMAZON PARROTS; conures; PARAKEETS; and many other kinds of parrots.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BIRDS that hunt and kill other animals, especially higher vertebrates, for food. They include the FALCONIFORMES order, or diurnal birds of prey, comprised of EAGLES, falcons, HAWKS, and others, as well as the STRIGIFORMES order, or nocturnal birds of prey, which includes OWLS.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BIRG587' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BISMUTH-ARSENIC COMPOUNDS was heading 1963-91 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BIV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BK 8644' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BK Channels' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BK Virus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BK polyomavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BK-8644' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BK8644' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL 191' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL P 1322' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL S 578' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL S 640' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL S578' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL S640' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL-S578' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL-S640' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BL191' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLACK NIGHTSHADE see SOLANUM NIGRUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLEO cell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLEOcell' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLOOD PRESERVATION; ORGAN PRESERVATION and TISSUE PRESERVATION are also available; CRYOPRESERVATION is also available; DF: PRESERVATION BIOL%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLP 1322' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLS 578' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLS 640' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLS578' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLS640' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLV' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLV HTLV Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLV Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BLV-HTLV Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BM 15.075' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BM 40 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BM-40' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BM15.075' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMK1 Kinase' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Type I Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Type IA Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Type IB Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Type II Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMP Type II Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR I Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR IA Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR IB Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR II Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR-I Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR-IA Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR-IB Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR-II Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMPR2 Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMY 27857' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMY 28689' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMY27857' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BMY28689' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BN Rat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BN Rat, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BN Rats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BN Rats, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BNP 32' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BNP Gene Product' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BNP-32' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BNPI Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BONE DEVELOPMENT is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BONIN ISLANDS was see JAPAN 1975-83 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BOOP' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BOR Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BOR Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BOSTON is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BOUILLAUD%27%S DISEASE was see RHEUMATIC FEVER 1964-91 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BPDE' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BPP-9a' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BPTI, Basic Pancreatic Trypsin Inhibitor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BR 750' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BR750' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRACHIAL-BASILAR INSUFFICIENCY SYNDROME see SUBCLAVIAN STEAL SYNDROME is available%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRACHIOPODA was heading 1963-85; MESOZOA was heading 1977-85%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRAF Kinases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRAIN HEMORRHAGE, TRAUMATIC and specifics are available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA stands for %22%BReast CAncer%22% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA1 Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA1 Gene Product' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA1 Genes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA1 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA2 Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA2 Gene Product' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA2 Genes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRCA2 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRFSS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRIGHT DISEASE was BRIGHT%27%S DISEASE see NEPHRITIS 1963-78%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 2288' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 2333' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 25000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 26921' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 29060' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 3475' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 38226' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 38227' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 43694' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 43694A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 4910A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL 8988' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL-43694' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL2288' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL2333' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL25000' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL26921' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL29060' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL3475' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL38226' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL38227' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL43694' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL43694A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL4910A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRL8988' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BROD' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BROMCHLORTRIFLUORETHANE was see HALOTHANE 1978-94 ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRONCHITIS is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BRUXISM is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BS 100 141' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BS100141' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BSE %28%Bovine Spongiform Encephalopathy%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BSEs %28%Bovine Spongiform Encephalopathy%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BSF-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BSF-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BSIPSS' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BTC 2125' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BTC2125' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BTF2 Transcription Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BTF2, Transcription Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BTS 18322' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BTS18322' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BU 3839T' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BU3839T' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUF Rat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUF Rat, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUF Rats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUF Rats, Inbred' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BULIMIA NERVOSA is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BULIMIA is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BULLHEAD CATFISHES and CHANNEL CATFISH see ICTALURIDAE are also available; X ref EREMOPHILUS MUTISII: EREMOPHILA PLANT and EREMOPHILA ALPESTRIS see SONGBIRDS are also available%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUN' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BURNS, INHALATION is also available; DF: SMOKE INHAL INJ ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUTANOLS is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUTYRIC ACID is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver and occurs at high levels in the blood and urine in KETOSIS. %28%From Dorland%27%s, 28th ed%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUTYRIC ACIDS is also available ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BUdR' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVDV Type 1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVDV Type 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVDV-1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVDV-2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVDV1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVDV2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BVL' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 180C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 33A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 48 80' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 48-80' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 4880' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 57 323H' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 57323H' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW 755C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW-284-C-51' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW180C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW284C51' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW33A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BW755C' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BWA-509U' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BYM' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ba-126-129, 131, 133, 139-143; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ba-34647' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ba34,276' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ba34,647' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ba34647' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesia %28%1969-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesia %28%1975-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesia bovis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesia microti' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesiases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesiasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesioses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babesiosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babies, Bush' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babies, Test-Tube' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski Reflex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski Reflexes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski Sign' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski Sign Negative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski Sign Positive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski Signs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski%27%s Reflex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski%27%s Sign' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Babinski%27%s Signs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon orthoreovirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Chacma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Gelada' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Guinea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Hamadryas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Olive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Savanna' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboon, Yellow' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons, Chacma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons, Gelada' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons, Hamadryas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons, Olive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons, Savanna' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baboons, Yellow' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Booms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Busts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Equipment' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Formula' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Formulas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Stroller' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Strollers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Swing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Swings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Walker' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby Walkers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby, Bush' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baby, Test-Tube' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baccalaureate Nursing Education' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baccalaureate Nursing Educations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baccharis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baci IM' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baci Rx' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baci-Rx' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillaceae Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillaceae Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillariophyta' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillariophytas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillary Angiomatoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillary Angiomatosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillary Dysentery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillary Epithelioid Angiomatoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillary Epithelioid Angiomatosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus Bacteriophage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus Bacteriophages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus Calmette Guerin Vaccine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus Phage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus Phages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus anthracis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus cereus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus infect; human %26% animal; /vet permitted ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus megaterium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus megatherium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus stearothermophilus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus subtilis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus subtilis %28%natto%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus subtilis var. natto' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacillus thuringiensis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin Akorn Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin Dioptic Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin Lee Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin McNeil Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin Pharmascience Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin Zinc' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacitracin, Zinc' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Ache' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Ache, Low' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Aches' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Aches, Low' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Injuries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Injury' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pain %28%1966-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pain, Low' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pain, Lower' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pains' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pains, Low' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back Pains, Lower' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Back/injuries %28%1966-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backache' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backache, Low' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backaches' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backaches, Low' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backcrossings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backflow of blood from the aorta into the left ventricle, owing to imperfect functioning of the aortic semilunar valve.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backflow of blood from the left ventricle into the left atrium, owing to imperfect functioning of the mitral valve.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backflow of blood from the pulmonary artery into the right ventricle, owing to imperfect functioning of the pulmonary valve.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backflow of blood from the right ventricle into the right atrium, owing to imperfect functioning of the tricuspid valve.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Background Potassium Channel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Background Potassium Channels' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Background Radiation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Background Radiations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Background, Cultural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backgrounds, Cultural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Backs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclof%C3%%A8%ne Irex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclof%C3%%A8%neIrex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Alphapharm Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Apotex Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Ashbourne Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Athena Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Ciba-Geigy Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Irex Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Isis Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Medtronic Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Novartis Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Nu-Pharm Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Pharmascience Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Receptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclofen Receptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baclophen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacopa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteremia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteremia, Haemorrhagic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteremia, Hemorrhagic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteremias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1964-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1970%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1973%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1966-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1967-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1967-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1967-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1968-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1969-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1969-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1972-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1972-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1973-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1973-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1974-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1976-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1977-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1978-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1981-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1982-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria %28%1990-1996%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria Viability' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria that form endospores and are gram-positive. Representative genera include BACILLUS; CLOSTRIDIUM; MICROMONOSPORA; SACCHAROPOLYSPORA; and STREPTOMYCES.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria which lose crystal violet stain but are stained pink when treated by Gram%27%s method.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria which retain the crystal violet stain when treated by Gram%27%s method.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Aerobic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Anaerobic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Anaerobic %28%1984-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Anaerobic %28%1985-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Blue Green' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Blue-Green' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Green Non-Sulfur' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Green Nonsulfur' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Green Sulfur' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Purple' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Purple Nonsulfur' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria, Purple Sulfur' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria/classification %28%1994-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteria/physiology %28%1966-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Adhesin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Adhesins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Adhesion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Adhesions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Aneurysm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Aneurysms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Antenna Polypeptide' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Antibodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Antigens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Arthritides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Arthritis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Artificial Chromosome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Artificial Chromosomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Attachment Site' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Biotyping' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Capsule' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Capsules' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Chromatophore' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Chromatophores' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Chromosome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Chromosomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Conjunctivitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Conjunctivitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Counts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial DNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Endocarditides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Endocarditides, Subacute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Endocarditis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Endocarditis, Subacute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Eye Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Eye Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial F%28%1%29%F%28%0%29% ATPases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Fertility Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Fertility Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Fimbria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Fimbriae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Forms, Atypical' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Gene' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Gene Expression Regulation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Gene Product' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Gene Products' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Gene Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Gene Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Genes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Genome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Genomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infection, Gram-Negative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infection, Gram-Positive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections %28%1970-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections %28%1972-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections %28%1972-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections %28%1972-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections %28%1976-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections %28%1983-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections and Mycoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections or specifics %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections, Central Nervous System' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections, Gram Negative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections, Gram Positive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections, Gram-Negative' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections, Gram-Positive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Infections/prevention %26% control %28%1972-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Interference' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Interferences' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Luciferases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Meningitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Meningitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial O Antigen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Ocular Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Ocular Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Outer Membrane Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Outer Membrane Proteins %28%1985-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Outer Membrane Proteins %28%1985-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Overgrowth Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Photosynthetic Reaction Center' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Physiologies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Physiology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Pili' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Pneumonia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Pneumonias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Polysaccharides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1972%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1978%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1968-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1970-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1972-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1972-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1972-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1973-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1974-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1978-2004%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1980-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1981-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1982-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1989-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1994-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proteins %28%1994-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proton Translocating ATPases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Proton-Translocating ATPases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Sensitivity Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Sex Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Sex Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Sexually Transmitted Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Sexually Transmitted Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Skin Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Skin Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Spore' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Spores' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Topoisomerase I' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Topoisomerase II' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Toxins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Toxins %28%1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Toxins %28%1977-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Toxins %28%1980-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Transferrin Receptor Complex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Transformation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Translocation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Typing Technic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Typing Technics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Typing Technique' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Typing Techniques' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Typing Techniques %28%1991-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1965-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1967-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1968-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1970-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1971-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1975-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaccines %28%1992-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaginitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaginitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaginoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Vaginosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Venereal Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial Venereal Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial diseases transmitted or propagated by sexual conduct.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial enzymes of the DNA TOPOISOMERASES, TYPE I class that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These bacterial enzymes reduce the topological stress in the DNA structure by relaxing negatively, but not positively, supercoiled DNA.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial enzymes of the DNA TOPOISOMERASES, TYPE II class that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA duplex. Bacterial DNA topoisomerases in the Type II class exist as heterotetramers of 2 subunits, such as 2 gyrA and 2 gyrB in DNA GYRASE.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial infections of the brain, spinal cord, and meninges, including infections involving the perimeningeal spaces.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots. The type of causative organism varies with age and clinical status %28%e.g., post-operative, immunodeficient, or post-traumatic states%29%. Clinical manifestations include the acute onset of fever, stiff neck, altered mentation, seizures, and focal neurologic deficits. Death may occur within 24 hours of disease onset. Pathologic features include a purulent exudate in the subarachnoid space, and diffuse inflammation of neural and vascular structures. %28%From Joynt, Clinical Neurology, 1994, Ch24, pp1-5%29%%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial polysaccharides that are rich in phosphodiester linkages. They are the major components of the cell walls and membranes of many bacteria.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial proteins that are used by BACTERIOPHAGES to incorporate their DNA into the DNA of the %22%host%22% bacteria. They are DNA-binding proteins that function in genetic recombination as well as in transcriptional and translational regulation.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules %28%L bodies%29% appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterial, viral, or parasitic diseases transmitted to humans and animals by the bite of infected ticks. The families Ixodidae and Argasidae contain many bloodsucking species that are important pests of man and domestic birds and mammals and probably exceed all other arthropods in the number and variety of disease agents they transmit. Many of the tick-borne diseases are zoonotic.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal Activities, Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal Activity, Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal Dysfunction, Phagocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal Dysfunctions, Phagocyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal Test, Serum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal Tests, Serum' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacterin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriochlorophyll' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriochlorophyll A' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriochlorophylls' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriochlorophylls %28%1982-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocin Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocin Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocin Plasmid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocin Plasmids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocins %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocins %28%1968-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocins elaborated by mutant strains of Bacillus megaterium. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same species.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocins elaborated by mutant strains of Pseudomonas aeruginosa. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same or related species.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriocins elaborated by strains of Escherichia coli and related species. They are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriologic Technic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriologic Technics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriologic Technique' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriologic Techniques' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Technic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Technics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Technique' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Techniques' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Techniques %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Techniques %28%1966-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriological Techniques %28%1967-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriolyses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriolysis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriolysis %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriolysis %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage G4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage HK022' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage IKe' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage M13' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage MS2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage N4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage P1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage P1 Artificial Chromosomes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage P2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage P22' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage PM2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage PRD1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage Pf1' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage T3' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage T4' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage T7' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage Typing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage Typing %28%1966-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage and type species in the genus Tectivirus, family TECTIVIRIDAE. They are specific for Gram-negative bacteria.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage fd' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage in the genus T7-like Phages, of the family PODOVIRIDAE, which is very closely related to BACTERIOPHAGE T7.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage lambda' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage lambda %28%1990-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage mu' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage phi 105' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage phi 29' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage phi 6' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage phi X 174' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, Bacillus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, Filamentous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, PM2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, Pseudomonas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, Salmonella' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, Staphylococcal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophage, Streptococcus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1965-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1966-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1974-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1980-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1983-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages %28%1984-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages T' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage phi 6 %28%BACTERIOPHAGE PHI 6%29%. All RNA phages infect their host bacteria via the host%27%s surface pili. Some frequently encountered RNA phages are: BF23, F2, R17, fr, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, PP7, Q beta phage, MS2 phage, and BACTERIOPHAGE PHI 6.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, Bacillus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, Filamentous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, PM2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, Pseudomonas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, RNA' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, Salmonella' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, Staphylococcal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriophages, Streptococcus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriorhodopsin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriorhodopsin %28%1976-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriorhodopsin %28%1988-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriorhodopsins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriorhodopsins %28%1981-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriuria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriuria %28%1974-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteriurias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidaceae %28%1971-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidaceae %28%1986-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidaceae Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidaceae Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1966-1967%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1966-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1973-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1975-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1976-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1979-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1981-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1988-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1990-1994%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides %28%1991-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides corrodens' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides corrodens %28%1976-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides fragilis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides gingivalis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides intermedius' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides melaninogenicus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroides nodosus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidetes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bacteroidetes %28%1978-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bactrocera tryoni' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baculoviral Inhibitor Of Apoptosis Repeat Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baculoviridae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baculoviridae %28%1973-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baculoviridae %28%1995-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baculoviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bad Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badge Dosimetries, Film' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badge Dosimetry, Film' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badge, Film' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badger' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badges, Film' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badnavirus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Badnaviruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bag, Air' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bags, Air' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bahamas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bahiagrass' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bahrain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baiji' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baikal Skullcap' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baillarger Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bailly Brand of Warfarin Sodium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bajra' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bak Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baked food product made of flour or meal that is moistened, kneaded, and sometimes fermented. A major food since prehistoric times, it has been made in various forms using a variety of ingredients and methods.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baker Cyst' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baker Cysts' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baker Yeast' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baker%27%s Cyst' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baker%27%s Yeast' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baker%27%s Yeast Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baking Soda' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaena mysticetus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera acutorostrata' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera acutorostrata bonaerensis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera borealis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera brydei' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera musculus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balaenoptera physalus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balance, Acid-Base' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balance, Electrolyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balance, Fluid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balance, Postural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balance, Water-Electrolyte' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanced Dental Occlusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanced Dental Occlusions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanites' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanitides' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanitis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balanophoraceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balantidiases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balantidiasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balantidium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bald Cypress' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baldness' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baldness, Male Pattern' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balkan Endemic Nephropathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balkan Nephropathy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ball, Hair' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ball, Racket' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ballistic, Forensic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ballistics, Forensic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ballistocardiographies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ballistocardiography' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ballobes Balloons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasties, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasties, Laser' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasties, Laser-Assisted' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasty, Coronary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasty, Laser' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Angioplasty, Laser-Assisted' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Catheterization' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Catheterization, Fogarty' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Catheterization, Foley' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Catheterizations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilatation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilatation %28%1988-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilatation %28%1988-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilatation, Coronary Artery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilatations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilation' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Dilations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Embolizations' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Flower' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Occlusion' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Occlusions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Pumping, Intra-Aortic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Pumping, Intraaortic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Tamponade' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Tamponades' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Valvotomies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Valvotomy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon Valvuloplasties' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon, Ballobes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloon, Gastric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloons, Ballobes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balloons, Gastric' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ballota' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balls, Hair' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balneology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balo%27%s Concentric Sclerosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balsa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balsam Fir' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balsaminaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Balsams' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baltic Myoclonus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baltic Myoclonus Epilepsies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baltic Myoclonus Epilepsy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baltic States' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baltimore' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamFI Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamHI Deoxyribonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamHI Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamHI stands for Bacillus amyloliquefaciens + strain ident; DF: BAMHI%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamI Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamKI Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'BamNI Endonuclease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bambermycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bambermycins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bamboo Grass' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bambusa' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Ban Xia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banana Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bancroftian Elephantiases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bancroftian Elephantiasis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band 2 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band 3 Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band 4.5 Preactin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band 6 Protein, Desmosomal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band III Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band Shift Mobility Assay' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band, Amniotic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Band, Matrix' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandage, Hydrocolloid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandage, Hydrogel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandage, Occlusive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandages %28%1966-1977%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandages, Hydrocolloid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandicoot Rat' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandicoot Rats' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandicotas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banding, Chromosome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandings, Chromosome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bands, Amniotic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bands, Matrix' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bands, Oligoclonal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandshift Mobility Assay' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bandshift Mobility Assays' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baneberry' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bang Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bang%27%s Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bangladesh' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bangs Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banha' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banisterine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banisteriopsis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Biological Specimen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Biological Substance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Bone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, DNA Data' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Eye' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Genetic Data' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Sperm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bank, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banking, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bankruptcies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bankruptcy' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Biological Specimen' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Biological Substance' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Bone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, DNA Data' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Eye' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Genetic Data' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Milk' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Sperm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Banks, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baobab' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baptist' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baptists' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bar Code' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barany Nystagmus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barany Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barany%27%s Nystagmus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baranys Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbados' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbarea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbary Apes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbasco' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barber Surgeon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barber Surgeons' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbering' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbering/history %28%1966-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barberings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barberry' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barberry, Hollyleaved' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbital' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbital Faes Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbitone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbiturates' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbiturates %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbiturates %28%1968-1975%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbiturates %28%1969-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barbus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bardet Biedl Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bardet-Biedl Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bardet-Biedl Syndrome %28%1966-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bare Lymphocyte Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barefoot Doctor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bargaining, Collective' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bargainings, Collective' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bariatric Surgeries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bariatric Surgery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bariatrics' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium %28%1968-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium Compounds' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium Radioisotopes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium Sulfate/diagnostic use %28%1981-1997%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barium, Tartrazine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bark, Plant' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bark, Tree' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barley Yellow Dwarf Viruses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barn Owl' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barn Swallows' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barnacles' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baroreceptor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baroreceptor Reflex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baroreceptor Reflexes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baroreceptors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baroreflex' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baroreflexes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barosmin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barotrauma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barotraumas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barr Bodies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barre Brand of Aminophylline' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barre Lieou Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrett Esophagus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrett Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrett%27%s Esophagus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrett%27%s Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barretts Esophagus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barretts Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier Contraception' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier Method, Contraceptive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier Methods, Contraceptive' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Air-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Aqueous-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Architectural' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Blood-Air' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Blood-Aqueous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Blood-Brain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Blood-Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Blood-Retinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Blood-Testis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Brain-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Communication' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Hemato-Encephalic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Retinal-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barrier, Testis-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Air-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Aqueous-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Blood-Air' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Blood-Aqueous' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Blood-Brain' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Blood-Nerve' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Blood-Retinal' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Blood-Testis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Brain-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Communication' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Hemato-Encephalic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Retinal-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barriers, Testis-Blood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barringtonia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barter Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barter%27%s Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Barters Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartholin Glands' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartholin%27%s Glands' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartholins Glands' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella %28%1966-2003%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella Infections %28%1966-1976%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella bacilliformis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella henselae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonella quintana' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonellaceae' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonellaceae Infection' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonellaceae Infections' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonelloses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartonellosis' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartor Brand of Testosterone' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartter Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartter Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartter%27%s Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bartters Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baryon' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Adenocarcinoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Adenocarcinomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Adenoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Adenomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Cancers' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Carcinoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Carcinomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Epithelioma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Epitheliomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Neoplasm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Neoplasms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Cell Nevus Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia %28%1966-1971%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia %28%1966-1973%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia %28%1967-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia %28%1982-1983%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Cerebrovascular Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Diseases %28%1979-1984%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Disorder' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Disorders' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Hematoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Hematomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Hemorrhage' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Hemorrhages' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Ganglia Vascular Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Laminas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Metabolic Rate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Metabolic Rates' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Metabolism' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Nuclei' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Nucleus of Meynert' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Nucleus, Olivary' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basal Veins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basalgel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basalis, Olivary Nucleus' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Composition' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Composition %28%1980-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Composition %28%1990-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Compositions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Excision Repairs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Pair' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Pair Mismatch' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Pair Mismatches' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Pairing' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Pairings' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Pairs' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Ratios' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1971-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1971-1980%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1971-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1971-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1971-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1971-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1972-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1973-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1973-1992%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1975-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1976-1981%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1977-1986%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1977-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1977-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1978-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1978-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1979-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1980-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1980-1987%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1980-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1980-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1980-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1981-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1983-1990%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1983-2000%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1984-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1987-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1987-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1989-1995%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence %28%1989-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence Homologies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequence Homology' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base Sequences' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base of Skull' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Acridine Orange' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Cranial' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Denture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Knowledge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Knowledge %28%Computer%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Schiff' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Base, Skull' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baseball' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basedow Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basedow%27%s Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basedows Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baseline Potassium Channel' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baseline Potassium Channels' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baseline Surveys' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Lamina' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Laminas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membrane' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membrane %28%1965-2005%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membrane %28%1967-1991%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membrane Tumor Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membrane, Glomerular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membranes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basement Membranes, Glomerular' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bases, Denture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bases, Knowledge' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bases, Knowledge %28%Computer%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bases, Mannich' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bases, Ointment' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bases, Schiff' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bashkir Republic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bashkiria' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bashkortostan' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Aluminum Sucrose Sulfate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Amino Acid' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Amino Acid Transport Proteins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Amino Acid Transport Systems' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Amino Acids' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Fibroblast Growth Factor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Helix Loop Helix Leucine Zipper Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Helix Loop Helix Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Helix-Loop-Helix Leucine Zipper Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Helix-Loop-Helix Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Leucine Zipper Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Pancreatic Trypsin Inhibitor' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Polypeptide, Cardiotoxin-Like' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Protein, Eosinophil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Proteins, Encephalitogenic' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Proteins, Myelin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Reproduction Number' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Reproduction Ratio' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Reproductive Rate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic Transcription Factor 2' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic glycoprotein members of the SERPIN SUPERFAMILY that function as COLLAGEN-specific MOLECULAR CHAPERONES in the ENDOPLASMIC RETICULUM.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic peptide antibiotic from Bacillus brevis. It exhibits broad-spectrum antibacterial activity and inhibits bacterial DNA synthesis.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic polypeptide antibiotic group obtained from Bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. At least eleven different members of the polymyxin group have been identified, each designated by a letter.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic polypeptide from the venom of the honey bee %28%Apis mellifera%29%; it contains 62 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes. Synonyms: melittin; melliten.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basic-Leucine Zipper Transcription Factors' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basicranium' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basics Brand of Cetirizine Dihydrochloride' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basics Brand of Nitrendipine' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basics Brand of Roxithromycin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basics, Nitrendipin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycetes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycetes %28%1966-1974%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycetes %28%1966-1985%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota %28%1966-1993%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota %28%1966-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota %28%1970-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota %28%1971-2002%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota %28%1978-1998%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basidiomycota %28%1979-1999%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basigin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basigin Protein' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Arteries' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery %28%1966-1979%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery Aneurysm' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery Aneurysms' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery Insufficiencies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery Ischemia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery Ischemias' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Artery Stenoses' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Bones' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Impression' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Impressions' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Insufficiencies' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Insufficiency' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Membrane' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Membranes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Migraines' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Skull Fracture' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Skull Fractures' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Steal Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basilar Steal Syndromes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basis cranii' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basketball' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophil' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophil Adenoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophil Adenomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophil Degranulation Test' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophil Degranulation Tests' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophil, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophilic Adenoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophilic Adenomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophilic Leukemia, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophilic Leukemias, Acute' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophils' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophils %28%1966-1988%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophils %28%1966-1989%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basophils, Tissue' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basosquamous Carcinoma' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basosquamous Carcinomas' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bass' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bass, Sea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bassen Kornzweig Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bassen Kornzweig Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bassen-Kornzweig Disease' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bassen-Kornzweig Diseases' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bassen-Kornzweig Syndrome' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basses, Sea' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basses, Temperate' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bassia scoparia' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basswood' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bastian Brand of Methocarbamol' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Basutoland' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bath' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bath, Finnish' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bath, Mud' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bath, Sand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bath, Steam' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bath, Whirlpool' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bathing Beaches' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baths' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baths, Finnish %28%1963-2001%29%' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Baths, Whirlpool' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Batrachoidiformes' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Batrachotoxin B' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers.%A% ' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Batrachotoxins' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Batroxobin' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Batroxobin Serono Brand' = 0).
% 42.08/41.99 fof(interp, fi_functors, 'Bats' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten Mayou Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten Spielmeyer Vogt Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten-Mayou Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten-Mayou Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Batten-Spielmeyer-Vogt Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battered Child Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battered Child Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battered Woman' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battered Women' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battery, Luria-Nebraska Neuropsychological' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battle%27%s Sign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Battles Sign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bauhinia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bausch %26% Lomb Brand 1 of Naphazoline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bausch %26% Lomb Brand 2 of Naphazoline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax Apoptosis Regulator Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax alpha Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax beta Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax delta Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax omega Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax sigma Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax-alpha Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax-beta Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax-delta Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax-omega Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bax-sigma Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Anaesthesia Brand of Enflurane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Brand of Antithrombin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Brand of Doxorubicin Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Brand of Etoposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Brand of Fructose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Brand of Lorazepam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Brand of Sorbitol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Oncology Brand of Etoposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baxter Oncology Brand of Mitoxantrone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay 09867' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay K 8644' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay K8644' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay Laurel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay Laurel, California' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay R 5417' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay R5417' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay Region' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay Region %28%Chemistry%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay Regions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay Regions %28%Chemistry%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay e 6905' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay f 1353' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay, Sweet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay-K8644' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bay09867' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BayK8644' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BayR5417' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayberry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baye 6905' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Acarbose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Acebutolol Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Antithrombin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Aprotinin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Asparaginase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Azithromycin Dihydrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Azlocillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Azlocillin Sodium Salt' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Benperidol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Benzathine Benzylpenicillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Bezafibrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Chlorpheniramine Maleate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Dehydrocholic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Desonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Mezlocillin Sodium %28%Sterile%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Niclosamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Nimodipine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Nitrendipine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Praziquantel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of Sodium Nitroprusside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayer Brand of alpha-Amylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayes Theorem' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayf 1353' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayotensin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Baypen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayvit Brand of Gemfibrozil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayvit Brand of Nimodipine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayvit Brand of Nitrendipine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayvit, Gemfibrozilo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bayvit, Nitrendipino' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bazin Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bazin%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bazins Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bb Fragment of Factor B' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bb, Complement Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bdellovibrio' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Be Antigens, Hepatitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Be-9; Be-6-8, 10, 11 = BERYLLIUM %28%IM%29% + RADIOISOTOPES %28%IM%29%; /adv eff /tox permitted but /pois = BERYLLIOSIS%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beach Diet, South' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beaches, Bathing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beaches, both natural and man-made, used for bathing and other activities.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beacon Brand of Polygeline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bead Technique, Immunomagnetic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bead Techniques, Immunomagnetic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bead, Latex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beads, Latex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beak' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beaked Whale' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beaks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beam Tomographies, Electron' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beam Tomography, Electron' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean Curd, Soy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean Curds, Soy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean Lectins, Kidney' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean Plant, Precatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean, African Yam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean, Faba' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean, Horse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean, Soy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean, Velvet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bean, Yam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beans, Soy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bear' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bear, Black' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bear, Grizzly' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bear, Polar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bear, Spectacled' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bearberry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bears' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bears, Black' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bears, Grizzly' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bears, Polar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bears, Spectacled' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beat, Atrial Ectopic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beat, Premature' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beat, Premature Atrial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beat, Premature Supraventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beat, Premature Ventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beat, Ventricular Ectopic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beating Heart Coronary Artery Bypass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beats, Atrial Ectopic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beats, Premature' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beats, Premature Atrial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beats, Premature Supraventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beats, Premature Ventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beats, Ventricular Ectopic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beaufour Brand of Betaine Citrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beauty' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beauty Culture' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beauty Cultures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beaver' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beavers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bechterew Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bechterew%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bechterews Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bechuanaland' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beckwith Wiedemann Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beckwith-Wiedemann Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beclazone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beclazone Easy Breathe' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Becloforte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beclometasone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beclomethasone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Becloturmant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Becodisks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Becotide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Bugs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Capacities, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Capacity, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Conversion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Conversions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Nucleus of Stria Terminalis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Occupancies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Occupancy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Occupancy %28%1978-1981%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Rest' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Rests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Size, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Sizes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Sizes, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Sore' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed Sores' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bed, Swing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedapin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedbugs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedding and Linens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedding and Linens %28%1988-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beddings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedford Brand of Ergonovine Maleate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedouin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedrest' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedrests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedside Computings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedside Technologies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedside Testings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedsore' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedsores' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bedstraw' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bee Bread' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bee Glue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bee Venom' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bee Venoms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beef Isophane Insulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beef NPH Insulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beef-Pork Isophane Insulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beer %28%1974-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bees' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bees %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bees %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bees %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bees %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beetles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beetles %28%1965-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beetles %28%1966-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beggarticks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beginning of Human Life' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Begomoviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Begoniaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior %28%1974-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Control' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Controls' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Disorder, Disruptive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Disorder, REM' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Disorder, Rapid Eye Movement Sleep' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Disorders, Child' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Disorders, REM' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Disorders, Social' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Modification' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Modifications' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Risk Factor Surveillance System' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Therapies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Therapies, Cognitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Therapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Therapy %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Therapy %28%1967-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior Therapy, Cognitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior and Behavior Mechanisms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior associated with the elimination of feces and urine from the body.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior exhibited by individuals who are overly suspicious, but without the constellation of symptoms characteristic of paranoid personality disorder or paranoid type of schizophrenia.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior in defense of an area against another individual or individuals primarily of the same species.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior patterns consistent with those expected of an individual functioning in a state of ill health.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior patterns of those practicing CONTRACEPTION. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior with respect to an excessive number of individuals, human or animal, in relation to available space.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Addictive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Adolescent' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Agonistic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal %28%1966%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal %28%1966-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal Eliminative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal Mating' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Animal Sex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Appetitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Assaultive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Ceremonial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Child' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Choice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Competitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Compliant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Compulsive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Consummatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Cooperative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Coping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Dangerous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Drinking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Dyssocial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Eating' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Eliminative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Exploratory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Extramarital Sex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Feeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Firesetting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Health' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Helping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Homing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Illness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Imitative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Impulsive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Infant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Innate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Mass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Maternal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Nesting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Novelty-Seeking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Obsessive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Paranoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Paternal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Predatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Premarital Sex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Reproductive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Risk' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Risk Reduction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Runaway' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Searching' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Self-Destructive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Self-Injurious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Sex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Sexual' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Social' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Spatial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Stereotyped' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Sucking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior, Verbal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavior-response patterns that characterize the individual.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Disciplines and Activities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Genetics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Manipulation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Manipulations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Medicine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Research' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Risk Factor Surveillance System' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Science' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Sciences' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Symptom' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral Symptoms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral or attitudinal compliance with recognized social patterns or standards.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral response associated with the achieving of gratification.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behavioral, psychological, and social relations among various members of the nuclear family and the extended family.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviorism' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviorisms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors associated with the giving of assistance or aid to individuals.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors associated with the ingesting of alcoholic beverages, including social drinking.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking %28%time intervals - onset and duration%29%, frequency and satiety.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors expressed by individuals to protect, maintain or promote their health status. For example, proper diet, and appropriate exercise are activities perceived to influence health status. Life style is closely associated with health behavior and factors influencing life style are socioeconomic, educational, and cultural.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors which are at variance with the expected social norm and which affect other individuals.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Adaptive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Addictive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Adolescent' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Agonistic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Animal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Animal Eliminative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Animal Mating' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Animal Sex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Appetitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Ceremonial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Choice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Competitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Compliant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Compulsive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Consummatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Cooperative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Coping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Drinking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Dyssocial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Eating' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Eliminative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Exploratory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Feeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Firesetting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Health' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Helping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Homing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Illness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Imitative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Impulsive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Innate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Mass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Maternal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Nesting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Novelty-Seeking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Obsessive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Paranoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Paternal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Predatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Risk' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Risk Reduction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Searching' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Social' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Spatial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Stereotyped' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Sucking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behaviors, Verbal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behcet Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behcet Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behcet%27%s Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Behcets Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beijerinckiaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bejels' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bek Fgf Receptor Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bek Related Fibroblast Growth Factor Receptor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bek-Related Fibroblast Growth Factor-Receptor-1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bekesy Audiometry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belarus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belching' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belchings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belgian Congo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belgium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belief' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beliefs and values shared by all members of the organization. These shared values are reflected in the day to day operations of the organization.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beliefs, Religious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belize' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bell Palsies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bell Palsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bell Peppers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bell%27%s Palsies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bell%27%s Palsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belladonna' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belladonna %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belladonna %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belladonna Alkaloids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bellflower' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bellflower, Chinese' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bellon Brand of Altretamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bellon Brand of Asparaginase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bellon Brand of Bleomycin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bellon, Bl%C3%%A9%omycine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bells Palsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belly Syndrome, Prune' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belly Syndromes, Prune' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belmac Brand of Carisoprodol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belmac Brand of Dipyridamole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belmac Brand of Oxyphenbutazone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belmac, Dexametasona' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beloc Duriles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BelocDuriles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belonidae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beloniformes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belorussia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belorussian S.S.R.' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belorussian SSR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Below Replacement Fertility' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belph 10' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belph-10' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belt, Seat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Belts, Seat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beluga Whale' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beluga Whales' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bemedrex Easyhaler' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bemegride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benactyzine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bence Jones Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bencetonium Chloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benchmarking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benchmarking, Healthcare' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bencyclane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bender Gestalt Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bender Visual Motor Gestalt Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bender-Gestalt Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendrofluazide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide Apothecon Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide Berk Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide DDSA Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide Goldshield Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide Knoll Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide Leo Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bendroflumethiazide Protea Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bends' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beneficence' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit Risk Assessment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit, Fringe' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit, Health' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit, Insurance' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit, Paternity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit, Retirement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefit-Risk Assessments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits and Costs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits and Risks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits, Fringe' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits, Health' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits, Insurance' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits, Paternity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benefits, Retirement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benemycin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benevolence' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bengal, Rose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benhydramin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Brain Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Brain Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Cerebellar Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Childhood Epilepsy With Centro Temporal Spikes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Childhood Epilepsy With Centro-Temporal Spikes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Cough Headache' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Cough Headaches' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Cranial Nerve Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Cranial Neuroma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Cranial Neuromas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Epilepsy, Childhood, Centrotemporal Spikes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Essential Tremor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Essential Tremors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Exertional Headache' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Exertional Headaches' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Familial Neonatal Convulsions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Familial Pemphigus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Fasciculation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Fasciculation-Cramp Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Fasciculation-Cramp Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Fasciculations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Fibrous Histiocytoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Fibrous Histiocytomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Frontal Childhood Epilepsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Ganglioglioma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Gangliogliomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Hepatoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Hepatomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Hereditary Chorea' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Hereditary Choreas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Hypothalamic Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Infratentorial Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Intracranial Hypertension' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Mastocytoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Meningeal Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Meningiomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Migratory Glossitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Monoclonal Gammapathies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Monoclonal Gammapathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Monoclonal Gammopathies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Monoclonal Gammopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Mucous Membrane Pemphigoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Convulsion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Convulsions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Epilepsies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Epilepsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Non Familial Convulsions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Non-Familial Convulsions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Nonfamilial Epilepsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neonatal Sleep Myoclonus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Neoplasm, Brain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Non Familial Neonatal Convulsions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Non-Familial Neonatal Convulsions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Occipital Epilepsy, Childhood' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Optic Nerve Sheath Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Optic Nerve Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Prostatic Hyperplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Prostatic Hyperplasias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Prostatic Hypertrophy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Psychomotor Epilepsy, Childhood' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Recurrent Abducens Palsy of Childhood' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Recurrent Abducens Palsy, Children' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Rolandic Epilepsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Rolandic Epilepsy of Childhood' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign Supratentorial Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant central nervous system neoplasms derived from glial cells %28%i.e., astrocytes, oligodendrocytes, and ependymocytes%29%. Astrocytes may give rise to astrocytomas %28%ASTROCYTOMA%29% or glioblastoma multiforme %28%see GLIOBLASTOMA%29%. Oligodendrocytes give rise to oligodendrogliomas %28%OLIGODENDROGLIOMA%29% and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. %28%From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies %28%see CRANIAL NERVE DISEASES%29%, NAUSEA, hemiparesis %28%see HEMIPLEGIA%29%, and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant neoplasms that arise from one or more of the twelve cranial nerves.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant neoplasms which occur within the substance of the spinal cord %28%intramedullary neoplasms%29% or in the space between the dura and spinal cord %28%intradural extramedullary neoplasms%29%. The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve %28%see OPTIC NERVE NEOPLASMS%29%, and pituitary gland %28%see PITUITARY NEOPLASMS%29%. Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. %28%From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign circumscribed tumor of spongy bone occurring especially in the bones of the extremities and vertebrae, most often in young persons. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign disorder of infants and children characterized by multiple nodules with lipid-laden, non-Langerhans-cell histiocytes.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign eccrine poromas that present as multiple oval, brown-to-black plaques, located mostly on the chest and back. The age of onset is usually in the fourth or fifth decade.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign epidermal proliferations or tumors; some are viral in origin.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign growths of cartilage in the metaphyses of several bones.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign neoplasms derived from glandular epithelium. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign or malignant tumors which arise from the choroid plexus of the ventricles of the brain. Papillomas %28%see PAPILLOMA, CHOROID PLEXUS%29% and carcinomas are the most common histologic subtypes, and tend to seed throughout the ventricular and subarachnoid spaces. Clinical features include headaches, ataxia and alterations of consciousness, primarily resulting from associated HYDROCEPHALUS. %28%From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2072; J Neurosurg 1998 Mar;88%28%3%29%:521-8%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex %28%adenomatous without atypia%29%, and atypical hyperplasia representing also the ascending risk of becoming malignant.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign unilocular lytic areas in the proximal end of a long bone with well defined and narrow endosteal margins. The cysts contain fluid and the cyst walls may contain some giant cells. Bone cysts usually occur in males between the ages 3-15 years.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benodaine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benomyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benperidol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benperidol Bayer Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benperidol Janssen Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benperidol neuraxpharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benperidol neuraxpharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benperidolneuraxpharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benserazide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bensokain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bensulfamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bentgrass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bentonite' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benuryl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benz%28%a%29%Anthracenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benz%28%b%29%Anthracenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benz%28%b%29%Phenanthrenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzalacetophenone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzaldehyde Dehydrogenase %28%NADP%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzaldehyde Dehydrogenase %28%NADP+%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzaldehyde Dehydrogenase, NADP-Linked' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzaldehydes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzalkonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzalolin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamide derivative with dopamine antagonist actions similar to SULPIRIDE. It has been used as an antipsychotic and in the treatment of various movement disorders.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1973-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1973-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1974-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1977-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1982-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1984-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamides %28%1985-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzamidines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzanthracenes %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzanthracenes %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzathine Benzylpenicillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzathine Penicillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzathine Penicillin G' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzathine, Penicillin G' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzatina, Provipen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzatropine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzatropine Mesylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1968-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1968-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1968-1973%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1968-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1969-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1970-1973%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1970-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzazepines %28%1982-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromaron' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromaron ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromarone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromarone Aliud Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromarone Heumann Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromarone Sanfer Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromarone ratiopharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzbromaronratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenaminium, 4,4%27%-%28%3-oxo-1,5-pentanediyl%29%bis%28%N,N-dimethyl-N-2-propenyl-%29%, Dibromide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1968-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1968-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1968-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1968-1973%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Derivatives %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene Hexachloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene derivatives which are substituted with three nitro groups in any position.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzeneacetamide, 3,4-dichloro-N-methyl-N-%28%2-%28%1-pyrrolidinyl%29%cyclohexyl%29%-, %28%trans%29%-Isomer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzeneacetamides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenemethanaminium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenemethanesulfonyl Fluoride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenemethanol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenesulfonate derivative used as a systemic hemostatic.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenesulfonates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenesulfonates %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenesulfonates %28%1974-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzenesulfonates %28%1974-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzethonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzfetamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzhexol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzhydramine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzhydryl Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzhydryl Compounds %28%1975-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzhydryl Compounds %28%1975-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzhydryl Compounds %28%1982-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzidamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzide M' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzide-M' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BenzideM' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzidines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzidines/AA %28%1975-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzilate, Quinuclidinyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzilates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzilates %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzilates %28%1974-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1971-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1974-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1977-1981%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzimidazoles %28%1989-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzindamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzo%28%a%29%pyrene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzo%28%a%29%pyrene 7,8-Dihydrodiol 9,10-Epoxide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzo%28%a%29%pyrene Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzo%28%a%29%pyrene Monooxygenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzo%28%a%29%pyrene-7,8-diol 9,10-Epoxide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoaric Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate 4 Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate 4 Monooxygenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate 4-Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate 4-Monooxygenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate Para Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate, Potassium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate, Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoate-Para-Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1961-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1973%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1966-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1969-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1972-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1973-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoates %28%1980-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzocaine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzochloryl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzocycloheptenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzocycloheptenes %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine GABA Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine Gaba Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine Tranquilizers %28%1975-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine-GABA Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepine-Gaba Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepines %28%1975-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepines %28%1975-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepinones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepinones %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepinones %28%1974-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepinones %28%1974-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiazepinones %28%1986-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodiones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzodioxoles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoflavones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoflavones %28%1981-1996%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzofurans %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic acid esters or salts substituted with one or more iodine atoms.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic acid or benzoic acid esters substituted with one or more bromine atoms.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic acid or benzoic acid esters substituted with one or more chlorine atoms.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic acid or benzoic acid esters substituted with one or more nitro groups.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic acid substituted by one or more hydroxy groups in any position on the benzene ring.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoic acids which are substituted with an amino group in the C-2 position.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzolamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzomorphans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzophenoneidum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzophenones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzophenones %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyran 2 ones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyran-2-ones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans %28%1969-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans %28%1973-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans %28%1986-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrans saturated in the 2 and 3 positions. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrene 3 Monooxygenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrene Dihydrodiols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrene Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrene-3-Monooxygenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrenes %28%1966-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrenes %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrenes %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzopyrenes saturated in any two adjacent positions and substituted with two hydroxyl groups in any position. The majority of these compounds have carcinogenic or mutagenic activity.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoquinones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzothiadiazine Diuretics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzothiadiazines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzothiadiazines %28%1963-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzothiazoles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzothiepins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoxazines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoxazoles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoxazoles %28%1966-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoxazoles %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoxepins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoxepins %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoyl Peroxide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoyl Superoxide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylarginine 2 Naphthylamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylarginine Nitroanilide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylarginine beta Naphthylamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylarginine beta-Naphthylamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylarginine-2-Naphthylamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylcholine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylcholinesterase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzoylhydratropic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzphetamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benztropine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benztropine Mesylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzydamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzydamine Monohydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Alcohol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Alcohols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Alcohols %28%1981-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Ammonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Carbinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1969-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1971-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1972-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Compounds %28%1974-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Isoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl Viologen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyl-Isoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylamine Oxidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylamines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylammonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylhydrazine, Seryltrihydroxy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylidene Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylidene Compounds %28%1975-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylidene Compounds %28%1989-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylideneacetophenone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylisoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyloxyresorufin O Dealkylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzyloxyresorufin O-Dealkylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylp%C3%%A9%nicilline Panpharma, Benzathine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylpenicillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylpenicillin Potassium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylpenicillin Procaine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Benzylpenicillin, Benzathine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bephenium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bephenium Derivatives' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bepridil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bepridil Monohydrochloride, alpha Isomer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bepridil, alpha Isomer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Ber H2 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Ber H2 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Ber-H2 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Ber-H2 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berardinelli Seip Congenital Lipodystrophy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berardinelli-Seip Congenital Lipodystrophy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berardius' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berberidaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berberine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berberine Alkaloids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berberis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berbines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berbines %28%1972-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bereavement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bereavements' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bereitschaftspotential' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bereitschaftspotentials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berenguer Infale Brand of Amiodarone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berenguer Infale Brand of Androstanolone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berger Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berger%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bergers Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beriberi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beriberi, Cerebral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berk Brand of Ancrod' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berk Brand of Bendroflumethiazide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berkelium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berkelium. A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlex Brand of Aminophylline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlex Brand of Gadopentetate Dimeglumine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlex Brand of Levonorgestrel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Abmbroxol Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Aminocaproic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Aminophenazone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Bezafibrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Bromhexine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Dipyridamole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Levothyroxine Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin Chemie Brand of Tolbutamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Abmbroxol Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Aminocaproic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Aminophenazone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Bezafibrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Bromhexine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Caffeine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Dipyridamole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Levothyroxine Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berlin-Chemie Brand of Tolbutamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bermuda' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bermudagrass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berna Brand of Noscapine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berna, Triviraten' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bernard Soulier Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bernard Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bernard Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bernard%27%s Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bernard-Soulier Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bernards Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berne Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berolina Brand of Amiloride Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beromycin, Penicillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berotec' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berromycin, Penicillin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berry Aneurysms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bertek Brand of Aminolevulinic Acid Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bertek Brand of Digoxin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bertek Brand of Mafenide Acetate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bertholletia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bertielliases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beryllioses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Berylliosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beryllium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beryllium Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beryllium. An element with the atomic symbol Be, atomic number 4, and atomic weight 9.01218. Short exposure to this element can lead to a type of poisoning known as BERYLLIOSIS.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besilate, Atracurium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besins Iscovesco Brand of Androstanolone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besins-Iscovesco Brand of Androstanolone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besitran' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besnier Boeck Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besnier-Boeck Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besnoitiases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besnoitioses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besnoitiosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bespar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Best Practice Analysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Besylate, Amlodipine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bet HCys MTase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bet-HCys MTase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta 1 4 Endoxylanase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta 1,3 Glucanase Type II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Alanyl 3 Methylhistidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Carbolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta D Acetamido 2 Deoxyglucosidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Disease, Broad' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Diseases, Broad' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Ecdysone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulins %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulins %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulins %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulins %28%1974-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Globulins %28%1978-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Glucancellobiohydrolase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Glutamylphosphate Reductase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Hydroxypyruvate Reductase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Lactamases/antagonists %26% inhibitors %28%1979-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta N Acetylglucosaminidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Particle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Particles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Radiation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Radiations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Rays' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Rhythm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Rhythms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta Stathmin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta galactosidase Protective Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta vulgaris' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta, Recombinant Interferon' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-1-3-Galactosyltransferase, UDP-Galactose-GM2 Ganglioside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-1-4-Endoxylanase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Alanyl-3-Methylhistidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-D-Acetamido-2-Deoxyglucosidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Ecdysone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Globulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Globulins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Glucancellobiohydrolase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Glutamylphosphate Reductase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Hydroxypyruvate Reductase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-N-Acetylglucosaminidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep%27%s fleece, where the wool is exposed to light and weather.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-galactosidase Protective Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beta1-3-Galactosyltransferase, UDPGal-GM2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene 3M Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene Hermal Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene Marlyn Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene Merck Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene Roche Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacarotene Solgar Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betacyanins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betadexamethasone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaherpesvirinae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betahistin ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betahistine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betahistine Biphar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betahistine Dihydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betahistine Methanesulfonate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betahistine Methanesulphonate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine Aldehyde Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine Aldehyde Oxidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine Homocysteine Methyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine Homocysteine Methyltransferase 2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine Homocysteine S Methyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine Orphan Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine, Glycine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine-Aldehyde Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine-Homocysteine Methyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine-Homocysteine Methyltransferase-2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaine-Homocysteine S-Methyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betalains' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betalipoprotein Deficiency Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betalipoprotein Deficiency Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaloc' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaloc Astra' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BetalocAstra' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betamethasone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betamethasone %28%1974%29% /AA %28%1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betamethasone %28%1974-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betamethasone 17 Valerate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betamethasone 17-Valerate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betanidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betapharm Brand of Acetylcysteine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betapharm Brand of Aciclovir' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betapharm Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betapharm Brand of Amiodarone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betapharm Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betapharm Brand of Bezafibrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaproteobacteria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaproteobacteria %28%1995-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaproteobacteria %28%1995-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaproteobacteria %28%1998-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaproteobacteria %28%2000-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaretrovirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaretroviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaserc' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betatron' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaxanthins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaxolol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betaxolol Alcon' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betazole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betel may go here or under PIPER BETLE; %27%catechu%27% may go here or under ACACIA CATECHU see ACACIA; check text; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bethanechol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bethanechol Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bethanecol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bethanidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bethanidine, Sulfate %28%2:1%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betonica' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betoptima' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betula' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Betulaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beutlich Brand of Aminacrine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverage, Alcoholic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverage, Carbonated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverage, Soy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverages and Food' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverages, Alcoholic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverages, Carbonated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beverages, Soy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bexal Brand of Gemfibrozil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bexal, Gemfibrozilo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beza Lande' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Beza Puren' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BezaLande' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BezaPuren' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Azupharma Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Bayer Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Berlin-Chemie Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Betapharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Cryopharma Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Elfar Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Hennig Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Hexal Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Isis Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Lakeside Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Merckle Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Roche Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Synthelabo Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate TAD Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezafibrate Teva Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezoar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bezoars' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bhutan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bi 58' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bi-209; Bi-199-208, 210-215 = BISMUTH %28%IM%29% + RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bi-Specific NAD%28%P%29%H Nitrate Reductase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bi58' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biacetyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bial Brand of Terfenadine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bianilines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias %28%Epidemiology%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Ecological' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Epidemiologic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Gender' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Insurance Selection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Observer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Publication' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Sampling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Selection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Sex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Statistical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Systematic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bias, Truncation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biases, Ecological' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biases, Epidemiologic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biases, Sampling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biases, Selection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biases, Truncation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibenzyls' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bible' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographic Database' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographic Databases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographies, Descriptive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographies, Medical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographies, National' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliographies, Statistical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography %28%1968-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography of Medicine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography, Descriptive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography, Medical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography, National' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliography, Statistical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliometric Analyses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliometric Analysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliometrics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliotherapies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bibliotherapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonate Chloride Antiport' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonate Ion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonate Symport, Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonate, Lithium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonate, Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonate-Chloride Antiport' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicarbonates %28%1980-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bichloride, Mercury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bichloride, Methylene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bichromate, Potassium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicillin L A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicillin L-A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicillin LA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biclin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicther Brand of Allopurinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicuculline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicuspid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicuspid Valve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicuspid Valves' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicuspids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicycle Ergometry Tests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicyclic Heterocyclic Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicyclic Heterocyclic Cpds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicycling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicyclo Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicyclo Compounds %28%1975-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicyclo Compounds %28%1984-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bicyclo Compounds, Heterocyclic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bid Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bidding, Competitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bidding, Contract' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biddings, Competitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biddings, Contract' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bidens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bieffe Brand of Fructose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifida, Spina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifidobacteriales Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifidobacteriales Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifidobacterium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biflavonoids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifunctional Antibodies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifunctional Reagents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes. It is used as reagent or fixative in immunohistochemistry and is a proposed antisickling agent.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big Endothelin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big Endothelin 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big Endothelin-1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big Endothelin-3' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big K Channels' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big MAP Kinase 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Big Renin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bigemina, Corpora' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bighorn Sheep' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bignoniaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bigonist' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biguanides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biguanides %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biklin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Acoustic Neurofibromatoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Acoustic Neurofibromatosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Deafness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Headaches' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Hearing Loss' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Hearing Losses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Sciatica' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Sciaticas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral Synchronous Inferior Petrosal Sinus Sampling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral dissection of the abdominal branches of the vagus nerve. It is used frequently in the surgical management of duodenal and gastric ulcers, as well as in physiologic studies of gastrointestinal secretion and motility.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilaterial Ovariectomies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilaterial Ovariectomy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilayer Fluidities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilayer Fluidity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilayer, Lipid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilayers, Lipid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile %28%1966-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Acids and Salts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Acids and Salts %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Acids and Salts %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Alcohols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Canaliculi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Canaliculus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Adenoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Adenomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Cancers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Diseases/congenital %28%1966-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Neoplasms %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Neoplasms %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Neoplasms %28%1981-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Obstruction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Obstruction, Extrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Obstruction, Intrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct Obstructions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct, Common' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct, Extrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Duct, Intrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts, Extrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts, Intrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts, Intrahepatic %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts, Intrahepatic %28%1966-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts, Intrahepatic/abnormalities %28%1980-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts, Intrahepatic/abnormalities %28%1985-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts/abnormalities %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Ducts/surgery %28%1971-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Pigment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Pigments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Pigments %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Pigments %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Pigments %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bile Reflux' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilharzia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilharziases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilharziasis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Atresia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Atresia/surgery %28%1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Calculi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Calculi, Common Bile Duct' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Cirrhosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Dyskinesia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Dyskinesia %28%1966-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Dyskinesias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Fistula' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Fistulas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Stases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Stases, Intrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Stasis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Stasis, Extrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Stasis, Intrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Surgical Procedure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Surgical Procedures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary System' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary System, Extrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Systems, Extrahepatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Cancers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Diseases %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Diseases %28%1972-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Diseases/surgery %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Hemorrhage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Hemorrhages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Surgical Procedure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract Surgical Procedures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tract/surgery %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary Tree' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliary or Urinary Stones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio Pancreatic Bypass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio Pancreatic Bypasses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio Pancreatic Diversion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio Pancreatic Diversions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio-Pancreatic Bypass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio-Pancreatic Bypasses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio-Pancreatic Diversion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilio-Pancreatic Diversions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliopancreatic Bypass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliopancreatic Bypasses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliopancreatic Diversion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliopancreatic Diversions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubin %28%1969-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubin Encephalopathies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubin Encephalopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubin IX alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubin UDP Glucuronyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubinate, Calcium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubinemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilirubinemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliverdin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biliverdine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Billroth I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Billroth I Operation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Billroth II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Billroth II Operation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bills, Avian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilobalides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilophila' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilophila Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bilutac' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bimaleate, Pheniramine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binary compounds of oxygen containing the anion O%28%2-%29%. The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binasal Hemianopias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binasal Hemianopsia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binasal Hemianopsias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binazin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Factors, Core' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Globulin, Testosterone-Estradiol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Inhibitor, Diazepam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Lectin, beta-Galactoside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Protein, Androgen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Protein, CAAT-Enhancer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Protein, Cap' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Protein, DNA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Protein, IgE' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins %28%1978-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Calcium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Cap' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Nucleosomal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Periplasmic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Rapamycin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Retinoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Proteins, Retinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Site' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Site, Antibody' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites %28%1968-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites %28%1968-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites %28%1968-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites %28%1993-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites %28%1994-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites, Antibody' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites, Antibody %28%1973-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites, Antibody %28%1973-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites, Antibody %28%1973-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding Sites, Histamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding, Competitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binding, Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bindings, Competitive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bindweed, False' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bindweed, Field' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binet Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binetrakin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binge Eating' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binge Eating Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binge-Eating Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binge-Eating Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binocular Disparities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binocular Disparity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binocular Vision' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binocular Visions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binomial Distribution' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binomial Distribution, Negative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binomial Distributions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binomial Distributions, Negative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binomial Model' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binomial Models' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binswanger Encephalopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Binswanger%27%s Encephalopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bio Breeding Inbred Rats' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bio-Breeding Inbred Rat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bio-Breeding Inbred Rats' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioabsorbable Implant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioabsorbable Implants' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioartificial Liver' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioartificial Livers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioartificial Organ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioartificial Organs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioassay' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioassays' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioavailabilities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioavailability' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biobibliographies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biobibliography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biobibliography %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biobibliography %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Genetic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Genetics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Markers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Phenomena' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Phenomena, Metabolism, and Nutrition' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Tumor Marker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical Tumor Markers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical functions, activities, and processes at organic and molecular levels in humans, animals, microorganisms, and plants.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemical identification of mutational changes in a nucleotide sequence.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemie Brand of Gemfibrozil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemie, Nitrendi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemistry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochemistry %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochip, Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biochips, Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocodex Brand of Nefopam Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatibility Testing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible Coated Materials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible Materials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible Materials %28%1967-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible Materials %28%1972-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible Materials %28%1975-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible Materials Testing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible materials placed into %28%endosseous%29% or onto %28%subperiosteal%29% the jawbone to support a crown, bridge, or artificial tooth, or to stabilize a diseased tooth.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocompatible materials usually used in dental and bone implants that enhance biologic fixation, thereby increasing the bond strength between the coated material and bone, and minimize possible biological effects that may result from the implant itself.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocontrols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocur Brand of Biotin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biocytin Hydrolase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biodegradable Implant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biodegradable Implants' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biodegradation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biodegradations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biodim Brand of Medrogestone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biodiversity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioelectric Energy Source' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioelectric Energy Sources' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioelectric Power Source' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioelectric Power Sources' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioenergetic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioequivalence' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioequivalences' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethical Issue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethical Issues' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethicist' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethics %28%1974-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethics Consultant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioethics Consultants' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofeedback' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofeedback %28%Psychology%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofeedbacks %28%Psychology%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofilm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofilms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofiltration, Acetate Free' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofiltration, Acetate-Free' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biofiltrations, Acetate-Free' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioflavonoids %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioflavonoids %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogeneses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenesis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenesis %28%1993-1996%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amine Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amine Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amine Transporters, Vesicular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amines %28%1971-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Amines Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Monoamines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Polyamines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic Stimulator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic amines having more than one amine group. These are long-chain aliphatic compounds that contain multiple amino and/or imino groups. Because of the linear arrangement of positive charge on these molecules, polyamines bind electrostatically to ribosomes, DNA, and RNA.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Anthralin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Bufexamac' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Fluocinolone Acetonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Fluocinonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Glutaral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Minocycline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioglan Brand of Tolnaftate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biographies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biography %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biography %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biohazard Containment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biohazards Containment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioiberica Brand of Acetylcysteine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioinformatics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioinorganic Chemistries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioinorganic Chemistry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biokanol Brand of Probenecid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biolectric Impedance' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biolistic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biolistics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Adaptation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Assay' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Assays' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Availabilities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Availability' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Availability, Nutritional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Characteristic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Characteristics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Clock' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Clocks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Containment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Dressing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Dressings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Effectiveness, Relative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Energy Source' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Energy Sources' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Factors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Marker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Markers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Model' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Models' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Nutritional Availability' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Oscillator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Oscillators' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Pacemaker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Pacemakers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Pest Control' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Pest Controls' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Phenomena' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Phenomena, Cell Phenomena, and Immunity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Preservation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Products' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Psychiatry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Pump' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Relative Effectiveness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Science' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Sciences' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Therapies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Therapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Transport' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Transport, Active' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Tumor Marker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Tumor Markers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Warfare' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologic Waste Disposal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Adaptation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Assay' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Assay %28%1980-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Assays' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Availabilities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Availability' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Availability, Nutritional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Characteristic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Characteristics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Clock' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Clock Disturbance' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Clock Disturbances' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Clocks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Clocks %28%1966-1985%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Containment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Diversity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Dressing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Dressings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Effectiveness, Relative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Energy Source' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Energy Sources' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Factors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Factors %28%1988-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Factors %28%1989-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Marker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Markers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Metamorphoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Metamorphosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Mimetic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Mimetics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Model' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Models' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Nutritional Availability' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Oscillator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Oscillators' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Pacemaker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Pacemakers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Pest Control' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Pest Controls' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Phenomena' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Phenomena, Cell Phenomena, and Immunity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Pigments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Preservation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Products' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Products %28%1976-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Products %28%1987-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Psychiatry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Pump' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Relative Effectiveness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Response Modifiers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Science' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Sciences' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Specimen Bank' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Specimen Banks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Substance Bank' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Substance Banks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Terrorism' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Therapies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Therapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Toxins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1964-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1966-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1966-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1974-1981%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1975-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1980-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1982-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport %28%1989-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport, Active' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport, Active %28%1967-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Transport, Active %28%1976-1982%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Tumor Marker' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Tumor Markers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Warfare' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological Warfare %28%1996-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological action and events that support the functions of the EYE and VISION.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological actions and events that support the functions involved in systemic or regional BLOOD CIRCULATION.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological actions and events that support the functions of the BLOOD.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological actions and events that support the functions of the CARDIOVASCULAR SYSTEM.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological actions and events that support the functions of the MUSCULOSKELETAL SYSTEM.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological actions and events that support the functions of the RESPIRATORY SYSTEM.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological catalysts and their cofactors. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological functions and activities at the organic and molecular levels in humans, animals, microorganisms, and plants. For biochemical and metabolic processes, BIOCHEMICAL PHENOMENA is available.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological or synthetic agents that are capable of eliciting specific and/or non-specific effects on immune responsiveness, thereby ultimately leading to an improvement in overall health of the patient. These agents can be further subcategorized into those that facilitate a normal immune response, those that stimulate the immune response, those that are capable of inducing noncytotoxic immunosuppression, and those that increase the ability of the host to tolerate damage by the cytotoxic modalities of the treatment.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biological processes and activities of viruses. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on proteins.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologically active substances whose activities affect or play a role in the functioning of the immune system.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologically functional sequences of DNA chemically synthesized in vitro.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biologics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology %28%1966-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology %28%1975-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology, Computational' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology, Developmental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology, Marine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology, Molecular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology, Radiation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biology, Systems' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioluminescent Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomasses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomaterials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomechanics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomechanics %28%1968-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomechanics %28%1968-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomechanics %28%1974-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomed Brand of Nitrendipine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Engineering' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Enhancement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Enhancements' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Research' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Technologies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Technology' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Technology Assessment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical Technology Assessments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomedical and Dental Materials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomet Brand of Methadone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biometals' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biometrics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biometry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomicroscopies, Ultrasonic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomicroscopies, Ultrasonographic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomicroscopies, Ultrasound' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomicroscopy, Ultrasonic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomicroscopy, Ultrasonographic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomicroscopy, Ultrasound' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomimetic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomimetic Device' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomimetic Material' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomimetic Materials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomimetics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomodulators' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomolecular NMR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomolecular Nuclear Magnetic Resonance' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biomphalaria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bionators' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bionic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioniche Brand of Carbachol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioniche Brand of Penicillin G Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bionics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bionics %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopat Brand of Methyldopa' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioperiodicities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioperiodicity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopharma Brand of Trimetazidine Dihydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopharmaceutics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopharmaceutics %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biophysics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biophysics %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biophysics %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopolymers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprobe' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopropazepan Trimethoxybenzoate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprostheses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprostheses, Heterograft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprostheses, Porcine Xenograft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprostheses, Xenograft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprosthesis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprosthesis, Heterograft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprosthesis, Porcine Xenograft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioprosthesis, Xenograft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Aspiration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Chorionic Villi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Fine Needle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Fine-Needle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Fine-Needle Aspiration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Needle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsies, Puncture' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy %28%1966-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy %28%1968-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy %28%1983-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Aspiration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Chorionic Villi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Fine Needle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Fine-Needle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Fine-Needle Aspiration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Needle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Needle %28%1972-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Puncture' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopsy, Sentinel Lymph Node' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopterin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biopterin/analogs %26% derivatives %28%1977-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioreactor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioreactors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioremediations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biorhythm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosatellite' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensing Technic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensing Technics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensing Technique' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensing Techniques' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensing Techniques %28%1991-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosensors %28%1989-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biostatistics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biostimulation, Laser' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthesis, Extra-Ribosomal Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthesis, Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthesis, Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthesis, Ribosomal Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthesis, Ribosomal Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biosynthetic Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biota orientalis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotechnologies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotechnology' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotechnology %28%1986-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotechnology %28%1987-1996%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bioterrorism' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Biocur Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Dermapharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Hermes Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Medopharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Responsive Encephalopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Roche Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Simons Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Strathmann Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin Ziethen Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin ratiopharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotin-Responsive Encephalopathies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotinidase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotinidase Deficiencies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotinidase Deficiency' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotinratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotinylation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotinylations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotransformation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biotransformations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biov%C3%%A9% Brand of Carbaril' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biovail Brand of Enalaprilat Anhydrous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biozzi Mice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biperiden' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biperidene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipharma Brand of Carbachol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipharma Brand of Desoximetasone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1969-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1970-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1973-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl Compounds %28%1990-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyl compounds which are extensively brominated. Many of these compounds are toxic environmental pollutants.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenylamines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyldiamines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyls, Polybrominated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphenyls, Polychlorinated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphosphate Carboxylase, Ribulose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphosphate Carboxylase-Oxygenase, Ribulose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biphosphonate, Dichloromethylene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Affective Psychosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Cell, Retinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Cells, Retinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Depression' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Disorder/drug therapy %28%1966-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Disorder/prevention %26% control %28%1968-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bipolar Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Fancier Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Fancier%27%s Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Fancier%27%s Lungs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Fanciers Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Pox' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Pox Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Pox Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird of Prey' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bird, Kiwi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1963-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1964-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1965-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1965-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1965-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1966-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1966-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1967-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1967-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1968-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1968-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1968-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1970-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1971-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1973-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1973-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds %28%1984-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birds of Prey' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birefraction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birefractions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birefringence' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birefringences' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birnaviridae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birnaviridae Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birnaviridae Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Attendant, Traditional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Attendants, Traditional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Center' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Center, Free Standing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Center, Free-Standing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Center, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Centers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Centers, Free-Standing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Centers, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Certificate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Certificates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Control' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Defect' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Defects' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Histories' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Interval' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Intervals' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Offspring, Multiple' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Order' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Orders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Place' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Rate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Rate, Age-Specific' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Rates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Rates, Age-Specific' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Record' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Spacing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Spacings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weight' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weight %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weight %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weight %28%1967-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weight, Low' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weights' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth Weights, Low' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth of Full Term Infant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth of Full Term Newborn' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth of Full-Term Infant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth of Full-Term Newborn' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, First' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Fullterm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Multiple' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Premature' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Preterm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Term' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Unwanted' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birth, Wrongful' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Center' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Center, Free-Standing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Center, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Centers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Centers, Free Standing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Centers, Free-Standing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthing Centers, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births, First' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births, Fullterm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births, Premature' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births, Preterm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births, Unwanted' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Births, Wrongful' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Birthwort' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis Benzyl Isoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis Benzylisoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis DEAE Fluorenone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis GMA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis GMA Polymer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis GMA Resin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis Pen Enkephalin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis Penicillamine Enkephalin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis Trimethyl Ammonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis Trimethylammonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%1-methylethyl%29% Phosphorofluoridate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%2-chloroethyl%29%methylamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%2-ethylhexyl%29%phthalate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%4-Methyl-1-Homopiperazinylthiocarbonyl%29%disulfide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%5%27%-Nucleosidyl%29%Oligophosphates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%5%27%-Nucleosidyl%29%Tetraphosphate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%Chloromethyl%29% Ether' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%Chloromethyl%29%Ether' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%Phenol A-Glycidyl Methacrylate%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%Phenol A-Glycidyl Methacrylate%29%, Homopolymer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%Phenol A-Glycydyl Methacrylate%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%beta-chloroethyl%29% Sulfide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%diethylthiocarbamoyl%29% Disulfide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%monothiosulfato%28%2-%29%-O,S%29%aurate%28%3-%29% Trisodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis%28%nitrato-O%29%dioxouranium. A compound used in photography and the porcelain industry. It causes severe renal insufficiency and renal tubular necrosis in mammals and is an effective lymphocyte mitogen.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-Benzyl-Isoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-Benzylisoquinolines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-DEAE-Fluorenone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-GMA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-GMA Polymer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-GMA Resin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-Pen-Enkephalin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-Thioallophanate, Dimethylphenylene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-Trimethyl-Ammonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bis-Trimethylammonium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisabol Myrrh' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisac Evac' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisacodyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisacodyl L%C3%%BC%nopharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisacodyl Richardson-Vicks Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisacodyl Upsher-Smith Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisacodyl, Bekunis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisacodyl, Fleet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisbenzimide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisco Lax' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisco Zitron' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biscoumacetate, Ethyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biscova Brand of Bisacodyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biscyclohexanone Oxaldihydrazone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisdimethylamide, Diazodicarboxylic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biseptol 480' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biseptol480' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisexual' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisexuality' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bishydroxycoumarin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bismethyl Suberimidate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bismuth' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bismuth %28%1981-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bismuth Salt Ditiocarb' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisnorephedrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bison' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisons' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisoprolol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisorcate, Deanol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bispecific Antibodies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphenol A Glycidyl Methacrylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphenol A Glycidyl Methacrylate Homopolymer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphenol A Glycidyl Methacrylate Polymer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphenol A-Glycidyl Methacrylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphenol A-Glycidyl Methacrylate Polymer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphate Carboxylase, Ribulose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphoglycerate Mutase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphoglycerate Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphoglycerates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphoglyceromutase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphonate, Aminohydroxybutane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisphosphonates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisulfate, Chlortetracycline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisulfate, Quinine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisulfite Reductase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bisulfite Reductases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Choline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Cysteamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Hexamethonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Levophed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Metaraminol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Nicotine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Noradrenaline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Norepinephrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitartrate, Prajmalium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite Force' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite Forces' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite Registrations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite, Cross' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite, Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite, Insect' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite, Open' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite, Snake' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bite, Spider' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitemporal Hemianopias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitemporal Hemianopsia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitemporal Hemianopsias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites and Stings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites and Stings %28%1966-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites and stings inflicted by insects. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites by snakes. The condition of having been bitten by a venomous snake, characterized by stinging pain at the wound puncture. The venom injected at the site of the bite is capable of producing a deleterious effect on the blood or on the nervous system. %28%Webster%27%s 3d ed; from Dorland, 27th ed, at snake, venomous%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites inflicted by humans. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites, Cross' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites, Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites, Insect' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites, Snake' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bites, Spider' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitewing Radiographies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitewing Radiography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bithionol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biting Lice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biting, Nail' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitter Gourd' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bitter Kola' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bittner Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biureas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biuret' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biuret Reaction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Biuret Reactions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalves' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalvia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalvia %28%1970-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalvia %28%1971-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalvia %28%1973-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalvia %28%1978-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bivalvia %28%1979-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bixaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bjerrum Scotoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bjerrum Scotomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Apes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Bear' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Bryony' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Chokeberry Tree' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Chokecherry Tree' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Cohosh' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Cumin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Elder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Flies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Nightshade' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Panther' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Pepper' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Water Fever' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Water Fevers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black Widow Spider' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black, Amido' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black, Carbon' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Black-legged Tick' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blackflies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blacks %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blackwater Fever' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blackwater Fevers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blackwell Brand of Minocycline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Calculi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Calculus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Cancers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Disease, Gall' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Diseases, Gall' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Disorder, Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Disorders, Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Drug Administration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Drug Administrations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Exstrophies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Exstrophy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Extrophies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Extrophy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Fistula' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Fistulas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Instillation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Instillations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Neck Obstruction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Neck Obstructions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Neoplasms %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Stone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Stones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Air' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Atonic Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Neuropathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Overactive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Spastic Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder, Uninhibited Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladder/surgery %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders, Air' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders, Atonic Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders, Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders, Neuropathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders, Spastic Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bladders, Uninhibited Neurogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blade Implantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blade Implantations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blanoxan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast 2 Antigen, B Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Crises' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Crisis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Phase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Phases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast Transformation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blast-2 Antigen, B-Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocladiella' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst %28%1974-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst %28%1975-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst %28%1980-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Culture Technique' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Implantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Implantation Inhibition' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Implantation Suppression' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Implantation, Delayed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Implantations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst Implantations, Delayed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyst/transplantation %28%1974-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocystina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocystis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocystis Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocystis Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocystis hominis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastoderm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastoderms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastogenesis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastokinin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastoma, Pulmonary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomas, Pulmonary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomere' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomeres' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomyces' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomycoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomycosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomycosis %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastomycosis, South American' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastopores' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastula' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blastulae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blattellidae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleaching, Tooth' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleb' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blebs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding Between Periods' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding Time' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding Time, Template' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding Times' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding Times, Template' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding from a PEPTIC ULCER that can be located in any segment of the GASTROINTESTINAL TRACT.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding from the nose. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding from the vessels of the retina. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding in the anterior chamber of the eye. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding into a cerebral hemisphere of the brain, including lobar, subcortical white matter, and basal ganglia hemorrhages. Commonly associated conditions include HYPERTENSION; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL ANEURYSM; CRANIOCEREBRAL TRAUMA; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; CEREBRAL AMYLOID ANGIOPATHY; and CEREBRAL INFARCTION.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding into the CEREBRAL CORTEX; CORPUS CALLOSUM; BASAL GANGLIA, or subcortical white matter following CRANIOCEREBRAL TRAUMA. DIFFUSE AXONAL INJURY, cerebral edema, and INTRACRANIAL HYPERTENSION are frequently associated conditions. Relatively frequent clinical manifestations include SEIZURES; APHASIA; VISION DISORDERS; MOVEMENT DISORDERS; PARALYSIS, and COMA.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding into the PUTAMEN, a BASAL GANGLIA nucleus. This is a relatively common site of spontaneous intracranial hemorrhage and is associated with chronic HYPERTENSION and lipohyalinosis of small blood vessels in the putamen. Clinical manifestations vary with the size of hemorrhage, but include hemiparesis, headache, and alterations of consciousness.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding into the subarachnoid space following CRANIOCEREBRAL TRAUMA. Minor hemorrhages may be asymptomatic; moderate to severe hemorrhages may be associated with INTRACRANIAL HYPERTENSION and VASOSPASM, INTRACRANIAL.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding or escape of blood from a vessel. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding within the brain as a result of penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA. Traumatically induced hemorrhages may occur in any area of the brain, including the cerebral hemispheres, diencephalon, brain stem %28%see BRAIN STEM HEMORRHAGE, TRAUMATIC%29%, and cerebellum.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding within the brain or adjacent structures which results from systemic HYPERTENSION, usually in association with INTRACRANIAL ARTERIOSCLEROSIS. Hypertensive hemorrhages are most frequent in the BASAL GANGLIA; CEREBELLUM; PONS; and THALAMUS; but may also involve the CEREBRAL CORTEX, subcortical white matter, and other brain structures.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding within the cranial vault induced by penetrating and nonpenetrating traumatic injuries, including hemorrhages into the epidural, subdural and subarachnoid spaces, cerebral hemispheres, DIENCEPHALON; BRAIN STEM; and CEREBELLUM.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding within the intracranial cavity, including hemorrhages in the brain and within the cranial epidural, subdural, and subarachnoid spaces.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding, Breakthrough' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleeding, Uterine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blennorrhagica, Keratosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blennorrhagicas, Keratosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blennorrhagicum, Keratoderma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blennorrhagicums, Keratoderma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blennorrhea, Inclusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blennorrheas, Inclusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleomycin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleomycin A%28%2%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleomycin B%28%2%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleomycins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bleomycins %28%1979-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharitides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharophimoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharophimosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharoplasties' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharoplasty' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharoptoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharoptosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharoptosis %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharoptosis %28%1972-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm %28%1975-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm Oromandibular Dyskinesia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm Oromandibular Dystonia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm Oromandibular Dystonia Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm Oromandibular Dystonia Syndrome, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dyskinesia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dyskinesias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dystonia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dystonia Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dystonia Syndrome, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dystonia Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasm-Oromandibular Dystonias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blepharospasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blessed Thistle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blighia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blind' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blind Loop Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blind Spots' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Acquired Word' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Color' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Cortical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Day' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Monocular, Transient' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Night' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Pure Word' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, River' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Transient Monocular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness, Word' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindness/rehabilitation %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindnesses, Acquired Word' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindnesses, Pure Word' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blindnesses, Word' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blinds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blink Reflex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blinking' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blister' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blister, Fever' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blisters' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blisters, Fever' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloch Sulzberger Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloch-Sulzberger Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Atrioventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Autonomic Nerve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Bundle-Branch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Fascicular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Heart' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Nerve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Neuromuscular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Paracervical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Sinoatrial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Block, Sympathetic Nerve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockade, Neuromuscular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Adrenergic Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Adrenergic alpha-Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Adrenergic beta-Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Exogenous Calcium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Ganglionic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, H1 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, H2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Histamine H1 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Histamine H2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, Serotonin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, alpha-Adrenergic Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockaders, beta-Adrenergic Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockage of a systemic artery by a thrombus originating in a systemic vein, which has passed through a defect that permits direct communication between the right and the left side of the heart, notably an open foramen ovale. It is also called crossed embolism. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocker of both alpha- and beta-adrenergic receptors that is used as an antihypertensive.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocker, Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Calcium Channel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Depolarizing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Ganglionic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Histamine H1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Histamine H2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Neuromuscular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Nondepolarizing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, Potassium Channel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, alpha-Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blockers, beta-Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking Agents, Ganglionic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking Agents, Neuromuscular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking Agents, alpha-Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking Agents, beta-Adrenergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking Antibodies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking of a blood vessel by a blood clot or foreign matter that has been transported from a distant site by the blood stream.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking of maternal circulation by AMNIOTIC FLUID that is forced into uterine VEINS by strong UTERINE CONTRACTION near the end of pregnancy. It is characterized by the sudden onset of severe respiratory distress and HYPOTENSION that can lead to maternal DEATH.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Atrioventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Autonomic Nerve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Bundle-Branch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Fascicular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Heart' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Nerve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Paracervical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Sinoatrial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blocks, Sympathetic Nerve' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood %28%1974-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Air Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Aqueous Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Bactericidal Activities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Bactericidal Activity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Bactericidal Activity %28%1972-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Bank' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Banks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Brain Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Count %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Count %28%1968-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Count, Red' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Count, White' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Number' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell Numbers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell, Red' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cell, White' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cells' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cells %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cells, Red' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Cells, White' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Chemical Analyses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Chemical Analysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Circulation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Circulation %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Circulation %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Circulation Time' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Circulation Times' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Circulation, Collateral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Clotting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Clottings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorders %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorders %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorders %28%1966-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorders %28%1995-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Disorders, Inherited' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor Deficiencies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor III' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor IV' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor IX' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor IX, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor V' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor V, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor VII' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor VII, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor VIII' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor VIII, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor X' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor X, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor XI' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor XI, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor XII, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor XIII' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factor XIII, Activated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation FactorXI' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factors %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factors %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factors %28%1973-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Factors %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Tests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Tests %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Coagulation Time, Whole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Collateral Circulation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Component Removal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Component Removal %28%1986-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Component Removals' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Component Transfusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Component Transfusion %28%1992-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Component Transfusions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Counts, Complete' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Crossmatching' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Donations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Donor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Donors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Dopings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Expanders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocity %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocity %28%1974-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocity %28%1982-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocity %28%1982-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow Velocity %28%1985-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow, Regional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow, Renal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flow, Renal, Effective' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Flows, Regional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Gas Analyses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Gas Analysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Gas Monitoring, Transcutaneous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose %28%1978-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose %28%1981-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose Self Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose Self-Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose Self-Monitorings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Glucose/metabolism %28%1975-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Group Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Group Incompatibilities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Group Incompatibility' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Group Incompatibility %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Group, ABH' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Group, H' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Grouping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Grouping and Crossmatching' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Groups %28%1966-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Groups %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Groups, ABH' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Groups, H' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Loss, Postoperative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Loss, Surgical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Nerve Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Patch, Epidural' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Patchs, Epidural' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Physiologic Phenomena' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Physiologic Processes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Physiological Phenomenon' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Physiological Processes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Physiologies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Physiology' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Plasma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Plasma Volume' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Plasma Volumes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Plasmas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Aggregation Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Antagonists' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Antiaggregants' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Disorders %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Disorders %28%1967-1985%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Number' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Numbers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Transfusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelet Transfusions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Plateletphereses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Plateletpheresis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1965-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1972-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets %28%1974-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Platelets/transplantation %28%1972-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Poisoning' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pool Scintigraphy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Preservation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Preservations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure %28%1966-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure %28%1966-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure %28%1966-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Determination' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Determination %28%1981-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Determination/instrumentation %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Determination/instrumentation %28%1970-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Determinations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Monitor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Monitoring, Ambulatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Monitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure Monitors %28%1990-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure, High' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure, Low' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressure, Venous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressures, High' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressures, Low' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Pressures, Venous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Disorders %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Disorders %28%1966-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Disorders %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Electrophoreses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Protein Electrophoresis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1983%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1985%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1972-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1977-1983%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1979-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1979-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1981-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1981-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1981-2004%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1984-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1984-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1985-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Proteins %28%1985-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Retinal Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Sedimentation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Serum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Specimen Collection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Specimen Collection %28%1985-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Specimen Collection %28%1987-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Specimen Collections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Stain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Stains' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Substitutes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Sugar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Sugar Self Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Sugar Self-Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Sugar Self-Monitorings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Testis Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Tests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1966-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1968-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1969-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1969-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion %28%1974-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion, Autologous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusion, Intrauterine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusions, Autologous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Transfusions, Intrauterine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Urea Nitrogen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Prostheses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Prosthesis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Prosthesis %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Prosthesis %28%1967-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Prosthesis Implantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessel, Retinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessels' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessels or specific %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Vessels, Retinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Viscosities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Viscosity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Viscosity %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Viscosity %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Volume' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Volume %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Volume %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Volume Determination' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Volume Determinations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood Volumes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood clot formation in the common, internal, or external carotid artery which may produce stenosis or occlusion of the vessel, leading to ischemia or infarction of tissue supplied by these arteries. Thrombosis of the common and internal carotid arteries may result in ISCHEMIC ATTACKS, TRANSIENT; CEREBRAL INFARCTION; or AMAUROSIS FUGAX.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood coagulation disorder usually inherited as an autosomal recessive trait, though it can be acquired. It is characterized by defective activity in both the intrinsic and extrinsic pathways, impaired thromboplastin time, and impaired prothrombin consumption.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood in the SEMEN, usually due to INFLAMMATION of the PROSTATE, the SEMINAL VESICLES, or both.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels %28%UMBILICAL CORD%29% at the time of delivery.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood proteins whose activities affect or play a role in the functioning of the immune system.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood vessels supplying the nerves. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood, Artificial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood, Cord' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood, Fetal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood, Occult' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood, Umbilical Cord' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Air Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Air Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Aqueous Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Aqueous Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Borne Pathogens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Brain Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Brain Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, ABO' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Duffy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Kell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Kidd' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Lewis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Lutheran' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, MNSs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, P' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Rh-Hr' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group System, Rhesus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group Systems, ABO' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group Systems, I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group Systems, MNSs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group Systems, P' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group Systems, Rh-Hr' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Group Systems, Rhesus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Nerve Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Nerve Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Pool Imaging, Gated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Pool Imagings, Gated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Pool Scintigraphies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Pool Scintigraphies, Gated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Pool Scintigraphy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Pool Scintigraphy, Gated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Retinal Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Retinal Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Testis Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-Testis Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-filled UTERUS. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood-sucking acarid parasites of the order Ixodida comprising two families: the softbacked ticks %28%ARGASIDAE%29% and hardbacked ticks %28%IXODIDAE%29%. Ticks are larger than their relatives, the MITES. They penetrate the skin of their host by means of highly specialized, hooked mouth parts and feed on its blood. Ticks attack all groups of terrestrial vertebrates. In humans they are responsible for many TICK-BORNE DISEASES, including the transmission of ROCKY MOUNTAIN SPOTTED FEVER; TULAREMIA; BABESIOSIS; AFRICAN SWINE FEVER; and RELAPSING FEVER. %28%From Barnes, Invertebrate Zoology, 5th ed, pp543-44%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blood/physiology %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloodborne Pathogens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloodletting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloodletting %28%1965-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloodletting %28%1966-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloodroot' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloods, Cord' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloods, Fetal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloods, Umbilical Cord' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloodsucking flies of the genus Glossina, found primarily in equatorial Africa. Several species are intermediate hosts of trypanosomes.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloom Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloom Torre Machacek Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloom, Algal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bloom-Torre-Machacek Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blooms, Algal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blooms, Plant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blossoms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blot Test, Ink' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blot Tests, Ink' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blot, Far Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blot, Far-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blot, West Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blot, West-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blots, Far-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blots, Northern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blots, Southwestern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blots, West-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blots, Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Far Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Far-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Northern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Southern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Southern %28%1989-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Southwestern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, West Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, West-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Western %28%1991-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blotting, Western %28%1994-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blottings, Far-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blottings, Northern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blottings, Southwestern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blottings, West-Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blottings, Western' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blow Out Fractures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blow-Out Fracture' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue 8GS, Alcian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue 8GX, Alcian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Asbestos' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Cohosh' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Color Blindness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Crab' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Cross' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Crosses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Eared Pig Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Green Algae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Green Bacteria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue N, Methylene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Nevi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Nevi, Cellular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Nevus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Nevus, Cellular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue O, Toluidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Reaction, Prussian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Reactions, Prussian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Shield' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Shields' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Spot, Mongolian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Toe Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Tongue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Tongue Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Tongue Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Vitriol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue Whales' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Alcian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Azovan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Bromophenol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Bromothymol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Bromphenol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Bromthymol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Evan%27%s' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Evans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Indigo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Methylene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Nitrotetrazolium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Soluble Indigo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Swiss' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Tetrabromophenol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Toluidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Trypan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Wurster' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue, Wurster%27%s' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue-Eared Pig Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue-Green Algae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blue-Green Bacteria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blueberries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blueberry Plant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluecomb Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluecomb Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluecomb of Turkeys' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluegills' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluegrass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluetongue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluetongue Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluetongue virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluish region in the superior angle of the fourth ventricle floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the ponto-mesencephalic central gray %28%griseum centrale%29%. It is also known as nucleus pigmentosus pontis.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluish, Eosine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bluish, Eosine I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blunt Head Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blunt Head Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blunt Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blunt Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blunt and penetrating traumatic injuries of the common, internal, or external carotid arteries which may result from CRANIOCEREBRAL TRAUMA; THORACIC INJURIES; and NECK INJURIES. Damage to the artery may lead to CAROTID ARTERY THROMBOSIS; CAROTID-CAVERNOUS SINUS FISTULA; pseudoaneurysm formation; and internal carotid artery dissection %28%CAROTID ARTERY, INTERNAL, DISSECTION%29%. Clinical manifestations %28%e.g., stroke, HORNER SYNDROME%29% may be immediate or delayed. %28%From Am J Forensic Med Pathol 1997 Sep;18%28%3%29%:251-7; J Trauma 1994 Sep;37%28%3%29%:473-9%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blushing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Blushings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BnaI Endonuclease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boar, Wild' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Board members of an institution or organization who are entrusted with the administering of funds and the directing of policy.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Board, Governing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Board, Institutional Review' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Board, Safety Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Board, Specialty' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Board, room, and other personal assistance services generally provided on a long term basis. It excludes regular medical care.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boards, Governing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boards, Institutional Review' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boards, Safety Monitoring' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boards, Specialty' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boars, Wild' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bob White' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bob-White' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bob-Whites' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bobcat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bobwhite' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bobwhites' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bode Brand of Glutaral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Acetone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Aortic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Aschoff' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Barr' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Carotid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Ciliary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Coiled' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Fat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Foreign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Geniculate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Heinz' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Howell-Jolly' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Inclusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Ketone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Lateral Geniculate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Lewy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Mamillary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Mammillary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Medial Geniculate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Negri' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Neuroepithelial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Nissl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Para-Aortic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Paraaortic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Pineal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Ultimobranchial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Vagal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Viral Inclusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Vitreous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodies, Weibel-Palade' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodily Secretion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bodily Secretions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Buffer Zone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Buffer Zones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Build' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Builds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Burden' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Burdens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Composition' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Compositions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Constitution' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Constitutions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fat Distribution' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fat Patterning' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluid Compartment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluid Compartments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids %28%1966-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids %28%1971-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Fluids/physiology %28%1966-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Height' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Heights' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Image' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Image Agnosia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Images' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Languages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Lice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Mass Index' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Measure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Modification, Cultural' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Modification, Non Therapeutic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Modification, Non-Therapeutic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Modifications, Cultural' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Modifications, Non-Therapeutic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Pattern Formation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Pattern Specification' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Patterning' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Piercing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Piercings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Plethysmographies, Whole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Plethysmography, Whole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Region' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Regions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Sensation Hallucination' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Sensation Hallucinations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Size' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Sizes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Surface Area' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Surface Areas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Surface Mapping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Surface Mappings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Surface Potential Mapping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature %28%1967-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature Change' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature Changes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature Regulation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature Regulation %28%1966-2000%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperature Regulations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Temperatures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Type' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Types' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Water' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Water %28%1972-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Water %28%1974-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Waters' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight Change' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight Changes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weight, Fetal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weights' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weights and Measures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body Weights, Fetal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level %28%i.e., GENETIC ENGINEERING%29% is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer DATABASES, and gene and protein structure function analysis and prediction.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators %28%%22%iron lung%22%%29%, Portalung, Pneumowrap, and chest cuirass %28%%22%tortoise shell%22%%29%.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Aortic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Carotid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Ciliary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Coiled' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Fat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Foreign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Inclusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Lateral Geniculate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Lewy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Mamillary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Mammillary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Medial Geniculate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Negri' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Neuroepithelial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Para-Aortic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Paraaortic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Pineal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Ultimobranchial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Vagal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Viral Inclusion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Vitreous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body, Wolffian' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Body-Image Agnosias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boeck Sarcoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boeck%27%s Sarcoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boecks Sarcoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehmeria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Acetylcysteine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Alteplase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Bisacodyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Bromhexine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Dipyridamole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Dobutamine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Enalaprilat Anhydrous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Etilefrine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Methoxsalen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Mexiletine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Pirenzepine Dihydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Sertraline Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Ingelheim Brand of Trazodone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Mannheim Brand of Allopurinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Mannheim Brand of Bezafibrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Mannheim Brand of Canrenoate Potassium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer Mannheim Brand of Ceftriaxone Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehringer, Digoxina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boehrvet Brand of Bromhexine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boerhaavia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bog Myrtle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bogaert-Bertrand Disease, Canavan-van' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bogaert-Scherer-Epstein Disease, Van' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bohm Brand of Disulfiram' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bohr effect is indexed OXYHEMOGLOBINS /metab %28%IM%29% + PH %28%NIM%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boidae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boiling Point Temperatures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boizot Brand of Betaine Aspartate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boldea fragrans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boldo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bolivia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bolivian Hemorrhagic Fever' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombacaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombax' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombesin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombesin 14' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombesin Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombesin Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bombyx' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonamia Plant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bond Isomerases, S-S' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bond Isomerases, Sulfur-Sulfur' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bond Issue, Construction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bond, Concise Enamel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bond, Emotional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bond, Pair' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding %28%Psychology%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding Agents, Dentin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Animal-Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Dental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Dental %28%1971-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Dental %28%1971-1983%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Human Pet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Human-Pet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Hydrogen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Pet-Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Psychological' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonding, Pyschological' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bondings %28%Psychology%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bondings, Animal-Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bondings, Human-Pet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bondings, Hydrogen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bondings, Pet-Human' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bondings, Pyschological' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonds, Emotional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonds, Pair' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone 4-Carboxyglutamic Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Age Measurement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Age Measurements' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Aseptic Necrosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Avascular Necrosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Bank' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Banks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cement, Zimmer' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cements' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Conduction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Conductions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cyst %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cyst, Aneurysmal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cysts %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Cysts, Aneurysmal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Demineralization Technic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Demineralization Technics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Demineralization Technique' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Demineralization Techniques' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Demineralization, Pathologic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Densities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Density' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Density Conservation Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Derived Transforming Growth Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Development' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Development %28%1967-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Disease, Developmental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Disease, Disappearing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Disease, Endocrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Disease, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Disease, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1969%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1966-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1967-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases %28%1975-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Developmental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Developmental %28%1970-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Developmental %28%1970-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Developmental %28%1973-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Endocrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Diseases, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Dysplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Dysplasias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Fibrous Dysplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Fibrous Dysplasias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Formation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Fracture' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Fractures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Gla Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Glue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Glues' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Grafting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Graftings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Hypertrophies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Hypertrophy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Inflammation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Lengthening' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Lengthening %28%1981-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Lengthening %28%1987-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Age Related' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Age-Related' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Alveolar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Osteoclastic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Perimenopausal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Periodontal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Loss, Postmenopausal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Losses, Age-Related' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Losses, Alveolar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Losses, Osteoclastic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Losses, Perimenopausal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Losses, Periodontal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Losses, Postmenopausal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Malalignment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Malalignments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Malposition' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Malpositions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow %28%1966-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow %28%1983-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Cells' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Cells %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Derived Macrophages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Diseases %28%1965-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Diseases %28%1966-1985%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Diseases %28%1966-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Examination' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Examinations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Fibroses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Fibrosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Grafting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Purging' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Transplantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow Transplantation %28%1988-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow-Derived Macrophage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow-Derived Macrophages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow/cytology %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow/cytology %28%1978-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow/pathology %28%1968-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow/transplantation %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Marrow/transplantation %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Matrices' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Matrix' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Mineral Contents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Mineral Densities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Mineral Density' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Mineralization' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Misalignment' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Misalignments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein Receptor II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein Receptor Type I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein Receptor Type II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein Receptors, Type I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Protein Receptors, Type II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Morphogenetic Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Nail' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Nails' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Neoplasms %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Paste' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Pastes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Patellar Tendon Bone Graft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Pin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Pins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Plate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Plates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Regeneration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Regeneration %28%1967-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Regenerations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Remodeling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Replacement Material' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Replacement Materials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Resorption' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Resorption %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Resorption %28%1967-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Resorptions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Screw' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Screws' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Substitute' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Substitutes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Tissue Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Tissue Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Tissues' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Transplantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Transplantation %28%1991-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Transplantations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Tuberculoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Wire' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone Wires' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone and Bones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone and Bones %28%1966-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone and Bones %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone and Bones %28%1966-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone and Bones/transplantation %28%1966-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone diseases caused by pathogenic microorganisms. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone gamma Carboxyglutamic Acid Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone gamma-Carboxyglutamic Acid Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone lengthening by gradual mechanical distraction. An external fixation device produces the distraction across the bone plate. The technique was originally applied to long bones but in recent years the method has been adapted for use with mandibular implants in maxillofacial surgery.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone loss due to osteoclastic activity. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Arm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Astragalus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Basilar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Broken' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Capitate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Carpal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Cheek' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Cuboid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Cuneiform' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Ethmoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Facial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Foot' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Frontal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Hamate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Heel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Hyoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Jugal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Leg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Lingual' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Lunate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Malar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Metatarsal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Nasal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Occipital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Palatine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Parietal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Pelvic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Petrous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Pisiform' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Pubic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Scaphoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Semilunar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Sesamoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Sphenoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Tarsal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Temporal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Trapezium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Trapezoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Triquetral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Triquetrum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone, Xiphoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone-Derived Transforming Growth Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone-Patellar Tendon-Bone Graft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone-Patellar Tendon-Bone Grafts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones and Bone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones and Bone Tissue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Arm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Feet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Fingers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Foot' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Hand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Hands' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Leg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Lower Extremity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Toes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Upper Extremity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones of Upper Extremity %28%1998-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones that make up the SKELETON of the FINGERS, consisting of two for the THUMB, and three for each of the other fingers.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones that make up the SKELETON of the TOES, consisting of two for the great toe, and three for each of the other toes.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Ankle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Arm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Astragalus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Basilar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Broken' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Capitate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Carpal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Cheek' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Cuboid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Cuneiform' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Ethmoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Facial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Finger' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Foot' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Frontal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Hamate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Hand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Hyoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Jugal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Leg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Lingual' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Lunate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Malar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Metacarpal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Metatarsal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Nasal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Occipital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Parietal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Pelvic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Petrous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Pisiform' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Pubic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Scaphoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Semilunar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Sesamoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Sphenoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Tarsal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Temporal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Toe' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Trapezium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Trapezoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Triquetral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Triquetrum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bones, Xiphoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bongkrekic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonnet Macaque' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonnet Macaques' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonnet Monkey' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonnet Monkeys' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonnevie Ullrich Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonobo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bonobos' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bony Callus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bony Labyrinths' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bony Tissue Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bony Tissue Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bony structure of the mouth that holds the teeth. It consists of the MANDIBLE and the MAXILLA.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boobialla' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Chapters' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Classification' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Classifications' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Collecting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Collectings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Illustrations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Illustrations %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Illustrations %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Imprint' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Imprints' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Industries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Industry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Ornamentation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Ornamentations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Plates %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Plates %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Price' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Prices' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Review' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Reviews' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Reviews %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Reviews %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Selection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Selection %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book Selections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book, Illustrated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book, Rare' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Book, Reference' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookbinding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookbindings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booklet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booklets' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookplate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookplates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookplates %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookplates %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books %28%1966-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books containing photographs, prints, drawings, portraits, plates, diagrams, facsimiles, maps, tables, or other representations or systematic arrangement of data designed to elucidate or decorate its contents. %28%From The ALA Glossary of Library and Information Science, 1983, p114%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books designed by the arrangement and treatment of their subject matter to be consulted for definite terms of information rather than to be read consecutively. Reference books include DICTIONARIES; ENCYCLOPEDIAS; ATLASES; etc. %28%From the ALA Glossary of Library and Information Science, 1983%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books designed to give factual information or instructions.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books in the field of medicine intended primarily for consultation.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books in which personal or commercial accounts of financial transactions are recorded. %28%From Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books intended for use in the study of specific subjects, containing systematic presentation of the principles and essential knowledge of the subjects.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books used for sex education and procedural instruction.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books, Illustrated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books, Medical Reference' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books, Rare' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Books, Reference' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookseller Catalogs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookseller%27%s Catalogs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booksellers Catalogs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booksellers%27% Catalog' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booksellers%27% Catalogs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bookselling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booksellings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booster Immunization' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Booster Immunizations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Allopurinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Betaxolol Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Bromhexine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Cetylpyridinium Chloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Dequalinium Chloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Mebendazole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Mepyramine Maleate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Naloxone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Noscapine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Phenindione' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boots Brand of Warfarin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boraginaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borago' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boranes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borates %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Border Crossings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Border Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Border Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Border disease virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Border, Brush' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Border, Striated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borderline Leprosies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borderline Leprosy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borderline Personality Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borderline Personality Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borderline Schizophrenia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borderline Schizophrenias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borders, Brush' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borders, Striated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella %28%1964-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella %28%1966-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella %28%1984-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella AC Toxin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Ac-Hly' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Adenylate Cyclase Toxin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Pertussis %28%1966-1985%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Virulence Determinant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella Virulence Factors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella avium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella bronchiseptica' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella cyaA Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella parapertussis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bordetella pertussis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boredom' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boredoms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boric Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borinic Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borna Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borna disease virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bornanes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bornaviridae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bornaviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borneo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bornholm Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borohydrides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron %28%1966-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron Compounds %28%1968-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron Compounds %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron Hydrides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron Neutron Capture Therapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boron-Neutron Capture Therapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boronic Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia %28%1984-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia %28%1986-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia burgdorferi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia burgdorferi Group' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia burgdorferi Group %28%1990-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia burgdorferi Neuroborreliosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia burgdorferi sensu lato' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borrelia burgdorferi sensu stricto' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Borreliosis, Lyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bosnia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bosnia and Hercegovina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bosnia and Herzegovina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bosnia-Herzegovina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boston' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boswellia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botanical Antineoplastics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botanically, a type of single-seeded fruit in which the pericarp enclosing the seed is a hard woody shell. In common usage the term is used loosely for any hard, oil-rich kernel. Of those commonly eaten, only hazel, filbert, and chestnut are strictly nuts. Walnuts, pecans, almonds, and coconuts are really drupes. Brazil nuts, pistachios, macadamias, and cashews are really seeds with a hard shell derived from the testa rather than the pericarp.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botanies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botany' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bothrops' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botrytis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botswana' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle Feeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle Feedings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle Nose Dolphins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle Nosed Dolphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle Nosed Dolphins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle-Nose Dolphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle-Nose Dolphins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle-Nosed Dolphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle-Nosed Dolphins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle-Nosed Whale, Giant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottle-Nosed Whales, Giant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottlefeeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottlefeedings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottlenose Dolphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottlenose Dolphins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottlenosed Dolphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bottlenosed Dolphins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum A Toxin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum Antitoxin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum Neurotoxin A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum Toxin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum Toxin Type A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum Toxins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulinum Toxins %28%1982-1996%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulism' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulism, Toxico Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Botulism, Toxico-Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouchara Brand of Acetylcysteine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouchara Brand of Betahistine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouchara Brand of Cephradine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouchara Brand of Nordazepam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouchara Brand of Procetofen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boucher %26% Muir Brand of Primaquine Phosphate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouillaud%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouillauds Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bound Immunoglobulin, Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boundary Element' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bourneville Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bourneville Phacomatosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bourneville Phakomatosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bourneville%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bournonville Brand of Acetylcholine Chloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouton, Synaptic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boutonneuse Fever' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boutonneuse Fevers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boutons, Synaptic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovicola' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Brucelloses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Brucellosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Coronaviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Diarrhea Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Diarrhea Virus %28%1975-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Diarrhea Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Enteroviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Hemorrhagic Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Herpes Mammillitis Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Immunodeficiency Like Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Immunodeficiency Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Immunodeficiency-Like Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Immunodeficiency-Like Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Kunitz Pancreatic Trypsin Inhibitor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Lentivirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Lentiviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Leukemia Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Leukemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Leukoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Leukoses, Enzootic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Leukosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Leukosis, Enzootic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Lymphomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Lymphosarcoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Lymphosarcomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Mastitides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Mastitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Pancreatic Trypsin Inhibitor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Papilloma Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Papilloma Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Papillomavirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Papillomaviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Papular Dermatitis Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Pestivirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Pestiviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Pulmonary Adenomatoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Respiratory Disease Complex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Rhinotracheitides, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Rhinotracheitis Virus, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Rhinotracheitis, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Serum Albumin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Spongiform Encephalitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Spongiform Encephalopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Syncytial Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Syncytial Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Trypanosomiases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Trypanosomiasis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Tuberculoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Tuberculosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Ulcerative Mammillitis Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Viral Diarrhea Virus Type 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Viral Diarrhea Virus Type 2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Viral Diarrhea Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Virus Diarrhea Mucosal Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Virus Diarrhea-Mucosal Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Virus Diarrhea-Mucosal Disease %28%1995-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Wart Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine Wart Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine coronavirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine encephalitis virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine encephalitis viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine enterovirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine ephemeral fever virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine herpesvirus 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine herpesvirus 2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine herpesvirus 4' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine herpesvirus 5' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine immunodeficiency virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine mamillitis virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine mamillitis viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine papillomatosis virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine papillomatosis viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine parainfluenza virus 3' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine respiratory disease found in animals that have been shipped or exposed to CATTLE recently transported. The major agent responsible for the disease is MANNHEIMIA HAEMOLYTICA and less commonly, PASTEURELLA MULTOCIDA or HAEMOPHILUS SOMNUS. All three agents are normal inhabitants of the bovine nasal pharyngeal mucosa but not the LUNG. They are considered opportunistic pathogens following STRESS and/or a viral infection. The resulting bacterial fibrinous BRONCHOPNEUMONIA is often fatal.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine respiratory syncytial virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine toroviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine viral diarrhea virus 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bovine viral diarrhea virus 2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bow, Orthodontic Face' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowel Diseases, Inflammatory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowel Syndrome, Short' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowel Syndromes, Short' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowen Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowen%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowens Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowhead Whale' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowhead Whales' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman Birk Soybean Trypsin Inhibitor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman Capsule' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman Membranes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman%27%s Capsule' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman%27%s Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman%27%s Membranes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowman-Birk Soybean Trypsin Inhibitor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowmans Capsule' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bowmans Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bows, Orthodontic Face' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box Elder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box Jellyfish' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box Protein 1, High Mobility Group' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box Protein 2, High Mobility Group' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box Protein 3, High Mobility Group' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box, Hogness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box, SOS' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Box, TATA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boxes in which physicians kept their drugs and other medications, medical instruments and supplies, manuals, etc. As a carrying case or convenient storage receptacle, or a kind of portable pharmacy, the medicine chest was indispensable to the itinerant physician. The chest was usually larger and sturdier than a doctor%27%s kit or bag.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boxing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boxings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Boxwood' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BpeI Endonuclease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Br Cycl AMP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Br-74-78, 80, 82-90; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bracco Brand of Sincalide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brace' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braces' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Arteries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Artery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Basilar Insufficiency Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Neuralgias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Neuritides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Neuritis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Pareses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Paresis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexopathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus %28%1972-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Neuritides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Neuritis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Neuropathies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial Plexus Neuropathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial-Basilar Insufficiency Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachial-Basilar Insufficiency Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachiaria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachiocephalic Trunk' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachiocephalic Trunks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachiocephalic Vein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachiocephalic Veins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachmann De Lange Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachmann-De Lange Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachydanio rerio' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachydanio rerio Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachytherapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachytherapy, Radioisotope' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brachyura' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brackenfern' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bracket, Orthodontic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brackets, Orthodontic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braconid Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bracytele' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradyarrhythmias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradycardia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradycardias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinesias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin B1 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin B1 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin B2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin B2 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin Potentiating Peptide 9a' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin Type 1 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin Type 2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin, Lysine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin, Lysyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykinin-Potentiating Peptide 9a' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradykininase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradyrhizobiaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bradyrhizobium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1966-1982%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1966-1983%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1970-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain %28%1983-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain 14 3 3 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain 14-3-3 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscess' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscess %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscess %28%1966-1983%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscesses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscesses, Multiple' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscesses, Pyogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Abscesses, Sterile' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Aneurysms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Anoxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Anoxia Ischemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Anoxia-Ischemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Anoxia-Ischemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Anoxic Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Anoxic Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Arterial Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Arterial Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Atrophy, Circumscribed Lobar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Autoimmune Demyelinating Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Benign Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Benign Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Blood Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Cancers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Capillary Telangiectasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Capillary Telangiectasias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Chemistries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Chemistry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Concussion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Concussion %28%1964-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Concussion %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Concussions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Congenital Absence' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Contusions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Creatine Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Cysticercosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Damage, Anoxic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Damage, Chronic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Damage, Chronic %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Damage, Chronic %28%1966-1968%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Damage, Hypoxic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Dead' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Deads' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Death' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Derived Neurotrophic Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Derived Neurotrophic Factor Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disease, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1964-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1984%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1968-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1981-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases %28%1985-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases, Metabolic %28%1977-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases, Metabolic %28%1977-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases, Metabolic %28%1987-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases, Metabolic, Familial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases, Metabolic, Inborn' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Diseases/veterinary %28%1988-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorder, Arterial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorder, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorders, Arterial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorders, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Disorders, Metabolic, Acquired' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Drains' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Edema' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Edema, Cytotoxic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Edema, Vasogenic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Emboli' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Embolus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhage, Cerebral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhage, Cerebral, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhage, Putaminal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhage, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhages, Cerebral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhages, Putaminal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hemorrhages, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hypoxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hypoxia Ischemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hypoxia-Ischemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hypoxia-Ischemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hypoxic Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Hypoxic Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Infarction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Infarction, Anterior Circulation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Infarction, Venous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Infarctions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Infarctions, Venous' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Inflammation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Inflammations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries %28%1968-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries %28%1976-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries %28%1982-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries %28%1984-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Acute' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Anoxic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Anoxic-Ischemic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Chronic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Hypoxic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Hypoxic-Ischemic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injuries, Ischemic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Acute' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Anoxic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Anoxic Ischemic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Anoxic-Ischemic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Chronic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Chronic %28%2000-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Diffuse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Focal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Hypoxic-Ischemic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Penetrating' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Injury, Vascular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia Anoxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia Hypoxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia-Anoxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia-Anoxias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia-Hypoxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemia-Hypoxias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ischemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Laceration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Malignant Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Malignant Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Mapping' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Mapping, Topographic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Mappings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Mappings, Topographic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Metabolic Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Metabolic Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Natriuretic Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Natriuretic Peptide 32' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Natriuretic Peptide-32' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasm, Benign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasm, Malignant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasm, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms %28%1966-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms %28%1970-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms, Benign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms, Malignant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms, Malignant, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Neoplasms, Primary Malignant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Pathology' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Revascularization' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Septum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Septums' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Specific Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Specific Na Dependent Inorganic Phosphate Cotransporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem %28%1966-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem %28%1968-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Auditory Evoked Potential' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Auditory Evoked Potentials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Hemorrhage, Post Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Hemorrhage, Post-Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Hemorrhage, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Implants, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Infarction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Infarctions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Transient Ischemic Attack' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem Vertigo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stem/blood supply %28%1975-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stems' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stimulation, Deep' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Stimulations, Deep' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Swelling' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Swellings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Syndrome, Metabolic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Syndrome, Metabolic, Acquired' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Syndrome, Metabolic, Inborn' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain TIA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Thromboses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tissue Grafting' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tissue Graftings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tissue Transplantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tissue Transplantations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Trauma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Traumas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tumors, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Tumors, Recurrent' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Type Fatty Acid Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Accident' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Accidents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Injury' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Malformation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Malformations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Vascular Trauma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Venous Infarction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Venous Infarctions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ventricular Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ventricular Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ventricular Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain Ventricular Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired %28%BRAIN ISCHEMIA%29%. Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status %28%in some cases progressing to COMA%29%; PAPILLEDEMA; and RETINAL HEMORRHAGE.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain injuries resulted from vigorous shaking of an infant or young child held by the chest, shoulders, or extremities causing extreme rotational cranial acceleration. It is characterized by the intracranial and intraocular hemorrhages with no evident external trauma. Serious cases may result in death.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain waves with frequency greater than 13 Hz seen on EEG during wakefulness.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain, Hind' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Blood Barrier' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Blood Barriers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Derived Neurotrophic Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Derived Neurotrophic Factor Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Specific Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Specific Na-Dependent Inorganic Phosphate Cotransporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain-Type Fatty Acid-Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain/abnormalities %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain/abnormalities %28%1967-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain/blood supply %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain/blood supply%28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain/metabolism %28%1968-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brain/transplantation %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brains' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brains, Hind' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Auditory Evoked Potential' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Auditory Evoked Potentials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Hematoma, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Hematomas, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Hemorrhage, Post-Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Hemorrhage, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Hemorrhages, Post-Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Hemorrhages, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Implant, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Implantation, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Implantations, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Implants, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Infarction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Infarctions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Ischemia, Transient' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Ischemias, Transient' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Neoplasm, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Neoplasms, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Response, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Responses, Auditory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Stroke' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Transient Ischemic Attack' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Vertigo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstem Vertigos' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brainstems' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bramble Brand of Amobarbital Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bran, Wheat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch Hospitals' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch of psychiatry concerned with problems related to the prevention, diagnosis, etiology, and treatment of mental or emotional disorders of Armed Forces personnel.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch of psychiatry concerned with the provision and delivery of a coordinated program of mental health care to a specified population. The foci included in this concept are: all social, psychological and physical factors related to etiology, prevention, and maintaining positive mental health in the community.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch of psychology that deals with paranormal behavior and events such as telepathy, precognition, and clairvoyance, which are not explicable by present day %22%natural laws%22%.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branch of the common carotid artery which supplies the exterior of the head, the face, and the greater part of the neck.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain 2 Oxo Acid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain Alpha Keto Acid Decarboxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain Alpha-Keto Acid Decarboxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain Keto Acid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain Ketoacid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain Ketoaciduria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched Chain Oxo Acid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched DNA Assay' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched DNA Assays' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched DNA Signal Amplification Assay' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain 2-Oxo Acid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain Amino Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain Keto Acid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain Ketoaciduria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain Ketoacidurias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain Oligosaccharides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branched-Chain Oxo-Acid Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brancher Deficiencies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brancher Deficiency' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branches of the VAGUS NERVE %28%the tenth cranial nerve%29%. The superior laryngeal nerves originate near the nodose ganglion and separate into external branches, which supply motor fibers to the cricothyroid muscles, and internal branches, which carry sensory fibers. The RECURRENT %28%inferior%29% LARYNGEAL NERVE originates more caudally and carries efferents to all muscles of the larynx except the cricothyroid. The laryngeal nerves and their various branches also carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branches of the vagus %28%tenth cranial%29% nerve. The recurrent laryngeal nerves originate more caudally than the superior laryngeal nerves and follow different paths on the right and left sides. They carry efferents to all muscles of the larynx except the cricothyroid and carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Arches' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Cleft' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Cleft Cyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Cleft Cysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Cyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Cysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Region' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Region %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchial Regions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branching Enzyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branching Enzyme, 1,4-alpha-Glucan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branching Enzyme, Amylopectin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branching Enzyme, Glycogen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branching Enzyme, Starch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branching Glycosyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio Oculo Facial Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio Oto Renal Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio Otorenal Dysplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio Otorenal Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Oculo-Facial Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Oto-Renal Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Oto-Renal Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Otorenal Dysplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Otorenal Dysplasias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Otorenal Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchio-Otorenal Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchioma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branchiomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brand Anistreplase, Monmouth' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Branhamella catarrhalis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brans, Wheat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brass Technic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brassica' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brassica %28%1977-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brassica %28%1998-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brassica napus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brassica rapa' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brassicaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brattleboro Rats' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Bupivacaine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Calcium Gluconate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Enbucrilate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Fructose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Mepivicaine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Pentastarch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Polygeline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Procaine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Propofol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun Brand of Thiopental Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun, Bupivacaina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Braun, Mepivacaina' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brazil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brazil Nut Tree' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brazilian Arrowroot' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brazilian Manatee' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brazilian Manatees' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BrdU' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bread' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bread, Bee' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breadboard Projects' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breads' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Break or rupture of a tooth or tooth root. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Break, Chromosomal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Break, Chromosome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Break, Retinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakage Syndrome, Nijmegen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakage, Chromosomal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakage, Chromosome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakages, Chromosomal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakages, Chromosome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakbone Fever Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakbone Fever Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakdown Syndrome, Social' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakdown Syndromes, Social' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakpoint Cluster Region Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breaks in CARTILAGE. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breaks in bones. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breaks, Chromosomal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breaks, Chromosome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breaks, Retinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breakthrough Bleeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast %28%1965-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast %28%1980-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Adenosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer 1 Gene Product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer 1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer 2 Gene Product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer 2 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer Anti Estrogen Resistance 1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer Anti-Estrogen Resistance 1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cancer, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Carcinoma, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Conserving Surgery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cystic Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cystic Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Cysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Disease, Cystic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Disease, Endocrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Disease, Fibrocystic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Diseases %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Diseases %28%1967-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Diseases, Endocrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Dysplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Enlargement, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Feeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Fibrocystic Change' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Fibrocystic Changes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Fibrocystic Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Implant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Implantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Implantations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Implants' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Implants %28%1995-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Milk' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Milks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasm, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms %28%1966-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms/radiography %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Neoplasms/surgery %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Prostheses, Internal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Prosthesis Implantation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Prosthesis Implantations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Prosthesis, Internal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Reconstruction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Reconstructions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Self Examination' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Self-Examination' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Self-Examinations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Tumor, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Tumors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Tumors, Male' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Ultrasonographies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Ultrasonography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast Xeroradiography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast-Conserving Surgeries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast/surgery %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breast/surgery %28%1966-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breastfeeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breastfeeding, Exclusive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breasts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breath Shortness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breath Shortnesses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breath Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breath Tests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathalyzer Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Capacities, Maximal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Capacity, Maximal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Exercises' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Mechanic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Mechanics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Sound' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Sounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Work' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing Works' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing, Central Sleep-Disordered' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing, Inspiratory Positive-Pressure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing, Intermittent Positive-Pressure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing, Mouth' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathing, Sleep-Disordered' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathings, Central Sleep-Disordered' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breathings, Mouth' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breckenridge Brand of Pancrelipase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breda Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breech Fetal Presentation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breech Labor Presentation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breech Presentation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breech Presentation, Frank' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breech, Complete' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breech, Incomplete' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breeding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breeding, Molecular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breedings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Breedings, Molecular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brefeldin A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brenner Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brenner Tumor, Benign' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brenner Tumor, Malignant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brenner Tumor, Proliferative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bretylium Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bretylium Compounds %28%1969-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bretylium Tosilate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bretylium Tosylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brevibacterium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brevibacterium %28%1967-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brevibacterium flavum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brevidensoviruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brewer%27%s Yeast' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bricanyl SA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridge, Fixed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridge, Maryland' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridge, Resin-Bonded' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged Compounds %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged Compounds %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged Compounds %28%1966-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged Compounds %28%1969-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged Ring Heterocyclic Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridged-Ring Heterocyclic Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridges, Fixed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridges, Resin-Bonded' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridgework, Dental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bridgeworks, Dental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief Psychiatric Rating Scale' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief Psychotherapies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief Psychotherapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief Reactive Psychoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief Reactive Psychosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief accounts or narratives of an incident or event. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief closing of the eyelids by involuntary normal periodic closing, as a protective measure, or by voluntary action.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology %28%e.g., embolic vs. thrombotic%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp814-6%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brief therapeutic approach which is ameliorative rather than curative of acute psychiatric emergencies. Used in contexts such as emergency rooms of psychiatric or general hospitals, or in the home or place of crisis occurrence, this treatment approach focuses on interpersonal and intrapsychic factors and environmental modification. %28%APA Thesaurus of Psychological Index Terms, 7th ed%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brietal Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brietal-Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bright Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brij 58' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brij58' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brill Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brill Symmers Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brill Zinsser Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brill%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brill-Symmers Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brills Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brine Shrimp' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brinjal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brinolase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Briquet Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bris Taxol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristle Coated Pits' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristle-Coated Pit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristle-Coated Pits' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristlegrass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Brand of Buspirone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Brand of Didanosine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Brand of Etoposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Brand of Megestrol Acetate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Brand of Teniposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Acetylcysteine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Acetylcysteine Sodium Salt' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Amikacin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Aztreonam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Bendroflumethiazide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Bleomycin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Buspirone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Dicloxacillin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Didanosine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Encainide Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Etoposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Fosinopril Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Halcinonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Lomustine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Megestrol Acetate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Mesna' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Mitotane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Naloxone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Naltrexone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Tegafur' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Teniposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Testolactone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol Myers Squibb Brand of Trazodone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Buspirone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Cephapirin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Didanosine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Etoposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Megestrol Acetate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Paclitaxel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Stavudine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Brand of Teniposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Acetylcysteine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Acetylcysteine Sodium Salt' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Amikacin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Aztreonam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Bendroflumethiazide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Bleomycin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Buspirone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Butorphanol Tartrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Caffeine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Carboplatin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Cefradine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Cephapirin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Dicloxacillin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Didanosine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Doxorubicin Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Encainide Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Etoposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Fosinopril Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Halcinonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Lomustine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Megestrol Acetate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Mesna' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Mitotane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Naloxone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Naltrexone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Oxymorphone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Paclitaxel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Pentastarch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Pravastatin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Procainamide Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Stavudine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Tegafur' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Teniposide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Testolactone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Trazodone Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Vincristine Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bristol-Myers Squibb Brand of Warfarin Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Britannia Brand of Apomorphine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Britannia Brand of Penicillin G Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Britisfarma Brand of Aciclovir' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Britisfarma Brand of Aciclovir Sodium Salt' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Anti Lewisite' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Anti Lewisite Agent' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Anti-Lewisite' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Anti-Lewisite Agent' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Columbia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Guiana' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Health Service, National' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Honduras' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British National Health Service' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Type Amyloid Polyneuropathy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'British Virgin Islands' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brittle Diabetes Mellitus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn 3 Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn 3A Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn 3B Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn 3c Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3 Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3, Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3A Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3A, Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3B Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3B, Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3C, Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brn-3c Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Beta Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Beta Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Ligament' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Ligaments' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Thumb Hallux Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Thumb-Hallux Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad Thumb-Hallux Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad spectrum anthelmintic for livestock. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad spectrum antinematodal anthelmintic used also in veterinary medicine.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broadened Gait' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broadside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broadsides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broadsides %28%PT%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broadsides %5B%Publication Type%5D%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broca Aphasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broca Aphasias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broca Diagonal Band' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broca Dysphasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broca%27%s Dysphasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brochure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brochures' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brock Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brock%27%s Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brocks Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brocresine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broken Bone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broken Bones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broken bones in the vertebral column. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromazepam' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromazepam Lichtenstein Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromazepam Roche Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromazepam ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromcresol Green' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromcresol Purple' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brome mosaic viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromegrass' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelain POS' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BromelainPOS' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains Aventis Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains Mucos Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains Nattermann Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains Rottapharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains Ursapharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelains Wiedemann Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromeliaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromelins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexin Berlin Chemie' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexin Berlin-Chemie' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexin BerlinChemie' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexin ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexin-ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexine Metabolite VIII' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexine Monohydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexine, Famel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexine/analogs %26% derivatives %28%1975-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromhexinratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, 2-Aminoethylisothiuronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Acetylcholine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Butylscopolammonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Cyanogen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Edrophonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Emepronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Ethidium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Ethylene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Glycopyrronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Hexadimethrine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Hexamethonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Homidium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Hydrogen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, N-Butylscopolammonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, N-Methylnaloxone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, N-Methylscopolamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Neostigmine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Oxyphenonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Pancuronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Pipecurium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Pipecuronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Propantheline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Pyridostigmine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Suxamethonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Tetraethylammonium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Trimedoxime' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, Vecuronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromide, beta-Aminoethylisothiuronium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromides %28%1974-1982%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brominated Hydrocarbons' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brominated Steroids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brominated analog of MANNITOL which is an antineoplastic agent appearing to act as an alkylating agent.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966-1970%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966-1973%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1966-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine %28%1974-1975%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine Compounds' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromine Radioisotopes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromisoval' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromisovalum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromoacetylcholine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromobenzenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromobenzoates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromocresol Green' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromocresol Purple' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromocriptin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromocriptine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromocriptine Mesylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromocryptin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromodeoxycytidine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromodeoxyuridine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromoisovalerylurea' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromophenol Blue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromosuccinimide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromosulfophthalein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromosulphthalein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromothymol Blue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromotrichloromethane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromouracil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromouracil Deoxyriboside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromovalcarbamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromovalerylurea' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromoviridae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromoviridae %28%1997-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromovirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brompheniramine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brompheniramine %28%1966-1983%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brompheniramine Maleate %28%1:1%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromphenol Blue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromthymol Blue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromuc' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromuracil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bromus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi %28%1966-1967%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi %28%1970-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi %28%1971-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi/abnormalities %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi/drug effects %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchi/physiology %28%1966-1990%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Allergen Challenge' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Allergen Challenges' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Arteries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Artery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Asthma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Asthmas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Carcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Carcinomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Catheterization' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Catheterizations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Challenge Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Challenge Tests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Constricting Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Constriction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Constrictions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Cyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Cysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Dilating Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Diseases %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Diseases %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Fistula' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Fistulas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Hyperreactivities' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Hyperreactivity' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Lavage Fluid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Lavage Fluids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Lavages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Neoplasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Neoplasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Provocation Test' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Provocation Tests' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Spasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Spasm %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial Spasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial hemorrhage manifested with spitting of blood.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial-Constricting Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchial-Dilating Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiectases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiectasis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchioalveolar Lavage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchioalveolar Lavages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolar Carcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolar Carcinomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitides, Exudative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitides, Proliferative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitides, Viral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis Obliterans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis Obliterans %28%1988-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis Obliterans Organizing Pneumonia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis, Exudative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis, Proliferative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis, Viral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolitis, Viral %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolo-Alveolar Adenocarcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolo-Alveolar Adenocarcinomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolo-Alveolar Carcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchiolo-Alveolar Carcinomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchioloalveolar Carcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchioloalveolar Carcinomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchitides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchitis %28%1965-2001%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchitis %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchitis, Chronic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broncho Fips' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BronchoFips' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoalveolar Lavage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoalveolar Lavage Fluid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoalveolar Lavage Fluids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoalveolar Lavages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoconstriction' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoconstrictions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoconstrictor Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoconstrictors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchodilator Agents' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchodilators' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchogenic Carcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchogenic Carcinomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchogenic Cyst' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchogenic Cysts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchographies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchography' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopneumonia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopneumonia %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopneumonias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Allergic Aspergilloses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Allergic Aspergillosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Aspergilloses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Aspergilloses, Allergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Aspergillosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Aspergillosis, Allergic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Dysplasia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Lavage' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Lavages' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Sequestration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchopulmonary Sequestrations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscope' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopic Surgeries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopic Surgery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopic Surgical Procedure' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopy %28%1966-1987%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchoscopy/instrumentation %28%1998-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchospasm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchospasm, Exercise Induced' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchospasms' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchospasms, Exercise-Induced' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchospirometries' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchospirometry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronchus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bronze Diabetes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom Rape' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom, Butcher%27%s' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom, Desert' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom, Dyers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom, Scotch' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broom, Spanish' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broomcorn Millet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broomrape' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brother' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brothier Brand of Dimenhydrinate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broussonetia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Adipose Tissue' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Adipose Tissues' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Algae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Dog Tick' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Fat' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Sequard Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Sequard Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Sequard%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Sequard%27%s Paralysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown Sequard%27%s Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown%27%s Tendon Sheath Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Pearce Carcinoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Pearce Epithelioma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequard Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequard Paralysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequard Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequard%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequard%27%s Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequards Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequards Paralysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brown-Sequards Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Browning Reactions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Browning, Food' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brownings, Food' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Broxuridine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucea' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella %28%1963-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella %28%1964-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella %28%1966-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella %28%1968-2002%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella %28%1972-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella Vaccine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella abortus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella canis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella melitensis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella melitensis biovar abortus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella melitensis biovar canis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella melitensis biovar ovis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella melitensis biovar suis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella ovis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucella suis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucellaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucelloses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucelloses, Bovine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucellosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brucellosis, Bovine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruch Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruch%27%s Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruchs Membrane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brueghel Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brugia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brugia %28%1975-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brugia malayi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brugia pahangi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruise' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruises' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunei' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunemycin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruneomycin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunhilde Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunner Gland' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunner Glands' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunner%27%s Glands' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brunners Glands' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruns Apraxia, Gait' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruns Gait Apraxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruns%27% Apraxia, Gait' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruns%27% Gait Apraxia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruns%27% Gait Apraxias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brush Borders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brush-Tailed Possum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brush-Tailed Possums' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxism' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxism %28%1965-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxism, Nocturnal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxism, Sleep' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxism, Sleep-Related' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxisms, Nocturnal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxisms, Sleep' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bruxisms, Sleep-Related' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryde Whale' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Brydes Whale' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryonia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryony, Black' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryophyta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryopsida' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryopsida %28%1995-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bryozoa' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bs, Haemophilia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bs, Hemophilia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BstI Deoxyribonuclease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'BstI Endonuclease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bubble, Garren-Edwards Gastric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bubble, Gastric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bubbles, Gastric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bucca' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buccal Administration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buccal Administrations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buccal Drug Administration' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buccal Drug Administrations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buccas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buchnera' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buchu Resin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckeye' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckling, Scleral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bucklings, Scleral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckminsterfullerenes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckthorn, Sea' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckwheat, Red' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckwheat, Wild' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckyballs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckytube' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buckytubes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bucladesine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bucrilate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bucrylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bud, Limb' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bud, Taste' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budd Chiari Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budd-Chiari Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buddhism' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buddhist Ethic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budding Yeast' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budding and Appendaged Bacteria %28%1998-1999%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buddleja' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budesonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgerigar' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgerigar Fancier Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgerigar Fancier%27%s Lungs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgerigar Fanciers Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgerigars' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budget' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgetary Controls' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Budgets' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buds, Limb' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buds, Taste' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buerger Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buerger%27%s Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buergers Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufanolides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufanolides %28%1970-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufenine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac AHP Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac Bioglan Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac Dermapharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac GALENpharma Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac Pharmacia Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac Scheurich Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac Whitehall Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac ratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamac ratiopharm Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufexamacratiopharm' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffalo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffalo Rats, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffalo, American' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffalo, Water' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffaloberry' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffaloes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffer Zone, Body' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffer Zones, Body' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffers' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buffers %28%1966-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufo arenarum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufo bufo' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufo marinus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufonidae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buformin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buformin Andromaco Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufos' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufotenin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufotenin %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bufotenine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bugbane' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bugbane, Black' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bugle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bugleweed' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bugs of the family CIMICIDAE, genus Cimex. They are flattened, oval, reddish insects which inhabit houses, wallpaper, furniture, and beds. C. lectularius, of temperate regions, is the common bedbug that attacks humans and is frequently a serious pest in houses, hotels, barracks, and other living quarters. Experiments have shown that bedbugs can transmit a variety of diseases, but they are not normal vectors under natural conditions. %28%From Dorland, 27th ed; Borror, et al., An Introduction to the Study of Insects, 4th ed, p272%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Build, Body' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Building Code' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Building Codes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Building, Medical Office' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buildings, Medical Office' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Builds, Body' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bukarban' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulb, Accessory Olfactory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulb, Olfactory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Hemorrhage, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Hemorrhages, Traumatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsies, Progressive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsies, Spastic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsy, Progressive' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsy, Progressive %28%1966-1982%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Palsy, Spastic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Paralyses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Paralysis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Polio' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbar Poliomyelitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbo Spinal Atrophy, X Linked' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbo-Spinal Atrophies, X-Linked' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbo-Spinal Atrophy, X-Linked' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbospinal Neuronopathies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbourethral Gland' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbourethral Glands' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbous cells that are medially placed in one row in the organ of Corti. In contrast to the outer hair cells, the inner hair cells are fewer in number, have fewer sensory hairs, and are less differentiated.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbous enlargement of the growing tip of nerve axons and dendrites. They are crucial to neuronal development because of their pathfinding ability and their role in synaptogenesis.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbs, Accessory Olfactory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbs, Krause%27%s End' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulbs, Olfactory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulgaria' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulimia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulimia %28%1986-2005%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulimia Nervosa' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulimias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulinus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bull Brand of Aciclovir' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bull Brand of Bleomycin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bull Brand of Gemfibrozil' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bull Brand of Moclobemide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bull Brand of Paclitaxel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bulla' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullfrog' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullfrogs' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullhead Catfishes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Congenital Ichthyosiform Erythroderma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Dermatoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Erythroderma Ichthyosiforme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Lesion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Lesions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Mastocytoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Mastocytosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Pemphigoid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Skin Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bullous Skin Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide AstraZeneca Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Atlantis Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Farmacusi Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Grossmann Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Leo Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Roche Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Senosiain Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Sensitive Na K Cl Transporter Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumetanide Sensitive Na-K-Cl-Transporter Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bumethanide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunaftide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunaftine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunaphtide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunaphtine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle Branch Block' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle of His' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle, Atrioventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle, Medial Forebrain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle, Median Forebrain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle-Branch Block' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundle-Branch Blocks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundles of actin filaments %28%MICROFILAMENTS%29% and myosin-II that span across the cell attaching to the cell membrane at FOCAL ADHESIONS and to the network of INTERMEDIATE FILAMENTS that surrounds the nucleus.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundles, Atrioventricular' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundles, Medial Forebrain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bundles, Median Forebrain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bungarotoxins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bungarus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunion, Tailor%27%s' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunion, Tailors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunionette' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunionettes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunions' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunions, Tailor%27%s' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunolol %28%1973-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunostomiases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyamwera Group Viruses %28%1975-1980%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyamwera virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1979-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1980-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1981-1993%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1982-1995%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1983-1991%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1985-1989%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae %28%1991-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae Infections %28%1984-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyaviridae Infections %28%1993-1994%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyavirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyavirus Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bunyavirus Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buphenin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buphenine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buphthalmos' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bupivacain RPR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bupivacaine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bupivacaine Monohydrochloride, Monohydrate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bupleurum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bupranolol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buprenorphine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buprenorphine Gr%C3%%BC%nenthal Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buprex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bupropion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burden of Illness' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burden, Body' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burden, Dependency' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burden, Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burden, Viral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burdens, Body' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burdock Plant' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burdock, Greater' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burdock, Lesser' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burgess Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burials' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burimamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia %28%1996-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia %28%1998-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia Infection' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia Infections' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia cepacia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia cepacia %28%1999-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia cepacia complex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia cocovenenans' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia gladioli' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia mallei' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia pseudomallei' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderia solanacearum' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkholderiaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkina Faso' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkina Fasso' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt Herpesvirus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt Lymphoma Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt%27%s Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt%27%s Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt%27%s Lymphoma Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt%27%s Lymphoma/complications %28%1980-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitt%27%s Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitts Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitts Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitts Lymphoma Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burkitts Tumor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn Center' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn Unit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn Units' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn, Chemical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn, Electric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn, Eye' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burn, Inhalation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burnet' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burning Mouth Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burning Mouth Syndromes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burning Pain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burning Pains' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burningbush %28%Bassia%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burningbush %28%Euonymus%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burnishing, Dental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burnout, Professional' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns of the respiratory tract caused by heat or inhaled chemicals.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns produced by contact with electric current or from a sudden discharge of electricity.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns, Chemical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns, Electric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns, Electric %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns, Eye' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns, Inhalation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burns, Inhalation %28%1966-1988%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursa Dependent Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursa of Fabricius' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursa, Omental' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursa, Synovial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursa-Dependent Lymphocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursa-Dependent Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursal Agent, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursal Agents, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursal Disease Virus, Infectious' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursas, Synovial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursera' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burseraceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursitides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burst Forming Units, Erythroid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burst Promoting Factor, Erythrocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burst, Oxidative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burst, Respiratory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burst-Forming Unit, Erythroid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burst-Promoting Factor, Erythrocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursting of the STOMACH. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursts of depolarization that move from the stomach to the ileocecal valve at regular frequency during the interdigestive period. The complex and its accompanying motor activity periodically cleanse the bowel of interdigestive secretion and debris in preparation for the next meal.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursts, Oxidative' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bursts, Respiratory' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Burundi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buserelin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buserelin Aventis Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buserelin/analogs %26% derivatives %28%1984-1992%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bush Babies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bush Baby' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bush Clover' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bushmasters' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Business Coalition %28%Health Care%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Business Coalition %28%Healthcare%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Business Coalitions %28%Healthcare%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Business Ethics' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Business management of medical and dental practices that may include capital financing, utilization management, and arrangement of capitation agreements with other parties.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Businesses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buspirone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Busulfan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Busulfan GlaxoSmithKline Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Busulfan Orphan Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Busulfan Wellcome Brand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Busulphan' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butaclamol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butadienes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butadienes %28%1966-1978%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butadienes %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butadion' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butalitab' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanedioic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanediols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanes %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanimides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanoic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanoic Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanols %28%1980-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanols %28%1981-1997%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanones %28%1970-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanones %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butanones %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butapirazol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butaxamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butcher%27%s Broom' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butea' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buthionine Sulfoximine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butirosin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butirosin Sulphate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butirosins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butorphanol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butoxamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butoxide, Piperonyl' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butter Yellow' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butterbur' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butterflies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butters' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buttock' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buttocks' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyl 2 Cyanacrylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyl 2-Cyanacrylate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyl Alcohols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyl Methoxyphenol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyl Phthalate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylamines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylamines %28%1966-1976%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylamines %28%1966-1977%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylamines %28%1970-1971%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylamines %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylamines %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylated Hydroxyanisole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylated Hydroxytoluene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylbiguanide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylbutanolnitrosamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylene Glycols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylhydroxides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylhydroxyanisole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylhydroxybutylnitrosamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylhydroxytoluene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylmethyl Ketone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylscopolamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butylscopolammonium Bromide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrate Response Factor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1966-1972%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1968-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1972-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1973-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrates %28%1974-2003%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyric Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyric Acids' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyric Acids %28%1981-1998%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrivibrio' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrobetaine Hydroxylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrophenones' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrophenones %28%1966-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrophenones %28%1971-1974%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyryl CoA Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyryl Coenzyme A Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyryl Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyryl-CoA Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyryl-Coenzyme A Dehydrogenase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrylcholinesterase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Butyrylthiocholine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buxaceae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Buxus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'By Vertin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'By adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake %28%NUTRITIONAL SUPPORT%29%.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byelarus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byelorussian S.S.R.' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byelorussian SSR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Aminophylline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Astemizole' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Betaine Phosphate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Carbenoxolone Disodium Salt' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Flavoxate Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Levothyroxine Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Mesalamine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Brand of Noscapine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Gulden Brand of Allopurinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Gulden Brand of Betahistine Hydrochloride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byk Gulden Brand of Chlorpropamide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bylaw' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bylaws and Constitution' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass Surgery, Coronary Artery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Aortocoronary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Bilio-Pancreatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Biliopancreatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Cardiopulmonary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Coronary Artery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, EC-IC Arterial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Extracranial-Intracranial Arterial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Gastric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Gastroileal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Heart-Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Ileojejunal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Intestinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Jejuno-Ileal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Jejunoileal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Judicial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Left Heart' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Right Heart' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, Roux-en-Y Gastric' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypass, STA-MCA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Aortocoronary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Bilio Pancreatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Bilio-Pancreatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Biliopancreatic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Cardiopulmonary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Coronary Artery' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, EC-IC Arterial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Extracranial-Intracranial Arterial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Heart-Lung' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Ileojejunal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Intestinal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Jejuno-Ileal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Jejunoileal' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Left Heart' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, Right Heart' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bypasses, STA-MCA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byssinoses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byssinosis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bystander Effect' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Bystander Effects' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byzantine Empire' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'Byzantium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 1 Esterase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 283' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 3 Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 3 Nephritic Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 36278 Ba' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 4898, Asta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C 5b-9' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C C Chemokines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Chemokines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Disease, Hemoglobin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Diseases, Hemoglobin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP Homologous Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP Nuclear Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP Related Protein 2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP beta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBP delta Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBPalpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C EBPbeta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Fiber' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Fragment Endorphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Fragment, Lipotropin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Fragment, beta-Lipotropin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Oncovirus, Type' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Oncoviruses, Type' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Phycocyanin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Promotor Binding Factor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Reactive Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Section %28%OB%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Type Lectin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Type Lectins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C Type Natriuretic Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C elegans Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C%28%23%29%-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C%C3%%A9%fobis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Cathepsin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Desacetyldigilanide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Desacetyllanatoside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Deslanatoside' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Erythromycin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Glycosylphosphatidylinositol-Specific Phospholipase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Hemoglobin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Lysophospholipase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Medicare Part' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Poly' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, RNA Polymerase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Tf' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, Transferrin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, alpha-Lactalbumin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C, beta-Lactoglobulin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-10,11,14-16; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-12 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-13; NIM ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Acetyltransferase, Acetyl-CoA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Acyltransferase, Acetyl-CoA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-C Chemokines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-C Double Bond Isomerases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-C Fistula' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-C Fistulas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP Homologous Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP Nuclear Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP beta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP delta Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP, Nuclear Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP-Related Protein 2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBP-beta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBPalpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-EBPbeta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Form DNA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Fragment Endorphin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Palmitoyltransferase, Serine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Promotor-Binding Factor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Reactive Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Reactive Protein %28%1966-1986%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Section %28%OB%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Sections %28%OB%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Terminal Esterase, Ubiquitin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Terminal Hydrolase, Ubiquitin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Type Lectin' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Type Lectin Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Type Lectins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Type Natriuretic Peptide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-Type Protein HnRNP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C-X-C Chemokines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C.I. 20470' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C.I.20470' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 - DISEASES-BACTERIAL AND FUNGAL ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 4B, Sepharose' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 Esterase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 Esterase Inhibitor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 Host Cell Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 INH Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1 Inhibitor Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1-INH Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1-Inhibitor Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C10 - DISEASES-NEUROLOGIC ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C11 - DISEASES-OCULAR ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C11, Raclopride' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C12 - DISEASES-UROLOGIC AND MALE GENITAL ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C13 - DISEASES-FEMALE GENITAL AND PREGNANCY COMPLICATIONS%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C14 - DISEASES-CARDIOVASCULAR ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C15 - DISEASES-HEMIC AND LYMPHATIC ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C16 - DISEASES-CONGENITAL AND NEONATAL AND ABNORMALITIES ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C17 - DISEASES - DERMATOLOGIC AND CONNECTIVE TISSUE ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C18 - DISEASES-NUTRITIONAL AND METABOLIC ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C19 - DISEASES-ENDOCRINE ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1q Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1q, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1r Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1r, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1s Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C1s, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2 - DISEASES-VIRAL ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C20 - DISEASES-IMMUNE ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C21 - DISORDERS OF ENVIRONMENTAL ORIGIN ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C22 - DISEASES-ANIMAL ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C22-unsaturated fatty acids found predominantly in FISH OILS.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C23 - PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C283' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2a Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2a Fragment, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2a, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2b Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2b Fragment, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C2b, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 - DISEASES-PARASITIC ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Activator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 C5 Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertase %28%C3bBb%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertase %28%C4b2a%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertase Activator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertase, Alternative Pathway' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertase, Classical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Convertases, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Nephritic Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Precursor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Precursor, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Proactivator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3 Proactivator Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3-C5 Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3-C5 Convertases, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C36278Ba' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3G Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3H Mice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3H Mice, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3H Mouse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3H Mouse, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3PA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3PA Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3PAse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3a Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3a, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b C4b Inactivator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b Inactivator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b Inactivators' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b, Inactivated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3b-C4b Inactivator' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3bi' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3c Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3c Fragment, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3c, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3d Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3d Fragment, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3d Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C3d, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4 - DISEASES-NEOPLASMS ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4 Complement Component' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4a Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4a, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b C3b INA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b C3b Inactivator Cofactor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b-Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b-Binding Protein, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b-C3b Inactivator Cofactor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b-C3b Inactivator, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4b-C3b-INA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4bC3bINA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4bC3bINA Cofactor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C4bC3bINA-Cofactor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 - DISEASES-MUSCULOSKELETAL ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Cleaving Enzyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Convertase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Convertase %28%C3bBb3b%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Convertase %28%C4b2a3b%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Convertase, Alternative Pathway' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Convertase, Classical' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 Convertases, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 a, des Arg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 a, des Arginine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 a, des-Arg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 a, des-Arginine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5, Precursor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5, Precursor Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C57BL Mice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C57BL Mice, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C57BL Mouse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C57BL Mouse, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a des Arginine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a des-Arg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a des-Arginine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a, des Arg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a, des Arginine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a, des-Arg' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a, des-Arginine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5a, des-Arginine Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5b 8 poly C9' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5b Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5b, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5b-8-poly-C9' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C5b-9' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C6 - DISEASES-DIGESTIVE ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C6 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C6, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C7 - DISEASES-STOMATOGNATHIC ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C7 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C7, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C8 - DISEASES-RESPIRATORY ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C8 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C8, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C9 - DISEASES-OTORHINOLARYNGOLOGIC ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C9 Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'C9, Complement' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 125 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 15 3 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 15-3 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 15.3 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 19 9 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 19-9 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA 19.9 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA I Hiroshima 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA%28%Oxford%29% Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA-125 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA-15-3 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA-15-3, Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA-19-9 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CA-19-9, Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAAT Box Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAAT Enhancer Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAAT Enhancer Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAAT-Enhancer Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAAT-Enhancer-Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAB' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAB-63' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CABP-P14' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CABP-P8' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CADASIL' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CADTK Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAEV' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAF20 Gene Product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAIV-T vaccine' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALAMUS ROOT see ACORUS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALCIPHYLAXIS was heading 1965-83 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALCIUM CHANNELS located in the neurons of the brain. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALCIUM CHANNELS located in the neurons of the brain. They are inhibited by the marine snail toxin, omega conotoxin MVIIC.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALCIUM CHANNELS located within the PURKINJE CELLS of the cerebellum. They are involved in stimulation-secretion coupling of neurons.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALCIUM CHANNELS that are concentrated in neural tissue. Omega toxins inhibit the actions of these channels by altering their voltage dependence.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALCIUM-BINDING PROTEINS is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALISTHENICS was see under GYMNASTICS 1963-82 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALL Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA Positive Lymphoblastic Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA-Positive Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA-Positive Leukemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA-Positive Lymphoblastic Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA-Positive Lymphoblastic Leukemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA-Positive Lymphocytic Leukemia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CALLA-Positive Lymphocytic Leukemias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAMAS see CAMASSIA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAMP Phosphodiesterase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAP hydrolyzing Enzyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAP-hydrolyzing Enzyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAP102 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAPD' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAPSID PROTEINS is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAPSID is also available; see SCR for many organism-specific VP numbered proteins%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAPTS gene product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CARBON DIOXIDE/blood is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CARBOXYLASES was see under CARBOXY-LYASES %26% LIGASES 1964-74, was heading 1963; CARBAMYL PHOSPHATE SYNTHASE %28%AMMONIA%29% %26% CARBAMYL PHOSPHATE SYNTHASE %28%GLUTAMINE%29% were see under PHOSPHOTRANSFERASES, ATP 1975-80%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CARDIOSPASM refers to spasm of the CARDIA, not the heart; not for esophageal spasm %28% = ESOPHAGEAL SPASM, DIFFUSE%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CARDUUS MARIANUS see MILK THISTLE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAS Export Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CASP1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CASPASE 1 is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CASR Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CASSIA SENNA; CASSIA ANGUSTIFOLIA and CASSIA OCCIDENTALIS see SENNA PLANT are also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 1 Transport Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 1 Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 2 Gene Product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 2 Transport Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 2 Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 2A Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT 2B Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Enzyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scan, Radionuclide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scan, X Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scan, X-Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scanner, X Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scanner, X-Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scanners, X Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scanners, X-Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scans, Radionuclide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT Scans, X-Ray' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT%27%S CLAW is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-1 Transport Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-1 Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-2 Gene Product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-2 Transport Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-2 Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-2A Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAT-2B Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: use NAF entry ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Do not use for current materials. ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use NAF entry ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use for annotated bibliographies. Do not also use publication type BIBLIOGRAPHY. Do not use for meeting abstracts. Use instead publication type CONGRESSES%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use for background material on diseases and other topics written for a nursing audience, which do not include specific nursing procedures. For works which include nursing procedures, use instead an appropriate main heading qualified by the topical subheading nursing, or coordinate with the main heading NURSING CARE or another appropriate nursing term%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use for collections of illustrative plates, charts, etc. and for items in which there are both illustrations and text, even when the text predominates, when the purpose of the text is to explain the illustrations. Do not use for geographic atlases or maps. Use instead the publication type MAPS.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use for single as well as for collections of autobiographical accounts and personal reminiscences. Do not use the main heading AUTOBIOGRAPHY, which is used only for works about AUTOBIOGRAPHY%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use when 20%25% or more of the content consists of statistical data. If presented in tabular form use also TABLES %5B%PUBLICATION TYPE%5D%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: Use when 20%25% or more of the content is presented in tabular form. For statistical data presented in tabular form use also the publication type STATISTICS%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: do not use ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: do not use for current materials ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: use NAF entry ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: use NAF entry for specific work ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: use for original publications only. Use COLLECTED WORKS %5B%PUBLICATION TYPE%5D% for collections of previously published papers%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CATALOG: use when 20%25% or more of the content consists of the text of laws, statutes, ordinances, or government regulations. Do not use for works that are merely discussion of law, etc%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CAVH' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB 1348' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB 154' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB1 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB1348' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB154' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CB2, Cannabinoid Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBA 93626' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBA Mice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBA Mice, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBA Mouse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBA Mouse, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBA93626' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBDCA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF A Protein, CCAAT Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF B Protein, CCAAT Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF C Protein, CCAAT Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF Protein, CCAAT Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF Protein, CCAAT-Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF-A Protein, CCAAT-Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF-B Protein, CCAAT-Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBF-C Protein, CCAAT-Binding' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFA 1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFA-1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFA1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFA3 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFB Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFalpha Runt Domain Transcription Factor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBFalpha1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBL E3 Ubiquitin Protein Ligase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP, Nuclear Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP-30' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP-35' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP20 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP3 %28%Liver%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP35' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CBP80 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CC' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CC Chemokine Receptor 5' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CC Chemokines' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CC-CKR5' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Binding Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Binding Factor, A Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Binding Factor, B Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Binding Factor, C Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Binding Protein, CP1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Binding Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Enhancer Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Enhancer Binding Protein alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Enhancer Binding Protein beta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Enhancer Binding Protein delta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Enhancer Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Sequence Specific DNA Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT Sequence-Specific DNA-Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding CBF Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding CBF-A Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding CBF-B Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding CBF-C Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding Protein, CP1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Binding-Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Enhancer-Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Enhancer-Binding Protein-alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Enhancer-Binding Protein-beta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Enhancer-Binding Protein-delta' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCAAT-Enhancer-Binding Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCCP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK %28%30-33%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK 4 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK 8 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK A Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK B Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK B Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK%28%1%29% Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK-4' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK-8' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK-A Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK-B Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK-B Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK-OP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCK2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCL2' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCND1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCR5 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCR5 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCl4 Poisoning' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CCl4 Poisonings' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 120a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 120b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 16 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 21 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 23 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 32 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 35 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD 64 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD-I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD-ROM' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD1 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD1 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD10 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD10 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD104 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD104 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD106 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD106 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD107a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD107a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD107b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD107b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD115 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD115 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD116 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD116 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD117 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD117 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11c Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD11c Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD120a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD120a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD120b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD120b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD122 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD124 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD124 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD126 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD126 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD127 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD13 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD13 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD130 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD135 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD135 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD14 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD14 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD14 Monocyte Differentiation Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD140a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD140a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD140b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD140b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD142 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD143 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD146 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD146 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD147 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD147 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD15 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD15 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD154 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD154 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD16 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD164 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD164 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD166 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD18 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD18 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD19 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD19 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD2 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD2 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD20 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD20 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD21 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD21 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD22 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD22 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD22 Glycoprotein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD23 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD23 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD24 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD24 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD24, Heat-Stable Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD25 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD25 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD26 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD26 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD27 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD27 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD28 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD28 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD29 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD29 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD3 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD3 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD3 Complex' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD30 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD30 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD30 Positive Anaplastic Large Cell Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD30+ Anaplastic Large Cell Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD30+ Anaplastic Large-Cell Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD30-Positive Anaplastic Large-Cell Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD31 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD31 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD34 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD34 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD35 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD35 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD36 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD36 Antigen %28%Collagen Type I Receptor, Thrombospondin Receptor%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD36 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD36 Fatty Acid Transporter' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD36 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD38 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD38 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD38, ADPR Cyclase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 CD8 Ratio' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Cell Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Cell Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 IgG' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Immunoadhesins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Lymphocyte Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Lymphocyte Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Molecule' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Positive T Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Positive T Lymphocytopenia, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Receptor, Surface' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4 Receptors, Surface' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ Cell Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ Cell Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ Count' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ Counts' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ T Lymphocytopenia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ T Lymphocytopenia, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ T-Lymphocytopenia' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ T-Lymphocytopenia, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4+ T-Lymphocytopenias' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-CD8 Ratio' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-CD8 Ratios' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-Positive Lymphocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-Positive Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-Positive T-Lymphocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-Positive T-Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-Positive T-Lymphocytopenia, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. These include naturally occurring CD4+CD25+ Treg cells, IL-10 secreting Tr1 cells, and Th3 cells.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40 Ligand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40 Receptor Associated Factor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40 Receptor-Associated Factor 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40L' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD40bp Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD41 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD41 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD41 Cell Surface Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD42a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD42a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD42b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD42c Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD42d Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD43 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD43 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD44 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD44 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD45 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD45 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD45R0 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD46 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD46 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD47 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD47 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD47, Thrombospondin-1 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49a-CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49b CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49b-CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49c Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49c Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49c-CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49d Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49d Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49d-CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49e Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49e Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49f Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49f Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49f CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD49f-CD29' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD5 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD5 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD51 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD51 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD54 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD54 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD55 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD55 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD56 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD56 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD57 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD57 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD58 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD58 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD59 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD59 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD6 Ligand' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD61 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD61 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD62E Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD62E Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD62L Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD62L Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD62P Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD62P Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD66e Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD66e Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD7 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD7 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD73 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD73 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD79 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD79 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD79a Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD79a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD79b Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD79b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8 Positive Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8 Positive T Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8-Positive Lymphocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8-Positive Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8-Positive T-Lymphocyte' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD8-Positive T-Lymphocytes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD80 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD80 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD82 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD82 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD86 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD86 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD88 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD88 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD90 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD90 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD94 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD94 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD94, Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD95 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD95 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Antigen Heavy Chain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Antigen Light Chain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Antigens Heavy Chain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Antigens Light Chain' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CD98 Transport Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2 CDC28 Kinases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2 Protein Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2 Related Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2 Related Kinases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2+ CDC28 related Protein Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2+-CDC28-related Protein Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2-CDC28 Kinases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC2-Related Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC28 Protein Kinase, S cerevisiae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC28 Related Kinases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC28 protein, S cerevisiae' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC33 Gene Product' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC42 GTP-BINDING PROTEIN is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDC42 GTP-BINDING PROTEIN, SACCHAROMYCES CEREVISIAE is also available%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDF Rat, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDF Rats, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK Inhibitor p27' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK Inhibitor, p27' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK2 Associated Protein 20 kDa' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK2 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK2-Associated Protein 20 kDa' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK4 Inhibitor, p15' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK6 Associated Protein p18' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK6 Inhibitor, p18' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK6 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK6-Associated Protein p18' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDK9 Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKI Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKI Proteins, CIP-KIP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKI Proteins, INK4' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN1A Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN1B Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN1C Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2 Gene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2 Genes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2A Gene' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2A Genes' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2A Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2B Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2C Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN2D Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDKN4 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP 1,2 Diacyl sn Glycerol Myoinositol 3 Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Choline' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Choline 1,2 Diglyceride Choline Phosphotransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Choline Cholinephosphotransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Choline Synthetase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP DG Inositol Transferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP DG Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerol Inositol 3 Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerol Myo Inositol 3 Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerol Serine O Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerol Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerol-Serine O-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diacylglycerols' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diglyceride Inositol Transferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diglyceride Inositoltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diglyceride Serine O Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diglyceride Serine O-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP Diglycerides' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-1,2-Diacyl-sn-Glycerol-Myoinositol 3-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Choline 1,2-Diglyceride Choline Phosphotransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Choline Cholinephosphotransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Choline Synthetase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-DG Inositol Transferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-DG Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Diacylglycerol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Diacylglycerol Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Diacylglycerol-Myo-Inositol 3-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Diglyceride-Inositol Transferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDP-Diglyceride-Inositoltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDPdiacylglycerol Inositol 3 Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDPdiacylglycerol Serine O Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDPdiacylglycerol-Inositol 3-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDPdiacylglycerol-Serine O-Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDPdiglyceride Inositol Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDPdiglyceride-Inositol Phosphatidyltransferase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDRK Potassium Channel' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDROM' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw121a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw121b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw124 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw128a Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw128b Antigens' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw29 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CDw40 Antigen' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEJ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEL1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus %28%CRICETULUS%29%. The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen %28%ANTIGENS, POLYOMAVIRUS TRANSFORMING%29%. They are used for transfection and cloning. %28%The CV-1 cell line was derived from the kidney of an adult male African green monkey %28%CERCOPITHECUS AETHIOPS%29%.%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELLULASE is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELLULASES is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELO Virus' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELO Viruses' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CELSS' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEMETERIES %26% CREMATION were see under MORTUARY PRACTICE 1963-78%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CENP B Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CENP-B Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CENTROPHENOXINE was see under ACETIC ACIDS 1968-74 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEO, Hospital' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEPA Brand of Penicillin G Sodium' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEPA Brand of Streptomycin Sulfate' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CEPA Brand of Testosterone' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CERM 1978' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CERM1978' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CERVIX HYPERTROPHY was heading 1963-96 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CF1 ATPase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFL1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFL2 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFTR Mice' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFTR Mice, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFTR Mouse' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFTR Mouse, Inbred' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFTR Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CFU-E' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CG Antigen Specific Helper Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CG alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CG-alpha' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGP 14221 E' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGP 2175' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGP 7174 E' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGP14221E' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGP2175' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGP7174E' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGRP Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGRP Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGS 16949A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CGS16949A' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CH 13437' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CH%28%50%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CH13437' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CH50 Assay' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CH50 Assays' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHAGAS CARDIOMYOPATHY is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHICAGO is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHILDBIRTH at the end of a normal duration of PREGNANCY, between 37 to 40 weeks of gestation or about 280 days from the first day of the mother%27%s last menstrual period.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHILDBIRTH before 37 weeks of PREGNANCY %28%259 days from the first day of the mother%27%s last menstrual period, or 245 days after FERTILIZATION%29%.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHINACRIN was see QUINACRINE 1977-93 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHINIOFON was heading 1963-82 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHINIOFON, DIIODOHYDROXYQUIN, IODOCHLORHYDROXYQUIN %26% CHLORQUINALDOL were headings 1963-82%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHIP28 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHLOROMERCURIBENZOATES is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adv eff-pois-tox was CHLOROTHIAZIDE TOXICOLOGY 1963-65%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHLORTHIZIDE was see CHLOROTHIAZIDE 1977-95; /adverse effects /poisoning /toxicity were CHLOROTHIAZIDE TOXICOLOGY 1963-65%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHO Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHO Cells' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHO stands for %22%Chinese Hamster Ovary%22%; almost always NIM with no subheadings; check ANIMALS %26% add HAMSTERS, CHINESE %28%NIM%29%; do not routinely add OVARY%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOLATES is available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOLECYSTOLITHIASIS and CHOLEDOCHOLITHIASIS are also available%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOLESTANES substituted with any number of keto groups.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOLESTENES with one or more double bonds and substituted by any number of keto groups.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOLIC ACIDS is available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHONDROITIN LYASES is available; DF: CHONDROITINASES ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOP, Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHOREA is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHRONIC CYSTIC MASTITIS see FIBROCYSTIC BREAST DISEASE is also available; MASTITIS, BOVINE is also available%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHRYSANTHEMUM PARTHENIUM see TANACETUM PARTHENIUM is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CHUK Kinase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 52040' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 581' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 628' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 634' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 716' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 719' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 825' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 888' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 898' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI 919' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI52040' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI581' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI628' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI634' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI716' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI719' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI825' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI888' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI898' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CI919' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIBA-34,647-BA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIBA34,647BA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIDP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIP KIP CDKI Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIP KIP CKI Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIP KIP Cyclin Dependent Kinase Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIP-KIP CDKI Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIP-KIP CKI Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIPC' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIRCULAR DNA that is interlaced together as links in a chain. It is used as an assay for the activity of DNA TOPOISOMERASES. Catenated DNA is attached loop to loop in contrast to CONCATENATED DNA which is attached end to end.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CIS Nations' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CISTERNA CHYLI was see under THORACIC DUCT 1963-78 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJD' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJD %28%Creutzfeldt Jakob Disease%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJD %28%Creutzfeldt-Jakob Disease%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJD Variant %28%V CJD%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJD Variant %28%V-CJD%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJD Variants %28%V-CJD%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CJDs %28%Creutzfeldt-Jakob Disease%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKI Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKI Proteins, CIP-KIP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKI Proteins, INK4' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKK 2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKK-2 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKK-4' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKR5 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CKRAS Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 11366' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 118532' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 13900' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 232325' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 297939' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 395' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 67,772' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL 71,563' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL11366' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL118532' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL13900' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL232325' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL297939' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL395' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL67,772' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CL71,563' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CLAIRVOYANCE was see under PARAPSYCHOLOGY 1965-78; EXTRASENSORY PERCEPTION %26% PSYCHICAL RESEARCH were see under PARAPSYCHOLOGY 1963-78%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CLL Lymphoplasmacytoid Lymphoma' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CLL Lymphoplasmacytoid Lymphomas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMC Brand of Iodoquinol' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CME Carbodiimide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CME-Carbodiimide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMEC' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMHC' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP Acetylneuraminic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP N Acetylneuraminic Acid Synthetase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP Sialate Pyrophosphorylase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP Sialate Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP Sialic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP Sialic Acid Synthetase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP, Cyclic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP-N-Acetylneuraminic Acid Synthetase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP-NANA' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP-Sialic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CMP-Sialic Acid Synthetase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CN-55945-27' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNP-22' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNPase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNQX' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Autoimmune Demyelinating Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Demyelinating Autoimmune Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Depressants' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Disease' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Diseases' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Disorder, Intracranial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Disorders, Intracranial' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Hypersomnolence, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Hypersomnolences, Idiopathic' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Infection, Viral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Infections, Viral' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Metabolic Disorder' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Metabolic Disorders' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Metabolic Disorders, Acquired' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Metabolic Disorders, Inborn' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitides, HIV-1-Associated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitides, HIV-Associated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitis' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitis, HIV Associated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitis, HIV-1-Associated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitis, HIV-Associated' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitis, Primary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS Vasculitis, Secondary' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS agents; from Greek nous, mind; GEN or unspecified: prefer specifics%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNS depressants; GEN: prefer specifics; DF: HYPNOTICS ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNTF' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CNTF Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COAD' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COCAINE DERIVATIVES was see under COCAINE 1975-77; was see under TROPANES 1969-74%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COCHLEAR DUCT was DUCTUS COCHLEARIS see under LABYRINTH 1963-78; BASILAR MEMBRANE was see under LABYRINTH 1960-89%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CODEINE DERIVATIVES was see under CODEINE 1975-77, was see under MORPHINANS 1969-74%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COLCHICINE is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COLONY-STIMULATING FACTORS prepared by recombinant DNA technology.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COMBAT DISORDERS is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COMMUNITY MENTAL HEALTH SERVICES %26% specifics are also available; Public Laws 89-105 %26% 89-164; DF: MENTAL HEALTH SERV%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COMMUNITY PHARMACIES was see under PHARMACIES 1968-78 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CONFERENCES was see under CONGRESSES 1963-77 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CONFORMAL RADIOTHERAPY that combines several intensity-modulated beams to provide improved dose homogeneity and highly conformal dose distributions.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CONGLUTINATION REACTION was heading 1975-96 %28%see under COMPLEMENT FIXATION TESTS 1975-90%29%; COMPLEMENT ABSORPTION TEST, CONGLUTINATING was see CONGLUTINATION REACTION 1992-96%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CONTOUR PERCEPTION was see under FORM PERCEPTION 1970-78 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CONTRACT SERVICES is also available ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COP Coated Vesicles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COP-1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COP-Coated Vesicle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COP-Coated Vesicles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COP-I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPD' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPI' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPI Coated Vesicles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPI Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPI-Coated Vesicle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPII Coated Vesicles' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COPII-Coated Vesicle' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CORNS was heading 1975-92 %28%see under CALLOSITIES 1975-90%29%%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CORYNANTHIDINE, RAUWOLSCINE %26% YOHIMBINE DERIVATIVES were see under YOHIMBINE 1975-77, were see under YOHIMBANS 1969-74%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COS 1 Cells' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COS 7 Cells' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COS Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COS Cells' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COS-1 Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COS-7 Cell' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUMARINS with an amino group, exemplified by NOVOBIOCIN.%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP TF Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP TFI Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP TFII Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP Transcription Factor I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP Transcription Factor II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP Transcription Factors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP-TF Proteins' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP-TFI Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COUP-TFII Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX 1 Prostaglandin Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX 2 Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX 2 Prostaglandin Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX-1 Prostaglandin Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX-2 Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX-2 Prostaglandin Synthase' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'COX2 Inhibitors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP %28%Cerebral Palsy%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 12,574' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 12574' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 15,467 61' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 16171' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 45899' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 62993' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 89044' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP 90033' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP Brand of Ursodeoxycholic Acid' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP Synthase I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP-12574' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP1 CCAAT-Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP12,574' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP12574' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP15,46761' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP16171' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP45899' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP62993' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP89044' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CP90033' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPAP Ventilation' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPEO' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPITN' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPK-MB, Isoenzyme' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPM Therapies' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPM Therapy' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPOE' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPR' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPRS Type I' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPRS Type Is' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF 100 kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF 160 kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF 30 kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF 30K' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF 73 kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF-100-kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF-160-kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF-30-kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPSF-73-kDa Subunit' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPT Code' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CPT II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CR1 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CR2 Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CR3 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CR4 Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRAF1 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRD 401' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRD401' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRE BPa Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRE Binding Protein 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRE-BPa Transcription Factor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRE-Binding Protein 1' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CREB Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CREB Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CREB-Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CREST Syndrome' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CREST syndrome: an acronym for Calcinosis, Raynaud phenomenon, Esophageal dysfunction, Sclerodactyly, Telangiectasis%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRF Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRF Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRF-41' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRH Receptor' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRH Receptors' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRIBRIFORM PLATE was see under ETHMOID BONE 1963-78 ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRKI Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRKII Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRP2 Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRPPP' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRPS %28%Complex Regional Pain Syndromes%29%' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRPS Type II' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CRUVEILHIER-BAUMGARTEN SYNDROME was heading 1975-96 %28%see under HYPERTENSION, PORTAL 1979-90, see under LIVER CIRRHOSIS 1975-78%29%; was see under LIVER CIRRHOSIS 1963-74%A% ' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CS 1170' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CS 514' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CS Brand of Desonide' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CS Tear Gas' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CS1170' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CS514' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CSAID Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CSAID-Binding Protein' = 0).
% 42.08/42.00 fof(interp, fi_functors, 'CSBP, Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSC Brand of Benzydamine Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSE1L Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF Recombinant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF-1 Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF-1 Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF-GM' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSF-M' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSIF-10' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSL Brand of Benzathine Benzylpenicillin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSL Brand of Carbenicillin Disodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSL Brand of Methicillin Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSL Brand of Penicillin G Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSL Brand of Ticarcillin Disodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSP Brand of Flucytosine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSP Brand of Fluorouracil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CSP Brand of Nitrazepam' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT 1341' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT Colonography' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT X Ray' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT X Rays' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT, Cholera Enterotoxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT, Helical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT, Spiral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT, Spiral Volumetric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT10 Regulator of Kinase Oncogene Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT10 Regulator of Kinase Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CT1341' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTG, Antepartum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTLA-8' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTP' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTP Phosphocholine Cytidylyl Transferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTP Phosphocholine Cytidylyl- Transferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTP Phosphocholine Cytidylyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTP Phosphorylcholine Cytidyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTX Toxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTs, Helical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTs, Spiral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CTs, Spiral Volumetric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CURARIFORM ANTAGONISTS was heading 1963-69 ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CURLING%27%S ULCER was heading 1975-96 %28%see under DUODENAL ULCER 1975-90%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CV 705' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CV705' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CVA %28%Cerebrovascular Accident%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CVAs %28%Cerebrovascular Accident%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CVFBb' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CX3C Chemokines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXC Chemokine Receptor 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXC Chemokine Receptor 2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXC Chemokines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR1 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR1 Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR1 Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR2 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR2 Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR4 Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CXCR4 Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CY 116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CY-216' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CY116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CY216' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYCLOPENTANES is also available ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYCLOPLEGICS was heading 1963-78 ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYCLOTRONS %26% SYNCHROTRONS are also available ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYNANCHUM INDICUM see TYLOPHORA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 11A1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 11B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 11B2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 19' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 1A1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 1A2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 2B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 2D6' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 2E1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 7' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP 7A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP IIE1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP101' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP11A1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP11B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP11B2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP17' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP19' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP19 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP1A1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP1A1 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP1A2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP1A2, Cytochrome P-450' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP27B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP2B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP2D6' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP2D6, Cytochrome P-450' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP2E1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP3A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP4A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP4A, Cytochrome P-450' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP7' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP73, Trans-Cinnamate 4-Monooxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP7A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYP8B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYPIIE1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYPRUS; MALTA; %26% SICILY are available; for Corsica, coord with FRANCE; for Crete, coord with GREECE%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66 ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca DTPA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca Mg ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca Mg-ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca Release Channel Ryanodine Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca Release Channel-Ryanodine Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca Sensing Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29% Mg%28%2+%29%-ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29% Mg%28%2+%29%-ATPase %28%1989-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29% Mg%28%2+%29%-ATPase %28%1989-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1973-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1994-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1995-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Calmodulin Dependent Protein Kinase %28%1996-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Na%28%+%29% Antiporter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Na%28%+%29% Exchanger' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Transporting ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca%28%2+%29%-Transporting ATPase %28%1986-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca-37-39, 41, 45, 47, 49, 50; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca-40; /antag permitted but consider also CALCIUM CHANNEL BLOCKERS; /blood: note see related terms; /defic: consider also HYPOCALCEMIA %26% note that CALCIUM, DIETARY is also available; /metab: consider also CALCIUM CHANNELS %26% CALCIUM PUMP: see CA%28%2+%29%-TRANSPORTING ATPASE; metab disord = CALCIUM METABOLISM DISORDERS; CALCIUM SIGNALING is available for calcium mobilization in the context of signal transduction%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca-42-44, 46, 48; NIM ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca-Sensing Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca-Sensing Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+ ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+ Activated K+ Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+ Activated Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+ Mg2+ ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+ Sensing Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+-Activated K+ Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+-Activated Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+-Mg2+ ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ca2+-Sensing Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CaATP' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CaDTPA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CaNa DTPA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CaNa-DTPA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cabbage, Skunk' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cabbages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cabin Ecologies, Sealed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cabin Ecology, Sealed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cacajaos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cacao' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cacatuidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cachectin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cachectin Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cachectin Tumor Necrosis Factor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cachectin-Tumor Necrosis Factor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cachexia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caco 2 Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caco stands for adenoCArcinoma of the COlon; almost always NIM with no subheadings; check HUMAN; do not routinely add ADENOCARCINOMA or COLONIC NEOPLASMS%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caco-2 Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caco-2 Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cacodylic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cacosmias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cactaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cactus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadaver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadaverine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadavers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cade' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadherin Associated Protein 102 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadherin-Associated Protein 102 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadherins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadherins, Desmosomal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium %28%1966-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium %28%1980-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium 2,3 Dimercaptopropanol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium Chloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium Compounds' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium Dichloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium Poisoning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium Poisonings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cadmium Radioisotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caenorhabditis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caenorhabditis %28%1979-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caenorhabditis elegans' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caenorhabditis elegans Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caerulein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caerulein Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caeruloplasmin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caesalpinia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caesarean Section' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caesarean Sections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cafe au Lait Spots' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cafe-au-Lait Spot' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cafe-au-Lait Spots' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caffea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caffeic Acids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caffeine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caffeine Demethylase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caffey De Toni Silvermann Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caffey-De Toni-Silvermann Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cage, Tissue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cages, Tissue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Amiloride Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Amitriptyline Embonate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Anthralin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Diflunisal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Finasteride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Flavoxate Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Fluorescein Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Glutaral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Meptazinol Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Methyldopa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Midodrine Monohydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Nevirapine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cahill May Roberts Brand of Sulindac' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caiman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cain Acridine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cain%27%s Acridine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cains Acridine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caisson Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caisson Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cajal Accessory Bodies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cajanus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cajuput' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calabar Bean' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calamus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcaneal Spur' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcaneal Spurs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcaneus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcidiol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcidiol 1 Monooxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcidiol 1-Monooxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifediol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifediol Aventis Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifediol Faes Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifediol Organon Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calciferol Binding Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calciferol-Binding Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calciferols' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcific Scleroses, Medial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcific Sclerosis, Medial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification of Posterior Longitudinal Ligament' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification, Dental Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification, Pathologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification, Physiologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification, Physiological' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification, Teeth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcification, Tooth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifications, Dental Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifications, Teeth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifications, Tooth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifying Odontogenic Cyst' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcifying Odontogenic Cysts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcimedin 35 alpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcimedin 67 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcimedin 67-kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcimedins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcimycin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcineurin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcinoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcinosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcinosis %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcinosis %28%1969-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcinosis %28%1975-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calciol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calciphylaxes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calciphylaxis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene Related Peptide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene Related Peptide I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene Related Peptide II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene Related Peptide Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene Related Peptide Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene-Related Peptide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Gene-Related Peptide Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin gene-related peptide. A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin%28%1-32%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin, Eel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitonin-Gene Related Peptide Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitrin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Abbott Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Alphapharm Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Cryopharma Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Galderma Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Gry Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Jenapharm Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol KyraMed Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Leo Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Medice Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Nefro' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol RenaCare Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcitriol Roche Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CalcitriolNefro' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1966-1967%29% /antagonists %26% inhibitors %28%1968-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1972-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1974-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1978-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium %28%1979-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Activated Neutral Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Activated Neutral Proteinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Activated Phospholipid Dependent Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Activated Potassium Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Activated Potassium Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Activated Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Adenosine Triphosphatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Adenosinetriphosphatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Antagonists, Exogenous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Bilirubinate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Binding Myeloid Protein P8,14' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Binding Protein 3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Binding Protein, Vitamin D Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Binding Protein, Vitamin K Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Binding Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Blockaders, Exogenous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Carbimide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Carbonate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel %28%T-Type%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Activators' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Agonist' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Agonists' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Agonists, Exogenous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Antagonist Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Antagonist Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Blocker Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Blocker Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Blockers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Blockers %28%1982-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel Blocking Drugs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel, L-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel, N-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel, P-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel, Q-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel, R-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channel, T-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1988-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1989-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1989-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1990-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1991-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1992-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1993-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels %28%1994-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, L Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, L-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Long-Lasting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, N Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, N-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Neural-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, P Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, P-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Purkinje-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Q Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Q-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, R Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, R-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, T Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, T-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Transient-Type' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Channels, Voltage-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Chloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Chloride, Anhydrous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Citrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Citrates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Compounds' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Cyanamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Cyanamide, Citrated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Dependent Activator Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Dependent Neutral Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Dependent Neutral Proteinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Dependent Protein Tyrosine Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Dependent Regulator' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Diphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Disodium Edetate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Dobesilate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Fluoride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Folinate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Gluconate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Hydroxide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Hydroxyapatite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Inhibitors, Exogenous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Ion Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Ion Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Iopodate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Isotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Leucovorin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Magnesium ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Magnesium Adenosine Triphosphatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Magnesium Adenosinetriphosphatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Metabolism Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Metabolism Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Milk' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Oscillation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Oscillations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Oxalate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Oxalate Dihydrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Oxalate Monohydrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Phosphates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Phospholipid Dependent Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Phospholipid-Dependent Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Puff' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Pump' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Pyrophosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Radioisotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Ryanodine Receptor Complex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt Bilirubin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt Chlortetracycline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt Cyanamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt Glycine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt Ibuprofen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt, Cystamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Salt, Niacin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sensing Peptides, Intracellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sensing Proteins, Intracellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sensing Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sensing Receptor Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sensing Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Signaling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Signalings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sodium Antiporter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sodium Carrier' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sodium Exchanger' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Spike' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sulfate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sulfate, Dihydrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Sulphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium Wave' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium and Phospholipid Binding Protein p68' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium and Phospholipid-Binding Protein p68' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Dietary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Dobesilate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Docusate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Doxycycline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Fenoprofen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Nadroparin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Nedocromil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Novobiocin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Oxytetracycline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium, Saccharin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-ATPase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated K+ Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated Neutral Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated Neutral Proteinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated Phospholipid-Dependent Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated Potassium Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated Potassium Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Activated Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Myeloid Protein P8,14' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Protein, Vitamin D-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Protein, Vitamin K-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Protein-3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1980-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1980-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1982-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1984-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1986-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1986-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1989-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1989-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1990-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1991-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1991-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Binding Proteins %28%1991-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Calmodulin Dependent Protein Kinases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Dependent Activator Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Dependent Neutral Protease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Dependent Neutral Proteinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Dependent Protein Tyrosine Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Dependent Regulator' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Ryanodine Receptor Complex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensing Peptides, Intracellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensing Proteins, Intracellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensing Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensing Receptor Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensing Receptor, Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensing Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sensor Proteins, Neuronal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sodium Antiporter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sodium Carrier' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-Sodium Exchanger' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium-binding motifs composed of two helixes %28%E and F%29% joined by a loop. Calcium is bound by the loop region. These motifs are found in many proteins that are regulated by calcium.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium/metab %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium/metabolism %28%1981-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calcium/physiology %28%1981-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculation, Computer-Assisted Dosimetry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculations, Computer-Assisted Dosimetry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculator, Programmable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi in any part of the urinary tract. According to their composition or pattern of chemical composition distribution, urinary calculi types may include alternating or combination, cystine, decubitus, encysted, fibrin, hemp seed, matrix, mulberry, oxalate, struvite, urostealith, and xanthic calculi.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi occurring in a salivary gland. Most salivary gland calculi occur in the submandibular gland, but can also occur in the parotid gland and in the sublingual and minor salivary glands.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi occurring in the KIDNEY. Calculi too large to pass spontaneously range in size from 1 cm to the staghorn stones that occupy the renal pelvis and calyces.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi of the ureter, usually the result of the passage of one originating in the kidney. It occurs usually in mid-life, rarely in children; and is more frequent in males than females. %28%From CMIT, 5th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi of the urinary bladder; also known as vesical calculi or bladder stones, and cystoliths.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Biliary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Bladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Renal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Salivary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Salivary Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Salivary Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Ureteral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Urinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculi, Vesical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Bladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Renal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Salivary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Salivary Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Salivary Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Ureteral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Urinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calculus, Vesical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calelectrin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calelectrin 32 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calelectrin 32-kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calelectrin 67 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calelectrin 67-kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calendula' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calf Pneumonia, Enzootic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calf Thymus Ribonuclease H' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calgranulin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calgranulin A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calgranulin B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calibration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calibrations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calice, Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calices, Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caliciviridae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caliciviridae %28%1975-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caliciviridae %28%1978-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caliciviridae %28%1991-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caliciviridae Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caliciviridae Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calicivirus Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calicivirus Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calicivirus, Feline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California Encephalitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California Encephalitis Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California Group Viruses %28%1975-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California Viral Encephalitides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California Viral Encephalitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'California encephalitis virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Californium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Californium. A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calisthenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calix%28%n%29%Arenes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calixarene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calixarenes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Call, House' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calla Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calleja Islands' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calleja Islets' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callicarpa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callicrein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callilepis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callimico' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callimicos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callithricidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callithricidae %28%1975-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callithrix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callitrichidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callitrichidae %28%1977-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callitrichinae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callosities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callosity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callosum, Corpus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callosums, Corpus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callotases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calls, House' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calluna' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callus, Bony' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Callyspongia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calm X' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmette Guerin Bacillus Vaccine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmette Vaccine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmette%27%s Vaccine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmette-Guerin Bacillus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmettes Vaccine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin Binding Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin Dependent Phosphodiesterase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin Dependent Protein Kinases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin-Binding Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin-Binding Proteins %28%1986-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin-Binding Proteins %28%1986-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin-Binding Proteins %28%1993-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin-Dependent Protein Kinases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calmodulin-Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calnexin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calophyllum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caloric Intake' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caloric Nystagmus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caloric Restriction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caloric Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caloric Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetric Differential Thermal Analysis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetries, Indirect' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetries, Respiration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetry %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetry, Differential Scanning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetry, Indirect' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calorimetry, Respiration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calotropis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calovo virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calpactin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calpactin I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calpactin II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calpain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calphobindin I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calphobindin II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calponin Phosphatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calprotectin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calregulin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calreticulin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calsenilin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calsenilin Like Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calsenilin-Like Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calsequestrin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calvarium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calycanthaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calymmatobacterium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calypsol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Calystegia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CamL1 Gene Product' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camallanina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camas, Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camassia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cambendazole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cambodia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cambridge Laboratories Brand of Activated Charcoal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cambridge Laboratories Brand of Tetrabenazine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camelid, New World' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camelids, New World' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camellia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camellia sinensis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camellia sinensis L. %28%formerly Thea sinensis%29% is an evergreen Asiatic shrub of the THEACEAE family. The infusion of leaves of this plant is used as Oriental TEA which contains CAFFEINE; THEOPHYLLINE; and epigallocatechin gallate.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camera, Gamma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camera, Nuclear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camera, Scintillation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cameras, Gamma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cameras, Nuclear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cameras, Scintillation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cameroon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cameroons' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camomile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camomile, German' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camomile, Roman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camomile, Scentless' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camomile, Stinking' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camoquin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camp, Concentration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camp, Refugee' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campaign, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campaigns, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campanulaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campbell Brand of Allantoin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphanes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor %28%1973-1982%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor 5 Monooxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor 5-Monooxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor Laurel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor Tree' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camphor-5-Monooxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campimetries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camping' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camps, Concentration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camps, Refugee' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camptotheca' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camptothecin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camptothecin/analogs %26% derivatives %28%1991-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camptothecine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1975-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1983-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1983-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1984-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1984-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1989-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1992-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter %28%1992-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter coli' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter fetus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter fetus %28%1974-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter hyointestinalis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter jejuni' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter lari' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter pylori' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter rectus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter sputorum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Campylobacter upsaliensis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camurati Engelmann Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Camurati-Engelmann Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canada' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canada %28%1966-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canada Snakeroot' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canaigre' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Irrigants, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Medicaments, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Obturation, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Obturations, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Preparation, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Preparations, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Sealants, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Therapies, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal Therapy, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, External Auditory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Inguinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Nutrient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Semicircular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canal, Spinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canaliculi, Bile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canaliculus, Bile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, External Auditory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Haversian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Inguinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Nutrient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Semicircular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canals, Spinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canaries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canary Grass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canarygrass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canarypox virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canarypox viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavalia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavan Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavan Disease, Type I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavan Disease, Type II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavan Disease, Type III' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavan van Bogaert Bertrand Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavan-van Bogaert-Bertrand Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canavanine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Antigen, Gastrointestinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Associated Carbohydrate Antigens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Associated Retinopathy Antigen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Care Facilities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Care Facility' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Care Unit' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Chemotherapy Protocol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Chemotherapy Protocols' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Chemotherapy, Regional Perfusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Drug Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Drug Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Gene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Hospitals' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Societies, American' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Society, American' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Staging' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Suppressor Gene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Suppressor Genes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Syndrome, Hereditary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Syndromes, Hereditary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Treatment Protocol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Treatment Protocols' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer Vaccines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Adrenal Cortex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Anus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Appendix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Bile Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Biliary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Bladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Duodenum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Endocrine Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Endometrium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Granulosa Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of ILEUM' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Jejunum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Ovary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Pituitary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Prostate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Sigmoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Thyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of Vagina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Adrenal Cortex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Adrenal Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Anus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Appendix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Bile Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Biliary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Bladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Cecum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Colon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Digestive System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Duodenum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Endocrine Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Endometrium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Esophagus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Eye' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Fallopian Tube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Gallbladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Gastrointestinal Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Head' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Head and Neck' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Intestines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Jaw' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Larynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Lip' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Liver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Mediastinum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Mouth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Nasopharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Neck' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Nose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Oropharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Ovary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Pancreas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Parotid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Pelvis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Penis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Pharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Pituitary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Prostate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Rectum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Retina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Salivary Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Sigmoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Skin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Spleen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Stomach' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Testis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Thymus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Thyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Tongue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Tonsil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Ureter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Urethra' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Urinary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Uterus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Vagina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer of the Vulva' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer or tumors of the MAXILLA or upper jaw. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer or tumors of the URETER. Hematuria, which occurs in 75%25% of patients with ureteral carcinoma, is the most common presenting symptom. The most common site for the occurrence of a ureteral tumor is in the lower third of the URETER, with a lesser incidence higher up.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer or tumors of the URETHRA. This condition is relatively uncommon and is the only cancer of the urinary system that has a higher incidence rate in females than males. Squamous cell carcinoma is the most frequent histologic type.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Adrenal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Adrenal Cortex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Adrenal Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Adrenocortical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Anal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Appendiceal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Appendix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Auricular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Basal Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Bile Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Biliary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Bladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Cecal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Cerebellar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Colon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Colonic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Colorectal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Digestive System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Duodenal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Endocrine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Endocrine Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Endometrial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Endometrium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Esophageal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Esophagus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Eye' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Fallopian Tube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Gallbladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Gastric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Gastrointestinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Genito-urinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Genitourinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Germ Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Granulosa Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Hepatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Hypopharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Hypothalamic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Ileal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Infratentorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Intestinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Intestines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Jaw' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Jejunal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Laryngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Larynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Lip' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Liver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Male Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Mediastinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Mediastinum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Meningeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Mouth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Nasopharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Nasopharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Nose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Oropharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Oropharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Ovarian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Ovary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pancreas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pancreatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Parotid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pelvic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pelvis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Penile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Penis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pharnyx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pituitary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Post-Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Prostate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Prostatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Pulmonary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Radiation Induced' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Radiation-Induced' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Rectal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Rectum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Renal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Residual' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Retinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Salivary Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Second' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Sigmoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Sigmoid Colon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Skin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Spleen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Splenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Squamous Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Stomach' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Testicular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Testis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Therapy-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Therapy-Related' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Thymic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Thymus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Thyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Tongue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Tonsil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Tonsillar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Treatment-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Treatment-Related' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Trophoblast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Trophoblastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Ureter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Ureteral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Urethra' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Urethral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Urinary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Urogenital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Urologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Urological' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Uterine Cervical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Uterus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Vagina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Vaginal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Vulva' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer, Vulvar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer-Associated Carbohydrate Antigens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancer-Associated Retinopathy Antigen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers or tumors of the PENIS or of its component tissues.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Adrenal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Adrenal Cortex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Adrenal Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Adrenocortical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Anal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Auricular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Basal Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Bile Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Biliary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Bladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Colon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Colonic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Colorectal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Digestive System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Embryonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Endocrine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Endometrial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Endometrium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Esophageal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Esophagus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Eye' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Fallopian Tube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Gallbladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Gastric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Gastrointestinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Genito-urinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Genitourinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Germ Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Granulosa Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Hepatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Hypopharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Hypothalamic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Ileal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Infratentorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Intestinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Intestines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Jaw' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Jejunal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Kidney' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Laryngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Larynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Lip' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Liver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Mediastinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Mediastinum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Meningeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Mouth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Nasopharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Nasopharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Nose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Oropharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Oropharynx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Ovarian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Ovary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pancreas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pancreatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Parotid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pelvic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pelvis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Penile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Penis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pharnyx' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pharyngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pituitary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Post-Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Prostate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Prostatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Pulmonary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Radiation-Induced' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Rectal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Rectum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Renal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Residual' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Retinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Salivary Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Second' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Second Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Skin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Spleen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Splenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Squamous Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Stomach' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Supratentorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Testicular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Testis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Therapy-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Therapy-Related' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Thymic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Thymus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Tongue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Tonsil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Tonsillar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Treatment-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Treatment-Related' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Trophoblast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Trophoblastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Ureter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Ureteral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Urethra' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Urethral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Urinary Tract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Urogenital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Urologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Urological' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Uterine Cervical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Uterus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Vagina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Vaginal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Vulva' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancers, Vulvar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cancrum Oris' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canderm Brand of Methoxsalen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canderm Brand of Podophyllotoxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candicidin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida %28%1964-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida %28%1967-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida albicans' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida glabrata' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candida tropicalis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidatus Helicobacter suis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiases, Chronic Mucocutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiases, Cutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiases, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis %28%1966-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis, Chronic Mucocutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis, Cutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis, Cutaneous %28%1966-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candidiasis, Vulvovaginal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Candy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canid herpesvirus 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Adenoviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Coronaviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Distemper Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Distempers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Hepatitides, Infectious' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Hepatitis Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Hepatitis Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Hepatitis, Infectious' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Herpesvirus 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Hip Dysplasia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Infectious Hepatitides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Infectious Hepatitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Infectious Hepatitis Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Parvoviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Teeth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Tooth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Tracheobronchitis Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine Tracheobronchitis Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine adenovirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine coronavirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine distemper virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canine parvovirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canis familiaris' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canis latrans' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canker Sore' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canker Sores' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabidiol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoid Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoid Receptor CB1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoid Receptor CB2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoid Receptor Modulators' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoid Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoids %28%1992-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinoids, Endogenous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabinol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis %28%1966-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis %28%1978-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannabis Related Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canned Food' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canned Foods' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannibalism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannibalisms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannulas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cannulations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canrenoate Potassium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canrenoate, Potassium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canrenone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cantabria Brand of Flurbiprofen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cantabria Brand of Gemfibrozil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cantabria Brand of Nimodipine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cantabria Brand of Terfenadine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cantharidin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cantharidine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canthaxanthin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canthaxanthine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Canton and Enderbury Islands' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Analogs, RNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Analogues, RNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Binding Complex 80 kDa protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Binding Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Binding Protein Complex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Binding Protein Complex, Nuclear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Binding Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap Z Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap, Cervical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap-Binding Complex 80-kDa protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap-Binding Protein Complex, Nuclear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cap-Binding Proteins, RNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CapZ Actin Capping Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CapZ Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CapZ Protein, alpha Subunit' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CapZ Protein, beta Subunit' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CapZ alpha Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CapZ beta Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacitance, Electric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacitance, Electrical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacitance, Vascular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacitation of Spermatozoa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacitation, Sperm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Carrying' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Forced Vital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Functional Residual' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Hospital Bed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Inspiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Maximal Breathing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Timed Vital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Total Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacities, Vital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity Evaluation, Work' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity Evaluations, Work' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Carrying' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Forced Vital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Functional Residual' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Hospital Bed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Inspiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Maximal Breathing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Pulmonary Diffusing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Timed Vital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Total Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capacity, Vital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capactin I Heavy Chain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capastat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caper' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caperea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capgras Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaria' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaria hepatica' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries %28%1969-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries %28%1970-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaries, Lymphatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillarities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillarity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaroscopies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillaroscopy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Electrophoreses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Electrophoresis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Endothelial Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Endotheliums' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Fragility' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Hemangioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Hemangioma, Lobular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Hemangiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Leak Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Leak Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Permeabilities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Permeability' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Permeability %28%1972-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Resistance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Resistance %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Resistances' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Telangiectasia, Pontine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Telangiectasias, Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary Telangiectasias, Pontine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capillary, Lymphatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Expenditure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Expenditures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Financing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Financings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Funding' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Fundings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Punishment' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capital Punishments' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capitalism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capitate Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capitate Bones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capitation Fee' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capitation Fees' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caplan Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caplan%27%s Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caplans Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capnocytophaga' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capnographies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capnography' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capnometries, Transcutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capnometry, Transcutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capnophorin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capparaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capparis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping Protein, Actin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping Proteins, Actin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping, Dental Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping, Immunologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping, Immunological' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping, Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capping, Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cappings, Dental Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cappings, Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capra' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capramol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capras' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capreomycin Sulfate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capric Acids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprifoliaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine Arthritis Encephalitis Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine Arthritis-Encephalitis Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine arthritis encephalitis virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine arthritis-encephalitis virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprine herpesvirus 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capripoxvirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capripoxviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caproate, Fluocortolone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caproate, Gestonorone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caproates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caproates %28%1967-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caproates %28%1969-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprolactam' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capromycin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caprylates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caps, Cervical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caps, RNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Alacan Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Centrum Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Elan Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Flemming Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Hydrolyzing Enzyme' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Link Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Medicis Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Smaller Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Thompson Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin Vinas Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicin-Hydrolyzing Enzyme' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsaicine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsella' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsicum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsicum %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid %28%1975-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid %28%1977-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid %28%1984-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid %28%1987-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid %28%1988-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsid Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsula Articularis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Articular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Bacterial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Bowman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Bowman%27%s' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Crystalline Lens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Internal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Joint' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsule, Synovial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Articular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Bacterial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Crystalline Lens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Internal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Joint' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsules, Synovial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsulitides, Adhesive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsulitis, Adhesive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsulorhexis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capsulorrhexis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Captan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Captopril' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capuchin Monkey' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capuchin Monkeys' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Capybara' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Car Phone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Car Phones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Car Seat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Car Sickness' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caragana' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carassius auratus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caraway' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Alcon Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Allphar Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Bioniche Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Bipharma Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Chauvin Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Mann Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Merck Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Novartis Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol NutraMax Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol Optopics Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbachol, Isopto' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbacholine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbadox' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbafos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamate derivative used as an insecticide, acaricide, and nematocide.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamate, Ethyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamate, Guaiphenesin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1963-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1968-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1969-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1971-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates %28%1974-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamates in which the -CO- group has been replaced by a -CS- group.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamazepine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamazine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamide, Methylergol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamimidothioic acid, 2-aminoethyl ester, dihydrobromide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl Phosphate Synthase %28%Ammonia%29% Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl Phosphate Synthetase I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl Phosphate Synthetase I Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl Transferases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthase %28%Ammonia%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthase %28%Ammonia%29%/deficiency %28%1989-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthase %28%Glutamine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthase %28%Glutamine-Hydrolyzing%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthase I Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthetase %28%Ammonia%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthetase I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyl-Phosphate Synthetase I Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoylaspartic Dehydrase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoylcholine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoylphosphate Synthetase I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoylphosphate Synthetase I Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoylphosphate Synthetase II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyltransferase, Aspartate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamoyltransferase, Ornithine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl Phosphate Synthase %28%Ammonia%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl Phosphate Synthase %28%Glutamine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl Phosphate Synthetase Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl Phosphate Synthetase I Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl Phosphate, Dilithium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl-Phosphate Synthase %28%Ammonia%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl-Phosphate Synthase %28%Glutamine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamyl-Phosphate Synthetase I Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamylphosphate Transferase, Ornithine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbamylurea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbanilides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbanilides %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbapenem Antibiotics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbapenems' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Avicopharma Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Biov%C3%%A9% Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Cl%C3%%A9%ment Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Coophavet Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril IntraVeno Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Mavlab Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Novartis Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Ornis Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Sanofi Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Sogeval Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril V%C3%%A9%toquinol Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaril Virbac Brand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbaryl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbazilquinone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbazoles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbazoles %28%1971-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbeneoxolone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbenicillin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbenicillin %28%1973-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbenoxalone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbenoxolone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbenoxolone Disodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbethoxydicoumarol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbidopa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbimazole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbimide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbimide, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbinol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbinol, Benzyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboca%C3%%AF%ne' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocholine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbochromen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbochromene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocromen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocromene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocyanines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocyclic Acids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocysteine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbocysteine, L Isomer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbodiimide cross-linking reagent. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbodiimide, CME' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbodiimide, Ethyldimethylaminopropyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbodiimides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbodiimides %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbodiimides %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbofos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbofuran' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Antigens, Cancer-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Antigens, Tumor Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Antigens, Tumor-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Binding Protein 35' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Conformation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Conformations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Deficient Glycoprotein Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Dehydrogenases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Diet, Low' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Diets, Low' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Epimerases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Isomerases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Isomerases %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Isomerases %28%1973-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Isomerases %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Linkages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Error' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1966-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1969-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1986-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Metabolism, Inborn Errors %28%1991-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Oxidoreductases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Sequence' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate Sequences' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. The mucin is expressed normally by most glandular epithelia but shows particularly increased expression in the breast at lactation and in malignancy. It is thus an established serum marker for breast cancer.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate antigen most commonly seen in tumors of the ovary and occasionally seen in breast, kidney, and gastrointestinal tract tumors and normal tissue. CA 125 is clearly tumor-associated but not tumor-specific.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate-Binding Protein 35' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate-Binding Protein, Liver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate-Deficient Glycoprotein Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate-Deficient Glycoprotein Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate-Restricted Diet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrate-Restricted Diets' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates %28%1969-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates consisting of between two %28%DISACCHARIDES%29% and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates covalently linked to a nonsugar moiety %28%lipids or proteins%29%. The major glycoconjugates are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. %28%From Biochemical Nomenclature and Related Documents, 2d ed; From Principles of Biochemistry, 2d ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes %28%FABACEAE%29%, tubers, etc. %28%From Claudio %26% Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates, Dietary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbohydrates/metabolism %28%1964-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbolic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbolines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbomonoxyhemoglobin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon %28%1980-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon %28%1991-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon %28%1996-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Carbon Double Bond Isomerases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Carbon Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Carbon Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Compounds, Inorganic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Dioxide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Dioxide %28%1966-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Dioxide Partial Pressure Determination, Transcutaneous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Dioxide Snow' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Dioxide/blood %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Dioxide/blood %28%1966-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Disulfide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Isotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Monoxide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Monoxide Poisoning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Monoxide Poisonings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Nanotube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Nanotubes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Nitrogen Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Nitrogen Ligases with Glutamine as Amide N Donor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Nitrogen Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Oxygen Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Oxygen Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Radioisotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Sulfur Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Sulfur Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Tetrachloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Tetrachloride Poisoning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon Tetrachloride Poisonings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon disulfide %28%CS2%29%. A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon monoxide %28%CO%29%. A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon, Vitreous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Carbon Double Bond Isomerases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Carbon Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Carbon Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Nitrogen Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Nitrogen Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Oxygen Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Oxygen Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Oxygen Lyases %28%1978-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Sulfur Ligases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbon-Sulfur Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonaceous Chondrite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate Dehydratase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate Dehydratase Inhibitors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate, Bupivacaine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate, Dilithium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate, Hydrogen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate, Lidocaine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonate, Lithium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonated Beverage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonated Beverages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonates, Hydrogen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Acid Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase 4' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase I Hiroshima 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase I Hiroshima-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase III' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase IV' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase Inhibitors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase Inhibitors %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase Isoenzyme B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase Isoenzyme C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase Isozyme IV' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase Isozyme V' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase V' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase, Muscle Specific' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrase, Muscle-Specific' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrases %28%1965-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrases %28%1967-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrases %28%1972-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrases %28%1990-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydrases %28%1992-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic Anhydride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic acid %28%H2C03%29%. The hypothetical acid of carbon dioxide and water. It exists only in the form of its salts %28%carbonates%29%, acid salts %28%hydrogen carbonates%29%, amines %28%carbamic acid%29%, and acid chlorides %28%carbonyl chloride%29%. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonic acid calcium salt %28%CaCO3%29%. An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonitrile, Pregnenolone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonmonoxyhemoglobin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide m Chlorophenyl Hydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide m-Chlorophenyl Hydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide meta Chlorophenyl Hydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide meta-Chlorophenyl Hydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide p Trifluoromethoxyphenylhydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide para Trifluoromethoxyphenylhydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Cyanide para-Trifluoromethoxyphenylhydrazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Formation, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonyl Reductases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonylated Protein Formation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonylation, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonylations, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbonylhemoglobin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbophos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboplat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboplatin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboprost' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboquinone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboquone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbostesin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbowax 400' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbowax400' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxamide, Aminoimidazole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxamide, Dimethyl Imidazole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyase, 2-Oxo Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyase, Glutamate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyase, Histidine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyase, Orotidine Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyase, Uroporphyrinogen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1970-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1974-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1974-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Lyases %28%1983-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Terminal Esterase, Ubiquitin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-Terminal Hydrolase, Ubiquitin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxy-lyase, Ornithine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyanhydrase Inhibitors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxybenzyl Penicillin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxycathepsin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxydismutase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyesterase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyglutaconic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyhemoglobin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxykinase, ATP-Dependent Phosphoenolpyruvate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxykinase, GTP-Dependent Phosphoenolpyruvate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyl %28%Acid%29% Proteinases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyl Transferases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyl and Carbamoyl Transferases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxyl-Methylase, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase Deficiencies, Combined' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase Deficiencies, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase Deficiency, Combined' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase Deficiency, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase Deficiency, Multiple, Late-Onset' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase Deficiency, Multiple, Neonatal Form' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Acetyl-CoA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Phosphoenolpyruvate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Propionyl-Coenzyme A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Pyruvate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Ribulose Biphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Ribulose Bisphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Ribulose Diphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Ribulose-1,5-Biphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Ribulose-Bisphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, Ribulosebiphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase, alpha-Ketoacid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase-Oxygenase, 1,5-Biphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase-Oxygenase, Ribulose Biphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylase-Oxygenase, Ribulose-1,5-Biphosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylate Esterase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylate Reductases, Pyrroline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylester Lipase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylesterase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylesterase B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylesterase is a serine-dependent esterase with wide substrate specificity. The enzyme is involved in the detoxification of XENOBIOTICS and the activation of ester and of amide PRODRUGS.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylesterase, Non-specific' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylesterases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Acids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Acids %28%1971-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Acids %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Acids %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Acids %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Acids %28%1992-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Ester Hydrolase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Ester Hydrolases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Ester Hydrolases %28%1981-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic Proteinases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic acids that have a homocyclic ring structure in which all the ring atoms are carbon.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylic acids that have open-chain molecular structures as opposed to ring-shaped structures.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxylmethyltransferase, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethoxyamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethyl Cellulose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethyl Transferase, S-Adenosylmethionine-Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethylase, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethylcellulose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethylcellulose, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethyltransferase, L-Isoaspartyl Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxymethyltransferase, S-Adenosylmethionine Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase E' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase G' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase H' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase II, Glutamate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase N' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase R' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase Transpeptidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase U' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase Y' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, D-D' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Enkephalin Dipeptidyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Enkephalin-Forming' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Enkephalin-Synthesizing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Lysine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Muramoylpentapeptide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Serine-Type Ala-Ala' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidase, Serine-Type D-Ala-D-Ala' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1968-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1974-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1979-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1982-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1993-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases %28%1999-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases that are primarily found the DIGESTIVE SYSTEM that catalyze the release of C-terminal amino acids. Carboxypeptidases A have little or no activity for hydrolysis of C-terminal ASPARTIC ACID; GLUTAMIC ACID; ARGININE; LYSINE; or PROLINE. This enzyme requires ZINC as a cofactor and was formerly listed as EC 3.4.2.1 and EC 3.4.12.2.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carboxypeptidases, Serine-Type D-Ala-D-Ala' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbuncle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbuncles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carbutamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoembryonic Antigen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogen Markers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogen Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogen Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenesis Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenesis Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic Activity Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic Activity Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic Potency Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic Potency Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic and neurotoxic glycoside occurring in a number of plant species, including Cycas revoluta.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic nitrosamine that may be formed from preservatives in meats during their preparation or in the liver during metabolism.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenic substances that are found in the environment.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenicity Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogenicity Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens %28%1966-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens Environmental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinogens, Environmental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid Heart Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid Heart Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid Syndrome, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid Syndromes, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoid Tumors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoids, Goblet Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma %28%1967-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma %28%1986-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma 256, Walker' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma Associated Antigen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma Cell, Embryonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma Cells, Embryonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma in Situ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma in Situ %28%1973-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma of Endometrium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Acinar Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Adenoid Cystic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Adenosquamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Adrenal Cortical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Adrenocortical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Alveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Animal Mammary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Basal Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Basal Cell %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Basal Cell, Pigmented' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Basosquamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Bronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Bronchiolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Bronchiolo Alveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Bronchiolo-Alveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Bronchioloalveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Bronchogenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Brown Pearce' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Brown-Pearce' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Collecting Duct %28%Kidney%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Colloid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Colorectal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Ductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Ductal, Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Ehrlich Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Embryonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Endocrine Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Endometrial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Endometrioid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Epidermoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Giant Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Hepatocellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Hepatocellular %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Human Mammary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Hypernephroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Infiltrating Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Intraductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Intraductal, Noninfiltrating' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Intraepithelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Invasive Ductal, Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Islet Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Krebs 2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Large Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Lewis Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Lobular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Male Breast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Medullary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Merkel Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Mucinous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Mucoepidermoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Nephroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Neuroendocrine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Non Small Cell Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Non-Small Cell Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Non-Small-Cell Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Non-Small-Cell Lung %28%1987-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Noninfiltrating Intraductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Oat Cell %28%1980-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Ovine Pulmonary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Pancreas Duct-Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Pancreatic Ductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Papillary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Papillary %28%1969-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Papillary %28%1970-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Papillary, Follicular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Pituitary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Planocellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Preinvasive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Renal Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Reserve Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Round Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Scirrhous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Signet Ring Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Skin Appendage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Small Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Small Cell Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Small Cell/complications %28%1982-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Spindle Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Squamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Squamous Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Squamous Cell %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Squamous Cell %28%1968-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Squamous Cell %28%1973-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Thyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Transitional Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Tubular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma, Verrucous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinoma-Associated Antigen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Acinar Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Adenoid Cystic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Adenosquamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Adrenal Cortical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Adrenocortical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Alveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Anaplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Animal Mammary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Basal Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Basosquamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Bronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Bronchiolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Bronchiolo-Alveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Bronchioloalveolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Bronchogenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Collecting Duct %28%Kidney%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Colloid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Colorectal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Cribriform' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Ductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Embryonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Endometrial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Endometrioid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Epidermoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Giant Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Granular Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Hepatocellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Human Mammary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Hypernephroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Infiltrating Duct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Intraductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Islet Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Large Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Lobular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Mammary Ductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Medullary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Mucinous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Mucoepidermoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Nephroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Neuroendocrine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Non-Small-Cell Lung' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Noninfiltrating Intraductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Oat Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Ovine Pulmonary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Pancreas Duct-Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Pancreatic Ductal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Papillary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Parathyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Pituitary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Planocellular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Renal Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Reserve Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Round Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Scirrhous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Skin Appendage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Small Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Spindle-Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Squamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Squamous Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Thymic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Transitional Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Tubular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Undifferentiated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomas, Verrucous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinomatoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinosarcoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinosarcoma 256, Walker' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carcinosarcomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Card, Donor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardamon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardanolides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardanolides %28%1968-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardanolides %28%1968-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardanolides %28%1971-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardel Brand of Spironolactone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardenolides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Aneurysm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Aneurysms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Arrest' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Arrest, Induced' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Asthma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Auscultation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Auscultations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Care Facilities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Care Facility' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Catheterization' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Catheterizations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Chronotropism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Chronotropisms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Complex, Premature' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Complexes, Premature' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Complexes, Premature %28%1966-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Complexes, Premature %28%1967-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Complices, Premature' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Death, Sudden' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Edema' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Edemas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Electrophysiologic Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Electrophysiologic Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Electrophysiologic Technique' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Electrophysiologic Techniques' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Electroversion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Electroversions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Function Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Function Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Gland' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Glycosides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Glycosides %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Glycosides %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Inotropism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Inotropisms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Life Support, Advanced' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Massage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Massages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Murmur' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Murmurs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Muscle Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Muscle Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Muscle Myosins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Muscles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Myoblast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Myoblasts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Myocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Myocytes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Myosin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Myosins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Neuroses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Neurosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output %28%1967-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output, High' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Output, Low' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Outputs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Outputs, High' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Pacemaker, Artificial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Pacemakers, Artificial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Pacing, Artificial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Pacings, Artificial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Premature Complex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Premature Complices' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Remodeling, Ventricular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Remodelings, Ventricular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Rupture' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Rupture, Post Infarction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Rupture, Post-Infarction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Rupture, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Ruptures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Ruptures, Post-Infarction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Ruptures, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Sound' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Sounds' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Stimulants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Sudden Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Surgery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Surgical Procedure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Surgical Procedures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Syndrome X' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Tamponade' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Tamponade/surgery %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Tamponades' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Transplantation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Transplantations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Valve' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Valve Prostheses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Valve Prosthesis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Valves' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Ventricle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Ventricles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Volume' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac Volumes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac alpha Myosin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac alpha-Myosin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac alpha-Myosin, Ventricular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac beta Myosin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac beta-Myosin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac beta-Myosin, Ventricular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac electrical stimulators that apply brief high-voltage electroshocks to the HEART. These stimulators are used to restore normal rhythm and contractile function in hearts of patients who are experiencing VENTRICULAR FIBRILLATION or ventricular tachycardia %28%TACHYCARDIA, VENTRICULAR%29% that is not accompanied by a palpable PULSE. Some defibrillators may also be used to correct certain noncritical dysrhythmias %28%called synchronized defibrillation or CARDIOVERSION%29%, using relatively low-level discharges synchronized to the patient%27%s ECG waveform. %28%UMDNS, 2003%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac malformation characterized by an atrioventricular spatial relation that places or appears to place each ventricle in a contralateral position relative to its associated atrium.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiac manifestation of MALIGNANT CARCINOID SYNDROME. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves. %28%DeVita Jr et al., Cancer: Principles %26% Practice of Oncology, 3d ed, p1307%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardio Green' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardio Pulmonary Resuscitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardio-Pulmonary Resuscitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioactive derivatives of lanatoside A or of DIGITOXIN. They are used for fast digitalization in congestive heart failure.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiobacteriaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiobacterium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiodilatin %28%99-126%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiodilatin Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiogenic Shock' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiogenic Syncope' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiogenic Syncopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiographies, Apex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiographies, Impedance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiography, Apex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiography, Impedance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiogreen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiolipin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiolipins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiology' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiology Hospital Service' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiology Hospital Services' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiology Service, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiology Services, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomegaly' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Congestive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Dilated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Familial Hypertrophic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Familial Idiopathic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Hypertrophic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Hypertrophic Obstructive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathies, Restrictive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Alcoholic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Chagas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Chagas%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Congestive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Dilated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Dilated, CMD1A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Dilated, LMNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Dilated, with Conduction Deffect1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Familial Hypertrophic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Hypertrophic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Hypertrophic Obstructive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Hypertrophic, Familial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Hypertrophic/genetics %28%1983-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Restrictive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyopathy, Secondary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyoplasties' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyoplasties, Dynamic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyoplasty' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyoplasty %28%1995-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiomyoplasty, Dynamic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardionatrin I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardionatrin IV' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioplegia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioplegias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioplegic Solution' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioplegic Solutions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioprotective Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiopulmonary Bypass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiopulmonary Bypass %28%1972-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiopulmonary Bypasses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiopulmonary Resuscitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiopulmonary Resuscitation %28%1992-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioscopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiospasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiospasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotocograms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotocography' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotonic Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotonic Drugs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotonic Steroids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotonics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotoxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotoxin Like Basic Polypeptide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotoxin, Cobra' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotoxin-Like Basic Polypeptide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiotrast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Abnormalities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Abnormality' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Agents %28%1979-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Deconditioning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diagnostic Technic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diagnostic Technics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diagnostic Technique' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diagnostic Techniques' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Disease %28%Specialty%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diseases %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Diseases %28%Specialty%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Drugs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Model' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Models' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiologic Phenomena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiologic Phenomenon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiologic Processes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiological Phenomena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiological Phenomenon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiological Process' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiological Processes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiologies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Physiology' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Pregnancy Complication' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Pregnancy Complications' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Surgical Procedure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Surgical Procedures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Syndrome, Metabolic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Syndromes, Metabolic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Syphilis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular System %28%1966-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular System/physiology %28%1966-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Systems' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Trypanosomiasis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Tuberculoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovascular Tuberculosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioversion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioversions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioverter Defibrillators, Implantable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioverter-Defibrillator, Implantable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioverter-Defibrillators, Implantable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovirus Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardiovirus Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardioxan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardo-santo' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardoon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cards, Donor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cardular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carduran' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carduus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carduus marianus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Agencies, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Agency, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Aide, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Aides, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Assistant, Animal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Assistants, Animal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Continuity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Continuity, Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Continuum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Episode' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Episodes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Facilities, Extended' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Facilities, Intermediate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Facility, Extended' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Facility, Intermediate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Giver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Givers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Management, Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Network, Community' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Networks, Community' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Pattern, Maternal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Patterns, Maternal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Plan, Nursing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Planning, Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Plans, Nursing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Services, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Survey, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Surveys, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Team, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Team, Medical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Team, Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Teams, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Teams, Medical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Teams, Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Tech Brand of Benzethonium Chloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Technician, Animal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Technicians, Animal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Technology Point' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Technology Points' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Unit, Coronary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Unit, Intensive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Unit, Respiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Units, Coronary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Units, Intensive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care Units, Respiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care alleviating symptoms without curing the underlying disease. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. %28%From Dictionary of Health Services Management, 2d ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care given to patients by nursing service personnel. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care of children in the home or institution. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care of infants in the home or institution. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care of the newborn infant in a crib near the mother%27%s bed, instead of in a nursery, during the hospital stay.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care which provides integrated, accessible health care services by clinicians who are accountable for addressing a large majority of personal health care needs, developing a sustained partnership with patients, and practicing in the context of family and community. %28%JAMA 1995;273%28%3%29%:192%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Ambulatory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Bereavement' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Child' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Community Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Comprehensive Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Critical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Custodial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Day' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Domiciliary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Foster Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Hospice' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Hospital Based Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Hospital-Based Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Indigent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Intensive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Intraoperative' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Life Support' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Long-Term' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Managed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Neonatal Intensive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Night' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Non-Professional Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Nonprofessional Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Nursing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Outpatient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Palliative' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Pastoral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Patient-Centered' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Patient-Focused' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Perinatal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Perioperative' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Peroperative' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Pharmaceutical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Postnatal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Postoperative' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Preconception' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Prenatal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Preoperative' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Prepaid Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Primary Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Primary Nursing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Progressive Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Respite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Rooming-in' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Self' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Self %28%Rehabilitation%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Skin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Sub-Acute' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Subacute' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Surgical Intensive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Terminal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Uncompensated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care, Withdrawing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Care-Tech Brand of Benzethonium Chloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Career Choice' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Career Choices' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Career Counseling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Career Ladder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Career Mobilities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Career Mobility' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caregiver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caregiver, Family' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caregiver, Spouse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caregivers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caregivers, Family' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caregivers, Spouse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Hospital Based Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Hospital-Based Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Night' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Pharmaceutical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Primary Nursing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Progressive Patient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Respite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Rooming-in' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Self %28%Rehabilitation%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Sub-Acute' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cares, Subacute' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carex Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carfecillin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carfecillin Sodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribbean' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribbean Islands' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribbean Manatee' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribbean Manatees' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribbean Region' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribbean Sea Region' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caribou' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carica' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caricaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caricature' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caricatures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caricatures %28%PT%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caricatures %5B%Publication Type%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caries Susceptibility, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caries, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caries, Root' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cariogenic Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cariogenic Diet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cariogenic Diets' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cariostatic Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carisoprodate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carisoprodol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carlavirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carlaviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carlsberg Subtilisin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carmine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carminomicin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carminomycin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carminomycin I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carmovirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carmoviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carmustine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnation mottle viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Acetyl CoA Transferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Acetylcarnitine Translocase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Acetyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Acylcarnitine Translocase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Acyltransferase I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Acyltransferases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine O Acetyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine O Palmitoyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine O-Acetyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine O-Palmitoyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Palmitoyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine Translocase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine, Acetyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine-Acetyl-CoA-Transferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnitine-Acylcarnitine Translocase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1963-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1964-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1965-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1966-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1966-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1967-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1969-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1970-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1971-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivora %28%1974-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivores of genus Mustela of the family MUSTELIDAE. The European mink, which has white upper and lower lips, was widely trapped for commercial purposes and is classified as endangered. The American mink, lacking a white upper lip, is farmed commercially.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnivores of the genus Procyon of the family PROCYONIDAE. Two subgenera and seven species are currently recognized. They range from southern Canada to Panama and are found in several of the Caribbean Islands.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnosine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carnot Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caroli Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caroli Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caroli%27%s Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caroli%27%s Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carolis Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carolis Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotene %28%1980-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotene Dioxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotene, beta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotene, zeta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotene/analogs %26% derivatives %28%1975-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotenoids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotenoids %28%1969-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotenoids %28%1986-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotenoids, Xanthophyll' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caroticum, Glomus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arterial Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arterial Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteries %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteries %28%1966-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteries, Common' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteries, External' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteries, Internal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteriopathies, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Arteriopathy, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Cavernous Sinus Fistula' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases %28%1964-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases %28%1965-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases %28%1966-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Diseases %28%1969-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Dissection, Internal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Injuries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Injury' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Narrowing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Narrowings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Plaques' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Stenoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Stenosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Thromboses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Thrombosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Trauma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Traumas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery Ulcerating Plaque' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery, Common' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery, External' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery, Internal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery, Internal, Dissection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Artery-Cavernous Sinus Fistula' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Atheroscleroses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Atherosclerotic Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Atherosclerotic Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Bodies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Body' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Body Paraganglioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Body Paragangliomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Body Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Body Tumors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Cavernous Sinus Fistula' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Endarterectomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Endarterectomy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Sinus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Sinus Syncope' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Sinus Syncopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Stenoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Stenosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Thrombosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid Ulcers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid-Cavernous Sinus Fistula' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carotid-Cavernous Sinus Fistulas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carp, Crucian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carp, Grass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carp, Koi' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carp, Silver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Bones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Bones %28%1971-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Bones %28%1972-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Bones %28%1972-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Bones %28%1978-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Joint' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Joints' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Tunnel Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal Tunnel Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpal, Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpals, Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carphecillin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carps' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carps, Crucian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carps, Grass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carps, Silver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carpus, Animal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrageen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrageenan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrageenin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Ampholytes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Detection, Genetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Detections, Genetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Protein, Acyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1966-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1971-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1971-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1971-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1971-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1971-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1971-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1972-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1973-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1975-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1978-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1978-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1978-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1979-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1979-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1980-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1981-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1981-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1982-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1982-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1983-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1984-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1984-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1984-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1985-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1986-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1987-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1989-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1990-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1990-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1991-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1991-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1991-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1991-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1992-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1992-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1992-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1993-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1994-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1994-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1995-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1996-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1996-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1997-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1997-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1997-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1998-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%1999-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%2000-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%2000-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%2001-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier Proteins %28%2001-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier State' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier States' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier of aroma of butter, vinegar, coffee, and other foods.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. They participate in the transport of androgens. Androgen-binding protein has the same amino acid sequence as SEX HORMONE-BINDING GLOBULIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Calcium-Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Detection Genetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Genetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Gestational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Insurance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Sodium-Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrier, Toxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Detection Genetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Dopamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Genetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Genetic, Detection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Gestational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Insurance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carriers, Toxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrion Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrion%27%s Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrions Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrot' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrots %28%1995-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carrying Capacities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carteolol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carteolol Monohydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carter Horner Brand of Capsaicin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carter Horner Brand of Carisoprodol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carter Horner Brand of Dimenhydrinate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carter Wallace Brand of Tolnaftate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carthamus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carthamus tinctorius' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carticain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carticaine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1964-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1966-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1966-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1967-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage %28%1971-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage Diseases %28%1968-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage Fracture' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage Fractures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Articular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Articular %28%1965-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Articular %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Articular %28%1966-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Articular %28%1969-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Articular %28%1986-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Arytenoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Cricoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Elastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Epiphyseal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Hyaline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Laryngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Semilunar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage, Thyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilage/embryology %28%1966-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages of the auricle %28%pinna%29% and the external acoustic meatus.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Articular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Arytenoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Cricoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Elastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Epiphyseal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Hyaline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Laryngeal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Semilunar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilages, Thyroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilaginous Exostoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilaginous Exostoses, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilaginous Exostosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartilaginous Exostosis, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartoon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartoons' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartoons %28%PT%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cartoons %5B%Publication Type%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carubicin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carvacrol %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cary, Cervical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Carya' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caryophyllaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caryophyllus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cas Protein, p130' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cascade, MAP Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cascades, MAP Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cascan Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cascara' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cascara Sagrada' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Base Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Comparison Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Compeer Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Control Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Control Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Fatality Rates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Management' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Management, Insurance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Mix Adjustment' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Mixes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Referent Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Referrent Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Report %28%1965-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Reports' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Reports %5B%PT%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Reports %5B%Pub Type%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Reports %5B%Publication Type%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Studies, Management' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case Studies, Organizational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Base Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Base Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Comparison Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Comparison Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Compeer Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Compeer Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Control Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Control Studies, Matched' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Control Studies, Nested' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Control Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Control Study, Matched' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Control Study, Nested' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Mix Adjustments' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Referent Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Referent Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Referrent Studies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Case-Referrent Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casearia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase 1 delta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase 1 epsilon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase 2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase 2alpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase 2alpha%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase I alpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase I delta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase Ialpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase Idelta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase Iepsilon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase TS' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinase-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casein Kinases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caseinate, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caseins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caseins %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caseosa, Vernix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caseosas, Vernix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casimiroa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casitas B Lineage Lymphoma Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casitas B-Lineage Lymphoma Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caspase 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caspases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassava' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassella med Brand of Ethacridine Lactate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassella-med Brand of Ethacridine Lactate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassette Mutageneses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassette Mutagenesis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassia Tree' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassia angustifolia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassia occidentalis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassia senna' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cassia, Chinese' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cast Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cast, Fiberglass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cast, Plaster' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cast, Plastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cast, Surgical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castanospermum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Investment, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Investments, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Technic, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Technics, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Technique, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Techniques, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting Wax, Inlay' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casting, Corrosion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castings, Corrosion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castleman Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castleman Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castleman%27%s Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castleman%27%s Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castlemans Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castlemans Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castor Bean' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castor Bean Lectin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castor Bean Tick' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castor Oil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castor Oil Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castration %28%1966-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castration Anxiety' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castration Complex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castration Complices' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castrations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Castrations, Male' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casts, Fiberglass' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casts, Plaster' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casts, Plastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casts, Surgical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Casuistry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Diseases %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Diseases %28%1966-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Diseases %28%1986-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Leukemia Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Leukemia Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Plague' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Plagues' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat Scratch Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat%27%s Claw' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat, Civet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat, Domestic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat-Scratch Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cat-Scratch Disease/microbiology %28%1992-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolic Gene Activator' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolic Gene Activators' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolite Activator Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolite Activator Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolite Gene Activator Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolite Gene Activator Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolite Regulator Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catabolite Regulator Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalase %28%1965-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalepsies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataleptic Freezing Reaction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataleptic Freezing Reactions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataleptic Immobilization Reaction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataleptic Immobilization Reactions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog, Booksellers%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog, Commercial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog, Drug' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog, Library' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog, Publishers%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalog, Union' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataloging' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs %28%PT%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs %5B%Publication Type%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Bookseller' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Bookseller%27%s' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Booksellers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Booksellers%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Commercial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Drug' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Library' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Publisher' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Publisher%27%s' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Publishers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Publishers%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalogs, Union' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalysis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalysis %28%1986-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Antibodies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Antibody' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Core' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Cores' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic DNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Domain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Domains' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic RNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Region' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Regions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Site' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Sites' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Subunit' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Subunit Cyclic AMP Dependent Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytic Subunits' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalytically active enzymes that are formed by the combination of an apoenzyme %28%APOENZYMES%29% and its appropriate cofactors and prosthetic groups.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyze the hydrolysis of nucleosides with the elimination of ammonia.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyze the hydrolysis of nucleotides with the elimination of ammonia.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyze the joining of preformed ribonucleotides or deoxyribonucleotides in phosphodiester linkage during genetic processes. EC 6.5.1.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the ATP-dependent PHOSPHORYLATION of GMP to generate GDP and ADP.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde. EC 4.1.1.1.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the final step in the galactocerebroside biosynthesis pathway.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the hydrolysis of pteroylpolyglutamic acids in gamma linkage to pterolylmonoglutamic acid and free glutamic acid. EC 3.4.19.9.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the hydrolysis of the gamma lactone, dehydroascorbate, to diketogulonate.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the oxidation of GLUTATHIONE to GLUTATHIONE DISULFIDE in the presence of NADP+. Deficiency in the enzyme is associated with HEMOLYTIC ANEMIA. Formerly listed as EC 1.6.4.2.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the oxidation of catechol to 2-hydroxymuconate semialdehyde in the CARBAZOLE and BENZOATE degradation via HYDROXYLATION pathways. It also catalyzes the conversion of 3-methylcatechol to cis, cis-2-hydroxy-6-oxohept-2,4-dienoate in the TOLUENE and XYLENE degradation pathway. This enzyme was formerly characterized as EC 1.13.1.2.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catalyzes the reduction of tetrazolium compounds in the presence of NADH.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catamium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataplexy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catapresan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catapressan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extraction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extraction %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extraction %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extraction %28%1967-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extraction %28%1970-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extraction %28%1987-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataract Extractions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataracts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cataracts, Membranous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catarrh, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catarrhinas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catarrhini' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catarrhs, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catastrophic Health Insurance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catastrophic Health Insurances' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catastrophic Illness' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catastrophic Illnesses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonia %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonia, Lethal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonia, Schizophreniform' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonias, Lethal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonias, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonias, Organic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonias, Schizophreniform' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonic Disorder, Organic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonic Disorders, Organic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonic Schizophrenia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catatonic Schizophrenias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catchment Area %28%Health%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catchment Areas %28%Health%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechinic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol 1,2 Dioxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol 1,2 Oxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol 1,2-Dioxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol 1,2-Oxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol 2,3 Dioxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol 2,3-Dioxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol Estrogens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol Methyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol O Methyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol O-Methyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol Oxidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol, Methyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol-1,2-Oxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol-2,3-Dioxygenase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechol-O-Methyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Carrier' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Plasma Membrane Transport Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Plasma Membrane Transporter Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Plasma Membrane Transporters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine Transport Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamine-Specific Neurotransmitter Transporters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamines %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamines %28%1974-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholamines Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catecholestrogens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1966-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1969-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1971-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1972-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1973-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechols %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catechuic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Categorical classification of MENTAL DISORDERS based on criteria sets with defining features. It is produced by the American Psychiatric Association. %28%DSM-IV, page xxii%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenanes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenanes, DNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenated DNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenin Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenin, alpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenin, alpha-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenin, alphaE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenin, beta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenin, gamma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catenulin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catfish' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catfish, Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catfish, Colombian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catfishes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catfishes, Bullhead' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catgut' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catguts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catharanthus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catharses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catharsis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathartics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathartics %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin A' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin B Like Activity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin B Like Proteinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin B1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin D' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsin E' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsins %28%1965-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsins %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsins %28%1966-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsins %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathepsins %28%1980-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheter Ablation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheter Ablation, Electrical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheter, Implantable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheter, In-Dwelling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheter, Indwelling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization %28%1966-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization %28%1971-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization %28%1972-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization %28%1977-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization or specific %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Balloon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Cardiac' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Central' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Central Venous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Fogarty Balloon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Foley Balloon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Heart' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Peripheral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Peripheral Venous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Pulmonary Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Swan Ganz' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Swan-Ganz' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterization, Urinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Balloon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Bronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Cardiac' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Central' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Central Venous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Heart' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Peripheral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Peripheral Arterial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Peripheral Venous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Pulmonary Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Ureteral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Urethral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheterizations, Urinary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters designed to be left within an organ or passage for an extended period of time.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters, Implantable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters, In-Dwelling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters, Indwelling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters, Indwelling %28%1972-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters, Indwelling %28%1978-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catheters, Indwelling %28%1980-1982%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathexis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathode Ray' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cathodes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catholic, Roman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catholicism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catholicism, Roman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catholics, Roman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Channels, TRP' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Channels, TRPC' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Channels, TRPM' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Channels, TRPP' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Channels, TRPV' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Exchange Resins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Exchangers %28%Proteins%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Exchangers %28%Resins%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Pumps' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cation Transport Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Amino Acid Transport Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Amino Acid Transport Systems' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Amino Acid Transporter 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Amino Acid Transporter 2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Amino Acid Transporters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Peptides, Antimicrobial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Protein, Eosinophil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic Proteins, Microbicidal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates the calcium fluxes in muscle fibers. It is used as a coccidiostat, especially in poultry.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cations, Divalent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cations, Divalent %28%1973-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cations, Monovalent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cations, Monovalent %28%1973-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catnip' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catostomidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cats' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cats %28%1969-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cats, Civet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cats, Domestic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Catscratch Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattail' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattell Personality Factor Questionnaire' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1966-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Diseases %28%1988-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Leukemia Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cattle Plague' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caucasian Race' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caucasian Races' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caucasoid Race %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caucasoid Race %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caucasoid Races' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cauda Equina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cauda Equina Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caudal Anesthesia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caudal Nucleus, Trigeminal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caudata' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caudate Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caudovirales' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulerpa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulimovirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulimoviruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulobacter' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulobacter crescentus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulobacteraceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caulophyllum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causalgia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causalgia Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causalgia Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causalities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causalities, Multifactorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causality' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causality, Multifactorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causation, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causations, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cause of Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Causes of Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caustic Soda' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caustics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cauteries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cautery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cava Filter, Vena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cava Filters, Vena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cava, Inferior Vena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cava, Superior Vena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavae, Venae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavas, Inferior Vena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavas, Superior Vena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveola' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin 2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin 2 is a binding partner of CAVEOLIN 1. It undergoes tyrosine phosphorylation by C-SRC PROTEIN PP60 and plays a regulatory role in CAVEOLAE formation.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin 3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin, Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolin-3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caveolins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernitides, Fibrous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernitis, Fibrous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Angioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Angioma, Central Nervous System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Angiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangioma, Central Nervous System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangioma, Cerebral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangiomas, Cerebral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangiomas, Extracerebral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Hemangiomas, Intracerebral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Lymphangioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Lymphangiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Sinus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Sinus %28%1964-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Sinus Thrombophlebitides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Sinus Thromboses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Sinus Thrombosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavernous Sinus, Phlebitis, Septic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caverous Sinus Septic Phlebitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavitas Oris' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavitas abdominis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavitas oris propria' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavitas thoracis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavities, Abdominal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavities, Dental Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavities, Nasal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavities, Pleural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavities, Tympanic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Liners, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Lining Varnish' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Lining Varnishes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Lining, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Linings, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Preparation, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Preparations, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Varnish' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity Varnishes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity in each of the cerebral hemispheres derived from the cavity of the embryonic neural tube. They are separated from each other by the SEPTUM PELLUCIDUM, and each communicates with the THIRD VENTRICLE by the foramen of Monro, through which also the choroid plexuses %28%CHOROID PLEXUS%29% of the lateral ventricles become continuous with that of the third ventricle.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Abdominal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Dental Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Nasal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Peritoneal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Pleural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Thoracic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavity, Tympanic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavopulmonary Anastomoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavopulmonary Anastomosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavopulmonary Shunt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavopulmonary Shunts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cavus Deformities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cayenne Peppers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cayman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Caymans' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CbhI Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cd-103-105, 107, 109, 115, 117-119; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cd-114; Cd-106, 108, 110-113, 116 = CADMIUM %28%IM%29% + ISOTOPES %28%NIM%29%; Cd-103-105, 107, 109, 115, 117-119 = CADMIUM RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CdCl2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdc2 Related Kinase PSSALRE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdc2 Related Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdc2 related Kinase PITALRE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdc2-Related Kinase PSSALRE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdc2-Related Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdc2-related Kinase PITALRE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk Interacting Protein 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk-Interacting Protein 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk1 Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk2 Inhibitor Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk2 Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk4 Associated Protein p16' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk4 Cyclin Dependent Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk4 Cyclin-Dependent Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk4 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk4 Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk4-Associated Protein p16' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk5 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk5 Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk6 Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdk9 Protein Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cdkn2a%28%p14ARF%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ce-132-135, 137, 139, 141-148; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ce-136, 138, 142; NIM ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceanothus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cebidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cebidae %28%1992-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cebinae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cebuellas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cebus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecal Cancer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecal Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecal Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecal Diseases/surgery %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecal Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecal Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecostomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecostomies, Tube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecostomy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecostomy, Tube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecropia Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecropiaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecum/surgery %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cecums' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar Tree' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar, Atlantic White' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar, Japanese' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar, Red Eastern' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar, Western' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar, Western Red' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedar, Yellow' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedilanid D' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'CedilanidD' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedrela' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cedrus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefacetrile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefaclor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefadroxil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefalexin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefaloglycin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefaloridine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefalotin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefamandole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefamandole/analogs %26% derivatives %28%1978-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefamandole/analogs %26% derivatives %28%1978-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefapirin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefatriaxone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefatrizine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefazolin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefixime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefmenoxime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefmenoxime Hydrochloride %28%2:1%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefmetazole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefmetazole Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefonicid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefonicid Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefonicid, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefoperazon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefoperazone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefoperazone Sodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotaxim' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotaxime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotaxime %28%1982-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotaxime %28%1982-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotaxime/analogs %26% derivatives %28%1982-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotaxime/analogs %26% derivatives %28%1986-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotetan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotetan Disodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefotiam' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefoxitin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefradine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefsulodin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefsulodin Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftazidime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftizoxime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftizoxime Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftriaxon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftriaxone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftriaxone, Disodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceftriaxone, Disodium Salt, Hemiheptahydrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cefuroxime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceiba' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceiling Diuretics, High' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek 8 Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek-8 Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek10 Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek11 Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek4 Eph Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek4 Receptor Protein Tyrosine Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek4 Receptor Protein-Tyrosine Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek4, Eph Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek5 Ligand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek5 RPTK Ligand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek7 Ligand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek7 RPTK Ligand' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cek9 Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celandine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celastraceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celastrus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celebes Ape' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celebes Apes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celgene Brand of Thalidomide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Arteries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Disease %28%1964-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Ganglion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Plexus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiac Sprue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celibacy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celioscope' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celioscopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celioscopic Cholecystectomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celioscopic Cholecystectomy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celioscopies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celioscopy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiprolol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celiprolol Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adenocarcinoma, Clear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adenocarcinomas, Clear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion %28%1986-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion %28%1991-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion %28%1991-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Kinase Beta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecule L1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecule, Neural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules %28%1989-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules %28%1989-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules %28%1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules %28%1990-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules %28%1995-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neuron Glia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neuron-Glia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neuronal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neuronal %28%1990-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neuronal %28%1992-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesion Molecules, Neuronal %28%1992-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Adhesions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Aggregation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Aggregations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Aging' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Anoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Anoxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Array Analyses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cancer, Basal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cancer, Granulosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cancer, Squamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cancers, Basal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cancers, Granulosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cancers, Squamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinoma, Acinar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinoma, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinoma, Large' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinoma, Transitional' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinomas, Acinar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinomas, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinomas, Large' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Carcinomas, Transitional' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Coat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Coats' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Communication' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Communications' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Compartmentation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Compartmentations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Component' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Components' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Count' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Count %28%1969-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Counts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Culture' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Culture Technique' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Culture Techniques' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Culture, Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cultures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cultures, Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle %28%1978-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Gene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Genes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Proteins %28%1991-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Proteins %28%1993-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Proteins %28%1995-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Proteins %28%1996-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Regulator p21' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycle Regulatory Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cycles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cytotoxicities, Antibody-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cytotoxicity, Antibody-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cytotoxins, Vero' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cytoxicities, Antibody-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cytoxicity, Antibody Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Cytoxicity, Antibody-Dependent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Death, Autophagic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Deaths, Autophagic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Degranulation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Densities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1966-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1966-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1967-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1968-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiation %28%1969-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Differentiations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1965-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1966-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division %28%1968-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division Cycle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division Cycle Genes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division Cycle Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division Cycles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division Phase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Division Protein Kinase 4' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Divisions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Enlargement' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Extracts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fractionation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fractionations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Free System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fusion %28%1971-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fusion %28%1972-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fusion %28%1975-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Fusions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Growth Inhibitors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Growth Processes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Growth in Number' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Growth in Size' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Hybrid, Somatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Hybrids, Somatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Hypoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Hypoxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Inhibitor, Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Interaction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Interactions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Isolation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Isolations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Junction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Junctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Leukemia, Plasma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Leukemias, Plasma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1966-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1969-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1971-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1972-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1973-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1975-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1976-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1976-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1977-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1978-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1979-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1979-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1981-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1981-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1983-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1984-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line %28%1991-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line, Pheochromocytoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line, Transformed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Line, Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Lineage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Lineages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Lines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Lines, Pheochromocytoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Lines, Transformed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Lines, Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Locomotion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Matrix Adherens Junctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Matrix Adhesions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Matrix Junctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Mediated Immunity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Mediated Lympholytic Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1966-1982%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1971-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1971-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane %28%1981-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Coated Pits' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Extension' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Extensions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Lipids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Permeability' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Projection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Projections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Protrusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Protrusions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Structure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membrane Structures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membranes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Membranes %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Migration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Migration Inhibition' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Migration Inhibition %28%1971-1973%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Migration Inhibition %28%1972-1973%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Motility' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Movement' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Movement %28%1968-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Movement %28%1970-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Movement %28%1972-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Movement %28%1991-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Movements' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Multiplication' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Myoblastoma, Granular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Myoblastomas, Granular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Neoplasm, Basal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Neoplasm, Squamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Neoplasms, Basal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Neoplasms, Squamous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Neoplastic Transformation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Neoplastic Transformations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nuclei' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleoli' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleolus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleolus %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleolus %28%1975-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleolus %28%1976-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1965-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1970-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1971-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1972-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus %28%1976-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus Division' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus Divisions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus Structure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus Structures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus/ME %28%1982-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus/UL %28%1966-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Nucleus/transplantation %28%1994-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Number' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Number Growth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Numbers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Phone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Phones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Physiology' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Polarities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Polarity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Proliferation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Proliferation Factor HCF' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Protection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Research, Embryo' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Research, Fetal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Respiration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Respirations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Sarcoma, Small' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Sarcomas, Small' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Segregation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Segregations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Senescence' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separation %28%1972-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separation %28%1978-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separation %28%1983-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separation, Immunomagnetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Separations, Immunomagnetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Shape' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Shapes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Size' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Size %28%1992-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Size %28%1993-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Size Growth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Sizes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Sorting, Fluorescence-Activated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Sortings, Fluorescence-Activated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Substitutes, Red' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Antigen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Antigens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Extension' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Extensions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Glycoprotein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Glycoprotein L1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Glycoproteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Hormone Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Microspike' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Microspikes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Projection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Projections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Protrusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Protrusions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Surface Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Survival' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Survival %28%1971-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Survival %28%1972-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Survival %28%1977-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Survival/drug effects %28%1971-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Thyroiditides, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Thyroiditis, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Trait, Sickle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Traits, Sickle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transfer, Adoptive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transfers, Adoptive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformation, Neoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformation, Neoplastic %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformation, Neoplastic %28%1968-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformation, Neoplastic %28%1970-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformation, Viral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformation, Viral %28%1978-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformations, Neoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transformations, Viral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transplant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transplantation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Transplantations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Tumor, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Tumor, Granular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Tumors, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Tumors, Granular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Viabilities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Viability' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Volumes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Volumes, Mean' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Wall' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Wall %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Wall %28%1967-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Wall Skeleton' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell Walls' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecule and CD antigen that mediates neutrophil, monocyte, and memory T-cell adhesion to cytokine-activated endothelial cells. E-selectin recognizes sialylated carbohydrate groups related to the Lewis X or Lewis A family.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecule expressed on activated leukocytes, fibroblasts, and neurons. It is a ligand for CD6. ALCAM-CD6 interactions may play a role in the binding of T and B cells to activated leukocytes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecule involved in a diverse range of contact-mediated interactions among neurons, astrocytes, oligodendrocytes, and myotubes. It is widely but transiently expressed in many tissues early in embryogenesis. Four main isoforms exist, including CD56; %28%ANTIGENS, CD56%29%; but there are many other variants resulting from alternative splicing and post-translational modifications. %28%From Pigott %26% Power, The Adhesion Molecule FactsBook, 1993, pp115-119%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. CD31 is highly expressed on endothelial cells and concentrated at the junctions between them.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell adhesion molecules that mediate neuron-neuron adhesion and neuron-astrocyte adhesion. They are expressed on neurons and Schwann cells, but not astrocytes and are involved in neuronal migration, neurite fasciculation, and outgrowth. Ng-CAM is immunologically and structurally distinct from NCAM %28%NEURAL CELL ADHESION MOLECULES%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell groups within the internal medullary lamina of the thalamus. They include a rostral division comprising the paracentral, central lateral, central dorsal, and central medial nuclei, and a caudal division composed of the centromedian and parafascicular nuclei.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell lines developed from disaggregated BALB/c mouse embryos. They are extremely sensitive to CONTACT INHIBITION, and highly susceptible to transformation by SV40 VIRUS and murine sarcoma virus %28%SARCOMA VIRUSES, MURINE%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell lines whose original growing procedure consisted being transferred %28%T%29% every 3 days and plated at 300,000 cells per plate %28%J Cell Biol 17:299-313, 1963%29%. Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell membrane glycoproteins selective for chloride ions.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell membrane glycoproteins selective for sodium ions. Fast sodium current is associated with the action potential in neural membranes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules %28%addressins%29% on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface glycoproteins that bind to chemokines and thus mediate the migration of pro-inflammatory molecules. The receptors are members of the seven-transmembrane G protein-coupled receptor family. Like the CHEMOKINES themselves, the receptors can be divided into at least three structural branches: CR, CCR, and CXCR, according to variations in a shared cysteine motif.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consists of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations of the gene for PROTO-ONCOGENE PROTEINS C-MET are associated with papillary renal carcinoma and other neoplasia.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind ATRIAL NATRIURETIC FACTOR with high affinity and trigger intracellular changes influencing the behavior of cells. They contain intrinsic guanylyl cyclase activity.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind ENDOTHELINS with high affinity and trigger intracellular changes which influence the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind FOLLICLE STIMULATING HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind GROWTH HORMONE with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind LIPOXINS with high affinity and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind PARATHYROID HORMONE with high affinity and trigger intracellular changes which influence the behavior of cells. Parathyroid hormone receptors on BONE; KIDNEY; and gastrointestinal cells mediate the hormone%27%s role in calcium and phosphate homeostasis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE; %28%VIP%29%; with high affinity and trigger intracellular changes which influence the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GAMMA-AMINOBUTYRIC ACID and glycine receptors are the most common receptors for fast inhibition.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behavior of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behavior of cells. Gastrin- releasing peptide %28%GRP%29%; GRP 18-27 %28%neuromedin C%29%, and neuromedin B are endogenous ligands of bombesin receptors in mammals.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind calcitonin and trigger intracellular changes which influence the behavior of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind calcitonin gene-related peptide %28%CGRP%29% with high affinity and trigger intracellular changes which influence the behavior of cells. CGRP receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behavior of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesized from tyrosine by a common biosynthetic pathway.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind cholecystokinin %28%CCK%29% with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by GASTRIN as well as by CCK-4; CCK-8; and CCK-33. Activation of these receptors evokes secretion of AMYLASE by pancreatic acinar cells, acid and PEPSIN by stomach mucosal cells, and contraction of the PYLORUS and GALLBLADDER. The role of the widespread CCK receptors in the central nervous system is not well understood.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behavior of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized cyclic AMP receptors are those of the slime mold Dictyostelium discoideum. The transcription regulator CYCLIC AMP RECEPTOR PROTEIN of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind eicosanoids with high affinity and trigger intracellular changes influencing the behavior of cells. Among the eicosanoid receptors are receptors for the prostaglandins, thromboxanes, and leukotrienes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind glutamate and directly gate ion channels in cell membranes. AMPA receptors were originally discriminated from other glutamate receptors by their affinity for the agonist AMPA %28%alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid%29%. They are probably the most common mediators of fast excitatory synaptic transmission in the central nervous system. Several subtypes have been cloned, and for some types the traditional distinction from kainate receptors may not apply.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind glutamate and directly gate ion channels. Kainic acid receptors were originally discriminated from other glutamate receptors by their affinity for the agonist kainic acid. Activation of kainic acid receptors is generally excitatory to cells. Subtypes have been cloned, and for some the traditional distinction from AMPA receptors may not apply.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognize the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind neurotensin with high affinity and trigger intracellular changes which influence the behavior of cells. Neurotensin and neurotensin receptors are found in the central nervous system and in the periphery.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behavior of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone%27%s stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behavior of cells. These include receptors for glucagon %28%secreted by alpha cells%29%, insulin %28%secreted by beta cells%29%, somatostatin %28%secreted by delta cells%29%, and pancreatic peptide %28%secreted by PP cells%29%. Some of these hormones and receptors also support neurotransmission.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind pituitary THYROTROPIN %28%also named thyroid stimulating hormone or TSH%29% and trigger intracellular changes of the target cells. TSH receptors are present in the nervous system and on target cells in the thyroid gland. Autoantibodies to TSH receptors are implicated in thyroid diseases such as GRAVES DISEASE and Hashimoto disease %28%THYROIDITIS, AUTOIMMUNE%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell %28%From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5%29%. Cell surface receptors, unlike enzymes, do not chemically alter their ligands.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin%27%s role as a neurotransmitter.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins that bind tachykinins with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1; NK-2; and NK-3; which prefer, respectively, substance P, neurokinin A %28%substance K, neurokinin alpha, neuromedin L%29%, and neurokinin B %28%neurokinin beta, neuromedin K%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and control an integral membrane chloride channel. GABA-A receptors are the most prevalent inhibitory neurotransmitter receptors in the brain. Several isoforms have been cloned, and they belong to a superfamily which includes nicotinic receptors, glycine receptors, and 5HT-3 receptors. Most GABA-A receptors have separate modulatory sites sensitive to benzodiazepines and to barbiturates.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and influence cells via interactions with G-proteins. GABA-B receptors are pharmacologically characterized by their insensitivity to the blocker bicuculline and sensitivity to the agonist L-baclofen. They are found both presynaptically and postsynaptically, and act variously by inhibition of adenylate cyclase, activation of phospholipase A2, activation of potassium channels, and inactivation of voltage-activated calcium channels.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptor for LAMININ, epiligrin, FIBRONECTINS, entactin, and COLLAGEN. Integrin alpha3beta1 is the major integrin present in EPITHELIAL CELLS, where it plays a role in the assembly of BASEMENT MEMBRANE as well as in cell migration, and may regulate the functions of other integrins. Two alternatively spliced isoforms of the alpha subunit %28%INTEGRIN ALPHA3%29%, are differentially expressed in different cell types.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors for EPOPROSTENOL. They are coupled to HETEROTRIMERIC G-PROTEINS.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors for colony stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of hemopoietic cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors for invertebrate peptide hormones or neuropeptides.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind BRADYKININ and related KININS with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types %28%B-1 and B-2, or BK-1 and BK-2%29% recognize endogenous KALLIDIN; t-kinins; and certain bradykinin fragments as well as bradykinin itself.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind CORTICOTROPIN; %28%ACTH, adrenocorticotropic hormone%29% with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple ACTH receptors. An ACTH receptor has been cloned and belongs to a subfamily of G-protein-coupled receptors. In addition to the adrenal cortex, ACTH receptors are found in the brain and immune systems.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind NERVE GROWTH FACTOR; %28%NGF%29% and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind TUMOR NECROSIS FACTORS and trigger changes which influence the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind glycine with high affinity and trigger intracellular changes which influence the behavior of cells. Glycine receptors in the central nervous system have an intrinsic chloride channel and are usually inhibitory.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 %28%DP receptors%29%, prostaglandin E2 %28%EP1, EP2, and EP3 receptors%29%, prostaglandin F2-alpha %28%FP receptors%29%, and prostacyclin %28%IP receptors%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behavior of cells. Many neuropeptides are also hormones outside of the nervous system.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind thyrotropin releasing hormone %28%TRH%29% with high affinity and trigger intracellular changes which influence the behavior of cells. Activated TRH receptors in the anterior pituitary stimulate the release of thyrotropin %28%thyroid stimulating hormone, TSH%29%; TRH receptors on neurons mediate neurotransmission by TRH.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that bind to ACETYLGLUCOSAMINE. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors that respond to PHEROMONES. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin E receptors prefer prostaglandin E2 to other endogenous prostaglandins. They are subdivided into EP1, EP2, and EP3 types based on their effects and their pharmacology.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell to Cell Interaction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, 3T3-L1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, APUD' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Amacrine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Aneuploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Anterior Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Antibody-Producing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Antibody-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Antigen-Presenting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Artificial beta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, BALB 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, BALB-3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, BALB-c 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Blood' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Bone Marrow' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, CHO' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, COS' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, COS-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, COS-7' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Caco-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Capillary Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Cardiac Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Cell-Mediated Lympholytic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Chromaffin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Clone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Connective Tissue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Cultured' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Cultured Neoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Cultured Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Dendritic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Diploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Dorsal Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Embolic Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Embryonal Carcinoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Enterochromaffin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Epithelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Epithelioid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Erythroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Erythroid Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Erythroid Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Erythroid Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Erythropoietic Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Erythropoietic Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Eukaryotic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Extraglomerular Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Fat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Foam' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Foreign-Body Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Gastric Parietal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Gastric Zymogenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Gastrin-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Germ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Germ-Line' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Glial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Glomerular Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Glucagon-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Goblet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Granulocyte Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Granulocytic Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Granulosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Granulosa-Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Granulosa-Lutein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HCT 116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HCT-116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HCT116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HL60' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HT-29' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HT29' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Haploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, HeLa-KB' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Heart Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Hela' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Hematopoietic Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Hematopoietic Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Hepatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Hybrid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Immobilized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Immunoglobulin-Producing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Immunoglobulin-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Immunologic Accessory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Inner Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Insulin-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Interdigitating Dendritic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Islet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Jurkat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, K' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, KB' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Kidney Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Killer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, L %28%Cell Line%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, LAK' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, LE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, LLC-PK1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Labyrinth Supporting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Lacis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Large Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Liver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Lutein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Lymphatic Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Lymphoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Lymphokine-Activated Killer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Mast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Mesenchymal Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Mesenchymal Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Mother' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Multinucleated Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Myeloid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Myeloid Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Myeloid Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Myogenic Satellite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, NIH 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, NIH-3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, NK' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Natural Killer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Neoplasm Circulating' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Neoplastic Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Nerve' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Neuroepithelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Neuroglial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Null' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Outer Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Ovarian Interstitial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Oxyntic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Pancreatic Polypeptide-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Perineuronal Satellite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Plasma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Polyploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Posterior Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Prokaryotic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Pyramidal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Renal Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Retinal Bipolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Retinal Ganglion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Retinal Horizontal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Small Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Smooth Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Stromal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, T8' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, TC1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, TC2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Testicular Interstitial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Th1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Th2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Th3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Theca' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Theca-Lutein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Totipotent Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Tr1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Treg' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Tumor Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, U937' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Vascular Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Ventral Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Vero' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell, Vestibular Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Cycle Regulatory Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Free System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Free Systems' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Growth Inducer, Myeloid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Matrix Adherens Junction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Matrix Adherens Junctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Matrix Adhesions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Matrix Junction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Matrix Junctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Mediated Immunities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Mediated Immunity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Mediated Lympholytic Cell' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Mediated Lympholytic Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Membrane Coated Pit' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Membrane Coated Pits' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-Stimulating Factor, Histamine-Producing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-cell junctions that seal adjacent epithelial cells together, preventing the passage of most dissolved molecules from one side of the epithelial sheet to the other. %28%Alberts et al., Molecular Biology of the Cell, 2nd ed, p22%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface components or appendages of bacteria that facilitate adhesion %28%BACTERIAL ADHESION%29% to other cells or to inanimate surfaces. Most fimbriae %28%FIMBRIAE, BACTERIAL%29% of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules %28%RECEPTORS, LEUKOCYTE-ADHESION%29%. A defect in the gene encoding CD18 causes LEUKOCYTE-ADHESION DEFICIENCY SYNDROME.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface glycoproteins and serine protease, also known as dipeptidyl-peptidase IV, that play a role in T-lymphocyte activation. CD26 binds to adenosine deaminase on the T-cell surface. EC 3.4.14.5%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors %28%AMPA, kainate, and N-methyl-D-aspartate receptors%29%, which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-surface receptors that bind LEUKOTRIENES with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4; LTC4; LTD4; and LTE4.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-to-Cell Interaction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cell-to-Cell Interactions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellfree System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellfree Systems' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellobiase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellobiases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellobiohydrolase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellobiohydrolase, 1,4-beta-D-Glucan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellobiose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellophane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellophanes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells Cancer, Granulosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells Cancers, Granulosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure or %22%monoclonal%22% antibodies or T-cell products, identical to those produced by the immunologically competent parent, and continually grow and divide as the neoplastic parent.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells contained in the bone marrow including fat cells %28%see ADIPOCYTES%29%, STROMAL CELLS, MEGAKARYOCYTES, and the immediate precursors of most blood cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells derived from primitive cell types in the neural crest. During ontogeny they migrate to the foregut and specific locations of the neuroendocrine system. Properly located these cells form part of the normal hormone producing tissues of the neuroendocrine system. If misdirected these cells may become hyperplastic, adenomatous, or malignant %28%cf. APUDOMA%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells forming a framework supporting the organ of Corti. Specific cells are those of Claudius, Deiters and Hensen.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells found throughout the lining of the GASTROINTESTINAL TRACT that contain and secrete regulatory PEPTIDE HORMONES and/or BIOGENIC AMINES.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells in invertebrates which are specialized to detect and transduce light and darkness and relay that information centrally in the nervous system.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells lining the outside of the BLASTOCYST. After binding to the ENDOMETRIUM, trophoblasts develop into two distinct layers, an inner layer of mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblasts, which form the early fetal-maternal interface %28%PLACENTA%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells of epithelial origin possessing specialized sensory functions. They include cells that are found in the TASTE BUDS; OLFACTORY MUCOSA; cochlear HAIR CELLS; and NEUROEPITHELIAL BODIES.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells of the innermost nuclear layer of the retina, the ganglion cell layer, which project axons through the optic nerve to the brain. They are quite variable in size and in the shapes of their dendritic arbors, which are generally confined to the inner plexiform layer. A small subset of these cells act as photoreceptors and project to the SUPRACHIASMATIC NUCLEUS, the location of the circadian clock, setting the CIRCADIAN RHYTHM.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells responsible for spontaneous cytotoxicity of a variety of tumor cells without prior immunization. These natural killer cells are found in non-immune humans and experimental animals and are thought by some to be the same as KILLER CELLS %28%killing by antibody-dependent cell cytotoxicity%29%, but they can also kill in the absence of antibody.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells specialized to detect and transduce light. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells specialized to detect and transduce light. Rods and cones are the photoreceptors in the vertebrate retina.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells specialized to detect chemical substances and relay that information centrally in the nervous system. Chemoreceptors may monitor external stimuli, as in TASTE and OLFACTION, or internal stimuli, such as the concentrations of OXYGEN and CARBON DIOXIDE in the blood.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells specialized to transduce mechanical stimuli and relay that information centrally in the nervous system. Mechanoreceptors include HAIR CELLS, which mediate hearing and balance, and the various somatosensory receptors, often with non-neural accessory structures.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells that can develop into distinct mesenchymal tissue such as BONE; TENDONS; MUSCLES; ADIPOSE TISSUE; CARTILAGE; NERVE TISSUE; and BLOOD and BLOOD VESSELS.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells that can give rise to most types of cells but not all types of cells necessary for fetal development. %28%Stem Cells: A Primer %5B%Internet%5D%. Bethesda %28%MD%29%: National Institutes of Health %28%US%29%; 2000 May %5B%cited 2002 Apr 5%5D%. Available from: http://www.nih.gov/news/stemcell/primer.htm%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells that line the inner and outer surfaces of the body by forming cellular layers %28%EPITHELIUM%29% or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others %28%CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM%29% from mesoderm.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia %28%PARAGANGLIA, CHROMAFFIN%29% of the sympathetic nervous system.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells with extensive dendritic processes found in the B-cell areas %28%primary follicles and germinal centers%29% of lymphoid tissue. They are unrelated to the DENDRITIC CELLS associated with T-cells. Follicular dendritic cells have Fc receptors %28%RECEPTORS, FC%29% and C3b receptors %28%RECEPTORS, COMPLEMENT 3B%29%, but unlike other dendritic cells, they do not process or present antigen in a way that allows recognition by T-cells. Instead, they hold antigen in the form of immune complexes on their surfaces for long periods and can present antigen to B-cells during an immune response. %28%From Herbert et al., Dictionary of Immunology, 4th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, 3T3-L1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, APUD' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Amacrine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Aneuploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Anterior Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Antibody-Producing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Antibody-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Antigen-Presenting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Artificial beta' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Askenazy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, BALB 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, BALB-3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, BALB-c 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Blood' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Bone Marrow' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, CHO' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, COS' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, COS-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, COS-7' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Caco-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Capillary Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cardiac Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cell-Mediated Lympholytic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Chromaffin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Clone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Connective Tissue' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1971-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1972-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1972-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1972-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1974-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1979-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1979-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1980-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured %28%1982-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured Neoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Cultured Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Dendritic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Diploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Dorsal Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Embolic Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Embryonal Carcinoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Enterochromaffin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Epithelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Epithelioid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Erythroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Erythroid Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Erythroid Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Erythroid Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Erythropoietic Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Erythropoietic Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Eukaryotic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Extraglomerular Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Fat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Foam' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Foreign-Body Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Gastric Parietal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Gastric Zymogenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Gastrin-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Germ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Germ-Line' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Glial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Glomerular Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Glucagon-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Goblet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Granulocyte Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Granulocytic Precursor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Granulosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Granulosa-Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Granulosa-Lutein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HCT 116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HCT-116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HCT116' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HL60' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HT-29' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HT29' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Haploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, HeLa-KB' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Heart Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hela' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hematopoietic Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hematopoietic Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hepatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hurthle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Hybrid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Immobilized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Immunoglobulin-Producing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Immunoglobulin-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Immunologic Accessory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Inner Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Insulin-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Interdigitating Dendritic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Islet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Jurkat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, K' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, K562' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, KB' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Kidney Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Killer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Kupffer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, L %28%Cell Line%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, LAK' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, LE' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, LLC-PK1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Labyrinth Supporting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Lacis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Langerhans' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Langhans Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Langhans-Type Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Large Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Leydig' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Liver' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Lutein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Lymphatic Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Lymphoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Lymphokine-Activated Killer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Mast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Merkel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Mesenchymal Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Mesenchymal Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Mother' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Multinucleated Giant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Myeloid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Myeloid Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Myeloid Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Myogenic Satellite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, NIH 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, NIH-3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, NK' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Natural Killer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Neoplasm Circulating' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Neoplastic Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Nerve' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Neuroepithelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Neuroglial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Null' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Outer Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Ovarian Interstitial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Oxyntic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Oxyphil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Pancreatic Polypeptide-Secreting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Paneth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Perineuronal Satellite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Plasma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Polyploid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Posterior Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Progenitor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Prokaryotic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Purkinje' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Pyramidal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Reed-Sternberg' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Renal Mesangial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Retinal Bipolar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Retinal Ganglion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Retinal Horizontal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Rouget' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Schwann' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Sertoli' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Small Luteal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Smooth Muscle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Sternberg-Reed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Stromal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Swiss 3T3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, T8' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, TC1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, TC2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Testicular Interstitial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Th1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Th2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Th3' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Theca' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Theca-Lutein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Totipotent Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Tr1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Treg' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Tumor Stem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, U937' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Vascular Endothelial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Ventral Horn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Vero' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, Vestibular Hair' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, such as those of bacteria and the blue green algae, which lack a nuclear membrane so that the nuclear material is either scattered in the cytoplasm or collected in a nucleoid region.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells, usually bacteria or yeast, which have partially lost their cell wall, lost their characteristic shape and become round.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells/SE %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells/physiology %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells/physiology %28%1968-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cells/transplantation %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celltech Brand of Beclomethasone Dipropionate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celltech Brand of Dextroamphetamine Sulfate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celltech Brand of Fendiline Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celltech Brand of Labetalol Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celltech Brand of Mesalamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celltech Brand of Methylphenidate Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellubrevin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Aging' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Anoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Anoxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Apoptosis Susceptibility Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Autophagies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Autophagy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Blue Nevi' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular DNA-binding proteins encoded by the c-fos genes %28%GENES, FOS%29%. They are involved in growth-related transcriptional control. c-fos combines with c-jun %28%PROTO-ONCOGENE PROTEINS C-JUN%29% to form a c-fos/c-jun heterodimer %28%TRANSCRIPTION FACTOR AP-1%29% that binds to the TRE %28%TPA-responsive element%29% in promoters of certain genes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular DNA-binding proteins encoded by the c-jun genes %28%GENES, JUN%29%. They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization %28%with c-fos%29%, DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated %28%constitutive%29% expression of c-myc proteins can cause tumorigenesis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular DNA-binding proteins encoded by the myb gene %28%GENES, MYB%29%. They are expressed in a wide variety of cells including thymocytes and lymphocytes, and regulate cell differentiation. Overexpression of myb is associated with autoimmune diseases and malignancies.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular DNA-binding proteins encoded by the rel gene %28%GENES, REL%29%. They are expressed predominately in hematopoietic cells and may play a role in lymphocyte differentiation. Rel frequently combines with other related proteins %28%NF-KAPPA B, I-kappa B, relA%29% to form heterodimers that regulate transcription. Rearrangement or overexpression of c-rel can cause tumorigenesis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular DNA-binding proteins encoded by the sis gene %28%GENES, SIS%29%. c-sis proteins make up the B chain of PLATELET-DERIVED GROWTH FACTOR. Overexpression of c-sis causes tumorigenesis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Ependymoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Ependymomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Hypoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Hypoxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Immunities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Immunity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Immunotherapies, Adoptive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Immunotherapy, Adoptive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Inclusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Inclusions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Inclusions %28%1970-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Inclusions %28%1972-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Mechanotransduction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Phone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Phone, Portable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Phone, Transportable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Phones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Phones, Portable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Phones, Transportable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Proliferation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Proto Oncogene Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Proto-Oncogene Products' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Proto-Oncogene Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Respiration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Respirations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Senescence' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Spheroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Spheroids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Structure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Structures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Telephone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Telephones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular Tumor Antigen p53' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular processes in biosynthesis %28%anabolism%29% and degradation %28%catabolism%29% of CARBOHYDRATES.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular proteins and protein complexes that transport amino acids across biological membranes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and is involved in signal transduction as a monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular proteins encoded by the c-mos genes %28%GENES, MOS%29%. They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN GP120.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular receptors which mediate the sense of temperature. Thermoreceptors in vertebrates are mostly located under the skin. In mammals there are separate types of thermoreceptors for cold and for warmth and NOCICEPTORS which detect cold or heat extreme enough to cause pain.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular signaling in which a factor secreted by a cell affects other cells in the local environment. This term is often used to denote the action of INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS on surrounding cells.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulase %28%1974-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulase Enzyme System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulitides, Pelvic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulitis, Pelvic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulomonas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose 1,4 beta Cellobiosidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose 1,4-beta-Cellobiosidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose Acetate Electrophoreses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose Acetate Electrophoresis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose Nitrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose derivative used in chromatography, as ion-exchange material, and for various industrial applications.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose, Absorbable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose, Carboxymethyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose, Methyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulose, Oxidized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulosic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulosome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulosomes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellulysin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cellvibrio' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Celosia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cembrane Diterpenes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cembranes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cemco Brand of Phenazopyridine Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Glass-Ionomer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Polycarboxylate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Resin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Silicate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Zimmer Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Zinc Oxide-Eugenol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Zinc Phosphate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cement, Zinc Polycarboxylate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementation %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementation %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementoblast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementoclast' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementoclasts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementoenamel Junction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementoenamel Junctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementogenesis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements that act through infiltration and polymerization within the dentinal matrix and are used for dental restoration. They can be adhesive resins themselves, adhesion-promoting monomers, or polymerization initiators that act in concert with other agents to form a dentin-bonding system.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Cermet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Glass Ionomer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Glass Polyalkenoate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Polyalkenoate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cements, Resin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cementum, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cemetery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cenchrus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Census' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Census Method' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Censuses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Histories, 15th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Histories, 16th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Histories, 17th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Histories, 19th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Histories, 20th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Histories, 21st %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. History, 15th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. History, 16th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. History, 18th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. History, 19th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. History, 20th %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. History, 21st %28%Medicine%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Medicine, 18th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Medicine, 21st' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cent. Medicines, 21st' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centaurea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centaurium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centchroman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centedrin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centella' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centenarian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center for Disease Control' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center for Disease Control and Prevention' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Abortion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Academic Medical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Ambulatory Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Birth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Birthing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Burn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Child Daycare' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Community Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Drug Rehabilitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Drug Treatment' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Family Planning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Fitness' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Germinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Hospital Birth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Hospital Birthing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Information' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Maternal-Child Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Multidisciplinary Pain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Neighborhood Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Pain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Poison Control' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Rehabilitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Respiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Rural Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Satellite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Trauma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, University Medical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Center, Wellness' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Disease Control' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Disease Control %28%U.S.%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Disease Control and Prevention' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Disease Control and Prevention %28%U.S.%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Health Planning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Medicare and Medicaid Services' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for Medicare and Medicaid Services %28%U.S.%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for acquiring and storing semen. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for acquiring, characterizing, and storing bones or bone tissue for future use.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for acquiring, characterizing, and storing organs or tissue for future use.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for acquiring, storing, and distributing human milk.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for collecting, characterizing and storing human blood.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers for storing various parts of the eye for future use.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Abortion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Academic Medical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Ambulatory Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Birth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Birthing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Burn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Child Daycare' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Community Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Drug Rehabilitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Drug Treatment' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Family Planning' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Fitness' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Germinal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Hospital Birth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Hospital Birthing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Information' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Maternal-Child Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Multidisciplinary Pain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Neighborhood Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Pain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Poison Control' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Rehabilitation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Respiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Rural Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Satellite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Trauma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, University Medical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centers, Wellness' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrafarm Brand of Acetylcysteine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central African Republic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Alveolar Hypoventilation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central America' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central American Amerind' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central American Amerinds' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central American Indian' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central American Indians' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Apnea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Apneas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Auditory Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Auditory Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Auditory Dysfunction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Auditory Pathway Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Auditory Processing Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Autonomic Nervous System Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Brand of Activated Charcoal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Catheterization' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Catheterizations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Cities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Cord Injury Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Cord Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Core Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Core Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Core Myopathies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Core Myopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Diabetes Insipidus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Dorsal Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central European Encephalitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Facial Paralyses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Facial Paralysis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Gray, Mesencephalic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Gray, Midbrain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Hearing Loss' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Horner Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Lateral Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Medial Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Muscle Relaxants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central NF2 Neurofibromatoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central NF2 Neurofibromatosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System AIDS Arteritis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Angiitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Bacterial Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Cavernous Hemangioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Cysticercosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Cysts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Demyelinating Diseases, Hereditary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Demyelinating Hereditary Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Depressants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Depressants %28%1966-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Diseases %28%1966-1968%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Diseases %28%1966-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Diseases %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Diseases %28%1967-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Diseases %28%1986-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Disorders, Intracranial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Drugs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Fungal Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Helminthiasis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Hereditary Demyelinating Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Inborn Metabolic Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Intracranial Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Lupus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Lupus Vasculitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Mycoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Parasitic Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Protozoal Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Schistosomiasis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Stimulants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Syphilis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Systemic Lupus Erythematosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Toxoplasmosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Tuberculosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Tumors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Vascular Anomalies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Vascular Malformations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Vasculitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Venous Angioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Viral Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous System Viral Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Nervous Systems' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Neurocytoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Neurocytomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Origin Vertigo' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Pontine Myelinoclasis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Pontine Myelinolysis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Retinal Arteries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Retinal Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Retinal Edema, Cystoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Retinal Vein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Retinal Veins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Scotoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Scotomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Sleep Apnea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Sleep Apnea Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Sleep Apneas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Sleep Disordered Breathing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Sleep-Disordered Breathing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Sleep-Disordered Breathings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Spinal Cord Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Stimulants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Supplies, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Supply, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Venous Catheterization' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Venous Catheterizations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Venous Pressure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central Venous Pressures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central gray matter surrounding the cerebral aqueduct in the mesencephalon. Physiologically it is probably involved in rage reactions, the lordosis reflex, feeding responses, bladder tonus, and pain.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central retinal artery and its branches. It arises from the ophthalmic artery, pierces the optic nerve and runs through its center, enters the eye through the porus opticus and branches to supply the retina.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Central retinal vein and its tributaries. It runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centralized Hospital Service' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centralized Hospital Services' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centralized Service, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centralized Services, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrally Acting Muscle Relaxants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centralopathic Epilepsies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centralopathic Epilepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centran' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrarchidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centric Dental Occlusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centric Relation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centric Relation, Dental' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. %28%From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugation, Density Gradient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugation, Isopycnic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugation, Zonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugations, Density Gradient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrifugations, Zonal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centriole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrioles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrioles %28%1982-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrocecal Scotoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrocecal Scotomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrocytic Small-Cell Lymphoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrocytic Small-Cell Lymphomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centromedian Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centromere' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centromere Autoantigen 80K' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centromere Protein B' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centromeres' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centronuclear Myopathies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrophenoxine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrosome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrosomes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrotemporal Epilepsies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrotemporal Epilepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrum Brand of Capsaicin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrum Brand of Fluocinolone Acetonide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Centrum Brand of Sulpiride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, 15th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, 16th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, 18th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, 19th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, 20th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, 21st' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Eighteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Fifteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Nineteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Seventeenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Sixteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Twentieth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century Histories, Twenty-first' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 15th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 16th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 17th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 18th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 19th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 20th' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, 21st' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Eighteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Fifteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Nineteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Seventeenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Sixteenth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Twentieth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Century History, Twenty-first' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cenuriases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephacetrile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephadroxyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephaelis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalalgia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalalgia, Trigeminal Autonomic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalalgias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalalgias, Trigeminal Autonomic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalexin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalexin %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalexin Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalexin/analogs %26% derivatives %28%1975-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgia Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgia Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgia, Histamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgia, Vascular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgias, Histamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalgias, Vascular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalic Version, External' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalic Versions, External' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalin Kaolin Coagulation Time' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalin N Methyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalin-Kaolin Coagulation Time' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalins %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalodynia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalodynias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephaloglycin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephaloglycine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalometry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalometry %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalomycine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalon Brand of Butorphanol Tartrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalon Brand of Methylphenidate Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalopelvic Disproportion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalopelvic Proportions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalopelvimetries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalopoda' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalopods' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalorhynchus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephaloridin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephaloridine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin Amido beta Lactam Hydrolase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin Amido-beta-Lactam Hydrolase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin Antibiotics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin Resistance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin Resistances' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin beta Lactamase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporin beta-Lactamase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporinase %28%1975-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1966-1984%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1970-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1973-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1979-1981%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins %28%1984-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporins/pharmacology %28%1966-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalosporium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalotaxine Alkaloids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalotaxus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalotaxus Alkaloids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalothin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalothin Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephalothin, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamandole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamezine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamycin Antibiotics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamycins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamycins %28%1975-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamycins %28%1979-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephamycins %28%1982-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephapirin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephapirin Monosodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephapirin, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephazolin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephazolin Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephazolin, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephotaxim' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephradine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephradine, Non Stoichiometric Hydrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cephuroxime' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramic, Alumina' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramidase, Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramidase, Glucosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramidase, Glycosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramide Diglyceride Kinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramide Galactosyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramide Synthetase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramide Trihexosidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramide Trihexosides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramide, Monosialosyl Tetraglycosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramides %28%1972-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramides, Galactosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramides, Glucosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramides, Lactosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceramides, Trihexosyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerastes Venom' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceratitis capitata' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceratopogonidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerclage of Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerclage of Uterine Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerclage, Cervical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercobin M 70' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercobin M70' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercocebus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercocebus atys' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecidae %28%1980-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecinae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecine herpesvirus 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecine herpesvirus 16' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus %28%1975-1980%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus aethiops' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus aethiops %28%1981-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus pygerythrus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus sabeus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cercopithecus tantalus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cereal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cereals' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cereals %28%1966-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cereals %28%1980-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia %28%1968-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia %28%1970-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia %28%1975-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia %28%1980-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia, Marie' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxia, Marie%27%s' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Ataxias, Dentate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Atrophy, Dentate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Cancers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Cortex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Degeneration, Paraneoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Degeneration, Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Diseases %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Diseases %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Diseases %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Diseases %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dysfunction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dysfunctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dysmetrias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dyssynergia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dyssynergia, Myoclonic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dyssynergias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Dyssynergias, Myoclonic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Gait' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Gait Ataxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Gaits' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Hemiataxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Hemorrhages, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Incoordination' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Incoordinations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Mossy Fiber' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasm, Benign' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasm, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasm, Primary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasms %28%1971-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasms, Benign' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Neoplasms, Malignant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Nuclei' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Nucleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Syndrome, Paraneoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Syndromes, Paraneoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar Tumors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellar degeneration associated with a remote neoplasm. Clinical manifestations include progressive limb and GAIT ATAXIA; DYSARTHRIA; and NYSTAGMUS, PATHOLOGIC. The histologic type of the associated neoplasm is usually carcinoma or lymphoma. Pathologically the cerebellar cortex and subcortical nuclei demonstrate diffuse degenerative changes. Anti-Purkinje cell antibodies %28%anti-Yo%29% are found in the serum of approximately 50%25% of affected individuals. %28%Adams et al., Principles of Neurology, 6th ed, p686%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebello-Retinal Angiomatoses, Familial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebello-Retinal Angiomatosis, Familial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellopontile Angle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellopontile Angles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellopontine Angle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellopontine Angles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebelloretinal Angiomatoses, Familial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebelloretinal Angiomatosis, Familial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellum %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellum Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellum Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellum Primary Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellum Primary Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebellums' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Abscesses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Amyloid Angiopathies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Amyloid Angiopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Amyloid Angiopathy %28%1992-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Amyloid Angiopathy, Familial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Aneurysmal Arteriopathy, AIDS Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Aneurysmal Arteriopathy, AIDS-Associated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Aneurysms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Angiographies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Angiography' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Anoxia Ischemia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Anoxia-Ischemia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Anoxia-Ischemias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Aqueduct' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Aqueduct %28%1971-1982%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Aqueducts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Circle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Diseases %28%1965-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Diseases %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Diseases %28%1967-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterial Diseases/classification %28%1967-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries %28%1984-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries, Anterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries, Middle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries, Posterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries/abnormalities %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteries/surgery %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arterioscleroses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteriosclerosis %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteriovenous Malformation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Arteriovenous Malformations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery Diseases %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery Spasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery Spasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery, Anterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery, Middle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Artery, Posterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Astrocytoma, Childhood' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Astrocytomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Astrocytomas, Childhood' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Atheroscleroses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Beriberi' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Brain Hemorrhage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Brain Hemorrhages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cavernous Hemangiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Concussion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Concussions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Convexity Meningiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex %28%1966-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex %28%1966-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex %28%1968-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex Decortication' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex Decortications' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortex/physiology %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cortices' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cryptococcoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cryptococcoses, Granulomous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Cryptococcosis, Granulomous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Decortication' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Decortications' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Demyelinating Diseases, Autoimmune' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Dominance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Dominances' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Edema, Cytotoxic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Edema, Vasogenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Edemas, Vasogenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Emboli' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Embolism and Thrombosis %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Embolus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hematomas, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemispheres, Absence, Congenital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhage %28%1964-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhage %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhage %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhage %28%1968-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhage, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhages, Hypertensive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hemorrhages, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hernia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hernias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hypertensive Hemorrhage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hypertensive Hemorrhages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hypoxia Ischemia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Hypoxia-Ischemias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Infarction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Infarction %28%1978-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Infarction %28%1979-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Infarction, Middle Cerebral Artery' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Infarctions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Intraparenchymal Hematoma, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Intraparenchymal Hemorrhage, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemia Anoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemia Hypoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemia-Anoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemia-Anoxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemia-Hypoxia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemia-Hypoxias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ischemias, Transient' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Leukomalacia, Neonatal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Leukomalacias, Neonatal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Malaria' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Microsurgical Revascularization' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Microsurgical Revascularizations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsies, Athetoid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsies, Dyskinetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsies, Dystonic-Rigid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsies, Monoplegic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsy, Dyskinetic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsy, Dystonic Rigid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsy, Hypotonic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Palsy, Monoplegic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Paraparesis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Paraplegia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Paraplegias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Parenchymal Hemorrhage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Parenchymal Hemorrhage, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Parenchymal Hemorrhages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Peduncles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Protozoal Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Pseudoscleroses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Pseudosclerosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Revascularization' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Sclerosis, Diffuse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Sclerosis, Diffuse %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Sclerosis, Diffuse %28%1966-1982%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Sclerosis, Diffuse %28%1981-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Stroke' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Strokes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Syncope' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Syncopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Thromboses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Toxoplasmosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Vasculitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Vasospasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Vein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Veins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle Neoplasms %28%1966-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle Neoplasms %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle Tumor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricle Tumors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1965-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1965-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1968%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles/abnormalities %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventricles/surgery %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventriculographies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral Ventriculography' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral tissue herniation through a congenital or acquired defect in the skull. The majority of congenital encephaloceles occur in the occipital or frontal regions. Clinical features include a protuberant mass that may be pulsatile. The quantity and location of protruding neural tissue determines the type and degree of neurologic deficit. Visual defects, psychomotor developmental delay, and persistent motor deficits frequently occur.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral, Left Hemisphere, Infarction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebral, Right Hemisphere, Infarction' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebri, Epiphysis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebritides, Listeria' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebritis, Listeria' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebro Hepato Renal Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebro Oculo Renal Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebro-Hepato-Renal Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebro-Hepato-Renal Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebro-Oculo-Renal Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebro-Oculo-Renal Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroatrophic Hyperammonemia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroatrophic Hyperammonemias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrohepatorenal Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrohepatorenal Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebromalacia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebromalacias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebromeningitides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebromeningitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrooculorenal Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrooculorenal Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroretinal Degeneration, Juvenile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroretinal Degenerations, Juvenile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroside Lipidosis Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroside Lipidosis Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroside Sulfatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroside Sulphatase Deficiency Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroside-Sulfatase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides %28%1970-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides %28%1972-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides %28%1972-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher%27%s disease.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Effusion, Subdural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Leakage, Subdural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Otorrhea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Otorrhea, Post Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Otorrhea, Post-Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Otorrheas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Pressure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Pressures' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Rhinorrhea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Rhinorrhea, Post Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Rhinorrhea, Traumatic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Rhinorrheas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Shunt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Shunts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Shunts %28%1969-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluid Shunts %28%1972-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Fluids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Otorrhea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Rhinorrhea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrospinal Rhinorrheas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrotendinous Xanthomatoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrotendinous Xanthomatosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Accident' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Accident, Acute' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Accidents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Accidents, Acute' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Apoplexy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Circulation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Circulation %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Circulation %28%1982-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disease, Basal Ganglia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1964-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1966-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1966-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1971-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1974-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1975-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1983-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1987-1992%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders %28%1994-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders/complications %28%1965-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Disorders/surgery %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Insufficiencies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Moyamoya Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Occlusions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Spasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Spasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Stroke' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Strokes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrovascular Trauma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroventricular Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebroventricular Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrum Hemorrhage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerebrum Hemorrhages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceremonial Behavior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceremonial Behaviors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerium %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerium Isotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerium Radioisotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cermet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cermet Cements' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceroid %28%1975-1982%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceroid Lipofuscinosis, Neuronal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceroid-Lipofuscinosis, Neuronal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certificate of Need' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certificate, Birth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certificate, Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certificates, Birth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certificates, Death' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certification' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certification %28%1968-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certification %28%1968-Jul 1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certification Levels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Certifications' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerulein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerulenin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceruletid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceruletide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceruloplasmin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceruloplasmin Ferroxidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceruloplasmin Oxidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cerumen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Cancer, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Cancers, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Caps' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Caries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Cary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Cerclage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Dilatations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Disease, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Diseases, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Dysplasia, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Erosion, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Esophagostomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Ganglia, Superior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Ganglion, Superior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Incompetence, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Intraepithelial Neoplasia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Intraepithelial Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Intraepithelial Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Lymphadenitis, Mycobacterial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Migraine Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Mucus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Neoplasm, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Neoplasms, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Pain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Pain, Anterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Pain, Posterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Pains' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Pains, Anterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Pains, Posterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Plexus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Radiculopathies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Radiculopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Rib Cervical Band Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Rib Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Rib Syndromes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Ripening' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Ripenings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Smear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Sympathetic Dystrophies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Tuberculous Lymphadenitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervical Vertebrae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicalgia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicalgias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervices, Incompetent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicitides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicitides, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicitis, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervico Brachial Neuralgia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervico-Brachial Neuralgias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicobrachial Neuralgia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicobrachial Neuralgias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicodynia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicodynias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicofacial Actinomycoses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicofacial Actinomycosis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicogenic Headaches' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicoplasty' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicothoracic Ganglia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervicothoracic Ganglion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Cancer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Dentis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Diseases' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Diseases %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Diseases %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Dysplasia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Dysplasia %28%1977-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Erosion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Erosion, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Incompetence' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Incompetence %28%1973-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Mucus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Neoplasm' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Neoplasms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Neoplasms %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Neoplasms %28%1966-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Uteri' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Uteri %28%1976-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix Uteri/surgery %28%1966-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix, Incompetent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix, Tooth' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervix, Uterine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cervixes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesarean Section' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesarean Section %28%1971-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesarean Section %28%1980-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesarean Section, Repeat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesarean Sections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesarean Sections, Repeat' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesium Isotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesium Isotopes %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cesium Radioisotopes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation of Treatment' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation of the habit of using tobacco products for smoking or chewing, including the use of snuff.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation of the heart beat. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation, Smokeless Tobacco' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation, Smoking' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation, Tobacco' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessation, Tobacco Use' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessations, Smokeless Tobacco' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessations, Smoking' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessations, Tobacco' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cessations, Tobacco Use' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestoda' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestoda %28%1965-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestoda %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestoda %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestoda %28%1966-1985%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestode Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestode Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestode Infections %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestodes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestrium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cestrum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1965-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1965-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1965-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1966-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1969-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetacea %28%1977-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetaceas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetamide, Isopto' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetirizine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetomacrogol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetrimonium Compounds' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetylpyridinium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetylpyridium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetyltrimethylammonium Compounds' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cetyltrimethylammonium compounds that have cationic detergent, antiseptic, and disinfectant activities. They are used in pharmaceuticals, foods, and cosmetics as preservatives; on skin, mucous membranes, etc., as antiseptics or cleansers, and also as emulsifiers. These compounds are toxic when used orally due to neuromuscular blockade.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cevane Alkaloids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cevanes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ceylon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ch%27%i' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'ChTX' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chacma Baboon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chacma Baboons' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chad' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaetochloa italica' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaetomium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chagas Cardiomyopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chagas Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chagas%27% Cardiomyopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chagas%27% Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Elongation, Peptide, Translational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Initiation, Peptide, Translational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Migrations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Pickerel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Reaction, Ligase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Reactions, Ligase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain Termination, Peptide, Translational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Cold' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Food' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Laminin M' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Markov' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Parasite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Predator' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Respiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, Saprophytic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, VLA-2 alpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chain, VLA-5 alpha' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Cold' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Food' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Immunoglobulin Light' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Markov' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Parasite' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Predator' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Respiratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, Saprophytic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chains, lambda-Immunoglobulin Light' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chair, High' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chair, Wheel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chairs mounted on wheels and designed to be propelled by the occupant.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chairs, High' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chairs, Wheel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaix et du Marais Brand of Calcium Gluconate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaix et du Marais Brand of Procaine Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalazion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalazions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalcogens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalcone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalcone/analogs %26% derivatives %28%1991-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalcones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalkone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenge Test, Bronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenge Test, Endobronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenge Tests, Bronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenge Tests, Endobronchial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenge, Bronchial Allergen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenge, Endobronchial Allergen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenges, Bronchial Allergen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Challenges, Endobronchial Allergen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chalones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamaecrista' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamaecyparis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamaemelum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamber, Anterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamber, Atmosphere Exposure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamber, Culture Diffusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamber, Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamber, Semi-Permeable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamber, Semipermeable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chambers, Anterior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chambers, Atmosphere Exposure' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chambers, Culture Diffusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chambers, Pulp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chambers, Semi-Permeable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chambers, Semipermeable' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomile %28%1999-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomile, German' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomile, Roman' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomile, Scentless' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomile, Stinking' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chamomilla recutita' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chancre' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chancres' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chancroid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chancroids' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change brought about to an organisms genetic composition by unidirectional transfer %28%TRANSFECTION; TRANSDUCTION, GENETIC; CONJUGATION, GENETIC, etc.%29% and incorporation of foreign DNA into prokaryotic or eukaryotic cells by recombination of part or all of that DNA into the cell%27%s genome.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change in learning in one situation due to prior learning in another situation. The transfer can be positive %28%with second learning improved by first%29% or negative %28%where the reverse holds%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change in the surface ANTIGEN of a microorganism. There are two different types. One is a phenomenon, especially associated with INFLUENZA VIRUSES, where they undergo spontaneous variation both as slow antigenic drift and sudden emergence of new strains %28%antigenic shift%29%. The second type is when certain PARASITES, especially trypanosomes, PLASMODIUM, and BORRELIA, survive the immune response of the host by changing the surface coat %28%antigen switching%29%. %28%From Herbert et al., The Dictionary of Immunology, 4th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change of Life' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change of Life, Female' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change of Life, Male' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change of heartbeat induced by pressure on the eyeball, manipulation of extraocular muscles, or pressure upon the tissue remaining in the orbital apex after enucleation.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change, Body Temperature' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change, Body Weight' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change, Postmortem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Change, Social' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes in biological features that help an organism cope with its ENVIRONMENT. These changes include physiological %28%ADAPTATION, PHYSIOLOGICAL%29%, phenotypic and genetic changes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes in the observed frequency of waves %28%as sound, light, or radio waves%29% due to the relative motion of source and observer. The effect was named for the 19th century Austrian physicist Johann Christian Doppler.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes in the organism associated with senescence, occurring at an accelerated rate.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes that occur to liberate the enzymes of the ACROSOME of a sperm %28%SPERMATOZOA%29%. Acrosome reaction allows the sperm to penetrate the ZONA PELLUCIDA and enter the OVUM during FERTILIZATION.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes, Body Temperature' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes, Body Weight' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes, Organizational' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes, Postmortem' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changes, Social' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Changing an open-chain hydrocarbon to a closed ring. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Activators, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Agonist, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Agonists, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Blockers, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Blockers, Potassium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Blockers, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Catfish' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Catfishes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Forming Integral Membrane Protein Of 28 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Islands' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Islands %28%1967-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel Proteins, Water' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel refers to the English Channel ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Chloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Chloride Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, IRK1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Ionic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Membrane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, N-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, P-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Potassium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Potassium Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Q-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, R-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, Sodium Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, T-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel, TRP' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channel-Forming Integral Membrane Protein Of 28 kDa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels Voltage-Dependent, Anion-Selective' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Chloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Chloride Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Ionic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Membrane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, N-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Neural-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, P-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Potassium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Potassium Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Purkinje-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Sodium Ion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, T-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, TRP Cation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, TRPC Cation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, TRPM Cation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, TRPP Cation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, TRPV Cation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Transient-Type Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Voltage-Dependent Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Channels, Water' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaos Theories' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaotic concept of self wherein one%27%s role in life appears to be an insoluble dilemma often expressed by isolation, withdrawal, rebellion and extremism.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperone, Molecular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperones, Molecular' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperonin 10' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperonin 10 %28%GroES%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperonin 60' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperonin 60 %28%GroEL%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperonin Family' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaperonins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaplaincy Hospital Service' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaplaincy Hospital Services' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaplaincy Service, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chaplaincy Services, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chapter, Book' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chapters, Book' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Char' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chara' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characeae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Character' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Character traits that are considered to be morally praiseworthy. %28%Bioethics Thesaurus%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Character, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Character, Polygenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic cells of granulomatous hypersensitivity. They appear as large, flattened cells with increased endoplasmic reticulum. They are believed to be activated macrophages that have differentiated as a result of prolonged antigenic stimulation. Further differentiation or fusion of epithelioid cells is thought to produce multinucleated giant cells %28%GIANT CELLS%29%.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Acceptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Biologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Biological' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Cultural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Dropout' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Epidemiologic Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Family' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Human' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Nonacceptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Population' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Receiver Operating' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Residence' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristic, Sex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics or attributes of persons or things which elicit pleasurable feelings.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Acceptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Biologic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Cultural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Dropout' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Epidemiologic Study' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Family' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Human' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Nonacceptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Population' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Receiver Operating' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Residence' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Sex' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characteristics, Social' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characters, Oral' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Characters, Polygenic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charadriiformes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcoal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcoal, Activated' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Gaits' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Joint' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Marie Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Marie Tooth Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Marie Tooth Disease, Type I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Marie Tooth Disease, Type II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Marie Tooth Disease, Type Ia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot Marie Tooth Disease, Type Ib' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot%27%s Gait' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot%27%s Joint' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot-Marie Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot-Marie Disease %28%1975-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot-Marie-Tooth Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot-Marie-Tooth Disease, Type I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcot-Marie-Tooth Disease, Type II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcots Gait' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charcots Joint' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charge' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charge Nurse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charge, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charges and Fees' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charges, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charity' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charophytes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chars' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chart, Flow %28%Computer%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charts %28%PT%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charts %5B%Publication Type%5D%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charts and Tables' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charts, Flow %28%Computer%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Charybdotoxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chasteberry Tree' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chastetree' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Atropine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Carbachol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Digitoxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Fluorescein Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Naphazoline Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Povidone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chauvin Brand of Sulfacetamide Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Checkpoint Genes, Cell Cycle' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chediak Higashi Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chediak-Higashi Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheek' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheek %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheek Bone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheek Bones' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheeks' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheese' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheese, Soy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheeses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheeses, Soy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheetah' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheetahs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chefaro Brand of Activated Charcoal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chefaro Brand of Benzydamine Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chefaro Brand of Tripelennamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheilitides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheilitis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheilitis Granulomatosa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheilitis Granulomatosa, Facial Neuropathy, Orofacial Edema' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheilitis Granulomatosa, Orofacial Edema, Facial Neuropathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheilitis, Miescher-Melkersson-Rosenthal Granulomatous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheirogaleidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheirogaleus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelatase, Porphyrin-Metal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelatase, Zinc' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelates, Iron' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelating Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelating Agents %28%1966-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelating Agents, Iron' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelating Agents/therapeutic use %28%1966-1989%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelating agent and inhibitor of cellular respiration. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelating agent used for heavy metal poisoning and assay. It causes diabetes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelation Therapies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelation Therapy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelators' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chelidonium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chem mart Brand of Gemfibrozil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chem mart Brand of Moclobemide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemexfoliation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemexfoliations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemia Brand of Fluconazole' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemia Brand of Sulindac' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Actions and Uses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Analyses, Blood' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Analysis, Blood' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Burn' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Burns' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Defoliants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Depression' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Depressions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Dictionaries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Dictionary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Engineering' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Evolution' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Evolutions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Face Peeling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Fractionation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Fractionations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Hypophysectomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Hypophysectomy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Industries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Industry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Industry %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Model' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Models' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Riot Control Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Sensitivities, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Sensitivity, Multiple' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Shift Imaging' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Shift Imagings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Stimulation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Stimulations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Sympathectomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Sympathectomy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Sympathetic Denervation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Sympathetic Denervations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Terrorism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Tubal Occlusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Tubal Occlusions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Vaccines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Warfare' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Warfare %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Warfare %28%1996-2005%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Warfare Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Warfares' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Water Pollutants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Water Pollution' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical Water Pollutions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical agents injected into veins to cause localized thrombosis and eventual fibrosis and obliteration of the vessels. They are used in the treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical agents or odors that stimulate sexual desires. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical agents that uncouple oxidation from phosphorylation in the metabolic cycle so that ATP synthesis does not occur. Included here are those IONOPHORES that disrupt electron transfer by short-circuiting the proton gradient across mitochondrial membranes.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical analysis by titration, the determination of a given component in solution by addition of a liquid reagent of known strength until a given endpoint %28%e.g., a change in color%29% is reached.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical and Pharmacologic Phenomena' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical and physical transformation of the biogenic elements from their nucleosynthesis in stars to their incorporation and subsequent modification in planetary bodies and terrestrial biochemistry. It includes the mechanism of incorporation of biogenic elements into complex molecules and molecular systems, leading up to the origin of life.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical compounds causing LUTEOLYSIS or degeneration. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical compounds derived from acids by the elimination of a molecule of water.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical compounds which pollute the water of rivers, streams, lakes, the sea, reservoirs, or other bodies of water.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water %28%neutralization%29%. An extension of the term includes substances dissolved in media other than water. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical decomposition by the action of light and the lysis or solution of cells under the influence of light. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical groups containing the covalent disulfide bonds -S-S-. The sulfur atoms can be bound to inorganic or organic moieties.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances excreted by humans that elicit behavior or physiological responses from other humans. Perception of these chemical signals may be olfactory or by contact.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances that are destructive to spermatozoa used as topically administered vaginal contraceptives.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances that attract or repel cells or organisms. The concept denotes especially those factors released as a result of tissue injury, invasion, or immunologic activity, that attract leukocytes, macrophages, or other cells to the site of infection or insult.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances that interrupt pregnancy after implantation.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances that prevent or reduce the probability of CONCEPTION.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances which are employed during a riot in order to control or disperse the rioting parties.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances with sperm immobilizing activity used as topically administered vaginal contraceptives.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances, excreted by an organism into the environment, that elicit behavioral or physiological responses from other organisms of the same species. Perception of these chemical signals may be olfactory or by contact.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical, biological, or medical measures designed to prevent the spread of ticks or the concomitant infestations which result in tick-borne diseases. It includes the veterinary as well as the public health aspects of tick and mite control.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical, pharmacologic, and metabolic action and interaction of drugs.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemically Defined Diet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemically Defined Diets' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals especially for use on instruments to destroy pathogenic organisms. %28%Boucher, Clinical Dental Terminology, 4th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals functioning in the visual cycle in retinal rod cells. Through excitation by visible light, a series of complex molecular changes occur that serve to trigger in the optical nerve endings an impulse transmitted to the brain, resulting in the perception of vision.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals necessary to perform experimental and/or investigative procedures and for the preparation of drugs and other chemicals.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals that are used to cause the disturbance, disease, or death of humans during war.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals that, while not possessing inherent pesticidal activity, nonetheless promote or enhance the effectiveness of other pesticides when combined.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals used in agriculture. These include pesticides, fumigants, fertilizers, plant hormones, steroids, antibiotics, mycotoxins, etc.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals used mainly to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, EDTA, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. Root canal irrigants include also rinsing solutions of distilled water, sodium chloride, etc.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals used to destroy pests of any sort. The concept includes fungicides %28%FUNGICIDES, INDUSTRIAL%29%; INSECTICIDES; RODENTICIDES; etc.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals, Agricultural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals, Endocrine Disrupting' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals, Hazardous' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals, Inorganic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals, Laboratory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemicals, Organic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemidex Brand of Mefenamic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescence Measurement' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescence Measurements' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescence, Physical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescent Assay' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescent Assays' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescent Measurement' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiluminescent Measurements' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheminova Brand of Paromomycin Sulfate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemiosmotic Mechanism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemirosa, Cloretilo' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistries, Agricultural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistries, Bioinorganic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistries, Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistries, Inorganic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistries, Physical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry Technic, Combinatorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry Technics, Combinatorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry Technique, Combinatorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry Techniques, Combinatorial' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry Test, Clinical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry Tests, Clinical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry that deals with the composition and preparation of substances used in treatment of patients or diagnostic studies. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Agricultural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Analytic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Analytical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Analytical %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Bioinorganic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Brain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Clinical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Clinical %28%1966-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Inorganic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Organic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Organic %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Organic %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Pharmaceutic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Pharmaceutical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Pharmaceutical %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Pharmaceutical %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Pharmaceutical %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Pharmaceutical %28%1984-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Physical' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Physical %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Physical %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Physical %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Physical %28%1966-1970%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemistry, Physical %28%1966-1990%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoattractant Factor, Lymphocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoattractant Protein-1, Monocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoattractant Proteins, Monocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoattractant Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoattractants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemodectoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemodectomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoembolization, Therapeutic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoembolizations, Therapeutic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokine Receptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines %28%1996-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines %28%1997-1999%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines that are chemoattractants for monocytes. These CC chemokines %28%cysteines adjacent%29% number at least three including MONOCYTE CHEMOATTRACTANT PROTEIN-1.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines, C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines, C-C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines, C-X-C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines, CC' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines, CX3C' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemokines, CXC' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoluminescence Measurement' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoluminescence Measurements' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemolyses, Intervertebral Disk' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemolysis, Intervertebral Disk' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemonucleolyses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemonucleolysis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoprevention' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoprophylaxis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoreceptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoreceptors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemoreceptors %28%1991-2003%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemosignals, Human' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemosterilants' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemosterilants %28%1966-1971%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemosympathectomies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemosympathectomy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Cytokines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factor, Macrophage Derived' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factor, Macrophage-Derived' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factor, Neutrophil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factor, Neutrophil, Monocyte-Derived' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors %28%1980-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors %28%1989-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors %28%1991-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors %28%1992-1995%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors %28%1992-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors %28%1994-1997%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors, Eosinophil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Factors, Macrophage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Peptide Receptor' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Peptide-Interleukin-8, Granulocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Protein-1, Monocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotactic Proteins, Monocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxins, Eosinophil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxins, Macrophage' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis %28%1966-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis %28%1970-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis, Leukocyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis, Leukocyte %28%1977-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotaxis, Leukocyte %28%1977-1983%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapies, Combination' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy Protocol, Antineoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy Protocol, Cancer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy Protocols, Antineoplastic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy Protocols, Cancer' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy, Adjuvant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy, Cancer, Regional Perfusion' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chemotherapy, Combination' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenique Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholate, Glycine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholate, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholate, Taurine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholic Acid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholic Acid %28%1973-1977%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholic Acid %28%1973-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholylglycine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodeoxycholyltaurine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenodiol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenophalk' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenopodiaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenopodiaceae %28%1998-2001%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenopodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenopodium album' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenopodium ambrosioides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chenopodium quinoa' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chephasaar Brand of Flutamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheplapharm Brand of Activated Charcoal' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cherimoya' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chernobyl Nuclear Accident' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chernobyl Nuclear Accident, Chornobyl, Ukraine, 1986' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chernobyl Nuclear Accidents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cherries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cherry Red Spot Myoclonus Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cherry, Ground' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cherubism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Compression, High-Frequency' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Compressions, High-Frequency' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Injuries' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Injury' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Pain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Pains' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Tube' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Tubes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Wall' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Wall Oscillation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest Wall Oscillations' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest, Flail' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest, Funnel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest, Medicine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chest, Stove-in' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chestnut, Horse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chestnut, Water' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chests, Funnel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chests, Medicine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chewing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chewing Gum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chewing Gums' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chewing Lice' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chewing Tobacco' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheyne Stokes Respiration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Cheyne-Stokes Respiration' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chi Square Distribution' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chi Square Test' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chi, Tai' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chi-Square Distribution' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chi-Square Distributions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chi-Square Tests' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiari Frommel Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiari Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiari%27%s Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiari-Frommel Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiaris Syndrome' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiasm, Optic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiasma Opticum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiasma Opticums' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiasma, Optic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiasmas, Optic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiasms, Optic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chibret' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chibro Proscar' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicago' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicana' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicanas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicano' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicanos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chick Embryo' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chick Embryo %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chick Embryo %28%1966-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chick Embryos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chick syncytial viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Anemia Agent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Anemia Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Infectious Anemia Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Ovalbumin Upstream Promoter Transcription Factor I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Ovalbumin Upstream Promoter Transcription Factor II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Ovalbumin Upstream Promoter Transcription Factors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Ovalbumin Upstream Promoter-Transcription Factor I' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Ovalbumin Upstream Promoter-Transcription Factor II' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Ovalbumin Upstream Promoter-Transcription Factors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken Pox' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken anemia virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicken anemia viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chickenpox' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chickenpox Vaccine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chickenpox Virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chickenpox Viruses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chickens' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chickweed, Mouse-ear' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chicory' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chief Cell, Gastric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chief Cells, Gastric' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chief Executive Officer, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chief Executive Officers, Hospital' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiesi Brand of Acetazolamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiesi Brand of Altretamine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiesi Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiesi Brand of Carboplatin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiesi Brand of Vancomycin Hydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiggers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chih Ya' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chikungunya virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chilblain' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chilblains' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child %28%1965-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child %28%1966-1968%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Abuse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Abuse %28%1966-1986%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Abuse %28%1984-2002%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Abuse, Sexual' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Abuse/legislation %26% jurisprudence %28%1966-1996%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Abuses' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Advocacies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Advocacy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Behavior' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Behavior %28%1966-1969%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Behavior %28%1967-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Behavior Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Behavior Disorders %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Behavior Disorders %28%1966-1968%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Brain Abscess' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Care' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Care %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Care %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Craniopharyngioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Craniopharyngiomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Custodies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Custody' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Day Care Centers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Daycare Center' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Daycare Centers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Development' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Development Deviation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Development Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Development Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Development Disorders, Pervasive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Guidance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Guidance Clinic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Guidance Clinics' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Guidances' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Health Service' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Health Services' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Health Services %28%1968-1978%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Language' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Languages' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Mental Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Molestation, Sexual' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Mortalities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Mortality' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Nutrition' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Nutrition Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Nutrition Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Nutritions' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Psychiatry' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Psychiatry %28%1966%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Psychology' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Psychology %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Psychology %28%1966-1968%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Reactive Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Reactive Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Rearing' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Rearing %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Rearing %28%1970-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Rearings' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Relationship, Parent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Relationships, Parent' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Service, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Services, Health' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Sexual Abuse' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Syndrome, Battered' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Syndromes, Battered' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Welfare' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Welfare %28%1966-1967%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Welfare %28%1966-1972%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Welfare %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child Welfare %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child hospitalized for short term care. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child of Impaired Parents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child who has no siblings. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child with one or more parents afflicted by a physical or mental disorder.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Abandoned' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Disabled' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Exceptional' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Gifted' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Homeless' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Hospitalized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Institutionalized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Only' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Preschool' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Preschool %28%1966-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Preschool %28%1966-1988%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Street' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Child, Unwanted' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbearing, Delayed' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirth at Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirth taking place in the home. ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirth, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirth, Natural' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirths' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirths at Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childbirths, Home' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood ALL' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Absence Epilepsies' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Absence Epilepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Benign Focal Epilepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Benign Frontal Epilepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Benign Psychomotor Epilepsy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Cerebral Astrocytomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Communication Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Eating and Feeding Disorders' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Lead Encephalopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Medulloblastoma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Medulloblastomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Mercurialism, Chronic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Mercurialisms, Chronic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Muscular Dystrophy, Pseudohypertrophic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Neurologic Saturnism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Night Terror' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Night Terrors' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Oligodendroglioma' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Oligodendrogliomas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Onset Dystonia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Onset Nemaline Myopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Pavor Nocturnus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Pseudohypertrophic Muscular Dystrophy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Saturine Encephalopathy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Schizophrenia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Schizophrenias' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Sleep Bruxism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Sleep Bruxisms' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Stuttering' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Tic Disorder' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Torsion Disease' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Type Dermatomyositides' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childhood Type Dermatomyositis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Childlessness, Voluntary' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children of Impaired Parents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children who have reached maturity or the legal age of majority.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children with Disabilities' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children with Disability' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children with mental or physical disabilities that interfere with usual activities of daily living and that may require accommodation or intervention.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Abandoned' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Adult' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Dentistry for' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Disabled' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Exceptional' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Gifted' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Handicapped' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Homeless' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Hospitalized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Impaired Parents%27%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Institutionalized' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Only' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Preschool' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Puppet' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Street' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Children, Unwanted' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chile' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chili Pepper' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chili Peppers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chilli Peppers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chills' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimaerin 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimaerin Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimaerin, alpha-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimaerin, alpha-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimera' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimera %28%1966-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimera %28%1978-1993%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimera, Radiation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimera, Transplantation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeras' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeras, Radiation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeras, Transplantation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeric Oncogene Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeric Proteins, Mutant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeric Proteins, Oncogene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeric Toxin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeric Toxins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimerin 1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimerin Proteins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimerin, alpha-1' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimerin, alpha-2' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimerism' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzee' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzee Coryza Agents' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzee Retrovirus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzee troglodyte' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzee troglodytes' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzee, Pygmy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzees' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chimpanzees, Pygmy' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'China' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'China %28%1970-1994%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'China-Sumac' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinaberry Tree' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chincaps, Orthodontic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinchilla' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinchillas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese American' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Chives' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Drugs, Plant' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Ephedra' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Hamster' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Hamsters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Herbal Drugs' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Licorice' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Medicine, Traditional' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Plant Extracts' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Traditional Medicine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese Water Chestnut' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.%A% ' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Ching Lo' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chingamin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinidin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinoin Brand of Lindane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinoin Brand of Methoxsalen' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinook Salmon' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinosol Brand of Ethacridine Lactate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinosol Brand of Oxyquinoline Potassium Sulfate %28%2:1%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chinosol Brand of Tolnaftate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chip, DNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chip, Gene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chip, Gene Expression' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chip, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chip, Protein Profiling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chipmunk' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chips, DNA' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chips, Gene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chips, Gene Expression' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chips, Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chips, Protein Profiling' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiro Inositol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiro-Inositol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiron Brand of Acetylcysteine Sodium Salt' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiron Brand of Flutamide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chironex Venom' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chironomidae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiropody' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiropractic' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiropractic %28%1992-1998%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiropractic Adjustment' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiropractic Manipulation' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chiroptera' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitin %28%1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitin Synthase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitin UDP Acetylglucosaminyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitin-UDP Acetylglucosaminyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitin/analogs %26% derivatives %28%1975-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitinase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitobiase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitons' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chitosan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chittoor virus' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chive' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chive, Chinese' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chives' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chives, Chinese' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia %28%1966-1974%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia %28%1966-1975%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia %28%1989-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia Infections %28%1967-1976%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia muridarum' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia pneumoniae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia psittaci' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia trachomatis' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydia trachomatis %28%1980-2000%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydiaceae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydiaceae Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydiaceae Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydiales' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydomonas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydomonas %28%1972-1991%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydomonas reinhardii' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydomonas reinhardtii' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydomonas, Heat-Shock Protein' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydophila' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydophila Infection' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydophila Infections' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydophila pneumoniae' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlamydophila psittaci' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloasmas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlolincocin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlomipramine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloracetophenone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloral Hydrate' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloralose' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorambucil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorambucil %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramines' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloraminophene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramiphene' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramp' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol %28%1966-1987%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol Acetyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol O Acetyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol O-Acetyltransferase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol Resistance' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol Resistances' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloramphenicol Transacetylase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloranil' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorates' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorazepate, Dipotassium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorbutin' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorbutol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorchinaldine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorchinaldol' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlordan' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlordane' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlordecone' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlordiazepoxide' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlordiazepoxide Monohydrochloride' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlordimeform' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorella' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorella %28%1971-2004%29%' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorella vulgaris' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorellas' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorethazine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorethylamine, Dibenzyl' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorfenvinphos' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorguanid' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorgyline' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorhexidine' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chlorhydrins' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Bicarbonate Antiporters' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Bicarbonate Exchanger' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Bicarbonate Exchangers' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Cotransporters, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Dihydrate, Calcium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Ion Channel' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Ion Channels' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Peroxidase' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride Symporters, Sodium' = 0).
% 42.08/42.01 fof(interp, fi_functors, 'Chloride and mercury-containing derivatives of benzoic acid.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Acriflavine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Alkyldimethylbenzylammonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ambenonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ammonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Anhydrous Calcium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Apomorphine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Bencetonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Benzalkonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Benzethonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Bethanechol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Cadmium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Calcium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ceepryn' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Cetylpyridinium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Chlorisondamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Chlorocholine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Choline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Choline Phosphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Dequalinium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Dietary Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Edrophonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ethyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ethyl Mercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ethylmercuric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ethylmercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ferriheme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Ferriprotoporphyrin IX' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Guanidinium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Guanidium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Hexamethonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Hexamethylpararosaniline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Hydrogen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Hydroxylammonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Lithium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Magnesium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Mercuric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Methacholine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Methionine Methylsulfonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Methyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Methylene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Methylmethioninesulfonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Methylrosaniline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Morphine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, NBD' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Nitrobenzoxadiazole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Obidoxime' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Oxyphenonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Phosphorylcholine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Picryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Polyvinyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Potassium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Prospidium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Protamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Tetraethylammonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Tolonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Tubocurarine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride, Vinyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride-Bicarbonate Antiporters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride-Bicarbonate Exchanger' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride-Bicarbonate Exchanger, AE1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloride-Bicarbonate Exchangers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorides %28%1966-1973%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorides %28%1977-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorides %28%1979-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorides %28%1980-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorides, Vinylidene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorimipramine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorinated Hydrocarbons' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorinated Steroids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorinated hydrocarbons containing heteroatoms that are present as contaminants of herbicides. Dioxins are carcinogenic, teratogenic, and mutagenic. They have been banned from use by the FDA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1971-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1972-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1973-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine %28%1974-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorine Compounds' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloriridoviruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorisondamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorisondamine Dichloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloriuretic Hormones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorlincocin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormadinon Acetate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormadinone Acetate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormequat' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormerodrin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormerodrin %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormeroprin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormethazanone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormethiazole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormethine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlormezanone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloro%28%7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato%28%4-%29%-N%28%21%29%,N%28%22%29%,N%28%23%29%,N%28%24%29%%29% ferrate%28%2-%29% dihydrogen.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroacetylcholine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroamines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobenzenes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobenzenes %28%1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobenzenes %28%1974-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobenzenes %28%1974-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobenzoates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobi' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobi %28%1996-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorobutanol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorochin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorodinitrobenzene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroethane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroethylene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroethylene Homopolymer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroethylene Polymer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroethylmercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroflexi' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroflexus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorofluorocarbons' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorofluorocarbons, Methane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroform' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroform %28%1974%29% /AA %28%1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorofos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorogenic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroguanide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorohemin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorohydrin, Ethylene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorohydrins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroiodoquine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercuribenzene p sulphonic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercuribenzenesulfonate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercuribenzoates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercuribenzoates %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercuribenzoates %28%1980-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercurinitrophenols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromercuriphenylsulfonate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethane, Tosyllysyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethane, Tosylphenylalanyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethyl Ether' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethyl Ketone, Tosyllysine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethyl Ketone, Tosylphenylalanyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloromethyl Ketones, Peptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloronitrobenzoxadiazole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroperoxidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophenols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophenoxyisobutyrate, Ethyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophenyl GABA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophenyltosylamidobutanone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll %28%1966-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll %28%1972-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll %28%1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll %28%1976-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll Protein Complexes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll Protein, Light-Harvesting' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll a Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll ab Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyll ac Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyllides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophylls from which the magnesium has been removed by treatment with weak acid.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorophyta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast ATP Synthase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast ATP Synthases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast ATPase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast ATPases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast Coupling Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast Coupling Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast F%28%1%29%F%28%0%29% ATPase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast Peptide Initiation Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast Proton Translocating ATPases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast Proton-Translocating ATPases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplast Reaction Center Protein D1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplasts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplasts %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplasts %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroplasts %28%1969-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroprene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroprene Polymer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroprene Polymers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroquinaldol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroquine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroquine Sulphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroquinolinols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorotetracycline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorothiazide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorotosylamidoaminoheptanone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorotrianisene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chloroxacillin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorphenamidine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorphenamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorphenesin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorpheniramine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorphentermine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorphenvinphos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorphthalidolone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorpiprazine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorpromazine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorpropamide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorpropham' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorprophenpyridamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorprothixene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorprotixen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorpyrifos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorquinaldol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlortalidone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlortetracycline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlortetracycline, 4 Epimer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorthalidone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chlorzoxazone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choanal Atresia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choanal Atresias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choice Behavior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choice Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choice of Health Care Provider Laws' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choice of Healthcare Provider Laws' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choice, Career' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choice, Medicare Plus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choices, Career' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choked Disk' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choked Disks' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholagogues and Choleretics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholagogues, Choleretics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholalic Acids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholanes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholanes %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiitides, Sclerosing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiitis, Sclerosing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiocarcinoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiocarcinomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiography %28%1966-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangioma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiopancreatographies, Endoscopic Retrograde' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiopancreatographies, Magnetic Resonance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiopancreatography, Endoscopic Retrograde' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangiopancreatography, Magnetic Resonance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangitides, Sclerosing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangitis %28%1966-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangitis, Chronic Nonsuppurative Destructive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholangitis, Sclerosing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholate, Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choleate, Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecalciferol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecalciferol Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecalciferols %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecalciferols %28%1966-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecalciferols substituted with two hydroxy groups in any position.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecalcin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomies, Celioscopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomies, Laparoscopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomy %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomy, Celioscopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystectomy, Laparoscopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis %28%1964-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis %28%1965-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis %28%1966-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis, Acalculous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis, Acute' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystitis, Emphysematous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin %28%1966-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin %28%1966-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin %28%30-33%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin 2 Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin 33' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin A Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin B Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Octapeptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Octapeptide Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Pancreozymin C Terminal Octapeptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Pancreozymin C-Terminal Octapeptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin Tetrapeptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin-2 Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystokinin-Tetrapeptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystolithiasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholecystostomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Cyst' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Cyst, Diverticulum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Cyst, Intrahepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Cysts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Cysts, Diverticulum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Cysts, Intrahepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochal Diverticulum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochocele' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochoceles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochoduodenostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochojejunostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledocholithiasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochostomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledochus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledojejunostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choledojejunostomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholelithiases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholelithiasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholelithiasis %28%1965-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholelithiasis, Common Bile Duct' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholene derivatives with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. They must have two double bonds in the ring system.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholenes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Enterotoxin CT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Exotoxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Morbus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Toxin A Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Toxin B Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Toxin Protomer B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Vaccines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera Virus, Hog' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera, Hog' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera, Pancreatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholera, Summer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choleragen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choleras' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choleras, Summer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choleretic used to allay dry mouth and constipation due to tranquilizers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choleretics and Cholagogues' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestadiene derivatives containing a hydroxy group anywhere in the molecule.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestadienes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestadienols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestadienols %28%1974-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestan 3 ol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestan-3-ol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanes %28%1968-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanes %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanes %28%1968-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestanones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestases, Intrahepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis %28%1965-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis with Peripheral Pulmonary Stenosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis, Extrahepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis, Intrahepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestasis, Intrahepatic %28%1979-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestatic Jaundice' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteatoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteatoma %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteatoma of the middle ear, usually associated with chronic infection, and commonly affecting the tympanum, epitympanum, and antrum.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteatoma, Middle Ear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteatomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteatomas, Middle Ear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenes %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenes %28%1973-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenone 5 alpha Reductase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenone 5 alpha-Reductase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestenones %28%1970-1982%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1966-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1966-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1968-1974%29% /AA %28%1975-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1971-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1972-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1973-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol %28%1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7 Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7 alpha Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7 alpha Monooxygenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7-alpha-Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7-alpha-Monooxygenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7alpha Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol 7alpha-Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Acyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Acyltransferase, Lecithin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Desmolase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Embolism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Embolisms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Ester Hydrolase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Ester Lysolecithin Acyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Ester Storage Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Esterase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Esterifying Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Esters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Esters %28%1978-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol HDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol High Density Lipoproteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Inhibitors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol LDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipidoses, Neuronal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipidosis, Neuronal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipoprotein, HDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipoprotein, LDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipoprotein, VLDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipoproteins, HDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipoproteins, LDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Lipoproteins, VLDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Low Density Lipoproteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Monooxygenase %28%Side-Chain-Cleaving%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Oxidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Side Chain Cleavage Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Side-Chain Cleavage Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Sulfatase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Sulfate Sulfatase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol VLDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol Very Low Density Lipoproteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol derivatives having an additional double bond in any position. 24-Dehydrocholesterol is DESMOSTEROL. The other most prevalent dehydrocholesterol is the 7-isomer. This compound is a precursor of cholesterol and of vitamin D3.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol present in food, especially in animal products.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol substituted in any position by a keto moiety. The 7-keto isomer inhibits 3-hydroxy-3-methylglutaryl-CoA reductase activity and inhibits cholesterol uptake in the coronary arteries and aorta in vitro.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol which is contained in or bound to high density lipoproteins %28%HDL%29%. High density lipoproteins transport cholesterol from peripheral tissues to the liver thereby acting as a scavenger to prevent excess accumulation and deposition of cholesterol in blood vessels.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol which is contained in or bound to low density lipoproteins %28%LDL%29%; LDL transport cholesterol to peripheral tissues and regulate de novo cholesterol synthesis at these sites. Atherosclerosis is caused by the deposit of cholesterol on the walls of blood vessels, because of high concentrations of LDL cholesterol in plasma.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol which is contained in or bound to very low density lipoproteins %28%VLDL%29%. High concentrations of VLDL cholesterol are found in Type IIB and Type V hyperlipoproteinemia. The end product of VLDL cholesterol catabolism is LDL %28%low density lipoproteins%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol which is substituted by a hydroxy group in any position.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, Dietary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, HDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, LDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, Prebetalipoprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, VLDL' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, alpha-Lipoprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol, beta-Lipoprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterol-7-Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteryl Ester Storage Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteryl Esters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesteryl Oleate Hydrolase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholesterylester Hydrolase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestyramine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholestyramine Resin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholic Acids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholic Acids %28%1978-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1968-1974%29% /AA %28%1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1969-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1974-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1974-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline %28%1975-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Acetylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Acetyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Alfoscerate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Alphoscerate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Chloride Dihydrogen Phosphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Deficiencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Deficiency' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Glycerophosphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Glycerophospholipids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Kinase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline O Acetyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline O Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline O-Acetyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Phosphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Phosphate Chloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Phosphate Cytidylyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Phosphoglycerides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Phosphokinase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Phosphotransferase, Diacylglycerol-CDP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline Transphosphatase, ATP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline, CDP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline, Cytidine Diphosphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choline-Phosphate Cytidylyltransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinephosphotransferase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinephosphotransferase, 1-alkyl-2-Acetylglycerol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinephosphotransferase, CDP-Choline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinephosphotransferase, Diacylglycerol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agonist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agonist, Muscarinic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agonist, Nicotinic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agonists' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agonists, Muscarinic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Agonists, Nicotinic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Antagonist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Antagonists' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Blocking Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Drugs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Fiber' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Fibers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic bundle of nerve fibers posterior to the anterior perforated substance. It interconnects the paraterminal gyrus in the septal area with the hippocampus and lateral olfactory area.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergic-Blocking Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinergics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase Inhibitors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase Inhibitors %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase Inhibitors %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase Reactivators' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase Reactivators %28%1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase reactivator occurring in two interchangeable isomeric forms, syn and anti.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterase reactivator used as an antidote in alkyl phosphate poisoning.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterases %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinesterases %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinoceptive Sites' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinoceptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholinolytics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholylglycine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cholyltaurine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrite' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrite, Carbonaceous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrites, Carbonaceous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondritides, Costal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondritis, Costal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondro 4 Sulfatase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondro-4-Sulfatase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroblast' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroblastoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroblastomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrocalcinoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrocalcinosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrocyte' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrocytes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrodysplasia Punctata' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrodysplasia Punctata %28%1971-1995%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrodysplasia Punctata, Rhizomelic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrodysplasia, Hereditary Deforming' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrodysplasias, Hereditary Deforming' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrodystrophia Calcificans Congenita' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroectodermal Dysplasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroectodermal Dysplasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrogenesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroid Syringoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroid Syringomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin %28%1970-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin %28%1971-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin %28%1974-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 4 Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 4 Sulfate Depolymerase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 4 Sulfate, Aluminum Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 4 Sulfate, Potassium Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 6 Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 6 Sulfate, Potassium Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin 6 Sulfate, Sodium Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin ABC Lyase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin AC Lyase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Lyases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfate 4 Sulfate, Sodium Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfate A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfate B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfate C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfate, Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitin Sulfohydrolase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitinase ABC' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitinase AC II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitinases and Chondroitin Lyases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitinsulfatase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroitinsulfatases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroma %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroma %28%1966-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondroma %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromalacia Patellae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromatoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromatoses, Synovial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromatosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromatosis, Synovial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromatosis, Synovial %28%1989-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondromatosis, Synovial %28%1990-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrometaplasia, Synovial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrometaplasias, Synovial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosarcoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosarcoma %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosarcoma, Mesenchymal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosarcomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosarcomas, Mesenchymal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosteoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrosteomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chondrus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorangioma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorangiomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorda Tympani Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorda Tympani Nerves' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordae Tendineae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordata' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordata %28%1966-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordata, Nonvertebrate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordata, Nonvertebrate %28%2000-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordopoxvirinae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordotomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chordotomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea %28%1966-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Acanthocytosis Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Gravidarum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Gravidarums' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Chronic Progressive Hereditary %28%Huntington%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Fibrillary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Habit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Hereditary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Huntington' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Huntington%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Morvan' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Morvan%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Pregnancy Induced' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Pregnancy-Induced' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea, Sydenham' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorea/diagnosis %28%1966-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Benign Hereditary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Chronic Progressive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Fibrillary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Habit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Hereditary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Morvan' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Pregnancy-Induced' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Rheumatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Senile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreas, Sydenham' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreatic Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreatic Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreatic Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreatic Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreic Movement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreic Movements' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreiform Movement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreiform Movements' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreoathetoses, Pregnancy-Associated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreoathetosis Self Mutilation Hyperuricemia Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreoathetosis Self-Mutilation Hyperuricemia Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreoathetosis, Pregnancy Associated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choreoathetosis, Pregnancy-Associated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioadenoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioadenomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioallantoic Membrane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioallantoic Membranes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioamnionitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioamnionitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinoma %28%1980-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinoma %28%1984-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinoma, Non gestational' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinoma, Non-gestational' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriocarcinomas, Non-gestational' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriogonadotropin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriomammotrophin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriomammotropin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choriomeningitis, Lymphocytic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorion %28%1975-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin, alpha' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin, alpha Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin, beta Chain, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin, beta Polypeptide, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Gonadotropin, beta Subunit, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Somatomammotropin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Somatomammotropin, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villi' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villi %28%1983-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villi Biopsies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villi Biopsy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villi Sampling' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villi Samplings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villus Sampling' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorionic Villus Samplings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioretinitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorioretinitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorismate Mutase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorismate Mutase Prephenate Dehydratase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorismate Mutase Prephenate Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorismate Pyruvatemutase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chorismic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choristoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choristomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chornobyl Nuclear Accident' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chornobyl Nuclear Accidents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chornobyl Nuclear Disaster' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chornobyl Nuclear Disasters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid %28%1966-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid %28%1966-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid %28%1966-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid %28%1970-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Hemorrhage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Neovascularization' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Neovascularizations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus %28%1966-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus Papilloma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus Papillomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus Tumor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid Plexus Tumors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroid/blood supply %28%1980-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Hemorrhage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Hemorrhages' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Neovascularization' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroidal Neovascularizations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroideremia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroideremias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroiditides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroiditis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Choroids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christ Siemens Touraine Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christiaens Brand of Aprindine Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christiaens Brand of Asparaginase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christiaens Brand of Midodrine Monohydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christian Ethic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christian Science' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christian Scientist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christianity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christianity %28%1974-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christianity %28%1979-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christmas Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christmas Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Christmas Island' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Cells' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Granule' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Granule Amine Transporter' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Granules' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Paraganglia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin System %28%1966-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin System %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin System %28%1967-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin System %28%1969-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromaffin Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromates %28%1969-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatiaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatiaceae %28%1976-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatiaceae %28%1988-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatid Exchange, Sister' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatid Exchanges, Sister' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatids %28%1968-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin %28%1971-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin %28%1972-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin Assembly and Disassembly' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin Associated RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin Disassemblies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin Immunoprecipitation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin Modeling' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatin/metabolism %28%1978-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatins, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographic techniques in which the mobile phase is a liquid.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Affinity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Agarose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Gas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Gas-Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Gas-Liquid-Mass Spectrometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Gas-Mass Spectrometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Ion Exchange' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Ion-Exchange' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Mass' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Mass Spectrometry-Gas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Paper' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Sepharose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Thin Layer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatographies, Thin-Layer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography %28%1966-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography %28%1966-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography %28%1976-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography %28%1980-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography %28%1987-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography on non-ionic gels without regard to the mechanism of solute discrimination.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Affinity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Agarose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Countercurrent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, DEAE Cellulose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, DEAE-Cellulose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Exclusion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas %28%1966-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas Liquid Mass Spectrometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas Mass Spectrometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas-Liquid-Mass Spectrometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gas-Mass Spectrometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gel' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gel Filtration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Gel Permeation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, High Performance Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, High Pressure Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, High Speed Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Ion Exchange' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Ion-Exchange' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Liquid %28%1985-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Liquid, High Pressure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Mass' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Mass Spectrometry-Gas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Micellar Electrokinetic Capillary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Molecular Sieve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Paper' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Paper %28%1966-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Sepharose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Supercritical Fluid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Thin Layer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography, Thin-Layer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography-Mass Spectrometries, Gas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography-Mass Spectrometries, Gas-Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography-Mass Spectrometry, Gas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatography-Mass Spectrometry, Gas-Liquid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophore' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophore, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophores' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophores %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophores %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophores %28%large pigment cells of fish, amphibia, reptiles and many invertebrates%29% which contain melanin. Short term color changes are brought about by an active redistribution of the melanophores pigment containing organelles %28%MELANOSOMES%29%. Mammals do not have melanophores; however they have retained smaller pigment cells known as MELANOCYTES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatophores, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromatotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromenes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromic acid %28%H2Cr2O7%29%, dipotassium salt. A compound having bright orange-red crystals and used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically it has been used externally as an astringent, antiseptic, and caustic. When taken internally, it is a corrosive poison.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Adenosine Triphosphate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Alloys' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Cobalt Alloys' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Compounds' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium EDTA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Isotopes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Nickel Alloys' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium Radioisotopes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromium-Cobalt Alloys' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromobacterium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromobindin 9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromoblastomycoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromoblastomycosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromogenic Compounds' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromogranins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromolaena' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromomycin A3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromomycins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromomycoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromomycosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromonar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromones %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromophobe Adenoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromophobe Adenomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromoplast' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Aberration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Aberrations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Abnormalities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Abnormality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Break' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Breakage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Breakages' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Breaks' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Colinearities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Colinearity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Fragility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Instabilities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Instability' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Inversion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Inversions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Phosphoproteins, Non-Histone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Probes, Whole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Proteins, Non Histone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Proteins, Non-Histone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Proteins, Non-Histone %28%1977-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Proteins, Nonhistone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Stabilities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Stability' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Synapsis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Translocation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal Translocations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomal, biochemical, intracellular, and other methods used in the study of genetics.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 10' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 11' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 12' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 13' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 14' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 15' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 16' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 17' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 18' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 19' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 20' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 21' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 22' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 22q11.2 Deletion Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 5 Short Arm Deletion Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 5p Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 5p- Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 5p- Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 6' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 6 Linked Autosomal Recessive Parkinsonism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 6-Linked Autosomal Recessive Parkinsonism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 8' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome 9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberration, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1967-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1967-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1968-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1968-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1968-1981%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1968-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations %28%1989-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Aberrations, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities %28%1964-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities %28%1966-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities %28%1966-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities %28%1980-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormalities, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormality Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormality Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Abnormality, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Banding' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Bandings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Break' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Breakage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Breakages' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Defective Micronuclei' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Deletion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Deletion %28%1975-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Deletion %28%1975-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Deletion %28%1976-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Deletion %28%1987-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Deletions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Disorder, Autosomal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Disorder, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Disorders, Autosomal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Disorders, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Fragile Site' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Fragile Sites' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Fragility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Fragility %28%1982-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Inactivation, X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Instabilities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Instability' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Instability Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Inversion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Inversions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1965-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1966-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1968-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1971-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1971-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1972-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping %28%1983-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mapping, Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mappings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Mappings, Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Marker' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Painting' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Paintings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Pairing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Pairings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Positioning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Replication Pattern, Temporal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Replication Timing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Replication Timings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Segregation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Segregation 1 Like Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Segregations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Stabilities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Structure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Structures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Walking' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome Walkings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome regions that are loosely packaged and more accessible to RNA polymerases than HETEROCHROMATIN. These regions also stain differentially in CHROMOSOME BANDING preparations.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Archaeal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Bacterial Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Fungal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group E' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group F' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Group G' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Human Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Human X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Human Y' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Mammalian' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Mammalian Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, P1-Derived Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Ph 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Ph1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Philadelphia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Plant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Ring' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Y' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome, Yeast Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome-Defective Micronuclei' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosome-Defective Micronucleus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1965-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1968-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1973-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1976-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1992-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes %28%1994-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes E' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes F' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes G' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes in which fragments of exogenous DNA ranging in length up to several hundred kilobase pairs have been cloned into yeast through ligation to vector sequences. These artificial chromosomes are used extensively in molecular biology for the construction of comprehensive genomic libraries of higher organisms.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Archaeal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Artificial, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Artificial, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Artificial, Mammalian' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Artificial, P1 Bacteriophage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Artificial, Yeast' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Bacterial %28%1989-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Bacterial %28%1994-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Bacterial Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Fungal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Fungal %28%1988-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group E' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group F' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Group G' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human %28%1978-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human %28%1987-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human Y' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 1-3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 1-3 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 13-15' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 13-15 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 16-18' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 16-18 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 19-20' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 19-20 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 21 22' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 21-22 %28%1968-1985%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 21-22 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 21-22 and Y' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 4-5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 4-5 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 6-12 %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 6-12 %28%1980-1985%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, 6-12 and X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 10' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 11' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 11 %28%1986-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 11 %28%1995-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 12' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 13' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 14' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 15' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 16' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 17' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 18' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 19' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 20' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 21' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 22' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 6' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 8' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Pair 9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Human, Y' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Mammalian' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Mammalian Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, P1 Bacteriophage Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, P1-Derived Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Ph 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Ph1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Plant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Ring' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Sex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Y' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes, Yeast Artificial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromosomes/UL %28%1975-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chromotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronaxie' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronaxies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronaxy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Actinic Dermatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Active Hepatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Airflow Obstruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Airflow Obstructions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Alcoholic Hepatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Alcoholic Intoxication' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Arthritis, Juvenile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Atrophic Polychondritides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Atrophic Polychondritis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic B-Cell Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic B-Cell Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic B-Lymphocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic B-Lymphocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Brain Damage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Brain Injuries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Brain Injury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Bronchitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Childhood Mercurialism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Childhood Mercurialisms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Cluster Headache' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Cluster Headaches' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Cyclitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Daily Headaches' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Delta Hepatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Delta Hepatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease %28%1966-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease %28%1973-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease %28%1983-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease %28%1989-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Disease Hospitals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Encephalopathies, Post-Concussive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Encephalopathy, Post Concussive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue Fibromyalgia Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue and Immune Dysfunction Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue-Fibromyalgia Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Fatigue-Fibromyalgia Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Gaucher Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Granulocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Granulocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Granulomatous Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Granulomatous Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Headaches' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Hepatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Hepatitis B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Hepatitis C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Hepatitis D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Hepatitis, Cryptogenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Idiopathic Jaundice' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Idiopathic Jaundices' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Illness' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Illnesses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Inflammatory Demyelinating Polyradiculoneuropathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Inflammatory Polyradiculoneuropathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Inflammatory Polyradiculoneuropathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Inflammatory Polyradiculopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Inflammatory Polyradiculopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Interstitial Cystitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Interstitial Cystitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Kidney Failure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Kidney Insufficiencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Kidney Insufficiency' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Limitation of Activity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Lymphoblastic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Lymphoblastic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Lymphocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Lymphocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Lymphocytic Thyroiditides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Lymphocytic Thyroiditis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Monocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Monocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Mucocutaneous Candidiases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Mucocutaneous Candidiasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myelocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myelocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myelogenous Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myelogenous Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myeloid Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myeloid Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myelomonocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Myelomonocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Neutrophilic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Neutrophilic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Obstructive Airway Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Obstructive Lung Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Obstructive Pulmonary Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Pancreatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Paroxysmal Hemicranias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Periaortitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Periaortitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Persistent Hepatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Persistent Hepatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Pityriasis Lichenoides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Plantar Fasciitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post Concussive Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post Traumatic Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post Traumatic Stress Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post-Concussive Encephalopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post-Concussive Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post-Concussive Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post-Concussive Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post-Traumatic Encephalopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Post-Traumatic Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Progressive Chorea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Progressive Choreas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Progressive Hereditary Chorea %28%Huntington%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Progressive Multiple Sclerosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Progressive Paraparesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Progressive Subcortical Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Renal Failure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Renal Insufficiencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Renal Insufficiency' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Subdural Hematoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Subdural Hematomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic T-Cell Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic T-Cell Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic T-Lymphocytic Leukemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic T-Lymphocytic Leukemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Toxicity Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Toxicity Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Traumatic Encephalopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic Wasting Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic absence from work or other duty. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic accumulation of blood in the subdural space, most frequently occurring over the lateral and superior aspects of a cerebral hemisphere. Clinical manifestations may be delayed for days to weeks, when affected individuals may present with confusion, drowsiness, hemiparesis, ATAXIA; APHASIA; and other signs of neurologic dysfunction. The condition tends to occur after the age of 50 years. It may be spontaneous, follow CRANIOCEREBRAL TRAUMA, or occur in association with bleeding disorders, the use of anticoagulant medication, locally invasive tumors, and other disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p887%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic endemic respiratory disease of dairy calves and an important component of bovine respiratory disease complex. It primarily affects calves up to six months of age and the etiology is multifactorial. Stress plus a primary viral infection is followed by a secondary bacterial infection. The latter is most commonly associated with PASTEURELLA MULTOCIDA producing a purulent BRONCHOPNEUMONIA. Sometimes present are MANNHEIMIA HAEMOLYTICA; HAEMOPHILUS SOMNUS and mycoplasma species.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic form of glomerulonephritis characterized by recurring hematuria with only slight proteinuria and by deposits of IMMUNOGLOBULIN A in the mesangial areas of the renal glomeruli. It usually occurs in young males.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic form of ichthyosis that is inherited as a sex-linked recessive trait carried on the X-chromosome and transmitted to the male offspring. It is characterized by severe scaling, especially on the extremities, and is associated with steroid sulfatase deficiency.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic glomerulonephritis characterized histologically by proliferation of mesangial cells, increase in the mesangial matrix, and a thickening of the glomerular capillary walls. The wall thickening is sometimes said to be a result of the interposition of mesangial cytoplasm or matrix between the basement membrane and the endothelium of the capillary wall. It is often divided into types I and II, and sometimes III. Pathogenesis is not well understood, but some types are thought to involve the immune system, with the complement system, in particular, being implicated.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic inflammation and granuloma formation around irritating foreign bodies.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system %28%persecutory delusions or delusions of jealousy%29%, accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic pruritic disease, usually in women, characterized by small follicular papular eruptions in apocrine areas. It is caused by obstruction and rupture of intraepidermal apocrine ducts. %28%From Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte %28%PULMONARY ADENOMATOSIS, OVINE%29% but is now recognized as a separate entity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic, localized granulomatous infection of mucocutaneous tissues, especially the NOSE, and characterized by HYPERPLASIA and the development of POLYPS. It is found in humans and other animals and is caused by the mesomycetozoean organism RHINOSPORIDIUM SEEBERI.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronically Ill, Dental Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronically Ill, Dentistry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronically depressed mood that occurs for most of the day more days than not for at least 2 years. The required minimum duration in children to make this diagnosis is 1 year. During periods of depressed mood, at least 2 of the following additional symptoms are present: poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self esteem, poor concentration or difficulty making decisions, and feelings of hopelessness. %28%DSM-IV%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronobiology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronobiology Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronobiology Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronologic Fetal Maturity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronology %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronology %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronotherapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronotropism, Cardiac' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chronotropisms, Cardiac' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysanthemum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysanthemum cinerariifolium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysanthemum parthenium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysaora fuscescens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysaora quinquecirrha' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysemonas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysenes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chryseobacterium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysobalanaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysocyon brachyurus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysophyceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysophyta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysosporium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chrysotropic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chubs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chufa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chum Salmon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chung I Hsueh' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church of Jesus Christ of Latter day Saints' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church of Jesus Christ of Latter-day Saints' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church of Latter day Saints' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church of Latter-day Saints' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church, Anglican' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church, Baptist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church, Episcopal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church, Lutheran' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church, Methodist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Church, Presbyterian' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Churg Strauss Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Churg-Strauss Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Churg-Strauss Vasculitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chuzan virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chyle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chyles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chyli, Cisterna' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chylomicrons' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chylopericardiums' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chyloperitoneum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chylothorax' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chylous Ascites' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chylus, Cisterna' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymopapain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymopapain %28%1975-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymosin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymotrypsin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymotrypsin %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymotrypsin/antagonists %26% inhibitors %28%1968-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chymotrypsinogen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chytridiomycota' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chytridiomycota %28%1989-1995%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Chytridiomycota %28%1991-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cialit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cianidanol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba 47175 BA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba 47175BA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Geigy Brand of Acenocoumarol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Geigy Brand of Amantadine Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Geigy Brand of Baclofen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand 1 of Naphazoline Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand 2 of Naphazoline Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Acetazolamide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Acetylcholine Chloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Aminoglutethimide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Bacitracin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Dehydrocholic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Levobunolol Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Povidone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba Vision Brand of Tolazoline Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba-Geigy Brand of Acenocoumarol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba-Geigy Brand of Amantadine Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciba-Geigy Brand of Baclofen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicatrices' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicatrices, Hypertrophic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicatricial Pemphigoid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicatrix' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicatrix %28%1966-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicatrix, Hypertrophic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cichlid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cichlid Fish' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cichlidae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cichlids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cichorium intybus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciclacillin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicloheximide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciclosporin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciclum Brand of Doxazosin Mesylate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciclum Brand of Flutamide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cicuta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cidifos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cignolin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciguatera' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciguatera Poisoning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciguatera Poisonings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciguatoxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciguatoxins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciguatoxins %28%1978-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilag Brand of Muromonab CD3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilag Brand of Muromonab-CD3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilag Brand of Tacrolimus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilastatin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilastatin Monosodium Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilazapril' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilia %28%1966-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilia %28%1966-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilia Syndrome, Immotile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilia Syndromes, Immotile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Arteries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Artery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Bodies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body %28%1966-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body %28%1966-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body %28%1966-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body Spasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body Spasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Body/surgery %28%1966-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Dyskinesia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Dyskinesia, Primary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Dyskinesias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Dyskinesias, Primary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Motility Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Motility Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Neuralgia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Neuralgias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Neuronotrophic Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Neurotrophic Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Neurotrophic Factor Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliary Neurotrophic Factor Receptor alpha Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliatine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliophora' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliophora %28%1966-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliophora %28%1973-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliophora Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciliophora Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cilium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciloprost' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cimetidine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cimetidine HCl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cimex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cimicidae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cimicifuga' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinanserin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinanserin Monohydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinarizine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinchocaine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinchona' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinchona %28%1966-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinchona Alkaloids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cine CT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cine MRI' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cine MRIs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cine Magnetic Resonance Imaging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cineangiographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cineangiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinefluorographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinefluorography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cineradiographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cineradiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinereum, Tuber' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinereums, Tuber' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinfa Brand of Dimenhydrinate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinfa, Doxazosina' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cingulate Epilepsies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cingulate Epilepsy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cingulate Gyrus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamate 4 Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamate 4-Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamates %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamates %28%1969-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamates %28%1969-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamates %28%1971-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamomum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamomum aromaticum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamomum camphora' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamomum cassia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamomum zeylanicum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnamon Rats, Long-Evans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnarizin-ratiopharm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnarizine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnarizine L Tartrate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinnarizine/analogs %26% derivatives %28%1975-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinoxacin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cinquefoil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciona intestinalis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciprofloxacin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciprofloxacin/analogs %26% derivatives %28%1987-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Dysregulation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythm %28%1966-1982%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythm %28%1966-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythm %28%1972-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythm Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythm Sleep Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circadian Rhythms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circle of Willis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circle, Management Quality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circle, Quality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circle, Willis%27%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circles, Management Quality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circles, Quality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circo Maren' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circoviridae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circoviridae Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circoviridae Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circovirus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circovirus Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circovirus, Porcine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circoviruses, Porcine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circular DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circular Dichroism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulating 38-kDa proteins that are internal peptide fragments of PLASMINOGEN. The name derives from the fact that they are potent ANGIOGENESIS INHIBITORS. Angiostatins contain four KRINGLE DOMAINS which are associated with their potent angiostatic activity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulating Cells, Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulating Factor, Thymic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulating Thymic Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation Time, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation Times, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Assisted' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Blood Collateral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Cerebrovascular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Collateral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Collateral Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Coronary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Cross' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Entero-Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Enterohepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Extracorporeal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Fetal-Placental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Fetoplacental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Kidney' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Liver' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Mesenteric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Persistent Fetal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Placental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Pulmonary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Renal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Respiratory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Splanchnic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulation, Uteroplacental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Cross' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Entero-Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Enterohepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Extracorporeal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Fetal-Placental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Fetoplacental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Mesenteric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulations, Splanchnic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulatory Arrest, Deep Hypothermia Induced' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulatory Collapse' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circulatory and Respiratory Physiology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumanal Gland' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumanal Gland Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumanal Gland Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumanal Glands' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcision' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcision %28%1990-1995%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcision, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcision, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcisions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcisions, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumcisions, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed Lipomatoses, Nodular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed Lipomatosis, Nodular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed Lobar Atrophy of the Brain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed Neurodermatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed Neurodermatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed Scleroderma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed collections of suppurative material occurring in the spinal or intracranial EPIDURAL SPACE. The majority of epidural abscesses occur in the spinal canal and are associated with OSTEOMYELITIS of a vertebral body; ANALGESIA, EPIDURAL; and other conditions. Clinical manifestations include local and radicular pain, weakness, sensory loss, URINARY INCONTINENCE, and FECAL INCONTINENCE. Cranial epidural abscesses are usually associated with OSTEOMYELITIS of a cranial bone, SINUSITIS, or OTITIS MEDIA. %28%From Adams et al., Principles of Neurology, 6th ed, p710 and pp1240-1; J Neurol Neurosurg Psychiatry 1998 Aug;65%28%2%29%:209-12%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Circumscribed masses of foreign or metabolically inactive materials, within the CELL NUCLEUS. Some are VIRAL INCLUSION BODIES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhoses, Experimental Liver' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhoses, Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhoses, Liver' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhosis, Biliary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhosis, Experimental Liver' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhosis, Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhosis, Liver' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirrhosis, Secondary Biliary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cirsium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cis Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cis Trans Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cis-Trans Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cis-acting regulatory sequences in the HIV long terminal repeat %28%LTR%29% which play a major role in induction or augmentation of HIV gene expression in response to environmental stimuli such as mitogens, phorbol esters, or other viruses. The HIV enhancer is the binding site for many cellular transcription factors including the nuclear factor NF-kappa B.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisapride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisplatin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cissampelos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cissus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cistaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cistafos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cistanche' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cistaphos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisterna Chylus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisterna Magna' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisterna Magnas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisternographies, Myelographic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisternographies, Pneumoencephalographic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cisticid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cistrons' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cistus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citalopram' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citellus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citicholine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citicoline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cities, Central' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citraconic Anhydrides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate %28%si%29%-Synthase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Cleavage Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Hydro Lyase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Hydro-Lyase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Hydrolyase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Lyase, ATP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Lyase, ATP-Dependent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Synthase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate Synthase, ATP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate de B%C3%%A9%ta%C3%%AF%ne Beaufour' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Calcium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Choline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Clomiphene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Diethylcarbamazine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Diphenhydramine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Enclomiphene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Fentanyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Norflex Orphenadrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Orphenadrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Potassium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Sufentanil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Toremifene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, Vecuronium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrate, trans-Clomiphene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrates %28%1979-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrates, Calcium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citric Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citric Acid Cycle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citric Acid Cycles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citridic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citridinic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrin Fruit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrinin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter %28%1973-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter %28%1975-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter diversus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter freundii' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter freundii %28%1995-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter freundii Biotype 4280' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter koseri' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrobacter rodentium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citron Tree' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citronella' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrovorum Factor %28%1966-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrulline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemia, Classical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemia, Late Onset' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemia, Late-Onset' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemia, Neonatal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemias, Classical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemias, Late-Onset' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinemias, Neonatal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinuria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullinurias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrullus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrus Fruit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrus aurantiifolia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrus grandis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrus paradisi' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Citrus sinensis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Hospital, Non-Public-Owned' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Hospitals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Hospitals, Non Public Owned' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Hospitals, Non-Public-Owned' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Planning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City Plannings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City, Central' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'City, urban, rural, or suburban areas which are characterized by severe economic deprivation and by accompanying physical and social decay.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civet' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civet Cat' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civet Cats' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civets' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Defense' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Defenses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Right' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Rights' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Rights %28%1968-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Rights %28%1968-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Rights %28%1968-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil War, American' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civil Wars, American' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civilization' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Civilizations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Ciwujia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl 227193' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl%28%-%29%-HCO3%28%-%29%-Exchanger' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl%C3%%A9%ment Brand of Carbaril' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl- HCO3- Exchanger' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl-35; Cl-37 = CHLORINE %28%IM%29% + ISOTOPES %28%NIM%29%; Cl-34, 36, 38-40 = CHLORINE %28%IM%29% + RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl227193' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cl2MDP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clade, DRIP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cladocera' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cladogeneses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cladogenesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cladosporium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cladribine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claim Reporting, Insurance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claim Review, Insurance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claim Reviews, Insurance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claim, Veterans Disability' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claims Analyses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claims Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claims Processing, Insurance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claims Review' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claims Reviews' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claims, Veterans Disability' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clam, Softshell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamoxyl G.A.' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamoxyl parenteral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamp, Euglycaemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamp, Euglycemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamp, Glucose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamp, Surgical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamping, Euglycaemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamping, Euglycemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamping, Glucose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clampings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamps, Euglycaemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamps, Euglycemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamps, Glucose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clamps, Surgical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clarben Brand of Mepivacaine Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clariana Brand of Amoxicillin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clariana Brand of Fluocinonide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clariana Brand of Streptomycin Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clarithromycin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clarkia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clasp Knife Spasticity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clasp, Dental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clasp, Denture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clasps, Dental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clasps, Denture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Genes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Heparin-Binding Growth Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Histocompatibility Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Human Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I Major Histocompatibility Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I human histocompatibility %28%HLA%29% antigens encoded by a small cluster of structural genes at the C locus on chromosome 6. They have significantly lower immunogenicity than the HLA-A and -B determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations %28%e.g., spondylarthritis, psoriasis, multiple myeloma%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I human histocompatibility %28%HLA%29% surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens %28%e.g., HLA-B27, -B7, -B8%29% are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I, Angle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class I-restricted activation of CD8-POSITIVE LYMPHOCYTES resulting from ANTIGEN PRESENTATION of exogenous ANTIGENS %28%cross-presentation%29%. This is in contrast to normal activation of these lymphocytes %28%direct-priming%29% which results from presentation of endogenous antigens.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Antigen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Genes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Heparin-Binding Growth Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Histocompatibility Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Human Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II Major Histocompatibility Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class II, Angle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class III, Angle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class Population, Middle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class Populations, Middle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class Switching' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class Switching, Immunoglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class Switchings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class Switchings, Immunoglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class of BACTERIA with diverse morphological properties. Strains of Actinobacteria show greater than 80%25% 16S rDNA/rRNA sequence similarity among each other and also the presence of certain signature nucleotides. %28%Stackebrandt E. et al, Int. J. Syst. Bacteriol. %28%1997%29% 47:479-491%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea. The digenetic trematodes are the only ones found in man. They are endoparasites and require two hosts to complete their life cycle.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; %28%CHEMOKINES, C%29%; CC; %28%CHEMOKINES, CC%29%; and CXC; %28%CHEMOKINES, CXC%29%; according to variations in a shared cysteine motif.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Class-phi, GST' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classes of retroviruses for which monkeys or apes are hosts. Those isolated from the West African green monkey and the Asian rhesus macaque monkey are of particular interest because of their similarities to viruses causing cancer and acquired immunodeficiency syndrome %28%AIDS%29% in humans.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classes, Antibody' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classes, Immunoglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classes, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Apraxia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Apraxias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Distal Renal Tubular Acidosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Galactosemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Galactosemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Globoid Cell Leukodystrophy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Migraine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Moyamoya Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic Pelizaeus Merzbacher Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance %28%radioligand%29% either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances %28%e.g., haptens%29% can be measured if coupled to larger carrier proteins %28%e.g., bovine gamma-globulin or human serum albumin%29% capable of inducing antibody formation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Antihistamines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Antihistaminics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Article' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Article %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Article %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical C3 Convertase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical C5 Convertase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Citrullinemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Citrullinemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Complement Activation Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Complement Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Conditioning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Conditionings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Dictionaries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Dictionary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Maple Syrup Urine Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Migraine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Migraines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Niemann Pick Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Niemann-Pick Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Pathway C3 C5 Convertases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Pathway C3 Convertase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Pathway C3-C5 Convertases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Pathway C5 Convertase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Phenylketonuria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Phenylketonurias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Philology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical Swine Fever' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical loci in acupuncture. They are main and collateral channels, regarded as a network of passages, through which vital energy circulates and along which acupoints %28%ACUPUNCTURE POINTS%29% are distributed. The meridians are a series of 14 lines upon which more than 400 acupoints are located on the body. %28%The Pinyin Chinese-English Dictionary, p. 359; Dr. Wu Lancheng, Academy of Traditional Chinese Medicine, Beijing%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classical swine fever virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classification' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classification Analyses, Multiple' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classification Analysis, Multiple' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classification system for assessing impact injury severity developed and published by the American Association for Automotive Medicine. It is the system of choice for coding single injuries and is the foundation for methods assessing multiple injuries or for assessing cumulative effects of more than one injury. These include Maximum AIS %28%MAIS%29%, Injury Severity Score %28%ISS%29%, and Probability of Death Score %28%PODS%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classification, Angle%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classification, Book' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classifications' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Classifications, Book' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin %28%1986-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin %28%1996-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Adaptor Protein Complex 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Adaptor Protein Complex 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Adaptor Protein Complex 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Adaptor Protein Complexes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Protein Complex 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Protein Complex 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Protein Complex 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Protein Complex alpha Subunits' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Protein Complex sigma Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Assembly Proteins, Monomeric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Associated Adaptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Associated Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Heavy Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Heavy Chains' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Light Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Light Chains' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin Uncoating Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin-Associated Adaptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin-Associated Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin-Coated Vesicle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clathrin-Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claude Bernard Horner Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claude Bernard-Horner Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claudication, Intermittent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claudications, Intermittent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claussena' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claustrophobias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claviceps' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavicle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavicle %28%1975-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavine Alkaloids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanate Potentiated Amoxycillin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanate, Potassium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanate, Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanate-Amoxicillin Combination, Potassium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanic Acids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanic Acids %28%1978-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanic Acids %28%1981-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with beta-lactam antibiotics prevents antibiotic inactivation by microbial lactamase.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claw Toes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claw and Hoof' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clawed Lobsters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clawless Otter' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claws' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Claws and Hooves' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clawtoe' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clawtoes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clay Park Brand of Desonide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clay-Park Brand of Desonide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clean Room' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleaners, Contact Lens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleansers, Denture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleansing Agent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Acanthoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Acanthomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Adenocarcinoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Adenocarcinomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Ependymoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Ependymomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Meningiomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Renal Carcinoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Sarcoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear Cell Sarcomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clear, All' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clearance Rate, Metabolic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clearance Rates, Metabolic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clearance, Mucociliary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clearances, Mucociliary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage And Polyadenylation Specificity Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage And Polyadenylation Specificity Factor, 100 kDa Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage And Polyadenylation Specificity Factor, 160 kDa Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage And Polyadenylation Specificity Factor, 30 kDa Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage And Polyadenylation Specificity Factor, 73 kDa Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage Enzyme, Citrate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage Polyadenylation Specificity Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage Stage, Ovum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage Stages, Ovum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage Stimulation Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage and Polyadenylation Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage and Polyadenylation Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavage-Polyadenylation Specificity Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleavers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleaving Enzyme, beta-Carotene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Cyst, Branchial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Cysts, Branchial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Cysts, Rathke%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Lip' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Lips' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Palate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Palate %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Palate Prostheses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Palate Prosthesis %28%1966-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft Palates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleft, Branchial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clefts, Branchial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleidocranial Dysostoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleidocranial Dysostosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleidocranial Dysplasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleidocranial Dysplasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleland Reagent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleland%27%s Reagent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clelands Reagent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clemastine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clematis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clenbuterol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cleome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerambault Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clergies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clergy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerkship, Clinical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerkships, Clinical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerodane Diterpenes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerodanes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerodendron' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clerodendrum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clethraceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Click-Murmur Syndrome, Mitral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Click-Murmur Syndrome, Systolic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Click-Murmur Syndromes, Mitral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Click-Murmur Syndromes, Systolic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clicking Tinnitus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client Centered Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client Staff Ratio' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client Staff Relations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client, Contacting' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client-Centered Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client-Centered Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client-Staff Ratios' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Client-Staff Relation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clients, Contacting' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climacteric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climacteric %28%1965-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climacteric %28%1969-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climacteric %28%1976-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climacteric %28%1980-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climacterics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climarest' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climate %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climate Controls' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climate, Cold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climate, Desert' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climate, Tropical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climates, Cold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climates, Desert' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climates, Tropical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Climopax' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clindamycin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic Activity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic Visit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Child Guidance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Dental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Free-Standing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Hospital Outpatient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Multidisciplinary Pain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Outpatient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Pain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinic, Veterinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Chemistry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Chemistry Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Chemistry Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Clerkship' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Clerkships' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Competence' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Competence %28%1975-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Conference' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Conference %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Conference %5B%Pub Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Conference %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Decision Support Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Distribution' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Distributions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Equivalencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Equivalency' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Ethicist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Ethics Committee' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Ethics Committees' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Investigator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Laboratory Information Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Laboratory Technique' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Laboratory Techniques' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Ladder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Marker' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Markers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Medicine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Nurse Specialist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Nurse Specialists' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Nursing Research' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Path' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pathology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pharmacist' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pharmacology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pharmacy Information Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pharmacy Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Pharmacy Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Practice Guideline %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Practice Nursing Research' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Practice Patterns' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Practice Variation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Protocol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Protocols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Psychology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Research Protocols' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Research, Nursing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Skills' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Term, SNOMED' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Terms, SNOMED' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial Overview' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial Overviews' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase I %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase I %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase II %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase II %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase III %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase III %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase IV' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase IV %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trial, Phase IV %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials %28%1966-1982%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials %28%1966-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials %28%1980-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials %28%1980-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials %28%1991-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials %28%1996-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials Data Monitoring Committees' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Controlled' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical Trials, Phase IV' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical and laboratory techniques used to enhance fertility in humans and animals.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical association of heavy PROTEINURIA; HYPOALBUMINEMIA; and generalized EDEMA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical characteristics of disease or illness. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical conditions caused by an abnormal chromosome constitution in which there is extra or missing chromosome material %28%either a whole chromosome or a chromosome segment%29%. %28%from Thompson et al., Genetics in Medicine, 5th ed, p429%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical conditions caused by an abnormal sex chromosome constitution %28%SEX CHROMOSOME ABERRATIONS%29% in which there is extra or missing sex chromosome material %28%either a whole chromosome or a chromosome segment%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical disturbances of the urinary system. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestation consisting of a deficiency of carbon dioxide in arterial blood.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestation of excessive LEANNESS usually caused by disease or a lack of nutrition %28%MALNUTRITION%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestation of respiratory distress consisting of a relatively complete absence of oxygen.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestation of respiratory distress consisting of relatively complete absence of oxygen in arterial blood.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestation of the digestive system consisting of contraction of the muscle of the pharynx caused by stimulation of sensory receptors on the soft palate, by psychic stimuli, or systemically by drugs.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestation of the urinary system consisting of a decrease in the amount of urine secreted.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or %22%seizure disorder.%22%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical practice by members of the nursing faculty in order to maintain a balance in their nursing activities--clinical, education, and research.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical presentations that may be followed by evaluative studies that eventually lead to a diagnosis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical protocols used to inhibit the growth or spread of NEOPLASMS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical signs and symptoms caused by nervous system injury or dysfunction.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance. Distinguishing tendinosis from tendinitis is clinically difficult and can be made only after histopathological examination.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinically atypical nevi %28%usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders%29% with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinically benign, histologically malignant, recurrent cutaneous eruption characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble Reed-Sternberg cells of Hodgkin%27%s disease or the malignant cells of cutaneous T-cell lymphoma. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including mycosis fungoides, Hodgkin%27%s disease, cutaneous T-cell lymphoma, or Ki-1 lymphoma.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinically severe acute disease of cattle caused by noncytopathic forms of Bovine viral diarrhea virus 2 %28%DIARRHEA VIRUS 2, BOVINE VIRAL%29%. Outbreaks are characterized by high morbidity and high mortality.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinician, Nurse' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinicians, Nurse' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinico-Pathologic Conference' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinico-Pathologic Conference %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinico-Pathological Conference' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinico-Pathological Conference %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Child Guidance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Dental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Free Standing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Hospital Outpatient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Multidisciplinary Pain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Outpatient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Pain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinics, Veterinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinorotations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clinoxacin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clione' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clioquinol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clip' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clip, Surgical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clip, Tantalum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clips, Surgical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clitorectomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clitorectomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clitoria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clitoridectomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clitoris' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloaca' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloacas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloacin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloacin Immunity Protein Complex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clobetasol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clock Headache, Alarm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clock Headaches, Alarm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clock, Biologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clock, Biological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clocks, Biologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clocks, Biological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clodronic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofazimine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofelin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofenapate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofenapate, Methyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofenazon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofenil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofenvinfos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofibrate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofibrate %28%1969-1974%29% /AA %28%1975-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofibrate/analogs %26% derivatives %28%1978-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofibric Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofibric Acid, Ethyl Ester' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clofibrinic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clomethiazole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clomide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clomifen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clomifene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clomiphene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clomipramine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonal Abortions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonal Anergies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonal Anergy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonal Deletion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonal Deletions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonazepam' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1968-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1970-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1975-1981%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1975-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1977-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1978-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clone Cells %28%1980-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonic Seizure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonic Seizures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonic Seizures, Focal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonidine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning Vector' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Embryo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Molecular %28%1980-1985%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Molecular %28%1980-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Molecular %28%1980-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Molecular %28%1980-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Molecular %28%1983-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloning, Organism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonings, Embryo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonings, Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonings, Organism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonixin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonmel Brand of Aciclovir' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonmel Brand of Allopurinol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonmel Brand of Aminophylline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonmel Brand of Mefenamic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonmel Brand of Methyldopa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonmel Brand of Penicillin G Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonogenic Cell Assay' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonogenic Cell Assay, Tumor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonogenic Cell Assays' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonorchiases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonorchiasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clonorchis sinensis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clopamide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clopenthixol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clopheline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clopidol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clopindol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloprostenol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloprostenol Monosodium Salt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloranfenicol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clorazepate Dipotassium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clorgilin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clorgiline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clorgyline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clorgyline Resistant Amine Oxidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloro-Trimeton' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clorpropamid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Circuit Anesthesia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Cohort Study' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Ecological System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Ecological Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Fractures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Head Injuries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Head Injury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Head Trauma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Head Traumas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed Spinal Bifida' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed-Angle Glaucoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed-Angle Glaucomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed-Circuit Anesthesia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closed-Circuit Anesthesias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. %28%Gilman et al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed, p1117%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closing Volume' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closing Volumes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closteroviridae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closterovirus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostilbegit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridiopeptidase A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1963-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1965-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1966-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1968-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1969-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1974-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1976-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1985-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1988-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium %28%1990-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium Botulinum %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium Botulinum Toxin Type A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium Infections/veterinary %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium acetobutylicum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium beijerinckii' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium bifermentans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum %28%1965-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum %28%1966-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum %28%1968-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum %28%1972-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum A Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum E' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum F' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum G' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum Toxins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type E' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type F' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium botulinum type G' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium butyricum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium cellulolyticum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium cellulovorans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium chauvoei' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium difficile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium histolyticum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium histolyticum Collagenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium histolyticum Collagenase %28%1975-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium infect; animal only; check tag ANIMALS; coord IM with precoord animal/dis term %28%IM%29% + animal %28%NIM%29% or with animal %28%IM%29% in absence of precoord%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium kluyveri' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium perfringens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium sordelli' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium sordellii' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium sticklandii' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium symbiosum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium tertium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium tetani' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium tetani Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium tetanomorphum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium thermocellum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium tyrobutyricum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clostridium welchii' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closure, Health Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closure, Orthodontic Space' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closure, Perceptual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closures, Health Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closures, Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closures, Orthodontic Space' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Closures, Perceptual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clot Retraction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clot Retractions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing %28%1966-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing %28%1967-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing %28%1983-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing %28%1990-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing designed to protect the individual against possible exposure to known hazards.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothing, Protective' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clothings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clotrimazole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clotting Protein %28%Seminal Vesicle%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clotting Proteins %28%Seminal Vesicle%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clotting time of PLASMA mixed with a THROMBIN solution. It is a measure of the conversion of FIBRINOGEN to FIBRIN, which is prolonged by AFIBRINOGENEMIA, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, or HEPARIN. BATROXOBIN, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clotting, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clouded Leopard' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clouded Leopards' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloudman S91 Melanoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clouston Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clouston%27%s Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloustons Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clove Oil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clover, Red' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clover, Sweet' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clover, Water' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloxacillin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloxacillin %28%1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloxacillin, Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cloxazepine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clozapine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clp Protease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Club, Health' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Club, Mothers%27%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Club, Therapeutic Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clubbed Finger' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clubfoot' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clubmoss' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clubs, Health' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clubs, Mothers%27%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clumping Factor %28%Staphylococcal%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clumping Factor, Staphylococcal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clupeine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusiaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Analyses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headache' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headache Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headache Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headache, Atypical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headache, Chronic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headache, Episodic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headaches' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headaches, Atypical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headaches, Chronic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster Headaches, Episodic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster, CpG' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cluster, Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusterin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clustering' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clustering, Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clustering, Space-Time' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusterings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusterings, Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusterings, Space-Time' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters of multipolar neurons surrounded by a capsule of loosely organized CONNECTIVE TISSUE located outside the CENTRAL NERVOUS SYSTEM.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters of neuronal cell bodies in invertebrates. Invertebrate ganglia may also contain neuronal processes and non-neuronal supporting cells. Many invertebrate ganglia are favorable subjects for research because they have small numbers of functional neuronal types which can be identified from one animal to another.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters of neurons and their processes in the autonomic nervous system. In the autonomic ganglia, the preganglionic fibers from the central nervous system synapse onto the neurons whose axons are the postganglionic fibers innervating target organs. The ganglia also contain intrinsic neurons and supporting cells and preganglionic fibers passing through to other ganglia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters of neurons in the somatic peripheral nervous system which contain the cell bodies of sensory nerve axons. Sensory ganglia may also have intrinsic interneurons and non-neuronal supporting cells.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters of topics that fall within the domain of BIOETHICS, the field of study concerned with value questions that arise in biomedicine and health care delivery.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters, CpG' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clusters, Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clutch Size' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clutch Sizes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clutterings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Clypeasteroida' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnicus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria %28%1965-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria %28%1968-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria %28%1969-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria %28%1970-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria %28%1971-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidaria %28%1986-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidarian Venom' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidarian Venoms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidarians' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cnidium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co A Ligases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dependence %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dependences %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dependencies %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dependency %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dergine Mesylate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dergocrine Mesilate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Dergocrine Mesylate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Fluocin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Immunoprecipitation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Pharma Brand of Diethylstilbestrol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Stimulator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Translational Amino Acid Modification' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Translational Protein Processing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co Transporters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co amoxiclav' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co beta Glucosidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co culture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co vidarabine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-54-64 except Co-59; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%; often discussed with RADIOISOTOPE TELETHERAPY %28%IM%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-59 ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-59; NIM ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dependence %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dependences %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dependencies %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dependency %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dergine Mesylate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dergocrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dergocrine Mesilate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Dergocrine Mesylate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Factor II, Heparin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Immunoprecipitations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Pharma Brand of Diethylstilbestrol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Stimulator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Translational Amino Acid Modification' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Translational Protein Modifications' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Translational Protein Processing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Transporters' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-Trimoxazole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-amoxiclav' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-beta-Glucosidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-culture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Co-cultures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Acyltransferase, Acetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Acyltransferase, Lysophosphatidylcholine-Palmitoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Deacylase, Palmitoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Dehydrogenase, Decanoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Dehydrogenase, Fatty-acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Dehydrogenase, Glutaryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Dehydrogenase, Isovaleryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Dehydrogenase, beta-Hydroxyacyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Dehydrogenases, 3-Hydroxyacyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Desaturase, Linoleoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Hydratases, Enoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Hydrolase, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Hydrolase, Stearoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Hydrolyases, 3-Hydroxyacyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Reductase, 3-Hydroxy-3-methylglutaryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Synthetase, Acetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Synthetases, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Synthetases, Succinyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Thiolase, 2-Methylacetoacetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Thiolase, 3-Ketoacyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Thiolase, 3-Oxoacyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Thiolase, Acetoacetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Transferase, Malonyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA Transferases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Acetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Fatty Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Hexadecanoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Long-Chain Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Malonyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Palmitoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA, Palmityl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-1-Acyl-Syn-Glycerol-3-Phosphate O-Acyltransferase, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-ACP Transacylase, Acetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-Dehydrogenase, Decanoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-Monoacylglycerophosphateacyltransferase, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-Reductase, NAD-Dependent 3-Hydroxy-3-methylglutaryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-Reductases, NADP-Dependent HMG' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-Retinol Acyltransferase, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoA-Transferases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'CoTherix Brand of Iloprost' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coactivator, p300-CBP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulant substances inhibiting the anticoagulant action of heparin.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulants' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulated exudate isolated from several species of the tropical tree Palaquium %28%Sapotaceae%29%. It is the trans-isomer of natural rubber and is used as a filling and impression material in dentistry and orthopedics and as an insulator in electronics. It has also been used as a rubber substitute.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Disorder, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Disorder, Hereditary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Disorder, Inherited' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Disorders, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Disorders, Hereditary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Disorders, Inherited' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor IV' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor IX' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor IXa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor V' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor VII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor VIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor VIIIa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor VIIa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor Va' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor XI' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor XII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor XIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor XIIa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor XIa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor Xa' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factor, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation FactorXI, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Factors, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Inhibitor, Lupus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Protein Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Protein Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Proteins Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Proteins Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Test, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Tests, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Time, Cephalin Kaolin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Time, Cephalin-Kaolin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Time, Kaolin-Cephalin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation Time, Whole Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation, Disseminated Intravascular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation, Intravascular Disseminated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation, Laser' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulation, Light' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulations, Cornual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulations, Disseminated Intravascular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulations, Intravascular Disseminated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulations, Laser' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulations, Light' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulopathies, Consumption' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coagulopathy, Consumption' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coal Mining' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coal Minings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coal Tar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalition, Business %28%Health Care%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalition, Business %28%Healthcare%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalition, Health Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalition, Healthcare' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalitions, Business %28%Health Care%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalitions, Business %28%Healthcare%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalitions, Health Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coalitions, Healthcare' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coamoxiclav' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coarctation, Aortic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coarctations, Aortic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coarse Tremors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coast Fever, East' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coat Protein Complex Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coat Protein Complex I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coat Protein Complex-Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coat Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coat Proteins, Viral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coat, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Materials, Biocompatible' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Pit, Cell-Membrane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Pits, Cell Membrane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Pits, Cell-Membrane' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Pits, Cell-Membrane %28%1983-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Vesicle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coated Vesicles %28%1995-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coating with a metal or alloy by electrolysis. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coatomer Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coatomer Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coatomer Subunit epsilon COP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coatomer Subunit epsilon-COP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coatomer-Coated Vesicle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coatomer-Coated Vesicles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coats, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalamin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalamin Binding Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalamin-Binding Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalt' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalt Chromium Alloys' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalt Chromium Molybdenum Alloy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalt Isotopes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalt Radioisotopes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobalt Salt Glycine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobamides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobitidae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra Cardiotoxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra Neurotoxins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra Venom' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra Venoms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra, Asiatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra, Egyptian' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobra, Water' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobras' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobras, Asiatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobras, Egyptian' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cobras, Water' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coca' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine %28%1986-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine HCl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine Related Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine User' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine, Crack' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine-Related Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocaine-Related Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocarboxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocarcinogeneses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocarcinogenesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidia %28%1975-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidia %28%1980-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidioides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidioides/IM %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidioidin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidioidomycoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidioidomycosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidioses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidiosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidiosis %28%1966-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidiosis %28%1978-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidiosis %28%1993-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccidiostats' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocculus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram%27%s method.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccygeal Regions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coccyx' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlea %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlea %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlea %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlea %28%1983-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Aqueduct' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Aqueducts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Duct' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Ducts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Hearing Loss' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implantation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implantation %28%1992-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implantations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implants' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implants %28%1980-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Implants %28%1992-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Microphonic Potential' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Microphonic Potentials' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerve %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerve Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerve Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerve Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerve Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nerves' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Neuritides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nuclei' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Nucleus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Prostheses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Prosthesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Prosthesis Implantation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlear Prosthesis Implantations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochlearis, Ductus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cochleas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockatiel' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockatoo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockatoos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Pelizaeus Merzbacher Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome %28%1987-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome, Group A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome, Group B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome, Group C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome, Type A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome, Type B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Syndrome, Type C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockayne Touraine Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocklebur' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocklebur, Spiny' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockroach' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockroaches' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockroaches %28%1965-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockscomb, Common' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cockscomb, Green' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocoanut' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocos' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocultivation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocultivations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coculture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coculture Technique' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coculture Techniques' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cocultures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cod Liver Oil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cod, Atlantic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code of Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, Bar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, Building' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, CPT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, Ethical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, Histone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Code, ICD' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coded listings of physician or other professional services using units that indicate the relative value of the various services they perform. They take into account time, skill, and overhead cost required for each service, but generally do not consider the relative cost-effectiveness. Appropriate conversion factors can be used to translate the abstract units of the relative value scales into dollar fees for each service based on work expended, practice costs, and training costs.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codeine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codeine %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codeine/analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codependence' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codependencies %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codependency %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes of Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes, Bar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes, Building' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes, CPT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes, Ethical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes, Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codes, ICD' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coding Region, Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coding Regions, Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon %28%1975-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Initiation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Initiator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Nonsense' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Premature Stop' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Premature Termination' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Sense' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Start' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Stop' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Termination' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Termination, Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codon, Terminator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codonopsis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Initiation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Initiator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Nonsense' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Premature Stop' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Premature Termination' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Sense' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Start' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Stop' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Termination' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Terminator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Codons, Unassigned' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cods' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coelenterata %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coelenterata %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coelenterata %28%1972-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coeliac Plexus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coeliacus, Plexus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenuriases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1966-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1972-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1973-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1973-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A %28%1974-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A Ligases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A Synthetases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A Synthetases %28%1973%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A Synthetases %28%1974-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A Transferases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A, Acetyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A, Malonyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A, Palmitoyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A-Monacylglycerophosphateacyltransferase, Acyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme A-Transferases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme PQQ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme Q' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme Q Cytochrome c Reductase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme Q-Cytochrome-c Reductase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme QH2 Cytochrome c Reductase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme QH2-Cytochrome-c Reductase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzyme, PQQ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzymes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzymes %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzymes %28%1966-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzymes %28%1973-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzymes and Enzymes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coenzymes, Vitamin B12' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coercion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coexistence of numerous distinct ethnic, racial, religious, or cultural groups within one social unit, organization, or population. %28%From American Heritage Dictionary, 2d college ed., 1982, p955%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor I, Heparin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor II, Heparin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor Protein S' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor, C4b-C3b Inactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor, FeMo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor, Iron-Molybdenum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor, PQQ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactor, Ristocetin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofactors, Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coffea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coffee' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coffee %28%1966-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coffee Senna' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coffin Lowry Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coffin-Lowry Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin 1 is a member of the cofilin family of proteins that is expressed in non-muscle CELLS. It has ACTIN depolymerization activity that is dependent on HYDROGEN-ION CONCENTRATION.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin, Muscle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin, Non-Muscle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilin-2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cofilins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coformycin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coformycin/analogs %26% derivatives %28%1979-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coglucosidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition %28%1967-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition %28%1981-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition %28%1993-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognition Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Behavior Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Behavior Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Dissonance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Dissonances' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Enhancers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Manifestation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Manifestations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Psychotherapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Psychotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Retention Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Retention Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Science' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Sciences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Symptom' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Symptoms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cognitive mechanism based on expectations or beliefs about one%27%s ability to perform actions necessary to produce a given effect. It is also a theoretical component of behavior change in various therapeutic treatments. %28%APA, Thesaurus of Psychological Index Terms, 1994%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cogwheel Rigidities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coherence Tomography, Optical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coho Salmon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Analyses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Effect' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Effects' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Studies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Studies, Closed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Studies, Historical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Study' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Study, Closed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohort Study, Historical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohosh, Black' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cohosh, Blue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coiled Bodies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coiled Body' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coiled Springs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coin Lesion, Pulmonary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coin Lesions, Pulmonary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coinsurance and Deductibles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coisogenic Animal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coisogenic Animals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coital Exanthema Virus, Equine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coital Frequencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coitus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coitus %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coitus Interruptus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coix' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coke' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cokes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Col Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Col Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cola' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colaspase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colcemid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colchamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colchicine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colchicine %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colchicine %28%1966-1974%29% /AA %28%1975-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colchicum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Agglutinin Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Chains' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Climate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Climates' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Gastric Lavage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Gastric Lavages' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Insoluble Globulins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Ischemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Ischemia Times' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Ischemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Ischemic Time' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Ischemic Times' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Panniculitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Paroxysmal Hemoglobinuria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Sore' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Sores' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Virus, Common' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold Viruses, Common' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold, Common' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cold-Insoluble Globulins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colds, Common' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colectomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colectomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colectomy %28%1981-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coleonol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coleoptera' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coleoptera %28%1974-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coleoptiles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colestipol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colestipol HCl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colestyramin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colestyramine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coleus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coleus forskohli' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colgate Brand of Tin Difluoride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colic Flexure, Left' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colic Flexure, Right' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colic, Infantile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicin E' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicin Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicin Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicin K K235' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicin Plasmid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicins %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colicky Pain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliform Bacilli' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colimycin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colinearities, Chromosomal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colinis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colinus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colipase I and II, consisting of 94-95 and 84-85 amino acid residues, respectively, have been isolated from porcine pancreas. Their role is to prevent the inhibitory effect of bile salts on the lipase-catalyzed intraduodenal hydrolysis of dietary long-chain triglycerides.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colipases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage M13' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage MS2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage N4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage P1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage P2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage Q beta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage T2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage T3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage T4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage T7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage fd' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage lambda' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage mu' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphage phi X 174' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1966-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1973-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1976-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1976-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages %28%1977-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages T' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coliphages/enzymology %28%1974-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colircusi Fluoresceina' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colircusi Sulfacetamida' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colisticin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colistin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitides, Amebic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitides, Amoebic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitides, Mucous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis %28%1966-1984%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis %28%1967-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis %28%1971-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis %28%1976-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis %28%1984-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Amebic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Amoebic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Antibiotic-Associated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Collagenous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Ischemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Lymphocytic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Microscopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Mucous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Ulcerative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Ulcerative %28%1965-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Ulcerative %28%1966-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colitis, Ulcerative %28%1980-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collaborations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1966-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1966-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1974-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1977-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1978-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1985-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1987-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1990-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1992-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1993-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1994-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen %28%1997-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Arthritides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Arthritis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Degrading Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Diseases %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Diseases %28%1972-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Hemostat, Microfibril' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Lysyl Hydroxylase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Lysyl Oxidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Peptidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Receptors %28%1991-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type I, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type I, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type II, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IV' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IV, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IV, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IX' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IX, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IX, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type IX, alpha3 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type V' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type V, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type V, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type V, alpha3 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VI' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VI, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VI, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VI, alpha3 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VII, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VIII, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type VIII, alpha1 Subunit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type X, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XI' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XI, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XI, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XI, alpha3 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XII, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XIII, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type XVIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-IX, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-IX, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-IX, alpha3 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-VI, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-VIII, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-XI, alpha1 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-XI, alpha2 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen Type-XI, alpha3 Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen XVIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%I%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%II%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%III%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%IV%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%IX%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%V%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%VI%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%VII%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%VIII%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%X%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%XI%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%XII%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%XIII%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha1%28%XVIII%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha2%28%I%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha2%28%IX%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha2%28%V%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha2%28%VI%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha2%28%XI%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha3%28%IX%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha3%28%V%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha3%28%VI%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen alpha3%28%XI%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen receptors are cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX. They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms. Collagen receptors include discoidin domain receptors, INTEGRINS, and glycoprotein VI.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, 7S' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Fibril-Associated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Fibrillar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Intima' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type IV' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type IX' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type V' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type VI' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type VII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type VIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type X' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type XI' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type XII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type XIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, Type XVIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen, XVIII' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen-Degrading Enzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen-Induced Arthritides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagen-Induced Arthritis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenase Like Peptidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenase, Clostridium histolyticum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenase, Fibroblast' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenase, Microbial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenase, Neutrophil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenases %28%1989-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenases %28%1991-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenases %28%1992-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenfleece' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenous Colitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagenous Lectins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagens, FACIT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagens, Fibril-Associated' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagens, Fibrillar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagens, Non-Fibrillar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagens, Nonfibrillar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collagens, Short-Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collalysine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapse Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapse Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapse, Circulatory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapse, Heat' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapsin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapsin 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapsin-1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collapsing Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collard Greens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Blood Circulation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Blood Circulations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Circulation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Circulation, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Circulations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Circulations, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Ligament' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Ligament, Medial, Knee' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Ligament, Tibial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Ligaments' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collateral Ligaments, Tibial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collaterale Tibiale, Ligamentum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collaterale Tibiales, Ligamentum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collected Correspondence %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collected Correspondence %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collected Works %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collected Works %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collectin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collecting Duct Carcinomas %28%Kidney%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collecting Duct, Kidney' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collecting Ducts, Kidney' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collecting Kidney Tubule' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collecting Kidney Tubules' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collecting, Book' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collectings, Book' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collectins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection Development %28%Libraries%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection Development, Library' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection Developments %28%Libraries%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection of air and blood in the pleural cavity. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection of granular epithelial cells in the uterine muscle beneath the placenta that develop during pregnancy in certain species of animals.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection of pleomorphic cells in the caudal part of the anterior horn of the lateral ventricle, in the region of the olfactory tubercle, lying between the head of the caudate nucleus and the anterior perforated substance. It is part of the so-called ventral striatum, a composite structure considered part of the basal ganglia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection of pooled secretions of the posterior vaginal fornix for cytologic examination.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection, Blood Specimen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection, Data' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collection, Dual Data' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections of facts, assumptions, beliefs, and heuristics that are used in combination with DATABASES to achieve desired results, such as a diagnosis, an interpretation, or a solution to a problem %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections of organized information for study and reference.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections of related records treated as a unit; ordering of such files.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections of small neurons centrally scattered among many fibers from the level of the trochlear nucleus in the midbrain to the hypoglossal area in the medulla oblongata.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collections, Blood Specimen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collective Bargaining' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collective Bargaining %28%1971-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collective Bargainings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collective behavior of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'College Admission Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'College Admission Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colles Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colles%27% Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colletotrichum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colliculus, Inferior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colliculus, Superior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collins Brand of Amikacin Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collins Syndrome, Treacher' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collodion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid Carcinoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid Carcinomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid, Gold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid, Radioactive Gold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid, Tc 99m-Albumin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid, Tc-99m Sulfur' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid, Technetium Sulfur' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloid, Technetium-99m Albumin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloidal Gold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloids %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloids of two immiscible liquids where either phase may be either fatty or aqueous; lipid-in-water emulsions are usually liquid, like milk or lotion and water-in-lipid emulsions tend to be creams.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloids with a gaseous dispersing phase and either liquid %28%fog%29% or solid %28%smoke%29% dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas %28%AEROSOLS%29% and other colloidal systems; water-insoluble drugs may be given as suspensions.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collu Hextril' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Collu-Hextril' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colo Pleon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colobinae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloboma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colobomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colobus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colobus Monkey' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colobus Monkeys' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colocasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colombia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colombian Catfish' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon %28%1965-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon %28%1966-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon %28%1967-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Cancer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Cancer, Familial Nonpolyposis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Cancer, Sigmoid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Cancers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Disease, Sigmoid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Diseases, Sigmoid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Diverticula' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Diverticulum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Neoplasms, Sigmoid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Surgeries %28%Specialty%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Surgery %28%Specialty%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon Surgery Specialty' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon and Rectal Surgery %28%Specialty%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon and Rectal Surgery Specialty' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon, Ascending' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon, Descending' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon, Irritable' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon, Sigmoid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon, Transverse' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colon/radiography %28%1994-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonialism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Aganglionosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Cancer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Cancers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Disease, Functional' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases %28%1964-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases %28%1965-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases %28%1966-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases %28%1966-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases %28%1967-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases, Functional' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases, Functional %28%1970-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diseases/radiography %28%1994-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diverticula' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diverticulitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diverticulosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Diverticulum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Neoplasms %28%1966-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Neoplasms %28%1966-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Neoplasms %28%1966-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Polyp' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Polyps' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Pouche' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Pouches' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Pseudo Obstruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Pseudo-Obstruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Pseudoobstruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Urinary Reservoir' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonic Urinary Reservoirs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonies, Leper' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonography, CT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonography, Computed Tomographic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscope' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopic Surgeries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopic Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopic Surgical Procedure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopy, Virtual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopy/instrumentation %28%1966-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopy/instrumentation %28%1966-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colonoscopy/methods %28%1994-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Count, Microbial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Counts, Microbial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Unit' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units Assay' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units Assay, Microbial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units Assay, Tumor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units Assays' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units Assays, Microbial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units, Hematopoietic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Forming Units, Neoplastic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor, Granulocyte Macrophage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor, Macrophage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor, Mast Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factor, Multipotential' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony Stimulating Factors, Recombinant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony, Leper' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Unit, Hematopoietic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Unit, Neoplastic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units Assay' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units Assay %28%1979-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units Assay %28%1979-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units Assay, Microbial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units Assay, Tumor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units Assays' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Forming Units, Neoplastic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor %28%1979-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor 2 Alpha' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor, Granulocyte-Macrophage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor, Macrophage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor, Mast-Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factor, Multipotential' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors %28%1976-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors %28%1985-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors %28%1985-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors %28%1986-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors %28%1992-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-Stimulating Factors, Recombinant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colony-forming cells which give rise to neoplasms. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloproctectomies, Restorative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloproctectomy, Restorative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color %28%1966-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color %28%1966-1975%29% or' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color %28%1972-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Anomias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Blindness, Red Green' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Doppler Echocardiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Doppler Ultrasonography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Echocardiography, Doppler' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Flow Echocardiographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Flow Echocardiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Perception' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Perception Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Perception Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Perceptions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Ultrasonography, Doppler' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Vision Defect' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Vision Defects' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color Visions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color of hair or fur. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color of the iris. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color, Eye' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Color, Hair' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorado' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorado Tick Fever' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorado tick fever virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorants, Food' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorants, Hair' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloration of the skin. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloration or discoloration of a part by a pigment. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Cancers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Carcinomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Neoplasms, Hereditary Nonpolyposis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Tumor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorectal Tumors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colored azo compounds formed by the reduction of tetrazolium salts. Employing this reaction, oxidoreductase activity can be determined quantitatively in tissue sections by allowing the enzymes to act on their specific substrates in the presence of tetrazolium salts.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorimetry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring Agents, Food' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring Agents, Hair' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring matter from the insect Coccus cacti L. It is used in foods, pharmaceuticals, toiletries, etc., as a dye, and also has use as a microscopic stain and biological marker.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring, Dental Prosthesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring, Prosthesis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coloring, shading, or tinting of prosthetic components, devices, and materials.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorless reduced precursors of porphyrins in which the pyrrole rings are linked by methylene %28%-CH2-%29% bridges.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens %28%not to be confused with pigment-synthesizing bacteria also called chromogens%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colorless, odorless crystals that are used extensively in research laboratories for the preparation of polyacrylamide gels for electrophoresis and in organic synthesis, and polymerization. Some of its polymers are used in sewage and wastewater treatment, permanent press fabrics, and as soil conditioning agents.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colors, Eye' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colors, Hair' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colostomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colostomy %28%1966-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colostrum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colostrum %28%1973-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colostrums' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colpohysterectomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colpohysterectomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcope' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopic Surgeries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopic Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopic Surgical Procedure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colposcopy %28%1978-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colpotomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colpotomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coltivirus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coltiviruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coltsfoot' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coltsfoot, Sweet' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colubridae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colubrina' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia Brand of Carboplatin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia Brand of Ceftriaxone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia Brand of Doxorubicin Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia Brand of Mitoxantrone Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia Brand of Vincristine Sulfate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia SK Viruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia SK virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbia-SK Viruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbidae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbiformes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columbine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Column, Spinal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Column, Vertebral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columns, Spinal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Columns, Vertebral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Colvasone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma %28%1965-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma %28%1972-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma %28%1976-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma Depasse' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma Scale, Glasgow' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma Therapies, Insulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma Vigil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma Vigilans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Diabetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Hyperglycemic Hyperosmolar Nonketotic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Insulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Irreversible' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Nonketotic Hyperglycemic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post Concussive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post Head Injury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post Trauma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post Traumatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post-Concussive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post-Head Injury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post-Trauma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Post-Traumatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coma, Traumatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comamonadaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comamonas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comamonas acidovorans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comamonas testosteroni' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comas, Diabetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comas, Hepatic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comas, Post-Concussive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comas, Post-Head Injury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comas, Post-Trauma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comatose' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comb Jellies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comb and Wattles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combat Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combat Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combat Neuroses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combat Neurosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination Chemotherapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination Chemotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination Drug Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination Drug Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination Vaccines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination of pulmonary valve stenosis and atrial septal defect with right ventricular hypertrophy.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination or superimposition of two images for demonstrating differences between them %28%e.g., radiograph with contrast vs. one without, radionuclide images using different radionuclides, radiograph vs. radionuclide image%29% and in the preparation of audiovisual materials %28%e.g., offsetting identical images, coloring of vessels in angiograms%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination, Ethinyl Estradiol-Norgestrel' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination, Norgestrel-Ethinyl Estradiol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combination, Potassium Clavulanate-Amoxicillin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinations of diagnostic or therapeutic substances linked with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; or ANTIGENS. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of DRUGS and RADIOISOTOPES in the CHEMOTHERAPY and RADIOIMMUNOTHERAPY of certain cancers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinations, Antineoplastic Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinations, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinatorial Chemistry Technic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinatorial Chemistry Technics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinatorial Chemistry Technique' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combinatorial Chemistry Techniques' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined vaccines consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and an acellular form of PERTUSSIS VACCINE. At least five different purified antigens of B. pertussis have been used in various combinations in these vaccines.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Anesthetics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Antineoplastic Agent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Antineoplastic Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Carboxylase Deficiencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Carboxylase Deficiency' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Hyperlipidemia, Familial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Hyperlipidemias, Familial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Immunodeficiencies, Severe' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Immunodeficiency, Severe' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Modality Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Modality Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Modality Therapy %28%1984-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Modality Therapy %28%1984-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Modality Therapy %28%1985-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Multiple Motor and Vocal Tic Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Oral Contraceptives' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Vaccines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combined Vocal and Multiple Motor Tic Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combining Site' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combining Sites' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combino Brand of Vancomycin Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combino Pharm, Doxazosina' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combretaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combretum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combustibilities, Preternatural Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combustibility, Preternatural Human' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combustion, Spontaneous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Combustions, Spontaneous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comet %28%Astronomy%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comet Assay' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comet Assay, Alkaline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comet Assays' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comet Assays, Alkaline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comfrey' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comitant Strabismus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comitant Strabismus, Convergent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commelina' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commelinaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comment %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comment %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commentary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commentary %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commerce' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commerce %28%1985-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commerce %28%1991-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commerces' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commercial Catalog' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commercial Catalogs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commercial Oil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commercial Sectors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comminuted Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comminuted Fractures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commiphora' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commission on Professional and Hospital Activities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commission on Professional, Hospital Activities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commission, Governmental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commissions, Governmental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commisural Aphasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commisural Aphasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitment Duration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitment Durations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitment of Mentally Ill' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitment, Involuntary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitment, Outpatient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitments, Involuntary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commitments, Outpatient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committed, erythroid stem cells derived from MYELOID PROGENITOR CELLS. The progenitor cells develop in two phases: erythroid burst-forming units %28%BFU-E%29% followed by erythroid colony-forming units %28%CFU-E%29%; BFU-E differentiate into CFU-E on stimulation by ERYTHROPOIETIN, and then further differentiate into ERYTHROBLASTS when stimulated by other factors.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee Member' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee Membership' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee Memberships' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Advisory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Animal Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Animal Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Clinical Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Data Monitoring' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Formulary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Hospital Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Institutional Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Pharmacy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Professional Staff' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Regional Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Research Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Review' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committee, Therapeutics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees established by professional societies, health facilities, or other institutions to consider decisions that have bioethical implications. The role of these committees may include consultation, education, mediation, and/or review of policies and practices. Committees that consider the ethical dimensions of patient care are ETHICS COMMITTEES, CLINICAL; committees established to protect the welfare of research subjects are ETHICS COMMITTEES, RESEARCH.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees established to review interim data and efficacy outcomes in CLINICAL TRIALS. The findings of these committees are used in deciding whether a trial should be continued as designed, changed, or terminated. Government regulations regarding federally-funded research involving human subjects %28%the %22%Common Rule%22%%29% require %28%45 CFR 46.111%29% that research ethics committees reviewing large-scale clinical trials monitor the data collected using a mechanism such as a data monitoring committee. FDA regulations %28%21 CFR 50.24%29% require that such committees be established to monitor studies conducted in emergency settings.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees of professional personnel who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Advisory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Animal Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Animal Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Clinical Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Data Monitoring' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Formulary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Hospital Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Institutional Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Pharmacy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Professional Staff' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Regional Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Research Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Review' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Committees, Therapeutics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commodification' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Acute Lymphoblastic Leukemia Antigens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Antigen, Trophoblast-Leukocyte' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct %28%1966-1993%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Calculi %28%1964-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Calculi %28%1965-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Calculi/surgery %28%1966-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Cyst' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Diseases %28%1980-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Diseases %28%1985-2004%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Gall Stones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Gallstones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Duct/surgery %28%1966-1987%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Bile Ducts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Carotid Arteries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Carotid Artery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Carotid Artery Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Cold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Cold Viruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Colds' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Dolphin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Dolphin, Long-Beaked' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Dolphin, Short-Beaked' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Dolphins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Dolphins, Long-Beaked' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Dolphins, Short-Beaked' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common European Frog' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Fimbria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Fimbriae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Frog, European' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Hepatic Duct' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Hepatic Ducts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Marmoset' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Marmosets' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Migraine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Migraines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Millet' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Peroneal Neuropathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Peroneal Neuropathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Pili' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Pilus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Porpoise' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Porpoises' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Salsify = TRAGOPOGON is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Shore Crab' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Smad' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Toad' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Toads' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Variable Immunodeficiencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common Variable Immunodeficiency' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common alpha Subunit Glycoprotein Hormones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common coronavirus infection of cats caused by the feline infectious peritonitis virus %28%CORONAVIRUS, FELINE%29%. The disease is characterized by a long incubation period, fever, depression, loss of appetite, wasting, and progressive abdominal enlargement. Infection of cells of the monocyte-macrophage lineage appears to be essential in FIP pathogenesis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common form of habitual body manipulation which is an expression of tension.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common member of the Gramineae family used as cattle fodder. It harbors several fungi and other parasites toxic to livestock and people and produces allergenic compounds, especially in its pollen. The most commonly seen varieties are L. perenne, L. multiflorum, and L. rigidum.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for Carassius auratus, a type of carp %28%CARPS%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for FISHES belonging to the order Perciformes and occurring in three different families.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for Ricinus communis, a species in the family EUPHORBIACEAE. It is the source of CASTOR OIL.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for a family of eel-shaped jawless fishes %28%Myxinidae%29%, the only family in the order MYXINIFORMES. They are not true vertebrates.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for a number of different species of fish in the family Cyprinidae. This includes, among others, the common carp, crucian carp, grass carp, and silver carp.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for an order %28%Anguilliformes%29% of voracious, elongate, snakelike teleost fishes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for large, quilled rodents %28%RODENTIA%29% comprised of two families: Old World porcupines %28%Hystricidae%29% and New World porcupines %28%Erethizontidae%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for many members of the FALCONIFORMES order, family Accipitridae, generally smaller than EAGLES, and containing short, rounded wings and a long tail.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for one of five species of small PARROTS, containing long tails.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for perch-like fish of the family Cichlidae, belonging to the suborder Labroidei, order PERCIFORMES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for several daisy-like plants %28%MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM%29% native to Europe and Western Asia, now naturalized in the United States and Australia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for small PASSERIFORMES in the family Fringillidae. They have a short stout bill %28%BEAK%29% adapted for crushing SEEDS. Some species of Old World finches are called CANARIES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for the largest birds in the order PASSERIFORMES, family Corvidae. These omnivorous black birds comprise most of the species in the genus Corvus, along with ravens and jackdaws %28%which are often also referred to as crows%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for the only family %28%Petromyzontidae%29% of eellike fish in the order Petromyzontiformes. They are jawless but have a sucking mouth with horny teeth.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for the order Pleuronectiformes. A very distinctive group in that during development they become asymmetrical, i.e., one eye migrates to lie adjacent to the other. They swim on the eyeless side. FLOUNDER, sole, and turbot, along with several others, are included in this order.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for two distinct groups of BIRDS in the order GALLIFORMES: the New World or American quails of the family Odontophoridae and the Old World quails in the genus COTURNIX, family Phasianidae.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for two families of FLATFISHES belonging to the order Pleuronectiformes: left-eye flounders %28%Bothidae%29% and right-eye flounders %28%Pleuronectidae%29%. The latter is more commonly used in research.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name for various species of large, vigorous ocean fishes in the family Scombridae.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Common name of the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commonlaw Marriages' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commonly known as parasitic worms, this group includes the ACANTHOCEPHALA; NEMATODA; and PLATYHELMINTHS. Some authors consider certain species of LEECHES that can become temporarily parasitic as helminths.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commonly observed structural components of proteins formed by simple combinations of adjacent secondary structures. A commonly observed structure may be composed of a CONSERVED SEQUENCE which can be represented by a CONSENSUS SEQUENCE.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commonwealth of Independent States' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Commotio Cerebri' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Disease Contact Tracing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Disease Control' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Disease Control %28%1966-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Disease Control %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Disease, Emerging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Diseases %28%1966-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Diseases, Emerging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicable Diseases/transmission %28%1974-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1966-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1969-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication %28%1972-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Aids for Disabled' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Aids for Handicapped' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Barrier' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Barriers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Board' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disability' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorder, Acquired' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorder, Childhood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorder, Developmental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorder, Neurogenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorders, Acquired' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorders, Childhood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Disorders, Neurogenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Hospital System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Hospital Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Method, Total' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Methods, Total' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Network, Computer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Networks, Computer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Program' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Protocol, Network' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Protocols, Network' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication System, EMS' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication System, Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Systems, EMS' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Systems, Emergency Medical Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication Systems, Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication between persons or between institutions or organizations by an exchange of letters. Its use in indexing and cataloging will generally figure in historical and biographical material.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication services provided by a person or a machine to record and relay the message from the caller.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication through a system of conventional vocal symbols.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Animal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Autocrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Cross-Disciplinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Husband-Wife' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Interdisciplinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Manual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Multidisciplinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Nonverbal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Paracrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Partner' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Personal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Persuasive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Privileged' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, Satellite' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communication, in the sense of cross-fertilization of ideas, involving two or more academic disciplines %28%such as the disciplines that comprise the cross-disciplinary field of bioethics, including the health and biological sciences, the humanities, and the social sciences and law%29%. Also includes problems in communication stemming from differences in patterns of language usage in different academic or medical disciplines.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications Media' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications networks connecting various hardware devices together within or between buildings by means of a continuous cable or voice data telephone system.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications using an active or passive satellite to extend the range of radio, television, or other electronic transmission by returning signals to earth from an orbiting satellite.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications via an interactive conference between two or more participants at different sites, using computer networks %28%COMPUTER COMMUNICATION NETWORKS%29% or other telecommunication links to transmit audio, video, and data.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Animal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Autocrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Cross-Disciplinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Husband-Wife' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Interdisciplinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Manual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Multidisciplinary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Nonverbal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Paracrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Partner' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Privileged' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communications, Satellite' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicative Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicative Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communicative Dysfunctions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communities, Rural' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Communities, Therapeutic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Acquired Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Actions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Based Distribution' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Care Network' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Consents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Dentistry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Developments' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Aide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Aides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Center' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Centers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Network' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Nursing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Nursings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Planning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Plannings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services %28%1966-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services %28%1966-1972%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health Services %28%1980-1995%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Health System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Healthcare' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Healthcares' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Hospitals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Institutional Relations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Medicine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Mental Health Centers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Mental Health Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Mental Health Services %28%1967-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Mental Health Services %28%1967-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Mental Health Services %28%1967-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Mental Health Services %28%1967-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Network' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Networks' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmaceutic Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmaceutic Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmaceutical Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmaceutical Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmacy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmacy Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Pharmacy Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Psychiatry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Relation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Survey' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community Worker' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community health and NURSING SERVICES providing coordinated multiple services to the patient at the patient%27%s homes. These home-care services are provided by a visiting nurse, home health agencies, HOSPITALS, or organized community groups using professional staff for care delivery. It differs from HOME NURSING which is provided by non-professionals.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community health education events focused on prevention of disease and promotion of health through audiovisual exhibits.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community of tiny aquatic organisms, both PLANTS and ANIMALS, that are either free-floating or suspended in the water, with little or no power of locomotion. They are divided into PHYTOPLANKTON and ZOOPLANKTON.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community or individual involvement in the decision-making process.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community, European Economic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community, Rural' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community, Therapeutic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community-Acquired Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community-Acquired Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community-Based Distributions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community-Institutional Relation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Community-Institutional Relations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comorbidities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comorbidity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comoro Islands' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comoros' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comoviridae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comovirus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disc' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Discs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disk' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disk Interactive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disk Read Only Memory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disk Read-Only Memory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disk, Interactive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disks' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disks %28%1993-1995%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compact Disks, Interactive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Companion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Anatomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Anatomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Histology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Physiology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Psychologies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Psychology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Studies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Study' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Study %28%1976-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Study %5B%PT%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Study %5B%Pub Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative Study %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative psychology of races and peoples. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparison, Cross-Cultural' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparison, Husband-Wife' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparison, Paired' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparisons, Cross-Cultural' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparisons, Husband-Wife' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comparisons, Paired' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartment Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartment Syndrome, Anterior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartment Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartment Syndromes, Anterior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartment, Body Fluid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartmentation, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartmentations, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compartments, Body Fluid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compatibilities, Tissue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compatibility, Tissue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensated Glaucoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensated Glaucomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation and Redress' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Dosage %28%Genetics%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Gene Dosage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Genetic Dosage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Worker%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Workers%27%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Workman%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensation, Workmen%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensations, Worker%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensations, Workers%27%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensations, Workman%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensations, Workmen%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensative Glaucoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensative Glaucomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compensatory plans designed to motivate physicians in relation to patient referral, physician recruitment, and efficient use of the health facility.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competence, Clinical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competence, Immunologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competence, Immunological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competence, Mental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competence, Professional' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competency Based Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competency, Mental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competency-Based Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competency-Based Educations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competition, Economic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competition, Managed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitions, Economic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Behavior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Bidding' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Biddings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Binding' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Bindings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Health Plan' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Health Plans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Medical Plan' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Competitive Medical Plans' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compilations of data on hospital activities and programs; excludes patient medical records.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complamine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1967-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1968-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1968-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1972-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1973-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement %28%1973-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1 %28%1975-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1 %28%1979-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1 %28%1980-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1 Esterase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1 Esterase Inhibitors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1q' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1r' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 1s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 2 %28%1985-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 2a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 2b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 %28%1974-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 %28%1975-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 %28%1975-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 Convertase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 Convertase, Alternative Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 Nephritic Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 Proactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3 Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Associated Factor B fragment Bb' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Complement 4b Inactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Inactivators' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Inactivators %28%1980-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Inhibitors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b-Associated Factor B-fragment Bb' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3b-Complement 4b Inactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3c' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3d' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3d Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 3d Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 4 %28%1975-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 4 %28%1978-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 4a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 4b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 4b Binding Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5 %28%1975-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5 %28%1979-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5 Convertase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5a Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5a, de Arginine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5a, de-Arginine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5a, des Arginine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5a, des-Arginine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 5b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 6' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 8' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement 9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Absorption Test, Conglutinating' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activating Enzymes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activating Enzymes %28%1978-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activating Enzymes %28%1979-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activating Enzymes %28%1983-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activation %28%1989-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activation Pathway, Alternative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activation Pathway, Classical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Activations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Associated Protein SP 40,40' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1 Inactivating Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1 Inactivator Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1 Inactivator Proteins %28%1970-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1 Inhibiting Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1 Inhibitor Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1 Inhibitor Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1-Inhibitor Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1q' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1r' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C1s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C2 Fragment a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C2a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C2a Fragment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C2b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C2b Fragment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 %28%1976-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 C5 Convertases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 C5 Convertases, Alternative Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 C5 Convertases, Classical Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 Convertase, Alternative Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 Convertase, Classical Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3 Nephritic Factor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3-C5 Convertases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3-C5 Convertases %28%1979-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3-C5 Convertases, Alternative Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3-C5 Convertases, Classical Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3b C4b Inactivator Cofactor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3b Inactivator Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3b Inactivators' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3b Inhibitor Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3b-C4b Inactivator Cofactor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3c' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3c Fragment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3d' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C3d Fragment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4b Binding Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4b C3b Inactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4b-Binding Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C4b-C3b Inactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5 %28%1976-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5 Convertase, Alternative Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5 Convertase, Classical Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5a, des Arginine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5a, des-Arginine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C5b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C6' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C8' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement C9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Complex C5b 9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Complex C5b-9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Complex, Terminal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 1 Inactivator Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 1q' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 1r' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 1s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 2b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 3a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 3b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 3c' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 3d' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 4a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 4b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 4b Binding Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 4b-Binding Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 5a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 5b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 6' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 8' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component 9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component C8 alpha Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component C8 beta Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component C8 gamma Chain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Component, C4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Cytolysis Inhibiting Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement D Component' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor B Derived Fragment Bb' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor B Fragment, Bb' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor B, Alternative Pathway' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor B-Derived Fragment Bb' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor H' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Factor P' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Fixation Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Fixation Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Fixation Tests %28%1966-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement H50s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Hemolytic Activity Assay' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Inactivating Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Inactivating Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Inactivator Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Inactivator Proteins %28%1981-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Inactivators, Serum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Inhibiting Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Lysis Inhibitor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Membrane Attack Complex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Pathway, Alternative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Pathway, Classical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Pathway, Classical %28%1980-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Pathway, Classical %28%1983-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Pathway, Mannose Binding Lectin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Pathway, Mannose-Binding Lectin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Protein B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Protein D' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Protein Factor B' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Receptor 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Receptor 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Receptor Type 4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement Receptors 2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement System Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement System Proteins %28%1975-2005%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE %28%C4B2A%29% and the subsequent C5 CONVERTASE %28%C4B2A3B%29% leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE %28%C3BBB%29% which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE %28%C3BBB3B%29% leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement activation triggered by the interaction of microbial POLYSACCHARIDES with serum MANNOSE-BINDING LECTIN resulting in the activation of MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES %28%MASP%29%. As in the classical pathway, MASPs cleave COMPLEMENT C4 and COMPLEMENT C2 to form C3 CONVERTASE %28%C4B2A%29% and the subsequent C5 CONVERTASE %28%C4B2A3B%29% leading to cleavage of COMPLEMENT C5 and assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C1q' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C1r' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C1s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C2' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C2a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C2b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C3a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C3b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C3c' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C3d' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C4' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C4a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C4b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C5a' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C5b' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C6' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C7' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C8' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, C9' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, Hemolytic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement, Total Hemolytic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement-Associated Protein SP-40,40' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complement/analysis %28%1969-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity Determining Region' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity Determining Region I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity Determining Region II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity Determining Region III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity Determining Regions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity-Determining Region' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity-Determining Region 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity-Determining Region 3s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity-Determining Region, Third' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity-Determining Regions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementarity-Determining Regions, Third' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementary DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementary Feeding' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementary Feedings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementary RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementary Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementation Test' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementation Test, Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementation Tests' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complementation Tests, Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complements, Total Hemolytic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Argininosuccinic Acid Synthetase Deficiency Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Blindness' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Blood Count' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Blood Counts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Denture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Dentures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete HGPRT Deficiency Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Hearing Loss' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Hydatidiform Mole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete Hydatidiform Moles' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete loss of phonation due to organic disease of the larynx or to nonorganic %28%i.e., psychogenic%29% causes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete or partial change from one sex to another with regard to gonadal development. Gonadal sex reversal may occur naturally or be induced by factors such as steroids, temperature, and autosomal abnormalities during the critical period of gonadal differentiation %28%SEX DIFFERENTIATION%29% in some species.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral %28%TRANSURETHRAL RESECTION OF PROSTATE%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete or severe weakness of the muscles of respiration. This condition may be associated with MOTOR NEURON DISEASES; PERIPHERAL NERVE DISEASES; NEUROMUSCULAR JUNCTION DISEASES; SPINAL CORD DISEASES; injury to the PHRENIC NERVE; and other disorders.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complete severing of the CORPUS CALLOSUM. In humans it is usually performed to treat medically intractable, multifocal EPILEPSY. EXPERIMENTAL ANIMAL MODELS of split brain preparations are used in research.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Completed Family Size' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Completed Family Sizes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. They include CAPSULES; LINIMENTS; OINTMENTS; PHARMACEUTICAL SOLUTIONS; POWDERS; TABLETS; etc.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Completion Phenomena, Perceptual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Endometrial Hyperplasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Factors, Ternary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex I Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Mixtures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Partial Epilepsy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Partial Seizure Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Proteins, Ternary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Regional Pain Syndrome Type II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Regional Pain Syndrome, Type I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex Regional Pain Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex and Mixed Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex compounds in which a dumbbell shaped molecule is encircled by a macrocycle. They are named after rota %28%wheel%29% and axis %28%axle%29%. Notation with a prefix is used to indicate the number of interlocked components. They have potential use in NANOTECHNOLOGY. Rotaxanes have been made with CYCLODEXTRINS and CYCLIC ETHERS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic %28%RNA%29% and deoxyribonucleic %28%DNA%29% acids, both of which consist of nucleotides %28%nucleoside phosphates linked together by phosphate bridges%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex compounds where two cyclic molecules are interlaced together as links in a chain. They have potential use in NANOTECHNOLOGY.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex mental function having four distinct phases: %28%1%29% memorizing or learning, %28%2%29% retention, %28%3%29% recall, and %28%4%29% recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of MAMMALS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex nucleoprotein structures which contain the genomic DNA and are part of the CELL NUCLEUS of PLANTS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor %28%RECEPTORS, ANTIGEN, T-CELL%29%. The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains %28%subunits%29%. When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains %28%subunits%29% are separate from and not related to the gamma/delta chains of the T-cell receptor %28%RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex petroleum hydrocarbons consisting mainly of residues from crude oil distillation. These liquid products include heating oils, stove oils, and furnace oils and are burned to generate energy.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease %28%as vaccines or pollen extracts%29%. Biological products are differentiated from BIOLOGICAL FACTORS in that the latter are compounds with biological or physiological activity made by living organisms. %28%From Webster%27%s 3d ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, 2-Oxoglutarate Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, AIDS Dementia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, AIDS-Related' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, AIDS-Related Dementia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Adenosine Triphosphatase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Antigen-Antibody' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Atrial Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Calcium-Ryanodine Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Cardiac Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Castration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Cloacin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Cloacin-Immunity Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Eisenmenger' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Eisenmenger%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Factor IX' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Golgi' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Histocompatibility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Immune' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Ketoglutarate Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Major Histocompatibility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Migrating Motor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Migrating Myoelectric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Multicatalytic Endopeptidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Oedipus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Premature Atrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Premature Cardiac' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Premature Ventricular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Proteasome Endopeptidase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Pyruvate Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, RNA-Induced Silencing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Sucrase Isomaltase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Sucrase-Isomaltase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Switching' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Synaptinemal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Synaptonemal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, TCR-CD3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Terminal Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Triangular Fibrocartilage' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, Ventricular Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complex, alpha-Ketoglutarate Dehydrogenase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes containing CHLOROPHYLL and other photosensitive molecules. They serve to capture energy in the form of PHOTONS are generally found as components of the PHOTOSYSTEM I PROTEIN COMPLEX or the PHOTOSYSTEM II PROTEIN COMPLEX.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes of RNA-binding proteins with ribonucleic acids %28%RNA%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes of enzymes that catalyze the covalent attachment of UBIQUITIN to other proteins by forming a peptide bond between the C-terminal GLYCINE of UBIQUITIN and the alpha-amino groups of LYSINE residues in the protein. The complexes play an important role in mediating the selective-degradation of short-lived and abnormal proteins. The complex of enzymes can be broken down into three components that involve activation of ubiquitin %28%UBIQUITIN-ACTIVATING ENZYMES%29%, conjugation of ubiquitin to the ligase complex %28%UBIQUITIN-CONJUGATING ENZYMES%29%, and ligation of ubiquitin to the substrate protein %28%UBIQUITIN-PROTEIN LIGASES%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes of iodine and non-ionic surface-active agent acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes of scRNA %28%RNA, SMALL CYTOPLASMIC%29% and protein found in the cytoplasm. An example is SIGNAL RECOGNITION PARTICLE.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Antigen-Antibody' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Atrial Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Immune' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Immuno-Stimulating' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Immunostimulating' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Light-Harvesting Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Macromolecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Macromolecular Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Migrating Motor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Migrating Myoelectric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Multienzyme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Multiprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Photosynthetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Premature Cardiac' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Proton-Translocating ATPase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Switch' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Switching' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Ubiquitin-Protein Ligase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, Ventricular Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexes, hnRNP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complexons' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance by health personnel or proxies with the stipulations of ADVANCE DIRECTIVES %28%or similar directives such as RESUSCITATION ORDERS%29% when patients are unable to direct their own care.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance with a set of standards defined by non-governmental organizations. Certification is applied for by individuals on a voluntary basis and represents a professional status when achieved, e.g., certification for a medical specialty.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance, Advance Directive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance, Lung' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance, Patient' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance, Policy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance, Protocol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliance, User' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliances, Lung' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compliant Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complicated Migraine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complicated Migraines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Cardiovascular Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Hematologic Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Hematological Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Infectious Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Intraoperative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Labor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Neoplastic Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Obstetric Labor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Parasitic Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Peroperative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Postoperative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complication, Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications Pregnancies, Parasitic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications Pregnancy, Parasitic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications of Diabetes Mellitus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Cardiovascular Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Hematologic Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Hematological Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Infectious Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Intraoperative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Labor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Neoplastic Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Obstetric Labor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Parasitic Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Peroperative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Postoperative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complications, Pregnancy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Atrial Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Cardiac Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Castration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Histocompatibility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Major Histocompatibility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Posterior Nuclear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Premature Atrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Premature Cardiac' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Premature Ventricular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, Ventricular Premature' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complices, WAGR' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Complicity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compomers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 1, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 1q, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 1r, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 1s, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 2, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 2b, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 3, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 3a, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 3b, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 3c, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 3d, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 4, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 4a, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 4b, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 5, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 5a, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 5b, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 6, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 7, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 8, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component 9, Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component Globulin, Group-Specific' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component Removal, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component Removals, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component Transfusion, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component Transfusions, Blood' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component of dermatan sulfate. Differs in configuration from glucuronic acid only at the C-5 position.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component, C4 Complement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component, Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component, Genome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Component, Tooth' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p163%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components of a cell. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components of a national health care system which administer specific services, e.g., national health insurance.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components of ribosomal RNA that undergo auto-catalyzed molecular rearrangements of their RNA sequence.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components of the cytoplasm excluding the CYTOSOL. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components of the extracellular matrix consisting primarily of fibrillin. They are essential for the integrity of elastic fibers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components, Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components, Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components, Genome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Components, Tooth' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compositae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins %28%1972-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins %28%1980-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins %28%1983-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins %28%1994-1999%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins, Polyacid Modified' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite Resins, Polyacid-Modified' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composite materials composed of an ion-leachable glass embedded in a polymeric matrix. They differ from GLASS IONOMER CEMENTS in that partially silanized glass particles are used to provide a direct bond to the resin matrix and the matrix is primarily formed by a light-activated, radical polymerization reaction.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composition, Base' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composition, Body' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composition, G+C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Composition, GC' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compositions written by hand, as one written before the invention or adoption of printing. A manuscript may also refer to a handwritten copy of an ancient author. A manuscript may be handwritten or typewritten as distinguished from a printed copy, especially the copy of a writer%27%s work from which printed copies are made. %28%Webster, 3d ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compositions, Base' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compositions, Body' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compositions, G+C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compositions, GC' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 201 995' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 201-995' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 201995' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 48 80' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 4880' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 67 20' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound 6720' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Antagonists, Sulfhydryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Depressed Skull Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Depressed Skull Fractures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Fractures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Inhibitors, Sulfhydryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Odontoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Odontomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound Q' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound isolated from Cannabis sativa extract. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound such as LUMINESCENT PROTEINS that cause or emit light %28%PHYSICAL LUMINESCENCE%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compound used for therapy of thiamine deficiency. It has also been suggested for several non-deficiency disorders but has not yet proven useful.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounding, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kD in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on 2-amino-4-hydroxypteridine. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on 5,6,7,8-tetrahydrofolate. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on ANTHRACENES which contains two KETONES in any position. Substitutions can be in any position except on the ketone groups.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on CHALCONE. They are important intermediates in the formation of FLAVONOIDS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on ERYTHROMYCIN with the 3-cladinose replaced by a ketone. They bind the 23S part of 70S bacterial RIBOSOMES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on a 7-membered heterocyclic ring including an oxygen. They can be considered a medium ring ether. A natural source is the MONTANOA plant genus. Some dibenzo-dioxepins, called depsidones, are found in GARCINIA plants.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on a propanolamine attached via an OXYGEN atom to a phenoxy ring. The side chain is one carbon longer than PHENYLETHYLAMINES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on a seven-membered ring fused to a five-membered ring. Heat can rearrange them to NAPHTHALENES which have two fused six-membered rings. They are similar to guaiazulenes which are SESQUITERPENES with a six-membered ring fused to a five-membered ring.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on an 8-membered heterocyclic ring including an oxygen. They can be considered medium ring ethers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on benzene fused to oxole. They can be formed from methylated CATECHOLS such as EUGENOL.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on benzeneacetamide, that are similar in structure to ACETANILIDES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on pyrazino%5B%2,3-d%5D%pyrimidine which is a pyrimidine fused to a pyrazine, containing four NITROGEN atoms.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on reduced IMIDAZOLES containing a single double bond.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds capable of relieving pain without the loss of CONSCIOUSNESS or without producing ANESTHESIA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds comprising branches from an inner core. The overall globular shape and presence of cavities gives potential as DRUG CARRIERS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds consisting of chains of AMINO ACIDS alternating with CARBOXYLIC ACIDS via ester and amide linkages. They are commonly cyclized.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds consisting of glucosamine and lactate joined by an ether linkage. They occur naturally as N-acetyl derivatives in peptidoglycan, the characteristic polysaccharide composing bacterial cell walls. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds consisting of three benzene rings linked to each other in either ortho, meta or para positions and substituted with chlorine atoms.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds consisting of two or more fused ring structures.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole %28%PYRAZOLES%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols. They act to anchor proteins or polysaccharides to cell membranes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing carbon-phosphorus bonds in which the phosphorus component is also bonded to one or more sulfur atoms. Many of these compounds function as CHOLINERGIC AGENTS and as INSECTICIDES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing phenyl-1-butanone. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing polymethylene bis-trimethylammonium cations. Members of this group frequently act as ganglionic blockers and neuromuscular depolarizing agents.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing the -SH radical. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing the PhCH= radical. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds containing the hexamethylenebis%28%trimethylammonium%29% cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds derived from TYROSINE via betalamic acid, including BETAXANTHINS and BETACYANINS. They are found in the Caryophyllales order of PLANTS and some BASIDIOMYCETES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds. These are especially found in plants of the APOCYNACEAE; LOGANIACEAE; and RUBIACEAE families.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules %28%e.g., BIOPOLYMERS; PLASTICS%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds functioning as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. They include the polyisoprenyl pyrophosphates.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds in which a methyl group is attached to the cyano moiety.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds in which one or more of the ketone groups on the pyrimidine ring of barbituric acid are replaced by thione groups.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds made by living organisms that contribute to or influence a phenomenon or process. They have biological or physiological activities.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds of silver and proteins used as topical anti-infective agents.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds of the general formula R-O-R arranged in a ring or crown formation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds or agents that combine with cyclooxygenase %28%PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES%29% and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds or agents that combine with lipoxygenase and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of the eicosanoid products hydroxyeicosatetraenoic acid and various leukotrienes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds or factors that act on a specific enzyme to increase its activity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds possessing both a hydroxyl %28%-OH%29% and an amino group %28%-NH2%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds similar to hydrocarbons in which a tetravalent silicon atom replaces the carbon atom. They are very reactive, ignite in air, and form useful derivatives.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. %28%Martindale, The Extra Pharmacopoeia, 30th ed, p1161%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that cause reproductive sterility in organisms. They are sometimes used to control pest populations by sterilizing males within the population.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that contain a 1-dimethylaminonaphthalene-5-sulfonyl group.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that contain the biogenic monoamine tryptamine and are substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that contain the decamethylenebis%28%trimethyl%29%ammonium radical. These compounds frequently act as neuromuscular depolarizing agents.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that contain the radical R2C=N.OH derived from condensation of ALDEHYDES or KETONES with HYDROXYLAMINE. Members of this group are CHOLINESTERASE REACTIVATORS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that contain the triphenylmethane aniline structure found in rosaniline. Many of them have a characteristic magenta color and are used as COLORING AGENTS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that contain three methine groups. They are frequently used as cationic dyes used for differential staining of biological materials.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that differ from COUMARINS in having the positions of the ring and ketone oxygens reversed so the keto oxygen is at the 1-position of the molecule.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that inhibit cell production of DNA or RNA. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that inhibit the action of prostaglandins. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds used extensively as acetylation, oxidation and dehydrating agents and in the modification of proteins and enzymes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds used in food or in food preparation to replace dietary fats. They may be carbohydrate-, protein-, or fat-based. Fat substitutes are usually lower in calories but provide the same texture as fats.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which increase the capacity of the male to induce conception.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which increase the capacity to conceive in females.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize biosynthesis or actions of integrase.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize biosynthesis or actions of proteases %28%ENDOPEPTIDASES%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize the biosynthesis or action of estradiol.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize the biosynthesis or action of insulin.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize the biosynthesis or actions of aldosterone.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize the biosynthesis or actions of androgens.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with 1,2-diphenylethane. They are structurally like reduced STILBENES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with BENZENE fused to AZEPINES. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a 10-carbon ring. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a BENZENE fused to IMIDAZOLES. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a benzene ring fused to a thiazole ring.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a core of 10 carbons generally formed via the mevalonate pathway from the combination of 3,3-dimethylallyl pyrophosphate and isopentenyl pyrophosphate. They are cyclized and oxidized in a variety of ways. Due to the low molecular weight many of them exist in the form of essential oils %28%OILS, VOLATILE%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a core of fused benzo-pyran rings. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with three contiguous nitrogen atoms in linear format, H2N-N=NH, and hydrocarbyl derivatives.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with two BENZENE rings fused to AZEPINES. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds with two peroxide groups, that is, two pairs of adjacent OXYGEN atoms. They may have activity against PLASMODIUM similar to the ARTEMISININS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, 1-Ring Heterocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, 2-PAM' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, 2-Ring Heterocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, 3-Ring Heterocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Alkyl Mercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Alkylmercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Allyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Alum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Aluminum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Aminobiphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Androgenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Aniline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Arsenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Aza' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Aza Crown' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Aza-Thia Crown' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Azo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Barium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Benzalkonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Benzhydryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Benzyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Benzylidene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bephenium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bethanechol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bicyclic Heterocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bicyclo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Biphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Boron' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bretylium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bridged' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bridged-Ring Heterocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Bromine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Cadmium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Calcium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Cetrimonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Cetyltrimethylammonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Chlorine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Chromium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Chromogenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Crown' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Dansyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Decamethonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Diazoamino' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Diazonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Dimethylaminonaphthalenesulfonyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Dinitrophenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Diphenylmethyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Diphenylurea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Epoxy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Estrogenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Ethoxy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Ethyl Mercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Ethylmercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Ferric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Ferrous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Fluorine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Gold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Heterocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Heterocyclic Bicyclo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Hexamethonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Hydroxyimino' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Inorganic Carbon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Inorganic Platinum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Intercalative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Iodine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Iron' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Lithium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Macrocycle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Macrocyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Macromolecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Magnesium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Manganese' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Mercapto' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Mercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Metallo-Organic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Methacholine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Methyl Mercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Methylmercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Methylurea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Mustard' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Nitro' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Nitrogen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Nitrogen Mustard' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Nitroso' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Nitrosourea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Onium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organochlorine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organogold' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organomercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organometallic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organophosphorus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organoplatinum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organopyrophosphorus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organoselenium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organotechnetium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organothiophosphorus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Organotin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Osmium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Oxygen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Pemoline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Phenyl Mercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Phenylmercury' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Phenylurea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Phosphatidal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Phosphorus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Platinum' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Polybromobiphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Polychlorobiphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Polychloroterphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Polychlorotriphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Polycyclic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Potassium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Pralidoxime' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Pyridinium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Pyrvinium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Quinolinium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Ruthenium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Selenium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Silicon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Silver' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Sodium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Spiro' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Sulfhydryl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Sulfine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Sulfonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Sulfonylurea' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Sulfur' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Technetium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Terphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Tetraethylammonium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Thia Crown' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Thorium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Tin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Toluenesulfonyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Tosyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Trialkyltin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Triethyltin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Trimethylsilyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Trimethyltin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Trinitrophenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Triphenyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Triphenylmethane Aniline' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Triphenylmethyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Trityl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Tungsten' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Uranium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Vanadium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Vinyl' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, Zinc' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, either natural or synthetic, which block development of the growing insect.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehension' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehension Disorder, Auditory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehension Disorders, Auditory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehension Test, Language' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehension Tests, Language' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive Dental Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive Health Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive Health Care %28%1968-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive Health Insurances' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive Healthcare' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive planning for the physical development of the city.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Comprehensive, methodical analysis of complex biological systems by monitoring responses to perturbations of biological processes. Large scale, computerized collection and analysis of the data are used to develop and test models of biological systems.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Fracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Fractures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Neuropathy, Carpal Tunnel' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Stocking' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Stockings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Syndrome, Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression Syndromes, Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression of the ULNAR NERVE in the cubital tunnel, which is formed by the two heads of the flexor carpi ulnaris muscle, humeral-ulnar aponeurosis, and medial ligaments of the elbow. This condition may follow trauma or occur in association with processes which produce nerve enlargement or narrowing of the canal. Manifestations include elbow pain and PARESTHESIA radiating distally, weakness of ulnar innervated intrinsic hand muscles, and loss of sensation over the hypothenar region, fifth finger, and ulnar aspect of the ring finger. %28%Joynt, Clinical Neurology, 1995, Ch51, p43%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression of the rotator cuff tendons and subacromial bursa between the humeral head and structures that make up the coracoacromial arch and the humeral tuberosities. This condition is associated with subacromial bursitis and rotator cuff %28%largely supraspinatus%29% and bicipital tendon inflammation, with or without degenerative changes in the tendon. Pain that is most severe when the arm is abducted in an arc between 40 and 120 degrees, sometimes associated with tears in the rotator cuff, is the chief symptom. %28%From Jablonski%27%s Dictionary of Syndromes and Eponymic Diseases, 2d ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression waves of large amplitude, across which density, pressure, and particle velocity change drastically. %28%From McGraw Hill Dictionary of Scientific and Technical Terms, 5th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression, Data' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression, Image' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression, Nerve Root' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression, Spinal Cord' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compression, Ulnar Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compressions, Nerve Root' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compressions, Spinal Cord' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compressive Myelopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compressive Strength' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compressive Strengths' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsion to pull out one%27%s hair. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsive Behavior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsive Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsive Personalities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsive Personality Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsive Personality Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsory Sterilization' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Compulsory Sterilizations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computation, DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computation, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computation, RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computational Biology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computations, DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computations, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computations, RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Radionuclide Tomography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographic Colonography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographic Scintigraphy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographies, Helical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographies, Spiral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographies, Transmission' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographies, X-Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomographies, Xray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography Scanner, X Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography Scanner, X-Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography Scanners, X Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography Scanners, X-Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography, Helical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography, Spiral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography, Transmission' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography, X-Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed Tomography, Xray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed X-Ray Tomographies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed X-Ray Tomography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computed tomography where there is continuous X-ray exposure to the patient while being transported through a rotating fan beam. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Aided Design' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Aided Manufacturing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Aided Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Architectures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Decision Making' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Design' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Diagnosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Drug Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Image Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Image Processing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Instruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Manufacturing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Numerical Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Protocol Directed Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Radiation Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Radiographic Image Interpretation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Radiotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Radiotherapy Planning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Assisted Three Dimensional Imaging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Communication Network' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Communication Networks' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Communication Networks %28%1995-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Communication Networks %28%1996-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Data Processing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Echotomography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Generated 3D Imaging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Graphic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Graphics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Hacker' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Hardware' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Literacies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Literacy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Memory System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Memory Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Model' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Models' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Peripheral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Peripheral Device' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Peripheral Devices' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Peripheral Equipment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Peripheral Equipments' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Peripherals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Program' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Programs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Programs %28%1983-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Reasoning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Science, Medical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Sciences, Medical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Security' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Simulation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Simulation %28%1987-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Simulation %28%1987-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Simulations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Software' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Storage Device' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Storage Devices' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Systems %28%1987-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Systems %28%1987-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Systems Evaluations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Terminal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Terminals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer User Training' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer User Trainings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Vision System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer Worm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer disks storing data with a maximum reduction of space and bandwidth. The compact size reduces cost of transmission and storage.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer processing of a language with rules that reflect and describe current usage rather than prescribed usage.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer programs based on knowledge developed from consultation with experts on a problem, and the processing and/or formalizing of this knowledge using these programs in such a manner that the problems may be solved.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer systems capable of assembling, storing, manipulating, and displaying geographically referenced information, i.e. data identified according to their locations.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer systems or networks designed to provide radiographic interpretive information.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer systems utilized as adjuncts in the treatment of disease.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Analog' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Analogue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Attitude to' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Digital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Handheld' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Hybrid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Mainframe' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, PDA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Palm-Top' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Palmtop' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, Personal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer, RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Aided Design' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Aided Designs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Aided Surgeries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Aided Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Decision Making' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Design' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Designs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Diagnoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Diagnosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Dosimetry Calculation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Dosimetry Calculations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Drug Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Drug Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Image Analyses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Image Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Image Interpretation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Image Interpretations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Image Processing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Instruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Instruction %28%1993-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Instructions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Manufacturing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Numerical Analyses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Numerical Analysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Protocol-Directed Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Protocol-Directed Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Radiation Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Radiation Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Radiographic Image Interpretation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Radiotherapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Radiotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Radiotherapy Planning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Signal Interpretation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Signal Interpretations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Signal Processing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Surgeries' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Surgery' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Three-Dimensional Imaging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Assisted Three-Dimensional Imagings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Generated 3D Imaging' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-Generated 3D Imagings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-assisted analysis and processing of problems in a particular area.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-assisted interpretation and analysis of various mathematical functions related to a particular problem.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-assisted study of methods for obtaining useful quantitative solutions to problems that have been expressed mathematically.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-based information systems used to integrate clinical and patient information and provide support for decision-making in patient care.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-based representation of physical systems and phenomena such as chemical processes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-based systems for input, storage, display, retrieval, and printing of information contained in a patient%27%s medical record.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Emission Tomography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Medical Record' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Medical Record System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Medical Record Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Medical Records' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Medical Records System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Medical Records Systems' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Model' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Models' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Patient Medical Records' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Patient Record' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Programmed Instruction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Self-Instruction Program' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Self-Instruction Programs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Tomographies, X-Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Tomography, X Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized Tomography, X-Ray' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computerized compilations of information units %28%text, sound, graphics, and/or video%29% interconnected by logical nonlinear linkages that enable users to follow optimal paths through the material and also the systems used to create and display this information. %28%From Thesaurus of ERIC Descriptors, 1994%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1982%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1985%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1966-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1968-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers %28%1981-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers in which quantities are represented by physical variables; problem parameters are translated into equivalent mechanical or electrical circuits as an analog for the physical phenomenon being investigated. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers that combine the functions of analog and digital computers. %28%Sippl, Computer Dictionary, 4th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers whose input, output and state transitions are carried out by biochemical interactions and reactions.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Analog' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Analogue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Attitude to' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Handheld' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Hybrid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Mainframe' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, PDA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Palm Top' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, Palm-Top' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computers, RNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing Methodologies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing Methodology' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing, Bedside' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing, High Performance' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing, Mathematic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing, Mathematical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing, Medical Informatics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computing, Statistical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computings, Bedside' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computings, Mathematic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computings, Mathematical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Computings, Statistical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conalbumin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concanavalin A' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concanavalin A %28%1971-1976%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concanavalin A Binding Sites' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concanavalin A Receptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concanavalin A Receptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concatenated DNA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrating Abilities, Kidney' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrating Abilities, Urine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrating Ability, Kidney' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrating Ability, Urine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration 50, Inhibitory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration Camp' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration Camps' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration, Hydrogen-Ion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration, Maximum Allowable' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration, Minimum Inhibitory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentration, Osmolar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrations, Hydrogen-Ion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrations, Maximum Allowable' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrations, Minimum Inhibitory' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentrations, Osmolar' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentric Sclerosis, Balo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concentric Sclerosis, Balo%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concept Formation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concept Formations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concept referring to the standardized fees for services rendered by health care providers, e.g., laboratories and physicians, and reimbursement for those services under Medicare Part B. It includes acceptance by the physician.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concept, Role' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concept, Self' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conception after the death of the male or female biological parent through techniques such as the use of gametes that have been stored during his or her lifetime or that were collected immediately after his or her death.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conception, Posthumous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conceptions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conceptions, Posthumous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concepts, Role' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concepts, Self' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concepts, definitions, and propositions applied to the study of various phenomena which pertain to nursing and nursing research.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conceptual functions or thinking in all its forms. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conceptual response of the person to the various aspects of death, which are based on individual psychosocial and cultural experience.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conchae Nasale' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conchae Nasales' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concise Enamel Bond System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conclusions derived from the nursing assessment that establish a health status profile for the patient and from which nursing interventions may be ordered.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concretions of swallowed hair, fruit or vegetable fibers, or similar substances found in the alimentary canal.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concurrent Review' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concurrent Reviews' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concurrent Studies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concurrent Study' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concussion, Brain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concussion, Cerebral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Concussive Convulsions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensation products of aromatic amines and aldehydes forming azomethines substituted on the N atom, containing the general formula R-N:CHR. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensed Tannin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensed Tannins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensed areas of cellular material that may be bounded by a membrane.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensing Enzyme, Acyl-Malonyl-ACP' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensing Enzyme, Malate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condensing Vacuole' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condiment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condiments' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condiments %28%1966-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles erythema multiforme. Sweet%27%s syndrome may herald the appearance of leukemia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition characterized by permanent deposition of substantial amounts of particulate matter in the lungs, usually of occupational or environmental origin, and by the tissue reaction to its presence.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition in which no acceleration, whether due to gravity or any other force, can be detected by an observer within a system. It also means the absence of weight or the absence of the force of gravity acting on a body. Microgravity, gravitational force between 0 and 10 -6 g, is included here. %28%From NASA Thesaurus, 1988%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition marked by attacks of rapid action of the heart having sudden onset and cessation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition of elevated triglyceride concentration in the blood; an inherited form occurs in familial hyperlipoproteinemia IIb and HYPERLIPOPROTEINEMIA TYPE IV. It has been linked to higher risk of heart disease and arteriosclerosis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition of having pores or open spaces. This often refers to bones, bone implants, or bone cements, but can refer to the porous state of any solid substance.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS %28%hypogonadotropic hypogonadism%29% or due to primary gonadal failure %28%hypergonadotropic hypogonadism%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition under normal Earth gravity where the force of gravity itself is not actually altered but its influence or effect may be modified and studied. %28%From ASGSB Bull 1992;5%28%2%29%:27%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition wherein the force of gravity is greater than or is increased above that on the surface of the earth. This is expressed as being greater than 1 g.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition wherein the force of gravity is less than or is decreased below that on the surface of the earth. This is expressed as being between 0 and 1 g.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition, Anatomical Pathological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition, Dominant Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition, Economic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition, Precancerous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition, Recessive Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condition, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditional Variable' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditional Variables' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioned Culture Media' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioned Culture Medium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioned Media' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioned Medium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioned Reflex' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning %28%Psychology%29% %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning %28%Psychology%29% %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning Therapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning to defecate and urinate in culturally acceptable places.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Air' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Animal Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Classical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Classical %28%1966-1968%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Dental Tissue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Eyelid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Human Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Operant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Tissue %28%Dental%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditioning, Transplantation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Air' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Animal Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Classical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Eyelid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Human Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Operant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Tissue %28%Dental%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditionings, Transplantation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions associated with damage or dysfunction of the nervous system caused by exposure to heavy metals, which may cause a variety of central, peripheral, or autonomic nervous system injuries.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by a significant discrepancy between an individual%27%s perceived level of intellect and their ability to acquire new language and other cognitive skills. These disorders may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, dyscalculia, and dysgraphia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by activation of the whole or some part of the ventricle by the atrial impulse earlier than would be expected if the impulse reached the ventricle by way of the normal specific conduction system only.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by an alteration in gustatory function or perception. Taste disorders are frequently associated with OLFACTION DISORDERS. Additional potential etiologies include METABOLIC DISEASES; DRUG TOXICITY; and taste pathway disorders %28%e.g., TASTE BUD diseases; FACIAL NERVE DISEASES; GLOSSOPHARYNGEAL NERVE DISEASES; and BRAIN STEM diseases%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS %28%i.e. disorders characterized by insomnia or hypersomnia%29%, PARASOMNIAS %28%abnormal sleep behaviors%29%, and sleep disorders secondary to medical or psychiatric disorders. %28%From Thorpy, Sleep Disorders Medicine, 1994, p187%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by language abilities %28%comprehension and expression of speech and writing%29% that are below the expected level for a given age, generally in the absence of an intellectual impairment. These conditions may be associated with DEAFNESS; BRAIN DISEASES; MENTAL DISORDERS; or environmental factors.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by loss or dysfunction of myelin %28%see MYELIN SHEATH%29% in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity %28%i.e., changes in sweating due to altered sympathetic innervation%29% or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; %28%REFLEX SYMPATHETIC DYSTROPHY%29% and type II; %28%CAUSALGIA%29%. %28%From Pain 1995 Oct;63%28%1%29%:127-33%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by persistent brain damage or dysfunction as sequelae of cranial trauma. This disorder may result from DIFFUSE AXONAL INJURY; INTRACRANIAL HEMORRHAGES; BRAIN EDEMA; and other conditions. Clinical features may include DEMENTIA; focal neurologic deficits; PERSISTENT VEGETATIVE STATE; AKINETIC MUTISM; or COMA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered %28%simple partial seizure%29% or disturbed %28%complex partial seizure%29%. Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. %28%From Adams et al., Principles of Neurology, 6th ed, pp317%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions characterized by the presence of a monoclonal serum %28%or urine%29% protein without clinical manifestations of plasma cell dyscrasia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which increased pressure within a limited space compromises the circulation and function of tissue within that space. Compartmentation involves mainly the leg but also involved are the forearm, arm, thigh, shoulder, and buttock. Some of the causes of increased pressure are trauma, tight dressings, hemorrhage, and exercise. Sequelae include nerve compression, paralysis, and contracture.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage %28%as measured by the level of PROTEINURIA%29%. The most severe form is the end-stage renal disease %28%CHRONIC KIDNEY FAILURE%29%. %28%Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage %28%as measured by the level of PROTEINURIA%29% and reduction in GLOMERULAR FILTRATION RATE. The most severe form is KIDNEY FAILURE. Renal function may deteriorate slowly %28%RENAL INSUFFICIENCY, CHRONIC%29% or precipitously %28%RENAL INSUFFICIENCY, ACUTE%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the LIVER functions fall below the normal ranges. Severe hepatic insufficiency may cause LIVER FAILURE or DEATH. Treatment may include LIVER TRANSPLANTATION.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the bone marrow shows qualitative and quantitative changes suggestive of a preleukemic process, but having a chronic course that does not necessarily terminate as acute leukemia.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE; %28%GMR%29%. The most severe stage is when the GFR drops below 15 ml per min %28%ACUTE KIDNEY FAILURE%29%.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the primary symptom is HEADACHE and the headache cannot be attributed to any known causes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which the production of adrenal CORTICOSTEROIDS falls below the requirement of the body. Adrenal insufficiency can be caused by defects in the ADRENAL GLANDS, the PITUITARY GLAND, or the HYPOTHALAMUS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the reticuloendothelial system, without demonstrable tissue damage. The name refers to the presence of stainable iron in the tissue in the form of hemosiderin.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. %28%From Rook et al., Textbook of Dermatology, 4th ed, p398%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions of abnormal THYROID HORMONES release in patients with apparently normal THYROID GLAND during severe systemic illness, physical TRAUMA, and psychiatric disturbances. It can be caused by the loss of endogenous hypothalamic input or by exogenous drug effects. The most common abnormality results in low T3 THYROID HORMONE with progressive decrease in THYROXINE; %28%T4%29% and TSH. Elevated T4 with normal T3 may be seen in diseases in which THYROXINE-BINDING GLOBULIN synthesis and release are increased.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions which affect the arteries of the brain, meninges, and intracranial portions of the cranial nerves. Relatively common disease processes in this category include: ATHEROSCLEROSIS; emboli; thrombosis %28%INTRACRANIAL EMBOLISM AND THROMBOSIS%29%; VASCULITIS, CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR TRAUMA; vasospasm %28%VASOSPASM, INTRACRANIAL%29%; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and infections.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions which affect the structure or function of the pupil of the eye, including disorders of innervation to the pupillary constrictor or dilator muscles, and disorders of pupillary reflexes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. %28%From Joynt, Clinical Neurology, 1998, Ch38, pp39-42%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions with HEADACHE symptom that can be attributed to a variety of causes including BRAIN VASCULAR DISORDERS; WOUNDS AND INJURIES; INFECTION; drug use or its withdrawal.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions, Anatomical Pathological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions, Dominant Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions, Economic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions, Precancerous' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions, Preneoplastic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conditions, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condom' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condom, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condoms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condoms, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduct Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduct Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductance, Skin Electric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductances, Skin Electric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Anesthesia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Aphasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Aphasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Blocking Anesthetics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Dysphasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Dysphasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction System, Heart' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction Systems, Heart' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction, Bone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction, Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction, Neural' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduction-Blocking Anesthetics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductions, Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductions, Neural' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductive Hearing Loss' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductivities, Thermal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductivity, Electric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductivity, Electrical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductivity, Thermal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductometric Titration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductometric Titrations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conductometry' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduit, Ileal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conduits, Ileal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condurango' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condyle, Mandibular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condyles, Mandibular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Condylomata Acuminata' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cone %28%Retina%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cone Photoreceptor' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cone Photoreceptors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coneflower, Orange' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coneflower, Prairie' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coneflower, Purple' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conepatus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cones %28%Retina%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Cones and Rods' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conferences, Consensus Development' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conferences, conventions or formal meetings usually attended by delegates representing a special field of interest.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidence Interval' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidence Intervals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidence in or reliance on a person or thing. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidentiality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidentiality %28%1976-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidentiality %28%1977-2001%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confidentiality %28%1980-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Configuration, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Configurations, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confined Space' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confined Spaces' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confinement of an individual to bed for therapeutic or experimental reasons.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict %28%Psychology%29% %28%1966-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict between Russia and its ally the Ottoman Empire and England, France, and Sardinia. The immediate dispute was between Russia and France over control of Palestinian holy places.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict between Spain and the United States, arising out of Spanish policies in Cuba.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict during which traditional monarchy was ended and modern government functions were instituted.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict from 1904 through 1905 between Russia and Japan regarding Manchuria and Korea.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict of Interest' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict, 1961-1975 Vietnamese' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict, Korean' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict, Viet Nam' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflict, Vietnam' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflicts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflicts %28%Psychology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conflicts, 1961-1975 Vietnamese' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confocal Laser Scanning Microscopy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confocal Microscopies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confocal Microscopy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confocal Microscopy, Scanning Laser' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformal Radiotherapies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformal Radiotherapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Carbohydrate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Nucleic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Protein alpha-Helical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Protein beta-Sheet' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, Protein beta-Strand' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, alpha-Helical Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, beta-Sheet Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformation, beta-Strand Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformational Polymorphism, Single-Stranded' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformational Polymorphisms, Single-Stranded' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Carbohydrate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Molecular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Nucleic Acid' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Protein alpha-Helical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Protein beta-Sheet' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, Protein beta-Strand' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, alpha-Helical Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, beta-Sheet Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformations, beta-Strand Protein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformities, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformity in fulfilling or following official, recognized, or institutional requirements, guidelines, recommendations, protocols, pathways, or other standards.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conformity, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confounding Factor %28%Epidemiology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confounding Factor, Epidemiologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confounding Factors %28%Epidemiology%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confounding Factors, Epidemiologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confounding Variable' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confounding Variables' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confucianism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confusion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confusion, Post Ictal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confusional Arousal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confusional State' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Confusional States' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenic Animal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenic Animals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenic Mice' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenita, Paramyotonia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenita, X-Linked Dyskeratosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Abnormalities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Abnormalities, Nervous System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Abnormality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Absence of Brain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Absence of Cerebral Hemispheres' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Adrenal Hyperplasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Adrenal Hyperplasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Amino Acidopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Amino Acidopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Analgesia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Anomalies, Nervous System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Arthromyodysplasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Arthromyodysplasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Auditory Agnosia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Auditory Agnosias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Bullous Ichthyosiform Erythroderma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Cerebral Palsy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Cortical Hyperostoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Cortical Hyperostosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Cystic Adenomatoid Malformation of Lung' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Defect' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Defects' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Dyserythropoietic Anemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Dyserythropoietic Anemia Type II' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Dyserythropoietic Anemia, Type I' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Dyserythropoietic Anemia, Type III' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Dyserythropoietic Anemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Ectodermal Defect' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Ectodermal Defects' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Epulis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Errors of Steroid Metabolism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Erythropoietic Porphyria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Erythropoietic Porphyrias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Foot Deformities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Foot Deformity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hand Deformities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hand Deformity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Heart Defect' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Heart Defects' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hemolytic Anemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hemolytic Anemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hip Dislocation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hip Dislocations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hip Dysplasia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hip Dysplasias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hyperinsulinism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hyperostoses, Cortical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hyperostosis, Cortical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hypocupremia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hypocupremias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hypoplastic Anemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hypoplastic Anemias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Hypothyroidism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Ichthyosiform Erythroderma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Ichthyosiform Erythrodermas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Indifference to Pain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Infection, Toxoplasma gondii' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Insensitivity to Pain with Anhidrosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Intracranial Arteriovenous Malformations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Limb Deformities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Limb Deformity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Lipoatrophic Diabetes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Lipodystrophy, Berardinelli-Seip' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital MEGACOLON resulting from the absence of ganglion cells %28%aganglionosis%29% in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Malformations, Nervous System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Megacolon' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Myasthenia Gravis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Myasthenic Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Myasthenic Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Myotonic Dystrophies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Myotonic Dystrophy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Non Progressive Myopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Non-Progressive Myopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Non-Progressive Myopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Nonbullous Ichthyosiform Erythroderma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Nonspherocytic Hemolytic Anemia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Nystagmus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Oculofacial Paralysis, Moebius' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Pain Indifference' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Pain Indifferences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Pain Insensitivity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Rubella Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Rubella Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Slow Channel Myasthenic Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Slow-Channel Myasthenic Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Structural Myopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Structural Myopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Syphilis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Toxoplasma Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Toxoplasma Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Toxoplasma gondii Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Toxoplasmoses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Toxoplasmosis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital Vascular Malformations, Central Nevous System' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of or defects in structures of the eye; may also be hereditary.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of or defects in structures of the jaw.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of or defects in structures of the mouth.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of or defects in structures of the teeth.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of the eye or eyes. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of the normal valvular orifice into the pulmonary artery. This condition is characterized by cardiomegaly, reduced pulmonary vascularity, and right ventricular atrophy. %28%From Stedman, 25th ed; Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital absence of the teeth; it may involve all %28%total anodontia%29% or only some of the teeth %28%partial anodontia, hypodontia%29%, and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital anomaly in which some of the structures of the eye are absent due to incomplete fusion of the fetal intraocular fissure during gestation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital cystic dilatation of the intrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC%29%. It consists of 2 types: simple Caroli disease is characterized by bile duct dilatation %28%ectasia%29% alone; and complex Caroli disease is characterized by bile duct dilatation with extensive hepatic fibrosis and portal hypertension %28%HYPERTENSION, PORTAL%29%. Benign renal tubular ectasia is associated with both types of Caroli disease.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital defect in the upper lip where the maxillary prominence fails to merge with the merged medial nasal prominences. It is thought to be caused by faulty migration of the mesoderm in the head region.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital defects of closure of one or more vertebral arches, which may be associated with malformations of the spinal cord, nerve roots, congenital fibrous bands, lipomas, and congenital cysts. These malformations range from mild %28%e.g., SPINA BIFIDA OCCULTA%29% to severe, including rachischisis where there is complete failure of neural tube and spinal cord fusion, resulting in exposure of the spinal cord at the surface. Spinal dysraphism includes all forms of spina bifida. The open form is called SPINA BIFIDA CYSTICA and the closed form is SPINA BIFIDA OCCULTA. %28%From Joynt, Clinical Neurology, 1992, Ch55, p34%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. %28%from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital displacement of the lens resulting from defective zonule formation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital downward displacement of the tricuspid valve with the septal and posterior leaflets being attached to the wall of the right ventricle.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital fissure of the soft and/or hard palate, due to faulty fusion.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital locomotor ataxia of lambs, thought to be associated with copper deficiency. It is characterized clinically by progressive incoordination of the hind limbs and pathologically by disruption of neuron and myelin development in the central nervous system. It is caused by a deficiency of metabolizable copper in the ewe during the last half of her pregnancy. %28%Dorland, 28th ed; Stedman, 26th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital malformations of organs or parts. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations %28%mainly involving the skull and vertebrae%29% may occur as a result of defects of neural tube closure. %28%From Joynt, Clinical Neurology, 1992, Ch55, pp31-41%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital obliteration of the lumen of the intestine, with the ILEUM involved in 50%25% of the cases and the JEJUNUM and DUODENUM following in frequency. It is the most frequent cause of INTESTINAL OBSTRUCTION in NEWBORNS. %28%From Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital open-angle glaucoma that results from dysgenesis of the angle structures accompanied by increased intraocular pressure and enlargement of the eye. Treatment is both medical and surgical.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital or acquired abnormal outpouching of an intracranial blood vessel wall. Saccular %28%berry%29% aneurysms are the most common variant, and tend to form at arterial branch points near the base of the brain. Rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms %28%%3E%2.5 cm in diameter%29% may compress adjacent structures, including the OCULOMOTOR NERVE %28%see also OCULOMOTOR NERVE DISEASES%29%. %28%From Adams et al., Principles of Neurology, 6th ed, p841%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital or acquired asymmetry of the face. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital or acquired cysts of the brain, spinal cord, or meninges which may remain stable in size or undergo progressive enlargement.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital or acquired malformations involving arteries, veins, or venous sinuses of the brain, spinal cord, and meninges.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital or acquired structural abnormalities of the lymphatic system %28%LYMPHOID TISSUE%29% including the lymph vessels.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital or developmental anomaly in which the eyeballs are abnormally small.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities and deformities of the musculoskeletal system.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the DIGESTIVE SYSTEM.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the LOWER EXTREMITY.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the UPPER EXTREMITY.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the cardiovascular system.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the mouth and jaws, including the dentition.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the respiratory system.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural abnormalities of the skin. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural deformities of the upper and lower extremities collectively or unspecified.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital structural deformities, malformations, or other abnormalities of the maxilla and face or facial bones.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital syndrome characterized by a spectrum of malformations including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency and HYPOCALCEMIA. Other features include defects in the outflow tract of the HEART and craniofacial anomalies %28%velocardiofacial syndrome%29%. Most cases result from a deletion of chromosome 21q11.2 or mutation in the TBX1 gene.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital vascular anomalies of the brain characterized by tangles of thin walled arteries which communicate directly with veins without intervening capillaries. The malformations vary greatly in size and location, and produce symptoms through rupture %28%see also INTRACRANIAL HEMORRHAGES%29%, mass effect, and vascular steal effect. Clinical presentation is often delayed until the fourth or fifth decade when affected individuals may develop headaches, seizures, and focal neurologic deficits. Large hemorrhages may result in coma or death. %28%From Adams et al., Principles of Neurology, 6th ed, p848%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital, often bilateral, retinal abnormality characterized by the arrangement of outer nuclear retinal cells in a palisading or radiating pattern surrounding a central ocular space. This disorder is sometimes hereditary.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congenital, or rarely acquired, herniation of meningeal and spinal cord tissue through a bony defect in the vertebral column. The majority of these defects occur in the lumbosacral region. Clinical features include PARAPLEGIA, loss of sensation in the lower body, and incontinence. This condition may be associated with the ARNOLD-CHIARI MALFORMATION and HYDROCEPHALUS. %28%From Joynt, Clinical Neurology, 1992, Ch55, pp35-6%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congestive Atelectases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congestive Atelectasis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congestive Cardiomyopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congestive Cardiomyopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congestive Heart Failure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congestive Ophthalmopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conglutination Reaction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conglutination Reactions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conglutinins, Immune' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conglutinogen Activating Factors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo %28%Brazzaville%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo %28%Kinshasa%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo Eel' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo Eels' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo Red' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo Virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo Virus Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congo Virus Infections' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congocidine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congophilic Angiopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congophilic Angiopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congresses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congresses %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congresses %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Congresses and Conferences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conidiobolus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Coniferophyta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conifers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conisation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conisations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conium' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conization' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conizations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjoined Twin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjoined Twins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugate Gaze Spasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugate Gaze Spasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugate Vaccines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugate, Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugated Estrogenic Hormones' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugated Estrogenic Substances' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugated Estrogens' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugated Linoleic Acids' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates of betalamic acid with AMINO ACIDS. Some of them are yellow COLORING AGENTS in the Caryophyllales order of PLANTS. This should not be confused with xanthin which is a term used for CAROTENES nor with XANTHINES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates of betalamic acid with cyclo-dopa, both of which derive from TYROSINE. They appear similar to INDOLES but are biosynthesized by a different path and contain N+. Members are red or violet COLORING AGENTS found in the Caryophyllales order of PLANTS and some BASIDIOMYCETES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates, Antibody-Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates, Cytotoxin-Antibody' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates, Monoclonal Antibody-Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates, Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugates, Toxin-Antibody' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugation of exogenous substances with various hydrophilic substituents to form water soluble products that are excretable in URINE. Phase II modifications include GLUTATHIONE; ACYLATION; and AMINATION. Phase II enzymes include GLUTATHIONE TRANSFERASE and GLUCURONOSYLTRANSFERASE. In a sense these reactions detoxify phase I reaction products.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugation, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugation, Genetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugation, Genetic %28%1968-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugative Metabolic Detoxication' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugative Metabolic Detoxications' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugative Pili' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjugative Pilus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctiva' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctiva %28%1966-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctival Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctival Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctival Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctival Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Acute Hemorrhagic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Allergic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Atopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Giant Papillary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Inclusion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Mucopurulent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Purulent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Vernal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitides, Viral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis %28%1966-1985%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis due to hypersensitivity to various allergens.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Acute Hemorrhagic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Allergic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Atopic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Bacterial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Inclusion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Mucopurulent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Purulent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conjunctivitis, Viral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conn Adenomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conn Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conn%27%s Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connaraceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connecticut' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connecting Peptide' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connectionist Model' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connectionist Models' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connections between cells which allow passage of small molecules and electric current. Gap junctions were first described anatomically as regions of close apposition between cells with a narrow %28%1-2 nm%29% gap between cell membranes. The variety in the properties of gap junctions is reflected in the number of CONNEXINS, the family of proteins which form the junctions.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue %28%1966-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Cell' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Cells' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Cells %28%1966-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Disease, Mixed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Diseases' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Neoplasm' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissue/cytology %28%1978-1997%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective Tissues' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective and Soft Tissue Neoplasms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective tissue composed of FAT CELLS lodged in the meshes of areolar tissue.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective tissue comprised chiefly of elastic fibers. Elastic fibers have two components: ELASTIN and MICROFIBRILS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connective tissue tumors, affecting primarily fowl, that are usually caused by avian sarcoma viruses.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connexin 43' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connexin43' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Connexins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conns Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conotoxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conotoxins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conradi Hunermann Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conradi-Hunermann Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consanguinities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consanguinity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consanguinous Matings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conscience' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conscious Sedation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conscious or unconscious emotional reaction of the therapist to the patient which may interfere with treatment. %28%APA, Thesaurus of Psychological Index Terms, 8th ed.%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousness' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousness %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousness %28%1966-1996%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousness Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousness Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousness, Loss of' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consciousnesses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensual Unions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conference' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conference %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conference %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conference, NIH' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conference, NIH %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conference, NIH %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conferences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conferences %28%1988-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Development Conferences, NIH' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Sequence' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Sequences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consensus Workshop' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent Document' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent Document, Informed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent Documents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent Documents, Informed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent Form' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent Forms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Community' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Informed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Judicial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Parental' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Presumed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Spousal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Third Party' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consent, Third-Party' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consents, Community' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservation of Energy Resources' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservation of Natural Resources' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservation of Natural Resources %28%1977-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservation, Energy Resources' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservation, Natural Resources' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservation, Syntenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservations, Energy Resources' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservations, Syntenic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conservative contouring of the alveolar process, in preparation for immediate or future denture construction. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conserved Helix Loop Helix Ubiquitous Kinase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conserved Helix-Loop-Helix Ubiquitous Kinase' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conserved Sequence' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conserved Sequences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conserved Syntenies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consists of a polypeptide chain and 4%27%-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. Acyl carrier protein is involved in every step of fatty acid synthesis by the cytoplasmic system.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consta, Risperdal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constant Region, Ig' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constant Region, Immunoglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constant Regions, Immunoglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constant T' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constant Vertigo' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'ConstantT' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constipation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of several essential oils, notably sassafras. It has been used as a topical antiseptic and it is carcinogenic to the liver so it is no longer used as a flavoring agent in foods.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of the 40S subunit of eukaryotic ribosomes. 18S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of the 50S subunit of prokaryotic ribosomes containing about 120 nucleotides and 34 proteins. It is also a constituent of the 60S subunit of eukaryotic ribosomes. 5S rRNA is involved in initiation of polypeptide synthesis.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of the 60S subunit of eukaryotic ribosomes. 28S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constituent of the 60S subunit of eukaryotic ribosomes. 5.8S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constitution' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constitution and Bylaws' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constitution, Body' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constitutional Amendment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constitutional Laws' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constitutions, Body' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constricted Pupil' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constricted Pupils' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction %28%1968-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction in the opening of the aortic valve or of the supravalvular or subvalvular regions.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction of the pupil in response to light stimulation of the retina. It refers also to any reflex involving the iris, with resultant alteration of the diameter of the pupil. %28%Cline et al., Dictionary of Visual Science, 4th ed%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction, Bronchial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction, Intrauterine Ring' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction, Pathologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction, Pathologic %28%1976-1982%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constriction, Pathological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constrictions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constrictions, Bronchial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constrictions, Intrauterine Ring' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constrictions, Pathologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constrictive Pericarditides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constrictive Pericarditis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construct Theories, Personal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construct Theory, Personal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Bond Issue' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Bond Issues' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Financing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Financings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Loan' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Material' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction Materials' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction, Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Construction, Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constructional Agraphias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Constructions, Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultant' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultants' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultants, Bioethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultants, Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultation and Referral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultation via remote telecommunications, generally for the purpose of diagnosis or treatment of a patient at a site remote from the patient or primary physician.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultation, Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultation, Remote' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consultations, Ethics' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Advocacies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Advocacy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Choice Brand of Phenazopyridine Hydrochloride' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Handout %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Handout %28%Pub Type%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Health Information %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Health Information %28%Publication Type%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Information %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Information Handout %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Information Handout %28%Pub Type%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Involvement' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Involvements' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Organization' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Organizations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Organizations %28%1968-1981%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Participation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Participation %28%1974-1978%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Participation %28%1974-1981%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Participation/economics %28%1974-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Preferences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Price Indices' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Product Safety' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Product Safety %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Satisfaction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Satisfaction %28%1966-1991%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Satisfaction %28%1968-1981%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumer Satisfaction %28%1983-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consummatory Behavior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consummatory Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption Coagulopathies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption Coagulopathy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption Test, Antiglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption Tests, Antiglobulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption, Alcohol' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption, Household' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption, Oxygen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumption, Water' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Consumptions, Oxygen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contac Husten Trunk' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contac HustenTrunk' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Activation Product' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitides, Allergic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitides, Photoallergic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitides, Photosensitive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitides, Phototoxic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitis, Allergic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitis, Photoallergic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitis, Photosensitive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Dermatitis, Phototoxic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Eczema' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Hypersensitivities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Hypersensitivity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Inhibition' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Inhibitions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens Disinfectant Solutions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens Disinfectants' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens Solution' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens Solutions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens, Extended Wear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens, Extended-Wear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens, Hydrophilic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens, Implantable' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lens, Soft' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses %28%1966-1969%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses %28%1966-1994%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses, Extended Wear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses, Extended-Wear' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses, Hydrophilic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses, Hydrophilic %28%1971-1983%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Lenses, Soft' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Sensitivities' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Sensitivity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Sensitizing Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact Tracing' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contact, Focal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contacting Client' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contacts, Focal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Ecthyma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Ecthyma Virus of Sheep' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Pleuropneumonia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Pleuropneumonias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Pustular Dermatitides' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Pustular Dermatitis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious Pustular Dermatitis Virus of Sheep' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious ecthyma virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious ecthyma viruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with rubella.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contagious pustular dermatitis virus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Container, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Container, Product' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containers, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containers, Product' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containers, packaging, and packaging materials for drugs and biological products. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. %28%From Code of Federal Regulations, 21 CFR 1 Section 210, 1993%29% DRUG LABELING is also available.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containers, packaging, and packaging materials for processed and raw foods and beverages. It includes packaging intended to be used for storage and also used for preparation of foods such as microwave food containers versus COOKING AND EATING UTENSILS. Packaging materials may be intended for food contact or designated non-contact, for example, shipping containers. FOOD LABELING is also available.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containment of Biohazards' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containment, Biohazard' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containment, Biohazards' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containment, Biological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containment, Cost' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containment, Physical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Containments, Cost' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contamination of the air by tobacco smoke. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contamination, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contamination, Equipment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contamination, Food' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contamination, Radioactive Food' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contaminations, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contaminations, Equipment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contaminations, Food' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contaminations, Radioactive Food' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Content, G+C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Content, GC' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Content, management, editing, policies, and printing of dental periodicals such as journals, newsletters, tabloids, and bulletins.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contents, G+C' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contents, GC' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contig Mapping' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contiguous Gene Syndrome, WAGR' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contiguous Gene Syndrome, Williams' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contin, MS' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continent Ileostomies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continent Ileostomy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continent Urinary Reservoir' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continent Urinary Reservoirs' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continental Population Group' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continental Population Groups' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contingent Negative Variation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contingent Negative Variations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuation of visual impression after cessation of stimuli causing the original image.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continued Stay Review' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continued Stay Reviews' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Dental Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Dental Educations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Medical Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Nursing Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Pharmaceutic Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Pharmaceutical Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuing Pharmacy Education' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuity of Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuity of Patient Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuity of Patient Care %28%1975-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Ambulatory Peritoneal Dialysis' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Arteriovenous Hemofiltration' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Arteriovenous Hemofiltrations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Doppler Echocardiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Muscle Activity Syndrome' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Myokymia' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Myokymias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Passive Motion Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Passive Movement Therapy' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Positive Airway Pressure' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Quality Management' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Sphygmomanometer' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Sphygmomanometers' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous Tremors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous frequency distribution of infinite range. Its properties are as follows: 1, continuous, symmetrical distribution with both tails extending to infinity; 2, arithmetic mean, mode, and median identical; and 3, shape completely determined by the mean and standard deviation.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. %28%From Adams et al., Principles of Neurology, 6th ed, p73%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous recording of the carbon dioxide content of expired air.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuous sequential changes which occur in the physiological and psychological functions during the life-time of an individual.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Continuum of Care' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contour Perception' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contour Perceptions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception Behavior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Barrier' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Immunologic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Immunologic %28%1977-2000%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Immunological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraception, Postcoital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptions, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptions, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents %28%1967-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents %28%1967-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents %28%1968-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Estrogen' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Female Sequential' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Female, Combined' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Oral, Hormonal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Oral, Sequential' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Post Coital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Post-Coital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Postcoital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Postcoital, Synthetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Postconception' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Spermatocidal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Agents, Spermicidal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Behavior' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Behaviors' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Device' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Device, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Device, Intrauterine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Device, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices %28%1966%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices %28%1966-1974%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices %28%1978-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices, Intrauterine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Devices, Male %28%1975-1992%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Distributions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Histories' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Importations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Method' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Methods' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Prevalence Survey' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Technic, Immunological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Technics, Immunological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Technique, Immunological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Techniques, Immunological' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive Vaccines' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive devices placed high in the uterine fundus with a string extending from the device through the cervical as into the vagina. %28%UMDNS, 1999%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive devices used by females. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive devices used by males. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive methods based on immunological processes and techniques, such as the use of CONTRACEPTIVE VACCINES.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive substances to be used after COITUS. These agents include high doses of estrogenic drugs, progesterone-receptor blockers, antimetabolites, ALKALOIDS, and PROSTAGLANDINS.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptive, Pearl Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Combined Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Female' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Hormonal Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Low-Dose Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Male' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral %28%1964-2002%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral %28%1966-1970%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral %28%1966-1971%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral %28%1970-1975%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral %28%1972-1977%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral, Combined' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral, Combined %28%1976-1982%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral, Hormonal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral, Sequential' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral, Synthetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Oral, Synthetic %28%1975-1989%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Phasic Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Post Coital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Post-Coital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Postcoital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Postcoital %28%1974-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Postcoital, Hormonal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Postcoital, Synthetic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Sequential Oral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraceptives, Synthetic Postcoital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract Bidding' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract Biddings' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract Service' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract Services' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract Services %28%1978-1985%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract Services %28%1996-1998%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contract, Ulysses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractile Proteins' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractile Proteins %28%1982-1986%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractile activity of the MYOCARDIUM. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractile tissue that produces movement in animals. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractilities, Heart' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractility, Heart' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction of the UTERINE MUSCLE. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Isometric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Isotonic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Mitochondrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Muscle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Muscular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Myocardial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Myometrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Premature Atrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Premature Ventricular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraction, Uterine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions of the abdominal muscles upon stimulation of the skin %28%superficial abdominal reflex%29% or tapping neighboring bony structures %28%deep abdominal reflex%29%. The superficial reflex may be weak or absent, for example, after a stroke, a sign of upper %28%suprasegmental%29% motor neuron lesions. %28%Stedman, 25th ed %26% Best %26% Taylor%27%s Physiological Basis of Medical Practice, 12th ed, p1073%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Isometric' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Isotonic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Mitochondrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Muscle' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Muscular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Myocardial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Myometrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Premature Atrial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Premature Ventricular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractions, Uterine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracts' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracts between an insurer and a subscriber or a group of subscribers whereby a specified set of health benefits is provided in return for a periodic premium.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracts, Ulysses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractual arrangement between the lessor %28%owner%29% and the lessee in which the use of equipment or facilities is granted to the lessee for a period of time and at a specified rate.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracture' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracture, Dupuytren%27%s' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracture, Equinus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracture, Hip' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contracture, Volkmann' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractures' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractures, Equinus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contractures, Hip' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contragest Brand of Mifepristone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Echocardiography' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Media' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Media %28%1966-1967%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Media %28%1966-1980%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Media %28%1973-2003%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Media Extravasation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Radiographies, Negative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Radiography, Negative' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Sensitivity' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrast Sensitivity, Visual' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contravirus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contraviruses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contribution, Financial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contributions, Financial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contrical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Agents, Reproductive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Centers, Poison' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Group' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Groups' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Locus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Policies, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Policy, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Region, Locus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control Regions, Locus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control of bleeding during or after surgery. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control of bleeding performed through the channel of the endoscope. Techniques include use of lasers, heater probes, bipolar electrocoagulation, and local injection. Endoscopic hemostasis is commonly used to treat bleeding esophageal and gastrointestinal varices and ulcers.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval %28%DRUG APPROVAL%29%, and marketing of drugs.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Budgetary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Climate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Communicable Disease' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Cost' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Dental Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Forms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Hazard' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Informal Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Insect' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Internal-External' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Mite' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Mosquito' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Narcotic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Parasite' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Pest' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Population' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Postcoital Fertility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Quality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Records' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Rodent' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, Tick' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Control, direction and financing of the total dental care of the population by a national government.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Clinical Trial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Clinical Trial %28%PT%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Clinical Trial %5B%Publication Type%5D%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Clinical Trials' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Environment' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Environments' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Hypotension' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Release Preparations' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Repressor, Heme' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Repressor, Hemin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Thesauri' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Trial, Randomized' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Trials, Randomized' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Vocabularies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled Vocabulary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision. %28%From Webster%27%s Collegiate Dictionary, 1993%29%%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled physical activity, more strenuous than at rest, which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal %28%most intense%29% exercise is usually required but submaximal exercise is also used. The intensity of exercise is often graded, using criteria such as rate of work done, oxygen consumption, and heart rate.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled vocabulary of clinical terms produced by the College of American Pathologists.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled vocabulary thesaurus produced by the NATIONAL LIBRARY OF MEDICINE. It consists of sets of terms naming descriptors in a hierarchical structure that permits searching at various levels of specificity.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controlled-Release Preparation' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Budgetary' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Climate' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Cost' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Dental Infection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Drug' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Forms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Informal Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Internal-External' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Mite' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Narcotic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Pest' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Population' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Quality' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Records' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Controls, Social' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusion, Brain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusion, Cortical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusion, Optic Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusion, Spinal Cord' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusions, Brain' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusions, Cortical' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusions, Optic Nerve' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Contusions, Spinal Cord' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus Medullaris Syndromes' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus Snail' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus Venom' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus geographus Toxin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus geographus Toxin GVIA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conus, Obstructive Subaortic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convalescence' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convalescences' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convalescent Hospital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convalescent Hospitals' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convallaria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convallatoxigenin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convection' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convergence Excesses' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convergence Insufficiencies' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convergence, Ocular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convergence, Ocular %28%1985-1988%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convergences, Ocular' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convergent Strabismus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Disorder' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Disorders' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Hysteria' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Hysterias' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Mutism' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Mutisms' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Reaction' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion Reactions' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion from one language to another language. ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion into nitroso compounds. An example is the reaction of nitrites with amino compounds to form carcinogenic N-nitrosamines.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions %28%activators%29%; 2, activation by cofactors %28%coenzymes%29%; and 3, conversion of an enzyme precursor %28%proenzyme or zymogen%29% to an active enzyme.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion, Analog-Digital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion, Analogue-Digital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion, Bed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion, Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversion, Health Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversions, Analog-Digital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversions, Analogue-Digital' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversions, Bed' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversions, Gene' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conversions, Health Facility' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase 1, Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase 2, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase 2, Proinsulin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase 5, Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase Activator, C3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase PC-6, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase PC1, Neuroendocrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase PC2, Neuroendocrine' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase PC2, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase PC5, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase SPC3, Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, C 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, C3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, C3 Proactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, C3-C5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, C3PA' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, Complement 3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, Enkephalin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, IL-1 beta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC1 Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC2 Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC3 Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC5 Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC5 Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC5A Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC5B Preprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, PC6A Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, POMC' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, Proactivator' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, Proopiomelanocortin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase, Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertase-6, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertases, Complement C3' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertases, Complement C3-C5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertases, Complement C5' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertases, Prohormone' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertases, Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convertases, Subtilisin-Like Proprotein' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Converting Enzyme, Interleukin-1' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Converting Enzyme, Interleukin-1beta' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Converting Enzyme, Pro-Opiocortin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Converting Enzyme, Pro-Opiomelanocortin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Converting Protease, Pro-Opiocortin' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convexity Meningioma, Cerebral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convexity Meningiomas, Cerebral' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Conveying ill or injured individuals from one place to another.%A% ' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convoluted T-Cell Lymphoma' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convoluted T-Cell Lymphomas' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convolvulaceae' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convolvulus' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsants' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsants %28%1974-1979%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsants %28%1975-1990%29%' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion Disorder, Tonic-Clonic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion Disorders, Tonic-Clonic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion Syndrome, Tonic-Clonic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion Syndromes, Tonic-Clonic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Benign Neonatal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Concussive' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Febrile' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Fever' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Grand Mal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Non Epileptic' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Petit Mal' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Pyrexial' = 0).
% 42.08/42.02 fof(interp, fi_functors, 'Convulsion, Tonic Clonic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions %28%1966-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions %28%1966-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions induced in order to treat MENTAL DISORDERS. It is used primarily in the treatment of severe affective disorders and SCHIZOPHRENIA.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Benign Neonatal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Benign Neonatal, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Benign Neonatal, Non-Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Concussive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Febrile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Fever' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Grand Mal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Non-Epileptic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Pyrexial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsions, Tonic Clonic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Epilepsies, Generalized' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Epilepsy, Generalized' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Seizure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Seizure Disorder, Generalized' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Syncope' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Syncopes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Therapies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Therapies, Electric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Therapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Convulsive Therapy, Electric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Conyza' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cookbook' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cookery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooking Utensil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooking and Eating Utensils' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooley%27%s Anemia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coomb Test' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coomb%27%s Test' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coombs Test' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coombs%27% Test' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coon Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coon Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coon%27%s Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coon%27%s Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coons Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coons Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooper Brand of Scopolamine Hydrobromide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperation among hospitals for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperation, International' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperation, Lymphocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperation, Patient' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperations, Lymphocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperative Behavior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperative Behavior %28%1971-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cooperative Behaviors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coophavet Brand of Calcium Gluconate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coophavet Brand of Carbaril' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coord IM with site %28%IM%29% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coord IM with specific infection %28%IM%29% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordinate with PILI, SEX if involved in BACTERIAL CONJUGATION, otherwise coordinate with FIMBRIAE, BACTERIAL%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination Disorder, Developmental' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination Impairment' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination Impairments' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination Lack' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under U.S. Public Law 89-239.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses%27% aides, and the practical nurse.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordination, Visual Motor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coordinations, Visual Motor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copepoda' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copepods' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copies of DNA sequences which lie adjacent to each other in the same orientation %28%direct tandem repeats%29% or in the opposite direction to each other %28%inverted tandem repeats%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copies of a work or document distributed to the public by sale, rental, lease, or lending. %28%From ALA Glossary of Library and Information Science, 1983, p181%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copies of transposable elements interspersed throughout the genome, some of which are still active and often referred to as %22%jumping genes%22%. There are two classes of interspersed repetitive elements. Class I elements %28%or RETROELEMENTS - such as retrotransposons, retroviruses, LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS%29% transpose via reverse transcription of an RNA intermediate. Class II elements %28%or DNA TRANSPOSABLE ELEMENTS - such as transposons, Tn elements, insertion sequence elements and mobile gene cassettes of bacterial integrons%29% transpose directly from one site in the DNA to another.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coping Behaviors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coping Skill' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copolymer of divinyl ether and maleic anhydride that acts as an immunostimulant with antineoplastic and anti-infective properties. It is used in combination with other antineoplastic agents.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copolymer, Pyran' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper %28%1966-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper %28%1969-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Amine Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Intrauterine Device' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Intrauterine Devices' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Level, Serum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Radioisotopes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Releasing IUD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Salt Glycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper chelator that inhibits monoamine oxidase and causes liver and brain damage.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper-Containing Amine Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper-Releasing IUD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copper-Releasing IUDs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copperheads' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coprinus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coprophagia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyria, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrinogen III Oxidases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrinogen Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrinogen Oxidase Deficiency' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrinogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrinogens' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coproporphyrins %28%1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coprostanol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coptis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copulation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copulations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copy Number, Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copy Numbers, Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copying Process' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copying Processes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copying Processes %28%1986-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copyright' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copyright %28%1993-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Copyrights' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cor Pulmonale' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cor Triatriatum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coral Snake' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coral Snakes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corazol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corazole' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corbicula' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corchorus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corchsularin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Blood Stem Cell Transplantation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Blood, Umbilical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Bloods' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Bloods, Umbilical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Contusion, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Contusions, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Factors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Injuries, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Injury, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Ischemia, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Ischemias, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Laceration, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Lacerations, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Transection, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Transections, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Trauma, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord Traumas, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord, Spermatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord, Umbilical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cord, Vocal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordarex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordarone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordipine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordis, Ectopia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordocenteses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordocentesis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordotomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordotomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cords, Spermatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cords, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cords, Umbilical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cords, Vocal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordyceps' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cordyline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor Alpha 1 Subunit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor Alpha 2 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor Alpha 2 Subunit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor Alpha 3 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor Alpha 3 Subunit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor alpha Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor alpha Subunits' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor beta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor beta Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factor beta Subunit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Binding Factors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core I Protein, UCCreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core I Protein, Ubiquinol Cytochrome c Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core II Protein, UCCreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core II Protein, Ubiquinol Cytochrome c Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Protein, Major' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Proteins, P30' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Proteins, Viral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core Vesicles, Dense' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core, Catalytic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core-Binding Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core-Binding Factor Alpha 2 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Core-Binding Factor Alpha 3 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corectomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corectomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coreopsis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cores, Catalytic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coretal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corethamid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cori Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cori%27%s Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coriandrum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coriolis Force' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coris Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corktree' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corn Oil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corn Oils' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corn, Indian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corncockle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1965-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1984%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea %28%1966-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea Transplantation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea Transplantations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/anatomy %26% histology %28%1975-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/blood supply %28%1978-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/pathology %28%1983-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/surgery %28%1983-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/surgery %28%1987-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/surgery %28%1995-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornea/transplantation %28%1966-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Angiogenesis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Arcus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Diseases %28%1974-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Dystrophies, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Dystrophy, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Edema' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Edemas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Endothelium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Epithelium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Epithelium, Anterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Grafting' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Graftings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Granular Dystrophies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Granular Dystrophy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Limbus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Macular Dystrophies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Macular Dystrophy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Neovascularization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Neovascularizations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Opacities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Opacity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Stroma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Stromal Dystrophies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Stromal Dystrophy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Stromas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Topographies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Topography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Transplantation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Transplantation %28%1981-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Transplantations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal Ulcer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornelia De Lange Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornell Medical Index' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneoscleral Junction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corneoscleral Junctions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornflower' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornsalad' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornu Ammonis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornual Coagulations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cornus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Aneurysm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Aneurysms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Angiographies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Angiography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Angioplasty, Transluminal Balloon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Arterioscleroses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Arteriosclerosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Arteriosclerosis %28%1989-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass Grafting' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass Surgery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass, Beating Heart' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass, Off Pump' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass, Off-Pump' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypass/methods %28%1996-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Bypasses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Stenoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Stenosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Vasospasm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Artery Vasospasms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Atherectomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Atherectomies, Directional' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Atherectomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Atherectomy, Directional' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Atheroscleroses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Atherosclerosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Balloon Angioplasties' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Balloon Angioplasty' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Care Unit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Care Units' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Circulation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Circulation %28%1973-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Circulation %28%1975-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1965-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1966-1969%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1966-1983%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1966-1984%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1966-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1971-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1973-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1980-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease %28%1983-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Disease/surgery %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Heart Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Heart Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Internal Mammary Artery Anastomosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Occlusions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Prone Personality' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Reperfusion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Reperfusions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Restenoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Restenosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Stenoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Stenosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Thromboses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Thrombosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vasospasm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vasospasms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessel Anomalies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessel Anomaly' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessels' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessels %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessels %28%1978-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessels/radiography %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary Vessels/surgery %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary artery bypass surgery on a beating HEART without a CARDIOPULMONARY BYPASS %28%diverting the flow of blood from the heart and lungs through an oxygenator%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary vasodilator that is an analog of iproveratril %28%VERAPAMIL%29% with one more methoxy group on the benzene ring.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary vasodilator with some antiarrhythmic action. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary vasodilator with some antiarrhythmic activity.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary-Internal Mammary Artery Anastomosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronary-Prone Personalities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae %28%1976-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae %28%1977-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae %28%1977-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae %28%1990-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviridae Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus %28%1993-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus 229E, Human' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus Infections %28%1978-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus OC43, Human' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Bovine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Canine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Feline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Feline Enteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Porcine Respiratory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Rat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, SARS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, SARS-Associated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, SARS-Related' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Turkey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronavirus, Urbani SARS-Associated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviruses, Bovine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviruses, Canine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviruses, Feline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviruses, Feline Enteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviruses, Rabbit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coronaviruses, Turkey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coroner' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coroners and Medical Examiners' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corotrop' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpora Allata' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpora Bigemina' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpora Lutea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpora Quadrigemina' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpora Quadrigemina %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corporate Culture' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corporate Cultures' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corporate Ethics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corporate Practices' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corporation, Professional' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corporations, Professional' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Allatum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Callosum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Callosum %28%1966-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Callosums' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum %28%1966-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum Cysts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum Hormones' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum Maintenance' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum Regression' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Luteum/drug effects %28%1968-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Striatum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Striatum %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpus Striatum %28%1974-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpuscle, Meissner%27%s' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpuscles, Golgi-Mazzoni' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpuscles, Pacinian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpuscles, Ruffini%27%s' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corpuscular Volumes, Mean' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrected and Republished Article' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrected and Republished Article %28%PT%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrected and Republished Article %5B%Publication Type%5D%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrective Endonuclease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrective Factor, Hunter' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrective Orthodontics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Correlation Studies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Correspondence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Correspondence Course' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrigenda' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrigenda %28%PT%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrinoids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrosion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrosion Casting' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrosion Castings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrosions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrosive Sublimate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corrosive oxidant, explosive; additive to diesel and rocket fuels; causes skin and lung irritation; proposed war gas. A useful reagent for studying the modification of specific amino acids, particularly tyrosine residues in proteins. Has also been used for studying carbanion formation and for detecting the presence of double bonds in organic compounds.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corsiaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortactin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortam%C3%%A9%thasone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex Decortication, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex Decortications, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex Disease, Adrenal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex Diseases, Adrenal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex Disorder, Auditory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex Disorders, Auditory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Adrenal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Auditory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Crystalline Lens' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Entorhinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Kidney' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Motor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Olfactory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Prefrontal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Somatosensory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Striate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortex, Visual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortexolone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortexone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corti Organ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corti%27%s Organ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Blindness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Congenital Hyperostoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Congenital Hyperostosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Contusions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Depression, Spreading' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Depressions, Spreading' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Desynchronizations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Diplopia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Diplopias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Hyperostoses, Congenital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Hyperostoses, Infantile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Hyperostosis, Congenital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Hyperostosis, Infantile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Lewy Body Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Synchronization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Synchronizations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical Vigilance' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortices, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortices, Entorhinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticobulbar Tract' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoid I Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoid I Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoid II Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoid II Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoid Type I Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoid Type II Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoliberin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticospinal Tract' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid 11 Oxidoreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid 11 Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid 11-Oxidoreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid 11-Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid Anionbinder IIIA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid Binding Globulin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroid-Binding Globulin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosteroids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticosterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticostriatal Spinal Degeneration' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticostriatal-Spinal Degenerations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotroph Adenoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotroph Adenomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotrophin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotrophin %28%1-39%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin %28%1-24%29%-Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin %28%1-24%29%-Tetracosapeptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin %28%1-39%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Factor 41' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Factor Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Hormone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Hormone 41' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Hormone Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing Hormone Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing-Factor Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing-Hormone Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin Releasing-Hormone Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin beta Lipotropin Precursor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Releasing Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Releasing Factor-41' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Releasing Hormone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Releasing Hormone Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Releasing Hormone-41' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Secreting Adenoma, Pituitary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-Secreting Adenomas, Pituitary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin-beta-Lipotropin Precursor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticotropin/blood %28%1985-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corticoviridae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortidexason' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortis Organ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisone %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisone %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisone 11 Oxoreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisone 11-Oxoreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisone Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortisumman' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cortodoxone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corydalis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corylus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynanthe johimbe' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacteriaceae %28%1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium %28%1967-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium %28%1969-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium Diphtheriae Toxin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium acnes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium diphtheriae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium equi' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium glutamicum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium parvum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium pseudotuberculosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium pyogenes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Corynebacterium vaginale' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coryneform Group %28%1976-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coryza Agent, Chimpanzee' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coryza Agents, Chimpanzee' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coryza Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmegen Lyovac' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Dentistries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Dentistry' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Surgery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetic Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetics %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetics %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmetics, Hair' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmic Dust' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmic Dusts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmic Radiation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmic Radiations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosmonauts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Allocation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Allocations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Apportionment' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Apportionments' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Benefit Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Benefit Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Benefit Data' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Containment' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Containments' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Control' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Control %28%1979-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Controls' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Measure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Saving' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Savings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Sharing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Sharing Insurance' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost Shiftings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost of Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost of Illness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost of Sickness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Cost Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Direct Service' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Drug' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Health' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Health Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Healthcare' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Hospital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Medical Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Sickness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost, Treatment' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost-Benefit Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost-Benefit Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cost-sharing mechanisms that provide for payment by the insured of some portion of covered expenses. Deductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costa Rica' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costal Chondritides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costal Chondritis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costen Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costen%27%s Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costens Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costimulator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costimulatory Molecule, B7-1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costimulatory Molecule, B7-2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costimulatory Molecule, B70' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costoclavicular Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Benefits' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs and Cost Analysis %28%1986-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs of Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs which are directly identifiable with a particular service.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Cost Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Direct Service' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Drug' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Health' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Health Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Healthcare' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Hospital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Medical Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Sickness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costs, Treatment' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Costus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosynthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosynthetase, Uroporphyrinogen III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cosyntropin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cot Death' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cot Deaths' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotazym S' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cote d%27%Ivoire' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cote d%27%Ivoire Ebola virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotinine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotranslational Protein Modification' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotranslational Protein Modifications' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotranslational Protein Processing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransport, Ion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter Proteins, Sodium-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, NaCl-KCl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, Pit1 Sodium-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, Pit2 Sodium-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, Sodium-Bicarbonate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, Sodium-Chloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, Sodium-Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporter, Sodium-Potassium-Chloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporters, Proton-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporters, Sodium Chloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotransporters, Sodium-Potassium-Chloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotrimoxazole' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton Fiber' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton Fibers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton Plant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton Rat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton Rats' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton, Collodion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton-Top Marmoset' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotton-Top Marmosets' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottonmouths' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottonseed Oil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottonseed Oils' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottonseeds' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottontail Rabbit Papillomaviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottontail rabbit papillomavirus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cottonwood' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coturnix' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coturnix japonica' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotyledon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cotyledons' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cougar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cougars' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cough' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cough Headache' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cough Headache, Benign' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cough Headaches, Benign' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cough, Whooping' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coughs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumafos' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumaphos' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumaric Acids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarin derivative that acts as a long acting oral anticoagulant.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1969-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1969-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1971-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1972-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1977-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarins %28%1999-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarones' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumarouna odorata' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coumestrol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Council, Health Planning' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Council, National Research %28%U.S.%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Councils, Health Planning' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Councils, National Research %28%U.S.%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling %28%1966-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling during which a professional plays an active role in a client%27%s or patient%27%s decision making by offering advice, guidance, and/or recommendations.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling or comfort given by ministers, priests, rabbis, etc., to those in need of help with emotional problems or stressful situations.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling, Career' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling, Directive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling, Prescriptive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counseling, Sex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counselings, Sex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counselor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Agar Dilution' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Blood Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Blood Platelet' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Complete Blood' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Differential Leukocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Erythrocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Fungal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Leukocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Microbial Colony' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Parasite Egg' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Platelet' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Pour Plate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Reticulocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Sperm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Spore' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Spread Plate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, Streak Plate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Count, T4 Lymphocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counter, Scintillation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counter, Whole-Body' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countercurrent Chromatography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countercurrent Distribution' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countercurrent Immunoelectrophoresis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counterimmunoelectrophoresis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countermeasure, Weightlessness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countermeasures, Weightlessness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counterpulsation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counterpulsation in which a pumping unit synchronized with the patient%27%s electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counterpulsation, Diastolic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counters, Geiger-Mueller' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counters, Scintillation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counters, Whole-Body' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countershock, Electric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countershocks, Electric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countertransference' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countertransference %28%Psychology%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countertransferences %28%Psychology%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counting, Scintillation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counting, Whole-Body' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries in the process of change directed toward economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries known in remote history %28%as BYZANTIUM%29% or former names of countries reflecting political changes in the 20th century %28%as GERMANY, EAST%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries, Developed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries, Developing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries, Industrialized' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries, Less-Developed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries, Third-World' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Countries, Under-Developed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Country, Developed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Country, Developing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Country, Industrialized' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Country, Less-Developed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Country, Third-World' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Country, Under-Developed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Agar Dilution' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Blood Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Blood Platelet' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Complete Blood' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Differential Leukocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Erythrocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Fungal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Leukocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Microbial Colony' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Parasite Egg' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Platelet' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Pour Plate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Reticulocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Sperm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Spore' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Spread Plate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, Streak Plate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Counts, T4 Lymphocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'County' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'County Hospital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'County Hospitals' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Couple Therapies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Couple Therapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Couples Therapies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Couples Therapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coupling Factor 0' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coupling Factor 1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Course, Correspondence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Course, Short-Term' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Courses, Short-Term' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Court Action' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Court Actions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Court Decisions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Courtship' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Courtships' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Covalent adducts between chemical mutagens and DNA. Such couplings activate DNA repair processes and, unless repaired prior to DNA replication, may lead to nucleotide substitutions, deletions, and chromosome rearrangements. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cover, Ice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cover, Sea Ice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coverage, Insurance' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coverage, Universal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coverings for the hands, usually with separations for the fingers, made of various materials, for protection against infections, toxic substances, extremes of hot and cold, radiations, water immersion, etc. The gloves may be worn by patients, care givers, housewives, laboratory and industrial workers, police, etc.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Covers, Ice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Covers, Sea Ice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Covidarabine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cow Pox' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cow Pox Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cow Pox Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cow, Domestic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cow, Sea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowden Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowden%27%s Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowdens Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowdria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowdria ruminantium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowitch' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowpea Mosaic Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowper Glands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowper%27%s Glands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowpers Glands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowpox' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowpox virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cowpox viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cows, Domestic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cows, Sea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxa Plana' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxarthroses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxarthrosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxibs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxiella' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxiella %28%1967-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxiella burnetii' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxiellaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackie A9 Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackie B Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackie Virus Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackie Virus Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackie Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackievirus A24 Variant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackievirus A24, Human' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackievirus A9, Human' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackievirus Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coxsackievirus Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coyote' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coyotes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Coyotillo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cp 33-35' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cp33-35, Scrapie' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG Cluster' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG Island' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG Islands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG Islands %28%1996-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG Rich Islands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG-Rich Island' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CpG-Rich Islands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cpds, 1-Ring Heterocyclic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cpds, Bicyclic Heterocyclic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cr%28%H2O%29%4 ATP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cr-46-49,51,55,56; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cr-50, 53, 54; NIM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cr-52 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CrATP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab Eating Macaque' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab Eating Monkey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab Lice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab, Blue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab, Common Shore' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab, Green' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab-Eating Macaque' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab-Eating Macaques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab-Eating Monkey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crab-Eating Monkeys' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crabgrass' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crabs, Horseshoe' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crabs, Short-Tailed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crabs, True' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crack Cocaine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cracked Tooth Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cracked Tooth Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crackle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crackles' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craft, Space' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crafts, Space' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crafts, trades, professions, or other means of earning a living.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crambe Plant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crambe Sponge' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp Bark' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp Fasciculation Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp, Abdominal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp, Heat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp, Limb' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp, Muscle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp, Muscular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp, Nocturnal Leg' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp-Fasciculation Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramp-Fasciculation Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps, Abdominal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps, Heat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps, Limb' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps, Muscle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps, Muscular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cramps, Nocturnal Leg' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranberries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranberry, Highbush' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crangonidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Airocele' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Airoceles' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Arteritides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Arteritis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Base' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Epidural Hematoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Epidural Hematomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Epidural Hemorrhage' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Epidural Hemorrhages' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Extradural Abscess' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Extradural Hematoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Extradural Hematomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Extradural Hemorrhage' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Extradural Hemorrhages' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Fossa, Anterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Fossa, Middle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Fossa, Posterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Fossas, Posterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Irradiation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Irradiations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Diseases %28%1981-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Eleven Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Eleven Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve I Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve I Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve II Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve II Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve II Injuries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve III Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IIIs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IIs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IV Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IX' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IX Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IX Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve IXs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Injuries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Injury' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Is' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Neoplasm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Neoplasms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Neoplasms %28%1976-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Neoplasms, Benign' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Palsy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Tumors, Benign' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve Tumors, Malignant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve V' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve V Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VI' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VI Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VI Injury' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VII Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VII Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VII Injuries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VIII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VIII Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VIII Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VIIIs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VIIs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve VIs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve X' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve X Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve XI' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve XI Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve XII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve XII Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve XII Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve XIIs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Eighth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Eleventh' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Fifth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, First' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Fourth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Ninth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Second' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Seventh' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Sixth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Tenth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Third' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerve, Twelfth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves %28%1966-1980%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves %28%1966-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Eighth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Eleventh' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Fifth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, First' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Fourth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Ninth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Second' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Sixth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Tenth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Third' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Nerves, Twelfth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Neuromas, Benign' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Neuropathies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Neuropathies, Traumatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Neuropathy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Neuropathy, Multiple' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Neuropathy, Traumatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Pain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Pains' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Pneumocyst' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Pneumocysts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Sinus Thromboses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Sinus Thrombosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Sinuses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Sinuses %28%1971-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Suture' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Sutures' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Trauma, Penetrating' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranial Traumas, Penetrating' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Injuries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Injury' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Trauma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Trauma %28%1965-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Trauma %28%1966-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Trauma %28%1971-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Trauma %28%1996-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Trauma, Penetrating' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Traumas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocerebral Traumas, Penetrating' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniocervical Injury' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniofacial Abnormalities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniofacial Abnormality' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniofacial Dysostoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniofacial Dysostosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniofacial Pain Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniofacial Pain Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniology' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniomandibular Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniomandibular Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniomandibular Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniomandibular Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniopharyngioma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniopharyngiomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniopharyngiomas, Adamantinous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniopharyngiomas, Adult' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniopharyngiomas, Child' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniopharyngiomas, Papillary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniorachischises' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranioschises' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniostenosis characterized by acrocephaly and syndactyly, probably occurring as an autosomal dominant trait and usually as a new mutation. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniosynostoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniosynostosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniotomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craniotomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cranium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crassostrea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crassulaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crataegus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Craterostigma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crateva marmelos' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crayfish' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cream, Ice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cream, Vaginal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creams, Ice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creams, Vaginal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Created 7 April 1992 as a result of the division of Yugoslavia.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Created as the Kingdom of Serbs, Croats, and Slovenes in 1918. Yugoslavia became the official name in 1929. BOSNIA-HERZEGOVINA; CROATIA; and SLOVENIA formed independent countries and split from Yugoslavia 7 April 1992. Macedonia, one of the Yugoslav republics, became an independent country 8 February 1994 as The Former Yugoslav Republic of Macedonia %28%MACEDONIA %28%REPUBLIC%29%;%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, BB' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, BB Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, Brain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, M' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, MB' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, MB Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, MM' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, MM Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, Mitochondrial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, Mitochondrial Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, Muscle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Kinase, Myocardial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Phosphokinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Phosphotransferase, ATP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatine Sulfate, 5,7-Dihydroxytryptamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creatinine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creation and development of bodies within solar systems, includes study of early planetary geology.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creation of a small incised opening in a vein to permit the passage of a needle or cannula for withdrawal of blood, administration of medication, or in diagnostic or therapeutic catheterization. %28%Dorland, 28th ed.; Stedman, 26th ed.%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creation of a smooth and glossy surface finish on a denture or amalgam.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creation of an artificial external opening or fistula in the intestines.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creation, Research Embryo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creations, Research Embryo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creativeness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creativenesses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Credentialing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Credit and Collection, Patient' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Credit, Patient' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Credits, Patient' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creeping Eruption' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creeping Eruptions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cremations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crenarchaeota' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crenarchaeota %28%1997-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creosote' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creosote Bush' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creosote, Beechwood' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crepis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresols' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresols %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresols %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresols %28%1968-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresols %28%1969-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cresols %28%1969-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Bitter' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Common Garden' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Garden' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Indian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Meadow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Mouse-ear' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Rock' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Upland' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Winter' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cress, Yellow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crest, Neural' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crests, Neural' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cretinism' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cretinism, Endemic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt Jakob Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt Jakob Disease, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt Jakob Disease, New Variant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt Jakob Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt-Jakob Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt-Jakob Disease, New Variant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt-Jakob Diseases, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Creutzfeldt-Jakob Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crevicular Fluid, Gingival' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crevicular Fluids, Gingival' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cri du Chat Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cri-du-Chat Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cri-du-Chat Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crib' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crib Death' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cribriform Carcinoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cribriform Carcinomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cribriform Plates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cricetinae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cricetulus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crickets' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cricoid Cartilage' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cricoid Cartilages' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cricopharyngeus Muscles' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crigler Najar Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crigler Najjar Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crigler-Najar Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crigler-Najjar Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crime' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crime %28%1968-1983%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crime %28%1986-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crime Victim' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crime Victims' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crime, War' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean Congo hemorrhagic fever virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean Hemorrhagic Fever' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean Hemorrhagic Fevers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean War' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean War, 1853 1856' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean War, 1853-1856' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimean-Congo hemorrhagic fever virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crimes, War' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminal Abortion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminal Abortions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminal Law' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminal Laws' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminal Psychology' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminology' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criminology %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crinex Brand of Amfepramone Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crinivirus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criniviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crinum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crises, Asthmatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crises, Blast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crises, Identity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis Intervention' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis Interventions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis, Asthmatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis, Blast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis, Identity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis, Thyroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisis, Thyrotoxic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisscross Heart' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crisscross Hearts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cristobalite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criteria to determine eligibility of patients for medical care programs and services.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criteria, School Admission' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Criteria, Selection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crithidia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crithidia %28%1979-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crithidia fasciculata' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Care %28%1975-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Illness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Illness Polyneuropathies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Illness Polyneuropathy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Illnesses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Incident Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Incident Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Incident Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Path' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Paths' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Pathway' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Pathways' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Period' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Period %28%Psychology%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Periods' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical Periods %28%Psychology%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. %28%Webster, 3d ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critically Ill' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Critiques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk 1 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk 2 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk Associated Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk Associated Substrate Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk-1 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk-2 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk-Associated Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk-Associated Substrate Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk-Associated Substrate, p130' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk-associated substrate was originally identified as a highly phosphorylated 130 kDa protein that associates with ONCOGENE PROTEIN CRK and ONCOGENE PROTEIN SRC. It is a signal transducing adaptor protein that undergoes tyrosine PHOSPHORYLATION in signaling pathways that regulate CELL MIGRATION and CELL PROLIFERATION.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crk3 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CrkII Adapter Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CrkIII Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croaker' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croatia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocidolite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocidolite Asbestos' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocker Sarcoma 180' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocodile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocodiles and Alligators' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crocus, Autumn' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crohn Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crohn Disease %28%1980-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crohn%27%s Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crohns Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromakalim' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromakalim, %28%3S-trans%29%-Isomer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromoglicic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromoglycate, Disodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromoglycate, Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromoglycic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cromolyn Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crookes Brand of Flurbiprofen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crookes Brand of Minocycline Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crop, Avian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crops, Agricultural' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crops, Avian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Bite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Bites' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Circulation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Circulations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Cultural Comparison' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Disciplinary Communication' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Eye' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infection %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infection %28%1966-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infection/prevention %26% control %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infection/prevention %26% control %28%1966-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infection/prevention %26% control %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Linking Reagents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Over Design' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Over Studies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Over Trials' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Presentation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Priming' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Product Ratio' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Reaction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Reactions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Sectional Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Sectional Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Sectional Anatomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Sectional Echocardiography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Sectional Studies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Sectional Survey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Talk, Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross Transfusion, Intrauterine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross, Blue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross, Red' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Cultural Comparison' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Cultural Comparisons' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Disciplinary Communication' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Disciplinary Communications' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Eye' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Eyes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Linking Reagents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Over Designs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Over Studies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Over Study' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Over Trials' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Priming' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Product Ratio' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Product Ratios' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Anatomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Echocardiography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Studies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Study' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Survey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Sectional Surveys' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Talk, Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Transfusion, Intrauterine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cross-Transfusions, Intrauterine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossarchus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossbites' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossbreeding' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossbreedings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossed Hemiplegia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossed Hemiplegias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossed Immunoelectrophoresis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crosses, Blue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crosses, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crosses, Red' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossing Over' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossing Over %28%Genetics%29% %28%1968-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossing Over, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossing Overs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossing, Border' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossing-Over, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossings, Border' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crosslinking Reagents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossmatching, Tissue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossmatchings, Tissue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover Design' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover Designs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover Immunoelectrophoresis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover Studies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover Study' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover Trials' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossover, Nerve' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossovers, Nerve' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossunited Fracture' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crossunited Fractures' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotalaria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotalid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotalid Venom' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotalid Venoms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotalus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croton' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croton Oil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croton Oil %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotonase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotonates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotonates %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotonic Acids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crotoxin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croup' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croup Associated Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croup Associated Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croup-Associated Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Croup-Associated Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crouzon Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crouzon%27%s Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crouzons Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crow Fukase Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crow-Fukase Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowding' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowding, Tooth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowdings, Tooth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Compounds' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Compounds, Aza' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Compounds, Aza-Thia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Compounds, Thia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Ethers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Ethers %28%1992-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Ethers, Aza-Oxa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Ethers, Oxa-Thia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Gall' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Galls' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Lengthening' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown Rump Length' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown, Dental' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown, Tooth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown-Rump Length' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crown-Rump Lengths' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowns' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowns %28%1966-1983%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowns, Dental' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crowns, Tooth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crows' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crucian Carp' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crucian Carps' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciate Ligament, Anterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciate Ligament, Posterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciate Ligaments, Anterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciate Ligaments, Posterior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciferae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciform Cutting Endonuclease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciform DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruciform DNA Resolving Endonuclease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crude Extracts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crude Oil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crude Oils' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruelty, Animal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crumbling or smashing of cancellous BONE by forces acting parallel to the long axis of bone. It is applied particularly to vertebral body fractures %28%SPINAL FRACTURES%29%. %28%Blauvelt and Nelson, A Manual of Orthopedic Terminology, 1994, p4%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crural Pareses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crural Paresis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crush Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crush Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crush, Nerve' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crushing Pain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crushing Pains' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crushing Skull Injuries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1965-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1966-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1966-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1967-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1968-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1969-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1970-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustacea %28%1979-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crustecdysone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crutch Palsies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crutches' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cruveilhier Baumgarten Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crying' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crying Cat Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crying Cat Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryo Tropin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryo electron Microscopy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryo-electron Microscopies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryo-electron Microscopy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CryoTropin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoablation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoablations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoanesthesia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoelectron Microscopies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoelectron Microscopy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryofixation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoglobulinemia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoglobulinemias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoglobulins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoglobulins %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoglobulins %28%1966-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryomicroscopies, Electron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryomicroscopy, Electron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryonic Suspensions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopharma Brand of Amikacin Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopharma Brand of Bezafibrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopharma Brand of Calcitriol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopharma Brand of Human Growth Hormone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopharma Brand of Propanidid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopreservation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryopreservation %28%1989-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoprotective Agents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryorenin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryosectioning' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryosurgeries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryosurgery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryosurgery %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryotherapies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryotherapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryoultramicrotomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptocarya' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcal Meningitides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcal Meningitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcoses, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcoses, Granulomous Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcosis %28%1967-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcosis, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcosis, Granulomous Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcus %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptococcus neoformans' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Epilepsies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Epilepsy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Infantile Spasm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Myoclonic Epilepsies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Myoclonic Epilepsy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Tonic Clonic Epilepsy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic Tonic-Clonic Epilepsies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptogenic West Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptolepis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptolepsis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptomeria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptomonads' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptophyta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchidism' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchidism, Abdominal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchidism, Bilateral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchidism, Inguinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchidism, Unilateral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchism' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptorchism %28%1966-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptosporidiidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptosporidioses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptosporidiosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptosporidium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptosporidium %28%1985-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cryptosporidium parvum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystal Violet' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystal, Liquid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallin-NADPH Oxidoreductase, zeta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystalline Lens' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystalline Lens Capsule' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystalline Lens Capsules' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystalline Lens Cortex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystalline Lens Nucleus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallinic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1965-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1966-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1968-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1973-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1978-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1982-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1984-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1985-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1987-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins %28%1988-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, alpha' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, alpha A Chain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, alpha B Chain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, beta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, beta A Chain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, beta B Chain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, delta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, epsilon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, gamma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, omega' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, tau' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallins, zeta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallizable fragments composed of the carboxy-terminal halves of both IMMUNOGLOBULIN HEAVY CHAINS linked to each other by disulfide bonds. Fc fragments contain the carboxy-terminal parts of the heavy chain constant regions that are responsible for the effector functions of an immunoglobulin %28%COMPLEMENT fixation, binding to the cell membrane via FC RECEPTORS, and placental transport%29%. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallization %28%1966-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallizations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallographies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallographies, X Ray' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallography %28%1968-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallography, X Ray' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallography, X-Ray' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystallography, Xray' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Crystals, Liquid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cs-123,125-32,134-144; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cs-133; NIM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CsA Neoral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CsANeoral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CstF Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Ctenopharyngodon idellus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Ctenophora' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Ctenophores' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cu Superoxide Dismutase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cu Zn Superoxide Dismutase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cu-58-62, 64, 66-68; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cu-63; Cu-65 = COPPER %28%IM%29% + ISOTOPES %28%NIM%29%; Cu-58-62, 64, 66-68 = COPPER RADIOISOTOPES %28%IM%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuba' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuban American' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cubeb Pepper' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cubital Tunnel Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cubital Tunnel Syndromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuboid Bones' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cubozoa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumaria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumber Mosaic Virus Satellite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumber Mosaic Virus Satellite RNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumber mosaic viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumis melo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumis sativus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumovirus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucumoviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucurbita' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucurbitaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucurbitaceae %28%1996-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cucurbitaceae %28%1998-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cues' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuff, Rotator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cul de Sac of Douglas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cul de Sac, Douglas%27%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cul-de-Sac of Douglas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cul-de-Sac, Douglas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cul-de-Sac, Douglas%27%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscope' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopic Surgeries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopic Surgery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopic Surgical Procedure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culdoscopy %28%1978-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culicidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culicidae %28%1972-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cullin Domain Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cullin Domain Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cullin Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cullin Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cullins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultivated plants or agricultural produce such as grain, vegetables, or fruit. %28%From American Heritage Dictionary, 1982%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultivation of PLANTS; %28%FRUIT; VEGETABLES; MEDICINAL HERBS%29% on small plots of ground or in containers.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultivation of natural faunal resources of water. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultivation, Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultivations, Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Anthropology' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Backgrounds' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Body Modifications' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Characteristic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Characteristics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Deprivation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Deprivation %28%1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Deprivations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Disadvantagement' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Disadvantagements' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Diversities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Diversity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Evolution' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural Evolutions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultural contacts between people of different races. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture %28%1966-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture %28%1975-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Diffusion Chamber' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Diffusion Chambers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Media' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Media %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Media %28%1967-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Media, Conditioned' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Media, Serum Free' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Media, Serum-Free' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Medium, Conditioned' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Technique, Blastocyst' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Technique, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Technique, Embryo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Technique, Organ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Technique, Tissue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques %28%1965-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques %28%1966-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques, Blastocyst' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques, Embryo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques, Organ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture Techniques, Tissue' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions %28%e.g., growth, lysis%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture, Beauty' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture, Corporate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Culture, Organizational' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Cells' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Milk Product' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Milk Products' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Neoplastic Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Neoplastic Cells' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Tumor Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultured Tumor Cells' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultures' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultures, Beauty' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultures, Corporate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cultures, Organizational' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cumin, Black' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuminum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cummingtonite Grunerite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cumulative Survival Rates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cumulative Trauma Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cumulative Trauma Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuneiform Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cunninghamella' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cunninghamia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuphea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cupressaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cupressus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cupric Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuprizone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuprozinc Superoxide Dismutase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curamed Brand of Ceftriaxone Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curamed Brand of Naloxone Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curamed Brand of Propofol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curamed Brand of Sufentanil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curamed, Naloxon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curantyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curare' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curare Like Agents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curare-Like Agents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curare-Like Agents %28%1970-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curare-Like Agents %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curariform Drugs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curculigo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curculionidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curcuma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curcumin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curd, Soy Bean' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curds, Soy Bean' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage and Dilatation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage, Gingival' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage, Subgingival' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage, Suction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettage, Vacuum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettages' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettages, Gingival' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettages, Subgingival' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettages, Suction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curettages, Vacuum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curietherapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curiosities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curling%27%s Ulcer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curlings Ulcer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Currant, Black' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Current Biog-Obit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Current Biog-Obit %28%1966-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Current Biog-Obit %5B%Publication Type%5D% %28%1966-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Current Procedural Terminology' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Current Procedural Terminology Codes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curricula' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curricula, Problem-Based' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curriculum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curriculum, Problem Based' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cursive Epilepsy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cursive Reflex Epilepsies %28%Running%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cursive Reflex Epilepsy %28%Running%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curtoviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curvature, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curvatures, Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curve, Area Under' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curve, ROC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curved bacteria, usually crescent-shaped rods, with ends often tapered, occurring singly, in pairs, or short chains. They are non-encapsulated, non-sporing, motile, and ferment glucose. Selenomonas are found mainly in the human buccal cavity, the rumen of herbivores, and the cecum of pigs and several rodents. %28%From Bergey%27%s Manual of Determinative Bacteriology, 9th ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curved rows of HAIR located on the upper edges of the eye sockets.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curves depicting MAXIMAL EXPIRATORY FLOW RATE, in liters/second, versus lung inflation, in liters or percentage of lung capacity, during a FORCED VITAL CAPACITY determination. Common abbreviation is MEFV.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curves, Area Under' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Curves, ROC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuscuta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushing Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushing Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushing Syndrome %28%1973-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushing%27%s Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushion Defect, Endocardial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushion Defects, Endocardial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushion Liner' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cushion Liners' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cusi Dexametasona, Oft' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cusi, Acetilcolina' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuspid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuspids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Custodial Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Custodies, Child' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Custody, Child' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Custom' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Custom, Mortuary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Customer satisfaction or dissatisfaction with a benefit or service received.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Customized Drugs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Customs, Mortuary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Administration' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Administration, Drug' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Administrations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Administrations, Drug' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Albinism' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Anaphylaxis, Passive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Angiitides, Allergic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Angiitis, Allergic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Candidiases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Candidiasis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Drug Administration' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Drug Administrations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Electrostimulation, Analgesic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Fistula' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Fistulas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Fungi' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Fungus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Histiocytoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Histiocytomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Leishmaniases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Leishmaniases, Diffuse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Leishmaniasis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Leishmaniasis, Diffuse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Leprosies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Leprosy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Lupus Erythematosus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytoses, Diffuse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytoses, Maculopapular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytosis, Diffuse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Mastocytosis, Maculopapular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Moniliases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Moniliasis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Oximetries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Syphilis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous T Cell Lymphoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous T-Cell Lymphoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous T-Cell Lymphomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Tuberculoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Tuberculosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Vasculitides, Allergic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous Vasculitis, Allergic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutaneous lesions arising from infection with Treponema pallidum. In the primary stage, 18-21 days following infection, one or more chancres appear. If untreated, the subsequent stages of the disease appear as syphilids. These eruptions are superficial, nondestructive, exanthematic, transient, macular roseolas that may later be maculopapular or papular polymorphous or scaly, pustular, pigmented eruptions.%28%Arnold, Odom, and James, Andrew%27%s Diseases of the Skin, 8th ed, p409%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutdown, Vein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutdown, Venous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutdowns, Vein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutdowns, Venous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuticle, Enamel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuticles, Enamel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutis Elastica' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutis Laxa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cutis, Aleukemic Leukemia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuttlefish' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cuxson Brand of Androstanolone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cx43' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CyA NOF' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CyA-NOF' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyamopsis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyamposis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanamid Brand of Acetazolamide Preparation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanamid Brand of Amoxapine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanamide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanamide, Calcium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanamide, Citrated Calcium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanates %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanates %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanidanol 3' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide Transsulphurase, Thiosulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide p-Trifluoromethoxyphenylhydrazone, Carbonyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide para-Trifluoromethoxyphenylhydrazone, Carbonyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide, Hydrogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide, Potassium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide, Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanide, Vinyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanides %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanides %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanides %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanides %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanides, Methyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoacrylate, Isobutyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoacrylate, Polybutyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoacrylates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoacrylates %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1969-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1969-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1969-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1970-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1970-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1970-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1971-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1973-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1977-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1980-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1985-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1985-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1993-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanobacteria %28%1995-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanocobalamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanogen Bromide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanogen bromide %28%CNBr%29%. A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoketone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanomethanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanomethylamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanomethylamine. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanonitrosylferrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanophora' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanophora paradoxas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanophoras' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanophyceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyanothece' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cybernetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cybernetics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycadophyta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycasin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclacillin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamate Calcium %28%2:1%29% Salt' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamate, Calcium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamate, Potassium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamate, Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamate, Sodium Salt' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclamen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclams' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclandelate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase CD38, ADPR' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase Receptors, Guanylyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase T10, ADPR' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase Toxin, Adenylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, 2%27%-P-ADPR' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, ADP Ribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, ADP-ribosyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, ADPR' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Adenyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Adenylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Adenylyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Deoxyguanylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Guanyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Guanylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Guanylyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Hydroperoxide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Inosinate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase, Inositol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase-Coupled Receptors, Guanylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase-Hemolysin, Adenylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclase-Linked Receptors, Guanylyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclazocine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclazocine %28%1966-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle Disorder, Sleep-Wake' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle Disorders, Sleep-Wake' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Activity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Cell Division' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Citric Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Endometrial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Estrous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Futile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Futile Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Krebs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Life' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Lunar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Menstrual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Moon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Ovarian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Tricarboxylic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycle, Ultradian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Activity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Cell Division' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Citric Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Endometrial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Estrous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Futile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Futile Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Life' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Lunar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Menstrual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Moon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Ovarian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Tricarboxylic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycles, Ultradian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic 3%27%,5%27%-Monophosphate, Adenosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic 3%27%,5%27%-Monophosphate, Guanosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic 3%27%,5%27%-Monophosphate, Inosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic ADP Ribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic ADP ribose Hydrolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic ADP-Ribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic ADPribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Dependent Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Dependent Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Phosphodiesterase Activator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Receptor Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Receptor Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Response Element Binding Protein 5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Response Element Binding Protein A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Response Element Modulator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Response Element-Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Response Element-Binding Protein A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP Responsive DNA Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP response element modulator is a basic leucine zipper transcription factor that is regulated by CYCLIC AMP. It plays an important role in SPERMATID development in the mammalian TESTIS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP, 8-Br' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP, 8-Bromo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP, Dibutyryl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP-Dependent Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP-Dependent Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic AMP-Responsive DNA-Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Acetylenes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Adenosine Diphosphate Ribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Alkenes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Amino Acids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic CMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Depsipeptides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Ethers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GLUCANS consisting of eight %28%8%29% glucopyranose units linked by 1,4-glycosidic bonds.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GLUCANS consisting of seven %28%7%29% glucopyranose units linked by 1,4-glycosidic bonds.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GLUCANS consisting of six %28%6%29% glucopyranose units linked by 1,4-glycosidic bonds.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GMP Dependent Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GMP Dependent Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GMP, Dibutyryl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GMP-Dependent Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic GMP-Dependent Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Hydrocarbons' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic IMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Monophosphate, Adenosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Monophosphate, Cytidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Monophosphate, Guanosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Monophosphate, Inosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic N Oxides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic N-Oxides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic N-Oxides %28%1971-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic N-Oxides %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic N-oxide radical functioning as a spin label and radiation-sensitizing agent.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Nucleotide Regulated Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Nucleotide-Regulated Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Nucleotides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Olefins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic P Oxides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic P-Oxides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic P-Oxides %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Peptides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic S Oxides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic S-Oxides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic S-Oxides %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic S-Oxides %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic Somatostatin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic TETRAPYRROLES based on the corrin skeleton. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic compounds with a ring size of approximately 1-4 dozen atoms.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic hydrocarbons that contain multiple rings and share one or more atoms.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 %28%or Colistins A, B, and C%29% which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic-3%27%,5%27%-Monophosphate, Adenosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic-3%27%,5%27%-Monophosphate, Cytidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic-3%27%,5%27%-Monophosphate, Guanosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclic-3%27%,5%27%-Monophosphate, Inosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclicities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclicity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin D Dependent Kinase CDK4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin D-Dependent Kinase CDK4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin D1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin D1 Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin D1 Genes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase 1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase 4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase 5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase 6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase 9' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 1A Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 1B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 1C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 2A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 2B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 2C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor 2D' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p15' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p16' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p18' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p19' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p27' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinase Inhibitor p57' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Dependent Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin E' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Kinase Inhibitor Protein 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Kinase Inhibitor Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin Kinase Inhibitor p21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase 1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase 4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase 5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase 6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase 9' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor 1A Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor 1B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor 1C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor 2B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor 2C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor 2D' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p15' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p16' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p18' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p19' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p27' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor p57' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase Inhibitor-2A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinase, Cdk4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Kinases %28%2000-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Dependent Protein Kinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-Kinase Inhibitor Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-dependent kinase 4 is a key regulator of G1 PHASE of the CELL CYCLE. It partners with CYCLIN D to phosphorylate RETINOBLASTOMA PROTEIN. CDK4 activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P16.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclin-dependent kinase 6 associates with CYCLIN D and phosphorylates RETINOBLASTOMA PROTEIN during G1 PHASE of the CELL CYCLE. It helps regulate the transition to S PHASE and its kinase activity is inhibited by CYCLIN-DEPENDENT KINASE INHIBITOR P18.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycling, Futile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycling, Futile Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycling, Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclings, Futile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclings, Futile Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclings, Substrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclins %28%1991-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclitides, Heterochromic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclitis, Chronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclitis, Heterochromic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclizations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclizine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclizine HCl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo Oxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo Oxygenase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo Oxygenase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo Oxygenase Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo-Oxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo-Oxygenase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo-Oxygenase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo-Oxygenase Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo-Oxygenase, Fatty Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclo-Oxygenase, Prostaglandin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CycloC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloaldolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloalkanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloamylose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclobutane Dimer, Thymine-Thymine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclobutane Pyrimidine Dimers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclobutane-Pyrimidine Dimers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclobutanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclocytidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclodecanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclodepsipeptides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclodextrins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclodextrins %28%1980-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclodextrins %28%1991-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclofenil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloheptanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloheptanes %28%1968-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloheptanes %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloheptanes %28%1971-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexane %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexane ring substituted by one or more ketones in any position.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanecarboxylic Acids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanecarboxylic Acids %28%1968-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanecarboxylic Acids %28%1968-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanecarboxylic Acids %28%1969-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanecarboxylic Acids %28%1971-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanecarboxylic Acids %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1968-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1968-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1969-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1969-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1971-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1971-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanes %28%1972-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanols' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanols %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanols %28%1979-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexanones' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexatriene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloheximide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexylamines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexylamines %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohexylamines %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohydrolase I, GTP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohydrolase II, GTP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohydrolase, 5,10-MTHF' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohydrolase, 5,10-Methenyltetrahydrofolate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohydrolase, GTP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclohydrolase, Methenyltetrahydrofolate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloleucine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclolysin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclomaltooligosaccharides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclomen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclomethiazide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclonamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooctanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase 1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase 2 Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase, Arachidonic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase, Prostaglandin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase-1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase-2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenase-2 Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclooxygenases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloparaffins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloparaffins %28%1963-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloparaffins %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloparaffins %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentacycloheptenes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1969-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1971-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1974-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentanes %28%1979-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopenthiazide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopentolate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophenil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophilin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophilin A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophilins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophorias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophosphamide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophosphamide %28%1975-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclophosphane' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopropanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopropanes %28%1970-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopropanes %28%1973-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclopropanes %28%1983-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cycloserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclospora' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporiases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporiasis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporin A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporin Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporin Binding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporin-Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporin-Binding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporine A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosporins %28%1982-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclosteroids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclothymic Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclothymic Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclothymic Personalities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclothymic Personality' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclotides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclotransferase, gamma-Glutamylamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclotron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyclotrons' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyctochrome P-450 c11AS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cydia pomonella granuloviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cylindrical epithelial cells in the innermost layer of the ENAMEL ORGAN. Their functions include contribution to the development of the dentinoenamel junction by the deposition of a layer of the matrix, thus producing the foundation for the prisms %28%the structural units of the DENTAL ENAMEL%29%, and production of the matrix for the enamel prisms and interprismatic substance. %28%From Jablonski%27%s Dictionary of Dentistry, 1992%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cylindroma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cylindromas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cylindrospermopsis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cymarigenin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cymarin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cymarine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cymbopogon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynanchum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynanchum indicum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynara' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynara scolymus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynodon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynomolgus Monkey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynomolgus Monkeys' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cynomorium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyperaceae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyperquat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyperus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cypoviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cypress, Bald' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cypress, Lawson%27%s False' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cypress, Yellow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyprinidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cypriniformes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyprinodons' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyprinodontidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyprinodontiformes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyprinus carpio' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyproheptadine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyproheptadine/analogs %26% derivatives %28%1987-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyproterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyproterone Acetate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyproterone/analogs %26% derivatives %28%1980-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyprus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyrtosperma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cys Transfer RNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly, cyclic 1-6 disulfide. The non-mammalian hormone that controls water and salt metabolism. It is the phylogenetic precursor of both ANTIDIURETIC HORMONES and OXYTOCIN and a possible neuroendocrine mediator in mammals. Vasotocin has oxytocic and vasopressor actions.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, cyclic 1-6 disulfide. The usual mammalian antidiuretic hormone, it is a cyclic nonapeptide with arginine in position 8 of the chain. Argipressin is used to treat DIABETES INSIPIDUS and as a hemostatic because of its vasoconstrictor action.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst Fluid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst Fluids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst due to the occlusion of the duct of a follicle or small gland.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Aneurysmal Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Apical Periodontal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Arachnoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Baker' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Branchial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Branchial Cleft' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Breast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Bronchial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Bronchogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Calcifying Odontogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Common Bile Duct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Corpus Luteum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Dental Root' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Dentigerous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Dentoalveolar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Dermoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Epidermal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Epidermoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Esophageal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Follicular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Ganglion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Ganglionic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Hepatic Hydatid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Hydatid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Intracranial Arachnoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Jaw' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Lateral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Leptomeningeal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Lymphatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Mediastinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Meibomian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Mesenteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Myxoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Neurenteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Neuroenteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Nonodontogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Odontogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Ovarian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Pancreatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Paratubal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Parovarian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Periapical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Pericardial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Perineural' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Periodontal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Pilar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Pilonidal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Popliteal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Pulmonary Hydatid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Radicular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Sebaceous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Solitary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Subchondral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Suprasellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Synovial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Thoracic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Thymic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Thyroglossal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Thyroglossal Duct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Thyrolingual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Tracheal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Umbilical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst, Urachal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyst-like space not lined by EPITHELIUM and contained within the PANCREAS. Pancreatic pseudocysts account for most of the cystic collections in the pancreas and are often associated with chronic PANCREATITIS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma %28%1975-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma %28%1980-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma, Mucinous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma, Papillary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinoma, Serous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinomas, Mucinous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinomas, Papillary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenocarcinomas, Serous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma %28%1969-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma %28%1971-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma Lymphomatosum, Papillary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma, Mucinous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma, Papillary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenoma, Serous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenomas, Mucinous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenomas, Papillary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystadenomas, Serous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystafos' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystaphos' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine Synthetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine beta Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine beta Synthase Deficiency Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine beta-Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine gamma Lyase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystathionine gamma-Lyase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystatin Superfamily' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystatins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystatins, Kininogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteamine, 35S Labeled' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystectomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystectomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteinamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteinamine Disulfide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine %28%1966-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine %28%1973-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Desulfhydrase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Dioxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Dioxygenase Type I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Endopeptidases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Endopeptidases %28%1986-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Protease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Protease Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteinase Antagonists' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteinase Inhibitors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteinases %28%1995-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Proteinases %28%1997-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Specific tRNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including neuropeptides, cytoskeletal proteins, proteins from smooth muscle, cardiac muscle, liver, platelets and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine-Specific tRNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteine/analogs %26% derivatives %28%1977-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysteinyldopa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Adenomatoid Malformation of Lung' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Adenomatoid Malformation of Lung, Congenital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Carcinoma, Adenoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Carcinomas, Adenoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Disease of Breast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Duct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Ducts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Fibrosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Fibrosis Antigen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Fibrosis Transmembrane Conductance Regulator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Fibrosis, Pancreatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Fibrosis, Pulmonary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Hygroma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Hygromas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Kidney' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Kidney Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Kidney Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Kidneys' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Lymphangioma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Lymphangiomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Mastitis, Chronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Mesothelioma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Mesotheliomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Periventricular Leukomalacias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Renal Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Renal Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Teratoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic Teratomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic dilatation of the ureter with ballooning of the ureteral orifice into the lumen of the bladder.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticercoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticercosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticercosis %28%1966-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticercosis, Brain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticercosis, Central Nervous System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticercus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysticide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystidyl Aminopeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinaminopeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine Aminopeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine Arylamidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine Desulfhydrase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine Desulfohydrolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine Knot Motif' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystine Knot Motifs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystineamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinuria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinurias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystinyl Aminopeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystitides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystitides, Chronic Interstitial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystitides, Interstitial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystitis %28%1966-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystitis, Interstitial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoceles' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoid Macular Edema' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoid Macular Edemas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoides Intestinalis, Pneumatosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystolith' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoliths' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystopyelitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystosarcoma Phyllodes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystosarcoma Phyllodes, Malignant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystosarcoma Phylloides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscope' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopic Surgeries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopic Surgery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopic Surgical Procedure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopy/instrumentation %28%1966-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoscopy/instrumentation %28%1966-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystostomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystostomies, Suprapubic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystostomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystostomy, Suprapubic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystoviridae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1966-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1966-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts %28%1967-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts found in the jaws and arising from epithelium involved in tooth formation. They include follicular cysts %28%e.g., primordial cyst, dentigerous cyst, multilocular cyst%29%, lateral periodontal cysts, and radicular cysts. They may become keratinized %28%odontogenic keratocysts%29%. Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Aneurysmal Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Apical Periodontal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Arachnoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Baker' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Branchial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Branchial Cleft' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Breast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Bronchial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Bronchogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Calcifying Odontogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Central Nervous System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Common Bile Duct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Corpus Luteum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Dental Root' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Dentigerous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Dentoalveolar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Dermoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Epidermal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Epidermoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Esophageal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Follicular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Ganglion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Ganglionic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Hepatic Hydatid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Hydatid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Intracranial Arachnoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Jaw' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Lateral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Leptomeningeal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Lymphatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Mediastinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Mesenteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Myxoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Neurenteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Neuroenteric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Nonodontogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Odontogenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Ovarian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Pancreatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Paratubal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Parovarian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Periapical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Pericardial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Perineural' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Periodontal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Pilar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Pilonidal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Popliteal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Pulmonary Hydatid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Radicular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Rathke Cleft' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Sebaceous' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Solitary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Subchondral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Suprasellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Synovial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Tarlov' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Thoracic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Thymic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Thyroglossal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Thyroglossal Duct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Thyrolingual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Tracheal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Umbilical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cysts, Urachal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cystyl Aminopeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytalopram' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytaphereses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytapheresis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytarabine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytarabine %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytarabine %28%1974-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytarabine Triphosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cyticholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine %28%1973%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine %28%dihydrogen phosphate%29%. A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2%27%, 3%27% or 5%27% position.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5 Monophosphosialate Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27% Diphosphate 1,2 Diacyl sn Glycerol Inositol Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27% Diphosphocholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27% Monophosphosialic Acid Synthetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27%-%28%tetrahydrogen triphosphate%29%. A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27%-%28%trihydrogen diphosphate%29%. A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27%-Diphosphate 1,2-Diacyl-sn-Glycerol - Inositol Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27%-Diphosphocholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5%27%-Monophosphosialic Acid Synthetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine 5-Monophosphosialate Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Aminohydrolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Cyclic 3%27%,5%27% Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Cyclic 3,5 Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Cyclic Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Cyclic-3%27%,5%27%-Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Deaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Diphosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Diphosphate Choline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Diphosphate Choline %28%1977-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Diphosphate Diglycerides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Diphosphodiacylglycerols' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Monophosphate %28%1966-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Monophosphate N Acetylneuraminic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Monophosphate N-Acetylneuraminic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Phosphates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidine Triphosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidyl Transferase, Phosphorylcholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylate Phosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylic Acids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidyltransferase, CTP Phosphorylcholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidyltransferase, Phosphocholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylyltransferase, Acylneuraminate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylyltransferase, CTP Phosphocholine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylyltransferase, Choline-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytidylyltransferase, N-Acylneuraminate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytisus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytisus laburnum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoadhesin Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochalasin B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochalasin D' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochalasins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochalasins %28%1973-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome B2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome C %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome C %28%1974-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome C 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome C-2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Oxidase Deficiencies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Oxidase Deficiency' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Oxidase Subunit III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 101' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 21 Hydroxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 4A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP11A1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP11B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP11B2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP19' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP1A1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP1A2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP27B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP2B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP2D6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP2E1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP3A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP4A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 CYP7' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Dependent Monooxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Dependent O Dealkylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Enzyme System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 IIE1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 IVA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 J' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Monooxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Oxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 c21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450 cam' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450IIIA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450c11AS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P 450d' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%1973-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%1975-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%1976-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%1982-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%1984-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%1985-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 %28%ALC%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 101' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 21-Hydroxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 4A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP11A1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP11B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP11B2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP19' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP1A1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP1A2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP27B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP2B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP2D6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP2E1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP3A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP4A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 CYP7' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 Enzyme System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 Enzyme System %28%1982-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 IIE1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 IVA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 LM%28%4%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 LM4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 c21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450 monooxygenases %28%MIXED FUNCTION OXYGENASES%29% that are important in steroid biosynthesis and metabolism.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%11 beta%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%16 alpha%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%17 alpha%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%17-alpha%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%AROM%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%c-21%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%cam%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450%28%scc%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450-Dependent Monooxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450-Dependent O-Dealkylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450-J' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450-cam' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450IIIA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450c11AS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P-450d' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 11A1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 11B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 11B2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 19' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 1A2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 2B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 2D6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 2E1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 3A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 7' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 8B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 CYP8B1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 IA1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450 Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450%28%17 alpha%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450%28%cam%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450Aldo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450c21' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome P450scc' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductase, Lactic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductases %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductases %28%1973-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductases %28%1974-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductases %28%1975-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome Reductases %28%1983-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a 1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a Group' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a Group %28%1994-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a%28%1%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a%28%3%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a,a3' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a-1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome a3' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b %28%1983-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b 5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b Group' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b Group %28%1983-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b Group %28%1984-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b c2 Oxidoreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b%28%6%29%-f Complex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b-5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b-c2 Oxidoreductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b6 f' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b6-f' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b6f' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome b6f Complex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome bc1 Complex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome bf Complex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c %28%1973-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c 1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c 551 Peroxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Group' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Group %28%1973-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Group %28%1981-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Group %28%1983-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Oxidase Deficiency' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Oxidase Subunit III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Oxidase Subunit IV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c Peroxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c%27%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c-1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome c6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome d' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome d Group' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome f' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-B%28%5%29% Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-c Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-c Oxidase %28%Complex IV%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-c Oxidase Deficiencies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-c Oxidase Deficiency' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-c Oxidase/deficiency %28%1976-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochrome-c Peroxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1966-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1967-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1973-1983%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1979-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1980-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1980-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%1991-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%electron-transporting proteins%29% in which the heme prosthetic group is heme a, i.e., the iron chelate of cytoporphyrin IX. %28%From Enzyme Nomenclature, 1992, p539%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%electron-transporting proteins%29% with a tetrapyrrolic chelate of iron as a prosthetic group in which the degree of conjugation of double bonds is less than in porphyrin. %28%From Enzyme Nomenclature, 1992, p539%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes %28%electron-transporting proteins%29% with protoheme %28%HEME B%29% as the prosthetic group.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes Type a' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes Type b' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes Type c' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes a' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes a1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes a3' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes b' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes b %28%1984-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes b5' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes b6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes c' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes c Prime' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes c%27%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes c1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes c2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes c6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes d' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes f' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes f are found as components of the CYTOCHROME B6F COMPLEX. They play important role in the transfer of electrons from PHOTOSYSTEM I to PHOTOSYSTEM II.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes of the b group that are found as components of the CYTOCHROME B6F COMPLEX. They contain two non-covalently bound HEME B groups.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes of the b group that are found bound to cytoplasmic side of ENDOPLASMIC RETICULUM. They serve as electron carrier proteins for a variety of membrane-bound OXYGENASES. They are reduced by the enzyme CYTOCHROME-B%28%5%29% REDUCTASE.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes of the b group that have alpha-band absorption of 563-564 nm. They occur as subunits in MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes of the c type that are found in eukaryotic MITOCHONDRIA. They serve as redox intermediates that accept electrons from MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX III and transfer them to MITOCHONDRIAL ELECTRON TRANSPORT COMPLEX IV.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes of the c type that are involved in the transfer of electrons from CYTOCHROME B6F COMPLEX and PHOTOSYSTEM I.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes, Heme a' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytochromes, Heme b' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytodiagnoses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytodiagnosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoecetes phagocytophila' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytofluorometries, Flow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytofluorometry, Flow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Aberration' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Aberrations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Abnormalities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Abnormality' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Technic, Molecular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Technics, Molecular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Technique, Molecular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetic Techniques, Molecular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytogenetics %28%1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistologic Preparation Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistologic Preparation Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistologic Preparation Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistologic Preparation Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistological Preparation Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistological Preparation Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistological Preparation Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytohistological Preparation Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokeratin 19' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokeratin, Endo-A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokeratin, Endo-B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokeratin, Endo-C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine Receptor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine Receptor gp130' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine Suppressive Anti inflammatory Drug Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine Suppressive Anti-inflammatory Drug Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine Synthesis Inhibitory Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine produced by activated T-lymphocytes that stimulates the migration of CD4-positive lymphocytes and monocytes. It has been reported to suppress HIV replication.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine that induces B-cell proliferation, inhibits immunoglobulin secretion, and selectively expands certain B-cell subpopulations.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine that stimulates the proliferation of T-lymphocytes and shares biological activities with IL-2. IL-15 also can induce B-lymphocyte proliferation and differentiation.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine which resembles IL-1 structurally and IL-12 functionally. It enhances the cytotoxic activity of NK cells and CTLs, and appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. %28%From Pigott %26% Power, The Adhesion Molecule FactsBook, 1993, p154%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines %28%1991-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines %28%1992-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines %28%1993-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines %28%1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines %28%1995-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokines, Chemotactic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokineses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokinesis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytokinins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytolinker Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytologic Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytologic Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytological Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytological Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytological Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytological Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytological Techniques %28%1971-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytological Techniques %28%1983-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytologies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology %28%1966-1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology %28%1966-1969%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytology %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytolytic Terminal Complement Complex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytolytic lymphocytes with the unique capacity of killing natural killer %28%NK%29%-resistant fresh tumor cells. They are interleukin-2-activated NK cells that have no MHC %28%major histocompatibility complex%29% restriction or need for antigen stimulation. LAK cells are used for adoptive immunotherapy in cancer patients.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalic Inclusion Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalic Inclusion Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegaloviral Retinitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus Infections %28%1972-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus Retinitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus Vaccines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus, Mouse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegalovirus, Rat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegaloviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegaloviruses, Mouse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegaloviruses, Murine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytomegaloviruses, Rat' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytometries, Flow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytometries, Image' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytometry, Flow' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytometry, Image' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytometry, Laser Scanning' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytopathic Effect, Viral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytopathic Effects, Viral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytopathogenic Effect, Viral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytopathogenic Effect, Viral %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytopathogenic Effects, Viral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytopathy, Kearn-Sayre Mitochondrial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytophaga' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytophaga %28%1974-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytophagaceae %28%1975-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytophosphan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytophotometries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytophotometry' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm %28%1966%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm %28%1966-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm %28%1975-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm %28%1977-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm %28%1980-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasm stored in an egg that contains nutritional reserves for the developing embryo. It is rich in polysaccharides, lipids, and proteins.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Antibodies, Anti-Neutrophil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Antibodies, Antineutrophil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Antibody, Anti-Neutrophil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Antibody, Antineutrophil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Aspartate Aminotransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Deoxyriboviruses, Icosahedral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Division' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Divisions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Elongation Factor 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Filament' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granule' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules %28%1966-1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules %28%1966-1969%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules %28%1966-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules %28%1976-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Granules %28%1981-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Hormone Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Inclusion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Membrane' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Membranes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Polyhedrosis Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Streaming' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Streaming %28%1967-1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Streamings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Structure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Structures' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Vesicle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic Vesicles' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic and Nuclear Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic filaments intermediate in diameter %28%about 10 nanometers%29% between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic proteins that bind certain aryl hydrocarbons, translocate to the nucleus, and activate transcription of particular DNA segments. AH receptors are identified by their high-affinity binding to several carcinogenic or teratogenic environmental chemicals including polycyclic aromatic hydrocarbons found in cigarette smoke and smog, heterocyclic amines found in cooked foods, and halogenated hydrocarbons including dioxins and polychlorinated biphenyls. No endogenous ligand has been identified, but an unknown natural messenger with a role in cell differentiation and development is suspected.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoplasms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoprotection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosar U' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosar-U' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'CytosarU' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine %28%1970-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine %28%1978-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Aminohydrolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Arabinoside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Arabinoside Triphosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Deaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Deoxyribonucleoside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Deoxyriboside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Methylases, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1966-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1969-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Nucleotides %28%1975-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Polynucleotides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Ribonucleoside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Riboside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine Thymine Dimers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine nucleotides which contain deoxyribose as the sugar moiety.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine-5-Methylase, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosine/analogs %26% derivatives %28%1991-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Adaptor Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Filament' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Linker Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins %28%1985-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins %28%1990-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins %28%1991-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins %28%1992-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins %28%1993-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletal Proteins %28%1994-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeleton' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeleton %28%1977-1984%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeleton %28%1977-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeleton %28%1978-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeleton %28%1980-1984%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeleton, Erythrocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletons' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoskeletons, Erythrocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosol Aminopeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosol and Nuclear Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosolic Lipid Binding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosolic Lipid-Binding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosolic Retinal Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosolic and Nuclear Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytosols' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytostatic Drugs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytostatic Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytostatics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotactin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotaxins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotaxins liberated from normal or invading cells that specifically attract macrophages. They may be lymphokines, products of antigen, antibody and complement interactions or other.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxic Antibiotics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxic T Lymphocytes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxic T-Lymphocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxic T-Lymphocytes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxic alkaloid from various species of Capsicum %28%pepper, paprika%29%, of the Solanaceae.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicities, Antibody-Dependent Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Test, Immunologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Test, Immunological' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Tests, Anti Human Globulin Complement Dependent' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Tests, Immunologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Tests, Immunologic %28%1971-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Tests, Immunologic %28%1973-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity Tests, Immunological' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity, Antibody Dependent Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity, Antibody-Dependent Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity, Immunologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity, Immunologic %28%1978-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxicity, Immunologic %28%1978-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin Antibody Conjugates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin, Pseudomonas aeruginosa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin, Shigella' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin, VT2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin, Vero' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin, Vero Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxin-Antibody Conjugates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotoxins, Vero Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytotrophoblast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoxicities, Antibody-Dependent Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoxicity, Antibody-Dependent Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Cytoxins, Vero' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Czech Republic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Czechoslovakia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Czechoslovakia %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 145' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 2, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 3 Hydroxybutyrate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 3 Mercaptovaline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 3 Phosphoglycerate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 600' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D 735' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Ala2 NMe Phe4 Gly ol Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Alanine Aminotransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Alanine Transaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Alanyl D Alanine Carboxypeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Alanyl D Alanine Cleaving Transpeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Amino Acid Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Amino Acid Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Aspartate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Aspartate Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Aspartic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Aspartyl L Isoaspartyl Methyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Cell, Gastric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Cells' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Cells, Gastric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Cells, Pancreatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Component of Complement' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D D Carboxypeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Fructose 1,6 Bisphosphate 1 Phosphohydrolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Galactose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Galactoside Binding Lectin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Glucaric Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Glucose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Glucuronolactone Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Glutamate D Alanine Transaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Glutamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Isoglucosamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Mannonate NAD Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Mannopyranosyldolichyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Mannose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Moramide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Norgestrel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Pen2, D Pen5 Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Pen2, L Pen5 Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Penicillamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Propoxyphene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Receptor, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Receptors, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Ribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Sorbose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Tamin retard L.U.T.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Thyroxine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Vert' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Xylose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D Xylulose Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D and C Yellow No. 7' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D and C Yellow No. 8' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D aspartic Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D beta Hydroxybutyrate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D sparteine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%26%C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%26%C Yellow No. 7' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%26%C Yellow No. 8' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%C3%%A9%fanyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%C3%%A9%sernil Sandoz' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%C3%%A9%sernil-Sandoz' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D%C3%%A9%socort' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D, Hydroxyvitamins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D, Prostaglandins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-3-Hydroxybutyrate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-3-Mercaptovaline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-3-Phosphoglycerate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-ASPARTIC ACID is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ala%28%2%29%,MePhe%28%4%29%,Met%28%0%29%-ol-enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ala%28%2%29%-D-Leu%28%5%29%-Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ala%28%2%29%-MePhe%28%4%29%-Gly-ol%28%5%29% Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ala-D-Ala Carboxypeptidase, Serine-Type' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ala-D-Ala Carboxypeptidases, Serine-Type' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ala2-NMe-Phe4-Gly-ol Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Alanine Aminotransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Alanine Transaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Alanyl-D-Alanine-Carboxypeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Alanyl-D-Alanine-Cleaving Transpeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Amino Acid Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Amino-Acid Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Aspartate Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Aspartic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Aspartyl-L-Isoaspartyl Methyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-D Carboxypeptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Fructose Transporter' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Fructose-1,6-Bisphosphate 1-Phosphohydrolase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Galactose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Galactose:NAD%28%P%29%+ 1-oxidoreductases. Catalyzes the oxidation of D-galactose in the presence of NAD+ or NADP+ to D-galactono-gamma-lactone and NADH or NADPH. Includes EC 1.1.1.48 and EC 1.1.1.120.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Galactoside-Binding Lectin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Glucaric Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Glucose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Glucose:1-oxidoreductases. Catalyzes the oxidation of D-glucose to D-glucono-gamma-lactone and reduced acceptor. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.47; EC 1.1.1.118; EC 1.1.1.119 and EC 1.1.99.10.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Glutamate-D-Alanine Transaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Isoglucosamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Mannonate-NAD Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Mannopyranosyldolichyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Mannose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Moramide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-NMMA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Norgestrel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Pen2, D-Pen5-Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Pen5-Enkephalin D-Pen2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Penicillamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Penicillamine %28%2,5%29%-Enkephalin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Propoxyphene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Ribose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Sorbose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-T4 Thyroid Hormone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Thyroxine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Transferase, GSTP1 Glutathione' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Trp-6-LH-RH' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Xylose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-Xylulose Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-aspartic Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-beta-Hydroxybutyrate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D-sparteine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D.C. Red No. 27' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D.H.E. 45' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D1 - INORGANIC CHEMICALS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D1 Receptors, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D10 - LIPIDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D12 - AMINO ACIDS, PEPTIDES, AND PROTEINS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D13 - NUCLEIC ACIDS, NUCLEOTIDES, AND NUCLEOSIDES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D145' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D1B Receptor, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D2 - ORGANIC CHEMICALS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D2 Receptors, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D2, Pro-Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D2, Prostaglandin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D2, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D20 - COMPLEX MIXTURES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D23 - BIOLOGICAL FACTORS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25 - BIOMEDICAL AND DENTAL MATERIALS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif only ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif with discretion ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: AGROCHEM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: BHA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: CETRIMONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: CONTACT LENS SOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: DANSYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: DENT ALLOYS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: DENT AMALGAM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: DENT MATERIALS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: DENT PORCELAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: MNNG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: NITRO BT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: PHARM AIDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: PIT SEALANTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: PRESERVATIVES PHARM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: RESINS SYN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF: note short X ref ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; DF:PDBU ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; HAIR DYES is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; POLYSORBATES is available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; POLYVINYL CHLORIDE is available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; acridinamines %26% acridinylamines = AMINOACRIDINES%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; also called %22%hydrating agents%22% but do not confuse these with intravenous solutions for rehydrating dehydrated subjects%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; benzoin gum %28%NM%29% is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; consider also DENTAL CARIES /prev or /drug ther%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; consider also FLATULENCE /drug ther ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord /ther use with dis /ther, not dis /drug ther; DF: SCLEROSING SOL%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with DENTURE RETENTION %28%IM%29% for denture adhesives; spray adhesives: coord IM with AEROSOLS %28%NIM%29% if pertinent; available also are BONE CEMENTS %26% DENTAL CEMENTS%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with source of oil %28%IM or NIM%29%; AROMATHERAPY %28%use of essential oils to treat dis in alternative med%29% is also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific chelating agent %28%IM%29% + metal being chelated %28%IM%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific drug %28%IM%29%; not restricted to FDA studies: may be used for investigational drugs in other countries%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific drug in solution %28%IM%29%; DF: CARDIOPLEGIC SOL%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific drug or chemical %28%IM%29%; do not confuse with DRUG DESIGN%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific plant source of oil %28%IM or NIM%29% but not PLANTS; %22%yusho poisoning%22%: see note on RICE%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific substance in solution %28%IM%29%; DF: DIALYSIS SOL%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; coord IM with specific substance in solution %28%IM%29%; DF: HEMODIALYSIS SOL%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; do not use /ther use when coordinating with disease /radiother but /ther use permitted with specific radiation-sensitizing agents in radiother; DF: RAD SENSITIZING AGENTS%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; for enema use BARIUM SULFATE /diag use, not BARIUM%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; includes sonic-action cleansers ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; protective against ionizing rad; not for SUNSCREENING AGENTS %26% not for shields %26% shielding in diag x-ray %28% = RADIATION PROTECTION%29%; DF: RAD PROTECTIVE AGENTS%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26 qualif; use with caution: few apply ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-26n qualif ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D25-D26 qualif ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D26 - PHARMACEUTICAL PREPARATIONS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D26-26 qualif ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D27 - CHEMICAL ACTIONS AND USES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 - HETEROCYCLIC COMPOUNDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 Receptor, 1,25-Dihydroxyvitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 Receptor, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 Receptor, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 Receptors, 1,25-Dihydroxyvitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 Receptors, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3 Receptors, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3, 1 alpha,25-Dihydroxyvitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3, 1,25-Dihydroxyvitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D3, 1,25-dihydroxy-20-epi-Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D4 - POLYCYCLIC COMPOUNDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D4 Receptor, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D4 Receptors, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D40TA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D4T' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D5 - MACROMOLECULAR SUBSTANCES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D5 Receptor, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D5 Receptors, Dopamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D6 - HORMONES, HORMONE SUBSTITUTES, AND HORMONE ANTAGONISTS%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D600' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D65MT' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D735' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D8 - ENZYMES AND COENZYMES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'D9 - CARBOHYDRATES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DA 2370' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DA2370' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DADDS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DADLE' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DADPS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAG Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAGAT Enzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAGO' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAGOL' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAHLIA, SEA see COREOPSIS is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAHP Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAI %28%Diffuse Axonal Injury%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAI Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAIs %28%Diffuse Axonal Injury%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAMGE' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAMGO' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAMME' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DARPP 32 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DARPP-32 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAT Dopamine Transporter' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DAT Dopamine Transporter Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DATABASES containing information about NUCLEIC ACIDS such as BASE SEQUENCE; SNPS; NUCLEIC ACID CONFORMATION; and other properties. Information about the DNA fragments kept in a GENE LIBRARY or GENOMIC LIBRARY is often maintained in DNA databases.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DATABASES containing information about PROTEINS such as AMINO ACID SEQUENCE; PROTEIN CONFORMATION; and other properties.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DATABASES devoted to knowledge about specific genes and gene products.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DATABASES, NUCLEIC ACID and DATABASES, PROTEIN are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DB Brand of Methoxsalen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DBA Mice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DBA Mice, Inbred' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DBA Mouse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DBA Mouse, Inbred' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DBI Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DC LAMP Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DC-LAMP Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCC Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCC Genes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCC stands for %22%Deleted in Colorectal Cancer%22% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCCD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCIS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCMP Deaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DCMU' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DD 234' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DD Peptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DD-Peptidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DD234' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDBJ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDD/PD %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDE' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDIT3 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDSA Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDSA Brand of Bendroflumethiazide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDSA Brand of Nitrazepam' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDT' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDVP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DDX' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAE Cellulose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAE Cellulose Chromatography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAE Dextran' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAE-Cellulose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAE-Cellulose Chromatography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAE-Dextran' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEAF-MUTISM was heading 1963-79 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEATH, SUDDEN, CARDIAC is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEET' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEFA Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEFENSINS found in azurophilic granules of neutrophils and in the secretory granules of intestinal PANETH CELLS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEFENSINS found mainly in epithelial cells. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEFICIENS Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEFICIENS is a homeotic gene involved in the genetic control of Antirrhinum majus flower development. Its protein is one of the four founder proteins that structurally define the superfamily of MADS DOMAIN PROTEINS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEFICIENS-AGAMOUS-LIKE PROTEINS see MADS DOMAIN PROTEINS is also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEHP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DEHYDROGENASES %26% OXIDASES were headings 1963 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DENDRITIC CELLS is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DENTAL CARE PLANS was see under INSURANCE, DENTAL 1963-78; PREPAID DENTAL CARE was see under INSURANCE, DENTAL 1969-78%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DENTAL CARIES CONTROL was heading 1965-66 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DENTATE CEREBELLAR ATAXIA see MYOCLONIC CEREBELLAR DYSSYNERGIA is also available; ATAXIAS, HEREDITARY see SPINOCEREBELLAR DEGENERATION is also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DERMATITIS, TOXICODENDRON is available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DERMATOMYOSITIS %26% POLYMYOSITIS are also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DERMOID was heading 1968-80 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DESMOLASES was see under LYASES 1963-80 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DET' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DETA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DETAPAC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: note short X ref ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: 2 3 CYCL NPD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: 2 5 DOM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AA TRANSPORT DIS INBORN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AAAD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ACA INFARCT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ACBU ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ADAPTATION PHYSIOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ADJUVANTS IMMUNOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ADJUVANTS PHARM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ADMIT DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ADR REPORT SYSTEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ADREN AGENTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AIDS ARTERITIS CNS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ALA DEHYDRASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ALDOSTERONE ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ALHE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ALKYLMERCURY CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ALLYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ALPHAPROTEOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AM PUBLIC HEALTH ASSOC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AMINOBIPHENYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANCILLARY SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANDROGEN ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANEMIA IRON DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANESTH DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANILINE CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANTISENSE ELEMENTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ANTISENSE OLIGODNA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AP5 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: APPETITE REG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: APRT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ATYPICAL BACT FORMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AUTO DRIVER EXAM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AUTOIMMUNE DIS NERVOUS SYSTEM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: AUTOMATED MED RECORDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: B CELL DIFFER ANTIGENS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BACT CAPSULES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BALT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BANA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BAPA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BDNA ASSAY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BENZHYDRYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BEPHENIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BETAPROTEOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BICYCLO CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BICYCLO CPDS HETEROCYCLIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BIOL WARFARE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BIPHENYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BLOOD COAG FACTOR INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BLOOD GROUPING or short X ref ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BP TESTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BPRS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BR CAMP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BRAIN TIA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BRAINSTEM INFARCT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BRIDGED CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: BVD DIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C C LIGASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C C LYASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C ELEGANS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C MET PROTEINS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C N LIGASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C N LIGASES GLN DONOR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C N LYASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C O LYASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C S LIGASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C S LYASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: C3B INACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CA ATPASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CA MG ATPASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CALMODULIN KINASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CAMP PROTEIN KINASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CAPNOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CARBONIC ANHYDRASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CARCINOGENS ENVIR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CARDIOL SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CATH SWAN GANZ ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CCK A RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CCK B RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CCL4 POIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CD4 LYMPHOCYTOPENIA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CDP CHOLINE SYNTHETASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CEA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CEO HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CEREBRAL INFARCT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CGRP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CHEM WARFARE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CHOLAGOGUES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CHOLINERGIC ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CHOLINESTERASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CHROMATOGR GEL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CHROMATOGR PAPER ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CLIN LABORATORY INFORMATION SYSTEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CLIN MED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CLIN PHARM INFORMATION SYSTEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CNTF RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COLLECTION DEVELOPMENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COMB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COMMUNITY PHARM SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COMPETITIVE MED PLANS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COMPLEMENT MAC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COMPREHENSIVE DENT CARE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COMPUTING METHODOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CON A ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CONSENSUS SEQ ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CONTRACEPTION IMMUNOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CONTRACT SERV; CONTRACTS is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: COOKING UTENSILS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CORNEAL NEOVASC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CORNEAL TOPOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CORONARY CIRC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CR4 RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CRPS TYPE I ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CSF OTORRHEA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CSF PRESSURE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CSF RHINORRHEA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CT Colonography ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CT SCANNERS X RAY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CYCL CMP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CYCL GMP PHOSPHODIESTERASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: CYCLOOXYGENASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DADLE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DCRFB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DECAMETHONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DEDUCTIBLES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DEFECOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DELTAPROTEOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT ARCH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT ARTICULATORS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT AUDIT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT AUXILIARIES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT BONDING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT CARIES ACTIVITY TESTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT CARIES SUSCEPTIBILITY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT CASTING TECHNIQUE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT CAVITY LINING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT CLINICS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT DEBONDING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT DEVICES HOME CARE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT DISINFECTANTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT ENAMEL SOLUBILITY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT FACILITIES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT HEALTH SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT HIGH SPEED TECHNIQUE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT IMPLANTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT IMPLANTS SINGLE TOOTH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT IMPRESSION TECHNIQUE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT MODELS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT OCCLUSION BALANCED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT OCCLUSION CENTRIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT OFFICES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT PINS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT PROSTHESIS IMPLANT SUP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT PULP CAPPING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT PULP TEST ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT RECORDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT STAFF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENT STAFF HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DENTIST PATIENT RELAT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIAG SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIAZONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIBU CYCL AMP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIBU CYCL GMP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIMETHYLPGE2 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIPYRIDYL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIRECT SERV COSTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DIRECTED MOL EVOLUTION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DISH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DME GLUE PROTEINS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DNA KINASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DNASE SS I ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DNASE SS III ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DNR ORDERS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DOWN REG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DRUG RESISTANCE NEOPL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: DURABLE MED EQUIPMENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC DENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC MEASUREMENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC MED UNDERGRAD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC PHARM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC PREDENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC PREMED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EDUC VET ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EEN COMBINATION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EFTU ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ELECTRON PROBE MICROANAL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EMBLEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EMERGENCY MED TAGS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EMERGENCY MED TECHNICIANS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EMERGENCY SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EMIGRATION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EMIT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENCEPH ST LOUIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENCEPH VARICELLA ZOSTER ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENDO GLUCANASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENGRAVING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENHANCER ELEMENTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENKEPHALIN MET or MET ENKEPHALIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENVIR DESIGN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ENVIR MONITORING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EPN300 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EPOXY CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EPSILONPROTEOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ERKS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ESTRADIOL ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ESTROGEN ANTAG; do not confuse with ANTIESTROGENS see ESTROGEN RECEPT MODULATORS%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EVLW ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EXTINCTION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EXTRAMARITAL RELAT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: EXTRAVASATION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FACTOR VII DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FACTOR XIII DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FEEDING EATING DIS CHILD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FEES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FEES DENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FEES MED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FELINE INFECT PERITONITIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FGF1 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FGFB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FMLP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FOLIC ACID ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FOOD SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FOUNDER EFF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: FUG TRANSFERASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: Finite Element Anal ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: G PROTEIN INHIB GI ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: G PROTEIN STIM GS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GAMMAPROTEOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GCSF RECOMBINANT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR ALPHA CHAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR B CELL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR BETA CHAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR DELTA CHAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR GAMMA CHAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR HEAVY CHAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR LIGHT CHAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENE REARR T CELL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENERALIZATION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENES SYN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENET COMPLEMENTATION TEST ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENET ENGINEERING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GENET HETEROGENEITY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GEPA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GERIATRIC ASSESS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GIP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GLUCAN BRANCHING ENZYME ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GLUTAMINE CP SYNTHASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GP160 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GPD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GPHAS; coord with THYROTROPIN, FOLLICLE STIMULATING HORMONE, LUTEINIZING HORMONE or CHORIONIC GONADOTROPIN if particularly discussed%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GPPNHP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GPTI ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: GROWTH INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HABITUATION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HALLERVORDEN SPATZ DIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HALOBACT SALINARUM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HBF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HEALTH EDUC DENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HEALTH FACILITY ENVIR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HEMORHEOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HEPARIN ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HGIV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HIAA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HIOMT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HISTOCYTOL PREP TECHNIQUES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HIV INTEGRASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HIV LTR or HIV TAR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HIV PROTEASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HMG COA SYNTHASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HMWK ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HNPCC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HOLOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HORMONE ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HOSP INFORMATION SYSTEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HVOD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: HYDROXYPG DEHYDROGENASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IABP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG CONSTANT REGION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG FAB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG FC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG FRAGMENTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG IDIOTYPES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG ISOTYPES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG JOINING REGION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG SWITCH REGION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG THYROID STIMULATING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IG VARIABLE REGION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IGA DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IGG DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 1 or IL1 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 10 or IL10 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 11 or IL11 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 12 or IL12 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 13 or IL13 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 15 or IL15 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 16 or IL16 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 17 or IL17 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 2 or IL2 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 3 or IL3 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 4 or IL4 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 5 or IL5 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 6 or IL6 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 7 or IL7 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 8 or IL8 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL 9 or IL9 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL18 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL8RA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IL8RB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IMAGE INTERP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INFECT CONTROL PRACTITIONERS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INFORMATION STORAGE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INSERV TRAINING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INSULIN ANTAG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INTERFERON IND ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INTERNSHIP NONMED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: INTERPERSONAL RELAT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IPA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IQSMP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: IUD EXPULSION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: JOINT VENTURES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: K CHANNEL BLOCK ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: K CHANNELS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: KINDLING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: KINETOCARDIOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: KK SYSTEM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: KYMOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LABORATORIES DENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LABORATORIES HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LAUNDRY SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LEU ENKEPHALIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LEUKOENCEPH ACUTE HEMOR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LEUKOENCEPH PROGRESSIVE MULTIFOCAL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LFA1 or LFA 1 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LIGHTNING INJ ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LIMBIC ENCEPH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LINKAGE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LIPOXYGENASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LIVER CIRRHOSIS EXPER ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LMWK ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LUPUS COAG INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LURIA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LYMPHOMA LARGE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: LYMPHOMA SMALL CLEAVED DIFFUSE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAGNESIUM DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAGNETOENCEPHALOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAI INFECT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAINSTREAMING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAINTENANCE HOSP or MAINTENANCE HOSPITAL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAMMOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MAO INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MARKETING HEALTH SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MCSF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MECHANORECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED AUDIT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED FUTILITY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED HIST TAKING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED INDIGENCY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED OFFICE BUILDINGS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED REC DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MED STAFF PRIVILEGES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MELAS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MENINGITIS E COLI ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MERRF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: METHONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: METHYLMERCURY CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: METHYLOBACT EXTORQUENS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: METHYLUREA CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MHC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MHL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MIBX ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MICROINJECT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MLCK ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MLNS or MCLS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MM DIFFER ANTIGENS or ANTIGENS DIFFER MM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MONITORING INTRAOP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MPS I ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MPS II ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MS CHRONIC PROGRESSIVE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MS RELAPSING REMITTING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MSHRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MSHRIH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MTOC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MUSIC THER ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MUSTARD CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: MYELOABLATIVE AG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: N GROUP TRANSFERASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NA CA EXCHANGER ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NA K ATPASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NDGA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NEURAL ANAL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NEUROPSYCHOL TESTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NFKB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NITRO CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NITROSO CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: NITROSOUREA CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OCCUP THER DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OLFACTORY RECEPT NEURONS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ONCOL SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OPCA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OPERATOR REGIONS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OPLL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGAN NONPROFIT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGANOMERCURY CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGANOPLATINUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGANOSELENIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGANOSILICON CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGANOTECHNETIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: ORGANOTIN CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OX PHOS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OX PHOS COUPLING FACTORS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OXOACYL ACP SYNTHASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: OXOPG REDUCTASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: P O LYASES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: P120 GAP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PAIN POSTOP or POSTOP PAIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PANNICULITIS LE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PAPS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PARANEOPL ENCEPH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PARANEOPL POLYNEUROPATHY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PARAPSYCHOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PARKINSON DIS POSTENCEPH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PATHOL DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PATIENT ACCEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PATIENT CREDIT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PATIENT ESCORT SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PATIENT ID SYSTEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PBBS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PCA INFARCT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PCN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PDGF ALPHA RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PDGF BETA RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PDHC DEFIC DIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PEPPTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PERSONNEL ADMIN HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PG SYNTHASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PGA SYN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PGE SYN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PGF SYN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PGI ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PGI2 RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHARM SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHARM SERV HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHENYLUREA CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHILA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHILOSOPHY DENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHILOSOPHY MED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHOSPHODIESTERASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHOSPHOSTRANSFERASES PHOSPHATE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHOSPHOTRANSFERASES ALCOHOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHOSPHOTRANSFERASES CARBOXYL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHOSPHOTRANSFERASES NITROGENOUS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHOSPHOTRANSFERASES PAIRED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHRENOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PHYS THER DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PLACENTAL CIRC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PLANT GROWTH REG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PLATELET INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PNEUMOCOCCAL INFECT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POLAROGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POLIO BULBAR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POLYCHLOROTERPHENYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POLYMORPHISM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POMR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POSTOP CARE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POSTPOLIO SYNDROME or PPMA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: POTASSIUM DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRACTICE MANAGEMENT DENT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRACTICE MANAGEMENT MED ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRALIDOXIME CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PREV HEALTH SERV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRIH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRK ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PROM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PROMOTER REGIONS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PROTEASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PROTEIN C DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PROTEOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PRPP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PSR SCALES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PSYCHOL TESTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PSYCHOTHER BRIEF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PSYCHOTHER RATIONAL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PTK RECEPT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PUBLIC RELAT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM ALVEOLAR PROTEINOSIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM ALVEOLI ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM ARTERY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM DIFFUSING CAPAC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM EMBOLISM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM HEART DIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM SURFACTANTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM VEINS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PULM WEDGE PRESSURE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PYRIDINIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: PYRVINIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: QUAL ASSUR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: QUINOLINIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAB1 PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAB2 PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAB3 PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAB3A PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAB4 PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAB5 PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAC1 PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RADIOGR IMAGE INTERP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RADIOL INFORMATION SYSTEMS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RAL PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RATE SETTING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ACTH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ADREN BETA 3 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT AGGREGATION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT AH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ALDOSTERONE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT AMPA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ANTIGEN B CELL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT APO E ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT BOMBESIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT C 3B ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT C 3D ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT CALCITONIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT CALCITRIOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT CCK ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT CSF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT CYTOKINE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT DOPAMINE D1 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT DOPAMINE D2 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT EGF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ENDOTHELIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ERYTHROPOIETIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT ESTRADIOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT FC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT FSH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT GABA A ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT GABA B ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT GCSF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT GLUCAGON ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT GLYCINE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT GMCSF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT H3 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IGE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IGF 1 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IGF 2 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IGG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IL 1 or RECEPT IL1 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IL 2 or RECEPT IL2 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IL 3 or RECEPT IL3 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IL 4 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT IL 6 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT KAINIC ACID ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT LDL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT LEUKOTRIENE B4 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT LH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT LHRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT LYMPHOCYTE HOMING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT MCSF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT MITOGEN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT NEUROPEPTIDE Y ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT NEUROTENSIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT NMDA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT OXYTOCIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT PCP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT PDGF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT PGE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT PHRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT PRL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT RETINOIC ACID ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT SENSORY ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT SOMATOTROPIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT SRIH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TACHYKININ ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TGF BETA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT THROMBIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TRANSFERRIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TRKA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TRKB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TRKC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT TSH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT VIP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECEPT VLA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECRUITMENT DETECTION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RECRUITMENT NEUROL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: REFRACTORY PERIOD NEUROL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RESP THER DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RESTRICT MOD ENZYMES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RETENTION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: REVERSE TRANSCRIPTASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RHIZOBIUM RADIOBACT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RHOA PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RHOB PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: RISA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SACCULE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SALARIES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SAR ISO ANG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SARCOIDOSIS PULM ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SELECTION ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SEQ ANAL DNA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SEQ ANAL RNA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SERINE PROTEINASE INHIB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SFC Chromatogr ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SIALOGR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SLEEP APNEA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SNRNA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SOCIAL WORK DEP HOSP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SOS RESPONSE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SP-C PROTEIN ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SP-D ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SPIRO CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SPLANCHNIC CIRC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SPLENIC INFARCT ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SRCA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SRT TEST ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: STAPH FOOD POIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: STAPH NUCLEASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: STAPH TOXOID ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: STEL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: STRIKES ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SULFONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: SURG DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: T CELL DIFFER ANTIGENS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TCR AB ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TERMINAL REPEAT SEQ ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TERMINATOR REGIONS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TERPHENYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TETRAETHYLAMMONIUM CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: THIOREDOXIN REDUCTASE ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TISSUE CONDITIONING ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TMP SMX ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TNBS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TOSYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRANSFERASES OSPG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRANSPL CHIMERA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRANSRECTAL HIFU ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRAUMATOL ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRIALKYLTIN CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRIETHYLTIN CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRIMETHYLSILYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TRIMETHYLTIN CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TTFD ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TTPA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: TUBERCULOSIS CNS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: U-PA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: U46619 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: UP REG ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: UROL DEP ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: UTIL REV ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: UVEOMENINGOENCEPH SYNDROME ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VBAC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VDCC L ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VDCC N ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VDCC P ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VDCC Q ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VDCC R ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VINYL CPDS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VITAMIN A DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VITAMIN D DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VITAMIN E DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VITAMIN K DEFIC ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: VWF ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: WERNICKE ENCEPH ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: WHO CATALOG: use NAF entry ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: WORD ASSOC TESTS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: do NOT shorten: short form can be confused with PATIENT ISOL for PATIENT ISOLATION%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: do not abbreviate since it would conflict with DF for STREPTOCOCCUS%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: note short X ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: note short X ref ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: note short X ref TMJ SYNDROME ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF: note short X refs ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF:DFMO ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF:DISRUPTIVE BEHAVIOR DIS ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF:IL 14 or IL14 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF:NASBA ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DF:QSAR ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DFP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DGKdelta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DH 581' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DH581' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHA Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHAQ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHBV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHE 45' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHE Puren' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHE ratiopharm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHE45' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHEA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHEA Sulfatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHEA Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHLA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DHP Ether' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIABETES MELLITUS, not DIABETES INSIPIDUS; coordinate IM with specific type of diabetes mellitus %28%IM%29% if pertinent; DF: PREGN IN DIABETES%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIABETIC FOOT is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIAGNOSIS, COMPUTER-ASSISTED is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIAPERS was see INFANT CARE 1989-91 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIARRHEA occurring in infants from newborn to 24-months old.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIASTOLIC PRESSURE see BLOOD PRESSURE %26% do not add DIASTOLE %28%NIM%29% unless particularly discussed%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIDMOAD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIDS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIMS %28%Disorders of Initiating and Maintaining Sleep%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIPHTHERIA-TETANUS VACCINE and DIPHTHERIA-TETANUS-PERTUSSIS VACCINE are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS VACCINE are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES and DIPHTHERIA-TETANUS-PERTUSSIS VACCINE are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIPHTHERIA-TETANUS-PERTUSSIS VACCINE is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DISC-PCR' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DISCLOSURE is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIT Receptors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DITERPENES with three LACTONES and a unique tert-butyl group, which are found in GINKGO plants along with BILOBALIDES.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DIVEMA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL 8280' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL Arginine Acetate, Monohydrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL Norgestrel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL alpha Difluoromethylornithine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL threo 3,4 Dihydroxyphenylserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-3-%28%4-Chlorophenyl%29%alanine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-Isomer Methionine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-Norgestrel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-Serine 2-%28%%28%2,3,4-trihydroxyphenyl%29%methyl%29%hydrazide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-Tyrosine, alpha-methyl-' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-alpha-Difluoromethylornithine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL-threo-3,4-Dihydroxyphenylserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DL8280' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMARD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMBA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMCP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMDT' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMF Index' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMF Indexe' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMF Indexes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMF Indices' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMPC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMPP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMPS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMPS Heyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMPS-Heyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMSA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DMSO' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1984%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1966-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1968-1980%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1969-1973%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1970-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1972-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1972-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1973-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1973-1984%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1974-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1976-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1977-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1978-1981%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1978-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1985-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1986-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1986-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%1988-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%Cytosine 5%29% Methyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%Cytosine-5-%29%-Methyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%Cytosine-5-%29%-Methyltransferase %28%1975-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%Cytosine-5-%29%-Methyltransferase %28%1975-88%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA %28%Cytosine-5-%29%-Methyltransferase %28%1978-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA 5%27% Hydroxylkinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA 5%27%-Hydroxylkinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Activated Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Adducts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Adenine Methylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Amplification Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Amplification Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Amplification Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Array' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Arrays' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Binding Protein B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Binding Protein Inhibitor ID 2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Binding Protein Inhibitor ID1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Binding Protein, Cyclic AMP Responsive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Binding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA CHIPS see OLIGONUCLEOTIDE SEQUENCE ANALYSIS and PROTEIN CHIPS see PROTEIN ARRAY ANALYSIS are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Catenanes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Chip' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Chips' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Computations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Computer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Cruciforms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Cytosine 5 Methylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Cytosine Methylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Cytosine-5-Methylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Damage' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Damage %28%1987-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Damage Inducible Transcript 3 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Damage-Inducible Transcript 3 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Damages' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Data Bank' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Data Banks' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Databank' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Databanks' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Database' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent DNA Polymerase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent DNA Polymerase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent DNA Polymerase III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent DNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent Protein Serine Threonine Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent RNA Polymerase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent RNA Polymerase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent RNA Polymerase III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Dependent RNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Directed DNA Polymerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Directed RNA Polymerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Directed RNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Endonuclease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Endonuclease, Apurinic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Exonucleases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA FINGERPRINTING is available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA FOOTPRINTING is available; do not confuse X ref DNA PROFILING with GENE EXPRESSION PROFILING%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Fingerprint' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Fingerprinting' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Fingerprintings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Footprint' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Footprinting' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Footprintings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Footprints' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Formamidopyrimidine Glycosylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Fragmentation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Fragmentation, Internucleosomal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Gene Probes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Glycosylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Glycosylase, Methylpurine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Glycosylase, Thymine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Glycosylase, Ung' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Glycosylase, Uracil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Glycosylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Gyrase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Helicases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Helicases %28%1974-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Hybridization Probes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Injuries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Injury' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Insertion Element' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Insertion Elements %28%1983-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Insertion Elements %28%1985-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Joinases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Libraries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Ligase, T4' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Ligases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Ligases %28%1978-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Lyase %28%Apurinic or Apyrimidinic%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Marker' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Markers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Maxicircles, Kinetoplast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Methylation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Methylations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Microarray' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Microchip' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Microchips' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Mimicries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Minicircles, Kinetoplast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Mismatch Repair Protein MutS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Modification Methylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Modification Methylases %28%Adenine-Specific%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Modification Methylases %28%Cytosine-Specific%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Modification Methylases Adenine Specific' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Modification Methylases Cytosine Specific' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Modification Methyltransferases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Mutational Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Mutational Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA N glycosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA N-glycosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nicking Enzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nicking-Closing Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nicking-Closing Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidylexotransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidylexotransferase %28%1989-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1968-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1968-1976%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1968-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1974-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1986-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1992-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1993-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases %28%1996-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases/antagonists %26% inhibitors %28%1993-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Nucleotidyltransferases/antagonists %26% inhibitors %28%1994-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Oligonucleotide Ligands' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Packaging' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Photolyase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Photoreactivating Enzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase I %28%1981-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase IV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase alpha' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase beta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase delta' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase epsilon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase, DNA-Directed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase, RNA Directed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase, RNA-Dependent' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase, RNA-Directed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerase, Taq' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerases, DNA-Dependent' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Polymerases/antagonists %26% inhibitors %28%1977-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Primase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Primers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA-A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA-B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA-C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA-D' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA-DR' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HLA-Dw' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, HPV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Probes, Histocompatibility Antigen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Profiling' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Profilings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Proteins, Recombinant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Rearrangement' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Rearrangements' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Recombinant Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Relaxing Enzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Relaxing Enzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Relaxing Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair %28%1971-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair %28%1975-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair %28%1977-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair And Recombination Protein RAD52' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair Deficiency' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair Deficiency Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair Enzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair, Defic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair-Deficiencies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair-Deficiency Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repair-Deficiency Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repairs, Defic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repeat Expansion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repeat Expansions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repeat, Expanded' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repeats, Expanded' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Repetitious Regions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication %28%1968-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication %28%1968-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication %28%1968-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication %28%1969-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication Factor A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication Order, Temporal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication Pattern, Temporal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication Timing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replication Timings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Replications' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Research, Recombinant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzyme BamHI' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzyme EcoRI' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzyme HindIII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzyme HpaII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes %28%1975-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes %28%1978-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes %28%1979-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes %28%1980-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes, Type I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes, Type II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Enzymes, Type III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction Modification Enzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Restriction-Modification Enzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequence Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequence Analysis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequence Database' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequence Determination' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequence Determinations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequence, Unstable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequences' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Sequences, Unstable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Shuffling' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Shufflings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Single Stranded Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Single-Stranded Binding Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Synthesis Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Therapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%1977-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%1978-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%1984-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%1990-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%ATP-Hydrolysing%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1979-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1980-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1984-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase %28%ATP-Hydrolysing%29% %28%1991-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase 1, Archaeal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase I, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase I, Eukaryotic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase II, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerase IV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases %28%1977-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases II, Eukaryotic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type I, Archaeal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type I, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type I, Eukaryotic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type II %28%1979-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type II, Archaeal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type II, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Topoisomerases, Type II, Eukaryotic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Transposable Element' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Transposable Elements' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Transposable Elements %28%1980-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Transposon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Tumor Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Tumor Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Type 1 Topoisomerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Type 2 Topoisomerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Typing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Typings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Untwisting Enzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Untwisting Enzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Untwisting Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Untwisting Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Untwisting Proteins %28%1978-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Unwinding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Unwinding Proteins %28%1981-1983%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Vaccines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Vaccines, Naked' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Vaccines, Recombinant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Virus Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Virus Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Virus Infections %28%1992-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1966-1973%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1966-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1966-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1970-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1975-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1986-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1991-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1997-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1998-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA Viruses %28%1999-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA analogs containing neutral amide backbone linkages composed of aminoethyl glycine units instead of the usual phosphodiester linkage of deoxyribose groups. Peptide nucleic acids have high biological stability and higher affinity for complementary DNA or RNA sequences than analogous DNA oligomers.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA constructs that are composed of, at least, a REPLICATION ORIGIN, for successful replication, propagation to and maintainance as an extra chromosome in bacteria. In addition, they can carry large amounts %28%about 200 kilobases%29% of other sequence for a variety of bioengineering purposes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, required for successful replication, propagation to and maintainance in progeny human cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA constructs that are composed of, at least, all elements, such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintainance in progeny mammalian cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA constructs that are composed of, at least, elements such as a REPLICATION ORIGIN; TELOMERE; and CENTROMERE, that are required for successful replication, propagation to and maintenance in progeny cells. In addition, they are constructed to carry other sequences for analysis or gene transfer.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA constructs that are derived from the DNA of BACTERIOPHAGE P1. They can carry large amounts %28%about 100-300 kilobases%29% of other sequence for a variety of bioengineering purposes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA delivery directly into organelles at high speed: from %22%biological ballistic%22%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA elements that include the component genes and insertion site for a site-specific recombination system that enables them to capture mobile gene cassettes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA locations with the consensus sequence CANNTG. ENHANCER ELEMENTS %28%GENETICS%29% may contain multiple copies of this element. E-boxes play a regulatory role in the control of transcription. They bind with basic helix-loop-helix %28%bHLH%29% type TRANSCRIPTION FACTORS. Binding specificity is determined by the specific bHLH heterodimer or homodimer combination and by the specific nucleotides at the 3rd and 4th position of the E-box sequence.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA of kinetoplasts which are specialized MITOCHONDRIA of trypanosomes and related parasitic protozoa within the order KINETOPLASTIDA. Kinetoplast DNA consists of a complex network of numerous catenated rings of two classes; the first being a large number of small DNA duplex rings, called minicircles, approximately 2000 base pairs in length, and the second being several dozen much larger rings, called maxicircles, approximately 37 kb in length.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA or specific %28%1975-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA or specific %28%1977-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA or specific DNA %28%1972-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA or specifics %28%1984-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA present in neoplastic tissue. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA probes specific for the human leukocyte antigen genes, which represent the major histocompatibility determinants in humans. The four known loci are designated as A, B, C, and D. Specific antigens are identified by a locus notation and number, e.g., HLA-A11. The inheritance of certain HLA alleles is associated with increased risk for certain diseases %28%e.g., insulin-dependent diabetes mellitus%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA probes specific for the identification of human papilloma virus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA restriction enzyme used as a DNA marker: coord probably NIM with GENETIC MARKER %28%IM%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences encoding RIBOSOMAL RNA and the segments of DNA separating the individual ribosomal RNA genes, referred to as RIBOSOMAL SPACER DNA.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences encoding the alpha chain of the T-cell receptor. The genomic organization of the TcR alpha genes is essentially the same in all species and is similar to the organization of Ig genes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences encoding the beta chain of the T-cell receptor. The genomic organization of the TcR beta genes is essentially the same in all species and is similar to the organization of Ig genes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences encoding the delta chain of the T-cell receptor. The delta-chain locus is located entirely within the alpha-chain locus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences encoding the gamma chain of the T-cell receptor. The human gamma-chain locus is organized similarly to the TcR beta-chain locus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for a protein that down-regulates the expression of human immunodeficiency virus %28%HIV%29%. nef is short for negative factor.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus %28%HIV%29%. rev is short for regulator of virion.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for a trans-activator protein that specifies rapid growth in human immunodeficiency virus %28%HIV%29%. vpr is short for viral protein R, where R is undefined.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for at least three proteins which regulate the expression of HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The proteins are p21%28%x%29%, p27%28%rex%29%, and p40%28%tax%29%. The tax %28%trans-activator x%29% and rex %28%regulator x%29% genes are part of pX but are in overlapping reading frames. X was the original designation for the sequences or region %28%at that time of unknown function%29% in the long open reading frame %28%lor%29% which is now called pX.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. %22%pol%22% is short for polymerase, the enzyme class of reverse transcriptase.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for the HIV-1 regulatory protein vpu %28%viral protein U%29% that greatly increases the export of virus particles from infected cells. The vpu genes are not present in HIV-2 or SIMIAN IMMUNODEFICIENCY VIRUS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for the protein responsible for trans-activation of transcription %28%tat%29% in human immunodeficiency virus %28%HIV%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for the vif %28%virion infectivity factor%29% protein that is important for the generation of infectious virions in human immunodeficiency virus %28%HIV%29%. The former name of this gene was sor %28%short open reading frame%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences that form the coding region for the viral envelope %28%env%29% proteins in retroviruses. The env genes contain a cis-acting RNA target sequence for the rev protein %28%= GENE PRODUCTS, REV%29%, termed the rev-responsive element %28%RRE%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences which are recognized %28%directly or indirectly%29% and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences which signal the termination of transcription.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA sequences, in cells of the T-lymphocyte lineage, that code for T-cell receptors. The TcR genes are formed by somatic rearrangement %28%see GENE REARRANGEMENT, T-LYMPHOCYTE and its children%29% of germline gene segments, and resemble Ig genes in their mechanisms of diversity generation and expression.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA that is complementary to the sense strand. %28%The sense strand has the same sequence as the mRNA transcript. The antisense strand is the template for mRNA synthesis.%29% Synthetic antisense DNAs are used to hybridize to complementary sequences in target RNAs or DNAs to effect the functioning of specific genes for investigative or therapeutic purposes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA viruses producing malignant tumors. Of the six major groupings of DNA viruses four contain members which are actually or potentially oncogenic: the Adenoviridae, the Herpesviridae, the Papovaviridae, and the Poxviridae.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, A Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, A-Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Algal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Anti-Sense' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Antisense' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Antisense %28%1991-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Archaeal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, B Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Bacterial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Bacterial %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Bacterial %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Bacterial %28%1975-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Bacterial %28%1976-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Bacterial %28%1979-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, C Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, C-Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Catalytic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Catanates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Catenated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Chloroplast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Circular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Circular %28%1973-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Circular %28%1973-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Circular %28%1976-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Complementary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Complementary %28%1994-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Concatemers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Concatenated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Cruciform' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Double Stranded' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Fungal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Fungal %28%1980-1983%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Fungal %28%1980-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Fungal %28%1980-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Helminth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Heteroduplex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Holliday Junction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Intergenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Kinetoplast' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Left-Handed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Mitochondrial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Mitochondrial %28%1988-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Neoplasm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Plant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Protozoan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Protozoan %28%1991-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Protozoan %28%1991-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, RIBOSOMAL SPACER is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, RIBOSOMAL and DNA, SPACER see DNA, INTERGENIC are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Recombinant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Recombinant %28%1977-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Recombinant %28%1977-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Ribosomal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Ribosomal %28%1984-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Ribosomal %28%1992-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Ribosomal Spacer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Satellite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Satellite %28%1989-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Satellite I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Selfish' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Single Stranded' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Single-Stranded' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Single-Stranded %28%1997-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Spacer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Supercoiled' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Superhelical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Superhelical %28%1978-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Supertwisted' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Viral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Viral %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Viral %28%1966-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Viral %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Viral %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Z Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA, Z-Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-%28%Apurinic or Apyrimidinic Site%29% Lyase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Activated Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Adenine Methylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Factors, Erythroid-Specific' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Protein Inhibitor ID-2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Protein Inhibitor ID1' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Protein, Cyclic AMP-Responsive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Protein, Single-Stranded' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1984-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1986-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1987-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1987-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1987-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1987-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1988-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1988-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1989-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1989-1992%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1989-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1989-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1990-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1991-1998%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1991-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1991-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1991-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1991-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1992-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1992-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1993-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1993-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1993-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1994-2000%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1994-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1994-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1994-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1995-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1995-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1996-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1996-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1997-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1998-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%1998-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Binding Proteins %28%2001-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Cytosine Methylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent DNA Polymerase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent DNA Polymerase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent DNA Polymerase III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent DNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent Protein Serine-Threonine Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent RNA Polymerase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent RNA Polymerase II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent RNA Polymerase III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Dependent RNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Directed DNA Polymerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Directed DNA Polymerase %28%1989-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Directed RNA Polymerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Directed RNA Polymerases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Formamidopyrimidine Glycosylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Gyrase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-Priming Protein, T7' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-binding domains present in proteins of the HMG-box superfamily including the archetypal HMGB PROTEINS, a number of sequence specific TRANSCRIPTION FACTORS, and other DNA-BINDING PROTEINS. The domains consist of 70-80 amino acids that form an L-shaped fold from three alpha-helical segments. The domain has the capacity to recognize and/or induce specific DNA structures and effect the accessibility of the DNA to other proteins involved in transcription, recombination, or DNA repair. %28%Note that not all HIGH MOBILITY GROUP PROTEINS contain this domain.%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-binding motifs formed from two alpha-helixes which intertwine for about eight turns into a coiled coil and then bifurcate to form Y shaped structures. Leucines occurring in heptad repeats end up on the same sides of the helixes and are adjacent to each other in the stem of the Y %28%the %22%zipper%22% region%29%. The DNA-binding residues are located in the bifurcated region of the Y.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-binding motifs, first described in one of the HMGA PROTEINS: HMG-I%28%Y%29% PROTEIN. They consist of positively charged sequences of nine amino acids centered on the invariant tripeptide glycine-arginine-proline. They act to fasten the protein to an AT RICH SEQUENCE in the DNA.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-binding proteins ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. EC 2.7.7.7.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA/biosynthesis %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA/biosynthesis %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNA/genetics %28%1977-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAs, Intergenic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAs, Junk' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAs, Satellite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAs, Satellite I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAs, Selfish' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAs, Spacer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAzyme' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNAzymes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNCB' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNFB' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNM1 Gene Product, Dynamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNM2 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNPI Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Alkaline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Pancreatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Site Specific, Type I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Site Specific, Type II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Site Specific, Type III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Site-Specific, Type I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Site-Specific, Type II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DNase, Site-Specific, Type III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOES %28%Disorders of Excessive Somnolence%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOESs %28%Disorders of Excessive Somnolence%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOM' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOPAC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOSE FRACTIONATION; CELL FRACTIONATION and FRACTIONATION, FIELD FLOW are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOSS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOUGLAS FIR see PSEUDOTSUGA is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOX SL' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DOXO cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DP-1 Transcription Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DP1 Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DP1, Transcription Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DPDPE' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DPDPE%28%SH%29%2' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DPLPE' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DPN' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DPNase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DPT Vaccine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DR 3355' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DR3355' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRAINAGE, SUCTION see SUCTION is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRB' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRG' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRG Outlier' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRG Outliers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRGs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRIP Clade' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRK1 Potassium Channel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRTF1 Transcription Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRTF1, Transcription Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, VIRAL; and DRUG RESISTANCE, MULTIPLE, FUNGAL are also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DSIP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DSRNA Dep Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DSRNA-Dep Protein Kinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DSTN Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DT Diaphorase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DT Vaccine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTIC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTIC Dome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTICDome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTNB' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTP Vaccine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTPA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTPA %28%1966-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTPA %28%1987-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTPA, Gadolinium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTPA/analogs %26% derivatives %28%1994-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTaP Vaccine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTaP Vaccines' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DTwP Vaccine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DU 21220' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DU 23000' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DU21220' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DU23000' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DUODENAL INTUBATION was heading 1963-65 ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DUODENAL OBSTRUCTION by the superior mesenteric artery %28%MESENTERIC ARTERY, SUPERIOR%29% which travels in the root of the MESENTERY and crosses over the DUODENUM. The syndrome is characterized by the dilated proximal duodenum and STOMACH, bloating, ABDOMINAL CRAMPS, and VOMITING. Often it is observed in patient with body casts after spinal surgery.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DVert' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DYNII Dynamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DYSENTERY caused by gram-negative rod-shaped enteric bacteria %28%ENTEROBACTERIACEAE%29%, most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE %28%severest%29%; Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI %28%mildest%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DYSENTERY caused by intestinal PROTOZOA infection, chiefly with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the LIVER and other distant sites.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DYSGAMMAGLOBULINEMIA is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DYSKINESIA SYNDROMES see MOVEMENT DISORDERS is also available%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DYSTONIA is also available ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacarbazine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryoadenitides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryocystitides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryocystitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryocystitis/surgery %28%1966-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryocystorhinostomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryocystorhinostomy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dacryocystostomies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dactinomycin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dactylis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dactylolysis Spontanea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daffodil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dagestan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dagra Brand of Azapropazone Dihydrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahl Hypertensive Rats' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahl Rats' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahl Rats, Inbred' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahl Salt Resistant Rats' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahl Salt Sensitive Rats' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahlia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahlia, Sea' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dahomey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daily Allowance, Recommended' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daily Allowances, Recommended' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daily Headache, Chronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daily Headaches, Chronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daily Living Activities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daily Living Activity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dairy Product' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dairy Products' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dairy Products %28%1966-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dairying' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dairyings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daisy, Oxeye' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dakota Brand of Fluorouracil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dakota Brand of Vancomycin Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dakota, Fluorouracile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dalamon Inyectable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dalbergia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dalmadorm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dalteparin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dam, Rubber' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage to the MYOCARDIUM resulting from reperfusion of ischemic areas of the HEART. Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion can cause EDEMA, injuries to cardiac myocytes %28%MYOCYTES, CARDIAC%29% and the conducting tissue with resultant ARRHYTHMIA. Degree of injury depends on the duration and extent of MYOCARDIAL ISCHEMIA before reperfusion, cytosolic calcium overload, and oxygen FREE RADICALS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage to tissues as the result of low environmental temperatures.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage, Anoxic Brain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage, Hypoxic Brain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damage, Reperfusion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damages to reproductive health prior to conception %28%FERTILIZATION%29%, a legal term for torts liability concerning environmental safety issues. Preconception injuries may involve either the male or the female, such as chromosomal mutations in the OVA or the SPERMATOZOA.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damages to the EMBRYO or the FETUS before BIRTH. Damages can be caused by any factors including biological, chemical, or physical.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damages, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Damages, Reperfusion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dammarane type triterpene saponins based mainly on the aglycones, protopanaxadiol and protopanaxatriol.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dams, Rubber' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dan-Shen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danatrol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danazol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dance Therapies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dance Therapy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dancing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dancing %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dancings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danco Brand of Mifepristone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandelion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandy Walker Malformation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandy Walker Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandy Walker Syndrome, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandy-Walker Malformation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandy-Walker Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dandy-Walker Syndrome, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daneral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dangerous Behavior' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dangerous Behaviors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dangshen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danio rerio' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danio rerio Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danon Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danshen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dansyl Compounds' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dantrolene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Danval Brand of Trimetazidine Dihydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daphne' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daphnia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dapsone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dapsone/analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daptomycin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daptomycin, 9 L beta Aspartic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Darier Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Darier%27%s Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dariers Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dark Adaptation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Darkness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Darkness Tremors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Darknesses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dasheen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Adjustments' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Analyses, Statistical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Analysis, Statistical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bank' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bank, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bank, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bank, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Banks' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Banks, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Banks, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Banks, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Base' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Base %28%PT%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Base Management Systems' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Base, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Base, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bases, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Bases, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Collection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Compression' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Compromising' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Correlation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Correlations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Display' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Displays' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data File' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data File, Machine-Readable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Files, Machine-Readable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Interpretation, Statistical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Interpretation, Statistical %28%1988-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Interpretations, Statistical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Linkages' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Monitoring Committee' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Monitoring Committees' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Pooling' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Poolings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Privacy, Patient' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Processing, Automatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Processing, Computer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Processing, Electronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Qualities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data Source' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data and Safety Monitoring Boards' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data collected during dental examination for the purpose of study, diagnosis, or treatment planning.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data processing largely performed by automatic means. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data recorded by nurses concerning the nursing care given to the patient, including judgment of the patient%27%s progress.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data, Cost-Benefit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data, Fraudulent' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data, Molecular Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Data, Molecular Sequencing' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databank' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databank, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databank, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databank, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databank, National Practitioner' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databanks' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databanks, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databanks, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databanks, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databanks, National Practitioner' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database %28%PT%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database %5B%Publication Type%5D%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database Management System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database Management Systems' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Bibliographic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, DNA Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Distributed' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Genetic Information' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Genetic Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Nucleic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Protein Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, Protein Structure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, RNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Database, RNA Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Amino Acid Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Bibliographic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, DNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, DNA Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Factual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Factual %28%1991-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Genetic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Genetic Information' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Genetic Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Nucleic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Nucleic Acid Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Protein Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, Protein Structure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, RNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Databases, RNA Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dataphone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dataphones' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Datura' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Datura stramonium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Datura stramonium %28%1974-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daucus carota' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daughter' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daughter, Adult' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daughters, Adult' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daughters, Radon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daughters, Thoron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dauno Rubidomycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dauno-Rubidomycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daunoblastine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daunomycin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daunorubicin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daunorubicin/analogs %26% derivatives %28%1975-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'David Veterinary Laboratories Brand of Carbaril' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Davur Brand of Dihydroergocristine Monomesylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day Blindness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day Care Centers for Children' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day Dream' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day Surgeries' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day Surgery' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day, Illness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Day, Sick' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daycare Center, Child' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daycare Centers for Children' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daycare Centers, Child' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daydream' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daydreams' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dayflower' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Daylily' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Days commemorating events. Holidays also include vacation periods.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Days, Illness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Days, Sick' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DdsI Endonuclease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'De Lange Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'De Lange%27%s Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'De Quervain Thyroiditis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'De Toni Debre Fanconi Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'De Toni-Debre-Fanconi Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'De novo fat synthesis in the body. This includes the synthetic processes of FATTY ACIDS and subsequent TRIGLYCERIDES in the LIVER and the ADIPOSE TISSUE. Lipogenesis is regulated by numerous factors, including nutritional, hormonal, and genetic elements.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetylase, Histone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. Some of these belong to the SIRTUINS protein family.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetylases, Histone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetylases, NAD-Dependent Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetylases, Sir2-like' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis lanata.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deactivated Toxins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacylase, Acetyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deacylase, Palmitoyl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dead Space, Respiratory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dead Spaces, Respiratory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaf' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaf Mutism' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafferentation Pain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1966%29% /rehabilitation %28%1967-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1966-1979%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1966-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1969-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness %28%1972-2005%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness, Bilateral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness, Cortical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness, Sudden %28%1979-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness/rehabilitation %28%1966-1972%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deafness/rehabilitation %28%1966-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dealkylase, 7-Ethoxycoumarin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dealkylation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dealkylation %28%1973-1975%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dealkylations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deamidase, Nicotinamide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, 5%27%-AMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, AMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Adenosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Adenylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Asparagine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Cytidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Cytosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, DCMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Deoxycytidine Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Deoxycytidylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Ethanolamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Guanine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Histidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Homoserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Myoadenylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Porphobilinogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Serine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminase, Threonine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminases, Nucleoside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminases, Nucleotide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deamination' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaminations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deamino Arginine Vasopressin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deanol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaspartylase, Aspartylglucosylamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death %28%1966-1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death %28%1966-1969%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Camas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Cause' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Causes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Certificate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Certificates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Factors %28%Apoptosis%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Feigning' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Feignings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Penalties' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Penalty' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Protein, bcl-Associated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Rate, Age-Specific' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Rates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Rates, Age-Specific' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death Record' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death and putrefaction of tissue usually due to a loss of blood supply.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death of a bone or part of a bone, either atraumatic or posttraumatic.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death of pulp tissue. When the necrosis is due to ischemia with superimposed bacterial infection, it is referred to as pulp gangrene.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death that occurs as a result of anoxia or heart arrest, associated with immersion in liquid.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Assisted' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Attitude to' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Attitudes to' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Autophagic Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Brain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Cardiac' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Cardiac Sudden' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Cot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Crib' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Embryo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Fetal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Sudden' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Sudden %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Sudden %28%1966-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Sudden Cardiac' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Sudden Infant' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Sudden, Cardiac' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Death, Wrongful' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaths, Assisted' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaths, Autophagic Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deaths, Wrongful' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deazaadenosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deazacyanoadenosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debat, F%C3%%A9%nofibrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debonding, Dental' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrancher Deficiencies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrancher Deficiency' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debranching Enzyme, Glycogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debridement' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debridements' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. %28%From Webster%27%s New Collegiate Dictionary, 1981%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquine 4 Hydroxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquine 4 Monooxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquine 4-Hydroxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquine 4-Monooxygenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Debrisoquine Hydroxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decadron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decadronal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decaject' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decaject L.A.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decaject-L.A.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DecajectL.A.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification, Pathologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decalcification, Pathological' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decameth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decamethonium Compounds' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decanoates' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decanoic Acids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decanoyl CoA-Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decapitation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decapitations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decapoda %28%Crustacea%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decapodiformes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decapods' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarbazine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxycystine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase Complex, Glycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase P-protein, Glycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, 5-Hydroxytryptophan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Adenosylmethionine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, BCKA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Dopa' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Glutamic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Glycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Histidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Hydroxytryptophan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Methylmalonyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, OMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Ornithine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Orotidine-5%27%-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Orotidine-5-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Orotidylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Pyruvate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Pyruvic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, S-Adenosylmethionine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Tryptophan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Tyrosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Uroporphyrinogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylase, Uroporphyrinogen III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylases, Aromatic-L-Amino-Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylated monoamine derivatives of TRYPTOPHAN. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decarboxylations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decaris' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decaspray' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decay Accelerating Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decay, Dental' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decay, Nuclear' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decay, RNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decay, mRNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decay-Accelerating Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deceleration' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decelerations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deception' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deceptions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decerebrate Posturings' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decerebrate Rigidity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decerebrate State' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decerebrate States' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decidua' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decidua %28%1966-2001%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decidual Cell Reactions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduous Dentition' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduous Teeth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduous Tooth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduous plant rich in volatile oil %28%OILS, VOLATILE%29%. It is used as a flavoring agent and has many other uses both internally and topically.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deciduum' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Aid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making %28%1966-1985%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making %28%1966-1986%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making %28%1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making %28%1985-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making, Computer Assisted' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making, Computer-Assisted' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Making, Organizational' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Model' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Models' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Systems, Clinical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Systems, Management' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Support Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Theories' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Theory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Tree' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision Trees' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision, Court' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision, Resuscitation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decision, Supreme Court' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decisions for determining and guiding present and future objectives from among alternatives.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decisions made by the United States Supreme Court. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decisions, Court' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decisions, Resuscitation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decisions, Supreme Court' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Declaration of Helsinki' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Declaration, Helsinki' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Declarations by patients, made in advance of a situation in which they may be incompetent to decide about their own care, stating their treatment preferences or authorizing a third party to make decisions for them. %28%Bioethics Thesaurus%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Declimed Brand of Fluvoxamine Maleate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Declimed Brand of Maprotiline Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decline in value of capital assets of a permanent or fixed nature over time with use.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Declines, Mortality' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompensation, Heart' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression %28%1981-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression Sickness' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression Sickness %28%1966-1978%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression external to the body, most often the slow lessening of external pressure on the whole body %28%especially in caisson workers, deep sea divers, and persons who ascend to great heights%29% to prevent DECOMPRESSION SICKNESS. It includes also sudden accidental decompression, but not surgical %28%local%29% decompression or decompression applied through body openings.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression, Abdominal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression, Explosive' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompression, Surgical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decompressions, Surgical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deconditioning, Cardiovascular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decongestants, Nasal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decontamination' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decoquinate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decorticate Rigidities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decorticate States' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decortication, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decortication, Cerebral Cortex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decortications, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decortications, Cerebral Cortex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decortin Brand of Prednisone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decrease in existing BODY WEIGHT. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decrease, Population' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. %28%From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decreased Bulbocavernosus Reflex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decreased Muscle Tone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decreased Reflex' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decreased salivary flow. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decreases, Population' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dectancyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decubitus Ulcer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decubitus Ulcers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decumbin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decussation, Optic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Decussations, Optic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dedication or commitment shown by employees to organizations or institutions where they work.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dedifferentiated Liposarcoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dedifferentiated Liposarcomas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deductibles and Coinsurance' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deductibles and Coinsurance %28%1968-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Brain Stimulation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Brain Stimulations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Hypothermic Circulatory Arrest' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Peroneal Neuropathies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Peroneal Neuropathy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Vein Thromboses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Venous Thromboses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep Venous Thrombosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep grooves or clefts in the surface of teeth equivalent to class 1 cavities in Black%27%s classification of dental caries.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep-Vein Thromboses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep-Vein Thrombosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep-Venous Thromboses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deep-Venous Thrombosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deeply perforating or puncturing type intraocular injuries.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deer %28%1970-1994%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deer Mice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deer Mouse' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deer Tick' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deer adenoviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deers' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deethylase, Ethoxycoumarin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defecation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defecation %28%1978-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defecations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defecographies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defecography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect of the interventricular septum with severe pulmonary hypertension, hypertrophy of the right ventricle, and latent or overt cyanosis.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Aorticopulmonary Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Aortopulmonary Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Atrial Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Birth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Color Vision' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Congenital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Congenital Ectodermal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Congenital Heart' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Deutan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Endocardial Cushion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Equipment' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Furcation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Heart Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Neural Tube' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Single-Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defect, Ventricular Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Hybrid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Hybrids' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Interfering Particle' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Interfering Particles' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Interfering Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Interfering Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective Viruses %28%1967-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective bone formation involving individual bones, singly or in combination.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective development of the THYROID GLAND. This concept includes thyroid agenesis %28%aplasia%29%, hypoplasia, or an ectopic gland %28%LINGUAL THYROID%29%. Clinical signs usually are those of CONGENITAL HYPOTHYROIDISM.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective nuclei produced during the TELOPHASE of MITOSIS or MEIOSIS by lagging CHROMOSOMES or chromosome fragments derived from spontaneous or experimentally induced chromosomal structural changes.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defective viruses which can multiply only by association with a helper virus which complements the defective gene. Satellite viruses may be associated with certain plant viruses, animal viruses, or bacteriophages. They differ from satellite RNA; %28%RNA, SATELLITE%29% in that satellite viruses encode their own coat protein.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects of color vision are mainly hereditary traits but can be secondary to acquired or developmental abnormalities in the CONES %28%RETINA%29%. Severity of hereditary defects of color vision depends on the degree of mutation of the OPSIN genes %28%on X CHROMOSOME and CHROMOSOME 3%29% that code the photopigments for red, green and blue.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects of coronary arteries or veins including anomalous origin, arteriovenous fistula or aneurysm, myocardial bridging, or other abnormalities of structure or development.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Aorticopulmonary Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Aortopulmonary Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Atrial Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Birth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Color Vision' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Congenital' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Congenital Ectodermal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Congenital Heart' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Endocardial Cushion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Furcation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Heart Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Neural Tube' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Single-Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defects, Ventricular Septal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defender, Public' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defenders, Public' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defenmetrazin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense Mechanisms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense Mechanisms %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense Mechanisms %28%1966-1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense Mechanisms %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense Mechanisms %28%1966-1997%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense mechanisms involving approach and avoidance responses to threatening stimuli. The sensitizing process involves intellectualization in approaching or controlling the stimulus whereas repression involves unconscious denial in avoiding the stimulus.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense, Civil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense, Insanity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defense, Perceptual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defenses, Civil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defenses, Perceptual' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defensins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defensive Medicine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defensive Practice' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defensive Practices' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferens, Ductus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferens, Vas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferoxamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferoxamine B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferoxamine Mesilate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferoxamine Mesylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferoxamine Methanesulfonate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferoximine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deferrioxamine B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defiant Disorder, Oppositional' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillation, Electric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillations, Electric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillator, Automated External' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillator, External' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillator, Implantable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillators' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillators, Automated External' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrillators, Implantable' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defibrol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defic DNA Repair' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defic DNA Repairs' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Antithrombin 3' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Antithrombin III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Ascorbic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Biotinidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Brancher' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Choline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Combined Carboxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Cytochrome Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Cytochrome-c Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Debrancher' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor IX' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor V' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor VII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor VIII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor X' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor XI' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor XII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Factor XIII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Fibrinogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Folic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Fructose-1,6-Bisphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Fructose-1,6-Diphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Fructose-Biphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Fructosediphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, GPD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Glucose-6-Phosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Glucosephosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Glucosephosphate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Hexosediphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Holocarboxylase Synthetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, IgA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, IgG' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Lecithin Acyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Magnesium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Mental' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Multiple Carboxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Muscle Phosphofructokinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Muscle Phosphorylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Oxidative Phosphorylation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Oxygen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, PTA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Potassium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Protein C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Protein S' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Prothrombin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Protoporphyrinogen Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Respiratory Chain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Riboflavin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Smooth Pursuit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Storage Pool' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Thiamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin B12' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin B6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin D' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin E' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, Vitamin K' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, alpha 1-Antitrypsin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiencies, alpha-Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease Hexosaminidase A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, 4 Hydroxyphenol Pyruvic Acid Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Acid Maltase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Alpha Aminoadipic Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Alpha-Aminoadipic Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Apolipoprotein B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Arginase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Argininosuccinate Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Argininosuccinic Acid Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Arylsulfatase A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Aspartoacylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Betalipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Carbamoyl Phosphate Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Carbamoyl Phosphate Synthase %28%Ammonia%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Carbamoyl-Phosphate Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Carbamoylphosphate Synthetase I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Carbamyl Phosphate Synthetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Cerebroside Sulphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Complete HGPRT' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Cystathionine beta Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Cystathionine beta-Synthase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Dihydropteridine Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Familial alpha Lipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Familial alpha-Lipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Fumarylacetoacetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, GM2 Protein Activator' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Galactokinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Galactose 1 Phosphate Uridyl Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Galactose-1-Phosphate Uridyl-Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Galactosylceramidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Galactosylceramide beta Galactosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Galactosylceramide-beta-Galactosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Ganglioside Sialidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Glucocerebrosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Glucosylceramide Beta Glucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Glucosylceramide Beta-Glucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, HDL Lipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Hexosaminidase A and B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Hypoxanthine Phosphoribosyl Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Hypoxanthine-Phosphoribosyl-Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Lysine Alpha Ketoglutarate Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Lysine Alpha-Ketoglutarate Reductase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Lysosomal alpha-1,4-Glucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Microsomal Triglyceride Transfer Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Multiple Sulfatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Multiple Sulphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Ornithine Carbamoyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Ornithine Transcarbamylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, PDHC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Phenylalanine Hydroxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Phenylalanine Hydroxylase, Severe' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Pyruvate Carboxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Saccharopine Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Sphingomyelinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, Tyrosine Transaminase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, UDP Galactose 4 Epimerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, UDP-Galactose-4-Epimerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, UDPglucose 4 Epimerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, UDPglucose 4-Epimerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, alpha Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, alpha High Density Lipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, alpha High-Density Lipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, alpha L Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, alpha-Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Disease, alpha-L-Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Arginase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Aspartoacylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Betalipoprotein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Fumarylacetoacetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Galactosylceramidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Galactosylceramide-beta-Galactosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Glucocerebrosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Hypoxanthine-Phosphoribosyl-Transferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, PDHC' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, Sphingomyelinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, UDP-Galactose-4-Epimerase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, alpha-Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases, alpha-L-Fucosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Diseases/veterinary %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndrome, Antibody' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndrome, Immunologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndrome, Immunological' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndrome, Leukocyte Adhesion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndrome, Leukocyte-Adhesion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndrome, Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndromes, Antibody' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndromes, Immunologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndromes, Immunological' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndromes, Leukocyte-Adhesion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency Syndromes, Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency in the number of spermatozoa in semen. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency of sodium in the blood; salt depletion. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN, leading primarily to degradation of elastin of the alveolar walls, as well as other structural proteins of a variety of tissues. %28%From Scriver, Beaudet, Sly, %26% Valle, The Metabolic and Molecular Bases of Inherited Disease, 7th ed, p4125%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Antithrombin 3' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Antithrombin III' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Argininosuccinic Acid Synthetase, Complete' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Argininosuccinic Acid Synthetase, Partial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Ascorbic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Biotinidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Brancher' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Choline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Combined Carboxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Coproporphyrinogen Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Cytochrome Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Cytochrome c Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Cytochrome-c Oxidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Debrancher' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor II' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor IX' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor V' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor VII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor VIII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor X' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor XI' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor XII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Factor XIII' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Fibrinogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Folic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Fructose-1,6-Bisphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Fructose-1,6-Diphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Fructose-Biphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Fructosediphosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, GPD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Glucose-6-Phosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Glucosephosphatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Glucosephosphate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Holocarboxylase Synthetase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, IgA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, IgG' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Lecithin Acyltransferase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Magnesium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Multiple Carboxylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Multiple Carboxylase, Late-Onset' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Multiple Carboxylase, Neonatal Form' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Muscle Phosphofructokinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Muscle Phosphorylase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Oxidative Phosphorylation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Oxygen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, PTA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Platelet Storage Pool' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Potassium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Protein' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Protein C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Protein S' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Prothrombin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Pyridoxine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Respiratory Chain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Riboflavin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Smooth Pursuit' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Storage Pool' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Stuart Prower' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Stuart Prower Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Stuart-Prower' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Stuart-Prower Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Thiamine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin B' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin B 12' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin B 6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin B12' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin B6' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin C' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin D' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin E' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Vitamin K' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Yang' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, Yin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, alpha 1-Antitrypsin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, alpha-Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiency, beta-Mannosidase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiens Agamous Like Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiens Agamous Related Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficiens-Agamous-Related Proteins' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficient oxygenation of FETAL BLOOD. ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficit Disorder, Attention' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficit Disorders, Attention' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficit, Focal Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficit, Memory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficit, Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficits, Focal Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficits, Memory' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deficits, Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Defoliants, Chemical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformability, Erythrocyte' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformed Pupils' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deforming Chondrodysplasia, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deforming Chondrodysplasias, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities acquired after birth as the result of injury or disease. The joint deformity is often associated with rheumatoid arthritis and leprosy.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities in nail structure or appearance, including hypertrophy, splitting, clubbing, furrowing, etc.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities of the hand, or a part of the hand, acquired after birth as the result of injury or disease.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities of the nose acquired after birth from injury or disease.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Acquired Ear' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Acquired Foot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Acquired Hand' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Acquired Joint' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Acquired Nose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Cavus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Congenital Foot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Congenital Hand' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Congenital Limb' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Equinus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Foot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Hand' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformities, Metatarsal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Acquired Ear' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Acquired Foot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Acquired Hand' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Acquired Joint' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Acquired Nose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Arnold-Chiari' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Cavus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Congenital Foot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Congenital Hand' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Congenital Limb' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Equinus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Foot' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Hand' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deformity, Metatarsal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deftan' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration of white matter adjacent to the CEREBRAL VENTRICLES following cerebral hypoxia or BRAIN ISCHEMIA in neonates. The condition primarily affects white matter in the perfusion zone between superficial and deep branches of the MIDDLE CEREBRAL ARTERY. Clinical manifestations include VISION DISORDERS; CEREBRAL PALSY; PARAPLEGIA; SEIZURES; and cognitive disorders. %28%From Adams et al., Principles of Neurology, 6th ed, p1021; Joynt, Clinical Neurology, 1997, Ch4, pp30-1%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Corticostriatal-Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Familial Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Frontotemporal Lobar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Hepatocerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Hepatolenticular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Hereditary Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Inherited Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Juvenile Cerebroretinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Macular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Nerve' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Neurohepatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Neuron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Nissl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Olivo-Ponto-Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Olivopontocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Paraneoplastic Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Pigmentary Pallidal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Primary Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Progressive Lenticular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Retinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Retrograde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Spino Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Spino-Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Striatonigral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Tapetoretinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Trans-Synaptic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Transneuronal Retrograde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degeneration, Wallerian' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Corticostriatal-Spinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Familial Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Frontotemporal Lobar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Hepatocerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Hereditary Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Inherited Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Juvenile Cerebroretinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Macular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Nerve' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Neurohepatic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Neuron' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Olivo-Ponto-Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Olivopontocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Pigmentary Pallidal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Primary Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Retinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Retrograde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Spino Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Spino-Cerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Spinocerebellar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Tapetoretinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Trans-Synaptic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerations, Transneuronal Retrograde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Arthritides' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Arthritis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Condition, Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Conditions, Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Disease, Nervous System, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Diseases, Nervous System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Diseases, Neurologic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Hereditary Diseases, Nervous System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Hereditary Disorders, Nervous System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Myopia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Myopias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Neurologic Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Neurologic Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Neurologic Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Neurologic Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Retinoschises' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative Retinoschisis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative changes in the macula lutea of the retina.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative or inflammatory conditions affecting the central or peripheral nervous system that develop in association with a systemic neoplasm without direct invasion by tumor. They may be associated with circulating antibodies that react with the affected neural tissue. %28%Intern Med 1996 Dec;35%28%12%29%:925-9%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degenerative, acquired lesions consisting of distorted, dilated, thin-walled vessels lined by vascular endothelium. This pathological state is seen especially in the gastrointestinal tract and is frequently a cause of upper and lower gastrointestinal hemorrhage in the elderly.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deglutition' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deglutition Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deglutition Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deglutitional Syncope' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deglutitional Syncopes' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deglutitions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degort%27%s Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degort%27%s Brand of Mebendazole' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degos Acanthoma' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degradation Products, Fibrin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degradation, RNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degradation, Soil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degradation, mRNA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degradation, mRNA Transcript' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degranulation Test, Basophil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degranulation Tests, Basophil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Degranulation, Cell' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehiscence, Surgical Wound' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehumanisation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehumanization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrase, Carbamoylaspartic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrase, Diol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrase, Threonine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrases, beta-Hydroxyacyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Aminolevulinic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Carbonate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Chorismate Mutase-Prephenate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Diol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Homoserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, L-Serine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Prephenate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Propanediol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Serine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Serine-Threonine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, Threonine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, delta-Aminolevulinate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratase, delta-Aminolevulinic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratases, 3-Hydroxyacyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydratases, beta-Hydroxyacyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydration' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroascorbatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroascorbic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrobilirubin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrocholate, Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrocholesterols' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrocholic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrocortisone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroepiandrosterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroepiandrosterone Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroepiandrosterone Sulfate Sulfatase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase Complex, 2-Oxoglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase Complex, Ketoglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase Complex, Pyruvate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase Complex, alpha-Ketoglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase Deficiencies, Glucosephosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase Deficiency, Glucosephosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase E1, Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase E2, Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 1-Pyrroline-5-Carboxylate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 11 beta-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 11-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 11B-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 11beta-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 17 beta-Estradiol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 2-AMS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 2-Aminomuconic 6-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 2-Keto-4-Hydroxyglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 2-Oxoglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 2-Oxoisocaproate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 2-Oxoisovalerate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 20-beta-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 3 alpha-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 3 beta-Hydroxy-delta-5-Steroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 3-Hydroxybutyrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 3-Isopropylmalate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 3-Phosphoglycerate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 3-beta-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 5-Ene-3 beta-hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, 6-Phosphogluconate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Acetoin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Acyl-ACP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Acyl-coenzyme A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Alanine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Alcohol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Alpha-Glycerophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Alpha-Keto Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Aminoadipate-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Aminomuconate-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Ascorbino' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Aspartate-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Aspartokinase Homoserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Betaine Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Betaine-Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Branched-Chain Oxo-Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Butyryl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Butyryl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Butyryl-Coenzyme A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Choline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Chorismate Mutase-Prephenate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Complex I' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Cytosolic Retinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, D-3-Hydroxybutyrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, D-3-Phosphoglycerate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, D-Amino Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, D-Glucuronolactone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, D-Mannonate-NAD' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, D-beta-Hydroxybutyrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Decanoyl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Dihydrofolate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Dihydrolipoamide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Dihydrolipoyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Dihydropyrimidine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Dihydrouracil' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Dimethylglycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Estradiol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Fatty-acyl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, GGS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glucose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glucose-6-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glucosephosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutamate 5-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutamate-5-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutamate-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutamic-Gamma-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutamyl-Gamma-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutaryl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutaryl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glutaryl-Coenzyme A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glyceraldehydephosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glycerol-3-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glycerolphosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glycerophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glycol Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Glycolaldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Homoserine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Hydroxybutyrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Hydroxyprostaglandin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Hypoxanthine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, IMP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Iditol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Inosine-5-Monophosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Inosinic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Isocitrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Isovaleryl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Isovaleryl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Isovaleryl-Coenzyme A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, L-Alanine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, L-Aminoadipate Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, L-Aminoadipate-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, L-Gulono-Gamma-Lactone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, L-Lactate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, L-Leucine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Lactate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Leucine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Lipoamide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Lipoic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Lipoyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Long-Chain Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Long-Chain-Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Long-Chain-Acyl-Coenzyme A' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, MMSA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Malate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Malic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Mannitol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Medium-Chain Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Methylenetetrahydrofolate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Monomethylglycine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NAD Isocitrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NAD-Dependent Glyceraldehyde-3-phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NAD-Dependent Xylitol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NAD-Formate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NAD-Malate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADH' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP+-Dependent Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP-Dependent Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP-Dependent Valine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP-Linked Benzaldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP-Malate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADP-Specific Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADPH' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, NADPH-Dependent Glutamate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Octanoyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Oxoglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Palmitoyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Phosphogluconate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Phosphoglyceraldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Phosphoglycerate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Phosphorylating Glyceraldehyde-3-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Polyol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Prephenate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Proline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Prostacyclin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Protoporphyrinogen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Retinal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Sarcosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Semiaspartate Aldehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Short-Chain Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Sorbitol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Succinate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Succinate Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Succinate-Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Succinic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Succinic Semialdehyde' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Sulfite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Sulphite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Tetrahydrofolate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Triosephosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, UDP Glucose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, UDPG' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Valine Lipoamide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Very-Long-Chain Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Xanthine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Xylitol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, Yeast Alcohol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, alpha-Ketoglutarate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, alpha-Ketoisovalerate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, beta-Hydroxyacyl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, beta-IPM' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase, beta-Isopropylmalate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenase-CoQ Reductase, Succinate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 11-beta-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 17 beta-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 17-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 20 Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 20-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 3 Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 3-Hydroxyacyl CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, 3-Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Acyl-CoA' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Carbohydrate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Estradiol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Formate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Galactose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Glucose' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Glyceraldehyde-3-Phosphate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Hydroxyprostaglandin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Hydroxysteroid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Lactate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Saccharopine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Sugar Alcohol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Sulfite' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, Testosterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogenases, beta-Hydroxyacyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydrogesterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroisoandrosterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydroisoandrosterone Sulfate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dehydromethyltestosterone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deinococcus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deinstitutionalization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deinstitutionalized Person' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiodase, Iodotyrosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiodinase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiodinase, Iodothyronine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiodinase, Iodotyrosine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiodinase, Triiodothyronine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiter Nucleus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiter%27%s Nucleus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deiters Nucleus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deja Vu' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deja Vu %28%1968%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dejerine Lichtheim Phenomenon' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dejerine Roussy Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dejerine Sottas Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dejerine Thomas Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dejerine-Sottas Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dejerine-Thomas Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dekasol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dekasol L.A.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dekasol-L.A.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'DekasolL.A.' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Del Brand of Dimenhydrinate' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deladande, Levothyroxin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delagrange Brand of Aminocaproic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delalande Brand of Chymotrypsin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delalande Brand of Levothyroxine Sodium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delalande, Levothyroxin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delavirdine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delaware' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delay in the attachment and implantation of BLASTOCYST to the uterine ENDOMETRIUM. The blastocyst remains unattached beyond the normal duration thus delaying embryonic development.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delay, Speech' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Action Preparations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Blastocyst Implantation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Blastocyst Implantations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Effects, Prenatal Exposure' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Embryo Implantation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Embryo Implantations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Fertilization' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Fertilizations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Graft Function' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Hypersensitivities' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Hypersensitivity' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Memories' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Nidation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Nidations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Onset Post Traumatic Stress Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Ovum Implantation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Ovum Implantations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Puberty' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Rectifier Potassium Channels' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed Rectifying Potassium Channels' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed-Action Preparation' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed-Action Preparations' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed-Action Preparations %28%1966-1974%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delayed-Action Preparations %28%1966-1987%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delays, Speech' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delegation, Personnel' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delegation, Professional' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion Syndrome, 5p' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion Syndromes, 5p' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion of Short Arm of Chromosome 5 Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion of sequences of nucleic acids from the genetic material of an individual.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion, Chromosome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion, Clonal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion, Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion, Out-of-Frame' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletion, Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletions, Chromosome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletions, Clonal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletions, Gene' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletions, Out-of-Frame' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deletions, Sequence' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delftia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delftia acidovorans' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delgamer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate Self Harm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate Self-Harm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate and planned acts of unlawful behavior engaged in by aggrieved segments of the population in seeking social change.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate introduction of air into the peritoneal cavity.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate introduction of air or gas into the mediastinum as an aid to examination and diagnosis.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate maltreatment of groups of humans beings including violations of generally-accepted fundamental rights as stated by the Universal Declaration of Human Rights, adopted and proclaimed by the United Nations General Assembly resolution 217 A %28%III%29% of 10 December 1948.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate prevention or diminution of the host%27%s immune response. It may be nonspecific as in the administration of immunosuppressive agents %28%drugs or radiation%29% or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate severe and repeated injury to one domestic partner by the other.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate stimulation of the host%27%s immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts %28%e.g., transfer factor, immune RNA%29% or transplantation of immunocompetent cell producing tissue %28%thymus or bone marrow%29%.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliberate, often repetitive, physical abuse by one family member against another: marital partners, parents, children, siblings, or any other member of a household.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delinquency, Juvenile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delirium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delirium Tremens' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delirium Tremens, Alcohol Withdrawal Induced' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delirium, Alcohol Withdrawal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delirium, Dementia, Amnestic, Cognitive Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delirium, Subacute' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliriums, Subacute' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliveries, Abdominal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliveries, Healthcare' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliveries, Home' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliveries, Obstetric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deliveries, Vacuum Extraction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery %28%1966-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery %28%1972-2002%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery %28%1980-1990%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery Room' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery Rooms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery System, Drug' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery System, Integrated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery Systems, Drug' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery Systems, Integrated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of Health Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of Health Care %28%1970-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of Health Care %28%1971-1977%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of Health Care %28%1985-1995%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of Health Care, Integrated' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of Healthcare' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of an infant through the vagina in a female who has had a prior cesarean section.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery of the FETUS and PLACENTA under the care of an obstetrician or a health worker. Obstetric deliveries may involve physical, psychological, medical, or surgical interventions.%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Abdominal' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Dental Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Health Care' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Healthcare' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Home' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Obstetric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delivery, Vacuum Extraction' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delix' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphi Study' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphi Technic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphi Technics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphi Technique' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphi Techniques' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphinapterus leucas' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphinidae' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphinium' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphinus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphinus capensis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delphinus delphis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta 5 Androstenediol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta 5-Androstenediol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta 6 Desaturase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta 6 FADTase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta 6 Fatty Acid Desaturase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Agent' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Agents' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Aminolevulinic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Brand of Methoxsalen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Element' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Hepatitides, Chronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Hepatitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Hepatitis, Chronic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Pharma Brand of Polygeline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Rhythm' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Rhythms' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Sleep Inducing Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Sleep Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Sleep-Inducing Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Superinfection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Superinfections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Transcription Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Virus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Virus, Hepatitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Viruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta Viruses, Hepatitis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta%28%1%29%-Pyrroline-5-Carboxylate Dehydrogenase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta%28%6%29%-Desaturase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-6 Fatty Acid Desaturase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-6-Desaturase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-6-Desaturase, Fatty Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-6-FADTase' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-Aminolevulinic Acid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-Pharma Brand of Polygeline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-Sleep Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-Sleep-Inducing Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delta-Sleep-Inducing-Peptide' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaproteobacteria' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaproteobacteria %28%2000-2003%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaretrovirus' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaretrovirus Antibodies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaretrovirus Antigens' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaretrovirus Infection' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaretrovirus Infections' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Deltaviruses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delusion' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delusional Disorder' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delusional Disorders' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delusions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Delusions %28%1983-1991%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demanol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demanyl' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demeclocycline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demecolcine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia %28%1966-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia %28%1981-1988%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia %28%1983-1989%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia Complex, AIDS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia Complex, AIDS Related' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia Complex, AIDS-Related' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia Complex, Acquired Immune Deficiency Syndrome' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia With Amyotrophic Lateral Sclerosis' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Alzheimer Type' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Arteriosclerotic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, HIV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Lacunar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Lewy Body' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Multi Infarct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Multi-Infarct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Multi-Infarct %28%1994-2004%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Multiinfarct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Presenile Alzheimer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Primary Senile Degenerative' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Semantic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Senile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Subcortical Vascular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Transmissible' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia, Vascular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementia/etiology %28%1968-1999%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Arteriosclerotic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Familial' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, HIV' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Lacunar' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Multi-Infarct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Multiinfarct' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Presenile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Semantic' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Senile' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Senile Paranoid' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Subcortical Vascular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Transmissible' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Dementias, Vascular' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethyl Epipodophyllotoxin Ethylidine Glucoside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethyl Epipodophyllotoxin Thenylidine Glucoside' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylase, Aminopyrine N' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylase, Caffeine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylase, Ethylmorphine N' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylase, Nitroanisole O' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylating Oxidoreductases, N' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylating Oxidoreductases, O' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylchlortetracycline' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethyldaunomycin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethyldaunorubicin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethyldiazepam' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demethylimipramine' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demetrin' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demineralization Technic, Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demineralization Technics, Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demineralization Technique, Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demineralization Techniques, Bone' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demineralization, Tooth' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Democracies' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Democracy' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Democratic Republic of Germany' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Democratic Republic of Timor-Leste' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Democratic Republic of the Congo' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Democratic Yemen' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographer' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Analyses' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Factor' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Factors' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Impact' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Impacts' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Survey' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Surveys' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic Transitions' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographic and epidemiologic changes that have occurred in the last five decades in many developing countries and that are characterized by major growth in the number and proportion of middle-aged and elderly persons and in the frequency of the diseases that occur in these age groups. The health transition is the result of efforts to improve maternal and child health via primary care and outreach services and such efforts have been responsible for a decrease in the birth rate; reduced maternal mortality; improved preventive services; reduced infant mortality, and the increased life expectancy that defines the transition. %28%From Ann Intern Med 1992 Mar 15;116%28%6%29%:499-504%29%%A% ' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographics' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographies, Family' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographies, Historical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demographies, Prehistoric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demography' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demography %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demography %28%1966-1996%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demography, Family' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demography, Historical' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demography, Prehistoric' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demosterol' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Disease, Peripheral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Diseases, Brain' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Diseases, CNS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Diseases, Central Nervous System' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Diseases, Cerebral' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Diseases, Spinal Cord' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Autoimmune Disorders, CNS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Central Nervous System Diseases, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Disease' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Disease, Autoimmune, CNS' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Disease, Peripheral Autoimmune' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases %28%1966-1967%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases %28%1966-1970%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases %28%1966-1971%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases %28%1966-1982%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases %28%1966-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases %28%1967-1993%29%' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Diseases, Central Nervous System, Hereditary' = 0).
% 42.08/42.03 fof(interp, fi_functors, 'Demyelinating Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Demyelinating Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Demyelinating Polyradiculoneuropathy, Acute Inflammatory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Demyelinating leukoencephalomyelitis of sheep caused by the VISNA-MAEDI VIRUS. It is similar to but not the same as SCRAPIE.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Demyelinations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denaturation, Nucleic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denaturation, Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denaturations, Nucleic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denaturations, Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendrimers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendrite' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendrites' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendrites %28%1973-2004%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cell, Follicular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cell, Interdigitating' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cells' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cells %28%1987-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cells, Follicular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Cells, Interdigitating' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Compounds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Keratitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Keratitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Spine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendritic Spines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendroaspis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendrobium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dendrons' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation %28%1966-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation %28%1970-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation, Autonomic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation, Chemical Sympathetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation, Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation, Parasympathetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation, Sympathetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervation, Sympathetic, Chemical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervations, Autonomic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervations, Chemical Sympathetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervations, Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervations, Parasympathetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denervations, Sympathetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dengue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dengue %28%1966-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dengue Fever' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dengue Hemorrhagic Fever' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dengue Virus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dengue Viruses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denial %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denials %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denmark' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dennstaedtiaceae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dens Axis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dens in Dente' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dens in Dentes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dense Core Vesicle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dense collection of cells in the caudal pontomesencephalic tegmentum known to play a role in the functional organization of the BASAL GANGLIA and in the modulation of the thalamocortical neuronal system.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dense fibrous layer formed from mesodermal tissue that surrounds the epithelial enamel organ. The cells eventually migrate to the external surface of the newly formed root dentin and give rise to the cementoblasts that deposit cementum on the developing root, fibroblasts of the developing periodontal ligament, and osteoblasts of the developing alveolar bone.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densities, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densities, Population' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densitometries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densitometry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densitometry %28%1966-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densitometry, X Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densitometry, X-Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densitometry, Xray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Density Gradient Centrifugation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Density Gradient Centrifugations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Density, Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Density, Bone Mineral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Density, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Density, Population' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densovirinae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densovirus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Densoviruses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Abrasion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Abutment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Abutments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Acid Etching' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Air Abrasion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Air Abrasions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Alloy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Alloys' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Alloys %28%1971-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Alloys %28%1988-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Alveolus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Amalgam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Amalgams' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Anesthesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Anxieties' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Anxiety' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Arch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Arches' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Articulator' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Articulators' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Assistant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Assistants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Assistants %28%1966-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Associateship Practice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Associateship Practices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Association, American' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Attrition' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Audit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Audits' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Auxiliaries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Auxiliaries %28%1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Auxiliary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Bonding' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Bonding %28%1976-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Bonding %28%1977-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Bonding %28%1982-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Bridgework' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Bridgeworks' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Calculus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care %28%1973-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care %28%1973-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care %28%1973-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care %28%1977-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care Delivery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care Plan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care Plans' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Aged' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Children' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Chronically Ill' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Disabled' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Disabled %28%1980-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Elderly' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care for Handicapped' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care, Comprehensive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Care, Prepaid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries %28%1966-1986%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries %28%1966-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries Activity Tests' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries Resistance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries Susceptibility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Caries Susceptibility %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Casting Investment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Casting Investments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Casting Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Casting Technics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Casting Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Casting Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Liner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Liners' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Lining' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Linings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparation %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparation %28%1966-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparation %28%1967-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparation %28%1981-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparation %28%1996-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cavity Preparations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cements' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cements %28%1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cements %28%1972-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cements %28%1974-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cements %28%1988-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cementum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Cementum %28%1967-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Centric Relation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Clasp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Clasps' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Clinic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Clinics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Crown' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Crowns' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Debonding' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Decay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Deposit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Deposits' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Devices, Home Care' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Dictionaries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Dictionary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Digital Radiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Disinfectants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Dowels' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Economics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Education' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Education, Continuing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Education, Graduate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Educations, Continuing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamel %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamel Hypoplasia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamel Permeability' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamel Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamel Solubility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Enamels' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Equipment %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Equipments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Esthetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Esthetics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Etching' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Ethic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Ethics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Facilities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Facility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Faculties' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Faculty' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fears' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fee' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fees' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Filling, Permanent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Filling, Temporary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fillings, Permanent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Finishing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fissure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fissures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fistula' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fistulas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Floss' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fluoroses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Fluorosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Focal Infection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Focal Infections' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Follicle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Follicles' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Formularies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Formulary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental General Practice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental General Practices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Granuloma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Group Practice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Group Practices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Handpiece' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Handpieces' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Health Education' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Health Service' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Health Services' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Health Services %28%1978-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Health Survey' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Health Surveys' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High Speed Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High Speed Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High Speed Technics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High Speed Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High Speed Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High-Speed Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High-Speed Equipments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High-Speed Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High-Speed Technics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High-Speed Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental High-Speed Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Hygiene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Hygienist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Hygienists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Hypnoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Hypnosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implant, Single Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implant, Single-Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation %28%1966-1970%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation %28%1966-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation %28%1966-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation, Endosseous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation, Endosseous %28%1977-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation, Endosseous, Endodontic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation, Osseointegrated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implantation, Subperiosteal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implants %28%1990-1995%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implants %28%1990-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implants, Single Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Implants, Single-Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Impression Material' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Impression Materials' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Impression Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Impression Technics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Impression Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Impression Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Infection Control' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Infection Controls' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Informatics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Inlay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Inlays' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Instrument' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Instruments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Insurance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Internship' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Internships' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Journalism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Laboratories' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Laboratory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Laminate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Laminates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Leakage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Leakages' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Legislation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Libraries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Library' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Licensure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Licensures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Marginal Adaptation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Marginal Adaptations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Material' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials %28%1966-1970%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials %28%1966-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Materials %28%1966-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Medicaid Programs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Microabrasion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Microabrasions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Model' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Models' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Nurse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Nurses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion, Balanced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion, Balanced %28%1993-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion, Centric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion, Centric %28%1966-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusion, Traumatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusions, Balanced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Occlusions, Traumatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Office' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Offices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Onlay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Onlays' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Papilla' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Papillae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Partnership Practice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Partnership Practices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Peg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pegs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pellicle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Permanent Filling' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Philosophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Philosophy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Phobia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Phobias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Photography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Physiologies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Physiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Plaque' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Plaque %28%1966-1982%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Plaque Index' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Plaque Indexes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Plaque Indices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Polishing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Porcelain' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Porcelain %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Practice Management' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Practice Pattern' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Practice Patterns' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Practice Purchase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prophylaxis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prophylaxis %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prostheses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prostheses, Implant-Supported' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prostheses, Interim' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prostheses, Temporary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis %28%1966-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Design' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Design %28%1970-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Designs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Failures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Implantation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Implantations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Repair' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Repairs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Retention' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis Retention %28%1966-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis, Implant Supported' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis, Implant-Supported' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis, Interim' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis, Surgical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Prosthesis/AE %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Autolyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Calcification' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Calcifications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Capping' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Cappings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Cavities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Cavity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Cavity %28%1981-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Devitalization' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Exposure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Gangrene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Necroses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Necrosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Stones' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Test' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulp Tests' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Pulps' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Radiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Receptionists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Record' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Records' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Records %28%1967%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Residencies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Residency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration Failure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration Failures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration Wear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration, Permanent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration, Permanent %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration, Permanent %28%1967-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restoration, Temporary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restorations, Permanent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Restorations, Temporary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Root Cyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Root Cysts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Sac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Sacs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Scaling' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental School' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Schools' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Sealants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Service, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Service, Hospital %28%1966-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Services, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Slotted Attachment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Slotted Attachments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Societies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Society' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Soldering' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Specialties' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Specialty' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Staff' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Staff, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Staffs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Staffs, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Stone, Artificial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Stress Analyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Stress Analysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Stress Analysis %28%1968-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Student' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Students' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technic, High Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technic, High-Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technician' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technicians' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technicians %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technics, High Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technics, High-Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technique, High Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technique, High-Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Techniques, High Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Techniques, High-Speed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Technology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Tissue Conditioning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Tissue Neoplasm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Tissue Neoplasms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Veneer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Veneers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Wastes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Welding' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental Weldings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental White Spots' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental care for patients with chronic diseases. These diseases include chronic cardiovascular, endocrinologic, hematologic, immunologic, neoplastic, and renal diseases. The concept does not include dental care for the mentally or physically disabled which is DENTAL CARE FOR DISABLED.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental care for the emotionally, mentally, or physically disabled patient. It does not include dental care for the chronically ill %28% = DENTAL CARE FOR CHRONICALLY ILL%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental caries involving the tooth root, cementum, or cervical area of the tooth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental cements composed either of polymethyl methacrylate or dimethacrylate, produced by mixing an acrylic monomer liquid with acrylic polymers and mineral fillers. The cement is insoluble in water and is thus resistant to fluids in the mouth, but is also irritating to the dental pulp. It is used chiefly as a luting agent for fabricated and temporary restorations. %28%Jablonski%27%s Dictionary of Dentistry, 1992, p159%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental occlusion in which the occlusal contact of the teeth on the working side of the jaw is accompanied by the harmonious contact of the teeth on the opposite %28%balancing%29% side. %28%From Jablonski, Dictionary of Dentistry, 1992, p556%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental personnel practicing in hospitals. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental technicians who provide dentures for patients without benefit of a dentist%27%s professional services. Their duties include taking impressions and bite registrations for preparing and repairing dentures and fitting dentures. They are rarely found in the United States, where their practice is illegal in many states, but are becoming increasingly common in Canada.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental, Implant-Supported Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dental, Interim Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentali, Alveolus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentalis, Alveolus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentals, Implant-Supported Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentals, Interim Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentata, Fascia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Cerebellar Ataxia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Cerebellar Ataxias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Cerebellar Atrophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Cerebellar Atrophy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Fascia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Gyrus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentate Nucleus Syndrome, Ramsay Hunt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentatorubral Pallidoluysian Atrophy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentatorubral-Pallidoluysian Atrophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dente, Dens in' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentes, Dens in' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denticle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denticles' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentifrices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentifrices %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentigerous Cyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentigerous Cysts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin %28%1966-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin %28%1981-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Bonding Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Dysplasia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Dysplasias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Hypersensitivities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Hypersensitivity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Permeabilities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Permeability' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Sensitivities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Sensitivity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Solubilities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin Solubility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin formed by normal pulp after completion of root end formation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin, Hereditary Opalescent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin, Secondary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentin-Bonding Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentinal Fluid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentinal Fluids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentinogeneses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentinogenesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentinogenesis Imperfecta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentinogenesis Imperfectas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentins, Hereditary Opalescent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentins, Secondary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist Patient Relations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist Patient Relationship' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist Patient Transmission' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist Practice Patterns' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist%27%s Practice Pattern' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist%27%s Practice Patterns' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist, Woman' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist-Patient Relation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist-Patient Relations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist-Patient Relationship' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist-Patient Relationships' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentist-Patient Transmission' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, Cosmetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, History' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, Industrial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, Military' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, Occupational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, Preventive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, School' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, Socialized' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistries, State' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry %28%1966-1967%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry %28%1966-1995%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry %28%1966-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry Chronically Ill' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry Histories' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry History' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry for Aged' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry for Children' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry for Handicapped' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Community' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Cosmetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Forensic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Geriatric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, History' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Military' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Occupational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Operative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Operative/instrumentation %28%1977-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Pediatric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Preventive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Public Health' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, School' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, Socialized' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentistry, State' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentists Practice Patterns' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentists, Woman' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentists, Women' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition %28%1966-1970%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition %28%1966-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition %28%1966-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Adult' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Deciduous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Mixed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Permanent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Primary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Secondary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentition, Transitional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentitions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentitions, Mixed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentitions, Transitional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentoalveolar Abscess, Apical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentoalveolar Abscesses, Apical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentoalveolar Ankyloses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentoalveolar Ankylosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentoalveolar Cyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentoalveolar Cysts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentsply Brand of Mepivacaine Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Base' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Bases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Clasp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Clasps' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Cleansers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Design' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Design %28%1970-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Designs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Identification Marking' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Identification Markings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Liner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Liners' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Precision Attachment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Precision Attachments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Rebasing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Rebasings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Relinings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Repair' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Repair %28%1972-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Repairs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Retention' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Retention %28%1990-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Stomatitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture Stomatitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Complete' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Complete %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Complete, Immediate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Complete, Lower' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Complete, Upper' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Fixed Partial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Implant Supported' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Implant-Supported' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Overlay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Fixed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Fixed %28%1982-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Fixed, Resin-Bonded' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Immediate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Removable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Removable %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Removable %28%1966-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Partial, Temporary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denture, Precision Attachment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures %28%1991-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures, Complete' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures, Fixed Partial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures, Implant-Supported' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures, Overlay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures, Partial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dentures, Precision Attachment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denturist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denturists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denys Drash Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Denys-Drash Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deodorants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deodorants %28%1965-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deontological Ethic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxy Sugars' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxy Sugars %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenine Nucleotides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenosine %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenosine Phosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenosine/analogs %26% derivatives %28%1975-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenosinecobalamins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenosines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadenosines %28%1986-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyadrenaline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholate, Glycine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholate, Taurine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholic Acid %28%1973-1974%29% /analogs %26% derivatives %28%1975-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholic Acid %28%1973-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholic Acid, 12beta Isomer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholic Acid, 3beta Isomer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholic Acid, 5alpha Isomer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholylglycine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycholyltaurine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycoformycin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycorticosterone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine %28%1973-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine %28%dihydrogen phosphate%29%. A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2%27%-,3%27%- or 5- positions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine Monophosphate %28%1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine Monophosphate Deaminase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine Phosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidine/analogs %26% derivatives %28%1986-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidylate Aminohydrolase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidylate Deaminase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytidylic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxycytosine Nucleotides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxydemoxepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxydexamethasone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyephedrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyepinephrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxygalactose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxygenated Sickle Hemoglobin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyglucose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyglucose/analogs %26% derivatives %28%1978-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyguanine Nucleotides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyguanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyguanosine Phosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyguanylate Cyclase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxymannose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxynucleoside Diphosphate Kinases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxynucleotidyl Transferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxynucleotidyl Transferase, Terminal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxynucleotidyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxypyrimidine Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribodipyrimidine Photo Lyase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribodipyrimidine Photo-Lyase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribodipyrimidine Photolyase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyriboendonuclease IV' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease %28%Pyrimidine Dimer%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease BamHI' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease BstI' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease EcoRI' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease HindIII' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease HpaII' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease IV %28%Phage T4-Induced%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease S1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonuclease, RecBC' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases %28%1966-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases %28%1966-1982%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases %28%1975-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type I Site Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type I Site-Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type I, Site Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type I, Site-Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type II Site Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type II Site-Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type II Site-Specific %28%1989-1995%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type II, Site Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type II, Site-Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type III Site Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type III Site-Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type III, Site Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleases, Type III, Site-Specific' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of ALGAE.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of CHLOROPLASTS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of archaea.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of bacteria.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of fungi.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of helminths.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of plants.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of protozoa.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleic acid that makes up the genetic material of viruses.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleoproteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleoside, Cytosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleosides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleosides %28%1971-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleosides %28%1971-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleosides %28%1973-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleosides, Adenine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleotides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleotides %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleotides %28%1973-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleotides %28%1973-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleotidyl Transferase, Terminal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribonucleotidyltransferase, Terminal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyriboside, Bromouracil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyriboside, Cytosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyriboviruses, Icosahedral Cytoplasmic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribozyme' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyribozymes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxythymidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxythymidine Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyuracil Nucleotides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyuridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyuridine %28%1966-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyuridine Phosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deoxyursocholic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depakine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department of Agriculture %28%U.S.%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department of Health and Human Services' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department of Health and Human Services %28%U.S.%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Admitting' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Anesthesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Admitting' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Anesthesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Anesthesia-Resuscitation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Education' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Pathology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Psychiatric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Radiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Surgery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Hospital Urology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Medical Records' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, Obstetrics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Department, X Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Admitting' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Anesthesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Admitting' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Anesthesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Anesthesia-Resuscitation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Education' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Pathology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Psychiatric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Radiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Surgery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Hospital Urology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Medical Records' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, Obstetrics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, X Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Departments, X-Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Amphetamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Cannabis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Co %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Cocaine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Heroin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Marijuana' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Morphine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Narcotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Nicotine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Opiate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Substance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence, Tobacco' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence-Independence, Field' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependence-Independences, Field' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependences, Co %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependences, Cocaine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependencies %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependencies, Co %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependency %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependency %28%Psychology%29% %28%1987-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependency, Co %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependent Ambulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependent Personality Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependent Personality Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependovirus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dependoviruses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depersonalization' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depersonalization Disorder %28%1969-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depersonalization Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depersonalizations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dephosphin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depilation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depilation, Electrolytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depilations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depilations, Electrolytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depleters, Adrenergic Neurohumor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depletion Procedure, Leukocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depletion Procedures, Leukocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depletion, Lymphocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depo Medroxyprogesterone Acetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depo Provera' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depo-Medroxyprogesterone Acetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DepoProvera' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolarizing Agents, Neuromuscular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolarizing Blockers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolarizing Muscle Relaxants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolymerase, Chondroitin-4-Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolymerase, Pectin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolymerizing Factor, Actin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolymerizing Factors, Actin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depolymerizing Proteins, Actin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deposit, Dental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deposits of ADIPOSE TISSUE throughout the body. The pattern of fat deposits in the body regions is an indicator of health status. Excess ABDOMINAL FAT increases health risks more than excess fat around the hips or thighs, therefore, WAIST-HIP RATIO is often used to determine health risks.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deposits, Dental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depot Preparation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depreciation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depreciations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprenalin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprenil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressant Factor, Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressants, Appetite' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressants, CNS' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressants, Cardiac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressants, Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressed Level of Consciousness' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressed Skull Fracture' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressed Skull Fractures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression %28%1966-1980%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression %28%1966-1995%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth %28%PARTURITION%29%. The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. %28%From DSM-IV, p386%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Chemical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Emotional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Homosynaptic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Involutional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Post-Natal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Post-Partum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Postnatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Postpartum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Spreading Cortical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depression, Unipolar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Chemical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Emotional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Endogenous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Neurotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Reactive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Spreading Cortical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Unipolar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressions, Ventilatory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorder %28%1981-1995%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorder %28%1981-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorder %28%1984-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorder, Major' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Disorders, Major' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Neuroses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Neurosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Symptom' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive Syndromes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Cultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Food' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Maternal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Paternal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Psychosocial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, REM Sleep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Sensory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Sleep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation, Water' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation-Induced Amblyopia, Stimulus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivation-Induced Amblyopias, Stimulus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Cultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Food' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Maternal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Paternal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Psychosocial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, REM Sleep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Sensory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Sleep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deprivations, Water' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depsipeptides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depth Intoxications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depth Perception' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Depth Perceptions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deptomycin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dequalinium Diacetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dequalinium Dichloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dercum Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dercum%27%s Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dercums Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derealizations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives and polymers of styrene. They are used in the manufacturing of synthetic rubber, plastics, and resins. Some of the polymers form the skeletal structures for ion exchange resin beads.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives and salts of SALICYLIC ACID. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of PHOSPHATIDIC ACIDS that lack one of its fatty acyl chains due to its hydrolytic removal.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of QUINOLINES with fused PYRROLES and a keto group or INDOLEQUINONES with fused PIPERIDINES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of acetic acid with one or more fluorines attached. They are almost odorless, difficult to detect chemically, and very stable. The acid itself, as well as the derivatives that are broken down in the body to the acid, are highly toxic substances, behaving as convulsant poisons with a delayed action. %28%From Miall%27%s Dictionary of Chemistry, 5th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN=CR2.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B %28%beta heparin; DERMATAN SULFATE%29% is a misnomer and this compound is not a true chondroitin sulfate.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of ethylene, a simple organic gas of biological origin with many industrial and biological use.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of folic acid %28%pteroylglutamic acid%29%. In gamma-glutamyl linkage they are found in many tissues. They are converted to folic acid by the action of pteroylpolyglutamate hydrolase or synthesized from folic acid by the action of folate polyglutamate synthetase. Synthetic pteroylpolyglutamic acids, which are in alpha-glutamyl linkage, are active in bacterial growth assays.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of phosphatidic acid in which the hydrophobic regions are composed of two fatty acids and a polar alcohol is joined to the C-3 position of glycerol through a phosphodiester bond. They are named according to their polar head groups, such as phosphatidylcholine and phosphatidylethanolamine.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and choline and 2 moles of fatty acids.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a serine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and serine and 2 moles of fatty acids.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of propylene glycol %28%1,2-propanediol%29%. They are used as humectants and solvents in pharmaceutical preparations.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of the dimethylisoalloxazine %28%7,8-dimethylbenzo%5B%g%5D%pteridine-2,4%28%3H,10H%29%-dione%29% skeleton. Flavin derivatives serve an electron transfer function as ENZYME COFACTORS in FLAVOPROTEINS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of the steroid androstane having three double bonds at any site in any of the rings.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of the steroid androstane having two double bonds at any site in any of the rings.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of uronic acid found throughout the plant and animal kingdoms. They detoxify drugs and toxins by conjugating with them to form GLUCURONIDES in the liver which are more water-soluble metabolites that can be easily eliminated from the body.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives of uronic acid that are distributed widely throughout the plant and animal kingdoms.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives, Atropine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives, Benzene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives, Bephenium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives, Morphine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives, Scopolamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derivatives, Sorbitan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derma Smooth/FS' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermabrasion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermabrasions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermacentor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Administration' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Administrations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Brand of Anthralin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Brand of Glutaral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Drug Administration' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Drug Administrations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Hypoplasia, Focal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermal Hypoplasias, Focal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermalog' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermalons' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermapharm Brand of Aciclovir' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermapharm Brand of Biotin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermapharm Brand of Bufexamac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermapharm Brand of Cetirizine Dihydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermapharm Brand of Terbutaline Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatan Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatech Brand of Flucytosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatech Brand of Fluorouracil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatech Brand of Glutaral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatech Brand of Methoxsalen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatech Brand of Nitrazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatech Brand of Ribavirin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Actinic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Allergic Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Allergic Eczematous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Atopic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Chronic Actinic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Contagious Pustular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Eczematous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Exfoliative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Irritant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Occupational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Periocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Perioral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Photoallergic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Photoallergic Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Photocontact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Photosensitive Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Phototoxic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Phototoxic Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Poison Ivy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Primary Irritant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Radiation-Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Rhus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Seborrheic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitides, Toxicodendron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis %28%1969-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Exfoliativa' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Exfoliativa %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Herpetiformis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Herpetiformis %28%1966-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Medicamentosa' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Venenata' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis Verrucosa' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Adverse Drug Reaction' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Allergic Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Allergic Eczematous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Atopic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Chronic Actinic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contact %28%1966-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contact, Allergic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contact, Photoallergic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contact, Photosensitive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contact, Phototoxic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Contagious Pustular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Eczematous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Exfoliative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Exfoliative %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Irritant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Occupational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Perioral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Photoallergic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Photoallergic Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Photocontact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Photosensitive Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Phototoxic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Phototoxic Contact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Primary Irritant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Radiation Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Radiation-Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Rhus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Seborrheic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Seborrheic %28%1966-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatitis, Toxicodendron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibroma %28%1964-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibroma %28%1966-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibroma %28%1968-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibroma %28%1972-2004%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibromas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibrosarcoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatofibrosarcomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoglyphic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoglyphics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatologic Agent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatologic Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatologic Agents %28%1967-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatologic Agents %28%1975-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatologic disorders attendant upon non-dermatologic disease or injury.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatological Agent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatological Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatolyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatolysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomegaly' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomyces' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomycoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomycosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomyositides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomyositides, Adult Type' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomyositides, Childhood Type' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatomyositis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophagoides Antigens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophagoides farinae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophagoides farinae Antigens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophagoides pteronyssinus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophagoides pteronyssinus Antigens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophytes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatophytoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoplasties' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoplasty' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatopolymyositides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatopolymyositis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoscopies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoscopy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Bullous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Facial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Foot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Hand' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Industrial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Leg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Scalp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Subcorneal Pustular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatoses, Vesiculobullous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Facial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Foot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Hand' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Industrial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Leg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Neutrophilic, Febrile, Acute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Scalp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatosis, Subcorneal Pustular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermatotoxins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermik Brand of Desoximetasone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermik Brand of Fluorouracil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermoid Cyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermoid Cysts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermoids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermoscopies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermoscopy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermotoxins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dermtek Brand of Triclosan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Derris' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Des Asp Angiotensin II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Des Aspartyl Angiotensin II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Des-Asp Angiotensin II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Des-Aspartyl-Angiotensin II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desacetyl Lanatoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desacetyldigilanide C' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desacetyllanatoside C' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desacetylvinblastine Amide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturase, Linoleoyl CoA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturase, Linoleoyl-CoA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturase, Stearate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturase, Stearoyl-CoA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturase, Stearyl-CoA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturase, delta-9' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desaturases, Fatty Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descemet Membrane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descemet Membranes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descemet%27%s Membrane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descemets Membrane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descending Aorta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descending Colon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Description, Job' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Description, Position' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Description, Program' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptions and evaluations of specific health care organizations.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory %28%EMBL%29%, National Biomedical Research Foundation %28%NBRF%29%, or other sequence repositories.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptions, Job' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptions, Position' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptions, Program' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptive Bibliographies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptive Bibliography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptive anatomy based on three-dimensional imaging %28%IMAGING, THREE-DIMENSIONAL%29% of the body, organs, and structures using a series of computer multiplane sections, displayed by transverse, coronal, and sagittal analyses. It is essential to accurate interpretation by the radiologist of such techniques as ultrasonic diagnosis, MAGNETIC RESONANCE IMAGING, and computed tomography %28%TOMOGRAPHY, X-RAY COMPUTED%29%. %28%From Lane %26% Sharfaei, Modern Sectional Anatomy, 1992, Preface%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptive histopathologic term for renal disease without an inflammatory component.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptive terms and identifying codes for reporting medical services and procedures performed by PHYSICIANS. It is produced by the AMERICAN MEDICAL ASSOCIATION and used in insurance claim reporting for MEDICARE; MEDICAID; and private health insurance programs %28%From CPT 2002%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Descriptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desensitization %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desensitization, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desensitization, Psychologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desensitization, Psychological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desensitizations %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desensitizations, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deseril' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desert Climate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desert Climates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desert Shield, Operation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desert Storm, Operation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desferioximine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desferrioxamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desferrioxamine B' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desferroxamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desglucolanatosides A' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desglucolanatosides C' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desglucotransvaaline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desialylated Glycoproteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desiccated Thyroid Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desiccation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design of patient care wherein institutional resources and personnel are organized around patients rather than around specialized departments. %28%From Hospitals 1993 Feb 5;67%28%3%29%:14%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Computer-Aided' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Computer-Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Cross-Over' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Crossover' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Dental Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Denture' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Device' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Environment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Epidemiologic Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Epidemiological Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Experimental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Facility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Interior' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Medical Device' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Orthodontic Appliance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Questionnaire' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, Software' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Design, development, manufacture, and operation of heavier-than-air aircraft.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designated locations along nerves or organ meridians for inserting acupuncture needles.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designation for several severe forms of ichthyosis, present at birth, that are characterized by hyperkeratotic scaling. Infants may be born encased in a collodion membrane which begins shedding within 24 hours. This is followed in about two weeks by persistent generalized scaling. The forms include bullous %28%HYPERKERATOSIS, EPIDERMOLYTIC%29%, non-bullous %28%ICHTHYOSIS, LAMELLAR%29%, wet type, and dry type.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designations for persons whose names are not known or who wish to remain anonymous %28%anonyms%29% and for persons who wish to conceal or obscure their identity by assuming a fictitious name %28%pseudonyms%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designer Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs for approaching areas inside or outside facilities.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Computer-Aided' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Computer-Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Cross-Over' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Crossover' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Dental Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Denture' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Device' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Environment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Epidemiologic Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Epidemiological Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Experimental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Facility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Interior' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Medical Device' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Orthodontic Appliance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Prosthesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Questionnaire' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Designs, Software' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desipramine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desirabilities, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desirability, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desired Family Size' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desired Family Sizes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Amantadine Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Dihydroergocristine Monomesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Dihydroergocryptine Monomesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Dihydroergotamine Mesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Doxepin Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Ethosuximide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Lorazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Nitrazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Primidone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Sulpiride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin Brand of Temazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitin, Amitriptylin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desitriptyline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deslanatoside C' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deslanoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desma Brand of Bupranolol Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmethylamitriptylin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmethyldiazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmethylimipramine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmethylloxapine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desminase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmocollins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmogalen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein 2' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein 3' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoglein III' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmogleins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplakin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplakin I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplakin II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplakins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplakins are cytoskeletal linker proteins that anchor INTERMEDIATE FILAMENTS to the PLASMA MEMBRANE at DESMOSOMES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplastic Fibroma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplastic Fibromas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplastic Medulloblastoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmoplastic Medulloblastomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmopressin Monoacetate, Trihydrate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmopressine Ferring' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosomal Cadherins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosomal Glycoprotein 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosomal Glycoprotein 2' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosomal Glycoprotein 3' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosome Band 6 Polypeptide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosome Band 6 Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosomes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosomes %28%1972-2000%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmospray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmosterol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desmotabs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desocort' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desogestrel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desonide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoximetasone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxone 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxone1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxyadrenaline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxycholic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxycorticosterone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxycorticosterone %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxycorticosterone %28%1979-1982%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxycortone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxyephedrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxyepinephrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxylagosin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxymethasone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxynorephedrin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxynucleotidyl Transferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxynucleotidyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxyphenobarbital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desoxyribonucleases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desquamating Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desril' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dessication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destinations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destombes Rosai Dorfman Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destombes-Rosai-Dorfman Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destrin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destruction by passage of a galvanic electric current, as in disintegration of a chemical compound in solution.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destruction, Thermal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destructions, Thermal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Destructive lesions of the thoracic inlet with involvement of the brachial and sympathetic plexus or carcinoma of the lung apex. It is characterized by pain in the shoulder region radiating toward the axilla and scapula, sensory and motor disorders and wasting of the muscles of the hand, the Bernard-Horner syndrome, and compression of the blood vessels with edema. %28%Jablonski%27%s Dictionary of Syndromes and Eponymic Diseases, 2d ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfhydrase, Cysteine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfhydrase, Cystine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfitobacterium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfohydrolase, Cystine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfotomaculum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio %28%1966-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio %28%1968-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio %28%1971-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio Infection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio africanus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio desulfuricans' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio gigas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrio vulgaris' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrionaceae Infection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfovibrionaceae Infections' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfoviridins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfurococcaceae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfurococcaceae %28%2000-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfurococcales' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desulfuromonas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desynchronization, Cortical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Desynchronizations, Cortical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachment of the corpus vitreum %28%VITREOUS BODY%29% from its normal attachments, especially the retina, due to shrinkage from degenerative or inflammatory conditions, trauma, myopia, or senility.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachment, Posterior Vitreous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachment, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachment, Vitreous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachments, Posterior Vitreous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachments, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detachments, Vitreous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection Genetic Carrier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection Genetic Carriers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection and counting of scintillations produced in a fluorescent material by ionizing radiation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Drug Abuse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Estrus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Genetic Carrier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Heterozygote' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Illicit Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Lie' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Loudness Recruitment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Nuclear Track' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Ovulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Recruitment %28%Audiology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Signal %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Street Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detection, Substance Abuse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Drug Abuse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Estrus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Genetic Carrier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Heterozygote' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Illicit Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Lie' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Loudness Recruitment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Recruitment %28%Audiology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Signal %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Street Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detections, Substance Abuse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detergent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detergent-insoluble CELL MEMBRANE components. They are enriched in SPHINGOLIPIDS and CHOLESTEROL and clustered with glycosyl-phosphatidylinositol %28%GPI%29%-anchored proteins.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detergents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinant, Bordetella Virulence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinant, Epidemiologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinant, Fertility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinant, Mortality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinant, SSEA 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Antigenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Epidemiologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Fertility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Immunodominant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Immunodominant Antigenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Lymphocyte-Activating' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Minor Lymphocyte-Stimulating' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Mls' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinants, Mortality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of Healthcare Needs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of economic value of an established health care provider practice including value of patient lists, equipment, and other assets, and process of buying or selling rights to said practice.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of reliability and maintainability of equipment.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen%27%s compensation benefits.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the energy distribution of gamma rays emitted by nuclei. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the extent of the visual field for various types and intensities of stimuli.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the nature of a pathological condition or disease in the ovum, zygote, or blastocyst prior to implantation. CYTOGENETIC ANALYSIS is performed to determine the presence or absence of genetic disease.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the nature of a pathological condition or disease in the postimplantation embryo, fetus, or pregnant female before birth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the quantity of a material present in a mixture by measurement of its effect on the electrical conductivity of the mixture. %28%Webster, 3d ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Blood Pressure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Blood Volume' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, DNA Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Eligibility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Endpoint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Erythrocyte Size' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Gastric Acidity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, RNA Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Sex %28%Analysis%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, Sex %28%Genetics%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Blood Pressure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Blood Volume' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, DNA Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Eligibility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, End Point' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Endpoint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Erythrocyte Size' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Gastric Acidity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, RNA Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Sequence Homology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Sex %28%Analysis%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinations, Sex %28%Genetics%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Determinism, Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deterrents, Alcohol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxication, Conjugative Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxication, Drug Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxication, Drug, Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxication, Metabolic Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxication, Oxidative Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxication, Sorption' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxications, Conjugative Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxications, Drug Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxications, Metabolic Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxications, Oxidative Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxications, Sorption' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxification, Drug Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxification, Drug, Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxification, Phase I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxification, Phase II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxification, Sorption' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxifications, Drug Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxifications, Phase I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxifications, Phase II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detoxifications, Sorption' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detrusor Muscle Hypertonia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Detrusor Muscle Hypertonias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deutan Defect' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium %28%1965-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium %28%1980-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium Exchange Measurement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium Exchange Measurements' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium Oxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuterium. The stable isotope of hydrogen. It has one neutron and one proton in the nucleus.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuteromycetes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuteromycetes %28%1966-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuteromycota' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuteroporphyrin, Cobalt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deuteroporphyrins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devazepide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developed Countries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developed Country' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developed Nation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developed Nations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developing Countries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developing Country' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developing Nation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developing Nations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Deviation, Child' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Deviations, Child' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Disorder, Child' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Disorder, Language' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Disorder, Pervasive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Disorders, Child' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Disorders, Pervasive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Plan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Plannings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Polarity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development Policies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development and Growth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development and Research' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development of a library collection, including the determination and coordination of selection policy, assessment of needs of users and potential users, collection use studies, collection evaluation, identification of collection needs, selection of materials, planning for resource sharing, collection maintenance and weeding, and budgeting.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development of lesions in the lymph node characterized by infiltration of the cortex or paracortex by large collections of proliferating histiocytes and complete or, more often, incomplete necrosis of lymphoid tissue.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus %28%HIV/HTLV-III/LAV%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Adolescent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Agricultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Child' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Collection %28%Libraries%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Community' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Computer Systems' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Consensus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Economic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Embryo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Embryonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Fetal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Human' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Human Resources' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Infant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Language' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Library Collection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Maxillofacial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Moral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Muscular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Musculoskeletal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Musculoskeletal System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Policy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Postnidation Embryo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Program' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Psychosexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Rural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Sexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Staff' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Sustainable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Development, Urban' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Academic Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Agnosias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Agraphias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Amblyopia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Amblyopias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Articulation Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Articulation Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Biology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Bone Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Bone Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Communication Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Communication Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Coordination Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Defects, Neural Tube' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Delay Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Delay Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Disabilities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Disability' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Disorder, Speech or Language' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Disorders of Scholastic Skills' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Dysgraphia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Dysgraphias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Dyslexia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Dyslexias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Gene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Gene Expression Regulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Genes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Gerstmann Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Gerstmanns Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Language Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Language Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Neural Tube Defects' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Prosopagnosia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Prosopagnosias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Psychomotor Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Reading Disabilities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Reading Disability' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Reading Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Reading Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Stuttering' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Verbal Apraxia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental Verbal Apraxias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmental events leading to the formation of adult muscular system, which includes differentiation of the various types of muscle cell precursors, migration of myoblasts, activation of myogenesis and development of muscle anchorage.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmentally Regulated EPH Related Tyrosine Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developmentally Regulated EPH-Related Tyrosine Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Collection %28%Libraries%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Community' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Language' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Maxillofacial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Policy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Psychosexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Rural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Developments, Urban' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviation, Child Development' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviation, Epistatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviation, Interaction' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviation, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviation, Skew' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations of the spine from its normal direction or position. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations, Epistatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations, Interaction' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Deviations, Skew' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devic Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devic Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devic%27%s Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devic%27%s Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devic%27%s Syndromes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Approval' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Approval Process' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Approval Processes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Approval, New' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Approvals' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Approvals, New' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Design, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Designs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Designs, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Failure, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Failures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Failures, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Migration, Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Migrations, Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Removal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Removals' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device Safety, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device%28%s%29% which can substitute for normally functioning kidneys in cleansing the blood.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Assistive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Biomimetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Computer Peripheral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Computer Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Copper Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Ear Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, External Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Eye Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Female Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Head Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Hearing Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Heart-Assist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Hormone-Releasing Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Inhalation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Internal Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Intrauterine Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Male Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Mass Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Medicated Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Microarray Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Microchip Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Microfluidic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Nanoarray Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Nanochip Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Optical Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Orthopedic Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Orthotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Progesterone-Releasing Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Respiratory Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Safety' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Self-Help' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Vascular-Assist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Device, Ventricle-Assist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining nuclear fission chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated. %28%McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices designed to provide personal protection against injury to individuals exposed to hazards in industry, sports, aviation, or daily activities.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for accelerating protons or electrons in closed orbits where the accelerating voltage and magnetic field strength varies %28%the accelerating voltage is held constant for electrons%29% in order to keep the orbit radius constant.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for continuously measuring and displaying the arterial blood pressure.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for examining the interior of the eye, permitting the clear visualization of the structures of the eye at any depth. %28%UMDNS, 1999%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for simulating the activities of the liver. They often consist of a hybrid between both biological and artificial materials.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for simulating the activity of the pancreas. They can be either electromechanical, consisting of a glucose sensor, computer, and insulin pump or bioartificial, consisting of isolated islets of Langerhans in an artificial membrane.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices for the compression of a blood vessel by application around an extremity to control the circulation and prevent the flow of blood to or from the distal area. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices implanted to control intraocular pressure by allowing aqueous fluid to drain from the anterior chamber. %28%Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices in which blood and oxygen are separated by a semipermeable membrane, generally of Teflon or polypropylene, across which gas exchange occurs. The membrane may be arranged as a series of parallel plates or as a number of hollow fibers; in the latter arrangement, the blood may flow inside the fibers, which are surrounded by gas, or the blood may flow outside the fibers and the gas inside the fibers. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices intended to replace non-functioning organs. They may be temporary or permanent. Since they are intended always to function as the natural organs they are replacing, they should be differentiated from PROSTHESES AND IMPLANTS and specific types of prostheses which, though also replacements for body parts, are frequently cosmetic %28%EYE, ARTIFICIAL%29% as well as functional %28%ARTIFICIAL LIMBS%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices or objects in various imaging techniques used to visualize or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with x-ray or ultrasonic machines. %28%From Iturralde, Dictionary and Handbook of Nuclear Medicine and Clinical Imaging, 1990%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices or pieces of equipment placed in or around the mouth or attached to instruments to protect the external or internal tissues of the mouth and the teeth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices that babies can suck on when they are not feeding. The extra sucking can be comforting to the babies and pacify them. Pacifiers usually are used as a substitute for the thumb in babies who suck on their thumb or fingers almost constantly.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices that cause a liquid or solid to be converted into an aerosol %28%spray%29% or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices that control the supply an electric current for running electrical equipment.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices that cover the nose and mouth to maintain aseptic conditions or to administer inhaled anesthetics or other gases. %28%UMDNS, 1999%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices that diminish the likelihood of or prevent conception. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices used for influencing tooth position. Orthodontic appliances may be classified as fixed or removable, active or retaining, and intraoral or extraoral. %28%Boucher%27%s Clinical Dental Terminology, 4th ed, p19%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices used in the home by persons to maintain dental and periodontal health. The devices include toothbrushes, dental flosses, water irrigators, gingival stimulators, etc.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices used to measure the flow of fluids %28%see RHEOLOGY%29% or the AIR to measure RESPIRATION.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices which are used in the treatment of orthopedic injuries and diseases.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices which are very resistant to wear and may be used over a long period of time. They include items such as wheelchairs, hospital beds, artificial limbs, etc.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices which mechanically oxygenate venous blood extracorporeally. They are used in combination with one or more pumps for maintaining circulation during open heart surgery and for assisting the circulation in patients seriously ill with some cardiac and pulmonary disorders. %28%UMDNS, 1999%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices worn in the vagina to provide support to displaced uterus or rectum. Pessaries are used in conditions such as UTERINE PROLAPSE; CYSTOCELE; or RECTOCELE.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Assistive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Biomimetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Computer Peripheral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Computer Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Copper Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Ear Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, External Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Eye Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Female Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Head Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Hearing Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Heart-Assist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Hormone-Releasing Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Inhalation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Internal Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Intrauterine Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Male Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Mass Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Medicated Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Microarray Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Microchip Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Microfluidic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Nanoarray Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Nanochip Analytical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Optical Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Orthopedic Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Orthotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Progesterone-Releasing Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Respiratory Protective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Safety' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Self-Help' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Vascular-Assist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, Ventricle-Assist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, manned and unmanned, which are designed to be placed into an orbit about the Earth or into a trajectory to another celestial body. %28%NASA Thesaurus, 1988%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, usually alloplastic, surgically inserted into or onto the jawbone, which support a single prosthetic tooth and serve either as abutments or as cosmetic replacements for missing teeth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devices, usually incorporating unidirectional valves, which are surgically inserted in the sclera to maintain normal intraocular pressure.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devics Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devics Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devil%27%s Club' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devils Claw' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devitalization, Dental Pulp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devitalized Teeth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Devitalized Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Allvoran' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Effekton' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Jenapharm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Loscon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Phlogont' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Pos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Sine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa Siozwo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa ratiopharm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa-Allvoran' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa-Effekton' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa-Phlogont' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa-Pos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa-Sine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexa-ratiopharm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexaAllvoran' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexaEDO' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexaEffekton' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexaPhlogont' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexaSine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexabene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexabeta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexachel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexadreson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexaflam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexafort' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexagalen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexagel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexagrin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexahexal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexair' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexalone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamedium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexametasona Belmac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexametasona, Oft Cusi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason Azupharma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason FNA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason GALEN' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason Jenapharm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason LAW' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason Monofree' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason Rotexmedica' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason mp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason-Rotexmedica' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethason-mp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexamethasonRotexmedica' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethasone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethasone %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethasone %28%1972-1974%29% /analogs %26% derivatives %28%1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethasone Intensol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethasone Isonicotinate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamethasonmp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamfetamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamonozon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexamphetamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexapent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexaphos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexapos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexaratiopharm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexasel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexason' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexatad' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexavene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexazone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexbenzetimid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexbenzetimide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexcel Brand of Nicergoline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexcel Brand of Nitrendipine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexetimide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexfenfluramine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexmedetomidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexmethsone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexo Brand of Amfepramone Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexo Brand of Betahistine Mesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexo Brand of Cephradine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexo Brand of Glycyrrhetinic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexo Brand of Pentaerythritol Tetranitrate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexo Brand of Spironolactone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexon S' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DexonS' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexone L.A.' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexoral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexpak' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dexsone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran B 1355' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran B 1355 S' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran B-1355' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran Iron Complex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran Sulfate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran T 40' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran T 500' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextran-Iron Complex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextranase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrans' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrans %28%1966-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrans %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrinoses, Limit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrinosis, Limit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrins %28%1975-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextro Amphetamine Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of DEXTROMETHORPHAN.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextro-Amphetamine Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextroamphetamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrocardia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrocardias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextromethorphan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextromoramide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextropropoxyphene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrorphan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrosulfenidol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dextrothyroxine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dey Brand of Acetylcysteine Sodium Salt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dhaman Tree' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di 2 Ethylhexylphthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di 2 chloroethyl Sulfide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Actane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Adreson F' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Cyclonex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Guglielmo Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Guglielmo%27%s Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Guglielmos Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di N Acetylchitobiosyl beta N Acetylglucosaminidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Spaz' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Syston' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di Te Per Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di isopropylphosphorofluoridate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di n Butyl Phthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di%C3%%A9%t%C3%%A9%tiques et Sant%C3%%A9% Brand of Aspartame' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-%28%2-%28%4-acetamidophenoxy%29%ethyl%29% Ether' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-10-undecenoate, Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-2-Ethylhexylphthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-2-chloroethyl Sulfide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-N-Acetylchitobiosyl beta-N-Acetylglucosaminidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-Te-Per Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-isopropylphosphorofluoridate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Di-n-Butyl Phthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DiActane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DiAdresonF' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DiGeorge Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabete, Autoimmune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabete, Streptozocin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Complication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Complications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus %28%1966-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus %28%1966-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus %28%1966-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Central' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Nephrogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Nephrogenic, Type I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Nephrogenic, Type II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Neurogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Neurohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Insipidus, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus %28%1966-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus %28%1966-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus %28%1969-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus Complication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus Complications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Adult Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Adult-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Brittle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Experimental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Experimental %28%1980-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Gestational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Insulin Dependent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Insulin-Dependent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Insulin-Dependent %28%1984-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Juvenile Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Juvenile-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Ketosis Prone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Ketosis Resistant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Ketosis-Prone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Ketosis-Resistant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Lipoatrophic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Maturity Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Maturity-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Non Insulin Dependent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Non-Insulin-Dependent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Noninsulin Dependent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Slow Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Slow-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Stable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Sudden Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Sudden-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Type 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Type 2' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Type I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus, Type II' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Mellitus/complications %28%1965-2004%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes Related Complications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant %28%PREGNANCY IN DIABETICS%29%. Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Alloxan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Bronze' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Congenital Lipoatrophic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Gestational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Pregnancy Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Pregnancy-Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Streptozocin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes, Streptozotocin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes-Related Complication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetes-Related Complications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Acidoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Acidosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Amyotrophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Angiopathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Angiopathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Asymmetric Polyneuropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Autonomic Neuropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Coma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Coma %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Comas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Complication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Complications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Diet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Diets' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Feet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Foot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Ketoacidoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Ketoacidosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Ketoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Ketosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Kidney Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Kidney Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mice, Non-Obese' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mice, Nonobese' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Microangiopathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Microangiopathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mononeuropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mononeuropathy Simplex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mononeuropathy Simplices' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mouse, Non-Obese' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Mouse, Nonobese' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Nephropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Nephropathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Neuralgias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Neuropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Neuropathies, Painful' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Neuropathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Neuropathy, Painful' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Polyneuropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Retinopathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Retinopathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Vascular Complication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Vascular Complications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Vascular Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diabetic Vascular Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetate, 2-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetate, Cystamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetate, Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetate, Ethyndiol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetate, Ethynodiol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetate, beta-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetyl Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetyldapsone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetylmorphine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetylmorphine %28%1966-1968%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetylmorphine %28%1966-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacetylmorphine Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol Acyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol CDP Choline Phosphotransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol Cholinephosphotransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol Lipase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol O Acyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol O Acyltransferase 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol O-Acyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol O-Acyltransferase 1' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol-CDP Choline Phosphotransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol-Lyase, Phosphatidylinositol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerol-Serine O-Phosphatidyltransferase, CDP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerols' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diacylglycerols, CDP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses and Laboratory Examinations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Antemortem' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Antenatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Computer-Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Differential' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Dual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Dual %28%Psychiatry%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Dual Psychiatric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Early' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Immunological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Laboratory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Nursing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Oral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Postmortem' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Preimplantation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Preimplantation Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Prenatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Prenatal Ultrasonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Psychiatric Dual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Ultrasonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnoses, Ultrasonic Prenatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis %28%1966-1967%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis %28%1966-1969%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis %28%1966-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis %28%1989-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis Related Group Outliers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis Related Groups' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis Related Groups %28%1986-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis of disease states by recording the spontaneous electrical activity of tissues or organs or by the response to stimulation of electrically excitable tissue.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. %28%Stedman, 26th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Antemortem' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Antenatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Computer Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Computer-Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Differential' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Dual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Dual %28%Psychiatry%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Dual Psychiatric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Early' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Immunological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Intrauterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Laboratory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Nursing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Oral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Oral %28%1966-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Postmortem' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Preimplantation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Preimplantation Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Prenatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Prenatal Ultrasonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Psychiatric Dual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis, Ultrasonic Prenatal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis-Related Group' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis-Related Group Outlier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis-Related Group Outliers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis-Related Groups' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnosis-Related Groups %28%1986-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Equipments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Error' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Errors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Imaging' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Pneumomediastinum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Pneumomediastinums' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Reagent Kit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Reagent Kits' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Related Group' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Related Group Outliers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Service' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Services' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Cardiovascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Molecular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Neurologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Neurological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Obstetric and Gynecologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Obstetrical and Gynecological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Ophthalmologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Ophthalmological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Otologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Otological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Respiratory System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Surgical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Urologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technic, Urological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics and Procedures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Cardiovascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Molecular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Neurologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Neurological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Obstetric and Gynecologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Obstetrical and Gynecological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Ophthalmologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Ophthalmological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Otologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Otological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Respiratory System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Surgical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Urologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technics, Urological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Cardiovascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Molecular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Neurologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Neurological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Obstetric and Gynecologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Obstetrical and Gynecological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Ophthalmologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Ophthalmological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Otologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Otological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Respiratory System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Surgical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Urologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Technique, Urological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques and Procedures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Cardiovascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Molecular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Neurologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Neurological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Obstetric and Gynecologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Obstetrical and Gynecological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Ophthalmologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Ophthalmological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Otologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Otological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Otological %28%1978-2002%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Respiratory System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Surgical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Urologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Techniques, Urological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Test' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Test, Routine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Testing, Molecular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic Tests, Routine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic X Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic X Ray Radiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic X-Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic X-Ray Radiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic X-Rays' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic aid in pancreas function determination. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic and Statistical Manual of Mental Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic measurement of the nose and its cavity through acoustic reflections. Used to measure nasal anatomical landmarks, nasal septal deviation, and nasal airway changes in response to allergen provocation tests %28%NASAL PROVOCATION TESTS%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic procedures involving immunoglobulin reactions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic procedures, such as laboratory tests and x-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. These include routine tests administered to neonates.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic techniques involving the demonstration or measurement of an immune response, including antibody production or assay, antigen-antibody reactions, serologic cross-reactivity, delayed hypersensitivity reactions, or heterogenetic responses.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic, therapeutic and preventive health services provided for individuals in the community.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic, therapeutic and preventive mental health services provided for individuals in the community.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic, therapeutic, and investigative procedures prescribed and performed by health professionals, the results of which do not justify the benefits or hazards and costs to the patient.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic-Related Group' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic-Related Group Outlier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic-Related Group Outliers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostic-Related Groups' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagnostics, Regression' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagonal Band Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diagonal Band of Broca' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diakineses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diallylnortoxiferine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyses, Extracorporeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyses, Home Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyses, Peritoneal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyses, Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyses, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis %28%1966-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis %28%1966-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis Solutions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis Solutions, Hemodialysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis, Home Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis, Peritoneal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialysis, Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dialyzates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamantane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diameter, Erythrocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diameters, Erythrocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamfenetide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamine Oxidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamine Oxidase, Xylylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamine, Tetramethyl Acridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamines %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamines %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamines %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamines %28%1974-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamino Amino Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaminobenzidine, 3,3' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaminobenzidine, 3,3%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaminodiphenylsulfone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaminopimelic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaminopropiophenone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamminodichloride, Platinum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamond' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamond Blackfan Anemia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamond-Blackfan Anemia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamond. A crystalline form of carbon that occurs as hard, colorless or tinted isomeric crystals. It is used as a precious stone, for cutting glass, and as bearings for delicate mechanisms. %28%From Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamonds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamorf' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamorphine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diamphenethide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dianhydrodulcitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dianhydrogalactitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dianisidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dianisyl Trichloroethane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dianthoviruses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dianthus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaper Pin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaper Rash' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaper Rashes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaper, Adult' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaper, Infant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diapers, Adult' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diapers, Infant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphanographies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphanoscopies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphanoscopy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphenylsulfone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase %28%Lipoamide Dehydrogenase%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase %28%NADH Dehydrogenase%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase, DT' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase, NAD' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase, NADH' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase, NADP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase, NADPH' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphorase, TPN' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragm %28%1966-1986%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragm Eventration' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragm, Respiratory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragm, Vaginal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragmatic Eventration' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragmatic Hernia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragmatic Hernia, Traumatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragmatic Hernias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragmatic Hernias, Traumatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragmatic Paralysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragms, Respiratory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphragms, Vaginal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphyseal Aclases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphyseal Aclasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphyseal Dysplasia, Progressive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphyseal Dysplasias, Progressive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaphysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaries %28%PT%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaries %5B%Publication Type%5D%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaries, Food' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaries, Health' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea %28%1966-1981%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea %28%1966-1982%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Syndrome, Watery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Virus 1, Bovine Viral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Virus 2, Bovine Viral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Virus, Bovine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Virus, Bovine Viral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Viruses, Bovine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea Viruses, Bovine Viral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea, Infantile' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrhea, Infantile %28%1975-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrheal Disease, Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrheas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrheas, Infantile' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrheogenic Islet Cell Tumor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrheogenic Tumor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarrheogenic Tumors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diary, Food' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diary, Health' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diarylheptanoids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diasatine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastases, Pubic Symphysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastases, Symphysis Pubis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastasis Symphysis Pubis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastasis, Pubic Symphysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastasis, Symphysis Pubis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastema' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastemas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastematomyelias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diastoles' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diathermies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diathermy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diathermy, Surgical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatheses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatheses, Hemorrhagic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diathesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diathesis, Hemorrhagic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatom' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatomaceous Earth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatoms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate %28%1971-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate Meglumine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate Methylglucamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate, Meglumine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate, Methylglucamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diatrizoate, Sodium-Magnesium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diaza derivative of cholesterol which acts as a hypocholesteremic agent by blocking delta-24-reductase, which causes the accumulation of desmosterol.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazepam %28%1973-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazepam Binding Inhibitor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazepam Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazepam Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazinon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazirine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazodicarboxylic Acid Bis%28%N,N-dimethyl%29%amide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazodicarboxylic Acid Bisdimethylamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazomethane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazonium Compounds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazooxonorleucine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diazoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Albendazole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Astemizole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Fluorescein Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Iodoquinol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Mebendazole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diba Brand of Prednisone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibasic Amino Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibasic Processing Enzyme' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibasona' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibekacin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibekacin Sulphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibencycladine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenz%28%b,f%29%%28%1,4%29%oxazepine-10%28%11H%29%-carboxylic acid, 8-chloro-, 2-acetylhydrazide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzazepines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzazepines %28%1968-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzazepines %28%1968-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzazepines %28%1969-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzazepines %28%1971-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzazepines %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzocycloheptenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzocycloheptenes %28%1968-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzocycloheptenes %28%1968-1990%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzocycloheptenes %28%1969-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzoquinolines derived in plants from %28%S%29%-reticuline %28%BENZYLISOQUINOLINES%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzothiazepines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzothiepins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzothiepins %28%1968-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzothiepins %28%1968-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzoxazepines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzoxazepines %28%1971-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzoxazepines %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzoxepins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzoyl Peroxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzyl Chlorethylamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzylchlorethamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzyline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibenzyran' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diblocin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide Dihydrate, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide Pipecuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide, Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide, Dihydrate Pipecuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide, Diquat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide, Ethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromide, Succinylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromides, Ethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromodulcitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromomannitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromothymolsulfonphthalein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibromothymoquinone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibucaine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyl Phthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Adenosine 3%27%,5%27% Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Adenosine 3,5 Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Adenosine-3%27%,5%27%-Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Cyclic AMP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Cyclic GMP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Guanosine 3%27%,5%27% Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Guanosine 3,5 Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dibutyryl Guanosine-3%27%,5%27%-Monophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicalcium EHDP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicamba' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarbethoxydihydrocollidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarbonate, Diethyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylate Binding Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylate Carrier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylate Transport Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylate Transporter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylate-Binding Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic Acid Transport Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic Acid Transporters' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic Acids %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic Acids %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic Amino Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicarboxylic acids in which one of the carboxyl groups %28%-COOH%29% has been replaced by an aldehyde group %28%-CHO%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicesium Salt Methotrexate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichelobacter nodosus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlofenal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlofenamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlofos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride Dihydrate, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Alcuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Cadmium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Chlorisondamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Histamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Mercury' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Methylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, N,N%27%-Diallylnortoxiferinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloride, Succinylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorides, Ethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroacetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroacetate, Potassium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroacetate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroacetic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorobenzimidazole Riboside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorodiammineplatinum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorodiethyl Sulfide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorodiphenyl Dichloroethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorodiphenyldichloroethane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroethanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroethylene, Dichlorodiphenyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroethylenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroindophenol, 2,6' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethane Diphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethanediphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethanediphosphonic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethyl Ether' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethylene Biphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethylene Diphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloromethylenebisphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorophen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorophenol Indophenol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorophenolindophenol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorophos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlororibofuranosylbenzimidazole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichloroxacillin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorphenamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlorvos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichlothiazide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichotic Listening Test' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichotic Listening Tests' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichroism, Circular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dichromate, Potassium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diclofenac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diclofenac, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diclofenamid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diclophenac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicloxaciclin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicloxacillin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicloxacillin, Monosodium Salt, Mono-Hydrate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicloxacycline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicofol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicoumarol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicrocoeliases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicrocoeliasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicrocoeliidae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicrocoelium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicrocoelium dendriticum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicrofenac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictamnus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Chemical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Classical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Dental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Pharmaceutic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Pharmaceutical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Pharmacy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionaries, Polyglot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary %28%PT%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary %5B%Publication Type%5D%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Chemical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Classical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Dental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Pharmaceutic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Pharmaceutical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Pharmacy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictionary, Polyglot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyocauliases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyocauliasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyocaulus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyocaulus Infection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyocaulus Infections' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyoptera' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyostelid Cellular Slime Molds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyosteliida' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dictyostelium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicumarol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicyclohexylcarbodiimide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicyclomine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicycloverin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dicynene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Didanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Didelphidae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Didelphis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxyadenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxycytidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxyinosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxykanamycin B' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxynucleosides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxynucleosides %28%1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dideoxynucleosides %28%1989-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Didier, Digoxin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dieldrin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diemictylus viridescens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diencephalic Syndrome, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diencephalic Syndromes, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diencephalon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diencephalon %28%1966-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diencephalon %28%1967-1981%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diencephalon %28%1967-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dienestrol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dientamoeba' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dientamoebiases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dientamoebiasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diepoxydulcitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diepoxygalactitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diesel Fuels' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diester Phosphohydrolase, Orthophosphoric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diesters, Phorbol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diestrus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1966-1968%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1966-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1984-2002%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet %28%1986-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Fad' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Fads' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Fads %28%1966-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Habit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Habits' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Modification' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Modifications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Record' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Records' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Survey' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Surveys' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Therapies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Therapy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet Therapy %28%1974-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Atherogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Atkins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Carbohydrate Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Carbohydrate-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Cariogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Diabetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Fat Free' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Fat Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Fat-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low Carbohydrate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low Fat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low Salt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low-Fat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low-Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low-Salt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Low-Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Macrobiotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Mediterranean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Protein Free' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Protein Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Protein-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Reducing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Salt Free' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Sodium Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Sodium-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Sodium-Restricted %28%1966-1987%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, South Beach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Synthetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diet, Vegetarian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Allowance, Recommended' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Allowances, Recommended' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Calcium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Carbohydrates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Carbohydrates %28%1966-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Carbohydrates %28%1973-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Carbohydrates %28%1981-2002%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Cholesterol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Egg Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fat, Unsaturated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fats' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fats %28%1966-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fats %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fats %28%1966-1986%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fats %28%1966-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fats, Unsaturated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fiber' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Fibers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Formulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Habit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Iron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Modifications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Oil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Phosphorus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Potassium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Proteins %28%1966-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Proteins %28%1994-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Record' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Records' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Service' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Services' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Sodium Chloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Sucrose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Sugars' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Supplement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Supplementations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Supplements' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary Yolk Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietary practice of completely avoiding meat products in their DIET, consuming vegetables, grains, and nuts. Some who are called lacto-ovo also include milk and egg products.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietetics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietetics %28%1966-1967%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethoxycarbonyldihydrocollidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyl Dicarbonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyl Ether' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyl Oxydiformate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyl Pyrocarbonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyl p Nitrophenyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyl-p-Nitrophenyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylamide, Lysergic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylamide, Nicotinic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylamines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylamines %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylamines %28%1974-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylaminoethyldextran' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylaminoethyldiphenylpropyl Acetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylcarbamazine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylcarbamodithioic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyldithiocarbamate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyldithiocarbamate, Zinc' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethyldithiocarbamic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylenetriamine Pentaacetic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylenetriaminepenta-acetic Acid, Gadolinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylhexyl Phthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylmalonylurea' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylnicotinamid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylnitrosamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylpropion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylpyrocarbonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diethylstilbestrol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietil retard' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietil-retard' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dietilretard' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets which become fashionable, but which are not necessarily nutritious.%28%Lehninger 1982, page 484%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Atherogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Carbohydrate-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Cariogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Chemically Defined' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Diabetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Elemental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Fat-Free' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Fat-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Formula' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Low Carbohydrate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Low-Fat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Low-Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Low-Salt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Low-Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Macrobiotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Mediterranean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Protein-Free' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Protein-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Reducing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Salt-Free' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Sodium-Restricted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Synthetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Vegan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diets, Vegetarian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difaterol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diferuloylmethane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difference Limen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difference Limens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difference, Individual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difference, Just-Noticeable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difference, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differences of opinion or disagreements that may arise, for example, between health professionals and patients or their families, or against a political regime.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differences, Individual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differences, Just-Noticeable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differences, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Different forms of a protein that may be produced from different genes, or from the same gene by alternative splicing.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Diagnoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Diagnosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Display, mRNA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Displays, mRNA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Leukocyte Count' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Leukocyte Counts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Mortalities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Mortality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Scanning Calorimetry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Thermal Analyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Thermal Analysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Thermal Analysis, Calorimetric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Threshold' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential Thresholds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential response to different stimuli. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differential, Semantic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentials, Semantic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiated epithelial cells of the INTESTINAL MUCOSA, found in the basal part of the intestinal crypts of Lieberkuhn. Paneth cells secrete GROWTH FACTORS, digestive enzymes such as LYSOZYME and antimicrobial peptides such as cryptdins %28%ALPHA-DEFENSINS%29% into the crypt lumen.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, B Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, B Lymphocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, B-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, B-Lymphocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, Leukocyte, Human' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, Myelomonocytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, T Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, T Lymphocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, T-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, T-Lymphocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Antigens, VLA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Associated Na Dependent Inorganic Phosphate Cotransporter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Disorder, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Disorder, Sexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Disorders, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Disorders, Sexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Factor 2, B Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Factor, B Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Factor, B-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Factor, Eosinophil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Factor, neu' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Factor-2, B-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Markers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Proteins Inhibitor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation Reversal Factor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation antigens expressed on B-lymphocytes and B-cell precursors. They are involved in regulation of B-cell proliferation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation antigens expressed on a variety of cell lines including myeloid and lymphoblastoid cell lines. They are members of the tumor necrosis receptor superfamily involved in the regulation of peripheral immune responses and APOPTOSIS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation antigens expressed on pluripotential hematopoietic cells, most human thymocytes, and a major subset of peripheral blood T-lymphocytes. They have been implicated in integrin-mediated cellular adhesion and as signalling receptors on T-cells.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. CD8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC %28%Major Histocompatibility Complex%29% Class I-restricted interactions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation of male and female tissues and organs during embryogenesis, but after sex determination %28%SEX DETERMINATION %28%GENETICS%29%;%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation-Associated Na-Dependent Inorganic Phosphate Cotransporter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiation-Inducing Protein, Myeloid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Differentiations, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difficult or labored breathing. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difficulty Ambulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difficulty Walking' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difficulty in walking from place to place. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffraction Microscopy, Electron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffraction, Neutron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffraction, Powder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffraction, X-Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffraction, Xray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffractions, Neutron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffractions, X-Ray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffractions, Xray' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Axonal Injuries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Axonal Injury' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Brain Injuries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Brain Injury' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Cerebral Scleroses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Cerebral Sclerosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Cerebral Sclerosis of Schilder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Cerebral Sclerosis of Schilder %28%1966-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Cutaneous Leishmaniases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Cutaneous Leishmaniasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Esophageal Spasm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Esophageal Spasms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Globoid Body Sclerosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Histiocytic Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Histiocytic Lymphomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Idiopathic Skeletal Hyperostosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Immunoblastic Lymphosarcoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Immunoblastic Lymphosarcomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Large Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Large Follicular Center Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Large Follicular Center-Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Large-Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Large-Cell Lymphomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lewy Body Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lymphoblastic Lymphosarcoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lymphoblastic Lymphosarcomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lymphocytic Lymphoma, Poorly Differentiated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lymphocytic Lymphoma, Poorly-Differentiated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Lymphomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Mixed Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Mixed Small and Large Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Mixed-Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Mixed-Cell Lymphomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Myofascial Pain Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Scleroderma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Scleroses, Myelinoclastic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Sclerosis, Myelinoclastic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Small Cleaved Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Small Cleaved-Cell Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Undifferentiated Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Undifferentiated Lymphomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Well Differentiated Lymphocytic Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse Well-Differentiated Lymphocytic Lymphoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffuse or local inflammation and edema of the interstitial tissue of the kidney, including the tubules.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusing Capacity, Pulmonary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion %28%1966-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion %28%1968-1970%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion Chamber, Culture' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion Chambers, Culture' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion MRI' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion MRIs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion Magnetic Resonance Imaging' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion Test, Gel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion Tests, Gel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion Weighted MRI' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion of Innovation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusion, Innovation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diffusions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diflubenzuron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diflucortolone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diflunisal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diflunisal Novopharm Brand' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Difluoride, Tin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digenic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Brand of Pancrelipase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Epilepsies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Epilepsy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Physiologies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Physiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System %28%1997-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Abnormalities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Abnormality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Cancer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Cancers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Diagnostic Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Diagnostic Technics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Diagnostic Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Diagnostic Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Endoscopic Surgery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Endoscopies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Endoscopy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Fistula' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Fistulas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Neoplasm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Neoplasms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Neoplasms %28%1988-2004%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Surgical Procedure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System Surgical Procedures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System/abnormalities %28%1968-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive System/physiology %28%1970-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Tract Content' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Tract Contents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive Tracts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive system manifestations of diseases of the gastrointestinal system or of other organs.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digestive, Oral, and Skin Physiology' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digilanides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Assistant, Personal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Computer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Computers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Libraries' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Library' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Radiography, Dental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Rectal Examination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Rectal Examinations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Scan Projection Radiography, Dual Energy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Scan Projection Radiography, Dual-Energy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Scanned Projection Radiography, Dual Energy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Scanned Projection Radiography, Dual-Energy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Signal Processing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital Subtraction Angiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digital image data sets, created by the NATIONAL LIBRARY OF MEDICINE, consisting of complete, anatomically detailed, three-dimensional representations of the normal male and female human bodies. The images were generated from carefully selected and prepared CADAVERS in three modes: computerized tomography %28%TOMOGRAPHY, X-RAY COMPUTED%29%, magnetic resonance %28%MAGNETIC RESONANCE IMAGING%29% and cryosection %28%CRYOSECTIONING%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitalis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitalis Glycosides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitalis Glycosides %28%1966-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitalis glycosides; do not confuse with ACETYLDIGITOXINS; alpha isomer %26% beta isomer go here%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitaria' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitonin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitoxigenin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digitoxin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglyceride Acyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglyceride Kinase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglyceride Lipase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglycerides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglycerides %28%1975-1980%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglycerides, CDP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglycerides, Cytidine Diphosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diglycine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dignity, Death with' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digoras' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digoxigenin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digoxin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digoxin %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Digoxin/AA %28%1975-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihematoporphyrin Ester' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihematoporphyrin Ether' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihomo gamma Linolenic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihomo-gamma-Linolenic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihomogammalinolenic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydergot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydralazine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrallazine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate Calcium Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate Doxycycline Monohydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate Pipecuronium Dibromide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate Tolmetin Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Apazone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Azithromycin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Calcium Chloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Calcium Oxalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Carbamazepine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Cephaloglycin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Cephradine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Hexamethonium Dibromide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Hexamethonium Dichloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Ondansetron Monohydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrate, Oxytetracycline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrazinophthalazin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydride, Cephalexin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydride, Naloxone Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro Orotase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro Orotate Amidohydrolase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro Orotate Oxidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro analog of beta-erythroidine, which is isolated from the seeds and other plant parts of Erythrina sp. Leguminosae. It is an alkaloid with curarimimetic properties.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro beta Erythroidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro-2%28%3H%29%-furanone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro-Orotase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro-Orotate Amidohydrolase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro-Orotate Oxidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydro-beta-Erythroidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroalprenolol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrobenzopyrans' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrobenzopyrene Diols' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrobromide, Betahistine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrobromide, Cystamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrobromide, beta-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride Cinnarizine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, 2-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Acriflavine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Betahistine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Betazole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Bombesin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Cetirizine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Clonidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Cystamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Cysteamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Dianisidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Diazacholesterol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Dimaprit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Emetine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Flunarizine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Flurazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Histamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Imidocarb' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Meclizine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Metoclopramide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Perazine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Pirenzepine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Quinacrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, Trimetazidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochloride, beta-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrochlorothiazide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrocholesterol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrocodeinone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrodiethylstilbestrol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrodiolbenzopyrenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrodiols, Benzopyrene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrodipicolinate Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrodipicolinic Acid Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergocornine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergocristine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergocristine Mesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergocryptine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergokryptine Mesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergokryptine Monomesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotamine Methanesulfonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotamine Sandoz' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotamine-Sandoz' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxine %28%1975-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxine %28%1991-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxine Mesylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxine Methanesulfonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroergotoxine Monomethanesulfonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrofolate Dehydrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrofolate Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroharmine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrohydroxycodeinone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroiodide, 2-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroiodide, beta-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolase, GTP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoamide Acetyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoamide Dehydrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoamide S Acetyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoamide S-Acetyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoyl Acetyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoyl Dehydrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoyl Transacetylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoyllysine Residue Acetyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrolipoyllysine-Residue Acetyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydromorphine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydromorphinone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydromorphinone %28%1966-1968%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydronicotinamide Adenine Dinucleotide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydronorguaiaretic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrooleic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroorotase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroorotate Oxidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroprogesterone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroprogesterone %28%1976-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropteridine Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropteridine Reductase Deficiency Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropteroate Pyrophosphorylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropteroate Synthase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropteroate Synthetase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropyridine Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropyridine Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropyridines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropyridines %28%1991-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydropyrimidine Dehydrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrostreptomycin Sulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrotachysterin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrotachysterol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrotestosterone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrothymine Dehydrogenase %28%NAD%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrothymine Dehydrogenase %28%NADP%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroubiquinone Cytochrome c Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroubiquinone-Cytochrome-c Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrouracil Dehydrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrouracil Dehydrogenase %28%NAD%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrouracil Dehydrogenase %28%NAD+%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydrouracil Dehydrogenase %28%NADP%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxide, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyacetone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyacetone 3 Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyacetone 3-Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyacetone Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyanthranol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxybutanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxycholanoic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxycholecalciferols' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxycholecalciferols %28%1973-1981%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxycholecalciferols %28%1973-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxydihydrobenzopyrenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyethanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyisovalerate Dehydrogenase %28%Isomerizing%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyphenylalanine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxypregnadienes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyprogesterone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyprogesterone Acetophenide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxypropyltheophylline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxytryptamines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyvitamin D3, 24,25' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dihydroxyvitamins D' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodide, Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodide, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodide, Propidium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodide, Succinylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodohydroxyquin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodohydroxyquinoline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodothyronines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodotyrosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodotyrosine Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diiodotyrosine Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diisocyanate, Toluene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diisocyanate, Tolylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diisopropylfluorophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diisopropylphosphofluoridate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diisopyramide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diketobutane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diketopregnanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diketopregnenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dikinase Pyruvate, Orthophosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dikinase Pyruvate, Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dikinase Pyruvate, Pi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dikinase, Phosphopyruvate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation %26% Curettage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation %28%1968-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation %28%1968-1981%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation %28%1976-1987%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation %28%1978-1981%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation %28%1980-1987%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation and Curettage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation of an occluded coronary artery %28%or arteries%29% by means of a balloon catheter to restore myocardial blood supply.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by DIARRHEA; HYPOPROTEINEMIA; peripheral and/or abdominal EDEMA; and PROTEIN-LOSING ENTEROPATHIES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Balloon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Cervical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Pathologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Pathological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatation, Transluminal Arterial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatations, Balloon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatations, Cervical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatations, Pathologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatations, Pathological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilatations, Transluminal Arterial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilated Cardiomyopathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilated Cardiomyopathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation %28%PORTAL SYSTEM%29% to the systemic venous circulation. Often they are observed in individuals with portal hypertension %28%HYPERTENSION, PORTAL%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilation, Balloon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilation, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilation, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilations, Balloon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilazep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilemma, Prisoner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilemma, Prisoner%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilemma, Prisoners' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilemmas, Prisoner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilemmas, Prisoner%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilemmas, Prisoners' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilithium Carbonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dill Plant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dill Weed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilleniaceae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diltiazem' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Count, Agar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Counts, Agar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technic, Dye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technic, Indicator' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technic, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technics, Dye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technics, Indicator' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technics, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technique, Dye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technique, Indicator' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Technique, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Techniques, Dye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Techniques, Indicator' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dilution Techniques, Radioisotope' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimaleate, Methysergide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimaprit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimeglumine, Gadolinium DTPA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimeglumine, Gadopentetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimelor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimenhydrinate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimension, Rest Vertical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimension, Vertical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimensions, Rest Vertical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimensions, Vertical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimer, Thymine-Cyclobutane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimer, Thymine-Thymine Cyclobutane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimercaprol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimercaptosuccinate, Tin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimercaptosuccinic Acid, Tc-99m' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimeric cell surface receptor involved in angiogenesis %28%NEOVASCULARIZATION, PHYSIOLOGICAL%29% and axonal guidance. Neuropilin-1 is a 140-kDa transmembrane protein that binds CLASS 3 SEMAPHORINS, and several other growth factors. Neuropilin-1 forms complexes with plexins or VEGF RECEPTORS, and binding affinity and specificity are determined by the composition of the neuropilin dimer and the identity of other receptors complexed with it. Neuropilin-1 is expressed in distinct patterns during neural development, complementary to those described for NEUROPILIN-2.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimerization' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimerization Partner 1 Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimerizations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers %28%homo and hetero%29% of FLAVONOIDS. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers and oligomers of flavan-3-ol units %28%CATECHIN analogs%29% linked mainly through C4 to C8 bonds to leucoanthocyanidins. They are structurally similar to ANTHOCYANINS but are the result of a different fork in biosynthetic pathways.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers found in DNA chains damaged by ULTRAVIOLET RAYS. They consist of two adjacent PYRIMIDINE NUCLEOTIDES, usually THYMINE nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers block DNA REPLICATION.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers, Cyclobutane-Pyrimidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers, Cytosine-Thymine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers, Pyrimidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimers, Thymine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimesylate, Quinacrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimetane Ten' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimetapp Allergy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethadione' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethindene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethisterone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethoate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethoxyphenyl Penicillin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethoxyphenylethylamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethpyrindene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Adipimate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Adipimidate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Adipinamidate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Dichlorovinyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Imidazole Carboxamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl N aminoantipyrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Suberimidate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Sulfoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Sulphoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl Triazeno Imidazole Carboxamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl-N-aminoantipyrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyl-p-%28%m-tolylazo%29%aniline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylallyltransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylallyltranstransferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylamines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylamines %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylamines %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylamines %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylamines %28%1974-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylaminoantipyrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylaminoazobenzene %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylaminoethanol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylaminonaphthalenesulfonyl Compounds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylaminophenazone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylarsinate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylarsinic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylbenzenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylbiguanidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylcysteine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyldiketone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyldioxanedione Polymer with Dioxanedione Polymer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyldithiocarbamate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyldithiocarbamate, Zinc' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyleneimines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylergometrin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylethanolamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylformamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylglycine Dehydrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylglyoxal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylguanylguanidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylhydrazines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylhydrazines %28%1977-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylmeperidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylnitrosamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylnitrosamine N Demethylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylnitrosamine N-Demethylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyloxazolidinedione' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylphenylene Bis Thioallophanate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylphenylpiperazinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylphenylpiperazinium Iodide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylpolysiloxanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylserotonin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylsuberimidate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylsulfate, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylsulfoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylsulphinyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethylsulphoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyltryptamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimethyltryptamine %28%1973-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimetindene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimetridazole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimetriose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminazene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished Vision' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished effectiveness of INSULIN in lowering blood sugar levels: Requiring the use of 200 units or more of insulin per day to prevent hyperglycemia or ketosis. It is usually due to insulin binding by antibodies %28%INSULIN ANTIBODIES%29%, but abnormalities in insulin receptors %28%RECEPTOR, INSULIN%29% on cell surfaces also occur. It is associated with obesity, ketoacidosis, infection, and certain rare conditions. %28%from Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished or absent ability of a female to achieve conception.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished or absent ability of the male to effect conception.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished, Pain Sensation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminished, Pinprick Sensation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminisheds, Pain Sensation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminisheds, Pinprick Sensation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland %28%including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN%29%. This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimorphism, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimorphisms, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimorphous Leprosies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimorphous Leprosy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimpylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimycolates, Trehalose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimyristoyllecithin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dimyristoylphosphatidylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitolmide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrate, Isosorbide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrilotetraacetate, Disodium Ethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrilotetraacetate, Ethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrobenzenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrochlorobenzene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrocresols' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrofluorobenzene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrogenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrogenase Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrophenols' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrophenols %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrophenols %28%1980-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinitrotoluamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoflagellates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoflagellida' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoflagellida %28%1998%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoprost' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoprost %28%1992-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoprost %28%1994-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinoprostone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinosaur' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinosaurs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleoside Phosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleoside Phosphates %28%1989-1995%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleoside Phosphates %28%1989-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleosome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleotide Phosphate, Nicotinamide-Adenine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleotide Repeat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleotide Repeats' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleotide, Dihydronicotinamide Adenine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleotide, Flavin-Adenine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dinucleotide, Nicotinamide-Adenine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctophyma renale Infection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctophymatoidea' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctyl Phthalate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctyl Sulfosuccinate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctyl Sulfosuccinate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctyl Sulfosuccinic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctylsulfosuccinate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioctylsulphosuccinate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diodone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diodoquin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diodoxyquinoline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioflubenzuron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diol Dehydrase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diol Dehydratase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diolamine, Sulfisoxazole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diolefins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diols, Dihydrobenzopyrene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioncophyllaceae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioptic Brand of Acetazolamide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioptic Brand of Bacitracin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioptic Brand of Fluorescein Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioscorea' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioscoreaceae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diosgenin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diosmin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diospyros' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxanedione Polymer with Dimethyldioxanedione Polymer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxanes %28%1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxanes %28%1985-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxide Snow, Carbon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxide, Carbon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxide, Nitrogen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxide, Silicon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxide, Sulfur' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxide, Thorium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxin Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxin Receptor, Nuclear Translocator' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxin Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxins %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxins %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxins %28%1982-1984%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxolanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxolanes %28%1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxolanes %28%1978-1982%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1968-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1969-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1970-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1971-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1972-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxoles %28%1974-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxopregnanes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxopregnenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygen, Singlet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase gamma-Butyrobetaine, 2-Oxoglutarate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, 4-Hydroxyphenylpyruvate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, Carotene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, Cysteine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, Homogentisate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, IDO' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, Lysine 2-Oxoglutarate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, Procollagen-Proline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, TDO' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, gamma-Butyrobetaine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenase, gamma-Butyrobetaine,2-Oxoglutarate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenases %28%1969-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dioxygenases %28%2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipalmitoyl Phosphatidylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipalmitoylglycerophosphocholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipalmitoyllecithin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipalmitoylphosphatidylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidase, N-Acetylated-alpha-Linked Acidic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidases %28%1966-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidases %28%1988-1998%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidases/antagonists %26% inhibitors %28%1983-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptide, Muramyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptides %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptides %28%1966-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptides %28%1974-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptides %28%1981-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Aminopeptidase I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Aminopeptidases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Carboxypeptidase, Enkephalin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Peptidase A' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Peptidase I' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Peptidase IV' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Peptidases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Peptidases %28%1980-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Peptidases %28%1984-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl Transferase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidyl-Peptidase IV' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipeptidylpeptide Hydrolases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diperchlorate, 2-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diperchlorate, Hexamethonium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diperchlorate, Succinylcholine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diperchlorate, beta-Aminoethylisothiuronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipetalonema' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipetalonema Infection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipetalonema Infections' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenhydramine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenhydramine Citrate %28%1:1%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenhydramine Theoclate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenol Oxidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenol Oxidases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenol Oxidases %28%1968-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenoxylate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylacetic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylbutazone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylcarbazide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylglyoxal Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylhexatriene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylhydantoin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylhydantoinate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylhydramin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylhydramine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylmethyl Compounds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylthiocarbazone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphenylurea Compounds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphatase, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Carboxylase, Ribulose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Choline, Cytidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Diglycerides, Cytidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Fucose, Guanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Galactose, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Glucose, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Glucose, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Kinases, Deoxynucleoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Mannose, Guanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate N-Acetylgalactosamine, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate N-Acetylglucosamine, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Reductase, Ribonucleoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Ribose, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Sugars, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Sugars, Guanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Sugars, Nucleoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Sugars, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Synthase, Farnesyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Synthetase, Farnesyl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate Xylose, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Calcium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Cytidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Guanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Inosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Primaquine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphate-Ribose, Poly-Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphates, Dinucleoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphospho-N-Acetylglucosamine, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphodiacylglycerols, Cytidine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphofucose, Guanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphogalactose, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglucose Pyrophosphorylase, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglucose, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglucose, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglucuronic Acid, Uridine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglycerate Mutase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglyceric Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglyceric Acids %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglyceric Acids %28%1980-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoglyceromutase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphohydrolase, ATP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphokinases, Nucleoside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphomannose, Guanosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonate, 99mTc-Methylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonate, Dichloromethane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonate, Dichloromethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonate, Disodium 1-Hydroxyethylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonate, Tc-99m Methylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonate, Technetium Methylene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonates %28%1977-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonates %28%1987-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphonic Acid, Hydroxyethylidene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphopyridine Nucleotidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphopyridine Nucleotidases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphopyridine Nucleotide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoribose, Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoribosyltransferase, Nuclear Adenosine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoric Acid, Technetium Salt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphoric acid esters of fructose. The fructose-1,6- diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphosphotransferases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Antitoxin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Pertussis Tetanus Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Tetanus Pertussis Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Tetanus Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Tetanus acellular Pertussis Vaccines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Toxin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Toxoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Toxoid %28%1966-1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Toxoid %28%1983-2000%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria, Fowl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria-Pertussis-Tetanus Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria-Tetanus Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria-Tetanus-Pertussis Vaccine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria-Tetanus-Pertussis Vaccine %28%1996-2000%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtheria-Tetanus-acellular Pertussis Vaccines' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtherias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphtherias, Fowl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphylline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphyllobothriases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphyllobothriasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphyllobothrium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diphyllobothrium %28%1966-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplegia, Spastic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplegias, Spastic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplegic Infantile Cerebral Palsy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplococcus pneumoniae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploid Cells' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploidies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploidy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploma Program, Nursing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diploma Programs, Nursing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplomonadida' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplonema' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplonemas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopia %28%1966-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopia, Monocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Cortical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Horizontal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Intermittent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Monocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Refractive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Unilateral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diplopias, Vertical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipodidae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipodomys' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipotassium Chlorazepate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipotassium Salt Succimer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipotassium Salt, Fluorescein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipotassium Salt, Gossypol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipotassium, Clorazepate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diprenorphine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diprophylline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipropionate, Beclomethasone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipsacaceae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diptera' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diptera %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diptera %28%1966-1987%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diptera %28%1967-2002%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diptera %28%1975-1980%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipteryx' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipydolor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipylidiases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyramidole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyridamole' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyridoxolyldisulfide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyridyl, 2,2' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyridyl, 2,2%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyrone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyronium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dipyroxime' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diquat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Expenditure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Expenditures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Fluorescent Antibody Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Fluorescent Antibody Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescence Assay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescence Assays' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescence Technic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescence Technics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescence Technique' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescence Techniques' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Immunofluorescences' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct In Situ Copy PCR' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Inguinal Hernia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Inguinal Hernias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Lytic Factors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Repeats' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Service Cost' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct Service Costs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct contact of a cell with a neighboring cell. Most such junctions are too small to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. %28%From Alberts et al., Molecular Biology of the Cell, 2d ed, p792%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Direct myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. The internal mammary artery is the most frequent choice, especially for a single graft, for coronary artery bypass surgery.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Donation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Donations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Gamete Donations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Molecular Evolution' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Molecular Evolutions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Organ Donations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Reverie Therapies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Tissue Donation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed Tissue Donations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directional Coronary Atherectomies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directions written for the preparation and administration of a drug.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directive Adherence, Advance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directive Adherences' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directive Compliance, Advance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directive Counseling' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directive, Advance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directive, Ethical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directives, Advance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directives, Ethical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directly Observed Therapy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Director, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directories' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directories, Location' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directors, Medical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directory %28%PT%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directory %5B%Publication Type%5D%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directory signs or listings of designated areas within or without a facility.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Directory, Location' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dirofilaria' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dirofilaria immitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dirofilariases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dirofilariasis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dirt Bikes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dirt-Bike' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, Acquired Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, Communication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, Developmental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, Developmental Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, Learning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, People with' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabilities, Persons with' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Claim, Veterans' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Claims, Veterans' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Evaluation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Evaluation %28%1966-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Evaluations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Insurance' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability Leaves' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Acquired Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Children with' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Communication' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Developmental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Developmental Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Learning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disability, Persons with' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled %28%1983-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled Child' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled Children' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled Person' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled Persons' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled, Dentistry for' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled, Mentally' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disabled, Physically' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaccharidases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaccharides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaccharides %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaccharides %28%1971-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disadvantagement, Cultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disadvantagements, Cultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disagreement, Professional-Family' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disagreement, Professional-Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disagreements, Professional-Family' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disagreements, Professional-Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disappearance of a neoplasm or neoplastic state without the intervention of therapy.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disappearing Bone Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disarticulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disarticulation Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disarticulation Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disarticulations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disassembly, Chromatin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaster' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaster Planning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaster Plannings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaster, Chornobyl Nuclear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disaster, Natural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disasters' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disasters %28%1966-1968%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disasters %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disasters %28%1966-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disasters, Chornobyl Nuclear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disasters, Natural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disc Displacement, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disc Displacements, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disc Electrophoresis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disc, Compact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disc, Herniated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disc, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discarded animal and vegetable matter from a kitchen or the refuse from food preparation. %28%From Random House College Dictionary, 1982%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discectomies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discectomies, Percutaneous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discectomy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discectomy, Percutaneous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharge Plannings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx. This is usually associated with CRANIOCEREBRAL TRAUMA %28%e.g., SKULL FRACTURE involving the TEMPORAL BONE;%29%, NEUROSURGICAL PROCEDURES; or other conditions, but may rarely occur spontaneously. %28%From Am J Otol 1995 Nov;16%28%6%29%:765-71%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharge of cerebrospinal fluid through the nose. Common etiologies include trauma, neoplasms, and prior surgery, although the condition may occur spontaneously. %28%Otolaryngol Head Neck Surg 1997 Apr;116%28%4%29%:442-9%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharge, Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharge, Vaginal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharges, Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discharges, Vaginal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discipline or activities related to WEIGHT REDUCTION in patients with OBESITY. Treatment methods include DIET; EXERCISE; BEHAVIOR MODIFICATION; medications; and bariatric surgeries.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discipline, Employee' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discipline, Personnel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disciplines concerned with the study of human and animal behavior.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disciplines that apply sciences to law. Forensic sciences include a wide range of disciplines, such as TOXICOLOGY; FORENSIC ANTHROPOLOGY; FORENSIC MEDICINE; FORENSIC DENTISTRY; and others.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disciplines, Employee' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disciplines, Personnel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosure, Financial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosure, Information' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosure, Self' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosure, Truth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosures, Financial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosures, Self' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disclosures, Truth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discoid Lupus Erythematosus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discoloration, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discolorations, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discolyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discolysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discomfort and partial inhibition of the usual forms of behavior when in the presence of others.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discomfort or more intense forms of pain that are localized to the cervical region. This term generally refers to pain in the posterior or lateral regions of the neck.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discoveries, Incidental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discovery, Incidental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete Subaortic Stenoses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete Subaortic Stenosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete abnormal tissue masses that protrude into the lumen of the DIGESTIVE TRACT or the RESPIRATORY TRACT. Polyps can be spheroidal, hemispheroidal, or irregular mound-shaped structures attached to the MUCOUS MEMBRANE of the lumen wall either by a stalk, pedunculus, or by a broad base.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete abnormal tissue masses that protrude into the lumen of the INTESTINE. A polyp is attached to the intestinal wall either by a stalk, pedunculus, or by a broad base.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete clusters of pyramidal and polymorphic cells in the caudal part of the anterior perforated substance. The morphology, connections, and neurotransmitters associated with these cells suggest they are part of the striatopallidal system.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete concentrations of energy, apparently massless elementary particles, that move at the speed of light. They are the unit or quantum of electromagnetic radiation. Photons are emitted when electrons move from one energy state to another. %28%From Hawley%27%s Condensed Chemical Dictionary, 11th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS %28%insertion sequence%29% elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrete tissue masses that protrude into the lumen of the COLON. These POLYPS are connected to the wall of the colon either by a stalk, pedunculus, or by a broad base.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discretionary Adjustment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discretionary Adjustment Factors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discretionary Adjustments' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discriminant Analyses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discriminant Analysis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination %28%Psychology%29% %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination %28%Psychology%29% %28%1968-1993%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Disorder, Somatosensory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Disorders, Somatosensory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Learning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Learning %28%1966-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Learnings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Test, Speech' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination Tests, Speech' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination, Pitch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discrimination, Speech' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discriminations %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discriminations, Pitch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discriminatory Aphasia, Auditory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discriminatory Aphasias, Auditory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discs, Compact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discs, Herniated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discs, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Discussions with patients and/or their representatives about the goals and desired direction of the patient%27%s care, particularly end-of-life care, in the event that the patient is or becomes incompetent to make decisions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Attribute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Attributes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Clusterings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Cost' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Costs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Free Survival' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Frequency Survey' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Frequency Surveys' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Management' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Managements' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Manifestation, Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Manifestations, Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Model, Animal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Models, Animal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Models, Animal %28%1967-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Models, Autoimmune, Nervous System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Modifying Antirheumatic Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Modifying Second Line Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Notification' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Notifications' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Outbreak' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Outbreaks' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Outbreaks %28%1966-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Outbreaks %28%1976-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Progression' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Progressions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Reporting, Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Reportings, Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Reservoir' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Reservoirs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Susceptibilities' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Susceptibility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Horizontal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Patient Professional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Patient to Professional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Patient-Professional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Patient-to-Professional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Professional Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Professional to Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Professional-Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Professional-to-Patient' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmission, Vertical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmissions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Transmissions, Horizontal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Vaccines, Marek' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Vector' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Vectors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease Virus, Bornholm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease caused by the liberation of exotoxins of CLOSTRIDIUM PERFRINGENS in the intestines of sheep, goats, cattle, foals, and piglets. Type B enterotoxemia in lambs is lamb dysentery; type C enterotoxemia in mature sheep produces %22%struck%22%, and in calves, lambs and piglets it produces hemorrhagic enterotoxemia; type D enterotoxemia in sheep and goats is pulpy-kidney disease or overeating disease.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease having a short and relatively severe course. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease involving a spinal nerve root %28%see SPINAL NERVE ROOTS%29% which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease involving the RADIAL NERVE. Clinical features include weakness of elbow extension, elbow flexion, supination of the forearm, wrist and finger extension, and thumb abduction. Sensation may be impaired over regions of the dorsal forearm. Common sites of compression or traumatic injury include the AXILLA and radial groove of the HUMERUS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease involving the ULNAR NERVE from its origin in the BRACHIAL PLEXUS to its termination in the hand. Clinical manifestations may include PARESIS or PARALYSIS of wrist flexion, finger flexion, thumb adduction, finger abduction, and finger adduction. Sensation over the medial palm, fifth finger, and ulnar aspect of the ring finger may also be impaired. Common sites of injury include the AXILLA, cubital tunnel at the ELBOW, and Guyon%27%s canal at the wrist. %28%From Joynt, Clinical Neurology, 1995, Ch51 pp43-5%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease involving the common PERONEAL NERVE or its branches, the deep and superficial peroneal nerves. Lesions of the deep peroneal nerve are associated with PARALYSIS of dorsiflexion of the ankle and toes and loss of sensation from the web space between the first and second toe. Lesions of the superficial peroneal nerve result in weakness or paralysis of the peroneal muscles %28%which evert the foot%29% and loss of sensation over the dorsal and lateral surface of the leg. Traumatic injury to the common peroneal nerve near the head of the FIBULA is a relatively common cause of this condition. %28%From Joynt, Clinical Neurology, 1995, Ch51, p31%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease involving the femoral nerve. The femoral nerve may be injured by ISCHEMIA %28%e.g., in association with DIABETIC NEUROPATHIES%29%, nerve compression, trauma, COLLAGEN DISEASES, and other disease processes. Clinical features include MUSCLE WEAKNESS or PARALYSIS of hip flexion and knee extension, ATROPHY of the QUADRICEPS MUSCLE, reduced or absent patellar reflex, and impaired sensation over the anterior and medial thigh.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease involving the median nerve, from its origin at the BRACHIAL PLEXUS to its termination in the hand. Clinical features include weakness of wrist and finger flexion, forearm pronation, thenar abduction, and loss of sensation over the lateral palm, first three fingers, and radial half of the ring finger. Common sites of injury include the elbow, where the nerve passes through the two heads of the pronator teres muscle %28%pronator syndrome%29% and in the carpal tunnel %28%CARPAL TUNNEL SYNDROME%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease of CARDIAC MUSCLE resulted from chronic excessive alcohol consumption. Myocardial damage can be caused by: %28%1%29% a toxic effect of alcohol; %28%2%29% malnutrition in alcoholics such as THIAMINE DEFICIENCY; or %28%3%29% toxic effect of additives in alcoholic beverages such as COBALT. This disease is usually manifested by DYSPNEA and palpitations with CARDIOMEGALY and congestive heart failure %28%HEART FAILURE, CONGESTIVE%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease of the TIBIAL NERVE %28%also referred to as the posterior tibial nerve%29%. The most commonly associated condition is the TARSAL TUNNEL SYNDROME. However, LEG INJURIES; ISCHEMIA; and inflammatory conditions %28%e.g., COLLAGEN DISEASES%29% may also affect the nerve. Clinical features include PARALYSIS of plantar flexion, ankle inversion and toe flexion as well as loss of sensation over the sole of the foot. %28%From Joynt, Clinical Neurology, 1995, Ch51, p32%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease of the glandular, anterior portion of the pituitary %28%PITUITARY GLAND, ANTERIOR%29% resulting in hypersecretion of ADENOHYPOPHYSEAL HORMONES such as GROWTH HORMONE; PROLACTIN; THYROTROPIN; LUTEINIZING HORMONE; FOLLICLE STIMULATING HORMONE ; and CORTICOTROPIN. Hyperpituitarism usually is caused by a functional ADENOMA.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease or damage involving the SCIATIC NERVE, which divides into the PERONEAL NERVE and TIBIAL NERVE %28%see also PERONEAL NEUROPATHIES and TIBIAL NEUROPATHY%29%. Clinical manifestations may include SCIATICA or pain localized to the hip, PARESIS or PARALYSIS of posterior thigh muscles and muscles innervated by the peroneal and tibial nerves, and sensory loss involving the lateral and posterior thigh, posterior and lateral leg, and sole of the foot. The sciatic nerve may be affected by trauma; ISCHEMIA; COLLAGEN DISEASES; and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, p1363%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease or injury involving multiple SPINAL NERVE ROOTS. Polyradiculitis refers to inflammation of multiple spinal nerve roots.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ISCHEMIA; traumatic injury; compression; CONNECTIVE TISSUE DISEASES; CUMULATIVE TRAUMA DISORDERS; and other conditions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Acute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Acute Neuronopathic Gaucher' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Addison' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Adenohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Adnexal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Adrenal Cortex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Adrenal Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Agricultural Worker' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Agricultural Worker%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Agricultural Workers%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Albers-Schoenberg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Aleutian Mink' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Alpers%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Alzheimer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Alzheimer%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Andersen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Andersen%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Anderson-Fabry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Animal Parasitic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Anterior Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Anti-GBM' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Anus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Aortic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ape' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Arterial Obstructive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Arterial Occlusive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Aspartoacylase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Atypical Inclusion-Body' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Autoimmune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Avian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Azorean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Azorean %28%Machado-Joseph%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bacterial Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bacterial Venereal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bang' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bang%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Barter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Barter%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bartter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bartter%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Basedow' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Basedow%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bazin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bazin%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bechterew' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bechterew%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Berger' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Berger%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Beryllium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Besnier-Boeck' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Betalipoprotein Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bile Duct' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Biliary Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Binswanger' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bird' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bladder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bone Marrow' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bouillaud' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bouillaud%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bovine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bowen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bowen%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Breast' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bright' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Brill' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Brill%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Brill-Symmers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Brill-Zinsser' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Broad Beta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Bronchial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Buerger' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Buerger%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Caisson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Canine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Caprine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Carcinoid Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cardiac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cardiovascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cardiovascular %28%Specialty%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Caroli' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Caroli%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Carrion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Carrion%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cartilage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cat-Scratch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Catscratch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cattle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cecal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Celiac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cerebellar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cerebellum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cerebral Arterial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cerebral Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cervix' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Chagas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Chagas%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Choroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Choroidal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Christmas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Chronic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Chronic Gaucher' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Chronic Granulomatous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Classic Moyamoya' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cochlear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cold Agglutinin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Collagen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Communicable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Conjunctival' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Conn' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Conn%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Connective Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cori' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cori%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Corneal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Coronary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Coronary Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Coronary Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Corridor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cowden' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cowden%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Craniomandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Creutzfeldt-Jakob' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Crouzon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Crouzon%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cushing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cystic Breast' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cystic Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cystic Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Cytomegalic Inclusion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Danon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Darier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Darier%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, De Quervain' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Dejerine-Sottas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Dental Pulp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Dercum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Dercum%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Devic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Devic%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Di Guglielmo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Di Guglielmo%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Dog' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Duhring' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Duhring%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Duodenal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Eczematous Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ehlers-Danlos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Emerging Communicable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Emerging Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, End-Stage Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, End-Stage Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Endemic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Endocrine Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Endocrine Breast' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Endocrine System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Engelmann' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Engelmann%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Equine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Eulenburg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Eulenburg%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Extra-Mammary Paget' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Extra-Mammary Paget%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Extramammary Paget' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Extramammary Paget%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Eye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Eyelid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fabry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fabry%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Facial Nerve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fallopian Tube' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Familial Creutzfeldt-Jakob' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Feline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fetal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fibrocystic Breast' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fish' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Folling' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Folling%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fong' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Foot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Foot-and-Mouth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Forbes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Forestier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fothergill' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fox-Fordyce' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Friedreich' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Friedreich%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Frommel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Frommel%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fucosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fumarylacetoacetase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Functional Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fungal Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Fungus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Galactosylceramidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Galactosylceramide-beta-Galactosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gall Bladder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gallbladder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gastrointestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gaucher, Acute Neuronopathic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gaucher, Chronic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Genetic Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Genitourinary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gierke' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gierke%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gilbert' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gilbert%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gingival' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Glucocerebrosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Glycogen Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Goat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Graefe' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Graft-Versus-Host' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Graft-vs-Host' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Graves' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Graves%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Greasy Pig' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gunther' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Gunther%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Habermann' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Habermann%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hammond' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hammond%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hansen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hansen%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hashimoto' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hashimoto%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Heart Valve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Heartwater' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Heartworm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Heck' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Heck%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hematologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hematological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hemoglobin C' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hemoglobin F' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hemoglobin H' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hemoglobin S' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hemoglobin SC' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hepatic Veno-Occlusive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hereditary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hereditary Eye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hereditary Neurodegenerative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hers%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hirschsprung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hirschsprung%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hodgkin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hodgkin%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hodgkins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Homologous Wasting' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Horse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Horton' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Horton%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hurler' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hurler%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hurst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hurst%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hyaline Membrane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hypothalamic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Hypoxanthine-Phosphoribosyl-Transferase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, I-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Iatrogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ileal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Immune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Immune Complex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Immune System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Immunological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Inborn Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Inclusion Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Infectious Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Infectious Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Inflammatory Pelvic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Interstitial Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Intestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Iris' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ischemic Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Jakob-Creutzfeldt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Jaw' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Jejunal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Johne' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Johne%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Joseph' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Joseph Azorean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kawasaki' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kikuchi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kikuchi%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kikuchi-Fujimoto' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kimura' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Klippel-Trenaunay' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kugelberg-Welander' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Kyasanur Forest' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Labyrinth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lacrimal Apparatus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lafora' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lafora Body' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Laryngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Larynx' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Legg-Perthes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Legionnaire' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Legionnaires%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Leigh%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lesch-Nyhan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Letterer-Siwe' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lewandowsky-Lutz' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Libman-Sacks' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lip' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Liver' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lobstein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lobstein%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Luft' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Luft%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lumpy Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lutz-Lewandowsky' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lyme' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lymphatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Lysosomal Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Machado-Joseph' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Machado-Joseph Azorean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Male Genital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mammary Paget' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mammary Paget%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Marble Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Marie-Bamberger' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Marie-Struempell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mast-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Maxillary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, McArdle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, McArdle%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mediastinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Meleda' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Menetrier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Meniere' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Meniere%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Metabolic Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Metabolic Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mikulicz' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mikulicz%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Milroy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Milroy%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Minimal Residual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mitochondrial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Monkey' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Morquio' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Morquio%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Moschkowitz' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mouth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Moya-Moya' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Mucha-Habermann' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Musculoskeletal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Nail' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Nairobi Sheep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Nasopharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Nervous System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Neurodegenerative Hereditary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Neurohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Neurologic Autoimmune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Newcastle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Nose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Obstructive Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Occupational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ollier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ollier%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Orbital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ormond' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ormond%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Orphan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Osler-Rendu' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Osler-Vaquez' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Otorhinolaryngologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Otorhinolaryngological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ovarian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ovine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Owren' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Owren%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Papillon-Lefevre' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Papulosquamous Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Paranasal Sinus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parasitic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parasitic Intestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parasitic Liver' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parasitic Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parasitic Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parathyroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parotid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Parry-Romberg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pelvic Inflammatory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Penile' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Penis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Periapical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Periodontal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Peripheral Vascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Perthes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Peyronie' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Peyronie%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pharynx' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pick' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pick%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pituitary Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Placenta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Placental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Plant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pleural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Polycystic Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Polycystic Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pongidae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Posterior Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Postphlebitic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pott' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pott%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Poultry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Primary Moyamoya' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Primary Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Primate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Prostatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Psuedo-Hurler' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pulmonary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pulmonary %28%Specialty%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pulmonary Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Pulmonary Veno-Occlusive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Rare' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Rectal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Residual Minimal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Respiratory Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Retrocochlear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Rheumatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Rheumatic Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ritter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ritter%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Rodent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Romberg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Romberg%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Rosai-Dorfman' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Runt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, SC' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Salivary Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schamberg' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schamberg%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schaumann' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schaumann%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Scheuermann' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Scheuermann%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schilder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schilder%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Schueller-Christian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sclera' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Scleral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sebaceous Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Secondary Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Seitelberger%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sexually Transmitted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sheep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sigmoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sigmoid Colon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Silo Filler' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Silo Filler%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Silo Fillers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Silo Fillers%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Simmonds' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sixth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Slow Virus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sly' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sphingomyelinase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Spinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Splenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Staphylococcal Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Steely Hair' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Stomatognathic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Submandibular Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Sweat Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Swine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, TMJ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Takahara' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Takahara%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Talfan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tangier' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tarui' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tarui%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Temporomandibular Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Teschen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Testicular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Thalamic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Thoracic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Thyroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tick-Borne' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tongue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tracheal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Tsutsugamushi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, UDP-Galactose-4-Epimerase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Unverricht' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Ureteral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Urethral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Urinary Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Urogenital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Urologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Urological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Uterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Uterine Cervical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Uveal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Vaginal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Valvular Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Van Bogaert-Scherer-Epstein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Vascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Vascular Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Venereal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Vestibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Viral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Viral Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Viral Venereal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Virus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Vogt-Koyanagi-Harada' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Von Gierke' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Von Gierke%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Vulvar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Weber-Christian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Weil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Weil%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Werdnig Hoffman' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Werdnig-Hoffmann' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Werlhof' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Werlhof%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Whipple' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Whipple%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, White Heifer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, White Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Wolman' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Wolman%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, X-Linked Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, Y-Linked Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, alpha-Chain' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, alpha-Fucosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, alpha-L-Fucosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, von Willebrand' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease, von Willebrand%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease-Free Survival' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease-Free Survivals' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease-Modifying Antirheumatic Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disease-Modifying Second-Line Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases affecting the orderly growth and persistence of hair.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases caused by American hemorrhagic fever viruses %28%ARENAVIRUSES, NEW WORLD%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases caused by or resulting in abnormal functioning of heart valves.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases caused by the loss of one or more enzymes involved in the hydrolysis of mannoside linkages %28%MANNOSIDASES%29%. The defects in enzyme activity are primarily associated with genetic mutation of the genes that codes for a particular mannosidase isoenzyme.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles %28%e.g., intrinsic hand muscles%29% or occur as a generalized condition. These disorders may be associated with abnormal muscle SODIUM CHANNEL and CHLORIDE CHANNELS. MYOTONIC DYSTROPHY and MYOTONIA CONGENITA represent two relatively common forms of this disorder. Proximal myotonic myopathy often presents with myotonia and muscle pain in early adulthood and later in life thigh muscle weakness and cataracts develop. %28%From Adams et al., Principles of Neurology, 6th ed, p1392%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes %28%see MUSCULAR ATROPHY, SPINAL%29% the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy %28%BULBAR PALSY, PROGRESSIVE%29%, the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. %28%Adams et al., Principles of Neurology, 6th ed, p1089%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity %28%DRUG TOXICITY%29%; CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. %28%Adams et al., Principles of Neurology, 6th ed, pp1404-9%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy %28%GUILLAIN-BARRE SYNDROME%29% and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases due to factors involved in one%27%s employment. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases due to or propagated by sexual contact. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases existing at birth and often before birth, or that develop during the first month of life %28%INFANT, NEWBORN, DISEASES%29%, regardless of causation. Of these diseases, those characterized by structural deformities are termed ABNORMALITIES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in Twin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in Twins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in Twins %28%1966-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs %28%LIVER; BILIARY TRACT; PANCREAS%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in which arterial vessels are partially or completely obstructed or in which the blood flow through the vessels is impeded.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth %28%Duke%27%s disease%29%, fifth %28%ERYTHEMA INFECTIOSUM%29%, and sixth %28%EXANTHEMA SUBITUM%29% numeric designations survive as occasional synonyms in current terminology.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases in which there is a familial pattern of AMYLOIDOSIS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases involving the FALLOPIAN TUBES including neoplasms %28%FALLOPIAN TUBE NEOPLASMS%29%; SALPINGITIS; tubo-ovarian abscess; and blockage.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of BONES. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of Endocrine System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of Immune System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of Old World and New World monkeys. This term includes diseases of baboons but not of chimpanzees or gorillas %28%= APE DISEASES%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of any component of the brain %28%including the cerebral hemispheres, diencephalon, brain stem, and cerebellum%29% or the spinal cord.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of birds not considered poultry, therefore usually found in zoos, parks, and the wild. The concept is differentiated from POULTRY DISEASES which is for birds raised as a source of meat or eggs for human consumption, and usually found in barnyards, hatcheries, etc.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of chimpanzees, gorillas, and orangutans. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of domestic and mountain sheep of the genus Ovis.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of domestic and wild horses of the species Equus caballus.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of domestic swine and of the wild boar of the genus Sus.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts %28%true fish%29% and elasmobranchs %28%sharks, rays and skates%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of intracranial arteries which supply the cerebrum of the brain, including the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY. Included in this category are atherosclerotic, congenital, traumatic, infectious, inflammatory, and other conditions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of lymph or lymph vessels. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected %28%e.g., sensory, motor, or autonomic%29%, by the distribution of nerve injury %28%e.g., distal vs. proximal%29%, by nerve component primarily affected %28%e.g., demyelinating vs. axonal%29%, by etiology, or by pattern of inheritance.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of newborn infants present at birth %28%congenital%29% or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of non-human animals that may be transmitted to HUMANS or may be transmitted from humans to non-human animals.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of plants. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae %28%squirrels%29%, Geomyidae %28%gophers%29%, Heteromyidae %28%pouched mice%29%, Castoridae %28%beavers%29%, Cricetidae %28%rats and mice%29%, Muridae %28%Old World rats and mice%29%, Erethizontidae %28%porcupines%29%, and Caviidae %28%guinea pigs%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS %28%most notably involuntary movements and alterations of the rate of movement%29% represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the GALLBLADDER. They generally involve the impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, neoplasms, or other diseases.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the root.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the SWEAT GLANDS. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the VESTIBULOCOCHLEAR NERVE. Retrocochlear refers to the eighth cranial nerve and cerebellopontine angle as opposed to the cochlea. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the bony orbit and contents except the eyeball.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the cervical %28%and first thoracic%29% roots, nerve trunks, cords, and peripheral nerve components of the BRACHIAL PLEXUS. Clinical manifestations include regional pain, PARESTHESIA; MUSCLE WEAKNESS, and decreased sensation %28%HYPESTHESIA%29% in the upper extremity. These disorders may be associated with trauma %28%including BIRTH INJURIES%29%; THORACIC OUTLET SYNDROME; NEOPLASMS; NEURITIS; RADIOTHERAPY; and other conditions. %28%From Adams et al., Principles of Neurology, 6th ed, pp1351-2%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the cochlea, the part of the inner ear that is concerned with hearing.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the common, internal, and external carotid arteries. ATHEROSCLEROSIS and trauma are relatively frequent causes of carotid artery pathology.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the cornea. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the domestic cat %28%Felis catus or F. domesticus%29%. This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the domestic dog %28%Canis familiaris%29%. This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the domestic or wild goat of the genus Capra.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the ear, general or unspecified. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the eleventh cranial %28%spinal accessory%29% nerve. This nerve originates from motor neurons in the lower medulla %28%accessory portion of nerve%29% and upper spinal cord %28%spinal portion of nerve%29%. The two components of the nerve join and exit the skull via the jugular foramen, innervating the sternocleidomastoid and trapezius muscles, which become weak or paralyzed if the nerve is injured. The nerve is commonly involved in MOTOR NEURON DISEASE, and may be injured by trauma to the posterior triangle of the neck.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the facial nerve or nuclei. Pontine disorders may affect the facial nuclei or nerve fascicle. The nerve may be involved intracranially, along its course through the petrous portion of the temporal bone, or along its extracranial course. Clinical manifestations include facial muscle weakness, loss of taste from the anterior tongue, hyperacusis, and decreased lacrimation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the first cranial %28%olfactory%29% nerve, which usually feature anosmia or other alterations in the sense of smell and taste. Anosmia may be associated with NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CRANIOCEREBRAL TRAUMA; inherited conditions; toxins; METABOLIC DISEASES; tobacco abuse; and other conditions. %28%Adams et al., Principles of Neurology, 6th ed, pp229-31%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the fourth cranial %28%trochlear%29% nerve or its nucleus in the midbrain. The nerve crosses as it exits the midbrain dorsally and may be injured along its course through the intracranial space, cavernous sinus, superior orbital fissure, or orbit. Clinical manifestations include weakness of the superior oblique muscle which causes vertical DIPLOPIA that is maximal when the affected eye is adducted and directed inferiorly. Head tilt may be seen as a compensatory mechanism for diplopia and rotation of the visual axis. Common etiologies include CRANIOCEREBRAL TRAUMA and INFRATENTORIAL NEOPLASMS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the lacrimal apparatus. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the nail plate and tissues surrounding it. The concept is limited to primates.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the ninth cranial %28%glossopharyngeal%29% nerve or its nuclei in the medulla. The nerve may be injured by diseases affecting the lower brain stem, floor of the posterior fossa, jugular foramen, or the nerve%27%s extracranial course. Clinical manifestations include loss of sensation from the pharynx, decreased salivation, and syncope. Glossopharyngeal neuralgia refers to a condition that features recurrent unilateral sharp pain in the tongue, angle of the jaw, external auditory meatus and throat that may be associated with SYNCOPE. Episodes may be triggered by cough, sneeze, swallowing, or pressure on the tragus of the ear. %28%Adams et al., Principles of Neurology, 6th ed, p1390%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the oculomotor nerve or nucleus that result in weakness or paralysis of the superior rectus, inferior rectus, medial rectus, inferior oblique, or levator palpebrae muscles, or impaired parasympathetic innervation to the pupil. With a complete oculomotor palsy, the eyelid will be paralyzed, the eye will be in an abducted and inferior position, and the pupil will be markedly dilated. Commonly associated conditions include neoplasms, CRANIOCEREBRAL TRAUMA, ischemia %28%especially in association with DIABETES MELLITUS%29%, and aneurysmal compression. %28%From Adams et al., Principles of Neurology, 6th ed, p270%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the sebaceous glands such as sebaceous hyperplasia and sebaceous cell carcinoma %28%SEBACEOUS GLAND NEOPLASMS%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the sixth cranial %28%abducens%29% nerve or its nucleus in the pons. The nerve may be injured along its course in the pons, intracranially as it travels along the base of the brain, in the cavernous sinus, or at the level of superior orbital fissure or orbit. Dysfunction of the nerve causes lateral rectus muscle weakness, resulting in horizontal diplopia that is maximal when the affected eye is abducted and ESOTROPIA. Common conditions associated with nerve injury include INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; ISCHEMIA; and INFRATENTORIAL NEOPLASMS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the skin associated with underlying metabolic disorders.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the tenth cranial nerve, including brain stem lesions involving its nuclei %28%solitary, ambiguus, and dorsal motor%29%, nerve fascicles, and intracranial and extracranial course. Clinical manifestations may include dysphagia, vocal cord weakness, and alterations of parasympathetic tone in the thorax and abdomen.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the trigeminal nerve or its nuclei, which are located in the pons and medulla. The nerve is composed of three divisions: ophthalmic, maxillary, and mandibular, which provide sensory innervation to structures of the face, sinuses, and portions of the cranial vault. The mandibular nerve also innervates muscles of mastication. Clinical features include loss of facial and intra-oral sensation and weakness of jaw closure. Common conditions affecting the nerve include brain stem ischemia, INFRATENTORIAL NEOPLASMS, and TRIGEMINAL NEURALGIA.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the twelfth cranial %28%hypoglossal%29% nerve or nuclei. The nuclei and fascicles of the nerve are located in the medulla, and the nerve exits the skull via the hypoglossal foramen and innervates the muscles of the tongue. Lower brain stem diseases, including ischemia and MOTOR NEURON DISEASES may affect the nuclei or nerve fascicles. The nerve may also be injured by diseases of the posterior fossa or skull base. Clinical manifestations include unilateral weakness of tongue musculature and lingual dysarthria, with deviation of the tongue towards the side of weakness upon attempted protrusion.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the urinary tract in both male and female. It does not include the male genitalia for which UROGENITAL DISEASES is used for general discussions of diseases of both the urinary tract and the genitalia.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the uterine appendages %28%ADNEXA UTERI%29% including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus %28%BROAD LIGAMENT; ROUND LIGAMENT%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the uvea. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the vestibular and/or cochlear %28%acoustic%29% nerves, which join to form the vestibulocochlear nerve. VESTIBULAR NEURITIS, cochlear neuritis, and acoustic neuromas %28%NEUROMA, ACOUSTIC%29% are relatively common conditions that affect these nerves. Clinical manifestations vary with which nerve is primarily affected, and include hearing loss, vertigo, and tinnitus.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of the vestibule, the part of the inner ear that contains organs involved with balance.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as SUBACUTE SCLEROSING PANENCEPHALITIS, progressive multifocal leukoencephalopathy %28%LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL%29%, and AIDS. Diseases produced by unconventional agents were originally considered part of this group. They are now called PRION DISEASES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are TEMPOROMANDIBULAR JOINT DISORDERS and TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases that are caused by genetic mutations present during embryo or fetal development, although they may be observed later in life. The mutations may be inherited from a parent%27%s genome or they may be acquired in utero.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. %28%Dictionary of Health Services Management, 2d ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Acute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Adenohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Adnexal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Adrenal Cortex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Adrenal Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Adult Pelizaeus-Merzbacher' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Agricultural Worker' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Agricultural Worker%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Agricultural Workers%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Animal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Animal Parasitic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Anterior Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Anti-GBM' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Anus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Aortic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ape' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Arterial Obstructive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Arterial Occlusive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Aspartoacylase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Atypical Inclusion-Body' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Atypical Pelizaeus-Merzbacher' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Autoimmune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Avian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Azorean %28%Machado-Joseph%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bacterial Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bacterial Venereal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bassen-Kornzweig' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Batten' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Batten-Mayou' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Betalipoprotein Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bile Duct' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Biliary Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bird' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bladder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bone Marrow' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bovine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Breast' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Broad Beta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Bronchial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Caisson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Canine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Caprine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Carcinoid Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cardiac' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cardiovascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cardiovascular %28%Specialty%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cartilage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cattle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cecal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cerebral Arterial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cerebral Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cervix' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Choroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Choroidal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Chronic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Chronic Granulomatous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cochlear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cold Agglutinin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Collagen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Communicable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Conjunctival' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Connective Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Corneal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Coronary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Coronary Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Coronary Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Craniomandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cystic Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cystic Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Cytomegalic Inclusion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Dental Pulp' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Digestive System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Dog' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Duodenal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Eczematous Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Emerging Communicable' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Emerging Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Endemic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Endocrine Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Endocrine Breast' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Endocrine System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Equine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Experimental Parkinson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Eye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Eyelid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Facial Nerve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fallopian Tube' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Feline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Female Genital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fetal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fish' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Folling' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Foot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Foot-and-Mouth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fucosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fumarylacetoacetase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Functional Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fungal Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Fungus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Galactosylceramidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Galactosylceramide-beta-Galactosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Gall Bladder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Gallbladder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Gastrointestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Genetic Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Genitourinary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Gingival' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Glucocerebrosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Glycogen Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Goat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Graft-Versus-Host' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Graft-vs-Host' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Gynecologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hammond' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hammond%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Heart Valve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hematologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hematological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hemoglobin C' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hemoglobin H' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hemoglobin S' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hemoglobin SC' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hepato-Neurologic Wilson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hereditary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hereditary Eye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hereditary Neurodegenerative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hodgkins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Horse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hyaline Membrane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hypothalamic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Hypoxanthine-Phosphoribosyl-Transferase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, I-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Iatrogenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ileal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Immune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Immune Complex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Immune System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Immunological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Inborn Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Inclusion Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Infectious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Infectious Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Infectious Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Inflammatory Pelvic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Interstitial Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Intestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Iris' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ischemic Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Jaw' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Jejunal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Kinky Hair' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Kinnier-Wilson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Labyrinth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lacrimal Apparatus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Laryngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Larynx' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lindau%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lip' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Liver' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lumpy Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lymphatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Lysosomal Storage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Male Genital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Mandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Mannosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Mast-Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Maxillary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Mediastinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Menkes%27%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Metabolic Bone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Metabolic Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Minimal Residual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Monkey' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Mouth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Musculoskeletal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Nail' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Nasopharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Nervous System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Neurodegenerative Hereditary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Neurohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Neurologic Autoimmune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Nose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Obstructive Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Occupational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Orbital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Orphan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Otorhinolaryngologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Otorhinolaryngological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ovarian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ovine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Owren' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Owren%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Papulosquamous Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Paranasal Sinus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parasitic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parasitic Intestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parasitic Liver' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parasitic Lung' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parasitic Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parathyroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Parotid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pelvic Inflammatory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Penile' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Penis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Periapical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Periodontal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Peripheral Vascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pharynx' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pituitary Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Placenta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Placental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Plant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pleural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Polycystic Kidney' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Polycystic Renal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pongidae' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Posterior Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Postphlebitic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Poultry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Primary Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Primate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Prostatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Psuedo-Hurler' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pulmonary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pulmonary %28%Specialty%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pulmonary Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Pulmonary Veno-Occlusive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Rare' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Rectal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Residual Minimal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Respiratory Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Retrocochlear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Rheumatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Rheumatic Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Rodent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, SC' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Salivary Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sclera' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Scleral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sebaceous Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Secondary Myocardial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sexually Transmitted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sheep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sigmoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sigmoid Colon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Slow Virus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sphingomyelinase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Spinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Splenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Staphylococcal Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Steely Hair' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Stomatognathic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Submandibular Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Sweat Gland' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Swine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, TMJ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Temporomandibular Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Testicular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Thalamic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Thoracic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Thyroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Tick-Borne' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Tongue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Tracheal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Tsutsugamushi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, UDP-Galactose-4-Epimerase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Unverricht' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Ureteral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Urethral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Urinary Tract' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Urogenital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Urologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Urological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Uterine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Uterine Cervical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Uveal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Vaginal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Valvular Heart' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Vascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Vascular Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Venereal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Vestibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Viral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Viral Skin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Viral Venereal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Virus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Vulvar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Werdnig Hoffman' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, White Muscle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, X-Linked Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, Y-Linked Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, alpha-Chain' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, alpha-Fucosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, alpha-L-Fucosidase Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diseases, dysfunctions, or disorders of or located in the iris.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disequilibrium, Linkage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disequilibriums, Linkage' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disgerminoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disgerminomas' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disincentive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disinfectants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disinfectants %28%1967-1996%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disinfectants, Dental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disinfection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disinfection %28%1975-1981%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disintegration of Blastocyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disintegration of Embryo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disintegration, Blastocyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disintegrins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Chemolyses, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Chemolysis, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Disorder, Optic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Disorders, Optic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Displacement, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Displacements, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Electrophoresis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Nucleolyses, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Nucleolysis, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Prolapse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk Prolapses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Choked' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Compact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Interactive Compact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Optic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Prolapsed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Slipped' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Temporomandibular Articular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, Temporomandibular Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disk, WORM' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diskectomies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diskectomies, Percutaneous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diskectomy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diskectomy, Percutaneous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diskitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diskitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Choked' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Compact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Herniated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Interactive Compact' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Intervertebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Optic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Prolapsed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Slipped' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Temporomandibular Articular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, Temporomandibular Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disks, WORM' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocation, Congenital Hip' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocation, Knee' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocation, Lens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocation, Patellar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocation, Shoulder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations %28%1963-2004%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations %28%1965-2002%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations, Congenital Hip' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations, Knee' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations, Lens' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations, Patellar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations, Shoulder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dislocations, Tooth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Ag-Zn Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Cobalt Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Cu-Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Cu-Zn Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Cuprozinc Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Fe-Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Fe-Zn Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Iron Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Manganese Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Mn-Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dismutase, Superoxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium 1 Hydroxyethylene Diphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium 1-Hydroxyethylene Diphosphonate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Cromoglycate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium EDTA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Ethylene Dinitrilotetraacetate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Etidronate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Moxalactam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Aminopterin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Bilirubin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Bucladesine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Methotrexate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Nitroprusside' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Phosphocreatine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt Succimer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt, Amifostine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt, Cefotetan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt, Fluorescein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt, Foscarnet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium Salt, SITS' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium alpha Sulfobenzylpenicillin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium, Carbenicillin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium, Cefotetan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium, Clodronate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium, Moxalactam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium, Sulfobromophthalein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disodium, Ticarcillin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disofenin, Tc-99m' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disomies, Uniparental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disomy, Uniparental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disoprivan' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disoprofol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disopyramide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disopyramide Phosphate %28%1:1%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder Agents, Movement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet%27%s membrane, epithelial blisters, reduced vision, and pain.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder caused by motion, as sea sickness, train sickness, car sickness, air sickness, or SPACE MOTION SICKNESS. It may include nausea, vomiting and dizziness.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder characterized by intravascular hemolysis and hemoglobinuria. Some cases occur on exposure to cold and are due to the presence of an autohemolysin in the serum. Other cases are more marked during or immediately after sleep and are considered to be due to an acquired intracorpuscular defect.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder characterized by nausea, vomiting, and dizziness, possibly in response to vestibular disorientation or fluid shifts associated with space flight. %28%From Webster%27%s New World Dictionary%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder characterized by recurrent, intense sexually arousing fantasies, sexual urges, or behaviors involving cross-dressing in a heterosexual male. The fantasies, urges, or behaviors cause clinically significant distress or impairment in social, occupational or other areas of functioning. %28%from APA, DSM-IV, 1994%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder of cardiac rhythm characterized by rapid, irregular atrial impulses and ineffective atrial contractions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Acoustic Perceptual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Adjustment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Affective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Alcohol-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Amphetamine-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Animal Gait' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Antisocial Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Anxiety' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Atrophic Muscular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Attention Deficit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Auditory Comprehension' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Auditory Processing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Autistic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Binge-Eating' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Bipolar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Blood Coagulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Blood Platelet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Blood Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Borderline Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Calcium Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Cannabis-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Cerebellar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Child Mental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Chromosomal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Chromosome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Chromosome Abnormality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Ciliary Motility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Civil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Coagulation Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Coagulation Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Cocaine-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Cognition' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Combat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Complex Partial Seizures' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Compulsive Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Congenital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Craniomandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Cumulative Trauma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Cyclothymic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, DNA Repair-Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Delusional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Dependent Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Depersonalization' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Depressive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Developmental Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Disarticulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Dissociative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Dissociative Identity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Drug Use' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Dysthymic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Eczematous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Elimination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Esophageal Motility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Facial Nerve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Functional Gastrointestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Glucose Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Glucose Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Gonadal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Growth' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Heat Stress' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Hemorrhagic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Histrionic Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Hypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Hypothalamic-Adenohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Hypothalamic-Neurohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Immune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Immunoproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Iron Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Lactation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Late-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Leukocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Lymphoproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Lysosomal Enzyme' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Major Depressive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Malignant Histiocytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Manic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Menstruation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Mental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Migraine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Mitochondrial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Mood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Multiple Identity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Multiple Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Myeloproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Myoclonic Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Myotonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Necrobiotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Negativistic Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Nervous System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Neurologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Neurological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Neurotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Nicotine Use' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Obsessive-Compulsive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Opioid-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Panic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Papulosquamous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Paranoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Paranoid Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Parathyroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Passive-Aggressive Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Pervasive Development' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Phobic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Phosphorus Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Photosensitivity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Pigmentation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Placenta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Pneumogastric Nerve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Post-Traumatic Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Primary Headache' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Prion-Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Psychoacoustical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Psychosexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Psychotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Psychotic Affective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Puerperal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Reactive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Reactive Attachment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Refractive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Repetitive Motion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Respiration' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Rumination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Schizoaffective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Schizoid Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Schizophrenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Schizophreniform' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Schizotypal Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Seasonal Affective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Seasonal Mood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Secondary Headache' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Sex Differentiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Sexual Differentiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Shared Paranoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Shared Psychotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Substance Use' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, TMJ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Teeth Grinding' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Temporomandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Temporomandibular Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Tobacco Use' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Tobacco-Use' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Tonic-Clonic Convulsion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Tonic-Clonic Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Urination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, Vascular Hemostatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorder, X-Linked Lymphoproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders Usually Diagnosed in Infancy, Childhood or Adolescence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders affecting TWINS, one or both, at any age. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances %28%e.g., ACIDOSIS%29% and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus %28%GASTROESOPHAGEAL REFLUX%29%. Other disorders include hypermotility %28%spastic disorders%29% and markedly increased amplitude in contraction %28%nutcracker esophagus%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders affecting the organs of the thorax. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders associated with acute or chronic exposure to compounds containing ARSENIC %28%ARSENICALS%29% which may be fatal. Acute oral ingestion is associated with gastrointestinal symptoms and an encephalopathy which may manifest as SEIZURES, mental status changes, and COMA. Chronic exposure is associated with mucosal irritation, desquamating rash, myalgias, peripheral neuropathy, and white transverse %28%Mees%29% lines in the fingernails. %28%Adams et al., Principles of Neurology, 6th ed, p1212%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by abnormalities in platelet count or function.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components %28%e.g., myelin%29% and may be limited to the central nervous system %28%e.g., MULTIPLE SCLEROSIS%29% or the peripheral nervous system %28%e.g., GUILLAIN-BARRE SYNDROME%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by nutritional imbalance, either overnutrition or undernutrition, in the FETUS in utero.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in children ages 2 to 12 years.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by nutritional imbalance, either overnutrition or undernutrition, occurring in infants ages 1 month to 24 months.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders caused by nutritional imbalance, either overnutrition or undernutrition.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the CILIA shows that dynein arms are missing. The disorders manifest as KARTAGENER SYNDROME, chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by an abnormal reduction in muscle volume due to a decrease in the size or number of muscle fibers. Atrophy may result from diseases intrinsic to muscle tissue %28%e.g., MUSCULAR DYSTROPHY%29% or secondary to PERIPHERAL NERVOUS SYSTEM DISEASES that impair innervation to muscle tissue %28%e.g., MUSCULAR ATROPHY, SPINAL%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by defective transport of amino acids across cell membranes. These include deficits in transport across brush-border epithelial cell membranes of the small intestine %28%MICROVILLI%29% and KIDNEY TUBULES; transport across the basolateral membrane; and transport across the membranes of intracellular organelles. %28%From Nippon Rinsho 1992 Jul;50%28%7%29%:1587-92%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders %28%e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME%29% and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause %28%e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME%29%. %28%From J Neurol Sci 1998 Jan 8;153%28%2%29%:192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central %28%see SLEEP APNEA, CENTRAL%29%, obstructive %28%see SLEEP APNEA, OBSTRUCTIVE%29%, and mixed central-obstructive types.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by proliferation of lymphoid tissue, general or unspecified.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders characterized by recurrent TICS that may interfere with speech and other activities. Tics are sudden, rapid, nonrhythmic, stereotyped motor movements or vocalizations which may be exacerbated by stress and are generally attenuated during absorbing activities. Tic disorders are distinguished from conditions which feature other types of abnormal movements that may accompany general medical conditions. %28%From DSM-IV, 1994%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders claimed as a result of military service. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. %28%APA, DSM-IV%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in the frequency of urination, the volume of urine produced or eliminated, or the ability to retain or void urine in normal fashion.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization. %28%From Mosby%27%s Medical, Nursing, %26% Allied Health Dictionary, 4th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in which one or more stimuli cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in which phagocytic cells cannot kill ingested bacteria; characterized by frequent recurring infection with formulation of granulomas.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in which the essential feature is a severe disturbance in mood %28%depression, anxiety, elation, and excitement%29% accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. %28%From American Psychiatric Glossary, 6th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. %28%From DSM-IV, 1994%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of Environmental Origin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of Excessive Somnolence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of Excessive Somnolence %28%1975-1999%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of Initiating and Maintaining Sleep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of hearing or auditory perception resulting from disease of the central auditory pathways or auditory association cortical areas. These include HEARING LOSS, CENTRAL; cortical deafness; and AUDITORY PERCEPTUAL DISORDERS. Above the level of the pons, bilateral lesions are usually required to produce auditory dysfunction.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of increased melanin pigmentation that develop without preceding inflammatory disease.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of sensory information received from superficial and deep regions of the body. The somatosensory system conveys neural impulses which pertain to proprioception, tactile sensation, thermal sensation, pressure sensation, and pain. PERIPHERAL NERVOUS SYSTEM DISEASES; SPINAL CORD DISEASES; and BRAIN DISEASES may be associated with impaired or abnormal somatic sensation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of speech articulation caused by imperfect coordination of pharynx, larynx, tongue, or face muscles. This may result from CRANIAL NERVE DISEASES; NEUROMUSCULAR DISEASES; CEREBELLAR DISEASES; BASAL GANGLIA DISEASES; BRAIN STEM diseases; or diseases of the corticobulbar tracts %28%see PYRAMIDAL TRACTS%29%. The cortical language centers are intact in this condition. %28%From Adams et al., Principles of Neurology, 6th ed, p489%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the Autonomic Nervous System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the blood and blood forming tissues. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the brain and spinal cord that are associated with LUPUS ERYTHEMATOSUS, SYSTEMIC. Clinical manifestations may include neurobehavioral dysfunction; SEIZURES; cranial neuropathies %28%see CRANIAL NERVE DISEASES%29%; hypothalamic dysfunction; focal motor deficits; MYELITIS, TRANSVERSE, and other disorders. Pathologic features include multiple microinfarctions involving the CEREBRAL CORTEX; DIENCEPHALON; and BRAIN STEM %28%see also BRAIN INFARCTION%29%. %28%From Adams et al., Principles of Neurology, 6th ed, pp858-9%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the centrally located thalamus, which integrates a wide range of cortical and subcortical information. Manifestations include sensory loss, MOVEMENT DISORDERS; ATAXIA, pain syndromes, visual disorders, a variety of neuropsychological conditions, and COMA. Relatively common etiologies include CEREBROVASCULAR DISORDERS; CRANIOCEREBRAL TRAUMA; BRAIN NEOPLASMS; BRAIN HYPOXIA; INTRACRANIAL HEMORRHAGES; and infectious processes.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the larynx, general or unspecified. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the mediastinum, general or unspecified. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the mouth attendant upon non-oral disease or injury.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the nose, general or unspecified. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. Familial, primary %28%nonfamilial%29%, and secondary forms have been described. Some familial subtypes demonstrate an autosomal dominant pattern of inheritance. Clinical manifestations include sensory loss, mild weakness, autonomic dysfunction, and CARPAL TUNNEL SYNDROME. %28%Adams et al., Principles of Neurology, 6th ed, p1349%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the quality of speech characterized by the substitution, omission, distortion, and addition of phonemes.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of the special senses %28%i.e., VISION; HEARING; TASTE; and SMELL%29% or somatosensory system %28%i.e., afferent components of the PERIPHERAL NERVOUS SYSTEM%29%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of verbal and nonverbal communication caused by receptive or expressive LANGUAGE DISORDERS, cognitive dysfunction %28%e.g., MENTAL RETARDATION%29%, psychiatric conditions, and HEARING DISORDERS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders of voice pitch, loudness, or quality. Dysphonia refers to impaired utterance of sounds by the vocal folds.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders related or resulting from abuse or mis-use of opioids.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders related or resulting from use of amphetamines.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders related or resulting from use of cocaine. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders related to or resulting from abuse or mis-use of alcohol.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders related to substance abuse, the side effects of a medication, toxin exposure, and ALCOHOL-RELATED DISORDERS.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders representing collectively the results of assault by external forces, rather than by organic or physiologic dysfunction or by pathogens.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders resulting from defective DNA REPAIR processes or the associated cellular responses to DNA DAMAGE.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders stemming from the misuse and abuse of alcohol.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves %28%III, IV, and VI%29% are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition %28%e.g., OPSOCLONUS-MYOCLONUS SYNDROME%29%. %28%Adams et al., Principles of Neurology, 6th ed, p240%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders that include recurrent, intense sexually arousing fantasies, sexual urges, or behaviors generally involving nonhuman objects, suffering of oneself or partners, or children or other nonconsenting partners. %28%from DSM-IV, 1994%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Acoustic Perceptual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Adjustment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Affective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Alcohol-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Amphetamine-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Animal Gait' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Antisocial Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Anxiety' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Atrophic Muscular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Attention Deficit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Auditory Comprehension' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Auditory Processing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Autistic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Behavior' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Binge-Eating' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Blood Coagulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Blood Platelet' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Blood Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Borderline Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Calcium Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Carotid Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Child Behavior' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Child Mental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Chromosomal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Chromosome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Chronic Fatigue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Ciliary Motility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Civil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Coagulation Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Coagulation Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Cocaine-Related' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Cognition' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Combat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Compulsive Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Congenital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Craniomandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Cumulative Trauma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Cyclothymic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, DNA Repair-Deficiency' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Deglutition' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Delusional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Depersonalization' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Depressive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Developmental Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Disarticulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Dissociative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Eczematous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Elimination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Esophageal Motility' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Facial Nerve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Factitious' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Focal Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Functional Gastrointestinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Glucose Metabolic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Glucose Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Gonadal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Heat Stress' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Hemorrhagic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Histrionic Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Hypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Hypothalamic-Adenohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Hypothalamic-Neurohypophyseal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Immune' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Immunoproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Impulse Control' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Intermittent Explosive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Iron Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Lactation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Late-Onset' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Leukocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Lymphoproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Lysosomal Enzyme' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Major Depressive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Malignant Histiocytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Menstruation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Mental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Migraine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Mitochondrial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Mood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Myeloproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Myoclonic Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Myotonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Necrobiotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Negativistic Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Nervous System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Neurologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Neurological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Neurotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Obsessive-Compulsive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Organic Mental' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Orgasmic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Panic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Papulosquamous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Paranoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Paranoid Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Parathyroid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Partial Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Passive-Aggressive Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Pervasive Development' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Phobic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Phosphorus Metabolism' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Photosensitivity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Pigmentation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Pituitary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Placenta' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Pneumogastric Nerve' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Post-Traumatic Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Primary Headache' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Prion-Induced' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Psychoacoustical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Psychosexual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Psychotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Psychotic Affective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Puerperal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Reactive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Reactive Attachment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Reading' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Refractive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Repetitive Motion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Respiration' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Schizoaffective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Schizoid Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Schizophrenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Schizophreniform' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Schizotypal Personality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Seasonal Affective' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Seasonal Mood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Secondary Headache' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Sex Chromosome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Sex Chromosome Abnormality' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Sex Differentiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Sexual Arousal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Sexual Aversion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Sexual Differentiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Shared Paranoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Shared Psychotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Social Behavior' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, TMJ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Teeth Grinding' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Temporomandibular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Temporomandibular Joint' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Tonic-Clonic Convulsion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Tonic-Clonic Seizure' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Urination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, Vascular Hemostatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorders, X-Linked Lymphoproliferative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorganization of secondary structures of nucleic acids through cleavage of hydrogen bonds and hydrophobic linkages. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorganization, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorganizations, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorganized Schizophrenia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disorganized Schizophrenias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparities, Binocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparities, Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparities, Ocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparities, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparities, Vision' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparities, Visual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparity, Binocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparity, Fixation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparity, Ocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparity, Retinal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparity, Vision' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disparity, Visual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispensatories' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispensatory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispenser, Automatic Food' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispensers, Automatic Food' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispensing Fee' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispensing Fees' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispersed Repetitive Sequence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispersed Repetitive Sequences' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispersion, Optical Rotatory' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disphar Brand of Acetylcysteine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement %28%Psychology%29% %28%1968-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement of bones out of line in relation to joints. It may be congenital or traumatic in origin.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement of the PATELLA from the femoral groove. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement of the femur bone from its normal position at the HIP JOINT.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement of the great toe %28%HALLUX%29% towards the midline or away from the other TOES. It can be congenital or acquired.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement of the valves of the heart. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement, Intervertebral Disc' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacement, Intervertebral Disk' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacements %28%Psychology%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacements, Intervertebral Disc' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displacements, Intervertebral Disk' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Display Terminal, Video' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Display Terminals, Video' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Display, Data' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Display, Information' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Display, mRNA Differential' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displays, Data' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displays, Information' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Displays, mRNA Differential' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposable Equipment' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposable Equipment %28%1986-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Biologic Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Biological Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Fluid Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Infectious Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Medical Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Pathological Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Refuse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Solid Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, Specimen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposal, processing, controlling, recycling, and reusing the solid, liquid, and gaseous wastes of plants, animals, humans, and other organisms. It includes control within a closed ecological system to maintain a habitable environment.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposals, Fluid Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposals, Refuse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposals, Solid Waste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disposition, Embryo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispositions, Embryo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disproportion, Cephalopelvic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disproportionate Reimbursement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disproportionate Reimbursements' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disproportionate Share Reimbursement' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disproportionate Share Reimbursements' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dispute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disputes and Dissent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disruption of structural continuity of the body as a result of the discharge of firearms.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disruptions of the rhythmic cycle of bodily functions or activities.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disruptors, Endocrine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissecans, Osteochondritis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissecting Aneurysm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissecting Aneurysms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissecting Vertebral Artery Aneurysm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection %28%1966-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection in the neck to remove all disease tissues including cervical LYMPH NODES and to leave an adequate margin of normal tissue. This type of surgery is usually used in tumors or cervical metastases in the head and neck. The prototype of neck dissection is the radical neck dissection described by Crile in 1906.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection of the wall of the vertebral artery, leading to the formation of an aneurysm that may occlude the vessel. Thrombus formation may occur and give rise to emboli. Cervical fractures or related NECK INJURIES and CRANIOCEREBRAL TRAUMA are commonly associated conditions, although this process may occur spontaneously. Ischemia, infarction, and hemorrhage in the vascular distribution of the affected vertebral artery may complicate this condition.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection, Anterior Spinal Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection, Internal Carotid Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection, Lymph Node' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection, Neck' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection, Radical Neck' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissection, Vertebral Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissections' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissections, Lymph Node' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissections, Neck' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissections, Radical Neck' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissections, Vertebral Artery' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Coagulation, Intravascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Coagulations, Intravascular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Encephalomyelitides, Acute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Encephalomyelitis, Acute' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Intravascular Coagulation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Intravascular Coagulations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Neurodermatitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Neurodermatitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminated Sclerosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissemination, Information' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disseminatum, Xanthoma' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissent and Disputes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissent, Political' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissertation, Academic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissertations embodying results of original research and especially substantiating a specific view, e.g., substantial papers written by candidates for an academic degree under the individual direction of a professor or papers written by undergraduates desirous of achieving honors or distinction.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissertations, Academic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissimilatory Sulfite Reductase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociation Inhibitors, GDP' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociation, Antibody' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociation, Auriculo-Ventricular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociations, Antibody' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociations, Auriculo-Ventricular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Amnesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Amnesias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Anesthetics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Disorders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Hallucination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Hallucinations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Hysteria' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Identity Disorder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Reaction' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissociative Reactions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissolution of a vertebra, especially the pars interarticularis.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissolution of bone that particularly involves the removal or loss of calcium.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissonance, Cognitive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dissonances, Cognitive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dista Brand of Capreomycin Disulfate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dista Brand of Nortriptyline Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dista Brand of Vancomycin Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Kidney Tubule' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Kidney Tubules' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Medial Neuropathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Medial Neuropathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Muscular Dystrophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Muscular Dystrophy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Myopathies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Myopathy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Myopathy, Welander' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Paresthesia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Paresthesias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Renal Tubular Acidosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Renal Tubule' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distal Renal Tubules' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distamycins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distance Accommodation, Ocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distance Education' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distance Perception' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distance Perceptions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distance, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distances' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distances, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Virus, Canine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Virus, Phocid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Virus, Phocine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Virus, Seal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Viruses, Canine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Viruses, Phocid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Viruses, Phocine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper Viruses, Seal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper, Canine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distemper, Feline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distempers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distempers, Canine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distempers, Feline' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distensibility measure of a chamber such as the lungs %28%LUNG COMPLIANCE%29% or bladder. Compliance is expressed as a change in volume per unit change in pressure.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disthelm, Mediamix V' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distinct units in some bacterial, bacteriophage or plasmid GENOMES that are types of MOBILE GENETIC ELEMENTS. Encoded in them are a variety of fitness conferring genes, such as VIRULENCE FACTORS %28%in %22%pathogenicity islands or islets%22%%29%, ANTIBIOTIC RESISTANCE genes, or genes required for SYMBIOSIS %28%in %22%symbiosis islands or islets%22%%29%. They range in size from 10 - 500 kilobases, and their GC CONTENT and CODON usage differ from the rest of the genome. They typically contain an INTEGRASE gene, although in some cases this gene has been deleted resulting in %22%anchored genomic islands%22%.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distinctive neoplastic disorders of histiocytes. Included are acute monocytic leukemias, malignant histiocytosis %28%HISTIOCYTOSIS, MALIGNANT%29%, and true histiocytic lymphomas.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distolone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distorted Taste' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distortion or disfigurement of the ear caused by disease or injury after birth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distortion, Perceptual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distortions, Perceptual' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distraction Osteogeneses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distraction Osteogenesis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributed Database' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributed Databases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributed System' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution System, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution Systems, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Age' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Bernoulli' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Binomial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Body Fat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Chi-Square' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Clinical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Community-Based' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Countercurrent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Gaussian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Income' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Information' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Mail' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Negative Binomial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Non Clinical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Non-Clinical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Nonclinical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Normal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Pharmacy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Poisson' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Population' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Rural Spatial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Spatial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Statistical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distribution, Urban Spatial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributional Activity' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Age' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Binomial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Chi-Square' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Community-Based' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Contraceptive' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Income' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Mail' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Negative Binomial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Non-Clinical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Nonclinical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Normal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Pharmacy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Population' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Rural Spatial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Sex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Spatial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Statistical' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Distributions, Urban Spatial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'District Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'District Hospitals' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'District of Columbia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'District, Administrative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Districts, Administrative' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance of heart conduction in which the atrial response is delayed or omitted because of partial or complete interference with the propagation of impulses from the sinoatrial node to the atria.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Biological Clock' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Emotional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Learning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Loudness Perception' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Menstruation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Transient Situational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbance, Voice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM %28%see also ALCOHOL AMNESTIC DISORDER%29%; SCHIZOPHRENIA; and other conditions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty. %28%APA, DSM-IV, 1994%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances in the ACID-BASE EQUILIBRIUM of the body. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances in the body%27%s WATER-ELECTROLYTE BALANCE. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances in the mental process related to thinking, reasoning, and judgment.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances of MILK secretion in either SEX, not necessarily related to PREGNANCY.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Biological Clock' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Emotional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Learning' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Loudness Perception' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Menstruation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Transient Situational' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbances, Voice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbed Nyctohemeral Rhythm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disturbed Nyctohemeral Rhythms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide Interchange Enzyme' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide Isomerase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide Isomerase, Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide Oxidoreductase, Thiol-Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, Carbon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, Cysteinamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, Glutathione' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, TMT' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, Tetraethylthiuram' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, Tetramethylthiuram' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide, Thiamine Tetrahydrofurfuryl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfide-Isomerase, Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfides %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfides %28%1973-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfides %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfiram' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfonate, Indigo' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disulfoton' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disuse Atrophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disuse Atrophy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Disyston' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1974-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1974-1991%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1975-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1976-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1977-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes %28%1988-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes, Abietane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes, Clerodane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenes, Kaurane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diterpenoids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithane Z 78' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithane Z78' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithiazanine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithiocarb' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithioerythreitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithioerythritol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithiolthione, Anethol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithionite' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithionite, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithionite. The dithionous acid ion and its salts. ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithionitrobenzoic Acid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithiothreitol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithizon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithizone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dithranol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Ditiocarb' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Ditiocarb, Sodium Salt' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diundecenoate, Dequalinium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diureses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuresis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics %28%1965-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics %28%1966-1971%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Benzothiadiazine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, High Ceiling' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Loop' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Mercurial %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Osmotic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Potassium Depleting' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Potassium Sparing' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Sulfamyl %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Sulfamyl %28%1974-1975%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Sulfamyl %28%1974-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuretics, Thiazide %28%1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diurnal Dystonia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diurnal Rhythm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diurnal Rhythms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diuron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divalent Cations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divalproex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divergent Strabismus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversification, Hospital' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion of the flow of blood from the entrance of the right atrium directly to the aorta %28%or femoral artery%29% via an oxygenator thus bypassing both the heart and lungs.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion of the flow of blood from the entrance to the right atrium directly to the pulmonary arteries, avoiding the right atrium and right ventricle %28%Dorland, 28th ed%29%. This a permanent procedure often performed to bypass a congenitally deformed right atrium or right ventricle.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion of the flow of blood from the pulmonary veins directly to the aorta, avoiding the left atrium and the left ventricle %28%Dorland, 27th ed%29%. This is a temporary procedure usually performed to assist other surgical procedures.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion, Bilio Pancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion, Bilio-Pancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion, Roux-en-Y' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversion, Urinary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversions, Bilio Pancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversions, Bilio-Pancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversions, Biliopancreatic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversions, Roux-en-Y' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversions, Urinary' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversities, Antibody' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversities, Cultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversity, Antibody' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversity, Antigenic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversity, Biological' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversity, Cultural' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diversity, Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Arachnoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Colon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Esophago-Pharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Pharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Pharyngo-Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Pharyngoesophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Pharyngoesophageal Pulsion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticula, Zenker%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulas, Arachnoid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulitides' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulitis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulitis, Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulosis, Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulosis, Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulosis, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulosis, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum Choledochal Cyst' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum Choledochal Cysts' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Colon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Colon %28%1965-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Colonic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Esophageal %28%1967-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Esophago-Pharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Esophagopharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Gastric' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Meckel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Pharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Pharyngo-Esophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Pharyngoesophageal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Pharyngoesophageal Pulsion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Stomach' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Stomach %28%1968-2003%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Zenker' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulum, Zenker%27%s' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diverticulums, Esophagopharyngeal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diving' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diving %28%1966%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diving %28%1966-1985%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divinyl Ether Maleic Anhydride Copolymer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Diviser Aquilea Brand of Cetylpyridinium Chloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division Cycle, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division Cycles, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division Phase, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division of the tissues attaching the lung to the wall of the chest cavity, to permit collapse of the lung. It was formerly used to treat tuberculosis. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division of tissues by a high-frequency current applied locally with a metal instrument or needle. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division, Cell Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division, Cytoplasmic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Division, Nuclear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divisions, Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divisions, Cell Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divisions, Cytoplasmic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divisions, Nuclear' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divorce' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Divorces' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizene Dicarboxylic Acid Bis%28%N,N-dimethylamide%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizenedicarboxylic Acid Bis%28%N,N-dimethylamide%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizocilpine Maleate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizygotic Twin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizygotic Twins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizziness' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dizzyness' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Djibouti' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Djungarian' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Djungarian Hamsters' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DnaG Gene Product' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DnaG Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DnaJ Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do Not Resuscitate Orders' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do not confuse X ref BACTERIAL RHODOPSINS with BACTERIORHODOPSINS%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do not confuse with POLY A ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do not confuse with PRODIGIOSIN, an antibiotic from same source%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do not confuse with RGS proteins; DF: GTP BINDING PROTEIN REG%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do not confuse with defective interfering RNA %28%diRNA%29%, a viral RNA of DEFECTIVE VIRUSES.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Do-Not-Resuscitate Order' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobesilate Calcium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobesilate, Calcium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobrava Belgrade Virus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobutamin ratiopharm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobutamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobutamine Stress Echocardiographies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobutamine Stress Echocardiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dobutamine Tartrate %28%1:1%29%, %28%S-%28%R*,R*%29%%29%-Isomer' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dock, Yellow' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docosahexaenoic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docosahexenoic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docosenoic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docpharm Brand of Nitrendipine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor Assistants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor Patient Relation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor Patient Relations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor%27%s Assistant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor%27%s Assistants' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor, African Witch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor, Barefoot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor-Patient Relation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctor-Patient Relations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctors, African Witch' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doctors, Barefoot' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Document, Informed Consent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Document, Travel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documentaries and Factual Films' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documentaries and Factual Films %28%PT%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documentaries and Factual Films %5B%Publication Type%5D%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documentary and Factual Film %28%PT%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documentation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documentations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documents describing a medical treatment or research project, including proposed procedures, risks, and alternatives, that are to be signed by an individual, or the individual%27%s proxy, to indicate his/her understanding of the document and a willingness to undergo the treatment or to participate in the research.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documents, Informed Consent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Documents, Travel' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docusate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docusate Calcium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docusate Potassium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Docusate Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodder' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodecanoates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodecanoic Acids' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodecanol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodecapeptide tachykinin found in the central nervous system of the amphibian Kassina senegalensis. It is similar in structure and action to other tachykinins, but is especially effective in contracting smooth muscle tissue and stimulating the micturition reflex.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodecyl Alcohol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dodecyl Sulfate, Sodium' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Disease' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Diseases' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Diseases %28%1966-1978%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Diseases %28%1966-1983%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Heartworm' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Net Insecticide Poudre' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog Salmon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog, Prairie' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dog, Raccoon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DogNet Insecticide Poudre' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogbane' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogfish' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogfish %28%1992-2004%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogfish, Spiny' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogfishes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogs, Prairie' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dogs, Raccoon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolens, Phlegmasia Alba' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichoectasia, Vertebrobasilar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichoectasias, Vertebrobasilar' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichol %28%1975-1977%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichol Monophosphate Mannose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichol Phosphates' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichol, Mannosyl Phosphoryl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolicholphosphate Mannose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichos' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichyl Alpha D Mannopyranosyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichyl Alpha-D-Mannopyranosyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichyl Mannopyranosyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichyl Mannosyl Phosphate' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolichyl Phosphate Synthetase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolmatil' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolobis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolocid' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolorgiet Brand of Flurazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolorgiet Brand of Lorazepam' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolorgiet Brand of Maprotiline Hydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolorgiet Brand of Pirenzepine Dihydrochloride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolorgiet Brand of Sulpiride' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolorgiet Brand of Terfenadine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Bottle-Nose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Bottle-Nosed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Bottlenose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Bottlenosed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Common' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Ganges' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Ganges River' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Humpback' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Irrawaddy River' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, La Plata' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Marine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Ocean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Saddleback' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Spinner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Spotted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Striped' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Tucuxi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphin, Yangtze River' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins %28%1966-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins %28%1967-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins %28%1968-1997%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins %28%1968-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins %28%1990-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Amazon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Amazon River' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Bottle-Nose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Bottle-Nosed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Bottlenose' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Bottlenosed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Common' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Humpback' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Marine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Ocean' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Piebald' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Right Whale' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Saddleback' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Spinner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Spotted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Striped' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dolphins, Tucuxi' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain Protein, F-Box' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, Catalytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, HMG-1-Box' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, HMG-Box' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, Kringle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, Peptide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domain, Public' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, Catalytic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, HMG-1-Box' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, HMG-Box' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, Immunodominant' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, Kringle' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, Peptide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, Protein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domains, Public' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Animal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Animals' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Cat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Cats' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Cow' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Cows' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Fowl' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Fowls' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Horse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Horses' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Partner' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Pig' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Pigeon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Pigeons' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Pigs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Polecat' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Rabbit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Rabbits' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Sheep' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domestic Violence' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domiciles' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domiciliary Care' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domidon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance Hierarchies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance Hierarchy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance Subordination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance of one cerebral hemisphere over the other in cerebral functions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance, Cerebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance, Cerebral %28%1967-2001%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance, Eye' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance, Ocular' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance, Social' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance-Subordination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominance-Subordinations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominances, Cerebral' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Gene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Genes' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Genetic Condition' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Genetic Conditions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Hereditary Sensory Neuropathy, Type III' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Ichthyosis Vulgaris' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Optic Atrophies' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Optic Atrophy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant Parkinsonism, Autosomal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominant optic atrophy is a hereditary optic neuropathy causing decreased visual acuity, color vision deficits, a centrocecal scotoma, and optic nerve pallor %28%Hum. Genet. 1998; 102: 79-86%29%. Mutations leading to this condition have been mapped to the OPA1 gene at chromosome 3q28-q29. OPA1 codes for a dynamin-related GTPase that localizes to mitochondria.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominantly Inherited Spinocerebellar Ataxias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominantly-Inherited Spinocerebellar Ataxia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominantly-Inherited Spinocerebellar Ataxias' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominica' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dominican Republic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidon' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidon AL' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidon Hexal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidon Stada' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidon TEVA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidon-TEVA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'DomperidonTEVA' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidona Gamir' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Domperidone' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doms Adrian Brand of Alanine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doms-Adrian Brand of Alanine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Don%27%t confuse MAP Kinase 2 with MAP KINASE KINASES referred to as MAP2 Kinases%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Don%27%t confuse with HOLLIDAY JUNCTION RESOLVASES ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Don%27%t confuse with the closely related BCL-X PROTEIN ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Don%27%t confuse with the closely related BCL2-ASSOCIATED X PROTEIN%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dona S' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Directed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Directed Gamete' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Directed Organ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Directed Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Fetal Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Oocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donation, Ovum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Directed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Directed Gamete' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Directed Organ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Directed Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Fetal Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Oocyte' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donations, Ovum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doneurin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donkey' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Artificial Insemination' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Card' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Exclusions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Screening' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Screenings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Selection' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Site, Splice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor Sites, Splice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor of choline in biosynthesis of choline-containing phosphoglycerides.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor, Living' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor, Organ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor, Ovum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor, Semen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donor, Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Living' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Nitric Oxide' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Organ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Ovum' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Semen' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donors, Tissue' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donovania' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Donovanosis' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa %28%1966-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa %28%1972-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa Decarboxylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa Decarboxylase %28%1966-1979%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopa Oxidase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and Cyclic AMP Regulated Phosphoprotein Mr 32,000' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine %28%1966-1972%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine %28%1966-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine %28%1966-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine %28%1971-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Agents %28%1989-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Agonist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Agonists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Antagonists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Carriers' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D1 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D1 Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D1B Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D2 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D2 Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D3 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D3 Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D4 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D4 Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D5 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine D5 Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Plasma Membrane Transport Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Plasma Membrane Transporter Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Receptor Agonist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Receptor Agonists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Receptor Antagonists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Receptors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Reuptake Inhibitors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Transporter' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Transporter Proteins' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Transporter, DAT' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine Uptake Inhibitors' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and Adenosine 3%27%,5%27% Monophosphate Regulated Phosphoprotein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and Adenosine 3%27%,5%27%-Monophosphate-Regulated Phosphoprotein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and cAMP Regulated Phosphoprotein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and cAMP Regulated Phosphoprotein 32' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and cAMP-Regulated Phosphoprotein' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine and cAMP-Regulated Phosphoprotein 32' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine beta Hydroxylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine beta Monooxygenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine beta-Hydroxylase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine beta-Monooxygenase' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine- and Cyclic AMP-Regulated Phosphoprotein Mr 32,000' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine-D1 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine-D2 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine-D3 Receptor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine-Specific Neurotransmitter Transporters' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine/antagonists %26% inhibitors %28%1966-1994%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamine/metabolism %28%1966-1988%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopaminergic Agents' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopaminergic Agents %28%1989%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopaminergic Agonist' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopaminergic Agonists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopaminergic Antagonists' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopaminergic Drugs' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopamines with a hydroxy group substituted in one or more positions.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopegit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopergin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopergit' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doping in Sport' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doping in Sports' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doping, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dopings, Blood' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Color Echocardiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Color Ultrasonography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Duplex Ultrasonography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, 2 D' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, 2-D' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, 2D' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, Color' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, Continuous' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, Pulsed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, Two Dimensional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Echocardiography, Two-Dimensional' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Effect' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Effect %28%1975-1992%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Laser Flowmetry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Pulsed Echocardiography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Pulsed Ultrasonography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Shift' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Sonography, Transcranial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Transcranial Sonography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Transcranial Ultrasonography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Ultrasonography' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Ultrasonography, Color' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Ultrasonography, Duplex' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Ultrasonography, Pulsed' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler Ultrasonography, Transcranial' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doppler-Laser Flowmetry' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dormice' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dormodor' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dormouse' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Horn Cell' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Horn Cells' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Horn Neuron' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Horn Neurons' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Medial Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Position' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Positions' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Root' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Root Ganglia' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsal Root Ganglion' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsch Brand of Allopurinol' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsolateral Medullary Syndrome' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsomedial Hypothalamic Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsomedial Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dorsomedial Thalamic Nucleus' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Compensation %28%Genetics%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Compensation, Gene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Compensation, Genetic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Compensation, Genetic %28%1982-2005%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Form' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Forms' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Forms %28%1966-1970%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage Forms %28%1966-1974%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage forms of a drug that act over a period of time by controlled-release processes or technology.%A% ' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage, Gene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosage, Radiotherapy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosages, Gene' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosages, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosages, Radiotherapy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose 50, Lethal' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Fractionation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Fractionation, Radiotherapy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Fractionations' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Fractionations, Radiotherapy' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Response Relationship, Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Response Relationship, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose Response Relationship, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose, Maximal Tolerated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose, Maximally Tolerated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose, Maximum Tolerated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationship, Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationship, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationship, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationship, Radiation %28%1973-1976%29%' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationships, Drug' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationships, Immunologic' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dose-Response Relationships, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doses, Maximal Tolerated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doses, Maximally Tolerated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Doses, Maximum Tolerated' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetries, Film' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetries, Film Badge' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetries, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetries, Thermoluminescent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry Calculation, Computer-Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry Calculations, Computer Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry Calculations, Computer-Assisted' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry, Film' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry, Film Badge' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry, Radiation' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosimetry, Thermoluminescent' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dosulepin' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dot Immunoblottings' = 0).
% 42.08/42.04 fof(interp, fi_functors, 'Dot, Quantum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dothiepin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dots, Quantum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Bind Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Bind Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Bind Theories' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Blind Method' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Blind Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Effect' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Masked Method' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Masked Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Minute 2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Outlet Right Ventricle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Refraction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Refractions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded RNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded RNA Binding Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded RNA Dependent eIF 2 alpha Protein Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded RNA-Dependent Kinase %28%dsl%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded RNA-Dependent eIF-2 alpha Protein Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded Telomere Binding Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Stranded Telomeric Binding Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double Vision' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Blind Method' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Blind Methods' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Blind Studies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Blind Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Masked Method' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Masked Methods' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Masked Studies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Masked Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Stranded DNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Stranded RNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-Stranded Telomeric Binding Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-layered inflatable suits which, when inflated, exert pressure on the lower part of the wearer%27%s body. The suits are used to improve or stabilize the circulatory state, i.e., to prevent hypotension, control hemorrhage, and regulate blood pressure. The suits are also used by pilots under positive acceleration.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-stranded DNA of MITOCHONDRIA. In eukaryotes, the mitochondrial GENOME is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Double-stranded nucleic acid molecules %28%DNA-DNA or DNA-RNA%29% which contain regions of nucleotide mismatches %28%non-complementary%29%. In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doubly unsaturated pregnane derivatives substituted with three hydroxy groups anywhere within the ring structure or side chains.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douching, Vaginal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douchings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Brand of Allopurinol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Brand of Amiloride Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Brand of Amitriptyline Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Brand of Gemfibrozil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Brand of Tolnaftate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Cul-de-Sac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Fir' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas Pouch' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas%27% Cul-de-Sac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douglas%27% Pouch' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dourine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dourines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Douroucouli' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dove' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dove, Rock' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doves' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doves, Rock' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dowel, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dowels, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dowfume W85' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Down Regulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Down Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Down%27%s Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Down-Regulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Down-Regulation %28%Physiology%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Down-Regulation, Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Downregulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Downs Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Downsizing, Personnel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Downsizing, Staff' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Downstream Regulatory Element Antagonist Modulator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Downward displacement of the UTERUS. It is classified in various degrees: in the first degree the UTERINE CERVIX is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dowries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxa Puren' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DoxaPuren' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DoxaUro' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxapram' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin AZU' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin Apogepha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin Heumann' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin Klast' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin Stada' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin Wolff' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin findusFit' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin ratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin-Wolff' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosin-ratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DoxazosinWolff' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Alter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Cinfa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Combino Pharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Geminis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Normon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Pharmagenus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Ratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosina Ur' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxazosinratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin AL' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin AZU' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin Holsten' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin Hydrochloride, Cis-Trans Isomer Mixture %28%approximately 1:5%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin Lindo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin RPh' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin Stada' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin TEVA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin dura' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin neuraxpharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin ratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin-RPh' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin-TEVA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin-neuraxpharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepin-ratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DoxepinRPh' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DoxepinTEVA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepinneuraxpharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxepinratiopharm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxorubicin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxorubicin %28%1973-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxorubicin, Liposomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxycycline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxycycline Chinoin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxycycline Monohydrochloride, 6 epimer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Doxylamine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dr. K. Hollborn Brand of Gentian Violet' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dr. Kade Brand of Testosterone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracaena' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracunculiases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracunculiasis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracunculoidea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracunculoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracunculosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dracunculus Nematode' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dragline Silk Fibroins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dragon, Green' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dragonroot' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage %28%1965-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage %28%1966-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage %28%1966-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage Implant, Glaucoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage Implants, Glaucoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage, Postural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage, Postural Respiratory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage, Sanitary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainage, Suction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainages, Postural Respiratory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainages, Sanitary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drainages, Suction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drama' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dramas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drawings %28%PT%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drawings %5B%Publication Type%5D%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Draxis Brand of Pergolide Mesylate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Draxis Brand of Primidone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dream' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dream, Day' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dreams' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dreams, Day' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dreissena' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dreissena polymorpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dreluso Brand of Noscapine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dreluso Brand of Noscapine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing Apraxias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Allograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Amniotic Membrane' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Biologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Biological' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Heterograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Homograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Hydrocolloid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Occlusive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Periodontal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Pig Skin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Porcine Xenograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Spray-On' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressing, Xenograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings comprised of a self-adhesive matrix to which hydrophilic absorbent particles are embedded. The particles consist of CELLULOSE derivatives; calcium ALGINATES; PECTINS; or GELS. The utility is based on providing a moist environment for WOUND HEALING.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings made of fiberglass, plastic, or bandage impregnated with plaster of paris used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. In comparison with plaster casts, casts made of fiberglass or plastic are lightweight, radiolucent, able to withstand moisture, and less rigid.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Allograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Amniotic Membrane' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Biologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Biological' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Heterograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Homograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Hydrocolloid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Occlusive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Periodontal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Pig Skin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Porcine Xenograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Spray On' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dressings, Xenograft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dried Food' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dried Foods' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dried Yeast' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dried aged bark of a buckthorn, Frangula purshiana %28%FRANGULA%29%, that contains the anthraquinone EMODIN and cascarosides. It is used as a laxative %28%CATHARTICS%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dried rhizome and roots of Piper methysticum, a shrub native to Oceania and known for its anti-anxiety and sedative properties. Heavy usage results in some adverse effects. It contains ALKALOIDS; LACTONES; kawain, methysticin, mucilage, STARCH, and yangonin. Kava is also the name of the pungent beverage prepared from the plant%27%s roots.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dried, ripe seeds of Plantago psyllium, P. indica, and P. ovata %28%Plantaginaceae%29%. Plantain seeds swell in water and are used as demulcents and bulk laxatives.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drift, Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drills' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drimys' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinkable liquids combined with or impregnated with carbon dioxide.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinkable liquids containing ETHANOL. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinking' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinking Behavior' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinking Behaviors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinking, Alcohol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drinkings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drip Infusion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drip Infusions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drip, Intravenous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Driver Examination, Automobile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Driver Examinations, Automobile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drives' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Driving, Automobile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drivings, Automobile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drogenil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Droleptan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dromaiidae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dromaius novaehollandiae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dromedaries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dronabinol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drop Attacks' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drop Foot Gait' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Droperidol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropout' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropout Characteristic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropout, Patient' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropout, School' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropout, Student' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropouts, Patient' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropouts, School' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropouts, Student' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drops, Eye' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropwort' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dropwort, Water' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosera' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Droseraceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila Glue Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila Glue Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila Melanogaster %28%1972-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila SOS Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila Son of Sevenless Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophila melanogaster' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drosophilidae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drossapharm Brand of Hexetidine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Droughts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drowning' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drowning %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drowning, Near' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drownings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drownings, Near' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drowsinesses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Droxidopa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Detection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Detections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Screening' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Screenings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Testing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Testings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse Treatment Centers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuse, Intravenous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Abuses, Sports' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration Route' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration Routes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration Schedule' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration Schedule %28%1978-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration Schedules' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Anal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Bladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Buccal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Cutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Dermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Inhalation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Intranasal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Intravesical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Oral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Rectal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Respiratory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Sublingual' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Topical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administration, Vaginal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Anal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Bladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Buccal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Cutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Dermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Intranasal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Intravesical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Oral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Rectal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Sublingual' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Topical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Administrations, Vaginal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Adulterations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Allergies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Allergy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Antagonism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Antagonism %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Antagonisms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Approval' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Approval Processes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Approval, New' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Approvals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Approvals, New' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Benefit Plan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Carrier' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Carriers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Catalog' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Catalogs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combination, Anticancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combination, Antineoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations %28%1971-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations %28%1972-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations %28%1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations %28%1981-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations %28%1983-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations %28%1986-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations, Anticancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Combinations, Antineoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Committee' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Committees' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Compounding' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Compounding %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Container' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Containers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Contamination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Contaminations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Controls' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Cost' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Costs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Delivery System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Delivery Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Delivery Systems, Implantable' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Design' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Design %28%1992-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Designs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Detoxication, Metabolic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Detoxications, Metabolic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Distribution System, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Distribution Systems, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Dose-Response Relationship' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Dose-Response Relationships' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Effects on Physiology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Eruption' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Eruptions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation %28%1974-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation %28%1974-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation %28%1980-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation Studies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation Studies, Preclinical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, FDA Phase 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, FDA Phase 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, FDA Phase 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, FDA Phase 4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, FDA Phase III' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, FDA Phase IV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluation, Preclinical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Evaluations, Preclinical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Food Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Formulations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Herb Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Hypersensitivities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Hypersensitivity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Implants' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Implants %28%1977-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Incompatibilities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Incompatibility' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Induced Abnormalities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Induced Akathisia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Industries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Industry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Industry %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Industry %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Information Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Information Services' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Infusion System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Instillation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Instillations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Interaction, Herbal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Interactions %28%1970-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Interactions %28%1972-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Interactions, Herbal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Kinetics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Labeling' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Labelling' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Law' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Laws' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Legislation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Metabolic Detoxication' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Metabolic Detoxications' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Metabolic Detoxification' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Metabolic Detoxifications' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Modelings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Monitoring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Package Insert' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Package Inserts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Packaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Packagings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Pellets' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Physiological Effects' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Plant Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Potentiations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Precursors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Preparation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Preparations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Prescription' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Prescriptions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Product Labeling' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Production, Orphan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Psychoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Pulse Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Pulse Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Reaction Reporting Systems, Adverse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Recalls' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Regulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Rehabilitation Centers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Residue' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Residues' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance %28%1972-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance %28%1981-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance %28%1986-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Antineoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Bacterial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Fungal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1966-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1966-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1966-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1967-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1968-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1971-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1972-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1973-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1974-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1977-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1986-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Microbial %28%1990-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Multiple %28%1994-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Multiple %28%1995-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Multiple, Bacterial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Multiple, Fungal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Multiple, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistance, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistances, Microbial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Resistances, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screen, Anti-Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screen, Antitumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screening' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screening %28%1974-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screening %28%1979-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screening Assays, Antitumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screening Tests, Tumor Specific' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screening Tests, Tumor-Specific' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screenings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screens, Anti-Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Screens, Antitumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Sensitivity Assay, Microbial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Sensitivity Tests, Helminth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Sensitivity Tests, Parasitic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Sensitivity Tests, Protozoal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Skin Administrations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Stabilities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Stability' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Stability %28%1966-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Storage' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Storages' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Surveillances, Postmarketing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Synergism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Synergism %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Synergisms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Targeting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Targetings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Test, Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Testing, Illicit' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Testings, Illicit' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Tests, Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapies, Combination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapies, Computer-Assisted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapies, Pulse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy %28%1966-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Adjuvant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Aerosol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Combination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Combination %28%1974-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Combination %28%1997-2000%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Computer Assisted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Computer-Assisted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy, Pulse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Therapy/adverse effects %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Tolerance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Tolerances' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Toxicities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Toxicity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Treatment Center' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Treatment Centers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Use Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Use Review' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug User, IV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Users, IV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilization' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilization %28%1967-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilization Evaluation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilization Evaluations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilization Review' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilization Reviews' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Utilizations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug Withdrawal Symptom' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug and Narcotic Control' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug and Narcotic Control %28%1968-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug metabolizing enzymes which oxidize methyl ethers. Usually found in liver microsomes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug, Orphan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug, Veterinary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Food Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Food Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Herb Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Herb Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Abnormalities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Abnormality' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Abortion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Abortions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Acathisia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Acathisias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Akathisia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Dyskinesia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Induced Dyskinesias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Plant Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Plant Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Resistant Tuberculosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Use Review' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drug-Use Reviews' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs %28%1978-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs administered orally and sequentially for contraceptive purposes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs considered essential to meet the health needs of a population as well as to control drug costs. %28%World Health Organization Action Programme on Essential Drugs, 1994, p3%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures %28%e.g., amphetamines%29%. Of special interest are MPTP %28%a reverse ester of meperidine%29%, MDA %28%3,4-methylenedioxyamphetamine%29%, and MDMA %28%3,4-methylenedioxymethamphetamine%29%. Many drugs act on the aminergic system, the physiologically active biogenic amines.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs designed to treat inflammation of the nasal passages, generally the result of an infection %28%more often than not the common cold%29% or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. %28%From PharmAssist, The Family Guide to Health and Medicine, 1993%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs of Abuse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p367%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. %28%From Smith and Reynard, Textbook of Pharmacology, 1991, p75%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. %28%From AMA Drug Evaluations Annual, 1994, p2033%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that are used to treat RHEUMATOID ARTHRITIS. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that are used to treat asthma. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors %28%RECEPTORS, GABA%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate adrenergic receptors. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate cholinergic receptors. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate dopamine receptors. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate excitatory amino acid receptors.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate muscarinic cholinergic receptors %28%RECEPTORS, MUSCARINIC%29%. Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to and activate nicotinic cholinergic receptors %28%RECEPTORS, NICOTINIC%29%. Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate GAMMA-AMINOBUTYRIC ACID receptors, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID or GAMMA-AMINOBUTYRIC ACID agonists.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders %28%ANTIPSYCHOTIC AGENTS%29% are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate muscarinic cholinergic receptors %28%RECEPTORS, MUSCARINIC%29%, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. Antagonists that discriminate among the various muscarinic receptor subtypes and might allow better control of peripheral and central actions are under development.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonin agonists.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that bind to nicotinic cholinergic receptors %28%RECEPTORS, NICOTINIC%29% and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. %28%From Gilman AG, et. al., Goodman and Gilman%27%s The Pharmacological Basis of Therapeutics, 8th ed%29% Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants %28%ANTIDEPRESSIVE AGENTS, TRICYCLIC%29% and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that can be sold legally without a prescription. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the Controlled Substances Act. %28%From Drug Evaluations Annual, 1992, p109%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals %28%see ADRENERGIC AGENTS%29%. Drugs that act in the central nervous system to reduce sympathetic activity %28%e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS%29% are included here.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers %28%NEUROMUSCULAR NONDEPOLARIZING AGENTS%29% or noncompetitive, depolarizing agents %28%NEUROMUSCULAR DEPOLARIZING AGENTS%29%. Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine %28%CHOLINESTERASE INHIBITORS%29%. Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons %28%GANGLIONIC STIMULANTS%29% are not included here.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that prevent preterm labor and immature birth by suppressing uterine contractions. Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that selectively bind to and activate alpha adrenergic receptors.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that selectively bind to and activate beta-adrenergic receptors.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions %28%ABORTIFACIENTS%29%. Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. %28%From AMA Drug Evaluations, 1994, p1157%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used by veterinarians in the treatment of animal diseases. The veterinarian%27%s pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the United States most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their actions on histaminergic systems. Included are drugs that act at histamine receptors, affect the life cycle of histamine, or affect the state of histaminergic cells.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission %28%NEUROMUSCULAR BLOCKING AGENTS%29%, and drugs that act centrally as skeletal muscle relaxants %28%MUSCLE RELAXANTS, CENTRAL%29%. Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their effects on the kidneys%27% regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys%27% clearance of other drugs, and for diagnosis of renal function.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used for their effects on the respiratory system.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; %28%especially DIURETICS, THIAZIDE%29%; ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease %28%ANTIPARKINSON AGENTS%29% and those for the tardive dyskinesias.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used in the treatment of tuberculosis. They are divided into two main classes: %22%first-line%22% agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and %22%second-line%22% drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to cause constriction of the blood vessels. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to cause dilation of the blood vessels. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to increase fertility or to treat infertility.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to prevent NAUSEA or VOMITING. Antiemetics act by a wide range of mechanisms. Some act on the medullary control centers %28%the vomiting center and the chemoreceptive trigger zone%29% while others affect the peripheral receptors.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to prevent SEIZURES or reduce their severity.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. military, purposes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to treat or prevent parasitic infections. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs used to treat or prevent skin disorders or for the routine care of skin.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials %28%Treatment IND%29%. The main heading includes drugs under investigation in foreign countries.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Adrenergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Adrenergic Neuron' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Adrenolytic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Analeptic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Analgesic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anesthetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anorexic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anorexigenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Allergy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Angiogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Anxiety' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Arrhythmia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Asthmatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Carcinogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Hypertensive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Obesity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Rheumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anti-Ulcer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiallergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiarrhythmia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiarrhythmic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiasthmatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anticarcinogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anticholesteremic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anticholinesterase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anticoagulant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anticonvulsant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Anticonvulsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antidepressant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antidiabetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antidiarrheal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiemetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiepileptic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antihypertensive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antilipemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antimalarial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antimanic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antimitotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antinematodal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antineoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antineoplastic Alkylating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antineoplastic Hormonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antinociceptive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiobesity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiparasitic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiparkinson' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiperistaltic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiplatelet' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiplatyhelmintic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antipruritic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antipsychotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antirheumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antispasmodic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antisyphilitic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antithrombic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antithyroid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antitreponemal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antitrichomonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antitubercular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antitussive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Antiviral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Appetite-Depressing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Appetite-Stimulating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Appetite-Suppressant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Autonomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Cardiovascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Chinese Herbal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Cholinergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Curariform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Customized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Cytostatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Designer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Disease-Modifying Antirheumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Disease-Modifying Second-Line' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Dopamine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Dopaminergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Emetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Essential' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Female Infertility' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Fertility' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Fibrinolytic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Gastric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Generic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Hallucinogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Histamine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Histaminergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Hypoglycemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Illicit' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Infertility' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Investigational' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Investigational %28%1990-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Investigational New' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Lipotropic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Neuroleptic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Neuroprotective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Non Prescription' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Non-Prescription' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Nonprescription' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Nonproprietary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Nootropic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, OTC' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Over-the-Counter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Oxytocic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Parasympatholytic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Parasympathomimetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Protective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Psychoactive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Psychotropic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Radiation-Protective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Radiation-Sensitizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Radioprotective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Radiosensitizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Recreational' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Sclerosing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Second-Generation Antidepressive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Sensory System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Serotonergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Serotonin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Spermatocidal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Street' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Sympatholytic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Sympathomimetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Thrombolytic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Tranquilizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Tranquillizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Tricyclic Antidepressant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Trypanocidal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Vasoconstrictor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Vasodilator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Veterinary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs, Weight-Loss' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drugs/adverse effects %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drumsticktree' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drunkenness' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drunkenness, Sleep' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drunkennesses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drunkennesses, Sleep' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drusen, Optic Disc' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drusen, Optic Disk' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drusen, Optic Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drusen, Retinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dry Eye Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dry Eye Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dry Ice' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dry Socket' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dry Sockets' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN%27%S SYNDROME.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drying, Freeze' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dryings, Freeze' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Drynariae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dryness, Mouth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dryopteridaceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dryopteris' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dsg1 Antigen' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du Pont Brand of Amantadine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du Pont Brand of Azapropazone Dihydrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du Pont Brand of Bretylium Tosilate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du Pont Brand of Hydrocodone Tartrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du Pont Brand of Naltrexone Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du Pont Brand of Technetium Tc 99m Sestamibi' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Du-zhong' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DuP 753' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DuP753' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Diagnoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Diagnoses %28%Psychiatry%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Diagnoses, Psychiatric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Diagnosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Diagnosis %28%Psychiatry%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Diagnosis, Psychiatric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Energy Radiographic Absorptiometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Energy Scanned Projection Radiography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Energy X Ray Absorptiometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Photon Absorptiometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Psychiatric Diagnoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Psychiatric Diagnosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Specificity Mitogen Activated Protein Kinase Kinase 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual Specificity Mitogen-Activated Protein Kinase Kinase 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual-Energy Radiographic Absorptiometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual-Energy Scanned Projection Radiography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dual-Photon Absorptiometries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duane Retraction Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duane Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duane%27%s Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duanes Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dubin Johnson Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dubin-Johnson Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duboisia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duchenne Muscular Dystrophy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duchenne Type Progressive Muscular Dystrophy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duchenne-Type Progressive Muscular Dystrophy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duck' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duck Hepatitis B Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duck Hepatitis Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duck Hepatitis Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duck hepatitis B virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duckbilled Platypus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducks' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Calculi, Salivary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Calculus, Salivary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Carcinoma, Collecting %28%Kidney%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Carcinomas, Collecting %28%Kidney%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Cell Carcinoma of the Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Cell Carcinoma, Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Disease, Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Diseases, Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Obstruction, Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Obstruction, Lacrimal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Obstructions, Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Obstructions, Lacrimal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Stone, Salivary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct Stones, Salivary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct connecting the endolymphatic sac with the membranous labyrinth.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct of Santorini' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct of Wirsung' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Accessory Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Cochlear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Common Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Common Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Cystic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Ejaculatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Endolymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Extrahepatic Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Human Mammary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Intrahepatic Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Kidney Collecting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Main Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Mullerian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Nasolacrimal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Omphalomesenteric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Perilymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Salivary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Santorini%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Stensen%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Thoracic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Vitelline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Wharton%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Wirsung%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct, Wolffian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct-Cell Carcinoma of the Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct-Cell Carcinoma, Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duct-Cell Carcinomas, Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal Carcinoma In Situ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal Carcinoma of the Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal Carcinoma, Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal Carcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal Carcinomas, Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductal, Lobular, and Medullary Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductless glands that secrete HORMONES directly into the BLOOD CIRCULATION. These hormones influence the METABOLISM and other functions of cells in the body.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts that collect PANCREATIC JUICE from the PANCREAS and supply it to the DUODENUM.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts that serve exclusively for the passage of eggs from the ovaries to the exterior of the body. In non-mammals, they are termed oviducts. In mammals, they are highly specialized and known as FALLOPIAN TUBES.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Accessory Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Cochlear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Common Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Cystic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Ejaculatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Endolymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Extrahepatic Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Gartner%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Human Mammary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Intrahepatic Bile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Kidney Collecting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Main Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Mullerian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Nasolacrimal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Omphalomesenteric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Perilymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Salivary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Thoracic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ducts, Vitelline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductus Arteriosus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductus Arteriosus, Patent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductus Arteriosus, Patent %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductus Cochlearis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ductus Deferens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duffy Blood Group System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duffy Blood-Group System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dugong' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dugong dugon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dugong dugong' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dugongs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duhring Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duhring%27%s Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duhrings Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dulcitol %28%1972-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dulco Lax' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dulco lax perles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dulco-Lax' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dulco-lax perles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dulcolax perles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dumex Brand of Disulfiram' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dumirox' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dumping Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dumping Syndrome %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dumping Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dumping, Patient' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duncan Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duncan%27%s Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duncans Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dunnigan Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Compression Syndrome, Mesenteric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Diseases %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Diseases %28%1966-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Obstruction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Obstruction %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Obstructions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Papillas, Minor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Reflux' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Refluxs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Ulcer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Ulcer/surgery %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenal Ulcers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenitis, Erosive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodeno Gastric Reflux' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodeno-Gastric Reflux' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenogastric Reflux' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenopancreatectomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenopancreatectomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscope' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopic Surgeries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopic Surgery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopic Surgical Procedure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenoscopy/instrumentation %28%1981-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenostomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenostomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum %28%1966-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum/surgery %28%1966-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum/surgery %28%1971-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenum/surgery %28%1977-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duodenums' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplex Doppler Ultrasonography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplex Ultrasonography, Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicate Gene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicate Genes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicate Publication' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicate Publication %28%PT%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicate Publication %5B%Publication Type%5D%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicate Publications' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicating Process' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplicating Processes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplication, Gene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duplications, Gene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dupre Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dupre%27%s Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duprene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dupres Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dupuytren Contracture' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dupuytren%27%s Contracture' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dupuytrens Contracture' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dur Elix' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DurElix' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dura Mater' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dura Mater %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dura Maters' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Durable Medical Equipment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dural Arteriovenous Fistulas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duramed Brand of Estrogens, Conjugated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duramucal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duran Reynals Permeability Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duran-Reynals Permeability Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duranil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Durapatite' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duratears Free' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duration, Marriage' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Durazolam' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Durian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Durolax' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust %28%1968-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust Mites, House' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust, Angel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust, Cosmic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust, House' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust, Interplanetary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dust, Interstellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dusts, Cosmic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dusts, Interplanetary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dusts, Interstellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dutch Guiana' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dutch Type Hereditary Cerebral Amyloid Angiopathy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duties that are based in ETHICS, rather than in law. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duties, Moral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duty to Recontact' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duty to Warn' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Duty, Moral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarf Lemur' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarf Lemurs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarf Mongoose' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarf Mongooses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarf Sperm Whales' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfin C' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfin-C' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism %28%1966-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism %28%1976-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism occurring in association with defective development of skin, hair, and teeth, polydactyly, and defect of the cardiac septum. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism, Growth Hormone Deficiency' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism, Laron' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism, Pituitary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism, Polydystrophic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfism, Thanatophoric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dwarfisms, Thanatophoric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dydrogesterone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye Dilution Technic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye Dilution Technics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye Dilution Technique' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye Dilution Technique %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye Dilution Techniques' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye Laser Lithotripsies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye, 2,6-Dichlorobenzenoneindophenol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dye, Amaranth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes used as cosmetics to change hair color either permanently or temporarily.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes, Fluorescent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes, Hair' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes, Lissamine Green' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyes, Rosaniline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'DynII Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamic Cardiomyoplasties' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamic Cardiomyoplasty' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamic Electrocardiography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamic and kinetic mechanisms of exogenous chemical and drug ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and TOXICOLOGY as a function of dosage, and rate of METABOLISM. It includes toxicokinetics, the pharmacokinetic mechanism of the toxic effects of a substance. ADME and ADMET are short-hand abbreviations for absorption, distribution, metabolism, elimination and toxicology.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamic three-dimensional echocardiography using the added dimension of time to impart the cinematic perception of motion. %28%Mayo Clin Proc 1993;68:221-40%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamics, Non-linear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamics, Nonlinear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamics, Population' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin D100' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin I' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin II' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin III' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin K44A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin, Alanine44 Substituted With Lysine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin, DYNII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin, GTPase-Deficient' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin, Mutated Form, K44A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin, Testicular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamin-2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynamins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynein ATPase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynein Adenosine Triphosphatase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynein Adenosinetriphosphatase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynexan MHP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynorphin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynorphin A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynorphin A %28%1-17%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dynorphins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyphonate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyphylline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysalbuminemic Hyperthyroxinemia, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias, Flaccid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias, Guttural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias, Mixed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias, Pseudobulbar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias, Scanning' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysarthrias, Spastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomia Orthostatic Hypotension Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomia, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomia-Orthostatic Hypotension Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomia-Orthostatic Hypotension Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomic Orthostatic Hypotension' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysautonomic Orthostatic Hypotensions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysbetalipoproteinemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysbetalipoproteinemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyschondroplasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysembryoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysembryomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Amebic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Amoebic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Shigella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Shigella boydii' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Shigella dysenteriae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Shigella flexneri' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysenteries, Shigella sonnei' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery, Amebic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery, Amoebic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery, Bacillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery, Shiga bacillus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery, Shigella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysentery, Shigella dysenteriae type 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyserythropoietic Anemia, Congenital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyserythropoietic Anemias, Congenital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysesthesias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction Syndrome, Hypothalamic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction Syndromes, Hypothalamic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction of one or more cranial nerves causally related to a traumatic injury. Penetrating and nonpenetrating CRANIOCEREBRAL TRAUMA; NECK INJURIES; and trauma to the facial region are conditions associated with cranial nerve injuries.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction of the sinoatrial node manifested by persistent sinus bradycardia, sinus arrest, sinoatrial exit block, chronic atrial fibrillation and inability of the heart to resume sinus rhythm following cardioversion for atrial fibrillation.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction of the urinary bladder due to disease of the central or peripheral nervous system pathways involved in the control of micturition. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Central Auditory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Communicative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Erectile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, General Peroxisomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Left Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Liver' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Minimal Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Multiple Peroxisomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Neurologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Phagocyte Bactericidal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Psychological Sexual' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Psychosexual' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Right Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Single Peroxisomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Sleep Initiation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Tibialis Posterior' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunction, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctional Uterine Bleeding' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctional Uterine Bleedings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Central Auditory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Communicative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Erectile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, General Peroxisomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Left Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Liver' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Multiple Peroxisomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Neurologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Phagocyte Bactericidal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Psychological Sexual' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Psychosexual' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Right Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Single Peroxisomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Sleep Initiation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysfunctions, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgammaglobulinemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgammaglobulinemia %28%1975-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgammaglobulinemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgenesis, Gonadal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgenesis, Thyroid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgerminoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgerminoma %28%1966-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgerminomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgeusia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgeusias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysglossias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgraphia, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgraphia, Developmental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgraphias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgraphias, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysgraphias, Developmental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyshidrotic Eczema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyshidrotic Eczemas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyshydrotic Eczema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyshydrotic Eczemas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysidea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysinhibition Syndrome, Hypothalamic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysinhibition Syndromes, Hypothalamic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskeratosis Congenita' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskeratosis Congenita, X Linked' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskeratosis Congenita, X-Linked' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Biliary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Blepharospasm-Oromandibular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Ciliary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Drug Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Drug-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Gallbladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Idiopathic Orofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Lingual-Facial-Buccal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Medication Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Orofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Paroxysmal Ocular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesia, Primary Ciliary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Biliary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Blepharospasm-Oromandibular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Ciliary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Drug-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Gallbladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Idiopathic Orofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Lingual-Facial-Buccal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Medication-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Paroxysmal Ocular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinesias, Primary Ciliary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyskinetic Cerebral Palsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslalias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexia, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexia, Acquired %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexia, Acquired Global' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexia, Acquired Spelling' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexia, Developmental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslexias, Developmental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslipidemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyslipidemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmenorrhea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmenorrheas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmetabolic Syndrome X' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmetria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmetria, Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmetrias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmetrias, Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmnesic Psychoses, Alcohol-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmnesic Psychosis, Alcohol-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmnesic Syndrome, Alcohol-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmnesic Syndromes, Alcohol-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmotilities, Esophageal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmotility, Esophageal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmyelopoietic Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysmyelopoietic Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysnomia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysnomias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysosmia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysosmias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostoses, Cleidocranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostoses, Craniofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostoses, Mandibulofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostosis, Cleidocranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostosis, Craniofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysostosis, Mandibulofacial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspareunia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspepsia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspepsias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphagia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphagia, Esophageal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphagia, Oropharyngeal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Anomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Associative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Broca' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Broca%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Brocas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Conduction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Fluent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Global' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Nominal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Receptive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Sensory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Wernicke' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Wernicke%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasia, Wernickes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Anomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Associative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Conduction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Fluent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Global' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Nominal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Receptive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphasias, Sensory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonia, Flaccid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonia, Hyperkinetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonia, Organic Tremor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonia, Spastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonia, Spastic Pseudobulbar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonias, Flaccid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonias, Hyperkinetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonias, Organic Tremor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonias, Spastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysphonias, Spastic Pseudobulbar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia Epiphysialis Punctata' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Anhidrotic Ectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Arteriohepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Bone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Branchio-Otorenal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Breast' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Bronchopulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Canine Hip' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Cervix' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Chondroectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Cleidocranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Congenital Hip' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Dentin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Ectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Fibromuscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Hidrotic Ectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Mammary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Monostotic Fibrous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Multicystic Kidney' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Multicystic Renal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Multiple Epiphyseal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Odontogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Polyostotic Fibrous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Progressive Diaphyseal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Retinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Spondyloepiphyseal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Thanatophoric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasia, Uterine Cervical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Anhidrotic Ectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Arteriohepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Bone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Branchio-Otorenal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Chondroectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Cleidocranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Congenital Hip' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Dentin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Ectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Fibromuscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Hidrotic Ectodermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Monostotic Fibrous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Multicystic Kidney' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Multicystic Renal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Multiple Epiphyseal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Odontogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Polyostotic Fibrous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Progressive Diaphyseal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Retinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Spondyloepiphyseal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplasias, Thanatophoric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplastic Nevus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysplastic Nevus Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspnea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspnea, Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspnea, Paroxysmal Nocturnal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspneas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspneas, Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspneas, Paroxysmal Nocturnal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxia of Gait' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxia, Articulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxia, Ideomotor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxia, Oral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxia, Verbal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxias, Articulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxias, Ideomotor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxias, Oral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyspraxias, Verbal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysprosium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysprosium. An element of the rare earth family that has the atomic symbol Dy, atomic number 66, and atomic weight 162.50. Dysprosium is a silvery metal used primarily in the form of various salts.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysraphia, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysraphias, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysraphicus, Status' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysraphism, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysraphisms, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysreflexia, Autonomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysreflexia, Spinal Autonomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysreflexias, Autonomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysreflexias, Spinal Autonomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysregulation, Circadian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssocial Behaviors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssomnia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssomnias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssomnias %28%i.e., insomnias or hypersomnias%29% associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder %28%e.g., sleep apnea, post-traumatic sleep disorders, etc.%29%. %28%From Thorpy, Sleep Disorders Medicine, 1994, p187%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssomnias associated with disruption of the normal 24 hour sleep wake cycle secondary to travel %28%e.g., JET LAG SYNDROME%29%, shift work, or other causes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergia Cerebellaris Myoclonica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergia Cerebellaris Progressiva' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergia, Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergia, Myoclonic Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergias, Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dyssynergias, Myoclonic Cerebellar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysthymic Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysthymic Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysthyroid Ophthalmopathies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dysthyroid Ophthalmopathy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystocia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystocias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia %28%1981-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia %28%1982-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Deformans Musculorum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Deformans Progressiva' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Musculorum Deformans' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Syndrome, Blepharospasm-Oromandibular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia Syndromes, Blepharospasm-Oromandibular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Adult-Onset' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Blepharospasm-Oromandibular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Childhood Onset' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Focal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Hereditary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Hypnogenic Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Idiopathic Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Idiopathic Torsion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Muscle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Nocturnal Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Nocturnal, Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Psychogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Sleep-Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonia, Sporadic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Adult-Onset' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Blepharospasm-Oromandibular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Childhood Onset' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Focal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Hereditary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Hypnogenic Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Idiopathic Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Idiopathic Torsion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Nocturnal Paroxysmal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Primary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Psychogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Secondary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Sleep-Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonias, Torsion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonic Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonic Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonic-Rigid Cerebral Palsies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystonic-Rigid Cerebral Palsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystroglycan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystroglycans' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophia Brevicollis Congenita' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophia Brevicollis Congenitas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophia Myotonica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophic Epidermolysis Bullosa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Adult Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Animal Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Cervical Sympathetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Congenital Myotonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Corneal Granular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Corneal Macular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Corneal Stromal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Facioscapulohumeral Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Groenouw%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Hereditary Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Infantile Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Juvenile Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Landouzy-Dejerine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Myotonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Ocular Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Oculocerebrorenal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Oculopharyngeal Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Pseudohypertrophic Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Reflex Sympathetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Rod Cone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophies, Rod-Cone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin Associated Glycoprotein 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin Associated Protein Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin Associated Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin Related Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin Related Protein 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-Associated Glycoprotein, 43-kDa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-Associated Protein Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-Associated Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-Associated glycoprotein, 50-kDa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-Related Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-Related Protein 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophin-associated proteins that play role in the formation of a transmembrane link between laminin-2 and DYSTROPHIN. Both the alpha and the beta subtypes of dystroglycan originate via POST-TRANSLATIONAL PROTEIN PROCESSING of a single precursor protein.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Adult Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Animal Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Becker Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Cervical Sympathetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Congenital Myotonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Corneal Granular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Corneal Macular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Corneal Stromal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Duchenne Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Facioscapulohumeral Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Fuch%27%s Endothelial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Fuchs%27% Endothelial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Hereditary Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Infantile Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Juvenile Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Landouzy-Dejerine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Myotonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Neuroaxonal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Ocular Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Oculocerebrorenal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Oculopharyngeal Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Pseudohypertrophic Muscular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Reflex Sympathetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Rod Cone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Dystrophy, Rod-Cone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E 250' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E 600' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E B Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Box Elements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Box Motifs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Box Sequences' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Box Sites' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Cadherin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Cadherins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Chromosomes, Group' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Coli Proton Translocating ATPase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Coli Proton-Translocating ATPase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Mail' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Receptor, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Receptors, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Selectin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E Z CAT' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli Adhesin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli Coupling Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli F1F0 ATPase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli F1F0-ATPase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli K12' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli O157' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli O157-H7' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E coli Vaccines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E, Cathepsin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E, Hemoglobin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E, Immunoglobulin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E, Pronase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E, Prostaglandins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E, beta-Lactoglobulin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-B Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-B Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Element' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Elements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Motif' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Motifs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Sequence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Sequences' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Site' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Box Sites' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Cadherin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Catenin, alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Mail' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Mails' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E-Selectin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1 - PROCEDURES AND TECHNIQUES-DIAGNOSTIC ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1 Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1, Aldehyde Dehydrogenase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E16 Membrane Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E19 Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E19 Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1A Associated p300 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1A Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1A Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1A p60' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1A-Associated Coactivator, p300' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1A-Associated p300 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1B Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E1B Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2 - PROCEDURES AND TECHNIQUES-THERAPEUTIC ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2 Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2 Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2 alpha, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2, 16,16-Dimethylprostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2, Aldehyde Dehydrogenase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2, Ubiquitin-Conjugating Enzyme' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E250' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E29 Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E29 Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2A 72K Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2A Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2A Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F 4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F 4 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Dimerization Partner 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 1 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 3 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 5 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 6 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factor 7 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F Transcription Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-1 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-1 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-2, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-3, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-4 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-4, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-5, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F-6, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F1 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F2 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F3 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F4 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F5 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F6 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2F7 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E2alpha, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3 - PROCEDURES AND TECHNIQUES-ANESTHETIC AND ANALGESIC ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3 19K Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3 Ligase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3 Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3 Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3 Ubiquitin Ligase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E3, Ubiquitin Ligase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E4 - PROCEDURES AND TECHNIQUES-SURGICAL ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E4 Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E4 Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E4F Protein, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E5 - PROCEDURES AND TECHNIQUES- INVESTIGATIVE ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E6 - PROCEDURES AND TECHNIQUES-DENTAL ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E600' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E7 - EQUIPMENT AND SUPPLIES ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E7 Oncogene Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'E7 Proteins, Papillomavirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAA Agents' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAA Agonist' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAA Agonists' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAA Antagonists' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAC 1 Excitatory Amino Acid Carrier' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAC-1 Excitatory Amino-Acid Carrier' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT 1 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT 2 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT 3 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT 4 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT 5 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT-1 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT-2 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT-3 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT-4 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT-5 Excitatory Amino Acid Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAAT2 Neurotransmitter Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAN %28%Experimental Allergic Neuritis%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAN %28%Experimental Autoimmune Neuritis%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EAR, EXTERNAL, DEFORMITY was heading 1966-70 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EBV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EBV Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EBV Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EBV Nuclear Antigens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EC' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EC IC Arterial Bypass' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EC-IC Arterial Bypass' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EC-IC Arterial Bypasses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECDGF' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECE Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECE Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECG' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECHOCARDIOGRAPHY, FOUR-DIMENSIONAL is also available; DF: ECHOCARDIOGR 3D%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECHOCARDIOGRAPHY, THREE-DIMENSIONAL is also available; DF: ECHOCARDIOGR 4D%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECL Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECL Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECMO' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECNOS Enzyme' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECOLOGY is the science, ECOSYSTEM is the interrelat of organisms within the science; specify geog if pertinent%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECT %28%Psychotherapy%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ECTs %28%Psychotherapy%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDAP Carbodiimide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDAP-Carbodiimide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDG5 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDG7 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Chromium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Copper' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Dicobalt' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Disodium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Distannous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Gallium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Magnesium Disodium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Potassium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EDTA, Stannous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EEC' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EEE Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EEE Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EEG' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EELS, SWAMP see SMEGMAMORPHA and EEL, ELECTRIC see ELECTROPHORUS are also available%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 1H' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 1alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 1beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 1delta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 1gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF G' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF Hand' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF Hand Motif' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF Hand Motifs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF Hands' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF Tu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-1H' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-1alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-1beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-1delta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-1gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-G' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-TEM' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EF-Tu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EFNB1 Gene Product' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EFNB3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EFTEM' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EG Labo Brand of Vinblastine Sulfate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EG Labo Brand of Vincristine Sulfate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EG Labo Brand of Vindesine Sulfate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EG-VEGF' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGATA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGC' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGF' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGF Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGFR Gene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGFR Genes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGR Transcription Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGR1 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGR2 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGR3 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGTA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EGTA, Tetrasodium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHDP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHDP, Dicalcium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHF Wave' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHS Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHV-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHV-3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EHV-4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIAV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2 alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2 beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2 gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2B' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 2gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 4E' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 4F' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF 4G' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2 alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2 beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2 gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2B' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-2gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4A1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4A2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4A3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4E' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4F' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-4G' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF-5' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B delta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B epsilon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B-alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B-beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B-delta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B-epsilon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B-gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF2B1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3 Protein, p42' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3 alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3 epsilon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3 gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3 p110' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3 p42 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3-alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3-beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3-epsilon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3-gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3-p48' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3-zeta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3S3 Gene Product' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3S3 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF3S4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF4AIII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF4E' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF4F' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF4F Translation Initiation Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EIF4G' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EJB' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EJECTION SEATS was heading 1963-82 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EKG' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELAEOPHORIASIS was heading 1975-92 %28%see under FILARIASIS 1975-90%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELAM-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELASTIC CARTILAGE is also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELASTIC STOCKINGS %26% STOCKINGS, COMPRESSION were see CLOTHING 1982-89%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELASTIC TISSUE is also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELAV Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELAV Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELF 1 Protein, Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELF 2 Protein, Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELF-1 Protein, Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELF-2 Protein, Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELF-2, Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELISA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELK Related Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ELK-Related Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMB Fatol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMB Hefa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMB-Fatol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMBL Nucleotide Sequence Database' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMCV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMD 33512' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMD33512' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMERGENCY MEDICINE is the corresponding specialty; /nurs = the patient, EMERGENCY NURSING = the nursing specialty; emergencies in specific dis: coord NIM with specific dis %28%IM%29%; %22%drug emergencies%22%: coord NIM with specific drug or chem with probably /pois %28%IM%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMODIN was see under CATHARTICS 1963-74 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMS Communication System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMS Communication Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMT 966' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMT 967' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMT966' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMT967' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EMycin E' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN 141' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN 1639A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN 2234A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN 313' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN141' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN1639A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN2234A' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EN313' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENALLYNYMALUM was see METHOHEXITAL 1977-94 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENAMEL CUTICLE was heading 1965-96; NASMYTH%27%S MEMBRANE was see ENAMEL CUTICLE 1975-96%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by sulfhydryl reagents. EC 3.4.22.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENDOSCOPES for examining the abdominal and pelvic organs in the peritoneal cavity.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENGINEERING PSYCHOLOGY was see under HUMAN ENGINEERING 1969-78%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENOS Enzyme' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENT 17,798' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENT 27,093' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENT17,798' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENT27,093' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENTEROCOLITIS with extensive ulceration %28%ULCER%29% and NECROSIS. It is observed primarily in LOW BIRTH WEIGHT INFANT.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ENZYMATIC ZONULOLYSIS was heading 1963-96 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EOG' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPH %28%Edema, Proteinuria, Hypertension%29% = GESTOSIS, EPH %26% do not index under PROTEINURIA unless it is particularly discussed%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPH Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPH Gestosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPH Toxemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPH Toxemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPHA1 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPHA1 Receptor Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPHB4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPHT2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPLG1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPLG3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPLG4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPLG6 Gene Product' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPLG8 Gene Product' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPN 300' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPN300' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPSP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EPSP Synthase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERBA1 Gene Products' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERBA2 Gene Products' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERBF' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERCC2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERCP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EREMOPHILA ALPESTRIS see SONGBIRDS and EREMOPHILUS MUTISII see CATFISHES are also available; eremophilane compounds %28%NM%29% is also available; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERG Potassium Channels' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERGOTAMINE TARTRATE was ERGOTAMINE TARTRATE %28%NM%29% 1975-91 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERGOTAMINE TARTRATE was indexed under ERGOTAMINE DERIVATIVES 1977-91 %26% under ERGOTAMINE 1975-76%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERISA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK Kinase Kinase 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK MAP Kinases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK1 Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK2 Brain Kinase PK40' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK3 Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK5 Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERK6 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EROD' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERPF' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERVs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume %28%MCV%29%, the mean corpuscular hemoglobin %28%MCH%29%, and the mean corpuscular hemoglobin concentration %28%MCHC%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERYTHRODERMA ICHTHYOSIFORME was see under ICHTHYOSIS 1963-78%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERYTHROPOIETIN prepared by recombinant DNA technology. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERalpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERbeta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERp59 PDI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ERp60' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ES-1A, Esterase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESI Mass Spectrometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESOPHAGITIS, PEPTIC is also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESP Pharma Brand of Nicardipine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESRD' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESTs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESWL %28%Extracorporeal Shockwave Lithotripsy%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ESWLs %28%Extracorporeal Shockwave Lithotripsy%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ET 495' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ET Flavoprotein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ET-1 %28%Endothelin-1%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ET-2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ET-NANBH' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ET495' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHANOLAMINE is also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHANOLAMINES also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHICS, MEDICAL is available for ethics in relation to the physician. Do not use routinely; reserve for discussions of clinical ethics as a topic in its own right%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHINYL ESTRADIOL and NORGESTREL given in fixed proportions. It has proved to be an effective contraceptive %28%CONTRACEPTIVES, ORAL, COMBINED%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHOGLUCID was see under ALKYLATING AGENTS 1967-74 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHOXZOLAMIDE was see under CARBONIC ANHYDRASE INHIBITORS 1965-74%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHYLENE GLYCOL is also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHYLENE GLYCOLS also available ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETHYLMETHYLGLUTARIMIDE was see under ANALEPTICS 1963 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'ETYA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EU 4200' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EU4200' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EUPATORIUM REBAUDIANUM see STEVIA; EUPATORIUM ODORATUM see CHROMOLAENA and EUPATORIUM ADENOPHORUM see AGERATINA are also available; for other species check plant taxonomy reference: Manual 22.37; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATIONS or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EVA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EWS Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EWS Proto Oncogene Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EWS Proto-Oncogene Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EWS, RNA-Binding Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EXISTENTIAL PSYCHOLOGY was see under EXISTENTIALISM 1974-78%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EXODONTICS was see TOOTH EXTRACTION 1965-97; was EXODONTIA see TEETH EXTRACTION 1963-64%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EXOPEPTIDASES that specifically act on dipeptides. EC 3.4.13.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EXOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EYESTRAIN was heading 1963-67 ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EZCAT' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eag Potassium Channels' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eag Related Potassium Channels' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eag-Related Potassium Channels' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eagle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eagles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear %28%1966-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Acupuncture' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Acupunctures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Canal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Canals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Cancers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Cartilage' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Cartilages' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Deformities, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Deformity, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Diseases %28%1966-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Diseases %28%1966-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Effusion, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Effusions, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Implant, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Implants, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Mold' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Ossicle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Ossicles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Ossicles %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Ossicles %28%1966-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Piercings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Protective Device' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Protective Devices' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Ventilation, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Ventilations, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear Wax' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, External' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, External %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Inner' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Internal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Middle %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Middle %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Middle %28%1966-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear, Outer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ear-shaped appendage of either atrium of the heart. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earache' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earaches' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eardrum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eardrums' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eared Seal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eared Seals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earless Seal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earless Seals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Ambulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early B Cell Specific Binding Protein 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early B Cell-Specific Binding Protein-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Childhood, Myoclonic Epilepsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Diagnoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Diagnosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Growth Response Protein 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Growth Response Protein 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Growth Response Protein 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Growth Response Transcription Factor 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Growth Response Transcription Factor 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Growth Response Transcription Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Infantile Autism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Intervention' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Intervention %28%Education%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Interventions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Interventions %28%Education%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Modern Histories %28%Medicine%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Modern History' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Modern History %28%Medicine%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Modern History of Medicine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Onset Alzheimer Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Onset Cerebellar Ataxia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Onset Globoid Cell Leukodystrophy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Placental Phase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Placental Phases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Post Traumatic Seizures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Post-Traumatic Seizure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Promoter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Proteins, Adenovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early Response Factor Berg36' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early T Cell Costimulatory Molecule 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early pregnancy loss during the EMBRYO stage of development. In the human, this period comprises the second through eighth week after fertilization.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Early preimplantation mammalian EMBRYO in the post-MORULA stage. Its structure consists of a TROPHOBLASTS-enclosed fluid-filled cavity with an inner cell mass. After EMBRYO IMPLANTATION, the inner cell mass of the blastocyst becomes the embryonic disc of the developing embryo.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earmuff' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earplug' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ears' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ears, External' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ears, Inner' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ears, Internal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ears, Middle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ears, Outer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earth %28%Planet%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earth Metals, Alkaline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earth Metals, Rare' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earth or other matter in fine, dry particles. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earth, Diatomaceous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earth, Infusorial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Earthquake' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'East Asia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'East Indies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'East New Guinea is a part of Papua New Guinea %26% West New Guinea is part of Indonesia%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'East Timor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'East Timur' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Africa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Asia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Equine Encephalitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Equine Encephalitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Equine Encephalomyelitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Equine Encephalomyelitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Equine Encephalomyelitis Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Europe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Orthodoxy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Red Cedar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern Samoa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eastern equine encephalitis virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating %28%1966-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Behavior' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Behaviors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Disorders %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Induced Epilepsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating Utensil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as %22%ox hunger%22%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating of excrement. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating other individuals of one%27%s own species. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating, Binge' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating-Drinking Syndrome, Nocturnal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating-Drinking Syndromes, Nocturnal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating-Induced Epilepsies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating-Induced Epilepsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating-Induced Reflex Epilepsies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eating-Induced Reflex Epilepsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eatings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton Agent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton Lambert Myasthenic Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton Lambert Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton-Lambert Myasthenic Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton-Lambert Myasthenic-Myopathic Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton-Lambert Myopathic-Myasthenic Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton-Lambert Myopathic-Myasthenic Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eaton-Lambert Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebenaceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola Hemorrhagic Fever' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola Vaccines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola Virus Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola Virus Vaccines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola like Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola-like Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebola-like Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebstein Anomaly' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebstein%27%s Anomaly' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ebsteins Anomaly' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecarazine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccentro Osteochondrodysplasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccentro-Osteochondrodysplasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccentro-Osteochondrodysplasias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccentroosteochondrodysplasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccentroosteochondrodysplasias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecchymoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecchymosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccrine Acrospiroma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccrine Acrospiromas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccrine Gland' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccrine Glands' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccrine Hidradenitides, Neutrophilic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eccrine Hidradenitis, Neutrophilic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdyses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdysis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdysone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdysone %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdysteroid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdysteroids' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecdysterone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echidna' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinacea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinochloa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcis, Hepatic Alveolar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcoses, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcoses, Hepatic Alveolar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcoses, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcosis, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcosis, Hepatic Alveolar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcosis, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcus %28%1965-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcus granulosus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinococcus multilocularis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1965-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1965-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1966-1973%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1968-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1970-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1970-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinodermata %28%1971-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinoderms having bodies of usually five radially disposed arms coalescing at the center.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinoidea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinomycin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinopanax' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinopanax horridus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinops Plant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinostoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinostomatidae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinostomiases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echinostomiasis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Endoscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Endoscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Planar Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Planar MR Tomography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Planar Magnetic Resonance Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Reaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Speech' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Virus 6' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Virus 9' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Virus Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Virus Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo-Endoscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo-Endoscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo-Planar Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo-Planar Imagings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo-Planar MR Tomographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echo-Planar Magnetic Resonance Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, 3-D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, 3D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, 4-D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, 4D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, Color Flow' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, Dobutamine Stress' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, Four-Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, Stress' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiographies, Three-Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1972-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1974-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1977-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1983-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1985-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography %28%1993-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography amplified by the addition of depth to the conventional two-dimensional ECHOCARDIOGRAPHY visualizing only the length and width of the heart. Three-dimensional ultrasound imaging was first described in 1961 but its application to echocardiography did not take place until 1974. %28%Mayo Clin Proc 1993;68:221-40%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 2 D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 2 D Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 2-D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 2-D Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 2D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 2D Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 3 D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 3-D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 3D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 4 D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 4-D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, 4D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Color Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Color Flow' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Cross Sectional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Dobutamine Stress' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Doppler %28%1989-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Doppler Color' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Doppler Pulsed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Doppler, Color' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Doppler, Pulsed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Four Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Four-Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, M Mode' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Pulsed Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Stress' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Three Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Three-Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Transesophageal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Transthoracic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Two Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Two Dimensional Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Two-Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echocardiography, Two-Dimensional Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoencephalographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoencephalography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echolalia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echolocation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echolocations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echophrasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoplanar Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoplanar Imagings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoplanar MR Tomographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoplanar MR Tomography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echoplanar Magnetic Resonance Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echothiophate Iodide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echotomographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echotomography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus 22' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus 23' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus 6' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus 6, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus 9' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus 9, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Echovirus Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eck Fistula' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eck Ligand' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eck RPTK Ligand' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eclampsia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eclampsia %28%1985-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eclampsias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eclecticism, Historical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eclipta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eco RI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eco-RI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EcoRI Endonuclease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecobec' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecolab Brand of Glutaral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecologic Monitoring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecologic System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecologic Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological Biases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological Fallacies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological Fallacy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological Monitoring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological System, Closed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecological Systems, Closed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecologies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecologies, Sealed Cabin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecology %28%1982-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecology, Sealed Cabin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Econazole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Econometric Model' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Econometric Models' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Community, European' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Competition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Competition %28%1992-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Competition/legislation %26% jurisprudence %28%1982-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Competitions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Condition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Inflation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Life Valuation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Life Valuations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Model' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Models' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Policy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Recession' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Recessions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Value, Life' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic Values, Life' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic aspects of the dental profession and dental care.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic aspects of the field of medicine, the medical profession, and health care. It includes the economic and financial impact of disease in general on the patient, the physician, society, or government.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. %28%From J Res Pharm Econ 1989;1%28%1%29%; PharmacoEcon 1992;1%28%1%29%%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic aspects of the nursing profession. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic aspects related to the management and operation of a hospital.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic sector concerned with the provision, distribution, and consumption of health care services and related products.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economic, Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics %28%1966-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics %28%1986-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics %28%1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Dental %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Home' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Hospital %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Hospital %28%1966-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Hospital %28%1967-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Medical %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics, Pharmaceutical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economics/legislation %26% jurisprudence %28%1982-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economies, Token' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economo-Type Parkinsonism, Postencephalitic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Economy, Token' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecosystem' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecosystems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecothiopate Iodide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecothiophate Iodide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecstasy %28%Drug%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectasia, Antral Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectasias, Antral Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecthyma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecthyma %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecthyma contagiosum Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecthyma contagiosum Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecthyma, Contagious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecthymas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecto 5%27% Nucleotidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecto NAD+ Glycohydrolase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecto Phosphoprotein Phosphatase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecto-5%27%-Nucleotidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectoderm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Defect, Congenital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Defects, Congenital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasia %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasia, Anhidrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasia, Hidrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasias, Anhidrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectodermal Dysplasias, Hidrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectoderms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectogeneses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectogenesis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectogenesis %28%1975-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectomorphs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectoparasitic Infestation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectoparasitic Infestations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopia Lentis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic ACTH Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic ACTH Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Atrial Tachycardia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Atrial Tachycardias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Beat, Atrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Beat, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Beats, Atrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Beats, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Hormone Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Hormone Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Hormones' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Junctional Tachycardia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Junctional Tachycardias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Ossification' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Pregnancies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Pregnancy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Pupils' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tachycardia, Atrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tachycardia, Junctional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tachycardias, Atrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tachycardias, Junctional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tissue' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tissues' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tooth Eruption' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectopic Tooth Eruptions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectothiorhodospira' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectothiorhodospira halophila' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectothiorhodospira shaposhnikovii' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectothiorhodospira vacuolata' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectothiorhodospiraceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectromelia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectromelia virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectromelia viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectromelia, Infectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectropion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ectropions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ecuador' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema %28%1966-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema, Atopic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema, Contact' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema, Dyshidrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema, Dyshydrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczema, Vesicular Palmoplantar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczemas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczemas, Dyshidrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczemas, Dyshydrotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczemas, Vesicular Palmoplantar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Dermatitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Dermatitides, Allergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Dermatitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Dermatitis, Allergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Skin Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eczematous Skin Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edathamil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edeine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema %28%1966-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema Disease of Swine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema Proteinuria Hypertension Gestosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema due to obstruction of lymph vessels or disorders of the lymph nodes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema of any region of the larynx from a variety of causes. In the earliest stages it may be difficult to differentiate from infection, although mucosal injection and erythema are found more often in the latter. Allergic edema may result as a response from provocation induced by foods, inhalants, and drugs. The entire respiratory tract or only an isolated portion of the larynx may be affected. Laryngeal edema may also be hereditary. Other possible causes of laryngeal edema include increased capillary pressure due to superior vena cava syndrome, internal jugular vein ligation, lowered plasma osmotic failure induced by renal failure, impaired lymphatic flow, and increased capillary permeability to proteins. %28%From Paparella et al., Otolaryngology, 3d ed, p2253%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Angioneurotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Cytotoxic Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Cytotoxic Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Fetal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Intracranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Laryngeal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Optic Disk' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Optic Papilla' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Quincke%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Retinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Vasogenic Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema, Vasogenic Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema-Proteinuria-Hypertension Gestosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edema/veterinary %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Angioneurotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Laryngeal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Optic Disk' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Optic Papilla' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edemas, Retinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edematous Ophthalmopathies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edematous Ophthalmopathy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edentata' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edentulous Jaw' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edentulous Jaws' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edentulous Mouth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edentulous Mouths' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edetate, Calcium Disodium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edetic Acid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edetic Acid, Disodium, Magnesium Salt' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg 4 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg 5 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg 7 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg-4 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg-5 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg-7 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edg4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edible Vaccines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edible or potable substances. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edigen Brand of Methylcellulose' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edisylate Salt, Prochlorperazine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edisylate, Prochlorperazine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editing, RNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editings, RNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial %28%PT%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial %5B%Publication Type%5D%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial Comment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial Comment %28%PT%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial Policies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Editorial Policy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edodekin Alfa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edrophonium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edroponium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education Department, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education Departments, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education Research, Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education Researchs, Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education and training in PUBLIC HEALTH for the practice of the profession.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education and training outside of that for the professions.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education for specific trades or occupations. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education of Mentally Defective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education of Mentally Retarded' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education of Patients' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education via communication media %28%correspondence, radio, television, computer networks%29% with little or no in-person face-to-face contact between students and teachers. %28%ERIC Thesaurus, 1997%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of dental health on a personal or community basis.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Associate Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Baccalaureate Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Community Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Competency Based' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Competency-Based' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing Pharmaceutic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing Pharmaceutical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Continuing Pharmacy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Dental %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Dental Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Dental, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Dental, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Distance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Family Planning' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Graduate Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Graduate Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Graduate Pharmaceutic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Graduate Pharmaceutical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Graduate Pharmacy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical, Undergraduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Medical, Undergraduate %28%1971-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Mentally Retarded' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nonprofessional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Associate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Baccalaureate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Continuing %28%1966-1985%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Diploma Programs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Post-Basic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Post-Registration' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Nursing, Postgraduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Parenting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Patient' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmaceutic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmaceutic, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmaceutic, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmaceutical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmaceutical, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmaceutical, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmacy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmacy %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmacy, Continuing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Pharmacy, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Physical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Post-Basic Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Post-Registration Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Postgraduate Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Predental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Premedical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Professional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Professional, Retraining' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Public Health Professional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Sex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Special' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Special/trends %28%1968-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Undergraduate Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Veterinary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Education, Vocational' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Achievement' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Achievements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Activity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Assessments' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Exchange, International' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Exchanges, International' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Grant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Grants and Subsidies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Measurement' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Measurement %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Measurement %28%1974-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Measurements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Model' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Models' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Nursing Research' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Nursing Researchs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Personnel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Psychologies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Psychology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Status' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Subsidies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Subsidy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Technic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Technics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Technique' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Techniques' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Technologies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational Technology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational attainment or level of education of individuals.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of dentistry.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of library science or information.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of medicine.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of nursing.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of pharmacy.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of public health.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions for individuals specializing in the field of veterinary medicine.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions providing facilities for teaching and research and authorized to grant academic degrees.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational institutions. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs designed to inform dentists of recent advances in their fields.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs designed to inform graduate pharmacists of recent advances in their particular field.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs designed to inform individuals of recent advances in their particular field of interest. They do not lead to any formal advanced standing.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs designed to inform nurses of recent advances in their fields.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs designed to inform physicians of recent advances in their field.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs for dental graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic dental sciences, and may lead to board certification or an advanced dental degree.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs for individuals who have been inactive in their profession, or who wish to regain unused skills.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs for medical graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic medical sciences, and may lead to board certification or an advanced medical degree.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs for pharmacists who have a bachelor%27%s degree or a Doctor of Pharmacy degree entering a specific field of pharmacy. They may lead to an advanced degree.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educational programs structured in such a manner that the participating professionals, physicians, or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Associate Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Baccalaureate Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Competency-Based' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Continuing Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Graduate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Predental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Special' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Veterinary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educations, Vocational' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educator, Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Educators, Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edwards Brand of Phenazopyridine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edwardsiella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edwardsiella ictaluri' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Edwardsiella tarda' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eel, Electric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eel, Lamprey' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eel, Swamp' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eels' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eels %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eels, Congo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eels, Lamprey' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eels, Swamp' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efbn2 Gene Product' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect Modifier %28%Epidemiology%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect Modifier, Epidemiologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect Modifiers %28%Epidemiology%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect Modifiers, Epidemiologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Autokinetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Bystander' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Cohort' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Coriolis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Doppler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Double' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Founder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Generation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Graft-vs-Leukemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Graft-vs-Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Graft-vs-Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Greenhouse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Halo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Hawthorne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Healthy Worker' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Interviewer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Long-Term' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Longterm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Placebo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Radiation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Viral Cytopathic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effect, Viral Cytopathogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effective Renal Blood Flow' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effective Renal Plasma Flow' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Biologic Relative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Biological Relative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Cost' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Demographic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Program' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Relative Biologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Relative Biological' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Theoretical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effectiveness, Treatment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Autokinetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Bystander' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Cohort' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Drug Physiological' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Founder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Generation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Graft-vs-Leukemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Graft-vs-Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Graft-vs-Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Halo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Healthy Worker' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Interviewer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Long Term' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Long-Term' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Longterm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Placebo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Radiation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Viral Cytopathic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effects, Viral Cytopathogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efferent Neuron' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efferent Neurons' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efferent Pathway' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efferent Pathways' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efferent Pupillary Defects' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficacy, Self' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficacy, Treatment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficiency' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficiency %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficiency %28%1972-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficiency, Organizational' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efficiency, Program' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effik Brand of Ethinyl Estradiol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effik Brand of Fluconazole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effort' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effort Syncope' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effort Syncopes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effort Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effort, Physical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efforts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efforts and designs to reduce the incidence of unexpected undesirable events in various environments and situations.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efforts to prevent and control the spread of infections within dental health facilities or those involving provision of dental care.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efforts, Physical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusion, Malignant Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusion, Middle Ear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusion, Pericardial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusion, Peritoneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusion, Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusion, Subdural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusions, Malignant Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusions, Middle Ear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusions, Pericardial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusions, Peritoneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Effusions, Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eflornithine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eflornithine Monohydrochloride, Monohydrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Efudex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Allergies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Allergy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Count, Parasite' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Counts, Parasite' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Hypersensitivities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Hypersensitivity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Proteins %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Proteins %28%1972-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Proteins %28%1973-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Proteins, Dietary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Shell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Shells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Sperm Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg White' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg White %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Whites' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Yolk' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Yolk %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Yolk Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Yolk Proteins, Dietary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg Yolks' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg, Fertilized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg, Unfertilized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg-Sperm Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egg-Sperm Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eggplant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eggs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eggs %28%1965-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eggs, Fertilized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eggs, Unfertilized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ego' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ego-Dystonic Homosexualities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ego-Dystonic Homosexuality' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egos' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egtazic Acid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egtved virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egypt' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egypt 101 virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egyptian Cobra' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Egyptian Cobras' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehlers Danlos Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehlers Danlos Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehlers-Danlos Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehlers-Danlos Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlich Ascites Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlich Tumor Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia %28%1969-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia %28%1975-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia %28%1975-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia %28%1985-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia %28%1986-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia %28%1991-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia canis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia chaffeensis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia equi' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia phagocytophila' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia risticii' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia ruminantium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichia sennetsu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichieae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichioses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ehrlichiosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eichhornia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosamethyl octacontanonadecasen-1-o1. Polyprenol found in animal tissues that contains about 20 isoprene residues, the one carrying the alcohol group being saturated.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosanoic Acids' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosanoid Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosanoid Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosanoids' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosanoids Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosapentaenoic Acid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eicosatetraenoic acids substituted in any position by one or more hydroxy groups. They are important intermediates in a series of biosynthetic processes leading from arachidonic acid to a number of biologically active compounds such as prostaglandins, thromboxanes, and leukotrienes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eidetic Imageries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eidetic Imagery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eifelfango Brand of Testosterone Propionate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eigenmannias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eight-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighteen-carbon essential fatty acids that contain three double bonds.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighteen-carbon essential fatty acids that contain two double bonds.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighteenth Century Histories' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighteenth Century History' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighth Cranial Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighth Cranial Nerve Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eighth Cranial Nerves' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eikenella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eikenella corrodens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eikenella corrodens %28%1976-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eimeria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eimeria %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eimeria tenella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eimeriida' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eimeriidae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Einsteinium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Einsteinium. A man-made radioactive actinide with atomic symbol Es, atomic number 99, and atomic weight 252. Its known isotopes range in mass number from 243-246. Its valence can be +2 or +3. Einsteinium was originally discovered in the debris from a thermonuclear explosion in 1952.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eipico Brand of Benzydamine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eire' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisai Brand of Buspirone Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenia fetida' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenmenger Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenmenger Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenmenger%27%s Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenmenger%27%s Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenmengers Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eisenmengers Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of a pair of arteries originating from the internal iliac artery and passing through the umbilical cord to carry blood from the fetus to the placenta.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of a pair of tubular structures formed by DUCTUS DEFERENS; ARTERIES; VEINS; LYMPHATIC VESSELS; and nerves. The spermatic cord extends from the deep inguinal ring through the INGUINAL CANAL to the TESTIS in the SCROTUM.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of the two fleshy, full-blooded margins of the mouth.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of the two longitudinally adjacent threads formed when a eukaryotic chromosome replicates prior to mitosis. The chromatids are held together at the centromere. Sister chromatids are derived from the same chromosome. %28%Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of two diseases resulting from fungal infection of the hair shafts. Black piedra occurs mainly in and on the hairs of the scalp and is caused by Piedraia hortae; white piedra occurs in and on the hairs of the scalp, beard, moustache and genital areas and is caused by Trichosporon beigelii.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. %28%From Storer et al., General Zoology, 6th ed, p73%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of two genetic disorders characterized by urinary excretion of large amounts of oxalate, with nephrolithiasis, nephrocalcinosis, early onset of renal failure, and often a generalized deposit of calcium oxalate, resulting from a defect in glyoxylate metabolism.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Either of two small elongated rectangular bones that together form the bridge of the nose.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejaculation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejaculations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejaculatory Duct' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejaculatory Ducts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejection Fraction, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejection Fractions, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejection Seat' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ejection, Milk' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ekbom Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ekbom%27%s Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ekboms Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ekonazole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'El Salvador' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elaeagnaceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elaeocarpaceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elaeophoriases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Capreomycin Disulfate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Capsaicin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Doxorubicin Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Ethambutol Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Mefenamic Acid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Nimodipine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elan Brand of Nitrendipine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elanco Brand of Pergolide Mesylate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elapid Cardiotoxins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elapid Venom' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elapid Venoms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elapidae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasmobranch' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasmobranchii' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasmobranchius' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasmobranchs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase I, Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, Granulocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, Leukocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, Lysosomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, Neutrophil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, PMN' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, Pancreatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastase, Polymorphonuclear Leukocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Cartilage' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Cartilages' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Fiber' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Stocking' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Stockings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Tissue' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastic Tissues' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastica Posterior, Lamina' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastica Posteriors, Lamina' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasticity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasticity %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elasticity %28%1967-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastin %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastoidoses, Nodular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastoidosis, Nodular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastomer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastomers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastomers, Silicone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastoses, Nodular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastosils' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elastosis, Nodular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elavil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow %28%1966-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow Joint' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow Joint %28%1966-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow Joints' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow, Tennis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbow/injuries %28%1969-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbows' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elbows, Tennis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elcon Brand of Trifluridine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder Abuse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder Abuse/legislation %26% jurisprudence %28%1984-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder Neglect' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder Plant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder, Black' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder, Box' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder, European' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elder, Frail' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elderberries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elderly' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elderly, Frail' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elderly, Functionally-Impaired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elders, Frail' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elective Mutism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elective Mutisms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elective Surgical Procedure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elective Surgical Procedures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Ablation, Transvenous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Anesthesia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Anesthesias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Burn' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Burns' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Capacitance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Catheter Ablation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductance, Skin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductances, Skin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductivity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductivity %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductivity %28%1968-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductivity %28%1968-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Conductivity %28%1968-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Convulsive Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Convulsive Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Countershock' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Countershock %28%1967-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Countershock/instrumentation %28%1980-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Countershocks' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Defibrillation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Defibrillations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Eel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Fish' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Impedance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Injuries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Injuries %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Injury' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Organ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Organs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Power Plant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Power Source' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Power Sources' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Power Supplies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Power Supply' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Rays' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Shock Cardiac Stimulators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Shock Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Shock Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation %28%1966-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation %28%1966-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation %28%1973-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation Therapy %28%1966-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation Therapy %28%1973-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation, Therapeutic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulation, Transcutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Stimulations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric Wiring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electric conductors through which an electric current enters or leaves a medium. When inserted, usually surgically, they are referred to as implanted electrodes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Ablation, Transvenous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Capacitance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Catheter Ablation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Conductivity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Impedance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Resistance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Stimulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Stimulation, Transcutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Stimulations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Vacuum Pump' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Vacuum Pumps' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical Wiring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrical waves in the cerebral cortex generated by brain stem structures in response to auditory click stimuli. These are found to be abnormal in many patients with cerebellopontine angle lesions, multiple sclerosis, or other demyelinating diseases.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrically charged colloidal particles or ions consisting of oriented molecules; aggregates of a number of molecules held loosely together by secondary bonds.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrically induced convulsions primarily used in the treatment of severe affective disorders and schizophrenia.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrically powered devices that are intended to assist in the maintenance of the thermal balance of infants, principally by controlling the air temperature and humidity in an enclosure. %28%from UMDNS, 1999%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electricity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electricity %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electricity %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electricity %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electricity %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electricity, Static' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroacoustic Impedance Test' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroacupuncture' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroanesthesia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroanesthesias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiographic Monitoring, Ambulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiographies, Vector' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography %28%1966-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography Monitoring, Ambulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography, Ambulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography, Dynamic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography, Holter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocardiography, Vector' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocautery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrochemistries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrochemistry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocoagulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocochleographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroconvulsive Shock' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroconvulsive Shocks' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroconvulsive Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroconvulsive Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocutions, Accidental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrocutions, Judicial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrode' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrode, Enzyme' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrode, Implanted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrode, Ion-Selective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrode, Ion-Sensitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrode, Miniaturized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodeposition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodermal Response' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodermal Responses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes %28%1966-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes %28%1968-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes %28%1980-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes which can be used to measure the concentration of particular ions in cells, tissues, or solutions.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes, Implanted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes, Ion Selective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes, Ion-Selective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes, Ion-Sensitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodes, Miniaturized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodiagnoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrodiagnosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalic Response Audiometries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalic Response Audiometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalograms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalography %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalography %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalography, Beta Rhythm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalography, Delta Rhythm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroencephalography, Theta Rhythm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrofocusing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrogalvanism, Intraoral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrogalvanisms, Intraoral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrographic Status Epilepticus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrohydraulic Shockwave Lithotripsies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrohydraulic Shockwave Lithotripsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroimmunoblotting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroimmunoblottings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrokymographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrokymography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrolyses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrolysis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrolysis %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrolytes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrolytes %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrolytic Depilations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Field' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Fields' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiation, Ionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiation, Non Ionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiation, Non-Ionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiation, Nonionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiations, Ionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiations, Non-Ionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Radiations, Nonionizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic Waves' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic or corpuscular radiation capable of producing ions, directly or indirectly, in its passage through matter. The wavelengths are equal to or smaller than those of short %28%far%29% ultraviolet radiation and include gamma and X-rays and high-energy elementary particles.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic radiation which does not produce ions in matter through which it passes. Its wavelengths are generally greater than those of far ultraviolet radiation and range through the longest radio waves.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetic waves with frequencies between about 3 kilohertz %28%very low frequency - VLF%29% and 300,000 megahertz %28%extremely high frequency - EHF%29%. They are used in television and radio broadcasting, land and satellite communications systems, radionavigation, radiolocation, and DIATHERMY. The highest frequency radio waves are MICROWAVES.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromagnetics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromyographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electromyography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Beam Tomographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Beam Tomography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Cryomicroscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Cryomicroscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Energy Loss Spectroscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Energy-Loss Spectroscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Microscopies, Scanning' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Microscopy, Scanning' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Microscopy, Scanning Transmission' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Microscopy, Transmission' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Nuclear Double Resonance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Paramagnetic Resonance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Probe Microanalyses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Probe Microanalysis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Scanning Microscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Scanning Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Spectroscopic Imaging' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Spin Resonance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Spin Resonance %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Spin Resonance Spectroscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Spin Resonance Spectroscopy %28%1975-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transfer Flavoprotein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transferring Flavoprotein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transferring Flavoproteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport Chain Complex Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport Complex I' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport Complex II' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport Complex III' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport Complex IV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron Transport Complex IV %28%1981-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron microscopy in which the ELECTRONS or their reaction products that pass down through the specimen are imaged below the plane of the specimen.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron microscopy involving rapid freezing of the samples. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron, Fast' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron-Transferring Flavoprotein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron-Transferring Flavoproteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronarcoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronarcosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic Data Processing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic Mail' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic Publishings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic devices that increase the strength of an input signal, or apparatus for increasing the magnification of a microscope. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic hearing devices typically used for patients with normal outer and middle ear function, but defective inner ear function. In the COCHLEA, the hair cells %28%HAIR CELLS, VESTIBULAR%29% may be absent or damaged but there are residual nerve fibers. The device electrically stimulates the COCHLEAR NERVE to create sound sensation.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronic instruments that produce photographs or cathode-ray tube images of the gamma-ray emissions from organs containing radionuclide tracers.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronics %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronics %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronics, Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrons' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrons %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrons %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrons, Fast' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronystagmographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electronystagmography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrooculogram' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrooculography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrooculography %28%1973-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoreses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoreses, Blood Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoreses, Capillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoreses, Cellulose Acetate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoreses, Microchip' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoreses, Single-Cell Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1975-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1986-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1990-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis %28%1991-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis applied to blood proteins. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site %28%or focus%29% at which the pH is equal to their isoelectric point.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which a starch gel %28%a mixture of amylose and amylopectin%29% is used as the diffusion medium.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which agar or agarose gel is used as the diffusion medium.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which cellulose acetate is the diffusion medium.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which discontinuities in both the voltage and pH gradients are introduced by using buffers of different composition and pH in the different parts of the gel column. The term %27%disc%27% was originally used as an abbreviation for %27%discontinuous%27% referring to the buffers employed, and does not have anything to do with the shape of the separated zones.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis or specifics %28%1976-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, 2-D Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, 2D Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Agar Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Agar Gel %28%1979-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Agar Gel %28%1990-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Agarose Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Blood Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Capillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Capillary %28%1996-1998%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Cellulose Acetate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Disc' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Disc %28%1967-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Disk' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, 2-D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, 2D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, Pulsed Field' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, Pulsed-Field' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, Pulsed-Field Gradient' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, Single-Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, Two Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Gel, Two-Dimensional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Microchip' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Paper' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Paper %28%1973-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Polyacrylamide Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Polyacrylamide Gel %28%1975-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Polyacrylamide Gel %28%1980-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Polyacrylamide Gel %28%1982-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Polyacrylamide Gel %28%1984-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Pulsed Field Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Pulsed-Field Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Single-Cell Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Starch Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis, Two-Dimensional Gel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoresis/methods %28%1980-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophoretic Mobility Shift Assay' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophorus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiologic Studies, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiologic Studies, Transesophageal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiologic Study, Transesophageal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiologic Technique, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiologic Techniques, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology %28%1970-2000%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrophysiology %28%1975-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroplating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroporation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroporations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. %28%Grant %26% Hackh%27%s Chemical Dictionary, 5th ed%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroretinographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroretinography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroshock' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroshock Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroshock Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroshocks' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrosleep' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrospray Ionization Mass Spectrometry' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrostatics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrostimulation, Analgesic Cutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrostimulation, Programmed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrostimulation, Transdermal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrostimulations, Programmed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrosurgeries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrosurgery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrosurgical procedures used to treat hemorrhage %28%e.g., bleeding ulcers%29% and to ablate tumors, mucosal lesions, and refractory arrhythmias.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrosyneresis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrotherapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electrotherapy %28%1966-1985%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroversion Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroversion, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Electroversions, Cardiac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eledoisin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element Analyses, Finite' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element Analysis, Finite' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Alu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Boundary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, DNA Insertion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, DNA Transposable' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Delta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, E-Box' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Enhancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Enhancer %28%Genetics%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, HIV rev-Responsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, IAP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, IS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Insertion Sequence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Insulator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Interspersed Repetitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Intracisternal A-Particle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Jockey' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, L1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, LINE-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, MAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, MAR/SAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Mobile Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Response' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Retrovirus-like' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, SAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, SAR/MAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Serum Response' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Silencer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Silencing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Tn' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Transcriptional Regulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Transcriptional Silencer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, Transposable' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Element, rev-Responsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elemental Diet' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elemental Diets' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Hallucination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Hallucinations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Particle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Particle Interaction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Particle Interactions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Particles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Particles %28%1970-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elementary Particles %28%1975-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements of limited time intervals, contributing to particular results or situations.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements of the lanthanoid series including atomic number 57 %28%LATHANUM%29% through atomic number 71 %28%LUTETIUM%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements that are transcribed into RNA, reverse-transcribed into DNA and then inserted into a new site in the genome. Long terminal repeats %28%LTRs%29% similar to those from retroviruses are contained in retrotransposons and retrovirus-like elements. Retroposons, such as LONG INTERSPERSED NUCLEOTIDE ELEMENTS and SHORT INTERSPERSED NUCLEOTIDE ELEMENTS do not contain LTRs.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements that constitute group 18 %28%formerly the zero group%29% of the periodic table. They are gases that generally do not react chemically.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements which exhibit atomic emission due to natural or artificial nuclear transformation. These elements spontaneously undergo radioactive decay.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements with partially filled d orbitals. They constitute groups 3-12 of the periodic table of elements.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Actinoid Series' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Alu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Anti-Sense' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Boundary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, DNA Insertion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, DNA Transposable' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Delta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, E-Box' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Enhancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Enhancer %28%Genetics%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Group 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Group 16' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Group 17' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Group 18' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Group 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, HIV rev-Responsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, IAP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, IS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Insertion Sequence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Insulator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Interspersed Repetitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Intracisternal A-Particle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Jockey' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, L1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, LINE-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Lanthanoid Series' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, MAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, MAR/SAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Mobile Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Radioactive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Response' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Retrovirus-like' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, SAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, SAR/MAR' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Serum Response' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Silencer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Silencing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Tn' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Trace' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Transcriptional Regulatory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Transcriptional Silencer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Transition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, Transposable' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elements, rev-Responsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleocharis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephant Man Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephant Seal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephant Seals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantfish' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantfishes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiases, Bancroftian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiases, Filarial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiasis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiasis %28%1975-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiasis Neuromatoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiasis Neuromatosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiasis, Bancroftian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephantiasis, Filarial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elephants' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elettaria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elettaria cardamomum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleusine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleuthero' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleutherococcus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elevated ICP %28%Intracranial Pressure%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elevated Intracranial Pressure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elevation, Hindlimb' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elevator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elevators and Escalators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleventh Cranial Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleventh Cranial Nerve Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eleventh Cranial Nerves' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elfar Brand of Astemizole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elfar Brand of Bezafibrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elfar Brand of Mebendazole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elfar Brand of Nitrendipine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elfin Facies Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elfin Facies Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elgiprona' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eli Lilly Brand of Dobutamine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eli Lilly Brand of Human Growth Hormone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eli Lilly Brand of Methimazole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eli Lilly Brand of Vancomycin Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is not functioning.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eligibility Determination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eligibility Determinations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eliminase, Chondroitin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eliminase, Heparin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elimination Disorder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elimination Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elimination of toxic or biologically active substances from body fluids by interaction with a sorbent medium. The types of media include absorbents, adsorbents, ion-exchange materials, and complexing agents. Detoxification can be extracorporeal %28%hemodialysis, hemofiltration, hemoperfusion, plasmapheresis%29%, or occur inside the body %28%enterosorption, peritoneal dialysis%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eliminative Behavior, Animal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eliminative Behaviors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eliminative Behaviors, Animal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elisor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk 1 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk 1 ets Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk 4 ets Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk L Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk-1 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk-1 ets-Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk-1, ets-Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk-4 ets-Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk-4, ets-Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk-L Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk1 Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk1 ets Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk1 ets-Domain Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elk1, Transcription Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellagi Tannins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellagi-Tannins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellagic Acid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellice Islands' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellipticines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elliptocytoses, Hereditary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elliptocytosis, Hereditary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellis Van Creveld Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellis-Van Creveld Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellman Reagent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellman%27%s Reagent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ellmans Reagent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elm Tree' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elmuquimica Brand of Aminophylline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elmuquimica Brand of Bencyclane Fumarate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongated, spindle-shaped, quiescent myoblasts lying in close contact with adult skeletal muscle. They are thought to play a role in muscle repair and regeneration.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factor 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factor 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factor G' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factor Tu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factors, GTPase-Linked' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factors, Guanosinetriphosphatase-Linked' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factors, Peptide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elongation Factors, Transcriptional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elsix' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eltanolone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Elymus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emaciation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emaciations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Email' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emails' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embalming' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embalmings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embden Meyerhof Parnas Pathway' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embden Meyerhof Pathway' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embden-Meyerhof Pathways' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embden-Meyerhof-Parnas Pathway' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embedding, Paraffin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embedding, Plastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embedding, Tissue' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embelia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emblem' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emblems and Insignia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emblica officinalis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolectomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolectomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emboli, Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emboli, Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolic Tumor Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolic Tumor Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emboliformis, Nucleus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism %28%1966-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism %28%1966-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism %28%1975-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism %28%1976-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism and Thrombosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism and Thrombosis, Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism caused by fat entering the circulation. It is often seen after fractures of large bones or after corticosteroid administration.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism due to air bubbles entering the blood vessels after trauma, surgical procedures, or changes in atmospheric pressure.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism in the pulmonary artery or one of its branches.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Air' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Amniotic Fluid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Cholesterol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Fat' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Gas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Intracranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Paradoxical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolism, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Air' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Amniotic Fluid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Cholesterol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Fat' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Gas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Paradoxical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolisms, Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolization, Balloon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolization, Therapeutic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolization, Therapeutic %28%1975-2000%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolization, Therapeutic %28%1979-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolizations, Balloon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolizations, Therapeutic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolotherapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolotherapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolus, Brain' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolus, Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embolus, Middle Cerebral Artery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embonate, Noscapine Hydrogen' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embonate, Pyrantel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo %28%1966-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo %28%1985-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Clonings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Creation, Research' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Creations, Research' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Culture Technique' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Culture Techniques' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Deaths' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Development' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Development, Post-implantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Development, Postimplantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Development, Postnidation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Development, Pre-implantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Development, Preimplantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Disposition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Dispositions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Experimentation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Experimentations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Implantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Implantation Suppression' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Implantation, Delayed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Implantations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Implantations, Delayed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Loss' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Organizer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Organizers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Reductions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Research' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Research, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Transfer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Transfer %28%1985-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Transfer %28%1988-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Transfers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Vitelline Sac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo Vitelline Sacs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo and Fetal Development' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo and Fetal Development %28%1985-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Aborted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Chick' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Non Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Non-Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Nonmammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Nonmammalian %28%1975-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Plant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo, Preimplantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryo/transplantation %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryogenesis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryologic Gene Expression Regulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryologies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryology %28%1978-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Cancers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Carcinoma Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Carcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Rhabdomyosarcoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonal Rhabdomyosarcomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic %28%precursor%29% cells of the myogenic lineage that develop from the MESODERM. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes %28%MYOCYTES, SKELETAL; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Antigen-1, Stage-Specific' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Development' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Developments' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Induction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Induction %28%1990-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Inductions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Muscle Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Muscle Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Organizer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Organizers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Pattern Formations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Pattern Specification' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Structure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic Structures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic and Fetal Development' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic and Fetal Development %28%1973-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryonic and fetal development that takes place in an artificial environment in vitro.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryopathy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos, Aborted' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos, Chick' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos, Non-Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos, Nonmammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos, Plant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryos, Preimplantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryoscope' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryoscopic Surgeries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryoscopic Surgery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryoscopic Surgical Procedure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryoscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryotomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embryotoxins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Embyonic Artery, Persistent, Cerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emepronium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies %28%1966-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies, Hospital Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergencies/nursing %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Care, Prehospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Health Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Helicopter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Hospital Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Hospital Services' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Service Communication Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Services' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Services %28%1968-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Services %28%1968-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Services %28%1968-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Services %28%1968-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Services %28%1991-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Tag' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Tags' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Technician' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medical Technicians' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medicine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medicine Technician' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Medicine Technicians' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Mobile Unit' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Outpatient Units' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Paramedic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Paramedics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Psychiatric Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Psychiatric Services' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Room Nursing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Hospital %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Hospital %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Hospital %28%1966-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Hospital %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Service, Psychiatric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Services, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Services, Medical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Services, Psychiatric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Therapies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Therapy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Treatment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Treatments' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Unit, Mobile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency Units, Mobile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergency, Hospital Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emergicenter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emerging Communicable Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emerging Communicable Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emerging Infectious Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emerging Infectious Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emericella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emerogene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emerogenes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery Dreifuss Muscular Dystrophy 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery Dreifuss Muscular Dystrophy, Autosomal Recessive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery Dreifuss Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery-Dreifuss Muscular Dystrophy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery-Dreifuss Muscular Dystrophy 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery-Dreifuss Muscular Dystrophy, Autosomal Recessive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery-Dreifuss Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emery-Dreifuss Type Muscular Dystrophy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emeses, Postoperative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emesis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emesis and queasiness occurring after anesthesia. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emesis, Postoperative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emetic Agents' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emetic Drugs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emetic, Tartar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emetics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emetine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emigrant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emigration and Immigration' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emigration and Immigration %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emigrations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eminence, Median' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Computed Tomography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Spectrometry, X-Ray' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Spectrometry, Xray' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Spectrophotometry, Atomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Spectroscopy, X-Ray' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Spectroscopy, Xray' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission Tomography, Computerized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission of LIGHT by a substance as its temperature is raised. It is sometimes called hot light in contrast to LUMINESCENCE.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission of LIGHT when ELECTRONS return to the electronic ground state from an excited state and lose the energy as PHOTONS. It is sometimes called cool light in contrast to INCANDESCENCE. LUMINESCENT MEASUREMENTS take advantage of this type of light emitted from LUMINESCENT AGENTS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission or propagation of electromagnetic energy %28%waves/rays%29%, or the waves/rays themselves; a stream of electromagnetic particles %28%electrons, neutrons, protons, alpha particles%29% or a mixture of these. The most common source is the sun.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission, Spontaneous Otoacoustic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission, Vehicle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission, Vehicular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission-Computed Tomography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emission-Computed Tomography, Single-Photon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emissions, Spontaneous Otoacoustic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emissions, Vehicle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emissions, Vehicular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emmenagogues' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emmonsia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emmprin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emmprin Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emodin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emodin, Aloe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emodin, Frangula' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emodin, Rheum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emollients' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotion, Expressed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotional Bond' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotional Depression' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotional Depressions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotional Disturbance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotional attachment to someone or something in the environment.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotional, nutritional, or physical maltreatment of the older person generally by family members or by institutional personnel.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotions %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotions %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotions %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotions %28%1966-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emotions, Expressed' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empathy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysema %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysema, Acute Bovine Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysema, Mediastinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysema, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysema, Subcutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysemas, Mediastinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysemas, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysemas, Subcutaneous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emphysematous Cholecystitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empirical Research' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empiricism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Assistance Program %28%Health Care%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Discipline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Disciplines' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Grievance' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Grievances' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Health Benefit Plans' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Health Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Health Services' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Incentive Plan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Incentive Plans' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Incentive Plans %28%1979-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Orientation Program' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Orientation Programs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Performance Appraisal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Performance Appraisals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Retirement Income Security Act' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Strike' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Strikes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Turnover' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Turnovers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Work Load' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Work Loads' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employee Workloads' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employer Health Cost' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employer Health Costs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment %28%1970-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment Application' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment Applications' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment Based Services' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment Terminations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment or passage of a catheter into the bladder %28%urethral c.%29% or kidney %28%ureteral c.%29% for therapeutic or diagnostic purposes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment, Supported' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Employment-Based Service' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emporiatric Medicine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empty Sella Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empty Sella Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empty Sella Turcica Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emptying, Gall Bladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emptying, Gallbladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emptying, Gastric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emptyings, Gastric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema due to MYCOBACTERIUM TUBERCULOSIS. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema, Gall Bladder' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema, Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema, Pleural, Tuberculous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema, Subdural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema, Thoracic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyema, Tuberculous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyemas, Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyemas, Thoracic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Empyemas, Tuberculous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsifyers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsifying Agents' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsion beta D Glucosidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsions of fats or lipids used primarily in parenteral feeding.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsions, Fluorocarbon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsions, Intravenous Fat' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emulsions, Intravenous Lipid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Emus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'En Clomiphene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'En-Clomiphene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enabling Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enalapril' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enalapril %28%1986-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enalapril/analogs %26% derivatives %28%1986-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enalaprilat' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enalaprilic Acid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Ageneses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Agenesis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Bond, Concise' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Cuticles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Hypoplasia, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Microabrasion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Microabrasions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Organ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Organs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Pellicle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Permeability, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Proteins, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel Solubility, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel, Hypoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamel, Mottled' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamels' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamels, Dental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enamels, Mottled' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enanthates' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enbucrilate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enbucrylate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encainide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encainide Hydrochloride, %28%+-%29%-Isomer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encapsulated zygotes of sporozoan protozoa. Further development in an oocyst produces small individual infective organisms called SPOROZOITES. Then, depending on the genus, the entire oocyst is called a sporocyst or the oocyst contains multiple sporocysts encapsulating the sporozoites.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Acute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Arbovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Arthropod-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Arthropod-Borne Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, California Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Eastern Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Epidemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, European Tick-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Herpes Simplex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Herpetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Infectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Louping Ill' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Mosquito-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Paraneoplastic Limbic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Post-Vaccinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Powassan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Tick-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitides, Toxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis %28%1966-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis %28%1967-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Lethargica Type Parkinsonism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Periaxialis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Periaxialis Concentrica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Periaxialis Diffusa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Vaccines, Japanese' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, California' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Eastern Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Japanese' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Murray Valley' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, St. Louis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Tick Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Tick-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Venezuelan Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Virus, Western Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses %28%1967-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses %28%1972-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, California' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, Japanese' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, St. Louis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, Tick Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, Tick-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, Venezuelan Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis Viruses, Western Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis caused by neurotropic viruses that are transmitted via the bite of TICKS. In Europe, the diseases are caused by ENCEPHALITIS VIRUSES, TICK-BORNE, which give rise to Russian spring-summer encephalitis, central European encephalitis, louping ill encephalitis, and related disorders. Powassan encephalitis occurs in North America and Russia and is caused by the Powassan virus. ASEPTIC MENINGITIS and rarely encephalitis may complicate COLORADO TICK FEVER which is endemic to mountainous regions of the western United States. %28%From Joynt, Clinical Neurology, 1996, Ch26, pp14-5%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Arbovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Arthropod Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Arthropod-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Arthropod-Borne Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Bovine Spongiform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, California' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, California Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, California, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Eastern Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Epidemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, European Tick Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Herpes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Herpes Simplex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Herpes Zoster' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Herpetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Human Herpesvirus 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Infectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, JC Polyomavirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Japanese' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Japanese B' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Limbic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Mosquito Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Mosquito-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Paraneoplastic Limbic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Post Vaccinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Postvaccinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Powassan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Rasmussen' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Russian Spring Summer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Saint Louis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, St. Louis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Tick Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Tick-Borne' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Tick-Borne %28%1979-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Tick-Borne/veterinary %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Toxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, VZ Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Vaccination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Varicella' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Varicella Zoster' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Venezuelan Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Viral, St. Louis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis, Western Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitis/complications %28%1969-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitogenic Basic Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitogenic Basic Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitozoon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitozoon cuniculi' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitozoon cuniculi %28%1982-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitozoonoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalitozoonosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalocele' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalocele, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalocele, Frontal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalocele, Occipital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephaloceles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephaloceles, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephaloceles, Frontal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephaloceles, Occipital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephaloceles, Sincipital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalofacial Hemangiomatosis Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalofacial Hemangiomatosis Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalography, Alpha Rhythm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacia %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacia %28%1966-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacia, Multicystic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacia, Periventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacias, Multicystic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomalacias, Periventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomeningitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomeningitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Acute Disseminated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Eastern Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Hemorrhagic Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Ovine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Post-Vaccinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Subacute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitides, Venezuelan Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Avian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Eastern Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Enzootic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Mouse' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Murine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Murine %28%1975-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Porcine Hemagglutinating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Venezuelan Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Virus, Western Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis Viruses, Avian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Acute Disseminated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Acute Necrotizing Hemorrhagic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Allergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Autoimmune Experimental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Autoimmune, Experimental' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Eastern Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Enzootic Porcine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Equine %28%1966-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Equine %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Experimental Allergic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Experimental Autoimmune' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Hemorrhagic Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Infectious, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Lymphocytic Choriomeningitis Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Myalgic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Necrotizing Hemorrhagic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Ovine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Paraneoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Post-Vaccinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Postinfectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Subacute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Venezuelan Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Viral Infectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis, Western Equine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelitis-like Virus, Avian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelopathies, Subacute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyelopathy, Subacute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyocarditis Virus %28%1972-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyocarditis Virus %28%1979-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyocarditis Viruses %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyocarditis virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyopathies, Mitochondrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalomyopathy, Mitochondrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalon Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalon Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalons' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Acquired Metabolic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Anoxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Anoxic-Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Arsenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Bilirubin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Biotin-Responsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Chronic Post-Concussive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Chronic Post-Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Hepatocerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Hyperbilirubinemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Hypoxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Hypoxic-Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Ischemic-Hypoxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, JC Polyomavirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Lyme Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Metabolic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Metabolic, Inborn' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Portal-Systemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Portosystemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Post-Concussive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Post-Concussive Chronic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Post-Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Spongiform, Transmissible' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Subacute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Subacute Spongiform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Subcortical Arteriosclerotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Toxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Transmissible Spongiform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathies, Wernicke' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy Virus, Mink' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Acquired Metabolic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Anoxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Anoxic Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Anoxic-Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Arsenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Bilirubin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Binswanger' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Binswanger%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Binswangers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Biotin-Responsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Bovine Spongiform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Childhood Lead' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Childhood Saturine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Chronic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Chronic Post-Concussive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Chronic Post-Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Chronic Progressive Subcortical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Chronic Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Gayet Wernicke' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Gayet-Wernicke' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hepatocerebral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hyperbilirubinemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hypertensive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hypoxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hypoxic Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Hypoxic-Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Ischemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Ischemic-Hypoxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, JC Polyomavirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Kuru' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Mercury' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Metabolic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Metabolic, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Portal Systemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Portal-Systemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Portosystemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Post Concussive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Post Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Post-Concussive Chronic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Post-Traumatic, Chronic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Subacute Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Subacute Spongiform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Subcortical Arteriosclerotic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Subcortical, Chronic Progressive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Transmissible Spongiform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Wernicke' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Wernicke%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephalopathy, Wernickes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encephaltis, Inclusion Body, Measles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondroma, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondromas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondromas, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondromatoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondromatosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondroses, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enchondrosis, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enclomifene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enclomiphen' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encopresis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encorton' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encounter Group' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encouraging consumer behaviors most likely to optimize health potentials %28%physical and psychosocial%29% through health information, preventive programs, and access to medical care.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encyclopedia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encyclopedias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encyclopedias %28%PT%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Encyclopedias %5B%Publication Type%5D%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Bulbs, Krause%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Point Assay' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Point Assays' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Point Determination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Point Determinations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Point, Surrogate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Points, Surrogate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Stage Kidney Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End Stage Renal Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Diastolic Volume, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Diastolic Volumes, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Expiratory Pressure, Positive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Expiratory Pressures, Positive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Plate, Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Plates, Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Position Nystagmus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Stage Kidney Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Stage Renal Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Stage Renal Failure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Systolic Volume, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'End-Systolic Volumes, Ventricular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endamoeba histolytica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endantadine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarterectomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarterectomies, Carotid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarterectomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarterectomy %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarterectomy, Carotid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarteritides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endarteritis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endemic Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endemic Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endemic Flea-Borne Typhus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endemic Goiter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endemic Goiters' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endemic Nephropathy, Balkan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endep' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ending, Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ending, Presynaptic Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endings, Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endings, Presynaptic Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,3 beta Glucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,3 beta Xylanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,4 Xylanase II' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,4 beta Glucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,4 beta Xylanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,4 beta Xylanase II' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo 1,4 beta Xylanases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo A Cytokeratin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo A Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo B Cytokeratin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo B Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo Brand of Amantadine Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo Brand of Molindone Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo Brand of Naloxone Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo Brand of Oxymorphone Hydrochloride' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo C Cytokeratin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo D Endoglucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo Dextranase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo F Endoglucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo H Endoglucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo N Acetyl beta d glucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo beta Acetylglucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo beta D Glucuronidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo beta N Acetylglucosaminidase D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo beta N Acetylglucosaminidase F' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo beta N Acetylglucosaminidase H' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,3%28%4%29%-B-Glucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,3%28%4%29%-beta-Glucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,3-beta-D-Glucosidase, Glucan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,3-beta-Glucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,3-beta-Xylanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,3-beta-Xylosidase, Xylan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,4-Xylanase II' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,4-beta Xylanases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,4-beta-Glucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-1,4-beta-Xylanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-A Cytokeratin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-B Cytokeratin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-GF' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-N-Acetyl-beta-d-glucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-beta-Acetylglucosaminidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-beta-D-Glucuronidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endo-beta-N-Acetylglucosaminidase, Mannosyl-Glycoprotein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endobronchial Allergen Challenge' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endobronchial Allergen Challenges' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endobronchial Challenge Test' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endobronchial Challenge Tests' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocannabinoid' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocannabinoids' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocardial Cushion Defect' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocardial Cushion Defects' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocardial Fibroelastoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocardial Fibroelastosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditides, Bacterial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditides, Subacute Bacterial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis Lenta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis, Bacterial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis, Loeffler' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis, Loeffler%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis, Loefflers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocarditis, Subacute Bacterial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocardium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocardiums' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocavitary Fulguration' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocellulase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Adenomatoses, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Adenomatoses, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Adenomatosis, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Adenomatosis, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Adenopathies, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Adenopathy, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Bone Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Bone Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Breast Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Cancers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Cell, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Cells of Gut' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Cells, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diagnostic Technic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diagnostic Technics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diagnostic Technique' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diagnostic Techniques' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diseases %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diseases %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Diseases %28%1978-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Disrupting Chemicals' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Disruptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Gland' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Gland Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Gland Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Gland Derived Vascular Endothelial Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Gland Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Gland Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Glands' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Glands %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Glands %28%1973-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Glands/drug effects %28%1993-2005%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Neoplasia, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Neoplasms, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Pancreas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Pancreas, Artificial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Surgical Procedure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Surgical Procedures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Syndrome, Paraneoplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine System Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine System Diseases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine System/drug effects %28%1997-2005%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Tuberculoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine Tuberculosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine cells found throughout the GASTROINTESTINAL TRACT and in islets of the PANCREAS. D cells secrete SOMATOSTATIN that acts in both an endocrine and paracrine manner. Somatostatin acts on a variety of tissues including the PITUITARY GLAND; gastrointestinal tract; pancreas; and KIDNEY by inhibiting the release of hormones, such as GROWTH HORMONE; GASTRIN; INSULIN; and RENIN.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine cells which secrete GASTRIN, a peptide that induces GASTRIC ACID secretion. They are found predominantly in the GASTRIC GLANDS of PYLORIC ANTRUM in the STOMACH, but can also be found in the DUODENUM, nervous and other tissues.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrine-Gland-Derived Vascular Endothelial Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocrinology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocytic Vesicle' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocytic/exocytic CELL MEMBRANE STRUCTURES rich in glycosphingolipids, cholesterol, and lipid-anchored membrane proteins that function in ENDOCYTOSIS %28%potocytosis%29%, transcytosis, and SIGNAL TRANSDUCTION. Caveolae assume various shapes from open pits to closed vesicles. Caveolar coats are composed of CAVEOLINS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocytoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocytosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endocytosis %28%1973-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endod' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonuclease %28%Apurinic or Apyrimidinic%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonuclease %28%Pyrimidine Dimer%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonuclease ECoRI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonuclease HpaII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonuclease HsaI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonuclease VIII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonucleases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonucleases %28%1983-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonucleases %28%1983-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonucleases %28%1987-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonucleases %28%1991-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodeoxyribonucleases %28%1994-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoderm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodermal Sinus Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodermal Sinus Tumors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodermophyton' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoderms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic Endosseous Implantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic Endosseous Implantations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic Inflammation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic Inflammations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic Stabilization' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic Stabilizations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontic diseases of the DENTAL PULP inside the tooth, which is distinguished from PERIAPICAL DISEASES of the tissue surrounding the root.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontically-Treated Teeth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontically-Treated Tooth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endodontics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Cannabinoids' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Depression' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Depressions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Mitogens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Nitrate Vasodilator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Opiates' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Oscillator' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Oscillators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Retrovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Retrovirus, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Retroviruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Retroviruses, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous Substrate pp120' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous compounds that bind to CANNABINOID RECEPTORS. They are structurally different from the CANNABINOIDS which are primarily derived from plants.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous factors or drugs that act on fat metabolism by hastening the removal of or decreasing the deposit of fat in the liver. %28%From Dorland, 28th ed, p951%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous glycoproteins from which SIALIC ACID has been removed by the action of sialidases. They bind tightly to the ASIALOGLYCOPROTEIN RECEPTOR which is located on hepatocyte plasma membranes. After internalization by adsorptive ENDOCYTOSIS they are delivered to LYSOSOMES for degradation. Therefore receptor-mediated clearance of asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. They are elevated in serum of patients with HEPATIC CIRRHOSIS or HEPATITIS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth %28%= PLANT GROWTH REGULATORS%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is methionine.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; %28%HMWK%29%; is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; %28%LMWK%29%; is split by tissue kallikrein to produce KALLIDIN.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous proteins that inhibit or inactivate COMPLEMENT C3B. They include COMPLEMENT FACTOR H and COMPLEMENT FACTOR I %28%C3b/C4b inactivator%29%. They cleave or promote the cleavage of C3b into inactive fragments, and thus are important in the down-regulation of COMPLEMENT ACTIVATION and its cytolytic sequence.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous substances produced through the activity of intact cells of glands, tissues, or organs. They do not include hormones or enzymes.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous substances, usually proteins, that are involved in the blood coagulation process.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous superantigens responsible for inducing strong proliferative responses in T-cells in mixed lymphocyte reactions %28%see LYMPHOCYTE CULTURE TEST, MIXED%29%. They are encoded by mouse mammary tumor viruses that have integrated into the germ line as DNA proviruses %28%MINOR LYMPHOCYTE STIMULATORY LOCI%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endogenous tissue constituents that have the ability to interact with AUTOANTIBODIES and cause an immune response.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglucanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglucosaminidase D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglucosaminidase F' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglucosaminidase H' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglucosidase H' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglycosidase D' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoglycosidase F' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolimax' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoluminal Repairs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymph' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymph %28%1975-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Duct' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Ducts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Hydrops' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Injection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Injections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Sac' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Sac/surgery %28%1979-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Sacs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Shunt' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Shunts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Stromal Myoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphatic Stromal Myosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolymphs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolyn' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endolysin, T7' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Cancers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Carcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Cycles' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasia, Atypical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasia, Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasia, Simple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasias, Atypical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasias, Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Hyperplasias, Simple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Neoplasms %28%1992-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Stromal Sarcoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Stromal Sarcomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Stromal Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial Stromal Tumors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrial implantation of EMBRYO at the BLASTOCYST stage.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrioid Adenocarcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrioid Adenocarcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrioid Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrioid Carcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometriomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrioses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometriosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometriosis %28%1966-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometriosis %28%1975-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometritis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrium Cancer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrium Cancers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrium Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endometrium Carcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endomorphs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endomucin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endomycetales' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endomycetales %28%1975-1985%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endomyocardial Fibroses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endomyocardial Fibrosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoneuriums' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonexin II' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease BamHI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease BstFI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease EcoRI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease EcoVIII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease GdoI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease GinI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease GoxI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease HindIII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease HpaII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease I' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease IV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease Mapping, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease Mappings, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease MleI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease NasBI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease NspSAIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease RhsI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease S 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease S-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease S1, Aspergillus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease SsoI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, AP' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, ApaCI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Apurine-Apyrimidine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Apurinic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Apurinic DNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Corrective' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Cruciform Cutting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, DNA' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, HapII' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Neurospora' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, P1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease, SolI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonuclease-1, Flap' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1971-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1973-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1973-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1973-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1975-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1975-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1979-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1979-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases %28%1989-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases that remove 5%27% DNA sequences from a DNA structure called a DNA flap. The DNA flap structure occurs in double-stranded DNA containing a single-stranded break where the 5%27% portion of the downstream strand is too long and overlaps the 3%27% end of the upstream strand. Flap endonucleases cleave the downstream strand of the overlap flap structure precisely after the first base-paired nucleotide, creating a ligatable nick.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases, Flap' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleases, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endonucleolytic cleavage %28%cutting both strands%29% of genomic DNA into fragments at internucleosomal sites. DNA fragmentation along with chromatin condensation are considered the hallmarks of APOPTOSIS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeduncular Nucleus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeduncularis, Nucleus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase 24.11' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase 24.11, Neutral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase Activated Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase Clp' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase Complex, Multicatalytic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase Complex, Proteasome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase Inhibitors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase K' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase La' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase PC2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase, Neutral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase-24.11' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidase-Activated Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidases %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidases %28%1982-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endopeptidases, Serine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoperoxide Analogues, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoperoxide Synthetase, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoperoxides, Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoperoxides, Synthetic Prostaglandin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endophthalmitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endophthalmitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum %28%1966-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum, Agranular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum, Granular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum, Rough' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoplasmic Reticulum, Smooth' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease PC6' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease Ti, ATP-Dependent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease, ATP Dependent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease, ATP-Dependent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease, PC1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease, PC2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease, PC3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoprotease, PC6' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonuclease H' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonuclease H %28%Calf Thymus%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonucleases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonucleases %28%1980-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonucleases %28%1982-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonucleases %28%1983-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonucleases %28%1983-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoribonucleases %28%2001-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin ACTH Precursor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin, C-Fragment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin, alpha' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin, beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin, gamma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphin-ACTH Precursor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphins %28%1978-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphins %28%1978-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endorphins %28%Jul 1977-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscope' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscope, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes %28%1990-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes %28%1998-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the interior of the duodenum. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the interior of the esophagus.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the interior of the larynx. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the interior of the sigmoid colon.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the interior of the ureter. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the interior of the uterus. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining the pleural cavity. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for examining tissue of the anterior superior mediastinum.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for the visualization of the interior of the bronchi.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for viewing the embryo, fetus and amniotic cavity.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for visual examination of the rectum and anus.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for visual examination of the urinary bladder.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes for visualizing the interior of a joint. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes used for examining the interior of the stomach.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes used for viewing the interior of blood vessels.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopes, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Gastrointestinal Surgeries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Gastrointestinal Surgery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Gastrointestinal Surgical Procedures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Hemostases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Hemostasis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Papillotomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Papillotomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Retrograde Cholangiopancreatographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Retrograde Cholangiopancreatography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Sphincterotomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Sphincterotomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Surgical Procedure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Surgical Procedures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Ultrasonographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic Ultrasonography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy and surgery of the joint.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the anterior superior mediastinum of the thorax.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the bronchi.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the digestive tract.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the esophagus.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the female pelvic viscera by means of an endoscope introduced into the pelvic cavity through the posterior vaginal fornix.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the fetus and amniotic cavity through abdominal or uterine entry.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the gastrointestinal tract.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the interior of the stomach.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the interior of the uterus.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the luminal surface of the colon.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the luminal surface of the duodenum.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the pleural cavity.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the rectum.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the sigmoid flexure.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the ureter.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery of the urinary bladder.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic examination, therapy or surgery performed on the interior of blood vessels.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic instruments used for viewing the rectovaginal pouch and pelvic viscera.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic surgery of the pleural cavity performed with visualization via video transmission.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic surgical procedures performed with visualization via video transmission. When real-time video is combined interactively with prior CT scans or MRI images, this is called image-guided surgery %28%see SURGERY, COMPUTER-ASSISTED%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic, Digestive System, Surgery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopic, Digestive System, Surgical Procedure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Digestive System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Echo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Surgical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Ultrasonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopies, Uterine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1966-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1966-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1970-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1973-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1974-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1977-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1984-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy %28%1995-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy or specifics %28%1975-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Digestive System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Echo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Gastrointestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Gastrointestinal/instrumentation %28%1991-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Pleural' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Surgical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Ultrasonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy, Uterine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy/instrumentation %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy/instrumentation %28%1966-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy/instrumentation %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoscopy/instrumentation %28%1979-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosomes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosonographies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosonography' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endospore Forming Bacteria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endospore-Forming Bacteria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosseous Dental Implantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosseous Implantation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosseous Implantation, Endodontic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosseous Implantations, Endodontic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endostatin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endostatins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endosulfan' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cell Derived Growth Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cell, Capillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cell, Lymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cell, Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cell-Derived Growth Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cells, Capillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cells, Lymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Cells, Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Constitutive Nitric Oxide Synthase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Dystrophy, Fuch%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Dystrophy, Fuchs%27%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factor %28%1997-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factor Polypeptides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factors %28%1991-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factors %28%1996-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Growth Factors %28%2000-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Leukocyte Adhesion Molecule 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Leukocyte Adhesion Molecule-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Nitric Oxide Synthase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Plasminogen Activator Inhibitors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial Specific Sialomucin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelial-Specific Sialomucin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin 3, Big' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin A Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin A Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin B 2 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin B 2 Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin B Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin B Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin B-2 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin B-2 Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin Degradation Enzyme' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin Type 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin, Big' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin-1 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin-1, Big' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin-2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin-3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelin-3, Big' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelins %28%1991-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium %28%1973-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium %28%1973-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium %28%1984-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Dependent Relaxing Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Dependent Relaxing Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Dependent Vasodilators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Derived Relaxant Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Derived Relaxing Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Derived Vasoconstrictor Factor Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium Secreted Protein B61' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium, Capillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium, Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium, Lymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium, Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium, Vascular %28%1970-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium, Vascular %28%1988-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Dependent Relaxation, Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Dependent Relaxing Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Dependent Relaxing Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Dependent Vasodilators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Derived Nitric Oxide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Derived Relaxant Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Derived Relaxing Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endothelium-Derived Vasoconstrictor Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotheliums' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotheliums, Capillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotheliums, Lymphatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotheliums, Vascular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxic Shock' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxins %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxins %28%1966-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotoxins %28%1975-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotracheal Intubation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endotracheal Intubations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endovascular reconstruction of an artery, which may include the removal of atheromatous plaque and/or the endothelial lining as well as simple dilatation. These are procedures performed by catheterization. When reconstruction of an artery is performed surgically, it is called ENDARTERECTOMY.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endowment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endoxylanase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endozepine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endplate, Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endplates, Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endpoint Assays' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endpoint Determination' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endpoint Determinations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endpoint, Surrogate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endpoints, Surrogate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endrin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endurance, Physical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Endurances, Physical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enema' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enemas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enemata' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enematas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energies, Solar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energies, Vital %28%Philosophy%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Expenditure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Expenditures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Filtered TEM' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Filtered Transmission Electron Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Filtering Transmission Electron Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Generating Resources' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Intake' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Linked Transhydrogenase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Metabolism' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Metabolism %28%1975-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Metabolisms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Resources Conservation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Resources Conservations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Source, Bioelectric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Source, Biologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Source, Biological' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Sources, Bioelectric' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Sources, Biologic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Sources, Biological' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Transfer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Transfer %28%1968-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy Transfer, Linear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy released by nuclear fission or nuclear fusion. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work. Proton-motive force can be generated by a variety of phenomena including the operation of an electron transport chain, illumination of a PURPLE MEMBRANE, and the hydrolysis of ATP by a proton ATPase. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p171%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy transmitted from the sun in the form of electromagnetic radiation.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy, Atomic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy, Nuclear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy, Solar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy, Vital %28%Philosophy%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Filtered TEM' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Filtered Transmission Electron Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Filtering Transmission Electron Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Generating Resource' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Generating Resources' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Linked Transhydrogenase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Energy-Loss Spectroscopy, Electron' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enflurane' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enforcement Officer, Law' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enforcement Officers, Law' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enforcement, Law' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engelbreth-Holm-Swarm Sarcoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engelhard brand of Tyrothricin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engelmann Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engelmann%27%s Disease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineered Animal, Genetically' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineered Animals, Genetically' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineered Organism, Genetically' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineered Organisms, Genetically' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Biomedical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Chemical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Clinical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Hospital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Protein Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Sanitary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Software' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineering, Tissue' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engineerings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'England' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'English Abstract' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'English Chamomile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'English Sweating Sickness' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engorgement, Venous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engorgements, Venous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engraving and Engravings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engravings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Engravings and Engraving' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement Technology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors %28%RECEPTORS, FC%29% or by complement receptors %28%RECEPTORS, COMPLEMENT%29%. Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Antibody-Dependent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Biomedical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Graft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Image' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Immunologic Graft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Immunological Graft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancement, Radiographic Image' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Biomedical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Graft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Image' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Immunologic Graft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Immunological Graft' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancements, Radiographic Image' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer Binding Protein AP 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer Element' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer Element %28%Genetics%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer Elements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer Elements %28%Genetics%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer Elements %28%Genetics%29% %28%1986-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer, HIV-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer-Binding Protein AP-2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer-Binding Protein, AP-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancer-Binding Protein, Immunoglobulin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancers, Cognitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancers, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhancers, HIV-1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enhydra lutris' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enison' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin Convertase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin Dipeptidyl Carboxypeptidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin Forming Carboxypeptidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin Synthesizing Carboxypeptidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, 2-Alanyl-Leucine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, 5-Leucine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, 5-Leucine-2-Alanine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, 5-Methionine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Ala%28%2%29%-MePhe%28%4%29%-Gly%28%5%29%-' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, D-Ala2-NMe-Phe4-Gly-ol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, D-Penicillamine %28%2,5%29%-' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Leucine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Leucine %28%1983-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Leucine 2 Alanine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Leucine-2-Alanine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Methionine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Methionine/analogs %26% derivatives %28%1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Pen%28%2,5%29%-' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, Penicillamine %28%2,5%29%-' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin, alanyl%28%2%29%-methylphenylalanyl%28%4%29%-glycine%28%5%29%-' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin-2-Alanine, Leucine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin-Forming Carboxypeptidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin-Leu,Ala%28%2%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalin-Synthesizing Carboxypeptidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalinase 24.11' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalinase-24.11' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalins %28%1977-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalins %28%1978-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalins %28%1981-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalins %28%1983-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enkephalins %28%Aug 1977-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlarged Heart' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlarged Liver' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlarged Spleen' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlarged and tortuous VEINS. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure %28%HEART FAILURE, CONGESTIVE%29% or several forms of CARDIOMYOPATHIES.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function %28%euthyroidism%29%, thyroid deficiency %28%HYPOTHYROIDISM%29%, or hormone overproduction %28%HYPERTHYROIDISM%29%. Goiter may be congenital or acquired, sporadic or endemic %28%GOITER, ENDEMIC%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the left ventricle of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the liver. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the right ventricle of the heart. This increase in ventricular mass is often attributed to pulmonary hypertension and is a contributor to cardiovascular morbidity and mortality.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the spleen. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement of the thymus. A condition described in the late 1940%27%s and 1950%27%s as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. %28%From Segen, Dictionary of Modern Medicine, 1992; Cecil Textbook of Medicine, 19th ed, p1486%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement or overgrowth of the PROSTATE gland as a result of an increase in the number of its constituent cells.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement, Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement, Heart' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enlargement, Male Breast' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enolase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enolase, Cobalt' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enolase, Nervous System-Specific' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enolase, Neuron-Specific' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enolase, Non-Neuronal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enophthalmos' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoplida' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoplida Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoplida Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoptic Vision' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoptic Visions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoxacin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoxaparin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoxaparine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoximone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoxolone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl CoA Hydratase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl CoA Hydratases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl CoA Reductases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl Hydrase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl%28%Acyl-Carrier-Protein%29% Reductase %28%NADH%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl-%28%Acyl-Carrier Protein%29% Reductase %28%NADPH, B-Specific%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl-%28%Acyl-Carrier-Protein%29% Reductase %28%NADH%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl-%28%Acyl-Carrier-Protein%29%reductase %28%NADPH%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl-ACP Reductase, NADH-Dependent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enoyl-CoA Hydratase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enprostil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enriched Food' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enriched Foods' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enrollment, School' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enrollments, School' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ensoulment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ensoulments' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entamoeba' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entamoeba histolytica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entamoebiases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entamoebiases, Hepatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entamoebiases, Intestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entamoebiasis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteral Feeding %28%1966-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteral Nutrition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteral Nutrition %28%1969-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteramine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Bacteria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Coronavirus, Feline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Coronaviruses, Feline' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Fever' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Fevers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Nervous System' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric Nervous Systems' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteric-Coated Tablets' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterically Transmitted Non A, Non B Hepatitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterically-Transmitted Non-A, Non-B Hepatitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritides, Feline Infectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis Virus, Turkey' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis Viruses, Turkey' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis, Feline Infectious' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis, Infectious, of Mink' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis, Regional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis, Transmissible, of Turkeys' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteritis, Transmissible, of Turkeys %28%1997-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entero Hepatic Circulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entero Septol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entero Vioform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entero-Hepatic Circulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entero-Hepatic Circulations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EnteroSeptol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EnteroVioform' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacter %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacter %28%1979-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacter aerogenes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacter cloacae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacter sakazakii' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage HK022' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage IKe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage M13' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage MS2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage Mu' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage Mu 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage N4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage P1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage P2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage P22' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage PRD1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage Q beta' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage T2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage T3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage T4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage T7' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage fd' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage lambda' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteria phage phi X 174' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1969-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1974-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1974-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1980-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1983-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1984-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1988-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1994-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae %28%1995-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacteriaceae Infections %28%1970-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacterial Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobacterial Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobactin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobiases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobiasis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobius' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobius vermicularis Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterobius vermicularis Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochelin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cell, 5-HT-Containing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cell, Serotonin-Containing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cells %28%1975-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cells %28%1977-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cells, 5-HT-Containing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin Cells, Serotonin-Containing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin like Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin-like Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterochromaffin-like Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterococcus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterococcus faecalis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterococcus faecium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitis, Necrotizing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitis, Neutropenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitis, Pseudomembranous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitis, Pseudomembranous %28%1966-1998%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocolitis, Pseudomembranous %28%1976-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocytes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterocytozoon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterodes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroendocrine Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroendocrine Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroglucagon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroglucagon %28%1982-2005%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroglucagons' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterohepatic Circulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterohepatic Circulations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterokinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, AIDS-Associated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, Exudative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, Gluten' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, Gluten-Sensitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, HIV-Associated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, Idiopathic AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathies, Protein-Losing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, AIDS Associated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, AIDS-Associated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, Exudative' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, Gluten' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, Gluten-Sensitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, HIV Associated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, HIV-Associated' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, Idiopathic AIDS' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropathy, Protein-Losing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteropeptidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterosorption' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterosorptions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterostomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterostomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterotoxemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterotoxemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterotoxin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterotoxin CT, Cholera' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterotoxins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterotoxins %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus %28%1965-2001%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus %28%1975-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus 70' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus A, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus B, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus C, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus D, Human' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus Infection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus Infections %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus Infections %28%1966-1969%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus Infections %28%1966-1985%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus Type 70' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus, Bovine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus, Porcine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterovirus-70' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroviruses, Bovine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enteroviruses, Porcine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterprise, Private' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterprise, Public' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterprises, Private' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enterprises, Public' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enthesopathies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entities sponsored by local hospitals, physician groups, and other licensed providers which are affiliated through common ownership or control and share financial risk whose purpose is to deliver health care services.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomobirnavirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomobirnaviruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomophthora' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomophthorales' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomophthoramycoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomoplasma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomoplasmataceae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomopoxvirinae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomopoxvirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entomopoxviruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entopeduncular Nucleus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entopeduncularis, Nucleus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entoptic Vision' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entoptic Visions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entorhinal Area' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entorhinal Areas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entorhinal Cortex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entorhinal Cortices' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment Neuropathy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment Neuropathy, Carpal Tunnel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment Neuropathy, Tarsal Tunnel' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment Syndrome, Ulnar Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment of the MEDIAN NERVE in the carpal tunnel, which is formed by the flexor retinaculum and the CARPAL BONES. This syndrome may be associated with repetitive occupational trauma %28%CUMULATIVE TRAUMA DISORDERS%29%; wrist injuries; AMYLOID NEUROPATHIES; rheumatoid arthritis %28%see ARTHRITIS, RHEUMATOID%29%; ACROMEGALY; PREGNANCY; and other conditions. Symptoms include burning pain and paresthesias involving the ventral surface of the hand and fingers which may radiate proximally. Impairment of sensation in the distribution of the median nerve and thenar muscle atrophy may occur. %28%Joynt, Clinical Neurology, 1995, Ch51, p45%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment of the distal branches of the posterior TIBIAL NERVE %28%which divides into the medial plantar, lateral plantar, and calcanial nerves%29% in the tarsal tunnel, which lies posterior to the internal malleolus and beneath the retinaculum of the flexor muscles of the foot. Symptoms include ankle pain radiating into the foot which tends to be aggravated by walking. Examination may reveal Tinel%27%s sign %28%radiating pain following nerve percussion%29% over the tibial nerve at the ankle, weakness and atrophy of the small foot muscles, or loss of sensation in the foot. %28%From Foot Ankle 1990;11%28%1%29%:47-52%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment, Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapment, Ulnar Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapments, Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrapments, Ulnar Nerve' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entrepreneurship' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entropies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entropion' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entropions' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entropy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Entry Inhibitors, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enucleation, Eye' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enucleations, Eye' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. Each colony %28%i.e., microbial colony-forming unit%29% represents the progeny of a single cell in the original inoculum. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients%27% microbial load; and in antimicrobial drug testing.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enumerations of populations usually recording identities of all persons in every place of residence with age or date of birth, sex, occupation, national origin, language, marital status, income, relation to head of household, information on the dwelling place, education, literacy, health-related data %28%e.g., permanent disability%29%, etc. The census or %22%numbering of the people%22% is mentioned several times in the Old Testament. Among the Romans, censuses were intimately connected with the enumeration of troops before and after battle and probably a military necessity. %28%From Last, A Dictionary of Epidemiology, 3d ed; Garrison, An Introduction to the History of Medicine, 4th ed, p66, p119%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enuresis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Env stands for %22%envelope%22%; IM; coord with specific virus %28%IM%29%%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envelope Glycoprotein gp120, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envelope Glycoprotein gp160, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envelope Protein gp41, HIV' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envelope Proteins, Viral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envelope, Nuclear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envelopes, Nuclear' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envenomation, Snake' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Envenomations, Snake' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enviomycin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment Design' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment Designs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment and Public Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment, Controlled' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment, Controlled %28%1973-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment, Extraterrestrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment, Health Facility' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment, Preventive Medicine %26% Public Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environment, Social' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Air Pollutants' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Carcinogens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1967-1985%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1967-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1967-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1967-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1972-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1987-1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposure %28%1990-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Exposures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Hazards' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Health' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Health %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Health %28%1990-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Health Science' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Health Sciences' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Healths' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Hypersensitivities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Hypersensitivity' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Illness' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Illnesses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Impact' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Impacts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Intolerance, Idiopathic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Intolerances, Idiopathic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Medicine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Microbiology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Monitoring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Policy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollutants' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollutants %28%1975-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollutants %28%1975-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollutants, Air' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollution' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollution %28%1971-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollution %28%1971-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollution %28%1971-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Pollution, Tobacco Smoke' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Protection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Protection Agency' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Protection Agency %28%U.S.%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Protection Agency, United States' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Science' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Sciences' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Sleep Disorders' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Smoke Pollution, Tobacco' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Substances, Toxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Tobacco Smoke Pollution' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental Toxic Substances' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environmental, Carcinogens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environments' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environments, Controlled' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environments, Extraterrestrial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environments, Health Facility' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Environments, Social' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Ataxia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Ataxias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Bovine Leukoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Bovine Leukosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Calf Pneumonia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Calf Pneumonias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Encephalomyelitis Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Pneumonia of Calves' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Pneumonia of Pigs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Pneumonia of Swine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzootic Porcine Encephalomyelitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymatic Zonulolyses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activation %28%1969-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activation %28%1969-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activation %28%1974-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activation/drug effects %28%1976-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Activators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Analyses, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Analysis, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Antagonists, Angiotensin-Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Cofactors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Disorder, Lysosomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Disorders, Lysosomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme E1, Ubiquitin-Activating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme E2, Ubiquitin-Conjugating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Electrode' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Electrodes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Immunoassays' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Induction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Induction %28%1966-1970%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitor, Nonapeptide-Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors %28%1968-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors %28%1975-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors %28%1975-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors %28%1975-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors %28%1976-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors %28%1989-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Inhibitors, Angiotensin-Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Labeled Antibody Technic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Labeled Antibody Technique' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Linked Immunosorbent Assay' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Mapping, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Mappings, Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Multiplied Immunoassay Technique' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Precursors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Precursors %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Precursors %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Precursors %28%1973-1975%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Precursors %28%1979-1982%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Reactivators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Repression' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Repression %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Stabilities' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Stability' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme System, Cellulase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Systems, Cellulase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Test' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme Tests' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme catalyzing reversibly the hydrolysis of palmitoyl-CoA or other long-chain acyl coenzyme A compounds to yield CoA and palmitate or other acyl esters. The enzyme is involved in the esterification of fatty acids to form triglycerides. EC 3.1.2.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme of the HUMAN IMMUNODEFICIENCY VIRUS that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. EC 3.4.23.-%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as ATPases. They exist as complexes with modification methylases of similar specificity listed under EC 2.1.1.72 or EC 2.1.1.73. The systems recognize specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5%27%-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.5.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5%27%-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme systems containing three different subunits and requiring ATP, S-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5%27%-phosphates. They function also as DNA-dependent ATPases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognize specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme that catalyzes the final step of fatty acid oxidation in which ACETYL COA is released and the CoA ester of a fatty acid two carbons shorter is formed.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme that catalyzes the first step of the tricarboxylic acid cycle %28%CITRIC ACID CYCLE%29%. It catalyzes the reaction of oxaloacetate and acetyl CoA to form citrate and coenzyme A. This enzyme was formerly listed as EC 4.1.3.7.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine. EC 2.1.1.6.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen %28%CALLA Antigen%29%, an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, 1,4-alpha-Glucan Branching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Acetyl Activating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Amylopectin Branching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Branching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, CAP-hydrolyzing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, CAT' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Capsaicin-Hydrolyzing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Cholesterol Esterifying' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, DNA Photoreactivating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Dicer' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Disulfide Interchange' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Glycogen Branching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Glycogen Debranching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, IL-1 beta-Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Insulin-Degrading' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Interleukin-1 Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Interleukin-1beta Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Kinin-Forming' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Malate Condensing' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, OPH' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Old Yellow' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Oxygen Evolving' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Photoreactivating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Starch Branching' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Sulfhydryl-Disulfide Interchange' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Terminal Addition' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Thyroxine Converting' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, Ubiquitin-Activating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme, YGG-Forming' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme-Labeled Antibody Technic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme-Labeled Antibody Technics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme-Labeled Antibody Techniques' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme-Linked Immunosorbent Assay' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme-Linked Immunosorbent Assay %28%1983-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzyme-Linked Immunosorbent Assays' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1966-1967%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1966-1967%29% /antagonists %26% inhibitors %28%1968-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1966-1971%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes %28%1972-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes Activators' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes and Coenzymes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes catalyzing the dehydrogenation of or oxidation of compounds containing primary amines.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates %28%HPETES%29%. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids %28%HETES%29%. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- .%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes catalyzing the transfer of an acetyl group, usually from acetyl coenzyme A, to another compound. EC 2.3.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. EC 3.5.2.6.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes from the transferase class that catalyze the transfer of acyl groups from donor to acceptor, forming either esters or amides. %28%From Enzyme Nomenclature 1992%29% EC 2.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of the isomerase class that catalyze reactions in which a group can be regarded as eliminated from one part of a molecule, leaving a double bond, while remaining covalently attached to the molecule. %28%From Enzyme Nomenclature, 1992%29% EC 5.5.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of the isomerase class that catalyze the oxidation of one part of a molecule with a corresponding reduction of another part of the same molecule. They include enzymes converting aldoses to ketoses %28%ALDOSE-KETOSE ISOMERASES%29%, enzymes shifting a carbon-carbon double bond %28%CARBON-CARBON DOUBLE BOND ISOMERASES%29%, and enzymes transposing S-S bonds %28%SULFUR-SULFUR BOND ISOMERASES%29%. %28%From Enzyme Nomenclature, 1992%29% EC 5.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of the isomerase class that catalyze the transfer of acyl-, phospho-, amino- or other groups from one position within a molecule to another. EC 5.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of the oxidoreductase class that catalyze the dehydrogenation of hydroxysteroids. %28%From Enzyme Nomenclature, 1992%29% EC 1.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another. %28%Dorland, 28th ed%29% EC 2.4.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. They are further divided based on their catalytic mechanism into serine-type carboxypeptidases EC 3.4.16; metallocarboxypeptidases, EC 3.4.17; and cysteine-type carboxypeptidases, EC 3.4.18. EC 3.4.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that activate one or more COMPLEMENT PROTEINS in the complement system leading to the formation of the COMPLEMENT MEMBRANE ATTACK COMPLEX, an important response in host defense. They are enzymes in the various COMPLEMENT ACTIVATION pathways.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell%27%s own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell%27%s DNA. Cleavage yields random or specific double-stranded fragments with terminal 5%27%-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze DNA template-directed extension of the 3%27%-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. %28%From Enzyme Nomenclature, 1992%29%.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules %28%ALDEHYDES or KETONES%29%. EC 4.1.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze acyl group transfer from ACETYL-CoA to HISTONES forming CoA and acetyl-histones.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze either the racemization or epimerization of chiral centers within amino acids or derivatives. EC 5.1.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze inversion of the configuration around an asymmetric carbon in a substrate having one %28%racemase%29% or more %28%epimerase%29% center%28%s%29% of asymmetry. %28%Dorland, 28th ed%29% EC 5.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively. EC 3.3.2.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the S-adenosyl-L-methionine-dependent methylation of ribonucleotide bases within a transfer RNA molecule. EC 2.1.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the addition of a carboxyl group to a compound %28%carboxylases%29% or the removal of a carboxyl group from a compound %28%decarboxylases%29%. EC 4.1.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the breakage of a carbon-oxygen bond leading to unsaturated products via the removal of water. EC 4.2.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the cleavage of a carbon-carbon bond by means other than hydrolysis or oxidation. This subclass contains the DECARBOXYLASES, the ALDEHYDE-LYASES, and the OXO-ACID-LYASES. EC 4.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the cleavage of a carbon-carbon bond of a 3-hydroxy acid. %28%Dorland, 28th ed%29% EC 4.1.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the cleavage of a carbon-nitrogen bond by means other than hydrolysis or oxidation. Subclasses are the AMMONIA-LYASES, the AMIDINE-LYASES, the amine-lyases, and other carbon-nitrogen lyases. EC 4.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the cleavage of a carbon-oxygen bond by means other than hydrolysis or oxidation. EC 4.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the cleavage of a carbon-sulfur bond by means other than hydrolysis or oxidation. EC 4.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the cleavage of a phosphorus-oxygen bond by means other than hydrolysis or oxidation. EC 4.6.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the degradation of collagen by acting on the peptide bonds. EC 3.4.24.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the epimerization of chiral centers within carbohydrates or their derivatives. EC 5.1.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. EC 3.2.1.20.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the first step in the beta-oxidation of FATTY ACIDS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the first step leading to the oxidation of succinic acid by the reversible formation of succinyl-CoA from succinate and CoA with the concomitant cleavage of ATP to ADP %28%EC 6.2.1.5%29% or GTP to GDP %28%EC 6.2.1.4%29% and orthophosphate. Itaconate can act instead of succinate and ITP instead of GTP.EC 6.2.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the formation of a carbon-carbon double bond by the elimination of AMMONIA. EC 4.3.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the formation of acyl-CoA derivatives. EC 6.2.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the hydrolysis of N-acylhexosamine residues in N-acylhexosamides. Hexosaminidases also act on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy %28%LEUKODYSTROPHY, METACHROMATIC%29%. EC 3.1.6.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the incorporation of deoxyribonucleotides into a chain of DNA. EC 2.7.7.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the interconversion of aldoses and ketoses. EC 5.3.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the joining of either ammonia or an amide with another molecule, in which the linkage is in the form of a carbon-nitrogen bond. EC 6.3.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the joining of glutamine-derived ammonia and another molecule. The linkage is in the form of a carbon-nitrogen bond. EC 6.3.5.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the joining of two molecules by the formation of a carbon-carbon bond. These are the carboxylating enzymes and are mostly biotinyl-proteins. EC 6.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the joining of two molecules by the formation of a carbon-nitrogen bond. EC 6.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the joining of two molecules by the formation of a carbon-oxygen bond. EC 6.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the joining of two molecules by the formation of a carbon-sulfur bond. EC 6.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the methylation of amino acids after their incorporation into a polypeptide chain. S-Adenosyl-L-methionine acts as the methylating agent. EC 2.1.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the rearrangement of geometry about double bonds. EC 5.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the release of mononucleotides by the hydrolysis of the terminal bond of deoxyribonucleotide or ribonucleotide chains.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A to yield MEVALONIC ACID.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the shifting of a carbon-carbon double bond from one position to another within the same molecule. EC 5.3.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the template-directed incorporation of ribonucleotides into an RNA chain. EC 2.7.7.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of N-acetylgalactosamine from a nucleoside diphosphate N-acetylgalactosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of N-acetylglucosamine from a nucleoside diphosphate N-acetylglucosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of N-acetylhexosaminyl groups to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of aldehyde or ketone residues. EC 2.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of an aminoacyl group from donor to acceptor resulting in the formation of an ester or amide linkage. EC 2.3.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of galactose from a nucleoside diphosphate galactose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of glucose from a nucleoside diphosphate glucose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of glycosyl groups to an acceptor. Most often another carbohydrate molecule acts as an acceptor, but inorganic phosphate can also act as an acceptor, such as in the case of PHOSPHORYLASES. Some of the enzymes in this group also catalyze hydrolysis, which can be regarded as transfer of a glycosyl group from the donor to water. Subclasses include the HEXOSYLTRANSFERASES; PENTOSYLTRANSFERASES; SIALYLTRANSFERASES; and those transferring other glycosyl groups. EC 2.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of hexose groups. EC 2.4.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of hydroxymethyl or formyl groups. EC 2.1.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of mannose from a nucleoside diphosphate mannose to an acceptor molecule which is frequently another carbohydrate. The group includes EC 2.4.1.32, EC 2.4.1.48, EC 2.4.1.54, and EC 2.4.1.57.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide %28%NAD%29% onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of nitrogenous groups, primarily amino groups, from a donor, generally an amino acid, to an acceptor, usually a 2-oxoacid. EC 2.6.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transfer of sulfur atoms %28%2.8.1%29%, sulfur groups %28%2.8.2%29% or coenzyme A %28%2.8.3%29%. EC 2.8.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transposition of a sulfur-sulfur bond. EC 5.3.4.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that catalyze the transposition of double bond%28%s%29% in a steroid molecule. EC 5.3.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that hydrolyze O-glucosyl-compounds. %28%Enzyme Nomenclature, 1992%29% EC 3.2.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that oxidize certain LUMINESCENT AGENTS to emit light %28%PHYSICAL LUMINESCENCE%29%. The luciferases from different organisms have evolved differently so have different structures and substrates.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that recognize CRUCIFORM DNA structures and introduce paired incisions that help to resolve the structure into two DNA helices.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that recombine DNA segments by a process which involves the formation of a synapse between two DNA helices, the cleavage of single strands from each DNA helix and the ligation of a DNA strand from one DNA helix to the other. The resulting DNA structure is called a Holliday junction which can be resolved by DNA REPLICATION or by HOLLIDAY JUNCTION RESOLVASES.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that regulate the topology of DNA by actions such as breaking, relaxing, passing, and rejoining strands of DNA in cells. These enzymes are important components of the DNA replication system. They are classified by their substrate specificities. DNA TOPOISOMERASE I enzymes act on a single strand of DNA. DNA TOPOISOMERASE II enzymes act on double strands of DNA.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. EC 1.1.1.35.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water %28%i.e., hydrolysis%29% is catalyzed by the NADASES. The mono%28%ADP-ribose%29%transferases transfer a single ADP-ribose. POLY%28%ADP-RIBOSE%29% POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. EC 4.2.2.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which catalyze the endohydrolysis of 1,4-beta-D-xylosidic linkages in XYLANS.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which cleave dipeptides from the amino terminal of a polypeptide. Dipeptidyl peptidase I, II, III, IV are known. They hydrolyze the beta-naphthylamides of glycine-arginine, lysine-alanine, arginine-arginine and glycine-proline, respectively. DIPEPTIDYL PEPTIDASE I is cathepsin C. EC 3.4.14.-.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which reduce nitro groups %28%NITRO COMPOUNDS%29% and other nitrogenous compounds.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which transfer coenzyme A moieties from acyl- or acetyl-CoA to various carboxylic acceptors forming a thiol ester. Enzymes in this group are instrumental in ketone body metabolism and utilization of acetoacetate in mitochondria. EC 2.8.3.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes which transfer sulfur atoms to various acceptor molecules. EC 2.8.1.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, Complement Activating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, DNA Repair' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, DNA Restriction' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, DNA Restriction-Modification' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, Immobilized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, Ubiquitin-Activating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes, Ubiquitin-Conjugating' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes/antagonists %26% inhibitors %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymes/antagonists %26% inhibitors %28%1968-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Enzymologic Gene Expression Regulation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosin Y' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosine B' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosine Bluish' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosine I Bluish' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosine Yellowish' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosine Yellowish-%28%YS%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Adenoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Adenomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Associated Ribonuclease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Basic Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Cationic Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Chemotactic Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Chemotaxins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Derived Neurotoxin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Differentiation Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Granule Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil MBP Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Major Basic Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Mast Cell Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Peroxidase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil Protein X' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil-Associated Ribonuclease' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil-Derived Neurotoxin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophil-Mast Cell Growth-Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia %28%1966-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia %28%1966-1984%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia %28%1966-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia Myalgia Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia-Myalgia Syndrome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia-Myalgia Syndromes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilia/chemically induced %28%1989-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilias, Pulmonary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilias, Tropical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Adenoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Adenomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Granuloma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Granulomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Leukemia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Leukemia, Acute' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Leukemias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Leukemias, Acute' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Pneumonia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophilic Pneumonias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophils' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophils %28%1966-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophils %28%1966-1980%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eosinophils %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EpDBI' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epazote' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependyma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymoastrocytomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymoblastomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymoma, Anaplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymoma, Cellular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymoma, Clear Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymomas, Anaplastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymomas, Cellular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymomas, Clear Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymomas, Myxopapillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ependymomas, Papillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eperythrozoon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eperythrozoonoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph A4 Receptor Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Family Receptor Interacting Protein B1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Family Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Ligand Family 1 Protein, Mammalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Receptor Cek4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Receptor Ligands' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Receptor Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Receptor, Cek4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eph-A4 Receptor Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA1 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA2 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA2 Receptor Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA2 Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA2-Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA3 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA3 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA4 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA5 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA5 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA6 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA6 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA7 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA7 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA8 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphA8 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB1 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB2 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB2 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB2 Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB2 Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB2-Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB3 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB4 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB5 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB6 Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'EphB6, Ephrin Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephedra' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephedra sinica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephedrine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemera' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemera %28%PT%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemera %5B%Publication Type%5D%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemeral Fever' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemeral Fever Virus, Bovine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemerovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephemeroviruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin A1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin A2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin A3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin A4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin A5' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin B Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin B1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin B2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin B3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin Receptor A4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin Receptor EphB6' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-A1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-A2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-A3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-A4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-A5' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-B1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-B2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrin-B3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Ephrins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epichlorhydrin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epichlorohydrin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epicondylitides, Lateral Humeral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epicondylitis, Lateral Humeral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epicortisol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Acute Poliomyelitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Encephalitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Encephalitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Hemorrhagic Fever' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Hemorrhagic Fever Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Hemorrhagic Fevers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Louse-Borne Typhus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Myalgia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Myalgias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Neurolabyrinthitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Neurolabyrinthitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Non A, Non B Hepatitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Non-A, Non-B Hepatitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Parotitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Parotitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Parotitis Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Parotitis Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Pleurodynia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Pleurodynias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Tremor Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemic Tremor Viruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Biases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Confounding Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Confounding Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Determinant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Determinants' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Effect Modifier' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Effect Modifiers' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Measurement' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Measurements' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Method' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1966-1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1970-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1971-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1977-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Methods %28%1985-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Monitoring' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Research Design' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Research Designs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Studies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Study Characteristic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic Study Characteristics' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologic investigations designed to test a hypothesized cause-effect relation by modifying the supposed causal factor%28%s%29% in the study population.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiological Method' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiological Methods' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiological Research Design' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiological Research Designs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiological Studies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiological Study' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologies, Molecular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiologies, Pharmaceutical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology %28%1967-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology %28%1984-1993%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology, Molecular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidemiology, Pharmaceutical' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Cell Derived Thymocyte Activating Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Cyst' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Cysts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Receptor Genes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Receptor Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Receptor Protein Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Receptor Protein-Tyrosine Kinase' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Receptor Protein-Tyrosine Kinase %28%1994%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor Related Transforming Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor-Related Transforming Growth Factor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor-Urogastrone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factor-Urogastrone %28%1982-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Growth Factors %28%1977-1981%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Hyperplasia Virus 1, Walleye' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Hyperplasia Virus 2, Walleye' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Necrolyses, Toxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Necrolysis, Toxic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal Necrolysis, Toxic %28%1966-1985%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified %28%horny%29% layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermal dendritic pigment cells which control long-term morphological color changes by alteration in their number or in the amount of pigment they produce and store in the pigment containing organelles called MELANOSOMES; MELANOPHORES are larger cells which do not exist in mammals.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermis %28%1978-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermis, Plant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermis/cytology %28%1975-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermitis, Exudative of Swine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermitis, Exudative, of Swine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermodysplasia Verruciformis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermoid Carcinoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermoid Carcinomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermoid Cyst' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermoid Cysts' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa %28%1966-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Acquisita' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Dystrophica' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Dystrophica, Dominant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Dystrophica, Recessive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Herpetiformis Dowling Meara' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Simplex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Simplex, Generalized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa Simplex, Localized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa, Dystrophic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolysis Bullosa, Junctional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolytic Hyperkeratoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermolytic Hyperkeratosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermophyton' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidermophytoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epididymal Secretory Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epididymis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epididymitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epididymitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Abscess' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Abscess, Cranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Abscess, Intracranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Analgesia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Anesthesia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Anesthesia, Sacral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Blood Patch' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Blood Patchs' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hematoma, Cranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hematoma, Intracranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hematoma, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hematomas, Cranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hematomas, Intracranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hematomas, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hemorrhage, Cranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hemorrhage, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hemorrhages, Cranial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Hemorrhages, Spinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Injection' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Injections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Neoplasms, Malignant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Pneumocephalus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Space' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Space %28%1979-1986%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Space %28%1979-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Spaces' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Tumor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural Tumors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epidural anesthesia administered via the sacral canal. ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epigastric Arteries' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epigastric Artery' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epigenesis, Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiglottis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiglottitides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiglottitis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epikeratophakia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epikeratophakias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsia Partialis Continua' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsia Partialis Continua, Chronic Progressive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Abdominal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Adolescent Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Akinetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Amygdalo-Hippocampal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Anterior Fronto-Polar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Atonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Audiogenic Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Baltic Myoclonus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Benign Neonatal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Centralopathic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Centrotemporal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Childhood Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Cingulate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Cryptogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Cryptogenic Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Cryptogenic Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Cursive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Digestive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Eating-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Eating-Induced Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Familial Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Focal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Gelastic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Generalized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Generalized Convulsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Idiopathic Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Immersion Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Juvenile Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Juvenile Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Kojevnikov%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Lateral Temporal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Localization-Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Musicogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Musicogenic Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Myoclonic %28%1977-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Myoclonic Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Myoclonic Astatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Occipital Lobe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Orbito-Frontal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Partial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Partial %28%1977-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Photosensitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Photosensitive Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Post-Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Progressive Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Progressive Myoclonus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Reading' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Reading Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Rhinencephalic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Rolandic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Simple Partial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Supplementary Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Symptomatic Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Symptomatic Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Tactile Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Temporal Lobe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Tonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Uncinate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsies, Writing-Induced Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1965-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1965-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1965-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1966-1978%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1968-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy %28%1982-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Abdominal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Absence %28%1975-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Adolescent Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Anterior Fronto Polar' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Audiogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Audiogenic Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Awakening' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Baltic Myoclonus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Benign Frontal, Childhood' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Benign Neonatal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Benign Neonatal, Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Benign Neonatal, Nonfamilial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Benign Rolandic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Centralopathic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Centrotemporal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Childhood Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Complex Partial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Cryptogenic Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Cryptogenic Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Cryptogenic, Partial Complex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Cursive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Cursive Reflex %28%Running%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Early Childhood, Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Eating-Induced' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Eating-Induced Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Familial Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Focal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Focal Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Frontal Lobe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Generalized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Generalized Convulsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Generalized Nonconvulsive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Grand Mal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Hemimotor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Idiopathic Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Immersion Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Juvenile Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Juvenile Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Kojevnikov%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Kojewnikov%27%s' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Localization-Related' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Major' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Mediterranean Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Minor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Motor Partial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Musicogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Musicogenic Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic %28%1980-1992%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic Absence' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic Astatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic, Early Childhood' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic, Infantile, Benign' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonic, Juvenile' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Myoclonus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Orbito Frontal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Partial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Partial %28%1977-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Partial %28%1980-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Partial %28%1986-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Partial, Motor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Partial, Sensory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Petit Mal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Petit Mal %28%1966-1976%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Photosensitive' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Photosensitive Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Post Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Post-Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Progressive Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Progressive Myoclonic, Lafora' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Progressive Myoclonus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Psychic Equivalent' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Psychomotor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Reading' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Reading Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Rolandic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Rolands' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Sensory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Sensory Partial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Sylvian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Symptomatic Generalized' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Symptomatic Myoclonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Symptomatic Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Tactile Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Temporal Lobe' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Temporal Lobe %28%1965-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Temporal Lobe %28%1966-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Temporal Lobe %28%1979-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Tonic Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Tonic-Clonic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Tonic-Clonic, Cryptogenic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Traumatic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy, Writing-Induced Reflex' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilepsy/etiology %28%1966-1999%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epileptic Aphasia, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epileptic Aphasias, Acquired' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epileptic Seizure' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epileptic Seizures' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epileptiform Neuralgia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epileptiform Neuralgias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilespy, Benign Neonatal, Non-Familial' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiligrin Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiligrin Receptor, alpha3beta1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilincomycin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epilobium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiloia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiloias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiluminescence Microscopies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiluminescence Microscopy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epimedium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epimerase, UDP Galactose' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epimerase, UDP Glucose' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epimerases and Racemases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epimerases, Carbohydrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epimestrol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine %28%1966-1988%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine %28%1974%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine Bitartrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine Hydrogen Tartrate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epinephrine, Racemic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epineuriums' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyseal Cartilage' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyseal Cartilages' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyseal Dysplasia, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyseal Dysplasias, Multiple' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyseal Plate' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyseal Plates' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyses %28%1966%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyses %28%1966-1983%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyses, Slipped' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphyses, Stippled' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphysiolyses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphysiolysis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphysis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiphysis Cerebri' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epipregnanolone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiretinal Membrane' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epiretinal Membranes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epirizole' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epirubicin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episcleritides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episcopalian' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episcopalians' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episialin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episiotomies' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episiotomy' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episode of Care' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episode, Patient Care' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episode, Syncopal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episodes of Care' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episodes, Patient Care' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episodic Cluster Headaches' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episodic Paroxysmal Hemicranias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episodic Recurrent Vertigo' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episodic Recurrent Vertigos' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Episome' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epispadia' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epispadias' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistasis, Genetic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistatic Deviation' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistatic Deviations' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistatic Gene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistatic Genes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistaxis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epistropheus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitectin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitestosterone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithalamus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelia, Human Mammary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Attachment' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Attachments' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cell Kinase Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cells %28%1966-1977%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cells %28%1968-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cells %28%1973-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Cells, Glomerular Visceral' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Hyperplasia, Focal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Hyperplasias, Focal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Membrane Antigen' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Mucin, Polymorphic' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Neoplasm' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Neoplasm, Glandular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Neoplasm, Malignant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Neoplasms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Neoplasms, Glandular' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Neoplasms, Malignant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Tumor, Malignant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial Tumors, Malignant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial cell line originally derived from porcine kidneys. It is used for pharmacologic and metabolic studies.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial cells surrounding the dental papilla and differentiated into three layers: the inner enamel epithelium, consisting of ameloblasts which eventually form the enamel, and the enamel pulp and external enamel epithelium, both of which atrophy and disappear before and upon eruption of the tooth, respectively.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial cells that line the basal half of the GASTRIC GLANDS. Chief cells synthesize and export an inactive enzyme PEPSINOGEN which is converted into the highly proteolytic enzyme PEPSIN in the acid environment of the STOMACH.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelial hyperplasia of the oral mucosa associated with Epstein-Barr virus %28%HERPESVIRUS 4, HUMAN%29% and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Angiomatoses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Angiomatoses, Bacillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Angiomatosis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Angiomatosis, Bacillary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Cells' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Hemangioendothelioma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Hemangioendotheliomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Leiomyoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Leiomyomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Leiomyosarcoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Leiomyosarcomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Sarcoma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioid Sarcomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioma' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioma Contagiosum' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioma, Basal Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioma, Brown Pearce' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelioma, Brown-Pearce' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitheliomas' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitheliomas, Basal Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium %28%1966-1968%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium %28%1966-1987%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium %28%1966-1989%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium %28%1966-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium %28%1967-1996%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium in the retina, ciliary body, and iris containing pigment granules.%A% ' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Anterior Chamber' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Anterior Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Barrett' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Corneal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Corneal/surgery %28%2001-2004%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Human Mammary' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Intestinal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Junctional' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Laryngeal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Nasal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Olfactory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Respiratory' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium, Seminiferous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epithelium/cytology %28%1978-1997%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitheliums, Seminiferous' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitope Mapping' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitope Mappings' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitope, B-Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitope, B-Lymphocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitope, T-Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitope, T-Lymphocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes %28%1983-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes %28%1987-1995%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, B Lymphocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, B-Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, B-Lymphocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, Immunodominant' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, T Lymphocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, T-Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epitopes, T-Lymphocyte' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epizootic hemorrhagic disease virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epl1 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epl3 %28%Protein%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epl4 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eplg5 Gene Product' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eplg5 Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoetin Alfa' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eponym' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eponyms' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoprostanol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoprostenol' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoprostenol %28%1977-2003%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoprostenol %28%1978-1990%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoprostenol Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eposide' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epothilon' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epothilone' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epothilones' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxidase, Squalene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxide Hydrases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxide Hydratases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxide Hydrolase, Microsomal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxide Hydrolase, Styrene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxide Hydrolases' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxide, Heptachlor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxides' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxides, Trichothecene' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxy Compounds' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxy Compounds %28%1975-1979%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxy Compounds %28%1995-2002%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxy Resins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxy Resins %28%1979-1991%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxylite 9075' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxylite9075' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epoxytrichothecenes' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epsilon Binding Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epsilon Polylysine' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epsilon-Binding Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epsilonproteobacteria' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epsilonretrovirus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epsilonretroviruses' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein Barr Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein Barr Virus Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein Barr Virus Nuclear Antigens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein Barr Virus Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein Barr Virus Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein-Barr Virus' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein-Barr Virus Infections' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein-Barr Virus Nuclear Antigens' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein-Barr Virus Receptor' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epstein-Barr Virus Receptors' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Eptastatin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epulides, Congenital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epulides, Giant Cell' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epulis' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Epulis, Congenital' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equasym' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equatorial Guinea' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equid herpesvirus 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equid herpesvirus 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equid herpesvirus 3' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equid herpesvirus 4' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equidae' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilenin' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrations, Occlusal' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative NBMPR Sensitive Nucleoside Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative NBMPR-Sensitive Nucleoside Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative Nitrobenzylmercaptopurine Riboside Sensitive Nucleoside Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative Nitrobenzylmercaptopurine Riboside-Sensitive Nucleoside Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative Nucleoside Transport Protein' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative Nucleoside Transport Proteins' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative Nucleoside Transporter 1' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative, Nitrobenzylmercaptopurine Riboside %28%NBMPR%29%-Insensitive Nucleoside Transporter' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrative-Nucleoside Transporter 2' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrium %28%1966-1972%29%' = 0).
% 42.08/42.05 fof(interp, fi_functors, 'Equilibrium Radionuclide Angiocardiographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Radionuclide Angiocardiography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Radionuclide Angiographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Radionuclide Angiography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Radionuclide Ventriculographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Radionuclide Ventriculography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Scintigraphies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium Scintigraphy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium, Acid-Base' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium, Genetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium, Musculoskeletal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilibrium, Postural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equilin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equina, Cauda' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Arteritis Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalitides, Eastern' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalitis, Eastern' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalitis, Venezuelan' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalitis, Western' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitides, Eastern' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitides, Venezuelan' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitis Viral Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitis Virus Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitis, Eastern' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Encephalomyelitis, Venezuelan' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Estrogens, Conjugated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Gonadotropins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Herpesvirus 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Herpesvirus 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Herpesvirus 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Herpesvirus 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Infectious Anemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Infectious Anemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Infectious Arteritis Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Influenza Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Lentivirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Lentiviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Morbillivirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Morbilliviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Plague' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Plagues' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Rhinopneumonitis Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Rhinopneumonitis Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Strongyle Infection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Strongyle Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Strongyloses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine Strongylosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine abortion Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine abortion Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine arteritis virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine coital exanthema virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine infectious anemia virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine rhinovirus 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equine toroviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equinovarus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equinus Contracture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equinus Contractures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equinus Deformities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equinus Deformity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Alarm System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Contamination' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Contaminations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Defect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Defects' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Design' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Designs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Failure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Failure Analyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Failure Analysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Failures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Hazard' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Hazards' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Malfunction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Malfunctions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Misuse' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Misuses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Recycling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Reuse' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment Safety' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies %28%1993-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and Supplies, Hospital %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment and furniture used by infants and babies in the home, car, and play area.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment on which one may lie and sleep, especially as used to care for the hospital patient.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment required for engaging in a sport %28%such as balls, bats, rackets, skis, skates, ropes, weights%29% and devices for the protection of athletes during their performance %28%such as masks, gloves, mouth pieces%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment that provides mentally or physically disabled persons with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment that sends digital information over telephone lines. The term Modem is a short form of the phrase modulator-demodulator.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment used to prevent contamination of and by patients, especially those with bacterial infections. This includes plastic surgical isolators and isolators used to protect immunocompromised patients.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Athletic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Baby' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Computer Peripheral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Dental High-Speed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Diagnostic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Disposable' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Durable Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Household' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Infant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Medical, Durable' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Orthopedic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Sports' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipment, Surgical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipments, Computer Peripheral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipments, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipments, Dental High-Speed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipments, Diagnostic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipments, Orthopedic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equipments, Surgical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equisetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equisetum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equities, Pay' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equity, Pay' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalencies, Availability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalencies, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalencies, Generic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalencies, Therapeutic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalency, Availability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalency, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalency, Generic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equivalency, Therapeutic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equus asinus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Equus caballus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erabutoxins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eragrostis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb Duchenne Paralysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb Palsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb Paralyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb%27%s Palsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb%27%s Palsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb-Duchenne Paralyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erb-Duchenne Paralysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'ErbA Related Protein 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'ErbA-Related Protein-3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erbium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erbium. An element of the rare earth family of metals. It has the atomic symbol Er, atomic number 68, and atomic weight 167.26.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erbs Palsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erbumine, Perindopril' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ercalcidiol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erdheim Chester Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erdheim-Chester Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erectile Dysfunctions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erection, Penile' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erection, Sleep-Related Painful' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erections, Sleep-Related Painful' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eremophila Plant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erempharma Brand of Sulpiride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergastoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergha Brand of Betahistine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergo Kranit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'ErgoKranit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergobasin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergocalciferol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergocalciferol %28%1966%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergocalciferols' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergocalciferols %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergocornine, 9,10-dihydro-' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines %28%1969-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines %28%1969-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines %28%1969-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines %28%1971-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergolines %28%1981-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergoloid Mesylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergoloid Mesylates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergoloid Mesylates %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometrine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometrine Maleate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometry Test, Arm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometry Test, Bicycle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometry Tests, Arm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergometry Tests, Bicycle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergonovine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergonovine %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergostat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergosterol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Alkaloids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Alkaloids %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Alkaloids %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Alkaloids %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Mesylates %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Poisoning' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergot Poisonings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotamine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotamine %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotamine %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotamines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergothioneine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotisms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ergotoxin, Dihydro-, Monomethasulfonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ericaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erigeron' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erinaceidae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eriobotrya' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eriocaulaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eriodictyon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eriogonum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eritrea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ern Brand of Ethyl Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ern Brand of Fructose' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ern Brand of Penicillin G Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erosion, Cervix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erosion, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erosion, Uterine Cervical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erosion, Uterine Cervix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erosions, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erotic Stage, Oral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erotic Stages, Oral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erotica' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erp59' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erp59-PDI' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errata' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errata %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error Source' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Diagnostic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Inborn Metabolism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Medication' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Outcome Measurement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Refractive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Sampling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Error, Surgical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors Metabolism, Inborn' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors Metabolisms, Inborn' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors in metabolic processing of STEROIDS resulting from inborn genetic mutations that are inherited or acquired in utero.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors of brain metabolism resulting from inborn, primarily enzymatic, deficiency states. The majority of these conditions are familial, however spontaneous mutation may also occur. Deficient enzyme activity may cause brain dysfunction by leading to the accumulation of substrate, reduced product formation, or by causing metabolism to occur through alternate pathways.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors or mistakes committed by health professionals which result in harm to the patient. They include errors in diagnosis %28%DIAGNOSTIC ERRORS%29%, errors in the administration of drugs and other medications %28%MEDICATION ERRORS%29%, errors in the performance of surgical procedures, in the use of other types of therapy, in the use of equipment, and in the interpretation of laboratory findings. Medical errors are differentiated from MALPRACTICE in that the former are regarded as honest mistakes or accidents while the latter is the result of negligence, reprehensible ignorance, or criminal intent.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Diagnostic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Inborn Metabolism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Medication' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Outcome Measurement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Refractive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Sampling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Errors, Surgical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erucic Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eructation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eructations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Acneiform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Creeping' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Ectopic Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Forced' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Kaposi Varicelliform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Kaposi%27%s Varicelliform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Licheniform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Lichenoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruption, Volcanic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Acneiform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Creeping' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Ectopic Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Licheniform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Lichenoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eruptions, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia %28%1965-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia %28%1967-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia %28%1980-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia amylovora' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia carotovora' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erwinia chrysanthemi' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eryf1 Erythroid Specific Transcription Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eryf1 Erythroid-Specific Transcription Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eryngium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysimum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipelas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipelas, Swine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipeloid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipeloid %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipeloids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipelothrix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipelothrix Infection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipelothrix Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erysipelothrix infect; don%27%t forget also SWINE %28%NIM%29% %26% check tag ANIMALS%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema Chronicum Migrans' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema Induratum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema Infectiosum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema Multiforme' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema Nodosum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythema, Acrodynic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythemas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythermalgia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythermalgias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrasma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythremia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythremias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythremic Myeloses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythremic Myelosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythremic Myelosis %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrina' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythritol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrityl Tetranitrate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastic Anemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastic Leukemia, Acute' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastic Leukemias, Acute' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastoses, Fetal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastosis Fetali' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastosis Fetalis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastosis Virus, Avian' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastosis Viruses, Avian' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblastosis, Fetal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblasts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroblasts %28%1977-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocebus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocebus patas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocruorins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocuprein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aggregation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aggregations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aggregations, Intravascular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aging' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aging %28%1967-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Anion Exchanger' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Anion Transport Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aplasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Aplasias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Burst Promoting Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Burst-Promoting Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Count' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Count %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Count %28%1966-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Counts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Cytoskeleton' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Cytoskeletons' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Deformability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Deformability %28%1985-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Diameters' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Filterability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Ghost' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Ghosts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Glucose Transporter' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Hemoglobin, Mean Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Inclusion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Inclusions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Index' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Indexes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Indices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Lactate Transporter' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Membrane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Membrane Anion Transport Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Membrane Aspartic Proteinase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Membrane Band 3 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Membranes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Number' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Numbers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Rouleaux Formation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Rouleaux Formations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Sedimentation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Sedimentation Rates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Sialoglycoprotein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Size Determinations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Substitutes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Transfusion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Transfusions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Volume' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Volume %28%1978-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Volume, Mean Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Volume, Packed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Volumes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte Volumes, Packed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte isoantigens of the Rh %28%Rhesus%29% blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte, Abnormal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte, Nucleated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocyte-Binding Glycoprotein, T11' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1968-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1969-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes %28%1972-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes with protoplasmic projections giving the cell a thorny appearance.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes, Abnormal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes, Abnormal %28%1968-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes, Abnormal %28%1968-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes, Nucleated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytes/transplantation %28%1968-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrocytoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroderma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroderma Ichthyosiforme, Bullous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroderma Ichthyosiforme, Nonbullous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroderma, Congenital Ichthyosiform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroderma, Sezary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrodermas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrodermas, Congenital Ichthyosiform' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrodermas, Maculopapular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrohepatic Porphyria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrohepatic Porphyrias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Burst-Forming Unit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Burst-Forming Units' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Precursor Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Precursor Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Progenitor Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Progenitor Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Specific DNA Binding Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Specific Nuclear Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Stem Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Stem Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid Transcription Factor 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid-Specific DNA-Binding Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroid-Specific Nuclear Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroidine, Dihydro beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroleukemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroleukemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromelalgia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromelalgias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin %28%1970-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin Estolate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin Ethylsuccinate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin N Demethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin N-Demethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin Propionate Dodecyl Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin Propionate Lauryl Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin Propionate Monododecyl Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin/analogs %26% derivatives %28%1987-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycin/analogs %26% derivatives %28%1987-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycins, 3 Keto' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythromycins, 3-Keto' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroplasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroplasias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoieses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoiesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoiesis %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoiesis %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Porphyria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Porphyria, Congenital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Porphyrias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Porphyrias, Congenital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Progenitor Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Progenitor Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Protoporphyria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Protoporphyrias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Stem Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietic Stem Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietin %28%1986-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietin %28%1989-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietin Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietin Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythropoietin, Recombinant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrosin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrosin B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrosine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrosine B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythrovirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroxylaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Erythroxylon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escalator' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escalators and Elevators' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escaned Brand of Prenazone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escape Reaction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escape Reactions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli %28%1965-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli %28%1977-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Adhesin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Adhesins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Infection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli K12' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Meningitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Meningitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli O157' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Phage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Phages' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Proton Translocating ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Vaccine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escherichia coli Vaccines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eschrichtius robustus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eschscholzia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escina' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escort Service, Patient' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Escort Services, Patient' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esculin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esculoside' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esidrix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eskimo' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eskuzan' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eslectin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esocidae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esociformes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esodeviation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esodeviations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Achalasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Achalasias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Atresia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Atresias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Cancer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Cancers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Cyst' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Cysts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Diseases %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Diverticula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Diverticulosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Diverticulum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Diverticulum %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Dysmotilities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Dysmotility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Fistula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Fistulas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Hernia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Hernia, Sliding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Hernias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Hernias, Sliding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Motility Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Motility Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Perforation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Perforations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Reflux' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Spasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Spasm, Diffuse' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Spasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Spasms, Diffuse' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Speech' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Speechs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Sphincter, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Sphincter, Upper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Stenoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Stenosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Stenosis %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Stricture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal Varix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal and Gastric Varices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal and Gastric Varices/surgery %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal pH Monitoring' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal pH Monitorings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal pH Recording' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophageal pH Recordings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagectomies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagectomy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitides, Peptic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitides, Reflux' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitis, Peptic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitis, Peptic %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagitis, Reflux' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophago Pharyngeal Diverticula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophago Pharyngeal Diverticulum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophago-Pharyngeal Diverticula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophago-Pharyngeal Diverticulum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagogastric Junction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagogastric Junction %28%1966-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagogastroduodenoscopies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagopharyngeal Diverticulum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagopharyngeal Diverticulums' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoplasties' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoplasty' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscope' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopic Surgeries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopic Surgery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopic Surgical Procedure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagoscopy/instrumentation %28%1966-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagostomies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagostomies, Cervical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagostomy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagostomy, Cervical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagotracheal Fistula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagotracheal Fistulas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus %28%1966-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus %28%1975-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus Cancer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus Cancers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus, Barrett' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus, Barrett%27%s' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus, Nutcracker' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus/surgery %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophagus/surgery %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esophorias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropia, Intermittent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropia, Monocular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropia, Primary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropia, Secondary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropias, Intermittent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropias, Monocular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropias, Primary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esotropias, Secondary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Espadox' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esparma Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esparon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essays %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essays %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Amino Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Drugs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Fatty Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Gene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Genes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Hypercholesterolemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Hypercholesterolemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Intracranial Hypotension' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Modifier, NF-kappaB' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Oils' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Osteolyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Osteolysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Polyarteritides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Thrombocythemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Thrombocythemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Tremor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Tremor, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Tremors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Tremors, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential Vertigo' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential oil extracted from Melaleuca alternifolia %28%tea tree%29%. It is used as a topical antimicrobial due to the presence of terpineol.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic chromosomes. Telomerase appears to be repressed in normal human somatic tissues but reactivated in cancer, and thus may be necessary for malignant transformation. EC 2.7.7.-.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Amifostine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Buprenorphine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Doxorubicin Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Flutamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Netilmicin Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Ribavirin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Essex Brand of Tolnaftate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Established behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Established cell cultures that have the potential to propagate indefinitely.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Establishing the father relationship of a man and a child.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estazolam' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estedi Brand of Chenodeoxycholic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estedi Brand of Gentian Violet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estedi Brand of Methimazole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estedi Brand of Terbutaline Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estedi Brand of Ursodeoxycholic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estedi Brand of Warfarin Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteem, Self' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteems, Self' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ester Hydrolase, Carboxylic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ester Hydrolases, Carboxylic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ester Synthetase, Retinol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ester of CHLORAMBUCIL and PREDNISOLONE used as a combination alkylating agent and synthetic steroid to treat various leukemias and other neoplasms. It causes gastrointestinal and bone marrow toxicity.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ester, Ampicillin Pivaloyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ester, Tosylarginine Methyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase 17' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase ES 1A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase Inhibitor, C1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, 1-Alkyl-2-acetylglycerophosphocholine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Acetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, C 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, C1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Carboxylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Cholesterol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Complement 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Lipoidal Steroid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Naproxen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Non-specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Nonspecific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Procaine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Steroid Hormone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Ubiquitin C-Terminal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, Ubiquitin Carboxy-Terminal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, alpha-Naphthyl Acetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase, alpha-Naphthylacetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterase-17' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1970-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1971-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1972-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1975-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1976-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases %28%1980-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterases, Monoglyceride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterification' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterifications' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterified Estrogens %28%USP%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterified Fatty Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esterifying Enzyme, Cholesterol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteroproteases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters %28%1968-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters formed between the aldehydic carbon of sugars and the terminal phosphate of guanosine diphosphate.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Acetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Cholesterol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Cholesteryl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Formic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Phorbol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Phosphonic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Phosphoric Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Sulfuric Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Thiophosphoric Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esters, Thiosulfuric Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estetrol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Alfentanil Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Astemizole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Aztreonam' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Bupropion Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Calcium Dobesilate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Cinnarizine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Ethamsylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Fosinopril Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Mebendazole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Methadone Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Nimodipine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Pravastatin Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esteve Brand of Sertraline Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthesioneuroblastoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthesioneuroblastoma, Olfactory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthesioneuroblastoma, Paranasal Sinus Nasal Cavity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthesioneuroblastoma, Paranasal Sinus-Nasal Cavity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthesioneuroblastomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthesioneuroblastomas, Olfactory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthetic Surgeries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthetic, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthetics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Esthetics, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimate, Life Table' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimate, Maximum Likelihood' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimates, Life Table' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimates, Maximum Likelihood' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Technic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Technic, Indirect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Technics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Technics, Indirect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Technique' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Technique, Indirect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation Techniques, Indirect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimation, Population Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estimations, Population Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estivation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estolate, Erythromycin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estomycin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estonia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 16 alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 16-alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 17 alpha' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 17 alpha Dehydrogenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 17 beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 17 beta Dehydrogenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol 17beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Antagonists' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Combination, Norgestrel-Ethinyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Congeners' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Dehydrogenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Dehydrogenases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Receptor alpha' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol, %28%17-alpha%29%-Isomer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol, Ethinyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol, Ethynyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol-17 beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol-17beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estradiol-Norgestrel Combination, Ethinyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estramustine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estranes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estranes %28%1968-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estranes %28%1968-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estranes %28%1970-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estranes %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estranes %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrenes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrenes %28%1973-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrenes %28%1975-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrenes %28%1975-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrenolone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estriol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estriol %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen 16 alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen 16-alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Analogs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Analogues' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Antagonists' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Contraceptive Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Progestin Combination Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor Modulator' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor Modulator, Selective' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor Modulators' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor Modulators, Selective' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor Type I' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor Type II' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor alpha' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptor beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptors Type I' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptors Type II' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptors alpha' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Receptors beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Replacement Therapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Replacement Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Replacement Therapy %28%1990-1998%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Replacements' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Synthase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen Synthetase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen UDP Glucuronosyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogen, Stilbene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic Compounds' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic Hormones, Conjugated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic STEROIDS with aliphatic hydrocarbon chain substitution on C17 or other position. 17-alpha-ALKYLATION renders the molecule more stable, resistant to metabolic degradation, and improves oral efficacy. Examples of synthetic alkyl estrogens include ETHINYL ESTRADIOL and MESTRANOL. Substitutions at other sites generates antiestrogenic and cytotoxic properties.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic Steroids, Alkylated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic Substances, Conjugated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogenic Substances, Conjugated %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1964-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1966-1981%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Catechol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Conjugated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Conjugated %28%1975-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Conjugated %28%USP%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Esterified %28%USP%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Non Steroidal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Non-Steroidal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Non-Steroidal %28%1978-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Nonsteroidal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrogens, Synthetic %28%1975-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone %28%1972-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone 16 alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone 16-alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone 3 sulfate 16 alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone Sulfate Sulfatase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone Sulfate Sulfohydrolase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrone-3-sulfate 16-alpha Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrous Cycle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrous Cycles' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus %28%1964-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus Detection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus Detections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus Synchronization' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Estrus Synchronizations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etacrynic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etamsylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etanidazole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etazolate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etching, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etching, Dental Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etching, Freeze' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethacridine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethacrinic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethacrynic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethacrynic Acid, Sodium Salt' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethambutol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethaminal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethamoxytriphetol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethamsylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethane %28%1974%29% /AA %28%1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethane %28%1974-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethane Nitriles' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanedial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanedioic Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanediols' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanedione' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanehydroxydiphosphonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanehydroxyphosphate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanol Induced Disorders, Nervous System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanol Induced Nervous System Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanol-Induced Disorders, Nervous System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanol-Induced Nervous System Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamine Ammonia Lyase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamine Ammonia-Lyase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamine Deaminase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamine Phosphoglycerides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamineglycerophospholipids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolaminephosphotransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolaminephosphotransferase, sn-1,2-Diacylglycerol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1970-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1973-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1973-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1973-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethanolamines %28%1981-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethchlorovynol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethchlorvinol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethchlorvynol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethene Homopolymers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethenoadenosine Triphosphate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether A Go Go Potassium Channels' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether A Go Go Related Potassium Channels' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether Phosphatidates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether Phospholipids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether Phospholipids, Alkenyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether, Chloromethyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether, Dichloromethyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether, Diethyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether, Dihematoporphyrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether, Ethyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether, Guaiacol Glyceryl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether-A-Go-Go Potassium Channels' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ether-A-Go-Go Related Potassium Channels' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1966-1970%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1966-1973%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1969-1973%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1971-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1972-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers %28%1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Alkyl Glyceryl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Aza-Oxa Crown' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Crown' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1969-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1971-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1974-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1974-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Cyclic %28%1982-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Ethyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Glycerol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Glycerol Phosphate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Glycerophosphate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Glyceryl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Methyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Methylphenyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Oxa-Thia Crown' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Phenyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Phospholipid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethers, Sulfur' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Buddhist' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Christian' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Deontological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Feminist' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Health Facility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Institutional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Islamic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Jewish' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Normative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Organizational' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Pharmaceutic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Pharmaceutical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Pharmacy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Principle-Based' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Professional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Protestant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Religious' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Roman Catholic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethic, Teleological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Analyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Analysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Analysis %28%2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Code' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Codes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Directive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Issue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Oath' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Relativism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Review' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Review %28%2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Theories' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethical Theory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethicist' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethicist, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethicists' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethicists, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1966-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1974-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1974-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1977-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1979-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1979-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics %28%1989-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Code' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Code, Professional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Codes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Codes, Professional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee, Institutional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee, Regional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committee, Research' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees %28%1979-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees %28%1992-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees, Institutional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees, Regional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Committees, Research' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Consultant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Consultants' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Consultation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics Consultations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Biomedical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Buddhist' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Business' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Christian' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Deontological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Eastern Orthodox' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Feminist' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Health Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Hindu' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Institutional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Islamic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Jewish' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical %28%1966-1985%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical %28%1990-1994%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical %28%1992-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Medical %28%1997-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Narrative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Normative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Pharmaceutic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Pharmaceutical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Pharmacy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Principle-Based' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Professional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Professional %28%1974-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Protestant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Research' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Roman Catholic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Situational' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethics, Teleological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethidium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethidium %28%1974-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethilons' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethimizol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethimizole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol %28%1968-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol %28%1972-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol 3 Cyclopentyl Ether' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol 3 Methyl Ether' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol 3-Cyclopentyl Ether' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol 3-Methyl Ether' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol Norgestrel Combination' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Estradiol-Norgestrel Combination' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Oestradiol Effik' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyl Trichloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinylestrenol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinylnortestosterone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethinyloestradiol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiodized Oil' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiodized Oil %28%Injection%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiodized Oils' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiofos' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethionamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethioniamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethionine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiopia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiopia %28%1966-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethiopian Wolf' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethisterone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoid Bone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoid Bones' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoid Sinus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoid Sinusitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoid Sinusitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoidal Sinusitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmoidal Sinusitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethmozin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnic Group' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnic Groups' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnic Groups %28%1968-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnic Groups %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnic Groups %28%1968-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnic group originating in India and entering Europe in the 14th or 15th century.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnobotany' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnology %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnology %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnopharmacology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnopsychology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethnopsychology %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoglucid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethomidate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethomorphine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethopabate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethorphine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethosuccimid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethosuximide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxazolamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxyaniline' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxycoumarin Deethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxycoumarin O Deethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxycoumarin O-Deethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxyformic Anhydride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxyquin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxyresorufin Dealkylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxyresorufin O-Deethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxyzolamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethoxzolamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Alcohol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Alcohol Abuse Neurologic Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Aminobenzoate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Biscoumacetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Carbamate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Chlorophenoxyisobutyrate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Ether' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Ethers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Ethers %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Ethers %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Etrinoate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Mercury Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Mercury Compounds' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Mesilate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Mesylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Methanesulfonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Parathion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl Succinate, Eyrthromycin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl ester of iodinated fatty acid of poppyseed oil. It contains 37%25% organically bound iodine and has been used as a diagnostic aid %28%radiopaque medium%29% and as an antineoplastic agent when part of the iodine is 131-I. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl-6-%28%Decycloxy%29%-7-ethoxy-4-hydroxy-3-quinolinecarboxylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyl-p-Nitrophenyl Ethylphosphonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyladrianol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylamines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylamines %28%1966-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylamines %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylamines %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylamines %28%1974-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylbarbital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyldicoumarol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyldimethylaminopropyl Carbodiimide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Aldehyde' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Chlorohydrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Dibromide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Dibromides %28%1977-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Dichlorides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Dinitrilotetraacetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Dinitrilotetraacetate, Disodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Glycol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Glycol Bis%28%2-aminoethyl ether%29%tetraacetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Glycol Tetraacetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Glycols' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Glycols %28%1982-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Oxide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylene Polymers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenebis%28%dithiocarbamates%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenebis%28%oxyethylenenitrile%29%tetraacetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenechlorhydrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediamine, Theophylline' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediamines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediamines %28%1971-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediamines %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediamines %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediamines %28%1975-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenediaminetetraacetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenedinitrilotetraacetic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyleneimines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenes %28%1974-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylenethiourea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylestrenol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylestrenolone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylketazocine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylketocyclazocine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmaleimide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmercurials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmercuric Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmercury Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmercury Compounds' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmercury Compounds %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmercury Compounds %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmesilate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmesylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmethane Sulfonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmethylglutarimide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmethylsuccimide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmorphine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmorphine N Demethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylmorphine-N-Demethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylnitrosourea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylnorantifeine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylnorphenylephrine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylnortestosterone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyloestrenol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylphenylephrine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylphenylmalonamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylresorufin O-Deethylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethylsuccinate, Erythromycin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethymisole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethymizol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethyndiol Diacetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethynodiol Diacetate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ethynyl Estradiol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eti Puren' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etidocaine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etidronate, Dicalcium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etidronate, Disodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etidronate, Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etidronic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etilefrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etilefrin ratiopharm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etilefrine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etimizol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etiocholanolone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etioporphyrins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etmozin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eto CS' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eto GRY' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etodolac' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etodolic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etoglucid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etomedac' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etomidate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etoposide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etoposide, alpha D Glucopyranosyl Isomer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etorphine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etretin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etretinate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etrinoate, Ethyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets 1 Transcription Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets Like Protein 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets-1 Transcription Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets-Domain Protein, Sap-1a' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets-Domain Protein, Sap-1b' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets-Domain Protein, Sap1a' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets-Domain Protein, Sap1b' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ets-Like Protein 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etymologies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Etyprenalinum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eu Actinin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eubacteria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eubacterium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eubalaena australis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eucalyptus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euchromatin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euchromatins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eucoccidiida' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eucoccidiida %28%1990-2000%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eucommiaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eudesmane Sesquiterpenes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euflavin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euflavine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euflex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenic Abortion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenic Abortions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenics %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenics, Negative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenics, Positive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eugenol %28%1983-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglena' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglena %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglena gracilis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglena longa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglenida' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglenids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglenophyta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglycaemic Clamp' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglycaemic Clamping' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglycaemic Clamps' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglycemic Clamping' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euglycemic Clamps' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2, alpha Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2, beta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2, gamma Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2B, alpha Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2B, beta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2B, delta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2B, epsilon Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2B, gamma Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 2alpha Kinase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3 p110' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 7' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, Subunit 8' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, beta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, delta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, gamma Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 3, zeta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4A1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4A2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4A3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4E' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4F' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 4G' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor EIF 4A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor EIF-4A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-%28%iso%29%4F' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-1 %28%1989-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-2B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-3 p110' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-3, beta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-3, delta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-3, gamma Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-3, zeta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-4A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-4E' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-4F' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-4G' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factor-5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Initiation Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 2B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3, Subunit 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3, Subunit 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3, Subunit 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3, Subunit 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3, Subunit 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 3, alpha Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 4A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 4E' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 4G' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-2B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-3, Subunit 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-3, Subunit 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-3, Subunit 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-3, Subunit 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-3, alpha Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-4A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-4E' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-4G' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factor-5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Peptide Initiation Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Topoisomerase I' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Topoisomerases II' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Translation Initiation Factor 3, Subunit 8' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Translation Initiation Factor 4 gamma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Translation Initiation Factor 4AIII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Translation Initiation Factor 4G' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Translation Initiation Factor-3, Subunit 8' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic Translation-Initiation Factor 4AIII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic enzymes of the DNA TOPOISOMERASES, TYPE I class that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These eukaryotic enzymes reduce the topological stress in the DNA structure by relaxing both negatively and positively supercoiled DNA.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic enzymes of the DNA TOPOISOMERASES, TYPE II class that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. Isozymes of the eukaryotic DNA topoisomerase II consist of homodimers of alpha or beta subunits.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic initiation factor of protein synthesis. In higher eukaryotes the factor consists of three subunits: alpha, beta, and gamma. As initiation proceeds, eIF-2 forms a ternary complex with Met-tRNAi and GTP.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eukaryotic-Translation Initiation Factor 4G' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulenburg Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulenburg%27%s Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulenburgs Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euler Gaddum Substance P' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euler-Gaddum Substance P' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulexine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulitop' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulogies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulogies %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eulogies %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eumycetozoea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eunuchism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euodia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euonymus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euparyphium ilocanum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eupatorium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eupatorium adenophorum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eupatorium odoratum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eupatorium rebaudianum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphausiacea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphorbia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphorbiaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphorbiaceae %28%1998-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphoria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphorias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphrasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euphyllin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euploid female germ cells of an early stage of OOGENESIS, derived from primordial germ cells during ovarian differentiation. Oogonia undergo MEIOSIS and give rise to haploid OOCYTES%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euploid male germ cells of an early stage of SPERMATOGENESIS, derived from prespermatogonia. With the onset of puberty, spermatogonia at the basement membrane of the seminiferous tubule proliferate by mitotic then meiotic divisions and give rise to the haploid SPERMATOCYTES.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euplotes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eurim Brand of Betahistine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eurim Brand of Fluvoxamine Maleate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Europe' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Europe, Eastern' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Adder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Adders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Common Frog' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Common Market' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Community' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Continental Ancestry Group' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Economic Community' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Frog, Common' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European House Dust Mite' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Mink' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Pennyroyal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Polecats' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Shore Crab' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Tick Borne Encephalitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Tick-Borne Encephalitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Tick-Borne Encephalitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Union' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'European Vipers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Europharma Brand of Ademetionine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Europharma Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Europium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Europium. An element of the rare earth family of metals. It has the atomic symbol Eu, atomic number 63, and atomic weight 152. Europium is used in the form of its salts as coatings for cathode ray tubes and in the form of its organic derivatives as shift reagents in NMR spectroscopy.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eurotiales' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euryarchaeota' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eurycoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eustachian Tube' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eustachian Tubes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eutelegeneses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eutelegenesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euth%C3%%A9%rapie Brand of Almitrine Dimesilate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia %28%1974-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia %28%1974-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia %28%1976-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Active' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Active, Voluntary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Involuntary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Negative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Passive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Passive %28%1978-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthanasia, Voluntary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthyroid Sick Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Euthyroid Sick Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eutirox' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eutrophication' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eutrophications' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Mechanism, Healthcare' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Mechanisms, Healthcare' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Methodologies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Methodology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Reports' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Research, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Researchs, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies %28%1971-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies %28%Pub Type%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies %5B%PT%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, Drug, Pre-Clinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, Drug, Preclinical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, FDA Phase 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, FDA Phase 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, FDA Phase 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, FDA Phase 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Studies, Postmarketing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Study' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Study, Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Study, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation Study, Postmarketing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation and measurement of nutritional variables in order to assess the level of nutrition or the nutritional status of the individual. Nutrition surveys may be used in making the assessment.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation of the level of physical, physiological, or mental functioning in the older population group.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation procedures that focus on both the outcome or status %28%OUTCOME ASSESSMENT %28%HEALTH CARE%29%;%29% of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process %28%PROCESS ASSESSMENT %28%HEALTH CARE%29%;%29% - what is done for the patient diagnostically and therapeutically.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, practicability, etc., of these interventions in individual cases or series.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Computer Systems' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Disability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Drug Utilization' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Health Services' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Nurses Performance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Nursing Program' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Preclinical Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Program' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Qualitative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Quantitative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluation, Work Capacity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Computer Systems' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Disability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Drug Utilization' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Health Services' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Nurses Performance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Nursing Program' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Preclinical Drug' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Program' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Qualitative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Quantitative' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evaluations, Work Capacity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evan Blue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evan%27%s Blue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evans Blue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evans Brand of Alimemazine Tartrate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evans Rats, Long' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evans Vaccines Brand of Heroin Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evening Primrose' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event Free Survival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event History Analyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event History Analysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event Related Potentials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event Related Potentials, P300' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event, Life Change' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event, Sentinel Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event, Solar Particle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event, Special' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event, Stressful' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event-Free Survival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event-Free Survivals' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event-Related Potential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event-Related Potential, P300' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event-Related Potentials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Event-Related Potentials, P300' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eventration of Diaphragm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eventration, Diaphragmatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Events, Life Change' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Events, Sentinel Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Events, Solar Particle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Events, Special' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Events, Stressful' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Events, characteristics, or other definable entities that have the potential to bring about a change in a health condition or other defined outcome.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evidence Based Medicine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evidence-Based Medicine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evil, King%27%s' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evisceration, Eye' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evisceration, Orbit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evisceration, Orbital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eviscerations, Eye' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eviscerations, Orbit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eviscerations, Orbital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evodia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evodia rutaecarpa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evodiae Fructus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potential, Auditory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potential, Auditory, Brainstem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potential, Motor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potential, Somatosensory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potential, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials %28%1966-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials %28%1967-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials %28%1967-1981%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials %28%1967-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials %28%1970-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials %28%1975-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Auditory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Auditory %28%1979-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Auditory, Brain Stem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Auditory, Brainstem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Motor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, P300 Component' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Somatosensory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Potentials, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Response Audiometries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Response Audiometry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Response, Auditory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Response, Auditory, Brain Stem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Response, Auditory, Brainstem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Response, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Responses, Auditory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Responses, Auditory, Brain Stem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Responses, Auditory, Brainstem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evoked Responses, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution %28%1966-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution %28%1978-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution at the molecular level of DNA sequences and proteins. %28%Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Chemical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Cultural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Directed Molecular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Laboratory Molecular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Molecular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Molecular, Directed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolution, Planetary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolutions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolutions, Chemical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolutions, Cultural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolutions, Directed Molecular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolutions, Laboratory Molecular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Evolving Enzyme, Oxygen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ewing Sarcoma Breakpointregion 1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ewing Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ewing%27%s Sarcoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ewing%27%s Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ewings Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination Questions %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination Questions %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of any part of the body for diagnostic purposes by means of roentgen rays, recording the image on a sensitized surface %28%such as photographic film%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of chromosomes to diagnose, classify, screen for, or manage genetic diseases and abnormalities. Following preparation of the sample, KARYOTYPING is performed and/or the specific chromosomes are analyzed.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of foods to assure wholesome and clean products free from unsafe microbes or chemical contamination, natural or added deleterious substances, and decomposition during production, processing, packaging, etc.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of the EAR CANAL and eardrum with an OTOSCOPE.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of the angle of the anterior chamber of the eye with a specialized optical instrument %28%gonioscope%29% or a contact prism lens.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of the interior of the eye with an ophthalmoscope.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of the mouth and teeth toward the identification and diagnosis of intraoral disease or manifestation of non-oral conditions.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of the portal circulation by the use of X-ray films after injection of radiopaque material.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Automobile Driver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Bone Marrow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Digital Rectal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Graduate Records' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Neurologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Neurological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Physical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Preadmission Physical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Premarital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, Self' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examination, therapy or surgery of the interior of the larynx performed with a specially designed endoscope.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations and Diagnoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Automobile Driver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Bone Marrow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Digital Rectal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Graduate Records' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Neurologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Neurological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Oral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Physical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Preadmission Physical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Premarital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examinations, Self' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Examiners, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exanthem' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exanthema' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exanthema Subitum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excavatum, Pectus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exceptional Child' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exceptional Children' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excess Mortalities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excess Mortality' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate %28%within first 24 hours after birth%29% or delayed %28%after 24 hours postpartum%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excess of normal lymphocytes in the blood or in any effusion.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excess, Convergence' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive Periodic Sleep Related Leg Movements' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive Periodic Sleep-Related Leg Movements' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive Somnolence Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive Somnolence Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter %28%7.0mg/dL%29% in men or 0.36mmol per liter %28%6.0mg/dL%29% in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined %28%LESCH-NYHAN SYNDROME%29%. It is associated with HYPERTENSION and GOUT.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive accumulation of cerebrospinal fluid within the cranium which may be associated with dilation of cerebral ventricles, INTRACRANIAL HYPERTENSION; HEADACHE; lethargy; URINARY INCONTINENCE; and ATAXIA %28%and in infants macrocephaly%29%. This condition may be caused by obstruction of cerebrospinal fluid pathways due to neurologic abnormalities, INTRACRANIAL HEMORRHAGES; CENTRAL NERVOUS SYSTEM INFECTIONS; BRAIN NEOPLASMS; CRANIOCEREBRAL TRAUMA; and other conditions. Impaired resorption of cerebrospinal fluid from the arachnoid villi results in a communicating form of hydrocephalus. Hydrocephalus ex-vacuo refers to ventricular dilation that occurs as a result of brain substance loss from CEREBRAL INFARCTION and other conditions.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive amount of sodium in the blood. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive axial myopia associated with complications %28%especially posterior staphyloma and CHOROIDAL NEOVASCULARIZATION%29% that can lead to BLINDNESS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis %28%HEMATOPOIESIS, EXTRAMEDULLARY%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive growth of the gingiva either by an increase in the size of the constituent cells %28%GINGIVAL HYPERTROPHY%29% or by an increase in their number %28%GINGIVAL HYPERPLASIA%29%. %28%From Jablonski%27%s Dictionary of Dentistry, 1992, p574%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive lateral nail growth into the nail fold. Because the lateral margin of the nail acts as a foreign body, inflammation and granulation may result. It is caused by improperly fitting shoes and by improper trimming of the nail.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive or unnecessary utilization of health services by patients or physicians.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive periodic leg movements during sleep that cause micro-arousals and interfere with the maintenance of sleep. This condition induces a state of relative sleep deprivation which manifests as excessive daytime hypersomnolence. The movements are characterized by repetitive contractions of the tibialis anterior muscle, extension of the toe, and intermittent flexion of the hip, knee and ankle. %28%Adams et al., Principles of Neurology, 6th ed, p387%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive pigmentation of the skin, usually as a result of increased epidermal or dermal melanin pigmentation, hypermelanosis. Hyperpigmentation can be localized or generalized. The condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive rapidity in the action of the heart, usually with a heart rate above 100 beats per minute.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive slowness in the action of the heart, usually with a heart rate below 60 beats per minute.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive uterine bleeding during MENSTRUATION. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Factors, GDP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Measurement, Deuterium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Measurement, Hydrogen-Deuterium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Measurements, Deuterium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Measurements, Hydrogen-Deuterium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Proteins, Anion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Proteins, Cation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Resins, Anion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Resins, Cation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Resins, Ion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Transfusion, Whole Blood' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange Transfusion, Whole Blood %28%1968-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, International Educational' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, Intracellular Ion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, Ion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, Maternal-Fetal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, Plasma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, Pulmonary Gas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchange, Sister Chromatid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanger, Calcium-Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanger, Chloride-Bicarbonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanger, Sodium-Calcium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanger, Sodium-Hydrogen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchangers, Chloride-Bicarbonate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanges, International Educational' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanges, Plasma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exchanges, Sister Chromatid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excimer Laser Angioplasties' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excimer Laser Angioplasty' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excimer Laser Keratectomies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excimer Laser Keratectomy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excimer Laser Subepithelial Abalation %28%ELSA%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excipients' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excipients %28%1984-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Mastectomies, Local' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Mastectomy, Local' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Repair Cross Complementing Rodent Repair Deficiency, Group 2 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Repair Cross-Complementing Rodent Repair Deficiency, Group 2 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Repair, Base' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Repair, Nucleotide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision Repairs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of a kidney. %28%Dorland, 28th ed%29% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of a portion of the colon or of the whole colon. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of all or part of the liver. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of breast tissue with preservation of overlying skin, nipple, and areola so that breast form may be reconstructed.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of one or both adrenal glands. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of one or both of the parathyroid glands. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of part %28%partial%29% or all %28%total%29% of the esophagus. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the adenoids. %28%Dorland, 28th ed%29% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the apical portion of a tooth through an opening made in the overlying labial, buccal, or palatal alveolar bone. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the gallbladder through an abdominal incision using a laparoscope.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the posterior arch of a vertebra. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the prepuce or part of it. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the uterus. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision of the whole %28%total gastrectomy%29% or part %28%subtotal gastrectomy, partial gastrectomy, gastric resection%29% of the stomach. %28%Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision, Lymph Node' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision, Prophage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excision, in part or whole, of an intervertebral disk. The most common indication is disk displacement or herniation. In addition to standard surgical removal, it can be performed by percutaneous diskectomy %28%DISKECTOMY, PERCUTANEOUS%29% or by laparoscopic diskectomy, the former being the more common.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excisions, Lymph Node' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excisions, Prophage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Agonist' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Agonists' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Antagonists' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Transport Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Transporter 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Transporter 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Transporter 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Transporter 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acid Transporter 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Amino Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Neurotoxins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Postsynaptic Potential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitatory Postsynaptic Potentials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitement, Psychomotor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excitotoxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exclusion Chromatography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exclusion Chromatography, Size' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exclusive Breast Feeding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exclusive Breastfeeding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exclusive legal rights or privileges applied to inventions, plants, etc.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excretion of an excessive amount of oxalate in the urine.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Excretory-related psychiatric disorders usually diagnosed in infancy or childhood.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Executive, Physician' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Executives, Physician' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exelgyn Brand of Mifepristone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exemption, Tax' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exemptions, Tax' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exencephalies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exenteration, Pelvic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exenterations, Pelvic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise %28%1989-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Induced Asthma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Induced Bronchospasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Movement Technics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Movement Techniques' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Test' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Test %28%1966-1982%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Test %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Test %28%1966-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Test %28%1983-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Tests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Therapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Therapy %28%1972-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise Tolerance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise of governmental authority to control conduct. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise, Breathing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise, Physical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise-Induced Asthma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise-Induced Asthmas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise-Induced Bronchospasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercise-Induced Bronchospasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercises' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercises, Aerobic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercises, Isometric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exercises, Physical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion %28%1966-1982%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion %28%1966-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertion %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertional Headache, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertional Headaches, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exertions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliatins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliation Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliation Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliation, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliations, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliative Dermatitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliative Dermatitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliative Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliative Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exfoliative Toxin, Staphylococcal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhalation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhalations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhaling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhaust, Automobile' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhaust, Diesel' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhaust, Engine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhaustion, Heat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibitionism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibitionisms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibitions %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibitions %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibits' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhibits %28%1966-1982%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhumation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exhumations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Existentialism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo 1,3 beta D Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo 1,4 alpha Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo 1,4 beta Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo Cellobiohydrolase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo Oligo 1,6 Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo beta 1,4 Glucanase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo beta D Glucuronidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo cellulase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo-1,3 beta-D-Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo-1,4-alpha-Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo-1,4-beta-Glucosidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo-Cellobiohydrolase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo-beta-1,4-Glucanase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exo-cellulase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exobiology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocellulase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine Gland' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine Glands' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine IgA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine Pancreas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine Pancreatic Insufficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine Pancreatic Insufficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocrine glands in animals which secrete scents which either repel or attract other animals, e.g. perianal glands of skunks, anal glands of weasels, musk glands of foxes, ventral glands of wood rats, and dorsal glands of peccaries.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exocytosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exodeoxyribonuclease V' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exodeoxyribonucleases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exodeoxyribonucleases %28%1983-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exodeviation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exodeviations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous Calcium Antagonists' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous Calcium Blockaders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous Calcium Inhibitors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exogenous substances used to promote blood coagulation. The endogenous BLOOD COAGULATION FACTORS are considered to be coagulants only when administered as drugs.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exoglucanase II' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exomphalos' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exomphalos Macroglossia Gigantism Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exomphalos-Macroglossia-Gigantism Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exon, Hinge' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exon, VDJ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exons' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exons that are created in vivo during LYMPHOCYTE maturation from the V, D, and J gene segments of immunoglobulin superfamily genes %28%e.g., the IMMUNOGLOBULIN HEAVY CHAIN GENES, or the T-CELL RECEPTOR BETA GENES or T-CELL RECEPTOR GAMMA GENES %29% by the VDJ RECOMBINASE system.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exons, Hinge' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exons, VDJ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exonuclease V' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exonucleases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exonucleases %28%1973-1982%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exonucleases %28%1980-1982%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exonucleases, DNA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exopeptidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exopeptidases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exophiala' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exophiala jeanselmei' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exophthalmic Goiter' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exophthalmic Goiters' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exophthalmos' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exoprotease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exoproteases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exoribonucleases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses %28%1970-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Cartilaginous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Familial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Hereditary Multiple' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Multiple' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Multiple %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Multiple %28%1972-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Multiple Cartilaginous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Multiple Hereditary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Multiple Hereditary %28%1985-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostoses, Osteocartilaginous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis, Cartilaginous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis, Familial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis, Hereditary Multiple' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis, Multiple' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis, Multiple Cartilaginous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exostosis, Osteocartilaginous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotoxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotoxin, Cholera' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotoxins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotoxins produced by certain strains of streptococci, particularly those of group A %28%STREPTOCOCCUS PYOGENES%29%, that cause HEMOLYSIS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotropia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotropia, Alternating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotropia, Monocular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotropia, Primary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exotropia, Secondary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanded DNA Repeat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanded Trinucleotide Repeat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanded Trinucleotide Repeats' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. %28%American Heritage Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expander, Tissue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanders, Blood' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanders, Plasma Volume' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanders, Tissue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expanscience Brand of Minocycline Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion Technic, Palatal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion Technics, Palatal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion Technique, Palatal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion Techniques, Palatal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion, DNA Repeat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion, Maxillary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion, Tissue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansion, Trinucleotide Repeat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansions, DNA Repeat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansions, Tissue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expansions, Trinucleotide Repeat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expectancies, Life' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expectancy, Life' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expected Family Size' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expected Family Sizes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expectorants' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expedition' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expeditions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expendable and nonexpendable equipment, supplies, apparatus, and instruments that are used in diagnostic, surgical, therapeutic, scientific, and experimental procedures.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure of energy by skeletal muscles. Intensity of exertion may be measured by rate of oxygen consumption, heat produced, or heart rate. Perceived exertion, a psychological measure of exertion, is included.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure, Capital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure, Direct' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure, Energy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure, Indirect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditure, Personal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditures, Capital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditures, Energy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditures, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expenditures, Personal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experience, Life' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiences, Life' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiential, attitudinal, emotional, or behavioral phenomena occurring during the course of treatment. They apply to the patient or therapist %28%i.e., nurse, doctor, etc.%29% individually or to their interaction. %28%American Psychological Association: Thesaurus of Psychological Index Terms, 1994%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiment, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Allergic Encephalomyelitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Allergic Neuritis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Animal Model' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Autoimmune Encephalomyelitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Autoimmune Myositis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Autoimmune Neuritis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Autoimmune Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Autoimmune Neuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Designs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Diabetes Mellitus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Encephalomyelitis, Autoimmune' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Game' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Games' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Hepatic Cirrhosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Hepatomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Hypokinesia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Hypokinesias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Implant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Implants' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Leukemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Leukemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Liver Cirrhoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Liver Cirrhosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Liver Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Liver Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Lung Inflammations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Mammary Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Mammary Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Melanoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Melanomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Models' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Myasthenia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Myasthenia Gravis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Myasthenias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Myositis, Autoimmune' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Parkinson Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Parkinson Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Parkinsonism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Parkinsonism, MPTP Induced' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Parkinsonism, MPTP-Induced' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Parkinsonisms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Pneumococcal Meningitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Psychologies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Psychology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Radiation Injuries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Radiation Injury' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Sarcoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Sarcomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Therapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Use, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental Uses, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental animal models for human AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM. They include GUILLAIN-BARRE SYNDROME %28%see NEURITIS, AUTOIMMUNE, EXPERIMENTAL%29%; MYASTHENIA GRAVIS %28%see MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL%29%; and MULTIPLE SCLEROSIS %28%see ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental or veterinary; general or unspecified only; for specific experimental hepatitis, index the specific hepatitis term + ANIMALS check tag; for specific veterinary hepatitis, index the specific hepatitis term /vet + pre-coordinated animal disease term + ANIMALS check tag and do not coordinate with HEPATITIS, ANIMAL%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimental transplantation of neoplasms in laboratory animals for research purposes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally induced tumors of the LIVER. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus during the prenatal stage of development that is characterized by rapid morphological changes and the differentiation of basic structures. In humans, this includes the period from the time of fertilization to the end of the eighth week after fertilization.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation on, or using the organs or tissues from, a human or other mammalian conceptus in the postembryonic period, after the major structures have been outlined. In humans, this corresponds to the period from the third month after fertilization until birth.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation, Embryo' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation, Fetal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation, Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation, Nontherapeutic Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentation, Therapeutic Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experimentations, Embryo' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiments %28%Publication Type%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiments designed to determine the potential toxic effects of a long-term exposure to a chemical or chemicals.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiments designed to determine the potential toxic effects of one-time, short-term exposure to a chemical or chemicals.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Experiments, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expert Opinions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expert System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expert Systems' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expert Testimonies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expert Testimony' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expert Witnesses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expertise Generalization' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expertise, Technical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiration, Respiratory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expirations, Respiratory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiratory Forced Flow Rates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiratory Peak Flow Rate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiratory Reserve Volume' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiratory Reserve Volumes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiratory Volume, Forced' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expiratory Volumes, Forced' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exploitation through misrepresentation of the facts or concealment of the purposes of the exploiter.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exploration, Space' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explorations, Space' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exploratory Behavior' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exploratory Behaviors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explosion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explosion, Population' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explosions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explosions, Population' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explosive Decompression' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Explosive Disorder, Intermittent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Export Factor, CAS' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Export Signal, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Export Signals, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Export, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure Chamber, Atmosphere' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure Chambers, Atmosphere' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure Notifications' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure of myocardial tissue to brief, repeated periods of vascular occlusion in order to render the myocardium resistant to the deleterious effects of ISCHEMIA or REPERFUSION. The period of pre-exposure and the number of times the tissue is exposed to ischemia and reperfusion vary, the average being 3 to 5 minutes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Dental Pulp' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Environmental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Inhalation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Maternal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Occupational' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Paternal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposure, Transplacental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposures, Environmental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposures, Inhalation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposures, Maternal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposures, Occupational' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exposures, Paternal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressed Emotion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressed Emotions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressed Sequence Tag' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressed Sequence Tags' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expression Chip, Gene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expression Chips, Gene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expression Regulation, Gene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expression, Facial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expression, Gene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressions, Facial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressions, Gene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expressive Aphasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expulsion of milk from the mammary alveolar lumen, which is surrounded by a layer of milk-secreting EPITHELIAL CELLS and a network of myoepithelial cells. Contraction of the myoepithelial cells is regulated by neuroendocrine signals.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Expulsion of the product of FERTILIZATION before completing the term of GESTATION and without deliberate interference.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exstrophies, Bladder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exstrophy, Bladder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended Care Facilities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended Care Facility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended Families' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended Radical Mastectomies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended Radical Mastectomy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended care facilities which provide skilled nursing care or rehabilitation services for inpatients on a daily basis.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended-Wear Contact Lens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extended-Wear Contact Lenses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extender, Physicians%27%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extenders, Physicians%27%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extension, Cell Membrane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extension, Cell Surface' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensions, Cell Membrane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensions, Cell Surface' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensive and rapid death of parenchymal cells in the LIVER, often due to exposure to toxic materials. It is characterized by a soft, flabby, yellow-brown wrinkled, and shrunken liver. It was called %22%acute yellow atrophy%22%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensor Plantar Reflex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensor Plantar Response' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extensor Plantar Responses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Externa, Otitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Externa, Theca' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Auditory Canal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Auditory Canals' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Carotid Arteries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Carotid Artery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Cephalic Version' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Cephalic Versions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Chest Wall Oscillation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Compression Syndrome, Ulnar Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Counterpulsation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Defibrillator' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Defibrillator, Automated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Defibrillators' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Defibrillators, Automated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Degree Programs, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Ear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Ears' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fistula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fistulas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fixation Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fixation Devices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fixator' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fixators' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Fixators %28%1990-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Infusion Pump' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Infusion Pumps' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Ophthalmoplegia, Progressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Ophthalmoplegias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Ophthalmoplegias, Progressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Popliteal Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External Popliteal Neuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External application of water for therapeutic purposes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External decompression applied to the lower body. It is used to study orthostatic intolerance and the effects of gravitation and acceleration, to produce simulated hemorrhage in physiologic research, to assess cardiovascular function, and to reduce abdominal stress during childbirth.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External devices which hold wires or pins that are placed through one or both cortices of bone in order to hold the position of a fracture in proper alignment. These devices allow easy access to wounds, adjustment during the course of healing, and more functional use of the limbs involved.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120 kDa and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External or interstitial irradiation to treat lymphomas %28%e.g., Hodgkin%27%s and non-Hodgkin%27%s lymphomas%29% and lymph node metastases and also some autoimmune diseases, such as rheumatoid arthritis.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'External surgical fistulization of the pharynx for feeding.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Externas, Otitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extinction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extinction %28%Psychology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extinctions %28%Psychology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extinguishing System, Fire' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extinguishing Systems, Fire' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra Embryonic Membranes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra Mammary Paget Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra Mammary Paget%27%s Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra Vascular Lung Water' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Adrenal Paraganglioma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Adrenal Paragangliomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Adrenal Pheochromocytoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Adrenal Pheochromocytomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Embryonic Membrane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Embryonic Membranes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Mammary Paget Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Mammary Paget%27%s Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Mammary Pagets Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extra-Ribosomal Peptide Biosynthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Calcium Ion Sensing Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Calcium-Ion Sensing Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Fluid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Fluids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrices, Mesangial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix %28%1984-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix %28%1986-2000%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix %28%1991-2000%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix Metalloproteinase Inducer %28%EMMPRIN%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix Proteins %28%1990-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix Proteins %28%1991-1998%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Matrix, Mesangial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated Kinase 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated Kinase 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated Kinase 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated Kinase 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated Kinase 6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated Kinases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal Regulated MAP Kinases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated Kinase 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated Kinase 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated Kinase 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated Kinase 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated Kinase 6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated Kinases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Signal-Regulated MAP Kinases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Space' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Space %28%1964-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Space %28%1966-1983%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Space %28%1978-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular Spaces' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracellular structures found in a variety of microorganisms. They contain CELLULASES and play an important role in the digestion of CELLULOSE.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracerebral Cavernous Hemangioma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracerebral Cavernous Hemangiomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrachromosomal Inheritance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrachromosomal Inheritance %28%1968-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrachromosomal Inheritance %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Circulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Circulation %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Circulation %28%1967-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Circulation %28%1967-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Circulation %28%1971-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Circulations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Dialyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Dialysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Membrane Oxygenation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Membrane Oxygenations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Photochemotherapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Photochemotherapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Photopheresis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal Shockwave Lithotripsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracorporeal ultrafiltration technique without hemodialysis for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracranial Intracranial Arterial Bypass' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracranial Primitive Neuroectodermal Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracranial-Intracranial Arterial Bypasses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extract, Dialyzable Leukocyte' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extract, Senna' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction Deliveries, Vacuum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction Delivery, Vacuum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction and Processing Industry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction of the FETUS by means of abdominal HYSTEROTOMY.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction of the fetus by abdominal hysterotomy anytime following a previous cesarean.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction of the fetus by means of obstetrical instruments.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Cataract' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Obstetric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Obstetric Vacuum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Obstetrical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Obstetrical Vacuum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Serial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Supercritical Fluid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraction, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Cataract' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Obstetric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Obstetric Vacuum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Obstetrical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Obstetrical Vacuum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Serial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extractions, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts of the thymus that contain specific, but uncharacterized factors or proteins with specific activities; three distinct substances are already known: thymotoxin, thymin and thymosin.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Chinese Plant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Complex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Crude' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Liver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Pancreatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Placental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Plant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Thymus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extracts, Tissue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Abscess' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Abscess, Intracranial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Abscess, Spinal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Abscesses, Intracranial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Anesthesia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Hematoma, Cranial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Hematomas, Cranial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Hemorrhage, Cranial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Hemorrhages, Cranial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Injection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extradural Injections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraembryonic Membrane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraembryonic Membranes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraglomerular Mesangial Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrahepatic Bile Duct' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrahepatic Bile Ducts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrahepatic Biliary Stasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrahepatic Biliary System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrahepatic Biliary Systems' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrahepatic Cholestasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramammary Paget Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramammary Paget%27%s Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramammary Pagets Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramarital Relation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramarital Relations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramedullary Hematopoieses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramedullary Hematopoiesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramedullary Myeloid Cell Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramedullary Spinal Cord Compression' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramembranous Glomerulopathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extramembranous Glomerulopathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extranet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire MALT tissue as a result of an immunologically mediated disorder.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extranuclear Inheritance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraoral Traction Appliance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraoral Traction Appliances' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraoral body-section radiography depicting an entire maxilla, or both maxilla and mandible, on a single film.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraoral devices for applying force to the dentition in order to avoid some of the problems in anchorage control met with in intermaxillary traction and to apply force in directions not otherwise possible.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraordinary Treatments' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrapontine Myelinoclases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrapontine Myelinoclasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrapontine Myelinolyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrapyramidal Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrapyramidal Tract' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrapyramidal Tracts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraribosomal Peptide Biosynthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasensory Perceptions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasystole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasystole, Atrial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasystole, Ventricular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasystoles' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasystoles, Atrial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrasystoles, Ventricular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraterrestrial Environment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraterrestrial Environment %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraterrestrial Environment %28%1966-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraterrestrial Environment %28%1966-1994%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraterrestrial Environments' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravasation and subsequent accumulation of blood in the subdural space between the dural and arachnoidal layers of the MENINGES. This condition primarily occurs over the surface of a cerebral hemisphere %28%HEMATOMA, SUBDURAL, INTRACRANIAL%29%, but may develop in the posterior fossa and spinal canal %28%HEMATOMA, SUBDURAL, SPINAL%29%. Acute %28%HEMATOMA, SUBDURAL, ACUTE%29% and chronic %28%HEMATOMA, SUBDURAL, CHRONIC%29% forms exist.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravasation of Diagnostic and Therapeutic Materials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravasation of Diagnostic, Therapeutic Materials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravasation of blood into a basal ganglia nucleus %28%e.g., caudate, globus pallidus, amygdala, putamen, and claustrum%29%. Clinical manifestations may include acute hemiparesis, movement disorders, headache and/or alterations of consciousness. Hypertension and vascular malformations are relatively common causes of this condition. Pathologically, these hemorrhages are associated with lipohyalinosis of small blood vessels and Charcot-Bouchard microaneurysm formation. %28%Adams et al., Principles of Neurology, 6th ed, p836%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravasation of blood into the midbrain, pons, or medulla following CRANIOCEREBRAL TRAUMA. DIFFUSE AXONAL INJURY is commonly associated. Clinical manifestations which may be associated with this condition include OCULAR MOTILITY DISORDERS; ATAXIA; PARALYSIS; PERSISTENT VEGETATIVE STATE; and COMA.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravascular Lung Water' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extravehicular Activity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraversion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraversion %28%Psychology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extraversions %28%Psychology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extreme Hearing Loss' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremely High Frequency Radio Waves' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremities %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremities, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremities, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremities, Upper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremities/abnormalities %28%1968-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Bones, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Myoclonus, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Myoclonus, Upper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Pareses, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Pareses, Upper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Paresis, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity Paresis, Upper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity, Lower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extremity, Upper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrinsic Allergic Alveolitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrinsic Allergic Alveolitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrinsic Sleep Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrinsic Sleep Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrophies, Bladder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrophy, Bladder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extroversion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extroversion %28%Psychology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extroversions %28%Psychology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrusion, Orthodontic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Extrusion, Tooth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudate, Gingival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudates and Transudates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudates and Transudates %28%1969-1998%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudates, Gingival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudative Bronchiolitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudative Bronchiolitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudative Dermatitis of Swine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudative Enteropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudative Enteropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere. It may occur as a primary disorder or as a complication of or in association with another disease. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye %28%1966-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye %28%1975-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Abnormalities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Abnormality' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Bank' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Banks' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Burn' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Burns' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Cancer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Cancers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Color' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Colors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Disease, Hereditary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1967-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1968-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1976-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases %28%1981-1994%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases or specifics %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases, Hereditary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Diseases/genetics %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Dominance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Drops' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Enucleation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Enucleation %28%1989-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Enucleations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Evisceration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Eviscerations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Fatigue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Foreign Bodies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Foreign Body' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Hemorrhage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Hemorrhages' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infection, Bacterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infection, Fungal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infection, Parasitic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infection, Viral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infections, Bacterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infections, Fungal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infections, Parasitic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Infections, Viral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Injuries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Injuries %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Injuries %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Injuries, Penetrating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Injury' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Injury, Penetrating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Lens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Manifestation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Manifestations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Motility Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Motility Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movement Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movement Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movement, Rapid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movement, Saccadic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements %28%1966-1982%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements %28%1966-1983%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements, Rapid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Movements, Saccadic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Neoplasms %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Neoplasms %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Neoplasms %28%1968-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Neoplasms %28%1968-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Physiology' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Pigment Epithelium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Protective Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Protective Devices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Proteins %28%1973-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Proteins %28%1983-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Proteins %28%1992-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Segment, Anterior' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye Segments, Anterior' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye or specifics %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye, Lazy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye/abnormalities %28%1977-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye/physiology %28%1966-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eye/surgery %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyebright' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyebrow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyebrow Piercings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyebrows' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyeglasses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyeglasses %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelashes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Conditioning' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Conditionings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Diseases %28%1970-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Diseases %28%1976-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Myoclonus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Ptoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid Ptosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelid, Third' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids, Third' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids/abnormalities %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyelids/surgery %28%1966-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyes, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyes, Clear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyes, Lazy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyestrain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Eyrthromycin Ethyl Succinate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F 0 ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F 1 ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F 18, Fludeoxyglucose' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F 18, Fluorodeoxyglucose' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F 2 Toxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F 6066' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Actin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Box Domain Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Box Motifs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Box Protein Family' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Box Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Chemotactic Peptide Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F D %26% C %23%3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Kinase-F-bisphosphatase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Met Leu Phe' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Plasmid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Plasmids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Protein %28%Sendai Virus%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Protein Measles Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F Protein SV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F VIII C' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F VIII vWf' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F VIII-C' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F%28%0%29%F%28%1%29%-ATP Synthase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F%28%1%29%F%28%0%29%-ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F%C3%%A9%nofibrate Debat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F, Prostaglandins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F, Sex Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F, beta-Lactoglobulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-0-ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-1-ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-17, 18, 20-22; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-19; F-17, 18, 20-22 = FLUORINE RADIOISOTOPES %28%IM%29%; if discussed as a trace element, coordinate with TRACE ELEMENTS%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-2 Toxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Box Domain Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Box Motif' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Box Motifs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Box Protein Family' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Box Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Chemotactic Peptide Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Glycoprotein SV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F-Met-Leu-Phe' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F0 ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F0F1 ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1 - BEHAVIOR AND BEHAVIOR MECHANISMS ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1 ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1 alpha, 6-Ketoprostaglandin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1 alpha, 6-Oxoprostaglandin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1-ATPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F11 Glycoprotein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F18, Fluorodeoxyglucose' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1F0 ATPase Complex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F1F0-ATPase, E coli' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2 - PSYCHOLOGICAL PHENOMENA AND PROCESSES ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2 Isoprostane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2 Isoprostanes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2 Toxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2 alpha, 11-Dehydroprostaglandin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2 alpha, Prostaglandin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2-Isoprostane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2-Isoprostanes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2alpha, 11-Dehydroprostaglandin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F2alpha, Prostaglandin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F3 - MENTAL DISORDERS ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F344 Rat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F344 Rat, Inbred' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F344 Rats' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F344 Rats, Inbred' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F4 - BEHAVIORAL DISCIPLINES AND ACTIVITIES ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'F6066' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FACIT Collagen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FACIT Collagens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAD' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAD %28%1966-1970%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAGOPYRUM %26% RHEUM are also available; prefer specific plant; coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY %28%IM%29% + disease/drug ther %28%IM%29% + PLANT PREPARATION or its indentations/ther use %28%IM or NIM%29% + specific plant chemical /ther use %28%IM%29% if pertinent; Manual 26.29%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAIDS' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAK Autokinase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANC Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCA Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCC Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCD1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCD2 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCE Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCF Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCG Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANCL Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FANFT' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAO, United Nations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAPG, Fluocinonide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAPY DNA Glycosylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAPY-DNA Glycosylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FASCIOLOPSIASIS %26% METAGONIMIASIS were see under TREMATODE INFECTIONS 1967-81%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAT %28%Fatty Acid Translocase%29% - CD36 Antigen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FATTY ACIDS which have the first unsaturated bond in the sixth position from the omega carbon. A typical American diet tends to contain substantially more omega-6 than OMEGA-3 FATTY ACIDS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FATTY TUMOR was heading 1963-67 ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FAVRE-RACOUCHOT SYNDROME was heading 1964-96 %28%see under SKIN DISEASES 1964-90%29%; NODULAR ELASTOIDOSIS was see FAVRE-RACOUCHOT SYNDROME 1992-96%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FC 1157a' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FC1157a' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FCCP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FD %26% C Red No. 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FD%26%C Yellow No. 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FDC Red No. 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FDPase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FECV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEEDBACK and FEEDBACK, BIOCHEMICAL are also available ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEF 25 75 Percent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEF 25-75 Percent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEF 25-75 Percents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEN-1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FERTILIZATION, DELAYED %26% FERTILIZATION, POLYSPERMIC were see under FERTILIZATION 1975-84%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FES' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FESTIVALS was see under HOLIDAYS 1963-82 ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEVER BLISTER see HERPES LABIALIS is also available ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FEVt' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FG 9065' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FG9065' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF Receptor Like Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF Receptor-Like Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF-1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF-2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGF2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGFR1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGFR1 Tyrosine Kinase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGFR2 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGFR2b' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGFR2c' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FGFR3 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBRINOKINASE %26% PLASMINOKINASE were see STREPTODORNASE AND STREPTOKINASE 1963-93%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBROCYSTIC BREAST DISEASE is also available ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBROIDS, UTERINE was see UTERINE NEOPLASMS 1991-93 ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow %28%CHOLESTASIS%29% in the intrahepatic or extrahepatic bile ducts %28%BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC%29%. Primary biliary cirrhosis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cirrhosis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBROUS DYSPLASIA OF BONE affecting several or many bones. When associated with melanotic pigmentation of the skin and endocrine disorders, it is known as Albright%27%s syndrome. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIBROUS DYSPLASIA OF BONE involving only one bone. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIGF protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIGLU' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIGLU Test' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIGLU Tests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIK Channel' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FILUM TERMINALE was see under CAUDA EQUINA 1963-78 ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIPV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FISH Technic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FISH Technics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FISH Technique' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FISH Techniques' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FITC' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIVB' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FIXED ACTION PATTERN was see under BEHAVIOR, ANIMAL 1968-78; INNATE BEHAVIOR was see under INSTINCT 1968-78%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK 027' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK 33 824' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK 33824' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK 506' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK 506 Binding Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK 749' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK-33-824' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK-33824' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK-506-Binding Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK-749' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK027' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK33824' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506 Binding Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506 Binding Protein 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506 Binding Protein 1A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506 Binding Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506-Binding Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506-Binding Protein 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FK506-Binding Protein 1A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FKBP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FKBP 12' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FKBP Rotamase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FKBP-12' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FKBP12' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FL 1039' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FL 1060' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FL1039' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FL1060' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLA 870' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLA731' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLA870' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLB 472' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLB472' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLO 1347' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLO1347' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLRG Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLT VEGF Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLT1 RTK' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLT1 Receptor Tyrosine Kinase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FLT4 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FM1 Gene Product' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMC 33297' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMC33297' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMLP Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMN' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMN %28%1966-1970%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMN Oxidoreductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMN Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRF' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRF NH2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRF amide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRF-NH2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRF-amide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRFamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRFamide, %28%D-phenylalanine%29%-Isomer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FMRP Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA Brand of Anthralin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA Brand of Gentian Violet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA Brand of Sulfamethizole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA Brand of Sulfasalazine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA Brand of Sulfisoxazole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA, Dexamethason' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA, Gentiaanviolet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FNA, Sulfamethizol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FO 1561' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FO1561' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FOIA Request' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FOIA Requests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FOLH1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: HOSP RECORDS%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FORMS AND RECORDS CONTROL, also available, is probably NIM when coord; DF: NURS RECORDS%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPG' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPL 59002' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPL 670' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPL59002' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPL670' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPLV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPP FPP Farnesyl Transferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPP Synthetase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FPP-FPP Farnesyl Transferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR 13749' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR 17027' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR 860' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR 900506' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR13749' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR17027' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR860' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FR900506' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRA, Polyox' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRAP %28%Fluorescence Recovery After Photobleaching%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRAPs %28%Fluorescence Recovery After Photobleaching%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRAXA Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRAXE Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRAs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRECKLES was see LENTIGO 1963-79 ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRP 1 Heavy Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRP 1 protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRP-1 Heavy Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRP-1 protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FRP-2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH %28%1966-1973%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH %28%1972-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH %28%Follicle Stimulating Hormone%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH Hypersecretion, Pituitary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH Releasing Hormone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH Releasing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH alpha' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH, Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH, Urinary Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH, alpha Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH, beta Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH, beta Subunit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH, human %28%follicle stimulating hormone%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH-Releasing Hormone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH-Releasing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH-alpha' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSH-beta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSTL1 Gene Product' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FSTL3 Gene Product' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FT 207' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FT207' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FTA ABS Test' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FTA-ABS Test' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FTA-ABS Tests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FTIR' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FTLV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FUCHSINS was FUCHSIN see under ROSANILINE DYES 1963-80 ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FUS Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FUS RNA Binding Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FUS RNA-Binding Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FUSOBACTERIUM is also available; infection: coord IM with GRAM-NEGATIVE BACTERIAL INFECTIONS %28%IM%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FUdR' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fab Fragment Immunoglobulins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fab Fragment, Immunoglobulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fab Fragments' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fab Fragments, Immunoglobulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fab Immunoglobulin Fragments' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faba Bean' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabaceae %28%1978-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabaceae %28%1982-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabaceae %28%1995-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabavirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabaviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabricius Bursa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabrigen Brand of Aciclovir' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabry Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabry%27%s Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fabrys Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face %28%1966-1985%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face Bows, Orthodontic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face Fly' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face Lift' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face Lifts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face Pain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Face/abnormalities %28%1968-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facelift' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facelifts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faces' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facet Joint' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facet Joints' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Asymmetries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Asymmetry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Bone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Bones' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Bones %28%1966-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Bones/abnormalities %28%1969-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Dermatoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Dermatoses %28%1966-1981%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Dermatoses %28%1968-1996%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Dermatosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Expression' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Expressions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Hemiatrophies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Hemiatrophies, Progressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Hemiatrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Hemiatrophy of Romberg' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Hemiatrophy, Progressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Injuries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Injury' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Muscles' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Muscles %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Muscles %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Muscles %28%1966-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Myokymias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neoplasms %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Avulsions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Diseases %28%1981-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Diseases %28%1981-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Injuries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Injury' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Trauma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Nerve Traumas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuralgia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuralgia %28%1966-1985%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuralgias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuritides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathies, Acquired' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathies, Familial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathies, Traumatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Acquired' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Cheilitis Granulomatosa, Orofacial Edema' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Familial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Idiopathic Acute' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Inflammatory, Acute' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Orofacial Edema, Cheilitis Granulomatosa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Neuropathy, Traumatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Pain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Pain Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Pain Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Pain, Neuralgic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Pain, Referred' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Palsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Palsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralyses, Central' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralyses, Herpetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralyses, Idiopathic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralyses, Peripheral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis %28%1965-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis %28%1966-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis, Central' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis, Herpetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis, Idiopathic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Paralysis, Peripheral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Recognition Agnosia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Recognition Agnosias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Spasm, Unilateral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial Spasms, Unilateral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial-Oral Apraxia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facial-Oral Apraxias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilitation, Social' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilitations, Social' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities designed to serve patients who require surgical treatment exceeding the capabilities of usual physician%27%s office yet not of such proportion as to require hospitalization.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities equipped for performing surgery. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities equipped to carry out investigative procedures.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities for collecting and organizing information. They may be specialized by subject field, type of source material, persons served, location, or type of services.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities for the performance of services related to dental treatment but not done directly in the patient%27%s mouth.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities for the preparation and dispensing of drugs.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities having programs intended to promote and maintain a state of physical well-being for optimal performance and health.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities in which war or political prisoners are confined.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities or services which are especially devoted to providing palliative and supportive care to the patient with a terminal illness and to the patient%27%s family.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities provided for human excretion, often with accompanying handwashing facilities.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities providing diagnostic, therapeutic, and palliative services for patients with severe chronic pain. These may be free-standing clinics or hospital-based and serve ambulatory or inpatient populations. The approach is usually multidisciplinary. These clinics are often referred to as %22%acute pain services%22%. %28%From Br Med Bull 1991 Jul;47%28%3%29%:762-85%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities that collect, store, and distribute tissues, e.g., cell lines, microorganisms, blood, sperm, milk, breast tissue, for use by others. Other uses may include transplantation and comparison of diseased tissues in the identification of cancer.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities where dental care is provided to patients. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which administer the delivery of health care services to mothers and children.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which administer the delivery of health care services to people living in a community or neighborhood.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which administer the delivery of mental health counseling services to children.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which administer the delivery of psychologic and psychiatric services to people living in a neighborhood or community.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which provide care for infants. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which provide care for pre-school and school-age children.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which provide information concerning poisons and treatment of poisoning in emergencies.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities which provide programs for rehabilitating the mentally or physically disabled individuals.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Ambulatory Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Assisted Living' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Cancer Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Cardiac Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Extended Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Intermediate Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Parking' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Proprietary Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Public' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Residential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Skilled Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facilities, Toilet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Accesses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Acquisition, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Acquisitions, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Administrator, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Administrators, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Closure, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Closures, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Constructions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Controls' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Conversion, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Conversions, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Design and Construction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Design and Construction %28%1967-1983%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Designs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Environment, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Ethic, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Ethics, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Merger, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Mergers, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Moving, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Planning, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Plannings, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Regulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Regulation and Control' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Regulations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Size, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility Sizes, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Ambulatory Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Assisted Living' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Cancer Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Cardiac Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Extended Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Intermediate Care' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Parking' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Proprietary Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Public' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Residential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Skilled Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facility, Toilet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facioscapulohumeral Atrophies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facioscapulohumeral Atrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facioscapulohumeral Muscular Dystrophies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facioscapulohumeral Muscular Dystrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facioscapulohumeral Type Progressive Muscular Dystrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facsimile Transceivers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facsimile Transmissions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Facteur Thymique Serique' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factitious Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor 3, Platelet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor 4, Platelet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor 54, Sigma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Analyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Analyses, Statistical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Analysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Analysis, Statistical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor B, Complement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor B, Properdin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Ba, Complement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Ba, Properdin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Bb, Complement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Bb, Properdin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Bf, Properdin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor D' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor D, Complement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor D, Properdin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor DP-1, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Elk1, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor F, Sex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor For Inversion Stimulation Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Fs, Sex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor GATA-4, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor GATA1, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor GATA4, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor GATA6, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor H' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor H, Complement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Hemagglutinin, Leukocytosis-Promoting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Hydrolase, Platelet-Activating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor I' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor I, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor II' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor II Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor II Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor II, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor III' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor III, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IIIB, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IV, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX %28%1975-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX Complex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX Fraction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IX, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IXa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor IXa, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Inhibitors, Angiogenesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Maf, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor NF-kB, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor P, Complement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor PAX2, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor PAX7, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Pi' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Receptor, Trophic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor STAT2, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor TFIIIB, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Tu, Elongation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V %28%1974-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor V/genetics %28%1994-1998%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VII %28%1975-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VII Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VII Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VII, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VII, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII %28%1981-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII Clotting Antigen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII Heavy Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII Related Antigen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII, Thrombin Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIII, Thrombin-Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIIIR Ag' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIIIR RCo' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIIIa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIIIa, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIIa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor VIIa, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Va' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Va, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor X' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor X %28%1970-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor X Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor X Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor X, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor X, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XI' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XI %28%1972-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XI Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XI Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XI, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XI, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XII, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII A Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII Transamidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII, Activated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIII, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIIIa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIIa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIIa, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor XIa, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Xa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Xa Inhibitor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor Xa, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor isolated in a variety of tissues including epithelium, and maternal decidua. It is closely related to EPIDERMAL GROWTH FACTOR and binds to the EGF receptor. TGF-alpha acts synergistically with TGF-beta in inducing phenotypic transformation, but its physiological role is unknown.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor promoting eosinophil differentiation and activation in hematopoiesis. It also triggers activated B-cells for a terminal differentiation into Ig-secreting cells.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor that is a coregulator of mast cell growth. It is produced by T-cells and B-cells and shows extensive homology with the Epstein-Barr virus BCRFI gene.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor that is thought to be a regulator of hematopoiesis. It has been shown to enhance the growth of human mast cells and megakaryoblastic leukemic cells as well as murine helper t-cell clones. IL-9 is a glycoprotein with a molecular weight of 32-39 that is derived from T-cells, and maps to human chromosome 5.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor that stimulates the growth and differentiation of human B-cells and is also a growth factor for hybridomas and plasmacytomas. It is produced by many different cells including T-cells, monocytes, and fibroblasts.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, A-Subunit CCAAT-Binding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, ABO' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, ACTH-Releasing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Adipogenesis Inhibitory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Age' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Angiogenesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Angiogenic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Antinuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, B-Subunit CCAAT-Binding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Bacterial Fertility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Bacterial Sex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Bacteriocin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Biologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Biological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Blood Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Brain-Derived Neurotrophic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, C-Subunit CCAAT-Binding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Ciliary Neuronotrophic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Ciliary Neurotrophic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Circulating Thymic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Citrovorum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Col' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Colicin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Confounding %28%Epidemiology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Cord' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Corticotropin-Releasing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Demographic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Differentiation Reversal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Discretionary Adjustment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Duran-Reynals Permeability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Economic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Elongation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Enabling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Epidemiologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Epidemiologic Confounding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, F' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Fletcher' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, GATA-6 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Geographic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Growth Hormone-Releasing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Heparin-Clearing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Hepatocyte Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Hunter Corrective' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Hypothalamic Releasing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, IRF-1 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, IRF-7C Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, ISGF1 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Intrinsic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Lipemia-Clearing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Macroeconomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, MafK Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Meteorologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Meteorological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Microeconomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Milk Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Multiplication-Stimulating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, MyoD' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Myocardial Depressant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, N-Ethylmaleimide-Sensitive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, NFATC1 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, NFATC2 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, NFATC3 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, NFE2 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Neutrophil-Derived Relaxant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Nuclear Trans-Acting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Oct-6 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Phosphodiesterase Activating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Platelet Activating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Platelet-Derived Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Political' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Precipitating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Predisposing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Psychological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Psychosocial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Reinforcing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Resistance Transfer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Rh' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Rheumatoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Rho' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Risk' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, STAT5 Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Scatter' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Serum Thymic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Sex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Sigma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Sigma Initiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Socioeconomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Stable' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Staphylococcal Clumping' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Stringent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Sulfation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Termination Release' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Thymic Circulating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Thymic Serum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Time' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Trans-Acting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Transfer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Transforming Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, Tumor Angiogenic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, alpha-Trans Inducing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor, beta-Nerve Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-4A1, Eukaryotic Initiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-4A2, Eukaryotic Initiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-4A3, Eukaryotic Initiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-4E, Eukaryotic Initiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-6, Octamer Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-Hemagglutinin, Lymphocytosis-Promoting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factor-beta, Glia Maturation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FactorXI, Blood Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors associated with the definitive onset of a disease, illness, accident, behavioral response, or course of action. Usually one factor is more important or more obviously recognizable than others, if several are involved, and one may often be regarded as %22%necessary%22%. Examples include exposure to specific disease; amount or level of an infectious organism, drug, or noxious agent, etc.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors. They also modulate the expression of macrophage cell surface Ia antigens. One MAF is interferon-gamma %28%INTERFERON TYPE II%29%. Other factors antigenically distinct from IFN-gamma have also been identified.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that are involved in directing the cleavage and POLYADENYLATION of the of MESSENGER RNA near the site of the RNA 3%27% POLYADENYLATION SIGNALS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that associate with TATA-BOX BINDING FACTOR. Many of them are components of TRANSCRIPTION FACTOR TFIID%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that bind to RNA POLYMERASE III and aid in transcription. They include the assembly factors TFIIIA and TFIIIC and the initiation factor TFIIIB. All combine to form a preinitiation complex at the promotor that directs the binding of RNA POLYMERASE III.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that can cause or prevent the outcome of interest, are not intermediate variables, and are not associated with the factor%28%s%29% under investigation. They give rise to situations in which the effects of two processes are not separated, or the contribution of causal factors cannot be separated, or the measure of the effect of exposure or risk is distorted because of its association with other factors influencing the outcome of the study.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that form a preinitiation complex at promoters that are specifically transcribed by RNA POLYMERASE I.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that modify the effect of the putative causal factor%28%s%29% under study.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors that utilize energy from the hydrolysis of GTP to GDP for peptide chain elongation. EC 3.6.1.-.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, ABO' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, ATF Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Age' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Antinuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Bacterial Fertility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Bacterial Sex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Bacteriocin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Biologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Biological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Blood Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Bordetella Virulence' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Coagulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Col' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Colicin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Confounding %28%Epidemiology%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Conglutinogen Activating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Cord' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Core Binding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Direct Lytic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Discretionary Adjustment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Enabling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Eosinophil Chemotactic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Epidemiologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Epidemiologic Confounding' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, F' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, GDP Exchange' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, GDP-GTP Reversing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, GTPase-Linked Elongation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Geographic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Guanosinetriphosphatase-Linked Elongation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Hemolysin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Hly' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Immune' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Immunologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Immunologic Suppressor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Immunological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Insulin-Like Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Integration Host' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Lac' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Lactose' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Leukocyte Migration-Inhibition' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Leukocyte Migration-Inhibitory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Lipotropic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Macroeconomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Macrophage Chemotactic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Macrophage-Activating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Meteorologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Meteorological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Microeconomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Myogenic Regulatory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, N-Ethylmaleimide-Sensitive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Natriuretic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Nerve Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Neurite Outgrowth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Neuronotrophic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Neurotrophic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Pathogenicity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Peptide Elongation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Peptide Initiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Peptide Termination' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Political' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Precipitating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Predisposing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Psychological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Psychosocial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, R' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Recombinant Colony-Stimulating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Reinforcing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Resistance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Resistance Transfer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Rh' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Risk' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Sex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Socioeconomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Suppressor T-Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, T Suppressor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, T-Cell Suppressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, T-Suppressor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, TFIII Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Time' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Trans-Acting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Transcription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Transforming Growth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factors, Virulence' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Data Bank' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Data Banks' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Data Base' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Data Bases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Databank' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Databanks' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Database' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Factual Databases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculties' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculties, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculties, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculties, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculties, Pharmacy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty Practice, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty Practices, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty, Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faculty, Nursing %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fad, Diet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fad, Food' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fadrozole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fadrozole Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fads, Diet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fads, Food' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faes Brand of Barbital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faes Brand of Calcifediol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faes Brand of Ethosuximide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faes Brand of Naftidrofuryl Oxalate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faes Brand of Roxithromycin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faes, Etosuximida' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagaceae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagara boninensis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagara horrida' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagara rhetza' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagara xanthoxyloides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagara zanthoxyloides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagopyrum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fagus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failing to prevent death from natural causes, for reasons of mercy by the withdrawal or withholding of life-prolonging treatment.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure Analyses, Equipment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure Analyses, Materials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure Analyses, Prosthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure Analysis, Equipment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure Analysis, Materials' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure Analysis, Prosthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure of a professional person, a physician or lawyer, to render proper services through reprehensible ignorance or negligence or through criminal intent, especially when injury or loss follows. %28%Random House Unabridged Dictionary, 2d ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure of equipment to perform up to standards. The failure may be due to defects or improper use.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure of the PLACENTA to deliver an adequate supply of nutrients and OXYGEN to the FETUS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure of the UTERUS to contract with normal strength, duration, and intervals during childbirth %28%LABOR, OBSTETRIC%29%. It is also called uterine atony.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure of the soft palate to reach the posterior pharyngeal wall. It may be caused by cleft palate surgery, palatal or pharyngeal abnormalities or injury, or neuromuscular dysfunction of the velopharyngeal sphincter. It causes hypernasality of speech.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure or imperfection of vision at night or in dim light, with good vision only on bright days. %28%Dorland, 27th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure to Thrive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. %28%Stedman, 25th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Abortion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Acute Hepatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Acute Liver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Congestive Heart' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Dental Prosthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Dental Restoration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Equipment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Kidney' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Medical Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Multiple Organ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Progressive Autonomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Prosthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Renal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failure, Treatment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Abortion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Dental Prosthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Dental Restoration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Equipment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Kidney' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Medical Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Progressive Autonomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Prosthesis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Renal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Failures, Treatment' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faint, Neurally Mediated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fainting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faints, Neurally Mediated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fair, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fairs, Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fairy Shrimp' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faith Healing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falciparum Malaria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falconiformes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fali Cor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falisan Nassbeize' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FalisanNassbeize' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falk Brand of Chenodeoxycholic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falk Brand of Mesalamine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falk Brand of Ursodeoxycholic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falkland Islands' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fall Crocus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fall, Accidental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallacies, Ecological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallacy, Ecological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopia japonica' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Cancers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Diseases/surgery %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Patency Tests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tube Reanastomoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tubes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tubes %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tubes %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tubes %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tubes %28%1985-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallopian Tubes/surgery %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallot Tetralogy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallot Trilogy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallot%27%s Tetralogy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallot%27%s Trilogy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallots Tetralogy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallots Trilogy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallout, Radioactive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fallouts, Radioactive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falls due to slipping or tripping which result in injury.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Falls, Accidental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Allegation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Aneurysm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Aneurysms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Killer Whale' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Killer Whales' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Memory Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Negative Reaction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Negative Reactions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Positive Reaction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Positive Reactions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'False Smilacina' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Acoustic Neuroma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Adenomatous Polyposis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Adenomatous Polyposis Coli' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Neuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Neuropathy, Andrade Type' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Polyneuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Polyneuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Polyneuropathy, Type I' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Polyneuropathy, Type II' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloid Polyneuropathy, Type III' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloidoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Amyloidosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Ataxia, Friedreich' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Ataxia, Friedreich%27%s' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Atypical Multiple Mole Melanoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Benign Chronic Pemphigus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Benign Neonatal Convulsions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Benign Neonatal Epilepsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Cerebello Retinal Angiomatosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Cerebello-Retinal Angiomatoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Cerebello-Retinal Angiomatosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Cerebelloretinal Angiomatoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Cerebelloretinal Angiomatosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Cerebral Amyloid Angiopathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Combined Hyperlipidemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Combined Hyperlipidemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Creutzfeldt Jakob Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Creutzfeldt-Jakob Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Creutzfeldt-Jakob Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dandy-Walker Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dementias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dysalbuminemic Hyperthyroxinemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dysautonomia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dystonia, Autosomal Dominant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dystonia, Autosomal Recessive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dystonias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Dystonias, Idiopathic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Endocrine Adenomatoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Endocrine Adenomatosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Exostoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Exostosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Facial Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Form of Canavan Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hemiplegic Migraine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hemiplegic Migraines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hemophagocytic Lymphocytoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hemophagocytic Lymphohistiocytoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hemophagocytic Lymphohistiocytosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial High Density Lipoprotein Deficiency Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial High-Density Lipoprotein Deficiency Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypercholesterolemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypercholesterolemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hyperchylomicronemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hyperchylomicronemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hyperkalemic Periodic Paralysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hyperlysinemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hyperlysinemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypertriglyceridemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypertriglyceridemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypertrophic Cardiomyopathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypertrophic Cardiomyopathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypoalphalipoproteinemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypoalphalipoproteinemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypokalemic Periodic Paralysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypophosphatemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Hypophosphatemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Idiocies, Amaurotic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Idiocy, Amaurotic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Idiopathic Cardiomyopathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Idiopathic Cardiomyopathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Lipoprotein Lipase Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Mediterranean Fever' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Metabolic Brain Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Metabolic Disorders, Brain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Nephritides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Nephritis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Olivopontocerebellar Atrophies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Parkinson Disease, Autosomal Recessive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Partial Lipodystrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Pemphigus, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Periodic Paralyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Periodic Paralysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Polyneuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Polyneuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Polyposis Coli' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Polyposis Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Retinoblastomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Spinocerebellar Degeneration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Spinocerebellar Degenerations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Tonic Clonic Epilepsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Tonic-Clonic Epilepsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Tonic-Clonic Epilepsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Tremors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Ventricular Hypertrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Xanthomatoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial Xanthomatosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial alpha Lipoprotein Deficiency Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial alpha-Lipoprotein Deficiency Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Familial disorder characterized by hypophosphatemia associated with decreased renal tubular reabsorption of inorganic phosphorus. It is sometimes associated with osteomalacia or rickets which do not respond to the usual doses of vitamin D.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Alu' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Extended' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Multigene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, One Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, One-Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Reconstituted' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Single Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Families, Single-Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1965-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1966%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1966-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1966-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1974-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family %28%1988-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Allowance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Caregiver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Centered Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Characteristic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Characteristics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Characteristics %28%1968-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Demographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Health' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Health %28%1991-2000%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Leave' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Life Cycle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Life Survey' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Member' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Nursings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Patient Lodging' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Physician' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Physicians' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning %28%1968-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning %28%1968-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning %28%1983-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Center' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Instructor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Policies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Policy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Program' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Service' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning Services' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Planning, Natural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Policies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Practice' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Practice %28%1966%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Practice %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Practices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Reconstitutions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Relation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Relations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Relationship' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Relationship, Professional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Relationships' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Relationships, Professional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Sizes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Sizes, Average' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Sizes, Completed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Sizes, Desired' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Sizes, Expected' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Sizes, Ideal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Therapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family Trees' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family in the order COLUMBIFORMES, comprised of pigeons or doves. They are BIRDS with short legs, stout bodies, small heads, and slender bills. Some sources call the smaller species doves and the larger pigeons, but the names are interchangeable.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of INSECT VIRUSES containing two subfamilies: Eubaculovirinae %28%occluded baculoviruses%29% and Nudibaculovirinae %28%nonoccluded baculoviruses%29%. The Eubaculovirinae, which contain polyhedron-shaped inclusion bodies, have two genera: NUCLEOPOLYHEDROVIRUS and GRANULOVIRUS. Baculovirus vectors are used for expression of foreign genes in insects.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of MITES in the superfamily Trombiculoidea, suborder Prostigmata, which attack humans and other vertebrates, causing DERMATITIS and severe allergic reactions. Chiggers, red bugs, and harvest mites commonly refer to the larval stage of Trombiculid mites, the only parasitic stage of the mite%27%s life cycle.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of MITES, in the superfamily Acaroidea, order Astigmata. They are frequently found in cereal-based foodstuffs including GRAIN and FLOUR.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of MITES, in the superfamily Sarcoptoidea, order Astigmata. They are slow moving, obligate PARASITES that infect MAMMALS and BIRDS. The species SARCOPTIDAE SCABIEI causes SCABIES.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: DELTARETROVIRUS; LENTIVIRUS; RETROVIRUSES TYPE B, MAMMALIAN; ALPHARETROVIRUS; GAMMARETROVIRUS; RETROVIRUSES TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state %28%PROVIRUSES%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of antimicrobial peptides that have been identified in humans, animals, and plants. They are thought to play a role in host defenses against infections, inflammation, wound repair, and acquired immunity.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of archaeal viruses with a single genus: Sulfolobus SNDV-like Viruses.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of calcium- and phospholipid-binding proteins which are structurally related and exhibit immunological cross-reactivity. Each member contains four homologous 70-kDa repeats. The annexins are differentially distributed in vertebrate tissues %28%and lower eukaryotes%29% and appear to be involved in MEMBRANE FUSION and SIGNAL TRANSDUCTION.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of cell adhesion molecules consisting of a lectin-like domain, an epidermal growth factor-like domain, and a variable number of domains that encode proteins homologous to complement-binding proteins. Selectins mediate the binding of leukocytes to the vascular endothelium. %28%From Dorland, 28th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of enveloped, lipid-containing filamentous DNA viruses that infect ARCHAEA.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of genes originally isolated from the Susan McDonough strain of feline sarcoma virus %28%SARCOMA VIRUSES, FELINE%29%. The proto-oncogene fms %28%c-fms%29% codes for the MCSF receptor %28%RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR%29%. The oncogene fms %28%v-fms%29% codes for ONCOGENE PROTEIN GP140%28%V-FMS%29% which is a mutated form of the MCSF. The human c-fms gene is located between 5q33.2 and 5q33.3.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of gram-positive, facultatively anaerobic bacteria, in the order Bacillales. Genera include Gemella, Macrococcus, Salinicoccus, and STAPHYLOCOCCUS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of house dust mites, in the superfamily Analgoidea, order Astigmata. They include the genera Dermatophagoides and Euroglyphus.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of large marine CRUSTACEA, in the order DECAPODA. These are called clawed lobsters because they bear pincers on the first three pairs of legs. The American lobster and Cape lobster in the genus Homarus are commonly used for food.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of parasitic MITES, in the superfamily Sarcoptoidea, order Astigmata. Genera include Psoroptes and Chorioptes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of proteins associated with the capacity of LEUKOCYTES to adhere to each other and to certain substrata, e.g., the C3bi component of complement. Members of this family are the LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; %28%LFA-1%29%, the MACROPHAGE-1 ANTIGEN; %28%Mac-1%29%, and the INTEGRIN ALPHAXBETA2 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited LEUKOCYTE-ADHESION DEFICIENCY SYNDROME, which is characterized by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of retrovirus-associated DNA sequences %28%myc%29% originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc %28%c-myc%29% codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of retrovirus-associated DNA sequences %28%ras%29% originally isolated from Harvey %28%H-ras, Ha-ras, rasH%29% and Kirsten %28%K-ras, Ki-ras, rasK%29% murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of retrovirus-associated DNA sequences %28%v-rel%29% originally isolated from an avian reticuloendotheliosis virus strain. The proto-oncogene rel %28%c-rel%29% codes for a subcellular %28%nuclear and cytoplasmic%29% transcription factor that has a role in lymphocyte differentiation. Translocation or overexpression of c-rel or competition from v-rel causes oncogenesis. The human rel gene is located at 2p12-13 on the short arm of chromosome 2.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of rod-shaped DNA viruses infecting ARCHAEA. They lack viral envelopes or lipids.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of small, surface-dwelling fish that inhabit fresh and brackish waters, and coastal marine areas.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of spider MITES, in the superfamily Tetranychoidea, suborder Trombidiformes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family of the suborder HAPLORHINI %28%Anthropoidea%29% comprising bipedal primate MAMMALS. It includes modern man %28%HOMO SAPIENS%29% and the great apes: gorillas %28%GORILLA GORILLA%29%, chimpanzees %28%PAN PANISCUS and PAN TROGLODYTES%29%, and orangutans %28%PONGO PYGMAEUS%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Alu' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Chaperonin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Extended' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Gq-G11 G-Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Leu-CAM Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Multigene' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, One Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, One-Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Single Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, Single-Parent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, TIE Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, hsp10' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family, hsp60' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family-Centered Nursing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family-Centered Nursings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Family-Patient Lodgings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Famines' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Famotidine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Famous Person' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Famous Persons' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fampridine SR' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fampridine-SR' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia %28%1992-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group A Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group C Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group D1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group D2 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group E Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group F Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group G Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group L Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Complementation Group Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group A Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group A Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group C Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group C Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group D1 Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group D1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group D2 Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group D2 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group E Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group E Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group F Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group F Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group G Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group G Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group L Complementing Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Group L Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemia Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Anemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fanconi%27%s Anemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fangfeng' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fantasies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fantasy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far East' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far Eastern Russian Encephalitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far Go' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far Western Blot' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far Western Blotting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far-Western Blots' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far-Western Blotting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Far-Western Blottings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FarGo' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fardi Brand of Buphenine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farm Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farma Lepori Brand of Benzydamine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farma Lepori Brand of Nicardipine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farma Lepori Brand of Trazodone Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmacusi Brand of Bumetanide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmalider Brand of Dimenhydrinate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmamed Brand of Chymopapain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasa Brand of Mesalamine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasa Brand of Ursodeoxycholic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasan Brand of Acetylcysteine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasan Brand of Ambroxol Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasan Brand of Dihydroergotamine Mesylate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasierra Brand of Cefoperazone Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasierra Brand of Chlorpropamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasierra Brand of Gemfibrozil' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasierra Brand of Mefenamic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmasierra Brand of Tinidazole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmaya, Capsicum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmer Lung' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmer%27%s Lung' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmer%27%s Lung %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmer%27%s Lungs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmers Lung' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmistin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmorubicin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farmorubicine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesol %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesol %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Diphosphate Farnesyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Diphosphate Geranylgeranyl Diphosphate Synthase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Diphosphate Synthase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Diphosphate Synthetase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Diphosphate-Geranylgeranyl Diphosphate Synthase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Pyrophosphate Synthetase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl Transferase, FPP-FPP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyl-Diphosphate Farnesyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesylacetate, Geranyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesylation, Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyldiphosphate Farnesyldiphosphate Farnesyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyldiphosphate-Farnesyldiphosphate Farnesyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesylpyrophosphate Synthetase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyltransferase, Farnesyl-Diphosphate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyltransferase, Farnesyldiphosphate-Farnesyldiphosphate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farnesyltranstransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farr Assay' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Farsightedness' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia %28%1969-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia Dentata' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia Lata' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia Latas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia, Dentate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascia, Superficial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascicular Blocks' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculata, Adrenal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculata, Zona' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation %28%1985-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation %28%1995-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation Cramp Syndrome, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation, Muscular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation, Neural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation-Cramp Syndrome, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculation-Cramp Syndromes, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculations, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculations, Muscular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculations, Neural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculations, Skeletal Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculations, Tongue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciculus, Perforating' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitides, Necrotizing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis %28%1980-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis %28%1981-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis, Chronic Plantar' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis, Necrotizing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis, Plantar' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciitis, Plantar, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciola' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciola hepatica' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascioletta ilocanum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascioliases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascioliasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciolidae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascioloidiases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascioloidiasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasciolopsiases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascitides, Necrotizing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fascitis, Necrotizing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasigin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasigyne' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Atom Bombardment Mass Spectrometry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Atom Bombardment Mass Spectroscopy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Electron' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Neutron' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Neutrons' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Neutrons %28%1971-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast Wave Sleep' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast-Twitch Muscle Fiber' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast-Twitch Muscle Fibers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fast-Wave Sleep' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fastening devices composed of steel-tantalum alloys used to close operative wounds, especially of the skin, which minimizes infection by not introducing a foreign body that would connect external and internal regions of the body. %28%From Segen, Current Med Talk, 1995%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fastigii, Nucleus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fasygin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Bodies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Body' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Cell' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Cells' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Distribution, Body' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Embolism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Embolisms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Emulsions, Intravenous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Necroses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Necrosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Patterning, Body' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Restricted Diet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Substitute' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat Substitutes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Abdominal Subcutaneous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Abdominal Visceral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Brown' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Dietary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Intra Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Intra-Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Retroperitoneal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Subcutaneous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Unsaturated Dietary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat, Visceral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat-Free Diet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat-Free Diets' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat-Restricted Diet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat-Restricted Diets' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fat-storing cells found mostly in the abdominal cavity and subcutaneous tissue. Fat is usually stored in the form of TRYGLYCERIDES.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatal Familial Insomnia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatal Familial Insomnias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatal Outcome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatal Outcomes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father Child Relations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father Child Relationship' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father, Unmarried' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father-Child Relation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father-Child Relations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father-Child Relations %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father-Child Relationship' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Father-Child Relationships' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fathers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fathers, Unmarried' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue %28%1966-1994%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue %28%1977-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Disorder, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Disorders, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Fracture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Fractures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Syndrome, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Syndrome, Postviral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Syndromes, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue Syndromes, Postviral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue arising in consequence of mental effort. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Auditory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Eye' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Mental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Muscular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue, Voice' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue-Fibromyalgia Syndrome, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigue-Fibromyalgia Syndromes, Chronic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigues, Auditory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatigues, Voice' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatol Brand of Dapsone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatol Brand of Ethambutol Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatol Brand of Prothionamide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatol Brand of Streptomycin Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatol Brand of Terbutaline Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats containing one or more double bonds, as from oleic acid, an unsaturated fatty acid.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Abdominal Subcutaneous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Abdominal Visceral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Dietary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Intra-Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Retroperitoneal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Subcutaneous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Unsaturated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Unsaturated Dietary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fats, Visceral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Acyl CoA Oxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Acyl-CoA Oxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Protein, Cardiac Myocyte' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Protein, Myocardial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Adipocyte Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Brain Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Cytosolic Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Intestinal Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Liver Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Myocardial Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Binding Proteins, Plasma Membrane Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Cyclo Oxygenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Cyclo-Oxygenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Delta 6 Desaturase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Delta-6-Desaturase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturases %28%1974-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturases %28%1977-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturases %28%1980-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturases %28%1982-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturases %28%1988-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Desaturating Enzymes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Hydroperoxides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Omega Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Omega-Hydroxylase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Synthase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Synthetase Complex' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Transport Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid Transport Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid-Binding Protein, Cardiac Myocyte' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid-Binding Protein, Myocardial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid-Binding Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acid-Transport Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1965-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1966-1970%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1966-1973%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1968-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1969-1973%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1969-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1970-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids %28%1971-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Essential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Essential %28%1966%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Essential %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Essential %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Free' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Monounsaturated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, N-6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Nonesterified' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Nonesterified %28%1968-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Omega 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Omega 6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Omega-3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Omega-6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Polyunsaturated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Short Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Short-Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Trans' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1973-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1973-1985%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1973-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1973-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1975-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1980-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Unsaturated %28%1981-1983%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, Volatile' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids, n-3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acids/BI %28%1966-1970%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl CoA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl CoA Sphingosine Acyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl CoA Oxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl Coenzyme A Oxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl Coenzyme A Retinol Acyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl Coenzyme A-Retinol Acyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl Thioesterase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl-CoA - Sphingosine Acyltransferase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl-CoA Oxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Acyl-Coenzyme A Oxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Alcohols' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Alcohols %28%1972-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Alcohols %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Alcohols %28%1975-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Liver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Liver %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Liver, Alcoholic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Rats, Otsuka-Long-Evans-Tokushima' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Streaks, Arterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Tissue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Tissues' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty Tumors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty acids which are unsaturated in only one position.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty acyl CoA Dehydrogenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty tissue in the region of the ABDOMEN. It includes the ABDOMINAL SUBCUTANEOUS FAT and the INTRA-ABDOMINAL FAT.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty tissue under the SKIN in the region of the ABDOMEN.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty tissue under the SKIN through out the body. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty-Acyl-CoA Hydrolase, Long-Chain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty-Acyltransferase, Retinol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fatty-acyl CoA Dehydrogenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Altretamine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Dextromoramide Tartrate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Enoxacin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Gemfibrozil' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Minocycline Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Moclobemide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Sodium Nitroprusside' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Testosterone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faulding Brand of Vinblastine Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fava Bean' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Faverin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Favism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Favisms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Favre Racouchot Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Favus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fawns %26% McAllan Brand of Allopurinol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fawns %26% McAllan Brand of Amorbarbital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fawns %26% McAllan Brand of Prednisone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fawns %26% McAllan Brand of Quinidine Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fawns %26% McAllan Brand of Quinine Bisulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fawns %26% McAllan Brand of Quinine Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fax' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fazio Londe Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Fragment Immunoglobulins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Fragment, Immunoglobulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Fragments' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Fragments, Immunoglobulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Immunoglobulins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Receptors, epsilon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc Receptors, gamma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc epsilon Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc gamma RI' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc gamma RII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc gamma RIII' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fc gamma Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FdUMP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fe Superoxide Dismutase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fe Zn Superoxide Dismutase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fe-52, 53, 55, 59-61; NIM; /blood-csf-urine /metab permitted but not for tracer studies %28% = /diag use%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fe-54, 57, 58; NIM ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fe-56; Fe%28%II%29% = FERROUS COMPOUNDS, Fe%28%III%29% = FERRIC COMPOUNDS; /defic: permitted but consider ANEMIA, IRON DEFICIENCY; pneumoconiosis caused by iron particles = SIDEROSIS; /metab: consider also IRON OVERLOAD; metabolic disorders = IRON METABOLISM DISORDERS%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fe-Superoxide Dismutase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FeLV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'FeMo Cofactor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fear %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fear %28%1966-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fear %28%1978-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fear, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fears' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fears, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feasibility Studies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feasibility Study' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feather' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feathers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febena Brand of Naphazoline Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Convulsion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Convulsion Seizure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Convulsion Seizures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Convulsions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Fit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Fits' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Seizure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Febrile Seizures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecal Impaction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecal Incontinence' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecal Incontinence %28%1978-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecal Incontinences' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecalith' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feces' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feces %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feces %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecundability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fecundity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Aids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Government' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Health Insurance Plans, United States' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Hospitals' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Republic of Germany' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Trade Commission' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal Trade Commission %28%U.S.%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigent and medically indigent persons.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance %28%MEDICARE PART A%29% and supplementary medical insurance %28%MEDICARE PART B%29%. %28%Hospital Administration Terminology, AHA, 2d ed and A Discursive Dictionary of Health Care, US House of Representatives, 1976%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federal, state, or local government organized methods of financial assistance.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Federation of Malaya' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee Schedule' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee Schedules' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee Schedules %28%1988-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee for Service' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee for Service Plans' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee for Service, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee for Services' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Capitation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Dispensing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Pharmaceutic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Pharmaceutical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Pharmacy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee, Prescription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee-for-Service Plan' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee-for-Service Plans' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee-for-Service Reimbursement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee-for-Service Reimbursements' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fee-for-Services, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feed, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback %28%1964-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback %28%1965-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback Inhibition, Biochemical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback Regulation, Biochemical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback Stimulation, Biochemical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback, Biochemical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback, Biochemical Positive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback, Psychological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback, Psychophysiologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedback, Psychophysiological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Behavior' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Behavior %28%1969-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Behaviors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Method' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Methods' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Pattern' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Tube, Gastric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding Tubes, Gastric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding and Eating Disorders of Childhood' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Artificial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Bottle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Breast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Complementary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Enteral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Force' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Home Parenteral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Intravenous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Parenteral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Supplementary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeding, Tube' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedings, Bottle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedings, Complementary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedings, Force' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedings, Intravenous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedings, Parenteral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feedings, Supplementary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeds, Animal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeling' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feeling or emotion of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feer Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feer%27%s Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feers Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees and Charges' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees and Charges %28%1967-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees and Charges %28%1968-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees for Service' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees for Services' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Capitation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Dispensing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Medical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Medical %28%1969-1994%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Medical %28%1972-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Medical %28%1986-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Pharmaceutic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Pharmaceutical' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Pharmaceutical %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Pharmacy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fees, Prescription' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet Bone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet Bones' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet, Diabetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet, Flat' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet, Immersion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feet, Trench' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feigning, Death' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feignings, Death' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feijoa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feldsher' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felidae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline AIDS' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Acquired Immune Deficiency Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Acquired Immuno Deficiency Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Acquired Immuno-Deficiency Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Acquired Immunodeficiency Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Agranulocytoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Agranulocytosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Ataxia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Ataxias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Coronavirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Coronaviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Distemper' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Distempers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Enteric Coronavirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Enteric Coronaviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Immunodeficiency Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Immunodeficiency Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Infectious Enteritides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Infectious Enteritis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Infectious Enteritis Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Infectious Peritonitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Infectious Peritonitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Lentivirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Lentiviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Leukemia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Leukemia Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Leukemias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Lymphoma Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Lymphoma Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Panleukopenia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Panleukopenias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Parvoviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Proto Oncogene Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Proto-Oncogene Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Virus, Gardner Arnstein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Virus, Gardner-Arnstein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Virus, Hardy Zuckerman' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Virus, Hardy-Zuckerman' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Virus, Snyder Theilen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Virus, Snyder-Theilen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Sarcoma Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Syncytium Forming Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Syncytium-Forming Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline Syncytium-Forming Viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline T Lymphotropic Lentivirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline T Lymphotropic Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline T-Lymphotropic Lentivirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline T-Lymphotropic Virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline calicivirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline leukemia virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline panleukopenia virus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline panleukopenia viruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feline parvovirus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felis catus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felis concolor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felis domestica' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felis domesticus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felis sylvestris catus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fellowship' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fellowships and Scholarships' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felo Puren' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felodipin ratiopharm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felodipine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felty Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felty%27%s Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feltys Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Felypressin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Adolescent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Adolescents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Circumcision' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Circumcisions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Condom' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Condoms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Contraceptions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Contraceptive Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Contraceptive Device' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Contraceptive Devices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Contraceptives' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Fertility Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Diseases and Pregnancy Complications' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Organs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Tuberculoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genital Tuberculosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Genitalia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Homosexuality' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Infertility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Infertility Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Infertility Drugs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Inhibin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Inhibins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Pseudo Turner Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Pseudo-Turner Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Sterility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Sterilizations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female Sterilizations, Voluntary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female dentists. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova %28%OVUM%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Female parents, human or animal. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Females' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femavit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feminism' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feminist Ethic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feminization' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feminizations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Arteries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Artery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Fracture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Fractures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Fractures %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Head Prostheses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Hernia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Hernias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Mononeuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Mononeuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neck Fracture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neck Fractures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neck Fractures %28%1966-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Nerve %28%1966-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Nerve Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Nerve Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Nerves' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Neuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Vein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femoral Veins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Head' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Head %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Head Necroses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Head Necrosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Head Necrosis %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Heads' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Neck' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Neck Fracture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Neck Fractures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femur Necks' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Femurs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fen1 Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenazoxine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenbendazole' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenclonin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenclonine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fendilin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fendiline' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenelzin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenestra of the cochlea; an opening in the medial wall of the middle ear leading into the cochlea.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenestra of the vestibule; an oval opening in the medial wall of the middle ear leading into the vestibule. Normally it is covered by the base of the stapes.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenestration, Labyrinth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenestrations, Labyrinth' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenfluramine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenfluramine %28%1986-1998%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenfluramine Hydrochloride, R Isomer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenfluramine, R Isomer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenformin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenilprenazone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenitoin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenitrothion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenmetrazin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fennel, Dog' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fennel, Wild' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenofibrat FPh' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenofibrat ratiopharm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenofibrate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoldopam' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoperidine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoprofen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoprofen Dihydrate, Calcium Salt' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoterol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoximone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenoxymethylpenicillin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenretinide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenretinide, 13 cis Isomer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenretinimide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fentanyl' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fentanyl/analogs %26% derivatives %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fentanyl/analogs %26% derivatives %28%1979-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenthion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fentolamin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fenugreek' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fepalitan' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feparil' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feprazone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fer de Lance' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fer-de-Lances' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feral Pigeon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feral Pigeons' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feresa attenuata' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermentation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermentations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermented Milk Product' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermented Milk Products' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermented juice of fresh grapes or of other fruit or plant products used as a beverage.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fermium. A man-made radioactive actinide with atomic symbol Fm, atomic number 100, and atomic weight 257. Its known isotopes range from 244-254 and 256-258. Its valence can be +2 or +3. Like einsteinium, it was discovered in 1952 in the debris from a thermonuclear explosion.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern Tests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Bracken' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Brake' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Calaguala' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Giant Holly' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Licorice' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Male' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Rainbow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fern, Sweet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferndale Brand of Aminophylline' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferns' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin NADP Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin Nitrite Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin Oxidoreductase, Pyruvate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin Sulfite Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin-NADP Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxin-Nitrite Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxins %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxins %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxins %28%1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferredoxins %28%1977-1991%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrer Brand of Doxorubicin Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrer Brand of Etoposide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrer Brand of Fluorouracil' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrer Brand of Fosinopril Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrer Brand of Gemfibrozil' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferret' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrets' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferric Compounds' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferric Compounds %28%1975-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferric Oxalate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrichrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferricyanides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferricyanides %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferricytochrome b5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferricytochrome c' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferricytochrome c%27%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferridextran' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferriferrous Oxide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferriheme Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrihemoglobin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrihemoprotein P 450 Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrihemoprotein P-450 Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrihemoprotein P450 Reductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrimyoglobin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring Brand of Human Growth Hormone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring Brand of Menotropins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring Brand of Mesalamine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring Brand of Prednisone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring Brand of Testosterone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring Brand of Testosterone Propionate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferring, Desmopressine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferriprotoporphyrin IX Chloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferritin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferritin Repressor Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferro-Lyase, Protoheme' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrochelatase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocyanide Reaction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocyanide Reactions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocyanides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocyanides %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocytochrome a3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocytochrome c' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocytochrome c Oxygen Oxidoreductase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrocytochrome c2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferroprotoporphyrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrosoferric Oxide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrous Compounds' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferroxidase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferroxidase, Ceruloplasmin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferrozine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertile Period' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility %28%1971-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Agents %28%1973-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Agents, Female' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Agents, Female, Synthetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Agents, Male' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Agents, Male, Synthetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Control' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Control, Immunological' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Control, Involuntary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Control, Postcoital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Determinant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Drugs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Factor, Bacterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Factors, Bacterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Incentive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Preference' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Rate, Age-Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Rates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Rates, Age-Specific' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Survey, World' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility Surveys, World' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility, Differential' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility, Marital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility, Natural' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertility/drug effects %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization Inhibition' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization in Vitro' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization in Vitro %28%1985-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization in Vitro %28%1988-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization in Vitro %28%1989-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization in Vitro %28%1994-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilization, Test-Tube' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilizations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilizations in Vitro' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilizations, Delayed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilizations, Polyspermic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilizations, Test-Tube' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilized Egg' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilized Eggs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilized Ovum' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fertilizers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ferula harmonis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festinating Gait' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festschrift' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festschrift %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festschrift %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festschriften' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festschriften %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Festuca' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Activities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Activity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Age' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Ages' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Alcohol Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Alcohol Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Blood' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Bloods' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Body Weight' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Body Weights' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Circulation, Persistent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Death' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Death %28%1965-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Death %28%1966-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Death %28%1966-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Deaths' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Development' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Development %28%1994-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases %28%1965-1981%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases %28%1982-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Diseases/diagnosis %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Distress' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Edema' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Erythroblastoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Erythroblastosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Experimentation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Growth Retardation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Hair' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Hairs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Heart' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Heart %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Heart %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Heart %28%1969-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Heart Rate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Heart Rates' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Hearts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Hemoglobin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Hydrops' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Hypoxia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Immunities, Maternally-Acquired' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Immunity, Maternally Acquired' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Liver Kinase 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Liver Kinase 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Liver Kinase 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Liver Kinase-1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Liver Kinase-2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Liver Kinase-3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Macrosomia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Macrosomias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Malpresentations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Maturity, Chronologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Maturity, Functional' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Membrane' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Membranes %28%1965-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Membranes %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Membranes %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Membranes, Premature Rupture' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Membranes, Premature Rupture %28%1975-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Monitoring' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Monitoring %28%1978-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Monitorings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Mortalities' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Mortalities, Late' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Mortality' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Mortality, Late' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Movement' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Movements' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Nutrition Disorder' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Nutrition Disorders' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Organ Maturity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Placental Circulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Presentation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Presentation, Breech' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Proteins %28%1970-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Proteins %28%1999-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Reduction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Reductions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Research' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Resorption' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Resorptions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Status, Nonreassuring' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Structure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Terminations, Selective' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Therapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Tissue Donations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Tissue Grafting' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Tissue Graftings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Tissue Transplantation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Tissue Transplantations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Tissues' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Toxoplasmoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Toxoplasmosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Transfusion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Transfusions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Version' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Versions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Viability' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Weight' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal Weights' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal and neonatal addiction and withdrawal as a result of the mother%27%s dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal-Placental Circulation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetal-Placental Circulations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetali, Erythroblastosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetalis, Erythroblastosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetanol' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetishism %28%Psychiatric%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetishism, Transvestic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetishisms %28%Psychiatric%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetishisms, Transvestic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetofetal Transfusion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetofetal Transfusions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetomaternal Hemorrhage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetomaternal Hemorrhages' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetomaternal Transfusion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetomaternal Transfusions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetomaternal Transmission' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoplacental Circulations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoplacental Function Test' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoplacental Function Tests' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscope' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopic Surgeries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopic Surgery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopic Surgical Procedure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetoscopy/instrumentation %28%1977-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetuin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetuins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1965-1999%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1965-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1966-1980%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1968-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus %28%1968-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus, Aborted' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus, Harlequin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus/PH %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetus/physiology %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetuses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fetuses, Aborted' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevarin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever %28%1966-1970%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever %28%1966-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Blister' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Blisters' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Convulsion' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Convulsions' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Seizure' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Seizures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Vaccine, Yellow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Virus, Breakbone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever Viruses, Breakbone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever in which the etiology cannot be ascertained. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever of Unknown Origin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, American Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Animal Milk' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Argentinian Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Black Water' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Blackwater' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Bolivian Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Boutonneuse' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Colorado Tick' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Crimean Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Dengue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, East Coast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Enteric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Ephemeral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Familial Mediterranean' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Fog' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Glandular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Hay' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Lassa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Malta' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Marsh' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Mediterranean Spotted' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Omsk Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Oroya' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Paratyphoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Pharyngo-Conjunctival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Q' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Rat-Bite' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Ratbite' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Relapsing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Remittent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Rheumatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Rift Valley' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Scarlet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Shipping' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Show' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Swamp' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Trench' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Tsutsugamushi' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Typhoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Undulant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Uveoparotid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Viral Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fever, Yellow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Feverfew' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Black Water' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Blackwater' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Boutonneuse' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Crimean Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Enteric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Lassa' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Paratyphoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Q' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Rat-Bite' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Ratbite' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Relapsing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Rheumatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Scarlet' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Show' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Swamp' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Trench' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Tsutsugamushi' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Typhoid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Undulant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Uveoparotid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Viral Hemorrhagic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fevers, Yellow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fher Brand of Bromhexine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fher Brand of Etilefrine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber Optic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber Optics' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Adrenergic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Cholinergic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Cotton' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Dietary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Elastic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Fast-Twitch Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Intermediate Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Mineral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Myelinated Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Postganglionic Autonomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Postganglionic Parasympathetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Postganglionic Sympathetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Preganglionic Autonomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Red Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Reticular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Reticulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Slow-Twitch Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Stress' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, Sympathetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiber, White Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiberglass Cast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER%27%S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic %28%Vater%29% papillotomy %28%SPHINCTEROTOMY, ENDOSCOPIC%29% may be performed during this procedure.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers that arise from cell groups within the spinal cord and pass directly to the cerebellum. They include the anterior, posterior, and rostral spinocerebellar tracts, and the cuneocerebellar tract. %28%From Parent, Carpenter%27%s Human Neuroanatomy, 9th ed, p607%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers that arise from cells within the cerebral cortex, pass through the medullary pyramid, and descend in the spinal cord. Many authorities say the pyramidal tracts include both the corticospinal and corticobulbar tracts.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Adrenergic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Cholinergic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Cotton' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Dietary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Elastic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Fast-Twitch Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Intermediate Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Mineral' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Myelinated Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Postganglionic Autonomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Postganglionic Parasympathetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Postganglionic Sympathetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Preganglionic Autonomic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Purkinje' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Red Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Reticular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Reticulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Slow-Twitch Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Stress' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, Sympathetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibers, White Muscle' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibre, Stress' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibres, Stress' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril Associated Collagen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril Associated Collagens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril Associated Collagens With Interrupted Triple Helices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril Protein, Scrapie Associated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril, Reticular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril, Reticulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril-Associated Collagen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril-Associated Collagens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril-Associated Collagens With Interrupted Triple Helices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril-Protein, Scrapie Associated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibril-Protein, Scrapie-Associated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillar Collagen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillar Collagens' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillary Astrocytomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillary Chorea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillary Choreas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillation, Atrial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillation, Auricular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillation, Ventricular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillations, Atrial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillations, Auricular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrillations, Ventricular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrils, Amyloid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrils, Reticular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrils, Reticulin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrils, Scrapie Associated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrils, Scrapie-Associated' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Adhesive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Degradation Products' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Fibrinogen Degradation Products' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Fibrinogen Split Products' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Foam' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Glue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Modulating Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Modulators' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Sealant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Sealant System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Stabilizing Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin Tissue Adhesive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrin/metabolism %28%1970-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen %28%1966-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen %28%1966-1988%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen %28%1968-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen Adhesive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen Deficiencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen Deficiency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogen/metabolism %28%1970-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinogens, Abnormal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinoligase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolysin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolysin or agents that convert plasminogen to fibrinolysin %28%PLASMIN%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolysin/antagonists %26% inhibitors %28%1968-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolysis %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Agents' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Agents %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Agents %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Agents %28%1966-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Drugs' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Therapies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinolytic Therapy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinopeptide A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinopeptide B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinopeptides A' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrinopeptides B' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibro Odontoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibro odontoma, Ameloblastic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibro-Odontoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibro-Odontomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibro-odontomas, Ameloblastic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroadenoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroadenomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrobacter' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Collagenase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor %28%1984-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 10' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 6' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 7' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 8' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor 9' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor 1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor 5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptor-5' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptors 2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptors 2b' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptors 3' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor Receptors 4' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor, Acidic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor, Basic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor-1' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factor-2' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Factors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Growth Regulatory Factor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Interferon' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast Intermediate Filament Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblast-Derived Neutrophil-Activating Peptides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblasts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroblasts %28%1974-1983%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocartilage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocartilage Complex, Triangular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocartilage that makes up the triangular fibrocartilage complex which is found in the WRIST JOINT.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocartilage, Triangular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocartilages, Triangular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocystic Breast Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocystic Changes of Breast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocystic Disease of Breast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocystic Disease of Breast %28%1980-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocystic Disease of Pancreas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrocystic Mastopathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroelastoses, Endocardial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroelastosis, Endocardial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroepithelial Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroepithelial Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroid Tumor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroid Tumors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroid, Uterine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroids, Uterine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroins, Dragline Silk' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma %28%1966-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma %28%1967-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma %28%1969-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma %28%1981-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma Virus, Rabbit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma Virus, Shope' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma Viruses, Rabbit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma, Desmoplastic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma, Ossifying' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroma, Uterine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromas, Desmoplastic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromas, Ossifying' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromas, Uterine' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatoses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatoses, Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatoses, Aggressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatoses, Gingival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis Gingivae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis Virus of Rabbits' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis Virus, Rabbit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis Viruses, Rabbit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis, Abdominal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis, Aggressive' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromatosis, Gingival' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromuscular Dysplasia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromuscular Dysplasias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgia %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgia Fibromyositis Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgia-Fibromyositis Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgia-Fibromyositis Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgias, Primary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyalgias, Secondary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyositis Fibromyalgia Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyositis-Fibromyalgia Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyositis-Fibromyalgia Syndromes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyxoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibromyxomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibronectin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibronectin Receptor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibronectin Receptors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibronectins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroodontoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroodontomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroplasia, Retrolental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroplasias, Retrolental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosarcoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosarcoma %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosarcoma %28%1966-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosarcoma %28%1969-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosarcomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Bone Marrow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Endomyocardial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Liver' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Oral Submucous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Pulmonary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Radiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibroses, Retroperitoneal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosing Alveolitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosing Alveolitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Bone Marrow' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Cystic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Endomyocardial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Inflammatory Perianeurysmal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Oral Submucous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Perianeurysmal Inflammatory' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Pulmonary' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Radiation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrosis, Retroperitoneal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrositides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrositis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Cavernitides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Cavernitis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Dysplasia of Bone' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Dysplasia, Monostotic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Dysplasia, Polyostotic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Dysplasias, Monostotic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Dysplasias, Polyostotic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Histiocytoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Histiocytoma, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Histiocytoma, Malignant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Histiocytomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Histiocytomas, Benign' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Histiocytomas, Malignant' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Meningiomas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Tissue Neoplasm' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous Tissue Neoplasms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous bands or cords of CONNECTIVE TISSUE at the ends of MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous proteins secreted by INSECTS and SPIDERS. Generally, the term refers to silkworm fibroin secreted by the silk gland cells of SILKWORMS, Bombyx mori. Spider fibroins are called spidroins or dragline silk fibroins%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibrous, bony, cartilaginous and osteocartilaginous fragments in a synovial joint. Major causes are osteochondritis dissecans, synovial chondromatosis, osteophytes, fractured articular surfaces and damaged menisci.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibular Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibular Nerve Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibular Nerve Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibular Nerves' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibular Neuropathies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fibulas' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ficain' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ficin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ficoll' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiction %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiction %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fictional Works %28%PT%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fictional Works %5B%Publication Type%5D%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ficus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ficusin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Ficusin %28%1975-Feb 81%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fides Ecopharma Brand of Betahistine Hydrochloride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fides Ecopharma Brand of Glucosamine Sulfate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fides Ecopharma Brand of Podophyllotoxin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fides Ecopharma Brand of Sodium Nitroprusside' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fides Ecopharma Brand of Tranexamic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fido%27%s Free Itch' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fido%27%s FreeItch' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Dependence Independence' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Dependence-Independence' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Dependence-Independences' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Flow Fractionation' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field H Nucleus' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Hockeys' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Reports' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Worker' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field Workers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field and Track' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field of medicine concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations. It includes the interrelationships of host, agent, and environment as related to the distribution and control of disease.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field of psychology concerned with the normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field, Electromagnetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Field, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fields representing the joint interplay of electric and magnetic forces.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fields, Electromagnetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fields, Visual' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fieldworker' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fifteenth Century Histories' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fifteenth Century History' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fifth Cranial Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fifth Cranial Nerve Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fifth Cranial Nerves' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fifth Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Figural Aftereffect' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Figural Aftereffects' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Figure, Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Figures or symbols identifying or representing organizations or societies.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Figures, Human' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Figwort Betony' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fiji' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fijiviruses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filair' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filair Forte' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filament Proteins, Intermediate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filament, Actin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filament, Cytoplasmic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filament, Cytoskeletal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filament, Flower' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filament, Intermediate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filamentous Bacteriophage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filamentous Bacteriophages' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filamentous or elongated proteinaceous structures which extend from the cell surface in gram-negative bacteria that contain certain types of conjugative plasmid. These pili are the organs associated with genetic transfer and have essential roles in conjugation. Normally, only one or a few pili occur on a given donor cell. %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p675%29% This preferred use of %22%pili%22% refers to the sexual appendage, to be distinguished from bacterial fimbriae %28%FIMBRIAE, BACTERIAL%29%, also known as common pili, which are usually concerned with adhesion.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments %28%known also as filamentous or F-actin%29% can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaments which are composed primarily of actin and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaments, Actin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaments, Cytoplasmic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaments, Cytoskeletal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaments, Intermediate' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaria bancrofti' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaria ozzardi' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaria sanguinis hominis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarial Elephantiases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarial Elephantiasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20%25% are blind. The incidence of eye lesions has been reported to be as high as 30%25% in Central America and parts of Africa.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filariases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filariases, Lymphatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filariasis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filariasis %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filariasis %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filariasis, Lymphatic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaricides' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filaricides %28%1973-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarioidea' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarioidea %28%1966-1974%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarioidea %28%1966-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarioidea Infection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filarioidea Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filberts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'File, Data' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'File, Machine-Readable Data' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Files, Data' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Files, Machine-Readable Data' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filgrastim' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filimarisin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filipendula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filipin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filipin III' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filling, Dental Permanent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filling, Permanent Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filling, Temporary Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fillings, Dental Permanent' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fillings, Permanent Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fillings, Temporary Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film Badge Dosimetries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film Badge Dosimetry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film Badges' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film Dosimetries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film Dosimetry' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film Screen Systems, X Ray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film, Radiographic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film, X Ray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film, X-Ray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film, Xray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film-Screen System, X-Ray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Film-Screen Systems, X-Ray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Films of bacteria or other microbial organisms, usually embedded in extracellular polymers such as implanted medical devices, which adhere to surfaces submerged in, or subjected to, aquatic environments %28%From Singleton %26% Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed%29%. Biofilms consist of multilayers of microbial cells glued together to form microbial communities which are highly resistant to both phagocytes and antibiotics.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Films, Radiographic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Films, X-Ray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Films, Xray' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filoviridae' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filoviridae Infection' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filoviridae Infections' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filter, Inferior Vena Cava' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filter, Micropore' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filter, Umbrella' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filter, Vena Cava' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filterability, Erythrocyte' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtering Surgery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filters, Inferior Vena Cava' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filters, Micropore' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filters, Umbrella' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filters, Vena Cava' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration %28%1966-1971%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration %28%1966-1987%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration %28%1970-1972%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration Chromatography, Gel' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration Implant, Glaucoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration Implants, Glaucoma' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration Rate, Glomerular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration Rates, Glomerular' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration Surgery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration, Gel' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration, Leukocyte Reduction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtration/instrumentation %28%1972-1990%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtrations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Filtrations, Leukocyte Reduction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbria Fornix' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbria, Bacterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbria, Common' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbria-Fornices' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbriae Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbriae, Bacterial' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbriae, Bacterial %28%1980-1994%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbriae, Common' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbrias %28%Brain%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbriectomies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fimbriectomy, Kroener' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fin Whale' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fin Whales' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Activity' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Audit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Audits' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Contribution' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Disclosures' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Gift' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Gifts' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Insolvencies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Insolvency' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Management' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Management %28%1978-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Management %28%1978-1981%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Management %28%1978-1983%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Management %28%1978-1985%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Management, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Managements, Hospital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Risk Sharing' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Risk Sharings' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Support' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial Supports' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial assistance for the impoverished elderly through public funding of programs, services, and individual income supplements.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial assistance to impoverished persons for the essentials of living through federal, state or local government programs.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial resources provided for activities related to health planning and development.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial support for training including both student stipends and loans and training grants to institutions.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financial support of research activities. ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing of medical care provided to public assistance recipients.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Capital' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Community' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Construction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Government' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Government %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Government %28%1968-1979%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Organized' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Organized %28%1968-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Personal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financing, Public' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Financings, Construction' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finasteride' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finback Whale' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finback Whales' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finch' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finches' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finding, Incidental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finding, Neurologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Findings, Incidental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Findings, Neurologic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine Needle Aspiration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine Needle Biopsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine Needle Biopsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine Tremors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine-Needle Aspiration' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine-Needle Aspiration Biopsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine-Needle Aspiration Biopsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine-Needle Aspirations' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine-Needle Biopsies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fine-Needle Biopsy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finely divided solid matter with particle sizes smaller than a micrometeorite, thus with diameters much smaller than a millimeter, moving in interplanetary space. %28%NASA Thesaurus, 1994%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finely powdered native hydrous magnesium silicate. It is used as a dusting powder, either alone or with starch or boric acid, for medicinal and toilet preparations. It is also an excipient and filler for pills, tablets, and for dusting tablet molds. %28%From Merck Index, 11th ed%29%%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Agnosias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Bones' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Injuries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Injury' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Interphalangeal Joint' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Interphalangeal Joints' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Joint' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Joint %28%1966-1976%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Joints' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Phalanges' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Replacement Arthroplasties' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Replacement Arthroplasty' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger Sucking' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger, Clubbed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger, Zinc' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphia' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finger-Agnosia-Left-Right-Confusion-Acalculia-Agraphias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingernail' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprint' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprint, DNA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprint, Nucleotide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprint, Peptide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprint, Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprinting, DNA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprinting, Genetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprinting, Peptide' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprinting, Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprintings, DNA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprintings, Genetic' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprints, DNA' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingerprints, Protein' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers %28%1966-1984%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers %28%1966-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers %28%1967-2005%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers Bones' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers, Clubbed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers, Zinc' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers/abnormalities %28%1966%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingers/abnormalities %28%1966-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fingersucking' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finite Element Analyses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finite Element Analysis' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finland' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finless Porpoises' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish Bath' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish Markesbery Muscular Dystrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish Sauna' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish Type Familial Amyloid Neuropathy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish Type Sialuria' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish Type Sialurias' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Finnish-Markesbery Muscular Dystrophy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fir Tree' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fir, Balsam' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fir, Chinese' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire Extinguishing System' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire Extinguishing Systems' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire Retardants' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire, St. Anthonys' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire-Bellied Toad' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fire-Bellied Toads' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firearms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firebrush' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fireflies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firefly' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firefly Luciferases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firefly Luciferin' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fires' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fires %28%1966-1975%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fires %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fires %28%1966-Jul 1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firesetting Behavior' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firesetting Behaviors' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Firethorn' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fireweed' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Aid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Aid %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Aids' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Birth Interval' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Births' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Cranial Nerve' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Cranial Nerve Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Cranial Nerves' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Gap Phase' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Gap Phases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Horizon Brand of Mefenamic Acid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Intercourses' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Labor Stage' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Pass Radionuclide Angiography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Pass Ventriculography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Pregnancy Trimester' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Pregnancy Trimesters' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Stage Labor' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Trimester' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Trimester Pregnancies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Trimester Pregnancy' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First Trimesters' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First World War' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First World Wars' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First aid or other immediate intervention for accidents or medical conditions requiring immediate care and treatment before definitive medical and surgical management can be procured.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First-Pass Radionuclide Angiographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First-Pass Radionuclide Angiography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First-Pass Radionuclide Ventriculographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First-Pass Radionuclide Ventriculography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First-Pass Ventriculographies' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'First-Pass Ventriculography' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fischer Rats' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Antifreeze Proteins, Type IV' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Disease' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Diseases' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Diseases %28%1972-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Diseases %28%1997-2003%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Flour' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Flours' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Lice' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Oils' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Oils %28%1966-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Product' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Products' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Type I APF' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Type II AFP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Type III AFP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Type IV AFP' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Venom' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish Venoms' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. %28%Webster, 3d ed%29%.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish, Cichlid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish, Electric' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish, Mosquito' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish, Puffer' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish, Sparid' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fish-eating carnivores of the family MUSTELIDAE, found on both hemispheres.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fisher Syndrome' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fisheries' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fisheries %28%1966-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishery' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1965-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1965-1989%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1967%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1968%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1969%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1978%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1992%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1966-1995%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1967-1986%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1968-1981%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1968-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1969-2004%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1974-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1981-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%1983-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes %28%2001-2002%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes which generate an electric discharge. The voltage of the discharge varies from weak to strong in various groups of fish. The ELECTRIC ORGAN and electroplax are of prime interest in this group. They occur in more than one family.%A% ' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes, Poisonous' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes, Poisonous %28%1968-1977%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fishes, Poisonous %28%1993-2001%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fisons Brand of Nedocromil Sodium' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fission Yeast' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fission Yeast Proteins' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fission, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissions, Nuclear' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissure Sealants, Pit' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissure in Ano' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissure, Anal' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissure, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissured Tongue' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissured Tongues' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fissures, Dental' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fistula' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fistula %28%1966%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fistula %28%1966-1993%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fistula %28%1966-1997%29%' = 0).
% 42.08/42.06 fof(interp, fi_functors, 'Fistula, Arterio-Arterial' = 0).
%